id|nct_id|result_group_id|ctgov_group_code|period|reason|count
2196219|NCT01529749|3829144|FG000|Overall Study|Lost to Follow-up|0
2196220|NCT01529749|3829145|FG001|Overall Study|Lost to Follow-up|1
2196221|NCT01529749|3829146|FG002|Overall Study|Lost to Follow-up|1
2196222|NCT01529749|3829147|FG003|Overall Study|Lost to Follow-up|0
2196223|NCT01529749|3829144|FG000|Overall Study|Physician Decision|0
2196224|NCT01529749|3829145|FG001|Overall Study|Physician Decision|0
2196225|NCT01529749|3829146|FG002|Overall Study|Physician Decision|0
2196226|NCT01529749|3829147|FG003|Overall Study|Physician Decision|1
2196227|NCT01529749|3829144|FG000|Overall Study|Withdrawal by Subject|0
2196228|NCT01529749|3829145|FG001|Overall Study|Withdrawal by Subject|1
2196229|NCT01529749|3829146|FG002|Overall Study|Withdrawal by Subject|1
2196230|NCT01529749|3829147|FG003|Overall Study|Withdrawal by Subject|0
2196231|NCT01529749|3829144|FG000|Overall Study|Protocol Violation|0
2196232|NCT01529749|3829145|FG001|Overall Study|Protocol Violation|0
2196233|NCT01529749|3829146|FG002|Overall Study|Protocol Violation|0
2196234|NCT01529749|3829147|FG003|Overall Study|Protocol Violation|1
2196235|NCT01530256|3829192|FG000|Overall Study|Death|2
2196236|NCT01530334|3829196|FG000|Overall Study|Adverse Event|3
2196237|NCT01530334|3829196|FG000|Overall Study|unknown reason|1
2196238|NCT01530334|3829196|FG000|Overall Study|Progressive disease|47
2196239|NCT01530464|3829227|FG000|Washout (24h)|Withdrawal by Subject|1
2196240|NCT01530464|3829228|FG001|Washout (24h)|Withdrawal by Subject|0
2196241|NCT01530464|3829227|FG000|Washout (24h)|Withdrawal by Subject|0
2196242|NCT01530464|3829228|FG001|Washout (24h)|Withdrawal by Subject|1
2196243|NCT01531153|3829253|FG000|Overall Study|Withdrawal by Subject|10
2196244|NCT01531153|3829254|FG001|Overall Study|Withdrawal by Subject|9
2196245|NCT01531153|3829255|FG002|Overall Study|Withdrawal by Subject|15
2196246|NCT01531205|3829266|FG000|Overall Study|Did not proceed to surgery|1
2196247|NCT01531673|3829318|FG000|Overall Study|Non-Compliance|0
2196248|NCT01531673|3829319|FG001|Overall Study|Non-Compliance|0
2196249|NCT01531673|3829320|FG002|Overall Study|Non-Compliance|0
2196250|NCT01531673|3829321|FG003|Overall Study|Non-Compliance|0
2196251|NCT01531673|3829322|FG004|Overall Study|Non-Compliance|0
2196252|NCT01531673|3829323|FG005|Overall Study|Non-Compliance|1
2196253|NCT01531673|3829324|FG006|Overall Study|Non-Compliance|0
2196254|NCT01531673|3829325|FG007|Overall Study|Non-Compliance|0
2196255|NCT01531673|3829326|FG008|Overall Study|Non-Compliance|0
2196256|NCT01531673|3829327|FG009|Overall Study|Non-Compliance|0
2196257|NCT01531673|3829328|FG010|Overall Study|Non-Compliance|0
2196258|NCT01531673|3829329|FG011|Overall Study|Non-Compliance|0
2196259|NCT01531673|3829330|FG012|Overall Study|Non-Compliance|0
2196260|NCT01531673|3829318|FG000|Overall Study|Adverse Event|0
2196261|NCT01531673|3829319|FG001|Overall Study|Adverse Event|1
2196262|NCT01531673|3829320|FG002|Overall Study|Adverse Event|0
2274666|NCT02299388|3955853|FG000|Overall Study|Withdrawal by Subject|0
2274667|NCT02299388|3955854|FG001|Overall Study|Withdrawal by Subject|1
2274668|NCT02299427|3955862|FG000|Overall Study|Withdrawal by Subject|1
2274669|NCT02299427|3955863|FG001|Overall Study|Withdrawal by Subject|0
2274670|NCT02299427|3955862|FG000|Overall Study|Lost to Follow-up|1
2274671|NCT02299427|3955863|FG001|Overall Study|Lost to Follow-up|3
2274672|NCT02299427|3955862|FG000|Overall Study|not adherent to dog website use|21
2274673|NCT02299427|3955863|FG001|Overall Study|not adherent to dog website use|0
2274674|NCT02299635|3955891|FG000|Overall Study|Adverse Event|2
2274675|NCT02299635|3955891|FG000|Overall Study|Death|1
2274676|NCT02299635|3955891|FG000|Overall Study|Global deterioration of health status|1
2274677|NCT02299635|3955891|FG000|Overall Study|Objective progression or relapse|10
2274678|NCT02299635|3955891|FG000|Overall Study|Withdrawal by Subject|2
2274679|NCT02299635|3955891|FG000|Overall Study|Other|3
2274680|NCT02300103|3955949|FG000|Overall Study|Lack of Efficacy|3
2274681|NCT02300103|3955949|FG000|Overall Study|Protocol Violation|1
2274682|NCT02300103|3955949|FG000|Overall Study|Withdrew Consent|2
2274683|NCT02300129|3955953|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2274684|NCT02300129|3955954|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
2274685|NCT02300129|3955955|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2274686|NCT02300129|3955956|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2274687|NCT02300129|3955953|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2274688|NCT02300129|3955954|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2274689|NCT02300129|3955955|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2274690|NCT02300129|3955956|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
2274691|NCT02300129|3955953|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
2274692|NCT02300129|3955954|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2274693|NCT02300129|3955955|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2274694|NCT02300129|3955956|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2274695|NCT02300220|3955968|FG000|Overall Study|Lost to Follow-up|1
2274696|NCT02300220|3955969|FG001|Overall Study|Lost to Follow-up|2
2274697|NCT02300220|3955968|FG000|Overall Study|Death|1
2274698|NCT02300220|3955969|FG001|Overall Study|Death|1
2274699|NCT02300220|3955968|FG000|Overall Study|Adverse Event|1
2274700|NCT02300220|3955969|FG001|Overall Study|Adverse Event|1
2274701|NCT02300220|3955968|FG000|Overall Study|Protocol Violation|1
2274702|NCT02300220|3955969|FG001|Overall Study|Protocol Violation|0
2274703|NCT02300220|3955968|FG000|Overall Study|Withdrawal by Subject|0
2274704|NCT02300220|3955969|FG001|Overall Study|Withdrawal by Subject|2
2196263|NCT01531673|3829321|FG003|Overall Study|Adverse Event|0
2196264|NCT01531673|3829322|FG004|Overall Study|Adverse Event|0
2196265|NCT01531673|3829323|FG005|Overall Study|Adverse Event|0
2196266|NCT01531673|3829324|FG006|Overall Study|Adverse Event|0
2196267|NCT01531673|3829325|FG007|Overall Study|Adverse Event|0
2196268|NCT01531673|3829326|FG008|Overall Study|Adverse Event|0
2196269|NCT01531673|3829327|FG009|Overall Study|Adverse Event|0
2196270|NCT01531673|3829328|FG010|Overall Study|Adverse Event|0
2196271|NCT01531673|3829329|FG011|Overall Study|Adverse Event|0
2196272|NCT01531673|3829330|FG012|Overall Study|Adverse Event|0
2196273|NCT01531673|3829318|FG000|Overall Study|Lost to Follow-up|0
2196274|NCT01531673|3829319|FG001|Overall Study|Lost to Follow-up|0
2196275|NCT01531673|3829320|FG002|Overall Study|Lost to Follow-up|0
2196276|NCT01531673|3829321|FG003|Overall Study|Lost to Follow-up|0
2196277|NCT01531673|3829322|FG004|Overall Study|Lost to Follow-up|1
2196278|NCT01531673|3829323|FG005|Overall Study|Lost to Follow-up|0
2196279|NCT01531673|3829324|FG006|Overall Study|Lost to Follow-up|0
2196280|NCT01531673|3829325|FG007|Overall Study|Lost to Follow-up|0
2196281|NCT01531673|3829326|FG008|Overall Study|Lost to Follow-up|0
2196282|NCT01531673|3829327|FG009|Overall Study|Lost to Follow-up|0
2196283|NCT01531673|3829328|FG010|Overall Study|Lost to Follow-up|0
2196284|NCT01531673|3829329|FG011|Overall Study|Lost to Follow-up|0
2196285|NCT01531673|3829330|FG012|Overall Study|Lost to Follow-up|0
2196286|NCT01531673|3829318|FG000|Overall Study|Other|0
2196287|NCT01531673|3829319|FG001|Overall Study|Other|0
2196288|NCT01531673|3829320|FG002|Overall Study|Other|0
2196289|NCT01531673|3829321|FG003|Overall Study|Other|1
2196290|NCT01531673|3829322|FG004|Overall Study|Other|0
2196291|NCT01531673|3829323|FG005|Overall Study|Other|0
2196292|NCT01531673|3829324|FG006|Overall Study|Other|0
2196293|NCT01531673|3829325|FG007|Overall Study|Other|0
2196294|NCT01531673|3829326|FG008|Overall Study|Other|0
2196295|NCT01531673|3829327|FG009|Overall Study|Other|1
2196296|NCT01531673|3829328|FG010|Overall Study|Other|0
2196297|NCT01531673|3829329|FG011|Overall Study|Other|0
2196298|NCT01531673|3829330|FG012|Overall Study|Other|0
2196299|NCT01531725|3829382|FG000|Overall Study|Protocol Violation|5
2196300|NCT01531894|3829404|FG000|Overall Study|Physician Decision|8
2196301|NCT01531894|3829404|FG000|Overall Study|Death|1
2196302|NCT01531998|3829417|FG000|Overall Study|Withdrawal by Subject|3
2196303|NCT01532388|3829471|FG000|3-month Follow-up|Lost to Follow-up|68
2196304|NCT01532388|3829472|FG001|3-month Follow-up|Lost to Follow-up|68
2196305|NCT01532388|3829471|FG000|6-month Follow-up|Lost to Follow-up|74
2196306|NCT01532388|3829472|FG001|6-month Follow-up|Lost to Follow-up|66
2196307|NCT01532388|3829471|FG000|12-month Follow-up|Lost to Follow-up|69
2196308|NCT01532388|3829472|FG001|12-month Follow-up|Lost to Follow-up|67
2196309|NCT01532414|3829481|FG000|Overall Study|Lost to Follow-up|3
2196310|NCT01532414|3829482|FG001|Overall Study|Lost to Follow-up|0
2196311|NCT01532414|3829483|FG002|Overall Study|Lost to Follow-up|1
2196312|NCT01532414|3829481|FG000|Overall Study|Withdrawal by Subject|3
2196313|NCT01532414|3829482|FG001|Overall Study|Withdrawal by Subject|0
2196314|NCT01532414|3829483|FG002|Overall Study|Withdrawal by Subject|0
2196315|NCT01532414|3829481|FG000|Overall Study|No V6 semen sample|0
2196316|NCT01532414|3829482|FG001|Overall Study|No V6 semen sample|1
2196317|NCT01532414|3829483|FG002|Overall Study|No V6 semen sample|0
2196318|NCT01532414|3829481|FG000|Overall Study|Adverse Event|0
2196319|NCT01532414|3829482|FG001|Overall Study|Adverse Event|1
2196320|NCT01532414|3829483|FG002|Overall Study|Adverse Event|1
2196321|NCT01532414|3829481|FG000|Overall Study|Unable to complete 24 hour PK|0
2196322|NCT01532414|3829482|FG001|Overall Study|Unable to complete 24 hour PK|0
2196323|NCT01532414|3829483|FG002|Overall Study|Unable to complete 24 hour PK|1
2196324|NCT01532414|3829481|FG000|Overall Study|Withdrawn by sponsor|1
2196325|NCT01532414|3829482|FG001|Overall Study|Withdrawn by sponsor|0
2196326|NCT01532414|3829483|FG002|Overall Study|Withdrawn by sponsor|0
2196327|NCT01532570|3829504|FG000|Overall Study|Lack of Efficacy|1
2196328|NCT01532570|3829505|FG001|Overall Study|Lack of Efficacy|0
2196329|NCT01532570|3829506|FG002|Overall Study|Lack of Efficacy|0
2196330|NCT01532570|3829507|FG003|Overall Study|Lack of Efficacy|0
2196331|NCT01532570|3829504|FG000|Overall Study|Withdrawal by Subject|0
2196332|NCT01532570|3829505|FG001|Overall Study|Withdrawal by Subject|1
2196333|NCT01532570|3829506|FG002|Overall Study|Withdrawal by Subject|0
2196334|NCT01532570|3829507|FG003|Overall Study|Withdrawal by Subject|0
2196335|NCT01532648|3829526|FG000|Overall Study|Lost to Follow-up|3
2196336|NCT01532648|3829527|FG001|Overall Study|Lost to Follow-up|4
2274705|NCT02300220|3955968|FG000|Overall Study|Did not tolerate IMP|0
2196337|NCT01532648|3829526|FG000|Overall Study|Lack of Efficacy|4
2196338|NCT01532648|3829527|FG001|Overall Study|Lack of Efficacy|1
2196339|NCT01532648|3829526|FG000|Overall Study|Protocol Violation|1
2196340|NCT01532648|3829527|FG001|Overall Study|Protocol Violation|1
2196341|NCT01532648|3829526|FG000|Overall Study|Adverse Event|12
2196342|NCT01532648|3829527|FG001|Overall Study|Adverse Event|9
2196343|NCT01532648|3829526|FG000|Overall Study|Withdrawal by Subject|16
2196344|NCT01532648|3829527|FG001|Overall Study|Withdrawal by Subject|2
2196345|NCT01532687|3829535|FG000|Overall Study|Death|2
2196346|NCT01532687|3829536|FG001|Overall Study|Death|0
2196347|NCT01532687|3829535|FG000|Overall Study|Adverse Event|6
2196348|NCT01532687|3829536|FG001|Overall Study|Adverse Event|1
2196349|NCT01532687|3829535|FG000|Overall Study|Withdrawal by Subject|1
2196350|NCT01532687|3829536|FG001|Overall Study|Withdrawal by Subject|0
2196351|NCT01532687|3829535|FG000|Overall Study|Physician Decision|2
2196352|NCT01532687|3829536|FG001|Overall Study|Physician Decision|1
2196353|NCT01532687|3829535|FG000|Overall Study|Protocol-defined delay > 3 weeks|3
2196354|NCT01532687|3829536|FG001|Overall Study|Protocol-defined delay > 3 weeks|0
2196355|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0
2196356|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1
2196357|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
2196358|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
2196359|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
2196360|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
2196361|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
2196362|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
2196363|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
2196364|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
2196365|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
2196366|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
2196367|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0
2196368|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3
2196369|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
2196370|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
2196371|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
2196372|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
2196373|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
2196374|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
2196375|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
2196376|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
2196377|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
2196378|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
2196379|NCT01532869|3829558|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
2196380|NCT01532869|3829559|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
2196381|NCT01532869|3829558|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4
2196382|NCT01532869|3829559|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1
2196383|NCT01532869|3829558|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1
2196384|NCT01532869|3829559|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0
2196385|NCT01532869|3829558|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
2196386|NCT01532869|3829559|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
2196387|NCT01532869|3829558|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
2196388|NCT01532869|3829559|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
2196389|NCT01532908|3829572|FG000|Overall Study|Not Transplanted|1
2196390|NCT01532908|3829573|FG001|Overall Study|Not Transplanted|0
2196391|NCT01532921|3829579|FG000|Overall Study|Death|3
2196392|NCT01532921|3829579|FG000|Overall Study|Withdrawal by Subject|2
2196393|NCT01532921|3829579|FG000|Overall Study|Lost to Follow-up|3
2196394|NCT01532921|3829579|FG000|Overall Study|Physician Decision|7
2196395|NCT01532921|3829579|FG000|Overall Study|Device was explanted during procedure|1
2196396|NCT01532934|3829589|FG000|Overall Study|Lost to Follow-up|11
2196397|NCT01532934|3829590|FG001|Overall Study|Lost to Follow-up|11
2196398|NCT01532934|3829589|FG000|Overall Study|In controlled environment|3
2196399|NCT01532934|3829590|FG001|Overall Study|In controlled environment|2
2196400|NCT01532986|3829642|FG000|Overall Study|Death|9
2196401|NCT01532986|3829643|FG001|Overall Study|Death|9
2196402|NCT01532986|3829642|FG000|Overall Study|Withdrawal by Subject|7
2196403|NCT01532986|3829643|FG001|Overall Study|Withdrawal by Subject|10
2196404|NCT01532986|3829642|FG000|Overall Study|Physician Decision|7
2196405|NCT01532986|3829643|FG001|Overall Study|Physician Decision|5
2196406|NCT01532999|3829652|FG000|Overall Study|Lost to Follow-up|14
2196407|NCT01532999|3829653|FG001|Overall Study|Lost to Follow-up|8
2196408|NCT01532999|3829652|FG000|Overall Study|Physician Decision|1
2196409|NCT01532999|3829653|FG001|Overall Study|Physician Decision|2
2196410|NCT01532999|3829652|FG000|Overall Study|Withdrawal by Subject|5
2196411|NCT01532999|3829653|FG001|Overall Study|Withdrawal by Subject|0
2196412|NCT01532999|3829652|FG000|Overall Study|Relocated|2
2196413|NCT01532999|3829653|FG001|Overall Study|Relocated|0
2196414|NCT01532999|3829652|FG000|Overall Study|should not have been randomized|1
2196415|NCT01532999|3829653|FG001|Overall Study|should not have been randomized|0
2196416|NCT01532999|3829652|FG000|Overall Study|substantial noncompliance|2
2196417|NCT01532999|3829653|FG001|Overall Study|substantial noncompliance|0
2196418|NCT01532999|3829652|FG000|Overall Study|no show for week 9 assessments|6
2196419|NCT01532999|3829653|FG001|Overall Study|no show for week 9 assessments|4
2196420|NCT01532999|3829652|FG000|Overall Study|Adverse Event|0
2196421|NCT01532999|3829653|FG001|Overall Study|Adverse Event|1
2196422|NCT01532999|3829652|FG000|Overall Study|incarcerated|0
2196423|NCT01532999|3829653|FG001|Overall Study|incarcerated|1
2196424|NCT01532999|3829652|FG000|Overall Study|New job|0
2196425|NCT01532999|3829653|FG001|Overall Study|New job|2
2216861|NCT01703260|3859836|FG000|Overall Study|Withdrawal by Subject|0
2196426|NCT01533181|3829704|FG000|Overall Study|Disease progression pre-active treatment|0
2196427|NCT01533181|3829705|FG001|Overall Study|Disease progression pre-active treatment|1
2196428|NCT01533181|3829704|FG000|Overall Study|Patient withdrawal pre-active treatment|1
2196429|NCT01533181|3829705|FG001|Overall Study|Patient withdrawal pre-active treatment|0
2196430|NCT01533246|3829720|FG000|Overall Study|Adverse Event|1
2196431|NCT01533246|3829720|FG000|Overall Study|Withdrawal by Subject|1
2196432|NCT01533428|3829730|FG000|Overall Study|Adverse Event|0
2196433|NCT01533428|3829731|FG001|Overall Study|Adverse Event|1
2196434|NCT01533428|3829730|FG000|Overall Study|Lost to Follow-up|2
2196435|NCT01533428|3829731|FG001|Overall Study|Lost to Follow-up|1
2196436|NCT01533428|3829730|FG000|Overall Study|Withdrawal by Subject|7
2196437|NCT01533428|3829731|FG001|Overall Study|Withdrawal by Subject|6
2196438|NCT01533493|3829739|FG000|Overall Study|Adverse Event|2
2196439|NCT01533493|3829740|FG001|Overall Study|Adverse Event|1
2196440|NCT01533493|3829739|FG000|Overall Study|Withdrawal by Subject|1
2196441|NCT01533493|3829740|FG001|Overall Study|Withdrawal by Subject|2
2196442|NCT01533493|3829739|FG000|Overall Study|Lost to Follow-up|2
2196443|NCT01533493|3829740|FG001|Overall Study|Lost to Follow-up|0
2196444|NCT01533688|3829758|FG000|Overall Study|Withdrawal by Subject|5
2196445|NCT01533688|3829759|FG001|Overall Study|Withdrawal by Subject|4
2196446|NCT01533688|3829760|FG002|Overall Study|Withdrawal by Subject|3
2196447|NCT01533688|3829758|FG000|Overall Study|Medically unstable|1
2196448|NCT01533688|3829759|FG001|Overall Study|Medically unstable|3
2196449|NCT01533688|3829760|FG002|Overall Study|Medically unstable|3
2196450|NCT01533688|3829758|FG000|Overall Study|Had colonoscopy at outside hospital|2
2196451|NCT01533688|3829759|FG001|Overall Study|Had colonoscopy at outside hospital|3
2196452|NCT01533688|3829760|FG002|Overall Study|Had colonoscopy at outside hospital|2
2196453|NCT01533922|3829770|FG000|Overall Study|Adverse Event|5
2196454|NCT01533922|3829771|FG001|Overall Study|Adverse Event|8
2196455|NCT01533922|3829772|FG002|Overall Study|Adverse Event|6
2196456|NCT01533922|3829773|FG003|Overall Study|Adverse Event|3
2196457|NCT01533922|3829774|FG004|Overall Study|Adverse Event|4
2196458|NCT01533922|3829770|FG000|Overall Study|Lack of Efficacy|0
2196459|NCT01533922|3829771|FG001|Overall Study|Lack of Efficacy|0
2196460|NCT01533922|3829772|FG002|Overall Study|Lack of Efficacy|1
2196461|NCT01533922|3829773|FG003|Overall Study|Lack of Efficacy|0
2196462|NCT01533922|3829774|FG004|Overall Study|Lack of Efficacy|0
2196463|NCT01533922|3829770|FG000|Overall Study|Protocol Violation|0
2196464|NCT01533922|3829771|FG001|Overall Study|Protocol Violation|3
2196465|NCT01533922|3829772|FG002|Overall Study|Protocol Violation|0
2196466|NCT01533922|3829773|FG003|Overall Study|Protocol Violation|0
2196467|NCT01533922|3829774|FG004|Overall Study|Protocol Violation|1
2196468|NCT01533922|3829770|FG000|Overall Study|Withdrawal by Subject|3
2196469|NCT01533922|3829771|FG001|Overall Study|Withdrawal by Subject|1
2196470|NCT01533922|3829772|FG002|Overall Study|Withdrawal by Subject|2
2196471|NCT01533922|3829773|FG003|Overall Study|Withdrawal by Subject|2
2196472|NCT01533922|3829774|FG004|Overall Study|Withdrawal by Subject|1
2196473|NCT01533922|3829770|FG000|Overall Study|Other reason not defined above|2
2196474|NCT01533922|3829771|FG001|Overall Study|Other reason not defined above|0
2196475|NCT01533922|3829772|FG002|Overall Study|Other reason not defined above|1
2196476|NCT01533922|3829773|FG003|Overall Study|Other reason not defined above|0
2196477|NCT01533922|3829774|FG004|Overall Study|Other reason not defined above|0
2196478|NCT01533935|3829786|FG000|Overall Study|Adverse Event|5
2196479|NCT01533935|3829787|FG001|Overall Study|Adverse Event|7
2196480|NCT01533935|3829788|FG002|Overall Study|Adverse Event|1
2196481|NCT01533935|3829789|FG003|Overall Study|Adverse Event|5
2196482|NCT01533935|3829790|FG004|Overall Study|Adverse Event|3
2196483|NCT01533935|3829786|FG000|Overall Study|Protocol Violation|0
2196484|NCT01533935|3829787|FG001|Overall Study|Protocol Violation|2
2196485|NCT01533935|3829788|FG002|Overall Study|Protocol Violation|0
2196486|NCT01533935|3829789|FG003|Overall Study|Protocol Violation|0
2196487|NCT01533935|3829790|FG004|Overall Study|Protocol Violation|0
2196488|NCT01533935|3829786|FG000|Overall Study|Lost to Follow-up|0
2196489|NCT01533935|3829787|FG001|Overall Study|Lost to Follow-up|0
2196490|NCT01533935|3829788|FG002|Overall Study|Lost to Follow-up|1
2196491|NCT01533935|3829789|FG003|Overall Study|Lost to Follow-up|0
2196492|NCT01533935|3829790|FG004|Overall Study|Lost to Follow-up|0
2196493|NCT01533935|3829786|FG000|Overall Study|Withdrawal by Subject|0
2196494|NCT01533935|3829787|FG001|Overall Study|Withdrawal by Subject|4
2196495|NCT01533935|3829788|FG002|Overall Study|Withdrawal by Subject|5
2196496|NCT01533935|3829789|FG003|Overall Study|Withdrawal by Subject|2
2196497|NCT01533935|3829790|FG004|Overall Study|Withdrawal by Subject|4
2196498|NCT01533935|3829786|FG000|Overall Study|Other reason not defined above|1
2196499|NCT01533935|3829787|FG001|Overall Study|Other reason not defined above|0
2196500|NCT01533935|3829788|FG002|Overall Study|Other reason not defined above|1
2196501|NCT01533935|3829789|FG003|Overall Study|Other reason not defined above|0
2196502|NCT01533935|3829790|FG004|Overall Study|Other reason not defined above|1
2196503|NCT01534078|3829828|FG000|Overall Study|Death|1
2196504|NCT01534078|3829828|FG000|Overall Study|Withdrawal by Subject|1
2196505|NCT01534182|3829834|FG000|Overall Study|Administrative problems|1
2196506|NCT01534182|3829835|FG001|Overall Study|Administrative problems|0
2196507|NCT01534182|3829834|FG000|Overall Study|Withdrawal by Subject|4
2196508|NCT01534182|3829835|FG001|Overall Study|Withdrawal by Subject|7
2196509|NCT01534182|3829834|FG000|Overall Study|Adverse Event|7
2196510|NCT01534182|3829835|FG001|Overall Study|Adverse Event|3
2196511|NCT01534195|3829844|FG000|Overall Study|Withdrawal by Subject|1
2196512|NCT01534195|3829845|FG001|Overall Study|Withdrawal by Subject|1
2196513|NCT01534208|3829853|FG000|Overall Study|Lost to Follow-up|19
2196514|NCT01534208|3829854|FG001|Overall Study|Lost to Follow-up|14
2196515|NCT01534208|3829853|FG000|Overall Study|Withdrawal by Subject|6
2196516|NCT01534208|3829854|FG001|Overall Study|Withdrawal by Subject|20
2196517|NCT01534208|3829853|FG000|Overall Study|Adverse Event|15
2196518|NCT01534208|3829854|FG001|Overall Study|Adverse Event|8
2196519|NCT01534208|3829853|FG000|Overall Study|Physician Decision|2
2196520|NCT01534208|3829854|FG001|Overall Study|Physician Decision|0
2196521|NCT01534208|3829853|FG000|Overall Study|Lack of Efficacy|0
2196522|NCT01534208|3829854|FG001|Overall Study|Lack of Efficacy|3
2196523|NCT01534208|3829853|FG000|Overall Study|Protocol Violation|2
2196524|NCT01534208|3829854|FG001|Overall Study|Protocol Violation|2
2196525|NCT01534208|3829853|FG000|Overall Study|Sponsor decision|4
2196526|NCT01534208|3829854|FG001|Overall Study|Sponsor decision|1
2196527|NCT01534208|3829853|FG000|Overall Study|Subject relocation|2
2196528|NCT01534208|3829854|FG001|Overall Study|Subject relocation|0
2196529|NCT01534208|3829853|FG000|Overall Study|Lab assessment|2
2196530|NCT01534208|3829854|FG001|Overall Study|Lab assessment|1
2196531|NCT01534208|3829853|FG000|Overall Study|Eligibility error|3
2196532|NCT01534208|3829854|FG001|Overall Study|Eligibility error|0
2196533|NCT01534208|3829853|FG000|Overall Study|PCP decision|1
2196534|NCT01534208|3829854|FG001|Overall Study|PCP decision|0
2196535|NCT01534208|3829853|FG000|Overall Study|Needed prohibited meds|1
2196536|NCT01534208|3829854|FG001|Overall Study|Needed prohibited meds|0
2196537|NCT01534260|3829862|FG000|Overall Study|Adverse Event|1
2196538|NCT01534260|3829863|FG001|Overall Study|Adverse Event|8
2196539|NCT01534260|3829862|FG000|Overall Study|Death|2
2196540|NCT01534260|3829863|FG001|Overall Study|Death|0
2196541|NCT01534260|3829862|FG000|Overall Study|Lack of Efficacy|1
2196542|NCT01534260|3829863|FG001|Overall Study|Lack of Efficacy|1
2196543|NCT01534260|3829862|FG000|Overall Study|Withdrawal by Subject|1
2196544|NCT01534260|3829863|FG001|Overall Study|Withdrawal by Subject|3
2196545|NCT01534260|3829862|FG000|Overall Study|Disease Progression|8
2196546|NCT01534260|3829863|FG001|Overall Study|Disease Progression|6
2196547|NCT01534260|3829862|FG000|Overall Study|Physician Decision|3
2196548|NCT01534260|3829863|FG001|Overall Study|Physician Decision|1
2196549|NCT01534260|3829862|FG000|Overall Study|No treatment, per protocol|0
2196550|NCT01534260|3829863|FG001|Overall Study|No treatment, per protocol|1
2196551|NCT01534273|3829873|FG000|Period 1|Physician Decision|0
2196552|NCT01534273|3829874|FG001|Period 1|Physician Decision|0
2196553|NCT01534273|3829875|FG002|Period 1|Physician Decision|0
2196554|NCT01534273|3829876|FG003|Period 1|Physician Decision|1
2196555|NCT01534273|3829877|FG004|Period 1|Physician Decision|0
2196556|NCT01534273|3829878|FG005|Period 1|Physician Decision|0
2196557|NCT01534273|3829879|FG006|Period 1|Physician Decision|0
2196558|NCT01534351|3829903|FG000|Overall Study|Study Terminated Early|1
2196559|NCT01534351|3829904|FG001|Overall Study|Study Terminated Early|0
2196560|NCT01534351|3829905|FG002|Overall Study|Study Terminated Early|0
2196561|NCT01534520|3829934|FG000|Overall Study|Adverse Event|0
2196562|NCT01534520|3829935|FG001|Overall Study|Adverse Event|1
2196563|NCT01534533|3829949|FG000|Overall Study|Lost to Follow-up|3
2196564|NCT01534533|3829950|FG001|Overall Study|Lost to Follow-up|0
2196565|NCT01534533|3829951|FG002|Overall Study|Lost to Follow-up|4
2196566|NCT01534533|3829952|FG003|Overall Study|Lost to Follow-up|3
2196567|NCT01534533|3829949|FG000|Overall Study|Withdrawal by Subject|5
2196568|NCT01534533|3829950|FG001|Overall Study|Withdrawal by Subject|3
2196569|NCT01534533|3829951|FG002|Overall Study|Withdrawal by Subject|4
2196570|NCT01534533|3829952|FG003|Overall Study|Withdrawal by Subject|1
2196571|NCT01534637|3829964|FG000|Overall Study|Physician Decision|3
2196572|NCT01534637|3829964|FG000|Overall Study|Lack of Efficacy|3
2196573|NCT01534637|3829964|FG000|Overall Study|Withdrawal by Subject|1
2196574|NCT01534637|3829964|FG000|Overall Study|Adverse Event|1
2196575|NCT01534637|3829964|FG000|Overall Study|Liver Mets before treatment|1
2196576|NCT01534663|3829970|FG000|Overall Study|Lost to Follow-up|0
2196577|NCT01534663|3829971|FG001|Overall Study|Lost to Follow-up|2
2196578|NCT01534663|3829970|FG000|Overall Study|Adverse Event|2
2196579|NCT01534663|3829971|FG001|Overall Study|Adverse Event|1
2196580|NCT01534962|3830001|FG000|Overall Study|Randomized but did not start treatment|2
2196581|NCT01534962|3830002|FG001|Overall Study|Randomized but did not start treatment|0
2196582|NCT01534962|3830003|FG002|Overall Study|Randomized but did not start treatment|0
2196583|NCT01534962|3830004|FG003|Overall Study|Randomized but did not start treatment|1
2196584|NCT01534962|3830001|FG000|Overall Study|Discontinued at AF recurrence|35
2196585|NCT01534962|3830002|FG001|Overall Study|Discontinued at AF recurrence|26
2196586|NCT01534962|3830003|FG002|Overall Study|Discontinued at AF recurrence|24
2196587|NCT01534962|3830004|FG003|Overall Study|Discontinued at AF recurrence|31
2196588|NCT01535040|3830057|FG000|Overall Study|Physician Decision|0
2196589|NCT01535040|3830058|FG001|Overall Study|Physician Decision|1
2196590|NCT01535040|3830057|FG000|Overall Study|Withdrawal by Subject|13
2196591|NCT01535040|3830058|FG001|Overall Study|Withdrawal by Subject|10
2196592|NCT01535040|3830057|FG000|Overall Study|Never Started|9
2196593|NCT01535040|3830058|FG001|Overall Study|Never Started|4
2196594|NCT01535040|3830057|FG000|Overall Study|Toxicity|7
2196595|NCT01535040|3830058|FG001|Overall Study|Toxicity|5
2196596|NCT01535040|3830057|FG000|Overall Study|Multiple Reasons|1
2196597|NCT01535040|3830058|FG001|Overall Study|Multiple Reasons|1
2196598|NCT01535053|3830066|FG000|Overall Study|Ineligible|1
2196599|NCT01535053|3830067|FG001|Overall Study|Ineligible|2
2196600|NCT01535222|3830083|FG000|Overall Study|Inclusion/exclusion|0
2196601|NCT01535222|3830084|FG001|Overall Study|Inclusion/exclusion|0
2196602|NCT01535222|3830085|FG002|Overall Study|Inclusion/exclusion|1
2196603|NCT01535222|3830086|FG003|Overall Study|Inclusion/exclusion|0
2196604|NCT01535222|3830087|FG004|Overall Study|Inclusion/exclusion|0
2196605|NCT01535222|3830088|FG005|Overall Study|Inclusion/exclusion|0
2196606|NCT01535235|3830104|FG000|Overall Study|Adverse Event|1
2196607|NCT01535235|3830105|FG001|Overall Study|Adverse Event|0
2196608|NCT01535261|3830111|FG000|Overall Study|Physician Decision|8
2196609|NCT01535261|3830111|FG000|Overall Study|Protocol Violation|3
2196610|NCT01535261|3830111|FG000|Overall Study|Death|5
2196611|NCT01535261|3830111|FG000|Overall Study|Lost to Follow-up|8
2196612|NCT01535261|3830111|FG000|Overall Study|Withdrawal by Subject|14
2196613|NCT01535261|3830111|FG000|Overall Study|Adverse Event|12
2196614|NCT01535287|3830117|FG000|Overall Study|drug not prepared in time|5
2196615|NCT01535287|3830118|FG001|Overall Study|drug not prepared in time|6
2196616|NCT01535443|3830151|FG000|Overall Study|Physician Decision|3
2196617|NCT01535560|3830158|FG000|Overall Study|Adverse Event|12
2196618|NCT01535560|3830159|FG001|Overall Study|Adverse Event|7
2196619|NCT01535560|3830158|FG000|Overall Study|Lost to Follow-up|1
2196620|NCT01535560|3830159|FG001|Overall Study|Lost to Follow-up|3
2196621|NCT01535560|3830158|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3
2196622|NCT01535560|3830159|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1
2196623|NCT01535560|3830158|FG000|Overall Study|Treatment Failure|21
2196624|NCT01535560|3830159|FG001|Overall Study|Treatment Failure|83
2196625|NCT01535560|3830158|FG000|Overall Study|Other|0
2196626|NCT01535560|3830159|FG001|Overall Study|Other|1
2196627|NCT01535560|3830158|FG000|Overall Study|Randomized in Error|0
2196628|NCT01535560|3830159|FG001|Overall Study|Randomized in Error|1
2196629|NCT01535599|3830180|FG000|Overall Study|Adverse Event|6
2196630|NCT01535599|3830181|FG001|Overall Study|Adverse Event|15
2196631|NCT01535599|3830180|FG000|Overall Study|Lost to Follow-up|3
2196632|NCT01535599|3830181|FG001|Overall Study|Lost to Follow-up|4
2196633|NCT01535599|3830180|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4
2196634|NCT01535599|3830181|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3
2196635|NCT01535599|3830180|FG000|Overall Study|Treatment Failure|33
2196636|NCT01535599|3830181|FG001|Overall Study|Treatment Failure|66
2196637|NCT01535599|3830180|FG000|Overall Study|BL Culture + for Group A Strep|0
2196638|NCT01535599|3830181|FG001|Overall Study|BL Culture + for Group A Strep|1
2196639|NCT01535599|3830180|FG000|Overall Study|BL Culture + for Yeast//Fungi|0
2196640|NCT01535599|3830181|FG001|Overall Study|BL Culture + for Yeast//Fungi|1
2196641|NCT01535599|3830180|FG000|Overall Study|Randomized in Error|2
2196642|NCT01535599|3830181|FG001|Overall Study|Randomized in Error|4
2196643|NCT01535599|3830180|FG000|Overall Study|Did not use product|1
2196644|NCT01535599|3830181|FG001|Overall Study|Did not use product|0
2196645|NCT01535599|3830180|FG000|Overall Study|Other|1
2196646|NCT01535599|3830181|FG001|Overall Study|Other|0
2196647|NCT01535599|3830180|FG000|Overall Study|Stopped medication|0
2274706|NCT02300220|3955969|FG001|Overall Study|Did not tolerate IMP|1
2274707|NCT02300259|3955978|FG000|Period 1|Adverse Event|0
2274708|NCT02300259|3955979|FG001|Period 1|Adverse Event|0
2274709|NCT02300259|3955980|FG002|Period 1|Adverse Event|1
2274710|NCT02300259|3955978|FG000|Period 1|Withdrawal by Subject|0
2274711|NCT02300259|3955979|FG001|Period 1|Withdrawal by Subject|0
2274712|NCT02300259|3955980|FG002|Period 1|Withdrawal by Subject|1
2274713|NCT02300259|3955978|FG000|Period 2|Adverse Event|1
2274714|NCT02300259|3955979|FG001|Period 2|Adverse Event|0
2274715|NCT02300259|3955980|FG002|Period 2|Adverse Event|0
2274716|NCT02300259|3955978|FG000|Period 2|Withdrawal by Subject|0
2274717|NCT02300259|3955979|FG001|Period 2|Withdrawal by Subject|0
2274718|NCT02300259|3955980|FG002|Period 2|Withdrawal by Subject|1
2274719|NCT02300298|3956008|FG000|Disposition for Nintedanib|Progressive disease|10
2274720|NCT02300298|3956009|FG001|Disposition for Nintedanib|Progressive disease|0
2274721|NCT02300298|3956008|FG000|Disposition for Docetaxel|Progressive disease|0
2274722|NCT02300298|3956009|FG001|Disposition for Docetaxel|Progressive disease|6
2274723|NCT02300298|3956008|FG000|Disposition for Docetaxel|other adverse event|0
2274724|NCT02300298|3956009|FG001|Disposition for Docetaxel|other adverse event|4
2274725|NCT02300311|3956015|FG000|Overall Study|Other than the reason specified|1
2274726|NCT02300311|3956016|FG001|Overall Study|Other than the reason specified|0
2274727|NCT02300311|3956015|FG000|Overall Study|Refused to continue taking medication|18
2274728|NCT02300311|3956016|FG001|Overall Study|Refused to continue taking medication|0
2274729|NCT02300558|3956026|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
2274730|NCT02300558|3956026|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2
2274731|NCT02300558|3956026|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1
2274732|NCT02300558|3956026|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
2196648|NCT01535599|3830181|FG001|Overall Study|Stopped medication|1
2196649|NCT01535599|3830180|FG000|Overall Study|Noncompliance|0
2196650|NCT01535599|3830181|FG001|Overall Study|Noncompliance|1
2196651|NCT01535638|3830187|FG000|Treatment 1 (Single Dose)|Protocol Violation|0
2196652|NCT01535638|3830188|FG001|Treatment 1 (Single Dose)|Protocol Violation|0
2196653|NCT01535638|3830189|FG002|Treatment 1 (Single Dose)|Protocol Violation|0
2196654|NCT01535638|3830190|FG003|Treatment 1 (Single Dose)|Protocol Violation|0
2196655|NCT01535638|3830191|FG004|Treatment 1 (Single Dose)|Protocol Violation|0
2196656|NCT01535638|3830192|FG005|Treatment 1 (Single Dose)|Protocol Violation|1
2196657|NCT01535638|3830187|FG000|Treatment 3 (Single Dose)|Protocol Violation|0
2196658|NCT01535638|3830188|FG001|Treatment 3 (Single Dose)|Protocol Violation|0
2196659|NCT01535638|3830189|FG002|Treatment 3 (Single Dose)|Protocol Violation|0
2196660|NCT01535638|3830190|FG003|Treatment 3 (Single Dose)|Protocol Violation|1
2196661|NCT01535638|3830191|FG004|Treatment 3 (Single Dose)|Protocol Violation|0
2196662|NCT01535638|3830192|FG005|Treatment 3 (Single Dose)|Protocol Violation|0
2196663|NCT01535729|3830209|FG000|Overall Study|Withdrawal by Subject|2
2196664|NCT01535729|3830209|FG000|Overall Study|Disease progression|230
2196665|NCT01535729|3830209|FG000|Overall Study|Discontinued treatment|25
2196666|NCT01535729|3830209|FG000|Overall Study|Lost to Follow-up|8
2196667|NCT01535729|3830209|FG000|Overall Study|Death|52
2196668|NCT01535729|3830209|FG000|Overall Study|Other|19
2196669|NCT01535729|3830209|FG000|Overall Study|Did not sign informed consent|1
2196670|NCT01535729|3830209|FG000|Overall Study|No previous chemotherapy|33
2196671|NCT01535729|3830209|FG000|Overall Study|NSCLC grade IV histology not confirmed|20
2196672|NCT01535729|3830209|FG000|Overall Study|Protocol Violation|11
2196673|NCT01535729|3830209|FG000|Overall Study|Screening failure|1
2196674|NCT01535729|3830209|FG000|Overall Study|Not treated|9
2196675|NCT01535729|3830209|FG000|Overall Study|No participant record available|5
2196676|NCT01536067|3830257|FG000|Overall Study|Disease Progression|1
2196677|NCT01536093|3830263|FG000|Overall Study|Death|1
2196678|NCT01536093|3830264|FG001|Overall Study|Death|2
2196679|NCT01536093|3830263|FG000|Overall Study|absence of maternal colostrum|2
2196680|NCT01536093|3830264|FG001|Overall Study|absence of maternal colostrum|0
2196681|NCT01536093|3830263|FG000|Overall Study|Withdrawal by Subject|0
2196682|NCT01536093|3830264|FG001|Overall Study|Withdrawal by Subject|1
2216862|NCT01703260|3859837|FG001|Overall Study|Withdrawal by Subject|0
2216863|NCT01703260|3859838|FG002|Overall Study|Withdrawal by Subject|1
2216864|NCT01703260|3859836|FG000|Overall Study|Study Termination|1
2216865|NCT01703260|3859837|FG001|Overall Study|Study Termination|2
2216866|NCT01703260|3859838|FG002|Overall Study|Study Termination|0
2216867|NCT01703286|3859846|FG000|Period 1 Including Washout|Withdrawal by Subject|0
2216868|NCT01703286|3859847|FG001|Period 1 Including Washout|Withdrawal by Subject|0
2216869|NCT01703286|3859848|FG002|Period 1 Including Washout|Withdrawal by Subject|0
2216870|NCT01703286|3859849|FG003|Period 1 Including Washout|Withdrawal by Subject|1
2216871|NCT01703286|3859850|FG004|Period 1 Including Washout|Withdrawal by Subject|0
2216872|NCT01703286|3859851|FG005|Period 1 Including Washout|Withdrawal by Subject|1
2216873|NCT01703286|3859846|FG000|Period 2 Including Washout|Adverse Event|0
2216874|NCT01703286|3859847|FG001|Period 2 Including Washout|Adverse Event|0
2216875|NCT01703286|3859848|FG002|Period 2 Including Washout|Adverse Event|0
2216876|NCT01703286|3859849|FG003|Period 2 Including Washout|Adverse Event|1
2216877|NCT01703286|3859850|FG004|Period 2 Including Washout|Adverse Event|0
2216878|NCT01703286|3859851|FG005|Period 2 Including Washout|Adverse Event|0
2217623|NCT01709162|3860911|FG000|Overall Study|Administrative reason by sponsor|0
2217624|NCT01709162|3860912|FG001|Overall Study|Administrative reason by sponsor|1
2217625|NCT01709162|3860911|FG000|Overall Study|Other|1
2217626|NCT01709162|3860912|FG001|Overall Study|Other|0
2217627|NCT01709162|3860911|FG000|Overall Study|Withdrawal by Subject|0
2217628|NCT01709162|3860912|FG001|Overall Study|Withdrawal by Subject|1
2217629|NCT01709227|3860920|FG000|Overall Study|Physician Decision|1
2217630|NCT01709227|3860921|FG001|Overall Study|Physician Decision|0
2217631|NCT01709227|3860920|FG000|Overall Study|Pleural Peritoneal communication|0
2217632|NCT01709227|3860921|FG001|Overall Study|Pleural Peritoneal communication|9
2217633|NCT01709305|3860928|FG000|Phase 1|Clinical Adverse Event|80
2217634|NCT01709305|3860929|FG001|Phase 1|Clinical Adverse Event|0
2217635|NCT01709305|3860930|FG002|Phase 1|Clinical Adverse Event|0
2217636|NCT01709305|3860931|FG003|Phase 1|Clinical Adverse Event|0
2217637|NCT01709305|3860932|FG004|Phase 1|Clinical Adverse Event|0
2217638|NCT01709305|3860928|FG000|Phase 1|Death|2
2217639|NCT01709305|3860929|FG001|Phase 1|Death|0
2217640|NCT01709305|3860930|FG002|Phase 1|Death|0
2217641|NCT01709305|3860931|FG003|Phase 1|Death|0
2217642|NCT01709305|3860932|FG004|Phase 1|Death|0
2217643|NCT01709305|3860928|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13
2217644|NCT01709305|3860929|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0
2217645|NCT01709305|3860930|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0
2217646|NCT01709305|3860931|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0
2217647|NCT01709305|3860932|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0
2217648|NCT01709305|3860928|FG000|Phase 1|Laboratory Adverse Event|16
2217649|NCT01709305|3860929|FG001|Phase 1|Laboratory Adverse Event|0
2217650|NCT01709305|3860930|FG002|Phase 1|Laboratory Adverse Event|0
2217651|NCT01709305|3860931|FG003|Phase 1|Laboratory Adverse Event|0
2217652|NCT01709305|3860932|FG004|Phase 1|Laboratory Adverse Event|0
2217653|NCT01709305|3860928|FG000|Phase 1|Lost to Follow-up|147
2217654|NCT01709305|3860929|FG001|Phase 1|Lost to Follow-up|0
2217655|NCT01709305|3860930|FG002|Phase 1|Lost to Follow-up|0
2217656|NCT01709305|3860931|FG003|Phase 1|Lost to Follow-up|0
2217657|NCT01709305|3860932|FG004|Phase 1|Lost to Follow-up|0
2196683|NCT01536119|3830272|FG000|Overall Study|Lost to Follow-up|17
2196684|NCT01536119|3830273|FG001|Overall Study|Lost to Follow-up|14
2196685|NCT01536145|3830279|FG000|Overall Study|Progressive disease|3
2196686|NCT01536145|3830280|FG001|Overall Study|Progressive disease|4
2196687|NCT01536145|3830281|FG002|Overall Study|Progressive disease|1
2196688|NCT01536145|3830282|FG003|Overall Study|Progressive disease|2
2196689|NCT01536145|3830283|FG004|Overall Study|Progressive disease|1
2196690|NCT01536145|3830284|FG005|Overall Study|Progressive disease|2
2196691|NCT01536145|3830285|FG006|Overall Study|Progressive disease|1
2196692|NCT01536145|3830286|FG007|Overall Study|Progressive disease|2
2196693|NCT01536145|3830287|FG008|Overall Study|Progressive disease|1
2196694|NCT01536145|3830288|FG009|Overall Study|Progressive disease|3
2196695|NCT01536145|3830289|FG010|Overall Study|Progressive disease|3
2196696|NCT01536145|3830279|FG000|Overall Study|Withdrawal by Subject|0
2196697|NCT01536145|3830280|FG001|Overall Study|Withdrawal by Subject|0
2196698|NCT01536145|3830281|FG002|Overall Study|Withdrawal by Subject|1
2196699|NCT01536145|3830282|FG003|Overall Study|Withdrawal by Subject|0
2196700|NCT01536145|3830283|FG004|Overall Study|Withdrawal by Subject|0
2196701|NCT01536145|3830284|FG005|Overall Study|Withdrawal by Subject|1
2196702|NCT01536145|3830285|FG006|Overall Study|Withdrawal by Subject|0
2196703|NCT01536145|3830286|FG007|Overall Study|Withdrawal by Subject|0
2196704|NCT01536145|3830287|FG008|Overall Study|Withdrawal by Subject|2
2196705|NCT01536145|3830288|FG009|Overall Study|Withdrawal by Subject|0
2196706|NCT01536145|3830289|FG010|Overall Study|Withdrawal by Subject|2
2196707|NCT01536145|3830279|FG000|Overall Study|Other|0
2196708|NCT01536145|3830280|FG001|Overall Study|Other|0
2196709|NCT01536145|3830281|FG002|Overall Study|Other|0
2196710|NCT01536145|3830282|FG003|Overall Study|Other|0
2196711|NCT01536145|3830283|FG004|Overall Study|Other|1
2196712|NCT01536145|3830284|FG005|Overall Study|Other|0
2196713|NCT01536145|3830285|FG006|Overall Study|Other|0
2196714|NCT01536145|3830286|FG007|Overall Study|Other|0
2196715|NCT01536145|3830287|FG008|Overall Study|Other|0
2196716|NCT01536145|3830288|FG009|Overall Study|Other|3
2196717|NCT01536145|3830289|FG010|Overall Study|Other|2
2196718|NCT01536145|3830279|FG000|Overall Study|Death|0
2196719|NCT01536145|3830280|FG001|Overall Study|Death|0
2196720|NCT01536145|3830281|FG002|Overall Study|Death|0
2196721|NCT01536145|3830282|FG003|Overall Study|Death|0
2196722|NCT01536145|3830283|FG004|Overall Study|Death|0
2196723|NCT01536145|3830284|FG005|Overall Study|Death|0
2196724|NCT01536145|3830285|FG006|Overall Study|Death|1
2196725|NCT01536145|3830286|FG007|Overall Study|Death|0
2196726|NCT01536145|3830287|FG008|Overall Study|Death|0
2196727|NCT01536145|3830288|FG009|Overall Study|Death|0
2196728|NCT01536145|3830289|FG010|Overall Study|Death|0
2196729|NCT01536145|3830279|FG000|Overall Study|Adverse Event|0
2196730|NCT01536145|3830280|FG001|Overall Study|Adverse Event|0
2196731|NCT01536145|3830281|FG002|Overall Study|Adverse Event|0
2196732|NCT01536145|3830282|FG003|Overall Study|Adverse Event|0
2196733|NCT01536145|3830283|FG004|Overall Study|Adverse Event|0
2196734|NCT01536145|3830284|FG005|Overall Study|Adverse Event|0
2196735|NCT01536145|3830285|FG006|Overall Study|Adverse Event|0
2196736|NCT01536145|3830286|FG007|Overall Study|Adverse Event|2
2196737|NCT01536145|3830287|FG008|Overall Study|Adverse Event|0
2196738|NCT01536145|3830288|FG009|Overall Study|Adverse Event|0
2196739|NCT01536145|3830289|FG010|Overall Study|Adverse Event|3
2196740|NCT01536171|3830320|FG000|Overall Study|Withdrawal by Subject|1
2196741|NCT01536262|3830346|FG000|Overall Study|Adverse Event|6
2196742|NCT01536262|3830347|FG001|Overall Study|Adverse Event|1
2196743|NCT01536262|3830348|FG002|Overall Study|Adverse Event|2
2196744|NCT01536262|3830346|FG000|Overall Study|Withdrawal by Subject|1
2196745|NCT01536262|3830347|FG001|Overall Study|Withdrawal by Subject|1
2196746|NCT01536262|3830348|FG002|Overall Study|Withdrawal by Subject|0
2196747|NCT01536262|3830346|FG000|Overall Study|Other than stated above|1
2196748|NCT01536262|3830347|FG001|Overall Study|Other than stated above|0
2196749|NCT01536262|3830348|FG002|Overall Study|Other than stated above|0
2196750|NCT01536379|3830368|FG000|Overall Study|Adverse Event|1
2196751|NCT01536379|3830369|FG001|Overall Study|Adverse Event|2
2196752|NCT01536379|3830368|FG000|Overall Study|Withdrawal by Subject|1
2196753|NCT01536379|3830369|FG001|Overall Study|Withdrawal by Subject|1
2196754|NCT01536392|3830377|FG000|Overall Study|Adverse Event|2
2196755|NCT01536392|3830378|FG001|Overall Study|Adverse Event|2
2196756|NCT01536392|3830377|FG000|Overall Study|Physician Decision|2
2196757|NCT01536392|3830378|FG001|Overall Study|Physician Decision|3
2196758|NCT01536392|3830377|FG000|Overall Study|Withdrawal by Subject|3
2196759|NCT01536392|3830378|FG001|Overall Study|Withdrawal by Subject|6
2196760|NCT01536392|3830377|FG000|Overall Study|Non Compliance|3
2196761|NCT01536392|3830378|FG001|Overall Study|Non Compliance|4
2196762|NCT01536392|3830377|FG000|Overall Study|Completed therapy early|3
2196763|NCT01536392|3830378|FG001|Overall Study|Completed therapy early|0
2196764|NCT01536405|3830386|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
2196765|NCT01536405|3830387|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
2196766|NCT01536405|3830386|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
2196767|NCT01536405|3830387|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
2196768|NCT01536405|3830386|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
2216879|NCT01703741|3859896|FG000|Overall Study|Withdrawal by Subject|6
2196769|NCT01536405|3830387|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
2196770|NCT01536405|3830386|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
2196771|NCT01536405|3830387|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
2196772|NCT01536405|3830386|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
2196773|NCT01536405|3830387|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
2196774|NCT01536405|3830386|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
2196775|NCT01536405|3830387|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
2196776|NCT01536405|3830386|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
2196777|NCT01536405|3830387|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
2196778|NCT01536405|3830386|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
2196779|NCT01536405|3830387|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
2196780|NCT01536405|3830386|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
2196781|NCT01536405|3830387|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
2196782|NCT01536405|3830386|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
2196783|NCT01536405|3830387|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
2196784|NCT01536405|3830386|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
2196785|NCT01536405|3830387|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
2196786|NCT01536405|3830386|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0
2196787|NCT01536405|3830387|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1
2196788|NCT01536405|3830386|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
2196789|NCT01536405|3830387|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
2196790|NCT01536418|3830395|FG000|Overall Study|Protocol Violation|2
2196791|NCT01536418|3830396|FG001|Overall Study|Protocol Violation|3
2196792|NCT01536418|3830395|FG000|Overall Study|Physician Decision|1
2196793|NCT01536418|3830396|FG001|Overall Study|Physician Decision|3
2196794|NCT01536418|3830395|FG000|Overall Study|Study closed/terminated|41
2196795|NCT01536418|3830396|FG001|Overall Study|Study closed/terminated|37
2196796|NCT01536418|3830395|FG000|Overall Study|Lack of Efficacy|10
2196797|NCT01536418|3830396|FG001|Overall Study|Lack of Efficacy|16
2196798|NCT01536418|3830395|FG000|Overall Study|Adverse Event|9
2196799|NCT01536418|3830396|FG001|Overall Study|Adverse Event|4
2196800|NCT01536418|3830395|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1
2196801|NCT01536418|3830396|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0
2196802|NCT01536418|3830395|FG000|Overall Study|Withdrawal by Subject|5
2196803|NCT01536418|3830396|FG001|Overall Study|Withdrawal by Subject|3
2196804|NCT01536535|3830416|FG000|Overall Study|Withdrawal by Subject|10
2196805|NCT01536535|3830417|FG001|Overall Study|Withdrawal by Subject|5
2196806|NCT01536535|3830416|FG000|Overall Study|Lost to Follow-up|4
2196807|NCT01536535|3830417|FG001|Overall Study|Lost to Follow-up|6
2196808|NCT01536535|3830416|FG000|Overall Study|Physician Decision|1
2196809|NCT01536535|3830417|FG001|Overall Study|Physician Decision|1
2196810|NCT01536535|3830416|FG000|Overall Study|Participant moved|0
2196811|NCT01536535|3830417|FG001|Overall Study|Participant moved|1
2196812|NCT01536561|3830424|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40
2196813|NCT01536561|3830424|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
2196814|NCT01536561|3830424|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
2196815|NCT01536561|3830424|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
2196816|NCT01536561|3830424|FG000|Dosimetric and Therapeutic Treatment|Death|2
2196817|NCT01536561|3830424|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
2196818|NCT01536574|3830433|FG000|Overall Study|Adverse Event|4
2196819|NCT01536574|3830434|FG001|Overall Study|Adverse Event|5
2196820|NCT01536574|3830433|FG000|Overall Study|Withdrawal by Subject|1
2196821|NCT01536574|3830434|FG001|Overall Study|Withdrawal by Subject|2
2196822|NCT01536574|3830433|FG000|Overall Study|Lack of Efficacy|1
2196823|NCT01536574|3830434|FG001|Overall Study|Lack of Efficacy|0
2274733|NCT02300610|3956037|FG000|Overall Study|Withdrawal by Subject|1
2274734|NCT02300610|3956038|FG001|Overall Study|Withdrawal by Subject|0
2274735|NCT02300610|3956039|FG002|Overall Study|Withdrawal by Subject|1
2274736|NCT02300987|3956076|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1
2274737|NCT02300987|3956077|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0
2274738|NCT02300987|3956076|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2
2274739|NCT02300987|3956077|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0
2274740|NCT02300987|3956076|FG000|Primary Phase : Prior to Cross-over|progressive disease|3
2274741|NCT02300987|3956077|FG001|Primary Phase : Prior to Cross-over|progressive disease|2
2274742|NCT02300987|3956076|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1
2274743|NCT02300987|3956077|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0
2274744|NCT02300987|3956076|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0
2274745|NCT02300987|3956077|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1
2274746|NCT02301143|3956097|FG000|Induction Period|Enrolled But Not Treated|1
2274747|NCT02301143|3956098|FG001|Induction Period|Enrolled But Not Treated|0
2274748|NCT02301143|3956097|FG000|Induction Period|Death|1
2274749|NCT02301143|3956098|FG001|Induction Period|Death|0
2274750|NCT02301143|3956097|FG000|Induction Period|Adverse Event|22
2274751|NCT02301143|3956098|FG001|Induction Period|Adverse Event|0
2274752|NCT02301143|3956097|FG000|Induction Period|Progressive Disease|8
2274753|NCT02301143|3956098|FG001|Induction Period|Progressive Disease|0
2274754|NCT02301143|3956097|FG000|Induction Period|Withdrawal by Subject|3
2196824|NCT01536587|3830440|FG000|Overall Study|Adverse Event|2
2196825|NCT01536704|3830444|FG000|Washout Period 1|Withdrawal by Subject|1
2196826|NCT01536704|3830445|FG001|Washout Period 1|Withdrawal by Subject|2
2196827|NCT01536704|3830446|FG002|Washout Period 1|Withdrawal by Subject|0
2196828|NCT01536704|3830447|FG003|Washout Period 1|Withdrawal by Subject|0
2196829|NCT01536704|3830444|FG000|Washout Period 2|Adverse Event|1
2196830|NCT01536704|3830445|FG001|Washout Period 2|Adverse Event|0
2196831|NCT01536704|3830446|FG002|Washout Period 2|Adverse Event|0
2196832|NCT01536704|3830447|FG003|Washout Period 2|Adverse Event|0
2196833|NCT01536704|3830444|FG000|Washout Period 2|Withdrawal by Subject|0
2196834|NCT01536704|3830445|FG001|Washout Period 2|Withdrawal by Subject|0
2196835|NCT01536704|3830446|FG002|Washout Period 2|Withdrawal by Subject|0
2196836|NCT01536704|3830447|FG003|Washout Period 2|Withdrawal by Subject|1
2196837|NCT01536704|3830444|FG000|Period 3|Adverse Event|0
2196838|NCT01536704|3830445|FG001|Period 3|Adverse Event|0
2196839|NCT01536704|3830446|FG002|Period 3|Adverse Event|0
2196840|NCT01536704|3830447|FG003|Period 3|Adverse Event|1
2196841|NCT01536704|3830444|FG000|Washout Period 3|Adverse Event|0
2196842|NCT01536704|3830445|FG001|Washout Period 3|Adverse Event|0
2196843|NCT01536704|3830446|FG002|Washout Period 3|Adverse Event|1
2196844|NCT01536704|3830447|FG003|Washout Period 3|Adverse Event|0
2196845|NCT01536795|3830463|FG000|Overall Study|Lost to Follow-up|0
2196846|NCT01536795|3830464|FG001|Overall Study|Lost to Follow-up|2
2196847|NCT01536795|3830463|FG000|Overall Study|Lack of Efficacy|1
2196848|NCT01536795|3830464|FG001|Overall Study|Lack of Efficacy|0
2196849|NCT01536860|3830470|FG000|Washout Period (3 Days)|Lost to Follow-up|1
2196850|NCT01536860|3830471|FG001|Washout Period (3 Days)|Lost to Follow-up|0
2196851|NCT01536860|3830472|FG002|Washout Period (3 Days)|Lost to Follow-up|0
2196852|NCT01536951|3830512|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0
2196853|NCT01536951|3830513|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0
2196854|NCT01536951|3830514|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1
2196855|NCT01536951|3830515|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0
2196856|NCT01536951|3830516|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0
2196857|NCT01536951|3830517|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0
2196858|NCT01536951|3830518|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0
2196859|NCT01536951|3830519|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0
2196860|NCT01536951|3830520|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0
2196861|NCT01536951|3830512|FG000|Second Intervention and Washout Period 2|Adverse Event|0
2196862|NCT01536951|3830513|FG001|Second Intervention and Washout Period 2|Adverse Event|0
2196863|NCT01536951|3830514|FG002|Second Intervention and Washout Period 2|Adverse Event|0
2196864|NCT01536951|3830515|FG003|Second Intervention and Washout Period 2|Adverse Event|0
2196865|NCT01536951|3830516|FG004|Second Intervention and Washout Period 2|Adverse Event|0
2196866|NCT01536951|3830517|FG005|Second Intervention and Washout Period 2|Adverse Event|0
2196867|NCT01536951|3830518|FG006|Second Intervention and Washout Period 2|Adverse Event|0
2196868|NCT01536951|3830519|FG007|Second Intervention and Washout Period 2|Adverse Event|1
2196869|NCT01536951|3830520|FG008|Second Intervention and Washout Period 2|Adverse Event|0
2196870|NCT01537042|3830549|FG000|Overall Study|Adverse Event|0
2196871|NCT01537042|3830550|FG001|Overall Study|Adverse Event|2
2196872|NCT01537042|3830549|FG000|Overall Study|Lack of Efficacy|0
2196873|NCT01537042|3830550|FG001|Overall Study|Lack of Efficacy|1
2196874|NCT01537042|3830549|FG000|Overall Study|Protocol Violation|0
2196875|NCT01537042|3830550|FG001|Overall Study|Protocol Violation|1
2196876|NCT01537042|3830549|FG000|Overall Study|Other|0
2196877|NCT01537042|3830550|FG001|Overall Study|Other|1
2196878|NCT01537068|3830562|FG000|Overall Study|Lost to Follow-up|2
2196879|NCT01537068|3830563|FG001|Overall Study|Lost to Follow-up|1
2196880|NCT01537068|3830562|FG000|Overall Study|Adverse Event|0
2196881|NCT01537068|3830563|FG001|Overall Study|Adverse Event|1
2196882|NCT01537068|3830562|FG000|Overall Study|Withdrawal by Subject|1
2196883|NCT01537068|3830563|FG001|Overall Study|Withdrawal by Subject|1
2196884|NCT01537068|3830562|FG000|Overall Study|Lack of Efficacy|1
2196885|NCT01537068|3830563|FG001|Overall Study|Lack of Efficacy|0
2196886|NCT01537081|3830572|FG000|Overall Study|Adverse Event|5
2196887|NCT01537081|3830573|FG001|Overall Study|Adverse Event|2
2196888|NCT01537081|3830574|FG002|Overall Study|Adverse Event|2
2196889|NCT01537081|3830572|FG000|Overall Study|Lack of Efficacy|2
2196890|NCT01537081|3830573|FG001|Overall Study|Lack of Efficacy|1
2196891|NCT01537081|3830574|FG002|Overall Study|Lack of Efficacy|0
2196892|NCT01537081|3830572|FG000|Overall Study|Lost to Follow-up|17
2196893|NCT01537081|3830573|FG001|Overall Study|Lost to Follow-up|15
2196894|NCT01537081|3830574|FG002|Overall Study|Lost to Follow-up|9
2196895|NCT01537081|3830572|FG000|Overall Study|Protocol Violation|3
2196896|NCT01537081|3830573|FG001|Overall Study|Protocol Violation|2
2196897|NCT01537081|3830574|FG002|Overall Study|Protocol Violation|2
2196898|NCT01537081|3830572|FG000|Overall Study|Withdrawal by Subject|6
2196899|NCT01537081|3830573|FG001|Overall Study|Withdrawal by Subject|11
2196900|NCT01537081|3830574|FG002|Overall Study|Withdrawal by Subject|3
2196901|NCT01537081|3830572|FG000|Overall Study|Physician Decision|5
2196902|NCT01537081|3830573|FG001|Overall Study|Physician Decision|6
2196903|NCT01537081|3830574|FG002|Overall Study|Physician Decision|0
2196904|NCT01537081|3830572|FG000|Overall Study|Sponsor decision|0
2196905|NCT01537081|3830573|FG001|Overall Study|Sponsor decision|1
2196906|NCT01537081|3830574|FG002|Overall Study|Sponsor decision|0
2196907|NCT01537081|3830572|FG000|Overall Study|Assigned but never dosed|1
2196908|NCT01537081|3830573|FG001|Overall Study|Assigned but never dosed|0
2196909|NCT01537081|3830574|FG002|Overall Study|Assigned but never dosed|0
2196910|NCT01537120|3830583|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1
2196911|NCT01537120|3830583|FG000|3 Weeks Placebo|Withdrawal by Subject|1
2196912|NCT01537133|3830593|FG000|Overall Study|Withdrawal by Subject|2
2196913|NCT01537133|3830594|FG001|Overall Study|Withdrawal by Subject|0
2196914|NCT01537133|3830595|FG002|Overall Study|Withdrawal by Subject|0
2196915|NCT01537133|3830596|FG003|Overall Study|Withdrawal by Subject|0
2196916|NCT01537133|3830593|FG000|Overall Study|Lost to Follow-up|1
2196917|NCT01537133|3830594|FG001|Overall Study|Lost to Follow-up|0
2196918|NCT01537133|3830595|FG002|Overall Study|Lost to Follow-up|0
2196919|NCT01537133|3830596|FG003|Overall Study|Lost to Follow-up|0
2196920|NCT01537198|3830623|FG000|Overall Study|RSV infection|2
2196921|NCT01537198|3830623|FG000|Overall Study|Adverse Event|4
2196922|NCT01537198|3830623|FG000|Overall Study|No Further Visits to the Clinic|37
2196923|NCT01537198|3830623|FG000|Overall Study|Other|111
2196924|NCT01537211|3830629|FG000|Overall Study|Lost to Follow-up|0
2196925|NCT01537211|3830630|FG001|Overall Study|Lost to Follow-up|1
2196926|NCT01537393|3830668|FG000|Overall Study|Exclude prior to study|32
2196927|NCT01537393|3830669|FG001|Overall Study|Exclude prior to study|44
2196928|NCT01537393|3830668|FG000|Overall Study|Death|20
2196929|NCT01537393|3830669|FG001|Overall Study|Death|32
2196930|NCT01537393|3830668|FG000|Overall Study|Withdrawal by Subject|18
2196931|NCT01537393|3830669|FG001|Overall Study|Withdrawal by Subject|17
2196932|NCT01537393|3830668|FG000|Overall Study|Lost to Follow-up|53
2196933|NCT01537393|3830669|FG001|Overall Study|Lost to Follow-up|48
2196934|NCT01537393|3830668|FG000|Overall Study|Failure - Regrafted|28
2196935|NCT01537393|3830669|FG001|Overall Study|Failure - Regrafted|43
2196936|NCT01537393|3830668|FG000|Overall Study|Failure - Not regrafted|2
2196937|NCT01537393|3830669|FG001|Overall Study|Failure - Not regrafted|6
2196938|NCT01537393|3830668|FG000|Overall Study|Censored (severe event unrelated to PT)|1
2196939|NCT01537393|3830669|FG001|Overall Study|Censored (severe event unrelated to PT)|1
2196940|NCT01537432|3830686|FG000|Overall Study|Lost to Follow-up|3
2196941|NCT01537432|3830687|FG001|Overall Study|Lost to Follow-up|1
2196942|NCT01537432|3830686|FG000|Overall Study|Withdrawal by Subject|0
2196943|NCT01537432|3830687|FG001|Overall Study|Withdrawal by Subject|1
2196944|NCT01537432|3830686|FG000|Overall Study|Administrative problems|1
2196945|NCT01537432|3830687|FG001|Overall Study|Administrative problems|0
2196946|NCT01537432|3830686|FG000|Overall Study|Adverse Event|1
2196947|NCT01537432|3830687|FG001|Overall Study|Adverse Event|0
2196948|NCT01537432|3830686|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2196949|NCT01537432|3830687|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2196950|NCT01537549|3830693|FG000|Overall Study|Lost to Follow-up|1
2196951|NCT01537549|3830693|FG000|Overall Study|Withdrawal by Subject|2
2196952|NCT01537783|3830728|FG000|Overall Study|Lost to Follow-up|11
2196953|NCT01537783|3830729|FG001|Overall Study|Lost to Follow-up|2
2196954|NCT01537887|3830748|FG000|Period 1|Physician Decision|0
2196955|NCT01537887|3830749|FG001|Period 1|Physician Decision|0
2196956|NCT01537887|3830750|FG002|Period 1|Physician Decision|0
2196957|NCT01537887|3830751|FG003|Period 1|Physician Decision|0
2196958|NCT01537887|3830752|FG004|Period 1|Physician Decision|1
2196959|NCT01537887|3830753|FG005|Period 1|Physician Decision|1
2196960|NCT01537887|3830748|FG000|Period 1|Did not receive treatment|0
2196961|NCT01537887|3830749|FG001|Period 1|Did not receive treatment|0
2196962|NCT01537887|3830750|FG002|Period 1|Did not receive treatment|1
2196963|NCT01537887|3830751|FG003|Period 1|Did not receive treatment|0
2196964|NCT01537887|3830752|FG004|Period 1|Did not receive treatment|0
2196965|NCT01537887|3830753|FG005|Period 1|Did not receive treatment|0
2196966|NCT01537887|3830748|FG000|Period 2|Withdrawal by Subject|0
2196967|NCT01537887|3830749|FG001|Period 2|Withdrawal by Subject|1
2196968|NCT01537887|3830750|FG002|Period 2|Withdrawal by Subject|0
2196969|NCT01537887|3830751|FG003|Period 2|Withdrawal by Subject|0
2196970|NCT01537887|3830752|FG004|Period 2|Withdrawal by Subject|0
2196971|NCT01537887|3830753|FG005|Period 2|Withdrawal by Subject|0
2196972|NCT01537887|3830748|FG000|Period 3|Adverse Event|0
2196973|NCT01537887|3830749|FG001|Period 3|Adverse Event|0
2196974|NCT01537887|3830750|FG002|Period 3|Adverse Event|1
2196975|NCT01537887|3830751|FG003|Period 3|Adverse Event|0
2196976|NCT01537887|3830752|FG004|Period 3|Adverse Event|0
2196977|NCT01537887|3830753|FG005|Period 3|Adverse Event|0
2196978|NCT01537887|3830748|FG000|Period 3|Withdrawal by Subject|0
2196979|NCT01537887|3830749|FG001|Period 3|Withdrawal by Subject|1
2196980|NCT01537887|3830750|FG002|Period 3|Withdrawal by Subject|0
2196981|NCT01537887|3830751|FG003|Period 3|Withdrawal by Subject|0
2196982|NCT01537887|3830752|FG004|Period 3|Withdrawal by Subject|0
2196983|NCT01537887|3830753|FG005|Period 3|Withdrawal by Subject|0
2196984|NCT01538199|3830781|FG000|Overall Study|Lost to Follow-up|1
2196985|NCT01538199|3830782|FG001|Overall Study|Lost to Follow-up|2
2196986|NCT01538199|3830783|FG002|Overall Study|Lost to Follow-up|1
2196987|NCT01538199|3830784|FG003|Overall Study|Lost to Follow-up|0
2196988|NCT01538199|3830781|FG000|Overall Study|participant did not have time|1
2196989|NCT01538199|3830782|FG001|Overall Study|participant did not have time|0
2196990|NCT01538199|3830783|FG002|Overall Study|participant did not have time|0
2196991|NCT01538199|3830784|FG003|Overall Study|participant did not have time|2
2196992|NCT01538199|3830781|FG000|Overall Study|Lack of Efficacy|0
2196993|NCT01538199|3830782|FG001|Overall Study|Lack of Efficacy|1
2196994|NCT01538199|3830783|FG002|Overall Study|Lack of Efficacy|0
2196995|NCT01538199|3830784|FG003|Overall Study|Lack of Efficacy|0
2196996|NCT01538472|3830801|FG000|Overall Study|Disease Progression|3
2196997|NCT01538472|3830801|FG000|Overall Study|Death|1
2196998|NCT01538628|3830816|FG000|Overall Study|Withdrawal by Subject|1
2196999|NCT01538628|3830817|FG001|Overall Study|Withdrawal by Subject|1
2197000|NCT01538628|3830816|FG000|Overall Study|Lost to Follow-up|0
2197001|NCT01538628|3830817|FG001|Overall Study|Lost to Follow-up|1
2197002|NCT01538719|3830826|FG000|Overall Study|Lost to Follow-up|2
2197003|NCT01538719|3830827|FG001|Overall Study|Lost to Follow-up|0
2197004|NCT01539083|3830856|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4
2197005|NCT01539083|3830857|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0
2197006|NCT01539083|3830858|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0
2197007|NCT01539083|3830856|FG000|Before Randomization (VCD Induction)|Adverse Event|14
2197008|NCT01539083|3830857|FG001|Before Randomization (VCD Induction)|Adverse Event|0
2197009|NCT01539083|3830858|FG002|Before Randomization (VCD Induction)|Adverse Event|0
2197010|NCT01539083|3830856|FG000|Before Randomization (VCD Induction)|Death|6
2197011|NCT01539083|3830857|FG001|Before Randomization (VCD Induction)|Death|0
2197012|NCT01539083|3830858|FG002|Before Randomization (VCD Induction)|Death|0
2197013|NCT01539083|3830856|FG000|Before Randomization (VCD Induction)|Protocol Violation|2
2197014|NCT01539083|3830857|FG001|Before Randomization (VCD Induction)|Protocol Violation|0
2197015|NCT01539083|3830858|FG002|Before Randomization (VCD Induction)|Protocol Violation|0
2197016|NCT01539083|3830856|FG000|Before Randomization (VCD Induction)|Physician Decision|14
2197017|NCT01539083|3830857|FG001|Before Randomization (VCD Induction)|Physician Decision|0
2197018|NCT01539083|3830858|FG002|Before Randomization (VCD Induction)|Physician Decision|0
2197019|NCT01539083|3830856|FG000|Before Randomization (VCD Induction)|Progressive Disease|8
2197020|NCT01539083|3830857|FG001|Before Randomization (VCD Induction)|Progressive Disease|0
2197021|NCT01539083|3830858|FG002|Before Randomization (VCD Induction)|Progressive Disease|0
2197022|NCT01539083|3830856|FG000|Before Randomization (VCD Induction)|Other|5
2197023|NCT01539083|3830857|FG001|Before Randomization (VCD Induction)|Other|0
2197024|NCT01539083|3830858|FG002|Before Randomization (VCD Induction)|Other|0
2197025|NCT01539083|3830856|FG000|After Randomization (TP and VTP)|Physician Decision|0
2197026|NCT01539083|3830857|FG001|After Randomization (TP and VTP)|Physician Decision|0
2197027|NCT01539083|3830858|FG002|After Randomization (TP and VTP)|Physician Decision|1
2197028|NCT01539083|3830856|FG000|After Randomization (TP and VTP)|Other|0
2197029|NCT01539083|3830857|FG001|After Randomization (TP and VTP)|Other|1
2197030|NCT01539083|3830858|FG002|After Randomization (TP and VTP)|Other|1
2197031|NCT01539083|3830856|FG000|After Randomization (TP and VTP)|Adverse Event|0
2197032|NCT01539083|3830857|FG001|After Randomization (TP and VTP)|Adverse Event|1
2197033|NCT01539083|3830858|FG002|After Randomization (TP and VTP)|Adverse Event|1
2197034|NCT01539083|3830856|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0
2197035|NCT01539083|3830857|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2
2197036|NCT01539083|3830858|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2
2197037|NCT01539083|3830856|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0
2197038|NCT01539083|3830857|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5
2197039|NCT01539083|3830858|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4
2197040|NCT01539083|3830856|FG000|After Randomization (TP and VTP)|Progressive Disease|0
2197041|NCT01539083|3830857|FG001|After Randomization (TP and VTP)|Progressive Disease|6
2197042|NCT01539083|3830858|FG002|After Randomization (TP and VTP)|Progressive Disease|3
2197043|NCT01539083|3830856|FG000|After Randomization (TP and VTP)|Death|0
2197044|NCT01539083|3830857|FG001|After Randomization (TP and VTP)|Death|6
2197045|NCT01539083|3830858|FG002|After Randomization (TP and VTP)|Death|11
2197046|NCT01539239|3830876|FG000|Overall Study|Death|5
2197047|NCT01539239|3830877|FG001|Overall Study|Death|5
2197048|NCT01539239|3830876|FG000|Overall Study|Lost to Follow-up|7
2197049|NCT01539239|3830877|FG001|Overall Study|Lost to Follow-up|12
2274755|NCT02301143|3956098|FG001|Induction Period|Withdrawal by Subject|0
2274756|NCT02301143|3956097|FG000|Induction Period|Noncompliance with Study Drug|1
2274757|NCT02301143|3956098|FG001|Induction Period|Noncompliance with Study Drug|0
2274758|NCT02301143|3956097|FG000|Induction Period|Physician Decision|4
2274759|NCT02301143|3956098|FG001|Induction Period|Physician Decision|0
2274760|NCT02301143|3956097|FG000|Induction Period|Symptomatic Deterioration|2
2274761|NCT02301143|3956098|FG001|Induction Period|Symptomatic Deterioration|0
2274762|NCT02301143|3956097|FG000|Induction Period|Protocol Violation|2
2274763|NCT02301143|3956098|FG001|Induction Period|Protocol Violation|0
2274764|NCT02301143|3956097|FG000|Induction Period|Other|1
2274765|NCT02301143|3956098|FG001|Induction Period|Other|0
2274766|NCT02301143|3956097|FG000|Investigator's Choice|Adverse Event|0
2274767|NCT02301143|3956098|FG001|Investigator's Choice|Adverse Event|3
2274768|NCT02301143|3956097|FG000|Investigator's Choice|Progressive Disease|0
2274769|NCT02301143|3956098|FG001|Investigator's Choice|Progressive Disease|3
2274770|NCT02301143|3956097|FG000|Investigator's Choice|Noncompliance With Study Drug|0
2274771|NCT02301143|3956098|FG001|Investigator's Choice|Noncompliance With Study Drug|1
2322384|NCT02971228|4037355|FG004|Overall Study|Logistical challenges|0
2197050|NCT01539291|3830886|FG000|Study GS-US-312-0116|Adverse Event|9
2197051|NCT01539291|3830887|FG001|Study GS-US-312-0116|Adverse Event|0
2197052|NCT01539291|3830888|FG002|Study GS-US-312-0116|Adverse Event|0
2197053|NCT01539291|3830889|FG003|Study GS-US-312-0116|Adverse Event|0
2197054|NCT01539291|3830886|FG000|Study GS-US-312-0116|Physician Decision|1
2197055|NCT01539291|3830887|FG001|Study GS-US-312-0116|Physician Decision|0
2197056|NCT01539291|3830888|FG002|Study GS-US-312-0116|Physician Decision|0
2197057|NCT01539291|3830889|FG003|Study GS-US-312-0116|Physician Decision|0
2197058|NCT01539291|3830886|FG000|Study GS-US-312-0116|Withdrawal by Subject|12
2197059|NCT01539291|3830887|FG001|Study GS-US-312-0116|Withdrawal by Subject|0
2197060|NCT01539291|3830888|FG002|Study GS-US-312-0116|Withdrawal by Subject|0
2197061|NCT01539291|3830889|FG003|Study GS-US-312-0116|Withdrawal by Subject|0
2197062|NCT01539291|3830886|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2
2197063|NCT01539291|3830887|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0
2197064|NCT01539291|3830888|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0
2197065|NCT01539291|3830889|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0
2197066|NCT01539291|3830886|FG000|Study GS-US-312-0116|Other|1
2197067|NCT01539291|3830887|FG001|Study GS-US-312-0116|Other|0
2197068|NCT01539291|3830888|FG002|Study GS-US-312-0116|Other|0
2197069|NCT01539291|3830889|FG003|Study GS-US-312-0116|Other|0
2197070|NCT01539291|3830886|FG000|Study GS-US-312-0117|Adverse Event|22
2197071|NCT01539291|3830887|FG001|Study GS-US-312-0117|Adverse Event|1
2197072|NCT01539291|3830888|FG002|Study GS-US-312-0117|Adverse Event|9
2197073|NCT01539291|3830889|FG003|Study GS-US-312-0117|Adverse Event|12
2197074|NCT01539291|3830886|FG000|Study GS-US-312-0117|Physician Decision|9
2197075|NCT01539291|3830887|FG001|Study GS-US-312-0117|Physician Decision|0
2197076|NCT01539291|3830888|FG002|Study GS-US-312-0117|Physician Decision|6
2197077|NCT01539291|3830889|FG003|Study GS-US-312-0117|Physician Decision|4
2197078|NCT01539291|3830886|FG000|Study GS-US-312-0117|Withdrawal by Subject|5
2197079|NCT01539291|3830887|FG001|Study GS-US-312-0117|Withdrawal by Subject|0
2197080|NCT01539291|3830888|FG002|Study GS-US-312-0117|Withdrawal by Subject|6
2197081|NCT01539291|3830889|FG003|Study GS-US-312-0117|Withdrawal by Subject|4
2197082|NCT01539291|3830886|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3
2197083|NCT01539291|3830887|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0
2197084|NCT01539291|3830888|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0
2197085|NCT01539291|3830889|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5
2197086|NCT01539291|3830886|FG000|Study GS-US-312-0117|Other|2
2197087|NCT01539291|3830887|FG001|Study GS-US-312-0117|Other|1
2197088|NCT01539291|3830888|FG002|Study GS-US-312-0117|Other|1
2197089|NCT01539291|3830889|FG003|Study GS-US-312-0117|Other|1
2197090|NCT01539317|3830908|FG000|Overall Study|Screening Error. Deleted from analysis.|1
2197091|NCT01539317|3830909|FG001|Overall Study|Screening Error. Deleted from analysis.|0
2197092|NCT01539512|3830920|FG000|Overall Study|Adverse Event|9
2197093|NCT01539512|3830921|FG001|Overall Study|Adverse Event|7
2197094|NCT01539512|3830920|FG000|Overall Study|Physician Decision|1
2197095|NCT01539512|3830921|FG001|Overall Study|Physician Decision|1
2197096|NCT01539512|3830920|FG000|Overall Study|Withdrawal by Subject|12
2197097|NCT01539512|3830921|FG001|Overall Study|Withdrawal by Subject|5
2197098|NCT01539512|3830920|FG000|Overall Study|Richter's Transformation|1
2197099|NCT01539512|3830921|FG001|Overall Study|Richter's Transformation|0
2197100|NCT01539525|3830930|FG000|Overall Study|Lost to Follow-up|19
2197101|NCT01539525|3830931|FG001|Overall Study|Lost to Follow-up|12
2197102|NCT01539525|3830932|FG002|Overall Study|Lost to Follow-up|11
2197103|NCT01539525|3830930|FG000|Overall Study|Withdrawal by Subject|0
2197104|NCT01539525|3830931|FG001|Overall Study|Withdrawal by Subject|3
2197105|NCT01539525|3830932|FG002|Overall Study|Withdrawal by Subject|2
2197106|NCT01539525|3830930|FG000|Overall Study|Protocol Violation|1
2197107|NCT01539525|3830931|FG001|Overall Study|Protocol Violation|1
2197108|NCT01539525|3830932|FG002|Overall Study|Protocol Violation|4
2197109|NCT01539538|3830945|FG000|Overall Study|Adverse Event|13
2197110|NCT01539538|3830946|FG001|Overall Study|Adverse Event|18
2197111|NCT01539538|3830945|FG000|Overall Study|Lack of Efficacy|13
2197112|NCT01539538|3830946|FG001|Overall Study|Lack of Efficacy|16
2197113|NCT01539538|3830945|FG000|Overall Study|Withdrawal by Subject|2
2197114|NCT01539538|3830946|FG001|Overall Study|Withdrawal by Subject|3
2197115|NCT01539538|3830945|FG000|Overall Study|PCA no longer required or PCA problem|3
2197116|NCT01539538|3830946|FG001|Overall Study|PCA no longer required or PCA problem|7
2197117|NCT01539642|3830954|FG000|Overall Study|Lack of Efficacy|20
2197118|NCT01539642|3830955|FG001|Overall Study|Lack of Efficacy|18
2197119|NCT01539642|3830954|FG000|Overall Study|Patient ready for early discharge|8
2197120|NCT01539642|3830955|FG001|Overall Study|Patient ready for early discharge|7
2197121|NCT01539642|3830954|FG000|Overall Study|Adverse Event|6
2197122|NCT01539642|3830955|FG001|Overall Study|Adverse Event|4
2197123|NCT01539642|3830954|FG000|Overall Study|Withdrawal by Subject|2
2197124|NCT01539642|3830955|FG001|Overall Study|Withdrawal by Subject|2
2197125|NCT01539759|3830970|FG000|Overall Study|Lost to Follow-up|6
2197126|NCT01539759|3830971|FG001|Overall Study|Lost to Follow-up|8
2197127|NCT01539837|3830980|FG000|Overall Study|reduce neutrophil level|0
2197128|NCT01539837|3830981|FG001|Overall Study|reduce neutrophil level|1
2197129|NCT01539837|3830982|FG002|Overall Study|reduce neutrophil level|1
2197130|NCT01539837|3830980|FG000|Overall Study|bad compliance|0
2197131|NCT01539837|3830981|FG001|Overall Study|bad compliance|0
2197132|NCT01539837|3830982|FG002|Overall Study|bad compliance|1
2197133|NCT01539863|3830992|FG000|Overall Study|Lost to Follow-up|5
2197134|NCT01539863|3830993|FG001|Overall Study|Lost to Follow-up|4
2197135|NCT01540474|3831087|FG000|Vaccination Period|Lost to Follow-up|0
2197136|NCT01540474|3831088|FG001|Vaccination Period|Lost to Follow-up|1
2197137|NCT01540474|3831089|FG002|Vaccination Period|Lost to Follow-up|0
2197138|NCT01540474|3831090|FG003|Vaccination Period|Lost to Follow-up|0
2197139|NCT01540487|3831103|FG000|Overall Study|Protocol Violation|1
2197140|NCT01540487|3831104|FG001|Overall Study|Protocol Violation|0
2197141|NCT01540565|3831118|FG000|Overall Study|Ineligible|2
2197142|NCT01540838|3831188|FG000|Overall Study|Open nasogastric tube|9
2197143|NCT01540838|3831189|FG001|Overall Study|Open nasogastric tube|7
2197144|NCT01540838|3831188|FG000|Overall Study|Treatment doses missing|8
2197145|NCT01540838|3831189|FG001|Overall Study|Treatment doses missing|12
2197146|NCT01540838|3831188|FG000|Overall Study|Additional antibiotic treatment|1
2197147|NCT01540838|3831189|FG001|Overall Study|Additional antibiotic treatment|2
2197148|NCT01540838|3831188|FG000|Overall Study|Died before treatment initiation|1
2197149|NCT01540838|3831189|FG001|Overall Study|Died before treatment initiation|1
2197150|NCT01540838|3831188|FG000|Overall Study|Not BM. Other treatment|3
2197151|NCT01540838|3831189|FG001|Overall Study|Not BM. Other treatment|1
2197152|NCT01540851|3831197|FG000|Overall Study|Lost to Follow-up|14
2197153|NCT01540851|3831198|FG001|Overall Study|Lost to Follow-up|15
2197154|NCT01540851|3831197|FG000|Overall Study|Withdrawal by Subject|7
2197155|NCT01540851|3831198|FG001|Overall Study|Withdrawal by Subject|3
2197156|NCT01540981|3831208|FG000|Overall Study|Withdrawal by Subject|1
2197157|NCT01540981|3831209|FG001|Overall Study|Withdrawal by Subject|0
2197158|NCT01541215|3831217|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6
2197159|NCT01541215|3831218|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8
2197160|NCT01541215|3831217|FG000|Treatment Period (52 Weeks)|Non-compliance|4
2197161|NCT01541215|3831218|FG001|Treatment Period (52 Weeks)|Non-compliance|4
2197162|NCT01541215|3831217|FG000|Treatment Period (52 Weeks)|Adverse Event|0
2197163|NCT01541215|3831218|FG001|Treatment Period (52 Weeks)|Adverse Event|1
2197164|NCT01541215|3831217|FG000|Treatment Period (52 Weeks)|Unclassified|0
2197165|NCT01541215|3831218|FG001|Treatment Period (52 Weeks)|Unclassified|3
2197166|NCT01541215|3831217|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1
2197167|NCT01541215|3831218|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0
2197168|NCT01541215|3831217|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1
2197169|NCT01541215|3831218|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0
2197170|NCT01541254|3831228|FG000|Overall Study|Withdrawal by Subject|1
2197171|NCT01541254|3831228|FG000|Overall Study|excluded - metal allergy|1
2197172|NCT01541254|3831228|FG000|Overall Study|enrolled after study closed|1
2197173|NCT01541254|3831228|FG000|Overall Study|GI bleed prior to procedure|1
2197174|NCT01541254|3831228|FG000|Overall Study|stent not required|1
2197175|NCT01541254|3831228|FG000|Overall Study|alternate stent used|1
2197176|NCT01541371|3831237|FG000|Overall Study|Withdrawal by Subject|14
2197177|NCT01541371|3831237|FG000|Overall Study|Lost to Follow-up|21
2197178|NCT01541371|3831237|FG000|Overall Study|Adverse Event|15
2197179|NCT01541371|3831237|FG000|Overall Study|Lack of Efficacy|12
2197180|NCT01541371|3831237|FG000|Overall Study|Protocol Violation|6
2197181|NCT01541371|3831237|FG000|Overall Study|Study medication non-compliance|3
2197182|NCT01541371|3831237|FG000|Overall Study|Other|6
2197183|NCT01541644|3831267|FG000|Overall Study|Withdrawal by Subject|3
2197184|NCT01541748|3831280|FG000|Overall Study|Lost to Follow-up|17
2197185|NCT01541748|3831280|FG000|Overall Study|Moved out of state|1
2197186|NCT01541748|3831280|FG000|Overall Study|Withdrawal by Subject|7
2197187|NCT01541748|3831280|FG000|Overall Study|Screen failure|5
2197188|NCT01541748|3831280|FG000|Overall Study|Did not receive study device|1
2197189|NCT01541826|3831296|FG000|Overall Study|Lost to Follow-up|2
2197190|NCT01541826|3831297|FG001|Overall Study|Lost to Follow-up|3
2197191|NCT01541826|3831298|FG002|Overall Study|Lost to Follow-up|0
2197192|NCT01541826|3831296|FG000|Overall Study|Withdrawal by Subject|2
2197193|NCT01541826|3831297|FG001|Overall Study|Withdrawal by Subject|0
2197194|NCT01541826|3831298|FG002|Overall Study|Withdrawal by Subject|0
2197195|NCT01541865|3831306|FG000|Overall Study|Lost to Follow-up|11
2197196|NCT01541865|3831306|FG000|Overall Study|Withdrawal by Subject|9
2197197|NCT01541865|3831306|FG000|Overall Study|Adverse Event|1
2197198|NCT01541865|3831306|FG000|Overall Study|Protocol Violation|1
2197199|NCT01541917|3831324|FG000|Overall Study|Lost to Follow-up|2
2197200|NCT01541917|3831325|FG001|Overall Study|Lost to Follow-up|2
2197201|NCT01541917|3831324|FG000|Overall Study|Withdrawal by Subject|13
2197202|NCT01541917|3831325|FG001|Overall Study|Withdrawal by Subject|7
2197203|NCT01541930|3831334|FG000|Overall Study|Withdrawal by Subject|1
2197204|NCT01541969|3831351|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
2197205|NCT01541969|3831352|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
2197206|NCT01541969|3831351|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
2197207|NCT01541969|3831352|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
2197208|NCT01541969|3831351|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
2197209|NCT01541969|3831352|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
2197210|NCT01541969|3831351|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1
2197211|NCT01541969|3831352|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0
2197212|NCT01541969|3831351|FG000|Double-blind (0-12 Weeks)|Adverse Event|2
2197213|NCT01541969|3831352|FG001|Double-blind (0-12 Weeks)|Adverse Event|0
2197214|NCT01541969|3831351|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
2197215|NCT01541969|3831352|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
2197216|NCT01541969|3831351|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
2197217|NCT01541969|3831352|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
2197218|NCT01541969|3831351|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
2197219|NCT01541969|3831352|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
2197220|NCT01541969|3831351|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
2197221|NCT01541969|3831352|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
2197222|NCT01541969|3831351|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2
2197223|NCT01541969|3831352|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3
2197224|NCT01542034|3831363|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20
2197225|NCT01542034|3831364|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12
2197226|NCT01542034|3831363|FG000|Overall Study|Administrative decision|0
2197227|NCT01542034|3831364|FG001|Overall Study|Administrative decision|3
2197228|NCT01542034|3831363|FG000|Overall Study|Subject Noncompliance|1
2197229|NCT01542034|3831364|FG001|Overall Study|Subject Noncompliance|0
2197230|NCT01542034|3831363|FG000|Overall Study|Adverse Event|2
2197231|NCT01542034|3831364|FG001|Overall Study|Adverse Event|2
2197232|NCT01542034|3831363|FG000|Overall Study|Lost to Follow-up|7
2197233|NCT01542034|3831364|FG001|Overall Study|Lost to Follow-up|6
2216880|NCT01703741|3859896|FG000|Overall Study|Adverse Event|2
2216881|NCT01703741|3859896|FG000|Overall Study|Physician Decision|2
2216882|NCT01703741|3859896|FG000|Overall Study|Protocol Violation|1
2216883|NCT01703741|3859896|FG000|Overall Study|Lost to Follow-up|3
2216884|NCT01703741|3859896|FG000|Overall Study|Subject did not want to continue|2
2216885|NCT01703741|3859896|FG000|Overall Study|Subject cannot comply with study visits|1
2216886|NCT01703741|3859896|FG000|Overall Study|Subject started testosterone injections|1
2216887|NCT01703819|3859902|FG000|Overall Study|Adverse Event|0
2216888|NCT01703819|3859903|FG001|Overall Study|Adverse Event|1
2216889|NCT01703819|3859902|FG000|Overall Study|Withdrawal by Subject|0
2216890|NCT01703819|3859903|FG001|Overall Study|Withdrawal by Subject|1
2216891|NCT01703832|3859911|FG000|Overall Study|Withdrawal by Subject|1
2216892|NCT01703832|3859912|FG001|Overall Study|Withdrawal by Subject|0
2216893|NCT01703845|3859920|FG000|Overall Study|Adverse Event|1
2216894|NCT01703845|3859921|FG001|Overall Study|Adverse Event|0
2216895|NCT01703845|3859920|FG000|Overall Study|Protocol Violation|1
2216896|NCT01703845|3859921|FG001|Overall Study|Protocol Violation|0
2216897|NCT01703845|3859920|FG000|Overall Study|other than stated above|1
2216898|NCT01703845|3859921|FG001|Overall Study|other than stated above|0
2216899|NCT01703858|3859932|FG000|Overall Study|Withdrawal by Subject|0
2216900|NCT01703858|3859933|FG001|Overall Study|Withdrawal by Subject|1
2216901|NCT01703858|3859934|FG002|Overall Study|Withdrawal by Subject|0
2216902|NCT01703988|3859951|FG000|Overall Study|Investigator Judgment|0
2216903|NCT01703988|3859952|FG001|Overall Study|Investigator Judgment|0
2216904|NCT01703988|3859953|FG002|Overall Study|Investigator Judgment|0
2216905|NCT01703988|3859954|FG003|Overall Study|Investigator Judgment|1
2216906|NCT01704079|3859967|FG000|Overall Study|Withdrawal by Subject|5
2216907|NCT01704079|3859968|FG001|Overall Study|Withdrawal by Subject|7
2216908|NCT01704079|3859967|FG000|Overall Study|Lost to Follow-up|2
2216909|NCT01704079|3859968|FG001|Overall Study|Lost to Follow-up|5
2216910|NCT01704079|3859967|FG000|Overall Study|Adverse Event|4
2216911|NCT01704079|3859968|FG001|Overall Study|Adverse Event|7
2216912|NCT01704079|3859967|FG000|Overall Study|Protocol Violation|1
2216913|NCT01704079|3859968|FG001|Overall Study|Protocol Violation|0
2216914|NCT01704079|3859967|FG000|Overall Study|Subject noncompliance|2
2216915|NCT01704079|3859968|FG001|Overall Study|Subject noncompliance|3
2216916|NCT01704079|3859967|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
2216917|NCT01704079|3859968|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
2216918|NCT01704261|3859985|FG000|Overall Study|Withdrawal by Subject|12
2216919|NCT01704261|3859986|FG001|Overall Study|Withdrawal by Subject|15
2216920|NCT01704261|3859985|FG000|Overall Study|Lost to Follow-up|1
2216921|NCT01704261|3859986|FG001|Overall Study|Lost to Follow-up|0
2216922|NCT01704287|3859995|FG000|Initial Treatment Period|Death|139
2216923|NCT01704287|3859996|FG001|Initial Treatment Period|Death|129
2216924|NCT01704287|3859997|FG002|Initial Treatment Period|Death|71
2216925|NCT01704287|3859998|FG003|Initial Treatment Period|Death|0
2216926|NCT01704287|3859999|FG004|Initial Treatment Period|Death|0
2216927|NCT01704287|3859995|FG000|Initial Treatment Period|Withdrawal by Subject|3
2216928|NCT01704287|3859996|FG001|Initial Treatment Period|Withdrawal by Subject|2
2216929|NCT01704287|3859997|FG002|Initial Treatment Period|Withdrawal by Subject|4
2216930|NCT01704287|3859998|FG003|Initial Treatment Period|Withdrawal by Subject|0
2216931|NCT01704287|3859999|FG004|Initial Treatment Period|Withdrawal by Subject|0
2216932|NCT01704287|3859995|FG000|Initial Treatment Period|Lost to Follow-up|5
2216933|NCT01704287|3859996|FG001|Initial Treatment Period|Lost to Follow-up|3
2216934|NCT01704287|3859997|FG002|Initial Treatment Period|Lost to Follow-up|0
2216935|NCT01704287|3859998|FG003|Initial Treatment Period|Lost to Follow-up|0
2216936|NCT01704287|3859999|FG004|Initial Treatment Period|Lost to Follow-up|0
2197234|NCT01542528|3831428|FG000|Overall Study|Lost to Follow-up|2
2197235|NCT01542528|3831429|FG001|Overall Study|Lost to Follow-up|1
2197236|NCT01542528|3831428|FG000|Overall Study|Physician Decision|1
2197237|NCT01542528|3831429|FG001|Overall Study|Physician Decision|0
2197238|NCT01542528|3831428|FG000|Overall Study|Withdrawal by Subject|9
2197239|NCT01542528|3831429|FG001|Overall Study|Withdrawal by Subject|6
2197240|NCT01542632|3831450|FG000|Overall Study|Withdrawal of Consent|0
2197241|NCT01542632|3831451|FG001|Overall Study|Withdrawal of Consent|0
2197242|NCT01542632|3831452|FG002|Overall Study|Withdrawal of Consent|0
2197243|NCT01542632|3831453|FG003|Overall Study|Withdrawal of Consent|2
2197244|NCT01542632|3831454|FG004|Overall Study|Withdrawal of Consent|3
2197245|NCT01542632|3831455|FG005|Overall Study|Withdrawal of Consent|0
2197246|NCT01542632|3831450|FG000|Overall Study|Adverse Event|0
2197247|NCT01542632|3831451|FG001|Overall Study|Adverse Event|0
2197248|NCT01542632|3831452|FG002|Overall Study|Adverse Event|1
2197249|NCT01542632|3831453|FG003|Overall Study|Adverse Event|0
2197250|NCT01542632|3831454|FG004|Overall Study|Adverse Event|0
2197251|NCT01542632|3831455|FG005|Overall Study|Adverse Event|0
2197252|NCT01542632|3831450|FG000|Overall Study|Lost to Follow-up|0
2197253|NCT01542632|3831451|FG001|Overall Study|Lost to Follow-up|1
2197254|NCT01542632|3831452|FG002|Overall Study|Lost to Follow-up|0
2197255|NCT01542632|3831453|FG003|Overall Study|Lost to Follow-up|0
2197256|NCT01542632|3831454|FG004|Overall Study|Lost to Follow-up|0
2197257|NCT01542632|3831455|FG005|Overall Study|Lost to Follow-up|0
2197258|NCT01542632|3831450|FG000|Overall Study|Sponsor/Investigator Decision|0
2197259|NCT01542632|3831451|FG001|Overall Study|Sponsor/Investigator Decision|0
2197260|NCT01542632|3831452|FG002|Overall Study|Sponsor/Investigator Decision|0
2197261|NCT01542632|3831453|FG003|Overall Study|Sponsor/Investigator Decision|0
2197262|NCT01542632|3831454|FG004|Overall Study|Sponsor/Investigator Decision|1
2197263|NCT01542632|3831455|FG005|Overall Study|Sponsor/Investigator Decision|0
2197264|NCT01542788|3831493|FG000|Overall Study|Randomized but Not Treated|2
2197265|NCT01542788|3831494|FG001|Overall Study|Randomized but Not Treated|0
2197266|NCT01542788|3831493|FG000|Overall Study|Lack of Efficacy|41
2197267|NCT01542788|3831494|FG001|Overall Study|Lack of Efficacy|71
2197268|NCT01542788|3831493|FG000|Overall Study|Lost to Follow-up|5
2197269|NCT01542788|3831494|FG001|Overall Study|Lost to Follow-up|0
2197270|NCT01542788|3831493|FG000|Overall Study|Death|3
2197271|NCT01542788|3831494|FG001|Overall Study|Death|0
2197272|NCT01542788|3831493|FG000|Overall Study|Protocol Violation|2
2197273|NCT01542788|3831494|FG001|Overall Study|Protocol Violation|0
2197274|NCT01542788|3831493|FG000|Overall Study|Physician Decision|1
2197275|NCT01542788|3831494|FG001|Overall Study|Physician Decision|0
2197276|NCT01542788|3831493|FG000|Overall Study|Withdrawal by Subject|1
2197277|NCT01542788|3831494|FG001|Overall Study|Withdrawal by Subject|0
2197278|NCT01543087|3831536|FG000|Stage 1 (48 Months)|Lost to Follow-up|3
2197279|NCT01543087|3831537|FG001|Stage 1 (48 Months)|Lost to Follow-up|4
2197280|NCT01543087|3831538|FG002|Stage 1 (48 Months)|Lost to Follow-up|12
2197281|NCT01543087|3831539|FG003|Stage 1 (48 Months)|Lost to Follow-up|0
2197282|NCT01543087|3831540|FG004|Stage 1 (48 Months)|Lost to Follow-up|0
2197283|NCT01543087|3831541|FG005|Stage 1 (48 Months)|Lost to Follow-up|0
2197284|NCT01543087|3831536|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1
2197285|NCT01543087|3831537|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0
2197286|NCT01543087|3831538|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1
2197287|NCT01543087|3831539|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2
2197288|NCT01543087|3831540|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0
2197289|NCT01543087|3831541|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0
2197290|NCT01543087|3831536|FG000|Stage 1 (48 Months)|No longer willing to participate|5
2197291|NCT01543087|3831537|FG001|Stage 1 (48 Months)|No longer willing to participate|3
2197292|NCT01543087|3831538|FG002|Stage 1 (48 Months)|No longer willing to participate|18
2197293|NCT01543087|3831539|FG003|Stage 1 (48 Months)|No longer willing to participate|6
2197294|NCT01543087|3831540|FG004|Stage 1 (48 Months)|No longer willing to participate|3
2197295|NCT01543087|3831541|FG005|Stage 1 (48 Months)|No longer willing to participate|0
2197296|NCT01543087|3831536|FG000|Stage 1 (48 Months)|Other than specified|5
2197297|NCT01543087|3831537|FG001|Stage 1 (48 Months)|Other than specified|0
2197298|NCT01543087|3831538|FG002|Stage 1 (48 Months)|Other than specified|9
2197299|NCT01543087|3831539|FG003|Stage 1 (48 Months)|Other than specified|0
2197300|NCT01543087|3831540|FG004|Stage 1 (48 Months)|Other than specified|0
2197301|NCT01543087|3831541|FG005|Stage 1 (48 Months)|Other than specified|0
2197302|NCT01543087|3831536|FG000|Stage 1 (48 Months)|Protocol Violation|0
2197303|NCT01543087|3831537|FG001|Stage 1 (48 Months)|Protocol Violation|3
2197304|NCT01543087|3831538|FG002|Stage 1 (48 Months)|Protocol Violation|0
2197305|NCT01543087|3831539|FG003|Stage 1 (48 Months)|Protocol Violation|0
2197306|NCT01543087|3831540|FG004|Stage 1 (48 Months)|Protocol Violation|0
2197307|NCT01543087|3831541|FG005|Stage 1 (48 Months)|Protocol Violation|0
2197308|NCT01543087|3831536|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2197309|NCT01543087|3831537|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
2197310|NCT01543087|3831538|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2197311|NCT01543087|3831539|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2197312|NCT01543087|3831540|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
2322385|NCT02971605|4037381|FG000|Overall Study|Withdrawal by Subject|1
2197313|NCT01543087|3831541|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2197314|NCT01543087|3831536|FG000|Booster Stage (26 Months)|Lost to Follow-up|0
2197315|NCT01543087|3831537|FG001|Booster Stage (26 Months)|Lost to Follow-up|0
2197316|NCT01543087|3831538|FG002|Booster Stage (26 Months)|Lost to Follow-up|1
2197317|NCT01543087|3831539|FG003|Booster Stage (26 Months)|Lost to Follow-up|0
2197318|NCT01543087|3831540|FG004|Booster Stage (26 Months)|Lost to Follow-up|0
2197319|NCT01543087|3831541|FG005|Booster Stage (26 Months)|Lost to Follow-up|0
2197320|NCT01543152|3831582|FG000|Overall Study|Withdrawal by Subject|0
2197321|NCT01543152|3831583|FG001|Overall Study|Withdrawal by Subject|2
2197322|NCT01543152|3831584|FG002|Overall Study|Withdrawal by Subject|0
2197323|NCT01543152|3831585|FG003|Overall Study|Withdrawal by Subject|0
2197324|NCT01543152|3831586|FG004|Overall Study|Withdrawal by Subject|0
2197325|NCT01543204|3831610|FG000|Overall Study|Non-compliance|1
2197326|NCT01543204|3831610|FG000|Overall Study|Adverse Event|1
2197327|NCT01543204|3831610|FG000|Overall Study|Withdrawal by Subject|4
2197328|NCT01543204|3831610|FG000|Overall Study|Requirement for Alternative Therapy|1
2197329|NCT01543204|3831610|FG000|Overall Study|Lost to Follow-up|1
2197330|NCT01543490|3831620|FG000|Overall Study|Adverse Event|4
2197331|NCT01543490|3831621|FG001|Overall Study|Adverse Event|0
2197332|NCT01543490|3831620|FG000|Overall Study|Physician Decision|1
2197333|NCT01543490|3831621|FG001|Overall Study|Physician Decision|0
2197334|NCT01543490|3831620|FG000|Overall Study|Lack of Efficacy|3
2197335|NCT01543490|3831621|FG001|Overall Study|Lack of Efficacy|3
2197336|NCT01543490|3831620|FG000|Overall Study|Lost to Follow-up|5
2197337|NCT01543490|3831621|FG001|Overall Study|Lost to Follow-up|0
2197338|NCT01543490|3831620|FG000|Overall Study|Withdrawal by Subject|2
2197339|NCT01543490|3831621|FG001|Overall Study|Withdrawal by Subject|0
2197340|NCT01543490|3831620|FG000|Overall Study|Other-Various Administrative Reasons|1
2197341|NCT01543490|3831621|FG001|Overall Study|Other-Various Administrative Reasons|2
2197342|NCT01543503|3831629|FG000|Overall Study|Lost to Follow-up|32
2197343|NCT01543503|3831630|FG001|Overall Study|Lost to Follow-up|36
2197344|NCT01543503|3831629|FG000|Overall Study|Adverse Event|9
2197345|NCT01543503|3831630|FG001|Overall Study|Adverse Event|13
2197346|NCT01543503|3831629|FG000|Overall Study|Lack of Efficacy|4
2197347|NCT01543503|3831630|FG001|Overall Study|Lack of Efficacy|16
2197348|NCT01543503|3831629|FG000|Overall Study|Participant withdrew informed consent|8
2197349|NCT01543503|3831630|FG001|Overall Study|Participant withdrew informed consent|10
2197350|NCT01543503|3831629|FG000|Overall Study|Change of jobs|0
2197351|NCT01543503|3831630|FG001|Overall Study|Change of jobs|1
2197352|NCT01543503|3831629|FG000|Overall Study|Intolerance to the biologic treatment|0
2197353|NCT01543503|3831630|FG001|Overall Study|Intolerance to the biologic treatment|1
2197354|NCT01543503|3831629|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1
2197355|NCT01543503|3831630|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0
2197356|NCT01543503|3831629|FG000|Overall Study|Participant did not complete last visit|0
2197357|NCT01543503|3831630|FG001|Overall Study|Participant did not complete last visit|2
2197358|NCT01543503|3831629|FG000|Overall Study|Refused to continue treatment|7
2197359|NCT01543503|3831630|FG001|Overall Study|Refused to continue treatment|0
2197360|NCT01543503|3831629|FG000|Overall Study|Incorrect medication received|1
2197361|NCT01543503|3831630|FG001|Overall Study|Incorrect medication received|0
2197362|NCT01543503|3831629|FG000|Overall Study|Participant moved to another city|2
2197363|NCT01543503|3831630|FG001|Overall Study|Participant moved to another city|0
2197364|NCT01543503|3831629|FG000|Overall Study|Participant will not return for visits|0
2197365|NCT01543503|3831630|FG001|Overall Study|Participant will not return for visits|2
2197366|NCT01543503|3831629|FG000|Overall Study|Participant transferred to another city|1
2197367|NCT01543503|3831630|FG001|Overall Study|Participant transferred to another city|0
2197368|NCT01543503|3831629|FG000|Overall Study|Participant moved to Scotland|1
2197369|NCT01543503|3831630|FG001|Overall Study|Participant moved to Scotland|0
2197370|NCT01543503|3831629|FG000|Overall Study|Participant decision to stop treatment|1
2197371|NCT01543503|3831630|FG001|Overall Study|Participant decision to stop treatment|0
2197372|NCT01543503|3831629|FG000|Overall Study|Investigator did not wish to participate|1
2197373|NCT01543503|3831630|FG001|Overall Study|Investigator did not wish to participate|1
2197374|NCT01543503|3831629|FG000|Overall Study|Participant recruited after closing date|0
2197375|NCT01543503|3831630|FG001|Overall Study|Participant recruited after closing date|1
2197376|NCT01543503|3831629|FG000|Overall Study|Site stopped participation|5
2197377|NCT01543503|3831630|FG001|Overall Study|Site stopped participation|1
2197378|NCT01543503|3831629|FG000|Overall Study|Participant did not attend a visit|1
2197379|NCT01543503|3831630|FG001|Overall Study|Participant did not attend a visit|0
2197380|NCT01543503|3831629|FG000|Overall Study|Moved to other rheumatologic site|0
2197381|NCT01543503|3831630|FG001|Overall Study|Moved to other rheumatologic site|1
2197382|NCT01543503|3831629|FG000|Overall Study|Participant consented to another study|0
2197383|NCT01543503|3831630|FG001|Overall Study|Participant consented to another study|2
2197384|NCT01543503|3831629|FG000|Overall Study|Participant went to United States|1
2197385|NCT01543503|3831630|FG001|Overall Study|Participant went to United States|0
2197386|NCT01543503|3831629|FG000|Overall Study|Screen failure|1
2197387|NCT01543503|3831630|FG001|Overall Study|Screen failure|0
2197388|NCT01543685|3831656|FG000|Overall Study|Lack of Efficacy|1
2197389|NCT01543685|3831657|FG001|Overall Study|Lack of Efficacy|2
2197390|NCT01543685|3831658|FG002|Overall Study|Lack of Efficacy|2
2197391|NCT01543685|3831659|FG003|Overall Study|Lack of Efficacy|0
2197392|NCT01543685|3831660|FG004|Overall Study|Lack of Efficacy|2
2197393|NCT01543685|3831656|FG000|Overall Study|Adverse Event|2
2197394|NCT01543685|3831657|FG001|Overall Study|Adverse Event|1
2197395|NCT01543685|3831658|FG002|Overall Study|Adverse Event|0
2197396|NCT01543685|3831659|FG003|Overall Study|Adverse Event|0
2197397|NCT01543685|3831660|FG004|Overall Study|Adverse Event|2
2197398|NCT01543776|3831674|FG000|Overall Study|Withdrawal by Subject|2
2197399|NCT01543776|3831675|FG001|Overall Study|Withdrawal by Subject|2
2197400|NCT01543828|3831683|FG000|Treatment 2|Lost to Follow-up|1
2197401|NCT01543828|3831684|FG001|Treatment 2|Lost to Follow-up|0
2197402|NCT01543958|3831692|FG000|Overall Study|Loss to follow-up|3
2197403|NCT01543958|3831692|FG000|Overall Study|ART initiation|1
2197404|NCT01544114|3831722|FG000|Overall Study|Withdrawal by Subject|0
2197405|NCT01544114|3831723|FG001|Overall Study|Withdrawal by Subject|0
2197406|NCT01544114|3831724|FG002|Overall Study|Withdrawal by Subject|3
2197407|NCT01544114|3831722|FG000|Overall Study|Lost to Follow-up|0
2197408|NCT01544114|3831723|FG001|Overall Study|Lost to Follow-up|2
2197409|NCT01544114|3831724|FG002|Overall Study|Lost to Follow-up|0
2197410|NCT01544114|3831722|FG000|Overall Study|Adverse Event|1
2197411|NCT01544114|3831723|FG001|Overall Study|Adverse Event|1
2197412|NCT01544114|3831724|FG002|Overall Study|Adverse Event|2
2197413|NCT01544114|3831722|FG000|Overall Study|Protocol Violation|0
2197414|NCT01544114|3831723|FG001|Overall Study|Protocol Violation|1
2197415|NCT01544114|3831724|FG002|Overall Study|Protocol Violation|0
2197416|NCT01544153|3831738|FG000|Overall Study|Under 18|0
2197417|NCT01544153|3831739|FG001|Overall Study|Under 18|1
2197418|NCT01544153|3831740|FG002|Overall Study|Under 18|0
2197419|NCT01544153|3831741|FG003|Overall Study|Under 18|0
2197420|NCT01544153|3831738|FG000|Overall Study|Non-smoker|0
2197421|NCT01544153|3831739|FG001|Overall Study|Non-smoker|0
2197422|NCT01544153|3831740|FG002|Overall Study|Non-smoker|1
2197423|NCT01544153|3831741|FG003|Overall Study|Non-smoker|0
2197424|NCT01544179|3831760|FG000|Overall Study|Death|50
2197425|NCT01544179|3831761|FG001|Overall Study|Death|37
2197426|NCT01544179|3831760|FG000|Overall Study|Lost to Follow-up|0
2197427|NCT01544179|3831761|FG001|Overall Study|Lost to Follow-up|1
2197428|NCT01544179|3831760|FG000|Overall Study|Adverse Event|0
2197429|NCT01544179|3831761|FG001|Overall Study|Adverse Event|1
2197430|NCT01544179|3831760|FG000|Overall Study|Withdrawal by Subject|12
2197431|NCT01544179|3831761|FG001|Overall Study|Withdrawal by Subject|7
2197432|NCT01544179|3831760|FG000|Overall Study|Eligibility criteria not fulfilled|1
2197433|NCT01544179|3831761|FG001|Overall Study|Eligibility criteria not fulfilled|0
2197434|NCT01544309|3831769|FG000|Overall Study|Withdrawal by Subject|12
2197435|NCT01544309|3831770|FG001|Overall Study|Withdrawal by Subject|7
2197436|NCT01544309|3831769|FG000|Overall Study|Protocol Violation|2
2197437|NCT01544309|3831770|FG001|Overall Study|Protocol Violation|1
2197438|NCT01544309|3831769|FG000|Overall Study|Physician Decision|4
2197439|NCT01544309|3831770|FG001|Overall Study|Physician Decision|1
2197440|NCT01544309|3831769|FG000|Overall Study|Not performed pre-dose examination|1
2197441|NCT01544309|3831770|FG001|Overall Study|Not performed pre-dose examination|2
2197442|NCT01544309|3831769|FG000|Overall Study|Administered prohibit prior medication|1
2197443|NCT01544309|3831770|FG001|Overall Study|Administered prohibit prior medication|0
2197444|NCT01544335|3831778|FG000|Overall Study|Lost to Follow-up|27
2197445|NCT01544335|3831778|FG000|Overall Study|Death|4
2197446|NCT01544335|3831778|FG000|Overall Study|Disease progression|3
2197447|NCT01544335|3831778|FG000|Overall Study|Baseline Measurements not Available|19
2197448|NCT01544348|3831790|FG000|Overall Study|Lost to Follow-up|1
2197449|NCT01544348|3831791|FG001|Overall Study|Lost to Follow-up|0
2197450|NCT01544348|3831792|FG002|Overall Study|Lost to Follow-up|0
2197451|NCT01544348|3831793|FG003|Overall Study|Lost to Follow-up|0
2197452|NCT01544348|3831794|FG004|Overall Study|Lost to Follow-up|0
2197453|NCT01544348|3831795|FG005|Overall Study|Lost to Follow-up|0
2197454|NCT01544348|3831796|FG006|Overall Study|Lost to Follow-up|1
2197455|NCT01544348|3831797|FG007|Overall Study|Lost to Follow-up|0
2197456|NCT01544348|3831790|FG000|Overall Study|Withdrawal by Subject|1
2197457|NCT01544348|3831791|FG001|Overall Study|Withdrawal by Subject|0
2197458|NCT01544348|3831792|FG002|Overall Study|Withdrawal by Subject|0
2197459|NCT01544348|3831793|FG003|Overall Study|Withdrawal by Subject|0
2197460|NCT01544348|3831794|FG004|Overall Study|Withdrawal by Subject|1
2197461|NCT01544348|3831795|FG005|Overall Study|Withdrawal by Subject|2
2197462|NCT01544348|3831796|FG006|Overall Study|Withdrawal by Subject|1
2197463|NCT01544348|3831797|FG007|Overall Study|Withdrawal by Subject|0
2197464|NCT01544348|3831790|FG000|Overall Study|Physician Decision|0
2197465|NCT01544348|3831791|FG001|Overall Study|Physician Decision|0
2197466|NCT01544348|3831792|FG002|Overall Study|Physician Decision|0
2197467|NCT01544348|3831793|FG003|Overall Study|Physician Decision|0
2197468|NCT01544348|3831794|FG004|Overall Study|Physician Decision|0
2197469|NCT01544348|3831795|FG005|Overall Study|Physician Decision|1
2197470|NCT01544348|3831796|FG006|Overall Study|Physician Decision|0
2197471|NCT01544348|3831797|FG007|Overall Study|Physician Decision|0
2197472|NCT01544478|3831843|FG000|Overall Study|Adverse Event|1
2197473|NCT01544478|3831843|FG000|Overall Study|Death|1
2197474|NCT01544478|3831843|FG000|Overall Study|Lost to Follow-up|48
2197475|NCT01544478|3831843|FG000|Overall Study|Physician Decision|15
2197476|NCT01544478|3831843|FG000|Overall Study|Pregnancy|1
2197477|NCT01544478|3831843|FG000|Overall Study|Withdrawal by Subject|52
2197478|NCT01544491|3831849|FG000|Overall Study|Withdrawal by Subject|3
2197479|NCT01544491|3831850|FG001|Overall Study|Withdrawal by Subject|2
2197480|NCT01544491|3831849|FG000|Overall Study|Lost to Follow-up|0
2197481|NCT01544491|3831850|FG001|Overall Study|Lost to Follow-up|1
2197482|NCT01544491|3831849|FG000|Overall Study|administrative problems|2
2197483|NCT01544491|3831850|FG001|Overall Study|administrative problems|0
2197484|NCT01544582|3831859|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1
2197485|NCT01544582|3831860|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0
2197486|NCT01544582|3831861|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0
2197487|NCT01544582|3831862|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0
2197488|NCT01544582|3831859|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33
2274772|NCT02301143|3956097|FG000|Investigator's Choice|Symptomatic Deterioration|0
2274773|NCT02301143|3956098|FG001|Investigator's Choice|Symptomatic Deterioration|1
2274774|NCT02301143|3956097|FG000|Investigator's Choice|Other|0
2274775|NCT02301143|3956098|FG001|Investigator's Choice|Other|1
2274776|NCT02301143|3956097|FG000|Investigator's Choice|Unresectable Surgery|0
2274777|NCT02301143|3956098|FG001|Investigator's Choice|Unresectable Surgery|1
2274778|NCT02301169|3956111|FG000|Overall Study|Adverse Event|1
2274779|NCT02301169|3956112|FG001|Overall Study|Adverse Event|0
2274780|NCT02301390|3956140|FG000|Overall Study|Withdrawal by Subject|3
2274781|NCT02301390|3956141|FG001|Overall Study|Withdrawal by Subject|5
2274782|NCT02301390|3956140|FG000|Overall Study|Protocol Violation|1
2274783|NCT02301390|3956141|FG001|Overall Study|Protocol Violation|0
2274784|NCT02301390|3956140|FG000|Overall Study|Physician Decision|1
2274785|NCT02301390|3956141|FG001|Overall Study|Physician Decision|0
2274786|NCT02301390|3956140|FG000|Overall Study|Lost to Follow-up|0
2274787|NCT02301390|3956141|FG001|Overall Study|Lost to Follow-up|1
2274788|NCT02301390|3956140|FG000|Overall Study|Death|2
2274789|NCT02301390|3956141|FG001|Overall Study|Death|2
2274790|NCT02301390|3956140|FG000|Overall Study|Procedure not completed|0
2274791|NCT02301390|3956141|FG001|Overall Study|Procedure not completed|4
2274792|NCT02301390|3956140|FG000|Overall Study|Missed multiple visits|1
2274793|NCT02301390|3956141|FG001|Overall Study|Missed multiple visits|1
2274794|NCT02301390|3956140|FG000|Overall Study|study terminated|2
2274795|NCT02301390|3956141|FG001|Overall Study|study terminated|0
2274796|NCT02301403|3956149|FG000|Overall Study|Withdrawal by Subject|28
2274797|NCT02301403|3956150|FG001|Overall Study|Withdrawal by Subject|41
2274798|NCT02301429|3956165|FG000|Overall Study|not acceptable vascular anatomy|3
2274799|NCT02301546|3956171|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7
2274800|NCT02301546|3956172|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8
2274801|NCT02301546|3956171|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10
2274802|NCT02301546|3956172|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7
2274803|NCT02301546|3956171|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1
2274804|NCT02301546|3956172|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0
2274805|NCT02301546|3956171|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
2274806|NCT02301546|3956172|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
2274807|NCT02301546|3956171|FG000|Long Term Effectiveness (~1 Year)|Death|2
2274808|NCT02301546|3956172|FG001|Long Term Effectiveness (~1 Year)|Death|0
2274809|NCT02301546|3956171|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6
2274810|NCT02301546|3956172|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2
2274811|NCT02301546|3956171|FG000|Long Term Effectiveness (~1 Year)|moved away|1
2274812|NCT02301546|3956172|FG001|Long Term Effectiveness (~1 Year)|moved away|2
2274813|NCT02301624|3956180|FG000|Blind Induction Phase|Withdrawal by Subject|1
2274814|NCT02301624|3956181|FG001|Blind Induction Phase|Withdrawal by Subject|0
2274815|NCT02301624|3956180|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4
2274816|NCT02301624|3956181|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8
2274817|NCT02301624|3956180|FG000|Open-label Maintenance Phase|Adverse Event|2
2274818|NCT02301624|3956181|FG001|Open-label Maintenance Phase|Adverse Event|5
2274819|NCT02301624|3956180|FG000|Open-label Maintenance Phase|Physician Decision|3
2274820|NCT02301624|3956181|FG001|Open-label Maintenance Phase|Physician Decision|3
2274821|NCT02301624|3956180|FG000|Open-label Maintenance Phase|Death|2
2274822|NCT02301624|3956181|FG001|Open-label Maintenance Phase|Death|1
2274823|NCT02301624|3956180|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1
2274824|NCT02301624|3956181|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0
2274825|NCT02301897|3956200|FG000|Treatment Course 1|Non-Compliance|0
2274826|NCT02301897|3956201|FG001|Treatment Course 1|Non-Compliance|0
2274827|NCT02301897|3956202|FG002|Treatment Course 1|Non-Compliance|1
2274828|NCT02301897|3956200|FG000|Treatment Course 1|Adverse Event|1
2274829|NCT02301897|3956201|FG001|Treatment Course 1|Adverse Event|1
2274830|NCT02301897|3956202|FG002|Treatment Course 1|Adverse Event|0
2274831|NCT02301897|3956200|FG000|Treatment Course 1|Lost to Follow-up|1
2274832|NCT02301897|3956201|FG001|Treatment Course 1|Lost to Follow-up|2
2274833|NCT02301897|3956202|FG002|Treatment Course 1|Lost to Follow-up|1
2274834|NCT02301897|3956200|FG000|Treatment Course 1|Withdrawal by Sponsor|0
2197489|NCT01544582|3831860|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0
2197490|NCT01544582|3831861|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0
2197491|NCT01544582|3831862|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0
2197492|NCT01544582|3831859|FG000|Analysis Population|Participant Refuses to Continue Study|0
2197493|NCT01544582|3831860|FG001|Analysis Population|Participant Refuses to Continue Study|15
2197494|NCT01544582|3831861|FG002|Analysis Population|Participant Refuses to Continue Study|17
2197495|NCT01544582|3831862|FG003|Analysis Population|Participant Refuses to Continue Study|4
2197496|NCT01544582|3831859|FG000|Analysis Population|Physician Decision|0
2197497|NCT01544582|3831860|FG001|Analysis Population|Physician Decision|13
2197498|NCT01544582|3831861|FG002|Analysis Population|Physician Decision|10
2197499|NCT01544582|3831862|FG003|Analysis Population|Physician Decision|9
2197500|NCT01544582|3831859|FG000|Analysis Population|Safety Reason|0
2197501|NCT01544582|3831860|FG001|Analysis Population|Safety Reason|33
2197502|NCT01544582|3831861|FG002|Analysis Population|Safety Reason|31
2197503|NCT01544582|3831862|FG003|Analysis Population|Safety Reason|8
2197504|NCT01544582|3831859|FG000|Analysis Population|Effectiveness Reason|0
2197505|NCT01544582|3831860|FG001|Analysis Population|Effectiveness Reason|48
2197506|NCT01544582|3831861|FG002|Analysis Population|Effectiveness Reason|29
2197507|NCT01544582|3831862|FG003|Analysis Population|Effectiveness Reason|12
2197508|NCT01544582|3831859|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0
2197509|NCT01544582|3831860|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0
2197510|NCT01544582|3831861|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0
2197511|NCT01544582|3831862|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1
2197512|NCT01544582|3831859|FG000|Analysis Population|Lost to Follow-up|0
2197513|NCT01544582|3831860|FG001|Analysis Population|Lost to Follow-up|6
2197514|NCT01544582|3831861|FG002|Analysis Population|Lost to Follow-up|6
2197515|NCT01544582|3831862|FG003|Analysis Population|Lost to Follow-up|5
2197516|NCT01544582|3831859|FG000|Analysis Population|Bad Tolerance to Treatment|0
2197517|NCT01544582|3831860|FG001|Analysis Population|Bad Tolerance to Treatment|0
2197518|NCT01544582|3831861|FG002|Analysis Population|Bad Tolerance to Treatment|2
2197519|NCT01544582|3831862|FG003|Analysis Population|Bad Tolerance to Treatment|0
2197520|NCT01544582|3831859|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0
2197521|NCT01544582|3831860|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0
2197522|NCT01544582|3831861|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3
2197523|NCT01544582|3831862|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0
2197524|NCT01544582|3831859|FG000|Analysis Population|Intolerance|0
2197525|NCT01544582|3831860|FG001|Analysis Population|Intolerance|1
2197526|NCT01544582|3831861|FG002|Analysis Population|Intolerance|0
2197527|NCT01544582|3831862|FG003|Analysis Population|Intolerance|0
2197528|NCT01544582|3831859|FG000|Analysis Population|Liver Transplantation|0
2197529|NCT01544582|3831860|FG001|Analysis Population|Liver Transplantation|0
2197530|NCT01544582|3831861|FG002|Analysis Population|Liver Transplantation|1
2197531|NCT01544582|3831862|FG003|Analysis Population|Liver Transplantation|0
2197532|NCT01544582|3831859|FG000|Analysis Population|No Social Insurance|0
2197533|NCT01544582|3831860|FG001|Analysis Population|No Social Insurance|0
2197534|NCT01544582|3831861|FG002|Analysis Population|No Social Insurance|1
2197535|NCT01544582|3831862|FG003|Analysis Population|No Social Insurance|0
2197536|NCT01544582|3831859|FG000|Analysis Population|Poor Adherence|0
2197537|NCT01544582|3831860|FG001|Analysis Population|Poor Adherence|0
2197538|NCT01544582|3831861|FG002|Analysis Population|Poor Adherence|1
2197539|NCT01544582|3831862|FG003|Analysis Population|Poor Adherence|0
2197540|NCT01544582|3831859|FG000|Analysis Population|Poor Participant Compliance|0
2197541|NCT01544582|3831860|FG001|Analysis Population|Poor Participant Compliance|1
2197542|NCT01544582|3831861|FG002|Analysis Population|Poor Participant Compliance|0
2197543|NCT01544582|3831862|FG003|Analysis Population|Poor Participant Compliance|0
2197544|NCT01544582|3831859|FG000|Analysis Population|Programmed Surgery|0
2197545|NCT01544582|3831860|FG001|Analysis Population|Programmed Surgery|1
2274835|NCT02301897|3956201|FG001|Treatment Course 1|Withdrawal by Sponsor|0
2274836|NCT02301897|3956202|FG002|Treatment Course 1|Withdrawal by Sponsor|2
2274837|NCT02301897|3956200|FG000|Treatment Course 1|Withdrawal by Subject|0
2274838|NCT02301897|3956201|FG001|Treatment Course 1|Withdrawal by Subject|0
2274839|NCT02301897|3956202|FG002|Treatment Course 1|Withdrawal by Subject|2
2274840|NCT02301897|3956200|FG000|Treatment Course 1|Other Miscellaneous Reasons|1
2274841|NCT02301897|3956201|FG001|Treatment Course 1|Other Miscellaneous Reasons|0
2274842|NCT02301897|3956202|FG002|Treatment Course 1|Other Miscellaneous Reasons|0
2274843|NCT02301897|3956200|FG000|Treatment Course 2|Lost to Follow-up|0
2274844|NCT02301897|3956201|FG001|Treatment Course 2|Lost to Follow-up|2
2274845|NCT02301897|3956202|FG002|Treatment Course 2|Lost to Follow-up|0
2274846|NCT02301897|3956200|FG000|Treatment Course 2|Pregnancy|0
2274847|NCT02301897|3956201|FG001|Treatment Course 2|Pregnancy|1
2274848|NCT02301897|3956202|FG002|Treatment Course 2|Pregnancy|1
2274849|NCT02301897|3956200|FG000|Treatment Course 2|Withdrawal by Subject|0
2274850|NCT02301897|3956201|FG001|Treatment Course 2|Withdrawal by Subject|2
2274851|NCT02301897|3956202|FG002|Treatment Course 2|Withdrawal by Subject|0
2274852|NCT02301897|3956200|FG000|Treatment Course 2|Other Miscellaneous Reasons|1
2274853|NCT02301897|3956201|FG001|Treatment Course 2|Other Miscellaneous Reasons|0
2274854|NCT02301897|3956202|FG002|Treatment Course 2|Other Miscellaneous Reasons|0
2274855|NCT02301936|3956212|FG000|Overall Study|Lost to Follow-up|1
2274856|NCT02301936|3956213|FG001|Overall Study|Lost to Follow-up|0
2274857|NCT02301975|3956222|FG000|Overall Study|Adverse Event|8
2274858|NCT02301975|3956223|FG001|Overall Study|Adverse Event|3
2197546|NCT01544582|3831861|FG002|Analysis Population|Programmed Surgery|0
2197547|NCT01544582|3831862|FG003|Analysis Population|Programmed Surgery|0
2197548|NCT01544582|3831859|FG000|Analysis Population|Participant in Jail|0
2197549|NCT01544582|3831860|FG001|Analysis Population|Participant in Jail|0
2197550|NCT01544582|3831861|FG002|Analysis Population|Participant in Jail|1
2197551|NCT01544582|3831862|FG003|Analysis Population|Participant in Jail|0
2197552|NCT01544595|3831881|FG000|Status at Week 68|Adverse Event|3
2197553|NCT01544595|3831882|FG001|Status at Week 68|Adverse Event|2
2197554|NCT01544595|3831883|FG002|Status at Week 68|Adverse Event|1
2197555|NCT01544595|3831884|FG003|Status at Week 68|Adverse Event|0
2197556|NCT01544595|3831885|FG004|Status at Week 68|Adverse Event|0
2197557|NCT01544595|3831886|FG005|Status at Week 68|Adverse Event|0
2197558|NCT01544595|3831881|FG000|Status at Week 68|Lack of Efficacy|1
2197559|NCT01544595|3831882|FG001|Status at Week 68|Lack of Efficacy|0
2197560|NCT01544595|3831883|FG002|Status at Week 68|Lack of Efficacy|0
2197561|NCT01544595|3831884|FG003|Status at Week 68|Lack of Efficacy|0
2197562|NCT01544595|3831885|FG004|Status at Week 68|Lack of Efficacy|0
2197563|NCT01544595|3831886|FG005|Status at Week 68|Lack of Efficacy|0
2197564|NCT01544595|3831881|FG000|Status at Week 68|Lost to Follow-up|1
2197565|NCT01544595|3831882|FG001|Status at Week 68|Lost to Follow-up|1
2197566|NCT01544595|3831883|FG002|Status at Week 68|Lost to Follow-up|0
2197567|NCT01544595|3831884|FG003|Status at Week 68|Lost to Follow-up|0
2197568|NCT01544595|3831885|FG004|Status at Week 68|Lost to Follow-up|0
2197569|NCT01544595|3831886|FG005|Status at Week 68|Lost to Follow-up|0
2197570|NCT01544595|3831881|FG000|Status at Week 68|Non-compliance with study treatment|1
2197571|NCT01544595|3831882|FG001|Status at Week 68|Non-compliance with study treatment|0
2197572|NCT01544595|3831883|FG002|Status at Week 68|Non-compliance with study treatment|0
2197573|NCT01544595|3831884|FG003|Status at Week 68|Non-compliance with study treatment|1
2197574|NCT01544595|3831885|FG004|Status at Week 68|Non-compliance with study treatment|0
2197575|NCT01544595|3831886|FG005|Status at Week 68|Non-compliance with study treatment|0
2197576|NCT01544595|3831881|FG000|Status at Week 68|Protocol Violation|2
2197577|NCT01544595|3831882|FG001|Status at Week 68|Protocol Violation|0
2197578|NCT01544595|3831883|FG002|Status at Week 68|Protocol Violation|1
2197579|NCT01544595|3831884|FG003|Status at Week 68|Protocol Violation|1
2197580|NCT01544595|3831885|FG004|Status at Week 68|Protocol Violation|0
2197581|NCT01544595|3831886|FG005|Status at Week 68|Protocol Violation|0
2197582|NCT01544595|3831881|FG000|Status at Week 68|Technical problems|1
2197583|NCT01544595|3831882|FG001|Status at Week 68|Technical problems|0
2197584|NCT01544595|3831883|FG002|Status at Week 68|Technical problems|0
2197585|NCT01544595|3831884|FG003|Status at Week 68|Technical problems|1
2197586|NCT01544595|3831885|FG004|Status at Week 68|Technical problems|0
2197587|NCT01544595|3831886|FG005|Status at Week 68|Technical problems|0
2197588|NCT01544595|3831881|FG000|Status at Week 68|Withdrawal by Subject|0
2197589|NCT01544595|3831882|FG001|Status at Week 68|Withdrawal by Subject|1
2197590|NCT01544595|3831883|FG002|Status at Week 68|Withdrawal by Subject|1
2197591|NCT01544595|3831884|FG003|Status at Week 68|Withdrawal by Subject|2
2197592|NCT01544595|3831885|FG004|Status at Week 68|Withdrawal by Subject|0
2197593|NCT01544595|3831886|FG005|Status at Week 68|Withdrawal by Subject|0
2197594|NCT01544595|3831881|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30
2197595|NCT01544595|3831882|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13
2197596|NCT01544595|3831883|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60
2197597|NCT01544595|3831884|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46
2197598|NCT01544595|3831885|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0
2197599|NCT01544595|3831886|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0
2197600|NCT01544595|3831881|FG000|Status at Week 156|Withdrawal by Subject|9
2197601|NCT01544595|3831882|FG001|Status at Week 156|Withdrawal by Subject|10
2197602|NCT01544595|3831883|FG002|Status at Week 156|Withdrawal by Subject|4
2197603|NCT01544595|3831884|FG003|Status at Week 156|Withdrawal by Subject|9
2197604|NCT01544595|3831885|FG004|Status at Week 156|Withdrawal by Subject|20
2197605|NCT01544595|3831886|FG005|Status at Week 156|Withdrawal by Subject|6
2197606|NCT01544595|3831881|FG000|Status at Week 156|Adverse Event|9
2197607|NCT01544595|3831882|FG001|Status at Week 156|Adverse Event|11
2197608|NCT01544595|3831883|FG002|Status at Week 156|Adverse Event|1
2197609|NCT01544595|3831884|FG003|Status at Week 156|Adverse Event|3
2197610|NCT01544595|3831885|FG004|Status at Week 156|Adverse Event|4
2197611|NCT01544595|3831886|FG005|Status at Week 156|Adverse Event|2
2197612|NCT01544595|3831881|FG000|Status at Week 156|Lost to Follow-up|4
2197613|NCT01544595|3831882|FG001|Status at Week 156|Lost to Follow-up|4
2274859|NCT02301975|3956224|FG002|Overall Study|Adverse Event|2
2274860|NCT02301975|3956222|FG000|Overall Study|Lack of Efficacy|1
2274861|NCT02301975|3956223|FG001|Overall Study|Lack of Efficacy|1
2274862|NCT02301975|3956224|FG002|Overall Study|Lack of Efficacy|1
2274863|NCT02301975|3956222|FG000|Overall Study|Protocol Violation|3
2274864|NCT02301975|3956223|FG001|Overall Study|Protocol Violation|5
2274865|NCT02301975|3956224|FG002|Overall Study|Protocol Violation|3
2274866|NCT02301975|3956222|FG000|Overall Study|Lost to Follow-up|0
2274867|NCT02301975|3956223|FG001|Overall Study|Lost to Follow-up|2
2274868|NCT02301975|3956224|FG002|Overall Study|Lost to Follow-up|2
2274869|NCT02301975|3956222|FG000|Overall Study|Physician Decision|4
2274870|NCT02301975|3956223|FG001|Overall Study|Physician Decision|2
2274871|NCT02301975|3956224|FG002|Overall Study|Physician Decision|3
2197614|NCT01544595|3831883|FG002|Status at Week 156|Lost to Follow-up|0
2197615|NCT01544595|3831884|FG003|Status at Week 156|Lost to Follow-up|1
2197616|NCT01544595|3831885|FG004|Status at Week 156|Lost to Follow-up|4
2197617|NCT01544595|3831886|FG005|Status at Week 156|Lost to Follow-up|1
2197618|NCT01544595|3831881|FG000|Status at Week 156|Non-compliance with study treatement|0
2197619|NCT01544595|3831882|FG001|Status at Week 156|Non-compliance with study treatement|1
2197620|NCT01544595|3831883|FG002|Status at Week 156|Non-compliance with study treatement|0
2197621|NCT01544595|3831884|FG003|Status at Week 156|Non-compliance with study treatement|1
2197622|NCT01544595|3831885|FG004|Status at Week 156|Non-compliance with study treatement|0
2197623|NCT01544595|3831886|FG005|Status at Week 156|Non-compliance with study treatement|1
2197624|NCT01544595|3831881|FG000|Status at Week 156|Physician Decision|0
2197625|NCT01544595|3831882|FG001|Status at Week 156|Physician Decision|3
2197626|NCT01544595|3831883|FG002|Status at Week 156|Physician Decision|1
2197627|NCT01544595|3831884|FG003|Status at Week 156|Physician Decision|0
2197628|NCT01544595|3831885|FG004|Status at Week 156|Physician Decision|0
2197629|NCT01544595|3831886|FG005|Status at Week 156|Physician Decision|0
2197630|NCT01544595|3831881|FG000|Status at Week 156|Pregnancy|2
2197631|NCT01544595|3831882|FG001|Status at Week 156|Pregnancy|3
2197632|NCT01544595|3831883|FG002|Status at Week 156|Pregnancy|0
2197633|NCT01544595|3831884|FG003|Status at Week 156|Pregnancy|0
2197634|NCT01544595|3831885|FG004|Status at Week 156|Pregnancy|0
2197635|NCT01544595|3831886|FG005|Status at Week 156|Pregnancy|0
2197636|NCT01544595|3831881|FG000|Status at Week 156|Protocol Violation|3
2197637|NCT01544595|3831882|FG001|Status at Week 156|Protocol Violation|1
2197638|NCT01544595|3831883|FG002|Status at Week 156|Protocol Violation|2
2197639|NCT01544595|3831884|FG003|Status at Week 156|Protocol Violation|2
2197640|NCT01544595|3831885|FG004|Status at Week 156|Protocol Violation|0
2197641|NCT01544595|3831886|FG005|Status at Week 156|Protocol Violation|0
2197642|NCT01544595|3831881|FG000|Status at Week 156|Technical problems|3
2197643|NCT01544595|3831882|FG001|Status at Week 156|Technical problems|1
2197644|NCT01544595|3831883|FG002|Status at Week 156|Technical problems|0
2197645|NCT01544595|3831884|FG003|Status at Week 156|Technical problems|1
2197646|NCT01544595|3831885|FG004|Status at Week 156|Technical problems|0
2197647|NCT01544595|3831886|FG005|Status at Week 156|Technical problems|0
2197648|NCT01544595|3831881|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86
2197649|NCT01544595|3831882|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44
2197650|NCT01544595|3831883|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131
2197651|NCT01544595|3831884|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145
2197652|NCT01544595|3831885|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0
2197653|NCT01544595|3831886|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0
2197654|NCT01544595|3831881|FG000|Status at Week 156|Lack of Efficacy|1
2197655|NCT01544595|3831882|FG001|Status at Week 156|Lack of Efficacy|0
2197656|NCT01544595|3831883|FG002|Status at Week 156|Lack of Efficacy|1
2197657|NCT01544595|3831884|FG003|Status at Week 156|Lack of Efficacy|4
2197658|NCT01544595|3831885|FG004|Status at Week 156|Lack of Efficacy|10
2197659|NCT01544595|3831886|FG005|Status at Week 156|Lack of Efficacy|5
2197660|NCT01544920|3831906|FG000|Overall Study|Adverse Event|0
2197661|NCT01544920|3831907|FG001|Overall Study|Adverse Event|3
2197662|NCT01544920|3831906|FG000|Overall Study|Death|0
2197663|NCT01544920|3831907|FG001|Overall Study|Death|1
2197664|NCT01544920|3831906|FG000|Overall Study|Lost to Follow-up|11
2197665|NCT01544920|3831907|FG001|Overall Study|Lost to Follow-up|12
2197666|NCT01544920|3831906|FG000|Overall Study|Protocol Violation|0
2197667|NCT01544920|3831907|FG001|Overall Study|Protocol Violation|2
2274872|NCT02301975|3956222|FG000|Overall Study|Withdrawal by Subject|15
2274873|NCT02301975|3956223|FG001|Overall Study|Withdrawal by Subject|12
2274874|NCT02301975|3956224|FG002|Overall Study|Withdrawal by Subject|11
2274875|NCT02301988|3956234|FG000|Overall Study|Withdrawal by Subject|2
2274876|NCT02301988|3956235|FG001|Overall Study|Withdrawal by Subject|1
2274877|NCT02301988|3956234|FG000|Overall Study|Physician Decision|2
2274878|NCT02301988|3956235|FG001|Overall Study|Physician Decision|2
2274879|NCT02301988|3956234|FG000|Overall Study|Unknown Reason|1
2274880|NCT02301988|3956235|FG001|Overall Study|Unknown Reason|3
2274881|NCT02301988|3956234|FG000|Overall Study|Lack of Efficacy|3
2274882|NCT02301988|3956235|FG001|Overall Study|Lack of Efficacy|2
2274883|NCT02301988|3956234|FG000|Overall Study|Death|1
2274884|NCT02301988|3956235|FG001|Overall Study|Death|0
2274885|NCT02301988|3956234|FG000|Overall Study|Adverse Event|1
2274886|NCT02301988|3956235|FG001|Overall Study|Adverse Event|1
2274887|NCT02302066|3956245|FG000|Overall Study|Adverse Event|1
2274888|NCT02302066|3956246|FG001|Overall Study|Adverse Event|1
2274889|NCT02302066|3956247|FG002|Overall Study|Adverse Event|3
2274890|NCT02302066|3956248|FG003|Overall Study|Adverse Event|0
2274891|NCT02302066|3956245|FG000|Overall Study|Lost to Follow-up|4
2274892|NCT02302066|3956246|FG001|Overall Study|Lost to Follow-up|5
2274893|NCT02302066|3956247|FG002|Overall Study|Lost to Follow-up|24
2274894|NCT02302066|3956248|FG003|Overall Study|Lost to Follow-up|7
2274895|NCT02302066|3956245|FG000|Overall Study|Withdrawal by Subject|25
2274896|NCT02302066|3956246|FG001|Overall Study|Withdrawal by Subject|58
2274897|NCT02302066|3956247|FG002|Overall Study|Withdrawal by Subject|124
2274898|NCT02302066|3956248|FG003|Overall Study|Withdrawal by Subject|33
2274899|NCT02302066|3956245|FG000|Overall Study|Pregnancy|2
2197668|NCT01544920|3831906|FG000|Overall Study|Physician Decision|4
2197669|NCT01544920|3831907|FG001|Overall Study|Physician Decision|1
2197670|NCT01544920|3831906|FG000|Overall Study|Withdrawal by Subject|4
2197671|NCT01544920|3831907|FG001|Overall Study|Withdrawal by Subject|4
2197672|NCT01545076|3831924|FG000|IgPro10 Restabilization Period|Adverse Event|4
2197673|NCT01545076|3831925|FG001|IgPro10 Restabilization Period|Adverse Event|0
2197674|NCT01545076|3831926|FG002|IgPro10 Restabilization Period|Adverse Event|0
2197675|NCT01545076|3831927|FG003|IgPro10 Restabilization Period|Adverse Event|0
2197676|NCT01545076|3831928|FG004|IgPro10 Restabilization Period|Adverse Event|0
2197677|NCT01545076|3831924|FG000|IgPro10 Restabilization Period|Physician Decision|2
2197678|NCT01545076|3831925|FG001|IgPro10 Restabilization Period|Physician Decision|0
2197679|NCT01545076|3831926|FG002|IgPro10 Restabilization Period|Physician Decision|0
2197680|NCT01545076|3831927|FG003|IgPro10 Restabilization Period|Physician Decision|0
2197681|NCT01545076|3831928|FG004|IgPro10 Restabilization Period|Physician Decision|0
2197682|NCT01545076|3831924|FG000|IgPro10 Restabilization Period|Protocol Violation|1
2197683|NCT01545076|3831925|FG001|IgPro10 Restabilization Period|Protocol Violation|0
2197684|NCT01545076|3831926|FG002|IgPro10 Restabilization Period|Protocol Violation|0
2197685|NCT01545076|3831927|FG003|IgPro10 Restabilization Period|Protocol Violation|0
2197686|NCT01545076|3831928|FG004|IgPro10 Restabilization Period|Protocol Violation|0
2197687|NCT01545076|3831924|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
2197688|NCT01545076|3831925|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2197689|NCT01545076|3831926|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2197690|NCT01545076|3831927|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2197691|NCT01545076|3831928|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2197692|NCT01545076|3831924|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7
2197693|NCT01545076|3831925|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0
2274900|NCT02302066|3956246|FG001|Overall Study|Pregnancy|10
2274901|NCT02302066|3956247|FG002|Overall Study|Pregnancy|12
2274902|NCT02302066|3956248|FG003|Overall Study|Pregnancy|0
2274903|NCT02302066|3956245|FG000|Overall Study|Reason Not Specified|1
2274904|NCT02302066|3956246|FG001|Overall Study|Reason Not Specified|1
2274905|NCT02302066|3956247|FG002|Overall Study|Reason Not Specified|9
2274906|NCT02302066|3956248|FG003|Overall Study|Reason Not Specified|1
2274907|NCT02302222|3956305|FG000|Overall Study|Physician Decision|0
2274908|NCT02302222|3956306|FG001|Overall Study|Physician Decision|4
2274909|NCT02302222|3956305|FG000|Overall Study|Lost to Follow-up|1
2274910|NCT02302222|3956306|FG001|Overall Study|Lost to Follow-up|0
2274911|NCT02302222|3956305|FG000|Overall Study|Treatment discontinued before day 5|0
2274912|NCT02302222|3956306|FG001|Overall Study|Treatment discontinued before day 5|1
2274913|NCT02302222|3956305|FG000|Overall Study|Withdrawn prior to any treatment|0
2274914|NCT02302222|3956306|FG001|Overall Study|Withdrawn prior to any treatment|1
2274915|NCT02302339|3956316|FG000|Overall Study|Lost to Follow-up|1
2274916|NCT02302339|3956317|FG001|Overall Study|Lost to Follow-up|0
2274917|NCT02302339|3956318|FG002|Overall Study|Lost to Follow-up|0
2274918|NCT02302339|3956319|FG003|Overall Study|Lost to Follow-up|0
2274919|NCT02302339|3956316|FG000|Overall Study|Withdrawal by Subject|0
2274920|NCT02302339|3956317|FG001|Overall Study|Withdrawal by Subject|2
2274921|NCT02302339|3956318|FG002|Overall Study|Withdrawal by Subject|1
2274922|NCT02302339|3956319|FG003|Overall Study|Withdrawal by Subject|0
2274923|NCT02302716|3956340|FG000|Overall Study|Adverse Event|1
2274924|NCT02302716|3956341|FG001|Overall Study|Adverse Event|1
2274925|NCT02302716|3956340|FG000|Overall Study|Death|0
2274926|NCT02302716|3956341|FG001|Overall Study|Death|1
2274927|NCT02302716|3956340|FG000|Overall Study|Lack of Efficacy|0
2274928|NCT02302716|3956341|FG001|Overall Study|Lack of Efficacy|1
2274929|NCT02302716|3956340|FG000|Overall Study|Lost to Follow-up|2
2274930|NCT02302716|3956341|FG001|Overall Study|Lost to Follow-up|4
2274931|NCT02302716|3956340|FG000|Overall Study|Physician Decision|3
2274932|NCT02302716|3956341|FG001|Overall Study|Physician Decision|4
2274933|NCT02302716|3956340|FG000|Overall Study|Withdrawal by Subject|13
2274934|NCT02302716|3956341|FG001|Overall Study|Withdrawal by Subject|7
2274935|NCT02302716|3956340|FG000|Overall Study|Protocol Violation|0
2274936|NCT02302716|3956341|FG001|Overall Study|Protocol Violation|1
2274937|NCT02302807|3956349|FG000|Overall Study|Withdrawal by Subject|28
2274938|NCT02302807|3956350|FG001|Overall Study|Withdrawal by Subject|11
2274939|NCT02302807|3956349|FG000|Overall Study|Lost to Follow-up|4
2274940|NCT02302807|3956350|FG001|Overall Study|Lost to Follow-up|6
2274941|NCT02302807|3956349|FG000|Overall Study|Death|397
2274942|NCT02302807|3956350|FG001|Overall Study|Death|385
2274943|NCT02302807|3956349|FG000|Overall Study|Study Terminated By Sponsor|35
2274944|NCT02302807|3956350|FG001|Overall Study|Study Terminated By Sponsor|64
2274945|NCT02302807|3956349|FG000|Overall Study|Physician Decision|0
2274946|NCT02302807|3956350|FG001|Overall Study|Physician Decision|1
2274947|NCT02302846|3956369|FG000|Overall Study|Withdrawal by Subject|1
2274948|NCT02303041|3956375|FG000|Overall Study|Adverse Event|1
2274949|NCT02303041|3956376|FG001|Overall Study|Adverse Event|2
2197694|NCT01545076|3831926|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0
2197695|NCT01545076|3831927|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0
2197696|NCT01545076|3831928|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0
2197697|NCT01545076|3831924|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2197698|NCT01545076|3831925|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2197699|NCT01545076|3831926|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2197700|NCT01545076|3831927|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
2197701|NCT01545076|3831928|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2197702|NCT01545076|3831924|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
2197703|NCT01545076|3831925|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
2197704|NCT01545076|3831926|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
2197705|NCT01545076|3831927|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
2197706|NCT01545076|3831928|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
2197707|NCT01545076|3831924|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
2197708|NCT01545076|3831925|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
2197709|NCT01545076|3831926|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
2197710|NCT01545076|3831927|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
2197711|NCT01545076|3831928|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
2197712|NCT01545076|3831924|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
2197713|NCT01545076|3831925|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
2197714|NCT01545076|3831926|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
2197715|NCT01545076|3831927|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
2197716|NCT01545076|3831928|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
2197717|NCT01545375|3831990|FG000|Overall Study|Adverse Event|2
2197718|NCT01545375|3831991|FG001|Overall Study|Adverse Event|1
2197719|NCT01545375|3831990|FG000|Overall Study|Lost to Follow-up|34
2197720|NCT01545375|3831991|FG001|Overall Study|Lost to Follow-up|31
2197721|NCT01545375|3831990|FG000|Overall Study|Protocol Violation|3
2197722|NCT01545375|3831991|FG001|Overall Study|Protocol Violation|3
2197723|NCT01545375|3831990|FG000|Overall Study|Withdrawal by Subject|58
2197724|NCT01545375|3831991|FG001|Overall Study|Withdrawal by Subject|55
2197725|NCT01545388|3832000|FG000|Overall Study|Adverse Event|2
2197726|NCT01545388|3832001|FG001|Overall Study|Adverse Event|4
2197727|NCT01545388|3832002|FG002|Overall Study|Adverse Event|1
2197728|NCT01545388|3832000|FG000|Overall Study|Lack of Efficacy|3
2197729|NCT01545388|3832001|FG001|Overall Study|Lack of Efficacy|2
2197730|NCT01545388|3832002|FG002|Overall Study|Lack of Efficacy|5
2197731|NCT01545388|3832000|FG000|Overall Study|Participant moved or relocated|1
2197732|NCT01545388|3832001|FG001|Overall Study|Participant moved or relocated|0
2197733|NCT01545388|3832002|FG002|Overall Study|Participant moved or relocated|0
2197734|NCT01545388|3832000|FG000|Overall Study|Withdrawal by Subject|1
2197735|NCT01545388|3832001|FG001|Overall Study|Withdrawal by Subject|4
2197736|NCT01545388|3832002|FG002|Overall Study|Withdrawal by Subject|2
2197737|NCT01545388|3832000|FG000|Overall Study|Other|1
2197738|NCT01545388|3832001|FG001|Overall Study|Other|1
2197739|NCT01545388|3832002|FG002|Overall Study|Other|0
2197740|NCT01545817|3832106|FG000|Pazopanib|Disease progression|51
2197741|NCT01545817|3832107|FG001|Pazopanib|Disease progression|0
2197742|NCT01545817|3832106|FG000|Pazopanib|Adverse Event|19
2197743|NCT01545817|3832107|FG001|Pazopanib|Adverse Event|0
2197744|NCT01545817|3832106|FG000|Pazopanib|Other reason|4
2197745|NCT01545817|3832107|FG001|Pazopanib|Other reason|0
2197746|NCT01545817|3832106|FG000|Everolimus|Other reason|0
2197747|NCT01545817|3832107|FG001|Everolimus|Other reason|7
2197748|NCT01545817|3832106|FG000|Everolimus|Disease progression|0
2197749|NCT01545817|3832107|FG001|Everolimus|Disease progression|25
2197750|NCT01545817|3832106|FG000|Everolimus|Adverse Event|0
2197751|NCT01545817|3832107|FG001|Everolimus|Adverse Event|6
2197752|NCT01545934|3832133|FG000|Overall Study|Withdrawal by Subject|4
2197753|NCT01545934|3832134|FG001|Overall Study|Withdrawal by Subject|3
2197754|NCT01545934|3832133|FG000|Overall Study|Lost to Follow-up|1
2197755|NCT01545934|3832134|FG001|Overall Study|Lost to Follow-up|0
2197756|NCT01546038|3832147|FG000|Overall Study|Death|15
2197757|NCT01546038|3832148|FG001|Overall Study|Death|6
2197758|NCT01546038|3832149|FG002|Overall Study|Death|4
2197759|NCT01546038|3832150|FG003|Overall Study|Death|2
2197760|NCT01546038|3832151|FG004|Overall Study|Death|9
2197761|NCT01546038|3832152|FG005|Overall Study|Death|3
2197762|NCT01546038|3832153|FG006|Overall Study|Death|46
2197763|NCT01546038|3832154|FG007|Overall Study|Death|76
2197764|NCT01546038|3832155|FG008|Overall Study|Death|39
2197765|NCT01546038|3832147|FG000|Overall Study|Lost to Follow-up|0
2197766|NCT01546038|3832148|FG001|Overall Study|Lost to Follow-up|0
2197767|NCT01546038|3832149|FG002|Overall Study|Lost to Follow-up|0
2197768|NCT01546038|3832150|FG003|Overall Study|Lost to Follow-up|0
2197769|NCT01546038|3832151|FG004|Overall Study|Lost to Follow-up|1
2197770|NCT01546038|3832152|FG005|Overall Study|Lost to Follow-up|0
2197771|NCT01546038|3832153|FG006|Overall Study|Lost to Follow-up|2
2197772|NCT01546038|3832154|FG007|Overall Study|Lost to Follow-up|1
2197773|NCT01546038|3832155|FG008|Overall Study|Lost to Follow-up|0
2197774|NCT01546038|3832147|FG000|Overall Study|Withdrawal by Subject|1
2197775|NCT01546038|3832148|FG001|Overall Study|Withdrawal by Subject|0
2197776|NCT01546038|3832149|FG002|Overall Study|Withdrawal by Subject|0
2197777|NCT01546038|3832150|FG003|Overall Study|Withdrawal by Subject|1
2197778|NCT01546038|3832151|FG004|Overall Study|Withdrawal by Subject|0
2197779|NCT01546038|3832152|FG005|Overall Study|Withdrawal by Subject|1
2197780|NCT01546038|3832153|FG006|Overall Study|Withdrawal by Subject|3
2197781|NCT01546038|3832154|FG007|Overall Study|Withdrawal by Subject|3
2197782|NCT01546038|3832155|FG008|Overall Study|Withdrawal by Subject|1
2197783|NCT01546038|3832147|FG000|Overall Study|: Randomized, not treated|0
2197784|NCT01546038|3832148|FG001|Overall Study|: Randomized, not treated|0
2197785|NCT01546038|3832149|FG002|Overall Study|: Randomized, not treated|0
2197786|NCT01546038|3832150|FG003|Overall Study|: Randomized, not treated|0
2197787|NCT01546038|3832151|FG004|Overall Study|: Randomized, not treated|0
2197788|NCT01546038|3832152|FG005|Overall Study|: Randomized, not treated|0
2197789|NCT01546038|3832153|FG006|Overall Study|: Randomized, not treated|2
2197790|NCT01546038|3832154|FG007|Overall Study|: Randomized, not treated|4
2197791|NCT01546038|3832155|FG008|Overall Study|: Randomized, not treated|3
2197792|NCT01546142|3832207|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15
2197793|NCT01546142|3832208|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15
2197794|NCT01546142|3832207|FG000|Overall Study|Subject Noncompliance|1
2197795|NCT01546142|3832208|FG001|Overall Study|Subject Noncompliance|1
2197796|NCT01546142|3832207|FG000|Overall Study|Adverse Event|6
2197797|NCT01546142|3832208|FG001|Overall Study|Adverse Event|3
2197798|NCT01546142|3832207|FG000|Overall Study|Lost to Follow-up|20
2197799|NCT01546142|3832208|FG001|Overall Study|Lost to Follow-up|15
2197800|NCT01546142|3832207|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1
2197801|NCT01546142|3832208|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0
2197802|NCT01546142|3832207|FG000|Overall Study|Subject Randomized but Not Treated|1
2197803|NCT01546142|3832208|FG001|Overall Study|Subject Randomized but Not Treated|0
2197804|NCT01546155|3832214|FG000|Overall Study|could not tolerate long scan duration|3
2197805|NCT01546168|3832220|FG000|Overall Study|Lost to Follow-up|1
2197806|NCT01546168|3832221|FG001|Overall Study|Lost to Follow-up|0
2197807|NCT01546168|3832220|FG000|Overall Study|Withdrawal by Subject|1
2197808|NCT01546168|3832221|FG001|Overall Study|Withdrawal by Subject|0
2197809|NCT01546168|3832220|FG000|Overall Study|ineligible after signing consent|2
2197810|NCT01546168|3832221|FG001|Overall Study|ineligible after signing consent|0
2197811|NCT01546519|3832261|FG000|Overall Study|Adverse Event|0
2197812|NCT01546519|3832262|FG001|Overall Study|Adverse Event|0
2197813|NCT01546519|3832263|FG002|Overall Study|Adverse Event|1
2197814|NCT01546519|3832264|FG003|Overall Study|Adverse Event|1
2197815|NCT01546519|3832261|FG000|Overall Study|Death|0
2197816|NCT01546519|3832262|FG001|Overall Study|Death|1
2197817|NCT01546519|3832263|FG002|Overall Study|Death|3
2197818|NCT01546519|3832264|FG003|Overall Study|Death|1
2197819|NCT01546519|3832261|FG000|Overall Study|related to disease progression|2
2197820|NCT01546519|3832262|FG001|Overall Study|related to disease progression|2
2197821|NCT01546519|3832263|FG002|Overall Study|related to disease progression|2
2197822|NCT01546519|3832264|FG003|Overall Study|related to disease progression|1
2197823|NCT01546519|3832261|FG000|Overall Study|Physician Decision|6
2197824|NCT01546519|3832262|FG001|Overall Study|Physician Decision|5
2197825|NCT01546519|3832263|FG002|Overall Study|Physician Decision|2
2197826|NCT01546519|3832264|FG003|Overall Study|Physician Decision|3
2197827|NCT01546519|3832261|FG000|Overall Study|Withdrawal by Subject|1
2197828|NCT01546519|3832262|FG001|Overall Study|Withdrawal by Subject|0
2197829|NCT01546519|3832263|FG002|Overall Study|Withdrawal by Subject|0
2197830|NCT01546519|3832264|FG003|Overall Study|Withdrawal by Subject|0
2197831|NCT01546623|3832280|FG000|Overall Study|Adverse Event|2
2197832|NCT01546623|3832281|FG001|Overall Study|Adverse Event|3
2197833|NCT01546623|3832280|FG000|Overall Study|Major Protocol Deviation|1
2197834|NCT01546623|3832281|FG001|Overall Study|Major Protocol Deviation|1
2197835|NCT01546623|3832280|FG000|Overall Study|High Prostate specific antigen|2
2197836|NCT01546623|3832281|FG001|Overall Study|High Prostate specific antigen|1
2197837|NCT01546623|3832280|FG000|Overall Study|Did Not Receive Study Drug|1
2197838|NCT01546623|3832281|FG001|Overall Study|Did Not Receive Study Drug|1
2197839|NCT01546649|3832298|FG000|Overall Study|Adverse Event|4
2197840|NCT01546649|3832299|FG001|Overall Study|Adverse Event|5
2197841|NCT01546649|3832298|FG000|Overall Study|Protocol Violation|1
2197842|NCT01546649|3832299|FG001|Overall Study|Protocol Violation|0
2197843|NCT01546649|3832298|FG000|Overall Study|Lack of Efficacy|1
2197844|NCT01546649|3832299|FG001|Overall Study|Lack of Efficacy|0
2197845|NCT01546649|3832298|FG000|Overall Study|Recurrence|1
2197846|NCT01546649|3832299|FG001|Overall Study|Recurrence|1
2197847|NCT01546649|3832298|FG000|Overall Study|Discovery of secondary cancer|0
2197848|NCT01546649|3832299|FG001|Overall Study|Discovery of secondary cancer|1
2197849|NCT01546649|3832298|FG000|Overall Study|Withdrawal by Subject|1
2197850|NCT01546649|3832299|FG001|Overall Study|Withdrawal by Subject|2
2197851|NCT01546688|3832316|FG000|Overall Study|Adverse Event|0
2197852|NCT01546688|3832317|FG001|Overall Study|Adverse Event|4
2197853|NCT01546688|3832316|FG000|Overall Study|Withdrawal by Subject|2
2197854|NCT01546688|3832317|FG001|Overall Study|Withdrawal by Subject|1
2197855|NCT01546688|3832316|FG000|Overall Study|Lack of Efficacy|1
2197856|NCT01546688|3832317|FG001|Overall Study|Lack of Efficacy|0
2197857|NCT01546857|3832325|FG000|Overall Study|Withdrawal by Subject|2
2197858|NCT01546857|3832326|FG001|Overall Study|Withdrawal by Subject|3
2197859|NCT01546922|3832333|FG000|First Period of 10 Weeks|Protocol Violation|3
2197860|NCT01546922|3832334|FG001|First Period of 10 Weeks|Protocol Violation|1
2197861|NCT01546922|3832333|FG000|First Period of 10 Weeks|Withdrawal by Subject|1
2197862|NCT01546922|3832334|FG001|First Period of 10 Weeks|Withdrawal by Subject|1
2197863|NCT01546922|3832333|FG000|First Period of 10 Weeks|Investigator's judgment|1
2197864|NCT01546922|3832334|FG001|First Period of 10 Weeks|Investigator's judgment|0
2197865|NCT01546922|3832333|FG000|Second Period of 10 Weeks|Protocol Violation|3
2197866|NCT01546922|3832334|FG001|Second Period of 10 Weeks|Protocol Violation|1
2197867|NCT01546922|3832333|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0
2197868|NCT01546922|3832334|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2
2197869|NCT01547130|3832351|FG000|Overall Study|Lost to Follow-up|9
2197870|NCT01547130|3832352|FG001|Overall Study|Lost to Follow-up|5
2197871|NCT01547286|3832375|FG000|Overall Study|Did not meet all eligibility criteria|1
2197872|NCT01547286|3832375|FG000|Overall Study|Physician Decision|1
2197873|NCT01547299|3832382|FG000|Overall Study|Withdrawal by Subject|2
2197874|NCT01547299|3832383|FG001|Overall Study|Withdrawal by Subject|2
2197875|NCT01547390|3832391|FG000|Overall Study|Withdrawal by Subject|10
2197876|NCT01547390|3832392|FG001|Overall Study|Withdrawal by Subject|7
2197877|NCT01547390|3832391|FG000|Overall Study|termination of pregnancy|0
2197878|NCT01547390|3832392|FG001|Overall Study|termination of pregnancy|1
2197879|NCT01547390|3832391|FG000|Overall Study|Lost to Follow-up|0
2197880|NCT01547390|3832392|FG001|Overall Study|Lost to Follow-up|2
2197881|NCT01547390|3832391|FG000|Overall Study|Adverse Event|3
2197882|NCT01547390|3832392|FG001|Overall Study|Adverse Event|0
2197883|NCT01547598|3832400|FG000|Overall Study|Withdrew consent|1
2197884|NCT01547598|3832401|FG001|Overall Study|Withdrew consent|1
2197885|NCT01547598|3832400|FG000|Overall Study|Lost to Follow-up|1
2197886|NCT01547598|3832401|FG001|Overall Study|Lost to Follow-up|1
2197887|NCT01547598|3832400|FG000|Overall Study|Adverse Event|1
2197888|NCT01547598|3832401|FG001|Overall Study|Adverse Event|1
2197889|NCT01547598|3832400|FG000|Overall Study|Protocol Violation|1
2197890|NCT01547598|3832401|FG001|Overall Study|Protocol Violation|1
2197891|NCT01547598|3832400|FG000|Overall Study|Other Miscellaneous Reasons|2
2197892|NCT01547598|3832401|FG001|Overall Study|Other Miscellaneous Reasons|1
2197893|NCT01547780|3832426|FG000|Baseline PET Scan|Physician Decision|1
2197894|NCT01547780|3832427|FG001|Baseline PET Scan|Physician Decision|0
2197895|NCT01547780|3832428|FG002|Baseline PET Scan|Physician Decision|1
2197896|NCT01547780|3832429|FG003|Baseline PET Scan|Physician Decision|0
2197897|NCT01547780|3832426|FG000|Baseline PET Scan|Withdrawal by Subject|2
2197898|NCT01547780|3832427|FG001|Baseline PET Scan|Withdrawal by Subject|0
2197899|NCT01547780|3832428|FG002|Baseline PET Scan|Withdrawal by Subject|1
2197900|NCT01547780|3832429|FG003|Baseline PET Scan|Withdrawal by Subject|0
2197901|NCT01548287|3832457|FG000|Screening|No reason provided|0
2197902|NCT01548287|3832458|FG001|Screening|No reason provided|0
2197903|NCT01548287|3832459|FG002|Screening|No reason provided|0
2197904|NCT01548287|3832460|FG003|Screening|No reason provided|0
2197905|NCT01548287|3832461|FG004|Screening|No reason provided|9
2197906|NCT01548287|3832457|FG000|Screening|Did not meet eligibility criteria|0
2197907|NCT01548287|3832458|FG001|Screening|Did not meet eligibility criteria|0
2197908|NCT01548287|3832459|FG002|Screening|Did not meet eligibility criteria|0
2197909|NCT01548287|3832460|FG003|Screening|Did not meet eligibility criteria|0
2197910|NCT01548287|3832461|FG004|Screening|Did not meet eligibility criteria|74
2197911|NCT01548287|3832457|FG000|Randomized Period|Did not meet inclusion criteria|0
2197912|NCT01548287|3832458|FG001|Randomized Period|Did not meet inclusion criteria|0
2197913|NCT01548287|3832459|FG002|Randomized Period|Did not meet inclusion criteria|2
2197914|NCT01548287|3832460|FG003|Randomized Period|Did not meet inclusion criteria|0
2197915|NCT01548287|3832461|FG004|Randomized Period|Did not meet inclusion criteria|0
2197916|NCT01548287|3832457|FG000|Randomized Period|Adverse Event|0
2197917|NCT01548287|3832458|FG001|Randomized Period|Adverse Event|2
2197918|NCT01548287|3832459|FG002|Randomized Period|Adverse Event|5
2197919|NCT01548287|3832460|FG003|Randomized Period|Adverse Event|0
2197920|NCT01548287|3832461|FG004|Randomized Period|Adverse Event|0
2274950|NCT02303262|3956407|FG000|Overall Study|Withdrawal by Subject|2
2197921|NCT01548404|3832482|FG000|Overall Study|Adverse Event|3
2197922|NCT01548404|3832483|FG001|Overall Study|Adverse Event|1
2197923|NCT01548404|3832482|FG000|Overall Study|Physician Decision|2
2197924|NCT01548404|3832483|FG001|Overall Study|Physician Decision|1
2197925|NCT01548404|3832482|FG000|Overall Study|Inadequate response to study treatment|23
2197926|NCT01548404|3832483|FG001|Overall Study|Inadequate response to study treatment|7
2197927|NCT01548404|3832482|FG000|Overall Study|Lost to Follow-up|2
2197928|NCT01548404|3832483|FG001|Overall Study|Lost to Follow-up|0
2197929|NCT01548404|3832482|FG000|Overall Study|Withdrawal by Subject|0
2197930|NCT01548404|3832483|FG001|Overall Study|Withdrawal by Subject|3
2197931|NCT01548404|3832482|FG000|Overall Study|Other than specified above|0
2197932|NCT01548404|3832483|FG001|Overall Study|Other than specified above|2
2197933|NCT01548417|3832492|FG000|Overall Study|Withdrawal by Subject|0
2197934|NCT01548417|3832493|FG001|Overall Study|Withdrawal by Subject|2
2197935|NCT01548573|3832499|FG000|Overall Study|Death|3
2197936|NCT01548573|3832499|FG000|Overall Study|Withdrawal by Subject|2
2197937|NCT01548599|3832506|FG000|Overall Study|Lost to Follow-up|0
2197938|NCT01548599|3832507|FG001|Overall Study|Lost to Follow-up|1
2197939|NCT01548599|3832506|FG000|Overall Study|Withdrawal by Subject|4
2197940|NCT01548599|3832507|FG001|Overall Study|Withdrawal by Subject|0
2197941|NCT01548599|3832506|FG000|Overall Study|Death|2
2197942|NCT01548599|3832507|FG001|Overall Study|Death|1
2197943|NCT01548638|3832516|FG000|Overall Study|Protocol Violation|3
2197944|NCT01548638|3832516|FG000|Overall Study|Withdrawal by Subject|1
2197945|NCT01548768|3832556|FG000|Overall Study|Withdrawal by Subject|0
2197946|NCT01548768|3832557|FG001|Overall Study|Withdrawal by Subject|2
2197947|NCT01548768|3832558|FG002|Overall Study|Withdrawal by Subject|1
2197948|NCT01548768|3832559|FG003|Overall Study|Withdrawal by Subject|0
2197949|NCT01548768|3832556|FG000|Overall Study|Physician Decision|1
2197950|NCT01548768|3832557|FG001|Overall Study|Physician Decision|0
2197951|NCT01548768|3832558|FG002|Overall Study|Physician Decision|0
2197952|NCT01548768|3832559|FG003|Overall Study|Physician Decision|0
2197953|NCT01548768|3832556|FG000|Overall Study|Adverse Event|0
2197954|NCT01548768|3832557|FG001|Overall Study|Adverse Event|0
2197955|NCT01548768|3832558|FG002|Overall Study|Adverse Event|0
2197956|NCT01548768|3832559|FG003|Overall Study|Adverse Event|1
2197957|NCT01548768|3832556|FG000|Overall Study|Non-Compliance|0
2197958|NCT01548768|3832557|FG001|Overall Study|Non-Compliance|0
2197959|NCT01548768|3832558|FG002|Overall Study|Non-Compliance|0
2197960|NCT01548768|3832559|FG003|Overall Study|Non-Compliance|3
2197961|NCT01549002|3832585|FG000|Overall Study|Excessive pain|0
2197962|NCT01549002|3832586|FG001|Overall Study|Excessive pain|2
2197963|NCT01549002|3832585|FG000|Overall Study|Moderate sedation required|0
2197964|NCT01549002|3832586|FG001|Overall Study|Moderate sedation required|2
2197965|NCT01549041|3832594|FG000|Overall Study|Lack of Efficacy|2
2197966|NCT01549041|3832595|FG001|Overall Study|Lack of Efficacy|4
2197967|NCT01549041|3832594|FG000|Overall Study|Adverse Event|0
2197968|NCT01549041|3832595|FG001|Overall Study|Adverse Event|4
2197969|NCT01549275|3832612|FG000|Overall Study|Lost to Follow-up|1
2197970|NCT01549275|3832613|FG001|Overall Study|Lost to Follow-up|0
2216937|NCT01704287|3859995|FG000|Initial Treatment Period|Switched to Pembrolizumab|0
2216938|NCT01704287|3859996|FG001|Initial Treatment Period|Switched to Pembrolizumab|0
2216939|NCT01704287|3859997|FG002|Initial Treatment Period|Switched to Pembrolizumab|98
2216940|NCT01704287|3859998|FG003|Initial Treatment Period|Switched to Pembrolizumab|0
2216941|NCT01704287|3859999|FG004|Initial Treatment Period|Switched to Pembrolizumab|0
2216942|NCT01704287|3859995|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
2216943|NCT01704287|3859996|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
2216944|NCT01704287|3859997|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
2216945|NCT01704287|3859998|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
2216946|NCT01704287|3859999|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
2216947|NCT01704287|3859995|FG000|Switch to Pembrolizumab Treatment Period|Death|0
2216948|NCT01704287|3859996|FG001|Switch to Pembrolizumab Treatment Period|Death|0
2216949|NCT01704287|3859997|FG002|Switch to Pembrolizumab Treatment Period|Death|0
2216950|NCT01704287|3859998|FG003|Switch to Pembrolizumab Treatment Period|Death|35
2216951|NCT01704287|3859999|FG004|Switch to Pembrolizumab Treatment Period|Death|37
2216952|NCT01704287|3859995|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2216953|NCT01704287|3859996|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2216954|NCT01704287|3859997|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2216955|NCT01704287|3859998|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
2216956|NCT01704287|3859999|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2216957|NCT01704456|3860020|FG000|Overall Study|Lost to Follow-up|8
2216958|NCT01704456|3860021|FG001|Overall Study|Lost to Follow-up|14
2216959|NCT01704495|3860031|FG000|Subjects Randomized|Other Reason|3
2216960|NCT01704495|3860032|FG001|Subjects Randomized|Other Reason|2
2216961|NCT01704495|3860033|FG002|Subjects Randomized|Other Reason|3
2216962|NCT01704495|3860034|FG003|Subjects Randomized|Other Reason|2
2216963|NCT01704495|3860031|FG000|Subjects Randomized|Discontinuation criteria met|4
2216964|NCT01704495|3860032|FG001|Subjects Randomized|Discontinuation criteria met|2
2216965|NCT01704495|3860033|FG002|Subjects Randomized|Discontinuation criteria met|2
2216966|NCT01704495|3860034|FG003|Subjects Randomized|Discontinuation criteria met|0
2216967|NCT01704495|3860031|FG000|Subjects Randomized|Adverse Event|8
2216968|NCT01704495|3860032|FG001|Subjects Randomized|Adverse Event|2
2216969|NCT01704495|3860033|FG002|Subjects Randomized|Adverse Event|0
2216970|NCT01704495|3860034|FG003|Subjects Randomized|Adverse Event|7
2216971|NCT01704495|3860031|FG000|Subjects Randomized|Withdrawal by Subject|5
2216972|NCT01704495|3860032|FG001|Subjects Randomized|Withdrawal by Subject|5
2216973|NCT01704495|3860033|FG002|Subjects Randomized|Withdrawal by Subject|5
2216974|NCT01704495|3860034|FG003|Subjects Randomized|Withdrawal by Subject|5
2216975|NCT01704495|3860031|FG000|Subjects Randomized|Protocol Violation|1
2216976|NCT01704495|3860032|FG001|Subjects Randomized|Protocol Violation|1
2216977|NCT01704495|3860033|FG002|Subjects Randomized|Protocol Violation|2
2216978|NCT01704495|3860034|FG003|Subjects Randomized|Protocol Violation|0
2216979|NCT01704495|3860031|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1
2216980|NCT01704495|3860032|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3
2216981|NCT01704495|3860033|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4
2216982|NCT01704495|3860034|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3
2216983|NCT01704495|3860031|FG000|Optional Safety Extension|Adverse Event|0
2216984|NCT01704495|3860032|FG001|Optional Safety Extension|Adverse Event|4
2216985|NCT01704495|3860033|FG002|Optional Safety Extension|Adverse Event|0
2216986|NCT01704495|3860034|FG003|Optional Safety Extension|Adverse Event|1
2216987|NCT01704495|3860031|FG000|Optional Safety Extension|Other reason|27
2197971|NCT01549392|3832647|FG000|Overall Study|Withdrawal by Subject|1
2197972|NCT01549392|3832648|FG001|Overall Study|Withdrawal by Subject|0
2197973|NCT01549613|3832676|FG000|Overall Study|Lost to Follow-up|11
2197974|NCT01549613|3832677|FG001|Overall Study|Lost to Follow-up|11
2197975|NCT01549652|3832686|FG000|Overall Study|Did Not Receive Allocated Intervention|0
2197976|NCT01549652|3832687|FG001|Overall Study|Did Not Receive Allocated Intervention|0
2197977|NCT01549652|3832688|FG002|Overall Study|Did Not Receive Allocated Intervention|2
2197978|NCT01549652|3832689|FG003|Overall Study|Did Not Receive Allocated Intervention|0
2197979|NCT01549652|3832686|FG000|Overall Study|Study Drug Titration Failure|5
2197980|NCT01549652|3832687|FG001|Overall Study|Study Drug Titration Failure|6
2197981|NCT01549652|3832688|FG002|Overall Study|Study Drug Titration Failure|0
2197982|NCT01549652|3832689|FG003|Overall Study|Study Drug Titration Failure|0
2197983|NCT01549652|3832686|FG000|Overall Study|Withdrawal Effect|0
2197984|NCT01549652|3832687|FG001|Overall Study|Withdrawal Effect|2
2197985|NCT01549652|3832688|FG002|Overall Study|Withdrawal Effect|0
2197986|NCT01549652|3832689|FG003|Overall Study|Withdrawal Effect|0
2197987|NCT01549652|3832686|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5
2197988|NCT01549652|3832687|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1
2197989|NCT01549652|3832688|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0
2197990|NCT01549652|3832689|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0
2197991|NCT01549652|3832686|FG000|Overall Study|Problem with Infusion|1
2197992|NCT01549652|3832687|FG001|Overall Study|Problem with Infusion|0
2197993|NCT01549652|3832688|FG002|Overall Study|Problem with Infusion|0
2197994|NCT01549652|3832689|FG003|Overall Study|Problem with Infusion|0
2197995|NCT01549652|3832686|FG000|Overall Study|Titration Non-Compliance|1
2197996|NCT01549652|3832687|FG001|Overall Study|Titration Non-Compliance|3
2197997|NCT01549652|3832688|FG002|Overall Study|Titration Non-Compliance|4
2197998|NCT01549652|3832689|FG003|Overall Study|Titration Non-Compliance|5
2197999|NCT01549652|3832686|FG000|Overall Study|Titration Side Effects|0
2198000|NCT01549652|3832687|FG001|Overall Study|Titration Side Effects|0
2198001|NCT01549652|3832688|FG002|Overall Study|Titration Side Effects|6
2198002|NCT01549652|3832689|FG003|Overall Study|Titration Side Effects|3
2198003|NCT01549652|3832686|FG000|Overall Study|Withdrawal by Subject|0
2198004|NCT01549652|3832687|FG001|Overall Study|Withdrawal by Subject|0
2198005|NCT01549652|3832688|FG002|Overall Study|Withdrawal by Subject|5
2198006|NCT01549652|3832689|FG003|Overall Study|Withdrawal by Subject|3
2198007|NCT01549860|3832697|FG000|Overall Study|Withdrawal by Subject|1
2198008|NCT01549860|3832698|FG001|Overall Study|Withdrawal by Subject|0
2198009|NCT01549860|3832697|FG000|Overall Study|Physician Decision|1
2198010|NCT01549860|3832698|FG001|Overall Study|Physician Decision|1
2198011|NCT01549873|3832706|FG000|Overall Study|Physician Decision|0
2198012|NCT01549873|3832707|FG001|Overall Study|Physician Decision|1
2198013|NCT01549886|3832715|FG000|Overall Study|Sponsor's decision|2
2198014|NCT01549886|3832716|FG001|Overall Study|Sponsor's decision|3
2198015|NCT01549951|3832733|FG000|Overall Study|Adverse Event|15
2198016|NCT01549951|3832733|FG000|Overall Study|Withdrawal by Subject|2
2198017|NCT01549951|3832733|FG000|Overall Study|Unsatisfactory therapeutic response|1
2198018|NCT01549951|3832733|FG000|Overall Study|Progressive disease|29
2198019|NCT01549951|3832733|FG000|Overall Study|Symptomatic deterioration|1
2198020|NCT01549951|3832733|FG000|Overall Study|Other|2
2198021|NCT01549964|3832741|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50
2198022|NCT01549964|3832742|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104
2198023|NCT01549964|3832743|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104
2198024|NCT01549964|3832744|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105
2198025|NCT01549964|3832741|FG000|24-Week Treatment Period|Voluntary Withdrawal|6
2198026|NCT01549964|3832742|FG001|24-Week Treatment Period|Voluntary Withdrawal|3
2198027|NCT01549964|3832743|FG002|24-Week Treatment Period|Voluntary Withdrawal|3
2198028|NCT01549964|3832744|FG003|24-Week Treatment Period|Voluntary Withdrawal|8
2198029|NCT01549964|3832741|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
2274951|NCT02303574|3956432|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2274952|NCT02303574|3956433|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2274953|NCT02303574|3956434|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
2274954|NCT02303574|3956435|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2274955|NCT02303574|3956436|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2274956|NCT02303574|3956437|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2274957|NCT02303574|3956438|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2274958|NCT02303574|3956439|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2274959|NCT02303574|3956440|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2274960|NCT02303574|3956441|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2274961|NCT02303574|3956432|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2274962|NCT02303574|3956433|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2274963|NCT02303574|3956434|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2274964|NCT02303574|3956435|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2274965|NCT02303574|3956436|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2274966|NCT02303574|3956437|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2274967|NCT02303574|3956438|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2274968|NCT02303574|3956439|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
2198030|NCT01549964|3832742|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
2198031|NCT01549964|3832743|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
2198032|NCT01549964|3832744|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
2198033|NCT01549964|3832741|FG000|24-Week Treatment Period|Lost to Follow-up|1
2198034|NCT01549964|3832742|FG001|24-Week Treatment Period|Lost to Follow-up|0
2198035|NCT01549964|3832743|FG002|24-Week Treatment Period|Lost to Follow-up|1
2198036|NCT01549964|3832744|FG003|24-Week Treatment Period|Lost to Follow-up|2
2198037|NCT01549964|3832741|FG000|24-Week Treatment Period|Lack of Efficacy|1
2198038|NCT01549964|3832742|FG001|24-Week Treatment Period|Lack of Efficacy|0
2198039|NCT01549964|3832743|FG002|24-Week Treatment Period|Lack of Efficacy|1
2198040|NCT01549964|3832744|FG003|24-Week Treatment Period|Lack of Efficacy|1
2198041|NCT01549964|3832741|FG000|24-Week Treatment Period|Other|1
2198042|NCT01549964|3832742|FG001|24-Week Treatment Period|Other|0
2198043|NCT01549964|3832743|FG002|24-Week Treatment Period|Other|1
2198044|NCT01549964|3832744|FG003|24-Week Treatment Period|Other|0
2198045|NCT01549964|3832741|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
2198046|NCT01549964|3832742|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
2198047|NCT01549964|3832743|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
2198048|NCT01549964|3832744|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
2198049|NCT01549964|3832741|FG000|24-Week Treatment Period|Randomized but Not Treated|0
2198050|NCT01549964|3832742|FG001|24-Week Treatment Period|Randomized but Not Treated|0
2198051|NCT01549964|3832743|FG002|24-Week Treatment Period|Randomized but Not Treated|0
2198052|NCT01549964|3832744|FG003|24-Week Treatment Period|Randomized but Not Treated|1
2198053|NCT01549964|3832741|FG000|24-Week Treatment Period|Completion Status Unknown|1
2198054|NCT01549964|3832742|FG001|24-Week Treatment Period|Completion Status Unknown|0
2198055|NCT01549964|3832743|FG002|24-Week Treatment Period|Completion Status Unknown|1
2198056|NCT01549964|3832744|FG003|24-Week Treatment Period|Completion Status Unknown|0
2198057|NCT01549964|3832741|FG000|80-Week Extension Period|Pregnancy|0
2198058|NCT01549964|3832742|FG001|80-Week Extension Period|Pregnancy|0
2198059|NCT01549964|3832743|FG002|80-Week Extension Period|Pregnancy|1
2198060|NCT01549964|3832744|FG003|80-Week Extension Period|Pregnancy|0
2198061|NCT01549964|3832741|FG000|80-Week Extension Period|Study Terminated by Sponsor|65
2198062|NCT01549964|3832742|FG001|80-Week Extension Period|Study Terminated by Sponsor|137
2198063|NCT01549964|3832743|FG002|80-Week Extension Period|Study Terminated by Sponsor|132
2198064|NCT01549964|3832744|FG003|80-Week Extension Period|Study Terminated by Sponsor|132
2198065|NCT01549964|3832741|FG000|80-Week Extension Period|Voluntary Withdrawal|0
2198066|NCT01549964|3832742|FG001|80-Week Extension Period|Voluntary Withdrawal|1
2198067|NCT01549964|3832743|FG002|80-Week Extension Period|Voluntary Withdrawal|4
2198068|NCT01549964|3832744|FG003|80-Week Extension Period|Voluntary Withdrawal|2
2198069|NCT01549964|3832741|FG000|80-Week Extension Period|Lost to Follow-up|1
2198070|NCT01549964|3832742|FG001|80-Week Extension Period|Lost to Follow-up|0
2198071|NCT01549964|3832743|FG002|80-Week Extension Period|Lost to Follow-up|2
2198072|NCT01549964|3832744|FG003|80-Week Extension Period|Lost to Follow-up|1
2198073|NCT01549964|3832741|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0
2198074|NCT01549964|3832742|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0
2198075|NCT01549964|3832743|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1
2198076|NCT01549964|3832744|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2
2198077|NCT01550289|3832765|FG000|Overall Study|Protocol Violation|1
2198078|NCT01550289|3832766|FG001|Overall Study|Protocol Violation|0
2198079|NCT01550289|3832765|FG000|Overall Study|Lost to Follow-up|1
2198080|NCT01550289|3832766|FG001|Overall Study|Lost to Follow-up|1
2198081|NCT01550289|3832765|FG000|Overall Study|Withdrawal by Subject|11
2198082|NCT01550289|3832766|FG001|Overall Study|Withdrawal by Subject|3
2198083|NCT01550744|3832829|FG000|Open-Label|Lost to Follow-up|7
2198084|NCT01550744|3832830|FG001|Open-Label|Lost to Follow-up|0
2198085|NCT01550744|3832831|FG002|Open-Label|Lost to Follow-up|0
2198086|NCT01550744|3832829|FG000|Open-Label|Withdrawal by Subject|13
2198087|NCT01550744|3832830|FG001|Open-Label|Withdrawal by Subject|0
2198088|NCT01550744|3832831|FG002|Open-Label|Withdrawal by Subject|0
2198089|NCT01550744|3832829|FG000|Open-Label|Adverse Event|11
2198090|NCT01550744|3832830|FG001|Open-Label|Adverse Event|0
2198091|NCT01550744|3832831|FG002|Open-Label|Adverse Event|0
2198092|NCT01550744|3832829|FG000|Open-Label|Lack of Efficacy|4
2198093|NCT01550744|3832830|FG001|Open-Label|Lack of Efficacy|0
2198094|NCT01550744|3832831|FG002|Open-Label|Lack of Efficacy|0
2198095|NCT01550744|3832829|FG000|Open-Label|Protocol Violation|4
2198096|NCT01550744|3832830|FG001|Open-Label|Protocol Violation|0
2198097|NCT01550744|3832831|FG002|Open-Label|Protocol Violation|0
2198098|NCT01550744|3832829|FG000|Open-Label|Not all 3 study drug injections received|2
2198099|NCT01550744|3832830|FG001|Open-Label|Not all 3 study drug injections received|0
2198100|NCT01550744|3832831|FG002|Open-Label|Not all 3 study drug injections received|0
2198101|NCT01550744|3832829|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58
2198102|NCT01550744|3832830|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0
2198103|NCT01550744|3832831|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0
2198104|NCT01550744|3832829|FG000|Open-Label|Other|1
2198105|NCT01550744|3832830|FG001|Open-Label|Other|0
2198106|NCT01550744|3832831|FG002|Open-Label|Other|0
2198107|NCT01550744|3832829|FG000|Double-Blind|Lost to Follow-up|0
2274969|NCT02303574|3956440|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2198108|NCT01550744|3832830|FG001|Double-Blind|Lost to Follow-up|6
2198109|NCT01550744|3832831|FG002|Double-Blind|Lost to Follow-up|12
2198110|NCT01550744|3832829|FG000|Double-Blind|Withdrawal by Subject|0
2198111|NCT01550744|3832830|FG001|Double-Blind|Withdrawal by Subject|2
2198112|NCT01550744|3832831|FG002|Double-Blind|Withdrawal by Subject|15
2198113|NCT01550744|3832829|FG000|Double-Blind|Adverse Event|0
2198114|NCT01550744|3832830|FG001|Double-Blind|Adverse Event|4
2198115|NCT01550744|3832831|FG002|Double-Blind|Adverse Event|15
2198116|NCT01550744|3832829|FG000|Double-Blind|Death|0
2198117|NCT01550744|3832830|FG001|Double-Blind|Death|1
2198118|NCT01550744|3832831|FG002|Double-Blind|Death|0
2198119|NCT01550744|3832829|FG000|Double-Blind|Lack of Efficacy|0
2198120|NCT01550744|3832830|FG001|Double-Blind|Lack of Efficacy|2
2198121|NCT01550744|3832831|FG002|Double-Blind|Lack of Efficacy|8
2198122|NCT01550744|3832829|FG000|Double-Blind|Protocol Violation|0
2198123|NCT01550744|3832830|FG001|Double-Blind|Protocol Violation|0
2198124|NCT01550744|3832831|FG002|Double-Blind|Protocol Violation|4
2198125|NCT01550744|3832829|FG000|Double-Blind|Pregnancy|0
2198126|NCT01550744|3832830|FG001|Double-Blind|Pregnancy|0
2198127|NCT01550744|3832831|FG002|Double-Blind|Pregnancy|3
2198128|NCT01550744|3832829|FG000|Double-Blind|Other|0
2198129|NCT01550744|3832830|FG001|Double-Blind|Other|2
2198130|NCT01550744|3832831|FG002|Double-Blind|Other|10
2198131|NCT01550757|3832842|FG000|Overall Study|Lost to Follow-up|21
2198132|NCT01550757|3832843|FG001|Overall Study|Lost to Follow-up|14
2198133|NCT01550757|3832844|FG002|Overall Study|Lost to Follow-up|42
2198134|NCT01550757|3832845|FG003|Overall Study|Lost to Follow-up|53
2198135|NCT01550757|3832842|FG000|Overall Study|Withdrawal by Subject|2
2198136|NCT01550757|3832843|FG001|Overall Study|Withdrawal by Subject|0
2198137|NCT01550757|3832844|FG002|Overall Study|Withdrawal by Subject|3
2198138|NCT01550757|3832845|FG003|Overall Study|Withdrawal by Subject|1
2198139|NCT01550965|3832868|FG000|Overall Study|Adverse Event|26
2198140|NCT01550965|3832868|FG000|Overall Study|Withdrawal by Subject|10
2198141|NCT01550965|3832868|FG000|Overall Study|Lost to Follow-up|2
2198142|NCT01550965|3832868|FG000|Overall Study|Lack of Efficacy|59
2198143|NCT01550965|3832868|FG000|Overall Study|Other|13
2198144|NCT01551173|3832892|FG000|Overall Study|Withdrawal by Subject|11
2198145|NCT01551173|3832893|FG001|Overall Study|Withdrawal by Subject|16
2198146|NCT01551173|3832892|FG000|Overall Study|Adverse Event|7
2198147|NCT01551173|3832893|FG001|Overall Study|Adverse Event|6
2198148|NCT01551173|3832892|FG000|Overall Study|Lost to Follow-up|5
2198149|NCT01551173|3832893|FG001|Overall Study|Lost to Follow-up|7
2198150|NCT01551173|3832892|FG000|Overall Study|Other|5
2198151|NCT01551173|3832893|FG001|Overall Study|Other|3
2198152|NCT01551212|3832915|FG000|Overall Study|Graft loss/Retransplantation|0
2198153|NCT01551212|3832916|FG001|Overall Study|Graft loss/Retransplantation|1
2198154|NCT01551212|3832915|FG000|Overall Study|Administrative problems|1
2198155|NCT01551212|3832916|FG001|Overall Study|Administrative problems|2
2198156|NCT01551212|3832915|FG000|Overall Study|Lost to Follow-up|0
2198157|NCT01551212|3832916|FG001|Overall Study|Lost to Follow-up|1
2198158|NCT01551212|3832915|FG000|Overall Study|Protocol Violation|0
2198159|NCT01551212|3832916|FG001|Overall Study|Protocol Violation|1
2198160|NCT01551212|3832915|FG000|Overall Study|Withdrawal by Subject|0
2198161|NCT01551212|3832916|FG001|Overall Study|Withdrawal by Subject|7
2198162|NCT01551212|3832915|FG000|Overall Study|Death|2
2198163|NCT01551212|3832916|FG001|Overall Study|Death|4
2198164|NCT01551212|3832915|FG000|Overall Study|Never Received Study Treatment|2
2198165|NCT01551212|3832916|FG001|Overall Study|Never Received Study Treatment|4
2198166|NCT01551303|3832933|FG000|Overall Study|failed awareness check on vision test|4
2198167|NCT01551303|3832934|FG001|Overall Study|failed awareness check on vision test|7
2198168|NCT01551355|3832946|FG000|Overall Study|Lost to Follow-up|51
2198169|NCT01551355|3832947|FG001|Overall Study|Lost to Follow-up|49
2198170|NCT01551355|3832948|FG002|Overall Study|Lost to Follow-up|34
2198171|NCT01551355|3832949|FG003|Overall Study|Lost to Follow-up|24
2198172|NCT01551355|3832950|FG004|Overall Study|Lost to Follow-up|9
2198173|NCT01551355|3832951|FG005|Overall Study|Lost to Follow-up|6
2198174|NCT01551420|3832961|FG000|In-laboratory (Part A)|Lost to Follow-up|2
2198175|NCT01551420|3832962|FG001|In-laboratory (Part A)|Lost to Follow-up|1
2198176|NCT01551420|3832961|FG000|In-laboratory (Part A)|Withdrawal by Subject|2
2198177|NCT01551420|3832962|FG001|In-laboratory (Part A)|Withdrawal by Subject|0
2198178|NCT01551420|3832961|FG000|In-laboratory (Part A)|Scheduling conflict|2
2198179|NCT01551420|3832962|FG001|In-laboratory (Part A)|Scheduling conflict|1
2198180|NCT01551420|3832961|FG000|Screened for Part B Eligibility|Declined participation|8
2198181|NCT01551420|3832962|FG001|Screened for Part B Eligibility|Declined participation|1
2198182|NCT01551420|3832961|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1
2198183|NCT01551420|3832962|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2
2198184|NCT01551420|3832961|FG000|Home Use (Part B)|Withdrawal by Subject|6
2198185|NCT01551420|3832962|FG001|Home Use (Part B)|Withdrawal by Subject|0
2198186|NCT01551420|3832961|FG000|Home Use (Part B)|Withdrawal by staff|0
2198187|NCT01551420|3832962|FG001|Home Use (Part B)|Withdrawal by staff|1
2198188|NCT01551693|3832979|FG000|Overall Study|Disease Progression|1
2198189|NCT01551693|3832980|FG001|Overall Study|Disease Progression|0
2198190|NCT01551693|3832979|FG000|Overall Study|Adverse Event|0
2198191|NCT01551693|3832980|FG001|Overall Study|Adverse Event|1
2198192|NCT01551693|3832979|FG000|Overall Study|Withdrawal by Subject|0
2198193|NCT01551693|3832980|FG001|Overall Study|Withdrawal by Subject|1
2198194|NCT01551745|3832986|FG000|Overall Study|Withdrawal by Subject|1
2198195|NCT01551745|3832986|FG000|Overall Study|Disease Progression|2
2198196|NCT01551758|3832992|FG000|Overall Study|Adverse Event|29
2198197|NCT01551758|3832993|FG001|Overall Study|Adverse Event|43
2198198|NCT01551758|3832992|FG000|Overall Study|Lack of Efficacy|0
2198199|NCT01551758|3832993|FG001|Overall Study|Lack of Efficacy|1
2198200|NCT01551758|3832992|FG000|Overall Study|Protocol Violation|5
2198201|NCT01551758|3832993|FG001|Overall Study|Protocol Violation|6
2198202|NCT01551758|3832992|FG000|Overall Study|Met Protocol-defined stopping criteria|8
2198203|NCT01551758|3832993|FG001|Overall Study|Met Protocol-defined stopping criteria|10
2198204|NCT01551758|3832992|FG000|Overall Study|Lost to Follow-up|29
2198205|NCT01551758|3832993|FG001|Overall Study|Lost to Follow-up|25
2198206|NCT01551758|3832992|FG000|Overall Study|Physician Decision|9
2198207|NCT01551758|3832993|FG001|Overall Study|Physician Decision|3
2198208|NCT01551758|3832992|FG000|Overall Study|Withdrawal by Subject|14
2198209|NCT01551758|3832993|FG001|Overall Study|Withdrawal by Subject|17
2198210|NCT01552057|3833021|FG000|Overall Study|Adverse Event|14
2198211|NCT01552057|3833022|FG001|Overall Study|Adverse Event|15
2198212|NCT01552057|3833021|FG000|Overall Study|Lack of Efficacy|8
2198213|NCT01552057|3833022|FG001|Overall Study|Lack of Efficacy|23
2198214|NCT01552057|3833021|FG000|Overall Study|Withdrawal by Subject|5
2198215|NCT01552057|3833022|FG001|Overall Study|Withdrawal by Subject|8
2198216|NCT01552057|3833021|FG000|Overall Study|Entry Criteria Not Met|2
2198217|NCT01552057|3833022|FG001|Overall Study|Entry Criteria Not Met|2
2198218|NCT01552057|3833021|FG000|Overall Study|Physician Decision|1
2198219|NCT01552057|3833022|FG001|Overall Study|Physician Decision|0
2198220|NCT01552369|3833057|FG000|Overall Study|Did not consent to extended follow up|8
2274970|NCT02303574|3956441|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2274971|NCT02303704|3956476|FG000|Overall Study|Protocol Violation|5
2274972|NCT02303704|3956477|FG001|Overall Study|Protocol Violation|9
2274973|NCT02304380|3956516|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
2274974|NCT02304380|3956517|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
2274975|NCT02304380|3956518|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
2274976|NCT02304380|3956519|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34
2274977|NCT02304380|3956520|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
2274978|NCT02304380|3956521|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
2274979|NCT02304484|3956557|FG000|Overall Study|Death|9
2274980|NCT02304484|3956557|FG000|Overall Study|Withdrawal by Subject|14
2274981|NCT02304484|3956557|FG000|Overall Study|Lost to Follow-up|2
2274982|NCT02304705|3956563|FG000|Overall Study|Withdrawal by Subject|2
2274983|NCT02304705|3956564|FG001|Overall Study|Withdrawal by Subject|0
2274984|NCT02304705|3956563|FG000|Overall Study|Physician Decision|2
2274985|NCT02304705|3956564|FG001|Overall Study|Physician Decision|4
2274986|NCT02304705|3956563|FG000|Overall Study|Death|0
2274987|NCT02304705|3956564|FG001|Overall Study|Death|1
2274988|NCT02304705|3956563|FG000|Overall Study|Lost to Follow-up|0
2274989|NCT02304705|3956564|FG001|Overall Study|Lost to Follow-up|2
2274990|NCT02304926|3956581|FG000|Overall Study|Lost to Follow-up|2
2274991|NCT02304926|3956582|FG001|Overall Study|Lost to Follow-up|1
2274992|NCT02305238|3956606|FG000|Overall Study|Death|2
2274993|NCT02305238|3956607|FG001|Overall Study|Death|1
2274994|NCT02305238|3956608|FG002|Overall Study|Death|0
2274995|NCT02305238|3956606|FG000|Overall Study|Progressive disease|4
2274996|NCT02305238|3956607|FG001|Overall Study|Progressive disease|4
2274997|NCT02305238|3956608|FG002|Overall Study|Progressive disease|0
2274998|NCT02305238|3956606|FG000|Overall Study|Logistical difficulties|1
2274999|NCT02305238|3956607|FG001|Overall Study|Logistical difficulties|3
2275000|NCT02305238|3956608|FG002|Overall Study|Logistical difficulties|0
2275001|NCT02305238|3956606|FG000|Overall Study|Protocol Violation|0
2275002|NCT02305238|3956607|FG001|Overall Study|Protocol Violation|3
2275003|NCT02305238|3956608|FG002|Overall Study|Protocol Violation|0
2275004|NCT02305238|3956606|FG000|Overall Study|Physician Decision|2
2275005|NCT02305238|3956607|FG001|Overall Study|Physician Decision|1
2275006|NCT02305238|3956608|FG002|Overall Study|Physician Decision|0
2275007|NCT02305238|3956606|FG000|Overall Study|Adverse Event|4
2275008|NCT02305238|3956607|FG001|Overall Study|Adverse Event|2
2275009|NCT02305238|3956608|FG002|Overall Study|Adverse Event|0
2275010|NCT02305238|3956606|FG000|Overall Study|Withdrawal by Subject|3
2275011|NCT02305238|3956607|FG001|Overall Study|Withdrawal by Subject|4
2275012|NCT02305238|3956608|FG002|Overall Study|Withdrawal by Subject|0
2275013|NCT02305238|3956606|FG000|Overall Study|Randomized failure|0
2275014|NCT02305238|3956607|FG001|Overall Study|Randomized failure|0
2275015|NCT02305238|3956608|FG002|Overall Study|Randomized failure|8
2275016|NCT02305238|3956606|FG000|Overall Study|Required procedure failed|0
2275017|NCT02305238|3956607|FG001|Overall Study|Required procedure failed|1
2275018|NCT02305238|3956608|FG002|Overall Study|Required procedure failed|0
2275019|NCT02305381|3956669|FG000|Overall Study|Unclassified|5
2275020|NCT02305381|3956670|FG001|Overall Study|Unclassified|5
2275021|NCT02305381|3956671|FG002|Overall Study|Unclassified|7
2275022|NCT02305446|3956679|FG000|Overall Study|Adverse Event|1
2275023|NCT02305563|3956688|FG000|Treatment Period|Disease progression|0
2198221|NCT01552369|3833058|FG001|Overall Study|Did not consent to extended follow up|9
2198222|NCT01552408|3833068|FG000|Overall Study|Lost to Follow-up|2
2198223|NCT01552408|3833069|FG001|Overall Study|Lost to Follow-up|0
2198224|NCT01552408|3833068|FG000|Overall Study|Relocation|0
2198225|NCT01552408|3833069|FG001|Overall Study|Relocation|1
2198226|NCT01552408|3833068|FG000|Overall Study|Withdrawal by Subject|2
2198227|NCT01552408|3833069|FG001|Overall Study|Withdrawal by Subject|1
2198228|NCT01552603|3833076|FG000|Overall Study|Physician Decision|1
2198229|NCT01552681|3833082|FG000|Overall Study|Withdrawal by Subject|4
2198230|NCT01552681|3833083|FG001|Overall Study|Withdrawal by Subject|0
2198231|NCT01552681|3833082|FG000|Overall Study|Physician Decision|1
2198232|NCT01552681|3833083|FG001|Overall Study|Physician Decision|0
2198233|NCT01552681|3833082|FG000|Overall Study|Subject moved away|0
2198234|NCT01552681|3833083|FG001|Overall Study|Subject moved away|1
2198235|NCT01552694|3833091|FG000|Overall Study|Lost to Follow-up|0
2198236|NCT01552694|3833092|FG001|Overall Study|Lost to Follow-up|1
2198237|NCT01552694|3833091|FG000|Overall Study|Protocol Violation|0
2198238|NCT01552694|3833092|FG001|Overall Study|Protocol Violation|1
2198239|NCT01552772|3833098|FG000|Overall Study|Lost to Follow-up|2
2198240|NCT01552772|3833098|FG000|Overall Study|Adverse Event|1
2198241|NCT01552772|3833098|FG000|Overall Study|Protocol Deviation|1
2198242|NCT01552902|3833130|FG000|Overall Study|Adverse Event|1
2198243|NCT01552902|3833131|FG001|Overall Study|Adverse Event|15
2198244|NCT01552902|3833132|FG002|Overall Study|Adverse Event|14
2198245|NCT01552902|3833130|FG000|Overall Study|Protocol Violation|3
2198246|NCT01552902|3833131|FG001|Overall Study|Protocol Violation|3
2198247|NCT01552902|3833132|FG002|Overall Study|Protocol Violation|3
2198248|NCT01552902|3833130|FG000|Overall Study|Lack of Efficacy|4
2198249|NCT01552902|3833131|FG001|Overall Study|Lack of Efficacy|3
2198250|NCT01552902|3833132|FG002|Overall Study|Lack of Efficacy|1
2198251|NCT01552902|3833130|FG000|Overall Study|Withdrawal by Subject|1
2198252|NCT01552902|3833131|FG001|Overall Study|Withdrawal by Subject|9
2198253|NCT01552902|3833132|FG002|Overall Study|Withdrawal by Subject|6
2198254|NCT01552902|3833130|FG000|Overall Study|Lost to Follow-up|1
2198255|NCT01552902|3833131|FG001|Overall Study|Lost to Follow-up|3
2198256|NCT01552902|3833132|FG002|Overall Study|Lost to Follow-up|6
2198257|NCT01552902|3833130|FG000|Overall Study|Other|3
2198258|NCT01552902|3833131|FG001|Overall Study|Other|4
2198259|NCT01552902|3833132|FG002|Overall Study|Other|3
2198260|NCT01552915|3833143|FG000|Overall Study|Adverse Event|3
2198261|NCT01552915|3833144|FG001|Overall Study|Adverse Event|14
2198262|NCT01552915|3833145|FG002|Overall Study|Adverse Event|3
2198263|NCT01552915|3833143|FG000|Overall Study|Lost to Follow-up|4
2198264|NCT01552915|3833144|FG001|Overall Study|Lost to Follow-up|6
2198265|NCT01552915|3833145|FG002|Overall Study|Lost to Follow-up|5
2198266|NCT01552915|3833143|FG000|Overall Study|Withdrawal by Subject|6
2198267|NCT01552915|3833144|FG001|Overall Study|Withdrawal by Subject|4
2198268|NCT01552915|3833145|FG002|Overall Study|Withdrawal by Subject|5
2198269|NCT01552915|3833143|FG000|Overall Study|Protocol Violation|0
2198270|NCT01552915|3833144|FG001|Overall Study|Protocol Violation|4
2198271|NCT01552915|3833145|FG002|Overall Study|Protocol Violation|4
2198272|NCT01552915|3833143|FG000|Overall Study|Lack of Efficacy|8
2198273|NCT01552915|3833144|FG001|Overall Study|Lack of Efficacy|1
2198274|NCT01552915|3833145|FG002|Overall Study|Lack of Efficacy|4
2198275|NCT01552915|3833143|FG000|Overall Study|Other|2
2198276|NCT01552915|3833144|FG001|Overall Study|Other|0
2198277|NCT01552915|3833145|FG002|Overall Study|Other|6
2198278|NCT01552928|3833157|FG000|Period 3|Adverse Event|0
2198279|NCT01552928|3833158|FG001|Period 3|Adverse Event|0
2198280|NCT01552928|3833159|FG002|Period 3|Adverse Event|1
2198281|NCT01552928|3833160|FG003|Period 3|Adverse Event|0
2198282|NCT01552954|3833179|FG000|Overall Study|Adverse Event|1
2198283|NCT01552954|3833180|FG001|Overall Study|Adverse Event|2
2198284|NCT01552954|3833179|FG000|Overall Study|Lost to Follow-up|1
2198285|NCT01552954|3833180|FG001|Overall Study|Lost to Follow-up|1
2198286|NCT01552954|3833179|FG000|Overall Study|Withdrawal by Subject|1
2198287|NCT01552954|3833180|FG001|Overall Study|Withdrawal by Subject|1
2198288|NCT01552954|3833179|FG000|Overall Study|Protocol Violation|1
2198289|NCT01552954|3833180|FG001|Overall Study|Protocol Violation|2
2198290|NCT01552954|3833179|FG000|Overall Study|diagnosed DM|1
2198291|NCT01552954|3833180|FG001|Overall Study|diagnosed DM|0
2198292|NCT01553084|3833206|FG000|Overall Study|Withdrawal by Subject|15
2198293|NCT01553084|3833207|FG001|Overall Study|Withdrawal by Subject|13
2198294|NCT01553084|3833208|FG002|Overall Study|Withdrawal by Subject|35
2198295|NCT01553136|3833220|FG000|Overall Study|Adverse Event|3
2198296|NCT01553136|3833221|FG001|Overall Study|Adverse Event|2
2275024|NCT02305563|3956689|FG001|Treatment Period|Disease progression|0
2275025|NCT02305563|3956690|FG002|Treatment Period|Disease progression|15
2275026|NCT02305563|3956691|FG003|Treatment Period|Disease progression|6
2275027|NCT02305563|3956692|FG004|Treatment Period|Disease progression|6
2275028|NCT02305563|3956688|FG000|Treatment Period|Study drug toxicity|0
2275029|NCT02305563|3956689|FG001|Treatment Period|Study drug toxicity|0
2198297|NCT01553136|3833220|FG000|Overall Study|Withdrawal by Subject|2
2198298|NCT01553136|3833221|FG001|Overall Study|Withdrawal by Subject|3
2198299|NCT01553136|3833220|FG000|Overall Study|Lost to Follow-up|4
2198300|NCT01553136|3833221|FG001|Overall Study|Lost to Follow-up|10
2275030|NCT02305563|3956690|FG002|Treatment Period|Study drug toxicity|0
2198301|NCT01553136|3833220|FG000|Overall Study|Physician Decision|2
2198302|NCT01553136|3833221|FG001|Overall Study|Physician Decision|3
2198303|NCT01553136|3833220|FG000|Overall Study|Scheduling Difficulties|5
2198304|NCT01553136|3833221|FG001|Overall Study|Scheduling Difficulties|4
2198305|NCT01553188|3833231|FG000|Overall Study|Patient choice|1
2198306|NCT01553188|3833232|FG001|Overall Study|Patient choice|0
2198307|NCT01553188|3833233|FG002|Overall Study|Patient choice|0
2198308|NCT01553188|3833234|FG003|Overall Study|Patient choice|0
2198309|NCT01553188|3833231|FG000|Overall Study|Intercurrent illness and adverse event|0
2198310|NCT01553188|3833232|FG001|Overall Study|Intercurrent illness and adverse event|1
2198311|NCT01553188|3833233|FG002|Overall Study|Intercurrent illness and adverse event|2
2198312|NCT01553188|3833234|FG003|Overall Study|Intercurrent illness and adverse event|0
2198313|NCT01553279|3833258|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
2198314|NCT01553279|3833259|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
2198315|NCT01553279|3833258|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
2198316|NCT01553279|3833259|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
2198317|NCT01553279|3833258|FG000|Interim Period|Withdrawal by Subject|2
2198318|NCT01553279|3833259|FG001|Interim Period|Withdrawal by Subject|2
2198319|NCT01553279|3833258|FG000|Interim Period|Lost to Follow-up|1
2198320|NCT01553279|3833259|FG001|Interim Period|Lost to Follow-up|0
2198321|NCT01553279|3833258|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
2198322|NCT01553279|3833259|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
2198323|NCT01553279|3833258|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3
2198324|NCT01553279|3833259|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2
2198325|NCT01553318|3833274|FG000|Overall Study|Protocol Violation|3
2198326|NCT01553318|3833275|FG001|Overall Study|Protocol Violation|2
2198327|NCT01553591|3833290|FG000|Overall Study|Voluntarily withdrew|94
2198328|NCT01553591|3833291|FG001|Overall Study|Voluntarily withdrew|79
2198329|NCT01553591|3833292|FG002|Overall Study|Voluntarily withdrew|96
2198330|NCT01553591|3833290|FG000|Overall Study|Adverse Event|36
2198331|NCT01553591|3833291|FG001|Overall Study|Adverse Event|45
2198332|NCT01553591|3833292|FG002|Overall Study|Adverse Event|16
2198333|NCT01553591|3833290|FG000|Overall Study|Lost to Follow-up|25
2198334|NCT01553591|3833291|FG001|Overall Study|Lost to Follow-up|23
2198335|NCT01553591|3833292|FG002|Overall Study|Lost to Follow-up|16
2198336|NCT01553591|3833290|FG000|Overall Study|Physician decision: other|11
2198337|NCT01553591|3833291|FG001|Overall Study|Physician decision: other|14
2198338|NCT01553591|3833292|FG002|Overall Study|Physician decision: other|16
2198339|NCT01553591|3833290|FG000|Overall Study|Physician decision: lack of efficacy|2
2198340|NCT01553591|3833291|FG001|Overall Study|Physician decision: lack of efficacy|3
2198341|NCT01553591|3833292|FG002|Overall Study|Physician decision: lack of efficacy|7
2198342|NCT01553591|3833290|FG000|Overall Study|Protocol Violation|3
2198343|NCT01553591|3833291|FG001|Overall Study|Protocol Violation|4
2198344|NCT01553591|3833292|FG002|Overall Study|Protocol Violation|4
2198345|NCT01553591|3833290|FG000|Overall Study|Sponsor decision|1
2198346|NCT01553591|3833291|FG001|Overall Study|Sponsor decision|0
2198347|NCT01553591|3833292|FG002|Overall Study|Sponsor decision|3
2198348|NCT01553591|3833290|FG000|Overall Study|Randomized and never dispensed drug|0
2198349|NCT01553591|3833291|FG001|Overall Study|Randomized and never dispensed drug|1
2198350|NCT01553591|3833292|FG002|Overall Study|Randomized and never dispensed drug|0
2198351|NCT01553747|3833312|FG000|Overall Study|Protocol Violation|0
2198352|NCT01553747|3833313|FG001|Overall Study|Protocol Violation|2
2198353|NCT01553747|3833314|FG002|Overall Study|Protocol Violation|0
2198354|NCT01553747|3833312|FG000|Overall Study|Voluntarily withdrew|70
2198355|NCT01553747|3833313|FG001|Overall Study|Voluntarily withdrew|66
2198356|NCT01553747|3833314|FG002|Overall Study|Voluntarily withdrew|74
2198357|NCT01553747|3833312|FG000|Overall Study|Adverse event or SAE|32
2198358|NCT01553747|3833313|FG001|Overall Study|Adverse event or SAE|28
2198359|NCT01553747|3833314|FG002|Overall Study|Adverse event or SAE|19
2198360|NCT01553747|3833312|FG000|Overall Study|Physician decision: other|10
2198361|NCT01553747|3833313|FG001|Overall Study|Physician decision: other|8
2198362|NCT01553747|3833314|FG002|Overall Study|Physician decision: other|7
2198363|NCT01553747|3833312|FG000|Overall Study|Lost to Follow-up|11
2198364|NCT01553747|3833313|FG001|Overall Study|Lost to Follow-up|5
2198365|NCT01553747|3833314|FG002|Overall Study|Lost to Follow-up|6
2198366|NCT01553747|3833312|FG000|Overall Study|Sponsor decision, specify|7
2198367|NCT01553747|3833313|FG001|Overall Study|Sponsor decision, specify|5
2198368|NCT01553747|3833314|FG002|Overall Study|Sponsor decision, specify|0
2198369|NCT01553747|3833312|FG000|Overall Study|Physician decision: lack of efficacy|1
2198370|NCT01553747|3833313|FG001|Overall Study|Physician decision: lack of efficacy|5
2198371|NCT01553747|3833314|FG002|Overall Study|Physician decision: lack of efficacy|3
2198372|NCT01553851|3833325|FG000|Overall Study|Adverse Event|2
2198373|NCT01553851|3833325|FG000|Overall Study|constipation|1
2198374|NCT01553916|3833329|FG000|Overall Study|Withdrawal by Subject|2
2198375|NCT01553916|3833329|FG000|Overall Study|Pre-treatment MRI metastatic disease|1
2198376|NCT01554176|3833335|FG000|Treatment Phase|Protocol Violation|1
2198377|NCT01554176|3833336|FG001|Treatment Phase|Protocol Violation|2
2198378|NCT01554176|3833337|FG002|Treatment Phase|Protocol Violation|0
2198379|NCT01554176|3833338|FG003|Treatment Phase|Protocol Violation|0
2198380|NCT01554176|3833339|FG004|Treatment Phase|Protocol Violation|0
2198381|NCT01554176|3833335|FG000|Treatment Phase|Physician Decision|1
2198382|NCT01554176|3833336|FG001|Treatment Phase|Physician Decision|1
2198383|NCT01554176|3833337|FG002|Treatment Phase|Physician Decision|0
2198384|NCT01554176|3833338|FG003|Treatment Phase|Physician Decision|0
2198385|NCT01554176|3833339|FG004|Treatment Phase|Physician Decision|0
2198386|NCT01554176|3833335|FG000|Treatment Phase|Lack of Efficacy|0
2198387|NCT01554176|3833336|FG001|Treatment Phase|Lack of Efficacy|1
2198388|NCT01554176|3833337|FG002|Treatment Phase|Lack of Efficacy|0
2198389|NCT01554176|3833338|FG003|Treatment Phase|Lack of Efficacy|0
2198390|NCT01554176|3833339|FG004|Treatment Phase|Lack of Efficacy|0
2198391|NCT01554176|3833335|FG000|Treatment Phase|Adverse event, non-fatal|1
2198392|NCT01554176|3833336|FG001|Treatment Phase|Adverse event, non-fatal|1
2198393|NCT01554176|3833337|FG002|Treatment Phase|Adverse event, non-fatal|0
2198394|NCT01554176|3833338|FG003|Treatment Phase|Adverse event, non-fatal|0
2198395|NCT01554176|3833339|FG004|Treatment Phase|Adverse event, non-fatal|0
2198396|NCT01554176|3833335|FG000|Treatment Phase|Non-compliance with study drug|1
2198397|NCT01554176|3833336|FG001|Treatment Phase|Non-compliance with study drug|0
2198398|NCT01554176|3833337|FG002|Treatment Phase|Non-compliance with study drug|0
2198399|NCT01554176|3833338|FG003|Treatment Phase|Non-compliance with study drug|0
2198400|NCT01554176|3833339|FG004|Treatment Phase|Non-compliance with study drug|0
2198401|NCT01554176|3833335|FG000|Treatment Phase|Withdrawal by Subject|1
2198402|NCT01554176|3833336|FG001|Treatment Phase|Withdrawal by Subject|0
2198403|NCT01554176|3833337|FG002|Treatment Phase|Withdrawal by Subject|0
2198404|NCT01554176|3833338|FG003|Treatment Phase|Withdrawal by Subject|0
2198405|NCT01554176|3833339|FG004|Treatment Phase|Withdrawal by Subject|0
2198406|NCT01554176|3833335|FG000|Treatment Phase|Lost to Follow-up|3
2198407|NCT01554176|3833336|FG001|Treatment Phase|Lost to Follow-up|0
2198408|NCT01554176|3833337|FG002|Treatment Phase|Lost to Follow-up|0
2198409|NCT01554176|3833338|FG003|Treatment Phase|Lost to Follow-up|0
2198410|NCT01554176|3833339|FG004|Treatment Phase|Lost to Follow-up|0
2198411|NCT01554176|3833335|FG000|Run-out Phase|Protocol Violation|0
2198412|NCT01554176|3833336|FG001|Run-out Phase|Protocol Violation|0
2198413|NCT01554176|3833337|FG002|Run-out Phase|Protocol Violation|0
2198414|NCT01554176|3833338|FG003|Run-out Phase|Protocol Violation|1
2198415|NCT01554176|3833339|FG004|Run-out Phase|Protocol Violation|0
2198416|NCT01554241|3833355|FG000|Overall Study|Death|3
2198417|NCT01554241|3833356|FG001|Overall Study|Death|1
2198418|NCT01554241|3833357|FG002|Overall Study|Death|1
2198419|NCT01554241|3833358|FG003|Overall Study|Death|0
2198420|NCT01554241|3833355|FG000|Overall Study|protocol specified renal stone|0
2198421|NCT01554241|3833356|FG001|Overall Study|protocol specified renal stone|0
2198422|NCT01554241|3833357|FG002|Overall Study|protocol specified renal stone|0
2198423|NCT01554241|3833358|FG003|Overall Study|protocol specified renal stone|1
2198424|NCT01554241|3833355|FG000|Overall Study|protocol specified change in eGFR|0
2198425|NCT01554241|3833356|FG001|Overall Study|protocol specified change in eGFR|0
2198426|NCT01554241|3833357|FG002|Overall Study|protocol specified change in eGFR|1
2198427|NCT01554241|3833358|FG003|Overall Study|protocol specified change in eGFR|0
2198428|NCT01554241|3833355|FG000|Overall Study|Withdrawal by Subject|0
2198429|NCT01554241|3833356|FG001|Overall Study|Withdrawal by Subject|0
2198430|NCT01554241|3833357|FG002|Overall Study|Withdrawal by Subject|2
2198431|NCT01554241|3833358|FG003|Overall Study|Withdrawal by Subject|0
2198432|NCT01554514|3833393|FG000|Overall Study|1 patient ineligible with congenital TTP|1
2198433|NCT01554514|3833393|FG000|Overall Study|Physician Decision|1
2198434|NCT01554527|3833400|FG000|Overall Study|Withdrawal by Subject|1
2198435|NCT01554527|3833401|FG001|Overall Study|Withdrawal by Subject|0
2198436|NCT01554527|3833402|FG002|Overall Study|Withdrawal by Subject|3
2198437|NCT01554527|3833400|FG000|Overall Study|Lost to Follow-up|0
2198438|NCT01554527|3833401|FG001|Overall Study|Lost to Follow-up|0
2198439|NCT01554527|3833402|FG002|Overall Study|Lost to Follow-up|4
2198440|NCT01554527|3833400|FG000|Overall Study|Physician Decision|0
2198441|NCT01554527|3833401|FG001|Overall Study|Physician Decision|0
2198442|NCT01554527|3833402|FG002|Overall Study|Physician Decision|1
2198443|NCT01554579|3833413|FG000|Overall Study|Adverse Event|6
2275031|NCT02305563|3956691|FG003|Treatment Period|Study drug toxicity|1
2275032|NCT02305563|3956692|FG004|Treatment Period|Study drug toxicity|2
2275033|NCT02305563|3956688|FG000|Treatment Period|Death|0
2198444|NCT01554579|3833414|FG001|Overall Study|Adverse Event|25
2198445|NCT01554579|3833413|FG000|Overall Study|Lack of Efficacy|2
2198446|NCT01554579|3833414|FG001|Overall Study|Lack of Efficacy|1
2198447|NCT01554579|3833413|FG000|Overall Study|Withdrawal by Subject|2
2198448|NCT01554579|3833414|FG001|Overall Study|Withdrawal by Subject|1
2198449|NCT01554618|3833423|FG000|Randomized Through Start of Treatment|Adverse Event|1
2198450|NCT01554618|3833424|FG001|Randomized Through Start of Treatment|Adverse Event|0
2198451|NCT01554618|3833423|FG000|Controlled Assessment Period|Lost to Follow-up|2
2198452|NCT01554618|3833424|FG001|Controlled Assessment Period|Lost to Follow-up|1
2198453|NCT01554618|3833423|FG000|Controlled Assessment Period|Withdrawal by Subject|6
2198454|NCT01554618|3833424|FG001|Controlled Assessment Period|Withdrawal by Subject|0
2198455|NCT01554618|3833423|FG000|Open-Label Extension Period|Withdrawal by Subject|2
2198456|NCT01554618|3833424|FG001|Open-Label Extension Period|Withdrawal by Subject|3
2198457|NCT01554618|3833423|FG000|Open-Label Extension Period|Physician Decision|0
2198458|NCT01554618|3833424|FG001|Open-Label Extension Period|Physician Decision|1
2275034|NCT02305563|3956689|FG001|Treatment Period|Death|0
2198459|NCT01554618|3833423|FG000|Open-Label Extension Period|Lost to Follow-up|1
2198460|NCT01554618|3833424|FG001|Open-Label Extension Period|Lost to Follow-up|1
2198461|NCT01554904|3833460|FG000|Overall Study|Withdrawal by Subject|3
2198462|NCT01554904|3833460|FG000|Overall Study|Had sleep apnea on Home Study 1|1
2198463|NCT01555125|3833471|FG000|Induction Period|Lost to Follow-up|0
2198464|NCT01555125|3833472|FG001|Induction Period|Lost to Follow-up|2
2198465|NCT01555125|3833473|FG002|Induction Period|Lost to Follow-up|0
2198466|NCT01555125|3833474|FG003|Induction Period|Lost to Follow-up|0
2198467|NCT01555125|3833475|FG004|Induction Period|Lost to Follow-up|0
2198468|NCT01555125|3833471|FG000|Induction Period|Adverse Event|0
2198469|NCT01555125|3833472|FG001|Induction Period|Adverse Event|1
2198470|NCT01555125|3833473|FG002|Induction Period|Adverse Event|0
2198471|NCT01555125|3833474|FG003|Induction Period|Adverse Event|0
2198472|NCT01555125|3833475|FG004|Induction Period|Adverse Event|1
2198473|NCT01555125|3833471|FG000|Induction Period|Subject / guardian decision|0
2198474|NCT01555125|3833472|FG001|Induction Period|Subject / guardian decision|0
2198475|NCT01555125|3833473|FG002|Induction Period|Subject / guardian decision|0
2198476|NCT01555125|3833474|FG003|Induction Period|Subject / guardian decision|0
2198477|NCT01555125|3833475|FG004|Induction Period|Subject / guardian decision|2
2198478|NCT01555125|3833471|FG000|Induction Period|Death|1
2198479|NCT01555125|3833472|FG001|Induction Period|Death|0
2198480|NCT01555125|3833473|FG002|Induction Period|Death|0
2198481|NCT01555125|3833474|FG003|Induction Period|Death|0
2198482|NCT01555125|3833475|FG004|Induction Period|Death|0
2198483|NCT01555125|3833471|FG000|Maintenance Period|Adverse Event|1
2198484|NCT01555125|3833472|FG001|Maintenance Period|Adverse Event|1
2198485|NCT01555125|3833473|FG002|Maintenance Period|Adverse Event|0
2198486|NCT01555125|3833474|FG003|Maintenance Period|Adverse Event|0
2198487|NCT01555125|3833475|FG004|Maintenance Period|Adverse Event|0
2198488|NCT01555125|3833471|FG000|Maintenance Period|Subject / guardian decision|1
2198489|NCT01555125|3833472|FG001|Maintenance Period|Subject / guardian decision|2
2198490|NCT01555125|3833473|FG002|Maintenance Period|Subject / guardian decision|0
2198491|NCT01555125|3833474|FG003|Maintenance Period|Subject / guardian decision|0
2198492|NCT01555125|3833475|FG004|Maintenance Period|Subject / guardian decision|0
2198493|NCT01555125|3833471|FG000|Maintenance Period|Lost to Follow-up|2
2198494|NCT01555125|3833472|FG001|Maintenance Period|Lost to Follow-up|0
2198495|NCT01555125|3833473|FG002|Maintenance Period|Lost to Follow-up|0
2198496|NCT01555125|3833474|FG003|Maintenance Period|Lost to Follow-up|1
2198497|NCT01555125|3833475|FG004|Maintenance Period|Lost to Follow-up|0
2198498|NCT01555125|3833471|FG000|Maintenance Period|Lack of Efficacy|6
2198499|NCT01555125|3833472|FG001|Maintenance Period|Lack of Efficacy|1
2198500|NCT01555125|3833473|FG002|Maintenance Period|Lack of Efficacy|3
2198501|NCT01555125|3833474|FG003|Maintenance Period|Lack of Efficacy|0
2198502|NCT01555125|3833475|FG004|Maintenance Period|Lack of Efficacy|0
2198503|NCT01555125|3833471|FG000|Maintenance Period|Physician Decision|0
2198504|NCT01555125|3833472|FG001|Maintenance Period|Physician Decision|0
2198505|NCT01555125|3833473|FG002|Maintenance Period|Physician Decision|1
2198506|NCT01555125|3833474|FG003|Maintenance Period|Physician Decision|0
2198507|NCT01555125|3833475|FG004|Maintenance Period|Physician Decision|0
2198508|NCT01555125|3833471|FG000|Maintenance Period|Death|0
2198509|NCT01555125|3833472|FG001|Maintenance Period|Death|0
2198510|NCT01555125|3833473|FG002|Maintenance Period|Death|0
2198511|NCT01555125|3833474|FG003|Maintenance Period|Death|1
2198512|NCT01555125|3833475|FG004|Maintenance Period|Death|0
2198513|NCT01555125|3833471|FG000|Extension|Adverse Event|1
2198514|NCT01555125|3833472|FG001|Extension|Adverse Event|2
2198515|NCT01555125|3833473|FG002|Extension|Adverse Event|1
2198516|NCT01555125|3833474|FG003|Extension|Adverse Event|1
2198517|NCT01555125|3833475|FG004|Extension|Adverse Event|0
2198518|NCT01555125|3833471|FG000|Extension|Protocol deviation|1
2198519|NCT01555125|3833472|FG001|Extension|Protocol deviation|0
2198520|NCT01555125|3833473|FG002|Extension|Protocol deviation|0
2275035|NCT02305563|3956690|FG002|Treatment Period|Death|1
2275036|NCT02305563|3956691|FG003|Treatment Period|Death|2
2275037|NCT02305563|3956692|FG004|Treatment Period|Death|1
2275038|NCT02305563|3956688|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0
2275039|NCT02305563|3956689|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0
2275040|NCT02305563|3956690|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7
2275041|NCT02305563|3956691|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1
2275042|NCT02305563|3956692|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2
2275043|NCT02305563|3956688|FG000|Treatment Period|Participant request to stop therapy|0
2275044|NCT02305563|3956689|FG001|Treatment Period|Participant request to stop therapy|2
2275045|NCT02305563|3956690|FG002|Treatment Period|Participant request to stop therapy|0
2275046|NCT02305563|3956691|FG003|Treatment Period|Participant request to stop therapy|1
2275047|NCT02305563|3956692|FG004|Treatment Period|Participant request to stop therapy|0
2275048|NCT02305563|3956688|FG000|Treatment Period|Participant withdrew consent|0
2275049|NCT02305563|3956689|FG001|Treatment Period|Participant withdrew consent|0
2275050|NCT02305563|3956690|FG002|Treatment Period|Participant withdrew consent|1
2275051|NCT02305563|3956691|FG003|Treatment Period|Participant withdrew consent|1
2198521|NCT01555125|3833474|FG003|Extension|Protocol deviation|0
2198522|NCT01555125|3833475|FG004|Extension|Protocol deviation|0
2275052|NCT02305563|3956692|FG004|Treatment Period|Participant withdrew consent|1
2198523|NCT01555125|3833471|FG000|Extension|Lack of Efficacy|7
2198524|NCT01555125|3833472|FG001|Extension|Lack of Efficacy|6
2198525|NCT01555125|3833473|FG002|Extension|Lack of Efficacy|3
2198526|NCT01555125|3833474|FG003|Extension|Lack of Efficacy|0
2198527|NCT01555125|3833475|FG004|Extension|Lack of Efficacy|0
2198528|NCT01555125|3833471|FG000|Extension|Lost to Follow-up|2
2198529|NCT01555125|3833472|FG001|Extension|Lost to Follow-up|1
2198530|NCT01555125|3833473|FG002|Extension|Lost to Follow-up|2
2198531|NCT01555125|3833474|FG003|Extension|Lost to Follow-up|0
2198532|NCT01555125|3833475|FG004|Extension|Lost to Follow-up|0
2198533|NCT01555125|3833471|FG000|Extension|Study terminated by sponsor|32
2198534|NCT01555125|3833472|FG001|Extension|Study terminated by sponsor|33
2198535|NCT01555125|3833473|FG002|Extension|Study terminated by sponsor|16
2198536|NCT01555125|3833474|FG003|Extension|Study terminated by sponsor|20
2198537|NCT01555125|3833475|FG004|Extension|Study terminated by sponsor|0
2198538|NCT01555125|3833471|FG000|Extension|Subject/guardian decision|1
2198539|NCT01555125|3833472|FG001|Extension|Subject/guardian decision|9
2198540|NCT01555125|3833473|FG002|Extension|Subject/guardian decision|1
2198541|NCT01555125|3833474|FG003|Extension|Subject/guardian decision|0
2198542|NCT01555125|3833475|FG004|Extension|Subject/guardian decision|0
2198543|NCT01555125|3833471|FG000|Extension|Technical Problems|1
2198544|NCT01555125|3833472|FG001|Extension|Technical Problems|0
2198545|NCT01555125|3833473|FG002|Extension|Technical Problems|0
2198546|NCT01555125|3833474|FG003|Extension|Technical Problems|1
2198547|NCT01555125|3833475|FG004|Extension|Technical Problems|0
2198548|NCT01555125|3833471|FG000|Follow-Up Period|Lost to Follow-up|1
2198549|NCT01555125|3833472|FG001|Follow-Up Period|Lost to Follow-up|0
2198550|NCT01555125|3833473|FG002|Follow-Up Period|Lost to Follow-up|0
2198551|NCT01555125|3833474|FG003|Follow-Up Period|Lost to Follow-up|0
2198552|NCT01555125|3833475|FG004|Follow-Up Period|Lost to Follow-up|0
2198553|NCT01555125|3833471|FG000|Follow-Up Period|Subject / guardian decision|3
2198554|NCT01555125|3833472|FG001|Follow-Up Period|Subject / guardian decision|1
2198555|NCT01555125|3833473|FG002|Follow-Up Period|Subject / guardian decision|1
2198556|NCT01555125|3833474|FG003|Follow-Up Period|Subject / guardian decision|1
2198557|NCT01555125|3833475|FG004|Follow-Up Period|Subject / guardian decision|0
2198558|NCT01555138|3833492|FG000|Overall Study|Death|0
2198559|NCT01555138|3833493|FG001|Overall Study|Death|1
2198560|NCT01555138|3833492|FG000|Overall Study|Lost to Follow-up|1
2198561|NCT01555138|3833493|FG001|Overall Study|Lost to Follow-up|0
2198562|NCT01555138|3833492|FG000|Overall Study|Abnormal Lab reults|1
2198563|NCT01555138|3833493|FG001|Overall Study|Abnormal Lab reults|3
2198564|NCT01555138|3833492|FG000|Overall Study|Lack of Efficacy|2
2198565|NCT01555138|3833493|FG001|Overall Study|Lack of Efficacy|2
2198566|NCT01555138|3833492|FG000|Overall Study|Protocol Violation|5
2198567|NCT01555138|3833493|FG001|Overall Study|Protocol Violation|3
2198568|NCT01555138|3833492|FG000|Overall Study|Administrative problems|8
2198569|NCT01555138|3833493|FG001|Overall Study|Administrative problems|0
2198570|NCT01555138|3833492|FG000|Overall Study|Withdrawal by Subject|16
2198571|NCT01555138|3833493|FG001|Overall Study|Withdrawal by Subject|15
2198572|NCT01555138|3833492|FG000|Overall Study|Adverse Event|14
2198573|NCT01555138|3833493|FG001|Overall Study|Adverse Event|14
2198574|NCT01555151|3833503|FG000|Overall Study|Withdrawal by Subject|6
2198575|NCT01555151|3833504|FG001|Overall Study|Withdrawal by Subject|2
2198576|NCT01555151|3833505|FG002|Overall Study|Withdrawal by Subject|0
2198577|NCT01555151|3833506|FG003|Overall Study|Withdrawal by Subject|2
2198578|NCT01555151|3833503|FG000|Overall Study|Administrative|3
2198579|NCT01555151|3833504|FG001|Overall Study|Administrative|1
2198580|NCT01555151|3833505|FG002|Overall Study|Administrative|2
2198581|NCT01555151|3833506|FG003|Overall Study|Administrative|0
2198582|NCT01555151|3833503|FG000|Overall Study|Protocol Violation|3
2198583|NCT01555151|3833504|FG001|Overall Study|Protocol Violation|3
2198584|NCT01555151|3833505|FG002|Overall Study|Protocol Violation|3
2198585|NCT01555151|3833506|FG003|Overall Study|Protocol Violation|5
2198586|NCT01555151|3833503|FG000|Overall Study|Adverse Event|1
2198587|NCT01555151|3833504|FG001|Overall Study|Adverse Event|2
2198588|NCT01555151|3833505|FG002|Overall Study|Adverse Event|1
2198589|NCT01555151|3833506|FG003|Overall Study|Adverse Event|2
2198590|NCT01555151|3833503|FG000|Overall Study|Lost to Follow-up|0
2198591|NCT01555151|3833504|FG001|Overall Study|Lost to Follow-up|0
2198592|NCT01555151|3833505|FG002|Overall Study|Lost to Follow-up|0
2198593|NCT01555151|3833506|FG003|Overall Study|Lost to Follow-up|1
2198594|NCT01555164|3833519|FG000|Overall Study|Adverse Event|5
2198595|NCT01555164|3833520|FG001|Overall Study|Adverse Event|7
2198596|NCT01555164|3833519|FG000|Overall Study|Hyperglycemia|0
2198597|NCT01555164|3833520|FG001|Overall Study|Hyperglycemia|1
2198598|NCT01555164|3833519|FG000|Overall Study|Investigator's Discretion|2
2198599|NCT01555164|3833520|FG001|Overall Study|Investigator's Discretion|2
2198600|NCT01555164|3833519|FG000|Overall Study|Lost to Follow-up|4
2198601|NCT01555164|3833520|FG001|Overall Study|Lost to Follow-up|3
2198602|NCT01555164|3833519|FG000|Overall Study|Protocol Violation|9
2198603|NCT01555164|3833520|FG001|Overall Study|Protocol Violation|5
2198604|NCT01555164|3833519|FG000|Overall Study|Subject Non-compliance|14
2198605|NCT01555164|3833520|FG001|Overall Study|Subject Non-compliance|6
2198606|NCT01555164|3833519|FG000|Overall Study|Subject Withdrew Consent|6
2198607|NCT01555164|3833520|FG001|Overall Study|Subject Withdrew Consent|11
2198608|NCT01555463|3833528|FG000|Treatment|Adverse Event|6
2198609|NCT01555463|3833529|FG001|Treatment|Adverse Event|12
2198610|NCT01555463|3833528|FG000|Treatment|Withdrawal by Subject|24
2198611|NCT01555463|3833529|FG001|Treatment|Withdrawal by Subject|36
2198612|NCT01555463|3833528|FG000|Treatment|Lost to Follow-up|28
2198613|NCT01555463|3833529|FG001|Treatment|Lost to Follow-up|23
2198614|NCT01555463|3833528|FG000|Treatment|Protocol Violation|4
2198615|NCT01555463|3833529|FG001|Treatment|Protocol Violation|5
2198616|NCT01555463|3833528|FG000|Treatment|Other reason|2
2198617|NCT01555463|3833529|FG001|Treatment|Other reason|3
2198618|NCT01555463|3833528|FG000|Follow up|Adverse Event|2
2198619|NCT01555463|3833529|FG001|Follow up|Adverse Event|5
2198620|NCT01555463|3833528|FG000|Follow up|Death|0
2198621|NCT01555463|3833529|FG001|Follow up|Death|1
2198622|NCT01555463|3833528|FG000|Follow up|Withdrawal by Subject|22
2198623|NCT01555463|3833529|FG001|Follow up|Withdrawal by Subject|22
2198624|NCT01555463|3833528|FG000|Follow up|Lost to Follow-up|9
2198625|NCT01555463|3833529|FG001|Follow up|Lost to Follow-up|10
2198626|NCT01555463|3833528|FG000|Follow up|Protocol Violation|2
2198627|NCT01555463|3833529|FG001|Follow up|Protocol Violation|4
2198628|NCT01555463|3833528|FG000|Follow up|Other reason|3
2198629|NCT01555463|3833529|FG001|Follow up|Other reason|3
2198630|NCT01555671|3833559|FG000|Overall Study|Physician Decision|20
2198631|NCT01555671|3833560|FG001|Overall Study|Physician Decision|25
2198632|NCT01555762|3833595|FG000|Overall Study|No information on Bevacizumab intake|11
2198633|NCT01555762|3833595|FG000|Overall Study|Missing start date of infusion|8
2198634|NCT01555762|3833595|FG000|Overall Study|75 years old or more ticked No|1
2198635|NCT01555762|3833595|FG000|Overall Study|Treatment with Bevacizumab ticked No|24
2198636|NCT01555762|3833595|FG000|Overall Study|Death linked to progression of disease|165
2198637|NCT01555762|3833595|FG000|Overall Study|Lost follow-up/moved house/changed team|35
2198638|NCT01555762|3833595|FG000|Overall Study|Investigator's decision|10
2198639|NCT01555762|3833595|FG000|Overall Study|Participant not wishing to continue|5
2198640|NCT01555762|3833595|FG000|Overall Study|Missing data|1
2198641|NCT01555762|3833595|FG000|Overall Study|Death linked to an adverse event|14
2198642|NCT01555931|3833601|FG000|Overall Study|Lost to Follow-up|2
2198643|NCT01555931|3833602|FG001|Overall Study|Lost to Follow-up|5
2198644|NCT01555983|3833617|FG000|Overall Study|Withdrawal by Subject|1
2198645|NCT01555983|3833618|FG001|Overall Study|Withdrawal by Subject|0
2198646|NCT01555983|3833619|FG002|Overall Study|Withdrawal by Subject|0
2198647|NCT01555983|3833620|FG003|Overall Study|Withdrawal by Subject|0
2198648|NCT01555983|3833621|FG004|Overall Study|Withdrawal by Subject|1
2198649|NCT01555983|3833622|FG005|Overall Study|Withdrawal by Subject|1
2198650|NCT01556165|3833647|FG000|Overall Study|Adverse Event|5
2198651|NCT01556165|3833648|FG001|Overall Study|Adverse Event|3
2198652|NCT01556165|3833647|FG000|Overall Study|Protocol Violation|0
2198653|NCT01556165|3833648|FG001|Overall Study|Protocol Violation|3
2275053|NCT02305563|3956688|FG000|Treatment Period|Maximum clinical benefit|0
2275054|NCT02305563|3956689|FG001|Treatment Period|Maximum clinical benefit|0
2275055|NCT02305563|3956690|FG002|Treatment Period|Maximum clinical benefit|0
2275056|NCT02305563|3956691|FG003|Treatment Period|Maximum clinical benefit|0
2275057|NCT02305563|3956692|FG004|Treatment Period|Maximum clinical benefit|1
2275058|NCT02305563|3956688|FG000|Treatment Period|Poor/non-compliance|0
2275059|NCT02305563|3956689|FG001|Treatment Period|Poor/non-compliance|0
2275060|NCT02305563|3956690|FG002|Treatment Period|Poor/non-compliance|0
2275061|NCT02305563|3956691|FG003|Treatment Period|Poor/non-compliance|0
2275062|NCT02305563|3956692|FG004|Treatment Period|Poor/non-compliance|1
2275063|NCT02305563|3956688|FG000|Treatment Period|Administrative reason by Sponsor|0
2275064|NCT02305563|3956689|FG001|Treatment Period|Administrative reason by Sponsor|0
2275065|NCT02305563|3956690|FG002|Treatment Period|Administrative reason by Sponsor|0
2275066|NCT02305563|3956691|FG003|Treatment Period|Administrative reason by Sponsor|0
2275067|NCT02305563|3956692|FG004|Treatment Period|Administrative reason by Sponsor|1
2275068|NCT02305563|3956688|FG000|Treatment Period|other reason|2
2275069|NCT02305563|3956689|FG001|Treatment Period|other reason|0
2275070|NCT02305563|3956690|FG002|Treatment Period|other reason|2
2275071|NCT02305563|3956691|FG003|Treatment Period|other reason|2
2275072|NCT02305563|3956692|FG004|Treatment Period|other reason|1
2275073|NCT02305563|3956688|FG000|Treatment Period|Randomized but not treated|0
2275074|NCT02305563|3956689|FG001|Treatment Period|Randomized but not treated|0
2275075|NCT02305563|3956690|FG002|Treatment Period|Randomized but not treated|0
2275076|NCT02305563|3956691|FG003|Treatment Period|Randomized but not treated|0
2275077|NCT02305563|3956692|FG004|Treatment Period|Randomized but not treated|2
2275078|NCT02305563|3956688|FG000|Treatment Period|added ULO, then disease progression|0
2275079|NCT02305563|3956689|FG001|Treatment Period|added ULO, then disease progression|0
2275080|NCT02305563|3956690|FG002|Treatment Period|added ULO, then disease progression|0
2275081|NCT02305563|3956691|FG003|Treatment Period|added ULO, then disease progression|0
2275082|NCT02305563|3956692|FG004|Treatment Period|added ULO, then disease progression|4
2275083|NCT02305563|3956688|FG000|Treatment Period|added ULO; then other reason|0
2275084|NCT02305563|3956689|FG001|Treatment Period|added ULO; then other reason|0
2198654|NCT01556165|3833647|FG000|Overall Study|Withdrawal of Consent|7
2275085|NCT02305563|3956690|FG002|Treatment Period|added ULO; then other reason|0
2275086|NCT02305563|3956691|FG003|Treatment Period|added ULO; then other reason|0
2275087|NCT02305563|3956692|FG004|Treatment Period|added ULO; then other reason|1
2198655|NCT01556165|3833648|FG001|Overall Study|Withdrawal of Consent|1
2216988|NCT01704495|3860032|FG001|Optional Safety Extension|Other reason|29
2216989|NCT01704495|3860033|FG002|Optional Safety Extension|Other reason|30
2216990|NCT01704495|3860034|FG003|Optional Safety Extension|Other reason|28
2216991|NCT01704495|3860031|FG000|Optional Safety Extension|Withdrawal by Subject|2
2216992|NCT01704495|3860032|FG001|Optional Safety Extension|Withdrawal by Subject|0
2216993|NCT01704495|3860033|FG002|Optional Safety Extension|Withdrawal by Subject|1
2216994|NCT01704495|3860034|FG003|Optional Safety Extension|Withdrawal by Subject|2
2216995|NCT01704599|3860053|FG000|Overall Study|Adverse Event|1
2216996|NCT01704651|3860082|FG000|Overall Study|Pre-op withdrawal by subject|1
2216997|NCT01704651|3860083|FG001|Overall Study|Pre-op withdrawal by subject|1
2216998|NCT01704651|3860082|FG000|Overall Study|Pre-op change in treatment plan|1
2216999|NCT01704651|3860083|FG001|Overall Study|Pre-op change in treatment plan|4
2217000|NCT01704651|3860082|FG000|Overall Study|Nasogastric tube placement in surgery|1
2217001|NCT01704651|3860083|FG001|Overall Study|Nasogastric tube placement in surgery|1
2217002|NCT01704651|3860082|FG000|Overall Study|Post-op did not have laparotomy|2
2217003|NCT01704651|3860083|FG001|Overall Study|Post-op did not have laparotomy|1
2217004|NCT01704755|3860091|FG000|Overall Study|Adverse Event|4
2217005|NCT01704755|3860092|FG001|Overall Study|Adverse Event|1
2217006|NCT01704755|3860091|FG000|Overall Study|Lost to Follow-up|3
2217007|NCT01704755|3860092|FG001|Overall Study|Lost to Follow-up|4
2217008|NCT01704755|3860091|FG000|Overall Study|Withdrew consent|1
2217009|NCT01704755|3860092|FG001|Overall Study|Withdrew consent|1
2217010|NCT01704755|3860091|FG000|Overall Study|Other (not specified)|3
2217011|NCT01704755|3860092|FG001|Overall Study|Other (not specified)|1
2217012|NCT01704755|3860091|FG000|Overall Study|Withdrew consent and personal issues|1
2217013|NCT01704755|3860092|FG001|Overall Study|Withdrew consent and personal issues|0
2217014|NCT01704846|3860123|FG000|Treatment Period 2|Withdrawal by Subject|0
2217015|NCT01704846|3860124|FG001|Treatment Period 2|Withdrawal by Subject|1
2217016|NCT01705080|3860142|FG000|Overall Study|Missed visit|10
2217017|NCT01705080|3860143|FG001|Overall Study|Missed visit|4
2217018|NCT01705080|3860144|FG002|Overall Study|Missed visit|1
2217019|NCT01705080|3860142|FG000|Overall Study|Death|4
2217020|NCT01705080|3860143|FG001|Overall Study|Death|4
2217021|NCT01705080|3860144|FG002|Overall Study|Death|6
2217022|NCT01705080|3860142|FG000|Overall Study|Withdrawal by Subject|61
2217023|NCT01705080|3860143|FG001|Overall Study|Withdrawal by Subject|44
2217024|NCT01705080|3860144|FG002|Overall Study|Withdrawal by Subject|9
2217025|NCT01705145|3860152|FG000|Part B|Adverse Event|1
2217026|NCT01705236|3860168|FG000|Overall Study|Lost to Follow-up|1
2217027|NCT01705236|3860168|FG000|Overall Study|Administrative problems|2
2217028|NCT01705236|3860168|FG000|Overall Study|Unsatisfactory therapeutic effect|3
2217029|NCT01705236|3860168|FG000|Overall Study|Protocol Violation|3
2217030|NCT01705236|3860168|FG000|Overall Study|Abnormal test procedure result(s)|4
2217031|NCT01705236|3860168|FG000|Overall Study|Abnormal laboratory value(s)|4
2217032|NCT01705236|3860168|FG000|Overall Study|Withdrawal by Subject|5
2217033|NCT01705236|3860168|FG000|Overall Study|Adverse Event|5
2217034|NCT01705509|3860185|FG000|Inclusion CPET|Screen Failure|5
2217035|NCT01705509|3860185|FG000|Inclusion CPET|Withdrawal by Subject|2
2217036|NCT01705509|3860185|FG000|CPET w/ Ranexa|Screen Failure|2
2217037|NCT01705574|3860191|FG000|Double-Blind Phase|Lost to Follow-up|12
2217038|NCT01705574|3860192|FG001|Double-Blind Phase|Lost to Follow-up|16
2217039|NCT01705574|3860193|FG002|Double-Blind Phase|Lost to Follow-up|0
2217040|NCT01705574|3860194|FG003|Double-Blind Phase|Lost to Follow-up|0
2217041|NCT01705574|3860191|FG000|Double-Blind Phase|Adverse Event|3
2217042|NCT01705574|3860192|FG001|Double-Blind Phase|Adverse Event|10
2217043|NCT01705574|3860193|FG002|Double-Blind Phase|Adverse Event|0
2217044|NCT01705574|3860194|FG003|Double-Blind Phase|Adverse Event|0
2217045|NCT01705574|3860191|FG000|Double-Blind Phase|Withdrew Consent|8
2217046|NCT01705574|3860192|FG001|Double-Blind Phase|Withdrew Consent|5
2217047|NCT01705574|3860193|FG002|Double-Blind Phase|Withdrew Consent|0
2217048|NCT01705574|3860194|FG003|Double-Blind Phase|Withdrew Consent|0
2217049|NCT01705574|3860191|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
2217050|NCT01705574|3860192|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5
2217051|NCT01705574|3860193|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0
2217052|NCT01705574|3860194|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0
2217053|NCT01705574|3860191|FG000|Double-Blind Phase|Pregnancy|1
2217054|NCT01705574|3860192|FG001|Double-Blind Phase|Pregnancy|1
2217055|NCT01705574|3860193|FG002|Double-Blind Phase|Pregnancy|0
2217056|NCT01705574|3860194|FG003|Double-Blind Phase|Pregnancy|0
2217057|NCT01705574|3860191|FG000|Double-Blind Phase|Protocol Violation|1
2217058|NCT01705574|3860192|FG001|Double-Blind Phase|Protocol Violation|0
2217059|NCT01705574|3860193|FG002|Double-Blind Phase|Protocol Violation|0
2217060|NCT01705574|3860194|FG003|Double-Blind Phase|Protocol Violation|0
2217061|NCT01705574|3860191|FG000|Double-Blind Phase|Randomized but Not Treated|4
2275088|NCT02305563|3956688|FG000|Treatment Period|added ULO, then request to stop|0
2275089|NCT02305563|3956689|FG001|Treatment Period|added ULO, then request to stop|0
2275090|NCT02305563|3956690|FG002|Treatment Period|added ULO, then request to stop|0
2275091|NCT02305563|3956691|FG003|Treatment Period|added ULO, then request to stop|0
2275092|NCT02305563|3956692|FG004|Treatment Period|added ULO, then request to stop|1
2217062|NCT01705574|3860192|FG001|Double-Blind Phase|Randomized but Not Treated|4
2198656|NCT01556438|3833710|FG000|Overall Study|Adverse Event|4
2198657|NCT01556438|3833711|FG001|Overall Study|Adverse Event|2
2198658|NCT01556438|3833710|FG000|Overall Study|Sponsor Decision|0
2198659|NCT01556438|3833711|FG001|Overall Study|Sponsor Decision|2
2198660|NCT01556438|3833710|FG000|Overall Study|Progressive Disease|0
2198661|NCT01556438|3833711|FG001|Overall Study|Progressive Disease|6
2198662|NCT01556438|3833710|FG000|Overall Study|Death|0
2198663|NCT01556438|3833711|FG001|Overall Study|Death|1
2198664|NCT01556763|3833780|FG000|Overall Study|Withdrawal by Subject|0
2198665|NCT01556763|3833781|FG001|Overall Study|Withdrawal by Subject|1
2198666|NCT01556763|3833782|FG002|Overall Study|Withdrawal by Subject|0
2198667|NCT01556932|3833796|FG000|Time Point 60 Minutes|Withdrawal by Subject|1
2198668|NCT01556932|3833797|FG001|Time Point 60 Minutes|Withdrawal by Subject|1
2198669|NCT01556997|3833805|FG000|Overall Study|Adverse Event|10
2198670|NCT01556997|3833806|FG001|Overall Study|Adverse Event|12
2198671|NCT01556997|3833807|FG002|Overall Study|Adverse Event|12
2198672|NCT01556997|3833805|FG000|Overall Study|Lost to Follow-up|6
2198673|NCT01556997|3833806|FG001|Overall Study|Lost to Follow-up|6
2198674|NCT01556997|3833807|FG002|Overall Study|Lost to Follow-up|4
2198675|NCT01556997|3833805|FG000|Overall Study|Physician Decision|1
2198676|NCT01556997|3833806|FG001|Overall Study|Physician Decision|1
2198677|NCT01556997|3833807|FG002|Overall Study|Physician Decision|1
2198678|NCT01556997|3833805|FG000|Overall Study|Withdrawal by Subject|7
2198679|NCT01556997|3833806|FG001|Overall Study|Withdrawal by Subject|6
2198680|NCT01556997|3833807|FG002|Overall Study|Withdrawal by Subject|8
2198681|NCT01556997|3833805|FG000|Overall Study|Other|2
2198682|NCT01556997|3833806|FG001|Overall Study|Other|3
2198683|NCT01556997|3833807|FG002|Overall Study|Other|7
2198684|NCT01557166|3833817|FG000|Overall Study|Adverse Event|20
2198685|NCT01557166|3833818|FG001|Overall Study|Adverse Event|6
2198686|NCT01557166|3833817|FG000|Overall Study|Lack of Efficacy|2
2198687|NCT01557166|3833818|FG001|Overall Study|Lack of Efficacy|1
2198688|NCT01557166|3833817|FG000|Overall Study|Protocol Violation|8
2198689|NCT01557166|3833818|FG001|Overall Study|Protocol Violation|5
2198690|NCT01557166|3833817|FG000|Overall Study|Withdrawn consent|12
2198691|NCT01557166|3833818|FG001|Overall Study|Withdrawn consent|20
2198692|NCT01557166|3833817|FG000|Overall Study|Target dose not tolerated|1
2198693|NCT01557166|3833818|FG001|Overall Study|Target dose not tolerated|0
2198694|NCT01557166|3833817|FG000|Overall Study|Psychiatric disorder|1
2198695|NCT01557166|3833818|FG001|Overall Study|Psychiatric disorder|0
2198696|NCT01557166|3833817|FG000|Overall Study|Unclassified|2
2198697|NCT01557166|3833818|FG001|Overall Study|Unclassified|5
2198698|NCT01557244|3833829|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
2198699|NCT01557244|3833830|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
2198700|NCT01557244|3833831|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
2198701|NCT01557244|3833832|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
2198702|NCT01557244|3833833|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
2198703|NCT01557244|3833834|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
2198704|NCT01557244|3833835|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
2198705|NCT01557244|3833829|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2
2198706|NCT01557244|3833830|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
2198707|NCT01557244|3833831|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1
2198708|NCT01557244|3833832|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
2198709|NCT01557244|3833833|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
2198710|NCT01557244|3833834|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
2198711|NCT01557244|3833835|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
2198712|NCT01557244|3833829|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1
2198713|NCT01557244|3833830|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
2198714|NCT01557244|3833831|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
2198715|NCT01557244|3833832|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
2198716|NCT01557244|3833833|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
2198717|NCT01557244|3833834|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
2198718|NCT01557244|3833835|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
2198719|NCT01557244|3833829|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2
2198720|NCT01557244|3833830|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
2198721|NCT01557244|3833831|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
2198722|NCT01557244|3833832|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
2198723|NCT01557244|3833833|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
2198724|NCT01557244|3833834|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3
2198725|NCT01557244|3833835|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
2198726|NCT01557244|3833829|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
2198727|NCT01557244|3833830|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1
2198728|NCT01557244|3833831|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
2198729|NCT01557244|3833832|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
2198730|NCT01557244|3833833|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
2198731|NCT01557244|3833834|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
2198732|NCT01557244|3833835|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
2198733|NCT01557244|3833829|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
2198734|NCT01557244|3833830|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
2198735|NCT01557244|3833831|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
2275093|NCT02305563|3956688|FG000|Follow-up Period|Death|0
2275094|NCT02305563|3956689|FG001|Follow-up Period|Death|0
2275095|NCT02305563|3956690|FG002|Follow-up Period|Death|5
2275096|NCT02305563|3956691|FG003|Follow-up Period|Death|4
2275097|NCT02305563|3956692|FG004|Follow-up Period|Death|7
2275098|NCT02305563|3956688|FG000|Follow-up Period|Participant withdrew consent|0
2275099|NCT02305563|3956689|FG001|Follow-up Period|Participant withdrew consent|0
2275100|NCT02305563|3956690|FG002|Follow-up Period|Participant withdrew consent|2
2275101|NCT02305563|3956691|FG003|Follow-up Period|Participant withdrew consent|1
2275102|NCT02305563|3956692|FG004|Follow-up Period|Participant withdrew consent|0
2275103|NCT02305563|3956688|FG000|Follow-up Period|other reason|0
2275104|NCT02305563|3956689|FG001|Follow-up Period|other reason|0
2275105|NCT02305563|3956690|FG002|Follow-up Period|other reason|0
2275106|NCT02305563|3956691|FG003|Follow-up Period|other reason|0
2275107|NCT02305563|3956692|FG004|Follow-up Period|other reason|1
2275108|NCT02305563|3956688|FG000|Follow-up Period|Followup no longer required per protocol|3
2275109|NCT02305563|3956689|FG001|Follow-up Period|Followup no longer required per protocol|3
2275110|NCT02305563|3956690|FG002|Follow-up Period|Followup no longer required per protocol|4
2275111|NCT02305563|3956691|FG003|Follow-up Period|Followup no longer required per protocol|1
2275112|NCT02305563|3956692|FG004|Follow-up Period|Followup no longer required per protocol|4
2275113|NCT02305758|3956715|FG000|Overall Study|Death|27
2275114|NCT02305758|3956716|FG001|Overall Study|Death|27
2275115|NCT02305758|3956715|FG000|Overall Study|Withdrew consent|9
2275116|NCT02305758|3956716|FG001|Overall Study|Withdrew consent|2
2275117|NCT02305758|3956715|FG000|Overall Study|Lost to Follow-up|6
2275118|NCT02305758|3956716|FG001|Overall Study|Lost to Follow-up|1
2275119|NCT02305758|3956715|FG000|Overall Study|Study Terminated by Sponsor|21
2275120|NCT02305758|3956716|FG001|Overall Study|Study Terminated by Sponsor|34
2275121|NCT02305758|3956715|FG000|Overall Study|Other, not specified|2
2275122|NCT02305758|3956716|FG001|Overall Study|Other, not specified|1
2275123|NCT02305797|3956724|FG000|Overall Study|Adverse Event|11
2275124|NCT02305797|3956725|FG001|Overall Study|Adverse Event|2
2275125|NCT02305797|3956724|FG000|Overall Study|Withdrawal by Subject|9
2275126|NCT02305797|3956725|FG001|Overall Study|Withdrawal by Subject|10
2275127|NCT02305797|3956724|FG000|Overall Study|Lack of Efficacy|6
2275128|NCT02305797|3956725|FG001|Overall Study|Lack of Efficacy|0
2275129|NCT02305797|3956724|FG000|Overall Study|Lost to Follow-up|5
2275130|NCT02305797|3956725|FG001|Overall Study|Lost to Follow-up|11
2275131|NCT02305797|3956724|FG000|Overall Study|Pregnancy|0
2275132|NCT02305797|3956725|FG001|Overall Study|Pregnancy|2
2275133|NCT02305797|3956724|FG000|Overall Study|Noncompliance|14
2275134|NCT02305797|3956725|FG001|Overall Study|Noncompliance|12
2275135|NCT02305797|3956724|FG000|Overall Study|Reason not collected|0
2275136|NCT02305797|3956725|FG001|Overall Study|Reason not collected|1
2275137|NCT02305849|3956734|FG000|Overall Study|Adverse Event|10
2275138|NCT02305849|3956735|FG001|Overall Study|Adverse Event|12
2275139|NCT02305849|3956736|FG002|Overall Study|Adverse Event|7
2275140|NCT02305849|3956737|FG003|Overall Study|Adverse Event|3
2275141|NCT02305849|3956734|FG000|Overall Study|Lack of Efficacy|10
2275142|NCT02305849|3956735|FG001|Overall Study|Lack of Efficacy|6
2275143|NCT02305849|3956736|FG002|Overall Study|Lack of Efficacy|3
2275144|NCT02305849|3956737|FG003|Overall Study|Lack of Efficacy|9
2275145|NCT02305849|3956734|FG000|Overall Study|Withdrawal by Subject|2
2275146|NCT02305849|3956735|FG001|Overall Study|Withdrawal by Subject|2
2275147|NCT02305849|3956736|FG002|Overall Study|Withdrawal by Subject|1
2275148|NCT02305849|3956737|FG003|Overall Study|Withdrawal by Subject|4
2275149|NCT02305849|3956734|FG000|Overall Study|Lost to Follow-up|0
2275150|NCT02305849|3956735|FG001|Overall Study|Lost to Follow-up|2
2275151|NCT02305849|3956736|FG002|Overall Study|Lost to Follow-up|0
2275152|NCT02305849|3956737|FG003|Overall Study|Lost to Follow-up|0
2275153|NCT02305849|3956734|FG000|Overall Study|Protocol Violation|3
2275154|NCT02305849|3956735|FG001|Overall Study|Protocol Violation|2
2275155|NCT02305849|3956736|FG002|Overall Study|Protocol Violation|1
2275156|NCT02305849|3956737|FG003|Overall Study|Protocol Violation|1
2275157|NCT02305849|3956734|FG000|Overall Study|Lab data met discontinuation criteria|0
2275158|NCT02305849|3956735|FG001|Overall Study|Lab data met discontinuation criteria|1
2275159|NCT02305849|3956736|FG002|Overall Study|Lab data met discontinuation criteria|2
2275160|NCT02305849|3956737|FG003|Overall Study|Lab data met discontinuation criteria|1
2275161|NCT02305849|3956734|FG000|Overall Study|Miscellaneous|1
2275162|NCT02305849|3956735|FG001|Overall Study|Miscellaneous|2
2198736|NCT01557244|3833832|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
2198737|NCT01557244|3833833|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
2198738|NCT01557244|3833834|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
2198739|NCT01557244|3833835|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
2217063|NCT01705574|3860193|FG002|Double-Blind Phase|Randomized but Not Treated|0
2198740|NCT01557244|3833829|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
2198741|NCT01557244|3833830|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
2198742|NCT01557244|3833831|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
2198743|NCT01557244|3833832|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
2198744|NCT01557244|3833833|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
2198745|NCT01557244|3833834|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
2198746|NCT01557244|3833835|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
2198747|NCT01557244|3833829|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2
2198748|NCT01557244|3833830|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0
2198749|NCT01557244|3833831|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2
2198750|NCT01557244|3833832|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0
2198751|NCT01557244|3833833|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0
2198752|NCT01557244|3833834|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0
2198753|NCT01557244|3833835|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0
2198754|NCT01557244|3833829|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1
2198755|NCT01557244|3833830|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1
2198756|NCT01557244|3833831|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0
2198757|NCT01557244|3833832|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0
2198758|NCT01557244|3833833|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0
2198759|NCT01557244|3833834|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1
2198760|NCT01557244|3833835|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0
2198761|NCT01557244|3833829|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
2198762|NCT01557244|3833830|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
2198763|NCT01557244|3833831|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
2198764|NCT01557244|3833832|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
2198765|NCT01557244|3833833|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
2198766|NCT01557244|3833834|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
2198767|NCT01557244|3833835|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
2198768|NCT01557244|3833829|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
2198769|NCT01557244|3833830|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
2198770|NCT01557244|3833831|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
2198771|NCT01557244|3833832|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1
2198772|NCT01557244|3833833|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
2198773|NCT01557244|3833834|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
2198774|NCT01557244|3833835|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
2198775|NCT01557244|3833829|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1
2198776|NCT01557244|3833830|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2
2198777|NCT01557244|3833831|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
2198778|NCT01557244|3833832|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
2198779|NCT01557244|3833833|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
2198780|NCT01557244|3833834|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
2198781|NCT01557244|3833835|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
2198782|NCT01557283|3833863|FG000|Overall Study|Lost to Follow-up|7
2198783|NCT01557283|3833863|FG000|Overall Study|Non-responder|19
2198784|NCT01557283|3833863|FG000|Overall Study|Adverse Event|7
2198785|NCT01557283|3833863|FG000|Overall Study|Lack of Efficacy|1
2198786|NCT01557283|3833863|FG000|Overall Study|Non-compliance|1
2198787|NCT01557283|3833863|FG000|Overall Study|Withdrawal by Subject|1
2198788|NCT01557283|3833863|FG000|Overall Study|Participant's weight too high for dose|1
2198789|NCT01557283|3833863|FG000|Overall Study|Worsening of psoriasis|1
2198790|NCT01557283|3833863|FG000|Overall Study|Other|6
2198791|NCT01557348|3833878|FG000|Overall Study|Adverse Event|6
2198792|NCT01557348|3833879|FG001|Overall Study|Adverse Event|16
2198793|NCT01557348|3833878|FG000|Overall Study|Infusion reaction event|5
2198794|NCT01557348|3833879|FG001|Overall Study|Infusion reaction event|5
2198795|NCT01557348|3833878|FG000|Overall Study|Death|7
2198796|NCT01557348|3833879|FG001|Overall Study|Death|4
2198797|NCT01557348|3833878|FG000|Overall Study|Insufficient Therapeutic Response|13
2198798|NCT01557348|3833879|FG001|Overall Study|Insufficient Therapeutic Response|28
2198799|NCT01557348|3833878|FG000|Overall Study|Withdrawal by Subject|5
2198800|NCT01557348|3833879|FG001|Overall Study|Withdrawal by Subject|4
2198801|NCT01557348|3833878|FG000|Overall Study|Lost to Follow-up|26
2198802|NCT01557348|3833879|FG001|Overall Study|Lost to Follow-up|22
2198803|NCT01557348|3833878|FG000|Overall Study|Administrative|18
2198804|NCT01557348|3833879|FG001|Overall Study|Administrative|11
2198805|NCT01557400|3833886|FG000|Overall Study|Transitioned to Commercial Drug Product|40
2198806|NCT01557400|3833886|FG000|Overall Study|Adverse Event|3
2198807|NCT01557400|3833886|FG000|Overall Study|Lost to Follow-up|5
2198808|NCT01557400|3833886|FG000|Overall Study|Withdrawal by Subject|9
2198809|NCT01557504|3833897|FG000|Overall Study|Physician Decision|1
2198810|NCT01557504|3833898|FG001|Overall Study|Physician Decision|0
2198811|NCT01557517|3833912|FG000|Overall Study|Death|1
2198812|NCT01557517|3833913|FG001|Overall Study|Death|0
2198813|NCT01557517|3833912|FG000|Overall Study|Refused further treatment|0
2198814|NCT01557517|3833913|FG001|Overall Study|Refused further treatment|2
2198815|NCT01557517|3833912|FG000|Overall Study|Adverse Event|0
2198816|NCT01557517|3833913|FG001|Overall Study|Adverse Event|2
2198817|NCT01557517|3833912|FG000|Overall Study|Pt declined before treatment started|1
2198818|NCT01557517|3833913|FG001|Overall Study|Pt declined before treatment started|0
2198819|NCT01557569|3833928|FG000|Overall Study|Adverse Event|2
2198820|NCT01557569|3833929|FG001|Overall Study|Adverse Event|0
2198821|NCT01557569|3833928|FG000|Overall Study|high blood pressure|0
2198822|NCT01557569|3833929|FG001|Overall Study|high blood pressure|1
2198823|NCT01557569|3833928|FG000|Overall Study|Withdrawal by Subject|3
2198824|NCT01557569|3833929|FG001|Overall Study|Withdrawal by Subject|5
2198825|NCT01557569|3833928|FG000|Overall Study|noncompliance with rules of residential|0
2198826|NCT01557569|3833929|FG001|Overall Study|noncompliance with rules of residential|1
2198827|NCT01557582|3833935|FG000|Overall Study|Protocol Violation|4
2198828|NCT01557582|3833935|FG000|Overall Study|Operator error|2
2198829|NCT01557751|3833959|FG000|Overall Study|Physician Decision|3
2198830|NCT01557842|3833969|FG000|Overall Study|Lost to Follow-up|0
2198831|NCT01557842|3833970|FG001|Overall Study|Lost to Follow-up|1
2198832|NCT01557842|3833969|FG000|Overall Study|Death|1
2198833|NCT01557842|3833970|FG001|Overall Study|Death|0
2198834|NCT01557842|3833969|FG000|Overall Study|Lack of Efficacy|0
2198835|NCT01557842|3833970|FG001|Overall Study|Lack of Efficacy|1
2198836|NCT01557842|3833969|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
2198837|NCT01557842|3833970|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
2198838|NCT01557842|3833969|FG000|Overall Study|Study Terminated by Sponsor|3
2198839|NCT01557842|3833970|FG001|Overall Study|Study Terminated by Sponsor|4
2198840|NCT01557842|3833969|FG000|Overall Study|Not Ablated|2
2198841|NCT01557842|3833970|FG001|Overall Study|Not Ablated|0
2198842|NCT01557920|3833995|FG000|Overall Study|Withdrawal by Subject|2
2198843|NCT01557920|3833996|FG001|Overall Study|Withdrawal by Subject|3
2198844|NCT01557920|3833995|FG000|Overall Study|Lack of Efficacy|1
2198845|NCT01557920|3833996|FG001|Overall Study|Lack of Efficacy|0
2198846|NCT01557946|3834031|FG000|Overall Study|Adverse Event|3
2198847|NCT01557946|3834032|FG001|Overall Study|Adverse Event|0
2198848|NCT01558089|3834063|FG000|Overall Study|Adverse Event|1
2198849|NCT01558089|3834063|FG000|Overall Study|Lack of Efficacy|1
2198850|NCT01558089|3834063|FG000|Overall Study|Lost to Follow-up|5
2198851|NCT01558089|3834063|FG000|Overall Study|Withdrawal by Subject|6
2198852|NCT01558271|3834074|FG000|Overall Study|Adverse Event|6
2198853|NCT01558271|3834075|FG001|Overall Study|Adverse Event|3
2198854|NCT01558271|3834076|FG002|Overall Study|Adverse Event|4
2198855|NCT01558271|3834074|FG000|Overall Study|Lost to Follow-up|1
2198856|NCT01558271|3834075|FG001|Overall Study|Lost to Follow-up|0
2198857|NCT01558271|3834076|FG002|Overall Study|Lost to Follow-up|0
2198858|NCT01558271|3834074|FG000|Overall Study|Protocol Violation|1
2198859|NCT01558271|3834075|FG001|Overall Study|Protocol Violation|0
2198860|NCT01558271|3834076|FG002|Overall Study|Protocol Violation|0
2198861|NCT01558271|3834074|FG000|Overall Study|Withdrawal by Subject|10
2198862|NCT01558271|3834075|FG001|Overall Study|Withdrawal by Subject|6
2198863|NCT01558271|3834076|FG002|Overall Study|Withdrawal by Subject|12
2198864|NCT01558271|3834074|FG000|Overall Study|Physician Decision|0
2198865|NCT01558271|3834075|FG001|Overall Study|Physician Decision|2
2198866|NCT01558271|3834076|FG002|Overall Study|Physician Decision|1
2198867|NCT01558297|3834091|FG000|Overall Study|Withdrawal by Subject|2
2198868|NCT01558297|3834092|FG001|Overall Study|Withdrawal by Subject|2
2198869|NCT01558297|3834093|FG002|Overall Study|Withdrawal by Subject|1
2198870|NCT01558596|3834103|FG000|Overall Study|Withdrawal by Subject|1
2198871|NCT01558596|3834104|FG001|Overall Study|Withdrawal by Subject|0
2198872|NCT01558596|3834103|FG000|Overall Study|surgery elsewhere or cancelled|1
2198873|NCT01558596|3834104|FG001|Overall Study|surgery elsewhere or cancelled|1
2198874|NCT01558596|3834103|FG000|Overall Study|Protocol Violation|1
2198875|NCT01558596|3834104|FG001|Overall Study|Protocol Violation|0
2198876|NCT01558635|3834110|FG000|Overall Study|Death|1
2198877|NCT01558635|3834110|FG000|Overall Study|Withdrawal by Subject|2
2198878|NCT01558635|3834110|FG000|Overall Study|Physician Decision|1
2198879|NCT01558635|3834110|FG000|Overall Study|Subject received other treatment|1
2198880|NCT01558635|3834110|FG000|Overall Study|Reveal XT was explanted|1
2198881|NCT01558674|3834127|FG000|Part 1|Study Terminated by Sponsor|10
2198882|NCT01558674|3834128|FG001|Part 1|Study Terminated by Sponsor|0
2198883|NCT01558674|3834127|FG000|Part 1|Withdrawal by Subject|1
2198884|NCT01558674|3834128|FG001|Part 1|Withdrawal by Subject|0
2198885|NCT01558739|3834156|FG000|Overall Study|Adverse Event|7
2198886|NCT01558739|3834156|FG000|Overall Study|Withdrawal by Subject|2
2198887|NCT01558739|3834156|FG000|Overall Study|Death|3
2198888|NCT01558739|3834156|FG000|Overall Study|Disease Progression|4
2198889|NCT01558739|3834156|FG000|Overall Study|Protocol Violation|1
2198890|NCT01558752|3834162|FG000|Overall Study|Physician Decision|2
2198891|NCT01558752|3834163|FG001|Overall Study|Physician Decision|0
2198892|NCT01559012|3834182|FG000|Overall Study|Withdrawal by Subject|0
2198893|NCT01559012|3834183|FG001|Overall Study|Withdrawal by Subject|1
2198894|NCT01559090|3834220|FG000|Stage I|Withdrawal by Subject|2
2198895|NCT01559090|3834221|FG001|Stage I|Withdrawal by Subject|2
2198896|NCT01559090|3834222|FG002|Stage I|Withdrawal by Subject|3
2198897|NCT01559090|3834220|FG000|Stage II|Withdrawal by Subject|1
2198898|NCT01559090|3834221|FG001|Stage II|Withdrawal by Subject|0
2198899|NCT01559090|3834222|FG002|Stage II|Withdrawal by Subject|0
2198900|NCT01559116|3834230|FG000|Overall Study|Adverse Event|10
2198901|NCT01559116|3834230|FG000|Overall Study|Lack of Efficacy|1
2198902|NCT01559116|3834230|FG000|Overall Study|Lost to Follow-up|1
2198903|NCT01559116|3834230|FG000|Overall Study|Protocol Violation|1
2198904|NCT01559116|3834230|FG000|Overall Study|Withdrawal by Subject|4
2198905|NCT01559116|3834230|FG000|Overall Study|other than stated above|9
2198906|NCT01559129|3834249|FG000|Treatment Phase|Adverse Event|0
2198907|NCT01559129|3834250|FG001|Treatment Phase|Adverse Event|2
2198908|NCT01559129|3834249|FG000|Treatment Phase|Progressive Disease|1
2198909|NCT01559129|3834250|FG001|Treatment Phase|Progressive Disease|1
2198910|NCT01559129|3834249|FG000|Treatment Phase|Lack of Efficacy|0
2198911|NCT01559129|3834250|FG001|Treatment Phase|Lack of Efficacy|1
2198912|NCT01559129|3834249|FG000|Treatment Phase|Study Terminated by Sponsor|3
2198913|NCT01559129|3834250|FG001|Treatment Phase|Study Terminated by Sponsor|2
2198914|NCT01559129|3834249|FG000|Treatment Phase|Protocol Exclusion Criteria|1
2198915|NCT01559129|3834250|FG001|Treatment Phase|Protocol Exclusion Criteria|0
2198916|NCT01559129|3834249|FG000|Treatment Phase|Did Not Receive Study Drug|0
2198917|NCT01559129|3834250|FG001|Treatment Phase|Did Not Receive Study Drug|1
2198918|NCT01559129|3834249|FG000|Open-label Extension Period|Adverse Event|1
2198919|NCT01559129|3834250|FG001|Open-label Extension Period|Adverse Event|0
2198920|NCT01559129|3834249|FG000|Open-label Extension Period|Study Terminated by Sponsor|5
2198921|NCT01559129|3834250|FG001|Open-label Extension Period|Study Terminated by Sponsor|2
2198922|NCT01559259|3834267|FG000|Overall Study|Withdrawal by Subject|0
2198923|NCT01559259|3834268|FG001|Overall Study|Withdrawal by Subject|0
2198924|NCT01559259|3834269|FG002|Overall Study|Withdrawal by Subject|0
2198925|NCT01559259|3834270|FG003|Overall Study|Withdrawal by Subject|1
2198926|NCT01559259|3834271|FG004|Overall Study|Withdrawal by Subject|0
2198927|NCT01559259|3834267|FG000|Overall Study|Adverse Event|0
2198928|NCT01559259|3834268|FG001|Overall Study|Adverse Event|1
2198929|NCT01559259|3834269|FG002|Overall Study|Adverse Event|1
2198930|NCT01559259|3834270|FG003|Overall Study|Adverse Event|0
2198931|NCT01559259|3834271|FG004|Overall Study|Adverse Event|0
2198932|NCT01559311|3834286|FG000|Overall Study|Protocol Violation|0
2198933|NCT01559311|3834287|FG001|Overall Study|Protocol Violation|0
2198934|NCT01559311|3834288|FG002|Overall Study|Protocol Violation|2
2198935|NCT01559311|3834286|FG000|Overall Study|Difficulty in cannulating the lateral ve|1
2198936|NCT01559311|3834287|FG001|Overall Study|Difficulty in cannulating the lateral ve|0
2198937|NCT01559311|3834288|FG002|Overall Study|Difficulty in cannulating the lateral ve|0
2198938|NCT01559311|3834286|FG000|Overall Study|Withdrawal by Subject|2
2198939|NCT01559311|3834287|FG001|Overall Study|Withdrawal by Subject|1
2198940|NCT01559311|3834288|FG002|Overall Study|Withdrawal by Subject|0
2198941|NCT01559311|3834286|FG000|Overall Study|Death|0
2198942|NCT01559311|3834287|FG001|Overall Study|Death|2
2198943|NCT01559311|3834288|FG002|Overall Study|Death|3
2198944|NCT01559311|3834286|FG000|Overall Study|Lost to Follow-up|0
2198945|NCT01559311|3834287|FG001|Overall Study|Lost to Follow-up|3
2198946|NCT01559311|3834288|FG002|Overall Study|Lost to Follow-up|2
2198947|NCT01559311|3834286|FG000|Overall Study|Adverse Event|0
2198948|NCT01559311|3834287|FG001|Overall Study|Adverse Event|0
2198949|NCT01559311|3834288|FG002|Overall Study|Adverse Event|1
2198950|NCT01559389|3834298|FG000|Overall Study|Withdrawal by Subject|20
2198951|NCT01559389|3834299|FG001|Overall Study|Withdrawal by Subject|20
2198952|NCT01559454|3834311|FG000|Overall Study|Lost to Follow-up|3
2198953|NCT01559454|3834312|FG001|Overall Study|Lost to Follow-up|2
2198954|NCT01559454|3834311|FG000|Overall Study|Withdrawal by Subject|0
2198955|NCT01559454|3834312|FG001|Overall Study|Withdrawal by Subject|1
2198956|NCT01559454|3834311|FG000|Overall Study|Physician Decision|0
2198957|NCT01559454|3834312|FG001|Overall Study|Physician Decision|1
2198958|NCT01559454|3834311|FG000|Overall Study|Protocol Violation|0
2198959|NCT01559454|3834312|FG001|Overall Study|Protocol Violation|1
2198960|NCT01559454|3834311|FG000|Overall Study|Lack of Efficacy|0
2198961|NCT01559454|3834312|FG001|Overall Study|Lack of Efficacy|1
2198962|NCT01559675|3834339|FG000|Overall Study|Protocol Violation|1
2198963|NCT01559675|3834340|FG001|Overall Study|Protocol Violation|2
2198964|NCT01559675|3834339|FG000|Overall Study|2nd operation on same patient excluded|14
2198965|NCT01559675|3834340|FG001|Overall Study|2nd operation on same patient excluded|12
2198966|NCT01559844|3834346|FG000|Overall Study|Consent Withdrawn|7
2198967|NCT01559844|3834346|FG000|Overall Study|Death|5
2198968|NCT01559844|3834346|FG000|Overall Study|Efficacy Failure|10
2198969|NCT01559844|3834346|FG000|Overall Study|No Longer A Transplant Candidate|3
2198970|NCT01559935|3834370|FG000|Car Phase|Toxicity|4
2198971|NCT01559935|3834370|FG000|Car Phase|Death|1
2198972|NCT01559935|3834370|FG000|Car Phase|Lack of Efficacy|2
2198973|NCT01559935|3834370|FG000|Car Phase|Lost to Follow-up|1
2198974|NCT01559935|3834370|FG000|Car Phase|Physician Decision|1
2198975|NCT01559935|3834370|FG000|Car Phase|Withdrawal by Subject|2
2198976|NCT01559935|3834370|FG000|Car Phase|Per protocol|1
2198977|NCT01559935|3834370|FG000|Car Phase|Insurance|1
2198978|NCT01559935|3834370|FG000|Car Phase|non-compliance|1
2198979|NCT01559935|3834370|FG000|BiRD Phase|Toxicity|1
2198980|NCT01559935|3834370|FG000|BiRD Phase|Lack of Efficacy|1
2198981|NCT01559935|3834370|FG000|BiRD Phase|Withdrawal by Subject|2
2198982|NCT01559935|3834370|FG000|Maintenance Phase|Remains on study|28
2198983|NCT01559935|3834370|FG000|Maintenance Phase|Toxicity|1
2198984|NCT01559935|3834370|FG000|Maintenance Phase|Lack of Efficacy|18
2198985|NCT01559935|3834370|FG000|Maintenance Phase|Withdrawal by Subject|5
2198986|NCT01559935|3834370|FG000|Maintenance Phase|Non-compliance|2
2198987|NCT01560234|3834399|FG000|Overall Study|Lost to Follow-up|3
2198988|NCT01560234|3834400|FG001|Overall Study|Lost to Follow-up|0
2198989|NCT01560234|3834401|FG002|Overall Study|Lost to Follow-up|1
2198990|NCT01560234|3834402|FG003|Overall Study|Lost to Follow-up|0
2198991|NCT01560234|3834403|FG004|Overall Study|Lost to Follow-up|0
2198992|NCT01560234|3834404|FG005|Overall Study|Lost to Follow-up|2
2198993|NCT01560234|3834405|FG006|Overall Study|Lost to Follow-up|0
2198994|NCT01560234|3834406|FG007|Overall Study|Lost to Follow-up|2
2198995|NCT01560403|3834440|FG000|Overall Study|Lost to Follow-up|0
2198996|NCT01560403|3834441|FG001|Overall Study|Lost to Follow-up|1
2275163|NCT02305849|3956736|FG002|Overall Study|Miscellaneous|4
2275164|NCT02305849|3956737|FG003|Overall Study|Miscellaneous|1
2275165|NCT02305849|3956734|FG000|Overall Study|Not fulfill eligibility criteria|1
2275166|NCT02305849|3956735|FG001|Overall Study|Not fulfill eligibility criteria|1
2275167|NCT02305849|3956736|FG002|Overall Study|Not fulfill eligibility criteria|0
2275168|NCT02305849|3956737|FG003|Overall Study|Not fulfill eligibility criteria|0
2275169|NCT02305888|3956771|FG000|Overall Study|Lost to Follow-up|0
2275170|NCT02305888|3956772|FG001|Overall Study|Lost to Follow-up|0
2275171|NCT02305888|3956773|FG002|Overall Study|Lost to Follow-up|1
2275172|NCT02305888|3956771|FG000|Overall Study|Adverse Event|0
2275173|NCT02305888|3956772|FG001|Overall Study|Adverse Event|1
2275174|NCT02305888|3956773|FG002|Overall Study|Adverse Event|0
2275175|NCT02306265|3956781|FG000|Overall Study|Withdrawal by Subject|1
2275176|NCT02306694|3956786|FG000|Overall Study|Withdrawal by Subject|3
2275177|NCT02306694|3956786|FG000|Overall Study|Lost to Follow-up|1
2275178|NCT02306850|3956801|FG000|Overall Study|Lack of Efficacy|2
2275179|NCT02307266|3956817|FG000|Overall Study|Adverse Event|3
2275180|NCT02307266|3956818|FG001|Overall Study|Adverse Event|1
2275181|NCT02307266|3956819|FG002|Overall Study|Adverse Event|5
2275182|NCT02307266|3956817|FG000|Overall Study|Withdrawal by Subject|2
2275183|NCT02307266|3956818|FG001|Overall Study|Withdrawal by Subject|0
2275184|NCT02307266|3956819|FG002|Overall Study|Withdrawal by Subject|1
2275185|NCT02307266|3956817|FG000|Overall Study|Lost to Follow-up|3
2275186|NCT02307266|3956818|FG001|Overall Study|Lost to Follow-up|0
2275187|NCT02307266|3956819|FG002|Overall Study|Lost to Follow-up|0
2275188|NCT02307370|3956831|FG000|Overall Study|Death|5
2275189|NCT02307370|3956831|FG000|Overall Study|Lost to Follow-up|1
2275190|NCT02307370|3956831|FG000|Overall Study|Withdrawal by Subject|1
2275191|NCT02307370|3956831|FG000|Overall Study|Declined Addendum ICF|6
2275192|NCT02307370|3956831|FG000|Overall Study|No response during telephone contact|5
2275193|NCT02307370|3956831|FG000|Overall Study|Protocol Violation|1
2275194|NCT02307513|3956839|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
2275195|NCT02307513|3956840|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
2275196|NCT02307513|3956839|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
2275197|NCT02307513|3956840|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
2275198|NCT02307513|3956839|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
2275199|NCT02307513|3956840|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
2275200|NCT02307513|3956839|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
2275201|NCT02307513|3956840|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
2275202|NCT02307513|3956839|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
2275203|NCT02307513|3956840|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
2275204|NCT02307513|3956839|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
2275205|NCT02307513|3956840|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
2275206|NCT02307513|3956839|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
2275207|NCT02307513|3956840|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
2275208|NCT02307513|3956839|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
2275209|NCT02307513|3956840|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
2275210|NCT02307513|3956839|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
2275211|NCT02307513|3956840|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
2275212|NCT02307513|3956839|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
2275213|NCT02307513|3956840|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
2275214|NCT02307513|3956839|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
2275215|NCT02307513|3956840|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
2275216|NCT02307513|3956839|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
2275217|NCT02307513|3956840|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
2275218|NCT02307513|3956839|FG000|Long-term Extension|Physician Decision|1
2275219|NCT02307513|3956840|FG001|Long-term Extension|Physician Decision|0
2275220|NCT02307682|3956863|FG000|Overall Study|Adverse Event|9
2275221|NCT02307682|3956864|FG001|Overall Study|Adverse Event|8
2275222|NCT02307682|3956865|FG002|Overall Study|Adverse Event|12
2275223|NCT02307682|3956863|FG000|Overall Study|Lack of Efficacy|1
2275224|NCT02307682|3956864|FG001|Overall Study|Lack of Efficacy|0
2275225|NCT02307682|3956865|FG002|Overall Study|Lack of Efficacy|1
2198997|NCT01560416|3834449|FG000|Randomized Phase|Crossover Participants|7
2198998|NCT01560416|3834450|FG001|Randomized Phase|Crossover Participants|0
2198999|NCT01560429|3834460|FG000|Overall Study|Protocol Violation|3
2199000|NCT01560429|3834461|FG001|Overall Study|Protocol Violation|6
2199001|NCT01560780|3834480|FG000|Overall Study|Death|2
2199002|NCT01560780|3834481|FG001|Overall Study|Death|1
2199003|NCT01560780|3834480|FG000|Overall Study|Patient Preference|11
2199004|NCT01560780|3834481|FG001|Overall Study|Patient Preference|11
2199005|NCT01560819|3834489|FG000|Overall Study|Physician Decision|1
2199006|NCT01560819|3834490|FG001|Overall Study|Physician Decision|0
2199007|NCT01560871|3834496|FG000|Overall Study|transportation issues|2
2199008|NCT01560871|3834497|FG001|Overall Study|transportation issues|1
2199009|NCT01560871|3834496|FG000|Overall Study|relocation|1
2199010|NCT01560871|3834497|FG001|Overall Study|relocation|0
2199011|NCT01560871|3834496|FG000|Overall Study|readmission to a hospital|2
2199012|NCT01560871|3834497|FG001|Overall Study|readmission to a hospital|1
2199013|NCT01560871|3834496|FG000|Overall Study|Lost to Follow-up|1
2199014|NCT01560871|3834497|FG001|Overall Study|Lost to Follow-up|0
2199015|NCT01560949|3834513|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6
2199016|NCT01560949|3834513|FG000|Surgery Phase|Physician Decision|3
2199017|NCT01560988|3834529|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7
2199018|NCT01560988|3834530|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4
2199019|NCT01560988|3834529|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3
2199020|NCT01560988|3834530|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0
2199021|NCT01560988|3834529|FG000|Washout (Six Weeks)|Lost to Follow-up|2
2199022|NCT01560988|3834530|FG001|Washout (Six Weeks)|Lost to Follow-up|2
2199023|NCT01561079|3834559|FG000|Overall Study|Physician Decision|17
2199024|NCT01561079|3834559|FG000|Overall Study|Withdrawal by Subject|59
2199025|NCT01561079|3834559|FG000|Overall Study|Protocol Violation|2
2199026|NCT01561300|3834602|FG000|Run in on Placebo|Adverse Event|1
2199027|NCT01561300|3834603|FG001|Run in on Placebo|Adverse Event|0
2199028|NCT01561313|3834612|FG000|Overall Study|Withdrawal by Subject|1
2199029|NCT01561313|3834613|FG001|Overall Study|Withdrawal by Subject|0
2199030|NCT01561313|3834612|FG000|Overall Study|Adverse event and withdrawal by subject|1
2199031|NCT01561313|3834613|FG001|Overall Study|Adverse event and withdrawal by subject|0
2199032|NCT01561560|3834628|FG000|First Two Weeks of Wear|Time/job conflict|0
2199033|NCT01561560|3834629|FG001|First Two Weeks of Wear|Time/job conflict|1
2199034|NCT01561560|3834628|FG000|First Two Weeks of Wear|Adverse Event|0
2199035|NCT01561560|3834629|FG001|First Two Weeks of Wear|Adverse Event|1
2199036|NCT01561560|3834628|FG000|Second Two Weeks of Wear|Adverse Event|0
2199037|NCT01561560|3834629|FG001|Second Two Weeks of Wear|Adverse Event|1
2199038|NCT01561755|3834671|FG000|Overall Study|Lost to Follow-up|0
2199039|NCT01561755|3834672|FG001|Overall Study|Lost to Follow-up|1
2199040|NCT01561898|3834686|FG000|Overall Study|Withdrawal by Subject|0
2199041|NCT01561898|3834687|FG001|Overall Study|Withdrawal by Subject|8
2199042|NCT01561898|3834688|FG002|Overall Study|Withdrawal by Subject|12
2199043|NCT01561898|3834689|FG003|Overall Study|Withdrawal by Subject|5
2199044|NCT01561898|3834686|FG000|Overall Study|Lack of Efficacy|0
2199045|NCT01561898|3834687|FG001|Overall Study|Lack of Efficacy|8
2199046|NCT01561898|3834688|FG002|Overall Study|Lack of Efficacy|10
2199047|NCT01561898|3834689|FG003|Overall Study|Lack of Efficacy|5
2199048|NCT01561898|3834686|FG000|Overall Study|Worsening of complications|0
2199049|NCT01561898|3834687|FG001|Overall Study|Worsening of complications|1
2199050|NCT01561898|3834688|FG002|Overall Study|Worsening of complications|0
2199051|NCT01561898|3834689|FG003|Overall Study|Worsening of complications|0
2199052|NCT01561898|3834686|FG000|Overall Study|Lost to Follow-up|0
2199053|NCT01561898|3834687|FG001|Overall Study|Lost to Follow-up|0
2199054|NCT01561898|3834688|FG002|Overall Study|Lost to Follow-up|1
2199055|NCT01561898|3834689|FG003|Overall Study|Lost to Follow-up|0
2199056|NCT01561898|3834686|FG000|Overall Study|Adverse Event|1
2199057|NCT01561898|3834687|FG001|Overall Study|Adverse Event|19
2199058|NCT01561898|3834688|FG002|Overall Study|Adverse Event|14
2199059|NCT01561898|3834689|FG003|Overall Study|Adverse Event|9
2199060|NCT01561898|3834686|FG000|Overall Study|Physician Decision|1
2199061|NCT01561898|3834687|FG001|Overall Study|Physician Decision|5
2199062|NCT01561898|3834688|FG002|Overall Study|Physician Decision|7
2199063|NCT01561898|3834689|FG003|Overall Study|Physician Decision|1
2199064|NCT01561963|3834697|FG000|Overall Study|Adverse Event|1
2199065|NCT01561976|3834712|FG000|Period 1|Adverse Event|0
2199066|NCT01561976|3834713|FG001|Period 1|Adverse Event|0
2199067|NCT01561976|3834714|FG002|Period 1|Adverse Event|1
2199068|NCT01561976|3834715|FG003|Period 1|Adverse Event|0
2199069|NCT01561976|3834716|FG004|Period 1|Adverse Event|0
2199070|NCT01561976|3834717|FG005|Period 1|Adverse Event|0
2199071|NCT01561976|3834712|FG000|Washout Period 1 (7 Days)|Adverse Event|0
2199072|NCT01561976|3834713|FG001|Washout Period 1 (7 Days)|Adverse Event|0
2199073|NCT01561976|3834714|FG002|Washout Period 1 (7 Days)|Adverse Event|0
2199074|NCT01561976|3834715|FG003|Washout Period 1 (7 Days)|Adverse Event|1
2199075|NCT01561976|3834716|FG004|Washout Period 1 (7 Days)|Adverse Event|0
2199076|NCT01561976|3834717|FG005|Washout Period 1 (7 Days)|Adverse Event|0
2199077|NCT01561976|3834712|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2199078|NCT01561976|3834713|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2199079|NCT01561976|3834714|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2199080|NCT01561976|3834715|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2199081|NCT01561976|3834716|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2199082|NCT01561976|3834717|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2199083|NCT01561976|3834712|FG000|Washout Period 2 (7 Days)|Non-compliance|1
2199084|NCT01561976|3834713|FG001|Washout Period 2 (7 Days)|Non-compliance|0
2199085|NCT01561976|3834714|FG002|Washout Period 2 (7 Days)|Non-compliance|1
2199086|NCT01561976|3834715|FG003|Washout Period 2 (7 Days)|Non-compliance|0
2199087|NCT01561976|3834716|FG004|Washout Period 2 (7 Days)|Non-compliance|0
2199088|NCT01561976|3834717|FG005|Washout Period 2 (7 Days)|Non-compliance|0
2199089|NCT01562028|3834727|FG000|Overall Study|Withdrawal by Subject|1
2199090|NCT01562028|3834728|FG001|Overall Study|Withdrawal by Subject|1
2199091|NCT01562028|3834727|FG000|Overall Study|Lost to Follow-up|2
2199092|NCT01562028|3834728|FG001|Overall Study|Lost to Follow-up|1
2199093|NCT01562275|3834760|FG000|Stage 1|Adverse Event|0
2199094|NCT01562275|3834761|FG001|Stage 1|Adverse Event|0
2199095|NCT01562275|3834762|FG002|Stage 1|Adverse Event|0
2199096|NCT01562275|3834763|FG003|Stage 1|Adverse Event|1
2199097|NCT01562275|3834764|FG004|Stage 1|Adverse Event|1
2199098|NCT01562275|3834765|FG005|Stage 1|Adverse Event|0
2199099|NCT01562275|3834766|FG006|Stage 1|Adverse Event|0
2199100|NCT01562275|3834767|FG007|Stage 1|Adverse Event|0
2199101|NCT01562275|3834768|FG008|Stage 1|Adverse Event|0
2199102|NCT01562275|3834769|FG009|Stage 1|Adverse Event|1
2199103|NCT01562275|3834770|FG010|Stage 1|Adverse Event|0
2199104|NCT01562275|3834771|FG011|Stage 1|Adverse Event|0
2199105|NCT01562275|3834772|FG012|Stage 1|Adverse Event|0
2199106|NCT01562275|3834760|FG000|Stage 1|Death|1
2199107|NCT01562275|3834761|FG001|Stage 1|Death|0
2199108|NCT01562275|3834762|FG002|Stage 1|Death|0
2199109|NCT01562275|3834763|FG003|Stage 1|Death|0
2199110|NCT01562275|3834764|FG004|Stage 1|Death|0
2199111|NCT01562275|3834765|FG005|Stage 1|Death|0
2199112|NCT01562275|3834766|FG006|Stage 1|Death|0
2199113|NCT01562275|3834767|FG007|Stage 1|Death|0
2199114|NCT01562275|3834768|FG008|Stage 1|Death|0
2199115|NCT01562275|3834769|FG009|Stage 1|Death|0
2199116|NCT01562275|3834770|FG010|Stage 1|Death|0
2199117|NCT01562275|3834771|FG011|Stage 1|Death|0
2199118|NCT01562275|3834772|FG012|Stage 1|Death|0
2199119|NCT01562275|3834760|FG000|Stage 1|Non Compliance|0
2199120|NCT01562275|3834761|FG001|Stage 1|Non Compliance|0
2199121|NCT01562275|3834762|FG002|Stage 1|Non Compliance|1
2199122|NCT01562275|3834763|FG003|Stage 1|Non Compliance|0
2199123|NCT01562275|3834764|FG004|Stage 1|Non Compliance|0
2199124|NCT01562275|3834765|FG005|Stage 1|Non Compliance|0
2199125|NCT01562275|3834766|FG006|Stage 1|Non Compliance|0
2199126|NCT01562275|3834767|FG007|Stage 1|Non Compliance|0
2199127|NCT01562275|3834768|FG008|Stage 1|Non Compliance|0
2199128|NCT01562275|3834769|FG009|Stage 1|Non Compliance|0
2199129|NCT01562275|3834770|FG010|Stage 1|Non Compliance|0
2199130|NCT01562275|3834771|FG011|Stage 1|Non Compliance|0
2199131|NCT01562275|3834772|FG012|Stage 1|Non Compliance|0
2199132|NCT01562275|3834760|FG000|Stage 1|Physician Decision|0
2199133|NCT01562275|3834761|FG001|Stage 1|Physician Decision|0
2199134|NCT01562275|3834762|FG002|Stage 1|Physician Decision|0
2199135|NCT01562275|3834763|FG003|Stage 1|Physician Decision|0
2199136|NCT01562275|3834764|FG004|Stage 1|Physician Decision|1
2199137|NCT01562275|3834765|FG005|Stage 1|Physician Decision|0
2199138|NCT01562275|3834766|FG006|Stage 1|Physician Decision|1
2199139|NCT01562275|3834767|FG007|Stage 1|Physician Decision|0
2199140|NCT01562275|3834768|FG008|Stage 1|Physician Decision|1
2199141|NCT01562275|3834769|FG009|Stage 1|Physician Decision|0
2199142|NCT01562275|3834770|FG010|Stage 1|Physician Decision|0
2199143|NCT01562275|3834771|FG011|Stage 1|Physician Decision|0
2199144|NCT01562275|3834772|FG012|Stage 1|Physician Decision|0
2199145|NCT01562275|3834760|FG000|Stage 1|Progression of Disease|2
2199146|NCT01562275|3834761|FG001|Stage 1|Progression of Disease|6
2199147|NCT01562275|3834762|FG002|Stage 1|Progression of Disease|2
2199148|NCT01562275|3834763|FG003|Stage 1|Progression of Disease|1
2199149|NCT01562275|3834764|FG004|Stage 1|Progression of Disease|2
2199150|NCT01562275|3834765|FG005|Stage 1|Progression of Disease|4
2199151|NCT01562275|3834766|FG006|Stage 1|Progression of Disease|1
2199152|NCT01562275|3834767|FG007|Stage 1|Progression of Disease|7
2199153|NCT01562275|3834768|FG008|Stage 1|Progression of Disease|2
2199154|NCT01562275|3834769|FG009|Stage 1|Progression of Disease|5
2199155|NCT01562275|3834770|FG010|Stage 1|Progression of Disease|3
2199156|NCT01562275|3834771|FG011|Stage 1|Progression of Disease|0
2199157|NCT01562275|3834772|FG012|Stage 1|Progression of Disease|0
2199158|NCT01562275|3834760|FG000|Stage 1|Withdrawal by Subject|0
2199159|NCT01562275|3834761|FG001|Stage 1|Withdrawal by Subject|1
2199160|NCT01562275|3834762|FG002|Stage 1|Withdrawal by Subject|0
2199161|NCT01562275|3834763|FG003|Stage 1|Withdrawal by Subject|2
2199162|NCT01562275|3834764|FG004|Stage 1|Withdrawal by Subject|0
2199163|NCT01562275|3834765|FG005|Stage 1|Withdrawal by Subject|0
2199164|NCT01562275|3834766|FG006|Stage 1|Withdrawal by Subject|1
2199165|NCT01562275|3834767|FG007|Stage 1|Withdrawal by Subject|0
2199166|NCT01562275|3834768|FG008|Stage 1|Withdrawal by Subject|0
2199167|NCT01562275|3834769|FG009|Stage 1|Withdrawal by Subject|1
2199168|NCT01562275|3834770|FG010|Stage 1|Withdrawal by Subject|0
2199169|NCT01562275|3834771|FG011|Stage 1|Withdrawal by Subject|0
2199170|NCT01562275|3834772|FG012|Stage 1|Withdrawal by Subject|0
2199171|NCT01562275|3834760|FG000|Stage 2|Death|0
2199172|NCT01562275|3834761|FG001|Stage 2|Death|0
2199173|NCT01562275|3834762|FG002|Stage 2|Death|0
2199174|NCT01562275|3834763|FG003|Stage 2|Death|0
2199175|NCT01562275|3834764|FG004|Stage 2|Death|0
2199176|NCT01562275|3834765|FG005|Stage 2|Death|0
2199177|NCT01562275|3834766|FG006|Stage 2|Death|0
2199178|NCT01562275|3834767|FG007|Stage 2|Death|0
2199179|NCT01562275|3834768|FG008|Stage 2|Death|0
2199180|NCT01562275|3834769|FG009|Stage 2|Death|0
2199181|NCT01562275|3834770|FG010|Stage 2|Death|0
2199182|NCT01562275|3834771|FG011|Stage 2|Death|2
2199183|NCT01562275|3834772|FG012|Stage 2|Death|1
2199184|NCT01562275|3834760|FG000|Stage 2|Progression of Disease|0
2199185|NCT01562275|3834761|FG001|Stage 2|Progression of Disease|0
2199186|NCT01562275|3834762|FG002|Stage 2|Progression of Disease|0
2199187|NCT01562275|3834763|FG003|Stage 2|Progression of Disease|0
2199188|NCT01562275|3834764|FG004|Stage 2|Progression of Disease|0
2199189|NCT01562275|3834765|FG005|Stage 2|Progression of Disease|0
2199190|NCT01562275|3834766|FG006|Stage 2|Progression of Disease|0
2199191|NCT01562275|3834767|FG007|Stage 2|Progression of Disease|0
2199192|NCT01562275|3834768|FG008|Stage 2|Progression of Disease|0
2199193|NCT01562275|3834769|FG009|Stage 2|Progression of Disease|0
2199194|NCT01562275|3834770|FG010|Stage 2|Progression of Disease|0
2199195|NCT01562275|3834771|FG011|Stage 2|Progression of Disease|12
2199196|NCT01562275|3834772|FG012|Stage 2|Progression of Disease|4
2199197|NCT01562314|3834804|FG000|Overall Study|Adverse Event|10
2199198|NCT01562314|3834805|FG001|Overall Study|Adverse Event|5
2199199|NCT01562314|3834804|FG000|Overall Study|Met Withdrawal Criteria|3
2199200|NCT01562314|3834805|FG001|Overall Study|Met Withdrawal Criteria|2
2199201|NCT01562314|3834804|FG000|Overall Study|Withdrawal by Subject|0
2199202|NCT01562314|3834805|FG001|Overall Study|Withdrawal by Subject|1
2199203|NCT01562327|3834811|FG000|Overall Study|Adverse Event|2
2199204|NCT01562327|3834811|FG000|Overall Study|Lack of Efficacy|1
2199205|NCT01562327|3834811|FG000|Overall Study|Participant drop-out|1
2199206|NCT01562327|3834811|FG000|Overall Study|Infusion not received at 6 month window|4
2199207|NCT01562444|3834840|FG000|Overall Study|Did not meet entry criteria|2
2199208|NCT01562444|3834841|FG001|Overall Study|Did not meet entry criteria|0
2199209|NCT01562444|3834842|FG002|Overall Study|Did not meet entry criteria|3
2199210|NCT01562444|3834840|FG000|Overall Study|Did not comply with blood draw schedule|1
2199211|NCT01562444|3834841|FG001|Overall Study|Did not comply with blood draw schedule|0
2199212|NCT01562444|3834842|FG002|Overall Study|Did not comply with blood draw schedule|1
2199213|NCT01562444|3834840|FG000|Overall Study|Unavailable serological results|0
2199214|NCT01562444|3834841|FG001|Overall Study|Unavailable serological results|2
2199215|NCT01562444|3834842|FG002|Overall Study|Unavailable serological results|2
2199216|NCT01562444|3834840|FG000|Overall Study|Protocol forbidden concomitant vaccine|1
2199217|NCT01562444|3834841|FG001|Overall Study|Protocol forbidden concomitant vaccine|0
2199218|NCT01562444|3834842|FG002|Overall Study|Protocol forbidden concomitant vaccine|1
2275226|NCT02307682|3956863|FG000|Overall Study|Physician Decision|2
2275227|NCT02307682|3956864|FG001|Overall Study|Physician Decision|2
2275228|NCT02307682|3956865|FG002|Overall Study|Physician Decision|8
2275229|NCT02307682|3956863|FG000|Overall Study|Progressive Disease|1
2275230|NCT02307682|3956864|FG001|Overall Study|Progressive Disease|0
2275231|NCT02307682|3956865|FG002|Overall Study|Progressive Disease|0
2275232|NCT02307682|3956863|FG000|Overall Study|Withdrawal by Subject|26
2275233|NCT02307682|3956864|FG001|Overall Study|Withdrawal by Subject|34
2275234|NCT02307682|3956865|FG002|Overall Study|Withdrawal by Subject|23
2275235|NCT02307682|3956863|FG000|Overall Study|Death|9
2275236|NCT02307682|3956864|FG001|Overall Study|Death|7
2275237|NCT02307682|3956865|FG002|Overall Study|Death|12
2275238|NCT02307682|3956863|FG000|Overall Study|Lost to Follow-up|1
2275239|NCT02307682|3956864|FG001|Overall Study|Lost to Follow-up|5
2275240|NCT02307682|3956865|FG002|Overall Study|Lost to Follow-up|6
2275241|NCT02307682|3956863|FG000|Overall Study|Protocol Deviation|0
2275242|NCT02307682|3956864|FG001|Overall Study|Protocol Deviation|0
2275243|NCT02307682|3956865|FG002|Overall Study|Protocol Deviation|2
2275244|NCT02307682|3956863|FG000|Overall Study|Other|1
2275245|NCT02307682|3956864|FG001|Overall Study|Other|1
2275246|NCT02307682|3956865|FG002|Overall Study|Other|0
2320567|NCT02951533|4034899|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0
2320568|NCT02951533|4034900|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16
2320569|NCT02951533|4034901|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0
2320570|NCT02951533|4034899|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
2320571|NCT02951533|4034900|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
2320572|NCT02951533|4034901|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
2320573|NCT02951533|4034899|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
2320574|NCT02951533|4034900|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
2320575|NCT02951533|4034901|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
2320576|NCT02951533|4034899|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
2320577|NCT02951533|4034900|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
2320578|NCT02951533|4034901|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
2320579|NCT02951533|4034899|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0
2320580|NCT02951533|4034900|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1
2199219|NCT01562444|3834840|FG000|Overall Study|Protocol forbidden medication|1
2199220|NCT01562444|3834841|FG001|Overall Study|Protocol forbidden medication|0
2199221|NCT01562444|3834842|FG002|Overall Study|Protocol forbidden medication|0
2199222|NCT01562548|3834854|FG000|Overall Study|Lost to Follow-up|0
2199223|NCT01562548|3834855|FG001|Overall Study|Lost to Follow-up|0
2199224|NCT01562548|3834856|FG002|Overall Study|Lost to Follow-up|1
2199225|NCT01562548|3834857|FG003|Overall Study|Lost to Follow-up|0
2217064|NCT01705574|3860194|FG003|Double-Blind Phase|Randomized but Not Treated|0
2217065|NCT01705574|3860191|FG000|Open-Label Extension Phase|Lost to Follow-up|6
2217066|NCT01705574|3860192|FG001|Open-Label Extension Phase|Lost to Follow-up|0
2217067|NCT01705574|3860193|FG002|Open-Label Extension Phase|Lost to Follow-up|2
2217068|NCT01705574|3860194|FG003|Open-Label Extension Phase|Lost to Follow-up|2
2217069|NCT01705574|3860191|FG000|Open-Label Extension Phase|Withdrew Consent|4
2217070|NCT01705574|3860192|FG001|Open-Label Extension Phase|Withdrew Consent|0
2217071|NCT01705574|3860193|FG002|Open-Label Extension Phase|Withdrew Consent|4
2217072|NCT01705574|3860194|FG003|Open-Label Extension Phase|Withdrew Consent|1
2217073|NCT01705574|3860191|FG000|Open-Label Extension Phase|Adverse Event|3
2217074|NCT01705574|3860192|FG001|Open-Label Extension Phase|Adverse Event|0
2217075|NCT01705574|3860193|FG002|Open-Label Extension Phase|Adverse Event|0
2217076|NCT01705574|3860194|FG003|Open-Label Extension Phase|Adverse Event|1
2217077|NCT01705574|3860191|FG000|Open-Label Extension Phase|Death|2
2217078|NCT01705574|3860192|FG001|Open-Label Extension Phase|Death|0
2217079|NCT01705574|3860193|FG002|Open-Label Extension Phase|Death|1
2217080|NCT01705574|3860194|FG003|Open-Label Extension Phase|Death|0
2217081|NCT01705574|3860191|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0
2217082|NCT01705574|3860192|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0
2217083|NCT01705574|3860193|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1
2217084|NCT01705574|3860194|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0
2217085|NCT01705574|3860191|FG000|Open-Label Extension Phase|Physician Decision|0
2217086|NCT01705574|3860192|FG001|Open-Label Extension Phase|Physician Decision|0
2217087|NCT01705574|3860193|FG002|Open-Label Extension Phase|Physician Decision|2
2217088|NCT01705574|3860194|FG003|Open-Label Extension Phase|Physician Decision|0
2217089|NCT01705574|3860191|FG000|Open-Label Extension Phase|Pregnancy|0
2217090|NCT01705574|3860192|FG001|Open-Label Extension Phase|Pregnancy|0
2217091|NCT01705574|3860193|FG002|Open-Label Extension Phase|Pregnancy|1
2217092|NCT01705574|3860194|FG003|Open-Label Extension Phase|Pregnancy|1
2217093|NCT01705587|3860212|FG000|Overall Study|Withdrawal by Subject|0
2217094|NCT01705587|3860213|FG001|Overall Study|Withdrawal by Subject|1
2217095|NCT01705652|3860221|FG000|Overall Study|Adverse Event|1
2217096|NCT01705652|3860222|FG001|Overall Study|Adverse Event|0
2217097|NCT01705652|3860221|FG000|Overall Study|Withdrawal by Subject|1
2217098|NCT01705652|3860222|FG001|Overall Study|Withdrawal by Subject|2
2217099|NCT01705652|3860221|FG000|Overall Study|non-compliance|1
2217100|NCT01705652|3860222|FG001|Overall Study|non-compliance|1
2217101|NCT01705691|3860230|FG000|Overall Study|Death|1
2217102|NCT01705691|3860231|FG001|Overall Study|Death|2
2217103|NCT01705691|3860230|FG000|Overall Study|Withdrawal by Subject|1
2217104|NCT01705691|3860231|FG001|Overall Study|Withdrawal by Subject|2
2217105|NCT01705691|3860230|FG000|Overall Study|Lost to Follow-up|1
2217106|NCT01705691|3860231|FG001|Overall Study|Lost to Follow-up|1
2217107|NCT01705691|3860230|FG000|Overall Study|Other|0
2217108|NCT01705691|3860231|FG001|Overall Study|Other|1
2217109|NCT01705717|3860239|FG000|Overall Study|Adverse Event|2
2217110|NCT01705717|3860240|FG001|Overall Study|Adverse Event|2
2217111|NCT01705717|3860239|FG000|Overall Study|Lack of Efficacy|0
2217112|NCT01705717|3860240|FG001|Overall Study|Lack of Efficacy|1
2217113|NCT01705717|3860239|FG000|Overall Study|Other|0
2217114|NCT01705717|3860240|FG001|Overall Study|Other|2
2217115|NCT01705730|3860245|FG000|Overall Study|Lack of Efficacy|1
2217116|NCT01705730|3860245|FG000|Overall Study|Adverse Event|3
2217117|NCT01705730|3860245|FG000|Overall Study|Lost to Follow-up|1
2217118|NCT01705730|3860245|FG000|Overall Study|Reason not Specified|4
2217119|NCT01705977|3860260|FG000|Overall Study|Withdrawal by Subject|128
2217120|NCT01705977|3860261|FG001|Overall Study|Withdrawal by Subject|128
2217121|NCT01705977|3860260|FG000|Overall Study|Adverse Event|57
2217122|NCT01705977|3860261|FG001|Overall Study|Adverse Event|49
2217123|NCT01705977|3860260|FG000|Overall Study|Protocol Violation|2
2217124|NCT01705977|3860261|FG001|Overall Study|Protocol Violation|4
2217125|NCT01705977|3860260|FG000|Overall Study|Site closure|3
2217126|NCT01705977|3860261|FG001|Overall Study|Site closure|2
2217127|NCT01705977|3860260|FG000|Overall Study|Lost to Follow-up|33
2217128|NCT01705977|3860261|FG001|Overall Study|Lost to Follow-up|37
2217129|NCT01705977|3860260|FG000|Overall Study|Physician Decision|48
2217130|NCT01705977|3860261|FG001|Overall Study|Physician Decision|38
2217131|NCT01705977|3860260|FG000|Overall Study|Missing study conclusion form|2
2217132|NCT01705977|3860261|FG001|Overall Study|Missing study conclusion form|2
2217133|NCT01706003|3860269|FG000|Overall Study|Withdrawal by Subject|2
2217134|NCT01706003|3860270|FG001|Overall Study|Withdrawal by Subject|0
2217135|NCT01706003|3860269|FG000|Overall Study|Not scheduled|3
2118097|NCT00949650|3715848|FG000|Overall Study|Progressive disease|188
2118098|NCT00949650|3715849|FG001|Overall Study|Progressive disease|19
2217136|NCT01706003|3860270|FG001|Overall Study|Not scheduled|0
2217137|NCT01706003|3860269|FG000|Overall Study|Lost to Follow-up|6
2217138|NCT01706003|3860270|FG001|Overall Study|Lost to Follow-up|4
2217139|NCT01706146|3860285|FG000|Overall Study|Withdrawal by Subject|1
2217140|NCT01706146|3860285|FG000|Overall Study|Adverse Event|3
2217141|NCT01706146|3860285|FG000|Overall Study|Developed AF and need for antiplatelets|2
2199226|NCT01562613|3834869|FG000|Overall Study|Lost to Follow-up|2
2199227|NCT01562613|3834869|FG000|Overall Study|Withdrawal by Subject|2
2199228|NCT01562743|3834882|FG000|Overall Study|Adverse Event|29
2199229|NCT01562743|3834882|FG000|Overall Study|Lack of Efficacy|3
2199230|NCT01562743|3834882|FG000|Overall Study|Withdrawal by Subject|13
2199231|NCT01562743|3834882|FG000|Overall Study|Protocol Violation|1
2199232|NCT01562743|3834882|FG000|Overall Study|Discontinuation criteria|2
2199233|NCT01562743|3834882|FG000|Overall Study|Lost to Follow-up|2
2199234|NCT01562743|3834882|FG000|Overall Study|Physician Decision|2
2199235|NCT01562782|3834892|FG000|Overall Study|Withdrawal by Subject|3
2199236|NCT01562782|3834893|FG001|Overall Study|Withdrawal by Subject|3
2199237|NCT01562782|3834892|FG000|Overall Study|screen failure|1
2199238|NCT01562782|3834893|FG001|Overall Study|screen failure|2
2199239|NCT01562873|3834899|FG000|Overall Study|Disease Progression per RECIST|10
2199240|NCT01562873|3834900|FG001|Overall Study|Disease Progression per RECIST|0
2199241|NCT01562873|3834899|FG000|Overall Study|Adverse Event|1
2199242|NCT01562873|3834900|FG001|Overall Study|Adverse Event|0
2199243|NCT01562873|3834899|FG000|Overall Study|Clinical Disease Progression|9
2199244|NCT01562873|3834900|FG001|Overall Study|Clinical Disease Progression|0
2199245|NCT01562873|3834899|FG000|Overall Study|Clinical PD and adverse event|1
2199246|NCT01562873|3834900|FG001|Overall Study|Clinical PD and adverse event|0
2199247|NCT01563029|3834922|FG000|Overall Study|Adverse Event|1
2199248|NCT01563029|3834923|FG001|Overall Study|Adverse Event|0
2199249|NCT01563029|3834924|FG002|Overall Study|Adverse Event|1
2199250|NCT01563029|3834925|FG003|Overall Study|Adverse Event|2
2199251|NCT01563029|3834926|FG004|Overall Study|Adverse Event|1
2199252|NCT01563029|3834922|FG000|Overall Study|Lack of Efficacy|42
2199253|NCT01563029|3834923|FG001|Overall Study|Lack of Efficacy|16
2199254|NCT01563029|3834924|FG002|Overall Study|Lack of Efficacy|23
2199255|NCT01563029|3834925|FG003|Overall Study|Lack of Efficacy|21
2199256|NCT01563029|3834926|FG004|Overall Study|Lack of Efficacy|19
2199257|NCT01563029|3834922|FG000|Overall Study|Protocol Violation|1
2199258|NCT01563029|3834923|FG001|Overall Study|Protocol Violation|2
2199259|NCT01563029|3834924|FG002|Overall Study|Protocol Violation|3
2199260|NCT01563029|3834925|FG003|Overall Study|Protocol Violation|1
2199261|NCT01563029|3834926|FG004|Overall Study|Protocol Violation|3
2199262|NCT01563029|3834922|FG000|Overall Study|Protocol defined stopping criteria|1
2199263|NCT01563029|3834923|FG001|Overall Study|Protocol defined stopping criteria|0
2199264|NCT01563029|3834924|FG002|Overall Study|Protocol defined stopping criteria|0
2199265|NCT01563029|3834925|FG003|Overall Study|Protocol defined stopping criteria|0
2199266|NCT01563029|3834926|FG004|Overall Study|Protocol defined stopping criteria|0
2199267|NCT01563029|3834922|FG000|Overall Study|Lost to Follow-up|1
2199268|NCT01563029|3834923|FG001|Overall Study|Lost to Follow-up|0
2199269|NCT01563029|3834924|FG002|Overall Study|Lost to Follow-up|1
2199270|NCT01563029|3834925|FG003|Overall Study|Lost to Follow-up|1
2199271|NCT01563029|3834926|FG004|Overall Study|Lost to Follow-up|1
2199272|NCT01563029|3834922|FG000|Overall Study|Physician Decision|3
2275247|NCT02308007|3956899|FG000|Overall Study|Normal Gram stain or neg yeast culture|66
2275248|NCT02308007|3956900|FG001|Overall Study|Normal Gram stain or neg yeast culture|64
2275249|NCT02308007|3956901|FG002|Overall Study|Normal Gram stain or neg yeast culture|67
2275250|NCT02308007|3956899|FG000|Overall Study|Positive for STD at Baseline|7
2275251|NCT02308007|3956900|FG001|Overall Study|Positive for STD at Baseline|11
2275252|NCT02308007|3956901|FG002|Overall Study|Positive for STD at Baseline|7
2275253|NCT02308007|3956899|FG000|Overall Study|Lost to Follow-up|3
2275254|NCT02308007|3956900|FG001|Overall Study|Lost to Follow-up|0
2275255|NCT02308007|3956901|FG002|Overall Study|Lost to Follow-up|1
2275256|NCT02308020|3956915|FG000|Overall Study|Lost to Follow-up|1
2275257|NCT02308020|3956916|FG001|Overall Study|Lost to Follow-up|7
2275258|NCT02308020|3956917|FG002|Overall Study|Lost to Follow-up|0
2275259|NCT02308020|3956918|FG003|Overall Study|Lost to Follow-up|0
2275260|NCT02308020|3956919|FG004|Overall Study|Lost to Follow-up|1
2275261|NCT02308020|3956920|FG005|Overall Study|Lost to Follow-up|2
2275262|NCT02308020|3956915|FG000|Overall Study|Sponsor Decision|0
2275263|NCT02308020|3956916|FG001|Overall Study|Sponsor Decision|8
2275264|NCT02308020|3956917|FG002|Overall Study|Sponsor Decision|0
2275265|NCT02308020|3956918|FG003|Overall Study|Sponsor Decision|2
2275266|NCT02308020|3956919|FG004|Overall Study|Sponsor Decision|2
2275267|NCT02308020|3956920|FG005|Overall Study|Sponsor Decision|1
2275268|NCT02308020|3956915|FG000|Overall Study|Withdrawal by Subject|3
2275269|NCT02308020|3956916|FG001|Overall Study|Withdrawal by Subject|5
2275270|NCT02308020|3956917|FG002|Overall Study|Withdrawal by Subject|3
2275271|NCT02308020|3956918|FG003|Overall Study|Withdrawal by Subject|2
2275272|NCT02308020|3956919|FG004|Overall Study|Withdrawal by Subject|1
2275273|NCT02308020|3956920|FG005|Overall Study|Withdrawal by Subject|2
2275274|NCT02308033|3956942|FG000|Overall Study|Normal Gram stain at Baseline|13
2275275|NCT02308033|3956943|FG001|Overall Study|Normal Gram stain at Baseline|10
2199273|NCT01563029|3834923|FG001|Overall Study|Physician Decision|5
2199274|NCT01563029|3834924|FG002|Overall Study|Physician Decision|2
2199275|NCT01563029|3834925|FG003|Overall Study|Physician Decision|4
2199276|NCT01563029|3834926|FG004|Overall Study|Physician Decision|2
2199277|NCT01563029|3834922|FG000|Overall Study|Withdrawal by Subject|4
2199278|NCT01563029|3834923|FG001|Overall Study|Withdrawal by Subject|1
2199279|NCT01563029|3834924|FG002|Overall Study|Withdrawal by Subject|3
2199280|NCT01563029|3834925|FG003|Overall Study|Withdrawal by Subject|4
2199281|NCT01563029|3834926|FG004|Overall Study|Withdrawal by Subject|3
2199282|NCT01563172|3834959|FG000|Overall Study|Adverse Event|5
2199283|NCT01563172|3834959|FG000|Overall Study|Lost to Follow-up|2
2199284|NCT01563172|3834959|FG000|Overall Study|Other (Protocol deviation)|5
2199285|NCT01563172|3834959|FG000|Overall Study|Other (Not specified)|1
2199286|NCT01563185|3834974|FG000|Overall Study|Withdrawal by Subject|1
2199287|NCT01563185|3834974|FG000|Overall Study|Non-Compliance with study drug|1
2199288|NCT01563237|3834982|FG000|Overall Study|Lost to Follow-up|6
2199289|NCT01563237|3834983|FG001|Overall Study|Lost to Follow-up|0
2199290|NCT01563237|3834982|FG000|Overall Study|Withdrawal by Subject|1
2199291|NCT01563237|3834983|FG001|Overall Study|Withdrawal by Subject|0
2199292|NCT01563237|3834982|FG000|Overall Study|Adverse Event|1
2199293|NCT01563237|3834983|FG001|Overall Study|Adverse Event|0
2199294|NCT01563237|3834982|FG000|Overall Study|Medical Reasons|1
2199295|NCT01563237|3834983|FG001|Overall Study|Medical Reasons|0
2199296|NCT01563237|3834982|FG000|Overall Study|Death|1
2199297|NCT01563237|3834983|FG001|Overall Study|Death|0
2199298|NCT01563354|3834991|FG000|Core Phase|Adverse Event|5
2199299|NCT01563354|3834992|FG001|Core Phase|Adverse Event|15
2199300|NCT01563354|3834993|FG002|Core Phase|Adverse Event|13
2199301|NCT01563354|3834991|FG000|Core Phase|Withdrawal by Subject|1
2199302|NCT01563354|3834992|FG001|Core Phase|Withdrawal by Subject|0
2199303|NCT01563354|3834993|FG002|Core Phase|Withdrawal by Subject|3
2199304|NCT01563354|3834991|FG000|Core Phase|Lost to Follow-up|1
2199305|NCT01563354|3834992|FG001|Core Phase|Lost to Follow-up|0
2199306|NCT01563354|3834993|FG002|Core Phase|Lost to Follow-up|0
2199307|NCT01563354|3834991|FG000|Core Phase|Death|1
2199308|NCT01563354|3834992|FG001|Core Phase|Death|5
2199309|NCT01563354|3834993|FG002|Core Phase|Death|2
2199310|NCT01563354|3834991|FG000|Core Phase|Diseasse progression|18
2199311|NCT01563354|3834992|FG001|Core Phase|Diseasse progression|7
2199312|NCT01563354|3834993|FG002|Core Phase|Diseasse progression|8
2199313|NCT01563354|3834991|FG000|Core Phase|Protocol deviation|2
2199314|NCT01563354|3834992|FG001|Core Phase|Protocol deviation|0
2199315|NCT01563354|3834993|FG002|Core Phase|Protocol deviation|0
2199316|NCT01563354|3834991|FG000|Core Phase|PI decision - did not enter extension|0
2199317|NCT01563354|3834992|FG001|Core Phase|PI decision - did not enter extension|1
2199318|NCT01563354|3834993|FG002|Core Phase|PI decision - did not enter extension|0
2199319|NCT01563354|3834991|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1
2199320|NCT01563354|3834992|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0
2199321|NCT01563354|3834993|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0
2199322|NCT01563354|3834991|FG000|Extension Phase|Adverse Event|0
2199323|NCT01563354|3834992|FG001|Extension Phase|Adverse Event|3
2199324|NCT01563354|3834993|FG002|Extension Phase|Adverse Event|2
2199325|NCT01563354|3834991|FG000|Extension Phase|Withdrawal by Subject|0
2199326|NCT01563354|3834992|FG001|Extension Phase|Withdrawal by Subject|1
2199327|NCT01563354|3834993|FG002|Extension Phase|Withdrawal by Subject|0
2199328|NCT01563354|3834991|FG000|Extension Phase|Administration problems|3
2199329|NCT01563354|3834992|FG001|Extension Phase|Administration problems|2
2199330|NCT01563354|3834993|FG002|Extension Phase|Administration problems|3
2199331|NCT01563354|3834991|FG000|Extension Phase|Disease progression|9
2199332|NCT01563354|3834992|FG001|Extension Phase|Disease progression|8
2199333|NCT01563354|3834993|FG002|Extension Phase|Disease progression|10
2199334|NCT01563536|3835024|FG000|Overall Study|Withdrawal by Subject|0
2199335|NCT01563536|3835025|FG001|Overall Study|Withdrawal by Subject|2
2199336|NCT01563536|3835024|FG000|Overall Study|Lost to Follow-up|1
2199337|NCT01563536|3835025|FG001|Overall Study|Lost to Follow-up|0
2199338|NCT01563913|3835033|FG000|Overall Study|Physician Decision|1
2199339|NCT01563913|3835034|FG001|Overall Study|Physician Decision|0
2199340|NCT01563913|3835033|FG000|Overall Study|Spouse Passed Away|1
2199341|NCT01563913|3835034|FG001|Overall Study|Spouse Passed Away|0
2199342|NCT01563978|3835042|FG000|Overall Study|Physician Decision|1
2199343|NCT01563978|3835043|FG001|Overall Study|Physician Decision|0
2199344|NCT01563978|3835042|FG000|Overall Study|Lost to Follow-up|1
2199345|NCT01563978|3835043|FG001|Overall Study|Lost to Follow-up|0
2199346|NCT01563978|3835042|FG000|Overall Study|Dev. of study specific discont. criteria|1
2199347|NCT01563978|3835043|FG001|Overall Study|Dev. of study specific discont. criteria|0
2199348|NCT01563978|3835042|FG000|Overall Study|Adverse Event|1
2199349|NCT01563978|3835043|FG001|Overall Study|Adverse Event|2
2199350|NCT01564277|3835051|FG000|Overall Study|Protocol Violation|0
2199351|NCT01564277|3835052|FG001|Overall Study|Protocol Violation|1
2199352|NCT01564277|3835051|FG000|Overall Study|Physician Decision|1
2199353|NCT01564277|3835052|FG001|Overall Study|Physician Decision|0
2199354|NCT01564394|3835060|FG000|Overall Study|Withdrawal by Subject|6
2199355|NCT01564394|3835061|FG001|Overall Study|Withdrawal by Subject|10
2199356|NCT01564407|3835072|FG000|Overall Study|Lost to Follow-up|0
2199357|NCT01564407|3835073|FG001|Overall Study|Lost to Follow-up|1
2199358|NCT01564407|3835074|FG002|Overall Study|Lost to Follow-up|0
2199359|NCT01564407|3835075|FG003|Overall Study|Lost to Follow-up|0
2199360|NCT01564407|3835076|FG004|Overall Study|Lost to Follow-up|0
2199361|NCT01564407|3835072|FG000|Overall Study|Withdrawal by Subject|0
2199362|NCT01564407|3835073|FG001|Overall Study|Withdrawal by Subject|1
2199363|NCT01564407|3835074|FG002|Overall Study|Withdrawal by Subject|0
2199364|NCT01564407|3835075|FG003|Overall Study|Withdrawal by Subject|0
2199365|NCT01564407|3835076|FG004|Overall Study|Withdrawal by Subject|0
2199366|NCT01564407|3835072|FG000|Overall Study|funding lost, study ended|0
2199367|NCT01564407|3835073|FG001|Overall Study|funding lost, study ended|0
2199368|NCT01564407|3835074|FG002|Overall Study|funding lost, study ended|0
2199369|NCT01564407|3835075|FG003|Overall Study|funding lost, study ended|1
2199370|NCT01564407|3835076|FG004|Overall Study|funding lost, study ended|0
2199371|NCT01564459|3835100|FG000|Run-In|Adverse Event|7
2199372|NCT01564459|3835101|FG001|Run-In|Adverse Event|0
2199373|NCT01564459|3835102|FG002|Run-In|Adverse Event|0
2199374|NCT01564459|3835100|FG000|Run-In|Lost to Follow-up|1
2199375|NCT01564459|3835101|FG001|Run-In|Lost to Follow-up|0
2199376|NCT01564459|3835102|FG002|Run-In|Lost to Follow-up|0
2199377|NCT01564459|3835100|FG000|Run-In|Non-compliance with study drug|2
2199378|NCT01564459|3835101|FG001|Run-In|Non-compliance with study drug|0
2199379|NCT01564459|3835102|FG002|Run-In|Non-compliance with study drug|0
2199380|NCT01564459|3835100|FG000|Run-In|Protocol Violation|1
2199381|NCT01564459|3835101|FG001|Run-In|Protocol Violation|0
2199382|NCT01564459|3835102|FG002|Run-In|Protocol Violation|0
2199383|NCT01564459|3835100|FG000|Run-In|Withdrawal by Subject|1
2199384|NCT01564459|3835101|FG001|Run-In|Withdrawal by Subject|0
2199385|NCT01564459|3835102|FG002|Run-In|Withdrawal by Subject|0
2199386|NCT01564459|3835100|FG000|Double-blind Treatment|Adverse Event|0
2199387|NCT01564459|3835101|FG001|Double-blind Treatment|Adverse Event|0
2199388|NCT01564459|3835102|FG002|Double-blind Treatment|Adverse Event|1
2199389|NCT01564758|3835149|FG000|Overall Study|Death|8
2199390|NCT01564758|3835149|FG000|Overall Study|Adverse Event|3
2199391|NCT01564758|3835149|FG000|Overall Study|Other|3
2199392|NCT01564784|3835155|FG000|Overall Study|Other|1
2199393|NCT01564784|3835156|FG001|Overall Study|Other|0
2199394|NCT01564784|3835155|FG000|Overall Study|Subject refused further follow-up|1
2199395|NCT01564784|3835156|FG001|Overall Study|Subject refused further follow-up|6
2199396|NCT01564784|3835155|FG000|Overall Study|Lost to Follow-up|1
2199397|NCT01564784|3835156|FG001|Overall Study|Lost to Follow-up|1
2199398|NCT01564784|3835155|FG000|Overall Study|Death|131
2199399|NCT01564784|3835156|FG001|Overall Study|Death|126
2199400|NCT01564862|3835165|FG000|Overall Study|Pretreatment Event or Adverse Event|6
2199401|NCT01564862|3835166|FG001|Overall Study|Pretreatment Event or Adverse Event|12
2199402|NCT01564862|3835167|FG002|Overall Study|Pretreatment Event or Adverse Event|6
2199403|NCT01564862|3835165|FG000|Overall Study|Major Protocol Deviation|3
2199404|NCT01564862|3835166|FG001|Overall Study|Major Protocol Deviation|3
2199405|NCT01564862|3835167|FG002|Overall Study|Major Protocol Deviation|4
2199406|NCT01564862|3835165|FG000|Overall Study|Lost to Follow-up|10
2199407|NCT01564862|3835166|FG001|Overall Study|Lost to Follow-up|8
2199408|NCT01564862|3835167|FG002|Overall Study|Lost to Follow-up|6
2199409|NCT01564862|3835165|FG000|Overall Study|Voluntary Withdrawal|9
2199410|NCT01564862|3835166|FG001|Overall Study|Voluntary Withdrawal|6
2199411|NCT01564862|3835167|FG002|Overall Study|Voluntary Withdrawal|8
2199412|NCT01564862|3835165|FG000|Overall Study|Lack of Efficacy|1
2199413|NCT01564862|3835166|FG001|Overall Study|Lack of Efficacy|5
2199414|NCT01564862|3835167|FG002|Overall Study|Lack of Efficacy|6
2199415|NCT01564862|3835165|FG000|Overall Study|Other reason(s)|1
2199416|NCT01564862|3835166|FG001|Overall Study|Other reason(s)|0
2199417|NCT01564862|3835167|FG002|Overall Study|Other reason(s)|0
2199418|NCT01565083|3835197|FG000|Overall Study|Withdrawal by Subject|6
2199419|NCT01565083|3835198|FG001|Overall Study|Withdrawal by Subject|4
2199420|NCT01565083|3835197|FG000|Overall Study|Lost to Follow-up|2
2199421|NCT01565083|3835198|FG001|Overall Study|Lost to Follow-up|7
2199422|NCT01565083|3835197|FG000|Overall Study|Death|22
2199423|NCT01565083|3835198|FG001|Overall Study|Death|23
2199424|NCT01565083|3835197|FG000|Overall Study|Other|3
2199425|NCT01565083|3835198|FG001|Overall Study|Other|5
2199426|NCT01565148|3835208|FG000|Overall Study|Withdrawal by Subject|1
2199427|NCT01565148|3835209|FG001|Overall Study|Withdrawal by Subject|1
2199428|NCT01565148|3835210|FG002|Overall Study|Withdrawal by Subject|1
2199429|NCT01565148|3835211|FG003|Overall Study|Withdrawal by Subject|2
2199430|NCT01565148|3835208|FG000|Overall Study|Lost to Follow-up|4
2199431|NCT01565148|3835209|FG001|Overall Study|Lost to Follow-up|4
2199432|NCT01565148|3835210|FG002|Overall Study|Lost to Follow-up|0
2199433|NCT01565148|3835211|FG003|Overall Study|Lost to Follow-up|3
2199434|NCT01565148|3835208|FG000|Overall Study|Rescue Therapy|8
2199435|NCT01565148|3835209|FG001|Overall Study|Rescue Therapy|5
2199436|NCT01565148|3835210|FG002|Overall Study|Rescue Therapy|5
2199437|NCT01565148|3835211|FG003|Overall Study|Rescue Therapy|8
2199438|NCT01565148|3835208|FG000|Overall Study|Death|0
2199439|NCT01565148|3835209|FG001|Overall Study|Death|0
2199440|NCT01565148|3835210|FG002|Overall Study|Death|1
2199441|NCT01565148|3835211|FG003|Overall Study|Death|0
2199442|NCT01565148|3835208|FG000|Overall Study|Physician Decision|2
2275276|NCT02308033|3956942|FG000|Overall Study|Positive for STD at Baseline|7
2275277|NCT02308033|3956943|FG001|Overall Study|Positive for STD at Baseline|4
2275278|NCT02308033|3956942|FG000|Overall Study|Lost to Follow-up|6
2275279|NCT02308033|3956943|FG001|Overall Study|Lost to Follow-up|5
2275280|NCT02308046|3956951|FG000|Overall Study|Negative yeast culture at Baseline|32
2199443|NCT01565148|3835209|FG001|Overall Study|Physician Decision|5
2199444|NCT01565148|3835210|FG002|Overall Study|Physician Decision|0
2199445|NCT01565148|3835211|FG003|Overall Study|Physician Decision|0
2199446|NCT01565291|3835227|FG000|Overall Study|Withdrawal by Subject|1
2199447|NCT01565291|3835228|FG001|Overall Study|Withdrawal by Subject|0
2199448|NCT01565343|3835255|FG000|Overall Study|Administrative decision/technical issues|1
2199449|NCT01565343|3835256|FG001|Overall Study|Administrative decision/technical issues|0
2199450|NCT01565343|3835257|FG002|Overall Study|Administrative decision/technical issues|0
2199451|NCT01565499|3835279|FG000|Overall Study|Physician Decision|1
2199452|NCT01565499|3835279|FG000|Overall Study|Adverse Event|5
2199453|NCT01565499|3835279|FG000|Overall Study|Withdrawal by Subject|2
2199454|NCT01565564|3835303|FG000|Overall Study|Lost to Follow-up|5
2199455|NCT01565564|3835304|FG001|Overall Study|Lost to Follow-up|1
2199456|NCT01565642|3835316|FG000|Overall Study|Withdrawal by Subject|2
2199457|NCT01565642|3835317|FG001|Overall Study|Withdrawal by Subject|1
2199458|NCT01565668|3835325|FG000|Overall Study|Death|2
2199459|NCT01565668|3835326|FG001|Overall Study|Death|1
2199460|NCT01565668|3835325|FG000|Overall Study|Lack of Efficacy|4
2199461|NCT01565668|3835326|FG001|Overall Study|Lack of Efficacy|2
2199462|NCT01565668|3835325|FG000|Overall Study|Participant went on Hospice Care|1
2199463|NCT01565668|3835326|FG001|Overall Study|Participant went on Hospice Care|0
2199464|NCT01565668|3835325|FG000|Overall Study|Adverse Event|6
2199465|NCT01565668|3835326|FG001|Overall Study|Adverse Event|1
2199466|NCT01565668|3835325|FG000|Overall Study|Randomized, but never received drug|0
2199467|NCT01565668|3835326|FG001|Overall Study|Randomized, but never received drug|2
2199468|NCT01565668|3835325|FG000|Overall Study|Progressive disease|13
2199469|NCT01565668|3835326|FG001|Overall Study|Progressive disease|14
2199470|NCT01565668|3835325|FG000|Overall Study|Withdrawal by Subject|1
2199471|NCT01565668|3835326|FG001|Overall Study|Withdrawal by Subject|3
2199472|NCT01565668|3835325|FG000|Overall Study|HSCT Transplant|11
2199473|NCT01565668|3835326|FG001|Overall Study|HSCT Transplant|15
2199474|NCT01565694|3835332|FG000|Dose-Titration Period|Adverse Event|4
2199475|NCT01565694|3835332|FG000|Dose-Titration Period|Protocol Violation|10
2199476|NCT01565694|3835332|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4
2199477|NCT01565707|3835340|FG000|Overall Study|Adverse Event|1
2199478|NCT01565707|3835341|FG001|Overall Study|Adverse Event|6
2199479|NCT01565707|3835342|FG002|Overall Study|Adverse Event|2
2199480|NCT01565707|3835343|FG003|Overall Study|Adverse Event|1
2199481|NCT01565707|3835340|FG000|Overall Study|Lost to Follow-up|1
2199482|NCT01565707|3835341|FG001|Overall Study|Lost to Follow-up|0
2199483|NCT01565707|3835342|FG002|Overall Study|Lost to Follow-up|0
2199484|NCT01565707|3835343|FG003|Overall Study|Lost to Follow-up|0
2199485|NCT01565707|3835340|FG000|Overall Study|Protocol Violation|1
2199486|NCT01565707|3835341|FG001|Overall Study|Protocol Violation|0
2199487|NCT01565707|3835342|FG002|Overall Study|Protocol Violation|0
2199488|NCT01565707|3835343|FG003|Overall Study|Protocol Violation|1
2199489|NCT01565707|3835340|FG000|Overall Study|Withdrawal by Subject|3
2199490|NCT01565707|3835341|FG001|Overall Study|Withdrawal by Subject|1
2199491|NCT01565707|3835342|FG002|Overall Study|Withdrawal by Subject|1
2199492|NCT01565707|3835343|FG003|Overall Study|Withdrawal by Subject|1
2199493|NCT01565707|3835340|FG000|Overall Study|Randomized but not evaluable|2
2199494|NCT01565707|3835341|FG001|Overall Study|Randomized but not evaluable|0
2199495|NCT01565707|3835342|FG002|Overall Study|Randomized but not evaluable|0
2199496|NCT01565707|3835343|FG003|Overall Study|Randomized but not evaluable|0
2199497|NCT01565707|3835340|FG000|Overall Study|Miscellaneous|1
2199498|NCT01565707|3835341|FG001|Overall Study|Miscellaneous|1
2199499|NCT01565707|3835342|FG002|Overall Study|Miscellaneous|0
2199500|NCT01565707|3835343|FG003|Overall Study|Miscellaneous|2
2199501|NCT01565850|3835362|FG000|Overall Study|Adverse Event|0
2275281|NCT02308046|3956952|FG001|Overall Study|Negative yeast culture at Baseline|33
2275282|NCT02308046|3956951|FG000|Overall Study|Positive for STD at Baseline|1
2275283|NCT02308046|3956952|FG001|Overall Study|Positive for STD at Baseline|2
2275284|NCT02308046|3956951|FG000|Overall Study|Lost to Follow-up|1
2275285|NCT02308046|3956952|FG001|Overall Study|Lost to Follow-up|3
2275286|NCT02308124|3956961|FG000|Overall Study|Lost to Follow-up|6
2275287|NCT02308124|3956962|FG001|Overall Study|Lost to Follow-up|6
2275288|NCT02308124|3956963|FG002|Overall Study|Lost to Follow-up|6
2275289|NCT02308124|3956961|FG000|Overall Study|Adverse Event|0
2275290|NCT02308124|3956962|FG001|Overall Study|Adverse Event|2
2275291|NCT02308124|3956963|FG002|Overall Study|Adverse Event|2
2275292|NCT02308163|3956975|FG000|Overall Study|Not fulfill eligible criteria|1
2275293|NCT02308163|3956976|FG001|Overall Study|Not fulfill eligible criteria|2
2275294|NCT02308163|3956977|FG002|Overall Study|Not fulfill eligible criteria|0
2275295|NCT02308163|3956978|FG003|Overall Study|Not fulfill eligible criteria|1
2275296|NCT02308163|3956979|FG004|Overall Study|Not fulfill eligible criteria|1
2275297|NCT02308163|3956975|FG000|Overall Study|Adverse Event|9
2275298|NCT02308163|3956976|FG001|Overall Study|Adverse Event|5
2275299|NCT02308163|3956977|FG002|Overall Study|Adverse Event|2
2275300|NCT02308163|3956978|FG003|Overall Study|Adverse Event|2
2275301|NCT02308163|3956979|FG004|Overall Study|Adverse Event|11
2275302|NCT02308163|3956975|FG000|Overall Study|Lack of Efficacy|11
2275303|NCT02308163|3956976|FG001|Overall Study|Lack of Efficacy|3
2199502|NCT01565850|3835363|FG001|Overall Study|Adverse Event|1
2199503|NCT01565850|3835362|FG000|Overall Study|Lost to Follow-up|12
2199504|NCT01565850|3835363|FG001|Overall Study|Lost to Follow-up|4
2275304|NCT02308163|3956977|FG002|Overall Study|Lack of Efficacy|8
2199505|NCT01565850|3835362|FG000|Overall Study|Investigator's Discretion|2
2199506|NCT01565850|3835363|FG001|Overall Study|Investigator's Discretion|1
2199507|NCT01565850|3835362|FG000|Overall Study|Participant noncompliance|2
2199508|NCT01565850|3835363|FG001|Overall Study|Participant noncompliance|0
2199509|NCT01565850|3835362|FG000|Overall Study|Withdrew Consent|4
2199510|NCT01565850|3835363|FG001|Overall Study|Withdrew Consent|2
2199511|NCT01565889|3835375|FG000|Part A|Withdrawal by Subject|1
2199512|NCT01565889|3835376|FG001|Part A|Withdrawal by Subject|0
2199513|NCT01565889|3835377|FG002|Part A|Withdrawal by Subject|0
2199514|NCT01565889|3835378|FG003|Part A|Withdrawal by Subject|0
2199515|NCT01565889|3835379|FG004|Part A|Withdrawal by Subject|0
2199516|NCT01565889|3835380|FG005|Part A|Withdrawal by Subject|0
2199517|NCT01565889|3835375|FG000|Part B|Withdrawal by Subject|0
2199518|NCT01565889|3835376|FG001|Part B|Withdrawal by Subject|0
2199519|NCT01565889|3835377|FG002|Part B|Withdrawal by Subject|0
2199520|NCT01565889|3835378|FG003|Part B|Withdrawal by Subject|0
2199521|NCT01565889|3835379|FG004|Part B|Withdrawal by Subject|0
2199522|NCT01565889|3835380|FG005|Part B|Withdrawal by Subject|1
2199523|NCT01565889|3835375|FG000|Part B|Lack of Efficacy|0
2199524|NCT01565889|3835376|FG001|Part B|Lack of Efficacy|0
2199525|NCT01565889|3835377|FG002|Part B|Lack of Efficacy|0
2199526|NCT01565889|3835378|FG003|Part B|Lack of Efficacy|0
2199527|NCT01565889|3835379|FG004|Part B|Lack of Efficacy|0
2199528|NCT01565889|3835380|FG005|Part B|Lack of Efficacy|2
2199529|NCT01565889|3835375|FG000|Part B|Lost to Follow-up|0
2199530|NCT01565889|3835376|FG001|Part B|Lost to Follow-up|0
2199531|NCT01565889|3835377|FG002|Part B|Lost to Follow-up|0
2199532|NCT01565889|3835378|FG003|Part B|Lost to Follow-up|0
2199533|NCT01565889|3835379|FG004|Part B|Lost to Follow-up|0
2199534|NCT01565889|3835380|FG005|Part B|Lost to Follow-up|1
2199535|NCT01565928|3835415|FG000|Overall Study|Adverse Event|3
2199536|NCT01565928|3835415|FG000|Overall Study|Other|3
2199537|NCT01565928|3835415|FG000|Overall Study|Progressive Disease|13
2199538|NCT01565928|3835415|FG000|Overall Study|Withdrawal by Subject|1
2199539|NCT01565928|3835415|FG000|Overall Study|Death|2
2199540|NCT01565941|3835424|FG000|Overall Study|Withdrawn by parent/guardian|3
2199541|NCT01565941|3835425|FG001|Overall Study|Withdrawn by parent/guardian|2
2199542|NCT01565941|3835424|FG000|Overall Study|Randomized; did not receive intevention|8
2199543|NCT01565941|3835425|FG001|Overall Study|Randomized; did not receive intevention|2
2199544|NCT01565980|3835435|FG000|Overall Study|Death|1
2199545|NCT01565980|3835436|FG001|Overall Study|Death|0
2199546|NCT01565980|3835435|FG000|Overall Study|Lost to Follow-up|1
2199547|NCT01565980|3835436|FG001|Overall Study|Lost to Follow-up|0
2199548|NCT01565980|3835435|FG000|Overall Study|health complications|1
2199549|NCT01565980|3835436|FG001|Overall Study|health complications|1
2199550|NCT01565980|3835435|FG000|Overall Study|stopped medical treatment|1
2199551|NCT01565980|3835436|FG001|Overall Study|stopped medical treatment|0
2199552|NCT01565980|3835435|FG000|Overall Study|Withdrawal by Subject|0
2199553|NCT01565980|3835436|FG001|Overall Study|Withdrawal by Subject|3
2199554|NCT01565993|3835448|FG000|Overall Study|Physician Decision|0
2199555|NCT01565993|3835449|FG001|Overall Study|Physician Decision|3
2199556|NCT01566214|3835478|FG000|Overall Study|Lost to Follow-up|3
2199557|NCT01566214|3835479|FG001|Overall Study|Lost to Follow-up|0
2199558|NCT01566435|3835503|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
2199559|NCT01566604|3835572|FG000|Overall Study|Patient's inability to use the device|1
2199560|NCT01566604|3835573|FG001|Overall Study|Patient's inability to use the device|0
2199561|NCT01566604|3835572|FG000|Overall Study|Administrative problems|1
2199562|NCT01566604|3835573|FG001|Overall Study|Administrative problems|0
2199563|NCT01566604|3835572|FG000|Overall Study|Lack of Efficacy|1
2199564|NCT01566604|3835573|FG001|Overall Study|Lack of Efficacy|2
2199565|NCT01566604|3835572|FG000|Overall Study|Protocol deviation|2
2199566|NCT01566604|3835573|FG001|Overall Study|Protocol deviation|0
2199567|NCT01566604|3835572|FG000|Overall Study|Abnormal laboratory value|2
2199568|NCT01566604|3835573|FG001|Overall Study|Abnormal laboratory value|0
2199569|NCT01566604|3835572|FG000|Overall Study|Death|4
2199570|NCT01566604|3835573|FG001|Overall Study|Death|1
2199571|NCT01566604|3835572|FG000|Overall Study|Adverse Event|4
2199572|NCT01566604|3835573|FG001|Overall Study|Adverse Event|2
2199573|NCT01566604|3835572|FG000|Overall Study|Withdrawal by Subject|9
2199574|NCT01566604|3835573|FG001|Overall Study|Withdrawal by Subject|6
2199575|NCT01566721|3835600|FG000|Treatment Period|Withdrawal by Subject|35
2275305|NCT02308163|3956978|FG003|Overall Study|Lack of Efficacy|4
2275306|NCT02308163|3956979|FG004|Overall Study|Lack of Efficacy|6
2275307|NCT02308163|3956975|FG000|Overall Study|Withdrawal of consent|2
2275308|NCT02308163|3956976|FG001|Overall Study|Withdrawal of consent|3
2275309|NCT02308163|3956977|FG002|Overall Study|Withdrawal of consent|0
2275310|NCT02308163|3956978|FG003|Overall Study|Withdrawal of consent|2
2275311|NCT02308163|3956979|FG004|Overall Study|Withdrawal of consent|6
2275312|NCT02308163|3956975|FG000|Overall Study|Protocol Violation|3
2275313|NCT02308163|3956976|FG001|Overall Study|Protocol Violation|3
2199576|NCT01566721|3835601|FG001|Treatment Period|Withdrawal by Subject|9
2199577|NCT01566721|3835600|FG000|Treatment Period|Disease Progression/Recurrence|37
2199578|NCT01566721|3835601|FG001|Treatment Period|Disease Progression/Recurrence|13
2199579|NCT01566721|3835600|FG000|Treatment Period|Investigator/Sponsor Decision|6
2199580|NCT01566721|3835601|FG001|Treatment Period|Investigator/Sponsor Decision|3
2199581|NCT01566721|3835600|FG000|Treatment Period|Other|13
2199582|NCT01566721|3835601|FG001|Treatment Period|Other|2
2199583|NCT01566721|3835600|FG000|Treatment Period|Lack of Compliance|5
2199584|NCT01566721|3835601|FG001|Treatment Period|Lack of Compliance|1
2199585|NCT01566721|3835600|FG000|Treatment Period|Adverse Event|100
2199586|NCT01566721|3835601|FG001|Treatment Period|Adverse Event|30
2199587|NCT01566721|3835600|FG000|Treatment Period|Pregnancy|1
2199588|NCT01566721|3835601|FG001|Treatment Period|Pregnancy|0
2199589|NCT01566721|3835600|FG000|Safety Follow-up|Physician Decision|6
2199590|NCT01566721|3835601|FG001|Safety Follow-up|Physician Decision|4
2199591|NCT01566721|3835600|FG000|Safety Follow-up|Lost to Follow-up|101
2199592|NCT01566721|3835601|FG001|Safety Follow-up|Lost to Follow-up|48
2199593|NCT01566721|3835600|FG000|Safety Follow-up|Withdrawal by Subject|155
2199594|NCT01566721|3835601|FG001|Safety Follow-up|Withdrawal by Subject|49
2199595|NCT01566721|3835600|FG000|Safety Follow-up|Death|28
2199596|NCT01566721|3835601|FG001|Safety Follow-up|Death|4
2199597|NCT01566721|3835600|FG000|Safety Follow-up|Non-compliance|7
2199598|NCT01566721|3835601|FG001|Safety Follow-up|Non-compliance|3
2199599|NCT01566721|3835600|FG000|Safety Follow-up|Protocol Violation|7
2199600|NCT01566721|3835601|FG001|Safety Follow-up|Protocol Violation|0
2199601|NCT01566721|3835600|FG000|Safety Follow-up|Site closure|2
2199602|NCT01566721|3835601|FG001|Safety Follow-up|Site closure|3
2199603|NCT01566721|3835600|FG000|Safety Follow-up|Erroneous reporting or late reporting|2
2199604|NCT01566721|3835601|FG001|Safety Follow-up|Erroneous reporting or late reporting|0
2199605|NCT01566721|3835600|FG000|Safety Follow-up|Missing|7
2199606|NCT01566721|3835601|FG001|Safety Follow-up|Missing|2
2199607|NCT01566721|3835600|FG000|Safety Follow-up|Disease progression /disease recurrence|223
2199608|NCT01566721|3835601|FG001|Safety Follow-up|Disease progression /disease recurrence|90
2199609|NCT01566721|3835600|FG000|Safety Follow-up|Sponsor decision|1
2199610|NCT01566721|3835601|FG001|Safety Follow-up|Sponsor decision|0
2199611|NCT01566721|3835600|FG000|Safety Follow-up|Adverse Event|8
2199612|NCT01566721|3835601|FG001|Safety Follow-up|Adverse Event|4
2199613|NCT01566773|3835614|FG000|Overall Study|Protocol specified criteria|4
2199614|NCT01566773|3835614|FG000|Overall Study|Protocol Violation|4
2199615|NCT01566773|3835614|FG000|Overall Study|Withdrawal by Subject|9
2199616|NCT01566773|3835614|FG000|Overall Study|Administrative reason|1
2199617|NCT01566773|3835614|FG000|Overall Study|Adverse Event|10
2199618|NCT01566773|3835614|FG000|Overall Study|Physician Decision|2
2199619|NCT01566981|3835645|FG000|Overall Study|Lost to Follow-up|5
2199620|NCT01566981|3835646|FG001|Overall Study|Lost to Follow-up|8
2199621|NCT01567085|3835671|FG000|Overall Study|Death|6
2199622|NCT01567085|3835671|FG000|Overall Study|Adverse Event|6
2199623|NCT01567085|3835671|FG000|Overall Study|Lost to Follow-up|3
2199624|NCT01567085|3835671|FG000|Overall Study|Graft loss|2
2199625|NCT01567085|3835671|FG000|Overall Study|Renal transplantectomy|1
2275314|NCT02308163|3956977|FG002|Overall Study|Protocol Violation|3
2275315|NCT02308163|3956978|FG003|Overall Study|Protocol Violation|2
2275316|NCT02308163|3956979|FG004|Overall Study|Protocol Violation|5
2275317|NCT02308163|3956975|FG000|Overall Study|Lab data met discontinuation criteria|3
2275318|NCT02308163|3956976|FG001|Overall Study|Lab data met discontinuation criteria|0
2275319|NCT02308163|3956977|FG002|Overall Study|Lab data met discontinuation criteria|0
2275320|NCT02308163|3956978|FG003|Overall Study|Lab data met discontinuation criteria|2
2275321|NCT02308163|3956979|FG004|Overall Study|Lab data met discontinuation criteria|0
2275322|NCT02308163|3956975|FG000|Overall Study|Miscellaneous|2
2275323|NCT02308163|3956976|FG001|Overall Study|Miscellaneous|2
2275324|NCT02308163|3956977|FG002|Overall Study|Miscellaneous|1
2275325|NCT02308163|3956978|FG003|Overall Study|Miscellaneous|0
2275326|NCT02308163|3956979|FG004|Overall Study|Miscellaneous|5
2275327|NCT02308228|3957017|FG000|Overall Study|Adverse Event|3
2275328|NCT02308228|3957018|FG001|Overall Study|Adverse Event|4
2275329|NCT02308228|3957017|FG000|Overall Study|Withdrawal by Subject|5
2275330|NCT02308228|3957018|FG001|Overall Study|Withdrawal by Subject|3
2275331|NCT02308540|3957056|FG000|Overall Study|Lost to Follow-up|0
2275332|NCT02308540|3957057|FG001|Overall Study|Lost to Follow-up|0
2275333|NCT02308540|3957058|FG002|Overall Study|Lost to Follow-up|0
2275334|NCT02308540|3957059|FG003|Overall Study|Lost to Follow-up|0
2275335|NCT02308540|3957060|FG004|Overall Study|Lost to Follow-up|0
2275336|NCT02308540|3957061|FG005|Overall Study|Lost to Follow-up|1
2275337|NCT02308696|3957112|FG000|Overall Study|Lost to Follow-up|28
2275338|NCT02308696|3957113|FG001|Overall Study|Lost to Follow-up|21
2275339|NCT02308696|3957112|FG000|Overall Study|Death|8
2275340|NCT02308696|3957113|FG001|Overall Study|Death|4
2275341|NCT02308696|3957112|FG000|Overall Study|Moved to a Higher Level of Care|17
2275342|NCT02308696|3957113|FG001|Overall Study|Moved to a Higher Level of Care|6
2275343|NCT02308748|3957119|FG000|Period 1|Withdrawal by Subject|0
2275344|NCT02308748|3957120|FG001|Period 1|Withdrawal by Subject|0
2199626|NCT01567085|3835671|FG000|Overall Study|Returned to chronic dialysis|1
2199627|NCT01567085|3835671|FG000|Overall Study|Terminal chronic kidney dysfunction|1
2199628|NCT01567163|3835684|FG000|Overall Study|Progressive Disease|2
2199629|NCT01567163|3835684|FG000|Overall Study|Lost to Follow-up|2
2199630|NCT01567306|3835699|FG000|Overall Study|Protocol Violation|2
2199631|NCT01567306|3835700|FG001|Overall Study|Protocol Violation|2
2199632|NCT01567306|3835701|FG002|Overall Study|Protocol Violation|0
2199633|NCT01567306|3835702|FG003|Overall Study|Protocol Violation|3
2199634|NCT01567306|3835703|FG004|Overall Study|Protocol Violation|1
2199635|NCT01567306|3835704|FG005|Overall Study|Protocol Violation|1
2199636|NCT01567306|3835699|FG000|Overall Study|Change site living|1
2199637|NCT01567306|3835700|FG001|Overall Study|Change site living|0
2199638|NCT01567306|3835701|FG002|Overall Study|Change site living|0
2199639|NCT01567306|3835702|FG003|Overall Study|Change site living|0
2199640|NCT01567306|3835703|FG004|Overall Study|Change site living|0
2199641|NCT01567306|3835704|FG005|Overall Study|Change site living|0
2199642|NCT01567306|3835699|FG000|Overall Study|Adverse Event|0
2199643|NCT01567306|3835700|FG001|Overall Study|Adverse Event|0
2199644|NCT01567306|3835701|FG002|Overall Study|Adverse Event|0
2199645|NCT01567306|3835702|FG003|Overall Study|Adverse Event|2
2199646|NCT01567306|3835703|FG004|Overall Study|Adverse Event|4
2199647|NCT01567306|3835704|FG005|Overall Study|Adverse Event|1
2199648|NCT01567306|3835699|FG000|Overall Study|Lost to Follow-up|0
2199649|NCT01567306|3835700|FG001|Overall Study|Lost to Follow-up|0
2199650|NCT01567306|3835701|FG002|Overall Study|Lost to Follow-up|0
2275345|NCT02308748|3957121|FG002|Period 1|Withdrawal by Subject|1
2275346|NCT02308748|3957122|FG003|Period 1|Withdrawal by Subject|0
2275347|NCT02308748|3957123|FG004|Period 1|Withdrawal by Subject|0
2275348|NCT02308748|3957124|FG005|Period 1|Withdrawal by Subject|0
2275349|NCT02308748|3957125|FG006|Period 1|Withdrawal by Subject|0
2275350|NCT02308748|3957126|FG007|Period 1|Withdrawal by Subject|0
2275351|NCT02308748|3957127|FG008|Period 1|Withdrawal by Subject|0
2275352|NCT02308748|3957128|FG009|Period 1|Withdrawal by Subject|0
2275353|NCT02308748|3957119|FG000|Period 2|Adverse Event|0
2275354|NCT02308748|3957120|FG001|Period 2|Adverse Event|0
2275355|NCT02308748|3957121|FG002|Period 2|Adverse Event|0
2275356|NCT02308748|3957122|FG003|Period 2|Adverse Event|0
2275357|NCT02308748|3957123|FG004|Period 2|Adverse Event|0
2275358|NCT02308748|3957124|FG005|Period 2|Adverse Event|0
2275359|NCT02308748|3957125|FG006|Period 2|Adverse Event|0
2275360|NCT02308748|3957126|FG007|Period 2|Adverse Event|1
2275361|NCT02308748|3957127|FG008|Period 2|Adverse Event|0
2275362|NCT02308748|3957128|FG009|Period 2|Adverse Event|0
2275363|NCT02308748|3957119|FG000|Period 3|Protocol Violation|0
2275364|NCT02308748|3957120|FG001|Period 3|Protocol Violation|0
2275365|NCT02308748|3957121|FG002|Period 3|Protocol Violation|0
2275366|NCT02308748|3957122|FG003|Period 3|Protocol Violation|0
2275367|NCT02308748|3957123|FG004|Period 3|Protocol Violation|0
2275368|NCT02308748|3957124|FG005|Period 3|Protocol Violation|0
2275369|NCT02308748|3957125|FG006|Period 3|Protocol Violation|0
2275370|NCT02308748|3957126|FG007|Period 3|Protocol Violation|0
2275371|NCT02308748|3957127|FG008|Period 3|Protocol Violation|0
2275372|NCT02308748|3957128|FG009|Period 3|Protocol Violation|1
2275373|NCT02308748|3957119|FG000|Period 5|Adverse Event|1
2275374|NCT02308748|3957120|FG001|Period 5|Adverse Event|0
2275375|NCT02308748|3957121|FG002|Period 5|Adverse Event|0
2275376|NCT02308748|3957122|FG003|Period 5|Adverse Event|0
2275377|NCT02308748|3957123|FG004|Period 5|Adverse Event|0
2275378|NCT02308748|3957124|FG005|Period 5|Adverse Event|0
2275379|NCT02308748|3957125|FG006|Period 5|Adverse Event|0
2275380|NCT02308748|3957126|FG007|Period 5|Adverse Event|0
2275381|NCT02308748|3957127|FG008|Period 5|Adverse Event|1
2275382|NCT02308748|3957128|FG009|Period 5|Adverse Event|0
2275383|NCT02309099|3957150|FG000|Overall Study|Adverse Event|2
2275384|NCT02309099|3957151|FG001|Overall Study|Adverse Event|0
2275385|NCT02309112|3957160|FG000|Overall Study|Withdrawal by Subject|1
2275386|NCT02309112|3957161|FG001|Overall Study|Withdrawal by Subject|0
2275387|NCT02309112|3957162|FG002|Overall Study|Withdrawal by Subject|1
2275388|NCT02309112|3957160|FG000|Overall Study|Lost to Follow-up|0
2275389|NCT02309112|3957161|FG001|Overall Study|Lost to Follow-up|1
2275390|NCT02309112|3957162|FG002|Overall Study|Lost to Follow-up|0
2275391|NCT02309138|3957174|FG000|Overall Study|Withdrawal by Subject|44
2275392|NCT02309138|3957175|FG001|Overall Study|Withdrawal by Subject|15
2275393|NCT02309138|3957174|FG000|Overall Study|Protocol Violation|4
2275394|NCT02309138|3957175|FG001|Overall Study|Protocol Violation|2
2275395|NCT02309138|3957174|FG000|Overall Study|delivered before visit 2|0
2275396|NCT02309138|3957175|FG001|Overall Study|delivered before visit 2|1
2275397|NCT02309294|3957191|FG000|Overall Study|Withdrawal by Subject|2
2275398|NCT02309359|3957200|FG000|Overall Study|Adverse Event|4
2275399|NCT02309359|3957201|FG001|Overall Study|Adverse Event|5
2275400|NCT02309359|3957202|FG002|Overall Study|Adverse Event|5
2275401|NCT02309359|3957203|FG003|Overall Study|Adverse Event|4
2275402|NCT02309359|3957204|FG004|Overall Study|Adverse Event|4
2275403|NCT02309359|3957200|FG000|Overall Study|Death|1
2275404|NCT02309359|3957201|FG001|Overall Study|Death|0
2275405|NCT02309359|3957202|FG002|Overall Study|Death|0
2275406|NCT02309359|3957203|FG003|Overall Study|Death|0
2275407|NCT02309359|3957204|FG004|Overall Study|Death|0
2275408|NCT02309359|3957200|FG000|Overall Study|Withdrawal by Subject|2
2275409|NCT02309359|3957201|FG001|Overall Study|Withdrawal by Subject|2
2275410|NCT02309359|3957202|FG002|Overall Study|Withdrawal by Subject|4
2199651|NCT01567306|3835702|FG003|Overall Study|Lost to Follow-up|0
2275411|NCT02309359|3957203|FG003|Overall Study|Withdrawal by Subject|4
2275412|NCT02309359|3957204|FG004|Overall Study|Withdrawal by Subject|0
2275413|NCT02309359|3957200|FG000|Overall Study|Lack of Efficacy|3
2275414|NCT02309359|3957201|FG001|Overall Study|Lack of Efficacy|1
2275415|NCT02309359|3957202|FG002|Overall Study|Lack of Efficacy|0
2199652|NCT01567306|3835703|FG004|Overall Study|Lost to Follow-up|2
2199653|NCT01567306|3835704|FG005|Overall Study|Lost to Follow-up|0
2199654|NCT01567306|3835699|FG000|Overall Study|Withdrawal by Subject|0
2199655|NCT01567306|3835700|FG001|Overall Study|Withdrawal by Subject|0
2199656|NCT01567306|3835701|FG002|Overall Study|Withdrawal by Subject|0
2199657|NCT01567306|3835702|FG003|Overall Study|Withdrawal by Subject|0
2199658|NCT01567306|3835703|FG004|Overall Study|Withdrawal by Subject|0
2199659|NCT01567306|3835704|FG005|Overall Study|Withdrawal by Subject|1
2199660|NCT01567462|3835724|FG000|Overall Study|Withdrawal by Subject|4
2199661|NCT01567462|3835725|FG001|Overall Study|Withdrawal by Subject|7
2199662|NCT01567527|3835733|FG000|Conversion Phase.|Protocol deviation|3
2199663|NCT01567527|3835734|FG001|Conversion Phase.|Protocol deviation|0
2199664|NCT01567527|3835735|FG002|Conversion Phase.|Protocol deviation|0
2199665|NCT01567527|3835736|FG003|Conversion Phase.|Protocol deviation|0
2199666|NCT01567527|3835737|FG004|Conversion Phase.|Protocol deviation|0
2199667|NCT01567527|3835733|FG000|Conversion Phase.|Met withdrawal criteria|10
2199668|NCT01567527|3835734|FG001|Conversion Phase.|Met withdrawal criteria|0
2199669|NCT01567527|3835735|FG002|Conversion Phase.|Met withdrawal criteria|0
2199670|NCT01567527|3835736|FG003|Conversion Phase.|Met withdrawal criteria|0
2199671|NCT01567527|3835737|FG004|Conversion Phase.|Met withdrawal criteria|0
2199672|NCT01567527|3835733|FG000|Conversion Phase.|Withdrawal by Subject|32
2199673|NCT01567527|3835734|FG001|Conversion Phase.|Withdrawal by Subject|0
2199674|NCT01567527|3835735|FG002|Conversion Phase.|Withdrawal by Subject|0
2199675|NCT01567527|3835736|FG003|Conversion Phase.|Withdrawal by Subject|0
2275416|NCT02309359|3957203|FG003|Overall Study|Lack of Efficacy|0
2275417|NCT02309359|3957204|FG004|Overall Study|Lack of Efficacy|3
2275418|NCT02309359|3957200|FG000|Overall Study|Lost to Follow-up|0
2275419|NCT02309359|3957201|FG001|Overall Study|Lost to Follow-up|0
2275420|NCT02309359|3957202|FG002|Overall Study|Lost to Follow-up|0
2275421|NCT02309359|3957203|FG003|Overall Study|Lost to Follow-up|1
2275422|NCT02309359|3957204|FG004|Overall Study|Lost to Follow-up|0
2275423|NCT02309359|3957200|FG000|Overall Study|Other|2
2275424|NCT02309359|3957201|FG001|Overall Study|Other|0
2275425|NCT02309359|3957202|FG002|Overall Study|Other|2
2275426|NCT02309359|3957203|FG003|Overall Study|Other|3
2275427|NCT02309359|3957204|FG004|Overall Study|Other|2
2275428|NCT02309372|3957219|FG000|Overall Study|Lost to Follow-up|3
2275429|NCT02309372|3957220|FG001|Overall Study|Lost to Follow-up|2
2275430|NCT02309411|3957229|FG000|Overall Study|Physician Decision|1
2275431|NCT02309411|3957230|FG001|Overall Study|Physician Decision|0
2275432|NCT02309411|3957231|FG002|Overall Study|Physician Decision|0
2275433|NCT02309411|3957229|FG000|Overall Study|Withdrawal by Subject|1
2275434|NCT02309411|3957230|FG001|Overall Study|Withdrawal by Subject|1
2275435|NCT02309411|3957231|FG002|Overall Study|Withdrawal by Subject|0
2275436|NCT02309515|3957249|FG000|Overall Study|Withdrawal by Subject|0
2275437|NCT02309515|3957250|FG001|Overall Study|Withdrawal by Subject|1
2275438|NCT02309723|3957259|FG000|Overall Study|Withdrawal by Subject|24
2275439|NCT02309723|3957260|FG001|Overall Study|Withdrawal by Subject|23
2275440|NCT02309723|3957261|FG002|Overall Study|Withdrawal by Subject|24
2275441|NCT02310100|3957278|FG000|Overall Study|Physician Decision|3
2275442|NCT02310100|3957278|FG000|Overall Study|Withdrawal by Subject|10
2275443|NCT02310100|3957278|FG000|Overall Study|Enrollment closure|1
2275444|NCT02310100|3957278|FG000|Overall Study|Unapproved ablation operator|1
2275445|NCT02310100|3957278|FG000|Overall Study|Visit compliance|1
2275446|NCT02310100|3957278|FG000|Overall Study|Lost to Follow-up|2
2275447|NCT02310126|3957285|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0
2275448|NCT02310126|3957286|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1
2275449|NCT02310126|3957285|FG000|Period 1 (15 Minutes)|Protocol Violation|0
2275450|NCT02310126|3957286|FG001|Period 1 (15 Minutes)|Protocol Violation|1
2275451|NCT02310568|3957297|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2275452|NCT02310568|3957298|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2275453|NCT02310568|3957299|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2275454|NCT02310568|3957300|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2275455|NCT02310568|3957301|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
2275456|NCT02310568|3957297|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
2275457|NCT02310568|3957298|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2275458|NCT02310568|3957299|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2275459|NCT02310568|3957300|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2275460|NCT02310568|3957301|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2275461|NCT02310568|3957297|FG000|Stage 1 ( 4 Weeks)|Other|1
2275462|NCT02310568|3957298|FG001|Stage 1 ( 4 Weeks)|Other|1
2275463|NCT02310568|3957299|FG002|Stage 1 ( 4 Weeks)|Other|0
2275464|NCT02310568|3957300|FG003|Stage 1 ( 4 Weeks)|Other|0
2275465|NCT02310568|3957301|FG004|Stage 1 ( 4 Weeks)|Other|0
2275466|NCT02310568|3957297|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1
2275467|NCT02310568|3957298|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1
2275468|NCT02310568|3957299|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1
2275469|NCT02310568|3957300|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0
2275470|NCT02310568|3957301|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0
2275471|NCT02310568|3957297|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2275472|NCT02310568|3957298|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2275473|NCT02310568|3957299|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2275474|NCT02310568|3957300|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
2199676|NCT01567527|3835737|FG004|Conversion Phase.|Withdrawal by Subject|0
2199677|NCT01567527|3835733|FG000|Conversion Phase.|Lost to Follow-up|16
2199678|NCT01567527|3835734|FG001|Conversion Phase.|Lost to Follow-up|0
2199679|NCT01567527|3835735|FG002|Conversion Phase.|Lost to Follow-up|0
2199680|NCT01567527|3835736|FG003|Conversion Phase.|Lost to Follow-up|0
2199681|NCT01567527|3835737|FG004|Conversion Phase.|Lost to Follow-up|0
2199682|NCT01567527|3835733|FG000|Conversion Phase.|Lack of Efficacy|2
2199683|NCT01567527|3835734|FG001|Conversion Phase.|Lack of Efficacy|0
2199684|NCT01567527|3835735|FG002|Conversion Phase.|Lack of Efficacy|0
2199685|NCT01567527|3835736|FG003|Conversion Phase.|Lack of Efficacy|0
2199686|NCT01567527|3835737|FG004|Conversion Phase.|Lack of Efficacy|0
2199687|NCT01567527|3835733|FG000|Conversion Phase.|Adverse Event|33
2199688|NCT01567527|3835734|FG001|Conversion Phase.|Adverse Event|0
2199689|NCT01567527|3835735|FG002|Conversion Phase.|Adverse Event|0
2199690|NCT01567527|3835736|FG003|Conversion Phase.|Adverse Event|0
2199691|NCT01567527|3835737|FG004|Conversion Phase.|Adverse Event|0
2199692|NCT01567527|3835733|FG000|Conversion Phase.|Withdrawn by the investigator|3
2199693|NCT01567527|3835734|FG001|Conversion Phase.|Withdrawn by the investigator|0
2199694|NCT01567527|3835735|FG002|Conversion Phase.|Withdrawn by the investigator|0
2199695|NCT01567527|3835736|FG003|Conversion Phase.|Withdrawn by the investigator|0
2199696|NCT01567527|3835737|FG004|Conversion Phase.|Withdrawn by the investigator|0
2199697|NCT01567527|3835733|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2199698|NCT01567527|3835734|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
2199699|NCT01567527|3835735|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2199700|NCT01567527|3835736|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2199701|NCT01567527|3835737|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2199702|NCT01567527|3835733|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2199703|NCT01567527|3835734|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
2199704|NCT01567527|3835735|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2199705|NCT01567527|3835736|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2199706|NCT01567527|3835737|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2199707|NCT01567527|3835733|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2199708|NCT01567527|3835734|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
2199709|NCT01567527|3835735|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2199710|NCT01567527|3835736|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2199711|NCT01567527|3835737|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2199712|NCT01567527|3835733|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2199713|NCT01567527|3835734|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
2199714|NCT01567527|3835735|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2199715|NCT01567527|3835736|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2199716|NCT01567527|3835737|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2199717|NCT01567527|3835733|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2199718|NCT01567527|3835734|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
2199719|NCT01567527|3835735|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2199720|NCT01567527|3835736|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2199721|NCT01567527|3835737|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2199722|NCT01567527|3835733|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2199723|NCT01567527|3835734|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
2199724|NCT01567527|3835735|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2199725|NCT01567527|3835736|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2199726|NCT01567527|3835737|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2199727|NCT01567527|3835733|FG000|IM Depot Stabilization.|Protocol deviation|0
2199728|NCT01567527|3835734|FG001|IM Depot Stabilization.|Protocol deviation|0
2199729|NCT01567527|3835735|FG002|IM Depot Stabilization.|Protocol deviation|5
2199730|NCT01567527|3835736|FG003|IM Depot Stabilization.|Protocol deviation|0
2199731|NCT01567527|3835737|FG004|IM Depot Stabilization.|Protocol deviation|0
2199732|NCT01567527|3835733|FG000|IM Depot Stabilization.|Met withdrawal criteria|0
2199733|NCT01567527|3835734|FG001|IM Depot Stabilization.|Met withdrawal criteria|0
2199734|NCT01567527|3835735|FG002|IM Depot Stabilization.|Met withdrawal criteria|26
2199735|NCT01567527|3835736|FG003|IM Depot Stabilization.|Met withdrawal criteria|0
2199736|NCT01567527|3835737|FG004|IM Depot Stabilization.|Met withdrawal criteria|0
2199737|NCT01567527|3835733|FG000|IM Depot Stabilization.|Withdrawal by Subject|0
2199738|NCT01567527|3835734|FG001|IM Depot Stabilization.|Withdrawal by Subject|0
2199739|NCT01567527|3835735|FG002|IM Depot Stabilization.|Withdrawal by Subject|56
2199740|NCT01567527|3835736|FG003|IM Depot Stabilization.|Withdrawal by Subject|0
2199741|NCT01567527|3835737|FG004|IM Depot Stabilization.|Withdrawal by Subject|0
2199742|NCT01567527|3835733|FG000|IM Depot Stabilization.|Sponsor discontinued study|0
2199743|NCT01567527|3835734|FG001|IM Depot Stabilization.|Sponsor discontinued study|0
2199744|NCT01567527|3835735|FG002|IM Depot Stabilization.|Sponsor discontinued study|1
2199745|NCT01567527|3835736|FG003|IM Depot Stabilization.|Sponsor discontinued study|0
2199746|NCT01567527|3835737|FG004|IM Depot Stabilization.|Sponsor discontinued study|0
2199747|NCT01567527|3835733|FG000|IM Depot Stabilization.|Lost to Follow-up|0
2199748|NCT01567527|3835734|FG001|IM Depot Stabilization.|Lost to Follow-up|0
2199749|NCT01567527|3835735|FG002|IM Depot Stabilization.|Lost to Follow-up|21
2199750|NCT01567527|3835736|FG003|IM Depot Stabilization.|Lost to Follow-up|0
2199751|NCT01567527|3835737|FG004|IM Depot Stabilization.|Lost to Follow-up|0
2199752|NCT01567527|3835733|FG000|IM Depot Stabilization.|Lack of Efficacy|0
2199753|NCT01567527|3835734|FG001|IM Depot Stabilization.|Lack of Efficacy|0
2199754|NCT01567527|3835735|FG002|IM Depot Stabilization.|Lack of Efficacy|7
2199755|NCT01567527|3835736|FG003|IM Depot Stabilization.|Lack of Efficacy|0
2199756|NCT01567527|3835737|FG004|IM Depot Stabilization.|Lack of Efficacy|0
2199757|NCT01567527|3835733|FG000|IM Depot Stabilization.|Adverse Event|0
2199758|NCT01567527|3835734|FG001|IM Depot Stabilization.|Adverse Event|0
2199759|NCT01567527|3835735|FG002|IM Depot Stabilization.|Adverse Event|37
2199760|NCT01567527|3835736|FG003|IM Depot Stabilization.|Adverse Event|0
2199761|NCT01567527|3835737|FG004|IM Depot Stabilization.|Adverse Event|0
2199762|NCT01567527|3835733|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0
2199763|NCT01567527|3835734|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0
2199764|NCT01567527|3835735|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6
2199765|NCT01567527|3835736|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0
2199766|NCT01567527|3835737|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0
2199767|NCT01567527|3835733|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0
2199768|NCT01567527|3835734|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0
2199769|NCT01567527|3835735|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0
2199770|NCT01567527|3835736|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1
2199771|NCT01567527|3835737|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1
2199772|NCT01567527|3835733|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
2199773|NCT01567527|3835734|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
2199774|NCT01567527|3835735|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
2199775|NCT01567527|3835736|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
2199776|NCT01567527|3835737|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
2199777|NCT01567527|3835733|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
2199778|NCT01567527|3835734|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
2199779|NCT01567527|3835735|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
2199780|NCT01567527|3835736|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
2199781|NCT01567527|3835737|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
2199782|NCT01567527|3835733|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
2199783|NCT01567527|3835734|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
2199784|NCT01567527|3835735|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
2199785|NCT01567527|3835736|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
2199786|NCT01567527|3835737|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
2199787|NCT01567527|3835733|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2199788|NCT01567527|3835734|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2199789|NCT01567527|3835735|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2199790|NCT01567527|3835736|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
2199791|NCT01567527|3835737|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
2199792|NCT01567527|3835733|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
2199793|NCT01567527|3835734|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
2199794|NCT01567527|3835735|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
2199795|NCT01567527|3835736|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
2199796|NCT01567527|3835737|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
2199797|NCT01567527|3835733|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
2199798|NCT01567527|3835734|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
2199799|NCT01567527|3835735|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
2199800|NCT01567527|3835736|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
2199801|NCT01567527|3835737|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
2199802|NCT01567527|3835733|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2199803|NCT01567527|3835734|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2199804|NCT01567527|3835735|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2199805|NCT01567527|3835736|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
2199806|NCT01567527|3835737|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
2199807|NCT01567826|3835748|FG000|Overall Study|Lost to Follow-up|3
2199808|NCT01567826|3835749|FG001|Overall Study|Lost to Follow-up|2
2199809|NCT01567852|3835767|FG000|Overall Study|Withdrawal by Subject|3
2199810|NCT01567852|3835768|FG001|Overall Study|Withdrawal by Subject|6
2199811|NCT01567852|3835767|FG000|Overall Study|ECT discontinued|1
2199812|NCT01567852|3835768|FG001|Overall Study|ECT discontinued|1
2199813|NCT01567865|3835778|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
2199814|NCT01567865|3835779|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
2199815|NCT01567865|3835780|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
2199816|NCT01567865|3835781|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
2199817|NCT01567865|3835778|FG000|Evaluated for Immunogenicity|Missing blood sample|17
2199818|NCT01567865|3835779|FG001|Evaluated for Immunogenicity|Missing blood sample|24
2199819|NCT01567865|3835780|FG002|Evaluated for Immunogenicity|Missing blood sample|16
2199820|NCT01567865|3835781|FG003|Evaluated for Immunogenicity|Missing blood sample|28
2199821|NCT01568034|3835823|FG000|Overall Study|Withdrawal by Subject|1
2199822|NCT01568034|3835824|FG001|Overall Study|Withdrawal by Subject|0
2199823|NCT01568034|3835825|FG002|Overall Study|Withdrawal by Subject|0
2199824|NCT01568034|3835826|FG003|Overall Study|Withdrawal by Subject|0
2199825|NCT01568047|3835840|FG000|Overall Study|Ineligibility|1
2199826|NCT01568047|3835841|FG001|Overall Study|Ineligibility|0
2199827|NCT01568047|3835842|FG002|Overall Study|Ineligibility|0
2199828|NCT01568047|3835843|FG003|Overall Study|Ineligibility|0
2199829|NCT01568047|3835840|FG000|Overall Study|Withdrawal by Subject|0
2199830|NCT01568047|3835841|FG001|Overall Study|Withdrawal by Subject|1
2199831|NCT01568047|3835842|FG002|Overall Study|Withdrawal by Subject|0
2199832|NCT01568047|3835843|FG003|Overall Study|Withdrawal by Subject|0
2199833|NCT01568047|3835840|FG000|Overall Study|Adverse Event|0
2199834|NCT01568047|3835841|FG001|Overall Study|Adverse Event|0
2199835|NCT01568047|3835842|FG002|Overall Study|Adverse Event|1
2199836|NCT01568047|3835843|FG003|Overall Study|Adverse Event|1
2199837|NCT01568112|3835878|FG000|Overall Study|Randomized But Not Treated|0
2199838|NCT01568112|3835879|FG001|Overall Study|Randomized But Not Treated|1
2199839|NCT01568112|3835880|FG002|Overall Study|Randomized But Not Treated|0
2199840|NCT01568112|3835881|FG003|Overall Study|Randomized But Not Treated|0
2199841|NCT01568112|3835878|FG000|Overall Study|Withdrew due to Adverse Event|2
2199842|NCT01568112|3835879|FG001|Overall Study|Withdrew due to Adverse Event|4
2199843|NCT01568112|3835880|FG002|Overall Study|Withdrew due to Adverse Event|6
2199844|NCT01568112|3835881|FG003|Overall Study|Withdrew due to Adverse Event|3
2199845|NCT01568112|3835878|FG000|Overall Study|Lost to Follow-up|0
2199846|NCT01568112|3835879|FG001|Overall Study|Lost to Follow-up|0
2199847|NCT01568112|3835880|FG002|Overall Study|Lost to Follow-up|0
2199848|NCT01568112|3835881|FG003|Overall Study|Lost to Follow-up|1
2199849|NCT01568112|3835878|FG000|Overall Study|Withdrawal by Subject|2
2199850|NCT01568112|3835879|FG001|Overall Study|Withdrawal by Subject|3
2199851|NCT01568112|3835880|FG002|Overall Study|Withdrawal by Subject|0
2199852|NCT01568112|3835881|FG003|Overall Study|Withdrawal by Subject|7
2199853|NCT01568112|3835878|FG000|Overall Study|Withdrawal by Physician|1
2199854|NCT01568112|3835879|FG001|Overall Study|Withdrawal by Physician|0
2199855|NCT01568112|3835880|FG002|Overall Study|Withdrawal by Physician|1
2199856|NCT01568112|3835881|FG003|Overall Study|Withdrawal by Physician|1
2199857|NCT01568320|3835901|FG000|Overall Study|Death|20
2199858|NCT01568320|3835901|FG000|Overall Study|Lost to Follow-up|9
2199859|NCT01568320|3835901|FG000|Overall Study|Withdrawal by Subject|10
2199860|NCT01568320|3835901|FG000|Overall Study|Conversion to open repair|1
2199861|NCT01568320|3835901|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1
2217142|NCT01706159|3860291|FG000|Overall Study|Withdrawal Criteria|2
2217143|NCT01706159|3860292|FG001|Overall Study|Withdrawal Criteria|1
2217144|NCT01706159|3860291|FG000|Overall Study|Unclassified|6
2217145|NCT01706159|3860292|FG001|Overall Study|Unclassified|1
2217146|NCT01706198|3860300|FG000|Overall Study|Adverse Event|12
2217147|NCT01706198|3860301|FG001|Overall Study|Adverse Event|15
2217148|NCT01706198|3860300|FG000|Overall Study|Protocol Violation|7
2217149|NCT01706198|3860301|FG001|Overall Study|Protocol Violation|5
2217150|NCT01706198|3860300|FG000|Overall Study|Other: Subject reached stopping criteria|11
2217151|NCT01706198|3860301|FG001|Overall Study|Other: Subject reached stopping criteria|13
2217152|NCT01706198|3860300|FG000|Overall Study|Lost to Follow-up|97
2217153|NCT01706198|3860301|FG001|Overall Study|Lost to Follow-up|93
2217154|NCT01706198|3860300|FG000|Overall Study|Physician Decision|23
2217155|NCT01706198|3860301|FG001|Overall Study|Physician Decision|37
2217156|NCT01706198|3860300|FG000|Overall Study|Withdrawal by Subject|23
2217157|NCT01706198|3860301|FG001|Overall Study|Withdrawal by Subject|31
2217158|NCT01706250|3860307|FG000|Overall Study|Lost to Follow-up|2
2217159|NCT01706328|3860323|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
2217160|NCT01706328|3860324|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2217161|NCT01706328|3860325|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2217162|NCT01706328|3860323|FG000|2-week Run-in Period|Withdrawal by Subject|15
2217163|NCT01706328|3860324|FG001|2-week Run-in Period|Withdrawal by Subject|0
2217164|NCT01706328|3860325|FG002|2-week Run-in Period|Withdrawal by Subject|0
2217165|NCT01706328|3860323|FG000|2-week Run-in Period|Physician Decision|4
2217166|NCT01706328|3860324|FG001|2-week Run-in Period|Physician Decision|0
2217167|NCT01706328|3860325|FG002|2-week Run-in Period|Physician Decision|0
2217168|NCT01706328|3860323|FG000|2-week Run-in Period|Adverse Event|4
2217169|NCT01706328|3860324|FG001|2-week Run-in Period|Adverse Event|0
2217170|NCT01706328|3860325|FG002|2-week Run-in Period|Adverse Event|0
2217171|NCT01706328|3860323|FG000|2-week Run-in Period|Lost to Follow-up|2
2217172|NCT01706328|3860324|FG001|2-week Run-in Period|Lost to Follow-up|0
2217173|NCT01706328|3860325|FG002|2-week Run-in Period|Lost to Follow-up|0
2217174|NCT01706328|3860323|FG000|12-week Double-blind Treatment Period|Adverse Event|0
2217175|NCT01706328|3860324|FG001|12-week Double-blind Treatment Period|Adverse Event|14
2199862|NCT01568593|3835924|FG000|Overall Study|Lack of Efficacy|4
2199863|NCT01568593|3835925|FG001|Overall Study|Lack of Efficacy|1
2199864|NCT01568593|3835924|FG000|Overall Study|Adverse Event|3
2199865|NCT01568593|3835925|FG001|Overall Study|Adverse Event|2
2199866|NCT01568866|3835946|FG000|Overall Study|Disease Progression|208
2199867|NCT01568866|3835947|FG001|Overall Study|Disease Progression|183
2199868|NCT01568866|3835946|FG000|Overall Study|Adverse Event|94
2199869|NCT01568866|3835947|FG001|Overall Study|Adverse Event|96
2199870|NCT01568866|3835946|FG000|Overall Study|Patient Request|55
2199871|NCT01568866|3835947|FG001|Overall Study|Patient Request|71
2199872|NCT01568866|3835946|FG000|Overall Study|Physician Decision|40
2199873|NCT01568866|3835947|FG001|Overall Study|Physician Decision|32
2199874|NCT01568866|3835946|FG000|Overall Study|Withdrawal by Subject|19
2199875|NCT01568866|3835947|FG001|Overall Study|Withdrawal by Subject|11
2199876|NCT01568866|3835946|FG000|Overall Study|Death|10
2199877|NCT01568866|3835947|FG001|Overall Study|Death|18
2199878|NCT01568866|3835946|FG000|Overall Study|Protocol Non-compliance|2
2199879|NCT01568866|3835947|FG001|Overall Study|Protocol Non-compliance|4
2199880|NCT01568866|3835946|FG000|Overall Study|Lost to Follow-up|1
2199881|NCT01568866|3835947|FG001|Overall Study|Lost to Follow-up|0
2199882|NCT01568866|3835946|FG000|Overall Study|Randomized but Not Dosed|9
2199883|NCT01568866|3835947|FG001|Overall Study|Randomized but Not Dosed|1
2199884|NCT01568892|3835955|FG000|Open-label Phase|Adverse Event|2
2199885|NCT01568892|3835956|FG001|Open-label Phase|Adverse Event|0
2199886|NCT01568892|3835955|FG000|Open-label Phase|Lack of Efficacy|4
2199887|NCT01568892|3835956|FG001|Open-label Phase|Lack of Efficacy|2
2199888|NCT01568892|3835955|FG000|Open-label Phase|Lost to Follow-up|0
2199889|NCT01568892|3835956|FG001|Open-label Phase|Lost to Follow-up|1
2199890|NCT01569022|3835985|FG000|First Intervention|Lost to Follow-up|2
2199891|NCT01569022|3835986|FG001|First Intervention|Lost to Follow-up|1
2199892|NCT01569022|3835985|FG000|Second Intervention|Lost to Follow-up|2
2199893|NCT01569022|3835986|FG001|Second Intervention|Lost to Follow-up|2
2199894|NCT01569074|3835999|FG000|Overall Study|Study stopped|6
2199895|NCT01569074|3836000|FG001|Overall Study|Study stopped|6
2199896|NCT01569074|3836001|FG002|Overall Study|Study stopped|8
2199897|NCT01569074|3836002|FG003|Overall Study|Study stopped|7
2199898|NCT01569074|3836003|FG004|Overall Study|Study stopped|7
2199899|NCT01569074|3835999|FG000|Overall Study|Study-specific discontinuation criteria|0
2199900|NCT01569074|3836000|FG001|Overall Study|Study-specific discontinuation criteria|1
2199901|NCT01569074|3836001|FG002|Overall Study|Study-specific discontinuation criteria|0
2275475|NCT02310568|3957301|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2275476|NCT02310568|3957297|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2275477|NCT02310568|3957298|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2275478|NCT02310568|3957299|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2275479|NCT02310568|3957300|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
2275480|NCT02310568|3957301|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2275481|NCT02310568|3957297|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1
2275482|NCT02310568|3957298|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0
2275483|NCT02310568|3957299|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0
2275484|NCT02310568|3957300|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1
2275485|NCT02310568|3957301|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0
2275486|NCT02310568|3957297|FG000|Stage 2 (4 Weeks)|Other|0
2275487|NCT02310568|3957298|FG001|Stage 2 (4 Weeks)|Other|1
2275488|NCT02310568|3957299|FG002|Stage 2 (4 Weeks)|Other|1
2275489|NCT02310568|3957300|FG003|Stage 2 (4 Weeks)|Other|0
2275490|NCT02310568|3957301|FG004|Stage 2 (4 Weeks)|Other|0
2275491|NCT02310568|3957297|FG000|Stage 2 (4 Weeks)|Adverse Event|0
2275492|NCT02310568|3957298|FG001|Stage 2 (4 Weeks)|Adverse Event|0
2275493|NCT02310568|3957299|FG002|Stage 2 (4 Weeks)|Adverse Event|0
2275494|NCT02310568|3957300|FG003|Stage 2 (4 Weeks)|Adverse Event|1
2275495|NCT02310568|3957301|FG004|Stage 2 (4 Weeks)|Adverse Event|1
2275496|NCT02310568|3957297|FG000|Stage 2 (4 Weeks)|Protocol Violation|0
2275497|NCT02310568|3957298|FG001|Stage 2 (4 Weeks)|Protocol Violation|0
2275498|NCT02310568|3957299|FG002|Stage 2 (4 Weeks)|Protocol Violation|0
2275499|NCT02310568|3957300|FG003|Stage 2 (4 Weeks)|Protocol Violation|1
2275500|NCT02310568|3957301|FG004|Stage 2 (4 Weeks)|Protocol Violation|0
2275501|NCT02310568|3957297|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0
2275502|NCT02310568|3957298|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0
2275503|NCT02310568|3957299|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0
2275504|NCT02310568|3957300|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2
2275505|NCT02310568|3957301|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0
2275506|NCT02310581|3957323|FG000|Overall Study|Adverse Event|1
2275507|NCT02310581|3957324|FG001|Overall Study|Adverse Event|1
2275508|NCT02310581|3957325|FG002|Overall Study|Adverse Event|1
2275509|NCT02310581|3957326|FG003|Overall Study|Adverse Event|0
2275510|NCT02310581|3957323|FG000|Overall Study|Withdrawal by Subject|2
2275511|NCT02310581|3957324|FG001|Overall Study|Withdrawal by Subject|1
2275512|NCT02310581|3957325|FG002|Overall Study|Withdrawal by Subject|0
2275513|NCT02310581|3957326|FG003|Overall Study|Withdrawal by Subject|1
2199902|NCT01569074|3836002|FG003|Overall Study|Study-specific discontinuation criteria|0
2217658|NCT01709305|3860928|FG000|Phase 1|Travel, moving, etc.|30
2275514|NCT02310646|3957338|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
2275515|NCT02310646|3957339|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
2199903|NCT01569074|3836003|FG004|Overall Study|Study-specific discontinuation criteria|0
2199904|NCT01569074|3835999|FG000|Overall Study|Severe non-compliance to protocol|0
2199905|NCT01569074|3836000|FG001|Overall Study|Severe non-compliance to protocol|0
2199906|NCT01569074|3836001|FG002|Overall Study|Severe non-compliance to protocol|1
2199907|NCT01569074|3836002|FG003|Overall Study|Severe non-compliance to protocol|0
2199908|NCT01569074|3836003|FG004|Overall Study|Severe non-compliance to protocol|0
2199909|NCT01569074|3835999|FG000|Overall Study|eg change in circumstances|0
2199910|NCT01569074|3836000|FG001|Overall Study|eg change in circumstances|2
2199911|NCT01569074|3836001|FG002|Overall Study|eg change in circumstances|0
2199912|NCT01569074|3836002|FG003|Overall Study|eg change in circumstances|1
2199913|NCT01569074|3836003|FG004|Overall Study|eg change in circumstances|1
2199914|NCT01569074|3835999|FG000|Overall Study|Adverse Event|1
2199915|NCT01569074|3836000|FG001|Overall Study|Adverse Event|0
2199916|NCT01569074|3836001|FG002|Overall Study|Adverse Event|3
2199917|NCT01569074|3836002|FG003|Overall Study|Adverse Event|0
2199918|NCT01569074|3836003|FG004|Overall Study|Adverse Event|0
2199919|NCT01569152|3836064|FG000|Phase IIa, Period 1|Early Escape|5
2199920|NCT01569152|3836065|FG001|Phase IIa, Period 1|Early Escape|22
2199921|NCT01569152|3836066|FG002|Phase IIa, Period 1|Early Escape|0
2199922|NCT01569152|3836064|FG000|Phase IIa, Period 1|Adverse Event|4
2199923|NCT01569152|3836065|FG001|Phase IIa, Period 1|Adverse Event|0
2199924|NCT01569152|3836066|FG002|Phase IIa, Period 1|Adverse Event|0
2199925|NCT01569152|3836064|FG000|Phase IIa, Period 1|Lost to Follow-up|1
2199926|NCT01569152|3836065|FG001|Phase IIa, Period 1|Lost to Follow-up|0
2199927|NCT01569152|3836066|FG002|Phase IIa, Period 1|Lost to Follow-up|0
2199928|NCT01569152|3836064|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9
2199929|NCT01569152|3836065|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8
2199930|NCT01569152|3836066|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0
2199931|NCT01569152|3836064|FG000|Phase IIa, Period 1|Protocol Violation|0
2199932|NCT01569152|3836065|FG001|Phase IIa, Period 1|Protocol Violation|1
2199933|NCT01569152|3836066|FG002|Phase IIa, Period 1|Protocol Violation|0
2199934|NCT01569152|3836064|FG000|Phase IIa, Period 1|Withdrawal by Subject|2
2199935|NCT01569152|3836065|FG001|Phase IIa, Period 1|Withdrawal by Subject|1
2199936|NCT01569152|3836066|FG002|Phase IIa, Period 1|Withdrawal by Subject|0
2199937|NCT01569152|3836064|FG000|Safety Extension, Period 3|Adverse Event|0
2199938|NCT01569152|3836065|FG001|Safety Extension, Period 3|Adverse Event|0
2199939|NCT01569152|3836066|FG002|Safety Extension, Period 3|Adverse Event|4
2199940|NCT01569152|3836064|FG000|Safety Extension, Period 3|Withdrawal by Subject|0
2199941|NCT01569152|3836065|FG001|Safety Extension, Period 3|Withdrawal by Subject|0
2199942|NCT01569152|3836066|FG002|Safety Extension, Period 3|Withdrawal by Subject|2
2199943|NCT01569152|3836064|FG000|Safety Extension, Period 3|Physician Decision|0
2199944|NCT01569152|3836065|FG001|Safety Extension, Period 3|Physician Decision|0
2199945|NCT01569152|3836066|FG002|Safety Extension, Period 3|Physician Decision|2
2199946|NCT01569152|3836064|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0
2199947|NCT01569152|3836065|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0
2199948|NCT01569152|3836066|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47
2199949|NCT01569295|3836088|FG000|Overall Study|Progressive Disease|75
2199950|NCT01569295|3836089|FG001|Overall Study|Progressive Disease|139
2199951|NCT01569295|3836088|FG000|Overall Study|Adverse Event|39
2199952|NCT01569295|3836089|FG001|Overall Study|Adverse Event|14
2199953|NCT01569295|3836088|FG000|Overall Study|Withdrawal by Subject|25
2199954|NCT01569295|3836089|FG001|Overall Study|Withdrawal by Subject|12
2199955|NCT01569295|3836088|FG000|Overall Study|Death|19
2199956|NCT01569295|3836089|FG001|Overall Study|Death|15
2199957|NCT01569295|3836088|FG000|Overall Study|Physician Decision|13
2199958|NCT01569295|3836089|FG001|Overall Study|Physician Decision|18
2199959|NCT01569295|3836088|FG000|Overall Study|Study Terminated by Sponsor|24
2275516|NCT02310646|3957338|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
2275517|NCT02310646|3957339|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
2275518|NCT02310672|3957361|FG000|Overall Study|Death|1
2275519|NCT02310672|3957361|FG000|Overall Study|Lost to Follow-up|1
2275520|NCT02310672|3957361|FG000|Overall Study|Withdrawal by Subject|1
2275521|NCT02310672|3957361|FG000|Overall Study|Sponsor's decision|12
2275522|NCT02310750|3957376|FG000|HP Period 1|Lost to Follow-up|0
2275523|NCT02310750|3957377|FG001|HP Period 1|Lost to Follow-up|0
2275524|NCT02310750|3957378|FG002|HP Period 1|Lost to Follow-up|0
2275525|NCT02310750|3957379|FG003|HP Period 1|Lost to Follow-up|0
2275526|NCT02310750|3957380|FG004|HP Period 1|Lost to Follow-up|0
2275527|NCT02310750|3957381|FG005|HP Period 1|Lost to Follow-up|0
2275528|NCT02310750|3957382|FG006|HP Period 1|Lost to Follow-up|1
2275529|NCT02310750|3957383|FG007|HP Period 1|Lost to Follow-up|0
2275530|NCT02310750|3957384|FG008|HP Period 1|Lost to Follow-up|0
2275531|NCT02310750|3957385|FG009|HP Period 1|Lost to Follow-up|0
2275532|NCT02310750|3957386|FG010|HP Period 1|Lost to Follow-up|0
2275533|NCT02310750|3957387|FG011|HP Period 1|Lost to Follow-up|0
2275534|NCT02310750|3957388|FG012|HP Period 1|Lost to Follow-up|0
2275535|NCT02310750|3957389|FG013|HP Period 1|Lost to Follow-up|0
2275536|NCT02310750|3957390|FG014|HP Period 1|Lost to Follow-up|0
2275537|NCT02310750|3957391|FG015|HP Period 1|Lost to Follow-up|0
2275538|NCT02310750|3957376|FG000|HP Period 1|Withdrawal by Subject|1
2275539|NCT02310750|3957377|FG001|HP Period 1|Withdrawal by Subject|0
2275540|NCT02310750|3957378|FG002|HP Period 1|Withdrawal by Subject|0
2275541|NCT02310750|3957379|FG003|HP Period 1|Withdrawal by Subject|1
2199960|NCT01569295|3836089|FG001|Overall Study|Study Terminated by Sponsor|2
2199961|NCT01569295|3836088|FG000|Overall Study|Other Reason not Specified|3
2199962|NCT01569295|3836089|FG001|Overall Study|Other Reason not Specified|5
2199963|NCT01569295|3836088|FG000|Overall Study|Non-Compliance with Study Drug|6
2199964|NCT01569295|3836089|FG001|Overall Study|Non-Compliance with Study Drug|1
2199965|NCT01569295|3836088|FG000|Overall Study|Other Anticancer/Experimental Therapy|2
2199966|NCT01569295|3836089|FG001|Overall Study|Other Anticancer/Experimental Therapy|2
2275542|NCT02310750|3957380|FG004|HP Period 1|Withdrawal by Subject|0
2275543|NCT02310750|3957381|FG005|HP Period 1|Withdrawal by Subject|0
2275544|NCT02310750|3957382|FG006|HP Period 1|Withdrawal by Subject|0
2275545|NCT02310750|3957383|FG007|HP Period 1|Withdrawal by Subject|0
2275546|NCT02310750|3957384|FG008|HP Period 1|Withdrawal by Subject|0
2275547|NCT02310750|3957385|FG009|HP Period 1|Withdrawal by Subject|0
2275548|NCT02310750|3957386|FG010|HP Period 1|Withdrawal by Subject|0
2275549|NCT02310750|3957387|FG011|HP Period 1|Withdrawal by Subject|0
2275550|NCT02310750|3957388|FG012|HP Period 1|Withdrawal by Subject|0
2275551|NCT02310750|3957389|FG013|HP Period 1|Withdrawal by Subject|0
2275552|NCT02310750|3957390|FG014|HP Period 1|Withdrawal by Subject|0
2275553|NCT02310750|3957391|FG015|HP Period 1|Withdrawal by Subject|0
2275554|NCT02310750|3957376|FG000|HP Washout 1|Lost to Follow-up|0
2275555|NCT02310750|3957377|FG001|HP Washout 1|Lost to Follow-up|0
2275556|NCT02310750|3957378|FG002|HP Washout 1|Lost to Follow-up|1
2275557|NCT02310750|3957379|FG003|HP Washout 1|Lost to Follow-up|1
2275558|NCT02310750|3957380|FG004|HP Washout 1|Lost to Follow-up|2
2275559|NCT02310750|3957381|FG005|HP Washout 1|Lost to Follow-up|2
2275560|NCT02310750|3957382|FG006|HP Washout 1|Lost to Follow-up|3
2275561|NCT02310750|3957383|FG007|HP Washout 1|Lost to Follow-up|0
2275562|NCT02310750|3957384|FG008|HP Washout 1|Lost to Follow-up|0
2275563|NCT02310750|3957385|FG009|HP Washout 1|Lost to Follow-up|0
2275564|NCT02310750|3957386|FG010|HP Washout 1|Lost to Follow-up|0
2275565|NCT02310750|3957387|FG011|HP Washout 1|Lost to Follow-up|0
2275566|NCT02310750|3957388|FG012|HP Washout 1|Lost to Follow-up|0
2275567|NCT02310750|3957389|FG013|HP Washout 1|Lost to Follow-up|0
2275568|NCT02310750|3957390|FG014|HP Washout 1|Lost to Follow-up|0
2275569|NCT02310750|3957391|FG015|HP Washout 1|Lost to Follow-up|0
2275570|NCT02310750|3957376|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275571|NCT02310750|3957377|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275572|NCT02310750|3957378|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275573|NCT02310750|3957379|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
2275574|NCT02310750|3957380|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275575|NCT02310750|3957381|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
2275576|NCT02310750|3957382|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275577|NCT02310750|3957383|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275578|NCT02310750|3957384|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
2275579|NCT02310750|3957385|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
2275580|NCT02310750|3957386|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275581|NCT02310750|3957387|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275582|NCT02310750|3957388|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275583|NCT02310750|3957389|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275584|NCT02310750|3957390|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275585|NCT02310750|3957391|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2275586|NCT02310750|3957376|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275587|NCT02310750|3957377|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275588|NCT02310750|3957378|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275589|NCT02310750|3957379|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275590|NCT02310750|3957380|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275591|NCT02310750|3957381|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275592|NCT02310750|3957382|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275593|NCT02310750|3957383|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275594|NCT02310750|3957384|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275595|NCT02310750|3957385|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
2275596|NCT02310750|3957386|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275597|NCT02310750|3957387|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275598|NCT02310750|3957388|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275599|NCT02310750|3957389|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275600|NCT02310750|3957390|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275601|NCT02310750|3957391|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2275602|NCT02310750|3957376|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275603|NCT02310750|3957377|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275604|NCT02310750|3957378|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275605|NCT02310750|3957379|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275606|NCT02310750|3957380|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275607|NCT02310750|3957381|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275608|NCT02310750|3957382|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275609|NCT02310750|3957383|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
2322386|NCT02971670|4037399|FG000|Overall Study|Withdrawal by Subject|4
2199967|NCT01569295|3836088|FG000|Overall Study|Lost to Follow-up|1
2199968|NCT01569295|3836089|FG001|Overall Study|Lost to Follow-up|1
2199969|NCT01569438|3836098|FG000|Overall Study|Lack of Efficacy|1
2199970|NCT01569438|3836099|FG001|Overall Study|Lack of Efficacy|2
2199971|NCT01569438|3836098|FG000|Overall Study|Withdrawal by Subject|0
2199972|NCT01569438|3836099|FG001|Overall Study|Withdrawal by Subject|3
2275610|NCT02310750|3957384|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
2275611|NCT02310750|3957385|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
2275612|NCT02310750|3957386|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275613|NCT02310750|3957387|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275614|NCT02310750|3957388|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275615|NCT02310750|3957389|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275616|NCT02310750|3957390|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275617|NCT02310750|3957391|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2275618|NCT02310750|3957376|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275619|NCT02310750|3957377|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275620|NCT02310750|3957378|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275621|NCT02310750|3957379|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275622|NCT02310750|3957380|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275623|NCT02310750|3957381|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275624|NCT02310750|3957382|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275625|NCT02310750|3957383|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
2275626|NCT02310750|3957384|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
2275627|NCT02310750|3957385|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275628|NCT02310750|3957386|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2199973|NCT01569438|3836098|FG000|Overall Study|Adverse Event|2
2199974|NCT01569438|3836099|FG001|Overall Study|Adverse Event|15
2199975|NCT01569438|3836098|FG000|Overall Study|Protocol Violation|2
2275629|NCT02310750|3957387|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275630|NCT02310750|3957388|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275631|NCT02310750|3957389|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275632|NCT02310750|3957390|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275633|NCT02310750|3957391|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2275634|NCT02310750|3957376|FG000|HP Washout 2|Lost to Follow-up|0
2275635|NCT02310750|3957377|FG001|HP Washout 2|Lost to Follow-up|0
2275636|NCT02310750|3957378|FG002|HP Washout 2|Lost to Follow-up|0
2275637|NCT02310750|3957379|FG003|HP Washout 2|Lost to Follow-up|0
2275638|NCT02310750|3957380|FG004|HP Washout 2|Lost to Follow-up|1
2275639|NCT02310750|3957381|FG005|HP Washout 2|Lost to Follow-up|0
2275640|NCT02310750|3957382|FG006|HP Washout 2|Lost to Follow-up|7
2275641|NCT02310750|3957383|FG007|HP Washout 2|Lost to Follow-up|0
2275642|NCT02310750|3957384|FG008|HP Washout 2|Lost to Follow-up|0
2275643|NCT02310750|3957385|FG009|HP Washout 2|Lost to Follow-up|0
2275644|NCT02310750|3957386|FG010|HP Washout 2|Lost to Follow-up|0
2275645|NCT02310750|3957387|FG011|HP Washout 2|Lost to Follow-up|0
2275646|NCT02310750|3957388|FG012|HP Washout 2|Lost to Follow-up|0
2275647|NCT02310750|3957389|FG013|HP Washout 2|Lost to Follow-up|0
2275648|NCT02310750|3957390|FG014|HP Washout 2|Lost to Follow-up|0
2275649|NCT02310750|3957391|FG015|HP Washout 2|Lost to Follow-up|0
2275650|NCT02310763|3957475|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
2275651|NCT02310763|3957476|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
2275652|NCT02310763|3957477|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
2275653|NCT02310763|3957475|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
2275654|NCT02310763|3957476|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
2275655|NCT02310763|3957477|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
2275656|NCT02310763|3957475|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
2275657|NCT02310763|3957476|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
2275658|NCT02310763|3957477|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
2275659|NCT02310763|3957475|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1
2275660|NCT02310763|3957476|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0
2275661|NCT02310763|3957477|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0
2275662|NCT02310763|3957475|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
2275663|NCT02310763|3957476|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
2275664|NCT02310763|3957477|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
2275665|NCT02310789|3957507|FG000|Overall Study|Adverse Event|1
2275666|NCT02310906|3957515|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
2275667|NCT02310906|3957516|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
2275668|NCT02310906|3957517|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
2275669|NCT02310906|3957518|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2
2275670|NCT02310906|3957515|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
2275671|NCT02310906|3957516|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
2275672|NCT02310906|3957517|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2
2275673|NCT02310906|3957518|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4
2275674|NCT02310906|3957515|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
2199976|NCT01569438|3836099|FG001|Overall Study|Protocol Violation|0
2199977|NCT01569438|3836098|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1
2199978|NCT01569438|3836099|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0
2275675|NCT02310906|3957516|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
2275676|NCT02310906|3957517|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
2275677|NCT02310906|3957518|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1
2275678|NCT02310906|3957515|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
2275679|NCT02310906|3957516|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
2275680|NCT02310906|3957517|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
2275681|NCT02310906|3957518|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1
2275682|NCT02311153|3957541|FG000|Overall Study|Lost to Follow-up|5
2275683|NCT02311153|3957542|FG001|Overall Study|Lost to Follow-up|7
2275684|NCT02311361|3957565|FG000|Overall Study|Did not receive treatment|0
2275685|NCT02311361|3957566|FG001|Overall Study|Did not receive treatment|1
2275686|NCT02311361|3957567|FG002|Overall Study|Did not receive treatment|0
2275687|NCT02311361|3957568|FG003|Overall Study|Did not receive treatment|1
2275688|NCT02311478|3957582|FG000|Overall Study|Withdrawal by Subject|1
2275689|NCT02311478|3957582|FG000|Overall Study|Lost to Follow-up|5
2275690|NCT02311478|3957582|FG000|Overall Study|Failed IUD Insertion|1
2275691|NCT02311881|3957589|FG000|Overall Study|Did not meet the study criteria|2
2275692|NCT02311881|3957590|FG001|Overall Study|Did not meet the study criteria|2
2199979|NCT01569438|3836098|FG000|Overall Study|Sponsor/Physician decision|1
2199980|NCT01569438|3836099|FG001|Overall Study|Sponsor/Physician decision|1
2199981|NCT01569438|3836098|FG000|Overall Study|Unable to adhere to study schedule|0
2199982|NCT01569438|3836099|FG001|Overall Study|Unable to adhere to study schedule|1
2199983|NCT01569464|3836118|FG000|Overall Study|Adverse Event|4
2199984|NCT01569464|3836119|FG001|Overall Study|Adverse Event|0
2199985|NCT01569464|3836118|FG000|Overall Study|Lack of Efficacy|1
2199986|NCT01569464|3836119|FG001|Overall Study|Lack of Efficacy|0
2275693|NCT02311881|3957591|FG002|Overall Study|Did not meet the study criteria|0
2275694|NCT02311881|3957589|FG000|Overall Study|Adverse Event|7
2275695|NCT02311881|3957590|FG001|Overall Study|Adverse Event|15
2275696|NCT02311881|3957591|FG002|Overall Study|Adverse Event|8
2275697|NCT02311881|3957589|FG000|Overall Study|Lost to Follow-up|3
2275698|NCT02311881|3957590|FG001|Overall Study|Lost to Follow-up|3
2275699|NCT02311881|3957591|FG002|Overall Study|Lost to Follow-up|2
2275700|NCT02311881|3957589|FG000|Overall Study|Protocol Violation|1
2275701|NCT02311881|3957590|FG001|Overall Study|Protocol Violation|2
2275702|NCT02311881|3957591|FG002|Overall Study|Protocol Violation|3
2275703|NCT02311881|3957589|FG000|Overall Study|Withdrawal of consent|14
2275704|NCT02311881|3957590|FG001|Overall Study|Withdrawal of consent|16
2275705|NCT02311881|3957591|FG002|Overall Study|Withdrawal of consent|17
2275706|NCT02311881|3957589|FG000|Overall Study|Other|0
2275707|NCT02311881|3957590|FG001|Overall Study|Other|0
2275708|NCT02311881|3957591|FG002|Overall Study|Other|1
2275709|NCT02311881|3957589|FG000|Overall Study|Lack of Efficacy|1
2275710|NCT02311881|3957590|FG001|Overall Study|Lack of Efficacy|2
2275711|NCT02311881|3957591|FG002|Overall Study|Lack of Efficacy|0
2275712|NCT02311881|3957589|FG000|Overall Study|Subject has border line pregnancy test|1
2275713|NCT02311881|3957590|FG001|Overall Study|Subject has border line pregnancy test|0
2275714|NCT02311881|3957591|FG002|Overall Study|Subject has border line pregnancy test|0
2275715|NCT02311881|3957589|FG000|Overall Study|Withdrawal by Subject|3
2275716|NCT02311881|3957590|FG001|Overall Study|Withdrawal by Subject|1
2275717|NCT02311881|3957591|FG002|Overall Study|Withdrawal by Subject|4
2275718|NCT02311881|3957589|FG000|Overall Study|Sponsor Decision|1
2275719|NCT02311881|3957590|FG001|Overall Study|Sponsor Decision|1
2275720|NCT02311881|3957591|FG002|Overall Study|Sponsor Decision|1
2275721|NCT02311881|3957589|FG000|Overall Study|Protocol Deviation|1
2275722|NCT02311881|3957590|FG001|Overall Study|Protocol Deviation|0
2275723|NCT02311881|3957591|FG002|Overall Study|Protocol Deviation|0
2199987|NCT01569464|3836118|FG000|Overall Study|Protocol Violation|1
2199988|NCT01569464|3836119|FG001|Overall Study|Protocol Violation|0
2199989|NCT01569464|3836118|FG000|Overall Study|Lost to Follow-up|2
2199990|NCT01569464|3836119|FG001|Overall Study|Lost to Follow-up|3
2199991|NCT01569464|3836118|FG000|Overall Study|Withdrawal by Subject|1
2199992|NCT01569464|3836119|FG001|Overall Study|Withdrawal by Subject|1
2199993|NCT01569464|3836118|FG000|Overall Study|Other|1
2199994|NCT01569464|3836119|FG001|Overall Study|Other|1
2199995|NCT01569568|3836138|FG000|Overall Study|Physician Decision|0
2199996|NCT01569568|3836139|FG001|Overall Study|Physician Decision|2
2199997|NCT01569594|3836145|FG000|Overall Study|Physician Decision|4
2199998|NCT01569594|3836145|FG000|Overall Study|Death|13
2199999|NCT01569594|3836145|FG000|Overall Study|Lost to Follow-up|22
2200000|NCT01569594|3836145|FG000|Overall Study|Adverse Event|2
2200001|NCT01569594|3836145|FG000|Overall Study|Withdrawal by Subject|13
2200002|NCT01569594|3836145|FG000|Overall Study|Other|4
2200003|NCT01569594|3836145|FG000|Overall Study|No ECM used|9
2200004|NCT01569763|3836164|FG000|Overall Study|Lack of Efficacy|2
2200005|NCT01569763|3836165|FG001|Overall Study|Lack of Efficacy|7
2275724|NCT02311881|3957589|FG000|Overall Study|Non-Compliance|1
2275725|NCT02311881|3957590|FG001|Overall Study|Non-Compliance|0
2275726|NCT02311881|3957591|FG002|Overall Study|Non-Compliance|2
2275727|NCT02311881|3957589|FG000|Overall Study|Physician Decision|0
2275728|NCT02311881|3957590|FG001|Overall Study|Physician Decision|0
2275729|NCT02311881|3957591|FG002|Overall Study|Physician Decision|1
2200006|NCT01569763|3836164|FG000|Overall Study|Adverse Event|1
2200007|NCT01569763|3836165|FG001|Overall Study|Adverse Event|0
2200008|NCT01569841|3836199|FG000|Period A (6 Weeks)|Withdrawal by Subject|0
2200009|NCT01569841|3836200|FG001|Period A (6 Weeks)|Withdrawal by Subject|1
2200010|NCT01570192|3836219|FG000|Overall Study|no qualifying organism|6
2200011|NCT01570192|3836220|FG001|Overall Study|no qualifying organism|12
2200012|NCT01570192|3836219|FG000|Overall Study|changed to palliative care|1
2200013|NCT01570192|3836220|FG001|Overall Study|changed to palliative care|0
2200014|NCT01570192|3836219|FG000|Overall Study|Physician Decision|0
2200015|NCT01570192|3836220|FG001|Overall Study|Physician Decision|1
2200016|NCT01570244|3836231|FG000|Microgynon+Faldaprevir|Adverse Event|1
2200017|NCT01570283|3836240|FG000|Cohort 1: Dose Level 1|Death|0
2200018|NCT01570283|3836241|FG001|Cohort 1: Dose Level 1|Death|1
2200019|NCT01570283|3836242|FG002|Cohort 1: Dose Level 1|Death|0
2200020|NCT01570283|3836243|FG003|Cohort 1: Dose Level 1|Death|0
2200021|NCT01570283|3836244|FG004|Cohort 1: Dose Level 1|Death|0
2200022|NCT01570283|3836245|FG005|Cohort 1: Dose Level 1|Death|0
2200023|NCT01570283|3836240|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2200024|NCT01570283|3836241|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
2200025|NCT01570283|3836242|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2200026|NCT01570283|3836243|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2200027|NCT01570283|3836244|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2200028|NCT01570283|3836245|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2200029|NCT01570283|3836240|FG000|Cohort 2: Dose Level 2|Death|0
2200030|NCT01570283|3836241|FG001|Cohort 2: Dose Level 2|Death|0
2200031|NCT01570283|3836242|FG002|Cohort 2: Dose Level 2|Death|1
2200032|NCT01570283|3836243|FG003|Cohort 2: Dose Level 2|Death|0
2200033|NCT01570283|3836244|FG004|Cohort 2: Dose Level 2|Death|0
2200034|NCT01570283|3836245|FG005|Cohort 2: Dose Level 2|Death|0
2200035|NCT01570283|3836240|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2200036|NCT01570283|3836241|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2200037|NCT01570283|3836242|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2200038|NCT01570283|3836243|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
2200039|NCT01570283|3836244|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2200040|NCT01570283|3836245|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2200041|NCT01570283|3836240|FG000|Cohort 3: Dose Level 3|Death|0
2200042|NCT01570283|3836241|FG001|Cohort 3: Dose Level 3|Death|0
2200043|NCT01570283|3836242|FG002|Cohort 3: Dose Level 3|Death|0
2200044|NCT01570283|3836243|FG003|Cohort 3: Dose Level 3|Death|0
2200045|NCT01570283|3836244|FG004|Cohort 3: Dose Level 3|Death|0
2200046|NCT01570283|3836245|FG005|Cohort 3: Dose Level 3|Death|1
2200047|NCT01570283|3836240|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2200048|NCT01570283|3836241|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2200049|NCT01570283|3836242|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2200050|NCT01570283|3836243|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2200051|NCT01570283|3836244|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2200052|NCT01570283|3836245|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
2200053|NCT01570309|3836261|FG000|Overall Study|Withdrawal by Subject|3
2200054|NCT01570309|3836262|FG001|Overall Study|Withdrawal by Subject|3
2200055|NCT01570361|3836278|FG000|Overall Study|Subject discontinued|1
2200056|NCT01570361|3836279|FG001|Overall Study|Subject discontinued|2
2200057|NCT01570361|3836278|FG000|Overall Study|Sponsor closing the study|51
2200058|NCT01570361|3836279|FG001|Overall Study|Sponsor closing the study|50
2200059|NCT01570361|3836278|FG000|Overall Study|Subject excluded|5
2200060|NCT01570361|3836279|FG001|Overall Study|Subject excluded|3
2200061|NCT01570361|3836278|FG000|Overall Study|Subject withdrew consent|14
2200062|NCT01570361|3836279|FG001|Overall Study|Subject withdrew consent|9
2200063|NCT01570361|3836278|FG000|Overall Study|Adverse Event|2
2200064|NCT01570361|3836279|FG001|Overall Study|Adverse Event|1
2200065|NCT01570361|3836278|FG000|Overall Study|Lost to Follow-up|4
2200066|NCT01570361|3836279|FG001|Overall Study|Lost to Follow-up|4
2200067|NCT01570361|3836278|FG000|Overall Study|Death|5
2200068|NCT01570361|3836279|FG001|Overall Study|Death|4
2200069|NCT01570361|3836278|FG000|Overall Study|Other|0
2200070|NCT01570361|3836279|FG001|Overall Study|Other|2
2200071|NCT01570387|3836292|FG000|Overall Study|Adverse Event|1
2200072|NCT01570387|3836293|FG001|Overall Study|Adverse Event|0
2200073|NCT01570387|3836294|FG002|Overall Study|Adverse Event|0
2200074|NCT01570387|3836295|FG003|Overall Study|Adverse Event|0
2200075|NCT01570387|3836292|FG000|Overall Study|Death|0
2200076|NCT01570387|3836293|FG001|Overall Study|Death|0
2200077|NCT01570387|3836294|FG002|Overall Study|Death|0
2200078|NCT01570387|3836295|FG003|Overall Study|Death|1
2200079|NCT01570387|3836292|FG000|Overall Study|Withdrawal by Subject|0
2200080|NCT01570387|3836293|FG001|Overall Study|Withdrawal by Subject|0
2200081|NCT01570387|3836294|FG002|Overall Study|Withdrawal by Subject|0
2200082|NCT01570387|3836295|FG003|Overall Study|Withdrawal by Subject|1
2200083|NCT01570491|3836304|FG000|Overall Study|Lost to Follow-up|3
2200084|NCT01570491|3836305|FG001|Overall Study|Lost to Follow-up|1
2200085|NCT01570491|3836304|FG000|Overall Study|treatment: not given or discontinued|2
2200086|NCT01570491|3836305|FG001|Overall Study|treatment: not given or discontinued|0
2200087|NCT01570686|3836313|FG000|Overall Study|Abnormal test procedure result(s)|1
2200088|NCT01570686|3836314|FG001|Overall Study|Abnormal test procedure result(s)|1
2200089|NCT01570686|3836313|FG000|Overall Study|Administrative problems|0
2200090|NCT01570686|3836314|FG001|Overall Study|Administrative problems|1
2200091|NCT01570686|3836313|FG000|Overall Study|Adverse Event|8
2200092|NCT01570686|3836314|FG001|Overall Study|Adverse Event|6
2200093|NCT01570686|3836313|FG000|Overall Study|Lost to Follow-up|4
2200094|NCT01570686|3836314|FG001|Overall Study|Lost to Follow-up|3
2200095|NCT01570686|3836313|FG000|Overall Study|Protocol Deviation|3
2200096|NCT01570686|3836314|FG001|Overall Study|Protocol Deviation|0
2200097|NCT01570686|3836313|FG000|Overall Study|Withdrawal by Subject|4
2200098|NCT01570686|3836314|FG001|Overall Study|Withdrawal by Subject|4
2200099|NCT01570686|3836313|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2200100|NCT01570686|3836314|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2200101|NCT01570751|3836322|FG000|Period A (16 Weeks)|Protocol Violation|1
2200102|NCT01570751|3836323|FG001|Period A (16 Weeks)|Protocol Violation|1
2200103|NCT01570751|3836322|FG000|Period A (16 Weeks)|Withdrawal criteria|0
2200104|NCT01570751|3836323|FG001|Period A (16 Weeks)|Withdrawal criteria|1
2200105|NCT01570751|3836322|FG000|Period A (16 Weeks)|Unclassified|2
2200106|NCT01570751|3836323|FG001|Period A (16 Weeks)|Unclassified|3
2200107|NCT01570751|3836322|FG000|Period B (16 Weeks)|Adverse Event|1
2200108|NCT01570751|3836323|FG001|Period B (16 Weeks)|Adverse Event|0
2200109|NCT01570751|3836322|FG000|Period B (16 Weeks)|Protocol Violation|0
2200110|NCT01570751|3836323|FG001|Period B (16 Weeks)|Protocol Violation|1
2200111|NCT01570868|3836342|FG000|Overall Study|Adverse Event|8
2200112|NCT01570868|3836343|FG001|Overall Study|Adverse Event|1
2200113|NCT01570868|3836342|FG000|Overall Study|FDA Recommendation|23
2200114|NCT01570868|3836343|FG001|Overall Study|FDA Recommendation|3
2200115|NCT01570868|3836342|FG000|Overall Study|Physician Decision|10
2200116|NCT01570868|3836343|FG001|Overall Study|Physician Decision|4
2200117|NCT01570868|3836342|FG000|Overall Study|Lost to Follow-up|1
2200118|NCT01570868|3836343|FG001|Overall Study|Lost to Follow-up|0
2200119|NCT01570868|3836342|FG000|Overall Study|Withdrawal by Subject|1
2200120|NCT01570868|3836343|FG001|Overall Study|Withdrawal by Subject|0
2200121|NCT01571232|3836355|FG000|Overall Study|Lost to Follow-up|0
2200122|NCT01571232|3836356|FG001|Overall Study|Lost to Follow-up|1
2200123|NCT01571232|3836355|FG000|Overall Study|Withdrawal by Subject|1
2200124|NCT01571232|3836356|FG001|Overall Study|Withdrawal by Subject|0
2200125|NCT01571284|3836363|FG000|Overall Study|Participant's decision|84
2200126|NCT01571284|3836363|FG000|Overall Study|Lost to Follow-up|3
2200127|NCT01571284|3836363|FG000|Overall Study|Enrolled but not treated|2
2200128|NCT01571284|3836363|FG000|Overall Study|Other than specified above|80
2200129|NCT01571362|3836367|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
2200130|NCT01571362|3836368|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
2200131|NCT01571362|3836369|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
2200132|NCT01571362|3836367|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7
2200133|NCT01571362|3836368|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0
2200134|NCT01571362|3836369|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0
2200135|NCT01571362|3836367|FG000|Open-Label Conversion + Titration Period|Adverse Event|57
2200136|NCT01571362|3836368|FG001|Open-Label Conversion + Titration Period|Adverse Event|0
2200137|NCT01571362|3836369|FG002|Open-Label Conversion + Titration Period|Adverse Event|0
2200138|NCT01571362|3836367|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10
2200139|NCT01571362|3836368|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0
2200140|NCT01571362|3836369|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0
2200141|NCT01571362|3836367|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
2200142|NCT01571362|3836368|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
2200143|NCT01571362|3836369|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
2200144|NCT01571362|3836367|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3
2200145|NCT01571362|3836368|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0
2200146|NCT01571362|3836369|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0
2200147|NCT01571362|3836367|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
2200148|NCT01571362|3836368|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11
2200149|NCT01571362|3836369|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5
2200150|NCT01571362|3836367|FG000|Double-Blind Treatment Period|Protocol Violation|0
2200151|NCT01571362|3836368|FG001|Double-Blind Treatment Period|Protocol Violation|8
2200152|NCT01571362|3836369|FG002|Double-Blind Treatment Period|Protocol Violation|9
2200153|NCT01571362|3836367|FG000|Double-Blind Treatment Period|Adverse Event|0
2200154|NCT01571362|3836368|FG001|Double-Blind Treatment Period|Adverse Event|9
2200155|NCT01571362|3836369|FG002|Double-Blind Treatment Period|Adverse Event|14
2200156|NCT01571362|3836367|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
2200157|NCT01571362|3836368|FG001|Double-Blind Treatment Period|Lost to Follow-up|3
2200158|NCT01571362|3836369|FG002|Double-Blind Treatment Period|Lost to Follow-up|6
2200159|NCT01571362|3836367|FG000|Double-Blind Treatment Period|Insufficient clinical response|0
2200160|NCT01571362|3836368|FG001|Double-Blind Treatment Period|Insufficient clinical response|16
2200161|NCT01571362|3836369|FG002|Double-Blind Treatment Period|Insufficient clinical response|4
2200162|NCT01571362|3836367|FG000|Double-Blind Treatment Period|Other - unspecified|0
2200163|NCT01571362|3836368|FG001|Double-Blind Treatment Period|Other - unspecified|6
2200164|NCT01571362|3836369|FG002|Double-Blind Treatment Period|Other - unspecified|1
2200165|NCT01571453|3836388|FG000|Overall Study|Adverse Event|14
2200166|NCT01571453|3836389|FG001|Overall Study|Adverse Event|32
2200167|NCT01571453|3836388|FG000|Overall Study|Lack of Efficacy|8
2200168|NCT01571453|3836389|FG001|Overall Study|Lack of Efficacy|3
2200169|NCT01571453|3836388|FG000|Overall Study|Non-compliance|2
2200170|NCT01571453|3836389|FG001|Overall Study|Non-compliance|4
2200171|NCT01571453|3836388|FG000|Overall Study|Protocol Violation|1
2200172|NCT01571453|3836389|FG001|Overall Study|Protocol Violation|5
2200173|NCT01571453|3836388|FG000|Overall Study|Withdrawal of consent|5
2200174|NCT01571453|3836389|FG001|Overall Study|Withdrawal of consent|13
2200175|NCT01571453|3836388|FG000|Overall Study|Lost to Follow-up|4
2200176|NCT01571453|3836389|FG001|Overall Study|Lost to Follow-up|2
2200177|NCT01571453|3836388|FG000|Overall Study|Administrative or other reason(s)|4
2200178|NCT01571453|3836389|FG001|Overall Study|Administrative or other reason(s)|3
2200179|NCT01571596|3836402|FG000|Overall Study|Adverse Event|2
2200180|NCT01571596|3836403|FG001|Overall Study|Adverse Event|0
2200181|NCT01571596|3836404|FG002|Overall Study|Adverse Event|0
2200182|NCT01571596|3836402|FG000|Overall Study|Study Terminated by the Sponsor|0
2200183|NCT01571596|3836403|FG001|Overall Study|Study Terminated by the Sponsor|1
2200184|NCT01571596|3836404|FG002|Overall Study|Study Terminated by the Sponsor|1
2200185|NCT01572038|3836414|FG000|Overall Study|Death|648
2200186|NCT01572038|3836414|FG000|Overall Study|Withdrawal by Subject|204
2200187|NCT01572038|3836414|FG000|Overall Study|Lost to Follow-up|81
2200188|NCT01572038|3836414|FG000|Overall Study|Physician Decision|20
2200189|NCT01572038|3836414|FG000|Overall Study|Patient Decision|14
2200190|NCT01572038|3836414|FG000|Overall Study|Progressive Disease|8
2118099|NCT00949650|3715848|FG000|Overall Study|Completed 6 courses of chemotherapy|0
2118100|NCT00949650|3715849|FG001|Overall Study|Completed 6 courses of chemotherapy|60
2118101|NCT00949650|3715848|FG000|Overall Study|Other Adverse Event (AE)|28
2118102|NCT00949650|3715849|FG001|Overall Study|Other Adverse Event (AE)|17
2118103|NCT00949650|3715848|FG000|Overall Study|Protocol Violation|1
2118104|NCT00949650|3715849|FG001|Overall Study|Protocol Violation|4
2118105|NCT00949650|3715848|FG000|Overall Study|Refusal to continue medication|7
2118106|NCT00949650|3715849|FG001|Overall Study|Refusal to continue medication|11
2118107|NCT00949650|3715848|FG000|Overall Study|Not treated|1
2118108|NCT00949650|3715849|FG001|Overall Study|Not treated|4
2118109|NCT00949650|3715848|FG000|Overall Study|Other not specified above|5
2118110|NCT00949650|3715849|FG001|Overall Study|Other not specified above|0
2118111|NCT00949702|3715859|FG000|Overall Study|Death|40
2118112|NCT00949702|3715859|FG000|Overall Study|Disease progression|7
2200191|NCT01572038|3836414|FG000|Overall Study|Site Closed Before Completing Form|6
2200192|NCT01572038|3836414|FG000|Overall Study|Enrolled into Another Trial|3
2200193|NCT01572038|3836414|FG000|Overall Study|Participated in Another Trial|3
2200194|NCT01572038|3836414|FG000|Overall Study|Termination by Sponsor|2
2200195|NCT01572038|3836414|FG000|Overall Study|Patient Deterioration|1
2200196|NCT01572038|3836414|FG000|Overall Study|Sponsor Decision|1
2200197|NCT01572389|3836453|FG000|Overall Study|Death|1
2200198|NCT01572389|3836454|FG001|Overall Study|Death|3
2200199|NCT01572389|3836453|FG000|Overall Study|Withdrawal by Subject|14
2200200|NCT01572389|3836454|FG001|Overall Study|Withdrawal by Subject|2
2200201|NCT01572389|3836453|FG000|Overall Study|Lost to Follow-up|25
2200202|NCT01572389|3836454|FG001|Overall Study|Lost to Follow-up|14
2200203|NCT01572389|3836453|FG000|Overall Study|Only A1C or Assessment was Collected|6
2200204|NCT01572389|3836454|FG001|Overall Study|Only A1C or Assessment was Collected|2
2200205|NCT01572727|3836471|FG000|Overall Study|Adverse Event|43
2200206|NCT01572727|3836472|FG001|Overall Study|Adverse Event|15
2200207|NCT01572727|3836471|FG000|Overall Study|Lost to Follow-up|1
2200208|NCT01572727|3836472|FG001|Overall Study|Lost to Follow-up|1
2200209|NCT01572727|3836471|FG000|Overall Study|Physician Decision|23
2200210|NCT01572727|3836472|FG001|Overall Study|Physician Decision|9
2200211|NCT01572727|3836471|FG000|Overall Study|Progressive disease|59
2200212|NCT01572727|3836472|FG001|Overall Study|Progressive disease|82
2200213|NCT01572727|3836471|FG000|Overall Study|Protocol Violation|0
2200214|NCT01572727|3836472|FG001|Overall Study|Protocol Violation|1
2200215|NCT01572727|3836471|FG000|Overall Study|Study terminated by sponsor|61
2200216|NCT01572727|3836472|FG001|Overall Study|Study terminated by sponsor|83
2200217|NCT01572727|3836471|FG000|Overall Study|Parent/guardian decision|14
2200218|NCT01572727|3836472|FG001|Overall Study|Parent/guardian decision|9
2200219|NCT01572727|3836471|FG000|Overall Study|Death|2
2200220|NCT01572727|3836472|FG001|Overall Study|Death|2
2275730|NCT02311881|3957589|FG000|Overall Study|Medical Monitor Discretion|0
2275731|NCT02311881|3957590|FG001|Overall Study|Medical Monitor Discretion|0
2275732|NCT02311881|3957591|FG002|Overall Study|Medical Monitor Discretion|1
2275733|NCT02311881|3957589|FG000|Overall Study|Participant taking another medication|0
2275734|NCT02311881|3957590|FG001|Overall Study|Participant taking another medication|0
2275735|NCT02311881|3957591|FG002|Overall Study|Participant taking another medication|1
2275736|NCT02311881|3957589|FG000|Overall Study|Serious Adverse Event|0
2275737|NCT02311881|3957590|FG001|Overall Study|Serious Adverse Event|1
2275738|NCT02311881|3957591|FG002|Overall Study|Serious Adverse Event|0
2275739|NCT02311894|3957602|FG000|Overall Study|Discontinued in error|1
2118113|NCT00949702|3715859|FG000|Overall Study|Withdrawal of consent|1
2200221|NCT01572727|3836471|FG000|Overall Study|Untreated|4
2200222|NCT01572727|3836472|FG001|Overall Study|Untreated|7
2200223|NCT01572740|3836480|FG000|Overall Study|Adverse Event|1
2200224|NCT01572740|3836481|FG001|Overall Study|Adverse Event|1
2275740|NCT02311894|3957602|FG000|Overall Study|Lost to Follow-up|1
2275741|NCT02311894|3957602|FG000|Overall Study|Adverse Event|1
2275742|NCT02311894|3957602|FG000|Overall Study|Withdrawal by Subject|1
2275743|NCT02312063|3957636|FG000|Overall Study|Withdrawal by Subject|0
2275744|NCT02312063|3957637|FG001|Overall Study|Withdrawal by Subject|1
2275745|NCT02312206|3957651|FG000|Overall Study|Adverse Event|3
2275746|NCT02312206|3957652|FG001|Overall Study|Adverse Event|6
2275747|NCT02312206|3957651|FG000|Overall Study|Withdrawal by Subject|7
2275748|NCT02312206|3957652|FG001|Overall Study|Withdrawal by Subject|6
2275749|NCT02312206|3957651|FG000|Overall Study|Physician Decision|7
2275750|NCT02312206|3957652|FG001|Overall Study|Physician Decision|6
2275751|NCT02312206|3957651|FG000|Overall Study|Death|30
2275752|NCT02312206|3957652|FG001|Overall Study|Death|36
2275753|NCT02312206|3957651|FG000|Overall Study|Study Terminated by Sponsor|81
2275754|NCT02312206|3957652|FG001|Overall Study|Study Terminated by Sponsor|74
2275755|NCT02312206|3957651|FG000|Overall Study|Disease Progression|1
2275756|NCT02312206|3957652|FG001|Overall Study|Disease Progression|0
2275757|NCT02312206|3957651|FG000|Overall Study|Patient progression and new therapy|1
2275758|NCT02312206|3957652|FG001|Overall Study|Patient progression and new therapy|0
2275759|NCT02312206|3957651|FG000|Overall Study|Patient transferred to hospice|0
2275760|NCT02312206|3957652|FG001|Overall Study|Patient transferred to hospice|1
2275761|NCT02312206|3957651|FG000|Overall Study|Subject missed 3 consecutive tx visits|0
2275762|NCT02312206|3957652|FG001|Overall Study|Subject missed 3 consecutive tx visits|1
2275763|NCT02312219|3957660|FG000|Overall Study|Withdrawal by Subject|1
2275764|NCT02312219|3957661|FG001|Overall Study|Withdrawal by Subject|2
2275765|NCT02312219|3957660|FG000|Overall Study|could not schedule imaging in time|0
2275766|NCT02312219|3957661|FG001|Overall Study|could not schedule imaging in time|2
2275767|NCT02312219|3957660|FG000|Overall Study|Other|0
2275768|NCT02312219|3957661|FG001|Overall Study|Other|1
2275769|NCT02312219|3957660|FG000|Overall Study|Not randomized. Ineligible|0
2275770|NCT02312219|3957661|FG001|Overall Study|Not randomized. Ineligible|1
2275771|NCT02312687|3957704|FG000|Overall Study|Other, Not Specified|1
2275772|NCT02312856|3957748|FG000|Overall Study|Death|1
2275773|NCT02312856|3957748|FG000|Overall Study|Lost to Follow-up|3
2275774|NCT02312934|3957758|FG000|Overall Study|Lost to Follow-up|1
2275775|NCT02312934|3957759|FG001|Overall Study|Lost to Follow-up|0
2275776|NCT02312934|3957758|FG000|Overall Study|Physician Decision|1
2275777|NCT02312934|3957759|FG001|Overall Study|Physician Decision|0
2275778|NCT02313155|3957772|FG000|Overall Study|Lost to Follow-up|0
2275779|NCT02313155|3957773|FG001|Overall Study|Lost to Follow-up|1
2275780|NCT02313233|3957781|FG000|Overall Study|Withdrawal by Subject|1
2275781|NCT02313233|3957782|FG001|Overall Study|Withdrawal by Subject|2
2275782|NCT02313233|3957781|FG000|Overall Study|Administrative reason|1
2275783|NCT02313233|3957782|FG001|Overall Study|Administrative reason|1
2275784|NCT02313558|3957809|FG000|Overall Study|Withdrawal by Subject|2
2275785|NCT02313558|3957810|FG001|Overall Study|Withdrawal by Subject|0
2275786|NCT02313558|3957809|FG000|Overall Study|Lost to Follow-up|4
2275787|NCT02313558|3957810|FG001|Overall Study|Lost to Follow-up|4
2275788|NCT02313766|3957845|FG000|Overall Study|surgery cancelled|1
2275789|NCT02313766|3957846|FG001|Overall Study|surgery cancelled|0
2275790|NCT02313766|3957847|FG002|Overall Study|surgery cancelled|0
2275791|NCT02313766|3957845|FG000|Overall Study|Lost to Follow-up|0
2275792|NCT02313766|3957846|FG001|Overall Study|Lost to Follow-up|2
2275793|NCT02313766|3957847|FG002|Overall Study|Lost to Follow-up|0
2275794|NCT02313766|3957845|FG000|Overall Study|Adverse Event|0
2275795|NCT02313766|3957846|FG001|Overall Study|Adverse Event|1
2275796|NCT02313766|3957847|FG002|Overall Study|Adverse Event|0
2275797|NCT02313909|3957857|FG000|Overall Study|Consent withdrawn by participant|33
2275798|NCT02313909|3957858|FG001|Overall Study|Consent withdrawn by participant|33
2275799|NCT02313909|3957857|FG000|Overall Study|Lost to Follow-up|24
2275800|NCT02313909|3957858|FG001|Overall Study|Lost to Follow-up|17
2275801|NCT02314026|3957874|FG000|Overall Study|Protocol Violation|28
2275802|NCT02314052|3957878|FG000|Cycle One|Adverse Event|0
2275803|NCT02314052|3957879|FG001|Cycle One|Adverse Event|0
2275804|NCT02314052|3957880|FG002|Cycle One|Adverse Event|0
2275805|NCT02314052|3957881|FG003|Cycle One|Adverse Event|1
2275806|NCT02314052|3957882|FG004|Cycle One|Adverse Event|0
2275807|NCT02314052|3957883|FG005|Cycle One|Adverse Event|0
2275808|NCT02314117|3957912|FG000|Overall Study|Lost to Follow-up|9
2275809|NCT02314117|3957913|FG001|Overall Study|Lost to Follow-up|14
2275810|NCT02314117|3957912|FG000|Overall Study|Withdrawal by Subject|3
2275811|NCT02314117|3957913|FG001|Overall Study|Withdrawal by Subject|2
2275812|NCT02314143|3957923|FG000|Overall Study|Adverse Event|0
2275813|NCT02314143|3957924|FG001|Overall Study|Adverse Event|6
2275814|NCT02314143|3957925|FG002|Overall Study|Adverse Event|4
2275815|NCT02314143|3957923|FG000|Overall Study|Other (Study Closed/Terminated)|5
2275816|NCT02314143|3957924|FG001|Overall Study|Other (Study Closed/Terminated)|3
2200225|NCT01572740|3836480|FG000|Overall Study|Withdrawal by Subject|1
2200226|NCT01572740|3836481|FG001|Overall Study|Withdrawal by Subject|1
2275817|NCT02314143|3957925|FG002|Overall Study|Other (Study Closed/Terminated)|4
2275818|NCT02314143|3957923|FG000|Overall Study|Physician Decision|2
2275819|NCT02314143|3957924|FG001|Overall Study|Physician Decision|1
2200227|NCT01572740|3836480|FG000|Overall Study|unclassified|4
2200228|NCT01572740|3836481|FG001|Overall Study|unclassified|3
2200229|NCT01572792|3836492|FG000|Lead-in Study|Lost to Follow-up|5
2200230|NCT01572792|3836493|FG001|Lead-in Study|Lost to Follow-up|9
2200231|NCT01572792|3836494|FG002|Lead-in Study|Lost to Follow-up|4
2200232|NCT01572792|3836495|FG003|Lead-in Study|Lost to Follow-up|2
2200233|NCT01572792|3836496|FG004|Lead-in Study|Lost to Follow-up|4
2200234|NCT01572792|3836492|FG000|Lead-in Study|Withdrawal by Subject|22
2200235|NCT01572792|3836493|FG001|Lead-in Study|Withdrawal by Subject|11
2200236|NCT01572792|3836494|FG002|Lead-in Study|Withdrawal by Subject|12
2200237|NCT01572792|3836495|FG003|Lead-in Study|Withdrawal by Subject|24
2200238|NCT01572792|3836496|FG004|Lead-in Study|Withdrawal by Subject|11
2200239|NCT01572792|3836492|FG000|Lead-in Study|Protocol Violation|19
2200240|NCT01572792|3836493|FG001|Lead-in Study|Protocol Violation|10
2200241|NCT01572792|3836494|FG002|Lead-in Study|Protocol Violation|12
2200242|NCT01572792|3836495|FG003|Lead-in Study|Protocol Violation|13
2200243|NCT01572792|3836496|FG004|Lead-in Study|Protocol Violation|21
2200244|NCT01572792|3836492|FG000|Lead-in Study|Lack of Efficacy|20
2200245|NCT01572792|3836493|FG001|Lead-in Study|Lack of Efficacy|5
2200246|NCT01572792|3836494|FG002|Lead-in Study|Lack of Efficacy|4
2200247|NCT01572792|3836495|FG003|Lead-in Study|Lack of Efficacy|8
2200248|NCT01572792|3836496|FG004|Lead-in Study|Lack of Efficacy|10
2200249|NCT01572792|3836492|FG000|Lead-in Study|Adverse Event|21
2200250|NCT01572792|3836493|FG001|Lead-in Study|Adverse Event|21
2200251|NCT01572792|3836494|FG002|Lead-in Study|Adverse Event|22
2200252|NCT01572792|3836495|FG003|Lead-in Study|Adverse Event|16
2275820|NCT02314143|3957925|FG002|Overall Study|Physician Decision|0
2275821|NCT02314143|3957923|FG000|Overall Study|Withdrawal by Subject|1
2275822|NCT02314143|3957924|FG001|Overall Study|Withdrawal by Subject|0
2275823|NCT02314143|3957925|FG002|Overall Study|Withdrawal by Subject|1
2275824|NCT02314247|3957936|FG000|Overall Study|Adverse Event|2
2275825|NCT02314247|3957937|FG001|Overall Study|Adverse Event|1
2275826|NCT02314247|3957938|FG002|Overall Study|Adverse Event|0
2275827|NCT02314247|3957936|FG000|Overall Study|Withdrawal by Subject|1
2275828|NCT02314247|3957937|FG001|Overall Study|Withdrawal by Subject|3
2275829|NCT02314247|3957938|FG002|Overall Study|Withdrawal by Subject|1
2275830|NCT02314247|3957936|FG000|Overall Study|Progression of Disease|6
2275831|NCT02314247|3957937|FG001|Overall Study|Progression of Disease|2
2275832|NCT02314247|3957938|FG002|Overall Study|Progression of Disease|0
2275833|NCT02314637|3957985|FG000|Overall Study|Adverse Event|4
2275834|NCT02314637|3957986|FG001|Overall Study|Adverse Event|8
2275835|NCT02314637|3957985|FG000|Overall Study|Lack of Efficacy|1
2275836|NCT02314637|3957986|FG001|Overall Study|Lack of Efficacy|0
2275837|NCT02314637|3957985|FG000|Overall Study|Physician Decision|5
2275838|NCT02314637|3957986|FG001|Overall Study|Physician Decision|2
2275839|NCT02314637|3957985|FG000|Overall Study|Withdrawal by Subject|5
2275840|NCT02314637|3957986|FG001|Overall Study|Withdrawal by Subject|4
2275841|NCT02314637|3957985|FG000|Overall Study|Other Reason|1
2275842|NCT02314637|3957986|FG001|Overall Study|Other Reason|0
2275843|NCT02314728|3957998|FG000|Overall Study|Protocol Violation|1
2275844|NCT02314728|3957999|FG001|Overall Study|Protocol Violation|0
2275845|NCT02314728|3957998|FG000|Overall Study|Lost to Follow-up|0
2275846|NCT02314728|3957999|FG001|Overall Study|Lost to Follow-up|1
2275847|NCT02314780|3958010|FG000|Overall Study|organizational reasons|0
2275848|NCT02314780|3958011|FG001|Overall Study|organizational reasons|2
2275849|NCT02314780|3958012|FG002|Overall Study|organizational reasons|0
2275850|NCT02314780|3958010|FG000|Overall Study|Adverse Event|0
2275851|NCT02314780|3958011|FG001|Overall Study|Adverse Event|1
2275852|NCT02314780|3958012|FG002|Overall Study|Adverse Event|0
2275853|NCT02315560|3958090|FG000|Overall Study|noncompliance by subjects|3
2275854|NCT02315625|3958096|FG000|First Intervention|Disease Progression|1
2275855|NCT02315625|3958097|FG001|First Intervention|Disease Progression|0
2275856|NCT02315625|3958096|FG000|Second Intervention|Physician Decision|2
2275857|NCT02315625|3958097|FG001|Second Intervention|Physician Decision|1
2275858|NCT02315625|3958096|FG000|Second Intervention|Study closure|1
2275859|NCT02315625|3958097|FG001|Second Intervention|Study closure|0
2275860|NCT02315625|3958096|FG000|Second Intervention|Disease Progression|1
2275861|NCT02315625|3958097|FG001|Second Intervention|Disease Progression|0
2275862|NCT02315664|3958107|FG000|Overall Study|Lost to Follow-up|1
2275863|NCT02315664|3958108|FG001|Overall Study|Lost to Follow-up|1
2275864|NCT02315664|3958107|FG000|Overall Study|Withdrawal by Subject|0
2275865|NCT02315664|3958108|FG001|Overall Study|Withdrawal by Subject|3
2320581|NCT02951533|4034901|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0
2320582|NCT02951533|4034899|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
2320583|NCT02951533|4034900|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
2320584|NCT02951533|4034901|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
2320585|NCT02951533|4034899|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0
2320586|NCT02951533|4034900|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2
2320587|NCT02951533|4034901|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0
2320588|NCT02951533|4034899|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
2320589|NCT02951533|4034900|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
2320590|NCT02951533|4034901|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
2200253|NCT01572792|3836496|FG004|Lead-in Study|Adverse Event|14
2200254|NCT01572792|3836492|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14
2200255|NCT01572792|3836493|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10
2200256|NCT01572792|3836494|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8
2200257|NCT01572792|3836495|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9
2200258|NCT01572792|3836496|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9
2322387|NCT02971670|4037400|FG001|Overall Study|Withdrawal by Subject|1
2200259|NCT01572792|3836492|FG000|Extension Study|Lost to Follow-up|6
2200260|NCT01572792|3836493|FG001|Extension Study|Lost to Follow-up|2
2200261|NCT01572792|3836494|FG002|Extension Study|Lost to Follow-up|0
2200262|NCT01572792|3836495|FG003|Extension Study|Lost to Follow-up|3
2200263|NCT01572792|3836496|FG004|Extension Study|Lost to Follow-up|3
2200264|NCT01572792|3836492|FG000|Extension Study|Withdrawal by Subject|7
2200265|NCT01572792|3836493|FG001|Extension Study|Withdrawal by Subject|6
2200266|NCT01572792|3836494|FG002|Extension Study|Withdrawal by Subject|11
2200267|NCT01572792|3836495|FG003|Extension Study|Withdrawal by Subject|8
2200268|NCT01572792|3836496|FG004|Extension Study|Withdrawal by Subject|14
2200269|NCT01572792|3836492|FG000|Extension Study|Protocol Violation|0
2200270|NCT01572792|3836493|FG001|Extension Study|Protocol Violation|4
2200271|NCT01572792|3836494|FG002|Extension Study|Protocol Violation|3
2200272|NCT01572792|3836495|FG003|Extension Study|Protocol Violation|4
2200273|NCT01572792|3836496|FG004|Extension Study|Protocol Violation|3
2200274|NCT01572792|3836492|FG000|Extension Study|Lack of Efficacy|2
2200275|NCT01572792|3836493|FG001|Extension Study|Lack of Efficacy|3
2200276|NCT01572792|3836494|FG002|Extension Study|Lack of Efficacy|3
2200277|NCT01572792|3836495|FG003|Extension Study|Lack of Efficacy|2
2200278|NCT01572792|3836496|FG004|Extension Study|Lack of Efficacy|2
2200279|NCT01572792|3836492|FG000|Extension Study|Adverse Event|7
2200280|NCT01572792|3836493|FG001|Extension Study|Adverse Event|6
2200281|NCT01572792|3836494|FG002|Extension Study|Adverse Event|5
2200282|NCT01572792|3836495|FG003|Extension Study|Adverse Event|6
2200283|NCT01572792|3836496|FG004|Extension Study|Adverse Event|4
2200284|NCT01572792|3836492|FG000|Extension Study|Site termination/COPD exacerbation/other|3
2200285|NCT01572792|3836493|FG001|Extension Study|Site termination/COPD exacerbation/other|8
2200286|NCT01572792|3836494|FG002|Extension Study|Site termination/COPD exacerbation/other|4
2200287|NCT01572792|3836495|FG003|Extension Study|Site termination/COPD exacerbation/other|6
2200288|NCT01572792|3836496|FG004|Extension Study|Site termination/COPD exacerbation/other|6
2200289|NCT01572844|3836509|FG000|Overall Study|Physician Decision|1
2200290|NCT01572844|3836510|FG001|Overall Study|Physician Decision|1
2200291|NCT01572909|3836521|FG000|Overall Study|Adverse Event|7
2200292|NCT01572909|3836522|FG001|Overall Study|Adverse Event|2
2200293|NCT01572909|3836521|FG000|Overall Study|Death|3
2200294|NCT01572909|3836522|FG001|Overall Study|Death|1
2200295|NCT01572909|3836521|FG000|Overall Study|Lost to Follow-up|8
2200296|NCT01572909|3836522|FG001|Overall Study|Lost to Follow-up|7
2200297|NCT01572909|3836521|FG000|Overall Study|Physician Decision|1
2200298|NCT01572909|3836522|FG001|Overall Study|Physician Decision|1
2200299|NCT01572909|3836521|FG000|Overall Study|Technical Issues|1
2200300|NCT01572909|3836522|FG001|Overall Study|Technical Issues|0
2200301|NCT01572909|3836521|FG000|Overall Study|Withdrawal by Subject|12
2200302|NCT01572909|3836522|FG001|Overall Study|Withdrawal by Subject|11
2200303|NCT01572909|3836521|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0
2200304|NCT01572909|3836522|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3
2200305|NCT01572922|3836530|FG000|Overall Study|Adverse Event|1
2200306|NCT01572922|3836530|FG000|Overall Study|Protocol Violation|1
2200307|NCT01572922|3836530|FG000|Overall Study|Death|1
2200308|NCT01572948|3836541|FG000|Overall Study|Lost to Follow-up|1
2200309|NCT01572948|3836542|FG001|Overall Study|Lost to Follow-up|0
2200310|NCT01572948|3836541|FG000|Overall Study|unable to contact|0
2200311|NCT01572948|3836542|FG001|Overall Study|unable to contact|1
2200312|NCT01573000|3836554|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
2200313|NCT01573000|3836555|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
2200314|NCT01573000|3836554|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
2200315|NCT01573000|3836555|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
2200316|NCT01573000|3836554|FG000|Dosimetric and Therapeutic Treatment|Death|0
2200317|NCT01573000|3836555|FG001|Dosimetric and Therapeutic Treatment|Death|1
2200318|NCT01573000|3836554|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
2200319|NCT01573000|3836555|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
2200320|NCT01573000|3836554|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
2200321|NCT01573000|3836555|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
2200322|NCT01573000|3836554|FG000|Crossover Phase|Lack of Efficacy|0
2200323|NCT01573000|3836555|FG001|Crossover Phase|Lack of Efficacy|13
2200324|NCT01573000|3836554|FG000|Crossover Phase|Lost to Follow-up|0
2200325|NCT01573000|3836555|FG001|Crossover Phase|Lost to Follow-up|2
2200326|NCT01573000|3836554|FG000|Crossover Phase|Death|0
2200327|NCT01573000|3836555|FG001|Crossover Phase|Death|3
2200328|NCT01573000|3836554|FG000|Long-Term Follow-Up|Death|3
2200329|NCT01573000|3836555|FG001|Long-Term Follow-Up|Death|0
2200330|NCT01573000|3836554|FG000|Long-Term Follow-Up|Lost to Follow-up|0
2200331|NCT01573000|3836555|FG001|Long-Term Follow-Up|Lost to Follow-up|1
2200332|NCT01573442|3836643|FG000|Overall Study|Cancels|9
2200333|NCT01573442|3836644|FG001|Overall Study|Cancels|10
2217659|NCT01709305|3860929|FG001|Phase 1|Travel, moving, etc.|0
2200334|NCT01573624|3836658|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2200335|NCT01573624|3836659|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2200336|NCT01573624|3836660|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
2200337|NCT01573624|3836661|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2200338|NCT01573624|3836662|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2200339|NCT01573624|3836663|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
2200340|NCT01573624|3836664|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2200341|NCT01573624|3836658|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
2200342|NCT01573624|3836659|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
2200343|NCT01573624|3836660|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
2200344|NCT01573624|3836661|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
2200345|NCT01573624|3836662|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
2200346|NCT01573624|3836663|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
2200347|NCT01573624|3836664|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
2200348|NCT01573624|3836658|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
2200349|NCT01573624|3836659|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2200350|NCT01573624|3836660|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2200351|NCT01573624|3836661|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2200352|NCT01573624|3836662|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2200353|NCT01573624|3836663|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2200354|NCT01573624|3836664|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2200355|NCT01573624|3836658|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2200356|NCT01573624|3836659|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2200357|NCT01573624|3836660|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2200358|NCT01573624|3836661|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2200359|NCT01573624|3836662|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2200360|NCT01573624|3836663|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
2200361|NCT01573624|3836664|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2200362|NCT01573624|3836658|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
2200363|NCT01573624|3836659|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
2200364|NCT01573624|3836660|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2200365|NCT01573624|3836661|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2200366|NCT01573624|3836662|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
2200367|NCT01573624|3836663|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2200368|NCT01573624|3836664|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2200369|NCT01573624|3836658|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2200370|NCT01573624|3836659|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2200371|NCT01573624|3836660|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2200372|NCT01573624|3836661|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2200373|NCT01573624|3836662|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2200374|NCT01573624|3836663|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
2200375|NCT01573624|3836664|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2200376|NCT01573624|3836658|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2200377|NCT01573624|3836659|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
2200378|NCT01573624|3836660|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2200379|NCT01573624|3836661|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
2200380|NCT01573624|3836662|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2200381|NCT01573624|3836663|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2200382|NCT01573624|3836664|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
2200383|NCT01573624|3836658|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
2200384|NCT01573624|3836659|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2200385|NCT01573624|3836660|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
2200386|NCT01573624|3836661|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
2200387|NCT01573624|3836662|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2200388|NCT01573624|3836663|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2200389|NCT01573624|3836664|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2200390|NCT01573624|3836658|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2200391|NCT01573624|3836659|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2200392|NCT01573624|3836660|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2200393|NCT01573624|3836661|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2200394|NCT01573624|3836662|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2200395|NCT01573624|3836663|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
2200396|NCT01573624|3836664|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2200397|NCT01573624|3836658|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2200398|NCT01573624|3836659|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2200399|NCT01573624|3836660|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2200400|NCT01573624|3836661|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
2200401|NCT01573624|3836662|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2200402|NCT01573624|3836663|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2200403|NCT01573624|3836664|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2200404|NCT01573624|3836658|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2200405|NCT01573624|3836659|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2200406|NCT01573624|3836660|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
2200407|NCT01573624|3836661|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
2200408|NCT01573624|3836662|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2200409|NCT01573624|3836663|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
2200410|NCT01573624|3836664|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2200411|NCT01573624|3836658|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
2200412|NCT01573624|3836659|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
2200413|NCT01573624|3836660|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
2200414|NCT01573624|3836661|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
2200415|NCT01573624|3836662|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
2200416|NCT01573624|3836663|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
2200417|NCT01573624|3836664|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
2200418|NCT01573624|3836658|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2200419|NCT01573624|3836659|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
2200420|NCT01573624|3836660|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2200421|NCT01573624|3836661|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2200422|NCT01573624|3836662|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2200423|NCT01573624|3836663|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
2200424|NCT01573624|3836664|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2200425|NCT01573624|3836658|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
2200426|NCT01573624|3836659|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2200427|NCT01573624|3836660|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2200428|NCT01573624|3836661|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2200429|NCT01573624|3836662|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2200430|NCT01573624|3836663|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2200431|NCT01573624|3836664|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2200432|NCT01573624|3836658|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2200433|NCT01573624|3836659|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2200434|NCT01573624|3836660|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2200435|NCT01573624|3836661|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2200436|NCT01573624|3836662|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2200437|NCT01573624|3836663|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2200438|NCT01573624|3836664|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2200439|NCT01573624|3836658|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
2200440|NCT01573624|3836659|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2200441|NCT01573624|3836660|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2200442|NCT01573624|3836661|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2200443|NCT01573624|3836662|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2200444|NCT01573624|3836663|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2200445|NCT01573624|3836664|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2200446|NCT01573624|3836658|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
2200447|NCT01573624|3836659|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2200448|NCT01573624|3836660|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2200449|NCT01573624|3836661|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2200450|NCT01573624|3836662|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2200451|NCT01573624|3836663|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2200452|NCT01573624|3836664|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
2200453|NCT01573624|3836658|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
2200454|NCT01573624|3836659|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2200455|NCT01573624|3836660|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2200456|NCT01573624|3836661|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2200457|NCT01573624|3836662|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2200458|NCT01573624|3836663|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
2200459|NCT01573624|3836664|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2200460|NCT01573624|3836658|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2200461|NCT01573624|3836659|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
2200462|NCT01573624|3836660|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2200463|NCT01573624|3836661|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2200464|NCT01573624|3836662|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2200465|NCT01573624|3836663|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2200466|NCT01573624|3836664|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2200467|NCT01573624|3836658|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2200468|NCT01573624|3836659|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
2200469|NCT01573624|3836660|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2200470|NCT01573624|3836661|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2200471|NCT01573624|3836662|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2200472|NCT01573624|3836663|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2200473|NCT01573624|3836664|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2200474|NCT01573624|3836658|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2200475|NCT01573624|3836659|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2200476|NCT01573624|3836660|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2200477|NCT01573624|3836661|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2200478|NCT01573624|3836662|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2200479|NCT01573624|3836663|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2200480|NCT01573624|3836664|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2275866|NCT02316171|3958141|FG000|Overall Study|difficulties with urinary catheter|1
2275867|NCT02316171|3958142|FG001|Overall Study|difficulties with urinary catheter|0
2275868|NCT02316171|3958143|FG002|Overall Study|difficulties with urinary catheter|0
2275869|NCT02316171|3958144|FG003|Overall Study|difficulties with urinary catheter|0
2275870|NCT02316223|3958153|FG000|Overall Study|Lack of Efficacy|0
2275871|NCT02316223|3958154|FG001|Overall Study|Lack of Efficacy|1
2275872|NCT02316223|3958155|FG002|Overall Study|Lack of Efficacy|1
2275873|NCT02316223|3958153|FG000|Overall Study|Lost to Follow-up|27
2275874|NCT02316223|3958154|FG001|Overall Study|Lost to Follow-up|34
2275875|NCT02316223|3958155|FG002|Overall Study|Lost to Follow-up|36
2275876|NCT02316223|3958153|FG000|Overall Study|COPD Diagnosis|3
2275877|NCT02316223|3958154|FG001|Overall Study|COPD Diagnosis|2
2275878|NCT02316223|3958155|FG002|Overall Study|COPD Diagnosis|3
2275879|NCT02316223|3958153|FG000|Overall Study|Reside outside study area|1
2275880|NCT02316223|3958154|FG001|Overall Study|Reside outside study area|1
2275881|NCT02316223|3958155|FG002|Overall Study|Reside outside study area|1
2275882|NCT02316223|3958153|FG000|Overall Study|No asthma|2
2275883|NCT02316223|3958154|FG001|Overall Study|No asthma|0
2275884|NCT02316223|3958155|FG002|Overall Study|No asthma|0
2275885|NCT02316223|3958153|FG000|Overall Study|Discontinued by PI|11
2275886|NCT02316223|3958154|FG001|Overall Study|Discontinued by PI|19
2275887|NCT02316223|3958155|FG002|Overall Study|Discontinued by PI|3
2275888|NCT02316353|3958165|FG000|Overall Study|Pregnancy|1
2275889|NCT02316353|3958166|FG001|Overall Study|Pregnancy|3
2275890|NCT02316353|3958165|FG000|Overall Study|Adverse Event|1
2275891|NCT02316353|3958166|FG001|Overall Study|Adverse Event|3
2275892|NCT02316353|3958165|FG000|Overall Study|Withdrawal by Subject|6
2275893|NCT02316353|3958166|FG001|Overall Study|Withdrawal by Subject|2
2275894|NCT02316548|3958203|FG000|Overall Study|Protocol Violation|0
2275895|NCT02316548|3958204|FG001|Overall Study|Protocol Violation|1
2275896|NCT02316613|3958210|FG000|Overall Study|Death|63
2275897|NCT02316613|3958210|FG000|Overall Study|Lost to Follow-up|9
2275898|NCT02316613|3958210|FG000|Overall Study|Lymphoma transformation|2
2275899|NCT02316613|3958210|FG000|Overall Study|Participant moved/changed medical team|11
2275900|NCT02316613|3958210|FG000|Overall Study|No data and duplicate cases|5
2275901|NCT02316613|3958210|FG000|Overall Study|Did not met selection criteria|14
2275902|NCT02316717|3958237|FG000|Overall Study|Adverse Event|2
2275903|NCT02316717|3958238|FG001|Overall Study|Adverse Event|2
2275904|NCT02316717|3958239|FG002|Overall Study|Adverse Event|0
2275905|NCT02316717|3958237|FG000|Overall Study|Lost to Follow-up|1
2275906|NCT02316717|3958238|FG001|Overall Study|Lost to Follow-up|2
2275907|NCT02316717|3958239|FG002|Overall Study|Lost to Follow-up|1
2275908|NCT02316717|3958237|FG000|Overall Study|Non compliance|3
2275909|NCT02316717|3958238|FG001|Overall Study|Non compliance|1
2275910|NCT02316717|3958239|FG002|Overall Study|Non compliance|0
2275911|NCT02316717|3958237|FG000|Overall Study|Protocol Violation|2
2275912|NCT02316717|3958238|FG001|Overall Study|Protocol Violation|0
2275913|NCT02316717|3958239|FG002|Overall Study|Protocol Violation|0
2275914|NCT02316717|3958237|FG000|Overall Study|Withdrawal by Subject|2
2275915|NCT02316717|3958238|FG001|Overall Study|Withdrawal by Subject|1
2275916|NCT02316717|3958239|FG002|Overall Study|Withdrawal by Subject|1
2275917|NCT02316717|3958237|FG000|Overall Study|Death|0
2275918|NCT02316717|3958238|FG001|Overall Study|Death|0
2275919|NCT02316717|3958239|FG002|Overall Study|Death|1
2275920|NCT02316717|3958237|FG000|Overall Study|Physician Decision|0
2275921|NCT02316717|3958238|FG001|Overall Study|Physician Decision|1
2275922|NCT02316717|3958239|FG002|Overall Study|Physician Decision|0
2275923|NCT02316717|3958237|FG000|Overall Study|TBC|1
2275924|NCT02316717|3958238|FG001|Overall Study|TBC|0
2275925|NCT02316717|3958239|FG002|Overall Study|TBC|0
2275926|NCT02316769|3958252|FG000|Overall Study|Physician Decision|1
2275927|NCT02316769|3958253|FG001|Overall Study|Physician Decision|0
2275928|NCT02316769|3958252|FG000|Overall Study|Withdrawal by Subject|1
2275929|NCT02316769|3958253|FG001|Overall Study|Withdrawal by Subject|0
2200481|NCT01573624|3836658|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
2275930|NCT02316847|3958261|FG000|Overall Study|Adverse Event|0
2275931|NCT02316847|3958262|FG001|Overall Study|Adverse Event|3
2275932|NCT02316847|3958261|FG000|Overall Study|Lost to Follow-up|0
2275933|NCT02316847|3958262|FG001|Overall Study|Lost to Follow-up|2
2275934|NCT02316847|3958261|FG000|Overall Study|Physician Decision|0
2275935|NCT02316847|3958262|FG001|Overall Study|Physician Decision|1
2275936|NCT02316847|3958261|FG000|Overall Study|Pregnancy|0
2275937|NCT02316847|3958262|FG001|Overall Study|Pregnancy|1
2275938|NCT02316847|3958261|FG000|Overall Study|Withdrawal by Subject|2
2275939|NCT02316847|3958262|FG001|Overall Study|Withdrawal by Subject|9
2275940|NCT02316847|3958261|FG000|Overall Study|Noncompliance with study drug|0
2275941|NCT02316847|3958262|FG001|Overall Study|Noncompliance with study drug|3
2275942|NCT02316847|3958261|FG000|Overall Study|Withdrawn due to termination by Sponsor|7
2275943|NCT02316847|3958262|FG001|Overall Study|Withdrawn due to termination by Sponsor|67
2275944|NCT02317016|3958270|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
2275945|NCT02317016|3958270|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
2275946|NCT02317016|3958270|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
2275947|NCT02317016|3958270|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
2275948|NCT02317016|3958270|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
2275949|NCT02317016|3958270|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
2275950|NCT02317016|3958270|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5
2275951|NCT02317432|3958289|FG000|Overall Study|Death|4
2275952|NCT02317432|3958290|FG001|Overall Study|Death|1
2275953|NCT02317432|3958289|FG000|Overall Study|Lost to Follow-up|0
2275954|NCT02317432|3958290|FG001|Overall Study|Lost to Follow-up|5
2275955|NCT02317432|3958289|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27
2275956|NCT02317432|3958290|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0
2275957|NCT02317510|3958298|FG000|Overall Study|Adverse Event|0
2275958|NCT02317510|3958299|FG001|Overall Study|Adverse Event|1
2275959|NCT02317562|3958317|FG000|Overall Study|Physician Decision|1
2275960|NCT02317562|3958317|FG000|Overall Study|early termination of the study|8
2275961|NCT02317562|3958317|FG000|Overall Study|Lack of Efficacy|4
2275962|NCT02317562|3958317|FG000|Overall Study|Withdrawal by Subject|1
2275963|NCT02317575|3958321|FG000|Period 1|Difficulty with venous cannulation|0
2275964|NCT02317575|3958322|FG001|Period 1|Difficulty with venous cannulation|1
2275965|NCT02317575|3958323|FG002|Period 1|Difficulty with venous cannulation|0
2275966|NCT02317575|3958324|FG003|Period 1|Difficulty with venous cannulation|0
2275967|NCT02317575|3958325|FG004|Period 1|Difficulty with venous cannulation|0
2275968|NCT02317575|3958321|FG000|Period 1|Withdrawal by Subject|1
2275969|NCT02317575|3958322|FG001|Period 1|Withdrawal by Subject|0
2275970|NCT02317575|3958323|FG002|Period 1|Withdrawal by Subject|0
2275971|NCT02317575|3958324|FG003|Period 1|Withdrawal by Subject|0
2275972|NCT02317575|3958325|FG004|Period 1|Withdrawal by Subject|0
2275973|NCT02317614|3958345|FG000|Overall Study|Lost to Follow-up|1
2275974|NCT02317614|3958346|FG001|Overall Study|Lost to Follow-up|1
2275975|NCT02317614|3958345|FG000|Overall Study|Withdrawal by Subject|1
2275976|NCT02317614|3958346|FG001|Overall Study|Withdrawal by Subject|0
2275977|NCT02317614|3958345|FG000|Overall Study|Death|1
2275978|NCT02317614|3958346|FG001|Overall Study|Death|1
2275979|NCT02317627|3958355|FG000|Overall Study|Withdrawal by Subject|0
2275980|NCT02317627|3958356|FG001|Overall Study|Withdrawal by Subject|1
2275981|NCT02317627|3958357|FG002|Overall Study|Withdrawal by Subject|1
2275982|NCT02317627|3958355|FG000|Overall Study|Lost to Follow-up|2
2275983|NCT02317627|3958356|FG001|Overall Study|Lost to Follow-up|0
2275984|NCT02317627|3958357|FG002|Overall Study|Lost to Follow-up|0
2275985|NCT02317627|3958355|FG000|Overall Study|Stopped by Investigator|0
2275986|NCT02317627|3958356|FG001|Overall Study|Stopped by Investigator|1
2275987|NCT02317627|3958357|FG002|Overall Study|Stopped by Investigator|0
2275988|NCT02317627|3958355|FG000|Overall Study|Adverse Event|0
2275989|NCT02317627|3958356|FG001|Overall Study|Adverse Event|2
2275990|NCT02317627|3958357|FG002|Overall Study|Adverse Event|3
2275991|NCT02317627|3958355|FG000|Overall Study|Non-compliance with study drug|0
2275992|NCT02317627|3958356|FG001|Overall Study|Non-compliance with study drug|1
2275993|NCT02317627|3958357|FG002|Overall Study|Non-compliance with study drug|0
2275994|NCT02317809|3958389|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2
2275995|NCT02317809|3958390|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0
2275996|NCT02317809|3958389|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
2275997|NCT02317809|3958390|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
2275998|NCT02318095|3958399|FG000|Overall Study|Adverse Event|1
2275999|NCT02318134|3958406|FG000|Overall Study|Withdrawal by Subject|2
2200482|NCT01573624|3836659|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2200483|NCT01573624|3836660|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2200484|NCT01573624|3836661|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2200485|NCT01573624|3836662|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
2200486|NCT01573624|3836663|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2276000|NCT02318134|3958407|FG001|Overall Study|Withdrawal by Subject|1
2276001|NCT02318368|3958446|FG000|Overall Study|Withdrawal by Subject|2
2276002|NCT02318368|3958447|FG001|Overall Study|Withdrawal by Subject|0
2276003|NCT02318368|3958446|FG000|Overall Study|Study terminated by the sponsor|5
2276004|NCT02318368|3958447|FG001|Overall Study|Study terminated by the sponsor|2
2276005|NCT02318368|3958446|FG000|Overall Study|Death|0
2276006|NCT02318368|3958447|FG001|Overall Study|Death|1
2276007|NCT02318602|3958460|FG000|Overall Study|Adverse Event|0
2276008|NCT02318602|3958461|FG001|Overall Study|Adverse Event|1
2276009|NCT02318602|3958462|FG002|Overall Study|Adverse Event|1
2276010|NCT02318602|3958460|FG000|Overall Study|Withdrawal by Subject|0
2276011|NCT02318602|3958461|FG001|Overall Study|Withdrawal by Subject|3
2276012|NCT02318602|3958462|FG002|Overall Study|Withdrawal by Subject|0
2276013|NCT02318602|3958460|FG000|Overall Study|Death|1
2276014|NCT02318602|3958461|FG001|Overall Study|Death|0
2276015|NCT02318602|3958462|FG002|Overall Study|Death|0
2276016|NCT02318602|3958460|FG000|Overall Study|Guardian decision to withdraw|0
2276017|NCT02318602|3958461|FG001|Overall Study|Guardian decision to withdraw|0
2276018|NCT02318602|3958462|FG002|Overall Study|Guardian decision to withdraw|1
2276019|NCT02318667|3958476|FG000|Overall Study|Adverse Event|1
2276020|NCT02318667|3958476|FG000|Overall Study|Lack of Efficacy|6
2276021|NCT02318667|3958476|FG000|Overall Study|Protocol Violation|2
2276022|NCT02318693|3958486|FG000|Overall Study|Protocol Violation|0
2276023|NCT02318693|3958487|FG001|Overall Study|Protocol Violation|1
2276024|NCT02318706|3958497|FG000|Double-blind Phase|Adverse Event|7
2276025|NCT02318706|3958498|FG001|Double-blind Phase|Adverse Event|4
2276026|NCT02318706|3958499|FG002|Double-blind Phase|Adverse Event|3
2276027|NCT02318706|3958500|FG003|Double-blind Phase|Adverse Event|10
2276028|NCT02318706|3958501|FG004|Double-blind Phase|Adverse Event|0
2276029|NCT02318706|3958497|FG000|Double-blind Phase|Lost to Follow-up|1
2276030|NCT02318706|3958498|FG001|Double-blind Phase|Lost to Follow-up|0
2276031|NCT02318706|3958499|FG002|Double-blind Phase|Lost to Follow-up|0
2276032|NCT02318706|3958500|FG003|Double-blind Phase|Lost to Follow-up|0
2276033|NCT02318706|3958501|FG004|Double-blind Phase|Lost to Follow-up|0
2276034|NCT02318706|3958497|FG000|Double-blind Phase|Protocol Violation|4
2276035|NCT02318706|3958498|FG001|Double-blind Phase|Protocol Violation|2
2276036|NCT02318706|3958499|FG002|Double-blind Phase|Protocol Violation|4
2276037|NCT02318706|3958500|FG003|Double-blind Phase|Protocol Violation|3
2276038|NCT02318706|3958501|FG004|Double-blind Phase|Protocol Violation|0
2276039|NCT02318706|3958497|FG000|Double-blind Phase|Withdrawal by Subject|9
2276040|NCT02318706|3958498|FG001|Double-blind Phase|Withdrawal by Subject|5
2276041|NCT02318706|3958499|FG002|Double-blind Phase|Withdrawal by Subject|7
2276042|NCT02318706|3958500|FG003|Double-blind Phase|Withdrawal by Subject|10
2276043|NCT02318706|3958501|FG004|Double-blind Phase|Withdrawal by Subject|0
2276044|NCT02318706|3958497|FG000|Double-blind Phase|Other|4
2276045|NCT02318706|3958498|FG001|Double-blind Phase|Other|1
2276046|NCT02318706|3958499|FG002|Double-blind Phase|Other|2
2276047|NCT02318706|3958500|FG003|Double-blind Phase|Other|1
2276048|NCT02318706|3958501|FG004|Double-blind Phase|Other|0
2276049|NCT02318706|3958497|FG000|Double-blind Phase|Death|0
2276050|NCT02318706|3958498|FG001|Double-blind Phase|Death|0
2276051|NCT02318706|3958499|FG002|Double-blind Phase|Death|2
2276052|NCT02318706|3958500|FG003|Double-blind Phase|Death|0
2276053|NCT02318706|3958501|FG004|Double-blind Phase|Death|0
2276054|NCT02318706|3958497|FG000|Open-label Extension Phase|Adverse Event|0
2276055|NCT02318706|3958498|FG001|Open-label Extension Phase|Adverse Event|0
2276056|NCT02318706|3958499|FG002|Open-label Extension Phase|Adverse Event|0
2276057|NCT02318706|3958500|FG003|Open-label Extension Phase|Adverse Event|0
2276058|NCT02318706|3958501|FG004|Open-label Extension Phase|Adverse Event|21
2276059|NCT02318706|3958497|FG000|Open-label Extension Phase|Lack of Efficacy|0
2276060|NCT02318706|3958498|FG001|Open-label Extension Phase|Lack of Efficacy|0
2276061|NCT02318706|3958499|FG002|Open-label Extension Phase|Lack of Efficacy|0
2276062|NCT02318706|3958500|FG003|Open-label Extension Phase|Lack of Efficacy|0
2276063|NCT02318706|3958501|FG004|Open-label Extension Phase|Lack of Efficacy|1
2276064|NCT02318706|3958497|FG000|Open-label Extension Phase|Death|0
2276065|NCT02318706|3958498|FG001|Open-label Extension Phase|Death|0
2276066|NCT02318706|3958499|FG002|Open-label Extension Phase|Death|0
2276067|NCT02318706|3958500|FG003|Open-label Extension Phase|Death|0
2276068|NCT02318706|3958501|FG004|Open-label Extension Phase|Death|1
2276069|NCT02318706|3958497|FG000|Open-label Extension Phase|Withdrawal by Subject|0
2276070|NCT02318706|3958498|FG001|Open-label Extension Phase|Withdrawal by Subject|0
2276071|NCT02318706|3958499|FG002|Open-label Extension Phase|Withdrawal by Subject|0
2276072|NCT02318706|3958500|FG003|Open-label Extension Phase|Withdrawal by Subject|0
2276073|NCT02318706|3958501|FG004|Open-label Extension Phase|Withdrawal by Subject|19
2276074|NCT02318719|3958517|FG000|Double-blind Phase|Adverse Event|7
2276075|NCT02318719|3958518|FG001|Double-blind Phase|Adverse Event|6
2276076|NCT02318719|3958519|FG002|Double-blind Phase|Adverse Event|12
2276077|NCT02318719|3958520|FG003|Double-blind Phase|Adverse Event|4
2276078|NCT02318719|3958521|FG004|Double-blind Phase|Adverse Event|0
2276079|NCT02318719|3958517|FG000|Double-blind Phase|Lack of Efficacy|5
2276080|NCT02318719|3958518|FG001|Double-blind Phase|Lack of Efficacy|0
2276081|NCT02318719|3958519|FG002|Double-blind Phase|Lack of Efficacy|1
2276082|NCT02318719|3958520|FG003|Double-blind Phase|Lack of Efficacy|1
2276083|NCT02318719|3958521|FG004|Double-blind Phase|Lack of Efficacy|0
2200487|NCT01573624|3836664|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
2200488|NCT01573624|3836658|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
2200489|NCT01573624|3836659|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
2200490|NCT01573624|3836660|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
2200491|NCT01573624|3836661|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
2200492|NCT01573624|3836662|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
2200493|NCT01573624|3836663|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
2200494|NCT01573624|3836664|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
2200495|NCT01573624|3836658|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2200496|NCT01573624|3836659|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
2200497|NCT01573624|3836660|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2200498|NCT01573624|3836661|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2200499|NCT01573624|3836662|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2200500|NCT01573624|3836663|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
2276084|NCT02318719|3958517|FG000|Double-blind Phase|Protocol Violation|0
2276085|NCT02318719|3958518|FG001|Double-blind Phase|Protocol Violation|1
2276086|NCT02318719|3958519|FG002|Double-blind Phase|Protocol Violation|3
2276087|NCT02318719|3958520|FG003|Double-blind Phase|Protocol Violation|0
2276088|NCT02318719|3958521|FG004|Double-blind Phase|Protocol Violation|0
2276089|NCT02318719|3958517|FG000|Double-blind Phase|Withdrawal by Subject|25
2276090|NCT02318719|3958518|FG001|Double-blind Phase|Withdrawal by Subject|7
2276091|NCT02318719|3958519|FG002|Double-blind Phase|Withdrawal by Subject|9
2276092|NCT02318719|3958520|FG003|Double-blind Phase|Withdrawal by Subject|10
2276093|NCT02318719|3958521|FG004|Double-blind Phase|Withdrawal by Subject|0
2276094|NCT02318719|3958517|FG000|Double-blind Phase|Other|1
2276095|NCT02318719|3958518|FG001|Double-blind Phase|Other|2
2276096|NCT02318719|3958519|FG002|Double-blind Phase|Other|0
2276097|NCT02318719|3958520|FG003|Double-blind Phase|Other|0
2276098|NCT02318719|3958521|FG004|Double-blind Phase|Other|0
2276099|NCT02318719|3958517|FG000|Open-label Extension Phase|Adverse Event|0
2276100|NCT02318719|3958518|FG001|Open-label Extension Phase|Adverse Event|0
2276101|NCT02318719|3958519|FG002|Open-label Extension Phase|Adverse Event|0
2276102|NCT02318719|3958520|FG003|Open-label Extension Phase|Adverse Event|0
2276103|NCT02318719|3958521|FG004|Open-label Extension Phase|Adverse Event|15
2039042|NCT00424632|3609374|FG000|Overall Study|Death|0
2039043|NCT00424632|3609375|FG001|Overall Study|Death|0
2039044|NCT00424632|3609376|FG002|Overall Study|Death|0
2039045|NCT00424632|3609377|FG003|Overall Study|Death|0
2039046|NCT00424632|3609378|FG004|Overall Study|Death|0
2039047|NCT00424632|3609379|FG005|Overall Study|Death|2
2039048|NCT00424632|3609380|FG006|Overall Study|Death|0
2039049|NCT00424632|3609381|FG007|Overall Study|Death|0
2039050|NCT00424632|3609382|FG008|Overall Study|Death|0
2039051|NCT00424632|3609383|FG009|Overall Study|Death|0
2039052|NCT00424632|3609374|FG000|Overall Study|Adverse Event|0
2039053|NCT00424632|3609375|FG001|Overall Study|Adverse Event|0
2039054|NCT00424632|3609376|FG002|Overall Study|Adverse Event|0
2039055|NCT00424632|3609377|FG003|Overall Study|Adverse Event|0
2039056|NCT00424632|3609378|FG004|Overall Study|Adverse Event|0
2039057|NCT00424632|3609379|FG005|Overall Study|Adverse Event|0
2039058|NCT00424632|3609380|FG006|Overall Study|Adverse Event|0
2039059|NCT00424632|3609381|FG007|Overall Study|Adverse Event|0
2039060|NCT00424632|3609382|FG008|Overall Study|Adverse Event|3
2039061|NCT00424632|3609383|FG009|Overall Study|Adverse Event|2
2039062|NCT00424632|3609374|FG000|Overall Study|Global deterioration of health status|0
2039063|NCT00424632|3609375|FG001|Overall Study|Global deterioration of health status|0
2039064|NCT00424632|3609376|FG002|Overall Study|Global deterioration of health status|0
2039065|NCT00424632|3609377|FG003|Overall Study|Global deterioration of health status|1
2276104|NCT02318719|3958517|FG000|Open-label Extension Phase|Death|0
2276105|NCT02318719|3958518|FG001|Open-label Extension Phase|Death|0
2276106|NCT02318719|3958519|FG002|Open-label Extension Phase|Death|0
2276107|NCT02318719|3958520|FG003|Open-label Extension Phase|Death|0
2276108|NCT02318719|3958521|FG004|Open-label Extension Phase|Death|1
2276109|NCT02318719|3958517|FG000|Open-label Extension Phase|Lack of Efficacy|0
2276110|NCT02318719|3958518|FG001|Open-label Extension Phase|Lack of Efficacy|0
2276111|NCT02318719|3958519|FG002|Open-label Extension Phase|Lack of Efficacy|0
2276112|NCT02318719|3958520|FG003|Open-label Extension Phase|Lack of Efficacy|0
2276113|NCT02318719|3958521|FG004|Open-label Extension Phase|Lack of Efficacy|1
2276114|NCT02318719|3958517|FG000|Open-label Extension Phase|Withdrawal by Subject|0
2276115|NCT02318719|3958518|FG001|Open-label Extension Phase|Withdrawal by Subject|0
2276116|NCT02318719|3958519|FG002|Open-label Extension Phase|Withdrawal by Subject|0
2276117|NCT02318719|3958520|FG003|Open-label Extension Phase|Withdrawal by Subject|0
2276118|NCT02318719|3958521|FG004|Open-label Extension Phase|Withdrawal by Subject|31
2276119|NCT02318719|3958517|FG000|Open-label Extension Phase|Other|0
2276120|NCT02318719|3958518|FG001|Open-label Extension Phase|Other|0
2276121|NCT02318719|3958519|FG002|Open-label Extension Phase|Other|0
2276122|NCT02318719|3958520|FG003|Open-label Extension Phase|Other|0
2276123|NCT02318719|3958521|FG004|Open-label Extension Phase|Other|7
2276124|NCT02318797|3958535|FG000|Overall Study|Death|3
2276125|NCT02318797|3958536|FG001|Overall Study|Death|6
2039066|NCT00424632|3609378|FG004|Overall Study|Global deterioration of health status|1
2200501|NCT01573624|3836664|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2200502|NCT01573624|3836658|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
2200503|NCT01573624|3836659|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2200504|NCT01573624|3836660|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2200505|NCT01573624|3836661|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2200506|NCT01573624|3836662|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2200507|NCT01573624|3836663|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2200508|NCT01573624|3836664|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2200509|NCT01573624|3836658|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2200510|NCT01573624|3836659|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2200511|NCT01573624|3836660|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2200512|NCT01573624|3836661|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2200513|NCT01573624|3836662|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
2200514|NCT01573624|3836663|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
2200515|NCT01573624|3836664|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2200516|NCT01573624|3836658|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
2200517|NCT01573624|3836659|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2200518|NCT01573624|3836660|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2200519|NCT01573624|3836661|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2276126|NCT02318797|3958535|FG000|Overall Study|Lost to Follow-up|85
2276127|NCT02318797|3958536|FG001|Overall Study|Lost to Follow-up|96
2276128|NCT02318940|3958544|FG000|Overall Study|lost the record|1
2276129|NCT02318940|3958545|FG001|Overall Study|lost the record|0
2276130|NCT02319031|3958579|FG000|Treatment Period|Death|1
2276131|NCT02319031|3958580|FG001|Treatment Period|Death|0
2276132|NCT02319044|3958589|FG000|Overall Study|Death, PI/sponsor decision, med history|0
2276133|NCT02319044|3958590|FG001|Overall Study|Death, PI/sponsor decision, med history|1
2276134|NCT02319044|3958591|FG002|Overall Study|Death, PI/sponsor decision, med history|4
2276135|NCT02319044|3958589|FG000|Overall Study|Withdrawal by Subject|3
2276136|NCT02319044|3958590|FG001|Overall Study|Withdrawal by Subject|3
2276137|NCT02319044|3958591|FG002|Overall Study|Withdrawal by Subject|6
2276138|NCT02319044|3958589|FG000|Overall Study|Condition under investigation worsened|100
2276139|NCT02319044|3958590|FG001|Overall Study|Condition under investigation worsened|50
2276140|NCT02319044|3958591|FG002|Overall Study|Condition under investigation worsened|46
2276141|NCT02319044|3958589|FG000|Overall Study|Adverse Event|17
2276142|NCT02319044|3958590|FG001|Overall Study|Adverse Event|2
2276143|NCT02319044|3958591|FG002|Overall Study|Adverse Event|8
2276144|NCT02319044|3958589|FG000|Overall Study|Study specific discontinuation criteria|2
2276145|NCT02319044|3958590|FG001|Overall Study|Study specific discontinuation criteria|2
2276146|NCT02319044|3958591|FG002|Overall Study|Study specific discontinuation criteria|1
2276147|NCT02319044|3958589|FG000|Overall Study|Not treated|0
2276148|NCT02319044|3958590|FG001|Overall Study|Not treated|2
2276149|NCT02319044|3958591|FG002|Overall Study|Not treated|2
2276150|NCT02319148|3958603|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0
2276151|NCT02319148|3958604|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0
2276152|NCT02319148|3958605|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1
2276153|NCT02319148|3958606|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1
2276154|NCT02319148|3958603|FG000|Second Intervention Period|No longer willing to participate|0
2276155|NCT02319148|3958604|FG001|Second Intervention Period|No longer willing to participate|1
2276156|NCT02319148|3958605|FG002|Second Intervention Period|No longer willing to participate|0
2276157|NCT02319148|3958606|FG003|Second Intervention Period|No longer willing to participate|0
2276158|NCT02319148|3958603|FG000|Second Intervention Period|Other|0
2276159|NCT02319148|3958604|FG001|Second Intervention Period|Other|0
2276160|NCT02319148|3958605|FG002|Second Intervention Period|Other|0
2276161|NCT02319148|3958606|FG003|Second Intervention Period|Other|1
2276162|NCT02319525|3958714|FG000|Overall Study|Withdrawal by Subject|2
2276163|NCT02319525|3958715|FG001|Overall Study|Withdrawal by Subject|1
2276164|NCT02319642|3958723|FG000|Overall Study|Adverse Event|2
2276165|NCT02319642|3958724|FG001|Overall Study|Adverse Event|4
2276166|NCT02319642|3958723|FG000|Overall Study|Lack of Efficacy|1
2276167|NCT02319642|3958724|FG001|Overall Study|Lack of Efficacy|1
2276168|NCT02319642|3958723|FG000|Overall Study|Withdrawal by Subject|1
2276169|NCT02319642|3958724|FG001|Overall Study|Withdrawal by Subject|1
2276170|NCT02319668|3958734|FG000|Overall Study|Other (Not specified)|0
2276171|NCT02319668|3958735|FG001|Overall Study|Other (Not specified)|2
2276172|NCT02319759|3958746|FG000|Week 0 - 16|Lack of Efficacy|1
2276173|NCT02319759|3958747|FG001|Week 0 - 16|Lack of Efficacy|0
2276174|NCT02319759|3958748|FG002|Week 0 - 16|Lack of Efficacy|0
2276175|NCT02319759|3958749|FG003|Week 0 - 16|Lack of Efficacy|0
2276176|NCT02319759|3958750|FG004|Week 0 - 16|Lack of Efficacy|0
2276177|NCT02319759|3958746|FG000|Week 0 - 16|Not met all Inclusion Criteria|0
2276178|NCT02319759|3958747|FG001|Week 0 - 16|Not met all Inclusion Criteria|0
2276179|NCT02319759|3958748|FG002|Week 0 - 16|Not met all Inclusion Criteria|1
2276180|NCT02319759|3958749|FG003|Week 0 - 16|Not met all Inclusion Criteria|0
2276181|NCT02319759|3958750|FG004|Week 0 - 16|Not met all Inclusion Criteria|0
2200520|NCT01573624|3836662|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2200521|NCT01573624|3836663|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2200522|NCT01573624|3836664|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2200523|NCT01573767|3836695|FG000|Overall Study|Adverse Event|0
2200524|NCT01573767|3836696|FG001|Overall Study|Adverse Event|1
2200525|NCT01573767|3836697|FG002|Overall Study|Adverse Event|0
2200526|NCT01573767|3836698|FG003|Overall Study|Adverse Event|1
2200527|NCT01573767|3836695|FG000|Overall Study|Lack of Efficacy|18
2200528|NCT01573767|3836696|FG001|Overall Study|Lack of Efficacy|15
2200529|NCT01573767|3836697|FG002|Overall Study|Lack of Efficacy|12
2200530|NCT01573767|3836698|FG003|Overall Study|Lack of Efficacy|17
2200531|NCT01573767|3836695|FG000|Overall Study|Protocol Violation|3
2200532|NCT01573767|3836696|FG001|Overall Study|Protocol Violation|1
2276182|NCT02319759|3958746|FG000|Week 16 - 24|Lack of Efficacy|1
2276183|NCT02319759|3958747|FG001|Week 16 - 24|Lack of Efficacy|0
2276184|NCT02319759|3958748|FG002|Week 16 - 24|Lack of Efficacy|1
2276185|NCT02319759|3958749|FG003|Week 16 - 24|Lack of Efficacy|0
2276186|NCT02319759|3958750|FG004|Week 16 - 24|Lack of Efficacy|0
2276187|NCT02319759|3958746|FG000|Week 16 - 24|Lost to Follow-up|1
2276188|NCT02319759|3958747|FG001|Week 16 - 24|Lost to Follow-up|0
2276189|NCT02319759|3958748|FG002|Week 16 - 24|Lost to Follow-up|0
2276190|NCT02319759|3958749|FG003|Week 16 - 24|Lost to Follow-up|0
2276191|NCT02319759|3958750|FG004|Week 16 - 24|Lost to Follow-up|0
2276192|NCT02319759|3958746|FG000|Week 16 - 24|Withdrawal by Subject|0
2276193|NCT02319759|3958747|FG001|Week 16 - 24|Withdrawal by Subject|0
2276194|NCT02319759|3958748|FG002|Week 16 - 24|Withdrawal by Subject|2
2276195|NCT02319759|3958749|FG003|Week 16 - 24|Withdrawal by Subject|0
2276196|NCT02319759|3958750|FG004|Week 16 - 24|Withdrawal by Subject|0
2276197|NCT02319759|3958746|FG000|Week 24 - 56|Adverse Event|0
2276198|NCT02319759|3958747|FG001|Week 24 - 56|Adverse Event|0
2276199|NCT02319759|3958748|FG002|Week 24 - 56|Adverse Event|2
2276200|NCT02319759|3958749|FG003|Week 24 - 56|Adverse Event|0
2276201|NCT02319759|3958750|FG004|Week 24 - 56|Adverse Event|0
2276202|NCT02319759|3958746|FG000|Week 24 - 56|Lack of Efficacy|0
2276203|NCT02319759|3958747|FG001|Week 24 - 56|Lack of Efficacy|0
2276204|NCT02319759|3958748|FG002|Week 24 - 56|Lack of Efficacy|0
2276205|NCT02319759|3958749|FG003|Week 24 - 56|Lack of Efficacy|2
2276206|NCT02319759|3958750|FG004|Week 24 - 56|Lack of Efficacy|1
2276207|NCT02319759|3958746|FG000|Week 24 - 56|Withdrawal by Subject|0
2276208|NCT02319759|3958747|FG001|Week 24 - 56|Withdrawal by Subject|1
2276209|NCT02319759|3958748|FG002|Week 24 - 56|Withdrawal by Subject|0
2276210|NCT02319759|3958749|FG003|Week 24 - 56|Withdrawal by Subject|0
2276211|NCT02319759|3958750|FG004|Week 24 - 56|Withdrawal by Subject|0
2276212|NCT02319759|3958746|FG000|Week 24 - 56|Lost to Follow-up|0
2276213|NCT02319759|3958747|FG001|Week 24 - 56|Lost to Follow-up|0
2276214|NCT02319759|3958748|FG002|Week 24 - 56|Lost to Follow-up|0
2276215|NCT02319759|3958749|FG003|Week 24 - 56|Lost to Follow-up|0
2276216|NCT02319759|3958750|FG004|Week 24 - 56|Lost to Follow-up|1
2276217|NCT02320058|3958783|FG000|Overall Study|Death|25
2276218|NCT02320058|3958784|FG001|Overall Study|Death|10
2276219|NCT02320058|3958783|FG000|Overall Study|Lost to Follow-up|4
2276220|NCT02320058|3958784|FG001|Overall Study|Lost to Follow-up|0
2276221|NCT02320058|3958783|FG000|Overall Study|Other reasons|4
2276222|NCT02320058|3958784|FG001|Overall Study|Other reasons|1
2276223|NCT02320058|3958783|FG000|Overall Study|Withdrawal by Subject|8
2276224|NCT02320058|3958784|FG001|Overall Study|Withdrawal by Subject|2
2276225|NCT02320058|3958783|FG000|Overall Study|Not reported|1
2276226|NCT02320058|3958784|FG001|Overall Study|Not reported|0
2276227|NCT02320123|3958792|FG000|Overall Study|Lost to Follow-up|4
2276228|NCT02320123|3958793|FG001|Overall Study|Lost to Follow-up|6
2276229|NCT02320123|3958792|FG000|Overall Study|Death|6
2276230|NCT02320123|3958793|FG001|Overall Study|Death|5
2276231|NCT02320149|3958805|FG000|Overall Study|Adverse Event|3
2276232|NCT02320149|3958806|FG001|Overall Study|Adverse Event|7
2276233|NCT02320149|3958805|FG000|Overall Study|Withdrawal of Consent|28
2276234|NCT02320149|3958806|FG001|Overall Study|Withdrawal of Consent|32
2276235|NCT02320149|3958805|FG000|Overall Study|Lost to Follow-up|21
2276236|NCT02320149|3958806|FG001|Overall Study|Lost to Follow-up|34
2276237|NCT02320149|3958805|FG000|Overall Study|Protocol Violation|2
2276238|NCT02320149|3958806|FG001|Overall Study|Protocol Violation|1
2276239|NCT02320149|3958805|FG000|Overall Study|Noncompliance with Study Treatment|7
2276240|NCT02320149|3958806|FG001|Overall Study|Noncompliance with Study Treatment|2
2276241|NCT02320149|3958805|FG000|Overall Study|Lack of Efficacy|0
2276242|NCT02320149|3958806|FG001|Overall Study|Lack of Efficacy|1
2276243|NCT02320149|3958805|FG000|Overall Study|Other Miscellaneous Reasons|2
2276244|NCT02320149|3958806|FG001|Overall Study|Other Miscellaneous Reasons|3
2276245|NCT02320253|3958836|FG000|Overall Study|Withdrawal by Subject|3
2276246|NCT02320253|3958837|FG001|Overall Study|Withdrawal by Subject|0
2276247|NCT02320253|3958838|FG002|Overall Study|Withdrawal by Subject|0
2276248|NCT02320253|3958836|FG000|Overall Study|Lost to Follow-up|2
2276249|NCT02320253|3958837|FG001|Overall Study|Lost to Follow-up|2
2200533|NCT01573767|3836697|FG002|Overall Study|Protocol Violation|1
2276250|NCT02320253|3958838|FG002|Overall Study|Lost to Follow-up|1
2276251|NCT02320253|3958836|FG000|Overall Study|Death|1
2276252|NCT02320253|3958837|FG001|Overall Study|Death|0
2276253|NCT02320253|3958838|FG002|Overall Study|Death|1
2276254|NCT02320487|3958846|FG000|Overall Study|Reason not Specified|1
2200534|NCT01573767|3836698|FG003|Overall Study|Protocol Violation|3
2200535|NCT01573767|3836695|FG000|Overall Study|Lost to Follow-up|0
2200536|NCT01573767|3836696|FG001|Overall Study|Lost to Follow-up|1
2200537|NCT01573767|3836697|FG002|Overall Study|Lost to Follow-up|1
2200538|NCT01573767|3836698|FG003|Overall Study|Lost to Follow-up|1
2200539|NCT01573767|3836695|FG000|Overall Study|Physician Decision|1
2200540|NCT01573767|3836696|FG001|Overall Study|Physician Decision|2
2200541|NCT01573767|3836697|FG002|Overall Study|Physician Decision|0
2200542|NCT01573767|3836698|FG003|Overall Study|Physician Decision|2
2200543|NCT01573767|3836695|FG000|Overall Study|Withdrawal by Subject|0
2200544|NCT01573767|3836696|FG001|Overall Study|Withdrawal by Subject|1
2200545|NCT01573767|3836697|FG002|Overall Study|Withdrawal by Subject|0
2200546|NCT01573767|3836698|FG003|Overall Study|Withdrawal by Subject|0
2200547|NCT01573910|3836710|FG000|Overall Study|Adverse Event|4
2200548|NCT01573910|3836711|FG001|Overall Study|Adverse Event|4
2200549|NCT01573910|3836710|FG000|Overall Study|Lost to Follow-up|2
2200550|NCT01573910|3836711|FG001|Overall Study|Lost to Follow-up|1
2200551|NCT01573910|3836710|FG000|Overall Study|Withdrawal by Subject|0
2200552|NCT01573910|3836711|FG001|Overall Study|Withdrawal by Subject|1
2200553|NCT01573910|3836710|FG000|Overall Study|Protocol Violation|3
2200554|NCT01573910|3836711|FG001|Overall Study|Protocol Violation|0
2200555|NCT01573910|3836710|FG000|Overall Study|Patient decision unrelated to Advs Event|11
2200556|NCT01573910|3836711|FG001|Overall Study|Patient decision unrelated to Advs Event|11
2200557|NCT01574079|3836723|FG000|Overall Study|Physician Decision|0
2200558|NCT01574079|3836724|FG001|Overall Study|Physician Decision|2
2200559|NCT01574079|3836723|FG000|Overall Study|Lost to Follow-up|1
2200560|NCT01574079|3836724|FG001|Overall Study|Lost to Follow-up|0
2200561|NCT01574157|3836746|FG000|Overall Study|Withdrawal by Subject|4
2200562|NCT01574157|3836747|FG001|Overall Study|Withdrawal by Subject|5
2200563|NCT01574157|3836746|FG000|Overall Study|Lost to Follow-up|0
2200564|NCT01574157|3836747|FG001|Overall Study|Lost to Follow-up|3
2200565|NCT01574248|3836770|FG000|Overall Study|Withdrawal by Subject|2
2200566|NCT01574248|3836771|FG001|Overall Study|Withdrawal by Subject|0
2200567|NCT01574248|3836770|FG000|Overall Study|Missing primary endpoint data|1
2200568|NCT01574248|3836771|FG001|Overall Study|Missing primary endpoint data|0
2200569|NCT01574326|3836783|FG000|Overall Study|Randomized but not treated|0
2200570|NCT01574326|3836784|FG001|Overall Study|Randomized but not treated|1
2200571|NCT01574326|3836783|FG000|Overall Study|Withdrawal by Participant|2
2200572|NCT01574326|3836784|FG001|Overall Study|Withdrawal by Participant|4
2200573|NCT01574326|3836783|FG000|Overall Study|Physician Decision|5
2200574|NCT01574326|3836784|FG001|Overall Study|Physician Decision|3
2200575|NCT01574326|3836783|FG000|Overall Study|Adverse Event|1
2200576|NCT01574326|3836784|FG001|Overall Study|Adverse Event|3
2200577|NCT01574326|3836783|FG000|Overall Study|Other: Mainly kidney transplant|8
2200578|NCT01574326|3836784|FG001|Overall Study|Other: Mainly kidney transplant|8
2200579|NCT01574352|3836797|FG000|Overall Study|Withdrawal by Subject|6
2200580|NCT01574352|3836798|FG001|Overall Study|Withdrawal by Subject|13
2200581|NCT01574352|3836797|FG000|Overall Study|Injury in non-camp related sport|1
2200582|NCT01574352|3836798|FG001|Overall Study|Injury in non-camp related sport|0
2200583|NCT01574612|3836804|FG000|Overall Study|Adverse Event|3
2200584|NCT01574612|3836804|FG000|Overall Study|non compliant with drug|2
2200585|NCT01574612|3836804|FG000|Overall Study|Withdrawal by Subject|1
2200586|NCT01574612|3836804|FG000|Overall Study|Lost to Follow-up|2
2200587|NCT01574651|3836810|FG000|Overall Study|Lost to Follow-up|2
2200588|NCT01574651|3836811|FG001|Overall Study|Lost to Follow-up|4
2200589|NCT01574651|3836810|FG000|Overall Study|Administrative problems|0
2200590|NCT01574651|3836811|FG001|Overall Study|Administrative problems|1
2200591|NCT01574651|3836810|FG000|Overall Study|Death|3
2200592|NCT01574651|3836811|FG001|Overall Study|Death|3
2200593|NCT01574651|3836810|FG000|Overall Study|Patient's inability to use the device|0
2200594|NCT01574651|3836811|FG001|Overall Study|Patient's inability to use the device|1
2200595|NCT01574651|3836810|FG000|Overall Study|Adverse Event|36
2200596|NCT01574651|3836811|FG001|Overall Study|Adverse Event|27
2200597|NCT01574651|3836810|FG000|Overall Study|Abnormal laboratory value(s)|1
2200598|NCT01574651|3836811|FG001|Overall Study|Abnormal laboratory value(s)|0
2200599|NCT01574651|3836810|FG000|Overall Study|Abnormal test procedure result(s)|1
2200600|NCT01574651|3836811|FG001|Overall Study|Abnormal test procedure result(s)|1
2200601|NCT01574651|3836810|FG000|Overall Study|Unsatisfactory therapeutic effect|6
2200602|NCT01574651|3836811|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2200603|NCT01574651|3836810|FG000|Overall Study|Protocol Violation|3
2200604|NCT01574651|3836811|FG001|Overall Study|Protocol Violation|5
2200605|NCT01574651|3836810|FG000|Overall Study|Withdrawal by Subject|9
2200606|NCT01574651|3836811|FG001|Overall Study|Withdrawal by Subject|10
2200607|NCT01574703|3836821|FG000|Overall Study|Adverse Event|0
2200608|NCT01574703|3836822|FG001|Overall Study|Adverse Event|2
2200609|NCT01574703|3836823|FG002|Overall Study|Adverse Event|1
2200610|NCT01574703|3836824|FG003|Overall Study|Adverse Event|1
2200611|NCT01574703|3836821|FG000|Overall Study|Protocol Violation|0
2200612|NCT01574703|3836822|FG001|Overall Study|Protocol Violation|0
2200613|NCT01574703|3836823|FG002|Overall Study|Protocol Violation|0
2200614|NCT01574703|3836824|FG003|Overall Study|Protocol Violation|1
2200615|NCT01574703|3836821|FG000|Overall Study|Unspecified Reason|27
2200616|NCT01574703|3836822|FG001|Overall Study|Unspecified Reason|15
2200617|NCT01574703|3836823|FG002|Overall Study|Unspecified Reason|20
2200618|NCT01574703|3836824|FG003|Overall Study|Unspecified Reason|16
2200619|NCT01574703|3836821|FG000|Overall Study|Withdrawal by Subject|53
2200620|NCT01574703|3836822|FG001|Overall Study|Withdrawal by Subject|52
2200621|NCT01574703|3836823|FG002|Overall Study|Withdrawal by Subject|36
2200622|NCT01574703|3836824|FG003|Overall Study|Withdrawal by Subject|61
2200623|NCT01574703|3836821|FG000|Overall Study|Met Withdrawal Criteria|0
2200624|NCT01574703|3836822|FG001|Overall Study|Met Withdrawal Criteria|1
2200625|NCT01574703|3836823|FG002|Overall Study|Met Withdrawal Criteria|1
2200626|NCT01574703|3836824|FG003|Overall Study|Met Withdrawal Criteria|0
2200627|NCT01574703|3836821|FG000|Overall Study|Lost to Follow-up|43
2200628|NCT01574703|3836822|FG001|Overall Study|Lost to Follow-up|41
2200629|NCT01574703|3836823|FG002|Overall Study|Lost to Follow-up|46
2200630|NCT01574703|3836824|FG003|Overall Study|Lost to Follow-up|35
2200631|NCT01574703|3836821|FG000|Overall Study|Death|2
2200632|NCT01574703|3836822|FG001|Overall Study|Death|1
2200633|NCT01574703|3836823|FG002|Overall Study|Death|1
2200634|NCT01574703|3836824|FG003|Overall Study|Death|0
2200635|NCT01574716|3836839|FG000|Part 1|Death|3
2200636|NCT01574716|3836840|FG001|Part 1|Death|1
2276255|NCT02320487|3958846|FG000|Overall Study|Physician Decision|5
2276256|NCT02320487|3958846|FG000|Overall Study|Withdrawal by Subject|1
2276257|NCT02320487|3958846|FG000|Overall Study|Death|3
2276258|NCT02320487|3958846|FG000|Overall Study|Adverse Event|11
2276259|NCT02320721|3958861|FG000|Overall Study|Adverse Event|6
2276260|NCT02320721|3958862|FG001|Overall Study|Adverse Event|6
2276261|NCT02320721|3958861|FG000|Overall Study|Lack of Efficacy|2
2276262|NCT02320721|3958862|FG001|Overall Study|Lack of Efficacy|0
2276263|NCT02320721|3958861|FG000|Overall Study|Poor compliance to protocol|3
2276264|NCT02320721|3958862|FG001|Overall Study|Poor compliance to protocol|7
2276265|NCT02320721|3958861|FG000|Overall Study|Randomized but not treated|0
2276266|NCT02320721|3958862|FG001|Overall Study|Randomized but not treated|1
2276267|NCT02320721|3958861|FG000|Overall Study|Hypoglycemia|1
2276268|NCT02320721|3958862|FG001|Overall Study|Hypoglycemia|0
2276269|NCT02320721|3958861|FG000|Overall Study|Other than specified above|15
2276270|NCT02320721|3958862|FG001|Overall Study|Other than specified above|20
2276271|NCT02320903|3958891|FG000|Overall Study|Withdrawal by Subject|0
2276272|NCT02320903|3958892|FG001|Overall Study|Withdrawal by Subject|9
2276273|NCT02320903|3958893|FG002|Overall Study|Withdrawal by Subject|9
2276274|NCT02320903|3958891|FG000|Overall Study|Exited therapy; no longer eligible|8
2276275|NCT02320903|3958892|FG001|Overall Study|Exited therapy; no longer eligible|2
2276276|NCT02320903|3958893|FG002|Overall Study|Exited therapy; no longer eligible|2
2276277|NCT02320903|3958891|FG000|Overall Study|Lost to Follow-up|0
2276278|NCT02320903|3958892|FG001|Overall Study|Lost to Follow-up|5
2276279|NCT02320903|3958893|FG002|Overall Study|Lost to Follow-up|5
2276280|NCT02321098|3958905|FG000|12 Weeks Treament|Lost to Follow-up|1
2276281|NCT02321098|3958906|FG001|12 Weeks Treament|Lost to Follow-up|1
2276282|NCT02321098|3958907|FG002|12 Weeks Treament|Lost to Follow-up|0
2276283|NCT02321098|3958905|FG000|Additional 15 Months Treatment|Lack of Efficacy|0
2276284|NCT02321098|3958906|FG001|Additional 15 Months Treatment|Lack of Efficacy|0
2276285|NCT02321098|3958907|FG002|Additional 15 Months Treatment|Lack of Efficacy|6
2276286|NCT02321098|3958905|FG000|Additional 15 Months Treatment|Lost to Follow-up|0
2276287|NCT02321098|3958906|FG001|Additional 15 Months Treatment|Lost to Follow-up|0
2276288|NCT02321098|3958907|FG002|Additional 15 Months Treatment|Lost to Follow-up|1
2276289|NCT02321098|3958905|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0
2276290|NCT02321098|3958906|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0
2276291|NCT02321098|3958907|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1
2276292|NCT02321319|3958929|FG000|Overall Study|Product discontinued|5
2276293|NCT02321436|3958935|FG000|Overall Study|Withdrawal by Subject|1
2276294|NCT02321436|3958936|FG001|Overall Study|Withdrawal by Subject|0
2276295|NCT02321436|3958935|FG000|Overall Study|Lost to Follow-up|0
2276296|NCT02321436|3958936|FG001|Overall Study|Lost to Follow-up|1
2276297|NCT02321462|3958945|FG000|Overall Study|Withdrawal by Subject|5
2276298|NCT02321462|3958946|FG001|Overall Study|Withdrawal by Subject|2
2276299|NCT02321462|3958945|FG000|Overall Study|Subject withdrawn before any treatment|1
2276300|NCT02321462|3958946|FG001|Overall Study|Subject withdrawn before any treatment|1
2276301|NCT02321800|3958971|FG000|Overall Study|Withdrawal by Subject|3
2276302|NCT02321800|3958972|FG001|Overall Study|Withdrawal by Subject|3
2276303|NCT02321800|3958971|FG000|Overall Study|Death|1
2276304|NCT02321800|3958972|FG001|Overall Study|Death|0
2276305|NCT02321800|3958971|FG000|Overall Study|Protocol Violation|1
2276306|NCT02321800|3958972|FG001|Overall Study|Protocol Violation|0
2276307|NCT02321800|3958971|FG000|Overall Study|Lost to Follow-up|10
2276308|NCT02321800|3958972|FG001|Overall Study|Lost to Follow-up|4
2276309|NCT02321800|3958971|FG000|Overall Study|Adverse Event|2
2276310|NCT02321800|3958972|FG001|Overall Study|Adverse Event|3
2200637|NCT01574716|3836841|FG002|Part 1|Death|8
2200638|NCT01574716|3836842|FG003|Part 1|Death|0
2200639|NCT01574716|3836843|FG004|Part 1|Death|0
2200640|NCT01574716|3836839|FG000|Part 1|Discontinuation of study by sponsor|0
2200641|NCT01574716|3836840|FG001|Part 1|Discontinuation of study by sponsor|0
2276311|NCT02321800|3958971|FG000|Overall Study|Other, Miscellaneous|3
2276312|NCT02321800|3958972|FG001|Overall Study|Other, Miscellaneous|1
2276313|NCT02321930|3958978|FG000|Overall Study|Lost to Follow-up|1
2200642|NCT01574716|3836841|FG002|Part 1|Discontinuation of study by sponsor|1
2200643|NCT01574716|3836842|FG003|Part 1|Discontinuation of study by sponsor|0
2200644|NCT01574716|3836843|FG004|Part 1|Discontinuation of study by sponsor|0
2200645|NCT01574716|3836839|FG000|Part 1|Withdrawal by Subject|0
2200646|NCT01574716|3836840|FG001|Part 1|Withdrawal by Subject|2
2200647|NCT01574716|3836841|FG002|Part 1|Withdrawal by Subject|0
2200648|NCT01574716|3836842|FG003|Part 1|Withdrawal by Subject|0
2200649|NCT01574716|3836843|FG004|Part 1|Withdrawal by Subject|0
2200650|NCT01574716|3836839|FG000|Part 1|Lost to Follow-up|0
2200651|NCT01574716|3836840|FG001|Part 1|Lost to Follow-up|1
2200652|NCT01574716|3836841|FG002|Part 1|Lost to Follow-up|0
2200653|NCT01574716|3836842|FG003|Part 1|Lost to Follow-up|0
2200654|NCT01574716|3836843|FG004|Part 1|Lost to Follow-up|0
2200655|NCT01574716|3836839|FG000|Part 2|Progressive disease|0
2200656|NCT01574716|3836840|FG001|Part 2|Progressive disease|0
2200657|NCT01574716|3836841|FG002|Part 2|Progressive disease|0
2200658|NCT01574716|3836842|FG003|Part 2|Progressive disease|1
2200659|NCT01574716|3836843|FG004|Part 2|Progressive disease|0
2200660|NCT01574716|3836839|FG000|Part 2|Death|0
2200661|NCT01574716|3836840|FG001|Part 2|Death|0
2200662|NCT01574716|3836841|FG002|Part 2|Death|0
2200663|NCT01574716|3836842|FG003|Part 2|Death|76
2200664|NCT01574716|3836843|FG004|Part 2|Death|35
2200665|NCT01574716|3836839|FG000|Part 2|Discontinuation of study by sponsor|0
2200666|NCT01574716|3836840|FG001|Part 2|Discontinuation of study by sponsor|0
2200667|NCT01574716|3836841|FG002|Part 2|Discontinuation of study by sponsor|0
2200668|NCT01574716|3836842|FG003|Part 2|Discontinuation of study by sponsor|51
2200669|NCT01574716|3836843|FG004|Part 2|Discontinuation of study by sponsor|31
2200670|NCT01574716|3836839|FG000|Part 2|Withdrawal by Subject|0
2200671|NCT01574716|3836840|FG001|Part 2|Withdrawal by Subject|0
2200672|NCT01574716|3836841|FG002|Part 2|Withdrawal by Subject|0
2200673|NCT01574716|3836842|FG003|Part 2|Withdrawal by Subject|5
2200674|NCT01574716|3836843|FG004|Part 2|Withdrawal by Subject|4
2200675|NCT01574716|3836839|FG000|Part 2|Brain metastases|0
2200676|NCT01574716|3836840|FG001|Part 2|Brain metastases|0
2200677|NCT01574716|3836841|FG002|Part 2|Brain metastases|0
2200678|NCT01574716|3836842|FG003|Part 2|Brain metastases|1
2200679|NCT01574716|3836843|FG004|Part 2|Brain metastases|0
2200680|NCT01574716|3836839|FG000|Part 2|Lost to Follow-up|0
2200681|NCT01574716|3836840|FG001|Part 2|Lost to Follow-up|0
2200682|NCT01574716|3836841|FG002|Part 2|Lost to Follow-up|0
2200683|NCT01574716|3836842|FG003|Part 2|Lost to Follow-up|3
2200684|NCT01574716|3836843|FG004|Part 2|Lost to Follow-up|0
2200685|NCT01575054|3836860|FG000|Overall Study|Other Reasons|5
2200686|NCT01575054|3836861|FG001|Overall Study|Other Reasons|3
2200687|NCT01575054|3836860|FG000|Overall Study|Protocol Violation|2
2200688|NCT01575054|3836861|FG001|Overall Study|Protocol Violation|1
2200689|NCT01575054|3836860|FG000|Overall Study|Personal Reasons|10
2200690|NCT01575054|3836861|FG001|Overall Study|Personal Reasons|11
2200691|NCT01575054|3836860|FG000|Overall Study|Lost to Follow-up|3
2200692|NCT01575054|3836861|FG001|Overall Study|Lost to Follow-up|3
2200693|NCT01575054|3836860|FG000|Overall Study|Adverse Event|9
2200694|NCT01575054|3836861|FG001|Overall Study|Adverse Event|8
2200695|NCT01575197|3836879|FG000|Overall Study|Migration out of study area|1
2200696|NCT01575197|3836880|FG001|Overall Study|Migration out of study area|5
2200697|NCT01575197|3836881|FG002|Overall Study|Migration out of study area|4
2200698|NCT01575197|3836879|FG000|Overall Study|SAE|0
2200699|NCT01575197|3836880|FG001|Overall Study|SAE|1
2200700|NCT01575197|3836881|FG002|Overall Study|SAE|0
2200701|NCT01575197|3836879|FG000|Overall Study|Lost to Follow-up|0
2276314|NCT02322021|3958986|FG000|Core Phase|Adverse Event|1
2276315|NCT02322021|3958987|FG001|Core Phase|Adverse Event|3
2276316|NCT02322021|3958988|FG002|Core Phase|Adverse Event|4
2276317|NCT02322021|3958989|FG003|Core Phase|Adverse Event|2
2276318|NCT02322021|3958990|FG004|Core Phase|Adverse Event|0
2276319|NCT02322021|3958986|FG000|Core Phase|Participant Choice|4
2276320|NCT02322021|3958987|FG001|Core Phase|Participant Choice|5
2276321|NCT02322021|3958988|FG002|Core Phase|Participant Choice|4
2276322|NCT02322021|3958989|FG003|Core Phase|Participant Choice|2
2276323|NCT02322021|3958990|FG004|Core Phase|Participant Choice|0
2276324|NCT02322021|3958986|FG000|Core Phase|Lost to Follow-up|0
2276325|NCT02322021|3958987|FG001|Core Phase|Lost to Follow-up|0
2276326|NCT02322021|3958988|FG002|Core Phase|Lost to Follow-up|0
2276327|NCT02322021|3958989|FG003|Core Phase|Lost to Follow-up|1
2276328|NCT02322021|3958990|FG004|Core Phase|Lost to Follow-up|0
2276329|NCT02322021|3958986|FG000|Core Phase|Other|0
2276330|NCT02322021|3958987|FG001|Core Phase|Other|0
2276331|NCT02322021|3958988|FG002|Core Phase|Other|1
2276332|NCT02322021|3958989|FG003|Core Phase|Other|0
2276333|NCT02322021|3958990|FG004|Core Phase|Other|0
2276334|NCT02322021|3958986|FG000|Extension Phase|Adverse Event|0
2276335|NCT02322021|3958987|FG001|Extension Phase|Adverse Event|0
2200702|NCT01575197|3836880|FG001|Overall Study|Lost to Follow-up|1
2200703|NCT01575197|3836881|FG002|Overall Study|Lost to Follow-up|0
2200704|NCT01575197|3836879|FG000|Overall Study|Withdrawal by Subject|0
2200705|NCT01575197|3836880|FG001|Overall Study|Withdrawal by Subject|1
2200706|NCT01575197|3836881|FG002|Overall Study|Withdrawal by Subject|1
2200707|NCT01575197|3836879|FG000|Overall Study|Protocol Violation|2
2276336|NCT02322021|3958988|FG002|Extension Phase|Adverse Event|0
2276337|NCT02322021|3958989|FG003|Extension Phase|Adverse Event|0
2200708|NCT01575197|3836880|FG001|Overall Study|Protocol Violation|1
2200709|NCT01575197|3836881|FG002|Overall Study|Protocol Violation|1
2200710|NCT01575561|3836900|FG000|Overall Study|Adverse Event|9
2200711|NCT01575561|3836900|FG000|Overall Study|Lack of Efficacy|8
2200712|NCT01575561|3836900|FG000|Overall Study|Lost to Follow-up|6
2200713|NCT01575561|3836900|FG000|Overall Study|Protocol Violation|4
2200714|NCT01575561|3836900|FG000|Overall Study|Withdrawal by Subject|11
2200715|NCT01575561|3836900|FG000|Overall Study|administration|1
2200716|NCT01575769|3836912|FG000|Overall Study|Adverse Event|1
2200717|NCT01575769|3836912|FG000|Overall Study|Study terminated by sponsor|40
2200718|NCT01575808|3836920|FG000|Overall Study|Death|2
2200719|NCT01575808|3836921|FG001|Overall Study|Death|0
2200720|NCT01575808|3836920|FG000|Overall Study|Withdrawal by Subject|1
2200721|NCT01575808|3836921|FG001|Overall Study|Withdrawal by Subject|0
2200722|NCT01575834|3836931|FG000|Overall Study|Withdrawal by Subject|352
2200723|NCT01575834|3836932|FG001|Overall Study|Withdrawal by Subject|390
2200724|NCT01575834|3836931|FG000|Overall Study|Death|81
2200725|NCT01575834|3836932|FG001|Overall Study|Death|74
2200726|NCT01575834|3836931|FG000|Overall Study|Other|70
2200727|NCT01575834|3836932|FG001|Overall Study|Other|70
2200728|NCT01575834|3836931|FG000|Overall Study|Adverse Event|63
2200729|NCT01575834|3836932|FG001|Overall Study|Adverse Event|61
2200730|NCT01575834|3836931|FG000|Overall Study|Lost to Follow-up|55
2200731|NCT01575834|3836932|FG001|Overall Study|Lost to Follow-up|68
2200732|NCT01575834|3836931|FG000|Overall Study|Noncompliance|52
2200733|NCT01575834|3836932|FG001|Overall Study|Noncompliance|27
2200734|NCT01575834|3836931|FG000|Overall Study|Administrative decision|15
2200735|NCT01575834|3836932|FG001|Overall Study|Administrative decision|33
2200736|NCT01575834|3836931|FG000|Overall Study|Ineligibility Determined|5
2200737|NCT01575834|3836932|FG001|Overall Study|Ineligibility Determined|8
2200738|NCT01575834|3836931|FG000|Overall Study|Protocol Deviation|4
2200739|NCT01575834|3836932|FG001|Overall Study|Protocol Deviation|3
2200740|NCT01575834|3836931|FG000|Overall Study|Requirement for Alternative Therapy|2
2200741|NCT01575834|3836932|FG001|Overall Study|Requirement for Alternative Therapy|4
2200742|NCT01575860|3836942|FG000|Overall Study|Withdrawal by Subject|1
2200743|NCT01575860|3836942|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1
2200744|NCT01575873|3836951|FG000|Overall Study|Withdrawal by Subject|15
2200745|NCT01575873|3836952|FG001|Overall Study|Withdrawal by Subject|20
2200746|NCT01575873|3836953|FG002|Overall Study|Withdrawal by Subject|34
2200747|NCT01575873|3836954|FG003|Overall Study|Withdrawal by Subject|34
2200748|NCT01575873|3836951|FG000|Overall Study|Adverse Event|7
2200749|NCT01575873|3836952|FG001|Overall Study|Adverse Event|7
2200750|NCT01575873|3836953|FG002|Overall Study|Adverse Event|9
2200751|NCT01575873|3836954|FG003|Overall Study|Adverse Event|12
2200752|NCT01575873|3836951|FG000|Overall Study|Lost to Follow-up|1
2276338|NCT02322021|3958990|FG004|Extension Phase|Adverse Event|3
2276339|NCT02322021|3958986|FG000|Extension Phase|Participant Choice|0
2276340|NCT02322021|3958987|FG001|Extension Phase|Participant Choice|0
2276341|NCT02322021|3958988|FG002|Extension Phase|Participant Choice|0
2276342|NCT02322021|3958989|FG003|Extension Phase|Participant Choice|0
2276343|NCT02322021|3958990|FG004|Extension Phase|Participant Choice|6
2276344|NCT02322021|3958986|FG000|Extension Phase|Other|0
2276345|NCT02322021|3958987|FG001|Extension Phase|Other|0
2276346|NCT02322021|3958988|FG002|Extension Phase|Other|0
2276347|NCT02322021|3958989|FG003|Extension Phase|Other|0
2276348|NCT02322021|3958990|FG004|Extension Phase|Other|3
2276349|NCT02322021|3958986|FG000|Extension Phase|Lost to Follow-up|0
2276350|NCT02322021|3958987|FG001|Extension Phase|Lost to Follow-up|0
2276351|NCT02322021|3958988|FG002|Extension Phase|Lost to Follow-up|0
2276352|NCT02322021|3958989|FG003|Extension Phase|Lost to Follow-up|0
2276353|NCT02322021|3958990|FG004|Extension Phase|Lost to Follow-up|1
2276354|NCT02322021|3958986|FG000|Extension Phase|Study terminated by sponsor|0
2276355|NCT02322021|3958987|FG001|Extension Phase|Study terminated by sponsor|0
2276356|NCT02322021|3958988|FG002|Extension Phase|Study terminated by sponsor|0
2276357|NCT02322021|3958989|FG003|Extension Phase|Study terminated by sponsor|0
2276358|NCT02322021|3958990|FG004|Extension Phase|Study terminated by sponsor|28
2276359|NCT02322047|3959009|FG000|Overall Study|Physician Decision|1
2276360|NCT02322047|3959010|FG001|Overall Study|Physician Decision|0
2276361|NCT02322047|3959011|FG002|Overall Study|Physician Decision|0
2276362|NCT02322047|3959012|FG003|Overall Study|Physician Decision|0
2276363|NCT02322047|3959009|FG000|Overall Study|Withdrawal by Subject|1
2276364|NCT02322047|3959010|FG001|Overall Study|Withdrawal by Subject|0
2276365|NCT02322047|3959011|FG002|Overall Study|Withdrawal by Subject|0
2276366|NCT02322047|3959012|FG003|Overall Study|Withdrawal by Subject|1
2276367|NCT02322047|3959009|FG000|Overall Study|Adverse Event|0
2276368|NCT02322047|3959010|FG001|Overall Study|Adverse Event|1
2276369|NCT02322047|3959011|FG002|Overall Study|Adverse Event|0
2276370|NCT02322047|3959012|FG003|Overall Study|Adverse Event|0
2200753|NCT01575873|3836952|FG001|Overall Study|Lost to Follow-up|3
2200754|NCT01575873|3836953|FG002|Overall Study|Lost to Follow-up|13
2200755|NCT01575873|3836954|FG003|Overall Study|Lost to Follow-up|5
2200756|NCT01575873|3836951|FG000|Overall Study|Death|3
2200757|NCT01575873|3836952|FG001|Overall Study|Death|2
2200758|NCT01575873|3836953|FG002|Overall Study|Death|8
2276371|NCT02322047|3959009|FG000|Overall Study|Lost to Follow-up|0
2276372|NCT02322047|3959010|FG001|Overall Study|Lost to Follow-up|0
2200759|NCT01575873|3836954|FG003|Overall Study|Death|9
2200760|NCT01575873|3836951|FG000|Overall Study|Noncompliance|1
2200761|NCT01575873|3836952|FG001|Overall Study|Noncompliance|2
2200762|NCT01575873|3836953|FG002|Overall Study|Noncompliance|4
2200763|NCT01575873|3836954|FG003|Overall Study|Noncompliance|3
2200764|NCT01575873|3836951|FG000|Overall Study|Administrative decision|1
2200765|NCT01575873|3836952|FG001|Overall Study|Administrative decision|1
2200766|NCT01575873|3836953|FG002|Overall Study|Administrative decision|1
2200767|NCT01575873|3836954|FG003|Overall Study|Administrative decision|0
2200768|NCT01575873|3836951|FG000|Overall Study|Protocol deviation|0
2276373|NCT02322047|3959011|FG002|Overall Study|Lost to Follow-up|1
2276374|NCT02322047|3959012|FG003|Overall Study|Lost to Follow-up|1
2276375|NCT02322125|3959022|FG000|Overall Study|Withdrawal by Subject|2
2276376|NCT02322190|3959026|FG000|Overall Study|Death on study|1
2276377|NCT02322190|3959027|FG001|Overall Study|Death on study|0
2276378|NCT02322216|3959034|FG000|Overall Study|Adverse Event|1
2276379|NCT02322216|3959035|FG001|Overall Study|Adverse Event|0
2276380|NCT02322216|3959034|FG000|Overall Study|Withdrawal by Subject|1
2276381|NCT02322216|3959035|FG001|Overall Study|Withdrawal by Subject|4
2276382|NCT02322229|3959042|FG000|Overall Study|Physician Decision|2
2276383|NCT02322281|3959059|FG000|Overall Study|Progressive Disease|42
2276384|NCT02322281|3959060|FG001|Overall Study|Progressive Disease|14
2276385|NCT02322281|3959061|FG002|Overall Study|Progressive Disease|49
2276386|NCT02322281|3959059|FG000|Overall Study|Adverse Event|3
2276387|NCT02322281|3959060|FG001|Overall Study|Adverse Event|4
2276388|NCT02322281|3959061|FG002|Overall Study|Adverse Event|6
2276389|NCT02322281|3959059|FG000|Overall Study|Death|3
2276390|NCT02322281|3959060|FG001|Overall Study|Death|3
2276391|NCT02322281|3959061|FG002|Overall Study|Death|3
2276392|NCT02322281|3959059|FG000|Overall Study|Withdrawal by Subject|1
2276393|NCT02322281|3959060|FG001|Overall Study|Withdrawal by Subject|1
2276394|NCT02322281|3959061|FG002|Overall Study|Withdrawal by Subject|6
2276395|NCT02322281|3959059|FG000|Overall Study|Physician Decision|2
2276396|NCT02322281|3959060|FG001|Overall Study|Physician Decision|0
2276397|NCT02322281|3959061|FG002|Overall Study|Physician Decision|5
2276398|NCT02322281|3959059|FG000|Overall Study|Study Terminated by Sponsor|2
2276399|NCT02322281|3959060|FG001|Overall Study|Study Terminated by Sponsor|0
2276400|NCT02322281|3959061|FG002|Overall Study|Study Terminated by Sponsor|0
2276401|NCT02322281|3959059|FG000|Overall Study|Missing|0
2276402|NCT02322281|3959060|FG001|Overall Study|Missing|0
2276403|NCT02322281|3959061|FG002|Overall Study|Missing|1
2276404|NCT02322281|3959059|FG000|Overall Study|Miscellaneous|0
2276405|NCT02322281|3959060|FG001|Overall Study|Miscellaneous|0
2276406|NCT02322281|3959061|FG002|Overall Study|Miscellaneous|4
2276407|NCT02322411|3959095|FG000|Overall Study|Lost to Follow-up|4
2276408|NCT02322411|3959096|FG001|Overall Study|Lost to Follow-up|7
2276409|NCT02322411|3959095|FG000|Overall Study|Withdrawal by Subject|1
2276410|NCT02322411|3959096|FG001|Overall Study|Withdrawal by Subject|0
2276411|NCT02322710|3959108|FG000|Overall Study|No efficacy assessment post-baseline|0
2276412|NCT02322710|3959109|FG001|Overall Study|No efficacy assessment post-baseline|1
2276413|NCT02322710|3959108|FG000|Overall Study|Protocol Violation|20
2276414|NCT02322710|3959109|FG001|Overall Study|Protocol Violation|25
2276415|NCT02322749|3959115|FG000|Period 2|Adverse Event|0
2276416|NCT02322749|3959116|FG001|Period 2|Adverse Event|0
2276417|NCT02322749|3959117|FG002|Period 2|Adverse Event|0
2276418|NCT02322749|3959118|FG003|Period 2|Adverse Event|1
2276419|NCT02322749|3959119|FG004|Period 2|Adverse Event|0
2276420|NCT02322749|3959120|FG005|Period 2|Adverse Event|0
2276421|NCT02322749|3959115|FG000|Period 2|Withdrawal by Subject|0
2276422|NCT02322749|3959116|FG001|Period 2|Withdrawal by Subject|0
2276423|NCT02322749|3959117|FG002|Period 2|Withdrawal by Subject|0
2276424|NCT02322749|3959118|FG003|Period 2|Withdrawal by Subject|1
2276425|NCT02322749|3959119|FG004|Period 2|Withdrawal by Subject|0
2276426|NCT02322749|3959120|FG005|Period 2|Withdrawal by Subject|0
2276427|NCT02322749|3959115|FG000|Period 3|Withdrawal by Subject|0
2276428|NCT02322749|3959116|FG001|Period 3|Withdrawal by Subject|0
2276429|NCT02322749|3959117|FG002|Period 3|Withdrawal by Subject|1
2276430|NCT02322749|3959118|FG003|Period 3|Withdrawal by Subject|0
2276431|NCT02322749|3959119|FG004|Period 3|Withdrawal by Subject|0
2276432|NCT02322749|3959120|FG005|Period 3|Withdrawal by Subject|0
2276433|NCT02322775|3959131|FG000|Overall Study|Adverse Event|1
2276434|NCT02322775|3959132|FG001|Overall Study|Adverse Event|0
2276435|NCT02322775|3959131|FG000|Overall Study|Lost to Follow-up|0
2276436|NCT02322775|3959132|FG001|Overall Study|Lost to Follow-up|1
2276437|NCT02322775|3959131|FG000|Overall Study|Protocol Violation|1
2276438|NCT02322775|3959132|FG001|Overall Study|Protocol Violation|0
2276439|NCT02322775|3959131|FG000|Overall Study|Withdrawal by Subject|3
2276440|NCT02322775|3959132|FG001|Overall Study|Withdrawal by Subject|4
2276441|NCT02322775|3959131|FG000|Overall Study|Not willing to perform all FU visits|0
2276442|NCT02322775|3959132|FG001|Overall Study|Not willing to perform all FU visits|1
2276443|NCT02322814|3959156|FG000|Overall Study|Ongoing Study|0
2276444|NCT02322814|3959157|FG001|Overall Study|Ongoing Study|13
2276445|NCT02322814|3959158|FG002|Overall Study|Ongoing Study|14
2276446|NCT02322814|3959159|FG003|Overall Study|Ongoing Study|20
2276447|NCT02322814|3959160|FG004|Overall Study|Ongoing Study|22
2276448|NCT02322814|3959156|FG000|Overall Study|Progressive Disease|0
2276449|NCT02322814|3959157|FG001|Overall Study|Progressive Disease|2
2200769|NCT01575873|3836952|FG001|Overall Study|Protocol deviation|1
2200770|NCT01575873|3836953|FG002|Overall Study|Protocol deviation|0
2200771|NCT01575873|3836954|FG003|Overall Study|Protocol deviation|1
2200772|NCT01575873|3836951|FG000|Overall Study|Requirement for Alternative Therapy|0
2200773|NCT01575873|3836952|FG001|Overall Study|Requirement for Alternative Therapy|0
2200774|NCT01575873|3836953|FG002|Overall Study|Requirement for Alternative Therapy|1
2200775|NCT01575873|3836954|FG003|Overall Study|Requirement for Alternative Therapy|1
2200776|NCT01575873|3836951|FG000|Overall Study|Other|0
2200777|NCT01575873|3836952|FG001|Overall Study|Other|0
2200778|NCT01575873|3836953|FG002|Overall Study|Other|4
2200779|NCT01575873|3836954|FG003|Overall Study|Other|2
2276450|NCT02322814|3959158|FG002|Overall Study|Progressive Disease|0
2276451|NCT02322814|3959159|FG003|Overall Study|Progressive Disease|1
2276452|NCT02322814|3959160|FG004|Overall Study|Progressive Disease|0
2276453|NCT02322814|3959156|FG000|Overall Study|Lost to Follow-up|1
2200780|NCT01575899|3836965|FG000|Overall Study|Lost to Follow-up|3
2200781|NCT01575899|3836966|FG001|Overall Study|Lost to Follow-up|4
2200782|NCT01575899|3836967|FG002|Overall Study|Lost to Follow-up|2
2200783|NCT01575899|3836965|FG000|Overall Study|Protocol Violation|2
2200784|NCT01575899|3836966|FG001|Overall Study|Protocol Violation|1
2200785|NCT01575899|3836967|FG002|Overall Study|Protocol Violation|0
2217176|NCT01706328|3860325|FG002|12-week Double-blind Treatment Period|Adverse Event|16
2217177|NCT01706328|3860323|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0
2217178|NCT01706328|3860324|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4
2217179|NCT01706328|3860325|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4
2217180|NCT01706328|3860323|FG000|12-week Double-blind Treatment Period|Protocol Violation|0
2217181|NCT01706328|3860324|FG001|12-week Double-blind Treatment Period|Protocol Violation|4
2217182|NCT01706328|3860325|FG002|12-week Double-blind Treatment Period|Protocol Violation|2
2217183|NCT01706328|3860323|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
2217184|NCT01706328|3860324|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
2217185|NCT01706328|3860325|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
2217186|NCT01706328|3860323|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0
2217187|NCT01706328|3860324|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3
2217188|NCT01706328|3860325|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1
2217189|NCT01706328|3860323|FG000|12-week Double-blind Treatment Period|Physician Decision|0
2217190|NCT01706328|3860324|FG001|12-week Double-blind Treatment Period|Physician Decision|2
2217191|NCT01706328|3860325|FG002|12-week Double-blind Treatment Period|Physician Decision|2
2217192|NCT01706328|3860323|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0
2217193|NCT01706328|3860324|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8
2217194|NCT01706328|3860325|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11
2217195|NCT01706458|3860333|FG000|Overall Study|Physician Decision|3
2217196|NCT01706458|3860334|FG001|Overall Study|Physician Decision|4
2217197|NCT01706536|3860349|FG000|Overall Study|Withdrawal by Subject|1
2217198|NCT01706536|3860350|FG001|Overall Study|Withdrawal by Subject|0
2217199|NCT01706536|3860351|FG002|Overall Study|Withdrawal by Subject|1
2217200|NCT01706536|3860352|FG003|Overall Study|Withdrawal by Subject|0
2217201|NCT01706536|3860353|FG004|Overall Study|Withdrawal by Subject|0
2217202|NCT01706536|3860349|FG000|Overall Study|Adverse Event|2
2217203|NCT01706536|3860350|FG001|Overall Study|Adverse Event|3
2217204|NCT01706536|3860351|FG002|Overall Study|Adverse Event|4
2217205|NCT01706536|3860352|FG003|Overall Study|Adverse Event|3
2217206|NCT01706536|3860353|FG004|Overall Study|Adverse Event|2
2217207|NCT01706536|3860349|FG000|Overall Study|Lack of Efficacy|1
2217208|NCT01706536|3860350|FG001|Overall Study|Lack of Efficacy|0
2217209|NCT01706536|3860351|FG002|Overall Study|Lack of Efficacy|0
2217210|NCT01706536|3860352|FG003|Overall Study|Lack of Efficacy|1
2217211|NCT01706536|3860353|FG004|Overall Study|Lack of Efficacy|0
2276454|NCT02322814|3959157|FG001|Overall Study|Lost to Follow-up|2
2276455|NCT02322814|3959158|FG002|Overall Study|Lost to Follow-up|1
2276456|NCT02322814|3959159|FG003|Overall Study|Lost to Follow-up|0
2217212|NCT01706536|3860349|FG000|Overall Study|non compliance|0
2217213|NCT01706536|3860350|FG001|Overall Study|non compliance|1
2217214|NCT01706536|3860351|FG002|Overall Study|non compliance|0
2217215|NCT01706536|3860352|FG003|Overall Study|non compliance|0
2217216|NCT01706536|3860353|FG004|Overall Study|non compliance|0
2217217|NCT01706575|3860370|FG000|Overall Study|Participant Withdrew Consent|4
2217218|NCT01706575|3860370|FG000|Overall Study|Lost to Follow-up|2
2217219|NCT01706575|3860370|FG000|Overall Study|Started but not Treated|6
2217220|NCT01706770|3860410|FG000|Overall Study|Lost to Follow-up|1
2217221|NCT01706770|3860411|FG001|Overall Study|Lost to Follow-up|0
2217222|NCT01706770|3860410|FG000|Overall Study|Physician Decision|1
2217223|NCT01706770|3860411|FG001|Overall Study|Physician Decision|0
2217224|NCT01706926|3860425|FG000|Overall Study|Lost to Follow-up|0
2217225|NCT01706926|3860426|FG001|Overall Study|Lost to Follow-up|0
2217226|NCT01706926|3860427|FG002|Overall Study|Lost to Follow-up|1
2217227|NCT01706926|3860428|FG003|Overall Study|Lost to Follow-up|0
2217228|NCT01706926|3860425|FG000|Overall Study|Withdrawal by Subject|2
2217229|NCT01706926|3860426|FG001|Overall Study|Withdrawal by Subject|0
2217230|NCT01706926|3860427|FG002|Overall Study|Withdrawal by Subject|1
2217231|NCT01706926|3860428|FG003|Overall Study|Withdrawal by Subject|2
2217232|NCT01706926|3860425|FG000|Overall Study|Other|4
2200786|NCT01576016|3837005|FG000|Lead Safety|Death|132
2200787|NCT01576016|3837006|FG001|Lead Safety|Death|0
2200788|NCT01576016|3837005|FG000|Lead Safety|Withdrawal by Subject|81
2200789|NCT01576016|3837006|FG001|Lead Safety|Withdrawal by Subject|0
2200790|NCT01576016|3837005|FG000|Lead Safety|System Explanted without Replacement|24
2200791|NCT01576016|3837006|FG001|Lead Safety|System Explanted without Replacement|0
2200792|NCT01576016|3837005|FG000|Lead Safety|Physician Decision|14
2200793|NCT01576016|3837006|FG001|Lead Safety|Physician Decision|0
2200794|NCT01576016|3837005|FG000|Lead Safety|Lost to Follow-up|13
2200795|NCT01576016|3837006|FG001|Lead Safety|Lost to Follow-up|0
2200796|NCT01576016|3837005|FG000|Lead Safety|Unsuccessful implant|2
2200797|NCT01576016|3837006|FG001|Lead Safety|Unsuccessful implant|0
2200798|NCT01576016|3837005|FG000|Lead Safety|Sponsor request|1
2200799|NCT01576016|3837006|FG001|Lead Safety|Sponsor request|0
2200800|NCT01576016|3837005|FG000|Lead Safety|Device replaced with CRT-D|1
2200801|NCT01576016|3837006|FG001|Lead Safety|Device replaced with CRT-D|0
2200802|NCT01576016|3837005|FG000|Lead Safety|Patient on Palliative Care|1
2200803|NCT01576016|3837006|FG001|Lead Safety|Patient on Palliative Care|0
2200804|NCT01576016|3837005|FG000|Lead Safety|Patient noncompliance|1
2200805|NCT01576016|3837006|FG001|Lead Safety|Patient noncompliance|0
2200806|NCT01576016|3837005|FG000|Lead Safety|Too far from study site|1
2200807|NCT01576016|3837006|FG001|Lead Safety|Too far from study site|0
2200808|NCT01576016|3837005|FG000|Lead Safety|System deactivated|1
2200809|NCT01576016|3837006|FG001|Lead Safety|System deactivated|0
2200810|NCT01576016|3837005|FG000|Lead Safety|Patient no longer followed by study PI|1
2200811|NCT01576016|3837006|FG001|Lead Safety|Patient no longer followed by study PI|0
2200812|NCT01576016|3837005|FG000|MRI Safety|Withdrawal by Subject|0
2200813|NCT01576016|3837006|FG001|MRI Safety|Withdrawal by Subject|10
2200814|NCT01576016|3837005|FG000|MRI Safety|Non-MRI Compatible Device or Material|0
2200815|NCT01576016|3837006|FG001|MRI Safety|Non-MRI Compatible Device or Material|5
2200816|NCT01576016|3837005|FG000|MRI Safety|Has not yet completed MRI scan|0
2200817|NCT01576016|3837006|FG001|MRI Safety|Has not yet completed MRI scan|56
2200818|NCT01576016|3837005|FG000|MRI Safety|MRI scan not performed at MRI visit|0
2200819|NCT01576016|3837006|FG001|MRI Safety|MRI scan not performed at MRI visit|3
2200820|NCT01576042|3837016|FG000|Overall Study|Physician Decision|2
2200821|NCT01576042|3837017|FG001|Overall Study|Physician Decision|0
2200822|NCT01576146|3837041|FG000|Extension Period 1|Adverse Event|2
2200823|NCT01576146|3837041|FG000|Extension Period 1|Death|2
2200824|NCT01576146|3837041|FG000|Extension Period 1|Physician Decision|2
2200825|NCT01576146|3837041|FG000|Extension Period 1|Withdrawal by Subject|1
2200826|NCT01576146|3837041|FG000|Extension Period 1|Lost to Follow-up|1
2200827|NCT01576146|3837041|FG000|Extension Period 1|Parathyroidectomy|1
2200828|NCT01576146|3837041|FG000|Extension Period 1|Renal Transplant|1
2200829|NCT01576146|3837041|FG000|Extension Period 2|Sponsor Decision|13
2200830|NCT01576146|3837041|FG000|Extension Period 2|Death|1
2200831|NCT01576146|3837041|FG000|Extension Period 2|Adverse Event|1
2200832|NCT01576146|3837041|FG000|Extension Period 2|Renal Transplant|1
2200833|NCT01576146|3837041|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
2200834|NCT01576159|3837049|FG000|Overall Study|Withdrawal by Subject|0
2200835|NCT01576159|3837050|FG001|Overall Study|Withdrawal by Subject|1
2200836|NCT01576159|3837051|FG002|Overall Study|Withdrawal by Subject|0
2200837|NCT01576159|3837052|FG003|Overall Study|Withdrawal by Subject|0
2200838|NCT01576159|3837049|FG000|Overall Study|Physician Decision|0
2200839|NCT01576159|3837050|FG001|Overall Study|Physician Decision|0
2200840|NCT01576159|3837051|FG002|Overall Study|Physician Decision|1
2200841|NCT01576159|3837052|FG003|Overall Study|Physician Decision|0
2200842|NCT01576159|3837049|FG000|Overall Study|Lost to Follow-up|0
2200843|NCT01576159|3837050|FG001|Overall Study|Lost to Follow-up|0
2200844|NCT01576159|3837051|FG002|Overall Study|Lost to Follow-up|0
2200845|NCT01576159|3837052|FG003|Overall Study|Lost to Follow-up|1
2200846|NCT01576159|3837049|FG000|Overall Study|Protocol Violation|1
2200847|NCT01576159|3837050|FG001|Overall Study|Protocol Violation|0
2200848|NCT01576159|3837051|FG002|Overall Study|Protocol Violation|0
2200849|NCT01576159|3837052|FG003|Overall Study|Protocol Violation|0
2200850|NCT01576172|3837071|FG000|Overall Study|Ineligible|2
2200851|NCT01576172|3837072|FG001|Overall Study|Ineligible|1
2200852|NCT01576172|3837071|FG000|Overall Study|Withdrawal by Subject|2
2200853|NCT01576172|3837072|FG001|Overall Study|Withdrawal by Subject|0
2200854|NCT01576172|3837071|FG000|Overall Study|Insurance issue|1
2200855|NCT01576172|3837072|FG001|Overall Study|Insurance issue|0
2200856|NCT01576341|3837090|FG000|Overall Study|Withdrawal by Subject|24
2276457|NCT02322814|3959160|FG004|Overall Study|Lost to Follow-up|0
2276458|NCT02322814|3959156|FG000|Overall Study|Other|2
2276459|NCT02322814|3959157|FG001|Overall Study|Other|0
2276460|NCT02322814|3959158|FG002|Overall Study|Other|0
2276461|NCT02322814|3959159|FG003|Overall Study|Other|0
2276462|NCT02322814|3959160|FG004|Overall Study|Other|0
2276463|NCT02322814|3959156|FG000|Overall Study|Protocol Violation|1
2276464|NCT02322814|3959157|FG001|Overall Study|Protocol Violation|0
2276465|NCT02322814|3959158|FG002|Overall Study|Protocol Violation|0
2200857|NCT01576341|3837090|FG000|Overall Study|Adverse Event|10
2200858|NCT01576341|3837090|FG000|Overall Study|Death|21
2200859|NCT01576341|3837090|FG000|Overall Study|Physician Decision|2
2200860|NCT01576341|3837090|FG000|Overall Study|Lost to Follow-up|2
2200861|NCT01576341|3837090|FG000|Overall Study|Kidney transplantation|10
2276466|NCT02322814|3959159|FG003|Overall Study|Protocol Violation|0
2200862|NCT01576341|3837090|FG000|Overall Study|Protocol Violation|12
2200863|NCT01576341|3837090|FG000|Overall Study|Other|12
2200864|NCT01576367|3837097|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2200865|NCT01576367|3837097|FG000|Overall Study|Moved to commercial use after 6 months|1
2200866|NCT01576406|3837107|FG000|Overall Study|Lost to Follow-up|1
2200867|NCT01576406|3837108|FG001|Overall Study|Lost to Follow-up|2
2200868|NCT01576406|3837109|FG002|Overall Study|Lost to Follow-up|0
2200869|NCT01576406|3837110|FG003|Overall Study|Lost to Follow-up|0
2200870|NCT01576406|3837111|FG004|Overall Study|Lost to Follow-up|0
2200871|NCT01576406|3837112|FG005|Overall Study|Lost to Follow-up|0
2200872|NCT01576406|3837107|FG000|Overall Study|Death|3
2200873|NCT01576406|3837108|FG001|Overall Study|Death|4
2200874|NCT01576406|3837109|FG002|Overall Study|Death|8
2200875|NCT01576406|3837110|FG003|Overall Study|Death|5
2200876|NCT01576406|3837111|FG004|Overall Study|Death|7
2200877|NCT01576406|3837112|FG005|Overall Study|Death|9
2200878|NCT01576406|3837107|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0
2200879|NCT01576406|3837108|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0
2200880|NCT01576406|3837109|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1
2200881|NCT01576406|3837110|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1
2200882|NCT01576406|3837111|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0
2200883|NCT01576406|3837112|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0
2200884|NCT01576406|3837107|FG000|Overall Study|Withdrawal the consent|2
2200885|NCT01576406|3837108|FG001|Overall Study|Withdrawal the consent|2
2200886|NCT01576406|3837109|FG002|Overall Study|Withdrawal the consent|5
2200887|NCT01576406|3837110|FG003|Overall Study|Withdrawal the consent|1
2276467|NCT02322814|3959160|FG004|Overall Study|Protocol Violation|0
2276468|NCT02322814|3959156|FG000|Overall Study|Death|7
2200888|NCT01576406|3837111|FG004|Overall Study|Withdrawal the consent|1
2200889|NCT01576406|3837112|FG005|Overall Study|Withdrawal the consent|3
2200890|NCT01576406|3837107|FG000|Overall Study|Other|0
2200891|NCT01576406|3837108|FG001|Overall Study|Other|0
2200892|NCT01576406|3837109|FG002|Overall Study|Other|2
2200893|NCT01576406|3837110|FG003|Overall Study|Other|2
2200894|NCT01576406|3837111|FG004|Overall Study|Other|0
2200895|NCT01576406|3837112|FG005|Overall Study|Other|0
2200896|NCT01576484|3837137|FG000|Overall Study|Adverse Event|1
2200897|NCT01576484|3837138|FG001|Overall Study|Adverse Event|1
2200898|NCT01576484|3837137|FG000|Overall Study|Protocol Violation|0
2200899|NCT01576484|3837138|FG001|Overall Study|Protocol Violation|2
2200900|NCT01576484|3837137|FG000|Overall Study|Sponsor Decision|2
2200901|NCT01576484|3837138|FG001|Overall Study|Sponsor Decision|8
2200902|NCT01576484|3837137|FG000|Overall Study|Withdrawal by Subject|0
2200903|NCT01576484|3837138|FG001|Overall Study|Withdrawal by Subject|3
2200904|NCT01576484|3837137|FG000|Overall Study|Other|2
2200905|NCT01576484|3837138|FG001|Overall Study|Other|5
2200906|NCT01576705|3837179|FG000|Overall Study|TSH > 7 mIU/L at baseline|3
2200907|NCT01576705|3837180|FG001|Overall Study|TSH > 7 mIU/L at baseline|7
2200908|NCT01576705|3837181|FG002|Overall Study|TSH > 7 mIU/L at baseline|5
2200909|NCT01576705|3837182|FG003|Overall Study|TSH > 7 mIU/L at baseline|3
2200910|NCT01576705|3837179|FG000|Overall Study|invalid ICF|0
2200911|NCT01576705|3837180|FG001|Overall Study|invalid ICF|1
2200912|NCT01576705|3837181|FG002|Overall Study|invalid ICF|0
2200913|NCT01576705|3837182|FG003|Overall Study|invalid ICF|0
2200914|NCT01576718|3837198|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
2276469|NCT02322814|3959157|FG001|Overall Study|Death|22
2276470|NCT02322814|3959158|FG002|Overall Study|Death|30
2276471|NCT02322814|3959159|FG003|Overall Study|Death|10
2276472|NCT02322814|3959160|FG004|Overall Study|Death|6
2276473|NCT02322814|3959156|FG000|Overall Study|Withdrawal by Subject|5
2276474|NCT02322814|3959157|FG001|Overall Study|Withdrawal by Subject|4
2276475|NCT02322814|3959158|FG002|Overall Study|Withdrawal by Subject|2
2276476|NCT02322814|3959159|FG003|Overall Study|Withdrawal by Subject|1
2276477|NCT02322814|3959160|FG004|Overall Study|Withdrawal by Subject|3
2276478|NCT02322866|3959173|FG000|Overall Study|Adverse Event|6
2276479|NCT02322866|3959174|FG001|Overall Study|Adverse Event|11
2276480|NCT02322866|3959173|FG000|Overall Study|Withdrawal of Consent|16
2276481|NCT02322866|3959174|FG001|Overall Study|Withdrawal of Consent|25
2276482|NCT02322866|3959173|FG000|Overall Study|Lost to Follow-up|36
2276483|NCT02322866|3959174|FG001|Overall Study|Lost to Follow-up|39
2276484|NCT02322866|3959173|FG000|Overall Study|Protocol Violation|1
2276485|NCT02322866|3959174|FG001|Overall Study|Protocol Violation|0
2276486|NCT02322866|3959173|FG000|Overall Study|Noncompliance with Treatment|3
2276487|NCT02322866|3959174|FG001|Overall Study|Noncompliance with Treatment|4
2276488|NCT02322866|3959173|FG000|Overall Study|Lack of Efficacy|3
2276489|NCT02322866|3959174|FG001|Overall Study|Lack of Efficacy|1
2276490|NCT02322866|3959173|FG000|Overall Study|Other Miscellaneous Reasons|6
2276491|NCT02322866|3959174|FG001|Overall Study|Other Miscellaneous Reasons|6
2276492|NCT02322879|3959182|FG000|First Intervention|Physician Decision|1
2276493|NCT02322879|3959183|FG001|First Intervention|Physician Decision|0
2276494|NCT02322892|3959191|FG000|Overall Study|Surgery cancelled|1
2276495|NCT02322892|3959192|FG001|Overall Study|Surgery cancelled|2
2200915|NCT01576718|3837199|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2200916|NCT01576718|3837200|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2217233|NCT01706926|3860426|FG001|Overall Study|Other|4
2200917|NCT01576718|3837201|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2200918|NCT01576718|3837202|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2200919|NCT01576718|3837203|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2200920|NCT01576718|3837204|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2200921|NCT01576718|3837198|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
2200922|NCT01576718|3837199|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2200923|NCT01576718|3837200|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2200924|NCT01576718|3837201|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2200925|NCT01576718|3837202|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2200926|NCT01576718|3837203|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2200927|NCT01576718|3837204|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2200928|NCT01576718|3837198|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
2200929|NCT01576718|3837199|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2200930|NCT01576718|3837200|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2200931|NCT01576718|3837201|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2200932|NCT01576718|3837202|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2200933|NCT01576718|3837203|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2200934|NCT01576718|3837204|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2200935|NCT01576718|3837198|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
2200936|NCT01576718|3837199|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2200937|NCT01576718|3837200|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2200938|NCT01576718|3837201|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2200939|NCT01576718|3837202|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2200940|NCT01576718|3837203|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2200941|NCT01576718|3837204|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2200942|NCT01576718|3837198|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
2276496|NCT02322892|3959191|FG000|Overall Study|Met exclusion criteria|0
2276497|NCT02322892|3959192|FG001|Overall Study|Met exclusion criteria|1
2276498|NCT02322892|3959191|FG000|Overall Study|Protocol Violation|1
2276499|NCT02322892|3959192|FG001|Overall Study|Protocol Violation|0
2276500|NCT02323113|3959226|FG000|Overall Study|Adverse Event|3
2276501|NCT02323113|3959227|FG001|Overall Study|Adverse Event|3
2276502|NCT02323113|3959228|FG002|Overall Study|Adverse Event|2
2276503|NCT02323113|3959229|FG003|Overall Study|Adverse Event|5
2276504|NCT02323113|3959230|FG004|Overall Study|Adverse Event|8
2276505|NCT02323113|3959231|FG005|Overall Study|Adverse Event|3
2276506|NCT02323113|3959232|FG006|Overall Study|Adverse Event|6
2276507|NCT02323113|3959233|FG007|Overall Study|Adverse Event|0
2276508|NCT02323113|3959226|FG000|Overall Study|Progressive Disease|0
2276509|NCT02323113|3959227|FG001|Overall Study|Progressive Disease|1
2276510|NCT02323113|3959228|FG002|Overall Study|Progressive Disease|1
2276511|NCT02323113|3959229|FG003|Overall Study|Progressive Disease|0
2276512|NCT02323113|3959230|FG004|Overall Study|Progressive Disease|0
2276513|NCT02323113|3959231|FG005|Overall Study|Progressive Disease|3
2276514|NCT02323113|3959232|FG006|Overall Study|Progressive Disease|0
2276515|NCT02323113|3959233|FG007|Overall Study|Progressive Disease|0
2276516|NCT02323113|3959226|FG000|Overall Study|Symptomatic Deterioration|0
2276517|NCT02323113|3959227|FG001|Overall Study|Symptomatic Deterioration|0
2276518|NCT02323113|3959228|FG002|Overall Study|Symptomatic Deterioration|1
2276519|NCT02323113|3959229|FG003|Overall Study|Symptomatic Deterioration|0
2276520|NCT02323113|3959230|FG004|Overall Study|Symptomatic Deterioration|1
2276521|NCT02323113|3959231|FG005|Overall Study|Symptomatic Deterioration|0
2276522|NCT02323113|3959232|FG006|Overall Study|Symptomatic Deterioration|0
2276523|NCT02323113|3959233|FG007|Overall Study|Symptomatic Deterioration|0
2276524|NCT02323113|3959226|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
2276525|NCT02323113|3959227|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
2276526|NCT02323113|3959228|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
2276527|NCT02323113|3959229|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
2276528|NCT02323113|3959230|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
2276529|NCT02323113|3959231|FG005|Overall Study|Unsatisfactory Therapeutic Response|2
2276530|NCT02323113|3959232|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
2276531|NCT02323113|3959233|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
2276532|NCT02323113|3959226|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
2276533|NCT02323113|3959227|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1
2276534|NCT02323113|3959228|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
2276535|NCT02323113|3959229|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
2276536|NCT02323113|3959230|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
2276537|NCT02323113|3959231|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
2276538|NCT02323113|3959232|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
2320591|NCT02951533|4034899|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
2200943|NCT01576718|3837199|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
2200944|NCT01576718|3837200|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
2200945|NCT01576718|3837201|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
2200946|NCT01576718|3837202|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
2200947|NCT01576718|3837203|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
2200948|NCT01576718|3837204|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
2200949|NCT01576718|3837198|FG000|Treatment Period|Adverse Event|0
2200950|NCT01576718|3837199|FG001|Treatment Period|Adverse Event|1
2200951|NCT01576718|3837200|FG002|Treatment Period|Adverse Event|1
2200952|NCT01576718|3837201|FG003|Treatment Period|Adverse Event|1
2200953|NCT01576718|3837202|FG004|Treatment Period|Adverse Event|1
2200954|NCT01576718|3837203|FG005|Treatment Period|Adverse Event|1
2200955|NCT01576718|3837204|FG006|Treatment Period|Adverse Event|0
2200956|NCT01576718|3837198|FG000|Treatment Period|Withdrawal by Subject|0
2200957|NCT01576718|3837199|FG001|Treatment Period|Withdrawal by Subject|1
2200958|NCT01576718|3837200|FG002|Treatment Period|Withdrawal by Subject|1
2200959|NCT01576718|3837201|FG003|Treatment Period|Withdrawal by Subject|0
2200960|NCT01576718|3837202|FG004|Treatment Period|Withdrawal by Subject|2
2200961|NCT01576718|3837203|FG005|Treatment Period|Withdrawal by Subject|4
2200962|NCT01576718|3837204|FG006|Treatment Period|Withdrawal by Subject|2
2200963|NCT01576718|3837198|FG000|Treatment Period|Physician Decision|0
2200964|NCT01576718|3837199|FG001|Treatment Period|Physician Decision|1
2200965|NCT01576718|3837200|FG002|Treatment Period|Physician Decision|1
2276539|NCT02323113|3959233|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
2276554|NCT02323204|3959266|FG000|Baseline Survey Completion|Withdrawal by Subject|10
2276555|NCT02323204|3959267|FG001|Baseline Survey Completion|Withdrawal by Subject|9
2276556|NCT02323204|3959268|FG002|Baseline Survey Completion|Withdrawal by Subject|5
2276557|NCT02323204|3959269|FG003|Baseline Survey Completion|Withdrawal by Subject|3
2276558|NCT02323204|3959266|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29
2276559|NCT02323204|3959267|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28
2276560|NCT02323204|3959268|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39
2276561|NCT02323204|3959269|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35
2276562|NCT02323204|3959266|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12
2276563|NCT02323204|3959267|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8
2276564|NCT02323204|3959268|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3
2276565|NCT02323204|3959269|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2
2276566|NCT02323204|3959266|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0
2276567|NCT02323204|3959267|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35
2276568|NCT02323204|3959268|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0
2276569|NCT02323204|3959269|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34
2276570|NCT02323204|3959266|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
2276571|NCT02323204|3959267|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
2276572|NCT02323204|3959268|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
2276573|NCT02323204|3959269|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
2276574|NCT02323204|3959266|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54
2276575|NCT02323204|3959267|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45
2276576|NCT02323204|3959268|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41
2276577|NCT02323204|3959269|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42
2276578|NCT02323204|3959266|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0
2276579|NCT02323204|3959267|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2
2276580|NCT02323204|3959268|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0
2276581|NCT02323204|3959269|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2
2276582|NCT02323204|3959266|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49
2276583|NCT02323204|3959267|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50
2276584|NCT02323204|3959268|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38
2276585|NCT02323204|3959269|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43
2276586|NCT02323204|3959266|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0
2276587|NCT02323204|3959267|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0
2276588|NCT02323204|3959268|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3
2276589|NCT02323204|3959269|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1
2276590|NCT02323334|3959293|FG000|Period 3|Lost to Follow-up|0
2276591|NCT02323334|3959294|FG001|Period 3|Lost to Follow-up|0
2200966|NCT01576718|3837201|FG003|Treatment Period|Physician Decision|1
2200967|NCT01576718|3837202|FG004|Treatment Period|Physician Decision|1
2200968|NCT01576718|3837203|FG005|Treatment Period|Physician Decision|0
2276592|NCT02323334|3959295|FG002|Period 3|Lost to Follow-up|1
2276593|NCT02323334|3959296|FG003|Period 3|Lost to Follow-up|0
2276594|NCT02323334|3959297|FG004|Period 3|Lost to Follow-up|0
2276595|NCT02323334|3959298|FG005|Period 3|Lost to Follow-up|0
2276596|NCT02323334|3959299|FG006|Period 3|Lost to Follow-up|0
2276597|NCT02323334|3959300|FG007|Period 3|Lost to Follow-up|0
2276598|NCT02323334|3959301|FG008|Period 3|Lost to Follow-up|0
2276599|NCT02323334|3959302|FG009|Period 3|Lost to Follow-up|0
2276600|NCT02323334|3959303|FG010|Period 3|Lost to Follow-up|0
2276601|NCT02323334|3959304|FG011|Period 3|Lost to Follow-up|0
2276602|NCT02323334|3959305|FG012|Period 3|Lost to Follow-up|0
2276603|NCT02323334|3959306|FG013|Period 3|Lost to Follow-up|0
2276604|NCT02323334|3959307|FG014|Period 3|Lost to Follow-up|0
2276605|NCT02323334|3959308|FG015|Period 3|Lost to Follow-up|0
2276606|NCT02323334|3959309|FG016|Period 3|Lost to Follow-up|0
2276607|NCT02323334|3959293|FG000|Period 3|Withdrawal by Subject|1
2276608|NCT02323334|3959294|FG001|Period 3|Withdrawal by Subject|0
2276609|NCT02323334|3959295|FG002|Period 3|Withdrawal by Subject|0
2276610|NCT02323334|3959296|FG003|Period 3|Withdrawal by Subject|0
2276611|NCT02323334|3959297|FG004|Period 3|Withdrawal by Subject|0
2276612|NCT02323334|3959298|FG005|Period 3|Withdrawal by Subject|0
2276613|NCT02323334|3959299|FG006|Period 3|Withdrawal by Subject|0
2276614|NCT02323334|3959300|FG007|Period 3|Withdrawal by Subject|0
2276615|NCT02323334|3959301|FG008|Period 3|Withdrawal by Subject|0
2276616|NCT02323334|3959302|FG009|Period 3|Withdrawal by Subject|0
2276617|NCT02323334|3959303|FG010|Period 3|Withdrawal by Subject|0
2276618|NCT02323334|3959304|FG011|Period 3|Withdrawal by Subject|0
2276619|NCT02323334|3959305|FG012|Period 3|Withdrawal by Subject|0
2276620|NCT02323334|3959306|FG013|Period 3|Withdrawal by Subject|0
2276621|NCT02323334|3959307|FG014|Period 3|Withdrawal by Subject|0
2276622|NCT02323334|3959308|FG015|Period 3|Withdrawal by Subject|0
2276623|NCT02323334|3959309|FG016|Period 3|Withdrawal by Subject|0
2320592|NCT02951533|4034900|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
2320593|NCT02951533|4034901|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
2320594|NCT02951533|4034899|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
2320595|NCT02951533|4034900|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
2320596|NCT02951533|4034901|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
2320597|NCT02951533|4034899|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
2320598|NCT02951533|4034900|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
2320599|NCT02951533|4034901|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
2320600|NCT02951780|4034936|FG000|Period 1|Adverse Event|0
2320601|NCT02951780|4034937|FG001|Period 1|Adverse Event|0
2320602|NCT02951780|4034938|FG002|Period 1|Adverse Event|0
2320603|NCT02951780|4034939|FG003|Period 1|Adverse Event|1
2320604|NCT02951780|4034940|FG004|Period 1|Adverse Event|0
2320605|NCT02951780|4034941|FG005|Period 1|Adverse Event|0
2320606|NCT02951780|4034942|FG006|Period 1|Adverse Event|0
2320607|NCT02951780|4034943|FG007|Period 1|Adverse Event|0
2320608|NCT02951780|4034944|FG008|Period 1|Adverse Event|0
2320609|NCT02951780|4034936|FG000|Period 1|Scheduling Conflicts|0
2320610|NCT02951780|4034937|FG001|Period 1|Scheduling Conflicts|0
2320611|NCT02951780|4034938|FG002|Period 1|Scheduling Conflicts|0
2320612|NCT02951780|4034939|FG003|Period 1|Scheduling Conflicts|0
2320613|NCT02951780|4034940|FG004|Period 1|Scheduling Conflicts|0
2320614|NCT02951780|4034941|FG005|Period 1|Scheduling Conflicts|0
2320615|NCT02951780|4034942|FG006|Period 1|Scheduling Conflicts|0
2320616|NCT02951780|4034943|FG007|Period 1|Scheduling Conflicts|1
2200969|NCT01576718|3837204|FG006|Treatment Period|Physician Decision|0
2200970|NCT01576718|3837198|FG000|Treatment Period|Protocol Violation|0
2200971|NCT01576718|3837199|FG001|Treatment Period|Protocol Violation|5
2200972|NCT01576718|3837200|FG002|Treatment Period|Protocol Violation|4
2200973|NCT01576718|3837201|FG003|Treatment Period|Protocol Violation|10
2200974|NCT01576718|3837202|FG004|Treatment Period|Protocol Violation|6
2200975|NCT01576718|3837203|FG005|Treatment Period|Protocol Violation|8
2200976|NCT01576718|3837204|FG006|Treatment Period|Protocol Violation|12
2200977|NCT01576718|3837198|FG000|Treatment Period|Sponsor request|0
2200978|NCT01576718|3837199|FG001|Treatment Period|Sponsor request|1
2200979|NCT01576718|3837200|FG002|Treatment Period|Sponsor request|0
2200980|NCT01576718|3837201|FG003|Treatment Period|Sponsor request|0
2200981|NCT01576718|3837202|FG004|Treatment Period|Sponsor request|0
2200982|NCT01576718|3837203|FG005|Treatment Period|Sponsor request|1
2200983|NCT01576718|3837204|FG006|Treatment Period|Sponsor request|0
2200984|NCT01576718|3837198|FG000|Treatment Period|Met stopping criteria|0
2200985|NCT01576718|3837199|FG001|Treatment Period|Met stopping criteria|16
2200986|NCT01576718|3837200|FG002|Treatment Period|Met stopping criteria|13
2200987|NCT01576718|3837201|FG003|Treatment Period|Met stopping criteria|19
2200988|NCT01576718|3837202|FG004|Treatment Period|Met stopping criteria|16
2200989|NCT01576718|3837203|FG005|Treatment Period|Met stopping criteria|33
2200990|NCT01576718|3837204|FG006|Treatment Period|Met stopping criteria|15
2320617|NCT02951780|4034944|FG008|Period 1|Scheduling Conflicts|0
2320618|NCT02951780|4034936|FG000|Period 2|Scheduling Conflicts|0
2200991|NCT01576718|3837198|FG000|Treatment Period|Lost to Follow-up|0
2200992|NCT01576718|3837199|FG001|Treatment Period|Lost to Follow-up|0
2200993|NCT01576718|3837200|FG002|Treatment Period|Lost to Follow-up|0
2200994|NCT01576718|3837201|FG003|Treatment Period|Lost to Follow-up|0
2276624|NCT02323646|3959374|FG000|Treatment Course 1|Adverse Event|1
2276625|NCT02323646|3959375|FG001|Treatment Course 1|Adverse Event|0
2276626|NCT02323646|3959376|FG002|Treatment Course 1|Adverse Event|1
2276627|NCT02323646|3959374|FG000|Treatment Course 1|Heavy Bleeding|1
2276628|NCT02323646|3959375|FG001|Treatment Course 1|Heavy Bleeding|1
2276629|NCT02323646|3959376|FG002|Treatment Course 1|Heavy Bleeding|0
2276630|NCT02323646|3959374|FG000|Treatment Course 1|Lost to Follow-up|1
2276631|NCT02323646|3959375|FG001|Treatment Course 1|Lost to Follow-up|0
2276632|NCT02323646|3959376|FG002|Treatment Course 1|Lost to Follow-up|2
2276633|NCT02323646|3959374|FG000|Treatment Course 1|Withdrawal by Subject|0
2276634|NCT02323646|3959375|FG001|Treatment Course 1|Withdrawal by Subject|2
2276635|NCT02323646|3959376|FG002|Treatment Course 1|Withdrawal by Subject|0
2276636|NCT02323646|3959374|FG000|Treatment Course 2|Adverse Event|1
2276637|NCT02323646|3959375|FG001|Treatment Course 2|Adverse Event|0
2276638|NCT02323646|3959376|FG002|Treatment Course 2|Adverse Event|1
2276639|NCT02323646|3959374|FG000|Treatment Course 2|Lost to Follow-up|0
2276640|NCT02323646|3959375|FG001|Treatment Course 2|Lost to Follow-up|0
2276641|NCT02323646|3959376|FG002|Treatment Course 2|Lost to Follow-up|1
2276642|NCT02323646|3959374|FG000|Treatment Course 2|Non-compliance|0
2276643|NCT02323646|3959375|FG001|Treatment Course 2|Non-compliance|1
2276644|NCT02323646|3959376|FG002|Treatment Course 2|Non-compliance|1
2276645|NCT02324049|3959388|FG000|Part C|Study terminated|11
2276646|NCT02324153|3959404|FG000|Overall Study|Withdrawal by Subject|4
2276647|NCT02324153|3959405|FG001|Overall Study|Withdrawal by Subject|1
2276648|NCT02324153|3959404|FG000|Overall Study|Surgery postponed after randomization|3
2276649|NCT02324153|3959405|FG001|Overall Study|Surgery postponed after randomization|0
2276650|NCT02324153|3959404|FG000|Overall Study|Developed delirium preoperatively|1
2276651|NCT02324153|3959405|FG001|Overall Study|Developed delirium preoperatively|0
2276652|NCT02324205|3959411|FG000|Overall Study|Withdrawal by Subject|37
2276653|NCT02324270|3959418|FG000|Overall Study|Withdrawal by Subject|0
2276654|NCT02324270|3959419|FG001|Overall Study|Withdrawal by Subject|1
2276655|NCT02324270|3959420|FG002|Overall Study|Withdrawal by Subject|0
2276656|NCT02324270|3959418|FG000|Overall Study|Lost to Follow-up|4
2276657|NCT02324270|3959419|FG001|Overall Study|Lost to Follow-up|3
2276658|NCT02324270|3959420|FG002|Overall Study|Lost to Follow-up|4
2276659|NCT02324270|3959418|FG000|Overall Study|Protocol Violation|0
2276660|NCT02324270|3959419|FG001|Overall Study|Protocol Violation|1
2276661|NCT02324270|3959420|FG002|Overall Study|Protocol Violation|1
2276662|NCT02324270|3959418|FG000|Overall Study|Non Compliance with Study Drug|1
2276663|NCT02324270|3959419|FG001|Overall Study|Non Compliance with Study Drug|2
2276664|NCT02324270|3959420|FG002|Overall Study|Non Compliance with Study Drug|0
2276665|NCT02324361|3959439|FG000|Overall Study|Lost to Follow-up|5
2276666|NCT02324361|3959440|FG001|Overall Study|Lost to Follow-up|2
2276667|NCT02324465|3959448|FG000|Overall Study|device failure|0
2276668|NCT02324465|3959449|FG001|Overall Study|device failure|1
2276669|NCT02324569|3959485|FG000|Overall Study|Pretreatment Event/Adverse Event|9
2276670|NCT02324569|3959486|FG001|Overall Study|Pretreatment Event/Adverse Event|10
2276671|NCT02324569|3959485|FG000|Overall Study|Voluntary Withdrawal|3
2276672|NCT02324569|3959486|FG001|Overall Study|Voluntary Withdrawal|6
2276673|NCT02324569|3959485|FG000|Overall Study|Lack of Efficacy|2
2276674|NCT02324569|3959486|FG001|Overall Study|Lack of Efficacy|3
2276675|NCT02324569|3959485|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0
2276676|NCT02324569|3959486|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2
2276677|NCT02324569|3959485|FG000|Overall Study|Inconvenient Schedule|2
2276678|NCT02324569|3959486|FG001|Overall Study|Inconvenient Schedule|0
2276679|NCT02324699|3959510|FG000|Overall Study|study terminated|1
2276680|NCT02324842|3959517|FG000|Overall Study|Lost to Follow-up|1
2276681|NCT02324842|3959518|FG001|Overall Study|Lost to Follow-up|1
2276682|NCT02324842|3959519|FG002|Overall Study|Lost to Follow-up|2
2276683|NCT02325219|3959548|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6
2200995|NCT01576718|3837202|FG004|Treatment Period|Lost to Follow-up|1
2200996|NCT01576718|3837203|FG005|Treatment Period|Lost to Follow-up|0
2200997|NCT01576718|3837204|FG006|Treatment Period|Lost to Follow-up|0
2200998|NCT01576718|3837198|FG000|Treatment Period|Noncompliance to study medication|0
2200999|NCT01576718|3837199|FG001|Treatment Period|Noncompliance to study medication|0
2201000|NCT01576718|3837200|FG002|Treatment Period|Noncompliance to study medication|0
2201001|NCT01576718|3837201|FG003|Treatment Period|Noncompliance to study medication|0
2201002|NCT01576718|3837202|FG004|Treatment Period|Noncompliance to study medication|0
2201003|NCT01576718|3837203|FG005|Treatment Period|Noncompliance to study medication|1
2201004|NCT01576718|3837204|FG006|Treatment Period|Noncompliance to study medication|1
2201005|NCT01576783|3837220|FG000|Overall Study|Change in Medical Care|1
2201006|NCT01576783|3837221|FG001|Overall Study|Change in Medical Care|0
2201007|NCT01576783|3837220|FG000|Overall Study|Lost to Follow-up|14
2201008|NCT01576783|3837221|FG001|Overall Study|Lost to Follow-up|16
2201009|NCT01576783|3837220|FG000|Overall Study|Withdrawal by Subject|5
2201010|NCT01576783|3837221|FG001|Overall Study|Withdrawal by Subject|1
2201011|NCT01577160|3837262|FG000|Overall Study|Adverse Event|9
2201012|NCT01577160|3837262|FG000|Overall Study|Lack of Efficacy|15
2201013|NCT01577160|3837262|FG000|Overall Study|Lost to Follow-up|40
2201014|NCT01577160|3837262|FG000|Overall Study|Withdrawal by Subject|18
2201015|NCT01577160|3837262|FG000|Overall Study|Subject Uncooperative|7
2201016|NCT01577160|3837262|FG000|Overall Study|Other|9
2276684|NCT02325219|3959549|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1
2276685|NCT02325219|3959550|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0
2276686|NCT02325219|3959551|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0
2276687|NCT02325219|3959552|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0
2276688|NCT02325219|3959548|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
2276689|NCT02325219|3959549|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
2276690|NCT02325219|3959550|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2276691|NCT02325219|3959551|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2276692|NCT02325219|3959552|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2276693|NCT02325219|3959548|FG000|Controlled Period (Week 0 - 16)|Other|0
2276694|NCT02325219|3959549|FG001|Controlled Period (Week 0 - 16)|Other|0
2276695|NCT02325219|3959550|FG002|Controlled Period (Week 0 - 16)|Other|1
2276696|NCT02325219|3959551|FG003|Controlled Period (Week 0 - 16)|Other|0
2276697|NCT02325219|3959552|FG004|Controlled Period (Week 0 - 16)|Other|0
2276698|NCT02325219|3959548|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
2276699|NCT02325219|3959549|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0
2276700|NCT02325219|3959550|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0
2276701|NCT02325219|3959551|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0
2276702|NCT02325219|3959552|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1
2276703|NCT02325219|3959548|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
2276704|NCT02325219|3959549|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
2276705|NCT02325219|3959550|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
2276706|NCT02325219|3959551|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
2276707|NCT02325219|3959552|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
2276708|NCT02325219|3959548|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
2276709|NCT02325219|3959549|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1
2276710|NCT02325219|3959550|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
2276711|NCT02325219|3959551|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0
2276712|NCT02325219|3959552|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0
2276713|NCT02325401|3959568|FG000|Overall Study|Withdrawal by Subject|0
2276714|NCT02325401|3959569|FG001|Overall Study|Withdrawal by Subject|1
2276715|NCT02325401|3959570|FG002|Overall Study|Withdrawal by Subject|1
2276716|NCT02325414|3959586|FG000|Overall Study|Withdrawal by Subject|3
2276717|NCT02325414|3959587|FG001|Overall Study|Withdrawal by Subject|1
2276718|NCT02325414|3959586|FG000|Overall Study|Lost to Follow-up|5
2276719|NCT02325414|3959587|FG001|Overall Study|Lost to Follow-up|5
2276720|NCT02325518|3959597|FG000|Overall Study|Adverse Event|4
2276721|NCT02325518|3959598|FG001|Overall Study|Adverse Event|1
2276722|NCT02325518|3959597|FG000|Overall Study|Physician Decision|0
2276723|NCT02325518|3959598|FG001|Overall Study|Physician Decision|1
2276724|NCT02325518|3959597|FG000|Overall Study|Withdrawal by Subject|0
2276725|NCT02325518|3959598|FG001|Overall Study|Withdrawal by Subject|1
2276726|NCT02325713|3959634|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276727|NCT02325713|3959635|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276728|NCT02325713|3959636|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276729|NCT02325713|3959637|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276730|NCT02325713|3959638|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276731|NCT02325713|3959639|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276732|NCT02325713|3959640|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276733|NCT02325713|3959641|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276734|NCT02325713|3959642|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276735|NCT02325713|3959643|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276736|NCT02325713|3959644|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
2276737|NCT02325713|3959645|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276738|NCT02325713|3959646|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276739|NCT02325713|3959647|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276740|NCT02325713|3959648|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276741|NCT02325713|3959649|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2276742|NCT02325713|3959634|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
2276743|NCT02325713|3959635|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276744|NCT02325713|3959636|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276745|NCT02325713|3959637|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276746|NCT02325713|3959638|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276747|NCT02325713|3959639|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276748|NCT02325713|3959640|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276749|NCT02325713|3959641|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276750|NCT02325713|3959642|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276751|NCT02325713|3959643|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276752|NCT02325713|3959644|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2201017|NCT01577186|3837266|FG000|Overall Study|Adverse Event|23
2201018|NCT01577186|3837266|FG000|Overall Study|Death|1
2201019|NCT01577186|3837266|FG000|Overall Study|Lost to Follow-up|28
2201020|NCT01577186|3837266|FG000|Overall Study|Withdrawal by Subject|35
2201021|NCT01577186|3837266|FG000|Overall Study|Insufficient Response|18
2201022|NCT01577186|3837266|FG000|Overall Study|Ineligible to Continue|15
2201023|NCT01577186|3837266|FG000|Overall Study|Non-Compliant|8
2201024|NCT01577186|3837266|FG000|Overall Study|Other|2
2201025|NCT01577381|3837292|FG000|Overall Study|Discontinued|2
2201026|NCT01577381|3837293|FG001|Overall Study|Discontinued|1
2201027|NCT01577381|3837294|FG002|Overall Study|Discontinued|2
2201028|NCT01577381|3837295|FG003|Overall Study|Discontinued|2
2201029|NCT01577381|3837292|FG000|Overall Study|Ongoing at Date of Cut-Off|0
2201030|NCT01577381|3837293|FG001|Overall Study|Ongoing at Date of Cut-Off|2
2201031|NCT01577381|3837294|FG002|Overall Study|Ongoing at Date of Cut-Off|1
2201032|NCT01577381|3837295|FG003|Overall Study|Ongoing at Date of Cut-Off|0
2201033|NCT01577745|3837334|FG000|Overall Study|Withdrawal by Subject|0
2276753|NCT02325713|3959645|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276754|NCT02325713|3959646|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276755|NCT02325713|3959647|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276756|NCT02325713|3959648|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276757|NCT02325713|3959649|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2276758|NCT02325713|3959634|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276759|NCT02325713|3959635|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276760|NCT02325713|3959636|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276761|NCT02325713|3959637|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276762|NCT02325713|3959638|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276763|NCT02325713|3959639|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276764|NCT02325713|3959640|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276765|NCT02325713|3959641|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276766|NCT02325713|3959642|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276767|NCT02325713|3959643|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
2276768|NCT02325713|3959644|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276769|NCT02325713|3959645|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276770|NCT02325713|3959646|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276771|NCT02325713|3959647|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276772|NCT02325713|3959648|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276773|NCT02325713|3959649|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2276774|NCT02325739|3959675|FG000|Phase I Part|Adverse Event|1
2276775|NCT02325739|3959676|FG001|Phase I Part|Adverse Event|0
2276776|NCT02325739|3959677|FG002|Phase I Part|Adverse Event|1
2276777|NCT02325739|3959678|FG003|Phase I Part|Adverse Event|2
2276778|NCT02325739|3959679|FG004|Phase I Part|Adverse Event|3
2276779|NCT02325739|3959680|FG005|Phase I Part|Adverse Event|1
2276780|NCT02325739|3959681|FG006|Phase I Part|Adverse Event|0
2276781|NCT02325739|3959682|FG007|Phase I Part|Adverse Event|2
2276782|NCT02325739|3959683|FG008|Phase I Part|Adverse Event|0
2276783|NCT02325739|3959684|FG009|Phase I Part|Adverse Event|0
2276784|NCT02325739|3959685|FG010|Phase I Part|Adverse Event|0
2276785|NCT02325739|3959675|FG000|Phase I Part|Progressive disease|9
2276786|NCT02325739|3959676|FG001|Phase I Part|Progressive disease|6
2276787|NCT02325739|3959677|FG002|Phase I Part|Progressive disease|3
2276788|NCT02325739|3959678|FG003|Phase I Part|Progressive disease|23
2276789|NCT02325739|3959679|FG004|Phase I Part|Progressive disease|14
2276790|NCT02325739|3959680|FG005|Phase I Part|Progressive disease|6
2276791|NCT02325739|3959681|FG006|Phase I Part|Progressive disease|6
2276792|NCT02325739|3959682|FG007|Phase I Part|Progressive disease|3
2276793|NCT02325739|3959683|FG008|Phase I Part|Progressive disease|0
2276794|NCT02325739|3959684|FG009|Phase I Part|Progressive disease|0
2276795|NCT02325739|3959685|FG010|Phase I Part|Progressive disease|0
2276796|NCT02325739|3959675|FG000|Phase I Part|Subject/guardian decision|1
2276797|NCT02325739|3959676|FG001|Phase I Part|Subject/guardian decision|0
2276798|NCT02325739|3959677|FG002|Phase I Part|Subject/guardian decision|1
2276799|NCT02325739|3959678|FG003|Phase I Part|Subject/guardian decision|1
2276800|NCT02325739|3959679|FG004|Phase I Part|Subject/guardian decision|0
2276801|NCT02325739|3959680|FG005|Phase I Part|Subject/guardian decision|0
2276802|NCT02325739|3959681|FG006|Phase I Part|Subject/guardian decision|0
2276803|NCT02325739|3959682|FG007|Phase I Part|Subject/guardian decision|1
2276804|NCT02325739|3959683|FG008|Phase I Part|Subject/guardian decision|0
2276805|NCT02325739|3959684|FG009|Phase I Part|Subject/guardian decision|0
2276806|NCT02325739|3959685|FG010|Phase I Part|Subject/guardian decision|0
2276807|NCT02325739|3959675|FG000|Phase I Part|Death|0
2276808|NCT02325739|3959676|FG001|Phase I Part|Death|0
2276809|NCT02325739|3959677|FG002|Phase I Part|Death|0
2276810|NCT02325739|3959678|FG003|Phase I Part|Death|0
2276811|NCT02325739|3959679|FG004|Phase I Part|Death|2
2276812|NCT02325739|3959680|FG005|Phase I Part|Death|0
2276813|NCT02325739|3959681|FG006|Phase I Part|Death|0
2276814|NCT02325739|3959682|FG007|Phase I Part|Death|0
2276815|NCT02325739|3959683|FG008|Phase I Part|Death|0
2276816|NCT02325739|3959684|FG009|Phase I Part|Death|0
2201034|NCT01577745|3837335|FG001|Overall Study|Withdrawal by Subject|1
2201035|NCT01577745|3837336|FG002|Overall Study|Withdrawal by Subject|0
2201036|NCT01577745|3837337|FG003|Overall Study|Withdrawal by Subject|3
2201037|NCT01577745|3837338|FG004|Overall Study|Withdrawal by Subject|2
2201038|NCT01577745|3837339|FG005|Overall Study|Withdrawal by Subject|0
2201039|NCT01577745|3837334|FG000|Overall Study|Death|3
2201040|NCT01577745|3837335|FG001|Overall Study|Death|2
2201041|NCT01577745|3837336|FG002|Overall Study|Death|2
2201042|NCT01577745|3837337|FG003|Overall Study|Death|1
2201043|NCT01577745|3837338|FG004|Overall Study|Death|1
2201044|NCT01577745|3837339|FG005|Overall Study|Death|3
2201045|NCT01577745|3837334|FG000|Overall Study|Physician Decision|0
2201046|NCT01577745|3837335|FG001|Overall Study|Physician Decision|0
2276817|NCT02325739|3959685|FG010|Phase I Part|Death|0
2276818|NCT02325739|3959675|FG000|Phase II Part|Adverse Event|0
2276819|NCT02325739|3959676|FG001|Phase II Part|Adverse Event|0
2276820|NCT02325739|3959677|FG002|Phase II Part|Adverse Event|0
2276821|NCT02325739|3959678|FG003|Phase II Part|Adverse Event|0
2276822|NCT02325739|3959679|FG004|Phase II Part|Adverse Event|0
2276823|NCT02325739|3959680|FG005|Phase II Part|Adverse Event|0
2276824|NCT02325739|3959681|FG006|Phase II Part|Adverse Event|0
2276825|NCT02325739|3959682|FG007|Phase II Part|Adverse Event|0
2276826|NCT02325739|3959683|FG008|Phase II Part|Adverse Event|4
2276827|NCT02325739|3959684|FG009|Phase II Part|Adverse Event|5
2276828|NCT02325739|3959685|FG010|Phase II Part|Adverse Event|1
2276829|NCT02325739|3959675|FG000|Phase II Part|Physician Decision|0
2276830|NCT02325739|3959676|FG001|Phase II Part|Physician Decision|0
2276831|NCT02325739|3959677|FG002|Phase II Part|Physician Decision|0
2276832|NCT02325739|3959678|FG003|Phase II Part|Physician Decision|0
2276833|NCT02325739|3959679|FG004|Phase II Part|Physician Decision|0
2276834|NCT02325739|3959680|FG005|Phase II Part|Physician Decision|0
2276835|NCT02325739|3959681|FG006|Phase II Part|Physician Decision|0
2276836|NCT02325739|3959682|FG007|Phase II Part|Physician Decision|0
2276837|NCT02325739|3959683|FG008|Phase II Part|Physician Decision|0
2276838|NCT02325739|3959684|FG009|Phase II Part|Physician Decision|1
2276839|NCT02325739|3959685|FG010|Phase II Part|Physician Decision|0
2276840|NCT02325739|3959675|FG000|Phase II Part|Progressive disease|0
2276841|NCT02325739|3959676|FG001|Phase II Part|Progressive disease|0
2276842|NCT02325739|3959677|FG002|Phase II Part|Progressive disease|0
2276843|NCT02325739|3959678|FG003|Phase II Part|Progressive disease|0
2276844|NCT02325739|3959679|FG004|Phase II Part|Progressive disease|0
2276845|NCT02325739|3959680|FG005|Phase II Part|Progressive disease|0
2276846|NCT02325739|3959681|FG006|Phase II Part|Progressive disease|0
2276847|NCT02325739|3959682|FG007|Phase II Part|Progressive disease|0
2276848|NCT02325739|3959683|FG008|Phase II Part|Progressive disease|22
2276849|NCT02325739|3959684|FG009|Phase II Part|Progressive disease|29
2276850|NCT02325739|3959685|FG010|Phase II Part|Progressive disease|18
2276851|NCT02325739|3959675|FG000|Phase II Part|Subject/guardian decision|0
2276852|NCT02325739|3959676|FG001|Phase II Part|Subject/guardian decision|0
2276853|NCT02325739|3959677|FG002|Phase II Part|Subject/guardian decision|0
2276854|NCT02325739|3959678|FG003|Phase II Part|Subject/guardian decision|0
2276855|NCT02325739|3959679|FG004|Phase II Part|Subject/guardian decision|0
2276856|NCT02325739|3959680|FG005|Phase II Part|Subject/guardian decision|0
2276857|NCT02325739|3959681|FG006|Phase II Part|Subject/guardian decision|0
2276858|NCT02325739|3959682|FG007|Phase II Part|Subject/guardian decision|0
2276859|NCT02325739|3959683|FG008|Phase II Part|Subject/guardian decision|4
2276860|NCT02325739|3959684|FG009|Phase II Part|Subject/guardian decision|1
2276861|NCT02325739|3959685|FG010|Phase II Part|Subject/guardian decision|1
2276862|NCT02325791|3959734|FG000|Overall Study|Adverse Event|0
2276863|NCT02325791|3959735|FG001|Overall Study|Adverse Event|1
2276864|NCT02325791|3959736|FG002|Overall Study|Adverse Event|1
2276865|NCT02325791|3959737|FG003|Overall Study|Adverse Event|0
2276866|NCT02325791|3959734|FG000|Overall Study|Death|0
2276867|NCT02325791|3959735|FG001|Overall Study|Death|3
2276868|NCT02325791|3959736|FG002|Overall Study|Death|0
2276869|NCT02325791|3959737|FG003|Overall Study|Death|1
2276870|NCT02325791|3959734|FG000|Overall Study|Lost to Follow-up|0
2276871|NCT02325791|3959735|FG001|Overall Study|Lost to Follow-up|15
2276872|NCT02325791|3959736|FG002|Overall Study|Lost to Follow-up|14
2276873|NCT02325791|3959737|FG003|Overall Study|Lost to Follow-up|9
2276874|NCT02325791|3959734|FG000|Overall Study|Physician Decision|0
2276875|NCT02325791|3959735|FG001|Overall Study|Physician Decision|1
2276876|NCT02325791|3959736|FG002|Overall Study|Physician Decision|1
2276877|NCT02325791|3959737|FG003|Overall Study|Physician Decision|0
2276878|NCT02325791|3959734|FG000|Overall Study|Protocol Violation|0
2276879|NCT02325791|3959735|FG001|Overall Study|Protocol Violation|0
2276880|NCT02325791|3959736|FG002|Overall Study|Protocol Violation|1
2276881|NCT02325791|3959737|FG003|Overall Study|Protocol Violation|0
2276882|NCT02325791|3959734|FG000|Overall Study|Withdrawal by Subject|0
2276883|NCT02325791|3959735|FG001|Overall Study|Withdrawal by Subject|5
2276884|NCT02325791|3959736|FG002|Overall Study|Withdrawal by Subject|8
2276885|NCT02325791|3959737|FG003|Overall Study|Withdrawal by Subject|16
2276886|NCT02326025|3959761|FG000|Overall Study|Adverse Event|3
2276887|NCT02326025|3959762|FG001|Overall Study|Adverse Event|0
2201047|NCT01577745|3837336|FG002|Overall Study|Physician Decision|0
2276888|NCT02326025|3959761|FG000|Overall Study|Physician Decision|1
2276889|NCT02326025|3959762|FG001|Overall Study|Physician Decision|2
2276890|NCT02326025|3959761|FG000|Overall Study|Physician and Participant Decision|1
2201048|NCT01577745|3837337|FG003|Overall Study|Physician Decision|1
2201049|NCT01577745|3837338|FG004|Overall Study|Physician Decision|1
2201050|NCT01577745|3837339|FG005|Overall Study|Physician Decision|0
2201051|NCT01577745|3837334|FG000|Overall Study|Lost to Follow-up|0
2201052|NCT01577745|3837335|FG001|Overall Study|Lost to Follow-up|0
2201053|NCT01577745|3837336|FG002|Overall Study|Lost to Follow-up|0
2201054|NCT01577745|3837337|FG003|Overall Study|Lost to Follow-up|0
2201055|NCT01577745|3837338|FG004|Overall Study|Lost to Follow-up|0
2201056|NCT01577745|3837339|FG005|Overall Study|Lost to Follow-up|1
2201057|NCT01577745|3837334|FG000|Overall Study|Alternative Therapy|0
2201058|NCT01577745|3837335|FG001|Overall Study|Alternative Therapy|0
2201059|NCT01577745|3837336|FG002|Overall Study|Alternative Therapy|0
2201060|NCT01577745|3837337|FG003|Overall Study|Alternative Therapy|1
2201061|NCT01577745|3837338|FG004|Overall Study|Alternative Therapy|1
2201062|NCT01577745|3837339|FG005|Overall Study|Alternative Therapy|0
2217234|NCT01706926|3860427|FG002|Overall Study|Other|4
2217235|NCT01706926|3860428|FG003|Overall Study|Other|3
2217236|NCT01707004|3860465|FG000|Overall Study|Physician Decision|3
2276891|NCT02326025|3959762|FG001|Overall Study|Physician and Participant Decision|0
2276892|NCT02326025|3959761|FG000|Overall Study|Withdrawal by Subject|0
2276893|NCT02326025|3959762|FG001|Overall Study|Withdrawal by Subject|2
2276894|NCT02326025|3959761|FG000|Overall Study|Protocol Violation|0
2276895|NCT02326025|3959762|FG001|Overall Study|Protocol Violation|1
2276896|NCT02326220|3959783|FG000|Double-blind Treatment Period|Adverse Event|1
2276897|NCT02326220|3959784|FG001|Double-blind Treatment Period|Adverse Event|2
2276898|NCT02326220|3959785|FG002|Double-blind Treatment Period|Adverse Event|0
2276899|NCT02326220|3959783|FG000|Double-blind Treatment Period|Protocol Violation|0
2276900|NCT02326220|3959784|FG001|Double-blind Treatment Period|Protocol Violation|1
2276901|NCT02326220|3959785|FG002|Double-blind Treatment Period|Protocol Violation|0
2276902|NCT02326220|3959783|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
2276903|NCT02326220|3959784|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
2276904|NCT02326220|3959785|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
2276905|NCT02326220|3959783|FG000|Open-label Treatment Period|Withdrawal by Subject|0
2276906|NCT02326220|3959784|FG001|Open-label Treatment Period|Withdrawal by Subject|0
2276907|NCT02326220|3959785|FG002|Open-label Treatment Period|Withdrawal by Subject|1
2276908|NCT02326220|3959783|FG000|Open-label Treatment Period|Lost to Follow-up|0
2276909|NCT02326220|3959784|FG001|Open-label Treatment Period|Lost to Follow-up|0
2276910|NCT02326220|3959785|FG002|Open-label Treatment Period|Lost to Follow-up|1
2276911|NCT02326272|3959807|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276912|NCT02326272|3959808|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3
2276913|NCT02326272|3959809|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
2276914|NCT02326272|3959810|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276915|NCT02326272|3959811|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276916|NCT02326272|3959812|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276917|NCT02326272|3959813|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276918|NCT02326272|3959814|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276919|NCT02326272|3959815|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276920|NCT02326272|3959816|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276921|NCT02326272|3959817|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276922|NCT02326272|3959818|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276923|NCT02326272|3959819|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276924|NCT02326272|3959820|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276925|NCT02326272|3959821|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0
2276926|NCT02326272|3959807|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
2276927|NCT02326272|3959808|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
2276928|NCT02326272|3959809|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276929|NCT02326272|3959810|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276930|NCT02326272|3959811|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276931|NCT02326272|3959812|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276932|NCT02326272|3959813|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276933|NCT02326272|3959814|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276934|NCT02326272|3959815|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276935|NCT02326272|3959816|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276936|NCT02326272|3959817|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276937|NCT02326272|3959818|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2217237|NCT01707030|3860472|FG000|Overall Study|Death|1
2217238|NCT01707030|3860473|FG001|Overall Study|Death|1
2217239|NCT01707030|3860472|FG000|Overall Study|Withdrawal by Subject|2
2217240|NCT01707030|3860473|FG001|Overall Study|Withdrawal by Subject|3
2217241|NCT01707030|3860472|FG000|Overall Study|Lost to Follow-up|8
2217242|NCT01707030|3860473|FG001|Overall Study|Lost to Follow-up|13
2217243|NCT01707147|3860506|FG000|Overall Study|Administered Trajenta prior to contract|5
2217244|NCT01707147|3860506|FG000|Overall Study|Patients who have not taken Trajenta|1
2217245|NCT01707147|3860506|FG000|Overall Study|Follow-up failure|17
2217246|NCT01707147|3860506|FG000|Overall Study|Violated inclusion/exclusion criteria|77
2217247|NCT01707290|3860526|FG000|Overall Study|Adverse event (AE)|1
2217248|NCT01707290|3860527|FG001|Overall Study|Adverse event (AE)|0
2217249|NCT01707290|3860526|FG000|Overall Study|Physician Decision|1
2276938|NCT02326272|3959819|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276939|NCT02326272|3959820|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276940|NCT02326272|3959821|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2276941|NCT02326272|3959807|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
2276942|NCT02326272|3959808|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
2276943|NCT02326272|3959809|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
2276944|NCT02326272|3959810|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276945|NCT02326272|3959811|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276946|NCT02326272|3959812|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276947|NCT02326272|3959813|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276948|NCT02326272|3959814|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276949|NCT02326272|3959815|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276950|NCT02326272|3959816|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276951|NCT02326272|3959817|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276952|NCT02326272|3959818|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276953|NCT02326272|3959819|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276954|NCT02326272|3959820|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276955|NCT02326272|3959821|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2276956|NCT02326272|3959807|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276957|NCT02326272|3959808|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276958|NCT02326272|3959809|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1
2276959|NCT02326272|3959810|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276960|NCT02326272|3959811|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276961|NCT02326272|3959812|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276962|NCT02326272|3959813|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276963|NCT02326272|3959814|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276964|NCT02326272|3959815|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276965|NCT02326272|3959816|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276966|NCT02326272|3959817|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276967|NCT02326272|3959818|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276968|NCT02326272|3959819|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276969|NCT02326272|3959820|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276970|NCT02326272|3959821|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2276971|NCT02326272|3959807|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276972|NCT02326272|3959808|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276973|NCT02326272|3959809|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1
2276974|NCT02326272|3959810|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276975|NCT02326272|3959811|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276976|NCT02326272|3959812|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276977|NCT02326272|3959813|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276978|NCT02326272|3959814|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276979|NCT02326272|3959815|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276980|NCT02326272|3959816|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276981|NCT02326272|3959817|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276982|NCT02326272|3959818|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276983|NCT02326272|3959819|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276984|NCT02326272|3959820|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276985|NCT02326272|3959821|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0
2276986|NCT02326272|3959807|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276987|NCT02326272|3959808|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276988|NCT02326272|3959809|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
2276989|NCT02326272|3959810|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276990|NCT02326272|3959811|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276991|NCT02326272|3959812|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276992|NCT02326272|3959813|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276993|NCT02326272|3959814|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276994|NCT02326272|3959815|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276995|NCT02326272|3959816|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276996|NCT02326272|3959817|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276997|NCT02326272|3959818|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276998|NCT02326272|3959819|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2276999|NCT02326272|3959820|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2277000|NCT02326272|3959821|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2277001|NCT02326272|3959807|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277002|NCT02326272|3959808|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2201063|NCT01577758|3837358|FG000|Dose Escalation Phase|Adverse Event|0
2201064|NCT01577758|3837359|FG001|Dose Escalation Phase|Adverse Event|0
2201065|NCT01577758|3837360|FG002|Dose Escalation Phase|Adverse Event|0
2201066|NCT01577758|3837361|FG003|Dose Escalation Phase|Adverse Event|0
2201067|NCT01577758|3837362|FG004|Dose Escalation Phase|Adverse Event|0
2201068|NCT01577758|3837363|FG005|Dose Escalation Phase|Adverse Event|2
2201069|NCT01577758|3837364|FG006|Dose Escalation Phase|Adverse Event|1
2201070|NCT01577758|3837365|FG007|Dose Escalation Phase|Adverse Event|0
2201071|NCT01577758|3837358|FG000|Dose Escalation Phase|Symptomatic Deterioration|0
2201072|NCT01577758|3837359|FG001|Dose Escalation Phase|Symptomatic Deterioration|0
2201073|NCT01577758|3837360|FG002|Dose Escalation Phase|Symptomatic Deterioration|1
2201074|NCT01577758|3837361|FG003|Dose Escalation Phase|Symptomatic Deterioration|0
2201075|NCT01577758|3837362|FG004|Dose Escalation Phase|Symptomatic Deterioration|1
2201076|NCT01577758|3837363|FG005|Dose Escalation Phase|Symptomatic Deterioration|1
2201077|NCT01577758|3837364|FG006|Dose Escalation Phase|Symptomatic Deterioration|0
2201078|NCT01577758|3837365|FG007|Dose Escalation Phase|Symptomatic Deterioration|0
2201079|NCT01577758|3837358|FG000|Dose Escalation Phase|Withdrawal by Subject|0
2201080|NCT01577758|3837359|FG001|Dose Escalation Phase|Withdrawal by Subject|0
2201081|NCT01577758|3837360|FG002|Dose Escalation Phase|Withdrawal by Subject|0
2201082|NCT01577758|3837361|FG003|Dose Escalation Phase|Withdrawal by Subject|0
2201083|NCT01577758|3837362|FG004|Dose Escalation Phase|Withdrawal by Subject|0
2201084|NCT01577758|3837363|FG005|Dose Escalation Phase|Withdrawal by Subject|1
2201085|NCT01577758|3837364|FG006|Dose Escalation Phase|Withdrawal by Subject|0
2201086|NCT01577758|3837365|FG007|Dose Escalation Phase|Withdrawal by Subject|0
2201087|NCT01577758|3837358|FG000|Dose Escalation Phase|Progression Disease|2
2201088|NCT01577758|3837359|FG001|Dose Escalation Phase|Progression Disease|2
2201089|NCT01577758|3837360|FG002|Dose Escalation Phase|Progression Disease|1
2201090|NCT01577758|3837361|FG003|Dose Escalation Phase|Progression Disease|2
2201091|NCT01577758|3837362|FG004|Dose Escalation Phase|Progression Disease|5
2201092|NCT01577758|3837363|FG005|Dose Escalation Phase|Progression Disease|0
2201093|NCT01577758|3837364|FG006|Dose Escalation Phase|Progression Disease|0
2201094|NCT01577758|3837365|FG007|Dose Escalation Phase|Progression Disease|0
2201095|NCT01577758|3837358|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0
2201096|NCT01577758|3837359|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0
2201097|NCT01577758|3837360|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0
2201098|NCT01577758|3837361|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0
2201099|NCT01577758|3837362|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0
2201100|NCT01577758|3837363|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0
2201101|NCT01577758|3837364|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0
2201102|NCT01577758|3837365|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4
2201103|NCT01577758|3837358|FG000|mCRC Expansion Phase|Withdrawal by Subject|0
2201104|NCT01577758|3837359|FG001|mCRC Expansion Phase|Withdrawal by Subject|0
2201105|NCT01577758|3837360|FG002|mCRC Expansion Phase|Withdrawal by Subject|0
2201106|NCT01577758|3837361|FG003|mCRC Expansion Phase|Withdrawal by Subject|0
2201107|NCT01577758|3837362|FG004|mCRC Expansion Phase|Withdrawal by Subject|0
2201108|NCT01577758|3837363|FG005|mCRC Expansion Phase|Withdrawal by Subject|0
2201109|NCT01577758|3837364|FG006|mCRC Expansion Phase|Withdrawal by Subject|0
2201110|NCT01577758|3837365|FG007|mCRC Expansion Phase|Withdrawal by Subject|2
2201111|NCT01577758|3837358|FG000|mCRC Expansion Phase|Progression Disease|0
2201112|NCT01577758|3837359|FG001|mCRC Expansion Phase|Progression Disease|0
2201113|NCT01577758|3837360|FG002|mCRC Expansion Phase|Progression Disease|0
2201114|NCT01577758|3837361|FG003|mCRC Expansion Phase|Progression Disease|0
2201115|NCT01577758|3837362|FG004|mCRC Expansion Phase|Progression Disease|0
2201116|NCT01577758|3837363|FG005|mCRC Expansion Phase|Progression Disease|0
2201117|NCT01577758|3837364|FG006|mCRC Expansion Phase|Progression Disease|0
2201118|NCT01577758|3837365|FG007|mCRC Expansion Phase|Progression Disease|19
2201119|NCT01578187|3837413|FG000|Usability Phase|Withdrawal by Subject|1
2201120|NCT01578239|3837421|FG000|Treatment Period|Progressive Disease|19
2201121|NCT01578239|3837422|FG001|Treatment Period|Progressive Disease|64
2201122|NCT01578239|3837421|FG000|Treatment Period|Physician Decision|17
2201123|NCT01578239|3837422|FG001|Treatment Period|Physician Decision|17
2201124|NCT01578239|3837421|FG000|Treatment Period|Adverse Event|13
2201125|NCT01578239|3837422|FG001|Treatment Period|Adverse Event|10
2201126|NCT01578239|3837421|FG000|Treatment Period|Non-compliance|2
2201127|NCT01578239|3837422|FG001|Treatment Period|Non-compliance|0
2201128|NCT01578239|3837421|FG000|Treatment Period|Withdrawal by Subject|10
2201129|NCT01578239|3837422|FG001|Treatment Period|Withdrawal by Subject|9
2201130|NCT01578239|3837421|FG000|Treatment Period|Other|6
2201131|NCT01578239|3837422|FG001|Treatment Period|Other|1
2201132|NCT01578239|3837421|FG000|Long-term Follow-Up Period|Death|69
2201133|NCT01578239|3837422|FG001|Long-term Follow-Up Period|Death|64
2201134|NCT01578239|3837421|FG000|Long-term Follow-Up Period|Consent withdrawal|4
2201135|NCT01578239|3837422|FG001|Long-term Follow-Up Period|Consent withdrawal|10
2201136|NCT01578239|3837421|FG000|Long-term Follow-Up Period|Lost to Follow-up|2
2201137|NCT01578239|3837422|FG001|Long-term Follow-Up Period|Lost to Follow-up|4
2201138|NCT01578239|3837421|FG000|Long-term Follow-Up Period|Other|2
2201139|NCT01578239|3837422|FG001|Long-term Follow-Up Period|Other|2
2201140|NCT01578330|3837454|FG000|Overall Study|Adverse Event|2
2201141|NCT01578330|3837454|FG000|Overall Study|Protocol Violation|5
2201142|NCT01578486|3837458|FG000|Overall Study|Physician Decision|3
2201143|NCT01578486|3837458|FG000|Overall Study|Withdrawal by Subject|2
2201144|NCT01578499|3837464|FG000|Overall Study|Reason not Specified|0
2201145|NCT01578499|3837465|FG001|Overall Study|Reason not Specified|1
2201146|NCT01578499|3837464|FG000|Overall Study|Lost to Follow-up|2
2201147|NCT01578499|3837465|FG001|Overall Study|Lost to Follow-up|1
2201148|NCT01578499|3837464|FG000|Overall Study|Withdrawal by Subject|10
2201149|NCT01578499|3837465|FG001|Overall Study|Withdrawal by Subject|16
2201150|NCT01578499|3837464|FG000|Overall Study|Death|20
2201151|NCT01578499|3837465|FG001|Overall Study|Death|25
2201152|NCT01578499|3837464|FG000|Overall Study|Died and End of Study Page not Completed|2
2201153|NCT01578499|3837465|FG001|Overall Study|Died and End of Study Page not Completed|0
2201154|NCT01578551|3837477|FG000|Overall Study|Adverse Event|1
2201155|NCT01578551|3837478|FG001|Overall Study|Adverse Event|0
2201156|NCT01578850|3837524|FG000|Period 1|Insufficient Clinical Response|1
2201157|NCT01578850|3837525|FG001|Period 1|Insufficient Clinical Response|0
2201158|NCT01578850|3837526|FG002|Period 1|Insufficient Clinical Response|0
2201159|NCT01578850|3837524|FG000|Period 1|Adverse Event|11
2201160|NCT01578850|3837525|FG001|Period 1|Adverse Event|0
2201161|NCT01578850|3837526|FG002|Period 1|Adverse Event|0
2201162|NCT01578850|3837524|FG000|Period 1|Death|1
2201163|NCT01578850|3837525|FG001|Period 1|Death|0
2201164|NCT01578850|3837526|FG002|Period 1|Death|0
2201165|NCT01578850|3837524|FG000|Period 1|Does Not Meet Entrance Criteria|12
2201166|NCT01578850|3837525|FG001|Period 1|Does Not Meet Entrance Criteria|0
2201167|NCT01578850|3837526|FG002|Period 1|Does Not Meet Entrance Criteria|0
2201168|NCT01578850|3837524|FG000|Period 1|Withdrawal by Subject|9
2201169|NCT01578850|3837525|FG001|Period 1|Withdrawal by Subject|0
2201170|NCT01578850|3837526|FG002|Period 1|Withdrawal by Subject|0
2201171|NCT01578850|3837524|FG000|Period 1|Study Terminated by Sponsor|3
2201172|NCT01578850|3837525|FG001|Period 1|Study Terminated by Sponsor|0
2201173|NCT01578850|3837526|FG002|Period 1|Study Terminated by Sponsor|0
2201174|NCT01578850|3837524|FG000|Period 2|Insufficient Clinical Response|0
2201175|NCT01578850|3837525|FG001|Period 2|Insufficient Clinical Response|1
2201176|NCT01578850|3837526|FG002|Period 2|Insufficient Clinical Response|0
2201177|NCT01578850|3837524|FG000|Period 2|Adverse Event|0
2201178|NCT01578850|3837525|FG001|Period 2|Adverse Event|3
2201179|NCT01578850|3837526|FG002|Period 2|Adverse Event|6
2201180|NCT01578850|3837524|FG000|Period 2|Lost to Follow-up|0
2201181|NCT01578850|3837525|FG001|Period 2|Lost to Follow-up|1
2201182|NCT01578850|3837526|FG002|Period 2|Lost to Follow-up|2
2201183|NCT01578850|3837524|FG000|Period 2|Withdrawal by Subject|0
2201184|NCT01578850|3837525|FG001|Period 2|Withdrawal by Subject|2
2201185|NCT01578850|3837526|FG002|Period 2|Withdrawal by Subject|2
2201186|NCT01578850|3837524|FG000|Period 2|Study Terminated by Sponsor|0
2201187|NCT01578850|3837525|FG001|Period 2|Study Terminated by Sponsor|5
2201188|NCT01578850|3837526|FG002|Period 2|Study Terminated by Sponsor|4
2201189|NCT01578850|3837524|FG000|Period 2|Unspecified Reasons|0
2201190|NCT01578850|3837525|FG001|Period 2|Unspecified Reasons|1
2201191|NCT01578850|3837526|FG002|Period 2|Unspecified Reasons|0
2201192|NCT01579006|3837549|FG000|Overall Study|Lack of Efficacy|10
2201193|NCT01579006|3837549|FG000|Overall Study|Adverse Event|13
2201194|NCT01579006|3837549|FG000|Overall Study|Withdrawal by Subject|5
2201195|NCT01579006|3837549|FG000|Overall Study|Non-compliance|3
2201196|NCT01579006|3837549|FG000|Overall Study|Due to participant's health fund|1
2201197|NCT01579006|3837549|FG000|Overall Study|Scheduled surgery|1
2201198|NCT01579318|3837640|FG000|Overall Study|Disease Progression|1
2201199|NCT01579474|3837650|FG000|Overall Study|Adverse Event|1
2201200|NCT01579474|3837651|FG001|Overall Study|Adverse Event|13
2201201|NCT01579474|3837652|FG002|Overall Study|Adverse Event|2
2201202|NCT01579474|3837653|FG003|Overall Study|Adverse Event|0
2201203|NCT01579474|3837654|FG004|Overall Study|Adverse Event|0
2201204|NCT01579474|3837655|FG005|Overall Study|Adverse Event|1
2201205|NCT01579474|3837650|FG000|Overall Study|Lack of Efficacy|1
2201206|NCT01579474|3837651|FG001|Overall Study|Lack of Efficacy|0
2201207|NCT01579474|3837652|FG002|Overall Study|Lack of Efficacy|0
2201208|NCT01579474|3837653|FG003|Overall Study|Lack of Efficacy|0
2201209|NCT01579474|3837654|FG004|Overall Study|Lack of Efficacy|1
2201210|NCT01579474|3837655|FG005|Overall Study|Lack of Efficacy|0
2201211|NCT01579474|3837650|FG000|Overall Study|Withdrawal by Subject|1
2277003|NCT02326272|3959809|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
2277004|NCT02326272|3959810|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277005|NCT02326272|3959811|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277006|NCT02326272|3959812|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277007|NCT02326272|3959813|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2201212|NCT01579474|3837651|FG001|Overall Study|Withdrawal by Subject|0
2201213|NCT01579474|3837652|FG002|Overall Study|Withdrawal by Subject|0
2201214|NCT01579474|3837653|FG003|Overall Study|Withdrawal by Subject|0
2201215|NCT01579474|3837654|FG004|Overall Study|Withdrawal by Subject|0
2118114|NCT00949715|3715865|FG000|Overall Study|Physician Decision|1
2201216|NCT01579474|3837655|FG005|Overall Study|Withdrawal by Subject|0
2201217|NCT01579565|3837679|FG000|Randomized|Adverse Event|1
2201218|NCT01579565|3837680|FG001|Randomized|Adverse Event|3
2201219|NCT01579565|3837679|FG000|Randomized|Withdrawal by Subject|3
2201220|NCT01579565|3837680|FG001|Randomized|Withdrawal by Subject|0
2201221|NCT01579565|3837679|FG000|Randomized|inadequate preoperative pupil dilation|0
2201222|NCT01579565|3837680|FG001|Randomized|inadequate preoperative pupil dilation|1
2201223|NCT01579565|3837679|FG000|Randomized|prohibited preoperative eating|1
2201224|NCT01579565|3837680|FG001|Randomized|prohibited preoperative eating|0
2201225|NCT01579565|3837679|FG000|Randomized|prohibited preoperative medication|0
2201226|NCT01579565|3837680|FG001|Randomized|prohibited preoperative medication|1
2201227|NCT01579565|3837679|FG000|Treated|Physician Decision|0
2201228|NCT01579565|3837680|FG001|Treated|Physician Decision|1
2201229|NCT01579565|3837679|FG000|Treated|Lost to Follow-up|2
2201230|NCT01579565|3837680|FG001|Treated|Lost to Follow-up|1
2277008|NCT02326272|3959814|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277009|NCT02326272|3959815|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277010|NCT02326272|3959816|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277011|NCT02326272|3959817|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277012|NCT02326272|3959818|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277013|NCT02326272|3959819|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277014|NCT02326272|3959820|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277015|NCT02326272|3959821|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2277016|NCT02326272|3959807|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277017|NCT02326272|3959808|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277018|NCT02326272|3959809|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277019|NCT02326272|3959810|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277020|NCT02326272|3959811|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2277021|NCT02326272|3959812|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
2277022|NCT02326272|3959813|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
2277023|NCT02326272|3959814|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2277024|NCT02326272|3959815|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2277025|NCT02326272|3959816|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277026|NCT02326272|3959817|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277027|NCT02326272|3959818|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277028|NCT02326272|3959819|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277029|NCT02326272|3959820|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277030|NCT02326272|3959821|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277031|NCT02326272|3959807|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2277032|NCT02326272|3959808|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2277033|NCT02326272|3959809|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2277034|NCT02326272|3959810|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2277035|NCT02326272|3959811|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2277036|NCT02326272|3959812|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
2277037|NCT02326272|3959813|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2277038|NCT02326272|3959814|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2277039|NCT02326272|3959815|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2277040|NCT02326272|3959816|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2277041|NCT02326272|3959817|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2277042|NCT02326272|3959818|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2277043|NCT02326272|3959819|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2277044|NCT02326272|3959820|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2277045|NCT02326272|3959821|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2277046|NCT02326272|3959807|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277047|NCT02326272|3959808|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277048|NCT02326272|3959809|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277049|NCT02326272|3959810|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277050|NCT02326272|3959811|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277051|NCT02326272|3959812|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
2277052|NCT02326272|3959813|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277053|NCT02326272|3959814|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
2277054|NCT02326272|3959815|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277055|NCT02326272|3959816|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277056|NCT02326272|3959817|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277057|NCT02326272|3959818|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277058|NCT02326272|3959819|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277059|NCT02326272|3959820|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277060|NCT02326272|3959821|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277061|NCT02326272|3959807|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277062|NCT02326272|3959808|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277063|NCT02326272|3959809|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2320619|NCT02951780|4034937|FG001|Period 2|Scheduling Conflicts|0
2201231|NCT01579565|3837679|FG000|Treated|declined to return for final visit|0
2201232|NCT01579565|3837680|FG001|Treated|declined to return for final visit|1
2201233|NCT01579578|3837690|FG000|Overall Study|Death|4
2201234|NCT01579578|3837691|FG001|Overall Study|Death|1
2201235|NCT01579578|3837690|FG000|Overall Study|Lost to Follow-up|1
2201236|NCT01579578|3837691|FG001|Overall Study|Lost to Follow-up|1
2201237|NCT01579578|3837690|FG000|Overall Study|Withdrawal by Subject|2
2201238|NCT01579578|3837691|FG001|Overall Study|Withdrawal by Subject|1
2201239|NCT01579578|3837690|FG000|Overall Study|Eligibility criteria|3
2201240|NCT01579578|3837691|FG001|Overall Study|Eligibility criteria|9
2201241|NCT01579578|3837690|FG000|Overall Study|Ongoing|3
2201242|NCT01579578|3837691|FG001|Overall Study|Ongoing|0
2201243|NCT01579812|3837715|FG000|Overall Study|Ineligible after treatment start|40
2201244|NCT01579812|3837715|FG000|Overall Study|Patient choice|3
2201245|NCT01579812|3837715|FG000|Overall Study|Noncompliance|3
2201246|NCT01579812|3837715|FG000|Overall Study|Withdrawal by Subject|6
2201247|NCT01579916|3837724|FG000|Overall Study|Lost to Follow-up|6
2201248|NCT01579916|3837725|FG001|Overall Study|Lost to Follow-up|1
2201249|NCT01579916|3837724|FG000|Overall Study|Withdrawal by Subject|1
2201250|NCT01579916|3837725|FG001|Overall Study|Withdrawal by Subject|1
2201251|NCT01579916|3837724|FG000|Overall Study|Death|1
2201252|NCT01579916|3837725|FG001|Overall Study|Death|0
2201253|NCT01580020|3837733|FG000|Overall Study|Lack of Efficacy|0
2201254|NCT01580020|3837734|FG001|Overall Study|Lack of Efficacy|5
2201255|NCT01580020|3837735|FG002|Overall Study|Lack of Efficacy|0
2201256|NCT01580020|3837736|FG003|Overall Study|Lack of Efficacy|1
2201257|NCT01580020|3837733|FG000|Overall Study|Withdrawal by Subject|0
2201258|NCT01580020|3837734|FG001|Overall Study|Withdrawal by Subject|1
2201259|NCT01580020|3837735|FG002|Overall Study|Withdrawal by Subject|1
2201260|NCT01580020|3837736|FG003|Overall Study|Withdrawal by Subject|0
2201261|NCT01580020|3837733|FG000|Overall Study|Adverse Event|1
2201262|NCT01580020|3837734|FG001|Overall Study|Adverse Event|1
2201263|NCT01580020|3837735|FG002|Overall Study|Adverse Event|1
2201264|NCT01580020|3837736|FG003|Overall Study|Adverse Event|1
2201265|NCT01580020|3837733|FG000|Overall Study|Administrative Problems|0
2201266|NCT01580020|3837734|FG001|Overall Study|Administrative Problems|0
2201267|NCT01580020|3837735|FG002|Overall Study|Administrative Problems|1
2201268|NCT01580020|3837736|FG003|Overall Study|Administrative Problems|0
2201269|NCT01580020|3837733|FG000|Overall Study|Lost to Follow-up|0
2201270|NCT01580020|3837734|FG001|Overall Study|Lost to Follow-up|0
2201271|NCT01580020|3837735|FG002|Overall Study|Lost to Follow-up|1
2201272|NCT01580020|3837736|FG003|Overall Study|Lost to Follow-up|0
2201273|NCT01580293|3837777|FG000|Part A_Main Trial|Adverse Event|0
2201274|NCT01580293|3837778|FG001|Part A_Main Trial|Adverse Event|2
2201275|NCT01580293|3837779|FG002|Part A_Main Trial|Adverse Event|0
2201276|NCT01580293|3837777|FG000|Part A_Main Trial|Withdrawal by Subject|1
2201277|NCT01580293|3837778|FG001|Part A_Main Trial|Withdrawal by Subject|4
2201278|NCT01580293|3837779|FG002|Part A_Main Trial|Withdrawal by Subject|0
2201279|NCT01580293|3837777|FG000|Part A_Main Trial|Non-adherence to the protocol|1
2201280|NCT01580293|3837778|FG001|Part A_Main Trial|Non-adherence to the protocol|0
2201281|NCT01580293|3837779|FG002|Part A_Main Trial|Non-adherence to the protocol|0
2201282|NCT01580293|3837777|FG000|Part A_Extension|Adverse Event|0
2201283|NCT01580293|3837778|FG001|Part A_Extension|Adverse Event|2
2201284|NCT01580293|3837779|FG002|Part A_Extension|Adverse Event|0
2277064|NCT02326272|3959810|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2277065|NCT02326272|3959811|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277066|NCT02326272|3959812|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
2277067|NCT02326272|3959813|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2201285|NCT01580293|3837777|FG000|Part A_Extension|Withdrawal by Subject|0
2201286|NCT01580293|3837778|FG001|Part A_Extension|Withdrawal by Subject|3
2201287|NCT01580293|3837779|FG002|Part A_Extension|Withdrawal by Subject|0
2201288|NCT01580293|3837777|FG000|Part A_Extension|Lost to Follow-up|0
2201289|NCT01580293|3837778|FG001|Part A_Extension|Lost to Follow-up|1
2201290|NCT01580293|3837779|FG002|Part A_Extension|Lost to Follow-up|0
2201291|NCT01580293|3837777|FG000|Part A_Extension|Other Reason|0
2201292|NCT01580293|3837778|FG001|Part A_Extension|Other Reason|1
2201293|NCT01580293|3837779|FG002|Part A_Extension|Other Reason|0
2201294|NCT01580293|3837777|FG000|Part A_Extension|Completed Japan only|0
2201295|NCT01580293|3837778|FG001|Part A_Extension|Completed Japan only|5
2201296|NCT01580293|3837779|FG002|Part A_Extension|Completed Japan only|0
2201297|NCT01580293|3837777|FG000|Part B|Withdrawal by Subject|0
2201298|NCT01580293|3837778|FG001|Part B|Withdrawal by Subject|0
2201299|NCT01580293|3837779|FG002|Part B|Withdrawal by Subject|1
2201300|NCT01580293|3837777|FG000|Part B|Other reason|0
2201301|NCT01580293|3837778|FG001|Part B|Other reason|0
2201302|NCT01580293|3837779|FG002|Part B|Other reason|1
2201303|NCT01580488|3837840|FG000|Overall Study|Withdrawal by Subject|1
2201304|NCT01580670|3837876|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1
2201305|NCT01580670|3837876|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
2277068|NCT02326272|3959814|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2277069|NCT02326272|3959815|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277070|NCT02326272|3959816|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2201306|NCT01580969|3837893|FG000|Overall Study|Physician Decision|3
2201307|NCT01580969|3837894|FG001|Overall Study|Physician Decision|0
2201308|NCT01580969|3837895|FG002|Overall Study|Physician Decision|0
2277071|NCT02326272|3959817|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277072|NCT02326272|3959818|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277073|NCT02326272|3959819|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277074|NCT02326272|3959820|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277075|NCT02326272|3959821|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277076|NCT02326272|3959807|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277077|NCT02326272|3959808|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277078|NCT02326272|3959809|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277079|NCT02326272|3959810|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277080|NCT02326272|3959811|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277081|NCT02326272|3959812|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277082|NCT02326272|3959813|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277083|NCT02326272|3959814|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
2277084|NCT02326272|3959815|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277085|NCT02326272|3959816|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277086|NCT02326272|3959817|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277087|NCT02326272|3959818|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277088|NCT02326272|3959819|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277089|NCT02326272|3959820|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277090|NCT02326272|3959821|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2277091|NCT02326272|3959807|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2201309|NCT01580995|3837905|FG000|Overall Study|Lost to Follow-up|2
2201310|NCT01580995|3837906|FG001|Overall Study|Lost to Follow-up|2
2201311|NCT01581021|3837924|FG000|Overall Study|Lost to Follow-up|4
2201312|NCT01581021|3837925|FG001|Overall Study|Lost to Follow-up|6
2201313|NCT01581021|3837924|FG000|Overall Study|More than 2 hooks in thoracic|3
2201314|NCT01581021|3837925|FG001|Overall Study|More than 2 hooks in thoracic|0
2201315|NCT01581021|3837924|FG000|Overall Study|Neuromuscular|2
2118115|NCT00949715|3715866|FG001|Overall Study|Physician Decision|0
2118116|NCT00949715|3715865|FG000|Overall Study|Lost to Follow-up|1
2118117|NCT00949715|3715866|FG001|Overall Study|Lost to Follow-up|0
2118118|NCT00949715|3715865|FG000|Overall Study|Missing 24 month LVEF measurement|2
2118119|NCT00949715|3715866|FG001|Overall Study|Missing 24 month LVEF measurement|0
2118120|NCT00949884|3715874|FG000|Overall Study|Adverse Event|14
2118121|NCT00949884|3715875|FG001|Overall Study|Adverse Event|3
2118122|NCT00949884|3715876|FG002|Overall Study|Adverse Event|12
2118123|NCT00949884|3715874|FG000|Overall Study|Did not meet inclusion/exclusion|2
2118124|NCT00949884|3715875|FG001|Overall Study|Did not meet inclusion/exclusion|1
2118125|NCT00949884|3715876|FG002|Overall Study|Did not meet inclusion/exclusion|3
2118126|NCT00949884|3715874|FG000|Overall Study|Lost to Follow-up|7
2118127|NCT00949884|3715875|FG001|Overall Study|Lost to Follow-up|5
2118128|NCT00949884|3715876|FG002|Overall Study|Lost to Follow-up|5
2118129|NCT00949884|3715874|FG000|Overall Study|Physician Decision|5
2118130|NCT00949884|3715875|FG001|Overall Study|Physician Decision|0
2118131|NCT00949884|3715876|FG002|Overall Study|Physician Decision|6
2118132|NCT00949884|3715874|FG000|Overall Study|Treatment non-compliance|5
2118133|NCT00949884|3715875|FG001|Overall Study|Treatment non-compliance|0
2118134|NCT00949884|3715876|FG002|Overall Study|Treatment non-compliance|8
2118135|NCT00949884|3715874|FG000|Overall Study|Withdrawal by Subject|13
2118136|NCT00949884|3715875|FG001|Overall Study|Withdrawal by Subject|4
2118137|NCT00949884|3715876|FG002|Overall Study|Withdrawal by Subject|16
2201316|NCT01581021|3837925|FG001|Overall Study|Neuromuscular|1
2201317|NCT01581021|3837924|FG000|Overall Study|Not Randomized|1
2201318|NCT01581021|3837925|FG001|Overall Study|Not Randomized|2
2201319|NCT01581021|3837924|FG000|Overall Study|Lenke 6 Classification|0
2201320|NCT01581021|3837925|FG001|Overall Study|Lenke 6 Classification|1
2201321|NCT01581021|3837924|FG000|Overall Study|Lack of Efficacy|0
2201322|NCT01581021|3837925|FG001|Overall Study|Lack of Efficacy|1
2201323|NCT01581281|3837934|FG000|Overall Study|Early Study Closure|15
2201324|NCT01581281|3837935|FG001|Overall Study|Early Study Closure|6
2201325|NCT01581281|3837936|FG002|Overall Study|Early Study Closure|12
2201326|NCT01581307|3837945|FG000|Overall Study|Withdrawal by Subject|1
2201327|NCT01581593|3837992|FG000|Overall Study|Withdrawal by Subject|1
2201328|NCT01581619|3838000|FG000|Overall Study|Withdrawal by Subject|1
2201329|NCT01581619|3838000|FG000|Overall Study|Lost to Follow-up|1
2201330|NCT01581684|3838033|FG000|Overall Study|Other reason not defined|0
2201331|NCT01581684|3838034|FG001|Overall Study|Other reason not defined|0
2201332|NCT01581684|3838035|FG002|Overall Study|Other reason not defined|0
2201333|NCT01581684|3838036|FG003|Overall Study|Other reason not defined|0
2201334|NCT01581684|3838037|FG004|Overall Study|Other reason not defined|0
2201335|NCT01581684|3838038|FG005|Overall Study|Other reason not defined|0
2201336|NCT01581684|3838039|FG006|Overall Study|Other reason not defined|0
2201337|NCT01581684|3838040|FG007|Overall Study|Other reason not defined|0
2201338|NCT01581684|3838041|FG008|Overall Study|Other reason not defined|1
2201339|NCT01581684|3838042|FG009|Overall Study|Other reason not defined|0
2201340|NCT01581931|3838086|FG000|Washout|Adverse Event|0
2201341|NCT01581931|3838087|FG001|Washout|Adverse Event|1
2201342|NCT01582009|3838097|FG000|Overall Study|Withdrawal by Subject|1
2201343|NCT01582009|3838097|FG000|Overall Study|Physician Decision|1
2201344|NCT01582061|3838103|FG000|Overall Study|Lack of Efficacy|3
2201345|NCT01582061|3838104|FG001|Overall Study|Lack of Efficacy|23
2277092|NCT02326272|3959808|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277093|NCT02326272|3959809|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2201346|NCT01582061|3838103|FG000|Overall Study|Adverse Event|12
2201347|NCT01582061|3838104|FG001|Overall Study|Adverse Event|8
2201348|NCT01582061|3838103|FG000|Overall Study|Withdrawal by Subject|10
2201349|NCT01582061|3838104|FG001|Overall Study|Withdrawal by Subject|4
2201350|NCT01582061|3838103|FG000|Overall Study|Abnormal laboratory value(s)|1
2201351|NCT01582061|3838104|FG001|Overall Study|Abnormal laboratory value(s)|0
2201352|NCT01582061|3838103|FG000|Overall Study|Death|0
2201353|NCT01582061|3838104|FG001|Overall Study|Death|1
2201354|NCT01582061|3838103|FG000|Overall Study|condition no longer requires study drug|1
2201355|NCT01582061|3838104|FG001|Overall Study|condition no longer requires study drug|0
2201356|NCT01582061|3838103|FG000|Overall Study|Lost to Follow-up|1
2201357|NCT01582061|3838104|FG001|Overall Study|Lost to Follow-up|0
2201358|NCT01582152|3838131|FG000|Overall Study|Disease Progression|4
2201359|NCT01582152|3838132|FG001|Overall Study|Disease Progression|5
2201360|NCT01582152|3838131|FG000|Overall Study|Adverse Event|2
2201361|NCT01582152|3838132|FG001|Overall Study|Adverse Event|1
2201362|NCT01582178|3838140|FG000|Overall Study|Physician Decision|6
2201363|NCT01582178|3838141|FG001|Overall Study|Physician Decision|5
2217250|NCT01707290|3860527|FG001|Overall Study|Physician Decision|0
2217251|NCT01707290|3860526|FG000|Overall Study|Lost to Follow-up|3
2217252|NCT01707290|3860527|FG001|Overall Study|Lost to Follow-up|0
2217253|NCT01707290|3860526|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4
2217254|NCT01707290|3860527|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0
2217255|NCT01707290|3860526|FG000|Overall Study|Commercial drug available|60
2217256|NCT01707290|3860527|FG001|Overall Study|Commercial drug available|1
2217257|NCT01707290|3860526|FG000|Overall Study|Other unspecified|17
2217258|NCT01707290|3860527|FG001|Overall Study|Other unspecified|0
2217259|NCT01707667|3860577|FG000|Period 1|expulsion of colonic sensor catheter|1
2217260|NCT01707667|3860578|FG001|Period 1|expulsion of colonic sensor catheter|0
2217261|NCT01707693|3860586|FG000|Overall Study Allocation|Withdrawal by Subject|9
2217262|NCT01707693|3860587|FG001|Overall Study Allocation|Withdrawal by Subject|5
2217263|NCT01707693|3860586|FG000|Overall Study Allocation|Protocol Violation|4
2217264|NCT01707693|3860587|FG001|Overall Study Allocation|Protocol Violation|3
2217265|NCT01707693|3860586|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
2217266|NCT01707693|3860587|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
2217267|NCT01707693|3860586|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
2217268|NCT01707693|3860587|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
2217269|NCT01707992|3860597|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8
2217270|NCT01707992|3860598|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13
2217271|NCT01707992|3860599|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9
2217272|NCT01707992|3860600|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0
2217273|NCT01707992|3860601|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0
2277094|NCT02326272|3959810|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277095|NCT02326272|3959811|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277096|NCT02326272|3959812|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277097|NCT02326272|3959813|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
2217274|NCT01707992|3860602|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0
2217275|NCT01707992|3860597|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
2217276|NCT01707992|3860598|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
2217277|NCT01707992|3860599|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
2217278|NCT01707992|3860600|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
2217279|NCT01707992|3860601|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
2217280|NCT01707992|3860602|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
2217281|NCT01707992|3860597|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
2217282|NCT01707992|3860598|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
2217283|NCT01707992|3860599|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
2217284|NCT01707992|3860600|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
2217285|NCT01707992|3860601|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
2217286|NCT01707992|3860602|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
2217287|NCT01707992|3860597|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
2217288|NCT01707992|3860598|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2217289|NCT01707992|3860599|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2217290|NCT01707992|3860600|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2217291|NCT01707992|3860601|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2217292|NCT01707992|3860602|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2217293|NCT01707992|3860597|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12
2217294|NCT01707992|3860598|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5
2217295|NCT01707992|3860599|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9
2217296|NCT01707992|3860600|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0
2201364|NCT01582243|3838147|FG000|Overall Study|Withdrawal by Subject|1
2201365|NCT01582243|3838147|FG000|Overall Study|Adverse Event|1
2201366|NCT01582243|3838147|FG000|Overall Study|Lost to Follow-up|1
2201367|NCT01582282|3838154|FG000|Overall Study|Adverse Event|1
2201368|NCT01582282|3838155|FG001|Overall Study|Adverse Event|1
2201369|NCT01582282|3838156|FG002|Overall Study|Adverse Event|0
2201370|NCT01582282|3838154|FG000|Overall Study|Lost to Follow-up|1
2201371|NCT01582282|3838155|FG001|Overall Study|Lost to Follow-up|0
2201372|NCT01582282|3838156|FG002|Overall Study|Lost to Follow-up|0
2201373|NCT01582282|3838154|FG000|Overall Study|fasting blood glucose outside Protocol|0
2201374|NCT01582282|3838155|FG001|Overall Study|fasting blood glucose outside Protocol|1
2201375|NCT01582282|3838156|FG002|Overall Study|fasting blood glucose outside Protocol|0
2201376|NCT01582308|3838164|FG000|Period 1|Withdrawal by Subject|0
2201377|NCT01582308|3838165|FG001|Period 1|Withdrawal by Subject|0
2201378|NCT01582308|3838166|FG002|Period 1|Withdrawal by Subject|0
2201379|NCT01582308|3838167|FG003|Period 1|Withdrawal by Subject|0
2201380|NCT01582308|3838168|FG004|Period 1|Withdrawal by Subject|0
2201381|NCT01582308|3838169|FG005|Period 1|Withdrawal by Subject|0
2201382|NCT01582308|3838170|FG006|Period 1|Withdrawal by Subject|1
2201383|NCT01582308|3838171|FG007|Period 1|Withdrawal by Subject|0
2201384|NCT01582308|3838172|FG008|Period 1|Withdrawal by Subject|0
2201385|NCT01582308|3838173|FG009|Period 1|Withdrawal by Subject|0
2201386|NCT01582308|3838164|FG000|10-day Washout Following Period 1|Physician Decision|0
2201387|NCT01582308|3838165|FG001|10-day Washout Following Period 1|Physician Decision|0
2201388|NCT01582308|3838166|FG002|10-day Washout Following Period 1|Physician Decision|0
2201389|NCT01582308|3838167|FG003|10-day Washout Following Period 1|Physician Decision|0
2201390|NCT01582308|3838168|FG004|10-day Washout Following Period 1|Physician Decision|1
2201391|NCT01582308|3838169|FG005|10-day Washout Following Period 1|Physician Decision|0
2201392|NCT01582308|3838170|FG006|10-day Washout Following Period 1|Physician Decision|0
2201393|NCT01582308|3838171|FG007|10-day Washout Following Period 1|Physician Decision|0
2201394|NCT01582308|3838172|FG008|10-day Washout Following Period 1|Physician Decision|0
2201395|NCT01582308|3838173|FG009|10-day Washout Following Period 1|Physician Decision|0
2201396|NCT01582308|3838164|FG000|Period 4|Physician Decision|1
2201397|NCT01582308|3838165|FG001|Period 4|Physician Decision|0
2201398|NCT01582308|3838166|FG002|Period 4|Physician Decision|0
2201399|NCT01582308|3838167|FG003|Period 4|Physician Decision|0
2201400|NCT01582308|3838168|FG004|Period 4|Physician Decision|0
2201401|NCT01582308|3838169|FG005|Period 4|Physician Decision|1
2201402|NCT01582308|3838170|FG006|Period 4|Physician Decision|0
2201403|NCT01582308|3838171|FG007|Period 4|Physician Decision|0
2201404|NCT01582308|3838172|FG008|Period 4|Physician Decision|0
2201405|NCT01582308|3838173|FG009|Period 4|Physician Decision|1
2201406|NCT01582451|3838188|FG000|Overall Study|Adverse Event|1
2201407|NCT01582451|3838189|FG001|Overall Study|Adverse Event|3
2201408|NCT01582451|3838188|FG000|Overall Study|Death|3
2201409|NCT01582451|3838189|FG001|Overall Study|Death|3
2201410|NCT01582451|3838188|FG000|Overall Study|Lost to Follow-up|0
2201411|NCT01582451|3838189|FG001|Overall Study|Lost to Follow-up|2
2201412|NCT01582451|3838188|FG000|Overall Study|Protocol Violation|11
2201413|NCT01582451|3838189|FG001|Overall Study|Protocol Violation|3
2201414|NCT01582451|3838188|FG000|Overall Study|Withdrawal by Subject|13
2201415|NCT01582451|3838189|FG001|Overall Study|Withdrawal by Subject|9
2201416|NCT01582451|3838188|FG000|Overall Study|Physician Decision|3
2201417|NCT01582451|3838189|FG001|Overall Study|Physician Decision|0
2201418|NCT01582451|3838188|FG000|Overall Study|Sponsor Decision|1
2201419|NCT01582451|3838189|FG001|Overall Study|Sponsor Decision|0
2201420|NCT01582789|3838215|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1
2201421|NCT01582789|3838216|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0
2201422|NCT01582854|3838226|FG000|Overall Study|Death|8
2118138|NCT00949884|3715874|FG000|Overall Study|Lack of Efficacy|4
2118139|NCT00949884|3715875|FG001|Overall Study|Lack of Efficacy|2
2118140|NCT00949884|3715876|FG002|Overall Study|Lack of Efficacy|7
2118141|NCT00949884|3715874|FG000|Overall Study|Study terminated by sponsor|0
2118142|NCT00949884|3715875|FG001|Overall Study|Study terminated by sponsor|0
2118143|NCT00949884|3715876|FG002|Overall Study|Study terminated by sponsor|1
2201423|NCT01582854|3838227|FG001|Overall Study|Death|5
2201424|NCT01582854|3838226|FG000|Overall Study|Adverse Event|2
2201425|NCT01582854|3838227|FG001|Overall Study|Adverse Event|3
2201426|NCT01582854|3838226|FG000|Overall Study|Withdrawal by Participant|8
2201427|NCT01582854|3838227|FG001|Overall Study|Withdrawal by Participant|11
2201428|NCT01582854|3838226|FG000|Overall Study|Lost to Follow-up|1
2201429|NCT01582854|3838227|FG001|Overall Study|Lost to Follow-up|2
2201430|NCT01582854|3838226|FG000|Overall Study|Physician Decision|0
2201431|NCT01582854|3838227|FG001|Overall Study|Physician Decision|1
2201432|NCT01582854|3838226|FG000|Overall Study|Recurrent Stroke|13
2201433|NCT01582854|3838227|FG001|Overall Study|Recurrent Stroke|8
2201434|NCT01582854|3838226|FG000|Overall Study|Disallowed Concomitant Medication|3
2201435|NCT01582854|3838227|FG001|Overall Study|Disallowed Concomitant Medication|2
2201436|NCT01582854|3838226|FG000|Overall Study|Carotid or Neurosurgery|0
2201437|NCT01582854|3838227|FG001|Overall Study|Carotid or Neurosurgery|1
2201438|NCT01582854|3838226|FG000|Overall Study|General Anaesthesia|0
2201439|NCT01582854|3838227|FG001|Overall Study|General Anaesthesia|1
2201440|NCT01582854|3838226|FG000|Overall Study|Other Miscellaneous Reason|1
2201441|NCT01582854|3838227|FG001|Overall Study|Other Miscellaneous Reason|0
2201442|NCT01582945|3838237|FG000|Overall Study|Intolerable side-effects|1
2201443|NCT01582945|3838237|FG000|Overall Study|Scheduling conflicts|1
2277098|NCT02326272|3959814|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277099|NCT02326272|3959815|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277100|NCT02326272|3959816|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277101|NCT02326272|3959817|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277102|NCT02326272|3959818|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277103|NCT02326272|3959819|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277104|NCT02326272|3959820|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277105|NCT02326272|3959821|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277106|NCT02326272|3959807|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2277107|NCT02326272|3959808|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2277108|NCT02326272|3959809|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2277109|NCT02326272|3959810|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2277110|NCT02326272|3959811|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2201444|NCT01582971|3838243|FG000|Overall Study|Death|2
2201445|NCT01582971|3838244|FG001|Overall Study|Death|1
2201446|NCT01582971|3838243|FG000|Overall Study|Lost to Follow-up|18
2201447|NCT01582971|3838244|FG001|Overall Study|Lost to Follow-up|21
2201448|NCT01582971|3838243|FG000|Overall Study|Withdrawal by Subject|4
2201449|NCT01582971|3838244|FG001|Overall Study|Withdrawal by Subject|2
2201450|NCT01582971|3838243|FG000|Overall Study|Other|15
2201451|NCT01582971|3838244|FG001|Overall Study|Other|13
2201452|NCT01583166|3838267|FG000|Overall Study|Withdrawal by Subject|4
2201453|NCT01583166|3838268|FG001|Overall Study|Withdrawal by Subject|6
2201454|NCT01583179|3838276|FG000|Overall Study|Screen failure|1
2201455|NCT01583179|3838277|FG001|Overall Study|Screen failure|2
2201456|NCT01583218|3838285|FG000|Overall Study|Withdrawal by Subject|43
2201457|NCT01583218|3838286|FG001|Overall Study|Withdrawal by Subject|29
2201458|NCT01583218|3838285|FG000|Overall Study|Death|206
2201459|NCT01583218|3838286|FG001|Overall Study|Death|211
2201460|NCT01583218|3838285|FG000|Overall Study|Lost to Follow-up|11
2201461|NCT01583218|3838286|FG001|Overall Study|Lost to Follow-up|17
2201462|NCT01583218|3838285|FG000|Overall Study|Adverse event or serious adverse event|3
2201463|NCT01583218|3838286|FG001|Overall Study|Adverse event or serious adverse event|3
2201464|NCT01583218|3838285|FG000|Overall Study|Patient /Family decision|3
2201465|NCT01583218|3838286|FG001|Overall Study|Patient /Family decision|0
2201466|NCT01583218|3838285|FG000|Overall Study|Cannot contact patient directly|1
2201467|NCT01583218|3838286|FG001|Overall Study|Cannot contact patient directly|2
2201468|NCT01583218|3838285|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
2201469|NCT01583218|3838286|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
2201470|NCT01583218|3838285|FG000|Overall Study|Patient did not wish to attend visits|0
2201471|NCT01583218|3838286|FG001|Overall Study|Patient did not wish to attend visits|1
2201472|NCT01583218|3838285|FG000|Overall Study|Patient randomized but not dosed|17
2201473|NCT01583218|3838286|FG001|Overall Study|Patient randomized but not dosed|16
2201474|NCT01583218|3838285|FG000|Overall Study|Patient was assessed via phone in person|1
2201475|NCT01583218|3838286|FG001|Overall Study|Patient was assessed via phone in person|0
2201476|NCT01583218|3838285|FG000|Overall Study|Patient deemed ineligible after random|2
2201477|NCT01583218|3838286|FG001|Overall Study|Patient deemed ineligible after random|0
2201478|NCT01583218|3838285|FG000|Overall Study|Patient was early terminated from study|0
2201479|NCT01583218|3838286|FG001|Overall Study|Patient was early terminated from study|1
2201480|NCT01583218|3838285|FG000|Overall Study|Patient was randomized due to mistake|1
2201481|NCT01583218|3838286|FG001|Overall Study|Patient was randomized due to mistake|0
2201482|NCT01583218|3838285|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
2201483|NCT01583218|3838286|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
2201484|NCT01583218|3838285|FG000|Overall Study|Withdraw of consent on day of random|1
2201485|NCT01583218|3838286|FG001|Overall Study|Withdraw of consent on day of random|0
2201486|NCT01583296|3838294|FG000|Overall Study|Withdrawal by Subject|11
2201487|NCT01583296|3838295|FG001|Overall Study|Withdrawal by Subject|10
2201488|NCT01583374|3838304|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
2201489|NCT01583374|3838305|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
2201490|NCT01583374|3838306|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
2201491|NCT01583374|3838307|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2201492|NCT01583374|3838308|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2201493|NCT01583374|3838309|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2201494|NCT01583374|3838310|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2201495|NCT01583374|3838311|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2201496|NCT01583374|3838312|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2201497|NCT01583374|3838304|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
2201498|NCT01583374|3838305|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
2201499|NCT01583374|3838306|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
2201500|NCT01583374|3838307|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2277111|NCT02326272|3959812|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2277112|NCT02326272|3959813|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2201501|NCT01583374|3838308|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2201502|NCT01583374|3838309|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2201503|NCT01583374|3838310|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2201504|NCT01583374|3838311|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2201505|NCT01583374|3838312|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2201506|NCT01583374|3838304|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
2201507|NCT01583374|3838305|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
2201508|NCT01583374|3838306|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2201509|NCT01583374|3838307|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2201510|NCT01583374|3838308|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2201511|NCT01583374|3838309|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2201512|NCT01583374|3838310|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2201513|NCT01583374|3838311|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2201514|NCT01583374|3838312|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2201515|NCT01583374|3838304|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
2201516|NCT01583374|3838305|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
2201517|NCT01583374|3838306|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
2201518|NCT01583374|3838307|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2201519|NCT01583374|3838308|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2201520|NCT01583374|3838309|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2201521|NCT01583374|3838310|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2201522|NCT01583374|3838311|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2201523|NCT01583374|3838312|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2201524|NCT01583374|3838304|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
2201525|NCT01583374|3838305|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
2201526|NCT01583374|3838306|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2201527|NCT01583374|3838307|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2201528|NCT01583374|3838308|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2201529|NCT01583374|3838309|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2201530|NCT01583374|3838310|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2201531|NCT01583374|3838311|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2201532|NCT01583374|3838312|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2201533|NCT01583374|3838304|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2201534|NCT01583374|3838305|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2201535|NCT01583374|3838306|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
2201536|NCT01583374|3838307|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2201537|NCT01583374|3838308|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2201538|NCT01583374|3838309|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2201539|NCT01583374|3838310|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2201540|NCT01583374|3838311|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2201541|NCT01583374|3838312|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2201542|NCT01583374|3838304|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
2201543|NCT01583374|3838305|FG001|Placebo-controlled Phase (Week 0-24)|Other|1
2201544|NCT01583374|3838306|FG002|Placebo-controlled Phase (Week 0-24)|Other|0
2201545|NCT01583374|3838307|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
2201546|NCT01583374|3838308|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
2277113|NCT02326272|3959814|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2277114|NCT02326272|3959815|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
2277115|NCT02326272|3959816|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2277116|NCT02326272|3959817|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2201547|NCT01583374|3838309|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
2201548|NCT01583374|3838310|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
2201549|NCT01583374|3838311|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
2201550|NCT01583374|3838312|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
2201551|NCT01583374|3838304|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2201552|NCT01583374|3838305|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2201553|NCT01583374|3838306|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2201554|NCT01583374|3838307|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2201555|NCT01583374|3838308|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2201556|NCT01583374|3838309|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2201557|NCT01583374|3838310|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2201558|NCT01583374|3838311|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
2201559|NCT01583374|3838312|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2201560|NCT01583374|3838304|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2201561|NCT01583374|3838305|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2201562|NCT01583374|3838306|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2
2201563|NCT01583374|3838307|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2201564|NCT01583374|3838308|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2201565|NCT01583374|3838309|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2201566|NCT01583374|3838310|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2201567|NCT01583374|3838311|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2201568|NCT01583374|3838312|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2201569|NCT01583374|3838304|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
2277117|NCT02326272|3959818|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2277118|NCT02326272|3959819|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2201570|NCT01583374|3838305|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
2201571|NCT01583374|3838306|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
2201572|NCT01583374|3838307|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
2201573|NCT01583374|3838308|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
2201574|NCT01583374|3838309|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
2201575|NCT01583374|3838310|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
2201576|NCT01583374|3838311|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
2201577|NCT01583374|3838312|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
2201578|NCT01583374|3838304|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2201579|NCT01583374|3838305|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
2201580|NCT01583374|3838306|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
2201581|NCT01583374|3838307|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2201582|NCT01583374|3838308|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
2201583|NCT01583374|3838309|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2201584|NCT01583374|3838310|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2201585|NCT01583374|3838311|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2201586|NCT01583374|3838312|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2201587|NCT01583374|3838304|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2201588|NCT01583374|3838305|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2201589|NCT01583374|3838306|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
2201590|NCT01583374|3838307|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2201591|NCT01583374|3838308|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
2201592|NCT01583374|3838309|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
2201593|NCT01583374|3838310|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2201594|NCT01583374|3838311|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2201595|NCT01583374|3838312|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2201596|NCT01583374|3838304|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
2201597|NCT01583374|3838305|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
2201598|NCT01583374|3838306|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2201599|NCT01583374|3838307|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2201600|NCT01583374|3838308|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
2201601|NCT01583374|3838309|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2201602|NCT01583374|3838310|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2201603|NCT01583374|3838311|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
2201604|NCT01583374|3838312|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
2201605|NCT01583374|3838304|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
2201606|NCT01583374|3838305|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
2201607|NCT01583374|3838306|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
2201608|NCT01583374|3838307|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
2201609|NCT01583374|3838308|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
2201610|NCT01583374|3838309|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
2201611|NCT01583374|3838310|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
2201612|NCT01583374|3838311|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
2201613|NCT01583374|3838312|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
2201614|NCT01583374|3838304|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2201615|NCT01583374|3838305|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2201616|NCT01583374|3838306|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2201617|NCT01583374|3838307|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2201618|NCT01583374|3838308|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
2201619|NCT01583374|3838309|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2201620|NCT01583374|3838310|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2201621|NCT01583374|3838311|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
2201622|NCT01583374|3838312|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
2201623|NCT01583374|3838304|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
2201624|NCT01583374|3838305|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
2201625|NCT01583374|3838306|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
2201626|NCT01583374|3838307|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
2201627|NCT01583374|3838308|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
2201628|NCT01583374|3838309|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
2201629|NCT01583374|3838310|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
2201630|NCT01583374|3838311|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
2201631|NCT01583374|3838312|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
2201632|NCT01583374|3838304|FG000|Long-Term Extension Phase Weeks 52-260|Death|0
2201633|NCT01583374|3838305|FG001|Long-Term Extension Phase Weeks 52-260|Death|0
2201634|NCT01583374|3838306|FG002|Long-Term Extension Phase Weeks 52-260|Death|0
2201635|NCT01583374|3838307|FG003|Long-Term Extension Phase Weeks 52-260|Death|0
2201636|NCT01583374|3838308|FG004|Long-Term Extension Phase Weeks 52-260|Death|1
2201637|NCT01583374|3838309|FG005|Long-Term Extension Phase Weeks 52-260|Death|0
2201638|NCT01583374|3838310|FG006|Long-Term Extension Phase Weeks 52-260|Death|1
2201639|NCT01583374|3838311|FG007|Long-Term Extension Phase Weeks 52-260|Death|0
2201640|NCT01583374|3838312|FG008|Long-Term Extension Phase Weeks 52-260|Death|0
2201641|NCT01583374|3838304|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2201642|NCT01583374|3838305|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2201643|NCT01583374|3838306|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2201644|NCT01583374|3838307|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2201645|NCT01583374|3838308|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2201646|NCT01583374|3838309|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2201647|NCT01583374|3838310|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2201648|NCT01583374|3838311|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2201649|NCT01583374|3838312|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2201650|NCT01583374|3838304|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
2201651|NCT01583374|3838305|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
2201652|NCT01583374|3838306|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
2201653|NCT01583374|3838307|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
2201654|NCT01583374|3838308|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
2201655|NCT01583374|3838309|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
2201656|NCT01583374|3838310|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
2201657|NCT01583374|3838311|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
2201658|NCT01583374|3838312|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
2201659|NCT01583530|3838349|FG000|Overall Study|Adverse Event|0
2201660|NCT01583530|3838350|FG001|Overall Study|Adverse Event|0
2201661|NCT01583530|3838351|FG002|Overall Study|Adverse Event|0
2201662|NCT01583530|3838352|FG003|Overall Study|Adverse Event|0
2201663|NCT01583530|3838353|FG004|Overall Study|Adverse Event|0
2201664|NCT01583530|3838354|FG005|Overall Study|Adverse Event|1
2201665|NCT01583530|3838349|FG000|Overall Study|Withdrawal by Subject|0
2201666|NCT01583530|3838350|FG001|Overall Study|Withdrawal by Subject|3
2201667|NCT01583530|3838351|FG002|Overall Study|Withdrawal by Subject|0
2201668|NCT01583530|3838352|FG003|Overall Study|Withdrawal by Subject|1
2201669|NCT01583530|3838353|FG004|Overall Study|Withdrawal by Subject|1
2201670|NCT01583530|3838354|FG005|Overall Study|Withdrawal by Subject|2
2201671|NCT01583530|3838349|FG000|Overall Study|Lost to Follow-up|0
2201672|NCT01583530|3838350|FG001|Overall Study|Lost to Follow-up|0
2201673|NCT01583530|3838351|FG002|Overall Study|Lost to Follow-up|0
2201674|NCT01583530|3838352|FG003|Overall Study|Lost to Follow-up|0
2201675|NCT01583530|3838353|FG004|Overall Study|Lost to Follow-up|3
2201676|NCT01583530|3838354|FG005|Overall Study|Lost to Follow-up|0
2201677|NCT01583530|3838349|FG000|Overall Study|Lack of compliance|0
2201678|NCT01583530|3838350|FG001|Overall Study|Lack of compliance|0
2201679|NCT01583530|3838351|FG002|Overall Study|Lack of compliance|0
2201680|NCT01583530|3838352|FG003|Overall Study|Lack of compliance|0
2201681|NCT01583530|3838353|FG004|Overall Study|Lack of compliance|1
2201682|NCT01583530|3838354|FG005|Overall Study|Lack of compliance|0
2201683|NCT01584024|3838428|FG000|Overall Study|Lost to Follow-up|10
2201684|NCT01584024|3838428|FG000|Overall Study|Withdrawal by Subject|3
2201685|NCT01584232|3838435|FG000|Overall Study|Adverse Event|3
2201686|NCT01584232|3838436|FG001|Overall Study|Adverse Event|1
2201687|NCT01584232|3838435|FG000|Overall Study|Withdrawal by Subject|2
2201688|NCT01584232|3838436|FG001|Overall Study|Withdrawal by Subject|1
2201689|NCT01584232|3838435|FG000|Overall Study|Physician Decision|2
2201690|NCT01584232|3838436|FG001|Overall Study|Physician Decision|1
2201691|NCT01584232|3838435|FG000|Overall Study|Lost to Follow-up|1
2201692|NCT01584232|3838436|FG001|Overall Study|Lost to Follow-up|0
2201693|NCT01584440|3838462|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1
2201694|NCT01584440|3838463|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
2201695|NCT01584440|3838464|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
2201696|NCT01584440|3838465|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
2201697|NCT01584440|3838466|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
2201698|NCT01584440|3838462|FG000|Stage 1 (5 Weeks)|Adverse Event|5
2201699|NCT01584440|3838463|FG001|Stage 1 (5 Weeks)|Adverse Event|3
2201700|NCT01584440|3838464|FG002|Stage 1 (5 Weeks)|Adverse Event|0
2201701|NCT01584440|3838465|FG003|Stage 1 (5 Weeks)|Adverse Event|0
2201702|NCT01584440|3838466|FG004|Stage 1 (5 Weeks)|Adverse Event|0
2201703|NCT01584440|3838462|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1
2201704|NCT01584440|3838463|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0
2201705|NCT01584440|3838464|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0
2201706|NCT01584440|3838465|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0
2201707|NCT01584440|3838466|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0
2201708|NCT01584440|3838462|FG000|Stage 1 (5 Weeks)|Protocol Violation|2
2201709|NCT01584440|3838463|FG001|Stage 1 (5 Weeks)|Protocol Violation|3
2201710|NCT01584440|3838464|FG002|Stage 1 (5 Weeks)|Protocol Violation|0
2201711|NCT01584440|3838465|FG003|Stage 1 (5 Weeks)|Protocol Violation|0
2201712|NCT01584440|3838466|FG004|Stage 1 (5 Weeks)|Protocol Violation|0
2201713|NCT01584440|3838462|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1
2201714|NCT01584440|3838463|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0
2201715|NCT01584440|3838464|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0
2201716|NCT01584440|3838465|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0
2201717|NCT01584440|3838466|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0
2201718|NCT01584440|3838462|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
2201719|NCT01584440|3838463|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2
2201720|NCT01584440|3838464|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
2201721|NCT01584440|3838465|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
2201722|NCT01584440|3838466|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
2201723|NCT01584440|3838462|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0
2201724|NCT01584440|3838463|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0
2201725|NCT01584440|3838464|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1
2201726|NCT01584440|3838465|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2
2201727|NCT01584440|3838466|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0
2201728|NCT01584440|3838462|FG000|Stage 2 (5 Weeks)|Adverse Event|0
2201729|NCT01584440|3838463|FG001|Stage 2 (5 Weeks)|Adverse Event|0
2201730|NCT01584440|3838464|FG002|Stage 2 (5 Weeks)|Adverse Event|1
2201731|NCT01584440|3838465|FG003|Stage 2 (5 Weeks)|Adverse Event|2
2201732|NCT01584440|3838466|FG004|Stage 2 (5 Weeks)|Adverse Event|1
2201733|NCT01584440|3838462|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
2201734|NCT01584440|3838463|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
2201735|NCT01584440|3838464|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1
2201736|NCT01584440|3838465|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
2201737|NCT01584440|3838466|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
2201738|NCT01584648|3838537|FG000|Overall Study|Death|136
2201739|NCT01584648|3838538|FG001|Overall Study|Death|146
2201740|NCT01584648|3838537|FG000|Overall Study|Lost to Follow-up|9
2201741|NCT01584648|3838538|FG001|Overall Study|Lost to Follow-up|9
2201742|NCT01584648|3838537|FG000|Overall Study|Investigator discretion|3
2201743|NCT01584648|3838538|FG001|Overall Study|Investigator discretion|2
2201744|NCT01584648|3838537|FG000|Overall Study|Withdrew consent|13
2201745|NCT01584648|3838538|FG001|Overall Study|Withdrew consent|4
2201746|NCT01584648|3838537|FG000|Overall Study|Study closed/terminated|50
2201747|NCT01584648|3838538|FG001|Overall Study|Study closed/terminated|23
2201748|NCT01584648|3838537|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0
2201749|NCT01584648|3838538|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28
2201750|NCT01584843|3838551|FG000|First Treatment Period|Adverse Event|0
2201751|NCT01584843|3838552|FG001|First Treatment Period|Adverse Event|0
2201752|NCT01584843|3838553|FG002|First Treatment Period|Adverse Event|1
2201753|NCT01584843|3838554|FG003|First Treatment Period|Adverse Event|0
2201754|NCT01584843|3838555|FG004|First Treatment Period|Adverse Event|0
2201755|NCT01584843|3838556|FG005|First Treatment Period|Adverse Event|0
2201756|NCT01584843|3838551|FG000|First Treatment Period|Protocol Violation|0
2201757|NCT01584843|3838552|FG001|First Treatment Period|Protocol Violation|0
2201758|NCT01584843|3838553|FG002|First Treatment Period|Protocol Violation|0
2201759|NCT01584843|3838554|FG003|First Treatment Period|Protocol Violation|0
2201760|NCT01584843|3838555|FG004|First Treatment Period|Protocol Violation|0
2201761|NCT01584843|3838556|FG005|First Treatment Period|Protocol Violation|1
2201762|NCT01584843|3838551|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2201763|NCT01584843|3838552|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2201764|NCT01584843|3838553|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2201765|NCT01584843|3838554|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2201766|NCT01584843|3838555|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2201767|NCT01584843|3838556|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1
2201768|NCT01584843|3838551|FG000|Second Treatment Period|Withdrawal by Subject|0
2201769|NCT01584843|3838552|FG001|Second Treatment Period|Withdrawal by Subject|0
2201770|NCT01584843|3838553|FG002|Second Treatment Period|Withdrawal by Subject|0
2201771|NCT01584843|3838554|FG003|Second Treatment Period|Withdrawal by Subject|0
2201772|NCT01584843|3838555|FG004|Second Treatment Period|Withdrawal by Subject|0
2201773|NCT01584843|3838556|FG005|Second Treatment Period|Withdrawal by Subject|1
2201774|NCT01585025|3838575|FG000|Overall Study|Withdrawal by Subject|0
2201775|NCT01585025|3838576|FG001|Overall Study|Withdrawal by Subject|3
2201776|NCT01585025|3838577|FG002|Overall Study|Withdrawal by Subject|4
2201777|NCT01585038|3838587|FG000|Overall Study|Adverse Event|2
2201778|NCT01585038|3838588|FG001|Overall Study|Adverse Event|2
2201779|NCT01585155|3838603|FG000|Overall Study|Adverse Event|1
2201780|NCT01585155|3838603|FG000|Overall Study|Lack of Efficacy|2
2201781|NCT01585155|3838603|FG000|Overall Study|Worsening ulcerative colitis|2
2201782|NCT01585168|3838609|FG000|Overall Study|Lost to Follow-up|3
2201783|NCT01585168|3838610|FG001|Overall Study|Lost to Follow-up|1
2201784|NCT01585168|3838611|FG002|Overall Study|Lost to Follow-up|1
2201785|NCT01585168|3838612|FG003|Overall Study|Lost to Follow-up|1
2201786|NCT01585194|3838620|FG000|Overall Study|Withdrawal by Subject|1
2201787|NCT01585194|3838620|FG000|Overall Study|Physician Decision|2
2201788|NCT01585194|3838620|FG000|Overall Study|Lack of insurance|1
2201789|NCT01585246|3838633|FG000|Overall Study|Lost to Follow-up|0
2201790|NCT01585246|3838634|FG001|Overall Study|Lost to Follow-up|0
2201791|NCT01585246|3838635|FG002|Overall Study|Lost to Follow-up|2
2201792|NCT01585246|3838636|FG003|Overall Study|Lost to Follow-up|1
2201793|NCT01585246|3838637|FG004|Overall Study|Lost to Follow-up|0
2201794|NCT01585246|3838633|FG000|Overall Study|Protocol Violation|0
2201795|NCT01585246|3838634|FG001|Overall Study|Protocol Violation|0
2201796|NCT01585246|3838635|FG002|Overall Study|Protocol Violation|0
2201797|NCT01585246|3838636|FG003|Overall Study|Protocol Violation|0
2201798|NCT01585246|3838637|FG004|Overall Study|Protocol Violation|1
2201799|NCT01585246|3838633|FG000|Overall Study|Withdrawal by Subject|0
2201800|NCT01585246|3838634|FG001|Overall Study|Withdrawal by Subject|0
2201801|NCT01585246|3838635|FG002|Overall Study|Withdrawal by Subject|1
2201802|NCT01585246|3838636|FG003|Overall Study|Withdrawal by Subject|2
2201803|NCT01585246|3838637|FG004|Overall Study|Withdrawal by Subject|1
2201804|NCT01585246|3838633|FG000|Overall Study|Other|0
2201805|NCT01585246|3838634|FG001|Overall Study|Other|1
2201806|NCT01585246|3838635|FG002|Overall Study|Other|1
2201807|NCT01585246|3838636|FG003|Overall Study|Other|1
2201808|NCT01585246|3838637|FG004|Overall Study|Other|0
2201809|NCT01585272|3838652|FG000|Overall Study|Adverse Event|22
2201810|NCT01585272|3838652|FG000|Overall Study|Protocol Violation|7
2201811|NCT01585272|3838652|FG000|Overall Study|Withdrawal by Subject|10
2201812|NCT01585298|3838656|FG000|Overall Study|Study completion was not documented.|1
2201813|NCT01585298|3838656|FG000|Overall Study|Protocol deviation|1
2201814|NCT01585298|3838656|FG000|Overall Study|Administrative problems|4
2201815|NCT01585298|3838656|FG000|Overall Study|Lost to Follow-up|2
2201816|NCT01585298|3838656|FG000|Overall Study|Withdrawal by Subject|4
2201817|NCT01585298|3838656|FG000|Overall Study|Abnormal test procedure results|1
2201818|NCT01585298|3838656|FG000|Overall Study|Adverse Event|24
2201819|NCT01585428|3838668|FG000|Overall Study|Death during treatment|1
2201820|NCT01585428|3838669|FG001|Overall Study|Death during treatment|0
2201821|NCT01585558|3838688|FG000|Overall Study|Withdrawal by Subject|4
2201822|NCT01585558|3838689|FG001|Overall Study|Withdrawal by Subject|5
2201823|NCT01585558|3838690|FG002|Overall Study|Withdrawal by Subject|8
2201824|NCT01585558|3838688|FG000|Overall Study|Lost to Follow-up|2
2201825|NCT01585558|3838689|FG001|Overall Study|Lost to Follow-up|0
2201826|NCT01585558|3838690|FG002|Overall Study|Lost to Follow-up|3
2201827|NCT01585558|3838688|FG000|Overall Study|Adverse Event|3
2201828|NCT01585558|3838689|FG001|Overall Study|Adverse Event|4
2201829|NCT01585558|3838690|FG002|Overall Study|Adverse Event|1
2201830|NCT01585558|3838688|FG000|Overall Study|Protocol Violation|4
2201831|NCT01585558|3838689|FG001|Overall Study|Protocol Violation|3
2201832|NCT01585558|3838690|FG002|Overall Study|Protocol Violation|2
2201833|NCT01585558|3838688|FG000|Overall Study|Lack of Efficacy|0
2201834|NCT01585558|3838689|FG001|Overall Study|Lack of Efficacy|0
2201835|NCT01585558|3838690|FG002|Overall Study|Lack of Efficacy|1
2201836|NCT01585584|3838698|FG000|Overall Study|Lack of Efficacy|1
2201837|NCT01585584|3838698|FG000|Overall Study|Withdrawal by Subject|1
2201838|NCT01585584|3838698|FG000|Overall Study|Physician Decision|2
2201839|NCT01585766|3838712|FG000|Overall Study|Withdrawal by Subject|0
2201840|NCT01585766|3838713|FG001|Overall Study|Withdrawal by Subject|1
2201841|NCT01585766|3838714|FG002|Overall Study|Withdrawal by Subject|1
2201842|NCT01585766|3838715|FG003|Overall Study|Withdrawal by Subject|0
2201843|NCT01585766|3838716|FG004|Overall Study|Withdrawal by Subject|0
2201844|NCT01585766|3838717|FG005|Overall Study|Withdrawal by Subject|0
2201845|NCT01585766|3838712|FG000|Overall Study|Death|0
2201846|NCT01585766|3838713|FG001|Overall Study|Death|1
2201847|NCT01585766|3838714|FG002|Overall Study|Death|0
2201848|NCT01585766|3838715|FG003|Overall Study|Death|0
2201849|NCT01585766|3838716|FG004|Overall Study|Death|0
2201850|NCT01585766|3838717|FG005|Overall Study|Death|0
2201851|NCT01585766|3838712|FG000|Overall Study|Physician Decision|0
2201852|NCT01585766|3838713|FG001|Overall Study|Physician Decision|0
2201853|NCT01585766|3838714|FG002|Overall Study|Physician Decision|1
2201854|NCT01585766|3838715|FG003|Overall Study|Physician Decision|0
2201855|NCT01585766|3838716|FG004|Overall Study|Physician Decision|0
2201856|NCT01585766|3838717|FG005|Overall Study|Physician Decision|0
2201857|NCT01585831|3838750|FG000|Overall Study|Physician Decision|0
2201858|NCT01585831|3838751|FG001|Overall Study|Physician Decision|1
2201859|NCT01585831|3838750|FG000|Overall Study|Withdrawal by Subject|2
2201860|NCT01585831|3838751|FG001|Overall Study|Withdrawal by Subject|1
2201861|NCT01585961|3838757|FG000|Overall Study|Death|6
2201862|NCT01585961|3838757|FG000|Overall Study|Physician Decision|1
2201863|NCT01585961|3838757|FG000|Overall Study|Decision to use non-study catheter|1
2201864|NCT01585961|3838757|FG000|Overall Study|Withdrawal by Subject|1
2201865|NCT01585961|3838757|FG000|Overall Study|Lost to Follow-up|23
2201866|NCT01585961|3838757|FG000|Overall Study|Ablation cancelled for slow-heal wound|1
2201867|NCT01585987|3838763|FG000|Randomized|Withdrawal by Subject|0
2201868|NCT01585987|3838764|FG001|Randomized|Withdrawal by Subject|4
2201869|NCT01585987|3838763|FG000|Randomized|No longer met criteria|0
2201870|NCT01585987|3838764|FG001|Randomized|No longer met criteria|2
2201871|NCT01585987|3838763|FG000|Treated|Disease Progression|39
2201872|NCT01585987|3838764|FG001|Treated|Disease Progression|36
2201873|NCT01585987|3838763|FG000|Treated|Study Drug Toxicity|9
2201874|NCT01585987|3838764|FG001|Treated|Study Drug Toxicity|5
2201875|NCT01585987|3838763|FG000|Treated|Adverse Event|3
2201876|NCT01585987|3838764|FG001|Treated|Adverse Event|0
2201877|NCT01585987|3838763|FG000|Treated|Withdrawal by Subject|1
2201878|NCT01585987|3838764|FG001|Treated|Withdrawal by Subject|2
2201879|NCT01585987|3838763|FG000|Treated|Death|1
2201880|NCT01585987|3838764|FG001|Treated|Death|0
2201881|NCT01585987|3838763|FG000|Treated|Lost to Follow-up|0
2201882|NCT01585987|3838764|FG001|Treated|Lost to Follow-up|1
2201883|NCT01585987|3838763|FG000|Treated|Maximum Clinical Benefit|0
2201884|NCT01585987|3838764|FG001|Treated|Maximum Clinical Benefit|1
2201885|NCT01585987|3838763|FG000|Treated|Non-Specified|1
2201886|NCT01585987|3838764|FG001|Treated|Non-Specified|2
2201887|NCT01585987|3838763|FG000|Treated|Subject Request|0
2201888|NCT01585987|3838764|FG001|Treated|Subject Request|1
2201889|NCT01585987|3838763|FG000|Treated|Poor/Non-Compliance|0
2201890|NCT01585987|3838764|FG001|Treated|Poor/Non-Compliance|1
2201891|NCT01586156|3838817|FG000|Overall Study|Pregnancy|0
2201892|NCT01586156|3838818|FG001|Overall Study|Pregnancy|1
2201893|NCT01586156|3838819|FG002|Overall Study|Pregnancy|0
2201894|NCT01586195|3838827|FG000|Overall Study|Death|11
2201895|NCT01586195|3838827|FG000|Overall Study|Withdrawal of Consent|5
2201896|NCT01586195|3838827|FG000|Overall Study|Started new anti-melanoma therapy|1
2201897|NCT01586195|3838827|FG000|Overall Study|Reason not specified|9
2201898|NCT01586338|3838840|FG000|Overall Study|Adverse Event|3
2201899|NCT01586338|3838840|FG000|Overall Study|Lost to Follow-up|1
2201900|NCT01586338|3838840|FG000|Overall Study|Withdrawal by participant|3
2201901|NCT01586338|3838840|FG000|Overall Study|Other|1
2201902|NCT01586364|3838844|FG000|Overall Study|Withdrawal by Subject|40
2201903|NCT01586364|3838844|FG000|Overall Study|Adverse Event|37
2201904|NCT01586364|3838844|FG000|Overall Study|Lost to Follow-up|17
2201905|NCT01586364|3838844|FG000|Overall Study|Protocol Violation|16
2201906|NCT01586364|3838844|FG000|Overall Study|Lack of Efficacy|1
2201907|NCT01586364|3838844|FG000|Overall Study|Other-Did not feel better post-treatment|1
2201908|NCT01586364|3838844|FG000|Overall Study|Other-Subject wasn't getting much relief|1
2201909|NCT01586364|3838844|FG000|Overall Study|Other-Site closure due to PI illness|1
2201910|NCT01586364|3838844|FG000|Overall Study|Other-PI discretion, site closing|2
2201911|NCT01586364|3838844|FG000|Overall Study|Other-Not specified|1
2201912|NCT01586624|3838856|FG000|Overall Study|Adverse Event|3
2201913|NCT01586624|3838857|FG001|Overall Study|Adverse Event|0
2201914|NCT01586624|3838858|FG002|Overall Study|Adverse Event|2
2201915|NCT01586624|3838859|FG003|Overall Study|Adverse Event|1
2201916|NCT01586624|3838860|FG004|Overall Study|Adverse Event|3
2201917|NCT01586624|3838861|FG005|Overall Study|Adverse Event|3
2201918|NCT01586624|3838862|FG006|Overall Study|Adverse Event|2
2201919|NCT01586624|3838863|FG007|Overall Study|Adverse Event|3
2201920|NCT01586624|3838856|FG000|Overall Study|Physician Decision|0
2201921|NCT01586624|3838857|FG001|Overall Study|Physician Decision|1
2201922|NCT01586624|3838858|FG002|Overall Study|Physician Decision|1
2201923|NCT01586624|3838859|FG003|Overall Study|Physician Decision|0
2201924|NCT01586624|3838860|FG004|Overall Study|Physician Decision|2
2201925|NCT01586624|3838861|FG005|Overall Study|Physician Decision|0
2201926|NCT01586624|3838862|FG006|Overall Study|Physician Decision|1
2277119|NCT02326272|3959820|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2201927|NCT01586624|3838863|FG007|Overall Study|Physician Decision|1
2201928|NCT01586624|3838856|FG000|Overall Study|Withdrawal by Subject|0
2201929|NCT01586624|3838857|FG001|Overall Study|Withdrawal by Subject|0
2201930|NCT01586624|3838858|FG002|Overall Study|Withdrawal by Subject|0
2201931|NCT01586624|3838859|FG003|Overall Study|Withdrawal by Subject|1
2201932|NCT01586624|3838860|FG004|Overall Study|Withdrawal by Subject|0
2201933|NCT01586624|3838861|FG005|Overall Study|Withdrawal by Subject|0
2201934|NCT01586624|3838862|FG006|Overall Study|Withdrawal by Subject|0
2201935|NCT01586624|3838863|FG007|Overall Study|Withdrawal by Subject|0
2201936|NCT01586624|3838856|FG000|Overall Study|Evidence of disease progression|1
2201937|NCT01586624|3838857|FG001|Overall Study|Evidence of disease progression|3
2201938|NCT01586624|3838858|FG002|Overall Study|Evidence of disease progression|2
2201939|NCT01586624|3838859|FG003|Overall Study|Evidence of disease progression|5
2201940|NCT01586624|3838860|FG004|Overall Study|Evidence of disease progression|3
2201941|NCT01586624|3838861|FG005|Overall Study|Evidence of disease progression|5
2201942|NCT01586624|3838862|FG006|Overall Study|Evidence of disease progression|4
2201943|NCT01586624|3838863|FG007|Overall Study|Evidence of disease progression|6
2201944|NCT01586624|3838856|FG000|Overall Study|Screen failure (no treatment received)|0
2201945|NCT01586624|3838857|FG001|Overall Study|Screen failure (no treatment received)|0
2201946|NCT01586624|3838858|FG002|Overall Study|Screen failure (no treatment received)|0
2201947|NCT01586624|3838859|FG003|Overall Study|Screen failure (no treatment received)|0
2201948|NCT01586624|3838860|FG004|Overall Study|Screen failure (no treatment received)|0
2201949|NCT01586624|3838861|FG005|Overall Study|Screen failure (no treatment received)|0
2201950|NCT01586624|3838862|FG006|Overall Study|Screen failure (no treatment received)|1
2201951|NCT01586624|3838863|FG007|Overall Study|Screen failure (no treatment received)|0
2201952|NCT01586806|3838898|FG000|Overall Study|Protocol Violation|0
2201953|NCT01586806|3838899|FG001|Overall Study|Protocol Violation|1
2201954|NCT01586806|3838900|FG002|Overall Study|Protocol Violation|0
2201955|NCT01586806|3838898|FG000|Overall Study|Withdrawal by Subject|1
2201956|NCT01586806|3838899|FG001|Overall Study|Withdrawal by Subject|0
2201957|NCT01586806|3838900|FG002|Overall Study|Withdrawal by Subject|0
2201958|NCT01586806|3838898|FG000|Overall Study|Lost to Follow-up|2
2201959|NCT01586806|3838899|FG001|Overall Study|Lost to Follow-up|3
2201960|NCT01586806|3838900|FG002|Overall Study|Lost to Follow-up|2
2201961|NCT01586819|3838910|FG000|Overall Study|Withdrawal by Subject|1
2201962|NCT01586819|3838911|FG001|Overall Study|Withdrawal by Subject|0
2201963|NCT01586910|3838943|FG000|Overall Study|Death|4
2201964|NCT01586910|3838944|FG001|Overall Study|Death|4
2201965|NCT01586910|3838943|FG000|Overall Study|Withdrawal by Subject|6
2201966|NCT01586910|3838944|FG001|Overall Study|Withdrawal by Subject|43
2201967|NCT01586910|3838943|FG000|Overall Study|Physician withdrew Subject|5
2201968|NCT01586910|3838944|FG001|Overall Study|Physician withdrew Subject|24
2201969|NCT01587001|3838971|FG000|Overall Study|Lost to Follow-up|2
2201970|NCT01587001|3838972|FG001|Overall Study|Lost to Follow-up|0
2201971|NCT01587001|3838971|FG000|Overall Study|Insufficient samples to complete testing|4
2201972|NCT01587001|3838972|FG001|Overall Study|Insufficient samples to complete testing|1
2201973|NCT01587014|3838979|FG000|Overall Study|Death|2
2201974|NCT01587040|3838996|FG000|Overall Study|Protocol Violation|0
2201975|NCT01587040|3838997|FG001|Overall Study|Protocol Violation|0
2201976|NCT01587040|3838998|FG002|Overall Study|Protocol Violation|1
2201977|NCT01587040|3838999|FG003|Overall Study|Protocol Violation|0
2201978|NCT01587040|3838996|FG000|Overall Study|Adverse Event|0
2201979|NCT01587040|3838997|FG001|Overall Study|Adverse Event|1
2201980|NCT01587040|3838998|FG002|Overall Study|Adverse Event|10
2201981|NCT01587040|3838999|FG003|Overall Study|Adverse Event|0
2201982|NCT01587040|3838996|FG000|Overall Study|Disease progression|12
2201983|NCT01587040|3838997|FG001|Overall Study|Disease progression|1
2201984|NCT01587040|3838998|FG002|Overall Study|Disease progression|15
2201985|NCT01587040|3838999|FG003|Overall Study|Disease progression|3
2201986|NCT01587040|3838996|FG000|Overall Study|Other than specified|5
2201987|NCT01587040|3838997|FG001|Overall Study|Other than specified|1
2201988|NCT01587040|3838998|FG002|Overall Study|Other than specified|11
2201989|NCT01587040|3838999|FG003|Overall Study|Other than specified|1
2201990|NCT01587079|3839009|FG000|Overall Study|Protocol-specified criteria|9
2201991|NCT01587079|3839009|FG000|Overall Study|Protocol Violation|5
2201992|NCT01587079|3839009|FG000|Overall Study|Lost to Follow-up|2
2201993|NCT01587079|3839009|FG000|Overall Study|Physician Decision|2
2201994|NCT01587079|3839009|FG000|Overall Study|Withdrawal by Subject|7
2201995|NCT01587079|3839009|FG000|Overall Study|Adverse Event|14
2201996|NCT01587118|3839052|FG000|Overall Study|Adverse Event|3
2201997|NCT01587118|3839052|FG000|Overall Study|Lost to Follow-up|2
2201998|NCT01587118|3839052|FG000|Overall Study|Relocation|1
2201999|NCT01587118|3839052|FG000|Overall Study|nonresponse|1
2202000|NCT01587274|3839059|FG000|Overall Study|Lost to Follow-up|4
2202001|NCT01587274|3839060|FG001|Overall Study|Lost to Follow-up|5
2202002|NCT01587274|3839061|FG002|Overall Study|Lost to Follow-up|3
2202003|NCT01587651|3839072|FG000|Overall Study|Adverse Event|0
2202004|NCT01587651|3839073|FG001|Overall Study|Adverse Event|1
2202005|NCT01587651|3839074|FG002|Overall Study|Adverse Event|0
2202006|NCT01587651|3839072|FG000|Overall Study|Protocol Violation|0
2202007|NCT01587651|3839073|FG001|Overall Study|Protocol Violation|1
2202008|NCT01587651|3839074|FG002|Overall Study|Protocol Violation|1
2202009|NCT01587651|3839072|FG000|Overall Study|Withdrawal by Subject|0
2202010|NCT01587651|3839073|FG001|Overall Study|Withdrawal by Subject|1
2202011|NCT01587651|3839074|FG002|Overall Study|Withdrawal by Subject|0
2202012|NCT01587703|3839101|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
2202013|NCT01587703|3839102|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202014|NCT01587703|3839103|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202015|NCT01587703|3839104|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202016|NCT01587703|3839105|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202017|NCT01587703|3839106|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202018|NCT01587703|3839107|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202019|NCT01587703|3839108|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202020|NCT01587703|3839109|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202021|NCT01587703|3839110|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202022|NCT01587703|3839111|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202023|NCT01587703|3839112|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202024|NCT01587703|3839113|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202025|NCT01587703|3839114|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202026|NCT01587703|3839115|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202027|NCT01587703|3839116|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202028|NCT01587703|3839117|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202029|NCT01587703|3839118|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202030|NCT01587703|3839119|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2202031|NCT01587703|3839101|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202032|NCT01587703|3839102|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202033|NCT01587703|3839103|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202034|NCT01587703|3839104|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2217660|NCT01709305|3860930|FG002|Phase 1|Travel, moving, etc.|0
2202035|NCT01587703|3839105|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202036|NCT01587703|3839106|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
2202037|NCT01587703|3839107|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202038|NCT01587703|3839108|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
2202039|NCT01587703|3839109|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202040|NCT01587703|3839110|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202041|NCT01587703|3839111|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202042|NCT01587703|3839112|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202043|NCT01587703|3839113|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202044|NCT01587703|3839114|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202045|NCT01587703|3839115|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202046|NCT01587703|3839116|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202047|NCT01587703|3839117|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202048|NCT01587703|3839118|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202049|NCT01587703|3839119|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2202050|NCT01587703|3839101|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202051|NCT01587703|3839102|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202052|NCT01587703|3839103|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202053|NCT01587703|3839104|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202054|NCT01587703|3839105|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202055|NCT01587703|3839106|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202056|NCT01587703|3839107|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2
2202057|NCT01587703|3839108|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202058|NCT01587703|3839109|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202059|NCT01587703|3839110|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202060|NCT01587703|3839111|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202061|NCT01587703|3839112|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202062|NCT01587703|3839113|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202063|NCT01587703|3839114|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202064|NCT01587703|3839115|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202065|NCT01587703|3839116|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202066|NCT01587703|3839117|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202067|NCT01587703|3839118|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202068|NCT01587703|3839119|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2202069|NCT01587703|3839101|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2
2202070|NCT01587703|3839102|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4
2202071|NCT01587703|3839103|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1
2202072|NCT01587703|3839104|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3
2202073|NCT01587703|3839105|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4
2202074|NCT01587703|3839106|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7
2202075|NCT01587703|3839107|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30
2277120|NCT02326272|3959821|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2277121|NCT02326272|3959807|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2277122|NCT02326272|3959808|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2277123|NCT02326272|3959809|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2277124|NCT02326272|3959810|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2277125|NCT02326272|3959811|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2277126|NCT02326272|3959812|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
2202076|NCT01587703|3839108|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7
2202077|NCT01587703|3839109|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0
2202078|NCT01587703|3839110|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0
2202079|NCT01587703|3839111|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0
2202080|NCT01587703|3839112|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0
2202081|NCT01587703|3839113|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0
2202082|NCT01587703|3839114|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0
2202083|NCT01587703|3839115|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0
2202084|NCT01587703|3839116|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0
2202085|NCT01587703|3839117|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0
2202086|NCT01587703|3839118|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0
2202087|NCT01587703|3839119|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0
2202088|NCT01587703|3839101|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0
2202089|NCT01587703|3839102|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0
2202090|NCT01587703|3839103|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0
2202091|NCT01587703|3839104|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0
2202092|NCT01587703|3839105|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0
2202093|NCT01587703|3839106|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0
2202094|NCT01587703|3839107|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0
2202095|NCT01587703|3839108|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0
2202096|NCT01587703|3839109|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1
2202097|NCT01587703|3839110|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9
2202098|NCT01587703|3839111|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3
2202099|NCT01587703|3839112|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0
2202100|NCT01587703|3839113|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0
2202101|NCT01587703|3839114|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0
2202102|NCT01587703|3839115|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0
2202103|NCT01587703|3839116|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0
2277127|NCT02326272|3959813|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
2277128|NCT02326272|3959814|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
2277129|NCT02326272|3959815|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
2277130|NCT02326272|3959816|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2277131|NCT02326272|3959817|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2277132|NCT02326272|3959818|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2277133|NCT02326272|3959819|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2277134|NCT02326272|3959820|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2277135|NCT02326272|3959821|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2277136|NCT02326272|3959807|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277137|NCT02326272|3959808|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277138|NCT02326272|3959809|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277139|NCT02326272|3959810|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277140|NCT02326272|3959811|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277141|NCT02326272|3959812|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
2277142|NCT02326272|3959813|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277143|NCT02326272|3959814|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277144|NCT02326272|3959815|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277145|NCT02326272|3959816|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277146|NCT02326272|3959817|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277147|NCT02326272|3959818|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277148|NCT02326272|3959819|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277149|NCT02326272|3959820|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277150|NCT02326272|3959821|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2277151|NCT02326272|3959807|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277152|NCT02326272|3959808|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277153|NCT02326272|3959809|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277154|NCT02326272|3959810|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277155|NCT02326272|3959811|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277156|NCT02326272|3959812|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277157|NCT02326272|3959813|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
2277158|NCT02326272|3959814|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277159|NCT02326272|3959815|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277160|NCT02326272|3959816|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277161|NCT02326272|3959817|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277162|NCT02326272|3959818|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277163|NCT02326272|3959819|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277164|NCT02326272|3959820|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277165|NCT02326272|3959821|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2277166|NCT02326272|3959807|FG000|Open-label Period (Week 48 to Week 144)|Death|0
2277167|NCT02326272|3959808|FG001|Open-label Period (Week 48 to Week 144)|Death|0
2277168|NCT02326272|3959809|FG002|Open-label Period (Week 48 to Week 144)|Death|0
2277169|NCT02326272|3959810|FG003|Open-label Period (Week 48 to Week 144)|Death|0
2277170|NCT02326272|3959811|FG004|Open-label Period (Week 48 to Week 144)|Death|0
2277171|NCT02326272|3959812|FG005|Open-label Period (Week 48 to Week 144)|Death|0
2277172|NCT02326272|3959813|FG006|Open-label Period (Week 48 to Week 144)|Death|0
2277173|NCT02326272|3959814|FG007|Open-label Period (Week 48 to Week 144)|Death|0
2277174|NCT02326272|3959815|FG008|Open-label Period (Week 48 to Week 144)|Death|0
2277175|NCT02326272|3959816|FG009|Open-label Period (Week 48 to Week 144)|Death|0
2277176|NCT02326272|3959817|FG010|Open-label Period (Week 48 to Week 144)|Death|0
2277177|NCT02326272|3959818|FG011|Open-label Period (Week 48 to Week 144)|Death|0
2277178|NCT02326272|3959819|FG012|Open-label Period (Week 48 to Week 144)|Death|1
2202104|NCT01587703|3839117|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0
2202105|NCT01587703|3839118|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0
2202106|NCT01587703|3839119|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0
2202107|NCT01587703|3839101|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202108|NCT01587703|3839102|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202109|NCT01587703|3839103|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202110|NCT01587703|3839104|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2217661|NCT01709305|3860931|FG003|Phase 1|Travel, moving, etc.|0
2202111|NCT01587703|3839105|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202112|NCT01587703|3839106|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202113|NCT01587703|3839107|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202114|NCT01587703|3839108|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202115|NCT01587703|3839109|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
2202116|NCT01587703|3839110|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202117|NCT01587703|3839111|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
2202118|NCT01587703|3839112|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202119|NCT01587703|3839113|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202120|NCT01587703|3839114|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202121|NCT01587703|3839115|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202122|NCT01587703|3839116|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202123|NCT01587703|3839117|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202124|NCT01587703|3839118|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202125|NCT01587703|3839119|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2202126|NCT01587703|3839101|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202127|NCT01587703|3839102|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202128|NCT01587703|3839103|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202129|NCT01587703|3839104|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202130|NCT01587703|3839105|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202131|NCT01587703|3839106|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202132|NCT01587703|3839107|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202133|NCT01587703|3839108|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202134|NCT01587703|3839109|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202135|NCT01587703|3839110|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1
2202136|NCT01587703|3839111|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1
2202137|NCT01587703|3839112|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202138|NCT01587703|3839113|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202139|NCT01587703|3839114|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202140|NCT01587703|3839115|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202141|NCT01587703|3839116|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202142|NCT01587703|3839117|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202143|NCT01587703|3839118|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202144|NCT01587703|3839119|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2202145|NCT01587703|3839101|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202146|NCT01587703|3839102|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202147|NCT01587703|3839103|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202148|NCT01587703|3839104|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202149|NCT01587703|3839105|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202150|NCT01587703|3839106|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202151|NCT01587703|3839107|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202152|NCT01587703|3839108|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202153|NCT01587703|3839109|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
2202154|NCT01587703|3839110|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202155|NCT01587703|3839111|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202156|NCT01587703|3839112|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202157|NCT01587703|3839113|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202158|NCT01587703|3839114|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202159|NCT01587703|3839115|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202160|NCT01587703|3839116|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202161|NCT01587703|3839117|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202162|NCT01587703|3839118|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202163|NCT01587703|3839119|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2202164|NCT01587703|3839101|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202165|NCT01587703|3839102|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202166|NCT01587703|3839103|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202167|NCT01587703|3839104|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202168|NCT01587703|3839105|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202169|NCT01587703|3839106|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202170|NCT01587703|3839107|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202171|NCT01587703|3839108|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202172|NCT01587703|3839109|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202173|NCT01587703|3839110|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202174|NCT01587703|3839111|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202175|NCT01587703|3839112|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202176|NCT01587703|3839113|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202177|NCT01587703|3839114|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202178|NCT01587703|3839115|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202179|NCT01587703|3839116|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202180|NCT01587703|3839117|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202181|NCT01587703|3839118|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2202182|NCT01587703|3839119|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
2202183|NCT01587703|3839101|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202184|NCT01587703|3839102|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202185|NCT01587703|3839103|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202186|NCT01587703|3839104|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202187|NCT01587703|3839105|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202188|NCT01587703|3839106|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202189|NCT01587703|3839107|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202190|NCT01587703|3839108|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202191|NCT01587703|3839109|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202192|NCT01587703|3839110|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202193|NCT01587703|3839111|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202194|NCT01587703|3839112|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202195|NCT01587703|3839113|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202196|NCT01587703|3839114|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202197|NCT01587703|3839115|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202198|NCT01587703|3839116|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202199|NCT01587703|3839117|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2202200|NCT01587703|3839118|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5
2202201|NCT01587703|3839119|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4
2202202|NCT01587703|3839101|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202203|NCT01587703|3839102|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202204|NCT01587703|3839103|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202205|NCT01587703|3839104|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202206|NCT01587703|3839105|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202207|NCT01587703|3839106|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202208|NCT01587703|3839107|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202209|NCT01587703|3839108|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202210|NCT01587703|3839109|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202211|NCT01587703|3839110|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202212|NCT01587703|3839111|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202213|NCT01587703|3839112|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202214|NCT01587703|3839113|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202215|NCT01587703|3839114|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202216|NCT01587703|3839115|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202217|NCT01587703|3839116|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
2202218|NCT01587703|3839117|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202219|NCT01587703|3839118|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202220|NCT01587703|3839119|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2202221|NCT01587703|3839101|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202222|NCT01587703|3839102|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202223|NCT01587703|3839103|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202224|NCT01587703|3839104|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202225|NCT01587703|3839105|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202226|NCT01587703|3839106|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202227|NCT01587703|3839107|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202228|NCT01587703|3839108|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202229|NCT01587703|3839109|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202230|NCT01587703|3839110|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202231|NCT01587703|3839111|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202232|NCT01587703|3839112|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
2202233|NCT01587703|3839113|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202234|NCT01587703|3839114|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202235|NCT01587703|3839115|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
2202236|NCT01587703|3839116|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202237|NCT01587703|3839117|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202238|NCT01587703|3839118|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202239|NCT01587703|3839119|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2202240|NCT01587703|3839101|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202241|NCT01587703|3839102|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202242|NCT01587703|3839103|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202243|NCT01587703|3839104|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202244|NCT01587703|3839105|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202245|NCT01587703|3839106|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202246|NCT01587703|3839107|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202247|NCT01587703|3839108|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202248|NCT01587703|3839109|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202249|NCT01587703|3839110|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202250|NCT01587703|3839111|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202251|NCT01587703|3839112|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2
2202252|NCT01587703|3839113|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2
2202253|NCT01587703|3839114|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1
2202254|NCT01587703|3839115|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1
2202255|NCT01587703|3839116|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3
2202256|NCT01587703|3839117|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8
2202257|NCT01587703|3839118|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202258|NCT01587703|3839119|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0
2202259|NCT01587703|3839101|FG000|Part2(Median Exposure of 1.41 Months)|Death|0
2202260|NCT01587703|3839102|FG001|Part2(Median Exposure of 1.41 Months)|Death|0
2202261|NCT01587703|3839103|FG002|Part2(Median Exposure of 1.41 Months)|Death|0
2202262|NCT01587703|3839104|FG003|Part2(Median Exposure of 1.41 Months)|Death|0
2202263|NCT01587703|3839105|FG004|Part2(Median Exposure of 1.41 Months)|Death|0
2202264|NCT01587703|3839106|FG005|Part2(Median Exposure of 1.41 Months)|Death|0
2202265|NCT01587703|3839107|FG006|Part2(Median Exposure of 1.41 Months)|Death|0
2202266|NCT01587703|3839108|FG007|Part2(Median Exposure of 1.41 Months)|Death|0
2202267|NCT01587703|3839109|FG008|Part2(Median Exposure of 1.41 Months)|Death|0
2202268|NCT01587703|3839110|FG009|Part2(Median Exposure of 1.41 Months)|Death|0
2202269|NCT01587703|3839111|FG010|Part2(Median Exposure of 1.41 Months)|Death|0
2202270|NCT01587703|3839112|FG011|Part2(Median Exposure of 1.41 Months)|Death|8
2202271|NCT01587703|3839113|FG012|Part2(Median Exposure of 1.41 Months)|Death|12
2202272|NCT01587703|3839114|FG013|Part2(Median Exposure of 1.41 Months)|Death|21
2202273|NCT01587703|3839115|FG014|Part2(Median Exposure of 1.41 Months)|Death|16
2202274|NCT01587703|3839116|FG015|Part2(Median Exposure of 1.41 Months)|Death|17
2202275|NCT01587703|3839117|FG016|Part2(Median Exposure of 1.41 Months)|Death|5
2202276|NCT01587703|3839118|FG017|Part2(Median Exposure of 1.41 Months)|Death|0
2202277|NCT01587703|3839119|FG018|Part2(Median Exposure of 1.41 Months)|Death|0
2202278|NCT01587703|3839101|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202279|NCT01587703|3839102|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202280|NCT01587703|3839103|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202281|NCT01587703|3839104|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202282|NCT01587703|3839105|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202283|NCT01587703|3839106|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202284|NCT01587703|3839107|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202285|NCT01587703|3839108|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202286|NCT01587703|3839109|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202287|NCT01587703|3839110|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202288|NCT01587703|3839111|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202289|NCT01587703|3839112|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
2277179|NCT02326272|3959820|FG013|Open-label Period (Week 48 to Week 144)|Death|0
2277180|NCT02326272|3959821|FG014|Open-label Period (Week 48 to Week 144)|Death|0
2202290|NCT01587703|3839113|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202291|NCT01587703|3839114|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202292|NCT01587703|3839115|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2277181|NCT02326272|3959807|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277182|NCT02326272|3959808|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277183|NCT02326272|3959809|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277184|NCT02326272|3959810|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277185|NCT02326272|3959811|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277186|NCT02326272|3959812|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2202293|NCT01587703|3839116|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202294|NCT01587703|3839117|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202295|NCT01587703|3839118|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202296|NCT01587703|3839119|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2202297|NCT01587885|3839178|FG000|Treatment Period 1|Failure to Return|0
2202298|NCT01587885|3839179|FG001|Treatment Period 1|Failure to Return|1
2202299|NCT01587885|3839178|FG000|Treatment Period 1|Protocol Violation|0
2202300|NCT01587885|3839179|FG001|Treatment Period 1|Protocol Violation|2
2202301|NCT01587898|3839190|FG000|Overall Study|Adverse Event|1
2202302|NCT01587898|3839191|FG001|Overall Study|Adverse Event|1
2202303|NCT01587898|3839192|FG002|Overall Study|Adverse Event|0
2202304|NCT01587898|3839193|FG003|Overall Study|Adverse Event|0
2202305|NCT01587898|3839190|FG000|Overall Study|Protocol Violation|0
2202306|NCT01587898|3839191|FG001|Overall Study|Protocol Violation|2
2202307|NCT01587898|3839192|FG002|Overall Study|Protocol Violation|1
2202308|NCT01587898|3839193|FG003|Overall Study|Protocol Violation|1
2202309|NCT01587898|3839190|FG000|Overall Study|Lost to Follow-up|0
2202310|NCT01587898|3839191|FG001|Overall Study|Lost to Follow-up|0
2202311|NCT01587898|3839192|FG002|Overall Study|Lost to Follow-up|0
2277187|NCT02326272|3959813|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2202312|NCT01587898|3839193|FG003|Overall Study|Lost to Follow-up|1
2202313|NCT01587898|3839190|FG000|Overall Study|Withdrawal by Subject|2
2202314|NCT01587898|3839191|FG001|Overall Study|Withdrawal by Subject|1
2202315|NCT01587898|3839192|FG002|Overall Study|Withdrawal by Subject|0
2202316|NCT01587898|3839193|FG003|Overall Study|Withdrawal by Subject|0
2202317|NCT01587898|3839190|FG000|Overall Study|Met haemoglobin stopping criteria|1
2202318|NCT01587898|3839191|FG001|Overall Study|Met haemoglobin stopping criteria|1
2202319|NCT01587898|3839192|FG002|Overall Study|Met haemoglobin stopping criteria|1
2202320|NCT01587898|3839193|FG003|Overall Study|Met haemoglobin stopping criteria|0
2202321|NCT01587924|3839210|FG000|Overall Study|Adverse Event|0
2202322|NCT01587924|3839211|FG001|Overall Study|Adverse Event|2
2202323|NCT01587924|3839212|FG002|Overall Study|Adverse Event|0
2202324|NCT01587924|3839213|FG003|Overall Study|Adverse Event|0
2202325|NCT01587924|3839210|FG000|Overall Study|Protocol Violation|2
2202326|NCT01587924|3839211|FG001|Overall Study|Protocol Violation|1
2202327|NCT01587924|3839212|FG002|Overall Study|Protocol Violation|2
2202328|NCT01587924|3839213|FG003|Overall Study|Protocol Violation|1
2202329|NCT01587924|3839210|FG000|Overall Study|Met Hemoglobin stopping criteria|2
2202330|NCT01587924|3839211|FG001|Overall Study|Met Hemoglobin stopping criteria|0
2202331|NCT01587924|3839212|FG002|Overall Study|Met Hemoglobin stopping criteria|1
2202332|NCT01587924|3839213|FG003|Overall Study|Met Hemoglobin stopping criteria|0
2202333|NCT01587924|3839210|FG000|Overall Study|Withdrawal by Subject|0
2202334|NCT01587924|3839211|FG001|Overall Study|Withdrawal by Subject|1
2202335|NCT01587924|3839212|FG002|Overall Study|Withdrawal by Subject|1
2202336|NCT01587924|3839213|FG003|Overall Study|Withdrawal by Subject|0
2202337|NCT01587989|3839238|FG000|12-Week Open-Label Run-In Period|Physician Decision|7
2202338|NCT01587989|3839239|FG001|12-Week Open-Label Run-In Period|Physician Decision|0
2202339|NCT01587989|3839240|FG002|12-Week Open-Label Run-In Period|Physician Decision|0
2202340|NCT01587989|3839238|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
2202341|NCT01587989|3839239|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
2202342|NCT01587989|3839240|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
2202343|NCT01587989|3839238|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4
2202344|NCT01587989|3839239|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0
2202345|NCT01587989|3839240|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0
2202346|NCT01587989|3839238|FG000|Randomized Study Treatment|Withdrawal by Subject|0
2202347|NCT01587989|3839239|FG001|Randomized Study Treatment|Withdrawal by Subject|1
2202348|NCT01587989|3839240|FG002|Randomized Study Treatment|Withdrawal by Subject|0
2202349|NCT01587989|3839238|FG000|Randomized Study Treatment|Screening failure|0
2202350|NCT01587989|3839239|FG001|Randomized Study Treatment|Screening failure|1
2202351|NCT01587989|3839240|FG002|Randomized Study Treatment|Screening failure|0
2202352|NCT01587989|3839238|FG000|Randomized Study Treatment|Physician Decision|0
2202353|NCT01587989|3839239|FG001|Randomized Study Treatment|Physician Decision|0
2202354|NCT01587989|3839240|FG002|Randomized Study Treatment|Physician Decision|1
2202355|NCT01588106|3839248|FG000|Overall Study|Withdrawal by Subject|5
2202356|NCT01588106|3839249|FG001|Overall Study|Withdrawal by Subject|4
2202357|NCT01588184|3839270|FG000|Overall Study|Death|1
2202358|NCT01588184|3839271|FG001|Overall Study|Death|0
2202359|NCT01588184|3839272|FG002|Overall Study|Death|0
2202360|NCT01588184|3839273|FG003|Overall Study|Death|1
2202361|NCT01588184|3839274|FG004|Overall Study|Death|1
2202362|NCT01588184|3839275|FG005|Overall Study|Death|1
2202363|NCT01588184|3839270|FG000|Overall Study|Withdrawal by Subject|2
2202364|NCT01588184|3839271|FG001|Overall Study|Withdrawal by Subject|4
2202365|NCT01588184|3839272|FG002|Overall Study|Withdrawal by Subject|0
2202366|NCT01588184|3839273|FG003|Overall Study|Withdrawal by Subject|1
2202367|NCT01588184|3839274|FG004|Overall Study|Withdrawal by Subject|0
2202368|NCT01588184|3839275|FG005|Overall Study|Withdrawal by Subject|0
2202369|NCT01588184|3839270|FG000|Overall Study|Bevacizumab treatment provision changed|0
2202370|NCT01588184|3839271|FG001|Overall Study|Bevacizumab treatment provision changed|6
2202371|NCT01588184|3839272|FG002|Overall Study|Bevacizumab treatment provision changed|2
2202372|NCT01588184|3839273|FG003|Overall Study|Bevacizumab treatment provision changed|0
2202373|NCT01588184|3839274|FG004|Overall Study|Bevacizumab treatment provision changed|1
2202374|NCT01588184|3839275|FG005|Overall Study|Bevacizumab treatment provision changed|3
2202375|NCT01588184|3839270|FG000|Overall Study|multiple reasons|0
2202376|NCT01588184|3839271|FG001|Overall Study|multiple reasons|3
2202377|NCT01588184|3839272|FG002|Overall Study|multiple reasons|0
2202378|NCT01588184|3839273|FG003|Overall Study|multiple reasons|1
2202379|NCT01588184|3839274|FG004|Overall Study|multiple reasons|0
2202380|NCT01588184|3839275|FG005|Overall Study|multiple reasons|0
2202381|NCT01588197|3839291|FG000|Overall Study|Lack of Efficacy|0
2202382|NCT01588197|3839292|FG001|Overall Study|Lack of Efficacy|1
2202383|NCT01588197|3839291|FG000|Overall Study|No MRI|1
2202384|NCT01588197|3839292|FG001|Overall Study|No MRI|0
2202385|NCT01588353|3839314|FG000|Step2|Withdrawal by Subject|0
2202386|NCT01588353|3839315|FG001|Step2|Withdrawal by Subject|1
2202387|NCT01588353|3839316|FG002|Step2|Withdrawal by Subject|0
2202388|NCT01588353|3839314|FG000|Step3|Adverse Event|0
2202389|NCT01588353|3839315|FG001|Step3|Adverse Event|0
2202390|NCT01588353|3839316|FG002|Step3|Adverse Event|2
2202391|NCT01588366|3839328|FG000|Overall Study|Adverse Event|0
2202392|NCT01588366|3839329|FG001|Overall Study|Adverse Event|1
2202393|NCT01588366|3839330|FG002|Overall Study|Adverse Event|0
2202394|NCT01588366|3839331|FG003|Overall Study|Adverse Event|1
2202395|NCT01588366|3839332|FG004|Overall Study|Adverse Event|0
2202396|NCT01588366|3839333|FG005|Overall Study|Adverse Event|2
2202397|NCT01588405|3839349|FG000|Overall Study|Adverse Event|1
2202398|NCT01588405|3839349|FG000|Overall Study|Clinical Worsening|1
2202399|NCT01588496|3839409|FG000|Overall Study|Withdrawal by Subject|0
2202400|NCT01588496|3839410|FG001|Overall Study|Withdrawal by Subject|1
2202401|NCT01588496|3839411|FG002|Overall Study|Withdrawal by Subject|0
2217297|NCT01707992|3860601|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0
2217298|NCT01707992|3860602|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0
2217299|NCT01707992|3860597|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
2217300|NCT01707992|3860598|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
2217301|NCT01707992|3860599|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
2217302|NCT01707992|3860600|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
2217303|NCT01707992|3860601|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
2217304|NCT01707992|3860602|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
2217305|NCT01707992|3860597|FG000|Placebo-Controlled Phase (24 Months)|Death|2
2217306|NCT01707992|3860598|FG001|Placebo-Controlled Phase (24 Months)|Death|1
2217307|NCT01707992|3860599|FG002|Placebo-Controlled Phase (24 Months)|Death|1
2217308|NCT01707992|3860600|FG003|Placebo-Controlled Phase (24 Months)|Death|0
2217309|NCT01707992|3860601|FG004|Placebo-Controlled Phase (24 Months)|Death|0
2217310|NCT01707992|3860602|FG005|Placebo-Controlled Phase (24 Months)|Death|0
2217311|NCT01707992|3860597|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
2217312|NCT01707992|3860598|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
2217313|NCT01707992|3860599|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
2217314|NCT01707992|3860600|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
2217315|NCT01707992|3860601|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
2217316|NCT01707992|3860602|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
2217317|NCT01707992|3860597|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11
2217318|NCT01707992|3860598|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9
2217319|NCT01707992|3860599|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10
2217320|NCT01707992|3860600|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0
2217321|NCT01707992|3860601|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0
2217322|NCT01707992|3860602|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0
2217323|NCT01707992|3860597|FG000|Active Treatment Phase (24 Months)|Adverse Event|0
2217324|NCT01707992|3860598|FG001|Active Treatment Phase (24 Months)|Adverse Event|0
2217325|NCT01707992|3860599|FG002|Active Treatment Phase (24 Months)|Adverse Event|0
2217326|NCT01707992|3860600|FG003|Active Treatment Phase (24 Months)|Adverse Event|4
2217327|NCT01707992|3860601|FG004|Active Treatment Phase (24 Months)|Adverse Event|1
2217328|NCT01707992|3860602|FG005|Active Treatment Phase (24 Months)|Adverse Event|0
2217329|NCT01707992|3860597|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0
2217330|NCT01707992|3860598|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0
2217331|NCT01707992|3860599|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0
2217332|NCT01707992|3860600|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3
2217333|NCT01707992|3860601|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1
2217334|NCT01707992|3860602|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2
2217335|NCT01707992|3860597|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
2217336|NCT01707992|3860598|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
2217337|NCT01707992|3860599|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
2217338|NCT01707992|3860600|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
2217339|NCT01707992|3860601|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
2217340|NCT01707992|3860602|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
2217341|NCT01707992|3860597|FG000|Active Treatment Phase (24 Months)|Pregnancy|0
2217342|NCT01707992|3860598|FG001|Active Treatment Phase (24 Months)|Pregnancy|0
2217343|NCT01707992|3860599|FG002|Active Treatment Phase (24 Months)|Pregnancy|0
2217344|NCT01707992|3860600|FG003|Active Treatment Phase (24 Months)|Pregnancy|2
2217345|NCT01707992|3860601|FG004|Active Treatment Phase (24 Months)|Pregnancy|5
2217346|NCT01707992|3860602|FG005|Active Treatment Phase (24 Months)|Pregnancy|2
2217347|NCT01707992|3860597|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0
2217348|NCT01707992|3860598|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0
2217349|NCT01707992|3860599|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0
2217350|NCT01707992|3860600|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5
2217351|NCT01707992|3860601|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11
2217352|NCT01707992|3860602|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1
2217353|NCT01707992|3860597|FG000|Active Treatment Phase (24 Months)|Death|0
2217354|NCT01707992|3860598|FG001|Active Treatment Phase (24 Months)|Death|0
2217355|NCT01707992|3860599|FG002|Active Treatment Phase (24 Months)|Death|0
2217356|NCT01707992|3860600|FG003|Active Treatment Phase (24 Months)|Death|2
2217357|NCT01707992|3860601|FG004|Active Treatment Phase (24 Months)|Death|0
2217358|NCT01707992|3860602|FG005|Active Treatment Phase (24 Months)|Death|0
2217359|NCT01707992|3860597|FG000|Active Treatment Phase (24 Months)|Other than specified|0
2202402|NCT01588509|3839421|FG000|Overall Study|Lost to Follow-up|1
2202403|NCT01588509|3839422|FG001|Overall Study|Lost to Follow-up|0
2202404|NCT01588548|3839434|FG000|Overall Study|Withdrawal by Subject|0
2202405|NCT01588548|3839435|FG001|Overall Study|Withdrawal by Subject|1
2202406|NCT01588548|3839436|FG002|Overall Study|Withdrawal by Subject|1
2202407|NCT01588548|3839437|FG003|Overall Study|Withdrawal by Subject|1
2202408|NCT01588548|3839438|FG004|Overall Study|Withdrawal by Subject|2
2202409|NCT01588548|3839439|FG005|Overall Study|Withdrawal by Subject|3
2202410|NCT01588548|3839434|FG000|Overall Study|Adverse Event|0
2202411|NCT01588548|3839435|FG001|Overall Study|Adverse Event|0
2202412|NCT01588548|3839436|FG002|Overall Study|Adverse Event|1
2202413|NCT01588548|3839437|FG003|Overall Study|Adverse Event|2
2202414|NCT01588548|3839438|FG004|Overall Study|Adverse Event|1
2202415|NCT01588548|3839439|FG005|Overall Study|Adverse Event|0
2202416|NCT01588548|3839434|FG000|Overall Study|Condition Under Investigation Worsened|3
2202417|NCT01588548|3839435|FG001|Overall Study|Condition Under Investigation Worsened|6
2202418|NCT01588548|3839436|FG002|Overall Study|Condition Under Investigation Worsened|4
2202419|NCT01588548|3839437|FG003|Overall Study|Condition Under Investigation Worsened|4
2202420|NCT01588548|3839438|FG004|Overall Study|Condition Under Investigation Worsened|3
2202421|NCT01588548|3839439|FG005|Overall Study|Condition Under Investigation Worsened|3
2202422|NCT01588951|3839468|FG000|Overall Study|Ineligible in retrospect|0
2202423|NCT01588951|3839469|FG001|Overall Study|Ineligible in retrospect|0
2202424|NCT01588951|3839470|FG002|Overall Study|Ineligible in retrospect|1
2202425|NCT01588990|3839478|FG000|Phase A|Withdrawal by Subject|5
2202426|NCT01588990|3839478|FG000|Phase A|Physician Decision|11
2202427|NCT01588990|3839478|FG000|Phase A|Other|14
2202428|NCT01588990|3839478|FG000|Phase A|Lost to Follow-up|1
2202429|NCT01588990|3839478|FG000|Phase A|Death|5
2202430|NCT01588990|3839478|FG000|Phase A|Adverse Event|28
2202431|NCT01588990|3839478|FG000|Phase A|Still on therapy at end of study|6
2202432|NCT01588990|3839478|FG000|Phase B|Adverse Event|2
2202433|NCT01588990|3839478|FG000|Phase B|Still on therapy at end of study|5
2202434|NCT01588990|3839478|FG000|Phase B|Withdrawal by Subject|3
2202435|NCT01588990|3839478|FG000|Phase B|Physician Decision|4
2202436|NCT01588990|3839478|FG000|Phase B|Other|2
2202437|NCT01589094|3839486|FG000|Overall Study|Did not receive treatment|2
2202438|NCT01589185|3839495|FG000|Overall Study|Death|1
2202439|NCT01589185|3839496|FG001|Overall Study|Death|2
2202440|NCT01589185|3839497|FG002|Overall Study|Death|2
2202441|NCT01589185|3839498|FG003|Overall Study|Death|0
2202442|NCT01589185|3839499|FG004|Overall Study|Death|1
2202443|NCT01589185|3839495|FG000|Overall Study|Lost to Follow-up|1
2202444|NCT01589185|3839496|FG001|Overall Study|Lost to Follow-up|0
2202445|NCT01589185|3839497|FG002|Overall Study|Lost to Follow-up|2
2202446|NCT01589185|3839498|FG003|Overall Study|Lost to Follow-up|3
2202447|NCT01589185|3839499|FG004|Overall Study|Lost to Follow-up|0
2202448|NCT01589237|3839516|FG000|Part A (52 Weeks)|Subject/guardian decision|2
2202449|NCT01589237|3839517|FG001|Part A (52 Weeks)|Subject/guardian decision|3
2202450|NCT01589237|3839518|FG002|Part A (52 Weeks)|Subject/guardian decision|2
2202451|NCT01589237|3839519|FG003|Part A (52 Weeks)|Subject/guardian decision|0
2202452|NCT01589237|3839516|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
2202453|NCT01589237|3839517|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
2202454|NCT01589237|3839518|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
2202455|NCT01589237|3839519|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
2202456|NCT01589237|3839516|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
2202457|NCT01589237|3839517|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
2202458|NCT01589237|3839518|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
2202459|NCT01589237|3839519|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
2202460|NCT01589237|3839516|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0
2202461|NCT01589237|3839517|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0
2202462|NCT01589237|3839518|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0
2202463|NCT01589237|3839519|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1
2202464|NCT01589445|3839551|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1
2202465|NCT01589445|3839551|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
2202466|NCT01589445|3839551|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
2202467|NCT01589445|3839551|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
2202468|NCT01589445|3839551|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
2202469|NCT01589445|3839551|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1
2202470|NCT01589445|3839551|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2
2202471|NCT01589445|3839551|FG000|002 (Metformin)-3 Months|Protocol Violation|2
2202472|NCT01589445|3839551|FG000|002 (Metformin)-3 Months|Adverse Event|2
2202473|NCT01589445|3839551|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2
2202474|NCT01589497|3839568|FG000|Overall Study|Withdrawal by Subject|0
2202475|NCT01589497|3839569|FG001|Overall Study|Withdrawal by Subject|1
2202476|NCT01589497|3839570|FG002|Overall Study|Withdrawal by Subject|0
2202477|NCT01589497|3839571|FG003|Overall Study|Withdrawal by Subject|1
2202478|NCT01589497|3839568|FG000|Overall Study|Death|1
2202479|NCT01589497|3839569|FG001|Overall Study|Death|0
2202480|NCT01589497|3839570|FG002|Overall Study|Death|0
2202481|NCT01589497|3839571|FG003|Overall Study|Death|0
2202482|NCT01589497|3839568|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0
2202483|NCT01589497|3839569|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0
2202484|NCT01589497|3839570|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1
2202485|NCT01589497|3839571|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0
2202486|NCT01589653|3839601|FG000|Overall Study|Protocol Violation|3
2202487|NCT01589653|3839602|FG001|Overall Study|Protocol Violation|1
2202488|NCT01589653|3839601|FG000|Overall Study|Withdrawal criteria|4
2202489|NCT01589653|3839602|FG001|Overall Study|Withdrawal criteria|7
2202490|NCT01589653|3839601|FG000|Overall Study|Unclassified|0
2202491|NCT01589653|3839602|FG001|Overall Study|Unclassified|3
2202492|NCT01589770|3839610|FG000|Overall Study|EGFR <60ml/min|6
2202493|NCT01589770|3839611|FG001|Overall Study|EGFR <60ml/min|4
2202494|NCT01589770|3839610|FG000|Overall Study|claustrophobic when entering cardiac MRI|2
2202495|NCT01589770|3839611|FG001|Overall Study|claustrophobic when entering cardiac MRI|1
2202496|NCT01589822|3839620|FG000|Overall Study|Withdrawal by Subject|1
2202497|NCT01589822|3839621|FG001|Overall Study|Withdrawal by Subject|2
2202498|NCT01589822|3839622|FG002|Overall Study|Withdrawal by Subject|0
2202499|NCT01589822|3839620|FG000|Overall Study|Death|1
2202500|NCT01589822|3839621|FG001|Overall Study|Death|0
2202501|NCT01589822|3839622|FG002|Overall Study|Death|0
2202502|NCT01589822|3839620|FG000|Overall Study|Missed 90 day visit|2
2202503|NCT01589822|3839621|FG001|Overall Study|Missed 90 day visit|1
2202504|NCT01589822|3839622|FG002|Overall Study|Missed 90 day visit|1
2202505|NCT01590017|3839637|FG000|Overall Study|Adverse Event|1
2202506|NCT01590017|3839637|FG000|Overall Study|Withdrawal by Subject|1
2202507|NCT01590017|3839637|FG000|Overall Study|Lack of Efficacy|1
2202508|NCT01590017|3839637|FG000|Overall Study|Physician Decision|1
2202509|NCT01590082|3839643|FG000|Overall Study|Withdrawal by Subject|1
2202510|NCT01590082|3839644|FG001|Overall Study|Withdrawal by Subject|0
2202511|NCT01590082|3839643|FG000|Overall Study|Ineligible|1
2202512|NCT01590082|3839644|FG001|Overall Study|Ineligible|0
2202513|NCT01590212|3839653|FG000|Overall Study|Withdrawal by Subject|2
2202514|NCT01590212|3839654|FG001|Overall Study|Withdrawal by Subject|2
2202515|NCT01590212|3839655|FG002|Overall Study|Withdrawal by Subject|2
2202516|NCT01590212|3839653|FG000|Overall Study|Lost to Follow-up|1
2202517|NCT01590212|3839654|FG001|Overall Study|Lost to Follow-up|2
2202518|NCT01590212|3839655|FG002|Overall Study|Lost to Follow-up|3
2202519|NCT01590433|3839674|FG000|Overall Study|Lost to Follow-up|20
2202520|NCT01590433|3839675|FG001|Overall Study|Lost to Follow-up|8
2202521|NCT01590433|3839674|FG000|Overall Study|Withdrawal by Subject|21
2202522|NCT01590433|3839675|FG001|Overall Study|Withdrawal by Subject|11
2202523|NCT01590433|3839674|FG000|Overall Study|Adverse Event|11
2202524|NCT01590433|3839675|FG001|Overall Study|Adverse Event|3
2202525|NCT01590563|3839686|FG000|Overall Study|simple uterine hyperplasia - not related|1
2202526|NCT01590758|3839693|FG000|Overall Study|Withdrawal by Subject|0
2202527|NCT01590758|3839694|FG001|Overall Study|Withdrawal by Subject|3
2202528|NCT01590758|3839693|FG000|Overall Study|Physician Decision|1
2202529|NCT01590758|3839694|FG001|Overall Study|Physician Decision|2
2202530|NCT01590758|3839693|FG000|Overall Study|Lost to Follow-up|4
2202531|NCT01590758|3839694|FG001|Overall Study|Lost to Follow-up|2
2202532|NCT01590771|3839702|FG000|Overall Study|Other Protocol Specified Criteria|5
2202533|NCT01590771|3839703|FG001|Overall Study|Other Protocol Specified Criteria|14
2202534|NCT01590771|3839702|FG000|Overall Study|Withdrawal by Subject|8
2202535|NCT01590771|3839703|FG001|Overall Study|Withdrawal by Subject|15
2202536|NCT01590771|3839702|FG000|Overall Study|Protocol Violation|1
2202537|NCT01590771|3839703|FG001|Overall Study|Protocol Violation|2
2202538|NCT01590771|3839702|FG000|Overall Study|Lost to Follow-up|1
2202539|NCT01590771|3839703|FG001|Overall Study|Lost to Follow-up|1
2202540|NCT01590771|3839702|FG000|Overall Study|Lack of Efficacy|1
2202541|NCT01590771|3839703|FG001|Overall Study|Lack of Efficacy|0
2202542|NCT01590771|3839702|FG000|Overall Study|Adverse Event|3
2202543|NCT01590771|3839703|FG001|Overall Study|Adverse Event|7
2202544|NCT01590797|3839711|FG000|Overall Study|Adverse Event|4
2202545|NCT01590797|3839712|FG001|Overall Study|Adverse Event|3
2202546|NCT01590797|3839711|FG000|Overall Study|Lack of Efficacy|0
2202547|NCT01590797|3839712|FG001|Overall Study|Lack of Efficacy|2
2202548|NCT01590797|3839711|FG000|Overall Study|Lost to Follow-up|0
2202549|NCT01590797|3839712|FG001|Overall Study|Lost to Follow-up|1
2202550|NCT01590797|3839711|FG000|Overall Study|Protocol Violation|4
2202551|NCT01590797|3839712|FG001|Overall Study|Protocol Violation|1
2202552|NCT01590797|3839711|FG000|Overall Study|Withdrawal by Subject|7
2202553|NCT01590797|3839712|FG001|Overall Study|Withdrawal by Subject|5
2202554|NCT01590797|3839711|FG000|Overall Study|Other Protocol Specified Criteria|2
2202555|NCT01590797|3839712|FG001|Overall Study|Other Protocol Specified Criteria|4
2202556|NCT01590810|3839723|FG000|Overall Study|Physician Decision|0
2202557|NCT01590810|3839724|FG001|Overall Study|Physician Decision|1
2202558|NCT01590810|3839725|FG002|Overall Study|Physician Decision|1
2202559|NCT01590810|3839726|FG003|Overall Study|Physician Decision|0
2202560|NCT01590810|3839727|FG004|Overall Study|Physician Decision|0
2202561|NCT01590888|3839774|FG000|Overall Study|Adverse Event|3
2202562|NCT01590888|3839775|FG001|Overall Study|Adverse Event|0
2202563|NCT01590888|3839776|FG002|Overall Study|Adverse Event|1
2202564|NCT01590888|3839774|FG000|Overall Study|Lost to Follow-up|1
2202565|NCT01590888|3839775|FG001|Overall Study|Lost to Follow-up|0
2202566|NCT01590888|3839776|FG002|Overall Study|Lost to Follow-up|0
2202567|NCT01591330|3839859|FG000|Period 1|Adverse Event|1
2202568|NCT01591330|3839860|FG001|Period 1|Adverse Event|0
2202569|NCT01591330|3839861|FG002|Period 1|Adverse Event|0
2202570|NCT01591330|3839862|FG003|Period 1|Adverse Event|0
2202571|NCT01591330|3839859|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1
2202572|NCT01591330|3839860|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0
2202573|NCT01591330|3839861|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0
2202574|NCT01591330|3839862|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0
2202575|NCT01591330|3839859|FG000|Period 2|Adverse Event|1
2202576|NCT01591330|3839860|FG001|Period 2|Adverse Event|0
2202577|NCT01591330|3839861|FG002|Period 2|Adverse Event|0
2202578|NCT01591330|3839862|FG003|Period 2|Adverse Event|0
2202579|NCT01591382|3839874|FG000|Overall Study|Discharged Prior to Study Completion|2
2202580|NCT01591382|3839875|FG001|Overall Study|Discharged Prior to Study Completion|1
2202581|NCT01591382|3839874|FG000|Overall Study|Participant Opted for Morphine PCA|1
2202582|NCT01591382|3839875|FG001|Overall Study|Participant Opted for Morphine PCA|1
2202583|NCT01591460|3839890|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
2202584|NCT01591460|3839890|FG000|Overall Study|Futility Rule (Week 12)|7
2202585|NCT01591460|3839890|FG000|Overall Study|Futility Rule (Week 24)|3
2202586|NCT01591460|3839890|FG000|Overall Study|Rebound or Breakthrough|3
2202587|NCT01591460|3839890|FG000|Overall Study|Treatment Discontinued by Error|1
2202588|NCT01591460|3839890|FG000|Overall Study|Lost to Follow-up|1
2202589|NCT01591460|3839890|FG000|Overall Study|Noncompliance|1
2202590|NCT01591460|3839890|FG000|Overall Study|Participant Refusal|3
2202591|NCT01591460|3839890|FG000|Overall Study|Withdrawal by Subject|1
2202592|NCT01591460|3839890|FG000|Overall Study|Protocol Violation|1
2202593|NCT01591499|3839902|FG000|Baseline Visit|Withdrawal by Subject|0
2202594|NCT01591499|3839903|FG001|Baseline Visit|Withdrawal by Subject|2
2202595|NCT01591499|3839904|FG002|Baseline Visit|Withdrawal by Subject|0
2202596|NCT01591499|3839905|FG003|Baseline Visit|Withdrawal by Subject|2
2202597|NCT01591499|3839902|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
2202598|NCT01591499|3839903|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
2202599|NCT01591499|3839904|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
2202600|NCT01591499|3839905|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
2202601|NCT01591499|3839902|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4
2202602|NCT01591499|3839903|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3
2202603|NCT01591499|3839904|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1
2202604|NCT01591499|3839905|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3
2202605|NCT01591616|3839929|FG000|Overall Study|Withdrawal by Subject|1
2202606|NCT01591681|3840077|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3
2202607|NCT01591681|3840077|FG000|Overall Study|Failed to use system during run-in|1
2202608|NCT01591785|3840100|FG000|Overall Study|worsening condition|1
2202609|NCT01591785|3840101|FG001|Overall Study|worsening condition|2
2202610|NCT01591785|3840100|FG000|Overall Study|Protocol Violation|2
2202611|NCT01591785|3840101|FG001|Overall Study|Protocol Violation|0
2202612|NCT01591785|3840100|FG000|Overall Study|Lost to Follow-up|1
2202613|NCT01591785|3840101|FG001|Overall Study|Lost to Follow-up|0
2202614|NCT01591863|3840116|FG000|Overall Study|Adverse Event|3
2202615|NCT01591863|3840116|FG000|Overall Study|Withdrawal by Subject|1
2202616|NCT01591863|3840116|FG000|Overall Study|recurrence|9
2202617|NCT01591863|3840116|FG000|Overall Study|Lack of Efficacy|1
2202618|NCT01592045|3840126|FG000|Overall Study|Disease Progression|1
2202619|NCT01592045|3840127|FG001|Overall Study|Disease Progression|1
2202620|NCT01592045|3840126|FG000|Overall Study|Adverse Event|1
2202621|NCT01592045|3840127|FG001|Overall Study|Adverse Event|1
2202622|NCT01592045|3840126|FG000|Overall Study|Withdrawal by Subject|1
2202623|NCT01592045|3840127|FG001|Overall Study|Withdrawal by Subject|0
2202624|NCT01592045|3840126|FG000|Overall Study|Moved out of country|2
2202625|NCT01592045|3840127|FG001|Overall Study|Moved out of country|0
2202626|NCT01592240|3840144|FG000|Overall Study|Adverse Event|1
2202627|NCT01592240|3840145|FG001|Overall Study|Adverse Event|0
2202628|NCT01592240|3840146|FG002|Overall Study|Adverse Event|0
2202629|NCT01592240|3840147|FG003|Overall Study|Adverse Event|1
2202630|NCT01592240|3840148|FG004|Overall Study|Adverse Event|1
2202631|NCT01592240|3840149|FG005|Overall Study|Adverse Event|0
2202632|NCT01592240|3840150|FG006|Overall Study|Adverse Event|0
2202633|NCT01592240|3840144|FG000|Overall Study|Death|0
2202634|NCT01592240|3840145|FG001|Overall Study|Death|1
2202635|NCT01592240|3840146|FG002|Overall Study|Death|0
2202636|NCT01592240|3840147|FG003|Overall Study|Death|0
2202637|NCT01592240|3840148|FG004|Overall Study|Death|0
2202638|NCT01592240|3840149|FG005|Overall Study|Death|0
2202639|NCT01592240|3840150|FG006|Overall Study|Death|0
2202640|NCT01592240|3840144|FG000|Overall Study|Lost to Follow-up|1
2202641|NCT01592240|3840145|FG001|Overall Study|Lost to Follow-up|3
2202642|NCT01592240|3840146|FG002|Overall Study|Lost to Follow-up|1
2202643|NCT01592240|3840147|FG003|Overall Study|Lost to Follow-up|0
2202644|NCT01592240|3840148|FG004|Overall Study|Lost to Follow-up|3
2202645|NCT01592240|3840149|FG005|Overall Study|Lost to Follow-up|2
2202646|NCT01592240|3840150|FG006|Overall Study|Lost to Follow-up|0
2202647|NCT01592240|3840144|FG000|Overall Study|Protocol Violation|0
2202648|NCT01592240|3840145|FG001|Overall Study|Protocol Violation|0
2202649|NCT01592240|3840146|FG002|Overall Study|Protocol Violation|0
2202650|NCT01592240|3840147|FG003|Overall Study|Protocol Violation|0
2202651|NCT01592240|3840148|FG004|Overall Study|Protocol Violation|0
2202652|NCT01592240|3840149|FG005|Overall Study|Protocol Violation|1
2202653|NCT01592240|3840150|FG006|Overall Study|Protocol Violation|0
2202654|NCT01592240|3840144|FG000|Overall Study|Withdrawal by Subject|0
2202655|NCT01592240|3840145|FG001|Overall Study|Withdrawal by Subject|4
2202656|NCT01592240|3840146|FG002|Overall Study|Withdrawal by Subject|4
2202657|NCT01592240|3840147|FG003|Overall Study|Withdrawal by Subject|1
2202658|NCT01592240|3840148|FG004|Overall Study|Withdrawal by Subject|3
2202659|NCT01592240|3840149|FG005|Overall Study|Withdrawal by Subject|0
2202660|NCT01592240|3840150|FG006|Overall Study|Withdrawal by Subject|2
2202661|NCT01592240|3840144|FG000|Overall Study|Other|0
2202662|NCT01592240|3840145|FG001|Overall Study|Other|3
2202663|NCT01592240|3840146|FG002|Overall Study|Other|1
2202664|NCT01592240|3840147|FG003|Overall Study|Other|1
2202665|NCT01592240|3840148|FG004|Overall Study|Other|0
2202666|NCT01592240|3840149|FG005|Overall Study|Other|0
2202667|NCT01592240|3840150|FG006|Overall Study|Other|1
2202668|NCT01592240|3840144|FG000|Overall Study|Did Not Meet Entrance Criteria|1
2202669|NCT01592240|3840145|FG001|Overall Study|Did Not Meet Entrance Criteria|0
2202670|NCT01592240|3840146|FG002|Overall Study|Did Not Meet Entrance Criteria|1
2202671|NCT01592240|3840147|FG003|Overall Study|Did Not Meet Entrance Criteria|0
2202672|NCT01592240|3840148|FG004|Overall Study|Did Not Meet Entrance Criteria|0
2202673|NCT01592240|3840149|FG005|Overall Study|Did Not Meet Entrance Criteria|0
2202674|NCT01592240|3840150|FG006|Overall Study|Did Not Meet Entrance Criteria|0
2202675|NCT01592292|3840173|FG000|Overall Study|Follow-up loss|3
2202676|NCT01592292|3840174|FG001|Overall Study|Follow-up loss|3
2202677|NCT01592292|3840175|FG002|Overall Study|Follow-up loss|1
2202678|NCT01592292|3840176|FG003|Overall Study|Follow-up loss|0
2202679|NCT01592292|3840173|FG000|Overall Study|Withdrew consent|2
2202680|NCT01592292|3840174|FG001|Overall Study|Withdrew consent|1
2202681|NCT01592292|3840175|FG002|Overall Study|Withdrew consent|0
2202682|NCT01592292|3840176|FG003|Overall Study|Withdrew consent|0
2202683|NCT01592292|3840173|FG000|Overall Study|Other|1
2202684|NCT01592292|3840174|FG001|Overall Study|Other|1
2202685|NCT01592292|3840175|FG002|Overall Study|Other|2
2202686|NCT01592292|3840176|FG003|Overall Study|Other|1
2277188|NCT02326272|3959814|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277189|NCT02326272|3959815|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277190|NCT02326272|3959816|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2202687|NCT01592344|3840184|FG000|Overall Study|Adverse Event|1
2202688|NCT01592344|3840185|FG001|Overall Study|Adverse Event|1
2202689|NCT01592344|3840184|FG000|Overall Study|Lack of Efficacy|1
2202690|NCT01592344|3840185|FG001|Overall Study|Lack of Efficacy|0
2202691|NCT01592344|3840184|FG000|Overall Study|not available at primary outcome visit|2
2202692|NCT01592344|3840185|FG001|Overall Study|not available at primary outcome visit|4
2202693|NCT01592409|3840203|FG000|Overall Study|Withdrawal by Subject|0
2202694|NCT01592409|3840204|FG001|Overall Study|Withdrawal by Subject|1
2202695|NCT01592695|3840235|FG000|Overall Study|Lost to Follow-up|8
2202696|NCT01592695|3840236|FG001|Overall Study|Lost to Follow-up|4
2202697|NCT01592708|3840244|FG000|Overall Study|Protocol Violation|3
2202698|NCT01592708|3840245|FG001|Overall Study|Protocol Violation|0
2202699|NCT01592747|3840257|FG000|Overall Study|Loss of Therapeutic Response|107
2202700|NCT01592747|3840258|FG001|Overall Study|Loss of Therapeutic Response|108
2202701|NCT01592747|3840259|FG002|Overall Study|Loss of Therapeutic Response|100
2202702|NCT01592747|3840257|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
2202703|NCT01592747|3840258|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
2202704|NCT01592747|3840259|FG002|Overall Study|Inclusion/Exclusion criteria not met|1
2202705|NCT01592747|3840257|FG000|Overall Study|Adverse Event|1
2202706|NCT01592747|3840258|FG001|Overall Study|Adverse Event|0
2202707|NCT01592747|3840259|FG002|Overall Study|Adverse Event|0
2202708|NCT01592747|3840257|FG000|Overall Study|Protocol Violation|4
2202709|NCT01592747|3840258|FG001|Overall Study|Protocol Violation|0
2202710|NCT01592747|3840259|FG002|Overall Study|Protocol Violation|4
2202711|NCT01592747|3840257|FG000|Overall Study|Lack of Efficacy|0
2202712|NCT01592747|3840258|FG001|Overall Study|Lack of Efficacy|1
2202713|NCT01592747|3840259|FG002|Overall Study|Lack of Efficacy|0
2202714|NCT01592747|3840257|FG000|Overall Study|Withdrawal by Subject|2
2202715|NCT01592747|3840258|FG001|Overall Study|Withdrawal by Subject|0
2202716|NCT01592747|3840259|FG002|Overall Study|Withdrawal by Subject|2
2202717|NCT01592747|3840257|FG000|Overall Study|Lost to Follow-up|1
2202718|NCT01592747|3840258|FG001|Overall Study|Lost to Follow-up|0
2202719|NCT01592747|3840259|FG002|Overall Study|Lost to Follow-up|1
2202720|NCT01592747|3840257|FG000|Overall Study|Other Reasons|1
2202721|NCT01592747|3840258|FG001|Overall Study|Other Reasons|1
2202722|NCT01592747|3840259|FG002|Overall Study|Other Reasons|0
2202723|NCT01592760|3840271|FG000|24-hour Follow-Up|Lost to Follow-up|4
2202724|NCT01592760|3840272|FG001|24-hour Follow-Up|Lost to Follow-up|3
2202725|NCT01592760|3840273|FG002|24-hour Follow-Up|Lost to Follow-up|2
2202726|NCT01592773|3840284|FG000|Overall Study|Study Terminated by Sponsor|582
2202727|NCT01592773|3840284|FG000|Overall Study|Withdrawal by Subject|35
2202728|NCT01592773|3840284|FG000|Overall Study|Lost to Follow-up|19
2202729|NCT01592773|3840284|FG000|Overall Study|Adverse Event|17
2202730|NCT01592773|3840284|FG000|Overall Study|Lack of Efficacy|9
2202731|NCT01592773|3840284|FG000|Overall Study|Protocol Violation|2
2202732|NCT01592773|3840284|FG000|Overall Study|Inclusion/exclusion not meet|1
2202733|NCT01592773|3840284|FG000|Overall Study|Other Reason|1
2202734|NCT01592786|3840288|FG000|Overall Study|Adverse Event|60
2202735|NCT01592786|3840288|FG000|Overall Study|Lack of Efficacy|19
2202736|NCT01592786|3840288|FG000|Overall Study|Protocol Violation|14
2202737|NCT01592786|3840288|FG000|Overall Study|Withdrawal by Subject|23
2202738|NCT01592786|3840288|FG000|Overall Study|Lost to Follow-up|19
2202739|NCT01592786|3840288|FG000|Overall Study|Other|3
2202740|NCT01592864|3840309|FG000|Overall Study|Withdrawal by Subject|0
2202741|NCT01592864|3840310|FG001|Overall Study|Withdrawal by Subject|1
2202742|NCT01593020|3840318|FG000|Overall Study|Adverse Event|1
2202743|NCT01593020|3840319|FG001|Overall Study|Adverse Event|1
2202744|NCT01593020|3840318|FG000|Overall Study|Death|0
2202745|NCT01593020|3840319|FG001|Overall Study|Death|1
2202746|NCT01593020|3840318|FG000|Overall Study|Ineligible|1
2202747|NCT01593020|3840319|FG001|Overall Study|Ineligible|0
2202748|NCT01593696|3840351|FG000|Dose Escalation|Progressive Disease|2
2202749|NCT01593696|3840352|FG001|Dose Escalation|Progressive Disease|0
2202750|NCT01593696|3840353|FG002|Dose Escalation|Progressive Disease|0
2202751|NCT01593696|3840354|FG003|Dose Escalation|Progressive Disease|0
2202752|NCT01593696|3840351|FG000|Dose Expansion|Fungal infection|0
2202753|NCT01593696|3840352|FG001|Dose Expansion|Fungal infection|0
2202754|NCT01593696|3840353|FG002|Dose Expansion|Fungal infection|1
2202755|NCT01593696|3840354|FG003|Dose Expansion|Fungal infection|0
2202756|NCT01593787|3840387|FG000|Overall Study|Adverse Event|1
2202757|NCT01593787|3840388|FG001|Overall Study|Adverse Event|0
2202758|NCT01593787|3840389|FG002|Overall Study|Adverse Event|0
2202759|NCT01593917|3840408|FG000|Overall Study|Death|67
2202760|NCT01593917|3840408|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60
2202761|NCT01593917|3840408|FG000|Overall Study|Withdrawal by Subject|23
2202762|NCT01593917|3840408|FG000|Overall Study|Lost to Follow-up|12
2202763|NCT01593917|3840408|FG000|Overall Study|Protocol Violation|5
2202764|NCT01593917|3840408|FG000|Overall Study|Physician Decision|3
2202765|NCT01594125|3840417|FG000|Overall Study|Withdrawal by Subject|1
2202766|NCT01594125|3840418|FG001|Overall Study|Withdrawal by Subject|0
2202767|NCT01594125|3840419|FG002|Overall Study|Withdrawal by Subject|0
2202768|NCT01594125|3840420|FG003|Overall Study|Withdrawal by Subject|1
2202769|NCT01594125|3840421|FG004|Overall Study|Withdrawal by Subject|0
2202770|NCT01594125|3840417|FG000|Overall Study|Progressive Disease|3
2202771|NCT01594125|3840418|FG001|Overall Study|Progressive Disease|12
2202772|NCT01594125|3840419|FG002|Overall Study|Progressive Disease|3
2202773|NCT01594125|3840420|FG003|Overall Study|Progressive Disease|3
2202774|NCT01594125|3840421|FG004|Overall Study|Progressive Disease|7
2202775|NCT01594281|3840436|FG000|Interventional Core Phase|Protocol Deviation|1
2202776|NCT01594281|3840437|FG001|Interventional Core Phase|Protocol Deviation|0
2202777|NCT01594281|3840438|FG002|Interventional Core Phase|Protocol Deviation|0
2202778|NCT01594281|3840436|FG000|Interventional Core Phase|Subject Withdrew Consent|0
2202779|NCT01594281|3840437|FG001|Interventional Core Phase|Subject Withdrew Consent|1
2202780|NCT01594281|3840438|FG002|Interventional Core Phase|Subject Withdrew Consent|1
2202781|NCT01594281|3840436|FG000|Interventional Core Phase|Death|1
2202782|NCT01594281|3840437|FG001|Interventional Core Phase|Death|1
2202783|NCT01594281|3840438|FG002|Interventional Core Phase|Death|2
2202784|NCT01594281|3840436|FG000|Interventional Core Phase|Lost to Follow-up|1
2202785|NCT01594281|3840437|FG001|Interventional Core Phase|Lost to Follow-up|4
2202786|NCT01594281|3840438|FG002|Interventional Core Phase|Lost to Follow-up|1
2202787|NCT01594281|3840436|FG000|Interventional Core Phase|Adverse Event|4
2202788|NCT01594281|3840437|FG001|Interventional Core Phase|Adverse Event|4
2202789|NCT01594281|3840438|FG002|Interventional Core Phase|Adverse Event|4
2202790|NCT01594281|3840436|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2
2202791|NCT01594281|3840437|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2
2202792|NCT01594281|3840438|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0
2202793|NCT01594281|3840436|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0
2202794|NCT01594281|3840437|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0
2202795|NCT01594281|3840438|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1
2202796|NCT01594281|3840436|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
2202797|NCT01594281|3840437|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
2202798|NCT01594281|3840438|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
2202799|NCT01594333|3840460|FG000|Overall Study|Death|96
2202800|NCT01594333|3840461|FG001|Overall Study|Death|83
2202801|NCT01594333|3840460|FG000|Overall Study|Lost to Follow-up|5
2202802|NCT01594333|3840461|FG001|Overall Study|Lost to Follow-up|5
2202803|NCT01594333|3840460|FG000|Overall Study|Withdrawal by Subject|60
2202804|NCT01594333|3840461|FG001|Overall Study|Withdrawal by Subject|63
2202805|NCT01594411|3840480|FG000|Overall Study|Lost to Follow-up|2
2202806|NCT01594476|3840493|FG000|Overall Study|Protocol Violation|1
2202807|NCT01594476|3840494|FG001|Overall Study|Protocol Violation|3
2202808|NCT01594749|3840558|FG000|Overall Study|Adverse Event|2
2202809|NCT01594749|3840559|FG001|Overall Study|Adverse Event|1
2202810|NCT01594749|3840558|FG000|Overall Study|Withdrawal by Subject|2
2202811|NCT01594749|3840559|FG001|Overall Study|Withdrawal by Subject|2
2202812|NCT01594749|3840558|FG000|Overall Study|Protocol Violation|2
2202813|NCT01594749|3840559|FG001|Overall Study|Protocol Violation|0
2202814|NCT01594749|3840558|FG000|Overall Study|Physician Decision|1
2202815|NCT01594749|3840559|FG001|Overall Study|Physician Decision|1
2202816|NCT01594749|3840558|FG000|Overall Study|Non-compliance with Protocol|0
2202817|NCT01594749|3840559|FG001|Overall Study|Non-compliance with Protocol|1
2202818|NCT01594749|3840558|FG000|Overall Study|Lost to Follow-up|1
2202819|NCT01594749|3840559|FG001|Overall Study|Lost to Follow-up|0
2202820|NCT01594749|3840558|FG000|Overall Study|Death|9
2202821|NCT01594749|3840559|FG001|Overall Study|Death|3
2202822|NCT01594749|3840558|FG000|Overall Study|Not Treated|4
2202823|NCT01594749|3840559|FG001|Overall Study|Not Treated|10
2202824|NCT01594749|3840558|FG000|Overall Study|Lost Source Documentation|1
2202825|NCT01594749|3840559|FG001|Overall Study|Lost Source Documentation|0
2202826|NCT01594762|3840567|FG000|Overall Study|Withdrawal by Subject|1
2202827|NCT01594762|3840568|FG001|Overall Study|Withdrawal by Subject|0
2202828|NCT01594762|3840567|FG000|Overall Study|Lost to Follow-up|10
2202829|NCT01594762|3840568|FG001|Overall Study|Lost to Follow-up|10
2202830|NCT01594827|3840576|FG000|Overall Study|Adverse Event|1
2202831|NCT01594827|3840577|FG001|Overall Study|Adverse Event|0
2202832|NCT01594827|3840576|FG000|Overall Study|Physician Decision|3
2202833|NCT01594827|3840577|FG001|Overall Study|Physician Decision|0
2202834|NCT01594853|3840587|FG000|Overall Study|Withdrawal by Subject|1
2202835|NCT01594853|3840588|FG001|Overall Study|Withdrawal by Subject|1
2202836|NCT01594853|3840587|FG000|Overall Study|Lost to Follow-up|1
2202837|NCT01594853|3840588|FG001|Overall Study|Lost to Follow-up|1
2202838|NCT01594853|3840587|FG000|Overall Study|noncompliance with exercise|0
2202839|NCT01594853|3840588|FG001|Overall Study|noncompliance with exercise|1
2202840|NCT01594931|3840597|FG000|Overall Study|Adverse Event|3
2202841|NCT01594931|3840598|FG001|Overall Study|Adverse Event|1
2202842|NCT01594931|3840599|FG002|Overall Study|Adverse Event|1
2202843|NCT01594931|3840597|FG000|Overall Study|Withdrawal by Subject|2
2202844|NCT01594931|3840598|FG001|Overall Study|Withdrawal by Subject|1
2202845|NCT01594931|3840599|FG002|Overall Study|Withdrawal by Subject|1
2202846|NCT01594931|3840597|FG000|Overall Study|Lack of Efficacy|7
2202847|NCT01594931|3840598|FG001|Overall Study|Lack of Efficacy|2
2202848|NCT01594931|3840599|FG002|Overall Study|Lack of Efficacy|2
2202849|NCT01594931|3840597|FG000|Overall Study|Lost to Follow-up|4
2202850|NCT01594931|3840598|FG001|Overall Study|Lost to Follow-up|3
2202851|NCT01594931|3840599|FG002|Overall Study|Lost to Follow-up|3
2202852|NCT01594931|3840597|FG000|Overall Study|Protocol Violation|2
2202853|NCT01594931|3840598|FG001|Overall Study|Protocol Violation|1
2202854|NCT01594931|3840599|FG002|Overall Study|Protocol Violation|0
2202855|NCT01594931|3840597|FG000|Overall Study|No defiined|11
2202856|NCT01594931|3840598|FG001|Overall Study|No defiined|4
2202857|NCT01594931|3840599|FG002|Overall Study|No defiined|7
2202858|NCT01594970|3840610|FG000|Overall Study|Non-Adverse Event Related|4
2202859|NCT01594970|3840611|FG001|Overall Study|Non-Adverse Event Related|5
2202860|NCT01594970|3840612|FG002|Overall Study|Non-Adverse Event Related|6
2202861|NCT01594970|3840610|FG000|Overall Study|Adverse Event|17
2202862|NCT01594970|3840611|FG001|Overall Study|Adverse Event|23
2202863|NCT01594970|3840612|FG002|Overall Study|Adverse Event|23
2202864|NCT01594970|3840610|FG000|Overall Study|Lost to Follow-up|54
2202865|NCT01594970|3840611|FG001|Overall Study|Lost to Follow-up|54
2202866|NCT01594970|3840612|FG002|Overall Study|Lost to Follow-up|37
2217360|NCT01707992|3860598|FG001|Active Treatment Phase (24 Months)|Other than specified|0
2217361|NCT01707992|3860599|FG002|Active Treatment Phase (24 Months)|Other than specified|0
2217362|NCT01707992|3860600|FG003|Active Treatment Phase (24 Months)|Other than specified|1
2217363|NCT01707992|3860601|FG004|Active Treatment Phase (24 Months)|Other than specified|5
2217364|NCT01707992|3860602|FG005|Active Treatment Phase (24 Months)|Other than specified|2
2217365|NCT01707992|3860597|FG000|Active Treatment Phase (24 Months)|Noncompliance|0
2217366|NCT01707992|3860598|FG001|Active Treatment Phase (24 Months)|Noncompliance|0
2217367|NCT01707992|3860599|FG002|Active Treatment Phase (24 Months)|Noncompliance|0
2217368|NCT01707992|3860600|FG003|Active Treatment Phase (24 Months)|Noncompliance|0
2217369|NCT01707992|3860601|FG004|Active Treatment Phase (24 Months)|Noncompliance|4
2217370|NCT01707992|3860602|FG005|Active Treatment Phase (24 Months)|Noncompliance|2
2217371|NCT01707992|3860597|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
2217372|NCT01707992|3860598|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
2217373|NCT01707992|3860599|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
2217374|NCT01707992|3860600|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
2217375|NCT01707992|3860601|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
2217376|NCT01707992|3860602|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
2217377|NCT01707992|3860597|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2217378|NCT01707992|3860598|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2217379|NCT01707992|3860599|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2217380|NCT01707992|3860600|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2217381|NCT01707992|3860601|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
2217382|NCT01707992|3860602|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2217383|NCT01708161|3860632|FG000|Overall Study|Adverse Event|1
2217384|NCT01708161|3860633|FG001|Overall Study|Adverse Event|3
2202867|NCT01595438|3840640|FG000|Overall Study|Lost to Follow-up|20
2202868|NCT01595438|3840641|FG001|Overall Study|Lost to Follow-up|20
2202869|NCT01595438|3840640|FG000|Overall Study|Withdrawal by Subject|12
2202870|NCT01595438|3840641|FG001|Overall Study|Withdrawal by Subject|12
2202871|NCT01595438|3840640|FG000|Overall Study|Other Eligibility criteria|11
2202872|NCT01595438|3840641|FG001|Overall Study|Other Eligibility criteria|9
2202873|NCT01595529|3840676|FG000|Overall Study|Adverse Event|2
2202874|NCT01595529|3840677|FG001|Overall Study|Adverse Event|0
2202875|NCT01595529|3840676|FG000|Overall Study|Subject Non-Compliant|2
2202876|NCT01595529|3840677|FG001|Overall Study|Subject Non-Compliant|0
2202877|NCT01595529|3840676|FG000|Overall Study|Lost to Follow-up|8
2202878|NCT01595529|3840677|FG001|Overall Study|Lost to Follow-up|14
2202879|NCT01595529|3840676|FG000|Overall Study|Protocol Violation|1
2202880|NCT01595529|3840677|FG001|Overall Study|Protocol Violation|2
2202881|NCT01595529|3840676|FG000|Overall Study|Physician Decision|1
2202882|NCT01595529|3840677|FG001|Overall Study|Physician Decision|0
2202883|NCT01595529|3840676|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
2202884|NCT01595529|3840677|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
2202885|NCT01595529|3840676|FG000|Overall Study|Administrative Decision|1
2202886|NCT01595529|3840677|FG001|Overall Study|Administrative Decision|0
2202887|NCT01595529|3840676|FG000|Overall Study|Entry Failure/Screening Failure|6
2202888|NCT01595529|3840677|FG001|Overall Study|Entry Failure/Screening Failure|1
2202889|NCT01595646|3840686|FG000|Overall Study|Withdrawal by Subject|1
2202890|NCT01595646|3840687|FG001|Overall Study|Withdrawal by Subject|0
2202891|NCT01595646|3840688|FG002|Overall Study|Withdrawal by Subject|0
2202892|NCT01596062|3840729|FG000|Overall Study|Adverse Event|1
2202893|NCT01596062|3840730|FG001|Overall Study|Adverse Event|0
2202894|NCT01596062|3840731|FG002|Overall Study|Adverse Event|2
2202895|NCT01596062|3840729|FG000|Overall Study|Lack of Efficacy|0
2202896|NCT01596062|3840730|FG001|Overall Study|Lack of Efficacy|0
2202897|NCT01596062|3840731|FG002|Overall Study|Lack of Efficacy|1
2202898|NCT01596127|3840743|FG000|Overall Study|Patient Ineligible|1
2202899|NCT01596335|3840769|FG000|Overall Study|exacerbation of primary disease|5
2202900|NCT01596335|3840770|FG001|Overall Study|exacerbation of primary disease|9
2202901|NCT01596504|3840779|FG000|Overall Study|Participant's Private Reason|0
2202902|NCT01596504|3840780|FG001|Overall Study|Participant's Private Reason|1
2202903|NCT01596504|3840781|FG002|Overall Study|Participant's Private Reason|0
2202904|NCT01596504|3840779|FG000|Overall Study|Adverse Event|1
2202905|NCT01596504|3840780|FG001|Overall Study|Adverse Event|2
2202906|NCT01596504|3840781|FG002|Overall Study|Adverse Event|1
2202907|NCT01596504|3840779|FG000|Overall Study|Withdrawal by Subject|1
2202908|NCT01596504|3840780|FG001|Overall Study|Withdrawal by Subject|0
2202909|NCT01596504|3840781|FG002|Overall Study|Withdrawal by Subject|0
2202910|NCT01596582|3840792|FG000|Overall Study|Deemed ineligible after study visit|3
2202911|NCT01596582|3840793|FG001|Overall Study|Deemed ineligible after study visit|6
2202912|NCT01596582|3840792|FG000|Overall Study|Missing all outcome data|1
2202913|NCT01596582|3840793|FG001|Overall Study|Missing all outcome data|1
2202914|NCT01596972|3840864|FG000|Overall Study|Physician Decision|1
2202915|NCT01596972|3840865|FG001|Overall Study|Physician Decision|9
2202916|NCT01596972|3840864|FG000|Overall Study|Lost to Follow-up|0
2202917|NCT01596972|3840865|FG001|Overall Study|Lost to Follow-up|4
2202918|NCT01596972|3840864|FG000|Overall Study|Withdrawal by Subject|0
2202919|NCT01596972|3840865|FG001|Overall Study|Withdrawal by Subject|1
2202920|NCT01597050|3840873|FG000|Overall Study|Withdrawal by Subject|1
2202921|NCT01597050|3840874|FG001|Overall Study|Withdrawal by Subject|0
2202922|NCT01597193|3840907|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7
2202923|NCT01597193|3840908|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8
2202924|NCT01597193|3840909|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2202925|NCT01597193|3840910|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2202926|NCT01597193|3840911|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2202927|NCT01597193|3840912|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2202928|NCT01597193|3840913|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2202929|NCT01597193|3840907|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2202930|NCT01597193|3840908|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2202931|NCT01597193|3840909|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2202932|NCT01597193|3840910|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
2202933|NCT01597193|3840911|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
2202934|NCT01597193|3840912|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
2202935|NCT01597193|3840913|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2202936|NCT01597193|3840907|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
2202937|NCT01597193|3840908|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
2202938|NCT01597193|3840909|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
2202939|NCT01597193|3840910|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
2202940|NCT01597193|3840911|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
2202941|NCT01597193|3840912|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
2202942|NCT01597193|3840913|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
2202943|NCT01597193|3840907|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0
2202944|NCT01597193|3840908|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0
2202945|NCT01597193|3840909|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0
2202946|NCT01597193|3840910|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0
2202947|NCT01597193|3840911|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0
2202948|NCT01597193|3840912|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1
2202949|NCT01597193|3840913|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0
2202950|NCT01597193|3840907|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2202951|NCT01597193|3840908|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2202952|NCT01597193|3840909|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2202953|NCT01597193|3840910|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
2202954|NCT01597193|3840911|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2202955|NCT01597193|3840912|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
2202956|NCT01597193|3840913|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2202957|NCT01597245|3840938|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1
2202958|NCT01597245|3840939|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5
2202959|NCT01597245|3840940|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5
2202960|NCT01597245|3840941|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4
2202961|NCT01597245|3840942|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202962|NCT01597245|3840943|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202963|NCT01597245|3840944|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202964|NCT01597245|3840945|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202965|NCT01597245|3840946|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202966|NCT01597245|3840947|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202967|NCT01597245|3840948|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202968|NCT01597245|3840949|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202969|NCT01597245|3840950|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202970|NCT01597245|3840951|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202971|NCT01597245|3840952|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202972|NCT01597245|3840953|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202973|NCT01597245|3840954|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202974|NCT01597245|3840955|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202975|NCT01597245|3840956|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202976|NCT01597245|3840957|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202977|NCT01597245|3840958|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0
2202978|NCT01597245|3840938|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
2202979|NCT01597245|3840939|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
2202980|NCT01597245|3840940|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
2202981|NCT01597245|3840941|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
2202982|NCT01597245|3840942|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202983|NCT01597245|3840943|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202984|NCT01597245|3840944|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202985|NCT01597245|3840945|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202986|NCT01597245|3840946|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202987|NCT01597245|3840947|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202988|NCT01597245|3840948|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202989|NCT01597245|3840949|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202990|NCT01597245|3840950|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202991|NCT01597245|3840951|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202992|NCT01597245|3840952|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202993|NCT01597245|3840953|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202994|NCT01597245|3840954|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202995|NCT01597245|3840955|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202996|NCT01597245|3840956|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202997|NCT01597245|3840957|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202998|NCT01597245|3840958|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2202999|NCT01597245|3840938|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2
2203000|NCT01597245|3840939|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4
2203001|NCT01597245|3840940|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5
2203002|NCT01597245|3840941|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2
2203003|NCT01597245|3840942|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203004|NCT01597245|3840943|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203005|NCT01597245|3840944|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203006|NCT01597245|3840945|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203007|NCT01597245|3840946|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203008|NCT01597245|3840947|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203009|NCT01597245|3840948|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203010|NCT01597245|3840949|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203011|NCT01597245|3840950|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203012|NCT01597245|3840951|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203013|NCT01597245|3840952|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203014|NCT01597245|3840953|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203015|NCT01597245|3840954|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203016|NCT01597245|3840955|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2217385|NCT01708161|3860634|FG002|Overall Study|Adverse Event|4
2203017|NCT01597245|3840956|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203018|NCT01597245|3840957|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203019|NCT01597245|3840958|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2203020|NCT01597245|3840938|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
2203021|NCT01597245|3840939|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
2203022|NCT01597245|3840940|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
2203023|NCT01597245|3840941|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203024|NCT01597245|3840942|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203025|NCT01597245|3840943|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203026|NCT01597245|3840944|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203027|NCT01597245|3840945|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203028|NCT01597245|3840946|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203029|NCT01597245|3840947|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203030|NCT01597245|3840948|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203031|NCT01597245|3840949|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203032|NCT01597245|3840950|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203033|NCT01597245|3840951|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203034|NCT01597245|3840952|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203035|NCT01597245|3840953|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203036|NCT01597245|3840954|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203037|NCT01597245|3840955|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203038|NCT01597245|3840956|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203039|NCT01597245|3840957|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203040|NCT01597245|3840958|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2203041|NCT01597245|3840938|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1
2203042|NCT01597245|3840939|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203043|NCT01597245|3840940|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203044|NCT01597245|3840941|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1
2203045|NCT01597245|3840942|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203046|NCT01597245|3840943|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203047|NCT01597245|3840944|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203048|NCT01597245|3840945|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203049|NCT01597245|3840946|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203050|NCT01597245|3840947|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203051|NCT01597245|3840948|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203052|NCT01597245|3840949|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203053|NCT01597245|3840950|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203054|NCT01597245|3840951|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203055|NCT01597245|3840952|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203056|NCT01597245|3840953|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203057|NCT01597245|3840954|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203058|NCT01597245|3840955|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203059|NCT01597245|3840956|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203060|NCT01597245|3840957|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203061|NCT01597245|3840958|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0
2203062|NCT01597245|3840938|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
2203063|NCT01597245|3840939|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
2203064|NCT01597245|3840940|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
2203065|NCT01597245|3840941|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203066|NCT01597245|3840942|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203067|NCT01597245|3840943|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203068|NCT01597245|3840944|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203069|NCT01597245|3840945|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203070|NCT01597245|3840946|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203071|NCT01597245|3840947|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203072|NCT01597245|3840948|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203073|NCT01597245|3840949|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203074|NCT01597245|3840950|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203075|NCT01597245|3840951|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203076|NCT01597245|3840952|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203077|NCT01597245|3840953|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203078|NCT01597245|3840954|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203079|NCT01597245|3840955|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203080|NCT01597245|3840956|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203081|NCT01597245|3840957|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203082|NCT01597245|3840958|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2203083|NCT01597245|3840938|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203084|NCT01597245|3840939|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203085|NCT01597245|3840940|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203086|NCT01597245|3840941|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203087|NCT01597245|3840942|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203088|NCT01597245|3840943|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1
2203089|NCT01597245|3840944|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1
2203090|NCT01597245|3840945|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203091|NCT01597245|3840946|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203092|NCT01597245|3840947|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203093|NCT01597245|3840948|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203094|NCT01597245|3840949|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203095|NCT01597245|3840950|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203096|NCT01597245|3840951|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203097|NCT01597245|3840952|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203098|NCT01597245|3840953|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203099|NCT01597245|3840954|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203100|NCT01597245|3840955|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203101|NCT01597245|3840956|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203102|NCT01597245|3840957|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203103|NCT01597245|3840958|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2203104|NCT01597245|3840938|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203105|NCT01597245|3840939|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203106|NCT01597245|3840940|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203107|NCT01597245|3840941|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203108|NCT01597245|3840942|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150
2203109|NCT01597245|3840943|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22
2203110|NCT01597245|3840944|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80
2203111|NCT01597245|3840945|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2
2203112|NCT01597245|3840946|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203113|NCT01597245|3840947|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114
2203114|NCT01597245|3840948|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203115|NCT01597245|3840949|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203116|NCT01597245|3840950|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203117|NCT01597245|3840951|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203118|NCT01597245|3840952|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203119|NCT01597245|3840953|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203120|NCT01597245|3840954|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203121|NCT01597245|3840955|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203122|NCT01597245|3840956|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203123|NCT01597245|3840957|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203124|NCT01597245|3840958|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2203125|NCT01597245|3840938|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203126|NCT01597245|3840939|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203127|NCT01597245|3840940|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203128|NCT01597245|3840941|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203129|NCT01597245|3840942|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203130|NCT01597245|3840943|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
2203131|NCT01597245|3840944|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203132|NCT01597245|3840945|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203133|NCT01597245|3840946|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
2203134|NCT01597245|3840947|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203135|NCT01597245|3840948|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
2203136|NCT01597245|3840949|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
2203137|NCT01597245|3840950|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
2203138|NCT01597245|3840951|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203139|NCT01597245|3840952|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203140|NCT01597245|3840953|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203141|NCT01597245|3840954|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203142|NCT01597245|3840955|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203143|NCT01597245|3840956|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203144|NCT01597245|3840957|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203145|NCT01597245|3840958|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2203146|NCT01597245|3840938|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203147|NCT01597245|3840939|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203148|NCT01597245|3840940|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203149|NCT01597245|3840941|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203150|NCT01597245|3840942|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
2203151|NCT01597245|3840943|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
2203152|NCT01597245|3840944|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
2203153|NCT01597245|3840945|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
2203154|NCT01597245|3840946|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
2203155|NCT01597245|3840947|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
2203156|NCT01597245|3840948|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
2203157|NCT01597245|3840949|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
2203158|NCT01597245|3840950|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
2203159|NCT01597245|3840951|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203160|NCT01597245|3840952|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203161|NCT01597245|3840953|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203162|NCT01597245|3840954|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203163|NCT01597245|3840955|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203164|NCT01597245|3840956|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203165|NCT01597245|3840957|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203166|NCT01597245|3840958|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2203167|NCT01597245|3840938|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203168|NCT01597245|3840939|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203169|NCT01597245|3840940|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203170|NCT01597245|3840941|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203171|NCT01597245|3840942|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
2203172|NCT01597245|3840943|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
2203173|NCT01597245|3840944|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
2203174|NCT01597245|3840945|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203175|NCT01597245|3840946|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
2203176|NCT01597245|3840947|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
2203177|NCT01597245|3840948|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
2203178|NCT01597245|3840949|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
2203179|NCT01597245|3840950|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
2203180|NCT01597245|3840951|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203181|NCT01597245|3840952|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203182|NCT01597245|3840953|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203183|NCT01597245|3840954|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203184|NCT01597245|3840955|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203185|NCT01597245|3840956|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203186|NCT01597245|3840957|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203187|NCT01597245|3840958|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2203188|NCT01597245|3840938|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203189|NCT01597245|3840939|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203190|NCT01597245|3840940|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203191|NCT01597245|3840941|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203192|NCT01597245|3840942|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
2203193|NCT01597245|3840943|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203194|NCT01597245|3840944|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203195|NCT01597245|3840945|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203196|NCT01597245|3840946|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
2203197|NCT01597245|3840947|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
2203198|NCT01597245|3840948|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
2203199|NCT01597245|3840949|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203200|NCT01597245|3840950|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
2203201|NCT01597245|3840951|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203202|NCT01597245|3840952|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203203|NCT01597245|3840953|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203204|NCT01597245|3840954|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203205|NCT01597245|3840955|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203206|NCT01597245|3840956|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203207|NCT01597245|3840957|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203208|NCT01597245|3840958|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2203209|NCT01597245|3840938|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203210|NCT01597245|3840939|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203211|NCT01597245|3840940|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203212|NCT01597245|3840941|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203213|NCT01597245|3840942|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
2203214|NCT01597245|3840943|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
2203215|NCT01597245|3840944|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
2203216|NCT01597245|3840945|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203217|NCT01597245|3840946|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
2203218|NCT01597245|3840947|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
2203219|NCT01597245|3840948|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
2203220|NCT01597245|3840949|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
2203221|NCT01597245|3840950|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
2203222|NCT01597245|3840951|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203223|NCT01597245|3840952|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203224|NCT01597245|3840953|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203225|NCT01597245|3840954|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203226|NCT01597245|3840955|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203227|NCT01597245|3840956|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203228|NCT01597245|3840957|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203229|NCT01597245|3840958|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2203230|NCT01597245|3840938|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203231|NCT01597245|3840939|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203232|NCT01597245|3840940|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203233|NCT01597245|3840941|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203234|NCT01597245|3840942|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203235|NCT01597245|3840943|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2203236|NCT01597245|3840944|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203237|NCT01597245|3840945|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203238|NCT01597245|3840946|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2203239|NCT01597245|3840947|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2203240|NCT01597245|3840948|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2203241|NCT01597245|3840949|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2203242|NCT01597245|3840950|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203243|NCT01597245|3840951|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203244|NCT01597245|3840952|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203245|NCT01597245|3840953|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203246|NCT01597245|3840954|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203247|NCT01597245|3840955|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203248|NCT01597245|3840956|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203249|NCT01597245|3840957|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203250|NCT01597245|3840958|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2203251|NCT01597245|3840938|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203252|NCT01597245|3840939|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203253|NCT01597245|3840940|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203254|NCT01597245|3840941|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203255|NCT01597245|3840942|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203256|NCT01597245|3840943|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203257|NCT01597245|3840944|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203258|NCT01597245|3840945|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203259|NCT01597245|3840946|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203260|NCT01597245|3840947|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203261|NCT01597245|3840948|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
2203262|NCT01597245|3840949|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203263|NCT01597245|3840950|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203264|NCT01597245|3840951|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203265|NCT01597245|3840952|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203266|NCT01597245|3840953|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203267|NCT01597245|3840954|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203268|NCT01597245|3840955|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203269|NCT01597245|3840956|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203270|NCT01597245|3840957|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203271|NCT01597245|3840958|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2203272|NCT01597245|3840938|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203273|NCT01597245|3840939|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203274|NCT01597245|3840940|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203275|NCT01597245|3840941|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2277191|NCT02326272|3959817|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1
2277192|NCT02326272|3959818|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8
2277193|NCT02326272|3959819|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
2277194|NCT02326272|3959820|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277195|NCT02326272|3959821|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1
2277196|NCT02326272|3959807|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277197|NCT02326272|3959808|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277198|NCT02326272|3959809|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277199|NCT02326272|3959810|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277200|NCT02326272|3959811|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277201|NCT02326272|3959812|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277202|NCT02326272|3959813|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277203|NCT02326272|3959814|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277204|NCT02326272|3959815|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277205|NCT02326272|3959816|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2203276|NCT01597245|3840942|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203277|NCT01597245|3840943|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203278|NCT01597245|3840944|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203279|NCT01597245|3840945|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203280|NCT01597245|3840946|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203281|NCT01597245|3840947|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203282|NCT01597245|3840948|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203283|NCT01597245|3840949|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203284|NCT01597245|3840950|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203285|NCT01597245|3840951|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1
2203286|NCT01597245|3840952|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69
2203287|NCT01597245|3840953|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70
2203288|NCT01597245|3840954|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203289|NCT01597245|3840955|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203290|NCT01597245|3840956|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203291|NCT01597245|3840957|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203292|NCT01597245|3840958|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
2203293|NCT01597245|3840938|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203294|NCT01597245|3840939|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203295|NCT01597245|3840940|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203296|NCT01597245|3840941|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203297|NCT01597245|3840942|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203298|NCT01597245|3840943|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203299|NCT01597245|3840944|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203300|NCT01597245|3840945|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203301|NCT01597245|3840946|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203302|NCT01597245|3840947|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203303|NCT01597245|3840948|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203304|NCT01597245|3840949|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203305|NCT01597245|3840950|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203306|NCT01597245|3840951|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1
2203307|NCT01597245|3840952|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62
2203308|NCT01597245|3840953|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63
2203309|NCT01597245|3840954|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203310|NCT01597245|3840955|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203311|NCT01597245|3840956|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203312|NCT01597245|3840957|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203313|NCT01597245|3840958|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
2203314|NCT01597245|3840938|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203315|NCT01597245|3840939|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203316|NCT01597245|3840940|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203317|NCT01597245|3840941|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203318|NCT01597245|3840942|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203319|NCT01597245|3840943|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203320|NCT01597245|3840944|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203321|NCT01597245|3840945|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203322|NCT01597245|3840946|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203323|NCT01597245|3840947|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203324|NCT01597245|3840948|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203325|NCT01597245|3840949|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203326|NCT01597245|3840950|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203327|NCT01597245|3840951|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203328|NCT01597245|3840952|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
2203329|NCT01597245|3840953|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
2203330|NCT01597245|3840954|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203331|NCT01597245|3840955|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203332|NCT01597245|3840956|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2217386|NCT01708161|3860635|FG003|Overall Study|Adverse Event|2
2277206|NCT02326272|3959817|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2277207|NCT02326272|3959818|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277208|NCT02326272|3959819|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2277209|NCT02326272|3959820|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277210|NCT02326272|3959821|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277211|NCT02326272|3959807|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277212|NCT02326272|3959808|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277213|NCT02326272|3959809|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2320620|NCT02951780|4034938|FG002|Period 2|Scheduling Conflicts|0
2277214|NCT02326272|3959810|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277215|NCT02326272|3959811|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277216|NCT02326272|3959812|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277217|NCT02326272|3959813|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277218|NCT02326272|3959814|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277219|NCT02326272|3959815|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277220|NCT02326272|3959816|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277221|NCT02326272|3959817|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277222|NCT02326272|3959818|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
2277223|NCT02326272|3959819|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277224|NCT02326272|3959820|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277225|NCT02326272|3959821|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277226|NCT02326272|3959807|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277227|NCT02326272|3959808|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277228|NCT02326272|3959809|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277229|NCT02326272|3959810|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277230|NCT02326272|3959811|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277231|NCT02326272|3959812|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277232|NCT02326272|3959813|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277233|NCT02326272|3959814|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277234|NCT02326272|3959815|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277235|NCT02326272|3959816|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277236|NCT02326272|3959817|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
2277237|NCT02326272|3959818|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277238|NCT02326272|3959819|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
2277239|NCT02326272|3959820|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277240|NCT02326272|3959821|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
2277241|NCT02326272|3959807|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277242|NCT02326272|3959808|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277243|NCT02326272|3959809|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277244|NCT02326272|3959810|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277245|NCT02326272|3959811|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277246|NCT02326272|3959812|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277247|NCT02326272|3959813|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277248|NCT02326272|3959814|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277249|NCT02326272|3959815|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277250|NCT02326272|3959816|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277251|NCT02326272|3959817|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277252|NCT02326272|3959818|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
2277253|NCT02326272|3959819|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277254|NCT02326272|3959820|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277255|NCT02326272|3959821|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
2277256|NCT02326272|3959807|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277257|NCT02326272|3959808|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277258|NCT02326272|3959809|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277259|NCT02326272|3959810|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277260|NCT02326272|3959811|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277261|NCT02326272|3959812|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277262|NCT02326272|3959813|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277263|NCT02326272|3959814|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277264|NCT02326272|3959815|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277265|NCT02326272|3959816|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277266|NCT02326272|3959817|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277267|NCT02326272|3959818|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
2277268|NCT02326272|3959819|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
2277269|NCT02326272|3959820|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277270|NCT02326272|3959821|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
2277271|NCT02326272|3959807|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277272|NCT02326272|3959808|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277273|NCT02326272|3959809|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277274|NCT02326272|3959810|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277275|NCT02326272|3959811|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277276|NCT02326272|3959812|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277277|NCT02326272|3959813|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277278|NCT02326272|3959814|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277279|NCT02326272|3959815|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2203333|NCT01597245|3840957|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203334|NCT01597245|3840958|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
2203335|NCT01597245|3840938|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203336|NCT01597245|3840939|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203337|NCT01597245|3840940|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203338|NCT01597245|3840941|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203339|NCT01597245|3840942|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203340|NCT01597245|3840943|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203341|NCT01597245|3840944|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203342|NCT01597245|3840945|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203343|NCT01597245|3840946|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203344|NCT01597245|3840947|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203345|NCT01597245|3840948|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203346|NCT01597245|3840949|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203347|NCT01597245|3840950|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203348|NCT01597245|3840951|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203349|NCT01597245|3840952|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
2203350|NCT01597245|3840953|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
2203351|NCT01597245|3840954|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203352|NCT01597245|3840955|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203353|NCT01597245|3840956|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203354|NCT01597245|3840957|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203355|NCT01597245|3840958|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
2203356|NCT01597245|3840938|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203357|NCT01597245|3840939|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203358|NCT01597245|3840940|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203359|NCT01597245|3840941|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203360|NCT01597245|3840942|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203361|NCT01597245|3840943|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203362|NCT01597245|3840944|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203363|NCT01597245|3840945|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203364|NCT01597245|3840946|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203365|NCT01597245|3840947|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203366|NCT01597245|3840948|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203367|NCT01597245|3840949|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203368|NCT01597245|3840950|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203369|NCT01597245|3840951|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1
2203370|NCT01597245|3840952|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11
2203371|NCT01597245|3840953|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12
2203372|NCT01597245|3840954|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203373|NCT01597245|3840955|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203374|NCT01597245|3840956|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203375|NCT01597245|3840957|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203376|NCT01597245|3840958|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
2203377|NCT01597245|3840938|FG000|Long Term Extension (Week 60 - Week 264)|Death|0
2203378|NCT01597245|3840939|FG001|Long Term Extension (Week 60 - Week 264)|Death|0
2203379|NCT01597245|3840940|FG002|Long Term Extension (Week 60 - Week 264)|Death|0
2203380|NCT01597245|3840941|FG003|Long Term Extension (Week 60 - Week 264)|Death|0
2203381|NCT01597245|3840942|FG004|Long Term Extension (Week 60 - Week 264)|Death|0
2203382|NCT01597245|3840943|FG005|Long Term Extension (Week 60 - Week 264)|Death|0
2203383|NCT01597245|3840944|FG006|Long Term Extension (Week 60 - Week 264)|Death|0
2203384|NCT01597245|3840945|FG007|Long Term Extension (Week 60 - Week 264)|Death|0
2203385|NCT01597245|3840946|FG008|Long Term Extension (Week 60 - Week 264)|Death|0
2203386|NCT01597245|3840947|FG009|Long Term Extension (Week 60 - Week 264)|Death|0
2203387|NCT01597245|3840948|FG010|Long Term Extension (Week 60 - Week 264)|Death|0
2203388|NCT01597245|3840949|FG011|Long Term Extension (Week 60 - Week 264)|Death|0
2203389|NCT01597245|3840950|FG012|Long Term Extension (Week 60 - Week 264)|Death|0
2203390|NCT01597245|3840951|FG013|Long Term Extension (Week 60 - Week 264)|Death|0
2203391|NCT01597245|3840952|FG014|Long Term Extension (Week 60 - Week 264)|Death|8
2203392|NCT01597245|3840953|FG015|Long Term Extension (Week 60 - Week 264)|Death|8
2203393|NCT01597245|3840954|FG016|Long Term Extension (Week 60 - Week 264)|Death|0
2203394|NCT01597245|3840955|FG017|Long Term Extension (Week 60 - Week 264)|Death|0
2203395|NCT01597245|3840956|FG018|Long Term Extension (Week 60 - Week 264)|Death|0
2203396|NCT01597245|3840957|FG019|Long Term Extension (Week 60 - Week 264)|Death|0
2203397|NCT01597245|3840958|FG020|Long Term Extension (Week 60 - Week 264)|Death|0
2203398|NCT01597245|3840938|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203399|NCT01597245|3840939|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203400|NCT01597245|3840940|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203401|NCT01597245|3840941|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203402|NCT01597245|3840942|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203403|NCT01597245|3840943|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203404|NCT01597245|3840944|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203405|NCT01597245|3840945|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203406|NCT01597245|3840946|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203407|NCT01597245|3840947|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203408|NCT01597245|3840948|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203409|NCT01597245|3840949|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203410|NCT01597245|3840950|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203411|NCT01597245|3840951|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2277280|NCT02326272|3959816|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277281|NCT02326272|3959817|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277282|NCT02326272|3959818|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
2277283|NCT02326272|3959819|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277284|NCT02326272|3959820|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277285|NCT02326272|3959821|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2277286|NCT02326272|3959807|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2277287|NCT02326272|3959808|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2203412|NCT01597245|3840952|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
2203413|NCT01597245|3840953|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
2203414|NCT01597245|3840954|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203415|NCT01597245|3840955|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203416|NCT01597245|3840956|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203417|NCT01597245|3840957|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203418|NCT01597245|3840958|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
2203419|NCT01597245|3840938|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203420|NCT01597245|3840939|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203421|NCT01597245|3840940|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203422|NCT01597245|3840941|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203423|NCT01597245|3840942|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203424|NCT01597245|3840943|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203425|NCT01597245|3840944|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203426|NCT01597245|3840945|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203427|NCT01597245|3840946|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203428|NCT01597245|3840947|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203429|NCT01597245|3840948|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203430|NCT01597245|3840949|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203431|NCT01597245|3840950|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203432|NCT01597245|3840951|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203433|NCT01597245|3840952|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
2203434|NCT01597245|3840953|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
2203435|NCT01597245|3840954|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203436|NCT01597245|3840955|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203437|NCT01597245|3840956|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203438|NCT01597245|3840957|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203439|NCT01597245|3840958|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
2203440|NCT01597245|3840938|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203441|NCT01597245|3840939|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203442|NCT01597245|3840940|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203443|NCT01597245|3840941|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203444|NCT01597245|3840942|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203445|NCT01597245|3840943|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203446|NCT01597245|3840944|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203447|NCT01597245|3840945|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203448|NCT01597245|3840946|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203449|NCT01597245|3840947|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203450|NCT01597245|3840948|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203451|NCT01597245|3840949|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203452|NCT01597245|3840950|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203453|NCT01597245|3840951|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203454|NCT01597245|3840952|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
2203455|NCT01597245|3840953|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
2203456|NCT01597245|3840954|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203457|NCT01597245|3840955|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203458|NCT01597245|3840956|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203459|NCT01597245|3840957|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203460|NCT01597245|3840958|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
2203461|NCT01597245|3840938|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203462|NCT01597245|3840939|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203463|NCT01597245|3840940|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203464|NCT01597245|3840941|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203465|NCT01597245|3840942|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203466|NCT01597245|3840943|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203467|NCT01597245|3840944|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203468|NCT01597245|3840945|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203469|NCT01597245|3840946|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203470|NCT01597245|3840947|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203471|NCT01597245|3840948|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203472|NCT01597245|3840949|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203473|NCT01597245|3840950|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203474|NCT01597245|3840951|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23
2203475|NCT01597245|3840952|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203476|NCT01597245|3840953|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203477|NCT01597245|3840954|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203478|NCT01597245|3840955|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203479|NCT01597245|3840956|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203480|NCT01597245|3840957|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203481|NCT01597245|3840958|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
2203482|NCT01597245|3840938|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203483|NCT01597245|3840939|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203484|NCT01597245|3840940|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203485|NCT01597245|3840941|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203486|NCT01597245|3840942|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203487|NCT01597245|3840943|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203488|NCT01597245|3840944|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203489|NCT01597245|3840945|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203490|NCT01597245|3840946|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203491|NCT01597245|3840947|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203492|NCT01597245|3840948|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203493|NCT01597245|3840949|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203494|NCT01597245|3840950|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203495|NCT01597245|3840951|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203496|NCT01597245|3840952|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203497|NCT01597245|3840953|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
2203498|NCT01597245|3840954|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9
2203499|NCT01597245|3840955|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5
2203500|NCT01597245|3840956|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8
2203501|NCT01597245|3840957|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63
2203502|NCT01597245|3840958|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13
2203503|NCT01597245|3840938|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203504|NCT01597245|3840939|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203505|NCT01597245|3840940|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203506|NCT01597245|3840941|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203507|NCT01597245|3840942|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203508|NCT01597245|3840943|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203509|NCT01597245|3840944|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203510|NCT01597245|3840945|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203511|NCT01597245|3840946|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203512|NCT01597245|3840947|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203513|NCT01597245|3840948|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203514|NCT01597245|3840949|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203515|NCT01597245|3840950|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203516|NCT01597245|3840951|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203517|NCT01597245|3840952|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203518|NCT01597245|3840953|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203519|NCT01597245|3840954|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
2203520|NCT01597245|3840955|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
2203521|NCT01597245|3840956|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
2203522|NCT01597245|3840957|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41
2203523|NCT01597245|3840958|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13
2203524|NCT01597245|3840938|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203525|NCT01597245|3840939|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203526|NCT01597245|3840940|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203527|NCT01597245|3840941|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2217387|NCT01708161|3860636|FG004|Overall Study|Adverse Event|3
2203528|NCT01597245|3840942|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203529|NCT01597245|3840943|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203530|NCT01597245|3840944|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203531|NCT01597245|3840945|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203532|NCT01597245|3840946|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203533|NCT01597245|3840947|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203534|NCT01597245|3840948|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203535|NCT01597245|3840949|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203536|NCT01597245|3840950|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203537|NCT01597245|3840951|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203538|NCT01597245|3840952|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203539|NCT01597245|3840953|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203540|NCT01597245|3840954|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2
2203541|NCT01597245|3840955|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203542|NCT01597245|3840956|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
2203543|NCT01597245|3840957|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29
2203544|NCT01597245|3840958|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3
2203545|NCT01597245|3840938|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203546|NCT01597245|3840939|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203547|NCT01597245|3840940|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203548|NCT01597245|3840941|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203549|NCT01597245|3840942|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203550|NCT01597245|3840943|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203551|NCT01597245|3840944|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203552|NCT01597245|3840945|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203553|NCT01597245|3840946|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203554|NCT01597245|3840947|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203555|NCT01597245|3840948|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203556|NCT01597245|3840949|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203557|NCT01597245|3840950|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203558|NCT01597245|3840951|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203559|NCT01597245|3840952|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203560|NCT01597245|3840953|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203561|NCT01597245|3840954|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203562|NCT01597245|3840955|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
2203563|NCT01597245|3840956|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1
2203564|NCT01597245|3840957|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14
2203565|NCT01597245|3840958|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4
2203566|NCT01597245|3840938|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203567|NCT01597245|3840939|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203568|NCT01597245|3840940|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203569|NCT01597245|3840941|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203570|NCT01597245|3840942|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203571|NCT01597245|3840943|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203572|NCT01597245|3840944|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203573|NCT01597245|3840945|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203574|NCT01597245|3840946|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203575|NCT01597245|3840947|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203576|NCT01597245|3840948|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203577|NCT01597245|3840949|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203578|NCT01597245|3840950|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203579|NCT01597245|3840951|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203580|NCT01597245|3840952|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203581|NCT01597245|3840953|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203582|NCT01597245|3840954|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
2203583|NCT01597245|3840955|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203584|NCT01597245|3840956|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
2203585|NCT01597245|3840957|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9
2203586|NCT01597245|3840958|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
2277288|NCT02326272|3959809|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2277289|NCT02326272|3959810|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2277290|NCT02326272|3959811|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2277291|NCT02326272|3959812|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2277292|NCT02326272|3959813|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2277293|NCT02326272|3959814|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2277294|NCT02326272|3959815|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2277295|NCT02326272|3959816|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2277296|NCT02326272|3959817|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2277297|NCT02326272|3959818|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2277298|NCT02326272|3959819|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1
2203587|NCT01597245|3840938|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203588|NCT01597245|3840939|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203589|NCT01597245|3840940|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203590|NCT01597245|3840941|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203591|NCT01597245|3840942|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203592|NCT01597245|3840943|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203593|NCT01597245|3840944|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203594|NCT01597245|3840945|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203595|NCT01597245|3840946|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203596|NCT01597245|3840947|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203597|NCT01597245|3840948|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203598|NCT01597245|3840949|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203599|NCT01597245|3840950|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203600|NCT01597245|3840951|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203601|NCT01597245|3840952|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203602|NCT01597245|3840953|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203603|NCT01597245|3840954|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1
2203604|NCT01597245|3840955|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203605|NCT01597245|3840956|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
2203606|NCT01597245|3840957|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6
2203607|NCT01597245|3840958|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2
2203608|NCT01597245|3840938|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203609|NCT01597245|3840939|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203610|NCT01597245|3840940|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203611|NCT01597245|3840941|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203612|NCT01597245|3840942|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203613|NCT01597245|3840943|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203614|NCT01597245|3840944|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203615|NCT01597245|3840945|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203616|NCT01597245|3840946|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203617|NCT01597245|3840947|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203618|NCT01597245|3840948|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203619|NCT01597245|3840949|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203620|NCT01597245|3840950|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203621|NCT01597245|3840951|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203622|NCT01597245|3840952|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203623|NCT01597245|3840953|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203624|NCT01597245|3840954|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2
2203625|NCT01597245|3840955|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203626|NCT01597245|3840956|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203627|NCT01597245|3840957|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3
2203628|NCT01597245|3840958|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
2203629|NCT01597245|3840938|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203630|NCT01597245|3840939|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203631|NCT01597245|3840940|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203632|NCT01597245|3840941|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203633|NCT01597245|3840942|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203634|NCT01597245|3840943|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203635|NCT01597245|3840944|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203636|NCT01597245|3840945|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203637|NCT01597245|3840946|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203638|NCT01597245|3840947|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203639|NCT01597245|3840948|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203640|NCT01597245|3840949|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203641|NCT01597245|3840950|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203642|NCT01597245|3840951|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203643|NCT01597245|3840952|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203644|NCT01597245|3840953|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203645|NCT01597245|3840954|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
2203646|NCT01597245|3840955|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203647|NCT01597245|3840956|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2203648|NCT01597245|3840957|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
2203649|NCT01597245|3840958|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
2277299|NCT02326272|3959820|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2203650|NCT01597245|3840938|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203651|NCT01597245|3840939|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203652|NCT01597245|3840940|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203653|NCT01597245|3840941|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203654|NCT01597245|3840942|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203655|NCT01597245|3840943|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203656|NCT01597245|3840944|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203657|NCT01597245|3840945|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203658|NCT01597245|3840946|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203659|NCT01597245|3840947|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203660|NCT01597245|3840948|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203661|NCT01597245|3840949|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203662|NCT01597245|3840950|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203663|NCT01597245|3840951|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203664|NCT01597245|3840952|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203665|NCT01597245|3840953|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203666|NCT01597245|3840954|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203667|NCT01597245|3840955|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203668|NCT01597245|3840956|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203669|NCT01597245|3840957|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1
2203670|NCT01597245|3840958|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
2203671|NCT01597258|3840991|FG000|Overall Study|No Drug Administration|1
2203672|NCT01597375|3840995|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1
2203673|NCT01597375|3840996|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0
2203674|NCT01597375|3840995|FG000|First Intervention (4 Weeks)|Needed surgery|1
2203675|NCT01597375|3840996|FG001|First Intervention (4 Weeks)|Needed surgery|0
2203676|NCT01597375|3840995|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
2203677|NCT01597375|3840996|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
2203678|NCT01597375|3840995|FG000|Washout (2 Weeks)|Adverse Event|1
2203679|NCT01597375|3840996|FG001|Washout (2 Weeks)|Adverse Event|0
2203680|NCT01597375|3840995|FG000|Second Intervention|Failed to react at both Aspirin|1
2203681|NCT01597375|3840996|FG001|Second Intervention|Failed to react at both Aspirin|1
2203682|NCT01597479|3841016|FG000|Overall Study|Protocol Violation|1
2203683|NCT01597479|3841017|FG001|Overall Study|Protocol Violation|0
2203684|NCT01597479|3841016|FG000|Overall Study|Lost to Follow-up|1
2203685|NCT01597479|3841017|FG001|Overall Study|Lost to Follow-up|0
2203686|NCT01597492|3841026|FG000|Overall Study|Withdrawal by Subject|1
2203687|NCT01597492|3841027|FG001|Overall Study|Withdrawal by Subject|2
2203688|NCT01597492|3841026|FG000|Overall Study|Adverse Event|3
2203689|NCT01597492|3841027|FG001|Overall Study|Adverse Event|0
2203690|NCT01597492|3841026|FG000|Overall Study|Lost to Follow-up|0
2203691|NCT01597492|3841027|FG001|Overall Study|Lost to Follow-up|2
2203692|NCT01597492|3841026|FG000|Overall Study|Other Reason|2
2203693|NCT01597492|3841027|FG001|Overall Study|Other Reason|0
2203694|NCT01597505|3841035|FG000|Overall Study|Physician Decision|5
2203695|NCT01597505|3841036|FG001|Overall Study|Physician Decision|0
2203696|NCT01597505|3841035|FG000|Overall Study|Adverse Event|19
2203697|NCT01597505|3841036|FG001|Overall Study|Adverse Event|7
2203698|NCT01597505|3841035|FG000|Overall Study|Lost to Follow-up|4
2203699|NCT01597505|3841036|FG001|Overall Study|Lost to Follow-up|2
2203700|NCT01597505|3841035|FG000|Overall Study|Withdrawal by Subject|10
2203701|NCT01597505|3841036|FG001|Overall Study|Withdrawal by Subject|18
2203702|NCT01597505|3841035|FG000|Overall Study|Other|5
2203703|NCT01597505|3841036|FG001|Overall Study|Other|6
2203704|NCT01597505|3841035|FG000|Overall Study|Missing|1
2203705|NCT01597505|3841036|FG001|Overall Study|Missing|0
2203706|NCT01597557|3841045|FG000|Overall Study|Did not undergo cardioversion procedure|4
2203707|NCT01597557|3841046|FG001|Overall Study|Did not undergo cardioversion procedure|3
2203708|NCT01597596|3841054|FG000|Overall Study|Study terminated by sponsor|1
2203709|NCT01597596|3841055|FG001|Overall Study|Study terminated by sponsor|0
2203710|NCT01597596|3841054|FG000|Overall Study|Physician Decision|0
2203711|NCT01597596|3841055|FG001|Overall Study|Physician Decision|1
2203712|NCT01597622|3841061|FG000|Overall Study|Adverse Event|7
2203713|NCT01597622|3841061|FG000|Overall Study|Lack of Efficacy|3
2203714|NCT01597622|3841061|FG000|Overall Study|Protocol Violation|1
2203715|NCT01597622|3841061|FG000|Overall Study|Lost to Follow-up|1
2203716|NCT01597622|3841061|FG000|Overall Study|Investigator Discretion|5
2203717|NCT01597622|3841061|FG000|Overall Study|Withdrawal by Subject|20
2203718|NCT01597622|3841061|FG000|Overall Study|Death|1
2203719|NCT01597635|3841068|FG000|Part A|Adverse Event|3
2203720|NCT01597635|3841069|FG001|Part A|Adverse Event|0
2203721|NCT01597635|3841070|FG002|Part A|Adverse Event|0
2203722|NCT01597635|3841068|FG000|Part B|Adverse Event|0
2203723|NCT01597635|3841069|FG001|Part B|Adverse Event|0
2203724|NCT01597635|3841070|FG002|Part B|Adverse Event|1
2203725|NCT01597635|3841068|FG000|Part B|Protocol Violation|0
2203726|NCT01597635|3841069|FG001|Part B|Protocol Violation|1
2203727|NCT01597635|3841070|FG002|Part B|Protocol Violation|0
2203728|NCT01597635|3841068|FG000|Part B|Protocol-defined stopping criteria|0
2203729|NCT01597635|3841069|FG001|Part B|Protocol-defined stopping criteria|4
2203730|NCT01597635|3841070|FG002|Part B|Protocol-defined stopping criteria|3
2203731|NCT01597635|3841068|FG000|Part B|Withdrawal by Subject|0
2203732|NCT01597635|3841069|FG001|Part B|Withdrawal by Subject|1
2203733|NCT01597635|3841070|FG002|Part B|Withdrawal by Subject|0
2203734|NCT01597791|3841110|FG000|Overall Study|Physician Decision|2
2203735|NCT01597791|3841111|FG001|Overall Study|Physician Decision|1
2203736|NCT01597791|3841110|FG000|Overall Study|Cesarean Section|6
2203737|NCT01597791|3841111|FG001|Overall Study|Cesarean Section|7
2203738|NCT01597791|3841110|FG000|Overall Study|Subject withdrawal|0
2203739|NCT01597791|3841111|FG001|Overall Study|Subject withdrawal|1
2203740|NCT01597791|3841110|FG000|Overall Study|Protocol Violation|0
2203741|NCT01597791|3841111|FG001|Overall Study|Protocol Violation|1
2203742|NCT01597908|3841146|FG000|Randomized Phase|Death|217
2203743|NCT01597908|3841147|FG001|Randomized Phase|Death|238
2203744|NCT01597908|3841148|FG002|Randomized Phase|Death|0
2203745|NCT01597908|3841146|FG000|Randomized Phase|Sponsor Decision|93
2203746|NCT01597908|3841147|FG001|Randomized Phase|Sponsor Decision|39
2203747|NCT01597908|3841148|FG002|Randomized Phase|Sponsor Decision|0
2203748|NCT01597908|3841146|FG000|Randomized Phase|Lost to Follow-up|9
2203749|NCT01597908|3841147|FG001|Randomized Phase|Lost to Follow-up|16
2203750|NCT01597908|3841148|FG002|Randomized Phase|Lost to Follow-up|0
2203751|NCT01597908|3841146|FG000|Randomized Phase|Physician Decision|6
2203752|NCT01597908|3841147|FG001|Randomized Phase|Physician Decision|3
2203753|NCT01597908|3841148|FG002|Randomized Phase|Physician Decision|0
2203754|NCT01597908|3841146|FG000|Randomized Phase|Withdrawal by Subject|26
2203755|NCT01597908|3841147|FG001|Randomized Phase|Withdrawal by Subject|22
2203756|NCT01597908|3841148|FG002|Randomized Phase|Withdrawal by Subject|0
2203757|NCT01597908|3841146|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
2203758|NCT01597908|3841147|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34
2203759|NCT01597908|3841148|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
2203760|NCT01597908|3841146|FG000|Crossover Phase|Death|0
2203761|NCT01597908|3841147|FG001|Crossover Phase|Death|0
2203762|NCT01597908|3841148|FG002|Crossover Phase|Death|11
2203763|NCT01597908|3841146|FG000|Crossover Phase|Withdrawal by Subject|0
2203764|NCT01597908|3841147|FG001|Crossover Phase|Withdrawal by Subject|0
2203765|NCT01597908|3841148|FG002|Crossover Phase|Withdrawal by Subject|3
2203766|NCT01597908|3841146|FG000|Crossover Phase|Sponsor Decision|0
2203767|NCT01597908|3841147|FG001|Crossover Phase|Sponsor Decision|0
2203768|NCT01597908|3841148|FG002|Crossover Phase|Sponsor Decision|20
2203769|NCT01597973|3841159|FG000|Overall Study|Found ineligible before study medication started|4
2203770|NCT01597973|3841160|FG001|Overall Study|Found ineligible before study medication started|2
2203771|NCT01597973|3841159|FG000|Overall Study|Eligible pathogen not confirmed|14
2203772|NCT01597973|3841160|FG001|Overall Study|Eligible pathogen not confirmed|15
2203773|NCT01597973|3841159|FG000|Overall Study|LAR not authorized to consent|0
2203774|NCT01597973|3841160|FG001|Overall Study|LAR not authorized to consent|1
2203775|NCT01597973|3841159|FG000|Overall Study|Ineligible due to early seizures|1
2203776|NCT01597973|3841160|FG001|Overall Study|Ineligible due to early seizures|0
2203777|NCT01597973|3841159|FG000|Overall Study|Ineligible due to non-target infection|1
2203778|NCT01597973|3841160|FG001|Overall Study|Ineligible due to non-target infection|1
2203779|NCT01598090|3841182|FG000|Treatment Period|Poor/non-compliance|0
2203780|NCT01598090|3841183|FG001|Treatment Period|Poor/non-compliance|2
2277300|NCT02326272|3959821|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2203781|NCT01598090|3841184|FG002|Treatment Period|Poor/non-compliance|0
2203782|NCT01598090|3841182|FG000|Treatment Period|No longer meet study criteria|0
2203783|NCT01598090|3841183|FG001|Treatment Period|No longer meet study criteria|1
2203784|NCT01598090|3841184|FG002|Treatment Period|No longer meet study criteria|0
2203785|NCT01598090|3841182|FG000|Treatment Period|Lack of Efficacy|5
2203786|NCT01598090|3841183|FG001|Treatment Period|Lack of Efficacy|14
2203787|NCT01598090|3841184|FG002|Treatment Period|Lack of Efficacy|6
2203788|NCT01598090|3841182|FG000|Treatment Period|Adverse Event|2
2203789|NCT01598090|3841183|FG001|Treatment Period|Adverse Event|33
2203790|NCT01598090|3841184|FG002|Treatment Period|Adverse Event|17
2203791|NCT01598090|3841182|FG000|Treatment Period|Other reasons|0
2203792|NCT01598090|3841183|FG001|Treatment Period|Other reasons|4
2203793|NCT01598090|3841184|FG002|Treatment Period|Other reasons|1
2203794|NCT01598090|3841182|FG000|Treatment Period|Withdrawal by Subject|3
2203795|NCT01598090|3841183|FG001|Treatment Period|Withdrawal by Subject|13
2203796|NCT01598090|3841184|FG002|Treatment Period|Withdrawal by Subject|10
2203797|NCT01598090|3841182|FG000|Treatment Period|Lost to Follow-up|1
2203798|NCT01598090|3841183|FG001|Treatment Period|Lost to Follow-up|5
2203799|NCT01598090|3841184|FG002|Treatment Period|Lost to Follow-up|1
2203800|NCT01598090|3841182|FG000|Follow-up Period|Death|0
2203801|NCT01598090|3841183|FG001|Follow-up Period|Death|1
2203802|NCT01598090|3841184|FG002|Follow-up Period|Death|0
2203803|NCT01598090|3841182|FG000|Follow-up Period|No longer required per protocol|1
2203804|NCT01598090|3841183|FG001|Follow-up Period|No longer required per protocol|3
2203805|NCT01598090|3841184|FG002|Follow-up Period|No longer required per protocol|2
2203806|NCT01598090|3841182|FG000|Follow-up Period|Not reported|0
2203807|NCT01598090|3841183|FG001|Follow-up Period|Not reported|10
2203808|NCT01598090|3841184|FG002|Follow-up Period|Not reported|4
2203809|NCT01598090|3841182|FG000|Follow-up Period|Withdrawal by Subject|0
2203810|NCT01598090|3841183|FG001|Follow-up Period|Withdrawal by Subject|3
2203811|NCT01598090|3841184|FG002|Follow-up Period|Withdrawal by Subject|2
2203812|NCT01598090|3841182|FG000|Follow-up Period|Other reasons|2
2203813|NCT01598090|3841183|FG001|Follow-up Period|Other reasons|8
2203814|NCT01598090|3841184|FG002|Follow-up Period|Other reasons|8
2203815|NCT01598090|3841182|FG000|Follow-up Period|Lost to Follow-up|2
2203816|NCT01598090|3841183|FG001|Follow-up Period|Lost to Follow-up|10
2203817|NCT01598090|3841184|FG002|Follow-up Period|Lost to Follow-up|12
2203818|NCT01598129|3841195|FG000|Overall Study|Disease progression|6
2203819|NCT01598129|3841195|FG000|Overall Study|Deterioration of WHO status to WHO 4|2
2203820|NCT01598129|3841195|FG000|Overall Study|Withdrawal by Subject|1
2203821|NCT01598298|3841224|FG000|Overall Study|Not eligible|5
2203822|NCT01598298|3841225|FG001|Overall Study|Not eligible|5
2203823|NCT01598298|3841224|FG000|Overall Study|Adverse Event|21
2203824|NCT01598298|3841225|FG001|Overall Study|Adverse Event|19
2203825|NCT01598298|3841224|FG000|Overall Study|Progression/relapse|0
2203826|NCT01598298|3841225|FG001|Overall Study|Progression/relapse|2
2203827|NCT01598298|3841224|FG000|Overall Study|Withdrawal by Subject|10
2203828|NCT01598298|3841225|FG001|Overall Study|Withdrawal by Subject|15
2203829|NCT01598298|3841224|FG000|Overall Study|Other reason (not protocol specified)|4
2203830|NCT01598298|3841225|FG001|Overall Study|Other reason (not protocol specified)|0
2203831|NCT01598311|3841233|FG000|Overall Study|Physician Decision|4
2203832|NCT01598311|3841234|FG001|Overall Study|Physician Decision|5
2203833|NCT01598311|3841233|FG000|Overall Study|Adverse Event|9
2203834|NCT01598311|3841234|FG001|Overall Study|Adverse Event|13
2203835|NCT01598311|3841233|FG000|Overall Study|Lost to Follow-up|7
2203836|NCT01598311|3841234|FG001|Overall Study|Lost to Follow-up|12
2203837|NCT01598311|3841233|FG000|Overall Study|Withdrawal by Subject|9
2203838|NCT01598311|3841234|FG001|Overall Study|Withdrawal by Subject|13
2203839|NCT01598311|3841233|FG000|Overall Study|No reason provided.|0
2203840|NCT01598311|3841234|FG001|Overall Study|No reason provided.|5
2203841|NCT01598311|3841233|FG000|Overall Study|Randomized but never treated|8
2203842|NCT01598311|3841234|FG001|Overall Study|Randomized but never treated|5
2203843|NCT01598311|3841233|FG000|Overall Study|Treated but no confirmed CDAD|9
2203844|NCT01598311|3841234|FG001|Overall Study|Treated but no confirmed CDAD|8
2203845|NCT01598311|3841233|FG000|Overall Study|Assigned to CB but received vancomycin|1
2203846|NCT01598311|3841234|FG001|Overall Study|Assigned to CB but received vancomycin|0
2203847|NCT01598506|3841249|FG000|Overall Study|Withdrawal by Subject|2
2203848|NCT01598532|3841254|FG000|Overall Study|Lost to Follow-up|3
2203849|NCT01598532|3841254|FG000|Overall Study|Did not meet inclusion criteria|8
2203850|NCT01598610|3841265|FG000|Overall Study|Adverse Event|1
2203851|NCT01598662|3841271|FG000|Overall Study|Lost to Follow-up|10
2203852|NCT01598662|3841272|FG001|Overall Study|Lost to Follow-up|17
2203853|NCT01598662|3841271|FG000|Overall Study|Physician Decision|1
2203854|NCT01598662|3841272|FG001|Overall Study|Physician Decision|2
2203855|NCT01598662|3841271|FG000|Overall Study|IUD expelled before month 6|0
2203856|NCT01598662|3841272|FG001|Overall Study|IUD expelled before month 6|2
2203857|NCT01598753|3841301|FG000|Overall Study|Adverse Event|1
2203858|NCT01598753|3841302|FG001|Overall Study|Adverse Event|9
2203859|NCT01598753|3841303|FG002|Overall Study|Adverse Event|1
2203860|NCT01598753|3841304|FG003|Overall Study|Adverse Event|7
2203861|NCT01598753|3841301|FG000|Overall Study|Lost to Follow-up|4
2203862|NCT01598753|3841302|FG001|Overall Study|Lost to Follow-up|3
2203863|NCT01598753|3841303|FG002|Overall Study|Lost to Follow-up|7
2203864|NCT01598753|3841304|FG003|Overall Study|Lost to Follow-up|5
2203865|NCT01598753|3841301|FG000|Overall Study|Physician Decision|0
2203866|NCT01598753|3841302|FG001|Overall Study|Physician Decision|1
2203867|NCT01598753|3841303|FG002|Overall Study|Physician Decision|0
2203868|NCT01598753|3841304|FG003|Overall Study|Physician Decision|2
2203869|NCT01598753|3841301|FG000|Overall Study|Withdrawal by Subject|7
2203870|NCT01598753|3841302|FG001|Overall Study|Withdrawal by Subject|2
2203871|NCT01598753|3841303|FG002|Overall Study|Withdrawal by Subject|0
2203872|NCT01598753|3841304|FG003|Overall Study|Withdrawal by Subject|1
2203873|NCT01598896|3841329|FG000|Overall Study|Withdrawal by Subject|0
2203874|NCT01598896|3841330|FG001|Overall Study|Withdrawal by Subject|1
2203875|NCT01598896|3841329|FG000|Overall Study|Lack of Efficacy|0
2203876|NCT01598896|3841330|FG001|Overall Study|Lack of Efficacy|1
2203877|NCT01598987|3841345|FG000|Baseline to Month 12|Administrative problems|2
2203878|NCT01598987|3841345|FG000|Baseline to Month 12|Withdrawal by Subject|4
2203879|NCT01598987|3841345|FG000|Baseline to 24 Month|Withdrawal by Subject|5
2203880|NCT01598987|3841345|FG000|Baseline to 24 Month|Administrative problems|2
2203881|NCT01598987|3841345|FG000|Baseline to 24 Month|Lost to Follow-up|1
2203882|NCT01599104|3841359|FG000|Overall Study|Withdrawal by Subject|1
2203883|NCT01599104|3841360|FG001|Overall Study|Withdrawal by Subject|1
2203884|NCT01599104|3841361|FG002|Overall Study|Withdrawal by Subject|2
2203885|NCT01599104|3841359|FG000|Overall Study|Technical Problems|1
2203886|NCT01599104|3841360|FG001|Overall Study|Technical Problems|0
2203887|NCT01599104|3841361|FG002|Overall Study|Technical Problems|0
2203888|NCT01599104|3841359|FG000|Overall Study|Physician Decision|3
2203889|NCT01599104|3841360|FG001|Overall Study|Physician Decision|2
2203890|NCT01599104|3841361|FG002|Overall Study|Physician Decision|2
2203891|NCT01599104|3841359|FG000|Overall Study|Non-compliance with study treatment|0
2203892|NCT01599104|3841360|FG001|Overall Study|Non-compliance with study treatment|1
2203893|NCT01599104|3841361|FG002|Overall Study|Non-compliance with study treatment|0
2203894|NCT01599104|3841359|FG000|Overall Study|Lack of Efficacy|4
2203895|NCT01599104|3841360|FG001|Overall Study|Lack of Efficacy|4
2203896|NCT01599104|3841361|FG002|Overall Study|Lack of Efficacy|10
2203897|NCT01599104|3841359|FG000|Overall Study|Adverse Event|7
2203898|NCT01599104|3841360|FG001|Overall Study|Adverse Event|6
2203899|NCT01599104|3841361|FG002|Overall Study|Adverse Event|12
2203900|NCT01599234|3841371|FG000|Overall Study|Adverse Event|9
2203901|NCT01599234|3841372|FG001|Overall Study|Adverse Event|5
2203902|NCT01599234|3841371|FG000|Overall Study|Withdrawal by Subject|2
2203903|NCT01599234|3841372|FG001|Overall Study|Withdrawal by Subject|1
2203904|NCT01599234|3841371|FG000|Overall Study|Lost to Follow-up|1
2203905|NCT01599234|3841372|FG001|Overall Study|Lost to Follow-up|2
2203906|NCT01599234|3841371|FG000|Overall Study|Lack of Efficacy|2
2203907|NCT01599234|3841372|FG001|Overall Study|Lack of Efficacy|4
2203908|NCT01599234|3841371|FG000|Overall Study|Unable to operate spray|1
2203909|NCT01599234|3841372|FG001|Overall Study|Unable to operate spray|0
2203910|NCT01599234|3841371|FG000|Overall Study|Sponsor request as creatinine levels <50|0
2203911|NCT01599234|3841372|FG001|Overall Study|Sponsor request as creatinine levels <50|1
2203912|NCT01599234|3841371|FG000|Overall Study|Death|1
2203913|NCT01599234|3841372|FG001|Overall Study|Death|0
2203914|NCT01599234|3841371|FG000|Overall Study|Patient would not stop driving|1
2203915|NCT01599234|3841372|FG001|Overall Study|Patient would not stop driving|0
2203916|NCT01599234|3841371|FG000|Overall Study|Contra-indication discovered|0
2203917|NCT01599234|3841372|FG001|Overall Study|Contra-indication discovered|1
2203918|NCT01599234|3841371|FG000|Overall Study|Pregnancy|0
2203919|NCT01599234|3841372|FG001|Overall Study|Pregnancy|1
2203920|NCT01599325|3841387|FG000|Primary Parent Phase|Adverse Event|5
2203921|NCT01599325|3841387|FG000|Primary Parent Phase|Disease Progression|7
2203922|NCT01599325|3841387|FG000|Primary Parent Phase|Withdrawal by Subject|20
2203923|NCT01599325|3841387|FG000|Primary Parent Phase|Death|13
2203924|NCT01599325|3841387|FG000|Primary Parent Phase|Protocol Violation|1
2203925|NCT01599325|3841387|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9
2203926|NCT01599325|3841387|FG000|Primary Parent Phase|Other|2
2203927|NCT01599325|3841387|FG000|Extension Phase|Study Closure|1
2203928|NCT01599325|3841387|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1
2203929|NCT01599325|3841387|FG000|Extension Phase|Lack of Therapeutic Effect|4
2203930|NCT01599325|3841387|FG000|Extension Phase|Disease Progression|1
2203931|NCT01599325|3841387|FG000|Extension Phase|Withdrawal by Subject|8
2203932|NCT01599585|3841394|FG000|Overall Study|Withdrawal by Subject|16
2203933|NCT01599585|3841395|FG001|Overall Study|Withdrawal by Subject|9
2203934|NCT01599585|3841394|FG000|Overall Study|Lost to Follow-up|3
2203935|NCT01599585|3841395|FG001|Overall Study|Lost to Follow-up|5
2203936|NCT01599585|3841394|FG000|Overall Study|randomized did not start treatment|3
2203937|NCT01599585|3841395|FG001|Overall Study|randomized did not start treatment|3
2203938|NCT01599637|3841404|FG000|Overall Study|administrative problems|0
2203939|NCT01599637|3841405|FG001|Overall Study|administrative problems|2
2203940|NCT01599637|3841406|FG002|Overall Study|administrative problems|0
2203941|NCT01599637|3841404|FG000|Overall Study|Adverse Event|1
2203942|NCT01599637|3841405|FG001|Overall Study|Adverse Event|0
2203943|NCT01599637|3841406|FG002|Overall Study|Adverse Event|0
2203944|NCT01599650|3841419|FG000|Overall Study|Administrative issue|1
2203945|NCT01599650|3841420|FG001|Overall Study|Administrative issue|0
2203946|NCT01599650|3841421|FG002|Overall Study|Administrative issue|1
2203947|NCT01599650|3841419|FG000|Overall Study|Physician Decision|2
2203948|NCT01599650|3841420|FG001|Overall Study|Physician Decision|0
2203949|NCT01599650|3841421|FG002|Overall Study|Physician Decision|7
2203950|NCT01599650|3841419|FG000|Overall Study|Protocol Violation|0
2203951|NCT01599650|3841420|FG001|Overall Study|Protocol Violation|3
2203952|NCT01599650|3841421|FG002|Overall Study|Protocol Violation|0
2203953|NCT01599650|3841419|FG000|Overall Study|Death|2
2203954|NCT01599650|3841420|FG001|Overall Study|Death|1
2203955|NCT01599650|3841421|FG002|Overall Study|Death|2
2203956|NCT01599650|3841419|FG000|Overall Study|Lost to Follow-up|3
2203957|NCT01599650|3841420|FG001|Overall Study|Lost to Follow-up|3
2203958|NCT01599650|3841421|FG002|Overall Study|Lost to Follow-up|3
2203959|NCT01599650|3841419|FG000|Overall Study|Withdrawal by Subject|11
2203960|NCT01599650|3841420|FG001|Overall Study|Withdrawal by Subject|11
2203961|NCT01599650|3841421|FG002|Overall Study|Withdrawal by Subject|10
2203962|NCT01599650|3841419|FG000|Overall Study|Adverse Event|3
2203963|NCT01599650|3841420|FG001|Overall Study|Adverse Event|8
2203964|NCT01599650|3841421|FG002|Overall Study|Adverse Event|4
2203965|NCT01599754|3841437|FG000|Overall Study|Anticancer therapy need not in protocol|5
2203966|NCT01599754|3841438|FG001|Overall Study|Anticancer therapy need not in protocol|2
2203967|NCT01599754|3841437|FG000|Overall Study|Participant noncompliance|4
2203968|NCT01599754|3841438|FG001|Overall Study|Participant noncompliance|4
2203969|NCT01599754|3841437|FG000|Overall Study|Lost to Follow-up|13
2203970|NCT01599754|3841438|FG001|Overall Study|Lost to Follow-up|6
2203971|NCT01599754|3841437|FG000|Overall Study|Death|31
2203972|NCT01599754|3841438|FG001|Overall Study|Death|33
2203973|NCT01599754|3841437|FG000|Overall Study|Adverse Event|3
2203974|NCT01599754|3841438|FG001|Overall Study|Adverse Event|2
2203975|NCT01599754|3841437|FG000|Overall Study|Investigator decision|1
2203976|NCT01599754|3841438|FG001|Overall Study|Investigator decision|3
2203977|NCT01599754|3841437|FG000|Overall Study|Withdrawal by Subject|24
2203978|NCT01599754|3841438|FG001|Overall Study|Withdrawal by Subject|25
2203979|NCT01599754|3841437|FG000|Overall Study|Study terminated by sponsor|282
2203980|NCT01599754|3841438|FG001|Overall Study|Study terminated by sponsor|285
2203981|NCT01599793|3841444|FG000|Overall Study|Adverse Event|2
2203982|NCT01599806|3841450|FG000|Overall Study|Lost to Follow-up|20
2203983|NCT01599806|3841451|FG001|Overall Study|Lost to Follow-up|20
2203984|NCT01599806|3841450|FG000|Overall Study|Withdrawal by Subject|12
2203985|NCT01599806|3841451|FG001|Overall Study|Withdrawal by Subject|12
2203986|NCT01599806|3841450|FG000|Overall Study|Other Eligibility criteria|11
2203987|NCT01599806|3841451|FG001|Overall Study|Other Eligibility criteria|9
2203988|NCT01600014|3841461|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
2203989|NCT01600014|3841462|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
2203990|NCT01600014|3841461|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
2203991|NCT01600014|3841462|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
2277301|NCT02326298|3959833|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
2277302|NCT02326298|3959834|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
2277303|NCT02326298|3959835|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
2277304|NCT02326298|3959836|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
2277305|NCT02326298|3959837|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
2277306|NCT02326298|3959838|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
2277307|NCT02326298|3959839|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
2277308|NCT02326298|3959840|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
2277309|NCT02326298|3959841|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
2277310|NCT02326298|3959842|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
2277311|NCT02326298|3959843|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
2277312|NCT02326298|3959844|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
2203992|NCT01600014|3841461|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6
2203993|NCT01600014|3841462|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0
2203994|NCT01600014|3841461|FG000|1. Cycle & Observation Period D1 to W52|Other|27
2203995|NCT01600014|3841462|FG001|1. Cycle & Observation Period D1 to W52|Other|0
2203996|NCT01600014|3841461|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
2203997|NCT01600014|3841462|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
2203998|NCT01600014|3841461|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
2203999|NCT01600014|3841462|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
2204000|NCT01600014|3841461|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
2204001|NCT01600014|3841462|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
2204002|NCT01600014|3841461|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
2204003|NCT01600014|3841462|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
2204004|NCT01600014|3841461|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
2204005|NCT01600014|3841462|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
2204006|NCT01600014|3841461|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
2204007|NCT01600014|3841462|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
2204008|NCT01600014|3841461|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
2204009|NCT01600014|3841462|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
2204010|NCT01600014|3841461|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
2204011|NCT01600014|3841462|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
2204012|NCT01600014|3841461|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
2204013|NCT01600014|3841462|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
2204014|NCT01600014|3841461|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
2204015|NCT01600014|3841462|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
2204016|NCT01600014|3841461|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
2204017|NCT01600014|3841462|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
2204018|NCT01600014|3841461|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
2204019|NCT01600014|3841462|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
2204020|NCT01600014|3841461|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
2204021|NCT01600014|3841462|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
2204022|NCT01600053|3841480|FG000|Overall Study|Adverse Event|2
2204023|NCT01600053|3841480|FG000|Overall Study|trial will not meet the interim endpoint|9
2204024|NCT01600092|3841486|FG000|Overall Study|Adverse Event|2
2204025|NCT01600092|3841487|FG001|Overall Study|Adverse Event|0
2204026|NCT01600092|3841486|FG000|Overall Study|Lost to Follow-up|4
2204027|NCT01600092|3841487|FG001|Overall Study|Lost to Follow-up|6
2204028|NCT01600092|3841486|FG000|Overall Study|Withdrawal by parent/guardian|8
2204029|NCT01600092|3841487|FG001|Overall Study|Withdrawal by parent/guardian|6
2204030|NCT01600092|3841486|FG000|Overall Study|Physician Decision|1
2204031|NCT01600092|3841487|FG001|Overall Study|Physician Decision|1
2204032|NCT01600092|3841486|FG000|Overall Study|Randomized but not vaccinated|3
2204033|NCT01600092|3841487|FG001|Overall Study|Randomized but not vaccinated|3
2204034|NCT01600105|3841495|FG000|Total Participants|Withdrawal by Subject|1
2204035|NCT01600105|3841496|FG001|Total Participants|Withdrawal by Subject|0
2204036|NCT01600105|3841495|FG000|Total Participants|No images in PACS|10
2204037|NCT01600105|3841496|FG001|Total Participants|No images in PACS|0
2204038|NCT01600105|3841495|FG000|Total Participants|Insufficient image quality|30
2277313|NCT02326298|3959845|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
2204039|NCT01600105|3841496|FG001|Total Participants|Insufficient image quality|10
2204040|NCT01600105|3841495|FG000|Sub Study I|Insufficient image quality|0
2204041|NCT01600105|3841496|FG001|Sub Study I|Insufficient image quality|10
2204042|NCT01600105|3841495|FG000|Sub Study II|Withdrawal by Subject|1
2204043|NCT01600105|3841496|FG001|Sub Study II|Withdrawal by Subject|0
2204044|NCT01600105|3841495|FG000|Sub Study II|No images in PACS|1
2204045|NCT01600105|3841496|FG001|Sub Study II|No images in PACS|0
2204046|NCT01600105|3841495|FG000|Sub Study II|Insufficient image quality|3
2204047|NCT01600105|3841496|FG001|Sub Study II|Insufficient image quality|0
2204048|NCT01600105|3841495|FG000|Sub Study III|Insufficient image quality|5
2204049|NCT01600105|3841496|FG001|Sub Study III|Insufficient image quality|0
2204050|NCT01600105|3841495|FG000|Sub Study V|Poor Image Quality|2
2204051|NCT01600105|3841496|FG001|Sub Study V|Poor Image Quality|0
2204052|NCT01600326|3841533|FG000|Overall Study|Lost to Follow-up|1
2204053|NCT01600326|3841534|FG001|Overall Study|Lost to Follow-up|1
2204054|NCT01600586|3841561|FG000|Overall Study|Physician Decision|3
2204055|NCT01600586|3841562|FG001|Overall Study|Physician Decision|3
2204056|NCT01600716|3841597|FG000|Overall Study|Other Reasons|3
2204057|NCT01600716|3841598|FG001|Overall Study|Other Reasons|1
2204058|NCT01600716|3841597|FG000|Overall Study|Personal Reasons|0
2204059|NCT01600716|3841598|FG001|Overall Study|Personal Reasons|2
2204060|NCT01600716|3841597|FG000|Overall Study|Lost to Follow-up|0
2204061|NCT01600716|3841598|FG001|Overall Study|Lost to Follow-up|2
2204062|NCT01600716|3841597|FG000|Overall Study|Pregnancy|1
2204063|NCT01600716|3841598|FG001|Overall Study|Pregnancy|0
2204064|NCT01600716|3841597|FG000|Overall Study|Lack of Efficacy|2
2204065|NCT01600716|3841598|FG001|Overall Study|Lack of Efficacy|1
2204066|NCT01600716|3841597|FG000|Overall Study|Adverse Event|1
2204067|NCT01600716|3841598|FG001|Overall Study|Adverse Event|1
2204068|NCT01600885|3841610|FG000|First Period|Adverse Event|1
2277314|NCT02326298|3959846|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
2277315|NCT02326298|3959833|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
2277316|NCT02326298|3959834|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277317|NCT02326298|3959835|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277318|NCT02326298|3959836|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277319|NCT02326298|3959837|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277320|NCT02326298|3959838|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277321|NCT02326298|3959839|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277322|NCT02326298|3959840|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277323|NCT02326298|3959841|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277324|NCT02326298|3959842|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277325|NCT02326298|3959843|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277326|NCT02326298|3959844|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277327|NCT02326298|3959845|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277328|NCT02326298|3959846|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2277329|NCT02326298|3959833|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
2277330|NCT02326298|3959834|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
2277331|NCT02326298|3959835|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277332|NCT02326298|3959836|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277333|NCT02326298|3959837|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277334|NCT02326298|3959838|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277335|NCT02326298|3959839|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277336|NCT02326298|3959840|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277337|NCT02326298|3959841|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277338|NCT02326298|3959842|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277339|NCT02326298|3959843|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277340|NCT02326298|3959844|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277341|NCT02326298|3959845|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277342|NCT02326298|3959846|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2277343|NCT02326298|3959833|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
2277344|NCT02326298|3959834|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
2277345|NCT02326298|3959835|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2277346|NCT02326298|3959836|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2277347|NCT02326298|3959837|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2277348|NCT02326298|3959838|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2204069|NCT01600885|3841611|FG001|First Period|Adverse Event|1
2204070|NCT01600885|3841610|FG000|First Period|moved out of area|1
2204071|NCT01600885|3841611|FG001|First Period|moved out of area|0
2204072|NCT01601132|3841633|FG000|Overall Study|Patient withdrew consent|1
2204073|NCT01601132|3841633|FG000|Overall Study|Protocol deviation|1
2204074|NCT01601470|3841669|FG000|Period 2 - LCZ696|Physician Decision|1
2204075|NCT01601496|3841675|FG000|Overall Study|Physician Decision|1
2204076|NCT01601496|3841675|FG000|Overall Study|Withdrawal by Subject|1
2277349|NCT02326298|3959839|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2277350|NCT02326298|3959840|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2277351|NCT02326298|3959841|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2277352|NCT02326298|3959842|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2204077|NCT01601496|3841675|FG000|Overall Study|Lost to Follow-up|6
2204078|NCT01601496|3841675|FG000|Overall Study|Death|4
2204079|NCT01601496|3841675|FG000|Overall Study|Other: patient refusal to continue|3
2204080|NCT01601535|3841685|FG000|Phase 1|Adverse Event|1
2204081|NCT01601535|3841686|FG001|Phase 1|Adverse Event|0
2204082|NCT01601535|3841687|FG002|Phase 1|Adverse Event|2
2204083|NCT01601535|3841688|FG003|Phase 1|Adverse Event|1
2204084|NCT01601535|3841689|FG004|Phase 1|Adverse Event|0
2204085|NCT01601535|3841690|FG005|Phase 1|Adverse Event|0
2204086|NCT01601535|3841685|FG000|Phase 1|Withdrawal by Subject|2
2204087|NCT01601535|3841686|FG001|Phase 1|Withdrawal by Subject|1
2204088|NCT01601535|3841687|FG002|Phase 1|Withdrawal by Subject|1
2204089|NCT01601535|3841688|FG003|Phase 1|Withdrawal by Subject|2
2204090|NCT01601535|3841689|FG004|Phase 1|Withdrawal by Subject|0
2204091|NCT01601535|3841690|FG005|Phase 1|Withdrawal by Subject|0
2204092|NCT01601535|3841685|FG000|Phase 1|Progressive Disease|2
2204093|NCT01601535|3841686|FG001|Phase 1|Progressive Disease|3
2204094|NCT01601535|3841687|FG002|Phase 1|Progressive Disease|2
2204095|NCT01601535|3841688|FG003|Phase 1|Progressive Disease|1
2204096|NCT01601535|3841689|FG004|Phase 1|Progressive Disease|0
2204097|NCT01601535|3841690|FG005|Phase 1|Progressive Disease|0
2204098|NCT01601535|3841685|FG000|Phase 1|Started Another Treatment|1
2204099|NCT01601535|3841686|FG001|Phase 1|Started Another Treatment|2
2204100|NCT01601535|3841687|FG002|Phase 1|Started Another Treatment|0
2204101|NCT01601535|3841688|FG003|Phase 1|Started Another Treatment|0
2204102|NCT01601535|3841689|FG004|Phase 1|Started Another Treatment|0
2204103|NCT01601535|3841690|FG005|Phase 1|Started Another Treatment|0
2204104|NCT01601535|3841685|FG000|Phase 2|Adverse Event|0
2204105|NCT01601535|3841686|FG001|Phase 2|Adverse Event|0
2204106|NCT01601535|3841687|FG002|Phase 2|Adverse Event|0
2204107|NCT01601535|3841688|FG003|Phase 2|Adverse Event|0
2204108|NCT01601535|3841689|FG004|Phase 2|Adverse Event|5
2204109|NCT01601535|3841690|FG005|Phase 2|Adverse Event|1
2204110|NCT01601535|3841685|FG000|Phase 2|Withdrawal by Subject|0
2204111|NCT01601535|3841686|FG001|Phase 2|Withdrawal by Subject|0
2204112|NCT01601535|3841687|FG002|Phase 2|Withdrawal by Subject|0
2204113|NCT01601535|3841688|FG003|Phase 2|Withdrawal by Subject|0
2204114|NCT01601535|3841689|FG004|Phase 2|Withdrawal by Subject|8
2204115|NCT01601535|3841690|FG005|Phase 2|Withdrawal by Subject|2
2204116|NCT01601535|3841685|FG000|Phase 2|Progressive Disease|0
2204117|NCT01601535|3841686|FG001|Phase 2|Progressive Disease|0
2204118|NCT01601535|3841687|FG002|Phase 2|Progressive Disease|0
2204119|NCT01601535|3841688|FG003|Phase 2|Progressive Disease|0
2204120|NCT01601535|3841689|FG004|Phase 2|Progressive Disease|5
2204121|NCT01601535|3841690|FG005|Phase 2|Progressive Disease|7
2204122|NCT01601535|3841685|FG000|Phase 2|Started Another Treatment|0
2204123|NCT01601535|3841686|FG001|Phase 2|Started Another Treatment|0
2204124|NCT01601535|3841687|FG002|Phase 2|Started Another Treatment|0
2204125|NCT01601535|3841688|FG003|Phase 2|Started Another Treatment|0
2204126|NCT01601535|3841689|FG004|Phase 2|Started Another Treatment|1
2204127|NCT01601535|3841690|FG005|Phase 2|Started Another Treatment|2
2204128|NCT01601626|3841716|FG000|Overall Study|Death|1
2204129|NCT01601626|3841717|FG001|Overall Study|Death|1
2204130|NCT01601626|3841718|FG002|Overall Study|Death|1
2204131|NCT01601626|3841716|FG000|Overall Study|Lost to Follow-up|1
2204132|NCT01601626|3841717|FG001|Overall Study|Lost to Follow-up|2
2204133|NCT01601626|3841718|FG002|Overall Study|Lost to Follow-up|0
2204134|NCT01601626|3841716|FG000|Overall Study|Unable to Get to Clinic|0
2204135|NCT01601626|3841717|FG001|Overall Study|Unable to Get to Clinic|1
2204136|NCT01601626|3841718|FG002|Overall Study|Unable to Get to Clinic|0
2204137|NCT01601626|3841716|FG000|Overall Study|Withdrawal by Subject|0
2204138|NCT01601626|3841717|FG001|Overall Study|Withdrawal by Subject|1
2204139|NCT01601626|3841718|FG002|Overall Study|Withdrawal by Subject|1
2204140|NCT01601626|3841716|FG000|Overall Study|Not Willing to Adhere to Requirements|1
2204141|NCT01601626|3841717|FG001|Overall Study|Not Willing to Adhere to Requirements|0
2204142|NCT01601626|3841718|FG002|Overall Study|Not Willing to Adhere to Requirements|0
2217388|NCT01708161|3860637|FG005|Overall Study|Adverse Event|0
2217389|NCT01708161|3860632|FG000|Overall Study|Death|0
2217390|NCT01708161|3860633|FG001|Overall Study|Death|0
2217391|NCT01708161|3860634|FG002|Overall Study|Death|0
2217392|NCT01708161|3860635|FG003|Overall Study|Death|1
2217393|NCT01708161|3860636|FG004|Overall Study|Death|0
2217394|NCT01708161|3860637|FG005|Overall Study|Death|1
2217395|NCT01708161|3860632|FG000|Overall Study|Withdrawal by Subject|0
2217396|NCT01708161|3860633|FG001|Overall Study|Withdrawal by Subject|1
2217397|NCT01708161|3860634|FG002|Overall Study|Withdrawal by Subject|1
2217398|NCT01708161|3860635|FG003|Overall Study|Withdrawal by Subject|0
2217399|NCT01708161|3860636|FG004|Overall Study|Withdrawal by Subject|0
2217400|NCT01708161|3860637|FG005|Overall Study|Withdrawal by Subject|0
2217401|NCT01708161|3860632|FG000|Overall Study|Administrative problems|0
2217402|NCT01708161|3860633|FG001|Overall Study|Administrative problems|1
2217403|NCT01708161|3860634|FG002|Overall Study|Administrative problems|0
2217404|NCT01708161|3860635|FG003|Overall Study|Administrative problems|0
2217405|NCT01708161|3860636|FG004|Overall Study|Administrative problems|0
2217406|NCT01708161|3860637|FG005|Overall Study|Administrative problems|0
2217407|NCT01708161|3860632|FG000|Overall Study|Disease progression|3
2217408|NCT01708161|3860633|FG001|Overall Study|Disease progression|5
2217409|NCT01708161|3860634|FG002|Overall Study|Disease progression|5
2204143|NCT01601652|3841726|FG000|Overall Study|Death|1
2204144|NCT01601704|3841736|FG000|Overall Study|Randomized but not dispensed study med|1
2204145|NCT01601704|3841737|FG001|Overall Study|Randomized but not dispensed study med|4
2204146|NCT01601821|3841749|FG000|Overall Study|Death|2
2277353|NCT02326298|3959843|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2277354|NCT02326298|3959844|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2277355|NCT02326298|3959845|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2277356|NCT02326298|3959846|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2204147|NCT01601821|3841750|FG001|Overall Study|Death|5
2204148|NCT01601821|3841749|FG000|Overall Study|Protocol Violation|2
2204149|NCT01601821|3841750|FG001|Overall Study|Protocol Violation|2
2204150|NCT01601821|3841749|FG000|Overall Study|Lost to Follow-up|6
2204151|NCT01601821|3841750|FG001|Overall Study|Lost to Follow-up|14
2204152|NCT01601821|3841749|FG000|Overall Study|Withdrawal by Subject|1
2204153|NCT01601821|3841750|FG001|Overall Study|Withdrawal by Subject|0
2204154|NCT01601821|3841749|FG000|Overall Study|Graft Loss|6
2204155|NCT01601821|3841750|FG001|Overall Study|Graft Loss|6
2204156|NCT01601821|3841749|FG000|Overall Study|Study Events|7
2204157|NCT01601821|3841750|FG001|Overall Study|Study Events|1
2204158|NCT01601821|3841749|FG000|Overall Study|Other|5
2204159|NCT01601821|3841750|FG001|Overall Study|Other|1
2204160|NCT01601847|3841758|FG000|Overall Study|Death|1
2204161|NCT01601847|3841759|FG001|Overall Study|Death|0
2204162|NCT01601847|3841758|FG000|Overall Study|Withdrawal by Subject|11
2204163|NCT01601847|3841759|FG001|Overall Study|Withdrawal by Subject|7
2204164|NCT01601847|3841758|FG000|Overall Study|Lost to Follow-up|1
2204165|NCT01601847|3841759|FG001|Overall Study|Lost to Follow-up|3
2204166|NCT01601873|3841777|FG000|Overall Study|Lost to Follow-up|2
2204167|NCT01601873|3841778|FG001|Overall Study|Lost to Follow-up|3
2204168|NCT01602120|3841803|FG000|Overall Study|Adverse Event|3
2204169|NCT01602120|3841804|FG001|Overall Study|Adverse Event|6
2204170|NCT01602120|3841805|FG002|Overall Study|Adverse Event|0
2204171|NCT01602120|3841806|FG003|Overall Study|Adverse Event|2
2204172|NCT01602120|3841803|FG000|Overall Study|Death|0
2204173|NCT01602120|3841804|FG001|Overall Study|Death|4
2204174|NCT01602120|3841805|FG002|Overall Study|Death|0
2204175|NCT01602120|3841806|FG003|Overall Study|Death|0
2204176|NCT01602120|3841803|FG000|Overall Study|Lost to Follow-up|0
2204177|NCT01602120|3841804|FG001|Overall Study|Lost to Follow-up|1
2204178|NCT01602120|3841805|FG002|Overall Study|Lost to Follow-up|0
2204179|NCT01602120|3841806|FG003|Overall Study|Lost to Follow-up|1
2204180|NCT01602120|3841803|FG000|Overall Study|Protocol Violation|1
2204181|NCT01602120|3841804|FG001|Overall Study|Protocol Violation|1
2204182|NCT01602120|3841805|FG002|Overall Study|Protocol Violation|0
2204183|NCT01602120|3841806|FG003|Overall Study|Protocol Violation|0
2204184|NCT01602120|3841803|FG000|Overall Study|Non-compliance|0
2204185|NCT01602120|3841804|FG001|Overall Study|Non-compliance|3
2204186|NCT01602120|3841805|FG002|Overall Study|Non-compliance|0
2204187|NCT01602120|3841806|FG003|Overall Study|Non-compliance|1
2204188|NCT01602120|3841803|FG000|Overall Study|Withdrawal by Subject|8
2204189|NCT01602120|3841804|FG001|Overall Study|Withdrawal by Subject|17
2204190|NCT01602120|3841805|FG002|Overall Study|Withdrawal by Subject|0
2204191|NCT01602120|3841806|FG003|Overall Study|Withdrawal by Subject|3
2204192|NCT01602120|3841803|FG000|Overall Study|Study Terminated by Sponsor|12
2204193|NCT01602120|3841804|FG001|Overall Study|Study Terminated by Sponsor|24
2204194|NCT01602120|3841805|FG002|Overall Study|Study Terminated by Sponsor|17
2204195|NCT01602120|3841806|FG003|Overall Study|Study Terminated by Sponsor|44
2204196|NCT01602120|3841803|FG000|Overall Study|Physician Decision|2
2204197|NCT01602120|3841804|FG001|Overall Study|Physician Decision|3
2204198|NCT01602120|3841805|FG002|Overall Study|Physician Decision|0
2204199|NCT01602120|3841806|FG003|Overall Study|Physician Decision|0
2204200|NCT01602120|3841803|FG000|Overall Study|Unspecified Reason|3
2204201|NCT01602120|3841804|FG001|Overall Study|Unspecified Reason|1
2204202|NCT01602120|3841805|FG002|Overall Study|Unspecified Reason|0
2204203|NCT01602120|3841806|FG003|Overall Study|Unspecified Reason|2
2204204|NCT01602224|3841840|FG000|Overall Study|Adverse Event|0
2204205|NCT01602224|3841841|FG001|Overall Study|Adverse Event|1
2204206|NCT01602224|3841842|FG002|Overall Study|Adverse Event|0
2204207|NCT01602224|3841840|FG000|Overall Study|Investigator Decison|1
2204208|NCT01602224|3841841|FG001|Overall Study|Investigator Decison|0
2204209|NCT01602224|3841842|FG002|Overall Study|Investigator Decison|0
2204210|NCT01602224|3841840|FG000|Overall Study|Lost to Follow-up|0
2204211|NCT01602224|3841841|FG001|Overall Study|Lost to Follow-up|0
2204212|NCT01602224|3841842|FG002|Overall Study|Lost to Follow-up|1
2204213|NCT01602224|3841840|FG000|Overall Study|Protocol Violation|0
2204214|NCT01602224|3841841|FG001|Overall Study|Protocol Violation|1
2204215|NCT01602224|3841842|FG002|Overall Study|Protocol Violation|0
2204216|NCT01602224|3841840|FG000|Overall Study|Sponsor Decision|2
2204217|NCT01602224|3841841|FG001|Overall Study|Sponsor Decision|3
2204218|NCT01602224|3841842|FG002|Overall Study|Sponsor Decision|2
2204219|NCT01602224|3841840|FG000|Overall Study|Withdrawal by Subject|5
2204220|NCT01602224|3841841|FG001|Overall Study|Withdrawal by Subject|3
2204221|NCT01602224|3841842|FG002|Overall Study|Withdrawal by Subject|3
2204222|NCT01602315|3841859|FG000|Overall Study|Protocol Violation|0
2204223|NCT01602315|3841860|FG001|Overall Study|Protocol Violation|0
2204224|NCT01602315|3841861|FG002|Overall Study|Protocol Violation|0
2204225|NCT01602315|3841862|FG003|Overall Study|Protocol Violation|0
2204226|NCT01602315|3841863|FG004|Overall Study|Protocol Violation|0
2204227|NCT01602315|3841864|FG005|Overall Study|Protocol Violation|1
2204228|NCT01602315|3841865|FG006|Overall Study|Protocol Violation|0
2204229|NCT01602315|3841859|FG000|Overall Study|Physician Decision|2
2204230|NCT01602315|3841860|FG001|Overall Study|Physician Decision|0
2204231|NCT01602315|3841861|FG002|Overall Study|Physician Decision|0
2204232|NCT01602315|3841862|FG003|Overall Study|Physician Decision|0
2204233|NCT01602315|3841863|FG004|Overall Study|Physician Decision|2
2204234|NCT01602315|3841864|FG005|Overall Study|Physician Decision|1
2204235|NCT01602315|3841865|FG006|Overall Study|Physician Decision|1
2204236|NCT01602315|3841859|FG000|Overall Study|Disease progression|6
2204237|NCT01602315|3841860|FG001|Overall Study|Disease progression|3
2204238|NCT01602315|3841861|FG002|Overall Study|Disease progression|10
2204239|NCT01602315|3841862|FG003|Overall Study|Disease progression|1
2204240|NCT01602315|3841863|FG004|Overall Study|Disease progression|41
2204241|NCT01602315|3841864|FG005|Overall Study|Disease progression|12
2204242|NCT01602315|3841865|FG006|Overall Study|Disease progression|15
2204243|NCT01602315|3841859|FG000|Overall Study|Death|1
2204244|NCT01602315|3841860|FG001|Overall Study|Death|1
2204245|NCT01602315|3841861|FG002|Overall Study|Death|1
2204246|NCT01602315|3841862|FG003|Overall Study|Death|1
2204247|NCT01602315|3841863|FG004|Overall Study|Death|7
2204248|NCT01602315|3841864|FG005|Overall Study|Death|2
2204249|NCT01602315|3841865|FG006|Overall Study|Death|2
2204250|NCT01602315|3841859|FG000|Overall Study|Withdrawal by Subject|2
2204251|NCT01602315|3841860|FG001|Overall Study|Withdrawal by Subject|0
2204252|NCT01602315|3841861|FG002|Overall Study|Withdrawal by Subject|2
2204253|NCT01602315|3841862|FG003|Overall Study|Withdrawal by Subject|0
2204254|NCT01602315|3841863|FG004|Overall Study|Withdrawal by Subject|6
2204255|NCT01602315|3841864|FG005|Overall Study|Withdrawal by Subject|0
2204256|NCT01602315|3841865|FG006|Overall Study|Withdrawal by Subject|1
2204257|NCT01602315|3841859|FG000|Overall Study|Adverse Event|5
2204258|NCT01602315|3841860|FG001|Overall Study|Adverse Event|1
2204259|NCT01602315|3841861|FG002|Overall Study|Adverse Event|5
2204260|NCT01602315|3841862|FG003|Overall Study|Adverse Event|4
2204261|NCT01602315|3841863|FG004|Overall Study|Adverse Event|15
2204262|NCT01602315|3841864|FG005|Overall Study|Adverse Event|3
2204263|NCT01602315|3841865|FG006|Overall Study|Adverse Event|9
2204264|NCT01602315|3841859|FG000|Overall Study|Subject/guardian decision|0
2204265|NCT01602315|3841860|FG001|Overall Study|Subject/guardian decision|0
2204266|NCT01602315|3841861|FG002|Overall Study|Subject/guardian decision|0
2204267|NCT01602315|3841862|FG003|Overall Study|Subject/guardian decision|0
2204268|NCT01602315|3841863|FG004|Overall Study|Subject/guardian decision|0
2204269|NCT01602315|3841864|FG005|Overall Study|Subject/guardian decision|0
2204270|NCT01602315|3841865|FG006|Overall Study|Subject/guardian decision|1
2204271|NCT01602315|3841859|FG000|Overall Study|Cross-over patients to combo treatment|0
2204272|NCT01602315|3841860|FG001|Overall Study|Cross-over patients to combo treatment|0
2204273|NCT01602315|3841861|FG002|Overall Study|Cross-over patients to combo treatment|0
2204274|NCT01602315|3841862|FG003|Overall Study|Cross-over patients to combo treatment|0
2204275|NCT01602315|3841863|FG004|Overall Study|Cross-over patients to combo treatment|0
2204276|NCT01602315|3841864|FG005|Overall Study|Cross-over patients to combo treatment|16
2204277|NCT01602315|3841865|FG006|Overall Study|Cross-over patients to combo treatment|0
2204278|NCT01602341|3841903|FG000|Overall Study|Adverse Event|0
2204279|NCT01602341|3841904|FG001|Overall Study|Adverse Event|1
2204280|NCT01602380|3841916|FG000|Overall Study|Death|63
2204281|NCT01602380|3841917|FG001|Overall Study|Death|68
2204282|NCT01602380|3841916|FG000|Overall Study|Withdrawal by Subject|22
2204283|NCT01602380|3841917|FG001|Overall Study|Withdrawal by Subject|29
2204284|NCT01602380|3841916|FG000|Overall Study|Lost to Follow-up|6
2204285|NCT01602380|3841917|FG001|Overall Study|Lost to Follow-up|1
2204286|NCT01602380|3841916|FG000|Overall Study|Eligibility criteria not fulfilled|2
2204287|NCT01602380|3841917|FG001|Overall Study|Eligibility criteria not fulfilled|3
2204288|NCT01602419|3841923|FG000|Overall Study|Not treated with Wilate|9
2204289|NCT01602419|3841923|FG000|Overall Study|Adverse Drug Reaction|4
2204290|NCT01602419|3841923|FG000|Overall Study|Insurance issues|3
2204291|NCT01602419|3841923|FG000|Overall Study|Changed treatment centre|1
2204292|NCT01602419|3841923|FG000|Overall Study|Treatment centre closed|1
2204293|NCT01602419|3841923|FG000|Overall Study|Withdrawal by Subject|5
2204294|NCT01602419|3841923|FG000|Overall Study|Lost to Follow-up|6
2204295|NCT01602484|3841970|FG000|Overall Study|Airway issues unrelated to study|0
2204296|NCT01602484|3841971|FG001|Overall Study|Airway issues unrelated to study|1
2204297|NCT01602510|3841977|FG000|Open Label Phase|Adverse Event|46
2204298|NCT01602510|3841978|FG001|Open Label Phase|Adverse Event|0
2204299|NCT01602510|3841979|FG002|Open Label Phase|Adverse Event|0
2204300|NCT01602510|3841977|FG000|Open Label Phase|Lack of Efficacy|22
2204301|NCT01602510|3841978|FG001|Open Label Phase|Lack of Efficacy|0
2204302|NCT01602510|3841979|FG002|Open Label Phase|Lack of Efficacy|0
2204303|NCT01602510|3841977|FG000|Open Label Phase|Protocol Violation|15
2204304|NCT01602510|3841978|FG001|Open Label Phase|Protocol Violation|0
2204305|NCT01602510|3841979|FG002|Open Label Phase|Protocol Violation|0
2204306|NCT01602510|3841977|FG000|Open Label Phase|Met protocol-defined stopping criteria|122
2204307|NCT01602510|3841978|FG001|Open Label Phase|Met protocol-defined stopping criteria|0
2204308|NCT01602510|3841979|FG002|Open Label Phase|Met protocol-defined stopping criteria|0
2204309|NCT01602510|3841977|FG000|Open Label Phase|Lost to Follow-up|22
2204310|NCT01602510|3841978|FG001|Open Label Phase|Lost to Follow-up|0
2204311|NCT01602510|3841979|FG002|Open Label Phase|Lost to Follow-up|0
2204312|NCT01602510|3841977|FG000|Open Label Phase|Physician Decision|19
2204313|NCT01602510|3841978|FG001|Open Label Phase|Physician Decision|0
2204314|NCT01602510|3841979|FG002|Open Label Phase|Physician Decision|0
2204315|NCT01602510|3841977|FG000|Open Label Phase|Withdrawal by Subject|57
2204316|NCT01602510|3841978|FG001|Open Label Phase|Withdrawal by Subject|0
2204317|NCT01602510|3841979|FG002|Open Label Phase|Withdrawal by Subject|0
2204318|NCT01602510|3841977|FG000|Randomized Phase|Adverse Event|0
2204319|NCT01602510|3841978|FG001|Randomized Phase|Adverse Event|2
2204320|NCT01602510|3841979|FG002|Randomized Phase|Adverse Event|6
2204321|NCT01602510|3841977|FG000|Randomized Phase|Lack of Efficacy|0
2204322|NCT01602510|3841978|FG001|Randomized Phase|Lack of Efficacy|4
2204323|NCT01602510|3841979|FG002|Randomized Phase|Lack of Efficacy|4
2204324|NCT01602510|3841977|FG000|Randomized Phase|Protocol Violation|0
2204325|NCT01602510|3841978|FG001|Randomized Phase|Protocol Violation|3
2204326|NCT01602510|3841979|FG002|Randomized Phase|Protocol Violation|3
2204327|NCT01602510|3841977|FG000|Randomized Phase|Met protocol-defined stopping criteria|0
2204328|NCT01602510|3841978|FG001|Randomized Phase|Met protocol-defined stopping criteria|58
2204329|NCT01602510|3841979|FG002|Randomized Phase|Met protocol-defined stopping criteria|48
2204330|NCT01602510|3841977|FG000|Randomized Phase|Lost to Follow-up|0
2204331|NCT01602510|3841978|FG001|Randomized Phase|Lost to Follow-up|1
2204332|NCT01602510|3841979|FG002|Randomized Phase|Lost to Follow-up|3
2204333|NCT01602510|3841977|FG000|Randomized Phase|Physician Decision|0
2204334|NCT01602510|3841978|FG001|Randomized Phase|Physician Decision|0
2204335|NCT01602510|3841979|FG002|Randomized Phase|Physician Decision|2
2204336|NCT01602510|3841977|FG000|Randomized Phase|Withdrawal by Subject|0
2204337|NCT01602510|3841978|FG001|Randomized Phase|Withdrawal by Subject|6
2204338|NCT01602510|3841979|FG002|Randomized Phase|Withdrawal by Subject|7
2204339|NCT01602549|3841987|FG000|Overall Study|Protocol Violation|0
2204340|NCT01602549|3841988|FG001|Overall Study|Protocol Violation|1
2204341|NCT01602549|3841987|FG000|Overall Study|Withdrawal by Subject|1
2204342|NCT01602549|3841988|FG001|Overall Study|Withdrawal by Subject|0
2204343|NCT01602562|3841998|FG000|Overall Study|Adverse Event|3
2204344|NCT01602562|3841999|FG001|Overall Study|Adverse Event|1
2204345|NCT01602562|3841998|FG000|Overall Study|Physician Decision|1
2204346|NCT01602562|3841999|FG001|Overall Study|Physician Decision|1
2204347|NCT01602562|3841998|FG000|Overall Study|Withdrawal by Subject|1
2204348|NCT01602562|3841999|FG001|Overall Study|Withdrawal by Subject|1
2204349|NCT01602744|3842057|FG000|Overall Study|Death|17
2204350|NCT01602744|3842058|FG001|Overall Study|Death|15
2204351|NCT01602744|3842057|FG000|Overall Study|Lost to Follow-up|13
2204352|NCT01602744|3842058|FG001|Overall Study|Lost to Follow-up|8
2204353|NCT01602965|3842066|FG000|Overall Study|Lost to Follow-up|4
2204354|NCT01602965|3842067|FG001|Overall Study|Lost to Follow-up|2
2204355|NCT01603082|3842084|FG000|Overall Study|Adverse Event|0
2204356|NCT01603082|3842085|FG001|Overall Study|Adverse Event|1
2204357|NCT01603082|3842084|FG000|Overall Study|Withdrawal by Subject|1
2204358|NCT01603082|3842085|FG001|Overall Study|Withdrawal by Subject|0
2204359|NCT01603082|3842084|FG000|Overall Study|Failed inclusion criterion after dosed|1
2204360|NCT01603082|3842085|FG001|Overall Study|Failed inclusion criterion after dosed|0
2204361|NCT01603277|3842093|FG000|Overall Study|Adverse Event|1
2204362|NCT01603277|3842094|FG001|Overall Study|Adverse Event|2
2204363|NCT01603277|3842093|FG000|Overall Study|Physician Decision|0
2204364|NCT01603277|3842094|FG001|Overall Study|Physician Decision|1
2204365|NCT01603277|3842093|FG000|Overall Study|Protocol Violation|6
2204366|NCT01603277|3842094|FG001|Overall Study|Protocol Violation|10
2204367|NCT01603277|3842093|FG000|Overall Study|Withdrawal by Subject|5
2204368|NCT01603277|3842094|FG001|Overall Study|Withdrawal by Subject|4
2204369|NCT01603277|3842093|FG000|Overall Study|Non-Compliance|2
2204370|NCT01603277|3842094|FG001|Overall Study|Non-Compliance|1
2204371|NCT01603355|3842100|FG000|Overall Study|Lack of Efficacy|2
2204372|NCT01603459|3842125|FG000|Overall Study|Adverse Event|5
2204373|NCT01603459|3842125|FG000|Overall Study|Withdrawal by Subject|5
2204374|NCT01603459|3842125|FG000|Overall Study|Lost to Follow-up|3
2204375|NCT01603459|3842125|FG000|Overall Study|Predefined discontinuation criteria|3
2204376|NCT01603459|3842125|FG000|Overall Study|Non-compliance|1
2204377|NCT01603459|3842125|FG000|Overall Study|Administrative reason|1
2204378|NCT01603602|3842150|FG000|Overall Study|Adverse Event|1
2204379|NCT01603602|3842151|FG001|Overall Study|Adverse Event|0
2204380|NCT01603602|3842152|FG002|Overall Study|Adverse Event|0
2204381|NCT01603602|3842150|FG000|Overall Study|Personal Reasons|1
2204382|NCT01603602|3842151|FG001|Overall Study|Personal Reasons|0
2204383|NCT01603602|3842152|FG002|Overall Study|Personal Reasons|1
2204384|NCT01603615|3842160|FG000|Overall Study|Did not Receive Treatment|7
2204385|NCT01603615|3842160|FG000|Overall Study|Lost to Follow-up|9
2204386|NCT01603615|3842160|FG000|Overall Study|Personal Reasons|17
2204387|NCT01603615|3842160|FG000|Overall Study|Other Miscellaneous|1
2204388|NCT01603628|3842167|FG000|Overall Study|Personal Reasons|1
2204389|NCT01603628|3842168|FG001|Overall Study|Personal Reasons|1
2204390|NCT01603628|3842169|FG002|Overall Study|Personal Reasons|2
2204391|NCT01603628|3842167|FG000|Overall Study|Protocol Violation|1
2204392|NCT01603628|3842168|FG001|Overall Study|Protocol Violation|1
2204393|NCT01603628|3842169|FG002|Overall Study|Protocol Violation|0
2204394|NCT01603628|3842167|FG000|Overall Study|Lost to Follow-up|0
2204395|NCT01603628|3842168|FG001|Overall Study|Lost to Follow-up|1
2204396|NCT01603628|3842169|FG002|Overall Study|Lost to Follow-up|0
2204397|NCT01603628|3842167|FG000|Overall Study|Other Miscellaneous Reason|1
2204398|NCT01603628|3842168|FG001|Overall Study|Other Miscellaneous Reason|0
2204399|NCT01603628|3842169|FG002|Overall Study|Other Miscellaneous Reason|0
2204400|NCT01603641|3842177|FG000|Overall Study|Did not Receive Treatment|3
2204401|NCT01603641|3842177|FG000|Overall Study|Adverse Event|1
2204402|NCT01603641|3842177|FG000|Overall Study|Lack of Efficacy|1
2204403|NCT01603641|3842177|FG000|Overall Study|Lost to Follow-up|6
2204404|NCT01603641|3842177|FG000|Overall Study|Personal Reasons|18
2204405|NCT01603641|3842177|FG000|Overall Study|Other Miscellaneous Reasons|6
2204406|NCT01603875|3842184|FG000|Overall Study|Preexisting rabies antibody|3
2204407|NCT01603875|3842185|FG001|Overall Study|Preexisting rabies antibody|4
2204408|NCT01603875|3842186|FG002|Overall Study|Preexisting rabies antibody|3
2118144|NCT00949910|3715885|FG000|Overall Study|Progressive Disease|3750
2118145|NCT00949910|3715885|FG000|Overall Study|Symptomatic Deterioration|1088
2118146|NCT00949910|3715885|FG000|Overall Study|Lost to Follow-up|100
2118147|NCT00949910|3715885|FG000|Overall Study|Study Drug-Related Adverse Event|315
2118148|NCT00949910|3715885|FG000|Overall Study|Participant Refusal|390
2277357|NCT02326298|3959833|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2277358|NCT02326298|3959834|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2277359|NCT02326298|3959835|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
2277360|NCT02326298|3959836|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2277361|NCT02326298|3959837|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2277362|NCT02326298|3959838|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2118149|NCT00949910|3715885|FG000|Overall Study|Death Due to Malignant Disease|456
2118150|NCT00949910|3715885|FG000|Overall Study|Death Due to Progression/Deterioration|4
2118151|NCT00949910|3715885|FG000|Overall Study|Death Due to Adverse Event|115
2118152|NCT00949910|3715885|FG000|Overall Study|Death Due to Toxicity|3
2118153|NCT00949910|3715885|FG000|Overall Study|Death from Unknown Cause|5
2118154|NCT00949910|3715885|FG000|Overall Study|Unspecified Progression/Deterioration|13
2118155|NCT00949910|3715885|FG000|Overall Study|Switched to Compassionate/Other Use|174
2118156|NCT00949910|3715885|FG000|Overall Study|Switched to Commercial Treatment|4
2118157|NCT00949910|3715885|FG000|Overall Study|Violation of Eligibility|23
2204409|NCT01603875|3842184|FG000|Overall Study|Lost to Follow-up|4
2204410|NCT01603875|3842185|FG001|Overall Study|Lost to Follow-up|3
2204411|NCT01603875|3842186|FG002|Overall Study|Lost to Follow-up|6
2204412|NCT01603875|3842184|FG000|Overall Study|Protocol Violation|0
2204413|NCT01603875|3842185|FG001|Overall Study|Protocol Violation|1
2204414|NCT01603875|3842186|FG002|Overall Study|Protocol Violation|0
2204415|NCT01604265|3842224|FG000|Overall Study|Adverse Event|1
2204416|NCT01604265|3842225|FG001|Overall Study|Adverse Event|0
2204417|NCT01604265|3842224|FG000|Overall Study|Withdrawal by Subject|1
2204418|NCT01604265|3842225|FG001|Overall Study|Withdrawal by Subject|0
2204419|NCT01604278|3842233|FG000|Overall Study|Lack of Efficacy|0
2204420|NCT01604278|3842234|FG001|Overall Study|Lack of Efficacy|1
2204421|NCT01604278|3842233|FG000|Overall Study|Lost to Follow-up|1
2204422|NCT01604278|3842234|FG001|Overall Study|Lost to Follow-up|0
2204423|NCT01604278|3842233|FG000|Overall Study|Administrative problems|2
2204424|NCT01604278|3842234|FG001|Overall Study|Administrative problems|1
2204425|NCT01604278|3842233|FG000|Overall Study|Withdrawal by Subject|3
2204426|NCT01604278|3842234|FG001|Overall Study|Withdrawal by Subject|3
2204427|NCT01604278|3842233|FG000|Overall Study|Adverse Event|3
2204428|NCT01604278|3842234|FG001|Overall Study|Adverse Event|5
2204429|NCT01604278|3842233|FG000|Overall Study|Protocol Deviation|5
2204430|NCT01604278|3842234|FG001|Overall Study|Protocol Deviation|3
2204431|NCT01604343|3842268|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
2204432|NCT01604343|3842269|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
2204433|NCT01604343|3842270|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
2204434|NCT01604343|3842271|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
2204435|NCT01604343|3842272|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
2204436|NCT01604343|3842268|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
2204437|NCT01604343|3842269|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
2204438|NCT01604343|3842270|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
2204439|NCT01604343|3842271|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
2204440|NCT01604343|3842272|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
2204441|NCT01604343|3842268|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25
2204442|NCT01604343|3842269|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0
2204443|NCT01604343|3842270|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41
2204444|NCT01604343|3842271|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0
2204445|NCT01604343|3842272|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42
2204446|NCT01604343|3842268|FG000|Prior to W52 Administration(Through W52)|Death|5
2204447|NCT01604343|3842269|FG001|Prior to W52 Administration(Through W52)|Death|0
2204448|NCT01604343|3842270|FG002|Prior to W52 Administration(Through W52)|Death|2
2204449|NCT01604343|3842271|FG003|Prior to W52 Administration(Through W52)|Death|0
2204450|NCT01604343|3842272|FG004|Prior to W52 Administration(Through W52)|Death|4
2204451|NCT01604343|3842268|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
2204452|NCT01604343|3842269|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
2204453|NCT01604343|3842270|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
2204454|NCT01604343|3842271|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
2204455|NCT01604343|3842272|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
2204456|NCT01604343|3842268|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4
2204457|NCT01604343|3842269|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0
2204458|NCT01604343|3842270|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1
2204459|NCT01604343|3842271|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0
2204460|NCT01604343|3842272|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2
2204461|NCT01604343|3842268|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1
2204462|NCT01604343|3842269|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0
2204463|NCT01604343|3842270|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1
2204464|NCT01604343|3842271|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0
2204465|NCT01604343|3842272|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0
2204466|NCT01604343|3842268|FG000|Prior to W52 Administration(Through W52)|Other|15
2204467|NCT01604343|3842269|FG001|Prior to W52 Administration(Through W52)|Other|0
2204468|NCT01604343|3842270|FG002|Prior to W52 Administration(Through W52)|Other|10
2204469|NCT01604343|3842271|FG003|Prior to W52 Administration(Through W52)|Other|0
2204470|NCT01604343|3842272|FG004|Prior to W52 Administration(Through W52)|Other|6
2204471|NCT01604343|3842268|FG000|Week 52 to Week 104|Lost to Follow-up|0
2204472|NCT01604343|3842269|FG001|Week 52 to Week 104|Lost to Follow-up|2
2204473|NCT01604343|3842270|FG002|Week 52 to Week 104|Lost to Follow-up|4
2204474|NCT01604343|3842271|FG003|Week 52 to Week 104|Lost to Follow-up|2
2204475|NCT01604343|3842272|FG004|Week 52 to Week 104|Lost to Follow-up|1
2204476|NCT01604343|3842268|FG000|Week 52 to Week 104|Withdrawal by Subject|0
2277363|NCT02326298|3959839|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2277364|NCT02326298|3959840|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2277365|NCT02326298|3959841|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2277366|NCT02326298|3959842|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2204477|NCT01604343|3842269|FG001|Week 52 to Week 104|Withdrawal by Subject|7
2204478|NCT01604343|3842270|FG002|Week 52 to Week 104|Withdrawal by Subject|12
2204479|NCT01604343|3842271|FG003|Week 52 to Week 104|Withdrawal by Subject|8
2204480|NCT01604343|3842272|FG004|Week 52 to Week 104|Withdrawal by Subject|4
2204481|NCT01604343|3842268|FG000|Week 52 to Week 104|Adverse Event|0
2204482|NCT01604343|3842269|FG001|Week 52 to Week 104|Adverse Event|12
2204483|NCT01604343|3842270|FG002|Week 52 to Week 104|Adverse Event|26
2204484|NCT01604343|3842271|FG003|Week 52 to Week 104|Adverse Event|21
2204485|NCT01604343|3842272|FG004|Week 52 to Week 104|Adverse Event|27
2204486|NCT01604343|3842268|FG000|Week 52 to Week 104|Death|0
2204487|NCT01604343|3842269|FG001|Week 52 to Week 104|Death|4
2204488|NCT01604343|3842270|FG002|Week 52 to Week 104|Death|2
2204489|NCT01604343|3842271|FG003|Week 52 to Week 104|Death|5
2204490|NCT01604343|3842272|FG004|Week 52 to Week 104|Death|0
2204491|NCT01604343|3842268|FG000|Week 52 to Week 104|Lack of Efficacy|0
2204492|NCT01604343|3842269|FG001|Week 52 to Week 104|Lack of Efficacy|6
2204493|NCT01604343|3842270|FG002|Week 52 to Week 104|Lack of Efficacy|11
2204494|NCT01604343|3842271|FG003|Week 52 to Week 104|Lack of Efficacy|2
2204495|NCT01604343|3842272|FG004|Week 52 to Week 104|Lack of Efficacy|3
2204496|NCT01604343|3842268|FG000|Week 52 to Week 104|Physician Decision|0
2204497|NCT01604343|3842269|FG001|Week 52 to Week 104|Physician Decision|1
2204498|NCT01604343|3842270|FG002|Week 52 to Week 104|Physician Decision|0
2204499|NCT01604343|3842271|FG003|Week 52 to Week 104|Physician Decision|0
2204500|NCT01604343|3842272|FG004|Week 52 to Week 104|Physician Decision|2
2204501|NCT01604343|3842268|FG000|Week 52 to Week 104|Pregnancy|0
2204502|NCT01604343|3842269|FG001|Week 52 to Week 104|Pregnancy|0
2204503|NCT01604343|3842270|FG002|Week 52 to Week 104|Pregnancy|1
2204504|NCT01604343|3842271|FG003|Week 52 to Week 104|Pregnancy|2
2204505|NCT01604343|3842272|FG004|Week 52 to Week 104|Pregnancy|1
2204506|NCT01604343|3842268|FG000|Week 52 to Week 104|Other|0
2204507|NCT01604343|3842269|FG001|Week 52 to Week 104|Other|11
2204508|NCT01604343|3842270|FG002|Week 52 to Week 104|Other|11
2204509|NCT01604343|3842271|FG003|Week 52 to Week 104|Other|6
2204510|NCT01604343|3842272|FG004|Week 52 to Week 104|Other|3
2204511|NCT01604343|3842268|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
2204512|NCT01604343|3842269|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
2204513|NCT01604343|3842270|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
2204514|NCT01604343|3842271|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
2204515|NCT01604343|3842272|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
2204516|NCT01604343|3842268|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
2204517|NCT01604343|3842269|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
2204518|NCT01604343|3842270|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
2204519|NCT01604343|3842271|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
2204520|NCT01604343|3842272|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
2204521|NCT01604343|3842268|FG000|Safety Follow-up Period (Week 104-120)|Other|15
2320621|NCT02951780|4034939|FG003|Period 2|Scheduling Conflicts|0
2204522|NCT01604343|3842269|FG001|Safety Follow-up Period (Week 104-120)|Other|2
2204523|NCT01604343|3842270|FG002|Safety Follow-up Period (Week 104-120)|Other|20
2204524|NCT01604343|3842271|FG003|Safety Follow-up Period (Week 104-120)|Other|6
2204525|NCT01604343|3842272|FG004|Safety Follow-up Period (Week 104-120)|Other|14
2204526|NCT01604408|3842284|FG000|Treatment Period 1|Protocol Violation|0
2204527|NCT01604408|3842285|FG001|Treatment Period 1|Protocol Violation|1
2204528|NCT01604408|3842284|FG000|Treatment Period 2|Withdrawal by Subject|1
2204529|NCT01604408|3842285|FG001|Treatment Period 2|Withdrawal by Subject|1
2204530|NCT01604408|3842284|FG000|Treatment Period 2|Protocol Violation|1
2204531|NCT01604408|3842285|FG001|Treatment Period 2|Protocol Violation|0
2204532|NCT01604408|3842284|FG000|Treatment Period 2|Adverse Event|0
2204533|NCT01604408|3842285|FG001|Treatment Period 2|Adverse Event|1
2204534|NCT01604408|3842284|FG000|Treatment Period 3|Protocol Violation|1
2204535|NCT01604408|3842285|FG001|Treatment Period 3|Protocol Violation|1
2204536|NCT01604408|3842284|FG000|Treatment Period 3|Adverse Event|0
2204537|NCT01604408|3842285|FG001|Treatment Period 3|Adverse Event|3
2204538|NCT01604408|3842284|FG000|Treatment Period 3|Withdrawal by Subject|3
2204539|NCT01604408|3842285|FG001|Treatment Period 3|Withdrawal by Subject|1
2204540|NCT01604408|3842284|FG000|Treatment Period 3|Sponsor Decision|1
2204541|NCT01604408|3842285|FG001|Treatment Period 3|Sponsor Decision|0
2204542|NCT01604408|3842284|FG000|Treatment Period 4|Death|1
2204543|NCT01604408|3842285|FG001|Treatment Period 4|Death|0
2204544|NCT01604408|3842284|FG000|Treatment Period 4|Withdrawal by Subject|2
2204545|NCT01604408|3842285|FG001|Treatment Period 4|Withdrawal by Subject|1
2204546|NCT01604408|3842284|FG000|Treatment Period 4|Adverse Event|0
2204547|NCT01604408|3842285|FG001|Treatment Period 4|Adverse Event|1
2204548|NCT01604408|3842284|FG000|Treatment Period 5|Adverse Event|4
2204549|NCT01604408|3842285|FG001|Treatment Period 5|Adverse Event|0
2204550|NCT01604408|3842284|FG000|Treatment Period 6|Lost to Follow-up|0
2204551|NCT01604408|3842285|FG001|Treatment Period 6|Lost to Follow-up|1
2204552|NCT01604408|3842284|FG000|Treatment Period 6|Adverse Event|2
2204553|NCT01604408|3842285|FG001|Treatment Period 6|Adverse Event|0
2204554|NCT01604408|3842284|FG000|Treatment Period 6|Sponsor decision|0
2204555|NCT01604408|3842285|FG001|Treatment Period 6|Sponsor decision|1
2204556|NCT01604408|3842284|FG000|Observation Period|Adverse Event|1
2204557|NCT01604408|3842285|FG001|Observation Period|Adverse Event|1
2204558|NCT01604408|3842284|FG000|Observation Period|Withdrawal by Subject|0
2204559|NCT01604408|3842285|FG001|Observation Period|Withdrawal by Subject|2
2204560|NCT01604785|3842298|FG000|Overall Study|Repeat Visits Not Included in Analysis|7
2204561|NCT01604785|3842299|FG001|Overall Study|Repeat Visits Not Included in Analysis|1
2204562|NCT01604824|3842309|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
2204563|NCT01604824|3842310|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
2204564|NCT01604824|3842311|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
2204565|NCT01604824|3842312|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
2204566|NCT01604824|3842313|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2
2204567|NCT01604824|3842314|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
2204568|NCT01604824|3842309|FG000|Open-label Extension (OLE) Period|Refused to come into office|0
2204569|NCT01604824|3842310|FG001|Open-label Extension (OLE) Period|Refused to come into office|0
2204570|NCT01604824|3842311|FG002|Open-label Extension (OLE) Period|Refused to come into office|0
2204571|NCT01604824|3842312|FG003|Open-label Extension (OLE) Period|Refused to come into office|0
2204572|NCT01604824|3842313|FG004|Open-label Extension (OLE) Period|Refused to come into office|1
2204573|NCT01604824|3842314|FG005|Open-label Extension (OLE) Period|Refused to come into office|0
2204574|NCT01604850|3842328|FG000|Overall Study|Enrolled but never treated|0
2204575|NCT01604850|3842329|FG001|Overall Study|Enrolled but never treated|1
2204576|NCT01604850|3842328|FG000|Overall Study|Efficacy Failure|50
2204577|NCT01604850|3842329|FG001|Overall Study|Efficacy Failure|29
2204578|NCT01604850|3842328|FG000|Overall Study|Lost to Follow-up|1
2204579|NCT01604850|3842329|FG001|Overall Study|Lost to Follow-up|0
2204580|NCT01604850|3842328|FG000|Overall Study|Subject withdrew consent|1
2204581|NCT01604850|3842329|FG001|Overall Study|Subject withdrew consent|0
2204582|NCT01604941|3842337|FG000|Overall Study|Adverse Event|1
2204583|NCT01604941|3842338|FG001|Overall Study|Adverse Event|2
2204584|NCT01604941|3842339|FG002|Overall Study|Adverse Event|0
2204585|NCT01604941|3842340|FG003|Overall Study|Adverse Event|0
2204586|NCT01604941|3842341|FG004|Overall Study|Adverse Event|1
2204587|NCT01604941|3842342|FG005|Overall Study|Adverse Event|5
2204588|NCT01604941|3842337|FG000|Overall Study|Non-compliance|1
2204589|NCT01604941|3842338|FG001|Overall Study|Non-compliance|0
2204590|NCT01604941|3842339|FG002|Overall Study|Non-compliance|0
2204591|NCT01604941|3842340|FG003|Overall Study|Non-compliance|0
2204592|NCT01604941|3842341|FG004|Overall Study|Non-compliance|0
2204593|NCT01604941|3842342|FG005|Overall Study|Non-compliance|0
2204594|NCT01604941|3842337|FG000|Overall Study|Participant Decision|0
2204595|NCT01604941|3842338|FG001|Overall Study|Participant Decision|0
2204596|NCT01604941|3842339|FG002|Overall Study|Participant Decision|0
2204597|NCT01604941|3842340|FG003|Overall Study|Participant Decision|0
2204598|NCT01604941|3842341|FG004|Overall Study|Participant Decision|0
2204599|NCT01604941|3842342|FG005|Overall Study|Participant Decision|2
2204600|NCT01604941|3842337|FG000|Overall Study|Early Study Termination|9
2204601|NCT01604941|3842338|FG001|Overall Study|Early Study Termination|2
2204602|NCT01604941|3842339|FG002|Overall Study|Early Study Termination|3
2204603|NCT01604941|3842340|FG003|Overall Study|Early Study Termination|3
2204604|NCT01604941|3842341|FG004|Overall Study|Early Study Termination|0
2204605|NCT01604941|3842342|FG005|Overall Study|Early Study Termination|0
2204606|NCT01605071|3842354|FG000|Overall Study|Withdrawal by Subject|3
2204607|NCT01605071|3842355|FG001|Overall Study|Withdrawal by Subject|2
2204608|NCT01605097|3842363|FG000|Overall Study|Protocol Violation|1
2204609|NCT01605136|3842370|FG000|Study Period|Withdrawal by Subject|2
2204610|NCT01605136|3842371|FG001|Study Period|Withdrawal by Subject|0
2204611|NCT01605136|3842370|FG000|Study Period|Physician Decision|1
2204612|NCT01605136|3842371|FG001|Study Period|Physician Decision|1
2204613|NCT01605136|3842370|FG000|Study Period|Lost to Follow-up|0
2204614|NCT01605136|3842371|FG001|Study Period|Lost to Follow-up|2
2204615|NCT01605136|3842370|FG000|Safety Follow-Up Period|Withdrawal by Subject|1
2204616|NCT01605136|3842371|FG001|Safety Follow-Up Period|Withdrawal by Subject|2
2204617|NCT01605227|3842379|FG000|Overall Study|Did not receive study treatment|2
2204618|NCT01605227|3842380|FG001|Overall Study|Did not receive study treatment|3
2204619|NCT01605227|3842379|FG000|Overall Study|Adverse Event|228
2204620|NCT01605227|3842380|FG001|Overall Study|Adverse Event|42
2204621|NCT01605227|3842379|FG000|Overall Study|Progressive Disease|132
2204622|NCT01605227|3842380|FG001|Overall Study|Progressive Disease|128
2204623|NCT01605227|3842379|FG000|Overall Study|Clinical Deterioration|227
2204624|NCT01605227|3842380|FG001|Overall Study|Clinical Deterioration|133
2204625|NCT01605227|3842379|FG000|Overall Study|Lost to Follow-up|1
2204626|NCT01605227|3842380|FG001|Overall Study|Lost to Follow-up|0
2204627|NCT01605227|3842379|FG000|Overall Study|Protocol Violation|1
2204628|NCT01605227|3842380|FG001|Overall Study|Protocol Violation|0
2204629|NCT01605227|3842379|FG000|Overall Study|Physician Decision|9
2204630|NCT01605227|3842380|FG001|Overall Study|Physician Decision|7
2204631|NCT01605227|3842379|FG000|Overall Study|Withdrawal by Subject|18
2204632|NCT01605227|3842380|FG001|Overall Study|Withdrawal by Subject|14
2204633|NCT01605227|3842379|FG000|Overall Study|Sponsor Decision|2
2204634|NCT01605227|3842380|FG001|Overall Study|Sponsor Decision|0
2204635|NCT01605227|3842379|FG000|Overall Study|Started New Therapy|1
2204636|NCT01605227|3842380|FG001|Overall Study|Started New Therapy|0
2204637|NCT01605227|3842379|FG000|Overall Study|Subject Decision|0
2204638|NCT01605227|3842380|FG001|Overall Study|Subject Decision|1
2204639|NCT01605227|3842379|FG000|Overall Study|Dose Held >6 weeks|0
2204640|NCT01605227|3842380|FG001|Overall Study|Dose Held >6 weeks|1
2204641|NCT01605396|3842397|FG000|Overall Study|Adverse Event|5
2204642|NCT01605396|3842398|FG001|Overall Study|Adverse Event|3
2204643|NCT01605396|3842397|FG000|Overall Study|Lost to Follow-up|1
2204644|NCT01605396|3842398|FG001|Overall Study|Lost to Follow-up|0
2204645|NCT01605396|3842397|FG000|Overall Study|Non-Compliance With Study Drug|1
2204646|NCT01605396|3842398|FG001|Overall Study|Non-Compliance With Study Drug|1
2204647|NCT01605396|3842397|FG000|Overall Study|Physician Decision|2
2204648|NCT01605396|3842398|FG001|Overall Study|Physician Decision|2
2204649|NCT01605396|3842397|FG000|Overall Study|Progressive Disease|23
2204650|NCT01605396|3842398|FG001|Overall Study|Progressive Disease|27
2204651|NCT01605396|3842397|FG000|Overall Study|Withdrawal by Subject|4
2204652|NCT01605396|3842398|FG001|Overall Study|Withdrawal by Subject|2
2204653|NCT01605396|3842397|FG000|Overall Study|Transfer Off Study|4
2204654|NCT01605396|3842398|FG001|Overall Study|Transfer Off Study|5
2204655|NCT01605461|3842422|FG000|Overall Study|Lost to Follow-up|3
2204656|NCT01605461|3842422|FG000|Overall Study|Withdrawal by Subject|1
2204657|NCT01605799|3842455|FG000|Overall Study|Withdrawal by Subject|2
2204658|NCT01605799|3842456|FG001|Overall Study|Withdrawal by Subject|1
2204659|NCT01605825|3842464|FG000|Overall Study|Adverse Event|4
2204660|NCT01605825|3842465|FG001|Overall Study|Adverse Event|2
2204661|NCT01605825|3842464|FG000|Overall Study|Withdrawal by Subject|0
2204662|NCT01605825|3842465|FG001|Overall Study|Withdrawal by Subject|1
2204663|NCT01605825|3842464|FG000|Overall Study|Non-Compliance -Investigational Drug|3
2204664|NCT01605825|3842465|FG001|Overall Study|Non-Compliance -Investigational Drug|0
2204665|NCT01605825|3842464|FG000|Overall Study|Non-Compliance with Protocol|3
2204666|NCT01605825|3842465|FG001|Overall Study|Non-Compliance with Protocol|0
2204667|NCT01605877|3842471|FG000|Overall Study|Withdrawal by Subject|1
2204668|NCT01605916|3842511|FG000|Overall Study|Adverse Event|1
2204669|NCT01605916|3842512|FG001|Overall Study|Adverse Event|0
2204670|NCT01605916|3842513|FG002|Overall Study|Adverse Event|0
2204671|NCT01605916|3842514|FG003|Overall Study|Adverse Event|1
2204672|NCT01605916|3842515|FG004|Overall Study|Adverse Event|0
2204673|NCT01605916|3842511|FG000|Overall Study|Lack of Efficacy|2
2204674|NCT01605916|3842512|FG001|Overall Study|Lack of Efficacy|3
2204675|NCT01605916|3842513|FG002|Overall Study|Lack of Efficacy|3
2204676|NCT01605916|3842514|FG003|Overall Study|Lack of Efficacy|5
2204677|NCT01605916|3842515|FG004|Overall Study|Lack of Efficacy|4
2204678|NCT01605916|3842511|FG000|Overall Study|Withdrawal by Subject|1
2204679|NCT01605916|3842512|FG001|Overall Study|Withdrawal by Subject|1
2204680|NCT01605916|3842513|FG002|Overall Study|Withdrawal by Subject|0
2204681|NCT01605916|3842514|FG003|Overall Study|Withdrawal by Subject|0
2204682|NCT01605916|3842515|FG004|Overall Study|Withdrawal by Subject|2
2204683|NCT01606007|3842540|FG000|Overall Study|Reason 'Other' in the protocol|0
2204684|NCT01606007|3842541|FG001|Overall Study|Reason 'Other' in the protocol|1
2217410|NCT01708161|3860635|FG003|Overall Study|Disease progression|13
2204685|NCT01606007|3842542|FG002|Overall Study|Reason 'Other' in the protocol|1
2204686|NCT01606007|3842540|FG000|Overall Study|Pregnancy|0
2204687|NCT01606007|3842541|FG001|Overall Study|Pregnancy|1
2204688|NCT01606007|3842542|FG002|Overall Study|Pregnancy|1
2204689|NCT01606007|3842540|FG000|Overall Study|Withdrawal by Subject|8
2204690|NCT01606007|3842541|FG001|Overall Study|Withdrawal by Subject|6
2204691|NCT01606007|3842542|FG002|Overall Study|Withdrawal by Subject|1
2204692|NCT01606007|3842540|FG000|Overall Study|Adverse Event|0
2204693|NCT01606007|3842541|FG001|Overall Study|Adverse Event|1
2204694|NCT01606007|3842542|FG002|Overall Study|Adverse Event|1
2204695|NCT01606007|3842540|FG000|Overall Study|discontinue study treatment|0
2204696|NCT01606007|3842541|FG001|Overall Study|discontinue study treatment|2
2204697|NCT01606007|3842542|FG002|Overall Study|discontinue study treatment|1
2204698|NCT01606007|3842540|FG000|Overall Study|Lost to Follow-up|6
2204699|NCT01606007|3842541|FG001|Overall Study|Lost to Follow-up|8
2204700|NCT01606007|3842542|FG002|Overall Study|Lost to Follow-up|5
2353321|NCT02696226|4105072|FG000|Overall Study|Study terminated - lack of enrollment|1
2353322|NCT02696226|4105073|FG001|Overall Study|Study terminated - lack of enrollment|0
2353323|NCT02696226|4105074|FG002|Overall Study|Study terminated - lack of enrollment|2
2353324|NCT02696226|4105075|FG003|Overall Study|Study terminated - lack of enrollment|0
2353325|NCT02693743|4105087|FG000|Overall Study|Physician Decision|1
2353326|NCT02693743|4105088|FG001|Overall Study|Physician Decision|0
2353327|NCT02706691|4105094|FG000|Overall Study|Adverse Event|1
2353328|NCT02694757|4105112|FG000|Overall Study|Lack of Efficacy|3
2353329|NCT02693002|4105118|FG000|Overall Study|Withdrawal by Subject|1
2353330|NCT02693002|4105119|FG001|Overall Study|Withdrawal by Subject|0
2353331|NCT02689518|4105125|FG000|Overall Study|Withdrawal by Subject|3
2353332|NCT02673684|4105156|FG000|Overall Study|Study not completed d/t loss of funding|9
2353333|NCT02673684|4105157|FG001|Overall Study|Study not completed d/t loss of funding|8
2353334|NCT02674204|4105167|FG000|Overall Study|Adverse Event|1
2353335|NCT02674204|4105168|FG001|Overall Study|Adverse Event|0
2353336|NCT02671461|4105190|FG000|Treatment|Adverse Event|0
2353337|NCT02671461|4105191|FG001|Treatment|Adverse Event|0
2353338|NCT02671461|4105192|FG002|Treatment|Adverse Event|1
2353339|NCT02671461|4105190|FG000|Treatment|Administrative Reason by Sponsor|1
2353340|NCT02671461|4105191|FG001|Treatment|Administrative Reason by Sponsor|3
2353341|NCT02671461|4105192|FG002|Treatment|Administrative Reason by Sponsor|4
2353342|NCT02671461|4105190|FG000|Treatment|Randomized, not treated|1
2353343|NCT02671461|4105191|FG001|Treatment|Randomized, not treated|0
2353344|NCT02671461|4105192|FG002|Treatment|Randomized, not treated|0
2353345|NCT02671461|4105190|FG000|Follow-up|Withdrawal by Subject|1
2204701|NCT01606007|3842540|FG000|Overall Study|Poor/Non-compliance|1
2204702|NCT01606007|3842541|FG001|Overall Study|Poor/Non-compliance|0
2204703|NCT01606007|3842542|FG002|Overall Study|Poor/Non-compliance|0
2204704|NCT01606137|3842559|FG000|Overall Study|Adverse Event|85
2204705|NCT01606137|3842559|FG000|Overall Study|Withdrawal by Subject|74
2204706|NCT01606137|3842559|FG000|Overall Study|Lack of Efficacy|56
2353346|NCT02671461|4105191|FG001|Follow-up|Withdrawal by Subject|0
2353347|NCT02671461|4105192|FG002|Follow-up|Withdrawal by Subject|0
2353348|NCT02671461|4105190|FG000|Follow-up|Lost to Follow-up|0
2353349|NCT02671461|4105191|FG001|Follow-up|Lost to Follow-up|0
2353350|NCT02671461|4105192|FG002|Follow-up|Lost to Follow-up|1
2353351|NCT02671461|4105190|FG000|Follow-up|Administrative Reason by Sponsor|0
2353352|NCT02671461|4105191|FG001|Follow-up|Administrative Reason by Sponsor|1
2353353|NCT02671461|4105192|FG002|Follow-up|Administrative Reason by Sponsor|0
2353354|NCT02653495|4105263|FG000|Overall Study|Lost to Follow-up|2
2353355|NCT02653495|4105264|FG001|Overall Study|Lost to Follow-up|0
2353356|NCT02653495|4105263|FG000|Overall Study|Screening Failure|10
2353357|NCT02653495|4105264|FG001|Overall Study|Screening Failure|0
2018984|NCT00296504|3586495|FG004|Interim Analysis|Death|0
2018985|NCT00296504|3586496|FG005|Interim Analysis|Death|0
2018986|NCT00296504|3586497|FG006|Interim Analysis|Death|0
2018987|NCT00296504|3586498|FG007|Interim Analysis|Death|0
2018988|NCT00296504|3586499|FG008|Interim Analysis|Death|0
2018989|NCT00296504|3586491|FG000|Interim Analysis|Participant Non-compliant|0
2018990|NCT00296504|3586492|FG001|Interim Analysis|Participant Non-compliant|1
2018991|NCT00296504|3586493|FG002|Interim Analysis|Participant Non-compliant|2
2018992|NCT00296504|3586494|FG003|Interim Analysis|Participant Non-compliant|1
2018993|NCT00296504|3586495|FG004|Interim Analysis|Participant Non-compliant|1
2018994|NCT00296504|3586496|FG005|Interim Analysis|Participant Non-compliant|3
2039067|NCT00424632|3609379|FG005|Overall Study|Global deterioration of health status|0
2018995|NCT00296504|3586497|FG006|Interim Analysis|Participant Non-compliant|6
2018996|NCT00296504|3586498|FG007|Interim Analysis|Participant Non-compliant|2
2018997|NCT00296504|3586499|FG008|Interim Analysis|Participant Non-compliant|0
2018998|NCT00296504|3586491|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0
2018999|NCT00296504|3586492|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0
2019000|NCT00296504|3586493|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2
2019001|NCT00296504|3586494|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0
2019002|NCT00296504|3586495|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0
2019003|NCT00296504|3586496|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1
2026047|NCT00348283|3594715|FG001|Double Blind|Lack of Efficacy|2
2204707|NCT01606137|3842559|FG000|Overall Study|Lost to Follow-up|15
2353358|NCT02639390|4105276|FG000|Overall Study|Subject unable to comply with treatment schedule.|0
2353359|NCT02639390|4105277|FG001|Overall Study|Subject unable to comply with treatment schedule.|2
2353360|NCT02634606|4105283|FG000|Overall Study|unable to obtain the drug at start|13
2353361|NCT02636283|4105297|FG000|Overall Study|Adverse Event|2
2353362|NCT02636283|4105298|FG001|Overall Study|Adverse Event|0
2353363|NCT02636283|4105297|FG000|Overall Study|Trial Terminated Prematurely|0
2353364|NCT02636283|4105298|FG001|Overall Study|Trial Terminated Prematurely|3
2353365|NCT02638129|4105306|FG000|Overall Study|Study terminated|28
2353366|NCT02638129|4105307|FG001|Overall Study|Study terminated|30
2353367|NCT02615990|4105315|FG000|Overall Study|study terminated|1
2353368|NCT02615990|4105316|FG001|Overall Study|study terminated|1
2353369|NCT02640677|4105322|FG000|Overall Study|Lost to Follow-up|1
2118158|NCT00949910|3715885|FG000|Overall Study|Logistical Reasons|13
2118159|NCT00949910|3715885|FG000|Overall Study|Non-Compliance|10
2118160|NCT00949910|3715885|FG000|Overall Study|Prolonged Dosing Interruption|4
2118161|NCT00949910|3715885|FG000|Overall Study|Adverse Event|83
2118162|NCT00949910|3715885|FG000|Overall Study|Serious Adverse Event|6
2118163|NCT00949910|3715885|FG000|Overall Study|Physician/Participant Decision|7
2118164|NCT00949910|3715885|FG000|Overall Study|Other|4
2118165|NCT00949910|3715885|FG000|Overall Study|No Data|9
2118166|NCT00949975|3715893|FG000|Overall Study|Voluntary discontinuation|6
2118167|NCT00949975|3715894|FG001|Overall Study|Voluntary discontinuation|5
2118168|NCT00949975|3715895|FG002|Overall Study|Voluntary discontinuation|3
2118169|NCT00949975|3715896|FG003|Overall Study|Voluntary discontinuation|6
2118170|NCT00949975|3715893|FG000|Overall Study|Adverse Event|11
2118171|NCT00949975|3715894|FG001|Overall Study|Adverse Event|11
2118172|NCT00949975|3715895|FG002|Overall Study|Adverse Event|10
2118173|NCT00949975|3715896|FG003|Overall Study|Adverse Event|10
2118174|NCT00949975|3715893|FG000|Overall Study|Safety reason|0
2118175|NCT00949975|3715894|FG001|Overall Study|Safety reason|1
2118176|NCT00949975|3715895|FG002|Overall Study|Safety reason|0
2118177|NCT00949975|3715896|FG003|Overall Study|Safety reason|0
2118178|NCT00949975|3715893|FG000|Overall Study|Study-specific criteria|0
2118179|NCT00949975|3715894|FG001|Overall Study|Study-specific criteria|1
2118180|NCT00949975|3715895|FG002|Overall Study|Study-specific criteria|1
2118181|NCT00949975|3715896|FG003|Overall Study|Study-specific criteria|0
2118182|NCT00949975|3715893|FG000|Overall Study|Incorrect enrolment|5
2118183|NCT00949975|3715894|FG001|Overall Study|Incorrect enrolment|10
2118184|NCT00949975|3715895|FG002|Overall Study|Incorrect enrolment|4
2118185|NCT00949975|3715896|FG003|Overall Study|Incorrect enrolment|7
2118186|NCT00949975|3715893|FG000|Overall Study|Severe non-compliance|3
2118187|NCT00949975|3715894|FG001|Overall Study|Severe non-compliance|1
2118188|NCT00949975|3715895|FG002|Overall Study|Severe non-compliance|0
2118189|NCT00949975|3715896|FG003|Overall Study|Severe non-compliance|2
2118190|NCT00949975|3715893|FG000|Overall Study|Lost to Follow-up|1
2039068|NCT00424632|3609380|FG006|Overall Study|Global deterioration of health status|0
2039069|NCT00424632|3609381|FG007|Overall Study|Global deterioration of health status|0
2039070|NCT00424632|3609382|FG008|Overall Study|Global deterioration of health status|0
2039071|NCT00424632|3609383|FG009|Overall Study|Global deterioration of health status|0
2039072|NCT00424632|3609374|FG000|Overall Study|Objective progression or relapse|1
2039073|NCT00424632|3609375|FG001|Overall Study|Objective progression or relapse|1
2039074|NCT00424632|3609376|FG002|Overall Study|Objective progression or relapse|1
2039075|NCT00424632|3609377|FG003|Overall Study|Objective progression or relapse|2
2039076|NCT00424632|3609378|FG004|Overall Study|Objective progression or relapse|2
2039077|NCT00424632|3609379|FG005|Overall Study|Objective progression or relapse|13
2039078|NCT00424632|3609380|FG006|Overall Study|Objective progression or relapse|7
2039079|NCT00424632|3609381|FG007|Overall Study|Objective progression or relapse|3
2039080|NCT00424632|3609382|FG008|Overall Study|Objective progression or relapse|12
2039081|NCT00424632|3609383|FG009|Overall Study|Objective progression or relapse|4
2039082|NCT00424632|3609374|FG000|Overall Study|Other|0
2039083|NCT00424632|3609375|FG001|Overall Study|Other|0
2039084|NCT00424632|3609376|FG002|Overall Study|Other|0
2039085|NCT00424632|3609377|FG003|Overall Study|Other|1
2039086|NCT00424632|3609378|FG004|Overall Study|Other|0
2039087|NCT00424632|3609379|FG005|Overall Study|Other|0
2039088|NCT00424632|3609380|FG006|Overall Study|Other|0
2039089|NCT00424632|3609381|FG007|Overall Study|Other|0
2039090|NCT00424632|3609382|FG008|Overall Study|Other|1
2039091|NCT00424632|3609383|FG009|Overall Study|Other|0
2118191|NCT00949975|3715894|FG001|Overall Study|Lost to Follow-up|0
2118192|NCT00949975|3715895|FG002|Overall Study|Lost to Follow-up|1
2118193|NCT00949975|3715896|FG003|Overall Study|Lost to Follow-up|3
2118194|NCT00949975|3715893|FG000|Overall Study|Other|1
2118195|NCT00949975|3715894|FG001|Overall Study|Other|0
2118196|NCT00949975|3715895|FG002|Overall Study|Other|0
2277367|NCT02326298|3959843|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2353370|NCT02640677|4105322|FG000|Overall Study|Withdrawal by Subject|1
2039092|NCT00424749|3609414|FG000|Overall Study|Withdrawal by Subject|1
2039093|NCT00424762|3609420|FG000|Overall Study|Withdrawal by Subject|18
2039094|NCT00424762|3609421|FG001|Overall Study|Withdrawal by Subject|19
2039095|NCT00424762|3609420|FG000|Overall Study|Lost to Follow-up|2
2039096|NCT00424762|3609421|FG001|Overall Study|Lost to Follow-up|3
2039097|NCT00424775|3609427|FG000|Overall Study|Adverse Event|2
2277368|NCT02326298|3959844|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2277369|NCT02326298|3959845|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2353371|NCT02623959|4105332|FG000|Overall Study|Progression|0
2353372|NCT02623959|4105333|FG001|Overall Study|Progression|1
2353373|NCT02631148|4105343|FG000|Overall Study|8 were ineligible|8
2353374|NCT02631148|4105344|FG001|Overall Study|8 were ineligible|0
2353375|NCT02631148|4105343|FG000|Overall Study|Withdrawal by Subject|1
2353376|NCT02631148|4105344|FG001|Overall Study|Withdrawal by Subject|0
2353377|NCT02631148|4105343|FG000|Overall Study|PAH not available to study participant|1
2353378|NCT02631148|4105344|FG001|Overall Study|PAH not available to study participant|0
2353379|NCT02630472|4105352|FG000|Overall Study|Physician Decision|10
2353380|NCT02630472|4105353|FG001|Overall Study|Physician Decision|0
2353381|NCT02626520|4105362|FG000|Overall Study|Physician Decision|1
2353382|NCT02626520|4105363|FG001|Overall Study|Physician Decision|1
2353383|NCT02626520|4105362|FG000|Overall Study|Adverse Event|0
2353384|NCT02626520|4105363|FG001|Overall Study|Adverse Event|4
2353385|NCT02626520|4105362|FG000|Overall Study|Lack of Efficacy|0
2353386|NCT02626520|4105363|FG001|Overall Study|Lack of Efficacy|2
2353387|NCT02626520|4105362|FG000|Overall Study|Did not start protocol therapy|0
2353388|NCT02626520|4105363|FG001|Overall Study|Did not start protocol therapy|2
2353389|NCT02626520|4105362|FG000|Overall Study|Study terminated|0
2353390|NCT02626520|4105363|FG001|Overall Study|Study terminated|1
2353391|NCT02614898|4105371|FG000|Overall Study|Participated until study termination|10
2204708|NCT01606137|3842559|FG000|Overall Study|Protocol Violation|1
2204709|NCT01606137|3842559|FG000|Overall Study|Patient non-compliance|9
2204710|NCT01606137|3842559|FG000|Overall Study|Death|1
2204711|NCT01606137|3842559|FG000|Overall Study|Decreased/no pain|4
2204712|NCT01606137|3842559|FG000|Overall Study|Issues with driving|4
2204713|NCT01606137|3842559|FG000|Overall Study|multiple sclerosis less stable|1
2204714|NCT01606137|3842559|FG000|Overall Study|Increased bilirubin|1
2204715|NCT01606137|3842559|FG000|Overall Study|Spray causes nausea|1
2204716|NCT01606137|3842559|FG000|Overall Study|Not enough improvement|4
2204717|NCT01606137|3842559|FG000|Overall Study|Wanted to try another treatment|1
2204718|NCT01606137|3842559|FG000|Overall Study|Patient leaving country|1
2204719|NCT01606137|3842559|FG000|Overall Study|Personal reasons|1
2204720|NCT01606137|3842559|FG000|Overall Study|Unable to tolerate study med. taste|1
2204721|NCT01606137|3842559|FG000|Overall Study|Patient moving|1
2204722|NCT01606137|3842559|FG000|Overall Study|Unable to collect consistent data|1
2204723|NCT01606176|3842565|FG000|Overall Study|Adverse Event|2
2204724|NCT01606176|3842566|FG001|Overall Study|Adverse Event|3
2204725|NCT01606176|3842565|FG000|Overall Study|Disease progression|1
2204726|NCT01606176|3842566|FG001|Overall Study|Disease progression|0
2204727|NCT01606176|3842565|FG000|Overall Study|Withdrawal by Subject|1
2204728|NCT01606176|3842566|FG001|Overall Study|Withdrawal by Subject|0
2204729|NCT01606189|3842572|FG000|Second Intenvention (14-20 Days)|Adverse Event|0
2204730|NCT01606189|3842573|FG001|Second Intenvention (14-20 Days)|Adverse Event|0
2204731|NCT01606189|3842574|FG002|Second Intenvention (14-20 Days)|Adverse Event|0
2204732|NCT01606189|3842575|FG003|Second Intenvention (14-20 Days)|Adverse Event|0
2204733|NCT01606189|3842576|FG004|Second Intenvention (14-20 Days)|Adverse Event|0
2204734|NCT01606189|3842577|FG005|Second Intenvention (14-20 Days)|Adverse Event|1
2204735|NCT01606189|3842572|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2353392|NCT02614898|4105372|FG001|Overall Study|Participated until study termination|26
2353393|NCT02614898|4105371|FG000|Overall Study|Lost to Follow-up|0
2353394|NCT02614898|4105372|FG001|Overall Study|Lost to Follow-up|2
2353395|NCT02614898|4105371|FG000|Overall Study|Physician Decision|1
2353396|NCT02614898|4105372|FG001|Overall Study|Physician Decision|8
2353397|NCT02614898|4105371|FG000|Overall Study|Study Terminated by Sponsor|3
2353398|NCT02614898|4105372|FG001|Overall Study|Study Terminated by Sponsor|0
2353399|NCT02614898|4105371|FG000|Overall Study|Withdrawal by Subject|0
2039098|NCT00424775|3609428|FG001|Overall Study|Adverse Event|0
2039099|NCT00424775|3609427|FG000|Overall Study|Lack of Efficacy|1
2039100|NCT00424775|3609428|FG001|Overall Study|Lack of Efficacy|0
2039101|NCT00424827|3609432|FG000|Overall Study|Adverse Event|1
2039102|NCT00425061|3609452|FG000|Overall Study|Adverse Event|1
2039103|NCT00425061|3609453|FG001|Overall Study|Adverse Event|0
2039104|NCT00425061|3609454|FG002|Overall Study|Adverse Event|0
2039105|NCT00425061|3609455|FG003|Overall Study|Adverse Event|2
2039106|NCT00425061|3609456|FG004|Overall Study|Adverse Event|2
2039107|NCT00425061|3609457|FG005|Overall Study|Adverse Event|0
2204736|NCT01606189|3842573|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2204737|NCT01606189|3842574|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2204738|NCT01606189|3842575|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2353400|NCT02614898|4105372|FG001|Overall Study|Withdrawal by Subject|2
2353401|NCT02614898|4105371|FG000|Overall Study|Withdrawal by Parent/Guardian|1
2353402|NCT02614898|4105372|FG001|Overall Study|Withdrawal by Parent/Guardian|1
2353403|NCT02614898|4105371|FG000|Overall Study|Other-Additional Information Unavailable|0
2353404|NCT02614898|4105372|FG001|Overall Study|Other-Additional Information Unavailable|11
2039108|NCT00425061|3609458|FG006|Overall Study|Adverse Event|0
2039109|NCT00425061|3609452|FG000|Overall Study|Lost to Follow-up|0
2039110|NCT00425061|3609453|FG001|Overall Study|Lost to Follow-up|1
2039111|NCT00425061|3609454|FG002|Overall Study|Lost to Follow-up|0
2353405|NCT02614898|4105371|FG000|Overall Study|Missing|0
2353406|NCT02614898|4105372|FG001|Overall Study|Missing|1
2353407|NCT02622828|4105379|FG000|Overall Study|participant withdrew|3
2353408|NCT02619812|4105405|FG000|Overall Study|Withdrawal by Subject|0
2353409|NCT02619812|4105406|FG001|Overall Study|Withdrawal by Subject|0
2353410|NCT02619812|4105407|FG002|Overall Study|Withdrawal by Subject|1
2353411|NCT02619812|4105408|FG003|Overall Study|Withdrawal by Subject|2
2353412|NCT02612285|4105418|FG000|Overall Study|Withdrawal by Subject|1
2353413|NCT02606279|4105428|FG000|Overall Study|Lost to Follow-up|0
2353414|NCT02606279|4105429|FG001|Overall Study|Lost to Follow-up|1
2353415|NCT02605824|4105437|FG000|Overall Study|Physician Decision|1
2353416|NCT02605824|4105438|FG001|Overall Study|Physician Decision|0
2353417|NCT02598622|4105446|FG000|Overall Study|Withdrawal by Subject|3
2353418|NCT02598622|4105447|FG001|Overall Study|Withdrawal by Subject|0
2353419|NCT02598622|4105446|FG000|Overall Study|Physician Decision|3
2353420|NCT02598622|4105447|FG001|Overall Study|Physician Decision|0
2353421|NCT02582749|4105468|FG000|Overall Study|Study terminated by funder|5
2353422|NCT02582749|4105469|FG001|Overall Study|Study terminated by funder|10
2353423|NCT02582749|4105468|FG000|Overall Study|Withdrawal by Subject|0
2039112|NCT00425061|3609455|FG003|Overall Study|Lost to Follow-up|0
2039113|NCT00425061|3609456|FG004|Overall Study|Lost to Follow-up|0
2039114|NCT00425061|3609457|FG005|Overall Study|Lost to Follow-up|0
2039115|NCT00425061|3609458|FG006|Overall Study|Lost to Follow-up|0
2039116|NCT00425061|3609452|FG000|Overall Study|Protocol Violation|1
2039117|NCT00425061|3609453|FG001|Overall Study|Protocol Violation|0
2039118|NCT00425061|3609454|FG002|Overall Study|Protocol Violation|0
2039119|NCT00425061|3609455|FG003|Overall Study|Protocol Violation|0
2039120|NCT00425061|3609456|FG004|Overall Study|Protocol Violation|0
2039121|NCT00425061|3609457|FG005|Overall Study|Protocol Violation|0
2039122|NCT00425061|3609458|FG006|Overall Study|Protocol Violation|0
2039123|NCT00425061|3609452|FG000|Overall Study|Withdrawal by Subject|0
2039124|NCT00425061|3609453|FG001|Overall Study|Withdrawal by Subject|1
2039125|NCT00425061|3609454|FG002|Overall Study|Withdrawal by Subject|0
2039126|NCT00425061|3609455|FG003|Overall Study|Withdrawal by Subject|0
2039127|NCT00425061|3609456|FG004|Overall Study|Withdrawal by Subject|1
2039128|NCT00425061|3609457|FG005|Overall Study|Withdrawal by Subject|0
2039129|NCT00425061|3609458|FG006|Overall Study|Withdrawal by Subject|3
2039130|NCT00425061|3609452|FG000|Overall Study|Sponsor's request|0
2039131|NCT00425061|3609453|FG001|Overall Study|Sponsor's request|0
2039132|NCT00425061|3609454|FG002|Overall Study|Sponsor's request|0
2039133|NCT00425061|3609455|FG003|Overall Study|Sponsor's request|0
2039134|NCT00425061|3609456|FG004|Overall Study|Sponsor's request|19
2039135|NCT00425061|3609457|FG005|Overall Study|Sponsor's request|4
2039136|NCT00425061|3609458|FG006|Overall Study|Sponsor's request|15
2039137|NCT00425061|3609452|FG000|Overall Study|Physician Decision|0
2039138|NCT00425061|3609453|FG001|Overall Study|Physician Decision|0
2039139|NCT00425061|3609454|FG002|Overall Study|Physician Decision|0
2039140|NCT00425061|3609455|FG003|Overall Study|Physician Decision|0
2039141|NCT00425061|3609456|FG004|Overall Study|Physician Decision|1
2039142|NCT00425061|3609457|FG005|Overall Study|Physician Decision|0
2039143|NCT00425061|3609458|FG006|Overall Study|Physician Decision|0
2039144|NCT00425061|3609452|FG000|Overall Study|Other|0
2039145|NCT00425061|3609453|FG001|Overall Study|Other|0
2039146|NCT00425061|3609454|FG002|Overall Study|Other|0
2039147|NCT00425061|3609455|FG003|Overall Study|Other|0
2039148|NCT00425061|3609456|FG004|Overall Study|Other|3
2039149|NCT00425061|3609457|FG005|Overall Study|Other|0
2039150|NCT00425061|3609458|FG006|Overall Study|Other|1
2039151|NCT00425113|3609478|FG000|Overall Study|uncontrolled diabetes mellitus|1
2039152|NCT00425113|3609479|FG001|Overall Study|uncontrolled diabetes mellitus|0
2039153|NCT00425113|3609478|FG000|Overall Study|diagnosis of abdominal TB|0
2039154|NCT00425113|3609479|FG001|Overall Study|diagnosis of abdominal TB|1
2039155|NCT00425113|3609478|FG000|Overall Study|missing study drug more than 14 days|0
2039156|NCT00425113|3609479|FG001|Overall Study|missing study drug more than 14 days|1
2039157|NCT00425113|3609478|FG000|Overall Study|Withdrawal by Subject|1
2039158|NCT00425113|3609479|FG001|Overall Study|Withdrawal by Subject|0
2039159|NCT00425269|3609488|FG000|Overall Study|Pregnancy|5
2039160|NCT00425269|3609489|FG001|Overall Study|Pregnancy|7
2039161|NCT00425269|3609488|FG000|Overall Study|Lost to Follow-up|9
2039162|NCT00425269|3609489|FG001|Overall Study|Lost to Follow-up|9
2039163|NCT00425269|3609488|FG000|Overall Study|moved or medical reason|5
2039164|NCT00425269|3609489|FG001|Overall Study|moved or medical reason|4
2039165|NCT00425308|3609497|FG000|Overall Study|Adverse Event|2
2039166|NCT00425308|3609498|FG001|Overall Study|Adverse Event|1
2039167|NCT00425308|3609497|FG000|Overall Study|Withdrawal by Subject|1
2039168|NCT00425308|3609498|FG001|Overall Study|Withdrawal by Subject|0
2039169|NCT00425308|3609497|FG000|Overall Study|Death|1
2039170|NCT00425308|3609498|FG001|Overall Study|Death|0
2039171|NCT00425373|3609513|FG000|Overall Study|Adverse Event|2
2039172|NCT00425373|3609514|FG001|Overall Study|Adverse Event|2
2039173|NCT00425373|3609515|FG002|Overall Study|Adverse Event|0
2353424|NCT02582749|4105469|FG001|Overall Study|Withdrawal by Subject|1
2039174|NCT00425373|3609516|FG003|Overall Study|Adverse Event|1
2039175|NCT00425373|3609517|FG004|Overall Study|Adverse Event|4
2039176|NCT00425373|3609518|FG005|Overall Study|Adverse Event|6
2039177|NCT00425373|3609519|FG006|Overall Study|Adverse Event|2
2353425|NCT02569957|4105502|FG000|Overall Study|Withdrawal by Subject|0
2353426|NCT02569957|4105503|FG001|Overall Study|Withdrawal by Subject|1
2353427|NCT02575365|4105522|FG000|Overall Study|Lost to Follow-up|4
2353428|NCT02547129|4105532|FG000|Overall Study|Difficulty with ongoing infection|1
2353429|NCT02547129|4105533|FG001|Overall Study|Difficulty with ongoing infection|0
2039178|NCT00425373|3609520|FG007|Overall Study|Adverse Event|3
2039179|NCT00425373|3609521|FG008|Overall Study|Adverse Event|8
2039180|NCT00425373|3609513|FG000|Overall Study|Lost to Follow-up|0
2039181|NCT00425373|3609514|FG001|Overall Study|Lost to Follow-up|1
2039182|NCT00425373|3609515|FG002|Overall Study|Lost to Follow-up|0
2039183|NCT00425373|3609516|FG003|Overall Study|Lost to Follow-up|0
2039184|NCT00425373|3609517|FG004|Overall Study|Lost to Follow-up|1
2039185|NCT00425373|3609518|FG005|Overall Study|Lost to Follow-up|0
2039186|NCT00425373|3609519|FG006|Overall Study|Lost to Follow-up|0
2039187|NCT00425373|3609520|FG007|Overall Study|Lost to Follow-up|0
2039188|NCT00425373|3609521|FG008|Overall Study|Lost to Follow-up|0
2039189|NCT00425373|3609513|FG000|Overall Study|Protocol Violation|1
2039190|NCT00425373|3609514|FG001|Overall Study|Protocol Violation|0
2039191|NCT00425373|3609515|FG002|Overall Study|Protocol Violation|1
2039192|NCT00425373|3609516|FG003|Overall Study|Protocol Violation|0
2039193|NCT00425373|3609517|FG004|Overall Study|Protocol Violation|0
2039194|NCT00425373|3609518|FG005|Overall Study|Protocol Violation|0
2039195|NCT00425373|3609519|FG006|Overall Study|Protocol Violation|0
2039196|NCT00425373|3609520|FG007|Overall Study|Protocol Violation|5
2039197|NCT00425373|3609521|FG008|Overall Study|Protocol Violation|3
2039198|NCT00425373|3609513|FG000|Overall Study|Withdrawal by Subject|2
2039199|NCT00425373|3609514|FG001|Overall Study|Withdrawal by Subject|0
2039200|NCT00425373|3609515|FG002|Overall Study|Withdrawal by Subject|2
2039201|NCT00425373|3609516|FG003|Overall Study|Withdrawal by Subject|1
2039202|NCT00425373|3609517|FG004|Overall Study|Withdrawal by Subject|4
2039203|NCT00425373|3609518|FG005|Overall Study|Withdrawal by Subject|0
2039204|NCT00425373|3609519|FG006|Overall Study|Withdrawal by Subject|2
2039205|NCT00425373|3609520|FG007|Overall Study|Withdrawal by Subject|2
2039206|NCT00425373|3609521|FG008|Overall Study|Withdrawal by Subject|2
2039207|NCT00425373|3609513|FG000|Overall Study|Lack of Efficacy|0
2039208|NCT00425373|3609514|FG001|Overall Study|Lack of Efficacy|0
2039209|NCT00425373|3609515|FG002|Overall Study|Lack of Efficacy|0
2039210|NCT00425373|3609516|FG003|Overall Study|Lack of Efficacy|0
2039211|NCT00425373|3609517|FG004|Overall Study|Lack of Efficacy|1
2039212|NCT00425373|3609518|FG005|Overall Study|Lack of Efficacy|3
2039213|NCT00425373|3609519|FG006|Overall Study|Lack of Efficacy|3
2039214|NCT00425373|3609520|FG007|Overall Study|Lack of Efficacy|0
2039215|NCT00425373|3609521|FG008|Overall Study|Lack of Efficacy|5
2039216|NCT00425503|3609549|FG000|Overall Study|Adverse Event|2
2039217|NCT00425503|3609549|FG000|Overall Study|Protocol Violation|1
2039218|NCT00425555|3609555|FG000|Overall Study|Withdrawal by Subject|11
2353430|NCT02533531|4105572|FG000|Overall Study|Device did not turn on|1
2353431|NCT02520726|4105588|FG000|Overall Study|Lost to Follow-up|3
2353432|NCT02520726|4105589|FG001|Overall Study|Lost to Follow-up|2
2353433|NCT02519712|4105599|FG000|Overall Study|Disease Relapse|1
2353434|NCT02519712|4105599|FG000|Overall Study|Disease Progression|1
2353435|NCT02519712|4105599|FG000|Overall Study|Accruals are donors|2
2353436|NCT02516228|4105607|FG000|Overall Study|Lost to Follow-up|1
2353437|NCT02516228|4105607|FG000|Overall Study|Withdrawal by Subject|1
2353438|NCT02516228|4105607|FG000|Overall Study|Physician Decision|1
2353439|NCT02506101|4105647|FG000|Overall Study|Transportation issues|1
2353440|NCT02506101|4105648|FG001|Overall Study|Transportation issues|0
2353441|NCT02506101|4105647|FG000|Overall Study|No enrollment and staff unavailability|1
2353442|NCT02506101|4105648|FG001|Overall Study|No enrollment and staff unavailability|0
2353443|NCT02500901|4105667|FG000|Overall Study|Disease ProgressionDD|2
2353444|NCT02483533|4105673|FG000|Overall Study|Lack of Efficacy|50
2353445|NCT02483533|4105674|FG001|Overall Study|Lack of Efficacy|50
2353446|NCT02496039|4105680|FG000|Overall Study|Adverse Event|3
2353447|NCT02496039|4105680|FG000|Overall Study|Protocol Violation|1
2353448|NCT02494206|4105689|FG000|Overall Study|Adverse Event|1
2353449|NCT02494206|4105689|FG000|Overall Study|Disease Progression|1
2353450|NCT02473445|4105693|FG000|Overall Study|Withdrawal by Subject|2
2353451|NCT02473445|4105693|FG000|Overall Study|Sponsor Decision|20
2353452|NCT02491411|4105697|FG000|Overall Study|Physician Decision|4
2353453|NCT02476994|4105703|FG000|Overall Study|Based on feedback from FDA|1
2353454|NCT02476994|4105704|FG001|Overall Study|Based on feedback from FDA|0
2353455|NCT02473523|4105710|FG000|Overall Study|Death|1
2353456|NCT02473523|4105710|FG000|Overall Study|Lost to Follow-up|1
2353457|NCT02472639|4105729|FG000|Overall Study|Physician Decision|4
2353458|NCT02472639|4105730|FG001|Overall Study|Physician Decision|3
2353459|NCT02469415|4105736|FG000|Overall Study|Withdrawal by Subject|1
2353460|NCT02469415|4105736|FG000|Overall Study|Investigational agent placed on hold|2
2353461|NCT02452359|4105748|FG000|Overall Study|Adverse Event|1
2353462|NCT02452359|4105748|FG000|Overall Study|Lost to Follow-up|15
2353463|NCT02452359|4105748|FG000|Overall Study|Pregnancy|1
2353464|NCT02452359|4105748|FG000|Overall Study|Withdrawal by Subject|4
2353465|NCT02452398|4105756|FG000|Overall Study|Adverse Event|1
2353466|NCT02452398|4105756|FG000|Overall Study|Lost to Follow-up|28
2353467|NCT02452398|4105756|FG000|Overall Study|Physician Decision|2
2353468|NCT02452398|4105756|FG000|Overall Study|Withdrawal by Subject|6
2353469|NCT02452398|4105756|FG000|Overall Study|Moved away|4
2353470|NCT02447887|4105760|FG000|Overall Study|Study was terminated|3
2353471|NCT02439970|4105781|FG000|Overall Study|Study Terminated|2
2353472|NCT02439970|4105782|FG001|Overall Study|Study Terminated|3
2353473|NCT02439957|4105790|FG000|Overall Study|Study Terminated|3
2353474|NCT02439957|4105791|FG001|Overall Study|Study Terminated|3
2353475|NCT02441036|4105802|FG000|Overall Study|No tissue resected|0
2353476|NCT02441036|4105803|FG001|Overall Study|No tissue resected|1
2353477|NCT02441036|4105804|FG002|Overall Study|No tissue resected|0
2353478|NCT02441036|4105805|FG003|Overall Study|No tissue resected|1
2353479|NCT02441036|4105806|FG004|Overall Study|No tissue resected|0
2353480|NCT02430532|4105843|FG000|Overall Study|Sponsor Decision to Stop Study Early|30
2353481|NCT02430532|4105844|FG001|Overall Study|Sponsor Decision to Stop Study Early|25
2353482|NCT02430532|4105843|FG000|Overall Study|Consent Withdrawn|0
2353483|NCT02430532|4105844|FG001|Overall Study|Consent Withdrawn|2
2353484|NCT02430532|4105843|FG000|Overall Study|Adverse Event|0
2353485|NCT02430532|4105844|FG001|Overall Study|Adverse Event|1
2353486|NCT02428231|4105854|FG000|Overall Study|Other|10
2353487|NCT02428231|4105855|FG001|Overall Study|Other|16
2353488|NCT02428231|4105854|FG000|Overall Study|Required Symptomatic Therapy|0
2353489|NCT02428231|4105855|FG001|Overall Study|Required Symptomatic Therapy|1
2353490|NCT02428231|4105854|FG000|Overall Study|Adverse Event|3
2353491|NCT02428231|4105855|FG001|Overall Study|Adverse Event|0
2353492|NCT02424565|4105861|FG000|Period 1 (D0)|Protocol Violation|0
2353493|NCT02424565|4105862|FG001|Period 1 (D0)|Protocol Violation|1
2353494|NCT02422303|4105883|FG000|Overall Study|Lost to Follow-up|1
2353495|NCT02422303|4105884|FG001|Overall Study|Lost to Follow-up|1
2353496|NCT02414152|4105907|FG000|Overall Study|Withdrawal by Subject|1
2353497|NCT02414152|4105907|FG000|Overall Study|Lack of Efficacy|1
2353498|NCT02410551|4105911|FG000|Overall Study|Adverse Event|1
2353499|NCT02410551|4105911|FG000|Overall Study|Withdrawal by Subject|1
2353500|NCT02410551|4105911|FG000|Overall Study|FDA Clinical hold-patients taken off|2
2353501|NCT02410954|4105922|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6
2039219|NCT00425555|3609556|FG001|Overall Study|Withdrawal by Subject|8
2039220|NCT00425555|3609555|FG000|Overall Study|Lost to Follow-up|0
2039221|NCT00425555|3609556|FG001|Overall Study|Lost to Follow-up|1
2039222|NCT00425555|3609555|FG000|Overall Study|Administrative problems|3
2039223|NCT00425555|3609556|FG001|Overall Study|Administrative problems|0
2039224|NCT00425555|3609555|FG000|Overall Study|Death|1
2039225|NCT00425555|3609556|FG001|Overall Study|Death|2
2039226|NCT00425555|3609555|FG000|Overall Study|New cancer therapy|2
2039227|NCT00425555|3609556|FG001|Overall Study|New cancer therapy|1
2039228|NCT00425555|3609555|FG000|Overall Study|Disease progression|36
2039229|NCT00425555|3609556|FG001|Overall Study|Disease progression|33
2039230|NCT00425555|3609555|FG000|Overall Study|Adverse Event|25
2039231|NCT00425555|3609556|FG001|Overall Study|Adverse Event|15
2353502|NCT02410954|4105923|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0
2353503|NCT02410954|4105922|FG000|Overall Study|Instrument malfunction generated unusable data|8
2353504|NCT02410954|4105923|FG001|Overall Study|Instrument malfunction generated unusable data|0
2353505|NCT02409355|4105935|FG000|Overall Study|Withdrawal by Subject|1
2353506|NCT02409355|4105936|FG001|Overall Study|Withdrawal by Subject|0
2353507|NCT02409355|4105935|FG000|Overall Study|Death|1
2353508|NCT02409355|4105936|FG001|Overall Study|Death|1
2353509|NCT02409355|4105935|FG000|Overall Study|Study terminated by Sponsor|2
2353510|NCT02409355|4105936|FG001|Overall Study|Study terminated by Sponsor|3
2353511|NCT02404545|4105961|FG000|Overall Study|Sponsor Termination|6
2353512|NCT02404545|4105962|FG001|Overall Study|Sponsor Termination|6
2353513|NCT02392377|4105971|FG000|Overall Study|Withdrawal by Subject|0
2353514|NCT02392377|4105972|FG001|Overall Study|Withdrawal by Subject|1
2353515|NCT02394665|4106006|FG000|Overall Study|Physician Decision|1
2353516|NCT02394665|4106007|FG001|Overall Study|Physician Decision|0
2353517|NCT02394665|4106008|FG002|Overall Study|Physician Decision|0
2353518|NCT02390362|4106027|FG000|Overall Study|Withdrawal by Subject|0
2353519|NCT02390362|4106028|FG001|Overall Study|Withdrawal by Subject|1
2353520|NCT02388776|4106034|FG000|Overall Study|Death|1
2353521|NCT02388776|4106034|FG000|Overall Study|Lost to Follow-up|1
2353522|NCT02383433|4106039|FG000|Overall Study|Disease progression|2
2353523|NCT02379390|4106067|FG000|Overall Study|Adverse Event|1
2353524|NCT02379390|4106068|FG001|Overall Study|Adverse Event|1
2353525|NCT02379390|4106067|FG000|Overall Study|Investigator's decision|1
2353526|NCT02379390|4106068|FG001|Overall Study|Investigator's decision|0
2353527|NCT02379390|4106067|FG000|Overall Study|Study Termination|0
2353528|NCT02379390|4106068|FG001|Overall Study|Study Termination|1
2353529|NCT02361580|4106092|FG000|Overall Study|Lost to Follow-up|6
2353530|NCT02361580|4106093|FG001|Overall Study|Lost to Follow-up|3
2353531|NCT02370888|4106124|FG000|Overall Study|disease progression|2
2353532|NCT02370888|4106124|FG000|Overall Study|did not meet chimerism criteria|6
2353533|NCT02365233|4106148|FG000|Overall Study|IRB withheld the data|1
2353534|NCT02365233|4106149|FG001|Overall Study|IRB withheld the data|2
2353535|NCT02365233|4106150|FG002|Overall Study|IRB withheld the data|2
2353536|NCT02347943|4106161|FG000|Overall Study|Study was cancelled|140
2353537|NCT02347943|4106162|FG001|Overall Study|Study was cancelled|67
2353538|NCT02347943|4106163|FG002|Overall Study|Study was cancelled|45
2353539|NCT02365207|4106171|FG000|Overall Study|Withdrawal by Subject|1
2353540|NCT02365207|4106171|FG000|Overall Study|Physician Decision|1
2353541|NCT02360111|4106175|FG000|Overall Study|Death|2
2353542|NCT02353468|4106179|FG000|Overall Study|Study terminated|3
2353543|NCT02346877|4106207|FG000|Overall Study|Adverse Event|1
2353544|NCT02346877|4106208|FG001|Overall Study|Adverse Event|0
2353545|NCT02346877|4106207|FG000|Overall Study|Administrative Decision|1
2353546|NCT02346877|4106208|FG001|Overall Study|Administrative Decision|0
2353547|NCT02346877|4106207|FG000|Overall Study|Sponsor Decision|12
2353548|NCT02346877|4106208|FG001|Overall Study|Sponsor Decision|0
2353549|NCT02346877|4106207|FG000|Overall Study|Missing|5
2353550|NCT02346877|4106208|FG001|Overall Study|Missing|0
2353551|NCT02353572|4106231|FG000|Overall Study|Withdrawal by Subject|1
2353552|NCT02353572|4106231|FG000|Overall Study|Study terminated|2
2353553|NCT02343263|4106247|FG000|Overall Study|Physician Decision|5
2353554|NCT02343263|4106248|FG001|Overall Study|Physician Decision|3
2353555|NCT02343263|4106249|FG002|Overall Study|Physician Decision|1
2353556|NCT02343159|4106264|FG000|Overall Study|Early Study Termination|16
2019004|NCT00296504|3586497|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0
2019005|NCT00296504|3586498|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0
2019006|NCT00296504|3586499|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0
2019007|NCT00296504|3586491|FG000|Interim Analysis|To Simplify Treatment|0
2019008|NCT00296504|3586492|FG001|Interim Analysis|To Simplify Treatment|0
2019009|NCT00296504|3586493|FG002|Interim Analysis|To Simplify Treatment|1
2019010|NCT00296504|3586494|FG003|Interim Analysis|To Simplify Treatment|0
2019011|NCT00296504|3586495|FG004|Interim Analysis|To Simplify Treatment|0
2019012|NCT00296504|3586496|FG005|Interim Analysis|To Simplify Treatment|0
2019013|NCT00296504|3586497|FG006|Interim Analysis|To Simplify Treatment|2
2019014|NCT00296504|3586498|FG007|Interim Analysis|To Simplify Treatment|0
2019015|NCT00296504|3586499|FG008|Interim Analysis|To Simplify Treatment|0
2019016|NCT00296504|3586491|FG000|Interim Analysis|Participant Had Problems with Alcohol|0
2019017|NCT00296504|3586492|FG001|Interim Analysis|Participant Had Problems with Alcohol|0
2039232|NCT00425555|3609555|FG000|Overall Study|Protocol Violation|1
2039233|NCT00425555|3609556|FG001|Overall Study|Protocol Violation|0
2039234|NCT00425607|3609565|FG000|Overall Study|Death|1
2039235|NCT00425607|3609565|FG000|Overall Study|Withdrawal by Subject|1
2039236|NCT00425698|3609575|FG000|Overall Study|Adverse Event|3
2039237|NCT00425698|3609576|FG001|Overall Study|Adverse Event|1
2039238|NCT00425698|3609575|FG000|Overall Study|Withdrawal by Subject|0
2039239|NCT00425698|3609576|FG001|Overall Study|Withdrawal by Subject|1
2039240|NCT00425750|3609582|FG000|Overall Study|Death|1
2039241|NCT00425750|3609582|FG000|Overall Study|Withdrawal by Subject|3
2039242|NCT00425750|3609582|FG000|Overall Study|Adverse Event|3
2039243|NCT00425750|3609582|FG000|Overall Study|Progression of disease|18
2118197|NCT00949975|3715896|FG003|Overall Study|Other|0
2353557|NCT02343159|4106265|FG001|Overall Study|Early Study Termination|19
2118198|NCT00950170|3715906|FG000|Overall Study|Parent/Legal Guardian Request|1
2118199|NCT00950170|3715906|FG000|Overall Study|Adverse Event|2
2118200|NCT00950170|3715906|FG000|Overall Study|Discontinuation of Study by Sponsor|1
2118201|NCT00950248|3715939|FG000|Year 1: Baseline|Withdrawal by Subject|6
2118202|NCT00950248|3715940|FG001|Year 1: Baseline|Withdrawal by Subject|0
2118203|NCT00950248|3715941|FG002|Year 1: Baseline|Withdrawal by Subject|0
2353558|NCT02343159|4106266|FG002|Overall Study|Early Study Termination|23
2353559|NCT02343159|4106264|FG000|Overall Study|Physician Decision|2
2353560|NCT02343159|4106265|FG001|Overall Study|Physician Decision|0
2353561|NCT02343159|4106266|FG002|Overall Study|Physician Decision|1
2353562|NCT02343159|4106264|FG000|Overall Study|Withdrawal by Subject|3
2353563|NCT02343159|4106265|FG001|Overall Study|Withdrawal by Subject|0
2353564|NCT02343159|4106266|FG002|Overall Study|Withdrawal by Subject|2
2353565|NCT02343159|4106264|FG000|Overall Study|Lost to Follow-up|0
2039244|NCT00425854|3609592|FG000|Overall Study|Progressive Disease|19
2039245|NCT00425854|3609593|FG001|Overall Study|Progressive Disease|12
2039246|NCT00425854|3609592|FG000|Overall Study|Dose reduction toxicity AE|8
2039247|NCT00425854|3609593|FG001|Overall Study|Dose reduction toxicity AE|7
2039248|NCT00425854|3609592|FG000|Overall Study|Other Adverse Event|2
2039249|NCT00425854|3609593|FG001|Overall Study|Other Adverse Event|2
2039250|NCT00425945|3609602|FG000|Overall Study|Concern about Supplement|2
2039251|NCT00425945|3609603|FG001|Overall Study|Concern about Supplement|0
2039252|NCT00425945|3609602|FG000|Overall Study|Inconvenience|0
2039253|NCT00425945|3609603|FG001|Overall Study|Inconvenience|2
2039254|NCT00425945|3609602|FG000|Overall Study|Lost to Follow-up|0
2039255|NCT00425945|3609603|FG001|Overall Study|Lost to Follow-up|2
2039256|NCT00425945|3609602|FG000|Overall Study|Began hypertension medication|1
2039257|NCT00425945|3609603|FG001|Overall Study|Began hypertension medication|0
2039258|NCT00425945|3609602|FG000|Overall Study|Began cancer treatments|1
2039259|NCT00425945|3609603|FG001|Overall Study|Began cancer treatments|0
2039260|NCT00425945|3609602|FG000|Overall Study|Moved from area|0
2039261|NCT00425945|3609603|FG001|Overall Study|Moved from area|1
2039262|NCT00426127|3609611|FG000|Overall Study|Adverse Event|1
2039263|NCT00426127|3609611|FG000|Overall Study|Removed due to disease progression|1
2039264|NCT00426231|3609626|FG000|Overall Study|Withdrawal by Subject|9
2039265|NCT00426231|3609627|FG001|Overall Study|Withdrawal by Subject|12
2039266|NCT00426270|3609633|FG000|Overall Study|Incorrectly Enrolled in the Study|1
2039267|NCT00426270|3609633|FG000|Overall Study|Adverse Event|5
2039268|NCT00426361|3609653|FG000|Overall Study|Lost to Follow-up|3
2039269|NCT00426361|3609654|FG001|Overall Study|Lost to Follow-up|2
2039270|NCT00426361|3609655|FG002|Overall Study|Lost to Follow-up|5
2039271|NCT00426361|3609653|FG000|Overall Study|Withdrawal by Subject|1
2039272|NCT00426361|3609654|FG001|Overall Study|Withdrawal by Subject|3
2039273|NCT00426361|3609655|FG002|Overall Study|Withdrawal by Subject|0
2039274|NCT00426556|3609684|FG000|Phase I - Core Phase|Disease Progression|0
2039275|NCT00426556|3609685|FG001|Phase I - Core Phase|Disease Progression|6
2039276|NCT00426556|3609686|FG002|Phase I - Core Phase|Disease Progression|2
2039277|NCT00426556|3609687|FG003|Phase I - Core Phase|Disease Progression|0
2039278|NCT00426556|3609684|FG000|Phase I - Core Phase|Adverse Event|1
2039279|NCT00426556|3609685|FG001|Phase I - Core Phase|Adverse Event|3
2039280|NCT00426556|3609686|FG002|Phase I - Core Phase|Adverse Event|1
2039281|NCT00426556|3609687|FG003|Phase I - Core Phase|Adverse Event|0
2039282|NCT00426556|3609684|FG000|Phase I - Core Phase|Death|0
2039283|NCT00426556|3609685|FG001|Phase I - Core Phase|Death|1
2039284|NCT00426556|3609686|FG002|Phase I - Core Phase|Death|0
2039285|NCT00426556|3609687|FG003|Phase I - Core Phase|Death|0
2039286|NCT00426556|3609684|FG000|Phase I - Extension Phase|Adverse Event|0
2039287|NCT00426556|3609685|FG001|Phase I - Extension Phase|Adverse Event|1
2039288|NCT00426556|3609686|FG002|Phase I - Extension Phase|Adverse Event|1
2039289|NCT00426556|3609687|FG003|Phase I - Extension Phase|Adverse Event|0
2039290|NCT00426556|3609684|FG000|Phase I - Extension Phase|Disease Progression|5
2039291|NCT00426556|3609685|FG001|Phase I - Extension Phase|Disease Progression|5
2039292|NCT00426556|3609686|FG002|Phase I - Extension Phase|Disease Progression|6
2039293|NCT00426556|3609687|FG003|Phase I - Extension Phase|Disease Progression|0
2039294|NCT00426556|3609684|FG000|Phase II - Core Phase|Withdrawal by Subject|0
2039295|NCT00426556|3609685|FG001|Phase II - Core Phase|Withdrawal by Subject|0
2039296|NCT00426556|3609686|FG002|Phase II - Core Phase|Withdrawal by Subject|0
2039297|NCT00426556|3609687|FG003|Phase II - Core Phase|Withdrawal by Subject|3
2039298|NCT00426556|3609684|FG000|Phase II - Core Phase|Disease Progression|0
2039299|NCT00426556|3609685|FG001|Phase II - Core Phase|Disease Progression|0
2039300|NCT00426556|3609686|FG002|Phase II - Core Phase|Disease Progression|0
2039301|NCT00426556|3609687|FG003|Phase II - Core Phase|Disease Progression|16
2039302|NCT00426556|3609684|FG000|Phase II - Core Phase|Adverse Event|0
2039303|NCT00426556|3609685|FG001|Phase II - Core Phase|Adverse Event|0
2039304|NCT00426556|3609686|FG002|Phase II - Core Phase|Adverse Event|0
2039305|NCT00426556|3609687|FG003|Phase II - Core Phase|Adverse Event|8
2039306|NCT00426556|3609684|FG000|Phase II - Extension Phase|Disease Progression|0
2039307|NCT00426556|3609685|FG001|Phase II - Extension Phase|Disease Progression|0
2039308|NCT00426556|3609686|FG002|Phase II - Extension Phase|Disease Progression|0
2039309|NCT00426556|3609687|FG003|Phase II - Extension Phase|Disease Progression|21
2039310|NCT00426556|3609684|FG000|Phase II - Extension Phase|Adverse Event|0
2353566|NCT02343159|4106265|FG001|Overall Study|Lost to Follow-up|2
2353567|NCT02343159|4106266|FG002|Overall Study|Lost to Follow-up|2
2353568|NCT02343159|4106264|FG000|Overall Study|Adverse Event|4
2353569|NCT02343159|4106265|FG001|Overall Study|Adverse Event|4
2353570|NCT02343159|4106266|FG002|Overall Study|Adverse Event|2
2353571|NCT02343159|4106264|FG000|Overall Study|Sponsor Decision|0
2353572|NCT02343159|4106265|FG001|Overall Study|Sponsor Decision|1
2353573|NCT02343159|4106266|FG002|Overall Study|Sponsor Decision|0
2353574|NCT02343159|4106264|FG000|Overall Study|Enrollment Error|1
2353575|NCT02343159|4106265|FG001|Overall Study|Enrollment Error|0
2353576|NCT02343159|4106266|FG002|Overall Study|Enrollment Error|0
2353577|NCT02336425|4106283|FG000|Overall Study|Study terminated.|2
2353578|NCT02336425|4106284|FG001|Overall Study|Study terminated.|2
2039311|NCT00426556|3609685|FG001|Phase II - Extension Phase|Adverse Event|0
2039312|NCT00426556|3609686|FG002|Phase II - Extension Phase|Adverse Event|0
2039313|NCT00426556|3609687|FG003|Phase II - Extension Phase|Adverse Event|2
2039314|NCT00426660|3609697|FG000|Overall Study|Death|14
2039315|NCT00426660|3609697|FG000|Overall Study|Adverse Event|23
2039316|NCT00426660|3609697|FG000|Overall Study|Insufficient Clinical Response|22
2039317|NCT00426660|3609697|FG000|Overall Study|Lost to Follow-up|15
2039318|NCT00426660|3609697|FG000|Overall Study|Other|23
2039319|NCT00426660|3609697|FG000|Overall Study|Withdrawal by Subject|18
2039320|NCT00426660|3609697|FG000|Overall Study|Protocol Violation|1
2039321|NCT00426660|3609697|FG000|Overall Study|Enrolled Not Treated|15
2039322|NCT00426751|3609703|FG000|Overall Study|Adverse Event|8
2039323|NCT00426751|3609704|FG001|Overall Study|Adverse Event|1
2039324|NCT00426751|3609703|FG000|Overall Study|Lost to Follow-up|7
2039325|NCT00426751|3609704|FG001|Overall Study|Lost to Follow-up|6
2039326|NCT00426751|3609703|FG000|Overall Study|Consent Withdrawn|0
2039327|NCT00426751|3609704|FG001|Overall Study|Consent Withdrawn|1
2039328|NCT00426751|3609703|FG000|Overall Study|Other Reasons|7
2039329|NCT00426751|3609704|FG001|Overall Study|Other Reasons|12
2039330|NCT00426764|3609710|FG000|Overall Study|Protocol Violation|1
2039331|NCT00426764|3609710|FG000|Overall Study|Withdrawal by Subject|4
2039332|NCT00426764|3609710|FG000|Overall Study|Physician Decision|6
2039333|NCT00426764|3609710|FG000|Overall Study|Compassionate Use|1
2039334|NCT00426764|3609710|FG000|Overall Study|Progressive Disease|83
2039335|NCT00426764|3609710|FG000|Overall Study|Adverse Event|24
2039336|NCT00426764|3609710|FG000|Overall Study|Other|1
2039337|NCT00426764|3609710|FG000|Overall Study|Death|1
2039338|NCT00426764|3609710|FG000|Overall Study|Other Reasons (Miscellaneous)|10
2039339|NCT00426842|3609720|FG000|Overall Study|Lost to Follow-up|1
2039340|NCT00427011|3609730|FG000|Overall Study|Adverse Event|10
2039341|NCT00427011|3609730|FG000|Overall Study|Withdrawal by Subject|1
2039342|NCT00427011|3609730|FG000|Overall Study|Lack of Efficacy|2
2039343|NCT00427011|3609730|FG000|Overall Study|Other|12
2039344|NCT00427349|3609770|FG000|Overall Study|Lack of Efficacy|23
2039345|NCT00427349|3609770|FG000|Overall Study|Adverse Event|14
2039346|NCT00427349|3609770|FG000|Overall Study|Death|1
2039347|NCT00427349|3609770|FG000|Overall Study|Withdrawal by Subject|3
2039348|NCT00427349|3609770|FG000|Overall Study|Alternative therapy|1
2039349|NCT00427349|3609770|FG000|Overall Study|Other|2
2039350|NCT00427349|3609770|FG000|Overall Study|Ineligible|1
2039351|NCT00427349|3609770|FG000|Overall Study|Never started therapy|1
2039352|NCT00427635|3609780|FG000|Treatment Phase|Withdrawal by Subject|1
2039353|NCT00427635|3609781|FG001|Treatment Phase|Withdrawal by Subject|0
2039354|NCT00427635|3609780|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0
2039355|NCT00427635|3609781|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1
2039356|NCT00427648|3609789|FG000|Overall Study|Protocol Violation|1
2039357|NCT00427648|3609790|FG001|Overall Study|Protocol Violation|2
2039358|NCT00427648|3609789|FG000|Overall Study|Adverse Event|0
2039359|NCT00427648|3609790|FG001|Overall Study|Adverse Event|1
2039360|NCT00427700|3609805|FG000|Overall Study|Lost to Follow-up|2
2039361|NCT00427700|3609806|FG001|Overall Study|Lost to Follow-up|5
2039362|NCT00427700|3609805|FG000|Overall Study|no induction of menses|1
2039363|NCT00427700|3609806|FG001|Overall Study|no induction of menses|4
2039364|NCT00427700|3609805|FG000|Overall Study|Pregnancy|0
2039365|NCT00427700|3609806|FG001|Overall Study|Pregnancy|2
2039366|NCT00427778|3609817|FG000|First Intervention (4 Weeks)|no longer interested|1
2039367|NCT00427778|3609818|FG001|First Intervention (4 Weeks)|no longer interested|0
2039368|NCT00427778|3609817|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2
2039369|NCT00427778|3609818|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0
2039370|NCT00427778|3609817|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
2039371|NCT00427778|3609818|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
2039372|NCT00427778|3609817|FG000|First Intervention (4 Weeks)|anxious about using ring|1
2039373|NCT00427778|3609818|FG001|First Intervention (4 Weeks)|anxious about using ring|0
2039374|NCT00427895|3609859|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2039375|NCT00427895|3609860|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2039376|NCT00427895|3609861|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2039377|NCT00427895|3609862|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
2039378|NCT00427895|3609863|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2039379|NCT00427895|3609864|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2353579|NCT02336425|4106285|FG002|Overall Study|Study terminated.|3
2353580|NCT02336425|4106286|FG003|Overall Study|Study terminated.|3
2039380|NCT00427895|3609865|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2039381|NCT00427895|3609866|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2039382|NCT00427895|3609859|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0
2039383|NCT00427895|3609860|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0
2039384|NCT00427895|3609861|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0
2039385|NCT00427895|3609862|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0
2039386|NCT00427895|3609863|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0
2039387|NCT00427895|3609864|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0
2039388|NCT00427895|3609865|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0
2039389|NCT00427895|3609866|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1
2039390|NCT00427895|3609859|FG000|Vax 2/Year 3 to 4|Protocol Violation|0
2039391|NCT00427895|3609860|FG001|Vax 2/Year 3 to 4|Protocol Violation|0
2039392|NCT00427895|3609861|FG002|Vax 2/Year 3 to 4|Protocol Violation|0
2039393|NCT00427895|3609862|FG003|Vax 2/Year 3 to 4|Protocol Violation|0
2039394|NCT00427895|3609863|FG004|Vax 2/Year 3 to 4|Protocol Violation|0
2039395|NCT00427895|3609864|FG005|Vax 2/Year 3 to 4|Protocol Violation|0
2039396|NCT00427895|3609865|FG006|Vax 2/Year 3 to 4|Protocol Violation|0
2039397|NCT00427895|3609866|FG007|Vax 2/Year 3 to 4|Protocol Violation|1
2039398|NCT00427895|3609859|FG000|Vax 2/Year 3 to 4|Failed to Return|0
2039399|NCT00427895|3609860|FG001|Vax 2/Year 3 to 4|Failed to Return|0
2039400|NCT00427895|3609861|FG002|Vax 2/Year 3 to 4|Failed to Return|0
2039401|NCT00427895|3609862|FG003|Vax 2/Year 3 to 4|Failed to Return|0
2039402|NCT00427895|3609863|FG004|Vax 2/Year 3 to 4|Failed to Return|1
2039403|NCT00427895|3609864|FG005|Vax 2/Year 3 to 4|Failed to Return|0
2039404|NCT00427895|3609865|FG006|Vax 2/Year 3 to 4|Failed to Return|0
2039405|NCT00427895|3609866|FG007|Vax 2/Year 3 to 4|Failed to Return|0
2039406|NCT00427895|3609859|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
2039407|NCT00427895|3609860|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
2039408|NCT00427895|3609861|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
2039409|NCT00427895|3609862|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
2039410|NCT00427895|3609863|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
2039411|NCT00427895|3609864|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
2039412|NCT00427895|3609865|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
2039413|NCT00427895|3609866|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
2039414|NCT00427895|3609859|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
2039415|NCT00427895|3609860|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
2039416|NCT00427895|3609861|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
2039417|NCT00427895|3609862|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
2039418|NCT00427895|3609863|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
2039419|NCT00427895|3609864|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
2039420|NCT00427895|3609865|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
2039421|NCT00427895|3609866|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
2039422|NCT00427895|3609859|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
2039423|NCT00427895|3609860|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
2104948|NCT00854113|3697374|FG003|Overall Study|Withdrawal by Subject|0
2353581|NCT02308735|4106347|FG000|Overall Study|Physician Decision|2
2353582|NCT02308735|4106348|FG001|Overall Study|Physician Decision|0
2353583|NCT02308735|4106349|FG002|Overall Study|Physician Decision|0
2353584|NCT02308735|4106350|FG003|Overall Study|Physician Decision|2
2353585|NCT02299206|4106360|FG000|Overall Study|Lost to Follow-up|1
2353586|NCT02299206|4106360|FG000|Overall Study|Withdrawal by Subject|1
2353587|NCT02302859|4106366|FG000|Overall Study|Lost Phone|1
2353588|NCT02302859|4106367|FG001|Overall Study|Lost Phone|1
2353589|NCT02302859|4106366|FG000|Overall Study|Withdrawal by Subject|0
2353590|NCT02302859|4106367|FG001|Overall Study|Withdrawal by Subject|1
2353591|NCT02299934|4106373|FG000|Overall Study|Termination of study|13
2353592|NCT02294981|4106400|FG000|Overall Study|Lost to Follow-up|1
2353593|NCT02284906|4106407|FG000|Overall Study|Pretreatment Event/Adverse Event|0
2353594|NCT02284906|4106408|FG001|Overall Study|Pretreatment Event/Adverse Event|1
2353595|NCT02284906|4106409|FG002|Overall Study|Pretreatment Event/Adverse Event|0
2353596|NCT02284906|4106407|FG000|Overall Study|Major Protocol Deviation|0
2353597|NCT02284906|4106408|FG001|Overall Study|Major Protocol Deviation|1
2353598|NCT02284906|4106409|FG002|Overall Study|Major Protocol Deviation|0
2353599|NCT02284906|4106407|FG000|Overall Study|Voluntary Withdrawal|2
2353600|NCT02284906|4106408|FG001|Overall Study|Voluntary Withdrawal|4
2353601|NCT02284906|4106409|FG002|Overall Study|Voluntary Withdrawal|5
2353602|NCT02284906|4106407|FG000|Overall Study|Study Termination|0
2353603|NCT02284906|4106408|FG001|Overall Study|Study Termination|11
2353604|NCT02284906|4106409|FG002|Overall Study|Study Termination|14
2353605|NCT02284906|4106407|FG000|Overall Study|Reason not Specified|1
2353606|NCT02284906|4106408|FG001|Overall Study|Reason not Specified|1
2353607|NCT02284906|4106409|FG002|Overall Study|Reason not Specified|0
2353608|NCT02287025|4106419|FG000|Overall Study|Not treated|2
2353609|NCT02287025|4106420|FG001|Overall Study|Not treated|0
2353610|NCT02287025|4106419|FG000|Overall Study|Progression of disease|3
2353611|NCT02287025|4106420|FG001|Overall Study|Progression of disease|2
2353612|NCT02287025|4106419|FG000|Overall Study|Adverse Event|2
2353613|NCT02287025|4106420|FG001|Overall Study|Adverse Event|4
2353614|NCT02287025|4106419|FG000|Overall Study|Withdrawal by Subject|2
2353615|NCT02287025|4106420|FG001|Overall Study|Withdrawal by Subject|2
2353616|NCT02287025|4106419|FG000|Overall Study|Screening failed|1
2353617|NCT02287025|4106420|FG001|Overall Study|Screening failed|1
2353618|NCT02276560|4106435|FG000|Overall Study|Adverse Event|1
2353619|NCT02276560|4106436|FG001|Overall Study|Adverse Event|0
2353620|NCT02276560|4106437|FG002|Overall Study|Adverse Event|0
2039424|NCT00427895|3609861|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2039425|NCT00427895|3609862|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2039426|NCT00427895|3609863|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2039427|NCT00427895|3609864|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2039428|NCT00427895|3609865|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2039429|NCT00427895|3609866|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2039430|NCT00427895|3609859|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
2039431|NCT00427895|3609860|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
2039432|NCT00427895|3609861|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
2039433|NCT00427895|3609862|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
2039434|NCT00427895|3609863|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
2039435|NCT00427895|3609864|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
2039436|NCT00427895|3609865|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
2039437|NCT00427895|3609866|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
2039438|NCT00427895|3609859|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2039439|NCT00427895|3609860|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2039440|NCT00427895|3609861|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2039441|NCT00427895|3609862|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
2039442|NCT00427895|3609863|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2039443|NCT00427895|3609864|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2039444|NCT00427895|3609865|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2039445|NCT00427895|3609866|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2039446|NCT00427895|3609859|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
2039447|NCT00427895|3609860|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
2039448|NCT00427895|3609861|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
2039449|NCT00427895|3609862|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
2039450|NCT00427895|3609863|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
2039451|NCT00427895|3609864|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
2039452|NCT00427895|3609865|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
2039453|NCT00427895|3609866|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
2039454|NCT00427895|3609859|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0
2039455|NCT00427895|3609860|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0
2039456|NCT00427895|3609861|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1
2039457|NCT00427895|3609862|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2
2039458|NCT00427895|3609863|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0
2039459|NCT00427895|3609864|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0
2118204|NCT00950248|3715939|FG000|Year 1: Baseline|worsening of symptoms|2
2353621|NCT02284373|4106452|FG000|Overall Study|Withdrawal by Subject|0
2353622|NCT02284373|4106453|FG001|Overall Study|Withdrawal by Subject|1
2353623|NCT02284373|4106454|FG002|Overall Study|Withdrawal by Subject|0
2353624|NCT02284373|4106452|FG000|Overall Study|Other|0
2353625|NCT02284373|4106453|FG001|Overall Study|Other|1
2353626|NCT02284373|4106454|FG002|Overall Study|Other|0
2353627|NCT02284373|4106452|FG000|Overall Study|Lost to Follow-up|0
2353628|NCT02284373|4106453|FG001|Overall Study|Lost to Follow-up|1
2353629|NCT02284373|4106454|FG002|Overall Study|Lost to Follow-up|0
2353630|NCT02285270|4106462|FG000|Overall Study|Lost to Follow-up|1
2353631|NCT02285270|4106462|FG000|Overall Study|Physician Decision|3
2353632|NCT02285270|4106462|FG000|Overall Study|Determined to be ineligible|1
2353633|NCT02275481|4106468|FG000|Overall Study|Death|2
2353634|NCT02275481|4106469|FG001|Overall Study|Death|1
2353635|NCT02275481|4106468|FG000|Overall Study|Lost to Follow-up|2
2353636|NCT02275481|4106469|FG001|Overall Study|Lost to Follow-up|0
2353637|NCT02275481|4106468|FG000|Overall Study|Withdrawal by Subject|3
2353638|NCT02275481|4106469|FG001|Overall Study|Withdrawal by Subject|0
2353639|NCT02275481|4106468|FG000|Overall Study|all other reasons combined|2
2353640|NCT02275481|4106469|FG001|Overall Study|all other reasons combined|1
2353641|NCT02275481|4106468|FG000|Overall Study|Physician Decision|0
2353642|NCT02275481|4106469|FG001|Overall Study|Physician Decision|1
2353643|NCT02273752|4106479|FG000|Overall Study|Trial was terminated early|2
2353644|NCT02270684|4106485|FG000|Overall Study|Lost to Follow-up|0
2353645|NCT02270684|4106486|FG001|Overall Study|Lost to Follow-up|3
2353646|NCT02270684|4106485|FG000|Overall Study|Study terminated|1
2353647|NCT02270684|4106486|FG001|Overall Study|Study terminated|0
2353648|NCT02271594|4106503|FG000|Overall Study|Study closed; recruiting failure|19
2353649|NCT02271594|4106504|FG001|Overall Study|Study closed; recruiting failure|12
2353650|NCT02263365|4106514|FG000|Overall Study|Physician Decision|22
2353651|NCT02263365|4106515|FG001|Overall Study|Physician Decision|18
2353652|NCT02241551|4106549|FG000|Overall Study|Adverse Event|1
2353653|NCT02241551|4106550|FG001|Overall Study|Adverse Event|0
2353654|NCT02246114|4106560|FG000|Overall Study|miscarriage|1
2353655|NCT02246114|4106561|FG001|Overall Study|miscarriage|0
2353656|NCT02232880|4106567|FG000|Overall Study|study stopped prior to randomization|1
2353657|NCT02244944|4106589|FG000|Overall Study|Withdrawal by Subject|1
2353658|NCT02244944|4106589|FG000|Overall Study|Study Terminated|1
2353659|NCT02241187|4106593|FG000|Overall Study|Protocol closed due to lack of accrual.|2
2353660|NCT02239926|4106599|FG000|Overall Study|Withdrawal by Subject|0
2353661|NCT02239926|4106600|FG001|Overall Study|Withdrawal by Subject|1
2353662|NCT02231892|4106609|FG000|Overall Study|Lost to Follow-up|1
2039460|NCT00427895|3609865|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0
2039461|NCT00427895|3609866|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0
2039462|NCT00427895|3609859|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
2039463|NCT00427895|3609860|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
2039464|NCT00427895|3609861|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
2039465|NCT00427895|3609862|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
2039466|NCT00427895|3609863|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
2039467|NCT00427895|3609864|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
2039468|NCT00427895|3609865|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
2039469|NCT00427895|3609866|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
2039470|NCT00427895|3609859|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3
2039471|NCT00427895|3609860|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3
2039472|NCT00427895|3609861|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0
2039473|NCT00427895|3609862|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1
2039474|NCT00427895|3609863|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0
2039475|NCT00427895|3609864|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0
2039476|NCT00427895|3609865|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0
2039477|NCT00427895|3609866|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0
2039478|NCT00427895|3609859|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
2039479|NCT00427895|3609860|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
2039480|NCT00427895|3609861|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
2039481|NCT00427895|3609862|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
2039482|NCT00427895|3609863|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
2039483|NCT00427895|3609864|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
2039484|NCT00427895|3609865|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
2039485|NCT00427895|3609866|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
2039486|NCT00427895|3609859|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0
2039487|NCT00427895|3609860|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1
2039488|NCT00427895|3609861|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0
2039489|NCT00427895|3609862|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0
2039490|NCT00427895|3609863|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0
2039491|NCT00427895|3609864|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0
2118205|NCT00950248|3715940|FG001|Year 1: Baseline|worsening of symptoms|0
2039492|NCT00427895|3609865|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0
2039493|NCT00427895|3609866|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0
2039494|NCT00427895|3609859|FG000|Vax 1/Year 1 Follow-up|Death|1
2039495|NCT00427895|3609860|FG001|Vax 1/Year 1 Follow-up|Death|0
2039496|NCT00427895|3609861|FG002|Vax 1/Year 1 Follow-up|Death|0
2039497|NCT00427895|3609862|FG003|Vax 1/Year 1 Follow-up|Death|0
2039498|NCT00427895|3609863|FG004|Vax 1/Year 1 Follow-up|Death|0
2353663|NCT02231892|4106610|FG001|Overall Study|Lost to Follow-up|0
2353664|NCT02231892|4106611|FG002|Overall Study|Lost to Follow-up|3
2353665|NCT02231892|4106609|FG000|Overall Study|Withdrawal by Subject|4
2353666|NCT02231892|4106610|FG001|Overall Study|Withdrawal by Subject|3
2204739|NCT01606189|3842576|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2204740|NCT01606189|3842577|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
2204741|NCT01606202|3842587|FG000|Overall Study|Adverse Event|5
2353667|NCT02231892|4106611|FG002|Overall Study|Withdrawal by Subject|15
2353668|NCT02231892|4106609|FG000|Overall Study|Physician Decision|0
2353669|NCT02231892|4106610|FG001|Overall Study|Physician Decision|2
2353670|NCT02231892|4106611|FG002|Overall Study|Physician Decision|4
2353671|NCT02231892|4106609|FG000|Overall Study|Motor activity when stimulating ante ACC|4
2353672|NCT02231892|4106610|FG001|Overall Study|Motor activity when stimulating ante ACC|7
2353673|NCT02231892|4106611|FG002|Overall Study|Motor activity when stimulating ante ACC|12
2353674|NCT02231892|4106609|FG000|Overall Study|Participant motor threshold was >83%|0
2353675|NCT02231892|4106610|FG001|Overall Study|Participant motor threshold was >83%|0
2039499|NCT00427895|3609864|FG005|Vax 1/Year 1 Follow-up|Death|0
2039500|NCT00427895|3609865|FG006|Vax 1/Year 1 Follow-up|Death|0
2039501|NCT00427895|3609866|FG007|Vax 1/Year 1 Follow-up|Death|0
2039502|NCT00427895|3609859|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0
2039503|NCT00427895|3609860|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0
2039504|NCT00427895|3609861|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12
2039505|NCT00427895|3609862|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5
2039506|NCT00427895|3609863|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0
2039507|NCT00427895|3609864|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0
2277370|NCT02326298|3959846|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2277371|NCT02326298|3959833|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277372|NCT02326298|3959834|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277373|NCT02326298|3959835|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277374|NCT02326298|3959836|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277375|NCT02326298|3959837|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277376|NCT02326298|3959838|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2277377|NCT02326298|3959839|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
2277378|NCT02326298|3959840|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2277379|NCT02326298|3959841|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2277380|NCT02326298|3959842|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2277381|NCT02326298|3959843|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277382|NCT02326298|3959844|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2277383|NCT02326298|3959845|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2039508|NCT00427895|3609865|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0
2039509|NCT00427895|3609866|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0
2039510|NCT00427895|3609859|FG000|Vax 1/Year 1 Follow-up|Other|0
2039511|NCT00427895|3609860|FG001|Vax 1/Year 1 Follow-up|Other|0
2039512|NCT00427895|3609861|FG002|Vax 1/Year 1 Follow-up|Other|0
2039513|NCT00427895|3609862|FG003|Vax 1/Year 1 Follow-up|Other|2
2039514|NCT00427895|3609863|FG004|Vax 1/Year 1 Follow-up|Other|0
2039515|NCT00427895|3609864|FG005|Vax 1/Year 1 Follow-up|Other|0
2039516|NCT00427895|3609865|FG006|Vax 1/Year 1 Follow-up|Other|0
2039517|NCT00427895|3609866|FG007|Vax 1/Year 1 Follow-up|Other|0
2039518|NCT00427895|3609859|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
2039519|NCT00427895|3609860|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
2039520|NCT00427895|3609861|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
2039521|NCT00427895|3609862|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
2039522|NCT00427895|3609863|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
2039523|NCT00427895|3609864|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
2039524|NCT00427895|3609865|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
2039525|NCT00427895|3609866|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
2039526|NCT00427908|3609909|FG000|Primary Phase|Lost to Follow-up|4
2039527|NCT00427908|3609910|FG001|Primary Phase|Lost to Follow-up|0
2204742|NCT01606202|3842588|FG001|Overall Study|Adverse Event|0
2204743|NCT01606202|3842587|FG000|Overall Study|Withdrawal by Subject|2
2204744|NCT01606202|3842588|FG001|Overall Study|Withdrawal by Subject|1
2204745|NCT01606202|3842587|FG000|Overall Study|Personal problems|0
2204746|NCT01606202|3842588|FG001|Overall Study|Personal problems|1
2204747|NCT01606202|3842587|FG000|Overall Study|Problems with administration|0
2204748|NCT01606202|3842588|FG001|Overall Study|Problems with administration|1
2204749|NCT01606228|3842594|FG000|Overall Study|Lost to Follow-up|20
2204750|NCT01606228|3842594|FG000|Overall Study|Withdrawal by Subject|3
2204751|NCT01606228|3842594|FG000|Overall Study|Non-compliant|3
2204752|NCT01606228|3842594|FG000|Overall Study|Lack of Efficacy|2
2204753|NCT01606228|3842594|FG000|Overall Study|Adverse Event|1
2204754|NCT01606254|3842602|FG000|Overall Study|Withdrawal by Subject|1
2204755|NCT01606254|3842603|FG001|Overall Study|Withdrawal by Subject|3
2204756|NCT01606254|3842604|FG002|Overall Study|Withdrawal by Subject|0
2204757|NCT01606254|3842605|FG003|Overall Study|Withdrawal by Subject|2
2204758|NCT01606254|3842602|FG000|Overall Study|Adverse Event|1
2204759|NCT01606254|3842603|FG001|Overall Study|Adverse Event|1
2353676|NCT02231892|4106611|FG002|Overall Study|Participant motor threshold was >83%|9
2353677|NCT02231892|4106609|FG000|Overall Study|Could not find motor threshold|2
2353678|NCT02231892|4106610|FG001|Overall Study|Could not find motor threshold|0
2353679|NCT02231892|4106611|FG002|Overall Study|Could not find motor threshold|1
2353680|NCT02231892|4106609|FG000|Overall Study|Could not find reliable motor hotspot|0
2353681|NCT02231892|4106610|FG001|Overall Study|Could not find reliable motor hotspot|0
2353682|NCT02231892|4106611|FG002|Overall Study|Could not find reliable motor hotspot|1
2353683|NCT02241343|4106625|FG000|Overall Study|Adverse Event|1
2353684|NCT02224599|4106660|FG000|Overall Study|Physician Decision|1
2353685|NCT02224599|4106660|FG000|Overall Study|Progression of Disease|1
2353686|NCT02201472|4106664|FG000|Overall Study|Lack of Efficacy|2
2019018|NCT00296504|3586493|FG002|Interim Analysis|Participant Had Problems with Alcohol|1
2039528|NCT00427908|3609911|FG002|Primary Phase|Lost to Follow-up|2
2039529|NCT00427908|3609912|FG003|Primary Phase|Lost to Follow-up|0
2039530|NCT00427908|3609909|FG000|Primary Phase|Withdrawal by Subject|1
2039531|NCT00427908|3609910|FG001|Primary Phase|Withdrawal by Subject|2
2039532|NCT00427908|3609911|FG002|Primary Phase|Withdrawal by Subject|1
2039533|NCT00427908|3609912|FG003|Primary Phase|Withdrawal by Subject|0
2039534|NCT00427908|3609909|FG000|Primary Phase|Adverse Event|0
2039535|NCT00427908|3609910|FG001|Primary Phase|Adverse Event|1
2039536|NCT00427908|3609911|FG002|Primary Phase|Adverse Event|0
2039537|NCT00427908|3609912|FG003|Primary Phase|Adverse Event|0
2039538|NCT00427921|3609947|FG000|Overall Study|Adverse Event|26
2039539|NCT00427921|3609947|FG000|Overall Study|Withdrawal by Subject|4
2039540|NCT00427921|3609947|FG000|Overall Study|Lost to Follow-up|2
2039541|NCT00427921|3609947|FG000|Overall Study|Other reason not specified|10
2039542|NCT00427921|3609947|FG000|Overall Study|Adverse Event + Hospitalization|1
2039543|NCT00427921|3609947|FG000|Overall Study|Adverse Event + Withdrew Consent|1
2039544|NCT00427921|3609947|FG000|Overall Study|Adverse Event + No Response|1
2039545|NCT00427921|3609947|FG000|Overall Study|Adverse Event + Worsening of CD|1
2039546|NCT00427921|3609947|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1
2039547|NCT00427921|3609947|FG000|Overall Study|Adverse Event + Lost Response|1
2039548|NCT00427921|3609947|FG000|Overall Study|Adverse Event + Withdrawn from Study|1
2039549|NCT00427921|3609947|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1
2039550|NCT00427934|3609955|FG000|Overall Study|Adverse Event|1
2039551|NCT00427934|3609956|FG001|Overall Study|Adverse Event|0
2039552|NCT00427934|3609957|FG002|Overall Study|Adverse Event|5
2039553|NCT00427934|3609958|FG003|Overall Study|Adverse Event|4
2039554|NCT00427934|3609955|FG000|Overall Study|Lack of Efficacy|0
2039555|NCT00427934|3609956|FG001|Overall Study|Lack of Efficacy|0
2039556|NCT00427934|3609957|FG002|Overall Study|Lack of Efficacy|5
2204760|NCT01606254|3842604|FG002|Overall Study|Adverse Event|0
2039557|NCT00427934|3609958|FG003|Overall Study|Lack of Efficacy|2
2039558|NCT00427934|3609955|FG000|Overall Study|Randomized But Did Not Receive Treatment|0
2039559|NCT00427934|3609956|FG001|Overall Study|Randomized But Did Not Receive Treatment|0
2039560|NCT00427934|3609957|FG002|Overall Study|Randomized But Did Not Receive Treatment|1
2039561|NCT00427934|3609958|FG003|Overall Study|Randomized But Did Not Receive Treatment|1
2204761|NCT01606254|3842605|FG003|Overall Study|Adverse Event|1
2204762|NCT01606306|3842621|FG000|Overall Study|Lack of Efficacy|2
2039562|NCT00427934|3609955|FG000|Overall Study|Other|0
2039563|NCT00427934|3609956|FG001|Overall Study|Other|0
2039564|NCT00427934|3609957|FG002|Overall Study|Other|11
2039565|NCT00427934|3609958|FG003|Overall Study|Other|5
2039566|NCT00427934|3609955|FG000|Overall Study|Withdrawal by Subject|0
2039567|NCT00427934|3609956|FG001|Overall Study|Withdrawal by Subject|0
2039568|NCT00427934|3609957|FG002|Overall Study|Withdrawal by Subject|1
2039569|NCT00427934|3609958|FG003|Overall Study|Withdrawal by Subject|3
2039570|NCT00427960|3609972|FG000|Overall Study|Adverse Event|2
2277384|NCT02326298|3959846|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2019019|NCT00296504|3586494|FG003|Interim Analysis|Participant Had Problems with Alcohol|0
2019020|NCT00296504|3586495|FG004|Interim Analysis|Participant Had Problems with Alcohol|0
2019021|NCT00296504|3586496|FG005|Interim Analysis|Participant Had Problems with Alcohol|0
2019022|NCT00296504|3586497|FG006|Interim Analysis|Participant Had Problems with Alcohol|0
2019023|NCT00296504|3586498|FG007|Interim Analysis|Participant Had Problems with Alcohol|0
2019024|NCT00296504|3586499|FG008|Interim Analysis|Participant Had Problems with Alcohol|0
2019025|NCT00296504|3586491|FG000|Interim Analysis|Participant Moved|1
2019026|NCT00296504|3586492|FG001|Interim Analysis|Participant Moved|0
2019027|NCT00296504|3586493|FG002|Interim Analysis|Participant Moved|1
2019028|NCT00296504|3586494|FG003|Interim Analysis|Participant Moved|0
2019029|NCT00296504|3586495|FG004|Interim Analysis|Participant Moved|0
2019030|NCT00296504|3586496|FG005|Interim Analysis|Participant Moved|1
2019031|NCT00296504|3586497|FG006|Interim Analysis|Participant Moved|1
2019032|NCT00296504|3586498|FG007|Interim Analysis|Participant Moved|0
2019033|NCT00296504|3586499|FG008|Interim Analysis|Participant Moved|0
2019034|NCT00296504|3586491|FG000|Interim Analysis|Participant Was Incarcerated|2
2019035|NCT00296504|3586492|FG001|Interim Analysis|Participant Was Incarcerated|0
2019036|NCT00296504|3586493|FG002|Interim Analysis|Participant Was Incarcerated|1
2019037|NCT00296504|3586494|FG003|Interim Analysis|Participant Was Incarcerated|0
2019038|NCT00296504|3586495|FG004|Interim Analysis|Participant Was Incarcerated|0
2353687|NCT02200042|4106687|FG000|Overall Study|Withdrawal by Subject|0
2353688|NCT02200042|4106688|FG001|Overall Study|Withdrawal by Subject|1
2353689|NCT02181790|4106696|FG000|Overall Study|study terminated|2
2353690|NCT02181790|4106697|FG001|Overall Study|study terminated|0
2353691|NCT02177266|4106725|FG000|Overall Study|Adverse Event|0
2353692|NCT02177266|4106726|FG001|Overall Study|Adverse Event|1
2353693|NCT02177266|4106725|FG000|Overall Study|Withdrawal by Subject|1
2353694|NCT02177266|4106726|FG001|Overall Study|Withdrawal by Subject|0
2353695|NCT02170298|4106743|FG000|Overall Study|Withdrawal by Subject|0
2353696|NCT02170298|4106744|FG001|Overall Study|Withdrawal by Subject|1
2353697|NCT02170298|4106743|FG000|Overall Study|unblinded, rerandomized to intervention|1
2353698|NCT02170298|4106744|FG001|Overall Study|unblinded, rerandomized to intervention|0
2353699|NCT02169830|4106766|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0
2353700|NCT02169830|4106767|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0
2353701|NCT02169830|4106768|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1
2353702|NCT02169830|4106766|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1
2353703|NCT02169830|4106767|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0
2353704|NCT02169830|4106768|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0
2353705|NCT02169830|4106766|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
2353706|NCT02169830|4106767|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5
2353707|NCT02169830|4106768|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0
2353708|NCT02169830|4106766|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0
2353709|NCT02169830|4106767|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1
2353710|NCT02169830|4106768|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0
2353711|NCT02169830|4106766|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0
2353712|NCT02169830|4106767|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1
2353713|NCT02169830|4106768|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0
2353714|NCT02163187|4106778|FG000|Overall Study|Device removed|1
2353715|NCT02163187|4106779|FG001|Overall Study|Device removed|0
2353716|NCT02163187|4106778|FG000|Overall Study|Progressive disease|1
2353717|NCT02163187|4106779|FG001|Overall Study|Progressive disease|0
2353718|NCT02161016|4106785|FG000|Overall Study|withdrawn by IRB|1
2353719|NCT02159040|4106789|FG000|Overall Study|Death|1
2353720|NCT02168270|4106793|FG000|Overall Study|Lack of Efficacy|4
2353721|NCT02157116|4106797|FG000|Overall Study|Withdrawal by Subject|4
2353722|NCT02157116|4106797|FG000|Overall Study|Physician Decision|3
2353723|NCT02157116|4106797|FG000|Overall Study|Failed Screening|2
2353724|NCT02154087|4106801|FG000|Overall Study|Study Termination|1
2039571|NCT00427960|3609973|FG001|Overall Study|Adverse Event|0
2039572|NCT00427960|3609972|FG000|Overall Study|Withdrawal by Subject|0
2039573|NCT00427960|3609973|FG001|Overall Study|Withdrawal by Subject|3
2039574|NCT00427960|3609972|FG000|Overall Study|Other|0
2039575|NCT00427960|3609973|FG001|Overall Study|Other|1
2039576|NCT00427999|3609983|FG000|Overall Study|Adverse Event|6
2039577|NCT00427999|3609983|FG000|Overall Study|Abnormal laboratory values|1
2039578|NCT00427999|3609983|FG000|Overall Study|Unsatisfactory therapeutic effect|13
2039579|NCT00427999|3609983|FG000|Overall Study|Protocol Violation|2
2039580|NCT00427999|3609983|FG000|Overall Study|Withdrawal by Subject|9
2039581|NCT00427999|3609983|FG000|Overall Study|Death|1
2039582|NCT00428090|3609996|FG000|Overall Study|Adverse Event|10
2039583|NCT00428090|3609997|FG001|Overall Study|Adverse Event|8
2039584|NCT00428090|3609998|FG002|Overall Study|Adverse Event|10
2039585|NCT00428090|3609999|FG003|Overall Study|Adverse Event|11
2039586|NCT00428090|3609996|FG000|Overall Study|Lost to Follow-up|3
2039587|NCT00428090|3609997|FG001|Overall Study|Lost to Follow-up|6
2039588|NCT00428090|3609998|FG002|Overall Study|Lost to Follow-up|1
2039589|NCT00428090|3609999|FG003|Overall Study|Lost to Follow-up|4
2039590|NCT00428090|3609996|FG000|Overall Study|Protocol Violation|3
2039591|NCT00428090|3609997|FG001|Overall Study|Protocol Violation|1
2039592|NCT00428090|3609998|FG002|Overall Study|Protocol Violation|3
2039593|NCT00428090|3609999|FG003|Overall Study|Protocol Violation|3
2039594|NCT00428090|3609996|FG000|Overall Study|Withdrawal by Subject|10
2039595|NCT00428090|3609997|FG001|Overall Study|Withdrawal by Subject|12
2039596|NCT00428090|3609998|FG002|Overall Study|Withdrawal by Subject|15
2039597|NCT00428090|3609999|FG003|Overall Study|Withdrawal by Subject|5
2039598|NCT00428090|3609996|FG000|Overall Study|Sponsor terminated study|0
2039599|NCT00428090|3609997|FG001|Overall Study|Sponsor terminated study|1
2039600|NCT00428090|3609998|FG002|Overall Study|Sponsor terminated study|0
2039601|NCT00428090|3609999|FG003|Overall Study|Sponsor terminated study|0
2039602|NCT00428090|3609996|FG000|Overall Study|Non-compliance|4
2039603|NCT00428090|3609997|FG001|Overall Study|Non-compliance|0
2039604|NCT00428090|3609998|FG002|Overall Study|Non-compliance|1
2039605|NCT00428090|3609999|FG003|Overall Study|Non-compliance|3
2039606|NCT00428090|3609996|FG000|Overall Study|Par. did not returned to visit|1
2039607|NCT00428090|3609997|FG001|Overall Study|Par. did not returned to visit|0
2039608|NCT00428090|3609998|FG002|Overall Study|Par. did not returned to visit|0
2039609|NCT00428090|3609999|FG003|Overall Study|Par. did not returned to visit|1
2039610|NCT00428090|3609996|FG000|Overall Study|Follow-Up visit not possible|1
2039611|NCT00428090|3609997|FG001|Overall Study|Follow-Up visit not possible|0
2039612|NCT00428090|3609998|FG002|Overall Study|Follow-Up visit not possible|0
2039613|NCT00428090|3609999|FG003|Overall Study|Follow-Up visit not possible|0
2353725|NCT02152566|4106809|FG000|Overall Study|Lost to Follow-up|1
2353726|NCT02152566|4106809|FG000|Overall Study|Withdrawal by Subject|2
2353727|NCT02145390|4106826|FG000|Overall Study|Withdrawal by Subject|1
2353728|NCT02150863|4106859|FG000|Overall Study|Lost to Follow-up|0
2353729|NCT02150863|4106860|FG001|Overall Study|Lost to Follow-up|1
2353730|NCT02150863|4106861|FG002|Overall Study|Lost to Follow-up|0
2353731|NCT02131155|4106897|FG000|Overall Study|Adverse Event|1
2353732|NCT02131155|4106898|FG001|Overall Study|Adverse Event|0
2353733|NCT02131155|4106897|FG000|Overall Study|Treatment completed|1
2353734|NCT02131155|4106898|FG001|Overall Study|Treatment completed|0
2353735|NCT02131155|4106897|FG000|Overall Study|Primary tumour recurrence|2
2353736|NCT02131155|4106898|FG001|Overall Study|Primary tumour recurrence|1
2353737|NCT02131155|4106897|FG000|Overall Study|Refused to continue study medication|1
2353738|NCT02131155|4106898|FG001|Overall Study|Refused to continue study medication|0
2353739|NCT02131155|4106897|FG000|Overall Study|Study early termination|20
2353740|NCT02131155|4106898|FG001|Overall Study|Study early termination|10
2353741|NCT02117050|4106904|FG000|Overall Study|Subject Enrolled but not Dosed|1
2353742|NCT02105116|4106926|FG000|Overall Study|not eligible for step 2 of trial|5
2353743|NCT02105116|4106926|FG000|Overall Study|Death|1
2353744|NCT02099344|4106943|FG000|Overall Study|Physician Decision|1
2039614|NCT00428090|3609996|FG000|Overall Study|Prohibited medication used for SAE|1
2039615|NCT00428090|3609997|FG001|Overall Study|Prohibited medication used for SAE|0
2039616|NCT00428090|3609998|FG002|Overall Study|Prohibited medication used for SAE|0
2039617|NCT00428090|3609999|FG003|Overall Study|Prohibited medication used for SAE|0
2039618|NCT00428090|3609996|FG000|Overall Study|Death of par.|1
2039619|NCT00428090|3609997|FG001|Overall Study|Death of par.|0
2039620|NCT00428090|3609998|FG002|Overall Study|Death of par.|1
2039621|NCT00428090|3609999|FG003|Overall Study|Death of par.|0
2039622|NCT00428090|3609996|FG000|Overall Study|Visit 7 exceed the visit window|0
2039623|NCT00428090|3609997|FG001|Overall Study|Visit 7 exceed the visit window|1
2039624|NCT00428090|3609998|FG002|Overall Study|Visit 7 exceed the visit window|0
2039625|NCT00428090|3609999|FG003|Overall Study|Visit 7 exceed the visit window|0
2039626|NCT00428090|3609996|FG000|Overall Study|Medical monitor terminated par.|0
2039627|NCT00428090|3609997|FG001|Overall Study|Medical monitor terminated par.|1
2039628|NCT00428090|3609998|FG002|Overall Study|Medical monitor terminated par.|0
2039629|NCT00428090|3609999|FG003|Overall Study|Medical monitor terminated par.|0
2039630|NCT00428090|3609996|FG000|Overall Study|Mental status of par. was|0
2039631|NCT00428090|3609997|FG001|Overall Study|Mental status of par. was|1
2039632|NCT00428090|3609998|FG002|Overall Study|Mental status of par. was|0
2039633|NCT00428090|3609999|FG003|Overall Study|Mental status of par. was|0
2039634|NCT00428090|3609996|FG000|Overall Study|Worsening of AD|0
2039635|NCT00428090|3609997|FG001|Overall Study|Worsening of AD|0
2039636|NCT00428090|3609998|FG002|Overall Study|Worsening of AD|1
2039637|NCT00428090|3609999|FG003|Overall Study|Worsening of AD|0
2039638|NCT00428090|3609996|FG000|Overall Study|Excluded for concerning QTc value|0
2039639|NCT00428090|3609997|FG001|Overall Study|Excluded for concerning QTc value|0
2039640|NCT00428090|3609998|FG002|Overall Study|Excluded for concerning QTc value|1
2039641|NCT00428090|3609999|FG003|Overall Study|Excluded for concerning QTc value|0
2039642|NCT00428090|3609996|FG000|Overall Study|Insufficient AD documentation|0
2039643|NCT00428090|3609997|FG001|Overall Study|Insufficient AD documentation|0
2039644|NCT00428090|3609998|FG002|Overall Study|Insufficient AD documentation|1
2039645|NCT00428090|3609999|FG003|Overall Study|Insufficient AD documentation|0
2039646|NCT00428090|3609996|FG000|Overall Study|High MMSE scores|0
2039647|NCT00428090|3609997|FG001|Overall Study|High MMSE scores|0
2039648|NCT00428090|3609998|FG002|Overall Study|High MMSE scores|1
2039649|NCT00428090|3609999|FG003|Overall Study|High MMSE scores|0
2039650|NCT00428090|3609996|FG000|Overall Study|Deterioration of cognitive status|0
2039651|NCT00428090|3609997|FG001|Overall Study|Deterioration of cognitive status|0
2039652|NCT00428090|3609998|FG002|Overall Study|Deterioration of cognitive status|1
2039653|NCT00428090|3609999|FG003|Overall Study|Deterioration of cognitive status|0
2039654|NCT00428090|3609996|FG000|Overall Study|Serious adverse event|0
2039655|NCT00428090|3609997|FG001|Overall Study|Serious adverse event|0
2039656|NCT00428090|3609998|FG002|Overall Study|Serious adverse event|1
2039657|NCT00428090|3609999|FG003|Overall Study|Serious adverse event|0
2039658|NCT00428090|3609996|FG000|Overall Study|Excluded for heart insufficiency|0
2039659|NCT00428090|3609997|FG001|Overall Study|Excluded for heart insufficiency|0
2039660|NCT00428090|3609998|FG002|Overall Study|Excluded for heart insufficiency|1
2039661|NCT00428090|3609999|FG003|Overall Study|Excluded for heart insufficiency|0
2039662|NCT00428090|3609996|FG000|Overall Study|Raised Creatinine Value|0
2039663|NCT00428090|3609997|FG001|Overall Study|Raised Creatinine Value|0
2039664|NCT00428090|3609998|FG002|Overall Study|Raised Creatinine Value|0
2039665|NCT00428090|3609999|FG003|Overall Study|Raised Creatinine Value|1
2039666|NCT00428116|3610019|FG000|Overall Study|Death|1
2039667|NCT00428116|3610020|FG001|Overall Study|Death|0
2039668|NCT00428116|3610019|FG000|Overall Study|Withdrawal by Subject|1
2039669|NCT00428116|3610020|FG001|Overall Study|Withdrawal by Subject|0
2039670|NCT00428116|3610019|FG000|Overall Study|Lost to Follow-up|1
2039671|NCT00428116|3610020|FG001|Overall Study|Lost to Follow-up|0
2039672|NCT00428220|3610027|FG000|Overall Study|Participant died|8
2039673|NCT00428220|3610027|FG000|Overall Study|Global deterioration of health status|7
2039674|NCT00428220|3610027|FG000|Overall Study|Lost to Follow-up|4
2353745|NCT02099344|4106944|FG001|Overall Study|Physician Decision|0
2353746|NCT02096042|4106961|FG000|Overall Study|Disease Progression|1
2353747|NCT02096042|4106962|FG001|Overall Study|Disease Progression|0
2353748|NCT02096042|4106963|FG002|Overall Study|Disease Progression|0
2353749|NCT02088957|4106970|FG000|Overall Study|Lack of Efficacy|1
2353750|NCT02088957|4106971|FG001|Overall Study|Lack of Efficacy|0
2353751|NCT02093689|4106980|FG000|Overall Study|Physician Decision|4
2353752|NCT02093689|4106981|FG001|Overall Study|Physician Decision|0
2353753|NCT02093689|4106982|FG002|Overall Study|Physician Decision|0
2353754|NCT02091752|4106988|FG000|Overall Study|Study terminated by Sponsor|2
2353755|NCT02091752|4106988|FG000|Overall Study|Adverse Event|1
2353756|NCT02068547|4106994|FG000|Overall Study|Lost to Follow-up|3
2353757|NCT02068547|4106995|FG001|Overall Study|Lost to Follow-up|3
2353758|NCT02068547|4106994|FG000|Overall Study|Physician Decision|1
2353759|NCT02068547|4106995|FG001|Overall Study|Physician Decision|0
2353760|NCT02081183|4107033|FG000|Overall Study|Lost to Follow-up|0
2039675|NCT00428220|3610027|FG000|Overall Study|Objective progression or relapse|123
2039676|NCT00428220|3610027|FG000|Overall Study|Participant refused continued treatment|7
2039677|NCT00428220|3610027|FG000|Overall Study|Adverse Event|51
2039678|NCT00428220|3610027|FG000|Overall Study|Other|23
2039679|NCT00428246|3610045|FG000|Overall Study|Withdrawal by Subject|0
2039680|NCT00428246|3610046|FG001|Overall Study|Withdrawal by Subject|0
2039681|NCT00428246|3610047|FG002|Overall Study|Withdrawal by Subject|1
2039682|NCT00428246|3610045|FG000|Overall Study|Adverse Event|1
2039683|NCT00428246|3610046|FG001|Overall Study|Adverse Event|0
2039684|NCT00428246|3610047|FG002|Overall Study|Adverse Event|0
2039685|NCT00428389|3610068|FG000|Core Phase|Adverse Event|6
2039686|NCT00428389|3610069|FG001|Core Phase|Adverse Event|4
2039687|NCT00428389|3610068|FG000|Core Phase|Lack of Efficacy|2
2039688|NCT00428389|3610069|FG001|Core Phase|Lack of Efficacy|0
2039689|NCT00428389|3610068|FG000|Core Phase|Abnormal test procedure result(s)|0
2039690|NCT00428389|3610069|FG001|Core Phase|Abnormal test procedure result(s)|1
2039691|NCT00428389|3610068|FG000|Core Phase|Withdrawal by Subject|3
2039692|NCT00428389|3610069|FG001|Core Phase|Withdrawal by Subject|4
2039693|NCT00428389|3610068|FG000|Core Phase|Protocol deviation|0
2039694|NCT00428389|3610069|FG001|Core Phase|Protocol deviation|2
2039695|NCT00428389|3610068|FG000|Extension Phase|Adverse Event|17
2039696|NCT00428389|3610069|FG001|Extension Phase|Adverse Event|11
2039697|NCT00428389|3610068|FG000|Extension Phase|Lack of Efficacy|4
2039698|NCT00428389|3610069|FG001|Extension Phase|Lack of Efficacy|3
2039699|NCT00428389|3610068|FG000|Extension Phase|Withdrawal by Subject|6
2039700|NCT00428389|3610069|FG001|Extension Phase|Withdrawal by Subject|6
2039701|NCT00428389|3610068|FG000|Extension Phase|Lost to Follow-up|0
2039702|NCT00428389|3610069|FG001|Extension Phase|Lost to Follow-up|3
2039703|NCT00428389|3610068|FG000|Extension Phase|Death|1
2039704|NCT00428389|3610069|FG001|Extension Phase|Death|0
2039705|NCT00428389|3610068|FG000|Extension Phase|Protocol Violation|3
2039706|NCT00428389|3610069|FG001|Extension Phase|Protocol Violation|2
2039707|NCT00428389|3610068|FG000|Extension Phase|Administrative problems|1
2039708|NCT00428389|3610069|FG001|Extension Phase|Administrative problems|1
2039709|NCT00428441|3610075|FG000|Overall Study|Lost to Follow-up|1
2039710|NCT00428597|3610094|FG000|Overall Study|Randomized but not treated|3
2039711|NCT00428597|3610095|FG001|Overall Study|Randomized but not treated|3
2039712|NCT00428597|3610094|FG000|Overall Study|Objective Progression or Relapse|19
2039713|NCT00428597|3610095|FG001|Overall Study|Objective Progression or Relapse|47
2039714|NCT00428597|3610094|FG000|Overall Study|Study Terminated by Sponsor|41
2039715|NCT00428597|3610095|FG001|Overall Study|Study Terminated by Sponsor|16
2039716|NCT00428597|3610094|FG000|Overall Study|Adverse Event|15
2039717|NCT00428597|3610095|FG001|Overall Study|Adverse Event|7
2277385|NCT02326298|3959833|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2277386|NCT02326298|3959834|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2039718|NCT00428597|3610094|FG000|Overall Study|Global Deterioration of Health Status|1
2039719|NCT00428597|3610095|FG001|Overall Study|Global Deterioration of Health Status|5
2039720|NCT00428597|3610094|FG000|Overall Study|Protocol Violation|2
2039721|NCT00428597|3610095|FG001|Overall Study|Protocol Violation|1
2039722|NCT00428597|3610094|FG000|Overall Study|Withdrawal by Subject|2
2039723|NCT00428597|3610095|FG001|Overall Study|Withdrawal by Subject|1
2039724|NCT00428597|3610094|FG000|Overall Study|Other|1
2039725|NCT00428597|3610095|FG001|Overall Study|Other|1
2039726|NCT00428597|3610094|FG000|Overall Study|Lost to Follow-up|0
2039727|NCT00428597|3610095|FG001|Overall Study|Lost to Follow-up|1
2039728|NCT00428597|3610094|FG000|Overall Study|Pregnancy|1
2039729|NCT00428597|3610095|FG001|Overall Study|Pregnancy|0
2039730|NCT00428597|3610094|FG000|Overall Study|Death|1
2039731|NCT00428597|3610095|FG001|Overall Study|Death|3
2039732|NCT00428610|3610104|FG000|Overall Study|Death Due to Adverse Event|3
2039733|NCT00428610|3610105|FG001|Overall Study|Death Due to Adverse Event|0
2039734|NCT00428610|3610106|FG002|Overall Study|Death Due to Adverse Event|5
2353761|NCT02081183|4107034|FG001|Overall Study|Lost to Follow-up|1
2039735|NCT00428610|3610104|FG000|Overall Study|Death Due to Progressive Disease|0
2039736|NCT00428610|3610105|FG001|Overall Study|Death Due to Progressive Disease|0
2039737|NCT00428610|3610106|FG002|Overall Study|Death Due to Progressive Disease|2
2039738|NCT00428610|3610104|FG000|Overall Study|Adverse Event|2
2353762|NCT02081183|4107033|FG000|Overall Study|Protocol Violation|1
2353763|NCT02081183|4107034|FG001|Overall Study|Protocol Violation|0
2353764|NCT02081183|4107033|FG000|Overall Study|Other|3
2353765|NCT02081183|4107034|FG001|Overall Study|Other|3
2353766|NCT02067104|4107054|FG000|Overall Study|Study termination due to low accrual|4
2353767|NCT02067104|4107055|FG001|Overall Study|Study termination due to low accrual|5
2353768|NCT02057874|4107065|FG000|Overall Study|participant did not return for scan|1
2353769|NCT02058537|4107079|FG000|Overall Study|Withdrawal by Subject|1
2277387|NCT02326298|3959835|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2039739|NCT00428610|3610105|FG001|Overall Study|Adverse Event|3
2204763|NCT01606306|3842622|FG001|Overall Study|Lack of Efficacy|1
2204764|NCT01606306|3842623|FG002|Overall Study|Lack of Efficacy|4
2204765|NCT01606306|3842624|FG003|Overall Study|Lack of Efficacy|4
2039740|NCT00428610|3610106|FG002|Overall Study|Adverse Event|2
2039741|NCT00428610|3610104|FG000|Overall Study|Investigator Decision|2
2039742|NCT00428610|3610105|FG001|Overall Study|Investigator Decision|1
2039743|NCT00428610|3610106|FG002|Overall Study|Investigator Decision|1
2039744|NCT00428610|3610104|FG000|Overall Study|Progressive Disease|42
2039745|NCT00428610|3610105|FG001|Overall Study|Progressive Disease|14
2039746|NCT00428610|3610106|FG002|Overall Study|Progressive Disease|22
2039747|NCT00428610|3610104|FG000|Overall Study|Withdrawal by Subject|4
2039748|NCT00428610|3610105|FG001|Overall Study|Withdrawal by Subject|0
2039749|NCT00428610|3610106|FG002|Overall Study|Withdrawal by Subject|0
2039750|NCT00428714|3610116|FG000|Overall Study|Progressive Disease|28
2039751|NCT00428714|3610117|FG001|Overall Study|Progressive Disease|36
2039752|NCT00428714|3610116|FG000|Overall Study|Withdrawal by Subject|0
2039753|NCT00428714|3610117|FG001|Overall Study|Withdrawal by Subject|3
2039754|NCT00428714|3610116|FG000|Overall Study|Adverse Event|0
2039755|NCT00428714|3610117|FG001|Overall Study|Adverse Event|2
2039756|NCT00428714|3610116|FG000|Overall Study|Physician Decision|1
2039757|NCT00428714|3610117|FG001|Overall Study|Physician Decision|1
2039758|NCT00428714|3610116|FG000|Overall Study|Death due to Progressive Disease (PD)|1
2039759|NCT00428714|3610117|FG001|Overall Study|Death due to Progressive Disease (PD)|0
2039760|NCT00428714|3610116|FG000|Overall Study|Death due to other then PD|1
2039761|NCT00428714|3610117|FG001|Overall Study|Death due to other then PD|0
2039762|NCT00428792|3610126|FG000|Overall Study|Lack of Efficacy|1
2039763|NCT00428792|3610127|FG001|Overall Study|Lack of Efficacy|3
2039764|NCT00428792|3610126|FG000|Overall Study|Lost to Follow-up|0
2039765|NCT00428792|3610127|FG001|Overall Study|Lost to Follow-up|1
2039766|NCT00428844|3610136|FG000|Completed Study Drug Treatment|Adverse Event|2
2039767|NCT00428844|3610137|FG001|Completed Study Drug Treatment|Adverse Event|4
2039768|NCT00428844|3610138|FG002|Completed Study Drug Treatment|Adverse Event|4
2039769|NCT00428844|3610136|FG000|Completed Study Drug Treatment|Protocol Violation|0
2204766|NCT01606306|3842625|FG004|Overall Study|Lack of Efficacy|1
2039770|NCT00428844|3610137|FG001|Completed Study Drug Treatment|Protocol Violation|1
2039771|NCT00428844|3610138|FG002|Completed Study Drug Treatment|Protocol Violation|1
2039772|NCT00428844|3610136|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0
2039773|NCT00428844|3610137|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1
2039774|NCT00428844|3610138|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1
2039775|NCT00428844|3610136|FG000|Completed Study Drug Treatment|Randomized Not Treated|0
2039776|NCT00428844|3610137|FG001|Completed Study Drug Treatment|Randomized Not Treated|0
2039777|NCT00428844|3610138|FG002|Completed Study Drug Treatment|Randomized Not Treated|1
2039778|NCT00428844|3610136|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0
2039779|NCT00428844|3610137|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1
2039780|NCT00428844|3610138|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1
2039781|NCT00428844|3610136|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0
2039782|NCT00428844|3610137|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0
2039783|NCT00428844|3610138|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1
2039784|NCT00428844|3610136|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
2039785|NCT00428844|3610137|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
2039786|NCT00428844|3610138|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
2039787|NCT00428844|3610136|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
2039788|NCT00428844|3610137|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
2039789|NCT00428844|3610138|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
2039790|NCT00428844|3610136|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
2039791|NCT00428844|3610137|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
2039792|NCT00428844|3610138|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
2039793|NCT00428948|3610152|FG000|Overall Study|Lost to Follow-up|15
2039794|NCT00428948|3610153|FG001|Overall Study|Lost to Follow-up|8
2039795|NCT00428948|3610152|FG000|Overall Study|Adverse Event|148
2039796|NCT00428948|3610153|FG001|Overall Study|Adverse Event|24
2039797|NCT00428948|3610152|FG000|Overall Study|Subject Met Withdrawal Criteria|4
2039798|NCT00428948|3610153|FG001|Overall Study|Subject Met Withdrawal Criteria|0
2039799|NCT00428948|3610152|FG000|Overall Study|Investigator Withdrew Subject|3
2039800|NCT00428948|3610153|FG001|Overall Study|Investigator Withdrew Subject|4
2039801|NCT00428948|3610152|FG000|Overall Study|Subject Withdrew Consent|50
2039802|NCT00428948|3610153|FG001|Overall Study|Subject Withdrew Consent|30
2039803|NCT00428948|3610152|FG000|Overall Study|Protocol Deviation|1
2039804|NCT00428948|3610153|FG001|Overall Study|Protocol Deviation|1
2039805|NCT00429104|3610177|FG000|Overall Study|Protocol Violation|1
2039806|NCT00429169|3610187|FG000|Overall Study|Lost to Follow-up|0
2039807|NCT00429169|3610188|FG001|Overall Study|Lost to Follow-up|1
2039808|NCT00429169|3610187|FG000|Overall Study|Ineligibility discovered after entry|2
2039809|NCT00429169|3610188|FG001|Overall Study|Ineligibility discovered after entry|1
2104949|NCT00854113|3697375|FG004|Overall Study|Withdrawal by Subject|0
2104950|NCT00854113|3697376|FG005|Overall Study|Withdrawal by Subject|0
2104951|NCT00854113|3697377|FG006|Overall Study|Withdrawal by Subject|0
2104952|NCT00854113|3697378|FG007|Overall Study|Withdrawal by Subject|1
2104953|NCT00854113|3697379|FG008|Overall Study|Withdrawal by Subject|1
2104954|NCT00854113|3697380|FG009|Overall Study|Withdrawal by Subject|0
2104955|NCT00854113|3697381|FG010|Overall Study|Withdrawal by Subject|0
2104956|NCT00854308|3697407|FG000|Overall Study|Disease progression|42
2104957|NCT00854308|3697408|FG001|Overall Study|Disease progression|50
2104958|NCT00854308|3697407|FG000|Overall Study|Adverse Event|8
2104959|NCT00854308|3697408|FG001|Overall Study|Adverse Event|3
2104960|NCT00854308|3697407|FG000|Overall Study|Death|2
2104961|NCT00854308|3697408|FG001|Overall Study|Death|5
2104962|NCT00854308|3697407|FG000|Overall Study|Physician Decision|6
2104963|NCT00854308|3697408|FG001|Overall Study|Physician Decision|6
2104964|NCT00854308|3697407|FG000|Overall Study|Withdrawal by Subject|4
2104965|NCT00854308|3697408|FG001|Overall Study|Withdrawal by Subject|2
2104966|NCT00854308|3697407|FG000|Overall Study|Sponsor's decision to terminate study|0
2104967|NCT00854308|3697408|FG001|Overall Study|Sponsor's decision to terminate study|1
2104968|NCT00854360|3697418|FG000|Overall Study|Adverse Event|0
2104969|NCT00854360|3697419|FG001|Overall Study|Adverse Event|1
2104970|NCT00854360|3697420|FG002|Overall Study|Adverse Event|2
2104971|NCT00854360|3697421|FG003|Overall Study|Adverse Event|6
2104972|NCT00854360|3697418|FG000|Overall Study|Withdrawal by Subject|0
2104973|NCT00854360|3697419|FG001|Overall Study|Withdrawal by Subject|0
2104974|NCT00854360|3697420|FG002|Overall Study|Withdrawal by Subject|0
2104975|NCT00854360|3697421|FG003|Overall Study|Withdrawal by Subject|1
2204767|NCT01606306|3842626|FG005|Overall Study|Lack of Efficacy|2
2204768|NCT01606306|3842621|FG000|Overall Study|Adverse Event|1
2039810|NCT00429182|3610196|FG000|Overall Study|Not evaluable, Disease Progression|2
2039811|NCT00429182|3610196|FG000|Overall Study|Not eligible|5
2039812|NCT00429273|3610203|FG000|Overall Study|Lost to Follow-up|1
2039813|NCT00429273|3610204|FG001|Overall Study|Lost to Follow-up|2
2039814|NCT00429273|3610205|FG002|Overall Study|Lost to Follow-up|2
2039815|NCT00429273|3610203|FG000|Overall Study|Physician Decision|6
2039816|NCT00429273|3610204|FG001|Overall Study|Physician Decision|5
2039817|NCT00429273|3610205|FG002|Overall Study|Physician Decision|5
2039818|NCT00429273|3610203|FG000|Overall Study|Adverse Event|1
2039819|NCT00429273|3610204|FG001|Overall Study|Adverse Event|1
2039820|NCT00429273|3610205|FG002|Overall Study|Adverse Event|2
2039821|NCT00429299|3610216|FG000|Overall Study|Disease Progression|1
2039822|NCT00429299|3610217|FG001|Overall Study|Disease Progression|1
2039823|NCT00429299|3610218|FG002|Overall Study|Disease Progression|0
2039824|NCT00429299|3610216|FG000|Overall Study|Adverse Event|2
2039825|NCT00429299|3610217|FG001|Overall Study|Adverse Event|5
2039826|NCT00429299|3610218|FG002|Overall Study|Adverse Event|1
2039827|NCT00429299|3610216|FG000|Overall Study|Protocol Violation|1
2039828|NCT00429299|3610217|FG001|Overall Study|Protocol Violation|0
2039829|NCT00429299|3610218|FG002|Overall Study|Protocol Violation|0
2039830|NCT00429299|3610216|FG000|Overall Study|Withdrawal by Subject|0
2039831|NCT00429299|3610217|FG001|Overall Study|Withdrawal by Subject|1
2039832|NCT00429299|3610218|FG002|Overall Study|Withdrawal by Subject|3
2039833|NCT00429364|3610228|FG000|Overall Study|Withdrawal by Subject|11
2039834|NCT00429364|3610229|FG001|Overall Study|Withdrawal by Subject|5
2039835|NCT00429364|3610228|FG000|Overall Study|Physician Decision|4
2039836|NCT00429364|3610229|FG001|Overall Study|Physician Decision|2
2039837|NCT00429364|3610228|FG000|Overall Study|Lost to Follow-up|7
2039838|NCT00429364|3610229|FG001|Overall Study|Lost to Follow-up|6
2039839|NCT00429364|3610228|FG000|Overall Study|Death|0
2039840|NCT00429364|3610229|FG001|Overall Study|Death|1
2039841|NCT00429364|3610228|FG000|Overall Study|Underwent aortic root surgery|10
2039842|NCT00429364|3610229|FG001|Overall Study|Underwent aortic root surgery|18
2277388|NCT02326298|3959836|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2277389|NCT02326298|3959837|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2277390|NCT02326298|3959838|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
2277391|NCT02326298|3959839|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
2277392|NCT02326298|3959840|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2277393|NCT02326298|3959841|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
2039843|NCT00429364|3610228|FG000|Overall Study|Pregnancy|0
2039844|NCT00429364|3610229|FG001|Overall Study|Pregnancy|1
2039845|NCT00429416|3610244|FG000|Overall Study|Death|1
2039846|NCT00429494|3610248|FG000|Overall Study|Withdrawal by Subject|9
2039847|NCT00429494|3610248|FG000|Overall Study|Death|6
2039848|NCT00429572|3610256|FG000|Overall Study|Disease progression|1
2039849|NCT00429585|3610262|FG000|Overall Study|Death|1
2039850|NCT00429585|3610263|FG001|Overall Study|Death|0
2039851|NCT00429585|3610262|FG000|Overall Study|Lost to Follow-up|27
2039852|NCT00429585|3610263|FG001|Overall Study|Lost to Follow-up|20
2039853|NCT00429585|3610262|FG000|Overall Study|Physician Decision|2
2039854|NCT00429585|3610263|FG001|Overall Study|Physician Decision|0
2039855|NCT00429663|3610271|FG000|Overall Study|Lost to Follow-up|24
2039856|NCT00429663|3610272|FG001|Overall Study|Lost to Follow-up|31
2039857|NCT00429663|3610271|FG000|Overall Study|Physician Decision|6
2039858|NCT00429663|3610272|FG001|Overall Study|Physician Decision|3
2039859|NCT00429663|3610271|FG000|Overall Study|Withdrawal by Subject|2
2039860|NCT00429663|3610272|FG001|Overall Study|Withdrawal by Subject|5
2039861|NCT00429663|3610271|FG000|Overall Study|Death|4
2039862|NCT00429663|3610272|FG001|Overall Study|Death|0
2039863|NCT00429793|3610287|FG000|Overall Study|Improper pre-protocol treatment|3
2039864|NCT00429793|3610287|FG000|Overall Study|Required test not done|1
2039865|NCT00429793|3610287|FG000|Overall Study|Never treated|1
2039866|NCT00429793|3610287|FG000|Overall Study|Non-measurable|1
2039867|NCT00430248|3610314|FG000|Overall Study|Adverse Event|49
2039868|NCT00430248|3610315|FG001|Overall Study|Adverse Event|61
2039869|NCT00430248|3610316|FG002|Overall Study|Adverse Event|64
2039870|NCT00430248|3610314|FG000|Overall Study|Protocol Violation|10
2039871|NCT00430248|3610315|FG001|Overall Study|Protocol Violation|2
2039872|NCT00430248|3610316|FG002|Overall Study|Protocol Violation|4
2039873|NCT00430248|3610314|FG000|Overall Study|Personal Reasons|12
2039874|NCT00430248|3610315|FG001|Overall Study|Personal Reasons|24
2039875|NCT00430248|3610316|FG002|Overall Study|Personal Reasons|9
2039876|NCT00430248|3610314|FG000|Overall Study|Lost to Follow-up|28
2039877|NCT00430248|3610315|FG001|Overall Study|Lost to Follow-up|33
2039878|NCT00430248|3610316|FG002|Overall Study|Lost to Follow-up|28
2039879|NCT00430248|3610314|FG000|Overall Study|Therapeutic Failure|1
2039880|NCT00430248|3610315|FG001|Overall Study|Therapeutic Failure|1
2039881|NCT00430248|3610316|FG002|Overall Study|Therapeutic Failure|1
2039882|NCT00430248|3610314|FG000|Overall Study|Withdrawal by Subject|14
2039883|NCT00430248|3610315|FG001|Overall Study|Withdrawal by Subject|20
2039884|NCT00430248|3610316|FG002|Overall Study|Withdrawal by Subject|16
2039885|NCT00430248|3610314|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2039886|NCT00430248|3610315|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
2039887|NCT00430248|3610316|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2039888|NCT00430248|3610314|FG000|Overall Study|Gout Flare|3
2039889|NCT00430248|3610315|FG001|Overall Study|Gout Flare|7
2039890|NCT00430248|3610316|FG002|Overall Study|Gout Flare|2
2039891|NCT00430248|3610314|FG000|Overall Study|Reason Not Specified|8
2039892|NCT00430248|3610315|FG001|Overall Study|Reason Not Specified|8
2039893|NCT00430248|3610316|FG002|Overall Study|Reason Not Specified|11
2039894|NCT00430300|3610328|FG000|Overall Study|Adverse Event|0
2039895|NCT00430300|3610329|FG001|Overall Study|Adverse Event|2
2039896|NCT00430300|3610330|FG002|Overall Study|Adverse Event|1
2039897|NCT00430300|3610331|FG003|Overall Study|Adverse Event|1
2039898|NCT00430300|3610328|FG000|Overall Study|Withdrawal by Subject|1
2039899|NCT00430300|3610329|FG001|Overall Study|Withdrawal by Subject|0
2039900|NCT00430300|3610330|FG002|Overall Study|Withdrawal by Subject|5
2039901|NCT00430300|3610331|FG003|Overall Study|Withdrawal by Subject|0
2039902|NCT00430300|3610328|FG000|Overall Study|Laboratory abnormality|1
2039903|NCT00430300|3610329|FG001|Overall Study|Laboratory abnormality|0
2039904|NCT00430300|3610330|FG002|Overall Study|Laboratory abnormality|0
2039905|NCT00430300|3610331|FG003|Overall Study|Laboratory abnormality|0
2039906|NCT00430300|3610328|FG000|Overall Study|Other|0
2039907|NCT00430300|3610329|FG001|Overall Study|Other|0
2039908|NCT00430300|3610330|FG002|Overall Study|Other|0
2039909|NCT00430300|3610331|FG003|Overall Study|Other|1
2039910|NCT00430352|3610341|FG000|Overall Study|Disease progression|58
2039911|NCT00430352|3610341|FG000|Overall Study|Withdrawal by Subject|11
2039912|NCT00430352|3610341|FG000|Overall Study|Adverse Event|16
2039913|NCT00430352|3610341|FG000|Overall Study|Death|5
2039914|NCT00430352|3610341|FG000|Overall Study|Other|48
2039915|NCT00430482|3610347|FG000|Completed Treatment|Insufficient Treatment|7
2039916|NCT00430482|3610348|FG001|Completed Treatment|Insufficient Treatment|11
2039917|NCT00430495|3610358|FG000|Overall Study|Adverse Event|2
2039918|NCT00430495|3610359|FG001|Overall Study|Adverse Event|3
2039919|NCT00430495|3610360|FG002|Overall Study|Adverse Event|2
2039920|NCT00430495|3610361|FG003|Overall Study|Adverse Event|0
2039921|NCT00430495|3610358|FG000|Overall Study|Death|0
2039922|NCT00430495|3610359|FG001|Overall Study|Death|0
2039923|NCT00430495|3610360|FG002|Overall Study|Death|1
2039924|NCT00430495|3610361|FG003|Overall Study|Death|0
2039925|NCT00430495|3610358|FG000|Overall Study|Lost to Follow-up|0
2039926|NCT00430495|3610359|FG001|Overall Study|Lost to Follow-up|1
2039927|NCT00430495|3610360|FG002|Overall Study|Lost to Follow-up|4
2039928|NCT00430495|3610361|FG003|Overall Study|Lost to Follow-up|0
2039929|NCT00430495|3610358|FG000|Overall Study|Protocol Violation|1
2039930|NCT00430495|3610359|FG001|Overall Study|Protocol Violation|0
2039931|NCT00430495|3610360|FG002|Overall Study|Protocol Violation|1
2039932|NCT00430495|3610361|FG003|Overall Study|Protocol Violation|0
2039933|NCT00430495|3610358|FG000|Overall Study|Disease Progression|1
2118206|NCT00950248|3715941|FG002|Year 1: Baseline|worsening of symptoms|0
2039934|NCT00430495|3610359|FG001|Overall Study|Disease Progression|1
2039935|NCT00430495|3610360|FG002|Overall Study|Disease Progression|0
2039936|NCT00430495|3610361|FG003|Overall Study|Disease Progression|0
2039937|NCT00430495|3610358|FG000|Overall Study|Other|8
2039938|NCT00430495|3610359|FG001|Overall Study|Other|2
2039939|NCT00430495|3610360|FG002|Overall Study|Other|5
2039940|NCT00430495|3610361|FG003|Overall Study|Other|4
2039941|NCT00430495|3610358|FG000|Overall Study|Randomized but not Treated|2
2039942|NCT00430495|3610359|FG001|Overall Study|Randomized but not Treated|0
2039943|NCT00430495|3610360|FG002|Overall Study|Randomized but not Treated|0
2039944|NCT00430495|3610361|FG003|Overall Study|Randomized but not Treated|0
2039945|NCT00430521|3610379|FG000|Overall Study|Adverse Event|0
2039946|NCT00430521|3610380|FG001|Overall Study|Adverse Event|0
2039947|NCT00430521|3610381|FG002|Overall Study|Adverse Event|0
2277394|NCT02326298|3959842|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2039948|NCT00430521|3610382|FG003|Overall Study|Adverse Event|0
2039949|NCT00430521|3610383|FG004|Overall Study|Adverse Event|0
2039950|NCT00430521|3610384|FG005|Overall Study|Adverse Event|2
2039951|NCT00430521|3610385|FG006|Overall Study|Adverse Event|1
2039952|NCT00430521|3610386|FG007|Overall Study|Adverse Event|0
2039953|NCT00430521|3610379|FG000|Overall Study|Lost to Follow-up|7
2039954|NCT00430521|3610380|FG001|Overall Study|Lost to Follow-up|8
2039955|NCT00430521|3610381|FG002|Overall Study|Lost to Follow-up|3
2039956|NCT00430521|3610382|FG003|Overall Study|Lost to Follow-up|5
2039957|NCT00430521|3610383|FG004|Overall Study|Lost to Follow-up|5
2039958|NCT00430521|3610384|FG005|Overall Study|Lost to Follow-up|2
2039959|NCT00430521|3610385|FG006|Overall Study|Lost to Follow-up|8
2039960|NCT00430521|3610386|FG007|Overall Study|Lost to Follow-up|10
2039961|NCT00430521|3610379|FG000|Overall Study|Pregnancy|0
2039962|NCT00430521|3610380|FG001|Overall Study|Pregnancy|0
2277395|NCT02326298|3959843|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2277396|NCT02326298|3959844|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2277397|NCT02326298|3959845|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2277398|NCT02326298|3959846|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2277399|NCT02326298|3959833|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277400|NCT02326298|3959834|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277401|NCT02326298|3959835|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277402|NCT02326298|3959836|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277403|NCT02326298|3959837|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277404|NCT02326298|3959838|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
2039963|NCT00430521|3610381|FG002|Overall Study|Pregnancy|0
2039964|NCT00430521|3610382|FG003|Overall Study|Pregnancy|0
2039965|NCT00430521|3610383|FG004|Overall Study|Pregnancy|0
2039966|NCT00430521|3610384|FG005|Overall Study|Pregnancy|0
2039967|NCT00430521|3610385|FG006|Overall Study|Pregnancy|1
2039968|NCT00430521|3610386|FG007|Overall Study|Pregnancy|0
2039969|NCT00430521|3610379|FG000|Overall Study|Vaccine Expired|0
2039970|NCT00430521|3610380|FG001|Overall Study|Vaccine Expired|0
2039971|NCT00430521|3610381|FG002|Overall Study|Vaccine Expired|0
2039972|NCT00430521|3610382|FG003|Overall Study|Vaccine Expired|0
2039973|NCT00430521|3610383|FG004|Overall Study|Vaccine Expired|0
2039974|NCT00430521|3610384|FG005|Overall Study|Vaccine Expired|1
2039975|NCT00430521|3610385|FG006|Overall Study|Vaccine Expired|0
2039976|NCT00430521|3610386|FG007|Overall Study|Vaccine Expired|0
2039977|NCT00430521|3610379|FG000|Overall Study|Protocol Violation|1
2039978|NCT00430521|3610380|FG001|Overall Study|Protocol Violation|0
2039979|NCT00430521|3610381|FG002|Overall Study|Protocol Violation|0
2039980|NCT00430521|3610382|FG003|Overall Study|Protocol Violation|0
2039981|NCT00430521|3610383|FG004|Overall Study|Protocol Violation|0
2039982|NCT00430521|3610384|FG005|Overall Study|Protocol Violation|0
2039983|NCT00430521|3610385|FG006|Overall Study|Protocol Violation|0
2039984|NCT00430521|3610386|FG007|Overall Study|Protocol Violation|0
2039985|NCT00430521|3610379|FG000|Overall Study|Withdrawal by Subject|3
2039986|NCT00430521|3610380|FG001|Overall Study|Withdrawal by Subject|1
2039987|NCT00430521|3610381|FG002|Overall Study|Withdrawal by Subject|0
2118207|NCT00950248|3715939|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0
2039988|NCT00430521|3610382|FG003|Overall Study|Withdrawal by Subject|3
2039989|NCT00430521|3610383|FG004|Overall Study|Withdrawal by Subject|0
2039990|NCT00430521|3610384|FG005|Overall Study|Withdrawal by Subject|0
2039991|NCT00430521|3610385|FG006|Overall Study|Withdrawal by Subject|0
2039992|NCT00430521|3610386|FG007|Overall Study|Withdrawal by Subject|2
2039993|NCT00430573|3610417|FG000|Overall Study|Withdrawal by Subject|5
2039994|NCT00430638|3610434|FG000|Overall Study|Adverse Event|15
2039995|NCT00430638|3610435|FG001|Overall Study|Adverse Event|15
2039996|NCT00430638|3610434|FG000|Overall Study|Uncontrolled blood pressure|48
2039997|NCT00430638|3610435|FG001|Overall Study|Uncontrolled blood pressure|13
2039998|NCT00430638|3610434|FG000|Overall Study|Lost to Follow-up|1
2039999|NCT00430638|3610435|FG001|Overall Study|Lost to Follow-up|7
2040000|NCT00430638|3610434|FG000|Overall Study|Protocol Violation|6
2040001|NCT00430638|3610435|FG001|Overall Study|Protocol Violation|4
2040002|NCT00430638|3610434|FG000|Overall Study|Withdrawal by Subject|4
2040003|NCT00430638|3610435|FG001|Overall Study|Withdrawal by Subject|6
2040004|NCT00430638|3610434|FG000|Overall Study|Non-compliant|2
2040005|NCT00430638|3610435|FG001|Overall Study|Non-compliant|1
2040006|NCT00430638|3610434|FG000|Overall Study|Other|2
2040007|NCT00430638|3610435|FG001|Overall Study|Other|2
2040008|NCT00430677|3610448|FG000|Short-term Period|Death|1
2040009|NCT00430677|3610449|FG001|Short-term Period|Death|1
2040010|NCT00430677|3610450|FG002|Short-term Period|Death|5
2040011|NCT00430677|3610448|FG000|Short-term Period|Adverse Event|15
2040012|NCT00430677|3610449|FG001|Short-term Period|Adverse Event|13
2040013|NCT00430677|3610450|FG002|Short-term Period|Adverse Event|9
2040014|NCT00430677|3610448|FG000|Short-term Period|Lack of Efficacy|5
2040015|NCT00430677|3610449|FG001|Short-term Period|Lack of Efficacy|6
2040016|NCT00430677|3610450|FG002|Short-term Period|Lack of Efficacy|4
2040017|NCT00430677|3610448|FG000|Short-term Period|Withdrawal by Subject|1
2040018|NCT00430677|3610449|FG001|Short-term Period|Withdrawal by Subject|1
2040019|NCT00430677|3610450|FG002|Short-term Period|Withdrawal by Subject|2
2040020|NCT00430677|3610448|FG000|Short-term Period|Participant no longer met study criteria|1
2040021|NCT00430677|3610449|FG001|Short-term Period|Participant no longer met study criteria|1
2040022|NCT00430677|3610450|FG002|Short-term Period|Participant no longer met study criteria|2
2040023|NCT00430677|3610448|FG000|Short-term Period|Poor compliance/ noncompliance|0
2040024|NCT00430677|3610449|FG001|Short-term Period|Poor compliance/ noncompliance|1
2040025|NCT00430677|3610450|FG002|Short-term Period|Poor compliance/ noncompliance|0
2040026|NCT00430677|3610448|FG000|Short-term Period|Pregnancy|0
2040027|NCT00430677|3610449|FG001|Short-term Period|Pregnancy|2
2040028|NCT00430677|3610450|FG002|Short-term Period|Pregnancy|0
2040029|NCT00430677|3610448|FG000|Long-term Extension Period|Death|1
2040030|NCT00430677|3610449|FG001|Long-term Extension Period|Death|0
2040031|NCT00430677|3610450|FG002|Long-term Extension Period|Death|0
2040032|NCT00430677|3610448|FG000|Long-term Extension Period|Adverse Event|3
2040033|NCT00430677|3610449|FG001|Long-term Extension Period|Adverse Event|2
2040034|NCT00430677|3610450|FG002|Long-term Extension Period|Adverse Event|5
2040035|NCT00430677|3610448|FG000|Long-term Extension Period|Lack of Efficacy|5
2040036|NCT00430677|3610449|FG001|Long-term Extension Period|Lack of Efficacy|3
2040037|NCT00430677|3610450|FG002|Long-term Extension Period|Lack of Efficacy|8
2040038|NCT00430677|3610448|FG000|Long-term Extension Period|Lost to Follow-up|1
2040039|NCT00430677|3610449|FG001|Long-term Extension Period|Lost to Follow-up|1
2040040|NCT00430677|3610450|FG002|Long-term Extension Period|Lost to Follow-up|1
2040041|NCT00430677|3610448|FG000|Long-term Extension Period|Withdrawal by Subject|5
2040042|NCT00430677|3610449|FG001|Long-term Extension Period|Withdrawal by Subject|1
2040043|NCT00430677|3610450|FG002|Long-term Extension Period|Withdrawal by Subject|2
2040044|NCT00430677|3610448|FG000|Long-term Extension Period|Pregnancy|1
2040045|NCT00430677|3610449|FG001|Long-term Extension Period|Pregnancy|1
2040046|NCT00430677|3610450|FG002|Long-term Extension Period|Pregnancy|0
2040047|NCT00430677|3610448|FG000|Long-term Extension Period|Administrative reason by sponsor|41
2118208|NCT00950248|3715940|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2
2040048|NCT00430677|3610449|FG001|Long-term Extension Period|Administrative reason by sponsor|49
2040049|NCT00430677|3610450|FG002|Long-term Extension Period|Administrative reason by sponsor|46
2040050|NCT00430677|3610448|FG000|Long-term Extension Period|Other|2
2040051|NCT00430677|3610449|FG001|Long-term Extension Period|Other|1
2040052|NCT00430677|3610450|FG002|Long-term Extension Period|Other|1
2040053|NCT00430677|3610448|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
2040054|NCT00430677|3610449|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
2040055|NCT00430677|3610450|FG002|Long-term Extension Period|Poor compliance/noncompliance|0
2040056|NCT00430716|3610479|FG000|Double Blind Phase|Death|1
2040057|NCT00430716|3610480|FG001|Double Blind Phase|Death|0
2040058|NCT00430716|3610481|FG002|Double Blind Phase|Death|0
2040059|NCT00430716|3610479|FG000|Double Blind Phase|No longer willing to participate|2
2040060|NCT00430716|3610480|FG001|Double Blind Phase|No longer willing to participate|1
2040061|NCT00430716|3610481|FG002|Double Blind Phase|No longer willing to participate|1
2204769|NCT01606306|3842622|FG001|Overall Study|Adverse Event|0
2019039|NCT00296504|3586496|FG005|Interim Analysis|Participant Was Incarcerated|0
2019040|NCT00296504|3586497|FG006|Interim Analysis|Participant Was Incarcerated|0
2019041|NCT00296504|3586498|FG007|Interim Analysis|Participant Was Incarcerated|0
2019042|NCT00296504|3586499|FG008|Interim Analysis|Participant Was Incarcerated|0
2019043|NCT00296504|3586491|FG000|Interim Analysis|Resistance to FPV|0
2019044|NCT00296504|3586492|FG001|Interim Analysis|Resistance to FPV|0
2019045|NCT00296504|3586493|FG002|Interim Analysis|Resistance to FPV|1
2019046|NCT00296504|3586494|FG003|Interim Analysis|Resistance to FPV|0
2019047|NCT00296504|3586495|FG004|Interim Analysis|Resistance to FPV|0
2019048|NCT00296504|3586496|FG005|Interim Analysis|Resistance to FPV|0
2019049|NCT00296504|3586497|FG006|Interim Analysis|Resistance to FPV|0
2019050|NCT00296504|3586498|FG007|Interim Analysis|Resistance to FPV|0
2019051|NCT00296504|3586499|FG008|Interim Analysis|Resistance to FPV|0
2019052|NCT00296504|3586491|FG000|Interim Analysis|Physician Decision|0
2019053|NCT00296504|3586492|FG001|Interim Analysis|Physician Decision|0
2019054|NCT00296504|3586493|FG002|Interim Analysis|Physician Decision|1
2040062|NCT00430716|3610479|FG000|Double Blind Phase|Other|0
2040063|NCT00430716|3610480|FG001|Double Blind Phase|Other|2
2040064|NCT00430716|3610481|FG002|Double Blind Phase|Other|0
2040065|NCT00430716|3610479|FG000|Double Blind Phase|Study terminated by sponsor|1
2040066|NCT00430716|3610480|FG001|Double Blind Phase|Study terminated by sponsor|1
2040067|NCT00430716|3610481|FG002|Double Blind Phase|Study terminated by sponsor|2
2040068|NCT00430716|3610479|FG000|Double Blind Phase|Adverse Event|1
2040069|NCT00430716|3610480|FG001|Double Blind Phase|Adverse Event|1
2040070|NCT00430716|3610481|FG002|Double Blind Phase|Adverse Event|3
2040071|NCT00430716|3610479|FG000|Double Blind Phase|Not treated|1
2040072|NCT00430716|3610480|FG001|Double Blind Phase|Not treated|0
2040073|NCT00430716|3610481|FG002|Double Blind Phase|Not treated|0
2040074|NCT00430716|3610479|FG000|Open Label Phase|Lost to Follow-up|1
2040075|NCT00430716|3610480|FG001|Open Label Phase|Lost to Follow-up|0
2040076|NCT00430716|3610481|FG002|Open Label Phase|Lost to Follow-up|1
2040077|NCT00430716|3610479|FG000|Open Label Phase|No longer willing to participate|0
2040078|NCT00430716|3610480|FG001|Open Label Phase|No longer willing to participate|1
2040079|NCT00430716|3610481|FG002|Open Label Phase|No longer willing to participate|1
2040080|NCT00430716|3610479|FG000|Open Label Phase|Other|3
2040081|NCT00430716|3610480|FG001|Open Label Phase|Other|1
2040082|NCT00430716|3610481|FG002|Open Label Phase|Other|1
2040083|NCT00430716|3610479|FG000|Open Label Phase|Protocol Violation|1
2040084|NCT00430716|3610480|FG001|Open Label Phase|Protocol Violation|0
2040085|NCT00430716|3610481|FG002|Open Label Phase|Protocol Violation|0
2040086|NCT00430716|3610479|FG000|Open Label Phase|Study terminated by sponsor|4
2040087|NCT00430716|3610480|FG001|Open Label Phase|Study terminated by sponsor|5
2040088|NCT00430716|3610481|FG002|Open Label Phase|Study terminated by sponsor|4
2040089|NCT00430755|3610489|FG000|Overall Study|Withdrawal by Subject|53
2040090|NCT00430781|3610515|FG000|Interim Analysis; 11 February 2008|Adverse Event|10
2040091|NCT00430781|3610516|FG001|Interim Analysis; 11 February 2008|Adverse Event|3
2040092|NCT00430781|3610517|FG002|Interim Analysis; 11 February 2008|Adverse Event|7
2040093|NCT00430781|3610515|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1
2040094|NCT00430781|3610516|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0
2040095|NCT00430781|3610517|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1
2040096|NCT00430781|3610515|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0
2040097|NCT00430781|3610516|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1
2040098|NCT00430781|3610517|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0
2204770|NCT01606306|3842623|FG002|Overall Study|Adverse Event|1
2204771|NCT01606306|3842624|FG003|Overall Study|Adverse Event|1
2204772|NCT01606306|3842625|FG004|Overall Study|Adverse Event|2
2040099|NCT00430781|3610515|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
2040100|NCT00430781|3610516|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
2040101|NCT00430781|3610517|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
2040102|NCT00430781|3610515|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
2204773|NCT01606306|3842626|FG005|Overall Study|Adverse Event|0
2277405|NCT02326298|3959839|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277406|NCT02326298|3959840|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277407|NCT02326298|3959841|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277408|NCT02326298|3959842|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277409|NCT02326298|3959843|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277410|NCT02326298|3959844|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277411|NCT02326298|3959845|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277412|NCT02326298|3959846|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2277413|NCT02326298|3959833|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277414|NCT02326298|3959834|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277415|NCT02326298|3959835|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277416|NCT02326298|3959836|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277417|NCT02326298|3959837|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277418|NCT02326298|3959838|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277419|NCT02326298|3959839|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
2277420|NCT02326298|3959840|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277421|NCT02326298|3959841|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277422|NCT02326298|3959842|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277423|NCT02326298|3959843|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277424|NCT02326298|3959844|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277425|NCT02326298|3959845|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277426|NCT02326298|3959846|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2277427|NCT02326298|3959833|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2277428|NCT02326298|3959834|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2040103|NCT00430781|3610516|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
2040104|NCT00430781|3610517|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
2040105|NCT00430781|3610515|FG000|Interim Analysis; 11 February 2008|Disease Progression|16
2040106|NCT00430781|3610516|FG001|Interim Analysis; 11 February 2008|Disease Progression|30
2040107|NCT00430781|3610517|FG002|Interim Analysis; 11 February 2008|Disease Progression|22
2040108|NCT00430781|3610515|FG000|Interim Analysis; 11 February 2008|Death|0
2040109|NCT00430781|3610516|FG001|Interim Analysis; 11 February 2008|Death|1
2040110|NCT00430781|3610517|FG002|Interim Analysis; 11 February 2008|Death|0
2040111|NCT00430781|3610515|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
2040112|NCT00430781|3610516|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
2040113|NCT00430781|3610517|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
2040114|NCT00430781|3610515|FG000|Interim Analysis; 11 February 2008|Physician Decision|2
2040115|NCT00430781|3610516|FG001|Interim Analysis; 11 February 2008|Physician Decision|3
2040116|NCT00430781|3610517|FG002|Interim Analysis; 11 February 2008|Physician Decision|3
2040117|NCT00430781|3610515|FG000|Interim Analysis; 11 February 2008|Ongoing|23
2040118|NCT00430781|3610516|FG001|Interim Analysis; 11 February 2008|Ongoing|20
2040119|NCT00430781|3610517|FG002|Interim Analysis; 11 February 2008|Ongoing|25
2040120|NCT00430781|3610515|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0
2040121|NCT00430781|3610516|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0
2040122|NCT00430781|3610517|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3
2040123|NCT00430781|3610515|FG000|Final Analysis; 31 July 2008|Protocol Violation|0
2040124|NCT00430781|3610516|FG001|Final Analysis; 31 July 2008|Protocol Violation|1
2040125|NCT00430781|3610517|FG002|Final Analysis; 31 July 2008|Protocol Violation|0
2040126|NCT00430781|3610515|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0
2040127|NCT00430781|3610516|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2
2040128|NCT00430781|3610517|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7
2040129|NCT00430781|3610515|FG000|Final Analysis; 31 July 2008|Physician Decision|0
2040130|NCT00430781|3610516|FG001|Final Analysis; 31 July 2008|Physician Decision|6
2040131|NCT00430781|3610517|FG002|Final Analysis; 31 July 2008|Physician Decision|6
2040132|NCT00430781|3610515|FG000|Final Analysis; 31 July 2008|Other|0
2040133|NCT00430781|3610516|FG001|Final Analysis; 31 July 2008|Other|1
2040134|NCT00430781|3610517|FG002|Final Analysis; 31 July 2008|Other|0
2040135|NCT00430781|3610515|FG000|Final Analysis; 31 July 2008|Ongoing|0
2040136|NCT00430781|3610516|FG001|Final Analysis; 31 July 2008|Ongoing|29
2040137|NCT00430781|3610517|FG002|Final Analysis; 31 July 2008|Ongoing|32
2040138|NCT00430781|3610515|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
2040139|NCT00430781|3610516|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
2040140|NCT00430781|3610517|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
2040141|NCT00430781|3610515|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
2040142|NCT00430781|3610516|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
2040143|NCT00430781|3610517|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
2040144|NCT00430781|3610515|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
2040145|NCT00430781|3610516|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
2118209|NCT00950248|3715941|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4
2118210|NCT00950248|3715939|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
2040146|NCT00430781|3610517|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
2040147|NCT00430781|3610515|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
2040148|NCT00430781|3610516|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
2040149|NCT00430781|3610517|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
2040150|NCT00430781|3610515|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4
2040151|NCT00430781|3610516|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6
2040152|NCT00430781|3610517|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6
2040153|NCT00430781|3610515|FG000|End-of-Study Analysis; 28 July 2011|Other|4
2040154|NCT00430781|3610516|FG001|End-of-Study Analysis; 28 July 2011|Other|1
2040155|NCT00430781|3610517|FG002|End-of-Study Analysis; 28 July 2011|Other|0
2040156|NCT00430937|3610530|FG000|Overall Study|Adverse Event|3
2040157|NCT00430937|3610531|FG001|Overall Study|Adverse Event|8
2040158|NCT00430937|3610530|FG000|Overall Study|Death|0
2040159|NCT00430937|3610531|FG001|Overall Study|Death|1
2040160|NCT00430937|3610530|FG000|Overall Study|Lost to Follow-up|6
2040161|NCT00430937|3610531|FG001|Overall Study|Lost to Follow-up|6
2040162|NCT00430937|3610530|FG000|Overall Study|Withdrawal by Subject|5
2040163|NCT00430937|3610531|FG001|Overall Study|Withdrawal by Subject|2
2040164|NCT00430937|3610530|FG000|Overall Study|Protocol Violation|3
2040165|NCT00430937|3610531|FG001|Overall Study|Protocol Violation|2
2040166|NCT00430937|3610530|FG000|Overall Study|Lack of Efficacy|6
2040167|NCT00430937|3610531|FG001|Overall Study|Lack of Efficacy|5
2040168|NCT00430937|3610530|FG000|Overall Study|Inappropriate enrollment|2
2040169|NCT00430937|3610531|FG001|Overall Study|Inappropriate enrollment|1
2040170|NCT00430937|3610530|FG000|Overall Study|Administrative reasons|1
2040171|NCT00430937|3610531|FG001|Overall Study|Administrative reasons|0
2040172|NCT00430937|3610530|FG000|Overall Study|Protocol discontinuation criteria met|1
2277429|NCT02326298|3959835|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2040173|NCT00430937|3610531|FG001|Overall Study|Protocol discontinuation criteria met|2
2040174|NCT00430937|3610530|FG000|Overall Study|Unable to classify|0
2040175|NCT00430937|3610531|FG001|Overall Study|Unable to classify|1
2040176|NCT00430989|3610539|FG000|Overall Study|Lost to Follow-up|2
2040177|NCT00430989|3610540|FG001|Overall Study|Lost to Follow-up|3
2040178|NCT00430989|3610539|FG000|Overall Study|Withdrawal by Subject|15
2040179|NCT00430989|3610540|FG001|Overall Study|Withdrawal by Subject|14
2040180|NCT00430989|3610539|FG000|Overall Study|Protocol Violation|30
2040181|NCT00430989|3610540|FG001|Overall Study|Protocol Violation|37
2040182|NCT00430989|3610539|FG000|Overall Study|Not eligible|13
2040183|NCT00430989|3610540|FG001|Overall Study|Not eligible|6
2040184|NCT00431067|3610557|FG000|Overall Study|Other Adverse Event|9
2040185|NCT00431067|3610557|FG000|Overall Study|Progressive disease|30
2040186|NCT00431067|3610557|FG000|Overall Study|Non-compliance,lost to follow-up|2
2040187|NCT00431444|3610578|FG000|Overall Study|Protocol Violation|1
2040188|NCT00431444|3610579|FG001|Overall Study|Protocol Violation|4
2040189|NCT00431444|3610578|FG000|Overall Study|Adverse Event|2
2040190|NCT00431444|3610579|FG001|Overall Study|Adverse Event|1
2040191|NCT00431444|3610578|FG000|Overall Study|Withdrawal by Subject|1
2040192|NCT00431444|3610579|FG001|Overall Study|Withdrawal by Subject|1
2040193|NCT00431444|3610578|FG000|Overall Study|Lost to Follow-up|1
2040194|NCT00431444|3610579|FG001|Overall Study|Lost to Follow-up|0
2040195|NCT00431444|3610578|FG000|Overall Study|Administrative Problems|0
2040196|NCT00431444|3610579|FG001|Overall Study|Administrative Problems|1
2040197|NCT00431496|3610585|FG000|Overall Study|Adverse Event|3
2040198|NCT00431496|3610585|FG000|Overall Study|Lost to Follow-up|1
2040199|NCT00431496|3610585|FG000|Overall Study|Withdrawal by Subject|2
2040200|NCT00431496|3610585|FG000|Overall Study|Protocol-specified criteria|5
2040201|NCT00431834|3610598|FG000|Overall Study|Withdrawal by Subject|7
2040202|NCT00431834|3610598|FG000|Overall Study|Death|3
2277430|NCT02326298|3959836|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2277431|NCT02326298|3959837|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2277432|NCT02326298|3959838|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2277433|NCT02326298|3959839|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2277434|NCT02326298|3959840|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
2277435|NCT02326298|3959841|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2277436|NCT02326298|3959842|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2277437|NCT02326298|3959843|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2277438|NCT02326298|3959844|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2040203|NCT00431834|3610598|FG000|Overall Study|Missed Endpoint Visit|2
2040204|NCT00431834|3610598|FG000|Overall Study|Lost to Follow-up|1
2040205|NCT00431847|3610609|FG000|Overall Study|completion of less than two study visits|6
2040206|NCT00431847|3610610|FG001|Overall Study|completion of less than two study visits|3
2040207|NCT00431847|3610611|FG002|Overall Study|completion of less than two study visits|4
2040208|NCT00431847|3610612|FG003|Overall Study|completion of less than two study visits|14
2040209|NCT00431847|3610613|FG004|Overall Study|completion of less than two study visits|0
2040210|NCT00431847|3610609|FG000|Overall Study|Protocol Violation|0
2040211|NCT00431847|3610610|FG001|Overall Study|Protocol Violation|0
2040212|NCT00431847|3610611|FG002|Overall Study|Protocol Violation|0
2040213|NCT00431847|3610612|FG003|Overall Study|Protocol Violation|0
2040214|NCT00431847|3610613|FG004|Overall Study|Protocol Violation|1
2040215|NCT00431951|3610627|FG000|Overall Study|Inability to follow study procedures|1
2040216|NCT00431951|3610628|FG001|Overall Study|Inability to follow study procedures|0
2040217|NCT00431951|3610629|FG002|Overall Study|Inability to follow study procedures|1
2040218|NCT00431951|3610630|FG003|Overall Study|Inability to follow study procedures|2
2040219|NCT00431951|3610627|FG000|Overall Study|Lost to Follow-up|0
2040220|NCT00431951|3610628|FG001|Overall Study|Lost to Follow-up|1
2040221|NCT00431951|3610629|FG002|Overall Study|Lost to Follow-up|0
2040222|NCT00431951|3610630|FG003|Overall Study|Lost to Follow-up|0
2040223|NCT00431951|3610627|FG000|Overall Study|Withdrawal by Subject|0
2040224|NCT00431951|3610628|FG001|Overall Study|Withdrawal by Subject|1
2040225|NCT00431951|3610629|FG002|Overall Study|Withdrawal by Subject|0
2040226|NCT00431951|3610630|FG003|Overall Study|Withdrawal by Subject|0
2040227|NCT00431951|3610627|FG000|Overall Study|Adverse Event|0
2040228|NCT00431951|3610628|FG001|Overall Study|Adverse Event|0
2040229|NCT00431951|3610629|FG002|Overall Study|Adverse Event|1
2040230|NCT00431951|3610630|FG003|Overall Study|Adverse Event|0
2040231|NCT00431964|3610646|FG000|Overall Study|Adverse Event|1
2040232|NCT00431964|3610647|FG001|Overall Study|Adverse Event|0
2040233|NCT00431964|3610646|FG000|Overall Study|Lost to Follow-up|1
2040234|NCT00431964|3610647|FG001|Overall Study|Lost to Follow-up|2
2040235|NCT00431964|3610646|FG000|Overall Study|Physician Decision|2
2040236|NCT00431964|3610647|FG001|Overall Study|Physician Decision|2
2040237|NCT00431964|3610646|FG000|Overall Study|Withdrawal by Subject|2
2040238|NCT00431964|3610647|FG001|Overall Study|Withdrawal by Subject|1
2040239|NCT00431964|3610646|FG000|Overall Study|Parental Consent Withdrawn|0
2040240|NCT00431964|3610647|FG001|Overall Study|Parental Consent Withdrawn|2
2040241|NCT00431964|3610646|FG000|Overall Study|Due to Unstable Health|0
2040242|NCT00431964|3610647|FG001|Overall Study|Due to Unstable Health|1
2040243|NCT00432042|3610656|FG000|Overall Study|Protocol Violation|2
2040244|NCT00432042|3610657|FG001|Overall Study|Protocol Violation|0
2040245|NCT00432042|3610658|FG002|Overall Study|Protocol Violation|0
2040246|NCT00432042|3610656|FG000|Overall Study|Withdrawal by Subject|0
2040247|NCT00432042|3610657|FG001|Overall Study|Withdrawal by Subject|0
2040248|NCT00432042|3610658|FG002|Overall Study|Withdrawal by Subject|2
2040249|NCT00432042|3610656|FG000|Overall Study|Lost to Follow-up|5
2040250|NCT00432042|3610657|FG001|Overall Study|Lost to Follow-up|1
2040251|NCT00432042|3610658|FG002|Overall Study|Lost to Follow-up|0
2040252|NCT00432159|3610671|FG000|Overall Study|Death|0
2040253|NCT00432159|3610672|FG001|Overall Study|Death|1
2040254|NCT00432159|3610673|FG002|Overall Study|Death|0
2040255|NCT00432159|3610674|FG003|Overall Study|Death|0
2040256|NCT00432159|3610675|FG004|Overall Study|Death|0
2040257|NCT00432159|3610671|FG000|Overall Study|Failure|9
2040258|NCT00432159|3610672|FG001|Overall Study|Failure|5
2040259|NCT00432159|3610673|FG002|Overall Study|Failure|3
2040260|NCT00432159|3610674|FG003|Overall Study|Failure|2
2040261|NCT00432159|3610675|FG004|Overall Study|Failure|3
2040262|NCT00432159|3610671|FG000|Overall Study|Missing NDI and/or neuro. assessment|13
2040263|NCT00432159|3610672|FG001|Overall Study|Missing NDI and/or neuro. assessment|24
2040264|NCT00432159|3610673|FG002|Overall Study|Missing NDI and/or neuro. assessment|1
2040265|NCT00432159|3610674|FG003|Overall Study|Missing NDI and/or neuro. assessment|3
2040266|NCT00432159|3610675|FG004|Overall Study|Missing NDI and/or neuro. assessment|7
2040267|NCT00432172|3610691|FG000|Overall Study|Physician Decision|0
2040268|NCT00432172|3610692|FG001|Overall Study|Physician Decision|0
2040269|NCT00432172|3610693|FG002|Overall Study|Physician Decision|2
2040270|NCT00432172|3610694|FG003|Overall Study|Physician Decision|0
2040271|NCT00432172|3610691|FG000|Overall Study|Adverse Event|4
2040272|NCT00432172|3610692|FG001|Overall Study|Adverse Event|2
2040273|NCT00432172|3610693|FG002|Overall Study|Adverse Event|4
2040274|NCT00432172|3610694|FG003|Overall Study|Adverse Event|3
2040275|NCT00432172|3610691|FG000|Overall Study|Disease progression|0
2040276|NCT00432172|3610692|FG001|Overall Study|Disease progression|2
2040277|NCT00432172|3610693|FG002|Overall Study|Disease progression|5
2040278|NCT00432172|3610694|FG003|Overall Study|Disease progression|1
2040279|NCT00432172|3610691|FG000|Overall Study|Withdrawal by Subject|0
2040280|NCT00432172|3610692|FG001|Overall Study|Withdrawal by Subject|1
2040281|NCT00432172|3610693|FG002|Overall Study|Withdrawal by Subject|0
2040282|NCT00432172|3610694|FG003|Overall Study|Withdrawal by Subject|2
2040283|NCT00432172|3610691|FG000|Overall Study|No treatment received|2
2040284|NCT00432172|3610692|FG001|Overall Study|No treatment received|2
2040285|NCT00432172|3610693|FG002|Overall Study|No treatment received|0
2040286|NCT00432172|3610694|FG003|Overall Study|No treatment received|1
2040287|NCT00432237|3610710|FG000|Overall Study|Adverse Event|0
2040288|NCT00432237|3610711|FG001|Overall Study|Adverse Event|0
2040289|NCT00432237|3610712|FG002|Overall Study|Adverse Event|0
2040290|NCT00432237|3610713|FG003|Overall Study|Adverse Event|1
2040291|NCT00432237|3610710|FG000|Overall Study|Lack of Efficacy|0
2040292|NCT00432237|3610711|FG001|Overall Study|Lack of Efficacy|0
2040293|NCT00432237|3610712|FG002|Overall Study|Lack of Efficacy|0
2040294|NCT00432237|3610713|FG003|Overall Study|Lack of Efficacy|1
2040295|NCT00432237|3610710|FG000|Overall Study|Lost to Follow-up|10
2040296|NCT00432237|3610711|FG001|Overall Study|Lost to Follow-up|10
2040297|NCT00432237|3610712|FG002|Overall Study|Lost to Follow-up|18
2040298|NCT00432237|3610713|FG003|Overall Study|Lost to Follow-up|18
2040299|NCT00432237|3610710|FG000|Overall Study|Physician Decision|1
2040300|NCT00432237|3610711|FG001|Overall Study|Physician Decision|3
2040301|NCT00432237|3610712|FG002|Overall Study|Physician Decision|2
2040302|NCT00432237|3610713|FG003|Overall Study|Physician Decision|1
2040303|NCT00432237|3610710|FG000|Overall Study|Pregnancy|0
2040304|NCT00432237|3610711|FG001|Overall Study|Pregnancy|1
2040305|NCT00432237|3610712|FG002|Overall Study|Pregnancy|0
2040306|NCT00432237|3610713|FG003|Overall Study|Pregnancy|0
2040307|NCT00432237|3610710|FG000|Overall Study|Protocol Violation|13
2040308|NCT00432237|3610711|FG001|Overall Study|Protocol Violation|10
2040309|NCT00432237|3610712|FG002|Overall Study|Protocol Violation|11
2040310|NCT00432237|3610713|FG003|Overall Study|Protocol Violation|8
2040311|NCT00432237|3610710|FG000|Overall Study|Withdrawal by Subject|5
2040312|NCT00432237|3610711|FG001|Overall Study|Withdrawal by Subject|6
2040313|NCT00432237|3610712|FG002|Overall Study|Withdrawal by Subject|9
2040314|NCT00432237|3610713|FG003|Overall Study|Withdrawal by Subject|11
2040315|NCT00432237|3610710|FG000|Overall Study|Lack of Qualifying Event|38
2040316|NCT00432237|3610711|FG001|Overall Study|Lack of Qualifying Event|71
2040317|NCT00432237|3610712|FG002|Overall Study|Lack of Qualifying Event|69
2040318|NCT00432237|3610713|FG003|Overall Study|Lack of Qualifying Event|84
2040319|NCT00432276|3610725|FG000|Overall Study|Hyperglycemic Rescue|44
2040320|NCT00432276|3610726|FG001|Overall Study|Hyperglycemic Rescue|87
2040321|NCT00432276|3610725|FG000|Overall Study|Adverse Event|13
2040322|NCT00432276|3610726|FG001|Overall Study|Adverse Event|16
2040323|NCT00432276|3610725|FG000|Overall Study|Protocol Violation|25
2040324|NCT00432276|3610726|FG001|Overall Study|Protocol Violation|20
2040325|NCT00432276|3610725|FG000|Overall Study|Lost to Follow-up|6
2040326|NCT00432276|3610726|FG001|Overall Study|Lost to Follow-up|2
2040327|NCT00432276|3610725|FG000|Overall Study|Withdrawal by Subject|25
2040328|NCT00432276|3610726|FG001|Overall Study|Withdrawal by Subject|20
2040329|NCT00432276|3610725|FG000|Overall Study|Physician Decision|6
2040330|NCT00432276|3610726|FG001|Overall Study|Physician Decision|8
2040331|NCT00432276|3610725|FG000|Overall Study|Other|2
2040332|NCT00432276|3610726|FG001|Overall Study|Other|3
2040333|NCT00432380|3610744|FG000|Overall Study|Migrated/moved from study area|3
2040334|NCT00432380|3610745|FG001|Overall Study|Migrated/moved from study area|4
2040335|NCT00432380|3610746|FG002|Overall Study|Migrated/moved from study area|1
2040336|NCT00432380|3610744|FG000|Overall Study|Adverse Event|1
2040337|NCT00432380|3610745|FG001|Overall Study|Adverse Event|0
2040338|NCT00432380|3610746|FG002|Overall Study|Adverse Event|0
2040339|NCT00432562|3610766|FG000|Overall Study|Death|3
2040340|NCT00432562|3610767|FG001|Overall Study|Death|0
2040341|NCT00432666|3610784|FG000|Main Period|Adverse Event|1
2040342|NCT00432666|3610785|FG001|Main Period|Adverse Event|1
2040343|NCT00432666|3610784|FG000|Main Period|Consent Withdrawn|1
2040344|NCT00432666|3610785|FG001|Main Period|Consent Withdrawn|0
2040345|NCT00432666|3610784|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1
2040346|NCT00432666|3610785|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0
2040347|NCT00432666|3610784|FG000|Open-Label Extension Period|Lack of Efficacy|6
2040348|NCT00432666|3610785|FG001|Open-Label Extension Period|Lack of Efficacy|0
2040349|NCT00432666|3610784|FG000|Open-Label Extension Period|Adverse Event|5
2040350|NCT00432666|3610785|FG001|Open-Label Extension Period|Adverse Event|0
2040351|NCT00432666|3610784|FG000|Open-Label Extension Period|Consent withdrawn|10
2040352|NCT00432666|3610785|FG001|Open-Label Extension Period|Consent withdrawn|0
2040353|NCT00432666|3610784|FG000|Open-Label Extension Period|Physician Decision|3
2040354|NCT00432666|3610785|FG001|Open-Label Extension Period|Physician Decision|0
2040355|NCT00432679|3610793|FG000|Overall Study|Adverse Event|2
2040356|NCT00432679|3610794|FG001|Overall Study|Adverse Event|1
2040357|NCT00432679|3610793|FG000|Overall Study|Withdrawal by Subject|3
2040358|NCT00432679|3610794|FG001|Overall Study|Withdrawal by Subject|2
2040359|NCT00432744|3610802|FG000|Months 0-6|Withdrawal by Subject|4
2040360|NCT00432744|3610803|FG001|Months 0-6|Withdrawal by Subject|4
2040361|NCT00432744|3610802|FG000|Months 0-6|Too disabled to score|1
2040362|NCT00432744|3610803|FG001|Months 0-6|Too disabled to score|0
2040363|NCT00432744|3610802|FG000|Months 7 - 12|Withdrawal by Subject|1
2040364|NCT00432744|3610803|FG001|Months 7 - 12|Withdrawal by Subject|0
2040365|NCT00432744|3610802|FG000|Months 7 - 12|Too disabled to score|0
2040366|NCT00432744|3610803|FG001|Months 7 - 12|Too disabled to score|1
2040367|NCT00432809|3610812|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2
2040368|NCT00432809|3610813|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0
2040369|NCT00432809|3610814|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0
2040370|NCT00432809|3610812|FG000|1 Year Follow-up|Withdrawal by Subject|7
2040371|NCT00432809|3610813|FG001|1 Year Follow-up|Withdrawal by Subject|0
2040372|NCT00432809|3610814|FG002|1 Year Follow-up|Withdrawal by Subject|1
2040373|NCT00432835|3610824|FG000|Overall Study|Adverse event: lead dislodgement.|6
2040374|NCT00432835|3610825|FG001|Overall Study|Adverse event: lead dislodgement.|7
2040375|NCT00432965|3610833|FG000|Overall Study|Lost to Follow-up|22
2040376|NCT00432965|3610834|FG001|Overall Study|Lost to Follow-up|19
2040377|NCT00432965|3610833|FG000|Overall Study|Withdrawal by Subject|13
2040378|NCT00432965|3610834|FG001|Overall Study|Withdrawal by Subject|13
2040379|NCT00432965|3610833|FG000|Overall Study|Physician Decision|14
2040380|NCT00432965|3610834|FG001|Overall Study|Physician Decision|13
2040381|NCT00432965|3610833|FG000|Overall Study|Lack of Efficacy|8
2040382|NCT00432965|3610834|FG001|Overall Study|Lack of Efficacy|13
2040383|NCT00432965|3610833|FG000|Overall Study|Non-compliance|7
2040384|NCT00432965|3610834|FG001|Overall Study|Non-compliance|0
2040385|NCT00432965|3610833|FG000|Overall Study|Adverse Event|22
2040386|NCT00432965|3610834|FG001|Overall Study|Adverse Event|19
2040387|NCT00432965|3610833|FG000|Overall Study|Death|3
2040388|NCT00432965|3610834|FG001|Overall Study|Death|4
2040389|NCT00432965|3610833|FG000|Overall Study|Exclusionary Methods|1
2040390|NCT00432965|3610834|FG001|Overall Study|Exclusionary Methods|2
2040391|NCT00432965|3610833|FG000|Overall Study|Incomplete Data|4
2040392|NCT00432965|3610834|FG001|Overall Study|Incomplete Data|3
2040393|NCT00432991|3610842|FG000|Overall Study|Protocol Violation|7
2040394|NCT00432991|3610843|FG001|Overall Study|Protocol Violation|12
2040395|NCT00433004|3610851|FG000|Overall Study|Lost to Follow-up|5
2040396|NCT00433004|3610852|FG001|Overall Study|Lost to Follow-up|7
2040397|NCT00433017|3610860|FG000|Overall Study|Adverse Event|5
2040398|NCT00433017|3610861|FG001|Overall Study|Adverse Event|3
2040399|NCT00433017|3610860|FG000|Overall Study|Withdrawal by Subject|4
2040400|NCT00433017|3610861|FG001|Overall Study|Withdrawal by Subject|5
2040401|NCT00433017|3610860|FG000|Overall Study|Lost to Follow-up|3
2040402|NCT00433017|3610861|FG001|Overall Study|Lost to Follow-up|4
2040403|NCT00433017|3610860|FG000|Overall Study|Administrative problems|80
2040404|NCT00433017|3610861|FG001|Overall Study|Administrative problems|86
2040405|NCT00433017|3610860|FG000|Overall Study|Protocol Violation|1
2040406|NCT00433017|3610861|FG001|Overall Study|Protocol Violation|0
2040407|NCT00433017|3610860|FG000|Overall Study|Death|2
2040408|NCT00433017|3610861|FG001|Overall Study|Death|2
2040409|NCT00433017|3610860|FG000|Overall Study|Subject no longer requires study drug|1
2040410|NCT00433017|3610861|FG001|Overall Study|Subject no longer requires study drug|1
2040411|NCT00433147|3610871|FG000|Overall Study|Adverse Event|0
2040412|NCT00433147|3610872|FG001|Overall Study|Adverse Event|1
2040413|NCT00433147|3610873|FG002|Overall Study|Adverse Event|0
2040414|NCT00433147|3610874|FG003|Overall Study|Adverse Event|0
2040415|NCT00433160|3610886|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6
2040416|NCT00433160|3610887|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2
2040417|NCT00433160|3610886|FG000|52-Week Double-Blind (DB) Period|Death|0
2040418|NCT00433160|3610887|FG001|52-Week Double-Blind (DB) Period|Death|0
2040419|NCT00433160|3610886|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
2040420|NCT00433160|3610887|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
2040421|NCT00433160|3610886|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
2040422|NCT00433160|3610887|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
2040423|NCT00433160|3610886|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0
2040424|NCT00433160|3610887|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2
2040425|NCT00433160|3610886|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
2040426|NCT00433160|3610887|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
2040427|NCT00433160|3610886|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4
2040428|NCT00433160|3610887|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2
2040429|NCT00433160|3610886|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0
2040430|NCT00433160|3610887|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0
2040431|NCT00433160|3610886|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
2040432|NCT00433160|3610887|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
2040433|NCT00433160|3610886|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
2040434|NCT00433160|3610887|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
2040435|NCT00433160|3610886|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
2040436|NCT00433160|3610887|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
2040437|NCT00433160|3610886|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
2040438|NCT00433160|3610887|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
2040439|NCT00433160|3610886|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
2040440|NCT00433160|3610887|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
2040441|NCT00433160|3610886|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2
2040442|NCT00433160|3610887|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0
2040443|NCT00433160|3610886|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
2040444|NCT00433160|3610887|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
2040445|NCT00433160|3610886|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0
2040446|NCT00433160|3610887|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1
2040447|NCT00433199|3610899|FG000|Double-Blind Period|Adverse Event|0
2040448|NCT00433199|3610900|FG001|Double-Blind Period|Adverse Event|25
2040449|NCT00433199|3610899|FG000|Double-Blind Period|Lack of Efficacy|0
2040450|NCT00433199|3610900|FG001|Double-Blind Period|Lack of Efficacy|2
2040451|NCT00433199|3610899|FG000|Double-Blind Period|Lost to Follow-up|2
2040452|NCT00433199|3610900|FG001|Double-Blind Period|Lost to Follow-up|5
2040453|NCT00433199|3610899|FG000|Double-Blind Period|Withdrawal by Subject|8
2040454|NCT00433199|3610900|FG001|Double-Blind Period|Withdrawal by Subject|19
2040455|NCT00433199|3610899|FG000|Double-Blind Period|Protocol Violation|1
2040456|NCT00433199|3610900|FG001|Double-Blind Period|Protocol Violation|10
2040457|NCT00433199|3610899|FG000|Double-Blind Period|Administrative|1
2040458|NCT00433199|3610900|FG001|Double-Blind Period|Administrative|5
2040459|NCT00433199|3610899|FG000|Open-Label Period|Adverse Event|0
2040460|NCT00433199|3610900|FG001|Open-Label Period|Adverse Event|19
2277439|NCT02326298|3959845|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2277440|NCT02326298|3959846|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2277441|NCT02326298|3959833|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277442|NCT02326298|3959834|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277443|NCT02326298|3959835|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277444|NCT02326298|3959836|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277445|NCT02326298|3959837|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277446|NCT02326298|3959838|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277447|NCT02326298|3959839|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
2277448|NCT02326298|3959840|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
2277449|NCT02326298|3959841|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2040461|NCT00433199|3610899|FG000|Open-Label Period|Lack of Efficacy|0
2040462|NCT00433199|3610900|FG001|Open-Label Period|Lack of Efficacy|2
2040463|NCT00433199|3610899|FG000|Open-Label Period|Lost to Follow-up|0
2040464|NCT00433199|3610900|FG001|Open-Label Period|Lost to Follow-up|3
2040465|NCT00433199|3610899|FG000|Open-Label Period|Withdrawal by Subject|0
2040466|NCT00433199|3610900|FG001|Open-Label Period|Withdrawal by Subject|7
2040467|NCT00433199|3610899|FG000|Open-Label Period|Protocol Violation|0
2040468|NCT00433199|3610900|FG001|Open-Label Period|Protocol Violation|2
2040469|NCT00433199|3610899|FG000|Open-Label Period|Administrative|0
2040470|NCT00433199|3610900|FG001|Open-Label Period|Administrative|1
2040471|NCT00433290|3610913|FG000|Overall Study|Adverse Event|24
2040472|NCT00433290|3610914|FG001|Overall Study|Adverse Event|7
2040473|NCT00433290|3610913|FG000|Overall Study|Lack of Efficacy|1
2040474|NCT00433290|3610914|FG001|Overall Study|Lack of Efficacy|5
2040475|NCT00433290|3610913|FG000|Overall Study|Withdrawal by Subject|4
2040476|NCT00433290|3610914|FG001|Overall Study|Withdrawal by Subject|2
2040477|NCT00433290|3610913|FG000|Overall Study|Protocol Violation|3
2040478|NCT00433290|3610914|FG001|Overall Study|Protocol Violation|2
2040479|NCT00433290|3610913|FG000|Overall Study|Physician Decision|2
2040480|NCT00433290|3610914|FG001|Overall Study|Physician Decision|0
2040481|NCT00433290|3610913|FG000|Overall Study|Entry Criteria Not Met|0
2040482|NCT00433290|3610914|FG001|Overall Study|Entry Criteria Not Met|1
2040483|NCT00433290|3610913|FG000|Overall Study|Lost to Follow-up|1
2040484|NCT00433290|3610914|FG001|Overall Study|Lost to Follow-up|0
2040485|NCT00433329|3610920|FG000|Overall Study|Adverse Event|9
2040486|NCT00433329|3610920|FG000|Overall Study|Death|4
2040487|NCT00433329|3610920|FG000|Overall Study|Withdrew consent|3
2040488|NCT00433329|3610920|FG000|Overall Study|Discontinued sildenafil|2
2019055|NCT00296504|3586494|FG003|Interim Analysis|Physician Decision|0
2019056|NCT00296504|3586495|FG004|Interim Analysis|Physician Decision|0
2019057|NCT00296504|3586496|FG005|Interim Analysis|Physician Decision|0
2019058|NCT00296504|3586497|FG006|Interim Analysis|Physician Decision|0
2019059|NCT00296504|3586498|FG007|Interim Analysis|Physician Decision|0
2019060|NCT00296504|3586499|FG008|Interim Analysis|Physician Decision|0
2019061|NCT00296504|3586491|FG000|Interim Analysis|Principle Investigator Discretion|2
2019062|NCT00296504|3586492|FG001|Interim Analysis|Principle Investigator Discretion|0
2019063|NCT00296504|3586493|FG002|Interim Analysis|Principle Investigator Discretion|1
2019064|NCT00296504|3586494|FG003|Interim Analysis|Principle Investigator Discretion|1
2019065|NCT00296504|3586495|FG004|Interim Analysis|Principle Investigator Discretion|0
2019066|NCT00296504|3586496|FG005|Interim Analysis|Principle Investigator Discretion|0
2019067|NCT00296504|3586497|FG006|Interim Analysis|Principle Investigator Discretion|0
2019068|NCT00296504|3586498|FG007|Interim Analysis|Principle Investigator Discretion|0
2019069|NCT00296504|3586499|FG008|Interim Analysis|Principle Investigator Discretion|0
2019070|NCT00296504|3586491|FG000|Interim Analysis|Principle Investigator Terminated Study|0
2019071|NCT00296504|3586492|FG001|Interim Analysis|Principle Investigator Terminated Study|0
2019072|NCT00296504|3586493|FG002|Interim Analysis|Principle Investigator Terminated Study|1
2040489|NCT00433329|3610920|FG000|Overall Study|Moved out of state|1
2040490|NCT00433329|3610920|FG000|Overall Study|Lost to Follow-up|1
2040491|NCT00433329|3610920|FG000|Overall Study|Physician Decision|1
2040492|NCT00433381|3610926|FG000|Overall Study|Ineligible / no protocol treatment|3
2040493|NCT00433381|3610927|FG001|Overall Study|Ineligible / no protocol treatment|3
2040494|NCT00433446|3610941|FG000|Overall Study|Adverse Event|4
2040495|NCT00433446|3610941|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
2040496|NCT00433446|3610941|FG000|Overall Study|Progression|44
2040497|NCT00433446|3610941|FG000|Overall Study|Other - Not Protocol specified|3
2040498|NCT00433446|3610941|FG000|Overall Study|Ineligible|9
2040499|NCT00433537|3610945|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
2040500|NCT00433537|3610946|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
2040501|NCT00433537|3610947|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
2040502|NCT00433537|3610945|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
2040503|NCT00433537|3610946|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
2040504|NCT00433537|3610947|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
2040505|NCT00433537|3610945|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0
2040506|NCT00433537|3610946|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0
2040507|NCT00433537|3610947|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4
2040508|NCT00433537|3610945|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
2040509|NCT00433537|3610946|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
2040510|NCT00433537|3610947|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
2040511|NCT00433537|3610945|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
2040512|NCT00433537|3610946|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
2040513|NCT00433537|3610947|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
2040514|NCT00433537|3610945|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
2040515|NCT00433537|3610946|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
2040516|NCT00433537|3610947|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
2040517|NCT00433537|3610945|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
2040518|NCT00433537|3610946|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
2040519|NCT00433537|3610947|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
2040520|NCT00433537|3610945|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
2040521|NCT00433537|3610946|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
2040522|NCT00433537|3610947|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
2040523|NCT00433537|3610945|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1
2040524|NCT00433537|3610946|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0
2040525|NCT00433537|3610947|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0
2040526|NCT00433654|3610969|FG000|Overall Study|Death|4
2040527|NCT00433654|3610970|FG001|Overall Study|Death|0
2040528|NCT00433654|3610969|FG000|Overall Study|Missed visit|6
2040529|NCT00433654|3610970|FG001|Overall Study|Missed visit|3
2040530|NCT00433654|3610969|FG000|Overall Study|Subject not yet due for visit|4
2040531|NCT00433654|3610970|FG001|Overall Study|Subject not yet due for visit|0
2040532|NCT00433654|3610969|FG000|Overall Study|Withdrawal by Subject|1
2040533|NCT00433654|3610970|FG001|Overall Study|Withdrawal by Subject|2
2040534|NCT00433771|3610987|FG000|Overall Study|screen fail|14
2040535|NCT00433771|3610987|FG000|Overall Study|Treated and later found to be ineligible|2
2040536|NCT00433771|3610987|FG000|Overall Study|Death|2
2040537|NCT00433771|3610987|FG000|Overall Study|Failure to deploy stent|1
2040538|NCT00433836|3610993|FG000|Overall Study|Adverse Event|7
2040539|NCT00433836|3610994|FG001|Overall Study|Adverse Event|0
2040540|NCT00433836|3610993|FG000|Overall Study|Lost to Follow-up|3
2040541|NCT00433836|3610994|FG001|Overall Study|Lost to Follow-up|0
2040542|NCT00433836|3610993|FG000|Overall Study|Withdrawal by Subject|2
2040543|NCT00433836|3610994|FG001|Overall Study|Withdrawal by Subject|1
2040544|NCT00433836|3610993|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2040545|NCT00433836|3610994|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2040546|NCT00433836|3610993|FG000|Overall Study|Protocol Violation|0
2040547|NCT00433836|3610994|FG001|Overall Study|Protocol Violation|2
2040548|NCT00433836|3610993|FG000|Overall Study|Condition no longer requires study drug|0
2040549|NCT00433836|3610994|FG001|Overall Study|Condition no longer requires study drug|1
2040550|NCT00433836|3610993|FG000|Overall Study|Abnormal laboratory values|0
2040551|NCT00433836|3610994|FG001|Overall Study|Abnormal laboratory values|1
2040552|NCT00433914|3611002|FG000|Overall Study|Withdrawal by Subject|0
2040553|NCT00433914|3611003|FG001|Overall Study|Withdrawal by Subject|2
2040554|NCT00433914|3611002|FG000|Overall Study|Lost to Follow-up|0
2040555|NCT00433914|3611003|FG001|Overall Study|Lost to Follow-up|1
2040556|NCT00433966|3611011|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
2040557|NCT00433966|3611012|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
2040558|NCT00433966|3611013|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
2040559|NCT00433966|3611014|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
2040560|NCT00433966|3611011|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97
2040561|NCT00433966|3611012|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103
2040562|NCT00433966|3611013|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0
2040563|NCT00433966|3611014|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0
2104976|NCT00854360|3697418|FG000|Overall Study|Pregnancy|0
2040564|NCT00433966|3611011|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
2040565|NCT00433966|3611012|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
2040566|NCT00433966|3611013|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
2040567|NCT00433966|3611014|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
2040568|NCT00433966|3611011|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0
2040569|NCT00433966|3611012|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0
2040570|NCT00433966|3611013|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41
2040571|NCT00433966|3611014|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15
2040572|NCT00433966|3611011|FG000|Stent Intervention/Randomization|Lost to Follow-up|0
2040573|NCT00433966|3611012|FG001|Stent Intervention/Randomization|Lost to Follow-up|0
2040574|NCT00433966|3611013|FG002|Stent Intervention/Randomization|Lost to Follow-up|113
2277450|NCT02326298|3959842|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277451|NCT02326298|3959843|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2040575|NCT00433966|3611014|FG003|Stent Intervention/Randomization|Lost to Follow-up|47
2040576|NCT00434057|3611047|FG000|Overall Study|Withdrawal by Subject|1
2040577|NCT00434109|3611051|FG000|Overall Study|Physician Decision|9
2040578|NCT00434109|3611051|FG000|Overall Study|Adverse Event|5
2040579|NCT00434109|3611051|FG000|Overall Study|Protocol Violation|1
2040580|NCT00434109|3611051|FG000|Overall Study|had embolism, did not receive sunitinib|3
2040581|NCT00434122|3611057|FG000|Overall Study|Non-compliance with protocol|0
2040582|NCT00434122|3611058|FG001|Overall Study|Non-compliance with protocol|1
2040583|NCT00434122|3611057|FG000|Overall Study|loss of subject contact|1
2040584|NCT00434122|3611058|FG001|Overall Study|loss of subject contact|1
2040585|NCT00434122|3611057|FG000|Overall Study|Personal reasons|1
2040586|NCT00434122|3611058|FG001|Overall Study|Personal reasons|1
2040587|NCT00434122|3611057|FG000|Overall Study|Large follicle size|2
2040588|NCT00434122|3611058|FG001|Overall Study|Large follicle size|2
2040589|NCT00434122|3611057|FG000|Overall Study|Low follicular response.|1
2040590|NCT00434122|3611058|FG001|Overall Study|Low follicular response.|2
2040591|NCT00434122|3611057|FG000|Overall Study|Travelling of subject.|1
2040592|NCT00434122|3611058|FG001|Overall Study|Travelling of subject.|0
2040593|NCT00434148|3611068|FG000|Overall Study|Adverse Event|18
2040594|NCT00434148|3611069|FG001|Overall Study|Adverse Event|18
2040595|NCT00434148|3611068|FG000|Overall Study|Lack of Efficacy|25
2040596|NCT00434148|3611069|FG001|Overall Study|Lack of Efficacy|28
2040597|NCT00434148|3611068|FG000|Overall Study|Withdrawal by Subject|15
2040598|NCT00434148|3611069|FG001|Overall Study|Withdrawal by Subject|15
2040599|NCT00434148|3611068|FG000|Overall Study|Protocol Violation|4
2040600|NCT00434148|3611069|FG001|Overall Study|Protocol Violation|0
2040601|NCT00434148|3611068|FG000|Overall Study|Administrative problems|6
2040602|NCT00434148|3611069|FG001|Overall Study|Administrative problems|10
2040603|NCT00434148|3611068|FG000|Overall Study|Lost to Follow-up|0
2040604|NCT00434148|3611069|FG001|Overall Study|Lost to Follow-up|1
2040605|NCT00434148|3611068|FG000|Overall Study|Condition no longer requires study drug|1
2040606|NCT00434148|3611069|FG001|Overall Study|Condition no longer requires study drug|0
2040607|NCT00434148|3611068|FG000|Overall Study|Abnormal test procedure result|0
2040608|NCT00434148|3611069|FG001|Overall Study|Abnormal test procedure result|1
2118211|NCT00950248|3715940|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
2040609|NCT00434161|3611078|FG000|Overall Study|Adverse Event|5
2040610|NCT00434161|3611079|FG001|Overall Study|Adverse Event|1
2040611|NCT00434161|3611080|FG002|Overall Study|Adverse Event|4
2040612|NCT00434161|3611078|FG000|Overall Study|Lost to Follow-up|0
2040613|NCT00434161|3611079|FG001|Overall Study|Lost to Follow-up|1
2040614|NCT00434161|3611080|FG002|Overall Study|Lost to Follow-up|0
2040615|NCT00434161|3611078|FG000|Overall Study|Death|1
2040616|NCT00434161|3611079|FG001|Overall Study|Death|0
2040617|NCT00434161|3611080|FG002|Overall Study|Death|1
2040618|NCT00434161|3611078|FG000|Overall Study|Non-Compliance|1
2040619|NCT00434161|3611079|FG001|Overall Study|Non-Compliance|1
2040620|NCT00434161|3611080|FG002|Overall Study|Non-Compliance|0
2040621|NCT00434161|3611078|FG000|Overall Study|Withdrawal by Subject|2
2040622|NCT00434161|3611079|FG001|Overall Study|Withdrawal by Subject|0
2040623|NCT00434161|3611080|FG002|Overall Study|Withdrawal by Subject|3
2040624|NCT00434161|3611078|FG000|Overall Study|Logistical error study assessments|1
2040625|NCT00434161|3611079|FG001|Overall Study|Logistical error study assessments|0
2040626|NCT00434161|3611080|FG002|Overall Study|Logistical error study assessments|3
2040627|NCT00434213|3611095|FG000|Overall Study|Adverse Event|12
2040628|NCT00434213|3611095|FG000|Overall Study|Lack of Efficacy|9
2040629|NCT00434213|3611095|FG000|Overall Study|Lost to Follow-up|14
2040630|NCT00434213|3611095|FG000|Overall Study|Withdrawal by Subject|7
2040631|NCT00434213|3611095|FG000|Overall Study|Protocol Violation|3
2040632|NCT00434213|3611095|FG000|Overall Study|Unable to comply with study visit window|2
2040633|NCT00434213|3611095|FG000|Overall Study|Application site reaction|1
2040634|NCT00434213|3611095|FG000|Overall Study|Non-compliant to study schedule|1
2040635|NCT00434252|3611101|FG000|Overall Study|Lack of Efficacy|50
2204774|NCT01606306|3842621|FG000|Overall Study|Lost to Follow-up|7
2204775|NCT01606306|3842622|FG001|Overall Study|Lost to Follow-up|4
2040636|NCT00434252|3611102|FG001|Overall Study|Lack of Efficacy|100
2040637|NCT00434252|3611101|FG000|Overall Study|Adverse Event|6
2040638|NCT00434252|3611102|FG001|Overall Study|Adverse Event|13
2040639|NCT00434252|3611101|FG000|Overall Study|Death|1
2040640|NCT00434252|3611102|FG001|Overall Study|Death|2
2040641|NCT00434252|3611101|FG000|Overall Study|Lost to Follow-up|0
2040642|NCT00434252|3611102|FG001|Overall Study|Lost to Follow-up|1
2040643|NCT00434252|3611101|FG000|Overall Study|Physician Decision|4
2040644|NCT00434252|3611102|FG001|Overall Study|Physician Decision|8
2040645|NCT00434252|3611101|FG000|Overall Study|Withdrawal by Subject|3
2040646|NCT00434252|3611102|FG001|Overall Study|Withdrawal by Subject|7
2040647|NCT00434304|3611117|FG000|Overall Study|Adverse Event|14
2040648|NCT00434304|3611117|FG000|Overall Study|Lack of Efficacy|2
2040649|NCT00434304|3611117|FG000|Overall Study|Withdrawal by Subject|4
2040650|NCT00434330|3611128|FG000|Overall Study|Adverse Event|0
2040651|NCT00434330|3611129|FG001|Overall Study|Adverse Event|0
2040652|NCT00434330|3611130|FG002|Overall Study|Adverse Event|1
2040653|NCT00434330|3611131|FG003|Overall Study|Adverse Event|0
2040654|NCT00434330|3611132|FG004|Overall Study|Adverse Event|0
2040655|NCT00434330|3611133|FG005|Overall Study|Adverse Event|0
2040656|NCT00434330|3611128|FG000|Overall Study|Death|1
2040657|NCT00434330|3611129|FG001|Overall Study|Death|0
2040658|NCT00434330|3611130|FG002|Overall Study|Death|0
2040659|NCT00434330|3611131|FG003|Overall Study|Death|0
2040660|NCT00434330|3611132|FG004|Overall Study|Death|1
2204776|NCT01606306|3842623|FG002|Overall Study|Lost to Follow-up|5
2204777|NCT01606306|3842624|FG003|Overall Study|Lost to Follow-up|4
2204778|NCT01606306|3842625|FG004|Overall Study|Lost to Follow-up|3
2040661|NCT00434330|3611133|FG005|Overall Study|Death|1
2040662|NCT00434330|3611128|FG000|Overall Study|Withdrawal by Subject|0
2040663|NCT00434330|3611129|FG001|Overall Study|Withdrawal by Subject|0
2040664|NCT00434330|3611130|FG002|Overall Study|Withdrawal by Subject|1
2040665|NCT00434330|3611131|FG003|Overall Study|Withdrawal by Subject|1
2040666|NCT00434330|3611132|FG004|Overall Study|Withdrawal by Subject|0
2040667|NCT00434330|3611133|FG005|Overall Study|Withdrawal by Subject|0
2040668|NCT00434330|3611128|FG000|Overall Study|Renal transplant|0
2204779|NCT01606306|3842626|FG005|Overall Study|Lost to Follow-up|5
2204780|NCT01606306|3842621|FG000|Overall Study|Withdrawal by Subject|4
2204781|NCT01606306|3842622|FG001|Overall Study|Withdrawal by Subject|3
2204782|NCT01606306|3842623|FG002|Overall Study|Withdrawal by Subject|4
2204783|NCT01606306|3842624|FG003|Overall Study|Withdrawal by Subject|4
2204784|NCT01606306|3842625|FG004|Overall Study|Withdrawal by Subject|5
2204785|NCT01606306|3842626|FG005|Overall Study|Withdrawal by Subject|4
2204786|NCT01606306|3842621|FG000|Overall Study|Physician Decision|1
2204787|NCT01606306|3842622|FG001|Overall Study|Physician Decision|2
2204788|NCT01606306|3842623|FG002|Overall Study|Physician Decision|0
2204789|NCT01606306|3842624|FG003|Overall Study|Physician Decision|0
2204790|NCT01606306|3842625|FG004|Overall Study|Physician Decision|0
2040669|NCT00434330|3611129|FG001|Overall Study|Renal transplant|0
2040670|NCT00434330|3611130|FG002|Overall Study|Renal transplant|0
2040671|NCT00434330|3611131|FG003|Overall Study|Renal transplant|1
2040672|NCT00434330|3611132|FG004|Overall Study|Renal transplant|0
2040673|NCT00434330|3611133|FG005|Overall Study|Renal transplant|0
2040674|NCT00434330|3611128|FG000|Overall Study|Subject Not Compliant With Study|0
2040675|NCT00434330|3611129|FG001|Overall Study|Subject Not Compliant With Study|0
2040676|NCT00434330|3611130|FG002|Overall Study|Subject Not Compliant With Study|1
2040677|NCT00434330|3611131|FG003|Overall Study|Subject Not Compliant With Study|0
2040678|NCT00434330|3611132|FG004|Overall Study|Subject Not Compliant With Study|0
2040679|NCT00434330|3611133|FG005|Overall Study|Subject Not Compliant With Study|0
2040680|NCT00434421|3611156|FG000|Overall Study|Withdrawal by Subject|1
2040681|NCT00434421|3611156|FG000|Overall Study|Non-compliance with study treatment|1
2040682|NCT00434512|3611179|FG000|Overall Study|Migrated/moved from study area|0
2040683|NCT00434512|3611180|FG001|Overall Study|Migrated/moved from study area|0
2040684|NCT00434512|3611181|FG002|Overall Study|Migrated/moved from study area|0
2040685|NCT00434512|3611182|FG003|Overall Study|Migrated/moved from study area|1
2040686|NCT00434512|3611183|FG004|Overall Study|Migrated/moved from study area|1
2040687|NCT00434512|3611184|FG005|Overall Study|Migrated/moved from study area|1
2040688|NCT00434512|3611179|FG000|Overall Study|Other|0
2040689|NCT00434512|3611180|FG001|Overall Study|Other|1
2040690|NCT00434512|3611181|FG002|Overall Study|Other|0
2040691|NCT00434512|3611182|FG003|Overall Study|Other|0
2040692|NCT00434512|3611183|FG004|Overall Study|Other|0
2040693|NCT00434512|3611184|FG005|Overall Study|Other|0
2040694|NCT00434577|3611207|FG000|Months 0-3|Serious Adverse Event|0
2040695|NCT00434577|3611208|FG001|Months 0-3|Serious Adverse Event|0
2040696|NCT00434577|3611209|FG002|Months 0-3|Serious Adverse Event|1
2040697|NCT00434577|3611210|FG003|Months 0-3|Serious Adverse Event|0
2040698|NCT00434577|3611211|FG004|Months 0-3|Serious Adverse Event|0
2040699|NCT00434577|3611207|FG000|Months 0-3|Adverse Event|0
2040700|NCT00434577|3611208|FG001|Months 0-3|Adverse Event|1
2040701|NCT00434577|3611209|FG002|Months 0-3|Adverse Event|1
2040702|NCT00434577|3611210|FG003|Months 0-3|Adverse Event|0
2040703|NCT00434577|3611211|FG004|Months 0-3|Adverse Event|0
2040704|NCT00434577|3611207|FG000|Months 0-3|Lost to Follow-up|0
2040705|NCT00434577|3611208|FG001|Months 0-3|Lost to Follow-up|0
2040706|NCT00434577|3611209|FG002|Months 0-3|Lost to Follow-up|0
2040707|NCT00434577|3611210|FG003|Months 0-3|Lost to Follow-up|0
2040708|NCT00434577|3611211|FG004|Months 0-3|Lost to Follow-up|2
2040709|NCT00434577|3611207|FG000|Months 0-3|Protocol Violation|1
2040710|NCT00434577|3611208|FG001|Months 0-3|Protocol Violation|0
2204791|NCT01606306|3842626|FG005|Overall Study|Physician Decision|0
2204792|NCT01606319|3842634|FG000|Overall Study|Lost to Follow-up|17
2040711|NCT00434577|3611209|FG002|Months 0-3|Protocol Violation|1
2040712|NCT00434577|3611210|FG003|Months 0-3|Protocol Violation|0
2040713|NCT00434577|3611211|FG004|Months 0-3|Protocol Violation|0
2040714|NCT00434577|3611207|FG000|Months 0-3|Withdrawal by Subject|2
2040715|NCT00434577|3611208|FG001|Months 0-3|Withdrawal by Subject|1
2040716|NCT00434577|3611209|FG002|Months 0-3|Withdrawal by Subject|1
2040717|NCT00434577|3611210|FG003|Months 0-3|Withdrawal by Subject|1
2040718|NCT00434577|3611211|FG004|Months 0-3|Withdrawal by Subject|1
2040719|NCT00434642|3611225|FG000|Blinded Treatment Phase|Adverse Event|12
2040720|NCT00434642|3611226|FG001|Blinded Treatment Phase|Adverse Event|58
2040721|NCT00434642|3611225|FG000|Blinded Treatment Phase|Clinical Disease Progression|4
2040722|NCT00434642|3611226|FG001|Blinded Treatment Phase|Clinical Disease Progression|5
2040723|NCT00434642|3611225|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168
2040724|NCT00434642|3611226|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109
2040725|NCT00434642|3611225|FG000|Blinded Treatment Phase|Physician Decision|19
2040726|NCT00434642|3611226|FG001|Blinded Treatment Phase|Physician Decision|27
2040727|NCT00434642|3611225|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
2040728|NCT00434642|3611226|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
2040729|NCT00434642|3611225|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
2040730|NCT00434642|3611226|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
2040731|NCT00434642|3611225|FG000|Blinded Treatment Phase|Did not Receive Treatment|4
2040732|NCT00434642|3611226|FG001|Blinded Treatment Phase|Did not Receive Treatment|1
2040733|NCT00434642|3611225|FG000|Open-label Treatment Phase|Adverse Event|0
2040734|NCT00434642|3611226|FG001|Open-label Treatment Phase|Adverse Event|5
2040735|NCT00434642|3611225|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0
2040736|NCT00434642|3611226|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6
2040737|NCT00434759|3611234|FG000|Overall Study|Lack of Efficacy|5
2040738|NCT00434759|3611235|FG001|Overall Study|Lack of Efficacy|4
2040739|NCT00434759|3611234|FG000|Overall Study|Withdrawal by Subject|17
2040740|NCT00434759|3611235|FG001|Overall Study|Withdrawal by Subject|1
2040741|NCT00434759|3611234|FG000|Overall Study|family affairs|2
2040742|NCT00434759|3611235|FG001|Overall Study|family affairs|0
2040743|NCT00434876|3611245|FG000|Overall Study|Lost to Follow-up|1
2040744|NCT00434876|3611246|FG001|Overall Study|Lost to Follow-up|1
2040745|NCT00434954|3611254|FG000|Overall Study|Adverse Event|17
2040746|NCT00434954|3611255|FG001|Overall Study|Adverse Event|2
2040747|NCT00434954|3611254|FG000|Overall Study|Entry criteria not met|14
2040748|NCT00434954|3611255|FG001|Overall Study|Entry criteria not met|16
2040749|NCT00434954|3611254|FG000|Overall Study|Lost to Follow-up|0
2040750|NCT00434954|3611255|FG001|Overall Study|Lost to Follow-up|1
2040751|NCT00434954|3611254|FG000|Overall Study|Physician Decision|6
2040752|NCT00434954|3611255|FG001|Overall Study|Physician Decision|3
2040753|NCT00434954|3611254|FG000|Overall Study|Protocol Violation|36
2040754|NCT00434954|3611255|FG001|Overall Study|Protocol Violation|27
2019073|NCT00296504|3586494|FG003|Interim Analysis|Principle Investigator Terminated Study|0
2019074|NCT00296504|3586495|FG004|Interim Analysis|Principle Investigator Terminated Study|0
2019075|NCT00296504|3586496|FG005|Interim Analysis|Principle Investigator Terminated Study|0
2019076|NCT00296504|3586497|FG006|Interim Analysis|Principle Investigator Terminated Study|0
2019077|NCT00296504|3586498|FG007|Interim Analysis|Principle Investigator Terminated Study|0
2019078|NCT00296504|3586499|FG008|Interim Analysis|Principle Investigator Terminated Study|0
2019079|NCT00296504|3586491|FG000|Interim Analysis|Non-adherence|2
2019080|NCT00296504|3586492|FG001|Interim Analysis|Non-adherence|0
2019081|NCT00296504|3586493|FG002|Interim Analysis|Non-adherence|0
2019082|NCT00296504|3586494|FG003|Interim Analysis|Non-adherence|0
2019083|NCT00296504|3586495|FG004|Interim Analysis|Non-adherence|1
2019084|NCT00296504|3586496|FG005|Interim Analysis|Non-adherence|0
2019085|NCT00296504|3586497|FG006|Interim Analysis|Non-adherence|0
2019086|NCT00296504|3586498|FG007|Interim Analysis|Non-adherence|1
2019087|NCT00296504|3586499|FG008|Interim Analysis|Non-adherence|0
2019088|NCT00296504|3586491|FG000|Interim Analysis|Site Closing|1
2019089|NCT00296504|3586492|FG001|Interim Analysis|Site Closing|0
2019090|NCT00296504|3586493|FG002|Interim Analysis|Site Closing|0
2019091|NCT00296504|3586494|FG003|Interim Analysis|Site Closing|0
2019092|NCT00296504|3586495|FG004|Interim Analysis|Site Closing|0
2019093|NCT00296504|3586496|FG005|Interim Analysis|Site Closing|1
2019094|NCT00296504|3586497|FG006|Interim Analysis|Site Closing|2
2019095|NCT00296504|3586498|FG007|Interim Analysis|Site Closing|0
2019096|NCT00296504|3586499|FG008|Interim Analysis|Site Closing|0
2019097|NCT00296504|3586491|FG000|Interim Analysis|Lack of Personnel at Site|1
2019098|NCT00296504|3586492|FG001|Interim Analysis|Lack of Personnel at Site|0
2019099|NCT00296504|3586493|FG002|Interim Analysis|Lack of Personnel at Site|0
2019100|NCT00296504|3586494|FG003|Interim Analysis|Lack of Personnel at Site|0
2019101|NCT00296504|3586495|FG004|Interim Analysis|Lack of Personnel at Site|0
2019102|NCT00296504|3586496|FG005|Interim Analysis|Lack of Personnel at Site|0
2019103|NCT00296504|3586497|FG006|Interim Analysis|Lack of Personnel at Site|0
2019104|NCT00296504|3586498|FG007|Interim Analysis|Lack of Personnel at Site|0
2019105|NCT00296504|3586499|FG008|Interim Analysis|Lack of Personnel at Site|0
2019106|NCT00296504|3586491|FG000|Interim Analysis|Missed Schedule Date|1
2019107|NCT00296504|3586492|FG001|Interim Analysis|Missed Schedule Date|0
2019108|NCT00296504|3586493|FG002|Interim Analysis|Missed Schedule Date|0
2019109|NCT00296504|3586494|FG003|Interim Analysis|Missed Schedule Date|0
2019110|NCT00296504|3586495|FG004|Interim Analysis|Missed Schedule Date|0
2019111|NCT00296504|3586496|FG005|Interim Analysis|Missed Schedule Date|0
2019112|NCT00296504|3586497|FG006|Interim Analysis|Missed Schedule Date|0
2019113|NCT00296504|3586498|FG007|Interim Analysis|Missed Schedule Date|0
2019114|NCT00296504|3586499|FG008|Interim Analysis|Missed Schedule Date|0
2019115|NCT00296504|3586491|FG000|Interim Analysis|Inclusion in Other Protocol|0
2019116|NCT00296504|3586492|FG001|Interim Analysis|Inclusion in Other Protocol|0
2019117|NCT00296504|3586493|FG002|Interim Analysis|Inclusion in Other Protocol|0
2019118|NCT00296504|3586494|FG003|Interim Analysis|Inclusion in Other Protocol|1
2019119|NCT00296504|3586495|FG004|Interim Analysis|Inclusion in Other Protocol|0
2019120|NCT00296504|3586496|FG005|Interim Analysis|Inclusion in Other Protocol|0
2019121|NCT00296504|3586497|FG006|Interim Analysis|Inclusion in Other Protocol|0
2019122|NCT00296504|3586498|FG007|Interim Analysis|Inclusion in Other Protocol|0
2019123|NCT00296504|3586499|FG008|Interim Analysis|Inclusion in Other Protocol|0
2019124|NCT00296504|3586491|FG000|Interim Analysis|Participant Stopped|0
2019125|NCT00296504|3586492|FG001|Interim Analysis|Participant Stopped|0
2019126|NCT00296504|3586493|FG002|Interim Analysis|Participant Stopped|0
2019127|NCT00296504|3586494|FG003|Interim Analysis|Participant Stopped|0
2040755|NCT00434954|3611254|FG000|Overall Study|Sponsor decision|1
2040756|NCT00434954|3611255|FG001|Overall Study|Sponsor decision|0
2040757|NCT00434954|3611254|FG000|Overall Study|Subject decision|8
2040758|NCT00434954|3611255|FG001|Overall Study|Subject decision|22
2040759|NCT00434967|3611265|FG000|Overall Study|Adverse Event|2
2040760|NCT00434967|3611266|FG001|Overall Study|Adverse Event|4
2040761|NCT00434967|3611267|FG002|Overall Study|Adverse Event|3
2040762|NCT00434967|3611268|FG003|Overall Study|Adverse Event|3
2040763|NCT00434967|3611265|FG000|Overall Study|Lost to Follow-up|0
2040764|NCT00434967|3611266|FG001|Overall Study|Lost to Follow-up|0
2040765|NCT00434967|3611267|FG002|Overall Study|Lost to Follow-up|1
2040766|NCT00434967|3611268|FG003|Overall Study|Lost to Follow-up|0
2040767|NCT00434967|3611265|FG000|Overall Study|Withdrawal by Subject|2
2040768|NCT00434967|3611266|FG001|Overall Study|Withdrawal by Subject|2
2040769|NCT00434967|3611267|FG002|Overall Study|Withdrawal by Subject|4
2040770|NCT00434967|3611268|FG003|Overall Study|Withdrawal by Subject|6
2040771|NCT00434967|3611265|FG000|Overall Study|Randomized in error|0
2040772|NCT00434967|3611266|FG001|Overall Study|Randomized in error|0
2040773|NCT00434967|3611267|FG002|Overall Study|Randomized in error|0
2040774|NCT00434967|3611268|FG003|Overall Study|Randomized in error|1
2040775|NCT00434967|3611265|FG000|Overall Study|Protocol Violation|0
2040776|NCT00434967|3611266|FG001|Overall Study|Protocol Violation|1
2040777|NCT00434967|3611267|FG002|Overall Study|Protocol Violation|0
2040778|NCT00434967|3611268|FG003|Overall Study|Protocol Violation|1
2040779|NCT00434967|3611265|FG000|Overall Study|Physician Decision|1
2040780|NCT00434967|3611266|FG001|Overall Study|Physician Decision|1
2040781|NCT00434967|3611267|FG002|Overall Study|Physician Decision|1
2040782|NCT00434967|3611268|FG003|Overall Study|Physician Decision|0
2040783|NCT00434967|3611265|FG000|Overall Study|Patient Disposition Challenges|2
2040784|NCT00434967|3611266|FG001|Overall Study|Patient Disposition Challenges|0
2040785|NCT00434967|3611267|FG002|Overall Study|Patient Disposition Challenges|0
2040786|NCT00434967|3611268|FG003|Overall Study|Patient Disposition Challenges|3
2040787|NCT00435019|3611289|FG000|Overall Study|Adverse Event|1
2040788|NCT00435019|3611290|FG001|Overall Study|Adverse Event|0
2040789|NCT00435019|3611289|FG000|Overall Study|Lack of Efficacy|1
2040790|NCT00435019|3611290|FG001|Overall Study|Lack of Efficacy|2
2040791|NCT00435019|3611289|FG000|Overall Study|Protocol Violation|3
2040792|NCT00435019|3611290|FG001|Overall Study|Protocol Violation|1
2040793|NCT00435019|3611289|FG000|Overall Study|Personal reasons for withdrawal|8
2040794|NCT00435019|3611290|FG001|Overall Study|Personal reasons for withdrawal|7
2104977|NCT00854360|3697419|FG001|Overall Study|Pregnancy|1
2104978|NCT00854360|3697420|FG002|Overall Study|Pregnancy|0
2104979|NCT00854360|3697421|FG003|Overall Study|Pregnancy|0
2104980|NCT00854360|3697418|FG000|Overall Study|Lack of Efficacy|2
2104981|NCT00854360|3697419|FG001|Overall Study|Lack of Efficacy|1
2104982|NCT00854360|3697420|FG002|Overall Study|Lack of Efficacy|0
2104983|NCT00854360|3697421|FG003|Overall Study|Lack of Efficacy|0
2104984|NCT00854360|3697418|FG000|Overall Study|Other|0
2104985|NCT00854360|3697419|FG001|Overall Study|Other|0
2104986|NCT00854360|3697420|FG002|Overall Study|Other|0
2104987|NCT00854360|3697421|FG003|Overall Study|Other|3
2104988|NCT00854373|3697433|FG000|Overall Study|Withdrawal by Subject|1
2104989|NCT00854373|3697434|FG001|Overall Study|Withdrawal by Subject|3
2104990|NCT00854373|3697433|FG000|Overall Study|Forgot to take study drug|1
2104991|NCT00854373|3697434|FG001|Overall Study|Forgot to take study drug|1
2104992|NCT00854581|3697440|FG000|Induction (Up to Day 21)|Lack of Efficacy|4
2104993|NCT00854581|3697440|FG000|Induction (Up to Day 21)|Death|1
2104994|NCT00854581|3697440|FG000|Induction (Up to Day 21)|Physician Decision|1
2104995|NCT00854581|3697440|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
2104996|NCT00854607|3697458|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
2104997|NCT00854620|3697469|FG000|Overall Study|Adverse Event|1
2104998|NCT00854724|3697475|FG000|First Intervention|Withdrawal by Subject|1
2104999|NCT00854724|3697476|FG001|First Intervention|Withdrawal by Subject|1
2105000|NCT00854724|3697475|FG000|Washout|Protocol Violation|1
2105001|NCT00854724|3697476|FG001|Washout|Protocol Violation|0
2105002|NCT00854724|3697475|FG000|Washout|Withdrawal by Subject|0
2105003|NCT00854724|3697476|FG001|Washout|Withdrawal by Subject|1
2105004|NCT00854724|3697475|FG000|Second Intervention|Protocol Violation|1
2040795|NCT00435045|3611298|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
2040796|NCT00435045|3611299|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
2204793|NCT01606319|3842635|FG001|Overall Study|Lost to Follow-up|14
2204794|NCT01606319|3842634|FG000|Overall Study|Withdrawal by Subject|9
2204795|NCT01606319|3842635|FG001|Overall Study|Withdrawal by Subject|12
2204796|NCT01606319|3842634|FG000|Overall Study|Physician Decision|1
2277452|NCT02326298|3959844|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277453|NCT02326298|3959845|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277454|NCT02326298|3959846|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2277455|NCT02326298|3959833|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277456|NCT02326298|3959834|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277457|NCT02326298|3959835|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277458|NCT02326298|3959836|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277459|NCT02326298|3959837|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277460|NCT02326298|3959838|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277461|NCT02326298|3959839|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277462|NCT02326298|3959840|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2277463|NCT02326298|3959841|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277464|NCT02326298|3959842|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277465|NCT02326298|3959843|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277466|NCT02326298|3959844|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277467|NCT02326298|3959845|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277468|NCT02326298|3959846|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2277469|NCT02326298|3959833|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2277470|NCT02326298|3959834|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2320622|NCT02951780|4034940|FG004|Period 2|Scheduling Conflicts|0
2204797|NCT01606319|3842635|FG001|Overall Study|Physician Decision|2
2204798|NCT01606319|3842634|FG000|Overall Study|Lack of Efficacy|6
2204799|NCT01606319|3842635|FG001|Overall Study|Lack of Efficacy|8
2204800|NCT01606319|3842634|FG000|Overall Study|Adverse Event|1
2204801|NCT01606319|3842635|FG001|Overall Study|Adverse Event|4
2019128|NCT00296504|3586495|FG004|Interim Analysis|Participant Stopped|1
2019129|NCT00296504|3586496|FG005|Interim Analysis|Participant Stopped|0
2019130|NCT00296504|3586497|FG006|Interim Analysis|Participant Stopped|0
2019131|NCT00296504|3586498|FG007|Interim Analysis|Participant Stopped|0
2019132|NCT00296504|3586499|FG008|Interim Analysis|Participant Stopped|0
2019133|NCT00296504|3586491|FG000|Interim Analysis|Physician and Participant Decision|0
2019134|NCT00296504|3586492|FG001|Interim Analysis|Physician and Participant Decision|0
2019135|NCT00296504|3586493|FG002|Interim Analysis|Physician and Participant Decision|0
2019136|NCT00296504|3586494|FG003|Interim Analysis|Physician and Participant Decision|0
2019137|NCT00296504|3586495|FG004|Interim Analysis|Physician and Participant Decision|0
2019138|NCT00296504|3586496|FG005|Interim Analysis|Physician and Participant Decision|1
2019139|NCT00296504|3586497|FG006|Interim Analysis|Physician and Participant Decision|0
2019140|NCT00296504|3586498|FG007|Interim Analysis|Physician and Participant Decision|0
2040797|NCT00435045|3611298|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
2040798|NCT00435045|3611299|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
2040799|NCT00435045|3611298|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
2040800|NCT00435045|3611299|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
2040801|NCT00435045|3611298|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
2040802|NCT00435045|3611299|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
2040803|NCT00435045|3611298|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
2040804|NCT00435045|3611299|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
2040805|NCT00435045|3611298|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
2040806|NCT00435045|3611299|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
2040807|NCT00435045|3611298|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
2040808|NCT00435045|3611299|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
2040809|NCT00435045|3611298|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
2040810|NCT00435045|3611299|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
2040811|NCT00435045|3611298|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
2040812|NCT00435045|3611299|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
2040813|NCT00435045|3611298|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
2040814|NCT00435045|3611299|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
2040815|NCT00435045|3611298|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
2040816|NCT00435045|3611299|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
2040817|NCT00435162|3611308|FG000|Period 2 (2 Weeks)|Adverse Event|0
2040818|NCT00435162|3611309|FG001|Period 2 (2 Weeks)|Adverse Event|1
2040819|NCT00435162|3611310|FG002|Period 2 (2 Weeks)|Adverse Event|0
2040820|NCT00435162|3611311|FG003|Period 2 (2 Weeks)|Adverse Event|0
2040821|NCT00435162|3611312|FG004|Period 2 (2 Weeks)|Adverse Event|0
2040822|NCT00435162|3611313|FG005|Period 2 (2 Weeks)|Adverse Event|0
2040823|NCT00435188|3611328|FG000|Overall Study|Death|1
2040824|NCT00435188|3611329|FG001|Overall Study|Death|6
2040825|NCT00435188|3611328|FG000|Overall Study|Withdrawal by Subject|16
2040826|NCT00435188|3611329|FG001|Overall Study|Withdrawal by Subject|11
2040827|NCT00435188|3611328|FG000|Overall Study|Lost to Follow-up|5
2040828|NCT00435188|3611329|FG001|Overall Study|Lost to Follow-up|6
2040829|NCT00435370|3611339|FG000|Overall Study|Adverse Event|8
2040830|NCT00435370|3611340|FG001|Overall Study|Adverse Event|8
2040831|NCT00435370|3611339|FG000|Overall Study|Withdrawal by Subject|10
2040832|NCT00435370|3611340|FG001|Overall Study|Withdrawal by Subject|10
2040833|NCT00435370|3611339|FG000|Overall Study|Antipsychotic medication changed|4
2040834|NCT00435370|3611340|FG001|Overall Study|Antipsychotic medication changed|2
2040835|NCT00435409|3611348|FG000|Overall Study|Protocol Violation|1
2040836|NCT00435409|3611349|FG001|Overall Study|Protocol Violation|2
2040837|NCT00435409|3611350|FG002|Overall Study|Protocol Violation|0
2040838|NCT00435409|3611348|FG000|Overall Study|Lost to Follow-up|1
2040839|NCT00435409|3611349|FG001|Overall Study|Lost to Follow-up|2
2040840|NCT00435409|3611350|FG002|Overall Study|Lost to Follow-up|0
2040841|NCT00435409|3611348|FG000|Overall Study|Death|8
2040842|NCT00435409|3611349|FG001|Overall Study|Death|6
2040843|NCT00435409|3611350|FG002|Overall Study|Death|6
2040844|NCT00435409|3611348|FG000|Overall Study|Objective progression or relapse|158
2040845|NCT00435409|3611349|FG001|Overall Study|Objective progression or relapse|93
2040846|NCT00435409|3611350|FG002|Overall Study|Objective progression or relapse|58
2040847|NCT00435409|3611348|FG000|Overall Study|Global deterioration of health status|0
2040848|NCT00435409|3611349|FG001|Overall Study|Global deterioration of health status|0
2040849|NCT00435409|3611350|FG002|Overall Study|Global deterioration of health status|4
2040850|NCT00435409|3611348|FG000|Overall Study|Withdrawal by Subject|8
2040851|NCT00435409|3611349|FG001|Overall Study|Withdrawal by Subject|7
2277471|NCT02326298|3959835|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2040852|NCT00435409|3611350|FG002|Overall Study|Withdrawal by Subject|1
2040853|NCT00435409|3611348|FG000|Overall Study|Other|45
2040854|NCT00435409|3611349|FG001|Overall Study|Other|30
2040855|NCT00435409|3611350|FG002|Overall Study|Other|1
2040856|NCT00435409|3611348|FG000|Overall Study|Adverse Event|0
2040857|NCT00435409|3611349|FG001|Overall Study|Adverse Event|0
2040858|NCT00435409|3611350|FG002|Overall Study|Adverse Event|8
2040859|NCT00435409|3611348|FG000|Overall Study|Sponsor decision|0
2040860|NCT00435409|3611349|FG001|Overall Study|Sponsor decision|3
2040861|NCT00435409|3611350|FG002|Overall Study|Sponsor decision|0
2040862|NCT00435461|3611359|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1
2040863|NCT00435461|3611360|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0
2040864|NCT00435461|3611361|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0
2277472|NCT02326298|3959836|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2277473|NCT02326298|3959837|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2277474|NCT02326298|3959838|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
2040865|NCT00435461|3611359|FG000|Overall Study|Protocol Violation|6
2040866|NCT00435461|3611360|FG001|Overall Study|Protocol Violation|9
2040867|NCT00435461|3611361|FG002|Overall Study|Protocol Violation|10
2040868|NCT00435461|3611359|FG000|Overall Study|Participant randomized(inadequate score)|1
2040869|NCT00435461|3611360|FG001|Overall Study|Participant randomized(inadequate score)|0
2277475|NCT02326298|3959839|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2277476|NCT02326298|3959840|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2277477|NCT02326298|3959841|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2277478|NCT02326298|3959842|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2277479|NCT02326298|3959843|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2320623|NCT02951780|4034941|FG005|Period 2|Scheduling Conflicts|0
2040870|NCT00435461|3611361|FG002|Overall Study|Participant randomized(inadequate score)|0
2040871|NCT00435461|3611359|FG000|Overall Study|Compliance less than 80 percent|1
2040872|NCT00435461|3611360|FG001|Overall Study|Compliance less than 80 percent|0
2040873|NCT00435461|3611361|FG002|Overall Study|Compliance less than 80 percent|0
2040874|NCT00435461|3611359|FG000|Overall Study|In error, two study medications switched|1
2040875|NCT00435461|3611360|FG001|Overall Study|In error, two study medications switched|0
2040876|NCT00435461|3611361|FG002|Overall Study|In error, two study medications switched|0
2040877|NCT00435461|3611359|FG000|Overall Study|Lack of Efficacy|2
2040878|NCT00435461|3611360|FG001|Overall Study|Lack of Efficacy|1
2040879|NCT00435461|3611361|FG002|Overall Study|Lack of Efficacy|0
2040880|NCT00435461|3611359|FG000|Overall Study|Withdrawal by Subject|1
2040881|NCT00435461|3611360|FG001|Overall Study|Withdrawal by Subject|0
2040882|NCT00435461|3611361|FG002|Overall Study|Withdrawal by Subject|2
2040883|NCT00435461|3611359|FG000|Overall Study|Randomized in error|1
2040884|NCT00435461|3611360|FG001|Overall Study|Randomized in error|0
2040885|NCT00435461|3611361|FG002|Overall Study|Randomized in error|0
2040886|NCT00435461|3611359|FG000|Overall Study|Participant could not tolerate symptoms|0
2040887|NCT00435461|3611360|FG001|Overall Study|Participant could not tolerate symptoms|0
2040888|NCT00435461|3611361|FG002|Overall Study|Participant could not tolerate symptoms|1
2040889|NCT00435461|3611359|FG000|Overall Study|Participant could not swallow capsule|0
2040890|NCT00435461|3611360|FG001|Overall Study|Participant could not swallow capsule|0
2040891|NCT00435461|3611361|FG002|Overall Study|Participant could not swallow capsule|1
2040892|NCT00435461|3611359|FG000|Overall Study|Pregnancy|2
2040893|NCT00435461|3611360|FG001|Overall Study|Pregnancy|0
2040894|NCT00435461|3611361|FG002|Overall Study|Pregnancy|0
2040895|NCT00435461|3611359|FG000|Overall Study|Participant moved eDiary,studymedication|1
2040896|NCT00435461|3611360|FG001|Overall Study|Participant moved eDiary,studymedication|0
2040897|NCT00435461|3611361|FG002|Overall Study|Participant moved eDiary,studymedication|0
2040898|NCT00435461|3611359|FG000|Overall Study|Participant ended study one day early|1
2040899|NCT00435461|3611360|FG001|Overall Study|Participant ended study one day early|0
2040900|NCT00435461|3611361|FG002|Overall Study|Participant ended study one day early|0
2040901|NCT00435461|3611359|FG000|Overall Study|Noncompliance with study requirements|1
2040902|NCT00435461|3611360|FG001|Overall Study|Noncompliance with study requirements|1
2040903|NCT00435461|3611361|FG002|Overall Study|Noncompliance with study requirements|1
2040904|NCT00435461|3611359|FG000|Overall Study|Adverse Event|1
2040905|NCT00435461|3611360|FG001|Overall Study|Adverse Event|2
2040906|NCT00435461|3611361|FG002|Overall Study|Adverse Event|6
2040907|NCT00435461|3611359|FG000|Overall Study|Non-Compliance of diary|2
2277480|NCT02326298|3959844|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2277481|NCT02326298|3959845|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2277482|NCT02326298|3959846|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2277483|NCT02326298|3959833|FG000|Open-label Period (Week 48 to Week 144)|Death|0
2277484|NCT02326298|3959834|FG001|Open-label Period (Week 48 to Week 144)|Death|0
2277485|NCT02326298|3959835|FG002|Open-label Period (Week 48 to Week 144)|Death|0
2277486|NCT02326298|3959836|FG003|Open-label Period (Week 48 to Week 144)|Death|0
2277487|NCT02326298|3959837|FG004|Open-label Period (Week 48 to Week 144)|Death|0
2277488|NCT02326298|3959838|FG005|Open-label Period (Week 48 to Week 144)|Death|0
2277489|NCT02326298|3959839|FG006|Open-label Period (Week 48 to Week 144)|Death|0
2277490|NCT02326298|3959840|FG007|Open-label Period (Week 48 to Week 144)|Death|0
2277491|NCT02326298|3959841|FG008|Open-label Period (Week 48 to Week 144)|Death|0
2277492|NCT02326298|3959842|FG009|Open-label Period (Week 48 to Week 144)|Death|0
2277493|NCT02326298|3959843|FG010|Open-label Period (Week 48 to Week 144)|Death|0
2277494|NCT02326298|3959844|FG011|Open-label Period (Week 48 to Week 144)|Death|1
2277495|NCT02326298|3959845|FG012|Open-label Period (Week 48 to Week 144)|Death|0
2277496|NCT02326298|3959846|FG013|Open-label Period (Week 48 to Week 144)|Death|0
2277497|NCT02326298|3959833|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277498|NCT02326298|3959834|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277499|NCT02326298|3959835|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277500|NCT02326298|3959836|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277501|NCT02326298|3959837|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277502|NCT02326298|3959838|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277503|NCT02326298|3959839|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277504|NCT02326298|3959840|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277505|NCT02326298|3959841|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277506|NCT02326298|3959842|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277507|NCT02326298|3959843|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277508|NCT02326298|3959844|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3
2277509|NCT02326298|3959845|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
2277510|NCT02326298|3959846|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2277511|NCT02326298|3959833|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277512|NCT02326298|3959834|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277513|NCT02326298|3959835|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277514|NCT02326298|3959836|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277515|NCT02326298|3959837|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277516|NCT02326298|3959838|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277517|NCT02326298|3959839|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277518|NCT02326298|3959840|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277519|NCT02326298|3959841|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277520|NCT02326298|3959842|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277521|NCT02326298|3959843|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277522|NCT02326298|3959844|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2277523|NCT02326298|3959845|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2277524|NCT02326298|3959846|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2277525|NCT02326298|3959833|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277526|NCT02326298|3959834|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277527|NCT02326298|3959835|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277528|NCT02326298|3959836|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277529|NCT02326298|3959837|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2040908|NCT00435461|3611360|FG001|Overall Study|Non-Compliance of diary|0
2040909|NCT00435461|3611361|FG002|Overall Study|Non-Compliance of diary|1
2040910|NCT00435461|3611359|FG000|Overall Study|Lost to Follow-up|1
2040911|NCT00435461|3611360|FG001|Overall Study|Lost to Follow-up|1
2040912|NCT00435461|3611361|FG002|Overall Study|Lost to Follow-up|2
2040913|NCT00435487|3611371|FG000|Overall Study|Death|3
2040914|NCT00435487|3611372|FG001|Overall Study|Death|4
2040915|NCT00435487|3611371|FG000|Overall Study|Adverse Event|0
2040916|NCT00435487|3611372|FG001|Overall Study|Adverse Event|3
2040917|NCT00435487|3611371|FG000|Overall Study|Lost to Follow-up|2
2040918|NCT00435487|3611372|FG001|Overall Study|Lost to Follow-up|2
2040919|NCT00435487|3611371|FG000|Overall Study|Other|5
2040920|NCT00435487|3611372|FG001|Overall Study|Other|2
2040921|NCT00435487|3611371|FG000|Overall Study|Withdrawal by Subject|2
2040922|NCT00435487|3611372|FG001|Overall Study|Withdrawal by Subject|1
2040923|NCT00435487|3611371|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0
2040924|NCT00435487|3611372|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2
2040925|NCT00435487|3611371|FG000|Overall Study|Received Drug in Other Treatment Group|0
2040926|NCT00435487|3611372|FG001|Overall Study|Received Drug in Other Treatment Group|1
2040927|NCT00435825|3611431|FG000|Overall Study|Abnormality of Laboratory Test|0
2040928|NCT00435825|3611432|FG001|Overall Study|Abnormality of Laboratory Test|1
2040929|NCT00435825|3611433|FG002|Overall Study|Abnormality of Laboratory Test|0
2040930|NCT00435825|3611434|FG003|Overall Study|Abnormality of Laboratory Test|0
2040931|NCT00435825|3611431|FG000|Overall Study|Insufficient Therapeutic Response|3
2040932|NCT00435825|3611432|FG001|Overall Study|Insufficient Therapeutic Response|1
2040933|NCT00435825|3611433|FG002|Overall Study|Insufficient Therapeutic Response|0
2040934|NCT00435825|3611434|FG003|Overall Study|Insufficient Therapeutic Response|3
2040935|NCT00435825|3611431|FG000|Overall Study|Other Protocol Violation|1
2040936|NCT00435825|3611432|FG001|Overall Study|Other Protocol Violation|0
2040937|NCT00435825|3611433|FG002|Overall Study|Other Protocol Violation|0
2040938|NCT00435825|3611434|FG003|Overall Study|Other Protocol Violation|0
2040939|NCT00435825|3611431|FG000|Overall Study|Refused treatment|2
2040940|NCT00435825|3611432|FG001|Overall Study|Refused treatment|0
2040941|NCT00435825|3611433|FG002|Overall Study|Refused treatment|0
2040942|NCT00435825|3611434|FG003|Overall Study|Refused treatment|5
2040943|NCT00435825|3611431|FG000|Overall Study|Failure to return|5
2040944|NCT00435825|3611432|FG001|Overall Study|Failure to return|0
2040945|NCT00435825|3611433|FG002|Overall Study|Failure to return|4
2040946|NCT00435825|3611434|FG003|Overall Study|Failure to return|0
2040947|NCT00435825|3611431|FG000|Overall Study|Did not receive study drug|1
2040948|NCT00435825|3611432|FG001|Overall Study|Did not receive study drug|0
2040949|NCT00435825|3611433|FG002|Overall Study|Did not receive study drug|2
2040950|NCT00435825|3611434|FG003|Overall Study|Did not receive study drug|0
2040951|NCT00435825|3611431|FG000|Overall Study|Did not enter follow-up|0
2040952|NCT00435825|3611432|FG001|Overall Study|Did not enter follow-up|4
2040953|NCT00435825|3611433|FG002|Overall Study|Did not enter follow-up|1
2040954|NCT00435825|3611434|FG003|Overall Study|Did not enter follow-up|3
2040955|NCT00435825|3611431|FG000|Overall Study|Did not complete full follow-up period|6
2040956|NCT00435825|3611432|FG001|Overall Study|Did not complete full follow-up period|6
2040957|NCT00435825|3611433|FG002|Overall Study|Did not complete full follow-up period|4
2040958|NCT00435825|3611434|FG003|Overall Study|Did not complete full follow-up period|5
2040959|NCT00435942|3611455|FG000|Overall Study|Death|17
2040960|NCT00435942|3611456|FG001|Overall Study|Death|10
2040961|NCT00435942|3611455|FG000|Overall Study|Withdrawal by Subject|2
2040962|NCT00435942|3611456|FG001|Overall Study|Withdrawal by Subject|0
2040963|NCT00435942|3611455|FG000|Overall Study|Lost to Follow-up|0
2040964|NCT00435942|3611456|FG001|Overall Study|Lost to Follow-up|16
2040965|NCT00435942|3611455|FG000|Overall Study|Conversion to Open Repair|1
2040966|NCT00435942|3611456|FG001|Overall Study|Conversion to Open Repair|0
2040967|NCT00435942|3611455|FG000|Overall Study|Technical Failure|3
2040968|NCT00435942|3611456|FG001|Overall Study|Technical Failure|0
2040969|NCT00435942|3611455|FG000|Overall Study|Other|0
2040970|NCT00435942|3611456|FG001|Overall Study|Other|1
2040971|NCT00435994|3611465|FG000|Overall Study|Lost to Follow-up|7
2040972|NCT00435994|3611466|FG001|Overall Study|Lost to Follow-up|0
2040973|NCT00435994|3611467|FG002|Overall Study|Lost to Follow-up|0
2040974|NCT00436007|3611479|FG000|Overall Study|Withdrawal by Subject|5
2040975|NCT00436007|3611480|FG001|Overall Study|Withdrawal by Subject|3
2040976|NCT00436007|3611481|FG002|Overall Study|Withdrawal by Subject|4
2040977|NCT00436007|3611479|FG000|Overall Study|Lost to Follow-up|14
2040978|NCT00436007|3611480|FG001|Overall Study|Lost to Follow-up|10
2040979|NCT00436007|3611481|FG002|Overall Study|Lost to Follow-up|13
2040980|NCT00436007|3611479|FG000|Overall Study|Physician Decision|0
2040981|NCT00436007|3611480|FG001|Overall Study|Physician Decision|0
2040982|NCT00436007|3611481|FG002|Overall Study|Physician Decision|2
2040983|NCT00436007|3611479|FG000|Overall Study|Death|0
2040984|NCT00436007|3611480|FG001|Overall Study|Death|1
2040985|NCT00436007|3611481|FG002|Overall Study|Death|3
2040986|NCT00436007|3611479|FG000|Overall Study|Other|0
2040987|NCT00436007|3611480|FG001|Overall Study|Other|0
2040988|NCT00436007|3611481|FG002|Overall Study|Other|1
2040989|NCT00436163|3611507|FG000|Overall Study|Lost to Follow-up|2
2040990|NCT00436163|3611507|FG000|Overall Study|Adverse Event|1
2040991|NCT00436215|3611512|FG000|Overall Study|Refused further treatment|3
2040992|NCT00436215|3611512|FG000|Overall Study|Small bowel obstruction|1
2040993|NCT00436280|3611516|FG000|Period 1: Induction|Adverse Event|8
2040994|NCT00436280|3611516|FG000|Period 1: Induction|Progressive Disease|12
2040995|NCT00436280|3611516|FG000|Period 1: Induction|Stable Disease|6
2040996|NCT00436280|3611516|FG000|Period 1: Induction|Withdrawal by Subject|1
2040997|NCT00436280|3611516|FG000|Period 1: Induction|Death|1
2040998|NCT00436280|3611516|FG000|Period 2: Consolidation|Adverse Event|1
2040999|NCT00436280|3611516|FG000|Period 2: Consolidation|Progressive Disease|10
2041000|NCT00436280|3611516|FG000|Period 2: Consolidation|Stable Disease|1
2041001|NCT00436280|3611516|FG000|Period 2: Consolidation|Physician Decision|2
2041002|NCT00436280|3611516|FG000|Period 2: Consolidation|Withdrawal by Subject|2
2041003|NCT00436280|3611516|FG000|Period 2: Consolidation|Death|1
2041004|NCT00436280|3611516|FG000|Period 3: Maintenance|Adverse Event|6
2041005|NCT00436280|3611516|FG000|Period 3: Maintenance|Progressive Disease|12
2041006|NCT00436332|3611520|FG000|Overall Study|Adverse Event|9
2041007|NCT00436332|3611520|FG000|Overall Study|Withdrawal by Subject|2
2041008|NCT00436332|3611520|FG000|Overall Study|Progression|59
2041009|NCT00436332|3611520|FG000|Overall Study|Death|2
2041010|NCT00436332|3611520|FG000|Overall Study|Not Protocol Specified|6
2041011|NCT00436332|3611520|FG000|Overall Study|Ineligible|2
2041012|NCT00436332|3611520|FG000|Overall Study|Never Received Treatment|3
2041013|NCT00436345|3611526|FG000|Overall Study|ICU resident beyond follow-up period|3
2041014|NCT00436345|3611527|FG001|Overall Study|ICU resident beyond follow-up period|0
2041015|NCT00436436|3611534|FG000|Overall Study|Progression|4
2041016|NCT00436436|3611534|FG000|Overall Study|Adverse Event|2
2041017|NCT00436436|3611534|FG000|Overall Study|Death|6
2041018|NCT00436501|3611557|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
2041019|NCT00436501|3611558|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
2041020|NCT00436501|3611557|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
2041021|NCT00436501|3611558|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
2041022|NCT00436553|3611568|FG000|Overall Study|Adverse Event|4
2041023|NCT00436553|3611569|FG001|Overall Study|Adverse Event|3
2041024|NCT00436553|3611570|FG002|Overall Study|Adverse Event|4
2041025|NCT00436553|3611568|FG000|Overall Study|Death|3
2041026|NCT00436553|3611569|FG001|Overall Study|Death|1
2204802|NCT01606670|3842641|FG000|Overall Study|Adverse Event|6
2277530|NCT02326298|3959838|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2041027|NCT00436553|3611570|FG002|Overall Study|Death|3
2041028|NCT00436553|3611568|FG000|Overall Study|Lost to Follow-up|0
2041029|NCT00436553|3611569|FG001|Overall Study|Lost to Follow-up|2
2041030|NCT00436553|3611570|FG002|Overall Study|Lost to Follow-up|0
2041031|NCT00436553|3611568|FG000|Overall Study|Protocol Violation|1
2041032|NCT00436553|3611569|FG001|Overall Study|Protocol Violation|0
2041033|NCT00436553|3611570|FG002|Overall Study|Protocol Violation|0
2041034|NCT00436553|3611568|FG000|Overall Study|Withdrawal by Subject|5
2041035|NCT00436553|3611569|FG001|Overall Study|Withdrawal by Subject|6
2041036|NCT00436553|3611570|FG002|Overall Study|Withdrawal by Subject|3
2041037|NCT00436566|3611578|FG000|Overall Study|Withdrawal by Subject|2
2041038|NCT00436566|3611578|FG000|Overall Study|Protocol Violation|1
2041039|NCT00436605|3611582|FG000|Overall Study|Protocol Violation|3
2204803|NCT01606670|3842641|FG000|Overall Study|Lack of Efficacy|2
2204804|NCT01606670|3842641|FG000|Overall Study|Lost to Follow-up|3
2041040|NCT00436618|3611589|FG000|Overall Study|Withdrawal by Subject|5
2041041|NCT00436618|3611590|FG001|Overall Study|Withdrawal by Subject|8
2041042|NCT00436618|3611591|FG002|Overall Study|Withdrawal by Subject|11
2041043|NCT00436618|3611589|FG000|Overall Study|Adverse Event|8
2041044|NCT00436618|3611590|FG001|Overall Study|Adverse Event|8
2041045|NCT00436618|3611591|FG002|Overall Study|Adverse Event|9
2041046|NCT00436618|3611589|FG000|Overall Study|Alternate Treatment|3
2041047|NCT00436618|3611590|FG001|Overall Study|Alternate Treatment|4
2041048|NCT00436618|3611591|FG002|Overall Study|Alternate Treatment|12
2041049|NCT00436618|3611589|FG000|Overall Study|Other Medical Problems|3
2041050|NCT00436618|3611590|FG001|Overall Study|Other Medical Problems|1
2041051|NCT00436618|3611591|FG002|Overall Study|Other Medical Problems|7
2041052|NCT00436618|3611589|FG000|Overall Study|Death|4
2041053|NCT00436618|3611590|FG001|Overall Study|Death|2
2041054|NCT00436618|3611591|FG002|Overall Study|Death|3
2041055|NCT00436618|3611589|FG000|Overall Study|New Primary or Other Reasons|6
2041056|NCT00436618|3611590|FG001|Overall Study|New Primary or Other Reasons|2
2041057|NCT00436618|3611591|FG002|Overall Study|New Primary or Other Reasons|12
2041058|NCT00436618|3611589|FG000|Overall Study|Still on treatment|1
2041059|NCT00436618|3611590|FG001|Overall Study|Still on treatment|2
2041060|NCT00436618|3611591|FG002|Overall Study|Still on treatment|7
2041061|NCT00436644|3611599|FG000|Overall Study|Adverse Event|2
2041062|NCT00436644|3611599|FG000|Overall Study|Death|1
2041063|NCT00436748|3611605|FG000|Overall Study|Ineligibility Determined|1
2041064|NCT00436748|3611606|FG001|Overall Study|Ineligibility Determined|1
2041065|NCT00436748|3611605|FG000|Overall Study|Adverse Event|0
2041066|NCT00436748|3611606|FG001|Overall Study|Adverse Event|2
2041067|NCT00436748|3611605|FG000|Overall Study|Consent Withdrawn|1
2041068|NCT00436748|3611606|FG001|Overall Study|Consent Withdrawn|4
2041069|NCT00436748|3611605|FG000|Overall Study|Administrative Decision|1
2041070|NCT00436748|3611606|FG001|Overall Study|Administrative Decision|0
2041071|NCT00436748|3611605|FG000|Overall Study|Lost to Follow-up|0
2041072|NCT00436748|3611606|FG001|Overall Study|Lost to Follow-up|1
2041073|NCT00436748|3611605|FG000|Overall Study|Protocol-specified Criteria|5
2041074|NCT00436748|3611606|FG001|Overall Study|Protocol-specified Criteria|4
2041075|NCT00436748|3611605|FG000|Overall Study|Other|3
2041076|NCT00436748|3611606|FG001|Overall Study|Other|0
2041077|NCT00436852|3611614|FG000|Overall Study|Death|23
2041078|NCT00436852|3611615|FG001|Overall Study|Death|34
2041079|NCT00436852|3611614|FG000|Overall Study|Lack of Efficacy|9
2041080|NCT00436852|3611615|FG001|Overall Study|Lack of Efficacy|7
2041081|NCT00436852|3611614|FG000|Overall Study|Withdrawal by Subject|2
2041082|NCT00436852|3611615|FG001|Overall Study|Withdrawal by Subject|4
2041083|NCT00436852|3611614|FG000|Overall Study|Ineligible|1
2041084|NCT00436852|3611615|FG001|Overall Study|Ineligible|0
2041085|NCT00436917|3611628|FG000|Overall Study|Withdrawal by Subject|13
2041086|NCT00436917|3611628|FG000|Overall Study|Adverse Event|2
2041087|NCT00436917|3611628|FG000|Overall Study|Physician Decision|1
2041088|NCT00436917|3611628|FG000|Overall Study|Death|1
2277531|NCT02326298|3959839|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277532|NCT02326298|3959840|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277533|NCT02326298|3959841|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277534|NCT02326298|3959842|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277535|NCT02326298|3959843|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2277536|NCT02326298|3959844|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2320624|NCT02951780|4034942|FG006|Period 2|Scheduling Conflicts|0
2204805|NCT01606670|3842641|FG000|Overall Study|Withdrawal by Subject|3
2204806|NCT01606670|3842641|FG000|Overall Study|Other Reason|2
2204807|NCT01606748|3842660|FG000|Overall Study|Adverse Event|1
2041089|NCT00436917|3611628|FG000|Overall Study|Lost to Follow-up|1
2041090|NCT00436917|3611628|FG000|Overall Study|Treatment for polymyalgia rheumatic|1
2041091|NCT00436917|3611628|FG000|Overall Study|Increased creatinine|1
2041092|NCT00436917|3611628|FG000|Overall Study|Personal conflicts of patient|1
2041093|NCT00436956|3611632|FG000|Overall Study|Not evaluable|1
2041094|NCT00436956|3611633|FG001|Overall Study|Not evaluable|0
2041095|NCT00436982|3611651|FG000|Overall Study|Withdrawal by Subject|3
2041096|NCT00436982|3611652|FG001|Overall Study|Withdrawal by Subject|1
2041097|NCT00436982|3611651|FG000|Overall Study|Did not receive allocated intervention|0
2204808|NCT01606748|3842661|FG001|Overall Study|Adverse Event|0
2204809|NCT01606748|3842660|FG000|Overall Study|Progressive Disease|1
2204810|NCT01606748|3842661|FG001|Overall Study|Progressive Disease|0
2204811|NCT01606748|3842660|FG000|Overall Study|Withdrawal by Subject|1
2204812|NCT01606748|3842661|FG001|Overall Study|Withdrawal by Subject|0
2204813|NCT01606761|3842682|FG000|Prior to Week 24|Lost to Follow-up|0
2204814|NCT01606761|3842683|FG001|Prior to Week 24|Lost to Follow-up|3
2041098|NCT00436982|3611652|FG001|Overall Study|Did not receive allocated intervention|1
2041099|NCT00436982|3611651|FG000|Overall Study|no RSA data|1
2041100|NCT00436982|3611652|FG001|Overall Study|no RSA data|2
2041101|NCT00437034|3611662|FG000|Overall Study|Adverse Event|1
2041102|NCT00437034|3611662|FG000|Overall Study|Disease progression during treatment|5
2041103|NCT00437073|3611668|FG000|Overall Study|Sponsor Terminated Study|1
2041104|NCT00437073|3611669|FG001|Overall Study|Sponsor Terminated Study|0
2041105|NCT00437073|3611668|FG000|Overall Study|Physician Decision|0
2041106|NCT00437073|3611669|FG001|Overall Study|Physician Decision|1
2041107|NCT00437125|3611675|FG000|Overall Study|Adverse Event|12
2041108|NCT00437125|3611675|FG000|Overall Study|Death|1
2041109|NCT00437125|3611675|FG000|Overall Study|Clinical Relapse|1
2041110|NCT00437125|3611675|FG000|Overall Study|Lack of Efficacy|1
2041111|NCT00437125|3611675|FG000|Overall Study|Lost to Follow-up|1
2041112|NCT00437125|3611675|FG000|Overall Study|Withdrawal by Subject|13
2041113|NCT00437125|3611675|FG000|Overall Study|Withdrawal by Caregiver|2
2041114|NCT00437125|3611675|FG000|Overall Study|Physician Decision|1
2041115|NCT00437203|3611689|FG000|Overall Study|Death|0
2041116|NCT00437203|3611690|FG001|Overall Study|Death|0
2041117|NCT00437203|3611691|FG002|Overall Study|Death|1
2041118|NCT00437203|3611692|FG003|Overall Study|Death|0
2041119|NCT00437203|3611693|FG004|Overall Study|Death|0
2041120|NCT00437203|3611694|FG005|Overall Study|Death|0
2041121|NCT00437203|3611695|FG006|Overall Study|Death|0
2041122|NCT00437203|3611696|FG007|Overall Study|Death|1
2041123|NCT00437203|3611697|FG008|Overall Study|Death|0
2041124|NCT00437203|3611698|FG009|Overall Study|Death|1
2041125|NCT00437203|3611689|FG000|Overall Study|Adverse Event|1
2041126|NCT00437203|3611690|FG001|Overall Study|Adverse Event|1
2041127|NCT00437203|3611691|FG002|Overall Study|Adverse Event|0
2041128|NCT00437203|3611692|FG003|Overall Study|Adverse Event|0
2041129|NCT00437203|3611693|FG004|Overall Study|Adverse Event|0
2041130|NCT00437203|3611694|FG005|Overall Study|Adverse Event|0
2041131|NCT00437203|3611695|FG006|Overall Study|Adverse Event|0
2041132|NCT00437203|3611696|FG007|Overall Study|Adverse Event|1
2041133|NCT00437203|3611697|FG008|Overall Study|Adverse Event|0
2041134|NCT00437203|3611698|FG009|Overall Study|Adverse Event|1
2041135|NCT00437203|3611689|FG000|Overall Study|Study terminated by sponsor|0
2041136|NCT00437203|3611690|FG001|Overall Study|Study terminated by sponsor|0
2041137|NCT00437203|3611691|FG002|Overall Study|Study terminated by sponsor|0
2041138|NCT00437203|3611692|FG003|Overall Study|Study terminated by sponsor|0
2041139|NCT00437203|3611693|FG004|Overall Study|Study terminated by sponsor|0
2041140|NCT00437203|3611694|FG005|Overall Study|Study terminated by sponsor|0
2041141|NCT00437203|3611695|FG006|Overall Study|Study terminated by sponsor|0
2041142|NCT00437203|3611696|FG007|Overall Study|Study terminated by sponsor|0
2041143|NCT00437203|3611697|FG008|Overall Study|Study terminated by sponsor|1
2041144|NCT00437203|3611698|FG009|Overall Study|Study terminated by sponsor|0
2041145|NCT00437203|3611689|FG000|Overall Study|Objective progression or relapse|5
2041146|NCT00437203|3611690|FG001|Overall Study|Objective progression or relapse|6
2041147|NCT00437203|3611691|FG002|Overall Study|Objective progression or relapse|2
2041148|NCT00437203|3611692|FG003|Overall Study|Objective progression or relapse|3
2041149|NCT00437203|3611693|FG004|Overall Study|Objective progression or relapse|3
2041150|NCT00437203|3611694|FG005|Overall Study|Objective progression or relapse|3
2041151|NCT00437203|3611695|FG006|Overall Study|Objective progression or relapse|6
2041152|NCT00437203|3611696|FG007|Overall Study|Objective progression or relapse|1
2041153|NCT00437203|3611697|FG008|Overall Study|Objective progression or relapse|2
2041154|NCT00437203|3611698|FG009|Overall Study|Objective progression or relapse|2
2041155|NCT00437203|3611689|FG000|Overall Study|Other|0
2041156|NCT00437203|3611690|FG001|Overall Study|Other|1
2041157|NCT00437203|3611691|FG002|Overall Study|Other|0
2041158|NCT00437203|3611692|FG003|Overall Study|Other|0
2041159|NCT00437203|3611693|FG004|Overall Study|Other|0
2041160|NCT00437203|3611694|FG005|Overall Study|Other|0
2041161|NCT00437203|3611695|FG006|Overall Study|Other|1
2041162|NCT00437203|3611696|FG007|Overall Study|Other|0
2041163|NCT00437203|3611697|FG008|Overall Study|Other|0
2041164|NCT00437203|3611698|FG009|Overall Study|Other|0
2041165|NCT00437268|3611731|FG000|Overall Study|Adverse Event|1
2041166|NCT00437268|3611732|FG001|Overall Study|Adverse Event|1
2204815|NCT01606761|3842684|FG002|Prior to Week 24|Lost to Follow-up|2
2204816|NCT01606761|3842685|FG003|Prior to Week 24|Lost to Follow-up|0
2204817|NCT01606761|3842686|FG004|Prior to Week 24|Lost to Follow-up|0
2041167|NCT00437268|3611731|FG000|Overall Study|Withdrawal by Subject|2
2041168|NCT00437268|3611732|FG001|Overall Study|Withdrawal by Subject|2
2041169|NCT00437268|3611731|FG000|Overall Study|Progressive disease|9
2041170|NCT00437268|3611732|FG001|Overall Study|Progressive disease|9
2041171|NCT00437268|3611731|FG000|Overall Study|Physician Decision|1
2041172|NCT00437268|3611732|FG001|Overall Study|Physician Decision|0
2041173|NCT00437268|3611731|FG000|Overall Study|Death|0
2041174|NCT00437268|3611732|FG001|Overall Study|Death|1
2041175|NCT00437281|3611760|FG000|Overall Study|Adverse Event|0
2041176|NCT00437281|3611761|FG001|Overall Study|Adverse Event|0
2041177|NCT00437281|3611762|FG002|Overall Study|Adverse Event|0
2041178|NCT00437281|3611763|FG003|Overall Study|Adverse Event|1
2041179|NCT00437281|3611764|FG004|Overall Study|Adverse Event|0
2041180|NCT00437281|3611765|FG005|Overall Study|Adverse Event|1
2041181|NCT00437281|3611766|FG006|Overall Study|Adverse Event|0
2041182|NCT00437281|3611767|FG007|Overall Study|Adverse Event|0
2041183|NCT00437281|3611768|FG008|Overall Study|Adverse Event|0
2041184|NCT00437281|3611769|FG009|Overall Study|Adverse Event|1
2041185|NCT00437281|3611770|FG010|Overall Study|Adverse Event|0
2041186|NCT00437281|3611771|FG011|Overall Study|Adverse Event|0
2041187|NCT00437281|3611772|FG012|Overall Study|Adverse Event|0
2041188|NCT00437281|3611773|FG013|Overall Study|Adverse Event|1
2041189|NCT00437281|3611774|FG014|Overall Study|Adverse Event|1
2041190|NCT00437281|3611775|FG015|Overall Study|Adverse Event|0
2041191|NCT00437281|3611776|FG016|Overall Study|Adverse Event|0
2041192|NCT00437281|3611777|FG017|Overall Study|Adverse Event|0
2041193|NCT00437281|3611778|FG018|Overall Study|Adverse Event|1
2041194|NCT00437281|3611779|FG019|Overall Study|Adverse Event|0
2041195|NCT00437281|3611760|FG000|Overall Study|Lost to Follow-up|0
2041196|NCT00437281|3611761|FG001|Overall Study|Lost to Follow-up|0
2041197|NCT00437281|3611762|FG002|Overall Study|Lost to Follow-up|0
2041198|NCT00437281|3611763|FG003|Overall Study|Lost to Follow-up|0
2041199|NCT00437281|3611764|FG004|Overall Study|Lost to Follow-up|0
2041200|NCT00437281|3611765|FG005|Overall Study|Lost to Follow-up|0
2041201|NCT00437281|3611766|FG006|Overall Study|Lost to Follow-up|0
2041202|NCT00437281|3611767|FG007|Overall Study|Lost to Follow-up|0
2041203|NCT00437281|3611768|FG008|Overall Study|Lost to Follow-up|0
2041204|NCT00437281|3611769|FG009|Overall Study|Lost to Follow-up|0
2041205|NCT00437281|3611770|FG010|Overall Study|Lost to Follow-up|0
2041206|NCT00437281|3611771|FG011|Overall Study|Lost to Follow-up|0
2041207|NCT00437281|3611772|FG012|Overall Study|Lost to Follow-up|0
2041208|NCT00437281|3611773|FG013|Overall Study|Lost to Follow-up|0
2041209|NCT00437281|3611774|FG014|Overall Study|Lost to Follow-up|0
2041210|NCT00437281|3611775|FG015|Overall Study|Lost to Follow-up|0
2041211|NCT00437281|3611776|FG016|Overall Study|Lost to Follow-up|0
2041212|NCT00437281|3611777|FG017|Overall Study|Lost to Follow-up|0
2041213|NCT00437281|3611778|FG018|Overall Study|Lost to Follow-up|0
2041214|NCT00437281|3611779|FG019|Overall Study|Lost to Follow-up|1
2041215|NCT00437294|3611853|FG000|Overall Study|Adverse Event|5
2041216|NCT00437294|3611854|FG001|Overall Study|Adverse Event|4
2041217|NCT00437294|3611853|FG000|Overall Study|Death|5
2041218|NCT00437294|3611854|FG001|Overall Study|Death|2
2041219|NCT00437294|3611853|FG000|Overall Study|Physician Decision|0
2041220|NCT00437294|3611854|FG001|Overall Study|Physician Decision|3
2041221|NCT00437294|3611853|FG000|Overall Study|Withdrawal by Subject|5
2041222|NCT00437294|3611854|FG001|Overall Study|Withdrawal by Subject|0
2041223|NCT00437294|3611853|FG000|Overall Study|Progressive Disease|19
2041224|NCT00437294|3611854|FG001|Overall Study|Progressive Disease|23
2041225|NCT00437294|3611853|FG000|Overall Study|Sponsor Decision|8
2041226|NCT00437294|3611854|FG001|Overall Study|Sponsor Decision|9
2041227|NCT00437294|3611853|FG000|Overall Study|Protocol Violation|0
2041228|NCT00437294|3611854|FG001|Overall Study|Protocol Violation|1
2041229|NCT00437294|3611853|FG000|Overall Study|Entry criteria not met|1
2041230|NCT00437294|3611854|FG001|Overall Study|Entry criteria not met|1
2041231|NCT00437489|3611868|FG000|Overall Study|Study terminated by sponsor|23
2041232|NCT00437489|3611869|FG001|Overall Study|Study terminated by sponsor|21
2041233|NCT00437489|3611868|FG000|Overall Study|Lost to Follow-up|0
2041234|NCT00437489|3611869|FG001|Overall Study|Lost to Follow-up|1
2041235|NCT00437645|3611877|FG000|Overall Study|Adverse Event|15
2041236|NCT00437645|3611878|FG001|Overall Study|Adverse Event|84
2041237|NCT00437645|3611877|FG000|Overall Study|Withdrawal by Subject|10
2204818|NCT01606761|3842682|FG000|Prior to Week 24|Withdrawal by Subject|12
2204819|NCT01606761|3842683|FG001|Prior to Week 24|Withdrawal by Subject|10
2041238|NCT00437645|3611878|FG001|Overall Study|Withdrawal by Subject|22
2041239|NCT00437645|3611877|FG000|Overall Study|Protocol Violation|3
2041240|NCT00437645|3611878|FG001|Overall Study|Protocol Violation|3
2041241|NCT00437645|3611877|FG000|Overall Study|Lost to Follow-up|2
2041242|NCT00437645|3611878|FG001|Overall Study|Lost to Follow-up|3
2041243|NCT00437645|3611877|FG000|Overall Study|Administrative problems|2
2041244|NCT00437645|3611878|FG001|Overall Study|Administrative problems|1
2204820|NCT01606761|3842684|FG002|Prior to Week 24|Withdrawal by Subject|9
2204821|NCT01606761|3842685|FG003|Prior to Week 24|Withdrawal by Subject|0
2204822|NCT01606761|3842686|FG004|Prior to Week 24|Withdrawal by Subject|0
2204823|NCT01606761|3842682|FG000|Prior to Week 24|Adverse Event|11
2041245|NCT00437645|3611877|FG000|Overall Study|Lack of Efficacy|2
2041246|NCT00437645|3611878|FG001|Overall Study|Lack of Efficacy|1
2041247|NCT00437645|3611877|FG000|Overall Study|Condition no longer requires study drug|1
2041248|NCT00437645|3611878|FG001|Overall Study|Condition no longer requires study drug|1
2041249|NCT00437658|3611887|FG000|Treatment Period (24 Weeks)|Adverse Event|4
2041250|NCT00437658|3611888|FG001|Treatment Period (24 Weeks)|Adverse Event|7
2041251|NCT00437658|3611889|FG002|Treatment Period (24 Weeks)|Adverse Event|14
2041252|NCT00437658|3611887|FG000|Treatment Period (24 Weeks)|Non-compliance|1
2041253|NCT00437658|3611888|FG001|Treatment Period (24 Weeks)|Non-compliance|1
2041254|NCT00437658|3611889|FG002|Treatment Period (24 Weeks)|Non-compliance|4
2041255|NCT00437658|3611887|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9
2041256|NCT00437658|3611888|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7
2041257|NCT00437658|3611889|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7
2041258|NCT00437658|3611887|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4
2041259|NCT00437658|3611888|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2
2041260|NCT00437658|3611889|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3
2041261|NCT00437658|3611887|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5
2041262|NCT00437658|3611888|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4
2041263|NCT00437658|3611889|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5
2041264|NCT00437658|3611887|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
2041265|NCT00437658|3611888|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
2041266|NCT00437658|3611889|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
2041267|NCT00437658|3611887|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1
2041268|NCT00437658|3611888|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0
2041269|NCT00437658|3611889|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1
2041270|NCT00437658|3611887|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3
2041271|NCT00437658|3611888|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0
2041272|NCT00437658|3611889|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1
2041273|NCT00437658|3611887|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
2041274|NCT00437658|3611888|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
2041275|NCT00437658|3611889|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
2041276|NCT00437658|3611887|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
2041277|NCT00437658|3611888|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
2041278|NCT00437658|3611889|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
2041279|NCT00437658|3611887|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
2041280|NCT00437658|3611888|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
2041281|NCT00437658|3611889|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
2041282|NCT00437658|3611887|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
2041283|NCT00437658|3611888|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
2041284|NCT00437658|3611889|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
2041285|NCT00437983|3611899|FG000|Overall Study|Adverse Event|6
2041286|NCT00437983|3611900|FG001|Overall Study|Adverse Event|6
2041287|NCT00437983|3611899|FG000|Overall Study|Protocol Violation|2
2041288|NCT00437983|3611900|FG001|Overall Study|Protocol Violation|1
2041289|NCT00437983|3611899|FG000|Overall Study|Withdrawal by Subject|5
2041290|NCT00437983|3611900|FG001|Overall Study|Withdrawal by Subject|6
2041291|NCT00438256|3611929|FG000|Overall Study|Ineligible for Resection|2
2041292|NCT00438256|3611930|FG001|Overall Study|Ineligible for Resection|1
2041293|NCT00438256|3611931|FG002|Overall Study|Ineligible for Resection|1
2041294|NCT00438256|3611932|FG003|Overall Study|Ineligible for Resection|7
2041295|NCT00438256|3611929|FG000|Overall Study|Excluded final Diagnosis|0
2041296|NCT00438256|3611930|FG001|Overall Study|Excluded final Diagnosis|0
2041297|NCT00438256|3611931|FG002|Overall Study|Excluded final Diagnosis|0
2041298|NCT00438256|3611932|FG003|Overall Study|Excluded final Diagnosis|2
2041299|NCT00438360|3611947|FG000|Overall Study|Adverse Event|6
2041300|NCT00438360|3611948|FG001|Overall Study|Adverse Event|1
2041301|NCT00438360|3611947|FG000|Overall Study|Lack of Efficacy|42
2041302|NCT00438360|3611948|FG001|Overall Study|Lack of Efficacy|27
2041303|NCT00438360|3611947|FG000|Overall Study|Other|24
2041304|NCT00438360|3611948|FG001|Overall Study|Other|15
2041305|NCT00438399|3611957|FG000|Overall Study|Lost to Follow-up|2
2041306|NCT00438399|3611958|FG001|Overall Study|Lost to Follow-up|2
2041307|NCT00438399|3611959|FG002|Overall Study|Lost to Follow-up|1
2041308|NCT00438399|3611960|FG003|Overall Study|Lost to Follow-up|1
2041309|NCT00438399|3611961|FG004|Overall Study|Lost to Follow-up|1
2041310|NCT00438399|3611962|FG005|Overall Study|Lost to Follow-up|1
2041311|NCT00438399|3611957|FG000|Overall Study|Adverse Event|0
2041312|NCT00438399|3611958|FG001|Overall Study|Adverse Event|0
2041313|NCT00438399|3611959|FG002|Overall Study|Adverse Event|1
2041314|NCT00438399|3611960|FG003|Overall Study|Adverse Event|1
2041315|NCT00438399|3611961|FG004|Overall Study|Adverse Event|0
2041316|NCT00438399|3611962|FG005|Overall Study|Adverse Event|1
2041317|NCT00438399|3611957|FG000|Overall Study|Withdrawal by Subject|5
2041318|NCT00438399|3611958|FG001|Overall Study|Withdrawal by Subject|6
2041319|NCT00438399|3611959|FG002|Overall Study|Withdrawal by Subject|3
2041320|NCT00438399|3611960|FG003|Overall Study|Withdrawal by Subject|2
2041321|NCT00438399|3611961|FG004|Overall Study|Withdrawal by Subject|2
2041322|NCT00438399|3611962|FG005|Overall Study|Withdrawal by Subject|2
2041323|NCT00438399|3611957|FG000|Overall Study|Protocol Violation|0
2041324|NCT00438399|3611958|FG001|Overall Study|Protocol Violation|0
2041325|NCT00438399|3611959|FG002|Overall Study|Protocol Violation|1
2041326|NCT00438399|3611960|FG003|Overall Study|Protocol Violation|0
2041327|NCT00438399|3611961|FG004|Overall Study|Protocol Violation|0
2041328|NCT00438399|3611962|FG005|Overall Study|Protocol Violation|1
2041329|NCT00438399|3611957|FG000|Overall Study|Subje stopped study|0
2041330|NCT00438399|3611958|FG001|Overall Study|Subje stopped study|0
2041331|NCT00438399|3611959|FG002|Overall Study|Subje stopped study|1
2041332|NCT00438399|3611960|FG003|Overall Study|Subje stopped study|0
2041333|NCT00438399|3611961|FG004|Overall Study|Subje stopped study|0
2041334|NCT00438399|3611962|FG005|Overall Study|Subje stopped study|0
2041335|NCT00438399|3611957|FG000|Overall Study|Pregnancy|0
2041336|NCT00438399|3611958|FG001|Overall Study|Pregnancy|0
2041337|NCT00438399|3611959|FG002|Overall Study|Pregnancy|0
2041338|NCT00438399|3611960|FG003|Overall Study|Pregnancy|0
2041339|NCT00438399|3611961|FG004|Overall Study|Pregnancy|0
2041340|NCT00438399|3611962|FG005|Overall Study|Pregnancy|1
2041341|NCT00438399|3611957|FG000|Overall Study|Patien stopped study at visit 4 by error|1
2118212|NCT00950248|3715941|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
2041342|NCT00438399|3611958|FG001|Overall Study|Patien stopped study at visit 4 by error|0
2041343|NCT00438399|3611959|FG002|Overall Study|Patien stopped study at visit 4 by error|0
2041344|NCT00438399|3611960|FG003|Overall Study|Patien stopped study at visit 4 by error|0
2041345|NCT00438399|3611961|FG004|Overall Study|Patien stopped study at visit 4 by error|0
2041346|NCT00438399|3611962|FG005|Overall Study|Patien stopped study at visit 4 by error|0
2041347|NCT00438464|3611986|FG000|Overall Study|Terminated Early|14
2041348|NCT00438464|3611987|FG001|Overall Study|Terminated Early|5
2041349|NCT00438464|3611986|FG000|Overall Study|Incomplete data submission|0
2041350|NCT00438464|3611987|FG001|Overall Study|Incomplete data submission|2
2019141|NCT00296504|3586499|FG008|Interim Analysis|Physician and Participant Decision|0
2041351|NCT00438633|3612020|FG000|Overall Study|Withdrawal by Subject|1
2041352|NCT00438633|3612021|FG001|Overall Study|Withdrawal by Subject|0
2041353|NCT00438633|3612020|FG000|Overall Study|Lost to Follow-up|15
2041354|NCT00438633|3612021|FG001|Overall Study|Lost to Follow-up|17
2041355|NCT00438659|3612029|FG000|Overall Study|Discontinued Mometasone/Placebo|1
2041356|NCT00438659|3612030|FG001|Overall Study|Discontinued Mometasone/Placebo|2
2041357|NCT00438659|3612029|FG000|Overall Study|Cancel|5
2041358|NCT00438659|3612030|FG001|Overall Study|Cancel|2
2041359|NCT00438672|3612039|FG000|Overall Study|Lost to Follow-up|7
2041360|NCT00438672|3612040|FG001|Overall Study|Lost to Follow-up|9
2041361|NCT00438815|3612070|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
2041362|NCT00438815|3612070|FG000|Overall Study|3-month follow-up no longer required|12
2041363|NCT00438815|3612070|FG000|Overall Study|Noncompliance with protocol requirements|9
2041364|NCT00438815|3612070|FG000|Overall Study|Transitioned to commercial C1INH-nf|6
2041365|NCT00438815|3612070|FG000|Overall Study|Lost to Follow-up|6
2041366|NCT00438815|3612070|FG000|Overall Study|Withdrawal by Subject|6
2041367|NCT00438815|3612070|FG000|Overall Study|Death|1
2041368|NCT00439140|3612112|FG000|Treatment Cycle 1|Lost to Follow-up|1
2041369|NCT00439140|3612113|FG001|Treatment Cycle 1|Lost to Follow-up|1
2041370|NCT00439140|3612114|FG002|Treatment Cycle 1|Lost to Follow-up|1
2041371|NCT00439140|3612112|FG000|Treatment Cycle 1|Personal reasons|0
2041372|NCT00439140|3612113|FG001|Treatment Cycle 1|Personal reasons|2
2041373|NCT00439140|3612114|FG002|Treatment Cycle 1|Personal reasons|0
2041374|NCT00439140|3612112|FG000|Treatment Cycle 1|Withdrawal by Subject|0
2041375|NCT00439140|3612113|FG001|Treatment Cycle 1|Withdrawal by Subject|1
2041376|NCT00439140|3612114|FG002|Treatment Cycle 1|Withdrawal by Subject|0
2041377|NCT00439140|3612112|FG000|Treatment Cycle 2|Withdrawal by Subject|1
2041378|NCT00439140|3612113|FG001|Treatment Cycle 2|Withdrawal by Subject|0
2041379|NCT00439140|3612114|FG002|Treatment Cycle 2|Withdrawal by Subject|0
2041380|NCT00439140|3612112|FG000|Treatment Cycle 2|Lost to Follow-up|1
2041381|NCT00439140|3612113|FG001|Treatment Cycle 2|Lost to Follow-up|1
2041382|NCT00439140|3612114|FG002|Treatment Cycle 2|Lost to Follow-up|0
2041383|NCT00439179|3612126|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0
2041384|NCT00439179|3612127|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2
2041385|NCT00439179|3612128|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0
2041386|NCT00439179|3612129|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0
2041387|NCT00439218|3612142|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
2041388|NCT00439231|3612146|FG000|Overall Study|Lack of Efficacy|28
2041389|NCT00439244|3612153|FG000|Overall Study|Adverse Event|5
2041390|NCT00439244|3612154|FG001|Overall Study|Adverse Event|2
2041391|NCT00439244|3612155|FG002|Overall Study|Adverse Event|3
2041392|NCT00439244|3612153|FG000|Overall Study|Withdrawal by Subject|3
2041393|NCT00439244|3612154|FG001|Overall Study|Withdrawal by Subject|1
2041394|NCT00439244|3612155|FG002|Overall Study|Withdrawal by Subject|2
2041395|NCT00439244|3612153|FG000|Overall Study|Lost to Follow-up|2
2041396|NCT00439244|3612154|FG001|Overall Study|Lost to Follow-up|1
2041397|NCT00439244|3612155|FG002|Overall Study|Lost to Follow-up|2
2041398|NCT00439244|3612153|FG000|Overall Study|Death|0
2041399|NCT00439244|3612154|FG001|Overall Study|Death|1
2041400|NCT00439244|3612155|FG002|Overall Study|Death|0
2041401|NCT00439244|3612153|FG000|Overall Study|Protocol Violation|0
2041402|NCT00439244|3612154|FG001|Overall Study|Protocol Violation|1
2041403|NCT00439244|3612155|FG002|Overall Study|Protocol Violation|0
2041404|NCT00439244|3612153|FG000|Overall Study|Administrative problems|1
2041405|NCT00439244|3612154|FG001|Overall Study|Administrative problems|0
2041406|NCT00439244|3612155|FG002|Overall Study|Administrative problems|0
2041407|NCT00439270|3612168|FG000|Phase 1 (18.1 Months)|Disease progression|3
2019142|NCT00296504|3586491|FG000|Interim Analysis|Participant Stopped HIV Medications|0
2019143|NCT00296504|3586492|FG001|Interim Analysis|Participant Stopped HIV Medications|0
2019144|NCT00296504|3586493|FG002|Interim Analysis|Participant Stopped HIV Medications|0
2019145|NCT00296504|3586494|FG003|Interim Analysis|Participant Stopped HIV Medications|0
2019146|NCT00296504|3586495|FG004|Interim Analysis|Participant Stopped HIV Medications|0
2019147|NCT00296504|3586496|FG005|Interim Analysis|Participant Stopped HIV Medications|0
2019148|NCT00296504|3586497|FG006|Interim Analysis|Participant Stopped HIV Medications|1
2026048|NCT00348283|3594714|FG000|Double Blind|Pregnancy|0
2041408|NCT00439270|3612169|FG001|Phase 1 (18.1 Months)|Disease progression|2
2041409|NCT00439270|3612170|FG002|Phase 1 (18.1 Months)|Disease progression|3
2041410|NCT00439270|3612171|FG003|Phase 1 (18.1 Months)|Disease progression|0
2041411|NCT00439270|3612172|FG004|Phase 1 (18.1 Months)|Disease progression|3
2041412|NCT00439270|3612168|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0
2041413|NCT00439270|3612169|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1
2041414|NCT00439270|3612170|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0
2041415|NCT00439270|3612171|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0
2041416|NCT00439270|3612172|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0
2041417|NCT00439270|3612168|FG000|Phase 2 (51.6 Months)|Disease progression|0
2041418|NCT00439270|3612169|FG001|Phase 2 (51.6 Months)|Disease progression|0
2041419|NCT00439270|3612170|FG002|Phase 2 (51.6 Months)|Disease progression|0
2041420|NCT00439270|3612171|FG003|Phase 2 (51.6 Months)|Disease progression|18
2041421|NCT00439270|3612172|FG004|Phase 2 (51.6 Months)|Disease progression|0
2041422|NCT00439270|3612168|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
2041423|NCT00439270|3612169|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
2041424|NCT00439270|3612170|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
2204824|NCT01606761|3842683|FG001|Prior to Week 24|Adverse Event|18
2204825|NCT01606761|3842684|FG002|Prior to Week 24|Adverse Event|22
2204826|NCT01606761|3842685|FG003|Prior to Week 24|Adverse Event|0
2041425|NCT00439270|3612171|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
2041426|NCT00439270|3612172|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
2041427|NCT00439270|3612168|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0
2041428|NCT00439270|3612169|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0
2041429|NCT00439270|3612170|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0
2041430|NCT00439270|3612171|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6
2041431|NCT00439270|3612172|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0
2041432|NCT00439270|3612168|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0
2041433|NCT00439270|3612169|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0
2041434|NCT00439270|3612170|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0
2041435|NCT00439270|3612171|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3
2041436|NCT00439270|3612172|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0
2041437|NCT00439270|3612168|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0
2041438|NCT00439270|3612169|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0
2041439|NCT00439270|3612170|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0
2041440|NCT00439270|3612171|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1
2041441|NCT00439270|3612172|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0
2041442|NCT00439270|3612168|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0
2041443|NCT00439270|3612169|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0
2041444|NCT00439270|3612170|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0
2041445|NCT00439270|3612171|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2
2041446|NCT00439270|3612172|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0
2041447|NCT00439270|3612168|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
2041448|NCT00439270|3612169|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
2041449|NCT00439270|3612170|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
2041450|NCT00439270|3612171|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
2041451|NCT00439270|3612172|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
2041452|NCT00439270|3612168|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
2041453|NCT00439270|3612169|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
2041454|NCT00439270|3612170|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
2041455|NCT00439270|3612171|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
2041456|NCT00439270|3612172|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
2041457|NCT00439309|3612202|FG000|Follow-Up|Death|1
2041458|NCT00439309|3612203|FG001|Follow-Up|Death|0
2041459|NCT00439309|3612202|FG000|Follow-Up|Lost to Follow-up|2
2041460|NCT00439309|3612203|FG001|Follow-Up|Lost to Follow-up|0
2041461|NCT00439309|3612202|FG000|Follow-Up|Withdrawal by Subject|0
2041462|NCT00439309|3612203|FG001|Follow-Up|Withdrawal by Subject|1
2041463|NCT00439309|3612202|FG000|Follow-Up|Late response by subject|0
2041464|NCT00439309|3612203|FG001|Follow-Up|Late response by subject|1
2041465|NCT00439517|3612247|FG000|Overall Study|Subject on treatment|1
2204827|NCT01606761|3842686|FG004|Prior to Week 24|Adverse Event|0
2041466|NCT00439517|3612248|FG001|Overall Study|Subject on treatment|0
2041467|NCT00439517|3612247|FG000|Overall Study|Subject in survival follow-up|1
2041468|NCT00439517|3612248|FG001|Overall Study|Subject in survival follow-up|0
2041469|NCT00439556|3612257|FG000|Overall Study|Patient was taken off study for non-comp|0
2041470|NCT00439556|3612258|FG001|Overall Study|Patient was taken off study for non-comp|1
2041471|NCT00439556|3612259|FG002|Overall Study|Patient was taken off study for non-comp|0
2041472|NCT00439647|3612274|FG000|Overall Study|Withdrawal by Subject|25
2041473|NCT00439647|3612275|FG001|Overall Study|Withdrawal by Subject|22
2041474|NCT00439647|3612274|FG000|Overall Study|Death|15
2041475|NCT00439647|3612275|FG001|Overall Study|Death|18
2041476|NCT00439647|3612274|FG000|Overall Study|Adverse Event|11
2041477|NCT00439647|3612275|FG001|Overall Study|Adverse Event|11
2041478|NCT00439647|3612274|FG000|Overall Study|Lost to Follow-up|4
2041479|NCT00439647|3612275|FG001|Overall Study|Lost to Follow-up|12
2041480|NCT00439647|3612274|FG000|Overall Study|Protocol Violation|3
2041481|NCT00439647|3612275|FG001|Overall Study|Protocol Violation|4
2041482|NCT00439647|3612274|FG000|Overall Study|Lack of Efficacy|0
2041483|NCT00439647|3612275|FG001|Overall Study|Lack of Efficacy|4
2041484|NCT00439725|3612287|FG000|Treatment Period|Withdrawal by Subject|22
2041485|NCT00439725|3612288|FG001|Treatment Period|Withdrawal by Subject|19
2041486|NCT00439725|3612287|FG000|Treatment Period|Study terminated by sponsor|156
2041487|NCT00439725|3612288|FG001|Treatment Period|Study terminated by sponsor|148
2041488|NCT00439725|3612287|FG000|Treatment Period|Site closed by investigator|1
2041489|NCT00439725|3612288|FG001|Treatment Period|Site closed by investigator|2
2041490|NCT00439725|3612287|FG000|Treatment Period|Adverse Event|39
2041491|NCT00439725|3612288|FG001|Treatment Period|Adverse Event|18
2041492|NCT00439725|3612287|FG000|Treatment Period|Physician Decision|1
2041493|NCT00439725|3612288|FG001|Treatment Period|Physician Decision|1
2041494|NCT00439725|3612287|FG000|Treatment Period|Protocol Violation|2
2041495|NCT00439725|3612288|FG001|Treatment Period|Protocol Violation|1
2041496|NCT00439725|3612287|FG000|Treatment Period|Clinical endpoint reached|6
2041497|NCT00439725|3612288|FG001|Treatment Period|Clinical endpoint reached|50
2041498|NCT00439725|3612287|FG000|Treatment Period|Technical problems|1
2041499|NCT00439725|3612288|FG001|Treatment Period|Technical problems|0
2041500|NCT00439725|3612287|FG000|Treatment Period|Lost to Follow-up|1
2041501|NCT00439725|3612288|FG001|Treatment Period|Lost to Follow-up|1
2041502|NCT00439725|3612287|FG000|Treatment Period|Participant convenience|1
2041503|NCT00439725|3612288|FG001|Treatment Period|Participant convenience|0
2041504|NCT00439725|3612287|FG000|Treatment Period|Protocol driven decision point|1
2041505|NCT00439725|3612288|FG001|Treatment Period|Protocol driven decision point|1
2041506|NCT00439725|3612287|FG000|Treatment Period|Death|1
2041507|NCT00439725|3612288|FG001|Treatment Period|Death|1
2041508|NCT00439725|3612287|FG000|Treatment Period|Participant did not receive treatment|4
2041509|NCT00439725|3612288|FG001|Treatment Period|Participant did not receive treatment|4
2041510|NCT00439725|3612287|FG000|Observational Period|Withdrawal by Subject|2
2041511|NCT00439725|3612288|FG001|Observational Period|Withdrawal by Subject|2
2041512|NCT00439725|3612287|FG000|Observational Period|Lost to Follow-up|0
2041513|NCT00439725|3612288|FG001|Observational Period|Lost to Follow-up|1
2041514|NCT00439725|3612287|FG000|Observational Period|Death|0
2041515|NCT00439725|3612288|FG001|Observational Period|Death|2
2041516|NCT00439725|3612287|FG000|Observational Period|Study termination by sponsor|1
2041517|NCT00439725|3612288|FG001|Observational Period|Study termination by sponsor|1
2041518|NCT00439725|3612287|FG000|Observational Period|Clinical endpoint reached|3
2041519|NCT00439725|3612288|FG001|Observational Period|Clinical endpoint reached|1
2041520|NCT00439725|3612287|FG000|Observational Period|Technical problems|1
2041521|NCT00439725|3612288|FG001|Observational Period|Technical problems|0
2041522|NCT00439725|3612287|FG000|Observational Period|Participant convenience|1
2041523|NCT00439725|3612288|FG001|Observational Period|Participant convenience|0
2041524|NCT00439777|3612296|FG000|Treatment Period|Death|29
2041525|NCT00439777|3612297|FG001|Treatment Period|Death|21
2041526|NCT00439777|3612296|FG000|Treatment Period|Study terminated by sponsor|125
2041527|NCT00439777|3612297|FG001|Treatment Period|Study terminated by sponsor|132
2041528|NCT00439777|3612296|FG000|Treatment Period|Site closed by investigator|0
2041529|NCT00439777|3612297|FG001|Treatment Period|Site closed by investigator|1
2041530|NCT00439777|3612296|FG000|Treatment Period|Did not take study treatment|7
2041531|NCT00439777|3612297|FG001|Treatment Period|Did not take study treatment|8
2041532|NCT00439777|3612296|FG000|Treatment Period|Adverse Event|111
2041533|NCT00439777|3612297|FG001|Treatment Period|Adverse Event|92
2041534|NCT00439777|3612296|FG000|Treatment Period|Protocol Violation|23
2041535|NCT00439777|3612297|FG001|Treatment Period|Protocol Violation|30
2118213|NCT00950248|3715939|FG000|Year 2&3 Treatment Randomization|Death|0
2118214|NCT00950248|3715940|FG001|Year 2&3 Treatment Randomization|Death|0
2118215|NCT00950248|3715941|FG002|Year 2&3 Treatment Randomization|Death|1
2118216|NCT00950248|3715939|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0
2118217|NCT00950248|3715940|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1
2118218|NCT00950248|3715941|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0
2118219|NCT00950300|3715950|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
2118220|NCT00950300|3715951|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
2118221|NCT00950300|3715950|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1
2118222|NCT00950300|3715951|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3
2118223|NCT00950300|3715950|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
2118224|NCT00950300|3715951|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
2118225|NCT00950300|3715950|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
2118226|NCT00950300|3715951|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
2118227|NCT00950300|3715950|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
2118228|NCT00950300|3715951|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
2118229|NCT00950300|3715950|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
2118230|NCT00950300|3715951|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
2118231|NCT00950300|3715950|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
2118232|NCT00950300|3715951|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
2118233|NCT00950300|3715950|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
2118234|NCT00950300|3715951|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
2118235|NCT00950300|3715950|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
2118236|NCT00950300|3715951|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
2118237|NCT00950300|3715950|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1
2118238|NCT00950300|3715951|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1
2118239|NCT00950300|3715950|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3
2118240|NCT00950300|3715951|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4
2118241|NCT00950300|3715950|FG000|TFFU Period|Death|4
2118242|NCT00950300|3715951|FG001|TFFU Period|Death|1
2118243|NCT00950300|3715950|FG000|TFFU Period|Refused Treatment|10
2118244|NCT00950300|3715951|FG001|TFFU Period|Refused Treatment|11
2118245|NCT00950300|3715950|FG000|TFFU Period|Failure to Return|16
2118246|NCT00950300|3715951|FG001|TFFU Period|Failure to Return|16
2118247|NCT00950300|3715950|FG000|TFFU Period|Recurrence of Disease|63
2118248|NCT00950300|3715951|FG001|TFFU Period|Recurrence of Disease|72
2118249|NCT00950300|3715950|FG000|TFFU Period|Other|4
2118250|NCT00950300|3715951|FG001|TFFU Period|Other|3
2118251|NCT00950300|3715950|FG000|SFU Period|Death|44
2118252|NCT00950300|3715951|FG001|SFU Period|Death|42
2118253|NCT00950300|3715950|FG000|SFU Period|Lost to Follow-up|30
2118254|NCT00950300|3715951|FG001|SFU Period|Lost to Follow-up|28
2118255|NCT00950300|3715950|FG000|SFU Period|Withdrawal by Subject|4
2118256|NCT00950300|3715951|FG001|SFU Period|Withdrawal by Subject|8
2118257|NCT00950599|3715984|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0
2118258|NCT00950599|3715985|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0
2118259|NCT00950599|3715986|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0
2118260|NCT00950599|3715987|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1
2118261|NCT00950599|3715988|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0
2118262|NCT00950599|3715989|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0
2118263|NCT00950599|3715990|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0
2118264|NCT00950599|3715991|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0
2118265|NCT00950599|3715992|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0
2118266|NCT00950599|3715993|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0
2118267|NCT00950599|3715984|FG000|Double-Blind Treatment Period|Adverse Event|0
2118268|NCT00950599|3715985|FG001|Double-Blind Treatment Period|Adverse Event|1
2118269|NCT00950599|3715986|FG002|Double-Blind Treatment Period|Adverse Event|1
2118270|NCT00950599|3715987|FG003|Double-Blind Treatment Period|Adverse Event|1
2118271|NCT00950599|3715988|FG004|Double-Blind Treatment Period|Adverse Event|1
2118272|NCT00950599|3715989|FG005|Double-Blind Treatment Period|Adverse Event|1
2118273|NCT00950599|3715990|FG006|Double-Blind Treatment Period|Adverse Event|0
2118274|NCT00950599|3715991|FG007|Double-Blind Treatment Period|Adverse Event|0
2118275|NCT00950599|3715992|FG008|Double-Blind Treatment Period|Adverse Event|0
2118276|NCT00950599|3715993|FG009|Double-Blind Treatment Period|Adverse Event|0
2118277|NCT00950599|3715984|FG000|Double-Blind Treatment Period|Lack of Efficacy|2
2118278|NCT00950599|3715985|FG001|Double-Blind Treatment Period|Lack of Efficacy|5
2118279|NCT00950599|3715986|FG002|Double-Blind Treatment Period|Lack of Efficacy|5
2118280|NCT00950599|3715987|FG003|Double-Blind Treatment Period|Lack of Efficacy|7
2118281|NCT00950599|3715988|FG004|Double-Blind Treatment Period|Lack of Efficacy|3
2118282|NCT00950599|3715989|FG005|Double-Blind Treatment Period|Lack of Efficacy|6
2118283|NCT00950599|3715990|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
2118284|NCT00950599|3715991|FG007|Double-Blind Treatment Period|Lack of Efficacy|1
2118285|NCT00950599|3715992|FG008|Double-Blind Treatment Period|Lack of Efficacy|0
2118286|NCT00950599|3715993|FG009|Double-Blind Treatment Period|Lack of Efficacy|0
2118287|NCT00950599|3715984|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
2118288|NCT00950599|3715985|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
2118289|NCT00950599|3715986|FG002|Double-Blind Treatment Period|Lost to Follow-up|0
2118290|NCT00950599|3715987|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
2118291|NCT00950599|3715988|FG004|Double-Blind Treatment Period|Lost to Follow-up|1
2118292|NCT00950599|3715989|FG005|Double-Blind Treatment Period|Lost to Follow-up|2
2118293|NCT00950599|3715990|FG006|Double-Blind Treatment Period|Lost to Follow-up|0
2118294|NCT00950599|3715991|FG007|Double-Blind Treatment Period|Lost to Follow-up|1
2118295|NCT00950599|3715992|FG008|Double-Blind Treatment Period|Lost to Follow-up|0
2118296|NCT00950599|3715993|FG009|Double-Blind Treatment Period|Lost to Follow-up|0
2118297|NCT00950599|3715984|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1
2118298|NCT00950599|3715985|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1
2118299|NCT00950599|3715986|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0
2118300|NCT00950599|3715987|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0
2118301|NCT00950599|3715988|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0
2118302|NCT00950599|3715989|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0
2118303|NCT00950599|3715990|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0
2118304|NCT00950599|3715991|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1
2118305|NCT00950599|3715992|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0
2118306|NCT00950599|3715993|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0
2118307|NCT00950599|3715984|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2118308|NCT00950599|3715985|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2118309|NCT00950599|3715986|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2118310|NCT00950599|3715987|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2118311|NCT00950599|3715988|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1
2118312|NCT00950599|3715989|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1
2118313|NCT00950599|3715990|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2118314|NCT00950599|3715991|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2118315|NCT00950599|3715992|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2118316|NCT00950599|3715993|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2118317|NCT00950599|3715984|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4
2118318|NCT00950599|3715985|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3
2118319|NCT00950599|3715986|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3
2118320|NCT00950599|3715987|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1
2118321|NCT00950599|3715988|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1
2118322|NCT00950599|3715989|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2
2118323|NCT00950599|3715990|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0
2118324|NCT00950599|3715991|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3
2118325|NCT00950599|3715992|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0
2118326|NCT00950599|3715993|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0
2118327|NCT00950599|3715984|FG000|Follow-Up Period|Adverse Event|0
2118328|NCT00950599|3715985|FG001|Follow-Up Period|Adverse Event|0
2118329|NCT00950599|3715986|FG002|Follow-Up Period|Adverse Event|0
2118330|NCT00950599|3715987|FG003|Follow-Up Period|Adverse Event|0
2118331|NCT00950599|3715988|FG004|Follow-Up Period|Adverse Event|0
2118332|NCT00950599|3715989|FG005|Follow-Up Period|Adverse Event|0
2118333|NCT00950599|3715990|FG006|Follow-Up Period|Adverse Event|0
2118334|NCT00950599|3715991|FG007|Follow-Up Period|Adverse Event|0
2118335|NCT00950599|3715992|FG008|Follow-Up Period|Adverse Event|1
2118336|NCT00950599|3715993|FG009|Follow-Up Period|Adverse Event|0
2118337|NCT00950599|3715984|FG000|Follow-Up Period|Lack of Efficacy|0
2118338|NCT00950599|3715985|FG001|Follow-Up Period|Lack of Efficacy|0
2118339|NCT00950599|3715986|FG002|Follow-Up Period|Lack of Efficacy|0
2118340|NCT00950599|3715987|FG003|Follow-Up Period|Lack of Efficacy|0
2118341|NCT00950599|3715988|FG004|Follow-Up Period|Lack of Efficacy|0
2118342|NCT00950599|3715989|FG005|Follow-Up Period|Lack of Efficacy|0
2118343|NCT00950599|3715990|FG006|Follow-Up Period|Lack of Efficacy|0
2118344|NCT00950599|3715991|FG007|Follow-Up Period|Lack of Efficacy|0
2118345|NCT00950599|3715992|FG008|Follow-Up Period|Lack of Efficacy|3
2118346|NCT00950599|3715993|FG009|Follow-Up Period|Lack of Efficacy|0
2118347|NCT00950599|3715984|FG000|Follow-Up Period|Lost to Follow-up|0
2118348|NCT00950599|3715985|FG001|Follow-Up Period|Lost to Follow-up|0
2118349|NCT00950599|3715986|FG002|Follow-Up Period|Lost to Follow-up|0
2118350|NCT00950599|3715987|FG003|Follow-Up Period|Lost to Follow-up|0
2118351|NCT00950599|3715988|FG004|Follow-Up Period|Lost to Follow-up|0
2118352|NCT00950599|3715989|FG005|Follow-Up Period|Lost to Follow-up|0
2118353|NCT00950599|3715990|FG006|Follow-Up Period|Lost to Follow-up|0
2118354|NCT00950599|3715991|FG007|Follow-Up Period|Lost to Follow-up|0
2118355|NCT00950599|3715992|FG008|Follow-Up Period|Lost to Follow-up|5
2118356|NCT00950599|3715993|FG009|Follow-Up Period|Lost to Follow-up|1
2118357|NCT00950599|3715984|FG000|Follow-Up Period|Physician Decision|0
2118358|NCT00950599|3715985|FG001|Follow-Up Period|Physician Decision|0
2118359|NCT00950599|3715986|FG002|Follow-Up Period|Physician Decision|0
2118360|NCT00950599|3715987|FG003|Follow-Up Period|Physician Decision|0
2118361|NCT00950599|3715988|FG004|Follow-Up Period|Physician Decision|0
2118362|NCT00950599|3715989|FG005|Follow-Up Period|Physician Decision|0
2118363|NCT00950599|3715990|FG006|Follow-Up Period|Physician Decision|0
2118364|NCT00950599|3715991|FG007|Follow-Up Period|Physician Decision|0
2118365|NCT00950599|3715992|FG008|Follow-Up Period|Physician Decision|1
2118366|NCT00950599|3715993|FG009|Follow-Up Period|Physician Decision|0
2118367|NCT00950599|3715984|FG000|Follow-Up Period|Poor/Noncompliance|0
2118368|NCT00950599|3715985|FG001|Follow-Up Period|Poor/Noncompliance|0
2118369|NCT00950599|3715986|FG002|Follow-Up Period|Poor/Noncompliance|0
2118370|NCT00950599|3715987|FG003|Follow-Up Period|Poor/Noncompliance|0
2118371|NCT00950599|3715988|FG004|Follow-Up Period|Poor/Noncompliance|0
2118372|NCT00950599|3715989|FG005|Follow-Up Period|Poor/Noncompliance|0
2118373|NCT00950599|3715990|FG006|Follow-Up Period|Poor/Noncompliance|0
2118374|NCT00950599|3715991|FG007|Follow-Up Period|Poor/Noncompliance|0
2118375|NCT00950599|3715992|FG008|Follow-Up Period|Poor/Noncompliance|1
2118376|NCT00950599|3715993|FG009|Follow-Up Period|Poor/Noncompliance|0
2118377|NCT00950599|3715984|FG000|Follow-Up Period|Subject withdrew Consent|0
2118378|NCT00950599|3715985|FG001|Follow-Up Period|Subject withdrew Consent|0
2118379|NCT00950599|3715986|FG002|Follow-Up Period|Subject withdrew Consent|0
2118380|NCT00950599|3715987|FG003|Follow-Up Period|Subject withdrew Consent|0
2118381|NCT00950599|3715988|FG004|Follow-Up Period|Subject withdrew Consent|0
2118382|NCT00950599|3715989|FG005|Follow-Up Period|Subject withdrew Consent|0
2118383|NCT00950599|3715990|FG006|Follow-Up Period|Subject withdrew Consent|0
2118384|NCT00950599|3715991|FG007|Follow-Up Period|Subject withdrew Consent|0
2118385|NCT00950599|3715992|FG008|Follow-Up Period|Subject withdrew Consent|2
2118386|NCT00950599|3715993|FG009|Follow-Up Period|Subject withdrew Consent|1
2118387|NCT00950651|3716027|FG000|Overall Study|Adverse Event|17
2118388|NCT00950651|3716028|FG001|Overall Study|Adverse Event|20
2118389|NCT00950651|3716027|FG000|Overall Study|Death|1
2118390|NCT00950651|3716028|FG001|Overall Study|Death|0
2118391|NCT00950651|3716027|FG000|Overall Study|Lack of Efficacy|2
2118392|NCT00950651|3716028|FG001|Overall Study|Lack of Efficacy|2
2118393|NCT00950651|3716027|FG000|Overall Study|Protocol Violation|3
2118394|NCT00950651|3716028|FG001|Overall Study|Protocol Violation|4
2118395|NCT00950651|3716027|FG000|Overall Study|Withdrawal by Subject|8
2118396|NCT00950651|3716028|FG001|Overall Study|Withdrawal by Subject|9
2118397|NCT00950664|3716036|FG000|First Intervention|Lost to Follow-up|1
2118398|NCT00950664|3716037|FG001|First Intervention|Lost to Follow-up|3
2118399|NCT00950664|3716036|FG000|First Intervention|Withdrawal by Subject|2
2204828|NCT01606761|3842682|FG000|Prior to Week 24|Lack of Efficacy|15
2204829|NCT01606761|3842683|FG001|Prior to Week 24|Lack of Efficacy|14
2204830|NCT01606761|3842684|FG002|Prior to Week 24|Lack of Efficacy|8
2204831|NCT01606761|3842685|FG003|Prior to Week 24|Lack of Efficacy|0
2204832|NCT01606761|3842686|FG004|Prior to Week 24|Lack of Efficacy|0
2204833|NCT01606761|3842682|FG000|Prior to Week 24|Physician Decision|0
2204834|NCT01606761|3842683|FG001|Prior to Week 24|Physician Decision|3
2204835|NCT01606761|3842684|FG002|Prior to Week 24|Physician Decision|1
2118400|NCT00950664|3716037|FG001|First Intervention|Withdrawal by Subject|2
2118401|NCT00950742|3716049|FG000|Overall Study|Other Adverse Event|1
2118402|NCT00950742|3716050|FG001|Overall Study|Other Adverse Event|0
2118403|NCT00950742|3716049|FG000|Overall Study|Withdrawal by Subject|3
2118404|NCT00950742|3716050|FG001|Overall Study|Withdrawal by Subject|0
2118405|NCT00950742|3716049|FG000|Overall Study|Progressive Disease|6
2118406|NCT00950742|3716050|FG001|Overall Study|Progressive Disease|2
2118407|NCT00950742|3716049|FG000|Overall Study|Dose limiting toxicity|6
2118408|NCT00950742|3716050|FG001|Overall Study|Dose limiting toxicity|0
2118409|NCT00950755|3716060|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
2204836|NCT01606761|3842685|FG003|Prior to Week 24|Physician Decision|0
2118410|NCT00950755|3716060|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
2118411|NCT00950755|3716060|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27
2118412|NCT00950755|3716060|FG000|Dosimetric and Therapeutic Treatment|Death|1
2118413|NCT00950755|3716060|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
2118414|NCT00950755|3716060|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
2118415|NCT00950755|3716060|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
2118416|NCT00950755|3716060|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
2118417|NCT00950755|3716060|FG000|Long-Term Follow-Up|Lost to Follow-up|1
2118418|NCT00950755|3716060|FG000|Long-Term Follow-Up|Death|8
2118419|NCT00950807|3716064|FG000|Treatment Period 1|Lack of Efficacy|1
2118420|NCT00950807|3716065|FG001|Treatment Period 1|Lack of Efficacy|0
2118421|NCT00950807|3716066|FG002|Treatment Period 1|Lack of Efficacy|0
2118422|NCT00950807|3716067|FG003|Treatment Period 1|Lack of Efficacy|0
2118423|NCT00950807|3716068|FG004|Treatment Period 1|Lack of Efficacy|0
2118424|NCT00950807|3716069|FG005|Treatment Period 1|Lack of Efficacy|1
2118425|NCT00950807|3716070|FG006|Treatment Period 1|Lack of Efficacy|0
2118426|NCT00950807|3716071|FG007|Treatment Period 1|Lack of Efficacy|0
2118427|NCT00950807|3716072|FG008|Treatment Period 1|Lack of Efficacy|0
2118428|NCT00950807|3716073|FG009|Treatment Period 1|Lack of Efficacy|0
2118429|NCT00950807|3716064|FG000|Treatment Period 1|Protocol Violation|1
2118430|NCT00950807|3716065|FG001|Treatment Period 1|Protocol Violation|0
2118431|NCT00950807|3716066|FG002|Treatment Period 1|Protocol Violation|0
2118432|NCT00950807|3716067|FG003|Treatment Period 1|Protocol Violation|0
2204837|NCT01606761|3842686|FG004|Prior to Week 24|Physician Decision|0
2204838|NCT01606761|3842682|FG000|Prior to Week 24|Other|4
2118433|NCT00950807|3716068|FG004|Treatment Period 1|Protocol Violation|0
2118434|NCT00950807|3716069|FG005|Treatment Period 1|Protocol Violation|0
2118435|NCT00950807|3716070|FG006|Treatment Period 1|Protocol Violation|0
2118436|NCT00950807|3716071|FG007|Treatment Period 1|Protocol Violation|0
2118437|NCT00950807|3716072|FG008|Treatment Period 1|Protocol Violation|0
2118438|NCT00950807|3716073|FG009|Treatment Period 1|Protocol Violation|0
2118439|NCT00950807|3716064|FG000|Treatment Period 1|Lost to Follow-up|0
2118440|NCT00950807|3716065|FG001|Treatment Period 1|Lost to Follow-up|0
2118441|NCT00950807|3716066|FG002|Treatment Period 1|Lost to Follow-up|1
2118442|NCT00950807|3716067|FG003|Treatment Period 1|Lost to Follow-up|0
2118443|NCT00950807|3716068|FG004|Treatment Period 1|Lost to Follow-up|0
2118444|NCT00950807|3716069|FG005|Treatment Period 1|Lost to Follow-up|0
2118445|NCT00950807|3716070|FG006|Treatment Period 1|Lost to Follow-up|0
2118446|NCT00950807|3716071|FG007|Treatment Period 1|Lost to Follow-up|0
2118447|NCT00950807|3716072|FG008|Treatment Period 1|Lost to Follow-up|0
2118448|NCT00950807|3716073|FG009|Treatment Period 1|Lost to Follow-up|0
2118449|NCT00950807|3716064|FG000|Treatment Period 1|Withdrawal by Subject|1
2118450|NCT00950807|3716065|FG001|Treatment Period 1|Withdrawal by Subject|0
2118451|NCT00950807|3716066|FG002|Treatment Period 1|Withdrawal by Subject|0
2118452|NCT00950807|3716067|FG003|Treatment Period 1|Withdrawal by Subject|0
2118453|NCT00950807|3716068|FG004|Treatment Period 1|Withdrawal by Subject|1
2118454|NCT00950807|3716069|FG005|Treatment Period 1|Withdrawal by Subject|0
2118455|NCT00950807|3716070|FG006|Treatment Period 1|Withdrawal by Subject|0
2118456|NCT00950807|3716071|FG007|Treatment Period 1|Withdrawal by Subject|0
2118457|NCT00950807|3716072|FG008|Treatment Period 1|Withdrawal by Subject|1
2118458|NCT00950807|3716073|FG009|Treatment Period 1|Withdrawal by Subject|0
2118459|NCT00950807|3716064|FG000|Treatment Period 1|Adverse Event|0
2118460|NCT00950807|3716065|FG001|Treatment Period 1|Adverse Event|0
2118461|NCT00950807|3716066|FG002|Treatment Period 1|Adverse Event|0
2118462|NCT00950807|3716067|FG003|Treatment Period 1|Adverse Event|0
2118463|NCT00950807|3716068|FG004|Treatment Period 1|Adverse Event|0
2118464|NCT00950807|3716069|FG005|Treatment Period 1|Adverse Event|1
2118465|NCT00950807|3716070|FG006|Treatment Period 1|Adverse Event|0
2118466|NCT00950807|3716071|FG007|Treatment Period 1|Adverse Event|0
2118467|NCT00950807|3716072|FG008|Treatment Period 1|Adverse Event|0
2118468|NCT00950807|3716073|FG009|Treatment Period 1|Adverse Event|0
2118469|NCT00950807|3716064|FG000|Washout Period 1|Lack of Efficacy|0
2118470|NCT00950807|3716065|FG001|Washout Period 1|Lack of Efficacy|0
2118471|NCT00950807|3716066|FG002|Washout Period 1|Lack of Efficacy|0
2118472|NCT00950807|3716067|FG003|Washout Period 1|Lack of Efficacy|0
2118473|NCT00950807|3716068|FG004|Washout Period 1|Lack of Efficacy|0
2118474|NCT00950807|3716069|FG005|Washout Period 1|Lack of Efficacy|0
2118475|NCT00950807|3716070|FG006|Washout Period 1|Lack of Efficacy|1
2118476|NCT00950807|3716071|FG007|Washout Period 1|Lack of Efficacy|0
2118477|NCT00950807|3716072|FG008|Washout Period 1|Lack of Efficacy|0
2118478|NCT00950807|3716073|FG009|Washout Period 1|Lack of Efficacy|0
2118479|NCT00950807|3716064|FG000|Washout Period 1|Withdrawal by Subject|0
2118480|NCT00950807|3716065|FG001|Washout Period 1|Withdrawal by Subject|0
2118481|NCT00950807|3716066|FG002|Washout Period 1|Withdrawal by Subject|0
2118482|NCT00950807|3716067|FG003|Washout Period 1|Withdrawal by Subject|0
2118483|NCT00950807|3716068|FG004|Washout Period 1|Withdrawal by Subject|0
2118484|NCT00950807|3716069|FG005|Washout Period 1|Withdrawal by Subject|0
2118485|NCT00950807|3716070|FG006|Washout Period 1|Withdrawal by Subject|0
2118486|NCT00950807|3716071|FG007|Washout Period 1|Withdrawal by Subject|0
2118487|NCT00950807|3716072|FG008|Washout Period 1|Withdrawal by Subject|1
2118488|NCT00950807|3716073|FG009|Washout Period 1|Withdrawal by Subject|0
2118489|NCT00950807|3716064|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3
2118490|NCT00950807|3716065|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0
2118491|NCT00950807|3716066|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0
2118492|NCT00950807|3716067|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0
2118493|NCT00950807|3716068|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0
2118494|NCT00950807|3716069|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0
2118495|NCT00950807|3716070|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1
2118496|NCT00950807|3716071|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1
2118497|NCT00950807|3716072|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0
2118498|NCT00950807|3716073|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0
2118499|NCT00950807|3716064|FG000|Washout Period 1|Adverse Event|2
2118500|NCT00950807|3716065|FG001|Washout Period 1|Adverse Event|0
2118501|NCT00950807|3716066|FG002|Washout Period 1|Adverse Event|0
2118502|NCT00950807|3716067|FG003|Washout Period 1|Adverse Event|1
2118503|NCT00950807|3716068|FG004|Washout Period 1|Adverse Event|1
2118504|NCT00950807|3716069|FG005|Washout Period 1|Adverse Event|0
2118505|NCT00950807|3716070|FG006|Washout Period 1|Adverse Event|0
2118506|NCT00950807|3716071|FG007|Washout Period 1|Adverse Event|0
2118507|NCT00950807|3716072|FG008|Washout Period 1|Adverse Event|0
2118508|NCT00950807|3716073|FG009|Washout Period 1|Adverse Event|0
2118509|NCT00950807|3716064|FG000|Treatment Period 2|Lack of Efficacy|1
2118510|NCT00950807|3716065|FG001|Treatment Period 2|Lack of Efficacy|0
2118511|NCT00950807|3716066|FG002|Treatment Period 2|Lack of Efficacy|0
2118512|NCT00950807|3716067|FG003|Treatment Period 2|Lack of Efficacy|0
2118513|NCT00950807|3716068|FG004|Treatment Period 2|Lack of Efficacy|0
2204839|NCT01606761|3842683|FG001|Prior to Week 24|Other|7
2118514|NCT00950807|3716069|FG005|Treatment Period 2|Lack of Efficacy|0
2118515|NCT00950807|3716070|FG006|Treatment Period 2|Lack of Efficacy|0
2118516|NCT00950807|3716071|FG007|Treatment Period 2|Lack of Efficacy|0
2118517|NCT00950807|3716072|FG008|Treatment Period 2|Lack of Efficacy|0
2118518|NCT00950807|3716073|FG009|Treatment Period 2|Lack of Efficacy|0
2118519|NCT00950807|3716064|FG000|Treatment Period 2|Withdrawal by Subject|0
2118520|NCT00950807|3716065|FG001|Treatment Period 2|Withdrawal by Subject|0
2118521|NCT00950807|3716066|FG002|Treatment Period 2|Withdrawal by Subject|0
2118522|NCT00950807|3716067|FG003|Treatment Period 2|Withdrawal by Subject|0
2118523|NCT00950807|3716068|FG004|Treatment Period 2|Withdrawal by Subject|0
2118524|NCT00950807|3716069|FG005|Treatment Period 2|Withdrawal by Subject|0
2118525|NCT00950807|3716070|FG006|Treatment Period 2|Withdrawal by Subject|1
2118526|NCT00950807|3716071|FG007|Treatment Period 2|Withdrawal by Subject|2
2118527|NCT00950807|3716072|FG008|Treatment Period 2|Withdrawal by Subject|0
2118528|NCT00950807|3716073|FG009|Treatment Period 2|Withdrawal by Subject|0
2118529|NCT00950807|3716064|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
2118530|NCT00950807|3716065|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
2118531|NCT00950807|3716066|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
2118532|NCT00950807|3716067|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
2118533|NCT00950807|3716068|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
2118534|NCT00950807|3716069|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
2118535|NCT00950807|3716070|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
2118536|NCT00950807|3716071|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
2118537|NCT00950807|3716072|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0
2118538|NCT00950807|3716073|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0
2118539|NCT00950807|3716064|FG000|Treatment Period 2|Adverse Event|0
2118540|NCT00950807|3716065|FG001|Treatment Period 2|Adverse Event|1
2118541|NCT00950807|3716066|FG002|Treatment Period 2|Adverse Event|0
2118542|NCT00950807|3716067|FG003|Treatment Period 2|Adverse Event|1
2118543|NCT00950807|3716068|FG004|Treatment Period 2|Adverse Event|0
2118544|NCT00950807|3716069|FG005|Treatment Period 2|Adverse Event|1
2118545|NCT00950807|3716070|FG006|Treatment Period 2|Adverse Event|0
2118546|NCT00950807|3716071|FG007|Treatment Period 2|Adverse Event|1
2118547|NCT00950807|3716072|FG008|Treatment Period 2|Adverse Event|0
2118548|NCT00950807|3716073|FG009|Treatment Period 2|Adverse Event|0
2118549|NCT00950807|3716064|FG000|Washout Period 2|Lack of Efficacy|1
2118550|NCT00950807|3716065|FG001|Washout Period 2|Lack of Efficacy|0
2118551|NCT00950807|3716066|FG002|Washout Period 2|Lack of Efficacy|0
2118552|NCT00950807|3716067|FG003|Washout Period 2|Lack of Efficacy|0
2118553|NCT00950807|3716068|FG004|Washout Period 2|Lack of Efficacy|0
2118554|NCT00950807|3716069|FG005|Washout Period 2|Lack of Efficacy|0
2118555|NCT00950807|3716070|FG006|Washout Period 2|Lack of Efficacy|0
2118556|NCT00950807|3716071|FG007|Washout Period 2|Lack of Efficacy|0
2118557|NCT00950807|3716072|FG008|Washout Period 2|Lack of Efficacy|0
2118558|NCT00950807|3716073|FG009|Washout Period 2|Lack of Efficacy|0
2118559|NCT00950807|3716064|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0
2118560|NCT00950807|3716065|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1
2118561|NCT00950807|3716066|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0
2118562|NCT00950807|3716067|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0
2118563|NCT00950807|3716068|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1
2118564|NCT00950807|3716069|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0
2118565|NCT00950807|3716070|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1
2118566|NCT00950807|3716071|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1
2118567|NCT00950807|3716072|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0
2118568|NCT00950807|3716073|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0
2118569|NCT00950807|3716064|FG000|Washout Period 2|Adverse Event|3
2118570|NCT00950807|3716065|FG001|Washout Period 2|Adverse Event|0
2118571|NCT00950807|3716066|FG002|Washout Period 2|Adverse Event|0
2118572|NCT00950807|3716067|FG003|Washout Period 2|Adverse Event|1
2118573|NCT00950807|3716068|FG004|Washout Period 2|Adverse Event|0
2118574|NCT00950807|3716069|FG005|Washout Period 2|Adverse Event|0
2118575|NCT00950807|3716070|FG006|Washout Period 2|Adverse Event|0
2118576|NCT00950807|3716071|FG007|Washout Period 2|Adverse Event|0
2118577|NCT00950807|3716072|FG008|Washout Period 2|Adverse Event|0
2118578|NCT00950807|3716073|FG009|Washout Period 2|Adverse Event|0
2118579|NCT00950807|3716064|FG000|Treatment Period 3|Withdrawal by Subject|0
2118580|NCT00950807|3716065|FG001|Treatment Period 3|Withdrawal by Subject|0
2118581|NCT00950807|3716066|FG002|Treatment Period 3|Withdrawal by Subject|0
2118582|NCT00950807|3716067|FG003|Treatment Period 3|Withdrawal by Subject|0
2118583|NCT00950807|3716068|FG004|Treatment Period 3|Withdrawal by Subject|0
2118584|NCT00950807|3716069|FG005|Treatment Period 3|Withdrawal by Subject|0
2118585|NCT00950807|3716070|FG006|Treatment Period 3|Withdrawal by Subject|0
2118586|NCT00950807|3716071|FG007|Treatment Period 3|Withdrawal by Subject|0
2118587|NCT00950807|3716072|FG008|Treatment Period 3|Withdrawal by Subject|0
2118588|NCT00950807|3716073|FG009|Treatment Period 3|Withdrawal by Subject|1
2118589|NCT00950807|3716064|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1
2118590|NCT00950807|3716065|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
2118591|NCT00950807|3716066|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
2204840|NCT01606761|3842684|FG002|Prior to Week 24|Other|5
2118592|NCT00950807|3716067|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
2118593|NCT00950807|3716068|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
2118594|NCT00950807|3716069|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
2118595|NCT00950807|3716070|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0
2118596|NCT00950807|3716071|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1
2118597|NCT00950807|3716072|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0
2204841|NCT01606761|3842685|FG003|Prior to Week 24|Other|0
2204842|NCT01606761|3842686|FG004|Prior to Week 24|Other|0
2204843|NCT01606761|3842682|FG000|Week 24 to Week 52|Lost to Follow-up|0
2118598|NCT00950807|3716073|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0
2118599|NCT00950807|3716064|FG000|Treatment Period 3|Adverse Event|0
2118600|NCT00950807|3716065|FG001|Treatment Period 3|Adverse Event|0
2118601|NCT00950807|3716066|FG002|Treatment Period 3|Adverse Event|0
2118602|NCT00950807|3716067|FG003|Treatment Period 3|Adverse Event|0
2118603|NCT00950807|3716068|FG004|Treatment Period 3|Adverse Event|0
2118604|NCT00950807|3716069|FG005|Treatment Period 3|Adverse Event|0
2118605|NCT00950807|3716070|FG006|Treatment Period 3|Adverse Event|1
2118606|NCT00950807|3716071|FG007|Treatment Period 3|Adverse Event|0
2118607|NCT00950807|3716072|FG008|Treatment Period 3|Adverse Event|0
2118608|NCT00950807|3716073|FG009|Treatment Period 3|Adverse Event|0
2118609|NCT00950859|3716112|FG000|Overall Study|Adverse Event|3
2118610|NCT00950859|3716113|FG001|Overall Study|Adverse Event|3
2118611|NCT00950859|3716112|FG000|Overall Study|Insufficient Viral Load Response|12
2118612|NCT00950859|3716113|FG001|Overall Study|Insufficient Viral Load Response|3
2118613|NCT00950859|3716112|FG000|Overall Study|Protocol Violation|1
2118614|NCT00950859|3716113|FG001|Overall Study|Protocol Violation|1
2118615|NCT00950859|3716112|FG000|Overall Study|Lost to Follow-up|0
2118616|NCT00950859|3716113|FG001|Overall Study|Lost to Follow-up|3
2118617|NCT00950872|3716119|FG000|Overall Study|Withdrawal by Subject|1
2118618|NCT00950872|3716119|FG000|Overall Study|Did not have surgery|2
2118619|NCT00950911|3716125|FG000|Overall Study|Adverse Event|0
2118620|NCT00950911|3716126|FG001|Overall Study|Adverse Event|2
2118621|NCT00950911|3716125|FG000|Overall Study|Death|4
2118622|NCT00950911|3716126|FG001|Overall Study|Death|6
2118623|NCT00950911|3716125|FG000|Overall Study|Disease progression|2
2118624|NCT00950911|3716126|FG001|Overall Study|Disease progression|2
2118625|NCT00950911|3716125|FG000|Overall Study|Consent withdrawn|1
2118626|NCT00950911|3716126|FG001|Overall Study|Consent withdrawn|3
2118627|NCT00950911|3716125|FG000|Overall Study|Administrative decision|3
2118628|NCT00950911|3716126|FG001|Overall Study|Administrative decision|1
2118629|NCT00950911|3716125|FG000|Overall Study|Ineligibility determined|1
2118630|NCT00950911|3716126|FG001|Overall Study|Ineligibility determined|0
2118631|NCT00950911|3716125|FG000|Overall Study|Noncompliance|1
2118632|NCT00950911|3716126|FG001|Overall Study|Noncompliance|0
2118633|NCT00950911|3716125|FG000|Overall Study|Poor performance status|0
2118634|NCT00950911|3716126|FG001|Overall Study|Poor performance status|1
2118635|NCT00950950|3716134|FG000|Overall Study|Adverse Event|1
2118636|NCT00950950|3716135|FG001|Overall Study|Adverse Event|0
2118637|NCT00950950|3716134|FG000|Overall Study|Withdrawal by Subject|0
2118638|NCT00950950|3716135|FG001|Overall Study|Withdrawal by Subject|1
2118639|NCT00950963|3716144|FG000|Overall Study|Lost to Follow-up|29
2118640|NCT00950963|3716145|FG001|Overall Study|Lost to Follow-up|24
2118641|NCT00951015|3716155|FG000|Randomization Phase 96 Week|Adverse Event|1
2118642|NCT00951015|3716156|FG001|Randomization Phase 96 Week|Adverse Event|1
2118643|NCT00951015|3716157|FG002|Randomization Phase 96 Week|Adverse Event|2
2118644|NCT00951015|3716158|FG003|Randomization Phase 96 Week|Adverse Event|5
2118645|NCT00951015|3716159|FG004|Randomization Phase 96 Week|Adverse Event|0
2118646|NCT00951015|3716155|FG000|Randomization Phase 96 Week|Lack of Efficacy|1
2118647|NCT00951015|3716156|FG001|Randomization Phase 96 Week|Lack of Efficacy|1
2118648|NCT00951015|3716157|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
2118649|NCT00951015|3716158|FG003|Randomization Phase 96 Week|Lack of Efficacy|0
2118650|NCT00951015|3716159|FG004|Randomization Phase 96 Week|Lack of Efficacy|0
2118651|NCT00951015|3716155|FG000|Randomization Phase 96 Week|Protocol Violation|1
2118652|NCT00951015|3716156|FG001|Randomization Phase 96 Week|Protocol Violation|1
2118653|NCT00951015|3716157|FG002|Randomization Phase 96 Week|Protocol Violation|1
2118654|NCT00951015|3716158|FG003|Randomization Phase 96 Week|Protocol Violation|0
2118655|NCT00951015|3716159|FG004|Randomization Phase 96 Week|Protocol Violation|0
2118656|NCT00951015|3716155|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2118657|NCT00951015|3716156|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2118658|NCT00951015|3716157|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2118659|NCT00951015|3716158|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
2118660|NCT00951015|3716159|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2118661|NCT00951015|3716155|FG000|Randomization Phase 96 Week|Lost to Follow-up|0
2118662|NCT00951015|3716156|FG001|Randomization Phase 96 Week|Lost to Follow-up|3
2118663|NCT00951015|3716157|FG002|Randomization Phase 96 Week|Lost to Follow-up|1
2118664|NCT00951015|3716158|FG003|Randomization Phase 96 Week|Lost to Follow-up|2
2118665|NCT00951015|3716159|FG004|Randomization Phase 96 Week|Lost to Follow-up|0
2118666|NCT00951015|3716155|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
2118667|NCT00951015|3716156|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1
2204844|NCT01606761|3842683|FG001|Week 24 to Week 52|Lost to Follow-up|1
2118668|NCT00951015|3716157|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1
2118669|NCT00951015|3716158|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2
2118670|NCT00951015|3716159|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0
2118671|NCT00951015|3716155|FG000|Open-label Phase|Adverse Event|0
2118672|NCT00951015|3716156|FG001|Open-label Phase|Adverse Event|0
2118673|NCT00951015|3716157|FG002|Open-label Phase|Adverse Event|0
2118674|NCT00951015|3716158|FG003|Open-label Phase|Adverse Event|0
2118675|NCT00951015|3716159|FG004|Open-label Phase|Adverse Event|3
2118676|NCT00951015|3716155|FG000|Open-label Phase|Lack of Efficacy|0
2118677|NCT00951015|3716156|FG001|Open-label Phase|Lack of Efficacy|0
2118678|NCT00951015|3716157|FG002|Open-label Phase|Lack of Efficacy|0
2118679|NCT00951015|3716158|FG003|Open-label Phase|Lack of Efficacy|0
2118680|NCT00951015|3716159|FG004|Open-label Phase|Lack of Efficacy|1
2118681|NCT00951015|3716155|FG000|Open-label Phase|Protocol Violation|0
2118682|NCT00951015|3716156|FG001|Open-label Phase|Protocol Violation|0
2118683|NCT00951015|3716157|FG002|Open-label Phase|Protocol Violation|0
2204845|NCT01606761|3842684|FG002|Week 24 to Week 52|Lost to Follow-up|1
2204846|NCT01606761|3842685|FG003|Week 24 to Week 52|Lost to Follow-up|1
2204847|NCT01606761|3842686|FG004|Week 24 to Week 52|Lost to Follow-up|0
2204848|NCT01606761|3842682|FG000|Week 24 to Week 52|Withdrawal by Subject|0
2204849|NCT01606761|3842683|FG001|Week 24 to Week 52|Withdrawal by Subject|6
2204850|NCT01606761|3842684|FG002|Week 24 to Week 52|Withdrawal by Subject|3
2204851|NCT01606761|3842685|FG003|Week 24 to Week 52|Withdrawal by Subject|0
2204852|NCT01606761|3842686|FG004|Week 24 to Week 52|Withdrawal by Subject|0
2118684|NCT00951015|3716158|FG003|Open-label Phase|Protocol Violation|0
2118685|NCT00951015|3716159|FG004|Open-label Phase|Protocol Violation|12
2118686|NCT00951015|3716155|FG000|Open-label Phase|Lost to Follow-up|0
2118687|NCT00951015|3716156|FG001|Open-label Phase|Lost to Follow-up|0
2118688|NCT00951015|3716157|FG002|Open-label Phase|Lost to Follow-up|0
2118689|NCT00951015|3716158|FG003|Open-label Phase|Lost to Follow-up|0
2118690|NCT00951015|3716159|FG004|Open-label Phase|Lost to Follow-up|12
2118691|NCT00951015|3716155|FG000|Open-label Phase|Withdrawal by Subject|0
2118692|NCT00951015|3716156|FG001|Open-label Phase|Withdrawal by Subject|0
2118693|NCT00951015|3716157|FG002|Open-label Phase|Withdrawal by Subject|0
2118694|NCT00951015|3716158|FG003|Open-label Phase|Withdrawal by Subject|0
2118695|NCT00951015|3716159|FG004|Open-label Phase|Withdrawal by Subject|14
2118696|NCT00951015|3716155|FG000|Open-label Phase|Physician Decision|0
2118697|NCT00951015|3716156|FG001|Open-label Phase|Physician Decision|0
2118698|NCT00951015|3716157|FG002|Open-label Phase|Physician Decision|0
2118699|NCT00951015|3716158|FG003|Open-label Phase|Physician Decision|0
2118700|NCT00951015|3716159|FG004|Open-label Phase|Physician Decision|8
2118701|NCT00951041|3716184|FG000|Overall Study|Withdrawal by Subject|1
2118702|NCT00951041|3716185|FG001|Overall Study|Withdrawal by Subject|1
2118703|NCT00951041|3716184|FG000|Overall Study|Lost to Follow-up|1
2118704|NCT00951041|3716185|FG001|Overall Study|Lost to Follow-up|0
2118705|NCT00951041|3716184|FG000|Overall Study|Other|3
2118706|NCT00951041|3716185|FG001|Overall Study|Other|0
2118707|NCT00951080|3716194|FG000|Overall Study|Adverse Event|3
2118708|NCT00951080|3716195|FG001|Overall Study|Adverse Event|3
2118709|NCT00951080|3716194|FG000|Overall Study|Lost to Follow-up|0
2118710|NCT00951080|3716195|FG001|Overall Study|Lost to Follow-up|1
2118711|NCT00951080|3716194|FG000|Overall Study|Physician Decision|4
2118712|NCT00951080|3716195|FG001|Overall Study|Physician Decision|1
2118713|NCT00951080|3716194|FG000|Overall Study|Other|19
2118714|NCT00951080|3716195|FG001|Overall Study|Other|22
2118715|NCT00951171|3716209|FG000|Overall Study|Adverse Event|2
2118716|NCT00951171|3716210|FG001|Overall Study|Adverse Event|0
2118717|NCT00951275|3716216|FG000|Overall Study|Administrative Reason|1
2118718|NCT00951275|3716216|FG000|Overall Study|Adverse Event|7
2118719|NCT00951275|3716216|FG000|Overall Study|Withdrawal by Subject|4
2118720|NCT00951275|3716216|FG000|Overall Study|Protocol Violation|1
2118721|NCT00951379|3716222|FG000|Overall Study|Adverse Event|4
2118722|NCT00951379|3716223|FG001|Overall Study|Adverse Event|1
2118723|NCT00951379|3716222|FG000|Overall Study|Withdrawal by Subject|1
2118724|NCT00951379|3716223|FG001|Overall Study|Withdrawal by Subject|0
2118725|NCT00951379|3716222|FG000|Overall Study|Noncompliance|1
2118726|NCT00951379|3716223|FG001|Overall Study|Noncompliance|0
2118727|NCT00951379|3716222|FG000|Overall Study|Disease Progression|0
2118728|NCT00951379|3716223|FG001|Overall Study|Disease Progression|1
2118729|NCT00951483|3716239|FG000|Overall Study|Physician Decision|4
2118730|NCT00951483|3716240|FG001|Overall Study|Physician Decision|0
2118731|NCT00951483|3716239|FG000|Overall Study|Withdrawal by Subject|15
2118732|NCT00951483|3716240|FG001|Overall Study|Withdrawal by Subject|0
2118733|NCT00951496|3716251|FG000|Overall Study|Did not initiate study treatment|10
2118734|NCT00951496|3716252|FG001|Overall Study|Did not initiate study treatment|8
2118735|NCT00951496|3716253|FG002|Overall Study|Did not initiate study treatment|13
2177641|NCT01376245|3801978|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
2177642|NCT01376245|3801979|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2
2177643|NCT01376245|3801980|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0
2177644|NCT01376245|3801981|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
2177645|NCT01376245|3801982|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
2204853|NCT01606761|3842682|FG000|Week 24 to Week 52|Adverse Event|0
2204854|NCT01606761|3842683|FG001|Week 24 to Week 52|Adverse Event|11
2118736|NCT00951509|3716264|FG000|Overall Study|Withdrawal by Subject|2
2118737|NCT00951665|3716286|FG000|Phase 1b|Adverse Event|2
2118738|NCT00951665|3716287|FG001|Phase 1b|Adverse Event|1
2118739|NCT00951665|3716288|FG002|Phase 1b|Adverse Event|0
2118740|NCT00951665|3716289|FG003|Phase 1b|Adverse Event|1
2118741|NCT00951665|3716290|FG004|Phase 1b|Adverse Event|0
2118742|NCT00951665|3716291|FG005|Phase 1b|Adverse Event|0
2118743|NCT00951665|3716286|FG000|Phase 1b|Death|1
2118744|NCT00951665|3716287|FG001|Phase 1b|Death|0
2118745|NCT00951665|3716288|FG002|Phase 1b|Death|2
2118746|NCT00951665|3716289|FG003|Phase 1b|Death|0
2118747|NCT00951665|3716290|FG004|Phase 1b|Death|0
2118748|NCT00951665|3716291|FG005|Phase 1b|Death|0
2118749|NCT00951665|3716286|FG000|Phase 1b|Physician Decision|4
2118750|NCT00951665|3716287|FG001|Phase 1b|Physician Decision|0
2118751|NCT00951665|3716288|FG002|Phase 1b|Physician Decision|1
2118752|NCT00951665|3716289|FG003|Phase 1b|Physician Decision|0
2118753|NCT00951665|3716290|FG004|Phase 1b|Physician Decision|0
2118754|NCT00951665|3716291|FG005|Phase 1b|Physician Decision|0
2118755|NCT00951665|3716286|FG000|Phase 1b|Withdrawal by Subject|0
2118756|NCT00951665|3716287|FG001|Phase 1b|Withdrawal by Subject|1
2118757|NCT00951665|3716288|FG002|Phase 1b|Withdrawal by Subject|0
2118758|NCT00951665|3716289|FG003|Phase 1b|Withdrawal by Subject|0
2118759|NCT00951665|3716290|FG004|Phase 1b|Withdrawal by Subject|0
2118760|NCT00951665|3716291|FG005|Phase 1b|Withdrawal by Subject|0
2118761|NCT00951665|3716286|FG000|Phase 1b|Disease Progression|13
2118762|NCT00951665|3716287|FG001|Phase 1b|Disease Progression|2
2118763|NCT00951665|3716288|FG002|Phase 1b|Disease Progression|14
2118764|NCT00951665|3716289|FG003|Phase 1b|Disease Progression|0
2118765|NCT00951665|3716290|FG004|Phase 1b|Disease Progression|0
2118766|NCT00951665|3716291|FG005|Phase 1b|Disease Progression|0
2118767|NCT00951665|3716286|FG000|Phase 1b|Protocol Violation|2
2118768|NCT00951665|3716287|FG001|Phase 1b|Protocol Violation|0
2118769|NCT00951665|3716288|FG002|Phase 1b|Protocol Violation|0
2118770|NCT00951665|3716289|FG003|Phase 1b|Protocol Violation|0
2118771|NCT00951665|3716290|FG004|Phase 1b|Protocol Violation|0
2118772|NCT00951665|3716291|FG005|Phase 1b|Protocol Violation|0
2118773|NCT00951665|3716286|FG000|Phase 2a|Adverse Event|0
2118774|NCT00951665|3716287|FG001|Phase 2a|Adverse Event|0
2118775|NCT00951665|3716288|FG002|Phase 2a|Adverse Event|0
2118776|NCT00951665|3716289|FG003|Phase 2a|Adverse Event|0
2118777|NCT00951665|3716290|FG004|Phase 2a|Adverse Event|2
2118778|NCT00951665|3716291|FG005|Phase 2a|Adverse Event|0
2118779|NCT00951665|3716286|FG000|Phase 2a|Death|0
2118780|NCT00951665|3716287|FG001|Phase 2a|Death|0
2118781|NCT00951665|3716288|FG002|Phase 2a|Death|0
2118782|NCT00951665|3716289|FG003|Phase 2a|Death|0
2118783|NCT00951665|3716290|FG004|Phase 2a|Death|1
2118784|NCT00951665|3716291|FG005|Phase 2a|Death|1
2118785|NCT00951665|3716286|FG000|Phase 2a|Lost to Follow-up|0
2118786|NCT00951665|3716287|FG001|Phase 2a|Lost to Follow-up|0
2118787|NCT00951665|3716288|FG002|Phase 2a|Lost to Follow-up|0
2118788|NCT00951665|3716289|FG003|Phase 2a|Lost to Follow-up|0
2118789|NCT00951665|3716290|FG004|Phase 2a|Lost to Follow-up|1
2118790|NCT00951665|3716291|FG005|Phase 2a|Lost to Follow-up|0
2118791|NCT00951665|3716286|FG000|Phase 2a|Physician Decision|0
2118792|NCT00951665|3716287|FG001|Phase 2a|Physician Decision|0
2118793|NCT00951665|3716288|FG002|Phase 2a|Physician Decision|0
2118794|NCT00951665|3716289|FG003|Phase 2a|Physician Decision|0
2118795|NCT00951665|3716290|FG004|Phase 2a|Physician Decision|0
2118796|NCT00951665|3716291|FG005|Phase 2a|Physician Decision|1
2118797|NCT00951665|3716286|FG000|Phase 2a|Withdrawal by Subject|0
2118798|NCT00951665|3716287|FG001|Phase 2a|Withdrawal by Subject|0
2118799|NCT00951665|3716288|FG002|Phase 2a|Withdrawal by Subject|0
2118800|NCT00951665|3716289|FG003|Phase 2a|Withdrawal by Subject|0
2118801|NCT00951665|3716290|FG004|Phase 2a|Withdrawal by Subject|2
2118802|NCT00951665|3716291|FG005|Phase 2a|Withdrawal by Subject|0
2118803|NCT00951665|3716286|FG000|Phase 2a|Disease Progression|0
2118804|NCT00951665|3716287|FG001|Phase 2a|Disease Progression|0
2118805|NCT00951665|3716288|FG002|Phase 2a|Disease Progression|0
2118806|NCT00951665|3716289|FG003|Phase 2a|Disease Progression|0
2118807|NCT00951665|3716290|FG004|Phase 2a|Disease Progression|6
2118808|NCT00951665|3716291|FG005|Phase 2a|Disease Progression|5
2118809|NCT00951912|3716354|FG000|Overall Study|Lack of Efficacy|1
2118810|NCT00951912|3716355|FG001|Overall Study|Lack of Efficacy|0
2118811|NCT00951912|3716356|FG002|Overall Study|Lack of Efficacy|0
2118812|NCT00951912|3716354|FG000|Overall Study|Adverse Event|0
2118813|NCT00951912|3716355|FG001|Overall Study|Adverse Event|1
2118814|NCT00951912|3716356|FG002|Overall Study|Adverse Event|1
2118815|NCT00951912|3716354|FG000|Overall Study|Lost to Follow-up|2
2118816|NCT00951912|3716355|FG001|Overall Study|Lost to Follow-up|2
2118817|NCT00951912|3716356|FG002|Overall Study|Lost to Follow-up|0
2118818|NCT00951912|3716354|FG000|Overall Study|Physician Decision|1
2118819|NCT00951912|3716355|FG001|Overall Study|Physician Decision|0
2118820|NCT00951912|3716356|FG002|Overall Study|Physician Decision|1
2118821|NCT00951912|3716354|FG000|Overall Study|Withdrawal by Subject|1
2118822|NCT00951912|3716355|FG001|Overall Study|Withdrawal by Subject|1
2118823|NCT00951912|3716356|FG002|Overall Study|Withdrawal by Subject|0
2118824|NCT00951912|3716354|FG000|Overall Study|Other:Depression|1
2118825|NCT00951912|3716355|FG001|Overall Study|Other:Depression|0
2118826|NCT00951912|3716356|FG002|Overall Study|Other:Depression|0
2118827|NCT00951912|3716354|FG000|Overall Study|Other: Colon cancer|1
2118828|NCT00951912|3716355|FG001|Overall Study|Other: Colon cancer|0
2118829|NCT00951912|3716356|FG002|Overall Study|Other: Colon cancer|0
2118830|NCT00951912|3716354|FG000|Overall Study|Other: Stroke|0
2118831|NCT00951912|3716355|FG001|Overall Study|Other: Stroke|1
2118832|NCT00951912|3716356|FG002|Overall Study|Other: Stroke|0
2118833|NCT00952068|3716364|FG000|Overall Study|Adverse Event|3
2118834|NCT00952068|3716364|FG000|Overall Study|Withdrawal by Subject|4
2118835|NCT00952276|3716408|FG000|Overall Study|Withdrawal by Subject|1
2118836|NCT00952276|3716409|FG001|Overall Study|Withdrawal by Subject|0
2118837|NCT00952276|3716410|FG002|Overall Study|Withdrawal by Subject|0
2118838|NCT00952276|3716411|FG003|Overall Study|Withdrawal by Subject|1
2118839|NCT00952276|3716412|FG004|Overall Study|Withdrawal by Subject|0
2118840|NCT00952289|3716426|FG000|All Participants|Death|9
2118841|NCT00952289|3716427|FG001|All Participants|Death|9
2118842|NCT00952289|3716426|FG000|All Participants|Adverse Event|8
2118843|NCT00952289|3716427|FG001|All Participants|Adverse Event|8
2118844|NCT00952289|3716426|FG000|All Participants|Disease progression|3
2118845|NCT00952289|3716427|FG001|All Participants|Disease progression|12
2118846|NCT00952289|3716426|FG000|All Participants|Withdrawal by Subject|1
2118847|NCT00952289|3716427|FG001|All Participants|Withdrawal by Subject|10
2118848|NCT00952289|3716426|FG000|All Participants|Data lost during site relocation|0
2118849|NCT00952289|3716427|FG001|All Participants|Data lost during site relocation|1
2118850|NCT00952289|3716426|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
2118851|NCT00952289|3716427|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
2118852|NCT00952289|3716426|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
2118853|NCT00952289|3716427|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
2118854|NCT00952289|3716426|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
2118855|NCT00952289|3716427|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
2118856|NCT00952289|3716426|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
2118857|NCT00952289|3716427|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
2118858|NCT00952289|3716426|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
2118859|NCT00952289|3716427|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
2118860|NCT00952341|3716451|FG000|Cycle 1|Adverse Event|4
2118861|NCT00952341|3716452|FG001|Cycle 1|Adverse Event|1
2118862|NCT00952341|3716451|FG000|Cycle 1|Withdrawal by Subject|3
2118863|NCT00952341|3716452|FG001|Cycle 1|Withdrawal by Subject|8
2118864|NCT00952341|3716451|FG000|Cycle 1|Protocol Violation|2
2118865|NCT00952341|3716452|FG001|Cycle 1|Protocol Violation|1
2118866|NCT00952341|3716451|FG000|Cycle 1|Lost to Follow-up|11
2118867|NCT00952341|3716452|FG001|Cycle 1|Lost to Follow-up|2
2118868|NCT00952341|3716451|FG000|Cycle 1|Physician Decision|0
2118869|NCT00952341|3716452|FG001|Cycle 1|Physician Decision|1
2118870|NCT00952341|3716451|FG000|Cycle 2|Withdrawal by Subject|1
2118871|NCT00952341|3716452|FG001|Cycle 2|Withdrawal by Subject|1
2118872|NCT00952341|3716451|FG000|Cycle 2|Protocol Violation|1
2118873|NCT00952341|3716452|FG001|Cycle 2|Protocol Violation|0
2118874|NCT00952341|3716451|FG000|Cycle 2|Lost to Follow-up|6
2118875|NCT00952341|3716452|FG001|Cycle 2|Lost to Follow-up|9
2118876|NCT00952341|3716451|FG000|Cycle 2|Physician Decision|1
2118877|NCT00952341|3716452|FG001|Cycle 2|Physician Decision|1
2118878|NCT00952341|3716451|FG000|Cycle 2|Progressive Disease|0
2118879|NCT00952341|3716452|FG001|Cycle 2|Progressive Disease|1
2204855|NCT01606761|3842684|FG002|Week 24 to Week 52|Adverse Event|14
2204856|NCT01606761|3842685|FG003|Week 24 to Week 52|Adverse Event|3
2204857|NCT01606761|3842686|FG004|Week 24 to Week 52|Adverse Event|15
2204858|NCT01606761|3842682|FG000|Week 24 to Week 52|Death|0
2204859|NCT01606761|3842683|FG001|Week 24 to Week 52|Death|0
2204860|NCT01606761|3842684|FG002|Week 24 to Week 52|Death|2
2277537|NCT02326298|3959845|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2118880|NCT00952367|3716458|FG000|Overall Study|Withdrawal by Subject|2
2118881|NCT00952367|3716458|FG000|Overall Study|Noncoordination|1
2118882|NCT00952367|3716458|FG000|Overall Study|Protocol Violation|3
2118883|NCT00952380|3716467|FG000|Overall Study|Other|0
2118884|NCT00952380|3716468|FG001|Overall Study|Other|0
2118885|NCT00952380|3716469|FG002|Overall Study|Other|0
2204861|NCT01606761|3842685|FG003|Week 24 to Week 52|Death|1
2204862|NCT01606761|3842686|FG004|Week 24 to Week 52|Death|0
2204863|NCT01606761|3842682|FG000|Week 24 to Week 52|Lack of Efficacy|0
2204864|NCT01606761|3842683|FG001|Week 24 to Week 52|Lack of Efficacy|13
2204865|NCT01606761|3842684|FG002|Week 24 to Week 52|Lack of Efficacy|7
2204866|NCT01606761|3842685|FG003|Week 24 to Week 52|Lack of Efficacy|10
2204867|NCT01606761|3842686|FG004|Week 24 to Week 52|Lack of Efficacy|3
2204868|NCT01606761|3842682|FG000|Week 24 to Week 52|Physician Decision|0
2204869|NCT01606761|3842683|FG001|Week 24 to Week 52|Physician Decision|1
2204870|NCT01606761|3842684|FG002|Week 24 to Week 52|Physician Decision|1
2204871|NCT01606761|3842685|FG003|Week 24 to Week 52|Physician Decision|0
2204872|NCT01606761|3842686|FG004|Week 24 to Week 52|Physician Decision|0
2204873|NCT01606761|3842682|FG000|Week 24 to Week 52|Other|0
2204874|NCT01606761|3842683|FG001|Week 24 to Week 52|Other|1
2204875|NCT01606761|3842684|FG002|Week 24 to Week 52|Other|5
2204876|NCT01606761|3842685|FG003|Week 24 to Week 52|Other|2
2204877|NCT01606761|3842686|FG004|Week 24 to Week 52|Other|2
2118886|NCT00952380|3716470|FG003|Overall Study|Other|0
2118887|NCT00952380|3716471|FG004|Overall Study|Other|1
2118888|NCT00952380|3716467|FG000|Overall Study|Withdrawal by Subject|0
2118889|NCT00952380|3716468|FG001|Overall Study|Withdrawal by Subject|0
2118890|NCT00952380|3716469|FG002|Overall Study|Withdrawal by Subject|1
2118891|NCT00952380|3716470|FG003|Overall Study|Withdrawal by Subject|0
2118892|NCT00952380|3716471|FG004|Overall Study|Withdrawal by Subject|2
2118893|NCT00952380|3716467|FG000|Overall Study|Adverse Event|0
2118894|NCT00952380|3716468|FG001|Overall Study|Adverse Event|1
2118895|NCT00952380|3716469|FG002|Overall Study|Adverse Event|0
2118896|NCT00952380|3716470|FG003|Overall Study|Adverse Event|0
2118897|NCT00952380|3716471|FG004|Overall Study|Adverse Event|3
2118898|NCT00952380|3716467|FG000|Overall Study|Physician Decision|0
2118899|NCT00952380|3716468|FG001|Overall Study|Physician Decision|0
2204878|NCT01606761|3842682|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
2204879|NCT01606761|3842683|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
2118900|NCT00952380|3716469|FG002|Overall Study|Physician Decision|1
2118901|NCT00952380|3716470|FG003|Overall Study|Physician Decision|2
2118902|NCT00952380|3716471|FG004|Overall Study|Physician Decision|0
2118903|NCT00952380|3716467|FG000|Overall Study|Non-compliant to protocol|0
2118904|NCT00952380|3716468|FG001|Overall Study|Non-compliant to protocol|0
2118905|NCT00952380|3716469|FG002|Overall Study|Non-compliant to protocol|0
2118906|NCT00952380|3716470|FG003|Overall Study|Non-compliant to protocol|1
2118907|NCT00952380|3716471|FG004|Overall Study|Non-compliant to protocol|0
2118908|NCT00952419|3716495|FG000|Overall Study|Adverse Event|2
2118909|NCT00952419|3716496|FG001|Overall Study|Adverse Event|0
2118910|NCT00952419|3716497|FG002|Overall Study|Adverse Event|0
2118911|NCT00952419|3716495|FG000|Overall Study|Protocol Violation|3
2118912|NCT00952419|3716496|FG001|Overall Study|Protocol Violation|7
2118913|NCT00952419|3716497|FG002|Overall Study|Protocol Violation|0
2118914|NCT00952419|3716495|FG000|Overall Study|Withdrawal by Subject|1
2118915|NCT00952419|3716496|FG001|Overall Study|Withdrawal by Subject|3
2118916|NCT00952419|3716497|FG002|Overall Study|Withdrawal by Subject|0
2118917|NCT00952484|3716508|FG000|Overall Study|Withdrawal by Subject|0
2118918|NCT00952484|3716509|FG001|Overall Study|Withdrawal by Subject|1
2118919|NCT00952484|3716510|FG002|Overall Study|Withdrawal by Subject|0
2118920|NCT00952523|3716519|FG000|Overall Study|Withdrawal by Subject|7
2118921|NCT00952588|3716527|FG000|Overall Study|Death|28
2118922|NCT00952588|3716528|FG001|Overall Study|Death|13
2118923|NCT00952588|3716527|FG000|Overall Study|Withdrawal by Subject|2
2118924|NCT00952588|3716528|FG001|Overall Study|Withdrawal by Subject|5
2118925|NCT00952588|3716527|FG000|Overall Study|Adverse Event|2
2118926|NCT00952588|3716528|FG001|Overall Study|Adverse Event|3
2118927|NCT00952588|3716527|FG000|Overall Study|Lost to Follow-up|2
2118928|NCT00952588|3716528|FG001|Overall Study|Lost to Follow-up|0
2118929|NCT00952588|3716527|FG000|Overall Study|Physician Decision|0
2118930|NCT00952588|3716528|FG001|Overall Study|Physician Decision|1
2118931|NCT00952588|3716527|FG000|Overall Study|Lack of Efficacy|2
2118932|NCT00952588|3716528|FG001|Overall Study|Lack of Efficacy|2
2118933|NCT00952614|3716534|FG000|Overall Study|Death|3
2118934|NCT00952614|3716534|FG000|Overall Study|Lost to Follow-up|3
2118935|NCT00952614|3716534|FG000|Overall Study|other reason|1
2118936|NCT00952705|3716549|FG000|Overall Study|Lost to Follow-up|24
2118937|NCT00952705|3716550|FG001|Overall Study|Lost to Follow-up|8
2118938|NCT00952705|3716551|FG002|Overall Study|Lost to Follow-up|9
2118939|NCT00952705|3716549|FG000|Overall Study|Withdrawal by Subject|2
2118940|NCT00952705|3716550|FG001|Overall Study|Withdrawal by Subject|1
2118941|NCT00952705|3716551|FG002|Overall Study|Withdrawal by Subject|1
2118942|NCT00952705|3716549|FG000|Overall Study|Death|2
2118943|NCT00952705|3716550|FG001|Overall Study|Death|0
2118944|NCT00952705|3716551|FG002|Overall Study|Death|0
2118945|NCT00952705|3716549|FG000|Overall Study|Incarcerated post dose|5
2118946|NCT00952705|3716550|FG001|Overall Study|Incarcerated post dose|0
2118947|NCT00952705|3716551|FG002|Overall Study|Incarcerated post dose|0
2118948|NCT00952705|3716549|FG000|Overall Study|Exclusion criteria not met pre dose|0
2118949|NCT00952705|3716550|FG001|Overall Study|Exclusion criteria not met pre dose|1
2118950|NCT00952705|3716551|FG002|Overall Study|Exclusion criteria not met pre dose|0
2118951|NCT00952731|3716576|FG000|Overall Study|Drug supply expired|1
2204880|NCT01606761|3842684|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
2204881|NCT01606761|3842685|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
2204882|NCT01606761|3842686|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
2204883|NCT01606761|3842682|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
2204884|NCT01606761|3842683|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
2118952|NCT00952731|3716577|FG001|Overall Study|Drug supply expired|0
2118953|NCT00952822|3716583|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
2118954|NCT00952822|3716584|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
2118955|NCT00952822|3716585|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
2118956|NCT00952822|3716586|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
2118957|NCT00952822|3716583|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
2118958|NCT00952822|3716584|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
2118959|NCT00952822|3716585|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
2118960|NCT00952822|3716586|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
2118961|NCT00952848|3716597|FG000|Overall Study|Withdrawal by Subject|4
2118962|NCT00953017|3716605|FG000|Overall Study|DId not show up for colonoscopy|4
2118963|NCT00953017|3716606|FG001|Overall Study|DId not show up for colonoscopy|4
2118964|NCT00953017|3716607|FG002|Overall Study|DId not show up for colonoscopy|5
2118965|NCT00953017|3716608|FG003|Overall Study|DId not show up for colonoscopy|4
2118966|NCT00953017|3716605|FG000|Overall Study|Incomplete data|1
2118967|NCT00953017|3716606|FG001|Overall Study|Incomplete data|1
2118968|NCT00953017|3716607|FG002|Overall Study|Incomplete data|0
2118969|NCT00953017|3716608|FG003|Overall Study|Incomplete data|0
2118970|NCT00953017|3716605|FG000|Overall Study|Procedure incomplete due to pain/looping|0
2118971|NCT00953017|3716606|FG001|Overall Study|Procedure incomplete due to pain/looping|1
2118972|NCT00953017|3716607|FG002|Overall Study|Procedure incomplete due to pain/looping|0
2118973|NCT00953017|3716608|FG003|Overall Study|Procedure incomplete due to pain/looping|1
2118974|NCT00953017|3716605|FG000|Overall Study|Brown stool prior to procedure|0
2118975|NCT00953017|3716606|FG001|Overall Study|Brown stool prior to procedure|0
2118976|NCT00953017|3716607|FG002|Overall Study|Brown stool prior to procedure|1
2118977|NCT00953017|3716608|FG003|Overall Study|Brown stool prior to procedure|0
2118978|NCT00953043|3716620|FG000|Overall Study|Withdrawal by Subject|4
2118979|NCT00953043|3716621|FG001|Overall Study|Withdrawal by Subject|0
2118980|NCT00953043|3716620|FG000|Overall Study|Physician Decision|0
2118981|NCT00953043|3716621|FG001|Overall Study|Physician Decision|2
2118982|NCT00953056|3716633|FG000|Overall Study|Withdrew Consent|0
2118983|NCT00953056|3716634|FG001|Overall Study|Withdrew Consent|0
2118984|NCT00953056|3716635|FG002|Overall Study|Withdrew Consent|0
2118985|NCT00953056|3716636|FG003|Overall Study|Withdrew Consent|0
2118986|NCT00953056|3716637|FG004|Overall Study|Withdrew Consent|2
2118987|NCT00953056|3716638|FG005|Overall Study|Withdrew Consent|3
2118988|NCT00953056|3716633|FG000|Overall Study|Serious Adverse Event|0
2118989|NCT00953056|3716634|FG001|Overall Study|Serious Adverse Event|0
2118990|NCT00953056|3716635|FG002|Overall Study|Serious Adverse Event|0
2118991|NCT00953056|3716636|FG003|Overall Study|Serious Adverse Event|0
2118992|NCT00953056|3716637|FG004|Overall Study|Serious Adverse Event|0
2118993|NCT00953056|3716638|FG005|Overall Study|Serious Adverse Event|1
2118994|NCT00953147|3716670|FG000|Overall Study|Adverse Event|8
2118995|NCT00953147|3716671|FG001|Overall Study|Adverse Event|16
2118996|NCT00953147|3716672|FG002|Overall Study|Adverse Event|6
2118997|NCT00953147|3716670|FG000|Overall Study|Protocol Violation|2
2118998|NCT00953147|3716671|FG001|Overall Study|Protocol Violation|8
2118999|NCT00953147|3716672|FG002|Overall Study|Protocol Violation|4
2119000|NCT00953147|3716670|FG000|Overall Study|Withdrawal by Subject|13
2119001|NCT00953147|3716671|FG001|Overall Study|Withdrawal by Subject|15
2119002|NCT00953147|3716672|FG002|Overall Study|Withdrawal by Subject|12
2119003|NCT00953147|3716670|FG000|Overall Study|Lost to Follow-up|8
2119004|NCT00953147|3716671|FG001|Overall Study|Lost to Follow-up|9
2119005|NCT00953147|3716672|FG002|Overall Study|Lost to Follow-up|4
2119006|NCT00953147|3716670|FG000|Overall Study|Physician Decision|2
2119007|NCT00953147|3716671|FG001|Overall Study|Physician Decision|7
2119008|NCT00953147|3716672|FG002|Overall Study|Physician Decision|3
2119009|NCT00953147|3716670|FG000|Overall Study|Other|4
2119010|NCT00953147|3716671|FG001|Overall Study|Other|11
2119011|NCT00953147|3716672|FG002|Overall Study|Other|13
2119012|NCT00953160|3716680|FG000|Overall Study|Lost to Follow-up|23
2119013|NCT00953160|3716680|FG000|Overall Study|Withdrawal by Subject|4
2119014|NCT00953225|3716722|FG000|Overall Study|Withdrawal by Subject|2
2119015|NCT00953225|3716723|FG001|Overall Study|Withdrawal by Subject|0
2119016|NCT00953407|3716741|FG000|Overall Study|Failed inclusion criteria|1
2119017|NCT00953407|3716742|FG001|Overall Study|Failed inclusion criteria|1
2119018|NCT00953407|3716743|FG002|Overall Study|Failed inclusion criteria|1
2119019|NCT00953407|3716744|FG003|Overall Study|Failed inclusion criteria|1
2119020|NCT00953407|3716745|FG004|Overall Study|Failed inclusion criteria|1
2119021|NCT00953407|3716741|FG000|Overall Study|Lost to Follow-up|0
2119022|NCT00953407|3716742|FG001|Overall Study|Lost to Follow-up|0
2119023|NCT00953407|3716743|FG002|Overall Study|Lost to Follow-up|0
2119024|NCT00953407|3716744|FG003|Overall Study|Lost to Follow-up|1
2119025|NCT00953407|3716745|FG004|Overall Study|Lost to Follow-up|0
2119026|NCT00953524|3716761|FG000|Overall Study|Adverse Event|2
2119027|NCT00953524|3716762|FG001|Overall Study|Adverse Event|0
2119028|NCT00953524|3716763|FG002|Overall Study|Adverse Event|1
2119029|NCT00953524|3716764|FG003|Overall Study|Adverse Event|2
2119030|NCT00953524|3716761|FG000|Overall Study|Protocol Violation|18
2119031|NCT00953524|3716762|FG001|Overall Study|Protocol Violation|10
2119032|NCT00953524|3716763|FG002|Overall Study|Protocol Violation|11
2119033|NCT00953524|3716764|FG003|Overall Study|Protocol Violation|6
2119034|NCT00953524|3716761|FG000|Overall Study|Lost to Follow-up|0
2119035|NCT00953524|3716762|FG001|Overall Study|Lost to Follow-up|1
2119036|NCT00953524|3716763|FG002|Overall Study|Lost to Follow-up|1
2119037|NCT00953524|3716764|FG003|Overall Study|Lost to Follow-up|0
2119038|NCT00953524|3716761|FG000|Overall Study|Withdrawal by Subject|2
2119039|NCT00953524|3716762|FG001|Overall Study|Withdrawal by Subject|4
2119040|NCT00953524|3716763|FG002|Overall Study|Withdrawal by Subject|1
2119041|NCT00953524|3716764|FG003|Overall Study|Withdrawal by Subject|0
2119042|NCT00953576|3716776|FG000|Overall Study|Adverse Event|0
2119043|NCT00953576|3716777|FG001|Overall Study|Adverse Event|1
2119044|NCT00953576|3716776|FG000|Overall Study|Ineligible after Consent|2
2119045|NCT00953576|3716777|FG001|Overall Study|Ineligible after Consent|0
2119046|NCT00953667|3716799|FG000|Overall Study|Lost to Follow-up|11
2119047|NCT00953667|3716799|FG000|Overall Study|Physician Decision|35
2119048|NCT00953667|3716799|FG000|Overall Study|Withdrawal by Subject|63
2119049|NCT00953667|3716799|FG000|Overall Study|Adverse Event|10
2119050|NCT00953667|3716799|FG000|Overall Study|poor venous access,unable to draw blood|4
2119051|NCT00953706|3716805|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
2119052|NCT00953706|3716806|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
2119053|NCT00953706|3716807|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
2119054|NCT00953706|3716808|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
2119055|NCT00953706|3716805|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
2119056|NCT00953706|3716806|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
2119057|NCT00953706|3716807|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
2119058|NCT00953706|3716808|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
2119059|NCT00953706|3716805|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
2119060|NCT00953706|3716806|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
2119061|NCT00953706|3716807|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
2119062|NCT00953706|3716808|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
2119063|NCT00953706|3716805|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
2204885|NCT01606761|3842684|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
2204886|NCT01606761|3842685|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
2204887|NCT01606761|3842686|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
2204888|NCT01606761|3842682|FG000|Safety Follow-up Period (Week 52-68)|Death|0
2204889|NCT01606761|3842683|FG001|Safety Follow-up Period (Week 52-68)|Death|0
2204890|NCT01606761|3842684|FG002|Safety Follow-up Period (Week 52-68)|Death|0
2119064|NCT00953706|3716806|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
2119065|NCT00953706|3716807|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
2204891|NCT01606761|3842685|FG003|Safety Follow-up Period (Week 52-68)|Death|0
2204892|NCT01606761|3842686|FG004|Safety Follow-up Period (Week 52-68)|Death|1
2204893|NCT01606761|3842682|FG000|Safety Follow-up Period (Week 52-68)|Other|0
2204894|NCT01606761|3842683|FG001|Safety Follow-up Period (Week 52-68)|Other|3
2204895|NCT01606761|3842684|FG002|Safety Follow-up Period (Week 52-68)|Other|9
2204896|NCT01606761|3842685|FG003|Safety Follow-up Period (Week 52-68)|Other|1
2204897|NCT01606761|3842686|FG004|Safety Follow-up Period (Week 52-68)|Other|3
2204898|NCT01606787|3842703|FG000|Overall Study|Withdrawal by Subject|4
2204899|NCT01606787|3842704|FG001|Overall Study|Withdrawal by Subject|5
2204900|NCT01606787|3842703|FG000|Overall Study|Surgery canceled|0
2204901|NCT01606787|3842704|FG001|Overall Study|Surgery canceled|2
2204902|NCT01606800|3842712|FG000|Overall Study|Adverse Event|3
2119066|NCT00953706|3716808|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
2119067|NCT00953706|3716805|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
2119068|NCT00953706|3716806|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
2119069|NCT00953706|3716807|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
2119070|NCT00953706|3716808|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
2119071|NCT00953706|3716805|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0
2119072|NCT00953706|3716806|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0
2204903|NCT01606800|3842713|FG001|Overall Study|Adverse Event|1
2204904|NCT01606800|3842712|FG000|Overall Study|Participant withdrew consent|0
2204905|NCT01606800|3842713|FG001|Overall Study|Participant withdrew consent|1
2204906|NCT01606800|3842712|FG000|Overall Study|Missing completion status|2
2204907|NCT01606800|3842713|FG001|Overall Study|Missing completion status|0
2204908|NCT01607073|3842728|FG000|Overall Study|Adverse Event|1
2204909|NCT01607346|3842771|FG000|Overall Study|Adverse Event|3
2119073|NCT00953706|3716807|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0
2119074|NCT00953706|3716808|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2
2119075|NCT00953706|3716805|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
2119076|NCT00953706|3716806|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
2119077|NCT00953706|3716807|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
2119078|NCT00953706|3716808|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
2119079|NCT00953706|3716805|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
2119080|NCT00953706|3716806|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
2119081|NCT00953706|3716807|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
2119082|NCT00953706|3716808|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
2119083|NCT00953706|3716805|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
2204910|NCT01607398|3842777|FG000|Overall Study|Adverse Event|0
2119084|NCT00953706|3716806|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
2119085|NCT00953706|3716807|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
2204911|NCT01607398|3842778|FG001|Overall Study|Adverse Event|2
2204912|NCT01607398|3842777|FG000|Overall Study|Severe COPD|2
2204913|NCT01607398|3842778|FG001|Overall Study|Severe COPD|0
2204914|NCT01607476|3842834|FG000|Overall Study|Withdrawal by Subject|1
2119086|NCT00953706|3716808|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
2119087|NCT00953706|3716805|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
2119088|NCT00953706|3716806|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
2119089|NCT00953706|3716807|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
2119090|NCT00953706|3716808|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
2119091|NCT00953706|3716805|FG000|Part B (96-Week Open-Label Extension)|Other|0
2119092|NCT00953706|3716806|FG001|Part B (96-Week Open-Label Extension)|Other|0
2119093|NCT00953706|3716807|FG002|Part B (96-Week Open-Label Extension)|Other|0
2119094|NCT00953706|3716808|FG003|Part B (96-Week Open-Label Extension)|Other|2
2119095|NCT00953745|3716829|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
2119096|NCT00953745|3716830|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
2119097|NCT00953745|3716829|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
2119098|NCT00953745|3716830|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
2119099|NCT00953745|3716829|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
2119100|NCT00953745|3716830|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
2119101|NCT00953745|3716829|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
2119102|NCT00953745|3716830|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
2119103|NCT00953745|3716829|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
2119104|NCT00953745|3716830|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
2119105|NCT00953745|3716829|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
2119106|NCT00953745|3716830|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
2119107|NCT00953927|3716867|FG000|Overall Study|Lost to Follow-up|61
2119108|NCT00953927|3716868|FG001|Overall Study|Lost to Follow-up|65
2119109|NCT00953927|3716867|FG000|Overall Study|Withdrawal by Subject|36
2119110|NCT00953927|3716868|FG001|Overall Study|Withdrawal by Subject|25
2119111|NCT00953927|3716867|FG000|Overall Study|Death|7
2119112|NCT00953927|3716868|FG001|Overall Study|Death|4
2119113|NCT00953927|3716867|FG000|Overall Study|Other study discontinuation|1
2119114|NCT00953927|3716868|FG001|Overall Study|Other study discontinuation|1
2119115|NCT00954122|3716878|FG000|Overall Study|Withdrawal by Subject|5
2119116|NCT00954122|3716878|FG000|Overall Study|Adverse Event|1
2119117|NCT00954122|3716878|FG000|Overall Study|Safety Reason|1
2119118|NCT00954174|3716887|FG000|Overall Study|Adverse Event|28
2119119|NCT00954174|3716888|FG001|Overall Study|Adverse Event|23
2119120|NCT00954174|3716889|FG002|Overall Study|Adverse Event|4
2119121|NCT00954174|3716890|FG003|Overall Study|Adverse Event|9
2119122|NCT00954174|3716887|FG000|Overall Study|Death|4
2119123|NCT00954174|3716888|FG001|Overall Study|Death|2
2119124|NCT00954174|3716889|FG002|Overall Study|Death|0
2119125|NCT00954174|3716890|FG003|Overall Study|Death|0
2119126|NCT00954174|3716887|FG000|Overall Study|Lack of Efficacy|32
2119127|NCT00954174|3716888|FG001|Overall Study|Lack of Efficacy|22
2119128|NCT00954174|3716889|FG002|Overall Study|Lack of Efficacy|8
2119129|NCT00954174|3716890|FG003|Overall Study|Lack of Efficacy|6
2119130|NCT00954174|3716887|FG000|Overall Study|Withdrawal by Subject|14
2119131|NCT00954174|3716888|FG001|Overall Study|Withdrawal by Subject|10
2119132|NCT00954174|3716889|FG002|Overall Study|Withdrawal by Subject|4
2119133|NCT00954174|3716890|FG003|Overall Study|Withdrawal by Subject|3
2119134|NCT00954174|3716887|FG000|Overall Study|Medical Reason|4
2119135|NCT00954174|3716888|FG001|Overall Study|Medical Reason|2
2119136|NCT00954174|3716889|FG002|Overall Study|Medical Reason|1
2119137|NCT00954174|3716890|FG003|Overall Study|Medical Reason|0
2119138|NCT00954174|3716887|FG000|Overall Study|Ineligible|40
2119139|NCT00954174|3716888|FG001|Overall Study|Ineligible|47
2119140|NCT00954174|3716889|FG002|Overall Study|Ineligible|7
2119141|NCT00954174|3716890|FG003|Overall Study|Ineligible|4
2119142|NCT00954174|3716887|FG000|Overall Study|Never Treated|4
2119143|NCT00954174|3716888|FG001|Overall Study|Never Treated|17
2119144|NCT00954174|3716889|FG002|Overall Study|Never Treated|0
2119145|NCT00954174|3716890|FG003|Overall Study|Never Treated|3
2119146|NCT00954421|3716912|FG000|Screening|screen failures|3
2119147|NCT00954421|3716912|FG000|6 Months of DBS|Withdrawal by Subject|1
2204915|NCT01607476|3842835|FG001|Overall Study|Withdrawal by Subject|0
2204916|NCT01607476|3842836|FG002|Overall Study|Withdrawal by Subject|1
2204917|NCT01607476|3842834|FG000|Overall Study|Lost to Follow-up|0
2204918|NCT01607476|3842835|FG001|Overall Study|Lost to Follow-up|0
2204919|NCT01607476|3842836|FG002|Overall Study|Lost to Follow-up|2
2204920|NCT01607554|3842844|FG000|Overall Study|Disease progression|2
2119148|NCT00954421|3716912|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
2119149|NCT00954447|3716920|FG000|Overall Study|Adverse Event|33
2119150|NCT00954447|3716921|FG001|Overall Study|Adverse Event|25
2119151|NCT00954447|3716920|FG000|Overall Study|Lack of Efficacy|17
2119152|NCT00954447|3716921|FG001|Overall Study|Lack of Efficacy|3
2119153|NCT00954447|3716920|FG000|Overall Study|Protocol Violation|5
2119154|NCT00954447|3716921|FG001|Overall Study|Protocol Violation|7
2119155|NCT00954447|3716920|FG000|Overall Study|Lost to Follow-up|8
2119156|NCT00954447|3716921|FG001|Overall Study|Lost to Follow-up|14
2119157|NCT00954447|3716920|FG000|Overall Study|Withdrawal by Subject|26
2119158|NCT00954447|3716921|FG001|Overall Study|Withdrawal by Subject|21
2119159|NCT00954447|3716920|FG000|Overall Study|Other|21
2119160|NCT00954447|3716921|FG001|Overall Study|Other|18
2204921|NCT01607593|3842848|FG000|Overall Study|Adverse Event|15
2119161|NCT00954512|3716933|FG000|Overall Study|Withdrawal by Subject|0
2119162|NCT00954512|3716934|FG001|Overall Study|Withdrawal by Subject|0
2119163|NCT00954512|3716935|FG002|Overall Study|Withdrawal by Subject|0
2119164|NCT00954512|3716936|FG003|Overall Study|Withdrawal by Subject|0
2119165|NCT00954512|3716937|FG004|Overall Study|Withdrawal by Subject|0
2119166|NCT00954512|3716938|FG005|Overall Study|Withdrawal by Subject|1
2119167|NCT00954512|3716933|FG000|Overall Study|Adverse Event|0
2119168|NCT00954512|3716934|FG001|Overall Study|Adverse Event|0
2119169|NCT00954512|3716935|FG002|Overall Study|Adverse Event|0
2119170|NCT00954512|3716936|FG003|Overall Study|Adverse Event|0
2119171|NCT00954512|3716937|FG004|Overall Study|Adverse Event|1
2204922|NCT01607593|3842848|FG000|Overall Study|Lack of Efficacy|16
2204923|NCT01607593|3842848|FG000|Overall Study|Lost to Follow-up|25
2204924|NCT01607593|3842848|FG000|Overall Study|Continuation|33
2204925|NCT01607593|3842848|FG000|Overall Study|Other|4
2119172|NCT00954512|3716938|FG005|Overall Study|Adverse Event|2
2119173|NCT00954512|3716933|FG000|Overall Study|Physician Decision|0
2119174|NCT00954512|3716934|FG001|Overall Study|Physician Decision|1
2277538|NCT02326298|3959846|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
2277539|NCT02326298|3959833|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277540|NCT02326298|3959834|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277541|NCT02326298|3959835|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277542|NCT02326298|3959836|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277543|NCT02326298|3959837|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277544|NCT02326298|3959838|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277545|NCT02326298|3959839|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277546|NCT02326298|3959840|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277547|NCT02326298|3959841|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2119175|NCT00954512|3716935|FG002|Overall Study|Physician Decision|0
2119176|NCT00954512|3716936|FG003|Overall Study|Physician Decision|1
2119177|NCT00954512|3716937|FG004|Overall Study|Physician Decision|0
2119178|NCT00954512|3716938|FG005|Overall Study|Physician Decision|0
2119179|NCT00954512|3716933|FG000|Overall Study|Symptomatic Deterioration|0
2119180|NCT00954512|3716934|FG001|Overall Study|Symptomatic Deterioration|1
2119181|NCT00954512|3716935|FG002|Overall Study|Symptomatic Deterioration|0
2119182|NCT00954512|3716936|FG003|Overall Study|Symptomatic Deterioration|0
2119183|NCT00954512|3716937|FG004|Overall Study|Symptomatic Deterioration|2
2119184|NCT00954512|3716938|FG005|Overall Study|Symptomatic Deterioration|0
2119185|NCT00954512|3716933|FG000|Overall Study|Progression of Disease|2
2119186|NCT00954512|3716934|FG001|Overall Study|Progression of Disease|1
2119187|NCT00954512|3716935|FG002|Overall Study|Progression of Disease|0
2119188|NCT00954512|3716936|FG003|Overall Study|Progression of Disease|1
2217411|NCT01708161|3860636|FG004|Overall Study|Disease progression|3
2217412|NCT01708161|3860637|FG005|Overall Study|Disease progression|0
2217413|NCT01708174|3860654|FG000|Treatment Period|Withdrawal by Subject|1
2217414|NCT01708174|3860655|FG001|Treatment Period|Withdrawal by Subject|0
2217415|NCT01708174|3860656|FG002|Treatment Period|Withdrawal by Subject|0
2217416|NCT01708174|3860654|FG000|Treatment Period|Progressive disease|0
2217417|NCT01708174|3860655|FG001|Treatment Period|Progressive disease|1
2217418|NCT01708174|3860656|FG002|Treatment Period|Progressive disease|0
2217419|NCT01708174|3860654|FG000|Treatment Period|Death|0
2217420|NCT01708174|3860655|FG001|Treatment Period|Death|0
2119189|NCT00954512|3716937|FG004|Overall Study|Progression of Disease|1
2119190|NCT00954512|3716938|FG005|Overall Study|Progression of Disease|1
2119191|NCT00954538|3716953|FG000|Part III|Withdrawal by Subject|0
2119192|NCT00954538|3716954|FG001|Part III|Withdrawal by Subject|0
2119193|NCT00954538|3716955|FG002|Part III|Withdrawal by Subject|0
2119194|NCT00954538|3716956|FG003|Part III|Withdrawal by Subject|0
2119195|NCT00954538|3716957|FG004|Part III|Withdrawal by Subject|1
2119196|NCT00954538|3716958|FG005|Part III|Withdrawal by Subject|0
2119197|NCT00954707|3716971|FG000|Overall Study|Death|34
2119198|NCT00954707|3716971|FG000|Overall Study|Withdrawal by Subject|100
2119199|NCT00954707|3716971|FG000|Overall Study|Lost to Follow-up|33
2119200|NCT00954733|3716975|FG000|Overall Study|blood gas machine did not work|1
2119201|NCT00954941|3716985|FG000|Overall Study|Received treatment at home|1
2119202|NCT00954941|3716986|FG001|Overall Study|Received treatment at home|0
2119203|NCT00954941|3716985|FG000|Overall Study|Withdrawal by Subject|1
2119204|NCT00954941|3716986|FG001|Overall Study|Withdrawal by Subject|0
2119205|NCT00954941|3716985|FG000|Overall Study|Insurance Denial|2
2119206|NCT00954941|3716986|FG001|Overall Study|Insurance Denial|2
2119207|NCT00954941|3716985|FG000|Overall Study|Physician Decision|2
2119208|NCT00954941|3716986|FG001|Overall Study|Physician Decision|2
2119209|NCT00954941|3716985|FG000|Overall Study|Ineligible|2
2119210|NCT00954941|3716986|FG001|Overall Study|Ineligible|2
2119211|NCT00954941|3716985|FG000|Overall Study|Adverse Event|0
2119212|NCT00954941|3716986|FG001|Overall Study|Adverse Event|1
2119213|NCT00955110|3717016|FG000|Qualification Phase|Did not meet eligibility criteria|24
2119214|NCT00955110|3717016|FG000|Treatment Phase|Adverse Event|2
2119215|NCT00955110|3717016|FG000|Treatment Phase|Administrative reasons|2
2217421|NCT01708174|3860656|FG002|Treatment Period|Death|1
2217422|NCT01708174|3860654|FG000|Treatment Period|Adverse Event|0
2217423|NCT01708174|3860655|FG001|Treatment Period|Adverse Event|1
2119216|NCT00955110|3717016|FG000|Treatment Phase|Non-compliance with study restrictions|1
2119217|NCT00955110|3717016|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1
2119218|NCT00955279|3717072|FG000|Overall Study|Other|0
2119219|NCT00955279|3717073|FG001|Overall Study|Other|0
2119220|NCT00955279|3717074|FG002|Overall Study|Other|3
2119221|NCT00955279|3717072|FG000|Overall Study|Death|1
2119222|NCT00955279|3717073|FG001|Overall Study|Death|1
2119223|NCT00955279|3717074|FG002|Overall Study|Death|1
2119224|NCT00955279|3717072|FG000|Overall Study|Lost to Follow-up|0
2119225|NCT00955279|3717073|FG001|Overall Study|Lost to Follow-up|3
2119226|NCT00955279|3717074|FG002|Overall Study|Lost to Follow-up|1
2119227|NCT00955279|3717072|FG000|Overall Study|Withdrawal by Subject|2
2119228|NCT00955279|3717073|FG001|Overall Study|Withdrawal by Subject|0
2119229|NCT00955279|3717074|FG002|Overall Study|Withdrawal by Subject|3
2119230|NCT00955305|3717084|FG000|Overall Study|Disease progression|39
2119231|NCT00955305|3717085|FG001|Overall Study|Disease progression|41
2119232|NCT00955305|3717084|FG000|Overall Study|Adverse Event|22
2119233|NCT00955305|3717085|FG001|Overall Study|Adverse Event|22
2119234|NCT00955305|3717084|FG000|Overall Study|Death|2
2119235|NCT00955305|3717085|FG001|Overall Study|Death|1
2119236|NCT00955305|3717084|FG000|Overall Study|Withdrawal by Subject|5
2119237|NCT00955305|3717085|FG001|Overall Study|Withdrawal by Subject|4
2119238|NCT00955305|3717084|FG000|Overall Study|Alternative therapy|4
2119239|NCT00955305|3717085|FG001|Overall Study|Alternative therapy|0
2119240|NCT00955305|3717084|FG000|Overall Study|Other complicating disease|2
2119241|NCT00955305|3717085|FG001|Overall Study|Other complicating disease|4
2119242|NCT00955305|3717084|FG000|Overall Study|Physician Decision|1
2119243|NCT00955305|3717085|FG001|Overall Study|Physician Decision|0
2119244|NCT00955305|3717084|FG000|Overall Study|Continued presence of residual disease|0
2119245|NCT00955305|3717085|FG001|Overall Study|Continued presence of residual disease|1
2119246|NCT00955305|3717084|FG000|Overall Study|Functional decline|2
2119247|NCT00955305|3717085|FG001|Overall Study|Functional decline|0
2119248|NCT00955305|3717084|FG000|Overall Study|Maximum response achieved|0
2119249|NCT00955305|3717085|FG001|Overall Study|Maximum response achieved|1
2119250|NCT00955305|3717084|FG000|Overall Study|Lost to Follow-up|0
2119251|NCT00955305|3717085|FG001|Overall Study|Lost to Follow-up|1
2119252|NCT00955305|3717084|FG000|Overall Study|No off-treatment reason submitted|1
2119253|NCT00955305|3717085|FG001|Overall Study|No off-treatment reason submitted|0
2119254|NCT00955305|3717084|FG000|Overall Study|Never started protocol treatment|5
2119255|NCT00955305|3717085|FG001|Overall Study|Never started protocol treatment|5
2119256|NCT00955305|3717084|FG000|Overall Study|Ineligible|5
2119257|NCT00955305|3717085|FG001|Overall Study|Ineligible|7
2119258|NCT00955357|3717093|FG000|Titration Phase|Adverse Event|9
2119259|NCT00955357|3717094|FG001|Titration Phase|Adverse Event|46
2119260|NCT00955357|3717093|FG000|Titration Phase|Lack of Efficacy|0
2119261|NCT00955357|3717094|FG001|Titration Phase|Lack of Efficacy|2
2119262|NCT00955357|3717093|FG000|Titration Phase|Protocol Violation|3
2119263|NCT00955357|3717094|FG001|Titration Phase|Protocol Violation|7
2119264|NCT00955357|3717093|FG000|Titration Phase|Lost to Follow-up|1
2119265|NCT00955357|3717094|FG001|Titration Phase|Lost to Follow-up|3
2119266|NCT00955357|3717093|FG000|Titration Phase|Withdrawal by Subject|3
2119267|NCT00955357|3717094|FG001|Titration Phase|Withdrawal by Subject|5
2119268|NCT00955357|3717093|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0
2119269|NCT00955357|3717094|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1
2119270|NCT00955357|3717093|FG000|Titration Phase|Study medication not tolerated|0
2119271|NCT00955357|3717094|FG001|Titration Phase|Study medication not tolerated|1
2119272|NCT00955357|3717093|FG000|Titration Phase|Non compliance to study procedures|0
2119273|NCT00955357|3717094|FG001|Titration Phase|Non compliance to study procedures|1
2119274|NCT00955357|3717093|FG000|Maintenance Phase|Adverse Event|3
2119275|NCT00955357|3717094|FG001|Maintenance Phase|Adverse Event|23
2119276|NCT00955357|3717093|FG000|Maintenance Phase|Lack of Efficacy|0
2119277|NCT00955357|3717094|FG001|Maintenance Phase|Lack of Efficacy|4
2119278|NCT00955357|3717093|FG000|Maintenance Phase|Protocol Violation|2
2119279|NCT00955357|3717094|FG001|Maintenance Phase|Protocol Violation|6
2119280|NCT00955357|3717093|FG000|Maintenance Phase|Lost to Follow-up|2
2119281|NCT00955357|3717094|FG001|Maintenance Phase|Lost to Follow-up|7
2119282|NCT00955357|3717093|FG000|Maintenance Phase|Withdrawal by Subject|4
2119283|NCT00955357|3717094|FG001|Maintenance Phase|Withdrawal by Subject|4
2119284|NCT00955357|3717093|FG000|Maintenance Phase|Patient moving out of area|0
2119285|NCT00955357|3717094|FG001|Maintenance Phase|Patient moving out of area|1
2119286|NCT00955357|3717093|FG000|Maintenance Phase|Non compliance to study procedures|1
2119287|NCT00955357|3717094|FG001|Maintenance Phase|Non compliance to study procedures|0
2119288|NCT00955409|3717110|FG000|Overall Study|Lack of Efficacy|1
2119289|NCT00955409|3717111|FG001|Overall Study|Lack of Efficacy|0
2119290|NCT00955409|3717112|FG002|Overall Study|Lack of Efficacy|0
2119291|NCT00955409|3717113|FG003|Overall Study|Lack of Efficacy|0
2119292|NCT00955409|3717114|FG004|Overall Study|Lack of Efficacy|0
2119293|NCT00955409|3717115|FG005|Overall Study|Lack of Efficacy|0
2119294|NCT00955409|3717116|FG006|Overall Study|Lack of Efficacy|0
2119295|NCT00955409|3717117|FG007|Overall Study|Lack of Efficacy|0
2119296|NCT00955409|3717118|FG008|Overall Study|Lack of Efficacy|0
2119297|NCT00955409|3717119|FG009|Overall Study|Lack of Efficacy|0
2119298|NCT00955409|3717110|FG000|Overall Study|Withdrawal by Subject|1
2119299|NCT00955409|3717111|FG001|Overall Study|Withdrawal by Subject|0
2119300|NCT00955409|3717112|FG002|Overall Study|Withdrawal by Subject|5
2119301|NCT00955409|3717113|FG003|Overall Study|Withdrawal by Subject|2
2119302|NCT00955409|3717114|FG004|Overall Study|Withdrawal by Subject|0
2119303|NCT00955409|3717115|FG005|Overall Study|Withdrawal by Subject|0
2119304|NCT00955409|3717116|FG006|Overall Study|Withdrawal by Subject|2
2119305|NCT00955409|3717117|FG007|Overall Study|Withdrawal by Subject|0
2119306|NCT00955409|3717118|FG008|Overall Study|Withdrawal by Subject|1
2119307|NCT00955409|3717119|FG009|Overall Study|Withdrawal by Subject|0
2119308|NCT00955409|3717110|FG000|Overall Study|Caregiver Request|2
2119309|NCT00955409|3717111|FG001|Overall Study|Caregiver Request|0
2119310|NCT00955409|3717112|FG002|Overall Study|Caregiver Request|6
2119311|NCT00955409|3717113|FG003|Overall Study|Caregiver Request|5
2119312|NCT00955409|3717114|FG004|Overall Study|Caregiver Request|0
2119313|NCT00955409|3717115|FG005|Overall Study|Caregiver Request|2
2119314|NCT00955409|3717116|FG006|Overall Study|Caregiver Request|3
2119315|NCT00955409|3717117|FG007|Overall Study|Caregiver Request|1
2119316|NCT00955409|3717118|FG008|Overall Study|Caregiver Request|3
2119317|NCT00955409|3717119|FG009|Overall Study|Caregiver Request|0
2119318|NCT00955409|3717110|FG000|Overall Study|Investigator Request|0
2119319|NCT00955409|3717111|FG001|Overall Study|Investigator Request|0
2119320|NCT00955409|3717112|FG002|Overall Study|Investigator Request|1
2119321|NCT00955409|3717113|FG003|Overall Study|Investigator Request|0
2119322|NCT00955409|3717114|FG004|Overall Study|Investigator Request|0
2119323|NCT00955409|3717115|FG005|Overall Study|Investigator Request|0
2119324|NCT00955409|3717116|FG006|Overall Study|Investigator Request|0
2119325|NCT00955409|3717117|FG007|Overall Study|Investigator Request|0
2119326|NCT00955409|3717118|FG008|Overall Study|Investigator Request|0
2119327|NCT00955409|3717119|FG009|Overall Study|Investigator Request|0
2119328|NCT00955409|3717110|FG000|Overall Study|Discontinuation of Study by Sponsor|0
2119329|NCT00955409|3717111|FG001|Overall Study|Discontinuation of Study by Sponsor|0
2119330|NCT00955409|3717112|FG002|Overall Study|Discontinuation of Study by Sponsor|0
2119331|NCT00955409|3717113|FG003|Overall Study|Discontinuation of Study by Sponsor|0
2119332|NCT00955409|3717114|FG004|Overall Study|Discontinuation of Study by Sponsor|0
2119333|NCT00955409|3717115|FG005|Overall Study|Discontinuation of Study by Sponsor|0
2119334|NCT00955409|3717116|FG006|Overall Study|Discontinuation of Study by Sponsor|0
2119335|NCT00955409|3717117|FG007|Overall Study|Discontinuation of Study by Sponsor|1
2119336|NCT00955409|3717118|FG008|Overall Study|Discontinuation of Study by Sponsor|0
2119337|NCT00955409|3717119|FG009|Overall Study|Discontinuation of Study by Sponsor|0
2119338|NCT00955409|3717110|FG000|Overall Study|Lost to Follow-up|0
2119339|NCT00955409|3717111|FG001|Overall Study|Lost to Follow-up|0
2119340|NCT00955409|3717112|FG002|Overall Study|Lost to Follow-up|1
2119341|NCT00955409|3717113|FG003|Overall Study|Lost to Follow-up|0
2119342|NCT00955409|3717114|FG004|Overall Study|Lost to Follow-up|0
2119343|NCT00955409|3717115|FG005|Overall Study|Lost to Follow-up|0
2119344|NCT00955409|3717116|FG006|Overall Study|Lost to Follow-up|1
2119345|NCT00955409|3717117|FG007|Overall Study|Lost to Follow-up|0
2119346|NCT00955409|3717118|FG008|Overall Study|Lost to Follow-up|0
2119347|NCT00955409|3717119|FG009|Overall Study|Lost to Follow-up|0
2119348|NCT00955409|3717110|FG000|Overall Study|Failed to Return|2
2119349|NCT00955409|3717111|FG001|Overall Study|Failed to Return|0
2119350|NCT00955409|3717112|FG002|Overall Study|Failed to Return|0
2119351|NCT00955409|3717113|FG003|Overall Study|Failed to Return|0
2119352|NCT00955409|3717114|FG004|Overall Study|Failed to Return|0
2119353|NCT00955409|3717115|FG005|Overall Study|Failed to Return|0
2119354|NCT00955409|3717116|FG006|Overall Study|Failed to Return|0
2119355|NCT00955409|3717117|FG007|Overall Study|Failed to Return|2
2119356|NCT00955409|3717118|FG008|Overall Study|Failed to Return|0
2119357|NCT00955409|3717119|FG009|Overall Study|Failed to Return|0
2119358|NCT00955409|3717110|FG000|Overall Study|Adverse Event (AE)|2
2119359|NCT00955409|3717111|FG001|Overall Study|Adverse Event (AE)|0
2119360|NCT00955409|3717112|FG002|Overall Study|Adverse Event (AE)|0
2119361|NCT00955409|3717113|FG003|Overall Study|Adverse Event (AE)|0
2119362|NCT00955409|3717114|FG004|Overall Study|Adverse Event (AE)|0
2119363|NCT00955409|3717115|FG005|Overall Study|Adverse Event (AE)|1
2119364|NCT00955409|3717116|FG006|Overall Study|Adverse Event (AE)|2
2119365|NCT00955409|3717117|FG007|Overall Study|Adverse Event (AE)|0
2119366|NCT00955409|3717118|FG008|Overall Study|Adverse Event (AE)|2
2119367|NCT00955409|3717119|FG009|Overall Study|Adverse Event (AE)|0
2119368|NCT00955409|3717110|FG000|Overall Study|Reason not Specified|2
2119369|NCT00955409|3717111|FG001|Overall Study|Reason not Specified|1
2119370|NCT00955409|3717112|FG002|Overall Study|Reason not Specified|13
2119371|NCT00955409|3717113|FG003|Overall Study|Reason not Specified|1
2119372|NCT00955409|3717114|FG004|Overall Study|Reason not Specified|2
2119373|NCT00955409|3717115|FG005|Overall Study|Reason not Specified|0
2119374|NCT00955409|3717116|FG006|Overall Study|Reason not Specified|16
2119375|NCT00955409|3717117|FG007|Overall Study|Reason not Specified|0
2119376|NCT00955409|3717118|FG008|Overall Study|Reason not Specified|8
2119377|NCT00955409|3717119|FG009|Overall Study|Reason not Specified|1
2119378|NCT00955474|3717147|FG000|Overall Study|Physician Decision|7
2119379|NCT00955474|3717148|FG001|Overall Study|Physician Decision|5
2119380|NCT00955617|3717188|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
2119381|NCT00955617|3717189|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
2119382|NCT00955617|3717188|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
2119383|NCT00955617|3717189|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
2119384|NCT00955617|3717188|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0
2119385|NCT00955617|3717189|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1
2119386|NCT00955617|3717188|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
2119387|NCT00955617|3717189|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
2119388|NCT00955682|3717197|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1
2119389|NCT00955682|3717198|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1
2119390|NCT00955708|3717212|FG000|Overall Study|Death|269
2119391|NCT00955708|3717212|FG000|Overall Study|Lost to Follow-up|72
2119392|NCT00955708|3717212|FG000|Overall Study|Physician Decision|36
2119393|NCT00955708|3717212|FG000|Overall Study|Protocol Violation|134
2119394|NCT00955708|3717212|FG000|Overall Study|Registry Conclusion|186
2119395|NCT00955708|3717212|FG000|Overall Study|Product removed from service|94
2119396|NCT00955708|3717212|FG000|Overall Study|Patient Refused to participate further|116
2119397|NCT00955708|3717212|FG000|Overall Study|Closure of study location|60
2119398|NCT00955708|3717212|FG000|Overall Study|Patient changed care provider/moved|91
2119399|NCT00955721|3717218|FG000|Overall Study|Physician Decision|1
2119400|NCT00955721|3717219|FG001|Overall Study|Physician Decision|0
2119401|NCT00955721|3717218|FG000|Overall Study|Death|1
2119402|NCT00955721|3717219|FG001|Overall Study|Death|0
2119403|NCT00955721|3717218|FG000|Overall Study|Withdrawal by Subject|1
2119404|NCT00955721|3717219|FG001|Overall Study|Withdrawal by Subject|0
2119405|NCT00955825|3717237|FG000|Overall Study|Adverse Event|15
2119406|NCT00955825|3717238|FG001|Overall Study|Adverse Event|2
2119407|NCT00955825|3717237|FG000|Overall Study|Withdrawal by Subject|4
2119408|NCT00955825|3717238|FG001|Overall Study|Withdrawal by Subject|6
2119409|NCT00955825|3717237|FG000|Overall Study|Any other reason not above-mentioned|7
2119410|NCT00955825|3717238|FG001|Overall Study|Any other reason not above-mentioned|9
2119411|NCT00955955|3717277|FG000|Overall Study|Lost to Follow-up|2
2119412|NCT00955955|3717278|FG001|Overall Study|Lost to Follow-up|0
2119413|NCT00955955|3717279|FG002|Overall Study|Lost to Follow-up|0
2119414|NCT00955968|3717295|FG000|Overall Study|Death|2
2119415|NCT00955968|3717296|FG001|Overall Study|Death|4
2119416|NCT00955968|3717295|FG000|Overall Study|Withdrawal by Subject|35
2119417|NCT00955968|3717296|FG001|Overall Study|Withdrawal by Subject|31
2119418|NCT00955968|3717295|FG000|Overall Study|Lost to Follow-up|45
2119419|NCT00955968|3717296|FG001|Overall Study|Lost to Follow-up|39
2119420|NCT00955968|3717295|FG000|Overall Study|Site closed|55
2119421|NCT00955968|3717296|FG001|Overall Study|Site closed|52
2119422|NCT00956293|3717330|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0
2119423|NCT00956293|3717331|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0
2119424|NCT00956293|3717332|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1
2119425|NCT00956293|3717330|FG000|Main Period (Pre-randomization)|Death|0
2119426|NCT00956293|3717331|FG001|Main Period (Pre-randomization)|Death|0
2119427|NCT00956293|3717332|FG002|Main Period (Pre-randomization)|Death|1
2119428|NCT00956293|3717330|FG000|Main Period (Pre-randomization)|Protocol Violation|0
2119429|NCT00956293|3717331|FG001|Main Period (Pre-randomization)|Protocol Violation|0
2119430|NCT00956293|3717332|FG002|Main Period (Pre-randomization)|Protocol Violation|1
2119431|NCT00956293|3717330|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0
2119432|NCT00956293|3717331|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0
2119433|NCT00956293|3717332|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2
2119434|NCT00956293|3717330|FG000|Main Period (Pre-randomization)|Administrative problems|0
2119435|NCT00956293|3717331|FG001|Main Period (Pre-randomization)|Administrative problems|0
2119436|NCT00956293|3717332|FG002|Main Period (Pre-randomization)|Administrative problems|6
2119437|NCT00956293|3717330|FG000|Main Period (Pre-randomization)|Graft loss|0
2119438|NCT00956293|3717331|FG001|Main Period (Pre-randomization)|Graft loss|0
2119439|NCT00956293|3717332|FG002|Main Period (Pre-randomization)|Graft loss|7
2119440|NCT00956293|3717330|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0
2119441|NCT00956293|3717331|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0
2119442|NCT00956293|3717332|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12
2119443|NCT00956293|3717330|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0
2119444|NCT00956293|3717331|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0
2119445|NCT00956293|3717332|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20
2119446|NCT00956293|3717330|FG000|Main Period (Pre-randomization)|Adverse Event|0
2119447|NCT00956293|3717331|FG001|Main Period (Pre-randomization)|Adverse Event|0
2119448|NCT00956293|3717332|FG002|Main Period (Pre-randomization)|Adverse Event|36
2119449|NCT00956293|3717330|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0
2119450|NCT00956293|3717331|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0
2119451|NCT00956293|3717332|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44
2119452|NCT00956293|3717330|FG000|Main Period (Randomization)|Abnormal laboratory value|0
2119453|NCT00956293|3717331|FG001|Main Period (Randomization)|Abnormal laboratory value|2
2119454|NCT00956293|3717332|FG002|Main Period (Randomization)|Abnormal laboratory value|0
2119455|NCT00956293|3717330|FG000|Main Period (Randomization)|Lack of Efficacy|1
2119456|NCT00956293|3717331|FG001|Main Period (Randomization)|Lack of Efficacy|10
2119457|NCT00956293|3717332|FG002|Main Period (Randomization)|Lack of Efficacy|0
2119458|NCT00956293|3717330|FG000|Main Period (Randomization)|Adverse Event|0
2119459|NCT00956293|3717331|FG001|Main Period (Randomization)|Adverse Event|15
2119460|NCT00956293|3717332|FG002|Main Period (Randomization)|Adverse Event|0
2119461|NCT00956293|3717330|FG000|Follow-up Period|Follow-up period was terminated.|20
2119462|NCT00956293|3717331|FG001|Follow-up Period|Follow-up period was terminated.|32
2119463|NCT00956293|3717332|FG002|Follow-up Period|Follow-up period was terminated.|0
2119464|NCT00956592|3717357|FG000|Overall Study|Protocol Violation|1
2119465|NCT00956592|3717358|FG001|Overall Study|Protocol Violation|3
2119466|NCT00956813|3717397|FG000|Flaxseed and Placebo|Withdrawal by Subject|5
2119467|NCT00956813|3717398|FG001|Flaxseed and Placebo|Withdrawal by Subject|4
2119468|NCT00956813|3717397|FG000|Flaxseed and Placebo|Ineligible|3
2119469|NCT00956813|3717398|FG001|Flaxseed and Placebo|Ineligible|1
2177646|NCT01376245|3801978|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2177647|NCT01376245|3801979|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
2177648|NCT01376245|3801980|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
2177649|NCT01376245|3801981|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
2177650|NCT01376245|3801982|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2177651|NCT01376245|3801978|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2177652|NCT01376245|3801979|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2177653|NCT01376245|3801980|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2177654|NCT01376245|3801981|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2177655|NCT01376245|3801982|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2177656|NCT01376245|3801978|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
2177657|NCT01376245|3801979|FG001|24-week, Double-blind Treatment Period|Physician Decision|0
2177658|NCT01376245|3801980|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
2177659|NCT01376245|3801981|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
2177660|NCT01376245|3801982|FG004|24-week, Double-blind Treatment Period|Physician Decision|0
2177661|NCT01376245|3801978|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2177662|NCT01376245|3801979|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
2177663|NCT01376245|3801980|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2177664|NCT01376245|3801981|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
2177665|NCT01376245|3801982|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
2180071|NCT01397825|3805928|FG001|Overall Study|Adverse Event|1
2180072|NCT01397825|3805929|FG002|Overall Study|Adverse Event|5
2180073|NCT01397825|3805930|FG003|Overall Study|Adverse Event|1
2180074|NCT01397825|3805931|FG004|Overall Study|Adverse Event|0
2180075|NCT01397825|3805927|FG000|Overall Study|Withdrawal by Subject|1
2180076|NCT01397825|3805928|FG001|Overall Study|Withdrawal by Subject|0
2180077|NCT01397825|3805929|FG002|Overall Study|Withdrawal by Subject|5
2180078|NCT01397825|3805930|FG003|Overall Study|Withdrawal by Subject|1
2180079|NCT01397825|3805931|FG004|Overall Study|Withdrawal by Subject|0
2180080|NCT01397890|3805956|FG000|Overall Study|Withdrawal by Subject|7
2180081|NCT01397890|3805957|FG001|Overall Study|Withdrawal by Subject|11
2180082|NCT01397890|3805956|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7
2180083|NCT01397890|3805957|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
2180084|NCT01397890|3805956|FG000|Overall Study|Death|2
2180085|NCT01397890|3805957|FG001|Overall Study|Death|3
2180086|NCT01397890|3805956|FG000|Overall Study|Lost to Follow-up|1
2180087|NCT01397890|3805957|FG001|Overall Study|Lost to Follow-up|4
2180088|NCT01397890|3805956|FG000|Overall Study|Condition under Investigation Worsened|1
2180089|NCT01397890|3805957|FG001|Overall Study|Condition under Investigation Worsened|3
2180090|NCT01397890|3805956|FG000|Overall Study|Adverse Event|1
2180091|NCT01397890|3805957|FG001|Overall Study|Adverse Event|2
2180092|NCT01397890|3805956|FG000|Overall Study|Severe Non-Compliance to Protocol|2
2180093|NCT01397890|3805957|FG001|Overall Study|Severe Non-Compliance to Protocol|1
2180094|NCT01397890|3805956|FG000|Overall Study|Others|2
2180095|NCT01397890|3805957|FG001|Overall Study|Others|1
2180096|NCT01398176|3805978|FG000|Overall Study|Lost to Follow-up|1
2180097|NCT01398176|3805979|FG001|Overall Study|Lost to Follow-up|3
2180098|NCT01398176|3805978|FG000|Overall Study|Physician Decision|2
2180099|NCT01398176|3805979|FG001|Overall Study|Physician Decision|3
2180100|NCT01398358|3805997|FG000|Overall Study|Lost to Follow-up|11
2180101|NCT01398358|3805998|FG001|Overall Study|Lost to Follow-up|21
2180102|NCT01398358|3805999|FG002|Overall Study|Lost to Follow-up|18
2180103|NCT01398358|3805997|FG000|Overall Study|Withdrawal by Subject|3
2180104|NCT01398358|3805998|FG001|Overall Study|Withdrawal by Subject|2
2180105|NCT01398358|3805999|FG002|Overall Study|Withdrawal by Subject|2
2180106|NCT01398358|3805997|FG000|Overall Study|no longer eligible|1
2180107|NCT01398358|3805998|FG001|Overall Study|no longer eligible|0
2180108|NCT01398358|3805999|FG002|Overall Study|no longer eligible|1
2180109|NCT01398410|3806009|FG000|Overall Study|Adverse Event|12
2180110|NCT01398410|3806010|FG001|Overall Study|Adverse Event|16
2180111|NCT01398410|3806009|FG000|Overall Study|Participants Choice|8
2180112|NCT01398410|3806010|FG001|Overall Study|Participants Choice|11
2180113|NCT01398410|3806009|FG000|Overall Study|Inadequate Therapeutic Effect|2
2180114|NCT01398410|3806010|FG001|Overall Study|Inadequate Therapeutic Effect|0
2180115|NCT01398410|3806009|FG000|Overall Study|Other|36
2180116|NCT01398410|3806010|FG001|Overall Study|Other|29
2119470|NCT00956839|3717408|FG000|Overall Study|Lost to Follow-up|3
2119471|NCT00956839|3717409|FG001|Overall Study|Lost to Follow-up|0
2119472|NCT00956839|3717410|FG002|Overall Study|Lost to Follow-up|3
2119473|NCT00956943|3717431|FG000|Overall Study|Lost to Follow-up|9
2119474|NCT00956943|3717432|FG001|Overall Study|Lost to Follow-up|10
2119475|NCT00957008|3717442|FG000|Overall Study|Withdrawal by Subject|13
2119476|NCT00957008|3717443|FG001|Overall Study|Withdrawal by Subject|10
2119477|NCT00957008|3717444|FG002|Overall Study|Withdrawal by Subject|12
2119478|NCT00957008|3717445|FG003|Overall Study|Withdrawal by Subject|16
2119479|NCT00957008|3717442|FG000|Overall Study|Lost to Follow-up|3
2119480|NCT00957008|3717443|FG001|Overall Study|Lost to Follow-up|1
2119481|NCT00957008|3717444|FG002|Overall Study|Lost to Follow-up|3
2119482|NCT00957008|3717445|FG003|Overall Study|Lost to Follow-up|4
2119483|NCT00957008|3717442|FG000|Overall Study|Physician Decision|1
2119484|NCT00957008|3717443|FG001|Overall Study|Physician Decision|0
2119485|NCT00957008|3717444|FG002|Overall Study|Physician Decision|1
2119486|NCT00957008|3717445|FG003|Overall Study|Physician Decision|1
2119487|NCT00957008|3717442|FG000|Overall Study|Relocated; Family conflict|4
2119488|NCT00957008|3717443|FG001|Overall Study|Relocated; Family conflict|1
2119489|NCT00957008|3717444|FG002|Overall Study|Relocated; Family conflict|1
2119490|NCT00957008|3717445|FG003|Overall Study|Relocated; Family conflict|3
2119491|NCT00957021|3717459|FG000|Overall Study|Death|5
2119492|NCT00957021|3717459|FG000|Overall Study|Lost to Follow-up|8
2119493|NCT00957021|3717459|FG000|Overall Study|Withdrawal by Subject|34
2119494|NCT00957021|3717459|FG000|Overall Study|No 2 yr ROM data|35
2119495|NCT00957021|3717459|FG000|Overall Study|Revised study component by 2 yr visit|8
2119496|NCT00957021|3717459|FG000|Overall Study|Site Termination by the 2 yr visit|16
2119497|NCT00957021|3717459|FG000|Overall Study|Surgery Cancelled|9
2119498|NCT00957021|3717459|FG000|Overall Study|Termination due to language issue|2
2119499|NCT00957229|3717492|FG000|Study Start|Adverse Event|0
2119500|NCT00957229|3717493|FG001|Study Start|Adverse Event|3
2119501|NCT00957229|3717492|FG000|Study Start|Disease Progression|1
2119502|NCT00957229|3717493|FG001|Study Start|Disease Progression|0
2119503|NCT00957229|3717492|FG000|Reallocated to or Continued Vismodegib|Death|1
2119504|NCT00957229|3717493|FG001|Reallocated to or Continued Vismodegib|Death|1
2119505|NCT00957229|3717492|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2
2119506|NCT00957229|3717493|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1
2119507|NCT00957268|3717515|FG000|Overall Study|Voluntary Withdrawal|0
2119508|NCT00957268|3717516|FG001|Overall Study|Voluntary Withdrawal|0
2119509|NCT00957268|3717517|FG002|Overall Study|Voluntary Withdrawal|1
2119510|NCT00957268|3717518|FG003|Overall Study|Voluntary Withdrawal|0
2119511|NCT00957268|3717519|FG004|Overall Study|Voluntary Withdrawal|0
2119512|NCT00957372|3717547|FG000|PART I|Lost to Follow-up|0
2119513|NCT00957372|3717548|FG001|PART I|Lost to Follow-up|0
2119514|NCT00957372|3717549|FG002|PART I|Lost to Follow-up|1
2119515|NCT00957372|3717550|FG003|PART I|Lost to Follow-up|0
2119516|NCT00957372|3717547|FG000|PART II|Withdrawal by Subject|0
2119517|NCT00957372|3717548|FG001|PART II|Withdrawal by Subject|0
2119518|NCT00957372|3717549|FG002|PART II|Withdrawal by Subject|0
2119519|NCT00957372|3717550|FG003|PART II|Withdrawal by Subject|8
2119520|NCT00957372|3717547|FG000|PART II|Physician Decision|0
2119521|NCT00957372|3717548|FG001|PART II|Physician Decision|0
2119522|NCT00957372|3717549|FG002|PART II|Physician Decision|0
2119523|NCT00957372|3717550|FG003|PART II|Physician Decision|1
2119524|NCT00957372|3717547|FG000|PART II|Pregnancy|0
2119525|NCT00957372|3717548|FG001|PART II|Pregnancy|0
2119526|NCT00957372|3717549|FG002|PART II|Pregnancy|0
2119527|NCT00957372|3717550|FG003|PART II|Pregnancy|1
2119528|NCT00957372|3717547|FG000|PART II|Not Know|0
2119529|NCT00957372|3717548|FG001|PART II|Not Know|0
2119530|NCT00957372|3717549|FG002|PART II|Not Know|0
2119531|NCT00957372|3717550|FG003|PART II|Not Know|20
2119532|NCT00957372|3717547|FG000|PART II|Adverse Event|0
2119533|NCT00957372|3717548|FG001|PART II|Adverse Event|0
2119534|NCT00957372|3717549|FG002|PART II|Adverse Event|0
2119535|NCT00957372|3717550|FG003|PART II|Adverse Event|10
2119536|NCT00957372|3717547|FG000|PART II|Patient non-compliance|0
2119537|NCT00957372|3717548|FG001|PART II|Patient non-compliance|0
2119538|NCT00957372|3717549|FG002|PART II|Patient non-compliance|0
2119539|NCT00957372|3717550|FG003|PART II|Patient non-compliance|4
2119540|NCT00957424|3717566|FG000|Overall Study|Lost to Follow-up|19
2119541|NCT00957424|3717566|FG000|Overall Study|Protocol Violation|3
2119542|NCT00957424|3717566|FG000|Overall Study|Withdrawal by Subject|1
2119543|NCT00957528|3717573|FG000|Overall Study|Protocol Violation|0
2119544|NCT00957528|3717574|FG001|Overall Study|Protocol Violation|1
2119545|NCT00957528|3717575|FG002|Overall Study|Protocol Violation|0
2119546|NCT00957528|3717573|FG000|Overall Study|Withdrawal by Subject|0
2119547|NCT00957528|3717574|FG001|Overall Study|Withdrawal by Subject|0
2119548|NCT00957528|3717575|FG002|Overall Study|Withdrawal by Subject|1
2119549|NCT00957580|3717586|FG000|Overall Study|Ongoing at data cut-off|0
2119550|NCT00957580|3717587|FG001|Overall Study|Ongoing at data cut-off|1
2119551|NCT00957580|3717588|FG002|Overall Study|Ongoing at data cut-off|0
2119552|NCT00957580|3717586|FG000|Overall Study|Enrolled but not treated|0
2119553|NCT00957580|3717587|FG001|Overall Study|Enrolled but not treated|1
2119554|NCT00957580|3717588|FG002|Overall Study|Enrolled but not treated|0
2119555|NCT00957658|3717620|FG000|Overall Study|Death|1
2119556|NCT00957658|3717620|FG000|Overall Study|Lost to Follow-up|4
2119557|NCT00957658|3717620|FG000|Overall Study|Withdrawal by Subject|12
2119558|NCT00957658|3717620|FG000|Overall Study|Revision|1
2119559|NCT00957658|3717620|FG000|Overall Study|Incomplete 2 yr data|28
2119560|NCT00957658|3717620|FG000|Overall Study|Site termination|10
2119561|NCT00957658|3717620|FG000|Overall Study|unwilling/unable to return|2
2119562|NCT00957658|3717620|FG000|Overall Study|surgery cancelled|2
2119563|NCT00957658|3717620|FG000|Overall Study|Protocol Violation|5
2119564|NCT00957723|3717649|FG000|Overall Study|Death|3
2119565|NCT00957723|3717649|FG000|Overall Study|Revision/ Removal of Study Implant|3
2119566|NCT00957723|3717649|FG000|Overall Study|Lost to Follow-up|8
2119567|NCT00957723|3717649|FG000|Overall Study|Withdrawal by Subject|24
2119568|NCT00957723|3717649|FG000|Overall Study|Investigative Site Terminated|61
2119569|NCT00957723|3717649|FG000|Overall Study|Intercurrent Illness|2
2119570|NCT00957723|3717649|FG000|Overall Study|2yr ROM Data Not Evaluable|12
2119571|NCT00957801|3717659|FG000|Overall Study|Withdrawal by Subject|0
2119572|NCT00957801|3717660|FG001|Overall Study|Withdrawal by Subject|0
2119573|NCT00957801|3717661|FG002|Overall Study|Withdrawal by Subject|0
2119574|NCT00957801|3717662|FG003|Overall Study|Withdrawal by Subject|1
2119575|NCT00957853|3717675|FG000|Overall Study|Withdrawal by Subject|1
2119576|NCT00957853|3717676|FG001|Overall Study|Withdrawal by Subject|0
2119577|NCT00957853|3717677|FG002|Overall Study|Withdrawal by Subject|0
2119578|NCT00957905|3717687|FG000|Part B|Not Treated|0
2119579|NCT00957905|3717688|FG001|Part B|Not Treated|1
2119580|NCT00957905|3717687|FG000|Part B|Physician Decision|0
2119581|NCT00957905|3717688|FG001|Part B|Physician Decision|1
2119582|NCT00957905|3717687|FG000|Part B|Death|0
2119583|NCT00957905|3717688|FG001|Part B|Death|1
2119584|NCT00957905|3717687|FG000|Part B|Protocol Violation|0
2119585|NCT00957905|3717688|FG001|Part B|Protocol Violation|1
2119586|NCT00957931|3717694|FG000|Overall Study|Death|4
2119587|NCT00957944|3717700|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0
2119588|NCT00957944|3717701|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1
2119589|NCT00957996|3717709|FG000|Overall Study|Death|4
2119590|NCT00957996|3717710|FG001|Overall Study|Death|10
2119591|NCT00957996|3717709|FG000|Overall Study|Lost to Follow-up|4
2119592|NCT00957996|3717710|FG001|Overall Study|Lost to Follow-up|7
2119593|NCT00957996|3717709|FG000|Overall Study|Withdrawal by Subject|9
2119594|NCT00957996|3717710|FG001|Overall Study|Withdrawal by Subject|2
2119595|NCT00957996|3717709|FG000|Overall Study|Adverse Event|2
2119596|NCT00957996|3717710|FG001|Overall Study|Adverse Event|1
2119597|NCT00957996|3717709|FG000|Overall Study|Physician Decision|1
2119598|NCT00957996|3717710|FG001|Overall Study|Physician Decision|1
2119599|NCT00957996|3717709|FG000|Overall Study|Influenza-related complication|0
2119600|NCT00957996|3717710|FG001|Overall Study|Influenza-related complication|1
2119601|NCT00957996|3717709|FG000|Overall Study|Missing|1
2119602|NCT00957996|3717710|FG001|Overall Study|Missing|0
2119603|NCT00957996|3717709|FG000|Overall Study|Noncompliance; Protocol Deviations|5
2119604|NCT00957996|3717710|FG001|Overall Study|Noncompliance; Protocol Deviations|6
2119605|NCT00958009|3717718|FG000|Overall Study|Adverse Event|1
2119606|NCT00958009|3717718|FG000|Overall Study|Subject found device difficult to use|1
2119607|NCT00958074|3717733|FG000|Overall Study|Withdrawal by Subject|0
2119608|NCT00958074|3717734|FG001|Overall Study|Withdrawal by Subject|1
2119609|NCT00958126|3717748|FG000|Overall Study|Serious Adverse Event|0
2119610|NCT00958126|3717749|FG001|Overall Study|Serious Adverse Event|2
2119611|NCT00958126|3717750|FG002|Overall Study|Serious Adverse Event|0
2119612|NCT00958126|3717751|FG003|Overall Study|Serious Adverse Event|0
2119613|NCT00958126|3717752|FG004|Overall Study|Serious Adverse Event|0
2119614|NCT00958126|3717753|FG005|Overall Study|Serious Adverse Event|0
2119615|NCT00958126|3717754|FG006|Overall Study|Serious Adverse Event|1
2119616|NCT00958126|3717755|FG007|Overall Study|Serious Adverse Event|0
2119617|NCT00958126|3717748|FG000|Overall Study|Withdrawal by Subject|0
2119618|NCT00958126|3717749|FG001|Overall Study|Withdrawal by Subject|2
2119619|NCT00958126|3717750|FG002|Overall Study|Withdrawal by Subject|0
2119620|NCT00958126|3717751|FG003|Overall Study|Withdrawal by Subject|0
2119621|NCT00958126|3717752|FG004|Overall Study|Withdrawal by Subject|0
2119622|NCT00958126|3717753|FG005|Overall Study|Withdrawal by Subject|0
2119623|NCT00958126|3717754|FG006|Overall Study|Withdrawal by Subject|0
2119624|NCT00958126|3717755|FG007|Overall Study|Withdrawal by Subject|0
2119625|NCT00958126|3717748|FG000|Overall Study|Moved away from study area|0
2119626|NCT00958126|3717749|FG001|Overall Study|Moved away from study area|0
2119627|NCT00958126|3717750|FG002|Overall Study|Moved away from study area|1
2119628|NCT00958126|3717751|FG003|Overall Study|Moved away from study area|1
2119629|NCT00958126|3717752|FG004|Overall Study|Moved away from study area|0
2119630|NCT00958126|3717753|FG005|Overall Study|Moved away from study area|0
2119631|NCT00958126|3717754|FG006|Overall Study|Moved away from study area|0
2119632|NCT00958126|3717755|FG007|Overall Study|Moved away from study area|0
2119633|NCT00958126|3717748|FG000|Overall Study|Lost to Follow-up|1
2119634|NCT00958126|3717749|FG001|Overall Study|Lost to Follow-up|5
2119635|NCT00958126|3717750|FG002|Overall Study|Lost to Follow-up|9
2119636|NCT00958126|3717751|FG003|Overall Study|Lost to Follow-up|8
2119637|NCT00958126|3717752|FG004|Overall Study|Lost to Follow-up|0
2119638|NCT00958126|3717753|FG005|Overall Study|Lost to Follow-up|0
2119639|NCT00958126|3717754|FG006|Overall Study|Lost to Follow-up|0
2119640|NCT00958126|3717755|FG007|Overall Study|Lost to Follow-up|0
2119641|NCT00958126|3717748|FG000|Overall Study|Sponsor/Investigator decision|0
2119642|NCT00958126|3717749|FG001|Overall Study|Sponsor/Investigator decision|0
2119643|NCT00958126|3717750|FG002|Overall Study|Sponsor/Investigator decision|0
2119644|NCT00958126|3717751|FG003|Overall Study|Sponsor/Investigator decision|1
2119645|NCT00958126|3717752|FG004|Overall Study|Sponsor/Investigator decision|0
2119646|NCT00958126|3717753|FG005|Overall Study|Sponsor/Investigator decision|0
2119647|NCT00958126|3717754|FG006|Overall Study|Sponsor/Investigator decision|0
2119648|NCT00958126|3717755|FG007|Overall Study|Sponsor/Investigator decision|0
2119649|NCT00958126|3717748|FG000|Overall Study|Other Reason|0
2119650|NCT00958126|3717749|FG001|Overall Study|Other Reason|0
2119651|NCT00958126|3717750|FG002|Overall Study|Other Reason|0
2119652|NCT00958126|3717751|FG003|Overall Study|Other Reason|1
2119653|NCT00958126|3717752|FG004|Overall Study|Other Reason|0
2119654|NCT00958126|3717753|FG005|Overall Study|Other Reason|1
2119655|NCT00958126|3717754|FG006|Overall Study|Other Reason|0
2119656|NCT00958126|3717755|FG007|Overall Study|Other Reason|0
2119657|NCT00958165|3717777|FG000|Overall Study|Lost to Follow-up|5
2119658|NCT00958165|3717777|FG000|Overall Study|Not eligible|9
2119659|NCT00958191|3717781|FG000|Overall Study|Death|4
2119660|NCT00958191|3717781|FG000|Overall Study|Lost to Follow-up|5
2119661|NCT00958191|3717781|FG000|Overall Study|Inadequate 5 yr x-ray quality|10
2119662|NCT00958191|3717781|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21
2119663|NCT00958191|3717781|FG000|Overall Study|Revision of study device|4
2119664|NCT00958191|3717781|FG000|Overall Study|Site termination|11
2119665|NCT00958191|3717781|FG000|Overall Study|No 5 yr x-rays|56
2119666|NCT00958217|3717789|FG000|Overall Study|Death|2
2119667|NCT00958217|3717790|FG001|Overall Study|Death|1
2119668|NCT00958217|3717789|FG000|Overall Study|Withdrawal by Subject|4
2119669|NCT00958217|3717790|FG001|Overall Study|Withdrawal by Subject|3
2119670|NCT00958217|3717789|FG000|Overall Study|Lost to Follow-up|17
2119671|NCT00958217|3717790|FG001|Overall Study|Lost to Follow-up|19
2119672|NCT00958217|3717789|FG000|Overall Study|Moved out of area|1
2119673|NCT00958217|3717790|FG001|Overall Study|Moved out of area|1
2119674|NCT00958217|3717789|FG000|Overall Study|Inpatient hospitalization|0
2119675|NCT00958217|3717790|FG001|Overall Study|Inpatient hospitalization|1
2119676|NCT00958243|3717803|FG000|Overall Study|Withdrawal by Subject|0
2119677|NCT00958243|3717804|FG001|Overall Study|Withdrawal by Subject|1
2119678|NCT00958243|3717805|FG002|Overall Study|Withdrawal by Subject|3
2119679|NCT00958243|3717806|FG003|Overall Study|Withdrawal by Subject|1
2119680|NCT00958243|3717807|FG004|Overall Study|Withdrawal by Subject|1
2119681|NCT00958243|3717808|FG005|Overall Study|Withdrawal by Subject|5
2119682|NCT00958243|3717803|FG000|Overall Study|Lost to Follow-up|2
2119683|NCT00958243|3717804|FG001|Overall Study|Lost to Follow-up|5
2119684|NCT00958243|3717805|FG002|Overall Study|Lost to Follow-up|11
2119685|NCT00958243|3717806|FG003|Overall Study|Lost to Follow-up|2
2119686|NCT00958243|3717807|FG004|Overall Study|Lost to Follow-up|8
2119687|NCT00958243|3717808|FG005|Overall Study|Lost to Follow-up|5
2119688|NCT00958256|3717828|FG000|Overall Study|Adverse Event|3
2119689|NCT00958360|3717869|FG000|Overall Study|Withdrawal by Subject|3
2119690|NCT00958360|3717870|FG001|Overall Study|Withdrawal by Subject|1
2119691|NCT00958360|3717869|FG000|Overall Study|Death|6
2119692|NCT00958360|3717870|FG001|Overall Study|Death|7
2119693|NCT00958360|3717869|FG000|Overall Study|Physician Decision|2
2119694|NCT00958360|3717870|FG001|Overall Study|Physician Decision|1
2119695|NCT00958360|3717869|FG000|Overall Study|Lost to Follow-up|0
2119696|NCT00958360|3717870|FG001|Overall Study|Lost to Follow-up|1
2119697|NCT00958412|3717876|FG000|Overall Study|Study prematurely terminated|18
2119698|NCT00958438|3717883|FG000|Overall Study|Protocol Violation|3
2119699|NCT00958438|3717884|FG001|Overall Study|Protocol Violation|2
2119700|NCT00958438|3717885|FG002|Overall Study|Protocol Violation|2
2119701|NCT00958438|3717883|FG000|Overall Study|Withdrawal by Subject|4
2119702|NCT00958438|3717884|FG001|Overall Study|Withdrawal by Subject|2
2119703|NCT00958438|3717885|FG002|Overall Study|Withdrawal by Subject|1
2119704|NCT00958438|3717883|FG000|Overall Study|Adverse Event|0
2119705|NCT00958438|3717884|FG001|Overall Study|Adverse Event|3
2119706|NCT00958438|3717885|FG002|Overall Study|Adverse Event|0
2119707|NCT00958438|3717883|FG000|Overall Study|Physician Decision|1
2119708|NCT00958438|3717884|FG001|Overall Study|Physician Decision|0
2119709|NCT00958438|3717885|FG002|Overall Study|Physician Decision|1
2119710|NCT00958438|3717883|FG000|Overall Study|Other than specified above|2
2119711|NCT00958438|3717884|FG001|Overall Study|Other than specified above|3
2119712|NCT00958438|3717885|FG002|Overall Study|Other than specified above|2
2119713|NCT00958568|3717916|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
2119714|NCT00958568|3717917|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
2119715|NCT00958568|3717918|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
2119716|NCT00958568|3717919|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
2119717|NCT00958568|3717916|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
2119718|NCT00958568|3717917|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
2119719|NCT00958568|3717918|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
2119720|NCT00958568|3717919|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
2119721|NCT00958568|3717916|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
2119722|NCT00958568|3717917|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
2177666|NCT01376310|3802003|FG000|Overall Study|Study closed/terminated|1
2119723|NCT00958568|3717918|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
2119724|NCT00958568|3717919|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
2119725|NCT00958568|3717916|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
2119726|NCT00958568|3717917|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
2119727|NCT00958568|3717918|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
2119728|NCT00958568|3717919|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
2119729|NCT00958568|3717916|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
2119730|NCT00958568|3717917|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
2119731|NCT00958568|3717918|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
2119732|NCT00958568|3717919|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
2119733|NCT00958568|3717916|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
2119734|NCT00958568|3717917|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
2119735|NCT00958568|3717918|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
2119736|NCT00958568|3717919|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
2119737|NCT00958568|3717916|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
2119738|NCT00958568|3717917|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
2119739|NCT00958568|3717918|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
2119740|NCT00958568|3717919|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
2119741|NCT00958568|3717916|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
2119742|NCT00958568|3717917|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
2119743|NCT00958568|3717918|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
2119744|NCT00958568|3717919|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
2119745|NCT00958568|3717916|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
2119746|NCT00958568|3717917|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
2119747|NCT00958568|3717918|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
2119748|NCT00958568|3717919|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
2119749|NCT00958568|3717916|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
2119750|NCT00958568|3717917|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
2119751|NCT00958568|3717918|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
2119752|NCT00958568|3717919|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
2119753|NCT00958568|3717916|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
2119754|NCT00958568|3717917|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
2119755|NCT00958568|3717918|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
2119756|NCT00958568|3717919|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
2119757|NCT00958568|3717916|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
2119758|NCT00958568|3717917|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
2119759|NCT00958568|3717918|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
2119760|NCT00958568|3717919|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
2119761|NCT00958568|3717916|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
2119762|NCT00958568|3717917|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
2119763|NCT00958568|3717918|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
2119764|NCT00958568|3717919|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
2119765|NCT00958568|3717916|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
2119766|NCT00958568|3717917|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
2119767|NCT00958568|3717918|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
2119768|NCT00958568|3717919|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
2119769|NCT00958568|3717916|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
2119770|NCT00958568|3717917|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
2119771|NCT00958568|3717918|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
2119772|NCT00958568|3717919|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
2119773|NCT00958568|3717916|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
2119774|NCT00958568|3717917|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
2119775|NCT00958568|3717918|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
2119776|NCT00958568|3717919|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
2119777|NCT00958568|3717916|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
2119778|NCT00958568|3717917|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
2119779|NCT00958568|3717918|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
2119780|NCT00958568|3717919|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
2119781|NCT00958568|3717916|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
2119782|NCT00958568|3717917|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
2119783|NCT00958568|3717918|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
2119784|NCT00958568|3717919|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
2119785|NCT00958568|3717916|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
2119786|NCT00958568|3717917|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
2119787|NCT00958568|3717918|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
2119788|NCT00958568|3717919|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
2177667|NCT01376310|3802004|FG001|Overall Study|Study closed/terminated|2
2119789|NCT00958568|3717916|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
2119790|NCT00958568|3717917|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
2119791|NCT00958568|3717918|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
2119792|NCT00958568|3717919|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
2119793|NCT00958568|3717916|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
2119794|NCT00958568|3717917|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
2119795|NCT00958568|3717918|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
2119796|NCT00958568|3717919|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
2119797|NCT00958568|3717916|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
2119798|NCT00958568|3717917|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
2119799|NCT00958568|3717918|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
2119800|NCT00958568|3717919|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
2119801|NCT00958568|3717916|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
2119802|NCT00958568|3717917|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
2119803|NCT00958568|3717918|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
2119804|NCT00958568|3717919|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
2119805|NCT00958568|3717916|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
2119806|NCT00958568|3717917|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
2119807|NCT00958568|3717918|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
2119808|NCT00958568|3717919|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
2119809|NCT00958568|3717916|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
2119810|NCT00958568|3717917|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
2119811|NCT00958568|3717918|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
2119812|NCT00958568|3717919|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
2119813|NCT00958568|3717916|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
2119814|NCT00958568|3717917|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
2119815|NCT00958568|3717918|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
2119816|NCT00958568|3717919|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
2119817|NCT00958568|3717916|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
2119818|NCT00958568|3717917|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
2119819|NCT00958568|3717918|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
2119820|NCT00958568|3717919|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
2119821|NCT00958568|3717916|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
2119822|NCT00958568|3717917|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
2119823|NCT00958568|3717918|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
2119824|NCT00958568|3717919|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
2119825|NCT00958568|3717916|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
2119826|NCT00958568|3717917|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
2119827|NCT00958568|3717918|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
2119828|NCT00958568|3717919|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
2119829|NCT00958711|3717948|FG000|Overall Study|Withdrawal by Subject|0
2119830|NCT00958711|3717949|FG001|Overall Study|Withdrawal by Subject|4
2119831|NCT00958711|3717948|FG000|Overall Study|Physician Decision|5
2119832|NCT00958711|3717949|FG001|Overall Study|Physician Decision|7
2119833|NCT00958711|3717948|FG000|Overall Study|Lost to Follow-up|4
2119834|NCT00958711|3717949|FG001|Overall Study|Lost to Follow-up|1
2119835|NCT00958711|3717948|FG000|Overall Study|Other|2
2119836|NCT00958711|3717949|FG001|Overall Study|Other|5
2119837|NCT00958711|3717948|FG000|Overall Study|Death|1
2119838|NCT00958711|3717949|FG001|Overall Study|Death|2
2119839|NCT00958711|3717948|FG000|Overall Study|Adverse Event|1
2119840|NCT00958711|3717949|FG001|Overall Study|Adverse Event|2
2119841|NCT00958724|3717955|FG000|Overall Study|Disease Progression|6
2119842|NCT00958776|3717961|FG000|Overall Study|Adverse Event|0
2119843|NCT00958776|3717962|FG001|Overall Study|Adverse Event|1
2119844|NCT00958776|3717961|FG000|Overall Study|Physician Decision|1
2119845|NCT00958776|3717962|FG001|Overall Study|Physician Decision|0
2119846|NCT00958776|3717961|FG000|Overall Study|Lost to Follow-up|2
2119847|NCT00958776|3717962|FG001|Overall Study|Lost to Follow-up|6
2119848|NCT00958776|3717961|FG000|Overall Study|Withdrawal by Subject|7
2119849|NCT00958776|3717962|FG001|Overall Study|Withdrawal by Subject|16
2119850|NCT00958776|3717961|FG000|Overall Study|Protocol Violation|1
2119851|NCT00958776|3717962|FG001|Overall Study|Protocol Violation|1
2119852|NCT00958776|3717961|FG000|Overall Study|Death|2
2119853|NCT00958776|3717962|FG001|Overall Study|Death|1
2119854|NCT00958776|3717961|FG000|Overall Study|Noncompliance; Protocol Deviations|2
2119855|NCT00958776|3717962|FG001|Overall Study|Noncompliance; Protocol Deviations|3
2119856|NCT00958776|3717961|FG000|Overall Study|Missing|1
2119857|NCT00958776|3717962|FG001|Overall Study|Missing|1
2119858|NCT00958789|3717969|FG000|Overall Study|Death|5
2119859|NCT00958789|3717969|FG000|Overall Study|Lost to Follow-up|14
2119860|NCT00958789|3717969|FG000|Overall Study|Withdrawal by Subject|17
2119861|NCT00958789|3717969|FG000|Overall Study|No 2 yr. Knee Society Score data|4
2119862|NCT00958789|3717969|FG000|Overall Study|2 yr. Knee Society Score not calculable|1
2119863|NCT00958789|3717969|FG000|Overall Study|Subject terminated|2
2119864|NCT00958789|3717969|FG000|Overall Study|Revision|7
2119865|NCT00958828|3717978|FG000|Period 1, 1 Week of Wear|Randomization break|0
2119866|NCT00958828|3717979|FG001|Period 1, 1 Week of Wear|Randomization break|1
2119867|NCT00958828|3717978|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0
2119868|NCT00958828|3717979|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1
2119869|NCT00958841|3717985|FG000|Overall Study|Abnormal laboratory value(s)|1
2119870|NCT00958841|3717985|FG000|Overall Study|Abnormal test procedure result(s)|3
2119871|NCT00958841|3717985|FG000|Overall Study|Administrative problems|1
2119872|NCT00958841|3717985|FG000|Overall Study|Adverse Event|8
2119873|NCT00958841|3717985|FG000|Overall Study|New cancer therapy|5
2119874|NCT00958841|3717985|FG000|Overall Study|Withdrawal by Subject|1
2119875|NCT00958841|3717985|FG000|Overall Study|Unsatisfactory therapeutic effect|22
2119876|NCT00958841|3717985|FG000|Overall Study|Completed M6/did not enter extension|27
2119877|NCT00958841|3717985|FG000|Overall Study|Discontinued prior to M*|28
2119878|NCT00958880|3718001|FG000|Overall Study|Lost to Follow-up|2
2119879|NCT00958880|3718002|FG001|Overall Study|Lost to Follow-up|2
2119880|NCT00959049|3718028|FG000|Overall Study|Adverse Event|1
2119881|NCT00959049|3718029|FG001|Overall Study|Adverse Event|0
2119882|NCT00959049|3718030|FG002|Overall Study|Adverse Event|0
2119883|NCT00959049|3718031|FG003|Overall Study|Adverse Event|0
2277548|NCT02326298|3959842|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277549|NCT02326298|3959843|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2277550|NCT02326298|3959844|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
2277551|NCT02326298|3959845|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
2277552|NCT02326298|3959846|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2277553|NCT02326298|3959833|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277554|NCT02326298|3959834|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277555|NCT02326298|3959835|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277556|NCT02326298|3959836|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277557|NCT02326298|3959837|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2119884|NCT00959049|3718032|FG004|Overall Study|Adverse Event|0
2119885|NCT00959049|3718033|FG005|Overall Study|Adverse Event|0
2119886|NCT00959049|3718028|FG000|Overall Study|Lost to Follow-up|17
2119887|NCT00959049|3718029|FG001|Overall Study|Lost to Follow-up|5
2119888|NCT00959049|3718030|FG002|Overall Study|Lost to Follow-up|1
2119889|NCT00959049|3718031|FG003|Overall Study|Lost to Follow-up|10
2119890|NCT00959049|3718032|FG004|Overall Study|Lost to Follow-up|9
2119891|NCT00959049|3718033|FG005|Overall Study|Lost to Follow-up|1
2119892|NCT00959049|3718028|FG000|Overall Study|Contraindicated medication|0
2119893|NCT00959049|3718029|FG001|Overall Study|Contraindicated medication|0
2119894|NCT00959049|3718030|FG002|Overall Study|Contraindicated medication|0
2119895|NCT00959049|3718031|FG003|Overall Study|Contraindicated medication|1
2119896|NCT00959049|3718032|FG004|Overall Study|Contraindicated medication|0
2119897|NCT00959049|3718033|FG005|Overall Study|Contraindicated medication|0
2119898|NCT00959049|3718028|FG000|Overall Study|Withdrawal by Subject|0
2119899|NCT00959049|3718029|FG001|Overall Study|Withdrawal by Subject|2
2119900|NCT00959049|3718030|FG002|Overall Study|Withdrawal by Subject|0
2119901|NCT00959049|3718031|FG003|Overall Study|Withdrawal by Subject|0
2119902|NCT00959049|3718032|FG004|Overall Study|Withdrawal by Subject|0
2119903|NCT00959049|3718033|FG005|Overall Study|Withdrawal by Subject|0
2119904|NCT00959192|3718071|FG000|Overall Study|Adverse Event|1
2119905|NCT00959192|3718072|FG001|Overall Study|Adverse Event|1
2119906|NCT00959192|3718073|FG002|Overall Study|Adverse Event|1
2119907|NCT00959192|3718074|FG003|Overall Study|Adverse Event|0
2119908|NCT00959192|3718071|FG000|Overall Study|Investigator Request|1
2119909|NCT00959192|3718072|FG001|Overall Study|Investigator Request|0
2119910|NCT00959192|3718073|FG002|Overall Study|Investigator Request|0
2119911|NCT00959192|3718074|FG003|Overall Study|Investigator Request|0
2119912|NCT00959192|3718071|FG000|Overall Study|Caregiver Request|0
2119913|NCT00959192|3718072|FG001|Overall Study|Caregiver Request|0
2119914|NCT00959192|3718073|FG002|Overall Study|Caregiver Request|2
2119915|NCT00959192|3718074|FG003|Overall Study|Caregiver Request|1
2119916|NCT00959374|3718085|FG000|Overall Study|Withdrawal by Subject|2
2119917|NCT00959374|3718085|FG000|Overall Study|Lost to Follow-up|14
2119918|NCT00959374|3718085|FG000|Overall Study|Death|1
2119919|NCT00959374|3718085|FG000|Overall Study|Protocol Violation|1
2119920|NCT00959374|3718085|FG000|Overall Study|Implant Removed/Not Replaced|4
2119921|NCT00959374|3718085|FG000|Overall Study|Physician Decision|1
2119922|NCT00959647|3718093|FG000|Overall Study|Adverse Event|2
2119923|NCT00959647|3718093|FG000|Overall Study|Progressive disease|6
2119924|NCT00959647|3718093|FG000|Overall Study|Study terminated by sponsor|4
2119925|NCT00959647|3718093|FG000|Overall Study|Withdrawal by Subject|7
2119926|NCT00959699|3718116|FG000|Treatment Period|Adverse Event|3
2119927|NCT00959699|3718117|FG001|Treatment Period|Adverse Event|13
2119928|NCT00959699|3718116|FG000|Treatment Period|Lack of Efficacy|15
2119929|NCT00959699|3718117|FG001|Treatment Period|Lack of Efficacy|6
2119930|NCT00959699|3718116|FG000|Treatment Period|Lost to Follow-up|0
2119931|NCT00959699|3718117|FG001|Treatment Period|Lost to Follow-up|1
2119932|NCT00959699|3718116|FG000|Treatment Period|Withdrawal by Subject|1
2119933|NCT00959699|3718117|FG001|Treatment Period|Withdrawal by Subject|3
2119934|NCT00959699|3718116|FG000|Treatment Period|Non-Compliance with Protocol|0
2119935|NCT00959699|3718117|FG001|Treatment Period|Non-Compliance with Protocol|1
2119936|NCT00959699|3718116|FG000|Treatment Period|Did not receive treatment|0
2119937|NCT00959699|3718117|FG001|Treatment Period|Did not receive treatment|1
2119938|NCT00959699|3718116|FG000|Treatment Period|Futility/crossover to boceprevir|4
2119939|NCT00959699|3718117|FG001|Treatment Period|Futility/crossover to boceprevir|0
2119940|NCT00959699|3718116|FG000|Follow-up Period|Lost to Follow-up|3
2119941|NCT00959699|3718117|FG001|Follow-up Period|Lost to Follow-up|2
2119942|NCT00959699|3718116|FG000|Follow-up Period|Withdrawal by Subject|3
2119943|NCT00959699|3718117|FG001|Follow-up Period|Withdrawal by Subject|4
2119944|NCT00959751|3718126|FG000|Overall Study|Lost to Follow-up|2
2119945|NCT00959751|3718127|FG001|Overall Study|Lost to Follow-up|3
2119946|NCT00959751|3718126|FG000|Overall Study|Consent Withdrawn|0
2119947|NCT00959751|3718127|FG001|Overall Study|Consent Withdrawn|1
2119948|NCT00959751|3718126|FG000|Overall Study|Non-compliance to Study Procedures|0
2119949|NCT00959751|3718127|FG001|Overall Study|Non-compliance to Study Procedures|1
2119950|NCT00959751|3718126|FG000|Overall Study|No migraine headache without aura|7
2119951|NCT00959751|3718127|FG001|Overall Study|No migraine headache without aura|7
2119952|NCT00959894|3718153|FG000|Overall Study|Lost to Follow-up|10
2119953|NCT00959894|3718153|FG000|Overall Study|Adverse Event|3
2119954|NCT00959894|3718153|FG000|Overall Study|Withdrawal by Subject|1
2119955|NCT00959894|3718153|FG000|Overall Study|Need for contraindicated medication|1
2119956|NCT00959894|3718153|FG000|Overall Study|Subject moved out of town|1
2119957|NCT00959907|3718160|FG000|Overall Study|Protocol Violation|0
2119958|NCT00959907|3718161|FG001|Overall Study|Protocol Violation|1
2119959|NCT00959907|3718160|FG000|Overall Study|Adverse Event|1
2119960|NCT00959907|3718161|FG001|Overall Study|Adverse Event|0
2119961|NCT00959907|3718160|FG000|Overall Study|Withdrawal by Subject|2
2119962|NCT00959907|3718161|FG001|Overall Study|Withdrawal by Subject|0
2119963|NCT00959946|3718186|FG000|Overall Study|Adverse Event|0
2119964|NCT00959946|3718187|FG001|Overall Study|Adverse Event|0
2119965|NCT00959946|3718188|FG002|Overall Study|Adverse Event|2
2119966|NCT00959946|3718189|FG003|Overall Study|Adverse Event|1
2119967|NCT00959946|3718190|FG004|Overall Study|Adverse Event|0
2119968|NCT00959946|3718191|FG005|Overall Study|Adverse Event|1
2119969|NCT00959946|3718192|FG006|Overall Study|Adverse Event|0
2119970|NCT00959946|3718193|FG007|Overall Study|Adverse Event|0
2119971|NCT00959946|3718186|FG000|Overall Study|Death|0
2119972|NCT00959946|3718187|FG001|Overall Study|Death|0
2119973|NCT00959946|3718188|FG002|Overall Study|Death|0
2119974|NCT00959946|3718189|FG003|Overall Study|Death|0
2119975|NCT00959946|3718190|FG004|Overall Study|Death|0
2119976|NCT00959946|3718191|FG005|Overall Study|Death|1
2119977|NCT00959946|3718192|FG006|Overall Study|Death|0
2119978|NCT00959946|3718193|FG007|Overall Study|Death|0
2119979|NCT00959946|3718186|FG000|Overall Study|Disease Progression|2
2119980|NCT00959946|3718187|FG001|Overall Study|Disease Progression|4
2119981|NCT00959946|3718188|FG002|Overall Study|Disease Progression|2
2119982|NCT00959946|3718189|FG003|Overall Study|Disease Progression|4
2119983|NCT00959946|3718190|FG004|Overall Study|Disease Progression|4
2119984|NCT00959946|3718191|FG005|Overall Study|Disease Progression|6
2119985|NCT00959946|3718192|FG006|Overall Study|Disease Progression|2
2119986|NCT00959946|3718193|FG007|Overall Study|Disease Progression|2
2119987|NCT00959946|3718186|FG000|Overall Study|Withdrawal by Subject|0
2119988|NCT00959946|3718187|FG001|Overall Study|Withdrawal by Subject|0
2119989|NCT00959946|3718188|FG002|Overall Study|Withdrawal by Subject|0
2119990|NCT00959946|3718189|FG003|Overall Study|Withdrawal by Subject|0
2119991|NCT00959946|3718190|FG004|Overall Study|Withdrawal by Subject|0
2119992|NCT00959946|3718191|FG005|Overall Study|Withdrawal by Subject|1
2119993|NCT00959946|3718192|FG006|Overall Study|Withdrawal by Subject|0
2119994|NCT00959946|3718193|FG007|Overall Study|Withdrawal by Subject|0
2119995|NCT00960011|3718235|FG000|Overall Study|Death|5
2119996|NCT00960011|3718236|FG001|Overall Study|Death|0
2119997|NCT00960011|3718235|FG000|Overall Study|Lost to Follow-up|6
2119998|NCT00960011|3718236|FG001|Overall Study|Lost to Follow-up|2
2119999|NCT00960063|3718279|FG000|Overall Study|Adverse Event|1
2120000|NCT00960063|3718280|FG001|Overall Study|Adverse Event|0
2120001|NCT00960063|3718281|FG002|Overall Study|Adverse Event|0
2120002|NCT00960063|3718279|FG000|Overall Study|Progression of Disease|0
2120003|NCT00960063|3718280|FG001|Overall Study|Progression of Disease|0
2120004|NCT00960063|3718281|FG002|Overall Study|Progression of Disease|3
2204926|NCT01607892|3842890|FG000|Overall Study|Need of treatment not allowed per protocol|0
2204927|NCT01607892|3842891|FG001|Overall Study|Need of treatment not allowed per protocol|0
2120005|NCT00960076|3718291|FG000|Overall Study|Adverse Event|1
2120006|NCT00960076|3718292|FG001|Overall Study|Adverse Event|7
2120007|NCT00960076|3718291|FG000|Overall Study|No longer met study criteria|1
2120008|NCT00960076|3718292|FG001|Overall Study|No longer met study criteria|5
2120009|NCT00960076|3718291|FG000|Overall Study|Withdrawal by Subject|1
2120010|NCT00960076|3718292|FG001|Overall Study|Withdrawal by Subject|2
2120011|NCT00960076|3718291|FG000|Overall Study|Lost to Follow-up|3
2120012|NCT00960076|3718292|FG001|Overall Study|Lost to Follow-up|3
2120013|NCT00960076|3718291|FG000|Overall Study|Severe non-compliance to protocol|1
2120014|NCT00960076|3718292|FG001|Overall Study|Severe non-compliance to protocol|2
2120015|NCT00960076|3718291|FG000|Overall Study|Hyperglycemia|1
2120016|NCT00960076|3718292|FG001|Overall Study|Hyperglycemia|5
2120017|NCT00960076|3718291|FG000|Overall Study|Did not attend the termination visit|0
2120018|NCT00960076|3718292|FG001|Overall Study|Did not attend the termination visit|1
2120019|NCT00960115|3718300|FG000|Overall Study|Ongoing treatment at data cut-off date|19
2120020|NCT00960115|3718301|FG001|Overall Study|Ongoing treatment at data cut-off date|15
2120021|NCT00960193|3718307|FG000|14 Day Washout Period|Withdrawal by Subject|1
2120022|NCT00960206|3718317|FG000|Overall Study|Death|7
2120023|NCT00960206|3718318|FG001|Overall Study|Death|4
2120024|NCT00960206|3718319|FG002|Overall Study|Death|1
2120025|NCT00960206|3718317|FG000|Overall Study|Unwilling/Unable to return|1
2120026|NCT00960206|3718318|FG001|Overall Study|Unwilling/Unable to return|2
2120027|NCT00960206|3718319|FG002|Overall Study|Unwilling/Unable to return|0
2120028|NCT00960206|3718317|FG000|Overall Study|Lost to Follow-up|8
2120029|NCT00960206|3718318|FG001|Overall Study|Lost to Follow-up|14
2120030|NCT00960206|3718319|FG002|Overall Study|Lost to Follow-up|8
2120031|NCT00960206|3718317|FG000|Overall Study|Withdrawal by Subject|2
2120032|NCT00960206|3718318|FG001|Overall Study|Withdrawal by Subject|4
2120033|NCT00960206|3718319|FG002|Overall Study|Withdrawal by Subject|0
2120034|NCT00960206|3718317|FG000|Overall Study|Revision of study component|2
2120035|NCT00960206|3718318|FG001|Overall Study|Revision of study component|2
2120036|NCT00960206|3718319|FG002|Overall Study|Revision of study component|2
2120037|NCT00960206|3718317|FG000|Overall Study|Missing 10 year data|20
2120038|NCT00960206|3718318|FG001|Overall Study|Missing 10 year data|1
2120039|NCT00960206|3718319|FG002|Overall Study|Missing 10 year data|1
2120040|NCT00960323|3718328|FG000|Atorvastatin Alone|Withdrawal by Subject|1
2120041|NCT00960375|3718338|FG000|Overall Study|Lost to Follow-up|20
2120042|NCT00960375|3718339|FG001|Overall Study|Lost to Follow-up|22
2120043|NCT00960440|3718349|FG000|Overall Study|Death|0
2120044|NCT00960440|3718350|FG001|Overall Study|Death|0
2120045|NCT00960440|3718351|FG002|Overall Study|Death|0
2120046|NCT00960440|3718352|FG003|Overall Study|Death|1
2120047|NCT00960440|3718349|FG000|Overall Study|Adverse Event|12
2120048|NCT00960440|3718350|FG001|Overall Study|Adverse Event|12
2120049|NCT00960440|3718351|FG002|Overall Study|Adverse Event|4
2120050|NCT00960440|3718352|FG003|Overall Study|Adverse Event|4
2120051|NCT00960440|3718349|FG000|Overall Study|Lack of Efficacy|2
2120052|NCT00960440|3718350|FG001|Overall Study|Lack of Efficacy|5
2120053|NCT00960440|3718351|FG002|Overall Study|Lack of Efficacy|3
2120054|NCT00960440|3718352|FG003|Overall Study|Lack of Efficacy|8
2120055|NCT00960440|3718349|FG000|Overall Study|Protocol Violation|2
2120056|NCT00960440|3718350|FG001|Overall Study|Protocol Violation|8
2120057|NCT00960440|3718351|FG002|Overall Study|Protocol Violation|3
2120058|NCT00960440|3718352|FG003|Overall Study|Protocol Violation|4
2120059|NCT00960440|3718349|FG000|Overall Study|Withdrawal by Subject|9
2120060|NCT00960440|3718350|FG001|Overall Study|Withdrawal by Subject|5
2120061|NCT00960440|3718351|FG002|Overall Study|Withdrawal by Subject|2
2120062|NCT00960440|3718352|FG003|Overall Study|Withdrawal by Subject|1
2120063|NCT00960440|3718349|FG000|Overall Study|Other|1
2120064|NCT00960440|3718350|FG001|Overall Study|Other|1
2120065|NCT00960440|3718351|FG002|Overall Study|Other|1
2120066|NCT00960440|3718352|FG003|Overall Study|Other|0
2120067|NCT00960531|3718387|FG000|Overall Study|Lack of Efficacy|1
2120068|NCT00960531|3718388|FG001|Overall Study|Lack of Efficacy|0
2120069|NCT00960531|3718389|FG002|Overall Study|Lack of Efficacy|0
2120070|NCT00960531|3718390|FG003|Overall Study|Lack of Efficacy|0
2120071|NCT00960531|3718391|FG004|Overall Study|Lack of Efficacy|0
2120072|NCT00960531|3718392|FG005|Overall Study|Lack of Efficacy|0
2120073|NCT00960531|3718393|FG006|Overall Study|Lack of Efficacy|0
2120074|NCT00960531|3718394|FG007|Overall Study|Lack of Efficacy|0
2120075|NCT00960531|3718395|FG008|Overall Study|Lack of Efficacy|0
2120076|NCT00960531|3718396|FG009|Overall Study|Lack of Efficacy|0
2120077|NCT00960531|3718387|FG000|Overall Study|Withdrawal by Subject|1
2120078|NCT00960531|3718388|FG001|Overall Study|Withdrawal by Subject|0
2120079|NCT00960531|3718389|FG002|Overall Study|Withdrawal by Subject|5
2120080|NCT00960531|3718390|FG003|Overall Study|Withdrawal by Subject|2
2120081|NCT00960531|3718391|FG004|Overall Study|Withdrawal by Subject|0
2120082|NCT00960531|3718392|FG005|Overall Study|Withdrawal by Subject|0
2120083|NCT00960531|3718393|FG006|Overall Study|Withdrawal by Subject|2
2120084|NCT00960531|3718394|FG007|Overall Study|Withdrawal by Subject|0
2120085|NCT00960531|3718395|FG008|Overall Study|Withdrawal by Subject|1
2120086|NCT00960531|3718396|FG009|Overall Study|Withdrawal by Subject|0
2120087|NCT00960531|3718387|FG000|Overall Study|Caregiver Request|2
2120088|NCT00960531|3718388|FG001|Overall Study|Caregiver Request|0
2120089|NCT00960531|3718389|FG002|Overall Study|Caregiver Request|6
2120090|NCT00960531|3718390|FG003|Overall Study|Caregiver Request|5
2120091|NCT00960531|3718391|FG004|Overall Study|Caregiver Request|0
2120092|NCT00960531|3718392|FG005|Overall Study|Caregiver Request|2
2120093|NCT00960531|3718393|FG006|Overall Study|Caregiver Request|3
2120094|NCT00960531|3718394|FG007|Overall Study|Caregiver Request|1
2120095|NCT00960531|3718395|FG008|Overall Study|Caregiver Request|3
2120096|NCT00960531|3718396|FG009|Overall Study|Caregiver Request|0
2120097|NCT00960531|3718387|FG000|Overall Study|Investigator Request|0
2120098|NCT00960531|3718388|FG001|Overall Study|Investigator Request|0
2120099|NCT00960531|3718389|FG002|Overall Study|Investigator Request|1
2120100|NCT00960531|3718390|FG003|Overall Study|Investigator Request|0
2120101|NCT00960531|3718391|FG004|Overall Study|Investigator Request|0
2120102|NCT00960531|3718392|FG005|Overall Study|Investigator Request|0
2120103|NCT00960531|3718393|FG006|Overall Study|Investigator Request|0
2120104|NCT00960531|3718394|FG007|Overall Study|Investigator Request|0
2120105|NCT00960531|3718395|FG008|Overall Study|Investigator Request|0
2120106|NCT00960531|3718396|FG009|Overall Study|Investigator Request|0
2120107|NCT00960531|3718387|FG000|Overall Study|Discontinuation of Study by Sponsor|0
2120108|NCT00960531|3718388|FG001|Overall Study|Discontinuation of Study by Sponsor|0
2120109|NCT00960531|3718389|FG002|Overall Study|Discontinuation of Study by Sponsor|0
2120110|NCT00960531|3718390|FG003|Overall Study|Discontinuation of Study by Sponsor|0
2120111|NCT00960531|3718391|FG004|Overall Study|Discontinuation of Study by Sponsor|0
2120112|NCT00960531|3718392|FG005|Overall Study|Discontinuation of Study by Sponsor|0
2120113|NCT00960531|3718393|FG006|Overall Study|Discontinuation of Study by Sponsor|0
2120114|NCT00960531|3718394|FG007|Overall Study|Discontinuation of Study by Sponsor|1
2120115|NCT00960531|3718395|FG008|Overall Study|Discontinuation of Study by Sponsor|0
2120116|NCT00960531|3718396|FG009|Overall Study|Discontinuation of Study by Sponsor|0
2120117|NCT00960531|3718387|FG000|Overall Study|Lost to Follow-up|0
2120118|NCT00960531|3718388|FG001|Overall Study|Lost to Follow-up|0
2120119|NCT00960531|3718389|FG002|Overall Study|Lost to Follow-up|1
2120120|NCT00960531|3718390|FG003|Overall Study|Lost to Follow-up|0
2120121|NCT00960531|3718391|FG004|Overall Study|Lost to Follow-up|0
2120122|NCT00960531|3718392|FG005|Overall Study|Lost to Follow-up|0
2120123|NCT00960531|3718393|FG006|Overall Study|Lost to Follow-up|1
2120124|NCT00960531|3718394|FG007|Overall Study|Lost to Follow-up|0
2120125|NCT00960531|3718395|FG008|Overall Study|Lost to Follow-up|0
2120126|NCT00960531|3718396|FG009|Overall Study|Lost to Follow-up|0
2120127|NCT00960531|3718387|FG000|Overall Study|Failed to Return|2
2120128|NCT00960531|3718388|FG001|Overall Study|Failed to Return|0
2120129|NCT00960531|3718389|FG002|Overall Study|Failed to Return|0
2120130|NCT00960531|3718390|FG003|Overall Study|Failed to Return|0
2120131|NCT00960531|3718391|FG004|Overall Study|Failed to Return|0
2120132|NCT00960531|3718392|FG005|Overall Study|Failed to Return|0
2120133|NCT00960531|3718393|FG006|Overall Study|Failed to Return|0
2120134|NCT00960531|3718394|FG007|Overall Study|Failed to Return|2
2120135|NCT00960531|3718395|FG008|Overall Study|Failed to Return|0
2120136|NCT00960531|3718396|FG009|Overall Study|Failed to Return|0
2120137|NCT00960531|3718387|FG000|Overall Study|Adverse Event (AE)|2
2120138|NCT00960531|3718388|FG001|Overall Study|Adverse Event (AE)|0
2120139|NCT00960531|3718389|FG002|Overall Study|Adverse Event (AE)|0
2120140|NCT00960531|3718390|FG003|Overall Study|Adverse Event (AE)|0
2120141|NCT00960531|3718391|FG004|Overall Study|Adverse Event (AE)|0
2120142|NCT00960531|3718392|FG005|Overall Study|Adverse Event (AE)|1
2120143|NCT00960531|3718393|FG006|Overall Study|Adverse Event (AE)|2
2120144|NCT00960531|3718394|FG007|Overall Study|Adverse Event (AE)|0
2120145|NCT00960531|3718395|FG008|Overall Study|Adverse Event (AE)|2
2120146|NCT00960531|3718396|FG009|Overall Study|Adverse Event (AE)|0
2120147|NCT00960531|3718387|FG000|Overall Study|Reason not Specified|2
2120148|NCT00960531|3718388|FG001|Overall Study|Reason not Specified|1
2120149|NCT00960531|3718389|FG002|Overall Study|Reason not Specified|13
2120150|NCT00960531|3718390|FG003|Overall Study|Reason not Specified|1
2120151|NCT00960531|3718391|FG004|Overall Study|Reason not Specified|2
2120152|NCT00960531|3718392|FG005|Overall Study|Reason not Specified|0
2120153|NCT00960531|3718393|FG006|Overall Study|Reason not Specified|16
2120154|NCT00960531|3718394|FG007|Overall Study|Reason not Specified|0
2120155|NCT00960531|3718395|FG008|Overall Study|Reason not Specified|8
2120156|NCT00960531|3718396|FG009|Overall Study|Reason not Specified|1
2120157|NCT00960570|3718422|FG000|21 Day Washout Period|Adverse Event|1
2120158|NCT00960570|3718422|FG000|21 Day Washout Period|Withdrawal by Subject|1
2120159|NCT00960570|3718422|FG000|1 Day Period Between Dosing|Adverse Event|2
2120160|NCT00960570|3718422|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1
2120161|NCT00960661|3718440|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
2120162|NCT00960661|3718441|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
2120163|NCT00960661|3718442|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
2120164|NCT00960661|3718440|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
2120165|NCT00960661|3718441|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
2120166|NCT00960661|3718442|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
2277558|NCT02326298|3959838|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277559|NCT02326298|3959839|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277560|NCT02326298|3959840|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277561|NCT02326298|3959841|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277562|NCT02326298|3959842|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277563|NCT02326298|3959843|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2277564|NCT02326298|3959844|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
2277565|NCT02326298|3959845|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
2277566|NCT02326298|3959846|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
2277567|NCT02326298|3959833|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277568|NCT02326298|3959834|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277569|NCT02326298|3959835|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277570|NCT02326298|3959836|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277571|NCT02326298|3959837|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277572|NCT02326298|3959838|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277573|NCT02326298|3959839|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277574|NCT02326298|3959840|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277575|NCT02326298|3959841|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277576|NCT02326298|3959842|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277577|NCT02326298|3959843|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2277578|NCT02326298|3959844|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
2277579|NCT02326298|3959845|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
2277580|NCT02326298|3959846|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
2277581|NCT02326467|3959866|FG000|Overall Study|Withdrawal by Subject|1
2277582|NCT02326597|3959873|FG000|Overall Study|Lost to Follow-up|42
2277583|NCT02326597|3959874|FG001|Overall Study|Lost to Follow-up|32
2277584|NCT02326883|3959902|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84
2277585|NCT02326883|3959903|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85
2277586|NCT02326883|3959904|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69
2277587|NCT02326974|3959912|FG000|Overall Study|Withdrawal by Subject|2
2277588|NCT02326974|3959912|FG000|Overall Study|failed heterogenity evaluation|5
2277589|NCT02327013|3959923|FG000|Overall Study|Adverse Event|4
2277590|NCT02327013|3959924|FG001|Overall Study|Adverse Event|4
2277591|NCT02327013|3959925|FG002|Overall Study|Adverse Event|3
2277592|NCT02327013|3959926|FG003|Overall Study|Adverse Event|0
2277593|NCT02327013|3959927|FG004|Overall Study|Adverse Event|1
2277594|NCT02327013|3959923|FG000|Overall Study|Lack of Efficacy|2
2277595|NCT02327013|3959924|FG001|Overall Study|Lack of Efficacy|0
2277596|NCT02327013|3959925|FG002|Overall Study|Lack of Efficacy|5
2277597|NCT02327013|3959926|FG003|Overall Study|Lack of Efficacy|0
2277598|NCT02327013|3959927|FG004|Overall Study|Lack of Efficacy|1
2277599|NCT02327013|3959923|FG000|Overall Study|Non-compliance with IMP|1
2277600|NCT02327013|3959924|FG001|Overall Study|Non-compliance with IMP|2
2277601|NCT02327013|3959925|FG002|Overall Study|Non-compliance with IMP|7
2277602|NCT02327013|3959926|FG003|Overall Study|Non-compliance with IMP|0
2277603|NCT02327013|3959927|FG004|Overall Study|Non-compliance with IMP|0
2277604|NCT02327013|3959923|FG000|Overall Study|Withdrawal of Consent|1
2277605|NCT02327013|3959924|FG001|Overall Study|Withdrawal of Consent|0
2277606|NCT02327013|3959925|FG002|Overall Study|Withdrawal of Consent|3
2277607|NCT02327013|3959926|FG003|Overall Study|Withdrawal of Consent|0
2277608|NCT02327013|3959927|FG004|Overall Study|Withdrawal of Consent|0
2277609|NCT02327013|3959923|FG000|Overall Study|Lost to Follow-up|2
2277610|NCT02327013|3959924|FG001|Overall Study|Lost to Follow-up|4
2277611|NCT02327013|3959925|FG002|Overall Study|Lost to Follow-up|5
2277612|NCT02327013|3959926|FG003|Overall Study|Lost to Follow-up|0
2277613|NCT02327013|3959927|FG004|Overall Study|Lost to Follow-up|0
2277614|NCT02327013|3959923|FG000|Overall Study|Administrative or other reason(s)|1
2277615|NCT02327013|3959924|FG001|Overall Study|Administrative or other reason(s)|5
2277616|NCT02327013|3959925|FG002|Overall Study|Administrative or other reason(s)|11
2277617|NCT02327013|3959926|FG003|Overall Study|Administrative or other reason(s)|1
2277618|NCT02327013|3959927|FG004|Overall Study|Administrative or other reason(s)|1
2277619|NCT02327013|3959923|FG000|Overall Study|Protocol Violation|0
2277620|NCT02327013|3959924|FG001|Overall Study|Protocol Violation|0
2277621|NCT02327013|3959925|FG002|Overall Study|Protocol Violation|3
2277622|NCT02327013|3959926|FG003|Overall Study|Protocol Violation|0
2277623|NCT02327013|3959927|FG004|Overall Study|Protocol Violation|1
2277624|NCT02327013|3959923|FG000|Overall Study|Withdrawal before treatment|2
2277625|NCT02327013|3959924|FG001|Overall Study|Withdrawal before treatment|1
2277626|NCT02327013|3959925|FG002|Overall Study|Withdrawal before treatment|5
2120167|NCT00960661|3718440|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
2120168|NCT00960661|3718441|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
2120169|NCT00960661|3718442|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
2120170|NCT00960661|3718440|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
2120171|NCT00960661|3718441|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
2120172|NCT00960661|3718442|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
2120173|NCT00960661|3718440|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
2120174|NCT00960661|3718441|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
2120175|NCT00960661|3718442|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
2120176|NCT00960661|3718440|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
2120177|NCT00960661|3718441|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
2120178|NCT00960661|3718442|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
2120179|NCT00960661|3718440|FG000|Interventional Phase|Adverse Event|0
2120180|NCT00960661|3718441|FG001|Interventional Phase|Adverse Event|17
2120181|NCT00960661|3718442|FG002|Interventional Phase|Adverse Event|8
2277627|NCT02327013|3959926|FG003|Overall Study|Withdrawal before treatment|0
2277628|NCT02327013|3959927|FG004|Overall Study|Withdrawal before treatment|0
2277629|NCT02327130|3959960|FG000|Overall Study|Discharged in less than 5 days|5
2277630|NCT02327130|3959960|FG000|Overall Study|Physician Decision|2
2277631|NCT02327130|3959960|FG000|Overall Study|Unable to provide breath sample|1
2277632|NCT02327130|3959960|FG000|Overall Study|Incorrectly place ventilator adaptor|1
2277633|NCT02327130|3959960|FG000|Overall Study|Met exclusion criteria|3
2277634|NCT02327169|3959989|FG000|Overall Study|Progressive Disease|1
2277635|NCT02327169|3959990|FG001|Overall Study|Progressive Disease|3
2277636|NCT02327169|3959991|FG002|Overall Study|Progressive Disease|4
2277637|NCT02327169|3959992|FG003|Overall Study|Progressive Disease|3
2277638|NCT02327169|3959993|FG004|Overall Study|Progressive Disease|4
2277639|NCT02327169|3959994|FG005|Overall Study|Progressive Disease|3
2277640|NCT02327169|3959995|FG006|Overall Study|Progressive Disease|3
2277641|NCT02327169|3959996|FG007|Overall Study|Progressive Disease|3
2277642|NCT02327169|3959997|FG008|Overall Study|Progressive Disease|4
2277643|NCT02327169|3959998|FG009|Overall Study|Progressive Disease|4
2277644|NCT02327169|3959999|FG010|Overall Study|Progressive Disease|4
2277645|NCT02327169|3960000|FG011|Overall Study|Progressive Disease|3
2277646|NCT02327169|3960001|FG012|Overall Study|Progressive Disease|1
2277647|NCT02327169|3960002|FG013|Overall Study|Progressive Disease|3
2277648|NCT02327169|3960003|FG014|Overall Study|Progressive Disease|3
2277649|NCT02327169|3959989|FG000|Overall Study|Adverse Event|2
2277650|NCT02327169|3959990|FG001|Overall Study|Adverse Event|0
2277651|NCT02327169|3959991|FG002|Overall Study|Adverse Event|1
2277652|NCT02327169|3959992|FG003|Overall Study|Adverse Event|0
2277653|NCT02327169|3959993|FG004|Overall Study|Adverse Event|1
2277654|NCT02327169|3959994|FG005|Overall Study|Adverse Event|0
2277655|NCT02327169|3959995|FG006|Overall Study|Adverse Event|0
2277656|NCT02327169|3959996|FG007|Overall Study|Adverse Event|0
2277657|NCT02327169|3959997|FG008|Overall Study|Adverse Event|0
2277658|NCT02327169|3959998|FG009|Overall Study|Adverse Event|2
2277659|NCT02327169|3959999|FG010|Overall Study|Adverse Event|0
2277660|NCT02327169|3960000|FG011|Overall Study|Adverse Event|3
2277661|NCT02327169|3960001|FG012|Overall Study|Adverse Event|0
2277662|NCT02327169|3960002|FG013|Overall Study|Adverse Event|2
2277663|NCT02327169|3960003|FG014|Overall Study|Adverse Event|1
2277664|NCT02327169|3959989|FG000|Overall Study|Symptomatic Deterioration|0
2277665|NCT02327169|3959990|FG001|Overall Study|Symptomatic Deterioration|0
2277666|NCT02327169|3959991|FG002|Overall Study|Symptomatic Deterioration|1
2277667|NCT02327169|3959992|FG003|Overall Study|Symptomatic Deterioration|0
2277668|NCT02327169|3959993|FG004|Overall Study|Symptomatic Deterioration|1
2277669|NCT02327169|3959994|FG005|Overall Study|Symptomatic Deterioration|1
2277670|NCT02327169|3959995|FG006|Overall Study|Symptomatic Deterioration|0
2277671|NCT02327169|3959996|FG007|Overall Study|Symptomatic Deterioration|0
2277672|NCT02327169|3959997|FG008|Overall Study|Symptomatic Deterioration|2
2277673|NCT02327169|3959998|FG009|Overall Study|Symptomatic Deterioration|1
2277674|NCT02327169|3959999|FG010|Overall Study|Symptomatic Deterioration|0
2277675|NCT02327169|3960000|FG011|Overall Study|Symptomatic Deterioration|0
2277676|NCT02327169|3960001|FG012|Overall Study|Symptomatic Deterioration|0
2277677|NCT02327169|3960002|FG013|Overall Study|Symptomatic Deterioration|2
2277678|NCT02327169|3960003|FG014|Overall Study|Symptomatic Deterioration|1
2277679|NCT02327169|3959989|FG000|Overall Study|Reason Not Specified|0
2277680|NCT02327169|3959990|FG001|Overall Study|Reason Not Specified|0
2277681|NCT02327169|3959991|FG002|Overall Study|Reason Not Specified|1
2277682|NCT02327169|3959992|FG003|Overall Study|Reason Not Specified|0
2277683|NCT02327169|3959993|FG004|Overall Study|Reason Not Specified|0
2277684|NCT02327169|3959994|FG005|Overall Study|Reason Not Specified|0
2277685|NCT02327169|3959995|FG006|Overall Study|Reason Not Specified|0
2277686|NCT02327169|3959996|FG007|Overall Study|Reason Not Specified|0
2277687|NCT02327169|3959997|FG008|Overall Study|Reason Not Specified|0
2277688|NCT02327169|3959998|FG009|Overall Study|Reason Not Specified|1
2277689|NCT02327169|3959999|FG010|Overall Study|Reason Not Specified|2
2277690|NCT02327169|3960000|FG011|Overall Study|Reason Not Specified|1
2277691|NCT02327169|3960001|FG012|Overall Study|Reason Not Specified|0
2277692|NCT02327169|3960002|FG013|Overall Study|Reason Not Specified|0
2277693|NCT02327169|3960003|FG014|Overall Study|Reason Not Specified|2
2277694|NCT02327169|3959989|FG000|Overall Study|Withdrawal by Subject|1
2277695|NCT02327169|3959990|FG001|Overall Study|Withdrawal by Subject|0
2277696|NCT02327169|3959991|FG002|Overall Study|Withdrawal by Subject|0
2277697|NCT02327169|3959992|FG003|Overall Study|Withdrawal by Subject|0
2277698|NCT02327169|3959993|FG004|Overall Study|Withdrawal by Subject|1
2277699|NCT02327169|3959994|FG005|Overall Study|Withdrawal by Subject|0
2277700|NCT02327169|3959995|FG006|Overall Study|Withdrawal by Subject|0
2277701|NCT02327169|3959996|FG007|Overall Study|Withdrawal by Subject|1
2277702|NCT02327169|3959997|FG008|Overall Study|Withdrawal by Subject|0
2277703|NCT02327169|3959998|FG009|Overall Study|Withdrawal by Subject|0
2277704|NCT02327169|3959999|FG010|Overall Study|Withdrawal by Subject|0
2277705|NCT02327169|3960000|FG011|Overall Study|Withdrawal by Subject|0
2277706|NCT02327169|3960001|FG012|Overall Study|Withdrawal by Subject|0
2277707|NCT02327169|3960002|FG013|Overall Study|Withdrawal by Subject|0
2277708|NCT02327169|3960003|FG014|Overall Study|Withdrawal by Subject|3
2277709|NCT02327169|3959989|FG000|Overall Study|Lost to Follow-up|0
2277710|NCT02327169|3959990|FG001|Overall Study|Lost to Follow-up|0
2277711|NCT02327169|3959991|FG002|Overall Study|Lost to Follow-up|0
2277712|NCT02327169|3959992|FG003|Overall Study|Lost to Follow-up|0
2277713|NCT02327169|3959993|FG004|Overall Study|Lost to Follow-up|1
2277714|NCT02327169|3959994|FG005|Overall Study|Lost to Follow-up|0
2277715|NCT02327169|3959995|FG006|Overall Study|Lost to Follow-up|0
2277716|NCT02327169|3959996|FG007|Overall Study|Lost to Follow-up|0
2277717|NCT02327169|3959997|FG008|Overall Study|Lost to Follow-up|0
2277718|NCT02327169|3959998|FG009|Overall Study|Lost to Follow-up|0
2277719|NCT02327169|3959999|FG010|Overall Study|Lost to Follow-up|0
2277720|NCT02327169|3960000|FG011|Overall Study|Lost to Follow-up|0
2277721|NCT02327169|3960001|FG012|Overall Study|Lost to Follow-up|0
2277722|NCT02327169|3960002|FG013|Overall Study|Lost to Follow-up|0
2277723|NCT02327169|3960003|FG014|Overall Study|Lost to Follow-up|0
2277724|NCT02327260|3960048|FG000|Overall Study|Lost to Follow-up|2
2277725|NCT02327260|3960049|FG001|Overall Study|Lost to Follow-up|3
2277726|NCT02327260|3960050|FG002|Overall Study|Lost to Follow-up|2
2277727|NCT02327260|3960048|FG000|Overall Study|invalid phone number|1
2277728|NCT02327260|3960049|FG001|Overall Study|invalid phone number|1
2277729|NCT02327260|3960050|FG002|Overall Study|invalid phone number|0
2277730|NCT02327260|3960048|FG000|Overall Study|non-adherence to protocol|2
2277731|NCT02327260|3960049|FG001|Overall Study|non-adherence to protocol|0
2277732|NCT02327260|3960050|FG002|Overall Study|non-adherence to protocol|0
2277733|NCT02327260|3960048|FG000|Overall Study|cognitive concerns|1
2277734|NCT02327260|3960049|FG001|Overall Study|cognitive concerns|0
2277735|NCT02327260|3960050|FG002|Overall Study|cognitive concerns|0
2277736|NCT02327325|3960062|FG000|Overall Study|Withdrawal by Subject|1
2277737|NCT02327325|3960063|FG001|Overall Study|Withdrawal by Subject|4
2277738|NCT02327325|3960064|FG002|Overall Study|Withdrawal by Subject|4
2277739|NCT02327325|3960062|FG000|Overall Study|Excluded by Study Team|0
2277740|NCT02327325|3960063|FG001|Overall Study|Excluded by Study Team|0
2277741|NCT02327325|3960064|FG002|Overall Study|Excluded by Study Team|1
2277742|NCT02328027|3960095|FG000|Overall Study|Withdrawal by Subject|0
2277743|NCT02328027|3960096|FG001|Overall Study|Withdrawal by Subject|1
2277744|NCT02328040|3960103|FG000|First Intervention (2 Days)|Withdrawal by Subject|1
2277745|NCT02328040|3960104|FG001|First Intervention (2 Days)|Withdrawal by Subject|1
2277746|NCT02328105|3960110|FG000|Overall Study|Death|6
2277747|NCT02328105|3960110|FG000|Overall Study|Withdrawal by Subject|1
2277748|NCT02328105|3960110|FG000|Overall Study|Still On Study in Follow-Up|4
2277749|NCT02328326|3960116|FG000|Overall Study|Withdrawal by Subject|10
2277750|NCT02328326|3960117|FG001|Overall Study|Withdrawal by Subject|3
2277751|NCT02328326|3960116|FG000|Overall Study|Death|2
2277752|NCT02328326|3960117|FG001|Overall Study|Death|1
2277753|NCT02328326|3960116|FG000|Overall Study|Lost to Follow-up|10
2277754|NCT02328326|3960117|FG001|Overall Study|Lost to Follow-up|4
2277755|NCT02328547|3960140|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
2277756|NCT02328547|3960141|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0
2277757|NCT02328547|3960140|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2
2277758|NCT02328547|3960141|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
2277759|NCT02328937|3960174|FG000|Period 1|Lost to Follow-up|0
2277760|NCT02328937|3960175|FG001|Period 1|Lost to Follow-up|0
2277761|NCT02328937|3960176|FG002|Period 1|Lost to Follow-up|0
2277762|NCT02328937|3960177|FG003|Period 1|Lost to Follow-up|1
2277763|NCT02328937|3960178|FG004|Period 1|Lost to Follow-up|0
2277764|NCT02328937|3960179|FG005|Period 1|Lost to Follow-up|0
2277765|NCT02328937|3960174|FG000|Period 2|Adverse Event|0
2277766|NCT02328937|3960175|FG001|Period 2|Adverse Event|0
2277767|NCT02328937|3960176|FG002|Period 2|Adverse Event|1
2277768|NCT02328937|3960177|FG003|Period 2|Adverse Event|0
2277769|NCT02328937|3960178|FG004|Period 2|Adverse Event|0
2277770|NCT02328937|3960179|FG005|Period 2|Adverse Event|0
2277771|NCT02329223|3960199|FG000|Overall Study|Withdrawal by Subject|1
2277772|NCT02329223|3960200|FG001|Overall Study|Withdrawal by Subject|2
2277773|NCT02329223|3960201|FG002|Overall Study|Withdrawal by Subject|5
2277774|NCT02329223|3960199|FG000|Overall Study|Physician Decision|0
2277775|NCT02329223|3960200|FG001|Overall Study|Physician Decision|0
2277776|NCT02329223|3960201|FG002|Overall Study|Physician Decision|1
2277777|NCT02329223|3960199|FG000|Overall Study|Adverse Event|0
2277778|NCT02329223|3960200|FG001|Overall Study|Adverse Event|1
2277779|NCT02329223|3960201|FG002|Overall Study|Adverse Event|0
2277780|NCT02329431|3960211|FG000|Overall Study|Lost to Follow-up|20
2277781|NCT02329431|3960212|FG001|Overall Study|Lost to Follow-up|13
2277782|NCT02329730|3960244|FG000|Overall Study|Protocol Violation|0
2277783|NCT02329730|3960245|FG001|Overall Study|Protocol Violation|0
2277784|NCT02329730|3960246|FG002|Overall Study|Protocol Violation|0
2277785|NCT02329730|3960247|FG003|Overall Study|Protocol Violation|0
2277786|NCT02329730|3960248|FG004|Overall Study|Protocol Violation|2
2277787|NCT02329730|3960249|FG005|Overall Study|Protocol Violation|2
2277788|NCT02329730|3960250|FG006|Overall Study|Protocol Violation|0
2277789|NCT02329730|3960251|FG007|Overall Study|Protocol Violation|0
2277790|NCT02329730|3960252|FG008|Overall Study|Protocol Violation|0
2277791|NCT02329730|3960253|FG009|Overall Study|Protocol Violation|0
2277792|NCT02329730|3960254|FG010|Overall Study|Protocol Violation|0
2277793|NCT02329730|3960255|FG011|Overall Study|Protocol Violation|0
2277794|NCT02329730|3960244|FG000|Overall Study|Withdrawal by Subject|0
2277795|NCT02329730|3960245|FG001|Overall Study|Withdrawal by Subject|0
2277796|NCT02329730|3960246|FG002|Overall Study|Withdrawal by Subject|0
2277797|NCT02329730|3960247|FG003|Overall Study|Withdrawal by Subject|0
2277798|NCT02329730|3960248|FG004|Overall Study|Withdrawal by Subject|1
2277799|NCT02329730|3960249|FG005|Overall Study|Withdrawal by Subject|0
2277800|NCT02329730|3960250|FG006|Overall Study|Withdrawal by Subject|1
2277801|NCT02329730|3960251|FG007|Overall Study|Withdrawal by Subject|1
2277802|NCT02329730|3960252|FG008|Overall Study|Withdrawal by Subject|1
2277803|NCT02329730|3960253|FG009|Overall Study|Withdrawal by Subject|1
2277804|NCT02329730|3960254|FG010|Overall Study|Withdrawal by Subject|0
2277805|NCT02329730|3960255|FG011|Overall Study|Withdrawal by Subject|0
2277806|NCT02329743|3960276|FG000|Overall Study|Adverse Event|1
2277807|NCT02329743|3960277|FG001|Overall Study|Adverse Event|1
2277808|NCT02329743|3960278|FG002|Overall Study|Adverse Event|3
2277809|NCT02329743|3960276|FG000|Overall Study|Lost to Follow-up|1
2277810|NCT02329743|3960277|FG001|Overall Study|Lost to Follow-up|0
2277811|NCT02329743|3960278|FG002|Overall Study|Lost to Follow-up|1
2277812|NCT02329743|3960276|FG000|Overall Study|Withdrawal by Subject|4
2277813|NCT02329743|3960277|FG001|Overall Study|Withdrawal by Subject|4
2277814|NCT02329743|3960278|FG002|Overall Study|Withdrawal by Subject|1
2277815|NCT02329743|3960276|FG000|Overall Study|Other|0
2277816|NCT02329743|3960277|FG001|Overall Study|Other|2
2277817|NCT02329743|3960278|FG002|Overall Study|Other|3
2277818|NCT02330055|3960297|FG000|Overall Study|technical issues|2
2277819|NCT02330055|3960298|FG001|Overall Study|technical issues|0
2277820|NCT02330055|3960297|FG000|Overall Study|participant forgot to wear device|5
2277821|NCT02330055|3960298|FG001|Overall Study|participant forgot to wear device|5
2277822|NCT02330055|3960297|FG000|Overall Study|data for less than 60 minutes|3
2277823|NCT02330055|3960298|FG001|Overall Study|data for less than 60 minutes|3
2277824|NCT02330055|3960297|FG000|Overall Study|participant did not sleep|0
2277825|NCT02330055|3960298|FG001|Overall Study|participant did not sleep|1
2277826|NCT02330081|3960304|FG000|Overall Study|Adverse Event|1
2277827|NCT02330081|3960304|FG000|Overall Study|Donation did not meet criteria|1
2277828|NCT02330081|3960304|FG000|Overall Study|Protocol Violation|6
2277829|NCT02330549|3960362|FG000|Overall Study|Adverse Event|1
2277830|NCT02330549|3960363|FG001|Overall Study|Adverse Event|0
2277831|NCT02330549|3960362|FG000|Overall Study|Subject withdrew consent|2
2277832|NCT02330549|3960363|FG001|Overall Study|Subject withdrew consent|1
2277833|NCT02330549|3960362|FG000|Overall Study|Failure to meet randomization criteria|1
2277834|NCT02330549|3960363|FG001|Overall Study|Failure to meet randomization criteria|0
2277835|NCT02331368|3960451|FG000|Overall Study|Withdrawal by Subject|3
2277836|NCT02331394|3960455|FG000|Overall Study|Disease progression|1
2277837|NCT02331446|3960474|FG000|Overall Study|Lost to Follow-up|2
2277838|NCT02331446|3960475|FG001|Overall Study|Lost to Follow-up|1
2277839|NCT02331446|3960476|FG002|Overall Study|Lost to Follow-up|0
2277840|NCT02331446|3960477|FG003|Overall Study|Lost to Follow-up|1
2277841|NCT02331446|3960474|FG000|Overall Study|Personal Problem|2
2277842|NCT02331446|3960475|FG001|Overall Study|Personal Problem|0
2277843|NCT02331446|3960476|FG002|Overall Study|Personal Problem|0
2277844|NCT02331446|3960477|FG003|Overall Study|Personal Problem|0
2277845|NCT02331446|3960474|FG000|Overall Study|Disease|0
2277846|NCT02331446|3960475|FG001|Overall Study|Disease|2
2277847|NCT02331446|3960476|FG002|Overall Study|Disease|2
2277848|NCT02331446|3960477|FG003|Overall Study|Disease|1
2277849|NCT02331446|3960474|FG000|Overall Study|Physician Decision|0
2277850|NCT02331446|3960475|FG001|Overall Study|Physician Decision|1
2277851|NCT02331446|3960476|FG002|Overall Study|Physician Decision|0
2277852|NCT02331446|3960477|FG003|Overall Study|Physician Decision|1
2277853|NCT02331446|3960474|FG000|Overall Study|Lost before baseline analysis|0
2277854|NCT02331446|3960475|FG001|Overall Study|Lost before baseline analysis|1
2277855|NCT02331446|3960476|FG002|Overall Study|Lost before baseline analysis|1
2277856|NCT02331446|3960477|FG003|Overall Study|Lost before baseline analysis|0
2277857|NCT02331680|3960499|FG000|Overall Study|Adverse Event|3
2277858|NCT02331680|3960500|FG001|Overall Study|Adverse Event|0
2277859|NCT02331680|3960501|FG002|Overall Study|Adverse Event|2
2277860|NCT02331680|3960499|FG000|Overall Study|Physician Decision|1
2277861|NCT02331680|3960500|FG001|Overall Study|Physician Decision|1
2120182|NCT00960661|3718440|FG000|Interventional Phase|Death|0
2120183|NCT00960661|3718441|FG001|Interventional Phase|Death|1
2120184|NCT00960661|3718442|FG002|Interventional Phase|Death|0
2120185|NCT00960661|3718440|FG000|Interventional Phase|Lost to Follow-up|0
2120186|NCT00960661|3718441|FG001|Interventional Phase|Lost to Follow-up|0
2120187|NCT00960661|3718442|FG002|Interventional Phase|Lost to Follow-up|2
2120188|NCT00960661|3718440|FG000|Interventional Phase|entry criteria not met|0
2120189|NCT00960661|3718441|FG001|Interventional Phase|entry criteria not met|3
2120190|NCT00960661|3718442|FG002|Interventional Phase|entry criteria not met|0
2120191|NCT00960661|3718440|FG000|Interventional Phase|Protocol Violation|0
2120192|NCT00960661|3718441|FG001|Interventional Phase|Protocol Violation|7
2120193|NCT00960661|3718442|FG002|Interventional Phase|Protocol Violation|2
2120194|NCT00960661|3718440|FG000|Interventional Phase|Withdrawal by Subject|0
2120195|NCT00960661|3718441|FG001|Interventional Phase|Withdrawal by Subject|18
2120196|NCT00960661|3718442|FG002|Interventional Phase|Withdrawal by Subject|29
2120197|NCT00960661|3718440|FG000|Interventional Phase|Physician Decision|0
2120198|NCT00960661|3718441|FG001|Interventional Phase|Physician Decision|3
2120199|NCT00960661|3718442|FG002|Interventional Phase|Physician Decision|5
2120200|NCT00960661|3718440|FG000|Interventional Phase|sponsor decision|0
2120201|NCT00960661|3718441|FG001|Interventional Phase|sponsor decision|1
2120202|NCT00960661|3718442|FG002|Interventional Phase|sponsor decision|0
2277862|NCT02331680|3960501|FG002|Overall Study|Physician Decision|2
2120203|NCT00960661|3718440|FG000|Interventional Phase|Lack of Efficacy|0
2120204|NCT00960661|3718441|FG001|Interventional Phase|Lack of Efficacy|2
2120205|NCT00960661|3718442|FG002|Interventional Phase|Lack of Efficacy|0
2120206|NCT00960687|3718448|FG000|Washout Period of 7 Days|Adverse Event|3
2120207|NCT00960687|3718449|FG001|Washout Period of 7 Days|Adverse Event|2
2120208|NCT00960687|3718448|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
2120209|NCT00960687|3718449|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
2120210|NCT00960804|3718467|FG000|Overall Study|Adverse Event|1
2120211|NCT00960804|3718468|FG001|Overall Study|Adverse Event|0
2120212|NCT00960804|3718469|FG002|Overall Study|Adverse Event|0
2120213|NCT00960804|3718467|FG000|Overall Study|Withdrawal by Subject|1
2120214|NCT00960804|3718468|FG001|Overall Study|Withdrawal by Subject|0
2120215|NCT00960804|3718469|FG002|Overall Study|Withdrawal by Subject|0
2120216|NCT00960804|3718467|FG000|Overall Study|Study terminated by the sponsor|5
2120217|NCT00960804|3718468|FG001|Overall Study|Study terminated by the sponsor|4
2120218|NCT00960804|3718469|FG002|Overall Study|Study terminated by the sponsor|10
2120219|NCT00960843|3718479|FG000|Overall Study|Lost to Follow-up|2
2120220|NCT00960843|3718480|FG001|Overall Study|Lost to Follow-up|0
2120221|NCT00960843|3718479|FG000|Overall Study|Protocol Violation|0
2120222|NCT00960843|3718480|FG001|Overall Study|Protocol Violation|4
2120223|NCT00960843|3718479|FG000|Overall Study|Repeated needle dislodgment|0
2120224|NCT00960843|3718480|FG001|Overall Study|Repeated needle dislodgment|1
2120225|NCT00960856|3718486|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
2120226|NCT00960856|3718487|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
2120227|NCT00960856|3718488|FG002|Washout Period of 7 Days|Withdrawal by Subject|0
2120228|NCT00960856|3718489|FG003|Washout Period of 7 Days|Withdrawal by Subject|0
2120229|NCT00960856|3718486|FG000|Washout Period of 7 Days|Adverse Event|0
2120230|NCT00960856|3718487|FG001|Washout Period of 7 Days|Adverse Event|0
2120231|NCT00960856|3718488|FG002|Washout Period of 7 Days|Adverse Event|1
2120232|NCT00960856|3718489|FG003|Washout Period of 7 Days|Adverse Event|0
2120233|NCT00960869|3718501|FG000|Overall Study|Adverse Event|17
2120234|NCT00960869|3718502|FG001|Overall Study|Adverse Event|26
2120235|NCT00960869|3718501|FG000|Overall Study|Withdrawal by Subject|16
2120236|NCT00960869|3718502|FG001|Overall Study|Withdrawal by Subject|14
2120237|NCT00960869|3718501|FG000|Overall Study|Lost to Follow-up|1
2120238|NCT00960869|3718502|FG001|Overall Study|Lost to Follow-up|4
2120239|NCT00960869|3718501|FG000|Overall Study|Misc|19
2120240|NCT00960869|3718502|FG001|Overall Study|Misc|18
2120241|NCT00960934|3718514|FG000|Overall Study|Adverse Event|2
2120242|NCT00960934|3718515|FG001|Overall Study|Adverse Event|3
2120243|NCT00960934|3718516|FG002|Overall Study|Adverse Event|3
2120244|NCT00960934|3718517|FG003|Overall Study|Adverse Event|2
2120245|NCT00960934|3718518|FG004|Overall Study|Adverse Event|4
2120246|NCT00960934|3718519|FG005|Overall Study|Adverse Event|3
2120247|NCT00960934|3718514|FG000|Overall Study|Lack of Efficacy|1
2120248|NCT00960934|3718515|FG001|Overall Study|Lack of Efficacy|0
2120249|NCT00960934|3718516|FG002|Overall Study|Lack of Efficacy|0
2120250|NCT00960934|3718517|FG003|Overall Study|Lack of Efficacy|0
2120251|NCT00960934|3718518|FG004|Overall Study|Lack of Efficacy|0
2120252|NCT00960934|3718519|FG005|Overall Study|Lack of Efficacy|0
2120253|NCT00960934|3718514|FG000|Overall Study|Lost to Follow-up|0
2120254|NCT00960934|3718515|FG001|Overall Study|Lost to Follow-up|1
2120255|NCT00960934|3718516|FG002|Overall Study|Lost to Follow-up|0
2120256|NCT00960934|3718517|FG003|Overall Study|Lost to Follow-up|0
2120257|NCT00960934|3718518|FG004|Overall Study|Lost to Follow-up|0
2120258|NCT00960934|3718519|FG005|Overall Study|Lost to Follow-up|0
2120259|NCT00960934|3718514|FG000|Overall Study|Other|2
2120260|NCT00960934|3718515|FG001|Overall Study|Other|1
2120261|NCT00960934|3718516|FG002|Overall Study|Other|5
2120262|NCT00960934|3718517|FG003|Overall Study|Other|4
2120263|NCT00960934|3718518|FG004|Overall Study|Other|2
2120264|NCT00960934|3718519|FG005|Overall Study|Other|2
2120265|NCT00960934|3718514|FG000|Overall Study|Physician Decision|0
2120266|NCT00960934|3718515|FG001|Overall Study|Physician Decision|1
2120267|NCT00960934|3718516|FG002|Overall Study|Physician Decision|0
2120268|NCT00960934|3718517|FG003|Overall Study|Physician Decision|0
2120269|NCT00960934|3718518|FG004|Overall Study|Physician Decision|0
2120270|NCT00960934|3718519|FG005|Overall Study|Physician Decision|0
2120271|NCT00960934|3718514|FG000|Overall Study|Progressive Disease|1
2120272|NCT00960934|3718515|FG001|Overall Study|Progressive Disease|1
2120273|NCT00960934|3718516|FG002|Overall Study|Progressive Disease|0
2120274|NCT00960934|3718517|FG003|Overall Study|Progressive Disease|0
2120275|NCT00960934|3718518|FG004|Overall Study|Progressive Disease|1
2120276|NCT00960934|3718519|FG005|Overall Study|Progressive Disease|1
2120277|NCT00960934|3718514|FG000|Overall Study|Protocol Violation|3
2120278|NCT00960934|3718515|FG001|Overall Study|Protocol Violation|4
2120279|NCT00960934|3718516|FG002|Overall Study|Protocol Violation|0
2120280|NCT00960934|3718517|FG003|Overall Study|Protocol Violation|3
2120281|NCT00960934|3718518|FG004|Overall Study|Protocol Violation|3
2120282|NCT00960934|3718519|FG005|Overall Study|Protocol Violation|2
2120283|NCT00960934|3718514|FG000|Overall Study|Withdrawal by Subject|5
2120284|NCT00960934|3718515|FG001|Overall Study|Withdrawal by Subject|6
2120285|NCT00960934|3718516|FG002|Overall Study|Withdrawal by Subject|4
2120286|NCT00960934|3718517|FG003|Overall Study|Withdrawal by Subject|5
2120287|NCT00960934|3718518|FG004|Overall Study|Withdrawal by Subject|5
2120288|NCT00960934|3718519|FG005|Overall Study|Withdrawal by Subject|7
2120289|NCT00960934|3718514|FG000|Overall Study|Study Terminated by Sponsor|50
2120290|NCT00960934|3718515|FG001|Overall Study|Study Terminated by Sponsor|46
2120291|NCT00960934|3718516|FG002|Overall Study|Study Terminated by Sponsor|52
2120292|NCT00960934|3718517|FG003|Overall Study|Study Terminated by Sponsor|50
2120293|NCT00960934|3718518|FG004|Overall Study|Study Terminated by Sponsor|49
2120294|NCT00960934|3718519|FG005|Overall Study|Study Terminated by Sponsor|49
2120295|NCT00960986|3718537|FG000|Period 1 (Screening and Washout)|Adverse Event|1
2120296|NCT00960986|3718538|FG001|Period 1 (Screening and Washout)|Adverse Event|2
2120297|NCT00960986|3718539|FG002|Period 1 (Screening and Washout)|Adverse Event|1
2120298|NCT00960986|3718540|FG003|Period 1 (Screening and Washout)|Adverse Event|1
2120299|NCT00960986|3718537|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0
2120300|NCT00960986|3718538|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0
2120301|NCT00960986|3718539|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2
2120302|NCT00960986|3718540|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1
2120303|NCT00960986|3718537|FG000|Period 1 (Screening and Washout)|Protocol Violation|1
2120304|NCT00960986|3718538|FG001|Period 1 (Screening and Washout)|Protocol Violation|0
2120305|NCT00960986|3718539|FG002|Period 1 (Screening and Washout)|Protocol Violation|0
2120306|NCT00960986|3718540|FG003|Period 1 (Screening and Washout)|Protocol Violation|0
2120307|NCT00960986|3718537|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1
2120308|NCT00960986|3718538|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2
2120309|NCT00960986|3718539|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1
2120310|NCT00960986|3718540|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1
2120311|NCT00960986|3718537|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17
2120312|NCT00960986|3718538|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15
2120313|NCT00960986|3718539|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10
2120314|NCT00960986|3718540|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12
2120315|NCT00960986|3718537|FG000|Period 3 (7-week Therapy Period)|Death|0
2120316|NCT00960986|3718538|FG001|Period 3 (7-week Therapy Period)|Death|0
2120317|NCT00960986|3718539|FG002|Period 3 (7-week Therapy Period)|Death|1
2120318|NCT00960986|3718540|FG003|Period 3 (7-week Therapy Period)|Death|0
2120319|NCT00960986|3718537|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
2120320|NCT00960986|3718538|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
2120321|NCT00960986|3718539|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
2120322|NCT00960986|3718540|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
2120323|NCT00960986|3718537|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10
2120324|NCT00960986|3718538|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4
2120325|NCT00960986|3718539|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3
2120326|NCT00960986|3718540|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11
2120327|NCT00960986|3718537|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
2120328|NCT00960986|3718538|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
2120329|NCT00960986|3718539|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
2120330|NCT00960986|3718540|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
2120331|NCT00960986|3718537|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
2120332|NCT00960986|3718538|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
2120333|NCT00960986|3718539|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
2120334|NCT00960986|3718540|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
2120335|NCT00960999|3718552|FG000|Overall Study|Withdrawal by Subject|1
2120336|NCT00960999|3718553|FG001|Overall Study|Withdrawal by Subject|0
2120337|NCT00960999|3718552|FG000|Overall Study|Protocol Violation|5
2120338|NCT00960999|3718553|FG001|Overall Study|Protocol Violation|2
2120339|NCT00960999|3718552|FG000|Overall Study|RT dose constraints not met|2
2204928|NCT01607892|3842892|FG002|Overall Study|Need of treatment not allowed per protocol|0
2204929|NCT01607892|3842893|FG003|Overall Study|Need of treatment not allowed per protocol|1
2204930|NCT01607892|3842894|FG004|Overall Study|Need of treatment not allowed per protocol|0
2204931|NCT01607892|3842890|FG000|Overall Study|Death|4
2120340|NCT00960999|3718553|FG001|Overall Study|RT dose constraints not met|0
2120341|NCT00961116|3718572|FG000|Washout Period of 7 Days|Adverse Event|1
2120342|NCT00961116|3718573|FG001|Washout Period of 7 Days|Adverse Event|1
2120343|NCT00961116|3718572|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
2120344|NCT00961116|3718573|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
2120345|NCT00961116|3718572|FG000|Washout Period of 7 Days|Protocol Violation|0
2120346|NCT00961116|3718573|FG001|Washout Period of 7 Days|Protocol Violation|1
2120347|NCT00961181|3718580|FG000|Overall Study|Death|2
2120348|NCT00961181|3718580|FG000|Overall Study|Withdrawal by Subject|2
2120349|NCT00961181|3718580|FG000|Overall Study|Lost to Follow-up|1
2120350|NCT00961220|3718584|FG000|Overall Study|Adverse Event|3
2120351|NCT00961220|3718584|FG000|Overall Study|Lack of Efficacy|1
2120352|NCT00961220|3718584|FG000|Overall Study|No IV access for O6BG|1
2120353|NCT00961220|3718584|FG000|Overall Study|O6BG no longer supplied|1
2120354|NCT00961220|3718584|FG000|Overall Study|Complete Response prior to 12 courses|1
2120355|NCT00961259|3718601|FG000|Washout Period of 7 Days|due to concomitant medication used|0
2120356|NCT00961259|3718602|FG001|Washout Period of 7 Days|due to concomitant medication used|1
2120357|NCT00961259|3718603|FG002|Washout Period of 7 Days|due to concomitant medication used|0
2120358|NCT00961298|3718612|FG000|Two Week Placebo Run in|Withdrawal by Subject|1
2120359|NCT00961298|3718612|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
2120360|NCT00961298|3718612|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
2120361|NCT00961350|3718622|FG000|Overall Study|Adverse Event|18
2120362|NCT00961350|3718623|FG001|Overall Study|Adverse Event|33
2120363|NCT00961350|3718622|FG000|Overall Study|Withdrawal by Subject|10
2120364|NCT00961350|3718623|FG001|Overall Study|Withdrawal by Subject|10
2120365|NCT00961350|3718622|FG000|Overall Study|Lost to Follow-up|3
2120366|NCT00961350|3718623|FG001|Overall Study|Lost to Follow-up|3
2120367|NCT00961350|3718622|FG000|Overall Study|Misc|16
2120368|NCT00961350|3718623|FG001|Overall Study|Misc|21
2177668|NCT01376310|3802003|FG000|Overall Study|Withdrawal by Subject|8
2177669|NCT01376310|3802004|FG001|Overall Study|Withdrawal by Subject|2
2177670|NCT01376310|3802003|FG000|Overall Study|Physician Decision|26
2177671|NCT01376310|3802004|FG001|Overall Study|Physician Decision|7
2177672|NCT01376310|3802003|FG000|Overall Study|Lost to Follow-up|1
2177673|NCT01376310|3802004|FG001|Overall Study|Lost to Follow-up|0
2177674|NCT01376349|3802013|FG000|Raondomized Treatment|Withdrawal by Subject|10
2177675|NCT01376349|3802014|FG001|Raondomized Treatment|Withdrawal by Subject|16
2177676|NCT01376349|3802015|FG002|Raondomized Treatment|Withdrawal by Subject|13
2177677|NCT01376349|3802013|FG000|Raondomized Treatment|Adverse Event|13
2177678|NCT01376349|3802014|FG001|Raondomized Treatment|Adverse Event|17
2177679|NCT01376349|3802015|FG002|Raondomized Treatment|Adverse Event|14
2177680|NCT01376349|3802013|FG000|Raondomized Treatment|Unkown|1
2177681|NCT01376349|3802014|FG001|Raondomized Treatment|Unkown|2
2177682|NCT01376349|3802015|FG002|Raondomized Treatment|Unkown|1
2177683|NCT01376349|3802013|FG000|Raondomized Treatment|Alternative Treatment|0
2177684|NCT01376349|3802014|FG001|Raondomized Treatment|Alternative Treatment|0
2177685|NCT01376349|3802015|FG002|Raondomized Treatment|Alternative Treatment|1
2177686|NCT01376388|3802028|FG000|Overall Study|Adverse Event|13
2177687|NCT01376388|3802028|FG000|Overall Study|Lack of Efficacy|2
2177688|NCT01376388|3802028|FG000|Overall Study|Withdrawal by Subject|3
2177689|NCT01376700|3802053|FG000|Overall Study|Sponsor terminated study early|8
2177690|NCT01376700|3802053|FG000|Overall Study|Low or high titer inhibitor|8
2177691|NCT01376804|3802060|FG000|Treatment Period|Withdrawal by Subject|1
2177692|NCT01376804|3802060|FG000|Treatment Period|Adverse Event|6
2177693|NCT01376804|3802060|FG000|Treatment Period|Patient did not receive study drug|1
2204932|NCT01607892|3842891|FG001|Overall Study|Death|2
2204933|NCT01607892|3842892|FG002|Overall Study|Death|8
2177694|NCT01376908|3802066|FG000|Overall Study|Protocol Violation|1
2177695|NCT01376908|3802067|FG001|Overall Study|Protocol Violation|1
2177696|NCT01376908|3802066|FG000|Overall Study|Withdrawal by Subject|1
2177697|NCT01376908|3802067|FG001|Overall Study|Withdrawal by Subject|2
2177698|NCT01377012|3802083|FG000|Core Study|Study terminated by Sponsor|47
2177699|NCT01377012|3802084|FG001|Core Study|Study terminated by Sponsor|54
2177700|NCT01377012|3802085|FG002|Core Study|Study terminated by Sponsor|46
2177701|NCT01377012|3802083|FG000|Core Study|Technical problems|1
2177702|NCT01377012|3802084|FG001|Core Study|Technical problems|0
2177703|NCT01377012|3802085|FG002|Core Study|Technical problems|0
2177704|NCT01377012|3802083|FG000|Core Study|Withdrawal by Subject|15
2177705|NCT01377012|3802084|FG001|Core Study|Withdrawal by Subject|23
2177706|NCT01377012|3802085|FG002|Core Study|Withdrawal by Subject|18
2177707|NCT01377012|3802083|FG000|Core Study|Protocol Violation|7
2177708|NCT01377012|3802084|FG001|Core Study|Protocol Violation|3
2177709|NCT01377012|3802085|FG002|Core Study|Protocol Violation|2
2177710|NCT01377012|3802083|FG000|Core Study|Pregnancy|0
2177711|NCT01377012|3802084|FG001|Core Study|Pregnancy|0
2177712|NCT01377012|3802085|FG002|Core Study|Pregnancy|1
2177713|NCT01377012|3802083|FG000|Core Study|Physician Decision|5
2177714|NCT01377012|3802084|FG001|Core Study|Physician Decision|4
2177715|NCT01377012|3802085|FG002|Core Study|Physician Decision|10
2177716|NCT01377012|3802083|FG000|Core Study|Non-Compliant with study treatment|0
2177717|NCT01377012|3802084|FG001|Core Study|Non-Compliant with study treatment|0
2177718|NCT01377012|3802085|FG002|Core Study|Non-Compliant with study treatment|1
2177719|NCT01377012|3802083|FG000|Core Study|No Longer require treatment|0
2177720|NCT01377012|3802084|FG001|Core Study|No Longer require treatment|0
2177721|NCT01377012|3802085|FG002|Core Study|No Longer require treatment|1
2177722|NCT01377012|3802083|FG000|Core Study|Lost to Follow-up|7
2177723|NCT01377012|3802084|FG001|Core Study|Lost to Follow-up|5
2177724|NCT01377012|3802085|FG002|Core Study|Lost to Follow-up|4
2177725|NCT01377012|3802083|FG000|Core Study|Lack of Efficacy|41
2177726|NCT01377012|3802084|FG001|Core Study|Lack of Efficacy|28
2177727|NCT01377012|3802085|FG002|Core Study|Lack of Efficacy|37
2177728|NCT01377012|3802083|FG000|Core Study|Death|1
2177729|NCT01377012|3802084|FG001|Core Study|Death|1
2177730|NCT01377012|3802085|FG002|Core Study|Death|1
2177731|NCT01377012|3802083|FG000|Core Study|Adverse Event|10
2177732|NCT01377012|3802084|FG001|Core Study|Adverse Event|14
2177733|NCT01377012|3802085|FG002|Core Study|Adverse Event|13
2177734|NCT01377012|3802083|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3
2177735|NCT01377012|3802084|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0
2177736|NCT01377012|3802085|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0
2177737|NCT01377012|3802083|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52
2177738|NCT01377012|3802084|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69
2177739|NCT01377012|3802085|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63
2204934|NCT01607892|3842893|FG003|Overall Study|Death|10
2120369|NCT00961415|3718640|FG000|Induction Treatment Phase|Withdrawal by Subject|11
2120370|NCT00961415|3718641|FG001|Induction Treatment Phase|Withdrawal by Subject|0
2120371|NCT00961415|3718642|FG002|Induction Treatment Phase|Withdrawal by Subject|0
2120372|NCT00961415|3718640|FG000|Induction Treatment Phase|Death|77
2120373|NCT00961415|3718641|FG001|Induction Treatment Phase|Death|0
2120374|NCT00961415|3718642|FG002|Induction Treatment Phase|Death|0
2120375|NCT00961415|3718640|FG000|Induction Treatment Phase|Protocol Violation|1
2120376|NCT00961415|3718641|FG001|Induction Treatment Phase|Protocol Violation|0
2120377|NCT00961415|3718642|FG002|Induction Treatment Phase|Protocol Violation|0
2120378|NCT00961415|3718640|FG000|Induction Treatment Phase|Physician Decision|2
2120379|NCT00961415|3718641|FG001|Induction Treatment Phase|Physician Decision|0
2204935|NCT01607892|3842894|FG004|Overall Study|Death|3
2204936|NCT01607892|3842890|FG000|Overall Study|Investigator discretion|2
2120380|NCT00961415|3718642|FG002|Induction Treatment Phase|Physician Decision|0
2120381|NCT00961415|3718640|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27
2120382|NCT00961415|3718641|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
2120383|NCT00961415|3718642|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
2120384|NCT00961415|3718640|FG000|Induction Treatment Phase|Other Reason|5
2120385|NCT00961415|3718641|FG001|Induction Treatment Phase|Other Reason|0
2120386|NCT00961415|3718642|FG002|Induction Treatment Phase|Other Reason|0
2120387|NCT00961415|3718640|FG000|Maintenance Treatment Phase|Death|0
2120388|NCT00961415|3718641|FG001|Maintenance Treatment Phase|Death|42
2120389|NCT00961415|3718642|FG002|Maintenance Treatment Phase|Death|34
2120390|NCT00961415|3718640|FG000|Maintenance Treatment Phase|Investigators decision|0
2120391|NCT00961415|3718641|FG001|Maintenance Treatment Phase|Investigators decision|2
2120392|NCT00961415|3718642|FG002|Maintenance Treatment Phase|Investigators decision|0
2120393|NCT00961415|3718640|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
2120394|NCT00961415|3718641|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3
2120395|NCT00961415|3718642|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8
2120396|NCT00961415|3718640|FG000|Maintenance Treatment Phase|Other reason|0
2120397|NCT00961415|3718641|FG001|Maintenance Treatment Phase|Other reason|1
2120398|NCT00961415|3718642|FG002|Maintenance Treatment Phase|Other reason|3
2120399|NCT00961571|3718669|FG000|Overall Study|Physician Decision|39
2120400|NCT00961636|3718676|FG000|Overall Study|Adverse Event|35
2120401|NCT00961636|3718677|FG001|Overall Study|Adverse Event|54
2120402|NCT00961636|3718678|FG002|Overall Study|Adverse Event|13
2120403|NCT00961636|3718676|FG000|Overall Study|Flushing Symptoms|29
2120404|NCT00961636|3718677|FG001|Overall Study|Flushing Symptoms|46
2120405|NCT00961636|3718678|FG002|Overall Study|Flushing Symptoms|3
2120406|NCT00961636|3718676|FG000|Overall Study|Lost to Follow-up|2
2120407|NCT00961636|3718677|FG001|Overall Study|Lost to Follow-up|3
2120408|NCT00961636|3718678|FG002|Overall Study|Lost to Follow-up|1
2120409|NCT00961636|3718676|FG000|Overall Study|Physician Decision|3
2120410|NCT00961636|3718677|FG001|Overall Study|Physician Decision|1
2120411|NCT00961636|3718678|FG002|Overall Study|Physician Decision|1
2120412|NCT00961636|3718676|FG000|Overall Study|Protocol Violation|9
2120413|NCT00961636|3718677|FG001|Overall Study|Protocol Violation|5
2120414|NCT00961636|3718678|FG002|Overall Study|Protocol Violation|1
2120415|NCT00961636|3718676|FG000|Overall Study|Withdrawal by Subject|29
2120416|NCT00961636|3718677|FG001|Overall Study|Withdrawal by Subject|22
2120417|NCT00961636|3718678|FG002|Overall Study|Withdrawal by Subject|13
2120418|NCT00961649|3718690|FG000|Overall Study|Adverse Event|4
2120419|NCT00961649|3718691|FG001|Overall Study|Adverse Event|0
2120420|NCT00961649|3718692|FG002|Overall Study|Adverse Event|0
2120421|NCT00961649|3718693|FG003|Overall Study|Adverse Event|2
2120422|NCT00961649|3718690|FG000|Overall Study|Inadequate control of IOP|0
2120423|NCT00961649|3718691|FG001|Overall Study|Inadequate control of IOP|0
2120424|NCT00961649|3718692|FG002|Overall Study|Inadequate control of IOP|0
2120425|NCT00961649|3718693|FG003|Overall Study|Inadequate control of IOP|1
2120426|NCT00961649|3718690|FG000|Overall Study|Patient has travel plans during holidays|0
2120427|NCT00961649|3718691|FG001|Overall Study|Patient has travel plans during holidays|0
2120428|NCT00961649|3718692|FG002|Overall Study|Patient has travel plans during holidays|1
2120429|NCT00961649|3718693|FG003|Overall Study|Patient has travel plans during holidays|0
2120430|NCT00961649|3718690|FG000|Overall Study|Patient left to Mexico-family emergency|1
2120431|NCT00961649|3718691|FG001|Overall Study|Patient left to Mexico-family emergency|0
2120432|NCT00961649|3718692|FG002|Overall Study|Patient left to Mexico-family emergency|0
2120433|NCT00961649|3718693|FG003|Overall Study|Patient left to Mexico-family emergency|0
2120434|NCT00961649|3718690|FG000|Overall Study|Study terminated by sponsor|4
2120435|NCT00961649|3718691|FG001|Overall Study|Study terminated by sponsor|4
2120436|NCT00961649|3718692|FG002|Overall Study|Study terminated by sponsor|4
2120437|NCT00961649|3718693|FG003|Overall Study|Study terminated by sponsor|1
2120438|NCT00961896|3718719|FG000|Overall Study|Abnormal laboratory value|0
2120439|NCT00961896|3718720|FG001|Overall Study|Abnormal laboratory value|0
2120440|NCT00961896|3718721|FG002|Overall Study|Abnormal laboratory value|1
2120441|NCT00961961|3718736|FG000|Phase I|Withdrawal by Subject|7
2120442|NCT00961961|3718737|FG001|Phase I|Withdrawal by Subject|0
2120443|NCT00961961|3718738|FG002|Phase I|Withdrawal by Subject|0
2120444|NCT00961961|3718739|FG003|Phase I|Withdrawal by Subject|0
2120445|NCT00961961|3718736|FG000|Phase I|Lost to Follow-up|10
2120446|NCT00961961|3718737|FG001|Phase I|Lost to Follow-up|0
2120447|NCT00961961|3718738|FG002|Phase I|Lost to Follow-up|0
2120448|NCT00961961|3718739|FG003|Phase I|Lost to Follow-up|0
2120449|NCT00961961|3718736|FG000|Phase I|Lack of Efficacy|94
2120450|NCT00961961|3718737|FG001|Phase I|Lack of Efficacy|0
2120451|NCT00961961|3718738|FG002|Phase I|Lack of Efficacy|0
2120452|NCT00961961|3718739|FG003|Phase I|Lack of Efficacy|0
2120453|NCT00961961|3718736|FG000|Phase I|Adverse Event|7
2120454|NCT00961961|3718737|FG001|Phase I|Adverse Event|0
2120455|NCT00961961|3718738|FG002|Phase I|Adverse Event|0
2120456|NCT00961961|3718739|FG003|Phase I|Adverse Event|0
2120457|NCT00961961|3718736|FG000|Phase I|Physician Decision|8
2120458|NCT00961961|3718737|FG001|Phase I|Physician Decision|0
2120459|NCT00961961|3718738|FG002|Phase I|Physician Decision|0
2120460|NCT00961961|3718739|FG003|Phase I|Physician Decision|0
2120461|NCT00961961|3718736|FG000|Phase II|Lost to Follow-up|0
2120462|NCT00961961|3718737|FG001|Phase II|Lost to Follow-up|0
2120463|NCT00961961|3718738|FG002|Phase II|Lost to Follow-up|10
2120464|NCT00961961|3718739|FG003|Phase II|Lost to Follow-up|7
2120465|NCT00961961|3718736|FG000|Phase II|Adverse Event|0
2120466|NCT00961961|3718737|FG001|Phase II|Adverse Event|0
2120467|NCT00961961|3718738|FG002|Phase II|Adverse Event|0
2120468|NCT00961961|3718739|FG003|Phase II|Adverse Event|1
2120469|NCT00961961|3718736|FG000|Phase II|Physician Decision|0
2120470|NCT00961961|3718737|FG001|Phase II|Physician Decision|0
2120471|NCT00961961|3718738|FG002|Phase II|Physician Decision|1
2120472|NCT00961961|3718739|FG003|Phase II|Physician Decision|0
2120473|NCT00961961|3718736|FG000|Phase II|Withdrawal by Subject|0
2120474|NCT00961961|3718737|FG001|Phase II|Withdrawal by Subject|0
2120475|NCT00961961|3718738|FG002|Phase II|Withdrawal by Subject|1
2120476|NCT00961961|3718739|FG003|Phase II|Withdrawal by Subject|0
2120477|NCT00962013|3718766|FG000|Overall Study|Did not have surgery|1
2120478|NCT00962013|3718766|FG000|Overall Study|Death|8
2120479|NCT00962013|3718766|FG000|Overall Study|Lost to Follow-up|12
2120480|NCT00962013|3718766|FG000|Overall Study|Unable/Unwilling to return|6
2120481|NCT00962013|3718766|FG000|Overall Study|Withdrawal by Subject|8
2120482|NCT00962013|3718766|FG000|Overall Study|Removal of study device|3
2120483|NCT00962013|3718766|FG000|Overall Study|Site Termination|24
2120484|NCT00962013|3718766|FG000|Overall Study|No 5 year evaluation|6
2120485|NCT00962091|3718808|FG000|Overall Study|Withdrawal by Subject|1
2120486|NCT00962091|3718809|FG001|Overall Study|Withdrawal by Subject|2
2120487|NCT00962091|3718810|FG002|Overall Study|Withdrawal by Subject|1
2120488|NCT00962091|3718811|FG003|Overall Study|Withdrawal by Subject|1
2120489|NCT00962091|3718812|FG004|Overall Study|Withdrawal by Subject|0
2120490|NCT00962091|3718813|FG005|Overall Study|Withdrawal by Subject|1
2120491|NCT00962091|3718814|FG006|Overall Study|Withdrawal by Subject|0
2120492|NCT00962091|3718808|FG000|Overall Study|Adverse Event|0
2120493|NCT00962091|3718809|FG001|Overall Study|Adverse Event|0
2120494|NCT00962091|3718810|FG002|Overall Study|Adverse Event|0
2120495|NCT00962091|3718811|FG003|Overall Study|Adverse Event|0
2120496|NCT00962091|3718812|FG004|Overall Study|Adverse Event|0
2120497|NCT00962091|3718813|FG005|Overall Study|Adverse Event|0
2120498|NCT00962091|3718814|FG006|Overall Study|Adverse Event|1
2120499|NCT00962104|3718840|FG000|Overall Study|Adverse Event|10
2120500|NCT00962104|3718841|FG001|Overall Study|Adverse Event|3
2120501|NCT00962104|3718840|FG000|Overall Study|Entry Criteria Not Met|1
2120502|NCT00962104|3718841|FG001|Overall Study|Entry Criteria Not Met|2
2120503|NCT00962104|3718840|FG000|Overall Study|Lack of Efficacy|0
2120504|NCT00962104|3718841|FG001|Overall Study|Lack of Efficacy|1
2120505|NCT00962104|3718840|FG000|Overall Study|Lost to Follow-up|10
2120506|NCT00962104|3718841|FG001|Overall Study|Lost to Follow-up|4
2120507|NCT00962104|3718840|FG000|Overall Study|Physician Decision|1
2120508|NCT00962104|3718841|FG001|Overall Study|Physician Decision|0
2120509|NCT00962104|3718840|FG000|Overall Study|Protocol Violation|6
2120510|NCT00962104|3718841|FG001|Overall Study|Protocol Violation|8
2120511|NCT00962104|3718840|FG000|Overall Study|Sponsor Decision|0
2120512|NCT00962104|3718841|FG001|Overall Study|Sponsor Decision|1
2120513|NCT00962104|3718840|FG000|Overall Study|Withdrawal by Subject|10
2120514|NCT00962104|3718841|FG001|Overall Study|Withdrawal by Subject|6
2120515|NCT00962104|3718840|FG000|Overall Study|Other|2
2120516|NCT00962104|3718841|FG001|Overall Study|Other|0
2120517|NCT00962208|3718849|FG000|Overall Study|Could not achieve good vision|9
2120518|NCT00962208|3718850|FG001|Overall Study|Could not achieve good vision|0
2120519|NCT00962208|3718849|FG000|Overall Study|Contraindicated to continue study|5
2120520|NCT00962208|3718850|FG001|Overall Study|Contraindicated to continue study|1
2120521|NCT00962208|3718849|FG000|Overall Study|Lost to Follow-up|0
2120522|NCT00962208|3718850|FG001|Overall Study|Lost to Follow-up|9
2120523|NCT00962247|3718856|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4
2120524|NCT00962247|3718856|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
2120525|NCT00962390|3718866|FG000|Overall Study|Adverse Event|0
2120526|NCT00962390|3718867|FG001|Overall Study|Adverse Event|0
2120527|NCT00962390|3718868|FG002|Overall Study|Adverse Event|3
2120528|NCT00962390|3718869|FG003|Overall Study|Adverse Event|1
2120529|NCT00962390|3718866|FG000|Overall Study|Lost to Follow-up|2
2120530|NCT00962390|3718867|FG001|Overall Study|Lost to Follow-up|2
2120531|NCT00962390|3718868|FG002|Overall Study|Lost to Follow-up|0
2120532|NCT00962390|3718869|FG003|Overall Study|Lost to Follow-up|0
2120533|NCT00962390|3718866|FG000|Overall Study|Protocol Violation|1
2120534|NCT00962390|3718867|FG001|Overall Study|Protocol Violation|0
2120535|NCT00962390|3718868|FG002|Overall Study|Protocol Violation|0
2120536|NCT00962390|3718869|FG003|Overall Study|Protocol Violation|0
2120537|NCT00962390|3718866|FG000|Overall Study|Withdrawal by Subject|1
2120538|NCT00962390|3718867|FG001|Overall Study|Withdrawal by Subject|1
2120539|NCT00962390|3718868|FG002|Overall Study|Withdrawal by Subject|1
2120540|NCT00962390|3718869|FG003|Overall Study|Withdrawal by Subject|0
2120541|NCT00962585|3718883|FG000|Overall Study|Adverse Event|0
2120542|NCT00962585|3718884|FG001|Overall Study|Adverse Event|2
2120543|NCT00962585|3718885|FG002|Overall Study|Adverse Event|1
2120544|NCT00962585|3718886|FG003|Overall Study|Adverse Event|0
2120545|NCT00962585|3718883|FG000|Overall Study|Lost to Follow-up|3
2120546|NCT00962585|3718884|FG001|Overall Study|Lost to Follow-up|0
2120547|NCT00962585|3718885|FG002|Overall Study|Lost to Follow-up|1
2120548|NCT00962585|3718886|FG003|Overall Study|Lost to Follow-up|0
2120549|NCT00962585|3718883|FG000|Overall Study|Protocol Violation|0
2120550|NCT00962585|3718884|FG001|Overall Study|Protocol Violation|0
2120551|NCT00962585|3718885|FG002|Overall Study|Protocol Violation|1
2120552|NCT00962585|3718886|FG003|Overall Study|Protocol Violation|0
2120553|NCT00962585|3718883|FG000|Overall Study|Withdrawal by Subject|1
2120554|NCT00962585|3718884|FG001|Overall Study|Withdrawal by Subject|0
2120555|NCT00962585|3718885|FG002|Overall Study|Withdrawal by Subject|0
2120556|NCT00962585|3718886|FG003|Overall Study|Withdrawal by Subject|0
2120557|NCT00962585|3718883|FG000|Overall Study|Withdrew Consent|2
2120558|NCT00962585|3718884|FG001|Overall Study|Withdrew Consent|0
2120559|NCT00962585|3718885|FG002|Overall Study|Withdrew Consent|0
2120560|NCT00962585|3718886|FG003|Overall Study|Withdrew Consent|0
2120561|NCT00962650|3718907|FG000|Overall Study|Transgastric DP was not completed|2
2120562|NCT00962741|3718911|FG000|Overall Study|Failed to return|3
2120563|NCT00962741|3718911|FG000|Overall Study|Lost to Follow-up|2
2120564|NCT00962741|3718911|FG000|Overall Study|Withdrawal by Subject|1
2120565|NCT00962741|3718911|FG000|Overall Study|Lack of Efficacy|1
2120566|NCT00962741|3718911|FG000|Overall Study|drug ineffective+prohibited drug taken|1
2120567|NCT00962780|3718930|FG000|Overall Study|Death|0
2120568|NCT00962780|3718931|FG001|Overall Study|Death|1
2120569|NCT00962780|3718930|FG000|Overall Study|Protocol Violation|9
2120570|NCT00962780|3718931|FG001|Overall Study|Protocol Violation|4
2120571|NCT00962780|3718930|FG000|Overall Study|Withdrawal by Subject|1
2120572|NCT00962780|3718931|FG001|Overall Study|Withdrawal by Subject|8
2120573|NCT00962780|3718930|FG000|Overall Study|Other|0
2120574|NCT00962780|3718931|FG001|Overall Study|Other|1
2120575|NCT00963235|3719003|FG000|Overall Study|Withdrawal by Subject|22
2120576|NCT00963235|3719003|FG000|Overall Study|Lost to Follow-up|14
2120577|NCT00963235|3719003|FG000|Overall Study|Failed to return|9
2120578|NCT00963235|3719003|FG000|Overall Study|Protocol Violation|7
2120579|NCT00963235|3719003|FG000|Overall Study|Adverse Event|5
2120580|NCT00963235|3719003|FG000|Overall Study|Physician Decision|2
2120581|NCT00963235|3719003|FG000|Overall Study|Other|1
2120582|NCT00963547|3719041|FG000|Overall Study|Adverse Event|0
2120583|NCT00963547|3719042|FG001|Overall Study|Adverse Event|1
2120584|NCT00963547|3719043|FG002|Overall Study|Adverse Event|0
2120585|NCT00963547|3719044|FG003|Overall Study|Adverse Event|1
2120586|NCT00963547|3719045|FG004|Overall Study|Adverse Event|0
2120587|NCT00963547|3719046|FG005|Overall Study|Adverse Event|0
2120588|NCT00963547|3719047|FG006|Overall Study|Adverse Event|0
2120589|NCT00963547|3719041|FG000|Overall Study|Physician Decision|1
2120590|NCT00963547|3719042|FG001|Overall Study|Physician Decision|1
2120591|NCT00963547|3719043|FG002|Overall Study|Physician Decision|0
2120592|NCT00963547|3719044|FG003|Overall Study|Physician Decision|0
2120593|NCT00963547|3719045|FG004|Overall Study|Physician Decision|0
2120594|NCT00963547|3719046|FG005|Overall Study|Physician Decision|0
2120595|NCT00963547|3719047|FG006|Overall Study|Physician Decision|0
2120596|NCT00963547|3719041|FG000|Overall Study|Progressive Disease|3
2120597|NCT00963547|3719042|FG001|Overall Study|Progressive Disease|8
2120598|NCT00963547|3719043|FG002|Overall Study|Progressive Disease|9
2120599|NCT00963547|3719044|FG003|Overall Study|Progressive Disease|5
2120600|NCT00963547|3719045|FG004|Overall Study|Progressive Disease|0
2120601|NCT00963547|3719046|FG005|Overall Study|Progressive Disease|0
2120602|NCT00963547|3719047|FG006|Overall Study|Progressive Disease|0
2120603|NCT00963547|3719041|FG000|Overall Study|Withdrawal by Subject|0
2120604|NCT00963547|3719042|FG001|Overall Study|Withdrawal by Subject|0
2120605|NCT00963547|3719043|FG002|Overall Study|Withdrawal by Subject|3
2120606|NCT00963547|3719044|FG003|Overall Study|Withdrawal by Subject|0
2120607|NCT00963547|3719045|FG004|Overall Study|Withdrawal by Subject|0
2120608|NCT00963547|3719046|FG005|Overall Study|Withdrawal by Subject|0
2120609|NCT00963547|3719047|FG006|Overall Study|Withdrawal by Subject|0
2120610|NCT00963547|3719041|FG000|Overall Study|Reason Unknown|0
2120611|NCT00963547|3719042|FG001|Overall Study|Reason Unknown|1
2120612|NCT00963547|3719043|FG002|Overall Study|Reason Unknown|0
2120613|NCT00963547|3719044|FG003|Overall Study|Reason Unknown|0
2120614|NCT00963547|3719045|FG004|Overall Study|Reason Unknown|0
2120615|NCT00963547|3719046|FG005|Overall Study|Reason Unknown|0
2120616|NCT00963547|3719047|FG006|Overall Study|Reason Unknown|0
2120617|NCT00963807|3719091|FG000|Overall Study|Physician Decision|2
2120618|NCT00963807|3719091|FG000|Overall Study|Reaction to study chemotherapy regimen|1
2120619|NCT00963807|3719091|FG000|Overall Study|Disease progression|15
2120620|NCT00963820|3719097|FG000|Dose Escalation Phase|Progressive Disease|3
2120621|NCT00963820|3719098|FG001|Dose Escalation Phase|Progressive Disease|3
2120622|NCT00963820|3719099|FG002|Dose Escalation Phase|Progressive Disease|3
2120623|NCT00963820|3719100|FG003|Dose Escalation Phase|Progressive Disease|3
2120624|NCT00963820|3719101|FG004|Dose Escalation Phase|Progressive Disease|4
2120625|NCT00963820|3719102|FG005|Dose Escalation Phase|Progressive Disease|3
2120626|NCT00963820|3719103|FG006|Dose Escalation Phase|Progressive Disease|3
2120627|NCT00963820|3719104|FG007|Dose Escalation Phase|Progressive Disease|2
2120628|NCT00963820|3719105|FG008|Dose Escalation Phase|Progressive Disease|0
2120629|NCT00963820|3719106|FG009|Dose Escalation Phase|Progressive Disease|0
2120630|NCT00963820|3719107|FG010|Dose Escalation Phase|Progressive Disease|0
2120631|NCT00963820|3719108|FG011|Dose Escalation Phase|Progressive Disease|0
2120632|NCT00963820|3719097|FG000|Dose Escalation Phase|Adverse Event|0
2120633|NCT00963820|3719098|FG001|Dose Escalation Phase|Adverse Event|0
2120634|NCT00963820|3719099|FG002|Dose Escalation Phase|Adverse Event|0
2120635|NCT00963820|3719100|FG003|Dose Escalation Phase|Adverse Event|0
2120636|NCT00963820|3719101|FG004|Dose Escalation Phase|Adverse Event|0
2120637|NCT00963820|3719102|FG005|Dose Escalation Phase|Adverse Event|0
2120638|NCT00963820|3719103|FG006|Dose Escalation Phase|Adverse Event|3
2120639|NCT00963820|3719104|FG007|Dose Escalation Phase|Adverse Event|1
2120640|NCT00963820|3719105|FG008|Dose Escalation Phase|Adverse Event|0
2120641|NCT00963820|3719106|FG009|Dose Escalation Phase|Adverse Event|0
2120642|NCT00963820|3719107|FG010|Dose Escalation Phase|Adverse Event|0
2120643|NCT00963820|3719108|FG011|Dose Escalation Phase|Adverse Event|0
2120644|NCT00963820|3719097|FG000|Dose Escalation Phase|Withdrawal by Subject|0
2120645|NCT00963820|3719098|FG001|Dose Escalation Phase|Withdrawal by Subject|0
2120646|NCT00963820|3719099|FG002|Dose Escalation Phase|Withdrawal by Subject|0
2120647|NCT00963820|3719100|FG003|Dose Escalation Phase|Withdrawal by Subject|0
2120648|NCT00963820|3719101|FG004|Dose Escalation Phase|Withdrawal by Subject|0
2120649|NCT00963820|3719102|FG005|Dose Escalation Phase|Withdrawal by Subject|0
2120650|NCT00963820|3719103|FG006|Dose Escalation Phase|Withdrawal by Subject|1
2120651|NCT00963820|3719104|FG007|Dose Escalation Phase|Withdrawal by Subject|2
2120652|NCT00963820|3719105|FG008|Dose Escalation Phase|Withdrawal by Subject|0
2120653|NCT00963820|3719106|FG009|Dose Escalation Phase|Withdrawal by Subject|0
2120654|NCT00963820|3719107|FG010|Dose Escalation Phase|Withdrawal by Subject|0
2120655|NCT00963820|3719108|FG011|Dose Escalation Phase|Withdrawal by Subject|0
2120656|NCT00963820|3719097|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2120657|NCT00963820|3719098|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2120658|NCT00963820|3719099|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2120659|NCT00963820|3719100|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2120660|NCT00963820|3719101|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2120661|NCT00963820|3719102|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2120662|NCT00963820|3719103|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
2120663|NCT00963820|3719104|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2120664|NCT00963820|3719105|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2120665|NCT00963820|3719106|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2120666|NCT00963820|3719107|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2120667|NCT00963820|3719108|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2120668|NCT00963820|3719097|FG000|Expansion Phase|Progressive Disease|0
2120669|NCT00963820|3719098|FG001|Expansion Phase|Progressive Disease|0
2120670|NCT00963820|3719099|FG002|Expansion Phase|Progressive Disease|0
2120671|NCT00963820|3719100|FG003|Expansion Phase|Progressive Disease|0
2120672|NCT00963820|3719101|FG004|Expansion Phase|Progressive Disease|0
2120673|NCT00963820|3719102|FG005|Expansion Phase|Progressive Disease|0
2120674|NCT00963820|3719103|FG006|Expansion Phase|Progressive Disease|0
2120675|NCT00963820|3719104|FG007|Expansion Phase|Progressive Disease|0
2120676|NCT00963820|3719105|FG008|Expansion Phase|Progressive Disease|8
2120677|NCT00963820|3719106|FG009|Expansion Phase|Progressive Disease|6
2120678|NCT00963820|3719107|FG010|Expansion Phase|Progressive Disease|4
2120679|NCT00963820|3719108|FG011|Expansion Phase|Progressive Disease|2
2120680|NCT00963820|3719097|FG000|Expansion Phase|Adverse Event|0
2120681|NCT00963820|3719098|FG001|Expansion Phase|Adverse Event|0
2120682|NCT00963820|3719099|FG002|Expansion Phase|Adverse Event|0
2120683|NCT00963820|3719100|FG003|Expansion Phase|Adverse Event|0
2120684|NCT00963820|3719101|FG004|Expansion Phase|Adverse Event|0
2120685|NCT00963820|3719102|FG005|Expansion Phase|Adverse Event|0
2120686|NCT00963820|3719103|FG006|Expansion Phase|Adverse Event|0
2120687|NCT00963820|3719104|FG007|Expansion Phase|Adverse Event|0
2120688|NCT00963820|3719105|FG008|Expansion Phase|Adverse Event|1
2120689|NCT00963820|3719106|FG009|Expansion Phase|Adverse Event|3
2120690|NCT00963820|3719107|FG010|Expansion Phase|Adverse Event|0
2120691|NCT00963820|3719108|FG011|Expansion Phase|Adverse Event|0
2120692|NCT00963820|3719097|FG000|Expansion Phase|Withdrawal by Subject|0
2120693|NCT00963820|3719098|FG001|Expansion Phase|Withdrawal by Subject|0
2120694|NCT00963820|3719099|FG002|Expansion Phase|Withdrawal by Subject|0
2120695|NCT00963820|3719100|FG003|Expansion Phase|Withdrawal by Subject|0
2120696|NCT00963820|3719101|FG004|Expansion Phase|Withdrawal by Subject|0
2120697|NCT00963820|3719102|FG005|Expansion Phase|Withdrawal by Subject|0
2120698|NCT00963820|3719103|FG006|Expansion Phase|Withdrawal by Subject|0
2120699|NCT00963820|3719104|FG007|Expansion Phase|Withdrawal by Subject|0
2120700|NCT00963820|3719105|FG008|Expansion Phase|Withdrawal by Subject|1
2120701|NCT00963820|3719106|FG009|Expansion Phase|Withdrawal by Subject|0
2120702|NCT00963820|3719107|FG010|Expansion Phase|Withdrawal by Subject|1
2120703|NCT00963820|3719108|FG011|Expansion Phase|Withdrawal by Subject|1
2120704|NCT00963820|3719097|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0
2120705|NCT00963820|3719098|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0
2120706|NCT00963820|3719099|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0
2120707|NCT00963820|3719100|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0
2120708|NCT00963820|3719101|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0
2120709|NCT00963820|3719102|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0
2277863|NCT02331680|3960499|FG000|Overall Study|Withdrawal by Subject|0
2277864|NCT02331680|3960500|FG001|Overall Study|Withdrawal by Subject|1
2277865|NCT02331680|3960501|FG002|Overall Study|Withdrawal by Subject|2
2277866|NCT02331680|3960499|FG000|Overall Study|Met withdrawal criteria|2
2277867|NCT02331680|3960500|FG001|Overall Study|Met withdrawal criteria|2
2277868|NCT02331680|3960501|FG002|Overall Study|Met withdrawal criteria|5
2277869|NCT02331680|3960499|FG000|Overall Study|Non-compliance with study drug|0
2277870|NCT02331680|3960500|FG001|Overall Study|Non-compliance with study drug|0
2277871|NCT02331680|3960501|FG002|Overall Study|Non-compliance with study drug|1
2277872|NCT02331680|3960499|FG000|Overall Study|Protocol Violation|0
2277873|NCT02331680|3960500|FG001|Overall Study|Protocol Violation|0
2277874|NCT02331680|3960501|FG002|Overall Study|Protocol Violation|3
2120710|NCT00963820|3719103|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0
2120711|NCT00963820|3719104|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0
2120712|NCT00963820|3719105|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0
2120713|NCT00963820|3719106|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0
2120714|NCT00963820|3719107|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0
2120715|NCT00963820|3719108|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1
2120716|NCT00963924|3719144|FG000|Overall Study|Adverse Event|1
2120717|NCT00963924|3719145|FG001|Overall Study|Adverse Event|0
2120718|NCT00963924|3719144|FG000|Overall Study|Withdrawal by Subject|0
2120719|NCT00963924|3719145|FG001|Overall Study|Withdrawal by Subject|1
2120720|NCT00963924|3719144|FG000|Overall Study|Changed antipsychotic|0
2120721|NCT00963924|3719145|FG001|Overall Study|Changed antipsychotic|1
2120722|NCT00963924|3719144|FG000|Overall Study|Lost to Follow-up|0
2120723|NCT00963924|3719145|FG001|Overall Study|Lost to Follow-up|1
2120724|NCT00963937|3719156|FG000|Overall Study|Protocol Violation|1
2120725|NCT00963937|3719157|FG001|Overall Study|Protocol Violation|1
2120726|NCT00963937|3719158|FG002|Overall Study|Protocol Violation|0
2120727|NCT00963937|3719156|FG000|Overall Study|Physician Decision|18
2120728|NCT00963937|3719157|FG001|Overall Study|Physician Decision|10
2120729|NCT00963937|3719158|FG002|Overall Study|Physician Decision|4
2120730|NCT00964028|3719175|FG000|Overall Study|Withdrawal by Subject|0
2120731|NCT00964028|3719176|FG001|Overall Study|Withdrawal by Subject|1
2120732|NCT00964158|3719189|FG000|Overall Study|Lost to Follow-up|0
2120733|NCT00964158|3719190|FG001|Overall Study|Lost to Follow-up|1
2120734|NCT00964158|3719191|FG002|Overall Study|Lost to Follow-up|2
2120735|NCT00964158|3719189|FG000|Overall Study|Withdrawal by Subject|0
2120736|NCT00964158|3719190|FG001|Overall Study|Withdrawal by Subject|0
2120737|NCT00964158|3719191|FG002|Overall Study|Withdrawal by Subject|6
2120738|NCT00964223|3719202|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
2120739|NCT00964366|3719218|FG000|Overall Study|Did not qualify at Day 1|1
2120740|NCT00964366|3719219|FG001|Overall Study|Did not qualify at Day 1|0
2120741|NCT00964366|3719218|FG000|Overall Study|Withdrawal by Subject|0
2120742|NCT00964366|3719219|FG001|Overall Study|Withdrawal by Subject|1
2120743|NCT00964392|3719227|FG000|Overall Study|Withdrawal by Subject|4
2120744|NCT00964392|3719228|FG001|Overall Study|Withdrawal by Subject|6
2120745|NCT00964392|3719227|FG000|Overall Study|Lost to Follow-up|4
2120746|NCT00964392|3719228|FG001|Overall Study|Lost to Follow-up|10
2120747|NCT00964392|3719227|FG000|Overall Study|Early Termination, non-study arrhythmia|1
2120748|NCT00964392|3719228|FG001|Overall Study|Early Termination, non-study arrhythmia|6
2120749|NCT00964392|3719227|FG000|Overall Study|Not completed|44
2120750|NCT00964392|3719228|FG001|Overall Study|Not completed|168
2120751|NCT00964678|3719273|FG000|Overall Study|Physician Decision|4
2120752|NCT00964743|3719278|FG000|Overall Study|Neither patient completed 8 weeks of tre|2
2120753|NCT00964782|3719284|FG000|Overall Study|Lost to Follow-up|1
2120754|NCT00964782|3719285|FG001|Overall Study|Lost to Follow-up|0
2120755|NCT00964795|3719293|FG000|Overall Study|Withdrawal by Subject|79
2120756|NCT00964795|3719293|FG000|Overall Study|Adverse Event|12
2120757|NCT00964795|3719293|FG000|Overall Study|Death|14
2120758|NCT00964795|3719293|FG000|Overall Study|Lost to Follow-up|7
2277875|NCT02332239|3960524|FG000|Overall Study|Lost to Follow-up|4
2277876|NCT02332239|3960525|FG001|Overall Study|Lost to Follow-up|6
2120759|NCT00964795|3719293|FG000|Overall Study|Termination of Study by Sponsor|169
2120760|NCT00964795|3719293|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3
2120761|NCT00964795|3719293|FG000|Overall Study|Other|23
2120762|NCT00964860|3719300|FG000|Overall Study|Withdrawal by Subject|0
2120763|NCT00964860|3719301|FG001|Overall Study|Withdrawal by Subject|1
2120764|NCT00964886|3719311|FG000|Overall Study|Lost to Follow-up|2
2120765|NCT00964886|3719312|FG001|Overall Study|Lost to Follow-up|2
2120766|NCT00964886|3719313|FG002|Overall Study|Lost to Follow-up|6
2120767|NCT00964886|3719314|FG003|Overall Study|Lost to Follow-up|4
2120768|NCT00964886|3719311|FG000|Overall Study|Withdrawal by Subject|6
2120769|NCT00964886|3719312|FG001|Overall Study|Withdrawal by Subject|2
2120770|NCT00964886|3719313|FG002|Overall Study|Withdrawal by Subject|5
2120771|NCT00964886|3719314|FG003|Overall Study|Withdrawal by Subject|3
2120772|NCT00964886|3719311|FG000|Overall Study|Adverse Event|3
2120773|NCT00964886|3719312|FG001|Overall Study|Adverse Event|1
2120774|NCT00964886|3719313|FG002|Overall Study|Adverse Event|5
2120775|NCT00964886|3719314|FG003|Overall Study|Adverse Event|2
2120776|NCT00964886|3719311|FG000|Overall Study|Protocol Violation|0
2120777|NCT00964886|3719312|FG001|Overall Study|Protocol Violation|2
2120778|NCT00964886|3719313|FG002|Overall Study|Protocol Violation|0
2120779|NCT00964886|3719314|FG003|Overall Study|Protocol Violation|0
2120780|NCT00965081|3719330|FG000|Overall Study|Adverse Event|14
2120781|NCT00965081|3719331|FG001|Overall Study|Adverse Event|9
2120782|NCT00965081|3719330|FG000|Overall Study|Lack of Efficacy|2
2120783|NCT00965081|3719331|FG001|Overall Study|Lack of Efficacy|5
2120784|NCT00965081|3719330|FG000|Overall Study|Lost to Follow-up|4
2120785|NCT00965081|3719331|FG001|Overall Study|Lost to Follow-up|5
2120786|NCT00965081|3719330|FG000|Overall Study|Physician Decision|2
2120787|NCT00965081|3719331|FG001|Overall Study|Physician Decision|0
2120788|NCT00965081|3719330|FG000|Overall Study|Protocol Violation|2
2120789|NCT00965081|3719331|FG001|Overall Study|Protocol Violation|5
2120790|NCT00965081|3719330|FG000|Overall Study|Sponsor Decision|1
2120791|NCT00965081|3719331|FG001|Overall Study|Sponsor Decision|0
2120792|NCT00965081|3719330|FG000|Overall Study|Withdrawal by Subject|4
2120793|NCT00965081|3719331|FG001|Overall Study|Withdrawal by Subject|7
2120794|NCT00965081|3719330|FG000|Overall Study|Switched to Rescue Arm|5
2120795|NCT00965081|3719331|FG001|Overall Study|Switched to Rescue Arm|12
2120796|NCT00965094|3719340|FG000|Overall Study|Adverse Event|5
2120797|NCT00965094|3719341|FG001|Overall Study|Adverse Event|0
2120798|NCT00965094|3719340|FG000|Overall Study|Lost to Follow-up|0
2120799|NCT00965094|3719341|FG001|Overall Study|Lost to Follow-up|1
2120800|NCT00965185|3719350|FG000|Overall Study|Lost to Follow-up|2
2120801|NCT00965185|3719351|FG001|Overall Study|Lost to Follow-up|0
2120802|NCT00965185|3719350|FG000|Overall Study|Withdrawal by Subject|0
2120803|NCT00965185|3719351|FG001|Overall Study|Withdrawal by Subject|1
2120804|NCT00965263|3719377|FG000|Overall Study|Physician Decision|2
2120805|NCT00965263|3719378|FG001|Overall Study|Physician Decision|0
2120806|NCT00965263|3719377|FG000|Overall Study|Family emergency|0
2120807|NCT00965263|3719378|FG001|Overall Study|Family emergency|1
2120808|NCT00965263|3719377|FG000|Overall Study|Protocol Violation|0
2120809|NCT00965263|3719378|FG001|Overall Study|Protocol Violation|2
2120810|NCT00965341|3719404|FG000|Overall Study|Withdrew consent|1
2120811|NCT00965341|3719405|FG001|Overall Study|Withdrew consent|5
2120812|NCT00965341|3719404|FG000|Overall Study|Lost to Follow-up|1
2120813|NCT00965341|3719405|FG001|Overall Study|Lost to Follow-up|0
2120814|NCT00965341|3719404|FG000|Overall Study|Transportation issues|4
2120815|NCT00965341|3719405|FG001|Overall Study|Transportation issues|3
2120816|NCT00965419|3719411|FG000|Open Label Treatment for Responders|Adverse Event|33
2120817|NCT00965419|3719411|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1
2120818|NCT00965419|3719411|FG000|Open Label Treatment for Responders|Protocol Violation|21
2120819|NCT00965419|3719411|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27
2120820|NCT00965419|3719411|FG000|Open Label Treatment for Responders|Physician Decision|6
2120821|NCT00965419|3719411|FG000|Open Label Treatment for Responders|Sponsor Decision|5
2120822|NCT00965419|3719411|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41
2120823|NCT00965419|3719411|FG000|Open Label Treatment for Responders|Lack of Efficacy|67
2120824|NCT00965419|3719411|FG000|Open Label Treatment for Responders|Lost to Follow-up|46
2120825|NCT00965419|3719411|FG000|Follow-up Phase|Adverse Event|9
2120826|NCT00965419|3719411|FG000|Follow-up Phase|Protocol Violation|4
2120827|NCT00965419|3719411|FG000|Follow-up Phase|Withdrawal by Subject|8
2120828|NCT00965419|3719411|FG000|Follow-up Phase|Physician Decision|4
2120829|NCT00965419|3719411|FG000|Follow-up Phase|Parent/Caregiver Decision|9
2120830|NCT00965419|3719411|FG000|Follow-up Phase|Lack of Efficacy|28
2120831|NCT00965458|3719418|FG000|Overall Study|Adverse Event|1
2120832|NCT00965458|3719419|FG001|Overall Study|Adverse Event|0
2204937|NCT01607892|3842891|FG001|Overall Study|Investigator discretion|4
2204938|NCT01607892|3842892|FG002|Overall Study|Investigator discretion|4
2204939|NCT01607892|3842893|FG003|Overall Study|Investigator discretion|8
2204940|NCT01607892|3842894|FG004|Overall Study|Investigator discretion|0
2120833|NCT00965458|3719418|FG000|Overall Study|Lost to Follow-up|1
2120834|NCT00965458|3719419|FG001|Overall Study|Lost to Follow-up|3
2120835|NCT00965458|3719418|FG000|Overall Study|Withdrawal by Subject|0
2120836|NCT00965458|3719419|FG001|Overall Study|Withdrawal by Subject|1
2120837|NCT00965484|3719427|FG000|Overall Study|Protocol Violation|1
2120838|NCT00965484|3719427|FG000|Overall Study|Withdrawal by Subject|1
2120839|NCT00965497|3719431|FG000|Overall Study|Physician Decision|1
2120840|NCT00965523|3719435|FG000|Study 221|Progressive Disease|4
2120841|NCT00965523|3719435|FG000|Study 221|Physician Decision|3
2120842|NCT00965523|3719435|FG000|Study 224|Progressive Disease|5
2120843|NCT00965523|3719435|FG000|Study 224|Physician Decision|1
2204941|NCT01607892|3842890|FG000|Overall Study|Other treatments became available|1
2120844|NCT00965562|3719442|FG000|Overall Study|Lost to Follow-up|1
2120845|NCT00965562|3719443|FG001|Overall Study|Lost to Follow-up|2
2120846|NCT00965562|3719444|FG002|Overall Study|Lost to Follow-up|3
2120847|NCT00965562|3719442|FG000|Overall Study|Withdrawal by Subject|2
2120848|NCT00965562|3719443|FG001|Overall Study|Withdrawal by Subject|2
2120849|NCT00965562|3719444|FG002|Overall Study|Withdrawal by Subject|0
2120850|NCT00965575|3719455|FG000|Overall Study|subject unwillingness to swallow study c|1
2120851|NCT00965575|3719456|FG001|Overall Study|subject unwillingness to swallow study c|0
2120852|NCT00965718|3719464|FG000|Overall Study|Withdrawal by Subject|4
2120853|NCT00965731|3719470|FG000|Overall Study|Death|0
2120854|NCT00965731|3719471|FG001|Overall Study|Death|4
2120855|NCT00965731|3719470|FG000|Overall Study|Withdrawal by Subject|0
2120856|NCT00965731|3719471|FG001|Overall Study|Withdrawal by Subject|1
2120857|NCT00965731|3719470|FG000|Overall Study|Other|7
2120858|NCT00965731|3719471|FG001|Overall Study|Other|15
2120859|NCT00965848|3719482|FG000|Overall Study|Protocol Violation|3
2120860|NCT00965848|3719483|FG001|Overall Study|Protocol Violation|0
2120861|NCT00965848|3719484|FG002|Overall Study|Protocol Violation|1
2120862|NCT00965848|3719482|FG000|Overall Study|Death|11
2120863|NCT00965848|3719483|FG001|Overall Study|Death|1
2120864|NCT00965848|3719484|FG002|Overall Study|Death|5
2120865|NCT00965848|3719482|FG000|Overall Study|Lost to Follow-up|0
2120866|NCT00965848|3719483|FG001|Overall Study|Lost to Follow-up|0
2120867|NCT00965848|3719484|FG002|Overall Study|Lost to Follow-up|1
2120868|NCT00965848|3719482|FG000|Overall Study|Withdrawal by Subject|1
2120869|NCT00965848|3719483|FG001|Overall Study|Withdrawal by Subject|0
2120870|NCT00965848|3719484|FG002|Overall Study|Withdrawal by Subject|0
2120871|NCT00965848|3719482|FG000|Overall Study|Indeterminate Clinical Outcome|2
2120872|NCT00965848|3719483|FG001|Overall Study|Indeterminate Clinical Outcome|0
2120873|NCT00965848|3719484|FG002|Overall Study|Indeterminate Clinical Outcome|1
2120874|NCT00965848|3719482|FG000|Overall Study|Not Clinically Evaluable|7
2120875|NCT00965848|3719483|FG001|Overall Study|Not Clinically Evaluable|1
2120876|NCT00965848|3719484|FG002|Overall Study|Not Clinically Evaluable|1
2120877|NCT00965848|3719482|FG000|Overall Study|Other|5
2120878|NCT00965848|3719483|FG001|Overall Study|Other|0
2120879|NCT00965848|3719484|FG002|Overall Study|Other|1
2120880|NCT00966264|3719528|FG000|Overall Study|Lost to Follow-up|4
2120881|NCT00966264|3719529|FG001|Overall Study|Lost to Follow-up|3
2120882|NCT00966277|3719537|FG000|Overall Study|Withdrawal by Subject|3
2120883|NCT00966277|3719538|FG001|Overall Study|Withdrawal by Subject|0
2120884|NCT00966277|3719537|FG000|Overall Study|Ineligible|1
2120885|NCT00966277|3719538|FG001|Overall Study|Ineligible|3
2120886|NCT00966277|3719537|FG000|Overall Study|Treatment Plan Changed|0
2120887|NCT00966277|3719538|FG001|Overall Study|Treatment Plan Changed|1
2120888|NCT00966355|3719547|FG000|Overall Study|non-variceal bleeding on endoscopy|68
2120889|NCT00966355|3719548|FG001|Overall Study|non-variceal bleeding on endoscopy|70
2120890|NCT00966355|3719549|FG002|Overall Study|non-variceal bleeding on endoscopy|71
2120891|NCT00966355|3719547|FG000|Overall Study|newly diagnosed advanced HCC|11
2120892|NCT00966355|3719548|FG001|Overall Study|newly diagnosed advanced HCC|12
2120893|NCT00966355|3719549|FG002|Overall Study|newly diagnosed advanced HCC|10
2120894|NCT00966355|3719547|FG000|Overall Study|Lost to Follow-up|5
2120895|NCT00966355|3719548|FG001|Overall Study|Lost to Follow-up|4
2120896|NCT00966355|3719549|FG002|Overall Study|Lost to Follow-up|3
2120897|NCT00966693|3719605|FG000|Overall Study|Adverse Event|0
2120898|NCT00966693|3719606|FG001|Overall Study|Adverse Event|0
2120899|NCT00966693|3719607|FG002|Overall Study|Adverse Event|1
2120900|NCT00966693|3719608|FG003|Overall Study|Adverse Event|2
2120901|NCT00966693|3719605|FG000|Overall Study|Death|0
2204942|NCT01607892|3842891|FG001|Overall Study|Other treatments became available|1
2204943|NCT01607892|3842892|FG002|Overall Study|Other treatments became available|0
2204944|NCT01607892|3842893|FG003|Overall Study|Other treatments became available|0
2204945|NCT01607892|3842894|FG004|Overall Study|Other treatments became available|2
2204946|NCT01607892|3842890|FG000|Overall Study|Intercurrent illness|1
2120902|NCT00966693|3719606|FG001|Overall Study|Death|0
2120903|NCT00966693|3719607|FG002|Overall Study|Death|1
2120904|NCT00966693|3719608|FG003|Overall Study|Death|0
2120905|NCT00966693|3719605|FG000|Overall Study|Withdrawal by Subject|1
2120906|NCT00966693|3719606|FG001|Overall Study|Withdrawal by Subject|0
2120907|NCT00966693|3719607|FG002|Overall Study|Withdrawal by Subject|0
2120908|NCT00966693|3719608|FG003|Overall Study|Withdrawal by Subject|5
2120909|NCT00966693|3719605|FG000|Overall Study|Disease Progression|0
2120910|NCT00966693|3719606|FG001|Overall Study|Disease Progression|0
2120911|NCT00966693|3719607|FG002|Overall Study|Disease Progression|1
2120912|NCT00966693|3719608|FG003|Overall Study|Disease Progression|16
2120913|NCT00966719|3719620|FG000|Overall Study|Lost to Follow-up|6
2120914|NCT00966719|3719621|FG001|Overall Study|Lost to Follow-up|11
2120915|NCT00966875|3719653|FG000|Part A|Adverse Event|2
2120916|NCT00966875|3719654|FG001|Part A|Adverse Event|1
2120917|NCT00966875|3719655|FG002|Part A|Adverse Event|0
2120918|NCT00966875|3719656|FG003|Part A|Adverse Event|1
2120919|NCT00966875|3719657|FG004|Part A|Adverse Event|0
2120920|NCT00966875|3719658|FG005|Part A|Adverse Event|1
2120921|NCT00966875|3719659|FG006|Part A|Adverse Event|0
2120922|NCT00966875|3719660|FG007|Part A|Adverse Event|3
2120923|NCT00966875|3719661|FG008|Part A|Adverse Event|3
2120924|NCT00966875|3719653|FG000|Part A|Entry Criteria|0
2120925|NCT00966875|3719654|FG001|Part A|Entry Criteria|0
2120926|NCT00966875|3719655|FG002|Part A|Entry Criteria|0
2120927|NCT00966875|3719656|FG003|Part A|Entry Criteria|0
2120928|NCT00966875|3719657|FG004|Part A|Entry Criteria|0
2120929|NCT00966875|3719658|FG005|Part A|Entry Criteria|2
2120930|NCT00966875|3719659|FG006|Part A|Entry Criteria|0
2120931|NCT00966875|3719660|FG007|Part A|Entry Criteria|0
2120932|NCT00966875|3719661|FG008|Part A|Entry Criteria|0
2120933|NCT00966875|3719653|FG000|Part A|Lack of Efficacy|0
2120934|NCT00966875|3719654|FG001|Part A|Lack of Efficacy|1
2120935|NCT00966875|3719655|FG002|Part A|Lack of Efficacy|0
2120936|NCT00966875|3719656|FG003|Part A|Lack of Efficacy|0
2120937|NCT00966875|3719657|FG004|Part A|Lack of Efficacy|0
2120938|NCT00966875|3719658|FG005|Part A|Lack of Efficacy|0
2120939|NCT00966875|3719659|FG006|Part A|Lack of Efficacy|4
2120940|NCT00966875|3719660|FG007|Part A|Lack of Efficacy|0
2120941|NCT00966875|3719661|FG008|Part A|Lack of Efficacy|0
2120942|NCT00966875|3719653|FG000|Part A|Lost to Follow-up|2
2120943|NCT00966875|3719654|FG001|Part A|Lost to Follow-up|0
2120944|NCT00966875|3719655|FG002|Part A|Lost to Follow-up|0
2120945|NCT00966875|3719656|FG003|Part A|Lost to Follow-up|0
2120946|NCT00966875|3719657|FG004|Part A|Lost to Follow-up|0
2120947|NCT00966875|3719658|FG005|Part A|Lost to Follow-up|1
2120948|NCT00966875|3719659|FG006|Part A|Lost to Follow-up|0
2120949|NCT00966875|3719660|FG007|Part A|Lost to Follow-up|0
2120950|NCT00966875|3719661|FG008|Part A|Lost to Follow-up|0
2120951|NCT00966875|3719653|FG000|Part A|Parent/Caregiver Decision|0
2120952|NCT00966875|3719654|FG001|Part A|Parent/Caregiver Decision|0
2120953|NCT00966875|3719655|FG002|Part A|Parent/Caregiver Decision|0
2120954|NCT00966875|3719656|FG003|Part A|Parent/Caregiver Decision|1
2120955|NCT00966875|3719657|FG004|Part A|Parent/Caregiver Decision|0
2120956|NCT00966875|3719658|FG005|Part A|Parent/Caregiver Decision|0
2120957|NCT00966875|3719659|FG006|Part A|Parent/Caregiver Decision|0
2120958|NCT00966875|3719660|FG007|Part A|Parent/Caregiver Decision|0
2120959|NCT00966875|3719661|FG008|Part A|Parent/Caregiver Decision|0
2120960|NCT00966875|3719653|FG000|Part A|Physician Decision|0
2120961|NCT00966875|3719654|FG001|Part A|Physician Decision|0
2120962|NCT00966875|3719655|FG002|Part A|Physician Decision|0
2120963|NCT00966875|3719656|FG003|Part A|Physician Decision|0
2120964|NCT00966875|3719657|FG004|Part A|Physician Decision|1
2120965|NCT00966875|3719658|FG005|Part A|Physician Decision|0
2120966|NCT00966875|3719659|FG006|Part A|Physician Decision|1
2120967|NCT00966875|3719660|FG007|Part A|Physician Decision|0
2120968|NCT00966875|3719661|FG008|Part A|Physician Decision|2
2120969|NCT00966875|3719653|FG000|Part A|Sponsor Decision|0
2120970|NCT00966875|3719654|FG001|Part A|Sponsor Decision|0
2120971|NCT00966875|3719655|FG002|Part A|Sponsor Decision|1
2120972|NCT00966875|3719656|FG003|Part A|Sponsor Decision|0
2120973|NCT00966875|3719657|FG004|Part A|Sponsor Decision|1
2120974|NCT00966875|3719658|FG005|Part A|Sponsor Decision|0
2120975|NCT00966875|3719659|FG006|Part A|Sponsor Decision|0
2120976|NCT00966875|3719660|FG007|Part A|Sponsor Decision|2
2120977|NCT00966875|3719661|FG008|Part A|Sponsor Decision|1
2120978|NCT00966875|3719653|FG000|Part A|Withdrawal by Subject|2
2120979|NCT00966875|3719654|FG001|Part A|Withdrawal by Subject|2
2120980|NCT00966875|3719655|FG002|Part A|Withdrawal by Subject|1
2120981|NCT00966875|3719656|FG003|Part A|Withdrawal by Subject|1
2120982|NCT00966875|3719657|FG004|Part A|Withdrawal by Subject|3
2120983|NCT00966875|3719658|FG005|Part A|Withdrawal by Subject|0
2120984|NCT00966875|3719659|FG006|Part A|Withdrawal by Subject|5
2120985|NCT00966875|3719660|FG007|Part A|Withdrawal by Subject|1
2120986|NCT00966875|3719661|FG008|Part A|Withdrawal by Subject|1
2120987|NCT00966875|3719653|FG000|Part A|Protocol Violation|0
2120988|NCT00966875|3719654|FG001|Part A|Protocol Violation|0
2120989|NCT00966875|3719655|FG002|Part A|Protocol Violation|0
2120990|NCT00966875|3719656|FG003|Part A|Protocol Violation|0
2120991|NCT00966875|3719657|FG004|Part A|Protocol Violation|0
2120992|NCT00966875|3719658|FG005|Part A|Protocol Violation|0
2120993|NCT00966875|3719659|FG006|Part A|Protocol Violation|2
2120994|NCT00966875|3719660|FG007|Part A|Protocol Violation|1
2120995|NCT00966875|3719661|FG008|Part A|Protocol Violation|1
2120996|NCT00966875|3719653|FG000|Part B|Adverse Event|0
2120997|NCT00966875|3719654|FG001|Part B|Adverse Event|1
2120998|NCT00966875|3719655|FG002|Part B|Adverse Event|1
2120999|NCT00966875|3719656|FG003|Part B|Adverse Event|0
2121000|NCT00966875|3719657|FG004|Part B|Adverse Event|1
2121001|NCT00966875|3719658|FG005|Part B|Adverse Event|0
2121002|NCT00966875|3719659|FG006|Part B|Adverse Event|5
2121003|NCT00966875|3719660|FG007|Part B|Adverse Event|2
2121004|NCT00966875|3719661|FG008|Part B|Adverse Event|2
2121005|NCT00966875|3719653|FG000|Part B|Death|0
2121006|NCT00966875|3719654|FG001|Part B|Death|0
2121007|NCT00966875|3719655|FG002|Part B|Death|1
2121008|NCT00966875|3719656|FG003|Part B|Death|0
2121009|NCT00966875|3719657|FG004|Part B|Death|0
2121010|NCT00966875|3719658|FG005|Part B|Death|0
2121011|NCT00966875|3719659|FG006|Part B|Death|0
2121012|NCT00966875|3719660|FG007|Part B|Death|1
2121013|NCT00966875|3719661|FG008|Part B|Death|0
2121014|NCT00966875|3719653|FG000|Part B|Lack of Efficacy|2
2121015|NCT00966875|3719654|FG001|Part B|Lack of Efficacy|1
2121016|NCT00966875|3719655|FG002|Part B|Lack of Efficacy|1
2121017|NCT00966875|3719656|FG003|Part B|Lack of Efficacy|1
2121018|NCT00966875|3719657|FG004|Part B|Lack of Efficacy|2
2121019|NCT00966875|3719658|FG005|Part B|Lack of Efficacy|3
2121020|NCT00966875|3719659|FG006|Part B|Lack of Efficacy|12
2121021|NCT00966875|3719660|FG007|Part B|Lack of Efficacy|9
2121022|NCT00966875|3719661|FG008|Part B|Lack of Efficacy|6
2121023|NCT00966875|3719653|FG000|Part B|Lost to Follow-up|0
2121024|NCT00966875|3719654|FG001|Part B|Lost to Follow-up|0
2121025|NCT00966875|3719655|FG002|Part B|Lost to Follow-up|0
2121026|NCT00966875|3719656|FG003|Part B|Lost to Follow-up|1
2121027|NCT00966875|3719657|FG004|Part B|Lost to Follow-up|0
2121028|NCT00966875|3719658|FG005|Part B|Lost to Follow-up|0
2121029|NCT00966875|3719659|FG006|Part B|Lost to Follow-up|0
2121030|NCT00966875|3719660|FG007|Part B|Lost to Follow-up|0
2121031|NCT00966875|3719661|FG008|Part B|Lost to Follow-up|1
2121032|NCT00966875|3719653|FG000|Part B|Physician Decision|0
2121033|NCT00966875|3719654|FG001|Part B|Physician Decision|0
2121034|NCT00966875|3719655|FG002|Part B|Physician Decision|1
2121035|NCT00966875|3719656|FG003|Part B|Physician Decision|0
2121036|NCT00966875|3719657|FG004|Part B|Physician Decision|2
2121037|NCT00966875|3719658|FG005|Part B|Physician Decision|1
2121038|NCT00966875|3719659|FG006|Part B|Physician Decision|0
2121039|NCT00966875|3719660|FG007|Part B|Physician Decision|0
2121040|NCT00966875|3719661|FG008|Part B|Physician Decision|2
2121041|NCT00966875|3719653|FG000|Part B|Sponsor Decision|1
2121042|NCT00966875|3719654|FG001|Part B|Sponsor Decision|0
2121043|NCT00966875|3719655|FG002|Part B|Sponsor Decision|0
2121044|NCT00966875|3719656|FG003|Part B|Sponsor Decision|0
2121045|NCT00966875|3719657|FG004|Part B|Sponsor Decision|0
2121046|NCT00966875|3719658|FG005|Part B|Sponsor Decision|1
2121047|NCT00966875|3719659|FG006|Part B|Sponsor Decision|0
2121048|NCT00966875|3719660|FG007|Part B|Sponsor Decision|2
2121049|NCT00966875|3719661|FG008|Part B|Sponsor Decision|1
2121050|NCT00966875|3719653|FG000|Part B|Withdrawal by Subject|2
2121051|NCT00966875|3719654|FG001|Part B|Withdrawal by Subject|1
2121052|NCT00966875|3719655|FG002|Part B|Withdrawal by Subject|2
2121053|NCT00966875|3719656|FG003|Part B|Withdrawal by Subject|1
2121054|NCT00966875|3719657|FG004|Part B|Withdrawal by Subject|2
2121055|NCT00966875|3719658|FG005|Part B|Withdrawal by Subject|1
2121056|NCT00966875|3719659|FG006|Part B|Withdrawal by Subject|4
2121057|NCT00966875|3719660|FG007|Part B|Withdrawal by Subject|5
2121058|NCT00966875|3719661|FG008|Part B|Withdrawal by Subject|5
2121059|NCT00966875|3719653|FG000|Part B|Entry Criteria|0
2121060|NCT00966875|3719654|FG001|Part B|Entry Criteria|0
2121061|NCT00966875|3719655|FG002|Part B|Entry Criteria|0
2121062|NCT00966875|3719656|FG003|Part B|Entry Criteria|0
2121063|NCT00966875|3719657|FG004|Part B|Entry Criteria|0
2121064|NCT00966875|3719658|FG005|Part B|Entry Criteria|0
2121065|NCT00966875|3719659|FG006|Part B|Entry Criteria|1
2121066|NCT00966875|3719660|FG007|Part B|Entry Criteria|0
2121067|NCT00966875|3719661|FG008|Part B|Entry Criteria|1
2121068|NCT00966940|3719736|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2
2121069|NCT00966940|3719737|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0
2121070|NCT00966940|3719736|FG000|Period 1, First 6 Weeks|Protocol Violation|1
2277877|NCT02332291|3960535|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3
2277878|NCT02332291|3960536|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5
2277879|NCT02332291|3960535|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0
2277880|NCT02332291|3960536|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4
2277881|NCT02332291|3960535|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1
2277882|NCT02332291|3960536|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0
2277883|NCT02332291|3960535|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2
2277884|NCT02332291|3960536|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7
2277885|NCT02332291|3960535|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0
2277886|NCT02332291|3960536|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1
2277887|NCT02332291|3960535|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1
2277888|NCT02332291|3960536|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0
2277889|NCT02332707|3960564|FG000|Overall Study|Adverse Event|0
2277890|NCT02332707|3960565|FG001|Overall Study|Adverse Event|0
2277891|NCT02332707|3960566|FG002|Overall Study|Adverse Event|0
2277892|NCT02332707|3960567|FG003|Overall Study|Adverse Event|0
2121071|NCT00966940|3719737|FG001|Period 1, First 6 Weeks|Protocol Violation|0
2121072|NCT00967005|3719745|FG000|Overall Study|Lost to Follow-up|7
2121073|NCT00967005|3719746|FG001|Overall Study|Lost to Follow-up|10
2121074|NCT00967018|3719752|FG000|Overall Study|Adverse Event|2
2121075|NCT00967018|3719752|FG000|Overall Study|Physician Decision|7
2277893|NCT02332707|3960568|FG004|Overall Study|Adverse Event|0
2121076|NCT00967018|3719752|FG000|Overall Study|Lost to Follow-up|2
2121077|NCT00967018|3719752|FG000|Overall Study|Withdrawal by Subject|1
2121078|NCT00967018|3719752|FG000|Overall Study|Miscellaneous Reasons|9
2121079|NCT00967226|3719762|FG000|Overall Study|Adverse Event|0
2121080|NCT00967226|3719763|FG001|Overall Study|Adverse Event|5
2121081|NCT00967226|3719762|FG000|Overall Study|Protocol Violation|2
2121082|NCT00967226|3719763|FG001|Overall Study|Protocol Violation|0
2121083|NCT00967226|3719762|FG000|Overall Study|Physician Decision|0
2121084|NCT00967226|3719763|FG001|Overall Study|Physician Decision|1
2121085|NCT00967330|3719795|FG000|Overall Study|Protocol Violation|3
2121086|NCT00967330|3719796|FG001|Overall Study|Protocol Violation|4
2121087|NCT00967330|3719795|FG000|Overall Study|Regular|10
2121088|NCT00967330|3719796|FG001|Overall Study|Regular|3
2121089|NCT00967330|3719795|FG000|Overall Study|Withdrawal by Subject|6
2121090|NCT00967330|3719796|FG001|Overall Study|Withdrawal by Subject|0
2121091|NCT00967330|3719795|FG000|Overall Study|Lost to Follow-up|1
2121092|NCT00967330|3719796|FG001|Overall Study|Lost to Follow-up|1
2121093|NCT00967330|3719795|FG000|Overall Study|Death|102
2121094|NCT00967330|3719796|FG001|Overall Study|Death|51
2121095|NCT00967330|3719795|FG000|Overall Study|Severe protocol deviation|0
2121096|NCT00967330|3719796|FG001|Overall Study|Severe protocol deviation|1
2177740|NCT01377012|3802083|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1
2177741|NCT01377012|3802084|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0
2177742|NCT01377012|3802085|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3
2177743|NCT01377012|3802083|FG000|Extension Study, Weeks 104-260|Physician Decision|1
2177744|NCT01377012|3802084|FG001|Extension Study, Weeks 104-260|Physician Decision|0
2177745|NCT01377012|3802085|FG002|Extension Study, Weeks 104-260|Physician Decision|0
2177746|NCT01377012|3802083|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0
2177747|NCT01377012|3802084|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0
2177748|NCT01377012|3802085|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1
2177749|NCT01377012|3802083|FG000|Extension Study, Weeks 104-260|Adverse Event|0
2177750|NCT01377012|3802084|FG001|Extension Study, Weeks 104-260|Adverse Event|2
2177751|NCT01377012|3802085|FG002|Extension Study, Weeks 104-260|Adverse Event|1
2177752|NCT01377194|3802096|FG000|Overall Study|Adverse Event|3
2177753|NCT01377194|3802097|FG001|Overall Study|Adverse Event|12
2177754|NCT01377194|3802098|FG002|Overall Study|Adverse Event|19
2177755|NCT01377194|3802096|FG000|Overall Study|Lack of Efficacy|3
2177756|NCT01377194|3802097|FG001|Overall Study|Lack of Efficacy|3
2177757|NCT01377194|3802098|FG002|Overall Study|Lack of Efficacy|3
2177758|NCT01377194|3802096|FG000|Overall Study|Protocol Violation|4
2177759|NCT01377194|3802097|FG001|Overall Study|Protocol Violation|10
2177760|NCT01377194|3802098|FG002|Overall Study|Protocol Violation|6
2177761|NCT01377194|3802096|FG000|Overall Study|Withdrawal by Subject|8
2177762|NCT01377194|3802097|FG001|Overall Study|Withdrawal by Subject|10
2177763|NCT01377194|3802098|FG002|Overall Study|Withdrawal by Subject|7
2177764|NCT01377194|3802096|FG000|Overall Study|Lost to Follow-up|14
2177765|NCT01377194|3802097|FG001|Overall Study|Lost to Follow-up|8
2177766|NCT01377194|3802098|FG002|Overall Study|Lost to Follow-up|11
2177767|NCT01377233|3802114|FG000|Open-label|Adverse Event|1
2177768|NCT01377233|3802115|FG001|Open-label|Adverse Event|0
2177769|NCT01377233|3802116|FG002|Open-label|Adverse Event|0
2177770|NCT01377233|3802117|FG003|Open-label|Adverse Event|0
2177771|NCT01377233|3802118|FG004|Open-label|Adverse Event|0
2177772|NCT01377233|3802114|FG000|Open-label|Withdrawal by Subject|3
2177773|NCT01377233|3802115|FG001|Open-label|Withdrawal by Subject|0
2177774|NCT01377233|3802116|FG002|Open-label|Withdrawal by Subject|0
2177775|NCT01377233|3802117|FG003|Open-label|Withdrawal by Subject|0
2177776|NCT01377233|3802118|FG004|Open-label|Withdrawal by Subject|0
2177777|NCT01377233|3802114|FG000|Double-blind|Adverse Event|0
2177778|NCT01377233|3802115|FG001|Double-blind|Adverse Event|1
2177779|NCT01377233|3802116|FG002|Double-blind|Adverse Event|2
2177780|NCT01377233|3802117|FG003|Double-blind|Adverse Event|2
2177781|NCT01377233|3802118|FG004|Double-blind|Adverse Event|0
2177782|NCT01377233|3802114|FG000|Double-blind|Protocol Violation|0
2177783|NCT01377233|3802115|FG001|Double-blind|Protocol Violation|0
2177784|NCT01377233|3802116|FG002|Double-blind|Protocol Violation|0
2177785|NCT01377233|3802117|FG003|Double-blind|Protocol Violation|0
2177786|NCT01377233|3802118|FG004|Double-blind|Protocol Violation|1
2177787|NCT01377233|3802114|FG000|Double-blind|Withdrawal by Subject|0
2177788|NCT01377233|3802115|FG001|Double-blind|Withdrawal by Subject|0
2177789|NCT01377233|3802116|FG002|Double-blind|Withdrawal by Subject|0
2177790|NCT01377233|3802117|FG003|Double-blind|Withdrawal by Subject|1
2177791|NCT01377233|3802118|FG004|Double-blind|Withdrawal by Subject|0
2177792|NCT01377233|3802114|FG000|Double-blind|Administrative or other|0
2177793|NCT01377233|3802115|FG001|Double-blind|Administrative or other|0
2177794|NCT01377233|3802116|FG002|Double-blind|Administrative or other|0
2177795|NCT01377233|3802117|FG003|Double-blind|Administrative or other|1
2177796|NCT01377233|3802118|FG004|Double-blind|Administrative or other|1
2177797|NCT01377389|3802134|FG000|Overall Study|Withdrawal by Subject|1
2177798|NCT01377389|3802134|FG000|Overall Study|Screen failure|2
2177799|NCT01377480|3802157|FG000|Overall Study|Protocol Violation|0
2177800|NCT01377480|3802158|FG001|Overall Study|Protocol Violation|0
2177801|NCT01377480|3802159|FG002|Overall Study|Protocol Violation|0
2177802|NCT01377480|3802160|FG003|Overall Study|Protocol Violation|4
2177803|NCT01377480|3802157|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0
2177804|NCT01377480|3802158|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1
2177805|NCT01377480|3802159|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1
2177806|NCT01377480|3802160|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0
2177807|NCT01377480|3802157|FG000|Overall Study|Withdrawal by Subject|0
2177808|NCT01377480|3802158|FG001|Overall Study|Withdrawal by Subject|0
2177809|NCT01377480|3802159|FG002|Overall Study|Withdrawal by Subject|1
2177810|NCT01377480|3802160|FG003|Overall Study|Withdrawal by Subject|0
2177811|NCT01377480|3802157|FG000|Overall Study|Serious adverse event|0
2177812|NCT01377480|3802158|FG001|Overall Study|Serious adverse event|0
2177813|NCT01377480|3802159|FG002|Overall Study|Serious adverse event|1
2177814|NCT01377480|3802160|FG003|Overall Study|Serious adverse event|1
2177815|NCT01377480|3802157|FG000|Overall Study|Other|0
2177816|NCT01377480|3802158|FG001|Overall Study|Other|0
2177817|NCT01377480|3802159|FG002|Overall Study|Other|7
2121097|NCT00967343|3719802|FG000|Overall Study|Study termination by sponsor|12
2121098|NCT00967343|3719802|FG000|Overall Study|Death|24
2121099|NCT00967343|3719802|FG000|Overall Study|Relapse|1
2121100|NCT00967343|3719802|FG000|Overall Study|Lost to Follow-up|1
2121101|NCT00967499|3719830|FG000|Overall Study|Adverse Event|0
2121102|NCT00967499|3719831|FG001|Overall Study|Adverse Event|1
2121103|NCT00967499|3719830|FG000|Overall Study|Protocol Violation|1
2121104|NCT00967499|3719831|FG001|Overall Study|Protocol Violation|0
2121105|NCT00967499|3719830|FG000|Overall Study|Sponsor Decision|1
2121106|NCT00967499|3719831|FG001|Overall Study|Sponsor Decision|0
2121107|NCT00967499|3719830|FG000|Overall Study|Randomized but not treated|63
2121108|NCT00967499|3719831|FG001|Overall Study|Randomized but not treated|59
2121109|NCT00967616|3719848|FG000|Overall Study|Adverse Event or Serious Adverse Event|2
2121110|NCT00967616|3719849|FG001|Overall Study|Adverse Event or Serious Adverse Event|17
2121111|NCT00967616|3719848|FG000|Overall Study|Death|0
2121112|NCT00967616|3719849|FG001|Overall Study|Death|3
2121113|NCT00967616|3719848|FG000|Overall Study|Withdrawal by Subject|8
2121114|NCT00967616|3719849|FG001|Overall Study|Withdrawal by Subject|4
2121115|NCT00967616|3719848|FG000|Overall Study|Progressive Disease|31
2121116|NCT00967616|3719849|FG001|Overall Study|Progressive Disease|18
2121117|NCT00967616|3719848|FG000|Overall Study|Other|8
2121118|NCT00967616|3719849|FG001|Overall Study|Other|8
2121119|NCT00967616|3719848|FG000|Overall Study|Protocol Violation|1
2121120|NCT00967616|3719849|FG001|Overall Study|Protocol Violation|0
2121121|NCT00967668|3719858|FG000|Overall Study|Withdrawal by Subject|13
2121122|NCT00967668|3719859|FG001|Overall Study|Withdrawal by Subject|8
2121123|NCT00967668|3719860|FG002|Overall Study|Withdrawal by Subject|8
2121124|NCT00967668|3719858|FG000|Overall Study|Death|0
2121125|NCT00967668|3719859|FG001|Overall Study|Death|2
2277894|NCT02332707|3960569|FG005|Overall Study|Adverse Event|0
2121126|NCT00967668|3719860|FG002|Overall Study|Death|4
2121127|NCT00967668|3719858|FG000|Overall Study|Removed due to behavior|1
2121128|NCT00967668|3719859|FG001|Overall Study|Removed due to behavior|1
2121129|NCT00967668|3719860|FG002|Overall Study|Removed due to behavior|2
2121130|NCT00967668|3719858|FG000|Overall Study|Refused Year 2|11
2121131|NCT00967668|3719859|FG001|Overall Study|Refused Year 2|6
2121132|NCT00967668|3719860|FG002|Overall Study|Refused Year 2|4
2121133|NCT00967668|3719858|FG000|Overall Study|Lost to follow-up at 12-mo|27
2121134|NCT00967668|3719859|FG001|Overall Study|Lost to follow-up at 12-mo|29
2121135|NCT00967668|3719860|FG002|Overall Study|Lost to follow-up at 12-mo|26
2121136|NCT00967668|3719858|FG000|Overall Study|Lost to Follow-up|15
2121137|NCT00967668|3719859|FG001|Overall Study|Lost to Follow-up|9
2121138|NCT00967668|3719860|FG002|Overall Study|Lost to Follow-up|16
2121139|NCT00967668|3719858|FG000|Overall Study|Refused 12-mo assessment|3
2121140|NCT00967668|3719859|FG001|Overall Study|Refused 12-mo assessment|1
2277895|NCT02332707|3960570|FG006|Overall Study|Adverse Event|0
2277896|NCT02332707|3960571|FG007|Overall Study|Adverse Event|0
2277897|NCT02332707|3960572|FG008|Overall Study|Adverse Event|0
2277898|NCT02332707|3960573|FG009|Overall Study|Adverse Event|0
2277899|NCT02332707|3960574|FG010|Overall Study|Adverse Event|0
2277900|NCT02332707|3960575|FG011|Overall Study|Adverse Event|0
2277901|NCT02332707|3960576|FG012|Overall Study|Adverse Event|1
2041536|NCT00439777|3612296|FG000|Treatment Period|Withdrawal by Subject|66
2041537|NCT00439777|3612297|FG001|Treatment Period|Withdrawal by Subject|118
2041538|NCT00439777|3612296|FG000|Treatment Period|Lack of Efficacy|1
2041539|NCT00439777|3612297|FG001|Treatment Period|Lack of Efficacy|4
2041540|NCT00439777|3612296|FG000|Treatment Period|Lost to Follow-up|8
2121141|NCT00967668|3719860|FG002|Overall Study|Refused 12-mo assessment|9
2121142|NCT00967668|3719858|FG000|Overall Study|Pregnancy|1
2121143|NCT00967668|3719859|FG001|Overall Study|Pregnancy|0
2121144|NCT00967668|3719860|FG002|Overall Study|Pregnancy|0
2121145|NCT00967694|3719871|FG000|Overall Study|Withdrawal by Subject|6
2121146|NCT00967798|3719877|FG000|Overall Study|Withdrawal by Subject|5
2121147|NCT00967798|3719878|FG001|Overall Study|Withdrawal by Subject|2
2121148|NCT00967798|3719877|FG000|Overall Study|Lost to Follow-up|4
2121149|NCT00967798|3719878|FG001|Overall Study|Lost to Follow-up|1
2177818|NCT01377480|3802160|FG003|Overall Study|Other|6
2177819|NCT01377844|3802215|FG000|Overall Study|Withdrawal by Subject|25
2177820|NCT01377844|3802216|FG001|Overall Study|Withdrawal by Subject|28
2177821|NCT01377844|3802215|FG000|Overall Study|Protocol Violation|2
2177822|NCT01377844|3802216|FG001|Overall Study|Protocol Violation|3
2177823|NCT01377844|3802215|FG000|Overall Study|Adverse Event|3
2177824|NCT01377844|3802216|FG001|Overall Study|Adverse Event|0
2177825|NCT01377844|3802215|FG000|Overall Study|Physician Decision|6
2177826|NCT01377844|3802216|FG001|Overall Study|Physician Decision|3
2277902|NCT02332707|3960577|FG013|Overall Study|Adverse Event|0
2277903|NCT02332707|3960578|FG014|Overall Study|Adverse Event|0
2177827|NCT01377844|3802215|FG000|Overall Study|Study terminated by Sponsor|0
2177828|NCT01377844|3802216|FG001|Overall Study|Study terminated by Sponsor|1
2177829|NCT01377922|3802225|FG000|Overall Study|rescue tx after part 2, entered part 4|1
2177830|NCT01377922|3802226|FG001|Overall Study|rescue tx after part 2, entered part 4|0
2177831|NCT01377987|3802232|FG000|Washout (7 Days)|Withdrawal by Subject|1
2177832|NCT01377987|3802233|FG001|Washout (7 Days)|Withdrawal by Subject|1
2177833|NCT01378104|3802245|FG000|Overall Study|Adverse Event|8
2177834|NCT01378104|3802246|FG001|Overall Study|Adverse Event|8
2277904|NCT02332707|3960579|FG015|Overall Study|Adverse Event|0
2121150|NCT00968253|3719920|FG000|Overall Study|Death|0
2121151|NCT00968253|3719921|FG001|Overall Study|Death|0
2121152|NCT00968253|3719922|FG002|Overall Study|Death|2
2121153|NCT00968253|3719920|FG000|Overall Study|Withdrawal by Subject|0
2121154|NCT00968253|3719921|FG001|Overall Study|Withdrawal by Subject|0
2121155|NCT00968253|3719922|FG002|Overall Study|Withdrawal by Subject|1
2121156|NCT00968253|3719920|FG000|Overall Study|Disease Progression|0
2121157|NCT00968253|3719921|FG001|Overall Study|Disease Progression|3
2121158|NCT00968253|3719922|FG002|Overall Study|Disease Progression|3
2121159|NCT00968253|3719920|FG000|Overall Study|Adverse Event|0
2121160|NCT00968253|3719921|FG001|Overall Study|Adverse Event|0
2121161|NCT00968253|3719922|FG002|Overall Study|Adverse Event|1
2121162|NCT00968526|3719942|FG000|Overall Study|Adverse Event|2
2121163|NCT00968526|3719943|FG001|Overall Study|Adverse Event|0
2121164|NCT00968526|3719942|FG000|Overall Study|Migrated/moved from study area|1
2121165|NCT00968526|3719943|FG001|Overall Study|Migrated/moved from study area|0
2121166|NCT00968539|3719960|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1
2121167|NCT00968539|3719961|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
2121168|NCT00968617|3719968|FG000|Overall Study|Study terminated by sponsor|6
2121169|NCT00968669|3719976|FG000|Overall Study|Lost to Follow-up|5
2121170|NCT00968669|3719977|FG001|Overall Study|Lost to Follow-up|2
2121171|NCT00968669|3719978|FG002|Overall Study|Lost to Follow-up|1
2121172|NCT00968669|3719979|FG003|Overall Study|Lost to Follow-up|4
2121173|NCT00968669|3719976|FG000|Overall Study|Withdrawal by Subject|9
2041541|NCT00439777|3612297|FG001|Treatment Period|Lost to Follow-up|10
2041542|NCT00439777|3612296|FG000|Treatment Period|Protocol driven decision point|1
2041543|NCT00439777|3612297|FG001|Treatment Period|Protocol driven decision point|3
2041544|NCT00439777|3612296|FG000|Treatment Period|Physician Decision|7
2041545|NCT00439777|3612297|FG001|Treatment Period|Physician Decision|18
2041546|NCT00439777|3612296|FG000|Treatment Period|Clinical endpoint reached|26
2041547|NCT00439777|3612297|FG001|Treatment Period|Clinical endpoint reached|13
2041548|NCT00439777|3612296|FG000|Treatment Period|Technical problems|3
2041549|NCT00439777|3612297|FG001|Treatment Period|Technical problems|1
2041550|NCT00439777|3612296|FG000|Treatment Period|Participant convenience|12
2041551|NCT00439777|3612297|FG001|Treatment Period|Participant convenience|8
2041552|NCT00439777|3612296|FG000|Observational Period|Protocol Violation|0
2041553|NCT00439777|3612297|FG001|Observational Period|Protocol Violation|2
2041554|NCT00439777|3612296|FG000|Observational Period|Withdrawal by Subject|9
2041555|NCT00439777|3612297|FG001|Observational Period|Withdrawal by Subject|5
2041556|NCT00439777|3612296|FG000|Observational Period|Lost to Follow-up|1
2121174|NCT00968669|3719977|FG001|Overall Study|Withdrawal by Subject|7
2121175|NCT00968669|3719978|FG002|Overall Study|Withdrawal by Subject|5
2121176|NCT00968669|3719979|FG003|Overall Study|Withdrawal by Subject|3
2121177|NCT00968669|3719976|FG000|Overall Study|Pregnancy|0
2121178|NCT00968669|3719977|FG001|Overall Study|Pregnancy|0
2121179|NCT00968669|3719978|FG002|Overall Study|Pregnancy|2
2121180|NCT00968669|3719979|FG003|Overall Study|Pregnancy|0
2121181|NCT00968669|3719976|FG000|Overall Study|AE|1
2121182|NCT00968669|3719977|FG001|Overall Study|AE|0
2121183|NCT00968669|3719978|FG002|Overall Study|AE|0
2121184|NCT00968669|3719979|FG003|Overall Study|AE|0
2121185|NCT00968669|3719976|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
2121186|NCT00968669|3719977|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
2121187|NCT00968669|3719978|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
2121188|NCT00968669|3719979|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
2121189|NCT00968669|3719976|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
2121190|NCT00968669|3719977|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
2121191|NCT00968669|3719978|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
2121192|NCT00968669|3719979|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
2121193|NCT00968669|3719976|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
2121194|NCT00968669|3719977|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
2121195|NCT00968669|3719978|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
2121196|NCT00968669|3719979|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
2121197|NCT00968669|3719976|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
2121198|NCT00968669|3719977|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
2121199|NCT00968669|3719978|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
2121200|NCT00968669|3719979|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
2121201|NCT00968669|3719976|FG000|Overall Study|EARLY WITHDRAWAL|0
2121202|NCT00968669|3719977|FG001|Overall Study|EARLY WITHDRAWAL|1
2121203|NCT00968669|3719978|FG002|Overall Study|EARLY WITHDRAWAL|0
2121204|NCT00968669|3719979|FG003|Overall Study|EARLY WITHDRAWAL|0
2121205|NCT00968669|3719976|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0
2121206|NCT00968669|3719977|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0
2121207|NCT00968669|3719978|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1
2121208|NCT00968669|3719979|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0
2121209|NCT00968669|3719976|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1
2121210|NCT00968669|3719977|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0
2121211|NCT00968669|3719978|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0
2121212|NCT00968669|3719979|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0
2121213|NCT00968669|3719976|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
2041557|NCT00439777|3612297|FG001|Observational Period|Lost to Follow-up|11
2121214|NCT00968669|3719977|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
2121215|NCT00968669|3719978|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
2121216|NCT00968669|3719979|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
2121217|NCT00968669|3719976|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
2121218|NCT00968669|3719977|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
2121219|NCT00968669|3719978|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
2121220|NCT00968669|3719979|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
2121221|NCT00968669|3719976|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
2121222|NCT00968669|3719977|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
2121223|NCT00968669|3719978|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
2121224|NCT00968669|3719979|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
2121225|NCT00968669|3719976|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0
2121226|NCT00968669|3719977|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1
2121227|NCT00968669|3719978|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0
2121228|NCT00968669|3719979|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0
2121229|NCT00968669|3719976|FG000|Overall Study|SPONSOR DECISION|0
2121230|NCT00968669|3719977|FG001|Overall Study|SPONSOR DECISION|1
2121231|NCT00968669|3719978|FG002|Overall Study|SPONSOR DECISION|0
2121232|NCT00968669|3719979|FG003|Overall Study|SPONSOR DECISION|0
2121233|NCT00968669|3719976|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
2121234|NCT00968669|3719977|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
2121235|NCT00968669|3719978|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
2121236|NCT00968669|3719979|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
2121237|NCT00968669|3719976|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
2121238|NCT00968669|3719977|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
2121239|NCT00968669|3719978|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
2121240|NCT00968669|3719979|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
2121241|NCT00968669|3719976|FG000|Overall Study|SUBJECT INCARCERATED|0
2121242|NCT00968669|3719977|FG001|Overall Study|SUBJECT INCARCERATED|1
2121243|NCT00968669|3719978|FG002|Overall Study|SUBJECT INCARCERATED|0
2121244|NCT00968669|3719979|FG003|Overall Study|SUBJECT INCARCERATED|0
2121245|NCT00968669|3719976|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
2121246|NCT00968669|3719977|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
2121247|NCT00968669|3719978|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
2121248|NCT00968669|3719979|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
2121249|NCT00968669|3719976|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
2121250|NCT00968669|3719977|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
2204947|NCT01607892|3842891|FG001|Overall Study|Intercurrent illness|0
2204948|NCT01607892|3842892|FG002|Overall Study|Intercurrent illness|0
2204949|NCT01607892|3842893|FG003|Overall Study|Intercurrent illness|3
2204950|NCT01607892|3842894|FG004|Overall Study|Intercurrent illness|0
2204951|NCT01607892|3842890|FG000|Overall Study|Non-Compliance with study procedures|0
2204952|NCT01607892|3842891|FG001|Overall Study|Non-Compliance with study procedures|0
2204953|NCT01607892|3842892|FG002|Overall Study|Non-Compliance with study procedures|1
2204954|NCT01607892|3842893|FG003|Overall Study|Non-Compliance with study procedures|0
2204955|NCT01607892|3842894|FG004|Overall Study|Non-Compliance with study procedures|0
2204956|NCT01607892|3842890|FG000|Overall Study|Consent withdrawn by participant|9
2204957|NCT01607892|3842891|FG001|Overall Study|Consent withdrawn by participant|4
2204958|NCT01607892|3842892|FG002|Overall Study|Consent withdrawn by participant|24
2204959|NCT01607892|3842893|FG003|Overall Study|Consent withdrawn by participant|14
2204960|NCT01607892|3842894|FG004|Overall Study|Consent withdrawn by participant|4
2204961|NCT01607892|3842890|FG000|Overall Study|Disease progression|38
2204962|NCT01607892|3842891|FG001|Overall Study|Disease progression|13
2204963|NCT01607892|3842892|FG002|Overall Study|Disease progression|37
2204964|NCT01607892|3842893|FG003|Overall Study|Disease progression|57
2204965|NCT01607892|3842894|FG004|Overall Study|Disease progression|9
2121251|NCT00968669|3719978|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
2121252|NCT00968669|3719979|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
2121253|NCT00968708|3719991|FG000|Overall Study|Adverse Event|169
2121254|NCT00968708|3719992|FG001|Overall Study|Adverse Event|150
2121255|NCT00968708|3719991|FG000|Overall Study|Major Protocol Deviation|0
2121256|NCT00968708|3719992|FG001|Overall Study|Major Protocol Deviation|1
2121257|NCT00968708|3719991|FG000|Overall Study|Lost to Follow-up|19
2121258|NCT00968708|3719992|FG001|Overall Study|Lost to Follow-up|11
2121259|NCT00968708|3719991|FG000|Overall Study|Voluntary Withdrawal|104
2121260|NCT00968708|3719992|FG001|Overall Study|Voluntary Withdrawal|101
2121261|NCT00968708|3719991|FG000|Overall Study|Investigator Discretion|0
2121262|NCT00968708|3719992|FG001|Overall Study|Investigator Discretion|1
2121263|NCT00968708|3719991|FG000|Overall Study|Other|26
2121264|NCT00968708|3719992|FG001|Overall Study|Other|34
2121265|NCT00968799|3719998|FG000|Overall Study|Advanced disease, HIPEC not applicable|2
2121266|NCT00968812|3720005|FG000|Overall Study|Adverse Event|30
2121267|NCT00968812|3720006|FG001|Overall Study|Adverse Event|46
2121268|NCT00968812|3720007|FG002|Overall Study|Adverse Event|33
2121269|NCT00968812|3720005|FG000|Overall Study|Death|2
2121270|NCT00968812|3720006|FG001|Overall Study|Death|2
2204966|NCT01607892|3842890|FG000|Overall Study|Incidence or severity of Adverse events|3
2204967|NCT01607892|3842891|FG001|Overall Study|Incidence or severity of Adverse events|3
2121271|NCT00968812|3720007|FG002|Overall Study|Death|1
2121272|NCT00968812|3720005|FG000|Overall Study|Lack of Efficacy|9
2121273|NCT00968812|3720006|FG001|Overall Study|Lack of Efficacy|7
2121274|NCT00968812|3720007|FG002|Overall Study|Lack of Efficacy|16
2121275|NCT00968812|3720005|FG000|Overall Study|Lost to Follow-up|17
2121276|NCT00968812|3720006|FG001|Overall Study|Lost to Follow-up|12
2121277|NCT00968812|3720007|FG002|Overall Study|Lost to Follow-up|11
2121278|NCT00968812|3720005|FG000|Overall Study|Physician Decision|8
2121279|NCT00968812|3720006|FG001|Overall Study|Physician Decision|5
2121280|NCT00968812|3720007|FG002|Overall Study|Physician Decision|9
2121281|NCT00968812|3720005|FG000|Overall Study|Protocol Violation|7
2121282|NCT00968812|3720006|FG001|Overall Study|Protocol Violation|4
2121283|NCT00968812|3720007|FG002|Overall Study|Protocol Violation|3
2121284|NCT00968812|3720005|FG000|Overall Study|Withdrawal by Subject|17
2121285|NCT00968812|3720006|FG001|Overall Study|Withdrawal by Subject|23
2121286|NCT00968812|3720007|FG002|Overall Study|Withdrawal by Subject|25
2121287|NCT00968812|3720005|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9
2121288|NCT00968812|3720006|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13
2121289|NCT00968812|3720007|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7
2121290|NCT00968812|3720005|FG000|Overall Study|Noncompliance with study drug|4
2121291|NCT00968812|3720006|FG001|Overall Study|Noncompliance with study drug|1
2121292|NCT00968812|3720007|FG002|Overall Study|Noncompliance with study drug|6
2121293|NCT00968812|3720005|FG000|Overall Study|Unable to take rescue therapy|12
2121294|NCT00968812|3720006|FG001|Overall Study|Unable to take rescue therapy|12
2121295|NCT00968812|3720007|FG002|Overall Study|Unable to take rescue therapy|17
2121296|NCT00968812|3720005|FG000|Overall Study|Other|25
2204968|NCT01607892|3842892|FG002|Overall Study|Incidence or severity of Adverse events|7
2204969|NCT01607892|3842893|FG003|Overall Study|Incidence or severity of Adverse events|2
2204970|NCT01607892|3842894|FG004|Overall Study|Incidence or severity of Adverse events|6
2204971|NCT01607905|3842927|FG000|Overall Study|Withdrawal by participant|7
2204972|NCT01607905|3842928|FG001|Overall Study|Withdrawal by participant|2
2204973|NCT01607905|3842929|FG002|Overall Study|Withdrawal by participant|4
2204974|NCT01607905|3842930|FG003|Overall Study|Withdrawal by participant|6
2204975|NCT01607905|3842931|FG004|Overall Study|Withdrawal by participant|0
2204976|NCT01607905|3842932|FG005|Overall Study|Withdrawal by participant|4
2204977|NCT01607905|3842933|FG006|Overall Study|Withdrawal by participant|12
2277905|NCT02332707|3960580|FG016|Overall Study|Adverse Event|0
2277906|NCT02332707|3960581|FG017|Overall Study|Adverse Event|0
2277907|NCT02332707|3960564|FG000|Overall Study|Lost to Follow-up|0
2277908|NCT02332707|3960565|FG001|Overall Study|Lost to Follow-up|0
2277909|NCT02332707|3960566|FG002|Overall Study|Lost to Follow-up|0
2277910|NCT02332707|3960567|FG003|Overall Study|Lost to Follow-up|0
2277911|NCT02332707|3960568|FG004|Overall Study|Lost to Follow-up|0
2277912|NCT02332707|3960569|FG005|Overall Study|Lost to Follow-up|1
2277913|NCT02332707|3960570|FG006|Overall Study|Lost to Follow-up|0
2277914|NCT02332707|3960571|FG007|Overall Study|Lost to Follow-up|0
2277915|NCT02332707|3960572|FG008|Overall Study|Lost to Follow-up|0
2277916|NCT02332707|3960573|FG009|Overall Study|Lost to Follow-up|0
2277917|NCT02332707|3960574|FG010|Overall Study|Lost to Follow-up|2
2277918|NCT02332707|3960575|FG011|Overall Study|Lost to Follow-up|0
2277919|NCT02332707|3960576|FG012|Overall Study|Lost to Follow-up|3
2277920|NCT02332707|3960577|FG013|Overall Study|Lost to Follow-up|0
2277921|NCT02332707|3960578|FG014|Overall Study|Lost to Follow-up|0
2277922|NCT02332707|3960579|FG015|Overall Study|Lost to Follow-up|0
2277923|NCT02332707|3960580|FG016|Overall Study|Lost to Follow-up|0
2277924|NCT02332707|3960581|FG017|Overall Study|Lost to Follow-up|0
2277925|NCT02332707|3960564|FG000|Overall Study|Physician Decision|0
2277926|NCT02332707|3960565|FG001|Overall Study|Physician Decision|0
2277927|NCT02332707|3960566|FG002|Overall Study|Physician Decision|0
2277928|NCT02332707|3960567|FG003|Overall Study|Physician Decision|1
2277929|NCT02332707|3960568|FG004|Overall Study|Physician Decision|0
2277930|NCT02332707|3960569|FG005|Overall Study|Physician Decision|0
2277931|NCT02332707|3960570|FG006|Overall Study|Physician Decision|0
2277932|NCT02332707|3960571|FG007|Overall Study|Physician Decision|0
2277933|NCT02332707|3960572|FG008|Overall Study|Physician Decision|0
2277934|NCT02332707|3960573|FG009|Overall Study|Physician Decision|0
2277935|NCT02332707|3960574|FG010|Overall Study|Physician Decision|0
2277936|NCT02332707|3960575|FG011|Overall Study|Physician Decision|0
2277937|NCT02332707|3960576|FG012|Overall Study|Physician Decision|1
2277938|NCT02332707|3960577|FG013|Overall Study|Physician Decision|0
2277939|NCT02332707|3960578|FG014|Overall Study|Physician Decision|0
2277940|NCT02332707|3960579|FG015|Overall Study|Physician Decision|0
2277941|NCT02332707|3960580|FG016|Overall Study|Physician Decision|0
2277942|NCT02332707|3960581|FG017|Overall Study|Physician Decision|0
2277943|NCT02332707|3960564|FG000|Overall Study|Withdrawal by Subject|0
2277944|NCT02332707|3960565|FG001|Overall Study|Withdrawal by Subject|0
2277945|NCT02332707|3960566|FG002|Overall Study|Withdrawal by Subject|1
2277946|NCT02332707|3960567|FG003|Overall Study|Withdrawal by Subject|0
2277947|NCT02332707|3960568|FG004|Overall Study|Withdrawal by Subject|0
2277948|NCT02332707|3960569|FG005|Overall Study|Withdrawal by Subject|0
2277949|NCT02332707|3960570|FG006|Overall Study|Withdrawal by Subject|0
2277950|NCT02332707|3960571|FG007|Overall Study|Withdrawal by Subject|0
2277951|NCT02332707|3960572|FG008|Overall Study|Withdrawal by Subject|0
2277952|NCT02332707|3960573|FG009|Overall Study|Withdrawal by Subject|3
2277953|NCT02332707|3960574|FG010|Overall Study|Withdrawal by Subject|0
2204978|NCT01607905|3842927|FG000|Overall Study|Incidence or severity of AEs|5
2204979|NCT01607905|3842928|FG001|Overall Study|Incidence or severity of AEs|1
2204980|NCT01607905|3842929|FG002|Overall Study|Incidence or severity of AEs|1
2204981|NCT01607905|3842930|FG003|Overall Study|Incidence or severity of AEs|3
2204982|NCT01607905|3842931|FG004|Overall Study|Incidence or severity of AEs|0
2204983|NCT01607905|3842932|FG005|Overall Study|Incidence or severity of AEs|2
2121297|NCT00968812|3720006|FG001|Overall Study|Other|37
2121298|NCT00968812|3720007|FG002|Overall Study|Other|40
2121299|NCT00968864|3720027|FG000|Overall Study|Protocol exception/ not evaluable|1
2121300|NCT00968968|3720047|FG000|Overall Study|Study closed/terminated|10
2121301|NCT00968968|3720048|FG001|Overall Study|Study closed/terminated|10
2121302|NCT00968968|3720047|FG000|Overall Study|Protocol defined stopping criteria|3
2121303|NCT00968968|3720048|FG001|Overall Study|Protocol defined stopping criteria|1
2121304|NCT00968968|3720047|FG000|Overall Study|Withdrawal by Subject|2
2121305|NCT00968968|3720048|FG001|Overall Study|Withdrawal by Subject|0
2121306|NCT00968968|3720047|FG000|Overall Study|Physician Decision|1
2121307|NCT00968968|3720048|FG001|Overall Study|Physician Decision|2
2121308|NCT00968968|3720047|FG000|Overall Study|Lost to Follow-up|0
2121309|NCT00968968|3720048|FG001|Overall Study|Lost to Follow-up|1
2121310|NCT00968981|3720058|FG000|Overall Study|Adverse Event|2
2121311|NCT00968981|3720059|FG001|Overall Study|Adverse Event|0
2121312|NCT00968981|3720060|FG002|Overall Study|Adverse Event|0
2121313|NCT00968981|3720058|FG000|Overall Study|Disease Progression|14
2121314|NCT00968981|3720059|FG001|Overall Study|Disease Progression|16
2121315|NCT00968981|3720060|FG002|Overall Study|Disease Progression|13
2121316|NCT00968981|3720058|FG000|Overall Study|Lost to Follow-up|0
2121317|NCT00968981|3720059|FG001|Overall Study|Lost to Follow-up|0
2121318|NCT00968981|3720060|FG002|Overall Study|Lost to Follow-up|1
2121319|NCT00968981|3720058|FG000|Overall Study|Physician Decision|5
2121320|NCT00968981|3720059|FG001|Overall Study|Physician Decision|3
2121321|NCT00968981|3720060|FG002|Overall Study|Physician Decision|5
2121322|NCT00968981|3720058|FG000|Overall Study|Withdrawal by Subject|1
2121323|NCT00968981|3720059|FG001|Overall Study|Withdrawal by Subject|3
2121324|NCT00968981|3720060|FG002|Overall Study|Withdrawal by Subject|3
2121325|NCT00969124|3720069|FG000|Overall Study|Protocol Violation|2
2121326|NCT00969124|3720069|FG000|Overall Study|Inadequate bowel preparation|15
2121327|NCT00969124|3720069|FG000|Overall Study|Inability to reach cecum|9
2121328|NCT00969124|3720069|FG000|Overall Study|Previously unrecognized disease|3
2121329|NCT00969124|3720069|FG000|Overall Study|Technical error|1
2121330|NCT00969150|3720076|FG000|Overall Study|Adverse Event|4
2121331|NCT00969150|3720077|FG001|Overall Study|Adverse Event|14
2121332|NCT00969150|3720076|FG000|Overall Study|Lack of Efficacy|1
2121333|NCT00969150|3720077|FG001|Overall Study|Lack of Efficacy|1
2121334|NCT00969150|3720076|FG000|Overall Study|Protocol Violation|9
2204984|NCT01607905|3842933|FG006|Overall Study|Incidence or severity of AEs|8
2277954|NCT02332707|3960575|FG011|Overall Study|Withdrawal by Subject|0
2277955|NCT02332707|3960576|FG012|Overall Study|Withdrawal by Subject|0
2277956|NCT02332707|3960577|FG013|Overall Study|Withdrawal by Subject|0
2277957|NCT02332707|3960578|FG014|Overall Study|Withdrawal by Subject|0
2277958|NCT02332707|3960579|FG015|Overall Study|Withdrawal by Subject|0
2277959|NCT02332707|3960580|FG016|Overall Study|Withdrawal by Subject|0
2277960|NCT02332707|3960581|FG017|Overall Study|Withdrawal by Subject|0
2121335|NCT00969150|3720077|FG001|Overall Study|Protocol Violation|12
2204985|NCT01607905|3842927|FG000|Overall Study|Disease progression|44
2204986|NCT01607905|3842928|FG001|Overall Study|Disease progression|16
2204987|NCT01607905|3842929|FG002|Overall Study|Disease progression|15
2204988|NCT01607905|3842930|FG003|Overall Study|Disease progression|11
2204989|NCT01607905|3842931|FG004|Overall Study|Disease progression|6
2204990|NCT01607905|3842932|FG005|Overall Study|Disease progression|7
2204991|NCT01607905|3842933|FG006|Overall Study|Disease progression|21
2204992|NCT01607905|3842927|FG000|Overall Study|Non-compliance with study procedures|0
2204993|NCT01607905|3842928|FG001|Overall Study|Non-compliance with study procedures|0
2204994|NCT01607905|3842929|FG002|Overall Study|Non-compliance with study procedures|0
2204995|NCT01607905|3842930|FG003|Overall Study|Non-compliance with study procedures|0
2204996|NCT01607905|3842931|FG004|Overall Study|Non-compliance with study procedures|0
2204997|NCT01607905|3842932|FG005|Overall Study|Non-compliance with study procedures|0
2204998|NCT01607905|3842933|FG006|Overall Study|Non-compliance with study procedures|1
2204999|NCT01607905|3842927|FG000|Overall Study|Death|1
2205000|NCT01607905|3842928|FG001|Overall Study|Death|1
2205001|NCT01607905|3842929|FG002|Overall Study|Death|1
2205002|NCT01607905|3842930|FG003|Overall Study|Death|1
2205003|NCT01607905|3842931|FG004|Overall Study|Death|0
2205004|NCT01607905|3842932|FG005|Overall Study|Death|0
2205005|NCT01607905|3842933|FG006|Overall Study|Death|3
2205006|NCT01607905|3842927|FG000|Overall Study|Other treatments become available|1
2205007|NCT01607905|3842928|FG001|Overall Study|Other treatments become available|0
2205008|NCT01607905|3842929|FG002|Overall Study|Other treatments become available|0
2205009|NCT01607905|3842930|FG003|Overall Study|Other treatments become available|0
2205010|NCT01607905|3842931|FG004|Overall Study|Other treatments become available|0
2205011|NCT01607905|3842932|FG005|Overall Study|Other treatments become available|0
2277961|NCT02332720|3960642|FG000|Part A and Part B|Lost to Follow-up|1
2121336|NCT00969150|3720076|FG000|Overall Study|Withdrawal by Subject|13
2121337|NCT00969150|3720077|FG001|Overall Study|Withdrawal by Subject|9
2121338|NCT00969150|3720076|FG000|Overall Study|Lost to Follow-up|5
2121339|NCT00969150|3720077|FG001|Overall Study|Lost to Follow-up|4
2121340|NCT00969150|3720076|FG000|Overall Study|Other reasons|1
2121341|NCT00969150|3720077|FG001|Overall Study|Other reasons|0
2121342|NCT00969228|3720085|FG000|Overall Study|Adverse Event|1
2205012|NCT01607905|3842933|FG006|Overall Study|Other treatments become available|1
2205013|NCT01607905|3842927|FG000|Overall Study|Investigator discretion|0
2205014|NCT01607905|3842928|FG001|Overall Study|Investigator discretion|0
2205015|NCT01607905|3842929|FG002|Overall Study|Investigator discretion|0
2205016|NCT01607905|3842930|FG003|Overall Study|Investigator discretion|0
2205017|NCT01607905|3842931|FG004|Overall Study|Investigator discretion|0
2205018|NCT01607905|3842932|FG005|Overall Study|Investigator discretion|1
2205019|NCT01607905|3842933|FG006|Overall Study|Investigator discretion|0
2205020|NCT01607905|3842927|FG000|Overall Study|Other|1
2205021|NCT01607905|3842928|FG001|Overall Study|Other|0
2205022|NCT01607905|3842929|FG002|Overall Study|Other|0
2205023|NCT01607905|3842930|FG003|Overall Study|Other|0
2205024|NCT01607905|3842931|FG004|Overall Study|Other|0
2205025|NCT01607905|3842932|FG005|Overall Study|Other|0
2205026|NCT01607905|3842933|FG006|Overall Study|Other|1
2205027|NCT01607905|3842927|FG000|Overall Study|Randomized but not treated|1
2205028|NCT01607905|3842928|FG001|Overall Study|Randomized but not treated|0
2205029|NCT01607905|3842929|FG002|Overall Study|Randomized but not treated|0
2205030|NCT01607905|3842930|FG003|Overall Study|Randomized but not treated|0
2205031|NCT01607905|3842931|FG004|Overall Study|Randomized but not treated|1
2205032|NCT01607905|3842932|FG005|Overall Study|Randomized but not treated|1
2205033|NCT01607905|3842933|FG006|Overall Study|Randomized but not treated|0
2205034|NCT01607957|3842993|FG000|Overall Study|Not treated|1
2205035|NCT01607957|3842994|FG001|Overall Study|Not treated|1
2205036|NCT01607957|3842993|FG000|Overall Study|Death|367
2205037|NCT01607957|3842994|FG001|Overall Study|Death|211
2205038|NCT01607957|3842993|FG000|Overall Study|Lost to Follow-up|3
2205039|NCT01607957|3842994|FG001|Overall Study|Lost to Follow-up|3
2205040|NCT01607957|3842993|FG000|Overall Study|Participant refusal|1
2121343|NCT00969228|3720086|FG001|Overall Study|Adverse Event|0
2121344|NCT00969228|3720085|FG000|Overall Study|Withdrawal by Subject|4
2121345|NCT00969228|3720086|FG001|Overall Study|Withdrawal by Subject|0
2121346|NCT00969228|3720085|FG000|Overall Study|Porcine circovirus detection in vaccine|38
2121347|NCT00969228|3720086|FG001|Overall Study|Porcine circovirus detection in vaccine|14
2121348|NCT00969280|3720094|FG000|Overall Study|Protocol Violation|2
2121349|NCT00969280|3720095|FG001|Overall Study|Protocol Violation|1
2121350|NCT00969280|3720094|FG000|Overall Study|Withdrawal by Subject|0
2121351|NCT00969280|3720095|FG001|Overall Study|Withdrawal by Subject|1
2121352|NCT00969280|3720094|FG000|Overall Study|infection of influenza A(H1N1)|0
2121353|NCT00969280|3720095|FG001|Overall Study|infection of influenza A(H1N1)|1
2121354|NCT00969332|3720101|FG000|Overall Study|Physician Decision|8
2121355|NCT00969332|3720101|FG000|Overall Study|Withdrawal by Subject|3
2121356|NCT00969436|3720109|FG000|Overall Study|Protocol Violation|1
2121357|NCT00969436|3720110|FG001|Overall Study|Protocol Violation|3
2121358|NCT00969436|3720111|FG002|Overall Study|Protocol Violation|0
2121359|NCT00969436|3720109|FG000|Overall Study|Migrated/moved from study area|12
2121360|NCT00969436|3720110|FG001|Overall Study|Migrated/moved from study area|10
2121361|NCT00969436|3720111|FG002|Overall Study|Migrated/moved from study area|2
2121362|NCT00969436|3720109|FG000|Overall Study|Father - serious health problem|0
2121363|NCT00969436|3720110|FG001|Overall Study|Father - serious health problem|0
2121364|NCT00969436|3720111|FG002|Overall Study|Father - serious health problem|1
2121365|NCT00969436|3720109|FG000|Overall Study|Parents personal problem|0
2121366|NCT00969436|3720110|FG001|Overall Study|Parents personal problem|0
2121367|NCT00969436|3720111|FG002|Overall Study|Parents personal problem|1
2121368|NCT00969436|3720109|FG000|Overall Study|Subject eliminated (other vaccine)|1
2121369|NCT00969436|3720110|FG001|Overall Study|Subject eliminated (other vaccine)|0
2121370|NCT00969436|3720111|FG002|Overall Study|Subject eliminated (other vaccine)|0
2121371|NCT00969436|3720109|FG000|Overall Study|Withdrawal by Subject|3
2121372|NCT00969436|3720110|FG001|Overall Study|Withdrawal by Subject|0
2121373|NCT00969436|3720111|FG002|Overall Study|Withdrawal by Subject|2
2121374|NCT00969436|3720109|FG000|Overall Study|Lost to Follow-up|8
2121375|NCT00969436|3720110|FG001|Overall Study|Lost to Follow-up|8
2121376|NCT00969436|3720111|FG002|Overall Study|Lost to Follow-up|5
2121377|NCT00969540|3720125|FG000|Overall Study|Lost to Follow-up|1
2121378|NCT00969540|3720126|FG001|Overall Study|Lost to Follow-up|1
2121379|NCT00969553|3720153|FG000|Overall Study|Progressive disease (PD)|2
2121380|NCT00969553|3720154|FG001|Overall Study|Progressive disease (PD)|2
2121381|NCT00969553|3720155|FG002|Overall Study|Progressive disease (PD)|6
2121382|NCT00969553|3720156|FG003|Overall Study|Progressive disease (PD)|9
2121383|NCT00969553|3720157|FG004|Overall Study|Progressive disease (PD)|2
2121384|NCT00969553|3720158|FG005|Overall Study|Progressive disease (PD)|4
2121385|NCT00969553|3720159|FG006|Overall Study|Progressive disease (PD)|2
2121386|NCT00969553|3720160|FG007|Overall Study|Progressive disease (PD)|12
2121387|NCT00969553|3720161|FG008|Overall Study|Progressive disease (PD)|3
2177835|NCT01378104|3802245|FG000|Overall Study|Lack of Efficacy|7
2205041|NCT01607957|3842994|FG001|Overall Study|Participant refusal|0
2121388|NCT00969553|3720153|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
2121389|NCT00969553|3720154|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
2121390|NCT00969553|3720155|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
2121391|NCT00969553|3720156|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
2121392|NCT00969553|3720157|FG004|Overall Study|Dose limiting Toxicity (DLT)|1
2121393|NCT00969553|3720158|FG005|Overall Study|Dose limiting Toxicity (DLT)|0
2121394|NCT00969553|3720159|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
2121395|NCT00969553|3720160|FG007|Overall Study|Dose limiting Toxicity (DLT)|0
2121396|NCT00969553|3720161|FG008|Overall Study|Dose limiting Toxicity (DLT)|0
2121397|NCT00969553|3720153|FG000|Overall Study|Other Adverse Event|0
2121398|NCT00969553|3720154|FG001|Overall Study|Other Adverse Event|0
2121399|NCT00969553|3720155|FG002|Overall Study|Other Adverse Event|0
2121400|NCT00969553|3720156|FG003|Overall Study|Other Adverse Event|1
2121401|NCT00969553|3720157|FG004|Overall Study|Other Adverse Event|0
2121402|NCT00969553|3720158|FG005|Overall Study|Other Adverse Event|0
2121403|NCT00969553|3720159|FG006|Overall Study|Other Adverse Event|1
2121404|NCT00969553|3720160|FG007|Overall Study|Other Adverse Event|0
2121405|NCT00969553|3720161|FG008|Overall Study|Other Adverse Event|0
2121406|NCT00969553|3720153|FG000|Overall Study|Refused cont. medication|1
2121407|NCT00969553|3720154|FG001|Overall Study|Refused cont. medication|1
2121408|NCT00969553|3720155|FG002|Overall Study|Refused cont. medication|0
2121409|NCT00969553|3720156|FG003|Overall Study|Refused cont. medication|2
2121410|NCT00969553|3720157|FG004|Overall Study|Refused cont. medication|0
2121411|NCT00969553|3720158|FG005|Overall Study|Refused cont. medication|0
2121412|NCT00969553|3720159|FG006|Overall Study|Refused cont. medication|0
2121413|NCT00969553|3720160|FG007|Overall Study|Refused cont. medication|1
2121414|NCT00969553|3720161|FG008|Overall Study|Refused cont. medication|0
2121415|NCT00969553|3720153|FG000|Overall Study|Not specified above|0
2121416|NCT00969553|3720154|FG001|Overall Study|Not specified above|0
2277962|NCT02332720|3960643|FG001|Part A and Part B|Lost to Follow-up|0
2277963|NCT02332720|3960644|FG002|Part A and Part B|Lost to Follow-up|0
2277964|NCT02332720|3960645|FG003|Part A and Part B|Lost to Follow-up|0
2277965|NCT02332720|3960646|FG004|Part A and Part B|Lost to Follow-up|0
2277966|NCT02332720|3960647|FG005|Part A and Part B|Lost to Follow-up|2
2277967|NCT02332720|3960648|FG006|Part A and Part B|Lost to Follow-up|1
2277968|NCT02332720|3960649|FG007|Part A and Part B|Lost to Follow-up|1
2277969|NCT02332720|3960650|FG008|Part A and Part B|Lost to Follow-up|0
2277970|NCT02332720|3960651|FG009|Part A and Part B|Lost to Follow-up|0
2277971|NCT02332720|3960652|FG010|Part A and Part B|Lost to Follow-up|0
2277972|NCT02332720|3960653|FG011|Part A and Part B|Lost to Follow-up|0
2277973|NCT02332720|3960654|FG012|Part A and Part B|Lost to Follow-up|0
2277974|NCT02332720|3960655|FG013|Part A and Part B|Lost to Follow-up|0
2277975|NCT02332720|3960656|FG014|Part A and Part B|Lost to Follow-up|0
2277976|NCT02332720|3960657|FG015|Part A and Part B|Lost to Follow-up|1
2277977|NCT02332720|3960658|FG016|Part A and Part B|Lost to Follow-up|0
2277978|NCT02332720|3960659|FG017|Part A and Part B|Lost to Follow-up|0
2277979|NCT02332720|3960660|FG018|Part A and Part B|Lost to Follow-up|0
2277980|NCT02332720|3960661|FG019|Part A and Part B|Lost to Follow-up|0
2277981|NCT02332720|3960662|FG020|Part A and Part B|Lost to Follow-up|0
2277982|NCT02332720|3960663|FG021|Part A and Part B|Lost to Follow-up|0
2277983|NCT02332720|3960664|FG022|Part A and Part B|Lost to Follow-up|0
2277984|NCT02332720|3960642|FG000|Part A and Part B|Adverse Event|0
2277985|NCT02332720|3960643|FG001|Part A and Part B|Adverse Event|0
2277986|NCT02332720|3960644|FG002|Part A and Part B|Adverse Event|0
2277987|NCT02332720|3960645|FG003|Part A and Part B|Adverse Event|0
2277988|NCT02332720|3960646|FG004|Part A and Part B|Adverse Event|0
2277989|NCT02332720|3960647|FG005|Part A and Part B|Adverse Event|0
2277990|NCT02332720|3960648|FG006|Part A and Part B|Adverse Event|0
2277991|NCT02332720|3960649|FG007|Part A and Part B|Adverse Event|0
2277992|NCT02332720|3960650|FG008|Part A and Part B|Adverse Event|0
2277993|NCT02332720|3960651|FG009|Part A and Part B|Adverse Event|0
2277994|NCT02332720|3960652|FG010|Part A and Part B|Adverse Event|0
2277995|NCT02332720|3960653|FG011|Part A and Part B|Adverse Event|0
2277996|NCT02332720|3960654|FG012|Part A and Part B|Adverse Event|0
2277997|NCT02332720|3960655|FG013|Part A and Part B|Adverse Event|0
2277998|NCT02332720|3960656|FG014|Part A and Part B|Adverse Event|0
2277999|NCT02332720|3960657|FG015|Part A and Part B|Adverse Event|0
2278000|NCT02332720|3960658|FG016|Part A and Part B|Adverse Event|0
2278001|NCT02332720|3960659|FG017|Part A and Part B|Adverse Event|1
2278002|NCT02332720|3960660|FG018|Part A and Part B|Adverse Event|0
2278003|NCT02332720|3960661|FG019|Part A and Part B|Adverse Event|0
2278004|NCT02332720|3960662|FG020|Part A and Part B|Adverse Event|0
2278005|NCT02332720|3960663|FG021|Part A and Part B|Adverse Event|0
2278006|NCT02332720|3960664|FG022|Part A and Part B|Adverse Event|0
2278007|NCT02332720|3960642|FG000|Part A and Part B|Physician Decision|0
2278008|NCT02332720|3960643|FG001|Part A and Part B|Physician Decision|0
2278009|NCT02332720|3960644|FG002|Part A and Part B|Physician Decision|0
2278010|NCT02332720|3960645|FG003|Part A and Part B|Physician Decision|0
2278011|NCT02332720|3960646|FG004|Part A and Part B|Physician Decision|0
2278012|NCT02332720|3960647|FG005|Part A and Part B|Physician Decision|0
2121417|NCT00969553|3720155|FG002|Overall Study|Not specified above|0
2121418|NCT00969553|3720156|FG003|Overall Study|Not specified above|4
2121419|NCT00969553|3720157|FG004|Overall Study|Not specified above|0
2121420|NCT00969553|3720158|FG005|Overall Study|Not specified above|0
2121421|NCT00969553|3720159|FG006|Overall Study|Not specified above|1
2121422|NCT00969553|3720160|FG007|Overall Study|Not specified above|1
2121423|NCT00969553|3720161|FG008|Overall Study|Not specified above|0
2121424|NCT00969618|3720189|FG000|Overall Study|Adverse Event|29
2278013|NCT02332720|3960648|FG006|Part A and Part B|Physician Decision|0
2278014|NCT02332720|3960649|FG007|Part A and Part B|Physician Decision|0
2278015|NCT02332720|3960650|FG008|Part A and Part B|Physician Decision|0
2278016|NCT02332720|3960651|FG009|Part A and Part B|Physician Decision|0
2278017|NCT02332720|3960652|FG010|Part A and Part B|Physician Decision|0
2278018|NCT02332720|3960653|FG011|Part A and Part B|Physician Decision|0
2278019|NCT02332720|3960654|FG012|Part A and Part B|Physician Decision|0
2278020|NCT02332720|3960655|FG013|Part A and Part B|Physician Decision|0
2278021|NCT02332720|3960656|FG014|Part A and Part B|Physician Decision|0
2278022|NCT02332720|3960657|FG015|Part A and Part B|Physician Decision|0
2278023|NCT02332720|3960658|FG016|Part A and Part B|Physician Decision|0
2278024|NCT02332720|3960659|FG017|Part A and Part B|Physician Decision|0
2278025|NCT02332720|3960660|FG018|Part A and Part B|Physician Decision|1
2278026|NCT02332720|3960661|FG019|Part A and Part B|Physician Decision|0
2278027|NCT02332720|3960662|FG020|Part A and Part B|Physician Decision|0
2278028|NCT02332720|3960663|FG021|Part A and Part B|Physician Decision|0
2278029|NCT02332720|3960664|FG022|Part A and Part B|Physician Decision|0
2278030|NCT02332720|3960642|FG000|Part A and Part B|Withdrawal by Subject|0
2278031|NCT02332720|3960643|FG001|Part A and Part B|Withdrawal by Subject|0
2278032|NCT02332720|3960644|FG002|Part A and Part B|Withdrawal by Subject|0
2278033|NCT02332720|3960645|FG003|Part A and Part B|Withdrawal by Subject|0
2278034|NCT02332720|3960646|FG004|Part A and Part B|Withdrawal by Subject|0
2278035|NCT02332720|3960647|FG005|Part A and Part B|Withdrawal by Subject|1
2278036|NCT02332720|3960648|FG006|Part A and Part B|Withdrawal by Subject|0
2278037|NCT02332720|3960649|FG007|Part A and Part B|Withdrawal by Subject|0
2278038|NCT02332720|3960650|FG008|Part A and Part B|Withdrawal by Subject|0
2278039|NCT02332720|3960651|FG009|Part A and Part B|Withdrawal by Subject|0
2278040|NCT02332720|3960652|FG010|Part A and Part B|Withdrawal by Subject|0
2278041|NCT02332720|3960653|FG011|Part A and Part B|Withdrawal by Subject|0
2278042|NCT02332720|3960654|FG012|Part A and Part B|Withdrawal by Subject|0
2278043|NCT02332720|3960655|FG013|Part A and Part B|Withdrawal by Subject|0
2278044|NCT02332720|3960656|FG014|Part A and Part B|Withdrawal by Subject|0
2278045|NCT02332720|3960657|FG015|Part A and Part B|Withdrawal by Subject|0
2278046|NCT02332720|3960658|FG016|Part A and Part B|Withdrawal by Subject|0
2278047|NCT02332720|3960659|FG017|Part A and Part B|Withdrawal by Subject|0
2278048|NCT02332720|3960660|FG018|Part A and Part B|Withdrawal by Subject|0
2278049|NCT02332720|3960661|FG019|Part A and Part B|Withdrawal by Subject|1
2278050|NCT02332720|3960662|FG020|Part A and Part B|Withdrawal by Subject|0
2278051|NCT02332720|3960663|FG021|Part A and Part B|Withdrawal by Subject|0
2278052|NCT02332720|3960664|FG022|Part A and Part B|Withdrawal by Subject|0
2278053|NCT02332798|3960729|FG000|Overall Study|Unwilling to Participate in Study|0
2278054|NCT02332798|3960730|FG001|Overall Study|Unwilling to Participate in Study|1
2278055|NCT02332798|3960731|FG002|Overall Study|Unwilling to Participate in Study|1
2278056|NCT02332798|3960729|FG000|Overall Study|Positive Urine Drug Test|0
2278057|NCT02332798|3960730|FG001|Overall Study|Positive Urine Drug Test|1
2278058|NCT02332798|3960731|FG002|Overall Study|Positive Urine Drug Test|0
2278059|NCT02332798|3960729|FG000|Overall Study|Abnormal Laboratory Findings|1
2278060|NCT02332798|3960730|FG001|Overall Study|Abnormal Laboratory Findings|0
2278061|NCT02332798|3960731|FG002|Overall Study|Abnormal Laboratory Findings|0
2278062|NCT02332824|3960745|FG000|Overall Study|Pretreatment Event/Adverse Event|4
2278063|NCT02332824|3960746|FG001|Overall Study|Pretreatment Event/Adverse Event|0
2278064|NCT02332824|3960747|FG002|Overall Study|Pretreatment Event/Adverse Event|1
2278065|NCT02332824|3960748|FG003|Overall Study|Pretreatment Event/Adverse Event|1
2278066|NCT02332824|3960749|FG004|Overall Study|Pretreatment Event/Adverse Event|4
2278067|NCT02332824|3960750|FG005|Overall Study|Pretreatment Event/Adverse Event|1
2278068|NCT02332824|3960745|FG000|Overall Study|Voluntary Withdrawal|1
2278069|NCT02332824|3960746|FG001|Overall Study|Voluntary Withdrawal|0
2278070|NCT02332824|3960747|FG002|Overall Study|Voluntary Withdrawal|0
2278071|NCT02332824|3960748|FG003|Overall Study|Voluntary Withdrawal|0
2278072|NCT02332824|3960749|FG004|Overall Study|Voluntary Withdrawal|0
2278073|NCT02332824|3960750|FG005|Overall Study|Voluntary Withdrawal|0
2278074|NCT02332824|3960745|FG000|Overall Study|Inconvenient schedule|1
2278075|NCT02332824|3960746|FG001|Overall Study|Inconvenient schedule|1
2278076|NCT02332824|3960747|FG002|Overall Study|Inconvenient schedule|0
2278077|NCT02332824|3960748|FG003|Overall Study|Inconvenient schedule|0
2278078|NCT02332824|3960749|FG004|Overall Study|Inconvenient schedule|0
2278079|NCT02332824|3960750|FG005|Overall Study|Inconvenient schedule|0
2278080|NCT02332824|3960745|FG000|Overall Study|Transfer|0
2278081|NCT02332824|3960746|FG001|Overall Study|Transfer|0
2278082|NCT02332824|3960747|FG002|Overall Study|Transfer|1
2278083|NCT02332824|3960748|FG003|Overall Study|Transfer|1
2278084|NCT02332824|3960749|FG004|Overall Study|Transfer|0
2278085|NCT02332824|3960750|FG005|Overall Study|Transfer|0
2278086|NCT02332876|3960775|FG000|Overall Study|Lost to Follow-up|1
2278087|NCT02332876|3960776|FG001|Overall Study|Lost to Follow-up|1
2278088|NCT02332889|3960782|FG000|Overall Study|Physician Decision|1
2121425|NCT00969618|3720189|FG000|Overall Study|Entry Criteria Not Met|3
2121426|NCT00969618|3720189|FG000|Overall Study|Lack of Efficacy|2
2121427|NCT00969618|3720189|FG000|Overall Study|Lost to Follow-up|7
2121428|NCT00969618|3720189|FG000|Overall Study|Physician Decision|1
2121429|NCT00969618|3720189|FG000|Overall Study|Protocol Violation|9
2121430|NCT00969618|3720189|FG000|Overall Study|Withdrawal by Subject|27
2121431|NCT00969709|3720197|FG000|Overall Study|Adverse Event|3
2121432|NCT00969709|3720198|FG001|Overall Study|Adverse Event|13
2121433|NCT00969709|3720199|FG002|Overall Study|Adverse Event|26
2121434|NCT00969709|3720200|FG003|Overall Study|Adverse Event|12
2121435|NCT00969709|3720197|FG000|Overall Study|Lack of Efficacy|7
2121436|NCT00969709|3720198|FG001|Overall Study|Lack of Efficacy|4
2121437|NCT00969709|3720199|FG002|Overall Study|Lack of Efficacy|1
2121438|NCT00969709|3720200|FG003|Overall Study|Lack of Efficacy|3
2121439|NCT00969709|3720197|FG000|Overall Study|Protocol Violation|9
2121440|NCT00969709|3720198|FG001|Overall Study|Protocol Violation|5
2121441|NCT00969709|3720199|FG002|Overall Study|Protocol Violation|9
2121442|NCT00969709|3720200|FG003|Overall Study|Protocol Violation|10
2121443|NCT00969709|3720197|FG000|Overall Study|Withdrawal by Subject|9
2121444|NCT00969709|3720198|FG001|Overall Study|Withdrawal by Subject|12
2121445|NCT00969709|3720199|FG002|Overall Study|Withdrawal by Subject|11
2121446|NCT00969709|3720200|FG003|Overall Study|Withdrawal by Subject|23
2121447|NCT00969709|3720197|FG000|Overall Study|Lost to Follow-up|10
2121448|NCT00969709|3720198|FG001|Overall Study|Lost to Follow-up|14
2121449|NCT00969709|3720199|FG002|Overall Study|Lost to Follow-up|8
2121450|NCT00969709|3720200|FG003|Overall Study|Lost to Follow-up|15
2121451|NCT00969709|3720197|FG000|Overall Study|Other reasons|0
2121452|NCT00969709|3720198|FG001|Overall Study|Other reasons|0
2121453|NCT00969709|3720199|FG002|Overall Study|Other reasons|3
2121454|NCT00969709|3720200|FG003|Overall Study|Other reasons|0
2121455|NCT00969761|3720226|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2121456|NCT00969761|3720227|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2121457|NCT00969761|3720228|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2121458|NCT00969761|3720229|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2121459|NCT00969761|3720230|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2121460|NCT00969761|3720231|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2278089|NCT02332915|3960792|FG000|Overall Study|Moved out of region|3
2278090|NCT02332915|3960793|FG001|Overall Study|Moved out of region|0
2278091|NCT02332915|3960792|FG000|Overall Study|Unrelated illness|1
2278092|NCT02332915|3960793|FG001|Overall Study|Unrelated illness|1
2278093|NCT02332915|3960792|FG000|Overall Study|Travel distance prohibitive|0
2278094|NCT02332915|3960793|FG001|Overall Study|Travel distance prohibitive|1
2278095|NCT02332915|3960792|FG000|Overall Study|did not meet inclusion criteria|2
2278096|NCT02332915|3960793|FG001|Overall Study|did not meet inclusion criteria|4
2278097|NCT02333331|3960828|FG000|Overall Study|Adverse Event|1
2278098|NCT02333331|3960829|FG001|Overall Study|Adverse Event|0
2278099|NCT02333331|3960830|FG002|Overall Study|Adverse Event|4
2278100|NCT02333331|3960831|FG003|Overall Study|Adverse Event|1
2278101|NCT02333331|3960828|FG000|Overall Study|Death|0
2278102|NCT02333331|3960829|FG001|Overall Study|Death|0
2278103|NCT02333331|3960830|FG002|Overall Study|Death|2
2278104|NCT02333331|3960831|FG003|Overall Study|Death|0
2278105|NCT02333331|3960828|FG000|Overall Study|Lost to Follow-up|0
2278106|NCT02333331|3960829|FG001|Overall Study|Lost to Follow-up|0
2278107|NCT02333331|3960830|FG002|Overall Study|Lost to Follow-up|1
2278108|NCT02333331|3960831|FG003|Overall Study|Lost to Follow-up|0
2278109|NCT02333331|3960828|FG000|Overall Study|Physician Decision|0
2278110|NCT02333331|3960829|FG001|Overall Study|Physician Decision|1
2278111|NCT02333331|3960830|FG002|Overall Study|Physician Decision|0
2278112|NCT02333331|3960831|FG003|Overall Study|Physician Decision|0
2278113|NCT02333331|3960828|FG000|Overall Study|Protocol Deviation|0
2278114|NCT02333331|3960829|FG001|Overall Study|Protocol Deviation|3
2278115|NCT02333331|3960830|FG002|Overall Study|Protocol Deviation|2
2278116|NCT02333331|3960831|FG003|Overall Study|Protocol Deviation|1
2278117|NCT02333331|3960828|FG000|Overall Study|Patient/Guardian Decision|1
2278118|NCT02333331|3960829|FG001|Overall Study|Patient/Guardian Decision|2
2278119|NCT02333331|3960830|FG002|Overall Study|Patient/Guardian Decision|9
2278120|NCT02333331|3960831|FG003|Overall Study|Patient/Guardian Decision|1
2278121|NCT02333383|3960841|FG000|Overall Study|Adalimumab discontinuation|21
2278122|NCT02333383|3960841|FG000|Overall Study|Lost to Follow-up|15
2278123|NCT02333383|3960841|FG000|Overall Study|Withdrawal by Subject|3
2278124|NCT02333383|3960841|FG000|Overall Study|Transfer to another hospital|2
2278125|NCT02333487|3960848|FG000|Overall Study|Adverse Event|0
2278126|NCT02333487|3960849|FG001|Overall Study|Adverse Event|2
2278127|NCT02333487|3960850|FG002|Overall Study|Adverse Event|0
2121461|NCT00969761|3720232|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2121462|NCT00969761|3720233|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2121463|NCT00969761|3720234|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2121464|NCT00969761|3720235|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2278128|NCT02333630|3960861|FG000|Overall Study|Lost to Follow-up|5
2278129|NCT02333630|3960862|FG001|Overall Study|Lost to Follow-up|2
2278130|NCT02334215|3960888|FG000|Overall Study|Death|1
2278131|NCT02334215|3960889|FG001|Overall Study|Death|1
2278132|NCT02334215|3960890|FG002|Overall Study|Death|0
2278133|NCT02334215|3960888|FG000|Overall Study|Lost to Follow-up|1
2121465|NCT00969761|3720236|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2121466|NCT00969761|3720237|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2121467|NCT00969761|3720226|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2121468|NCT00969761|3720227|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2121469|NCT00969761|3720228|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
2121470|NCT00969761|3720229|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2121471|NCT00969761|3720230|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2121472|NCT00969761|3720231|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2121473|NCT00969761|3720232|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2121474|NCT00969761|3720233|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2121475|NCT00969761|3720234|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2121476|NCT00969761|3720235|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2121477|NCT00969761|3720236|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2121478|NCT00969761|3720237|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2278134|NCT02334215|3960889|FG001|Overall Study|Lost to Follow-up|0
2278135|NCT02334215|3960890|FG002|Overall Study|Lost to Follow-up|4
2278136|NCT02334215|3960888|FG000|Overall Study|Withdrawal by Subject|2
2278137|NCT02334215|3960889|FG001|Overall Study|Withdrawal by Subject|2
2278138|NCT02334215|3960890|FG002|Overall Study|Withdrawal by Subject|1
2278139|NCT02334215|3960888|FG000|Overall Study|Not released from incarceration on time|3
2278140|NCT02334215|3960889|FG001|Overall Study|Not released from incarceration on time|3
2278141|NCT02334215|3960890|FG002|Overall Study|Not released from incarceration on time|3
2278142|NCT02334215|3960888|FG000|Overall Study|Incarcerated|0
2278143|NCT02334215|3960889|FG001|Overall Study|Incarcerated|0
2278144|NCT02334215|3960890|FG002|Overall Study|Incarcerated|7
2278145|NCT02334306|3960915|FG000|Double-blind Period|Adverse Event|0
2278146|NCT02334306|3960916|FG001|Double-blind Period|Adverse Event|1
2278147|NCT02334306|3960915|FG000|Double-blind Period|Withdrawal by Subject|1
2278148|NCT02334306|3960916|FG001|Double-blind Period|Withdrawal by Subject|1
2278149|NCT02334384|3960929|FG000|Overall Study|Lost to Follow-up|1
2278150|NCT02334384|3960930|FG001|Overall Study|Lost to Follow-up|1
2278151|NCT02334423|3960938|FG000|Overall Study|Protocol Violation|10
2278152|NCT02334423|3960939|FG001|Overall Study|Protocol Violation|3
2278153|NCT02334683|3960964|FG000|First 12 Week Period|Lost to Follow-up|1
2278154|NCT02334683|3960965|FG001|First 12 Week Period|Lost to Follow-up|0
2278155|NCT02334683|3960964|FG000|Second 12 Week Period|Adverse Event|0
2278156|NCT02334683|3960965|FG001|Second 12 Week Period|Adverse Event|1
2278157|NCT02334748|3960971|FG000|Overall Study|Adverse Event|1
2278158|NCT02334748|3960971|FG000|Overall Study|Inclusion in the CACZ8852306 study|1
2278159|NCT02334748|3960971|FG000|Overall Study|Patient no longer required study drug|2
2278160|NCT02334748|3960971|FG000|Overall Study|Lack of Efficacy|4
2278161|NCT02335346|3961106|FG000|Overall Study|Adverse Event|11
2278162|NCT02335346|3961106|FG000|Overall Study|Withdrawal by Subject|1
2278163|NCT02335450|3961110|FG000|Overall Study|Pregnancy|1
2278164|NCT02335489|3961120|FG000|Overall Study|Sponsor terminated study|4
2278165|NCT02335489|3961120|FG000|Overall Study|Lost to Follow-up|1
2278166|NCT02335489|3961120|FG000|Overall Study|Withdrawal by Subject|2
2278167|NCT02335489|3961120|FG000|Overall Study|Physician Decision|2
2278168|NCT02335489|3961120|FG000|Overall Study|Lack of Efficacy|1
2278169|NCT02335658|3961130|FG000|Overall Study|Adverse Event|18
2278170|NCT02335658|3961131|FG001|Overall Study|Adverse Event|12
2278171|NCT02335658|3961130|FG000|Overall Study|Lack of Efficacy|4
2278172|NCT02335658|3961131|FG001|Overall Study|Lack of Efficacy|5
2278173|NCT02335658|3961130|FG000|Overall Study|Pregnancy|1
2278174|NCT02335658|3961131|FG001|Overall Study|Pregnancy|0
2278175|NCT02335658|3961130|FG000|Overall Study|Withdrawal by Subject|13
2278176|NCT02335658|3961131|FG001|Overall Study|Withdrawal by Subject|21
2278177|NCT02335658|3961130|FG000|Overall Study|non-compliance|2
2278178|NCT02335658|3961131|FG001|Overall Study|non-compliance|3
2278179|NCT02335658|3961130|FG000|Overall Study|other reason|2
2278180|NCT02335658|3961131|FG001|Overall Study|other reason|3
2278181|NCT02335983|3961158|FG000|Overall Study|Sponsor Decision|0
2278182|NCT02335983|3961159|FG001|Overall Study|Sponsor Decision|0
2278183|NCT02335983|3961160|FG002|Overall Study|Sponsor Decision|1
2278184|NCT02335983|3961161|FG003|Overall Study|Sponsor Decision|1
2278185|NCT02335983|3961162|FG004|Overall Study|Sponsor Decision|0
2278186|NCT02335983|3961163|FG005|Overall Study|Sponsor Decision|1
2278187|NCT02335983|3961158|FG000|Overall Study|Withdrawal by Subject|3
2278188|NCT02335983|3961159|FG001|Overall Study|Withdrawal by Subject|2
2278189|NCT02335983|3961160|FG002|Overall Study|Withdrawal by Subject|2
2278190|NCT02335983|3961161|FG003|Overall Study|Withdrawal by Subject|1
2278191|NCT02335983|3961162|FG004|Overall Study|Withdrawal by Subject|3
2278192|NCT02335983|3961163|FG005|Overall Study|Withdrawal by Subject|9
2278193|NCT02335983|3961158|FG000|Overall Study|Death|0
2278194|NCT02335983|3961159|FG001|Overall Study|Death|0
2278195|NCT02335983|3961160|FG002|Overall Study|Death|2
2278196|NCT02335983|3961161|FG003|Overall Study|Death|0
2278197|NCT02335983|3961162|FG004|Overall Study|Death|0
2278198|NCT02335983|3961163|FG005|Overall Study|Death|0
2278199|NCT02335983|3961158|FG000|Overall Study|Lost to Follow-up|0
2121479|NCT00969761|3720226|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2121480|NCT00969761|3720227|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2121481|NCT00969761|3720228|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
2121482|NCT00969761|3720229|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2121483|NCT00969761|3720230|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2121484|NCT00969761|3720231|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2121485|NCT00969761|3720232|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2121486|NCT00969761|3720233|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2121487|NCT00969761|3720234|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2121488|NCT00969761|3720235|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2121489|NCT00969761|3720236|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2121490|NCT00969761|3720237|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2121491|NCT00969761|3720226|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2121492|NCT00969761|3720227|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2121493|NCT00969761|3720228|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2205042|NCT01608087|3843013|FG000|Overall Study|Lost to Follow-up|0
2205043|NCT01608087|3843014|FG001|Overall Study|Lost to Follow-up|1
2205044|NCT01608087|3843015|FG002|Overall Study|Lost to Follow-up|0
2205045|NCT01608087|3843013|FG000|Overall Study|Other Reason|0
2205046|NCT01608087|3843014|FG001|Overall Study|Other Reason|1
2205047|NCT01608087|3843015|FG002|Overall Study|Other Reason|0
2205048|NCT01608308|3843061|FG000|Overall Study|pretreatment medical and billing reasons|0
2205049|NCT01608308|3843062|FG001|Overall Study|pretreatment medical and billing reasons|2
2205050|NCT01608321|3843070|FG000|Overall Study|Withdrawal by Subject|1
2205051|NCT01608321|3843071|FG001|Overall Study|Withdrawal by Subject|0
2205052|NCT01608724|3843094|FG000|Overall Study|Withdrawal by Subject|131
2205053|NCT01608724|3843094|FG000|Overall Study|Lost to Follow-up|41
2278200|NCT02335983|3961159|FG001|Overall Study|Lost to Follow-up|0
2278201|NCT02335983|3961160|FG002|Overall Study|Lost to Follow-up|0
2278202|NCT02335983|3961161|FG003|Overall Study|Lost to Follow-up|0
2278203|NCT02335983|3961162|FG004|Overall Study|Lost to Follow-up|0
2278204|NCT02335983|3961163|FG005|Overall Study|Lost to Follow-up|1
2278205|NCT02335983|3961158|FG000|Overall Study|Protocol Specified Criteria|5
2278206|NCT02335983|3961159|FG001|Overall Study|Protocol Specified Criteria|7
2278207|NCT02335983|3961160|FG002|Overall Study|Protocol Specified Criteria|27
2278208|NCT02335983|3961161|FG003|Overall Study|Protocol Specified Criteria|7
2278209|NCT02335983|3961162|FG004|Overall Study|Protocol Specified Criteria|5
2278210|NCT02335983|3961163|FG005|Overall Study|Protocol Specified Criteria|21
2278211|NCT02336074|3961188|FG000|Overall Study|Adverse Event|0
2278212|NCT02336074|3961189|FG001|Overall Study|Adverse Event|2
2278213|NCT02336165|3961205|FG000|Overall Study|Death|3
2278214|NCT02336165|3961206|FG001|Overall Study|Death|0
2278215|NCT02336165|3961207|FG002|Overall Study|Death|0
2278216|NCT02336165|3961208|FG003|Overall Study|Death|0
2278217|NCT02336165|3961209|FG004|Overall Study|Death|1
2278218|NCT02336165|3961205|FG000|Overall Study|Physician Decision|2
2278219|NCT02336165|3961206|FG001|Overall Study|Physician Decision|2
2278220|NCT02336165|3961207|FG002|Overall Study|Physician Decision|1
2278221|NCT02336165|3961208|FG003|Overall Study|Physician Decision|1
2278222|NCT02336165|3961209|FG004|Overall Study|Physician Decision|0
2278223|NCT02336165|3961205|FG000|Overall Study|Withdrawal by Subject|0
2278224|NCT02336165|3961206|FG001|Overall Study|Withdrawal by Subject|0
2278225|NCT02336165|3961207|FG002|Overall Study|Withdrawal by Subject|1
2278226|NCT02336165|3961208|FG003|Overall Study|Withdrawal by Subject|0
2278227|NCT02336165|3961209|FG004|Overall Study|Withdrawal by Subject|1
2278228|NCT02336165|3961205|FG000|Overall Study|Adverse Event|4
2278229|NCT02336165|3961206|FG001|Overall Study|Adverse Event|1
2278230|NCT02336165|3961207|FG002|Overall Study|Adverse Event|2
2278231|NCT02336165|3961208|FG003|Overall Study|Adverse Event|4
2278232|NCT02336165|3961209|FG004|Overall Study|Adverse Event|1
2278233|NCT02336165|3961205|FG000|Overall Study|Progressive disease|23
2278234|NCT02336165|3961206|FG001|Overall Study|Progressive disease|22
2278235|NCT02336165|3961207|FG002|Overall Study|Progressive disease|27
2278236|NCT02336165|3961208|FG003|Overall Study|Progressive disease|24
2278237|NCT02336165|3961209|FG004|Overall Study|Progressive disease|19
2278238|NCT02336165|3961205|FG000|Overall Study|Non-compliance|1
2278239|NCT02336165|3961206|FG001|Overall Study|Non-compliance|0
2278240|NCT02336165|3961207|FG002|Overall Study|Non-compliance|0
2278241|NCT02336165|3961208|FG003|Overall Study|Non-compliance|1
2278242|NCT02336165|3961209|FG004|Overall Study|Non-compliance|0
2278243|NCT02336165|3961205|FG000|Overall Study|Other|1
2278244|NCT02336165|3961206|FG001|Overall Study|Other|0
2278245|NCT02336165|3961207|FG002|Overall Study|Other|0
2278246|NCT02336165|3961208|FG003|Overall Study|Other|1
2278247|NCT02336165|3961209|FG004|Overall Study|Other|0
2278248|NCT02336178|3961225|FG000|Overall Study|Lost to Follow-up|1
2278249|NCT02336178|3961225|FG000|Overall Study|Protocol Violation|1
2278250|NCT02336178|3961225|FG000|Overall Study|Withdrawal by Subject|1
2278251|NCT02336178|3961225|FG000|Overall Study|Other|1
2278252|NCT02336282|3961237|FG000|Overall Study|Unrelated illness|1
2278253|NCT02336282|3961237|FG000|Overall Study|Uncomfortable with technology|1
2278254|NCT02336282|3961237|FG000|Overall Study|Lost to Follow-up|1
2121494|NCT00969761|3720229|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2121495|NCT00969761|3720230|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2121496|NCT00969761|3720231|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2121497|NCT00969761|3720232|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2121498|NCT00969761|3720233|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2121499|NCT00969761|3720234|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
2121500|NCT00969761|3720235|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2205054|NCT01608724|3843094|FG000|Overall Study|Study-specific discontinuation criteria|32
2205055|NCT01608724|3843094|FG000|Overall Study|Adverse Event|29
2205056|NCT01608724|3843094|FG000|Overall Study|Protocol Violation|6
2205057|NCT01608724|3843094|FG000|Overall Study|bood sugar too high, etc.|3
2205058|NCT01608724|3843094|FG000|Overall Study|Safety reasons|1
2205059|NCT01609010|3843125|FG000|Overall Study|Stable disease (SD)|22
2205060|NCT01609010|3843126|FG001|Overall Study|Stable disease (SD)|16
2205061|NCT01609010|3843125|FG000|Overall Study|Progressive disease (PD)|8
2205062|NCT01609010|3843126|FG001|Overall Study|Progressive disease (PD)|10
2205063|NCT01609010|3843125|FG000|Overall Study|Adverse Event|3
2205064|NCT01609010|3843126|FG001|Overall Study|Adverse Event|6
2205065|NCT01609010|3843125|FG000|Overall Study|Withdrawal by Subject|2
2205066|NCT01609010|3843126|FG001|Overall Study|Withdrawal by Subject|2
2205067|NCT01609010|3843125|FG000|Overall Study|Other|2
2205068|NCT01609010|3843126|FG001|Overall Study|Other|0
2205069|NCT01609010|3843125|FG000|Overall Study|Other malignancy|1
2205070|NCT01609010|3843126|FG001|Overall Study|Other malignancy|0
2205071|NCT01609010|3843125|FG000|Overall Study|Pathology review|2
2205072|NCT01609010|3843126|FG001|Overall Study|Pathology review|1
2205073|NCT01609010|3843125|FG000|Overall Study|Protocol Violation|1
2121501|NCT00969761|3720236|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2121502|NCT00969761|3720237|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2121503|NCT00969761|3720226|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
2121504|NCT00969761|3720227|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2121505|NCT00969761|3720228|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
2121506|NCT00969761|3720229|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2121507|NCT00969761|3720230|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
2121508|NCT00969761|3720231|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2121509|NCT00969761|3720232|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2121510|NCT00969761|3720233|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
2121511|NCT00969761|3720234|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
2121512|NCT00969761|3720235|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
2121513|NCT00969761|3720236|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2121514|NCT00969761|3720237|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2121515|NCT00969761|3720226|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2121516|NCT00969761|3720227|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2121517|NCT00969761|3720228|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2205074|NCT01609010|3843126|FG001|Overall Study|Protocol Violation|1
2205075|NCT01609010|3843125|FG000|Overall Study|New cancer|1
2205076|NCT01609010|3843126|FG001|Overall Study|New cancer|0
2205077|NCT01609010|3843125|FG000|Overall Study|Lost to Follow-up|1
2205078|NCT01609010|3843126|FG001|Overall Study|Lost to Follow-up|1
2205079|NCT01609023|3843132|FG000|Overall Study|Lack of Efficacy|3
2205080|NCT01609023|3843132|FG000|Overall Study|Withdrawal by Subject|4
2278255|NCT02336282|3961237|FG000|Overall Study|Not enough time to complete sessions|2
2121518|NCT00969761|3720229|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
2121519|NCT00969761|3720230|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
2121520|NCT00969761|3720231|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2121521|NCT00969761|3720232|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2121522|NCT00969761|3720233|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2121523|NCT00969761|3720234|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
2121524|NCT00969761|3720235|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2121525|NCT00969761|3720236|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2121526|NCT00969761|3720237|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2121527|NCT00970268|3720302|FG000|Overall Study|Withdrawal by Subject|12
2278256|NCT02336373|3961253|FG000|Overall Study|Protocol closed early|4
2278257|NCT02336373|3961253|FG000|Overall Study|Physician Decision|14
2278258|NCT02336451|3961268|FG000|Overall Study|Adverse Event|1
2278259|NCT02336451|3961269|FG001|Overall Study|Adverse Event|2
2278260|NCT02336451|3961270|FG002|Overall Study|Adverse Event|0
2278261|NCT02336451|3961271|FG003|Overall Study|Adverse Event|6
2278262|NCT02336451|3961272|FG004|Overall Study|Adverse Event|4
2278263|NCT02336451|3961268|FG000|Overall Study|Death|6
2278264|NCT02336451|3961269|FG001|Overall Study|Death|2
2121528|NCT00970268|3720303|FG001|Overall Study|Withdrawal by Subject|19
2121529|NCT00970268|3720302|FG000|Overall Study|Adverse Event|15
2121530|NCT00970268|3720303|FG001|Overall Study|Adverse Event|12
2121531|NCT00970268|3720302|FG000|Overall Study|Lack of Efficacy|3
2121532|NCT00970268|3720303|FG001|Overall Study|Lack of Efficacy|6
2205081|NCT01609023|3843132|FG000|Overall Study|Lost to Follow-up|8
2205082|NCT01609023|3843132|FG000|Overall Study|Toxicity|3
2121533|NCT00970268|3720302|FG000|Overall Study|Protocol Violation|4
2121534|NCT00970268|3720303|FG001|Overall Study|Protocol Violation|7
2121535|NCT00970268|3720302|FG000|Overall Study|Other Reason|3
2121536|NCT00970268|3720303|FG001|Overall Study|Other Reason|1
2121537|NCT00970268|3720302|FG000|Overall Study|COPD Exacerbation|4
2121538|NCT00970268|3720303|FG001|Overall Study|COPD Exacerbation|2
2121539|NCT00970268|3720302|FG000|Overall Study|Lost to Follow-up|1
2121540|NCT00970268|3720303|FG001|Overall Study|Lost to Follow-up|2
2121541|NCT00970268|3720302|FG000|Overall Study|Inclusion/Exclusion Criteria|1
2121542|NCT00970268|3720303|FG001|Overall Study|Inclusion/Exclusion Criteria|0
2121543|NCT00970281|3720317|FG000|Overall Study|Lack of Efficacy|1
2121544|NCT00970281|3720318|FG001|Overall Study|Lack of Efficacy|14
2121545|NCT00970281|3720317|FG000|Overall Study|Withdrawal by Subject|0
2278265|NCT02336451|3961270|FG002|Overall Study|Death|3
2278266|NCT02336451|3961271|FG003|Overall Study|Death|6
2278267|NCT02336451|3961272|FG004|Overall Study|Death|6
2278268|NCT02336451|3961268|FG000|Overall Study|Physician Decision|9
2278269|NCT02336451|3961269|FG001|Overall Study|Physician Decision|6
2278270|NCT02336451|3961270|FG002|Overall Study|Physician Decision|7
2278271|NCT02336451|3961271|FG003|Overall Study|Physician Decision|16
2278272|NCT02336451|3961272|FG004|Overall Study|Physician Decision|3
2278273|NCT02336451|3961268|FG000|Overall Study|Progressive disease|23
2278274|NCT02336451|3961269|FG001|Overall Study|Progressive disease|26
2278275|NCT02336451|3961270|FG002|Overall Study|Progressive disease|2
2278276|NCT02336451|3961271|FG003|Overall Study|Progressive disease|14
2278277|NCT02336451|3961272|FG004|Overall Study|Progressive disease|4
2278278|NCT02336451|3961268|FG000|Overall Study|Protocol Violation|1
2278279|NCT02336451|3961269|FG001|Overall Study|Protocol Violation|0
2278280|NCT02336451|3961270|FG002|Overall Study|Protocol Violation|0
2278281|NCT02336451|3961271|FG003|Overall Study|Protocol Violation|0
2278282|NCT02336451|3961272|FG004|Overall Study|Protocol Violation|0
2278283|NCT02336451|3961268|FG000|Overall Study|Patient/guardian decision|2
2278284|NCT02336451|3961269|FG001|Overall Study|Patient/guardian decision|4
2278285|NCT02336451|3961270|FG002|Overall Study|Patient/guardian decision|0
2278286|NCT02336451|3961271|FG003|Overall Study|Patient/guardian decision|2
2278287|NCT02336451|3961272|FG004|Overall Study|Patient/guardian decision|1
2278288|NCT02336555|3961288|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2278289|NCT02336555|3961289|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2278290|NCT02336555|3961288|FG000|Treatment Period 1 (28 Days)|Physician Decision|2
2278291|NCT02336555|3961289|FG001|Treatment Period 1 (28 Days)|Physician Decision|0
2278292|NCT02336555|3961288|FG000|Treatment Period 2 (28 Days)|Adverse Event|0
2278293|NCT02336555|3961289|FG001|Treatment Period 2 (28 Days)|Adverse Event|1
2278294|NCT02336607|3961319|FG000|Overall Study|Physician Decision|1
2278295|NCT02336607|3961320|FG001|Overall Study|Physician Decision|4
2278296|NCT02336607|3961321|FG002|Overall Study|Physician Decision|3
2278297|NCT02336607|3961322|FG003|Overall Study|Physician Decision|15
2278298|NCT02336607|3961319|FG000|Overall Study|Lack of Efficacy|1
2278299|NCT02336607|3961320|FG001|Overall Study|Lack of Efficacy|0
2278300|NCT02336607|3961321|FG002|Overall Study|Lack of Efficacy|0
2278301|NCT02336607|3961322|FG003|Overall Study|Lack of Efficacy|2
2278302|NCT02336607|3961319|FG000|Overall Study|Lost to Follow-up|2
2278303|NCT02336607|3961320|FG001|Overall Study|Lost to Follow-up|1
2278304|NCT02336607|3961321|FG002|Overall Study|Lost to Follow-up|0
2278305|NCT02336607|3961322|FG003|Overall Study|Lost to Follow-up|21
2278306|NCT02336607|3961319|FG000|Overall Study|Protocol Violation|0
2278307|NCT02336607|3961320|FG001|Overall Study|Protocol Violation|1
2278308|NCT02336607|3961321|FG002|Overall Study|Protocol Violation|1
2278309|NCT02336607|3961322|FG003|Overall Study|Protocol Violation|3
2278310|NCT02336607|3961319|FG000|Overall Study|Adverse Event|0
2278311|NCT02336607|3961320|FG001|Overall Study|Adverse Event|2
2278312|NCT02336607|3961321|FG002|Overall Study|Adverse Event|2
2278313|NCT02336607|3961322|FG003|Overall Study|Adverse Event|26
2278314|NCT02336607|3961319|FG000|Overall Study|Withdrawal by Subject|0
2278315|NCT02336607|3961320|FG001|Overall Study|Withdrawal by Subject|2
2278316|NCT02336607|3961321|FG002|Overall Study|Withdrawal by Subject|0
2278317|NCT02336607|3961322|FG003|Overall Study|Withdrawal by Subject|20
2278318|NCT02336737|3961332|FG000|Overall Study|Withdrawal by Subject|5
2278319|NCT02336737|3961332|FG000|Overall Study|Physician Decision|8
2278320|NCT02336815|3961339|FG000|Overall Study|Disease Progression|45
2278321|NCT02336815|3961340|FG001|Overall Study|Disease Progression|70
2278322|NCT02336815|3961339|FG000|Overall Study|Adverse Event|18
2278323|NCT02336815|3961340|FG001|Overall Study|Adverse Event|39
2278324|NCT02336815|3961339|FG000|Overall Study|Physician Decision|11
2278325|NCT02336815|3961340|FG001|Overall Study|Physician Decision|4
2278326|NCT02336815|3961339|FG000|Overall Study|Withdrawal by Subject|3
2278327|NCT02336815|3961340|FG001|Overall Study|Withdrawal by Subject|2
2278328|NCT02336815|3961339|FG000|Overall Study|Lost to Follow-up|1
2278329|NCT02336815|3961340|FG001|Overall Study|Lost to Follow-up|3
2278330|NCT02336815|3961339|FG000|Overall Study|Other|1
2278331|NCT02336815|3961340|FG001|Overall Study|Other|5
2278332|NCT02337361|3961379|FG000|3-month Follow-up|Lost to Follow-up|19
2278333|NCT02337361|3961380|FG001|3-month Follow-up|Lost to Follow-up|14
2278334|NCT02337361|3961379|FG000|6-month Follow-up|Lost to Follow-up|2
2121546|NCT00970281|3720318|FG001|Overall Study|Withdrawal by Subject|1
2278335|NCT02337361|3961380|FG001|6-month Follow-up|Lost to Follow-up|4
2278336|NCT02337387|3961391|FG000|Overall Study|Adverse Event|0
2121547|NCT00970281|3720317|FG000|Overall Study|Physician Decision|1
2121548|NCT00970281|3720318|FG001|Overall Study|Physician Decision|1
2121549|NCT00970294|3720324|FG000|Overall Study|Physician Decision|4
2121550|NCT00970294|3720324|FG000|Overall Study|Withdrawal by Subject|1
2121551|NCT00970307|3720331|FG000|Overall Study|Serious Adverse Event|1
2121552|NCT00970307|3720332|FG001|Overall Study|Serious Adverse Event|0
2121553|NCT00970307|3720333|FG002|Overall Study|Serious Adverse Event|0
2121554|NCT00970307|3720331|FG000|Overall Study|Withdrawal by Subject|2
2121555|NCT00970307|3720332|FG001|Overall Study|Withdrawal by Subject|3
2121556|NCT00970307|3720333|FG002|Overall Study|Withdrawal by Subject|2
2121557|NCT00970359|3720362|FG000|Overall Study|Not Treated|4
2121558|NCT00970489|3720368|FG000|Overall Study|Death/Withdrew/Criteria Violation|54
2278337|NCT02337387|3961392|FG001|Overall Study|Adverse Event|1
2278338|NCT02337387|3961393|FG002|Overall Study|Adverse Event|0
2278339|NCT02337387|3961394|FG003|Overall Study|Adverse Event|0
2278340|NCT02337387|3961391|FG000|Overall Study|Sponsor Decision to Terminate Study|14
2278341|NCT02337387|3961392|FG001|Overall Study|Sponsor Decision to Terminate Study|7
2278342|NCT02337387|3961393|FG002|Overall Study|Sponsor Decision to Terminate Study|3
2278343|NCT02337387|3961394|FG003|Overall Study|Sponsor Decision to Terminate Study|3
2278344|NCT02337478|3961408|FG000|Overall Study|Lack of Efficacy|5
2278345|NCT02337491|3961414|FG000|Overall Study|Death|1
2278346|NCT02337491|3961415|FG001|Overall Study|Death|1
2278347|NCT02337491|3961414|FG000|Overall Study|Adverse Event|0
2278348|NCT02337491|3961415|FG001|Overall Study|Adverse Event|1
2278349|NCT02337491|3961414|FG000|Overall Study|Withdrawal by Subject|3
2278350|NCT02337491|3961415|FG001|Overall Study|Withdrawal by Subject|0
2278351|NCT02337491|3961414|FG000|Overall Study|Progressive Disease|44
2278352|NCT02337491|3961415|FG001|Overall Study|Progressive Disease|28
2278353|NCT02337491|3961414|FG000|Overall Study|On Treatment|2
2278354|NCT02337491|3961415|FG001|Overall Study|On Treatment|0
2278355|NCT02337725|3961441|FG000|Overall Study|Pretreatment Event/AE before Treatment|0
2278356|NCT02337725|3961442|FG001|Overall Study|Pretreatment Event/AE before Treatment|1
2278357|NCT02337725|3961441|FG000|Overall Study|Pretreatment Event/AE in Treatment|8
2278358|NCT02337725|3961442|FG001|Overall Study|Pretreatment Event/AE in Treatment|3
2278359|NCT02337725|3961441|FG000|Overall Study|Major Protocol Deviation|0
2278360|NCT02337725|3961442|FG001|Overall Study|Major Protocol Deviation|1
2278361|NCT02337725|3961441|FG000|Overall Study|Voluntary Withdrawal|14
2278362|NCT02337725|3961442|FG001|Overall Study|Voluntary Withdrawal|3
2278363|NCT02337725|3961441|FG000|Overall Study|Lack of Efficacy|4
2278364|NCT02337725|3961442|FG001|Overall Study|Lack of Efficacy|0
2278365|NCT02337738|3961451|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
2278366|NCT02337738|3961452|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
2278367|NCT02337738|3961453|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
2278368|NCT02337738|3961451|FG000|Overall Study|Pretreatment Event/Adverse Event|9
2278369|NCT02337738|3961452|FG001|Overall Study|Pretreatment Event/Adverse Event|18
2278370|NCT02337738|3961453|FG002|Overall Study|Pretreatment Event/Adverse Event|21
2278371|NCT02337738|3961451|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0
2278372|NCT02337738|3961452|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1
2278373|NCT02337738|3961453|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0
2278374|NCT02337738|3961451|FG000|Overall Study|Voluntary Withdrawal|10
2278375|NCT02337738|3961452|FG001|Overall Study|Voluntary Withdrawal|5
2278376|NCT02337738|3961453|FG002|Overall Study|Voluntary Withdrawal|2
2278377|NCT02337738|3961451|FG000|Overall Study|Lack of Efficacy|2
2278378|NCT02337738|3961452|FG001|Overall Study|Lack of Efficacy|4
2278379|NCT02337738|3961453|FG002|Overall Study|Lack of Efficacy|0
2278380|NCT02337738|3961451|FG000|Overall Study|Investigator's Judgment|1
2278381|NCT02337738|3961452|FG001|Overall Study|Investigator's Judgment|1
2278382|NCT02337738|3961453|FG002|Overall Study|Investigator's Judgment|3
2278383|NCT02337751|3961463|FG000|Overall Study|Pretreatment Event/Adverse Event|2
2278384|NCT02337751|3961464|FG001|Overall Study|Pretreatment Event/Adverse Event|3
2278385|NCT02337751|3961463|FG000|Overall Study|Voluntary Withdrawal|6
2278386|NCT02337751|3961464|FG001|Overall Study|Voluntary Withdrawal|8
2278387|NCT02337751|3961463|FG000|Overall Study|Lack of Efficacy|2
2278388|NCT02337751|3961464|FG001|Overall Study|Lack of Efficacy|5
2278389|NCT02337751|3961463|FG000|Overall Study|Investigator's Judgement|1
2278390|NCT02337751|3961464|FG001|Overall Study|Investigator's Judgement|0
2278391|NCT02337764|3961471|FG000|Overall Study|Pretreatment Event/Adverse Event|46
2278392|NCT02337764|3961471|FG000|Overall Study|Voluntary Withdrawal|12
2278393|NCT02337764|3961471|FG000|Overall Study|Lack of Efficacy|2
2278394|NCT02337907|3961481|FG000|Overall Study|Other than listed|1
2278395|NCT02337907|3961482|FG001|Overall Study|Other than listed|0
2121559|NCT00970489|3720369|FG001|Overall Study|Death/Withdrew/Criteria Violation|41
2121560|NCT00970502|3720375|FG000|Overall Study|Withdrawal by Subject|1
2278396|NCT02337907|3961483|FG002|Overall Study|Other than listed|0
2278397|NCT02337907|3961484|FG003|Overall Study|Other than listed|1
2278398|NCT02337907|3961485|FG004|Overall Study|Other than listed|1
2278399|NCT02337907|3961486|FG005|Overall Study|Other than listed|0
2278400|NCT02337907|3961481|FG000|Overall Study|Withdrawal by Subject|2
2278401|NCT02337907|3961482|FG001|Overall Study|Withdrawal by Subject|3
2278402|NCT02337907|3961483|FG002|Overall Study|Withdrawal by Subject|0
2278403|NCT02337907|3961484|FG003|Overall Study|Withdrawal by Subject|2
2121561|NCT00970593|3720390|FG000|Overall Study|Adverse Event|1
2121562|NCT00970593|3720391|FG001|Overall Study|Adverse Event|1
2278404|NCT02337907|3961485|FG004|Overall Study|Withdrawal by Subject|5
2278405|NCT02337907|3961486|FG005|Overall Study|Withdrawal by Subject|0
2278406|NCT02337907|3961481|FG000|Overall Study|Lost to Follow-up|0
2278407|NCT02337907|3961482|FG001|Overall Study|Lost to Follow-up|0
2278408|NCT02337907|3961483|FG002|Overall Study|Lost to Follow-up|0
2278409|NCT02337907|3961484|FG003|Overall Study|Lost to Follow-up|0
2278410|NCT02337907|3961485|FG004|Overall Study|Lost to Follow-up|0
2278411|NCT02337907|3961486|FG005|Overall Study|Lost to Follow-up|1
2205083|NCT01609023|3843132|FG000|Overall Study|Disease progression|10
2205084|NCT01609023|3843132|FG000|Overall Study|Physician Decision|2
2205085|NCT01609023|3843132|FG000|Overall Study|Death|2
2205086|NCT01609023|3843132|FG000|Overall Study|Personal reasons|1
2205087|NCT01609062|3843138|FG000|Extension Phase|Terminated by Sponsor|14
2205088|NCT01609062|3843139|FG001|Extension Phase|Terminated by Sponsor|9
2205089|NCT01609062|3843138|FG000|Extension Phase|Discontinued drug and then was pregnant|1
2205090|NCT01609062|3843139|FG001|Extension Phase|Discontinued drug and then was pregnant|0
2205091|NCT01609062|3843138|FG000|Extension Phase|Anticipated surgery & transition to EAP|0
2205092|NCT01609062|3843139|FG001|Extension Phase|Anticipated surgery & transition to EAP|1
2205093|NCT01609218|3843146|FG000|Period 1|Adverse Event|3
2205094|NCT01609218|3843147|FG001|Period 1|Adverse Event|5
2205095|NCT01609218|3843146|FG000|Period 1|Sponsor Decision|0
2205096|NCT01609218|3843147|FG001|Period 1|Sponsor Decision|1
2205097|NCT01609218|3843146|FG000|Period 2|Adverse Event|1
2205098|NCT01609218|3843147|FG001|Period 2|Adverse Event|0
2205099|NCT01609257|3843155|FG000|Overall Study|Lost to Follow-up|2
2205100|NCT01609257|3843156|FG001|Overall Study|Lost to Follow-up|1
2205101|NCT01609257|3843155|FG000|Overall Study|Voluntary Withdrawal by Subject|0
2205102|NCT01609257|3843156|FG001|Overall Study|Voluntary Withdrawal by Subject|1
2205103|NCT01609257|3843155|FG000|Overall Study|Non-compliance/Protocol deviation|4
2205104|NCT01609257|3843156|FG001|Overall Study|Non-compliance/Protocol deviation|6
2205105|NCT01609296|3843165|FG000|Overall Study|Death|253
2205106|NCT01609296|3843165|FG000|Overall Study|Withdrawal by Subject|151
2205107|NCT01609296|3843165|FG000|Overall Study|Lost to Follow-up|21
2205108|NCT01609296|3843165|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35
2205109|NCT01609296|3843165|FG000|Overall Study|missed visit but known to be alive|28
2205110|NCT01609478|3843185|FG000|Overall Study|Adverse Event|3
2205111|NCT01609478|3843186|FG001|Overall Study|Adverse Event|1
2205112|NCT01609478|3843187|FG002|Overall Study|Adverse Event|5
2205113|NCT01609478|3843185|FG000|Overall Study|Protocol Deviation|0
2205114|NCT01609478|3843186|FG001|Overall Study|Protocol Deviation|1
2205115|NCT01609478|3843187|FG002|Overall Study|Protocol Deviation|1
2205116|NCT01609478|3843185|FG000|Overall Study|Non-Compliance with study treatment|1
2205117|NCT01609478|3843186|FG001|Overall Study|Non-Compliance with study treatment|0
2205118|NCT01609478|3843187|FG002|Overall Study|Non-Compliance with study treatment|0
2205119|NCT01609478|3843185|FG000|Overall Study|Physician Decision|1
2205120|NCT01609478|3843186|FG001|Overall Study|Physician Decision|0
2205121|NCT01609478|3843187|FG002|Overall Study|Physician Decision|1
2205122|NCT01609478|3843185|FG000|Overall Study|Withdrawal by Subject|2
2205123|NCT01609478|3843186|FG001|Overall Study|Withdrawal by Subject|0
2205124|NCT01609478|3843187|FG002|Overall Study|Withdrawal by Subject|2
2205125|NCT01609543|3843195|FG000|Overall Study|Disease Progression|28
2205126|NCT01609543|3843195|FG000|Overall Study|Adverse Event|5
2205127|NCT01609543|3843195|FG000|Overall Study|Withdrawal by Subject|1
2205128|NCT01609543|3843195|FG000|Overall Study|Protocol Violation|1
2205129|NCT01609543|3843195|FG000|Overall Study|Death|7
2205130|NCT01609556|3843216|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
2205131|NCT01609556|3843217|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
2205132|NCT01609556|3843218|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
2205133|NCT01609556|3843219|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
2205134|NCT01609556|3843220|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
2205135|NCT01609556|3843221|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
2205136|NCT01609556|3843222|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
2205137|NCT01609556|3843223|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
2205138|NCT01609556|3843224|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
2205139|NCT01609556|3843225|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
2205140|NCT01609556|3843226|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
2205141|NCT01609556|3843227|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
2205142|NCT01609556|3843228|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
2205143|NCT01609556|3843229|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
2205144|NCT01609556|3843230|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
2205145|NCT01609556|3843231|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
2205146|NCT01609556|3843216|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
2205147|NCT01609556|3843217|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
2205148|NCT01609556|3843218|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
2205149|NCT01609556|3843219|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
2205150|NCT01609556|3843220|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8
2205151|NCT01609556|3843221|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13
2205152|NCT01609556|3843222|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5
2205153|NCT01609556|3843223|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4
2205154|NCT01609556|3843224|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
2205155|NCT01609556|3843225|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
2205156|NCT01609556|3843226|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6
2121563|NCT00970593|3720392|FG002|Overall Study|Adverse Event|0
2121564|NCT00970593|3720393|FG003|Overall Study|Adverse Event|0
2121565|NCT00970593|3720394|FG004|Overall Study|Adverse Event|0
2278412|NCT02337907|3961481|FG000|Overall Study|Adverse Event|1
2278413|NCT02337907|3961482|FG001|Overall Study|Adverse Event|1
2278414|NCT02337907|3961483|FG002|Overall Study|Adverse Event|1
2278415|NCT02337907|3961484|FG003|Overall Study|Adverse Event|1
2278416|NCT02337907|3961485|FG004|Overall Study|Adverse Event|4
2278417|NCT02337907|3961486|FG005|Overall Study|Adverse Event|0
2278418|NCT02337946|3961510|FG000|Protocol Treatment 1 Period|Adverse Event|7
2278419|NCT02337946|3961511|FG001|Protocol Treatment 1 Period|Adverse Event|0
2278420|NCT02337946|3961512|FG002|Protocol Treatment 1 Period|Adverse Event|0
2278421|NCT02337946|3961510|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1
2278422|NCT02337946|3961511|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0
2278423|NCT02337946|3961512|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0
2278424|NCT02337946|3961510|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6
2278425|NCT02337946|3961511|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0
2278426|NCT02337946|3961512|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0
2278427|NCT02337946|3961510|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15
2278428|NCT02337946|3961511|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0
2278429|NCT02337946|3961512|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0
2278430|NCT02337946|3961510|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3
2278431|NCT02337946|3961511|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0
2278432|NCT02337946|3961512|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0
2278433|NCT02337946|3961510|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
2278434|NCT02337946|3961511|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
2278435|NCT02337946|3961512|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
2278436|NCT02337946|3961510|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
2278437|NCT02337946|3961511|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
2278438|NCT02337946|3961512|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
2278439|NCT02337946|3961510|FG000|Protocol Treatment 1 Period|Reason not specified|8
2278440|NCT02337946|3961511|FG001|Protocol Treatment 1 Period|Reason not specified|0
2278441|NCT02337946|3961512|FG002|Protocol Treatment 1 Period|Reason not specified|0
2278442|NCT02337946|3961510|FG000|In-between Period|Without Informed Consent|1
2278443|NCT02337946|3961511|FG001|In-between Period|Without Informed Consent|0
2278444|NCT02337946|3961512|FG002|In-between Period|Without Informed Consent|0
2278445|NCT02337946|3961510|FG000|Protocol Treatment 2 Period|Adverse Event|0
2278446|NCT02337946|3961511|FG001|Protocol Treatment 2 Period|Adverse Event|9
2278447|NCT02337946|3961512|FG002|Protocol Treatment 2 Period|Adverse Event|9
2278448|NCT02337946|3961510|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0
2278449|NCT02337946|3961511|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3
2278450|NCT02337946|3961512|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1
2278451|NCT02337946|3961510|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0
2278452|NCT02337946|3961511|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29
2278453|NCT02337946|3961512|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29
2278454|NCT02337946|3961510|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0
2278455|NCT02337946|3961511|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1
2278456|NCT02337946|3961512|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0
2278457|NCT02337946|3961510|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
2278458|NCT02337946|3961511|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
2278459|NCT02337946|3961512|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
2205157|NCT01609556|3843227|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
2205158|NCT01609556|3843228|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
2205159|NCT01609556|3843229|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
2205160|NCT01609556|3843230|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
2205161|NCT01609556|3843231|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
2205162|NCT01609556|3843216|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
2205163|NCT01609556|3843217|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
2205164|NCT01609556|3843218|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
2205165|NCT01609556|3843219|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
2205166|NCT01609556|3843220|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
2205167|NCT01609556|3843221|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
2205168|NCT01609556|3843222|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
2205169|NCT01609556|3843223|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
2205170|NCT01609556|3843224|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
2205171|NCT01609556|3843225|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
2121566|NCT00970593|3720395|FG005|Overall Study|Adverse Event|0
2121567|NCT00970593|3720396|FG006|Overall Study|Adverse Event|0
2121568|NCT00970593|3720390|FG000|Overall Study|Discontinuation of study by sponsor|0
2121569|NCT00970593|3720391|FG001|Overall Study|Discontinuation of study by sponsor|0
2121570|NCT00970593|3720392|FG002|Overall Study|Discontinuation of study by sponsor|5
2121571|NCT00970593|3720393|FG003|Overall Study|Discontinuation of study by sponsor|0
2121572|NCT00970593|3720394|FG004|Overall Study|Discontinuation of study by sponsor|0
2121573|NCT00970593|3720395|FG005|Overall Study|Discontinuation of study by sponsor|0
2121574|NCT00970593|3720396|FG006|Overall Study|Discontinuation of study by sponsor|2
2121575|NCT00970593|3720390|FG000|Overall Study|Withdrawal by Subject|0
2121576|NCT00970593|3720391|FG001|Overall Study|Withdrawal by Subject|0
2121577|NCT00970593|3720392|FG002|Overall Study|Withdrawal by Subject|1
2121578|NCT00970593|3720393|FG003|Overall Study|Withdrawal by Subject|0
2121579|NCT00970593|3720394|FG004|Overall Study|Withdrawal by Subject|0
2121580|NCT00970593|3720395|FG005|Overall Study|Withdrawal by Subject|0
2121581|NCT00970593|3720396|FG006|Overall Study|Withdrawal by Subject|0
2121582|NCT00970632|3720419|FG000|Overall Study|Adverse Event|2
2121583|NCT00970632|3720420|FG001|Overall Study|Adverse Event|2
2121584|NCT00970632|3720421|FG002|Overall Study|Adverse Event|1
2121585|NCT00970632|3720419|FG000|Overall Study|Lack of Efficacy|3
2121586|NCT00970632|3720420|FG001|Overall Study|Lack of Efficacy|0
2121587|NCT00970632|3720421|FG002|Overall Study|Lack of Efficacy|0
2121588|NCT00970632|3720419|FG000|Overall Study|Lost to Follow-up|3
2121589|NCT00970632|3720420|FG001|Overall Study|Lost to Follow-up|0
2121590|NCT00970632|3720421|FG002|Overall Study|Lost to Follow-up|2
2121591|NCT00970632|3720419|FG000|Overall Study|Protocol Violation|8
2121592|NCT00970632|3720420|FG001|Overall Study|Protocol Violation|5
2121593|NCT00970632|3720421|FG002|Overall Study|Protocol Violation|8
2121594|NCT00970632|3720419|FG000|Overall Study|Withdrawal by Subject|7
2121595|NCT00970632|3720420|FG001|Overall Study|Withdrawal by Subject|6
2121596|NCT00970632|3720421|FG002|Overall Study|Withdrawal by Subject|4
2121597|NCT00970632|3720419|FG000|Overall Study|Entry criteria not met|0
2121598|NCT00970632|3720420|FG001|Overall Study|Entry criteria not met|2
2121599|NCT00970632|3720421|FG002|Overall Study|Entry criteria not met|2
2121600|NCT00970632|3720419|FG000|Overall Study|Sponsor decision|1
2121601|NCT00970632|3720420|FG001|Overall Study|Sponsor decision|0
2121602|NCT00970632|3720421|FG002|Overall Study|Sponsor decision|1
2121603|NCT00970684|3720429|FG000|Overall Study|Lack of Efficacy|5
2121604|NCT00970684|3720429|FG000|Overall Study|Adverse Event|4
2121605|NCT00970684|3720429|FG000|Overall Study|Withdrawal by Subject|1
2121606|NCT00970944|3720453|FG000|Overall Study|Death|1
2121607|NCT00970944|3720454|FG001|Overall Study|Death|0
2121608|NCT00970944|3720453|FG000|Overall Study|Physician Decision|0
2121609|NCT00970944|3720454|FG001|Overall Study|Physician Decision|2
2121610|NCT00971048|3720465|FG000|Overall Study|Protocol Violation|1
2121611|NCT00971048|3720466|FG001|Overall Study|Protocol Violation|2
2121612|NCT00971048|3720467|FG002|Overall Study|Protocol Violation|0
2278460|NCT02337946|3961510|FG000|Protocol Treatment 2 Period|Reason not specified|0
2278461|NCT02337946|3961511|FG001|Protocol Treatment 2 Period|Reason not specified|4
2278462|NCT02337946|3961512|FG002|Protocol Treatment 2 Period|Reason not specified|4
2278463|NCT02338154|3961537|FG000|Overall Study|Death|46
2278464|NCT02338154|3961537|FG000|Overall Study|Valve Implant Failure|17
2278465|NCT02338154|3961537|FG000|Overall Study|Valve Explant|11
2278466|NCT02338154|3961537|FG000|Overall Study|Withdrawal by Subject or by Investigator|10
2278467|NCT02338154|3961537|FG000|Overall Study|Lost to Follow-up|8
2278468|NCT02338154|3961537|FG000|Overall Study|Other Reason|3
2278469|NCT02338154|3961537|FG000|Overall Study|Patients Without Exit Form|47
2278470|NCT02338154|3961537|FG000|Overall Study|Missing Exit Reason on Exit Form|1
2278471|NCT02338193|3961552|FG000|Overall Study|Withdrawal by Subject|0
2278472|NCT02338193|3961553|FG001|Overall Study|Withdrawal by Subject|0
2278473|NCT02338193|3961554|FG002|Overall Study|Withdrawal by Subject|2
2278474|NCT02338193|3961552|FG000|Overall Study|Pregnancy|0
2278475|NCT02338193|3961553|FG001|Overall Study|Pregnancy|1
2278476|NCT02338193|3961554|FG002|Overall Study|Pregnancy|1
2278477|NCT02338193|3961552|FG000|Overall Study|Noncompliant with visits|2
2278478|NCT02338193|3961553|FG001|Overall Study|Noncompliant with visits|2
2278479|NCT02338193|3961554|FG002|Overall Study|Noncompliant with visits|7
2278480|NCT02338193|3961552|FG000|Overall Study|moved out of state|0
2278481|NCT02338193|3961553|FG001|Overall Study|moved out of state|1
2278482|NCT02338193|3961554|FG002|Overall Study|moved out of state|0
2278483|NCT02338193|3961552|FG000|Overall Study|intolerant of side effects|1
2278484|NCT02338193|3961553|FG001|Overall Study|intolerant of side effects|0
2278485|NCT02338193|3961554|FG002|Overall Study|intolerant of side effects|0
2278486|NCT02338362|3961575|FG000|Overall Study|Withdrawal by Subject|1
2278487|NCT02338362|3961576|FG001|Overall Study|Withdrawal by Subject|1
2278488|NCT02338492|3961582|FG000|Overall Study|Death|32
2278489|NCT02338492|3961582|FG000|Overall Study|Adverse Event|3
2278490|NCT02338492|3961582|FG000|Overall Study|Lost to Follow-up|4
2121613|NCT00971048|3720468|FG003|Overall Study|Protocol Violation|1
2121614|NCT00971048|3720465|FG000|Overall Study|Adverse Event|0
2121615|NCT00971048|3720466|FG001|Overall Study|Adverse Event|0
2121616|NCT00971048|3720467|FG002|Overall Study|Adverse Event|1
2121617|NCT00971048|3720468|FG003|Overall Study|Adverse Event|0
2121618|NCT00971048|3720465|FG000|Overall Study|Physician Decision|0
2278491|NCT02338492|3961582|FG000|Overall Study|Reason not captured above|6
2278492|NCT02338843|3961594|FG000|Overall Study|Adverse Event|2
2278493|NCT02338843|3961595|FG001|Overall Study|Adverse Event|1
2278494|NCT02338843|3961594|FG000|Overall Study|Death|40
2278495|NCT02338843|3961595|FG001|Overall Study|Death|53
2278496|NCT02338843|3961594|FG000|Overall Study|Physician Decision|1
2278497|NCT02338843|3961595|FG001|Overall Study|Physician Decision|0
2278498|NCT02338843|3961594|FG000|Overall Study|Withdrawal by Subject|0
2278499|NCT02338843|3961595|FG001|Overall Study|Withdrawal by Subject|2
2278500|NCT02338843|3961594|FG000|Overall Study|Subject Recovered|0
2278501|NCT02338843|3961595|FG001|Overall Study|Subject Recovered|2
2278502|NCT02338843|3961594|FG000|Overall Study|Discontinued prior to randomizat|1
2121619|NCT00971048|3720466|FG001|Overall Study|Physician Decision|0
2121620|NCT00971048|3720467|FG002|Overall Study|Physician Decision|0
2121621|NCT00971048|3720468|FG003|Overall Study|Physician Decision|1
2121622|NCT00971178|3720483|FG000|Overall Study|Lost to Follow-up|2
2121623|NCT00971178|3720484|FG001|Overall Study|Lost to Follow-up|2
2121624|NCT00971178|3720485|FG002|Overall Study|Lost to Follow-up|2
2121625|NCT00971204|3720493|FG000|Overall Study|Did not meet all criteria-not treated|14
2121626|NCT00971204|3720493|FG000|Overall Study|Lost to Follow-up|10
2121627|NCT00971243|3720502|FG000|Double Blind Period|Adverse Event|2
2121628|NCT00971243|3720503|FG001|Double Blind Period|Adverse Event|3
2121629|NCT00971243|3720504|FG002|Double Blind Period|Adverse Event|2
2121630|NCT00971243|3720505|FG003|Double Blind Period|Adverse Event|2
2121631|NCT00971243|3720506|FG004|Double Blind Period|Adverse Event|3
2121632|NCT00971243|3720502|FG000|Double Blind Period|Lost to Follow-up|0
2121633|NCT00971243|3720503|FG001|Double Blind Period|Lost to Follow-up|1
2121634|NCT00971243|3720504|FG002|Double Blind Period|Lost to Follow-up|1
2121635|NCT00971243|3720505|FG003|Double Blind Period|Lost to Follow-up|0
2121636|NCT00971243|3720506|FG004|Double Blind Period|Lost to Follow-up|1
2278503|NCT02338843|3961595|FG001|Overall Study|Discontinued prior to randomizat|0
2278504|NCT02338882|3961603|FG000|Overall Study|Death|1
2278505|NCT02338882|3961604|FG001|Overall Study|Death|0
2278506|NCT02338882|3961603|FG000|Overall Study|Lost to Follow-up|6
2278507|NCT02338882|3961604|FG001|Overall Study|Lost to Follow-up|3
2278508|NCT02338999|3961710|FG000|First Intervention|Withdrawal by Subject|3
2278509|NCT02338999|3961711|FG001|First Intervention|Withdrawal by Subject|1
2278510|NCT02338999|3961710|FG000|Washout Period|Withdrawal by Subject|0
2278511|NCT02338999|3961711|FG001|Washout Period|Withdrawal by Subject|2
2278512|NCT02338999|3961710|FG000|Second Intervention|Withdrawal by Subject|0
2278513|NCT02338999|3961711|FG001|Second Intervention|Withdrawal by Subject|2
2278514|NCT02339155|3961723|FG000|Overall Study|Adverse Event|0
2278515|NCT02339155|3961724|FG001|Overall Study|Adverse Event|6
2278516|NCT02339155|3961723|FG000|Overall Study|Death|1
2278517|NCT02339155|3961724|FG001|Overall Study|Death|1
2278518|NCT02339155|3961723|FG000|Overall Study|Lost to Follow-up|8
2278519|NCT02339155|3961724|FG001|Overall Study|Lost to Follow-up|9
2278520|NCT02339155|3961723|FG000|Overall Study|Physician Decision|2
2278521|NCT02339155|3961724|FG001|Overall Study|Physician Decision|1
2278522|NCT02339155|3961723|FG000|Overall Study|Withdrawal by Subject|4
2278523|NCT02339155|3961724|FG001|Overall Study|Withdrawal by Subject|4
2278524|NCT02339285|3961747|FG000|Overall Study|Withdrawal by Subject|0
2278525|NCT02339285|3961748|FG001|Overall Study|Withdrawal by Subject|1
2278526|NCT02339285|3961749|FG002|Overall Study|Withdrawal by Subject|1
2278527|NCT02339285|3961747|FG000|Overall Study|Lost to Follow-up|1
2278528|NCT02339285|3961748|FG001|Overall Study|Lost to Follow-up|1
2278529|NCT02339285|3961749|FG002|Overall Study|Lost to Follow-up|1
2278530|NCT02339285|3961747|FG000|Overall Study|Protocol Deviation|0
2278531|NCT02339285|3961748|FG001|Overall Study|Protocol Deviation|1
2278532|NCT02339285|3961749|FG002|Overall Study|Protocol Deviation|0
2278533|NCT02339506|3961773|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
2278534|NCT02339506|3961774|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
2278535|NCT02339506|3961773|FG000|Washout (Period 2)|Withdrawal by Subject|2
2278536|NCT02339506|3961774|FG001|Washout (Period 2)|Withdrawal by Subject|0
2278537|NCT02339584|3961791|FG000|Overall Study|Adverse Event|11
2278538|NCT02339584|3961792|FG001|Overall Study|Adverse Event|7
2278539|NCT02339584|3961791|FG000|Overall Study|Lack of Efficacy|0
2278540|NCT02339584|3961792|FG001|Overall Study|Lack of Efficacy|1
2278541|NCT02339584|3961791|FG000|Overall Study|Physician Decision|1
2278542|NCT02339584|3961792|FG001|Overall Study|Physician Decision|2
2278543|NCT02339584|3961791|FG000|Overall Study|Protocol Violation|1
2278544|NCT02339584|3961792|FG001|Overall Study|Protocol Violation|1
2278545|NCT02339584|3961791|FG000|Overall Study|Withdrawal by Subject|2
2278546|NCT02339584|3961792|FG001|Overall Study|Withdrawal by Subject|4
2278547|NCT02339909|3961810|FG000|Overall Study|Became ineligible after randomisation|89
2278548|NCT02339909|3961811|FG001|Overall Study|Became ineligible after randomisation|63
2278549|NCT02339909|3961812|FG002|Overall Study|Became ineligible after randomisation|71
2121637|NCT00971243|3720502|FG000|Double Blind Period|Physician Decision|10
2121638|NCT00971243|3720503|FG001|Double Blind Period|Physician Decision|6
2121639|NCT00971243|3720504|FG002|Double Blind Period|Physician Decision|7
2121640|NCT00971243|3720505|FG003|Double Blind Period|Physician Decision|6
2278550|NCT02340000|3961822|FG000|Time Period 1|Withdrawal by Subject|6
2278551|NCT02340000|3961823|FG001|Time Period 1|Withdrawal by Subject|8
2278552|NCT02340000|3961822|FG000|Time Period 1|Lost to Follow-up|6
2121641|NCT00971243|3720506|FG004|Double Blind Period|Physician Decision|7
2121642|NCT00971243|3720502|FG000|Double Blind Period|Protocol Violation|2
2205172|NCT01609556|3843226|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
2205173|NCT01609556|3843227|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
2205174|NCT01609556|3843228|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
2205175|NCT01609556|3843229|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
2205176|NCT01609556|3843230|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
2205177|NCT01609556|3843231|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
2205178|NCT01609556|3843216|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205179|NCT01609556|3843217|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205180|NCT01609556|3843218|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205181|NCT01609556|3843219|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205182|NCT01609556|3843220|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205183|NCT01609556|3843221|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
2205184|NCT01609556|3843222|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205185|NCT01609556|3843223|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205186|NCT01609556|3843224|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205187|NCT01609556|3843225|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205188|NCT01609556|3843226|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205189|NCT01609556|3843227|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
2205190|NCT01609556|3843228|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205191|NCT01609556|3843229|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205192|NCT01609556|3843230|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205193|NCT01609556|3843231|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
2205194|NCT01609556|3843216|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205195|NCT01609556|3843217|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2278553|NCT02340000|3961823|FG001|Time Period 1|Lost to Follow-up|7
2278554|NCT02340000|3961822|FG000|Time Period 2|Withdrawal by Subject|9
2278555|NCT02340000|3961823|FG001|Time Period 2|Withdrawal by Subject|7
2278556|NCT02340000|3961822|FG000|Time Period 2|Lost to Follow-up|10
2278557|NCT02340000|3961823|FG001|Time Period 2|Lost to Follow-up|8
2278558|NCT02340078|3961836|FG000|Overall Study|Protocol Violation|1
2278559|NCT02340520|3961893|FG000|Overall Study|Lost to Follow-up|1
2121643|NCT00971243|3720503|FG001|Double Blind Period|Protocol Violation|0
2121644|NCT00971243|3720504|FG002|Double Blind Period|Protocol Violation|3
2121645|NCT00971243|3720505|FG003|Double Blind Period|Protocol Violation|2
2121646|NCT00971243|3720506|FG004|Double Blind Period|Protocol Violation|2
2121647|NCT00971243|3720502|FG000|Double Blind Period|Withdrawal by Subject|4
2121648|NCT00971243|3720503|FG001|Double Blind Period|Withdrawal by Subject|1
2121649|NCT00971243|3720504|FG002|Double Blind Period|Withdrawal by Subject|4
2121650|NCT00971243|3720505|FG003|Double Blind Period|Withdrawal by Subject|4
2121651|NCT00971243|3720506|FG004|Double Blind Period|Withdrawal by Subject|4
2121652|NCT00971243|3720502|FG000|Double Blind Period|Other reasons|1
2121653|NCT00971243|3720503|FG001|Double Blind Period|Other reasons|0
2121654|NCT00971243|3720504|FG002|Double Blind Period|Other reasons|2
2121655|NCT00971243|3720505|FG003|Double Blind Period|Other reasons|0
2121656|NCT00971243|3720506|FG004|Double Blind Period|Other reasons|1
2121657|NCT00971243|3720502|FG000|Open-label Period|Adverse Event|1
2121658|NCT00971243|3720503|FG001|Open-label Period|Adverse Event|0
2121659|NCT00971243|3720504|FG002|Open-label Period|Adverse Event|1
2121660|NCT00971243|3720505|FG003|Open-label Period|Adverse Event|1
2121661|NCT00971243|3720506|FG004|Open-label Period|Adverse Event|0
2121662|NCT00971243|3720502|FG000|Open-label Period|Physician Decision|5
2121663|NCT00971243|3720503|FG001|Open-label Period|Physician Decision|9
2121664|NCT00971243|3720504|FG002|Open-label Period|Physician Decision|3
2121665|NCT00971243|3720505|FG003|Open-label Period|Physician Decision|7
2121666|NCT00971243|3720506|FG004|Open-label Period|Physician Decision|2
2121667|NCT00971243|3720502|FG000|Open-label Period|Protocol Violation|1
2121668|NCT00971243|3720503|FG001|Open-label Period|Protocol Violation|1
2121669|NCT00971243|3720504|FG002|Open-label Period|Protocol Violation|1
2121670|NCT00971243|3720505|FG003|Open-label Period|Protocol Violation|0
2121671|NCT00971243|3720506|FG004|Open-label Period|Protocol Violation|1
2121672|NCT00971243|3720502|FG000|Open-label Period|Withdrawal by Subject|1
2121673|NCT00971243|3720503|FG001|Open-label Period|Withdrawal by Subject|0
2278560|NCT02340520|3961893|FG000|Overall Study|Patient did not take drug as specified|1
2278561|NCT02340520|3961893|FG000|Overall Study|Withdrawal by Subject|1
2278562|NCT02340663|3961899|FG000|Overall Study|Lost to Follow-up|1
2278563|NCT02340663|3961900|FG001|Overall Study|Lost to Follow-up|0
2278564|NCT02340663|3961899|FG000|Overall Study|Protocol Violation|1
2278565|NCT02340663|3961900|FG001|Overall Study|Protocol Violation|0
2121674|NCT00971243|3720504|FG002|Open-label Period|Withdrawal by Subject|0
2121675|NCT00971243|3720505|FG003|Open-label Period|Withdrawal by Subject|2
2121676|NCT00971243|3720506|FG004|Open-label Period|Withdrawal by Subject|1
2121677|NCT00971243|3720502|FG000|Open-label Period|Other reason|0
2121678|NCT00971243|3720503|FG001|Open-label Period|Other reason|0
2121679|NCT00971243|3720504|FG002|Open-label Period|Other reason|0
2121680|NCT00971243|3720505|FG003|Open-label Period|Other reason|0
2121681|NCT00971243|3720506|FG004|Open-label Period|Other reason|2
2121682|NCT00971321|3720533|FG000|Up to Month 7|Withdrawal by Subject|1
2121683|NCT00971321|3720534|FG001|Up to Month 7|Withdrawal by Subject|0
2121684|NCT00971321|3720533|FG000|Up to Month 7|Migrated/moved from study area|3
2121685|NCT00971321|3720534|FG001|Up to Month 7|Migrated/moved from study area|2
2121686|NCT00971321|3720533|FG000|Up to Month 11-12|Withdrawal by Subject|2
2121687|NCT00971321|3720534|FG001|Up to Month 11-12|Withdrawal by Subject|1
2121688|NCT00971321|3720533|FG000|Up to Month 11-12|Migrated/moved from study area|2
2121689|NCT00971321|3720534|FG001|Up to Month 11-12|Migrated/moved from study area|2
2121690|NCT00971321|3720533|FG000|Up to Month 11-12|Lost to Follow-up|1
2121691|NCT00971321|3720534|FG001|Up to Month 11-12|Lost to Follow-up|0
2121692|NCT00971425|3720542|FG000|Overall Study|Adverse Event|1
2121693|NCT00971425|3720543|FG001|Overall Study|Adverse Event|1
2121694|NCT00971425|3720542|FG000|Overall Study|Withdrawal by Subject|0
2121695|NCT00971425|3720543|FG001|Overall Study|Withdrawal by Subject|1
2121696|NCT00971932|3720594|FG000|Overall Study|Withdrawal by Subject|1
2121697|NCT00971932|3720594|FG000|Overall Study|Investigator's decision|2
2121698|NCT00971932|3720594|FG000|Overall Study|Ongoing|4
2121699|NCT00971945|3720598|FG000|Overall Study|Progressive Disease|3
2121700|NCT00971945|3720598|FG000|Overall Study|Change in treatment policy|1
2121701|NCT00971945|3720598|FG000|Overall Study|Other reasons|2
2121702|NCT00971997|3720602|FG000|Overall Study|Adverse Event|2
2121703|NCT00971997|3720602|FG000|Overall Study|Death|1
2121704|NCT00971997|3720602|FG000|Overall Study|Protocol Violation|4
2121705|NCT00971997|3720602|FG000|Overall Study|Withdrawal by Subject|5
2121706|NCT00971997|3720602|FG000|Overall Study|Physician Decision|7
2121707|NCT00972153|3720616|FG000|Overall Study|Equipment malfunction during case|0
2121708|NCT00972153|3720617|FG001|Overall Study|Equipment malfunction during case|1
2121709|NCT00972153|3720618|FG002|Overall Study|Equipment malfunction during case|0
2121710|NCT00972244|3720635|FG000|Overall Study|Incorrect Enrolment|1
2121711|NCT00972244|3720636|FG001|Overall Study|Incorrect Enrolment|0
2121712|NCT00972244|3720637|FG002|Overall Study|Incorrect Enrolment|0
2121713|NCT00972244|3720638|FG003|Overall Study|Incorrect Enrolment|0
2121714|NCT00972244|3720639|FG004|Overall Study|Incorrect Enrolment|0
2121715|NCT00972244|3720635|FG000|Overall Study|Adverse Event|0
2121716|NCT00972244|3720636|FG001|Overall Study|Adverse Event|1
2121717|NCT00972244|3720637|FG002|Overall Study|Adverse Event|1
2121718|NCT00972244|3720638|FG003|Overall Study|Adverse Event|0
2121719|NCT00972244|3720639|FG004|Overall Study|Adverse Event|0
2121720|NCT00972244|3720635|FG000|Overall Study|Subject No Longer Meets Study Criteria|2
2121721|NCT00972244|3720636|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
2121722|NCT00972244|3720637|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
2121723|NCT00972244|3720638|FG003|Overall Study|Subject No Longer Meets Study Criteria|0
2121724|NCT00972244|3720639|FG004|Overall Study|Subject No Longer Meets Study Criteria|5
2121725|NCT00972244|3720635|FG000|Overall Study|Withdrawal by Subject|1
2121726|NCT00972244|3720636|FG001|Overall Study|Withdrawal by Subject|2
2121727|NCT00972244|3720637|FG002|Overall Study|Withdrawal by Subject|1
2121728|NCT00972244|3720638|FG003|Overall Study|Withdrawal by Subject|0
2121729|NCT00972244|3720639|FG004|Overall Study|Withdrawal by Subject|1
2121730|NCT00972244|3720635|FG000|Overall Study|Safety|0
2121731|NCT00972244|3720636|FG001|Overall Study|Safety|0
2121732|NCT00972244|3720637|FG002|Overall Study|Safety|0
2121733|NCT00972244|3720638|FG003|Overall Study|Safety|0
2121734|NCT00972244|3720639|FG004|Overall Study|Safety|1
2121735|NCT00972244|3720635|FG000|Overall Study|Death|1
2121736|NCT00972244|3720636|FG001|Overall Study|Death|0
2121737|NCT00972244|3720637|FG002|Overall Study|Death|0
2121738|NCT00972244|3720638|FG003|Overall Study|Death|0
2121739|NCT00972244|3720639|FG004|Overall Study|Death|0
2121740|NCT00972244|3720635|FG000|Overall Study|Various|0
2121741|NCT00972244|3720636|FG001|Overall Study|Various|0
2121742|NCT00972244|3720637|FG002|Overall Study|Various|0
2121743|NCT00972244|3720638|FG003|Overall Study|Various|0
2121744|NCT00972244|3720639|FG004|Overall Study|Various|2
2121745|NCT00972283|3720653|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
2121746|NCT00972283|3720654|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
2121747|NCT00972283|3720653|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
2121748|NCT00972283|3720654|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
2121749|NCT00972283|3720653|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
2121750|NCT00972283|3720654|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
2121751|NCT00972283|3720653|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
2121752|NCT00972283|3720654|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
2121753|NCT00972283|3720653|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
2121754|NCT00972283|3720654|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
2121755|NCT00972283|3720653|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
2121756|NCT00972283|3720654|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
2121757|NCT00972283|3720653|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
2121758|NCT00972283|3720654|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
2121759|NCT00972283|3720653|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
2121760|NCT00972283|3720654|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
2121761|NCT00972283|3720653|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
2121762|NCT00972283|3720654|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
2121763|NCT00972283|3720653|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
2121764|NCT00972283|3720654|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
2121765|NCT00972322|3720662|FG000|Overall Study|Adverse Event|2
2121766|NCT00972322|3720663|FG001|Overall Study|Adverse Event|1
2121767|NCT00972322|3720662|FG000|Overall Study|Positive drug screen|0
2121768|NCT00972322|3720663|FG001|Overall Study|Positive drug screen|1
2121769|NCT00972322|3720662|FG000|Overall Study|Lost to Follow-up|0
2121770|NCT00972322|3720663|FG001|Overall Study|Lost to Follow-up|1
2121771|NCT00972322|3720662|FG000|Overall Study|Consistently high glucose values|1
2121772|NCT00972322|3720663|FG001|Overall Study|Consistently high glucose values|0
2121773|NCT00972478|3720697|FG000|Overall Study|Adverse Event|3
2121774|NCT00972478|3720698|FG001|Overall Study|Adverse Event|16
2121775|NCT00972478|3720697|FG000|Overall Study|Withdrawal by Subject|1
2121776|NCT00972478|3720698|FG001|Overall Study|Withdrawal by Subject|8
2121777|NCT00972478|3720697|FG000|Overall Study|Progression/Relapse|0
2121778|NCT00972478|3720698|FG001|Overall Study|Progression/Relapse|2
2121779|NCT00972478|3720697|FG000|Overall Study|Death|0
2121780|NCT00972478|3720698|FG001|Overall Study|Death|2
2121781|NCT00972478|3720697|FG000|Overall Study|Not protocol specified|1
2121782|NCT00972478|3720698|FG001|Overall Study|Not protocol specified|1
2121783|NCT00972478|3720697|FG000|Overall Study|Ineligible|1
2121784|NCT00972478|3720698|FG001|Overall Study|Ineligible|7
2121785|NCT00972478|3720697|FG000|Overall Study|Not start protocol treatment|1
2121786|NCT00972478|3720698|FG001|Overall Study|Not start protocol treatment|2
2121787|NCT00972504|3720705|FG000|Overall Study|Adverse Event|2
2121788|NCT00972504|3720705|FG000|Overall Study|Investigator discretion|1
2121789|NCT00972517|3720715|FG000|Overall Study|Adverse Event|0
2121790|NCT00972517|3720716|FG001|Overall Study|Adverse Event|0
2121791|NCT00972517|3720717|FG002|Overall Study|Adverse Event|0
2121792|NCT00972517|3720718|FG003|Overall Study|Adverse Event|1
2121793|NCT00972517|3720719|FG004|Overall Study|Adverse Event|0
2121794|NCT00972517|3720720|FG005|Overall Study|Adverse Event|0
2121795|NCT00972517|3720715|FG000|Overall Study|Withdrawal by Subject|0
2121796|NCT00972517|3720716|FG001|Overall Study|Withdrawal by Subject|1
2121797|NCT00972517|3720717|FG002|Overall Study|Withdrawal by Subject|0
2121798|NCT00972517|3720718|FG003|Overall Study|Withdrawal by Subject|2
2278566|NCT02340663|3961899|FG000|Overall Study|Withdrawal by Subject|3
2278567|NCT02340663|3961900|FG001|Overall Study|Withdrawal by Subject|1
2320625|NCT02951780|4034943|FG007|Period 2|Scheduling Conflicts|1
2320626|NCT02951780|4034944|FG008|Period 2|Scheduling Conflicts|0
2320627|NCT02951819|4034966|FG000|Overall Study|Death|9
2320628|NCT02951819|4034967|FG001|Overall Study|Death|7
2320629|NCT02951819|4034966|FG000|Overall Study|Withdrawal by Subject|3
2320630|NCT02951819|4034967|FG001|Overall Study|Withdrawal by Subject|0
2320631|NCT02951819|4034966|FG000|Overall Study|Adverse Event|1
2320632|NCT02951819|4034967|FG001|Overall Study|Adverse Event|0
2320633|NCT02951819|4034966|FG000|Overall Study|Lack of Efficacy|4
2320634|NCT02951819|4034967|FG001|Overall Study|Lack of Efficacy|0
2320635|NCT02951819|4034966|FG000|Overall Study|Lost to Follow-up|1
2320636|NCT02951819|4034967|FG001|Overall Study|Lost to Follow-up|0
2320637|NCT02951819|4034966|FG000|Overall Study|Progressive Disease|1
2320638|NCT02951819|4034967|FG001|Overall Study|Progressive Disease|0
2320639|NCT02951819|4034966|FG000|Overall Study|Other|9
2320640|NCT02951819|4034967|FG001|Overall Study|Other|0
2320641|NCT02951988|4034989|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8
2320642|NCT02951988|4034990|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0
2320643|NCT02951988|4034991|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0
2320644|NCT02951988|4034992|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0
2320645|NCT02951988|4034989|FG000|Open-Label Treatment Period|Study terminated by sponsor|9
2320646|NCT02951988|4034990|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
2320647|NCT02951988|4034991|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
2320648|NCT02951988|4034992|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
2320649|NCT02951988|4034989|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2
2320650|NCT02951988|4034990|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0
2320651|NCT02951988|4034991|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0
2320652|NCT02951988|4034992|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0
2320653|NCT02951988|4034989|FG000|Open-Label Treatment Period|Non-compliance with study drug|5
2320654|NCT02951988|4034990|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
2320655|NCT02951988|4034991|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
2320656|NCT02951988|4034992|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
2320657|NCT02951988|4034989|FG000|Open-Label Treatment Period|Protocol Violation|22
2320658|NCT02951988|4034990|FG001|Open-Label Treatment Period|Protocol Violation|0
2320659|NCT02951988|4034991|FG002|Open-Label Treatment Period|Protocol Violation|0
2320660|NCT02951988|4034992|FG003|Open-Label Treatment Period|Protocol Violation|0
2320661|NCT02951988|4034989|FG000|Open-Label Treatment Period|Pregnancy|2
2121799|NCT00972517|3720719|FG004|Overall Study|Withdrawal by Subject|1
2121800|NCT00972517|3720720|FG005|Overall Study|Withdrawal by Subject|0
2121801|NCT00972543|3720751|FG000|Overall Study|Adverse Event|1
2121802|NCT00972543|3720752|FG001|Overall Study|Adverse Event|0
2278568|NCT02340780|3961942|FG000|Overall Study|Ineligible|1
2278569|NCT02340806|3961948|FG000|Overall Study|Protocol Violation|2
2121803|NCT00972543|3720751|FG000|Overall Study|Early study termination by sponsor|4
2121804|NCT00972543|3720752|FG001|Overall Study|Early study termination by sponsor|1
2121805|NCT00972595|3720758|FG000|Period 1|Adverse Event|1
2121806|NCT00972595|3720759|FG001|Period 1|Adverse Event|0
2121807|NCT00972777|3720785|FG000|Overall Study|Adverse Event|3
2121808|NCT00972777|3720786|FG001|Overall Study|Adverse Event|2
2121809|NCT00972777|3720785|FG000|Overall Study|Lost to Follow-up|0
2121810|NCT00972777|3720786|FG001|Overall Study|Lost to Follow-up|4
2121811|NCT00972777|3720785|FG000|Overall Study|Withdrawal by Subject|4
2121812|NCT00972777|3720786|FG001|Overall Study|Withdrawal by Subject|5
2121813|NCT00972777|3720785|FG000|Overall Study|Physician Decision|4
2121814|NCT00972777|3720786|FG001|Overall Study|Physician Decision|0
2121815|NCT00972777|3720785|FG000|Overall Study|Protocol Violation|0
2121816|NCT00972777|3720786|FG001|Overall Study|Protocol Violation|2
2121817|NCT00972777|3720785|FG000|Overall Study|Screening Failure|2
2121818|NCT00972777|3720786|FG001|Overall Study|Screening Failure|1
2121819|NCT00972777|3720785|FG000|Overall Study|Missed visit|1
2121820|NCT00972777|3720786|FG001|Overall Study|Missed visit|0
2121821|NCT00972816|3720800|FG000|Overall Study|Adverse Event|0
2121822|NCT00972816|3720801|FG001|Overall Study|Adverse Event|0
2121823|NCT00972816|3720802|FG002|Overall Study|Adverse Event|1
2121824|NCT00972816|3720803|FG003|Overall Study|Adverse Event|0
2121825|NCT00972816|3720804|FG004|Overall Study|Adverse Event|0
2121826|NCT00972816|3720805|FG005|Overall Study|Adverse Event|0
2121827|NCT00972816|3720806|FG006|Overall Study|Adverse Event|0
2121828|NCT00972816|3720807|FG007|Overall Study|Adverse Event|0
2121829|NCT00972816|3720800|FG000|Overall Study|Withdrawal by Subject|4
2121830|NCT00972816|3720801|FG001|Overall Study|Withdrawal by Subject|2
2121831|NCT00972816|3720802|FG002|Overall Study|Withdrawal by Subject|1
2121832|NCT00972816|3720803|FG003|Overall Study|Withdrawal by Subject|3
2121833|NCT00972816|3720804|FG004|Overall Study|Withdrawal by Subject|0
2121834|NCT00972816|3720805|FG005|Overall Study|Withdrawal by Subject|1
2121835|NCT00972816|3720806|FG006|Overall Study|Withdrawal by Subject|1
2121836|NCT00972816|3720807|FG007|Overall Study|Withdrawal by Subject|2
2121837|NCT00972816|3720800|FG000|Overall Study|Lost to Follow-up|11
2121838|NCT00972816|3720801|FG001|Overall Study|Lost to Follow-up|9
2121839|NCT00972816|3720802|FG002|Overall Study|Lost to Follow-up|7
2121840|NCT00972816|3720803|FG003|Overall Study|Lost to Follow-up|5
2121841|NCT00972816|3720804|FG004|Overall Study|Lost to Follow-up|11
2121842|NCT00972816|3720805|FG005|Overall Study|Lost to Follow-up|10
2121843|NCT00972816|3720806|FG006|Overall Study|Lost to Follow-up|7
2121844|NCT00972816|3720807|FG007|Overall Study|Lost to Follow-up|7
2121845|NCT00972816|3720800|FG000|Overall Study|Inappropriate enrolment|0
2121846|NCT00972816|3720801|FG001|Overall Study|Inappropriate enrolment|0
2121847|NCT00972816|3720802|FG002|Overall Study|Inappropriate enrolment|0
2121848|NCT00972816|3720803|FG003|Overall Study|Inappropriate enrolment|0
2121849|NCT00972816|3720804|FG004|Overall Study|Inappropriate enrolment|0
2121850|NCT00972816|3720805|FG005|Overall Study|Inappropriate enrolment|0
2121851|NCT00972816|3720806|FG006|Overall Study|Inappropriate enrolment|2
2121852|NCT00972816|3720807|FG007|Overall Study|Inappropriate enrolment|0
2121853|NCT00972816|3720800|FG000|Overall Study|Unable to classify|2
2121854|NCT00972816|3720801|FG001|Overall Study|Unable to classify|0
2121855|NCT00972816|3720802|FG002|Overall Study|Unable to classify|0
2121856|NCT00972816|3720803|FG003|Overall Study|Unable to classify|0
2121857|NCT00972816|3720804|FG004|Overall Study|Unable to classify|1
2121858|NCT00972816|3720805|FG005|Overall Study|Unable to classify|0
2121859|NCT00972816|3720806|FG006|Overall Study|Unable to classify|0
2121860|NCT00972816|3720807|FG007|Overall Study|Unable to classify|0
2121861|NCT00973102|3720831|FG000|Overall Study|Protocol Violation|1
2121862|NCT00973102|3720832|FG001|Overall Study|Protocol Violation|0
2121863|NCT00973102|3720831|FG000|Overall Study|Prisoner|0
2121864|NCT00973102|3720832|FG001|Overall Study|Prisoner|1
2121865|NCT00973349|3720854|FG000|Overall Study|Adverse Event|0
2121866|NCT00973349|3720855|FG001|Overall Study|Adverse Event|0
2121867|NCT00973349|3720856|FG002|Overall Study|Adverse Event|0
2121868|NCT00973349|3720857|FG003|Overall Study|Adverse Event|0
2121869|NCT00973349|3720858|FG004|Overall Study|Adverse Event|1
2121870|NCT00973349|3720859|FG005|Overall Study|Adverse Event|0
2121871|NCT00973349|3720860|FG006|Overall Study|Adverse Event|0
2121872|NCT00973349|3720861|FG007|Overall Study|Adverse Event|0
2121873|NCT00973349|3720862|FG008|Overall Study|Adverse Event|1
2121874|NCT00973349|3720863|FG009|Overall Study|Adverse Event|0
2121875|NCT00973349|3720864|FG010|Overall Study|Adverse Event|0
2121876|NCT00973349|3720865|FG011|Overall Study|Adverse Event|0
2121877|NCT00973349|3720866|FG012|Overall Study|Adverse Event|0
2121878|NCT00973349|3720867|FG013|Overall Study|Adverse Event|0
2121879|NCT00973349|3720868|FG014|Overall Study|Adverse Event|1
2121880|NCT00973349|3720869|FG015|Overall Study|Adverse Event|0
2121881|NCT00973349|3720854|FG000|Overall Study|Withdrawal by Subject|1
2121882|NCT00973349|3720855|FG001|Overall Study|Withdrawal by Subject|2
2121883|NCT00973349|3720856|FG002|Overall Study|Withdrawal by Subject|2
2121884|NCT00973349|3720857|FG003|Overall Study|Withdrawal by Subject|3
2121885|NCT00973349|3720858|FG004|Overall Study|Withdrawal by Subject|2
2121886|NCT00973349|3720859|FG005|Overall Study|Withdrawal by Subject|0
2121887|NCT00973349|3720860|FG006|Overall Study|Withdrawal by Subject|2
2121888|NCT00973349|3720861|FG007|Overall Study|Withdrawal by Subject|2
2121889|NCT00973349|3720862|FG008|Overall Study|Withdrawal by Subject|0
2121890|NCT00973349|3720863|FG009|Overall Study|Withdrawal by Subject|2
2121891|NCT00973349|3720864|FG010|Overall Study|Withdrawal by Subject|0
2121892|NCT00973349|3720865|FG011|Overall Study|Withdrawal by Subject|1
2121893|NCT00973349|3720866|FG012|Overall Study|Withdrawal by Subject|0
2121894|NCT00973349|3720867|FG013|Overall Study|Withdrawal by Subject|0
2121895|NCT00973349|3720868|FG014|Overall Study|Withdrawal by Subject|0
2121896|NCT00973349|3720869|FG015|Overall Study|Withdrawal by Subject|0
2121897|NCT00973349|3720854|FG000|Overall Study|Lost to Follow-up|3
2121898|NCT00973349|3720855|FG001|Overall Study|Lost to Follow-up|1
2121899|NCT00973349|3720856|FG002|Overall Study|Lost to Follow-up|2
2121900|NCT00973349|3720857|FG003|Overall Study|Lost to Follow-up|2
2121901|NCT00973349|3720858|FG004|Overall Study|Lost to Follow-up|1
2121902|NCT00973349|3720859|FG005|Overall Study|Lost to Follow-up|3
2121903|NCT00973349|3720860|FG006|Overall Study|Lost to Follow-up|0
2121904|NCT00973349|3720861|FG007|Overall Study|Lost to Follow-up|1
2121905|NCT00973349|3720862|FG008|Overall Study|Lost to Follow-up|2
2121906|NCT00973349|3720863|FG009|Overall Study|Lost to Follow-up|1
2121907|NCT00973349|3720864|FG010|Overall Study|Lost to Follow-up|0
2121908|NCT00973349|3720865|FG011|Overall Study|Lost to Follow-up|1
2121909|NCT00973349|3720866|FG012|Overall Study|Lost to Follow-up|0
2121910|NCT00973349|3720867|FG013|Overall Study|Lost to Follow-up|0
2121911|NCT00973349|3720868|FG014|Overall Study|Lost to Follow-up|0
2121912|NCT00973349|3720869|FG015|Overall Study|Lost to Follow-up|1
2121913|NCT00973349|3720854|FG000|Overall Study|Inappropriate enrolment|0
2121914|NCT00973349|3720855|FG001|Overall Study|Inappropriate enrolment|0
2121915|NCT00973349|3720856|FG002|Overall Study|Inappropriate enrolment|1
2121916|NCT00973349|3720857|FG003|Overall Study|Inappropriate enrolment|0
2121917|NCT00973349|3720858|FG004|Overall Study|Inappropriate enrolment|0
2121918|NCT00973349|3720859|FG005|Overall Study|Inappropriate enrolment|0
2121919|NCT00973349|3720860|FG006|Overall Study|Inappropriate enrolment|0
2121920|NCT00973349|3720861|FG007|Overall Study|Inappropriate enrolment|0
2121921|NCT00973349|3720862|FG008|Overall Study|Inappropriate enrolment|0
2121922|NCT00973349|3720863|FG009|Overall Study|Inappropriate enrolment|2
2121923|NCT00973349|3720864|FG010|Overall Study|Inappropriate enrolment|0
2121924|NCT00973349|3720865|FG011|Overall Study|Inappropriate enrolment|0
2121925|NCT00973349|3720866|FG012|Overall Study|Inappropriate enrolment|1
2121926|NCT00973349|3720867|FG013|Overall Study|Inappropriate enrolment|0
2121927|NCT00973349|3720868|FG014|Overall Study|Inappropriate enrolment|1
2121928|NCT00973349|3720869|FG015|Overall Study|Inappropriate enrolment|1
2121929|NCT00973349|3720854|FG000|Overall Study|Protocol Violation|0
2121930|NCT00973349|3720855|FG001|Overall Study|Protocol Violation|0
2121931|NCT00973349|3720856|FG002|Overall Study|Protocol Violation|0
2121932|NCT00973349|3720857|FG003|Overall Study|Protocol Violation|0
2121933|NCT00973349|3720858|FG004|Overall Study|Protocol Violation|0
2121934|NCT00973349|3720859|FG005|Overall Study|Protocol Violation|0
2121935|NCT00973349|3720860|FG006|Overall Study|Protocol Violation|0
2121936|NCT00973349|3720861|FG007|Overall Study|Protocol Violation|0
2121937|NCT00973349|3720862|FG008|Overall Study|Protocol Violation|1
2121938|NCT00973349|3720863|FG009|Overall Study|Protocol Violation|0
2121939|NCT00973349|3720864|FG010|Overall Study|Protocol Violation|0
2121940|NCT00973349|3720865|FG011|Overall Study|Protocol Violation|0
2121941|NCT00973349|3720866|FG012|Overall Study|Protocol Violation|0
2121942|NCT00973349|3720867|FG013|Overall Study|Protocol Violation|0
2121943|NCT00973349|3720868|FG014|Overall Study|Protocol Violation|0
2121944|NCT00973349|3720869|FG015|Overall Study|Protocol Violation|0
2121945|NCT00973349|3720854|FG000|Overall Study|Unable to classify|0
2121946|NCT00973349|3720855|FG001|Overall Study|Unable to classify|0
2121947|NCT00973349|3720856|FG002|Overall Study|Unable to classify|0
2121948|NCT00973349|3720857|FG003|Overall Study|Unable to classify|0
2121949|NCT00973349|3720858|FG004|Overall Study|Unable to classify|1
2121950|NCT00973349|3720859|FG005|Overall Study|Unable to classify|1
2121951|NCT00973349|3720860|FG006|Overall Study|Unable to classify|0
2121952|NCT00973349|3720861|FG007|Overall Study|Unable to classify|0
2121953|NCT00973349|3720862|FG008|Overall Study|Unable to classify|0
2121954|NCT00973349|3720863|FG009|Overall Study|Unable to classify|1
2121955|NCT00973349|3720864|FG010|Overall Study|Unable to classify|0
2121956|NCT00973349|3720865|FG011|Overall Study|Unable to classify|0
2121957|NCT00973349|3720866|FG012|Overall Study|Unable to classify|0
2121958|NCT00973349|3720867|FG013|Overall Study|Unable to classify|0
2121959|NCT00973349|3720868|FG014|Overall Study|Unable to classify|0
2121960|NCT00973349|3720869|FG015|Overall Study|Unable to classify|0
2121961|NCT00973362|3720897|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25
2121962|NCT00973362|3720898|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0
2121963|NCT00973362|3720897|FG000|Baseline Evaluation|No colposcopy visit|62
2121964|NCT00973362|3720898|FG001|Baseline Evaluation|No colposcopy visit|0
2121965|NCT00973362|3720897|FG000|Baseline Evaluation|Inevaluable|686
2121966|NCT00973362|3720898|FG001|Baseline Evaluation|Inevaluable|223
2121967|NCT00973362|3720897|FG000|3-Year Follow-up|Lost to Follow-up|17
2121968|NCT00973362|3720898|FG001|3-Year Follow-up|Lost to Follow-up|0
2177836|NCT01378104|3802246|FG001|Overall Study|Lack of Efficacy|5
2177837|NCT01378104|3802245|FG000|Overall Study|Withdrawal by Subject|12
2177838|NCT01378104|3802246|FG001|Overall Study|Withdrawal by Subject|13
2121969|NCT00973479|3720909|FG000|Overall Study|Lost to Follow-up|0
2121970|NCT00973479|3720910|FG001|Overall Study|Lost to Follow-up|3
2121971|NCT00973479|3720909|FG000|Overall Study|Death|2
2121972|NCT00973479|3720910|FG001|Overall Study|Death|2
2121973|NCT00973479|3720909|FG000|Overall Study|Withdrawal by Subject|15
2121974|NCT00973479|3720910|FG001|Overall Study|Withdrawal by Subject|16
2121975|NCT00973479|3720909|FG000|Overall Study|Lack of Efficacy|5
2121976|NCT00973479|3720910|FG001|Overall Study|Lack of Efficacy|7
2121977|NCT00973479|3720909|FG000|Overall Study|Adverse Event|12
2121978|NCT00973479|3720910|FG001|Overall Study|Adverse Event|32
2121979|NCT00973479|3720909|FG000|Overall Study|Protocol Violation|2
2121980|NCT00973479|3720910|FG001|Overall Study|Protocol Violation|2
2121981|NCT00973479|3720909|FG000|Overall Study|Other|1
2121982|NCT00973479|3720910|FG001|Overall Study|Other|7
2121983|NCT00973622|3720920|FG000|Overall Study|did not attend MRI|14
2121984|NCT00973622|3720921|FG001|Overall Study|did not attend MRI|3
2121985|NCT00973622|3720920|FG000|Overall Study|did not pass MRI screen|6
2121986|NCT00973622|3720921|FG001|Overall Study|did not pass MRI screen|0
2121987|NCT00973622|3720920|FG000|Overall Study|did not complete rTMS sessions|11
2278570|NCT02340806|3961949|FG001|Overall Study|Protocol Violation|0
2278571|NCT02340806|3961948|FG000|Overall Study|epidural catheter replaced|2
2278572|NCT02340806|3961949|FG001|Overall Study|epidural catheter replaced|1
2278573|NCT02340806|3961948|FG000|Overall Study|history of chronic pain medication|1
2278574|NCT02340806|3961949|FG001|Overall Study|history of chronic pain medication|0
2278575|NCT02340806|3961948|FG000|Overall Study|re-dose < 90 min of CSE|1
2278576|NCT02340806|3961949|FG001|Overall Study|re-dose < 90 min of CSE|3
2278577|NCT02340819|3961955|FG000|Overall Study|Adverse Event|1
2278578|NCT02340819|3961955|FG000|Overall Study|Withdrawal by Subject|2
2278579|NCT02340819|3961955|FG000|Overall Study|Discontinued with other reason|1
2278580|NCT02340949|3961961|FG000|Overall Study|Adverse Event|4
2278581|NCT02340949|3961962|FG001|Overall Study|Adverse Event|2
2278582|NCT02340949|3961961|FG000|Overall Study|Withdrawal by Subject|2
2278583|NCT02340949|3961962|FG001|Overall Study|Withdrawal by Subject|0
2278584|NCT02340949|3961961|FG000|Overall Study|Progression disease|6
2278585|NCT02340949|3961962|FG001|Overall Study|Progression disease|2
2278586|NCT02340949|3961961|FG000|Overall Study|Death|3
2278587|NCT02340949|3961962|FG001|Overall Study|Death|0
2278588|NCT02340949|3961961|FG000|Overall Study|Physician Decision|1
2278589|NCT02340949|3961962|FG001|Overall Study|Physician Decision|0
2278590|NCT02340962|3961970|FG000|Overall Study|Lost to Follow-up|1
2278591|NCT02340962|3961971|FG001|Overall Study|Lost to Follow-up|0
2278592|NCT02340975|3961983|FG000|Overall Study|Death|6
2278593|NCT02340975|3961984|FG001|Overall Study|Death|23
2278594|NCT02340975|3961985|FG002|Overall Study|Death|21
2278595|NCT02340975|3961986|FG003|Overall Study|Death|7
2278596|NCT02340975|3961987|FG004|Overall Study|Death|21
2278597|NCT02340975|3961988|FG005|Overall Study|Death|13
2278598|NCT02340975|3961983|FG000|Overall Study|Lost to Follow-up|0
2278599|NCT02340975|3961984|FG001|Overall Study|Lost to Follow-up|0
2278600|NCT02340975|3961985|FG002|Overall Study|Lost to Follow-up|0
2278601|NCT02340975|3961986|FG003|Overall Study|Lost to Follow-up|0
2278602|NCT02340975|3961987|FG004|Overall Study|Lost to Follow-up|2
2278603|NCT02340975|3961988|FG005|Overall Study|Lost to Follow-up|0
2278604|NCT02340975|3961983|FG000|Overall Study|Withdrawal by Subject|0
2278605|NCT02340975|3961984|FG001|Overall Study|Withdrawal by Subject|0
2278606|NCT02340975|3961985|FG002|Overall Study|Withdrawal by Subject|3
2278607|NCT02340975|3961986|FG003|Overall Study|Withdrawal by Subject|3
2278608|NCT02340975|3961987|FG004|Overall Study|Withdrawal by Subject|2
2278609|NCT02340975|3961988|FG005|Overall Study|Withdrawal by Subject|0
2278610|NCT02340975|3961983|FG000|Overall Study|Other|0
2278611|NCT02340975|3961984|FG001|Overall Study|Other|4
2278612|NCT02340975|3961985|FG002|Overall Study|Other|0
2278613|NCT02340975|3961986|FG003|Overall Study|Other|2
2278614|NCT02340975|3961987|FG004|Overall Study|Other|0
2278615|NCT02340975|3961988|FG005|Overall Study|Other|6
2278616|NCT02341417|3962015|FG000|Overall Study|Withdrawal by Subject|0
2278617|NCT02341417|3962016|FG001|Overall Study|Withdrawal by Subject|2
2278618|NCT02341417|3962017|FG002|Overall Study|Withdrawal by Subject|0
2278619|NCT02341417|3962015|FG000|Overall Study|Decision by sponsor|2
2278620|NCT02341417|3962016|FG001|Overall Study|Decision by sponsor|0
2278621|NCT02341417|3962017|FG002|Overall Study|Decision by sponsor|0
2278622|NCT02341417|3962015|FG000|Overall Study|Death|0
2278623|NCT02341417|3962016|FG001|Overall Study|Death|0
2278624|NCT02341417|3962017|FG002|Overall Study|Death|1
2278625|NCT02341456|3962029|FG000|Overall Study|Disease progression|2
2278626|NCT02341456|3962030|FG001|Overall Study|Disease progression|3
2278627|NCT02341456|3962031|FG002|Overall Study|Disease progression|1
2278628|NCT02341456|3962029|FG000|Overall Study|Death|1
2278629|NCT02341456|3962030|FG001|Overall Study|Death|1
2278630|NCT02341456|3962031|FG002|Overall Study|Death|1
2278631|NCT02341456|3962029|FG000|Overall Study|Withdrawal by Subject|0
2278632|NCT02341456|3962030|FG001|Overall Study|Withdrawal by Subject|1
2121988|NCT00973622|3720921|FG001|Overall Study|did not complete rTMS sessions|2
2278633|NCT02341456|3962031|FG002|Overall Study|Withdrawal by Subject|1
2278634|NCT02341456|3962029|FG000|Overall Study|Moved to local access programme.|0
2278635|NCT02341456|3962030|FG001|Overall Study|Moved to local access programme.|1
2278636|NCT02341456|3962031|FG002|Overall Study|Moved to local access programme.|1
2121989|NCT00973674|3720929|FG000|Overall Study|Protocol Violation|2
2121990|NCT00973674|3720930|FG001|Overall Study|Protocol Violation|0
2121991|NCT00973700|3720942|FG000|Overall Study|Withdrawal by Subject|2
2121992|NCT00973700|3720943|FG001|Overall Study|Withdrawal by Subject|2
2121993|NCT00973700|3720944|FG002|Overall Study|Withdrawal by Subject|8
2121994|NCT00973700|3720945|FG003|Overall Study|Withdrawal by Subject|4
2121995|NCT00973700|3720946|FG004|Overall Study|Withdrawal by Subject|4
2121996|NCT00973700|3720942|FG000|Overall Study|Lost to Follow-up|5
2121997|NCT00973700|3720943|FG001|Overall Study|Lost to Follow-up|0
2121998|NCT00973700|3720944|FG002|Overall Study|Lost to Follow-up|1
2121999|NCT00973700|3720945|FG003|Overall Study|Lost to Follow-up|8
2122000|NCT00973700|3720946|FG004|Overall Study|Lost to Follow-up|5
2122001|NCT00973700|3720942|FG000|Overall Study|Inappropriate enrolment|0
2122002|NCT00973700|3720943|FG001|Overall Study|Inappropriate enrolment|0
2122003|NCT00973700|3720944|FG002|Overall Study|Inappropriate enrolment|0
2122004|NCT00973700|3720945|FG003|Overall Study|Inappropriate enrolment|4
2122005|NCT00973700|3720946|FG004|Overall Study|Inappropriate enrolment|0
2122006|NCT00973700|3720942|FG000|Overall Study|Unable to Classify|0
2122007|NCT00973700|3720943|FG001|Overall Study|Unable to Classify|0
2122008|NCT00973700|3720944|FG002|Overall Study|Unable to Classify|1
2122009|NCT00973700|3720945|FG003|Overall Study|Unable to Classify|2
2122010|NCT00973700|3720946|FG004|Overall Study|Unable to Classify|1
2122011|NCT00973765|3720983|FG000|Overall Study|Lost to Follow-up|8
2122012|NCT00973765|3720984|FG001|Overall Study|Lost to Follow-up|14
2122013|NCT00973921|3720990|FG000|Overall Study|IVUS results were not available|9
2122014|NCT00973973|3720996|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
2122015|NCT00973973|3720997|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
2122016|NCT00973973|3720996|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
2122017|NCT00973973|3720997|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
2122018|NCT00973973|3720996|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
2122019|NCT00973973|3720997|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
2122020|NCT00973973|3720996|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
2122021|NCT00973973|3720997|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
2122022|NCT00973973|3720996|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
2122023|NCT00973973|3720997|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
2122024|NCT00973973|3720996|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
2122025|NCT00973973|3720997|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
2122026|NCT00973973|3720996|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
2122027|NCT00973973|3720997|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
2122028|NCT00973973|3720996|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
2122029|NCT00973973|3720997|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
2122030|NCT00973973|3720996|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
2122031|NCT00973973|3720997|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
2122032|NCT00973973|3720996|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
2122033|NCT00973973|3720997|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
2122034|NCT00973973|3720996|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
2122035|NCT00973973|3720997|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
2122036|NCT00973973|3720996|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
2122037|NCT00973973|3720997|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
2122038|NCT00974090|3721016|FG000|Period 1: Double Blind Period|Adverse Event|2
2122039|NCT00974090|3721017|FG001|Period 1: Double Blind Period|Adverse Event|1
2122040|NCT00974090|3721016|FG000|Period 1: Double Blind Period|Physician Decision|1
2122041|NCT00974090|3721017|FG001|Period 1: Double Blind Period|Physician Decision|0
2122042|NCT00974090|3721016|FG000|Period 2: Open-label Period|Adverse Event|4
2122043|NCT00974090|3721017|FG001|Period 2: Open-label Period|Adverse Event|6
2122044|NCT00974090|3721016|FG000|Period 2: Open-label Period|Lack of Efficacy|3
2122045|NCT00974090|3721017|FG001|Period 2: Open-label Period|Lack of Efficacy|1
2122046|NCT00974090|3721016|FG000|Period 2: Open-label Period|Physician Decision|0
2122047|NCT00974090|3721017|FG001|Period 2: Open-label Period|Physician Decision|3
2122048|NCT00974090|3721016|FG000|Period 2: Open-label Period|Withdrawal by Subject|1
2122049|NCT00974090|3721017|FG001|Period 2: Open-label Period|Withdrawal by Subject|0
2122050|NCT00974220|3721036|FG000|Treatment Period 1|Adverse Event|2
2122051|NCT00974220|3721037|FG001|Treatment Period 1|Adverse Event|1
2122052|NCT00974220|3721036|FG000|Treatment Period 1|noncompliant subjects|0
2122053|NCT00974220|3721037|FG001|Treatment Period 1|noncompliant subjects|1
2122054|NCT00974233|3721043|FG000|Induction Chemoimmunotherapy|Death|2
2122055|NCT00974233|3721043|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5
2122056|NCT00974233|3721043|FG000|Induction Chemoimmunotherapy|Adverse Event|7
2122057|NCT00974233|3721043|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1
2122058|NCT00974233|3721043|FG000|Maintenance Lenalidomide|Lack of Efficacy|5
2122059|NCT00974233|3721043|FG000|Maintenance Lenalidomide|Adverse Event|8
2122060|NCT00974259|3721062|FG000|Overall Study|Technically inadequate PbtO2 recordings|2
2122061|NCT00974259|3721063|FG001|Overall Study|Technically inadequate PbtO2 recordings|1
2122062|NCT00974311|3721071|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5
2122063|NCT00974311|3721072|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2
2122064|NCT00974311|3721071|FG000|DB Phase (up to 24 Months)|Death|561
2122065|NCT00974311|3721072|FG001|DB Phase (up to 24 Months)|Death|298
2122066|NCT00974311|3721071|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16
2122067|NCT00974311|3721072|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7
2122068|NCT00974311|3721071|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
2122069|NCT00974311|3721072|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
2122070|NCT00974311|3721071|FG000|DB Phase (up to 24 Months)|Other|1
2122071|NCT00974311|3721072|FG001|DB Phase (up to 24 Months)|Other|0
2122072|NCT00974311|3721071|FG000|OLE Phase (up to 77 Months)|Death|14
2122073|NCT00974311|3721072|FG001|OLE Phase (up to 77 Months)|Death|21
2122074|NCT00974311|3721071|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
2122075|NCT00974311|3721072|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
2122076|NCT00974311|3721071|FG000|OLE Phase (up to 77 Months)|Other|15
2122077|NCT00974311|3721072|FG001|OLE Phase (up to 77 Months)|Other|2
2122078|NCT00974311|3721071|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
2122079|NCT00974311|3721072|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
2122080|NCT00974675|3721145|FG000|Overall Study|Adverse Event|2
2122081|NCT00974675|3721146|FG001|Overall Study|Adverse Event|1
2122082|NCT00974675|3721147|FG002|Overall Study|Adverse Event|1
2122083|NCT00974675|3721148|FG003|Overall Study|Adverse Event|1
2122084|NCT00974675|3721145|FG000|Overall Study|Physician Decision|0
2122085|NCT00974675|3721146|FG001|Overall Study|Physician Decision|0
2122086|NCT00974675|3721147|FG002|Overall Study|Physician Decision|1
2122087|NCT00974675|3721148|FG003|Overall Study|Physician Decision|0
2122088|NCT00974675|3721145|FG000|Overall Study|Participant on holiday; unable to attend|0
2122089|NCT00974675|3721146|FG001|Overall Study|Participant on holiday; unable to attend|0
2122090|NCT00974675|3721147|FG002|Overall Study|Participant on holiday; unable to attend|0
2122091|NCT00974675|3721148|FG003|Overall Study|Participant on holiday; unable to attend|1
2122092|NCT00974974|3721169|FG000|IR CD-LD Dose Adjustment|Adverse Event|0
2122093|NCT00974974|3721170|FG001|IR CD-LD Dose Adjustment|Adverse Event|3
2278637|NCT02341456|3962029|FG000|Overall Study|Physician Decision|1
2278638|NCT02341456|3962030|FG001|Overall Study|Physician Decision|0
2278639|NCT02341456|3962031|FG002|Overall Study|Physician Decision|0
2278640|NCT02341482|3962039|FG000|Overall Study|Adverse Event|1
2278641|NCT02342171|3962092|FG000|Overall Study|Death|4
2278642|NCT02342171|3962093|FG001|Overall Study|Death|87
2278643|NCT02342171|3962092|FG000|Overall Study|Received favipiravir|10
2278644|NCT02342171|3962093|FG001|Overall Study|Received favipiravir|0
2278645|NCT02342171|3962092|FG000|Overall Study|Missing cycle treshold value|1
2278646|NCT02342171|3962093|FG001|Overall Study|Missing cycle treshold value|0
2278647|NCT02342171|3962092|FG000|Overall Study|Unknown outcome|0
2278648|NCT02342171|3962093|FG001|Overall Study|Unknown outcome|1
2278649|NCT02342171|3962092|FG000|Overall Study|Missing age data|0
2278650|NCT02342171|3962093|FG001|Overall Study|Missing age data|1
2278651|NCT02342223|3962107|FG000|Overall Study|Lost to Follow-up|1
2278652|NCT02342288|3962113|FG000|Overall Study|no protocol anesthesiologist available|3
2278653|NCT02342288|3962114|FG001|Overall Study|no protocol anesthesiologist available|2
2278654|NCT02342288|3962113|FG000|Overall Study|anesthesia leak in system|1
2278655|NCT02342288|3962114|FG001|Overall Study|anesthesia leak in system|0
2278656|NCT02342288|3962113|FG000|Overall Study|Withdrawal by Subject|1
2278657|NCT02342288|3962114|FG001|Overall Study|Withdrawal by Subject|0
2278658|NCT02342288|3962113|FG000|Overall Study|coordinator contaminated with blood|0
2278659|NCT02342288|3962114|FG001|Overall Study|coordinator contaminated with blood|1
2278660|NCT02342288|3962113|FG000|Overall Study|subject cannot tolerate numbing drops|0
2278661|NCT02342288|3962114|FG001|Overall Study|subject cannot tolerate numbing drops|1
2278662|NCT02342288|3962113|FG000|Overall Study|coordinator not available|0
2278663|NCT02342288|3962114|FG001|Overall Study|coordinator not available|2
2278664|NCT02342418|3962224|FG000|Overall Study|Adverse Event|0
2278665|NCT02342418|3962225|FG001|Overall Study|Adverse Event|1
2278666|NCT02342548|3962238|FG000|Overall Study|Adverse Event|12
2278667|NCT02342548|3962239|FG001|Overall Study|Adverse Event|17
2278668|NCT02342548|3962240|FG002|Overall Study|Adverse Event|13
2278669|NCT02342548|3962238|FG000|Overall Study|Lost to Follow-up|0
2278670|NCT02342548|3962239|FG001|Overall Study|Lost to Follow-up|1
2278671|NCT02342548|3962240|FG002|Overall Study|Lost to Follow-up|0
2278672|NCT02342548|3962238|FG000|Overall Study|Study terminated by sponsor|20
2278673|NCT02342548|3962239|FG001|Overall Study|Study terminated by sponsor|39
2278674|NCT02342548|3962240|FG002|Overall Study|Study terminated by sponsor|25
2278675|NCT02342548|3962238|FG000|Overall Study|Protocol Violation|0
2278676|NCT02342548|3962239|FG001|Overall Study|Protocol Violation|1
2278677|NCT02342548|3962240|FG002|Overall Study|Protocol Violation|0
2278678|NCT02342548|3962238|FG000|Overall Study|Withdrawal by Subject|1
2278679|NCT02342548|3962239|FG001|Overall Study|Withdrawal by Subject|3
2278680|NCT02342548|3962240|FG002|Overall Study|Withdrawal by Subject|4
2278681|NCT02342548|3962238|FG000|Overall Study|Other|1
2278682|NCT02342548|3962239|FG001|Overall Study|Other|1
2278683|NCT02342548|3962240|FG002|Overall Study|Other|1
2278684|NCT02342639|3962258|FG000|Overall Study|Acute illness, unrelated to study drug|2
2278685|NCT02342639|3962259|FG001|Overall Study|Acute illness, unrelated to study drug|3
2278686|NCT02342639|3962258|FG000|Overall Study|Protocol Violation|0
2122094|NCT00974974|3721169|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0
2122095|NCT00974974|3721170|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1
2122096|NCT00974974|3721169|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
2122097|NCT00974974|3721170|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
2122098|NCT00974974|3721169|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
2122099|NCT00974974|3721170|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
2122100|NCT00974974|3721169|FG000|IR CD-LD Dose Adjustment|Various|0
2122101|NCT00974974|3721170|FG001|IR CD-LD Dose Adjustment|Various|9
2122102|NCT00974974|3721169|FG000|IPX066 Dose Conversion|Adverse Event|23
2122103|NCT00974974|3721170|FG001|IPX066 Dose Conversion|Adverse Event|0
2122104|NCT00974974|3721169|FG000|IPX066 Dose Conversion|Death|2
2122105|NCT00974974|3721170|FG001|IPX066 Dose Conversion|Death|0
2122106|NCT00974974|3721169|FG000|IPX066 Dose Conversion|Lack of Efficacy|13
2122107|NCT00974974|3721170|FG001|IPX066 Dose Conversion|Lack of Efficacy|0
2122108|NCT00974974|3721169|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12
2122109|NCT00974974|3721170|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0
2122110|NCT00974974|3721169|FG000|IPX066 Dose Conversion|Various|3
2122111|NCT00974974|3721170|FG001|IPX066 Dose Conversion|Various|0
2122112|NCT00974974|3721169|FG000|IPX066 Dose Conversion|Protocol Violation|4
2122113|NCT00974974|3721170|FG001|IPX066 Dose Conversion|Protocol Violation|0
2122114|NCT00974974|3721169|FG000|Maintenance - Double Blind Treatment|Adverse Event|3
2122115|NCT00974974|3721170|FG001|Maintenance - Double Blind Treatment|Adverse Event|3
2122116|NCT00974974|3721169|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1
2122117|NCT00974974|3721170|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1
2122118|NCT00974974|3721169|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
2122119|NCT00974974|3721170|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
2278687|NCT02342639|3962259|FG001|Overall Study|Protocol Violation|2
2278688|NCT02342678|3962269|FG000|Overall Study|Lost to Follow-up|0
2278689|NCT02342678|3962270|FG001|Overall Study|Lost to Follow-up|1
2278690|NCT02342678|3962269|FG000|Overall Study|Too busy to complete study|0
2278691|NCT02342678|3962270|FG001|Overall Study|Too busy to complete study|2
2278692|NCT02342678|3962269|FG000|Overall Study|Family illness/emergency|0
2278693|NCT02342678|3962270|FG001|Overall Study|Family illness/emergency|1
2278694|NCT02342678|3962269|FG000|Overall Study|Illness/medical reason|1
2278695|NCT02342678|3962270|FG001|Overall Study|Illness/medical reason|1
2278696|NCT02342704|3962278|FG000|Overall Study|Physician Decision|0
2278697|NCT02342704|3962279|FG001|Overall Study|Physician Decision|3
2278698|NCT02342704|3962278|FG000|Overall Study|Sponsor Termination|49
2278699|NCT02342704|3962279|FG001|Overall Study|Sponsor Termination|43
2278700|NCT02342704|3962278|FG000|Overall Study|Other|0
2278701|NCT02342704|3962279|FG001|Overall Study|Other|1
2278702|NCT02342704|3962278|FG000|Overall Study|Withdrawal by Subject|1
2278703|NCT02342704|3962279|FG001|Overall Study|Withdrawal by Subject|0
2278704|NCT02342704|3962278|FG000|Overall Study|Lost to Follow-up|2
2278705|NCT02342704|3962279|FG001|Overall Study|Lost to Follow-up|1
2278706|NCT02342704|3962278|FG000|Overall Study|Adverse Event|1
2278707|NCT02342704|3962279|FG001|Overall Study|Adverse Event|3
2278708|NCT02342743|3962285|FG000|Baseline Period|Withdrawal by Subject|3
2278709|NCT02342743|3962285|FG000|Baseline Period|Lost to Follow-up|2
2278710|NCT02342743|3962285|FG000|Baseline Period|Change in prophylactic medication|3
2278711|NCT02342743|3962285|FG000|Baseline Period|Screening failure regarding baseline|7
2122120|NCT00974974|3721169|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2
2122121|NCT00974974|3721170|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2
2122122|NCT00974974|3721169|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0
2122123|NCT00974974|3721170|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1
2122124|NCT00974974|3721169|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
2122125|NCT00974974|3721170|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
2122126|NCT00974974|3721169|FG000|Maintenance - Double Blind Treatment|Various|4
2122127|NCT00974974|3721170|FG001|Maintenance - Double Blind Treatment|Various|0
2122128|NCT00975000|3721178|FG000|Overall Study|Other|1
2122129|NCT00975000|3721179|FG001|Overall Study|Other|0
2122130|NCT00975000|3721178|FG000|Overall Study|Adverse Event|1
2122131|NCT00975000|3721179|FG001|Overall Study|Adverse Event|1
2122132|NCT00975000|3721178|FG000|Overall Study|Withdrawal by Subject|2
2122133|NCT00975000|3721179|FG001|Overall Study|Withdrawal by Subject|2
2122134|NCT00975000|3721178|FG000|Overall Study|Lost to Follow-up|0
2122135|NCT00975000|3721179|FG001|Overall Study|Lost to Follow-up|1
2122136|NCT00975000|3721178|FG000|Overall Study|Protocol-specified Criteria|1
2122137|NCT00975000|3721179|FG001|Overall Study|Protocol-specified Criteria|0
2122138|NCT00975000|3721178|FG000|Overall Study|Non-compliance|0
2122139|NCT00975000|3721179|FG001|Overall Study|Non-compliance|1
2122140|NCT00975130|3721185|FG000|Study Part 1|Adverse Event|150
2122141|NCT00975130|3721186|FG001|Study Part 1|Adverse Event|0
2122142|NCT00975130|3721187|FG002|Study Part 1|Adverse Event|0
2122143|NCT00975130|3721185|FG000|Study Part 1|Lost to Follow-up|19
2122144|NCT00975130|3721186|FG001|Study Part 1|Lost to Follow-up|0
2278712|NCT02342743|3962285|FG000|Treatment Period|Withdrawal by Subject|2
2278713|NCT02342743|3962285|FG000|Treatment Period|Lost to Follow-up|8
2278714|NCT02342743|3962285|FG000|Treatment Period|Change in prophylactic medication|1
2278715|NCT02342886|3962294|FG000|Overall Study|Treatment non-compliance|1
2278716|NCT02342886|3962295|FG001|Overall Study|Treatment non-compliance|0
2278717|NCT02342886|3962296|FG002|Overall Study|Treatment non-compliance|0
2122145|NCT00975130|3721187|FG002|Study Part 1|Lost to Follow-up|0
2122146|NCT00975130|3721185|FG000|Study Part 1|Withdrawal by Subject|61
2122147|NCT00975130|3721186|FG001|Study Part 1|Withdrawal by Subject|0
2122148|NCT00975130|3721187|FG002|Study Part 1|Withdrawal by Subject|0
2122149|NCT00975130|3721185|FG000|Study Part 1|Protocol Violation|13
2122150|NCT00975130|3721186|FG001|Study Part 1|Protocol Violation|0
2122151|NCT00975130|3721187|FG002|Study Part 1|Protocol Violation|0
2122152|NCT00975130|3721185|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9
2122153|NCT00975130|3721186|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0
2122154|NCT00975130|3721187|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0
2122155|NCT00975130|3721185|FG000|Study Part 1|Administrative|4
2122156|NCT00975130|3721186|FG001|Study Part 1|Administrative|0
2122157|NCT00975130|3721187|FG002|Study Part 1|Administrative|0
2122158|NCT00975130|3721185|FG000|Study Part 1|Withdrew Consent|24
2122159|NCT00975130|3721186|FG001|Study Part 1|Withdrew Consent|0
2122160|NCT00975130|3721187|FG002|Study Part 1|Withdrew Consent|0
2122161|NCT00975130|3721185|FG000|Study Part 2|Adverse Event|0
2122162|NCT00975130|3721186|FG001|Study Part 2|Adverse Event|14
2122163|NCT00975130|3721187|FG002|Study Part 2|Adverse Event|7
2122164|NCT00975130|3721185|FG000|Study Part 2|Lost to Follow-up|0
2122165|NCT00975130|3721186|FG001|Study Part 2|Lost to Follow-up|0
2122166|NCT00975130|3721187|FG002|Study Part 2|Lost to Follow-up|1
2122167|NCT00975130|3721185|FG000|Study Part 2|Withdrawal by Subject|0
2122168|NCT00975130|3721186|FG001|Study Part 2|Withdrawal by Subject|13
2122169|NCT00975130|3721187|FG002|Study Part 2|Withdrawal by Subject|5
2122170|NCT00975130|3721185|FG000|Study Part 2|Withdrew Consent|0
2122171|NCT00975130|3721186|FG001|Study Part 2|Withdrew Consent|6
2122172|NCT00975130|3721187|FG002|Study Part 2|Withdrew Consent|2
2122173|NCT00975130|3721185|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0
2122174|NCT00975130|3721186|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4
2122175|NCT00975130|3721187|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1
2122176|NCT00975130|3721185|FG000|Study Part 2|Administrative|0
2122177|NCT00975130|3721186|FG001|Study Part 2|Administrative|1
2122178|NCT00975130|3721187|FG002|Study Part 2|Administrative|0
2122179|NCT00975130|3721185|FG000|Study Part 2|Protocol Violation|0
2122180|NCT00975130|3721186|FG001|Study Part 2|Protocol Violation|0
2122181|NCT00975130|3721187|FG002|Study Part 2|Protocol Violation|1
2122182|NCT00975143|3721202|FG000|Overall Study|Adverse Event|19
2122183|NCT00975143|3721203|FG001|Overall Study|Adverse Event|15
2122184|NCT00975143|3721202|FG000|Overall Study|Withdrawal by Subject|15
2122185|NCT00975143|3721203|FG001|Overall Study|Withdrawal by Subject|15
2122186|NCT00975143|3721202|FG000|Overall Study|Lost to Follow-up|20
2122187|NCT00975143|3721203|FG001|Overall Study|Lost to Follow-up|16
2122188|NCT00975143|3721202|FG000|Overall Study|Non-compliance|5
2122189|NCT00975143|3721203|FG001|Overall Study|Non-compliance|8
2122190|NCT00975143|3721202|FG000|Overall Study|Physician Decision|1
2122191|NCT00975143|3721203|FG001|Overall Study|Physician Decision|2
2122192|NCT00975143|3721202|FG000|Overall Study|Details not available|10
2122193|NCT00975143|3721203|FG001|Overall Study|Details not available|4
2122194|NCT00975156|3721211|FG000|Overall Study|Protocol Violation|0
2122195|NCT00975156|3721212|FG001|Overall Study|Protocol Violation|1
2122196|NCT00975195|3721224|FG000|Overall Study|Adverse Event|108
2122197|NCT00975195|3721225|FG001|Overall Study|Adverse Event|101
2122198|NCT00975195|3721224|FG000|Overall Study|Lack of Efficacy|6
2122199|NCT00975195|3721225|FG001|Overall Study|Lack of Efficacy|6
2122200|NCT00975195|3721224|FG000|Overall Study|Protocol Violation|27
2122201|NCT00975195|3721225|FG001|Overall Study|Protocol Violation|23
2122202|NCT00975195|3721224|FG000|Overall Study|Lost to Follow-up|9
2122203|NCT00975195|3721225|FG001|Overall Study|Lost to Follow-up|7
2122204|NCT00975195|3721224|FG000|Overall Study|Withdrawal by Subject|48
2122205|NCT00975195|3721225|FG001|Overall Study|Withdrawal by Subject|61
2122206|NCT00975195|3721224|FG000|Overall Study|Other reason not defined above|29
2122207|NCT00975195|3721225|FG001|Overall Study|Other reason not defined above|33
2122208|NCT00975195|3721224|FG000|Overall Study|Not treated|1
2122209|NCT00975195|3721225|FG001|Overall Study|Not treated|2
2122210|NCT00975221|3721233|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
2122211|NCT00975221|3721234|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
2122212|NCT00975221|3721233|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
2122213|NCT00975221|3721234|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
2122214|NCT00975221|3721233|FG000|Titration Phase (Weeks 1-12)|Other|0
2122215|NCT00975221|3721234|FG001|Titration Phase (Weeks 1-12)|Other|1
2122216|NCT00975221|3721233|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
2122217|NCT00975221|3721234|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
2122218|NCT00975221|3721233|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
2122219|NCT00975221|3721234|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
2122220|NCT00975221|3721233|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
2122221|NCT00975221|3721234|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
2122222|NCT00975286|3721244|FG000|Overall Study|Adverse Event|9
2122223|NCT00975286|3721245|FG001|Overall Study|Adverse Event|19
2122224|NCT00975286|3721244|FG000|Overall Study|Protocol Violation|1
2122225|NCT00975286|3721245|FG001|Overall Study|Protocol Violation|2
2122226|NCT00975286|3721244|FG000|Overall Study|Withdrawal by Subject|0
2122227|NCT00975286|3721245|FG001|Overall Study|Withdrawal by Subject|2
2122228|NCT00975286|3721244|FG000|Overall Study|Familial and Personal Reasons|2
2122229|NCT00975286|3721245|FG001|Overall Study|Familial and Personal Reasons|2
2122230|NCT00975286|3721244|FG000|Overall Study|Poor Compliance to Protocol|0
2122231|NCT00975286|3721245|FG001|Overall Study|Poor Compliance to Protocol|2
2122232|NCT00975286|3721244|FG000|Overall Study|Sponsor Decision|0
2122233|NCT00975286|3721245|FG001|Overall Study|Sponsor Decision|2
2122234|NCT00975416|3721253|FG000|Overall Study|early discharge from tx|3
2122235|NCT00975416|3721254|FG001|Overall Study|early discharge from tx|5
2122236|NCT00975481|3721261|FG000|Second Intervention Period|Adverse Event|2
2122237|NCT00975481|3721262|FG001|Second Intervention Period|Adverse Event|1
2122238|NCT00975481|3721263|FG002|Second Intervention Period|Adverse Event|0
2122239|NCT00975481|3721264|FG003|Second Intervention Period|Adverse Event|0
2122240|NCT00975481|3721265|FG004|Second Intervention Period|Adverse Event|0
2122241|NCT00975481|3721266|FG005|Second Intervention Period|Adverse Event|0
2122242|NCT00975481|3721261|FG000|Second Intervention Period|Withdrawal by Subject|0
2122243|NCT00975481|3721262|FG001|Second Intervention Period|Withdrawal by Subject|0
2122244|NCT00975481|3721263|FG002|Second Intervention Period|Withdrawal by Subject|1
2122245|NCT00975481|3721264|FG003|Second Intervention Period|Withdrawal by Subject|0
2122246|NCT00975481|3721265|FG004|Second Intervention Period|Withdrawal by Subject|0
2122247|NCT00975481|3721266|FG005|Second Intervention Period|Withdrawal by Subject|0
2122248|NCT00975481|3721261|FG000|Fourth Intervention Period|Withdrawal by Subject|0
2122249|NCT00975481|3721262|FG001|Fourth Intervention Period|Withdrawal by Subject|0
2122250|NCT00975481|3721263|FG002|Fourth Intervention Period|Withdrawal by Subject|1
2122251|NCT00975481|3721264|FG003|Fourth Intervention Period|Withdrawal by Subject|1
2122252|NCT00975481|3721265|FG004|Fourth Intervention Period|Withdrawal by Subject|0
2122253|NCT00975481|3721266|FG005|Fourth Intervention Period|Withdrawal by Subject|0
2278718|NCT02342886|3962297|FG003|Overall Study|Treatment non-compliance|1
2278719|NCT02342886|3962298|FG004|Overall Study|Treatment non-compliance|0
2278720|NCT02342886|3962294|FG000|Overall Study|Late exclusion: rifampicin resistance|1
2278721|NCT02342886|3962295|FG001|Overall Study|Late exclusion: rifampicin resistance|0
2278722|NCT02342886|3962296|FG002|Overall Study|Late exclusion: rifampicin resistance|0
2278723|NCT02342886|3962297|FG003|Overall Study|Late exclusion: rifampicin resistance|0
2278724|NCT02342886|3962298|FG004|Overall Study|Late exclusion: rifampicin resistance|0
2278725|NCT02342886|3962294|FG000|Overall Study|Adverse event/specific toxicity|4
2278726|NCT02342886|3962295|FG001|Overall Study|Adverse event/specific toxicity|3
2278727|NCT02342886|3962296|FG002|Overall Study|Adverse event/specific toxicity|11
2278728|NCT02342886|3962297|FG003|Overall Study|Adverse event/specific toxicity|2
2278729|NCT02342886|3962298|FG004|Overall Study|Adverse event/specific toxicity|1
2122254|NCT00975481|3721261|FG000|Fifth Intervention Period|Withdrawal by Subject|0
2122255|NCT00975481|3721262|FG001|Fifth Intervention Period|Withdrawal by Subject|0
2122256|NCT00975481|3721263|FG002|Fifth Intervention Period|Withdrawal by Subject|0
2122257|NCT00975481|3721264|FG003|Fifth Intervention Period|Withdrawal by Subject|0
2122258|NCT00975481|3721265|FG004|Fifth Intervention Period|Withdrawal by Subject|1
2122259|NCT00975481|3721266|FG005|Fifth Intervention Period|Withdrawal by Subject|0
2122260|NCT00975507|3721286|FG000|Overall Study|Adverse Event|1
2122261|NCT00975507|3721287|FG001|Overall Study|Adverse Event|0
2122262|NCT00975507|3721286|FG000|Overall Study|Lost to Follow-up|7
2122263|NCT00975507|3721287|FG001|Overall Study|Lost to Follow-up|1
2122264|NCT00975507|3721286|FG000|Overall Study|Protocol Violation|2
2278730|NCT02342886|3962294|FG000|Overall Study|Lost to Follow-up|1
2278731|NCT02342886|3962295|FG001|Overall Study|Lost to Follow-up|0
2278732|NCT02342886|3962296|FG002|Overall Study|Lost to Follow-up|0
2122265|NCT00975507|3721287|FG001|Overall Study|Protocol Violation|0
2122266|NCT00975507|3721286|FG000|Overall Study|Withdrawal by Subject|10
2122267|NCT00975507|3721287|FG001|Overall Study|Withdrawal by Subject|3
2122268|NCT00975585|3721297|FG000|Overall Study|Adverse Event|0
2122269|NCT00975585|3721298|FG001|Overall Study|Adverse Event|4
2122270|NCT00975585|3721297|FG000|Overall Study|Lost to Follow-up|3
2122271|NCT00975585|3721298|FG001|Overall Study|Lost to Follow-up|5
2122272|NCT00975585|3721297|FG000|Overall Study|Withdrawal by Subject|2
2122273|NCT00975585|3721298|FG001|Overall Study|Withdrawal by Subject|1
2122274|NCT00975585|3721297|FG000|Overall Study|Lens issue|2
2122275|NCT00975585|3721298|FG001|Overall Study|Lens issue|2
2122276|NCT00975676|3721342|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6
2122277|NCT00975676|3721343|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8
2122278|NCT00975689|3721356|FG000|Overall Study|Adverse Event|0
2122279|NCT00975689|3721357|FG001|Overall Study|Adverse Event|3
2122280|NCT00975689|3721356|FG000|Overall Study|Withdrawal by Subject|1
2122281|NCT00975689|3721357|FG001|Overall Study|Withdrawal by Subject|0
2122282|NCT00975689|3721356|FG000|Overall Study|Physician Decision|1
2122283|NCT00975689|3721357|FG001|Overall Study|Physician Decision|0
2122284|NCT00975715|3721365|FG000|Titration Period|Adverse Event|6
2122285|NCT00975715|3721366|FG001|Titration Period|Adverse Event|0
2122286|NCT00975715|3721365|FG000|Titration Period|Protocol Violation|1
2122287|NCT00975715|3721366|FG001|Titration Period|Protocol Violation|0
2122288|NCT00975715|3721365|FG000|Maintenance Period|Adverse Event|2
2122289|NCT00975715|3721366|FG001|Maintenance Period|Adverse Event|1
2122290|NCT00975780|3721374|FG000|Follow Up|Death|88
2122291|NCT00975780|3721375|FG001|Follow Up|Death|122
2122292|NCT00975780|3721374|FG000|Follow Up|Facility Withdrawal|7
2122293|NCT00975780|3721375|FG001|Follow Up|Facility Withdrawal|23
2122294|NCT00975780|3721374|FG000|Follow Up|Discharged from Facility|7
2122295|NCT00975780|3721375|FG001|Follow Up|Discharged from Facility|12
2122296|NCT00975806|3721384|FG000|Overall Study|Adverse Event|2
2122297|NCT00975806|3721385|FG001|Overall Study|Adverse Event|1
2122298|NCT00975806|3721386|FG002|Overall Study|Adverse Event|2
2122299|NCT00975806|3721384|FG000|Overall Study|Disease Progression|1
2122300|NCT00975806|3721385|FG001|Overall Study|Disease Progression|5
2122301|NCT00975806|3721386|FG002|Overall Study|Disease Progression|1
2122302|NCT00975806|3721384|FG000|Overall Study|Withdrawal by Subject|1
2122303|NCT00975806|3721385|FG001|Overall Study|Withdrawal by Subject|0
2122304|NCT00975806|3721386|FG002|Overall Study|Withdrawal by Subject|0
2122305|NCT00975806|3721384|FG000|Overall Study|Death|0
2122306|NCT00975806|3721385|FG001|Overall Study|Death|1
2122307|NCT00975806|3721386|FG002|Overall Study|Death|0
2122308|NCT00975806|3721384|FG000|Overall Study|Physician decision and disease related|1
2122309|NCT00975806|3721385|FG001|Overall Study|Physician decision and disease related|0
2122310|NCT00975806|3721386|FG002|Overall Study|Physician decision and disease related|1
2122311|NCT00975884|3721398|FG000|Overall Study|Adverse Event|1
2122312|NCT00975884|3721399|FG001|Overall Study|Adverse Event|0
2122313|NCT00975884|3721398|FG000|Overall Study|Lost to Follow-up|5
2122314|NCT00975884|3721399|FG001|Overall Study|Lost to Follow-up|3
2122315|NCT00975884|3721398|FG000|Overall Study|Withdrawal by Subject|9
2122316|NCT00975884|3721399|FG001|Overall Study|Withdrawal by Subject|9
2122317|NCT00975884|3721398|FG000|Overall Study|Other|1
2122318|NCT00975884|3721399|FG001|Overall Study|Other|3
2122319|NCT00975923|3721417|FG000|Overall Study|Withdrawal by Subject|0
2122320|NCT00975923|3721418|FG001|Overall Study|Withdrawal by Subject|1
2122321|NCT00975975|3721425|FG000|Overall Study|Death|6
2122322|NCT00976027|3721431|FG000|Overall Study|Serious Adverse Event|36
2122323|NCT00976027|3721432|FG001|Overall Study|Serious Adverse Event|17
2122324|NCT00976027|3721431|FG000|Overall Study|Adverse Event|0
2122325|NCT00976027|3721432|FG001|Overall Study|Adverse Event|2
2122326|NCT00976027|3721431|FG000|Overall Study|Protocol Violation|60
2122327|NCT00976027|3721432|FG001|Overall Study|Protocol Violation|27
2122328|NCT00976027|3721431|FG000|Overall Study|Lost to Follow-up|208
2122329|NCT00976027|3721432|FG001|Overall Study|Lost to Follow-up|103
2122330|NCT00976027|3721431|FG000|Overall Study|Withdrawal by Subject|107
2122331|NCT00976027|3721432|FG001|Overall Study|Withdrawal by Subject|66
2122332|NCT00976209|3721444|FG000|Treatment Period 1|Protocol Violation|1
2122333|NCT00976209|3721445|FG001|Treatment Period 1|Protocol Violation|0
2122334|NCT00976209|3721444|FG000|Treatment Period 1|Lost to Follow-up|2
2122335|NCT00976209|3721445|FG001|Treatment Period 1|Lost to Follow-up|0
2122336|NCT00976209|3721444|FG000|Treatment Period 1|Other|0
2122337|NCT00976209|3721445|FG001|Treatment Period 1|Other|1
2122338|NCT00976209|3721444|FG000|Wash-out Period|Adverse Event|1
2122339|NCT00976209|3721445|FG001|Wash-out Period|Adverse Event|2
2122340|NCT00976209|3721444|FG000|Wash-out Period|Lost to Follow-up|1
2122341|NCT00976209|3721445|FG001|Wash-out Period|Lost to Follow-up|0
2122342|NCT00976209|3721444|FG000|Wash-out Period|Protocol Violation|1
2122343|NCT00976209|3721445|FG001|Wash-out Period|Protocol Violation|0
2122344|NCT00976209|3721444|FG000|Wash-out Period|Other|1
2122345|NCT00976209|3721445|FG001|Wash-out Period|Other|0
2122346|NCT00976209|3721444|FG000|Treatment Period 2|Withdrawal by Subject|0
2122347|NCT00976209|3721445|FG001|Treatment Period 2|Withdrawal by Subject|1
2122348|NCT00976209|3721444|FG000|Treatment Period 2|Lost to Follow-up|0
2122349|NCT00976209|3721445|FG001|Treatment Period 2|Lost to Follow-up|1
2122350|NCT00976274|3721457|FG000|Overall Study|Lost to Follow-up|5
2122351|NCT00976274|3721458|FG001|Overall Study|Lost to Follow-up|5
2122352|NCT00976274|3721457|FG000|Overall Study|Withdrawal by Subject|1
2122353|NCT00976274|3721458|FG001|Overall Study|Withdrawal by Subject|1
2122354|NCT00976274|3721457|FG000|Overall Study|Physician Decision|1
2122355|NCT00976274|3721458|FG001|Overall Study|Physician Decision|2
2122356|NCT00976391|3721479|FG000|Treatment Period (52 Weeks)|Adverse Event|16
2122357|NCT00976391|3721480|FG001|Treatment Period (52 Weeks)|Adverse Event|2
2122358|NCT00976391|3721479|FG000|Treatment Period (52 Weeks)|Protocol Violation|1
2122359|NCT00976391|3721480|FG001|Treatment Period (52 Weeks)|Protocol Violation|1
2122360|NCT00976391|3721479|FG000|Treatment Period (52 Weeks)|Noncompliance|4
2122361|NCT00976391|3721480|FG001|Treatment Period (52 Weeks)|Noncompliance|4
2122362|NCT00976391|3721479|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10
2122363|NCT00976391|3721480|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8
2122364|NCT00976391|3721479|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9
2122365|NCT00976391|3721480|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19
2122366|NCT00976391|3721479|FG000|Treatment Period (52 Weeks)|Physician Decision|1
2122367|NCT00976391|3721480|FG001|Treatment Period (52 Weeks)|Physician Decision|1
2122368|NCT00976391|3721479|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
2122369|NCT00976391|3721480|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
2122370|NCT00976391|3721479|FG000|Treatment Period (52 Weeks)|Pregnancy|1
2122371|NCT00976391|3721480|FG001|Treatment Period (52 Weeks)|Pregnancy|0
2122372|NCT00976391|3721479|FG000|Follow-up Period (8 Weeks)|Adverse Event|3
2122373|NCT00976391|3721480|FG001|Follow-up Period (8 Weeks)|Adverse Event|1
2122374|NCT00976391|3721479|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
2122375|NCT00976391|3721480|FG001|Follow-up Period (8 Weeks)|Noncompliance|2
2122376|NCT00976391|3721479|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14
2122377|NCT00976391|3721480|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
2122378|NCT00976391|3721479|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
2122379|NCT00976391|3721480|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
2122380|NCT00976391|3721479|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
2122381|NCT00976391|3721480|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
2122382|NCT00976391|3721479|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
2122383|NCT00976391|3721480|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
2122384|NCT00976456|3721499|FG000|Overall Study|Adverse Event|17
2122385|NCT00976456|3721500|FG001|Overall Study|Adverse Event|22
2122386|NCT00976456|3721499|FG000|Overall Study|Death|7
2122387|NCT00976456|3721500|FG001|Overall Study|Death|9
2122388|NCT00976456|3721499|FG000|Overall Study|Lack of Efficacy|5
2122389|NCT00976456|3721500|FG001|Overall Study|Lack of Efficacy|2
2122390|NCT00976456|3721499|FG000|Overall Study|Withdrawal by Subject|3
2122391|NCT00976456|3721500|FG001|Overall Study|Withdrawal by Subject|1
2122392|NCT00976456|3721499|FG000|Overall Study|screening failure, unknown|11
2122393|NCT00976456|3721500|FG001|Overall Study|screening failure, unknown|4
2278733|NCT02342886|3962297|FG003|Overall Study|Lost to Follow-up|0
2278734|NCT02342886|3962298|FG004|Overall Study|Lost to Follow-up|0
2278735|NCT02342886|3962294|FG000|Overall Study|Death|1
2278736|NCT02342886|3962295|FG001|Overall Study|Death|2
2278737|NCT02342886|3962296|FG002|Overall Study|Death|1
2278738|NCT02342886|3962297|FG003|Overall Study|Death|0
2278739|NCT02342886|3962298|FG004|Overall Study|Death|1
2278740|NCT02342886|3962294|FG000|Overall Study|Withdrawal by Subject|0
2278741|NCT02342886|3962295|FG001|Overall Study|Withdrawal by Subject|1
2278742|NCT02342886|3962296|FG002|Overall Study|Withdrawal by Subject|0
2278743|NCT02342886|3962297|FG003|Overall Study|Withdrawal by Subject|1
2278744|NCT02342886|3962298|FG004|Overall Study|Withdrawal by Subject|0
2278745|NCT02342886|3962294|FG000|Overall Study|Investigator/sponsor decision|0
2278746|NCT02342886|3962295|FG001|Overall Study|Investigator/sponsor decision|2
2278747|NCT02342886|3962296|FG002|Overall Study|Investigator/sponsor decision|0
2278748|NCT02342886|3962297|FG003|Overall Study|Investigator/sponsor decision|3
2278749|NCT02342886|3962298|FG004|Overall Study|Investigator/sponsor decision|1
2278750|NCT02342886|3962294|FG000|Overall Study|Pregnancy|0
2278751|NCT02342886|3962295|FG001|Overall Study|Pregnancy|0
2278752|NCT02342886|3962296|FG002|Overall Study|Pregnancy|2
2278753|NCT02342886|3962297|FG003|Overall Study|Pregnancy|0
2278754|NCT02342886|3962298|FG004|Overall Study|Pregnancy|0
2278755|NCT02342886|3962294|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0
2278756|NCT02342886|3962295|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0
2278757|NCT02342886|3962296|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1
2278758|NCT02342886|3962297|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0
2278759|NCT02342886|3962298|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0
2278760|NCT02342886|3962294|FG000|Overall Study|Protocol Violation|0
2278761|NCT02342886|3962295|FG001|Overall Study|Protocol Violation|0
2278762|NCT02342886|3962296|FG002|Overall Study|Protocol Violation|0
2278763|NCT02342886|3962297|FG003|Overall Study|Protocol Violation|2
2278764|NCT02342886|3962298|FG004|Overall Study|Protocol Violation|0
2278765|NCT02343003|3962312|FG000|Overall Study|Withdrawal by Subject|9
2278766|NCT02343003|3962313|FG001|Overall Study|Withdrawal by Subject|4
2278767|NCT02343003|3962312|FG000|Overall Study|Lost to Follow-up|5
2278768|NCT02343003|3962313|FG001|Overall Study|Lost to Follow-up|1
2278769|NCT02343003|3962312|FG000|Overall Study|Protocol Violation|1
2278770|NCT02343003|3962313|FG001|Overall Study|Protocol Violation|0
2278771|NCT02343003|3962312|FG000|Overall Study|Death|0
2278772|NCT02343003|3962313|FG001|Overall Study|Death|1
2278773|NCT02343003|3962312|FG000|Overall Study|exclusion criteria met|1
2278774|NCT02343003|3962313|FG001|Overall Study|exclusion criteria met|1
2278775|NCT02343003|3962312|FG000|Overall Study|terminated by sponsor|2
2278776|NCT02343003|3962313|FG001|Overall Study|terminated by sponsor|0
2278777|NCT02343406|3962361|FG000|Overall Study|Progressive disease|72
2278778|NCT02343406|3962362|FG001|Overall Study|Progressive disease|70
2278779|NCT02343406|3962363|FG002|Overall Study|Progressive disease|43
2278780|NCT02343406|3962364|FG003|Overall Study|Progressive disease|15
2278781|NCT02343406|3962365|FG004|Overall Study|Progressive disease|5
2278782|NCT02343406|3962361|FG000|Overall Study|Adverse Event|6
2278783|NCT02343406|3962362|FG001|Overall Study|Adverse Event|8
2278784|NCT02343406|3962363|FG002|Overall Study|Adverse Event|6
2278785|NCT02343406|3962364|FG003|Overall Study|Adverse Event|3
2278786|NCT02343406|3962365|FG004|Overall Study|Adverse Event|0
2278787|NCT02343406|3962361|FG000|Overall Study|Withdrawal by Subject|6
2278788|NCT02343406|3962362|FG001|Overall Study|Withdrawal by Subject|4
2278789|NCT02343406|3962363|FG002|Overall Study|Withdrawal by Subject|8
2278790|NCT02343406|3962364|FG003|Overall Study|Withdrawal by Subject|3
2122394|NCT00976482|3721506|FG000|Overall Study|Death|208
2278791|NCT02343406|3962365|FG004|Overall Study|Withdrawal by Subject|0
2278792|NCT02343406|3962361|FG000|Overall Study|Death|2
2278793|NCT02343406|3962362|FG001|Overall Study|Death|1
2278794|NCT02343406|3962363|FG002|Overall Study|Death|0
2278795|NCT02343406|3962364|FG003|Overall Study|Death|0
2278796|NCT02343406|3962365|FG004|Overall Study|Death|0
2122395|NCT00976482|3721506|FG000|Overall Study|Withdrawal by Subject|45
2122396|NCT00976482|3721506|FG000|Overall Study|Center terminated|1
2122397|NCT00976482|3721506|FG000|Overall Study|Protocol Violation|5
2122398|NCT00976495|3721513|FG000|Overall Study|Withdrawal by Subject|0
2122399|NCT00976495|3721514|FG001|Overall Study|Withdrawal by Subject|1
2122400|NCT00976495|3721515|FG002|Overall Study|Withdrawal by Subject|0
2122401|NCT00976508|3721525|FG000|Overall Study|Death|7
2122402|NCT00976508|3721526|FG001|Overall Study|Death|1
2122403|NCT00976508|3721525|FG000|Overall Study|Lost to Follow-up|1
2122404|NCT00976508|3721526|FG001|Overall Study|Lost to Follow-up|0
2122405|NCT00976508|3721525|FG000|Overall Study|Withdrawal by Subject|1
2122406|NCT00976508|3721526|FG001|Overall Study|Withdrawal by Subject|0
2122407|NCT00976508|3721525|FG000|Overall Study|Disease Progression|4
2122408|NCT00976508|3721526|FG001|Overall Study|Disease Progression|4
2122409|NCT00976508|3721525|FG000|Overall Study|Subject Enrolled in Hospice|1
2122410|NCT00976508|3721526|FG001|Overall Study|Subject Enrolled in Hospice|0
2122411|NCT00976508|3721525|FG000|Overall Study|Terminated by the Sponsor|0
2122412|NCT00976508|3721526|FG001|Overall Study|Terminated by the Sponsor|1
2122413|NCT00976560|3721555|FG000|Overall Study|Adverse Event|5
2122414|NCT00976560|3721556|FG001|Overall Study|Adverse Event|5
2122415|NCT00976560|3721555|FG000|Overall Study|Lack of Efficacy|3
2122416|NCT00976560|3721556|FG001|Overall Study|Lack of Efficacy|5
2122417|NCT00976560|3721555|FG000|Overall Study|Protocol Violation|1
2122418|NCT00976560|3721556|FG001|Overall Study|Protocol Violation|0
2122419|NCT00976560|3721555|FG000|Overall Study|Lost to Follow-up|1
2122420|NCT00976560|3721556|FG001|Overall Study|Lost to Follow-up|0
2122421|NCT00976560|3721555|FG000|Overall Study|Physician Decision|2
2122422|NCT00976560|3721556|FG001|Overall Study|Physician Decision|0
2122423|NCT00976560|3721555|FG000|Overall Study|Withdrawal by Subject|2
2122424|NCT00976560|3721556|FG001|Overall Study|Withdrawal by Subject|3
2122425|NCT00976573|3721564|FG000|Overall Study|Ineligible|0
2122426|NCT00976573|3721565|FG001|Overall Study|Ineligible|1
2122427|NCT00976573|3721564|FG000|Overall Study|Cancel prior to receiving treatment|4
2122428|NCT00976573|3721565|FG001|Overall Study|Cancel prior to receiving treatment|2
2122429|NCT00976677|3721591|FG000|Overall Study|Adverse Event|1
2122430|NCT00976677|3721592|FG001|Overall Study|Adverse Event|0
2122431|NCT00976677|3721591|FG000|Overall Study|Withdrawal by Subject|0
2122432|NCT00976677|3721592|FG001|Overall Study|Withdrawal by Subject|2
2122433|NCT00976677|3721591|FG000|Overall Study|Disease progression|1
2122434|NCT00976677|3721592|FG001|Overall Study|Disease progression|1
2122435|NCT00976677|3721591|FG000|Overall Study|Trial unblinded|2
2122436|NCT00976677|3721592|FG001|Overall Study|Trial unblinded|2
2205196|NCT01609556|3843218|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205197|NCT01609556|3843219|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205198|NCT01609556|3843220|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205199|NCT01609556|3843221|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1
2205200|NCT01609556|3843222|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205201|NCT01609556|3843223|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205202|NCT01609556|3843224|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205203|NCT01609556|3843225|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205204|NCT01609556|3843226|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205205|NCT01609556|3843227|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205206|NCT01609556|3843228|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205207|NCT01609556|3843229|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2205208|NCT01609556|3843230|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2278797|NCT02343406|3962361|FG000|Overall Study|Start of a new anti-cancer treatment|0
2278798|NCT02343406|3962362|FG001|Overall Study|Start of a new anti-cancer treatment|1
2278799|NCT02343406|3962363|FG002|Overall Study|Start of a new anti-cancer treatment|0
2122437|NCT00976677|3721591|FG000|Overall Study|Unknown/Missing|1
2122438|NCT00976677|3721592|FG001|Overall Study|Unknown/Missing|0
2278800|NCT02343406|3962364|FG003|Overall Study|Start of a new anti-cancer treatment|1
2278801|NCT02343406|3962365|FG004|Overall Study|Start of a new anti-cancer treatment|0
2278802|NCT02343406|3962361|FG000|Overall Study|Other primary malignancy|0
2278803|NCT02343406|3962362|FG001|Overall Study|Other primary malignancy|1
2278804|NCT02343406|3962363|FG002|Overall Study|Other primary malignancy|0
2278805|NCT02343406|3962364|FG003|Overall Study|Other primary malignancy|0
2278806|NCT02343406|3962365|FG004|Overall Study|Other primary malignancy|0
2278807|NCT02343406|3962361|FG000|Overall Study|Other, not specified|2
2278808|NCT02343406|3962362|FG001|Overall Study|Other, not specified|1
2278809|NCT02343406|3962363|FG002|Overall Study|Other, not specified|1
2278810|NCT02343406|3962364|FG003|Overall Study|Other, not specified|4
2122439|NCT00976703|3721600|FG000|Overall Study|Physician Decision|1
2122440|NCT00976703|3721601|FG001|Overall Study|Physician Decision|1
2122441|NCT00976703|3721600|FG000|Overall Study|ineligible for study|2
2122442|NCT00976703|3721601|FG001|Overall Study|ineligible for study|2
2122443|NCT00976716|3721607|FG000|Overall Study|Adverse Event|1
2122444|NCT00976820|3721616|FG000|Overall Study|Lost to Follow-up|5
2122445|NCT00976820|3721617|FG001|Overall Study|Lost to Follow-up|16
2122446|NCT00976820|3721618|FG002|Overall Study|Lost to Follow-up|2
2122447|NCT00976820|3721619|FG003|Overall Study|Lost to Follow-up|3
2122448|NCT00976820|3721616|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1
2122449|NCT00976820|3721617|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0
2122450|NCT00976820|3721618|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1
2122451|NCT00976820|3721619|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0
2122452|NCT00976820|3721616|FG000|Overall Study|Withdrawal by Subject|2
2122453|NCT00976820|3721617|FG001|Overall Study|Withdrawal by Subject|4
2122454|NCT00976820|3721618|FG002|Overall Study|Withdrawal by Subject|1
2122455|NCT00976820|3721619|FG003|Overall Study|Withdrawal by Subject|4
2122456|NCT00976898|3721670|FG000|Overall Study|Protocol Violation|1
2122457|NCT00976898|3721670|FG000|Overall Study|Adverse Event|1
2122458|NCT00976898|3721670|FG000|Overall Study|Physician Decision|1
2122459|NCT00976898|3721670|FG000|Overall Study|Liver Transplant|1
2122460|NCT00976898|3721670|FG000|Overall Study|Progressive Disease|1
2122461|NCT00976911|3721676|FG000|Overall Study|Withdrawal by Subject|4
2122462|NCT00976911|3721677|FG001|Overall Study|Withdrawal by Subject|6
2122463|NCT00976911|3721676|FG000|Overall Study|Death|138
2122464|NCT00976911|3721677|FG001|Overall Study|Death|126
2122465|NCT00976911|3721676|FG000|Overall Study|Adverse Event|0
2122466|NCT00976911|3721677|FG001|Overall Study|Adverse Event|1
2122467|NCT00976911|3721676|FG000|Overall Study|Protocol Violation|2
2122468|NCT00976911|3721677|FG001|Overall Study|Protocol Violation|0
2122469|NCT00976911|3721676|FG000|Overall Study|Other|8
2122470|NCT00976911|3721677|FG001|Overall Study|Other|9
2122471|NCT00976911|3721676|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30
2122472|NCT00976911|3721677|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37
2122473|NCT00976937|3721685|FG000|Overall Study|Adverse Event|4
2122474|NCT00976937|3721686|FG001|Overall Study|Adverse Event|5
2122475|NCT00976937|3721685|FG000|Overall Study|Lost to Follow-up|2
2278811|NCT02343406|3962365|FG004|Overall Study|Other, not specified|0
2278812|NCT02343458|3962380|FG000|Overall Study|Adverse Event|15
2278813|NCT02343458|3962381|FG001|Overall Study|Adverse Event|14
2278814|NCT02343458|3962382|FG002|Overall Study|Adverse Event|15
2278815|NCT02343458|3962383|FG003|Overall Study|Adverse Event|3
2278816|NCT02343458|3962380|FG000|Overall Study|Lack of Efficacy|3
2278817|NCT02343458|3962381|FG001|Overall Study|Lack of Efficacy|8
2278818|NCT02343458|3962382|FG002|Overall Study|Lack of Efficacy|4
2278819|NCT02343458|3962383|FG003|Overall Study|Lack of Efficacy|8
2278820|NCT02343458|3962380|FG000|Overall Study|Withdrawal by Subject|18
2278821|NCT02343458|3962381|FG001|Overall Study|Withdrawal by Subject|17
2278822|NCT02343458|3962382|FG002|Overall Study|Withdrawal by Subject|23
2278823|NCT02343458|3962383|FG003|Overall Study|Withdrawal by Subject|14
2278824|NCT02343458|3962380|FG000|Overall Study|Physician Decision|1
2278825|NCT02343458|3962381|FG001|Overall Study|Physician Decision|4
2278826|NCT02343458|3962382|FG002|Overall Study|Physician Decision|2
2278827|NCT02343458|3962383|FG003|Overall Study|Physician Decision|2
2278828|NCT02343458|3962380|FG000|Overall Study|Lost to Follow-up|5
2278829|NCT02343458|3962381|FG001|Overall Study|Lost to Follow-up|5
2278830|NCT02343458|3962382|FG002|Overall Study|Lost to Follow-up|3
2278831|NCT02343458|3962383|FG003|Overall Study|Lost to Follow-up|1
2278832|NCT02343458|3962380|FG000|Overall Study|Protocol Violation|2
2278833|NCT02343458|3962381|FG001|Overall Study|Protocol Violation|5
2278834|NCT02343458|3962382|FG002|Overall Study|Protocol Violation|2
2278835|NCT02343458|3962383|FG003|Overall Study|Protocol Violation|2
2278836|NCT02343458|3962380|FG000|Overall Study|Protocol Specified Criteria|17
2278837|NCT02343458|3962381|FG001|Overall Study|Protocol Specified Criteria|13
2278838|NCT02343458|3962382|FG002|Overall Study|Protocol Specified Criteria|14
2278839|NCT02343458|3962383|FG003|Overall Study|Protocol Specified Criteria|8
2278840|NCT02343549|3962393|FG000|Overall Study|Death|11
2278841|NCT02343549|3962393|FG000|Overall Study|Withdrawal by Subject|2
2278842|NCT02343939|3962424|FG000|Overall Study|Death|0
2278843|NCT02343939|3962425|FG001|Overall Study|Death|15
2278844|NCT02343939|3962426|FG002|Overall Study|Death|4
2278845|NCT02343939|3962427|FG003|Overall Study|Death|2
2278846|NCT02343939|3962428|FG004|Overall Study|Death|5
2278847|NCT02343939|3962429|FG005|Overall Study|Death|11
2278848|NCT02343939|3962430|FG006|Overall Study|Death|8
2278849|NCT02343939|3962431|FG007|Overall Study|Death|22
2278850|NCT02343939|3962432|FG008|Overall Study|Death|1
2278851|NCT02343939|3962424|FG000|Overall Study|Study terminated by sponsor|0
2278852|NCT02343939|3962425|FG001|Overall Study|Study terminated by sponsor|27
2278853|NCT02343939|3962426|FG002|Overall Study|Study terminated by sponsor|0
2278854|NCT02343939|3962427|FG003|Overall Study|Study terminated by sponsor|1
2278855|NCT02343939|3962428|FG004|Overall Study|Study terminated by sponsor|1
2278856|NCT02343939|3962429|FG005|Overall Study|Study terminated by sponsor|5
2278857|NCT02343939|3962430|FG006|Overall Study|Study terminated by sponsor|3
2278858|NCT02343939|3962431|FG007|Overall Study|Study terminated by sponsor|4
2278859|NCT02343939|3962432|FG008|Overall Study|Study terminated by sponsor|0
2278860|NCT02343939|3962424|FG000|Overall Study|Withdrew consent|3
2278861|NCT02343939|3962425|FG001|Overall Study|Withdrew consent|6
2278862|NCT02343939|3962426|FG002|Overall Study|Withdrew consent|1
2278863|NCT02343939|3962427|FG003|Overall Study|Withdrew consent|2
2278864|NCT02343939|3962428|FG004|Overall Study|Withdrew consent|2
2278865|NCT02343939|3962429|FG005|Overall Study|Withdrew consent|0
2278866|NCT02343939|3962430|FG006|Overall Study|Withdrew consent|0
2278867|NCT02343939|3962431|FG007|Overall Study|Withdrew consent|8
2278868|NCT02343939|3962432|FG008|Overall Study|Withdrew consent|6
2122476|NCT00976937|3721686|FG001|Overall Study|Lost to Follow-up|1
2122477|NCT00976937|3721685|FG000|Overall Study|Withdrawal by Subject|5
2122478|NCT00976937|3721686|FG001|Overall Study|Withdrawal by Subject|3
2122479|NCT00976937|3721685|FG000|Overall Study|Poor compliance to protocol|3
2122480|NCT00976937|3721686|FG001|Overall Study|Poor compliance to protocol|0
2122481|NCT00976937|3721685|FG000|Overall Study|Personal and Familial Reason|2
2122482|NCT00976937|3721686|FG001|Overall Study|Personal and Familial Reason|2
2122483|NCT00976950|3721692|FG000|Overall Study|Adverse Event|3
2122484|NCT00976950|3721692|FG000|Overall Study|Events with no relationship to Aptivus|3
2122485|NCT00976989|3721699|FG000|Overall Study|Violation of Selection Criteria at Entry|1
2122486|NCT00976989|3721700|FG001|Overall Study|Violation of Selection Criteria at Entry|0
2122487|NCT00976989|3721701|FG002|Overall Study|Violation of Selection Criteria at Entry|1
2122488|NCT00976989|3721699|FG000|Overall Study|Death|5
2122489|NCT00976989|3721700|FG001|Overall Study|Death|7
2122490|NCT00976989|3721701|FG002|Overall Study|Death|10
2122491|NCT00976989|3721699|FG000|Overall Study|Refused Treatment|4
2122492|NCT00976989|3721700|FG001|Overall Study|Refused Treatment|3
2122493|NCT00976989|3721701|FG002|Overall Study|Refused Treatment|5
2122494|NCT00976989|3721699|FG000|Overall Study|Failure to Return|2
2122495|NCT00976989|3721700|FG001|Overall Study|Failure to Return|1
2122496|NCT00976989|3721701|FG002|Overall Study|Failure to Return|0
2122497|NCT00976989|3721699|FG000|Overall Study|Recurrence of Disease|0
2122498|NCT00976989|3721700|FG001|Overall Study|Recurrence of Disease|1
2122499|NCT00976989|3721701|FG002|Overall Study|Recurrence of Disease|0
2122500|NCT00976989|3721699|FG000|Overall Study|Other|1
2122501|NCT00976989|3721700|FG001|Overall Study|Other|0
2122502|NCT00976989|3721701|FG002|Overall Study|Other|1
2122503|NCT00977080|3721713|FG000|Overall Study|Adverse Event|2
2122504|NCT00977080|3721714|FG001|Overall Study|Adverse Event|7
2122505|NCT00977080|3721715|FG002|Overall Study|Adverse Event|7
2122506|NCT00977080|3721716|FG003|Overall Study|Adverse Event|7
2122507|NCT00977080|3721713|FG000|Overall Study|Withdrawal by Subject|1
2122508|NCT00977080|3721714|FG001|Overall Study|Withdrawal by Subject|5
2122509|NCT00977080|3721715|FG002|Overall Study|Withdrawal by Subject|1
2122510|NCT00977080|3721716|FG003|Overall Study|Withdrawal by Subject|5
2122511|NCT00977080|3721713|FG000|Overall Study|Protocol Violation|7
2122512|NCT00977080|3721714|FG001|Overall Study|Protocol Violation|3
2122513|NCT00977080|3721715|FG002|Overall Study|Protocol Violation|4
2122514|NCT00977080|3721716|FG003|Overall Study|Protocol Violation|3
2122515|NCT00977080|3721713|FG000|Overall Study|Noncompliance|0
2122516|NCT00977080|3721714|FG001|Overall Study|Noncompliance|2
2122517|NCT00977080|3721715|FG002|Overall Study|Noncompliance|1
2122518|NCT00977080|3721716|FG003|Overall Study|Noncompliance|0
2122519|NCT00977080|3721713|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
2122520|NCT00977080|3721714|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
2122521|NCT00977080|3721715|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
2122522|NCT00977080|3721716|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
2122523|NCT00977080|3721713|FG000|Overall Study|Required kidney transplantation|1
2122524|NCT00977080|3721714|FG001|Overall Study|Required kidney transplantation|3
2122525|NCT00977080|3721715|FG002|Overall Study|Required kidney transplantation|3
2122526|NCT00977080|3721716|FG003|Overall Study|Required kidney transplantation|1
2122527|NCT00977080|3721713|FG000|Overall Study|Travel for family reasons|1
2122528|NCT00977080|3721714|FG001|Overall Study|Travel for family reasons|0
2122529|NCT00977080|3721715|FG002|Overall Study|Travel for family reasons|0
2122530|NCT00977080|3721716|FG003|Overall Study|Travel for family reasons|0
2122531|NCT00977106|3721728|FG000|Overall Study|Adverse Event|5
2122532|NCT00977106|3721729|FG001|Overall Study|Adverse Event|6
2122533|NCT00977106|3721728|FG000|Overall Study|Withdrawal by Subject|2
2122534|NCT00977106|3721729|FG001|Overall Study|Withdrawal by Subject|2
2122535|NCT00977106|3721728|FG000|Overall Study|Lack of Efficacy|2
2122536|NCT00977106|3721729|FG001|Overall Study|Lack of Efficacy|2
2122537|NCT00977106|3721728|FG000|Overall Study|Protocol Violation|0
2122538|NCT00977106|3721729|FG001|Overall Study|Protocol Violation|1
2122539|NCT00977106|3721728|FG000|Overall Study|Other|1
2122540|NCT00977106|3721729|FG001|Overall Study|Other|0
2122541|NCT00977197|3721759|FG000|Overall Study|Withdrawal by Subject|3
2122542|NCT00977197|3721760|FG001|Overall Study|Withdrawal by Subject|4
2122543|NCT00977197|3721759|FG000|Overall Study|Adverse Event|3
2122544|NCT00977197|3721760|FG001|Overall Study|Adverse Event|1
2122545|NCT00977197|3721759|FG000|Overall Study|Lack of Efficacy|1
2122546|NCT00977197|3721760|FG001|Overall Study|Lack of Efficacy|0
2122547|NCT00977197|3721759|FG000|Overall Study|Lost to Follow-up|1
2122548|NCT00977197|3721760|FG001|Overall Study|Lost to Follow-up|3
2122549|NCT00977197|3721759|FG000|Overall Study|Nonadherence|1
2122550|NCT00977197|3721760|FG001|Overall Study|Nonadherence|1
2122551|NCT00977314|3721768|FG000|Overall Study|Withdrawal by Subject|1
2122552|NCT00977314|3721769|FG001|Overall Study|Withdrawal by Subject|0
2122553|NCT00977314|3721768|FG000|Overall Study|Physician Decision|1
2122554|NCT00977314|3721769|FG001|Overall Study|Physician Decision|0
2122555|NCT00977379|3721777|FG000|Overall Study|Withdrawal by Subject|1
2122556|NCT00977379|3721778|FG001|Overall Study|Withdrawal by Subject|1
2122557|NCT00977379|3721777|FG000|Overall Study|Death|7
2122558|NCT00977379|3721778|FG001|Overall Study|Death|9
2122559|NCT00977379|3721777|FG000|Overall Study|Premature Study Termination|4
2122560|NCT00977379|3721778|FG001|Overall Study|Premature Study Termination|0
2122561|NCT00977379|3721777|FG000|Overall Study|Participant Moving House|0
2122562|NCT00977379|3721778|FG001|Overall Study|Participant Moving House|1
2122563|NCT00977379|3721777|FG000|Overall Study|Randomization Error|0
2122564|NCT00977379|3721778|FG001|Overall Study|Randomization Error|1
2122565|NCT00977431|3721789|FG000|Overall Study|Other than listed|1
2122566|NCT00977431|3721790|FG001|Overall Study|Other than listed|0
2122567|NCT00977431|3721791|FG002|Overall Study|Other than listed|0
2122568|NCT00977431|3721792|FG003|Overall Study|Other than listed|0
2122569|NCT00977431|3721793|FG004|Overall Study|Other than listed|2
2122570|NCT00977431|3721789|FG000|Overall Study|Protocol Violation|0
2122571|NCT00977431|3721790|FG001|Overall Study|Protocol Violation|0
2122572|NCT00977431|3721791|FG002|Overall Study|Protocol Violation|1
2122573|NCT00977431|3721792|FG003|Overall Study|Protocol Violation|0
2122574|NCT00977431|3721793|FG004|Overall Study|Protocol Violation|0
2122575|NCT00977431|3721789|FG000|Overall Study|Adverse Event|3
2122576|NCT00977431|3721790|FG001|Overall Study|Adverse Event|0
2122577|NCT00977431|3721791|FG002|Overall Study|Adverse Event|4
2122578|NCT00977431|3721792|FG003|Overall Study|Adverse Event|0
2122579|NCT00977431|3721793|FG004|Overall Study|Adverse Event|6
2122580|NCT00977431|3721789|FG000|Overall Study|Dose-limiting toxicity (DLT)|1
2122581|NCT00977431|3721790|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
2122582|NCT00977431|3721791|FG002|Overall Study|Dose-limiting toxicity (DLT)|1
2122583|NCT00977431|3721792|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
2122584|NCT00977431|3721793|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
2122585|NCT00977431|3721789|FG000|Overall Study|Progressive disease|2
2122586|NCT00977431|3721790|FG001|Overall Study|Progressive disease|6
2122587|NCT00977431|3721791|FG002|Overall Study|Progressive disease|1
2122588|NCT00977431|3721792|FG003|Overall Study|Progressive disease|3
2122589|NCT00977431|3721793|FG004|Overall Study|Progressive disease|5
2122590|NCT00977470|3721811|FG000|Overall Study|Lack of Efficacy|32
2122591|NCT00977470|3721812|FG001|Overall Study|Lack of Efficacy|30
2122592|NCT00977470|3721811|FG000|Overall Study|Physician Decision|2
2122593|NCT00977470|3721812|FG001|Overall Study|Physician Decision|0
2122594|NCT00977470|3721811|FG000|Overall Study|Adverse Event|1
2122595|NCT00977470|3721812|FG001|Overall Study|Adverse Event|2
2122596|NCT00977470|3721811|FG000|Overall Study|Protocol Violation|1
2122597|NCT00977470|3721812|FG001|Overall Study|Protocol Violation|0
2122598|NCT00977470|3721811|FG000|Overall Study|Withdrawal by Subject|0
2122599|NCT00977470|3721812|FG001|Overall Study|Withdrawal by Subject|2
2122600|NCT00977470|3721811|FG000|Overall Study|Death|0
2122601|NCT00977470|3721812|FG001|Overall Study|Death|2
2122602|NCT00977470|3721811|FG000|Overall Study|clinical decline|0
2122603|NCT00977470|3721812|FG001|Overall Study|clinical decline|1
2122604|NCT00977470|3721811|FG000|Overall Study|prolonged recovery post-surgery|0
2122605|NCT00977470|3721812|FG001|Overall Study|prolonged recovery post-surgery|1
2122606|NCT00977470|3721811|FG000|Overall Study|Still on-study|2
2122607|NCT00977470|3721812|FG001|Overall Study|Still on-study|0
2122608|NCT00977548|3721818|FG000|Overall Study|Ineligible|4
2122609|NCT00977548|3721818|FG000|Overall Study|Adverse Event|8
2122610|NCT00977548|3721818|FG000|Overall Study|Withdrawal by Subject|1
2122611|NCT00977561|3721824|FG000|Overall Study|Death|3
2122612|NCT00977561|3721825|FG001|Overall Study|Death|2
2122613|NCT00977561|3721824|FG000|Overall Study|Study terminated|0
2122614|NCT00977561|3721825|FG001|Overall Study|Study terminated|2
2122615|NCT00977561|3721824|FG000|Overall Study|Other|2
2122616|NCT00977561|3721825|FG001|Overall Study|Other|0
2122617|NCT00977613|3721833|FG000|Overall Study|Lost to Follow-up|16
2122618|NCT00977665|3721839|FG000|Overall Study|Withdrawal by Subject|1
2122619|NCT00977665|3721840|FG001|Overall Study|Withdrawal by Subject|3
2122620|NCT00977665|3721839|FG000|Overall Study|Physician Decision|2
2122621|NCT00977665|3721840|FG001|Overall Study|Physician Decision|1
2122622|NCT00977665|3721839|FG000|Overall Study|Sponsor requested withdrawal|0
2122623|NCT00977665|3721840|FG001|Overall Study|Sponsor requested withdrawal|1
2122624|NCT00977665|3721839|FG000|Overall Study|Lost to Follow-up|1
2122625|NCT00977665|3721840|FG001|Overall Study|Lost to Follow-up|0
2122626|NCT00977665|3721839|FG000|Overall Study|Death|3
2122627|NCT00977665|3721840|FG001|Overall Study|Death|2
2122628|NCT00977665|3721839|FG000|Overall Study|Adverse Event|14
2122629|NCT00977665|3721840|FG001|Overall Study|Adverse Event|7
2122630|NCT00977665|3721839|FG000|Overall Study|Treatment failure|0
2122631|NCT00977665|3721840|FG001|Overall Study|Treatment failure|1
2122632|NCT00977938|3721885|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
2122633|NCT00977938|3721886|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
2122634|NCT00977938|3721887|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
2122635|NCT00977938|3721888|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
2122636|NCT00977938|3721885|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
2122637|NCT00977938|3721886|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
2122638|NCT00977938|3721887|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
2122639|NCT00977938|3721888|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
2122640|NCT00977938|3721885|FG000|Treatment (12-30 mo. Post Procedure)|Other|17
2122641|NCT00977938|3721886|FG001|Treatment (12-30 mo. Post Procedure)|Other|18
2122642|NCT00977938|3721887|FG002|Treatment (12-30 mo. Post Procedure)|Other|3
2122643|NCT00977938|3721888|FG003|Treatment (12-30 mo. Post Procedure)|Other|4
2122644|NCT00977938|3721885|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
2122645|NCT00977938|3721886|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
2122646|NCT00977938|3721887|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
2122647|NCT00977938|3721888|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
2122648|NCT00977938|3721885|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
2122649|NCT00977938|3721886|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
2122650|NCT00977938|3721887|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
2122651|NCT00977938|3721888|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
2122652|NCT00977938|3721885|FG000|Observation (30-33 mo. Post Procedure)|Other|8
2122653|NCT00977938|3721886|FG001|Observation (30-33 mo. Post Procedure)|Other|4
2122654|NCT00977938|3721887|FG002|Observation (30-33 mo. Post Procedure)|Other|0
2122655|NCT00977938|3721888|FG003|Observation (30-33 mo. Post Procedure)|Other|0
2122656|NCT00978029|3721903|FG000|Overall Study|Adverse Event|1
2122657|NCT00978029|3721904|FG001|Overall Study|Adverse Event|2
2122658|NCT00978029|3721905|FG002|Overall Study|Adverse Event|5
2122659|NCT00978029|3721903|FG000|Overall Study|Withdrawal by Subject|0
2122660|NCT00978029|3721904|FG001|Overall Study|Withdrawal by Subject|0
2122661|NCT00978029|3721905|FG002|Overall Study|Withdrawal by Subject|1
2122662|NCT00978029|3721903|FG000|Overall Study|Protocol Violation|0
2122663|NCT00978029|3721904|FG001|Overall Study|Protocol Violation|1
2122664|NCT00978029|3721905|FG002|Overall Study|Protocol Violation|0
2122665|NCT00978042|3721915|FG000|Initial Treatment Period|Treated in Error|0
2122666|NCT00978042|3721916|FG001|Initial Treatment Period|Treated in Error|3
2122667|NCT00978042|3721915|FG000|Initial Treatment Period|Ineligibility|1
2122668|NCT00978042|3721916|FG001|Initial Treatment Period|Ineligibility|0
2122669|NCT00978042|3721915|FG000|Initial Treatment Period|Lost to Follow-up|21
2122670|NCT00978042|3721916|FG001|Initial Treatment Period|Lost to Follow-up|3
2122671|NCT00978042|3721915|FG000|Initial Treatment Period|Adverse Event|2
2122672|NCT00978042|3721916|FG001|Initial Treatment Period|Adverse Event|0
2122673|NCT00978042|3721915|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
2122674|NCT00978042|3721916|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
2122675|NCT00978042|3721915|FG000|Initial Treatment Period|Consent withdrawn|22
2122676|NCT00978042|3721916|FG001|Initial Treatment Period|Consent withdrawn|9
2122677|NCT00978042|3721915|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13
2122678|NCT00978042|3721916|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0
2122679|NCT00978068|3721924|FG000|Overall Study|Were Awaiting Initiation of ART|2
2122680|NCT00978068|3721925|FG001|Overall Study|Were Awaiting Initiation of ART|2
2122681|NCT00978068|3721924|FG000|Overall Study|Death|1
2122682|NCT00978068|3721925|FG001|Overall Study|Death|2
2122683|NCT00978068|3721924|FG000|Overall Study|Lost to Follow-up|1
2122684|NCT00978068|3721925|FG001|Overall Study|Lost to Follow-up|2
2122685|NCT00978068|3721924|FG000|Overall Study|Physician Decision|0
2122686|NCT00978068|3721925|FG001|Overall Study|Physician Decision|1
2122687|NCT00978068|3721924|FG000|Overall Study|Unable to Comply with Study|0
2122688|NCT00978068|3721925|FG001|Overall Study|Unable to Comply with Study|2
2122689|NCT00978120|3721939|FG000|Overall Study|Death|0
2122690|NCT00978120|3721940|FG001|Overall Study|Death|0
2122691|NCT00978120|3721941|FG002|Overall Study|Death|0
2122692|NCT00978120|3721942|FG003|Overall Study|Death|1
2122693|NCT00978120|3721939|FG000|Overall Study|Lost to Follow-up|0
2122694|NCT00978120|3721940|FG001|Overall Study|Lost to Follow-up|0
2122695|NCT00978120|3721941|FG002|Overall Study|Lost to Follow-up|3
2122696|NCT00978120|3721942|FG003|Overall Study|Lost to Follow-up|0
2122697|NCT00978120|3721939|FG000|Overall Study|Withdrawal by Subject|2
2122698|NCT00978120|3721940|FG001|Overall Study|Withdrawal by Subject|0
2278869|NCT02343939|3962424|FG000|Overall Study|Treatment failure|0
2278870|NCT02343939|3962425|FG001|Overall Study|Treatment failure|0
2278871|NCT02343939|3962426|FG002|Overall Study|Treatment failure|0
2278872|NCT02343939|3962427|FG003|Overall Study|Treatment failure|0
2278873|NCT02343939|3962428|FG004|Overall Study|Treatment failure|0
2278874|NCT02343939|3962429|FG005|Overall Study|Treatment failure|0
2278875|NCT02343939|3962430|FG006|Overall Study|Treatment failure|2
2278876|NCT02343939|3962431|FG007|Overall Study|Treatment failure|1
2278877|NCT02343939|3962432|FG008|Overall Study|Treatment failure|0
2278878|NCT02343939|3962424|FG000|Overall Study|Investigator's discretion|0
2278879|NCT02343939|3962425|FG001|Overall Study|Investigator's discretion|0
2278880|NCT02343939|3962426|FG002|Overall Study|Investigator's discretion|0
2278881|NCT02343939|3962427|FG003|Overall Study|Investigator's discretion|1
2278882|NCT02343939|3962428|FG004|Overall Study|Investigator's discretion|0
2278883|NCT02343939|3962429|FG005|Overall Study|Investigator's discretion|0
2278884|NCT02343939|3962430|FG006|Overall Study|Investigator's discretion|1
2278885|NCT02343939|3962431|FG007|Overall Study|Investigator's discretion|0
2278886|NCT02343939|3962432|FG008|Overall Study|Investigator's discretion|0
2278887|NCT02343939|3962424|FG000|Overall Study|Adverse Event|0
2278888|NCT02343939|3962425|FG001|Overall Study|Adverse Event|0
2278889|NCT02343939|3962426|FG002|Overall Study|Adverse Event|0
2278890|NCT02343939|3962427|FG003|Overall Study|Adverse Event|0
2278891|NCT02343939|3962428|FG004|Overall Study|Adverse Event|0
2278892|NCT02343939|3962429|FG005|Overall Study|Adverse Event|1
2122699|NCT00978120|3721941|FG002|Overall Study|Withdrawal by Subject|0
2278893|NCT02343939|3962430|FG006|Overall Study|Adverse Event|0
2122700|NCT00978120|3721942|FG003|Overall Study|Withdrawal by Subject|0
2122701|NCT00978120|3721939|FG000|Overall Study|Moved out of state|0
2122702|NCT00978120|3721940|FG001|Overall Study|Moved out of state|0
2122703|NCT00978120|3721941|FG002|Overall Study|Moved out of state|0
2122704|NCT00978120|3721942|FG003|Overall Study|Moved out of state|1
2122705|NCT00978250|3721960|FG000|Overall Study|Late determination of ineligibility|0
2122706|NCT00978250|3721961|FG001|Overall Study|Late determination of ineligibility|1
2122707|NCT00978250|3721962|FG002|Overall Study|Late determination of ineligibility|0
2122708|NCT00978250|3721963|FG003|Overall Study|Late determination of ineligibility|1
2122709|NCT00978341|3721975|FG000|Washout Period of 2 Weeks|Adverse Event|1
2122710|NCT00978341|3721976|FG001|Washout Period of 2 Weeks|Adverse Event|0
2122711|NCT00978380|3721983|FG000|Overall Study|Protocol Violation|2
2122712|NCT00978380|3721983|FG000|Overall Study|Withdrawal criteria|9
2122713|NCT00978380|3721983|FG000|Overall Study|Unclassified|8
2122714|NCT00978432|3721991|FG000|Overall Study|Withdrawal by Subject|0
2122715|NCT00978432|3721992|FG001|Overall Study|Withdrawal by Subject|0
2122716|NCT00978432|3721993|FG002|Overall Study|Withdrawal by Subject|1
2122717|NCT00978432|3721991|FG000|Overall Study|Lack of Efficacy|1
2122718|NCT00978432|3721992|FG001|Overall Study|Lack of Efficacy|1
2122719|NCT00978432|3721993|FG002|Overall Study|Lack of Efficacy|3
2122720|NCT00978432|3721991|FG000|Overall Study|Adverse Event|2
2122721|NCT00978432|3721992|FG001|Overall Study|Adverse Event|0
2122722|NCT00978432|3721993|FG002|Overall Study|Adverse Event|1
2177839|NCT01378117|3802257|FG000|Overall Study|withdrawal|2
2177840|NCT01378117|3802258|FG001|Overall Study|withdrawal|1
2177841|NCT01378117|3802259|FG002|Overall Study|withdrawal|2
2177842|NCT01378117|3802257|FG000|Overall Study|discharged before med given|2
2177843|NCT01378117|3802258|FG001|Overall Study|discharged before med given|0
2177844|NCT01378117|3802259|FG002|Overall Study|discharged before med given|1
2177845|NCT01378195|3802274|FG000|Overall Study|Lost to Follow-up|29
2177846|NCT01378195|3802275|FG001|Overall Study|Lost to Follow-up|18
2177847|NCT01378325|3802335|FG000|Overall Study|Protocol Violation|0
2177848|NCT01378325|3802336|FG001|Overall Study|Protocol Violation|1
2177849|NCT01378429|3802366|FG000|Overall Study|Noncompliance with study drug|1
2177850|NCT01378429|3802367|FG001|Overall Study|Noncompliance with study drug|0
2177851|NCT01378858|3802385|FG000|Overall Study|Withdrawal by Subject|4
2177852|NCT01378858|3802386|FG001|Overall Study|Withdrawal by Subject|4
2177853|NCT01378962|3802392|FG000|Overall Study|Death|14
2177854|NCT01378962|3802392|FG000|Overall Study|Lost to Follow-up|1
2177855|NCT01378962|3802392|FG000|Overall Study|Other|2
2177856|NCT01378975|3802398|FG000|Overall Study|Death|77
2177857|NCT01378975|3802399|FG001|Overall Study|Death|46
2177858|NCT01378975|3802398|FG000|Overall Study|Investigator Request|1
2177859|NCT01378975|3802399|FG001|Overall Study|Investigator Request|0
2177860|NCT01378975|3802398|FG000|Overall Study|Lost to Follow-up|4
2177861|NCT01378975|3802399|FG001|Overall Study|Lost to Follow-up|1
2177862|NCT01378975|3802398|FG000|Overall Study|Withdrew Consent|4
2177863|NCT01378975|3802399|FG001|Overall Study|Withdrew Consent|3
2177864|NCT01379508|3802434|FG000|Treatment to Week 104|Adverse Event|2
2177865|NCT01379508|3802435|FG001|Treatment to Week 104|Adverse Event|0
2177866|NCT01379508|3802436|FG002|Treatment to Week 104|Adverse Event|5
2177867|NCT01379508|3802437|FG003|Treatment to Week 104|Adverse Event|0
2177868|NCT01379508|3802434|FG000|Treatment to Week 104|Abnormal lab value|1
2177869|NCT01379508|3802435|FG001|Treatment to Week 104|Abnormal lab value|0
2177870|NCT01379508|3802436|FG002|Treatment to Week 104|Abnormal lab value|0
2177871|NCT01379508|3802437|FG003|Treatment to Week 104|Abnormal lab value|0
2177872|NCT01379508|3802434|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1
2177873|NCT01379508|3802435|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0
2177874|NCT01379508|3802436|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0
2177875|NCT01379508|3802437|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0
2177876|NCT01379508|3802434|FG000|Treatment to Week 104|Withdrawal by Subject|6
2177877|NCT01379508|3802435|FG001|Treatment to Week 104|Withdrawal by Subject|1
2177878|NCT01379508|3802436|FG002|Treatment to Week 104|Withdrawal by Subject|4
2177879|NCT01379508|3802437|FG003|Treatment to Week 104|Withdrawal by Subject|0
2278894|NCT02343939|3962431|FG007|Overall Study|Adverse Event|0
2278895|NCT02343939|3962432|FG008|Overall Study|Adverse Event|0
2278896|NCT02343939|3962424|FG000|Overall Study|Never Treated With ENTO|0
2278897|NCT02343939|3962425|FG001|Overall Study|Never Treated With ENTO|0
2278898|NCT02343939|3962426|FG002|Overall Study|Never Treated With ENTO|0
2278899|NCT02343939|3962427|FG003|Overall Study|Never Treated With ENTO|0
2278900|NCT02343939|3962428|FG004|Overall Study|Never Treated With ENTO|0
2278901|NCT02343939|3962429|FG005|Overall Study|Never Treated With ENTO|0
2278902|NCT02343939|3962430|FG006|Overall Study|Never Treated With ENTO|1
2278903|NCT02343939|3962431|FG007|Overall Study|Never Treated With ENTO|2
2278904|NCT02343939|3962432|FG008|Overall Study|Never Treated With ENTO|0
2278905|NCT02344004|3962468|FG000|Overall Study|Adverse Event|11
2278906|NCT02344004|3962469|FG001|Overall Study|Adverse Event|1
2278907|NCT02344004|3962468|FG000|Overall Study|Death|9
2278908|NCT02344004|3962469|FG001|Overall Study|Death|7
2278909|NCT02344004|3962468|FG000|Overall Study|Physician Decision|4
2278910|NCT02344004|3962469|FG001|Overall Study|Physician Decision|1
2278911|NCT02344004|3962468|FG000|Overall Study|Withdrawal by Subject|22
2278912|NCT02344004|3962469|FG001|Overall Study|Withdrawal by Subject|5
2122723|NCT00978627|3722016|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
2122724|NCT00978627|3722017|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
2122725|NCT00978627|3722016|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
2122726|NCT00978627|3722017|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
2122727|NCT00978627|3722016|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
2122728|NCT00978627|3722017|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
2122729|NCT00978627|3722016|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
2122730|NCT00978627|3722017|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
2122731|NCT00978627|3722016|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
2122732|NCT00978627|3722017|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
2278913|NCT02344004|3962468|FG000|Overall Study|Rescue Medication|2
2278914|NCT02344004|3962469|FG001|Overall Study|Rescue Medication|0
2278915|NCT02344004|3962468|FG000|Overall Study|Other Not Specified|12
2278916|NCT02344004|3962469|FG001|Overall Study|Other Not Specified|0
2278917|NCT02344004|3962468|FG000|Overall Study|Protocol Violation|1
2278918|NCT02344004|3962469|FG001|Overall Study|Protocol Violation|0
2278919|NCT02344173|3962476|FG000|Procedure|Ablation Procedure Not Performed|7
2278920|NCT02344173|3962476|FG000|12-month Visit|Death|8
2278921|NCT02344173|3962476|FG000|12-month Visit|Withdrawal by Subject|30
2278922|NCT02344173|3962476|FG000|12-month Visit|Lost to Follow-up|58
2278923|NCT02344342|3962536|FG000|Overall Study|Industry partner dropped out|11
2278924|NCT02344342|3962537|FG001|Overall Study|Industry partner dropped out|9
2278925|NCT02344342|3962538|FG002|Overall Study|Industry partner dropped out|14
2278926|NCT02344342|3962539|FG003|Overall Study|Industry partner dropped out|10
2278927|NCT02344576|3962570|FG000|Enrollment|Agreed to Medical Record Review Only|7
2278928|NCT02344576|3962571|FG001|Enrollment|Agreed to Medical Record Review Only|8
2278929|NCT02344576|3962572|FG002|Enrollment|Agreed to Medical Record Review Only|0
2278930|NCT02344576|3962573|FG003|Enrollment|Agreed to Medical Record Review Only|0
2278931|NCT02344576|3962570|FG000|1-Month Follow-Up|Death|13
2278932|NCT02344576|3962571|FG001|1-Month Follow-Up|Death|8
2278933|NCT02344576|3962572|FG002|1-Month Follow-Up|Death|0
2278934|NCT02344576|3962573|FG003|1-Month Follow-Up|Death|0
2278935|NCT02344576|3962570|FG000|1-Month Follow-Up|Withdrawal by Subject|3
2278936|NCT02344576|3962571|FG001|1-Month Follow-Up|Withdrawal by Subject|14
2278937|NCT02344576|3962572|FG002|1-Month Follow-Up|Withdrawal by Subject|8
2278938|NCT02344576|3962573|FG003|1-Month Follow-Up|Withdrawal by Subject|10
2278939|NCT02344576|3962570|FG000|1-Month Follow-Up|Lost to Follow-up|2
2278940|NCT02344576|3962571|FG001|1-Month Follow-Up|Lost to Follow-up|5
2278941|NCT02344576|3962572|FG002|1-Month Follow-Up|Lost to Follow-up|11
2278942|NCT02344576|3962573|FG003|1-Month Follow-Up|Lost to Follow-up|3
2278943|NCT02344576|3962570|FG000|6-Month Follow-Up|Death|14
2278944|NCT02344576|3962571|FG001|6-Month Follow-Up|Death|14
2278945|NCT02344576|3962572|FG002|6-Month Follow-Up|Death|0
2278946|NCT02344576|3962573|FG003|6-Month Follow-Up|Death|0
2278947|NCT02344576|3962570|FG000|6-Month Follow-Up|Withdrawal by Subject|1
2278948|NCT02344576|3962571|FG001|6-Month Follow-Up|Withdrawal by Subject|0
2278949|NCT02344576|3962572|FG002|6-Month Follow-Up|Withdrawal by Subject|1
2278950|NCT02344576|3962573|FG003|6-Month Follow-Up|Withdrawal by Subject|2
2278951|NCT02344576|3962570|FG000|6-Month Follow-Up|Lost to Follow-up|4
2278952|NCT02344576|3962571|FG001|6-Month Follow-Up|Lost to Follow-up|5
2278953|NCT02344576|3962572|FG002|6-Month Follow-Up|Lost to Follow-up|13
2278954|NCT02344576|3962573|FG003|6-Month Follow-Up|Lost to Follow-up|6
2278955|NCT02344745|3962596|FG000|Overall Study|Data collection sheets were lost|2
2278956|NCT02344745|3962597|FG001|Overall Study|Data collection sheets were lost|0
2278957|NCT02345070|3962617|FG000|Overall Study|Adverse Event|12
2278958|NCT02345070|3962618|FG001|Overall Study|Adverse Event|8
2278959|NCT02345070|3962619|FG002|Overall Study|Adverse Event|16
2278960|NCT02345070|3962617|FG000|Overall Study|Poor compliance to protocol|2
2278961|NCT02345070|3962618|FG001|Overall Study|Poor compliance to protocol|0
2278962|NCT02345070|3962619|FG002|Overall Study|Poor compliance to protocol|0
2278963|NCT02345070|3962617|FG000|Overall Study|Other than specified above|6
2278964|NCT02345070|3962618|FG001|Overall Study|Other than specified above|3
2278965|NCT02345070|3962619|FG002|Overall Study|Other than specified above|7
2278966|NCT02345161|3962629|FG000|Overall Study|Withdrawal by Subject|25
2278967|NCT02345161|3962630|FG001|Overall Study|Withdrawal by Subject|33
2278968|NCT02345161|3962629|FG000|Overall Study|Adverse Event|16
2278969|NCT02345161|3962630|FG001|Overall Study|Adverse Event|19
2278970|NCT02345161|3962629|FG000|Overall Study|Physician Decision|4
2278971|NCT02345161|3962630|FG001|Overall Study|Physician Decision|4
2278972|NCT02345161|3962629|FG000|Overall Study|Lost to Follow-up|0
2278973|NCT02345161|3962630|FG001|Overall Study|Lost to Follow-up|1
2278974|NCT02345226|3962643|FG000|Double-Blind Phase|Adverse Event|5
2278975|NCT02345226|3962644|FG001|Double-Blind Phase|Adverse Event|6
2278976|NCT02345226|3962643|FG000|Double-Blind Phase|Death|3
2278977|NCT02345226|3962644|FG001|Double-Blind Phase|Death|0
2278978|NCT02345226|3962643|FG000|Double-Blind Phase|Pregnancy|0
2278979|NCT02345226|3962644|FG001|Double-Blind Phase|Pregnancy|1
2278980|NCT02345226|3962643|FG000|Double-Blind Phase|Lack of Efficacy|1
2278981|NCT02345226|3962644|FG001|Double-Blind Phase|Lack of Efficacy|0
2278982|NCT02345226|3962643|FG000|Double-Blind Phase|Investigator's Discretion|4
2278983|NCT02345226|3962644|FG001|Double-Blind Phase|Investigator's Discretion|3
2278984|NCT02345226|3962643|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
2278985|NCT02345226|3962644|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
2278986|NCT02345226|3962643|FG000|Double-Blind Phase|Withdrew Consent|41
2278987|NCT02345226|3962644|FG001|Double-Blind Phase|Withdrew Consent|39
2278988|NCT02345226|3962643|FG000|Double-Blind Phase|Lost to Follow-up|12
2122733|NCT00978627|3722016|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
2122734|NCT00978627|3722017|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
2122735|NCT00978627|3722016|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
2122736|NCT00978627|3722017|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
2122737|NCT00978627|3722016|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
2122738|NCT00978627|3722017|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
2122739|NCT00978627|3722016|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
2122740|NCT00978627|3722017|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
2122741|NCT00978731|3722027|FG000|Overall Study|Death|4
2122742|NCT00978731|3722028|FG001|Overall Study|Death|1
2122743|NCT00978731|3722029|FG002|Overall Study|Death|1
2122744|NCT00978731|3722030|FG003|Overall Study|Death|0
2122745|NCT00978731|3722027|FG000|Overall Study|Lost to Follow-up|0
2122746|NCT00978731|3722028|FG001|Overall Study|Lost to Follow-up|0
2122747|NCT00978731|3722029|FG002|Overall Study|Lost to Follow-up|0
2122748|NCT00978731|3722030|FG003|Overall Study|Lost to Follow-up|1
2122749|NCT00978731|3722027|FG000|Overall Study|Adverse Event|5
2122750|NCT00978731|3722028|FG001|Overall Study|Adverse Event|2
2122751|NCT00978731|3722029|FG002|Overall Study|Adverse Event|0
2122752|NCT00978731|3722030|FG003|Overall Study|Adverse Event|0
2122753|NCT00978731|3722027|FG000|Overall Study|Participant's request|1
2122754|NCT00978731|3722028|FG001|Overall Study|Participant's request|0
2122755|NCT00978731|3722029|FG002|Overall Study|Participant's request|0
2122756|NCT00978731|3722030|FG003|Overall Study|Participant's request|0
2122757|NCT00978731|3722027|FG000|Overall Study|Administrative reason|3
2122758|NCT00978731|3722028|FG001|Overall Study|Administrative reason|3
2122759|NCT00978731|3722029|FG002|Overall Study|Administrative reason|1
2122760|NCT00978731|3722030|FG003|Overall Study|Administrative reason|0
2122761|NCT00978731|3722027|FG000|Overall Study|Deterioration without progression|0
2122762|NCT00978731|3722028|FG001|Overall Study|Deterioration without progression|1
2122763|NCT00978731|3722029|FG002|Overall Study|Deterioration without progression|0
2122764|NCT00978731|3722030|FG003|Overall Study|Deterioration without progression|0
2122765|NCT00978731|3722027|FG000|Overall Study|Disease progression/relapse|5
2122766|NCT00978731|3722028|FG001|Overall Study|Disease progression/relapse|4
2122767|NCT00978731|3722029|FG002|Overall Study|Disease progression/relapse|2
2122768|NCT00978731|3722030|FG003|Overall Study|Disease progression/relapse|2
2122769|NCT00978731|3722027|FG000|Overall Study|Study closure|3
2122770|NCT00978731|3722028|FG001|Overall Study|Study closure|4
2122771|NCT00978731|3722029|FG002|Overall Study|Study closure|1
2122772|NCT00978731|3722030|FG003|Overall Study|Study closure|1
2122773|NCT00978731|3722027|FG000|Overall Study|No response|1
2122774|NCT00978731|3722028|FG001|Overall Study|No response|0
2122775|NCT00978731|3722029|FG002|Overall Study|No response|0
2122776|NCT00978731|3722030|FG003|Overall Study|No response|0
2122777|NCT00978757|3722046|FG000|Overall Study|Physician Decision|1
2122778|NCT00978757|3722047|FG001|Overall Study|Physician Decision|3
2122779|NCT00979134|3722084|FG000|Overall Study|Disease progression|18
2122780|NCT00979134|3722085|FG001|Overall Study|Disease progression|2
2122781|NCT00979134|3722086|FG002|Overall Study|Disease progression|5
2122782|NCT00979134|3722084|FG000|Overall Study|Adverse Event|0
2122783|NCT00979134|3722085|FG001|Overall Study|Adverse Event|0
2122784|NCT00979134|3722086|FG002|Overall Study|Adverse Event|2
2205209|NCT01609556|3843231|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
2278989|NCT02345226|3962644|FG001|Double-Blind Phase|Lost to Follow-up|16
2205210|NCT01609556|3843216|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2278990|NCT02345226|3962643|FG000|Double-Blind Phase|Randomized but Never Treated|2
2278991|NCT02345226|3962644|FG001|Double-Blind Phase|Randomized but Never Treated|4
2278992|NCT02345226|3962643|FG000|Open-Label Extension Phase|Lost to Follow-up|0
2278993|NCT02345226|3962644|FG001|Open-Label Extension Phase|Lost to Follow-up|1
2278994|NCT02345252|3962654|FG000|Double-Blind Phase|Adverse Event|2
2278995|NCT02345252|3962655|FG001|Double-Blind Phase|Adverse Event|3
2278996|NCT02345252|3962654|FG000|Double-Blind Phase|Death|1
2205211|NCT01609556|3843217|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205212|NCT01609556|3843218|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205213|NCT01609556|3843219|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205214|NCT01609556|3843220|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205215|NCT01609556|3843221|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205216|NCT01609556|3843222|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205217|NCT01609556|3843223|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205218|NCT01609556|3843224|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1
2205219|NCT01609556|3843225|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2278997|NCT02345252|3962655|FG001|Double-Blind Phase|Death|2
2278998|NCT02345252|3962654|FG000|Double-Blind Phase|Lack of Efficacy|1
2278999|NCT02345252|3962655|FG001|Double-Blind Phase|Lack of Efficacy|0
2279000|NCT02345252|3962654|FG000|Double-Blind Phase|Investigator's Discretion|4
2122785|NCT00979134|3722084|FG000|Overall Study|Withdrawal by Subject|1
2122786|NCT00979134|3722085|FG001|Overall Study|Withdrawal by Subject|1
2122787|NCT00979134|3722086|FG002|Overall Study|Withdrawal by Subject|2
2122788|NCT00979134|3722084|FG000|Overall Study|Lost to Follow-up|2
2122789|NCT00979134|3722085|FG001|Overall Study|Lost to Follow-up|2
2122790|NCT00979134|3722086|FG002|Overall Study|Lost to Follow-up|0
2122791|NCT00979134|3722084|FG000|Overall Study|Death|4
2122792|NCT00979134|3722085|FG001|Overall Study|Death|0
2122793|NCT00979134|3722086|FG002|Overall Study|Death|26
2122794|NCT00979134|3722084|FG000|Overall Study|Other|8
2122795|NCT00979134|3722085|FG001|Overall Study|Other|1
2122796|NCT00979134|3722086|FG002|Overall Study|Other|5
2122797|NCT00979212|3722105|FG000|Overall Study|Protocol Violation|1
2122798|NCT00979212|3722106|FG001|Overall Study|Protocol Violation|8
2122799|NCT00979212|3722105|FG000|Overall Study|No protocol therapy received|1
2122800|NCT00979212|3722106|FG001|Overall Study|No protocol therapy received|0
2122801|NCT00979407|3722123|FG000|Overall Study|Withdrawal by Subject|3
2122802|NCT00979407|3722124|FG001|Overall Study|Withdrawal by Subject|4
2122803|NCT00979407|3722123|FG000|Overall Study|Lost to Follow-up|3
2122804|NCT00979407|3722124|FG001|Overall Study|Lost to Follow-up|3
2122805|NCT00979420|3722136|FG000|Overall Study|Adverse Event|1
2122806|NCT00979420|3722137|FG001|Overall Study|Adverse Event|0
2122807|NCT00979420|3722138|FG002|Overall Study|Adverse Event|0
2122808|NCT00979420|3722139|FG003|Overall Study|Adverse Event|0
2122809|NCT00979420|3722136|FG000|Overall Study|Lack of Efficacy|3
2122810|NCT00979420|3722137|FG001|Overall Study|Lack of Efficacy|0
2122811|NCT00979420|3722138|FG002|Overall Study|Lack of Efficacy|1
2122812|NCT00979420|3722139|FG003|Overall Study|Lack of Efficacy|1
2122813|NCT00979420|3722136|FG000|Overall Study|Other reasons not related to Viramune|3
2122814|NCT00979420|3722137|FG001|Overall Study|Other reasons not related to Viramune|0
2279001|NCT02345252|3962655|FG001|Double-Blind Phase|Investigator's Discretion|6
2279002|NCT02345252|3962654|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
2279003|NCT02345252|3962655|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
2279004|NCT02345252|3962654|FG000|Double-Blind Phase|Protocol Violation|2
2279005|NCT02345252|3962655|FG001|Double-Blind Phase|Protocol Violation|1
2279006|NCT02345252|3962654|FG000|Double-Blind Phase|Withdrew Consent|21
2279007|NCT02345252|3962655|FG001|Double-Blind Phase|Withdrew Consent|23
2279008|NCT02345252|3962654|FG000|Double-Blind Phase|Lost to Follow-up|8
2279009|NCT02345252|3962655|FG001|Double-Blind Phase|Lost to Follow-up|10
2279010|NCT02345252|3962654|FG000|Double-Blind Phase|Randomized but Never Treated|0
2279011|NCT02345252|3962655|FG001|Double-Blind Phase|Randomized but Never Treated|2
2279012|NCT02345330|3962663|FG000|Overall Study|Death|1
2279013|NCT02345330|3962663|FG000|Overall Study|Progressive Disease|2
2279014|NCT02345434|3962669|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5
2279015|NCT02345434|3962670|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2
2279016|NCT02345512|3962685|FG000|Overall Study|Adverse Event|1
2279017|NCT02345512|3962685|FG000|Overall Study|Withdrawal by Subject|1
2279018|NCT02345811|3962707|FG000|First Intervention|Withdrawal by Subject|1
2279019|NCT02345811|3962708|FG001|First Intervention|Withdrawal by Subject|1
2279020|NCT02345889|3962720|FG000|Overall Study|Inadequate Bowel Prep|17
2279021|NCT02345889|3962721|FG001|Overall Study|Inadequate Bowel Prep|16
2279022|NCT02345889|3962722|FG002|Overall Study|Inadequate Bowel Prep|18
2279023|NCT02345889|3962723|FG003|Overall Study|Inadequate Bowel Prep|14
2279024|NCT02345889|3962720|FG000|Overall Study|Polyposis identified during procedure|1
2279025|NCT02345889|3962721|FG001|Overall Study|Polyposis identified during procedure|1
2279026|NCT02345889|3962722|FG002|Overall Study|Polyposis identified during procedure|0
2279027|NCT02345889|3962723|FG003|Overall Study|Polyposis identified during procedure|1
2279028|NCT02345889|3962720|FG000|Overall Study|Recognized ineligible post-randomization|1
2279029|NCT02345889|3962721|FG001|Overall Study|Recognized ineligible post-randomization|0
2279030|NCT02345889|3962722|FG002|Overall Study|Recognized ineligible post-randomization|2
2279031|NCT02345889|3962723|FG003|Overall Study|Recognized ineligible post-randomization|1
2279032|NCT02345889|3962720|FG000|Overall Study|Ulcerative Colitis identified|1
2279033|NCT02345889|3962721|FG001|Overall Study|Ulcerative Colitis identified|0
2279034|NCT02345889|3962722|FG002|Overall Study|Ulcerative Colitis identified|0
2279035|NCT02345889|3962723|FG003|Overall Study|Ulcerative Colitis identified|0
2279036|NCT02345889|3962720|FG000|Overall Study|Cecum not intubated|1
2279037|NCT02345889|3962721|FG001|Overall Study|Cecum not intubated|0
2279038|NCT02345889|3962722|FG002|Overall Study|Cecum not intubated|0
2279039|NCT02345889|3962723|FG003|Overall Study|Cecum not intubated|0
2279040|NCT02346136|3962735|FG000|Overall Study|Withdrawal by Subject|7
2122815|NCT00979420|3722138|FG002|Overall Study|Other reasons not related to Viramune|0
2122816|NCT00979420|3722139|FG003|Overall Study|Other reasons not related to Viramune|1
2279041|NCT02346136|3962736|FG001|Overall Study|Withdrawal by Subject|5
2279042|NCT02346136|3962735|FG000|Overall Study|Death|1
2279043|NCT02346136|3962736|FG001|Overall Study|Death|0
2279044|NCT02346136|3962735|FG000|Overall Study|Study termination|14
2279045|NCT02346136|3962736|FG001|Overall Study|Study termination|18
2279046|NCT02346240|3962746|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0
2279047|NCT02346240|3962747|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4
2279048|NCT02346240|3962748|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1
2122817|NCT00979576|3722159|FG000|Combination Treatment Phase|Progressive disease|3
2122818|NCT00979576|3722160|FG001|Combination Treatment Phase|Progressive disease|1
2122819|NCT00979576|3722161|FG002|Combination Treatment Phase|Progressive disease|5
2122820|NCT00979576|3722159|FG000|Combination Treatment Phase|Dose limiting toxicity|0
2122821|NCT00979576|3722160|FG001|Combination Treatment Phase|Dose limiting toxicity|3
2122822|NCT00979576|3722161|FG002|Combination Treatment Phase|Dose limiting toxicity|2
2122823|NCT00979576|3722159|FG000|Combination Treatment Phase|Adverse Event|0
2122824|NCT00979576|3722160|FG001|Combination Treatment Phase|Adverse Event|2
2122825|NCT00979576|3722161|FG002|Combination Treatment Phase|Adverse Event|2
2122826|NCT00979576|3722159|FG000|Combination Followed by Monotherapy|Progressive Disease|0
2122827|NCT00979576|3722160|FG001|Combination Followed by Monotherapy|Progressive Disease|2
2122828|NCT00979576|3722161|FG002|Combination Followed by Monotherapy|Progressive Disease|1
2122829|NCT00979602|3722172|FG000|Overall Study|Serious Adverse Event|5
2122830|NCT00979602|3722173|FG001|Overall Study|Serious Adverse Event|3
2122831|NCT00979602|3722172|FG000|Overall Study|Protocol Violation|3
2122832|NCT00979602|3722173|FG001|Overall Study|Protocol Violation|0
2122833|NCT00979602|3722172|FG000|Overall Study|Withdrawal by Subject|31
2122834|NCT00979602|3722173|FG001|Overall Study|Withdrawal by Subject|25
2122835|NCT00979602|3722172|FG000|Overall Study|Lost to Follow-up|100
2122836|NCT00979602|3722173|FG001|Overall Study|Lost to Follow-up|96
2122837|NCT00979602|3722172|FG000|Overall Study|Migrated/moved from study area|3
2122838|NCT00979602|3722173|FG001|Overall Study|Migrated/moved from study area|6
2122839|NCT00979602|3722172|FG000|Overall Study|Others|3
2122840|NCT00979602|3722173|FG001|Overall Study|Others|3
2122841|NCT00979628|3722203|FG000|Overall Study|received regimen < 24 hours|7
2122842|NCT00979628|3722204|FG001|Overall Study|received regimen < 24 hours|6
2122843|NCT00979628|3722205|FG002|Overall Study|received regimen < 24 hours|5
2122844|NCT00979628|3722203|FG000|Overall Study|received steroids|1
2122845|NCT00979628|3722204|FG001|Overall Study|received steroids|1
2122846|NCT00979628|3722205|FG002|Overall Study|received steroids|0
2122847|NCT00979628|3722203|FG000|Overall Study|transferred to ICU|1
2122848|NCT00979628|3722204|FG001|Overall Study|transferred to ICU|2
2122849|NCT00979628|3722205|FG002|Overall Study|transferred to ICU|1
2122850|NCT00979654|3722216|FG000|Overall Study|Lost to Follow-up|1
2122851|NCT00979654|3722216|FG000|Overall Study|Withdrawal by Subject|22
2122852|NCT00979654|3722216|FG000|Overall Study|Death|1
2122853|NCT00979654|3722216|FG000|Overall Study|Lack of Efficacy|6
2122854|NCT00979654|3722216|FG000|Overall Study|Adverse Event|1
2122855|NCT00979654|3722216|FG000|Overall Study|Adverse Event of Diverticulitis|1
2122856|NCT00979654|3722216|FG000|Overall Study|Per Principal Investigator's Discretion|1
2122857|NCT00979654|3722216|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1
2122858|NCT00979654|3722216|FG000|Overall Study|Serious Adverse Event|1
2122859|NCT00979654|3722216|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1
2122860|NCT00979953|3722270|FG000|Overall Study|Adverse Event|5
2122861|NCT00979953|3722271|FG001|Overall Study|Adverse Event|2
2122862|NCT00979953|3722272|FG002|Overall Study|Adverse Event|17
2122863|NCT00979953|3722273|FG003|Overall Study|Adverse Event|4
2122864|NCT00979953|3722270|FG000|Overall Study|Lack of Efficacy|1
2122865|NCT00979953|3722271|FG001|Overall Study|Lack of Efficacy|2
2122866|NCT00979953|3722272|FG002|Overall Study|Lack of Efficacy|0
2122867|NCT00979953|3722273|FG003|Overall Study|Lack of Efficacy|0
2122868|NCT00979953|3722270|FG000|Overall Study|Lost to Follow-up|1
2122869|NCT00979953|3722271|FG001|Overall Study|Lost to Follow-up|1
2122870|NCT00979953|3722272|FG002|Overall Study|Lost to Follow-up|1
2122871|NCT00979953|3722273|FG003|Overall Study|Lost to Follow-up|0
2122872|NCT00979953|3722270|FG000|Overall Study|Withdrawal by Subject|0
2122873|NCT00979953|3722271|FG001|Overall Study|Withdrawal by Subject|0
2122874|NCT00979953|3722272|FG002|Overall Study|Withdrawal by Subject|2
2122875|NCT00979953|3722273|FG003|Overall Study|Withdrawal by Subject|1
2122876|NCT00979953|3722270|FG000|Overall Study|Protocol Violation|1
2122877|NCT00979953|3722271|FG001|Overall Study|Protocol Violation|0
2122878|NCT00979953|3722272|FG002|Overall Study|Protocol Violation|2
2122879|NCT00979953|3722273|FG003|Overall Study|Protocol Violation|2
2122880|NCT00979992|3722283|FG000|Overall Study|Ineligible - inadequate pathology|1
2122881|NCT00979992|3722283|FG000|Overall Study|Ineligible - wrong cell type|2
2122882|NCT00979992|3722283|FG000|Overall Study|Refused - Never Treated|2
2122883|NCT00980005|3722289|FG000|Overall Study|Withdrawal by Subject|6
2122884|NCT00980005|3722290|FG001|Overall Study|Withdrawal by Subject|17
2122885|NCT00980005|3722289|FG000|Overall Study|Lost to Follow-up|37
2122886|NCT00980005|3722290|FG001|Overall Study|Lost to Follow-up|43
2122887|NCT00980005|3722289|FG000|Overall Study|Other|4
2122888|NCT00980005|3722290|FG001|Overall Study|Other|3
2122889|NCT00980018|3722300|FG000|Overall Study|Adverse Event|8
2122890|NCT00980018|3722300|FG000|Overall Study|Patient withdrew consent|3
2122891|NCT00980018|3722300|FG000|Overall Study|Lost to Follow-up|1
2122892|NCT00980044|3722307|FG000|Overall Study|Withdrawal by Subject|5
2122893|NCT00980044|3722308|FG001|Overall Study|Withdrawal by Subject|7
2122894|NCT00980044|3722309|FG002|Overall Study|Withdrawal by Subject|3
2122895|NCT00980044|3722307|FG000|Overall Study|Protocol Violation|0
2122896|NCT00980044|3722308|FG001|Overall Study|Protocol Violation|0
2122897|NCT00980044|3722309|FG002|Overall Study|Protocol Violation|2
2122898|NCT00980057|3722322|FG000|Overall Study|Death|13
2122899|NCT00980057|3722323|FG001|Overall Study|Death|3
2122900|NCT00980057|3722322|FG000|Overall Study|Adverse Event|0
2122901|NCT00980057|3722323|FG001|Overall Study|Adverse Event|1
2122902|NCT00980057|3722322|FG000|Overall Study|Physician Decision|4
2122903|NCT00980057|3722323|FG001|Overall Study|Physician Decision|0
2122904|NCT00980057|3722322|FG000|Overall Study|Lost to Follow-up|1
2122905|NCT00980057|3722323|FG001|Overall Study|Lost to Follow-up|0
2122906|NCT00980057|3722322|FG000|Overall Study|Withdrawal by Subject|1
2122907|NCT00980057|3722323|FG001|Overall Study|Withdrawal by Subject|1
2122908|NCT00980148|3722332|FG000|Overall Study|Discharged from facility|89
2122909|NCT00980148|3722333|FG001|Overall Study|Discharged from facility|96
2122910|NCT00980148|3722332|FG000|Overall Study|Received other antichlamydia treatment|20
2122911|NCT00980148|3722333|FG001|Overall Study|Received other antichlamydia treatment|14
2122912|NCT00980148|3722332|FG000|Overall Study|Negative for chlamydia at enrollment|12
2122913|NCT00980148|3722333|FG001|Overall Study|Negative for chlamydia at enrollment|9
2122914|NCT00980148|3722332|FG000|Overall Study|Various other reasons|8
2122915|NCT00980148|3722333|FG001|Overall Study|Various other reasons|9
2122916|NCT00980174|3722341|FG000|Overall Study|Withdrawal by Subject|1
2122917|NCT00980174|3722342|FG001|Overall Study|Withdrawal by Subject|4
2122918|NCT00980174|3722341|FG000|Overall Study|Adverse Event|0
2122919|NCT00980174|3722342|FG001|Overall Study|Adverse Event|3
2122920|NCT00980174|3722341|FG000|Overall Study|Ineligibility determined|2
2122921|NCT00980174|3722342|FG001|Overall Study|Ineligibility determined|1
2122922|NCT00980174|3722341|FG000|Overall Study|Death|1
2122923|NCT00980174|3722342|FG001|Overall Study|Death|1
2122924|NCT00980174|3722341|FG000|Overall Study|Other|0
2122925|NCT00980174|3722342|FG001|Overall Study|Other|1
2122926|NCT00980200|3722348|FG000|7-day Treatment Period 1|Withdrawal by Subject|0
2122927|NCT00980200|3722349|FG001|7-day Treatment Period 1|Withdrawal by Subject|1
2122928|NCT00980200|3722350|FG002|7-day Treatment Period 1|Withdrawal by Subject|0
2122929|NCT00980200|3722351|FG003|7-day Treatment Period 1|Withdrawal by Subject|0
2122930|NCT00980200|3722352|FG004|7-day Treatment Period 1|Withdrawal by Subject|0
2122931|NCT00980200|3722348|FG000|7-day Treatment Period 3|Lack of Efficacy|0
2122932|NCT00980200|3722349|FG001|7-day Treatment Period 3|Lack of Efficacy|1
2122933|NCT00980200|3722350|FG002|7-day Treatment Period 3|Lack of Efficacy|0
2122934|NCT00980200|3722351|FG003|7-day Treatment Period 3|Lack of Efficacy|0
2122935|NCT00980200|3722352|FG004|7-day Treatment Period 3|Lack of Efficacy|1
2122936|NCT00980330|3722380|FG000|Overall Study|Adverse Event|0
2122937|NCT00980330|3722381|FG001|Overall Study|Adverse Event|0
2122938|NCT00980330|3722382|FG002|Overall Study|Adverse Event|0
2122939|NCT00980330|3722383|FG003|Overall Study|Adverse Event|1
2122940|NCT00980330|3722384|FG004|Overall Study|Adverse Event|0
2122941|NCT00980330|3722385|FG005|Overall Study|Adverse Event|0
2122942|NCT00980330|3722386|FG006|Overall Study|Adverse Event|0
2122943|NCT00980330|3722380|FG000|Overall Study|Lost to Follow-up|1
2122944|NCT00980330|3722381|FG001|Overall Study|Lost to Follow-up|1
2122945|NCT00980330|3722382|FG002|Overall Study|Lost to Follow-up|4
2122946|NCT00980330|3722383|FG003|Overall Study|Lost to Follow-up|2
2122947|NCT00980330|3722384|FG004|Overall Study|Lost to Follow-up|1
2122948|NCT00980330|3722385|FG005|Overall Study|Lost to Follow-up|1
2122949|NCT00980330|3722386|FG006|Overall Study|Lost to Follow-up|2
2122950|NCT00980330|3722380|FG000|Overall Study|Withdrawal by Subject|2
2122951|NCT00980330|3722381|FG001|Overall Study|Withdrawal by Subject|4
2122952|NCT00980330|3722382|FG002|Overall Study|Withdrawal by Subject|4
2122953|NCT00980330|3722383|FG003|Overall Study|Withdrawal by Subject|1
2122954|NCT00980330|3722384|FG004|Overall Study|Withdrawal by Subject|3
2122955|NCT00980330|3722385|FG005|Overall Study|Withdrawal by Subject|2
2122956|NCT00980330|3722386|FG006|Overall Study|Withdrawal by Subject|5
2122957|NCT00980330|3722380|FG000|Overall Study|(not specified)|2
2122958|NCT00980330|3722381|FG001|Overall Study|(not specified)|0
2122959|NCT00980330|3722382|FG002|Overall Study|(not specified)|0
2122960|NCT00980330|3722383|FG003|Overall Study|(not specified)|1
2122961|NCT00980330|3722384|FG004|Overall Study|(not specified)|1
2122962|NCT00980330|3722385|FG005|Overall Study|(not specified)|1
2122963|NCT00980330|3722386|FG006|Overall Study|(not specified)|0
2122964|NCT00980343|3722405|FG000|Overall Study|no tumor at surgery - treatment effect|1
2279049|NCT02346240|3962749|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1
2279050|NCT02346240|3962750|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0
2279051|NCT02346240|3962751|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0
2279052|NCT02346240|3962752|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0
2279053|NCT02346240|3962753|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0
2279054|NCT02346240|3962754|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0
2279055|NCT02346240|3962755|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0
2279056|NCT02346240|3962756|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0
2279057|NCT02346240|3962757|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0
2279058|NCT02346240|3962758|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0
2279059|NCT02346240|3962759|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0
2279060|NCT02346240|3962760|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0
2279061|NCT02346240|3962761|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0
2279062|NCT02346240|3962762|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0
2122965|NCT00980343|3722406|FG001|Overall Study|no tumor at surgery - treatment effect|3
2122966|NCT00980655|3722438|FG000|Overall Study|Adverse Event|13
2122967|NCT00980655|3722439|FG001|Overall Study|Adverse Event|31
2122968|NCT00980655|3722438|FG000|Overall Study|Death|0
2122969|NCT00980655|3722439|FG001|Overall Study|Death|7
2122970|NCT00980655|3722438|FG000|Overall Study|Protocol Violation|2
2122971|NCT00980655|3722439|FG001|Overall Study|Protocol Violation|7
2122972|NCT00980655|3722438|FG000|Overall Study|Withdrawal by Subject|0
2122973|NCT00980655|3722439|FG001|Overall Study|Withdrawal by Subject|4
2122974|NCT00980655|3722438|FG000|Overall Study|Lost to Follow-up|0
2122975|NCT00980655|3722439|FG001|Overall Study|Lost to Follow-up|1
2122976|NCT00980655|3722438|FG000|Overall Study|Parent/legal guardian request|1
2122977|NCT00980655|3722439|FG001|Overall Study|Parent/legal guardian request|0
2122978|NCT00980655|3722438|FG000|Overall Study|Other|0
2122979|NCT00980655|3722439|FG001|Overall Study|Other|1
2122980|NCT00980798|3722492|FG000|Overall Study|Adverse Event|7
2122981|NCT00980798|3722493|FG001|Overall Study|Adverse Event|36
2122982|NCT00980798|3722492|FG000|Overall Study|Lack of Efficacy|16
2122983|NCT00980798|3722493|FG001|Overall Study|Lack of Efficacy|5
2122984|NCT00980798|3722492|FG000|Overall Study|Lost to Follow-up|0
2122985|NCT00980798|3722493|FG001|Overall Study|Lost to Follow-up|1
2122986|NCT00980798|3722492|FG000|Overall Study|Physician Decision|2
2122987|NCT00980798|3722493|FG001|Overall Study|Physician Decision|1
2122988|NCT00980798|3722492|FG000|Overall Study|Withdrawal by Subject|8
2122989|NCT00980798|3722493|FG001|Overall Study|Withdrawal by Subject|11
2122990|NCT00980798|3722492|FG000|Overall Study|Other|0
2122991|NCT00980798|3722493|FG001|Overall Study|Other|1
2122992|NCT00980980|3722502|FG000|Overall Study|Withdrawal by Hospital|0
2122993|NCT00980980|3722503|FG001|Overall Study|Withdrawal by Hospital|1
2122994|NCT00980980|3722504|FG002|Overall Study|Withdrawal by Hospital|0
2122995|NCT00981019|3722515|FG000|Overall Study|Did not respond|65
2122996|NCT00981019|3722515|FG000|Overall Study|Did not match target population|94
2122997|NCT00981019|3722515|FG000|Overall Study|Inadvertent exclusion|239
2122998|NCT00981019|3722515|FG000|Overall Study|Hit the survey after closure|79
2122999|NCT00981084|3722530|FG000|Post Intervention (Data Analysis)|poor effort|1
2123000|NCT00981084|3722531|FG001|Post Intervention (Data Analysis)|poor effort|1
2123001|NCT00981084|3722530|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1
2205220|NCT01609556|3843226|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205221|NCT01609556|3843227|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205222|NCT01609556|3843228|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2279063|NCT02346240|3962763|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0
2279064|NCT02346240|3962764|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0
2279065|NCT02346240|3962765|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0
2279066|NCT02346240|3962766|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0
2279067|NCT02346240|3962767|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0
2279068|NCT02346240|3962768|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0
2279069|NCT02346240|3962769|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0
2279070|NCT02346240|3962746|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279071|NCT02346240|3962747|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
2279072|NCT02346240|3962748|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279073|NCT02346240|3962749|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279074|NCT02346240|3962750|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279075|NCT02346240|3962751|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279076|NCT02346240|3962752|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279077|NCT02346240|3962753|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279078|NCT02346240|3962754|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279079|NCT02346240|3962755|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279080|NCT02346240|3962756|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279081|NCT02346240|3962757|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279082|NCT02346240|3962758|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2123002|NCT00981084|3722531|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0
2205223|NCT01609556|3843229|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205224|NCT01609556|3843230|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205225|NCT01609556|3843231|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
2205226|NCT01609556|3843216|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2
2205227|NCT01609556|3843217|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205228|NCT01609556|3843218|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205229|NCT01609556|3843219|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205230|NCT01609556|3843220|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205231|NCT01609556|3843221|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1
2205232|NCT01609556|3843222|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205233|NCT01609556|3843223|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205234|NCT01609556|3843224|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205235|NCT01609556|3843225|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205236|NCT01609556|3843226|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1
2279083|NCT02346240|3962759|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279084|NCT02346240|3962760|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2123003|NCT00981149|3722541|FG000|Overall Study|Lost to Follow-up|1
2123004|NCT00981149|3722542|FG001|Overall Study|Lost to Follow-up|2
2123005|NCT00981149|3722541|FG000|Overall Study|Withdrawal by Subject|1
2123006|NCT00981149|3722542|FG001|Overall Study|Withdrawal by Subject|1
2123007|NCT00981175|3722551|FG000|Primary Dose Vaccination|Adverse Event|1
2123008|NCT00981175|3722552|FG001|Primary Dose Vaccination|Adverse Event|0
2123009|NCT00981175|3722551|FG000|Primary Dose Vaccination|Protocol Violation|0
2123010|NCT00981175|3722552|FG001|Primary Dose Vaccination|Protocol Violation|1
2123011|NCT00981175|3722551|FG000|Primary Dose Vaccination|Lost to Follow-up|2
2123012|NCT00981175|3722552|FG001|Primary Dose Vaccination|Lost to Follow-up|1
2123013|NCT00981175|3722551|FG000|Booster Dose Vaccination|Lost to Follow-up|2
2123014|NCT00981175|3722552|FG001|Booster Dose Vaccination|Lost to Follow-up|3
2123015|NCT00981292|3722614|FG000|Day 1|Protocol Violation|1
2123016|NCT00981292|3722615|FG001|Day 1|Protocol Violation|0
2123017|NCT00981292|3722616|FG002|Day 1|Protocol Violation|0
2123018|NCT00981292|3722617|FG003|Day 1|Protocol Violation|0
2123019|NCT00981292|3722618|FG004|Day 1|Protocol Violation|0
2123020|NCT00981292|3722619|FG005|Day 1|Protocol Violation|2
2123021|NCT00981292|3722614|FG000|Day 2|Protocol Violation|2
2123022|NCT00981292|3722615|FG001|Day 2|Protocol Violation|0
2123023|NCT00981292|3722616|FG002|Day 2|Protocol Violation|0
2123024|NCT00981292|3722617|FG003|Day 2|Protocol Violation|0
2123025|NCT00981292|3722618|FG004|Day 2|Protocol Violation|0
2123026|NCT00981292|3722619|FG005|Day 2|Protocol Violation|0
2123027|NCT00981292|3722614|FG000|Day 3|Protocol Violation|0
2123028|NCT00981292|3722615|FG001|Day 3|Protocol Violation|0
2123029|NCT00981292|3722616|FG002|Day 3|Protocol Violation|0
2123030|NCT00981292|3722617|FG003|Day 3|Protocol Violation|0
2123031|NCT00981292|3722618|FG004|Day 3|Protocol Violation|0
2123032|NCT00981292|3722619|FG005|Day 3|Protocol Violation|1
2123033|NCT00981409|3722642|FG000|Overall Study|Adverse Event|4
2123034|NCT00981409|3722643|FG001|Overall Study|Adverse Event|0
2123035|NCT00981409|3722642|FG000|Overall Study|Protocol Violation|0
2123036|NCT00981409|3722643|FG001|Overall Study|Protocol Violation|1
2123037|NCT00981409|3722642|FG000|Overall Study|Prostate Cancer Treatment before Trial|2
2123038|NCT00981409|3722643|FG001|Overall Study|Prostate Cancer Treatment before Trial|0
2123039|NCT00981461|3722664|FG000|Overall Study|Lost to Follow-up|5
2123040|NCT00981461|3722665|FG001|Overall Study|Lost to Follow-up|2
2123041|NCT00981526|3722684|FG000|Overall Study|Withdrawal by Subject|0
2123042|NCT00981526|3722685|FG001|Overall Study|Withdrawal by Subject|2
2123043|NCT00981526|3722684|FG000|Overall Study|Physician Decision|4
2123044|NCT00981526|3722685|FG001|Overall Study|Physician Decision|4
2123045|NCT00981578|3722693|FG000|Overall Study|Death|1
2123046|NCT00981578|3722693|FG000|Overall Study|Withdrawal by Subject|2
2123047|NCT00981682|3722723|FG000|Overall Study|Adverse Event|48
2123048|NCT00981682|3722723|FG000|Overall Study|Withdrawal by Subject|52
2123049|NCT00981682|3722723|FG000|Overall Study|Lost to Follow-up|14
2123050|NCT00981682|3722723|FG000|Overall Study|Lack of Efficacy|13
2123051|NCT00981682|3722723|FG000|Overall Study|Protocol Violation|6
2123052|NCT00981682|3722723|FG000|Overall Study|administrative|9
2123053|NCT00981747|3722727|FG000|Losartan|Withdrawal by Subject|1
2123054|NCT00981747|3722727|FG000|Losartan|Death|1
2123055|NCT00981747|3722727|FG000|Placebo Oral Tablet|Withdrawal by Subject|1
2123056|NCT00981799|3722741|FG000|Overall Study|Adverse Event|1
2123057|NCT00981799|3722742|FG001|Overall Study|Adverse Event|1
2123058|NCT00981799|3722743|FG002|Overall Study|Adverse Event|0
2123059|NCT00981799|3722744|FG003|Overall Study|Adverse Event|0
2123060|NCT00982020|3722787|FG000|Overall Study|Adverse Event|19
2123061|NCT00982020|3722788|FG001|Overall Study|Adverse Event|15
2123062|NCT00982020|3722787|FG000|Overall Study|Withdrawal by Subject|11
2123063|NCT00982020|3722788|FG001|Overall Study|Withdrawal by Subject|14
2123064|NCT00982020|3722787|FG000|Overall Study|Lost to Follow-up|5
2123065|NCT00982020|3722788|FG001|Overall Study|Lost to Follow-up|11
2123066|NCT00982020|3722787|FG000|Overall Study|Lack of Efficacy|10
2123067|NCT00982020|3722788|FG001|Overall Study|Lack of Efficacy|4
2123068|NCT00982020|3722787|FG000|Overall Study|Parent/Caregiver Decision|5
2123069|NCT00982020|3722788|FG001|Overall Study|Parent/Caregiver Decision|5
2123070|NCT00982020|3722787|FG000|Overall Study|Treatment Non-compliance|3
2123071|NCT00982020|3722788|FG001|Overall Study|Treatment Non-compliance|6
2123072|NCT00982020|3722787|FG000|Overall Study|Physician Decision|2
2123073|NCT00982020|3722788|FG001|Overall Study|Physician Decision|5
2123074|NCT00982020|3722787|FG000|Overall Study|Entry Criteria Not Met|2
2123075|NCT00982020|3722788|FG001|Overall Study|Entry Criteria Not Met|1
2123076|NCT00982020|3722787|FG000|Overall Study|Protocol Violation|0
2123077|NCT00982020|3722788|FG001|Overall Study|Protocol Violation|2
2123078|NCT00982020|3722787|FG000|Overall Study|Clinical Relapse|0
2123079|NCT00982020|3722788|FG001|Overall Study|Clinical Relapse|1
2123080|NCT00982137|3722821|FG000|Overall Study|Lost to Follow-up|0
2123081|NCT00982137|3722822|FG001|Overall Study|Lost to Follow-up|0
2123082|NCT00982137|3722823|FG002|Overall Study|Lost to Follow-up|0
2123083|NCT00982137|3722824|FG003|Overall Study|Lost to Follow-up|1
2123084|NCT00982137|3722821|FG000|Overall Study|Withdrawal by Subject|0
2123085|NCT00982137|3722822|FG001|Overall Study|Withdrawal by Subject|1
2123086|NCT00982137|3722823|FG002|Overall Study|Withdrawal by Subject|0
2123087|NCT00982137|3722824|FG003|Overall Study|Withdrawal by Subject|0
2123088|NCT00982228|3722862|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
2123089|NCT00982228|3722863|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
2123090|NCT00982228|3722862|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
2123091|NCT00982228|3722863|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
2123092|NCT00982228|3722862|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
2123093|NCT00982228|3722863|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
2123094|NCT00982228|3722862|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
2123095|NCT00982228|3722863|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
2123096|NCT00982228|3722862|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
2123097|NCT00982228|3722863|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
2123098|NCT00982228|3722862|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
2123099|NCT00982228|3722863|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
2123100|NCT00982228|3722862|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
2123101|NCT00982228|3722863|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
2123102|NCT00982228|3722862|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
2123103|NCT00982228|3722863|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
2123104|NCT00982228|3722862|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
2123105|NCT00982228|3722863|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
2123106|NCT00982228|3722862|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
2123107|NCT00982228|3722863|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
2123108|NCT00982280|3722869|FG000|Observation Period|Not eligible to be dosed|19
2123109|NCT00982280|3722869|FG000|Titration and Optimal Dose Period|Adverse Event|5
2123110|NCT00982280|3722869|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2
2123111|NCT00982280|3722869|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1
2279085|NCT02346240|3962761|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279086|NCT02346240|3962762|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279087|NCT02346240|3962763|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279088|NCT02346240|3962764|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279089|NCT02346240|3962765|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279090|NCT02346240|3962766|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279091|NCT02346240|3962767|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279092|NCT02346240|3962768|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2123112|NCT00982280|3722869|FG000|Maintenance Period|Adverse Event|1
2279093|NCT02346240|3962769|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2279094|NCT02346240|3962746|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279095|NCT02346240|3962747|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1
2279096|NCT02346240|3962748|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279097|NCT02346240|3962749|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279098|NCT02346240|3962750|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279099|NCT02346240|3962751|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279100|NCT02346240|3962752|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279101|NCT02346240|3962753|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279102|NCT02346240|3962754|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279103|NCT02346240|3962755|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279104|NCT02346240|3962756|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279105|NCT02346240|3962757|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279106|NCT02346240|3962758|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279107|NCT02346240|3962759|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279108|NCT02346240|3962760|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279109|NCT02346240|3962761|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279110|NCT02346240|3962762|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279111|NCT02346240|3962763|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279112|NCT02346240|3962764|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279113|NCT02346240|3962765|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279114|NCT02346240|3962766|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279115|NCT02346240|3962767|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279116|NCT02346240|3962768|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279117|NCT02346240|3962769|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0
2279118|NCT02346240|3962746|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
2279119|NCT02346240|3962747|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
2279120|NCT02346240|3962748|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
2279121|NCT02346240|3962749|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
2279122|NCT02346240|3962750|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279123|NCT02346240|3962751|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279124|NCT02346240|3962752|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279125|NCT02346240|3962753|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279126|NCT02346240|3962754|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279127|NCT02346240|3962755|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279128|NCT02346240|3962756|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279129|NCT02346240|3962757|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279130|NCT02346240|3962758|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2123113|NCT00982319|3722876|FG000|Overall Study|Surgery date change|1
2123114|NCT00982319|3722877|FG001|Overall Study|Surgery date change|0
2123115|NCT00982319|3722876|FG000|Overall Study|Preop values out of acceptable range|1
2123116|NCT00982319|3722877|FG001|Overall Study|Preop values out of acceptable range|1
2123117|NCT00982319|3722876|FG000|Overall Study|Pregnancy|0
2123118|NCT00982319|3722877|FG001|Overall Study|Pregnancy|1
2123119|NCT00982410|3722901|FG000|3-month Follow-up Assessment|Could not reach to schedule|8
2123120|NCT00982410|3722902|FG001|3-month Follow-up Assessment|Could not reach to schedule|9
2123121|NCT00982410|3722901|FG000|3-month Follow-up Assessment|Scheduled, no-show|1
2123122|NCT00982410|3722902|FG001|3-month Follow-up Assessment|Scheduled, no-show|2
2123123|NCT00982410|3722901|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0
2123124|NCT00982410|3722902|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2
2123125|NCT00982410|3722901|FG000|6-month Follow-up Assessment|Could not reach to schedule|5
2123126|NCT00982410|3722902|FG001|6-month Follow-up Assessment|Could not reach to schedule|7
2123127|NCT00982410|3722901|FG000|6-month Follow-up Assessment|participant no transportation|1
2123128|NCT00982410|3722902|FG001|6-month Follow-up Assessment|participant no transportation|0
2123129|NCT00982410|3722901|FG000|6-month Follow-up Assessment|incarceration|0
2123130|NCT00982410|3722902|FG001|6-month Follow-up Assessment|incarceration|2
2123131|NCT00982410|3722901|FG000|6-month Follow-up Assessment|patent surgery|0
2123132|NCT00982410|3722902|FG001|6-month Follow-up Assessment|patent surgery|1
2123133|NCT00982410|3722901|FG000|6-month Follow-up Assessment|scheduled, no-show|0
2123134|NCT00982410|3722902|FG001|6-month Follow-up Assessment|scheduled, no-show|1
2123135|NCT00982410|3722901|FG000|12-month Follow-up Assessment|Death|0
2123136|NCT00982410|3722902|FG001|12-month Follow-up Assessment|Death|2
2123137|NCT00982410|3722901|FG000|12-month Follow-up Assessment|could not reach to schedule|6
2123138|NCT00982410|3722902|FG001|12-month Follow-up Assessment|could not reach to schedule|5
2123139|NCT00982410|3722901|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0
2123140|NCT00982410|3722902|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1
2123141|NCT00982410|3722901|FG000|12-month Follow-up Assessment|incarceration|2
2123142|NCT00982410|3722902|FG001|12-month Follow-up Assessment|incarceration|1
2123143|NCT00982410|3722901|FG000|12-month Follow-up Assessment|scheduled, no-show|1
2123144|NCT00982410|3722902|FG001|12-month Follow-up Assessment|scheduled, no-show|0
2123145|NCT00982488|3722924|FG000|Overall Study|Administrative reason by sponsor|81
2123146|NCT00982488|3722925|FG001|Overall Study|Administrative reason by sponsor|3
2123147|NCT00982488|3722926|FG002|Overall Study|Administrative reason by sponsor|11
2123148|NCT00982488|3722927|FG003|Overall Study|Administrative reason by sponsor|0
2123149|NCT00982488|3722928|FG004|Overall Study|Administrative reason by sponsor|0
2123150|NCT00982488|3722924|FG000|Overall Study|Adverse event unrelated to study drug|5
2123151|NCT00982488|3722925|FG001|Overall Study|Adverse event unrelated to study drug|1
2279131|NCT02346240|3962759|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279132|NCT02346240|3962760|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279133|NCT02346240|3962761|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279134|NCT02346240|3962762|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279135|NCT02346240|3962763|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279136|NCT02346240|3962764|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279137|NCT02346240|3962765|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279138|NCT02346240|3962766|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279139|NCT02346240|3962767|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279140|NCT02346240|3962768|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279141|NCT02346240|3962769|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2279142|NCT02346240|3962746|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
2279143|NCT02346240|3962747|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
2279144|NCT02346240|3962748|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
2279145|NCT02346240|3962749|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
2279146|NCT02346240|3962750|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279147|NCT02346240|3962751|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279148|NCT02346240|3962752|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279149|NCT02346240|3962753|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279150|NCT02346240|3962754|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279151|NCT02346240|3962755|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279152|NCT02346240|3962756|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279153|NCT02346240|3962757|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279154|NCT02346240|3962758|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279155|NCT02346240|3962759|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279156|NCT02346240|3962760|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279157|NCT02346240|3962761|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279158|NCT02346240|3962762|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279159|NCT02346240|3962763|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279160|NCT02346240|3962764|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279161|NCT02346240|3962765|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2123152|NCT00982488|3722926|FG002|Overall Study|Adverse event unrelated to study drug|0
2123153|NCT00982488|3722927|FG003|Overall Study|Adverse event unrelated to study drug|0
2123154|NCT00982488|3722928|FG004|Overall Study|Adverse event unrelated to study drug|0
2123155|NCT00982488|3722924|FG000|Overall Study|Death|11
2123156|NCT00982488|3722925|FG001|Overall Study|Death|0
2123157|NCT00982488|3722926|FG002|Overall Study|Death|2
2123158|NCT00982488|3722927|FG003|Overall Study|Death|0
2123159|NCT00982488|3722928|FG004|Overall Study|Death|0
2123160|NCT00982488|3722924|FG000|Overall Study|Disease progression|30
2123161|NCT00982488|3722925|FG001|Overall Study|Disease progression|5
2279162|NCT02346240|3962766|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279163|NCT02346240|3962767|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279164|NCT02346240|3962768|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279165|NCT02346240|3962769|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2279166|NCT02346240|3962746|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0
2279167|NCT02346240|3962747|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1
2279168|NCT02346240|3962748|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0
2279169|NCT02346240|3962749|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1
2279170|NCT02346240|3962750|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0
2279171|NCT02346240|3962751|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0
2279172|NCT02346240|3962752|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0
2279173|NCT02346240|3962753|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0
2279174|NCT02346240|3962754|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0
2279175|NCT02346240|3962755|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0
2279176|NCT02346240|3962756|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0
2279177|NCT02346240|3962757|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0
2279178|NCT02346240|3962758|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0
2279179|NCT02346240|3962759|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0
2279180|NCT02346240|3962760|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0
2279181|NCT02346240|3962761|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0
2279182|NCT02346240|3962762|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0
2279183|NCT02346240|3962763|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0
2279184|NCT02346240|3962764|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0
2279185|NCT02346240|3962765|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0
2279186|NCT02346240|3962766|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0
2279187|NCT02346240|3962767|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0
2279188|NCT02346240|3962768|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0
2279189|NCT02346240|3962769|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0
2279190|NCT02346240|3962746|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279191|NCT02346240|3962747|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279192|NCT02346240|3962748|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
2279193|NCT02346240|3962749|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279194|NCT02346240|3962750|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279195|NCT02346240|3962751|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279196|NCT02346240|3962752|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279197|NCT02346240|3962753|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279198|NCT02346240|3962754|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279199|NCT02346240|3962755|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279200|NCT02346240|3962756|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279201|NCT02346240|3962757|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279202|NCT02346240|3962758|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279203|NCT02346240|3962759|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279204|NCT02346240|3962760|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279205|NCT02346240|3962761|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279206|NCT02346240|3962762|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279207|NCT02346240|3962763|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279208|NCT02346240|3962764|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279209|NCT02346240|3962765|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279210|NCT02346240|3962766|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279211|NCT02346240|3962767|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279212|NCT02346240|3962768|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279213|NCT02346240|3962769|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2279214|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279215|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279216|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279217|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279218|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279219|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2320662|NCT02951988|4034990|FG001|Open-Label Treatment Period|Pregnancy|0
2123162|NCT00982488|3722926|FG002|Overall Study|Disease progression|10
2123163|NCT00982488|3722927|FG003|Overall Study|Disease progression|1
2123164|NCT00982488|3722928|FG004|Overall Study|Disease progression|1
2123165|NCT00982488|3722924|FG000|Overall Study|Lost to Follow-up|1
2123166|NCT00982488|3722925|FG001|Overall Study|Lost to Follow-up|0
2123167|NCT00982488|3722926|FG002|Overall Study|Lost to Follow-up|0
2123168|NCT00982488|3722927|FG003|Overall Study|Lost to Follow-up|0
2123169|NCT00982488|3722928|FG004|Overall Study|Lost to Follow-up|0
2123170|NCT00982488|3722924|FG000|Overall Study|Maximum clinical benefit|1
2123171|NCT00982488|3722925|FG001|Overall Study|Maximum clinical benefit|1
2123172|NCT00982488|3722926|FG002|Overall Study|Maximum clinical benefit|1
2123173|NCT00982488|3722927|FG003|Overall Study|Maximum clinical benefit|0
2123174|NCT00982488|3722928|FG004|Overall Study|Maximum clinical benefit|0
2123175|NCT00982488|3722924|FG000|Overall Study|Other|15
2123176|NCT00982488|3722925|FG001|Overall Study|Other|1
2123177|NCT00982488|3722926|FG002|Overall Study|Other|3
2123178|NCT00982488|3722927|FG003|Overall Study|Other|1
2123179|NCT00982488|3722928|FG004|Overall Study|Other|0
2123180|NCT00982488|3722924|FG000|Overall Study|Poor compliance/noncompliance|0
2123181|NCT00982488|3722925|FG001|Overall Study|Poor compliance/noncompliance|1
2123182|NCT00982488|3722926|FG002|Overall Study|Poor compliance/noncompliance|0
2123183|NCT00982488|3722927|FG003|Overall Study|Poor compliance/noncompliance|0
2123184|NCT00982488|3722928|FG004|Overall Study|Poor compliance/noncompliance|0
2123185|NCT00982488|3722924|FG000|Overall Study|Stem cell transplant|2
2123186|NCT00982488|3722925|FG001|Overall Study|Stem cell transplant|0
2123187|NCT00982488|3722926|FG002|Overall Study|Stem cell transplant|0
2123188|NCT00982488|3722927|FG003|Overall Study|Stem cell transplant|1
2123189|NCT00982488|3722928|FG004|Overall Study|Stem cell transplant|0
2123190|NCT00982488|3722924|FG000|Overall Study|Study drug toxicity|34
2123191|NCT00982488|3722925|FG001|Overall Study|Study drug toxicity|1
2123192|NCT00982488|3722926|FG002|Overall Study|Study drug toxicity|6
2123193|NCT00982488|3722927|FG003|Overall Study|Study drug toxicity|0
2123194|NCT00982488|3722928|FG004|Overall Study|Study drug toxicity|0
2205237|NCT01609556|3843227|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205238|NCT01609556|3843228|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205239|NCT01609556|3843229|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205240|NCT01609556|3843230|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0
2123195|NCT00982488|3722924|FG000|Overall Study|Withdrawal by Subject|5
2123196|NCT00982488|3722925|FG001|Overall Study|Withdrawal by Subject|1
2123197|NCT00982488|3722926|FG002|Overall Study|Withdrawal by Subject|1
2123198|NCT00982488|3722927|FG003|Overall Study|Withdrawal by Subject|0
2123199|NCT00982488|3722928|FG004|Overall Study|Withdrawal by Subject|0
2123200|NCT00982644|3722960|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
2123201|NCT00982644|3722961|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
2123202|NCT00982644|3722960|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
2123203|NCT00982644|3722961|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
2123204|NCT00982644|3722960|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
2123205|NCT00982644|3722961|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
2123206|NCT00982644|3722960|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
2123207|NCT00982644|3722961|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
2123208|NCT00982644|3722960|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
2123209|NCT00982644|3722961|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
2205241|NCT01609556|3843231|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0
2205242|NCT01609556|3843216|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2279220|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279221|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2279222|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2279223|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279224|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279225|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279226|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279227|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2279228|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
2279229|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2279230|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2279231|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279232|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279233|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279234|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279235|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279236|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279237|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2279238|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279239|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2205243|NCT01609556|3843217|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2205244|NCT01609556|3843218|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2205245|NCT01609556|3843219|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2205246|NCT01609556|3843220|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2123210|NCT00982644|3722960|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
2123211|NCT00982644|3722961|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
2123212|NCT00982644|3722960|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
2123213|NCT00982644|3722961|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
2123214|NCT00982644|3722960|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
2279240|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279241|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279242|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279243|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279244|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279245|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279246|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279247|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279248|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279249|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279250|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279251|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2279252|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279253|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
2279254|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279255|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279256|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279257|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279258|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279259|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279260|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279261|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2279262|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279263|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279264|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279265|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279266|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279267|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279268|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279269|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279270|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279271|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279272|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279273|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279274|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279275|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279276|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
2279277|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279278|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279279|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279280|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279281|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279282|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279283|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279284|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279285|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2279286|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279287|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279288|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279289|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279290|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279291|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2279292|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2279293|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2279294|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2279295|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279296|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2279297|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
2279298|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279299|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
2279300|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
2279301|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
2279302|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2123215|NCT00982644|3722961|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
2123216|NCT00982644|3722960|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
2123217|NCT00982644|3722961|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
2123218|NCT00982644|3722960|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
2123219|NCT00982644|3722961|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
2123220|NCT00982657|3722971|FG000|Overall Study|Death|1
2123221|NCT00982657|3722972|FG001|Overall Study|Death|0
2123222|NCT00982657|3722973|FG002|Overall Study|Death|1
2123223|NCT00982657|3722974|FG003|Overall Study|Death|1
2123224|NCT00982657|3722971|FG000|Overall Study|Withdrawal by Subject|0
2123225|NCT00982657|3722972|FG001|Overall Study|Withdrawal by Subject|0
2123226|NCT00982657|3722973|FG002|Overall Study|Withdrawal by Subject|1
2123227|NCT00982657|3722974|FG003|Overall Study|Withdrawal by Subject|3
2123228|NCT00982657|3722971|FG000|Overall Study|Other|0
2123229|NCT00982657|3722972|FG001|Overall Study|Other|0
2123230|NCT00982657|3722973|FG002|Overall Study|Other|0
2123231|NCT00982657|3722974|FG003|Overall Study|Other|4
2123232|NCT00982657|3722971|FG000|Overall Study|On going at date of cut-off|0
2123233|NCT00982657|3722972|FG001|Overall Study|On going at date of cut-off|0
2123234|NCT00982657|3722973|FG002|Overall Study|On going at date of cut-off|0
2123235|NCT00982657|3722974|FG003|Overall Study|On going at date of cut-off|1
2123236|NCT00982735|3722994|FG000|Overall Study|Lost to Follow-up|6
2123237|NCT00982735|3722994|FG000|Overall Study|Patient ineligible for trial|224
2123238|NCT00982878|3723052|FG000|Overall Study|Physician Decision|1
2279303|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279304|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279305|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279306|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279307|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279308|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279309|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2279310|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279311|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279312|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279313|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279314|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279315|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279316|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279317|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279318|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279319|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279320|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279321|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279322|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279323|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
2279324|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
2279325|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
2279326|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
2279327|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279328|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279329|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279330|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279331|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279332|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279333|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2279334|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279335|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279336|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279337|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279338|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279339|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279340|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
2279341|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279342|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279343|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279344|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279345|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279346|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2123239|NCT00982930|3723056|FG000|Overall Study|Adverse Event|1
2123240|NCT00982930|3723056|FG000|Overall Study|Withdrawal by Subject|1
2123241|NCT00982930|3723056|FG000|Overall Study|Administrative Problems|2
2123242|NCT00983073|3723060|FG000|Titration and Optimal Dose Period|Adverse Event|19
2123243|NCT00983073|3723060|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11
2123244|NCT00983073|3723060|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5
2279347|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279348|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279349|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279350|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279351|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279352|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279353|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279354|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279355|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279356|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279357|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2279358|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279359|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279360|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279361|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279362|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279363|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279364|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279365|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279366|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2279367|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279368|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279369|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2279370|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279371|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2279372|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2279373|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279374|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279375|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279376|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279377|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279378|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279379|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279380|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279381|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2279382|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279383|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279384|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279385|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279386|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279387|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279388|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279389|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279390|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279391|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
2279392|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279393|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279394|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279395|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279396|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279397|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279398|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279399|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279400|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279401|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2123245|NCT00983073|3723060|FG000|Titration and Optimal Dose Period|Non-Compliance|1
2123246|NCT00983073|3723060|FG000|Titration and Optimal Dose Period|Other reason|4
2123247|NCT00983073|3723060|FG000|Maintenance Period|Adverse Event|5
2123248|NCT00983073|3723060|FG000|Maintenance Period|Withdrawal by Subject|2
2123249|NCT00983073|3723060|FG000|Maintenance Period|Lack of Efficacy|2
2123250|NCT00983073|3723060|FG000|Maintenance Period|Other Reason|7
2123251|NCT00983294|3723088|FG000|14 Day Washout Period|Withdrawal by Subject|2
2123252|NCT00983294|3723088|FG000|Colchicine With Azithromycin|Adverse Event|1
2123253|NCT00983372|3723107|FG000|14 Day Washout Period|Withdrawal by Subject|1
2123254|NCT00983372|3723107|FG000|Diltiazem ER Alone|missed diltiazem dose|2
2123255|NCT00983372|3723107|FG000|Diltiazem ER Alone|Adverse Event|1
2123256|NCT00983385|3723114|FG000|Observation Period|Not eligible to be dosed|20
2123257|NCT00983385|3723114|FG000|Observation Period|Not Evaluable due to Non Compliance|12
2123258|NCT00983476|3723136|FG000|Overall Study|Did not receive intervention|17
2123259|NCT00983476|3723137|FG001|Overall Study|Did not receive intervention|22
2123260|NCT00983476|3723138|FG002|Overall Study|Did not receive intervention|0
2177880|NCT01379508|3802434|FG000|Treatment to Week 104|Lost to Follow-up|5
2177881|NCT01379508|3802435|FG001|Treatment to Week 104|Lost to Follow-up|0
2177882|NCT01379508|3802436|FG002|Treatment to Week 104|Lost to Follow-up|3
2177883|NCT01379508|3802437|FG003|Treatment to Week 104|Lost to Follow-up|0
2177884|NCT01379508|3802434|FG000|Treatment to Week 104|Administrative problems|3
2177885|NCT01379508|3802435|FG001|Treatment to Week 104|Administrative problems|1
2177886|NCT01379508|3802436|FG002|Treatment to Week 104|Administrative problems|0
2177887|NCT01379508|3802437|FG003|Treatment to Week 104|Administrative problems|0
2177888|NCT01379508|3802434|FG000|Treatment to Week 104|Protocol Violation|1
2177889|NCT01379508|3802435|FG001|Treatment to Week 104|Protocol Violation|1
2177890|NCT01379508|3802436|FG002|Treatment to Week 104|Protocol Violation|1
2177891|NCT01379508|3802437|FG003|Treatment to Week 104|Protocol Violation|0
2177892|NCT01379508|3802434|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8
2177893|NCT01379508|3802435|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1
2177894|NCT01379508|3802436|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8
2177895|NCT01379508|3802437|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0
2177896|NCT01379508|3802434|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6
2177897|NCT01379508|3802435|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1
2177898|NCT01379508|3802436|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5
2177899|NCT01379508|3802437|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0
2177900|NCT01379508|3802434|FG000|Extension Period Weeks 109-156|Administrative problems|3
2177901|NCT01379508|3802435|FG001|Extension Period Weeks 109-156|Administrative problems|0
2177902|NCT01379508|3802436|FG002|Extension Period Weeks 109-156|Administrative problems|1
2177903|NCT01379508|3802437|FG003|Extension Period Weeks 109-156|Administrative problems|0
2177904|NCT01379508|3802434|FG000|Extension Period Weeks 109-156|Protocol Violation|2
2177905|NCT01379508|3802435|FG001|Extension Period Weeks 109-156|Protocol Violation|1
2177906|NCT01379508|3802436|FG002|Extension Period Weeks 109-156|Protocol Violation|0
2177907|NCT01379508|3802437|FG003|Extension Period Weeks 109-156|Protocol Violation|0
2177908|NCT01379521|3802453|FG000|Overall Study -Treatment Period|Adverse Event|3
2177909|NCT01379521|3802454|FG001|Overall Study -Treatment Period|Adverse Event|0
2177910|NCT01379521|3802453|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0
2177911|NCT01379521|3802454|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1
2177912|NCT01379521|3802453|FG000|Overall Study -Treatment Period|Disease Progression|23
2177913|NCT01379521|3802454|FG001|Overall Study -Treatment Period|Disease Progression|22
2279402|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279403|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279404|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279405|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2279406|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279407|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279408|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279409|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279410|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279411|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279412|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279413|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279414|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279415|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279416|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1
2279417|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279418|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279419|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279420|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2177914|NCT01379521|3802453|FG000|Overall Study -Treatment Period|New Cancer Therapy|1
2177915|NCT01379521|3802454|FG001|Overall Study -Treatment Period|New Cancer Therapy|0
2205247|NCT01609556|3843221|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2205248|NCT01609556|3843222|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2123261|NCT00983515|3723165|FG000|Ritonavir Alone|liver panel out of range|6
2279421|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279422|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2123262|NCT00983515|3723165|FG000|Colchicine With Ritonavir|Lost to Follow-up|1
2123263|NCT00983528|3723172|FG000|Overall Study|Death|4
2123264|NCT00983528|3723172|FG000|Overall Study|Lost to Follow-up|1
2123265|NCT00983528|3723172|FG000|Overall Study|Study Terminated|1
2205249|NCT01609556|3843223|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2123266|NCT00983580|3723182|FG000|Overall Study|Cancel Prior to treatment|1
2123267|NCT00983580|3723183|FG001|Overall Study|Cancel Prior to treatment|3
2123268|NCT00983580|3723182|FG000|Overall Study|Protocol Violation|1
2123269|NCT00983580|3723183|FG001|Overall Study|Protocol Violation|1
2123270|NCT00983580|3723182|FG000|Overall Study|Ineligible|3
2123271|NCT00983580|3723183|FG001|Overall Study|Ineligible|0
2123272|NCT00983619|3723202|FG000|Overall Study|Lost to Follow-up|0
2123273|NCT00983619|3723203|FG001|Overall Study|Lost to Follow-up|1
2123274|NCT00983619|3723204|FG002|Overall Study|Lost to Follow-up|0
2123275|NCT00983619|3723205|FG003|Overall Study|Lost to Follow-up|0
2123276|NCT00983619|3723206|FG004|Overall Study|Lost to Follow-up|0
2123277|NCT00983619|3723207|FG005|Overall Study|Lost to Follow-up|2
2123278|NCT00983619|3723208|FG006|Overall Study|Lost to Follow-up|0
2123279|NCT00983619|3723209|FG007|Overall Study|Lost to Follow-up|0
2123280|NCT00983619|3723210|FG008|Overall Study|Lost to Follow-up|0
2123281|NCT00983619|3723211|FG009|Overall Study|Lost to Follow-up|0
2123282|NCT00983619|3723212|FG010|Overall Study|Lost to Follow-up|0
2123283|NCT00983619|3723213|FG011|Overall Study|Lost to Follow-up|2
2123284|NCT00983619|3723202|FG000|Overall Study|Withdrawal by Subject|2
2123285|NCT00983619|3723203|FG001|Overall Study|Withdrawal by Subject|1
2123286|NCT00983619|3723204|FG002|Overall Study|Withdrawal by Subject|1
2123287|NCT00983619|3723205|FG003|Overall Study|Withdrawal by Subject|3
2123288|NCT00983619|3723206|FG004|Overall Study|Withdrawal by Subject|1
2123289|NCT00983619|3723207|FG005|Overall Study|Withdrawal by Subject|23
2123290|NCT00983619|3723208|FG006|Overall Study|Withdrawal by Subject|0
2123291|NCT00983619|3723209|FG007|Overall Study|Withdrawal by Subject|0
2123292|NCT00983619|3723210|FG008|Overall Study|Withdrawal by Subject|0
2123293|NCT00983619|3723211|FG009|Overall Study|Withdrawal by Subject|0
2123294|NCT00983619|3723212|FG010|Overall Study|Withdrawal by Subject|1
2123295|NCT00983619|3723213|FG011|Overall Study|Withdrawal by Subject|1
2123296|NCT00983619|3723202|FG000|Overall Study|Death|0
2123297|NCT00983619|3723203|FG001|Overall Study|Death|2
2123298|NCT00983619|3723204|FG002|Overall Study|Death|2
2123299|NCT00983619|3723205|FG003|Overall Study|Death|1
2123300|NCT00983619|3723206|FG004|Overall Study|Death|2
2123301|NCT00983619|3723207|FG005|Overall Study|Death|30
2123302|NCT00983619|3723208|FG006|Overall Study|Death|1
2123303|NCT00983619|3723209|FG007|Overall Study|Death|0
2205250|NCT01609556|3843224|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2279423|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279424|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279425|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279426|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279427|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279428|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279429|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
2279430|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279431|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279432|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279433|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279434|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279435|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279436|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279437|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279438|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279439|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279440|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279441|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279442|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2123304|NCT00983619|3723210|FG008|Overall Study|Death|1
2123305|NCT00983619|3723211|FG009|Overall Study|Death|2
2123306|NCT00983619|3723212|FG010|Overall Study|Death|9
2205251|NCT01609556|3843225|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2205252|NCT01609556|3843226|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2205253|NCT01609556|3843227|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
2205254|NCT01609556|3843228|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4
2123307|NCT00983619|3723213|FG011|Overall Study|Death|8
2123308|NCT00983619|3723202|FG000|Overall Study|Other|1
2123309|NCT00983619|3723203|FG001|Overall Study|Other|0
2123310|NCT00983619|3723204|FG002|Overall Study|Other|0
2123311|NCT00983619|3723205|FG003|Overall Study|Other|1
2123312|NCT00983619|3723206|FG004|Overall Study|Other|0
2123313|NCT00983619|3723207|FG005|Overall Study|Other|12
2123314|NCT00983619|3723208|FG006|Overall Study|Other|2
2123315|NCT00983619|3723209|FG007|Overall Study|Other|2
2123316|NCT00983619|3723210|FG008|Overall Study|Other|0
2123317|NCT00983619|3723211|FG009|Overall Study|Other|1
2123318|NCT00983619|3723212|FG010|Overall Study|Other|1
2123319|NCT00983619|3723213|FG011|Overall Study|Other|0
2123320|NCT00983749|3723261|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
2123321|NCT00983749|3723262|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
2123322|NCT00983827|3723272|FG000|Overall Study|Withdrawal by Subject|1
2123323|NCT00983853|3723282|FG000|Overall Study|Lost to Follow-up|1
2123324|NCT00983853|3723283|FG001|Overall Study|Lost to Follow-up|1
2123325|NCT00983853|3723284|FG002|Overall Study|Lost to Follow-up|2
2123326|NCT00983853|3723285|FG003|Overall Study|Lost to Follow-up|2
2123327|NCT00983853|3723286|FG004|Overall Study|Lost to Follow-up|2
2123328|NCT00983853|3723287|FG005|Overall Study|Lost to Follow-up|1
2123329|NCT00983853|3723282|FG000|Overall Study|Withdrawal by Subject|0
2123330|NCT00983853|3723283|FG001|Overall Study|Withdrawal by Subject|0
2123331|NCT00983853|3723284|FG002|Overall Study|Withdrawal by Subject|1
2123332|NCT00983853|3723285|FG003|Overall Study|Withdrawal by Subject|0
2123333|NCT00983853|3723286|FG004|Overall Study|Withdrawal by Subject|1
2123334|NCT00983853|3723287|FG005|Overall Study|Withdrawal by Subject|0
2123335|NCT00983853|3723282|FG000|Overall Study|Unable to come to study follow-up visits|0
2123336|NCT00983853|3723283|FG001|Overall Study|Unable to come to study follow-up visits|1
2123337|NCT00983853|3723284|FG002|Overall Study|Unable to come to study follow-up visits|0
2123338|NCT00983853|3723285|FG003|Overall Study|Unable to come to study follow-up visits|0
2123339|NCT00983853|3723286|FG004|Overall Study|Unable to come to study follow-up visits|0
2123340|NCT00983853|3723287|FG005|Overall Study|Unable to come to study follow-up visits|0
2123341|NCT00983892|3723305|FG000|Overall Study|Withdrawal by Subject|10
2123342|NCT00983892|3723306|FG001|Overall Study|Withdrawal by Subject|12
2123343|NCT00983905|3723312|FG000|Theophylline Alone|Adverse Event|1
2123344|NCT00983905|3723312|FG000|Colchicine Alone|Adverse Event|2
2123345|NCT00983918|3723323|FG000|Overall Study|conversion to open cholecystectomy|0
2123346|NCT00983918|3723324|FG001|Overall Study|conversion to open cholecystectomy|2
2123347|NCT00983918|3723325|FG002|Overall Study|conversion to open cholecystectomy|2
2123348|NCT00983918|3723326|FG003|Overall Study|conversion to open cholecystectomy|2
2123349|NCT00983931|3723336|FG000|14 Day Washout Period|Physician Decision|1
2123350|NCT00983957|3723342|FG000|Overall Study|Adverse Event|1
2123351|NCT00983957|3723342|FG000|Overall Study|Personal Reasons|1
2123352|NCT00984009|3723366|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1
2123353|NCT00984022|3723375|FG000|Overall Study|Lost to Follow-up|10
2123354|NCT00984022|3723376|FG001|Overall Study|Lost to Follow-up|14
2123355|NCT00984061|3723382|FG000|Clarithromycin Alone|Protocol Violation|1
2123356|NCT00984126|3723393|FG000|Overall Study|Protocol Violation|0
2123357|NCT00984126|3723394|FG001|Overall Study|Protocol Violation|0
2123358|NCT00984126|3723395|FG002|Overall Study|Protocol Violation|1
2123359|NCT00984126|3723396|FG003|Overall Study|Protocol Violation|2
2123360|NCT00984126|3723393|FG000|Overall Study|Adverse Event|0
2123361|NCT00984126|3723394|FG001|Overall Study|Adverse Event|0
2123362|NCT00984126|3723395|FG002|Overall Study|Adverse Event|0
2123363|NCT00984126|3723396|FG003|Overall Study|Adverse Event|2
2123364|NCT00984126|3723393|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7
2123365|NCT00984126|3723394|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7
2123366|NCT00984126|3723395|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3
2123367|NCT00984126|3723396|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46
2123368|NCT00984126|3723393|FG000|Overall Study|Withdrawal criteria|0
2123369|NCT00984126|3723394|FG001|Overall Study|Withdrawal criteria|1
2123370|NCT00984126|3723395|FG002|Overall Study|Withdrawal criteria|3
2123371|NCT00984126|3723396|FG003|Overall Study|Withdrawal criteria|9
2123372|NCT00984165|3723423|FG000|Overall Study|Death on study|2
2123373|NCT00984165|3723424|FG001|Overall Study|Death on study|0
2123374|NCT00984165|3723425|FG002|Overall Study|Death on study|0
2123375|NCT00984165|3723426|FG003|Overall Study|Death on study|0
2123376|NCT00984165|3723423|FG000|Overall Study|Disease progression on study|5
2123377|NCT00984165|3723424|FG001|Overall Study|Disease progression on study|1
2123378|NCT00984165|3723425|FG002|Overall Study|Disease progression on study|0
2123379|NCT00984165|3723426|FG003|Overall Study|Disease progression on study|0
2123380|NCT00984165|3723423|FG000|Overall Study|Death of recipient|0
2123381|NCT00984165|3723424|FG001|Overall Study|Death of recipient|0
2123382|NCT00984165|3723425|FG002|Overall Study|Death of recipient|0
2123383|NCT00984165|3723426|FG003|Overall Study|Death of recipient|1
2123384|NCT00984165|3723423|FG000|Overall Study|New protocol|0
2123385|NCT00984165|3723424|FG001|Overall Study|New protocol|0
2123386|NCT00984165|3723425|FG002|Overall Study|New protocol|0
2123387|NCT00984165|3723426|FG003|Overall Study|New protocol|1
2123388|NCT00984165|3723423|FG000|Overall Study|P+/donor pair removed from protocol|0
2123389|NCT00984165|3723424|FG001|Overall Study|P+/donor pair removed from protocol|0
2123390|NCT00984165|3723425|FG002|Overall Study|P+/donor pair removed from protocol|0
2123391|NCT00984165|3723426|FG003|Overall Study|P+/donor pair removed from protocol|1
2123392|NCT00984165|3723423|FG000|Overall Study|removed with a pair recipient|0
2123393|NCT00984165|3723424|FG001|Overall Study|removed with a pair recipient|0
2123394|NCT00984165|3723425|FG002|Overall Study|removed with a pair recipient|0
2123395|NCT00984165|3723426|FG003|Overall Study|removed with a pair recipient|1
2123396|NCT00984204|3723437|FG000|Overall Study|Death|1
2123397|NCT00984204|3723437|FG000|Overall Study|Lost to Follow-up|4
2123398|NCT00984204|3723437|FG000|Overall Study|Lack of Efficacy|10
2123399|NCT00984256|3723443|FG000|Overall Study|Withdrawal by Subject|0
2123400|NCT00984256|3723444|FG001|Overall Study|Withdrawal by Subject|1
2123401|NCT00984282|3723461|FG000|Double Blind Treatment|Adverse Event|40
2123402|NCT00984282|3723462|FG001|Double Blind Treatment|Adverse Event|6
2123403|NCT00984282|3723461|FG000|Double Blind Treatment|Progression, recurrence or relapse|25
2123404|NCT00984282|3723462|FG001|Double Blind Treatment|Progression, recurrence or relapse|3
2123405|NCT00984282|3723461|FG000|Double Blind Treatment|Physician Decision|1
2123406|NCT00984282|3723462|FG001|Double Blind Treatment|Physician Decision|2
2123407|NCT00984282|3723461|FG000|Double Blind Treatment|Noncompliance with study medication|3
2123408|NCT00984282|3723462|FG001|Double Blind Treatment|Noncompliance with study medication|0
2123409|NCT00984282|3723461|FG000|Double Blind Treatment|Progression by clinical judgment|2
2123410|NCT00984282|3723462|FG001|Double Blind Treatment|Progression by clinical judgment|0
2123411|NCT00984282|3723461|FG000|Double Blind Treatment|Withdrawal by Subject|13
2123412|NCT00984282|3723462|FG001|Double Blind Treatment|Withdrawal by Subject|18
2123413|NCT00984282|3723461|FG000|Double Blind Treatment|Lost to Follow-up|3
2123414|NCT00984282|3723462|FG001|Double Blind Treatment|Lost to Follow-up|0
2123415|NCT00984282|3723461|FG000|Double Blind Treatment|Death|8
2123416|NCT00984282|3723462|FG001|Double Blind Treatment|Death|4
2123417|NCT00984282|3723461|FG000|Double Blind Treatment|Not treated|0
2123418|NCT00984282|3723462|FG001|Double Blind Treatment|Not treated|1
2279443|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279444|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
2279445|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279446|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279447|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279448|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279449|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279450|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279451|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279452|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279453|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2279454|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279455|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279456|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279457|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279458|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279459|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279460|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279461|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279462|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279463|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279464|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279465|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279466|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279467|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279468|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
2279469|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279470|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279471|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279472|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279473|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279474|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279475|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279476|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2279477|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2123419|NCT00984282|3723461|FG000|Double Blind Treatment|Switched to commercial drug|6
2123420|NCT00984282|3723462|FG001|Double Blind Treatment|Switched to commercial drug|1
2123421|NCT00984282|3723461|FG000|Double Blind Treatment|protocol driven decision point|1
2123422|NCT00984282|3723462|FG001|Double Blind Treatment|protocol driven decision point|1
2123423|NCT00984282|3723461|FG000|Double Blind Treatment|Radiological and clinical progression|0
2123424|NCT00984282|3723462|FG001|Double Blind Treatment|Radiological and clinical progression|1
2123425|NCT00984282|3723461|FG000|Double Blind Treatment|Transferred to treat. continuation study|2
2123426|NCT00984282|3723462|FG001|Double Blind Treatment|Transferred to treat. continuation study|1
2123427|NCT00984282|3723461|FG000|Open-label Treatment|Adverse Event|20
2123428|NCT00984282|3723462|FG001|Open-label Treatment|Adverse Event|30
2123429|NCT00984282|3723461|FG000|Open-label Treatment|Withdrawal by Subject|6
2123430|NCT00984282|3723462|FG001|Open-label Treatment|Withdrawal by Subject|21
2123431|NCT00984282|3723461|FG000|Open-label Treatment|Death|7
2123432|NCT00984282|3723462|FG001|Open-label Treatment|Death|15
2123433|NCT00984282|3723461|FG000|Open-label Treatment|Progression, recurrence or relapse|40
2123434|NCT00984282|3723462|FG001|Open-label Treatment|Progression, recurrence or relapse|82
2123435|NCT00984282|3723461|FG000|Open-label Treatment|Lost to Follow-up|1
2123436|NCT00984282|3723462|FG001|Open-label Treatment|Lost to Follow-up|1
2123437|NCT00984282|3723461|FG000|Open-label Treatment|Patient convenience|1
2123438|NCT00984282|3723462|FG001|Open-label Treatment|Patient convenience|0
2123439|NCT00984282|3723461|FG000|Open-label Treatment|Non-compliant with study medication|1
2123440|NCT00984282|3723462|FG001|Open-label Treatment|Non-compliant with study medication|0
2123441|NCT00984282|3723461|FG000|Open-label Treatment|Target lesion removed|0
2123442|NCT00984282|3723462|FG001|Open-label Treatment|Target lesion removed|1
2123443|NCT00984282|3723461|FG000|Open-label Treatment|Protocol driven decision point|1
2123444|NCT00984282|3723462|FG001|Open-label Treatment|Protocol driven decision point|1
2123445|NCT00984282|3723461|FG000|Open-label Treatment|Transferred to treat. continuation study|2
2123446|NCT00984282|3723462|FG001|Open-label Treatment|Transferred to treat. continuation study|3
2123447|NCT00984282|3723461|FG000|Open-label Treatment|Switched to commercial drug|6
2123448|NCT00984282|3723462|FG001|Open-label Treatment|Switched to commercial drug|7
2123449|NCT00984282|3723461|FG000|Open-label Treatment|Physician Decision|1
2123450|NCT00984282|3723462|FG001|Open-label Treatment|Physician Decision|0
2123451|NCT00984282|3723461|FG000|Long Term Follow-up|Withdrawal by Subject|8
2123452|NCT00984282|3723462|FG001|Long Term Follow-up|Withdrawal by Subject|14
2123453|NCT00984282|3723461|FG000|Long Term Follow-up|Death|27
2123454|NCT00984282|3723462|FG001|Long Term Follow-up|Death|68
2123455|NCT00984282|3723461|FG000|Long Term Follow-up|Lost to Follow-up|3
2123456|NCT00984282|3723462|FG001|Long Term Follow-up|Lost to Follow-up|6
2123457|NCT00984282|3723461|FG000|Long Term Follow-up|Protocol driven decision point|25
2123458|NCT00984282|3723462|FG001|Long Term Follow-up|Protocol driven decision point|26
2123459|NCT00984282|3723461|FG000|Long Term Follow-up|Transferred to treat. continuation study|2
2123460|NCT00984282|3723462|FG001|Long Term Follow-up|Transferred to treat. continuation study|3
2123461|NCT00984282|3723461|FG000|Long Term Follow-up|Switched to commercial drug|4
2279478|NCT02346240|3962746|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279479|NCT02346240|3962747|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279480|NCT02346240|3962748|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279481|NCT02346240|3962749|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279482|NCT02346240|3962750|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279483|NCT02346240|3962751|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279484|NCT02346240|3962752|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279485|NCT02346240|3962753|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279486|NCT02346240|3962754|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279487|NCT02346240|3962755|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279488|NCT02346240|3962756|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279489|NCT02346240|3962757|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279490|NCT02346240|3962758|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279491|NCT02346240|3962759|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279492|NCT02346240|3962760|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
2279493|NCT02346240|3962761|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279494|NCT02346240|3962762|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279495|NCT02346240|3962763|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279496|NCT02346240|3962764|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279497|NCT02346240|3962765|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279498|NCT02346240|3962766|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279499|NCT02346240|3962767|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279500|NCT02346240|3962768|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279501|NCT02346240|3962769|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2279502|NCT02346240|3962746|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279503|NCT02346240|3962747|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2123462|NCT00984282|3723462|FG001|Long Term Follow-up|Switched to commercial drug|2
2123463|NCT00984282|3723461|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0
2123464|NCT00984282|3723462|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1
2123465|NCT00984295|3723473|FG000|Overall Study|Lost to Follow-up|31
2123466|NCT00984295|3723474|FG001|Overall Study|Lost to Follow-up|12
2279504|NCT02346240|3962748|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279505|NCT02346240|3962749|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279506|NCT02346240|3962750|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279507|NCT02346240|3962751|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279508|NCT02346240|3962752|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279509|NCT02346240|3962753|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279510|NCT02346240|3962754|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279511|NCT02346240|3962755|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279512|NCT02346240|3962756|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279513|NCT02346240|3962757|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279514|NCT02346240|3962758|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279515|NCT02346240|3962759|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279516|NCT02346240|3962760|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279517|NCT02346240|3962761|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279518|NCT02346240|3962762|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2279519|NCT02346240|3962763|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
2279520|NCT02346240|3962764|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
2279521|NCT02346240|3962765|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
2279522|NCT02346240|3962766|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
2279523|NCT02346240|3962767|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
2279524|NCT02346240|3962768|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
2279525|NCT02346240|3962769|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
2279526|NCT02346240|3962746|FG000|Open-Label Period (Week 48 to Week 144)|Death|0
2279527|NCT02346240|3962747|FG001|Open-Label Period (Week 48 to Week 144)|Death|0
2279528|NCT02346240|3962748|FG002|Open-Label Period (Week 48 to Week 144)|Death|0
2279529|NCT02346240|3962749|FG003|Open-Label Period (Week 48 to Week 144)|Death|0
2279530|NCT02346240|3962750|FG004|Open-Label Period (Week 48 to Week 144)|Death|0
2279531|NCT02346240|3962751|FG005|Open-Label Period (Week 48 to Week 144)|Death|0
2279532|NCT02346240|3962752|FG006|Open-Label Period (Week 48 to Week 144)|Death|0
2279533|NCT02346240|3962753|FG007|Open-Label Period (Week 48 to Week 144)|Death|0
2279534|NCT02346240|3962754|FG008|Open-Label Period (Week 48 to Week 144)|Death|0
2279535|NCT02346240|3962755|FG009|Open-Label Period (Week 48 to Week 144)|Death|0
2279536|NCT02346240|3962756|FG010|Open-Label Period (Week 48 to Week 144)|Death|0
2279537|NCT02346240|3962757|FG011|Open-Label Period (Week 48 to Week 144)|Death|0
2279538|NCT02346240|3962758|FG012|Open-Label Period (Week 48 to Week 144)|Death|0
2279539|NCT02346240|3962759|FG013|Open-Label Period (Week 48 to Week 144)|Death|0
2279540|NCT02346240|3962760|FG014|Open-Label Period (Week 48 to Week 144)|Death|0
2279541|NCT02346240|3962761|FG015|Open-Label Period (Week 48 to Week 144)|Death|0
2279542|NCT02346240|3962762|FG016|Open-Label Period (Week 48 to Week 144)|Death|0
2279543|NCT02346240|3962763|FG017|Open-Label Period (Week 48 to Week 144)|Death|0
2279544|NCT02346240|3962764|FG018|Open-Label Period (Week 48 to Week 144)|Death|1
2279545|NCT02346240|3962765|FG019|Open-Label Period (Week 48 to Week 144)|Death|1
2279546|NCT02346240|3962766|FG020|Open-Label Period (Week 48 to Week 144)|Death|0
2279547|NCT02346240|3962767|FG021|Open-Label Period (Week 48 to Week 144)|Death|1
2279548|NCT02346240|3962768|FG022|Open-Label Period (Week 48 to Week 144)|Death|0
2279549|NCT02346240|3962769|FG023|Open-Label Period (Week 48 to Week 144)|Death|0
2279550|NCT02346240|3962746|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279551|NCT02346240|3962747|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279552|NCT02346240|3962748|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279553|NCT02346240|3962749|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279554|NCT02346240|3962750|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279555|NCT02346240|3962751|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279556|NCT02346240|3962752|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279557|NCT02346240|3962753|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279558|NCT02346240|3962754|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279559|NCT02346240|3962755|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279560|NCT02346240|3962756|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279561|NCT02346240|3962757|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279562|NCT02346240|3962758|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279563|NCT02346240|3962759|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279564|NCT02346240|3962760|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279565|NCT02346240|3962761|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279566|NCT02346240|3962762|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279567|NCT02346240|3962763|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279568|NCT02346240|3962764|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
2279569|NCT02346240|3962765|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279570|NCT02346240|3962766|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279571|NCT02346240|3962767|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
2123467|NCT00984295|3723475|FG002|Overall Study|Lost to Follow-up|13
2123468|NCT00984295|3723473|FG000|Overall Study|Protocol Violation|2
2123469|NCT00984295|3723474|FG001|Overall Study|Protocol Violation|1
2123470|NCT00984295|3723475|FG002|Overall Study|Protocol Violation|4
2123471|NCT00984295|3723473|FG000|Overall Study|Withdrawal by Subject|18
2123472|NCT00984295|3723474|FG001|Overall Study|Withdrawal by Subject|9
2123473|NCT00984295|3723475|FG002|Overall Study|Withdrawal by Subject|12
2123474|NCT00984295|3723473|FG000|Overall Study|CAE - discontinued test vaccine|0
2123475|NCT00984295|3723474|FG001|Overall Study|CAE - discontinued test vaccine|1
2123476|NCT00984295|3723475|FG002|Overall Study|CAE - discontinued test vaccine|3
2123477|NCT00984295|3723473|FG000|Overall Study|Missed one or more blood samplings|3
2123478|NCT00984295|3723474|FG001|Overall Study|Missed one or more blood samplings|7
2123479|NCT00984295|3723475|FG002|Overall Study|Missed one or more blood samplings|2
2123480|NCT00984295|3723473|FG000|Overall Study|Incomplete safety follow-up|11
2123481|NCT00984295|3723474|FG001|Overall Study|Incomplete safety follow-up|2
2123482|NCT00984295|3723475|FG002|Overall Study|Incomplete safety follow-up|3
2123483|NCT00984542|3723513|FG000|Overall Study|disease progression|19
2123484|NCT00984542|3723513|FG000|Overall Study|toxicity|7
2123485|NCT00984542|3723513|FG000|Overall Study|Death|7
2123486|NCT00984542|3723513|FG000|Overall Study|complicating disease|3
2123487|NCT00984542|3723513|FG000|Overall Study|Withdrawal by Subject|3
2123488|NCT00984542|3723513|FG000|Overall Study|clinical deterioration|2
2123489|NCT00984568|3723520|FG000|Overall Study|Withdrawal by Subject|1
2123490|NCT00984568|3723521|FG001|Overall Study|Withdrawal by Subject|2
2123491|NCT00984568|3723520|FG000|Overall Study|Lack of Efficacy|2
2123492|NCT00984568|3723521|FG001|Overall Study|Lack of Efficacy|0
2123493|NCT00984568|3723520|FG000|Overall Study|Adverse Event|2
2123494|NCT00984568|3723521|FG001|Overall Study|Adverse Event|0
2123495|NCT00984568|3723520|FG000|Overall Study|Did Not Meet Randomization Criteria|1
2123496|NCT00984568|3723521|FG001|Overall Study|Did Not Meet Randomization Criteria|0
2123497|NCT00984568|3723520|FG000|Overall Study|Lost to Follow-up|0
2123498|NCT00984568|3723521|FG001|Overall Study|Lost to Follow-up|1
2123499|NCT00984568|3723520|FG000|Overall Study|Opportunistic Infection|1
2123500|NCT00984568|3723521|FG001|Overall Study|Opportunistic Infection|0
2123501|NCT00984568|3723520|FG000|Overall Study|Unknown Reason|1
2123502|NCT00984568|3723521|FG001|Overall Study|Unknown Reason|3
2123503|NCT00984594|3723529|FG000|Overall Study|Lost to Follow-up|1
2123504|NCT00984594|3723530|FG001|Overall Study|Lost to Follow-up|0
2123505|NCT00984594|3723529|FG000|Overall Study|Withdrawal by Subject|0
2123506|NCT00984594|3723530|FG001|Overall Study|Withdrawal by Subject|1
2123507|NCT00984620|3723540|FG000|Overall Study|Adverse Event|5
2123508|NCT00984620|3723541|FG001|Overall Study|Adverse Event|5
2123509|NCT00984620|3723540|FG000|Overall Study|Lost to Follow-up|1
2123510|NCT00984620|3723541|FG001|Overall Study|Lost to Follow-up|1
2123511|NCT00984620|3723540|FG000|Overall Study|Withdrawal by Subject|0
2123512|NCT00984620|3723541|FG001|Overall Study|Withdrawal by Subject|2
2123513|NCT00984620|3723540|FG000|Overall Study|reason other than listed above|0
2123514|NCT00984620|3723541|FG001|Overall Study|reason other than listed above|4
2123515|NCT00984659|3723553|FG000|2-week Run-in Period|Adverse Event|8
2123516|NCT00984659|3723554|FG001|2-week Run-in Period|Adverse Event|0
2123517|NCT00984659|3723555|FG002|2-week Run-in Period|Adverse Event|0
2123518|NCT00984659|3723556|FG003|2-week Run-in Period|Adverse Event|0
2123519|NCT00984659|3723553|FG000|2-week Run-in Period|Protocol Violation|5
2123520|NCT00984659|3723554|FG001|2-week Run-in Period|Protocol Violation|0
2123521|NCT00984659|3723555|FG002|2-week Run-in Period|Protocol Violation|0
2123522|NCT00984659|3723556|FG003|2-week Run-in Period|Protocol Violation|0
2123523|NCT00984659|3723553|FG000|2-week Run-in Period|Study Closed/Terminated|2
2123524|NCT00984659|3723554|FG001|2-week Run-in Period|Study Closed/Terminated|0
2123525|NCT00984659|3723555|FG002|2-week Run-in Period|Study Closed/Terminated|0
2123526|NCT00984659|3723556|FG003|2-week Run-in Period|Study Closed/Terminated|0
2123527|NCT00984659|3723553|FG000|2-week Run-in Period|Lost to Follow-up|3
2123528|NCT00984659|3723554|FG001|2-week Run-in Period|Lost to Follow-up|0
2279572|NCT02346240|3962768|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279573|NCT02346240|3962769|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2279574|NCT02346240|3962746|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279575|NCT02346240|3962747|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279576|NCT02346240|3962748|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279577|NCT02346240|3962749|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279578|NCT02346240|3962750|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279579|NCT02346240|3962751|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279580|NCT02346240|3962752|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279581|NCT02346240|3962753|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279582|NCT02346240|3962754|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279583|NCT02346240|3962755|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279584|NCT02346240|3962756|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279585|NCT02346240|3962757|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2123529|NCT00984659|3723555|FG002|2-week Run-in Period|Lost to Follow-up|0
2123530|NCT00984659|3723556|FG003|2-week Run-in Period|Lost to Follow-up|0
2123531|NCT00984659|3723553|FG000|2-week Run-in Period|Physician Decision|10
2123532|NCT00984659|3723554|FG001|2-week Run-in Period|Physician Decision|0
2123533|NCT00984659|3723555|FG002|2-week Run-in Period|Physician Decision|0
2123534|NCT00984659|3723556|FG003|2-week Run-in Period|Physician Decision|0
2123535|NCT00984659|3723553|FG000|2-week Run-in Period|Withdrawal by Subject|10
2123536|NCT00984659|3723554|FG001|2-week Run-in Period|Withdrawal by Subject|0
2123537|NCT00984659|3723555|FG002|2-week Run-in Period|Withdrawal by Subject|0
2123538|NCT00984659|3723556|FG003|2-week Run-in Period|Withdrawal by Subject|0
2123539|NCT00984659|3723553|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14
2123540|NCT00984659|3723554|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2123541|NCT00984659|3723555|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2123542|NCT00984659|3723556|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2123543|NCT00984659|3723553|FG000|6-week Double-blind Treatment Period|Adverse Event|0
2123544|NCT00984659|3723554|FG001|6-week Double-blind Treatment Period|Adverse Event|3
2123545|NCT00984659|3723555|FG002|6-week Double-blind Treatment Period|Adverse Event|3
2123546|NCT00984659|3723556|FG003|6-week Double-blind Treatment Period|Adverse Event|7
2123547|NCT00984659|3723553|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0
2123548|NCT00984659|3723554|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2
2123549|NCT00984659|3723555|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0
2123550|NCT00984659|3723556|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1
2123551|NCT00984659|3723553|FG000|6-week Double-blind Treatment Period|Protocol Violation|0
2123552|NCT00984659|3723554|FG001|6-week Double-blind Treatment Period|Protocol Violation|0
2123553|NCT00984659|3723555|FG002|6-week Double-blind Treatment Period|Protocol Violation|0
2123554|NCT00984659|3723556|FG003|6-week Double-blind Treatment Period|Protocol Violation|4
2123555|NCT00984659|3723553|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0
2123556|NCT00984659|3723554|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0
2123557|NCT00984659|3723555|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1
2123558|NCT00984659|3723556|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0
2123559|NCT00984659|3723553|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0
2123560|NCT00984659|3723554|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1
2123561|NCT00984659|3723555|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7
2123562|NCT00984659|3723556|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1
2123563|NCT00984867|3723578|FG000|Overall Study|Adverse Event|3
2123564|NCT00984867|3723579|FG001|Overall Study|Adverse Event|7
2123565|NCT00984867|3723578|FG000|Overall Study|Death|1
2123566|NCT00984867|3723579|FG001|Overall Study|Death|0
2123567|NCT00984867|3723578|FG000|Overall Study|Withdrawal by Subject|13
2123568|NCT00984867|3723579|FG001|Overall Study|Withdrawal by Subject|4
2123569|NCT00984867|3723578|FG000|Overall Study|Lost to Follow-up|3
2123570|NCT00984867|3723579|FG001|Overall Study|Lost to Follow-up|4
2123571|NCT00984867|3723578|FG000|Overall Study|Poor/non-compliance|0
2123572|NCT00984867|3723579|FG001|Overall Study|Poor/non-compliance|1
2123573|NCT00984867|3723578|FG000|Overall Study|Subject no longer meets study criteria|1
2123574|NCT00984867|3723579|FG001|Overall Study|Subject no longer meets study criteria|1
2123575|NCT00984867|3723578|FG000|Overall Study|site closing|1
2123576|NCT00984867|3723579|FG001|Overall Study|site closing|0
2123577|NCT00984867|3723578|FG000|Overall Study|lack of efficacy and subject compliance|1
2123578|NCT00984867|3723579|FG001|Overall Study|lack of efficacy and subject compliance|0
2123579|NCT00985088|3723604|FG000|Overall Study|Serious Adverse Event|1
2123580|NCT00985088|3723605|FG001|Overall Study|Serious Adverse Event|1
2123581|NCT00985088|3723606|FG002|Overall Study|Serious Adverse Event|0
2123582|NCT00985088|3723607|FG003|Overall Study|Serious Adverse Event|0
2123583|NCT00985088|3723608|FG004|Overall Study|Serious Adverse Event|0
2123584|NCT00985088|3723609|FG005|Overall Study|Serious Adverse Event|0
2123585|NCT00985088|3723610|FG006|Overall Study|Serious Adverse Event|0
2123586|NCT00985088|3723611|FG007|Overall Study|Serious Adverse Event|1
2123587|NCT00985088|3723604|FG000|Overall Study|Adverse Event|0
2123588|NCT00985088|3723605|FG001|Overall Study|Adverse Event|0
2123589|NCT00985088|3723606|FG002|Overall Study|Adverse Event|1
2123590|NCT00985088|3723607|FG003|Overall Study|Adverse Event|0
2123591|NCT00985088|3723608|FG004|Overall Study|Adverse Event|0
2279586|NCT02346240|3962758|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279587|NCT02346240|3962759|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279588|NCT02346240|3962760|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279589|NCT02346240|3962761|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279590|NCT02346240|3962762|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279591|NCT02346240|3962763|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279592|NCT02346240|3962764|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2123592|NCT00985088|3723609|FG005|Overall Study|Adverse Event|0
2123593|NCT00985088|3723610|FG006|Overall Study|Adverse Event|0
2123594|NCT00985088|3723611|FG007|Overall Study|Adverse Event|0
2123595|NCT00985088|3723604|FG000|Overall Study|Withdrawal by Subject|4
2123596|NCT00985088|3723605|FG001|Overall Study|Withdrawal by Subject|0
2123597|NCT00985088|3723606|FG002|Overall Study|Withdrawal by Subject|0
2123598|NCT00985088|3723607|FG003|Overall Study|Withdrawal by Subject|1
2123599|NCT00985088|3723608|FG004|Overall Study|Withdrawal by Subject|3
2123600|NCT00985088|3723609|FG005|Overall Study|Withdrawal by Subject|2
2123601|NCT00985088|3723610|FG006|Overall Study|Withdrawal by Subject|1
2123602|NCT00985088|3723611|FG007|Overall Study|Withdrawal by Subject|2
2123603|NCT00985088|3723604|FG000|Overall Study|Migrated/moved from study area|0
2123604|NCT00985088|3723605|FG001|Overall Study|Migrated/moved from study area|0
2123605|NCT00985088|3723606|FG002|Overall Study|Migrated/moved from study area|1
2123606|NCT00985088|3723607|FG003|Overall Study|Migrated/moved from study area|0
2123607|NCT00985088|3723608|FG004|Overall Study|Migrated/moved from study area|0
2123608|NCT00985088|3723609|FG005|Overall Study|Migrated/moved from study area|0
2123609|NCT00985088|3723610|FG006|Overall Study|Migrated/moved from study area|0
2123610|NCT00985088|3723611|FG007|Overall Study|Migrated/moved from study area|1
2123611|NCT00985088|3723604|FG000|Overall Study|Lost to Follow-up|6
2123612|NCT00985088|3723605|FG001|Overall Study|Lost to Follow-up|1
2123613|NCT00985088|3723606|FG002|Overall Study|Lost to Follow-up|2
2123614|NCT00985088|3723607|FG003|Overall Study|Lost to Follow-up|6
2123615|NCT00985088|3723608|FG004|Overall Study|Lost to Follow-up|6
2123616|NCT00985088|3723609|FG005|Overall Study|Lost to Follow-up|5
2123617|NCT00985088|3723610|FG006|Overall Study|Lost to Follow-up|3
2123618|NCT00985088|3723611|FG007|Overall Study|Lost to Follow-up|2
2123619|NCT00985114|3723641|FG000|Overall Study|Adverse Event|1
2123620|NCT00985114|3723642|FG001|Overall Study|Adverse Event|0
2123621|NCT00985114|3723641|FG000|Overall Study|Withdrawal by Subject|0
2123622|NCT00985114|3723642|FG001|Overall Study|Withdrawal by Subject|2
2123623|NCT00985153|3723656|FG000|Overall Study|Lost to Follow-up|16
2123624|NCT00985153|3723657|FG001|Overall Study|Lost to Follow-up|19
2123625|NCT00985153|3723658|FG002|Overall Study|Lost to Follow-up|17
2123626|NCT00985153|3723659|FG003|Overall Study|Lost to Follow-up|20
2123627|NCT00985153|3723656|FG000|Overall Study|Protocol Violation|3
2123628|NCT00985153|3723657|FG001|Overall Study|Protocol Violation|2
2123629|NCT00985153|3723658|FG002|Overall Study|Protocol Violation|4
2123630|NCT00985153|3723659|FG003|Overall Study|Protocol Violation|3
2123631|NCT00985153|3723656|FG000|Overall Study|Withdrawal by Subject|6
2123632|NCT00985153|3723657|FG001|Overall Study|Withdrawal by Subject|11
2123633|NCT00985153|3723658|FG002|Overall Study|Withdrawal by Subject|11
2123634|NCT00985153|3723659|FG003|Overall Study|Withdrawal by Subject|10
2123635|NCT00985153|3723656|FG000|Overall Study|Missed One or More Bleeds|7
2123636|NCT00985153|3723657|FG001|Overall Study|Missed One or More Bleeds|7
2123637|NCT00985153|3723658|FG002|Overall Study|Missed One or More Bleeds|8
2123638|NCT00985153|3723659|FG003|Overall Study|Missed One or More Bleeds|10
2123639|NCT00985153|3723656|FG000|Overall Study|Incomplete Safety Follow-up|3
2123640|NCT00985153|3723657|FG001|Overall Study|Incomplete Safety Follow-up|5
2123641|NCT00985153|3723658|FG002|Overall Study|Incomplete Safety Follow-up|4
2123642|NCT00985153|3723659|FG003|Overall Study|Incomplete Safety Follow-up|4
2123643|NCT00985166|3723672|FG000|Overall Study|Lost to Follow-up|3
2123644|NCT00985166|3723673|FG001|Overall Study|Lost to Follow-up|2
2123645|NCT00985166|3723674|FG002|Overall Study|Lost to Follow-up|2
2123646|NCT00985166|3723672|FG000|Overall Study|Withdrawal by Subject|3
2123647|NCT00985166|3723673|FG001|Overall Study|Withdrawal by Subject|2
2123648|NCT00985166|3723674|FG002|Overall Study|Withdrawal by Subject|0
2123649|NCT00985166|3723672|FG000|Overall Study|Test not done|2
2123650|NCT00985166|3723673|FG001|Overall Study|Test not done|0
2123651|NCT00985166|3723674|FG002|Overall Study|Test not done|4
2123652|NCT00985166|3723672|FG000|Overall Study|Other|1
2123653|NCT00985166|3723673|FG001|Overall Study|Other|0
2123654|NCT00985166|3723674|FG002|Overall Study|Other|1
2123655|NCT00985192|3723684|FG000|Overall Study|Withdrawal by Subject|1
2123656|NCT00985192|3723684|FG000|Overall Study|Disease Progression|1
2123657|NCT00985192|3723684|FG000|Overall Study|Determined to be Ineligible During Trial|2
2123658|NCT00985231|3723690|FG000|Overall Study|ineligible|1
2123659|NCT00985231|3723691|FG001|Overall Study|ineligible|0
2123660|NCT00985231|3723690|FG000|Overall Study|Protocol Violation|1
2123661|NCT00985231|3723691|FG001|Overall Study|Protocol Violation|0
2123662|NCT00985231|3723690|FG000|Overall Study|Withdrawal by Subject|1
2123663|NCT00985231|3723691|FG001|Overall Study|Withdrawal by Subject|0
2123664|NCT00985231|3723690|FG000|Overall Study|Lost to Follow-up|0
2123665|NCT00985231|3723691|FG001|Overall Study|Lost to Follow-up|1
2123666|NCT00985231|3723690|FG000|Overall Study|Study related symptoms & complaints|0
2123667|NCT00985231|3723691|FG001|Overall Study|Study related symptoms & complaints|2
2123668|NCT00985426|3723703|FG000|Overall Study|Adverse Event|0
2123669|NCT00985426|3723704|FG001|Overall Study|Adverse Event|1
2123670|NCT00985426|3723703|FG000|Overall Study|Subject Non-Compliance|3
2123671|NCT00985426|3723704|FG001|Overall Study|Subject Non-Compliance|3
2123672|NCT00985426|3723703|FG000|Overall Study|Withdrawal by Subject|12
2123673|NCT00985426|3723704|FG001|Overall Study|Withdrawal by Subject|16
2123674|NCT00985426|3723703|FG000|Overall Study|Lost to Follow-up|8
2123675|NCT00985426|3723704|FG001|Overall Study|Lost to Follow-up|10
2123676|NCT00985426|3723703|FG000|Overall Study|Death|7
2123677|NCT00985426|3723704|FG001|Overall Study|Death|3
2123678|NCT00985426|3723703|FG000|Overall Study|Protocol Violation|2
2123679|NCT00985426|3723704|FG001|Overall Study|Protocol Violation|0
2123680|NCT00985426|3723703|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
2123681|NCT00985426|3723704|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
2123682|NCT00985439|3723714|FG000|Overall Study|Adverse Event|0
2123683|NCT00985439|3723715|FG001|Overall Study|Adverse Event|0
2123684|NCT00985439|3723716|FG002|Overall Study|Adverse Event|1
2123685|NCT00985439|3723717|FG003|Overall Study|Adverse Event|0
2123686|NCT00985465|3723729|FG000|Overall Study|Withdrawal by Subject|1
2279593|NCT02346240|3962765|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279594|NCT02346240|3962766|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279595|NCT02346240|3962767|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
2279596|NCT02346240|3962768|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279597|NCT02346240|3962769|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2279598|NCT02346240|3962746|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279599|NCT02346240|3962747|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279600|NCT02346240|3962748|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279601|NCT02346240|3962749|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279602|NCT02346240|3962750|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279603|NCT02346240|3962751|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279604|NCT02346240|3962752|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279605|NCT02346240|3962753|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279606|NCT02346240|3962754|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279607|NCT02346240|3962755|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279608|NCT02346240|3962756|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279609|NCT02346240|3962757|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279610|NCT02346240|3962758|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279611|NCT02346240|3962759|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279612|NCT02346240|3962760|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279613|NCT02346240|3962761|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279614|NCT02346240|3962762|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279615|NCT02346240|3962763|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
2279616|NCT02346240|3962764|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
2279617|NCT02346240|3962765|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
2279618|NCT02346240|3962766|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2279619|NCT02346240|3962767|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
2279620|NCT02346240|3962768|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
2279621|NCT02346240|3962769|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
2279622|NCT02346240|3962746|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279623|NCT02346240|3962747|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279624|NCT02346240|3962748|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279625|NCT02346240|3962749|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2123687|NCT00985465|3723730|FG001|Overall Study|Withdrawal by Subject|2
2123688|NCT00985465|3723729|FG000|Overall Study|Considered to be part of the other group|0
2123689|NCT00985465|3723730|FG001|Overall Study|Considered to be part of the other group|1
2123690|NCT00985491|3723737|FG000|Overall Study|Adverse Event|8
2123691|NCT00985491|3723737|FG000|Overall Study|device migration|7
2123692|NCT00985491|3723737|FG000|Overall Study|Withdrawal by Subject|1
2123693|NCT00985491|3723737|FG000|Overall Study|implant failure|3
2123694|NCT00985504|3723744|FG000|Acute Treatment Period|Adverse Event|3
2123695|NCT00985504|3723745|FG001|Acute Treatment Period|Adverse Event|4
2123696|NCT00985504|3723744|FG000|Acute Treatment Period|Entry Criteria Not Met|1
2123697|NCT00985504|3723745|FG001|Acute Treatment Period|Entry Criteria Not Met|2
2123698|NCT00985504|3723744|FG000|Acute Treatment Period|Protocol Violation|2
2123699|NCT00985504|3723745|FG001|Acute Treatment Period|Protocol Violation|0
2123700|NCT00985504|3723744|FG000|Acute Treatment Period|Sponsor Decision|0
2123701|NCT00985504|3723745|FG001|Acute Treatment Period|Sponsor Decision|1
2123702|NCT00985504|3723744|FG000|Acute Treatment Period|Withdrawal by Subject|9
2123703|NCT00985504|3723745|FG001|Acute Treatment Period|Withdrawal by Subject|5
2123704|NCT00985504|3723744|FG000|Optimization Period|Adverse Event|7
2123705|NCT00985504|3723745|FG001|Optimization Period|Adverse Event|9
2123706|NCT00985504|3723744|FG000|Optimization Period|Death|0
2123707|NCT00985504|3723745|FG001|Optimization Period|Death|1
2123708|NCT00985504|3723744|FG000|Optimization Period|Lack of Efficacy|5
2123709|NCT00985504|3723745|FG001|Optimization Period|Lack of Efficacy|3
2123710|NCT00985504|3723744|FG000|Optimization Period|Lost to Follow-up|0
2123711|NCT00985504|3723745|FG001|Optimization Period|Lost to Follow-up|1
2123712|NCT00985504|3723744|FG000|Optimization Period|Physician Decision|1
2123713|NCT00985504|3723745|FG001|Optimization Period|Physician Decision|0
2123714|NCT00985504|3723744|FG000|Optimization Period|Protocol Violation|3
2123715|NCT00985504|3723745|FG001|Optimization Period|Protocol Violation|1
2123716|NCT00985504|3723744|FG000|Optimization Period|Withdrawal by Subject|10
2123717|NCT00985504|3723745|FG001|Optimization Period|Withdrawal by Subject|8
2123718|NCT00985621|3723779|FG000|Overall Study|Adverse Event|2
2123719|NCT00985621|3723780|FG001|Overall Study|Adverse Event|3
2123720|NCT00985621|3723781|FG002|Overall Study|Adverse Event|4
2123721|NCT00985621|3723782|FG003|Overall Study|Adverse Event|16
2123722|NCT00985621|3723779|FG000|Overall Study|Lack of Efficacy|10
2123723|NCT00985621|3723780|FG001|Overall Study|Lack of Efficacy|6
2123724|NCT00985621|3723781|FG002|Overall Study|Lack of Efficacy|5
2123725|NCT00985621|3723782|FG003|Overall Study|Lack of Efficacy|12
2123726|NCT00985621|3723779|FG000|Overall Study|Lost to Follow-up|2
2123727|NCT00985621|3723780|FG001|Overall Study|Lost to Follow-up|3
2123728|NCT00985621|3723781|FG002|Overall Study|Lost to Follow-up|4
2123729|NCT00985621|3723782|FG003|Overall Study|Lost to Follow-up|4
2123730|NCT00985621|3723779|FG000|Overall Study|Study Terminated by Sponsor|89
2123731|NCT00985621|3723780|FG001|Overall Study|Study Terminated by Sponsor|108
2123732|NCT00985621|3723781|FG002|Overall Study|Study Terminated by Sponsor|99
2123733|NCT00985621|3723782|FG003|Overall Study|Study Terminated by Sponsor|92
2123734|NCT00985621|3723779|FG000|Overall Study|Protocol Violation|1
2123735|NCT00985621|3723780|FG001|Overall Study|Protocol Violation|1
2123736|NCT00985621|3723781|FG002|Overall Study|Protocol Violation|1
2123737|NCT00985621|3723782|FG003|Overall Study|Protocol Violation|0
2123738|NCT00985621|3723779|FG000|Overall Study|Withdrawal by Subject|8
2123739|NCT00985621|3723780|FG001|Overall Study|Withdrawal by Subject|10
2123740|NCT00985621|3723781|FG002|Overall Study|Withdrawal by Subject|8
2123741|NCT00985621|3723782|FG003|Overall Study|Withdrawal by Subject|12
2123742|NCT00985621|3723779|FG000|Overall Study|Other|1
2123743|NCT00985621|3723780|FG001|Overall Study|Other|0
2123744|NCT00985621|3723781|FG002|Overall Study|Other|0
2123745|NCT00985621|3723782|FG003|Overall Study|Other|0
2123746|NCT00985621|3723779|FG000|Overall Study|Randomized but not Treated|1
2123747|NCT00985621|3723780|FG001|Overall Study|Randomized but not Treated|0
2123748|NCT00985621|3723781|FG002|Overall Study|Randomized but not Treated|2
2123749|NCT00985621|3723782|FG003|Overall Study|Randomized but not Treated|1
2123750|NCT00985673|3723800|FG000|Overall Study|Lost to Follow-up|6
2123751|NCT00985673|3723801|FG001|Overall Study|Lost to Follow-up|7
2123752|NCT00985673|3723802|FG002|Overall Study|Lost to Follow-up|6
2123753|NCT00985673|3723803|FG003|Overall Study|Lost to Follow-up|10
2205255|NCT01609556|3843229|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
2205256|NCT01609556|3843230|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
2123754|NCT00985673|3723804|FG004|Overall Study|Lost to Follow-up|5
2123755|NCT00985673|3723805|FG005|Overall Study|Lost to Follow-up|3
2123756|NCT00985673|3723800|FG000|Overall Study|Withdrawal by Subject|0
2279626|NCT02346240|3962750|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279627|NCT02346240|3962751|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279628|NCT02346240|3962752|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279629|NCT02346240|3962753|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279630|NCT02346240|3962754|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279631|NCT02346240|3962755|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279632|NCT02346240|3962756|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279633|NCT02346240|3962757|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279634|NCT02346240|3962758|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279635|NCT02346240|3962759|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279636|NCT02346240|3962760|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279637|NCT02346240|3962761|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279638|NCT02346240|3962762|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279639|NCT02346240|3962763|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2123757|NCT00985673|3723801|FG001|Overall Study|Withdrawal by Subject|4
2123758|NCT00985673|3723802|FG002|Overall Study|Withdrawal by Subject|5
2205257|NCT01609556|3843231|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
2205258|NCT01609556|3843216|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205259|NCT01609556|3843217|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205260|NCT01609556|3843218|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205261|NCT01609556|3843219|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205262|NCT01609556|3843220|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205263|NCT01609556|3843221|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205264|NCT01609556|3843222|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205265|NCT01609556|3843223|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205266|NCT01609556|3843224|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205267|NCT01609556|3843225|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205268|NCT01609556|3843226|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205269|NCT01609556|3843227|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
2205270|NCT01609556|3843228|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32
2205271|NCT01609556|3843229|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13
2205272|NCT01609556|3843230|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20
2205273|NCT01609556|3843231|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27
2205274|NCT01609556|3843216|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2205275|NCT01609556|3843217|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2205276|NCT01609556|3843218|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2205277|NCT01609556|3843219|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2205278|NCT01609556|3843220|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2205279|NCT01609556|3843221|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2205280|NCT01609556|3843222|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2205281|NCT01609556|3843223|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2205282|NCT01609556|3843224|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2123759|NCT00985673|3723803|FG003|Overall Study|Withdrawal by Subject|2
2123760|NCT00985673|3723804|FG004|Overall Study|Withdrawal by Subject|2
2123761|NCT00985673|3723805|FG005|Overall Study|Withdrawal by Subject|3
2123762|NCT00985673|3723800|FG000|Overall Study|Other|1
2123763|NCT00985673|3723801|FG001|Overall Study|Other|0
2205283|NCT01609556|3843225|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2123764|NCT00985673|3723802|FG002|Overall Study|Other|1
2123765|NCT00985673|3723803|FG003|Overall Study|Other|0
2123766|NCT00985673|3723804|FG004|Overall Study|Other|1
2123767|NCT00985673|3723805|FG005|Overall Study|Other|0
2123768|NCT00985686|3723824|FG000|Overall Study|Lost to Follow-up|1
2123769|NCT00985686|3723825|FG001|Overall Study|Lost to Follow-up|1
2123770|NCT00985686|3723826|FG002|Overall Study|Lost to Follow-up|0
2123771|NCT00985686|3723827|FG003|Overall Study|Lost to Follow-up|2
2123772|NCT00985712|3723837|FG000|Overall Study|Adverse Event|0
2123773|NCT00985712|3723838|FG001|Overall Study|Adverse Event|1
2123774|NCT00985712|3723837|FG000|Overall Study|Lost to Follow-up|2
2123775|NCT00985712|3723838|FG001|Overall Study|Lost to Follow-up|2
2123776|NCT00985712|3723837|FG000|Overall Study|Protocol Violation|0
2123777|NCT00985712|3723838|FG001|Overall Study|Protocol Violation|1
2123778|NCT00985712|3723837|FG000|Overall Study|Withdrawal by Subject|4
2123779|NCT00985712|3723838|FG001|Overall Study|Withdrawal by Subject|1
2123780|NCT00985712|3723837|FG000|Overall Study|Sponsor decision|0
2123781|NCT00985712|3723838|FG001|Overall Study|Sponsor decision|2
2123782|NCT00985725|3723846|FG000|Overall Study|Adverse Event|4
2123783|NCT00985725|3723847|FG001|Overall Study|Adverse Event|1
2123784|NCT00985725|3723846|FG000|Overall Study|Protocol Violation|1
2123785|NCT00985725|3723847|FG001|Overall Study|Protocol Violation|3
2123786|NCT00985725|3723846|FG000|Overall Study|Withdrawal by Subject|4
2123787|NCT00985725|3723847|FG001|Overall Study|Withdrawal by Subject|4
2123788|NCT00985725|3723846|FG000|Overall Study|Lost to Follow-up|1
2123789|NCT00985725|3723847|FG001|Overall Study|Lost to Follow-up|1
2123790|NCT00985725|3723846|FG000|Overall Study|Lack of Efficacy|0
2123791|NCT00985725|3723847|FG001|Overall Study|Lack of Efficacy|1
2123792|NCT00985725|3723846|FG000|Overall Study|Non-compliance|1
2123793|NCT00985725|3723847|FG001|Overall Study|Non-compliance|2
2123794|NCT00985725|3723846|FG000|Overall Study|Out-of-window visits|0
2123795|NCT00985725|3723847|FG001|Overall Study|Out-of-window visits|1
2123796|NCT00985751|3723858|FG000|Overall Study|Adverse Event|0
2123797|NCT00985751|3723859|FG001|Overall Study|Adverse Event|0
2123798|NCT00985751|3723860|FG002|Overall Study|Adverse Event|0
2123799|NCT00985751|3723861|FG003|Overall Study|Adverse Event|0
2123800|NCT00985751|3723862|FG004|Overall Study|Adverse Event|1
2123801|NCT00985790|3723879|FG000|Overall Study|Withdrawal by Subject|1
2123802|NCT00985790|3723880|FG001|Overall Study|Withdrawal by Subject|1
2123803|NCT00985790|3723879|FG000|Overall Study|Lost to Follow-up|6
2123804|NCT00985790|3723880|FG001|Overall Study|Lost to Follow-up|7
2123805|NCT00985946|3723900|FG000|Overall Study|Lost to Follow-up|6
2123806|NCT00985946|3723900|FG000|Overall Study|Withdrawal by Subject|1
2123807|NCT00985959|3723907|FG000|Overall Study|Adverse Event|0
2123808|NCT00985959|3723908|FG001|Overall Study|Adverse Event|0
2123809|NCT00985959|3723909|FG002|Overall Study|Adverse Event|19
2123810|NCT00985959|3723907|FG000|Overall Study|Withdrawal by Subject|0
2123811|NCT00985959|3723908|FG001|Overall Study|Withdrawal by Subject|0
2123812|NCT00985959|3723909|FG002|Overall Study|Withdrawal by Subject|8
2123813|NCT00985959|3723907|FG000|Overall Study|Progressive disease|1
2123814|NCT00985959|3723908|FG001|Overall Study|Progressive disease|2
2123815|NCT00985959|3723909|FG002|Overall Study|Progressive disease|8
2123816|NCT00985959|3723907|FG000|Overall Study|Unrecovered toxicity|0
2123817|NCT00985959|3723908|FG001|Overall Study|Unrecovered toxicity|0
2123818|NCT00985959|3723909|FG002|Overall Study|Unrecovered toxicity|7
2123819|NCT00985959|3723907|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2
2123820|NCT00985959|3723908|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0
2123821|NCT00985959|3723909|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2
2123822|NCT00985959|3723907|FG000|Overall Study|Complete response observed over 2 cycles|0
2123823|NCT00985959|3723908|FG001|Overall Study|Complete response observed over 2 cycles|1
2123824|NCT00985959|3723909|FG002|Overall Study|Complete response observed over 2 cycles|4
2123825|NCT00985959|3723907|FG000|Overall Study|Other|0
2123826|NCT00985959|3723908|FG001|Overall Study|Other|0
2123827|NCT00985959|3723909|FG002|Overall Study|Other|11
2123828|NCT00985985|3723927|FG000|Overall Study|Adverse Event|4
2123829|NCT00985985|3723928|FG001|Overall Study|Adverse Event|2
2123830|NCT00985985|3723929|FG002|Overall Study|Adverse Event|2
2123831|NCT00985985|3723930|FG003|Overall Study|Adverse Event|2
2123832|NCT00985985|3723927|FG000|Overall Study|Lost to Follow-up|4
2123833|NCT00985985|3723928|FG001|Overall Study|Lost to Follow-up|11
2123834|NCT00985985|3723929|FG002|Overall Study|Lost to Follow-up|2
2123835|NCT00985985|3723930|FG003|Overall Study|Lost to Follow-up|3
2123836|NCT00985985|3723927|FG000|Overall Study|Protocol Violation|1
2123837|NCT00985985|3723928|FG001|Overall Study|Protocol Violation|2
2123838|NCT00985985|3723929|FG002|Overall Study|Protocol Violation|0
2123839|NCT00985985|3723930|FG003|Overall Study|Protocol Violation|1
2123840|NCT00985985|3723927|FG000|Overall Study|Lack of Efficacy|5
2123841|NCT00985985|3723928|FG001|Overall Study|Lack of Efficacy|6
2123842|NCT00985985|3723929|FG002|Overall Study|Lack of Efficacy|1
2217424|NCT01708174|3860656|FG002|Treatment Period|Adverse Event|0
2123843|NCT00985985|3723930|FG003|Overall Study|Lack of Efficacy|3
2123844|NCT00985985|3723927|FG000|Overall Study|Withdrawal by Subject|4
2123845|NCT00985985|3723928|FG001|Overall Study|Withdrawal by Subject|2
2123846|NCT00985985|3723929|FG002|Overall Study|Withdrawal by Subject|2
2123847|NCT00985985|3723930|FG003|Overall Study|Withdrawal by Subject|2
2123848|NCT00985985|3723927|FG000|Overall Study|Other Reason|6
2123849|NCT00985985|3723928|FG001|Overall Study|Other Reason|1
2123850|NCT00985985|3723929|FG002|Overall Study|Other Reason|4
2123851|NCT00985985|3723930|FG003|Overall Study|Other Reason|2
2123852|NCT00986102|3723949|FG000|Overall Study|Lost to Follow-up|0
2123853|NCT00986102|3723950|FG001|Overall Study|Lost to Follow-up|1
2123854|NCT00986102|3723951|FG002|Overall Study|Lost to Follow-up|0
2123855|NCT00986102|3723952|FG003|Overall Study|Lost to Follow-up|1
2123856|NCT00986102|3723949|FG000|Overall Study|Withdrawal by Subject|1
2123857|NCT00986102|3723950|FG001|Overall Study|Withdrawal by Subject|1
2123858|NCT00986102|3723951|FG002|Overall Study|Withdrawal by Subject|0
2123859|NCT00986102|3723952|FG003|Overall Study|Withdrawal by Subject|0
2123860|NCT00986154|3723964|FG000|Overall Study|Death|136
2123861|NCT00986154|3723965|FG001|Overall Study|Death|127
2123862|NCT00986154|3723964|FG000|Overall Study|Lost to Follow-up|7
2123863|NCT00986154|3723965|FG001|Overall Study|Lost to Follow-up|4
2123864|NCT00986154|3723964|FG000|Overall Study|Withdrawal by Subject|32
2123865|NCT00986154|3723965|FG001|Overall Study|Withdrawal by Subject|33
2123866|NCT00986154|3723964|FG000|Overall Study|investigator/subject decide not continue|6
2205284|NCT01609556|3843226|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2205285|NCT01609556|3843227|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
2123867|NCT00986154|3723965|FG001|Overall Study|investigator/subject decide not continue|3
2123868|NCT00986154|3723964|FG000|Overall Study|never received study drug|25
2123869|NCT00986154|3723965|FG001|Overall Study|never received study drug|27
2123870|NCT00986180|3723973|FG000|Overall Study|Adverse Event|21
2123871|NCT00986180|3723974|FG001|Overall Study|Adverse Event|23
2123872|NCT00986180|3723973|FG000|Overall Study|Lack of Efficacy|4
2123873|NCT00986180|3723974|FG001|Overall Study|Lack of Efficacy|3
2123874|NCT00986180|3723973|FG000|Overall Study|Lost to Follow-up|5
2123875|NCT00986180|3723974|FG001|Overall Study|Lost to Follow-up|7
2123876|NCT00986180|3723973|FG000|Overall Study|Physician Decision|1
2123877|NCT00986180|3723974|FG001|Overall Study|Physician Decision|3
2123878|NCT00986180|3723973|FG000|Overall Study|Protocol Violation|2
2123879|NCT00986180|3723974|FG001|Overall Study|Protocol Violation|0
2123880|NCT00986180|3723973|FG000|Overall Study|Withdrawal by Subject|1
2123881|NCT00986180|3723974|FG001|Overall Study|Withdrawal by Subject|9
2123882|NCT00986180|3723973|FG000|Overall Study|Miscellanies|10
2123883|NCT00986180|3723974|FG001|Overall Study|Miscellanies|11
2123884|NCT00986232|3723984|FG000|Overall Study|Adverse Event|1
2123885|NCT00986232|3723985|FG001|Overall Study|Adverse Event|2
2123886|NCT00986232|3723986|FG002|Overall Study|Adverse Event|3
2123887|NCT00986232|3723987|FG003|Overall Study|Adverse Event|0
2123888|NCT00986232|3723984|FG000|Overall Study|Lost to Follow-up|19
2123889|NCT00986232|3723985|FG001|Overall Study|Lost to Follow-up|12
2123890|NCT00986232|3723986|FG002|Overall Study|Lost to Follow-up|12
2123891|NCT00986232|3723987|FG003|Overall Study|Lost to Follow-up|7
2123892|NCT00986232|3723984|FG000|Overall Study|Protocol Violation|2
2123893|NCT00986232|3723985|FG001|Overall Study|Protocol Violation|3
2123894|NCT00986232|3723986|FG002|Overall Study|Protocol Violation|0
2123895|NCT00986232|3723987|FG003|Overall Study|Protocol Violation|1
2123896|NCT00986232|3723984|FG000|Overall Study|Withdrawal by Subject|13
2123897|NCT00986232|3723985|FG001|Overall Study|Withdrawal by Subject|16
2123898|NCT00986232|3723986|FG002|Overall Study|Withdrawal by Subject|12
2123899|NCT00986232|3723987|FG003|Overall Study|Withdrawal by Subject|3
2123900|NCT00986232|3723984|FG000|Overall Study|Missed one or more bleeds|13
2123901|NCT00986232|3723985|FG001|Overall Study|Missed one or more bleeds|10
2123902|NCT00986232|3723986|FG002|Overall Study|Missed one or more bleeds|6
2123903|NCT00986232|3723987|FG003|Overall Study|Missed one or more bleeds|7
2279640|NCT02346240|3962764|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
2279641|NCT02346240|3962765|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2279642|NCT02346240|3962766|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2279643|NCT02346240|3962767|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
2279644|NCT02346240|3962768|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2279645|NCT02346240|3962769|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2279646|NCT02346240|3962746|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279647|NCT02346240|3962747|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279648|NCT02346240|3962748|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279649|NCT02346240|3962749|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2123904|NCT00986232|3723984|FG000|Overall Study|Incomplete safety follow-up|3
2123905|NCT00986232|3723985|FG001|Overall Study|Incomplete safety follow-up|7
2205286|NCT01609556|3843228|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
2205287|NCT01609556|3843229|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
2205288|NCT01609556|3843230|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
2205289|NCT01609556|3843231|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2
2205290|NCT01609556|3843216|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2123906|NCT00986232|3723986|FG002|Overall Study|Incomplete safety follow-up|2
2123907|NCT00986232|3723987|FG003|Overall Study|Incomplete safety follow-up|2
2123908|NCT00986245|3724003|FG000|First Intervention|Poor compliance|8
2123909|NCT00986245|3724004|FG001|First Intervention|Poor compliance|4
2123910|NCT00986245|3724003|FG000|First Intervention|Lack of Efficacy|1
2123911|NCT00986245|3724004|FG001|First Intervention|Lack of Efficacy|2
2123912|NCT00986245|3724003|FG000|First Intervention|Withdrawal by Subject|0
2123913|NCT00986245|3724004|FG001|First Intervention|Withdrawal by Subject|1
2123914|NCT00986245|3724003|FG000|First Intervention|Protocol Violation|0
2123915|NCT00986245|3724004|FG001|First Intervention|Protocol Violation|1
2123916|NCT00986245|3724003|FG000|First Intervention|Out of indication|1
2279650|NCT02346240|3962750|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279651|NCT02346240|3962751|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279652|NCT02346240|3962752|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279653|NCT02346240|3962753|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279654|NCT02346240|3962754|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279655|NCT02346240|3962755|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279656|NCT02346240|3962756|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279657|NCT02346240|3962757|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279658|NCT02346240|3962758|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279659|NCT02346240|3962759|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279660|NCT02346240|3962760|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279661|NCT02346240|3962761|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279662|NCT02346240|3962762|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279663|NCT02346240|3962763|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2123917|NCT00986245|3724004|FG001|First Intervention|Out of indication|0
2123918|NCT00986245|3724003|FG000|Second Intervention|Poor compliance|1
2123919|NCT00986245|3724004|FG001|Second Intervention|Poor compliance|0
2123920|NCT00986245|3724003|FG000|Second Intervention|Lost to Follow-up|1
2123921|NCT00986245|3724004|FG001|Second Intervention|Lost to Follow-up|0
2123922|NCT00986245|3724003|FG000|Second Intervention|Protocol Violation|0
2123923|NCT00986245|3724004|FG001|Second Intervention|Protocol Violation|1
2123924|NCT00986258|3724015|FG000|Observation Period|Not eligible to be dosed|11
2123925|NCT00986258|3724015|FG000|Titration and Optimal Dose Period|Adverse Event|15
2123926|NCT00986258|3724015|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3
2123927|NCT00986258|3724015|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3
2123928|NCT00986258|3724015|FG000|Titration and Optimal Dose Period|Non-Compliance|1
2123929|NCT00986258|3724015|FG000|Titration and Optimal Dose Period|Other|1
2123930|NCT00986258|3724015|FG000|Maintenance Period|Adverse Event|5
2123931|NCT00986258|3724015|FG000|Maintenance Period|Lack of Efficacy|2
2123932|NCT00986258|3724015|FG000|Maintenance Period|Withdrawal by Subject|2
2123933|NCT00986349|3724029|FG000|Overall Study|Unsuccessful implant procedure|3
2123934|NCT00986349|3724029|FG000|Overall Study|Adverse Event|2
2123935|NCT00986349|3724029|FG000|Overall Study|Physician Decision|1
2279664|NCT02346240|3962764|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
2279665|NCT02346240|3962765|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279666|NCT02346240|3962766|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2279667|NCT02346240|3962767|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
2279668|NCT02346240|3962768|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
2279669|NCT02346240|3962769|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
2279670|NCT02346240|3962746|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279671|NCT02346240|3962747|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279672|NCT02346240|3962748|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279673|NCT02346240|3962749|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279674|NCT02346240|3962750|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279675|NCT02346240|3962751|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279676|NCT02346240|3962752|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279677|NCT02346240|3962753|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279678|NCT02346240|3962754|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279679|NCT02346240|3962755|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279680|NCT02346240|3962756|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279681|NCT02346240|3962757|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279682|NCT02346240|3962758|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279683|NCT02346240|3962759|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279684|NCT02346240|3962760|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279685|NCT02346240|3962761|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279686|NCT02346240|3962762|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279687|NCT02346240|3962763|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2123936|NCT00986349|3724029|FG000|Overall Study|device migration|1
2123937|NCT00986362|3724044|FG000|Overall Study|Death|2
2123938|NCT00986362|3724045|FG001|Overall Study|Death|0
2123939|NCT00986362|3724044|FG000|Overall Study|Lost to Follow-up|0
2123940|NCT00986362|3724045|FG001|Overall Study|Lost to Follow-up|1
2123941|NCT00986427|3724065|FG000|Overall Study|Lost to Follow-up|2
2123942|NCT00986427|3724066|FG001|Overall Study|Lost to Follow-up|0
2123943|NCT00986427|3724065|FG000|Overall Study|Lack of Efficacy|1
2123944|NCT00986427|3724066|FG001|Overall Study|Lack of Efficacy|0
2123945|NCT00986427|3724065|FG000|Overall Study|Withdrawal by Subject|1
2123946|NCT00986427|3724066|FG001|Overall Study|Withdrawal by Subject|0
2123947|NCT00986440|3724078|FG000|Overall Study|Progressive disease|27
2123948|NCT00986440|3724079|FG001|Overall Study|Progressive disease|37
2123949|NCT00986440|3724078|FG000|Overall Study|Serious adverse event or adverse event|9
2123950|NCT00986440|3724079|FG001|Overall Study|Serious adverse event or adverse event|2
2123951|NCT00986440|3724078|FG000|Overall Study|Withdrawal by Subject|1
2123952|NCT00986440|3724079|FG001|Overall Study|Withdrawal by Subject|2
2123953|NCT00986440|3724078|FG000|Overall Study|Screen failure (not dosed)|4
2123954|NCT00986440|3724079|FG001|Overall Study|Screen failure (not dosed)|2
2123955|NCT00986479|3724093|FG000|Period 1|Improved mood|1
2279688|NCT02346240|3962764|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
2279689|NCT02346240|3962765|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279690|NCT02346240|3962766|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279691|NCT02346240|3962767|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279692|NCT02346240|3962768|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279693|NCT02346240|3962769|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2279694|NCT02346370|3962794|FG000|Overall Study|Not treated|1
2279695|NCT02346370|3962795|FG001|Overall Study|Not treated|0
2279696|NCT02346370|3962796|FG002|Overall Study|Not treated|0
2279697|NCT02346370|3962794|FG000|Overall Study|Withdrawal of consent|1
2279698|NCT02346370|3962795|FG001|Overall Study|Withdrawal of consent|0
2279699|NCT02346370|3962796|FG002|Overall Study|Withdrawal of consent|0
2279700|NCT02346370|3962794|FG000|Overall Study|Death|1
2279701|NCT02346370|3962795|FG001|Overall Study|Death|3
2279702|NCT02346370|3962796|FG002|Overall Study|Death|1
2279703|NCT02346370|3962794|FG000|Overall Study|Sponsor discontinued study|5
2279704|NCT02346370|3962795|FG001|Overall Study|Sponsor discontinued study|0
2279705|NCT02346370|3962796|FG002|Overall Study|Sponsor discontinued study|2
2279706|NCT02346370|3962794|FG000|Overall Study|Radiologic progression|0
2279707|NCT02346370|3962795|FG001|Overall Study|Radiologic progression|0
2279708|NCT02346370|3962796|FG002|Overall Study|Radiologic progression|1
2279709|NCT02346370|3962794|FG000|Overall Study|Physician Decision|0
2279710|NCT02346370|3962795|FG001|Overall Study|Physician Decision|1
2279711|NCT02346370|3962796|FG002|Overall Study|Physician Decision|0
2279712|NCT02346708|3962830|FG000|Overall Study|Adverse Event|2
2279713|NCT02346708|3962831|FG001|Overall Study|Adverse Event|0
2279714|NCT02346708|3962830|FG000|Overall Study|Protocol Violation|0
2279715|NCT02346708|3962831|FG001|Overall Study|Protocol Violation|1
2279716|NCT02346721|3962838|FG000|Overall Study|Withdrew Consent|3
2279717|NCT02346721|3962838|FG000|Overall Study|Lack of Efficacy|1
2279718|NCT02347072|3962852|FG000|Overall Study|Adverse Event|2
2279719|NCT02347072|3962852|FG000|Overall Study|Withdrawal by Subject|6
2279720|NCT02347072|3962852|FG000|Overall Study|Physician Decision|1
2279721|NCT02347072|3962852|FG000|Overall Study|Lost to Follow-up|2
2279722|NCT02347072|3962852|FG000|Overall Study|Protocol Violation|1
2279723|NCT02347072|3962852|FG000|Overall Study|Disc due to Protocol-specified Criteria|6
2279724|NCT02347085|3962860|FG000|Overall Study|Adverse Event|2
2279725|NCT02347085|3962860|FG000|Overall Study|Lack of Efficacy|1
2279726|NCT02347085|3962860|FG000|Overall Study|Withdrawal by Subject|4
2279727|NCT02347085|3962860|FG000|Overall Study|Lost to Follow-up|1
2279728|NCT02347085|3962860|FG000|Overall Study|Protocol Criteria|2
2279729|NCT02347098|3962868|FG000|Overall Study|Death|1
2279730|NCT02347098|3962869|FG001|Overall Study|Death|0
2279731|NCT02347098|3962868|FG000|Overall Study|Withdrawal by Subject|1
2279732|NCT02347098|3962869|FG001|Overall Study|Withdrawal by Subject|0
2279733|NCT02347098|3962868|FG000|Overall Study|Lost to Follow-up|2
2279734|NCT02347098|3962869|FG001|Overall Study|Lost to Follow-up|2
2279735|NCT02347098|3962868|FG000|Overall Study|Refuse Follow-up Visit|1
2279736|NCT02347098|3962869|FG001|Overall Study|Refuse Follow-up Visit|5
2279737|NCT02347098|3962868|FG000|Overall Study|no visit due to illness|2
2279738|NCT02347098|3962869|FG001|Overall Study|no visit due to illness|1
2279739|NCT02347176|3962888|FG000|Overall Study|Lost to Follow-up|2
2279740|NCT02347176|3962889|FG001|Overall Study|Lost to Follow-up|3
2279741|NCT02347176|3962890|FG002|Overall Study|Lost to Follow-up|1
2279742|NCT02347176|3962891|FG003|Overall Study|Lost to Follow-up|1
2279743|NCT02347176|3962888|FG000|Overall Study|Withdrawal by Subject|9
2279744|NCT02347176|3962889|FG001|Overall Study|Withdrawal by Subject|5
2279745|NCT02347176|3962890|FG002|Overall Study|Withdrawal by Subject|5
2279746|NCT02347176|3962891|FG003|Overall Study|Withdrawal by Subject|3
2279747|NCT02347176|3962888|FG000|Overall Study|Other|1
2279748|NCT02347176|3962889|FG001|Overall Study|Other|2
2279749|NCT02347176|3962890|FG002|Overall Study|Other|2
2123956|NCT00986479|3724094|FG001|Period 1|Improved mood|0
2123957|NCT00986479|3724093|FG000|Period 1|Administrative reasons|1
2123958|NCT00986479|3724094|FG001|Period 1|Administrative reasons|0
2279750|NCT02347176|3962891|FG003|Overall Study|Other|0
2279751|NCT02347189|3962901|FG000|Overall Study|No implant attempted of study device|9
2279752|NCT02347189|3962901|FG000|Overall Study|No primary outcome data available|2
2123959|NCT00986570|3724110|FG000|Overall Study|Lost to Follow-up|6
2123960|NCT00986570|3724110|FG000|Overall Study|Potential bias for objective assessment|1
2123961|NCT00986674|3724127|FG000|Overall Study|Lack of Efficacy|28
2123962|NCT00986674|3724128|FG001|Overall Study|Lack of Efficacy|25
2123963|NCT00986674|3724129|FG002|Overall Study|Lack of Efficacy|23
2123964|NCT00986674|3724127|FG000|Overall Study|Adverse Event|4
2123965|NCT00986674|3724128|FG001|Overall Study|Adverse Event|8
2123966|NCT00986674|3724129|FG002|Overall Study|Adverse Event|9
2279753|NCT02347332|3962918|FG000|Overall Study|Not treated|5
2279754|NCT02347332|3962919|FG001|Overall Study|Not treated|2
2279755|NCT02347332|3962918|FG000|Overall Study|Progressive disease|141
2279756|NCT02347332|3962919|FG001|Overall Study|Progressive disease|159
2279757|NCT02347332|3962918|FG000|Overall Study|Adverse Event|50
2279758|NCT02347332|3962919|FG001|Overall Study|Adverse Event|41
2279759|NCT02347332|3962918|FG000|Overall Study|Death (Unknown, Various reasons)|6
2279760|NCT02347332|3962919|FG001|Overall Study|Death (Unknown, Various reasons)|6
2279761|NCT02347332|3962918|FG000|Overall Study|Protocol Violation|1
2279762|NCT02347332|3962919|FG001|Overall Study|Protocol Violation|1
2279763|NCT02347332|3962918|FG000|Overall Study|Lost to Follow-up|2
2279764|NCT02347332|3962919|FG001|Overall Study|Lost to Follow-up|1
2279765|NCT02347332|3962918|FG000|Overall Study|Physician Decision|4
2279766|NCT02347332|3962919|FG001|Overall Study|Physician Decision|3
2279767|NCT02347332|3962918|FG000|Overall Study|Withdrawal by Subject|20
2279768|NCT02347332|3962919|FG001|Overall Study|Withdrawal by Subject|14
2279769|NCT02347332|3962918|FG000|Overall Study|Protocol requirement|1
2279770|NCT02347332|3962919|FG001|Overall Study|Protocol requirement|1
2279771|NCT02347332|3962918|FG000|Overall Study|Switch Post-Trial program|0
2279772|NCT02347332|3962919|FG001|Overall Study|Switch Post-Trial program|1
2279773|NCT02347631|3962978|FG000|First Intervention (2 Months)|Adverse Event|1
2279774|NCT02347631|3962979|FG001|First Intervention (2 Months)|Adverse Event|1
2279775|NCT02347631|3962978|FG000|First Intervention (2 Months)|Pregnancy|1
2279776|NCT02347631|3962979|FG001|First Intervention (2 Months)|Pregnancy|0
2279777|NCT02347631|3962978|FG000|First Intervention (2 Months)|Moved out of area|0
2279778|NCT02347631|3962979|FG001|First Intervention (2 Months)|Moved out of area|2
2279779|NCT02347631|3962978|FG000|First Intervention (2 Months)|Lost to Follow-up|5
2279780|NCT02347631|3962979|FG001|First Intervention (2 Months)|Lost to Follow-up|3
2279781|NCT02347631|3962978|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2
2279782|NCT02347631|3962979|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2
2279783|NCT02347631|3962978|FG000|Washout 2 (1 Month)|Lost to Follow-up|0
2279784|NCT02347631|3962979|FG001|Washout 2 (1 Month)|Lost to Follow-up|1
2279785|NCT02347631|3962978|FG000|Second Intervention (2 Months)|Lost to Follow-up|7
2279786|NCT02347631|3962979|FG001|Second Intervention (2 Months)|Lost to Follow-up|4
2279787|NCT02347631|3962978|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6
2279788|NCT02347631|3962979|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0
2279789|NCT02347657|3962989|FG000|Overall Study|Physician Decision|0
2279790|NCT02347657|3962990|FG001|Overall Study|Physician Decision|1
2279791|NCT02347657|3962989|FG000|Overall Study|Adverse Event|8
2279792|NCT02347657|3962990|FG001|Overall Study|Adverse Event|4
2279793|NCT02347657|3962989|FG000|Overall Study|Withdrawal by Subject|6
2279794|NCT02347657|3962990|FG001|Overall Study|Withdrawal by Subject|7
2279795|NCT02347657|3962989|FG000|Overall Study|Randomized but not treated|1
2279796|NCT02347657|3962990|FG001|Overall Study|Randomized but not treated|0
2279797|NCT02347657|3962989|FG000|Overall Study|Other|3
2279798|NCT02347657|3962990|FG001|Overall Study|Other|3
2279799|NCT02347761|3963000|FG000|All Collected|Death|1
2279800|NCT02347761|3963001|FG001|All Collected|Death|0
2279801|NCT02347761|3963002|FG002|All Collected|Death|0
2279802|NCT02347761|3963000|FG000|All Collected|Lost to Follow-up|3
2279803|NCT02347761|3963001|FG001|All Collected|Lost to Follow-up|2
2279804|NCT02347761|3963002|FG002|All Collected|Lost to Follow-up|3
2279805|NCT02347761|3963000|FG000|All Collected|Withdrawal by Subject|11
2279806|NCT02347761|3963001|FG001|All Collected|Withdrawal by Subject|11
2279807|NCT02347761|3963002|FG002|All Collected|Withdrawal by Subject|22
2279808|NCT02347761|3963000|FG000|All Collected|invetigator disretion|2
2279809|NCT02347761|3963001|FG001|All Collected|invetigator disretion|0
2279810|NCT02347761|3963002|FG002|All Collected|invetigator disretion|0
2279811|NCT02347761|3963000|FG000|All Collected|instillation site pain|0
2279812|NCT02347761|3963001|FG001|All Collected|instillation site pain|0
2279813|NCT02347761|3963002|FG002|All Collected|instillation site pain|1
2279814|NCT02347761|3963000|FG000|All Collected|exacerbation of COPD|0
2279815|NCT02347761|3963001|FG001|All Collected|exacerbation of COPD|0
2279816|NCT02347761|3963002|FG002|All Collected|exacerbation of COPD|1
2279817|NCT02347761|3963000|FG000|All Collected|moved/travel|0
2279818|NCT02347761|3963001|FG001|All Collected|moved/travel|1
2279819|NCT02347761|3963002|FG002|All Collected|moved/travel|0
2279820|NCT02347761|3963000|FG000|On Study Treatment|Lack of Efficacy|2
2279821|NCT02347761|3963001|FG001|On Study Treatment|Lack of Efficacy|3
2279822|NCT02347761|3963002|FG002|On Study Treatment|Lack of Efficacy|4
2279823|NCT02347761|3963000|FG000|On Study Treatment|non-compliance with study medication|0
2279824|NCT02347761|3963001|FG001|On Study Treatment|non-compliance with study medication|0
2123967|NCT00986674|3724127|FG000|Overall Study|Death|5
2123968|NCT00986674|3724128|FG001|Overall Study|Death|0
2123969|NCT00986674|3724129|FG002|Overall Study|Death|4
2123970|NCT00986674|3724127|FG000|Overall Study|Withdrawal by Subject|6
2123971|NCT00986674|3724128|FG001|Overall Study|Withdrawal by Subject|2
2123972|NCT00986674|3724129|FG002|Overall Study|Withdrawal by Subject|1
2123973|NCT00986674|3724127|FG000|Overall Study|alternative therapy|0
2123974|NCT00986674|3724128|FG001|Overall Study|alternative therapy|0
2123975|NCT00986674|3724129|FG002|Overall Study|alternative therapy|1
2123976|NCT00986674|3724127|FG000|Overall Study|not start protocol therapy|4
2123977|NCT00986674|3724128|FG001|Overall Study|not start protocol therapy|3
2123978|NCT00986674|3724129|FG002|Overall Study|not start protocol therapy|1
2123979|NCT00986674|3724127|FG000|Overall Study|unknown/not specify|0
2123980|NCT00986674|3724128|FG001|Overall Study|unknown/not specify|7
2123981|NCT00986674|3724129|FG002|Overall Study|unknown/not specify|9
2123982|NCT00986830|3724137|FG000|Overall Study|Death|1
2123983|NCT00986830|3724137|FG000|Overall Study|Lost to Follow-up|1
2123984|NCT00986830|3724137|FG000|Overall Study|Lack of Efficacy|1
2123985|NCT00986830|3724137|FG000|Overall Study|Unable to access sinus with device|5
2123986|NCT00986921|3724152|FG000|Overall Study|Physician Decision|1
2123987|NCT00986921|3724153|FG001|Overall Study|Physician Decision|0
2123988|NCT00986973|3724162|FG000|Overall Study|Withdrawn by study team|1
2123989|NCT00986986|3724169|FG000|Overall Study|Lost to Follow-up|0
2123990|NCT00986986|3724170|FG001|Overall Study|Lost to Follow-up|1
2123991|NCT00987337|3724180|FG000|Overall Study|Adverse Event|10
2123992|NCT00987337|3724181|FG001|Overall Study|Adverse Event|9
2123993|NCT00987337|3724182|FG002|Overall Study|Adverse Event|8
2123994|NCT00987337|3724180|FG000|Overall Study|Insufficient Virologic Response|10
2123995|NCT00987337|3724181|FG001|Overall Study|Insufficient Virologic Response|7
2123996|NCT00987337|3724182|FG002|Overall Study|Insufficient Virologic Response|12
2123997|NCT00987337|3724180|FG000|Overall Study|Virologic Breakthrough|2
2123998|NCT00987337|3724181|FG001|Overall Study|Virologic Breakthrough|2
2123999|NCT00987337|3724182|FG002|Overall Study|Virologic Breakthrough|8
2124000|NCT00987337|3724180|FG000|Overall Study|Lost to Follow-up|10
2124001|NCT00987337|3724181|FG001|Overall Study|Lost to Follow-up|6
2124002|NCT00987337|3724182|FG002|Overall Study|Lost to Follow-up|2
2124003|NCT00987337|3724180|FG000|Overall Study|Withdrawal by Subject|6
2124004|NCT00987337|3724181|FG001|Overall Study|Withdrawal by Subject|9
2124005|NCT00987337|3724182|FG002|Overall Study|Withdrawal by Subject|9
2124006|NCT00987337|3724180|FG000|Overall Study|Other|0
2124007|NCT00987337|3724181|FG001|Overall Study|Other|2
2124008|NCT00987337|3724182|FG002|Overall Study|Other|5
2124009|NCT00987337|3724180|FG000|Overall Study|Protocol Violation|1
2124010|NCT00987337|3724181|FG001|Overall Study|Protocol Violation|0
2124011|NCT00987337|3724182|FG002|Overall Study|Protocol Violation|2
2124012|NCT00987337|3724180|FG000|Overall Study|Participant Relapsed|18
2124013|NCT00987337|3724181|FG001|Overall Study|Participant Relapsed|20
2124014|NCT00987337|3724182|FG002|Overall Study|Participant Relapsed|5
2124015|NCT00987389|3724194|FG000|Overall Study|Ineligible|0
2124016|NCT00987389|3724195|FG001|Overall Study|Ineligible|3
2124017|NCT00987389|3724196|FG002|Overall Study|Ineligible|0
2124018|NCT00987389|3724197|FG003|Overall Study|Ineligible|0
2124019|NCT00987389|3724194|FG000|Overall Study|Lost to Follow-up|4
2124020|NCT00987389|3724195|FG001|Overall Study|Lost to Follow-up|1
2124021|NCT00987389|3724196|FG002|Overall Study|Lost to Follow-up|3
2124022|NCT00987389|3724197|FG003|Overall Study|Lost to Follow-up|1
2124023|NCT00987389|3724194|FG000|Overall Study|Withdrawal by Subject|4
2124024|NCT00987389|3724195|FG001|Overall Study|Withdrawal by Subject|3
2124025|NCT00987389|3724196|FG002|Overall Study|Withdrawal by Subject|2
2124026|NCT00987389|3724197|FG003|Overall Study|Withdrawal by Subject|1
2124027|NCT00987389|3724194|FG000|Overall Study|Withdrawn from Treatment|0
2124028|NCT00987389|3724195|FG001|Overall Study|Withdrawn from Treatment|1
2124029|NCT00987389|3724196|FG002|Overall Study|Withdrawn from Treatment|0
2124030|NCT00987389|3724197|FG003|Overall Study|Withdrawn from Treatment|0
2124031|NCT00987389|3724194|FG000|Overall Study|Multiple different reasons|1
2124032|NCT00987389|3724195|FG001|Overall Study|Multiple different reasons|0
2124033|NCT00987389|3724196|FG002|Overall Study|Multiple different reasons|3
2124034|NCT00987389|3724197|FG003|Overall Study|Multiple different reasons|1
2124035|NCT00987402|3724207|FG000|Overall Study|Insufficient data entry|86
2124036|NCT00987402|3724208|FG001|Overall Study|Insufficient data entry|98
2124037|NCT00987467|3724223|FG000|Overall Study|Lost to Follow-up|2
2124038|NCT00987623|3724242|FG000|Overall Study|Lost to Follow-up|2
2279825|NCT02347761|3963002|FG002|On Study Treatment|non-compliance with study medication|2
2279826|NCT02347761|3963000|FG000|On Study Treatment|Withdrawal by Subject|7
2279827|NCT02347761|3963001|FG001|On Study Treatment|Withdrawal by Subject|3
2279828|NCT02347761|3963002|FG002|On Study Treatment|Withdrawal by Subject|5
2279829|NCT02347761|3963000|FG000|On Study Treatment|move/travel|2
2279830|NCT02347761|3963001|FG001|On Study Treatment|move/travel|6
2279831|NCT02347761|3963002|FG002|On Study Treatment|move/travel|5
2279832|NCT02347761|3963000|FG000|On Study Treatment|dissastisfaction with device|2
2279833|NCT02347761|3963001|FG001|On Study Treatment|dissastisfaction with device|1
2279834|NCT02347761|3963002|FG002|On Study Treatment|dissastisfaction with device|4
2124039|NCT00987623|3724243|FG001|Overall Study|Lost to Follow-up|1
2124040|NCT00987623|3724242|FG000|Overall Study|Time/job conflict|2
2124041|NCT00987623|3724243|FG001|Overall Study|Time/job conflict|0
2124042|NCT00987623|3724242|FG000|Overall Study|Discomfort|1
2124043|NCT00987623|3724243|FG001|Overall Study|Discomfort|0
2124044|NCT00987623|3724242|FG000|Overall Study|Biomicroscopy|0
2124045|NCT00987623|3724243|FG001|Overall Study|Biomicroscopy|1
2124046|NCT00987623|3724242|FG000|Overall Study|Influenza|0
2124047|NCT00987623|3724243|FG001|Overall Study|Influenza|1
2124048|NCT00987831|3724261|FG000|Overall Study|Never flared in 12 months|1
2124049|NCT00987831|3724262|FG001|Overall Study|Never flared in 12 months|0
2124050|NCT00987831|3724263|FG002|Overall Study|Never flared in 12 months|0
2124051|NCT00987831|3724261|FG000|Overall Study|Lost to Follow-up|0
2124052|NCT00987831|3724262|FG001|Overall Study|Lost to Follow-up|3
2124053|NCT00987831|3724263|FG002|Overall Study|Lost to Follow-up|0
2124054|NCT00987935|3724281|FG000|Overall Study|Progressive disease|3
2124055|NCT00987935|3724282|FG001|Overall Study|Progressive disease|2
2124056|NCT00987935|3724283|FG002|Overall Study|Progressive disease|3
2124057|NCT00987935|3724284|FG003|Overall Study|Progressive disease|2
2124058|NCT00987935|3724285|FG004|Overall Study|Progressive disease|5
2124059|NCT00987935|3724286|FG005|Overall Study|Progressive disease|3
2124060|NCT00987935|3724287|FG006|Overall Study|Progressive disease|9
2124061|NCT00987935|3724288|FG007|Overall Study|Progressive disease|48
2279835|NCT02347761|3963000|FG000|On Study Treatment|Lost to Follow-up|2
2279836|NCT02347761|3963001|FG001|On Study Treatment|Lost to Follow-up|1
2279837|NCT02347761|3963002|FG002|On Study Treatment|Lost to Follow-up|1
2279838|NCT02347761|3963000|FG000|On Study Treatment|investigator discretion|2
2279839|NCT02347761|3963001|FG001|On Study Treatment|investigator discretion|0
2279840|NCT02347761|3963002|FG002|On Study Treatment|investigator discretion|0
2279841|NCT02347761|3963000|FG000|On Study Treatment|durg not working|0
2279842|NCT02347761|3963001|FG001|On Study Treatment|durg not working|1
2279843|NCT02347761|3963002|FG002|On Study Treatment|durg not working|1
2279844|NCT02347761|3963000|FG000|On Study Treatment|Adverse Event|10
2279845|NCT02347761|3963001|FG001|On Study Treatment|Adverse Event|8
2124062|NCT00987935|3724289|FG008|Overall Study|Progressive disease|23
2124063|NCT00987935|3724281|FG000|Overall Study|Adverse Event|0
2124064|NCT00987935|3724282|FG001|Overall Study|Adverse Event|1
2124065|NCT00987935|3724283|FG002|Overall Study|Adverse Event|0
2124066|NCT00987935|3724284|FG003|Overall Study|Adverse Event|1
2124067|NCT00987935|3724285|FG004|Overall Study|Adverse Event|1
2124068|NCT00987935|3724286|FG005|Overall Study|Adverse Event|0
2124069|NCT00987935|3724287|FG006|Overall Study|Adverse Event|2
2124070|NCT00987935|3724288|FG007|Overall Study|Adverse Event|10
2124071|NCT00987935|3724289|FG008|Overall Study|Adverse Event|6
2124072|NCT00987935|3724281|FG000|Overall Study|Refused to continue taking trial med.|1
2124073|NCT00987935|3724282|FG001|Overall Study|Refused to continue taking trial med.|0
2124074|NCT00987935|3724283|FG002|Overall Study|Refused to continue taking trial med.|0
2124075|NCT00987935|3724284|FG003|Overall Study|Refused to continue taking trial med.|0
2124076|NCT00987935|3724285|FG004|Overall Study|Refused to continue taking trial med.|1
2124077|NCT00987935|3724286|FG005|Overall Study|Refused to continue taking trial med.|0
2124078|NCT00987935|3724287|FG006|Overall Study|Refused to continue taking trial med.|4
2124079|NCT00987935|3724288|FG007|Overall Study|Refused to continue taking trial med.|4
2124080|NCT00987935|3724289|FG008|Overall Study|Refused to continue taking trial med.|2
2124081|NCT00987935|3724281|FG000|Overall Study|Reason other than those specified above|0
2124082|NCT00987935|3724282|FG001|Overall Study|Reason other than those specified above|0
2124083|NCT00987935|3724283|FG002|Overall Study|Reason other than those specified above|0
2124084|NCT00987935|3724284|FG003|Overall Study|Reason other than those specified above|0
2124085|NCT00987935|3724285|FG004|Overall Study|Reason other than those specified above|0
2124086|NCT00987935|3724286|FG005|Overall Study|Reason other than those specified above|0
2124087|NCT00987935|3724287|FG006|Overall Study|Reason other than those specified above|0
2124088|NCT00987935|3724288|FG007|Overall Study|Reason other than those specified above|0
2124089|NCT00987935|3724289|FG008|Overall Study|Reason other than those specified above|1
2124090|NCT00988065|3724356|FG000|Overall Study|Adverse Event|4
2124091|NCT00988065|3724357|FG001|Overall Study|Adverse Event|10
2124092|NCT00988065|3724358|FG002|Overall Study|Adverse Event|2
2124093|NCT00988065|3724356|FG000|Overall Study|Lost to Follow-up|1
2124094|NCT00988065|3724357|FG001|Overall Study|Lost to Follow-up|2
2124095|NCT00988065|3724358|FG002|Overall Study|Lost to Follow-up|2
2124096|NCT00988065|3724356|FG000|Overall Study|Subject withdrew consent|3
2124097|NCT00988065|3724357|FG001|Overall Study|Subject withdrew consent|5
2124098|NCT00988065|3724358|FG002|Overall Study|Subject withdrew consent|2
2124099|NCT00988065|3724356|FG000|Overall Study|Noncompliance with protocol|5
2124100|NCT00988065|3724357|FG001|Overall Study|Noncompliance with protocol|6
2124101|NCT00988065|3724358|FG002|Overall Study|Noncompliance with protocol|9
2177916|NCT01379521|3802453|FG000|Overall Study -Treatment Period|Protocol Deviation|0
2177917|NCT01379521|3802454|FG001|Overall Study -Treatment Period|Protocol Deviation|2
2177918|NCT01379521|3802453|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3
2177919|NCT01379521|3802454|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0
2177920|NCT01379521|3802453|FG000|Overall Study -Treatment Period|Administrative Problems|1
2177921|NCT01379521|3802454|FG001|Overall Study -Treatment Period|Administrative Problems|0
2279846|NCT02347761|3963002|FG002|On Study Treatment|Adverse Event|20
2279847|NCT02347774|3963013|FG000|Study Participation|Lost to Follow-up|3
2279848|NCT02347774|3963014|FG001|Study Participation|Lost to Follow-up|6
2279849|NCT02347774|3963015|FG002|Study Participation|Lost to Follow-up|2
2279850|NCT02347774|3963013|FG000|Study Participation|Withdrawal by Subject|8
2279851|NCT02347774|3963014|FG001|Study Participation|Withdrawal by Subject|9
2279852|NCT02347774|3963015|FG002|Study Participation|Withdrawal by Subject|15
2279853|NCT02347774|3963013|FG000|Study Participation|Adverse Event|1
2279854|NCT02347774|3963014|FG001|Study Participation|Adverse Event|4
2279855|NCT02347774|3963015|FG002|Study Participation|Adverse Event|6
2279856|NCT02347774|3963013|FG000|Study Participation|withdrew consent|1
2279857|NCT02347774|3963014|FG001|Study Participation|withdrew consent|1
2279858|NCT02347774|3963015|FG002|Study Participation|withdrew consent|1
2279859|NCT02347774|3963013|FG000|Study Participation|Met Prolonged QT criteria|1
2279860|NCT02347774|3963014|FG001|Study Participation|Met Prolonged QT criteria|0
2279861|NCT02347774|3963015|FG002|Study Participation|Met Prolonged QT criteria|0
2279862|NCT02347774|3963013|FG000|Study Participation|non-compliance with study drug|0
2279863|NCT02347774|3963014|FG001|Study Participation|non-compliance with study drug|1
2279864|NCT02347774|3963015|FG002|Study Participation|non-compliance with study drug|0
2279865|NCT02347774|3963013|FG000|Study Participation|incarceration|1
2279866|NCT02347774|3963014|FG001|Study Participation|incarceration|0
2279867|NCT02347774|3963015|FG002|Study Participation|incarceration|0
2279868|NCT02347774|3963013|FG000|Study Participation|randomized in error|0
2279869|NCT02347774|3963014|FG001|Study Participation|randomized in error|0
2279870|NCT02347774|3963015|FG002|Study Participation|randomized in error|1
2279871|NCT02347774|3963013|FG000|On Study Treatment|Adverse Event|9
2279872|NCT02347774|3963014|FG001|On Study Treatment|Adverse Event|15
2279873|NCT02347774|3963015|FG002|On Study Treatment|Adverse Event|19
2279874|NCT02347774|3963013|FG000|On Study Treatment|Lack of Efficacy|3
2279875|NCT02347774|3963014|FG001|On Study Treatment|Lack of Efficacy|0
2279876|NCT02347774|3963015|FG002|On Study Treatment|Lack of Efficacy|2
2279877|NCT02347774|3963013|FG000|On Study Treatment|non-complicance with study medication|0
2279878|NCT02347774|3963014|FG001|On Study Treatment|non-complicance with study medication|2
2279879|NCT02347774|3963015|FG002|On Study Treatment|non-complicance with study medication|0
2279880|NCT02347774|3963013|FG000|On Study Treatment|Protocol Violation|0
2279881|NCT02347774|3963014|FG001|On Study Treatment|Protocol Violation|0
2279882|NCT02347774|3963015|FG002|On Study Treatment|Protocol Violation|1
2279883|NCT02347774|3963013|FG000|On Study Treatment|withdrew consent|9
2279884|NCT02347774|3963014|FG001|On Study Treatment|withdrew consent|8
2279885|NCT02347774|3963015|FG002|On Study Treatment|withdrew consent|12
2279886|NCT02347774|3963013|FG000|On Study Treatment|Lost to Follow-up|2
2279887|NCT02347774|3963014|FG001|On Study Treatment|Lost to Follow-up|6
2279888|NCT02347774|3963015|FG002|On Study Treatment|Lost to Follow-up|1
2279889|NCT02347774|3963013|FG000|On Study Treatment|Met Prolonged QT criteria|1
2279890|NCT02347774|3963014|FG001|On Study Treatment|Met Prolonged QT criteria|0
2279891|NCT02347774|3963015|FG002|On Study Treatment|Met Prolonged QT criteria|0
2279892|NCT02347774|3963013|FG000|On Study Treatment|ranomized in error|0
2279893|NCT02347774|3963014|FG001|On Study Treatment|ranomized in error|0
2279894|NCT02347774|3963015|FG002|On Study Treatment|ranomized in error|1
2279895|NCT02347787|3963025|FG000|6 Month Follow-Up|Lost to Follow-up|63
2124102|NCT00988091|3724368|FG000|Double-blind Period|Withdrawal by Subject|15
2124103|NCT00988091|3724369|FG001|Double-blind Period|Withdrawal by Subject|13
2124104|NCT00988091|3724368|FG000|Double-blind Period|Lost to Follow-up|12
2124105|NCT00988091|3724369|FG001|Double-blind Period|Lost to Follow-up|14
2124106|NCT00988091|3724368|FG000|Double-blind Period|Other|8
2124107|NCT00988091|3724369|FG001|Double-blind Period|Other|8
2124108|NCT00988091|3724368|FG000|Double-blind Period|Adverse Event|6
2124109|NCT00988091|3724369|FG001|Double-blind Period|Adverse Event|9
2124110|NCT00988091|3724368|FG000|Double-blind Period|Use of exclusionary medication|2
2124111|NCT00988091|3724369|FG001|Double-blind Period|Use of exclusionary medication|3
2124112|NCT00988091|3724368|FG000|Open-label Period|Adverse Event|4
2124113|NCT00988091|3724369|FG001|Open-label Period|Adverse Event|7
2124114|NCT00988091|3724368|FG000|Open-label Period|Use of exclusionary medication|1
2124115|NCT00988091|3724369|FG001|Open-label Period|Use of exclusionary medication|1
2124116|NCT00988091|3724368|FG000|Open-label Period|Protocol Violation|1
2124117|NCT00988091|3724369|FG001|Open-label Period|Protocol Violation|1
2124118|NCT00988091|3724368|FG000|Open-label Period|Withdrawal by Subject|10
2124119|NCT00988091|3724369|FG001|Open-label Period|Withdrawal by Subject|16
2124120|NCT00988091|3724368|FG000|Open-label Period|Lost to Follow-up|3
2124121|NCT00988091|3724369|FG001|Open-label Period|Lost to Follow-up|5
2124122|NCT00988091|3724368|FG000|Open-label Period|Other|2
2124123|NCT00988091|3724369|FG001|Open-label Period|Other|3
2124124|NCT00988117|3724376|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
2124125|NCT00988117|3724376|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
2124126|NCT00988169|3724403|FG000|Overall Study|Withdrawal by Subject|1
2124127|NCT00988208|3724409|FG000|Overall Study|Adverse Event|71
2124128|NCT00988208|3724410|FG001|Overall Study|Adverse Event|122
2124129|NCT00988208|3724409|FG000|Overall Study|Disease Progression|103
2279896|NCT02347787|3963026|FG001|6 Month Follow-Up|Lost to Follow-up|47
2279897|NCT02347787|3963025|FG000|6 Month Follow-Up|Withdrawal by Subject|3
2279898|NCT02347787|3963026|FG001|6 Month Follow-Up|Withdrawal by Subject|9
2279899|NCT02347787|3963025|FG000|9 Month Follow-Up|Lost to Follow-up|52
2124130|NCT00988208|3724410|FG001|Overall Study|Disease Progression|89
2124131|NCT00988208|3724409|FG000|Overall Study|Withdrawal by Subject|50
2124132|NCT00988208|3724410|FG001|Overall Study|Withdrawal by Subject|57
2124133|NCT00988208|3724409|FG000|Overall Study|Death|9
2124134|NCT00988208|3724410|FG001|Overall Study|Death|15
2124135|NCT00988208|3724409|FG000|Overall Study|Lost to Follow-up|2
2124136|NCT00988208|3724410|FG001|Overall Study|Lost to Follow-up|3
2124137|NCT00988208|3724409|FG000|Overall Study|Protocol Violation|9
2124138|NCT00988208|3724410|FG001|Overall Study|Protocol Violation|2
2124139|NCT00988208|3724409|FG000|Overall Study|Sponsor Decision|102
2124140|NCT00988208|3724410|FG001|Overall Study|Sponsor Decision|78
2124141|NCT00988208|3724409|FG000|Overall Study|Clinical Progression|17
2124142|NCT00988208|3724410|FG001|Overall Study|Clinical Progression|16
2124143|NCT00988208|3724409|FG000|Overall Study|Biochemical Progression|21
2124144|NCT00988208|3724410|FG001|Overall Study|Biochemical Progression|7
2124145|NCT00988208|3724409|FG000|Overall Study|Clinical Deterioration|7
2124146|NCT00988208|3724410|FG001|Overall Study|Clinical Deterioration|14
2124147|NCT00988208|3724409|FG000|Overall Study|Subject Decision/Investigator Discretion|32
2124148|NCT00988208|3724410|FG001|Overall Study|Subject Decision/Investigator Discretion|32
2124149|NCT00988208|3724409|FG000|Overall Study|Other|8
2124150|NCT00988208|3724410|FG001|Overall Study|Other|3
2124151|NCT00988221|3724419|FG000|Part I|Adverse Event|0
2124152|NCT00988221|3724420|FG001|Part I|Adverse Event|1
2124153|NCT00988221|3724421|FG002|Part I|Adverse Event|2
2124154|NCT00988221|3724422|FG003|Part I|Adverse Event|0
2124155|NCT00988221|3724419|FG000|Part I|Insufficient Therapeutic Response|4
2124156|NCT00988221|3724420|FG001|Part I|Insufficient Therapeutic Response|6
2124157|NCT00988221|3724421|FG002|Part I|Insufficient Therapeutic Response|5
2124158|NCT00988221|3724422|FG003|Part I|Insufficient Therapeutic Response|0
2124159|NCT00988221|3724419|FG000|Part I|Refused Treatment|0
2124160|NCT00988221|3724420|FG001|Part I|Refused Treatment|2
2279900|NCT02347787|3963026|FG001|9 Month Follow-Up|Lost to Follow-up|59
2279901|NCT02347787|3963025|FG000|9 Month Follow-Up|Withdrawal by Subject|9
2279902|NCT02347787|3963026|FG001|9 Month Follow-Up|Withdrawal by Subject|12
2279903|NCT02347813|3963039|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1
2279904|NCT02347813|3963040|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1
2279905|NCT02347813|3963039|FG000|First Intervention, 24 Weeks|Adverse Event|1
2279906|NCT02347813|3963040|FG001|First Intervention, 24 Weeks|Adverse Event|1
2279907|NCT02348008|3963065|FG000|Overall Study|Adverse Event|2
2279908|NCT02348008|3963066|FG001|Overall Study|Adverse Event|3
2279909|NCT02348008|3963067|FG002|Overall Study|Adverse Event|3
2279910|NCT02348008|3963065|FG000|Overall Study|Disease Progression|1
2279911|NCT02348008|3963066|FG001|Overall Study|Disease Progression|5
2279912|NCT02348008|3963067|FG002|Overall Study|Disease Progression|16
2279913|NCT02348008|3963065|FG000|Overall Study|Withdrawal by Subject|0
2279914|NCT02348008|3963066|FG001|Overall Study|Withdrawal by Subject|1
2279915|NCT02348008|3963067|FG002|Overall Study|Withdrawal by Subject|0
2279916|NCT02348008|3963065|FG000|Overall Study|Symptomatic Deterioration|0
2279917|NCT02348008|3963066|FG001|Overall Study|Symptomatic Deterioration|1
2279918|NCT02348008|3963067|FG002|Overall Study|Symptomatic Deterioration|0
2279919|NCT02348216|3963089|FG000|Overall Study|Death|4
2279920|NCT02348216|3963090|FG001|Overall Study|Death|27
2279921|NCT02348216|3963091|FG002|Overall Study|Death|3
2279922|NCT02348216|3963092|FG003|Overall Study|Death|18
2279923|NCT02348216|3963093|FG004|Overall Study|Death|9
2279924|NCT02348216|3963094|FG005|Overall Study|Death|23
2279925|NCT02348216|3963095|FG006|Overall Study|Death|6
2279926|NCT02348216|3963089|FG000|Overall Study|Full consent withdrawal|0
2279927|NCT02348216|3963090|FG001|Overall Study|Full consent withdrawal|0
2279928|NCT02348216|3963091|FG002|Overall Study|Full consent withdrawal|0
2279929|NCT02348216|3963092|FG003|Overall Study|Full consent withdrawal|1
2279930|NCT02348216|3963093|FG004|Overall Study|Full consent withdrawal|0
2279931|NCT02348216|3963094|FG005|Overall Study|Full consent withdrawal|0
2279932|NCT02348216|3963095|FG006|Overall Study|Full consent withdrawal|1
2279933|NCT02348216|3963089|FG000|Overall Study|Lost to Follow-up|0
2279934|NCT02348216|3963090|FG001|Overall Study|Lost to Follow-up|0
2279935|NCT02348216|3963091|FG002|Overall Study|Lost to Follow-up|0
2279936|NCT02348216|3963092|FG003|Overall Study|Lost to Follow-up|0
2279937|NCT02348216|3963093|FG004|Overall Study|Lost to Follow-up|0
2279938|NCT02348216|3963094|FG005|Overall Study|Lost to Follow-up|0
2279939|NCT02348216|3963095|FG006|Overall Study|Lost to Follow-up|1
2279940|NCT02348216|3963089|FG000|Overall Study|Still on study|3
2279941|NCT02348216|3963090|FG001|Overall Study|Still on study|50
2279942|NCT02348216|3963091|FG002|Overall Study|Still on study|21
2279943|NCT02348216|3963092|FG003|Overall Study|Still on study|19
2279944|NCT02348216|3963093|FG004|Overall Study|Still on study|32
2279945|NCT02348216|3963094|FG005|Overall Study|Still on study|27
2279946|NCT02348216|3963095|FG006|Overall Study|Still on study|32
2279947|NCT02348216|3963089|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1
2279948|NCT02348216|3963090|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
2279949|NCT02348216|3963091|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6
2279950|NCT02348216|3963092|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
2279951|NCT02348216|3963093|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5
2124161|NCT00988221|3724421|FG002|Part I|Refused Treatment|1
2124162|NCT00988221|3724422|FG003|Part I|Refused Treatment|0
2124163|NCT00988221|3724419|FG000|Part I|Lost to Follow-up|0
2124164|NCT00988221|3724420|FG001|Part I|Lost to Follow-up|1
2124165|NCT00988221|3724421|FG002|Part I|Lost to Follow-up|0
2124166|NCT00988221|3724422|FG003|Part I|Lost to Follow-up|0
2124167|NCT00988221|3724419|FG000|Part II|Adverse Event|1
2124168|NCT00988221|3724420|FG001|Part II|Adverse Event|0
2124169|NCT00988221|3724421|FG002|Part II|Adverse Event|0
2124170|NCT00988221|3724422|FG003|Part II|Adverse Event|1
2124171|NCT00988221|3724419|FG000|Part II|Withdrawal by Subject|0
2124172|NCT00988221|3724420|FG001|Part II|Withdrawal by Subject|0
2124173|NCT00988221|3724421|FG002|Part II|Withdrawal by Subject|2
2124174|NCT00988221|3724422|FG003|Part II|Withdrawal by Subject|2
2124175|NCT00988221|3724419|FG000|Part II|Reason not Specified|0
2124176|NCT00988221|3724420|FG001|Part II|Reason not Specified|0
2124177|NCT00988221|3724421|FG002|Part II|Reason not Specified|1
2124178|NCT00988221|3724422|FG003|Part II|Reason not Specified|0
2124179|NCT00988221|3724419|FG000|Part III|Adverse Event|1
2124180|NCT00988221|3724420|FG001|Part III|Adverse Event|0
2124181|NCT00988221|3724421|FG002|Part III|Adverse Event|1
2124182|NCT00988221|3724422|FG003|Part III|Adverse Event|0
2124183|NCT00988221|3724419|FG000|Part III|Insufficient Therapeutic Response|0
2124184|NCT00988221|3724420|FG001|Part III|Insufficient Therapeutic Response|1
2124185|NCT00988221|3724421|FG002|Part III|Insufficient Therapeutic Response|1
2124186|NCT00988221|3724422|FG003|Part III|Insufficient Therapeutic Response|0
2124187|NCT00988221|3724419|FG000|Part III|Refused Treatment|0
2124188|NCT00988221|3724420|FG001|Part III|Refused Treatment|0
2124189|NCT00988221|3724421|FG002|Part III|Refused Treatment|1
2124190|NCT00988221|3724422|FG003|Part III|Refused Treatment|0
2124191|NCT00988351|3724460|FG000|Overall Study|Withdrawal by Subject|8
2124192|NCT00988351|3724461|FG001|Overall Study|Withdrawal by Subject|0
2124193|NCT00988351|3724460|FG000|Overall Study|Lost to Follow-up|6
2124194|NCT00988351|3724461|FG001|Overall Study|Lost to Follow-up|9
2124195|NCT00988351|3724460|FG000|Overall Study|not using CPAP|5
2124196|NCT00988351|3724461|FG001|Overall Study|not using CPAP|3
2124197|NCT00988429|3724470|FG000|Overall Study|Adverse Event|9
2124198|NCT00988429|3724471|FG001|Overall Study|Adverse Event|21
2124199|NCT00988429|3724472|FG002|Overall Study|Adverse Event|45
2124200|NCT00988429|3724470|FG000|Overall Study|Lack of Efficacy|0
2124201|NCT00988429|3724471|FG001|Overall Study|Lack of Efficacy|0
2124202|NCT00988429|3724472|FG002|Overall Study|Lack of Efficacy|1
2124203|NCT00988429|3724470|FG000|Overall Study|Non-Compliance with Study Drug|5
2124204|NCT00988429|3724471|FG001|Overall Study|Non-Compliance with Study Drug|1
2124205|NCT00988429|3724472|FG002|Overall Study|Non-Compliance with Study Drug|3
2124206|NCT00988429|3724470|FG000|Overall Study|Physician Decision|1
2124207|NCT00988429|3724471|FG001|Overall Study|Physician Decision|0
2124208|NCT00988429|3724472|FG002|Overall Study|Physician Decision|3
2124209|NCT00988429|3724470|FG000|Overall Study|Pregnancy|2
2124210|NCT00988429|3724471|FG001|Overall Study|Pregnancy|1
2124211|NCT00988429|3724472|FG002|Overall Study|Pregnancy|0
2124212|NCT00988429|3724470|FG000|Overall Study|Protocol Violation|4
2124213|NCT00988429|3724471|FG001|Overall Study|Protocol Violation|3
2124214|NCT00988429|3724472|FG002|Overall Study|Protocol Violation|3
2124215|NCT00988429|3724470|FG000|Overall Study|Withdrawal by Subject|7
2124216|NCT00988429|3724471|FG001|Overall Study|Withdrawal by Subject|7
2124217|NCT00988429|3724472|FG002|Overall Study|Withdrawal by Subject|12
2124218|NCT00988429|3724470|FG000|Overall Study|Administrative Reasons|1
2205291|NCT01609556|3843217|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2205292|NCT01609556|3843218|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2205293|NCT01609556|3843219|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2124219|NCT00988429|3724471|FG001|Overall Study|Administrative Reasons|2
2124220|NCT00988429|3724472|FG002|Overall Study|Administrative Reasons|1
2124221|NCT00988429|3724470|FG000|Overall Study|other reasons|8
2124222|NCT00988429|3724471|FG001|Overall Study|other reasons|8
2124223|NCT00988429|3724472|FG002|Overall Study|other reasons|1
2124224|NCT00988442|3724483|FG000|Overall Study|Death|1
2124225|NCT00988442|3724484|FG001|Overall Study|Death|2
2124226|NCT00988442|3724483|FG000|Overall Study|Lost to Follow-up|0
2124227|NCT00988442|3724484|FG001|Overall Study|Lost to Follow-up|1
2124228|NCT00988442|3724483|FG000|Overall Study|Early Study Closure|29
2124229|NCT00988442|3724484|FG001|Overall Study|Early Study Closure|25
2124230|NCT00988533|3724493|FG000|Overall Study|Lost to Follow-up|3
2124231|NCT00988559|3724501|FG000|Overall Study|Withdrawal by Subject|1
2124232|NCT00988559|3724502|FG001|Overall Study|Withdrawal by Subject|1
2124233|NCT00988559|3724503|FG002|Overall Study|Withdrawal by Subject|0
2124234|NCT00988559|3724504|FG003|Overall Study|Withdrawal by Subject|1
2124235|NCT00988559|3724501|FG000|Overall Study|Pregnancy|0
2124236|NCT00988559|3724502|FG001|Overall Study|Pregnancy|1
2124237|NCT00988559|3724503|FG002|Overall Study|Pregnancy|1
2124238|NCT00988559|3724504|FG003|Overall Study|Pregnancy|0
2124239|NCT00988559|3724501|FG000|Overall Study|Lost to Follow-up|0
2124240|NCT00988559|3724502|FG001|Overall Study|Lost to Follow-up|0
2124241|NCT00988559|3724503|FG002|Overall Study|Lost to Follow-up|1
2124242|NCT00988559|3724504|FG003|Overall Study|Lost to Follow-up|0
2124243|NCT00988598|3724516|FG000|Overall Study|Withdrawal by Subject|2
2124244|NCT00988598|3724517|FG001|Overall Study|Withdrawal by Subject|0
2124245|NCT00988637|3724525|FG000|Overall Study|Lost to Follow-up|2
2124246|NCT00988637|3724526|FG001|Overall Study|Lost to Follow-up|1
2124247|NCT00988637|3724525|FG000|Overall Study|Withdrawal by Subject|1
2124248|NCT00988637|3724526|FG001|Overall Study|Withdrawal by Subject|1
2124249|NCT00988637|3724525|FG000|Overall Study|non-compliance with study drug|0
2124250|NCT00988637|3724526|FG001|Overall Study|non-compliance with study drug|1
2124251|NCT00988858|3724539|FG000|Overall Study|Adverse Event|7
2124252|NCT00988858|3724539|FG000|Overall Study|Death|1
2124253|NCT00988858|3724539|FG000|Overall Study|Physician Decision|1
2124254|NCT00988858|3724539|FG000|Overall Study|Sponsor Decision|1
2124255|NCT00988884|3724545|FG000|Overall Study|Adverse Event|0
2124256|NCT00988884|3724546|FG001|Overall Study|Adverse Event|1
2124257|NCT00988884|3724545|FG000|Overall Study|Lost to Follow-up|20
2124258|NCT00988884|3724546|FG001|Overall Study|Lost to Follow-up|16
2124259|NCT00988884|3724545|FG000|Overall Study|Protocol Violation|0
2124260|NCT00988884|3724546|FG001|Overall Study|Protocol Violation|1
2124261|NCT00988884|3724545|FG000|Overall Study|Withdrawal by Subject|15
2124262|NCT00988884|3724546|FG001|Overall Study|Withdrawal by Subject|18
2124263|NCT00989092|3724571|FG000|Overall Study|Physician Decision|9
2124264|NCT00989092|3724572|FG001|Overall Study|Physician Decision|6
2124265|NCT00989092|3724571|FG000|Overall Study|Adverse Event|20
2124266|NCT00989092|3724572|FG001|Overall Study|Adverse Event|1
2124267|NCT00989092|3724571|FG000|Overall Study|Chemotherapy initiated|12
2124268|NCT00989092|3724572|FG001|Overall Study|Chemotherapy initiated|4
2124269|NCT00989092|3724571|FG000|Overall Study|Withdrawal by Subject|17
2124270|NCT00989092|3724572|FG001|Overall Study|Withdrawal by Subject|9
2124271|NCT00989092|3724571|FG000|Overall Study|Death|14
2124272|NCT00989092|3724572|FG001|Overall Study|Death|2
2124273|NCT00989092|3724571|FG000|Overall Study|Ineligibility determined|3
2124274|NCT00989092|3724572|FG001|Overall Study|Ineligibility determined|3
2124275|NCT00989092|3724571|FG000|Overall Study|Lost to Follow-up|6
2124276|NCT00989092|3724572|FG001|Overall Study|Lost to Follow-up|2
2124277|NCT00989092|3724571|FG000|Overall Study|Other|3
2124278|NCT00989092|3724572|FG001|Overall Study|Other|1
2124279|NCT00989092|3724571|FG000|Overall Study|Protocol deviation|2
2124280|NCT00989092|3724572|FG001|Overall Study|Protocol deviation|0
2124281|NCT00989092|3724571|FG000|Overall Study|Erythropoietin therapy initiated|2
2124282|NCT00989092|3724572|FG001|Overall Study|Erythropoietin therapy initiated|0
2279952|NCT02348216|3963094|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8
2279953|NCT02348216|3963095|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2
2279954|NCT02348489|3963146|FG000|Overall Study|Death|336
2279955|NCT02348489|3963147|FG001|Overall Study|Death|335
2279956|NCT02348489|3963146|FG000|Overall Study|Withdrawal by Subject|14
2279957|NCT02348489|3963147|FG001|Overall Study|Withdrawal by Subject|27
2279958|NCT02348489|3963146|FG000|Overall Study|Lost to Follow-up|3
2279959|NCT02348489|3963147|FG001|Overall Study|Lost to Follow-up|5
2320663|NCT02951988|4034991|FG002|Open-Label Treatment Period|Pregnancy|0
2124283|NCT00989092|3724571|FG000|Overall Study|Did not receive study drug|2
2124284|NCT00989092|3724572|FG001|Overall Study|Did not receive study drug|0
2124285|NCT00989196|3724590|FG000|Treatment Period|Lost to Follow-up|1
2124286|NCT00989196|3724591|FG001|Treatment Period|Lost to Follow-up|0
2124287|NCT00989235|3724599|FG000|Overall Study|Death|0
2124288|NCT00989235|3724600|FG001|Overall Study|Death|1
2124289|NCT00989235|3724599|FG000|Overall Study|Adverse Event|0
2124290|NCT00989235|3724600|FG001|Overall Study|Adverse Event|1
2124291|NCT00989235|3724599|FG000|Overall Study|Lack of Efficacy|1
2124292|NCT00989235|3724600|FG001|Overall Study|Lack of Efficacy|0
2124293|NCT00989235|3724599|FG000|Overall Study|Withdrawal of Consent|1
2124294|NCT00989235|3724600|FG001|Overall Study|Withdrawal of Consent|1
2124295|NCT00989235|3724599|FG000|Overall Study|Desire to Become Pregnant|1
2124296|NCT00989235|3724600|FG001|Overall Study|Desire to Become Pregnant|0
2124297|NCT00989235|3724599|FG000|Overall Study|Randomized by Mistake|0
2124298|NCT00989235|3724600|FG001|Overall Study|Randomized by Mistake|2
2124299|NCT00989235|3724599|FG000|Overall Study|Lost to Follow-up|0
2124300|NCT00989235|3724600|FG001|Overall Study|Lost to Follow-up|1
2124301|NCT00989261|3724611|FG000|Overall Study|Still in follow up|12
2124302|NCT00989261|3724612|FG001|Overall Study|Still in follow up|21
2124303|NCT00989261|3724611|FG000|Overall Study|Withdrawal by Subject|0
2124304|NCT00989261|3724612|FG001|Overall Study|Withdrawal by Subject|1
2124305|NCT00989261|3724611|FG000|Overall Study|Lost to Follow-up|3
2124306|NCT00989261|3724612|FG001|Overall Study|Lost to Follow-up|0
2124307|NCT00989287|3724620|FG000|Overall Study|Adverse Event|1
2124308|NCT00989287|3724621|FG001|Overall Study|Adverse Event|0
2124309|NCT00989287|3724620|FG000|Overall Study|Lost to Follow-up|0
2124310|NCT00989287|3724621|FG001|Overall Study|Lost to Follow-up|1
2124311|NCT00989573|3724643|FG000|Overall Study|Adverse Event|8
2124312|NCT00989573|3724644|FG001|Overall Study|Adverse Event|12
2124313|NCT00989573|3724645|FG002|Overall Study|Adverse Event|4
2124314|NCT00989573|3724643|FG000|Overall Study|Physician Decision|0
2124315|NCT00989573|3724644|FG001|Overall Study|Physician Decision|2
2124316|NCT00989573|3724645|FG002|Overall Study|Physician Decision|0
2124317|NCT00989573|3724643|FG000|Overall Study|Protocol Violation|1
2124318|NCT00989573|3724644|FG001|Overall Study|Protocol Violation|1
2124319|NCT00989573|3724645|FG002|Overall Study|Protocol Violation|1
2124320|NCT00989573|3724643|FG000|Overall Study|Withdrawal by Subject|4
2124321|NCT00989573|3724644|FG001|Overall Study|Withdrawal by Subject|7
2320664|NCT02951988|4034992|FG003|Open-Label Treatment Period|Pregnancy|0
2124322|NCT00989573|3724645|FG002|Overall Study|Withdrawal by Subject|3
2124323|NCT00989664|3724669|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
2124324|NCT00989664|3724669|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
2124325|NCT00989664|3724669|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49
2124326|NCT00989664|3724669|FG000|Dosimetric and Therapeutic Treatment|Death|1
2124327|NCT00989664|3724669|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
2124328|NCT00989664|3724669|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
2124329|NCT00989664|3724669|FG000|Long-Term Follow-Up|Death|3
2124330|NCT00989781|3724685|FG000|Ovarian Response to hCG|Lost to Follow-up|3
2124331|NCT00989781|3724686|FG001|Ovarian Response to hCG|Lost to Follow-up|2
2124332|NCT00989833|3724696|FG000|Overall Study|Lost to Follow-up|0
2124333|NCT00989833|3724697|FG001|Overall Study|Lost to Follow-up|1
2124334|NCT00989833|3724698|FG002|Overall Study|Lost to Follow-up|0
2124335|NCT00989833|3724696|FG000|Overall Study|Protocol Violation|1
2124336|NCT00989833|3724697|FG001|Overall Study|Protocol Violation|2
2124337|NCT00989833|3724698|FG002|Overall Study|Protocol Violation|1
2124338|NCT00989833|3724696|FG000|Overall Study|Withdrawal by Subject|0
2124339|NCT00989833|3724697|FG001|Overall Study|Withdrawal by Subject|0
2124340|NCT00989833|3724698|FG002|Overall Study|Withdrawal by Subject|1
2124341|NCT00989833|3724696|FG000|Overall Study|Incorrectly randomized|1
2124342|NCT00989833|3724697|FG001|Overall Study|Incorrectly randomized|0
2124343|NCT00989833|3724698|FG002|Overall Study|Incorrectly randomized|0
2124344|NCT00989950|3724714|FG000|Randomized Phase|Protocol Violation|1
2124345|NCT00989950|3724715|FG001|Randomized Phase|Protocol Violation|0
2124346|NCT00989950|3724716|FG002|Randomized Phase|Protocol Violation|0
2124347|NCT00989950|3724717|FG003|Randomized Phase|Protocol Violation|0
2124348|NCT00989950|3724714|FG000|Randomized Phase|Adverse Event|0
2124349|NCT00989950|3724715|FG001|Randomized Phase|Adverse Event|1
2124350|NCT00989950|3724716|FG002|Randomized Phase|Adverse Event|0
2124351|NCT00989950|3724717|FG003|Randomized Phase|Adverse Event|0
2124352|NCT00989963|3724730|FG000|Overall Study|Adverse Event|1
2124353|NCT00989963|3724731|FG001|Overall Study|Adverse Event|1
2124354|NCT00989963|3724732|FG002|Overall Study|Adverse Event|1
2124355|NCT00990093|3724753|FG000|Test Period 1 (1-14 Days)|Adverse Event|1
2124356|NCT00990093|3724754|FG001|Test Period 1 (1-14 Days)|Adverse Event|0
2124357|NCT00990093|3724753|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
2124358|NCT00990093|3724754|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
2124359|NCT00990093|3724753|FG000|Test Period 1 (1-14 Days)|Other|1
2124360|NCT00990093|3724754|FG001|Test Period 1 (1-14 Days)|Other|0
2124361|NCT00990093|3724753|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0
2124362|NCT00990093|3724754|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2
2124363|NCT00990093|3724753|FG000|Test Period 2 (15-28 Days)|Adverse Event|1
2124364|NCT00990093|3724754|FG001|Test Period 2 (15-28 Days)|Adverse Event|0
2124365|NCT00990093|3724753|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1
2124366|NCT00990093|3724754|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0
2124367|NCT00990093|3724753|FG000|Test Period 2 (15-28 Days)|Other|0
2124368|NCT00990093|3724754|FG001|Test Period 2 (15-28 Days)|Other|1
2124369|NCT00990106|3724762|FG000|Overall Study|"too busy to continue"|1
2124370|NCT00990106|3724763|FG001|Overall Study|"too busy to continue"|2
2124371|NCT00990106|3724762|FG000|Overall Study|Lost to Follow-up|1
2124372|NCT00990106|3724763|FG001|Overall Study|Lost to Follow-up|3
2124373|NCT00990106|3724762|FG000|Overall Study|Withdrawal by Subject|2
2124374|NCT00990106|3724763|FG001|Overall Study|Withdrawal by Subject|1
2124375|NCT00990106|3724762|FG000|Overall Study|opted for open label prazosin|1
2124376|NCT00990106|3724763|FG001|Overall Study|opted for open label prazosin|1
2124377|NCT00990106|3724762|FG000|Overall Study|relocation/deployment|4
2124378|NCT00990106|3724763|FG001|Overall Study|relocation/deployment|1
2124379|NCT00990106|3724762|FG000|Overall Study|started exclusionary medication|0
2124380|NCT00990106|3724763|FG001|Overall Study|started exclusionary medication|1
2124381|NCT00990106|3724762|FG000|Overall Study|planned major surgery|0
2124382|NCT00990106|3724763|FG001|Overall Study|planned major surgery|1
2124383|NCT00990106|3724762|FG000|Overall Study|scheduling conflicts|0
2124384|NCT00990106|3724763|FG001|Overall Study|scheduling conflicts|2
2124385|NCT00990184|3724769|FG000|Overall Study|Physician Decision|1
2124386|NCT00990249|3724784|FG000|Overall Study|Disease Progression|8
2124387|NCT00990249|3724784|FG000|Overall Study|Non-Compliance|1
2124388|NCT00990249|3724784|FG000|Overall Study|Death|2
2124389|NCT00990249|3724784|FG000|Overall Study|Not treated|2
2124390|NCT00990314|3724797|FG000|Overall Study|Death|2
2124391|NCT00990314|3724797|FG000|Overall Study|Adverse Event|2
2124392|NCT00990314|3724797|FG000|Overall Study|Withdrawal by Subject|3
2124393|NCT00990314|3724797|FG000|Overall Study|Non-Compliance|1
2124394|NCT00990314|3724797|FG000|Overall Study|Physician Decision|3
2124395|NCT00990314|3724797|FG000|Overall Study|Lack of Efficacy|1
2124396|NCT00990340|3724803|FG000|First 14-day Treatment|Not Compliant|2
2124397|NCT00990340|3724804|FG001|First 14-day Treatment|Not Compliant|1
2124398|NCT00990340|3724803|FG000|First 14-day Treatment|Lost to Follow-up|2
2124399|NCT00990340|3724804|FG001|First 14-day Treatment|Lost to Follow-up|1
2124400|NCT00990340|3724803|FG000|First 14-day Treatment|Protocol Violation|2
2124401|NCT00990340|3724804|FG001|First 14-day Treatment|Protocol Violation|2
2124402|NCT00990652|3724832|FG000|Pre-surgical Bortezomib|Adverse Event|1
2124403|NCT00990652|3724832|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
2124404|NCT00990665|3724837|FG000|Overall Study|Unsuccessful Implant|8
2124405|NCT00990665|3724837|FG000|Overall Study|Death|29
2124406|NCT00990665|3724837|FG000|Overall Study|Heart Transplant|1
2124407|NCT00990665|3724837|FG000|Overall Study|Withdrawal by Subject|6
2124408|NCT00990665|3724837|FG000|Overall Study|Lost to Follow-up|1
2124409|NCT00990665|3724837|FG000|Overall Study|System Explant|3
2124410|NCT00990704|3724845|FG000|Overall Study|Adverse Event|1
2124411|NCT00990704|3724846|FG001|Overall Study|Adverse Event|1
2124412|NCT00990704|3724845|FG000|Overall Study|Physician Decision|0
2124413|NCT00990704|3724846|FG001|Overall Study|Physician Decision|1
2124414|NCT00990821|3724879|FG000|Overall Study|Withdrawal by Subject|0
2124415|NCT00990821|3724880|FG001|Overall Study|Withdrawal by Subject|2
2124416|NCT00990821|3724881|FG002|Overall Study|Withdrawal by Subject|0
2124417|NCT00990821|3724882|FG003|Overall Study|Withdrawal by Subject|0
2124418|NCT00990821|3724883|FG004|Overall Study|Withdrawal by Subject|3
2124419|NCT00990821|3724884|FG005|Overall Study|Withdrawal by Subject|3
2124420|NCT00990821|3724885|FG006|Overall Study|Withdrawal by Subject|1
2124421|NCT00990821|3724886|FG007|Overall Study|Withdrawal by Subject|0
2124422|NCT00990821|3724887|FG008|Overall Study|Withdrawal by Subject|0
2124423|NCT00990821|3724888|FG009|Overall Study|Withdrawal by Subject|1
2124424|NCT00990821|3724889|FG010|Overall Study|Withdrawal by Subject|3
2124425|NCT00990821|3724890|FG011|Overall Study|Withdrawal by Subject|5
2124426|NCT00990821|3724891|FG012|Overall Study|Withdrawal by Subject|2
2124427|NCT00990821|3724892|FG013|Overall Study|Withdrawal by Subject|1
2124428|NCT00991276|3724968|FG000|First Intervention Period|Adverse Event|0
2124429|NCT00991276|3724969|FG001|First Intervention Period|Adverse Event|1
2124430|NCT00991276|3724970|FG002|First Intervention Period|Adverse Event|0
2124431|NCT00991276|3724971|FG003|First Intervention Period|Adverse Event|1
2124432|NCT00991276|3724972|FG004|First Intervention Period|Adverse Event|0
2124433|NCT00991276|3724973|FG005|First Intervention Period|Adverse Event|0
2124434|NCT00991276|3724968|FG000|First Intervention Period|Protocol Violation|0
2124435|NCT00991276|3724969|FG001|First Intervention Period|Protocol Violation|0
2124436|NCT00991276|3724970|FG002|First Intervention Period|Protocol Violation|0
2124437|NCT00991276|3724971|FG003|First Intervention Period|Protocol Violation|0
2124438|NCT00991276|3724972|FG004|First Intervention Period|Protocol Violation|2
2124439|NCT00991276|3724973|FG005|First Intervention Period|Protocol Violation|0
2124440|NCT00991276|3724968|FG000|First Intervention Period|Insufficient clinical response|0
2124441|NCT00991276|3724969|FG001|First Intervention Period|Insufficient clinical response|0
2124442|NCT00991276|3724970|FG002|First Intervention Period|Insufficient clinical response|0
2124443|NCT00991276|3724971|FG003|First Intervention Period|Insufficient clinical response|0
2124444|NCT00991276|3724972|FG004|First Intervention Period|Insufficient clinical response|1
2124445|NCT00991276|3724973|FG005|First Intervention Period|Insufficient clinical response|0
2124446|NCT00991276|3724968|FG000|First Intervention Period|Other|0
2124447|NCT00991276|3724969|FG001|First Intervention Period|Other|0
2124448|NCT00991276|3724970|FG002|First Intervention Period|Other|0
2124449|NCT00991276|3724971|FG003|First Intervention Period|Other|1
2124450|NCT00991276|3724972|FG004|First Intervention Period|Other|1
2124451|NCT00991276|3724973|FG005|First Intervention Period|Other|0
2124452|NCT00991276|3724968|FG000|First Intervention Period|Withdrawal by Subject|0
2124453|NCT00991276|3724969|FG001|First Intervention Period|Withdrawal by Subject|1
2124454|NCT00991276|3724970|FG002|First Intervention Period|Withdrawal by Subject|0
2124455|NCT00991276|3724971|FG003|First Intervention Period|Withdrawal by Subject|1
2124456|NCT00991276|3724972|FG004|First Intervention Period|Withdrawal by Subject|0
2124457|NCT00991276|3724973|FG005|First Intervention Period|Withdrawal by Subject|1
2124458|NCT00991276|3724968|FG000|First Intervention Period|Lost to Follow-up|0
2124459|NCT00991276|3724969|FG001|First Intervention Period|Lost to Follow-up|1
2124460|NCT00991276|3724970|FG002|First Intervention Period|Lost to Follow-up|0
2124461|NCT00991276|3724971|FG003|First Intervention Period|Lost to Follow-up|1
2124462|NCT00991276|3724972|FG004|First Intervention Period|Lost to Follow-up|0
2124463|NCT00991276|3724973|FG005|First Intervention Period|Lost to Follow-up|0
2124464|NCT00991276|3724968|FG000|Second Intervention Period|Adverse Event|0
2124465|NCT00991276|3724969|FG001|Second Intervention Period|Adverse Event|2
2124466|NCT00991276|3724970|FG002|Second Intervention Period|Adverse Event|0
2124467|NCT00991276|3724971|FG003|Second Intervention Period|Adverse Event|1
2124468|NCT00991276|3724972|FG004|Second Intervention Period|Adverse Event|1
2124469|NCT00991276|3724973|FG005|Second Intervention Period|Adverse Event|0
2124470|NCT00991276|3724968|FG000|Second Intervention Period|Protocol Violation|1
2124471|NCT00991276|3724969|FG001|Second Intervention Period|Protocol Violation|0
2124472|NCT00991276|3724970|FG002|Second Intervention Period|Protocol Violation|0
2124473|NCT00991276|3724971|FG003|Second Intervention Period|Protocol Violation|0
2124474|NCT00991276|3724972|FG004|Second Intervention Period|Protocol Violation|0
2124475|NCT00991276|3724973|FG005|Second Intervention Period|Protocol Violation|0
2124476|NCT00991276|3724968|FG000|Second Intervention Period|Other|0
2124477|NCT00991276|3724969|FG001|Second Intervention Period|Other|0
2124478|NCT00991276|3724970|FG002|Second Intervention Period|Other|0
2124479|NCT00991276|3724971|FG003|Second Intervention Period|Other|1
2124480|NCT00991276|3724972|FG004|Second Intervention Period|Other|0
2124481|NCT00991276|3724973|FG005|Second Intervention Period|Other|1
2177922|NCT01379521|3802453|FG000|Overall Study -Treatment Period|Death|2
2124482|NCT00991276|3724968|FG000|Third Intervention Period|Protocol Violation|1
2124483|NCT00991276|3724969|FG001|Third Intervention Period|Protocol Violation|0
2124484|NCT00991276|3724970|FG002|Third Intervention Period|Protocol Violation|0
2124485|NCT00991276|3724971|FG003|Third Intervention Period|Protocol Violation|0
2124486|NCT00991276|3724972|FG004|Third Intervention Period|Protocol Violation|0
2124487|NCT00991276|3724973|FG005|Third Intervention Period|Protocol Violation|0
2124488|NCT00991276|3724968|FG000|Third Intervention Period|Other|0
2124489|NCT00991276|3724969|FG001|Third Intervention Period|Other|0
2124490|NCT00991276|3724970|FG002|Third Intervention Period|Other|0
2124491|NCT00991276|3724971|FG003|Third Intervention Period|Other|0
2124492|NCT00991276|3724972|FG004|Third Intervention Period|Other|0
2124493|NCT00991276|3724973|FG005|Third Intervention Period|Other|1
2124494|NCT00991276|3724968|FG000|Third Intervention Period|Adverse Event|0
2124495|NCT00991276|3724969|FG001|Third Intervention Period|Adverse Event|0
2124496|NCT00991276|3724970|FG002|Third Intervention Period|Adverse Event|1
2124497|NCT00991276|3724971|FG003|Third Intervention Period|Adverse Event|0
2124498|NCT00991276|3724972|FG004|Third Intervention Period|Adverse Event|0
2124499|NCT00991276|3724973|FG005|Third Intervention Period|Adverse Event|0
2124500|NCT00991276|3724968|FG000|Third Intervention Period|Withdrawal by Subject|0
2124501|NCT00991276|3724969|FG001|Third Intervention Period|Withdrawal by Subject|0
2124502|NCT00991276|3724970|FG002|Third Intervention Period|Withdrawal by Subject|0
2124503|NCT00991276|3724971|FG003|Third Intervention Period|Withdrawal by Subject|1
2124504|NCT00991276|3724972|FG004|Third Intervention Period|Withdrawal by Subject|0
2124505|NCT00991276|3724973|FG005|Third Intervention Period|Withdrawal by Subject|0
2124506|NCT00991289|3724982|FG000|Overall Study|Adverse Event|1
2124507|NCT00991289|3724982|FG000|Overall Study|Physician Decision|2
2124508|NCT00991289|3724982|FG000|Overall Study|Withdrawal by Subject|3
2205294|NCT01609556|3843220|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2124509|NCT00991289|3724982|FG000|Overall Study|Lost to Follow-up|4
2124510|NCT00991289|3724982|FG000|Overall Study|Protocol Violation|2
2124511|NCT00991302|3724988|FG000|Overall Study|Death|0
2124512|NCT00991302|3724989|FG001|Overall Study|Death|1
2124513|NCT00991302|3724988|FG000|Overall Study|Lost to Follow-up|14
2124514|NCT00991302|3724989|FG001|Overall Study|Lost to Follow-up|12
2124515|NCT00991341|3724997|FG000|Overall Study|no surgery w/in 30 days of randomization|11
2124516|NCT00991341|3724998|FG001|Overall Study|no surgery w/in 30 days of randomization|18
2124517|NCT00991341|3724997|FG000|Overall Study|Death|3
2124518|NCT00991341|3724998|FG001|Overall Study|Death|0
2124519|NCT00991341|3724997|FG000|Overall Study|no RBCs received 96hrs after randomized|186
2124520|NCT00991341|3724998|FG001|Overall Study|no RBCs received 96hrs after randomized|155
2124521|NCT00991341|3724997|FG000|Overall Study|Physician Decision|1
2124522|NCT00991341|3724998|FG001|Overall Study|Physician Decision|2
2124523|NCT00991341|3724997|FG000|Overall Study|Withdrawal by Subject|3
2124524|NCT00991341|3724998|FG001|Overall Study|Withdrawal by Subject|4
2124525|NCT00991406|3725004|FG000|Overall Study|One participant did not respond to FES.|1
2124526|NCT00991510|3725023|FG000|Period I (Days 1-14)|Adverse Event|1
2124527|NCT00991510|3725024|FG001|Period I (Days 1-14)|Adverse Event|0
2124528|NCT00991510|3725023|FG000|Period III (Days 29-112)|Adverse Event|1
2124529|NCT00991510|3725024|FG001|Period III (Days 29-112)|Adverse Event|1
2124530|NCT00991887|3725047|FG000|Overall Study|Lost to Follow-up|2
2124531|NCT00991887|3725048|FG001|Overall Study|Lost to Follow-up|1
2124532|NCT00991939|3725056|FG000|Overall Study|Lost to Follow-up|0
2124533|NCT00991939|3725057|FG001|Overall Study|Lost to Follow-up|1
2124534|NCT00991939|3725056|FG000|Overall Study|Withdrawal by Subject|1
2124535|NCT00991939|3725057|FG001|Overall Study|Withdrawal by Subject|0
2124536|NCT00991939|3725056|FG000|Overall Study|Entire study terminated|4
2124537|NCT00991939|3725057|FG001|Overall Study|Entire study terminated|1
2124538|NCT00991952|3725067|FG000|Overall Study|Adverse Event|0
2124539|NCT00991952|3725068|FG001|Overall Study|Adverse Event|1
2124540|NCT00992017|3725074|FG000|Overall Study|Lost to Follow-up|2
2124541|NCT00992017|3725074|FG000|Overall Study|Withdrawal by Subject|2
2124542|NCT00992017|3725074|FG000|Overall Study|Unable to get to clinic|5
2124543|NCT00992017|3725074|FG000|Overall Study|Not adhere to study requirements|1
2124544|NCT00992056|3725085|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
2124545|NCT00992056|3725086|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
2124546|NCT00992056|3725085|FG000|Washout Period (2 Weeks)|Physician Decision|1
2124547|NCT00992056|3725086|FG001|Washout Period (2 Weeks)|Physician Decision|0
2124548|NCT00992108|3725094|FG000|Overall Study|Lost to Follow-up|0
2124549|NCT00992108|3725095|FG001|Overall Study|Lost to Follow-up|1
2124550|NCT00992186|3725101|FG000|Overall Study|Withdrawal by Subject|2
2124551|NCT00992186|3725101|FG000|Overall Study|Protocol Violation|1
2124552|NCT00992186|3725101|FG000|Overall Study|Physician Decision|1
2124553|NCT00992186|3725101|FG000|Overall Study|Adverse Event|9
2124554|NCT00992186|3725101|FG000|Overall Study|Progressive Disease|30
2124555|NCT00992186|3725101|FG000|Overall Study|Refusal To Receive Study Agent|3
2124556|NCT00992225|3725106|FG000|Overall Study|Entry Criteria Not Met|8
2124557|NCT00992225|3725106|FG000|Overall Study|Adverse Event|2
2124558|NCT00992394|3725154|FG000|Overall Study|Lack of Efficacy|6
2124559|NCT00992394|3725155|FG001|Overall Study|Lack of Efficacy|3
2124560|NCT00992394|3725154|FG000|Overall Study|Adverse Event|4
2124561|NCT00992394|3725155|FG001|Overall Study|Adverse Event|5
2124562|NCT00992394|3725154|FG000|Overall Study|Withdrawal by Subject|8
2124563|NCT00992394|3725155|FG001|Overall Study|Withdrawal by Subject|2
2124564|NCT00992394|3725154|FG000|Overall Study|Physician Decision|1
2124565|NCT00992394|3725155|FG001|Overall Study|Physician Decision|0
2124566|NCT00992394|3725154|FG000|Overall Study|Protocol Violation|2
2124567|NCT00992394|3725155|FG001|Overall Study|Protocol Violation|4
2124568|NCT00992394|3725154|FG000|Overall Study|Lost to Follow-up|2
2124569|NCT00992394|3725155|FG001|Overall Study|Lost to Follow-up|0
2124570|NCT00992394|3725154|FG000|Overall Study|Other event|1
2124571|NCT00992394|3725155|FG001|Overall Study|Other event|0
2124572|NCT00992407|3725163|FG000|Overall Study|Protocol Violation|2
2124573|NCT00992407|3725164|FG001|Overall Study|Protocol Violation|1
2124574|NCT00992407|3725163|FG000|Overall Study|Lost to Follow-up|3
2124575|NCT00992407|3725164|FG001|Overall Study|Lost to Follow-up|3
2124576|NCT00992407|3725163|FG000|Overall Study|Adverse Event|3
2124577|NCT00992407|3725164|FG001|Overall Study|Adverse Event|2
2124578|NCT00992407|3725163|FG000|Overall Study|protocol Violation & Adverse events|2
2124579|NCT00992407|3725164|FG001|Overall Study|protocol Violation & Adverse events|4
2124580|NCT00992407|3725163|FG000|Overall Study|Other|2
2124581|NCT00992407|3725164|FG001|Overall Study|Other|0
2124582|NCT00992407|3725163|FG000|Overall Study|Loss of follow-up & Adverse events|2
2124583|NCT00992407|3725164|FG001|Overall Study|Loss of follow-up & Adverse events|1
2124584|NCT00992407|3725163|FG000|Overall Study|Study medication not administered|17
2205295|NCT01609556|3843221|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2205296|NCT01609556|3843222|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2124585|NCT00992407|3725164|FG001|Overall Study|Study medication not administered|13
2124586|NCT00992446|3725182|FG000|Overall Study|Disease Progression|1
2124587|NCT00992446|3725182|FG000|Overall Study|Withdrawal by Subject|2
2124588|NCT00992446|3725182|FG000|Overall Study|Maintenance Therapy Screen Fail|5
2124589|NCT00992459|3725188|FG000|Overall Study|Withdrawal by Subject|0
2124590|NCT00992459|3725189|FG001|Overall Study|Withdrawal by Subject|1
2124591|NCT00992459|3725188|FG000|Overall Study|Adverse Event|1
2124592|NCT00992459|3725189|FG001|Overall Study|Adverse Event|0
2124593|NCT00992511|3725199|FG000|Overall Study|Migrated/moved from study area|1
2124594|NCT00992511|3725200|FG001|Overall Study|Migrated/moved from study area|0
2124595|NCT00992511|3725201|FG002|Overall Study|Migrated/moved from study area|1
2124596|NCT00992511|3725202|FG003|Overall Study|Migrated/moved from study area|2
2124597|NCT00992511|3725199|FG000|Overall Study|Lost to Follow-up|1
2124598|NCT00992511|3725200|FG001|Overall Study|Lost to Follow-up|0
2124599|NCT00992511|3725201|FG002|Overall Study|Lost to Follow-up|0
2124600|NCT00992511|3725202|FG003|Overall Study|Lost to Follow-up|2
2124601|NCT00992511|3725199|FG000|Overall Study|Withdrawal by Subject|0
2124602|NCT00992511|3725200|FG001|Overall Study|Withdrawal by Subject|0
2124603|NCT00992511|3725201|FG002|Overall Study|Withdrawal by Subject|1
2124604|NCT00992511|3725202|FG003|Overall Study|Withdrawal by Subject|1
2124605|NCT00992589|3725212|FG000|Open-Label Phase|Adverse Event|4
2124606|NCT00992589|3725213|FG001|Open-Label Phase|Adverse Event|0
2124607|NCT00992589|3725214|FG002|Open-Label Phase|Adverse Event|0
2124608|NCT00992589|3725215|FG003|Open-Label Phase|Adverse Event|0
2124609|NCT00992589|3725212|FG000|Open-Label Phase|Withdrawal by Subject|20
2124610|NCT00992589|3725213|FG001|Open-Label Phase|Withdrawal by Subject|0
2124611|NCT00992589|3725214|FG002|Open-Label Phase|Withdrawal by Subject|0
2124612|NCT00992589|3725215|FG003|Open-Label Phase|Withdrawal by Subject|0
2124613|NCT00992589|3725212|FG000|Open-Label Phase|Lost to Follow-up|1
2124614|NCT00992589|3725213|FG001|Open-Label Phase|Lost to Follow-up|0
2124615|NCT00992589|3725214|FG002|Open-Label Phase|Lost to Follow-up|0
2124616|NCT00992589|3725215|FG003|Open-Label Phase|Lost to Follow-up|0
2124617|NCT00992589|3725212|FG000|Open-Label Phase|Protocol Violation|3
2124618|NCT00992589|3725213|FG001|Open-Label Phase|Protocol Violation|0
2124619|NCT00992589|3725214|FG002|Open-Label Phase|Protocol Violation|0
2124620|NCT00992589|3725215|FG003|Open-Label Phase|Protocol Violation|0
2124621|NCT00992589|3725212|FG000|Open-Label Phase|Physician Decision|4
2124622|NCT00992589|3725213|FG001|Open-Label Phase|Physician Decision|0
2124623|NCT00992589|3725214|FG002|Open-Label Phase|Physician Decision|0
2124624|NCT00992589|3725215|FG003|Open-Label Phase|Physician Decision|0
2124625|NCT00992589|3725212|FG000|Open-Label Phase|Other|45
2124626|NCT00992589|3725213|FG001|Open-Label Phase|Other|0
2124627|NCT00992589|3725214|FG002|Open-Label Phase|Other|0
2124628|NCT00992589|3725215|FG003|Open-Label Phase|Other|0
2124629|NCT00992589|3725212|FG000|Double-Blind Phase|Adverse Event|0
2124630|NCT00992589|3725213|FG001|Double-Blind Phase|Adverse Event|6
2124631|NCT00992589|3725214|FG002|Double-Blind Phase|Adverse Event|2
2124632|NCT00992589|3725215|FG003|Double-Blind Phase|Adverse Event|3
2124633|NCT00992589|3725212|FG000|Double-Blind Phase|Withdrawal by Subject|0
2124634|NCT00992589|3725213|FG001|Double-Blind Phase|Withdrawal by Subject|6
2124635|NCT00992589|3725214|FG002|Double-Blind Phase|Withdrawal by Subject|5
2124636|NCT00992589|3725215|FG003|Double-Blind Phase|Withdrawal by Subject|2
2124637|NCT00992589|3725212|FG000|Double-Blind Phase|Lost to Follow-up|0
2124638|NCT00992589|3725213|FG001|Double-Blind Phase|Lost to Follow-up|0
2124639|NCT00992589|3725214|FG002|Double-Blind Phase|Lost to Follow-up|0
2124640|NCT00992589|3725215|FG003|Double-Blind Phase|Lost to Follow-up|2
2124641|NCT00992589|3725212|FG000|Double-Blind Phase|Other|0
2124642|NCT00992589|3725213|FG001|Double-Blind Phase|Other|1
2124643|NCT00992589|3725214|FG002|Double-Blind Phase|Other|6
2124644|NCT00992589|3725215|FG003|Double-Blind Phase|Other|3
2124645|NCT00992784|3725253|FG000|Overall Study|Adverse Event|2
2124646|NCT00992784|3725254|FG001|Overall Study|Adverse Event|1
2124647|NCT00992784|3725255|FG002|Overall Study|Adverse Event|0
2124648|NCT00992784|3725253|FG000|Overall Study|Withdrawal by Subject|1
2124649|NCT00992784|3725254|FG001|Overall Study|Withdrawal by Subject|1
2124650|NCT00992784|3725255|FG002|Overall Study|Withdrawal by Subject|1
2124651|NCT00992836|3725263|FG000|Overall Study|Lost to Follow-up|1
2124652|NCT00992836|3725263|FG000|Overall Study|Withdrawal by Subject|2
2279960|NCT02348723|3963220|FG000|Overall Study|No ablation|21
2279961|NCT02348723|3963221|FG001|Overall Study|No ablation|20
2279962|NCT02348723|3963220|FG000|Overall Study|Non-compliant with Protocol|1
2279963|NCT02348723|3963221|FG001|Overall Study|Non-compliant with Protocol|0
2279964|NCT02348723|3963220|FG000|Overall Study|Lost to Follow-up|1
2279965|NCT02348723|3963221|FG001|Overall Study|Lost to Follow-up|1
2279966|NCT02348723|3963220|FG000|Overall Study|Consent withdrawn|1
2279967|NCT02348723|3963221|FG001|Overall Study|Consent withdrawn|3
2279968|NCT02348723|3963220|FG000|Overall Study|Reason other than specified|1
2279969|NCT02348723|3963221|FG001|Overall Study|Reason other than specified|1
2279970|NCT02348723|3963220|FG000|Overall Study|Adverse Event|3
2279971|NCT02348723|3963221|FG001|Overall Study|Adverse Event|1
2279972|NCT02348840|3963240|FG000|Overall Study|Withdrawal by Subject|2
2279973|NCT02348840|3963241|FG001|Overall Study|Withdrawal by Subject|1
2124653|NCT00992836|3725263|FG000|Overall Study|Protocol Violation|2
2124654|NCT00992992|3725282|FG000|Overall Study|Lost to Follow-up|3
2124655|NCT00992992|3725282|FG000|Overall Study|Death|16
2124656|NCT00992992|3725282|FG000|Overall Study|GlaxoSmithKline Closed the Study|2
2124657|NCT00992992|3725282|FG000|Overall Study|Sponsor Closed the Study|4
2124658|NCT00993031|3725288|FG000|Overall Study|Death|0
2124659|NCT00993031|3725289|FG001|Overall Study|Death|1
2124660|NCT00993031|3725288|FG000|Overall Study|Physician Decision|0
2124661|NCT00993031|3725289|FG001|Overall Study|Physician Decision|2
2124662|NCT00993031|3725288|FG000|Overall Study|Withdrawal by Subject|3
2124663|NCT00993031|3725289|FG001|Overall Study|Withdrawal by Subject|3
2124664|NCT00993031|3725288|FG000|Overall Study|Lost to Follow-up|19
2124665|NCT00993031|3725289|FG001|Overall Study|Lost to Follow-up|13
2124666|NCT00993044|3725299|FG000|Irinotecan 50 mg|Physician Decision|1
2124667|NCT00993148|3725304|FG000|Overall Study|Lost to Follow-up|2
2124668|NCT00993148|3725304|FG000|Overall Study|never initiated treatment|1
2124669|NCT00993265|3725343|FG000|Overall Study|Adverse Event|1
2124670|NCT00993265|3725344|FG001|Overall Study|Adverse Event|0
2279974|NCT02348840|3963242|FG002|Overall Study|Withdrawal by Subject|0
2279975|NCT02348840|3963243|FG003|Overall Study|Withdrawal by Subject|0
2279976|NCT02349048|3963292|FG000|Overall Study|Withdrawal by Subject|4
2279977|NCT02349048|3963293|FG001|Overall Study|Withdrawal by Subject|0
2279978|NCT02349048|3963292|FG000|Overall Study|Lost to Follow-up|1
2279979|NCT02349048|3963293|FG001|Overall Study|Lost to Follow-up|0
2279980|NCT02349061|3963301|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4
2279981|NCT02349061|3963302|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3
2279982|NCT02349061|3963303|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0
2279983|NCT02349061|3963301|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
2279984|NCT02349061|3963302|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
2279985|NCT02349061|3963303|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
2279986|NCT02349061|3963301|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1
2279987|NCT02349061|3963302|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0
2279988|NCT02349061|3963303|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0
2279989|NCT02349061|3963301|FG000|Main Study: PCP (Up to Week 24)|Other|1
2279990|NCT02349061|3963302|FG001|Main Study: PCP (Up to Week 24)|Other|1
2279991|NCT02349061|3963303|FG002|Main Study: PCP (Up to Week 24)|Other|0
2279992|NCT02349061|3963301|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
2279993|NCT02349061|3963302|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
2279994|NCT02349061|3963303|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
2279995|NCT02349061|3963301|FG000|Main Study: Week 24 to 56|Adverse Event|0
2279996|NCT02349061|3963302|FG001|Main Study: Week 24 to 56|Adverse Event|2
2279997|NCT02349061|3963303|FG002|Main Study: Week 24 to 56|Adverse Event|1
2279998|NCT02349061|3963301|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0
2279999|NCT02349061|3963302|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1
2280000|NCT02349061|3963303|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0
2280001|NCT02349061|3963301|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0
2280002|NCT02349061|3963302|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0
2280003|NCT02349061|3963303|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1
2124671|NCT00993265|3725343|FG000|Overall Study|Changed dose of concomitant drug|2
2280004|NCT02349061|3963301|FG000|Main Study: Week 24 to 56|Physician Decision|0
2280005|NCT02349061|3963302|FG001|Main Study: Week 24 to 56|Physician Decision|0
2280006|NCT02349061|3963303|FG002|Main Study: Week 24 to 56|Physician Decision|1
2280007|NCT02349061|3963301|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0
2280008|NCT02349061|3963302|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3
2280009|NCT02349061|3963303|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0
2280010|NCT02349061|3963301|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
2280011|NCT02349061|3963302|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
2124672|NCT00993265|3725344|FG001|Overall Study|Changed dose of concomitant drug|0
2124673|NCT00993265|3725343|FG000|Overall Study|Non-compliant with study medication|1
2124674|NCT00993265|3725344|FG001|Overall Study|Non-compliant with study medication|0
2124675|NCT00993291|3725350|FG000|Overall Study|Withdrawal by Subject|1
2124676|NCT00993317|3725356|FG000|Overall Study|Adverse Event|2
2124677|NCT00993317|3725357|FG001|Overall Study|Adverse Event|4
2124678|NCT00993317|3725356|FG000|Overall Study|Lack of Efficacy|18
2124679|NCT00993317|3725357|FG001|Overall Study|Lack of Efficacy|18
2124680|NCT00993317|3725356|FG000|Overall Study|Withdrawal by Subject|0
2124681|NCT00993317|3725357|FG001|Overall Study|Withdrawal by Subject|2
2124682|NCT00993317|3725356|FG000|Overall Study|Investigator's opinion|0
2124683|NCT00993317|3725357|FG001|Overall Study|Investigator's opinion|1
2124684|NCT00993317|3725356|FG000|Overall Study|Early study termination at the site|1
2124685|NCT00993317|3725357|FG001|Overall Study|Early study termination at the site|0
2124686|NCT00993421|3725370|FG000|Overall Study|Adverse Event|2
2124687|NCT00993421|3725371|FG001|Overall Study|Adverse Event|7
2124688|NCT00993421|3725372|FG002|Overall Study|Adverse Event|6
2124689|NCT00993421|3725373|FG003|Overall Study|Adverse Event|9
2124690|NCT00993421|3725374|FG004|Overall Study|Adverse Event|5
2124691|NCT00993421|3725375|FG005|Overall Study|Adverse Event|7
2124692|NCT00993421|3725376|FG006|Overall Study|Adverse Event|1
2124693|NCT00993421|3725370|FG000|Overall Study|Sponsor Decision|36
2205297|NCT01609556|3843223|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2280012|NCT02349061|3963303|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
2280013|NCT02349061|3963301|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
2280014|NCT02349061|3963302|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
2205298|NCT01609556|3843224|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2205299|NCT01609556|3843225|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2280015|NCT02349061|3963303|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
2280016|NCT02349061|3963301|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0
2280017|NCT02349061|3963302|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0
2280018|NCT02349061|3963303|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1
2280019|NCT02349295|3963329|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7
2280020|NCT02349295|3963330|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5
2280021|NCT02349295|3963331|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5
2280022|NCT02349295|3963332|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0
2280023|NCT02349295|3963333|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0
2280024|NCT02349295|3963334|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0
2280025|NCT02349295|3963335|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0
2280026|NCT02349295|3963336|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0
2280027|NCT02349295|3963337|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0
2280028|NCT02349295|3963338|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0
2280029|NCT02349295|3963339|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0
2280030|NCT02349295|3963340|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0
2280031|NCT02349295|3963341|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0
2280032|NCT02349295|3963342|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0
2280033|NCT02349295|3963329|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
2280034|NCT02349295|3963330|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
2280035|NCT02349295|3963331|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
2280036|NCT02349295|3963332|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2280037|NCT02349295|3963333|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2280038|NCT02349295|3963334|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2280039|NCT02349295|3963335|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2280040|NCT02349295|3963336|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2280041|NCT02349295|3963337|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2280042|NCT02349295|3963338|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2280043|NCT02349295|3963339|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2280044|NCT02349295|3963340|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2280045|NCT02349295|3963341|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2280046|NCT02349295|3963342|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2280047|NCT02349295|3963329|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
2280048|NCT02349295|3963330|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
2280049|NCT02349295|3963331|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
2280050|NCT02349295|3963332|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2280051|NCT02349295|3963333|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2280052|NCT02349295|3963334|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2280053|NCT02349295|3963335|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2280054|NCT02349295|3963336|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2280055|NCT02349295|3963337|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2280056|NCT02349295|3963338|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2205300|NCT01609556|3843226|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2205301|NCT01609556|3843227|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2205302|NCT01609556|3843228|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1
2124694|NCT00993421|3725371|FG001|Overall Study|Sponsor Decision|31
2124695|NCT00993421|3725372|FG002|Overall Study|Sponsor Decision|28
2124696|NCT00993421|3725373|FG003|Overall Study|Sponsor Decision|30
2124697|NCT00993421|3725374|FG004|Overall Study|Sponsor Decision|38
2124698|NCT00993421|3725375|FG005|Overall Study|Sponsor Decision|30
2124699|NCT00993421|3725376|FG006|Overall Study|Sponsor Decision|29
2124700|NCT00993421|3725370|FG000|Overall Study|Lost to Follow-up|3
2124701|NCT00993421|3725371|FG001|Overall Study|Lost to Follow-up|5
2124702|NCT00993421|3725372|FG002|Overall Study|Lost to Follow-up|5
2124703|NCT00993421|3725373|FG003|Overall Study|Lost to Follow-up|0
2124704|NCT00993421|3725374|FG004|Overall Study|Lost to Follow-up|0
2124705|NCT00993421|3725375|FG005|Overall Study|Lost to Follow-up|0
2124706|NCT00993421|3725376|FG006|Overall Study|Lost to Follow-up|6
2124707|NCT00993421|3725370|FG000|Overall Study|Withdrawal by Subject|3
2124708|NCT00993421|3725371|FG001|Overall Study|Withdrawal by Subject|2
2124709|NCT00993421|3725372|FG002|Overall Study|Withdrawal by Subject|3
2124710|NCT00993421|3725373|FG003|Overall Study|Withdrawal by Subject|3
2124711|NCT00993421|3725374|FG004|Overall Study|Withdrawal by Subject|3
2124712|NCT00993421|3725375|FG005|Overall Study|Withdrawal by Subject|5
2124713|NCT00993421|3725376|FG006|Overall Study|Withdrawal by Subject|3
2124714|NCT00993421|3725370|FG000|Overall Study|Death|0
2124715|NCT00993421|3725371|FG001|Overall Study|Death|0
2124716|NCT00993421|3725372|FG002|Overall Study|Death|0
2124717|NCT00993421|3725373|FG003|Overall Study|Death|0
2124718|NCT00993421|3725374|FG004|Overall Study|Death|0
2124719|NCT00993421|3725375|FG005|Overall Study|Death|0
2124720|NCT00993421|3725376|FG006|Overall Study|Death|1
2124721|NCT00993421|3725370|FG000|Overall Study|Entry Criteria Exclusion|0
2124722|NCT00993421|3725371|FG001|Overall Study|Entry Criteria Exclusion|0
2124723|NCT00993421|3725372|FG002|Overall Study|Entry Criteria Exclusion|1
2124724|NCT00993421|3725373|FG003|Overall Study|Entry Criteria Exclusion|3
2124725|NCT00993421|3725374|FG004|Overall Study|Entry Criteria Exclusion|0
2124726|NCT00993421|3725375|FG005|Overall Study|Entry Criteria Exclusion|1
2124727|NCT00993421|3725376|FG006|Overall Study|Entry Criteria Exclusion|0
2124728|NCT00993421|3725370|FG000|Overall Study|Physician Decision|0
2124729|NCT00993421|3725371|FG001|Overall Study|Physician Decision|0
2124730|NCT00993421|3725372|FG002|Overall Study|Physician Decision|0
2124731|NCT00993421|3725373|FG003|Overall Study|Physician Decision|0
2124732|NCT00993421|3725374|FG004|Overall Study|Physician Decision|0
2124733|NCT00993421|3725375|FG005|Overall Study|Physician Decision|1
2124734|NCT00993421|3725376|FG006|Overall Study|Physician Decision|1
2124735|NCT00993421|3725370|FG000|Overall Study|Protocol Violation|0
2124736|NCT00993421|3725371|FG001|Overall Study|Protocol Violation|0
2124737|NCT00993421|3725372|FG002|Overall Study|Protocol Violation|0
2124738|NCT00993421|3725373|FG003|Overall Study|Protocol Violation|0
2124739|NCT00993421|3725374|FG004|Overall Study|Protocol Violation|0
2124740|NCT00993421|3725375|FG005|Overall Study|Protocol Violation|2
2124741|NCT00993421|3725376|FG006|Overall Study|Protocol Violation|1
2124742|NCT00993447|3725394|FG000|Overall Study|Withdrawal by Subject|23
2124743|NCT00993447|3725395|FG001|Overall Study|Withdrawal by Subject|8
2124744|NCT00993447|3725394|FG000|Overall Study|Protocol Violation|12
2124745|NCT00993447|3725395|FG001|Overall Study|Protocol Violation|8
2124746|NCT00993447|3725394|FG000|Overall Study|Lost to Follow-up|1
2124747|NCT00993447|3725395|FG001|Overall Study|Lost to Follow-up|3
2124748|NCT00993447|3725394|FG000|Overall Study|Adverse Event|1
2124749|NCT00993447|3725395|FG001|Overall Study|Adverse Event|0
2124750|NCT00993473|3725403|FG000|Overall Study|Adverse Event|0
2124751|NCT00993473|3725404|FG001|Overall Study|Adverse Event|2
2124752|NCT00993473|3725403|FG000|Overall Study|Protocol Violation|1
2124753|NCT00993473|3725404|FG001|Overall Study|Protocol Violation|2
2124754|NCT00993473|3725403|FG000|Overall Study|Lost to Follow-up|1
2124755|NCT00993473|3725404|FG001|Overall Study|Lost to Follow-up|0
2124756|NCT00993473|3725403|FG000|Overall Study|Withdrawal by Subject|1
2124757|NCT00993473|3725404|FG001|Overall Study|Withdrawal by Subject|5
2124758|NCT00993473|3725403|FG000|Overall Study|Technical problem with CGM device|0
2124759|NCT00993473|3725404|FG001|Overall Study|Technical problem with CGM device|1
2124760|NCT00993473|3725403|FG000|Overall Study|Family event|1
2124761|NCT00993473|3725404|FG001|Overall Study|Family event|0
2280057|NCT02349295|3963339|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2280058|NCT02349295|3963340|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2280059|NCT02349295|3963341|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2280060|NCT02349295|3963342|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2280061|NCT02349295|3963329|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
2280062|NCT02349295|3963330|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
2280063|NCT02349295|3963331|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
2280064|NCT02349295|3963332|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2280065|NCT02349295|3963333|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2124762|NCT00993499|3725416|FG000|Run-in Period (8 Days)|Adverse Event|0
2124763|NCT00993499|3725417|FG001|Run-in Period (8 Days)|Adverse Event|1
2124764|NCT00993499|3725418|FG002|Run-in Period (8 Days)|Adverse Event|0
2124765|NCT00993499|3725419|FG003|Run-in Period (8 Days)|Adverse Event|0
2124766|NCT00993499|3725420|FG004|Run-in Period (8 Days)|Adverse Event|0
2124767|NCT00993499|3725421|FG005|Run-in Period (8 Days)|Adverse Event|0
2177923|NCT01379521|3802454|FG001|Overall Study -Treatment Period|Death|1
2124768|NCT00993499|3725416|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
2124769|NCT00993499|3725417|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2124770|NCT00993499|3725418|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2124771|NCT00993499|3725419|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2124772|NCT00993499|3725420|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2124773|NCT00993499|3725421|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2124774|NCT00993499|3725416|FG000|Run-in Period (8 Days)|Consent withdrawn|0
2124775|NCT00993499|3725417|FG001|Run-in Period (8 Days)|Consent withdrawn|1
2124776|NCT00993499|3725418|FG002|Run-in Period (8 Days)|Consent withdrawn|0
2124777|NCT00993499|3725419|FG003|Run-in Period (8 Days)|Consent withdrawn|0
2124778|NCT00993499|3725420|FG004|Run-in Period (8 Days)|Consent withdrawn|0
2280066|NCT02349295|3963334|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2280067|NCT02349295|3963335|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2280068|NCT02349295|3963336|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2280069|NCT02349295|3963337|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2280070|NCT02349295|3963338|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2280071|NCT02349295|3963339|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2280072|NCT02349295|3963340|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2280073|NCT02349295|3963341|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2280074|NCT02349295|3963342|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2280075|NCT02349295|3963329|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280076|NCT02349295|3963330|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
2280077|NCT02349295|3963331|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
2280078|NCT02349295|3963332|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280079|NCT02349295|3963333|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280080|NCT02349295|3963334|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280081|NCT02349295|3963335|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280082|NCT02349295|3963336|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280083|NCT02349295|3963337|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280084|NCT02349295|3963338|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280085|NCT02349295|3963339|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280086|NCT02349295|3963340|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280087|NCT02349295|3963341|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280088|NCT02349295|3963342|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2280089|NCT02349295|3963329|FG000|IR (Week 16-24)|Lack of Efficacy|0
2280090|NCT02349295|3963330|FG001|IR (Week 16-24)|Lack of Efficacy|0
2280091|NCT02349295|3963331|FG002|IR (Week 16-24)|Lack of Efficacy|0
2280092|NCT02349295|3963332|FG003|IR (Week 16-24)|Lack of Efficacy|1
2280093|NCT02349295|3963333|FG004|IR (Week 16-24)|Lack of Efficacy|0
2280094|NCT02349295|3963334|FG005|IR (Week 16-24)|Lack of Efficacy|0
2280095|NCT02349295|3963335|FG006|IR (Week 16-24)|Lack of Efficacy|0
2280096|NCT02349295|3963336|FG007|IR (Week 16-24)|Lack of Efficacy|0
2280097|NCT02349295|3963337|FG008|IR (Week 16-24)|Lack of Efficacy|0
2280098|NCT02349295|3963338|FG009|IR (Week 16-24)|Lack of Efficacy|0
2280099|NCT02349295|3963339|FG010|IR (Week 16-24)|Lack of Efficacy|0
2280100|NCT02349295|3963340|FG011|IR (Week 16-24)|Lack of Efficacy|0
2280101|NCT02349295|3963341|FG012|IR (Week 16-24)|Lack of Efficacy|0
2280102|NCT02349295|3963342|FG013|IR (Week 16-24)|Lack of Efficacy|0
2280103|NCT02349295|3963329|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
2280104|NCT02349295|3963330|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
2280105|NCT02349295|3963331|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
2280106|NCT02349295|3963332|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
2280107|NCT02349295|3963333|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
2280108|NCT02349295|3963334|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
2280109|NCT02349295|3963335|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
2280110|NCT02349295|3963336|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32
2280111|NCT02349295|3963337|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25
2280112|NCT02349295|3963338|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19
2280113|NCT02349295|3963339|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18
2280114|NCT02349295|3963340|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
2280115|NCT02349295|3963341|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
2280116|NCT02349295|3963342|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
2280117|NCT02349295|3963329|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0
2280118|NCT02349295|3963330|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0
2280119|NCT02349295|3963331|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0
2280120|NCT02349295|3963332|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0
2280121|NCT02349295|3963333|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0
2280122|NCT02349295|3963334|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0
2280123|NCT02349295|3963335|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0
2280124|NCT02349295|3963336|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9
2280125|NCT02349295|3963337|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9
2280126|NCT02349295|3963338|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2
2124779|NCT00993499|3725421|FG005|Run-in Period (8 Days)|Consent withdrawn|0
2124780|NCT00993499|3725416|FG000|Run-in Period (8 Days)|Progressive disease|0
2124781|NCT00993499|3725417|FG001|Run-in Period (8 Days)|Progressive disease|1
2124782|NCT00993499|3725418|FG002|Run-in Period (8 Days)|Progressive disease|1
2124783|NCT00993499|3725419|FG003|Run-in Period (8 Days)|Progressive disease|0
2124784|NCT00993499|3725420|FG004|Run-in Period (8 Days)|Progressive disease|0
2124785|NCT00993499|3725421|FG005|Run-in Period (8 Days)|Progressive disease|0
2124786|NCT00993499|3725416|FG000|Discontinued Before Starting Course 3|Progressive Disease|2
2124787|NCT00993499|3725417|FG001|Discontinued Before Starting Course 3|Progressive Disease|2
2124788|NCT00993499|3725418|FG002|Discontinued Before Starting Course 3|Progressive Disease|0
2124789|NCT00993499|3725419|FG003|Discontinued Before Starting Course 3|Progressive Disease|0
2124790|NCT00993499|3725420|FG004|Discontinued Before Starting Course 3|Progressive Disease|0
2124791|NCT00993499|3725421|FG005|Discontinued Before Starting Course 3|Progressive Disease|0
2124792|NCT00993499|3725416|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2
2124793|NCT00993499|3725417|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2
2124794|NCT00993499|3725418|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2124795|NCT00993499|3725419|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2124796|NCT00993499|3725420|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2124797|NCT00993499|3725421|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2124798|NCT00993499|3725416|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2124799|NCT00993499|3725417|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2124800|NCT00993499|3725418|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
2124801|NCT00993499|3725419|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
2124802|NCT00993499|3725420|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2124803|NCT00993499|3725421|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2124804|NCT00993499|3725416|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2124805|NCT00993499|3725417|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2124806|NCT00993499|3725418|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2
2124807|NCT00993499|3725419|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2124808|NCT00993499|3725420|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2124809|NCT00993499|3725421|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2124810|NCT00993499|3725416|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0
2124811|NCT00993499|3725417|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1
2124812|NCT00993499|3725418|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0
2124813|NCT00993499|3725419|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0
2124814|NCT00993499|3725420|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0
2124815|NCT00993499|3725421|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0
2124816|NCT00993499|3725416|FG000|Discontinued After Starting Course 3|Progressive Disease|6
2124817|NCT00993499|3725417|FG001|Discontinued After Starting Course 3|Progressive Disease|4
2124818|NCT00993499|3725418|FG002|Discontinued After Starting Course 3|Progressive Disease|3
2124819|NCT00993499|3725419|FG003|Discontinued After Starting Course 3|Progressive Disease|1
2124820|NCT00993499|3725420|FG004|Discontinued After Starting Course 3|Progressive Disease|3
2124821|NCT00993499|3725421|FG005|Discontinued After Starting Course 3|Progressive Disease|3
2124822|NCT00993499|3725416|FG000|Discontinued After Starting Course 3|DLT|1
2124823|NCT00993499|3725417|FG001|Discontinued After Starting Course 3|DLT|0
2124824|NCT00993499|3725418|FG002|Discontinued After Starting Course 3|DLT|2
2124825|NCT00993499|3725419|FG003|Discontinued After Starting Course 3|DLT|1
2124826|NCT00993499|3725420|FG004|Discontinued After Starting Course 3|DLT|0
2124827|NCT00993499|3725421|FG005|Discontinued After Starting Course 3|DLT|0
2124828|NCT00993499|3725416|FG000|Discontinued After Starting Course 3|Other adverse event|1
2124829|NCT00993499|3725417|FG001|Discontinued After Starting Course 3|Other adverse event|0
2124830|NCT00993499|3725418|FG002|Discontinued After Starting Course 3|Other adverse event|1
2124831|NCT00993499|3725419|FG003|Discontinued After Starting Course 3|Other adverse event|0
2124832|NCT00993499|3725420|FG004|Discontinued After Starting Course 3|Other adverse event|0
2124833|NCT00993499|3725421|FG005|Discontinued After Starting Course 3|Other adverse event|0
2177924|NCT01379521|3802453|FG000|Post-Treatment Evaluations|Disease Progression|22
2177925|NCT01379521|3802454|FG001|Post-Treatment Evaluations|Disease Progression|20
2177926|NCT01379521|3802453|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2
2177927|NCT01379521|3802454|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1
2177928|NCT01379521|3802453|FG000|Post-Treatment Evaluations|Death|1
2177929|NCT01379521|3802454|FG001|Post-Treatment Evaluations|Death|0
2177930|NCT01379534|3802462|FG000|Treatment Phase|Withdrawal by Subject|2
2177931|NCT01379534|3802463|FG001|Treatment Phase|Withdrawal by Subject|2
2177932|NCT01379534|3802462|FG000|Treatment Phase|Progressive disease|13
2177933|NCT01379534|3802463|FG001|Treatment Phase|Progressive disease|22
2177934|NCT01379534|3802462|FG000|Treatment Phase|Adverse Event|7
2177935|NCT01379534|3802463|FG001|Treatment Phase|Adverse Event|7
2177936|NCT01379534|3802462|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0
2177937|NCT01379534|3802463|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1
2177938|NCT01379534|3802462|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
2124834|NCT00993616|3725435|FG000|Overall Study|No tumor at entry|1
2124835|NCT00993616|3725435|FG000|Overall Study|Never treated|1
2124836|NCT00993668|3725463|FG000|Single-Blind Period|Adverse Event|1
2124837|NCT00993668|3725464|FG001|Single-Blind Period|Adverse Event|1
2124838|NCT00993668|3725463|FG000|Single-Blind Period|Lack of Efficacy|0
2124839|NCT00993668|3725464|FG001|Single-Blind Period|Lack of Efficacy|1
2124840|NCT00993668|3725463|FG000|Single-Blind Period|Lost to Follow-up|3
2124841|NCT00993668|3725464|FG001|Single-Blind Period|Lost to Follow-up|1
2124842|NCT00993668|3725463|FG000|Open-Label Period|Adverse Event|9
2124843|NCT00993668|3725464|FG001|Open-Label Period|Adverse Event|8
2124844|NCT00993668|3725463|FG000|Open-Label Period|Lack of Efficacy|4
2124845|NCT00993668|3725464|FG001|Open-Label Period|Lack of Efficacy|3
2124846|NCT00993668|3725463|FG000|Open-Label Period|Withdrawal by Subject|4
2124847|NCT00993668|3725464|FG001|Open-Label Period|Withdrawal by Subject|3
2124848|NCT00993668|3725463|FG000|Open-Label Period|Lost to Follow-up|6
2124849|NCT00993668|3725464|FG001|Open-Label Period|Lost to Follow-up|1
2124850|NCT00993915|3725497|FG000|Overall Study|Insufficient clinical response|3
2124851|NCT00993915|3725497|FG000|Overall Study|Withdrawal by Subject|2
2124852|NCT00993915|3725497|FG000|Overall Study|Other|1
2124853|NCT00993915|3725497|FG000|Overall Study|Ongoing|3
2205303|NCT01609556|3843229|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2205304|NCT01609556|3843230|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2205305|NCT01609556|3843231|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
2205306|NCT01609556|3843216|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2280127|NCT02349295|3963339|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2
2280128|NCT02349295|3963340|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0
2280129|NCT02349295|3963341|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0
2280130|NCT02349295|3963342|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0
2280131|NCT02349295|3963329|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280132|NCT02349295|3963330|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280133|NCT02349295|3963331|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280134|NCT02349295|3963332|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280135|NCT02349295|3963333|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280136|NCT02349295|3963334|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280137|NCT02349295|3963335|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280138|NCT02349295|3963336|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2
2280139|NCT02349295|3963337|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280140|NCT02349295|3963338|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3
2280141|NCT02349295|3963339|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280142|NCT02349295|3963340|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280143|NCT02349295|3963341|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280144|NCT02349295|3963342|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
2280145|NCT02349295|3963329|FG000|Long-Term Extension Period (Week 24-156)|Death|0
2280146|NCT02349295|3963330|FG001|Long-Term Extension Period (Week 24-156)|Death|0
2280147|NCT02349295|3963331|FG002|Long-Term Extension Period (Week 24-156)|Death|0
2280148|NCT02349295|3963332|FG003|Long-Term Extension Period (Week 24-156)|Death|0
2280149|NCT02349295|3963333|FG004|Long-Term Extension Period (Week 24-156)|Death|0
2280150|NCT02349295|3963334|FG005|Long-Term Extension Period (Week 24-156)|Death|0
2280151|NCT02349295|3963335|FG006|Long-Term Extension Period (Week 24-156)|Death|0
2280152|NCT02349295|3963336|FG007|Long-Term Extension Period (Week 24-156)|Death|1
2280153|NCT02349295|3963337|FG008|Long-Term Extension Period (Week 24-156)|Death|1
2280154|NCT02349295|3963338|FG009|Long-Term Extension Period (Week 24-156)|Death|1
2280155|NCT02349295|3963339|FG010|Long-Term Extension Period (Week 24-156)|Death|0
2280156|NCT02349295|3963340|FG011|Long-Term Extension Period (Week 24-156)|Death|0
2124854|NCT00993928|3725503|FG000|Overall Study|Withdrawal by Subject|4
2124855|NCT00993928|3725504|FG001|Overall Study|Withdrawal by Subject|7
2124856|NCT00993928|3725503|FG000|Overall Study|ineligible|1
2205307|NCT01609556|3843217|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2205308|NCT01609556|3843218|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2205309|NCT01609556|3843219|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2205310|NCT01609556|3843220|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2205311|NCT01609556|3843221|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2205312|NCT01609556|3843222|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2205313|NCT01609556|3843223|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2205314|NCT01609556|3843224|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2205315|NCT01609556|3843225|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2205316|NCT01609556|3843226|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2205317|NCT01609556|3843227|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
2205318|NCT01609556|3843228|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1
2205319|NCT01609556|3843229|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4
2205320|NCT01609556|3843230|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2
2205321|NCT01609556|3843231|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5
2205322|NCT01609556|3843216|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2217425|NCT01708187|3860667|FG000|Overall Study|Lost to Follow-up|0
2124857|NCT00993928|3725504|FG001|Overall Study|ineligible|0
2124858|NCT00993954|3725516|FG000|Overall Study|Protocol Violation|21
2124859|NCT00993954|3725517|FG001|Overall Study|Protocol Violation|2
2124860|NCT00993967|3725523|FG000|Overall Study|Adverse Event|8
2280157|NCT02349295|3963341|FG012|Long-Term Extension Period (Week 24-156)|Death|0
2280158|NCT02349295|3963342|FG013|Long-Term Extension Period (Week 24-156)|Death|0
2280159|NCT02349295|3963329|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
2280160|NCT02349295|3963330|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
2280161|NCT02349295|3963331|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
2280162|NCT02349295|3963332|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
2280163|NCT02349295|3963333|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
2124861|NCT00993967|3725523|FG000|Overall Study|Death|1
2124862|NCT00993967|3725523|FG000|Overall Study|Lost to Follow-up|14
2124863|NCT00993967|3725523|FG000|Overall Study|Withdrawal by Subject|36
2124864|NCT00993967|3725523|FG000|Overall Study|Protocol Violation|2
2124865|NCT00994110|3725529|FG000|Overall Study|Withdrawal by Subject|9
2124866|NCT00994110|3725530|FG001|Overall Study|Withdrawal by Subject|9
2124867|NCT00994110|3725529|FG000|Overall Study|Not Treated|4
2124868|NCT00994110|3725530|FG001|Overall Study|Not Treated|8
2124869|NCT00994110|3725529|FG000|Overall Study|Adverse Event|1
2124870|NCT00994110|3725530|FG001|Overall Study|Adverse Event|0
2124871|NCT00994110|3725529|FG000|Overall Study|Patient not resected|41
2124872|NCT00994110|3725530|FG001|Overall Study|Patient not resected|52
2124873|NCT00994110|3725529|FG000|Overall Study|Pt not eligible|10
2124874|NCT00994110|3725530|FG001|Overall Study|Pt not eligible|5
2124875|NCT00994214|3725571|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0
2124876|NCT00994214|3725572|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1
2124877|NCT00994214|3725573|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0
2124878|NCT00994214|3725574|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0
2124879|NCT00994214|3725571|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
2124880|NCT00994214|3725572|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
2124881|NCT00994214|3725573|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
2124882|NCT00994214|3725574|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
2124883|NCT00994214|3725571|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
2124884|NCT00994214|3725572|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
2124885|NCT00994214|3725573|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
2124886|NCT00994214|3725574|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
2124887|NCT00994214|3725571|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
2124888|NCT00994214|3725572|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
2124889|NCT00994214|3725573|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
2124890|NCT00994214|3725574|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
2124891|NCT00994214|3725571|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
2124892|NCT00994214|3725572|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
2124893|NCT00994214|3725573|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
2124894|NCT00994214|3725574|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
2124895|NCT00994214|3725571|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
2124896|NCT00994214|3725572|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
2124897|NCT00994214|3725573|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
2124898|NCT00994214|3725574|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
2124899|NCT00994240|3725604|FG000|Overall Study|Lost to Follow-up|3
2124900|NCT00994240|3725605|FG001|Overall Study|Lost to Follow-up|2
2124901|NCT00994240|3725604|FG000|Overall Study|Withdrawal by Subject|1
2124902|NCT00994240|3725605|FG001|Overall Study|Withdrawal by Subject|0
2124903|NCT00994240|3725604|FG000|Overall Study|study termination|2
2124904|NCT00994240|3725605|FG001|Overall Study|study termination|3
2124905|NCT00994279|3725613|FG000|Overall Study|Withdrawal by Subject|2
2124906|NCT00994279|3725614|FG001|Overall Study|Withdrawal by Subject|2
2124907|NCT00994279|3725613|FG000|Overall Study|Toxicity|1
2124908|NCT00994279|3725614|FG001|Overall Study|Toxicity|0
2124909|NCT00994279|3725613|FG000|Overall Study|Multiple reasons|1
2124910|NCT00994279|3725614|FG001|Overall Study|Multiple reasons|3
2124911|NCT00994422|3725635|FG000|Overall Study|Lost to Follow-up|7
2124912|NCT00994422|3725636|FG001|Overall Study|Lost to Follow-up|1
2124913|NCT00994448|3725646|FG000|Overall Study|Adverse Event|1
2124914|NCT00994448|3725647|FG001|Overall Study|Adverse Event|0
2124915|NCT00994448|3725646|FG000|Overall Study|Lost to Follow-up|5
2124916|NCT00994448|3725647|FG001|Overall Study|Lost to Follow-up|1
2124917|NCT00994448|3725646|FG000|Overall Study|Withdrawal by Subject|1
2124918|NCT00994448|3725647|FG001|Overall Study|Withdrawal by Subject|1
2124919|NCT00994448|3725646|FG000|Overall Study|Physician Decision|1
2124920|NCT00994448|3725647|FG001|Overall Study|Physician Decision|0
2124921|NCT00994461|3725656|FG000|Overall Study|Adverse Event|2
2124922|NCT00994461|3725657|FG001|Overall Study|Adverse Event|1
2124923|NCT00994461|3725658|FG002|Overall Study|Adverse Event|0
2124924|NCT00994643|3725673|FG000|Overall Study|Withdrawal by Subject|1
2124925|NCT00994682|3725679|FG000|Double Bilnd|Withdrawal by Subject|5
2124926|NCT00994682|3725680|FG001|Double Bilnd|Withdrawal by Subject|6
2124927|NCT00994682|3725679|FG000|Double Bilnd|Lost to Follow-up|3
2124928|NCT00994682|3725680|FG001|Double Bilnd|Lost to Follow-up|3
2124929|NCT00994682|3725679|FG000|Double Bilnd|Adverse Event|1
2124930|NCT00994682|3725680|FG001|Double Bilnd|Adverse Event|0
2124931|NCT00994682|3725679|FG000|Pioglitazone Open Label|Withdrawal by Subject|4
2124932|NCT00994682|3725680|FG001|Pioglitazone Open Label|Withdrawal by Subject|4
2124933|NCT00994682|3725679|FG000|Pioglitazone Open Label|Lost to Follow-up|3
2124934|NCT00994682|3725680|FG001|Pioglitazone Open Label|Lost to Follow-up|2
2124935|NCT00994682|3725679|FG000|Pioglitazone Open Label|Physician Decision|6
2124936|NCT00994682|3725680|FG001|Pioglitazone Open Label|Physician Decision|1
2124937|NCT00994890|3725711|FG000|Overall Study|Adverse Event|13
2124938|NCT00994890|3725712|FG001|Overall Study|Adverse Event|9
2124939|NCT00994890|3725713|FG002|Overall Study|Adverse Event|11
2124940|NCT00994890|3725711|FG000|Overall Study|Lack of Efficacy|0
2124941|NCT00994890|3725712|FG001|Overall Study|Lack of Efficacy|0
2124942|NCT00994890|3725713|FG002|Overall Study|Lack of Efficacy|1
2124943|NCT00994890|3725711|FG000|Overall Study|Lost to Follow-up|6
2124944|NCT00994890|3725712|FG001|Overall Study|Lost to Follow-up|1
2124945|NCT00994890|3725713|FG002|Overall Study|Lost to Follow-up|3
2124946|NCT00994890|3725711|FG000|Overall Study|No longer willing to participate|8
2124947|NCT00994890|3725712|FG001|Overall Study|No longer willing to participate|5
2124948|NCT00994890|3725713|FG002|Overall Study|No longer willing to participate|13
2124949|NCT00994890|3725711|FG000|Overall Study|Protocol Violation|2
2124950|NCT00994890|3725712|FG001|Overall Study|Protocol Violation|4
2124951|NCT00994890|3725713|FG002|Overall Study|Protocol Violation|0
2124952|NCT00994890|3725711|FG000|Overall Study|Study terminated by sponsor|199
2124953|NCT00994890|3725712|FG001|Overall Study|Study terminated by sponsor|201
2124954|NCT00994890|3725713|FG002|Overall Study|Study terminated by sponsor|197
2124955|NCT00994890|3725711|FG000|Overall Study|Randomized, but not treated|1
2124956|NCT00994890|3725712|FG001|Overall Study|Randomized, but not treated|0
2124957|NCT00994890|3725713|FG002|Overall Study|Randomized, but not treated|0
2124958|NCT00994890|3725711|FG000|Overall Study|Other|2
2124959|NCT00994890|3725712|FG001|Overall Study|Other|2
2124960|NCT00994890|3725713|FG002|Overall Study|Other|1
2124961|NCT00995007|3725728|FG000|Overall Study|Withdrew consent|1
2124962|NCT00995007|3725729|FG001|Overall Study|Withdrew consent|0
2124963|NCT00995007|3725728|FG000|Overall Study|Refused further treatment|8
2124964|NCT00995007|3725729|FG001|Overall Study|Refused further treatment|2
2124965|NCT00995007|3725728|FG000|Overall Study|Toxicity|8
2124966|NCT00995007|3725729|FG001|Overall Study|Toxicity|0
2124967|NCT00995020|3725746|FG000|Overall Study|margin analysis not performed|2
2124968|NCT00995020|3725747|FG001|Overall Study|margin analysis not performed|5
2124969|NCT00995020|3725746|FG000|Overall Study|specimen fragmentation, thermal damage|1
2124970|NCT00995020|3725747|FG001|Overall Study|specimen fragmentation, thermal damage|2
2124971|NCT00995085|3725764|FG000|Overall Study|Withdrawal by Subject|5
2124972|NCT00995345|3725778|FG000|Overall Study|Withdrawal by Subject|4
2124973|NCT00995345|3725779|FG001|Overall Study|Withdrawal by Subject|2
2124974|NCT00995345|3725780|FG002|Overall Study|Withdrawal by Subject|1
2124975|NCT00995345|3725781|FG003|Overall Study|Withdrawal by Subject|3
2124976|NCT00995345|3725782|FG004|Overall Study|Withdrawal by Subject|1
2124977|NCT00995345|3725778|FG000|Overall Study|Adverse Event|3
2124978|NCT00995345|3725779|FG001|Overall Study|Adverse Event|1
2124979|NCT00995345|3725780|FG002|Overall Study|Adverse Event|2
2124980|NCT00995345|3725781|FG003|Overall Study|Adverse Event|0
2124981|NCT00995345|3725782|FG004|Overall Study|Adverse Event|1
2124982|NCT00995345|3725778|FG000|Overall Study|Lost to Follow-up|2
2124983|NCT00995345|3725779|FG001|Overall Study|Lost to Follow-up|2
2124984|NCT00995345|3725780|FG002|Overall Study|Lost to Follow-up|2
2124985|NCT00995345|3725781|FG003|Overall Study|Lost to Follow-up|1
2124986|NCT00995345|3725782|FG004|Overall Study|Lost to Follow-up|0
2124987|NCT00995345|3725778|FG000|Overall Study|all other reasons combined|2
2124988|NCT00995345|3725779|FG001|Overall Study|all other reasons combined|2
2124989|NCT00995345|3725780|FG002|Overall Study|all other reasons combined|2
2124990|NCT00995345|3725781|FG003|Overall Study|all other reasons combined|1
2124991|NCT00995345|3725782|FG004|Overall Study|all other reasons combined|3
2124992|NCT00995371|3725796|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
2124993|NCT00995371|3725797|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
2124994|NCT00995410|3725805|FG000|Overall Study|Adverse Event|51
2124995|NCT00995410|3725805|FG000|Overall Study|Withdrawal by Subject|7
2124996|NCT00995410|3725805|FG000|Overall Study|Lost to Follow-up|2
2124997|NCT00995410|3725805|FG000|Overall Study|Misc|28
2124998|NCT00995436|3725812|FG000|Overall Study|Withdrawal by Subject|2
2124999|NCT00995436|3725813|FG001|Overall Study|Withdrawal by Subject|5
2125000|NCT00995436|3725814|FG002|Overall Study|Withdrawal by Subject|0
2125001|NCT00995488|3725844|FG000|Overall Study|Withdrawal by Subject|1
2125002|NCT00995553|3725883|FG000|Overall Study|Withdrawal by Subject|2
2125003|NCT00995553|3725884|FG001|Overall Study|Withdrawal by Subject|6
2125004|NCT00995566|3725890|FG000|Overall Study|Adverse Event|2
2125005|NCT00995566|3725890|FG000|Overall Study|Early study termination|52
2125006|NCT00995670|3725897|FG000|Overall Study|Failed arterial cannulation|1
2125007|NCT00995670|3725898|FG001|Overall Study|Failed arterial cannulation|0
2125008|NCT00995670|3725899|FG002|Overall Study|Failed arterial cannulation|3
2125009|NCT00995709|3725910|FG000|Overall Study|Adverse Event|4
2125010|NCT00995709|3725911|FG001|Overall Study|Adverse Event|2
2125011|NCT00995709|3725912|FG002|Overall Study|Adverse Event|0
2125012|NCT00995709|3725910|FG000|Overall Study|Lack of Efficacy|0
2125013|NCT00995709|3725911|FG001|Overall Study|Lack of Efficacy|1
2125014|NCT00995709|3725912|FG002|Overall Study|Lack of Efficacy|4
2125015|NCT00995709|3725910|FG000|Overall Study|Withdrawal by Subject|0
2125016|NCT00995709|3725911|FG001|Overall Study|Withdrawal by Subject|4
2125017|NCT00995709|3725912|FG002|Overall Study|Withdrawal by Subject|1
2125018|NCT00995709|3725910|FG000|Overall Study|Lost to Follow-up|1
2125019|NCT00995709|3725911|FG001|Overall Study|Lost to Follow-up|0
2125020|NCT00995709|3725912|FG002|Overall Study|Lost to Follow-up|0
2125021|NCT00995709|3725910|FG000|Overall Study|Death|0
2125022|NCT00995709|3725911|FG001|Overall Study|Death|1
2125023|NCT00995709|3725912|FG002|Overall Study|Death|0
2125024|NCT00995709|3725910|FG000|Overall Study|Protocol Violation|2
2125025|NCT00995709|3725911|FG001|Overall Study|Protocol Violation|1
2280164|NCT02349295|3963334|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
2280165|NCT02349295|3963335|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
2280166|NCT02349295|3963336|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4
2280167|NCT02349295|3963337|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2
2280168|NCT02349295|3963338|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1
2280169|NCT02349295|3963339|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3
2280170|NCT02349295|3963340|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
2280171|NCT02349295|3963341|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
2280172|NCT02349295|3963342|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
2280173|NCT02349295|3963329|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280174|NCT02349295|3963330|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280175|NCT02349295|3963331|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280176|NCT02349295|3963332|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280177|NCT02349295|3963333|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280178|NCT02349295|3963334|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280179|NCT02349295|3963335|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280180|NCT02349295|3963336|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
2280181|NCT02349295|3963337|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
2280182|NCT02349295|3963338|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280183|NCT02349295|3963339|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280184|NCT02349295|3963340|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280185|NCT02349295|3963341|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280186|NCT02349295|3963342|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
2280187|NCT02349295|3963329|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280188|NCT02349295|3963330|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280189|NCT02349295|3963331|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280190|NCT02349295|3963332|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280191|NCT02349295|3963333|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280192|NCT02349295|3963334|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280193|NCT02349295|3963335|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280194|NCT02349295|3963336|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2
2280195|NCT02349295|3963337|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2
2280196|NCT02349295|3963338|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280197|NCT02349295|3963339|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280198|NCT02349295|3963340|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280199|NCT02349295|3963341|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280200|NCT02349295|3963342|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0
2280201|NCT02349295|3963329|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
2280202|NCT02349295|3963330|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
2280203|NCT02349295|3963331|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
2280204|NCT02349295|3963332|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
2280205|NCT02349295|3963333|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
2280206|NCT02349295|3963334|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
2280207|NCT02349295|3963335|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
2280208|NCT02349295|3963336|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
2280209|NCT02349295|3963337|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
2280210|NCT02349295|3963338|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
2280211|NCT02349295|3963339|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
2280212|NCT02349295|3963340|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
2280213|NCT02349295|3963341|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5
2125026|NCT00995709|3725912|FG002|Overall Study|Protocol Violation|0
2125027|NCT00995774|3725935|FG000|Training Period 2|Withdrawal by Subject|2
2125028|NCT00995774|3725936|FG001|Training Period 2|Withdrawal by Subject|0
2125029|NCT00995865|3725945|FG000|Overall Study|Protocol Violation|2
2125030|NCT00995865|3725946|FG001|Overall Study|Protocol Violation|0
2280214|NCT02349295|3963342|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
2280215|NCT02349295|3963329|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280216|NCT02349295|3963330|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280217|NCT02349295|3963331|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280218|NCT02349295|3963332|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280219|NCT02349295|3963333|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280220|NCT02349295|3963334|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280221|NCT02349295|3963335|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280222|NCT02349295|3963336|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280223|NCT02349295|3963337|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280224|NCT02349295|3963338|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280225|NCT02349295|3963339|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280226|NCT02349295|3963340|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1
2280227|NCT02349295|3963341|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2
2280228|NCT02349295|3963342|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
2280229|NCT02349295|3963329|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280230|NCT02349295|3963330|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280231|NCT02349295|3963331|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280232|NCT02349295|3963332|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280233|NCT02349295|3963333|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280234|NCT02349295|3963334|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280235|NCT02349295|3963335|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280236|NCT02349295|3963336|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280237|NCT02349295|3963337|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280238|NCT02349295|3963338|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280239|NCT02349295|3963339|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280240|NCT02349295|3963340|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
2280241|NCT02349295|3963341|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
2280242|NCT02349295|3963342|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
2280243|NCT02349295|3963329|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280244|NCT02349295|3963330|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280245|NCT02349295|3963331|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280246|NCT02349295|3963332|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280247|NCT02349295|3963333|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280248|NCT02349295|3963334|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280249|NCT02349295|3963335|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280250|NCT02349295|3963336|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280251|NCT02349295|3963337|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280252|NCT02349295|3963338|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280253|NCT02349295|3963339|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280254|NCT02349295|3963340|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2
2280255|NCT02349295|3963341|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280256|NCT02349295|3963342|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
2280257|NCT02349295|3963329|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280258|NCT02349295|3963330|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280259|NCT02349295|3963331|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280260|NCT02349295|3963332|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280261|NCT02349295|3963333|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280262|NCT02349295|3963334|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280263|NCT02349295|3963335|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280264|NCT02349295|3963336|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280265|NCT02349295|3963337|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280266|NCT02349295|3963338|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280267|NCT02349295|3963339|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280268|NCT02349295|3963340|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4
2280269|NCT02349295|3963341|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280270|NCT02349295|3963342|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
2280271|NCT02349360|3963369|FG000|Overall Study|Withdrawal by Subject|0
2280272|NCT02349360|3963370|FG001|Overall Study|Withdrawal by Subject|1
2280273|NCT02349412|3963378|FG000|Overall Study|Withdrawal by Subject|7
2280274|NCT02349412|3963379|FG001|Overall Study|Withdrawal by Subject|7
2280275|NCT02349425|3963389|FG000|Period 1|Adverse Event|1
2280276|NCT02349425|3963390|FG001|Period 1|Adverse Event|1
2280277|NCT02349425|3963391|FG002|Period 1|Adverse Event|0
2280278|NCT02349425|3963392|FG003|Period 1|Adverse Event|0
2280279|NCT02349425|3963389|FG000|Period 2|Adverse Event|0
2280280|NCT02349425|3963390|FG001|Period 2|Adverse Event|1
2280281|NCT02349425|3963391|FG002|Period 2|Adverse Event|1
2280282|NCT02349425|3963392|FG003|Period 2|Adverse Event|0
2280283|NCT02349451|3963441|FG000|Overall Study|Withdrawal by Subject|0
2280284|NCT02349451|3963442|FG001|Overall Study|Withdrawal by Subject|1
2280285|NCT02349451|3963443|FG002|Overall Study|Withdrawal by Subject|2
2205323|NCT01609556|3843217|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205324|NCT01609556|3843218|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2125031|NCT00995865|3725947|FG002|Overall Study|Protocol Violation|0
2125032|NCT00995865|3725945|FG000|Overall Study|Lost to Follow-up|0
2125033|NCT00995865|3725946|FG001|Overall Study|Lost to Follow-up|0
2125034|NCT00995865|3725947|FG002|Overall Study|Lost to Follow-up|1
2125035|NCT00995930|3725978|FG000|Overall Study|Protocol deviation|2
2125036|NCT00995930|3725979|FG001|Overall Study|Protocol deviation|5
2125037|NCT00995930|3725978|FG000|Overall Study|Death|0
2125038|NCT00995930|3725979|FG001|Overall Study|Death|1
2125039|NCT00995930|3725978|FG000|Overall Study|Administrative problems|4
2125040|NCT00995930|3725979|FG001|Overall Study|Administrative problems|2
2125041|NCT00995930|3725978|FG000|Overall Study|Lost to Follow-up|1
2125042|NCT00995930|3725979|FG001|Overall Study|Lost to Follow-up|2
2125043|NCT00995930|3725978|FG000|Overall Study|Withdrawal by Subject|3
2125044|NCT00995930|3725979|FG001|Overall Study|Withdrawal by Subject|4
2125045|NCT00995930|3725978|FG000|Overall Study|Adverse Event|11
2125046|NCT00995930|3725979|FG001|Overall Study|Adverse Event|14
2125047|NCT00996034|3725986|FG000|Overall Study|Lost to Follow-up|2
2125048|NCT00996034|3725986|FG000|Overall Study|withdrawn by PI|1
2125049|NCT00996125|3725992|FG000|Overall Study|Adverse Event|0
2125050|NCT00996125|3725993|FG001|Overall Study|Adverse Event|2
2125051|NCT00996125|3725992|FG000|Overall Study|Lost to Follow-up|1
2125052|NCT00996125|3725993|FG001|Overall Study|Lost to Follow-up|6
2205325|NCT01609556|3843219|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205326|NCT01609556|3843220|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2280286|NCT02349451|3963444|FG003|Overall Study|Withdrawal by Subject|1
2280287|NCT02349542|3963470|FG000|Overall Study|Withdrawal by Subject|5
2280288|NCT02349633|3963488|FG000|Overall Study|Death|0
2280289|NCT02349633|3963489|FG001|Overall Study|Death|1
2280290|NCT02349633|3963490|FG002|Overall Study|Death|0
2280291|NCT02349633|3963491|FG003|Overall Study|Death|0
2280292|NCT02349633|3963492|FG004|Overall Study|Death|0
2280293|NCT02349633|3963493|FG005|Overall Study|Death|1
2280294|NCT02349633|3963494|FG006|Overall Study|Death|1
2280295|NCT02349633|3963495|FG007|Overall Study|Death|1
2280296|NCT02349633|3963496|FG008|Overall Study|Death|0
2280297|NCT02349633|3963497|FG009|Overall Study|Death|1
2280298|NCT02349633|3963498|FG010|Overall Study|Death|0
2280299|NCT02349633|3963499|FG011|Overall Study|Death|0
2280300|NCT02349633|3963500|FG012|Overall Study|Death|0
2280301|NCT02349633|3963501|FG013|Overall Study|Death|0
2280302|NCT02349633|3963488|FG000|Overall Study|Withdrawal by Subject|0
2280303|NCT02349633|3963489|FG001|Overall Study|Withdrawal by Subject|0
2280304|NCT02349633|3963490|FG002|Overall Study|Withdrawal by Subject|0
2280305|NCT02349633|3963491|FG003|Overall Study|Withdrawal by Subject|1
2280306|NCT02349633|3963492|FG004|Overall Study|Withdrawal by Subject|0
2280307|NCT02349633|3963493|FG005|Overall Study|Withdrawal by Subject|0
2280308|NCT02349633|3963494|FG006|Overall Study|Withdrawal by Subject|0
2280309|NCT02349633|3963495|FG007|Overall Study|Withdrawal by Subject|2
2280310|NCT02349633|3963496|FG008|Overall Study|Withdrawal by Subject|2
2280311|NCT02349633|3963497|FG009|Overall Study|Withdrawal by Subject|1
2280312|NCT02349633|3963498|FG010|Overall Study|Withdrawal by Subject|0
2280313|NCT02349633|3963499|FG011|Overall Study|Withdrawal by Subject|0
2280314|NCT02349633|3963500|FG012|Overall Study|Withdrawal by Subject|0
2280315|NCT02349633|3963501|FG013|Overall Study|Withdrawal by Subject|0
2280316|NCT02349633|3963488|FG000|Overall Study|Withdrawal of informed consent|0
2280317|NCT02349633|3963489|FG001|Overall Study|Withdrawal of informed consent|0
2280318|NCT02349633|3963490|FG002|Overall Study|Withdrawal of informed consent|0
2125053|NCT00996125|3725992|FG000|Overall Study|Withdrawal by Subject|4
2125054|NCT00996125|3725993|FG001|Overall Study|Withdrawal by Subject|3
2205327|NCT01609556|3843221|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205328|NCT01609556|3843222|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205329|NCT01609556|3843223|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205330|NCT01609556|3843224|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205331|NCT01609556|3843225|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205332|NCT01609556|3843226|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205333|NCT01609556|3843227|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205334|NCT01609556|3843228|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205335|NCT01609556|3843229|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205336|NCT01609556|3843230|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
2205337|NCT01609556|3843231|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1
2205338|NCT01609556|3843216|FG000|Dose Expansion: Maximum 124 Weeks|Death|0
2205339|NCT01609556|3843217|FG001|Dose Expansion: Maximum 124 Weeks|Death|0
2205340|NCT01609556|3843218|FG002|Dose Expansion: Maximum 124 Weeks|Death|0
2205341|NCT01609556|3843219|FG003|Dose Expansion: Maximum 124 Weeks|Death|0
2205342|NCT01609556|3843220|FG004|Dose Expansion: Maximum 124 Weeks|Death|0
2205343|NCT01609556|3843221|FG005|Dose Expansion: Maximum 124 Weeks|Death|0
2205344|NCT01609556|3843222|FG006|Dose Expansion: Maximum 124 Weeks|Death|0
2205345|NCT01609556|3843223|FG007|Dose Expansion: Maximum 124 Weeks|Death|0
2205346|NCT01609556|3843224|FG008|Dose Expansion: Maximum 124 Weeks|Death|0
2125055|NCT00996203|3726008|FG000|Overall Study|Adverse Event|3
2125056|NCT00996203|3726008|FG000|Overall Study|Lost to Follow-up|1
2125057|NCT00996203|3726008|FG000|Overall Study|Lack of Efficacy|1
2125058|NCT00996203|3726008|FG000|Overall Study|Protocol Violation|2
2125059|NCT00996216|3726013|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
2125060|NCT00996216|3726013|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
2125061|NCT00996216|3726013|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
2125062|NCT00996281|3726020|FG000|Overall Study|Adverse Event|75
2125063|NCT00996281|3726021|FG001|Overall Study|Adverse Event|37
2125064|NCT00996281|3726020|FG000|Overall Study|Major Protocol Deviation|6
2205347|NCT01609556|3843225|FG009|Dose Expansion: Maximum 124 Weeks|Death|0
2205348|NCT01609556|3843226|FG010|Dose Expansion: Maximum 124 Weeks|Death|0
2125065|NCT00996281|3726021|FG001|Overall Study|Major Protocol Deviation|7
2205349|NCT01609556|3843227|FG011|Dose Expansion: Maximum 124 Weeks|Death|0
2280319|NCT02349633|3963491|FG003|Overall Study|Withdrawal of informed consent|1
2280320|NCT02349633|3963492|FG004|Overall Study|Withdrawal of informed consent|1
2280321|NCT02349633|3963493|FG005|Overall Study|Withdrawal of informed consent|0
2280322|NCT02349633|3963494|FG006|Overall Study|Withdrawal of informed consent|0
2280323|NCT02349633|3963495|FG007|Overall Study|Withdrawal of informed consent|3
2280324|NCT02349633|3963496|FG008|Overall Study|Withdrawal of informed consent|0
2280325|NCT02349633|3963497|FG009|Overall Study|Withdrawal of informed consent|0
2280326|NCT02349633|3963498|FG010|Overall Study|Withdrawal of informed consent|0
2280327|NCT02349633|3963499|FG011|Overall Study|Withdrawal of informed consent|0
2280328|NCT02349633|3963500|FG012|Overall Study|Withdrawal of informed consent|0
2280329|NCT02349633|3963501|FG013|Overall Study|Withdrawal of informed consent|0
2280330|NCT02349633|3963488|FG000|Overall Study|Transition to compassionate use|0
2280331|NCT02349633|3963489|FG001|Overall Study|Transition to compassionate use|0
2280332|NCT02349633|3963490|FG002|Overall Study|Transition to compassionate use|0
2280333|NCT02349633|3963491|FG003|Overall Study|Transition to compassionate use|0
2280334|NCT02349633|3963492|FG004|Overall Study|Transition to compassionate use|1
2280335|NCT02349633|3963493|FG005|Overall Study|Transition to compassionate use|0
2280336|NCT02349633|3963494|FG006|Overall Study|Transition to compassionate use|0
2280337|NCT02349633|3963495|FG007|Overall Study|Transition to compassionate use|3
2280338|NCT02349633|3963496|FG008|Overall Study|Transition to compassionate use|0
2280339|NCT02349633|3963497|FG009|Overall Study|Transition to compassionate use|1
2280340|NCT02349633|3963498|FG010|Overall Study|Transition to compassionate use|0
2280341|NCT02349633|3963499|FG011|Overall Study|Transition to compassionate use|0
2280342|NCT02349633|3963500|FG012|Overall Study|Transition to compassionate use|0
2280343|NCT02349633|3963501|FG013|Overall Study|Transition to compassionate use|0
2280344|NCT02349633|3963488|FG000|Overall Study|Early termination of survival follow-up|0
2280345|NCT02349633|3963489|FG001|Overall Study|Early termination of survival follow-up|0
2280346|NCT02349633|3963490|FG002|Overall Study|Early termination of survival follow-up|0
2280347|NCT02349633|3963491|FG003|Overall Study|Early termination of survival follow-up|0
2280348|NCT02349633|3963492|FG004|Overall Study|Early termination of survival follow-up|0
2280349|NCT02349633|3963493|FG005|Overall Study|Early termination of survival follow-up|0
2280350|NCT02349633|3963494|FG006|Overall Study|Early termination of survival follow-up|0
2280351|NCT02349633|3963495|FG007|Overall Study|Early termination of survival follow-up|4
2280352|NCT02349633|3963496|FG008|Overall Study|Early termination of survival follow-up|0
2280353|NCT02349633|3963497|FG009|Overall Study|Early termination of survival follow-up|0
2280354|NCT02349633|3963498|FG010|Overall Study|Early termination of survival follow-up|0
2280355|NCT02349633|3963499|FG011|Overall Study|Early termination of survival follow-up|0
2280356|NCT02349633|3963500|FG012|Overall Study|Early termination of survival follow-up|0
2280357|NCT02349633|3963501|FG013|Overall Study|Early termination of survival follow-up|0
2280358|NCT02349633|3963488|FG000|Overall Study|Termination by sponsor|0
2280359|NCT02349633|3963489|FG001|Overall Study|Termination by sponsor|0
2280360|NCT02349633|3963490|FG002|Overall Study|Termination by sponsor|0
2280361|NCT02349633|3963491|FG003|Overall Study|Termination by sponsor|0
2280362|NCT02349633|3963492|FG004|Overall Study|Termination by sponsor|0
2280363|NCT02349633|3963493|FG005|Overall Study|Termination by sponsor|0
2280364|NCT02349633|3963494|FG006|Overall Study|Termination by sponsor|0
2280365|NCT02349633|3963495|FG007|Overall Study|Termination by sponsor|1
2280366|NCT02349633|3963496|FG008|Overall Study|Termination by sponsor|0
2280367|NCT02349633|3963497|FG009|Overall Study|Termination by sponsor|2
2280368|NCT02349633|3963498|FG010|Overall Study|Termination by sponsor|0
2280369|NCT02349633|3963499|FG011|Overall Study|Termination by sponsor|0
2280370|NCT02349633|3963500|FG012|Overall Study|Termination by sponsor|0
2205350|NCT01609556|3843228|FG012|Dose Expansion: Maximum 124 Weeks|Death|4
2205351|NCT01609556|3843229|FG013|Dose Expansion: Maximum 124 Weeks|Death|2
2205352|NCT01609556|3843230|FG014|Dose Expansion: Maximum 124 Weeks|Death|0
2205353|NCT01609556|3843231|FG015|Dose Expansion: Maximum 124 Weeks|Death|3
2205354|NCT01609556|3843216|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205355|NCT01609556|3843217|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205356|NCT01609556|3843218|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205357|NCT01609556|3843219|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205358|NCT01609556|3843220|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2125066|NCT00996281|3726020|FG000|Overall Study|Lost to Follow-up|14
2125067|NCT00996281|3726021|FG001|Overall Study|Lost to Follow-up|16
2125068|NCT00996281|3726020|FG000|Overall Study|Withdrawal by Subject|31
2125069|NCT00996281|3726021|FG001|Overall Study|Withdrawal by Subject|20
2125070|NCT00996281|3726020|FG000|Overall Study|Lack of Efficacy|0
2125071|NCT00996281|3726021|FG001|Overall Study|Lack of Efficacy|2
2125072|NCT00996281|3726020|FG000|Overall Study|Other|5
2125073|NCT00996281|3726021|FG001|Overall Study|Other|7
2125074|NCT00996307|3726031|FG000|Overall Study|Adverse Event|0
2125075|NCT00996307|3726032|FG001|Overall Study|Adverse Event|1
2125076|NCT00996307|3726033|FG002|Overall Study|Adverse Event|0
2125077|NCT00996307|3726034|FG003|Overall Study|Adverse Event|0
2125078|NCT00996307|3726031|FG000|Overall Study|Withdrawal by Subject|3
2125079|NCT00996307|3726032|FG001|Overall Study|Withdrawal by Subject|2
2125080|NCT00996307|3726033|FG002|Overall Study|Withdrawal by Subject|5
2125081|NCT00996307|3726034|FG003|Overall Study|Withdrawal by Subject|5
2125082|NCT00996307|3726031|FG000|Overall Study|Lost to Follow-up|13
2125083|NCT00996307|3726032|FG001|Overall Study|Lost to Follow-up|13
2125084|NCT00996307|3726033|FG002|Overall Study|Lost to Follow-up|7
2125085|NCT00996307|3726034|FG003|Overall Study|Lost to Follow-up|15
2125086|NCT00996307|3726031|FG000|Overall Study|Administrative reason|0
2125087|NCT00996307|3726032|FG001|Overall Study|Administrative reason|1
2125088|NCT00996307|3726033|FG002|Overall Study|Administrative reason|0
2125089|NCT00996307|3726034|FG003|Overall Study|Administrative reason|0
2125090|NCT00996307|3726031|FG000|Overall Study|Unable to classify|4
2125091|NCT00996307|3726032|FG001|Overall Study|Unable to classify|0
2280371|NCT02349633|3963501|FG013|Overall Study|Termination by sponsor|0
2280372|NCT02349633|3963488|FG000|Overall Study|Other|0
2280373|NCT02349633|3963489|FG001|Overall Study|Other|0
2280374|NCT02349633|3963490|FG002|Overall Study|Other|0
2280375|NCT02349633|3963491|FG003|Overall Study|Other|0
2280376|NCT02349633|3963492|FG004|Overall Study|Other|0
2280377|NCT02349633|3963493|FG005|Overall Study|Other|0
2280378|NCT02349633|3963494|FG006|Overall Study|Other|0
2280379|NCT02349633|3963495|FG007|Overall Study|Other|2
2280380|NCT02349633|3963496|FG008|Overall Study|Other|0
2280381|NCT02349633|3963497|FG009|Overall Study|Other|0
2280382|NCT02349633|3963498|FG010|Overall Study|Other|0
2280383|NCT02349633|3963499|FG011|Overall Study|Other|0
2280384|NCT02349633|3963500|FG012|Overall Study|Other|0
2280385|NCT02349633|3963501|FG013|Overall Study|Other|0
2280386|NCT02349711|3963581|FG000|Overall Study|Withdrawal by Subject|2
2280387|NCT02349711|3963582|FG001|Overall Study|Withdrawal by Subject|1
2280388|NCT02349711|3963581|FG000|Overall Study|Lost to Follow-up|1
2280389|NCT02349711|3963582|FG001|Overall Study|Lost to Follow-up|1
2280390|NCT02349789|3963588|FG000|Overall Study|Withdrawal by Subject|2
2280391|NCT02350127|3963594|FG000|4-Month Assessment|Withdrawal by Subject|10
2280392|NCT02350127|3963595|FG001|4-Month Assessment|Withdrawal by Subject|9
2280393|NCT02350127|3963594|FG000|4-Month Assessment|Death|1
2280394|NCT02350127|3963595|FG001|4-Month Assessment|Death|0
2280395|NCT02350127|3963594|FG000|8-Month Assessment|Death|1
2280396|NCT02350127|3963595|FG001|8-Month Assessment|Death|1
2280397|NCT02350127|3963594|FG000|8-Month Assessment|Withdrawal by Subject|5
2280398|NCT02350127|3963595|FG001|8-Month Assessment|Withdrawal by Subject|8
2280399|NCT02350309|3963608|FG000|Treatment Period 1 (2 Days)|Physician Decision|0
2280400|NCT02350309|3963609|FG001|Treatment Period 1 (2 Days)|Physician Decision|0
2280401|NCT02350309|3963610|FG002|Treatment Period 1 (2 Days)|Physician Decision|1
2280402|NCT02350309|3963611|FG003|Treatment Period 1 (2 Days)|Physician Decision|0
2280403|NCT02350309|3963612|FG004|Treatment Period 1 (2 Days)|Physician Decision|0
2280404|NCT02350309|3963613|FG005|Treatment Period 1 (2 Days)|Physician Decision|0
2280405|NCT02350309|3963608|FG000|Treatment Period 4 (2 Days)|Death in the Family|0
2280406|NCT02350309|3963609|FG001|Treatment Period 4 (2 Days)|Death in the Family|0
2280407|NCT02350309|3963610|FG002|Treatment Period 4 (2 Days)|Death in the Family|0
2280408|NCT02350309|3963611|FG003|Treatment Period 4 (2 Days)|Death in the Family|0
2280409|NCT02350309|3963612|FG004|Treatment Period 4 (2 Days)|Death in the Family|0
2280410|NCT02350309|3963613|FG005|Treatment Period 4 (2 Days)|Death in the Family|1
2280411|NCT02350478|3963630|FG000|Overall Study|Lost to Follow-up|5
2280412|NCT02350478|3963631|FG001|Overall Study|Lost to Follow-up|1
2280413|NCT02351167|3963747|FG000|Overall Study|Withdrawal by Subject|19
2280414|NCT02351167|3963748|FG001|Overall Study|Withdrawal by Subject|18
2280415|NCT02351167|3963749|FG002|Overall Study|Withdrawal by Subject|21
2280416|NCT02351349|3963777|FG000|Overall Study|Withdrawal by Subject|2
2280417|NCT02351349|3963778|FG001|Overall Study|Withdrawal by Subject|3
2280418|NCT02351817|3963814|FG000|Period 1|Adverse Event|1
2280419|NCT02351817|3963815|FG001|Period 1|Adverse Event|2
2280420|NCT02351817|3963814|FG000|Period 1|Lack of Efficacy|0
2280421|NCT02351817|3963815|FG001|Period 1|Lack of Efficacy|1
2280422|NCT02351817|3963814|FG000|Period 2|Adverse Event|0
2280423|NCT02351817|3963815|FG001|Period 2|Adverse Event|2
2280424|NCT02351817|3963814|FG000|Period 2|Protocol Violation|1
2280425|NCT02351817|3963815|FG001|Period 2|Protocol Violation|0
2280426|NCT02351934|3963824|FG000|Allocation|POD weight<pre-op weight|3
2125092|NCT00996307|3726033|FG002|Overall Study|Unable to classify|2
2280427|NCT02351934|3963825|FG001|Allocation|POD weight<pre-op weight|0
2280428|NCT02351934|3963824|FG000|Allocation|Hypotension preventing administration|2
2280429|NCT02351934|3963825|FG001|Allocation|Hypotension preventing administration|0
2125093|NCT00996307|3726034|FG003|Overall Study|Unable to classify|1
2125094|NCT00996437|3726086|FG000|Overall Study|Death|1
2125095|NCT00996437|3726087|FG001|Overall Study|Death|0
2125096|NCT00996437|3726086|FG000|Overall Study|Dropped|2
2125097|NCT00996437|3726087|FG001|Overall Study|Dropped|2
2125098|NCT00996437|3726086|FG000|Overall Study|Missed|2
2125099|NCT00996437|3726087|FG001|Overall Study|Missed|5
2125100|NCT00996476|3726098|FG000|Overall Study|Withdrawal by Subject|1
2280430|NCT02351934|3963824|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1
2280431|NCT02351934|3963825|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0
2280432|NCT02351934|3963824|FG000|Follow-Up|POD weight<pre-op weight|3
2280433|NCT02351934|3963825|FG001|Follow-Up|POD weight<pre-op weight|0
2280434|NCT02351934|3963824|FG000|Follow-Up|Acute Kidney Injury|1
2280435|NCT02351934|3963825|FG001|Follow-Up|Acute Kidney Injury|0
2280436|NCT02351934|3963824|FG000|Follow-Up|Early dismissal|3
2280437|NCT02351934|3963825|FG001|Follow-Up|Early dismissal|0
2280438|NCT02351934|3963824|FG000|Follow-Up|Hypotension|3
2280439|NCT02351934|3963825|FG001|Follow-Up|Hypotension|0
2280440|NCT02351934|3963824|FG000|Follow-Up|No documentation|2
2280441|NCT02351934|3963825|FG001|Follow-Up|No documentation|0
2280442|NCT02351934|3963824|FG000|Follow-Up|1 ERAS Component Noncompliant|0
2280443|NCT02351934|3963825|FG001|Follow-Up|1 ERAS Component Noncompliant|6
2280444|NCT02351934|3963824|FG000|Follow-Up|2 ERAS Components Noncompliant|0
2280445|NCT02351934|3963825|FG001|Follow-Up|2 ERAS Components Noncompliant|4
2280446|NCT02351960|3963833|FG000|Overall Study|Pretreatment Event/Adverse Event|6
2280447|NCT02351960|3963834|FG001|Overall Study|Pretreatment Event/Adverse Event|3
2280448|NCT02351960|3963833|FG000|Overall Study|Voluntary Withdrawal|5
2280449|NCT02351960|3963834|FG001|Overall Study|Voluntary Withdrawal|4
2280450|NCT02351960|3963833|FG000|Overall Study|Significant Protocol Deviation|0
2280451|NCT02351960|3963834|FG001|Overall Study|Significant Protocol Deviation|5
2280452|NCT02352090|3963844|FG000|Overall Study|general malaise|1
2280453|NCT02352090|3963845|FG001|Overall Study|general malaise|0
2280454|NCT02352090|3963846|FG002|Overall Study|general malaise|0
2280455|NCT02352090|3963844|FG000|Overall Study|non-specified mild side-effects|0
2280456|NCT02352090|3963845|FG001|Overall Study|non-specified mild side-effects|0
2280457|NCT02352090|3963846|FG002|Overall Study|non-specified mild side-effects|2
2280458|NCT02352493|3963890|FG000|Overall Study|Pregnancy|0
2280459|NCT02352493|3963891|FG001|Overall Study|Pregnancy|0
2280460|NCT02352493|3963892|FG002|Overall Study|Pregnancy|0
2280461|NCT02352493|3963893|FG003|Overall Study|Pregnancy|0
2280462|NCT02352493|3963894|FG004|Overall Study|Pregnancy|0
2280463|NCT02352493|3963895|FG005|Overall Study|Pregnancy|0
2280464|NCT02352493|3963896|FG006|Overall Study|Pregnancy|1
2280465|NCT02352493|3963897|FG007|Overall Study|Pregnancy|0
2280466|NCT02352493|3963898|FG008|Overall Study|Pregnancy|1
2280467|NCT02352493|3963899|FG009|Overall Study|Pregnancy|0
2280468|NCT02352493|3963900|FG010|Overall Study|Pregnancy|0
2280469|NCT02352493|3963901|FG011|Overall Study|Pregnancy|0
2280470|NCT02352493|3963902|FG012|Overall Study|Pregnancy|0
2280471|NCT02352493|3963903|FG013|Overall Study|Pregnancy|0
2280472|NCT02352493|3963904|FG014|Overall Study|Pregnancy|0
2280473|NCT02352493|3963905|FG015|Overall Study|Pregnancy|0
2280474|NCT02352493|3963906|FG016|Overall Study|Pregnancy|0
2280475|NCT02352493|3963907|FG017|Overall Study|Pregnancy|0
2280476|NCT02352493|3963890|FG000|Overall Study|Withdrawal by Subject|0
2280477|NCT02352493|3963891|FG001|Overall Study|Withdrawal by Subject|0
2280478|NCT02352493|3963892|FG002|Overall Study|Withdrawal by Subject|0
2280479|NCT02352493|3963893|FG003|Overall Study|Withdrawal by Subject|0
2280480|NCT02352493|3963894|FG004|Overall Study|Withdrawal by Subject|0
2280481|NCT02352493|3963895|FG005|Overall Study|Withdrawal by Subject|0
2280482|NCT02352493|3963896|FG006|Overall Study|Withdrawal by Subject|0
2280483|NCT02352493|3963897|FG007|Overall Study|Withdrawal by Subject|0
2280484|NCT02352493|3963898|FG008|Overall Study|Withdrawal by Subject|1
2280485|NCT02352493|3963899|FG009|Overall Study|Withdrawal by Subject|0
2280486|NCT02352493|3963900|FG010|Overall Study|Withdrawal by Subject|0
2280487|NCT02352493|3963901|FG011|Overall Study|Withdrawal by Subject|0
2280488|NCT02352493|3963902|FG012|Overall Study|Withdrawal by Subject|0
2280489|NCT02352493|3963903|FG013|Overall Study|Withdrawal by Subject|0
2280490|NCT02352493|3963904|FG014|Overall Study|Withdrawal by Subject|1
2280491|NCT02352493|3963905|FG015|Overall Study|Withdrawal by Subject|0
2280492|NCT02352493|3963906|FG016|Overall Study|Withdrawal by Subject|0
2280493|NCT02352493|3963907|FG017|Overall Study|Withdrawal by Subject|0
2280494|NCT02352493|3963890|FG000|Overall Study|Lost to Follow-up|0
2280495|NCT02352493|3963891|FG001|Overall Study|Lost to Follow-up|0
2280496|NCT02352493|3963892|FG002|Overall Study|Lost to Follow-up|0
2280497|NCT02352493|3963893|FG003|Overall Study|Lost to Follow-up|0
2280498|NCT02352493|3963894|FG004|Overall Study|Lost to Follow-up|0
2280499|NCT02352493|3963895|FG005|Overall Study|Lost to Follow-up|0
2280500|NCT02352493|3963896|FG006|Overall Study|Lost to Follow-up|0
2280501|NCT02352493|3963897|FG007|Overall Study|Lost to Follow-up|0
2280502|NCT02352493|3963898|FG008|Overall Study|Lost to Follow-up|0
2280503|NCT02352493|3963899|FG009|Overall Study|Lost to Follow-up|1
2280504|NCT02352493|3963900|FG010|Overall Study|Lost to Follow-up|0
2280505|NCT02352493|3963901|FG011|Overall Study|Lost to Follow-up|0
2280506|NCT02352493|3963902|FG012|Overall Study|Lost to Follow-up|1
2280507|NCT02352493|3963903|FG013|Overall Study|Lost to Follow-up|2
2280508|NCT02352493|3963904|FG014|Overall Study|Lost to Follow-up|0
2125101|NCT00996476|3726099|FG001|Overall Study|Withdrawal by Subject|2
2125102|NCT00996476|3726100|FG002|Overall Study|Withdrawal by Subject|1
2125103|NCT00996476|3726101|FG003|Overall Study|Withdrawal by Subject|0
2125104|NCT00996476|3726102|FG004|Overall Study|Withdrawal by Subject|1
2125105|NCT00996476|3726098|FG000|Overall Study|Adverse Event|0
2125106|NCT00996476|3726099|FG001|Overall Study|Adverse Event|1
2125107|NCT00996476|3726100|FG002|Overall Study|Adverse Event|0
2125108|NCT00996476|3726101|FG003|Overall Study|Adverse Event|0
2125109|NCT00996476|3726102|FG004|Overall Study|Adverse Event|1
2125110|NCT00996489|3726119|FG000|Overall Study|Device failure|45
2125111|NCT00996489|3726119|FG000|Overall Study|Discontinued|116
2125112|NCT00996580|3726123|FG000|Overall Study|Adverse Event|466
2125113|NCT00996580|3726123|FG000|Overall Study|Lost to Follow-up|480
2125114|NCT00996580|3726123|FG000|Overall Study|Noncompliance with the protocol|137
2125115|NCT00996580|3726123|FG000|Overall Study|Physician Decision|5
2125116|NCT00996580|3726123|FG000|Overall Study|Pregnancy|68
2125117|NCT00996580|3726123|FG000|Overall Study|Protocol Violation|16
2125118|NCT00996580|3726123|FG000|Overall Study|Sponsor requested participant withdrawal|35
2125119|NCT00996580|3726123|FG000|Overall Study|Withdrawal by Subject|217
2125120|NCT00996580|3726123|FG000|Overall Study|Other|29
2125121|NCT00996593|3726130|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
2125122|NCT00996593|3726130|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
2125123|NCT00996593|3726130|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22
2125124|NCT00996593|3726130|FG000|Dosimetric and Therapeutic Treatment|Death|1
2125125|NCT00996593|3726130|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
2125126|NCT00996593|3726130|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
2125127|NCT00996593|3726130|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1
2125128|NCT00996593|3726130|FG000|Long-Term Follow-Up|Withdrawal by Subject|2
2125129|NCT00996593|3726130|FG000|Long-Term Follow-Up|Site Closed|1
2125130|NCT00996606|3726134|FG000|Overall Study|Adverse Event or Intercurrent Illness|2
2125131|NCT00996606|3726134|FG000|Overall Study|Insufficient Therapeutic Response|2
2125132|NCT00996606|3726134|FG000|Overall Study|Protocol Violation|1
2125133|NCT00996606|3726134|FG000|Overall Study|Withdrawal by Subject|3
2125134|NCT00996632|3726140|FG000|Overall Study|Physician Decision|0
2125135|NCT00996632|3726141|FG001|Overall Study|Physician Decision|0
2125136|NCT00996658|3726149|FG000|Overall Study|Adverse Event|2
2125137|NCT00996658|3726150|FG001|Overall Study|Adverse Event|5
2125138|NCT00996658|3726149|FG000|Overall Study|Protocol Violation|0
2125139|NCT00996658|3726150|FG001|Overall Study|Protocol Violation|1
2125140|NCT00996658|3726149|FG000|Overall Study|Lost to Follow-up|2
2125141|NCT00996658|3726150|FG001|Overall Study|Lost to Follow-up|5
2125142|NCT00996658|3726149|FG000|Overall Study|Non-compliance issues|3
2125143|NCT00996658|3726150|FG001|Overall Study|Non-compliance issues|3
2125144|NCT00996658|3726149|FG000|Overall Study|Other|9
2125145|NCT00996658|3726150|FG001|Overall Study|Other|7
2125146|NCT00996736|3726158|FG000|Overall Study|Death|1
2125147|NCT00996736|3726159|FG001|Overall Study|Death|1
2125148|NCT00996736|3726158|FG000|Overall Study|Lost to Follow-up|15
2125149|NCT00996736|3726159|FG001|Overall Study|Lost to Follow-up|14
2125150|NCT00996736|3726158|FG000|Overall Study|Visit not within 3-month window|5
2125151|NCT00996736|3726159|FG001|Overall Study|Visit not within 3-month window|3
2125152|NCT00996801|3726180|FG000|Overall Study|Adverse Event|6
2125153|NCT00996801|3726181|FG001|Overall Study|Adverse Event|4
2125154|NCT00996801|3726182|FG002|Overall Study|Adverse Event|12
2125155|NCT00996801|3726183|FG003|Overall Study|Adverse Event|17
2125156|NCT00996801|3726184|FG004|Overall Study|Adverse Event|31
2125157|NCT00996801|3726185|FG005|Overall Study|Adverse Event|3
2125158|NCT00996801|3726180|FG000|Overall Study|Lack of Efficacy|3
2125159|NCT00996801|3726181|FG001|Overall Study|Lack of Efficacy|0
2125160|NCT00996801|3726182|FG002|Overall Study|Lack of Efficacy|1
2125161|NCT00996801|3726183|FG003|Overall Study|Lack of Efficacy|3
2280509|NCT02352493|3963905|FG015|Overall Study|Lost to Follow-up|0
2280510|NCT02352493|3963906|FG016|Overall Study|Lost to Follow-up|0
2280511|NCT02352493|3963907|FG017|Overall Study|Lost to Follow-up|0
2280512|NCT02352779|3963965|FG000|Overall Study|Personal Issues|1
2280513|NCT02352779|3963966|FG001|Overall Study|Personal Issues|1
2280514|NCT02352779|3963967|FG002|Overall Study|Personal Issues|0
2280515|NCT02352779|3963965|FG000|Overall Study|Too Many Forms|2
2280516|NCT02352779|3963966|FG001|Overall Study|Too Many Forms|0
2280517|NCT02352779|3963967|FG002|Overall Study|Too Many Forms|0
2280518|NCT02352779|3963965|FG000|Overall Study|Feeling Overwhelmed|1
2280519|NCT02352779|3963966|FG001|Overall Study|Feeling Overwhelmed|0
2280520|NCT02352779|3963967|FG002|Overall Study|Feeling Overwhelmed|0
2280521|NCT02352779|3963965|FG000|Overall Study|Disliked Intervention|1
2280522|NCT02352779|3963966|FG001|Overall Study|Disliked Intervention|0
2280523|NCT02352779|3963967|FG002|Overall Study|Disliked Intervention|0
2280524|NCT02352779|3963965|FG000|Overall Study|Changed Mind|1
2280525|NCT02352779|3963966|FG001|Overall Study|Changed Mind|0
2280526|NCT02352779|3963967|FG002|Overall Study|Changed Mind|0
2125162|NCT00996801|3726184|FG004|Overall Study|Lack of Efficacy|0
2280527|NCT02352779|3963965|FG000|Overall Study|Study Related Symptoms|1
2280528|NCT02352779|3963966|FG001|Overall Study|Study Related Symptoms|0
2280529|NCT02352779|3963967|FG002|Overall Study|Study Related Symptoms|0
2280530|NCT02352779|3963965|FG000|Overall Study|Absence of Symptoms|1
2125163|NCT00996801|3726185|FG005|Overall Study|Lack of Efficacy|1
2125164|NCT00996801|3726180|FG000|Overall Study|Lost to Follow-up|0
2125165|NCT00996801|3726181|FG001|Overall Study|Lost to Follow-up|0
2125166|NCT00996801|3726182|FG002|Overall Study|Lost to Follow-up|0
2125167|NCT00996801|3726183|FG003|Overall Study|Lost to Follow-up|3
2125168|NCT00996801|3726184|FG004|Overall Study|Lost to Follow-up|3
2125169|NCT00996801|3726185|FG005|Overall Study|Lost to Follow-up|2
2125170|NCT00996801|3726180|FG000|Overall Study|Physician Decision|0
2125171|NCT00996801|3726181|FG001|Overall Study|Physician Decision|0
2125172|NCT00996801|3726182|FG002|Overall Study|Physician Decision|0
2125173|NCT00996801|3726183|FG003|Overall Study|Physician Decision|1
2125174|NCT00996801|3726184|FG004|Overall Study|Physician Decision|0
2125175|NCT00996801|3726185|FG005|Overall Study|Physician Decision|0
2125176|NCT00996801|3726180|FG000|Overall Study|Progressive Disease|0
2125177|NCT00996801|3726181|FG001|Overall Study|Progressive Disease|1
2125178|NCT00996801|3726182|FG002|Overall Study|Progressive Disease|0
2125179|NCT00996801|3726183|FG003|Overall Study|Progressive Disease|0
2125180|NCT00996801|3726184|FG004|Overall Study|Progressive Disease|0
2125181|NCT00996801|3726185|FG005|Overall Study|Progressive Disease|0
2125182|NCT00996801|3726180|FG000|Overall Study|Protocol Violation|3
2125183|NCT00996801|3726181|FG001|Overall Study|Protocol Violation|4
2125184|NCT00996801|3726182|FG002|Overall Study|Protocol Violation|1
2125185|NCT00996801|3726183|FG003|Overall Study|Protocol Violation|2
2125186|NCT00996801|3726184|FG004|Overall Study|Protocol Violation|3
2125187|NCT00996801|3726185|FG005|Overall Study|Protocol Violation|4
2125188|NCT00996801|3726180|FG000|Overall Study|Study Terminated by Sponsor|0
2125189|NCT00996801|3726181|FG001|Overall Study|Study Terminated by Sponsor|1
2125190|NCT00996801|3726182|FG002|Overall Study|Study Terminated by Sponsor|0
2125191|NCT00996801|3726183|FG003|Overall Study|Study Terminated by Sponsor|0
2125192|NCT00996801|3726184|FG004|Overall Study|Study Terminated by Sponsor|46
2125193|NCT00996801|3726185|FG005|Overall Study|Study Terminated by Sponsor|0
2125194|NCT00996801|3726180|FG000|Overall Study|Withdrawal by Subject|8
2125195|NCT00996801|3726181|FG001|Overall Study|Withdrawal by Subject|6
2125196|NCT00996801|3726182|FG002|Overall Study|Withdrawal by Subject|9
2280531|NCT02352779|3963966|FG001|Overall Study|Absence of Symptoms|0
2280532|NCT02352779|3963967|FG002|Overall Study|Absence of Symptoms|0
2280533|NCT02352779|3963965|FG000|Overall Study|Other Medical Reason|0
2280534|NCT02352779|3963966|FG001|Overall Study|Other Medical Reason|0
2280535|NCT02352779|3963967|FG002|Overall Study|Other Medical Reason|1
2280536|NCT02352779|3963965|FG000|Overall Study|No Reason|0
2280537|NCT02352779|3963966|FG001|Overall Study|No Reason|0
2280538|NCT02352779|3963967|FG002|Overall Study|No Reason|1
2280539|NCT02353169|3964025|FG000|Overall Study|QTc > 450 msec|1
2280540|NCT02353169|3964026|FG001|Overall Study|QTc > 450 msec|1
2280541|NCT02353169|3964027|FG002|Overall Study|QTc > 450 msec|1
2280542|NCT02353169|3964028|FG003|Overall Study|QTc > 450 msec|1
2280543|NCT02353169|3964025|FG000|Overall Study|OR team declined|2
2280544|NCT02353169|3964026|FG001|Overall Study|OR team declined|0
2280545|NCT02353169|3964027|FG002|Overall Study|OR team declined|0
2280546|NCT02353169|3964028|FG003|Overall Study|OR team declined|0
2280547|NCT02353169|3964025|FG000|Overall Study|Inhalational induction|0
2280548|NCT02353169|3964026|FG001|Overall Study|Inhalational induction|2
2280549|NCT02353169|3964027|FG002|Overall Study|Inhalational induction|0
2280550|NCT02353169|3964028|FG003|Overall Study|Inhalational induction|0
2280551|NCT02353169|3964025|FG000|Overall Study|ECG data error|0
2280552|NCT02353169|3964026|FG001|Overall Study|ECG data error|3
2280553|NCT02353169|3964027|FG002|Overall Study|ECG data error|2
2280554|NCT02353169|3964028|FG003|Overall Study|ECG data error|2
2280555|NCT02353169|3964025|FG000|Overall Study|Pre-op medication|0
2280556|NCT02353169|3964026|FG001|Overall Study|Pre-op medication|0
2280557|NCT02353169|3964027|FG002|Overall Study|Pre-op medication|1
2280558|NCT02353169|3964028|FG003|Overall Study|Pre-op medication|0
2280559|NCT02353442|3964061|FG000|Overall Study|Withdrawal by Subject|3
2280560|NCT02353442|3964062|FG001|Overall Study|Withdrawal by Subject|4
2280561|NCT02353871|3964102|FG000|Overall Study|Protocol deviation|0
2280562|NCT02353871|3964103|FG001|Overall Study|Protocol deviation|1
2280563|NCT02353871|3964102|FG000|Overall Study|Consent withdrawn|1
2280564|NCT02353871|3964103|FG001|Overall Study|Consent withdrawn|8
2280565|NCT02353871|3964102|FG000|Overall Study|Lost to Follow-up|2
2280566|NCT02353871|3964103|FG001|Overall Study|Lost to Follow-up|0
2280567|NCT02354222|3964129|FG000|Overall Study|Adverse Event|0
2280568|NCT02354222|3964130|FG001|Overall Study|Adverse Event|3
2280569|NCT02354222|3964129|FG000|Overall Study|Physician Decision|1
2280570|NCT02354222|3964130|FG001|Overall Study|Physician Decision|1
2125197|NCT00996801|3726183|FG003|Overall Study|Withdrawal by Subject|5
2125198|NCT00996801|3726184|FG004|Overall Study|Withdrawal by Subject|5
2125199|NCT00996801|3726185|FG005|Overall Study|Withdrawal by Subject|9
2125200|NCT00996840|3726206|FG000|Overall Study|Adverse Event|0
2125201|NCT00996840|3726207|FG001|Overall Study|Adverse Event|1
2280571|NCT02354222|3964129|FG000|Overall Study|Pregnancy|1
2280572|NCT02354222|3964130|FG001|Overall Study|Pregnancy|0
2280573|NCT02354222|3964129|FG000|Overall Study|Withdrawal by Subject|2
2280574|NCT02354222|3964130|FG001|Overall Study|Withdrawal by Subject|3
2280575|NCT02354222|3964129|FG000|Overall Study|Conflict with the stopping criteria|0
2280576|NCT02354222|3964130|FG001|Overall Study|Conflict with the stopping criteria|4
2280577|NCT02354235|3964138|FG000|Overall Study|Adverse Event|2
2125202|NCT00996840|3726208|FG002|Overall Study|Adverse Event|0
2125203|NCT00996840|3726209|FG003|Overall Study|Adverse Event|0
2125204|NCT00996840|3726210|FG004|Overall Study|Adverse Event|0
2125205|NCT00996840|3726206|FG000|Overall Study|Physician Decision|0
2125206|NCT00996840|3726207|FG001|Overall Study|Physician Decision|0
2125207|NCT00996840|3726208|FG002|Overall Study|Physician Decision|1
2125208|NCT00996840|3726209|FG003|Overall Study|Physician Decision|1
2125209|NCT00996840|3726210|FG004|Overall Study|Physician Decision|2
2125210|NCT00996840|3726206|FG000|Overall Study|Withdrawal by Subject|1
2125211|NCT00996840|3726207|FG001|Overall Study|Withdrawal by Subject|1
2125212|NCT00996840|3726208|FG002|Overall Study|Withdrawal by Subject|0
2125213|NCT00996840|3726209|FG003|Overall Study|Withdrawal by Subject|0
2125214|NCT00996840|3726210|FG004|Overall Study|Withdrawal by Subject|0
2125215|NCT00996892|3726226|FG000|Dose-Escalation Stage 1|Adverse Event|0
2125216|NCT00996892|3726227|FG001|Dose-Escalation Stage 1|Adverse Event|0
2125217|NCT00996892|3726228|FG002|Dose-Escalation Stage 1|Adverse Event|0
2125218|NCT00996892|3726229|FG003|Dose-Escalation Stage 1|Adverse Event|2
2125219|NCT00996892|3726230|FG004|Dose-Escalation Stage 1|Adverse Event|0
2125220|NCT00996892|3726231|FG005|Dose-Escalation Stage 1|Adverse Event|0
2125221|NCT00996892|3726232|FG006|Dose-Escalation Stage 1|Adverse Event|1
2125222|NCT00996892|3726233|FG007|Dose-Escalation Stage 1|Adverse Event|0
2125223|NCT00996892|3726234|FG008|Dose-Escalation Stage 1|Adverse Event|0
2125224|NCT00996892|3726235|FG009|Dose-Escalation Stage 1|Adverse Event|0
2125225|NCT00996892|3726236|FG010|Dose-Escalation Stage 1|Adverse Event|0
2125226|NCT00996892|3726237|FG011|Dose-Escalation Stage 1|Adverse Event|0
2125227|NCT00996892|3726238|FG012|Dose-Escalation Stage 1|Adverse Event|0
2125228|NCT00996892|3726239|FG013|Dose-Escalation Stage 1|Adverse Event|0
2125229|NCT00996892|3726240|FG014|Dose-Escalation Stage 1|Adverse Event|0
2125230|NCT00996892|3726241|FG015|Dose-Escalation Stage 1|Adverse Event|0
2125231|NCT00996892|3726242|FG016|Dose-Escalation Stage 1|Adverse Event|0
2125232|NCT00996892|3726243|FG017|Dose-Escalation Stage 1|Adverse Event|0
2125233|NCT00996892|3726244|FG018|Dose-Escalation Stage 1|Adverse Event|0
2125234|NCT00996892|3726245|FG019|Dose-Escalation Stage 1|Adverse Event|0
2125235|NCT00996892|3726226|FG000|Dose-Escalation Stage 1|Death|1
2125236|NCT00996892|3726227|FG001|Dose-Escalation Stage 1|Death|0
2125237|NCT00996892|3726228|FG002|Dose-Escalation Stage 1|Death|0
2125238|NCT00996892|3726229|FG003|Dose-Escalation Stage 1|Death|0
2125239|NCT00996892|3726230|FG004|Dose-Escalation Stage 1|Death|0
2125240|NCT00996892|3726231|FG005|Dose-Escalation Stage 1|Death|1
2125241|NCT00996892|3726232|FG006|Dose-Escalation Stage 1|Death|0
2125242|NCT00996892|3726233|FG007|Dose-Escalation Stage 1|Death|0
2125243|NCT00996892|3726234|FG008|Dose-Escalation Stage 1|Death|0
2125244|NCT00996892|3726235|FG009|Dose-Escalation Stage 1|Death|0
2125245|NCT00996892|3726236|FG010|Dose-Escalation Stage 1|Death|0
2125246|NCT00996892|3726237|FG011|Dose-Escalation Stage 1|Death|0
2125247|NCT00996892|3726238|FG012|Dose-Escalation Stage 1|Death|0
2280578|NCT02354235|3964139|FG001|Overall Study|Adverse Event|2
2280579|NCT02354235|3964138|FG000|Overall Study|Physician Decision|0
2280580|NCT02354235|3964139|FG001|Overall Study|Physician Decision|1
2280581|NCT02354235|3964138|FG000|Overall Study|Withdrawal by Subject|1
2280582|NCT02354235|3964139|FG001|Overall Study|Withdrawal by Subject|3
2280583|NCT02354235|3964138|FG000|Overall Study|Conflict with the stopping criteria|0
2280584|NCT02354235|3964139|FG001|Overall Study|Conflict with the stopping criteria|1
2280585|NCT02354417|3964172|FG000|Overall Study|Physician Decision|1
2320665|NCT02951988|4034989|FG000|Open-Label Treatment Period|Lost to Follow-up|28
2320666|NCT02951988|4034990|FG001|Open-Label Treatment Period|Lost to Follow-up|0
2320667|NCT02951988|4034991|FG002|Open-Label Treatment Period|Lost to Follow-up|0
2320668|NCT02951988|4034992|FG003|Open-Label Treatment Period|Lost to Follow-up|0
2320669|NCT02951988|4034989|FG000|Open-Label Treatment Period|Withdrawal by Subject|78
2320670|NCT02951988|4034990|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
2320671|NCT02951988|4034991|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
2320672|NCT02951988|4034992|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
2320673|NCT02951988|4034989|FG000|Open-Label Treatment Period|Lack of Efficacy|49
2320674|NCT02951988|4034990|FG001|Open-Label Treatment Period|Lack of Efficacy|0
2320675|NCT02951988|4034991|FG002|Open-Label Treatment Period|Lack of Efficacy|0
2320676|NCT02951988|4034992|FG003|Open-Label Treatment Period|Lack of Efficacy|0
2320677|NCT02951988|4034989|FG000|Open-Label Treatment Period|Adverse Event|45
2320678|NCT02951988|4034990|FG001|Open-Label Treatment Period|Adverse Event|0
2320679|NCT02951988|4034991|FG002|Open-Label Treatment Period|Adverse Event|0
2320680|NCT02951988|4034992|FG003|Open-Label Treatment Period|Adverse Event|0
2320681|NCT02951988|4034989|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0
2320682|NCT02951988|4034990|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0
2320683|NCT02951988|4034991|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1
2125248|NCT00996892|3726239|FG013|Dose-Escalation Stage 1|Death|0
2125249|NCT00996892|3726240|FG014|Dose-Escalation Stage 1|Death|0
2125250|NCT00996892|3726241|FG015|Dose-Escalation Stage 1|Death|0
2125251|NCT00996892|3726242|FG016|Dose-Escalation Stage 1|Death|0
2125252|NCT00996892|3726243|FG017|Dose-Escalation Stage 1|Death|0
2320684|NCT02951988|4034992|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1
2320685|NCT02951988|4034989|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0
2320686|NCT02951988|4034990|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58
2125253|NCT00996892|3726244|FG018|Dose-Escalation Stage 1|Death|0
2125254|NCT00996892|3726245|FG019|Dose-Escalation Stage 1|Death|0
2125255|NCT00996892|3726226|FG000|Dose-Escalation Stage 1|Physician Decision|1
2125256|NCT00996892|3726227|FG001|Dose-Escalation Stage 1|Physician Decision|0
2125257|NCT00996892|3726228|FG002|Dose-Escalation Stage 1|Physician Decision|0
2125258|NCT00996892|3726229|FG003|Dose-Escalation Stage 1|Physician Decision|1
2125259|NCT00996892|3726230|FG004|Dose-Escalation Stage 1|Physician Decision|0
2125260|NCT00996892|3726231|FG005|Dose-Escalation Stage 1|Physician Decision|1
2125261|NCT00996892|3726232|FG006|Dose-Escalation Stage 1|Physician Decision|2
2125262|NCT00996892|3726233|FG007|Dose-Escalation Stage 1|Physician Decision|0
2125263|NCT00996892|3726234|FG008|Dose-Escalation Stage 1|Physician Decision|0
2125264|NCT00996892|3726235|FG009|Dose-Escalation Stage 1|Physician Decision|0
2125265|NCT00996892|3726236|FG010|Dose-Escalation Stage 1|Physician Decision|0
2125266|NCT00996892|3726237|FG011|Dose-Escalation Stage 1|Physician Decision|0
2125267|NCT00996892|3726238|FG012|Dose-Escalation Stage 1|Physician Decision|0
2125268|NCT00996892|3726239|FG013|Dose-Escalation Stage 1|Physician Decision|0
2125269|NCT00996892|3726240|FG014|Dose-Escalation Stage 1|Physician Decision|0
2125270|NCT00996892|3726241|FG015|Dose-Escalation Stage 1|Physician Decision|0
2125271|NCT00996892|3726242|FG016|Dose-Escalation Stage 1|Physician Decision|0
2125272|NCT00996892|3726243|FG017|Dose-Escalation Stage 1|Physician Decision|0
2125273|NCT00996892|3726244|FG018|Dose-Escalation Stage 1|Physician Decision|0
2125274|NCT00996892|3726245|FG019|Dose-Escalation Stage 1|Physician Decision|0
2125275|NCT00996892|3726226|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125276|NCT00996892|3726227|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1
2125277|NCT00996892|3726228|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125278|NCT00996892|3726229|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2
2125279|NCT00996892|3726230|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1
2280586|NCT02354508|3964197|FG000|Period 1: Core Phase|Adverse Event|1
2280587|NCT02354508|3964198|FG001|Period 1: Core Phase|Adverse Event|1
2280588|NCT02354508|3964199|FG002|Period 1: Core Phase|Adverse Event|2
2280589|NCT02354508|3964197|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
2280590|NCT02354508|3964198|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
2280591|NCT02354508|3964199|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
2280592|NCT02354508|3964197|FG000|Period 1: Core Phase|Withdrawal by Subject|0
2280593|NCT02354508|3964198|FG001|Period 1: Core Phase|Withdrawal by Subject|1
2280594|NCT02354508|3964199|FG002|Period 1: Core Phase|Withdrawal by Subject|2
2280595|NCT02354508|3964197|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
2280596|NCT02354508|3964198|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
2280597|NCT02354508|3964199|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
2280598|NCT02354508|3964197|FG000|Period 2: Extension Phase|Withdrawal by Subject|0
2280599|NCT02354508|3964198|FG001|Period 2: Extension Phase|Withdrawal by Subject|1
2280600|NCT02354508|3964199|FG002|Period 2: Extension Phase|Withdrawal by Subject|0
2280601|NCT02354508|3964197|FG000|Period 2: Extension Phase|Physician Decision|5
2280602|NCT02354508|3964198|FG001|Period 2: Extension Phase|Physician Decision|0
2280603|NCT02354508|3964199|FG002|Period 2: Extension Phase|Physician Decision|1
2280604|NCT02354508|3964197|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
2280605|NCT02354508|3964198|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
2280606|NCT02354508|3964199|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
2280607|NCT02354508|3964197|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
2280608|NCT02354508|3964198|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
2280609|NCT02354508|3964199|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
2280610|NCT02354508|3964197|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3
2280611|NCT02354508|3964198|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0
2280612|NCT02354508|3964199|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1
2280613|NCT02354586|3964265|FG000|Overall Study|Death|168
2280614|NCT02354586|3964265|FG000|Overall Study|Withdrawal by Subject|51
2280615|NCT02354586|3964265|FG000|Overall Study|Lost to Follow-up|6
2280616|NCT02354586|3964265|FG000|Overall Study|Disease progression|116
2280617|NCT02354599|3964275|FG000|Overall Study|Pretreatment Event/Adverse Event|0
2280618|NCT02354599|3964276|FG001|Overall Study|Pretreatment Event/Adverse Event|0
2280619|NCT02354599|3964277|FG002|Overall Study|Pretreatment Event/Adverse Event|0
2280620|NCT02354599|3964278|FG003|Overall Study|Pretreatment Event/Adverse Event|0
2280621|NCT02354599|3964279|FG004|Overall Study|Pretreatment Event/Adverse Event|0
2280622|NCT02354599|3964280|FG005|Overall Study|Pretreatment Event/Adverse Event|1
2280623|NCT02354599|3964275|FG000|Overall Study|Withdrawal by Subject|1
2280624|NCT02354599|3964276|FG001|Overall Study|Withdrawal by Subject|1
2280625|NCT02354599|3964277|FG002|Overall Study|Withdrawal by Subject|0
2280626|NCT02354599|3964278|FG003|Overall Study|Withdrawal by Subject|0
2280627|NCT02354599|3964279|FG004|Overall Study|Withdrawal by Subject|0
2280628|NCT02354599|3964280|FG005|Overall Study|Withdrawal by Subject|0
2280629|NCT02354690|3964300|FG000|Overall Study|Physician Decision|1
2280630|NCT02354976|3964343|FG000|Overall Study|Other - reason not specified|1
2280631|NCT02354976|3964344|FG001|Overall Study|Other - reason not specified|0
2280632|NCT02354976|3964345|FG002|Overall Study|Other - reason not specified|1
2125280|NCT00996892|3726231|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1
2125281|NCT00996892|3726232|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1
2125282|NCT00996892|3726233|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125283|NCT00996892|3726234|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125284|NCT00996892|3726235|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125285|NCT00996892|3726236|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125286|NCT00996892|3726237|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125287|NCT00996892|3726238|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125288|NCT00996892|3726239|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125289|NCT00996892|3726240|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125290|NCT00996892|3726241|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125291|NCT00996892|3726242|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125292|NCT00996892|3726243|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125293|NCT00996892|3726244|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0
2125294|NCT00996892|3726245|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0
2280633|NCT02354976|3964343|FG000|Overall Study|Study-specifc withdrawal criteria|0
2280634|NCT02354976|3964344|FG001|Overall Study|Study-specifc withdrawal criteria|1
2280635|NCT02354976|3964345|FG002|Overall Study|Study-specifc withdrawal criteria|0
2280636|NCT02354976|3964343|FG000|Overall Study|Adverse Event|1
2280637|NCT02354976|3964344|FG001|Overall Study|Adverse Event|0
2280638|NCT02354976|3964345|FG002|Overall Study|Adverse Event|2
2280639|NCT02355028|3964355|FG000|Overall Study|Adverse Event|2
2280640|NCT02355028|3964356|FG001|Overall Study|Adverse Event|0
2280641|NCT02355028|3964355|FG000|Overall Study|Withdrawal by Subject|1
2280642|NCT02355028|3964356|FG001|Overall Study|Withdrawal by Subject|1
2280643|NCT02355028|3964355|FG000|Overall Study|Deemed ineligible after randomization|8
2280644|NCT02355028|3964356|FG001|Overall Study|Deemed ineligible after randomization|4
2280645|NCT02355665|3964411|FG000|Overall Study|Adverse Event|16
2280646|NCT02355665|3964412|FG001|Overall Study|Adverse Event|24
2280647|NCT02355665|3964411|FG000|Overall Study|Protocol Violation|2
2280648|NCT02355665|3964412|FG001|Overall Study|Protocol Violation|0
2280649|NCT02355665|3964411|FG000|Overall Study|Withdrawal by Subject|90
2280650|NCT02355665|3964412|FG001|Overall Study|Withdrawal by Subject|100
2280651|NCT02355665|3964411|FG000|Overall Study|Lost to Follow-up|131
2280652|NCT02355665|3964412|FG001|Overall Study|Lost to Follow-up|103
2280653|NCT02355665|3964411|FG000|Overall Study|Death|4
2280654|NCT02355665|3964412|FG001|Overall Study|Death|2
2280655|NCT02355665|3964411|FG000|Overall Study|Compliance, PI decision, move, eligible|6
2280656|NCT02355665|3964412|FG001|Overall Study|Compliance, PI decision, move, eligible|3
2280657|NCT02355691|3964420|FG000|Overall Study|Loss of Research Personnel|7
2280658|NCT02355691|3964421|FG001|Overall Study|Loss of Research Personnel|9
2280659|NCT02355743|3964427|FG000|Overall Study|Withdrawal by Subject|1
2280660|NCT02355743|3964427|FG000|Overall Study|Lost to Follow-up|1
2280661|NCT02356211|3964482|FG000|Overall Study|Withdrawal by Subject|2
2280662|NCT02356211|3964483|FG001|Overall Study|Withdrawal by Subject|2
2280663|NCT02356211|3964482|FG000|Overall Study|ineligible|1
2280664|NCT02356211|3964483|FG001|Overall Study|ineligible|8
2320687|NCT02951988|4034991|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54
2320688|NCT02951988|4034992|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69
2320689|NCT02951988|4034989|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0
2320690|NCT02951988|4034990|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1
2320691|NCT02951988|4034991|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3
2320692|NCT02951988|4034992|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0
2320693|NCT02951988|4034989|FG000|Double-Blind Treatment Period|Protocol Violation|0
2320694|NCT02951988|4034990|FG001|Double-Blind Treatment Period|Protocol Violation|4
2320695|NCT02951988|4034991|FG002|Double-Blind Treatment Period|Protocol Violation|4
2320696|NCT02951988|4034992|FG003|Double-Blind Treatment Period|Protocol Violation|8
2320697|NCT02951988|4034989|FG000|Double-Blind Treatment Period|Pregnancy|0
2320698|NCT02951988|4034990|FG001|Double-Blind Treatment Period|Pregnancy|1
2320699|NCT02951988|4034991|FG002|Double-Blind Treatment Period|Pregnancy|1
2320700|NCT02951988|4034992|FG003|Double-Blind Treatment Period|Pregnancy|0
2320701|NCT02951988|4034989|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
2320702|NCT02951988|4034990|FG001|Double-Blind Treatment Period|Lost to Follow-up|4
2320703|NCT02951988|4034991|FG002|Double-Blind Treatment Period|Lost to Follow-up|12
2320704|NCT02951988|4034992|FG003|Double-Blind Treatment Period|Lost to Follow-up|3
2320705|NCT02951988|4034989|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
2320706|NCT02951988|4034990|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23
2320707|NCT02951988|4034991|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22
2320708|NCT02951988|4034992|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28
2320709|NCT02951988|4034989|FG000|Double-Blind Treatment Period|Adverse Event|0
2320710|NCT02951988|4034990|FG001|Double-Blind Treatment Period|Adverse Event|8
2320711|NCT02951988|4034991|FG002|Double-Blind Treatment Period|Adverse Event|3
2320712|NCT02951988|4034992|FG003|Double-Blind Treatment Period|Adverse Event|6
2320713|NCT02951988|4034989|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0
2320714|NCT02951988|4034990|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2
2320715|NCT02951988|4034991|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1
2320716|NCT02951988|4034992|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0
2280665|NCT02356562|3964499|FG000|Overall Study|Withdrawal by Subject|0
2280666|NCT02356562|3964500|FG001|Overall Study|Withdrawal by Subject|1
2280667|NCT02356562|3964499|FG000|Overall Study|Re-entered treatment in a previous study|1
2280668|NCT02356562|3964500|FG001|Overall Study|Re-entered treatment in a previous study|0
2280669|NCT02356562|3964499|FG000|Overall Study|site closure|1
2280670|NCT02356562|3964500|FG001|Overall Study|site closure|0
2280671|NCT02356588|3964518|FG000|Overall Study|Lack of Efficacy|4
2280672|NCT02356588|3964519|FG001|Overall Study|Lack of Efficacy|10
2280673|NCT02356588|3964518|FG000|Overall Study|Adverse Event|0
2280674|NCT02356588|3964519|FG001|Overall Study|Adverse Event|2
2280675|NCT02356588|3964518|FG000|Overall Study|Withdrawal by Subject|1
2280676|NCT02356588|3964519|FG001|Overall Study|Withdrawal by Subject|0
2280677|NCT02356588|3964518|FG000|Overall Study|Protocol Violation|0
2280678|NCT02356588|3964519|FG001|Overall Study|Protocol Violation|1
2280679|NCT02356783|3964549|FG000|Overall Study|Lost to Follow-up|1
2280680|NCT02356783|3964550|FG001|Overall Study|Lost to Follow-up|3
2280681|NCT02356887|3964556|FG000|Overall Study|poor compliance|2
2280682|NCT02357134|3964583|FG000|Overall Study|Lost to Follow-up|1
2280683|NCT02357134|3964584|FG001|Overall Study|Lost to Follow-up|0
2280684|NCT02357134|3964585|FG002|Overall Study|Lost to Follow-up|0
2280685|NCT02357134|3964586|FG003|Overall Study|Lost to Follow-up|0
2280686|NCT02357147|3964598|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
2280687|NCT02357147|3964599|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
2280688|NCT02357147|3964598|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
2280689|NCT02357147|3964599|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
2280690|NCT02357147|3964598|FG000|Combination Treatment Phase|Investigator Discretion|1
2280691|NCT02357147|3964599|FG001|Combination Treatment Phase|Investigator Discretion|1
2280692|NCT02357147|3964598|FG000|Combination Treatment Phase|Withdrawal by Subject|4
2280693|NCT02357147|3964599|FG001|Combination Treatment Phase|Withdrawal by Subject|2
2280694|NCT02357147|3964598|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
2280695|NCT02357147|3964599|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
2280696|NCT02357147|3964598|FG000|Combination Treatment Phase|Adverse Event|12
2280697|NCT02357147|3964599|FG001|Combination Treatment Phase|Adverse Event|4
2280698|NCT02357147|3964598|FG000|Combination Treatment Phase|Death|1
2280699|NCT02357147|3964599|FG001|Combination Treatment Phase|Death|1
2280700|NCT02357147|3964598|FG000|Combination Treatment Phase|Sponsor Decision|0
2280701|NCT02357147|3964599|FG001|Combination Treatment Phase|Sponsor Decision|12
2280702|NCT02357147|3964598|FG000|Combination Treatment Phase|Other|1
2280703|NCT02357147|3964599|FG001|Combination Treatment Phase|Other|0
2280704|NCT02357147|3964598|FG000|Combination Treatment Phase|Not treated|0
2280705|NCT02357147|3964599|FG001|Combination Treatment Phase|Not treated|2
2280706|NCT02357147|3964598|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
2280707|NCT02357147|3964599|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
2280708|NCT02357147|3964598|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
2280709|NCT02357147|3964599|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1
2280710|NCT02357147|3964598|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
2280711|NCT02357147|3964599|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
2280712|NCT02357147|3964598|FG000|Maintenance Treatment Phase|Adverse Event|0
2280713|NCT02357147|3964599|FG001|Maintenance Treatment Phase|Adverse Event|3
2280714|NCT02357147|3964598|FG000|Maintenance Treatment Phase|Sponsor Decision|0
2280715|NCT02357147|3964599|FG001|Maintenance Treatment Phase|Sponsor Decision|15
2280716|NCT02357147|3964598|FG000|Maintenance Treatment Phase|Not Treated|1
2280717|NCT02357147|3964599|FG001|Maintenance Treatment Phase|Not Treated|0
2280718|NCT02357342|3964637|FG000|First 6 Months|Death|2
2280719|NCT02357342|3964638|FG001|First 6 Months|Death|0
2280720|NCT02357368|3964648|FG000|Overall Study|Lost to Follow-up|0
2280721|NCT02357368|3964649|FG001|Overall Study|Lost to Follow-up|0
2280722|NCT02357368|3964650|FG002|Overall Study|Lost to Follow-up|0
2280723|NCT02357368|3964651|FG003|Overall Study|Lost to Follow-up|1
2280724|NCT02357368|3964648|FG000|Overall Study|Pregnancy|3
2280725|NCT02357368|3964649|FG001|Overall Study|Pregnancy|2
2280726|NCT02357368|3964650|FG002|Overall Study|Pregnancy|0
2280727|NCT02357368|3964651|FG003|Overall Study|Pregnancy|0
2280728|NCT02357368|3964648|FG000|Overall Study|Withdrawal by Subject|3
2280729|NCT02357368|3964649|FG001|Overall Study|Withdrawal by Subject|1
2280730|NCT02357368|3964650|FG002|Overall Study|Withdrawal by Subject|1
2280731|NCT02357368|3964651|FG003|Overall Study|Withdrawal by Subject|2
2280732|NCT02357420|3964674|FG000|Overall Study|Adverse Event|3
2280733|NCT02357420|3964675|FG001|Overall Study|Adverse Event|3
2280734|NCT02357420|3964676|FG002|Overall Study|Adverse Event|8
2280735|NCT02357420|3964677|FG003|Overall Study|Adverse Event|9
2280736|NCT02357420|3964674|FG000|Overall Study|Investigator Decision|1
2280737|NCT02357420|3964675|FG001|Overall Study|Investigator Decision|0
2280738|NCT02357420|3964676|FG002|Overall Study|Investigator Decision|0
2280739|NCT02357420|3964677|FG003|Overall Study|Investigator Decision|0
2280740|NCT02357420|3964674|FG000|Overall Study|Prohibited Medication|1
2280741|NCT02357420|3964675|FG001|Overall Study|Prohibited Medication|1
2280742|NCT02357420|3964676|FG002|Overall Study|Prohibited Medication|0
2280743|NCT02357420|3964677|FG003|Overall Study|Prohibited Medication|0
2280744|NCT02357420|3964674|FG000|Overall Study|Protocol Non-compliance|0
2125295|NCT00996892|3726226|FG000|Dose-Escalation Stage 1|Disease Progression|2
2125296|NCT00996892|3726227|FG001|Dose-Escalation Stage 1|Disease Progression|2
2125297|NCT00996892|3726228|FG002|Dose-Escalation Stage 1|Disease Progression|3
2125298|NCT00996892|3726229|FG003|Dose-Escalation Stage 1|Disease Progression|4
2125299|NCT00996892|3726230|FG004|Dose-Escalation Stage 1|Disease Progression|10
2280745|NCT02357420|3964675|FG001|Overall Study|Protocol Non-compliance|0
2280746|NCT02357420|3964676|FG002|Overall Study|Protocol Non-compliance|0
2280747|NCT02357420|3964677|FG003|Overall Study|Protocol Non-compliance|1
2280748|NCT02357420|3964674|FG000|Overall Study|Withdrawn Consent|4
2280749|NCT02357420|3964675|FG001|Overall Study|Withdrawn Consent|8
2280750|NCT02357420|3964676|FG002|Overall Study|Withdrawn Consent|6
2280751|NCT02357420|3964677|FG003|Overall Study|Withdrawn Consent|6
2280752|NCT02357420|3964674|FG000|Overall Study|Lost to Follow-up|3
2280753|NCT02357420|3964675|FG001|Overall Study|Lost to Follow-up|0
2280754|NCT02357420|3964676|FG002|Overall Study|Lost to Follow-up|2
2280755|NCT02357420|3964677|FG003|Overall Study|Lost to Follow-up|3
2280756|NCT02357459|3964690|FG000|Overall Study|Adverse Event|0
2280757|NCT02357459|3964691|FG001|Overall Study|Adverse Event|1
2280758|NCT02357459|3964692|FG002|Overall Study|Adverse Event|1
2280759|NCT02357459|3964690|FG000|Overall Study|Withdrawal by Subject|5
2280760|NCT02357459|3964691|FG001|Overall Study|Withdrawal by Subject|3
2280761|NCT02357459|3964692|FG002|Overall Study|Withdrawal by Subject|3
2280762|NCT02357459|3964690|FG000|Overall Study|Physician Decision|0
2280763|NCT02357459|3964691|FG001|Overall Study|Physician Decision|2
2280764|NCT02357459|3964692|FG002|Overall Study|Physician Decision|0
2280765|NCT02357459|3964690|FG000|Overall Study|Protocol Violation|1
2280766|NCT02357459|3964691|FG001|Overall Study|Protocol Violation|1
2280767|NCT02357459|3964692|FG002|Overall Study|Protocol Violation|0
2280768|NCT02357459|3964690|FG000|Overall Study|Lost to Follow-up|1
2280769|NCT02357459|3964691|FG001|Overall Study|Lost to Follow-up|3
2280770|NCT02357459|3964692|FG002|Overall Study|Lost to Follow-up|0
2280771|NCT02357459|3964690|FG000|Overall Study|Lack of Efficacy|7
2280772|NCT02357459|3964691|FG001|Overall Study|Lack of Efficacy|4
2280773|NCT02357459|3964692|FG002|Overall Study|Lack of Efficacy|4
2280774|NCT02357459|3964690|FG000|Overall Study|Patient Relocated|2
2280775|NCT02357459|3964691|FG001|Overall Study|Patient Relocated|0
2280776|NCT02357459|3964692|FG002|Overall Study|Patient Relocated|0
2280777|NCT02357459|3964690|FG000|Overall Study|Instruction from PCP|1
2280778|NCT02357459|3964691|FG001|Overall Study|Instruction from PCP|0
2280779|NCT02357459|3964692|FG002|Overall Study|Instruction from PCP|0
2280780|NCT02357459|3964690|FG000|Overall Study|Incarceration|0
2280781|NCT02357459|3964691|FG001|Overall Study|Incarceration|0
2280782|NCT02357459|3964692|FG002|Overall Study|Incarceration|1
2280783|NCT02357459|3964690|FG000|Overall Study|Pre-planned Knee surgery|0
2280784|NCT02357459|3964691|FG001|Overall Study|Pre-planned Knee surgery|0
2280785|NCT02357459|3964692|FG002|Overall Study|Pre-planned Knee surgery|2
2280786|NCT02357459|3964690|FG000|Overall Study|Job Commitments|0
2280787|NCT02357459|3964691|FG001|Overall Study|Job Commitments|0
2280788|NCT02357459|3964692|FG002|Overall Study|Job Commitments|1
2280789|NCT02357576|3964710|FG000|Treatment Period|Withdrawal by Subject|0
2280790|NCT02357576|3964711|FG001|Treatment Period|Withdrawal by Subject|1
2280791|NCT02357576|3964710|FG000|Treatment Period|Physician Decision|0
2280792|NCT02357576|3964711|FG001|Treatment Period|Physician Decision|1
2280793|NCT02357576|3964710|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1
2280794|NCT02357576|3964711|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1
2280795|NCT02357576|3964710|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
2280796|NCT02357576|3964711|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
2280797|NCT02357576|3964710|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
2280798|NCT02357576|3964711|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
2280799|NCT02357576|3964710|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
2280800|NCT02357576|3964711|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
2280801|NCT02357810|3964740|FG000|Registered and Started Treatment|Withdrawal by Subject|1
2280802|NCT02357810|3964740|FG000|Registered and Started Treatment|Found not to be eligible for the study|26
2280803|NCT02357810|3964740|FG000|Reached 12 Weeks Response|Adverse Event|5
2280804|NCT02357810|3964740|FG000|Reached 12 Weeks Response|Progressive Disease|39
2280805|NCT02357810|3964740|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8
2280806|NCT02357810|3964740|FG000|Reached 12 Weeks Response|Protocol Violation|1
2280807|NCT02357810|3964740|FG000|Reached 12 Weeks Response|Death|1
2280808|NCT02357810|3964740|FG000|Reached 12 Weeks Response|Physician Decision|1
2280809|NCT02357810|3964740|FG000|Reached 12 Weeks Response|Other|1
2280810|NCT02357810|3964740|FG000|12 Week Response and Further Treatment|Adverse Event|5
2280811|NCT02357810|3964740|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1
2280812|NCT02357810|3964740|FG000|12 Week Response and Further Treatment|Progressive Disease|15
2280813|NCT02357810|3964740|FG000|12 Week Response and Further Treatment|Wound Complications|1
2280814|NCT02357810|3964740|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4
2280815|NCT02357810|3964740|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3
2125300|NCT00996892|3726231|FG005|Dose-Escalation Stage 1|Disease Progression|7
2280816|NCT02357810|3964740|FG000|Follow-up at Treatment Discontinuation|Still in Follow-up|11
2280817|NCT02357901|3964752|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161
2125301|NCT00996892|3726232|FG006|Dose-Escalation Stage 1|Disease Progression|0
2125302|NCT00996892|3726233|FG007|Dose-Escalation Stage 1|Disease Progression|0
2125303|NCT00996892|3726234|FG008|Dose-Escalation Stage 1|Disease Progression|0
2125304|NCT00996892|3726235|FG009|Dose-Escalation Stage 1|Disease Progression|0
2125305|NCT00996892|3726236|FG010|Dose-Escalation Stage 1|Disease Progression|0
2280818|NCT02357901|3964753|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0
2280819|NCT02357901|3964754|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0
2280820|NCT02357901|3964755|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0
2280821|NCT02357901|3964752|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
2280822|NCT02357901|3964753|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
2280823|NCT02357901|3964754|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
2280824|NCT02357901|3964755|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
2280825|NCT02357901|3964752|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
2280826|NCT02357901|3964753|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
2280827|NCT02357901|3964754|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
2280828|NCT02357901|3964755|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
2280829|NCT02357901|3964752|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
2280830|NCT02357901|3964753|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
2280831|NCT02357901|3964754|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
2280832|NCT02357901|3964755|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
2280833|NCT02357901|3964752|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0
2280834|NCT02357901|3964753|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6
2280835|NCT02357901|3964754|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10
2280836|NCT02357901|3964755|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2
2280837|NCT02357901|3964752|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
2280838|NCT02357901|3964753|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
2280839|NCT02357901|3964754|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
2280840|NCT02357901|3964755|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
2280841|NCT02357901|3964752|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
2280842|NCT02357901|3964753|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
2280843|NCT02357901|3964754|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
2280844|NCT02357901|3964755|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
2280845|NCT02357901|3964752|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
2280846|NCT02357901|3964753|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
2280847|NCT02357901|3964754|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
2280848|NCT02357901|3964755|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
2280849|NCT02357901|3964752|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
2280850|NCT02357901|3964753|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
2280851|NCT02357901|3964754|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
2280852|NCT02357901|3964755|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
2280853|NCT02357901|3964752|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0
2280854|NCT02357901|3964753|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0
2280855|NCT02357901|3964754|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1
2280856|NCT02357901|3964755|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1
2280857|NCT02357901|3964752|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
2280858|NCT02357901|3964753|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
2280859|NCT02357901|3964754|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
2280860|NCT02357901|3964755|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
2280861|NCT02357940|3964765|FG000|Overall Study|Adverse Event|0
2280862|NCT02357940|3964766|FG001|Overall Study|Adverse Event|1
2280863|NCT02357940|3964765|FG000|Overall Study|Investigator's judgement|0
2280864|NCT02357940|3964766|FG001|Overall Study|Investigator's judgement|1
2280865|NCT02357979|3964774|FG000|Overall Study|Lost to Follow-up|5
2280866|NCT02357979|3964775|FG001|Overall Study|Lost to Follow-up|5
2280867|NCT02358031|3964784|FG000|Overall Study|Death|226
2280868|NCT02358031|3964785|FG001|Overall Study|Death|204
2280869|NCT02358031|3964786|FG002|Overall Study|Death|249
2280870|NCT02358031|3964784|FG000|Overall Study|Lost to Follow-up|0
2280871|NCT02358031|3964785|FG001|Overall Study|Lost to Follow-up|1
2280872|NCT02358031|3964786|FG002|Overall Study|Lost to Follow-up|1
2280873|NCT02358031|3964784|FG000|Overall Study|Withdrawal by Subject|14
2280874|NCT02358031|3964785|FG001|Overall Study|Withdrawal by Subject|12
2280875|NCT02358031|3964786|FG002|Overall Study|Withdrawal by Subject|17
2280876|NCT02358031|3964784|FG000|Overall Study|Ongoing in Study|61
2280877|NCT02358031|3964785|FG001|Overall Study|Ongoing in Study|64
2280878|NCT02358031|3964786|FG002|Overall Study|Ongoing in Study|33
2280879|NCT02358044|3964796|FG000|Overall Study|Adverse Event|0
2280880|NCT02358044|3964797|FG001|Overall Study|Adverse Event|1
2280881|NCT02358044|3964796|FG000|Overall Study|Lost to Follow-up|2
2280882|NCT02358044|3964797|FG001|Overall Study|Lost to Follow-up|1
2280883|NCT02358044|3964796|FG000|Overall Study|Physician Decision|0
2280884|NCT02358044|3964797|FG001|Overall Study|Physician Decision|1
2280885|NCT02358044|3964796|FG000|Overall Study|Withdrawal by Subject|0
2125306|NCT00996892|3726237|FG011|Dose-Escalation Stage 1|Disease Progression|0
2125307|NCT00996892|3726238|FG012|Dose-Escalation Stage 1|Disease Progression|0
2125308|NCT00996892|3726239|FG013|Dose-Escalation Stage 1|Disease Progression|0
2125309|NCT00996892|3726240|FG014|Dose-Escalation Stage 1|Disease Progression|0
2125310|NCT00996892|3726241|FG015|Dose-Escalation Stage 1|Disease Progression|0
2280886|NCT02358044|3964797|FG001|Overall Study|Withdrawal by Subject|4
2280887|NCT02358343|3964817|FG000|Screening Intervention|Death|0
2280888|NCT02358343|3964818|FG001|Screening Intervention|Death|2
2280889|NCT02358343|3964819|FG002|Screening Intervention|Death|0
2280890|NCT02358343|3964820|FG003|Screening Intervention|Death|0
2280891|NCT02358343|3964821|FG004|Screening Intervention|Death|0
2280892|NCT02358343|3964817|FG000|Screening Intervention|Withdrawal by Subject|1
2280893|NCT02358343|3964818|FG001|Screening Intervention|Withdrawal by Subject|0
2280894|NCT02358343|3964819|FG002|Screening Intervention|Withdrawal by Subject|0
2280895|NCT02358343|3964820|FG003|Screening Intervention|Withdrawal by Subject|0
2280896|NCT02358343|3964821|FG004|Screening Intervention|Withdrawal by Subject|0
2280897|NCT02358343|3964817|FG000|Screening Intervention|Determined Ineligible|5
2280898|NCT02358343|3964818|FG001|Screening Intervention|Determined Ineligible|6
2280899|NCT02358343|3964819|FG002|Screening Intervention|Determined Ineligible|0
2280900|NCT02358343|3964820|FG003|Screening Intervention|Determined Ineligible|0
2280901|NCT02358343|3964821|FG004|Screening Intervention|Determined Ineligible|0
2280902|NCT02358343|3964817|FG000|Comparative Efficacy Trial / Observation|Death|0
2280903|NCT02358343|3964818|FG001|Comparative Efficacy Trial / Observation|Death|0
2280904|NCT02358343|3964819|FG002|Comparative Efficacy Trial / Observation|Death|2
2280905|NCT02358343|3964820|FG003|Comparative Efficacy Trial / Observation|Death|0
2280906|NCT02358343|3964821|FG004|Comparative Efficacy Trial / Observation|Death|0
2280907|NCT02358343|3964817|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
2280908|NCT02358343|3964818|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
2280909|NCT02358343|3964819|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
2280910|NCT02358343|3964820|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
2280911|NCT02358343|3964821|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
2280912|NCT02358343|3964817|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2280913|NCT02358343|3964818|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2280914|NCT02358343|3964819|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
2280915|NCT02358343|3964820|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2280916|NCT02358343|3964821|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2280917|NCT02358369|3964835|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35
2280918|NCT02358369|3964836|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0
2280919|NCT02358369|3964837|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0
2280920|NCT02358369|3964838|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0
2280921|NCT02358369|3964839|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0
2280922|NCT02358369|3964835|FG000|Treatment Period A/B|Adverse Event|0
2280923|NCT02358369|3964836|FG001|Treatment Period A/B|Adverse Event|0
2280924|NCT02358369|3964837|FG002|Treatment Period A/B|Adverse Event|1
2280925|NCT02358369|3964838|FG003|Treatment Period A/B|Adverse Event|2
2280926|NCT02358369|3964839|FG004|Treatment Period A/B|Adverse Event|0
2280927|NCT02358369|3964835|FG000|Treatment Period A/B|Death|0
2280928|NCT02358369|3964836|FG001|Treatment Period A/B|Death|0
2280929|NCT02358369|3964837|FG002|Treatment Period A/B|Death|1
2280930|NCT02358369|3964838|FG003|Treatment Period A/B|Death|0
2280931|NCT02358369|3964839|FG004|Treatment Period A/B|Death|0
2280932|NCT02358369|3964835|FG000|Treatment Period A/B|Withdrawal by Subject|0
2280933|NCT02358369|3964836|FG001|Treatment Period A/B|Withdrawal by Subject|2
2280934|NCT02358369|3964837|FG002|Treatment Period A/B|Withdrawal by Subject|0
2280935|NCT02358369|3964838|FG003|Treatment Period A/B|Withdrawal by Subject|2
2280936|NCT02358369|3964839|FG004|Treatment Period A/B|Withdrawal by Subject|0
2280937|NCT02358369|3964835|FG000|Treatment Period C|Adverse Event|0
2280938|NCT02358369|3964836|FG001|Treatment Period C|Adverse Event|0
2280939|NCT02358369|3964837|FG002|Treatment Period C|Adverse Event|0
2280940|NCT02358369|3964838|FG003|Treatment Period C|Adverse Event|0
2280941|NCT02358369|3964839|FG004|Treatment Period C|Adverse Event|7
2280942|NCT02358473|3964849|FG000|Overall Study|Disease Progession|6
2280943|NCT02358473|3964849|FG000|Overall Study|Adverse Event|3
2280944|NCT02358473|3964849|FG000|Overall Study|Withdrawal by Subject|2
2280945|NCT02358473|3964849|FG000|Overall Study|Physician Decision|2
2280946|NCT02358668|3964865|FG000|Overall Study|Adverse Event|2
2280947|NCT02358668|3964866|FG001|Overall Study|Adverse Event|0
2280948|NCT02358668|3964867|FG002|Overall Study|Adverse Event|0
2280949|NCT02358668|3964865|FG000|Overall Study|Withdrawal by Subject|0
2280950|NCT02358668|3964866|FG001|Overall Study|Withdrawal by Subject|1
2280951|NCT02358668|3964867|FG002|Overall Study|Withdrawal by Subject|0
2280952|NCT02358863|3964875|FG000|Overall Study|Physician Decision|3
2280953|NCT02359045|3964913|FG000|Overall Study|Eligibility criteria not fulfilled|3
2280954|NCT02359045|3964914|FG001|Overall Study|Eligibility criteria not fulfilled|1
2280955|NCT02359045|3964913|FG000|Overall Study|Lost to Follow-up|1
2280956|NCT02359045|3964914|FG001|Overall Study|Lost to Follow-up|1
2280957|NCT02359045|3964913|FG000|Overall Study|Adverse Event|0
2125311|NCT00996892|3726242|FG016|Dose-Escalation Stage 1|Disease Progression|0
2125312|NCT00996892|3726243|FG017|Dose-Escalation Stage 1|Disease Progression|0
2125313|NCT00996892|3726244|FG018|Dose-Escalation Stage 1|Disease Progression|0
2125314|NCT00996892|3726245|FG019|Dose-Escalation Stage 1|Disease Progression|0
2125315|NCT00996892|3726226|FG000|Dose-Escalation Stage 1A|Adverse Event|0
2125316|NCT00996892|3726227|FG001|Dose-Escalation Stage 1A|Adverse Event|0
2125317|NCT00996892|3726228|FG002|Dose-Escalation Stage 1A|Adverse Event|0
2125318|NCT00996892|3726229|FG003|Dose-Escalation Stage 1A|Adverse Event|0
2125319|NCT00996892|3726230|FG004|Dose-Escalation Stage 1A|Adverse Event|0
2125320|NCT00996892|3726231|FG005|Dose-Escalation Stage 1A|Adverse Event|0
2125321|NCT00996892|3726232|FG006|Dose-Escalation Stage 1A|Adverse Event|0
2125322|NCT00996892|3726233|FG007|Dose-Escalation Stage 1A|Adverse Event|0
2125323|NCT00996892|3726234|FG008|Dose-Escalation Stage 1A|Adverse Event|0
2125324|NCT00996892|3726235|FG009|Dose-Escalation Stage 1A|Adverse Event|0
2125325|NCT00996892|3726236|FG010|Dose-Escalation Stage 1A|Adverse Event|1
2125326|NCT00996892|3726237|FG011|Dose-Escalation Stage 1A|Adverse Event|0
2125327|NCT00996892|3726238|FG012|Dose-Escalation Stage 1A|Adverse Event|0
2125328|NCT00996892|3726239|FG013|Dose-Escalation Stage 1A|Adverse Event|1
2125329|NCT00996892|3726240|FG014|Dose-Escalation Stage 1A|Adverse Event|0
2125330|NCT00996892|3726241|FG015|Dose-Escalation Stage 1A|Adverse Event|0
2125331|NCT00996892|3726242|FG016|Dose-Escalation Stage 1A|Adverse Event|0
2125332|NCT00996892|3726243|FG017|Dose-Escalation Stage 1A|Adverse Event|0
2125333|NCT00996892|3726244|FG018|Dose-Escalation Stage 1A|Adverse Event|0
2125334|NCT00996892|3726245|FG019|Dose-Escalation Stage 1A|Adverse Event|0
2125335|NCT00996892|3726226|FG000|Dose-Escalation Stage 1A|Death|0
2125336|NCT00996892|3726227|FG001|Dose-Escalation Stage 1A|Death|0
2125337|NCT00996892|3726228|FG002|Dose-Escalation Stage 1A|Death|0
2125338|NCT00996892|3726229|FG003|Dose-Escalation Stage 1A|Death|0
2125339|NCT00996892|3726230|FG004|Dose-Escalation Stage 1A|Death|0
2125340|NCT00996892|3726231|FG005|Dose-Escalation Stage 1A|Death|0
2125341|NCT00996892|3726232|FG006|Dose-Escalation Stage 1A|Death|0
2125342|NCT00996892|3726233|FG007|Dose-Escalation Stage 1A|Death|0
2125343|NCT00996892|3726234|FG008|Dose-Escalation Stage 1A|Death|0
2125344|NCT00996892|3726235|FG009|Dose-Escalation Stage 1A|Death|2
2125345|NCT00996892|3726236|FG010|Dose-Escalation Stage 1A|Death|0
2125346|NCT00996892|3726237|FG011|Dose-Escalation Stage 1A|Death|1
2125347|NCT00996892|3726238|FG012|Dose-Escalation Stage 1A|Death|1
2125348|NCT00996892|3726239|FG013|Dose-Escalation Stage 1A|Death|0
2125349|NCT00996892|3726240|FG014|Dose-Escalation Stage 1A|Death|0
2125350|NCT00996892|3726241|FG015|Dose-Escalation Stage 1A|Death|0
2125351|NCT00996892|3726242|FG016|Dose-Escalation Stage 1A|Death|0
2125352|NCT00996892|3726243|FG017|Dose-Escalation Stage 1A|Death|0
2125353|NCT00996892|3726244|FG018|Dose-Escalation Stage 1A|Death|0
2125354|NCT00996892|3726245|FG019|Dose-Escalation Stage 1A|Death|0
2125355|NCT00996892|3726226|FG000|Dose-Escalation Stage 1A|Physician Decision|0
2125356|NCT00996892|3726227|FG001|Dose-Escalation Stage 1A|Physician Decision|0
2125357|NCT00996892|3726228|FG002|Dose-Escalation Stage 1A|Physician Decision|0
2125358|NCT00996892|3726229|FG003|Dose-Escalation Stage 1A|Physician Decision|0
2125359|NCT00996892|3726230|FG004|Dose-Escalation Stage 1A|Physician Decision|0
2125360|NCT00996892|3726231|FG005|Dose-Escalation Stage 1A|Physician Decision|0
2125361|NCT00996892|3726232|FG006|Dose-Escalation Stage 1A|Physician Decision|0
2125362|NCT00996892|3726233|FG007|Dose-Escalation Stage 1A|Physician Decision|1
2125363|NCT00996892|3726234|FG008|Dose-Escalation Stage 1A|Physician Decision|0
2125364|NCT00996892|3726235|FG009|Dose-Escalation Stage 1A|Physician Decision|0
2125365|NCT00996892|3726236|FG010|Dose-Escalation Stage 1A|Physician Decision|0
2125366|NCT00996892|3726237|FG011|Dose-Escalation Stage 1A|Physician Decision|0
2125367|NCT00996892|3726238|FG012|Dose-Escalation Stage 1A|Physician Decision|0
2125368|NCT00996892|3726239|FG013|Dose-Escalation Stage 1A|Physician Decision|0
2125369|NCT00996892|3726240|FG014|Dose-Escalation Stage 1A|Physician Decision|0
2125370|NCT00996892|3726241|FG015|Dose-Escalation Stage 1A|Physician Decision|0
2125371|NCT00996892|3726242|FG016|Dose-Escalation Stage 1A|Physician Decision|0
2125372|NCT00996892|3726243|FG017|Dose-Escalation Stage 1A|Physician Decision|0
2125373|NCT00996892|3726244|FG018|Dose-Escalation Stage 1A|Physician Decision|0
2125374|NCT00996892|3726245|FG019|Dose-Escalation Stage 1A|Physician Decision|0
2125375|NCT00996892|3726226|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125376|NCT00996892|3726227|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125377|NCT00996892|3726228|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125378|NCT00996892|3726229|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125379|NCT00996892|3726230|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125380|NCT00996892|3726231|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125381|NCT00996892|3726232|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125382|NCT00996892|3726233|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125383|NCT00996892|3726234|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125384|NCT00996892|3726235|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2125385|NCT00996892|3726236|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2125386|NCT00996892|3726237|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2125387|NCT00996892|3726238|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2125388|NCT00996892|3726239|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125389|NCT00996892|3726240|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125390|NCT00996892|3726241|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125391|NCT00996892|3726242|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125392|NCT00996892|3726243|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125393|NCT00996892|3726244|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125394|NCT00996892|3726245|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2125395|NCT00996892|3726226|FG000|Dose-Escalation Stage 1A|Disease Progression|0
2125396|NCT00996892|3726227|FG001|Dose-Escalation Stage 1A|Disease Progression|0
2125397|NCT00996892|3726228|FG002|Dose-Escalation Stage 1A|Disease Progression|0
2125398|NCT00996892|3726229|FG003|Dose-Escalation Stage 1A|Disease Progression|0
2125399|NCT00996892|3726230|FG004|Dose-Escalation Stage 1A|Disease Progression|0
2125400|NCT00996892|3726231|FG005|Dose-Escalation Stage 1A|Disease Progression|0
2125401|NCT00996892|3726232|FG006|Dose-Escalation Stage 1A|Disease Progression|0
2125402|NCT00996892|3726233|FG007|Dose-Escalation Stage 1A|Disease Progression|2
2125403|NCT00996892|3726234|FG008|Dose-Escalation Stage 1A|Disease Progression|3
2125404|NCT00996892|3726235|FG009|Dose-Escalation Stage 1A|Disease Progression|1
2125405|NCT00996892|3726236|FG010|Dose-Escalation Stage 1A|Disease Progression|5
2125406|NCT00996892|3726237|FG011|Dose-Escalation Stage 1A|Disease Progression|7
2125407|NCT00996892|3726238|FG012|Dose-Escalation Stage 1A|Disease Progression|6
2125408|NCT00996892|3726239|FG013|Dose-Escalation Stage 1A|Disease Progression|4
2125409|NCT00996892|3726240|FG014|Dose-Escalation Stage 1A|Disease Progression|0
2125410|NCT00996892|3726241|FG015|Dose-Escalation Stage 1A|Disease Progression|0
2125411|NCT00996892|3726242|FG016|Dose-Escalation Stage 1A|Disease Progression|0
2125412|NCT00996892|3726243|FG017|Dose-Escalation Stage 1A|Disease Progression|0
2205359|NCT01609556|3843221|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205360|NCT01609556|3843222|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205361|NCT01609556|3843223|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205362|NCT01609556|3843224|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205363|NCT01609556|3843225|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205364|NCT01609556|3843226|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205365|NCT01609556|3843227|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205366|NCT01609556|3843228|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1
2205367|NCT01609556|3843229|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205368|NCT01609556|3843230|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205369|NCT01609556|3843231|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
2205370|NCT01609582|3843274|FG000|Overall Study|Adverse Event|20
2205371|NCT01609582|3843275|FG001|Overall Study|Adverse Event|18
2205372|NCT01609582|3843274|FG000|Overall Study|Lost to Follow-up|10
2205373|NCT01609582|3843275|FG001|Overall Study|Lost to Follow-up|10
2205374|NCT01609582|3843274|FG000|Overall Study|Withdrawal by Subject|21
2205375|NCT01609582|3843275|FG001|Overall Study|Withdrawal by Subject|15
2205376|NCT01609582|3843274|FG000|Overall Study|Study Terminated by Sponsor|1543
2205377|NCT01609582|3843275|FG001|Overall Study|Study Terminated by Sponsor|1548
2205378|NCT01609582|3843274|FG000|Overall Study|Other|9
2205379|NCT01609582|3843275|FG001|Overall Study|Other|10
2125413|NCT00996892|3726244|FG018|Dose-Escalation Stage 1A|Disease Progression|0
2125414|NCT00996892|3726245|FG019|Dose-Escalation Stage 1A|Disease Progression|0
2125415|NCT00996892|3726226|FG000|Dose-Escalation Stage 1B|Physician Decision|0
2125416|NCT00996892|3726227|FG001|Dose-Escalation Stage 1B|Physician Decision|0
2125417|NCT00996892|3726228|FG002|Dose-Escalation Stage 1B|Physician Decision|0
2125418|NCT00996892|3726229|FG003|Dose-Escalation Stage 1B|Physician Decision|0
2125419|NCT00996892|3726230|FG004|Dose-Escalation Stage 1B|Physician Decision|0
2125420|NCT00996892|3726231|FG005|Dose-Escalation Stage 1B|Physician Decision|0
2125421|NCT00996892|3726232|FG006|Dose-Escalation Stage 1B|Physician Decision|0
2125422|NCT00996892|3726233|FG007|Dose-Escalation Stage 1B|Physician Decision|0
2125423|NCT00996892|3726234|FG008|Dose-Escalation Stage 1B|Physician Decision|0
2125424|NCT00996892|3726235|FG009|Dose-Escalation Stage 1B|Physician Decision|0
2125425|NCT00996892|3726236|FG010|Dose-Escalation Stage 1B|Physician Decision|0
2125426|NCT00996892|3726237|FG011|Dose-Escalation Stage 1B|Physician Decision|0
2125427|NCT00996892|3726238|FG012|Dose-Escalation Stage 1B|Physician Decision|0
2125428|NCT00996892|3726239|FG013|Dose-Escalation Stage 1B|Physician Decision|0
2125429|NCT00996892|3726240|FG014|Dose-Escalation Stage 1B|Physician Decision|0
2125430|NCT00996892|3726241|FG015|Dose-Escalation Stage 1B|Physician Decision|0
2125431|NCT00996892|3726242|FG016|Dose-Escalation Stage 1B|Physician Decision|0
2205380|NCT01609582|3843274|FG000|Overall Study|Randomized, but not treated|0
2205381|NCT01609582|3843275|FG001|Overall Study|Randomized, but not treated|3
2125432|NCT00996892|3726243|FG017|Dose-Escalation Stage 1B|Physician Decision|2
2125433|NCT00996892|3726244|FG018|Dose-Escalation Stage 1B|Physician Decision|0
2125434|NCT00996892|3726245|FG019|Dose-Escalation Stage 1B|Physician Decision|0
2125435|NCT00996892|3726226|FG000|Dose-Escalation Stage 1B|Disease Progression|0
2125436|NCT00996892|3726227|FG001|Dose-Escalation Stage 1B|Disease Progression|0
2125437|NCT00996892|3726228|FG002|Dose-Escalation Stage 1B|Disease Progression|0
2125438|NCT00996892|3726229|FG003|Dose-Escalation Stage 1B|Disease Progression|0
2125439|NCT00996892|3726230|FG004|Dose-Escalation Stage 1B|Disease Progression|0
2125440|NCT00996892|3726231|FG005|Dose-Escalation Stage 1B|Disease Progression|0
2125441|NCT00996892|3726232|FG006|Dose-Escalation Stage 1B|Disease Progression|0
2205382|NCT01609933|3843281|FG000|Overall Study|Adverse Event|1
2125442|NCT00996892|3726233|FG007|Dose-Escalation Stage 1B|Disease Progression|0
2125443|NCT00996892|3726234|FG008|Dose-Escalation Stage 1B|Disease Progression|0
2125444|NCT00996892|3726235|FG009|Dose-Escalation Stage 1B|Disease Progression|0
2125445|NCT00996892|3726236|FG010|Dose-Escalation Stage 1B|Disease Progression|0
2125446|NCT00996892|3726237|FG011|Dose-Escalation Stage 1B|Disease Progression|0
2125447|NCT00996892|3726238|FG012|Dose-Escalation Stage 1B|Disease Progression|0
2125448|NCT00996892|3726239|FG013|Dose-Escalation Stage 1B|Disease Progression|0
2125449|NCT00996892|3726240|FG014|Dose-Escalation Stage 1B|Disease Progression|4
2125450|NCT00996892|3726241|FG015|Dose-Escalation Stage 1B|Disease Progression|3
2125451|NCT00996892|3726242|FG016|Dose-Escalation Stage 1B|Disease Progression|3
2125452|NCT00996892|3726243|FG017|Dose-Escalation Stage 1B|Disease Progression|3
2125453|NCT00996892|3726244|FG018|Dose-Escalation Stage 1B|Disease Progression|0
2125454|NCT00996892|3726245|FG019|Dose-Escalation Stage 1B|Disease Progression|0
2125455|NCT00996892|3726226|FG000|Expansion Stage 2|Adverse Event|0
2125456|NCT00996892|3726227|FG001|Expansion Stage 2|Adverse Event|0
2125457|NCT00996892|3726228|FG002|Expansion Stage 2|Adverse Event|0
2125458|NCT00996892|3726229|FG003|Expansion Stage 2|Adverse Event|0
2125459|NCT00996892|3726230|FG004|Expansion Stage 2|Adverse Event|0
2125460|NCT00996892|3726231|FG005|Expansion Stage 2|Adverse Event|0
2125461|NCT00996892|3726232|FG006|Expansion Stage 2|Adverse Event|0
2125462|NCT00996892|3726233|FG007|Expansion Stage 2|Adverse Event|0
2125463|NCT00996892|3726234|FG008|Expansion Stage 2|Adverse Event|0
2125464|NCT00996892|3726235|FG009|Expansion Stage 2|Adverse Event|0
2125465|NCT00996892|3726236|FG010|Expansion Stage 2|Adverse Event|0
2125466|NCT00996892|3726237|FG011|Expansion Stage 2|Adverse Event|0
2125467|NCT00996892|3726238|FG012|Expansion Stage 2|Adverse Event|0
2125468|NCT00996892|3726239|FG013|Expansion Stage 2|Adverse Event|0
2125469|NCT00996892|3726240|FG014|Expansion Stage 2|Adverse Event|0
2125470|NCT00996892|3726241|FG015|Expansion Stage 2|Adverse Event|0
2125471|NCT00996892|3726242|FG016|Expansion Stage 2|Adverse Event|0
2125472|NCT00996892|3726243|FG017|Expansion Stage 2|Adverse Event|0
2125473|NCT00996892|3726244|FG018|Expansion Stage 2|Adverse Event|3
2125474|NCT00996892|3726245|FG019|Expansion Stage 2|Adverse Event|0
2125475|NCT00996892|3726226|FG000|Expansion Stage 2|Death|0
2125476|NCT00996892|3726227|FG001|Expansion Stage 2|Death|0
2125477|NCT00996892|3726228|FG002|Expansion Stage 2|Death|0
2125478|NCT00996892|3726229|FG003|Expansion Stage 2|Death|0
2125479|NCT00996892|3726230|FG004|Expansion Stage 2|Death|0
2125480|NCT00996892|3726231|FG005|Expansion Stage 2|Death|0
2125481|NCT00996892|3726232|FG006|Expansion Stage 2|Death|0
2125482|NCT00996892|3726233|FG007|Expansion Stage 2|Death|0
2125483|NCT00996892|3726234|FG008|Expansion Stage 2|Death|0
2125484|NCT00996892|3726235|FG009|Expansion Stage 2|Death|0
2125485|NCT00996892|3726236|FG010|Expansion Stage 2|Death|0
2125486|NCT00996892|3726237|FG011|Expansion Stage 2|Death|0
2125487|NCT00996892|3726238|FG012|Expansion Stage 2|Death|0
2125488|NCT00996892|3726239|FG013|Expansion Stage 2|Death|0
2125489|NCT00996892|3726240|FG014|Expansion Stage 2|Death|0
2125490|NCT00996892|3726241|FG015|Expansion Stage 2|Death|0
2125491|NCT00996892|3726242|FG016|Expansion Stage 2|Death|0
2125492|NCT00996892|3726243|FG017|Expansion Stage 2|Death|0
2125493|NCT00996892|3726244|FG018|Expansion Stage 2|Death|2
2125494|NCT00996892|3726245|FG019|Expansion Stage 2|Death|0
2125495|NCT00996892|3726226|FG000|Expansion Stage 2|Physician Decision|0
2125496|NCT00996892|3726227|FG001|Expansion Stage 2|Physician Decision|0
2125497|NCT00996892|3726228|FG002|Expansion Stage 2|Physician Decision|0
2125498|NCT00996892|3726229|FG003|Expansion Stage 2|Physician Decision|0
2125499|NCT00996892|3726230|FG004|Expansion Stage 2|Physician Decision|0
2125500|NCT00996892|3726231|FG005|Expansion Stage 2|Physician Decision|0
2125501|NCT00996892|3726232|FG006|Expansion Stage 2|Physician Decision|0
2125502|NCT00996892|3726233|FG007|Expansion Stage 2|Physician Decision|0
2125503|NCT00996892|3726234|FG008|Expansion Stage 2|Physician Decision|0
2125504|NCT00996892|3726235|FG009|Expansion Stage 2|Physician Decision|0
2125505|NCT00996892|3726236|FG010|Expansion Stage 2|Physician Decision|0
2125506|NCT00996892|3726237|FG011|Expansion Stage 2|Physician Decision|0
2125507|NCT00996892|3726238|FG012|Expansion Stage 2|Physician Decision|0
2125508|NCT00996892|3726239|FG013|Expansion Stage 2|Physician Decision|0
2125509|NCT00996892|3726240|FG014|Expansion Stage 2|Physician Decision|0
2125510|NCT00996892|3726241|FG015|Expansion Stage 2|Physician Decision|0
2125511|NCT00996892|3726242|FG016|Expansion Stage 2|Physician Decision|0
2125512|NCT00996892|3726243|FG017|Expansion Stage 2|Physician Decision|0
2125513|NCT00996892|3726244|FG018|Expansion Stage 2|Physician Decision|1
2125514|NCT00996892|3726245|FG019|Expansion Stage 2|Physician Decision|0
2125515|NCT00996892|3726226|FG000|Expansion Stage 2|Withdrawal by Subject|0
2125516|NCT00996892|3726227|FG001|Expansion Stage 2|Withdrawal by Subject|0
2125517|NCT00996892|3726228|FG002|Expansion Stage 2|Withdrawal by Subject|0
2125518|NCT00996892|3726229|FG003|Expansion Stage 2|Withdrawal by Subject|0
2125519|NCT00996892|3726230|FG004|Expansion Stage 2|Withdrawal by Subject|0
2125520|NCT00996892|3726231|FG005|Expansion Stage 2|Withdrawal by Subject|0
2125521|NCT00996892|3726232|FG006|Expansion Stage 2|Withdrawal by Subject|0
2125522|NCT00996892|3726233|FG007|Expansion Stage 2|Withdrawal by Subject|0
2125523|NCT00996892|3726234|FG008|Expansion Stage 2|Withdrawal by Subject|0
2125524|NCT00996892|3726235|FG009|Expansion Stage 2|Withdrawal by Subject|0
2125525|NCT00996892|3726236|FG010|Expansion Stage 2|Withdrawal by Subject|0
2125526|NCT00996892|3726237|FG011|Expansion Stage 2|Withdrawal by Subject|0
2125527|NCT00996892|3726238|FG012|Expansion Stage 2|Withdrawal by Subject|0
2125528|NCT00996892|3726239|FG013|Expansion Stage 2|Withdrawal by Subject|0
2125529|NCT00996892|3726240|FG014|Expansion Stage 2|Withdrawal by Subject|0
2125530|NCT00996892|3726241|FG015|Expansion Stage 2|Withdrawal by Subject|0
2125531|NCT00996892|3726242|FG016|Expansion Stage 2|Withdrawal by Subject|0
2125532|NCT00996892|3726243|FG017|Expansion Stage 2|Withdrawal by Subject|0
2125533|NCT00996892|3726244|FG018|Expansion Stage 2|Withdrawal by Subject|1
2125534|NCT00996892|3726245|FG019|Expansion Stage 2|Withdrawal by Subject|0
2125535|NCT00996892|3726226|FG000|Expansion Stage 2|Disease Progression|0
2125536|NCT00996892|3726227|FG001|Expansion Stage 2|Disease Progression|0
2125537|NCT00996892|3726228|FG002|Expansion Stage 2|Disease Progression|0
2125538|NCT00996892|3726229|FG003|Expansion Stage 2|Disease Progression|0
2125539|NCT00996892|3726230|FG004|Expansion Stage 2|Disease Progression|0
2125540|NCT00996892|3726231|FG005|Expansion Stage 2|Disease Progression|0
2125541|NCT00996892|3726232|FG006|Expansion Stage 2|Disease Progression|0
2125542|NCT00996892|3726233|FG007|Expansion Stage 2|Disease Progression|0
2125543|NCT00996892|3726234|FG008|Expansion Stage 2|Disease Progression|0
2125544|NCT00996892|3726235|FG009|Expansion Stage 2|Disease Progression|0
2125545|NCT00996892|3726236|FG010|Expansion Stage 2|Disease Progression|0
2125546|NCT00996892|3726237|FG011|Expansion Stage 2|Disease Progression|0
2125547|NCT00996892|3726238|FG012|Expansion Stage 2|Disease Progression|0
2125548|NCT00996892|3726239|FG013|Expansion Stage 2|Disease Progression|0
2125549|NCT00996892|3726240|FG014|Expansion Stage 2|Disease Progression|0
2125550|NCT00996892|3726241|FG015|Expansion Stage 2|Disease Progression|0
2125551|NCT00996892|3726242|FG016|Expansion Stage 2|Disease Progression|0
2125552|NCT00996892|3726243|FG017|Expansion Stage 2|Disease Progression|0
2125553|NCT00996892|3726244|FG018|Expansion Stage 2|Disease Progression|28
2125554|NCT00996892|3726245|FG019|Expansion Stage 2|Disease Progression|0
2125555|NCT00996892|3726226|FG000|Expansion Stage 2A|Adverse Event|0
2125556|NCT00996892|3726227|FG001|Expansion Stage 2A|Adverse Event|0
2125557|NCT00996892|3726228|FG002|Expansion Stage 2A|Adverse Event|0
2125558|NCT00996892|3726229|FG003|Expansion Stage 2A|Adverse Event|0
2125559|NCT00996892|3726230|FG004|Expansion Stage 2A|Adverse Event|0
2125560|NCT00996892|3726231|FG005|Expansion Stage 2A|Adverse Event|0
2125561|NCT00996892|3726232|FG006|Expansion Stage 2A|Adverse Event|0
2125562|NCT00996892|3726233|FG007|Expansion Stage 2A|Adverse Event|0
2125563|NCT00996892|3726234|FG008|Expansion Stage 2A|Adverse Event|0
2125564|NCT00996892|3726235|FG009|Expansion Stage 2A|Adverse Event|0
2125565|NCT00996892|3726236|FG010|Expansion Stage 2A|Adverse Event|0
2125566|NCT00996892|3726237|FG011|Expansion Stage 2A|Adverse Event|0
2125567|NCT00996892|3726238|FG012|Expansion Stage 2A|Adverse Event|0
2125568|NCT00996892|3726239|FG013|Expansion Stage 2A|Adverse Event|0
2125569|NCT00996892|3726240|FG014|Expansion Stage 2A|Adverse Event|0
2125570|NCT00996892|3726241|FG015|Expansion Stage 2A|Adverse Event|0
2125571|NCT00996892|3726242|FG016|Expansion Stage 2A|Adverse Event|0
2125572|NCT00996892|3726243|FG017|Expansion Stage 2A|Adverse Event|0
2125573|NCT00996892|3726244|FG018|Expansion Stage 2A|Adverse Event|0
2125574|NCT00996892|3726245|FG019|Expansion Stage 2A|Adverse Event|8
2125575|NCT00996892|3726226|FG000|Expansion Stage 2A|Physician Decision|0
2125576|NCT00996892|3726227|FG001|Expansion Stage 2A|Physician Decision|0
2125577|NCT00996892|3726228|FG002|Expansion Stage 2A|Physician Decision|0
2125578|NCT00996892|3726229|FG003|Expansion Stage 2A|Physician Decision|0
2125579|NCT00996892|3726230|FG004|Expansion Stage 2A|Physician Decision|0
2125580|NCT00996892|3726231|FG005|Expansion Stage 2A|Physician Decision|0
2125581|NCT00996892|3726232|FG006|Expansion Stage 2A|Physician Decision|0
2125582|NCT00996892|3726233|FG007|Expansion Stage 2A|Physician Decision|0
2125583|NCT00996892|3726234|FG008|Expansion Stage 2A|Physician Decision|0
2125584|NCT00996892|3726235|FG009|Expansion Stage 2A|Physician Decision|0
2125585|NCT00996892|3726236|FG010|Expansion Stage 2A|Physician Decision|0
2125586|NCT00996892|3726237|FG011|Expansion Stage 2A|Physician Decision|0
2125587|NCT00996892|3726238|FG012|Expansion Stage 2A|Physician Decision|0
2125588|NCT00996892|3726239|FG013|Expansion Stage 2A|Physician Decision|0
2125589|NCT00996892|3726240|FG014|Expansion Stage 2A|Physician Decision|0
2125590|NCT00996892|3726241|FG015|Expansion Stage 2A|Physician Decision|0
2125591|NCT00996892|3726242|FG016|Expansion Stage 2A|Physician Decision|0
2280958|NCT02359045|3964914|FG001|Overall Study|Adverse Event|1
2280959|NCT02359435|3964964|FG000|Overall Study|Lost to Follow-up|4
2280960|NCT02359435|3964965|FG001|Overall Study|Lost to Follow-up|4
2280961|NCT02359552|3964973|FG000|Overall Study|Lost to Follow-up|3
2280962|NCT02359552|3964974|FG001|Overall Study|Lost to Follow-up|4
2280963|NCT02359851|3964980|FG000|Overall Study|Death|1
2280964|NCT02359851|3964980|FG000|Overall Study|Disease progression|1
2280965|NCT02359877|3964988|FG000|Overall Study|Withdrawal by Subject|1
2280966|NCT02359877|3964989|FG001|Overall Study|Withdrawal by Subject|0
2280967|NCT02359877|3964990|FG002|Overall Study|Withdrawal by Subject|0
2280968|NCT02359877|3964991|FG003|Overall Study|Withdrawal by Subject|2
2280969|NCT02359877|3964988|FG000|Overall Study|Adverse Event|0
2280970|NCT02359877|3964989|FG001|Overall Study|Adverse Event|0
2280971|NCT02359877|3964990|FG002|Overall Study|Adverse Event|0
2280972|NCT02359877|3964991|FG003|Overall Study|Adverse Event|1
2125592|NCT00996892|3726243|FG017|Expansion Stage 2A|Physician Decision|0
2125593|NCT00996892|3726244|FG018|Expansion Stage 2A|Physician Decision|0
2125594|NCT00996892|3726245|FG019|Expansion Stage 2A|Physician Decision|2
2280973|NCT02359890|3965019|FG000|Overall Study|Not meeting eligibility|4
2125595|NCT00996892|3726226|FG000|Expansion Stage 2A|Withdrawal by Subject|0
2125596|NCT00996892|3726227|FG001|Expansion Stage 2A|Withdrawal by Subject|0
2125597|NCT00996892|3726228|FG002|Expansion Stage 2A|Withdrawal by Subject|0
2125598|NCT00996892|3726229|FG003|Expansion Stage 2A|Withdrawal by Subject|0
2125599|NCT00996892|3726230|FG004|Expansion Stage 2A|Withdrawal by Subject|0
2125600|NCT00996892|3726231|FG005|Expansion Stage 2A|Withdrawal by Subject|0
2125601|NCT00996892|3726232|FG006|Expansion Stage 2A|Withdrawal by Subject|0
2125602|NCT00996892|3726233|FG007|Expansion Stage 2A|Withdrawal by Subject|0
2125603|NCT00996892|3726234|FG008|Expansion Stage 2A|Withdrawal by Subject|0
2125604|NCT00996892|3726235|FG009|Expansion Stage 2A|Withdrawal by Subject|0
2125605|NCT00996892|3726236|FG010|Expansion Stage 2A|Withdrawal by Subject|0
2125606|NCT00996892|3726237|FG011|Expansion Stage 2A|Withdrawal by Subject|0
2125607|NCT00996892|3726238|FG012|Expansion Stage 2A|Withdrawal by Subject|0
2125608|NCT00996892|3726239|FG013|Expansion Stage 2A|Withdrawal by Subject|0
2125609|NCT00996892|3726240|FG014|Expansion Stage 2A|Withdrawal by Subject|0
2125610|NCT00996892|3726241|FG015|Expansion Stage 2A|Withdrawal by Subject|0
2125611|NCT00996892|3726242|FG016|Expansion Stage 2A|Withdrawal by Subject|0
2125612|NCT00996892|3726243|FG017|Expansion Stage 2A|Withdrawal by Subject|0
2125613|NCT00996892|3726244|FG018|Expansion Stage 2A|Withdrawal by Subject|0
2125614|NCT00996892|3726245|FG019|Expansion Stage 2A|Withdrawal by Subject|4
2125615|NCT00996892|3726226|FG000|Expansion Stage 2A|Disease Progression|0
2125616|NCT00996892|3726227|FG001|Expansion Stage 2A|Disease Progression|0
2125617|NCT00996892|3726228|FG002|Expansion Stage 2A|Disease Progression|0
2125618|NCT00996892|3726229|FG003|Expansion Stage 2A|Disease Progression|0
2125619|NCT00996892|3726230|FG004|Expansion Stage 2A|Disease Progression|0
2125620|NCT00996892|3726231|FG005|Expansion Stage 2A|Disease Progression|0
2125621|NCT00996892|3726232|FG006|Expansion Stage 2A|Disease Progression|0
2125622|NCT00996892|3726233|FG007|Expansion Stage 2A|Disease Progression|0
2125623|NCT00996892|3726234|FG008|Expansion Stage 2A|Disease Progression|0
2125624|NCT00996892|3726235|FG009|Expansion Stage 2A|Disease Progression|0
2125625|NCT00996892|3726236|FG010|Expansion Stage 2A|Disease Progression|0
2125626|NCT00996892|3726237|FG011|Expansion Stage 2A|Disease Progression|0
2125627|NCT00996892|3726238|FG012|Expansion Stage 2A|Disease Progression|0
2125628|NCT00996892|3726239|FG013|Expansion Stage 2A|Disease Progression|0
2125629|NCT00996892|3726240|FG014|Expansion Stage 2A|Disease Progression|0
2125630|NCT00996892|3726241|FG015|Expansion Stage 2A|Disease Progression|0
2125631|NCT00996892|3726242|FG016|Expansion Stage 2A|Disease Progression|0
2125632|NCT00996892|3726243|FG017|Expansion Stage 2A|Disease Progression|0
2125633|NCT00996892|3726244|FG018|Expansion Stage 2A|Disease Progression|0
2125634|NCT00996892|3726245|FG019|Expansion Stage 2A|Disease Progression|31
2125635|NCT00996918|3726311|FG000|Overall Study|Lack of Efficacy|1
2125636|NCT00996918|3726312|FG001|Overall Study|Lack of Efficacy|1
2125637|NCT00996918|3726313|FG002|Overall Study|Lack of Efficacy|2
2125638|NCT00996918|3726314|FG003|Overall Study|Lack of Efficacy|2
2125639|NCT00996918|3726315|FG004|Overall Study|Lack of Efficacy|0
2125640|NCT00996918|3726311|FG000|Overall Study|Adverse Event|2
2125641|NCT00996918|3726312|FG001|Overall Study|Adverse Event|5
2125642|NCT00996918|3726313|FG002|Overall Study|Adverse Event|2
2125643|NCT00996918|3726314|FG003|Overall Study|Adverse Event|6
2125644|NCT00996918|3726315|FG004|Overall Study|Adverse Event|0
2125645|NCT00996918|3726311|FG000|Overall Study|Withdrawal by Subject|1
2125646|NCT00996918|3726312|FG001|Overall Study|Withdrawal by Subject|4
2125647|NCT00996918|3726313|FG002|Overall Study|Withdrawal by Subject|3
2125648|NCT00996918|3726314|FG003|Overall Study|Withdrawal by Subject|3
2125649|NCT00996918|3726315|FG004|Overall Study|Withdrawal by Subject|2
2125650|NCT00996918|3726311|FG000|Overall Study|Physician Decision|1
2125651|NCT00996918|3726312|FG001|Overall Study|Physician Decision|0
2125652|NCT00996918|3726313|FG002|Overall Study|Physician Decision|0
2125653|NCT00996918|3726314|FG003|Overall Study|Physician Decision|0
2125654|NCT00996918|3726315|FG004|Overall Study|Physician Decision|0
2125655|NCT00996918|3726311|FG000|Overall Study|Discontinuation of Study by Sponsor|31
2125656|NCT00996918|3726312|FG001|Overall Study|Discontinuation of Study by Sponsor|54
2125657|NCT00996918|3726313|FG002|Overall Study|Discontinuation of Study by Sponsor|30
2125658|NCT00996918|3726314|FG003|Overall Study|Discontinuation of Study by Sponsor|45
2125659|NCT00996918|3726315|FG004|Overall Study|Discontinuation of Study by Sponsor|2
2125660|NCT00996918|3726311|FG000|Overall Study|Loss of Caregiver|0
2125661|NCT00996918|3726312|FG001|Overall Study|Loss of Caregiver|1
2125662|NCT00996918|3726313|FG002|Overall Study|Loss of Caregiver|0
2125663|NCT00996918|3726314|FG003|Overall Study|Loss of Caregiver|0
2125664|NCT00996918|3726315|FG004|Overall Study|Loss of Caregiver|0
2125665|NCT00996918|3726311|FG000|Overall Study|Other|3
2125666|NCT00996918|3726312|FG001|Overall Study|Other|1
2125667|NCT00996918|3726313|FG002|Overall Study|Other|0
2125668|NCT00996918|3726314|FG003|Overall Study|Other|0
2125669|NCT00996918|3726315|FG004|Overall Study|Other|0
2125670|NCT00996944|3726334|FG000|Double-blind Treatment Period|Adverse Event|2
2125671|NCT00996944|3726335|FG001|Double-blind Treatment Period|Adverse Event|1
2125672|NCT00996944|3726334|FG000|Double-blind Treatment Period|Protocol Violation|1
2125673|NCT00996944|3726335|FG001|Double-blind Treatment Period|Protocol Violation|0
2125674|NCT00996944|3726334|FG000|Double-blind Treatment Period|Study Closed/Terminated|6
2125675|NCT00996944|3726335|FG001|Double-blind Treatment Period|Study Closed/Terminated|5
2125676|NCT00996944|3726334|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
2125677|NCT00996944|3726335|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
2125678|NCT00996944|3726334|FG000|Long-term Treatment Period|Study Closed/Terminated|12
2125679|NCT00996944|3726335|FG001|Long-term Treatment Period|Study Closed/Terminated|5
2125680|NCT00996996|3726343|FG000|Overall Study|Progressive Disease|10
2125681|NCT00996996|3726343|FG000|Overall Study|Non-compliance|8
2125682|NCT00996996|3726343|FG000|Overall Study|Lost to Follow-up|9
2125683|NCT00996996|3726343|FG000|Overall Study|Death|5
2125684|NCT00996996|3726343|FG000|Overall Study|Did Not Receive Study Medications|1
2125685|NCT00997035|3726349|FG000|3-week Followup Visit|Lost to Follow-up|9
2125686|NCT00997035|3726350|FG001|3-week Followup Visit|Lost to Follow-up|6
2125687|NCT00997035|3726349|FG000|3-month Follow-up Visit|Lost to Follow-up|12
2125688|NCT00997035|3726350|FG001|3-month Follow-up Visit|Lost to Follow-up|6
2125689|NCT00997126|3726377|FG000|Overall Study|Physician Decision|7
2125690|NCT00997126|3726378|FG001|Overall Study|Physician Decision|11
2125691|NCT00997243|3726403|FG000|Overall Study|Early termination of study by sponsor|7
2125692|NCT00997321|3726409|FG000|Overall Study|did not undergo sedation after enrollmen|0
2125693|NCT00997321|3726410|FG001|Overall Study|did not undergo sedation after enrollmen|3
2125694|NCT00997334|3726422|FG000|Overall Study|still on therapy|12
2205383|NCT01609933|3843281|FG000|Overall Study|Withdrawal by Subject|3
2205384|NCT01610037|3843299|FG000|All Patients|Adverse Event|27
2125695|NCT00997334|3726422|FG000|Overall Study|Adverse Event|3
2125696|NCT00997334|3726422|FG000|Overall Study|Patient non-compliance|1
2125697|NCT00997334|3726422|FG000|Overall Study|Withdrawal by Subject|3
2125698|NCT00997334|3726422|FG000|Overall Study|Death|2
2125699|NCT00997334|3726422|FG000|Overall Study|Urgent Palliative Care|2
2125700|NCT00997334|3726422|FG000|Overall Study|No lesion amenable|1
2125701|NCT00997334|3726422|FG000|Overall Study|Ineligible|1
2125702|NCT00997373|3726428|FG000|Overall Study|Withdrawal by Subject|5
2125703|NCT00997373|3726429|FG001|Overall Study|Withdrawal by Subject|0
2125704|NCT00997373|3726428|FG000|Overall Study|wrong tumor type|4
2125705|NCT00997373|3726429|FG001|Overall Study|wrong tumor type|0
2125706|NCT00997373|3726428|FG000|Overall Study|could not have hysterectomy|6
2125707|NCT00997373|3726429|FG001|Overall Study|could not have hysterectomy|0
2125708|NCT00997438|3726443|FG000|Overall Study|Blood draw difficulty|2
2205385|NCT01610037|3843300|FG001|All Patients|Adverse Event|22
2280974|NCT02359890|3965019|FG000|Overall Study|Never treated with study catheter|6
2280975|NCT02359903|3965025|FG000|Overall Study|Adverse Event|0
2280976|NCT02359903|3965026|FG001|Overall Study|Adverse Event|2
2280977|NCT02360098|3965092|FG000|Overall Study|Physician Decision|7
2280978|NCT02360228|3965125|FG000|Overall Study|Withdrawal by Subject|1
2280979|NCT02360228|3965126|FG001|Overall Study|Withdrawal by Subject|0
2280980|NCT02360228|3965127|FG002|Overall Study|Withdrawal by Subject|0
2280981|NCT02360228|3965125|FG000|Overall Study|Self-discontinued medication|0
2280982|NCT02360228|3965126|FG001|Overall Study|Self-discontinued medication|1
2280983|NCT02360228|3965127|FG002|Overall Study|Self-discontinued medication|0
2280984|NCT02360228|3965125|FG000|Overall Study|Unstable symptoms during screening|0
2280985|NCT02360228|3965126|FG001|Overall Study|Unstable symptoms during screening|0
2280986|NCT02360228|3965127|FG002|Overall Study|Unstable symptoms during screening|1
2280987|NCT02360280|3965137|FG000|Overall Study|Withdrawal by Subject|2
2280988|NCT02360280|3965138|FG001|Overall Study|Withdrawal by Subject|0
2280989|NCT02360280|3965137|FG000|Overall Study|Adverse Event|0
2280990|NCT02360280|3965138|FG001|Overall Study|Adverse Event|1
2280991|NCT02360280|3965137|FG000|Overall Study|Lost to Follow-up|1
2280992|NCT02360280|3965138|FG001|Overall Study|Lost to Follow-up|0
2280993|NCT02360293|3965146|FG000|Overall Study|Lost to Follow-up|73
2280994|NCT02360293|3965147|FG001|Overall Study|Lost to Follow-up|95
2280995|NCT02360293|3965146|FG000|Overall Study|Withdrawal by Subject|2
2280996|NCT02360293|3965147|FG001|Overall Study|Withdrawal by Subject|1
2280997|NCT02360293|3965146|FG000|Overall Study|Excluded|1
2280998|NCT02360293|3965147|FG001|Overall Study|Excluded|0
2280999|NCT02360397|3965175|FG000|Overall Study|Incomplete screening|3
2281000|NCT02360397|3965175|FG000|Overall Study|Adverse Event|1
2281001|NCT02360475|3965184|FG000|Overall Study|Lost to Follow-up|4
2281002|NCT02360475|3965185|FG001|Overall Study|Lost to Follow-up|12
2281003|NCT02360475|3965186|FG002|Overall Study|Lost to Follow-up|6
2281004|NCT02360475|3965187|FG003|Overall Study|Lost to Follow-up|4
2281005|NCT02360475|3965184|FG000|Overall Study|Withdrawal by Subject|0
2281006|NCT02360475|3965185|FG001|Overall Study|Withdrawal by Subject|1
2281007|NCT02360475|3965186|FG002|Overall Study|Withdrawal by Subject|2
2281008|NCT02360475|3965187|FG003|Overall Study|Withdrawal by Subject|0
2205386|NCT01610037|3843301|FG002|All Patients|Adverse Event|26
2205387|NCT01610037|3843299|FG000|All Patients|Withdrawal by Subject|12
2205388|NCT01610037|3843300|FG001|All Patients|Withdrawal by Subject|10
2205389|NCT01610037|3843301|FG002|All Patients|Withdrawal by Subject|20
2205390|NCT01610037|3843299|FG000|All Patients|Unsatisfactory therapeutic effect|9
2205391|NCT01610037|3843300|FG001|All Patients|Unsatisfactory therapeutic effect|8
2205392|NCT01610037|3843301|FG002|All Patients|Unsatisfactory therapeutic effect|27
2205393|NCT01610037|3843299|FG000|All Patients|Death|4
2205394|NCT01610037|3843300|FG001|All Patients|Death|2
2205395|NCT01610037|3843301|FG002|All Patients|Death|1
2205396|NCT01610037|3843299|FG000|All Patients|Protocol deviation|4
2205397|NCT01610037|3843300|FG001|All Patients|Protocol deviation|3
2125709|NCT00997438|3726444|FG001|Overall Study|Blood draw difficulty|0
2125710|NCT00997438|3726445|FG002|Overall Study|Blood draw difficulty|1
2125711|NCT00997438|3726443|FG000|Overall Study|Withdrawal by Subject|1
2125712|NCT00997438|3726444|FG001|Overall Study|Withdrawal by Subject|1
2125713|NCT00997438|3726445|FG002|Overall Study|Withdrawal by Subject|0
2125714|NCT00997438|3726443|FG000|Overall Study|Exclusion criteria at visit 1|2
2125715|NCT00997438|3726444|FG001|Overall Study|Exclusion criteria at visit 1|2
2125716|NCT00997438|3726445|FG002|Overall Study|Exclusion criteria at visit 1|3
2125717|NCT00997503|3726454|FG000|Overall Study|Death|53
2125718|NCT00997503|3726454|FG000|Overall Study|Withdrawal by Subject|76
2281009|NCT02360475|3965184|FG000|Overall Study|Migrated/moved from study area|0
2281010|NCT02360475|3965185|FG001|Overall Study|Migrated/moved from study area|0
2125719|NCT00997503|3726454|FG000|Overall Study|Lost to Follow-up|33
2125720|NCT00997503|3726454|FG000|Overall Study|Adverse Event|3
2125721|NCT00997503|3726454|FG000|Overall Study|Physician Decision|10
2125722|NCT00997503|3726454|FG000|Overall Study|Missed 12-month follow-up|85
2125723|NCT00997503|3726454|FG000|Overall Study|Other reason|13
2281011|NCT02360475|3965186|FG002|Overall Study|Migrated/moved from study area|0
2281012|NCT02360475|3965187|FG003|Overall Study|Migrated/moved from study area|1
2281013|NCT02360605|3965208|FG000|Overall Study|Withdrawal by Subject|4
2281014|NCT02360605|3965209|FG001|Overall Study|Withdrawal by Subject|9
2281015|NCT02360605|3965208|FG000|Overall Study|Lost to Follow-up|7
2281016|NCT02360605|3965209|FG001|Overall Study|Lost to Follow-up|8
2281017|NCT02360605|3965208|FG000|Overall Study|Death|0
2281018|NCT02360605|3965209|FG001|Overall Study|Death|1
2281019|NCT02360995|3965240|FG000|Overall Study|Lost to Follow-up|2
2281020|NCT02360995|3965241|FG001|Overall Study|Lost to Follow-up|0
2281021|NCT02360995|3965242|FG002|Overall Study|Lost to Follow-up|2
2281022|NCT02360995|3965240|FG000|Overall Study|Withdrawal by Subject|0
2281023|NCT02360995|3965241|FG001|Overall Study|Withdrawal by Subject|1
2281024|NCT02360995|3965242|FG002|Overall Study|Withdrawal by Subject|0
2281025|NCT02361216|3965252|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
2281026|NCT02361216|3965253|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
2281027|NCT02361216|3965252|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
2281028|NCT02361216|3965253|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
2281029|NCT02361216|3965252|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
2281030|NCT02361216|3965253|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
2281031|NCT02361216|3965252|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
2281032|NCT02361216|3965253|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
2281033|NCT02361216|3965252|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
2281034|NCT02361216|3965253|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
2281035|NCT02361216|3965252|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
2281036|NCT02361216|3965253|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
2281037|NCT02361307|3965264|FG000|Overall Study|Unstable medical condition.|0
2281038|NCT02361307|3965265|FG001|Overall Study|Unstable medical condition.|1
2281039|NCT02361762|3965291|FG000|Overall Study|Withdrawal by Subject|0
2281040|NCT02361762|3965292|FG001|Overall Study|Withdrawal by Subject|1
2281041|NCT02361762|3965291|FG000|Overall Study|Lost to Follow-up|0
2281042|NCT02361762|3965292|FG001|Overall Study|Lost to Follow-up|1
2281043|NCT02362269|3965313|FG000|Overall Study|Moved|1
2281044|NCT02362269|3965314|FG001|Overall Study|Moved|0
2281045|NCT02362269|3965313|FG000|Overall Study|Lost to Follow-up|0
2281046|NCT02362269|3965314|FG001|Overall Study|Lost to Follow-up|6
2281047|NCT02362282|3965322|FG000|Overall Study|Withdrawal by Subject|1
2281048|NCT02362282|3965323|FG001|Overall Study|Withdrawal by Subject|0
2281049|NCT02362360|3965338|FG000|Period 1|Lack of Efficacy|1
2281050|NCT02362360|3965339|FG001|Period 1|Lack of Efficacy|0
2281051|NCT02362360|3965338|FG000|Period 1|Withdrawal by Subject|2
2281052|NCT02362360|3965339|FG001|Period 1|Withdrawal by Subject|1
2281053|NCT02362412|3965349|FG000|Treatment Period III|Lost to Follow-up|0
2281054|NCT02362412|3965350|FG001|Treatment Period III|Lost to Follow-up|1
2281055|NCT02362425|3965366|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
2281056|NCT02362425|3965367|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
2281057|NCT02362425|3965368|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
2281058|NCT02362425|3965369|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
2281059|NCT02362425|3965366|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1
2281060|NCT02362425|3965367|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0
2281061|NCT02362425|3965368|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0
2281062|NCT02362425|3965369|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0
2281063|NCT02362425|3965366|FG000|Phase 1 (up to 6 Months)|Screening failure|1
2281064|NCT02362425|3965367|FG001|Phase 1 (up to 6 Months)|Screening failure|0
2281065|NCT02362425|3965368|FG002|Phase 1 (up to 6 Months)|Screening failure|0
2281066|NCT02362425|3965369|FG003|Phase 1 (up to 6 Months)|Screening failure|0
2281067|NCT02362425|3965366|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
2281068|NCT02362425|3965367|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
2281069|NCT02362425|3965368|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
2281070|NCT02362425|3965369|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
2281071|NCT02362425|3965366|FG000|Phase 1 (up to 6 Months)|Study closure|9
2125724|NCT00997893|3726512|FG000|Overall Study|Adverse Event|1
2125725|NCT00997893|3726513|FG001|Overall Study|Adverse Event|0
2125726|NCT00997893|3726514|FG002|Overall Study|Adverse Event|0
2125727|NCT00997893|3726512|FG000|Overall Study|Unable to meet study timelines|1
2125728|NCT00997893|3726513|FG001|Overall Study|Unable to meet study timelines|0
2125729|NCT00997893|3726514|FG002|Overall Study|Unable to meet study timelines|0
2125730|NCT00997893|3726512|FG000|Overall Study|Pain/pain meds during Visit 4|0
2125731|NCT00997893|3726513|FG001|Overall Study|Pain/pain meds during Visit 4|1
2125732|NCT00997893|3726514|FG002|Overall Study|Pain/pain meds during Visit 4|0
2125733|NCT00997984|3726530|FG000|Overall Study|Adverse Event|1
2125734|NCT00997984|3726531|FG001|Overall Study|Adverse Event|8
2125735|NCT00997984|3726532|FG002|Overall Study|Adverse Event|8
2125736|NCT00997984|3726530|FG000|Overall Study|Protocol Violation|1
2125737|NCT00997984|3726531|FG001|Overall Study|Protocol Violation|3
2125738|NCT00997984|3726532|FG002|Overall Study|Protocol Violation|0
2125739|NCT00997984|3726530|FG000|Overall Study|Withdrawal by Subject|6
2125740|NCT00997984|3726531|FG001|Overall Study|Withdrawal by Subject|9
2125741|NCT00997984|3726532|FG002|Overall Study|Withdrawal by Subject|5
2125742|NCT00997984|3726530|FG000|Overall Study|Lost to Follow-up|8
2125743|NCT00997984|3726531|FG001|Overall Study|Lost to Follow-up|5
2125744|NCT00997984|3726532|FG002|Overall Study|Lost to Follow-up|4
2125745|NCT00997984|3726530|FG000|Overall Study|Lack of Efficacy|20
2125746|NCT00997984|3726531|FG001|Overall Study|Lack of Efficacy|6
2125747|NCT00997984|3726532|FG002|Overall Study|Lack of Efficacy|3
2125748|NCT00997984|3726530|FG000|Overall Study|Met exclusion criteria|1
2281072|NCT02362425|3965367|FG001|Phase 1 (up to 6 Months)|Study closure|0
2281073|NCT02362425|3965368|FG002|Phase 1 (up to 6 Months)|Study closure|0
2281074|NCT02362425|3965369|FG003|Phase 1 (up to 6 Months)|Study closure|0
2281075|NCT02362425|3965366|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
2281076|NCT02362425|3965367|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
2281077|NCT02362425|3965368|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
2281078|NCT02362425|3965369|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
2281079|NCT02362425|3965366|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
2281080|NCT02362425|3965367|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
2125749|NCT00997984|3726531|FG001|Overall Study|Met exclusion criteria|0
2125750|NCT00997984|3726532|FG002|Overall Study|Met exclusion criteria|0
2125751|NCT00997984|3726530|FG000|Overall Study|non-compliance|0
2125752|NCT00997984|3726531|FG001|Overall Study|non-compliance|2
2125753|NCT00997984|3726532|FG002|Overall Study|non-compliance|3
2125754|NCT00997984|3726530|FG000|Overall Study|Wrong medication dispensed|0
2125755|NCT00997984|3726531|FG001|Overall Study|Wrong medication dispensed|1
2125756|NCT00997984|3726532|FG002|Overall Study|Wrong medication dispensed|0
2125757|NCT00997984|3726530|FG000|Overall Study|Suicidal ideation|0
2125758|NCT00997984|3726531|FG001|Overall Study|Suicidal ideation|0
2125759|NCT00997984|3726532|FG002|Overall Study|Suicidal ideation|1
2125760|NCT00997984|3726530|FG000|Overall Study|Work schedule|0
2125761|NCT00997984|3726531|FG001|Overall Study|Work schedule|0
2125762|NCT00997984|3726532|FG002|Overall Study|Work schedule|2
2125763|NCT00998296|3726575|FG000|Overall Study|Progressive disease|0
2125764|NCT00998296|3726576|FG001|Overall Study|Progressive disease|1
2125765|NCT00998296|3726577|FG002|Overall Study|Progressive disease|0
2205398|NCT01610037|3843301|FG002|All Patients|Protocol deviation|3
2125766|NCT00998296|3726578|FG003|Overall Study|Progressive disease|0
2125767|NCT00998296|3726579|FG004|Overall Study|Progressive disease|0
2125768|NCT00998296|3726580|FG005|Overall Study|Progressive disease|0
2125769|NCT00998296|3726581|FG006|Overall Study|Progressive disease|1
2125770|NCT00998296|3726582|FG007|Overall Study|Progressive disease|0
2125771|NCT00998296|3726583|FG008|Overall Study|Progressive disease|0
2125772|NCT00998296|3726584|FG009|Overall Study|Progressive disease|14
2125773|NCT00998296|3726585|FG010|Overall Study|Progressive disease|5
2205399|NCT01610037|3843299|FG000|All Patients|Abnormal laboratory value|1
2205400|NCT01610037|3843300|FG001|All Patients|Abnormal laboratory value|1
2205401|NCT01610037|3843301|FG002|All Patients|Abnormal laboratory value|0
2205402|NCT01610037|3843299|FG000|All Patients|Administrative problems|1
2205403|NCT01610037|3843300|FG001|All Patients|Administrative problems|4
2125774|NCT00998296|3726575|FG000|Overall Study|Dose limiting or dose reducing toxicity|0
2125775|NCT00998296|3726576|FG001|Overall Study|Dose limiting or dose reducing toxicity|0
2125776|NCT00998296|3726577|FG002|Overall Study|Dose limiting or dose reducing toxicity|0
2205404|NCT01610037|3843301|FG002|All Patients|Administrative problems|4
2205405|NCT01610037|3843299|FG000|All Patients|Lost to Follow-up|1
2205406|NCT01610037|3843300|FG001|All Patients|Lost to Follow-up|0
2205407|NCT01610037|3843301|FG002|All Patients|Lost to Follow-up|0
2205408|NCT01610037|3843299|FG000|All Patients|Abnormal test procedure result(s)|0
2205409|NCT01610037|3843300|FG001|All Patients|Abnormal test procedure result(s)|1
2205410|NCT01610037|3843301|FG002|All Patients|Abnormal test procedure result(s)|3
2205411|NCT01610037|3843299|FG000|Treatment and Follow up Period|Subject withdrew consent|13
2205412|NCT01610037|3843300|FG001|Treatment and Follow up Period|Subject withdrew consent|14
2205413|NCT01610037|3843301|FG002|Treatment and Follow up Period|Subject withdrew consent|16
2205414|NCT01610037|3843299|FG000|Treatment and Follow up Period|Death|10
2205415|NCT01610037|3843300|FG001|Treatment and Follow up Period|Death|5
2205416|NCT01610037|3843301|FG002|Treatment and Follow up Period|Death|4
2125777|NCT00998296|3726578|FG003|Overall Study|Dose limiting or dose reducing toxicity|0
2125778|NCT00998296|3726579|FG004|Overall Study|Dose limiting or dose reducing toxicity|1
2125779|NCT00998296|3726580|FG005|Overall Study|Dose limiting or dose reducing toxicity|0
2125780|NCT00998296|3726581|FG006|Overall Study|Dose limiting or dose reducing toxicity|0
2125781|NCT00998296|3726582|FG007|Overall Study|Dose limiting or dose reducing toxicity|2
2125782|NCT00998296|3726583|FG008|Overall Study|Dose limiting or dose reducing toxicity|2
2125783|NCT00998296|3726584|FG009|Overall Study|Dose limiting or dose reducing toxicity|0
2125784|NCT00998296|3726585|FG010|Overall Study|Dose limiting or dose reducing toxicity|0
2125785|NCT00998296|3726575|FG000|Overall Study|Other adverse event|0
2125786|NCT00998296|3726576|FG001|Overall Study|Other adverse event|0
2125787|NCT00998296|3726577|FG002|Overall Study|Other adverse event|0
2125788|NCT00998296|3726578|FG003|Overall Study|Other adverse event|0
2125789|NCT00998296|3726579|FG004|Overall Study|Other adverse event|1
2125790|NCT00998296|3726580|FG005|Overall Study|Other adverse event|0
2125791|NCT00998296|3726581|FG006|Overall Study|Other adverse event|0
2125792|NCT00998296|3726582|FG007|Overall Study|Other adverse event|0
2125793|NCT00998296|3726583|FG008|Overall Study|Other adverse event|0
2125794|NCT00998296|3726584|FG009|Overall Study|Other adverse event|1
2125795|NCT00998296|3726585|FG010|Overall Study|Other adverse event|2
2125796|NCT00998296|3726575|FG000|Overall Study|Refused to continue taking trial med.|0
2125797|NCT00998296|3726576|FG001|Overall Study|Refused to continue taking trial med.|0
2125798|NCT00998296|3726577|FG002|Overall Study|Refused to continue taking trial med.|0
2125799|NCT00998296|3726578|FG003|Overall Study|Refused to continue taking trial med.|0
2125800|NCT00998296|3726579|FG004|Overall Study|Refused to continue taking trial med.|0
2125801|NCT00998296|3726580|FG005|Overall Study|Refused to continue taking trial med.|0
2125802|NCT00998296|3726581|FG006|Overall Study|Refused to continue taking trial med.|0
2125803|NCT00998296|3726582|FG007|Overall Study|Refused to continue taking trial med.|0
2125804|NCT00998296|3726583|FG008|Overall Study|Refused to continue taking trial med.|0
2125805|NCT00998296|3726584|FG009|Overall Study|Refused to continue taking trial med.|2
2125806|NCT00998296|3726585|FG010|Overall Study|Refused to continue taking trial med.|0
2125807|NCT00998296|3726575|FG000|Overall Study|Reason other than those specified above|0
2125808|NCT00998296|3726576|FG001|Overall Study|Reason other than those specified above|0
2125809|NCT00998296|3726577|FG002|Overall Study|Reason other than those specified above|0
2125810|NCT00998296|3726578|FG003|Overall Study|Reason other than those specified above|0
2125811|NCT00998296|3726579|FG004|Overall Study|Reason other than those specified above|0
2125812|NCT00998296|3726580|FG005|Overall Study|Reason other than those specified above|0
2125813|NCT00998296|3726581|FG006|Overall Study|Reason other than those specified above|0
2125814|NCT00998296|3726582|FG007|Overall Study|Reason other than those specified above|0
2125815|NCT00998296|3726583|FG008|Overall Study|Reason other than those specified above|0
2125816|NCT00998296|3726584|FG009|Overall Study|Reason other than those specified above|1
2125817|NCT00998296|3726585|FG010|Overall Study|Reason other than those specified above|0
2125818|NCT00998309|3726614|FG000|Overall Study|Protocol Violation|4
2177939|NCT01379534|3802463|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
2177940|NCT01379534|3802462|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
2177941|NCT01379534|3802463|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
2177942|NCT01379534|3802462|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
2177943|NCT01379534|3802463|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
2177944|NCT01379573|3802469|FG000|Overall Study|Lost to Follow-up|1
2177945|NCT01379573|3802469|FG000|Overall Study|Screen Failure|10
2177946|NCT01379703|3802500|FG000|Study Start Through 9 Months|Lost to Follow-up|2
2177947|NCT01379703|3802501|FG001|Study Start Through 9 Months|Lost to Follow-up|61
2177948|NCT01379703|3802502|FG002|Study Start Through 9 Months|Lost to Follow-up|104
2177949|NCT01379703|3802500|FG000|Study Start Through 9 Months|Adverse Event|0
2177950|NCT01379703|3802501|FG001|Study Start Through 9 Months|Adverse Event|14
2177951|NCT01379703|3802502|FG002|Study Start Through 9 Months|Adverse Event|10
2177952|NCT01379703|3802500|FG000|Study Start Through 9 Months|Withdrawal by Subject|0
2177953|NCT01379703|3802501|FG001|Study Start Through 9 Months|Withdrawal by Subject|6
2177954|NCT01379703|3802502|FG002|Study Start Through 9 Months|Withdrawal by Subject|1
2177955|NCT01379703|3802500|FG000|Study Start Through 9 Months|Treatment Failure|0
2177956|NCT01379703|3802501|FG001|Study Start Through 9 Months|Treatment Failure|2
2177957|NCT01379703|3802502|FG002|Study Start Through 9 Months|Treatment Failure|2
2177958|NCT01379703|3802500|FG000|Study Start Through 9 Months|Patient Noncompliance|0
2177959|NCT01379703|3802501|FG001|Study Start Through 9 Months|Patient Noncompliance|0
2177960|NCT01379703|3802502|FG002|Study Start Through 9 Months|Patient Noncompliance|1
2177961|NCT01379703|3802500|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0
2177962|NCT01379703|3802501|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4
2177963|NCT01379703|3802502|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0
2177964|NCT01379703|3802500|FG000|Study Start Through 9 Months|Medication not available|0
2177965|NCT01379703|3802501|FG001|Study Start Through 9 Months|Medication not available|2
2177966|NCT01379703|3802502|FG002|Study Start Through 9 Months|Medication not available|1
2177967|NCT01379703|3802500|FG000|Study Start Through 9 Months|Poor general condition|0
2177968|NCT01379703|3802501|FG001|Study Start Through 9 Months|Poor general condition|1
2177969|NCT01379703|3802502|FG002|Study Start Through 9 Months|Poor general condition|0
2125819|NCT00998335|3726668|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
2125820|NCT00998335|3726669|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
2125821|NCT00998400|3726694|FG000|Overall Study|Lack of interest/motivation|1
2125822|NCT00998400|3726695|FG001|Overall Study|Lack of interest/motivation|2
2125823|NCT00998400|3726694|FG000|Overall Study|Logistical problems|1
2125824|NCT00998400|3726695|FG001|Overall Study|Logistical problems|0
2125825|NCT00998764|3726738|FG000|Overall Study|Lack of Efficacy|3
2125826|NCT00998764|3726739|FG001|Overall Study|Lack of Efficacy|6
2125827|NCT00998764|3726738|FG000|Overall Study|Adverse Event|17
2125828|NCT00998764|3726739|FG001|Overall Study|Adverse Event|12
2125829|NCT00998764|3726738|FG000|Overall Study|Withdrawal by Subject|19
2125830|NCT00998764|3726739|FG001|Overall Study|Withdrawal by Subject|25
2125831|NCT00998764|3726738|FG000|Overall Study|Physician Decision|3
2125832|NCT00998764|3726739|FG001|Overall Study|Physician Decision|3
2125833|NCT00998764|3726738|FG000|Overall Study|Death|3
2125834|NCT00998764|3726739|FG001|Overall Study|Death|1
2125835|NCT00998764|3726738|FG000|Overall Study|Discontinuation of Study by Sponsor|164
2125836|NCT00998764|3726739|FG001|Overall Study|Discontinuation of Study by Sponsor|217
2125837|NCT00998764|3726738|FG000|Overall Study|Protocol Violation|0
2125838|NCT00998764|3726739|FG001|Overall Study|Protocol Violation|1
2125839|NCT00998764|3726738|FG000|Overall Study|Failed to Return|1
2125840|NCT00998764|3726739|FG001|Overall Study|Failed to Return|1
2125841|NCT00998764|3726738|FG000|Overall Study|Lost to Follow-up|1
2125842|NCT00998764|3726739|FG001|Overall Study|Lost to Follow-up|1
2125843|NCT00998764|3726738|FG000|Overall Study|Loss of Caregiver|0
2125844|NCT00998764|3726739|FG001|Overall Study|Loss of Caregiver|3
2125845|NCT00998764|3726738|FG000|Overall Study|Other|4
2125846|NCT00998764|3726739|FG001|Overall Study|Other|4
2125847|NCT00998764|3726738|FG000|Overall Study|Recurrent Episode of vasogenic edema|1
2125848|NCT00998764|3726739|FG001|Overall Study|Recurrent Episode of vasogenic edema|0
2125849|NCT00998790|3726747|FG000|Overall Study|Withdrawal by Subject|21
2125850|NCT00998881|3726757|FG000|Overall Study|Adverse Event|2
2125851|NCT00998881|3726758|FG001|Overall Study|Adverse Event|2
2125852|NCT00998881|3726757|FG000|Overall Study|Lack of Efficacy|1
2125853|NCT00998881|3726758|FG001|Overall Study|Lack of Efficacy|0
2125854|NCT00998881|3726757|FG000|Overall Study|Physician Decision|3
2125855|NCT00998881|3726758|FG001|Overall Study|Physician Decision|0
2125856|NCT00998881|3726757|FG000|Overall Study|Withdrawal by Subject|1
2125857|NCT00998881|3726758|FG001|Overall Study|Withdrawal by Subject|0
2125858|NCT00998881|3726757|FG000|Overall Study|Personal matter|1
2125859|NCT00998881|3726758|FG001|Overall Study|Personal matter|0
2125860|NCT00998946|3726764|FG000|Overall Study|Lost to Follow-up|1
2125861|NCT00998946|3726764|FG000|Overall Study|Withdrawal by Subject|1
2125862|NCT00998946|3726764|FG000|Overall Study|Death|2
2125863|NCT00998946|3726764|FG000|Overall Study|Reason Unspecified|3
2125864|NCT00998946|3726764|FG000|Overall Study|Enrolled but not Dosed|2
2125865|NCT00998985|3726782|FG000|Overall Study|Withdrawal by Subject|0
2125866|NCT00998985|3726783|FG001|Overall Study|Withdrawal by Subject|0
2125867|NCT00998985|3726784|FG002|Overall Study|Withdrawal by Subject|0
2205417|NCT01610037|3843299|FG000|Treatment and Follow up Period|Administrative problems|1
2205418|NCT01610037|3843300|FG001|Treatment and Follow up Period|Administrative problems|3
2125868|NCT00998985|3726785|FG003|Overall Study|Withdrawal by Subject|0
2205419|NCT01610037|3843301|FG002|Treatment and Follow up Period|Administrative problems|2
2205420|NCT01610037|3843299|FG000|Treatment and Follow up Period|Lost to Follow-up|1
2205421|NCT01610037|3843300|FG001|Treatment and Follow up Period|Lost to Follow-up|6
2205422|NCT01610037|3843301|FG002|Treatment and Follow up Period|Lost to Follow-up|4
2205423|NCT01610063|3843311|FG000|Overall Study|Lost to Follow-up|42
2205424|NCT01610063|3843312|FG001|Overall Study|Lost to Follow-up|20
2205425|NCT01610076|3843320|FG000|Overall Study|Technical issue with video|0
2205426|NCT01610076|3843321|FG001|Overall Study|Technical issue with video|1
2205427|NCT01610076|3843320|FG000|Overall Study|Lost to Follow-up|3
2205428|NCT01610076|3843321|FG001|Overall Study|Lost to Follow-up|4
2205429|NCT01610167|3843337|FG000|Overall Study|Scheduling conflict.|0
2205430|NCT01610167|3843338|FG001|Overall Study|Scheduling conflict.|0
2205431|NCT01610167|3843339|FG002|Overall Study|Scheduling conflict.|2
2125869|NCT00998985|3726786|FG004|Overall Study|Withdrawal by Subject|0
2125870|NCT00998985|3726787|FG005|Overall Study|Withdrawal by Subject|0
2125871|NCT00998985|3726788|FG006|Overall Study|Withdrawal by Subject|0
2125872|NCT00998985|3726789|FG007|Overall Study|Withdrawal by Subject|0
2125873|NCT00998985|3726790|FG008|Overall Study|Withdrawal by Subject|1
2125874|NCT00998985|3726791|FG009|Overall Study|Withdrawal by Subject|0
2125875|NCT00998985|3726792|FG010|Overall Study|Withdrawal by Subject|0
2125876|NCT00998985|3726793|FG011|Overall Study|Withdrawal by Subject|0
2125877|NCT00998985|3726794|FG012|Overall Study|Withdrawal by Subject|0
2125878|NCT00998985|3726795|FG013|Overall Study|Withdrawal by Subject|0
2125879|NCT00998985|3726782|FG000|Overall Study|Protocol Violation|0
2125880|NCT00998985|3726783|FG001|Overall Study|Protocol Violation|0
2125881|NCT00998985|3726784|FG002|Overall Study|Protocol Violation|0
2125882|NCT00998985|3726785|FG003|Overall Study|Protocol Violation|0
2125883|NCT00998985|3726786|FG004|Overall Study|Protocol Violation|0
2125884|NCT00998985|3726787|FG005|Overall Study|Protocol Violation|1
2125885|NCT00998985|3726788|FG006|Overall Study|Protocol Violation|0
2125886|NCT00998985|3726789|FG007|Overall Study|Protocol Violation|0
2125887|NCT00998985|3726790|FG008|Overall Study|Protocol Violation|0
2125888|NCT00998985|3726791|FG009|Overall Study|Protocol Violation|0
2125889|NCT00998985|3726792|FG010|Overall Study|Protocol Violation|0
2205432|NCT01610206|3843349|FG000|Overall Study|Adverse Event|10
2205433|NCT01610206|3843350|FG001|Overall Study|Adverse Event|30
2205434|NCT01610271|3843358|FG000|Overall Study|Surgery not complete|0
2205435|NCT01610271|3843359|FG001|Overall Study|Surgery not complete|1
2205436|NCT01610271|3843358|FG000|Overall Study|Prosthesis not implanted|2
2205437|NCT01610271|3843359|FG001|Overall Study|Prosthesis not implanted|3
2205438|NCT01610284|3843369|FG000|Randomization Phase|Adverse Event|1
2205439|NCT01610284|3843370|FG001|Randomization Phase|Adverse Event|0
2205440|NCT01610284|3843369|FG000|Randomization Phase|Physician Decision|1
2205441|NCT01610284|3843370|FG001|Randomization Phase|Physician Decision|1
2205442|NCT01610284|3843369|FG000|Randomization Phase|Death|0
2205443|NCT01610284|3843370|FG001|Randomization Phase|Death|1
2125890|NCT00998985|3726793|FG011|Overall Study|Protocol Violation|0
2125891|NCT00998985|3726794|FG012|Overall Study|Protocol Violation|0
2205444|NCT01610284|3843369|FG000|Treatment Phase|Adverse Event|80
2205445|NCT01610284|3843370|FG001|Treatment Phase|Adverse Event|12
2205446|NCT01610284|3843369|FG000|Treatment Phase|Lost to Follow-up|1
2205447|NCT01610284|3843370|FG001|Treatment Phase|Lost to Follow-up|0
2205448|NCT01610284|3843369|FG000|Treatment Phase|Non-compliance with Study Treatment|8
2205449|NCT01610284|3843370|FG001|Treatment Phase|Non-compliance with Study Treatment|1
2205450|NCT01610284|3843369|FG000|Treatment Phase|Physician Decision|27
2205451|NCT01610284|3843370|FG001|Treatment Phase|Physician Decision|24
2205452|NCT01610284|3843369|FG000|Treatment Phase|Progressive Disease|377
2205453|NCT01610284|3843370|FG001|Treatment Phase|Progressive Disease|486
2205454|NCT01610284|3843369|FG000|Treatment Phase|Protocol Deviation|2
2205455|NCT01610284|3843370|FG001|Treatment Phase|Protocol Deviation|3
2205456|NCT01610284|3843369|FG000|Treatment Phase|Study terminated by Sponsor|18
2205457|NCT01610284|3843370|FG001|Treatment Phase|Study terminated by Sponsor|15
2205458|NCT01610284|3843369|FG000|Treatment Phase|Subject/Guardian Decision|55
2205459|NCT01610284|3843370|FG001|Treatment Phase|Subject/Guardian Decision|23
2205460|NCT01610284|3843369|FG000|Treatment Phase|Death|6
2205461|NCT01610284|3843370|FG001|Treatment Phase|Death|5
2205462|NCT01610284|3843369|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
2205463|NCT01610284|3843370|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
2205464|NCT01610284|3843369|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10
2205465|NCT01610284|3843370|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3
2205466|NCT01610284|3843369|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24
2205467|NCT01610284|3843370|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8
2205468|NCT01610284|3843369|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11
2205469|NCT01610284|3843370|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
2205470|NCT01610284|3843369|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4
2205471|NCT01610284|3843370|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4
2205472|NCT01610284|3843369|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38
2205473|NCT01610284|3843370|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13
2205474|NCT01610297|3843376|FG000|Overall Study|Lost to Follow-up|1
2205475|NCT01610336|3843391|FG000|Overall Study|Progressive Disease|4
2205476|NCT01610336|3843392|FG001|Overall Study|Progressive Disease|6
2205477|NCT01610336|3843393|FG002|Overall Study|Progressive Disease|6
2205478|NCT01610336|3843394|FG003|Overall Study|Progressive Disease|5
2205479|NCT01610336|3843395|FG004|Overall Study|Progressive Disease|3
2205480|NCT01610336|3843396|FG005|Overall Study|Progressive Disease|10
2205481|NCT01610336|3843397|FG006|Overall Study|Progressive Disease|1
2205482|NCT01610336|3843398|FG007|Overall Study|Progressive Disease|6
2205483|NCT01610336|3843399|FG008|Overall Study|Progressive Disease|6
2205484|NCT01610336|3843400|FG009|Overall Study|Progressive Disease|40
2205485|NCT01610336|3843401|FG010|Overall Study|Progressive Disease|36
2205486|NCT01610336|3843391|FG000|Overall Study|Adverse Event|0
2205487|NCT01610336|3843392|FG001|Overall Study|Adverse Event|0
2205488|NCT01610336|3843393|FG002|Overall Study|Adverse Event|0
2205489|NCT01610336|3843394|FG003|Overall Study|Adverse Event|1
2205490|NCT01610336|3843395|FG004|Overall Study|Adverse Event|1
2205491|NCT01610336|3843396|FG005|Overall Study|Adverse Event|1
2125892|NCT00998985|3726795|FG013|Overall Study|Protocol Violation|0
2125893|NCT00999167|3726920|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
2205492|NCT01610336|3843397|FG006|Overall Study|Adverse Event|0
2281081|NCT02362425|3965368|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
2281082|NCT02362425|3965369|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
2281083|NCT02362425|3965366|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
2320717|NCT02952001|4035004|FG000|Overall Study|Adverse Event|3
2125894|NCT00999167|3726921|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
2125895|NCT00999167|3726922|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
2125896|NCT00999167|3726920|FG000|Part A: Open Label Safety run-in|Adverse Event|3
2205493|NCT01610336|3843398|FG007|Overall Study|Adverse Event|0
2205494|NCT01610336|3843399|FG008|Overall Study|Adverse Event|2
2205495|NCT01610336|3843400|FG009|Overall Study|Adverse Event|8
2205496|NCT01610336|3843401|FG010|Overall Study|Adverse Event|6
2205497|NCT01610336|3843391|FG000|Overall Study|Subject/Guardian decision|1
2281084|NCT02362425|3965367|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
2281085|NCT02362425|3965368|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
2281086|NCT02362425|3965369|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
2281087|NCT02362503|3965383|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0
2281088|NCT02362503|3965384|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2
2281089|NCT02362503|3965385|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0
2281090|NCT02362503|3965383|FG000|Double-blind Period-Up to 8 Days|Death|1
2281091|NCT02362503|3965384|FG001|Double-blind Period-Up to 8 Days|Death|0
2281092|NCT02362503|3965385|FG002|Double-blind Period-Up to 8 Days|Death|0
2281093|NCT02362503|3965383|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
2281094|NCT02362503|3965384|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
2281095|NCT02362503|3965385|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
2281096|NCT02362503|3965383|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
2281097|NCT02362503|3965384|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
2281098|NCT02362503|3965385|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
2281099|NCT02362503|3965383|FG000|Open Label Period-Up to 96 Weeks|Other|0
2281100|NCT02362503|3965384|FG001|Open Label Period-Up to 96 Weeks|Other|1
2281101|NCT02362503|3965385|FG002|Open Label Period-Up to 96 Weeks|Other|1
2281102|NCT02362503|3965383|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0
2281103|NCT02362503|3965384|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
2281104|NCT02362503|3965385|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
2125897|NCT00999167|3726921|FG001|Part A: Open Label Safety run-in|Adverse Event|0
2125898|NCT00999167|3726922|FG002|Part A: Open Label Safety run-in|Adverse Event|0
2125899|NCT00999167|3726920|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
2125900|NCT00999167|3726921|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
2125901|NCT00999167|3726922|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
2125902|NCT00999167|3726920|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
2125903|NCT00999167|3726921|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
2125904|NCT00999167|3726922|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
2125905|NCT00999167|3726920|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0
2125906|NCT00999167|3726921|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6
2125907|NCT00999167|3726922|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1
2125908|NCT00999167|3726920|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0
2125909|NCT00999167|3726921|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1
2125910|NCT00999167|3726922|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0
2125911|NCT00999167|3726920|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0
2125912|NCT00999167|3726921|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1
2125913|NCT00999167|3726922|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0
2205498|NCT01610336|3843392|FG001|Overall Study|Subject/Guardian decision|1
2205499|NCT01610336|3843393|FG002|Overall Study|Subject/Guardian decision|0
2205500|NCT01610336|3843394|FG003|Overall Study|Subject/Guardian decision|1
2205501|NCT01610336|3843395|FG004|Overall Study|Subject/Guardian decision|0
2125914|NCT00999167|3726920|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
2125915|NCT00999167|3726921|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
2125916|NCT00999167|3726922|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
2125917|NCT00999466|3726935|FG000|Main Part|Withdrawal by Subject|0
2125918|NCT00999466|3726936|FG001|Main Part|Withdrawal by Subject|0
2125919|NCT00999466|3726937|FG002|Main Part|Withdrawal by Subject|2
2125920|NCT00999466|3726935|FG000|Main Part|Adverse Event|0
2125921|NCT00999466|3726936|FG001|Main Part|Adverse Event|4
2125922|NCT00999466|3726937|FG002|Main Part|Adverse Event|2
2125923|NCT00999518|3726950|FG000|Overall Study|Adverse Event|1
2125924|NCT00999518|3726951|FG001|Overall Study|Adverse Event|6
2125925|NCT00999518|3726952|FG002|Overall Study|Adverse Event|3
2125926|NCT00999518|3726953|FG003|Overall Study|Adverse Event|1
2125927|NCT00999518|3726954|FG004|Overall Study|Adverse Event|2
2125928|NCT00999518|3726950|FG000|Overall Study|Lack of Efficacy|2
2125929|NCT00999518|3726951|FG001|Overall Study|Lack of Efficacy|0
2205502|NCT01610336|3843396|FG005|Overall Study|Subject/Guardian decision|0
2205503|NCT01610336|3843397|FG006|Overall Study|Subject/Guardian decision|0
2205504|NCT01610336|3843398|FG007|Overall Study|Subject/Guardian decision|1
2205505|NCT01610336|3843399|FG008|Overall Study|Subject/Guardian decision|0
2205506|NCT01610336|3843400|FG009|Overall Study|Subject/Guardian decision|2
2205507|NCT01610336|3843401|FG010|Overall Study|Subject/Guardian decision|2
2205508|NCT01610336|3843391|FG000|Overall Study|Death|0
2205509|NCT01610336|3843392|FG001|Overall Study|Death|0
2205510|NCT01610336|3843393|FG002|Overall Study|Death|0
2205511|NCT01610336|3843394|FG003|Overall Study|Death|0
2205512|NCT01610336|3843395|FG004|Overall Study|Death|0
2205513|NCT01610336|3843396|FG005|Overall Study|Death|1
2205514|NCT01610336|3843397|FG006|Overall Study|Death|3
2205515|NCT01610336|3843398|FG007|Overall Study|Death|0
2125930|NCT00999518|3726952|FG002|Overall Study|Lack of Efficacy|0
2125931|NCT00999518|3726953|FG003|Overall Study|Lack of Efficacy|2
2125932|NCT00999518|3726954|FG004|Overall Study|Lack of Efficacy|2
2205516|NCT01610336|3843399|FG008|Overall Study|Death|0
2205517|NCT01610336|3843400|FG009|Overall Study|Death|1
2125933|NCT00999518|3726950|FG000|Overall Study|Lost to Follow-up|0
2125934|NCT00999518|3726951|FG001|Overall Study|Lost to Follow-up|0
2125935|NCT00999518|3726952|FG002|Overall Study|Lost to Follow-up|0
2125936|NCT00999518|3726953|FG003|Overall Study|Lost to Follow-up|4
2125937|NCT00999518|3726954|FG004|Overall Study|Lost to Follow-up|1
2125938|NCT00999518|3726950|FG000|Overall Study|Did not meet entrance criteria|0
2125939|NCT00999518|3726951|FG001|Overall Study|Did not meet entrance criteria|0
2125940|NCT00999518|3726952|FG002|Overall Study|Did not meet entrance criteria|0
2125941|NCT00999518|3726953|FG003|Overall Study|Did not meet entrance criteria|0
2125942|NCT00999518|3726954|FG004|Overall Study|Did not meet entrance criteria|1
2125943|NCT00999518|3726950|FG000|Overall Study|Study terminated by sponsor|10
2125944|NCT00999518|3726951|FG001|Overall Study|Study terminated by sponsor|6
2125945|NCT00999518|3726952|FG002|Overall Study|Study terminated by sponsor|5
2125946|NCT00999518|3726953|FG003|Overall Study|Study terminated by sponsor|5
2125947|NCT00999518|3726954|FG004|Overall Study|Study terminated by sponsor|9
2125948|NCT00999518|3726950|FG000|Overall Study|Pregnancy|0
2125949|NCT00999518|3726951|FG001|Overall Study|Pregnancy|0
2125950|NCT00999518|3726952|FG002|Overall Study|Pregnancy|1
2125951|NCT00999518|3726953|FG003|Overall Study|Pregnancy|0
2125952|NCT00999518|3726954|FG004|Overall Study|Pregnancy|0
2125953|NCT00999518|3726950|FG000|Overall Study|Protocol Violation|0
2125954|NCT00999518|3726951|FG001|Overall Study|Protocol Violation|1
2125955|NCT00999518|3726952|FG002|Overall Study|Protocol Violation|0
2125956|NCT00999518|3726953|FG003|Overall Study|Protocol Violation|0
2125957|NCT00999518|3726954|FG004|Overall Study|Protocol Violation|2
2125958|NCT00999518|3726950|FG000|Overall Study|Withdrawal by Subject|5
2125959|NCT00999518|3726951|FG001|Overall Study|Withdrawal by Subject|4
2125960|NCT00999518|3726952|FG002|Overall Study|Withdrawal by Subject|10
2125961|NCT00999518|3726953|FG003|Overall Study|Withdrawal by Subject|6
2125962|NCT00999518|3726954|FG004|Overall Study|Withdrawal by Subject|1
2125963|NCT00999518|3726950|FG000|Overall Study|Other|5
2125964|NCT00999518|3726951|FG001|Overall Study|Other|7
2125965|NCT00999518|3726952|FG002|Overall Study|Other|1
2125966|NCT00999518|3726953|FG003|Overall Study|Other|4
2125967|NCT00999518|3726954|FG004|Overall Study|Other|5
2125968|NCT00999518|3726950|FG000|Overall Study|Randomized but not Treated|1
2281105|NCT02362503|3965383|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0
2281106|NCT02362503|3965384|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1
2281107|NCT02362503|3965385|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0
2281108|NCT02362503|3965383|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3
2281109|NCT02362503|3965384|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8
2281110|NCT02362503|3965385|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6
2281111|NCT02362503|3965383|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4
2281112|NCT02362503|3965384|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3
2281113|NCT02362503|3965385|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1
2281114|NCT02362503|3965383|FG000|Open Label Period-Up to 96 Weeks|Death|1
2281115|NCT02362503|3965384|FG001|Open Label Period-Up to 96 Weeks|Death|7
2281116|NCT02362503|3965385|FG002|Open Label Period-Up to 96 Weeks|Death|15
2281117|NCT02362503|3965383|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0
2281118|NCT02362503|3965384|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5
2281119|NCT02362503|3965385|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1
2281120|NCT02362503|3965383|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3
2281121|NCT02362503|3965384|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2
2281122|NCT02362503|3965385|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4
2281123|NCT02362503|3965383|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3
2281124|NCT02362503|3965384|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9
2281125|NCT02362503|3965385|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6
2281126|NCT02362503|3965383|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54
2281127|NCT02362503|3965384|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159
2281128|NCT02362503|3965385|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61
2281129|NCT02362646|3965407|FG000|Overall Study|Death|15
2281130|NCT02362646|3965408|FG001|Overall Study|Death|8
2281131|NCT02362646|3965407|FG000|Overall Study|Withdrawal by Subject|2
2281132|NCT02362646|3965408|FG001|Overall Study|Withdrawal by Subject|2
2281133|NCT02362646|3965407|FG000|Overall Study|received transplant|21
2281134|NCT02362646|3965408|FG001|Overall Study|received transplant|14
2281135|NCT02362724|3965431|FG000|Overall Study|Withdrawal by Subject|3
2281136|NCT02362724|3965432|FG001|Overall Study|Withdrawal by Subject|1
2281137|NCT02362724|3965431|FG000|Overall Study|Adverse Event|3
2281138|NCT02362724|3965432|FG001|Overall Study|Adverse Event|0
2281139|NCT02362789|3965440|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
2281140|NCT02362789|3965441|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
2281141|NCT02362789|3965442|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
2281142|NCT02362789|3965440|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1
2281143|NCT02362789|3965441|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0
2281144|NCT02362789|3965442|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0
2125969|NCT00999518|3726951|FG001|Overall Study|Randomized but not Treated|1
2125970|NCT00999518|3726952|FG002|Overall Study|Randomized but not Treated|2
2125971|NCT00999518|3726953|FG003|Overall Study|Randomized but not Treated|0
2125972|NCT00999518|3726954|FG004|Overall Study|Randomized but not Treated|1
2125973|NCT00999544|3726970|FG000|Overall Study|Withdrawal by Subject|1
2125974|NCT00999596|3727003|FG000|Overall Study|Statistical population not required|101
2125975|NCT00999661|3727008|FG000|Overall Study|Lost to Follow-up|59
2125976|NCT00999661|3727008|FG000|Overall Study|Adverse Event|1
2125977|NCT00999661|3727008|FG000|Overall Study|Withdrawal by Subject|1
2125978|NCT00999661|3727008|FG000|Overall Study|Not meeting eligibility criteria|9
2125979|NCT00999687|3727012|FG000|First Intervention|Withdrawal by Subject|1
2125980|NCT00999687|3727012|FG000|Second Intervention|Withdrawal by Subject|2
2125981|NCT00999687|3727012|FG000|Second Intervention|Lack of Efficacy|1
2125982|NCT00999713|3727020|FG000|Overall Study|Physician Decision|2
2125983|NCT00999713|3727021|FG001|Overall Study|Physician Decision|0
2125984|NCT00999804|3727029|FG000|Overall Study|Lack of Efficacy|9
2125985|NCT00999804|3727030|FG001|Overall Study|Lack of Efficacy|2
2125986|NCT00999804|3727029|FG000|Overall Study|Adverse Event|4
2125987|NCT00999804|3727030|FG001|Overall Study|Adverse Event|3
2125988|NCT00999804|3727029|FG000|Overall Study|Withdrawal by Subject|4
2125989|NCT00999804|3727030|FG001|Overall Study|Withdrawal by Subject|0
2125990|NCT00999804|3727029|FG000|Overall Study|Death|1
2125991|NCT00999804|3727030|FG001|Overall Study|Death|0
2125992|NCT00999804|3727029|FG000|Overall Study|Ineligible|3
2125993|NCT00999804|3727030|FG001|Overall Study|Ineligible|0
2125994|NCT00999908|3727045|FG000|Treatment Period 1|Subject withdrew consent|2
2125995|NCT00999908|3727046|FG001|Treatment Period 1|Subject withdrew consent|0
2125996|NCT00999908|3727047|FG002|Treatment Period 1|Subject withdrew consent|0
2125997|NCT00999908|3727045|FG000|Treatment Period 2|Protocol Violation|1
2125998|NCT00999908|3727046|FG001|Treatment Period 2|Protocol Violation|0
2125999|NCT00999908|3727047|FG002|Treatment Period 2|Protocol Violation|0
2126000|NCT00999921|3727057|FG000|Overall Study|Lost to Follow-up|10
2126001|NCT00999921|3727058|FG001|Overall Study|Lost to Follow-up|19
2126002|NCT01000025|3727069|FG000|Overall Study|Adverse Event|43
2126003|NCT01000025|3727070|FG001|Overall Study|Adverse Event|2
2126004|NCT01000025|3727069|FG000|Overall Study|Withdrawal by Subject|13
2126005|NCT01000025|3727070|FG001|Overall Study|Withdrawal by Subject|8
2126006|NCT01000025|3727069|FG000|Overall Study|Death|23
2126007|NCT01000025|3727070|FG001|Overall Study|Death|13
2126008|NCT01000025|3727069|FG000|Overall Study|Lack of Efficacy|363
2126009|NCT01000025|3727070|FG001|Overall Study|Lack of Efficacy|208
2126010|NCT01000025|3727069|FG000|Overall Study|Intercurrent Illness|26
2126011|NCT01000025|3727070|FG001|Overall Study|Intercurrent Illness|7
2126012|NCT01000051|3727078|FG000|Overall Study|Withdrawal by Subject|1
2126013|NCT01000051|3727079|FG001|Overall Study|Withdrawal by Subject|1
2126014|NCT01000051|3727078|FG000|Overall Study|Disease Progression|1
2126015|NCT01000051|3727079|FG001|Overall Study|Disease Progression|0
2126016|NCT01000051|3727078|FG000|Overall Study|Serious noncompliance|1
2126017|NCT01000051|3727079|FG001|Overall Study|Serious noncompliance|0
2126018|NCT01000064|3727085|FG000|Overall Study|Withdrawal by Subject|1
2126019|NCT01000064|3727086|FG001|Overall Study|Withdrawal by Subject|1
2126020|NCT01000155|3727095|FG000|Overall Study|Withdrawal by Subject|1
2126021|NCT01000155|3727095|FG000|Overall Study|Adverse Event|1
2126022|NCT01000311|3727117|FG000|Overall Study|Adverse Event|2
2126023|NCT01000311|3727118|FG001|Overall Study|Adverse Event|5
2126024|NCT01000311|3727117|FG000|Overall Study|Withdrawal by Subject|16
2126025|NCT01000311|3727118|FG001|Overall Study|Withdrawal by Subject|24
2126026|NCT01000311|3727117|FG000|Overall Study|Lost to Follow-up|15
2126027|NCT01000311|3727118|FG001|Overall Study|Lost to Follow-up|24
2126028|NCT01000311|3727117|FG000|Overall Study|Protocol Violation|1
2126029|NCT01000311|3727118|FG001|Overall Study|Protocol Violation|2
2126030|NCT01000311|3727117|FG000|Overall Study|Inappropriate enrollment|2
2126031|NCT01000311|3727118|FG001|Overall Study|Inappropriate enrollment|0
2126032|NCT01000311|3727117|FG000|Overall Study|Administrative reason|9
2126033|NCT01000311|3727118|FG001|Overall Study|Administrative reason|15
2126034|NCT01000337|3727131|FG000|Overall Study|Lost to Follow-up|4
2126035|NCT01000337|3727132|FG001|Overall Study|Lost to Follow-up|3
2126036|NCT01000376|3727140|FG000|Cycle 1 Day 1|Adverse Event|1
2126037|NCT01000376|3727141|FG001|Cycle 1 Day 1|Adverse Event|0
2126038|NCT01000376|3727140|FG000|Cycle 1 Day 1|Progressive Disease|1
2126039|NCT01000376|3727141|FG001|Cycle 1 Day 1|Progressive Disease|0
2126040|NCT01000480|3727147|FG000|Induction Phase|Adverse Event|2
2126041|NCT01000480|3727147|FG000|Induction Phase|Lost to Follow-up|1
2126042|NCT01000480|3727147|FG000|Induction Phase|Physician Decision|1
2126043|NCT01000480|3727147|FG000|Induction Phase|Entry Criteria Not Met|3
2126044|NCT01000480|3727147|FG000|Concurrent Therapy Phase|Adverse Event|4
2126045|NCT01000480|3727147|FG000|Concurrent Therapy Phase|Protocol Violation|2
2126046|NCT01000480|3727147|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3
2126047|NCT01000480|3727147|FG000|Concurrent Therapy Phase|Physician Decision|1
2126048|NCT01000493|3727153|FG000|Overall Study|Adverse Event|3
2126049|NCT01000493|3727154|FG001|Overall Study|Adverse Event|6
2126050|NCT01000493|3727153|FG000|Overall Study|Lack of Efficacy|1
2126051|NCT01000493|3727154|FG001|Overall Study|Lack of Efficacy|1
2126052|NCT01000493|3727153|FG000|Overall Study|Protocol Violation|1
2126053|NCT01000493|3727154|FG001|Overall Study|Protocol Violation|8
2126054|NCT01000493|3727153|FG000|Overall Study|Study closed/terminated|25
2126055|NCT01000493|3727154|FG001|Overall Study|Study closed/terminated|23
2126056|NCT01000493|3727153|FG000|Overall Study|Lost to Follow-up|5
2126057|NCT01000493|3727154|FG001|Overall Study|Lost to Follow-up|9
2126058|NCT01000493|3727153|FG000|Overall Study|Physician Decision|1
2126059|NCT01000493|3727154|FG001|Overall Study|Physician Decision|1
2126060|NCT01000493|3727153|FG000|Overall Study|Withdrawal by Subject|3
2126061|NCT01000493|3727154|FG001|Overall Study|Withdrawal by Subject|7
2126062|NCT01000506|3727164|FG000|Overall Study|Adverse Event|6
2126063|NCT01000506|3727165|FG001|Overall Study|Adverse Event|5
2126064|NCT01000506|3727166|FG002|Overall Study|Adverse Event|8
2126065|NCT01000506|3727167|FG003|Overall Study|Adverse Event|9
2126066|NCT01000506|3727164|FG000|Overall Study|Lack of Efficacy|8
2126067|NCT01000506|3727165|FG001|Overall Study|Lack of Efficacy|6
2126068|NCT01000506|3727166|FG002|Overall Study|Lack of Efficacy|4
2126069|NCT01000506|3727167|FG003|Overall Study|Lack of Efficacy|4
2126070|NCT01000506|3727164|FG000|Overall Study|Protocol Violation|1
2126071|NCT01000506|3727165|FG001|Overall Study|Protocol Violation|1
2126072|NCT01000506|3727166|FG002|Overall Study|Protocol Violation|0
2126073|NCT01000506|3727167|FG003|Overall Study|Protocol Violation|0
2126074|NCT01000506|3727164|FG000|Overall Study|Lost to Follow-up|1
2126075|NCT01000506|3727165|FG001|Overall Study|Lost to Follow-up|1
2126076|NCT01000506|3727166|FG002|Overall Study|Lost to Follow-up|4
2126077|NCT01000506|3727167|FG003|Overall Study|Lost to Follow-up|0
2126078|NCT01000506|3727164|FG000|Overall Study|Physician Decision|1
2126079|NCT01000506|3727165|FG001|Overall Study|Physician Decision|3
2126080|NCT01000506|3727166|FG002|Overall Study|Physician Decision|3
2126081|NCT01000506|3727167|FG003|Overall Study|Physician Decision|3
2126082|NCT01000506|3727164|FG000|Overall Study|Withdrawal by Subject|11
2126083|NCT01000506|3727165|FG001|Overall Study|Withdrawal by Subject|8
2126084|NCT01000506|3727166|FG002|Overall Study|Withdrawal by Subject|2
2126085|NCT01000506|3727167|FG003|Overall Study|Withdrawal by Subject|7
2126086|NCT01000610|3727177|FG000|Overall Study|Adverse Event|1
2126087|NCT01000610|3727177|FG000|Overall Study|Lost to Follow-up|4
2126088|NCT01000610|3727177|FG000|Overall Study|Treatment failure|1
2126089|NCT01000636|3727181|FG000|Overall Study|Withdrawal by Subject|1
2126090|NCT01000636|3727181|FG000|Overall Study|Adverse Event|1
2126091|NCT01000649|3727189|FG000|Overall Study|Adverse Event|5
2126092|NCT01000649|3727190|FG001|Overall Study|Adverse Event|1
2126093|NCT01000649|3727191|FG002|Overall Study|Adverse Event|2
2126094|NCT01000649|3727192|FG003|Overall Study|Adverse Event|4
2126095|NCT01000649|3727189|FG000|Overall Study|Lost to Follow-up|0
2126096|NCT01000649|3727190|FG001|Overall Study|Lost to Follow-up|2
2126097|NCT01000649|3727191|FG002|Overall Study|Lost to Follow-up|0
2126098|NCT01000649|3727192|FG003|Overall Study|Lost to Follow-up|2
2126099|NCT01000727|3727214|FG000|Overall Study|Lost to Follow-up|41
2126100|NCT01000727|3727215|FG001|Overall Study|Lost to Follow-up|43
2205518|NCT01610336|3843401|FG010|Overall Study|Death|2
2205519|NCT01610336|3843391|FG000|Overall Study|Non-Compliance with study treatment|0
2205520|NCT01610336|3843392|FG001|Overall Study|Non-Compliance with study treatment|0
2126101|NCT01000727|3727214|FG000|Overall Study|Withdrawal by Subject|111
2126102|NCT01000727|3727215|FG001|Overall Study|Withdrawal by Subject|109
2126103|NCT01000727|3727214|FG000|Overall Study|Study closed/terminated|23
2126104|NCT01000727|3727215|FG001|Overall Study|Study closed/terminated|24
2126105|NCT01000805|3727225|FG000|Overall Study|Adverse Event|21
2126106|NCT01000805|3727226|FG001|Overall Study|Adverse Event|9
2126107|NCT01000805|3727225|FG000|Overall Study|Lack of Efficacy|5
2126108|NCT01000805|3727226|FG001|Overall Study|Lack of Efficacy|16
2126109|NCT01000805|3727225|FG000|Overall Study|Lost to Follow-up|16
2126110|NCT01000805|3727226|FG001|Overall Study|Lost to Follow-up|21
2126111|NCT01000805|3727225|FG000|Overall Study|Physician Decision|0
2126112|NCT01000805|3727226|FG001|Overall Study|Physician Decision|1
2126113|NCT01000805|3727225|FG000|Overall Study|Protocol Violation|12
2126114|NCT01000805|3727226|FG001|Overall Study|Protocol Violation|8
2126115|NCT01000805|3727225|FG000|Overall Study|Withdrawal by Subject|16
2126116|NCT01000805|3727226|FG001|Overall Study|Withdrawal by Subject|6
2126117|NCT01000805|3727225|FG000|Overall Study|Sponsor Decision|0
2126118|NCT01000805|3727226|FG001|Overall Study|Sponsor Decision|1
2126119|NCT01000961|3727242|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
2126120|NCT01000961|3727243|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
2126121|NCT01000961|3727242|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
2126122|NCT01000961|3727243|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
2126123|NCT01000974|3727254|FG000|Primary Vaccination Phase|Withdrawal by Subject|109
2126124|NCT01000974|3727255|FG001|Primary Vaccination Phase|Withdrawal by Subject|17
2126125|NCT01000974|3727256|FG002|Primary Vaccination Phase|Withdrawal by Subject|21
2126126|NCT01000974|3727254|FG000|Primary Vaccination Phase|Lost to Follow-up|171
2126127|NCT01000974|3727255|FG001|Primary Vaccination Phase|Lost to Follow-up|19
2126128|NCT01000974|3727256|FG002|Primary Vaccination Phase|Lost to Follow-up|26
2126129|NCT01000974|3727254|FG000|Primary Vaccination Phase|Protocol Violation|40
2126130|NCT01000974|3727255|FG001|Primary Vaccination Phase|Protocol Violation|3
2126131|NCT01000974|3727256|FG002|Primary Vaccination Phase|Protocol Violation|2
2126132|NCT01000974|3727254|FG000|Primary Vaccination Phase|Adverse Event|14
2126133|NCT01000974|3727255|FG001|Primary Vaccination Phase|Adverse Event|2
2126134|NCT01000974|3727256|FG002|Primary Vaccination Phase|Adverse Event|2
2126135|NCT01000974|3727254|FG000|Primary Vaccination Phase|Other|4
2126136|NCT01000974|3727255|FG001|Primary Vaccination Phase|Other|9
2126137|NCT01000974|3727256|FG002|Primary Vaccination Phase|Other|12
2126138|NCT01000974|3727254|FG000|Booster Vaccination Phase|Protocol Violation|0
2126139|NCT01000974|3727255|FG001|Booster Vaccination Phase|Protocol Violation|0
2126140|NCT01000974|3727256|FG002|Booster Vaccination Phase|Protocol Violation|2
2126141|NCT01000974|3727254|FG000|Booster Vaccination Phase|Withdrawal by Subject|3
2126142|NCT01000974|3727255|FG001|Booster Vaccination Phase|Withdrawal by Subject|1
2126143|NCT01000974|3727256|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
2126144|NCT01000974|3727254|FG000|Booster Vaccination Phase|Lost to Follow-up|40
2126145|NCT01000974|3727255|FG001|Booster Vaccination Phase|Lost to Follow-up|5
2126146|NCT01000974|3727256|FG002|Booster Vaccination Phase|Lost to Follow-up|7
2126147|NCT01000974|3727254|FG000|Booster Vaccination Phase|Other|24
2126148|NCT01000974|3727255|FG001|Booster Vaccination Phase|Other|6
2126149|NCT01000974|3727256|FG002|Booster Vaccination Phase|Other|4
2205521|NCT01610336|3843393|FG002|Overall Study|Non-Compliance with study treatment|0
2205522|NCT01610336|3843394|FG003|Overall Study|Non-Compliance with study treatment|0
2205523|NCT01610336|3843395|FG004|Overall Study|Non-Compliance with study treatment|0
2205524|NCT01610336|3843396|FG005|Overall Study|Non-Compliance with study treatment|0
2281145|NCT02362789|3965440|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
2281146|NCT02362789|3965441|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
2281147|NCT02362789|3965442|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
2281148|NCT02362789|3965440|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
2281149|NCT02362789|3965441|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
2281150|NCT02362789|3965442|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
2281151|NCT02362789|3965440|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
2281152|NCT02362789|3965441|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
2281153|NCT02362789|3965442|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
2281154|NCT02363283|3965471|FG000|Overall Study|Withdrawal by Subject|1
2281155|NCT02363283|3965471|FG000|Overall Study|Not eligible due to transaminitis|1
2281156|NCT02363322|3965477|FG000|Overall Study|Lost to Follow-up|1
2281157|NCT02363322|3965478|FG001|Overall Study|Lost to Follow-up|0
2281158|NCT02363439|3965484|FG000|Overall Study|Lack of Efficacy|4
2281159|NCT02363478|3965488|FG000|Overall Study|Lost to Follow-up|4
2281160|NCT02363478|3965488|FG000|Overall Study|Adverse Event|4
2281161|NCT02363686|3965502|FG000|Overall Study|Withdrawal by Subject|22
2281162|NCT02363686|3965502|FG000|Overall Study|incomplete FEES examinations|13
2281163|NCT02363738|3965508|FG000|Overall Study|Adverse Event|5
2281164|NCT02363738|3965509|FG001|Overall Study|Adverse Event|2
2281165|NCT02363738|3965508|FG000|Overall Study|Lack of Efficacy|1
2205525|NCT01610336|3843397|FG006|Overall Study|Non-Compliance with study treatment|0
2205526|NCT01610336|3843398|FG007|Overall Study|Non-Compliance with study treatment|0
2205527|NCT01610336|3843399|FG008|Overall Study|Non-Compliance with study treatment|0
2205528|NCT01610336|3843400|FG009|Overall Study|Non-Compliance with study treatment|1
2205529|NCT01610336|3843401|FG010|Overall Study|Non-Compliance with study treatment|0
2205530|NCT01610336|3843391|FG000|Overall Study|Physician Decision|0
2205531|NCT01610336|3843392|FG001|Overall Study|Physician Decision|0
2205532|NCT01610336|3843393|FG002|Overall Study|Physician Decision|0
2205533|NCT01610336|3843394|FG003|Overall Study|Physician Decision|0
2205534|NCT01610336|3843395|FG004|Overall Study|Physician Decision|0
2205535|NCT01610336|3843396|FG005|Overall Study|Physician Decision|0
2205536|NCT01610336|3843397|FG006|Overall Study|Physician Decision|1
2281166|NCT02363738|3965509|FG001|Overall Study|Lack of Efficacy|2
2281167|NCT02363738|3965508|FG000|Overall Study|Lost to Follow-up|2
2281168|NCT02363738|3965509|FG001|Overall Study|Lost to Follow-up|1
2320718|NCT02952001|4035005|FG001|Overall Study|Adverse Event|0
2320719|NCT02952001|4035004|FG000|Overall Study|Prohibited therapy|10
2320720|NCT02952001|4035005|FG001|Overall Study|Prohibited therapy|3
2320721|NCT02952001|4035004|FG000|Overall Study|Due to Posterior Capsular Opacity|1
2320722|NCT02952001|4035005|FG001|Overall Study|Due to Posterior Capsular Opacity|0
2320723|NCT02952261|4035014|FG000|Overall Study|Withdrawal by Subject|4
2320724|NCT02952261|4035015|FG001|Overall Study|Withdrawal by Subject|5
2320725|NCT02952261|4035014|FG000|Overall Study|Protocol Violation|1
2320726|NCT02952261|4035015|FG001|Overall Study|Protocol Violation|0
2320727|NCT02952313|4035021|FG000|Primary Endpoint|Lost to Follow-up|4
2320728|NCT02952313|4035021|FG000|Primary Endpoint|Withdrawal by Subject|1
2320729|NCT02952313|4035021|FG000|Primary Endpoint|Lack of Efficacy|1
2320730|NCT02952313|4035021|FG000|Primary Endpoint|Missed visit|1
2320731|NCT02952313|4035021|FG000|Long-term Follow-up|Lost to Follow-up|12
2320732|NCT02952313|4035021|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7
2320733|NCT02952313|4035021|FG000|Long-term Follow-up|Lack of Efficacy|6
2320734|NCT02952313|4035021|FG000|Long-term Follow-up|Withdrawal by Subject|5
2320735|NCT02952313|4035021|FG000|Long-term Follow-up|Physician Decision|1
2320736|NCT02952313|4035021|FG000|Long-term Follow-up|Death|1
2320737|NCT02952586|4035028|FG000|Lead-In Phase (7 Days)|Death|0
2320738|NCT02952586|4035029|FG001|Lead-In Phase (7 Days)|Death|1
2320739|NCT02952586|4035028|FG000|Lead-In Phase (7 Days)|Adverse Event|3
2320740|NCT02952586|4035029|FG001|Lead-In Phase (7 Days)|Adverse Event|0
2320741|NCT02952586|4035028|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0
2320742|NCT02952586|4035029|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1
2320743|NCT02952586|4035028|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2
2320744|NCT02952586|4035029|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2
2205537|NCT01610336|3843398|FG007|Overall Study|Physician Decision|0
2205538|NCT01610336|3843399|FG008|Overall Study|Physician Decision|0
2205539|NCT01610336|3843400|FG009|Overall Study|Physician Decision|0
2205540|NCT01610336|3843401|FG010|Overall Study|Physician Decision|0
2126150|NCT01001104|3727302|FG000|Overall Study|Adverse Event|2
2126151|NCT01001104|3727303|FG001|Overall Study|Adverse Event|1
2126152|NCT01001104|3727304|FG002|Overall Study|Adverse Event|0
2126153|NCT01001104|3727305|FG003|Overall Study|Adverse Event|0
2126154|NCT01001104|3727302|FG000|Overall Study|Lost to Follow-up|0
2126155|NCT01001104|3727303|FG001|Overall Study|Lost to Follow-up|0
2126156|NCT01001104|3727304|FG002|Overall Study|Lost to Follow-up|1
2126157|NCT01001104|3727305|FG003|Overall Study|Lost to Follow-up|0
2126158|NCT01001104|3727302|FG000|Overall Study|Entry Criteria Not Met|0
2126159|NCT01001104|3727303|FG001|Overall Study|Entry Criteria Not Met|0
2126160|NCT01001104|3727304|FG002|Overall Study|Entry Criteria Not Met|0
2126161|NCT01001104|3727305|FG003|Overall Study|Entry Criteria Not Met|1
2126162|NCT01001104|3727302|FG000|Overall Study|Withdrawal by Subject|0
2126163|NCT01001104|3727303|FG001|Overall Study|Withdrawal by Subject|0
2126164|NCT01001104|3727304|FG002|Overall Study|Withdrawal by Subject|0
2126165|NCT01001104|3727305|FG003|Overall Study|Withdrawal by Subject|2
2126166|NCT01001169|3727320|FG000|Overall Study|Withdrawal by Subject|2
2205541|NCT01610336|3843391|FG000|Overall Study|Protocol Deviation|0
2205542|NCT01610336|3843392|FG001|Overall Study|Protocol Deviation|0
2205543|NCT01610336|3843393|FG002|Overall Study|Protocol Deviation|0
2205544|NCT01610336|3843394|FG003|Overall Study|Protocol Deviation|0
2205545|NCT01610336|3843395|FG004|Overall Study|Protocol Deviation|0
2205546|NCT01610336|3843396|FG005|Overall Study|Protocol Deviation|0
2205547|NCT01610336|3843397|FG006|Overall Study|Protocol Deviation|0
2205548|NCT01610336|3843398|FG007|Overall Study|Protocol Deviation|0
2205549|NCT01610336|3843399|FG008|Overall Study|Protocol Deviation|0
2205550|NCT01610336|3843400|FG009|Overall Study|Protocol Deviation|1
2205551|NCT01610336|3843401|FG010|Overall Study|Protocol Deviation|0
2205552|NCT01610336|3843391|FG000|Overall Study|Transfer to another trial|0
2205553|NCT01610336|3843392|FG001|Overall Study|Transfer to another trial|0
2205554|NCT01610336|3843393|FG002|Overall Study|Transfer to another trial|0
2205555|NCT01610336|3843394|FG003|Overall Study|Transfer to another trial|0
2205556|NCT01610336|3843395|FG004|Overall Study|Transfer to another trial|0
2205557|NCT01610336|3843396|FG005|Overall Study|Transfer to another trial|0
2205558|NCT01610336|3843397|FG006|Overall Study|Transfer to another trial|0
2205559|NCT01610336|3843398|FG007|Overall Study|Transfer to another trial|0
2205560|NCT01610336|3843399|FG008|Overall Study|Transfer to another trial|0
2205561|NCT01610336|3843400|FG009|Overall Study|Transfer to another trial|0
2205562|NCT01610336|3843401|FG010|Overall Study|Transfer to another trial|1
2205563|NCT01610414|3843431|FG000|Study Start - Month 13|Serious Adverse Event|65
2205564|NCT01610414|3843432|FG001|Study Start - Month 13|Serious Adverse Event|67
2205565|NCT01610414|3843431|FG000|Study Start - Month 13|Adverse Event|14
2205566|NCT01610414|3843432|FG001|Study Start - Month 13|Adverse Event|14
2205567|NCT01610414|3843431|FG000|Study Start - Month 13|Protocol Violation|3
2205568|NCT01610414|3843432|FG001|Study Start - Month 13|Protocol Violation|1
2205569|NCT01610414|3843431|FG000|Study Start - Month 13|Withdrawal by Subject|23
2205570|NCT01610414|3843432|FG001|Study Start - Month 13|Withdrawal by Subject|30
2205571|NCT01610414|3843431|FG000|Study Start - Month 13|Migrated/moved from study area|2
2205572|NCT01610414|3843432|FG001|Study Start - Month 13|Migrated/moved from study area|4
2205573|NCT01610414|3843431|FG000|Study Start - Month 13|Lost to Follow-up|4
2205574|NCT01610414|3843432|FG001|Study Start - Month 13|Lost to Follow-up|6
2205575|NCT01610414|3843431|FG000|Study Start - Month 13|Suspected HZ episode|1
2205576|NCT01610414|3843432|FG001|Study Start - Month 13|Suspected HZ episode|3
2205577|NCT01610414|3843431|FG000|Study Start - Month 13|Other reasons for withdrawal|3
2205578|NCT01610414|3843432|FG001|Study Start - Month 13|Other reasons for withdrawal|4
2205579|NCT01610414|3843431|FG000|Month 13 - Month 25|Serious Adverse Event|35
2205580|NCT01610414|3843432|FG001|Month 13 - Month 25|Serious Adverse Event|38
2205581|NCT01610414|3843431|FG000|Month 13 - Month 25|Adverse Event|8
2205582|NCT01610414|3843432|FG001|Month 13 - Month 25|Adverse Event|4
2205583|NCT01610414|3843431|FG000|Month 13 - Month 25|Withdrawal by Subject|7
2205584|NCT01610414|3843432|FG001|Month 13 - Month 25|Withdrawal by Subject|8
2205585|NCT01610414|3843431|FG000|Month 13 - Month 25|Migrated/moved from study area|4
2205586|NCT01610414|3843432|FG001|Month 13 - Month 25|Migrated/moved from study area|2
2205587|NCT01610414|3843431|FG000|Month 13 - Month 25|Protocol Violation|0
2205588|NCT01610414|3843432|FG001|Month 13 - Month 25|Protocol Violation|2
2205589|NCT01610414|3843431|FG000|Month 13 - Month 25|Lost to Follow-up|5
2205590|NCT01610414|3843432|FG001|Month 13 - Month 25|Lost to Follow-up|9
2205591|NCT01610414|3843431|FG000|Month 13 - Month 25|Other reasons for withdrawal|6
2205592|NCT01610414|3843432|FG001|Month 13 - Month 25|Other reasons for withdrawal|7
2205593|NCT01610414|3843431|FG000|After Month 25|Study end not reached|48
2205594|NCT01610414|3843432|FG001|After Month 25|Study end not reached|53
2205595|NCT01610492|3843448|FG000|Overall Study|Adverse Event|1
2205596|NCT01610492|3843448|FG000|Overall Study|Lack of Efficacy|3
2217426|NCT01708187|3860668|FG001|Overall Study|Lost to Follow-up|1
2126167|NCT01001169|3727321|FG001|Overall Study|Withdrawal by Subject|1
2126168|NCT01001208|3727354|FG000|Overall Study|Adverse Event|10
2126169|NCT01001208|3727355|FG001|Overall Study|Adverse Event|5
2126170|NCT01001208|3727354|FG000|Overall Study|Lost to Follow-up|5
2281169|NCT02363946|3965551|FG000|Overall Study|Lost to Follow-up|0
2281170|NCT02363946|3965552|FG001|Overall Study|Lost to Follow-up|0
2126171|NCT01001208|3727355|FG001|Overall Study|Lost to Follow-up|9
2126172|NCT01001208|3727354|FG000|Overall Study|Physician Decision|1
2126173|NCT01001208|3727355|FG001|Overall Study|Physician Decision|0
2126174|NCT01001208|3727354|FG000|Overall Study|Withdrawal by Subject|4
2126175|NCT01001208|3727355|FG001|Overall Study|Withdrawal by Subject|5
2126176|NCT01001208|3727354|FG000|Overall Study|Ineligibility Determined|4
2126177|NCT01001208|3727355|FG001|Overall Study|Ineligibility Determined|2
2126178|NCT01001208|3727354|FG000|Overall Study|Noncompliance|4
2126179|NCT01001208|3727355|FG001|Overall Study|Noncompliance|7
2126180|NCT01001208|3727354|FG000|Overall Study|Disease Progression|0
2126181|NCT01001208|3727355|FG001|Overall Study|Disease Progression|3
2126182|NCT01001208|3727354|FG000|Overall Study|Other|0
2126183|NCT01001208|3727355|FG001|Overall Study|Other|2
2126184|NCT01001221|3727365|FG000|Overall Study|Adverse Event|1
2126185|NCT01001221|3727366|FG001|Overall Study|Adverse Event|2
2126186|NCT01001221|3727367|FG002|Overall Study|Adverse Event|0
2126187|NCT01001221|3727368|FG003|Overall Study|Adverse Event|2
2126188|NCT01001221|3727369|FG004|Overall Study|Adverse Event|0
2126189|NCT01001221|3727365|FG000|Overall Study|Disease progression|3
2126190|NCT01001221|3727366|FG001|Overall Study|Disease progression|2
2126191|NCT01001221|3727367|FG002|Overall Study|Disease progression|2
2126192|NCT01001221|3727368|FG003|Overall Study|Disease progression|4
2126193|NCT01001221|3727369|FG004|Overall Study|Disease progression|0
2126194|NCT01001221|3727365|FG000|Overall Study|Other|1
2126195|NCT01001221|3727366|FG001|Overall Study|Other|1
2126196|NCT01001221|3727367|FG002|Overall Study|Other|0
2126197|NCT01001221|3727368|FG003|Overall Study|Other|0
2126198|NCT01001221|3727369|FG004|Overall Study|Other|0
2126199|NCT01001221|3727365|FG000|Overall Study|Not treated; protocol exclusion|0
2126200|NCT01001221|3727366|FG001|Overall Study|Not treated; protocol exclusion|0
2126201|NCT01001221|3727367|FG002|Overall Study|Not treated; protocol exclusion|1
2126202|NCT01001221|3727368|FG003|Overall Study|Not treated; protocol exclusion|0
2126203|NCT01001221|3727369|FG004|Overall Study|Not treated; protocol exclusion|0
2126204|NCT01001299|3727380|FG000|Overall Study|Insufficient Therapeutic Response|20
2126205|NCT01001299|3727380|FG000|Overall Study|Adverse event or Intercurrent Illness|1
2126206|NCT01001299|3727380|FG000|Overall Study|Death|1
2126207|NCT01001299|3727380|FG000|Overall Study|Began Taking Commercially Available Drug|2
2126208|NCT01001299|3727380|FG000|Overall Study|Withdrew Consent|1
2126209|NCT01001325|3727386|FG000|Overall Study|Lost to Follow-up|16
2126210|NCT01001325|3727387|FG001|Overall Study|Lost to Follow-up|10
2126211|NCT01001325|3727386|FG000|Overall Study|Protocol Violation|2
2126212|NCT01001325|3727387|FG001|Overall Study|Protocol Violation|0
2126213|NCT01001377|3727395|FG000|Overall Study|Ineligibility determined|2
2126214|NCT01001377|3727396|FG001|Overall Study|Ineligibility determined|0
2126215|NCT01001377|3727395|FG000|Overall Study|Withdrawal by Subject|19
2126216|NCT01001377|3727396|FG001|Overall Study|Withdrawal by Subject|20
2126217|NCT01001377|3727395|FG000|Overall Study|Lost to Follow-up|14
2126218|NCT01001377|3727396|FG001|Overall Study|Lost to Follow-up|17
2126219|NCT01001377|3727395|FG000|Overall Study|Death|391
2126220|NCT01001377|3727396|FG001|Overall Study|Death|384
2126221|NCT01001429|3727413|FG000|Overall Study|surgery cancelled|0
2126222|NCT01001429|3727414|FG001|Overall Study|surgery cancelled|1
2126223|NCT01001494|3727484|FG000|Overall Study|Adverse Event|8
2126224|NCT01001494|3727485|FG001|Overall Study|Adverse Event|4
2126225|NCT01001494|3727486|FG002|Overall Study|Adverse Event|6
2126226|NCT01001494|3727484|FG000|Overall Study|Protocol Violation|0
2126227|NCT01001494|3727485|FG001|Overall Study|Protocol Violation|1
2126228|NCT01001494|3727486|FG002|Overall Study|Protocol Violation|1
2126229|NCT01001494|3727484|FG000|Overall Study|Lost to Follow-up|2
2126230|NCT01001494|3727485|FG001|Overall Study|Lost to Follow-up|0
2126231|NCT01001494|3727486|FG002|Overall Study|Lost to Follow-up|1
2126232|NCT01001494|3727484|FG000|Overall Study|Withdrawal by Subject|9
2126233|NCT01001494|3727485|FG001|Overall Study|Withdrawal by Subject|7
2126234|NCT01001494|3727486|FG002|Overall Study|Withdrawal by Subject|17
2126235|NCT01001494|3727484|FG000|Overall Study|COPD exacerbation|3
2126236|NCT01001494|3727485|FG001|Overall Study|COPD exacerbation|4
2126237|NCT01001494|3727486|FG002|Overall Study|COPD exacerbation|5
2126238|NCT01001494|3727484|FG000|Overall Study|Lack of Efficacy|2
2126239|NCT01001494|3727485|FG001|Overall Study|Lack of Efficacy|0
2126240|NCT01001494|3727486|FG002|Overall Study|Lack of Efficacy|8
2126241|NCT01001494|3727484|FG000|Overall Study|Other|0
2126242|NCT01001494|3727485|FG001|Overall Study|Other|1
2126243|NCT01001494|3727486|FG002|Overall Study|Other|3
2126244|NCT01001520|3727494|FG000|Medication Period 1|Withdrawal by Subject|2
2126245|NCT01001520|3727495|FG001|Medication Period 1|Withdrawal by Subject|2
2126246|NCT01001520|3727494|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
2126247|NCT01001520|3727495|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
2126248|NCT01001520|3727494|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0
2126249|NCT01001520|3727495|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2
2126250|NCT01001520|3727494|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
2126251|NCT01001520|3727495|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
2126252|NCT01001520|3727494|FG000|Washout Period|Withdrawal by Subject|2
2126253|NCT01001520|3727495|FG001|Washout Period|Withdrawal by Subject|1
2126254|NCT01001520|3727494|FG000|Medication Period 2|Withdrawal by Subject|0
2281171|NCT02363946|3965553|FG002|Overall Study|Lost to Follow-up|0
2281172|NCT02363946|3965554|FG003|Overall Study|Lost to Follow-up|0
2281173|NCT02363946|3965555|FG004|Overall Study|Lost to Follow-up|0
2281174|NCT02363946|3965556|FG005|Overall Study|Lost to Follow-up|0
2281175|NCT02363946|3965557|FG006|Overall Study|Lost to Follow-up|0
2281176|NCT02363946|3965558|FG007|Overall Study|Lost to Follow-up|1
2281177|NCT02363946|3965559|FG008|Overall Study|Lost to Follow-up|0
2281178|NCT02363946|3965560|FG009|Overall Study|Lost to Follow-up|0
2281179|NCT02363946|3965561|FG010|Overall Study|Lost to Follow-up|0
2281180|NCT02363946|3965562|FG011|Overall Study|Lost to Follow-up|0
2281181|NCT02363946|3965563|FG012|Overall Study|Lost to Follow-up|0
2281182|NCT02363959|3965593|FG000|Overall Study|Medical instability|1
2281183|NCT02363959|3965594|FG001|Overall Study|Medical instability|0
2281184|NCT02364037|3965626|FG000|Overall Study|Withdrawal by Subject|7
2281185|NCT02364037|3965627|FG001|Overall Study|Withdrawal by Subject|4
2281186|NCT02364037|3965626|FG000|Overall Study|Lost to Follow-up|37
2281187|NCT02364037|3965627|FG001|Overall Study|Lost to Follow-up|49
2281188|NCT02364180|3965637|FG000|Overall Study|Screen Fail|1
2281189|NCT02364336|3965653|FG000|Overall Study|Adverse Event|0
2281190|NCT02364336|3965654|FG001|Overall Study|Adverse Event|1
2281191|NCT02364388|3965661|FG000|Overall Study|Protocol Violation|1
2281192|NCT02364388|3965661|FG000|Overall Study|Technical Failure|3
2281193|NCT02364388|3965661|FG000|Overall Study|No OA/US data|2
2281194|NCT02364388|3965661|FG000|Overall Study|No Biopsy|2
2281195|NCT02364947|3965705|FG000|Overall Study|Withdrawal by Subject|10
2281196|NCT02364947|3965706|FG001|Overall Study|Withdrawal by Subject|8
2281197|NCT02364947|3965707|FG002|Overall Study|Withdrawal by Subject|9
2281198|NCT02364947|3965705|FG000|Overall Study|Adverse Event|45
2281199|NCT02364947|3965706|FG001|Overall Study|Adverse Event|33
2281200|NCT02364947|3965707|FG002|Overall Study|Adverse Event|11
2281201|NCT02364947|3965705|FG000|Overall Study|Protocol Violation|1
2281202|NCT02364947|3965706|FG001|Overall Study|Protocol Violation|1
2281203|NCT02364947|3965707|FG002|Overall Study|Protocol Violation|1
2281204|NCT02364947|3965705|FG000|Overall Study|Physician Decision|3
2281205|NCT02364947|3965706|FG001|Overall Study|Physician Decision|2
2281206|NCT02364947|3965707|FG002|Overall Study|Physician Decision|5
2281207|NCT02364947|3965705|FG000|Overall Study|Death|0
2281208|NCT02364947|3965706|FG001|Overall Study|Death|1
2281209|NCT02364947|3965707|FG002|Overall Study|Death|0
2281210|NCT02364999|3965717|FG000|Overall Study|Death|136
2281211|NCT02364999|3965718|FG001|Overall Study|Death|138
2281212|NCT02364999|3965717|FG000|Overall Study|Lost to Follow-up|10
2281213|NCT02364999|3965718|FG001|Overall Study|Lost to Follow-up|15
2281214|NCT02364999|3965717|FG000|Overall Study|Protocol Violation|3
2281215|NCT02364999|3965718|FG001|Overall Study|Protocol Violation|2
2281216|NCT02364999|3965717|FG000|Overall Study|Withdrawal by Subject|14
2281217|NCT02364999|3965718|FG001|Overall Study|Withdrawal by Subject|14
2281218|NCT02364999|3965717|FG000|Overall Study|Other|0
2281219|NCT02364999|3965718|FG001|Overall Study|Other|1
2281220|NCT02364999|3965717|FG000|Overall Study|Randomized but did not receive treatment|2
2281221|NCT02364999|3965718|FG001|Overall Study|Randomized but did not receive treatment|3
2281222|NCT02365064|3965727|FG000|Overall Study|Patients met baseline exclusion requirem|2
2281223|NCT02365064|3965728|FG001|Overall Study|Patients met baseline exclusion requirem|15
2281224|NCT02365064|3965727|FG000|Overall Study|Withdrawal by Subject|6
2281225|NCT02365064|3965728|FG001|Overall Study|Withdrawal by Subject|9
2281226|NCT02365064|3965727|FG000|Overall Study|Treatment intolerance|2
2281227|NCT02365064|3965728|FG001|Overall Study|Treatment intolerance|4
2281228|NCT02365285|3965738|FG000|Overall Study|Physician Decision|0
2281229|NCT02365285|3965739|FG001|Overall Study|Physician Decision|1
2281230|NCT02365285|3965740|FG002|Overall Study|Physician Decision|1
2281231|NCT02365285|3965741|FG003|Overall Study|Physician Decision|0
2281232|NCT02365285|3965738|FG000|Overall Study|Adverse Event|0
2281233|NCT02365285|3965739|FG001|Overall Study|Adverse Event|0
2281234|NCT02365285|3965740|FG002|Overall Study|Adverse Event|0
2281235|NCT02365285|3965741|FG003|Overall Study|Adverse Event|2
2281236|NCT02365298|3965753|FG000|Period 2|incorrect Rx dispensed|1
2281237|NCT02365298|3965754|FG001|Period 2|incorrect Rx dispensed|0
2281238|NCT02365298|3965753|FG000|Period 2|Discontinued at request of Sponsor|1
2281239|NCT02365298|3965754|FG001|Period 2|Discontinued at request of Sponsor|0
2281240|NCT02365298|3965753|FG000|Period 2|Test Article longer available|0
2281241|NCT02365298|3965754|FG001|Period 2|Test Article longer available|1
2281242|NCT02365298|3965753|FG000|Period 2|Protocol Violation|0
2281243|NCT02365298|3965754|FG001|Period 2|Protocol Violation|1
2281244|NCT02365480|3965762|FG000|Overall Study|Withdrawal by Subject|2
2281245|NCT02365480|3965763|FG001|Overall Study|Withdrawal by Subject|0
2281246|NCT02365506|3965772|FG000|Overall Study|Investigator's Discretion|0
2281247|NCT02365506|3965773|FG001|Overall Study|Investigator's Discretion|0
2281248|NCT02365506|3965774|FG002|Overall Study|Investigator's Discretion|1
2281249|NCT02365519|3965784|FG000|Randomized and Treated|Adverse Event|0
2281250|NCT02365519|3965785|FG001|Randomized and Treated|Adverse Event|1
2281251|NCT02365519|3965786|FG002|Randomized and Treated|Adverse Event|0
2281252|NCT02365519|3965784|FG000|Randomized and Treated|Withdrawal by Subject|0
2281253|NCT02365519|3965785|FG001|Randomized and Treated|Withdrawal by Subject|1
2281254|NCT02365519|3965786|FG002|Randomized and Treated|Withdrawal by Subject|1
2281255|NCT02365558|3965795|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1
2281256|NCT02365558|3965796|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0
2281257|NCT02365558|3965795|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
2281258|NCT02365558|3965796|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
2281259|NCT02365584|3965807|FG000|Overall Study|Adverse Event|2
2281260|NCT02365584|3965808|FG001|Overall Study|Adverse Event|2
2281261|NCT02365584|3965807|FG000|Overall Study|Withdrawal by Subject|1
2281262|NCT02365584|3965808|FG001|Overall Study|Withdrawal by Subject|0
2281263|NCT02365584|3965807|FG000|Overall Study|Disease Progression|9
2281264|NCT02365584|3965808|FG001|Overall Study|Disease Progression|12
2281265|NCT02365636|3965817|FG000|Overall Study|Adverse Event|3
2281266|NCT02365636|3965818|FG001|Overall Study|Adverse Event|3
2281267|NCT02365636|3965819|FG002|Overall Study|Adverse Event|2
2281268|NCT02365636|3965817|FG000|Overall Study|Protocol Violation|1
2281269|NCT02365636|3965818|FG001|Overall Study|Protocol Violation|4
2281270|NCT02365636|3965819|FG002|Overall Study|Protocol Violation|0
2281271|NCT02365636|3965817|FG000|Overall Study|Lost to Follow-up|0
2281272|NCT02365636|3965818|FG001|Overall Study|Lost to Follow-up|0
2281273|NCT02365636|3965819|FG002|Overall Study|Lost to Follow-up|1
2281274|NCT02365636|3965817|FG000|Overall Study|Other|2
2281275|NCT02365636|3965818|FG001|Overall Study|Other|0
2281276|NCT02365636|3965819|FG002|Overall Study|Other|0
2281277|NCT02366091|3965853|FG000|Overall Study|Withdrawal by Subject|3
2281278|NCT02366091|3965854|FG001|Overall Study|Withdrawal by Subject|7
2281279|NCT02366091|3965855|FG002|Overall Study|Withdrawal by Subject|3
2126255|NCT01001520|3727495|FG001|Medication Period 2|Withdrawal by Subject|3
2126256|NCT01001572|3727524|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
2126257|NCT01001572|3727525|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
2126258|NCT01001572|3727526|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
2126259|NCT01001572|3727524|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11
2126260|NCT01001572|3727525|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0
2126261|NCT01001572|3727526|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0
2126262|NCT01001572|3727524|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
2126263|NCT01001572|3727525|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
2126264|NCT01001572|3727526|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
2126265|NCT01001572|3727524|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
2126266|NCT01001572|3727525|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
2126267|NCT01001572|3727526|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
2126268|NCT01001572|3727524|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
2126269|NCT01001572|3727525|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
2126270|NCT01001572|3727526|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
2126271|NCT01001572|3727524|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
2126272|NCT01001572|3727525|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
2126273|NCT01001572|3727526|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
2126274|NCT01001572|3727524|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82
2126275|NCT01001572|3727525|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0
2126276|NCT01001572|3727526|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0
2126277|NCT01001572|3727524|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
2126278|NCT01001572|3727525|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
2126279|NCT01001572|3727526|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
2126280|NCT01001572|3727524|FG000|Double-Blind Treatment Phase|Adverse Event|0
2126281|NCT01001572|3727525|FG001|Double-Blind Treatment Phase|Adverse Event|2
2126282|NCT01001572|3727526|FG002|Double-Blind Treatment Phase|Adverse Event|2
2126283|NCT01001572|3727524|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
2126284|NCT01001572|3727525|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8
2126285|NCT01001572|3727526|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13
2126286|NCT01001572|3727524|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
2126287|NCT01001572|3727525|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
2126288|NCT01001572|3727526|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
2126289|NCT01001572|3727524|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
2126290|NCT01001572|3727525|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
2126291|NCT01001572|3727526|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
2126292|NCT01001572|3727524|FG000|Double-Blind Treatment Phase|Protocol deviation|0
2126293|NCT01001572|3727525|FG001|Double-Blind Treatment Phase|Protocol deviation|0
2126294|NCT01001572|3727526|FG002|Double-Blind Treatment Phase|Protocol deviation|1
2126295|NCT01001572|3727524|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
2126296|NCT01001572|3727525|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
2126297|NCT01001572|3727526|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
2126298|NCT01001598|3727532|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1
2126299|NCT01001598|3727532|FG000|Overall Study|Adverse Event|1
2126300|NCT01001702|3727536|FG000|Overall Study|Lost to Follow-up|7
2126301|NCT01001702|3727536|FG000|Overall Study|Adverse Event|7
2126302|NCT01001702|3727536|FG000|Overall Study|Sponsor Discontinued Study|4
2126303|NCT01001702|3727536|FG000|Overall Study|Subject met Withdrawal Criteria|22
2126304|NCT01001702|3727536|FG000|Overall Study|Investigator withdrew Subject|10
2126305|NCT01001702|3727536|FG000|Overall Study|Withdrawal by Subject|19
2126306|NCT01001702|3727536|FG000|Overall Study|Lack of Efficacy per Investigator|3
2126307|NCT01001767|3727542|FG000|Overall Study|no baseline study performed|1
2126308|NCT01001767|3727543|FG001|Overall Study|no baseline study performed|0
2126309|NCT01001767|3727542|FG000|Overall Study|Protocol Violation|1
2126310|NCT01001767|3727543|FG001|Overall Study|Protocol Violation|0
2126311|NCT01001767|3727542|FG000|Overall Study|Lost to Follow-up|1
2126312|NCT01001767|3727543|FG001|Overall Study|Lost to Follow-up|0
2126313|NCT01001767|3727542|FG000|Overall Study|Physician Decision|1
2126314|NCT01001767|3727543|FG001|Overall Study|Physician Decision|0
2126315|NCT01001832|3727564|FG000|Short-term Period|Adverse Event|2
2126316|NCT01001832|3727565|FG001|Short-term Period|Adverse Event|3
2126317|NCT01001832|3727564|FG000|Long-term Period|Adverse Event|2
2126318|NCT01001832|3727565|FG001|Long-term Period|Adverse Event|1
2126319|NCT01001832|3727564|FG000|Long-term Period|Withdrawal by Subject|1
2126320|NCT01001832|3727565|FG001|Long-term Period|Withdrawal by Subject|0
2126321|NCT01001832|3727564|FG000|Long-term Period|Lack of Efficacy|0
2126322|NCT01001832|3727565|FG001|Long-term Period|Lack of Efficacy|2
2126323|NCT01001832|3727564|FG000|Long-term Period|Other|1
2126324|NCT01001832|3727565|FG001|Long-term Period|Other|2
2126325|NCT01001832|3727564|FG000|Follow-up Period|Withdrawal by Subject|1
2126326|NCT01001832|3727565|FG001|Follow-up Period|Withdrawal by Subject|0
2126327|NCT01001832|3727564|FG000|Follow-up Period|Follow-up no longer required /protocol|15
2126328|NCT01001832|3727565|FG001|Follow-up Period|Follow-up no longer required /protocol|20
2126329|NCT01001832|3727564|FG000|Follow-up Period|Other|2
2205597|NCT01610492|3843448|FG000|Overall Study|Other: Reached stopping criteria|1
2205598|NCT01610492|3843448|FG000|Overall Study|Other:Treatment stopped due to remission|1
2205599|NCT01610557|3843456|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2205600|NCT01610557|3843457|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
2205601|NCT01610557|3843458|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2205602|NCT01610557|3843459|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2205603|NCT01610557|3843460|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2205604|NCT01610557|3843456|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0
2281280|NCT02366091|3965856|FG003|Overall Study|Withdrawal by Subject|1
2281281|NCT02366130|3965866|FG000|Overall Study|Withdrawal by Subject|3
2281282|NCT02366130|3965866|FG000|Overall Study|Ineligible|6
2281283|NCT02366143|3965873|FG000|Overall Study|Death|307
2281284|NCT02366143|3965874|FG001|Overall Study|Death|278
2281285|NCT02366143|3965875|FG002|Overall Study|Death|280
2281286|NCT02366143|3965873|FG000|Overall Study|Lost to Follow-up|2
2281287|NCT02366143|3965874|FG001|Overall Study|Lost to Follow-up|4
2281288|NCT02366143|3965875|FG002|Overall Study|Lost to Follow-up|2
2281289|NCT02366143|3965873|FG000|Overall Study|Physician Decision|1
2281290|NCT02366143|3965874|FG001|Overall Study|Physician Decision|2
2281291|NCT02366143|3965875|FG002|Overall Study|Physician Decision|1
2281292|NCT02366143|3965873|FG000|Overall Study|Protocol Violation|0
2281293|NCT02366143|3965874|FG001|Overall Study|Protocol Violation|0
2281294|NCT02366143|3965875|FG002|Overall Study|Protocol Violation|2
2281295|NCT02366143|3965873|FG000|Overall Study|Withdrawal by Subject|16
2281296|NCT02366143|3965874|FG001|Overall Study|Withdrawal by Subject|17
2281297|NCT02366143|3965875|FG002|Overall Study|Withdrawal by Subject|22
2281298|NCT02366143|3965873|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0
2281299|NCT02366143|3965874|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6
2281300|NCT02366143|3965875|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0
2281301|NCT02366143|3965873|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0
2281302|NCT02366143|3965874|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1
2281303|NCT02366143|3965875|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0
2281304|NCT02366143|3965873|FG000|Overall Study|Randomization Error|1
2281305|NCT02366143|3965874|FG001|Overall Study|Randomization Error|0
2281306|NCT02366143|3965875|FG002|Overall Study|Randomization Error|0
2281307|NCT02366143|3965873|FG000|Overall Study|PI Move and Site Closure|1
2281308|NCT02366143|3965874|FG001|Overall Study|PI Move and Site Closure|0
2281309|NCT02366143|3965875|FG002|Overall Study|PI Move and Site Closure|1
2281310|NCT02366143|3965873|FG000|Overall Study|Study Terminated By Sponsor|0
2281311|NCT02366143|3965874|FG001|Overall Study|Study Terminated By Sponsor|0
2281312|NCT02366143|3965875|FG002|Overall Study|Study Terminated By Sponsor|2
2281313|NCT02366143|3965873|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70
2281314|NCT02366143|3965874|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57
2281315|NCT02366143|3965875|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52
2281316|NCT02366143|3965873|FG000|Overall Study|Patient moved to roll-over study|1
2281317|NCT02366143|3965874|FG001|Overall Study|Patient moved to roll-over study|19
2281318|NCT02366143|3965875|FG002|Overall Study|Patient moved to roll-over study|28
2281319|NCT02366143|3965873|FG000|Overall Study|Patient moved to commercial stock|0
2281320|NCT02366143|3965874|FG001|Overall Study|Patient moved to commercial stock|0
2126330|NCT01001832|3727565|FG001|Follow-up Period|Other|1
2126331|NCT01001910|3727574|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6
2126332|NCT01001988|3727587|FG000|Overall Study|Protocol Violation|84
2126333|NCT01001988|3727587|FG000|Overall Study|Withdrawal by Subject|18
2205605|NCT01610557|3843457|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0
2205606|NCT01610557|3843458|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0
2205607|NCT01610557|3843459|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0
2205608|NCT01610557|3843460|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3
2205609|NCT01610596|3843496|FG000|Overall Study|Lost to Follow-up|0
2205610|NCT01610596|3843497|FG001|Overall Study|Lost to Follow-up|1
2205611|NCT01610687|3843503|FG000|Overall Study|Lack of Efficacy|26
2205612|NCT01610687|3843503|FG000|Overall Study|Adverse Event|18
2205613|NCT01610687|3843503|FG000|Overall Study|Moved out of area|6
2205614|NCT01610687|3843503|FG000|Overall Study|Withdrawal by Subject|7
2205615|NCT01610687|3843503|FG000|Overall Study|Lost to Follow-up|4
2205616|NCT01610687|3843503|FG000|Overall Study|Symptom control without study medication|2
2205617|NCT01610687|3843503|FG000|Overall Study|Unable to make journey|1
2205618|NCT01610687|3843503|FG000|Overall Study|Death|1
2205619|NCT01610687|3843503|FG000|Overall Study|Cannabis affecting job|1
2126334|NCT01001988|3727587|FG000|Overall Study|Lost to Follow-up|15
2126335|NCT01002105|3727593|FG000|Overall Study|Lost to Follow-up|10
2126336|NCT01002105|3727594|FG001|Overall Study|Lost to Follow-up|16
2126337|NCT01002105|3727593|FG000|Overall Study|non compliance|5
2126338|NCT01002105|3727594|FG001|Overall Study|non compliance|3
2126339|NCT01002105|3727593|FG000|Overall Study|condition worsened|4
2126340|NCT01002105|3727594|FG001|Overall Study|condition worsened|2
2126341|NCT01002339|3727619|FG000|Overall Study|Withdrawal by Subject|0
2126342|NCT01002339|3727620|FG001|Overall Study|Withdrawal by Subject|1
2126343|NCT01002339|3727621|FG002|Overall Study|Withdrawal by Subject|0
2126344|NCT01002339|3727619|FG000|Overall Study|Incorrect treatment assignment|0
2205620|NCT01610687|3843503|FG000|Overall Study|Felt more alter without study medication|1
2205621|NCT01610700|3843509|FG000|Overall Study|Adverse Event|3
2205622|NCT01610700|3843510|FG001|Overall Study|Adverse Event|1
2281321|NCT02366143|3965875|FG002|Overall Study|Patient moved to commercial stock|1
2281322|NCT02366143|3965873|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
2281323|NCT02366143|3965874|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
2281324|NCT02366143|3965875|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1
2281325|NCT02366143|3965873|FG000|Overall Study|Patient rolling over to patient assistance program|0
2281326|NCT02366143|3965874|FG001|Overall Study|Patient rolling over to patient assistance program|0
2281327|NCT02366143|3965875|FG002|Overall Study|Patient rolling over to patient assistance program|1
2281328|NCT02366143|3965873|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
2281329|NCT02366143|3965874|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
2281330|NCT02366143|3965875|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1
2281331|NCT02366143|3965873|FG000|Overall Study|Requester's instructions|1
2281332|NCT02366143|3965874|FG001|Overall Study|Requester's instructions|1
2281333|NCT02366143|3965875|FG002|Overall Study|Requester's instructions|1
2281334|NCT02366143|3965873|FG000|Overall Study|Uneligible|0
2281335|NCT02366143|3965874|FG001|Overall Study|Uneligible|1
2281336|NCT02366143|3965875|FG002|Overall Study|Uneligible|0
2281337|NCT02366143|3965873|FG000|Overall Study|Post Trial Migration|0
2281338|NCT02366143|3965874|FG001|Overall Study|Post Trial Migration|1
2281339|NCT02366143|3965875|FG002|Overall Study|Post Trial Migration|0
2281340|NCT02366143|3965873|FG000|Overall Study|Patient moving onto PTAP commercial stock|0
2281341|NCT02366143|3965874|FG001|Overall Study|Patient moving onto PTAP commercial stock|1
2281342|NCT02366143|3965875|FG002|Overall Study|Patient moving onto PTAP commercial stock|0
2281343|NCT02366143|3965873|FG000|Overall Study|Patient switched to PTAP|0
2281344|NCT02366143|3965874|FG001|Overall Study|Patient switched to PTAP|1
2281345|NCT02366143|3965875|FG002|Overall Study|Patient switched to PTAP|0
2281346|NCT02366143|3965873|FG000|Overall Study|Patient moved to commercial atezolizumab use|0
2281347|NCT02366143|3965874|FG001|Overall Study|Patient moved to commercial atezolizumab use|11
2281348|NCT02366143|3965875|FG002|Overall Study|Patient moved to commercial atezolizumab use|7
2281349|NCT02366195|3965887|FG000|Overall Study|Protocol-specified criteria|3
2281350|NCT02366195|3965887|FG000|Overall Study|Withdrawal by Subject|9
2281351|NCT02366195|3965887|FG000|Overall Study|Lost to Follow-up|1
2281352|NCT02366195|3965887|FG000|Overall Study|Death|41
2281353|NCT02366312|3965893|FG000|Overall Study|Lost to Follow-up|0
2281354|NCT02366312|3965894|FG001|Overall Study|Lost to Follow-up|1
2281355|NCT02366468|3965924|FG000|Overall Study|Adverse Event|2
2281356|NCT02366468|3965925|FG001|Overall Study|Adverse Event|0
2281357|NCT02366468|3965924|FG000|Overall Study|Withdrawal by Subject|1
2281358|NCT02366468|3965925|FG001|Overall Study|Withdrawal by Subject|5
2281359|NCT02366468|3965924|FG000|Overall Study|Lost to Follow-up|2
2281360|NCT02366468|3965925|FG001|Overall Study|Lost to Follow-up|0
2281361|NCT02366468|3965924|FG000|Overall Study|Death|1
2281362|NCT02366468|3965925|FG001|Overall Study|Death|2
2281363|NCT02366468|3965924|FG000|Overall Study|Other|0
2281364|NCT02366468|3965925|FG001|Overall Study|Other|2
2281365|NCT02366637|3965941|FG000|First Intervention Period|Adverse Event|0
2281366|NCT02366637|3965942|FG001|First Intervention Period|Adverse Event|1
2281367|NCT02366637|3965941|FG000|First Intervention Period|Study Terminated by Sponsor|6
2205623|NCT01610700|3843509|FG000|Overall Study|Withdrawal by Subject|0
2126345|NCT01002339|3727620|FG001|Overall Study|Incorrect treatment assignment|0
2126346|NCT01002339|3727621|FG002|Overall Study|Incorrect treatment assignment|1
2126347|NCT01002339|3727619|FG000|Overall Study|Protocol Violation|0
2126348|NCT01002339|3727620|FG001|Overall Study|Protocol Violation|0
2126349|NCT01002339|3727621|FG002|Overall Study|Protocol Violation|2
2126350|NCT01002339|3727619|FG000|Overall Study|Lung cancer detected before transplant|0
2126351|NCT01002339|3727620|FG001|Overall Study|Lung cancer detected before transplant|0
2126352|NCT01002339|3727621|FG002|Overall Study|Lung cancer detected before transplant|1
2126353|NCT01002339|3727619|FG000|Overall Study|Randomized. Not transplanted|0
2126354|NCT01002339|3727620|FG001|Overall Study|Randomized. Not transplanted|0
2126355|NCT01002339|3727621|FG002|Overall Study|Randomized. Not transplanted|1
2126356|NCT01002482|3727642|FG000|Overall Study|Withdrawal by Subject|14
2126357|NCT01002482|3727643|FG001|Overall Study|Withdrawal by Subject|21
2126358|NCT01002482|3727642|FG000|Overall Study|Included twice|1
2126359|NCT01002482|3727643|FG001|Overall Study|Included twice|0
2126360|NCT01002547|3727652|FG000|Overall Study|Withdrawal by Subject|4
2126361|NCT01002547|3727653|FG001|Overall Study|Withdrawal by Subject|0
2126362|NCT01002547|3727654|FG002|Overall Study|Withdrawal by Subject|5
2126363|NCT01002547|3727652|FG000|Overall Study|Lost to Follow-up|2
2126364|NCT01002547|3727653|FG001|Overall Study|Lost to Follow-up|1
2126365|NCT01002547|3727654|FG002|Overall Study|Lost to Follow-up|1
2126366|NCT01002547|3727652|FG000|Overall Study|Physician Decision|1
2126367|NCT01002547|3727653|FG001|Overall Study|Physician Decision|0
2126368|NCT01002547|3727654|FG002|Overall Study|Physician Decision|0
2126369|NCT01002547|3727652|FG000|Overall Study|Death|0
2126370|NCT01002547|3727653|FG001|Overall Study|Death|2
2126371|NCT01002547|3727654|FG002|Overall Study|Death|2
2126372|NCT01002547|3727652|FG000|Overall Study|Adverse Event|1
2126373|NCT01002547|3727653|FG001|Overall Study|Adverse Event|0
2126374|NCT01002547|3727654|FG002|Overall Study|Adverse Event|0
2126375|NCT01002573|3727664|FG000|Overall Study|Subject did not receive at least 1 dose|11
2126376|NCT01002573|3727665|FG001|Overall Study|Subject did not receive at least 1 dose|7
2126377|NCT01002742|3727673|FG000|Overall Study|Determined to be ineligible|0
2281368|NCT02366637|3965942|FG001|First Intervention Period|Study Terminated by Sponsor|4
2281369|NCT02366637|3965941|FG000|Second Intervention Period|Study Terminated by Sponsor|1
2281370|NCT02366637|3965942|FG001|Second Intervention Period|Study Terminated by Sponsor|1
2281371|NCT02366689|3965960|FG000|Overall Study|Withdrawal by Subject|1
2281372|NCT02366689|3965961|FG001|Overall Study|Withdrawal by Subject|0
2281373|NCT02366689|3965962|FG002|Overall Study|Withdrawal by Subject|1
2281374|NCT02366689|3965960|FG000|Overall Study|Lost to Follow-up|3
2281375|NCT02366689|3965961|FG001|Overall Study|Lost to Follow-up|2
2281376|NCT02366689|3965962|FG002|Overall Study|Lost to Follow-up|0
2281377|NCT02366689|3965960|FG000|Overall Study|Pregnancy|0
2281378|NCT02366689|3965961|FG001|Overall Study|Pregnancy|1
2281379|NCT02366689|3965962|FG002|Overall Study|Pregnancy|1
2281380|NCT02366767|3965972|FG000|Overall Study|left for home after 1 day at camp|1
2281381|NCT02366767|3965973|FG001|Overall Study|left for home after 1 day at camp|0
2281382|NCT02366910|3965997|FG000|Overall Study|Withdrawal by Subject|2
2281383|NCT02366910|3965997|FG000|Overall Study|Screen Failure|3
2281384|NCT02366923|3966003|FG000|Overall Study|Withdrawal by Subject|1
2281385|NCT02366923|3966003|FG000|Overall Study|Positive Slit Lamp Findings|2
2281386|NCT02366923|3966003|FG000|Overall Study|High Astigmatism|3
2281387|NCT02366936|3966008|FG000|Overall Study|Withdrawal by Subject|2
2281388|NCT02366936|3966008|FG000|Overall Study|Lost to Follow-up|4
2281389|NCT02366936|3966008|FG000|Overall Study|Physician Decision|2
2281390|NCT02367131|3966045|FG000|Overall Study|Adverse Event|64
2281391|NCT02367131|3966045|FG000|Overall Study|No visit since the first visit|4
2281392|NCT02367131|3966045|FG000|Overall Study|Request by patient|54
2281393|NCT02367131|3966045|FG000|Overall Study|Improvement/remission|2
2281394|NCT02367131|3966045|FG000|Overall Study|No change/progressive disease|78
2281395|NCT02367131|3966045|FG000|Overall Study|Other than stated above|20
2281396|NCT02367352|3966049|FG000|Overall Study|Progressive disease|7
2281397|NCT02367352|3966050|FG001|Overall Study|Progressive disease|0
2281398|NCT02367352|3966051|FG002|Overall Study|Progressive disease|0
2281399|NCT02367352|3966049|FG000|Overall Study|Participant Received Alternative Therapy|1
2281400|NCT02367352|3966050|FG001|Overall Study|Participant Received Alternative Therapy|0
2281401|NCT02367352|3966051|FG002|Overall Study|Participant Received Alternative Therapy|0
2281402|NCT02367352|3966049|FG000|Overall Study|Adverse Event|1
2281403|NCT02367352|3966050|FG001|Overall Study|Adverse Event|0
2281404|NCT02367352|3966051|FG002|Overall Study|Adverse Event|0
2281405|NCT02367521|3966072|FG000|Overall Study|severe headache after intervention|2
2281406|NCT02367521|3966073|FG001|Overall Study|severe headache after intervention|0
2281407|NCT02367521|3966072|FG000|Overall Study|unable to find transportation|2
2281408|NCT02367521|3966073|FG001|Overall Study|unable to find transportation|0
2281409|NCT02367716|3966088|FG000|Overall Study|Patient did not meet inclusion criteria|1
2281410|NCT02367729|3966095|FG000|Overall Study|Organic disorder diagnosed|2
2281411|NCT02367729|3966096|FG001|Overall Study|Organic disorder diagnosed|1
2281412|NCT02367729|3966095|FG000|Overall Study|Adverse Event|1
2281413|NCT02367729|3966096|FG001|Overall Study|Adverse Event|2
2281414|NCT02367729|3966095|FG000|Overall Study|Withdrawal by Subject|0
2281415|NCT02367729|3966096|FG001|Overall Study|Withdrawal by Subject|5
2126378|NCT01002742|3727674|FG001|Overall Study|Determined to be ineligible|1
2126379|NCT01002989|3727684|FG000|Overall Study|exclusion criteria, no consent|5
2126380|NCT01003184|3727733|FG000|Overall Study|Adverse Event|12
2126381|NCT01003184|3727734|FG001|Overall Study|Adverse Event|5
2126382|NCT01003184|3727733|FG000|Overall Study|Lost to Follow-up|1
2126383|NCT01003184|3727734|FG001|Overall Study|Lost to Follow-up|0
2126384|NCT01003184|3727733|FG000|Overall Study|Loss of glucose control|1
2126385|NCT01003184|3727734|FG001|Overall Study|Loss of glucose control|1
2126386|NCT01003184|3727733|FG000|Overall Study|Protocol Violation|3
2126387|NCT01003184|3727734|FG001|Overall Study|Protocol Violation|0
2126388|NCT01003184|3727733|FG000|Overall Study|Withdrawal by Subject|1
2126389|NCT01003184|3727734|FG001|Overall Study|Withdrawal by Subject|6
2126390|NCT01003184|3727733|FG000|Overall Study|Physician Decision|1
2126391|NCT01003184|3727734|FG001|Overall Study|Physician Decision|0
2126392|NCT01003210|3727742|FG000|Overall Study|Lost to Follow-up|1
2126393|NCT01003210|3727743|FG001|Overall Study|Lost to Follow-up|3
2126394|NCT01003249|3727749|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1
2126395|NCT01003249|3727750|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
2126396|NCT01003249|3727749|FG000|First Intervention (4 Weeks)|Non-Serious Event|1
2126397|NCT01003249|3727750|FG001|First Intervention (4 Weeks)|Non-Serious Event|1
2126398|NCT01003249|3727749|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0
2126399|NCT01003249|3727750|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2126400|NCT01003249|3727749|FG000|Second Intervention (4 Weeks)|Adverse Event|1
2126401|NCT01003249|3727750|FG001|Second Intervention (4 Weeks)|Adverse Event|0
2126402|NCT01003639|3727796|FG000|Overall Study|Lost to Follow-up|6
2126403|NCT01003639|3727797|FG001|Overall Study|Lost to Follow-up|9
2126404|NCT01003639|3727796|FG000|Overall Study|Withdrawal by Subject|9
2126405|NCT01003639|3727797|FG001|Overall Study|Withdrawal by Subject|5
2126406|NCT01003639|3727796|FG000|Overall Study|Lack of Efficacy|1
2126407|NCT01003639|3727797|FG001|Overall Study|Lack of Efficacy|6
2126408|NCT01003639|3727796|FG000|Overall Study|Adverse Event|0
2126409|NCT01003639|3727797|FG001|Overall Study|Adverse Event|1
2126410|NCT01003639|3727796|FG000|Overall Study|Protocol Violation|0
2126411|NCT01003639|3727797|FG001|Overall Study|Protocol Violation|1
2126412|NCT01003639|3727796|FG000|Overall Study|Physician Decision|1
2126413|NCT01003639|3727797|FG001|Overall Study|Physician Decision|0
2126414|NCT01003886|3727807|FG000|Overall Study|Lack of Efficacy|5
2126415|NCT01003886|3727807|FG000|Overall Study|Lost to Follow-up|169
2126416|NCT01003886|3727807|FG000|Overall Study|Withdrawal by Subject|39
2126417|NCT01003886|3727807|FG000|Overall Study|Other|14
2126418|NCT01003886|3727807|FG000|Overall Study|Adverse Event|3
2177970|NCT01379703|3802500|FG000|Study Start Through 9 Months|Increased triglycerides|0
2177971|NCT01379703|3802501|FG001|Study Start Through 9 Months|Increased triglycerides|1
2177972|NCT01379703|3802502|FG002|Study Start Through 9 Months|Increased triglycerides|0
2205624|NCT01610700|3843510|FG001|Overall Study|Withdrawal by Subject|1
2205625|NCT01610700|3843509|FG000|Overall Study|subject took one dose of street cannabis|0
2205626|NCT01610700|3843510|FG001|Overall Study|subject took one dose of street cannabis|1
2205627|NCT01610713|3843519|FG000|Overall Study|Adverse Event|3
2205628|NCT01610713|3843520|FG001|Overall Study|Adverse Event|0
2205629|NCT01610713|3843519|FG000|Overall Study|Lack of Efficacy|1
2205630|NCT01610713|3843520|FG001|Overall Study|Lack of Efficacy|0
2205631|NCT01610713|3843519|FG000|Overall Study|low mood and poor motivation|1
2205632|NCT01610713|3843520|FG001|Overall Study|low mood and poor motivation|0
2205633|NCT01610713|3843519|FG000|Overall Study|adv. to use original dose/amitriptyline|1
2205634|NCT01610713|3843520|FG001|Overall Study|adv. to use original dose/amitriptyline|0
2205635|NCT01610713|3843519|FG000|Overall Study|Lost to Follow-up|0
2205636|NCT01610713|3843520|FG001|Overall Study|Lost to Follow-up|1
2205637|NCT01610752|3843529|FG000|Overall Study|Miscarriage/Pregnancy loss|0
2177973|NCT01379703|3802500|FG000|Study Start Through 9 Months|Reason unknown|2
2177974|NCT01379703|3802501|FG001|Study Start Through 9 Months|Reason unknown|31
2177975|NCT01379703|3802502|FG002|Study Start Through 9 Months|Reason unknown|24
2177976|NCT01379703|3802500|FG000|9 Months Through 18 Months|Lost to Follow-up|0
2177977|NCT01379703|3802501|FG001|9 Months Through 18 Months|Lost to Follow-up|178
2177978|NCT01379703|3802502|FG002|9 Months Through 18 Months|Lost to Follow-up|0
2177979|NCT01379703|3802500|FG000|9 Months Through 18 Months|Withdrawal by Subject|0
2177980|NCT01379703|3802501|FG001|9 Months Through 18 Months|Withdrawal by Subject|11
2177981|NCT01379703|3802502|FG002|9 Months Through 18 Months|Withdrawal by Subject|0
2177982|NCT01379703|3802500|FG000|9 Months Through 18 Months|Adverse Event|0
2177983|NCT01379703|3802501|FG001|9 Months Through 18 Months|Adverse Event|6
2177984|NCT01379703|3802502|FG002|9 Months Through 18 Months|Adverse Event|0
2177985|NCT01379703|3802500|FG000|9 Months Through 18 Months|Treatment failure|0
2177986|NCT01379703|3802501|FG001|9 Months Through 18 Months|Treatment failure|5
2177987|NCT01379703|3802502|FG002|9 Months Through 18 Months|Treatment failure|0
2177988|NCT01379703|3802500|FG000|9 Months Through 18 Months|Patient Noncompliance|0
2177989|NCT01379703|3802501|FG001|9 Months Through 18 Months|Patient Noncompliance|4
2177990|NCT01379703|3802502|FG002|9 Months Through 18 Months|Patient Noncompliance|0
2177991|NCT01379703|3802500|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0
2205638|NCT01610752|3843530|FG001|Overall Study|Miscarriage/Pregnancy loss|0
2205639|NCT01610752|3843531|FG002|Overall Study|Miscarriage/Pregnancy loss|4
2205640|NCT01610791|3843539|FG000|Overall Study|Lost to Follow-up|7
2126419|NCT01003899|3727811|FG000|Overall Study|Other Adverse Event|8
2126420|NCT01003899|3727811|FG000|Overall Study|Not entered|4
2126421|NCT01003899|3727811|FG000|Overall Study|Not treated|1
2126422|NCT01003899|3727811|FG000|Overall Study|Progressive disease|34
2126423|NCT01003990|3727822|FG000|Overall Study|Adverse Event|8
2126424|NCT01003990|3727823|FG001|Overall Study|Adverse Event|5
2126425|NCT01003990|3727824|FG002|Overall Study|Adverse Event|11
2126426|NCT01003990|3727822|FG000|Overall Study|Death|0
2126427|NCT01003990|3727823|FG001|Overall Study|Death|8
2126428|NCT01003990|3727824|FG002|Overall Study|Death|1
2126429|NCT01003990|3727822|FG000|Overall Study|Lack of Efficacy|10
2126430|NCT01003990|3727823|FG001|Overall Study|Lack of Efficacy|2
2126431|NCT01003990|3727824|FG002|Overall Study|Lack of Efficacy|3
2126432|NCT01003990|3727822|FG000|Overall Study|Lost to Follow-up|30
2126433|NCT01003990|3727823|FG001|Overall Study|Lost to Follow-up|12
2126434|NCT01003990|3727824|FG002|Overall Study|Lost to Follow-up|7
2126435|NCT01003990|3727822|FG000|Overall Study|Reasons Not Identified|14
2126436|NCT01003990|3727823|FG001|Overall Study|Reasons Not Identified|13
2126437|NCT01003990|3727824|FG002|Overall Study|Reasons Not Identified|8
2126438|NCT01003990|3727822|FG000|Overall Study|Poor/Non-compliance|4
2126439|NCT01003990|3727823|FG001|Overall Study|Poor/Non-compliance|3
2126440|NCT01003990|3727824|FG002|Overall Study|Poor/Non-compliance|2
2126441|NCT01003990|3727822|FG000|Overall Study|Pregnancy|10
2126442|NCT01003990|3727823|FG001|Overall Study|Pregnancy|2
2126443|NCT01003990|3727824|FG002|Overall Study|Pregnancy|4
2126444|NCT01003990|3727822|FG000|Overall Study|No Longer Met Study Criteria|4
2126445|NCT01003990|3727823|FG001|Overall Study|No Longer Met Study Criteria|1
2126446|NCT01003990|3727824|FG002|Overall Study|No Longer Met Study Criteria|0
2126447|NCT01003990|3727822|FG000|Overall Study|Subject Withdrew Consent|12
2126448|NCT01003990|3727823|FG001|Overall Study|Subject Withdrew Consent|5
2126449|NCT01003990|3727824|FG002|Overall Study|Subject Withdrew Consent|7
2126450|NCT01004003|3727841|FG000|Overall Study|Progressive disease|2
2126451|NCT01004003|3727842|FG001|Overall Study|Progressive disease|1
2126452|NCT01004003|3727843|FG002|Overall Study|Progressive disease|1
2126453|NCT01004003|3727844|FG003|Overall Study|Progressive disease|0
2126454|NCT01004003|3727845|FG004|Overall Study|Progressive disease|2
2126455|NCT01004003|3727846|FG005|Overall Study|Progressive disease|1
2126456|NCT01004003|3727847|FG006|Overall Study|Progressive disease|1
2126457|NCT01004003|3727848|FG007|Overall Study|Progressive disease|39
2126458|NCT01004003|3727849|FG008|Overall Study|Progressive disease|22
2126459|NCT01004003|3727841|FG000|Overall Study|Adverse Event|4
2126460|NCT01004003|3727842|FG001|Overall Study|Adverse Event|2
2126461|NCT01004003|3727843|FG002|Overall Study|Adverse Event|3
2126462|NCT01004003|3727844|FG003|Overall Study|Adverse Event|3
2126463|NCT01004003|3727845|FG004|Overall Study|Adverse Event|2
2126464|NCT01004003|3727846|FG005|Overall Study|Adverse Event|2
2126465|NCT01004003|3727847|FG006|Overall Study|Adverse Event|7
2126466|NCT01004003|3727848|FG007|Overall Study|Adverse Event|21
2126467|NCT01004003|3727849|FG008|Overall Study|Adverse Event|6
2126468|NCT01004003|3727841|FG000|Overall Study|Refused to continue taking trial med.|0
2126469|NCT01004003|3727842|FG001|Overall Study|Refused to continue taking trial med.|0
2126470|NCT01004003|3727843|FG002|Overall Study|Refused to continue taking trial med.|0
2126471|NCT01004003|3727844|FG003|Overall Study|Refused to continue taking trial med.|0
2126472|NCT01004003|3727845|FG004|Overall Study|Refused to continue taking trial med.|0
2126473|NCT01004003|3727846|FG005|Overall Study|Refused to continue taking trial med.|0
2126474|NCT01004003|3727847|FG006|Overall Study|Refused to continue taking trial med.|0
2126475|NCT01004003|3727848|FG007|Overall Study|Refused to continue taking trial med.|0
2126476|NCT01004003|3727849|FG008|Overall Study|Refused to continue taking trial med.|2
2126477|NCT01004003|3727841|FG000|Overall Study|Other|0
2126478|NCT01004003|3727842|FG001|Overall Study|Other|0
2126479|NCT01004003|3727843|FG002|Overall Study|Other|0
2126480|NCT01004003|3727844|FG003|Overall Study|Other|0
2126481|NCT01004003|3727845|FG004|Overall Study|Other|0
2126482|NCT01004003|3727846|FG005|Overall Study|Other|1
2126483|NCT01004003|3727847|FG006|Overall Study|Other|0
2126484|NCT01004003|3727848|FG007|Overall Study|Other|0
2126485|NCT01004003|3727849|FG008|Overall Study|Other|0
2126486|NCT01004146|3727920|FG000|Overall Study|Withdrawal by Subject|4
2126487|NCT01004146|3727921|FG001|Overall Study|Withdrawal by Subject|5
2126488|NCT01004159|3727927|FG000|Overall Study|Adverse Event|2
2126489|NCT01004159|3727927|FG000|Overall Study|Disease Progression|18
2126490|NCT01004172|3727931|FG000|Overall Study|Progressive Disease in CNS Only|16
2126491|NCT01004172|3727931|FG000|Overall Study|Progressive Disease in Non-CNS Only|16
2126492|NCT01004172|3727931|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2
2126493|NCT01004172|3727931|FG000|Overall Study|Adverse Event|1
2126494|NCT01004172|3727931|FG000|Overall Study|Physician Decision|1
2126495|NCT01004172|3727931|FG000|Overall Study|Symptomatic Deterioration|2
2126496|NCT01004185|3727938|FG000|Overall Study|Adverse Event|1
2126497|NCT01004185|3727939|FG001|Overall Study|Adverse Event|1
2126498|NCT01004185|3727938|FG000|Overall Study|Lost to Follow-up|0
2126499|NCT01004185|3727939|FG001|Overall Study|Lost to Follow-up|1
2126500|NCT01004185|3727938|FG000|Overall Study|Lack of Efficacy|2
2126501|NCT01004185|3727939|FG001|Overall Study|Lack of Efficacy|1
2126502|NCT01004185|3727938|FG000|Overall Study|Sponsor Terminated Study|4
2126503|NCT01004185|3727939|FG001|Overall Study|Sponsor Terminated Study|5
2126504|NCT01004185|3727938|FG000|Overall Study|Withdrawal by Subject|2
2126505|NCT01004185|3727939|FG001|Overall Study|Withdrawal by Subject|1
2126506|NCT01004250|3727945|FG000|Induction Therapy Period|Adverse Event|10
2126507|NCT01004250|3727945|FG000|Induction Therapy Period|Entry Criteria Not Met|1
2126508|NCT01004250|3727945|FG000|Induction Therapy Period|Withdrawal by Subject|2
2126509|NCT01004250|3727945|FG000|Induction Therapy Period|Physician Decision|2
2126510|NCT01004250|3727945|FG000|Maintenance Therapy Period|Adverse Event|15
2126511|NCT01004250|3727945|FG000|Maintenance Therapy Period|Lost to Follow-up|1
2205641|NCT01610791|3843539|FG000|Overall Study|Adverse Event|6
2126512|NCT01004250|3727945|FG000|Maintenance Therapy Period|Protocol Violation|1
2126513|NCT01004250|3727945|FG000|Maintenance Therapy Period|Withdrawal by Subject|5
2126514|NCT01004250|3727945|FG000|Maintenance Therapy Period|Physician Decision|4
2126515|NCT01004250|3727945|FG000|Follow-Up (FU) Period|Lost to Follow-up|1
2126516|NCT01004406|3727963|FG000|Overall Study|Withdrawal by Subject|2
2126517|NCT01004406|3727964|FG001|Overall Study|Withdrawal by Subject|0
2126518|NCT01004406|3727963|FG000|Overall Study|Lost to Follow-up|1
2126519|NCT01004406|3727964|FG001|Overall Study|Lost to Follow-up|0
2126520|NCT01004432|3727970|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20
2126521|NCT01004432|3727971|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
2126522|NCT01004432|3727972|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
2126523|NCT01004432|3727973|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
2126524|NCT01004432|3727974|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
2126525|NCT01004432|3727970|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29
2126526|NCT01004432|3727971|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
2126527|NCT01004432|3727972|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
2126528|NCT01004432|3727973|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
2126529|NCT01004432|3727974|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
2126530|NCT01004432|3727970|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17
2126531|NCT01004432|3727971|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
2126532|NCT01004432|3727972|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
2126533|NCT01004432|3727973|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
2126534|NCT01004432|3727974|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
2205642|NCT01610791|3843539|FG000|Overall Study|Physician Decision|1
2217427|NCT01708291|3860705|FG000|Overall Study|fighting|2
2281416|NCT02367781|3966105|FG000|Overall Study|Withdrawal by Subject|20
2281417|NCT02367781|3966106|FG001|Overall Study|Withdrawal by Subject|13
2281418|NCT02367781|3966105|FG000|Overall Study|Protocol Violation|0
2281419|NCT02367781|3966106|FG001|Overall Study|Protocol Violation|1
2281420|NCT02367781|3966105|FG000|Overall Study|Physician Decision|7
2281421|NCT02367781|3966106|FG001|Overall Study|Physician Decision|0
2281422|NCT02367781|3966105|FG000|Overall Study|Randomized in Error|5
2281423|NCT02367781|3966106|FG001|Overall Study|Randomized in Error|4
2281424|NCT02367781|3966105|FG000|Overall Study|Non-Compliance|1
2281425|NCT02367781|3966106|FG001|Overall Study|Non-Compliance|0
2281426|NCT02367781|3966105|FG000|Overall Study|Lost to Follow-up|1
2281427|NCT02367781|3966106|FG001|Overall Study|Lost to Follow-up|2
2281428|NCT02367781|3966105|FG000|Overall Study|Death|330
2281429|NCT02367781|3966106|FG001|Overall Study|Death|176
2281430|NCT02367781|3966105|FG000|Overall Study|Patient Moving to Roll-Over Study|17
2281431|NCT02367781|3966106|FG001|Overall Study|Patient Moving to Roll-Over Study|5
2281432|NCT02367781|3966105|FG000|Overall Study|Prolonged Hospitalization|1
2281433|NCT02367781|3966106|FG001|Overall Study|Prolonged Hospitalization|0
2281434|NCT02367781|3966105|FG000|Overall Study|Death Prior First Dose|1
2281435|NCT02367781|3966106|FG001|Overall Study|Death Prior First Dose|0
2281436|NCT02367781|3966105|FG000|Overall Study|Administrative-Change Facility|1
2281437|NCT02367781|3966106|FG001|Overall Study|Administrative-Change Facility|0
2281438|NCT02367781|3966105|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78
2281439|NCT02367781|3966106|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29
2281440|NCT02367781|3966105|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14
2281441|NCT02367781|3966106|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9
2281442|NCT02367781|3966105|FG000|Overall Study|Study Terminated by Sponsor|3
2281443|NCT02367781|3966106|FG001|Overall Study|Study Terminated by Sponsor|1
2281444|NCT02367781|3966105|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1
2281445|NCT02367781|3966106|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0
2281446|NCT02367781|3966105|FG000|Overall Study|Sponsor Decision|2
2281447|NCT02367781|3966106|FG001|Overall Study|Sponsor Decision|0
2281448|NCT02367781|3966105|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1
2281449|NCT02367781|3966106|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0
2281450|NCT02367794|3966117|FG000|Overall Study|Death|230
2281451|NCT02367794|3966118|FG001|Overall Study|Death|223
2281452|NCT02367794|3966119|FG002|Overall Study|Death|229
2281453|NCT02367794|3966117|FG000|Overall Study|Lost to Follow-up|1
2281454|NCT02367794|3966118|FG001|Overall Study|Lost to Follow-up|2
2281455|NCT02367794|3966119|FG002|Overall Study|Lost to Follow-up|1
2281456|NCT02367794|3966117|FG000|Overall Study|Physician Decision|0
2281457|NCT02367794|3966118|FG001|Overall Study|Physician Decision|3
2281458|NCT02367794|3966119|FG002|Overall Study|Physician Decision|1
2126535|NCT01004432|3727970|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15
2126536|NCT01004432|3727971|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
2126537|NCT01004432|3727972|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
2126538|NCT01004432|3727973|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
2126539|NCT01004432|3727974|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
2126540|NCT01004432|3727970|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2
2126541|NCT01004432|3727971|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
2126542|NCT01004432|3727972|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
2126543|NCT01004432|3727973|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
2126544|NCT01004432|3727974|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
2126545|NCT01004432|3727970|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
2126546|NCT01004432|3727971|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
2126547|NCT01004432|3727972|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
2126548|NCT01004432|3727973|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
2126549|NCT01004432|3727974|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
2180117|NCT01398514|3806031|FG000|Overall Study|Adverse Event|1
2281459|NCT02367794|3966117|FG000|Overall Study|Protocol Violation|1
2281460|NCT02367794|3966118|FG001|Overall Study|Protocol Violation|0
2281461|NCT02367794|3966119|FG002|Overall Study|Protocol Violation|1
2281462|NCT02367794|3966117|FG000|Overall Study|Withdrawal by Subject|25
2281463|NCT02367794|3966118|FG001|Overall Study|Withdrawal by Subject|12
2281464|NCT02367794|3966119|FG002|Overall Study|Withdrawal by Subject|14
2281465|NCT02367794|3966117|FG000|Overall Study|Brain metastasis|1
2281466|NCT02367794|3966118|FG001|Overall Study|Brain metastasis|0
2281467|NCT02367794|3966119|FG002|Overall Study|Brain metastasis|0
2281468|NCT02367794|3966117|FG000|Overall Study|Randomized in error|0
2281469|NCT02367794|3966118|FG001|Overall Study|Randomized in error|0
2281470|NCT02367794|3966119|FG002|Overall Study|Randomized in error|1
2281471|NCT02367794|3966117|FG000|Overall Study|Patient unable to receive carboplatin|0
2281472|NCT02367794|3966118|FG001|Overall Study|Patient unable to receive carboplatin|0
2281473|NCT02367794|3966119|FG002|Overall Study|Patient unable to receive carboplatin|1
2281474|NCT02367794|3966117|FG000|Overall Study|Hypercalcemia prior to C1D1|0
2281475|NCT02367794|3966118|FG001|Overall Study|Hypercalcemia prior to C1D1|0
2281476|NCT02367794|3966119|FG002|Overall Study|Hypercalcemia prior to C1D1|1
2281477|NCT02367833|3966144|FG000|Overall Study|Withdrawal by Subject|1
2281478|NCT02367833|3966145|FG001|Overall Study|Withdrawal by Subject|1
2281479|NCT02367833|3966146|FG002|Overall Study|Withdrawal by Subject|0
2281480|NCT02367885|3966203|FG000|Overall Study|Lost to Follow-up|1
2281481|NCT02367885|3966204|FG001|Overall Study|Lost to Follow-up|0
2281482|NCT02367885|3966205|FG002|Overall Study|Lost to Follow-up|0
2281483|NCT02367885|3966203|FG000|Overall Study|Withdrawal by Subject|1
2281484|NCT02367885|3966204|FG001|Overall Study|Withdrawal by Subject|0
2281485|NCT02367885|3966205|FG002|Overall Study|Withdrawal by Subject|0
2281486|NCT02367911|3966218|FG000|Overall Study|Withdrawal by Subject|3
2281487|NCT02367911|3966219|FG001|Overall Study|Withdrawal by Subject|2
2281488|NCT02367911|3966218|FG000|Overall Study|Lost to Follow-up|2
2281489|NCT02367911|3966219|FG001|Overall Study|Lost to Follow-up|2
2281490|NCT02368210|3966236|FG000|Overall Study|Withdrawal by Subject|1
2281491|NCT02368210|3966237|FG001|Overall Study|Withdrawal by Subject|0
2281492|NCT02368210|3966236|FG000|Overall Study|Adverse Event|0
2281493|NCT02368210|3966237|FG001|Overall Study|Adverse Event|1
2281494|NCT02368314|3966245|FG000|Overall Study|Withdrawal by Subject|2
2281495|NCT02368314|3966246|FG001|Overall Study|Withdrawal by Subject|1
2281496|NCT02368314|3966245|FG000|Overall Study|Adverse Event|1
2281497|NCT02368314|3966246|FG001|Overall Study|Adverse Event|2
2281498|NCT02368691|3966271|FG000|Overall Study|Death|13
2281499|NCT02368691|3966271|FG000|Overall Study|Lack of Efficacy|15
2281500|NCT02368691|3966271|FG000|Overall Study|Physician Decision|4
2281501|NCT02369159|3966286|FG000|Overall Study|Adverse Event|0
2281502|NCT02369159|3966287|FG001|Overall Study|Adverse Event|1
2281503|NCT02369159|3966286|FG000|Overall Study|Lost to Follow-up|1
2281504|NCT02369159|3966287|FG001|Overall Study|Lost to Follow-up|1
2281505|NCT02369159|3966286|FG000|Overall Study|Withdrawal by Subject|7
2281506|NCT02369159|3966287|FG001|Overall Study|Withdrawal by Subject|0
2281507|NCT02369341|3966337|FG000|Overall Study|Migrated/moved from study area|1
2281508|NCT02369341|3966338|FG001|Overall Study|Migrated/moved from study area|0
2281509|NCT02369510|3966355|FG000|Overall Study|Spilled Medication|1
2281510|NCT02369510|3966356|FG001|Overall Study|Spilled Medication|2
2281511|NCT02369510|3966357|FG002|Overall Study|Spilled Medication|1
2281512|NCT02369510|3966355|FG000|Overall Study|Epidural Activation|1
2281513|NCT02369510|3966356|FG001|Overall Study|Epidural Activation|1
2281514|NCT02369510|3966357|FG002|Overall Study|Epidural Activation|5
2281515|NCT02369848|3966395|FG000|Overall Study|Death|1
2281516|NCT02369848|3966395|FG000|Overall Study|Withdrawal by Subject|2
2281517|NCT02369848|3966395|FG000|Overall Study|Lost to Follow-up|1
2281518|NCT02369874|3966402|FG000|Overall Study|Lost to Follow-up|2
2281519|NCT02369874|3966403|FG001|Overall Study|Lost to Follow-up|2
2281520|NCT02369874|3966404|FG002|Overall Study|Lost to Follow-up|2
2281521|NCT02369874|3966402|FG000|Overall Study|Withdrawal by Subject|7
2281522|NCT02369874|3966403|FG001|Overall Study|Withdrawal by Subject|9
2281523|NCT02369874|3966404|FG002|Overall Study|Withdrawal by Subject|27
2126550|NCT01004432|3727970|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
2126551|NCT01004432|3727971|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
2126552|NCT01004432|3727972|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
2281524|NCT02369874|3966402|FG000|Overall Study|Miscellaneous|1
2281525|NCT02369874|3966403|FG001|Overall Study|Miscellaneous|1
2281526|NCT02369874|3966404|FG002|Overall Study|Miscellaneous|0
2281527|NCT02369874|3966402|FG000|Overall Study|On Treatment/Off Study|34
2281528|NCT02369874|3966403|FG001|Overall Study|On Treatment/Off Study|45
2281529|NCT02369874|3966404|FG002|Overall Study|On Treatment/Off Study|32
2281530|NCT02370043|3966430|FG000|Overall Study|Withdrawal by Subject|0
2281531|NCT02370043|3966431|FG001|Overall Study|Withdrawal by Subject|0
2281532|NCT02370043|3966432|FG002|Overall Study|Withdrawal by Subject|0
2281533|NCT02370043|3966433|FG003|Overall Study|Withdrawal by Subject|0
2281534|NCT02370043|3966434|FG004|Overall Study|Withdrawal by Subject|1
2281535|NCT02370043|3966435|FG005|Overall Study|Withdrawal by Subject|1
2281536|NCT02370095|3966474|FG000|Overall Study|Withdrawal by Subject|0
2281537|NCT02370095|3966475|FG001|Overall Study|Withdrawal by Subject|1
2281538|NCT02370121|3966483|FG000|Overall Study|Lost to Follow-up|1
2281539|NCT02370121|3966484|FG001|Overall Study|Lost to Follow-up|1
2281540|NCT02370160|3966490|FG000|Overall Study|Death|3
2281541|NCT02370160|3966491|FG001|Overall Study|Death|4
2281542|NCT02370160|3966492|FG002|Overall Study|Death|1
2281543|NCT02370238|3966507|FG000|Overall Study|Death|42
2281544|NCT02370238|3966508|FG001|Overall Study|Death|35
2281545|NCT02370238|3966507|FG000|Overall Study|Lost to Follow-up|1
2281546|NCT02370238|3966508|FG001|Overall Study|Lost to Follow-up|3
2281547|NCT02370238|3966507|FG000|Overall Study|Withdrawal by Subject|2
2281548|NCT02370238|3966508|FG001|Overall Study|Withdrawal by Subject|6
2281549|NCT02370238|3966507|FG000|Overall Study|Other|2
2281550|NCT02370238|3966508|FG001|Overall Study|Other|1
2281551|NCT02370251|3966518|FG000|Overall Study|Received less than 8 days of Omegaven|7
2281552|NCT02370251|3966518|FG000|Overall Study|Death|4
2281553|NCT02370368|3966524|FG000|Overall Study|Adverse Event|1
2281554|NCT02370368|3966525|FG001|Overall Study|Adverse Event|2
2281555|NCT02370368|3966524|FG000|Overall Study|Withdrawal by Subject|5
2281556|NCT02370368|3966525|FG001|Overall Study|Withdrawal by Subject|4
2281557|NCT02370394|3966533|FG000|Overall Study|Lost to Follow-up|2
2281558|NCT02370394|3966534|FG001|Overall Study|Lost to Follow-up|1
2281559|NCT02370394|3966533|FG000|Overall Study|Withdrawal by Subject|0
2281560|NCT02370394|3966534|FG001|Overall Study|Withdrawal by Subject|1
2281561|NCT02370420|3966556|FG000|Overall Study|Physician Decision|3
2281562|NCT02370420|3966557|FG001|Overall Study|Physician Decision|3
2281563|NCT02370420|3966556|FG000|Overall Study|Lost to Follow-up|11
2281564|NCT02370420|3966557|FG001|Overall Study|Lost to Follow-up|9
2281565|NCT02370498|3966565|FG000|Overall Study|Adverse Event|10
2281566|NCT02370498|3966566|FG001|Overall Study|Adverse Event|8
2281567|NCT02370498|3966565|FG000|Overall Study|Death|222
2281568|NCT02370498|3966566|FG001|Overall Study|Death|242
2281569|NCT02370498|3966565|FG000|Overall Study|Lost to Follow-up|1
2281570|NCT02370498|3966566|FG001|Overall Study|Lost to Follow-up|0
2281571|NCT02370498|3966565|FG000|Overall Study|Protocol Violation|1
2281572|NCT02370498|3966566|FG001|Overall Study|Protocol Violation|2
2281573|NCT02370498|3966565|FG000|Overall Study|Withdrawal by Subject|6
2281574|NCT02370498|3966566|FG001|Overall Study|Withdrawal by Subject|11
2281575|NCT02370498|3966565|FG000|Overall Study|Ongoing In Trial|56
2281576|NCT02370498|3966566|FG001|Overall Study|Ongoing In Trial|33
2281577|NCT02370511|3966575|FG000|Overall Study|Death|10
2281578|NCT02370511|3966576|FG001|Overall Study|Death|7
2281579|NCT02370511|3966577|FG002|Overall Study|Death|1
2281580|NCT02370511|3966575|FG000|Overall Study|Withdrawal by Subject|2
2281581|NCT02370511|3966576|FG001|Overall Study|Withdrawal by Subject|0
2281582|NCT02370511|3966577|FG002|Overall Study|Withdrawal by Subject|0
2281583|NCT02370511|3966575|FG000|Overall Study|Lost to Follow-up|0
2281584|NCT02370511|3966576|FG001|Overall Study|Lost to Follow-up|4
2281585|NCT02370511|3966577|FG002|Overall Study|Lost to Follow-up|0
2281586|NCT02370537|3966588|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0
2281587|NCT02370537|3966589|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1
2281588|NCT02370537|3966590|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0
2281589|NCT02370537|3966588|FG000|Part A (Open-label Recruitment)|Adverse Event|0
2180118|NCT01398514|3806032|FG001|Overall Study|Adverse Event|0
2281590|NCT02370537|3966589|FG001|Part A (Open-label Recruitment)|Adverse Event|0
2281591|NCT02370537|3966590|FG002|Part A (Open-label Recruitment)|Adverse Event|1
2281592|NCT02370537|3966588|FG000|Part B|Not randomised to receive treatment|1
2281593|NCT02370537|3966589|FG001|Part B|Not randomised to receive treatment|2
2281594|NCT02370537|3966590|FG002|Part B|Not randomised to receive treatment|259
2281595|NCT02370537|3966588|FG000|Part B|Withdrawal by Subject|0
2281596|NCT02370537|3966589|FG001|Part B|Withdrawal by Subject|1
2281597|NCT02370537|3966590|FG002|Part B|Withdrawal by Subject|0
2281598|NCT02370602|3966613|FG000|Overall Study|Pretreatment Event/Adverse Event|1
2281599|NCT02370602|3966614|FG001|Overall Study|Pretreatment Event/Adverse Event|0
2281600|NCT02370602|3966615|FG002|Overall Study|Pretreatment Event/Adverse Event|0
2281601|NCT02370602|3966616|FG003|Overall Study|Pretreatment Event/Adverse Event|0
2281602|NCT02370602|3966617|FG004|Overall Study|Pretreatment Event/Adverse Event|0
2126553|NCT01004432|3727973|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
2126554|NCT01004432|3727974|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
2126555|NCT01004432|3727970|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
2126556|NCT01004432|3727971|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
2126557|NCT01004432|3727972|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
2126558|NCT01004432|3727973|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
2126559|NCT01004432|3727974|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
2126560|NCT01004432|3727970|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2126561|NCT01004432|3727971|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2126562|NCT01004432|3727972|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2126563|NCT01004432|3727973|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
2126564|NCT01004432|3727974|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2126565|NCT01004432|3727970|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
2126566|NCT01004432|3727971|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
2126567|NCT01004432|3727972|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
2126568|NCT01004432|3727973|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
2126569|NCT01004432|3727974|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
2126570|NCT01004432|3727970|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
2126571|NCT01004432|3727971|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
2126572|NCT01004432|3727972|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
2126573|NCT01004432|3727973|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
2126574|NCT01004432|3727974|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
2126575|NCT01004432|3727970|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0
2126576|NCT01004432|3727971|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0
2126577|NCT01004432|3727972|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0
2126578|NCT01004432|3727973|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0
2126579|NCT01004432|3727974|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2
2126580|NCT01004432|3727970|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2126581|NCT01004432|3727971|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2126582|NCT01004432|3727972|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2126583|NCT01004432|3727973|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2126584|NCT01004432|3727974|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4
2126585|NCT01004432|3727970|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2126586|NCT01004432|3727971|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2126587|NCT01004432|3727972|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2126588|NCT01004432|3727973|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2126589|NCT01004432|3727974|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
2126590|NCT01004432|3727970|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2126591|NCT01004432|3727971|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2126592|NCT01004432|3727972|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2126593|NCT01004432|3727973|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2126594|NCT01004432|3727974|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
2126595|NCT01004614|3727992|FG000|Washout|Withdrawal by Subject|0
2126596|NCT01004614|3727993|FG001|Washout|Withdrawal by Subject|1
2126597|NCT01004614|3727994|FG002|Washout|Withdrawal by Subject|0
2126598|NCT01004614|3727995|FG003|Washout|Withdrawal by Subject|0
2126599|NCT01004822|3728052|FG000|Overall Study|Objective progression or relapse|3
2126600|NCT01004822|3728053|FG001|Overall Study|Objective progression or relapse|3
2126601|NCT01004822|3728054|FG002|Overall Study|Objective progression or relapse|0
2126602|NCT01004822|3728055|FG003|Overall Study|Objective progression or relapse|1
2126603|NCT01004822|3728056|FG004|Overall Study|Objective progression or relapse|2
2126604|NCT01004822|3728057|FG005|Overall Study|Objective progression or relapse|2
2126605|NCT01004822|3728058|FG006|Overall Study|Objective progression or relapse|1
2126606|NCT01004822|3728059|FG007|Overall Study|Objective progression or relapse|4
2126607|NCT01004822|3728052|FG000|Overall Study|Global deterioration of health status|0
2126608|NCT01004822|3728053|FG001|Overall Study|Global deterioration of health status|0
2126609|NCT01004822|3728054|FG002|Overall Study|Global deterioration of health status|0
2126610|NCT01004822|3728055|FG003|Overall Study|Global deterioration of health status|1
2126611|NCT01004822|3728056|FG004|Overall Study|Global deterioration of health status|0
2126612|NCT01004822|3728057|FG005|Overall Study|Global deterioration of health status|0
2126613|NCT01004822|3728058|FG006|Overall Study|Global deterioration of health status|1
2126614|NCT01004822|3728059|FG007|Overall Study|Global deterioration of health status|0
2126615|NCT01004822|3728052|FG000|Overall Study|No longer willing to continue|0
2126616|NCT01004822|3728053|FG001|Overall Study|No longer willing to continue|0
2126617|NCT01004822|3728054|FG002|Overall Study|No longer willing to continue|0
2126618|NCT01004822|3728055|FG003|Overall Study|No longer willing to continue|1
2126619|NCT01004822|3728056|FG004|Overall Study|No longer willing to continue|2
2126620|NCT01004822|3728057|FG005|Overall Study|No longer willing to continue|1
2126621|NCT01004822|3728058|FG006|Overall Study|No longer willing to continue|1
2126622|NCT01004822|3728059|FG007|Overall Study|No longer willing to continue|0
2126623|NCT01004822|3728052|FG000|Overall Study|Adverse Event|0
2126624|NCT01004822|3728053|FG001|Overall Study|Adverse Event|0
2126625|NCT01004822|3728054|FG002|Overall Study|Adverse Event|0
2126626|NCT01004822|3728055|FG003|Overall Study|Adverse Event|0
2126627|NCT01004822|3728056|FG004|Overall Study|Adverse Event|0
2126628|NCT01004822|3728057|FG005|Overall Study|Adverse Event|0
2126629|NCT01004822|3728058|FG006|Overall Study|Adverse Event|1
2126630|NCT01004822|3728059|FG007|Overall Study|Adverse Event|1
2126631|NCT01004822|3728052|FG000|Overall Study|Other|0
2126632|NCT01004822|3728053|FG001|Overall Study|Other|0
2126633|NCT01004822|3728054|FG002|Overall Study|Other|4
2126634|NCT01004822|3728055|FG003|Overall Study|Other|1
2126635|NCT01004822|3728056|FG004|Overall Study|Other|0
2126636|NCT01004822|3728057|FG005|Overall Study|Other|1
2126637|NCT01004822|3728058|FG006|Overall Study|Other|0
2126638|NCT01004822|3728059|FG007|Overall Study|Other|0
2126639|NCT01004848|3728081|FG000|Overall Study|Lost to Follow-up|55
2126640|NCT01004848|3728082|FG001|Overall Study|Lost to Follow-up|45
2126641|NCT01005251|3728109|FG000|Overall Study|Withdrawal by Subject|2
2126642|NCT01005251|3728110|FG001|Overall Study|Withdrawal by Subject|5
2126643|NCT01005251|3728111|FG002|Overall Study|Withdrawal by Subject|3
2126644|NCT01005251|3728112|FG003|Overall Study|Withdrawal by Subject|4
2126645|NCT01005251|3728113|FG004|Overall Study|Withdrawal by Subject|9
2126646|NCT01005251|3728109|FG000|Overall Study|Eligibility criteria not fulfilled|4
2126647|NCT01005251|3728110|FG001|Overall Study|Eligibility criteria not fulfilled|0
2126648|NCT01005251|3728111|FG002|Overall Study|Eligibility criteria not fulfilled|4
2126649|NCT01005251|3728112|FG003|Overall Study|Eligibility criteria not fulfilled|1
2126650|NCT01005251|3728113|FG004|Overall Study|Eligibility criteria not fulfilled|0
2126651|NCT01005251|3728109|FG000|Overall Study|Adverse Event|2
2126652|NCT01005251|3728110|FG001|Overall Study|Adverse Event|6
2126653|NCT01005251|3728111|FG002|Overall Study|Adverse Event|8
2126654|NCT01005251|3728112|FG003|Overall Study|Adverse Event|5
2126655|NCT01005251|3728113|FG004|Overall Study|Adverse Event|4
2126656|NCT01005251|3728109|FG000|Overall Study|Protocol Violation|1
2126657|NCT01005251|3728110|FG001|Overall Study|Protocol Violation|0
2126658|NCT01005251|3728111|FG002|Overall Study|Protocol Violation|0
2126659|NCT01005251|3728112|FG003|Overall Study|Protocol Violation|0
2126660|NCT01005251|3728113|FG004|Overall Study|Protocol Violation|2
2126661|NCT01005251|3728109|FG000|Overall Study|Developed study-specific withdrawal crit|2
2126662|NCT01005251|3728110|FG001|Overall Study|Developed study-specific withdrawal crit|0
2126663|NCT01005251|3728111|FG002|Overall Study|Developed study-specific withdrawal crit|3
2126664|NCT01005251|3728112|FG003|Overall Study|Developed study-specific withdrawal crit|0
2126665|NCT01005251|3728113|FG004|Overall Study|Developed study-specific withdrawal crit|1
2126666|NCT01005251|3728109|FG000|Overall Study|Lost to Follow-up|1
2281603|NCT02370602|3966618|FG005|Overall Study|Pretreatment Event/Adverse Event|0
2281604|NCT02370615|3966637|FG000|Overall Study|Adverse Event|1
2281605|NCT02370615|3966638|FG001|Overall Study|Adverse Event|0
2281606|NCT02370641|3966653|FG000|Overall Study|dropped study|4
2281607|NCT02370641|3966654|FG001|Overall Study|dropped study|2
2320745|NCT02952586|4035028|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5
2320746|NCT02952586|4035029|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8
2320747|NCT02952586|4035028|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
2320748|NCT02952586|4035029|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
2320749|NCT02952586|4035028|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2
2320750|NCT02952586|4035029|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1
2320751|NCT02952586|4035028|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1
2320752|NCT02952586|4035029|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0
2320753|NCT02952586|4035028|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10
2320754|NCT02952586|4035029|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4
2320755|NCT02952586|4035028|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
2320756|NCT02952586|4035029|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
2320757|NCT02952586|4035028|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2
2320758|NCT02952586|4035029|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1
2320759|NCT02952586|4035028|FG000|CRT for Cisplatin (63 Days)|Death|3
2320760|NCT02952586|4035029|FG001|CRT for Cisplatin (63 Days)|Death|8
2320761|NCT02952586|4035028|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82
2320762|NCT02952586|4035029|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81
2320763|NCT02952586|4035028|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12
2320764|NCT02952586|4035029|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10
2320765|NCT02952586|4035028|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1
2320766|NCT02952586|4035029|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0
2320767|NCT02952586|4035028|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11
2320768|NCT02952586|4035029|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3
2320769|NCT02952586|4035028|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
2320770|NCT02952586|4035029|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
2320771|NCT02952586|4035028|FG000|CRT for Cisplatin (63 Days)|Other|1
2320772|NCT02952586|4035029|FG001|CRT for Cisplatin (63 Days)|Other|1
2320773|NCT02952586|4035028|FG000|CRT for IMRT (63 Days)|Death|5
2320774|NCT02952586|4035029|FG001|CRT for IMRT (63 Days)|Death|8
2320775|NCT02952586|4035028|FG000|CRT for IMRT (63 Days)|Adverse Event|5
2320776|NCT02952586|4035029|FG001|CRT for IMRT (63 Days)|Adverse Event|5
2320777|NCT02952586|4035028|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1
2126667|NCT01005251|3728110|FG001|Overall Study|Lost to Follow-up|4
2126668|NCT01005251|3728111|FG002|Overall Study|Lost to Follow-up|2
2126669|NCT01005251|3728112|FG003|Overall Study|Lost to Follow-up|0
2126670|NCT01005251|3728113|FG004|Overall Study|Lost to Follow-up|0
2126671|NCT01005251|3728109|FG000|Overall Study|Physician Decision|0
2126672|NCT01005251|3728110|FG001|Overall Study|Physician Decision|0
2126673|NCT01005251|3728111|FG002|Overall Study|Physician Decision|0
2126674|NCT01005251|3728112|FG003|Overall Study|Physician Decision|0
2126675|NCT01005251|3728113|FG004|Overall Study|Physician Decision|2
2126676|NCT01005251|3728109|FG000|Overall Study|Patient moved|1
2126677|NCT01005251|3728110|FG001|Overall Study|Patient moved|0
2126678|NCT01005251|3728111|FG002|Overall Study|Patient moved|0
2126679|NCT01005251|3728112|FG003|Overall Study|Patient moved|0
2126680|NCT01005251|3728113|FG004|Overall Study|Patient moved|0
2126681|NCT01005251|3728109|FG000|Overall Study|Wrong drug dispensed|0
2126682|NCT01005251|3728110|FG001|Overall Study|Wrong drug dispensed|1
2126683|NCT01005251|3728111|FG002|Overall Study|Wrong drug dispensed|0
2126684|NCT01005251|3728112|FG003|Overall Study|Wrong drug dispensed|0
2126685|NCT01005251|3728113|FG004|Overall Study|Wrong drug dispensed|0
2126686|NCT01005251|3728109|FG000|Overall Study|Randomized in error|0
2126687|NCT01005251|3728110|FG001|Overall Study|Randomized in error|0
2126688|NCT01005251|3728111|FG002|Overall Study|Randomized in error|1
2126689|NCT01005251|3728112|FG003|Overall Study|Randomized in error|1
2126690|NCT01005251|3728113|FG004|Overall Study|Randomized in error|0
2126691|NCT01005251|3728109|FG000|Overall Study|Lack of Efficacy|0
2126692|NCT01005251|3728110|FG001|Overall Study|Lack of Efficacy|0
2126693|NCT01005251|3728111|FG002|Overall Study|Lack of Efficacy|1
2126694|NCT01005251|3728112|FG003|Overall Study|Lack of Efficacy|1
2126695|NCT01005251|3728113|FG004|Overall Study|Lack of Efficacy|0
2126696|NCT01005316|3728137|FG000|Overall Study|Adverse Event|0
2126697|NCT01005316|3728138|FG001|Overall Study|Adverse Event|0
2126698|NCT01005316|3728139|FG002|Overall Study|Adverse Event|0
2126699|NCT01005316|3728140|FG003|Overall Study|Adverse Event|1
2126700|NCT01005316|3728137|FG000|Overall Study|Death|20
2126701|NCT01005316|3728138|FG001|Overall Study|Death|5
2126702|NCT01005316|3728139|FG002|Overall Study|Death|1
2126703|NCT01005316|3728140|FG003|Overall Study|Death|15
2126704|NCT01005316|3728137|FG000|Overall Study|Study Termination|5
2126705|NCT01005316|3728138|FG001|Overall Study|Study Termination|63
2126706|NCT01005316|3728139|FG002|Overall Study|Study Termination|9
2126707|NCT01005316|3728140|FG003|Overall Study|Study Termination|85
2126708|NCT01005316|3728137|FG000|Overall Study|Lost to Follow-up|1
2126709|NCT01005316|3728138|FG001|Overall Study|Lost to Follow-up|3
2126710|NCT01005316|3728139|FG002|Overall Study|Lost to Follow-up|0
2126711|NCT01005316|3728140|FG003|Overall Study|Lost to Follow-up|2
2126712|NCT01005316|3728137|FG000|Overall Study|Physician Decision|6
2126713|NCT01005316|3728138|FG001|Overall Study|Physician Decision|0
2126714|NCT01005316|3728139|FG002|Overall Study|Physician Decision|0
2126715|NCT01005316|3728140|FG003|Overall Study|Physician Decision|0
2126716|NCT01005316|3728137|FG000|Overall Study|Sponsor Decision|6
2126717|NCT01005316|3728138|FG001|Overall Study|Sponsor Decision|3
2126718|NCT01005316|3728139|FG002|Overall Study|Sponsor Decision|0
2126719|NCT01005316|3728140|FG003|Overall Study|Sponsor Decision|0
2126720|NCT01005316|3728137|FG000|Overall Study|Withdrawal by Subject|1
2126721|NCT01005316|3728138|FG001|Overall Study|Withdrawal by Subject|1
2126722|NCT01005316|3728139|FG002|Overall Study|Withdrawal by Subject|0
2126723|NCT01005316|3728140|FG003|Overall Study|Withdrawal by Subject|2
2126724|NCT01005316|3728137|FG000|Overall Study|Consented to Another Study|2
2126725|NCT01005316|3728138|FG001|Overall Study|Consented to Another Study|0
2126726|NCT01005316|3728139|FG002|Overall Study|Consented to Another Study|0
2126727|NCT01005316|3728140|FG003|Overall Study|Consented to Another Study|0
2126728|NCT01005316|3728137|FG000|Overall Study|Delisted|8
2126729|NCT01005316|3728138|FG001|Overall Study|Delisted|0
2126730|NCT01005316|3728139|FG002|Overall Study|Delisted|0
2126731|NCT01005316|3728140|FG003|Overall Study|Delisted|0
2126732|NCT01005316|3728137|FG000|Overall Study|Transferred Care|1
2126733|NCT01005316|3728138|FG001|Overall Study|Transferred Care|0
2126734|NCT01005316|3728139|FG002|Overall Study|Transferred Care|1
2126735|NCT01005316|3728140|FG003|Overall Study|Transferred Care|3
2126736|NCT01005316|3728137|FG000|Overall Study|Retransplanted|0
2126737|NCT01005316|3728138|FG001|Overall Study|Retransplanted|1
2126738|NCT01005316|3728139|FG002|Overall Study|Retransplanted|0
2126739|NCT01005316|3728140|FG003|Overall Study|Retransplanted|0
2126740|NCT01005329|3728151|FG000|Overall Study|Ineligible or received no protocol trt.|4
2126741|NCT01005602|3728196|FG000|Overall Study|Excluded due to unreliable clinical data|1
2126742|NCT01005602|3728197|FG001|Overall Study|Excluded due to unreliable clinical data|0
2126743|NCT01005680|3728212|FG000|Overall Study|Lost to Follow-up|4
2126744|NCT01005680|3728213|FG001|Overall Study|Lost to Follow-up|6
2126745|NCT01005680|3728212|FG000|Overall Study|Withdrawal by Subject|1
2126746|NCT01005680|3728213|FG001|Overall Study|Withdrawal by Subject|4
2126747|NCT01005680|3728212|FG000|Overall Study|Physician Decision|1
2126748|NCT01005680|3728213|FG001|Overall Study|Physician Decision|1
2126749|NCT01005719|3728229|FG000|Period 1|Adverse Event|0
2126750|NCT01005719|3728230|FG001|Period 1|Adverse Event|0
2126751|NCT01005719|3728231|FG002|Period 1|Adverse Event|0
2126752|NCT01005719|3728232|FG003|Period 1|Adverse Event|1
2126753|NCT01005719|3728233|FG004|Period 1|Adverse Event|0
2126754|NCT01005719|3728234|FG005|Period 1|Adverse Event|0
2126755|NCT01005719|3728229|FG000|Period 1|Delay in completing study procedures|0
2126756|NCT01005719|3728230|FG001|Period 1|Delay in completing study procedures|0
2126757|NCT01005719|3728231|FG002|Period 1|Delay in completing study procedures|0
2126758|NCT01005719|3728232|FG003|Period 1|Delay in completing study procedures|0
2126759|NCT01005719|3728233|FG004|Period 1|Delay in completing study procedures|0
2126760|NCT01005719|3728234|FG005|Period 1|Delay in completing study procedures|1
2126761|NCT01005719|3728229|FG000|Period 2|Adverse Event|0
2126762|NCT01005719|3728230|FG001|Period 2|Adverse Event|0
2126763|NCT01005719|3728231|FG002|Period 2|Adverse Event|0
2126764|NCT01005719|3728232|FG003|Period 2|Adverse Event|0
2126765|NCT01005719|3728233|FG004|Period 2|Adverse Event|1
2126766|NCT01005719|3728234|FG005|Period 2|Adverse Event|1
2126767|NCT01005732|3728243|FG000|Overall Study|Lost to Follow-up|10
2126768|NCT01005732|3728243|FG000|Overall Study|Death|1
2126769|NCT01005745|3728251|FG000|Overall Study|No TIL growth|1
2126770|NCT01005745|3728251|FG000|Overall Study|Disease progressed during TIL growth|3
2126771|NCT01005745|3728251|FG000|Overall Study|Death prior to treatment|1
2126772|NCT01005745|3728251|FG000|Overall Study|Inappropriate antidiuretic hormone|1
2126773|NCT01005875|3728264|FG000|Overall Study|Death|3
2126774|NCT01005901|3728281|FG000|Overall Study|Withdrawal by Subject|38
2126775|NCT01005901|3728282|FG001|Overall Study|Withdrawal by Subject|14
2126776|NCT01005901|3728281|FG000|Overall Study|Adverse Event|30
2126777|NCT01005901|3728282|FG001|Overall Study|Adverse Event|16
2126778|NCT01005901|3728281|FG000|Overall Study|Administrative problems|21
2126779|NCT01005901|3728282|FG001|Overall Study|Administrative problems|13
2126780|NCT01005901|3728281|FG000|Overall Study|Unsatisfactory therapeutic effect|5
2126781|NCT01005901|3728282|FG001|Overall Study|Unsatisfactory therapeutic effect|5
2281608|NCT02370667|3966663|FG000|Overall Study|Lost to Follow-up|0
2281609|NCT02370667|3966664|FG001|Overall Study|Lost to Follow-up|1
2281610|NCT02370667|3966665|FG002|Overall Study|Lost to Follow-up|0
2281611|NCT02370784|3966685|FG000|Overall Study|Patient started prohibited medication|0
2281612|NCT02370784|3966686|FG001|Overall Study|Patient started prohibited medication|1
2281613|NCT02370914|3966705|FG000|Overall Study|Protocol Violation|2
2281614|NCT02371369|3966750|FG000|Part 1|Physician Decision|0
2281615|NCT02371369|3966751|FG001|Part 1|Physician Decision|3
2281616|NCT02371369|3966750|FG000|Part 1|Adverse Event|8
2281617|NCT02371369|3966751|FG001|Part 1|Adverse Event|0
2281618|NCT02371369|3966750|FG000|Part 1|Withdrawal by Subject|1
2281619|NCT02371369|3966751|FG001|Part 1|Withdrawal by Subject|6
2281620|NCT02371369|3966750|FG000|Part 1|Disease progression|0
2281621|NCT02371369|3966751|FG001|Part 1|Disease progression|1
2281622|NCT02371369|3966750|FG000|Part 1|Protocol Violation|0
2281623|NCT02371369|3966751|FG001|Part 1|Protocol Violation|1
2281624|NCT02371369|3966750|FG000|Part 2|Adverse Event|3
2281625|NCT02371369|3966751|FG001|Part 2|Adverse Event|2
2281626|NCT02371369|3966750|FG000|Part 2|Withdrawal by Subject|5
2281627|NCT02371369|3966751|FG001|Part 2|Withdrawal by Subject|1
2281628|NCT02371369|3966750|FG000|Part 2|Physician Decision|1
2281629|NCT02371369|3966751|FG001|Part 2|Physician Decision|0
2281630|NCT02371369|3966750|FG000|Part 2|Death|0
2281631|NCT02371369|3966751|FG001|Part 2|Death|1
2281632|NCT02371616|3966778|FG000|Overall Study|Protocol Violation|2
2281633|NCT02371616|3966779|FG001|Overall Study|Protocol Violation|1
2281634|NCT02371616|3966778|FG000|Overall Study|Adverse Event|0
2281635|NCT02371616|3966779|FG001|Overall Study|Adverse Event|1
2281636|NCT02371616|3966778|FG000|Overall Study|Withdrawal of Consent|1
2281637|NCT02371616|3966779|FG001|Overall Study|Withdrawal of Consent|0
2281638|NCT02371616|3966778|FG000|Overall Study|Other (Not specified)|1
2281639|NCT02371616|3966779|FG001|Overall Study|Other (Not specified)|5
2281640|NCT02371629|3966787|FG000|Overall Study|Patient decision|14
2281641|NCT02371629|3966788|FG001|Overall Study|Patient decision|10
2281642|NCT02371629|3966787|FG000|Overall Study|Adverse Event|8
2281643|NCT02371629|3966788|FG001|Overall Study|Adverse Event|8
2281644|NCT02371629|3966787|FG000|Overall Study|Physician Decision|2
2281645|NCT02371629|3966788|FG001|Overall Study|Physician Decision|3
2281646|NCT02371629|3966787|FG000|Overall Study|Death|1
2281647|NCT02371629|3966788|FG001|Overall Study|Death|1
2281648|NCT02371629|3966787|FG000|Overall Study|Noncompliance with study treatment|1
2281649|NCT02371629|3966788|FG001|Overall Study|Noncompliance with study treatment|0
2281650|NCT02371629|3966787|FG000|Overall Study|Lack of Efficacy|0
2281651|NCT02371629|3966788|FG001|Overall Study|Lack of Efficacy|2
2281652|NCT02371629|3966787|FG000|Overall Study|Protocol deviation|0
2281653|NCT02371629|3966788|FG001|Overall Study|Protocol deviation|1
2281654|NCT02371746|3966810|FG000|Overall Study|Consent withdrawn|0
2281655|NCT02371746|3966811|FG001|Overall Study|Consent withdrawn|0
2281656|NCT02371746|3966812|FG002|Overall Study|Consent withdrawn|0
2281657|NCT02371746|3966813|FG003|Overall Study|Consent withdrawn|0
2281658|NCT02371746|3966814|FG004|Overall Study|Consent withdrawn|0
2281659|NCT02371746|3966815|FG005|Overall Study|Consent withdrawn|0
2281660|NCT02371746|3966816|FG006|Overall Study|Consent withdrawn|1
2281661|NCT02371759|3966840|FG000|Overall Study|Protocol Violation|3
2281662|NCT02371759|3966841|FG001|Overall Study|Protocol Violation|1
2281663|NCT02371759|3966842|FG002|Overall Study|Protocol Violation|1
2281664|NCT02371759|3966843|FG003|Overall Study|Protocol Violation|0
2281665|NCT02371759|3966844|FG004|Overall Study|Protocol Violation|3
2281666|NCT02371759|3966845|FG005|Overall Study|Protocol Violation|1
2126782|NCT01005901|3728281|FG000|Overall Study|Protocol Violation|4
2126783|NCT01005901|3728282|FG001|Overall Study|Protocol Violation|3
2126784|NCT01005901|3728281|FG000|Overall Study|Death|2
2126785|NCT01005901|3728282|FG001|Overall Study|Death|3
2126786|NCT01005901|3728281|FG000|Overall Study|Lost to Follow-up|1
2126787|NCT01005901|3728282|FG001|Overall Study|Lost to Follow-up|2
2281667|NCT02371759|3966846|FG006|Overall Study|Protocol Violation|0
2281668|NCT02371759|3966847|FG007|Overall Study|Protocol Violation|3
2281669|NCT02371759|3966840|FG000|Overall Study|Withdrawal by Subject|0
2281670|NCT02371759|3966841|FG001|Overall Study|Withdrawal by Subject|0
2281671|NCT02371759|3966842|FG002|Overall Study|Withdrawal by Subject|0
2281672|NCT02371759|3966843|FG003|Overall Study|Withdrawal by Subject|0
2281673|NCT02371759|3966844|FG004|Overall Study|Withdrawal by Subject|0
2281674|NCT02371759|3966845|FG005|Overall Study|Withdrawal by Subject|0
2281675|NCT02371759|3966846|FG006|Overall Study|Withdrawal by Subject|0
2281676|NCT02371759|3966847|FG007|Overall Study|Withdrawal by Subject|1
2281677|NCT02371980|3966894|FG000|Open-label Period|Pretreatment Event/Adverse Event|63
2281678|NCT02371980|3966895|FG001|Open-label Period|Pretreatment Event/Adverse Event|0
2281679|NCT02371980|3966896|FG002|Open-label Period|Pretreatment Event/Adverse Event|0
2281680|NCT02371980|3966897|FG003|Open-label Period|Pretreatment Event/Adverse Event|0
2281681|NCT02371980|3966898|FG004|Open-label Period|Pretreatment Event/Adverse Event|0
2281682|NCT02371980|3966894|FG000|Open-label Period|Significant Protocol Deviation|19
2281683|NCT02371980|3966895|FG001|Open-label Period|Significant Protocol Deviation|0
2281684|NCT02371980|3966896|FG002|Open-label Period|Significant Protocol Deviation|0
2281685|NCT02371980|3966897|FG003|Open-label Period|Significant Protocol Deviation|0
2281686|NCT02371980|3966898|FG004|Open-label Period|Significant Protocol Deviation|0
2281687|NCT02371980|3966894|FG000|Open-label Period|Noncompliance with Study Drug|10
2281688|NCT02371980|3966895|FG001|Open-label Period|Noncompliance with Study Drug|0
2281689|NCT02371980|3966896|FG002|Open-label Period|Noncompliance with Study Drug|0
2281690|NCT02371980|3966897|FG003|Open-label Period|Noncompliance with Study Drug|0
2281691|NCT02371980|3966898|FG004|Open-label Period|Noncompliance with Study Drug|0
2281692|NCT02371980|3966894|FG000|Open-label Period|Lost to Follow-up|55
2281693|NCT02371980|3966895|FG001|Open-label Period|Lost to Follow-up|0
2281694|NCT02371980|3966896|FG002|Open-label Period|Lost to Follow-up|0
2281695|NCT02371980|3966897|FG003|Open-label Period|Lost to Follow-up|0
2281696|NCT02371980|3966898|FG004|Open-label Period|Lost to Follow-up|0
2281697|NCT02371980|3966894|FG000|Open-label Period|Voluntary Withdrawal|91
2281698|NCT02371980|3966895|FG001|Open-label Period|Voluntary Withdrawal|0
2281699|NCT02371980|3966896|FG002|Open-label Period|Voluntary Withdrawal|0
2281700|NCT02371980|3966897|FG003|Open-label Period|Voluntary Withdrawal|0
2281701|NCT02371980|3966898|FG004|Open-label Period|Voluntary Withdrawal|0
2281702|NCT02371980|3966894|FG000|Open-label Period|Pregnancy|1
2281703|NCT02371980|3966895|FG001|Open-label Period|Pregnancy|0
2281704|NCT02371980|3966896|FG002|Open-label Period|Pregnancy|0
2281705|NCT02371980|3966897|FG003|Open-label Period|Pregnancy|0
2281706|NCT02371980|3966898|FG004|Open-label Period|Pregnancy|0
2281707|NCT02371980|3966894|FG000|Open-label Period|Lack of Efficacy|116
2281708|NCT02371980|3966895|FG001|Open-label Period|Lack of Efficacy|0
2281709|NCT02371980|3966896|FG002|Open-label Period|Lack of Efficacy|0
2281710|NCT02371980|3966897|FG003|Open-label Period|Lack of Efficacy|0
2281711|NCT02371980|3966898|FG004|Open-label Period|Lack of Efficacy|0
2281712|NCT02371980|3966894|FG000|Open-label Period|Did not Meet Randomization Criteria|162
2281713|NCT02371980|3966895|FG001|Open-label Period|Did not Meet Randomization Criteria|0
2281714|NCT02371980|3966896|FG002|Open-label Period|Did not Meet Randomization Criteria|0
2281715|NCT02371980|3966897|FG003|Open-label Period|Did not Meet Randomization Criteria|0
2281716|NCT02371980|3966898|FG004|Open-label Period|Did not Meet Randomization Criteria|0
2281717|NCT02371980|3966894|FG000|Open-label Period|Reason not Specified|9
2281718|NCT02371980|3966895|FG001|Open-label Period|Reason not Specified|0
2281719|NCT02371980|3966896|FG002|Open-label Period|Reason not Specified|0
2281720|NCT02371980|3966897|FG003|Open-label Period|Reason not Specified|0
2281721|NCT02371980|3966898|FG004|Open-label Period|Reason not Specified|0
2281722|NCT02371980|3966894|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0
2281723|NCT02371980|3966895|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4
2281724|NCT02371980|3966896|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3
2281725|NCT02371980|3966897|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2
2281726|NCT02371980|3966898|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9
2281727|NCT02371980|3966894|FG000|Double-blind Period|Significant Protocol Deviation|0
2281728|NCT02371980|3966895|FG001|Double-blind Period|Significant Protocol Deviation|2
2281729|NCT02371980|3966896|FG002|Double-blind Period|Significant Protocol Deviation|7
2281730|NCT02371980|3966897|FG003|Double-blind Period|Significant Protocol Deviation|3
2281731|NCT02371980|3966898|FG004|Double-blind Period|Significant Protocol Deviation|3
2281732|NCT02371980|3966894|FG000|Double-blind Period|Noncompliance with Study Drug|0
2281733|NCT02371980|3966895|FG001|Double-blind Period|Noncompliance with Study Drug|1
2281734|NCT02371980|3966896|FG002|Double-blind Period|Noncompliance with Study Drug|2
2281735|NCT02371980|3966897|FG003|Double-blind Period|Noncompliance with Study Drug|2
2281736|NCT02371980|3966898|FG004|Double-blind Period|Noncompliance with Study Drug|3
2281737|NCT02371980|3966894|FG000|Double-blind Period|Lost to Follow-up|0
2281738|NCT02371980|3966895|FG001|Double-blind Period|Lost to Follow-up|8
2126788|NCT01005901|3728281|FG000|Overall Study|Patient's inability to use the device|1
2126789|NCT01005901|3728282|FG001|Overall Study|Patient's inability to use the device|1
2126790|NCT01005901|3728281|FG000|Overall Study|No longer requires study drug|0
2126791|NCT01005901|3728282|FG001|Overall Study|No longer requires study drug|1
2126792|NCT01005966|3728288|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
2126793|NCT01005966|3728289|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
2126794|NCT01005966|3728290|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
2126795|NCT01005966|3728291|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
2126796|NCT01005966|3728292|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
2126797|NCT01005966|3728288|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
2126798|NCT01005966|3728289|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0
2126799|NCT01005966|3728290|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1
2126800|NCT01005966|3728291|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0
2126801|NCT01005966|3728292|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0
2180156|NCT01399190|3806115|FG000|Overall Study|Participant's Request|5
2281739|NCT02371980|3966896|FG002|Double-blind Period|Lost to Follow-up|8
2281740|NCT02371980|3966897|FG003|Double-blind Period|Lost to Follow-up|6
2281741|NCT02371980|3966898|FG004|Double-blind Period|Lost to Follow-up|5
2281742|NCT02371980|3966894|FG000|Double-blind Period|Voluntary Withdrawal|0
2281743|NCT02371980|3966895|FG001|Double-blind Period|Voluntary Withdrawal|12
2281744|NCT02371980|3966896|FG002|Double-blind Period|Voluntary Withdrawal|8
2281745|NCT02371980|3966897|FG003|Double-blind Period|Voluntary Withdrawal|9
2281746|NCT02371980|3966898|FG004|Double-blind Period|Voluntary Withdrawal|11
2281747|NCT02371980|3966894|FG000|Double-blind Period|Relapse|0
2281748|NCT02371980|3966895|FG001|Double-blind Period|Relapse|50
2281749|NCT02371980|3966896|FG002|Double-blind Period|Relapse|25
2281750|NCT02371980|3966897|FG003|Double-blind Period|Relapse|25
2281751|NCT02371980|3966898|FG004|Double-blind Period|Relapse|26
2281752|NCT02371980|3966894|FG000|Double-blind Period|Reason not Specified|0
2281753|NCT02371980|3966895|FG001|Double-blind Period|Reason not Specified|3
2281754|NCT02371980|3966896|FG002|Double-blind Period|Reason not Specified|3
2281755|NCT02371980|3966897|FG003|Double-blind Period|Reason not Specified|2
2281756|NCT02371980|3966898|FG004|Double-blind Period|Reason not Specified|1
2281757|NCT02371980|3966894|FG000|Double-blind Period|Missing|0
2281758|NCT02371980|3966895|FG001|Double-blind Period|Missing|1
2281759|NCT02371980|3966896|FG002|Double-blind Period|Missing|0
2281760|NCT02371980|3966897|FG003|Double-blind Period|Missing|0
2281761|NCT02371980|3966898|FG004|Double-blind Period|Missing|0
2281762|NCT02372006|3966912|FG000|Overall Study|Progressive disease|8
2281763|NCT02372006|3966913|FG001|Overall Study|Progressive disease|7
2281764|NCT02372006|3966914|FG002|Overall Study|Progressive disease|34
2281765|NCT02372006|3966912|FG000|Overall Study|Dose limiting toxicity|0
2281766|NCT02372006|3966913|FG001|Overall Study|Dose limiting toxicity|1
2281767|NCT02372006|3966914|FG002|Overall Study|Dose limiting toxicity|0
2281768|NCT02372006|3966912|FG000|Overall Study|Adverse Event|0
2281769|NCT02372006|3966913|FG001|Overall Study|Adverse Event|0
2281770|NCT02372006|3966914|FG002|Overall Study|Adverse Event|3
2281771|NCT02372006|3966912|FG000|Overall Study|Withdrawal by Subject|0
2281772|NCT02372006|3966913|FG001|Overall Study|Withdrawal by Subject|1
2281773|NCT02372006|3966914|FG002|Overall Study|Withdrawal by Subject|1
2281774|NCT02372006|3966912|FG000|Overall Study|Other reason for not completing|0
2281775|NCT02372006|3966913|FG001|Overall Study|Other reason for not completing|0
2281776|NCT02372006|3966914|FG002|Overall Study|Other reason for not completing|1
2281777|NCT02372058|3966923|FG000|Overall Study|Withdrawal by Subject|3
2281778|NCT02372071|3966929|FG000|Overall Study|Protocol Violation|18
2281779|NCT02372136|3966945|FG000|Overall Study|Death|3
2281780|NCT02372136|3966946|FG001|Overall Study|Death|1
2281781|NCT02372253|3966956|FG000|Overall Study|Non Compliance|2
2281782|NCT02372253|3966957|FG001|Overall Study|Non Compliance|0
2281783|NCT02372383|3966977|FG000|First Intervention (1 Day)|Unable to collect blood|0
2281784|NCT02372383|3966978|FG001|First Intervention (1 Day)|Unable to collect blood|1
2281785|NCT02372383|3966979|FG002|First Intervention (1 Day)|Unable to collect blood|0
2281786|NCT02372396|3966991|FG000|Overall Study|Lost to Follow-up|7
2281787|NCT02372396|3966992|FG001|Overall Study|Lost to Follow-up|9
2281788|NCT02372799|3967017|FG000|Treatment Period|Adverse Event|3
2281789|NCT02372799|3967018|FG001|Treatment Period|Adverse Event|10
2281790|NCT02372799|3967019|FG002|Treatment Period|Adverse Event|6
2281791|NCT02372799|3967017|FG000|Treatment Period|Insufficient therapeutic response|2
2281792|NCT02372799|3967018|FG001|Treatment Period|Insufficient therapeutic response|2
2281793|NCT02372799|3967019|FG002|Treatment Period|Insufficient therapeutic response|0
2281794|NCT02372799|3967017|FG000|Treatment Period|Withdrawal by Subject|10
2281795|NCT02372799|3967018|FG001|Treatment Period|Withdrawal by Subject|10
2281796|NCT02372799|3967019|FG002|Treatment Period|Withdrawal by Subject|2
2281797|NCT02372799|3967017|FG000|Treatment Period|Lost to Follow-up|11
2281798|NCT02372799|3967018|FG001|Treatment Period|Lost to Follow-up|5
2281799|NCT02372799|3967019|FG002|Treatment Period|Lost to Follow-up|3
2281800|NCT02372799|3967017|FG000|Treatment Period|Protocol Violation|3
2281801|NCT02372799|3967018|FG001|Treatment Period|Protocol Violation|0
2281802|NCT02372799|3967019|FG002|Treatment Period|Protocol Violation|0
2281803|NCT02372799|3967017|FG000|Treatment Period|Non-compliance with study drug|4
2281804|NCT02372799|3967018|FG001|Treatment Period|Non-compliance with study drug|4
2126802|NCT01005966|3728288|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2126803|NCT01005966|3728289|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2126804|NCT01005966|3728290|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2126805|NCT01005966|3728291|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1
2126806|NCT01005966|3728292|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2126807|NCT01005966|3728288|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
2126808|NCT01005966|3728289|FG001|Treatment Period 2 (14 Days)|Adverse Event|1
2126809|NCT01005966|3728290|FG002|Treatment Period 2 (14 Days)|Adverse Event|1
2126810|NCT01005966|3728291|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
2126811|NCT01005966|3728292|FG004|Treatment Period 2 (14 Days)|Adverse Event|0
2126812|NCT01005966|3728288|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
2126813|NCT01005966|3728289|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
2126814|NCT01005966|3728290|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
2126815|NCT01005966|3728291|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
2126816|NCT01005966|3728292|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
2126817|NCT01005966|3728288|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2126818|NCT01005966|3728289|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2126819|NCT01005966|3728290|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2126820|NCT01005966|3728291|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2126821|NCT01005966|3728292|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2126822|NCT01005966|3728288|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0
2126823|NCT01005966|3728289|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1
2126824|NCT01005966|3728290|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0
2126825|NCT01005966|3728291|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0
2205643|NCT01610791|3843539|FG000|Overall Study|Adverse event and Investigator decision|1
2205644|NCT01610791|3843539|FG000|Overall Study|Death|1
2126826|NCT01005966|3728292|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1
2126827|NCT01005966|3728288|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0
2126828|NCT01005966|3728289|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1
2126829|NCT01005966|3728290|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0
2126830|NCT01005966|3728291|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0
2126831|NCT01005966|3728292|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0
2126832|NCT01005966|3728288|FG000|Treatment Period 4 (14 Days)|Other Reason|0
2126833|NCT01005966|3728289|FG001|Treatment Period 4 (14 Days)|Other Reason|0
2126834|NCT01005966|3728290|FG002|Treatment Period 4 (14 Days)|Other Reason|0
2126835|NCT01005966|3728291|FG003|Treatment Period 4 (14 Days)|Other Reason|0
2126836|NCT01005966|3728292|FG004|Treatment Period 4 (14 Days)|Other Reason|1
2126837|NCT01006122|3728309|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
2126838|NCT01006122|3728310|FG001|First Double-blind Intervention Period|Lost to Follow-up|2
2126839|NCT01006122|3728309|FG000|First Double-blind Intervention Period|Protocol Violation|1
2126840|NCT01006122|3728310|FG001|First Double-blind Intervention Period|Protocol Violation|1
2126841|NCT01006122|3728309|FG000|First Double-blind Intervention Period|Pregnancy|0
2126842|NCT01006122|3728310|FG001|First Double-blind Intervention Period|Pregnancy|1
2126843|NCT01006122|3728309|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9
2126844|NCT01006122|3728310|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8
2126845|NCT01006122|3728309|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1
2126846|NCT01006122|3728310|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0
2126847|NCT01006122|3728309|FG000|First Double-blind Intervention Period|Lack of Efficacy|2
2126848|NCT01006122|3728310|FG001|First Double-blind Intervention Period|Lack of Efficacy|1
2126849|NCT01006122|3728309|FG000|First Double-blind Intervention Period|Other|3
2126850|NCT01006122|3728310|FG001|First Double-blind Intervention Period|Other|0
2126851|NCT01006122|3728309|FG000|First Double-blind Intervention Period|Adverse Event|0
2126852|NCT01006122|3728310|FG001|First Double-blind Intervention Period|Adverse Event|4
2126853|NCT01006122|3728309|FG000|Second Double-blind Intervention Period|Adverse Event|1
2126854|NCT01006122|3728310|FG001|Second Double-blind Intervention Period|Adverse Event|1
2126855|NCT01006122|3728309|FG000|Second Double-blind Intervention Period|Protocol Violation|1
2126856|NCT01006122|3728310|FG001|Second Double-blind Intervention Period|Protocol Violation|0
2126857|NCT01006122|3728309|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
2126858|NCT01006122|3728310|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3
2126859|NCT01006122|3728309|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
2126860|NCT01006122|3728310|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2
2126861|NCT01006122|3728309|FG000|Second Double-blind Intervention Period|Death|0
2126862|NCT01006122|3728310|FG001|Second Double-blind Intervention Period|Death|1
2126863|NCT01006135|3728316|FG000|Overall Study|Adverse Event|22
2126864|NCT01006135|3728316|FG000|Overall Study|Protocol Violation|14
2126865|NCT01006135|3728316|FG000|Overall Study|Lost to Follow-up|32
2126866|NCT01006135|3728316|FG000|Overall Study|Other|72
2126867|NCT01006291|3728336|FG000|Overall Study|Adverse Event|2
2126868|NCT01006291|3728337|FG001|Overall Study|Adverse Event|1
2126869|NCT01006291|3728338|FG002|Overall Study|Adverse Event|2
2126870|NCT01006291|3728336|FG000|Overall Study|Lack of Efficacy|2
2126871|NCT01006291|3728337|FG001|Overall Study|Lack of Efficacy|2
2126872|NCT01006291|3728338|FG002|Overall Study|Lack of Efficacy|1
2126873|NCT01006291|3728336|FG000|Overall Study|Protocol Violation|3
2205645|NCT01610791|3843539|FG000|Overall Study|Not determined|5
2205646|NCT01611090|3843545|FG000|Randomized Period|Lost to Follow-up|8
2205647|NCT01611090|3843546|FG001|Randomized Period|Lost to Follow-up|3
2205648|NCT01611090|3843547|FG002|Randomized Period|Lost to Follow-up|0
2205649|NCT01611090|3843545|FG000|Randomized Period|Withdrawal by Subject|22
2205650|NCT01611090|3843546|FG001|Randomized Period|Withdrawal by Subject|26
2126874|NCT01006291|3728337|FG001|Overall Study|Protocol Violation|3
2126875|NCT01006291|3728338|FG002|Overall Study|Protocol Violation|3
2126876|NCT01006291|3728336|FG000|Overall Study|Withdrawal criteria|5
2126877|NCT01006291|3728337|FG001|Overall Study|Withdrawal criteria|4
2126878|NCT01006291|3728338|FG002|Overall Study|Withdrawal criteria|4
2126879|NCT01006291|3728336|FG000|Overall Study|Other|14
2126880|NCT01006291|3728337|FG001|Overall Study|Other|14
2126881|NCT01006291|3728338|FG002|Overall Study|Other|17
2126882|NCT01006356|3728346|FG000|Overall Study|Adverse Event|6
2126883|NCT01006356|3728346|FG000|Overall Study|Physician Decision|1
2126884|NCT01006356|3728346|FG000|Overall Study|Paticipants did not cooperate|6
2126885|NCT01006356|3728346|FG000|Overall Study|Withdrawal by Subject|1
2126886|NCT01006356|3728346|FG000|Overall Study|Choice by participants|2
2126887|NCT01006356|3728346|FG000|Overall Study|Protocol Violation|3
2126888|NCT01006356|3728346|FG000|Overall Study|Other|23
2126889|NCT01006590|3728369|FG000|Overall Study|Adverse Event|2
2126890|NCT01006590|3728370|FG001|Overall Study|Adverse Event|3
2126891|NCT01006590|3728369|FG000|Overall Study|Death|1
2126892|NCT01006590|3728370|FG001|Overall Study|Death|1
2126893|NCT01006590|3728369|FG000|Overall Study|Lost to Follow-up|1
2205651|NCT01611090|3843547|FG002|Randomized Period|Withdrawal by Subject|0
2205652|NCT01611090|3843545|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
2281805|NCT02372799|3967019|FG002|Treatment Period|Non-compliance with study drug|4
2281806|NCT02372799|3967017|FG000|Treatment Period|Miscellaneous Reasons|1
2281807|NCT02372799|3967018|FG001|Treatment Period|Miscellaneous Reasons|1
2281808|NCT02372799|3967019|FG002|Treatment Period|Miscellaneous Reasons|0
2281809|NCT02372799|3967017|FG000|Down-taper Period|Lost to Follow-up|1
2281810|NCT02372799|3967018|FG001|Down-taper Period|Lost to Follow-up|2
2281811|NCT02372799|3967019|FG002|Down-taper Period|Lost to Follow-up|2
2281812|NCT02373098|3967029|FG000|Overall Study|Lost to Follow-up|1
2281813|NCT02373098|3967030|FG001|Overall Study|Lost to Follow-up|0
2281814|NCT02373098|3967029|FG000|Overall Study|Protocol Violation|3
2281815|NCT02373098|3967030|FG001|Overall Study|Protocol Violation|0
2281816|NCT02373098|3967029|FG000|Overall Study|Withdrawal by Subject|5
2281817|NCT02373098|3967030|FG001|Overall Study|Withdrawal by Subject|0
2281818|NCT02373098|3967029|FG000|Overall Study|Adverse Event|3
2281819|NCT02373098|3967030|FG001|Overall Study|Adverse Event|0
2281820|NCT02373202|3967060|FG000|Overall Study|Adverse Event|2
2281821|NCT02373202|3967061|FG001|Overall Study|Adverse Event|5
2281822|NCT02373202|3967062|FG002|Overall Study|Adverse Event|2
2281823|NCT02373202|3967063|FG003|Overall Study|Adverse Event|1
2281824|NCT02373202|3967060|FG000|Overall Study|Lack of Efficacy|0
2281825|NCT02373202|3967061|FG001|Overall Study|Lack of Efficacy|0
2281826|NCT02373202|3967062|FG002|Overall Study|Lack of Efficacy|1
2281827|NCT02373202|3967063|FG003|Overall Study|Lack of Efficacy|0
2281828|NCT02373202|3967060|FG000|Overall Study|Other|0
2281829|NCT02373202|3967061|FG001|Overall Study|Other|1
2281830|NCT02373202|3967062|FG002|Overall Study|Other|0
2281831|NCT02373202|3967063|FG003|Overall Study|Other|0
2281832|NCT02373813|3967085|FG000|Run-In Period|Other, Not Specified|5
2281833|NCT02373813|3967086|FG001|Run-In Period|Other, Not Specified|0
2281834|NCT02373813|3967087|FG002|Run-In Period|Other, Not Specified|0
2281835|NCT02373813|3967088|FG003|Run-In Period|Other, Not Specified|0
2281836|NCT02373813|3967085|FG000|Run-In Period|Withdrawal by Subject|16
2281837|NCT02373813|3967086|FG001|Run-In Period|Withdrawal by Subject|0
2281838|NCT02373813|3967087|FG002|Run-In Period|Withdrawal by Subject|0
2281839|NCT02373813|3967088|FG003|Run-In Period|Withdrawal by Subject|0
2281840|NCT02373813|3967085|FG000|Run-In Period|Decision by Sponsor|11
2281841|NCT02373813|3967086|FG001|Run-In Period|Decision by Sponsor|0
2281842|NCT02373813|3967087|FG002|Run-In Period|Decision by Sponsor|0
2281843|NCT02373813|3967088|FG003|Run-In Period|Decision by Sponsor|0
2281844|NCT02373813|3967085|FG000|Run-In Period|Protocol Violation|75
2281845|NCT02373813|3967086|FG001|Run-In Period|Protocol Violation|0
2281846|NCT02373813|3967087|FG002|Run-In Period|Protocol Violation|0
2281847|NCT02373813|3967088|FG003|Run-In Period|Protocol Violation|0
2126894|NCT01006590|3728370|FG001|Overall Study|Lost to Follow-up|1
2126895|NCT01006590|3728369|FG000|Overall Study|Protocol Violation|1
2126896|NCT01006590|3728370|FG001|Overall Study|Protocol Violation|0
2205653|NCT01611090|3843546|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
2281848|NCT02373813|3967085|FG000|Run-In Period|Lost to Follow-up|2
2281849|NCT02373813|3967086|FG001|Run-In Period|Lost to Follow-up|0
2281850|NCT02373813|3967087|FG002|Run-In Period|Lost to Follow-up|0
2281851|NCT02373813|3967088|FG003|Run-In Period|Lost to Follow-up|0
2281852|NCT02373813|3967085|FG000|Run-In Period|Adverse Event|3
2281853|NCT02373813|3967086|FG001|Run-In Period|Adverse Event|0
2281854|NCT02373813|3967087|FG002|Run-In Period|Adverse Event|0
2281855|NCT02373813|3967088|FG003|Run-In Period|Adverse Event|0
2281856|NCT02373813|3967085|FG000|Run-In Period|Noncompliance|1
2281857|NCT02373813|3967086|FG001|Run-In Period|Noncompliance|0
2281858|NCT02373813|3967087|FG002|Run-In Period|Noncompliance|0
2281859|NCT02373813|3967088|FG003|Run-In Period|Noncompliance|0
2126897|NCT01006590|3728369|FG000|Overall Study|Withdrawal by Subject|4
2126898|NCT01006590|3728370|FG001|Overall Study|Withdrawal by Subject|2
2126899|NCT01006590|3728369|FG000|Overall Study|Study specific discontinuation criteria|16
2126900|NCT01006590|3728370|FG001|Overall Study|Study specific discontinuation criteria|23
2126901|NCT01006590|3728369|FG000|Overall Study|Other|3
2126902|NCT01006590|3728370|FG001|Overall Study|Other|2
2126903|NCT01006603|3728378|FG000|Overall Study|Withdrawal by Subject|17
2126904|NCT01006603|3728379|FG001|Overall Study|Withdrawal by Subject|19
2126905|NCT01006603|3728378|FG000|Overall Study|Lost to Follow-up|0
2126906|NCT01006603|3728379|FG001|Overall Study|Lost to Follow-up|1
2126907|NCT01006603|3728378|FG000|Overall Study|Safety reason|1
2126908|NCT01006603|3728379|FG001|Overall Study|Safety reason|1
2126909|NCT01006603|3728378|FG000|Overall Study|Protocol Violation|1
2126910|NCT01006603|3728379|FG001|Overall Study|Protocol Violation|3
2126911|NCT01006603|3728378|FG000|Overall Study|Incorrect enrolment|0
2281860|NCT02373813|3967085|FG000|Run-In Period|Ineligibility Determined|3
2281861|NCT02373813|3967086|FG001|Run-In Period|Ineligibility Determined|0
2281862|NCT02373813|3967087|FG002|Run-In Period|Ineligibility Determined|0
2281863|NCT02373813|3967088|FG003|Run-In Period|Ineligibility Determined|0
2281864|NCT02373813|3967085|FG000|Double-Blind Treatment Period|Decision by Sponsor|0
2281865|NCT02373813|3967086|FG001|Double-Blind Treatment Period|Decision by Sponsor|1
2281866|NCT02373813|3967087|FG002|Double-Blind Treatment Period|Decision by Sponsor|2
2281867|NCT02373813|3967088|FG003|Double-Blind Treatment Period|Decision by Sponsor|0
2281868|NCT02373813|3967085|FG000|Double-Blind Treatment Period|Protocol Violation|0
2281869|NCT02373813|3967086|FG001|Double-Blind Treatment Period|Protocol Violation|2
2281870|NCT02373813|3967087|FG002|Double-Blind Treatment Period|Protocol Violation|0
2281871|NCT02373813|3967088|FG003|Double-Blind Treatment Period|Protocol Violation|0
2281872|NCT02373813|3967085|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
2281873|NCT02373813|3967086|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
2281874|NCT02373813|3967087|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
2281875|NCT02373813|3967088|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
2281876|NCT02373813|3967085|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
2281877|NCT02373813|3967086|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10
2281878|NCT02373813|3967087|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6
2281879|NCT02373813|3967088|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3
2281880|NCT02374099|3967118|FG000|Overall Study|Adverse Event|1
2281881|NCT02374099|3967119|FG001|Overall Study|Adverse Event|0
2281882|NCT02374099|3967118|FG000|Overall Study|Progressive Disease|35
2281883|NCT02374099|3967119|FG001|Overall Study|Progressive Disease|40
2281884|NCT02374099|3967118|FG000|Overall Study|Withdrawal by Subject|5
2281885|NCT02374099|3967119|FG001|Overall Study|Withdrawal by Subject|1
2281886|NCT02374099|3967118|FG000|Overall Study|Miscellaneous|2
2281887|NCT02374099|3967119|FG001|Overall Study|Miscellaneous|3
2281888|NCT02374099|3967118|FG000|Overall Study|Randomized, but not treated|2
2281889|NCT02374099|3967119|FG001|Overall Study|Randomized, but not treated|1
2281890|NCT02374099|3967118|FG000|Overall Study|Study Terminated by Sponsor|3
2281891|NCT02374099|3967119|FG001|Overall Study|Study Terminated by Sponsor|4
2281892|NCT02374255|3967152|FG000|Overall Study|Withdrawal by Subject|2
2281893|NCT02374255|3967153|FG001|Overall Study|Withdrawal by Subject|0
2281894|NCT02374255|3967154|FG002|Overall Study|Withdrawal by Subject|0
2281895|NCT02374255|3967155|FG003|Overall Study|Withdrawal by Subject|0
2281896|NCT02374307|3967173|FG000|3-months Follow-up|Lost to Follow-up|1
2281897|NCT02374307|3967174|FG001|3-months Follow-up|Lost to Follow-up|2
2281898|NCT02374307|3967173|FG000|3-months Follow-up|Withdrawal by Subject|1
2281899|NCT02374307|3967174|FG001|3-months Follow-up|Withdrawal by Subject|4
2281900|NCT02374307|3967173|FG000|3-months Follow-up|Death|1
2281901|NCT02374307|3967174|FG001|3-months Follow-up|Death|2
2281902|NCT02374307|3967173|FG000|3-months Follow-up|Missed first follow-up|5
2281903|NCT02374307|3967174|FG001|3-months Follow-up|Missed first follow-up|1
2281904|NCT02374307|3967173|FG000|6-months Follow-up|Lost to Follow-up|1
2281905|NCT02374307|3967174|FG001|6-months Follow-up|Lost to Follow-up|2
2281906|NCT02374307|3967173|FG000|6-months Follow-up|Death|2
2281907|NCT02374307|3967174|FG001|6-months Follow-up|Death|1
2281908|NCT02374307|3967173|FG000|6-months Follow-up|Withdrawal by Subject|0
2281909|NCT02374307|3967174|FG001|6-months Follow-up|Withdrawal by Subject|3
2281910|NCT02374346|3967180|FG000|Overall Study|operated or discharged during weekend|48
2281911|NCT02374463|3967206|FG000|Overall Study|Withdrawal by Subject|3
2281912|NCT02374463|3967207|FG001|Overall Study|Withdrawal by Subject|3
2281913|NCT02374593|3967216|FG000|Overall Study|non-compliant|2
2281914|NCT02374593|3967217|FG001|Overall Study|non-compliant|0
2126912|NCT01006603|3728379|FG001|Overall Study|Incorrect enrolment|2
2126913|NCT01006603|3728378|FG000|Overall Study|Adverse Event|15
2281915|NCT02374671|3967230|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0
2281916|NCT02374671|3967231|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0
2281917|NCT02374671|3967232|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4
2281918|NCT02374671|3967230|FG000|Observation (Deferred Implantation)|Adverse Event|0
2281919|NCT02374671|3967231|FG001|Observation (Deferred Implantation)|Adverse Event|0
2281920|NCT02374671|3967232|FG002|Observation (Deferred Implantation)|Adverse Event|1
2281921|NCT02374671|3967230|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
2281922|NCT02374671|3967231|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
2126914|NCT01006603|3728379|FG001|Overall Study|Adverse Event|7
2126915|NCT01006603|3728378|FG000|Overall Study|Death|1
2126916|NCT01006603|3728379|FG001|Overall Study|Death|1
2281923|NCT02374671|3967232|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
2281924|NCT02374671|3967230|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7
2281925|NCT02374671|3967231|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0
2281926|NCT02374671|3967232|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1
2281927|NCT02374671|3967230|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
2281928|NCT02374671|3967231|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
2281929|NCT02374671|3967232|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
2281930|NCT02374918|3967242|FG000|Overall Study|Protocol Violation|2
2281931|NCT02374918|3967243|FG001|Overall Study|Protocol Violation|0
2281932|NCT02374918|3967244|FG002|Overall Study|Protocol Violation|2
2281933|NCT02374918|3967245|FG003|Overall Study|Protocol Violation|1
2281934|NCT02374918|3967242|FG000|Overall Study|Withdrawal by Subject|1
2281935|NCT02374918|3967243|FG001|Overall Study|Withdrawal by Subject|1
2281936|NCT02374918|3967244|FG002|Overall Study|Withdrawal by Subject|1
2281937|NCT02374918|3967245|FG003|Overall Study|Withdrawal by Subject|0
2281938|NCT02374918|3967242|FG000|Overall Study|Lack of Efficacy|0
2281939|NCT02374918|3967243|FG001|Overall Study|Lack of Efficacy|0
2281940|NCT02374918|3967244|FG002|Overall Study|Lack of Efficacy|1
2281941|NCT02374918|3967245|FG003|Overall Study|Lack of Efficacy|1
2281942|NCT02374957|3967255|FG000|Overall Study|Patient did not complete forms correctly|1
2281943|NCT02374957|3967256|FG001|Overall Study|Patient did not complete forms correctly|0
2281944|NCT02375347|3967262|FG000|Overall Study|Protocol Violation|1
2281945|NCT02375373|3967266|FG000|Overall Study|Withdrawal by Subject|11
2281946|NCT02375698|3967272|FG000|Overall Study|Withdrawal by Subject|0
2281947|NCT02375698|3967273|FG001|Overall Study|Withdrawal by Subject|2
2281948|NCT02375698|3967272|FG000|Overall Study|Physician Decision|2
2281949|NCT02375698|3967273|FG001|Overall Study|Physician Decision|0
2281950|NCT02375724|3967281|FG000|Overall Study|Lack of Efficacy|1
2281951|NCT02375724|3967282|FG001|Overall Study|Lack of Efficacy|1
2281952|NCT02375724|3967281|FG000|Overall Study|Withdrawal by Subject|1
2281953|NCT02375724|3967282|FG001|Overall Study|Withdrawal by Subject|1
2281954|NCT02375724|3967281|FG000|Overall Study|Lost to Follow-up|1
2281955|NCT02375724|3967282|FG001|Overall Study|Lost to Follow-up|0
2281956|NCT02375724|3967281|FG000|Overall Study|Protocol Violation|1
2281957|NCT02375724|3967282|FG001|Overall Study|Protocol Violation|0
2281958|NCT02375724|3967281|FG000|Overall Study|Adverse Event|2
2281959|NCT02375724|3967282|FG001|Overall Study|Adverse Event|4
2281960|NCT02375971|3967291|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
2281961|NCT02375971|3967292|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
2281962|NCT02375971|3967293|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
2281963|NCT02375971|3967291|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1
2281964|NCT02375971|3967292|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1
2281965|NCT02375971|3967293|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1
2281966|NCT02375971|3967291|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
2281967|NCT02375971|3967292|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
2281968|NCT02375971|3967293|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
2281969|NCT02375971|3967291|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0
2281970|NCT02375971|3967292|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0
2281971|NCT02375971|3967293|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1
2281972|NCT02375971|3967291|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1
2281973|NCT02375971|3967292|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0
2281974|NCT02375971|3967293|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0
2281975|NCT02375971|3967291|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
2281976|NCT02375971|3967292|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
2281977|NCT02375971|3967293|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
2281978|NCT02375971|3967291|FG000|Follow-Up Phase (up to Day 169)|Death|4
2281979|NCT02375971|3967292|FG001|Follow-Up Phase (up to Day 169)|Death|4
2281980|NCT02375971|3967293|FG002|Follow-Up Phase (up to Day 169)|Death|4
2281981|NCT02375971|3967291|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
2281982|NCT02375971|3967292|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
2281983|NCT02375971|3967293|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
2281984|NCT02376166|3967314|FG000|Overall Study|Adverse Event|1
2281985|NCT02376166|3967314|FG000|Overall Study|Discontinued metformin early|2
2281986|NCT02376790|3967378|FG000|Overall Study|Withdrawal by Subject|43
2281987|NCT02376790|3967379|FG001|Overall Study|Withdrawal by Subject|36
2126917|NCT01006603|3728378|FG000|Overall Study|Study specific discontinuation criteria|33
2281988|NCT02376790|3967380|FG002|Overall Study|Withdrawal by Subject|37
2281989|NCT02376790|3967378|FG000|Overall Study|Decision by Sponsor|2
2281990|NCT02376790|3967379|FG001|Overall Study|Decision by Sponsor|1
2281991|NCT02376790|3967380|FG002|Overall Study|Decision by Sponsor|4
2281992|NCT02376790|3967378|FG000|Overall Study|Lost to Follow-up|15
2281993|NCT02376790|3967379|FG001|Overall Study|Lost to Follow-up|10
2281994|NCT02376790|3967380|FG002|Overall Study|Lost to Follow-up|12
2281995|NCT02377063|3967392|FG000|Overall Study|Non-compliance|5
2281996|NCT02377349|3967398|FG000|Overall Study|Serious Adverse Event|1
2281997|NCT02377349|3967399|FG001|Overall Study|Serious Adverse Event|0
2126918|NCT01006603|3728379|FG001|Overall Study|Study specific discontinuation criteria|34
2126919|NCT01006603|3728378|FG000|Overall Study|Other|3
2126920|NCT01006603|3728379|FG001|Overall Study|Other|7
2126921|NCT01006616|3728389|FG000|Period 1 (6 Months)|Adverse Event|10
2281998|NCT02377349|3967398|FG000|Overall Study|Protocol Violation|3
2281999|NCT02377349|3967399|FG001|Overall Study|Protocol Violation|2
2282000|NCT02377349|3967398|FG000|Overall Study|Withdrawal by Subject|5
2282001|NCT02377349|3967399|FG001|Overall Study|Withdrawal by Subject|3
2282002|NCT02377349|3967398|FG000|Overall Study|Lost to follow-up (partial vaccination)|1
2282003|NCT02377349|3967399|FG001|Overall Study|Lost to follow-up (partial vaccination)|0
2282004|NCT02377349|3967398|FG000|Overall Study|Lost to follow-up (complete vaccination)|6
2282005|NCT02377349|3967399|FG001|Overall Study|Lost to follow-up (complete vaccination)|5
2282006|NCT02377349|3967398|FG000|Overall Study|Other|0
2282007|NCT02377349|3967399|FG001|Overall Study|Other|1
2282008|NCT02377362|3967427|FG000|Part A Second Treatment|Protocol Violation|0
2282009|NCT02377362|3967428|FG001|Part A Second Treatment|Protocol Violation|0
2282010|NCT02377362|3967429|FG002|Part A Second Treatment|Protocol Violation|0
2282011|NCT02377362|3967430|FG003|Part A Second Treatment|Protocol Violation|0
2282012|NCT02377362|3967431|FG004|Part A Second Treatment|Protocol Violation|1
2282013|NCT02377362|3967432|FG005|Part A Second Treatment|Protocol Violation|0
2282014|NCT02377362|3967433|FG006|Part A Second Treatment|Protocol Violation|0
2282015|NCT02377362|3967434|FG007|Part A Second Treatment|Protocol Violation|0
2282016|NCT02377362|3967435|FG008|Part A Second Treatment|Protocol Violation|0
2282017|NCT02377362|3967436|FG009|Part A Second Treatment|Protocol Violation|0
2282018|NCT02377362|3967437|FG010|Part A Second Treatment|Protocol Violation|0
2282019|NCT02377362|3967438|FG011|Part A Second Treatment|Protocol Violation|0
2282020|NCT02377362|3967439|FG012|Part A Second Treatment|Protocol Violation|0
2282021|NCT02377362|3967427|FG000|Part A Third Treatment|Highest dose level 1200 not used|0
2282022|NCT02377362|3967428|FG001|Part A Third Treatment|Highest dose level 1200 not used|0
2282023|NCT02377362|3967429|FG002|Part A Third Treatment|Highest dose level 1200 not used|0
2282024|NCT02377362|3967430|FG003|Part A Third Treatment|Highest dose level 1200 not used|4
2282025|NCT02377362|3967431|FG004|Part A Third Treatment|Highest dose level 1200 not used|3
2282026|NCT02377362|3967432|FG005|Part A Third Treatment|Highest dose level 1200 not used|4
2282027|NCT02377362|3967433|FG006|Part A Third Treatment|Highest dose level 1200 not used|0
2282028|NCT02377362|3967434|FG007|Part A Third Treatment|Highest dose level 1200 not used|0
2282029|NCT02377362|3967435|FG008|Part A Third Treatment|Highest dose level 1200 not used|0
2282030|NCT02377362|3967436|FG009|Part A Third Treatment|Highest dose level 1200 not used|0
2282031|NCT02377362|3967437|FG010|Part A Third Treatment|Highest dose level 1200 not used|0
2282032|NCT02377362|3967438|FG011|Part A Third Treatment|Highest dose level 1200 not used|0
2282033|NCT02377362|3967439|FG012|Part A Third Treatment|Highest dose level 1200 not used|0
2282034|NCT02377362|3967427|FG000|Part B Overall|Protocol Violation|0
2282035|NCT02377362|3967428|FG001|Part B Overall|Protocol Violation|0
2282036|NCT02377362|3967429|FG002|Part B Overall|Protocol Violation|0
2282037|NCT02377362|3967430|FG003|Part B Overall|Protocol Violation|0
2282038|NCT02377362|3967431|FG004|Part B Overall|Protocol Violation|0
2282039|NCT02377362|3967432|FG005|Part B Overall|Protocol Violation|0
2282040|NCT02377362|3967433|FG006|Part B Overall|Protocol Violation|0
2282041|NCT02377362|3967434|FG007|Part B Overall|Protocol Violation|0
2282042|NCT02377362|3967435|FG008|Part B Overall|Protocol Violation|0
2282043|NCT02377362|3967436|FG009|Part B Overall|Protocol Violation|1
2282044|NCT02377362|3967437|FG010|Part B Overall|Protocol Violation|0
2282045|NCT02377362|3967438|FG011|Part B Overall|Protocol Violation|0
2282046|NCT02377362|3967439|FG012|Part B Overall|Protocol Violation|0
2282047|NCT02377362|3967427|FG000|Part B Overall|Adverse Event|0
2282048|NCT02377362|3967428|FG001|Part B Overall|Adverse Event|0
2282049|NCT02377362|3967429|FG002|Part B Overall|Adverse Event|0
2282050|NCT02377362|3967430|FG003|Part B Overall|Adverse Event|0
2282051|NCT02377362|3967431|FG004|Part B Overall|Adverse Event|0
2282052|NCT02377362|3967432|FG005|Part B Overall|Adverse Event|0
2282053|NCT02377362|3967433|FG006|Part B Overall|Adverse Event|1
2282054|NCT02377362|3967434|FG007|Part B Overall|Adverse Event|1
2282055|NCT02377362|3967435|FG008|Part B Overall|Adverse Event|0
2282056|NCT02377362|3967436|FG009|Part B Overall|Adverse Event|0
2282057|NCT02377362|3967437|FG010|Part B Overall|Adverse Event|0
2282058|NCT02377362|3967438|FG011|Part B Overall|Adverse Event|0
2282059|NCT02377362|3967439|FG012|Part B Overall|Adverse Event|0
2282060|NCT02377362|3967427|FG000|Part B Overall|Withdrawal by Subject|0
2126922|NCT01006616|3728390|FG001|Period 1 (6 Months)|Adverse Event|31
2282061|NCT02377362|3967428|FG001|Part B Overall|Withdrawal by Subject|0
2282062|NCT02377362|3967429|FG002|Part B Overall|Withdrawal by Subject|0
2282063|NCT02377362|3967430|FG003|Part B Overall|Withdrawal by Subject|0
2282064|NCT02377362|3967431|FG004|Part B Overall|Withdrawal by Subject|0
2282065|NCT02377362|3967432|FG005|Part B Overall|Withdrawal by Subject|0
2282066|NCT02377362|3967433|FG006|Part B Overall|Withdrawal by Subject|1
2282067|NCT02377362|3967434|FG007|Part B Overall|Withdrawal by Subject|0
2282068|NCT02377362|3967435|FG008|Part B Overall|Withdrawal by Subject|0
2282069|NCT02377362|3967436|FG009|Part B Overall|Withdrawal by Subject|0
2282070|NCT02377362|3967437|FG010|Part B Overall|Withdrawal by Subject|0
2282071|NCT02377362|3967438|FG011|Part B Overall|Withdrawal by Subject|1
2282072|NCT02377362|3967439|FG012|Part B Overall|Withdrawal by Subject|0
2282073|NCT02377427|3967479|FG000|Part A (Up to Week 20)|Physician Decision|1
2282074|NCT02377427|3967480|FG001|Part A (Up to Week 20)|Physician Decision|0
2282075|NCT02377427|3967481|FG002|Part A (Up to Week 20)|Physician Decision|0
2282076|NCT02377427|3967482|FG003|Part A (Up to Week 20)|Physician Decision|0
2282077|NCT02377427|3967483|FG004|Part A (Up to Week 20)|Physician Decision|0
2282078|NCT02377427|3967479|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
2282079|NCT02377427|3967480|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2282080|NCT02377427|3967481|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2282081|NCT02377427|3967482|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2282082|NCT02377427|3967483|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2282083|NCT02377427|3967479|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2
2282084|NCT02377427|3967480|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0
2282085|NCT02377427|3967481|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0
2282086|NCT02377427|3967482|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0
2282087|NCT02377427|3967483|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0
2282088|NCT02377427|3967479|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2282089|NCT02377427|3967480|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2282090|NCT02377427|3967481|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
2282091|NCT02377427|3967482|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2282092|NCT02377427|3967483|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2282093|NCT02377466|3967498|FG000|Overall Study|Other: Randomized and not treated|0
2282094|NCT02377466|3967499|FG001|Overall Study|Other: Randomized and not treated|2
2282095|NCT02377817|3967542|FG000|Overall Study|Transportation/childcare barriers.|2
2282096|NCT02377817|3967543|FG001|Overall Study|Transportation/childcare barriers.|0
2282097|NCT02377817|3967542|FG000|Overall Study|Unrelated injury prevented lateral sleep|1
2282098|NCT02377817|3967543|FG001|Overall Study|Unrelated injury prevented lateral sleep|0
2282099|NCT02377921|3967553|FG000|Overall Study|Subject non-compliance|1
2282100|NCT02377921|3967554|FG001|Overall Study|Subject non-compliance|1
2282101|NCT02378220|3967600|FG000|Overall Study|Death|6
2282102|NCT02378220|3967601|FG001|Overall Study|Death|1
2282103|NCT02378480|3967623|FG000|Overall Study|Physician Decision|1
2282104|NCT02378480|3967624|FG001|Overall Study|Physician Decision|1
2282105|NCT02378480|3967623|FG000|Overall Study|Death|1
2282106|NCT02378480|3967624|FG001|Overall Study|Death|2
2282107|NCT02378480|3967623|FG000|Overall Study|Randomized, but Not Treated|6
2282108|NCT02378480|3967624|FG001|Overall Study|Randomized, but Not Treated|4
2282109|NCT02378480|3967623|FG000|Overall Study|Adverse Event|0
2282110|NCT02378480|3967624|FG001|Overall Study|Adverse Event|1
2282111|NCT02378480|3967623|FG000|Overall Study|Missed EOT/PTE Visit|1
2282112|NCT02378480|3967624|FG001|Overall Study|Missed EOT/PTE Visit|2
2282113|NCT02378480|3967623|FG000|Overall Study|Withdrawal by Subject|9
2282114|NCT02378480|3967624|FG001|Overall Study|Withdrawal by Subject|4
2282115|NCT02378480|3967623|FG000|Overall Study|Lost to Follow-up|10
2282116|NCT02378480|3967624|FG001|Overall Study|Lost to Follow-up|18
2282117|NCT02378506|3967630|FG000|Overall Study|Lack of Efficacy|3
2282118|NCT02378506|3967630|FG000|Overall Study|Withdrawal by Subject|4
2282119|NCT02378506|3967630|FG000|Overall Study|Protocol Violation|2
2282120|NCT02378506|3967630|FG000|Overall Study|Death|1
2282121|NCT02378506|3967630|FG000|Overall Study|Adverse Event|14
2282122|NCT02378506|3967630|FG000|Overall Study|Randomized But Not Treated|1
2282123|NCT02378662|3967636|FG000|Overall Study|Early Discontinuation|2
2282124|NCT02378662|3967637|FG001|Overall Study|Early Discontinuation|0
2282125|NCT02378883|3967705|FG000|Enrollment|Subject did not meet Inclusion criteria|6
2282126|NCT02378883|3967705|FG000|Enrollment|Attempt to use Apollo was not performed|3
2282127|NCT02378883|3967705|FG000|30 Day Follow-Up|Withdrawal by Subject|1
2282128|NCT02378883|3967705|FG000|30 Day Follow-Up|Physician Decision|2
2282129|NCT02378883|3967705|FG000|30 Day Follow-Up|Missed Visit|2
2282130|NCT02378883|3967705|FG000|30 Day Follow-Up|Death|1
2282131|NCT02378883|3967705|FG000|12 Months Follow-Up|Lost to Follow-up|3
2282132|NCT02378883|3967705|FG000|12 Months Follow-Up|Death|2
2282133|NCT02378935|3967717|FG000|Overall Study|Lack of Efficacy|10
2282134|NCT02378935|3967718|FG001|Overall Study|Lack of Efficacy|0
2282135|NCT02378935|3967719|FG002|Overall Study|Lack of Efficacy|2
2282136|NCT02378935|3967720|FG003|Overall Study|Lack of Efficacy|6
2282137|NCT02378935|3967721|FG004|Overall Study|Lack of Efficacy|0
2282138|NCT02378935|3967722|FG005|Overall Study|Lack of Efficacy|0
2282139|NCT02378935|3967723|FG006|Overall Study|Lack of Efficacy|0
2282140|NCT02378935|3967717|FG000|Overall Study|Death|0
2282141|NCT02378935|3967718|FG001|Overall Study|Death|0
2282142|NCT02378935|3967719|FG002|Overall Study|Death|1
2282143|NCT02378935|3967720|FG003|Overall Study|Death|0
2282144|NCT02378935|3967721|FG004|Overall Study|Death|0
2282145|NCT02378935|3967722|FG005|Overall Study|Death|0
2282146|NCT02378935|3967723|FG006|Overall Study|Death|0
2282147|NCT02378961|3967743|FG000|Overall Study|Lack of Efficacy|4
2282148|NCT02378961|3967744|FG001|Overall Study|Lack of Efficacy|2
2282149|NCT02378961|3967745|FG002|Overall Study|Lack of Efficacy|0
2282150|NCT02378961|3967746|FG003|Overall Study|Lack of Efficacy|1
2282151|NCT02378961|3967743|FG000|Overall Study|Death|0
2282152|NCT02378961|3967744|FG001|Overall Study|Death|0
2282153|NCT02378961|3967745|FG002|Overall Study|Death|1
2282154|NCT02378961|3967746|FG003|Overall Study|Death|0
2126923|NCT01006616|3728391|FG002|Period 1 (6 Months)|Adverse Event|37
2126924|NCT01006616|3728392|FG003|Period 1 (6 Months)|Adverse Event|9
2126925|NCT01006616|3728389|FG000|Period 1 (6 Months)|Lack of Efficacy|3
2126926|NCT01006616|3728390|FG001|Period 1 (6 Months)|Lack of Efficacy|4
2205654|NCT01611090|3843547|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
2205655|NCT01611090|3843545|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
2205656|NCT01611090|3843546|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
2205657|NCT01611090|3843547|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
2205658|NCT01611155|3843556|FG000|Overall Study|Adverse Event|1
2205659|NCT01611155|3843557|FG001|Overall Study|Adverse Event|1
2282155|NCT02379052|3967758|FG000|Overall Study|Protocol Violation|0
2282156|NCT02379052|3967759|FG001|Overall Study|Protocol Violation|1
2282157|NCT02379052|3967758|FG000|Overall Study|Adverse Event|0
2282158|NCT02379052|3967759|FG001|Overall Study|Adverse Event|1
2282159|NCT02379052|3967758|FG000|Overall Study|Physician Decision|1
2282160|NCT02379052|3967759|FG001|Overall Study|Physician Decision|1
2282161|NCT02379052|3967758|FG000|Overall Study|Withdrawal by Subject|2
2282162|NCT02379052|3967759|FG001|Overall Study|Withdrawal by Subject|0
2282163|NCT02379052|3967758|FG000|Overall Study|Lost to Follow-up|2
2282164|NCT02379052|3967759|FG001|Overall Study|Lost to Follow-up|1
2282165|NCT02379052|3967758|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
2282166|NCT02379052|3967759|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
2282167|NCT02379052|3967758|FG000|Overall Study|Subject was Incarcerated|0
2282168|NCT02379052|3967759|FG001|Overall Study|Subject was Incarcerated|1
2282169|NCT02379078|3967767|FG000|Overall Study|Lost to Follow-up|33
2282170|NCT02379078|3967768|FG001|Overall Study|Lost to Follow-up|30
2282171|NCT02379078|3967767|FG000|Overall Study|Withdrawal by Subject|6
2282172|NCT02379078|3967768|FG001|Overall Study|Withdrawal by Subject|5
2282173|NCT02379091|3967778|FG000|Overall Study|Pretreatment Event/Adverse Event|0
2282174|NCT02379091|3967779|FG001|Overall Study|Pretreatment Event/Adverse Event|2
2282175|NCT02379091|3967780|FG002|Overall Study|Pretreatment Event/Adverse Event|0
2282176|NCT02379091|3967781|FG003|Overall Study|Pretreatment Event/Adverse Event|1
2282177|NCT02379091|3967778|FG000|Overall Study|Principal Investigator Discretion|0
2282178|NCT02379091|3967779|FG001|Overall Study|Principal Investigator Discretion|1
2282179|NCT02379091|3967780|FG002|Overall Study|Principal Investigator Discretion|0
2282180|NCT02379091|3967781|FG003|Overall Study|Principal Investigator Discretion|0
2282181|NCT02379091|3967778|FG000|Overall Study|Lost to Follow-up|0
2282182|NCT02379091|3967779|FG001|Overall Study|Lost to Follow-up|0
2282183|NCT02379091|3967780|FG002|Overall Study|Lost to Follow-up|0
2282184|NCT02379091|3967781|FG003|Overall Study|Lost to Follow-up|1
2282185|NCT02379091|3967778|FG000|Overall Study|Voluntary Withdrawal|2
2282186|NCT02379091|3967779|FG001|Overall Study|Voluntary Withdrawal|5
2282187|NCT02379091|3967780|FG002|Overall Study|Voluntary Withdrawal|2
2282188|NCT02379091|3967781|FG003|Overall Study|Voluntary Withdrawal|4
2282189|NCT02379091|3967778|FG000|Overall Study|Study Termination|7
2282190|NCT02379091|3967779|FG001|Overall Study|Study Termination|2
2282191|NCT02379091|3967780|FG002|Overall Study|Study Termination|5
2282192|NCT02379091|3967781|FG003|Overall Study|Study Termination|8
2282193|NCT02379091|3967778|FG000|Overall Study|Lack of Efficacy|3
2282194|NCT02379091|3967779|FG001|Overall Study|Lack of Efficacy|0
2282195|NCT02379091|3967780|FG002|Overall Study|Lack of Efficacy|0
2282196|NCT02379091|3967781|FG003|Overall Study|Lack of Efficacy|0
2282197|NCT02379221|3967806|FG000|Overall Study|Lost to Follow-up|1
2320778|NCT02952586|4035029|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0
2320779|NCT02952586|4035028|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10
2320780|NCT02952586|4035029|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6
2320781|NCT02952586|4035028|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1
2320782|NCT02952586|4035029|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1
2320783|NCT02952586|4035028|FG000|CRT for IMRT (63 Days)|Other|1
2320784|NCT02952586|4035029|FG001|CRT for IMRT (63 Days)|Other|0
2320785|NCT02952586|4035028|FG000|Maintenance Phase (12 Months)|Death|17
2320786|NCT02952586|4035029|FG001|Maintenance Phase (12 Months)|Death|11
2320787|NCT02952586|4035028|FG000|Maintenance Phase (12 Months)|Progressive disease|60
2320788|NCT02952586|4035029|FG001|Maintenance Phase (12 Months)|Progressive disease|54
2320789|NCT02952586|4035028|FG000|Maintenance Phase (12 Months)|Adverse Event|24
2320790|NCT02952586|4035029|FG001|Maintenance Phase (12 Months)|Adverse Event|21
2320791|NCT02952586|4035028|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
2320792|NCT02952586|4035029|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
2320793|NCT02952586|4035028|FG000|Maintenance Phase (12 Months)|Physician Decision|1
2320794|NCT02952586|4035029|FG001|Maintenance Phase (12 Months)|Physician Decision|1
2126927|NCT01006616|3728391|FG002|Period 1 (6 Months)|Lack of Efficacy|0
2126928|NCT01006616|3728392|FG003|Period 1 (6 Months)|Lack of Efficacy|4
2205660|NCT01611155|3843556|FG000|Overall Study|Refused further treatment|6
2205661|NCT01611155|3843557|FG001|Overall Study|Refused further treatment|4
2320795|NCT02952586|4035028|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14
2320796|NCT02952586|4035029|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5
2320797|NCT02952586|4035028|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31
2320798|NCT02952586|4035029|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25
2320799|NCT02952586|4035028|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1
2205662|NCT01611155|3843556|FG000|Overall Study|Disease progression|1
2205663|NCT01611155|3843557|FG001|Overall Study|Disease progression|0
2205664|NCT01611155|3843556|FG000|Overall Study|Withdrawal by Subject|1
2205665|NCT01611155|3843557|FG001|Overall Study|Withdrawal by Subject|0
2205666|NCT01611155|3843556|FG000|Overall Study|Alternative treatment|0
2205667|NCT01611155|3843557|FG001|Overall Study|Alternative treatment|1
2205668|NCT01611155|3843556|FG000|Overall Study|Ineligible patient|0
2205669|NCT01611155|3843557|FG001|Overall Study|Ineligible patient|1
2205670|NCT01611194|3843565|FG000|Overall Study|Lost to Follow-up|0
2205671|NCT01611194|3843566|FG001|Overall Study|Lost to Follow-up|1
2282198|NCT02379637|3967845|FG000|Overall Study|Protocol Violation|0
2126929|NCT01006616|3728389|FG000|Period 1 (6 Months)|Lost to Follow-up|0
2126930|NCT01006616|3728390|FG001|Period 1 (6 Months)|Lost to Follow-up|0
2126931|NCT01006616|3728391|FG002|Period 1 (6 Months)|Lost to Follow-up|1
2126932|NCT01006616|3728392|FG003|Period 1 (6 Months)|Lost to Follow-up|0
2126933|NCT01006616|3728389|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
2126934|NCT01006616|3728390|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
2126935|NCT01006616|3728391|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
2126936|NCT01006616|3728392|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
2126937|NCT01006616|3728389|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
2126938|NCT01006616|3728390|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
2126939|NCT01006616|3728391|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
2126940|NCT01006616|3728392|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
2126941|NCT01006616|3728389|FG000|Period 1 (6 Months)|Withdrawal by Subject|2
2126942|NCT01006616|3728390|FG001|Period 1 (6 Months)|Withdrawal by Subject|2
2126943|NCT01006616|3728391|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
2205672|NCT01611194|3843565|FG000|Overall Study|Withdrawal by Subject|0
2282199|NCT02379637|3967846|FG001|Overall Study|Protocol Violation|1
2282200|NCT02379637|3967845|FG000|Overall Study|Adverse Event|1
2282201|NCT02379637|3967846|FG001|Overall Study|Adverse Event|0
2282202|NCT02379637|3967845|FG000|Overall Study|Withdrawal by Subject|1
2282203|NCT02379637|3967846|FG001|Overall Study|Withdrawal by Subject|0
2282204|NCT02379728|3967854|FG000|Overall Study|Lost to Follow-up|1
2282205|NCT02379728|3967855|FG001|Overall Study|Lost to Follow-up|0
2282206|NCT02379728|3967856|FG002|Overall Study|Lost to Follow-up|3
2282207|NCT02379728|3967857|FG003|Overall Study|Lost to Follow-up|0
2282208|NCT02379728|3967854|FG000|Overall Study|Withdrawal by Subject|5
2282209|NCT02379728|3967855|FG001|Overall Study|Withdrawal by Subject|0
2282210|NCT02379728|3967856|FG002|Overall Study|Withdrawal by Subject|5
2282211|NCT02379728|3967857|FG003|Overall Study|Withdrawal by Subject|3
2282212|NCT02379728|3967854|FG000|Overall Study|Protocol Violation|0
2282213|NCT02379728|3967855|FG001|Overall Study|Protocol Violation|0
2282214|NCT02379728|3967856|FG002|Overall Study|Protocol Violation|2
2282215|NCT02379728|3967857|FG003|Overall Study|Protocol Violation|0
2282216|NCT02379923|3967875|FG000|Overall Study|Death|5
2282217|NCT02380248|3967891|FG000|Overall Study|Lost to Follow-up|11
2282218|NCT02380248|3967891|FG000|Overall Study|Withdrawal by Subject|3
2282219|NCT02380287|3967908|FG000|Overall Study|Adverse Event|0
2282220|NCT02380287|3967909|FG001|Overall Study|Adverse Event|0
2282221|NCT02380287|3967910|FG002|Overall Study|Adverse Event|1
2282222|NCT02380287|3967911|FG003|Overall Study|Adverse Event|0
2282223|NCT02380287|3967912|FG004|Overall Study|Adverse Event|0
2282224|NCT02380287|3967913|FG005|Overall Study|Adverse Event|0
2282225|NCT02380287|3967914|FG006|Overall Study|Adverse Event|0
2282226|NCT02380287|3967915|FG007|Overall Study|Adverse Event|0
2282227|NCT02380677|3967959|FG000|Overall Study|Adverse Event|0
2282228|NCT02380677|3967960|FG001|Overall Study|Adverse Event|0
2282229|NCT02380677|3967961|FG002|Overall Study|Adverse Event|0
2282230|NCT02380677|3967962|FG003|Overall Study|Adverse Event|1
2282231|NCT02380677|3967963|FG004|Overall Study|Adverse Event|1
2282232|NCT02380677|3967964|FG005|Overall Study|Adverse Event|4
2282233|NCT02380677|3967965|FG006|Overall Study|Adverse Event|2
2282234|NCT02380677|3967966|FG007|Overall Study|Adverse Event|2
2282235|NCT02380677|3967967|FG008|Overall Study|Adverse Event|2
2282236|NCT02380677|3967968|FG009|Overall Study|Adverse Event|1
2282237|NCT02380677|3967969|FG010|Overall Study|Adverse Event|2
2282238|NCT02380677|3967970|FG011|Overall Study|Adverse Event|1
2282239|NCT02380677|3967959|FG000|Overall Study|Physician Decision|1
2282240|NCT02380677|3967960|FG001|Overall Study|Physician Decision|0
2282241|NCT02380677|3967961|FG002|Overall Study|Physician Decision|1
2282242|NCT02380677|3967962|FG003|Overall Study|Physician Decision|1
2282243|NCT02380677|3967963|FG004|Overall Study|Physician Decision|0
2282244|NCT02380677|3967964|FG005|Overall Study|Physician Decision|0
2282245|NCT02380677|3967965|FG006|Overall Study|Physician Decision|0
2282246|NCT02380677|3967966|FG007|Overall Study|Physician Decision|0
2282247|NCT02380677|3967967|FG008|Overall Study|Physician Decision|0
2205673|NCT01611194|3843566|FG001|Overall Study|Withdrawal by Subject|1
2282248|NCT02380677|3967968|FG009|Overall Study|Physician Decision|0
2282249|NCT02380677|3967969|FG010|Overall Study|Physician Decision|0
2282250|NCT02380677|3967970|FG011|Overall Study|Physician Decision|0
2282251|NCT02380677|3967959|FG000|Overall Study|Lack of Efficacy|0
2282252|NCT02380677|3967960|FG001|Overall Study|Lack of Efficacy|1
2282253|NCT02380677|3967961|FG002|Overall Study|Lack of Efficacy|2
2282254|NCT02380677|3967962|FG003|Overall Study|Lack of Efficacy|0
2126944|NCT01006616|3728392|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
2126945|NCT01006616|3728389|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
2126946|NCT01006616|3728390|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
2126947|NCT01006616|3728391|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
2126948|NCT01006616|3728392|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
2126949|NCT01006616|3728389|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0
2126950|NCT01006616|3728390|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2
2126951|NCT01006616|3728391|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2
2126952|NCT01006616|3728392|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3
2126953|NCT01006616|3728389|FG000|Period 1 (6 Months)|Not Treated|0
2126954|NCT01006616|3728390|FG001|Period 1 (6 Months)|Not Treated|0
2126955|NCT01006616|3728391|FG002|Period 1 (6 Months)|Not Treated|1
2126956|NCT01006616|3728392|FG003|Period 1 (6 Months)|Not Treated|1
2126957|NCT01006616|3728389|FG000|Period 2 (18 Months)|Adverse Event|6
2126958|NCT01006616|3728390|FG001|Period 2 (18 Months)|Adverse Event|6
2126959|NCT01006616|3728391|FG002|Period 2 (18 Months)|Adverse Event|6
2126960|NCT01006616|3728392|FG003|Period 2 (18 Months)|Adverse Event|4
2126961|NCT01006616|3728389|FG000|Period 2 (18 Months)|Lack of Efficacy|0
2126962|NCT01006616|3728390|FG001|Period 2 (18 Months)|Lack of Efficacy|0
2126963|NCT01006616|3728391|FG002|Period 2 (18 Months)|Lack of Efficacy|1
2282255|NCT02380677|3967963|FG004|Overall Study|Lack of Efficacy|4
2282256|NCT02380677|3967964|FG005|Overall Study|Lack of Efficacy|1
2282257|NCT02380677|3967965|FG006|Overall Study|Lack of Efficacy|1
2282258|NCT02380677|3967966|FG007|Overall Study|Lack of Efficacy|2
2282259|NCT02380677|3967967|FG008|Overall Study|Lack of Efficacy|2
2282260|NCT02380677|3967968|FG009|Overall Study|Lack of Efficacy|0
2282261|NCT02380677|3967969|FG010|Overall Study|Lack of Efficacy|2
2282262|NCT02380677|3967970|FG011|Overall Study|Lack of Efficacy|1
2282263|NCT02380677|3967959|FG000|Overall Study|Withdrawal by Subject|0
2282264|NCT02380677|3967960|FG001|Overall Study|Withdrawal by Subject|0
2282265|NCT02380677|3967961|FG002|Overall Study|Withdrawal by Subject|0
2282266|NCT02380677|3967962|FG003|Overall Study|Withdrawal by Subject|0
2282267|NCT02380677|3967963|FG004|Overall Study|Withdrawal by Subject|0
2282268|NCT02380677|3967964|FG005|Overall Study|Withdrawal by Subject|0
2282269|NCT02380677|3967965|FG006|Overall Study|Withdrawal by Subject|0
2282270|NCT02380677|3967966|FG007|Overall Study|Withdrawal by Subject|0
2282271|NCT02380677|3967967|FG008|Overall Study|Withdrawal by Subject|0
2282272|NCT02380677|3967968|FG009|Overall Study|Withdrawal by Subject|1
2282273|NCT02380677|3967969|FG010|Overall Study|Withdrawal by Subject|0
2282274|NCT02380677|3967970|FG011|Overall Study|Withdrawal by Subject|3
2282275|NCT02380677|3967959|FG000|Overall Study|Other|0
2282276|NCT02380677|3967960|FG001|Overall Study|Other|0
2282277|NCT02380677|3967961|FG002|Overall Study|Other|0
2282278|NCT02380677|3967962|FG003|Overall Study|Other|1
2282279|NCT02380677|3967963|FG004|Overall Study|Other|1
2282280|NCT02380677|3967964|FG005|Overall Study|Other|1
2282281|NCT02380677|3967965|FG006|Overall Study|Other|0
2282282|NCT02380677|3967966|FG007|Overall Study|Other|0
2282283|NCT02380677|3967967|FG008|Overall Study|Other|0
2282284|NCT02380677|3967968|FG009|Overall Study|Other|0
2282285|NCT02380677|3967969|FG010|Overall Study|Other|0
2282286|NCT02380677|3967970|FG011|Overall Study|Other|0
2282287|NCT02380690|3968000|FG000|Overall Study|Lost to Follow-up|14
2282288|NCT02380690|3968001|FG001|Overall Study|Lost to Follow-up|4
2282289|NCT02380690|3968000|FG000|Overall Study|Withdrawal by Subject|20
2282290|NCT02380690|3968001|FG001|Overall Study|Withdrawal by Subject|8
2282291|NCT02380703|3968009|FG000|Overall Study|Withdrawal by Subject|12
2282292|NCT02380703|3968010|FG001|Overall Study|Withdrawal by Subject|9
2282293|NCT02380703|3968009|FG000|Overall Study|Lost to Follow-up|12
2282294|NCT02380703|3968010|FG001|Overall Study|Lost to Follow-up|12
2282295|NCT02380703|3968009|FG000|Overall Study|Caregiver death|1
2282296|NCT02380703|3968010|FG001|Overall Study|Caregiver death|0
2282297|NCT02380703|3968009|FG000|Overall Study|Person with dementia (PWD) death|7
2282298|NCT02380703|3968010|FG001|Overall Study|Person with dementia (PWD) death|8
2282299|NCT02380703|3968009|FG000|Overall Study|Entered Long-term Care|4
2282300|NCT02380703|3968010|FG001|Overall Study|Entered Long-term Care|7
2282301|NCT02380742|3968018|FG000|Overall Study|Withdrawal by Subject|1
2282302|NCT02380742|3968019|FG001|Overall Study|Withdrawal by Subject|0
2282303|NCT02380859|3968027|FG000|Overall Study|Withdrawal by Subject|2
2282304|NCT02380859|3968028|FG001|Overall Study|Withdrawal by Subject|0
2282305|NCT02381652|3968093|FG000|Overall Study|Withdrawal by Subject|0
2282306|NCT02381652|3968094|FG001|Overall Study|Withdrawal by Subject|0
2282307|NCT02381652|3968095|FG002|Overall Study|Withdrawal by Subject|1
2282308|NCT02381795|3968110|FG000|Overall Study|Withdrawal by Subject|1
2282309|NCT02381795|3968110|FG000|Overall Study|Study Terminated|2
2282310|NCT02382016|3968116|FG000|Double-blind (DB) Treatment Period|Physician Decision|3
2282311|NCT02382016|3968117|FG001|Double-blind (DB) Treatment Period|Physician Decision|0
2282312|NCT02382016|3968116|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1
2282313|NCT02382016|3968117|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0
2282314|NCT02382016|3968116|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
2282315|NCT02382016|3968117|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
2282316|NCT02382016|3968116|FG000|Open-label (OL) Treatment Period|Physician Decision|3
2126964|NCT01006616|3728392|FG003|Period 2 (18 Months)|Lack of Efficacy|2
2126965|NCT01006616|3728389|FG000|Period 2 (18 Months)|Lost to Follow-up|2
2126966|NCT01006616|3728390|FG001|Period 2 (18 Months)|Lost to Follow-up|0
2126967|NCT01006616|3728391|FG002|Period 2 (18 Months)|Lost to Follow-up|0
2126968|NCT01006616|3728392|FG003|Period 2 (18 Months)|Lost to Follow-up|0
2126969|NCT01006616|3728389|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
2126970|NCT01006616|3728390|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
2126971|NCT01006616|3728391|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
2126972|NCT01006616|3728392|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
2126973|NCT01006616|3728389|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
2126974|NCT01006616|3728390|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
2126975|NCT01006616|3728391|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
2126976|NCT01006616|3728392|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
2126977|NCT01006616|3728389|FG000|Period 2 (18 Months)|Withdrawal by Subject|1
2126978|NCT01006616|3728390|FG001|Period 2 (18 Months)|Withdrawal by Subject|4
2282317|NCT02382016|3968117|FG001|Open-label (OL) Treatment Period|Physician Decision|0
2282318|NCT02382016|3968116|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2
2282319|NCT02382016|3968117|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0
2282320|NCT02382016|3968116|FG000|Open-label (OL) Treatment Period|Death|4
2282321|NCT02382016|3968117|FG001|Open-label (OL) Treatment Period|Death|0
2282322|NCT02382016|3968116|FG000|OL Extension Period|Physician Decision|3
2282323|NCT02382016|3968117|FG001|OL Extension Period|Physician Decision|0
2282324|NCT02382016|3968116|FG000|OL Extension Period|Death|2
2282325|NCT02382016|3968117|FG001|OL Extension Period|Death|0
2282326|NCT02382016|3968116|FG000|OL Extension Period|Withdrawal by Subject|1
2282327|NCT02382016|3968117|FG001|OL Extension Period|Withdrawal by Subject|0
2282328|NCT02382133|3968125|FG000|Overall Study|Death|22
2282329|NCT02382133|3968125|FG000|Overall Study|transfer out of ICU|4
2282330|NCT02382133|3968125|FG000|Overall Study|Physician Decision|2
2282331|NCT02382133|3968125|FG000|Overall Study|arterial catheter loss|4
2282332|NCT02382133|3968125|FG000|Overall Study|pressure injury both sites|1
2282333|NCT02382276|3968132|FG000|Overall Study|Withdrawal by Subject|4
2282334|NCT02382276|3968133|FG001|Overall Study|Withdrawal by Subject|8
2282335|NCT02382276|3968134|FG002|Overall Study|Withdrawal by Subject|5
2282336|NCT02382276|3968132|FG000|Overall Study|Adverse Event|7
2282337|NCT02382276|3968133|FG001|Overall Study|Adverse Event|2
2282338|NCT02382276|3968134|FG002|Overall Study|Adverse Event|32
2282339|NCT02382276|3968132|FG000|Overall Study|Physician Decision|0
2282340|NCT02382276|3968133|FG001|Overall Study|Physician Decision|0
2282341|NCT02382276|3968134|FG002|Overall Study|Physician Decision|2
2282342|NCT02382640|3968144|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
2282343|NCT02382640|3968145|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2282344|NCT02382640|3968146|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2282345|NCT02382640|3968147|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2282346|NCT02382796|3968174|FG000|Overall Study|Global deterioration of health status|1
2282347|NCT02382796|3968174|FG000|Overall Study|Objective progression or relapse|3
2282348|NCT02382796|3968174|FG000|Overall Study|Commercial dacomitinib became available|3
2282349|NCT02382939|3968228|FG000|Overall Study|Adverse Event|1
2282350|NCT02382939|3968229|FG001|Overall Study|Adverse Event|1
2282351|NCT02382939|3968228|FG000|Overall Study|Withdrawal by Subject|2
2282352|NCT02382939|3968229|FG001|Overall Study|Withdrawal by Subject|2
2282353|NCT02382991|3968238|FG000|Overall Study|Adverse Event|1
2282354|NCT02382991|3968239|FG001|Overall Study|Adverse Event|2
2282355|NCT02382991|3968238|FG000|Overall Study|Lost to Follow-up|1
2282356|NCT02382991|3968239|FG001|Overall Study|Lost to Follow-up|0
2282357|NCT02382991|3968238|FG000|Overall Study|Withdrawal by Subject|0
2282358|NCT02382991|3968239|FG001|Overall Study|Withdrawal by Subject|1
2282359|NCT02383017|3968246|FG000|Overall Study|Injury Sustained Outside Study|1
2282360|NCT02383017|3968247|FG001|Overall Study|Injury Sustained Outside Study|0
2282361|NCT02383017|3968246|FG000|Overall Study|Compliance|3
2282362|NCT02383017|3968247|FG001|Overall Study|Compliance|2
2282363|NCT02383017|3968246|FG000|Overall Study|Found to be Hypogonadal|1
2282364|NCT02383017|3968247|FG001|Overall Study|Found to be Hypogonadal|0
2282365|NCT02383056|3968269|FG000|Overall Study|Adverse Event|1
2282366|NCT02383056|3968270|FG001|Overall Study|Adverse Event|0
2282367|NCT02383056|3968269|FG000|Overall Study|Lost to Follow-up|0
2282368|NCT02383056|3968270|FG001|Overall Study|Lost to Follow-up|2
2282369|NCT02383173|3968278|FG000|Overall Study|Palliative Care Team withdrew|0
2282370|NCT02383173|3968279|FG001|Overall Study|Palliative Care Team withdrew|2
2282371|NCT02383355|3968287|FG000|Overall Study|Adverse Event|2
2282372|NCT02383355|3968288|FG001|Overall Study|Adverse Event|0
2282373|NCT02383472|3968309|FG000|Overall Study|Withdrawal by Subject|1
2282374|NCT02383472|3968310|FG001|Overall Study|Withdrawal by Subject|1
2282375|NCT02383576|3968320|FG000|Overall Study|Death|53
2282376|NCT02383576|3968321|FG001|Overall Study|Death|33
2282377|NCT02383576|3968320|FG000|Overall Study|Lost to Follow-up|7
2282378|NCT02383576|3968321|FG001|Overall Study|Lost to Follow-up|1
2282379|NCT02383576|3968320|FG000|Overall Study|Withdrew Consent|1
2282380|NCT02383576|3968321|FG001|Overall Study|Withdrew Consent|6
2282381|NCT02383576|3968320|FG000|Overall Study|Investigator's Decision|0
2205674|NCT01611194|3843565|FG000|Overall Study|drug use|0
2282382|NCT02383576|3968321|FG001|Overall Study|Investigator's Decision|1
2282383|NCT02383576|3968320|FG000|Overall Study|Administrative/Other|2
2282384|NCT02383576|3968321|FG001|Overall Study|Administrative/Other|4
2282385|NCT02383589|3968329|FG000|Treatment Period|Adverse Event|1
2282386|NCT02383589|3968330|FG001|Treatment Period|Adverse Event|3
2282387|NCT02383589|3968329|FG000|Treatment Period|Lost to Follow-up|0
2282388|NCT02383589|3968330|FG001|Treatment Period|Lost to Follow-up|1
2282389|NCT02383589|3968329|FG000|Treatment Period|Withdrawal by Subject|0
2282390|NCT02383589|3968330|FG001|Treatment Period|Withdrawal by Subject|5
2282391|NCT02383589|3968329|FG000|Treatment Period|Non-compliance with study drug|0
2282392|NCT02383589|3968330|FG001|Treatment Period|Non-compliance with study drug|1
2282393|NCT02383589|3968329|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2
2282394|NCT02383589|3968330|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4
2282395|NCT02383589|3968329|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5
2282396|NCT02383589|3968330|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0
2282397|NCT02383589|3968329|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0
2282398|NCT02383589|3968330|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1
2282399|NCT02383758|3968353|FG000|Overall Study|Withdrawal by Subject|0
2282400|NCT02383758|3968354|FG001|Overall Study|Withdrawal by Subject|2
2282401|NCT02383862|3968362|FG000|3 Month Follow up|Lost to Follow-up|23
2282402|NCT02383862|3968363|FG001|3 Month Follow up|Lost to Follow-up|21
2282403|NCT02383940|3968378|FG000|Overall Study|Adverse Event|1
2282404|NCT02383940|3968379|FG001|Overall Study|Adverse Event|0
2282405|NCT02383940|3968378|FG000|Overall Study|Lost to Follow-up|2
2282406|NCT02383940|3968379|FG001|Overall Study|Lost to Follow-up|2
2282407|NCT02383940|3968378|FG000|Overall Study|Physician Decision|2
2282408|NCT02383940|3968379|FG001|Overall Study|Physician Decision|0
2282409|NCT02383940|3968378|FG000|Overall Study|Withdrawal by Subject|1
2282410|NCT02383940|3968379|FG001|Overall Study|Withdrawal by Subject|1
2282411|NCT02383940|3968378|FG000|Overall Study|Randomized but not treated|2
2282412|NCT02383940|3968379|FG001|Overall Study|Randomized but not treated|0
2282413|NCT02383940|3968378|FG000|Overall Study|Other than specified above|1
2282414|NCT02383940|3968379|FG001|Overall Study|Other than specified above|0
2282415|NCT02383966|3968387|FG000|Overall Study|Ongoing at clinical cut-off date|25
2282416|NCT02383966|3968388|FG001|Overall Study|Ongoing at clinical cut-off date|4
2282417|NCT02383966|3968387|FG000|Overall Study|Randomized, but not treated|1
2282418|NCT02383966|3968388|FG001|Overall Study|Randomized, but not treated|3
2282419|NCT02384382|3968433|FG000|Overall Study|Transitioned to study-NCT02960022|5
2282420|NCT02384382|3968433|FG000|Overall Study|Death|1
2282421|NCT02384382|3968433|FG000|Overall Study|Adverse Event|1
2282422|NCT02384382|3968433|FG000|Overall Study|Disease progression|16
2282423|NCT02384395|3968437|FG000|Overall Study|Physician Decision|4
2282424|NCT02384395|3968437|FG000|Overall Study|Withdrawal by Subject|3
2282425|NCT02384395|3968437|FG000|Overall Study|Lost to Follow-up|3
2282426|NCT02384460|3968443|FG000|Overall Study|Protocol Violation|0
2282427|NCT02384460|3968444|FG001|Overall Study|Protocol Violation|1
2282428|NCT02384460|3968443|FG000|Overall Study|Returned to previous therapeutic regimen|0
2282429|NCT02384460|3968444|FG001|Overall Study|Returned to previous therapeutic regimen|1
2282430|NCT02384460|3968443|FG000|Overall Study|Adverse Event|5
2282431|NCT02384460|3968444|FG001|Overall Study|Adverse Event|2
2282432|NCT02384460|3968443|FG000|Overall Study|Withdrawal by Subject|0
2282433|NCT02384460|3968444|FG001|Overall Study|Withdrawal by Subject|3
2282434|NCT02384460|3968443|FG000|Overall Study|Elective medical treatment|1
2282435|NCT02384460|3968444|FG001|Overall Study|Elective medical treatment|0
2282436|NCT02384460|3968443|FG000|Overall Study|Non-compliance|1
2282437|NCT02384460|3968444|FG001|Overall Study|Non-compliance|0
2282438|NCT02384538|3968452|FG000|Overall Study|Adverse Event|1
2282439|NCT02384538|3968453|FG001|Overall Study|Adverse Event|4
2282440|NCT02384538|3968452|FG000|Overall Study|Lack of Efficacy|4
2282441|NCT02384538|3968453|FG001|Overall Study|Lack of Efficacy|4
2282442|NCT02384538|3968452|FG000|Overall Study|Withdrew Consent|0
2282443|NCT02384538|3968453|FG001|Overall Study|Withdrew Consent|4
2282444|NCT02384538|3968452|FG000|Overall Study|Other|1
2282445|NCT02384538|3968453|FG001|Overall Study|Other|3
2282446|NCT02384941|3968462|FG000|Overall Study|Adverse Event|11
2282447|NCT02384941|3968463|FG001|Overall Study|Adverse Event|13
2282448|NCT02384941|3968464|FG002|Overall Study|Adverse Event|17
2282449|NCT02384941|3968462|FG000|Overall Study|Lost to Follow-up|3
2282450|NCT02384941|3968463|FG001|Overall Study|Lost to Follow-up|2
2282451|NCT02384941|3968464|FG002|Overall Study|Lost to Follow-up|1
2282452|NCT02384941|3968462|FG000|Overall Study|Non-Compliance With Study Drug|2
2205675|NCT01611194|3843566|FG001|Overall Study|drug use|1
2205676|NCT01611259|3843572|FG000|Overall Study|Physician Decision|1
2205677|NCT01611259|3843572|FG000|Overall Study|Lack of Efficacy|2
2205678|NCT01611259|3843572|FG000|Overall Study|Adverse Event|4
2205679|NCT01611259|3843572|FG000|Overall Study|Withdrawal by Subject|7
2205680|NCT01611298|3843576|FG000|Overall Study|Relapsed|2
2205681|NCT01611454|3843582|FG000|Overall Study|Lack of Efficacy|18
2205682|NCT01611454|3843583|FG001|Overall Study|Lack of Efficacy|10
2205683|NCT01611558|3843593|FG000|Induction Phase|Study drug toxicity|15
2205684|NCT01611558|3843593|FG000|Induction Phase|Disease progression|18
2205685|NCT01611558|3843593|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1
2205686|NCT01611558|3843593|FG000|Induction Phase|Adverse event unrelated to study drug|3
2205687|NCT01611558|3843593|FG000|Induction Phase|Death|1
2205688|NCT01611558|3843593|FG000|Maintenance Phase|Withdrawal by Subject|1
2205689|NCT01611558|3843593|FG000|Maintenance Phase|Elevated Uric acid|1
2205690|NCT01611792|3843621|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
2205691|NCT01611792|3843622|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
2205692|NCT01611792|3843621|FG000|Followup: at 6 Months|Lost to Follow-up|6
2205693|NCT01611792|3843622|FG001|Followup: at 6 Months|Lost to Follow-up|13
2205694|NCT01611857|3843631|FG000|Overall Study|Withdrawal by Subject|0
2205695|NCT01611857|3843632|FG001|Overall Study|Withdrawal by Subject|2
2205696|NCT01611935|3843642|FG000|Overall Study|Family Declined Participation|1
2205697|NCT01611935|3843643|FG001|Overall Study|Family Declined Participation|0
2205698|NCT01611974|3843661|FG000|Overall Study|Death|10
2126979|NCT01006616|3728391|FG002|Period 2 (18 Months)|Withdrawal by Subject|0
2126980|NCT01006616|3728392|FG003|Period 2 (18 Months)|Withdrawal by Subject|1
2126981|NCT01006616|3728389|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0
2126982|NCT01006616|3728390|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1
2126983|NCT01006616|3728391|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0
2126984|NCT01006616|3728392|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1
2126985|NCT01006616|3728389|FG000|Period 2 (18 Months)|Study Terminated|63
2126986|NCT01006616|3728390|FG001|Period 2 (18 Months)|Study Terminated|46
2126987|NCT01006616|3728391|FG002|Period 2 (18 Months)|Study Terminated|44
2126988|NCT01006616|3728392|FG003|Period 2 (18 Months)|Study Terminated|70
2126989|NCT01006629|3728402|FG000|Overall Study|Adverse Event|1
2126990|NCT01006629|3728402|FG000|Overall Study|Parent refused to continue participation|1
2126991|NCT01006629|3728402|FG000|Overall Study|Parent unable to perform site visit|4
2126992|NCT01006707|3728415|FG000|Study Session 1|Lost to Follow-up|2
2126993|NCT01006707|3728416|FG001|Study Session 1|Lost to Follow-up|0
2126994|NCT01006707|3728417|FG002|Study Session 1|Lost to Follow-up|0
2126995|NCT01006707|3728415|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3
2126996|NCT01006707|3728416|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0
2126997|NCT01006707|3728417|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0
2126998|NCT01006889|3728425|FG000|Overall Study|Withdrawal by Subject|3
2126999|NCT01006980|3728443|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
2127000|NCT01006980|3728444|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
2127001|NCT01006980|3728443|FG000|Vemurafenib and Dacarbazine|Adverse Event|25
2127002|NCT01006980|3728444|FG001|Vemurafenib and Dacarbazine|Adverse Event|5
2127003|NCT01006980|3728443|FG000|Vemurafenib and Dacarbazine|Death|13
2127004|NCT01006980|3728444|FG001|Vemurafenib and Dacarbazine|Death|12
2127005|NCT01006980|3728443|FG000|Vemurafenib and Dacarbazine|Progression|257
2127006|NCT01006980|3728444|FG001|Vemurafenib and Dacarbazine|Progression|218
2127007|NCT01006980|3728443|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
2127008|NCT01006980|3728444|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
2127009|NCT01006980|3728443|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9
2127010|NCT01006980|3728444|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6
2127011|NCT01006980|3728443|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2
2127012|NCT01006980|3728444|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3
2127013|NCT01006980|3728443|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26
2127014|NCT01006980|3728444|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43
2127015|NCT01006980|3728443|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
2127016|NCT01006980|3728444|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
2127017|NCT01006980|3728443|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0
2127018|NCT01006980|3728444|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4
2127019|NCT01006980|3728443|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0
2127020|NCT01006980|3728444|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65
2127021|NCT01006980|3728443|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
2127022|NCT01006980|3728444|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
2127023|NCT01006980|3728443|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
2127024|NCT01006980|3728444|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
2127025|NCT01007032|3728455|FG000|Overall Study|On Study Treatment at Cut-off Date|0
2127026|NCT01007032|3728456|FG001|Overall Study|On Study Treatment at Cut-off Date|1
2127027|NCT01007032|3728457|FG002|Overall Study|On Study Treatment at Cut-off Date|1
2127028|NCT01007032|3728458|FG003|Overall Study|On Study Treatment at Cut-off Date|0
2127029|NCT01007032|3728455|FG000|Overall Study|Withdrawal by Subject|0
2127030|NCT01007032|3728456|FG001|Overall Study|Withdrawal by Subject|0
2127031|NCT01007032|3728457|FG002|Overall Study|Withdrawal by Subject|0
2127032|NCT01007032|3728458|FG003|Overall Study|Withdrawal by Subject|1
2127033|NCT01007123|3728497|FG000|Overall Study|Adverse Event|3
2127034|NCT01007123|3728498|FG001|Overall Study|Adverse Event|4
2127035|NCT01007123|3728499|FG002|Overall Study|Adverse Event|7
2127036|NCT01007123|3728500|FG003|Overall Study|Adverse Event|1
2127037|NCT01007123|3728497|FG000|Overall Study|Lack of Efficacy|1
2127038|NCT01007123|3728498|FG001|Overall Study|Lack of Efficacy|0
2127039|NCT01007123|3728499|FG002|Overall Study|Lack of Efficacy|1
2127040|NCT01007123|3728500|FG003|Overall Study|Lack of Efficacy|4
2127041|NCT01007123|3728497|FG000|Overall Study|Protocol Violation|1
2205699|NCT01611974|3843662|FG001|Overall Study|Death|12
2205700|NCT01611974|3843663|FG002|Overall Study|Death|10
2127042|NCT01007123|3728498|FG001|Overall Study|Protocol Violation|1
2127043|NCT01007123|3728499|FG002|Overall Study|Protocol Violation|2
2127044|NCT01007123|3728500|FG003|Overall Study|Protocol Violation|1
2127045|NCT01007123|3728497|FG000|Overall Study|Withdrawal by Subject|1
2127046|NCT01007123|3728498|FG001|Overall Study|Withdrawal by Subject|0
2127047|NCT01007123|3728499|FG002|Overall Study|Withdrawal by Subject|1
2127048|NCT01007123|3728500|FG003|Overall Study|Withdrawal by Subject|0
2127049|NCT01007123|3728497|FG000|Overall Study|Lost to Follow-up|0
2127050|NCT01007123|3728498|FG001|Overall Study|Lost to Follow-up|1
2127051|NCT01007123|3728499|FG002|Overall Study|Lost to Follow-up|0
2127052|NCT01007123|3728500|FG003|Overall Study|Lost to Follow-up|0
2127053|NCT01007149|3728533|FG000|Overall Study|Administrative problems|0
2127054|NCT01007149|3728534|FG001|Overall Study|Administrative problems|1
2127055|NCT01007253|3728540|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1
2127056|NCT01007253|3728541|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0
2127057|NCT01007253|3728542|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0
2127058|NCT01007253|3728543|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0
2127059|NCT01007396|3728553|FG000|Overall Study|Lost to Follow-up|47
2127060|NCT01007435|3728561|FG000|Overall Study|Adverse Event|16
2127061|NCT01007435|3728562|FG001|Overall Study|Adverse Event|25
2127062|NCT01007435|3728563|FG002|Overall Study|Adverse Event|47
2127063|NCT01007435|3728564|FG003|Overall Study|Adverse Event|31
2127064|NCT01007435|3728561|FG000|Overall Study|Death|2
2127065|NCT01007435|3728562|FG001|Overall Study|Death|4
2127066|NCT01007435|3728563|FG002|Overall Study|Death|2
2127067|NCT01007435|3728564|FG003|Overall Study|Death|1
2127068|NCT01007435|3728561|FG000|Overall Study|Insufficient Therapeutic Response|21
2127069|NCT01007435|3728562|FG001|Overall Study|Insufficient Therapeutic Response|7
2127070|NCT01007435|3728563|FG002|Overall Study|Insufficient Therapeutic Response|2
2127071|NCT01007435|3728564|FG003|Overall Study|Insufficient Therapeutic Response|9
2127072|NCT01007435|3728561|FG000|Overall Study|Violation of Selection Criteria at Entry|3
2127073|NCT01007435|3728562|FG001|Overall Study|Violation of Selection Criteria at Entry|5
2127074|NCT01007435|3728563|FG002|Overall Study|Violation of Selection Criteria at Entry|2
2127075|NCT01007435|3728564|FG003|Overall Study|Violation of Selection Criteria at Entry|0
2127076|NCT01007435|3728561|FG000|Overall Study|Other Protocol Violation|2
2127077|NCT01007435|3728562|FG001|Overall Study|Other Protocol Violation|0
2127078|NCT01007435|3728563|FG002|Overall Study|Other Protocol Violation|1
2127079|NCT01007435|3728564|FG003|Overall Study|Other Protocol Violation|0
2127080|NCT01007435|3728561|FG000|Overall Study|Refused Treatment|13
2127081|NCT01007435|3728562|FG001|Overall Study|Refused Treatment|13
2127082|NCT01007435|3728563|FG002|Overall Study|Refused Treatment|5
2127083|NCT01007435|3728564|FG003|Overall Study|Refused Treatment|8
2127084|NCT01007435|3728561|FG000|Overall Study|Failure to Return|5
2127085|NCT01007435|3728562|FG001|Overall Study|Failure to Return|4
2127086|NCT01007435|3728563|FG002|Overall Study|Failure to Return|3
2127087|NCT01007435|3728564|FG003|Overall Study|Failure to Return|6
2127088|NCT01007435|3728561|FG000|Overall Study|Reason not Specified|1
2127089|NCT01007435|3728562|FG001|Overall Study|Reason not Specified|1
2127090|NCT01007435|3728563|FG002|Overall Study|Reason not Specified|2
2127091|NCT01007435|3728564|FG003|Overall Study|Reason not Specified|1
2127092|NCT01007448|3728576|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1
2127093|NCT01007448|3728577|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0
2127094|NCT01007448|3728576|FG000|Overall Study|Staph Skin Infection Flare|1
2127095|NCT01007448|3728577|FG001|Overall Study|Staph Skin Infection Flare|0
2127096|NCT01007448|3728576|FG000|Overall Study|Participant Leaving the Country|1
2127097|NCT01007448|3728577|FG001|Overall Study|Participant Leaving the Country|0
2127098|NCT01007448|3728576|FG000|Overall Study|Participant Given Prohibited Medication|1
2127099|NCT01007448|3728577|FG001|Overall Study|Participant Given Prohibited Medication|0
2127100|NCT01007448|3728576|FG000|Overall Study|Progressive Disease|1
2127101|NCT01007448|3728577|FG001|Overall Study|Progressive Disease|2
2127102|NCT01007448|3728576|FG000|Overall Study|Lack of Efficacy|2
2127103|NCT01007448|3728577|FG001|Overall Study|Lack of Efficacy|0
2127104|NCT01007448|3728576|FG000|Overall Study|Withdrawal by Subject|2
2127105|NCT01007448|3728577|FG001|Overall Study|Withdrawal by Subject|3
2127106|NCT01007448|3728576|FG000|Overall Study|Adverse Event|1
2127107|NCT01007448|3728577|FG001|Overall Study|Adverse Event|4
2127108|NCT01007552|3728587|FG000|Overall Study|Withdrawal by Subject|1
2127109|NCT01007812|3728613|FG000|Period 1, One Week|Lost to Follow-up|0
2127110|NCT01007812|3728614|FG001|Period 1, One Week|Lost to Follow-up|1
2127111|NCT01007812|3728613|FG000|Period 1, One Week|Discomfort|1
2127112|NCT01007812|3728614|FG001|Period 1, One Week|Discomfort|0
2127113|NCT01007838|3728624|FG000|Overall Study|Withdrawal by Subject|1
2127114|NCT01007838|3728625|FG001|Overall Study|Withdrawal by Subject|0
2127115|NCT01007838|3728626|FG002|Overall Study|Withdrawal by Subject|0
2127116|NCT01007838|3728627|FG003|Overall Study|Withdrawal by Subject|0
2127117|NCT01007838|3728624|FG000|Overall Study|Physician Decision|1
2127118|NCT01007838|3728625|FG001|Overall Study|Physician Decision|0
2127119|NCT01007838|3728626|FG002|Overall Study|Physician Decision|0
2127120|NCT01007838|3728627|FG003|Overall Study|Physician Decision|0
2127121|NCT01007838|3728624|FG000|Overall Study|Started home haemodialysis|1
2127122|NCT01007838|3728625|FG001|Overall Study|Started home haemodialysis|0
2127123|NCT01007838|3728626|FG002|Overall Study|Started home haemodialysis|0
2205701|NCT01611974|3843661|FG000|Overall Study|Lost to Follow-up|0
2205702|NCT01611974|3843662|FG001|Overall Study|Lost to Follow-up|1
2127124|NCT01007838|3728627|FG003|Overall Study|Started home haemodialysis|0
2127125|NCT01007916|3728637|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
2127126|NCT01007916|3728638|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
2127127|NCT01007916|3728637|FG000|Period 2, 4 Weeks of Wear|Relocation|1
2127128|NCT01007916|3728638|FG001|Period 2, 4 Weeks of Wear|Relocation|0
2127129|NCT01007942|3728646|FG000|Overall Study|Adverse Event|29
2127130|NCT01007942|3728647|FG001|Overall Study|Adverse Event|14
2127131|NCT01007942|3728646|FG000|Overall Study|Abnormal test procedure|0
2127132|NCT01007942|3728647|FG001|Overall Study|Abnormal test procedure|1
2127133|NCT01007942|3728646|FG000|Overall Study|Disease progression|217
2127134|NCT01007942|3728647|FG001|Overall Study|Disease progression|242
2127135|NCT01007942|3728646|FG000|Overall Study|New cancer therapy|5
2127136|NCT01007942|3728647|FG001|Overall Study|New cancer therapy|1
2127137|NCT01007942|3728646|FG000|Overall Study|Protocol Violation|1
2127138|NCT01007942|3728647|FG001|Overall Study|Protocol Violation|1
2127139|NCT01007942|3728646|FG000|Overall Study|Withdrawal by Subject|19
2127140|NCT01007942|3728647|FG001|Overall Study|Withdrawal by Subject|14
2127141|NCT01007942|3728646|FG000|Overall Study|Lost to Follow-up|1
2127142|NCT01007942|3728647|FG001|Overall Study|Lost to Follow-up|0
2127143|NCT01007942|3728646|FG000|Overall Study|Administrative problems|2
2127144|NCT01007942|3728647|FG001|Overall Study|Administrative problems|0
2127145|NCT01007942|3728646|FG000|Overall Study|Death|3
2127146|NCT01007942|3728647|FG001|Overall Study|Death|2
2127147|NCT01007942|3728646|FG000|Overall Study|Patients untreated|4
2127148|NCT01007942|3728647|FG001|Overall Study|Patients untreated|3
2127149|NCT01008150|3728688|FG000|Overall Study|did not receive study drug|1
2127150|NCT01008150|3728689|FG001|Overall Study|did not receive study drug|1
2127151|NCT01008150|3728690|FG002|Overall Study|did not receive study drug|1
2127152|NCT01008150|3728691|FG003|Overall Study|did not receive study drug|0
2127153|NCT01008410|3728726|FG000|Overall Study|Adverse Event|13
2127154|NCT01008410|3728727|FG001|Overall Study|Adverse Event|7
2127155|NCT01008410|3728726|FG000|Overall Study|Withdrawal by Subject|6
2127156|NCT01008410|3728727|FG001|Overall Study|Withdrawal by Subject|2
2127157|NCT01008410|3728726|FG000|Overall Study|Lost to Follow-up|1
2127158|NCT01008410|3728727|FG001|Overall Study|Lost to Follow-up|0
2127159|NCT01008410|3728726|FG000|Overall Study|Noncompliance|1
2127160|NCT01008410|3728727|FG001|Overall Study|Noncompliance|0
2127161|NCT01008410|3728726|FG000|Overall Study|Low Cortisol|2
2127162|NCT01008410|3728727|FG001|Overall Study|Low Cortisol|0
2127163|NCT01008410|3728726|FG000|Overall Study|Lack of Efficacy|2
2127164|NCT01008410|3728727|FG001|Overall Study|Lack of Efficacy|6
2127165|NCT01008410|3728726|FG000|Overall Study|Met Exclusion Criterion|0
2127166|NCT01008410|3728727|FG001|Overall Study|Met Exclusion Criterion|1
2127167|NCT01008423|3728735|FG000|Overall Study|Adverse Event|13
2127168|NCT01008423|3728736|FG001|Overall Study|Adverse Event|6
2127169|NCT01008423|3728735|FG000|Overall Study|Withdrawal by Subject|4
2127170|NCT01008423|3728736|FG001|Overall Study|Withdrawal by Subject|7
2127171|NCT01008423|3728735|FG000|Overall Study|Lost to Follow-up|0
2127172|NCT01008423|3728736|FG001|Overall Study|Lost to Follow-up|2
2127173|NCT01008423|3728735|FG000|Overall Study|Low Cortisol|0
2127174|NCT01008423|3728736|FG001|Overall Study|Low Cortisol|1
2127175|NCT01008423|3728735|FG000|Overall Study|Lack of Efficacy|0
2127176|NCT01008423|3728736|FG001|Overall Study|Lack of Efficacy|5
2127177|NCT01008423|3728735|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1
2127178|NCT01008423|3728736|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0
2127179|NCT01008423|3728735|FG000|Overall Study|Personal Conflict|1
2127180|NCT01008423|3728736|FG001|Overall Study|Personal Conflict|0
2127181|NCT01008423|3728735|FG000|Overall Study|Other|0
2127182|NCT01008423|3728736|FG001|Overall Study|Other|1
2127183|NCT01008449|3728744|FG000|Overall Study|Lost to Follow-up|29
2127184|NCT01008449|3728745|FG001|Overall Study|Lost to Follow-up|19
2127185|NCT01008475|3728762|FG000|Overall Study|Ongoing treatment at data cut-off date|0
2127186|NCT01008475|3728763|FG001|Overall Study|Ongoing treatment at data cut-off date|0
2127187|NCT01008475|3728764|FG002|Overall Study|Ongoing treatment at data cut-off date|0
2127188|NCT01008475|3728765|FG003|Overall Study|Ongoing treatment at data cut-off date|0
2127189|NCT01008475|3728766|FG004|Overall Study|Ongoing treatment at data cut-off date|5
2127190|NCT01008475|3728767|FG005|Overall Study|Ongoing treatment at data cut-off date|6
2127191|NCT01008475|3728768|FG006|Overall Study|Ongoing treatment at data cut-off date|4
2127192|NCT01008553|3728784|FG000|Period 1 (Titration Period)|Physician Decision|2
2127193|NCT01008553|3728785|FG001|Period 1 (Titration Period)|Physician Decision|0
2127194|NCT01008553|3728786|FG002|Period 1 (Titration Period)|Physician Decision|0
2127195|NCT01008553|3728784|FG000|Period 1 (Titration Period)|Adverse Event|33
2127196|NCT01008553|3728785|FG001|Period 1 (Titration Period)|Adverse Event|0
2127197|NCT01008553|3728786|FG002|Period 1 (Titration Period)|Adverse Event|0
2127198|NCT01008553|3728784|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6
2127199|NCT01008553|3728785|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
2127200|NCT01008553|3728786|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
2127201|NCT01008553|3728784|FG000|Period 1 (Titration Period)|Determined to increase dosage|3
2127202|NCT01008553|3728785|FG001|Period 1 (Titration Period)|Determined to increase dosage|0
2127203|NCT01008553|3728786|FG002|Period 1 (Titration Period)|Determined to increase dosage|0
2127204|NCT01008553|3728784|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
2127205|NCT01008553|3728785|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2127206|NCT01008553|3728786|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2127207|NCT01008553|3728784|FG000|Period 1 (Titration Period)|Not appropriate for this study|1
2127208|NCT01008553|3728785|FG001|Period 1 (Titration Period)|Not appropriate for this study|0
2127209|NCT01008553|3728786|FG002|Period 1 (Titration Period)|Not appropriate for this study|0
2127210|NCT01008553|3728784|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
2127211|NCT01008553|3728785|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
2127212|NCT01008553|3728786|FG002|Period 2 (Double-Blind Period)|Physician Decision|2
2127213|NCT01008553|3728784|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
2127214|NCT01008553|3728785|FG001|Period 2 (Double-Blind Period)|Adverse Event|14
2127215|NCT01008553|3728786|FG002|Period 2 (Double-Blind Period)|Adverse Event|4
2127216|NCT01008553|3728784|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
2127217|NCT01008553|3728785|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
2127218|NCT01008553|3728786|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
2127219|NCT01008553|3728784|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
2127220|NCT01008553|3728785|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
2127221|NCT01008553|3728786|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
2127222|NCT01008553|3728784|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
2127223|NCT01008553|3728785|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
2127224|NCT01008553|3728786|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
2127225|NCT01008553|3728784|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
2127226|NCT01008553|3728785|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
2127227|NCT01008553|3728786|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
2127228|NCT01008553|3728784|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2127229|NCT01008553|3728785|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2127230|NCT01008553|3728786|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
2127231|NCT01008553|3728784|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
2127232|NCT01008553|3728785|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
2127233|NCT01008553|3728786|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
2127234|NCT01008618|3728807|FG000|Period 1 (Titration Period)|Physician Decision|2
2127235|NCT01008618|3728808|FG001|Period 1 (Titration Period)|Physician Decision|0
2127236|NCT01008618|3728809|FG002|Period 1 (Titration Period)|Physician Decision|0
2127237|NCT01008618|3728807|FG000|Period 1 (Titration Period)|Adverse Event|33
2127238|NCT01008618|3728808|FG001|Period 1 (Titration Period)|Adverse Event|0
2127239|NCT01008618|3728809|FG002|Period 1 (Titration Period)|Adverse Event|0
2127240|NCT01008618|3728807|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11
2127241|NCT01008618|3728808|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
2127242|NCT01008618|3728809|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
2127243|NCT01008618|3728807|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
2127244|NCT01008618|3728808|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2127245|NCT01008618|3728809|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2127246|NCT01008618|3728807|FG000|Period 1 (Titration Period)|Aggravated symptom|2
2127247|NCT01008618|3728808|FG001|Period 1 (Titration Period)|Aggravated symptom|0
2127248|NCT01008618|3728809|FG002|Period 1 (Titration Period)|Aggravated symptom|0
2127249|NCT01008618|3728807|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
2127250|NCT01008618|3728808|FG001|Period 2 (Double-Blind Period)|Adverse Event|11
2127251|NCT01008618|3728809|FG002|Period 2 (Double-Blind Period)|Adverse Event|2
2127252|NCT01008618|3728807|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
2127253|NCT01008618|3728808|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
2127254|NCT01008618|3728809|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
2127255|NCT01008618|3728807|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
2127256|NCT01008618|3728808|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
2127257|NCT01008618|3728809|FG002|Period 2 (Double-Blind Period)|Physician Decision|0
2127258|NCT01008618|3728807|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
2127259|NCT01008618|3728808|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
2127260|NCT01008618|3728809|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
2127261|NCT01008618|3728807|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2127262|NCT01008618|3728808|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2127263|NCT01008618|3728809|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
2127264|NCT01008618|3728807|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
2127265|NCT01008618|3728808|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
2127266|NCT01008618|3728809|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
2127267|NCT01008618|3728807|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0
2127268|NCT01008618|3728808|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0
2127269|NCT01008618|3728809|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1
2127270|NCT01008696|3728820|FG000|Overall Study|Participant's evasion of hospital visit|5
2205703|NCT01611974|3843663|FG002|Overall Study|Lost to Follow-up|0
2127271|NCT01008696|3728821|FG001|Overall Study|Participant's evasion of hospital visit|4
2127272|NCT01008696|3728820|FG000|Overall Study|Withdrawal by Subject|2
2127273|NCT01008696|3728821|FG001|Overall Study|Withdrawal by Subject|4
2127274|NCT01008696|3728820|FG000|Overall Study|Physician Decision|5
2127275|NCT01008696|3728821|FG001|Overall Study|Physician Decision|1
2127276|NCT01008696|3728820|FG000|Overall Study|Adverse Event|1
2127277|NCT01008696|3728821|FG001|Overall Study|Adverse Event|0
2127278|NCT01008696|3728820|FG000|Overall Study|Participants' non-cooperation|2
2127279|NCT01008696|3728821|FG001|Overall Study|Participants' non-cooperation|3
2127280|NCT01008696|3728820|FG000|Overall Study|Other|2
2127281|NCT01008696|3728821|FG001|Overall Study|Other|3
2127282|NCT01008696|3728820|FG000|Overall Study|Other|0
2127283|NCT01008696|3728821|FG001|Overall Study|Other|2
2127284|NCT01008748|3728837|FG000|Overall Study|Lost to Follow-up|80
2127285|NCT01008748|3728837|FG000|Overall Study|Other|1
2127286|NCT01008904|3728841|FG000|Overall Study|Lost to Follow-up|1
2127287|NCT01008904|3728841|FG000|Overall Study|Adverse Event|2
2127288|NCT01008904|3728841|FG000|Overall Study|unexpected unrelated surgery|1
2127289|NCT01008943|3728845|FG000|Overall Study|Withdrawal by Subject|1
2127290|NCT01008995|3728855|FG000|Controlled Period|Adverse Event|1
2127291|NCT01008995|3728856|FG001|Controlled Period|Adverse Event|2
2127292|NCT01008995|3728857|FG002|Controlled Period|Adverse Event|0
2127293|NCT01008995|3728858|FG003|Controlled Period|Adverse Event|0
2127294|NCT01008995|3728855|FG000|Controlled Period|Other|2
2127295|NCT01008995|3728856|FG001|Controlled Period|Other|1
2127296|NCT01008995|3728857|FG002|Controlled Period|Other|0
2127297|NCT01008995|3728858|FG003|Controlled Period|Other|0
2127298|NCT01008995|3728855|FG000|After Controlled Period|Adverse Event|0
2127299|NCT01008995|3728856|FG001|After Controlled Period|Adverse Event|0
2127300|NCT01008995|3728857|FG002|After Controlled Period|Adverse Event|1
2127301|NCT01008995|3728858|FG003|After Controlled Period|Adverse Event|1
2127302|NCT01008995|3728855|FG000|After Controlled Period|Other|0
2127303|NCT01008995|3728856|FG001|After Controlled Period|Other|0
2127304|NCT01008995|3728857|FG002|After Controlled Period|Other|1
2127305|NCT01008995|3728858|FG003|After Controlled Period|Other|0
2177992|NCT01379703|3802501|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2
2177993|NCT01379703|3802502|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0
2177994|NCT01379703|3802500|FG000|9 Months Through 18 Months|Fatigue|0
2177995|NCT01379703|3802501|FG001|9 Months Through 18 Months|Fatigue|1
2177996|NCT01379703|3802502|FG002|9 Months Through 18 Months|Fatigue|0
2177997|NCT01379703|3802500|FG000|9 Months Through 18 Months|Reason Unknown|0
2177998|NCT01379703|3802501|FG001|9 Months Through 18 Months|Reason Unknown|23
2177999|NCT01379703|3802502|FG002|9 Months Through 18 Months|Reason Unknown|0
2178000|NCT01379768|3802514|FG000|Overall Study|Adverse Event|1
2178001|NCT01379768|3802515|FG001|Overall Study|Adverse Event|1
2178002|NCT01379768|3802516|FG002|Overall Study|Adverse Event|0
2178003|NCT01379768|3802514|FG000|Overall Study|Lost to Follow-up|2
2178004|NCT01379768|3802515|FG001|Overall Study|Lost to Follow-up|0
2178005|NCT01379768|3802516|FG002|Overall Study|Lost to Follow-up|0
2178006|NCT01379781|3802526|FG000|Overall Study|Lost to Follow-up|11
2178007|NCT01379781|3802527|FG001|Overall Study|Lost to Follow-up|8
2178008|NCT01379937|3802549|FG000|Overall Study|Protocol Violation|0
2205704|NCT01611974|3843661|FG000|Overall Study|Physician Decision|5
2205705|NCT01611974|3843662|FG001|Overall Study|Physician Decision|1
2205706|NCT01611974|3843663|FG002|Overall Study|Physician Decision|2
2205707|NCT01611974|3843661|FG000|Overall Study|Withdrawal by Subject|0
2205708|NCT01611974|3843662|FG001|Overall Study|Withdrawal by Subject|1
2205709|NCT01611974|3843663|FG002|Overall Study|Withdrawal by Subject|4
2205710|NCT01612000|3843675|FG000|Overall Study|Lost to Follow-up|6
2178009|NCT01379937|3802550|FG001|Overall Study|Protocol Violation|0
2178010|NCT01379937|3802551|FG002|Overall Study|Protocol Violation|0
2178011|NCT01379937|3802552|FG003|Overall Study|Protocol Violation|1
2178012|NCT01379937|3802549|FG000|Overall Study|Consent withdrawal|0
2178013|NCT01379937|3802550|FG001|Overall Study|Consent withdrawal|1
2178014|NCT01379937|3802551|FG002|Overall Study|Consent withdrawal|0
2178015|NCT01379937|3802552|FG003|Overall Study|Consent withdrawal|0
2178016|NCT01379937|3802549|FG000|Overall Study|Lost to Follow-up|1
2178017|NCT01379937|3802550|FG001|Overall Study|Lost to Follow-up|2
2178018|NCT01379937|3802551|FG002|Overall Study|Lost to Follow-up|2
2178019|NCT01379937|3802552|FG003|Overall Study|Lost to Follow-up|0
2178020|NCT01380080|3802573|FG000|Overall Study|Death|36
2178021|NCT01380080|3802574|FG001|Overall Study|Death|44
2178022|NCT01380080|3802573|FG000|Overall Study|Site is closing|28
2178023|NCT01380080|3802574|FG001|Overall Study|Site is closing|31
2178024|NCT01380080|3802573|FG000|Overall Study|Not able to get to clinic|7
2178025|NCT01380080|3802574|FG001|Overall Study|Not able to get to clinic|1
2178026|NCT01380080|3802573|FG000|Overall Study|Not willing to adhere to requirements|6
2178027|NCT01380080|3802574|FG001|Overall Study|Not willing to adhere to requirements|2
2178028|NCT01380080|3802573|FG000|Overall Study|Withdrawal by Subject|5
2178029|NCT01380080|3802574|FG001|Overall Study|Withdrawal by Subject|2
2178030|NCT01380080|3802573|FG000|Overall Study|Lost to Follow-up|3
2205711|NCT01612000|3843676|FG001|Overall Study|Lost to Follow-up|4
2205712|NCT01612000|3843677|FG002|Overall Study|Lost to Follow-up|4
2205713|NCT01612000|3843678|FG003|Overall Study|Lost to Follow-up|8
2127306|NCT01009034|3728866|FG000|Overall Study|Lost to Follow-up|2
2127307|NCT01009034|3728866|FG000|Overall Study|Withdrawal by Subject|2
2127308|NCT01009047|3728872|FG000|Overall Study|Adverse Event|5
2127309|NCT01009047|3728873|FG001|Overall Study|Adverse Event|0
2127310|NCT01009047|3728872|FG000|Overall Study|Lost to Follow-up|0
2127311|NCT01009047|3728873|FG001|Overall Study|Lost to Follow-up|2
2127312|NCT01009047|3728872|FG000|Overall Study|Lack of Efficacy|4
2127313|NCT01009047|3728873|FG001|Overall Study|Lack of Efficacy|11
2127314|NCT01009047|3728872|FG000|Overall Study|Withdrawal by consent|16
2127315|NCT01009047|3728873|FG001|Overall Study|Withdrawal by consent|11
2127316|NCT01009047|3728872|FG000|Overall Study|Other|3
2127317|NCT01009047|3728873|FG001|Overall Study|Other|2
2127318|NCT01009060|3728881|FG000|Overall Study|Adverse Event|1
2127319|NCT01009060|3728882|FG001|Overall Study|Adverse Event|2
2127320|NCT01009060|3728881|FG000|Overall Study|Protocol Violation|0
2127321|NCT01009060|3728882|FG001|Overall Study|Protocol Violation|1
2127322|NCT01009060|3728881|FG000|Overall Study|Lost to Follow-up|1
2127323|NCT01009060|3728882|FG001|Overall Study|Lost to Follow-up|0
2127324|NCT01009060|3728881|FG000|Overall Study|Physician Decision|1
2127325|NCT01009060|3728882|FG001|Overall Study|Physician Decision|1
2127326|NCT01009060|3728881|FG000|Overall Study|Withdrawal by Subject|1
2127327|NCT01009060|3728882|FG001|Overall Study|Withdrawal by Subject|1
2127328|NCT01009086|3728895|FG000|Overall Study|Lack of Efficacy|16
2127329|NCT01009086|3728896|FG001|Overall Study|Lack of Efficacy|15
2127330|NCT01009086|3728897|FG002|Overall Study|Lack of Efficacy|9
2127331|NCT01009086|3728895|FG000|Overall Study|Lost to Follow-up|4
2127332|NCT01009086|3728896|FG001|Overall Study|Lost to Follow-up|5
2127333|NCT01009086|3728897|FG002|Overall Study|Lost to Follow-up|3
2127334|NCT01009086|3728895|FG000|Overall Study|Adverse Event|12
2127335|NCT01009086|3728896|FG001|Overall Study|Adverse Event|11
2127336|NCT01009086|3728897|FG002|Overall Study|Adverse Event|8
2127337|NCT01009086|3728895|FG000|Overall Study|Withdrawal by Subject|9
2127338|NCT01009086|3728896|FG001|Overall Study|Withdrawal by Subject|11
2127339|NCT01009086|3728897|FG002|Overall Study|Withdrawal by Subject|13
2127340|NCT01009086|3728895|FG000|Overall Study|Other|3
2127341|NCT01009086|3728896|FG001|Overall Study|Other|5
2127342|NCT01009086|3728897|FG002|Overall Study|Other|1
2127343|NCT01009099|3728912|FG000|Overall Study|Lost to Follow-up|1
2127344|NCT01009099|3728913|FG001|Overall Study|Lost to Follow-up|0
2127345|NCT01009099|3728912|FG000|Overall Study|Physician Decision|3
2127346|NCT01009099|3728913|FG001|Overall Study|Physician Decision|2
2127347|NCT01009099|3728912|FG000|Overall Study|Withdrawal by Subject|1
2282453|NCT02384941|3968463|FG001|Overall Study|Non-Compliance With Study Drug|0
2282454|NCT02384941|3968464|FG002|Overall Study|Non-Compliance With Study Drug|1
2282455|NCT02384941|3968462|FG000|Overall Study|Physician Decision|1
2282456|NCT02384941|3968463|FG001|Overall Study|Physician Decision|1
2282457|NCT02384941|3968464|FG002|Overall Study|Physician Decision|0
2282458|NCT02384941|3968462|FG000|Overall Study|Protocol Violation|3
2282459|NCT02384941|3968463|FG001|Overall Study|Protocol Violation|0
2282460|NCT02384941|3968464|FG002|Overall Study|Protocol Violation|0
2282461|NCT02384941|3968462|FG000|Overall Study|Withdrawal by Subject|26
2282462|NCT02384941|3968463|FG001|Overall Study|Withdrawal by Subject|19
2282463|NCT02384941|3968464|FG002|Overall Study|Withdrawal by Subject|20
2282464|NCT02384941|3968462|FG000|Overall Study|Pregnancy|0
2282465|NCT02384941|3968463|FG001|Overall Study|Pregnancy|0
2282466|NCT02384941|3968464|FG002|Overall Study|Pregnancy|1
2282467|NCT02384941|3968462|FG000|Overall Study|Other than specified above|4
2127348|NCT01009099|3728913|FG001|Overall Study|Withdrawal by Subject|1
2127349|NCT01009099|3728912|FG000|Overall Study|Death|0
2127350|NCT01009099|3728913|FG001|Overall Study|Death|1
2127351|NCT01009203|3728928|FG000|Overall Study|Withdrawal by Subject|1
2127352|NCT01009203|3728928|FG000|Overall Study|Adverse Event|5
2127353|NCT01009203|3728928|FG000|Overall Study|Treatment-unrelated death|1
2127354|NCT01009281|3728932|FG000|Overall Study|Administrative problems|7
2127355|NCT01009346|3728949|FG000|Overall Study|Adverse Event|4
2127356|NCT01009463|3728958|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
2127357|NCT01009463|3728959|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2127358|NCT01009463|3728960|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2127359|NCT01009463|3728961|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2127360|NCT01009463|3728962|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2127361|NCT01009463|3728958|FG000|4-week, Open-label Run-In Period|Adverse Event|10
2127362|NCT01009463|3728959|FG001|4-week, Open-label Run-In Period|Adverse Event|0
2127363|NCT01009463|3728960|FG002|4-week, Open-label Run-In Period|Adverse Event|0
2127364|NCT01009463|3728961|FG003|4-week, Open-label Run-In Period|Adverse Event|0
2127365|NCT01009463|3728962|FG004|4-week, Open-label Run-In Period|Adverse Event|0
2127366|NCT01009463|3728958|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
2127367|NCT01009463|3728959|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
2127368|NCT01009463|3728960|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
2127369|NCT01009463|3728961|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
2127370|NCT01009463|3728962|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
2282468|NCT02384941|3968463|FG001|Overall Study|Other than specified above|0
2282469|NCT02384941|3968464|FG002|Overall Study|Other than specified above|1
2127371|NCT01009463|3728958|FG000|4-week, Open-label Run-In Period|Physician Decision|10
2127372|NCT01009463|3728959|FG001|4-week, Open-label Run-In Period|Physician Decision|0
2127373|NCT01009463|3728960|FG002|4-week, Open-label Run-In Period|Physician Decision|0
2127374|NCT01009463|3728961|FG003|4-week, Open-label Run-In Period|Physician Decision|0
2127375|NCT01009463|3728962|FG004|4-week, Open-label Run-In Period|Physician Decision|0
2127376|NCT01009463|3728958|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50
2127377|NCT01009463|3728959|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2127378|NCT01009463|3728960|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2127379|NCT01009463|3728961|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2127380|NCT01009463|3728962|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2127381|NCT01009463|3728958|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
2127382|NCT01009463|3728959|FG001|52-week, Double-blind Treatment Period|Adverse Event|22
2127383|NCT01009463|3728960|FG002|52-week, Double-blind Treatment Period|Adverse Event|25
2127384|NCT01009463|3728961|FG003|52-week, Double-blind Treatment Period|Adverse Event|29
2127385|NCT01009463|3728962|FG004|52-week, Double-blind Treatment Period|Adverse Event|31
2127386|NCT01009463|3728958|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
2127387|NCT01009463|3728959|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
2127388|NCT01009463|3728960|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
2127389|NCT01009463|3728961|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
2127390|NCT01009463|3728962|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
2127391|NCT01009463|3728958|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
2127392|NCT01009463|3728959|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24
2127393|NCT01009463|3728960|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16
2127394|NCT01009463|3728961|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11
2127395|NCT01009463|3728962|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18
2127396|NCT01009463|3728958|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
2127397|NCT01009463|3728959|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8
2127398|NCT01009463|3728960|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7
2127399|NCT01009463|3728961|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8
2127400|NCT01009463|3728962|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7
2127401|NCT01009463|3728958|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2127402|NCT01009463|3728959|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
2127403|NCT01009463|3728960|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
2127404|NCT01009463|3728961|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
2127405|NCT01009463|3728962|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
2127406|NCT01009463|3728958|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2127407|NCT01009463|3728959|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
2127408|NCT01009463|3728960|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2127409|NCT01009463|3728961|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
2127410|NCT01009463|3728962|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2127411|NCT01009463|3728958|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
2127412|NCT01009463|3728959|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11
2205714|NCT01612000|3843675|FG000|Overall Study|Physician Decision|0
2205715|NCT01612000|3843676|FG001|Overall Study|Physician Decision|0
2205716|NCT01612000|3843677|FG002|Overall Study|Physician Decision|1
2205717|NCT01612000|3843678|FG003|Overall Study|Physician Decision|0
2205718|NCT01612000|3843675|FG000|Overall Study|Withdrawal by Subject|3
2205719|NCT01612000|3843676|FG001|Overall Study|Withdrawal by Subject|1
2205720|NCT01612000|3843677|FG002|Overall Study|Withdrawal by Subject|2
2205721|NCT01612000|3843678|FG003|Overall Study|Withdrawal by Subject|2
2205722|NCT01612156|3843690|FG000|Overall Study|Protocol Violation|2
2205723|NCT01612156|3843691|FG001|Overall Study|Protocol Violation|0
2205724|NCT01612676|3843723|FG000|Overall Study|Adverse Event|2
2205725|NCT01612676|3843724|FG001|Overall Study|Adverse Event|3
2205726|NCT01612676|3843725|FG002|Overall Study|Adverse Event|1
2205727|NCT01612676|3843726|FG003|Overall Study|Adverse Event|3
2205728|NCT01612676|3843723|FG000|Overall Study|Protocol Violation|0
2205729|NCT01612676|3843724|FG001|Overall Study|Protocol Violation|1
2205730|NCT01612676|3843725|FG002|Overall Study|Protocol Violation|0
2205731|NCT01612676|3843726|FG003|Overall Study|Protocol Violation|0
2205732|NCT01612702|3843740|FG000|Overall Study|Protocol Violation|11
2205733|NCT01612702|3843741|FG001|Overall Study|Protocol Violation|11
2205734|NCT01612780|3843772|FG000|Overall Study|Treatment not completed|1
2205735|NCT01612780|3843772|FG000|Overall Study|Withdrawal by Subject|5
2205736|NCT01612858|3843787|FG000|Overall Study|Withdrawal by Subject|5
2282470|NCT02385084|3968473|FG000|Period 2|Protocol Violation|0
2282471|NCT02385084|3968474|FG001|Period 2|Protocol Violation|0
2282472|NCT02385084|3968475|FG002|Period 2|Protocol Violation|1
2282473|NCT02385084|3968476|FG003|Period 2|Protocol Violation|0
2282474|NCT02385084|3968477|FG004|Period 2|Protocol Violation|0
2282475|NCT02385084|3968478|FG005|Period 2|Protocol Violation|0
2282476|NCT02385526|3968525|FG000|Overall Study|Withdrawal by Subject|0
2282477|NCT02385526|3968526|FG001|Overall Study|Withdrawal by Subject|2
2205737|NCT01612858|3843788|FG001|Overall Study|Withdrawal by Subject|1
2205738|NCT01613027|3843812|FG000|Overall Study|Lost to Follow-up|5
2205739|NCT01613027|3843812|FG000|Overall Study|Switched Physician|1
2205740|NCT01613027|3843812|FG000|Overall Study|Lack of Efficacy|1
2205741|NCT01613027|3843812|FG000|Overall Study|Patient's Decision Due to Adverse Event|1
2205742|NCT01613131|3843836|FG000|Overall Study|Withdrawal by Subject|3
2205743|NCT01613131|3843837|FG001|Overall Study|Withdrawal by Subject|5
2205744|NCT01613222|3843843|FG000|Overall Study|Physician Decision|1
2205745|NCT01613222|3843843|FG000|Overall Study|Unable to place arterial line|1
2205746|NCT01613222|3843843|FG000|Overall Study|Reused disposable sensors|10
2205747|NCT01613248|3843862|FG000|Overall Study|Adverse Event|0
2205748|NCT01613248|3843863|FG001|Overall Study|Adverse Event|0
2205749|NCT01613248|3843864|FG002|Overall Study|Adverse Event|0
2205750|NCT01613248|3843865|FG003|Overall Study|Adverse Event|1
2205751|NCT01613248|3843866|FG004|Overall Study|Adverse Event|0
2205752|NCT01613248|3843867|FG005|Overall Study|Adverse Event|0
2205753|NCT01613248|3843862|FG000|Overall Study|Withdrawal by Subject|3
2205754|NCT01613248|3843863|FG001|Overall Study|Withdrawal by Subject|2
2205755|NCT01613248|3843864|FG002|Overall Study|Withdrawal by Subject|2
2205756|NCT01613248|3843865|FG003|Overall Study|Withdrawal by Subject|5
2205757|NCT01613248|3843866|FG004|Overall Study|Withdrawal by Subject|0
2205758|NCT01613248|3843867|FG005|Overall Study|Withdrawal by Subject|1
2205759|NCT01613248|3843862|FG000|Overall Study|Lost to Follow-up|5
2205760|NCT01613248|3843863|FG001|Overall Study|Lost to Follow-up|7
2205761|NCT01613248|3843864|FG002|Overall Study|Lost to Follow-up|4
2205762|NCT01613248|3843865|FG003|Overall Study|Lost to Follow-up|8
2205763|NCT01613248|3843866|FG004|Overall Study|Lost to Follow-up|4
2127413|NCT01009463|3728960|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7
2127414|NCT01009463|3728961|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
2127415|NCT01009463|3728962|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5
2127416|NCT01009463|3728958|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
2127417|NCT01009463|3728959|FG001|52-week, Double-blind Treatment Period|Physician Decision|4
2127418|NCT01009463|3728960|FG002|52-week, Double-blind Treatment Period|Physician Decision|6
2127419|NCT01009463|3728961|FG003|52-week, Double-blind Treatment Period|Physician Decision|6
2127420|NCT01009463|3728962|FG004|52-week, Double-blind Treatment Period|Physician Decision|8
2127421|NCT01009515|3728973|FG000|Overall Study|Withdrawal by Subject|3
2127422|NCT01009554|3728979|FG000|Overall Study|Adverse Event|1
2127423|NCT01009554|3728980|FG001|Overall Study|Adverse Event|1
2127424|NCT01009554|3728979|FG000|Overall Study|Withdrawal by Subject|1
2127425|NCT01009554|3728980|FG001|Overall Study|Withdrawal by Subject|3
2127426|NCT01009554|3728979|FG000|Overall Study|Noncompliant with Study Product|0
2127427|NCT01009554|3728980|FG001|Overall Study|Noncompliant with Study Product|3
2127428|NCT01009580|3728988|FG000|Overall Study|Adverse Event|4
2127429|NCT01009580|3728989|FG001|Overall Study|Adverse Event|4
2127430|NCT01009580|3728988|FG000|Overall Study|Lack of Efficacy|0
2127431|NCT01009580|3728989|FG001|Overall Study|Lack of Efficacy|1
2127432|NCT01009580|3728988|FG000|Overall Study|Protocol Violation|2
2127433|NCT01009580|3728989|FG001|Overall Study|Protocol Violation|3
2127434|NCT01009580|3728988|FG000|Overall Study|Withdrawal Criteria|4
2205764|NCT01613248|3843867|FG005|Overall Study|Lost to Follow-up|2
2205765|NCT01613248|3843862|FG000|Overall Study|Study Terminated by Sponsor|4
2205766|NCT01613248|3843863|FG001|Overall Study|Study Terminated by Sponsor|6
2205767|NCT01613248|3843864|FG002|Overall Study|Study Terminated by Sponsor|8
2205768|NCT01613248|3843865|FG003|Overall Study|Study Terminated by Sponsor|8
2205769|NCT01613248|3843866|FG004|Overall Study|Study Terminated by Sponsor|9
2205770|NCT01613248|3843867|FG005|Overall Study|Study Terminated by Sponsor|11
2205771|NCT01613248|3843862|FG000|Overall Study|Physician Decision|8
2205772|NCT01613248|3843863|FG001|Overall Study|Physician Decision|8
2205773|NCT01613248|3843864|FG002|Overall Study|Physician Decision|9
2205774|NCT01613248|3843865|FG003|Overall Study|Physician Decision|4
2205775|NCT01613248|3843866|FG004|Overall Study|Physician Decision|7
2205776|NCT01613248|3843867|FG005|Overall Study|Physician Decision|6
2205777|NCT01613248|3843862|FG000|Overall Study|Lack of Qualifying Event|9
2205778|NCT01613248|3843863|FG001|Overall Study|Lack of Qualifying Event|11
2205779|NCT01613248|3843864|FG002|Overall Study|Lack of Qualifying Event|10
2205780|NCT01613248|3843865|FG003|Overall Study|Lack of Qualifying Event|11
2205781|NCT01613248|3843866|FG004|Overall Study|Lack of Qualifying Event|15
2205782|NCT01613248|3843867|FG005|Overall Study|Lack of Qualifying Event|18
2205783|NCT01613248|3843862|FG000|Overall Study|Pregnancy|0
2205784|NCT01613248|3843863|FG001|Overall Study|Pregnancy|0
2282478|NCT02385526|3968527|FG002|Overall Study|Withdrawal by Subject|0
2282479|NCT02385526|3968525|FG000|Overall Study|Lost to Follow-up|0
2282480|NCT02385526|3968526|FG001|Overall Study|Lost to Follow-up|1
2282481|NCT02385526|3968527|FG002|Overall Study|Lost to Follow-up|0
2282482|NCT02385526|3968525|FG000|Overall Study|Physician Decision|1
2282483|NCT02385526|3968526|FG001|Overall Study|Physician Decision|0
2282484|NCT02385526|3968527|FG002|Overall Study|Physician Decision|0
2282485|NCT02385526|3968525|FG000|Overall Study|Protocol Violation|1
2282486|NCT02385526|3968526|FG001|Overall Study|Protocol Violation|0
2282487|NCT02385526|3968527|FG002|Overall Study|Protocol Violation|0
2282488|NCT02385669|3968535|FG000|Overall Study|Adverse Event|2
2282489|NCT02385708|3968541|FG000|Overall Study|Withdrawal by Subject|0
2282490|NCT02385708|3968542|FG001|Overall Study|Withdrawal by Subject|2
2282491|NCT02385708|3968541|FG000|Overall Study|Withdrawn - surgery canceled|2
2282492|NCT02385708|3968542|FG001|Overall Study|Withdrawn - surgery canceled|5
2282493|NCT02385708|3968541|FG000|Overall Study|Investigator decision|5
2282494|NCT02385708|3968542|FG001|Overall Study|Investigator decision|7
2282495|NCT02385708|3968541|FG000|Overall Study|Protocol Violation|1
2282496|NCT02385708|3968542|FG001|Overall Study|Protocol Violation|1
2282497|NCT02385799|3968554|FG000|Overall Study|Lost to Follow-up|1
2282498|NCT02385799|3968555|FG001|Overall Study|Lost to Follow-up|2
2282499|NCT02385799|3968554|FG000|Overall Study|Adverse Event|4
2282500|NCT02385799|3968555|FG001|Overall Study|Adverse Event|2
2282501|NCT02385799|3968554|FG000|Overall Study|Withdrawal by Subject|0
2282502|NCT02385799|3968555|FG001|Overall Study|Withdrawal by Subject|4
2282503|NCT02386098|3968566|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
2282504|NCT02386098|3968567|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
2282505|NCT02386098|3968568|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
2282506|NCT02386098|3968569|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
2282507|NCT02386098|3968570|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
2282508|NCT02386098|3968566|FG000|Stage 1 (96 Weeks)|Adverse Event|2
2282509|NCT02386098|3968567|FG001|Stage 1 (96 Weeks)|Adverse Event|1
2282510|NCT02386098|3968568|FG002|Stage 1 (96 Weeks)|Adverse Event|0
2282511|NCT02386098|3968569|FG003|Stage 1 (96 Weeks)|Adverse Event|0
2282512|NCT02386098|3968570|FG004|Stage 1 (96 Weeks)|Adverse Event|0
2282513|NCT02386098|3968566|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2
2282514|NCT02386098|3968567|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2
2282515|NCT02386098|3968568|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0
2282516|NCT02386098|3968569|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0
2282517|NCT02386098|3968570|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0
2127435|NCT01009580|3728989|FG001|Overall Study|Withdrawal Criteria|6
2127436|NCT01009580|3728988|FG000|Overall Study|Unclassified|17
2127437|NCT01009580|3728989|FG001|Overall Study|Unclassified|21
2127438|NCT01009645|3729008|FG000|Overall Study|Lost to Follow-up|2
2127439|NCT01009645|3729009|FG001|Overall Study|Lost to Follow-up|8
2127440|NCT01009645|3729010|FG002|Overall Study|Lost to Follow-up|4
2127441|NCT01009645|3729011|FG003|Overall Study|Lost to Follow-up|5
2127442|NCT01009814|3729037|FG000|Overall Study|No longer met study criteria|1
2127443|NCT01009814|3729038|FG001|Overall Study|No longer met study criteria|1
2127444|NCT01009814|3729039|FG002|Overall Study|No longer met study criteria|0
2127445|NCT01009814|3729040|FG003|Overall Study|No longer met study criteria|0
2127446|NCT01009814|3729041|FG004|Overall Study|No longer met study criteria|0
2127447|NCT01009840|3729057|FG000|Overall Study|Lost to Follow-up|1
2127448|NCT01009840|3729057|FG000|Overall Study|Adverse Event|4
2127449|NCT01009840|3729057|FG000|Overall Study|Subject Met Withdrawal Criteria|7
2127450|NCT01009840|3729057|FG000|Overall Study|Subject was Withdrawn by Investigator|1
2282518|NCT02386098|3968566|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2282519|NCT02386098|3968567|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
2282520|NCT02386098|3968568|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2282521|NCT02386098|3968569|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2282522|NCT02386098|3968570|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2282523|NCT02386098|3968566|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3
2282524|NCT02386098|3968567|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1
2282525|NCT02386098|3968568|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0
2282526|NCT02386098|3968569|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0
2127451|NCT01009840|3729057|FG000|Overall Study|Subject Withdrew Consent to Participate|1
2127452|NCT01009983|3729074|FG000|Overall Study|necessary scans not completed|1
2127453|NCT01010061|3729093|FG000|Overall Study|Adverse Events or Intercurrent Illness|33
2127454|NCT01010061|3729094|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
2127455|NCT01010061|3729093|FG000|Overall Study|Disease Progression|2
2127456|NCT01010061|3729094|FG001|Overall Study|Disease Progression|8
2127457|NCT01010061|3729093|FG000|Overall Study|Withdrew Consent|5
2127458|NCT01010061|3729094|FG001|Overall Study|Withdrew Consent|1
2127459|NCT01010061|3729093|FG000|Overall Study|Death|3
2127460|NCT01010061|3729094|FG001|Overall Study|Death|6
2127461|NCT01010061|3729093|FG000|Overall Study|Administrative/Other|0
2127462|NCT01010061|3729094|FG001|Overall Study|Administrative/Other|1
2127463|NCT01010061|3729093|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2
2127464|NCT01010061|3729094|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
2127465|NCT01010061|3729093|FG000|Overall Study|Insufficient Therapeutic Response|1
2127466|NCT01010061|3729094|FG001|Overall Study|Insufficient Therapeutic Response|5
2127467|NCT01010061|3729093|FG000|Overall Study|Violation of Selection Criteria|0
2127468|NCT01010061|3729094|FG001|Overall Study|Violation of Selection Criteria|1
2127469|NCT01010061|3729093|FG000|Overall Study|Did Not Receive Treatment|2
2127470|NCT01010061|3729094|FG001|Overall Study|Did Not Receive Treatment|2
2127471|NCT01010126|3729108|FG000|Overall Study|Withdrawal by Subject|1
2127472|NCT01010126|3729109|FG001|Overall Study|Withdrawal by Subject|0
2127473|NCT01010126|3729110|FG002|Overall Study|Withdrawal by Subject|1
2127474|NCT01010126|3729111|FG003|Overall Study|Withdrawal by Subject|0
2127475|NCT01010126|3729112|FG004|Overall Study|Withdrawal by Subject|3
2127476|NCT01010126|3729113|FG005|Overall Study|Withdrawal by Subject|0
2282527|NCT02386098|3968570|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0
2282528|NCT02386098|3968566|FG000|Stage 1 (96 Weeks)|Other|1
2282529|NCT02386098|3968567|FG001|Stage 1 (96 Weeks)|Other|0
2282530|NCT02386098|3968568|FG002|Stage 1 (96 Weeks)|Other|0
2282531|NCT02386098|3968569|FG003|Stage 1 (96 Weeks)|Other|0
2282532|NCT02386098|3968570|FG004|Stage 1 (96 Weeks)|Other|0
2282533|NCT02386098|3968566|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
2282534|NCT02386098|3968567|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
2127477|NCT01010204|3729129|FG000|Overall Study|Lost to Follow-up|2
2127478|NCT01010204|3729130|FG001|Overall Study|Lost to Follow-up|2
2127479|NCT01010204|3729129|FG000|Overall Study|Adverse Event|1
2127480|NCT01010204|3729130|FG001|Overall Study|Adverse Event|3
2127481|NCT01010204|3729129|FG000|Overall Study|Withdrawal by Subject|2
2127482|NCT01010204|3729130|FG001|Overall Study|Withdrawal by Subject|3
2127483|NCT01010204|3729129|FG000|Overall Study|psychiatric hospitalization|2
2127484|NCT01010204|3729130|FG001|Overall Study|psychiatric hospitalization|1
2127485|NCT01010217|3729141|FG000|Overall Study|Lost to Follow-up|4
2127486|NCT01010217|3729142|FG001|Overall Study|Lost to Follow-up|5
2127487|NCT01010217|3729143|FG002|Overall Study|Lost to Follow-up|1
2127488|NCT01010217|3729144|FG003|Overall Study|Lost to Follow-up|0
2127489|NCT01010217|3729145|FG004|Overall Study|Lost to Follow-up|0
2127490|NCT01010217|3729141|FG000|Overall Study|Withdrawal by Subject|1
2282535|NCT02386098|3968568|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
2127491|NCT01010217|3729142|FG001|Overall Study|Withdrawal by Subject|0
2127492|NCT01010217|3729143|FG002|Overall Study|Withdrawal by Subject|0
2127493|NCT01010217|3729144|FG003|Overall Study|Withdrawal by Subject|0
2127494|NCT01010217|3729145|FG004|Overall Study|Withdrawal by Subject|0
2127495|NCT01010217|3729141|FG000|Overall Study|Physician Decision|0
2127496|NCT01010217|3729142|FG001|Overall Study|Physician Decision|0
2127497|NCT01010217|3729143|FG002|Overall Study|Physician Decision|0
2127498|NCT01010217|3729144|FG003|Overall Study|Physician Decision|6
2127499|NCT01010217|3729145|FG004|Overall Study|Physician Decision|3
2127500|NCT01010230|3729159|FG000|Overall Study|Withdrawal by Subject|6
2205785|NCT01613248|3843864|FG002|Overall Study|Pregnancy|0
2205786|NCT01613248|3843865|FG003|Overall Study|Pregnancy|1
2205787|NCT01613248|3843866|FG004|Overall Study|Pregnancy|0
2205788|NCT01613248|3843867|FG005|Overall Study|Pregnancy|0
2205789|NCT01613326|3843900|FG000|Overall Study|Adverse Event|7
2282536|NCT02386098|3968569|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
2282537|NCT02386098|3968570|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
2282538|NCT02386189|3968584|FG000|Overall Study|Lost to Follow-up|2
2282539|NCT02386189|3968585|FG001|Overall Study|Lost to Follow-up|3
2282540|NCT02386189|3968584|FG000|Overall Study|Withdrawal by Subject|1
2282541|NCT02386189|3968585|FG001|Overall Study|Withdrawal by Subject|0
2282542|NCT02386189|3968584|FG000|Overall Study|Death|1
2282543|NCT02386189|3968585|FG001|Overall Study|Death|0
2282544|NCT02386345|3968600|FG000|Overall Study|Not treated|14
2282545|NCT02386345|3968600|FG000|Overall Study|Lost to Follow-up|1
2282546|NCT02386345|3968600|FG000|Overall Study|Adverse Event|5
2282547|NCT02386345|3968600|FG000|Overall Study|Repeat Procedure|10
2282548|NCT02386345|3968600|FG000|Overall Study|Did not complete 12-month follow-up|72
2282549|NCT02387164|3968633|FG000|Overall Study|Lost to Follow-up|2
2282550|NCT02387164|3968634|FG001|Overall Study|Lost to Follow-up|0
2282551|NCT02387164|3968633|FG000|Overall Study|Diagnosed|1
2282552|NCT02387164|3968634|FG001|Overall Study|Diagnosed|2
2282553|NCT02387216|3968642|FG000|Overall Study|Progressive disease|2
2282554|NCT02387216|3968643|FG001|Overall Study|Progressive disease|0
2282555|NCT02387216|3968642|FG000|Overall Study|Withdrawal by Subject|3
2282556|NCT02387216|3968643|FG001|Overall Study|Withdrawal by Subject|5
2282557|NCT02387216|3968642|FG000|Overall Study|Physician Decision|2
2282558|NCT02387216|3968643|FG001|Overall Study|Physician Decision|0
2282559|NCT02387216|3968642|FG000|Overall Study|Sponsor Decision|28
2282560|NCT02387216|3968643|FG001|Overall Study|Sponsor Decision|12
2282561|NCT02387216|3968642|FG000|Overall Study|Death|60
2282562|NCT02387216|3968643|FG001|Overall Study|Death|23
2282563|NCT02387216|3968642|FG000|Overall Study|Other|5
2282564|NCT02387216|3968643|FG001|Overall Study|Other|4
2282565|NCT02387216|3968642|FG000|Overall Study|Lost to Follow-up|0
2282566|NCT02387216|3968643|FG001|Overall Study|Lost to Follow-up|3
2282567|NCT02387372|3968678|FG000|Overall Study|Not Treated|1
2127501|NCT01010230|3729160|FG001|Overall Study|Withdrawal by Subject|5
2205790|NCT01613326|3843901|FG001|Overall Study|Adverse Event|5
2205791|NCT01613326|3843900|FG000|Overall Study|Withdrawal by Subject|3
2205792|NCT01613326|3843901|FG001|Overall Study|Withdrawal by Subject|4
2205793|NCT01613326|3843900|FG000|Overall Study|Abnormal test procedure result(s)|2
2205794|NCT01613326|3843901|FG001|Overall Study|Abnormal test procedure result(s)|0
2282568|NCT02387372|3968679|FG001|Overall Study|Not Treated|0
2282569|NCT02387580|3968740|FG000|Overall Study|Withdrawal by Subject|0
2282570|NCT02387580|3968741|FG001|Overall Study|Withdrawal by Subject|0
2282571|NCT02387580|3968742|FG002|Overall Study|Withdrawal by Subject|0
2282572|NCT02387580|3968743|FG003|Overall Study|Withdrawal by Subject|1
2282573|NCT02387580|3968744|FG004|Overall Study|Withdrawal by Subject|0
2282574|NCT02387580|3968745|FG005|Overall Study|Withdrawal by Subject|0
2282575|NCT02387762|3968781|FG000|Overall Study|Withdrawal by Subject|1
2282576|NCT02387762|3968782|FG001|Overall Study|Withdrawal by Subject|0
2205795|NCT01613326|3843900|FG000|Overall Study|inability to use device|1
2205796|NCT01613326|3843901|FG001|Overall Study|inability to use device|0
2205797|NCT01613326|3843900|FG000|Overall Study|Lack of Efficacy|0
2205798|NCT01613326|3843901|FG001|Overall Study|Lack of Efficacy|1
2205799|NCT01613326|3843900|FG000|Overall Study|Lost to Follow-up|0
2205800|NCT01613326|3843901|FG001|Overall Study|Lost to Follow-up|1
2205801|NCT01613326|3843900|FG000|Overall Study|Administrative|0
2205802|NCT01613326|3843901|FG001|Overall Study|Administrative|2
2205803|NCT01613326|3843900|FG000|Overall Study|Protocol Violation|0
2205804|NCT01613326|3843901|FG001|Overall Study|Protocol Violation|1
2205805|NCT01613378|3843915|FG000|Overall Study|Lack of Efficacy|13
2205806|NCT01613378|3843915|FG000|Overall Study|Adverse Event|11
2205807|NCT01613378|3843915|FG000|Overall Study|Withdrawal by Subject|8
2282577|NCT02387840|3968822|FG000|Overall Study|Death|0
2127502|NCT01010230|3729159|FG000|Overall Study|Lost to Follow-up|4
2127503|NCT01010230|3729160|FG001|Overall Study|Lost to Follow-up|2
2127504|NCT01010503|3729192|FG000|Overall Study|Adverse Event|1
2127505|NCT01010503|3729192|FG000|Overall Study|Death|1
2127506|NCT01010633|3729214|FG000|Overall Study|Adverse Event|1
2127507|NCT01010633|3729215|FG001|Overall Study|Adverse Event|1
2127508|NCT01010633|3729214|FG000|Overall Study|Protocol Violation|1
2127509|NCT01010633|3729215|FG001|Overall Study|Protocol Violation|2
2127510|NCT01010633|3729214|FG000|Overall Study|Withdrawal by Subject|2
2127511|NCT01010633|3729215|FG001|Overall Study|Withdrawal by Subject|1
2127512|NCT01010633|3729214|FG000|Overall Study|Investigator decision|0
2127513|NCT01010633|3729215|FG001|Overall Study|Investigator decision|1
2127514|NCT01010750|3729227|FG000|Second Intervention|Adverse Event|0
2127515|NCT01010750|3729228|FG001|Second Intervention|Adverse Event|1
2127516|NCT01010750|3729229|FG002|Second Intervention|Adverse Event|0
2127517|NCT01010750|3729230|FG003|Second Intervention|Adverse Event|0
2127518|NCT01010750|3729231|FG004|Second Intervention|Adverse Event|0
2127519|NCT01010750|3729232|FG005|Second Intervention|Adverse Event|0
2127520|NCT01010776|3729249|FG000|Main Phase|Withdrawal by Subject|14
2127521|NCT01010776|3729249|FG000|Main Phase|Lack of Efficacy|8
2127522|NCT01010776|3729249|FG000|Main Phase|Adverse Event|7
2127523|NCT01010776|3729249|FG000|Main Phase|Lost to Follow-up|6
2127524|NCT01010776|3729249|FG000|Main Phase|Non-compliance to study medication|5
2127525|NCT01010776|3729249|FG000|Main Phase|Selection failure|2
2127526|NCT01010776|3729249|FG000|Main Phase|Inform consent withdrawal|1
2127527|NCT01010776|3729249|FG000|Main Phase|Other|1
2127528|NCT01010776|3729249|FG000|Main Phase|Did not received study medication|5
2127529|NCT01010776|3729249|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15
2127530|NCT01010776|3729249|FG000|Extension Phase|Other|3
2127531|NCT01010867|3729268|FG000|Overall Study|< 50% adherence to probiotic|1
2127532|NCT01010971|3729308|FG000|Overall Study|Adverse Event|2
2127533|NCT01010971|3729309|FG001|Overall Study|Adverse Event|4
2127534|NCT01010971|3729310|FG002|Overall Study|Adverse Event|3
2127535|NCT01010971|3729308|FG000|Overall Study|Withdrawal by Subject|0
2127536|NCT01010971|3729309|FG001|Overall Study|Withdrawal by Subject|2
2127537|NCT01010971|3729310|FG002|Overall Study|Withdrawal by Subject|5
2127538|NCT01010971|3729308|FG000|Overall Study|Lost to Follow-up|0
2127539|NCT01010971|3729309|FG001|Overall Study|Lost to Follow-up|2
2127540|NCT01010971|3729310|FG002|Overall Study|Lost to Follow-up|3
2282578|NCT02387840|3968823|FG001|Overall Study|Death|0
2282579|NCT02387840|3968824|FG002|Overall Study|Death|0
2282580|NCT02387840|3968825|FG003|Overall Study|Death|0
2282581|NCT02387840|3968826|FG004|Overall Study|Death|0
2282582|NCT02387840|3968827|FG005|Overall Study|Death|1
2282583|NCT02387957|3968854|FG000|Overall Study|The study was discontinued|21
2282584|NCT02387957|3968855|FG001|Overall Study|The study was discontinued|21
2282585|NCT02387957|3968856|FG002|Overall Study|The study was discontinued|20
2282586|NCT02387970|3968866|FG000|Overall Study|Did not complete 1-year follow up|1
2282587|NCT02387970|3968867|FG001|Overall Study|Did not complete 1-year follow up|2
2282588|NCT02387983|3968873|FG000|Overall Study|Adverse Event|4
2282589|NCT02387983|3968873|FG000|Overall Study|Protocol Violation|1
2282590|NCT02387983|3968873|FG000|Overall Study|Withdrawal by Subject|2
2282591|NCT02387996|3968877|FG000|Overall Study|Disease Progression|144
2282592|NCT02387996|3968877|FG000|Overall Study|Study Drug Toxicity|14
2282593|NCT02387996|3968877|FG000|Overall Study|Adverse Event Unrelated to Study Drug|34
2282594|NCT02387996|3968877|FG000|Overall Study|Subject Request to Discontinue Treatment|9
2282595|NCT02387996|3968877|FG000|Overall Study|Subject Withdrew Consent|1
2282596|NCT02387996|3968877|FG000|Overall Study|Lost to Follow-up|1
2282597|NCT02387996|3968877|FG000|Overall Study|Poor/Non-Compliance|1
2282598|NCT02388074|3968881|FG000|Overall Study|Lost in Transit|2
2282599|NCT02388074|3968881|FG000|Overall Study|Sample Not Returned|1
2282600|NCT02388165|3968887|FG000|Overall Study|Study terminated by sponsor|5
2282601|NCT02388165|3968888|FG001|Overall Study|Study terminated by sponsor|5
2282602|NCT02388165|3968887|FG000|Overall Study|Other|11
2282603|NCT02388165|3968888|FG001|Overall Study|Other|13
2282604|NCT02388165|3968887|FG000|Overall Study|No longer meet eligibility criteria|40
2127541|NCT01010971|3729308|FG000|Overall Study|Other|1
2127542|NCT01010971|3729309|FG001|Overall Study|Other|0
2127543|NCT01010971|3729310|FG002|Overall Study|Other|2
2205808|NCT01613378|3843915|FG000|Overall Study|Death|2
2282605|NCT02388165|3968888|FG001|Overall Study|No longer meet eligibility criteria|43
2282606|NCT02388165|3968887|FG000|Overall Study|Withdrawal of consent|31
2127544|NCT01011049|3729327|FG000|Overall Study|Protocol Violation|0
2127545|NCT01011049|3729328|FG001|Overall Study|Protocol Violation|0
2127546|NCT01011049|3729329|FG002|Overall Study|Protocol Violation|2
2127547|NCT01011049|3729330|FG003|Overall Study|Protocol Violation|0
2127548|NCT01011049|3729327|FG000|Overall Study|Lost to Follow-up|1
2127549|NCT01011049|3729328|FG001|Overall Study|Lost to Follow-up|2
2127550|NCT01011049|3729329|FG002|Overall Study|Lost to Follow-up|1
2127551|NCT01011049|3729330|FG003|Overall Study|Lost to Follow-up|0
2127552|NCT01011049|3729327|FG000|Overall Study|Withdrawal by Subject|0
2127553|NCT01011049|3729328|FG001|Overall Study|Withdrawal by Subject|0
2127554|NCT01011049|3729329|FG002|Overall Study|Withdrawal by Subject|1
2282607|NCT02388165|3968888|FG001|Overall Study|Withdrawal of consent|32
2282608|NCT02388165|3968887|FG000|Overall Study|Lost to Follow-up|19
2282609|NCT02388165|3968888|FG001|Overall Study|Lost to Follow-up|20
2282610|NCT02388165|3968887|FG000|Overall Study|Death|13
2282611|NCT02388165|3968888|FG001|Overall Study|Death|10
2282612|NCT02388165|3968887|FG000|Overall Study|Adverse Event|3
2282613|NCT02388165|3968888|FG001|Overall Study|Adverse Event|5
2282614|NCT02388165|3968887|FG000|Overall Study|Did not meet entrance criteria|5
2282615|NCT02388165|3968888|FG001|Overall Study|Did not meet entrance criteria|2
2282616|NCT02388191|3968896|FG000|Overall Study|Patient did not receive IUD|1
2282617|NCT02388191|3968897|FG001|Overall Study|Patient did not receive IUD|0
2282618|NCT02388269|3968907|FG000|Overall Study|Adverse Event|2
2127555|NCT01011049|3729330|FG003|Overall Study|Withdrawal by Subject|0
2127556|NCT01011153|3729347|FG000|Overall Study|Less than 78 cases completed|8
2127557|NCT01011153|3729348|FG001|Overall Study|Less than 78 cases completed|11
2127558|NCT01011153|3729349|FG002|Overall Study|Less than 78 cases completed|9
2127559|NCT01011283|3729395|FG000|Overall Study|Adverse Event|4
2127560|NCT01011283|3729396|FG001|Overall Study|Adverse Event|2
2127561|NCT01011283|3729395|FG000|Overall Study|Progressive Disease|0
2127562|NCT01011283|3729396|FG001|Overall Study|Progressive Disease|2
2127563|NCT01011283|3729395|FG000|Overall Study|Terminated by Sponsor|5
2127564|NCT01011283|3729396|FG001|Overall Study|Terminated by Sponsor|5
2127565|NCT01011283|3729395|FG000|Overall Study|Other|2
2127566|NCT01011283|3729396|FG001|Overall Study|Other|2
2127567|NCT01011309|3729405|FG000|Overall Study|Adverse Event|2
2127568|NCT01011309|3729406|FG001|Overall Study|Adverse Event|1
2127569|NCT01011309|3729407|FG002|Overall Study|Adverse Event|2
2127570|NCT01011309|3729405|FG000|Overall Study|Lack of Efficacy|0
2127571|NCT01011309|3729406|FG001|Overall Study|Lack of Efficacy|1
2127572|NCT01011309|3729407|FG002|Overall Study|Lack of Efficacy|0
2127573|NCT01011309|3729405|FG000|Overall Study|Protocol Violation|0
2127574|NCT01011309|3729406|FG001|Overall Study|Protocol Violation|1
2127575|NCT01011309|3729407|FG002|Overall Study|Protocol Violation|3
2127576|NCT01011335|3729419|FG000|Overall Study|Lost to Follow-up|0
2127577|NCT01011335|3729420|FG001|Overall Study|Lost to Follow-up|0
2127578|NCT01011335|3729421|FG002|Overall Study|Lost to Follow-up|1
2127579|NCT01011335|3729422|FG003|Overall Study|Lost to Follow-up|1
2127580|NCT01011335|3729423|FG004|Overall Study|Lost to Follow-up|1
2127581|NCT01011335|3729424|FG005|Overall Study|Lost to Follow-up|1
2127582|NCT01011335|3729425|FG006|Overall Study|Lost to Follow-up|2
2127583|NCT01011335|3729426|FG007|Overall Study|Lost to Follow-up|2
2127584|NCT01011335|3729427|FG008|Overall Study|Lost to Follow-up|1
2127585|NCT01011335|3729428|FG009|Overall Study|Lost to Follow-up|0
2127586|NCT01011335|3729429|FG010|Overall Study|Lost to Follow-up|0
2127587|NCT01011335|3729430|FG011|Overall Study|Lost to Follow-up|1
2127588|NCT01011335|3729431|FG012|Overall Study|Lost to Follow-up|2
2127589|NCT01011335|3729419|FG000|Overall Study|Protocol Violation|0
2127590|NCT01011335|3729420|FG001|Overall Study|Protocol Violation|1
2127591|NCT01011335|3729421|FG002|Overall Study|Protocol Violation|0
2127592|NCT01011335|3729422|FG003|Overall Study|Protocol Violation|0
2127593|NCT01011335|3729423|FG004|Overall Study|Protocol Violation|0
2127594|NCT01011335|3729424|FG005|Overall Study|Protocol Violation|0
2127595|NCT01011335|3729425|FG006|Overall Study|Protocol Violation|0
2127596|NCT01011335|3729426|FG007|Overall Study|Protocol Violation|0
2127597|NCT01011335|3729427|FG008|Overall Study|Protocol Violation|0
2127598|NCT01011335|3729428|FG009|Overall Study|Protocol Violation|0
2127599|NCT01011335|3729429|FG010|Overall Study|Protocol Violation|0
2127600|NCT01011335|3729430|FG011|Overall Study|Protocol Violation|0
2127601|NCT01011335|3729431|FG012|Overall Study|Protocol Violation|0
2127602|NCT01011335|3729419|FG000|Overall Study|Moved/deployed or no booster|1
2127603|NCT01011335|3729420|FG001|Overall Study|Moved/deployed or no booster|0
2127604|NCT01011335|3729421|FG002|Overall Study|Moved/deployed or no booster|0
2282619|NCT02388269|3968908|FG001|Overall Study|Adverse Event|0
2127605|NCT01011335|3729422|FG003|Overall Study|Moved/deployed or no booster|1
2127606|NCT01011335|3729423|FG004|Overall Study|Moved/deployed or no booster|0
2127607|NCT01011335|3729424|FG005|Overall Study|Moved/deployed or no booster|0
2127608|NCT01011335|3729425|FG006|Overall Study|Moved/deployed or no booster|1
2127609|NCT01011335|3729426|FG007|Overall Study|Moved/deployed or no booster|0
2127610|NCT01011335|3729427|FG008|Overall Study|Moved/deployed or no booster|1
2127611|NCT01011335|3729428|FG009|Overall Study|Moved/deployed or no booster|0
2127612|NCT01011335|3729429|FG010|Overall Study|Moved/deployed or no booster|2
2127613|NCT01011335|3729430|FG011|Overall Study|Moved/deployed or no booster|0
2127614|NCT01011335|3729431|FG012|Overall Study|Moved/deployed or no booster|0
2127615|NCT01011335|3729419|FG000|Overall Study|Adverse Event|0
2127616|NCT01011335|3729420|FG001|Overall Study|Adverse Event|0
2127617|NCT01011335|3729421|FG002|Overall Study|Adverse Event|0
2127618|NCT01011335|3729422|FG003|Overall Study|Adverse Event|0
2127619|NCT01011335|3729423|FG004|Overall Study|Adverse Event|0
2127620|NCT01011335|3729424|FG005|Overall Study|Adverse Event|0
2127621|NCT01011335|3729425|FG006|Overall Study|Adverse Event|0
2127622|NCT01011335|3729426|FG007|Overall Study|Adverse Event|0
2127623|NCT01011335|3729427|FG008|Overall Study|Adverse Event|0
2127624|NCT01011335|3729428|FG009|Overall Study|Adverse Event|0
2127625|NCT01011335|3729429|FG010|Overall Study|Adverse Event|4
2127626|NCT01011335|3729430|FG011|Overall Study|Adverse Event|0
2127627|NCT01011335|3729431|FG012|Overall Study|Adverse Event|1
2127628|NCT01011387|3729468|FG000|Overall Study|Withdrawal by Subject|3
2127629|NCT01011387|3729468|FG000|Overall Study|Adverse Event|2
2127630|NCT01011387|3729468|FG000|Overall Study|Protocol Violation|1
2127631|NCT01011439|3729488|FG000|Overall Study|Death|37
2127632|NCT01011439|3729488|FG000|Overall Study|Lost to Follow-up|4
2127633|NCT01011439|3729488|FG000|Overall Study|Withdrawal by Subject|1
2127634|NCT01011439|3729488|FG000|Overall Study|Sponsor's decision|15
2127635|NCT01011465|3729501|FG000|Overall Study|Withdrawal by Subject|2
2127636|NCT01011465|3729502|FG001|Overall Study|Withdrawal by Subject|1
2127637|NCT01011465|3729503|FG002|Overall Study|Withdrawal by Subject|0
2127638|NCT01011465|3729504|FG003|Overall Study|Withdrawal by Subject|0
2127639|NCT01011465|3729505|FG004|Overall Study|Withdrawal by Subject|1
2127640|NCT01011465|3729506|FG005|Overall Study|Withdrawal by Subject|0
2127641|NCT01011465|3729507|FG006|Overall Study|Withdrawal by Subject|1
2127642|NCT01011465|3729508|FG007|Overall Study|Withdrawal by Subject|0
2127643|NCT01011556|3729528|FG000|Overall Study|Adverse Event|1
2127644|NCT01011556|3729529|FG001|Overall Study|Adverse Event|3
2127645|NCT01011556|3729530|FG002|Overall Study|Adverse Event|2
2127646|NCT01011556|3729531|FG003|Overall Study|Adverse Event|1
2127647|NCT01011556|3729528|FG000|Overall Study|Lost to Follow-up|1
2127648|NCT01011556|3729529|FG001|Overall Study|Lost to Follow-up|0
2127649|NCT01011556|3729530|FG002|Overall Study|Lost to Follow-up|0
2127650|NCT01011556|3729531|FG003|Overall Study|Lost to Follow-up|0
2127651|NCT01011556|3729528|FG000|Overall Study|Physician Decision|1
2127652|NCT01011556|3729529|FG001|Overall Study|Physician Decision|0
2127653|NCT01011556|3729530|FG002|Overall Study|Physician Decision|0
2127654|NCT01011556|3729531|FG003|Overall Study|Physician Decision|1
2127655|NCT01011556|3729528|FG000|Overall Study|Protocol Violation|0
2127656|NCT01011556|3729529|FG001|Overall Study|Protocol Violation|1
2127657|NCT01011556|3729530|FG002|Overall Study|Protocol Violation|0
2127658|NCT01011556|3729531|FG003|Overall Study|Protocol Violation|0
2127659|NCT01011556|3729528|FG000|Overall Study|Withdrawal by Subject|1
2127660|NCT01011556|3729529|FG001|Overall Study|Withdrawal by Subject|2
2205809|NCT01613378|3843915|FG000|Overall Study|Lost to Follow-up|1
2127661|NCT01011556|3729530|FG002|Overall Study|Withdrawal by Subject|4
2127662|NCT01011556|3729531|FG003|Overall Study|Withdrawal by Subject|4
2127663|NCT01011556|3729528|FG000|Overall Study|Sponsor decision|0
2205810|NCT01613378|3843915|FG000|Overall Study|Other Reason|4
2205811|NCT01613417|3843921|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
2205812|NCT01613417|3843922|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
2127664|NCT01011556|3729529|FG001|Overall Study|Sponsor decision|1
2127665|NCT01011556|3729530|FG002|Overall Study|Sponsor decision|1
2127666|NCT01011556|3729531|FG003|Overall Study|Sponsor decision|2
2127667|NCT01011556|3729528|FG000|Overall Study|Inclusion/exclusion criteria not met|2
2127668|NCT01011556|3729529|FG001|Overall Study|Inclusion/exclusion criteria not met|1
2127669|NCT01011556|3729530|FG002|Overall Study|Inclusion/exclusion criteria not met|3
2127670|NCT01011556|3729531|FG003|Overall Study|Inclusion/exclusion criteria not met|5
2127671|NCT01011673|3729546|FG000|Randomized|Secondary headache|2
2127672|NCT01011673|3729547|FG001|Randomized|Secondary headache|1
2127673|NCT01011673|3729546|FG000|24 Hour Follow-up|Lost to Follow-up|3
2127674|NCT01011673|3729547|FG001|24 Hour Follow-up|Lost to Follow-up|3
2127675|NCT01011738|3729556|FG000|Overall Study|Death|12
2127676|NCT01011738|3729557|FG001|Overall Study|Death|3
2127677|NCT01011738|3729558|FG002|Overall Study|Death|0
2127678|NCT01011738|3729556|FG000|Overall Study|Unknown reasons|312
2127679|NCT01011738|3729557|FG001|Overall Study|Unknown reasons|291
2127680|NCT01011738|3729558|FG002|Overall Study|Unknown reasons|17
2127681|NCT01011868|3729590|FG000|After Week 18 Follow-up|Adverse Event|8
2127682|NCT01011868|3729591|FG001|After Week 18 Follow-up|Adverse Event|6
2127683|NCT01011868|3729592|FG002|After Week 18 Follow-up|Adverse Event|13
2127684|NCT01011868|3729590|FG000|After Week 18 Follow-up|Lack of Efficacy|1
2127685|NCT01011868|3729591|FG001|After Week 18 Follow-up|Lack of Efficacy|0
2127686|NCT01011868|3729592|FG002|After Week 18 Follow-up|Lack of Efficacy|0
2127687|NCT01011868|3729590|FG000|After Week 18 Follow-up|Protocol Violation|1
2127688|NCT01011868|3729591|FG001|After Week 18 Follow-up|Protocol Violation|1
2127689|NCT01011868|3729592|FG002|After Week 18 Follow-up|Protocol Violation|1
2127690|NCT01011868|3729590|FG000|After Week 18 Follow-up|Lost to Follow-up|5
2127691|NCT01011868|3729591|FG001|After Week 18 Follow-up|Lost to Follow-up|3
2127692|NCT01011868|3729592|FG002|After Week 18 Follow-up|Lost to Follow-up|0
2127693|NCT01011868|3729590|FG000|After Week 18 Follow-up|Withdrawal by Subject|6
2127694|NCT01011868|3729591|FG001|After Week 18 Follow-up|Withdrawal by Subject|3
2205813|NCT01613599|3843938|FG000|Overall Study|Death|9
2127695|NCT01011868|3729592|FG002|After Week 18 Follow-up|Withdrawal by Subject|0
2127696|NCT01011868|3729590|FG000|After Week 18 Follow-up|Other reason not defined above|2
2127697|NCT01011868|3729591|FG001|After Week 18 Follow-up|Other reason not defined above|3
2127698|NCT01011868|3729592|FG002|After Week 18 Follow-up|Other reason not defined above|12
2127699|NCT01011868|3729590|FG000|After Week 78 Follow-up|Adverse Event|14
2127700|NCT01011868|3729591|FG001|After Week 78 Follow-up|Adverse Event|18
2127701|NCT01011868|3729592|FG002|After Week 78 Follow-up|Adverse Event|21
2127702|NCT01011868|3729590|FG000|After Week 78 Follow-up|Lack of Efficacy|4
2127703|NCT01011868|3729591|FG001|After Week 78 Follow-up|Lack of Efficacy|0
2127704|NCT01011868|3729592|FG002|After Week 78 Follow-up|Lack of Efficacy|0
2127705|NCT01011868|3729590|FG000|After Week 78 Follow-up|Protocol Violation|9
2127706|NCT01011868|3729591|FG001|After Week 78 Follow-up|Protocol Violation|1
2127707|NCT01011868|3729592|FG002|After Week 78 Follow-up|Protocol Violation|2
2127708|NCT01011868|3729590|FG000|After Week 78 Follow-up|Lost to Follow-up|11
2127709|NCT01011868|3729591|FG001|After Week 78 Follow-up|Lost to Follow-up|6
2127710|NCT01011868|3729592|FG002|After Week 78 Follow-up|Lost to Follow-up|4
2127711|NCT01011868|3729590|FG000|After Week 78 Follow-up|Withdrawal by Subject|9
2127712|NCT01011868|3729591|FG001|After Week 78 Follow-up|Withdrawal by Subject|8
2127713|NCT01011868|3729592|FG002|After Week 78 Follow-up|Withdrawal by Subject|1
2127714|NCT01011868|3729590|FG000|After Week 78 Follow-up|Other reason not defined above|5
2127715|NCT01011868|3729591|FG001|After Week 78 Follow-up|Other reason not defined above|5
2127716|NCT01011868|3729592|FG002|After Week 78 Follow-up|Other reason not defined above|16
2127717|NCT01011907|3729606|FG000|Overall Study|Withdrawal by Subject|13
2127718|NCT01011907|3729607|FG001|Overall Study|Withdrawal by Subject|11
2127719|NCT01011907|3729606|FG000|Overall Study|Adverse Event|1
2127720|NCT01011907|3729607|FG001|Overall Study|Adverse Event|4
2127721|NCT01011933|3729613|FG000|Overall Study|Wrong cell type|1
2127722|NCT01011933|3729613|FG000|Overall Study|Improper pre-protocol Rx|1
2127723|NCT01011933|3729613|FG000|Overall Study|Inadequate pathology|1
2127724|NCT01011933|3729613|FG000|Overall Study|Never treated|1
2127725|NCT01011946|3729623|FG000|Overall Study|Transferred to another hospital|2
2127726|NCT01011946|3729623|FG000|Overall Study|No pathological lab value|1
2127727|NCT01012037|3729630|FG000|Overall Study|Adverse Event|0
2127728|NCT01012037|3729631|FG001|Overall Study|Adverse Event|8
2127729|NCT01012037|3729632|FG002|Overall Study|Adverse Event|3
2127730|NCT01012037|3729630|FG000|Overall Study|Protocol Violation|0
2127731|NCT01012037|3729631|FG001|Overall Study|Protocol Violation|3
2127732|NCT01012037|3729632|FG002|Overall Study|Protocol Violation|5
2127733|NCT01012037|3729630|FG000|Overall Study|Withdrawal by Subject|0
2127734|NCT01012037|3729631|FG001|Overall Study|Withdrawal by Subject|4
2127735|NCT01012037|3729632|FG002|Overall Study|Withdrawal by Subject|1
2127736|NCT01012037|3729630|FG000|Overall Study|Other reason (not specified)|1
2127737|NCT01012037|3729631|FG001|Overall Study|Other reason (not specified)|1
2127738|NCT01012037|3729632|FG002|Overall Study|Other reason (not specified)|1
2127739|NCT01012219|3729648|FG000|Period 1|Withdrawal by Subject|1
2127740|NCT01012219|3729648|FG000|Period 2|Withdrawal by Subject|1
2127741|NCT01012258|3729670|FG000|Overall Study|Death|14
2127742|NCT01012258|3729670|FG000|Overall Study|Lost to Follow-up|1
2127743|NCT01012258|3729670|FG000|Overall Study|Adverse Event|1
2127744|NCT01012258|3729670|FG000|Overall Study|Progressive Disease (PD)|18
2127745|NCT01012258|3729670|FG000|Overall Study|Symptomatic Deterioration|1
2127746|NCT01012258|3729670|FG000|Overall Study|Another Anti-cancer Drug Received|1
2127747|NCT01012258|3729670|FG000|Overall Study|Another Tumor Discovered|1
2127748|NCT01012258|3729670|FG000|Overall Study|Ongoing|29
2127749|NCT01012323|3729684|FG000|Overall Study|Investigator Judgment|1
2127750|NCT01012440|3729721|FG000|Overall Study|Withdrawal by Subject|2
2127751|NCT01012609|3729731|FG000|Overall Study|Withdrawal by Subject|1
2127752|NCT01012609|3729732|FG001|Overall Study|Withdrawal by Subject|1
2127753|NCT01012622|3729739|FG000|Overall Study|Withdrawal by Subject|6
2127754|NCT01012622|3729739|FG000|Overall Study|Lost to Follow-up|5
2127755|NCT01012622|3729739|FG000|Overall Study|Adverse Event|7
2127756|NCT01012622|3729739|FG000|Overall Study|non-compliance with the drug|9
2127757|NCT01012622|3729739|FG000|Overall Study|Other|1
2127758|NCT01012622|3729739|FG000|Overall Study|screening failure|1
2127759|NCT01012622|3729739|FG000|Overall Study|withdrawal of consent by a parent|2
2127760|NCT01012713|3729757|FG000|Overall Study|Lack of Efficacy|3
2205814|NCT01613599|3843938|FG000|Overall Study|Lost to Follow-up|5
2205815|NCT01613599|3843938|FG000|Overall Study|Withdrawal by Subject|8
2205816|NCT01613599|3843938|FG000|Overall Study|Reason not specified|3
2127761|NCT01012739|3729762|FG000|Treatment Period 1|Adverse Event|0
2127762|NCT01012739|3729763|FG001|Treatment Period 1|Adverse Event|0
2127763|NCT01012739|3729764|FG002|Treatment Period 1|Adverse Event|0
2127764|NCT01012739|3729765|FG003|Treatment Period 1|Adverse Event|1
2127765|NCT01012739|3729762|FG000|Treatment Period 2|Abnormal test procedure results|0
2127766|NCT01012739|3729763|FG001|Treatment Period 2|Abnormal test procedure results|0
2127767|NCT01012739|3729764|FG002|Treatment Period 2|Abnormal test procedure results|0
2127768|NCT01012739|3729765|FG003|Treatment Period 2|Abnormal test procedure results|1
2127769|NCT01012765|3729776|FG000|Treatment Period 1|Adverse Event|1
2127770|NCT01012765|3729777|FG001|Treatment Period 1|Adverse Event|0
2127771|NCT01012765|3729778|FG002|Treatment Period 1|Adverse Event|1
2205817|NCT01613716|3843942|FG000|Overall Study|screen failures|3
2127772|NCT01012765|3729779|FG003|Treatment Period 1|Adverse Event|0
2127773|NCT01012765|3729780|FG004|Treatment Period 1|Adverse Event|0
2127774|NCT01012765|3729781|FG005|Treatment Period 1|Adverse Event|0
2127775|NCT01012765|3729776|FG000|Treatment Period 1|Withdrawal by Subject|2
2127776|NCT01012765|3729777|FG001|Treatment Period 1|Withdrawal by Subject|0
2127777|NCT01012765|3729778|FG002|Treatment Period 1|Withdrawal by Subject|0
2127778|NCT01012765|3729779|FG003|Treatment Period 1|Withdrawal by Subject|0
2127779|NCT01012765|3729780|FG004|Treatment Period 1|Withdrawal by Subject|0
2127780|NCT01012765|3729781|FG005|Treatment Period 1|Withdrawal by Subject|0
2127781|NCT01012765|3729776|FG000|Treatment Period 1|Administrative problems|0
2127782|NCT01012765|3729777|FG001|Treatment Period 1|Administrative problems|0
2127783|NCT01012765|3729778|FG002|Treatment Period 1|Administrative problems|1
2127784|NCT01012765|3729779|FG003|Treatment Period 1|Administrative problems|1
2127785|NCT01012765|3729780|FG004|Treatment Period 1|Administrative problems|1
2127786|NCT01012765|3729781|FG005|Treatment Period 1|Administrative problems|0
2205818|NCT01613716|3843942|FG000|Overall Study|Lost to Follow-up|4
2205819|NCT01614093|3843951|FG000|Overall Study|Withdrawal by Subject|1
2205820|NCT01614249|3843962|FG000|Overall Study|Lost to Follow-up|11
2205821|NCT01614249|3843963|FG001|Overall Study|Lost to Follow-up|23
2205822|NCT01614457|3843980|FG000|Overall Study|Non-Compliance|1
2205823|NCT01614457|3843981|FG001|Overall Study|Non-Compliance|0
2205824|NCT01614457|3843980|FG000|Overall Study|Pregnancy (Self or Partner)|1
2282620|NCT02388269|3968909|FG002|Overall Study|Adverse Event|0
2282621|NCT02388269|3968907|FG000|Overall Study|Withdrawal by Subject|1
2282622|NCT02388269|3968908|FG001|Overall Study|Withdrawal by Subject|2
2282623|NCT02388269|3968909|FG002|Overall Study|Withdrawal by Subject|0
2282624|NCT02388269|3968907|FG000|Overall Study|less than 50% stimulations|1
2282625|NCT02388269|3968908|FG001|Overall Study|less than 50% stimulations|0
2282626|NCT02388269|3968909|FG002|Overall Study|less than 50% stimulations|0
2282627|NCT02388269|3968907|FG000|Overall Study|no diary data|3
2282628|NCT02388269|3968908|FG001|Overall Study|no diary data|0
2282629|NCT02388269|3968909|FG002|Overall Study|no diary data|0
2282630|NCT02388269|3968907|FG000|Overall Study|Protocol Violation|2
2282631|NCT02388269|3968908|FG001|Overall Study|Protocol Violation|0
2282632|NCT02388269|3968909|FG002|Overall Study|Protocol Violation|0
2282633|NCT02388269|3968907|FG000|Overall Study|Screen Failure|0
2282634|NCT02388269|3968908|FG001|Overall Study|Screen Failure|0
2282635|NCT02388269|3968909|FG002|Overall Study|Screen Failure|10
2282636|NCT02388295|3968936|FG000|Dose Escalation Week 1|Adverse Event|1
2282637|NCT02388295|3968937|FG001|Dose Escalation Week 1|Adverse Event|2
2282638|NCT02388295|3968938|FG002|Dose Escalation Week 1|Adverse Event|1
2282639|NCT02388295|3968936|FG000|Dose Escalation Week 1|Determined not eligible|1
2282640|NCT02388295|3968937|FG001|Dose Escalation Week 1|Determined not eligible|1
2127787|NCT01012765|3729776|FG000|Treatment Period 1|Protocol Violation|0
2127788|NCT01012765|3729777|FG001|Treatment Period 1|Protocol Violation|0
2127789|NCT01012765|3729778|FG002|Treatment Period 1|Protocol Violation|0
2127790|NCT01012765|3729779|FG003|Treatment Period 1|Protocol Violation|2
2127791|NCT01012765|3729780|FG004|Treatment Period 1|Protocol Violation|1
2127792|NCT01012765|3729781|FG005|Treatment Period 1|Protocol Violation|0
2322388|NCT02971670|4037401|FG002|Overall Study|Withdrawal by Subject|1
2127793|NCT01012765|3729776|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0
2127794|NCT01012765|3729777|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0
2127795|NCT01012765|3729778|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0
2127796|NCT01012765|3729779|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0
2127797|NCT01012765|3729780|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1
2127798|NCT01012765|3729781|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0
2127799|NCT01012765|3729776|FG000|Treatment Period 2|Withdrawal by Subject|1
2127800|NCT01012765|3729777|FG001|Treatment Period 2|Withdrawal by Subject|0
2127801|NCT01012765|3729778|FG002|Treatment Period 2|Withdrawal by Subject|1
2127802|NCT01012765|3729779|FG003|Treatment Period 2|Withdrawal by Subject|0
2127803|NCT01012765|3729780|FG004|Treatment Period 2|Withdrawal by Subject|1
2127804|NCT01012765|3729781|FG005|Treatment Period 2|Withdrawal by Subject|0
2127805|NCT01012765|3729776|FG000|Treatment Period 2|Abnormal laboratory value(s)|0
2127806|NCT01012765|3729777|FG001|Treatment Period 2|Abnormal laboratory value(s)|0
2127807|NCT01012765|3729778|FG002|Treatment Period 2|Abnormal laboratory value(s)|0
2127808|NCT01012765|3729779|FG003|Treatment Period 2|Abnormal laboratory value(s)|0
2127809|NCT01012765|3729780|FG004|Treatment Period 2|Abnormal laboratory value(s)|0
2205825|NCT01614457|3843981|FG001|Overall Study|Pregnancy (Self or Partner)|0
2205826|NCT01614470|3843989|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
2205827|NCT01614470|3843990|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2205828|NCT01614470|3843991|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2205829|NCT01614470|3843989|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
2205830|NCT01614470|3843990|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
2205831|NCT01614470|3843991|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
2217428|NCT01708291|3860706|FG001|Overall Study|fighting|1
2217429|NCT01708902|3860792|FG000|Overall Study|Adverse Event|3
2217430|NCT01708902|3860793|FG001|Overall Study|Adverse Event|4
2217431|NCT01708902|3860794|FG002|Overall Study|Adverse Event|9
2217432|NCT01708902|3860795|FG003|Overall Study|Adverse Event|2
2127810|NCT01012765|3729781|FG005|Treatment Period 2|Abnormal laboratory value(s)|1
2127811|NCT01012765|3729776|FG000|Treatment Period 2|Adverse Event|0
2127812|NCT01012765|3729777|FG001|Treatment Period 2|Adverse Event|1
2127813|NCT01012765|3729778|FG002|Treatment Period 2|Adverse Event|1
2127814|NCT01012765|3729779|FG003|Treatment Period 2|Adverse Event|0
2127815|NCT01012765|3729780|FG004|Treatment Period 2|Adverse Event|0
2127816|NCT01012765|3729781|FG005|Treatment Period 2|Adverse Event|0
2127817|NCT01012765|3729776|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0
2127818|NCT01012765|3729777|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1
2127819|NCT01012765|3729778|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1
2127820|NCT01012765|3729779|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0
2127821|NCT01012765|3729780|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0
2127822|NCT01012765|3729781|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0
2205832|NCT01614600|3844013|FG000|Overall Study|Unacceptable fit|1
2127823|NCT01012947|3729803|FG000|Overall Study|Lost to Follow-up|131
2127824|NCT01012947|3729804|FG001|Overall Study|Lost to Follow-up|135
2127825|NCT01012947|3729805|FG002|Overall Study|Lost to Follow-up|130
2127826|NCT01012947|3729806|FG003|Overall Study|Lost to Follow-up|118
2127827|NCT01012947|3729807|FG004|Overall Study|Lost to Follow-up|142
2127828|NCT01012973|3729821|FG000|Overall Study|Adverse Event|5
2127829|NCT01012973|3729822|FG001|Overall Study|Adverse Event|5
2127830|NCT01012973|3729821|FG000|Overall Study|Lack of Efficacy|0
2127831|NCT01012973|3729822|FG001|Overall Study|Lack of Efficacy|5
2127832|NCT01012973|3729821|FG000|Overall Study|Lost to Follow-up|1
2127833|NCT01012973|3729822|FG001|Overall Study|Lost to Follow-up|0
2127834|NCT01012973|3729821|FG000|Overall Study|(Overseas travel - indefinite period)|1
2127835|NCT01012973|3729822|FG001|Overall Study|(Overseas travel - indefinite period)|0
2127836|NCT01012973|3729821|FG000|Overall Study|Increase in vis. acuity, never injected|0
2127837|NCT01012973|3729822|FG001|Overall Study|Increase in vis. acuity, never injected|1
2127838|NCT01012973|3729821|FG000|Overall Study|Protocol Violation|5
2127839|NCT01012973|3729822|FG001|Overall Study|Protocol Violation|2
2127840|NCT01012973|3729821|FG000|Overall Study|Withdrawal by Subject|4
2127841|NCT01012973|3729822|FG001|Overall Study|Withdrawal by Subject|6
2127842|NCT01012999|3729832|FG000|Overall Study|Protocol Violation|1
2127843|NCT01013207|3729849|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6
2127844|NCT01013285|3729855|FG000|Overall Study|Death|48
2127845|NCT01013285|3729856|FG001|Overall Study|Death|89
2127846|NCT01013350|3729863|FG000|Overall Study|Lost to Follow-up|15
2127847|NCT01013350|3729864|FG001|Overall Study|Lost to Follow-up|95
2127848|NCT01013350|3729863|FG000|Overall Study|Adverse Event|0
2127849|NCT01013350|3729864|FG001|Overall Study|Adverse Event|1
2127850|NCT01013350|3729863|FG000|Overall Study|Physician Decision|4
2127851|NCT01013350|3729864|FG001|Overall Study|Physician Decision|20
2127852|NCT01013350|3729863|FG000|Overall Study|Withdrawal by Subject|15
2127853|NCT01013350|3729864|FG001|Overall Study|Withdrawal by Subject|38
2127854|NCT01013350|3729863|FG000|Overall Study|Death|3
2127855|NCT01013350|3729864|FG001|Overall Study|Death|5
2127856|NCT01013350|3729863|FG000|Overall Study|Participant entered interventional study|0
2205833|NCT01614600|3844013|FG000|Overall Study|Discomfort|1
2205834|NCT01614600|3844013|FG000|Overall Study|Unable to remove lens at the end of day|1
2205835|NCT01614600|3844013|FG000|Overall Study|Protocol deviation|1
2282641|NCT02388295|3968938|FG002|Dose Escalation Week 1|Determined not eligible|1
2282642|NCT02388295|3968936|FG000|Dose Escalation Week 2|Protocol Violation|0
2282643|NCT02388295|3968937|FG001|Dose Escalation Week 2|Protocol Violation|1
2282644|NCT02388295|3968938|FG002|Dose Escalation Week 2|Protocol Violation|0
2282645|NCT02388295|3968936|FG000|Dose Escalation Week 2|Determined not eligible|1
2282646|NCT02388295|3968937|FG001|Dose Escalation Week 2|Determined not eligible|1
2282647|NCT02388295|3968938|FG002|Dose Escalation Week 2|Determined not eligible|1
2282648|NCT02388295|3968936|FG000|Treatment Weeks 3 to 12|Adverse Event|1
2282649|NCT02388295|3968937|FG001|Treatment Weeks 3 to 12|Adverse Event|1
2282650|NCT02388295|3968938|FG002|Treatment Weeks 3 to 12|Adverse Event|0
2320800|NCT02952586|4035029|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2
2320801|NCT02952586|4035028|FG000|Maintenance Phase (12 Months)|Other|2
2320802|NCT02952586|4035029|FG001|Maintenance Phase (12 Months)|Other|1
2320803|NCT02952586|4035028|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1
2320804|NCT02952586|4035029|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6
2320805|NCT02952586|4035028|FG000|Follow-Up Phase (90 Days)|Death|12
2320806|NCT02952586|4035029|FG001|Follow-Up Phase (90 Days)|Death|10
2320807|NCT02952586|4035028|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6
2320808|NCT02952586|4035029|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2
2320809|NCT02952586|4035028|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1
2320810|NCT02952586|4035029|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1
2320811|NCT02952586|4035028|FG000|Follow-Up Phase (90 Days)|Other|7
2320812|NCT02952586|4035029|FG001|Follow-Up Phase (90 Days)|Other|5
2320813|NCT02952586|4035028|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32
2320814|NCT02952586|4035029|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50
2320815|NCT02952586|4035028|FG000|LT Follow-up (up to 45 Months)|Death|51
2127857|NCT01013350|3729864|FG001|Overall Study|Participant entered interventional study|8
2127858|NCT01013350|3729863|FG000|Overall Study|Other|1
2127859|NCT01013350|3729864|FG001|Overall Study|Other|25
2205836|NCT01614769|3844031|FG000|Period 1|Discontinued due to Hypoglycemia|0
2127860|NCT01013597|3729871|FG000|Overall Study|Withdrawal by Subject|1
2127861|NCT01013740|3729877|FG000|Overall Study|Lost to Follow-up|3
2127862|NCT01013740|3729878|FG001|Overall Study|Lost to Follow-up|5
2127863|NCT01013740|3729877|FG000|Overall Study|Physician Decision|2
2127864|NCT01013740|3729878|FG001|Overall Study|Physician Decision|0
2127865|NCT01013740|3729877|FG000|Overall Study|Withdrawal by Subject|2
2127866|NCT01013740|3729878|FG001|Overall Study|Withdrawal by Subject|10
2127867|NCT01013740|3729877|FG000|Overall Study|study close / terminated : done in error|2
2127868|NCT01013740|3729878|FG001|Overall Study|study close / terminated : done in error|1
2127869|NCT01013740|3729877|FG000|Overall Study|Missing|2
2127870|NCT01013740|3729878|FG001|Overall Study|Missing|1
2127871|NCT01013740|3729877|FG000|Overall Study|Ongoing: Study records not completed|0
2127872|NCT01013740|3729878|FG001|Overall Study|Ongoing: Study records not completed|2
2127873|NCT01013753|3729886|FG000|Overall Study|Adverse Event|8
2127874|NCT01013753|3729886|FG000|Overall Study|Protocol Violation|3
2127875|NCT01013753|3729886|FG000|Overall Study|Lost to Follow-up|1
2127876|NCT01013753|3729886|FG000|Overall Study|Withdrawal by Subject|2
2127877|NCT01013753|3729886|FG000|Overall Study|Other|2
2127878|NCT01013792|3729902|FG000|Overall Study|Study suspended|2
2127879|NCT01013792|3729903|FG001|Overall Study|Study suspended|1
2127880|NCT01013792|3729902|FG000|Overall Study|Adverse Event|0
2127881|NCT01013792|3729903|FG001|Overall Study|Adverse Event|3
2127882|NCT01013792|3729902|FG000|Overall Study|Lost to Follow-up|0
2127883|NCT01013792|3729903|FG001|Overall Study|Lost to Follow-up|1
2127884|NCT01013870|3729924|FG000|Overall Study|Lost to Follow-up|1
2127885|NCT01013870|3729925|FG001|Overall Study|Lost to Follow-up|3
2127886|NCT01013883|3729933|FG000|Overall Study|Lost to Follow-up|2
2127887|NCT01013883|3729934|FG001|Overall Study|Lost to Follow-up|2
2127888|NCT01013961|3729942|FG000|Overall Study|Adverse Event|2
2127889|NCT01013961|3729943|FG001|Overall Study|Adverse Event|2
2127890|NCT01013961|3729942|FG000|Overall Study|Withdrawal by Subject|1
2127891|NCT01013961|3729943|FG001|Overall Study|Withdrawal by Subject|0
2127892|NCT01013961|3729942|FG000|Overall Study|Physician Decision|0
2127893|NCT01013961|3729943|FG001|Overall Study|Physician Decision|1
2178031|NCT01380080|3802574|FG001|Overall Study|Lost to Follow-up|3
2178032|NCT01380093|3802580|FG000|Naloxone Challenge Phase|Screen failures|21
2178033|NCT01380093|3802581|FG001|Naloxone Challenge Phase|Screen failures|0
2178034|NCT01380093|3802582|FG002|Naloxone Challenge Phase|Screen failures|0
2178035|NCT01380093|3802583|FG003|Naloxone Challenge Phase|Screen failures|0
2282651|NCT02388347|3968960|FG000|Overall Study|Withdrawal by Subject|0
2282652|NCT02388347|3968961|FG001|Overall Study|Withdrawal by Subject|0
2282653|NCT02388347|3968962|FG002|Overall Study|Withdrawal by Subject|1
2282654|NCT02388347|3968963|FG003|Overall Study|Withdrawal by Subject|0
2282655|NCT02388347|3968964|FG004|Overall Study|Withdrawal by Subject|0
2282656|NCT02388724|3969016|FG000|Overall Study|Reason not Specified|0
2282657|NCT02388724|3969017|FG001|Overall Study|Reason not Specified|1
2282658|NCT02388724|3969016|FG000|Overall Study|Major Protocol Deviation|3
2282659|NCT02388724|3969017|FG001|Overall Study|Major Protocol Deviation|3
2282660|NCT02388724|3969016|FG000|Overall Study|Pretreatment Event/Adverse Event|3
2282661|NCT02388724|3969017|FG001|Overall Study|Pretreatment Event/Adverse Event|2
2282662|NCT02388724|3969016|FG000|Overall Study|Voluntary Withdrawal|6
2282663|NCT02388724|3969017|FG001|Overall Study|Voluntary Withdrawal|5
2282664|NCT02388724|3969016|FG000|Overall Study|Randomized but not Treated|0
2282665|NCT02388724|3969017|FG001|Overall Study|Randomized but not Treated|2
2282666|NCT02388737|3969026|FG000|Overall Study|Pretreatment Event/Adverse Event|13
2282667|NCT02388737|3969027|FG001|Overall Study|Pretreatment Event/Adverse Event|11
2282668|NCT02388737|3969028|FG002|Overall Study|Pretreatment Event/Adverse Event|12
2282669|NCT02388737|3969026|FG000|Overall Study|Major Protocol Deviation|18
2282670|NCT02388737|3969027|FG001|Overall Study|Major Protocol Deviation|25
2282671|NCT02388737|3969028|FG002|Overall Study|Major Protocol Deviation|22
2282672|NCT02388737|3969026|FG000|Overall Study|Lost to Follow-up|5
2282673|NCT02388737|3969027|FG001|Overall Study|Lost to Follow-up|1
2282674|NCT02388737|3969028|FG002|Overall Study|Lost to Follow-up|4
2282675|NCT02388737|3969026|FG000|Overall Study|Voluntary Withdrawal|10
2282676|NCT02388737|3969027|FG001|Overall Study|Voluntary Withdrawal|18
2282677|NCT02388737|3969028|FG002|Overall Study|Voluntary Withdrawal|17
2282678|NCT02388737|3969026|FG000|Overall Study|Lack of Efficacy|3
2282679|NCT02388737|3969027|FG001|Overall Study|Lack of Efficacy|0
2282680|NCT02388737|3969028|FG002|Overall Study|Lack of Efficacy|3
2282681|NCT02388737|3969026|FG000|Overall Study|Reason Not Specified|5
2282682|NCT02388737|3969027|FG001|Overall Study|Reason Not Specified|5
2282683|NCT02388737|3969028|FG002|Overall Study|Reason Not Specified|4
2282684|NCT02388763|3969036|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1
2282685|NCT02388763|3969037|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1
2282686|NCT02388763|3969036|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1
2282687|NCT02388763|3969037|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1
2282688|NCT02388906|3969056|FG000|Pre-Treatment Period|Participant withdrew consent|1
2282689|NCT02388906|3969057|FG001|Pre-Treatment Period|Participant withdrew consent|0
2282690|NCT02388906|3969056|FG000|Treatment Period|Disease progression|121
2282691|NCT02388906|3969057|FG001|Treatment Period|Disease progression|101
2282692|NCT02388906|3969056|FG000|Treatment Period|Study drug toxicity|41
2282693|NCT02388906|3969057|FG001|Treatment Period|Study drug toxicity|208
2127894|NCT01014013|3729951|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
2127895|NCT01014013|3729952|FG001|Overall Study|Inclusion/Exclusion criteria not met|3
2127896|NCT01014013|3729951|FG000|Overall Study|Clinical adverse experience|4
2127897|NCT01014013|3729952|FG001|Overall Study|Clinical adverse experience|2
2127898|NCT01014013|3729951|FG000|Overall Study|Laboratory adverse experience|1
2127899|NCT01014013|3729952|FG001|Overall Study|Laboratory adverse experience|1
2127900|NCT01014013|3729951|FG000|Overall Study|Protocol Violation|1
2127901|NCT01014013|3729952|FG001|Overall Study|Protocol Violation|3
2127902|NCT01014013|3729951|FG000|Overall Study|Withdrawal by Subject|7
2127903|NCT01014013|3729952|FG001|Overall Study|Withdrawal by Subject|4
2127904|NCT01014013|3729951|FG000|Overall Study|Clinical/microbiologic failure|1
2127905|NCT01014013|3729952|FG001|Overall Study|Clinical/microbiologic failure|2
2127906|NCT01014013|3729951|FG000|Overall Study|Pathogen culture = no growth|26
2127907|NCT01014013|3729952|FG001|Overall Study|Pathogen culture = no growth|34
2127908|NCT01014013|3729951|FG000|Overall Study|Negative urine culture|2
2127909|NCT01014013|3729952|FG001|Overall Study|Negative urine culture|0
2127910|NCT01014013|3729951|FG000|Overall Study|Pathogen resistant|7
2127911|NCT01014013|3729952|FG001|Overall Study|Pathogen resistant|4
2127912|NCT01014013|3729951|FG000|Overall Study|Physician Decision|0
2127913|NCT01014013|3729952|FG001|Overall Study|Physician Decision|1
2127914|NCT01014013|3729951|FG000|Overall Study|Another antibiotic therapy required|0
2127915|NCT01014013|3729952|FG001|Overall Study|Another antibiotic therapy required|1
2127916|NCT01014013|3729951|FG000|Overall Study|Appendectomy|1
2127917|NCT01014013|3729952|FG001|Overall Study|Appendectomy|0
2127918|NCT01014013|3729951|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0
2127919|NCT01014013|3729952|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1
2127920|NCT01014143|3729997|FG000|Second Intervention|Lost to Follow-up|2
2127921|NCT01014143|3729998|FG001|Second Intervention|Lost to Follow-up|0
2127922|NCT01014143|3729999|FG002|Second Intervention|Lost to Follow-up|0
2127923|NCT01014208|3730018|FG000|Overall Study|Lost to Follow-up|2
2127924|NCT01014208|3730019|FG001|Overall Study|Lost to Follow-up|5
2127925|NCT01014208|3730018|FG000|Overall Study|Participant Withdrew Consent|12
2127926|NCT01014208|3730019|FG001|Overall Study|Participant Withdrew Consent|12
2127927|NCT01014208|3730018|FG000|Overall Study|Did Not Receive Study Drug|2
2127928|NCT01014208|3730019|FG001|Overall Study|Did Not Receive Study Drug|0
2127929|NCT01014208|3730018|FG000|Overall Study|Study Closed/terminated|78
2127930|NCT01014208|3730019|FG001|Overall Study|Study Closed/terminated|83
2127931|NCT01014442|3730044|FG000|Overall Study|Adverse Event|0
2127932|NCT01014442|3730045|FG001|Overall Study|Adverse Event|8
2127933|NCT01014442|3730044|FG000|Overall Study|Withdrawal by Subject|4
2127934|NCT01014442|3730045|FG001|Overall Study|Withdrawal by Subject|4
2127935|NCT01014442|3730044|FG000|Overall Study|Protocol Violation|2
2127936|NCT01014442|3730045|FG001|Overall Study|Protocol Violation|5
2127937|NCT01014442|3730044|FG000|Overall Study|Lack of Compliance|0
2127938|NCT01014442|3730045|FG001|Overall Study|Lack of Compliance|1
2127939|NCT01014442|3730044|FG000|Overall Study|Unspecified Reason|1
2127940|NCT01014442|3730045|FG001|Overall Study|Unspecified Reason|1
2127941|NCT01014533|3730066|FG000|Overall Study|Protocol Violation|3
2127942|NCT01014533|3730067|FG001|Overall Study|Protocol Violation|2
2127943|NCT01014533|3730066|FG000|Overall Study|Withdrawal by Subject|2
2127944|NCT01014533|3730067|FG001|Overall Study|Withdrawal by Subject|0
2127945|NCT01014533|3730066|FG000|Overall Study|unable to come to appointment|0
2127946|NCT01014533|3730067|FG001|Overall Study|unable to come to appointment|3
2127947|NCT01014585|3730078|FG000|Overall Study|Adverse Event|0
2127948|NCT01014585|3730079|FG001|Overall Study|Adverse Event|2
2127949|NCT01014585|3730080|FG002|Overall Study|Adverse Event|0
2127950|NCT01014585|3730081|FG003|Overall Study|Adverse Event|3
2127951|NCT01014585|3730078|FG000|Overall Study|Withdrawal by Subject|2
2127952|NCT01014585|3730079|FG001|Overall Study|Withdrawal by Subject|0
2127953|NCT01014585|3730080|FG002|Overall Study|Withdrawal by Subject|1
2127954|NCT01014585|3730081|FG003|Overall Study|Withdrawal by Subject|3
2127955|NCT01014585|3730078|FG000|Overall Study|Lost to Follow-up|0
2127956|NCT01014585|3730079|FG001|Overall Study|Lost to Follow-up|0
2127957|NCT01014585|3730080|FG002|Overall Study|Lost to Follow-up|0
2127958|NCT01014585|3730081|FG003|Overall Study|Lost to Follow-up|2
2127959|NCT01014585|3730078|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
2127960|NCT01014585|3730079|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
2127961|NCT01014585|3730080|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
2127962|NCT01014585|3730081|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
2127963|NCT01014624|3730093|FG000|Overall Study|Adverse Event|0
2127964|NCT01014624|3730094|FG001|Overall Study|Adverse Event|1
2127965|NCT01014624|3730093|FG000|Overall Study|Protocol Violation|1
2127966|NCT01014624|3730094|FG001|Overall Study|Protocol Violation|0
2127967|NCT01014624|3730093|FG000|Overall Study|Withdrawal by Subject|1
2127968|NCT01014624|3730094|FG001|Overall Study|Withdrawal by Subject|0
2127969|NCT01014689|3730104|FG000|Overall Study|Lack of Efficacy|0
2127970|NCT01014689|3730105|FG001|Overall Study|Lack of Efficacy|1
2127971|NCT01014689|3730104|FG000|Overall Study|Adverse Event|3
2127972|NCT01014689|3730105|FG001|Overall Study|Adverse Event|0
2127973|NCT01014689|3730104|FG000|Overall Study|Withdrawal by Subject|5
2127974|NCT01014689|3730105|FG001|Overall Study|Withdrawal by Subject|4
2127975|NCT01014689|3730104|FG000|Overall Study|Protocol Violation|1
2127976|NCT01014689|3730105|FG001|Overall Study|Protocol Violation|1
2127977|NCT01014689|3730104|FG000|Overall Study|Lost to Follow-up|3
2205837|NCT01614769|3844032|FG001|Period 1|Discontinued due to Hypoglycemia|0
2205838|NCT01614769|3844033|FG002|Period 1|Discontinued due to Hypoglycemia|0
2127978|NCT01014689|3730105|FG001|Overall Study|Lost to Follow-up|7
2127979|NCT01014689|3730104|FG000|Overall Study|Pregnancy|1
2127980|NCT01014689|3730105|FG001|Overall Study|Pregnancy|0
2127981|NCT01014910|3730137|FG000|Overall Study|Withdrawal by Subject|0
2127982|NCT01014910|3730138|FG001|Overall Study|Withdrawal by Subject|2
2127983|NCT01014975|3730215|FG000|Overall Study|Withdrawal by Subject|1
2127984|NCT01014975|3730216|FG001|Overall Study|Withdrawal by Subject|0
2127985|NCT01014975|3730217|FG002|Overall Study|Withdrawal by Subject|1
2127986|NCT01014975|3730215|FG000|Overall Study|Death|3
2127987|NCT01014975|3730216|FG001|Overall Study|Death|3
2127988|NCT01014975|3730217|FG002|Overall Study|Death|4
2127989|NCT01014975|3730215|FG000|Overall Study|Lost to Follow-up|0
2127990|NCT01014975|3730216|FG001|Overall Study|Lost to Follow-up|0
2127991|NCT01014975|3730217|FG002|Overall Study|Lost to Follow-up|1
2127992|NCT01014988|3730231|FG000|Overall Study|Adverse Event|20
2127993|NCT01014988|3730232|FG001|Overall Study|Adverse Event|0
2127994|NCT01014988|3730233|FG002|Overall Study|Adverse Event|1
2127995|NCT01014988|3730234|FG003|Overall Study|Adverse Event|0
2127996|NCT01014988|3730235|FG004|Overall Study|Adverse Event|1
2127997|NCT01014988|3730236|FG005|Overall Study|Adverse Event|3
2127998|NCT01014988|3730231|FG000|Overall Study|Lost to Follow-up|1
2127999|NCT01014988|3730232|FG001|Overall Study|Lost to Follow-up|0
2128000|NCT01014988|3730233|FG002|Overall Study|Lost to Follow-up|1
2128001|NCT01014988|3730234|FG003|Overall Study|Lost to Follow-up|0
2128002|NCT01014988|3730235|FG004|Overall Study|Lost to Follow-up|0
2128003|NCT01014988|3730236|FG005|Overall Study|Lost to Follow-up|0
2128004|NCT01014988|3730231|FG000|Overall Study|Physician Decision|1
2128005|NCT01014988|3730232|FG001|Overall Study|Physician Decision|0
2128006|NCT01014988|3730233|FG002|Overall Study|Physician Decision|0
2128007|NCT01014988|3730234|FG003|Overall Study|Physician Decision|0
2128008|NCT01014988|3730235|FG004|Overall Study|Physician Decision|0
2128009|NCT01014988|3730236|FG005|Overall Study|Physician Decision|0
2128010|NCT01014988|3730231|FG000|Overall Study|Withdrawal by Subject|1
2128011|NCT01014988|3730232|FG001|Overall Study|Withdrawal by Subject|0
2128012|NCT01014988|3730233|FG002|Overall Study|Withdrawal by Subject|0
2128013|NCT01014988|3730234|FG003|Overall Study|Withdrawal by Subject|0
2128014|NCT01014988|3730235|FG004|Overall Study|Withdrawal by Subject|0
2128015|NCT01014988|3730236|FG005|Overall Study|Withdrawal by Subject|0
2128016|NCT01015118|3730260|FG000|Overall Study|Protocol Violation|5
2128017|NCT01015118|3730261|FG001|Overall Study|Protocol Violation|6
2128018|NCT01015118|3730260|FG000|Overall Study|Withdrawal by Subject|103
2128019|NCT01015118|3730261|FG001|Overall Study|Withdrawal by Subject|27
2128020|NCT01015118|3730260|FG000|Overall Study|Other Adverse Event (AE)|141
2128021|NCT01015118|3730261|FG001|Overall Study|Other Adverse Event (AE)|33
2128022|NCT01015118|3730260|FG000|Overall Study|Worsening or AE of underlying disease|5
2128023|NCT01015118|3730261|FG001|Overall Study|Worsening or AE of underlying disease|4
2128024|NCT01015118|3730260|FG000|Overall Study|Progressive disease|364
2128025|NCT01015118|3730261|FG001|Overall Study|Progressive disease|229
2128026|NCT01015118|3730260|FG000|Overall Study|Not treated|9
2128027|NCT01015118|3730261|FG001|Overall Study|Not treated|5
2128028|NCT01015118|3730260|FG000|Overall Study|Other than stated above|42
2128029|NCT01015118|3730261|FG001|Overall Study|Other than stated above|23
2128030|NCT01015131|3730267|FG000|Overall Study|Physician Decision|1
2128031|NCT01015131|3730267|FG000|Overall Study|Protocol Violation|1
2128032|NCT01015131|3730267|FG000|Overall Study|Withdrawal by Subject|2
2128033|NCT01015131|3730267|FG000|Overall Study|Other Protocol Specified Criteria|4
2205839|NCT01614769|3844034|FG003|Period 1|Discontinued due to Hypoglycemia|1
2205840|NCT01614769|3844035|FG004|Period 1|Discontinued due to Hypoglycemia|0
2205841|NCT01614769|3844036|FG005|Period 1|Discontinued due to Hypoglycemia|1
2205842|NCT01614769|3844031|FG000|Period 1|Protocol Violation|0
2205843|NCT01614769|3844032|FG001|Period 1|Protocol Violation|0
2205844|NCT01614769|3844033|FG002|Period 1|Protocol Violation|0
2205845|NCT01614769|3844034|FG003|Period 1|Protocol Violation|1
2205846|NCT01614769|3844035|FG004|Period 1|Protocol Violation|0
2205847|NCT01614769|3844036|FG005|Period 1|Protocol Violation|0
2205848|NCT01614769|3844031|FG000|Period 1|Withdrawal by Subject|1
2205849|NCT01614769|3844032|FG001|Period 1|Withdrawal by Subject|0
2205850|NCT01614769|3844033|FG002|Period 1|Withdrawal by Subject|0
2205851|NCT01614769|3844034|FG003|Period 1|Withdrawal by Subject|0
2282694|NCT02388906|3969056|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5
2282695|NCT02388906|3969057|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5
2128034|NCT01015287|3730279|FG000|Overall Study|Death|21
2128035|NCT01015287|3730280|FG001|Overall Study|Death|16
2128036|NCT01015287|3730279|FG000|Overall Study|Adverse Event|1
2128037|NCT01015287|3730280|FG001|Overall Study|Adverse Event|0
2128038|NCT01015287|3730279|FG000|Overall Study|Sponsor Decision|3
2128039|NCT01015287|3730280|FG001|Overall Study|Sponsor Decision|7
2205852|NCT01614769|3844035|FG004|Period 1|Withdrawal by Subject|0
2205853|NCT01614769|3844036|FG005|Period 1|Withdrawal by Subject|0
2205854|NCT01614769|3844031|FG000|Period 3|Withdrawal by Subject|0
2205855|NCT01614769|3844032|FG001|Period 3|Withdrawal by Subject|0
2205856|NCT01614769|3844033|FG002|Period 3|Withdrawal by Subject|1
2128040|NCT01015287|3730279|FG000|Overall Study|Physician Decision|19
2128041|NCT01015287|3730280|FG001|Overall Study|Physician Decision|21
2128042|NCT01015287|3730279|FG000|Overall Study|Withdrawal by Subject|14
2128043|NCT01015287|3730280|FG001|Overall Study|Withdrawal by Subject|19
2128044|NCT01015287|3730279|FG000|Overall Study|Entry Criteria not Met|11
2128045|NCT01015287|3730280|FG001|Overall Study|Entry Criteria not Met|14
2128046|NCT01015287|3730279|FG000|Overall Study|Lost to Follow-up|2
2128047|NCT01015287|3730280|FG001|Overall Study|Lost to Follow-up|1
2128048|NCT01015287|3730279|FG000|Overall Study|Protocol Violation|1
2128049|NCT01015287|3730280|FG001|Overall Study|Protocol Violation|1
2128050|NCT01015560|3730318|FG000|Overall Study|Adverse Event|1
2128051|NCT01015560|3730318|FG000|Overall Study|Not protocol specified|1
2128052|NCT01015560|3730318|FG000|Overall Study|Withdrawal by Subject|1
2128053|NCT01015612|3730331|FG000|Overall Study|Death|113
2128054|NCT01015612|3730331|FG000|Overall Study|Withdrawal by Subject|40
2128055|NCT01015638|3730337|FG000|Overall Study|Withdrawal by Subject|1
2128056|NCT01015638|3730338|FG001|Overall Study|Withdrawal by Subject|0
2128057|NCT01015677|3730347|FG000|Overall Study|Adverse Event|0
2128058|NCT01015677|3730348|FG001|Overall Study|Adverse Event|1
2128059|NCT01015677|3730349|FG002|Overall Study|Adverse Event|0
2128060|NCT01015677|3730347|FG000|Overall Study|Lack of Efficacy|0
2128061|NCT01015677|3730348|FG001|Overall Study|Lack of Efficacy|1
2128062|NCT01015677|3730349|FG002|Overall Study|Lack of Efficacy|0
2128063|NCT01015677|3730347|FG000|Overall Study|Protocol Violation|0
2128064|NCT01015677|3730348|FG001|Overall Study|Protocol Violation|1
2128065|NCT01015677|3730349|FG002|Overall Study|Protocol Violation|0
2128066|NCT01015677|3730347|FG000|Overall Study|Withdrawal by Subject|1
2128067|NCT01015677|3730348|FG001|Overall Study|Withdrawal by Subject|1
2128068|NCT01015677|3730349|FG002|Overall Study|Withdrawal by Subject|0
2128069|NCT01015703|3730362|FG000|Overall Study|Withdrawal by Subject|0
2128070|NCT01015703|3730363|FG001|Overall Study|Withdrawal by Subject|1
2128071|NCT01015703|3730364|FG002|Overall Study|Withdrawal by Subject|0
2128072|NCT01015703|3730365|FG003|Overall Study|Withdrawal by Subject|0
2128073|NCT01015703|3730366|FG004|Overall Study|Withdrawal by Subject|0
2128074|NCT01015703|3730362|FG000|Overall Study|Adverse Event|1
2128075|NCT01015703|3730363|FG001|Overall Study|Adverse Event|0
2128076|NCT01015703|3730364|FG002|Overall Study|Adverse Event|0
2128077|NCT01015703|3730365|FG003|Overall Study|Adverse Event|0
2128078|NCT01015703|3730366|FG004|Overall Study|Adverse Event|0
2128079|NCT01015703|3730362|FG000|Overall Study|Protocol Violation|1
2128080|NCT01015703|3730363|FG001|Overall Study|Protocol Violation|0
2128081|NCT01015703|3730364|FG002|Overall Study|Protocol Violation|0
2128082|NCT01015703|3730365|FG003|Overall Study|Protocol Violation|0
2128083|NCT01015703|3730366|FG004|Overall Study|Protocol Violation|0
2128084|NCT01015768|3730378|FG000|Overall Study|Some subject data unuseable|4
2128085|NCT01015768|3730379|FG001|Overall Study|Some subject data unuseable|4
2128086|NCT01015820|3730411|FG000|Overall Study|Suboptimal measurements|1
2128087|NCT01015820|3730412|FG001|Overall Study|Suboptimal measurements|0
2128088|NCT01016015|3730423|FG000|Overall Study|Not Treated|3
2128089|NCT01016015|3730423|FG000|Overall Study|Withdrawal by Subject|1
2128090|NCT01016015|3730423|FG000|Overall Study|Adverse Event|15
2128091|NCT01016067|3730429|FG000|Overall Study|Lost to Follow-up|1
2128092|NCT01016067|3730430|FG001|Overall Study|Lost to Follow-up|2
2128093|NCT01016067|3730429|FG000|Overall Study|Physician Decision|1
2128094|NCT01016067|3730430|FG001|Overall Study|Physician Decision|1
2128095|NCT01016067|3730429|FG000|Overall Study|Withdrew due to Relocation|0
2128096|NCT01016067|3730430|FG001|Overall Study|Withdrew due to Relocation|1
2128097|NCT01016132|3730445|FG000|Overall Study|Discomfort|1
2128098|NCT01016262|3730452|FG000|Double-blind Phase|Adverse Event|0
2128099|NCT01016262|3730453|FG001|Double-blind Phase|Adverse Event|0
2128100|NCT01016262|3730454|FG002|Double-blind Phase|Adverse Event|1
2128101|NCT01016262|3730455|FG003|Double-blind Phase|Adverse Event|0
2128102|NCT01016262|3730456|FG004|Double-blind Phase|Adverse Event|0
2128103|NCT01016262|3730457|FG005|Double-blind Phase|Adverse Event|0
2128104|NCT01016262|3730452|FG000|Double-blind Phase|Lack of Efficacy|1
2128105|NCT01016262|3730453|FG001|Double-blind Phase|Lack of Efficacy|0
2128106|NCT01016262|3730454|FG002|Double-blind Phase|Lack of Efficacy|5
2128107|NCT01016262|3730455|FG003|Double-blind Phase|Lack of Efficacy|0
2128108|NCT01016262|3730456|FG004|Double-blind Phase|Lack of Efficacy|0
2128109|NCT01016262|3730457|FG005|Double-blind Phase|Lack of Efficacy|0
2128110|NCT01016262|3730452|FG000|Double-blind Phase|Disease Progression|0
2128111|NCT01016262|3730453|FG001|Double-blind Phase|Disease Progression|1
2128112|NCT01016262|3730454|FG002|Double-blind Phase|Disease Progression|2
2128113|NCT01016262|3730455|FG003|Double-blind Phase|Disease Progression|0
2128114|NCT01016262|3730456|FG004|Double-blind Phase|Disease Progression|0
2128115|NCT01016262|3730457|FG005|Double-blind Phase|Disease Progression|0
2128116|NCT01016262|3730452|FG000|Double-blind Phase|Withdrawal of Informed Consent|0
2128117|NCT01016262|3730453|FG001|Double-blind Phase|Withdrawal of Informed Consent|0
2128118|NCT01016262|3730454|FG002|Double-blind Phase|Withdrawal of Informed Consent|1
2128119|NCT01016262|3730455|FG003|Double-blind Phase|Withdrawal of Informed Consent|0
2128120|NCT01016262|3730456|FG004|Double-blind Phase|Withdrawal of Informed Consent|0
2128121|NCT01016262|3730457|FG005|Double-blind Phase|Withdrawal of Informed Consent|0
2128122|NCT01016262|3730452|FG000|Open-Label Phase|Adverse Event|0
2128123|NCT01016262|3730453|FG001|Open-Label Phase|Adverse Event|0
2128124|NCT01016262|3730454|FG002|Open-Label Phase|Adverse Event|0
2128125|NCT01016262|3730455|FG003|Open-Label Phase|Adverse Event|1
2128126|NCT01016262|3730456|FG004|Open-Label Phase|Adverse Event|0
2128127|NCT01016262|3730457|FG005|Open-Label Phase|Adverse Event|0
2128128|NCT01016262|3730452|FG000|Open-Label Phase|Lost to Follow-up|0
2128129|NCT01016262|3730453|FG001|Open-Label Phase|Lost to Follow-up|0
2128130|NCT01016262|3730454|FG002|Open-Label Phase|Lost to Follow-up|0
2128131|NCT01016262|3730455|FG003|Open-Label Phase|Lost to Follow-up|0
2128132|NCT01016262|3730456|FG004|Open-Label Phase|Lost to Follow-up|1
2128133|NCT01016262|3730457|FG005|Open-Label Phase|Lost to Follow-up|0
2128134|NCT01016262|3730452|FG000|Open-Label Phase|Lack of Efficacy|0
2128135|NCT01016262|3730453|FG001|Open-Label Phase|Lack of Efficacy|0
2128136|NCT01016262|3730454|FG002|Open-Label Phase|Lack of Efficacy|0
2128137|NCT01016262|3730455|FG003|Open-Label Phase|Lack of Efficacy|1
2128138|NCT01016262|3730456|FG004|Open-Label Phase|Lack of Efficacy|0
2128139|NCT01016262|3730457|FG005|Open-Label Phase|Lack of Efficacy|0
2128140|NCT01016262|3730452|FG000|Open-Label Phase|Withdrawal of Informed Consent|0
2128141|NCT01016262|3730453|FG001|Open-Label Phase|Withdrawal of Informed Consent|0
2128142|NCT01016262|3730454|FG002|Open-Label Phase|Withdrawal of Informed Consent|0
2128143|NCT01016262|3730455|FG003|Open-Label Phase|Withdrawal of Informed Consent|0
2128144|NCT01016262|3730456|FG004|Open-Label Phase|Withdrawal of Informed Consent|1
2128145|NCT01016262|3730457|FG005|Open-Label Phase|Withdrawal of Informed Consent|0
2128146|NCT01016600|3730526|FG000|Overall Study|Did not start treatment|1
2282696|NCT02388906|3969056|FG000|Treatment Period|Participant request to stop treatment|5
2282697|NCT02388906|3969057|FG001|Treatment Period|Participant request to stop treatment|9
2282698|NCT02388906|3969056|FG000|Treatment Period|Participant withdrew consent|2
2282699|NCT02388906|3969057|FG001|Treatment Period|Participant withdrew consent|3
2282700|NCT02388906|3969056|FG000|Treatment Period|Poor/non-compliance|0
2282701|NCT02388906|3969057|FG001|Treatment Period|Poor/non-compliance|1
2282702|NCT02388906|3969056|FG000|Treatment Period|Participant no longer meets study criteria|0
2282703|NCT02388906|3969057|FG001|Treatment Period|Participant no longer meets study criteria|1
2282704|NCT02388906|3969056|FG000|Treatment Period|Other reasons|3
2282705|NCT02388906|3969057|FG001|Treatment Period|Other reasons|3
2282706|NCT02388932|3969063|FG000|Overall Study|Death|1
2282707|NCT02388997|3969070|FG000|Overall Study|Adverse Event|1
2282708|NCT02388997|3969071|FG001|Overall Study|Adverse Event|2
2282709|NCT02388997|3969070|FG000|Overall Study|Withdrawal by Subject|2
2282710|NCT02388997|3969071|FG001|Overall Study|Withdrawal by Subject|1
2282711|NCT02388997|3969070|FG000|Overall Study|Lung function exclusion criteria|0
2282712|NCT02388997|3969071|FG001|Overall Study|Lung function exclusion criteria|2
2282713|NCT02388997|3969070|FG000|Overall Study|Tested positive for virus during run-in|0
2282714|NCT02388997|3969071|FG001|Overall Study|Tested positive for virus during run-in|1
2282715|NCT02389452|3969118|FG000|Overall Study|Lost to Follow-up|13
2282716|NCT02389452|3969118|FG000|Overall Study|Adverse Event|1
2282717|NCT02389452|3969118|FG000|Overall Study|Withdrawal by Subject|5
2282718|NCT02389452|3969118|FG000|Overall Study|Enrolled but Not Eligible for Study|6
2282719|NCT02389621|3969125|FG000|Treatment Period|Withdrawal by Subject|1
2282720|NCT02389621|3969126|FG001|Treatment Period|Withdrawal by Subject|1
2282721|NCT02389621|3969125|FG000|Posttreatment Period|Adverse Event|3
2282722|NCT02389621|3969126|FG001|Posttreatment Period|Adverse Event|1
2282723|NCT02389621|3969125|FG000|Posttreatment Period|Withdrawal by Subject|3
2282724|NCT02389621|3969126|FG001|Posttreatment Period|Withdrawal by Subject|2
2282725|NCT02389621|3969125|FG000|Posttreatment Period|Lost to Follow-up|1
2282726|NCT02389621|3969126|FG001|Posttreatment Period|Lost to Follow-up|1
2282727|NCT02389621|3969125|FG000|Posttreatment Period|Other - Miscellaneous|2
2282728|NCT02389621|3969126|FG001|Posttreatment Period|Other - Miscellaneous|0
2282729|NCT02389764|3969151|FG000|Overall Study|Lack of Efficacy|9
2282730|NCT02389816|3969158|FG000|Overall Study|Randomized but Not Treated|1
2282731|NCT02389816|3969159|FG001|Overall Study|Randomized but Not Treated|0
2282732|NCT02389816|3969160|FG002|Overall Study|Randomized but Not Treated|0
2282733|NCT02389816|3969158|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4
2282734|NCT02389816|3969159|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6
2282735|NCT02389816|3969160|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7
2282736|NCT02389816|3969158|FG000|Overall Study|Major Protocol Deviation|1
2282737|NCT02389816|3969159|FG001|Overall Study|Major Protocol Deviation|0
2282738|NCT02389816|3969160|FG002|Overall Study|Major Protocol Deviation|0
2282739|NCT02389816|3969158|FG000|Overall Study|Lost to Follow-up|1
2282740|NCT02389816|3969159|FG001|Overall Study|Lost to Follow-up|0
2282741|NCT02389816|3969160|FG002|Overall Study|Lost to Follow-up|0
2282742|NCT02389816|3969158|FG000|Overall Study|Withdrawal of Consent|6
2282743|NCT02389816|3969159|FG001|Overall Study|Withdrawal of Consent|4
2282744|NCT02389816|3969160|FG002|Overall Study|Withdrawal of Consent|4
2282745|NCT02389816|3969158|FG000|Overall Study|Lack of Efficacy|1
2282746|NCT02389816|3969159|FG001|Overall Study|Lack of Efficacy|0
2282747|NCT02389816|3969160|FG002|Overall Study|Lack of Efficacy|0
2282748|NCT02389816|3969158|FG000|Overall Study|Non Compliance with Study Drug|1
2128147|NCT01016600|3730527|FG001|Overall Study|Did not start treatment|0
2282749|NCT02389816|3969159|FG001|Overall Study|Non Compliance with Study Drug|1
2128148|NCT01016600|3730528|FG002|Overall Study|Did not start treatment|0
2128149|NCT01016600|3730529|FG003|Overall Study|Did not start treatment|0
2128150|NCT01016912|3730624|FG000|End of Treatment Period|Lack of Efficacy|0
2128151|NCT01016912|3730625|FG001|End of Treatment Period|Lack of Efficacy|1
2128152|NCT01016912|3730626|FG002|End of Treatment Period|Lack of Efficacy|0
2128153|NCT01016912|3730627|FG003|End of Treatment Period|Lack of Efficacy|4
2128154|NCT01016912|3730628|FG004|End of Treatment Period|Lack of Efficacy|4
2128155|NCT01016912|3730624|FG000|End of Treatment Period|Adverse Event|0
2128156|NCT01016912|3730625|FG001|End of Treatment Period|Adverse Event|1
2128157|NCT01016912|3730626|FG002|End of Treatment Period|Adverse Event|1
2128158|NCT01016912|3730627|FG003|End of Treatment Period|Adverse Event|0
2128159|NCT01016912|3730628|FG004|End of Treatment Period|Adverse Event|0
2128160|NCT01016912|3730624|FG000|End of Treatment Period|Completed double-blind period only|0
2128161|NCT01016912|3730625|FG001|End of Treatment Period|Completed double-blind period only|1
2128162|NCT01016912|3730626|FG002|End of Treatment Period|Completed double-blind period only|0
2128163|NCT01016912|3730627|FG003|End of Treatment Period|Completed double-blind period only|0
2128164|NCT01016912|3730628|FG004|End of Treatment Period|Completed double-blind period only|0
2128165|NCT01016912|3730624|FG000|Follow-up Period|Other reason|0
2128166|NCT01016912|3730625|FG001|Follow-up Period|Other reason|0
2128167|NCT01016912|3730626|FG002|Follow-up Period|Other reason|1
2128168|NCT01016912|3730627|FG003|Follow-up Period|Other reason|1
2128169|NCT01016912|3730628|FG004|Follow-up Period|Other reason|0
2128170|NCT01016964|3730667|FG000|Overall Study|Lost to Follow-up|3
2128171|NCT01016964|3730668|FG001|Overall Study|Lost to Follow-up|3
2128172|NCT01016977|3730676|FG000|Overall Study|Lost to Follow-up|1
2128173|NCT01016977|3730677|FG001|Overall Study|Lost to Follow-up|0
2128174|NCT01016977|3730676|FG000|Overall Study|Withdrawal by Subject|2
2128175|NCT01016977|3730677|FG001|Overall Study|Withdrawal by Subject|2
2128176|NCT01017029|3730694|FG000|Overall Study|Lost to Follow-up|1
2128177|NCT01017029|3730695|FG001|Overall Study|Lost to Follow-up|0
2128178|NCT01017029|3730694|FG000|Overall Study|Administrative problem|0
2128179|NCT01017029|3730695|FG001|Overall Study|Administrative problem|1
2128180|NCT01017029|3730694|FG000|Overall Study|Death|3
2128181|NCT01017029|3730695|FG001|Overall Study|Death|1
2128182|NCT01017120|3730712|FG000|Overall Study|Adverse Event|9
2128183|NCT01017120|3730713|FG001|Overall Study|Adverse Event|0
2128184|NCT01017120|3730712|FG000|Overall Study|Lost to Follow-up|13
2128185|NCT01017120|3730713|FG001|Overall Study|Lost to Follow-up|11
2128186|NCT01017120|3730712|FG000|Overall Study|Lack of Efficacy|1
2128187|NCT01017120|3730713|FG001|Overall Study|Lack of Efficacy|0
2128188|NCT01017120|3730712|FG000|Overall Study|Withdrawal by Subject|39
2128189|NCT01017120|3730713|FG001|Overall Study|Withdrawal by Subject|21
2128190|NCT01017120|3730712|FG000|Overall Study|Pregnancy|1
2128191|NCT01017120|3730713|FG001|Overall Study|Pregnancy|1
2128192|NCT01017120|3730712|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
2128193|NCT01017120|3730713|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
2128194|NCT01017120|3730712|FG000|Overall Study|Relocated Out of Town|0
2128195|NCT01017120|3730713|FG001|Overall Study|Relocated Out of Town|2
2128196|NCT01017120|3730712|FG000|Overall Study|Protocol Violation|1
2128197|NCT01017120|3730713|FG001|Overall Study|Protocol Violation|0
2128198|NCT01017120|3730712|FG000|Overall Study|Parent Unable to Provide Transportation|1
2128199|NCT01017120|3730713|FG001|Overall Study|Parent Unable to Provide Transportation|0
2128200|NCT01017146|3730721|FG000|Overall Study|Adverse Event|11
2128201|NCT01017146|3730722|FG001|Overall Study|Adverse Event|1
2128202|NCT01017146|3730721|FG000|Overall Study|Lost to Follow-up|14
2128203|NCT01017146|3730722|FG001|Overall Study|Lost to Follow-up|14
2128204|NCT01017146|3730721|FG000|Overall Study|Noncompliance with Study Product|1
2128205|NCT01017146|3730722|FG001|Overall Study|Noncompliance with Study Product|1
2128206|NCT01017146|3730721|FG000|Overall Study|Withdrawal by Subject|32
2128207|NCT01017146|3730722|FG001|Overall Study|Withdrawal by Subject|16
2128208|NCT01017146|3730721|FG000|Overall Study|Relocation|0
2128209|NCT01017146|3730722|FG001|Overall Study|Relocation|4
2128210|NCT01017146|3730721|FG000|Overall Study|Pregnancy|2
2128211|NCT01017146|3730722|FG001|Overall Study|Pregnancy|1
2128212|NCT01017146|3730721|FG000|Overall Study|Protocol Violation|2
2128213|NCT01017146|3730722|FG001|Overall Study|Protocol Violation|0
2128214|NCT01017146|3730721|FG000|Overall Study|Took Excluded Medication|2
2128215|NCT01017146|3730722|FG001|Overall Study|Took Excluded Medication|0
2128216|NCT01017146|3730721|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
2128217|NCT01017146|3730722|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
2128218|NCT01017146|3730721|FG000|Overall Study|Change in Work Situation|1
2128219|NCT01017146|3730722|FG001|Overall Study|Change in Work Situation|0
2128220|NCT01017549|3730760|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
2128221|NCT01017549|3730760|FG000|One-year Follow-up|Lost to Follow-up|2
2128222|NCT01017549|3730760|FG000|One-year Follow-up|Withdrawal by Subject|5
2128223|NCT01017549|3730760|FG000|5 Year Follow-up|Lost to Follow-up|9
2128224|NCT01017549|3730760|FG000|5 Year Follow-up|Mastectomy|3
2128225|NCT01017575|3730769|FG000|Overall Study|Lack of Efficacy|0
2128226|NCT01017575|3730770|FG001|Overall Study|Lack of Efficacy|1
2128227|NCT01017575|3730771|FG002|Overall Study|Lack of Efficacy|0
2128228|NCT01017575|3730772|FG003|Overall Study|Lack of Efficacy|1
2128229|NCT01017575|3730773|FG004|Overall Study|Lack of Efficacy|1
2128230|NCT01017575|3730769|FG000|Overall Study|Adverse Event|0
2128231|NCT01017575|3730770|FG001|Overall Study|Adverse Event|1
2128232|NCT01017575|3730771|FG002|Overall Study|Adverse Event|0
2128233|NCT01017575|3730772|FG003|Overall Study|Adverse Event|0
2128234|NCT01017575|3730773|FG004|Overall Study|Adverse Event|2
2128235|NCT01017575|3730769|FG000|Overall Study|Withdrawal by Subject|1
2128236|NCT01017575|3730770|FG001|Overall Study|Withdrawal by Subject|0
2128237|NCT01017575|3730771|FG002|Overall Study|Withdrawal by Subject|0
2128238|NCT01017575|3730772|FG003|Overall Study|Withdrawal by Subject|0
2128239|NCT01017575|3730773|FG004|Overall Study|Withdrawal by Subject|0
2128240|NCT01017601|3730787|FG000|Overall Study|Disease Progression|12
2128241|NCT01017601|3730788|FG001|Overall Study|Disease Progression|12
2128242|NCT01017601|3730787|FG000|Overall Study|Withdrawal by Subject|0
2128243|NCT01017601|3730788|FG001|Overall Study|Withdrawal by Subject|1
2128244|NCT01017731|3730798|FG000|Overall Study|Lost to Follow-up|2
2128245|NCT01017731|3730798|FG000|Overall Study|Withdrawal by Subject|3
2128246|NCT01017731|3730798|FG000|Overall Study|Physician Decision|2
2128247|NCT01017731|3730798|FG000|Overall Study|Adverse Event|1
2128248|NCT01017874|3730805|FG000|Overall Study|Withdrawal by Subject|23
2128249|NCT01017874|3730806|FG001|Overall Study|Withdrawal by Subject|20
2128250|NCT01017874|3730805|FG000|Overall Study|Sponsor decision|3
2128251|NCT01017874|3730806|FG001|Overall Study|Sponsor decision|1
2128252|NCT01017874|3730805|FG000|Overall Study|Lost to Follow-up|3
2128253|NCT01017874|3730806|FG001|Overall Study|Lost to Follow-up|2
2128254|NCT01017874|3730805|FG000|Overall Study|Physician Decision|1
2128255|NCT01017874|3730806|FG001|Overall Study|Physician Decision|3
2128256|NCT01017952|3730816|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
2128257|NCT01017952|3730817|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2128258|NCT01017952|3730818|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2128259|NCT01017952|3730819|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2128260|NCT01017952|3730820|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2128261|NCT01017952|3730816|FG000|4-week, Open-label Run-In Period|Adverse Event|23
2128262|NCT01017952|3730817|FG001|4-week, Open-label Run-In Period|Adverse Event|0
2128263|NCT01017952|3730818|FG002|4-week, Open-label Run-In Period|Adverse Event|0
2128264|NCT01017952|3730819|FG003|4-week, Open-label Run-In Period|Adverse Event|0
2128265|NCT01017952|3730820|FG004|4-week, Open-label Run-In Period|Adverse Event|0
2128266|NCT01017952|3730816|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
2128267|NCT01017952|3730817|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2128268|NCT01017952|3730818|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2128269|NCT01017952|3730819|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2128270|NCT01017952|3730820|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2128271|NCT01017952|3730816|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
2128272|NCT01017952|3730817|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
2128273|NCT01017952|3730818|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
2128274|NCT01017952|3730819|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
2128275|NCT01017952|3730820|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
2128276|NCT01017952|3730816|FG000|4-week, Open-label Run-In Period|Physician Decision|10
2128277|NCT01017952|3730817|FG001|4-week, Open-label Run-In Period|Physician Decision|0
2128278|NCT01017952|3730818|FG002|4-week, Open-label Run-In Period|Physician Decision|0
2128279|NCT01017952|3730819|FG003|4-week, Open-label Run-In Period|Physician Decision|0
2128280|NCT01017952|3730820|FG004|4-week, Open-label Run-In Period|Physician Decision|0
2128281|NCT01017952|3730816|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63
2128282|NCT01017952|3730817|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2128283|NCT01017952|3730818|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2128284|NCT01017952|3730819|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2128285|NCT01017952|3730820|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2128286|NCT01017952|3730816|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
2128287|NCT01017952|3730817|FG001|52-week, Double-blind Treatment Period|Adverse Event|25
2128288|NCT01017952|3730818|FG002|52-week, Double-blind Treatment Period|Adverse Event|32
2128289|NCT01017952|3730819|FG003|52-week, Double-blind Treatment Period|Adverse Event|35
2128290|NCT01017952|3730820|FG004|52-week, Double-blind Treatment Period|Adverse Event|30
2128291|NCT01017952|3730816|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
2128292|NCT01017952|3730817|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
2128293|NCT01017952|3730818|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
2128294|NCT01017952|3730819|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
2128295|NCT01017952|3730820|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
2128296|NCT01017952|3730816|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
2128297|NCT01017952|3730817|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35
2128298|NCT01017952|3730818|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14
2128299|NCT01017952|3730819|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16
2128300|NCT01017952|3730820|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14
2128301|NCT01017952|3730816|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
2128302|NCT01017952|3730817|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7
2128303|NCT01017952|3730818|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11
2128304|NCT01017952|3730819|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9
2128305|NCT01017952|3730820|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8
2128306|NCT01017952|3730816|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2128307|NCT01017952|3730817|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
2128308|NCT01017952|3730818|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
2128309|NCT01017952|3730819|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
2128310|NCT01017952|3730820|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
2128311|NCT01017952|3730816|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2128312|NCT01017952|3730817|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
2128313|NCT01017952|3730818|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
2128314|NCT01017952|3730819|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2128315|NCT01017952|3730820|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2128316|NCT01017952|3730816|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
2128317|NCT01017952|3730817|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6
2128318|NCT01017952|3730818|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8
2128319|NCT01017952|3730819|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
2128320|NCT01017952|3730820|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10
2128321|NCT01017952|3730816|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
2128322|NCT01017952|3730817|FG001|52-week, Double-blind Treatment Period|Physician Decision|10
2128323|NCT01017952|3730818|FG002|52-week, Double-blind Treatment Period|Physician Decision|8
2128324|NCT01017952|3730819|FG003|52-week, Double-blind Treatment Period|Physician Decision|9
2128325|NCT01017952|3730820|FG004|52-week, Double-blind Treatment Period|Physician Decision|7
2128326|NCT01018030|3730833|FG000|Overall Study|Adverse Event|10
2128327|NCT01018030|3730834|FG001|Overall Study|Adverse Event|5
2128328|NCT01018030|3730835|FG002|Overall Study|Adverse Event|5
2128329|NCT01018030|3730833|FG000|Overall Study|Withdrawal by Subject|2
2128330|NCT01018030|3730834|FG001|Overall Study|Withdrawal by Subject|2
2128331|NCT01018030|3730835|FG002|Overall Study|Withdrawal by Subject|4
2128332|NCT01018030|3730833|FG000|Overall Study|Lost to Follow-up|2
2128333|NCT01018030|3730834|FG001|Overall Study|Lost to Follow-up|0
2128334|NCT01018030|3730835|FG002|Overall Study|Lost to Follow-up|3
2128335|NCT01018030|3730833|FG000|Overall Study|Protocol Violation|2
2128336|NCT01018030|3730834|FG001|Overall Study|Protocol Violation|1
2128337|NCT01018030|3730835|FG002|Overall Study|Protocol Violation|0
2128338|NCT01018030|3730833|FG000|Overall Study|Physician Decision|1
2128339|NCT01018030|3730834|FG001|Overall Study|Physician Decision|0
2128340|NCT01018030|3730835|FG002|Overall Study|Physician Decision|1
2128341|NCT01018030|3730833|FG000|Overall Study|Lack of Efficacy|1
2128342|NCT01018030|3730834|FG001|Overall Study|Lack of Efficacy|0
2128343|NCT01018030|3730835|FG002|Overall Study|Lack of Efficacy|0
2128344|NCT01018030|3730833|FG000|Overall Study|Did Not Receive Study Drug|1
2128345|NCT01018030|3730834|FG001|Overall Study|Did Not Receive Study Drug|3
2128346|NCT01018030|3730835|FG002|Overall Study|Did Not Receive Study Drug|0
2128347|NCT01018186|3730898|FG000|2-week Run-in Period|Protocol Violation|1
2128348|NCT01018186|3730899|FG001|2-week Run-in Period|Protocol Violation|0
2128349|NCT01018186|3730900|FG002|2-week Run-in Period|Protocol Violation|0
2128350|NCT01018186|3730901|FG003|2-week Run-in Period|Protocol Violation|0
2128351|NCT01018186|3730898|FG000|2-week Run-in Period|Lost to Follow-up|2
2128352|NCT01018186|3730899|FG001|2-week Run-in Period|Lost to Follow-up|0
2128353|NCT01018186|3730900|FG002|2-week Run-in Period|Lost to Follow-up|0
2128354|NCT01018186|3730901|FG003|2-week Run-in Period|Lost to Follow-up|0
2128355|NCT01018186|3730898|FG000|2-week Run-in Period|Physician Decision|3
2128356|NCT01018186|3730899|FG001|2-week Run-in Period|Physician Decision|0
2128357|NCT01018186|3730900|FG002|2-week Run-in Period|Physician Decision|0
2128358|NCT01018186|3730901|FG003|2-week Run-in Period|Physician Decision|0
2128359|NCT01018186|3730898|FG000|2-week Run-in Period|Withdrawal by Subject|11
2128360|NCT01018186|3730899|FG001|2-week Run-in Period|Withdrawal by Subject|0
2128361|NCT01018186|3730900|FG002|2-week Run-in Period|Withdrawal by Subject|0
2128362|NCT01018186|3730901|FG003|2-week Run-in Period|Withdrawal by Subject|0
2128363|NCT01018186|3730898|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97
2128364|NCT01018186|3730899|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2128365|NCT01018186|3730900|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2128366|NCT01018186|3730901|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2128367|NCT01018186|3730898|FG000|52-week Double-blind Treatment Period|Adverse Event|0
2128368|NCT01018186|3730899|FG001|52-week Double-blind Treatment Period|Adverse Event|5
2128369|NCT01018186|3730900|FG002|52-week Double-blind Treatment Period|Adverse Event|3
2128370|NCT01018186|3730901|FG003|52-week Double-blind Treatment Period|Adverse Event|6
2128371|NCT01018186|3730898|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
2128372|NCT01018186|3730899|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1
2128373|NCT01018186|3730900|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4
2128374|NCT01018186|3730901|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1
2128375|NCT01018186|3730898|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
2128376|NCT01018186|3730899|FG001|52-week Double-blind Treatment Period|Protocol Violation|8
2128377|NCT01018186|3730900|FG002|52-week Double-blind Treatment Period|Protocol Violation|8
2128378|NCT01018186|3730901|FG003|52-week Double-blind Treatment Period|Protocol Violation|2
2128379|NCT01018186|3730898|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
2128380|NCT01018186|3730899|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
2128381|NCT01018186|3730900|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
2128382|NCT01018186|3730901|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
2128383|NCT01018186|3730898|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
2128384|NCT01018186|3730899|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1
2128385|NCT01018186|3730900|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3
2128386|NCT01018186|3730901|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4
2128387|NCT01018186|3730898|FG000|52-week Double-blind Treatment Period|Physician Decision|0
2128388|NCT01018186|3730899|FG001|52-week Double-blind Treatment Period|Physician Decision|1
2128389|NCT01018186|3730900|FG002|52-week Double-blind Treatment Period|Physician Decision|0
2128390|NCT01018186|3730901|FG003|52-week Double-blind Treatment Period|Physician Decision|3
2128391|NCT01018186|3730898|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
2128392|NCT01018186|3730899|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10
2128393|NCT01018186|3730900|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7
2128394|NCT01018186|3730901|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9
2128395|NCT01018264|3730915|FG000|Overall Study|Withdrawal by Subject|1
2128396|NCT01018264|3730916|FG001|Overall Study|Withdrawal by Subject|0
2128397|NCT01018264|3730915|FG000|Overall Study|Lost to Follow-up|0
2128398|NCT01018264|3730916|FG001|Overall Study|Lost to Follow-up|1
2128399|NCT01018394|3730924|FG000|Overall Study|Withdrawal by Subject|5
2128400|NCT01018394|3730925|FG001|Overall Study|Withdrawal by Subject|5
2128401|NCT01018394|3730924|FG000|Overall Study|Lost to Follow-up|4
2128402|NCT01018394|3730925|FG001|Overall Study|Lost to Follow-up|3
2128403|NCT01018511|3730961|FG000|Overall Study|Not fulfilling eligibility criteria|6
2128404|NCT01018511|3730962|FG001|Overall Study|Not fulfilling eligibility criteria|7
2128405|NCT01018511|3730963|FG002|Overall Study|Not fulfilling eligibility criteria|7
2128406|NCT01018511|3730964|FG003|Overall Study|Not fulfilling eligibility criteria|3
2128407|NCT01018511|3730961|FG000|Overall Study|Adverse Event|5
2128408|NCT01018511|3730962|FG001|Overall Study|Adverse Event|9
2128409|NCT01018511|3730963|FG002|Overall Study|Adverse Event|13
2128410|NCT01018511|3730964|FG003|Overall Study|Adverse Event|10
2128411|NCT01018511|3730961|FG000|Overall Study|Lack of Efficacy|4
2128412|NCT01018511|3730962|FG001|Overall Study|Lack of Efficacy|1
2128413|NCT01018511|3730963|FG002|Overall Study|Lack of Efficacy|1
2128414|NCT01018511|3730964|FG003|Overall Study|Lack of Efficacy|2
2128415|NCT01018511|3730961|FG000|Overall Study|Withdrawal by Subject|6
2128416|NCT01018511|3730962|FG001|Overall Study|Withdrawal by Subject|5
2128417|NCT01018511|3730963|FG002|Overall Study|Withdrawal by Subject|11
2128418|NCT01018511|3730964|FG003|Overall Study|Withdrawal by Subject|9
2128419|NCT01018511|3730961|FG000|Overall Study|Lost to Follow-up|0
2128420|NCT01018511|3730962|FG001|Overall Study|Lost to Follow-up|0
2128421|NCT01018511|3730963|FG002|Overall Study|Lost to Follow-up|1
2128422|NCT01018511|3730964|FG003|Overall Study|Lost to Follow-up|0
2128423|NCT01018511|3730961|FG000|Overall Study|Protocol Violation|5
2128424|NCT01018511|3730962|FG001|Overall Study|Protocol Violation|8
2128425|NCT01018511|3730963|FG002|Overall Study|Protocol Violation|7
2128426|NCT01018511|3730964|FG003|Overall Study|Protocol Violation|9
2128427|NCT01018511|3730961|FG000|Overall Study|Miscellaneous|0
2128428|NCT01018511|3730962|FG001|Overall Study|Miscellaneous|2
2128429|NCT01018511|3730963|FG002|Overall Study|Miscellaneous|0
2128430|NCT01018511|3730964|FG003|Overall Study|Miscellaneous|0
2128431|NCT01018680|3730982|FG000|Overall Study|Adverse Event|23
2128432|NCT01018680|3730983|FG001|Overall Study|Adverse Event|40
2128433|NCT01018680|3730982|FG000|Overall Study|Withdrawal by Subject|10
2128434|NCT01018680|3730983|FG001|Overall Study|Withdrawal by Subject|10
2128435|NCT01018680|3730982|FG000|Overall Study|Protocol Violation|5
2128436|NCT01018680|3730983|FG001|Overall Study|Protocol Violation|8
2128437|NCT01018680|3730982|FG000|Overall Study|Sponsor Decision|6
2128438|NCT01018680|3730983|FG001|Overall Study|Sponsor Decision|7
2128439|NCT01018680|3730982|FG000|Overall Study|Lack of Efficacy|8
2128440|NCT01018680|3730983|FG001|Overall Study|Lack of Efficacy|2
2128441|NCT01018680|3730982|FG000|Overall Study|Lost to Follow-up|5
2128442|NCT01018680|3730983|FG001|Overall Study|Lost to Follow-up|3
2128443|NCT01018680|3730982|FG000|Overall Study|Entry Criteria Not Met|1
2128444|NCT01018680|3730983|FG001|Overall Study|Entry Criteria Not Met|4
2128445|NCT01018680|3730982|FG000|Overall Study|Physician Decision|3
2128446|NCT01018680|3730983|FG001|Overall Study|Physician Decision|1
2128447|NCT01018732|3730992|FG000|Overall Study|Lost to Follow-up|0
2128448|NCT01018732|3730993|FG001|Overall Study|Lost to Follow-up|0
2128449|NCT01018732|3730994|FG002|Overall Study|Lost to Follow-up|3
2128450|NCT01018732|3730992|FG000|Overall Study|Protocol Violation|1
2128451|NCT01018732|3730993|FG001|Overall Study|Protocol Violation|1
2128452|NCT01018732|3730994|FG002|Overall Study|Protocol Violation|0
2128453|NCT01018732|3730992|FG000|Overall Study|Inappropriate Enrollment|0
2128454|NCT01018732|3730993|FG001|Overall Study|Inappropriate Enrollment|1
2128455|NCT01018732|3730994|FG002|Overall Study|Inappropriate Enrollment|0
2128456|NCT01018732|3730992|FG000|Overall Study|Unable to Classify|0
2128457|NCT01018732|3730993|FG001|Overall Study|Unable to Classify|0
2128458|NCT01018732|3730994|FG002|Overall Study|Unable to Classify|1
2128459|NCT01018862|3731005|FG000|Overall Study|Adverse Event|2
2128460|NCT01018862|3731006|FG001|Overall Study|Adverse Event|0
2128461|NCT01018862|3731007|FG002|Overall Study|Adverse Event|6
2128462|NCT01018862|3731005|FG000|Overall Study|Lack of Efficacy|1
2128463|NCT01018862|3731006|FG001|Overall Study|Lack of Efficacy|0
2128464|NCT01018862|3731007|FG002|Overall Study|Lack of Efficacy|2
2128465|NCT01018862|3731005|FG000|Overall Study|Lost to Follow-up|3
2128466|NCT01018862|3731006|FG001|Overall Study|Lost to Follow-up|1
2128467|NCT01018862|3731007|FG002|Overall Study|Lost to Follow-up|0
2128468|NCT01018862|3731005|FG000|Overall Study|Protocol Violation|1
2128469|NCT01018862|3731006|FG001|Overall Study|Protocol Violation|3
2128470|NCT01018862|3731007|FG002|Overall Study|Protocol Violation|3
2128471|NCT01018862|3731005|FG000|Overall Study|Withdrawal by Subject|1
2128472|NCT01018862|3731006|FG001|Overall Study|Withdrawal by Subject|2
2128473|NCT01018862|3731007|FG002|Overall Study|Withdrawal by Subject|1
2128474|NCT01018862|3731005|FG000|Overall Study|administrative problems|5
2128475|NCT01018862|3731006|FG001|Overall Study|administrative problems|4
2128476|NCT01018862|3731007|FG002|Overall Study|administrative problems|4
2128477|NCT01018953|3731015|FG000|Overall Study|Adverse Event|2
2128478|NCT01018953|3731015|FG000|Overall Study|Withdrawal by Subject|1
2128479|NCT01018953|3731015|FG000|Overall Study|Study termination by sponsor|5
2128480|NCT01018979|3731022|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
2128481|NCT01018979|3731023|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
2128482|NCT01018979|3731022|FG000|Overall Study|Not received at least one dose|0
2128483|NCT01018979|3731023|FG001|Overall Study|Not received at least one dose|1
2128484|NCT01018992|3731034|FG000|Overall Study|Adverse Event|8
2128485|NCT01018992|3731035|FG001|Overall Study|Adverse Event|3
2128486|NCT01018992|3731034|FG000|Overall Study|Withdrawal by Subject|3
2128487|NCT01018992|3731035|FG001|Overall Study|Withdrawal by Subject|8
2128488|NCT01018992|3731034|FG000|Overall Study|Protocol Violation|0
2128489|NCT01018992|3731035|FG001|Overall Study|Protocol Violation|4
2128490|NCT01018992|3731034|FG000|Overall Study|Lost to Follow-up|5
2128491|NCT01018992|3731035|FG001|Overall Study|Lost to Follow-up|1
2128492|NCT01019135|3731044|FG000|Overall Study|Did not receive allocated intervention|12
2128493|NCT01019135|3731045|FG001|Overall Study|Did not receive allocated intervention|6
2128494|NCT01019135|3731046|FG002|Overall Study|Did not receive allocated intervention|25
2128495|NCT01019135|3731044|FG000|Overall Study|Did not attend CR|8
2128496|NCT01019135|3731045|FG001|Overall Study|Did not attend CR|13
2128497|NCT01019135|3731046|FG002|Overall Study|Did not attend CR|6
2128498|NCT01019252|3731056|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2
2128499|NCT01019252|3731057|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0
2128500|NCT01019252|3731056|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
2128501|NCT01019252|3731057|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
2128502|NCT01019252|3731056|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0
2128503|NCT01019252|3731057|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2
2128504|NCT01019252|3731056|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
2128505|NCT01019252|3731057|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
2128506|NCT01019317|3731063|FG000|Overall Study|Not Eligible|4
2128507|NCT01019369|3731069|FG000|Overall Study|Lost to Follow-up|10
2128508|NCT01019369|3731070|FG001|Overall Study|Lost to Follow-up|6
2128509|NCT01019369|3731069|FG000|Overall Study|Withdrawal by Subject|0
2128510|NCT01019369|3731070|FG001|Overall Study|Withdrawal by Subject|1
2128511|NCT01019486|3731080|FG000|Overall Study|Withdrawal by Subject|1
2128512|NCT01019486|3731081|FG001|Overall Study|Withdrawal by Subject|1
2128513|NCT01019486|3731082|FG002|Overall Study|Withdrawal by Subject|1
2128514|NCT01019694|3731094|FG000|Overall Study|Adverse Event|12
2128515|NCT01019694|3731095|FG001|Overall Study|Adverse Event|16
2128516|NCT01019694|3731096|FG002|Overall Study|Adverse Event|19
2128517|NCT01019694|3731094|FG000|Overall Study|Protocol Violation|2
2128518|NCT01019694|3731095|FG001|Overall Study|Protocol Violation|6
2128519|NCT01019694|3731096|FG002|Overall Study|Protocol Violation|4
2128520|NCT01019694|3731094|FG000|Overall Study|Lost to Follow-up|5
2128521|NCT01019694|3731095|FG001|Overall Study|Lost to Follow-up|3
2128522|NCT01019694|3731096|FG002|Overall Study|Lost to Follow-up|3
2128523|NCT01019694|3731094|FG000|Overall Study|Withdrawal by Subject|4
2128524|NCT01019694|3731095|FG001|Overall Study|Withdrawal by Subject|6
2128525|NCT01019694|3731096|FG002|Overall Study|Withdrawal by Subject|12
2128526|NCT01019694|3731094|FG000|Overall Study|Not treated|0
2128527|NCT01019694|3731095|FG001|Overall Study|Not treated|2
2128528|NCT01019694|3731096|FG002|Overall Study|Not treated|3
2128529|NCT01019694|3731094|FG000|Overall Study|Other reason (not specified)|1
2128530|NCT01019694|3731095|FG001|Overall Study|Other reason (not specified)|5
2128531|NCT01019694|3731096|FG002|Overall Study|Other reason (not specified)|6
2128532|NCT01020019|3731135|FG000|Overall Study|Lost to Follow-up|21
2128533|NCT01020019|3731136|FG001|Overall Study|Lost to Follow-up|18
2128534|NCT01020019|3731135|FG000|Overall Study|Adverse Event|1
2128535|NCT01020019|3731136|FG001|Overall Study|Adverse Event|5
2128536|NCT01020019|3731135|FG000|Overall Study|not interested in treatment|4
2128537|NCT01020019|3731136|FG001|Overall Study|not interested in treatment|4
2128538|NCT01020019|3731135|FG000|Overall Study|moving|0
2128539|NCT01020019|3731136|FG001|Overall Study|moving|2
2128540|NCT01020123|3731149|FG000|Main Period|Withdrawal by Subject|6
2128541|NCT01020123|3731150|FG001|Main Period|Withdrawal by Subject|5
2128542|NCT01020123|3731151|FG002|Main Period|Withdrawal by Subject|3
2128543|NCT01020123|3731152|FG003|Main Period|Withdrawal by Subject|1
2128544|NCT01020123|3731153|FG004|Main Period|Withdrawal by Subject|6
2128545|NCT01020123|3731154|FG005|Main Period|Withdrawal by Subject|3
2128546|NCT01020123|3731155|FG006|Main Period|Withdrawal by Subject|2
2128547|NCT01020123|3731149|FG000|Main Period|Eligibility Criteria not fullfilled|0
2128548|NCT01020123|3731150|FG001|Main Period|Eligibility Criteria not fullfilled|1
2128549|NCT01020123|3731151|FG002|Main Period|Eligibility Criteria not fullfilled|0
2128550|NCT01020123|3731152|FG003|Main Period|Eligibility Criteria not fullfilled|0
2128551|NCT01020123|3731153|FG004|Main Period|Eligibility Criteria not fullfilled|1
2128552|NCT01020123|3731154|FG005|Main Period|Eligibility Criteria not fullfilled|0
2128553|NCT01020123|3731155|FG006|Main Period|Eligibility Criteria not fullfilled|0
2128554|NCT01020123|3731149|FG000|Main Period|Adverse Event|5
2128555|NCT01020123|3731150|FG001|Main Period|Adverse Event|2
2128556|NCT01020123|3731151|FG002|Main Period|Adverse Event|2
2128557|NCT01020123|3731152|FG003|Main Period|Adverse Event|1
2205857|NCT01614769|3844034|FG003|Period 3|Withdrawal by Subject|0
2205858|NCT01614769|3844035|FG004|Period 3|Withdrawal by Subject|0
2205859|NCT01614769|3844036|FG005|Period 3|Withdrawal by Subject|0
2205860|NCT01614795|3844048|FG000|Overall Study|Adverse Event|0
2205861|NCT01614795|3844049|FG001|Overall Study|Adverse Event|0
2205862|NCT01614795|3844050|FG002|Overall Study|Adverse Event|1
2205863|NCT01614795|3844051|FG003|Overall Study|Adverse Event|1
2205864|NCT01614795|3844048|FG000|Overall Study|Lack of Efficacy|10
2205865|NCT01614795|3844049|FG001|Overall Study|Lack of Efficacy|10
2205866|NCT01614795|3844050|FG002|Overall Study|Lack of Efficacy|9
2205867|NCT01614795|3844051|FG003|Overall Study|Lack of Efficacy|8
2205868|NCT01614795|3844048|FG000|Overall Study|Physician Decision|1
2205869|NCT01614795|3844049|FG001|Overall Study|Physician Decision|0
2128558|NCT01020123|3731153|FG004|Main Period|Adverse Event|1
2128559|NCT01020123|3731154|FG005|Main Period|Adverse Event|2
2128560|NCT01020123|3731155|FG006|Main Period|Adverse Event|1
2128561|NCT01020123|3731149|FG000|Main Period|Protocol Violation|4
2128562|NCT01020123|3731150|FG001|Main Period|Protocol Violation|4
2128563|NCT01020123|3731151|FG002|Main Period|Protocol Violation|2
2128564|NCT01020123|3731152|FG003|Main Period|Protocol Violation|5
2128565|NCT01020123|3731153|FG004|Main Period|Protocol Violation|2
2205870|NCT01614795|3844050|FG002|Overall Study|Physician Decision|1
2205871|NCT01614795|3844051|FG003|Overall Study|Physician Decision|1
2128566|NCT01020123|3731154|FG005|Main Period|Protocol Violation|3
2128567|NCT01020123|3731155|FG006|Main Period|Protocol Violation|2
2128568|NCT01020123|3731149|FG000|Main Period|Lost to Follow-up|0
2128569|NCT01020123|3731150|FG001|Main Period|Lost to Follow-up|2
2128570|NCT01020123|3731151|FG002|Main Period|Lost to Follow-up|0
2128571|NCT01020123|3731152|FG003|Main Period|Lost to Follow-up|0
2128572|NCT01020123|3731153|FG004|Main Period|Lost to Follow-up|0
2128573|NCT01020123|3731154|FG005|Main Period|Lost to Follow-up|0
2128574|NCT01020123|3731155|FG006|Main Period|Lost to Follow-up|0
2128575|NCT01020123|3731149|FG000|Main Period|Unclasified|2
2128576|NCT01020123|3731150|FG001|Main Period|Unclasified|0
2128577|NCT01020123|3731151|FG002|Main Period|Unclasified|1
2128578|NCT01020123|3731152|FG003|Main Period|Unclasified|0
2128579|NCT01020123|3731153|FG004|Main Period|Unclasified|1
2128580|NCT01020123|3731154|FG005|Main Period|Unclasified|3
2128581|NCT01020123|3731155|FG006|Main Period|Unclasified|6
2128582|NCT01020123|3731149|FG000|Extention Period|Withdrawal by Subject|2
2128583|NCT01020123|3731150|FG001|Extention Period|Withdrawal by Subject|1
2128584|NCT01020123|3731151|FG002|Extention Period|Withdrawal by Subject|1
2128585|NCT01020123|3731152|FG003|Extention Period|Withdrawal by Subject|0
2128586|NCT01020123|3731153|FG004|Extention Period|Withdrawal by Subject|0
2128587|NCT01020123|3731154|FG005|Extention Period|Withdrawal by Subject|0
2128588|NCT01020123|3731155|FG006|Extention Period|Withdrawal by Subject|0
2128589|NCT01020123|3731149|FG000|Extention Period|Adverse Event|0
2128590|NCT01020123|3731150|FG001|Extention Period|Adverse Event|0
2128591|NCT01020123|3731151|FG002|Extention Period|Adverse Event|0
2128592|NCT01020123|3731152|FG003|Extention Period|Adverse Event|1
2128593|NCT01020123|3731153|FG004|Extention Period|Adverse Event|0
2128594|NCT01020123|3731154|FG005|Extention Period|Adverse Event|0
2128595|NCT01020123|3731155|FG006|Extention Period|Adverse Event|0
2128596|NCT01020123|3731149|FG000|Extention Period|Protocol Violation|1
2128597|NCT01020123|3731150|FG001|Extention Period|Protocol Violation|1
2128598|NCT01020123|3731151|FG002|Extention Period|Protocol Violation|1
2128599|NCT01020123|3731152|FG003|Extention Period|Protocol Violation|0
2128600|NCT01020123|3731153|FG004|Extention Period|Protocol Violation|0
2128601|NCT01020123|3731154|FG005|Extention Period|Protocol Violation|0
2128602|NCT01020123|3731155|FG006|Extention Period|Protocol Violation|1
2205872|NCT01614795|3844048|FG000|Overall Study|Withdrawal by Subject|0
2128603|NCT01020123|3731149|FG000|Extention Period|Lost to Follow-up|0
2128604|NCT01020123|3731150|FG001|Extention Period|Lost to Follow-up|0
2128605|NCT01020123|3731151|FG002|Extention Period|Lost to Follow-up|0
2128606|NCT01020123|3731152|FG003|Extention Period|Lost to Follow-up|0
2205873|NCT01614795|3844049|FG001|Overall Study|Withdrawal by Subject|1
2205874|NCT01614795|3844050|FG002|Overall Study|Withdrawal by Subject|0
2205875|NCT01614795|3844051|FG003|Overall Study|Withdrawal by Subject|2
2205876|NCT01614795|3844048|FG000|Overall Study|Ineligible|0
2205877|NCT01614795|3844049|FG001|Overall Study|Ineligible|1
2205878|NCT01614795|3844050|FG002|Overall Study|Ineligible|0
2205879|NCT01614795|3844051|FG003|Overall Study|Ineligible|0
2205880|NCT01614886|3844082|FG000|Overall Study|Adverse Event|15
2205881|NCT01614886|3844083|FG001|Overall Study|Adverse Event|20
2205882|NCT01614886|3844082|FG000|Overall Study|Withdrawal by Subject|4
2205883|NCT01614886|3844083|FG001|Overall Study|Withdrawal by Subject|4
2128607|NCT01020123|3731153|FG004|Extention Period|Lost to Follow-up|0
2128608|NCT01020123|3731154|FG005|Extention Period|Lost to Follow-up|2
2128609|NCT01020123|3731155|FG006|Extention Period|Lost to Follow-up|0
2128610|NCT01020305|3731172|FG000|Overall Study|Adverse Event|2
2178036|NCT01380093|3802584|FG004|Naloxone Challenge Phase|Screen failures|0
2178037|NCT01380093|3802585|FG005|Naloxone Challenge Phase|Screen failures|0
2178038|NCT01380093|3802586|FG006|Naloxone Challenge Phase|Screen failures|0
2178039|NCT01380093|3802587|FG007|Naloxone Challenge Phase|Screen failures|0
2178040|NCT01380093|3802588|FG008|Naloxone Challenge Phase|Screen failures|0
2178041|NCT01380093|3802580|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0
2178042|NCT01380093|3802581|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1
2178043|NCT01380093|3802582|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0
2178044|NCT01380093|3802583|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0
2178045|NCT01380093|3802584|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0
2178046|NCT01380093|3802585|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0
2178047|NCT01380093|3802586|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0
2178048|NCT01380093|3802587|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0
2178049|NCT01380093|3802588|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0
2178050|NCT01380093|3802580|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0
2178051|NCT01380093|3802581|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3
2178052|NCT01380093|3802582|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1
2178053|NCT01380093|3802583|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0
2178054|NCT01380093|3802584|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0
2205884|NCT01614886|3844082|FG000|Overall Study|Death|1
2205885|NCT01614886|3844083|FG001|Overall Study|Death|0
2282750|NCT02389816|3969160|FG002|Overall Study|Non Compliance with Study Drug|1
2282751|NCT02389816|3969158|FG000|Overall Study|Reason not Specified|0
2282752|NCT02389816|3969159|FG001|Overall Study|Reason not Specified|2
2282753|NCT02389816|3969160|FG002|Overall Study|Reason not Specified|0
2282754|NCT02389829|3969170|FG000|Overall Study|Lost to Follow-up|0
2282755|NCT02389829|3969171|FG001|Overall Study|Lost to Follow-up|1
2282756|NCT02389894|3969209|FG000|Overall Study|Death|4
2282757|NCT02389894|3969210|FG001|Overall Study|Death|5
2282758|NCT02389894|3969211|FG002|Overall Study|Death|3
2282759|NCT02389894|3969209|FG000|Overall Study|Withdrawal by Subject|2
2282760|NCT02389894|3969210|FG001|Overall Study|Withdrawal by Subject|4
2205886|NCT01614886|3844082|FG000|Overall Study|Protocol deviation|0
2205887|NCT01614886|3844083|FG001|Overall Study|Protocol deviation|2
2205888|NCT01614925|3844108|FG000|Overall Study|Withdrawal by Subject|1
2205889|NCT01614925|3844109|FG001|Overall Study|Withdrawal by Subject|0
2205890|NCT01614925|3844108|FG000|Overall Study|Protocol Violation|3
2205891|NCT01614925|3844109|FG001|Overall Study|Protocol Violation|2
2205892|NCT01615198|3844126|FG000|Overall Study|Withdrawal by Subject|5
2205893|NCT01615198|3844127|FG001|Overall Study|Withdrawal by Subject|5
2205894|NCT01615198|3844126|FG000|Overall Study|Protocol deviation|1
2205895|NCT01615198|3844127|FG001|Overall Study|Protocol deviation|1
2205896|NCT01615198|3844126|FG000|Overall Study|Physician Decision|5
2205897|NCT01615198|3844127|FG001|Overall Study|Physician Decision|1
2205898|NCT01615198|3844126|FG000|Overall Study|Lost to Follow-up|1
2205899|NCT01615198|3844127|FG001|Overall Study|Lost to Follow-up|1
2205900|NCT01615198|3844126|FG000|Overall Study|Lack of Efficacy|1
2205901|NCT01615198|3844127|FG001|Overall Study|Lack of Efficacy|6
2205902|NCT01615198|3844126|FG000|Overall Study|Adverse Event|11
2205903|NCT01615198|3844127|FG001|Overall Study|Adverse Event|5
2205904|NCT01615263|3844135|FG000|Overall Study|Post-randomization exclusion|0
2205905|NCT01615263|3844136|FG001|Overall Study|Post-randomization exclusion|2
2205906|NCT01615328|3844144|FG000|Overall Study|Lost to Follow-up|3
2205907|NCT01615328|3844145|FG001|Overall Study|Lost to Follow-up|5
2205908|NCT01615822|3844189|FG000|Period 1|Withdrawal by Subject|0
2205909|NCT01615822|3844190|FG001|Period 1|Withdrawal by Subject|1
2205910|NCT01615822|3844191|FG002|Period 1|Withdrawal by Subject|0
2205911|NCT01615822|3844189|FG000|Period 1|Adverse Event|1
2205912|NCT01615822|3844190|FG001|Period 1|Adverse Event|1
2205913|NCT01615822|3844191|FG002|Period 1|Adverse Event|0
2205914|NCT01615822|3844189|FG000|Period 2|Lost to Follow-up|0
2205915|NCT01615822|3844190|FG001|Period 2|Lost to Follow-up|1
2205916|NCT01615822|3844191|FG002|Period 2|Lost to Follow-up|2
2205917|NCT01615939|3844204|FG000|Overall Study|Lost to Follow-up|5
2205918|NCT01615939|3844205|FG001|Overall Study|Lost to Follow-up|0
2205919|NCT01616173|3844232|FG000|Overall Study|Lost to Follow-up|0
2205920|NCT01616173|3844233|FG001|Overall Study|Lost to Follow-up|2
2205921|NCT01616173|3844234|FG002|Overall Study|Lost to Follow-up|0
2205922|NCT01616459|3844246|FG000|Overall Study|Adverse Event|1
2205923|NCT01616459|3844247|FG001|Overall Study|Adverse Event|1
2205924|NCT01616459|3844248|FG002|Overall Study|Adverse Event|2
2205925|NCT01616459|3844249|FG003|Overall Study|Adverse Event|0
2205926|NCT01616459|3844246|FG000|Overall Study|Lost to Follow-up|1
2128611|NCT01020435|3731178|FG000|Overall Study|Lost to Follow-up|0
2128612|NCT01020435|3731179|FG001|Overall Study|Lost to Follow-up|1
2128613|NCT01020448|3731186|FG000|Pre-assignment|Adverse Event|6
2128614|NCT01020448|3731186|FG000|Pre-assignment|Withdrawal by Subject|5
2128615|NCT01020448|3731186|FG000|Pre-assignment|Does Not Meet Entry Criteria|2
2128616|NCT01020448|3731186|FG000|Treatment|Adverse Event|11
2128617|NCT01020448|3731186|FG000|Treatment|Consent Withdrawn|3
2128618|NCT01020448|3731186|FG000|Treatment|Disease Progression|2
2128619|NCT01020448|3731186|FG000|Treatment|Lack of Efficacy|8
2128620|NCT01020448|3731186|FG000|Treatment|Lost to Follow-up|2
2128621|NCT01020474|3731193|FG000|Overall Study|Adverse Event|4
2128622|NCT01020474|3731194|FG001|Overall Study|Adverse Event|4
2128623|NCT01020474|3731193|FG000|Overall Study|Protocol Violation|0
2128624|NCT01020474|3731194|FG001|Overall Study|Protocol Violation|2
2128625|NCT01020474|3731193|FG000|Overall Study|Withdrawal by Subject|5
2128626|NCT01020474|3731194|FG001|Overall Study|Withdrawal by Subject|7
2128627|NCT01020474|3731193|FG000|Overall Study|Other Reasons|1
2128628|NCT01020474|3731194|FG001|Overall Study|Other Reasons|1
2128629|NCT01020474|3731193|FG000|Overall Study|Insufficient Clinical Response|0
2128630|NCT01020474|3731194|FG001|Overall Study|Insufficient Clinical Response|3
2128631|NCT01020487|3731203|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0
2128632|NCT01020487|3731204|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2
2128633|NCT01020487|3731205|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1
2128634|NCT01020487|3731203|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
2128635|NCT01020487|3731204|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
2128636|NCT01020487|3731205|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
2128637|NCT01020487|3731203|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
2128638|NCT01020487|3731204|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
2128639|NCT01020487|3731205|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
2128640|NCT01020487|3731203|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0
2128641|NCT01020487|3731204|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0
2128642|NCT01020487|3731205|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1
2128643|NCT01020487|3731203|FG000|Part 2 Open-label Period|Adverse Event|0
2128644|NCT01020487|3731204|FG001|Part 2 Open-label Period|Adverse Event|4
2128645|NCT01020487|3731205|FG002|Part 2 Open-label Period|Adverse Event|1
2128646|NCT01020526|3731215|FG000|Overall Study|Withdrawal by Subject|5
2128647|NCT01020526|3731215|FG000|Overall Study|Other reasons|3
2128648|NCT01020526|3731215|FG000|Overall Study|Insufficient clinical response|3
2128649|NCT01020526|3731215|FG000|Overall Study|Lost to Follow-up|1
2128650|NCT01020526|3731215|FG000|Overall Study|Adverse Event|2
2128651|NCT01020747|3731230|FG000|Overall Study|Withdrawal by Subject|1
2128652|NCT01020773|3731237|FG000|Overall Study|Withdrawal by Subject|4
2128653|NCT01020773|3731238|FG001|Overall Study|Withdrawal by Subject|3
2128654|NCT01020786|3731244|FG000|Induction Period|Entry Criteria Not Met|2
2128655|NCT01020786|3731244|FG000|Induction Period|Adverse Event|10
2128656|NCT01020786|3731244|FG000|Induction Period|Progressive Disease|31
2128657|NCT01020786|3731244|FG000|Induction Period|Investigator Decision|3
2128658|NCT01020786|3731244|FG000|Induction Period|Withdrawal by Subject|3
2128659|NCT01020786|3731244|FG000|Maintenance Period|Adverse Event|8
2128660|NCT01020786|3731244|FG000|Maintenance Period|Progressive Disease|43
2128661|NCT01020786|3731244|FG000|Maintenance Period|Withdrawal by Subject|8
2128662|NCT01020786|3731244|FG000|Maintenance Period|Sponsor Decision|1
2128663|NCT01020799|3731252|FG000|Overall Study|Adverse Event|4
2128664|NCT01020799|3731253|FG001|Overall Study|Adverse Event|3
2128665|NCT01020799|3731254|FG002|Overall Study|Adverse Event|2
2128666|NCT01020799|3731252|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4
2128667|NCT01020799|3731253|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3
2128668|NCT01020799|3731254|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0
2128669|NCT01020799|3731252|FG000|Overall Study|Protocol Violation|3
2128670|NCT01020799|3731253|FG001|Overall Study|Protocol Violation|2
2128671|NCT01020799|3731254|FG002|Overall Study|Protocol Violation|0
2128672|NCT01020799|3731252|FG000|Overall Study|Withdrawal by Subject|2
2128673|NCT01020799|3731253|FG001|Overall Study|Withdrawal by Subject|2
2128674|NCT01020799|3731254|FG002|Overall Study|Withdrawal by Subject|3
2128675|NCT01020799|3731252|FG000|Overall Study|Lost to Follow-up|6
2128676|NCT01020799|3731253|FG001|Overall Study|Lost to Follow-up|4
2128677|NCT01020799|3731254|FG002|Overall Study|Lost to Follow-up|2
2128678|NCT01020812|3731262|FG000|Overall Study|Physician Decision|1
2282761|NCT02389894|3969211|FG002|Overall Study|Withdrawal by Subject|5
2282762|NCT02389894|3969209|FG000|Overall Study|Lost to Follow-up|2
2282763|NCT02389894|3969210|FG001|Overall Study|Lost to Follow-up|1
2282764|NCT02389894|3969211|FG002|Overall Study|Lost to Follow-up|1
2128679|NCT01020812|3731262|FG000|Overall Study|Withdrawal by Subject|1
2128680|NCT01020812|3731262|FG000|Overall Study|Protocol Violation|1
2128681|NCT01020838|3731266|FG000|Overall Study|Death|90
2128682|NCT01020838|3731266|FG000|Overall Study|Adverse Event|1
2128683|NCT01020838|3731266|FG000|Overall Study|Withdrawal by Subject|9
2128684|NCT01020838|3731266|FG000|Overall Study|Lost to Follow-up|6
2128685|NCT01020838|3731266|FG000|Overall Study|Most common: Study ended by sponsor|77
2128686|NCT01020877|3731281|FG000|Second Intervention|Withdrawal by Subject|1
2282765|NCT02389998|3969239|FG000|Overall Study|car accident|1
2282766|NCT02389998|3969240|FG001|Overall Study|car accident|0
2282767|NCT02390076|3969268|FG000|Overall Study|Lost to Follow-up|2
2282768|NCT02390076|3969269|FG001|Overall Study|Lost to Follow-up|1
2282769|NCT02390076|3969270|FG002|Overall Study|Lost to Follow-up|4
2282770|NCT02390167|3969278|FG000|Overall Study|Lost to Follow-up|1
2282771|NCT02390219|3969286|FG000|Overall Study|Death|1
2282772|NCT02390219|3969286|FG000|Overall Study|Physician Decision|1
2282773|NCT02390219|3969286|FG000|Overall Study|Adverse Event|6
2282774|NCT02390219|3969286|FG000|Overall Study|Withdrawal by Subject|1
2282775|NCT02390219|3969286|FG000|Overall Study|Lost to Follow-up|2
2282776|NCT02390219|3969286|FG000|Overall Study|Other|2
2282777|NCT02390557|3969293|FG000|Wave 2|Survey non-respondent|72
2282778|NCT02390557|3969294|FG001|Wave 2|Survey non-respondent|41
2282779|NCT02390557|3969295|FG002|Wave 2|Survey non-respondent|23
2282780|NCT02391038|3969338|FG000|Overall Study|Progressive disease|3
2282781|NCT02391038|3969339|FG001|Overall Study|Progressive disease|3
2282782|NCT02391038|3969340|FG002|Overall Study|Progressive disease|6
2282783|NCT02391116|3969349|FG000|Treatment|Withdrawal by Subject|1
2282784|NCT02391116|3969349|FG000|Treatment|Protocol Violation|1
2282785|NCT02391116|3969349|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9
2282786|NCT02391116|3969349|FG000|Treatment|AE with Clinical PD|3
2282787|NCT02391116|3969349|FG000|Safety Follow-up|Adverse Event|1
2282788|NCT02391116|3969349|FG000|Safety Follow-up|Withdrawal by Subject|4
2282789|NCT02391116|3969349|FG000|Safety Follow-up|Switching to Other Therapy|4
2282790|NCT02391116|3969349|FG000|Safety Follow-up|No Follow Up|1
2282791|NCT02391116|3969349|FG000|Safety Follow-up|Deterioration of General Conditions|3
2282792|NCT02391116|3969349|FG000|Active Follow-up|Withdrawal by Subject|1
2282793|NCT02391116|3969349|FG000|Active Follow-up|Switching to Other Therapy|2
2282794|NCT02391116|3969349|FG000|Survival Follow-up|Withdrawal by Subject|3
2282795|NCT02391116|3969349|FG000|Survival Follow-up|Switching to Other Therapy|1
2282796|NCT02391311|3969362|FG000|Overall Study|Lost to Follow-up|2
2282797|NCT02391311|3969363|FG001|Overall Study|Lost to Follow-up|1
2128687|NCT01020877|3731282|FG001|Second Intervention|Withdrawal by Subject|0
2128688|NCT01020981|3731290|FG000|Overall Study|Did not return mailed survey|74
2128689|NCT01020981|3731291|FG001|Overall Study|Did not return mailed survey|58
2128690|NCT01020981|3731290|FG000|Overall Study|Survey returned undeliverable|8
2128691|NCT01020981|3731291|FG001|Overall Study|Survey returned undeliverable|32
2128692|NCT01020981|3731290|FG000|Overall Study|Participant declined to complete survey|2
2128693|NCT01020981|3731291|FG001|Overall Study|Participant declined to complete survey|0
2128694|NCT01021007|3731301|FG000|Overall Study|Lost to Follow-up|1
2128695|NCT01021007|3731302|FG001|Overall Study|Lost to Follow-up|1
2128696|NCT01021007|3731301|FG000|Overall Study|Adverse Event|1
2282798|NCT02391311|3969362|FG000|Overall Study|deemed ineligible after baseline|1
2282799|NCT02391311|3969363|FG001|Overall Study|deemed ineligible after baseline|1
2282800|NCT02391337|3969371|FG000|6 Months Follow-up|Death|5
2282801|NCT02391337|3969372|FG001|6 Months Follow-up|Death|4
2282802|NCT02391337|3969371|FG000|6 Months Follow-up|Withdrawal by Subject|1
2282803|NCT02391337|3969372|FG001|6 Months Follow-up|Withdrawal by Subject|1
2282804|NCT02391337|3969371|FG000|12 Months Follow-up|Death|2
2282805|NCT02391337|3969372|FG001|12 Months Follow-up|Death|0
2282806|NCT02391337|3969371|FG000|12 Months Follow-up|Withdrawal by Subject|0
2282807|NCT02391337|3969372|FG001|12 Months Follow-up|Withdrawal by Subject|1
2282808|NCT02391337|3969371|FG000|12 Months Follow-up|Lost to Follow-up|0
2282809|NCT02391337|3969372|FG001|12 Months Follow-up|Lost to Follow-up|2
2282810|NCT02391363|3969389|FG000|Overall Study|Lost to Follow-up|5
2282811|NCT02391363|3969390|FG001|Overall Study|Lost to Follow-up|5
2282812|NCT02391363|3969389|FG000|Overall Study|Withdrawal by Subject|6
2282813|NCT02391363|3969390|FG001|Overall Study|Withdrawal by Subject|3
2282814|NCT02391545|3969398|FG000|Overall Study|Death|0
2282815|NCT02391545|3969399|FG001|Overall Study|Death|2
2282816|NCT02391545|3969398|FG000|Overall Study|Lost to Follow-up|0
2282817|NCT02391545|3969399|FG001|Overall Study|Lost to Follow-up|1
2282818|NCT02391545|3969398|FG000|Overall Study|Termination of study by sponsor|20
2282819|NCT02391545|3969399|FG001|Overall Study|Termination of study by sponsor|20
2282820|NCT02391545|3969398|FG000|Overall Study|Withdrawal by Subject|0
2282821|NCT02391545|3969399|FG001|Overall Study|Withdrawal by Subject|1
2282822|NCT02391545|3969398|FG000|Overall Study|Other Reasons|6
2282823|NCT02391545|3969399|FG001|Overall Study|Other Reasons|4
2282824|NCT02391584|3969408|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1
2282825|NCT02391584|3969409|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2
2282826|NCT02391584|3969408|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
2282827|NCT02391584|3969409|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
2282828|NCT02391584|3969408|FG000|3 Month|Lost to Follow-up|1
2282829|NCT02391584|3969409|FG001|3 Month|Lost to Follow-up|0
2282830|NCT02391584|3969408|FG000|6 Month|Withdrawal by Subject|1
2282831|NCT02391584|3969409|FG001|6 Month|Withdrawal by Subject|0
2282832|NCT02391584|3969408|FG000|12 Month (End of Study)|Lost to Follow-up|2
2282833|NCT02391584|3969409|FG001|12 Month (End of Study)|Lost to Follow-up|0
2282834|NCT02391948|3969443|FG000|6-month Assessment|Death|0
2282835|NCT02391948|3969444|FG001|6-month Assessment|Death|0
2282836|NCT02391948|3969445|FG002|6-month Assessment|Death|0
2128697|NCT01021007|3731302|FG001|Overall Study|Adverse Event|3
2282837|NCT02391948|3969446|FG003|6-month Assessment|Death|0
2282838|NCT02391948|3969447|FG004|6-month Assessment|Death|1
2128698|NCT01021020|3731308|FG000|Period I|Protocol Violation|1
2128699|NCT01021020|3731308|FG000|Period I|Withdrawal by Subject|1
2128700|NCT01021020|3731308|FG000|14 Day Washout Period A|Physician Decision|1
2128701|NCT01021137|3731328|FG000|Overall Study|Lost to Follow-up|9
2128702|NCT01021137|3731329|FG001|Overall Study|Lost to Follow-up|4
2128703|NCT01021137|3731330|FG002|Overall Study|Lost to Follow-up|2
2128704|NCT01021137|3731331|FG003|Overall Study|Lost to Follow-up|6
2128705|NCT01021137|3731328|FG000|Overall Study|Withdrawal by Subject|1
2128706|NCT01021137|3731329|FG001|Overall Study|Withdrawal by Subject|0
2128707|NCT01021137|3731330|FG002|Overall Study|Withdrawal by Subject|0
2128708|NCT01021137|3731331|FG003|Overall Study|Withdrawal by Subject|3
2128709|NCT01021215|3731344|FG000|Overall Study|Lost to Follow-up|3
2128710|NCT01021215|3731345|FG001|Overall Study|Lost to Follow-up|0
2128711|NCT01021293|3731353|FG000|Overall Study|Serious Adverse Event|2
2128712|NCT01021293|3731354|FG001|Overall Study|Serious Adverse Event|1
2128713|NCT01021293|3731353|FG000|Overall Study|Adverse Event|2
2128714|NCT01021293|3731354|FG001|Overall Study|Adverse Event|1
2128715|NCT01021293|3731353|FG000|Overall Study|Withdrawal by Subject|1
2128716|NCT01021293|3731354|FG001|Overall Study|Withdrawal by Subject|3
2128717|NCT01021293|3731353|FG000|Overall Study|Migrated/moved from study area|6
2128718|NCT01021293|3731354|FG001|Overall Study|Migrated/moved from study area|18
2128719|NCT01021293|3731353|FG000|Overall Study|Lost to Follow-up|1
2128720|NCT01021293|3731354|FG001|Overall Study|Lost to Follow-up|1
2128721|NCT01021332|3731378|FG000|Overall Study|Not fulfilling incl./excl.criteria|5
2128722|NCT01021332|3731378|FG000|Overall Study|Adverse Event|43
2128723|NCT01021332|3731378|FG000|Overall Study|Lack of Efficacy|19
2128724|NCT01021332|3731378|FG000|Overall Study|Withdrawal of Consent|23
2128725|NCT01021332|3731378|FG000|Overall Study|Lost to Follow-up|4
2128726|NCT01021332|3731378|FG000|Overall Study|Protocol Violation|9
2128727|NCT01021332|3731378|FG000|Overall Study|Miscellaneous|3
2128728|NCT01021423|3731386|FG000|Overall Study|Study terminated|4
2128729|NCT01021423|3731387|FG001|Overall Study|Study terminated|5
2128730|NCT01021553|3731396|FG000|Overall Study|Adverse Event|1
2282839|NCT02391948|3969443|FG000|6-month Assessment|Withdrawal by Subject|0
2282840|NCT02391948|3969444|FG001|6-month Assessment|Withdrawal by Subject|0
2282841|NCT02391948|3969445|FG002|6-month Assessment|Withdrawal by Subject|1
2282842|NCT02391948|3969446|FG003|6-month Assessment|Withdrawal by Subject|2
2282843|NCT02391948|3969447|FG004|6-month Assessment|Withdrawal by Subject|0
2282844|NCT02391948|3969443|FG000|6-month Assessment|Lost to Follow-up|4
2282845|NCT02391948|3969444|FG001|6-month Assessment|Lost to Follow-up|5
2282846|NCT02391948|3969445|FG002|6-month Assessment|Lost to Follow-up|2
2282847|NCT02391948|3969446|FG003|6-month Assessment|Lost to Follow-up|3
2282848|NCT02391948|3969447|FG004|6-month Assessment|Lost to Follow-up|1
2282849|NCT02391948|3969443|FG000|6-month Assessment|Medical issue/illness|1
2282850|NCT02391948|3969444|FG001|6-month Assessment|Medical issue/illness|1
2282851|NCT02391948|3969445|FG002|6-month Assessment|Medical issue/illness|0
2282852|NCT02391948|3969446|FG003|6-month Assessment|Medical issue/illness|0
2282853|NCT02391948|3969447|FG004|6-month Assessment|Medical issue/illness|0
2282854|NCT02391948|3969443|FG000|6-month Assessment|Not able to schedule visit in timeframe|6
2282855|NCT02391948|3969444|FG001|6-month Assessment|Not able to schedule visit in timeframe|8
2282856|NCT02391948|3969445|FG002|6-month Assessment|Not able to schedule visit in timeframe|4
2282857|NCT02391948|3969446|FG003|6-month Assessment|Not able to schedule visit in timeframe|5
2282858|NCT02391948|3969447|FG004|6-month Assessment|Not able to schedule visit in timeframe|0
2282859|NCT02391948|3969443|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68
2282860|NCT02391948|3969444|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42
2282861|NCT02391948|3969445|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24
2282862|NCT02391948|3969446|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35
2282863|NCT02391948|3969447|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24
2282864|NCT02391948|3969443|FG000|12-month Assessment|Death|0
2282865|NCT02391948|3969444|FG001|12-month Assessment|Death|0
2282866|NCT02391948|3969445|FG002|12-month Assessment|Death|0
2282867|NCT02391948|3969446|FG003|12-month Assessment|Death|1
2282868|NCT02391948|3969447|FG004|12-month Assessment|Death|0
2282869|NCT02391948|3969443|FG000|12-month Assessment|Withdrawal by Subject|1
2282870|NCT02391948|3969444|FG001|12-month Assessment|Withdrawal by Subject|0
2282871|NCT02391948|3969445|FG002|12-month Assessment|Withdrawal by Subject|0
2282872|NCT02391948|3969446|FG003|12-month Assessment|Withdrawal by Subject|1
2282873|NCT02391948|3969447|FG004|12-month Assessment|Withdrawal by Subject|0
2282874|NCT02391948|3969443|FG000|12-month Assessment|Lost to Follow-up|5
2282875|NCT02391948|3969444|FG001|12-month Assessment|Lost to Follow-up|4
2282876|NCT02391948|3969445|FG002|12-month Assessment|Lost to Follow-up|4
2282877|NCT02391948|3969446|FG003|12-month Assessment|Lost to Follow-up|4
2282878|NCT02391948|3969447|FG004|12-month Assessment|Lost to Follow-up|5
2128731|NCT01021553|3731397|FG001|Overall Study|Adverse Event|0
2128732|NCT01021553|3731398|FG002|Overall Study|Adverse Event|0
2128733|NCT01021553|3731396|FG000|Overall Study|Lack of Efficacy|2
2128734|NCT01021553|3731397|FG001|Overall Study|Lack of Efficacy|2
2128735|NCT01021553|3731398|FG002|Overall Study|Lack of Efficacy|0
2282879|NCT02391948|3969443|FG000|12-month Assessment|Medical issue/illness|0
2128736|NCT01021553|3731396|FG000|Overall Study|Protocol Violation|0
2128737|NCT01021553|3731397|FG001|Overall Study|Protocol Violation|2
2128738|NCT01021553|3731398|FG002|Overall Study|Protocol Violation|2
2128739|NCT01021553|3731396|FG000|Overall Study|Lost to Follow-up|0
2128740|NCT01021553|3731397|FG001|Overall Study|Lost to Follow-up|0
2128741|NCT01021553|3731398|FG002|Overall Study|Lost to Follow-up|1
2128742|NCT01021553|3731396|FG000|Overall Study|Withdrawal by Subject|1
2128743|NCT01021553|3731397|FG001|Overall Study|Withdrawal by Subject|1
2128744|NCT01021553|3731398|FG002|Overall Study|Withdrawal by Subject|0
2128745|NCT01021683|3731420|FG000|Overall Study|Lack of Efficacy|12
2128746|NCT01021683|3731420|FG000|Overall Study|Recovery of neutrophil count|51
2128747|NCT01021683|3731420|FG000|Overall Study|Other|8
2128748|NCT01021748|3731433|FG000|Overall Study|Adverse Event|2
2128749|NCT01021748|3731434|FG001|Overall Study|Adverse Event|1
2128750|NCT01021748|3731435|FG002|Overall Study|Adverse Event|2
2128751|NCT01021748|3731436|FG003|Overall Study|Adverse Event|0
2128752|NCT01021748|3731437|FG004|Overall Study|Adverse Event|2
2128753|NCT01021748|3731438|FG005|Overall Study|Adverse Event|0
2128754|NCT01021748|3731439|FG006|Overall Study|Adverse Event|1
2128755|NCT01021748|3731440|FG007|Overall Study|Adverse Event|0
2128756|NCT01021748|3731441|FG008|Overall Study|Adverse Event|7
2128757|NCT01021748|3731433|FG000|Overall Study|Physician Decision|1
2128758|NCT01021748|3731434|FG001|Overall Study|Physician Decision|0
2128759|NCT01021748|3731435|FG002|Overall Study|Physician Decision|1
2282880|NCT02391948|3969444|FG001|12-month Assessment|Medical issue/illness|1
2282881|NCT02391948|3969445|FG002|12-month Assessment|Medical issue/illness|0
2282882|NCT02391948|3969446|FG003|12-month Assessment|Medical issue/illness|1
2282883|NCT02391948|3969447|FG004|12-month Assessment|Medical issue/illness|0
2282884|NCT02391948|3969443|FG000|12-month Assessment|Not able to schedule visit in timeframe|2
2282885|NCT02391948|3969444|FG001|12-month Assessment|Not able to schedule visit in timeframe|4
2282886|NCT02391948|3969445|FG002|12-month Assessment|Not able to schedule visit in timeframe|0
2282887|NCT02391948|3969446|FG003|12-month Assessment|Not able to schedule visit in timeframe|2
2282888|NCT02391948|3969447|FG004|12-month Assessment|Not able to schedule visit in timeframe|1
2282889|NCT02391948|3969443|FG000|18-month Assessment|Death|0
2282890|NCT02391948|3969444|FG001|18-month Assessment|Death|0
2282891|NCT02391948|3969445|FG002|18-month Assessment|Death|0
2282892|NCT02391948|3969446|FG003|18-month Assessment|Death|1
2282893|NCT02391948|3969447|FG004|18-month Assessment|Death|1
2282894|NCT02391948|3969443|FG000|18-month Assessment|Withdrawal by Subject|1
2282895|NCT02391948|3969444|FG001|18-month Assessment|Withdrawal by Subject|0
2282896|NCT02391948|3969445|FG002|18-month Assessment|Withdrawal by Subject|0
2282897|NCT02391948|3969446|FG003|18-month Assessment|Withdrawal by Subject|1
2282898|NCT02391948|3969447|FG004|18-month Assessment|Withdrawal by Subject|0
2282899|NCT02391948|3969443|FG000|18-month Assessment|Lost to Follow-up|2
2282900|NCT02391948|3969444|FG001|18-month Assessment|Lost to Follow-up|6
2282901|NCT02391948|3969445|FG002|18-month Assessment|Lost to Follow-up|2
2282902|NCT02391948|3969446|FG003|18-month Assessment|Lost to Follow-up|2
2282903|NCT02391948|3969447|FG004|18-month Assessment|Lost to Follow-up|3
2282904|NCT02391948|3969443|FG000|18-month Assessment|Not able to schedule visit in timeframe|3
2282905|NCT02391948|3969444|FG001|18-month Assessment|Not able to schedule visit in timeframe|3
2282906|NCT02391948|3969445|FG002|18-month Assessment|Not able to schedule visit in timeframe|2
2282907|NCT02391948|3969446|FG003|18-month Assessment|Not able to schedule visit in timeframe|1
2282908|NCT02391948|3969447|FG004|18-month Assessment|Not able to schedule visit in timeframe|4
2282909|NCT02391948|3969443|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
2282910|NCT02391948|3969444|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
2282911|NCT02391948|3969445|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
2282912|NCT02391948|3969446|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
2282913|NCT02391948|3969447|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
2282914|NCT02391948|3969443|FG000|24-month Assessment|Death|0
2282915|NCT02391948|3969444|FG001|24-month Assessment|Death|0
2282916|NCT02391948|3969445|FG002|24-month Assessment|Death|0
2282917|NCT02391948|3969446|FG003|24-month Assessment|Death|0
2282918|NCT02391948|3969447|FG004|24-month Assessment|Death|1
2282919|NCT02391948|3969443|FG000|24-month Assessment|Withdrawal by Subject|1
2282920|NCT02391948|3969444|FG001|24-month Assessment|Withdrawal by Subject|1
2282921|NCT02391948|3969445|FG002|24-month Assessment|Withdrawal by Subject|0
2282922|NCT02391948|3969446|FG003|24-month Assessment|Withdrawal by Subject|0
2282923|NCT02391948|3969447|FG004|24-month Assessment|Withdrawal by Subject|1
2282924|NCT02391948|3969443|FG000|24-month Assessment|Lost to Follow-up|5
2282925|NCT02391948|3969444|FG001|24-month Assessment|Lost to Follow-up|4
2282926|NCT02391948|3969445|FG002|24-month Assessment|Lost to Follow-up|0
2282927|NCT02391948|3969446|FG003|24-month Assessment|Lost to Follow-up|0
2282928|NCT02391948|3969447|FG004|24-month Assessment|Lost to Follow-up|0
2282929|NCT02391948|3969443|FG000|24-month Assessment|Medical issue/illness|0
2282930|NCT02391948|3969444|FG001|24-month Assessment|Medical issue/illness|0
2282931|NCT02391948|3969445|FG002|24-month Assessment|Medical issue/illness|1
2282932|NCT02391948|3969446|FG003|24-month Assessment|Medical issue/illness|0
2282933|NCT02391948|3969447|FG004|24-month Assessment|Medical issue/illness|0
2320816|NCT02952586|4035029|FG001|LT Follow-up (up to 45 Months)|Death|31
2128760|NCT01021748|3731436|FG003|Overall Study|Physician Decision|1
2128761|NCT01021748|3731437|FG004|Overall Study|Physician Decision|0
2128762|NCT01021748|3731438|FG005|Overall Study|Physician Decision|0
2128763|NCT01021748|3731439|FG006|Overall Study|Physician Decision|1
2128764|NCT01021748|3731440|FG007|Overall Study|Physician Decision|1
2128765|NCT01021748|3731441|FG008|Overall Study|Physician Decision|2
2128766|NCT01021748|3731433|FG000|Overall Study|Progressive Disease|3
2128767|NCT01021748|3731434|FG001|Overall Study|Progressive Disease|3
2128768|NCT01021748|3731435|FG002|Overall Study|Progressive Disease|4
2128769|NCT01021748|3731436|FG003|Overall Study|Progressive Disease|6
2128770|NCT01021748|3731437|FG004|Overall Study|Progressive Disease|7
2128771|NCT01021748|3731438|FG005|Overall Study|Progressive Disease|3
2128772|NCT01021748|3731439|FG006|Overall Study|Progressive Disease|0
2128773|NCT01021748|3731440|FG007|Overall Study|Progressive Disease|5
2128774|NCT01021748|3731441|FG008|Overall Study|Progressive Disease|6
2128775|NCT01021748|3731433|FG000|Overall Study|Withdrawal by Subject|0
2128776|NCT01021748|3731434|FG001|Overall Study|Withdrawal by Subject|0
2128777|NCT01021748|3731435|FG002|Overall Study|Withdrawal by Subject|0
2128778|NCT01021748|3731436|FG003|Overall Study|Withdrawal by Subject|0
2128779|NCT01021748|3731437|FG004|Overall Study|Withdrawal by Subject|0
2128780|NCT01021748|3731438|FG005|Overall Study|Withdrawal by Subject|0
2128781|NCT01021748|3731439|FG006|Overall Study|Withdrawal by Subject|1
2128782|NCT01021748|3731440|FG007|Overall Study|Withdrawal by Subject|0
2128783|NCT01021748|3731441|FG008|Overall Study|Withdrawal by Subject|1
2128784|NCT01021748|3731433|FG000|Overall Study|Not Treated|0
2128785|NCT01021748|3731434|FG001|Overall Study|Not Treated|1
2128786|NCT01021748|3731435|FG002|Overall Study|Not Treated|0
2128787|NCT01021748|3731436|FG003|Overall Study|Not Treated|0
2128788|NCT01021748|3731437|FG004|Overall Study|Not Treated|0
2128789|NCT01021748|3731438|FG005|Overall Study|Not Treated|0
2128790|NCT01021748|3731439|FG006|Overall Study|Not Treated|0
2128791|NCT01021748|3731440|FG007|Overall Study|Not Treated|0
2128792|NCT01021748|3731441|FG008|Overall Study|Not Treated|0
2128793|NCT01021813|3731476|FG000|DB Treatment Phase|Adverse Event|60
2128794|NCT01021813|3731477|FG001|DB Treatment Phase|Adverse Event|22
2128795|NCT01021813|3731478|FG002|DB Treatment Phase|Adverse Event|0
2128796|NCT01021813|3731479|FG003|DB Treatment Phase|Adverse Event|0
2128797|NCT01021813|3731480|FG004|DB Treatment Phase|Adverse Event|0
2128798|NCT01021813|3731476|FG000|DB Treatment Phase|Lack of Efficacy|44
2128799|NCT01021813|3731477|FG001|DB Treatment Phase|Lack of Efficacy|28
2128800|NCT01021813|3731478|FG002|DB Treatment Phase|Lack of Efficacy|0
2128801|NCT01021813|3731479|FG003|DB Treatment Phase|Lack of Efficacy|0
2128802|NCT01021813|3731480|FG004|DB Treatment Phase|Lack of Efficacy|0
2128803|NCT01021813|3731476|FG000|DB Treatment Phase|Lost to Follow-up|14
2128804|NCT01021813|3731477|FG001|DB Treatment Phase|Lost to Follow-up|12
2128805|NCT01021813|3731478|FG002|DB Treatment Phase|Lost to Follow-up|0
2128806|NCT01021813|3731479|FG003|DB Treatment Phase|Lost to Follow-up|0
2128807|NCT01021813|3731480|FG004|DB Treatment Phase|Lost to Follow-up|0
2128808|NCT01021813|3731476|FG000|DB Treatment Phase|Physician Decision|17
2128809|NCT01021813|3731477|FG001|DB Treatment Phase|Physician Decision|8
2128810|NCT01021813|3731478|FG002|DB Treatment Phase|Physician Decision|0
2128811|NCT01021813|3731479|FG003|DB Treatment Phase|Physician Decision|0
2128812|NCT01021813|3731480|FG004|DB Treatment Phase|Physician Decision|0
2128813|NCT01021813|3731476|FG000|DB Treatment Phase|Pregnancy|1
2128814|NCT01021813|3731477|FG001|DB Treatment Phase|Pregnancy|0
2128815|NCT01021813|3731478|FG002|DB Treatment Phase|Pregnancy|0
2128816|NCT01021813|3731479|FG003|DB Treatment Phase|Pregnancy|0
2128817|NCT01021813|3731480|FG004|DB Treatment Phase|Pregnancy|0
2128818|NCT01021813|3731476|FG000|DB Treatment Phase|Protocol Violation|4
2128819|NCT01021813|3731477|FG001|DB Treatment Phase|Protocol Violation|3
2128820|NCT01021813|3731478|FG002|DB Treatment Phase|Protocol Violation|0
2128821|NCT01021813|3731479|FG003|DB Treatment Phase|Protocol Violation|0
2128822|NCT01021813|3731480|FG004|DB Treatment Phase|Protocol Violation|0
2128823|NCT01021813|3731476|FG000|DB Treatment Phase|Withdrawal by Subject|60
2128824|NCT01021813|3731477|FG001|DB Treatment Phase|Withdrawal by Subject|24
2128825|NCT01021813|3731478|FG002|DB Treatment Phase|Withdrawal by Subject|0
2205927|NCT01616459|3844247|FG001|Overall Study|Lost to Follow-up|11
2205928|NCT01616459|3844248|FG002|Overall Study|Lost to Follow-up|3
2205929|NCT01616459|3844249|FG003|Overall Study|Lost to Follow-up|2
2205930|NCT01616459|3844246|FG000|Overall Study|Protocol Violation|0
2205931|NCT01616459|3844247|FG001|Overall Study|Protocol Violation|0
2205932|NCT01616459|3844248|FG002|Overall Study|Protocol Violation|0
2205933|NCT01616459|3844249|FG003|Overall Study|Protocol Violation|2
2205934|NCT01616459|3844246|FG000|Overall Study|Withdrawal by Subject|2
2128826|NCT01021813|3731479|FG003|DB Treatment Phase|Withdrawal by Subject|0
2128827|NCT01021813|3731480|FG004|DB Treatment Phase|Withdrawal by Subject|0
2128828|NCT01021813|3731476|FG000|DB Randomized Discontinuation Phase|Adverse Event|0
2128829|NCT01021813|3731477|FG001|DB Randomized Discontinuation Phase|Adverse Event|0
2128830|NCT01021813|3731478|FG002|DB Randomized Discontinuation Phase|Adverse Event|0
2128831|NCT01021813|3731479|FG003|DB Randomized Discontinuation Phase|Adverse Event|3
2128832|NCT01021813|3731480|FG004|DB Randomized Discontinuation Phase|Adverse Event|1
2128833|NCT01021813|3731476|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2128834|NCT01021813|3731477|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2128835|NCT01021813|3731478|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2128836|NCT01021813|3731479|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1
2128837|NCT01021813|3731480|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2128838|NCT01021813|3731476|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2205935|NCT01616459|3844247|FG001|Overall Study|Withdrawal by Subject|4
2205936|NCT01616459|3844248|FG002|Overall Study|Withdrawal by Subject|4
2205937|NCT01616459|3844249|FG003|Overall Study|Withdrawal by Subject|4
2205938|NCT01616459|3844246|FG000|Overall Study|Other reason|0
2205939|NCT01616459|3844247|FG001|Overall Study|Other reason|1
2205940|NCT01616459|3844248|FG002|Overall Study|Other reason|1
2282934|NCT02391948|3969443|FG000|24-month Assessment|Not able to schedule visit in timeframe|8
2282935|NCT02391948|3969444|FG001|24-month Assessment|Not able to schedule visit in timeframe|5
2282936|NCT02391948|3969445|FG002|24-month Assessment|Not able to schedule visit in timeframe|2
2282937|NCT02391948|3969446|FG003|24-month Assessment|Not able to schedule visit in timeframe|9
2282938|NCT02391948|3969447|FG004|24-month Assessment|Not able to schedule visit in timeframe|8
2128839|NCT01021813|3731477|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2128840|NCT01021813|3731478|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2282939|NCT02391961|3969464|FG000|First Intervention (4 Weeks)|Adverse Event|2
2282940|NCT02391961|3969465|FG001|First Intervention (4 Weeks)|Adverse Event|0
2282941|NCT02391961|3969464|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
2282942|NCT02391961|3969465|FG001|Washout (2 Weeks)|Withdrawal by Subject|1
2282943|NCT02391961|3969464|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2282944|NCT02391961|3969465|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2282945|NCT02392000|3969480|FG000|Overall Study|Greater than mild sleep apnea exclusion|18
2282946|NCT02392000|3969480|FG000|Overall Study|Withdrawal by Subject|1
2282947|NCT02392000|3969480|FG000|Overall Study|Lost to Follow-up|8
2282948|NCT02392104|3969485|FG000|Overall Study|discontinuation of warfarin|3
2282949|NCT02392104|3969485|FG000|Overall Study|bleeding event|1
2282950|NCT02392104|3969485|FG000|Overall Study|transferred care to another doctor|2
2282951|NCT02392104|3969485|FG000|Overall Study|INR goal range changed|1
2282952|NCT02392104|3969485|FG000|Overall Study|admitted to skilled nursing facility|3
2282953|NCT02392104|3969485|FG000|Overall Study|INRs drawn by visiting nurse services|1
2282954|NCT02392195|3969489|FG000|Overall Study|Lost to Follow-up|4
2282955|NCT02392195|3969489|FG000|Overall Study|Withdrawal by Subject|4
2282956|NCT02392234|3969504|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1
2282957|NCT02392234|3969505|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0
2282958|NCT02392234|3969506|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1
2282959|NCT02392234|3969507|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0
2282960|NCT02392234|3969508|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1
2282961|NCT02392234|3969509|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1
2282962|NCT02392234|3969504|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2282963|NCT02392234|3969505|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2282964|NCT02392234|3969506|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2282965|NCT02392234|3969507|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2282966|NCT02392234|3969508|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
2282967|NCT02392234|3969509|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2282968|NCT02392234|3969504|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2282969|NCT02392234|3969505|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2282970|NCT02392234|3969506|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2282971|NCT02392234|3969507|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2282972|NCT02392234|3969508|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2282973|NCT02392234|3969509|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
2282974|NCT02392234|3969504|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1
2282975|NCT02392234|3969505|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0
2282976|NCT02392234|3969506|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0
2282977|NCT02392234|3969507|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1
2282978|NCT02392234|3969508|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0
2282979|NCT02392234|3969509|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0
2282980|NCT02392234|3969504|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0
2282981|NCT02392234|3969505|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0
2282982|NCT02392234|3969506|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0
2282983|NCT02392234|3969507|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0
2282984|NCT02392234|3969508|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0
2282985|NCT02392234|3969509|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1
2282986|NCT02392234|3969504|FG000|Treatment Period 1 (8 Weeks)|Other|1
2282987|NCT02392234|3969505|FG001|Treatment Period 1 (8 Weeks)|Other|0
2282988|NCT02392234|3969506|FG002|Treatment Period 1 (8 Weeks)|Other|0
2282989|NCT02392234|3969507|FG003|Treatment Period 1 (8 Weeks)|Other|0
2282990|NCT02392234|3969508|FG004|Treatment Period 1 (8 Weeks)|Other|0
2282991|NCT02392234|3969509|FG005|Treatment Period 1 (8 Weeks)|Other|0
2282992|NCT02392234|3969504|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2282993|NCT02392234|3969505|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2282994|NCT02392234|3969506|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
2282995|NCT02392234|3969507|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2282996|NCT02392234|3969508|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
2282997|NCT02392234|3969509|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2128841|NCT01021813|3731479|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2128842|NCT01021813|3731480|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1
2128843|NCT01021813|3731476|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0
2128844|NCT01021813|3731477|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0
2128845|NCT01021813|3731478|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1
2128846|NCT01021813|3731479|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0
2128847|NCT01021813|3731480|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0
2128848|NCT01021813|3731476|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
2128849|NCT01021813|3731477|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
2128850|NCT01021813|3731478|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
2128851|NCT01021813|3731479|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
2128852|NCT01021813|3731480|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
2128853|NCT01021852|3731505|FG000|Treatment Period 1|Adverse Event|3
2128854|NCT01021852|3731506|FG001|Treatment Period 1|Adverse Event|1
2128855|NCT01021852|3731507|FG002|Treatment Period 1|Adverse Event|1
2128856|NCT01021852|3731508|FG003|Treatment Period 1|Adverse Event|0
2128857|NCT01021852|3731509|FG004|Treatment Period 1|Adverse Event|2
2128858|NCT01021852|3731510|FG005|Treatment Period 1|Adverse Event|2
2128859|NCT01021852|3731511|FG006|Treatment Period 1|Adverse Event|0
2128860|NCT01021852|3731512|FG007|Treatment Period 1|Adverse Event|0
2128861|NCT01021852|3731505|FG000|Treatment Period 1|Pregnancy|0
2128862|NCT01021852|3731506|FG001|Treatment Period 1|Pregnancy|0
2128863|NCT01021852|3731507|FG002|Treatment Period 1|Pregnancy|1
2128864|NCT01021852|3731508|FG003|Treatment Period 1|Pregnancy|0
2128865|NCT01021852|3731509|FG004|Treatment Period 1|Pregnancy|0
2128866|NCT01021852|3731510|FG005|Treatment Period 1|Pregnancy|0
2128867|NCT01021852|3731511|FG006|Treatment Period 1|Pregnancy|0
2128868|NCT01021852|3731512|FG007|Treatment Period 1|Pregnancy|0
2128869|NCT01021852|3731505|FG000|Treatment Period 1|Withdrawal by Subject|0
2128870|NCT01021852|3731506|FG001|Treatment Period 1|Withdrawal by Subject|0
2128871|NCT01021852|3731507|FG002|Treatment Period 1|Withdrawal by Subject|0
2128872|NCT01021852|3731508|FG003|Treatment Period 1|Withdrawal by Subject|0
2128873|NCT01021852|3731509|FG004|Treatment Period 1|Withdrawal by Subject|1
2128874|NCT01021852|3731510|FG005|Treatment Period 1|Withdrawal by Subject|0
2128875|NCT01021852|3731511|FG006|Treatment Period 1|Withdrawal by Subject|0
2128876|NCT01021852|3731512|FG007|Treatment Period 1|Withdrawal by Subject|1
2128877|NCT01021852|3731505|FG000|Treatment Period 1|Not Treated|0
2128878|NCT01021852|3731506|FG001|Treatment Period 1|Not Treated|0
2128879|NCT01021852|3731507|FG002|Treatment Period 1|Not Treated|0
2128880|NCT01021852|3731508|FG003|Treatment Period 1|Not Treated|2
2128881|NCT01021852|3731509|FG004|Treatment Period 1|Not Treated|0
2128882|NCT01021852|3731510|FG005|Treatment Period 1|Not Treated|0
2128883|NCT01021852|3731511|FG006|Treatment Period 1|Not Treated|0
2128884|NCT01021852|3731512|FG007|Treatment Period 1|Not Treated|0
2128885|NCT01021852|3731505|FG000|Washout Period-Placebo|Adverse Event|0
2128886|NCT01021852|3731506|FG001|Washout Period-Placebo|Adverse Event|0
2128887|NCT01021852|3731507|FG002|Washout Period-Placebo|Adverse Event|0
2128888|NCT01021852|3731508|FG003|Washout Period-Placebo|Adverse Event|1
2128889|NCT01021852|3731509|FG004|Washout Period-Placebo|Adverse Event|0
2128890|NCT01021852|3731510|FG005|Washout Period-Placebo|Adverse Event|1
2128891|NCT01021852|3731511|FG006|Washout Period-Placebo|Adverse Event|0
2128892|NCT01021852|3731512|FG007|Washout Period-Placebo|Adverse Event|0
2128893|NCT01021852|3731505|FG000|Washout Period-Placebo|Lost to Follow-up|0
2128894|NCT01021852|3731506|FG001|Washout Period-Placebo|Lost to Follow-up|0
2128895|NCT01021852|3731507|FG002|Washout Period-Placebo|Lost to Follow-up|0
2128896|NCT01021852|3731508|FG003|Washout Period-Placebo|Lost to Follow-up|0
2128897|NCT01021852|3731509|FG004|Washout Period-Placebo|Lost to Follow-up|1
2128898|NCT01021852|3731510|FG005|Washout Period-Placebo|Lost to Follow-up|0
2128899|NCT01021852|3731511|FG006|Washout Period-Placebo|Lost to Follow-up|0
2128900|NCT01021852|3731512|FG007|Washout Period-Placebo|Lost to Follow-up|0
2282998|NCT02392234|3969504|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1
2282999|NCT02392234|3969505|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0
2283000|NCT02392234|3969506|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0
2283001|NCT02392234|3969507|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0
2283002|NCT02392234|3969508|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0
2283003|NCT02392234|3969509|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0
2283004|NCT02392247|3969520|FG000|Overall Study|Withdrawal by Subject|1
2283005|NCT02392247|3969520|FG000|Overall Study|Surgery cancelled; no data|1
2283006|NCT02392403|3969542|FG000|Overall Study|Adverse Event|1
2283007|NCT02392403|3969542|FG000|Overall Study|Death|1
2283008|NCT02392403|3969542|FG000|Overall Study|Withdrawal by Subject|1
2283009|NCT02392481|3969550|FG000|Overall Study|Adverse Event|0
2283010|NCT02392481|3969551|FG001|Overall Study|Adverse Event|0
2283011|NCT02392481|3969552|FG002|Overall Study|Adverse Event|1
2283012|NCT02392481|3969553|FG003|Overall Study|Adverse Event|2
2283013|NCT02392481|3969550|FG000|Overall Study|Withdrawal by Subject|0
2283014|NCT02392481|3969551|FG001|Overall Study|Withdrawal by Subject|0
2283015|NCT02392481|3969552|FG002|Overall Study|Withdrawal by Subject|1
2283016|NCT02392481|3969553|FG003|Overall Study|Withdrawal by Subject|0
2128901|NCT01021852|3731505|FG000|Washout Period-Placebo|Protocol Violation|0
2128902|NCT01021852|3731506|FG001|Washout Period-Placebo|Protocol Violation|0
2128903|NCT01021852|3731507|FG002|Washout Period-Placebo|Protocol Violation|0
2283017|NCT02392507|3969577|FG000|Induction Regimen|Death|3
2283018|NCT02392507|3969577|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1
2283019|NCT02392507|3969577|FG000|Induction Regimen|Physician Decision|1
2283020|NCT02392507|3969577|FG000|Induction Regimen|Withdrawal by Subject|2
2128904|NCT01021852|3731508|FG003|Washout Period-Placebo|Protocol Violation|0
2205941|NCT01616459|3844249|FG003|Overall Study|Other reason|0
2205942|NCT01616563|3844264|FG000|Overall Study|Lost to Follow-up|40
2205943|NCT01616654|3844286|FG000|Overall Study|Lack of Efficacy|1
2205944|NCT01616654|3844287|FG001|Overall Study|Lack of Efficacy|0
2205945|NCT01616654|3844288|FG002|Overall Study|Lack of Efficacy|0
2205946|NCT01616654|3844289|FG003|Overall Study|Lack of Efficacy|0
2205947|NCT01616654|3844290|FG004|Overall Study|Lack of Efficacy|1
2205948|NCT01616654|3844286|FG000|Overall Study|Adverse Event|0
2205949|NCT01616654|3844287|FG001|Overall Study|Adverse Event|1
2128905|NCT01021852|3731509|FG004|Washout Period-Placebo|Protocol Violation|0
2128906|NCT01021852|3731510|FG005|Washout Period-Placebo|Protocol Violation|0
2128907|NCT01021852|3731511|FG006|Washout Period-Placebo|Protocol Violation|1
2128908|NCT01021852|3731512|FG007|Washout Period-Placebo|Protocol Violation|0
2283021|NCT02392507|3969577|FG000|Maintenance Regimen|Death|1
2283022|NCT02392507|3969577|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1
2283023|NCT02392559|3969588|FG000|Overall Study|Withdrawal by Subject|0
2283024|NCT02392559|3969589|FG001|Overall Study|Withdrawal by Subject|1
2283025|NCT02392611|3969605|FG000|Overall Study|Adverse Event|0
2283026|NCT02392611|3969606|FG001|Overall Study|Adverse Event|0
2283027|NCT02392611|3969607|FG002|Overall Study|Adverse Event|0
2283028|NCT02392611|3969608|FG003|Overall Study|Adverse Event|1
2283029|NCT02392611|3969609|FG004|Overall Study|Adverse Event|0
2283030|NCT02392611|3969610|FG005|Overall Study|Adverse Event|0
2283031|NCT02392611|3969611|FG006|Overall Study|Adverse Event|0
2283032|NCT02392611|3969612|FG007|Overall Study|Adverse Event|0
2283033|NCT02392611|3969613|FG008|Overall Study|Adverse Event|0
2283034|NCT02392611|3969605|FG000|Overall Study|Progressive disease|0
2283035|NCT02392611|3969606|FG001|Overall Study|Progressive disease|0
2283036|NCT02392611|3969607|FG002|Overall Study|Progressive disease|0
2283037|NCT02392611|3969608|FG003|Overall Study|Progressive disease|2
2283038|NCT02392611|3969609|FG004|Overall Study|Progressive disease|1
2283039|NCT02392611|3969610|FG005|Overall Study|Progressive disease|0
2283040|NCT02392611|3969611|FG006|Overall Study|Progressive disease|0
2283041|NCT02392611|3969612|FG007|Overall Study|Progressive disease|0
2283042|NCT02392611|3969613|FG008|Overall Study|Progressive disease|0
2283043|NCT02392611|3969605|FG000|Overall Study|Death|1
2283044|NCT02392611|3969606|FG001|Overall Study|Death|0
2283045|NCT02392611|3969607|FG002|Overall Study|Death|0
2283046|NCT02392611|3969608|FG003|Overall Study|Death|0
2283047|NCT02392611|3969609|FG004|Overall Study|Death|0
2283048|NCT02392611|3969610|FG005|Overall Study|Death|1
2283049|NCT02392611|3969611|FG006|Overall Study|Death|0
2283050|NCT02392611|3969612|FG007|Overall Study|Death|0
2283051|NCT02392611|3969613|FG008|Overall Study|Death|0
2283052|NCT02392611|3969605|FG000|Overall Study|Withdrawal by Subject|0
2283053|NCT02392611|3969606|FG001|Overall Study|Withdrawal by Subject|0
2283054|NCT02392611|3969607|FG002|Overall Study|Withdrawal by Subject|0
2283055|NCT02392611|3969608|FG003|Overall Study|Withdrawal by Subject|1
2283056|NCT02392611|3969609|FG004|Overall Study|Withdrawal by Subject|0
2283057|NCT02392611|3969610|FG005|Overall Study|Withdrawal by Subject|0
2283058|NCT02392611|3969611|FG006|Overall Study|Withdrawal by Subject|0
2283059|NCT02392611|3969612|FG007|Overall Study|Withdrawal by Subject|0
2283060|NCT02392611|3969613|FG008|Overall Study|Withdrawal by Subject|0
2283061|NCT02392611|3969605|FG000|Overall Study|Lost to Follow-up|0
2283062|NCT02392611|3969606|FG001|Overall Study|Lost to Follow-up|0
2283063|NCT02392611|3969607|FG002|Overall Study|Lost to Follow-up|0
2283064|NCT02392611|3969608|FG003|Overall Study|Lost to Follow-up|0
2283065|NCT02392611|3969609|FG004|Overall Study|Lost to Follow-up|0
2283066|NCT02392611|3969610|FG005|Overall Study|Lost to Follow-up|0
2283067|NCT02392611|3969611|FG006|Overall Study|Lost to Follow-up|1
2283068|NCT02392611|3969612|FG007|Overall Study|Lost to Follow-up|0
2283069|NCT02392611|3969613|FG008|Overall Study|Lost to Follow-up|0
2283070|NCT02392611|3969605|FG000|Overall Study|Enrolled, not treated|0
2128909|NCT01021852|3731505|FG000|Washout Period-No Drug|Adverse Event|1
2128910|NCT01021852|3731506|FG001|Washout Period-No Drug|Adverse Event|0
2128911|NCT01021852|3731507|FG002|Washout Period-No Drug|Adverse Event|0
2205950|NCT01616654|3844288|FG002|Overall Study|Adverse Event|2
2205951|NCT01616654|3844289|FG003|Overall Study|Adverse Event|1
2205952|NCT01616654|3844290|FG004|Overall Study|Adverse Event|0
2205953|NCT01616654|3844286|FG000|Overall Study|Withdrawal by Subject|2
2205954|NCT01616654|3844287|FG001|Overall Study|Withdrawal by Subject|2
2205955|NCT01616654|3844288|FG002|Overall Study|Withdrawal by Subject|3
2205956|NCT01616654|3844289|FG003|Overall Study|Withdrawal by Subject|1
2205957|NCT01616654|3844290|FG004|Overall Study|Withdrawal by Subject|5
2205958|NCT01616654|3844286|FG000|Overall Study|Protocol Violation|0
2205959|NCT01616654|3844287|FG001|Overall Study|Protocol Violation|5
2205960|NCT01616654|3844288|FG002|Overall Study|Protocol Violation|2
2205961|NCT01616654|3844289|FG003|Overall Study|Protocol Violation|4
2205962|NCT01616654|3844290|FG004|Overall Study|Protocol Violation|4
2283071|NCT02392611|3969606|FG001|Overall Study|Enrolled, not treated|0
2283072|NCT02392611|3969607|FG002|Overall Study|Enrolled, not treated|0
2283073|NCT02392611|3969608|FG003|Overall Study|Enrolled, not treated|2
2283074|NCT02392611|3969609|FG004|Overall Study|Enrolled, not treated|0
2283075|NCT02392611|3969610|FG005|Overall Study|Enrolled, not treated|0
2283076|NCT02392611|3969611|FG006|Overall Study|Enrolled, not treated|0
2205963|NCT01616654|3844286|FG000|Overall Study|Lost to Follow-up|1
2128912|NCT01021852|3731508|FG003|Washout Period-No Drug|Adverse Event|0
2128913|NCT01021852|3731509|FG004|Washout Period-No Drug|Adverse Event|0
2128914|NCT01021852|3731510|FG005|Washout Period-No Drug|Adverse Event|1
2205964|NCT01616654|3844287|FG001|Overall Study|Lost to Follow-up|0
2283077|NCT02392611|3969612|FG007|Overall Study|Enrolled, not treated|0
2283078|NCT02392611|3969613|FG008|Overall Study|Enrolled, not treated|0
2283079|NCT02392624|3969636|FG000|Overall Study|Withdrawal by Subject|15
2283080|NCT02392624|3969637|FG001|Overall Study|Withdrawal by Subject|12
2283081|NCT02392624|3969638|FG002|Overall Study|Withdrawal by Subject|9
2283082|NCT02392624|3969636|FG000|Overall Study|Adverse Event|4
2283083|NCT02392624|3969637|FG001|Overall Study|Adverse Event|1
2283084|NCT02392624|3969638|FG002|Overall Study|Adverse Event|2
2283085|NCT02392624|3969636|FG000|Overall Study|Pregnancy|1
2283086|NCT02392624|3969637|FG001|Overall Study|Pregnancy|0
2283087|NCT02392624|3969638|FG002|Overall Study|Pregnancy|0
2283088|NCT02392624|3969636|FG000|Overall Study|Protocol Violation|0
2283089|NCT02392624|3969637|FG001|Overall Study|Protocol Violation|0
2283090|NCT02392624|3969638|FG002|Overall Study|Protocol Violation|1
2283091|NCT02392624|3969636|FG000|Overall Study|Sponsor/Investigator Decision|2
2283092|NCT02392624|3969637|FG001|Overall Study|Sponsor/Investigator Decision|1
2283093|NCT02392624|3969638|FG002|Overall Study|Sponsor/Investigator Decision|0
2283094|NCT02392624|3969636|FG000|Overall Study|Other|49
2283095|NCT02392624|3969637|FG001|Overall Study|Other|1
2283096|NCT02392624|3969638|FG002|Overall Study|Other|1
2283097|NCT02393209|3969668|FG000|Overall Study|Study Terminated by Sponsor|1
2283098|NCT02393209|3969669|FG001|Overall Study|Study Terminated by Sponsor|1
2283099|NCT02393209|3969670|FG002|Overall Study|Study Terminated by Sponsor|0
2283100|NCT02393209|3969671|FG003|Overall Study|Study Terminated by Sponsor|0
2283101|NCT02393209|3969668|FG000|Overall Study|Withdrawal by Patient|1
2283102|NCT02393209|3969669|FG001|Overall Study|Withdrawal by Patient|0
2283103|NCT02393209|3969670|FG002|Overall Study|Withdrawal by Patient|0
2283104|NCT02393209|3969671|FG003|Overall Study|Withdrawal by Patient|0
2128915|NCT01021852|3731511|FG006|Washout Period-No Drug|Adverse Event|0
2128916|NCT01021852|3731512|FG007|Washout Period-No Drug|Adverse Event|0
2128917|NCT01021852|3731505|FG000|Treatment Period 2|Adverse Event|0
2128918|NCT01021852|3731506|FG001|Treatment Period 2|Adverse Event|1
2128919|NCT01021852|3731507|FG002|Treatment Period 2|Adverse Event|0
2128920|NCT01021852|3731508|FG003|Treatment Period 2|Adverse Event|0
2128921|NCT01021852|3731509|FG004|Treatment Period 2|Adverse Event|1
2128922|NCT01021852|3731510|FG005|Treatment Period 2|Adverse Event|0
2128923|NCT01021852|3731511|FG006|Treatment Period 2|Adverse Event|1
2128924|NCT01021852|3731512|FG007|Treatment Period 2|Adverse Event|0
2128925|NCT01021852|3731505|FG000|Treatment Period 2|Lack of Efficacy|0
2128926|NCT01021852|3731506|FG001|Treatment Period 2|Lack of Efficacy|0
2128927|NCT01021852|3731507|FG002|Treatment Period 2|Lack of Efficacy|0
2128928|NCT01021852|3731508|FG003|Treatment Period 2|Lack of Efficacy|0
2205965|NCT01616654|3844288|FG002|Overall Study|Lost to Follow-up|3
2205966|NCT01616654|3844289|FG003|Overall Study|Lost to Follow-up|2
2205967|NCT01616654|3844290|FG004|Overall Study|Lost to Follow-up|1
2205968|NCT01616654|3844286|FG000|Overall Study|Pregnancy|1
2205969|NCT01616654|3844287|FG001|Overall Study|Pregnancy|0
2205970|NCT01616654|3844288|FG002|Overall Study|Pregnancy|0
2205971|NCT01616654|3844289|FG003|Overall Study|Pregnancy|0
2205972|NCT01616654|3844290|FG004|Overall Study|Pregnancy|1
2205973|NCT01616693|3844307|FG000|Evaluated for Safety|Physician Decision|1
2205974|NCT01616693|3844308|FG001|Evaluated for Safety|Physician Decision|0
2205975|NCT01616693|3844309|FG002|Evaluated for Safety|Physician Decision|1
2205976|NCT01616693|3844310|FG003|Evaluated for Safety|Physician Decision|0
2205977|NCT01616693|3844307|FG000|Received Both Vaccines|Adverse Event|2
2205978|NCT01616693|3844308|FG001|Received Both Vaccines|Adverse Event|0
2205979|NCT01616693|3844309|FG002|Received Both Vaccines|Adverse Event|0
2205980|NCT01616693|3844310|FG003|Received Both Vaccines|Adverse Event|0
2205981|NCT01616693|3844307|FG000|Received Both Vaccines|Withdrawal by Subject|7
2205982|NCT01616693|3844308|FG001|Received Both Vaccines|Withdrawal by Subject|7
2205983|NCT01616693|3844309|FG002|Received Both Vaccines|Withdrawal by Subject|8
2205984|NCT01616693|3844310|FG003|Received Both Vaccines|Withdrawal by Subject|15
2205985|NCT01616693|3844307|FG000|Received Both Vaccines|Lost to Follow-up|4
2205986|NCT01616693|3844308|FG001|Received Both Vaccines|Lost to Follow-up|3
2205987|NCT01616693|3844309|FG002|Received Both Vaccines|Lost to Follow-up|4
2205988|NCT01616693|3844310|FG003|Received Both Vaccines|Lost to Follow-up|4
2205989|NCT01616693|3844307|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4
2205990|NCT01616693|3844308|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2
2205991|NCT01616693|3844309|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6
2205992|NCT01616693|3844310|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1
2205993|NCT01616771|3844324|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4
2205994|NCT01616953|3844335|FG000|Overall Study|Lost to Follow-up|1
2205995|NCT01616953|3844336|FG001|Overall Study|Lost to Follow-up|0
2205996|NCT01616953|3844335|FG000|Overall Study|lack of bone and soft tissue|1
2283105|NCT02393209|3969668|FG000|Overall Study|Death|2
2283106|NCT02393209|3969669|FG001|Overall Study|Death|2
2283107|NCT02393209|3969670|FG002|Overall Study|Death|0
2283108|NCT02393209|3969671|FG003|Overall Study|Death|0
2128929|NCT01021852|3731509|FG004|Treatment Period 2|Lack of Efficacy|0
2128930|NCT01021852|3731510|FG005|Treatment Period 2|Lack of Efficacy|1
2128931|NCT01021852|3731511|FG006|Treatment Period 2|Lack of Efficacy|0
2128932|NCT01021852|3731512|FG007|Treatment Period 2|Lack of Efficacy|0
2128933|NCT01021852|3731505|FG000|Treatment Period 2|Physician Decision|0
2128934|NCT01021852|3731506|FG001|Treatment Period 2|Physician Decision|0
2128935|NCT01021852|3731507|FG002|Treatment Period 2|Physician Decision|1
2128936|NCT01021852|3731508|FG003|Treatment Period 2|Physician Decision|0
2128937|NCT01021852|3731509|FG004|Treatment Period 2|Physician Decision|0
2128938|NCT01021852|3731510|FG005|Treatment Period 2|Physician Decision|0
2128939|NCT01021852|3731511|FG006|Treatment Period 2|Physician Decision|0
2128940|NCT01021852|3731512|FG007|Treatment Period 2|Physician Decision|0
2128941|NCT01021852|3731505|FG000|Treatment Period 2|Protocol Violation|0
2128942|NCT01021852|3731506|FG001|Treatment Period 2|Protocol Violation|0
2128943|NCT01021852|3731507|FG002|Treatment Period 2|Protocol Violation|0
2128944|NCT01021852|3731508|FG003|Treatment Period 2|Protocol Violation|0
2128945|NCT01021852|3731509|FG004|Treatment Period 2|Protocol Violation|1
2128946|NCT01021852|3731510|FG005|Treatment Period 2|Protocol Violation|0
2128947|NCT01021852|3731511|FG006|Treatment Period 2|Protocol Violation|1
2128948|NCT01021852|3731512|FG007|Treatment Period 2|Protocol Violation|0
2128949|NCT01021852|3731505|FG000|Treatment Period 2|Withdrawal by Subject|0
2128950|NCT01021852|3731506|FG001|Treatment Period 2|Withdrawal by Subject|0
2128951|NCT01021852|3731507|FG002|Treatment Period 2|Withdrawal by Subject|0
2128952|NCT01021852|3731508|FG003|Treatment Period 2|Withdrawal by Subject|0
2128953|NCT01021852|3731509|FG004|Treatment Period 2|Withdrawal by Subject|0
2128954|NCT01021852|3731510|FG005|Treatment Period 2|Withdrawal by Subject|0
2128955|NCT01021852|3731511|FG006|Treatment Period 2|Withdrawal by Subject|1
2128956|NCT01021852|3731512|FG007|Treatment Period 2|Withdrawal by Subject|2
2128957|NCT01021878|3731528|FG000|Overall Study|Lost to Follow-up|4
2128958|NCT01021878|3731529|FG001|Overall Study|Lost to Follow-up|3
2128959|NCT01021878|3731528|FG000|Overall Study|Death|0
2128960|NCT01021878|3731529|FG001|Overall Study|Death|1
2128961|NCT01021878|3731528|FG000|Overall Study|Adverse Event|6
2128962|NCT01021878|3731529|FG001|Overall Study|Adverse Event|5
2128963|NCT01021878|3731528|FG000|Overall Study|Transplantation|6
2128964|NCT01021878|3731529|FG001|Overall Study|Transplantation|1
2128965|NCT01022112|3731570|FG000|Overall Study|Adverse Event|1
2128966|NCT01022112|3731571|FG001|Overall Study|Adverse Event|2
2205997|NCT01616953|3844336|FG001|Overall Study|lack of bone and soft tissue|0
2205998|NCT01617005|3844342|FG000|Overall Study|Pregnancy|1
2205999|NCT01617005|3844342|FG000|Overall Study|Lack of motivation for treatment|1
2206000|NCT01617070|3844346|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
2206001|NCT01617434|3844385|FG000|Overall Study|Adverse Event|12
2206002|NCT01617434|3844386|FG001|Overall Study|Adverse Event|3
2206003|NCT01617434|3844385|FG000|Overall Study|Protocol Violation|8
2206004|NCT01617434|3844386|FG001|Overall Study|Protocol Violation|7
2206005|NCT01617434|3844385|FG000|Overall Study|Withdrawal Criteria|12
2206006|NCT01617434|3844386|FG001|Overall Study|Withdrawal Criteria|37
2206007|NCT01617434|3844385|FG000|Overall Study|Unclassified|3
2206008|NCT01617434|3844386|FG001|Overall Study|Unclassified|4
2206009|NCT01617447|3844394|FG000|Overall Study|Adverse Event|0
2206010|NCT01617447|3844395|FG001|Overall Study|Adverse Event|1
2206011|NCT01617447|3844394|FG000|Overall Study|Physician Decision|0
2206012|NCT01617447|3844395|FG001|Overall Study|Physician Decision|2
2206013|NCT01617460|3844401|FG000|Overall Study|Adverse Event|10
2206014|NCT01617460|3844401|FG000|Overall Study|Physician Decision|16
2206015|NCT01617460|3844401|FG000|Overall Study|Protocol Violation|5
2206016|NCT01617460|3844401|FG000|Overall Study|Withdrawal by Subject|9
2206017|NCT01617629|3844428|FG000|Overall Study|Death|2
2206018|NCT01617629|3844428|FG000|Overall Study|Investigator's Clinical Judgement|1
2206019|NCT01617629|3844428|FG000|Overall Study|Reason Not Specified|1
2206020|NCT01617629|3844428|FG000|Overall Study|Participant Withdrew Consent|2
2206021|NCT01617655|3844434|FG000|Overall Study|Adverse Event|2
2206022|NCT01617655|3844435|FG001|Overall Study|Adverse Event|3
2206023|NCT01617655|3844434|FG000|Overall Study|Poor compliance to protocol|1
2128967|NCT01022112|3731572|FG002|Overall Study|Adverse Event|0
2128968|NCT01022112|3731573|FG003|Overall Study|Adverse Event|1
2128969|NCT01022112|3731574|FG004|Overall Study|Adverse Event|0
2128970|NCT01022112|3731570|FG000|Overall Study|Lack of Efficacy|1
2128971|NCT01022112|3731571|FG001|Overall Study|Lack of Efficacy|0
2128972|NCT01022112|3731572|FG002|Overall Study|Lack of Efficacy|0
2128973|NCT01022112|3731573|FG003|Overall Study|Lack of Efficacy|0
2206024|NCT01617655|3844435|FG001|Overall Study|Poor compliance to protocol|4
2283109|NCT02393209|3969668|FG000|Overall Study|Death due to Disease Progression|2
2283110|NCT02393209|3969669|FG001|Overall Study|Death due to Disease Progression|2
2283111|NCT02393209|3969670|FG002|Overall Study|Death due to Disease Progression|0
2283112|NCT02393209|3969671|FG003|Overall Study|Death due to Disease Progression|0
2283113|NCT02393209|3969668|FG000|Overall Study|Death from Legionella Infection|0
2283114|NCT02393209|3969669|FG001|Overall Study|Death from Legionella Infection|1
2283115|NCT02393209|3969670|FG002|Overall Study|Death from Legionella Infection|0
2128974|NCT01022112|3731574|FG004|Overall Study|Lack of Efficacy|1
2128975|NCT01022112|3731570|FG000|Overall Study|Physician Decision|0
2128976|NCT01022112|3731571|FG001|Overall Study|Physician Decision|0
2128977|NCT01022112|3731572|FG002|Overall Study|Physician Decision|1
2128978|NCT01022112|3731573|FG003|Overall Study|Physician Decision|0
2128979|NCT01022112|3731574|FG004|Overall Study|Physician Decision|1
2128980|NCT01022112|3731570|FG000|Overall Study|Withdrawal by Subject|0
2128981|NCT01022112|3731571|FG001|Overall Study|Withdrawal by Subject|1
2128982|NCT01022112|3731572|FG002|Overall Study|Withdrawal by Subject|2
2128983|NCT01022112|3731573|FG003|Overall Study|Withdrawal by Subject|2
2128984|NCT01022112|3731574|FG004|Overall Study|Withdrawal by Subject|1
2128985|NCT01022112|3731570|FG000|Overall Study|Fasting plasma glucose level increased|1
2128986|NCT01022112|3731571|FG001|Overall Study|Fasting plasma glucose level increased|0
2128987|NCT01022112|3731572|FG002|Overall Study|Fasting plasma glucose level increased|0
2128988|NCT01022112|3731573|FG003|Overall Study|Fasting plasma glucose level increased|0
2128989|NCT01022112|3731574|FG004|Overall Study|Fasting plasma glucose level increased|7
2128990|NCT01022203|3731592|FG000|Post Treatment Assessment|Withdrawal by Subject|12
2128991|NCT01022203|3731593|FG001|Post Treatment Assessment|Withdrawal by Subject|12
2128992|NCT01022203|3731592|FG000|Post Treatment Assessment|Physician Decision|2
2128993|NCT01022203|3731593|FG001|Post Treatment Assessment|Physician Decision|0
2128994|NCT01022203|3731592|FG000|Post Treatment Assessment|Adverse Event|0
2128995|NCT01022203|3731593|FG001|Post Treatment Assessment|Adverse Event|2
2128996|NCT01022203|3731592|FG000|Follow-Up Assessment|Lost to Follow-up|2
2128997|NCT01022203|3731593|FG001|Follow-Up Assessment|Lost to Follow-up|2
2128998|NCT01022424|3731629|FG000|Overall Study|Adverse Event|1
2128999|NCT01022424|3731629|FG000|Overall Study|Physician Decision|1
2129000|NCT01022424|3731629|FG000|Overall Study|eGFR under the withdrawal criteria|2
2129001|NCT01022502|3731637|FG000|Overall Study|Adverse Event|1
2129002|NCT01022502|3731637|FG000|Overall Study|employment related reasons|1
2129003|NCT01022502|3731637|FG000|Overall Study|Withdrawal by Subject|1
2129004|NCT01022580|3731654|FG000|Overall Study|Death|18
2129005|NCT01022580|3731655|FG001|Overall Study|Death|22
2129006|NCT01022762|3731669|FG000|Overall Study|Adverse Event|3
2129007|NCT01022762|3731670|FG001|Overall Study|Adverse Event|1
2129008|NCT01022762|3731669|FG000|Overall Study|Lack of Efficacy|0
2129009|NCT01022762|3731670|FG001|Overall Study|Lack of Efficacy|1
2129010|NCT01022762|3731669|FG000|Overall Study|Protocol Violation|7
2129011|NCT01022762|3731670|FG001|Overall Study|Protocol Violation|6
2129012|NCT01022762|3731669|FG000|Overall Study|Unclassified|12
2129013|NCT01022762|3731670|FG001|Overall Study|Unclassified|20
2283116|NCT02393209|3969671|FG003|Overall Study|Death from Legionella Infection|0
2283117|NCT02393209|3969668|FG000|Overall Study|Patient Seen by Another Oncologist|0
2283118|NCT02393209|3969669|FG001|Overall Study|Patient Seen by Another Oncologist|1
2283119|NCT02393209|3969670|FG002|Overall Study|Patient Seen by Another Oncologist|0
2283120|NCT02393209|3969671|FG003|Overall Study|Patient Seen by Another Oncologist|0
2283121|NCT02393209|3969668|FG000|Overall Study|Lost to Follow-up|0
2283122|NCT02393209|3969669|FG001|Overall Study|Lost to Follow-up|1
2283123|NCT02393209|3969670|FG002|Overall Study|Lost to Follow-up|0
2283124|NCT02393209|3969671|FG003|Overall Study|Lost to Follow-up|0
2283125|NCT02393547|3969716|FG000|Overall Study|Adverse Event|2
2283126|NCT02393547|3969716|FG000|Overall Study|Withdrawal by Subject|3
2283127|NCT02393547|3969716|FG000|Overall Study|Lost to Follow-up|1
2283128|NCT02393755|3969740|FG000|Overall Study|Withdrawal by Subject|0
2283129|NCT02393755|3969741|FG001|Overall Study|Withdrawal by Subject|3
2283130|NCT02393755|3969740|FG000|Overall Study|Adverse Event|0
2283131|NCT02393755|3969741|FG001|Overall Study|Adverse Event|2
2283132|NCT02393755|3969740|FG000|Overall Study|Physician Decision|0
2283133|NCT02393755|3969741|FG001|Overall Study|Physician Decision|2
2283134|NCT02393950|3969748|FG000|Overall Study|Adverse Event|1
2283135|NCT02393950|3969749|FG001|Overall Study|Adverse Event|0
2283136|NCT02393950|3969748|FG000|Overall Study|Withdrawal by Subject|0
2283137|NCT02393950|3969749|FG001|Overall Study|Withdrawal by Subject|1
2283138|NCT02394275|3969784|FG000|Overall Study|Adverse Event|22
2283139|NCT02394275|3969784|FG000|Overall Study|Lost to Follow-up|7
2283140|NCT02394340|3969789|FG000|Overall Study|Failed drug screen test|1
2283141|NCT02394340|3969789|FG000|Overall Study|Adverse Event|1
2283142|NCT02394561|3969804|FG000|CORE Phase|Adverse Event|7
2283143|NCT02394561|3969805|FG001|CORE Phase|Adverse Event|9
2283144|NCT02394561|3969804|FG000|CORE Phase|Death|0
2283145|NCT02394561|3969805|FG001|CORE Phase|Death|1
2283146|NCT02394561|3969804|FG000|CORE Phase|Pregnancy|1
2283147|NCT02394561|3969805|FG001|CORE Phase|Pregnancy|0
2283148|NCT02394561|3969804|FG000|CORE Phase|Lost to Follow-up|1
2283149|NCT02394561|3969805|FG001|CORE Phase|Lost to Follow-up|0
2283150|NCT02394561|3969804|FG000|CORE Phase|Physician Decision|1
2283151|NCT02394561|3969805|FG001|CORE Phase|Physician Decision|1
2283152|NCT02394561|3969804|FG000|CORE Phase|Withdrawal by Subject|2
2129014|NCT01022853|3731681|FG000|Overall Study|Progressive disease|2
2129015|NCT01022853|3731682|FG001|Overall Study|Progressive disease|3
2129016|NCT01022853|3731683|FG002|Overall Study|Progressive disease|11
2129017|NCT01022853|3731684|FG003|Overall Study|Progressive disease|7
2129018|NCT01022853|3731685|FG004|Overall Study|Progressive disease|1
2129019|NCT01022853|3731681|FG000|Overall Study|Dose-limiting toxicity|0
2283153|NCT02394561|3969805|FG001|CORE Phase|Withdrawal by Subject|2
2283154|NCT02394561|3969804|FG000|CORE Phase|Lack of Efficacy|1
2283155|NCT02394561|3969805|FG001|CORE Phase|Lack of Efficacy|6
2283156|NCT02394561|3969804|FG000|Extension Phase|Adverse Event|6
2283157|NCT02394561|3969805|FG001|Extension Phase|Adverse Event|1
2129020|NCT01022853|3731682|FG001|Overall Study|Dose-limiting toxicity|0
2129021|NCT01022853|3731683|FG002|Overall Study|Dose-limiting toxicity|0
2129022|NCT01022853|3731684|FG003|Overall Study|Dose-limiting toxicity|0
2129023|NCT01022853|3731685|FG004|Overall Study|Dose-limiting toxicity|1
2129024|NCT01022853|3731681|FG000|Overall Study|Withdrawal by Subject|0
2129025|NCT01022853|3731682|FG001|Overall Study|Withdrawal by Subject|1
2129026|NCT01022853|3731683|FG002|Overall Study|Withdrawal by Subject|1
2129027|NCT01022853|3731684|FG003|Overall Study|Withdrawal by Subject|1
2129028|NCT01022853|3731685|FG004|Overall Study|Withdrawal by Subject|0
2129029|NCT01022853|3731681|FG000|Overall Study|Other not stated above|1
2129030|NCT01022853|3731682|FG001|Overall Study|Other not stated above|0
2129031|NCT01022853|3731683|FG002|Overall Study|Other not stated above|1
2129032|NCT01022853|3731684|FG003|Overall Study|Other not stated above|0
2129033|NCT01022853|3731685|FG004|Overall Study|Other not stated above|0
2283158|NCT02394561|3969804|FG000|Extension Phase|Death|0
2283159|NCT02394561|3969805|FG001|Extension Phase|Death|1
2283160|NCT02394561|3969804|FG000|Extension Phase|Protocol Violation|1
2283161|NCT02394561|3969805|FG001|Extension Phase|Protocol Violation|0
2283162|NCT02394561|3969804|FG000|Extension Phase|Lost to Follow-up|1
2283163|NCT02394561|3969805|FG001|Extension Phase|Lost to Follow-up|0
2283164|NCT02394561|3969804|FG000|Extension Phase|Physician Decision|0
2283165|NCT02394561|3969805|FG001|Extension Phase|Physician Decision|2
2283166|NCT02394561|3969804|FG000|Extension Phase|Withdrawal by Subject|0
2283167|NCT02394561|3969805|FG001|Extension Phase|Withdrawal by Subject|5
2283168|NCT02394561|3969804|FG000|Extension Phase|Lack of Efficacy|3
2283169|NCT02394561|3969805|FG001|Extension Phase|Lack of Efficacy|3
2283170|NCT02394600|3969816|FG000|Overall Study|Adverse Event|3
2283171|NCT02394600|3969817|FG001|Overall Study|Adverse Event|0
2283172|NCT02394600|3969816|FG000|Overall Study|Lost to Follow-up|0
2283173|NCT02394600|3969817|FG001|Overall Study|Lost to Follow-up|1
2283174|NCT02394600|3969816|FG000|Overall Study|Withdrawal by Subject|0
2283175|NCT02394600|3969817|FG001|Overall Study|Withdrawal by Subject|1
2283176|NCT02394600|3969816|FG000|Overall Study|Protocol Violation|1
2283177|NCT02394600|3969817|FG001|Overall Study|Protocol Violation|0
2283178|NCT02394730|3969825|FG000|Overall Study|Lost to Follow-up|1
2283179|NCT02394730|3969826|FG001|Overall Study|Lost to Follow-up|0
2283180|NCT02394730|3969825|FG000|Overall Study|Withdrawal by Subject|0
2283181|NCT02394730|3969826|FG001|Overall Study|Withdrawal by Subject|1
2283182|NCT02394756|3969832|FG000|Period 1|Lens Discomfort|0
2283183|NCT02394756|3969833|FG001|Period 1|Lens Discomfort|0
2283184|NCT02394756|3969834|FG002|Period 1|Lens Discomfort|0
2283185|NCT02394756|3969835|FG003|Period 1|Lens Discomfort|0
2283186|NCT02394756|3969836|FG004|Period 1|Lens Discomfort|0
2283187|NCT02394756|3969837|FG005|Period 1|Lens Discomfort|1
2283188|NCT02394756|3969832|FG000|Period 1|Withdrawal by Subject|0
2283189|NCT02394756|3969833|FG001|Period 1|Withdrawal by Subject|1
2283190|NCT02394756|3969834|FG002|Period 1|Withdrawal by Subject|1
2283191|NCT02394756|3969835|FG003|Period 1|Withdrawal by Subject|1
2283192|NCT02394756|3969836|FG004|Period 1|Withdrawal by Subject|0
2283193|NCT02394756|3969837|FG005|Period 1|Withdrawal by Subject|0
2283194|NCT02394756|3969832|FG000|Period 2|Unsatisfactory Visual Response|0
2283195|NCT02394756|3969833|FG001|Period 2|Unsatisfactory Visual Response|0
2283196|NCT02394756|3969834|FG002|Period 2|Unsatisfactory Visual Response|0
2283197|NCT02394756|3969835|FG003|Period 2|Unsatisfactory Visual Response|0
2283198|NCT02394756|3969836|FG004|Period 2|Unsatisfactory Visual Response|1
2283199|NCT02394756|3969837|FG005|Period 2|Unsatisfactory Visual Response|0
2283200|NCT02394808|3969858|FG000|Period 1|Unsatisfactory lens fitting|0
2283201|NCT02394808|3969859|FG001|Period 1|Unsatisfactory lens fitting|1
2283202|NCT02394808|3969858|FG000|Period 2|Lost to Follow-up|1
2283203|NCT02394808|3969859|FG001|Period 2|Lost to Follow-up|0
2283204|NCT02394925|3969871|FG000|Overall Study|Adverse Event|1
2283205|NCT02394925|3969871|FG000|Overall Study|Lens Discomfort|3
2283206|NCT02394925|3969871|FG000|Overall Study|Lens handling difficulities|5
2283207|NCT02394925|3969871|FG000|Overall Study|Lost to Follow-up|9
2283208|NCT02394925|3969871|FG000|Overall Study|Protocol Violation|5
2283209|NCT02394925|3969871|FG000|Overall Study|No longer meet eligibility criteria|1
2283210|NCT02394925|3969871|FG000|Overall Study|Unsatisfactory Visual Response|5
2283211|NCT02395042|3969887|FG000|Treatment 1 Period|Adverse Event|1
2283212|NCT02395042|3969888|FG001|Treatment 1 Period|Adverse Event|3
2283213|NCT02395042|3969889|FG002|Treatment 1 Period|Adverse Event|1
2283214|NCT02395042|3969887|FG000|Treatment 1 Period|Lack of Efficacy|1
2283215|NCT02395042|3969888|FG001|Treatment 1 Period|Lack of Efficacy|1
2283216|NCT02395042|3969889|FG002|Treatment 1 Period|Lack of Efficacy|0
2283217|NCT02395042|3969887|FG000|Treatment 1 Period|Lost to Follow-up|1
2283218|NCT02395042|3969888|FG001|Treatment 1 Period|Lost to Follow-up|0
2283219|NCT02395042|3969889|FG002|Treatment 1 Period|Lost to Follow-up|0
2283220|NCT02395042|3969887|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0
2283221|NCT02395042|3969888|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2
2283222|NCT02395042|3969889|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1
2283223|NCT02395042|3969887|FG000|Treatment 2 Period|Lack of Efficacy|1
2283224|NCT02395042|3969888|FG001|Treatment 2 Period|Lack of Efficacy|1
2283225|NCT02395042|3969889|FG002|Treatment 2 Period|Lack of Efficacy|0
2283226|NCT02395055|3969902|FG000|Overall Study|Withdrawal by Subject|7
2283227|NCT02395055|3969903|FG001|Overall Study|Withdrawal by Subject|3
2129034|NCT01022996|3731700|FG000|Overall Study|Adverse Event|14
2129035|NCT01022996|3731700|FG000|Overall Study|Withdrawal by Subject|3
2129036|NCT01022996|3731700|FG000|Overall Study|Lost to Follow-up|1
2129037|NCT01022996|3731700|FG000|Overall Study|Administrative problems|6
2129038|NCT01022996|3731700|FG000|Overall Study|Disease Progression|32
2129039|NCT01022996|3731700|FG000|Overall Study|Protocol Violation|1
2129040|NCT01023022|3731704|FG000|Overall Study|Death|5
2129041|NCT01023022|3731704|FG000|Overall Study|Lost to Follow-up|7
2206025|NCT01617655|3844434|FG000|Overall Study|Participants moved|0
2206026|NCT01617655|3844435|FG001|Overall Study|Participants moved|4
2206027|NCT01617655|3844434|FG000|Overall Study|Consent withdrawn by participant|1
2206028|NCT01617655|3844435|FG001|Overall Study|Consent withdrawn by participant|1
2206029|NCT01617655|3844434|FG000|Overall Study|Last visit outside protocol visit window|1
2206030|NCT01617655|3844435|FG001|Overall Study|Last visit outside protocol visit window|10
2206031|NCT01617655|3844434|FG000|Overall Study|Site closure|3
2206032|NCT01617655|3844435|FG001|Overall Study|Site closure|5
2206033|NCT01617655|3844434|FG000|Overall Study|Other than specified above|1
2206034|NCT01617655|3844435|FG001|Overall Study|Other than specified above|2
2206035|NCT01617668|3844445|FG000|Overall Study|Adverse Event|7
2206036|NCT01617668|3844446|FG001|Overall Study|Adverse Event|0
2206037|NCT01617668|3844447|FG002|Overall Study|Adverse Event|12
2206038|NCT01617668|3844448|FG003|Overall Study|Adverse Event|5
2206039|NCT01617668|3844445|FG000|Overall Study|Physician Decision|1
2283228|NCT02395081|3969912|FG000|Overall Study|Withdrawal by Subject|1
2283229|NCT02395081|3969913|FG001|Overall Study|Withdrawal by Subject|1
2283230|NCT02395081|3969914|FG002|Overall Study|Withdrawal by Subject|0
2283231|NCT02395081|3969912|FG000|Overall Study|Moved where blood couldn't be collected|4
2283232|NCT02395081|3969913|FG001|Overall Study|Moved where blood couldn't be collected|1
2283233|NCT02395081|3969914|FG002|Overall Study|Moved where blood couldn't be collected|3
2283234|NCT02395081|3969912|FG000|Overall Study|Fetal Loss|2
2283235|NCT02395081|3969913|FG001|Overall Study|Fetal Loss|3
2283236|NCT02395081|3969914|FG002|Overall Study|Fetal Loss|1
2283237|NCT02395133|3969929|FG000|Overall Study|Adverse Event|4
2283238|NCT02395133|3969930|FG001|Overall Study|Adverse Event|1
2283239|NCT02395133|3969931|FG002|Overall Study|Adverse Event|3
2283240|NCT02395133|3969932|FG003|Overall Study|Adverse Event|0
2283241|NCT02395133|3969929|FG000|Overall Study|Lack of Efficacy|1
2283242|NCT02395133|3969930|FG001|Overall Study|Lack of Efficacy|0
2283243|NCT02395133|3969931|FG002|Overall Study|Lack of Efficacy|1
2283244|NCT02395133|3969932|FG003|Overall Study|Lack of Efficacy|1
2283245|NCT02395133|3969929|FG000|Overall Study|Protocol Violation|1
2283246|NCT02395133|3969930|FG001|Overall Study|Protocol Violation|1
2283247|NCT02395133|3969931|FG002|Overall Study|Protocol Violation|0
2283248|NCT02395133|3969932|FG003|Overall Study|Protocol Violation|3
2283249|NCT02395133|3969929|FG000|Overall Study|Lost to Follow-up|0
2283250|NCT02395133|3969930|FG001|Overall Study|Lost to Follow-up|1
2283251|NCT02395133|3969931|FG002|Overall Study|Lost to Follow-up|1
2283252|NCT02395133|3969932|FG003|Overall Study|Lost to Follow-up|0
2283253|NCT02395133|3969929|FG000|Overall Study|Pregnancy|0
2283254|NCT02395133|3969930|FG001|Overall Study|Pregnancy|0
2283255|NCT02395133|3969931|FG002|Overall Study|Pregnancy|3
2283256|NCT02395133|3969932|FG003|Overall Study|Pregnancy|0
2283257|NCT02395133|3969929|FG000|Overall Study|Consent withdrawn with no reason given|1
2283258|NCT02395133|3969930|FG001|Overall Study|Consent withdrawn with no reason given|3
2283259|NCT02395133|3969931|FG002|Overall Study|Consent withdrawn with no reason given|0
2283260|NCT02395133|3969932|FG003|Overall Study|Consent withdrawn with no reason given|2
2283261|NCT02395133|3969929|FG000|Overall Study|Consent withdrawn with personal reason|0
2283262|NCT02395133|3969930|FG001|Overall Study|Consent withdrawn with personal reason|1
2283263|NCT02395133|3969931|FG002|Overall Study|Consent withdrawn with personal reason|0
2283264|NCT02395133|3969932|FG003|Overall Study|Consent withdrawn with personal reason|3
2283265|NCT02395133|3969929|FG000|Overall Study|Sponsor decision|2
2283266|NCT02395133|3969930|FG001|Overall Study|Sponsor decision|0
2283267|NCT02395133|3969931|FG002|Overall Study|Sponsor decision|0
2283268|NCT02395133|3969932|FG003|Overall Study|Sponsor decision|1
2283269|NCT02395133|3969929|FG000|Overall Study|Other than specified above|5
2283270|NCT02395133|3969930|FG001|Overall Study|Other than specified above|2
2283271|NCT02395133|3969931|FG002|Overall Study|Other than specified above|2
2283272|NCT02395133|3969932|FG003|Overall Study|Other than specified above|4
2283273|NCT02395172|3969944|FG000|Overall Study|Participants randomized but not treated|3
2283274|NCT02395172|3969945|FG001|Overall Study|Participants randomized but not treated|31
2283275|NCT02395302|3969959|FG000|Overall Study|Screen Failure|3
2283276|NCT02395302|3969959|FG000|Overall Study|Run In Failure|7
2283277|NCT02395302|3969959|FG000|Overall Study|Withdrawal by Subject|2
2283278|NCT02395302|3969959|FG000|Overall Study|Physician Decision|2
2283279|NCT02395471|3969965|FG000|Overall Study|Lost to Follow-up|2
2283280|NCT02395471|3969966|FG001|Overall Study|Lost to Follow-up|0
2283281|NCT02395471|3969965|FG000|Overall Study|Withdrawal by Subject|2
2283282|NCT02395471|3969966|FG001|Overall Study|Withdrawal by Subject|1
2129042|NCT01023022|3731704|FG000|Overall Study|due to technical issues|2
2129043|NCT01023035|3731711|FG000|Treatment Period|Adverse Event|27
2129044|NCT01023035|3731712|FG001|Treatment Period|Adverse Event|32
2129045|NCT01023035|3731713|FG002|Treatment Period|Adverse Event|50
2129046|NCT01023035|3731711|FG000|Treatment Period|Non-Medical Reasons|19
2206040|NCT01617668|3844446|FG001|Overall Study|Physician Decision|2
2206041|NCT01617668|3844447|FG002|Overall Study|Physician Decision|3
2206042|NCT01617668|3844448|FG003|Overall Study|Physician Decision|0
2206043|NCT01617668|3844445|FG000|Overall Study|Progressive Disease|4
2206044|NCT01617668|3844446|FG001|Overall Study|Progressive Disease|4
2206045|NCT01617668|3844447|FG002|Overall Study|Progressive Disease|6
2206046|NCT01617668|3844448|FG003|Overall Study|Progressive Disease|9
2206047|NCT01617668|3844445|FG000|Overall Study|Subject/guardian decision|1
2206048|NCT01617668|3844446|FG001|Overall Study|Subject/guardian decision|3
2206049|NCT01617668|3844447|FG002|Overall Study|Subject/guardian decision|2
2206050|NCT01617668|3844448|FG003|Overall Study|Subject/guardian decision|1
2206051|NCT01617681|3844466|FG000|Period 1 Double Blind|Adverse Event|2
2206052|NCT01617681|3844467|FG001|Period 1 Double Blind|Adverse Event|0
2206053|NCT01617681|3844468|FG002|Period 1 Double Blind|Adverse Event|0
2129047|NCT01023035|3731712|FG001|Treatment Period|Non-Medical Reasons|22
2129048|NCT01023035|3731713|FG002|Treatment Period|Non-Medical Reasons|44
2129049|NCT01023035|3731711|FG000|Treatment Period|Treatment Failure|26
2129050|NCT01023035|3731712|FG001|Treatment Period|Treatment Failure|31
2129051|NCT01023035|3731713|FG002|Treatment Period|Treatment Failure|24
2129052|NCT01023035|3731711|FG000|Follow-up Period (up to Week 72)|Adverse Event|2
2206054|NCT01617681|3844469|FG003|Period 1 Double Blind|Adverse Event|2
2206055|NCT01617681|3844470|FG004|Period 1 Double Blind|Adverse Event|0
2206056|NCT01617681|3844466|FG000|Period 1 Double Blind|Withdrawal by Subject|1
2283283|NCT02395471|3969965|FG000|Overall Study|Physician Decision|1
2283284|NCT02395471|3969966|FG001|Overall Study|Physician Decision|0
2283285|NCT02395471|3969965|FG000|Overall Study|Protocol Violation|0
2283286|NCT02395471|3969966|FG001|Overall Study|Protocol Violation|1
2283287|NCT02395471|3969965|FG000|Overall Study|Failure to swollow sponge twice|1
2283288|NCT02395471|3969966|FG001|Overall Study|Failure to swollow sponge twice|0
2283289|NCT02395471|3969965|FG000|Overall Study|Patient did not return for procedure|0
2283290|NCT02395471|3969966|FG001|Overall Study|Patient did not return for procedure|1
2283291|NCT02395471|3969965|FG000|Overall Study|Subject not eligible|1
2283292|NCT02395471|3969966|FG001|Overall Study|Subject not eligible|0
2283293|NCT02395536|3969983|FG000|Overall Study|Lost to Follow-up|4
2283294|NCT02395536|3969984|FG001|Overall Study|Lost to Follow-up|4
2283295|NCT02395536|3969983|FG000|Overall Study|Death|2
2283296|NCT02395536|3969984|FG001|Overall Study|Death|0
2283297|NCT02395536|3969983|FG000|Overall Study|Physician Decision|4
2283298|NCT02395536|3969984|FG001|Overall Study|Physician Decision|6
2283299|NCT02395536|3969983|FG000|Overall Study|Withdrawal by Subject|9
2283300|NCT02395536|3969984|FG001|Overall Study|Withdrawal by Subject|17
2283301|NCT02395536|3969983|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1
2283302|NCT02395536|3969984|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2
2283303|NCT02395536|3969983|FG000|Overall Study|Insurance issue|0
2283304|NCT02395536|3969984|FG001|Overall Study|Insurance issue|1
2283305|NCT02395627|3969993|FG000|Overall Study|Withdrawal by Subject|0
2283306|NCT02395627|3969994|FG001|Overall Study|Withdrawal by Subject|2
2283307|NCT02395627|3969995|FG002|Overall Study|Withdrawal by Subject|0
2283308|NCT02395627|3969993|FG000|Overall Study|Did not receive pembrolizumab|3
2283309|NCT02395627|3969994|FG001|Overall Study|Did not receive pembrolizumab|1
2283310|NCT02395627|3969995|FG002|Overall Study|Did not receive pembrolizumab|0
2283311|NCT02395653|3970005|FG000|Overall Study|Exclusion Criteria Met at Screening|4
2283312|NCT02395653|3970005|FG000|Overall Study|Consent Withdrawn at Screening|1
2283313|NCT02395653|3970005|FG000|Overall Study|SSEC Application But With 0 Dose|1
2283314|NCT02395653|3970005|FG000|Overall Study|Investigator Decision at Screening|1
2283315|NCT02395653|3970005|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3
2283316|NCT02395653|3970005|FG000|Overall Study|Withdrawal by Subject|1
2283317|NCT02395653|3970005|FG000|Overall Study|Lost to Follow-up|1
2283318|NCT02395822|3970017|FG000|Overall Study|Withdrawal by Subject|1
2283319|NCT02395822|3970017|FG000|Overall Study|Death|1
2320817|NCT02952586|4035028|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7
2320818|NCT02952586|4035029|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1
2320819|NCT02952586|4035028|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2
2320820|NCT02952586|4035029|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4
2320821|NCT02952586|4035028|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187
2320822|NCT02952586|4035029|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201
2320823|NCT02952820|4035039|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
2320824|NCT02952820|4035040|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
2320825|NCT02952820|4035041|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
2320826|NCT02952820|4035039|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
2320827|NCT02952820|4035040|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
2320828|NCT02952820|4035041|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
2320829|NCT02952820|4035039|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15
2320830|NCT02952820|4035040|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12
2320831|NCT02952820|4035041|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17
2320832|NCT02952820|4035039|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
2320833|NCT02952820|4035040|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
2206057|NCT01617681|3844467|FG001|Period 1 Double Blind|Withdrawal by Subject|1
2129053|NCT01023035|3731712|FG001|Follow-up Period (up to Week 72)|Adverse Event|0
2129054|NCT01023035|3731713|FG002|Follow-up Period (up to Week 72)|Adverse Event|1
2129055|NCT01023035|3731711|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26
2129056|NCT01023035|3731712|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28
2129057|NCT01023035|3731713|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38
2129058|NCT01023061|3731723|FG000|Overall Study|Withdrawal prior to treatment|2
2129059|NCT01023217|3731759|FG000|Overall Study|Withdrawal by Subject|1
2129060|NCT01023217|3731760|FG001|Overall Study|Withdrawal by Subject|0
2129061|NCT01023256|3731770|FG000|Overall Study|Protocol Violation|2
2129062|NCT01023256|3731771|FG001|Overall Study|Protocol Violation|3
2283320|NCT02396212|3970074|FG000|Overall Study|Adverse Event|1
2283321|NCT02396212|3970074|FG000|Overall Study|Lack of Efficacy|2
2283322|NCT02396316|3970088|FG000|Overall Study|Physician Decision|1
2283323|NCT02396316|3970089|FG001|Overall Study|Physician Decision|0
2283324|NCT02396316|3970088|FG000|Overall Study|Progressive disease|6
2283325|NCT02396316|3970089|FG001|Overall Study|Progressive disease|3
2283326|NCT02396316|3970088|FG000|Overall Study|Protocol Violation|0
2283327|NCT02396316|3970089|FG001|Overall Study|Protocol Violation|1
2283328|NCT02396316|3970088|FG000|Overall Study|Treatment unblinded|0
2283329|NCT02396316|3970089|FG001|Overall Study|Treatment unblinded|1
2283330|NCT02396381|3970101|FG000|Overall Study|Adverse Event|3
2283331|NCT02396381|3970102|FG001|Overall Study|Adverse Event|2
2206058|NCT01617681|3844468|FG002|Period 1 Double Blind|Withdrawal by Subject|1
2206059|NCT01617681|3844469|FG003|Period 1 Double Blind|Withdrawal by Subject|0
2206060|NCT01617681|3844470|FG004|Period 1 Double Blind|Withdrawal by Subject|0
2206061|NCT01617681|3844466|FG000|Period 2 Open Label|Adverse Event|0
2206062|NCT01617681|3844467|FG001|Period 2 Open Label|Adverse Event|0
2206063|NCT01617681|3844468|FG002|Period 2 Open Label|Adverse Event|0
2206064|NCT01617681|3844469|FG003|Period 2 Open Label|Adverse Event|0
2206065|NCT01617681|3844470|FG004|Period 2 Open Label|Adverse Event|3
2206066|NCT01617681|3844466|FG000|Period 2 Open Label|Withdrawal by Subject|0
2206067|NCT01617681|3844467|FG001|Period 2 Open Label|Withdrawal by Subject|0
2206068|NCT01617681|3844468|FG002|Period 2 Open Label|Withdrawal by Subject|0
2206069|NCT01617681|3844469|FG003|Period 2 Open Label|Withdrawal by Subject|0
2206070|NCT01617681|3844470|FG004|Period 2 Open Label|Withdrawal by Subject|3
2206071|NCT01617967|3844485|FG000|Overall Study|Protocol Violation|0
2206072|NCT01617967|3844486|FG001|Overall Study|Protocol Violation|0
2206073|NCT01617967|3844487|FG002|Overall Study|Protocol Violation|0
2206074|NCT01617967|3844488|FG003|Overall Study|Protocol Violation|1
2206075|NCT01617967|3844489|FG004|Overall Study|Protocol Violation|0
2206076|NCT01617967|3844490|FG005|Overall Study|Protocol Violation|0
2206077|NCT01617967|3844485|FG000|Overall Study|Withdrawal by Subject|0
2206078|NCT01617967|3844486|FG001|Overall Study|Withdrawal by Subject|0
2206079|NCT01617967|3844487|FG002|Overall Study|Withdrawal by Subject|0
2206080|NCT01617967|3844488|FG003|Overall Study|Withdrawal by Subject|0
2206081|NCT01617967|3844489|FG004|Overall Study|Withdrawal by Subject|0
2206082|NCT01617967|3844490|FG005|Overall Study|Withdrawal by Subject|1
2206083|NCT01617967|3844485|FG000|Overall Study|Dosing Suspended by Sponsor|1
2206084|NCT01617967|3844486|FG001|Overall Study|Dosing Suspended by Sponsor|0
2206085|NCT01617967|3844487|FG002|Overall Study|Dosing Suspended by Sponsor|0
2206086|NCT01617967|3844488|FG003|Overall Study|Dosing Suspended by Sponsor|0
2206087|NCT01617967|3844489|FG004|Overall Study|Dosing Suspended by Sponsor|0
2206088|NCT01617967|3844490|FG005|Overall Study|Dosing Suspended by Sponsor|0
2206089|NCT01618019|3844507|FG000|Overall Study|Withdrawal by Subject|14
2283332|NCT02396381|3970101|FG000|Overall Study|Withdrawal by Subject|33
2283333|NCT02396381|3970102|FG001|Overall Study|Withdrawal by Subject|24
2283334|NCT02396381|3970101|FG000|Overall Study|Lost to Follow-up|49
2283335|NCT02396381|3970102|FG001|Overall Study|Lost to Follow-up|31
2283336|NCT02396381|3970101|FG000|Overall Study|Protocol Violation|1
2283337|NCT02396381|3970102|FG001|Overall Study|Protocol Violation|0
2283338|NCT02396381|3970101|FG000|Overall Study|Site terminated by sponsor|7
2283339|NCT02396381|3970102|FG001|Overall Study|Site terminated by sponsor|8
2283340|NCT02396381|3970101|FG000|Overall Study|Physician Decision|5
2283341|NCT02396381|3970102|FG001|Overall Study|Physician Decision|5
2283342|NCT02396381|3970101|FG000|Overall Study|Pregnancy|2
2283343|NCT02396381|3970102|FG001|Overall Study|Pregnancy|0
2283344|NCT02396381|3970101|FG000|Overall Study|Non-compliance with study procedures|1
2283345|NCT02396381|3970102|FG001|Overall Study|Non-compliance with study procedures|0
2283346|NCT02396381|3970101|FG000|Overall Study|Moved out of town/state|1
2283347|NCT02396381|3970102|FG001|Overall Study|Moved out of town/state|3
2283348|NCT02396381|3970101|FG000|Overall Study|Could not complete visit|1
2283349|NCT02396381|3970102|FG001|Overall Study|Could not complete visit|0
2283350|NCT02396381|3970101|FG000|Overall Study|Possible conflict of interest|1
2283351|NCT02396381|3970102|FG001|Overall Study|Possible conflict of interest|0
2283352|NCT02396381|3970101|FG000|Overall Study|Randomization/Screening Error|3
2283353|NCT02396381|3970102|FG001|Overall Study|Randomization/Screening Error|1
2283354|NCT02396420|3970111|FG000|Overall Study|Death|1
2283355|NCT02396537|3970122|FG000|Overall Study|Protocol Violation|0
2283356|NCT02396537|3970123|FG001|Overall Study|Protocol Violation|1
2283357|NCT02396758|3970146|FG000|Overall Study|Withdrawal by Subject|2
2283358|NCT02396758|3970147|FG001|Overall Study|Withdrawal by Subject|0
2283359|NCT02396758|3970148|FG002|Overall Study|Withdrawal by Subject|0
2283360|NCT02396758|3970149|FG003|Overall Study|Withdrawal by Subject|1
2283361|NCT02396758|3970146|FG000|Overall Study|Lost to Follow-up|8
2283362|NCT02396758|3970147|FG001|Overall Study|Lost to Follow-up|5
2283363|NCT02396758|3970148|FG002|Overall Study|Lost to Follow-up|3
2283364|NCT02396758|3970149|FG003|Overall Study|Lost to Follow-up|3
2283365|NCT02396758|3970146|FG000|Overall Study|Death|1
2283366|NCT02396758|3970147|FG001|Overall Study|Death|1
2283367|NCT02396758|3970148|FG002|Overall Study|Death|0
2283368|NCT02396758|3970149|FG003|Overall Study|Death|1
2283369|NCT02396758|3970146|FG000|Overall Study|Randomized but not treated|1
2283370|NCT02396758|3970147|FG001|Overall Study|Randomized but not treated|0
2129063|NCT01023256|3731772|FG002|Overall Study|Protocol Violation|0
2129064|NCT01023256|3731773|FG003|Overall Study|Protocol Violation|0
2129065|NCT01023256|3731770|FG000|Overall Study|Randomized but not treated|1
2129066|NCT01023256|3731771|FG001|Overall Study|Randomized but not treated|0
2129067|NCT01023256|3731772|FG002|Overall Study|Randomized but not treated|1
2283371|NCT02396758|3970148|FG002|Overall Study|Randomized but not treated|1
2283372|NCT02396758|3970149|FG003|Overall Study|Randomized but not treated|0
2283373|NCT02396849|3970161|FG000|Overall Study|Lost to Follow-up|1
2283374|NCT02396849|3970162|FG001|Overall Study|Lost to Follow-up|1
2283375|NCT02396849|3970161|FG000|Overall Study|Did not tolerate intervention|1
2283376|NCT02396849|3970162|FG001|Overall Study|Did not tolerate intervention|1
2283377|NCT02396953|3970173|FG000|Overall Study|Withdrawal by Subject|0
2283378|NCT02396953|3970174|FG001|Overall Study|Withdrawal by Subject|0
2283379|NCT02396953|3970175|FG002|Overall Study|Withdrawal by Subject|1
2283380|NCT02396953|3970173|FG000|Overall Study|Insulin like Growth Factor-1 increased|3
2283381|NCT02396953|3970174|FG001|Overall Study|Insulin like Growth Factor-1 increased|2
2283382|NCT02396953|3970175|FG002|Overall Study|Insulin like Growth Factor-1 increased|2
2283383|NCT02396953|3970173|FG000|Overall Study|Personal Reasons|1
2283384|NCT02396953|3970174|FG001|Overall Study|Personal Reasons|1
2283385|NCT02396953|3970175|FG002|Overall Study|Personal Reasons|0
2283386|NCT02397057|3970192|FG000|Overall Study|Withdrawal by Subject|6
2283387|NCT02397057|3970193|FG001|Overall Study|Withdrawal by Subject|7
2283388|NCT02397057|3970192|FG000|Overall Study|Lost to Follow-up|4
2283389|NCT02397057|3970193|FG001|Overall Study|Lost to Follow-up|3
2283390|NCT02397057|3970192|FG000|Overall Study|Death|1
2283391|NCT02397057|3970193|FG001|Overall Study|Death|0
2283392|NCT02397057|3970192|FG000|Overall Study|Adverse Event|0
2283393|NCT02397057|3970193|FG001|Overall Study|Adverse Event|1
2283394|NCT02397057|3970192|FG000|Overall Study|Physician Decision|0
2283395|NCT02397057|3970193|FG001|Overall Study|Physician Decision|1
2283396|NCT02397057|3970192|FG000|Overall Study|Subject did not receive study drug|0
2283397|NCT02397057|3970193|FG001|Overall Study|Subject did not receive study drug|1
2283398|NCT02397096|3970201|FG000|Day 1 to Week 24|Adverse Event|7
2283399|NCT02397096|3970202|FG001|Day 1 to Week 24|Adverse Event|1
2283400|NCT02397096|3970201|FG000|Day 1 to Week 24|Death|1
2283401|NCT02397096|3970202|FG001|Day 1 to Week 24|Death|0
2283402|NCT02397096|3970201|FG000|Day 1 to Week 24|Lack of Efficacy|0
2283403|NCT02397096|3970202|FG001|Day 1 to Week 24|Lack of Efficacy|1
2283404|NCT02397096|3970201|FG000|Day 1 to Week 24|Lost to Follow-up|3
2283405|NCT02397096|3970202|FG001|Day 1 to Week 24|Lost to Follow-up|4
2283406|NCT02397096|3970201|FG000|Day 1 to Week 24|Physician Decision|2
2283407|NCT02397096|3970202|FG001|Day 1 to Week 24|Physician Decision|3
2283408|NCT02397096|3970201|FG000|Day 1 to Week 24|Protocol Violation|1
2283409|NCT02397096|3970202|FG001|Day 1 to Week 24|Protocol Violation|4
2283410|NCT02397096|3970201|FG000|Day 1 to Week 24|Withdrawal by Subject|6
2283411|NCT02397096|3970202|FG001|Day 1 to Week 24|Withdrawal by Subject|1
2283412|NCT02397096|3970201|FG000|Week 24 to Week 48|Adverse Event|6
2283413|NCT02397096|3970202|FG001|Week 24 to Week 48|Adverse Event|2
2283414|NCT02397096|3970201|FG000|Week 24 to Week 48|Lack of Efficacy|5
2283415|NCT02397096|3970202|FG001|Week 24 to Week 48|Lack of Efficacy|1
2283416|NCT02397096|3970201|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0
2283417|NCT02397096|3970202|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1
2283418|NCT02397096|3970201|FG000|Week 24 to Week 48|Physician Decision|2
2283419|NCT02397096|3970202|FG001|Week 24 to Week 48|Physician Decision|1
2129068|NCT01023256|3731773|FG003|Overall Study|Randomized but not treated|0
2129069|NCT01023256|3731770|FG000|Overall Study|Other|1
2129070|NCT01023256|3731771|FG001|Overall Study|Other|0
2129071|NCT01023256|3731772|FG002|Overall Study|Other|0
2129072|NCT01023256|3731773|FG003|Overall Study|Other|2
2129073|NCT01023256|3731770|FG000|Overall Study|Adverse Event|0
2129074|NCT01023256|3731771|FG001|Overall Study|Adverse Event|0
2129075|NCT01023256|3731772|FG002|Overall Study|Adverse Event|0
2129076|NCT01023256|3731773|FG003|Overall Study|Adverse Event|1
2129077|NCT01023256|3731770|FG000|Overall Study|Withdrawal by Subject|0
2129078|NCT01023256|3731771|FG001|Overall Study|Withdrawal by Subject|0
2129079|NCT01023256|3731772|FG002|Overall Study|Withdrawal by Subject|0
2129080|NCT01023256|3731773|FG003|Overall Study|Withdrawal by Subject|2
2129081|NCT01023269|3731786|FG000|Overall Study|early termination of the study|2
2129082|NCT01023269|3731787|FG001|Overall Study|early termination of the study|0
2129083|NCT01023308|3731793|FG000|Overall Study|Abnormal test proceedure results|3
2129084|NCT01023308|3731794|FG001|Overall Study|Abnormal test proceedure results|8
2129085|NCT01023308|3731793|FG000|Overall Study|Administrative problems|2
2129086|NCT01023308|3731794|FG001|Overall Study|Administrative problems|1
2206090|NCT01618019|3844508|FG001|Overall Study|Withdrawal by Subject|14
2206091|NCT01618162|3844516|FG000|Overall Study|Protocol Violation|13
2129087|NCT01023308|3731793|FG000|Overall Study|Adverse Event|130
2129088|NCT01023308|3731794|FG001|Overall Study|Adverse Event|66
2129089|NCT01023308|3731793|FG000|Overall Study|Death|21
2129090|NCT01023308|3731794|FG001|Overall Study|Death|17
2129091|NCT01023308|3731793|FG000|Overall Study|Disease progression|82
2129092|NCT01023308|3731794|FG001|Overall Study|Disease progression|153
2129093|NCT01023308|3731793|FG000|Overall Study|New Cancer therapy|4
2129094|NCT01023308|3731794|FG001|Overall Study|New Cancer therapy|7
2129095|NCT01023308|3731793|FG000|Overall Study|Protocol Violation|3
2129096|NCT01023308|3731794|FG001|Overall Study|Protocol Violation|4
2129097|NCT01023308|3731793|FG000|Overall Study|Untreated|5
2129098|NCT01023308|3731794|FG001|Overall Study|Untreated|5
2129099|NCT01023308|3731793|FG000|Overall Study|Lost to Follow-up|1
2129100|NCT01023308|3731794|FG001|Overall Study|Lost to Follow-up|0
2129101|NCT01023308|3731793|FG000|Overall Study|Withdrawal by Subject|34
2129102|NCT01023308|3731794|FG001|Overall Study|Withdrawal by Subject|18
2129103|NCT01023516|3731811|FG000|Overall Study|Voluntary discontinuation|7
2129104|NCT01023516|3731812|FG001|Overall Study|Voluntary discontinuation|5
2129105|NCT01023516|3731811|FG000|Overall Study|Adverse Event|9
2129106|NCT01023516|3731812|FG001|Overall Study|Adverse Event|6
2129107|NCT01023516|3731811|FG000|Overall Study|Safety reason|0
2129108|NCT01023516|3731812|FG001|Overall Study|Safety reason|3
2129109|NCT01023516|3731811|FG000|Overall Study|Study-specific criteria|4
2206092|NCT01618162|3844517|FG001|Overall Study|Protocol Violation|10
2206093|NCT01618162|3844516|FG000|Overall Study|Adverse Event|9
2206094|NCT01618162|3844517|FG001|Overall Study|Adverse Event|2
2206095|NCT01618162|3844516|FG000|Overall Study|Withdrawal Criteria|2
2206096|NCT01618162|3844517|FG001|Overall Study|Withdrawal Criteria|10
2206097|NCT01618162|3844516|FG000|Overall Study|Unclassified|14
2206098|NCT01618162|3844517|FG001|Overall Study|Unclassified|13
2206099|NCT01618214|3844525|FG000|Overall Study|Adverse Event|3
2206100|NCT01618214|3844526|FG001|Overall Study|Adverse Event|1
2206101|NCT01618214|3844525|FG000|Overall Study|Lack of Efficacy|1
2206102|NCT01618214|3844526|FG001|Overall Study|Lack of Efficacy|1
2206103|NCT01618214|3844525|FG000|Overall Study|Protocol Violation|1
2206104|NCT01618214|3844526|FG001|Overall Study|Protocol Violation|4
2206105|NCT01618214|3844525|FG000|Overall Study|Withdrawal Criteria|1
2206106|NCT01618214|3844526|FG001|Overall Study|Withdrawal Criteria|2
2206107|NCT01618214|3844525|FG000|Overall Study|Unclassified|4
2206108|NCT01618214|3844526|FG001|Overall Study|Unclassified|5
2206109|NCT01618266|3844545|FG000|Overall Study|Lost to Follow-up|9
2206110|NCT01618266|3844545|FG000|Overall Study|Treatment satisfaction|10
2206111|NCT01618266|3844545|FG000|Overall Study|Other reasons|11
2206112|NCT01618266|3844545|FG000|Overall Study|Lack of Efficacy|23
2206113|NCT01618266|3844545|FG000|Overall Study|Protocol Violation|43
2206114|NCT01618305|3844551|FG000|Overall Study|Death|0
2206115|NCT01618305|3844552|FG001|Overall Study|Death|1
2206116|NCT01618305|3844551|FG000|Overall Study|Lost to Follow-up|11
2206117|NCT01618305|3844552|FG001|Overall Study|Lost to Follow-up|7
2206118|NCT01618305|3844551|FG000|Overall Study|Protocol Violation|1
2206119|NCT01618305|3844552|FG001|Overall Study|Protocol Violation|0
2206120|NCT01618305|3844551|FG000|Overall Study|Withdrawal by Subject|3
2206121|NCT01618305|3844552|FG001|Overall Study|Withdrawal by Subject|2
2206122|NCT01618669|3844577|FG000|Overall Study|Lost to Follow-up|1
2206123|NCT01618669|3844578|FG001|Overall Study|Lost to Follow-up|1
2206124|NCT01618669|3844577|FG000|Overall Study|Randomized but Never Received Study Drug|3
2206125|NCT01618669|3844578|FG001|Overall Study|Randomized but Never Received Study Drug|2
2206126|NCT01618669|3844577|FG000|Overall Study|Adverse Event|16
2206127|NCT01618669|3844578|FG001|Overall Study|Adverse Event|7
2206128|NCT01618669|3844577|FG000|Overall Study|Protocol Violation|5
2206129|NCT01618669|3844578|FG001|Overall Study|Protocol Violation|3
2206130|NCT01618669|3844577|FG000|Overall Study|Withdrawal by Subject|9
2206131|NCT01618669|3844578|FG001|Overall Study|Withdrawal by Subject|9
2206132|NCT01618669|3844577|FG000|Overall Study|Miscellaneous Reason|0
2206133|NCT01618669|3844578|FG001|Overall Study|Miscellaneous Reason|1
2206134|NCT01618695|3844600|FG000|Core Phase|Adverse Event|4
2206135|NCT01618695|3844601|FG001|Core Phase|Adverse Event|5
2206136|NCT01618695|3844602|FG002|Core Phase|Adverse Event|15
2206137|NCT01618695|3844603|FG003|Core Phase|Adverse Event|20
2206138|NCT01618695|3844600|FG000|Core Phase|Lost to Follow-up|0
2206139|NCT01618695|3844601|FG001|Core Phase|Lost to Follow-up|0
2206140|NCT01618695|3844602|FG002|Core Phase|Lost to Follow-up|1
2206141|NCT01618695|3844603|FG003|Core Phase|Lost to Follow-up|0
2206142|NCT01618695|3844600|FG000|Core Phase|Withdrawal by Subject|16
2206143|NCT01618695|3844601|FG001|Core Phase|Withdrawal by Subject|11
2206144|NCT01618695|3844602|FG002|Core Phase|Withdrawal by Subject|9
2206145|NCT01618695|3844603|FG003|Core Phase|Withdrawal by Subject|13
2206146|NCT01618695|3844600|FG000|Core Phase|Pregnancy|2
2206147|NCT01618695|3844601|FG001|Core Phase|Pregnancy|0
2129110|NCT01023516|3731812|FG001|Overall Study|Study-specific criteria|2
2129111|NCT01023516|3731811|FG000|Overall Study|Incorrect enrolment|4
2129112|NCT01023516|3731812|FG001|Overall Study|Incorrect enrolment|2
2129113|NCT01023581|3731838|FG000|Overall Study|Adverse Event|4
2206148|NCT01618695|3844602|FG002|Core Phase|Pregnancy|0
2206149|NCT01618695|3844603|FG003|Core Phase|Pregnancy|0
2206150|NCT01618695|3844600|FG000|Core Phase|Lack of Efficacy|1
2129114|NCT01023581|3731839|FG001|Overall Study|Adverse Event|4
2129115|NCT01023581|3731840|FG002|Overall Study|Adverse Event|7
2129116|NCT01023581|3731841|FG003|Overall Study|Adverse Event|3
2129117|NCT01023581|3731842|FG004|Overall Study|Adverse Event|2
2129118|NCT01023581|3731843|FG005|Overall Study|Adverse Event|5
2129119|NCT01023581|3731844|FG006|Overall Study|Adverse Event|11
2129120|NCT01023581|3731838|FG000|Overall Study|Major protocol deviation|2
2129121|NCT01023581|3731839|FG001|Overall Study|Major protocol deviation|0
2129122|NCT01023581|3731840|FG002|Overall Study|Major protocol deviation|3
2129123|NCT01023581|3731841|FG003|Overall Study|Major protocol deviation|0
2129124|NCT01023581|3731842|FG004|Overall Study|Major protocol deviation|0
2129125|NCT01023581|3731843|FG005|Overall Study|Major protocol deviation|0
2129126|NCT01023581|3731844|FG006|Overall Study|Major protocol deviation|0
2129127|NCT01023581|3731838|FG000|Overall Study|Lost to Follow-up|4
2206151|NCT01618695|3844601|FG001|Core Phase|Lack of Efficacy|2
2206152|NCT01618695|3844602|FG002|Core Phase|Lack of Efficacy|1
2206153|NCT01618695|3844603|FG003|Core Phase|Lack of Efficacy|1
2206154|NCT01618695|3844600|FG000|Core Phase|Other than specified|1
2206155|NCT01618695|3844601|FG001|Core Phase|Other than specified|2
2206156|NCT01618695|3844602|FG002|Core Phase|Other than specified|2
2206157|NCT01618695|3844603|FG003|Core Phase|Other than specified|2
2206158|NCT01618695|3844600|FG000|Core Phase|Not treated|1
2206159|NCT01618695|3844601|FG001|Core Phase|Not treated|0
2206160|NCT01618695|3844602|FG002|Core Phase|Not treated|2
2206161|NCT01618695|3844603|FG003|Core Phase|Not treated|0
2206162|NCT01618695|3844600|FG000|Extension Phase|Lack of Efficacy|17
2206163|NCT01618695|3844601|FG001|Extension Phase|Lack of Efficacy|33
2206164|NCT01618695|3844602|FG002|Extension Phase|Lack of Efficacy|26
2206165|NCT01618695|3844603|FG003|Extension Phase|Lack of Efficacy|24
2283420|NCT02397096|3970201|FG000|Week 24 to Week 48|Withdrawal by Subject|5
2283421|NCT02397096|3970202|FG001|Week 24 to Week 48|Withdrawal by Subject|2
2283422|NCT02397096|3970201|FG000|Week 24 to Week 48|Lost to Follow-up|2
2283423|NCT02397096|3970202|FG001|Week 24 to Week 48|Lost to Follow-up|0
2283424|NCT02397096|3970201|FG000|Study Extensions|Ongoing|399
2283425|NCT02397096|3970202|FG001|Study Extensions|Ongoing|202
2283426|NCT02397278|3970237|FG000|Overall Study|Withdrawal by Subject|0
2283427|NCT02397278|3970238|FG001|Overall Study|Withdrawal by Subject|2
2283428|NCT02397278|3970237|FG000|Overall Study|Deemed ineligible following surgery|1
2283429|NCT02397278|3970238|FG001|Overall Study|Deemed ineligible following surgery|1
2283430|NCT02397408|3970253|FG000|Overall Study|Physician Decision|4
2283431|NCT02397408|3970253|FG000|Overall Study|Surgery not completed within protocol timeframe|2
2283432|NCT02397447|3970259|FG000|Overall Study|Lost to Follow-up|2
2283433|NCT02397447|3970260|FG001|Overall Study|Lost to Follow-up|2
2283434|NCT02397460|3970274|FG000|Treatment Period 2|Adverse Event|0
2283435|NCT02397460|3970275|FG001|Treatment Period 2|Adverse Event|0
2283436|NCT02397460|3970276|FG002|Treatment Period 2|Adverse Event|0
2283437|NCT02397460|3970277|FG003|Treatment Period 2|Adverse Event|0
2283438|NCT02397460|3970278|FG004|Treatment Period 2|Adverse Event|0
2283439|NCT02397460|3970279|FG005|Treatment Period 2|Adverse Event|0
2283440|NCT02397460|3970280|FG006|Treatment Period 2|Adverse Event|0
2283441|NCT02397460|3970281|FG007|Treatment Period 2|Adverse Event|1
2283442|NCT02397460|3970274|FG000|Treatment Period 4|Adverse Event|0
2283443|NCT02397460|3970275|FG001|Treatment Period 4|Adverse Event|1
2283444|NCT02397460|3970276|FG002|Treatment Period 4|Adverse Event|0
2283445|NCT02397460|3970277|FG003|Treatment Period 4|Adverse Event|0
2283446|NCT02397460|3970278|FG004|Treatment Period 4|Adverse Event|0
2283447|NCT02397460|3970279|FG005|Treatment Period 4|Adverse Event|0
2283448|NCT02397460|3970280|FG006|Treatment Period 4|Adverse Event|0
2283449|NCT02397460|3970281|FG007|Treatment Period 4|Adverse Event|0
2283450|NCT02397460|3970274|FG000|Treatment Period 4|Physician Decision|0
2283451|NCT02397460|3970275|FG001|Treatment Period 4|Physician Decision|0
2283452|NCT02397460|3970276|FG002|Treatment Period 4|Physician Decision|0
2283453|NCT02397460|3970277|FG003|Treatment Period 4|Physician Decision|0
2283454|NCT02397460|3970278|FG004|Treatment Period 4|Physician Decision|1
2283455|NCT02397460|3970279|FG005|Treatment Period 4|Physician Decision|0
2283456|NCT02397460|3970280|FG006|Treatment Period 4|Physician Decision|0
2283457|NCT02397460|3970281|FG007|Treatment Period 4|Physician Decision|0
2283458|NCT02397473|3970357|FG000|Treatment Phase|Adverse Event|1
2283459|NCT02397473|3970358|FG001|Treatment Phase|Adverse Event|2
2283460|NCT02397473|3970357|FG000|Treatment Phase|Lack of Efficacy|8
2283461|NCT02397473|3970358|FG001|Treatment Phase|Lack of Efficacy|1
2283462|NCT02397473|3970357|FG000|Treatment Phase|Lost to Follow-up|1
2283463|NCT02397473|3970358|FG001|Treatment Phase|Lost to Follow-up|0
2283464|NCT02397473|3970357|FG000|Treatment Phase|Withdrawal by Subject|2
2283465|NCT02397473|3970358|FG001|Treatment Phase|Withdrawal by Subject|1
2283466|NCT02397473|3970357|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0
2283467|NCT02397473|3970358|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3
2129128|NCT01023581|3731839|FG001|Overall Study|Lost to Follow-up|8
2129129|NCT01023581|3731840|FG002|Overall Study|Lost to Follow-up|7
2129130|NCT01023581|3731841|FG003|Overall Study|Lost to Follow-up|2
2206166|NCT01618695|3844600|FG000|Extension Phase|Pregnancy|2
2206167|NCT01618695|3844601|FG001|Extension Phase|Pregnancy|0
2206168|NCT01618695|3844602|FG002|Extension Phase|Pregnancy|1
2283468|NCT02397473|3970357|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1
2283469|NCT02397473|3970358|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1
2129131|NCT01023581|3731842|FG004|Overall Study|Lost to Follow-up|5
2129132|NCT01023581|3731843|FG005|Overall Study|Lost to Follow-up|2
2129133|NCT01023581|3731844|FG006|Overall Study|Lost to Follow-up|2
2129134|NCT01023581|3731838|FG000|Overall Study|Withdrawal by Subject|13
2129135|NCT01023581|3731839|FG001|Overall Study|Withdrawal by Subject|8
2129136|NCT01023581|3731840|FG002|Overall Study|Withdrawal by Subject|16
2129137|NCT01023581|3731841|FG003|Overall Study|Withdrawal by Subject|10
2206169|NCT01618695|3844603|FG003|Extension Phase|Pregnancy|1
2206170|NCT01618695|3844600|FG000|Extension Phase|Withdrawal by Subject|43
2283470|NCT02397473|3970357|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1
2283471|NCT02397473|3970358|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0
2283472|NCT02397473|3970357|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
2283473|NCT02397473|3970358|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
2283474|NCT02397473|3970357|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0
2283475|NCT02397473|3970358|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
2283476|NCT02397655|3970372|FG000|Overall Study|data not completed|1301
2283477|NCT02397694|3970378|FG000|Double-Blinded Phase|Adverse Event|1
2283478|NCT02397694|3970379|FG001|Double-Blinded Phase|Adverse Event|0
2283479|NCT02397694|3970378|FG000|Double-Blinded Phase|Non-compliance with study drug|0
2283480|NCT02397694|3970379|FG001|Double-Blinded Phase|Non-compliance with study drug|2
2283481|NCT02397694|3970378|FG000|Double-Blinded Phase|Withdrawal by Subject|1
2283482|NCT02397694|3970379|FG001|Double-Blinded Phase|Withdrawal by Subject|0
2283483|NCT02397694|3970378|FG000|Double-Blinded Phase|Lost to Follow-up|1
2283484|NCT02397694|3970379|FG001|Double-Blinded Phase|Lost to Follow-up|1
2283485|NCT02397694|3970378|FG000|Open Label Extension Phase|Protocol Violation|1
2283486|NCT02397694|3970379|FG001|Open Label Extension Phase|Protocol Violation|0
2283487|NCT02397694|3970378|FG000|Open Label Extension Phase|Withdrew Consent|3
2283488|NCT02397694|3970379|FG001|Open Label Extension Phase|Withdrew Consent|1
2283489|NCT02397694|3970378|FG000|Open Label Extension Phase|Lost to Follow-up|4
2283490|NCT02397694|3970379|FG001|Open Label Extension Phase|Lost to Follow-up|0
2283491|NCT02397837|3970414|FG000|Overall Study|Withdrawal by Subject|6
2283492|NCT02397837|3970415|FG001|Overall Study|Withdrawal by Subject|5
2283493|NCT02397837|3970414|FG000|Overall Study|Physician Decision|1
2283494|NCT02397837|3970415|FG001|Overall Study|Physician Decision|1
2283495|NCT02397889|3970423|FG000|Overall Study|Physician Decision|1
2283496|NCT02397889|3970424|FG001|Overall Study|Physician Decision|0
2283497|NCT02397915|3970430|FG000|Period 1|Protocol Violation|0
2283498|NCT02397915|3970431|FG001|Period 1|Protocol Violation|1
2283499|NCT02397915|3970432|FG002|Period 1|Protocol Violation|0
2283500|NCT02397915|3970433|FG003|Period 1|Protocol Violation|0
2283501|NCT02397915|3970430|FG000|Period 1|Physician Decision|1
2283502|NCT02397915|3970431|FG001|Period 1|Physician Decision|0
2283503|NCT02397915|3970432|FG002|Period 1|Physician Decision|0
2283504|NCT02397915|3970433|FG003|Period 1|Physician Decision|0
2283505|NCT02398188|3970447|FG000|Overall Study|Adverse Event|2
2283506|NCT02398188|3970448|FG001|Overall Study|Adverse Event|3
2283507|NCT02398188|3970447|FG000|Overall Study|Lost to Follow-up|5
2283508|NCT02398188|3970448|FG001|Overall Study|Lost to Follow-up|0
2283509|NCT02398188|3970447|FG000|Overall Study|Non-compliance|4
2283510|NCT02398188|3970448|FG001|Overall Study|Non-compliance|4
2283511|NCT02398188|3970447|FG000|Overall Study|Protocol Violation|6
2283512|NCT02398188|3970448|FG001|Overall Study|Protocol Violation|10
2283513|NCT02398188|3970447|FG000|Overall Study|Sponsor Decision|2
2283514|NCT02398188|3970448|FG001|Overall Study|Sponsor Decision|1
2283515|NCT02398188|3970447|FG000|Overall Study|Pregnancy|1
2283516|NCT02398188|3970448|FG001|Overall Study|Pregnancy|0
2283517|NCT02398188|3970447|FG000|Overall Study|Withdrawal by Subject|7
2283518|NCT02398188|3970448|FG001|Overall Study|Withdrawal by Subject|16
2283519|NCT02398227|3970456|FG000|Overall Study|Lost to Follow-up|21
2283520|NCT02398227|3970457|FG001|Overall Study|Lost to Follow-up|12
2283521|NCT02398227|3970456|FG000|Overall Study|Withdrawal by Subject|5
2283522|NCT02398227|3970457|FG001|Overall Study|Withdrawal by Subject|6
2283523|NCT02398227|3970456|FG000|Overall Study|Removed from treatment and dropped out|1
2283524|NCT02398227|3970457|FG001|Overall Study|Removed from treatment and dropped out|0
2283525|NCT02399163|3970476|FG000|Overall Study|Adverse Event|2
2283526|NCT02399163|3970476|FG000|Overall Study|Protocol Deviation|2
2283527|NCT02399163|3970476|FG000|Overall Study|Withdrawal by Participant|5
2283528|NCT02399254|3970492|FG000|Overall Study|Physician Decision|2
2283529|NCT02399475|3970503|FG000|Overall Study|Physician Decision|1
2283530|NCT02399475|3970504|FG001|Overall Study|Physician Decision|0
2283531|NCT02400307|3970530|FG000|Overall Study|Enrolled and Never Dosed|1
2283532|NCT02400307|3970531|FG001|Overall Study|Enrolled and Never Dosed|0
2283533|NCT02400333|3970541|FG000|Overall Study|Withdrawal by Subject|0
2283534|NCT02400333|3970542|FG001|Overall Study|Withdrawal by Subject|1
2283535|NCT02400333|3970543|FG002|Overall Study|Withdrawal by Subject|0
2283536|NCT02400333|3970544|FG003|Overall Study|Withdrawal by Subject|1
2283537|NCT02400333|3970541|FG000|Overall Study|Protocol Violation|1
2129138|NCT01023581|3731842|FG004|Overall Study|Withdrawal by Subject|6
2206171|NCT01618695|3844601|FG001|Extension Phase|Withdrawal by Subject|48
2206172|NCT01618695|3844602|FG002|Extension Phase|Withdrawal by Subject|42
2206173|NCT01618695|3844603|FG003|Extension Phase|Withdrawal by Subject|33
2283538|NCT02400333|3970542|FG001|Overall Study|Protocol Violation|0
2206174|NCT01618695|3844600|FG000|Extension Phase|Adverse Event|18
2206175|NCT01618695|3844601|FG001|Extension Phase|Adverse Event|16
2206176|NCT01618695|3844602|FG002|Extension Phase|Adverse Event|9
2206177|NCT01618695|3844603|FG003|Extension Phase|Adverse Event|20
2206178|NCT01618695|3844600|FG000|Extension Phase|Lost to Follow-up|2
2206179|NCT01618695|3844601|FG001|Extension Phase|Lost to Follow-up|1
2206180|NCT01618695|3844602|FG002|Extension Phase|Lost to Follow-up|1
2206181|NCT01618695|3844603|FG003|Extension Phase|Lost to Follow-up|1
2206182|NCT01618695|3844600|FG000|Extension Phase|Other than specified|13
2206183|NCT01618695|3844601|FG001|Extension Phase|Other than specified|18
2206184|NCT01618695|3844602|FG002|Extension Phase|Other than specified|13
2206185|NCT01618695|3844603|FG003|Extension Phase|Other than specified|18
2129139|NCT01023581|3731843|FG005|Overall Study|Withdrawal by Subject|8
2129140|NCT01023581|3731844|FG006|Overall Study|Withdrawal by Subject|5
2129141|NCT01023581|3731838|FG000|Overall Study|Pregnancy|0
2129142|NCT01023581|3731839|FG001|Overall Study|Pregnancy|0
2129143|NCT01023581|3731840|FG002|Overall Study|Pregnancy|0
2129144|NCT01023581|3731841|FG003|Overall Study|Pregnancy|2
2129145|NCT01023581|3731842|FG004|Overall Study|Pregnancy|0
2129146|NCT01023581|3731843|FG005|Overall Study|Pregnancy|1
2129147|NCT01023581|3731844|FG006|Overall Study|Pregnancy|0
2129148|NCT01023581|3731838|FG000|Overall Study|Lack of Efficacy|9
2129149|NCT01023581|3731839|FG001|Overall Study|Lack of Efficacy|3
2129150|NCT01023581|3731840|FG002|Overall Study|Lack of Efficacy|6
2129151|NCT01023581|3731841|FG003|Overall Study|Lack of Efficacy|2
2129152|NCT01023581|3731842|FG004|Overall Study|Lack of Efficacy|1
2129153|NCT01023581|3731843|FG005|Overall Study|Lack of Efficacy|2
2129154|NCT01023581|3731844|FG006|Overall Study|Lack of Efficacy|1
2129155|NCT01023581|3731838|FG000|Overall Study|Physician Decision|2
2129156|NCT01023581|3731839|FG001|Overall Study|Physician Decision|0
2129157|NCT01023581|3731840|FG002|Overall Study|Physician Decision|2
2129158|NCT01023581|3731841|FG003|Overall Study|Physician Decision|1
2129159|NCT01023581|3731842|FG004|Overall Study|Physician Decision|1
2129160|NCT01023581|3731843|FG005|Overall Study|Physician Decision|1
2129161|NCT01023581|3731844|FG006|Overall Study|Physician Decision|1
2129162|NCT01023581|3731838|FG000|Overall Study|Other|1
2129163|NCT01023581|3731839|FG001|Overall Study|Other|0
2129164|NCT01023581|3731840|FG002|Overall Study|Other|1
2129165|NCT01023581|3731841|FG003|Overall Study|Other|0
2129166|NCT01023581|3731842|FG004|Overall Study|Other|1
2129167|NCT01023581|3731843|FG005|Overall Study|Other|0
2129168|NCT01023581|3731844|FG006|Overall Study|Other|0
2129169|NCT01023659|3731863|FG000|Overall Study|Lost to Follow-up|73
2129170|NCT01023659|3731864|FG001|Overall Study|Lost to Follow-up|228
2129171|NCT01023659|3731865|FG002|Overall Study|Lost to Follow-up|99
2129172|NCT01023672|3731874|FG000|Overall Study|Worsening disease|2
2129173|NCT01023672|3731874|FG000|Overall Study|Death|1
2129174|NCT01023789|3731896|FG000|3 - Year Visit|Death|29
2129175|NCT01023789|3731896|FG000|3 - Year Visit|Withdrawal of consent|1
2129176|NCT01023789|3731896|FG000|3 - Year Visit|Lost to Follow-up|13
2129177|NCT01023815|3731904|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
2129178|NCT01023815|3731905|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
2129179|NCT01023815|3731906|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
2129180|NCT01023815|3731907|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
2129181|NCT01023815|3731904|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
2129182|NCT01023815|3731905|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
2129183|NCT01023815|3731906|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
2129184|NCT01023815|3731907|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
2129185|NCT01023815|3731904|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
2129186|NCT01023815|3731905|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
2129187|NCT01023815|3731906|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
2129188|NCT01023815|3731907|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
2129189|NCT01023815|3731904|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
2129190|NCT01023815|3731905|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
2129191|NCT01023815|3731906|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
2129192|NCT01023815|3731907|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
2129193|NCT01023815|3731904|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0
2129194|NCT01023815|3731905|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1
2129195|NCT01023815|3731906|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0
2129196|NCT01023815|3731907|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0
2129197|NCT01023958|3731927|FG000|Overall Study|Progressive disease|48
2129198|NCT01023958|3731927|FG000|Overall Study|Other adverse event|1
2129199|NCT01023958|3731927|FG000|Overall Study|Refused to continue medication|1
2129200|NCT01024036|3731942|FG000|Blinded Treatment|Adverse Event|1
2129201|NCT01024036|3731943|FG001|Blinded Treatment|Adverse Event|1
2129202|NCT01024036|3731942|FG000|Blinded Treatment|Lack of Efficacy|16
2129203|NCT01024036|3731943|FG001|Blinded Treatment|Lack of Efficacy|14
2129204|NCT01024036|3731942|FG000|Blinded Treatment|Physician Decision|1
2129205|NCT01024036|3731943|FG001|Blinded Treatment|Physician Decision|0
2129206|NCT01024036|3731942|FG000|Blinded Treatment|Death|0
2129207|NCT01024036|3731943|FG001|Blinded Treatment|Death|2
2206186|NCT01618708|3844616|FG000|Overall Study|Adverse Event|10
2129208|NCT01024036|3731942|FG000|Blinded Treatment|Withdrawal by Subject|4
2129209|NCT01024036|3731943|FG001|Blinded Treatment|Withdrawal by Subject|3
2129210|NCT01024036|3731942|FG000|Unblinded Treatment|Adverse Event|0
2129211|NCT01024036|3731943|FG001|Unblinded Treatment|Adverse Event|1
2129212|NCT01024036|3731942|FG000|Unblinded Treatment|Lack of Efficacy|0
2129213|NCT01024036|3731943|FG001|Unblinded Treatment|Lack of Efficacy|2
2129214|NCT01024036|3731942|FG000|Follow-Up Period|Lost to Follow-up|1
2129215|NCT01024036|3731943|FG001|Follow-Up Period|Lost to Follow-up|1
2129216|NCT01024036|3731942|FG000|Follow-Up Period|Withdrawal by Subject|0
2129217|NCT01024036|3731943|FG001|Follow-Up Period|Withdrawal by Subject|1
2129218|NCT01024036|3731942|FG000|Follow-Up Period|Adverse Event|4
2129219|NCT01024036|3731943|FG001|Follow-Up Period|Adverse Event|1
2129220|NCT01024231|3731959|FG000|Overall Study|Other Reasons|1
2129221|NCT01024231|3731960|FG001|Overall Study|Other Reasons|2
2129222|NCT01024231|3731961|FG002|Overall Study|Other Reasons|0
2129223|NCT01024231|3731962|FG003|Overall Study|Other Reasons|0
2129224|NCT01024231|3731963|FG004|Overall Study|Other Reasons|2
2129225|NCT01024231|3731964|FG005|Overall Study|Other Reasons|0
2129226|NCT01024231|3731965|FG006|Overall Study|Other Reasons|1
2129227|NCT01024231|3731959|FG000|Overall Study|Maximum Clinical Benefit|1
2129228|NCT01024231|3731960|FG001|Overall Study|Maximum Clinical Benefit|2
2129229|NCT01024231|3731961|FG002|Overall Study|Maximum Clinical Benefit|0
2129230|NCT01024231|3731962|FG003|Overall Study|Maximum Clinical Benefit|1
2129231|NCT01024231|3731963|FG004|Overall Study|Maximum Clinical Benefit|1
2129232|NCT01024231|3731964|FG005|Overall Study|Maximum Clinical Benefit|0
2129233|NCT01024231|3731965|FG006|Overall Study|Maximum Clinical Benefit|0
2129234|NCT01024231|3731959|FG000|Overall Study|Disease Progression|3
2129235|NCT01024231|3731960|FG001|Overall Study|Disease Progression|1
2129236|NCT01024231|3731961|FG002|Overall Study|Disease Progression|3
2129237|NCT01024231|3731962|FG003|Overall Study|Disease Progression|0
2129238|NCT01024231|3731963|FG004|Overall Study|Disease Progression|4
2129239|NCT01024231|3731964|FG005|Overall Study|Disease Progression|11
2129240|NCT01024231|3731965|FG006|Overall Study|Disease Progression|6
2129241|NCT01024231|3731959|FG000|Overall Study|AE unrelated to Study Drug|0
2129242|NCT01024231|3731960|FG001|Overall Study|AE unrelated to Study Drug|1
2129243|NCT01024231|3731961|FG002|Overall Study|AE unrelated to Study Drug|0
2129244|NCT01024231|3731962|FG003|Overall Study|AE unrelated to Study Drug|0
2206187|NCT01618708|3844617|FG001|Overall Study|Adverse Event|10
2206188|NCT01618708|3844616|FG000|Overall Study|Lost to Follow-up|3
2206189|NCT01618708|3844617|FG001|Overall Study|Lost to Follow-up|3
2206190|NCT01618708|3844616|FG000|Overall Study|Withdrawal by Subject|17
2206191|NCT01618708|3844617|FG001|Overall Study|Withdrawal by Subject|22
2206192|NCT01618708|3844616|FG000|Overall Study|Lack of Efficacy|8
2206193|NCT01618708|3844617|FG001|Overall Study|Lack of Efficacy|8
2206194|NCT01618708|3844616|FG000|Overall Study|Technical problems|2
2206195|NCT01618708|3844617|FG001|Overall Study|Technical problems|0
2206196|NCT01618708|3844616|FG000|Overall Study|Other than specified above|1
2206197|NCT01618708|3844617|FG001|Overall Study|Other than specified above|1
2206198|NCT01618708|3844616|FG000|Overall Study|Randomized but not treated|3
2206199|NCT01618708|3844617|FG001|Overall Study|Randomized but not treated|2
2206200|NCT01618838|3844624|FG000|Overall Study|slow accrual, trial closed prematurely.|4
2206201|NCT01618864|3844629|FG000|Overall Study|Withdrawal by Subject|2
2206202|NCT01618864|3844629|FG000|Overall Study|Lost to Follow-up|2
2206203|NCT01618916|3844644|FG000|Overall Study|Adverse Event|1
2206204|NCT01618916|3844645|FG001|Overall Study|Adverse Event|0
2206205|NCT01618916|3844646|FG002|Overall Study|Adverse Event|0
2206206|NCT01618916|3844647|FG003|Overall Study|Adverse Event|0
2206207|NCT01618916|3844648|FG004|Overall Study|Adverse Event|0
2206208|NCT01618916|3844649|FG005|Overall Study|Adverse Event|0
2206209|NCT01618916|3844644|FG000|Overall Study|Withdrawal by Subject|0
2206210|NCT01618916|3844645|FG001|Overall Study|Withdrawal by Subject|1
2206211|NCT01618916|3844646|FG002|Overall Study|Withdrawal by Subject|1
2206212|NCT01618916|3844647|FG003|Overall Study|Withdrawal by Subject|0
2206213|NCT01618916|3844648|FG004|Overall Study|Withdrawal by Subject|1
2206214|NCT01618916|3844649|FG005|Overall Study|Withdrawal by Subject|0
2206215|NCT01618916|3844644|FG000|Overall Study|Lost to Follow-up|1
2206216|NCT01618916|3844645|FG001|Overall Study|Lost to Follow-up|0
2206217|NCT01618916|3844646|FG002|Overall Study|Lost to Follow-up|0
2206218|NCT01618916|3844647|FG003|Overall Study|Lost to Follow-up|2
2206219|NCT01618916|3844648|FG004|Overall Study|Lost to Follow-up|0
2206220|NCT01618916|3844649|FG005|Overall Study|Lost to Follow-up|0
2206221|NCT01618968|3844692|FG000|Overall Study|Adverse Event|1
2206222|NCT01618968|3844693|FG001|Overall Study|Adverse Event|0
2206223|NCT01618968|3844694|FG002|Overall Study|Adverse Event|0
2206224|NCT01618968|3844695|FG003|Overall Study|Adverse Event|0
2206225|NCT01618968|3844692|FG000|Overall Study|Death|0
2206226|NCT01618968|3844693|FG001|Overall Study|Death|0
2206227|NCT01618968|3844694|FG002|Overall Study|Death|0
2206228|NCT01618968|3844695|FG003|Overall Study|Death|1
2206229|NCT01619059|3844706|FG000|Short-Term (ST) Treatment Period|Adverse Event|1
2206230|NCT01619059|3844707|FG001|Short-Term (ST) Treatment Period|Adverse Event|0
2206231|NCT01619059|3844706|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
2206232|NCT01619059|3844707|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
2206233|NCT01619059|3844706|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2
2206234|NCT01619059|3844707|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4
2206235|NCT01619059|3844706|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
2206236|NCT01619059|3844707|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
2206237|NCT01619059|3844706|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0
2206238|NCT01619059|3844707|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1
2206239|NCT01619059|3844706|FG000|Long-Term (LT) Treatment Period|Adverse Event|2
2206240|NCT01619059|3844707|FG001|Long-Term (LT) Treatment Period|Adverse Event|3
2206241|NCT01619059|3844706|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
2206242|NCT01619059|3844707|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
2206243|NCT01619059|3844706|FG000|Long-Term (LT) Treatment Period|Death|1
2206244|NCT01619059|3844707|FG001|Long-Term (LT) Treatment Period|Death|0
2206245|NCT01619059|3844706|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2
2206246|NCT01619059|3844707|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2
2206247|NCT01619059|3844706|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
2206248|NCT01619059|3844707|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
2206256|NCT01619410|3844719|FG000|Overall Study|Lost to Follow-up|7
2206257|NCT01619410|3844720|FG001|Overall Study|Lost to Follow-up|4
2206258|NCT01619423|3844730|FG000|Part 1 (Dose Escalation)|High basal Mn|0
2206259|NCT01619423|3844731|FG001|Part 1 (Dose Escalation)|High basal Mn|2
2206260|NCT01619423|3844732|FG002|Part 1 (Dose Escalation)|High basal Mn|0
2129245|NCT01024231|3731963|FG004|Overall Study|AE unrelated to Study Drug|0
2129246|NCT01024231|3731964|FG005|Overall Study|AE unrelated to Study Drug|0
2129247|NCT01024231|3731965|FG006|Overall Study|AE unrelated to Study Drug|0
2129248|NCT01024231|3731959|FG000|Overall Study|No longer meets criteria|0
2129249|NCT01024231|3731960|FG001|Overall Study|No longer meets criteria|0
2129250|NCT01024231|3731961|FG002|Overall Study|No longer meets criteria|0
2206261|NCT01619423|3844733|FG003|Part 1 (Dose Escalation)|High basal Mn|0
2206262|NCT01619579|3844746|FG000|Overall Study|Withdrawal by Subject|0
2206263|NCT01619579|3844747|FG001|Overall Study|Withdrawal by Subject|3
2206264|NCT01619787|3844759|FG000|Overall Study|Lost to Follow-up|5
2206265|NCT01619852|3844785|FG000|24 Hour Assessment|Withdrawal by Subject|1
2206266|NCT01619852|3844786|FG001|24 Hour Assessment|Withdrawal by Subject|1
2206267|NCT01619852|3844785|FG000|3 Month Follow up|Lost to Follow-up|31
2206268|NCT01619852|3844786|FG001|3 Month Follow up|Lost to Follow-up|34
2206269|NCT01619865|3844793|FG000|Overall Study|Adverse Event|1
2206270|NCT01619865|3844793|FG000|Overall Study|Death|2
2206271|NCT01619865|3844793|FG000|Overall Study|subject not able to comply|1
2206272|NCT01619878|3844798|FG000|6 Week Follow-up Phase|Adverse Event|1
2206273|NCT01619878|3844798|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1
2206274|NCT01619878|3844798|FG000|Follow-up at 12 Months of Age|Death|2
2206275|NCT01620060|3844828|FG000|Overall Study|Adverse Event|9
2206276|NCT01620060|3844828|FG000|Overall Study|Protocol Violation|1
2206277|NCT01620060|3844828|FG000|Overall Study|Withdrawal by Subject|1
2206278|NCT01620060|3844828|FG000|Overall Study|Did not comply with Study Produre|1
2129251|NCT01024231|3731962|FG003|Overall Study|No longer meets criteria|0
2129252|NCT01024231|3731963|FG004|Overall Study|No longer meets criteria|1
2129253|NCT01024231|3731964|FG005|Overall Study|No longer meets criteria|0
2129254|NCT01024231|3731965|FG006|Overall Study|No longer meets criteria|1
2129255|NCT01024231|3731959|FG000|Overall Study|Study Drug Toxicity|1
2129256|NCT01024231|3731960|FG001|Overall Study|Study Drug Toxicity|6
2129257|NCT01024231|3731961|FG002|Overall Study|Study Drug Toxicity|6
2129258|NCT01024231|3731962|FG003|Overall Study|Study Drug Toxicity|4
2129259|NCT01024231|3731963|FG004|Overall Study|Study Drug Toxicity|2
2129260|NCT01024231|3731964|FG005|Overall Study|Study Drug Toxicity|0
2129261|NCT01024231|3731965|FG006|Overall Study|Study Drug Toxicity|7
2129262|NCT01024231|3731959|FG000|Overall Study|Death|6
2129263|NCT01024231|3731960|FG001|Overall Study|Death|2
2129264|NCT01024231|3731961|FG002|Overall Study|Death|1
2129265|NCT01024231|3731962|FG003|Overall Study|Death|0
2129266|NCT01024231|3731963|FG004|Overall Study|Death|4
2129267|NCT01024231|3731964|FG005|Overall Study|Death|3
2129268|NCT01024231|3731965|FG006|Overall Study|Death|5
2129269|NCT01024231|3731959|FG000|Overall Study|Lost to Follow-up|0
2129270|NCT01024231|3731960|FG001|Overall Study|Lost to Follow-up|0
2129271|NCT01024231|3731961|FG002|Overall Study|Lost to Follow-up|0
2129272|NCT01024231|3731962|FG003|Overall Study|Lost to Follow-up|0
2129273|NCT01024231|3731963|FG004|Overall Study|Lost to Follow-up|0
2129274|NCT01024231|3731964|FG005|Overall Study|Lost to Follow-up|0
2129275|NCT01024231|3731965|FG006|Overall Study|Lost to Follow-up|1
2129276|NCT01024231|3731959|FG000|Overall Study|Withdrew Consent|0
2129277|NCT01024231|3731960|FG001|Overall Study|Withdrew Consent|1
2129278|NCT01024231|3731961|FG002|Overall Study|Withdrew Consent|0
2129279|NCT01024231|3731962|FG003|Overall Study|Withdrew Consent|0
2129280|NCT01024231|3731963|FG004|Overall Study|Withdrew Consent|0
2129281|NCT01024231|3731964|FG005|Overall Study|Withdrew Consent|0
2129282|NCT01024231|3731965|FG006|Overall Study|Withdrew Consent|0
2129283|NCT01024231|3731959|FG000|Overall Study|Continuing on Treatment|0
2129284|NCT01024231|3731960|FG001|Overall Study|Continuing on Treatment|0
2129285|NCT01024231|3731961|FG002|Overall Study|Continuing on Treatment|0
2129286|NCT01024231|3731962|FG003|Overall Study|Continuing on Treatment|0
2129287|NCT01024231|3731963|FG004|Overall Study|Continuing on Treatment|3
2129288|NCT01024231|3731964|FG005|Overall Study|Continuing on Treatment|2
2129289|NCT01024231|3731965|FG006|Overall Study|Continuing on Treatment|0
2129290|NCT01024244|3731991|FG000|Overall Study|Adverse Event|1
2129291|NCT01024244|3731992|FG001|Overall Study|Adverse Event|2
2129292|NCT01024244|3731993|FG002|Overall Study|Adverse Event|0
2129293|NCT01024244|3731994|FG003|Overall Study|Adverse Event|1
2129294|NCT01024244|3731995|FG004|Overall Study|Adverse Event|2
2129295|NCT01024244|3731991|FG000|Overall Study|Entry Criteria Not Met|0
2129296|NCT01024244|3731992|FG001|Overall Study|Entry Criteria Not Met|1
2129297|NCT01024244|3731993|FG002|Overall Study|Entry Criteria Not Met|0
2129298|NCT01024244|3731994|FG003|Overall Study|Entry Criteria Not Met|0
2129299|NCT01024244|3731995|FG004|Overall Study|Entry Criteria Not Met|0
2129300|NCT01024244|3731991|FG000|Overall Study|Lack of Efficacy|1
2129301|NCT01024244|3731992|FG001|Overall Study|Lack of Efficacy|0
2129302|NCT01024244|3731993|FG002|Overall Study|Lack of Efficacy|0
2129303|NCT01024244|3731994|FG003|Overall Study|Lack of Efficacy|0
2129304|NCT01024244|3731995|FG004|Overall Study|Lack of Efficacy|0
2129305|NCT01024244|3731991|FG000|Overall Study|Protocol Violation|1
2129306|NCT01024244|3731992|FG001|Overall Study|Protocol Violation|0
2129307|NCT01024244|3731993|FG002|Overall Study|Protocol Violation|0
2129308|NCT01024244|3731994|FG003|Overall Study|Protocol Violation|0
2129309|NCT01024244|3731995|FG004|Overall Study|Protocol Violation|2
2129310|NCT01024244|3731991|FG000|Overall Study|Sponsor Decision|14
2129311|NCT01024244|3731992|FG001|Overall Study|Sponsor Decision|7
2129312|NCT01024244|3731993|FG002|Overall Study|Sponsor Decision|14
2129313|NCT01024244|3731994|FG003|Overall Study|Sponsor Decision|12
2129314|NCT01024244|3731995|FG004|Overall Study|Sponsor Decision|10
2129315|NCT01024244|3731991|FG000|Overall Study|Withdrawal by Subject|0
2129316|NCT01024244|3731992|FG001|Overall Study|Withdrawal by Subject|1
2129317|NCT01024244|3731993|FG002|Overall Study|Withdrawal by Subject|0
2129318|NCT01024244|3731994|FG003|Overall Study|Withdrawal by Subject|0
2129319|NCT01024244|3731995|FG004|Overall Study|Withdrawal by Subject|0
2129320|NCT01024309|3732013|FG000|Overall Study|Physician Decision|4
2129321|NCT01024309|3732014|FG001|Overall Study|Physician Decision|0
2129322|NCT01024309|3732013|FG000|Overall Study|Withdrawal by Subject|4
2129323|NCT01024309|3732014|FG001|Overall Study|Withdrawal by Subject|4
2129324|NCT01024387|3732029|FG000|Overall Study|Radiographic Progression|29
2129325|NCT01024387|3732029|FG000|Overall Study|Symptomatic Progression|10
2129326|NCT01024387|3732029|FG000|Overall Study|Physician Decision|5
2129327|NCT01024387|3732029|FG000|Overall Study|Withdrawal by Subject|5
2129328|NCT01024387|3732029|FG000|Overall Study|Death|2
2129329|NCT01024387|3732029|FG000|Overall Study|Prolonged Treatment Delay|1
2129330|NCT01024387|3732029|FG000|Overall Study|Adverse Event|3
2129331|NCT01024387|3732029|FG000|Overall Study|Other|5
2129332|NCT01024465|3732033|FG000|Overall Study|Adverse Event|2
2129333|NCT01024465|3732033|FG000|Overall Study|Physician Decision|1
2129334|NCT01024751|3732076|FG000|Enrolled Participants|Ineligible at baseline|3
2129335|NCT01024751|3732077|FG001|Enrolled Participants|Ineligible at baseline|4
2129336|NCT01024751|3732076|FG000|Eligible Participants|Withdrawal by Subject|0
2129337|NCT01024751|3732077|FG001|Eligible Participants|Withdrawal by Subject|1
2129338|NCT01024751|3732076|FG000|Eligible Participants|Lost to Follow-up|0
2129339|NCT01024751|3732077|FG001|Eligible Participants|Lost to Follow-up|1
2129340|NCT01024751|3732076|FG000|Eligible Participants|Ineligible|0
2129341|NCT01024751|3732077|FG001|Eligible Participants|Ineligible|1
2129342|NCT01024855|3732083|FG000|Overall Study|Inclusion/exclusion criteria|1
2129343|NCT01024920|3732090|FG000|Overall Study|Progressive disease|47
2129344|NCT01024920|3732091|FG001|Overall Study|Progressive disease|25
2129345|NCT01024920|3732090|FG000|Overall Study|Adverse Event|8
2129346|NCT01024920|3732091|FG001|Overall Study|Adverse Event|4
2129347|NCT01024920|3732090|FG000|Overall Study|Lost to Follow-up|0
2129348|NCT01024920|3732091|FG001|Overall Study|Lost to Follow-up|1
2129349|NCT01024920|3732090|FG000|Overall Study|Patient refusal to continue|4
2129350|NCT01024920|3732091|FG001|Overall Study|Patient refusal to continue|0
2129351|NCT01024920|3732090|FG000|Overall Study|Other than listed|5
2129352|NCT01024920|3732091|FG001|Overall Study|Other than listed|1
2129353|NCT01024920|3732090|FG000|Overall Study|Not treated|3
2129354|NCT01024920|3732091|FG001|Overall Study|Not treated|0
2129355|NCT01024920|3732090|FG000|Overall Study|Protocol Violation|0
2129356|NCT01024920|3732091|FG001|Overall Study|Protocol Violation|1
2129357|NCT01024946|3732097|FG000|Overall Study|Screen Failure|3
2129358|NCT01024946|3732097|FG000|Overall Study|Withdrawal by Subject|1
2129359|NCT01024946|3732097|FG000|Overall Study|Adverse Event|1
2129360|NCT01024959|3732101|FG000|Overall Study|ineligible|12
2129361|NCT01024959|3732101|FG000|Overall Study|results not evaluable|12
2129362|NCT01024959|3732101|FG000|Overall Study|missing results required for analysis|17
2129363|NCT01025037|3732120|FG000|Overall Study|Adverse Event|3
2129364|NCT01025037|3732120|FG000|Overall Study|Lost to Follow-up|7
2129365|NCT01025037|3732120|FG000|Overall Study|Withdrawal by Subject|1
2129366|NCT01025154|3732128|FG000|Overall Study|Lost to Follow-up|1
2129367|NCT01025154|3732128|FG000|Overall Study|Withdrawal by Subject|1
2129368|NCT01025193|3732132|FG000|Overall Study|Protocol Violation|1
2129369|NCT01025193|3732132|FG000|Overall Study|Adverse Event|3
2129370|NCT01025232|3732142|FG000|Overall Study|Study drug no longer available|3
2129371|NCT01025232|3732143|FG001|Overall Study|Study drug no longer available|6
2129372|NCT01025284|3732152|FG000|Overall Study|Investigator Decision|0
2129373|NCT01025284|3732153|FG001|Overall Study|Investigator Decision|1
2129374|NCT01025284|3732154|FG002|Overall Study|Investigator Decision|0
2129375|NCT01025284|3732152|FG000|Overall Study|Withdrawal by Subject|0
2129376|NCT01025284|3732153|FG001|Overall Study|Withdrawal by Subject|1
2129377|NCT01025284|3732154|FG002|Overall Study|Withdrawal by Subject|0
2129378|NCT01025336|3732169|FG000|Overall Study|Protocol Violation|0
2129379|NCT01025336|3732170|FG001|Overall Study|Protocol Violation|0
2129380|NCT01025336|3732171|FG002|Overall Study|Protocol Violation|0
2129381|NCT01025336|3732172|FG003|Overall Study|Protocol Violation|2
2283539|NCT02400333|3970543|FG002|Overall Study|Protocol Violation|2
2283540|NCT02400333|3970544|FG003|Overall Study|Protocol Violation|1
2283541|NCT02400346|3970555|FG000|Overall Study|Adverse Event|24
2283542|NCT02400346|3970555|FG000|Overall Study|Lack of Efficacy|9
2283543|NCT02400346|3970555|FG000|Overall Study|Non-compliance with IMP|1
2283544|NCT02400346|3970555|FG000|Overall Study|Withdrawal by Subject|7
2283545|NCT02400346|3970555|FG000|Overall Study|Administrative or other reason(s)|2
2283546|NCT02400346|3970555|FG000|Overall Study|Lost to Follow-up|1
2283547|NCT02400580|3970571|FG000|Overall Study|Withdrawal by Subject|1
2283548|NCT02400580|3970572|FG001|Overall Study|Withdrawal by Subject|1
2283549|NCT02400580|3970571|FG000|Overall Study|Adverse Event|1
2283550|NCT02400580|3970572|FG001|Overall Study|Adverse Event|0
2283551|NCT02400736|3970589|FG000|Overall Study|Lost to Follow-up|6
2283552|NCT02400736|3970590|FG001|Overall Study|Lost to Follow-up|6
2283553|NCT02400736|3970589|FG000|Overall Study|Withdrawal by Subject|2
2283554|NCT02400736|3970590|FG001|Overall Study|Withdrawal by Subject|1
2283555|NCT02400736|3970589|FG000|Overall Study|Moved from the area|3
2283556|NCT02400736|3970590|FG001|Overall Study|Moved from the area|1
2283557|NCT02400749|3970600|FG000|Week 0 -16|Withdrawal by Subject|5
2283558|NCT02400749|3970601|FG001|Week 0 -16|Withdrawal by Subject|5
2283559|NCT02400749|3970600|FG000|Week 0 -16|Adverse Event|3
2283560|NCT02400749|3970601|FG001|Week 0 -16|Adverse Event|1
2283561|NCT02400749|3970600|FG000|Week 0 -16|Lost to Follow-up|2
2283562|NCT02400749|3970601|FG001|Week 0 -16|Lost to Follow-up|0
2283563|NCT02400749|3970600|FG000|Week 0 -16|Protocol Violation|1
2283564|NCT02400749|3970601|FG001|Week 0 -16|Protocol Violation|0
2283565|NCT02400749|3970600|FG000|Week 17 - 32|Withdrawal by Subject|3
2283566|NCT02400749|3970601|FG001|Week 17 - 32|Withdrawal by Subject|2
2283567|NCT02400749|3970600|FG000|Week 17 - 32|Adverse Event|2
2283568|NCT02400749|3970601|FG001|Week 17 - 32|Adverse Event|1
2283569|NCT02400905|3970607|FG000|Overall Study|Death|24
2283570|NCT02400905|3970607|FG000|Overall Study|Lost to Follow-up|18
2283571|NCT02400905|3970607|FG000|Overall Study|Withdrawal by Subject|16
2283572|NCT02400905|3970607|FG000|Overall Study|Physician Decision|4
2283573|NCT02400905|3970607|FG000|Overall Study|Other|1
2283574|NCT02401230|3970642|FG000|Overall Study|Adverse Event|3
2283575|NCT02401230|3970643|FG001|Overall Study|Adverse Event|2
2283576|NCT02401230|3970644|FG002|Overall Study|Adverse Event|0
2283577|NCT02401230|3970642|FG000|Overall Study|Withdrawal by Subject|2
2283578|NCT02401230|3970643|FG001|Overall Study|Withdrawal by Subject|1
2283579|NCT02401230|3970644|FG002|Overall Study|Withdrawal by Subject|1
2283580|NCT02401230|3970642|FG000|Overall Study|Lost to Follow-up|1
2283581|NCT02401230|3970643|FG001|Overall Study|Lost to Follow-up|3
2283582|NCT02401230|3970644|FG002|Overall Study|Lost to Follow-up|3
2283583|NCT02401256|3970656|FG000|Overall Study|Adverse Event|5
2283584|NCT02401256|3970656|FG000|Overall Study|Withdrawal by Subject|12
2283585|NCT02401412|3970664|FG000|Overall Study|Lost to Follow-up|1
2283586|NCT02401412|3970665|FG001|Overall Study|Lost to Follow-up|0
2283587|NCT02401412|3970664|FG000|Overall Study|Discontinued Intervention|15
2283588|NCT02401412|3970665|FG001|Overall Study|Discontinued Intervention|21
2283589|NCT02401412|3970664|FG000|Overall Study|Withdrawal by Subject|4
2283590|NCT02401412|3970665|FG001|Overall Study|Withdrawal by Subject|4
2283591|NCT02401412|3970664|FG000|Overall Study|Subject withdrawal prior to intervention|0
2283592|NCT02401412|3970665|FG001|Overall Study|Subject withdrawal prior to intervention|1
2283593|NCT02401412|3970664|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10
2283594|NCT02401412|3970665|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6
2283595|NCT02401529|3970692|FG000|Overall Study|Lost to Follow-up|2
2283596|NCT02401529|3970693|FG001|Overall Study|Lost to Follow-up|1
2283597|NCT02401529|3970692|FG000|Overall Study|Physician Decision|2
2283598|NCT02401529|3970693|FG001|Overall Study|Physician Decision|6
2283599|NCT02401529|3970692|FG000|Overall Study|Protocol Violation|5
2283600|NCT02401529|3970693|FG001|Overall Study|Protocol Violation|0
2283601|NCT02401672|3970730|FG000|Overall Study|Withdrawal by Subject|1
2283602|NCT02401672|3970731|FG001|Overall Study|Withdrawal by Subject|3
2283603|NCT02401867|3970737|FG000|Specimen Collection|Didn't receive 1 or more tests|10
2283604|NCT02401867|3970737|FG000|Analysis|Cervical assay could not be conducted|9
2283605|NCT02402166|3970772|FG000|Overall Study|Adverse Event|2
2283606|NCT02402166|3970772|FG000|Overall Study|Withdrawal by Subject|2
2283607|NCT02402166|3970772|FG000|Overall Study|Lost to Follow-up|1
2283608|NCT02402218|3970793|FG000|Overall Study|Did not pickup study medication|12
2129382|NCT01025336|3732173|FG004|Overall Study|Protocol Violation|0
2129383|NCT01025635|3732207|FG000|Overall Study|Withdrawal by Subject|6
2129384|NCT01025635|3732208|FG001|Overall Study|Withdrawal by Subject|7
2129385|NCT01025635|3732207|FG000|Overall Study|Protocol Violation|4
2129386|NCT01025635|3732208|FG001|Overall Study|Protocol Violation|2
2129387|NCT01025635|3732207|FG000|Overall Study|Lack of Efficacy|0
2129388|NCT01025635|3732208|FG001|Overall Study|Lack of Efficacy|1
2129389|NCT01025635|3732207|FG000|Overall Study|Lost to Follow-up|9
2129390|NCT01025635|3732208|FG001|Overall Study|Lost to Follow-up|13
2129391|NCT01025635|3732207|FG000|Overall Study|Reason not known|4
2129392|NCT01025635|3732208|FG001|Overall Study|Reason not known|2
2129393|NCT01025752|3732216|FG000|Overall Study|Lost to Follow-up|7
2129394|NCT01025752|3732217|FG001|Overall Study|Lost to Follow-up|10
2129395|NCT01025752|3732216|FG000|Overall Study|Physician Decision|1
2129396|NCT01025752|3732217|FG001|Overall Study|Physician Decision|3
2206279|NCT01620060|3844828|FG000|Overall Study|Family emergency|1
2206280|NCT01620060|3844828|FG000|Overall Study|Per Sponsor Decision|2
2206281|NCT01620086|3844834|FG000|Overall Study|Withdrawal by Subject|3
2206282|NCT01620086|3844835|FG001|Overall Study|Withdrawal by Subject|3
2206283|NCT01620086|3844836|FG002|Overall Study|Withdrawal by Subject|0
2206284|NCT01620086|3844834|FG000|Overall Study|failed study criteria|1
2206285|NCT01620086|3844835|FG001|Overall Study|failed study criteria|4
2206286|NCT01620086|3844836|FG002|Overall Study|failed study criteria|0
2206287|NCT01620086|3844834|FG000|Overall Study|Physician Decision|1
2206288|NCT01620086|3844835|FG001|Overall Study|Physician Decision|0
2206289|NCT01620086|3844836|FG002|Overall Study|Physician Decision|0
2206290|NCT01620138|3844847|FG000|Overall Study|Withdrawal by Subject|3
2206291|NCT01620138|3844848|FG001|Overall Study|Withdrawal by Subject|0
2206292|NCT01620138|3844847|FG000|Overall Study|Lack of Efficacy|1
2206293|NCT01620138|3844848|FG001|Overall Study|Lack of Efficacy|0
2206294|NCT01620138|3844847|FG000|Overall Study|Adverse Event|2
2206295|NCT01620138|3844848|FG001|Overall Study|Adverse Event|0
2206296|NCT01620177|3844854|FG000|Overall Study|Failure at Screening Visit|43
2129397|NCT01025817|3732292|FG000|Completed Study Medication|Adverse Event|66
2129398|NCT01025817|3732293|FG001|Completed Study Medication|Adverse Event|39
2129399|NCT01025817|3732292|FG000|Completed Study Medication|Protocol Deviation|9
2129400|NCT01025817|3732293|FG001|Completed Study Medication|Protocol Deviation|8
2129401|NCT01025817|3732292|FG000|Completed Study Medication|Withdrawal by Subject|8
2129402|NCT01025817|3732293|FG001|Completed Study Medication|Withdrawal by Subject|9
2129403|NCT01025817|3732292|FG000|Completed Study Medication|Administrative problems|7
2129404|NCT01025817|3732293|FG001|Completed Study Medication|Administrative problems|5
2129405|NCT01025817|3732292|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7
2129406|NCT01025817|3732293|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0
2129407|NCT01025817|3732292|FG000|Completed Study Medication|Abnormal test procedure|4
2129408|NCT01025817|3732293|FG001|Completed Study Medication|Abnormal test procedure|0
2129409|NCT01025817|3732292|FG000|Completed Study Medication|Graft loss|2
2129410|NCT01025817|3732293|FG001|Completed Study Medication|Graft loss|5
2129411|NCT01025817|3732292|FG000|Completed Study Medication|Death|2
2129412|NCT01025817|3732293|FG001|Completed Study Medication|Death|2
2129413|NCT01025817|3732292|FG000|Completed Study Medication|Abnormal lab values|0
2129414|NCT01025817|3732293|FG001|Completed Study Medication|Abnormal lab values|2
2206297|NCT01620177|3844854|FG000|Overall Study|Withdrawal by Subject|26
2206298|NCT01620177|3844854|FG000|Overall Study|Lost to Follow-up|7
2206299|NCT01620177|3844854|FG000|Overall Study|Physician Decision|2
2206300|NCT01620177|3844854|FG000|Overall Study|Randomized, Not Active due to Scheduling|1
2206301|NCT01620255|3844909|FG000|Overall Study|Withdrawal by Subject|4
2206302|NCT01620255|3844910|FG001|Overall Study|Withdrawal by Subject|1
2206303|NCT01620255|3844911|FG002|Overall Study|Withdrawal by Subject|1
2206304|NCT01620255|3844912|FG003|Overall Study|Withdrawal by Subject|2
2206305|NCT01620255|3844913|FG004|Overall Study|Withdrawal by Subject|4
2206306|NCT01620255|3844909|FG000|Overall Study|Participant underwent fecal transplant|0
2206307|NCT01620255|3844910|FG001|Overall Study|Participant underwent fecal transplant|0
2206308|NCT01620255|3844911|FG002|Overall Study|Participant underwent fecal transplant|1
2206309|NCT01620255|3844912|FG003|Overall Study|Participant underwent fecal transplant|0
2206310|NCT01620255|3844913|FG004|Overall Study|Participant underwent fecal transplant|0
2206311|NCT01620255|3844909|FG000|Overall Study|Non-compliance|0
2206312|NCT01620255|3844910|FG001|Overall Study|Non-compliance|1
2206313|NCT01620255|3844911|FG002|Overall Study|Non-compliance|0
2206314|NCT01620255|3844912|FG003|Overall Study|Non-compliance|0
2129415|NCT01025817|3732292|FG000|Completed Study Medication|Subject no longer required study drug|0
2129416|NCT01025817|3732293|FG001|Completed Study Medication|Subject no longer required study drug|1
2129417|NCT01025817|3732292|FG000|Completed Study Medication|Lost to Follow-up|0
2129418|NCT01025817|3732293|FG001|Completed Study Medication|Lost to Follow-up|1
2129419|NCT01025817|3732292|FG000|Completed Study|Withdrawal by Subject|8
2129420|NCT01025817|3732293|FG001|Completed Study|Withdrawal by Subject|16
2206315|NCT01620255|3844913|FG004|Overall Study|Non-compliance|0
2206316|NCT01620255|3844909|FG000|Overall Study|Adverse Event|0
2206317|NCT01620255|3844910|FG001|Overall Study|Adverse Event|4
2206318|NCT01620255|3844911|FG002|Overall Study|Adverse Event|0
2206319|NCT01620255|3844912|FG003|Overall Study|Adverse Event|1
2129421|NCT01025817|3732292|FG000|Completed Study|Death|6
2129422|NCT01025817|3732293|FG001|Completed Study|Death|5
2129423|NCT01025817|3732292|FG000|Completed Study|Missing|2
2129424|NCT01025817|3732293|FG001|Completed Study|Missing|0
2129425|NCT01025817|3732292|FG000|Completed Study|Lost to Follow-up|0
2129426|NCT01025817|3732293|FG001|Completed Study|Lost to Follow-up|1
2178055|NCT01380093|3802585|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0
2178056|NCT01380093|3802586|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0
2178057|NCT01380093|3802587|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0
2178058|NCT01380093|3802588|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0
2178059|NCT01380093|3802580|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2178060|NCT01380093|3802581|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
2178061|NCT01380093|3802582|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2178062|NCT01380093|3802583|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2178063|NCT01380093|3802584|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2178064|NCT01380093|3802585|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2178065|NCT01380093|3802586|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2178066|NCT01380093|3802587|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2178067|NCT01380093|3802588|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2178068|NCT01380093|3802580|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0
2178069|NCT01380093|3802581|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4
2178070|NCT01380093|3802582|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9
2178071|NCT01380093|3802583|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0
2178072|NCT01380093|3802584|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0
2178073|NCT01380093|3802585|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0
2178074|NCT01380093|3802586|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0
2178075|NCT01380093|3802587|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0
2178076|NCT01380093|3802588|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0
2178077|NCT01380093|3802580|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2178078|NCT01380093|3802581|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
2178079|NCT01380093|3802582|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
2178080|NCT01380093|3802583|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2178081|NCT01380093|3802584|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2178082|NCT01380093|3802585|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2178083|NCT01380093|3802586|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2178084|NCT01380093|3802587|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2178085|NCT01380093|3802588|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2178086|NCT01380093|3802580|FG000|Drug Discrimination Phase: Day 2|Backup participant|0
2178087|NCT01380093|3802581|FG001|Drug Discrimination Phase: Day 2|Backup participant|0
2178088|NCT01380093|3802582|FG002|Drug Discrimination Phase: Day 2|Backup participant|1
2178089|NCT01380093|3802583|FG003|Drug Discrimination Phase: Day 2|Backup participant|0
2178090|NCT01380093|3802584|FG004|Drug Discrimination Phase: Day 2|Backup participant|0
2178091|NCT01380093|3802585|FG005|Drug Discrimination Phase: Day 2|Backup participant|0
2178092|NCT01380093|3802586|FG006|Drug Discrimination Phase: Day 2|Backup participant|0
2178093|NCT01380093|3802587|FG007|Drug Discrimination Phase: Day 2|Backup participant|0
2178094|NCT01380093|3802588|FG008|Drug Discrimination Phase: Day 2|Backup participant|0
2178095|NCT01380093|3802580|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0
2178096|NCT01380093|3802581|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0
2178097|NCT01380093|3802582|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1
2178098|NCT01380093|3802583|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0
2283609|NCT02402218|3970794|FG001|Overall Study|Did not pickup study medication|9
2283610|NCT02402218|3970795|FG002|Overall Study|Did not pickup study medication|13
2283611|NCT02402218|3970793|FG000|Overall Study|Lack of Efficacy|0
2283612|NCT02402218|3970794|FG001|Overall Study|Lack of Efficacy|1
2283613|NCT02402218|3970795|FG002|Overall Study|Lack of Efficacy|1
2283614|NCT02402218|3970793|FG000|Overall Study|Death|1
2283615|NCT02402218|3970794|FG001|Overall Study|Death|0
2283616|NCT02402218|3970795|FG002|Overall Study|Death|0
2283617|NCT02402218|3970793|FG000|Overall Study|Reinfection|0
2283618|NCT02402218|3970794|FG001|Overall Study|Reinfection|0
2283619|NCT02402218|3970795|FG002|Overall Study|Reinfection|1
2283620|NCT02402218|3970793|FG000|Overall Study|Adverse Event|0
2283621|NCT02402218|3970794|FG001|Overall Study|Adverse Event|2
2283622|NCT02402218|3970795|FG002|Overall Study|Adverse Event|1
2283623|NCT02402218|3970793|FG000|Overall Study|Withdrawal by Subject|1
2283624|NCT02402218|3970794|FG001|Overall Study|Withdrawal by Subject|1
2283625|NCT02402218|3970795|FG002|Overall Study|Withdrawal by Subject|1
2283626|NCT02402322|3970815|FG000|Pretreatment|Withdrawal by Subject|3
2283627|NCT02402322|3970816|FG001|Pretreatment|Withdrawal by Subject|1
2283628|NCT02402322|3970817|FG002|Pretreatment|Withdrawal by Subject|1
2283629|NCT02402322|3970815|FG000|Follow-up|Withdrawal by Subject|6
2283630|NCT02402322|3970816|FG001|Follow-up|Withdrawal by Subject|3
2283631|NCT02402322|3970817|FG002|Follow-up|Withdrawal by Subject|24
2283632|NCT02402907|3970849|FG000|Overall Study|Delivered vaginally|9
2283633|NCT02402907|3970850|FG001|Overall Study|Delivered vaginally|3
2283634|NCT02402907|3970849|FG000|Overall Study|Delivered outside of Sinai|1
2129427|NCT01025843|3732321|FG000|Washout 4|Withdrawal by Subject|0
2129428|NCT01025843|3732322|FG001|Washout 4|Withdrawal by Subject|0
2129429|NCT01025843|3732323|FG002|Washout 4|Withdrawal by Subject|1
2129430|NCT01025843|3732324|FG003|Washout 4|Withdrawal by Subject|1
2129431|NCT01025843|3732325|FG004|Washout 4|Withdrawal by Subject|0
2129432|NCT01025843|3732326|FG005|Washout 4|Withdrawal by Subject|0
2129433|NCT01025843|3732327|FG006|Washout 4|Withdrawal by Subject|0
2129434|NCT01025843|3732328|FG007|Washout 4|Withdrawal by Subject|0
2129435|NCT01025843|3732329|FG008|Washout 4|Withdrawal by Subject|0
2129436|NCT01025843|3732330|FG009|Washout 4|Withdrawal by Subject|0
2129437|NCT01026038|3732365|FG000|Overall Study|Lost to Follow-up|1
2129438|NCT01026038|3732366|FG001|Overall Study|Lost to Follow-up|1
2129439|NCT01026038|3732367|FG002|Overall Study|Lost to Follow-up|0
2129440|NCT01026103|3732375|FG000|Overall Study|Physician Decision|1
2129441|NCT01026103|3732375|FG000|Overall Study|did not receive study device bc of error|1
2129442|NCT01026142|3732381|FG000|Overall Study|Death|136
2129443|NCT01026142|3732382|FG001|Overall Study|Death|134
2129444|NCT01026142|3732381|FG000|Overall Study|Withdrew consent or lost to follow-up|36
2129445|NCT01026142|3732382|FG001|Overall Study|Withdrew consent or lost to follow-up|29
2129446|NCT01026194|3732403|FG000|Period 1：Double Blind Period|Adverse Event|2
2129447|NCT01026194|3732404|FG001|Period 1：Double Blind Period|Adverse Event|1
2129448|NCT01026194|3732403|FG000|Period 1：Double Blind Period|Lack of Efficacy|1
2129449|NCT01026194|3732404|FG001|Period 1：Double Blind Period|Lack of Efficacy|0
2129450|NCT01026194|3732403|FG000|Period 1：Double Blind Period|Physician Decision|0
2129451|NCT01026194|3732404|FG001|Period 1：Double Blind Period|Physician Decision|4
2129452|NCT01026194|3732403|FG000|Period 2：Open-label Period|Adverse Event|4
2129453|NCT01026194|3732404|FG001|Period 2：Open-label Period|Adverse Event|5
2129454|NCT01026194|3732403|FG000|Period 2：Open-label Period|Physician Decision|3
2129455|NCT01026194|3732404|FG001|Period 2：Open-label Period|Physician Decision|1
2129456|NCT01026194|3732403|FG000|Period 2：Open-label Period|Withdrawal by Subject|0
2129457|NCT01026194|3732404|FG001|Period 2：Open-label Period|Withdrawal by Subject|4
2129458|NCT01026324|3732415|FG000|Follow up/Survival|Withdrawal by Subject|1
2129459|NCT01026324|3732416|FG001|Follow up/Survival|Withdrawal by Subject|0
2129460|NCT01026324|3732417|FG002|Follow up/Survival|Withdrawal by Subject|0
2129461|NCT01026389|3732428|FG000|Overall Study|Withdrawal by Subject|1
2129462|NCT01026389|3732429|FG001|Overall Study|Withdrawal by Subject|3
2129463|NCT01026389|3732428|FG000|Overall Study|change of treatment, patient moved|4
2129464|NCT01026389|3732429|FG001|Overall Study|change of treatment, patient moved|2
2129465|NCT01026454|3732509|FG000|Second Intervention|Pregnancy|1
2129466|NCT01026454|3732510|FG001|Second Intervention|Pregnancy|1
2129467|NCT01026493|3732524|FG000|Overall Study|Protocol Violation|0
2129468|NCT01026493|3732525|FG001|Overall Study|Protocol Violation|1
2129469|NCT01026493|3732526|FG002|Overall Study|Protocol Violation|0
2129470|NCT01026493|3732527|FG003|Overall Study|Protocol Violation|0
2129471|NCT01026493|3732528|FG004|Overall Study|Protocol Violation|2
2129472|NCT01026493|3732529|FG005|Overall Study|Protocol Violation|3
2129473|NCT01026493|3732530|FG006|Overall Study|Protocol Violation|4
2129474|NCT01026493|3732531|FG007|Overall Study|Protocol Violation|1
2129475|NCT01026792|3732563|FG000|Overall Study|Protocol Violation|1
2129476|NCT01026818|3732574|FG000|Screening Period|Entry Criteria Not Met|105
2129477|NCT01026818|3732575|FG001|Screening Period|Entry Criteria Not Met|0
2129478|NCT01026818|3732576|FG002|Screening Period|Entry Criteria Not Met|0
2129479|NCT01026818|3732577|FG003|Screening Period|Entry Criteria Not Met|0
2129480|NCT01026818|3732574|FG000|Screening Period|Withdrawal by Subject|49
2129481|NCT01026818|3732575|FG001|Screening Period|Withdrawal by Subject|0
2129482|NCT01026818|3732576|FG002|Screening Period|Withdrawal by Subject|0
2129483|NCT01026818|3732577|FG003|Screening Period|Withdrawal by Subject|0
2129484|NCT01026818|3732574|FG000|Screening Period|Protocol Deviation|3
2129485|NCT01026818|3732575|FG001|Screening Period|Protocol Deviation|0
2129486|NCT01026818|3732576|FG002|Screening Period|Protocol Deviation|0
2129487|NCT01026818|3732577|FG003|Screening Period|Protocol Deviation|0
2129488|NCT01026818|3732574|FG000|Screening Period|Adverse Event|2
2129489|NCT01026818|3732575|FG001|Screening Period|Adverse Event|0
2129490|NCT01026818|3732576|FG002|Screening Period|Adverse Event|0
2129491|NCT01026818|3732577|FG003|Screening Period|Adverse Event|0
2129492|NCT01026818|3732574|FG000|Screening Period|Physician Decision|1
2129493|NCT01026818|3732575|FG001|Screening Period|Physician Decision|0
2129494|NCT01026818|3732576|FG002|Screening Period|Physician Decision|0
2129495|NCT01026818|3732577|FG003|Screening Period|Physician Decision|0
2129496|NCT01026818|3732574|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0
2129497|NCT01026818|3732575|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10
2129498|NCT01026818|3732576|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6
2129499|NCT01026818|3732577|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4
2129500|NCT01026818|3732574|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
2129501|NCT01026818|3732575|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
2129502|NCT01026818|3732576|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
2129503|NCT01026818|3732577|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
2129504|NCT01026818|3732574|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
2129505|NCT01026818|3732575|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
2129506|NCT01026818|3732576|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
2129507|NCT01026818|3732577|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
2129508|NCT01026818|3732574|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
2129509|NCT01026818|3732575|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
2129510|NCT01026818|3732576|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
2129511|NCT01026818|3732577|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
2129512|NCT01026818|3732574|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
2129513|NCT01026818|3732575|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
2129514|NCT01026818|3732576|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
2129515|NCT01026818|3732577|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
2129516|NCT01026818|3732574|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
2129517|NCT01026818|3732575|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
2129518|NCT01026818|3732576|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
2129519|NCT01026818|3732577|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
2129520|NCT01026818|3732574|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
2129521|NCT01026818|3732575|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
2129522|NCT01026818|3732576|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
2129523|NCT01026818|3732577|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
2129524|NCT01026818|3732574|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
2129525|NCT01026818|3732575|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
2129526|NCT01026818|3732576|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
2129527|NCT01026818|3732577|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
2129528|NCT01026818|3732574|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
2129529|NCT01026818|3732575|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
2129530|NCT01026818|3732576|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
2129531|NCT01026818|3732577|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
2129532|NCT01026818|3732574|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
2129533|NCT01026818|3732575|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
2129534|NCT01026818|3732576|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
2129535|NCT01026818|3732577|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
2129536|NCT01026818|3732574|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
2129537|NCT01026818|3732575|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
2129538|NCT01026818|3732576|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
2129539|NCT01026818|3732577|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
2129540|NCT01026818|3732574|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
2129541|NCT01026818|3732575|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
2129542|NCT01026818|3732576|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
2206320|NCT01620255|3844913|FG004|Overall Study|Adverse Event|1
2206321|NCT01620255|3844909|FG000|Overall Study|Withdrawn at discretion of investigator|0
2206322|NCT01620255|3844910|FG001|Overall Study|Withdrawn at discretion of investigator|0
2206323|NCT01620255|3844911|FG002|Overall Study|Withdrawn at discretion of investigator|0
2206324|NCT01620255|3844912|FG003|Overall Study|Withdrawn at discretion of investigator|0
2206325|NCT01620255|3844913|FG004|Overall Study|Withdrawn at discretion of investigator|1
2206326|NCT01620489|3844927|FG000|Overall Study|Adverse Event|17
2206327|NCT01620489|3844928|FG001|Overall Study|Adverse Event|4
2206328|NCT01620489|3844927|FG000|Overall Study|Protocol Violation|0
2206329|NCT01620489|3844928|FG001|Overall Study|Protocol Violation|3
2206330|NCT01620489|3844927|FG000|Overall Study|Withdrawal Criteria|17
2206331|NCT01620489|3844928|FG001|Overall Study|Withdrawal Criteria|25
2206332|NCT01620489|3844927|FG000|Overall Study|Unclassified|1
2206333|NCT01620489|3844928|FG001|Overall Study|Unclassified|2
2206334|NCT01620528|3844937|FG000|Treatment Period|Did Not Receive Study Drug|0
2206335|NCT01620528|3844938|FG001|Treatment Period|Did Not Receive Study Drug|0
2206336|NCT01620528|3844939|FG002|Treatment Period|Did Not Receive Study Drug|1
2206337|NCT01620528|3844937|FG000|Treatment Period|Withdrawal by Subject|35
2206338|NCT01620528|3844938|FG001|Treatment Period|Withdrawal by Subject|21
2206339|NCT01620528|3844939|FG002|Treatment Period|Withdrawal by Subject|16
2206340|NCT01620528|3844937|FG000|Treatment Period|Adverse Event|17
2206341|NCT01620528|3844938|FG001|Treatment Period|Adverse Event|13
2206342|NCT01620528|3844939|FG002|Treatment Period|Adverse Event|21
2206343|NCT01620528|3844937|FG000|Treatment Period|Lost to Follow-up|16
2129543|NCT01026818|3732577|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
2129544|NCT01026818|3732574|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
2129545|NCT01026818|3732575|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
2206344|NCT01620528|3844938|FG001|Treatment Period|Lost to Follow-up|8
2206345|NCT01620528|3844939|FG002|Treatment Period|Lost to Follow-up|14
2206346|NCT01620528|3844937|FG000|Treatment Period|Other|9
2206347|NCT01620528|3844938|FG001|Treatment Period|Other|5
2206348|NCT01620528|3844939|FG002|Treatment Period|Other|7
2206349|NCT01620528|3844937|FG000|Treatment Period|Subject Noncompliant|11
2206350|NCT01620528|3844938|FG001|Treatment Period|Subject Noncompliant|2
2206351|NCT01620528|3844939|FG002|Treatment Period|Subject Noncompliant|2
2206352|NCT01620528|3844937|FG000|Treatment Period|Pregnancy|7
2206353|NCT01620528|3844938|FG001|Treatment Period|Pregnancy|2
2206354|NCT01620528|3844939|FG002|Treatment Period|Pregnancy|2
2206355|NCT01620528|3844937|FG000|Treatment Period|Surgery/Invasive Intervention|5
2206356|NCT01620528|3844938|FG001|Treatment Period|Surgery/Invasive Intervention|1
2206357|NCT01620528|3844939|FG002|Treatment Period|Surgery/Invasive Intervention|3
2206358|NCT01620528|3844937|FG000|Treatment Period|Exclusionary Medication Received|0
2206359|NCT01620528|3844938|FG001|Treatment Period|Exclusionary Medication Received|1
2206360|NCT01620528|3844939|FG002|Treatment Period|Exclusionary Medication Received|0
2206361|NCT01620528|3844937|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
2206362|NCT01620528|3844938|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
2206363|NCT01620528|3844939|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
2206364|NCT01620528|3844937|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
2206365|NCT01620528|3844938|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
2206366|NCT01620528|3844939|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
2206367|NCT01620528|3844937|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
2206368|NCT01620528|3844938|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
2206369|NCT01620528|3844939|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
2206370|NCT01620528|3844937|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
2206371|NCT01620528|3844938|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
2206372|NCT01620528|3844939|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
2206373|NCT01620528|3844937|FG000|Post-Treatment Follow-Up Period|Other|6
2206374|NCT01620528|3844938|FG001|Post-Treatment Follow-Up Period|Other|4
2206375|NCT01620528|3844939|FG002|Post-Treatment Follow-Up Period|Other|2
2206376|NCT01620762|3844990|FG000|Overall Study|Protocol Violation|1
2206377|NCT01620762|3844991|FG001|Overall Study|Protocol Violation|1
2206378|NCT01620762|3844992|FG002|Overall Study|Protocol Violation|1
2206379|NCT01620762|3844990|FG000|Overall Study|Adverse Event|9
2206380|NCT01620762|3844991|FG001|Overall Study|Adverse Event|5
2206381|NCT01620762|3844992|FG002|Overall Study|Adverse Event|2
2206382|NCT01620762|3844990|FG000|Overall Study|Withdrawal by Subject|23
2206383|NCT01620762|3844991|FG001|Overall Study|Withdrawal by Subject|26
2206384|NCT01620762|3844992|FG002|Overall Study|Withdrawal by Subject|27
2206385|NCT01620762|3844990|FG000|Overall Study|Lost to Follow-up|11
2283635|NCT02402907|3970850|FG001|Overall Study|Delivered outside of Sinai|1
2206386|NCT01620762|3844991|FG001|Overall Study|Lost to Follow-up|17
2206387|NCT01620762|3844992|FG002|Overall Study|Lost to Follow-up|10
2206388|NCT01620762|3844990|FG000|Overall Study|Protocol deviation|1
2206389|NCT01620762|3844991|FG001|Overall Study|Protocol deviation|1
2206390|NCT01620762|3844992|FG002|Overall Study|Protocol deviation|6
2206391|NCT01620762|3844990|FG000|Overall Study|Subject deterioration|0
2206392|NCT01620762|3844991|FG001|Overall Study|Subject deterioration|1
2206393|NCT01620762|3844992|FG002|Overall Study|Subject deterioration|1
2206394|NCT01620762|3844990|FG000|Overall Study|Non-specified|3
2206395|NCT01620762|3844991|FG001|Overall Study|Non-specified|6
2206396|NCT01620762|3844992|FG002|Overall Study|Non-specified|5
2206397|NCT01620762|3844990|FG000|Overall Study|Use of prohibted therapies|0
2206398|NCT01620762|3844991|FG001|Overall Study|Use of prohibted therapies|1
2206399|NCT01620762|3844992|FG002|Overall Study|Use of prohibted therapies|1
2206400|NCT01620983|3845003|FG000|Overall Study|Lost to Follow-up|8
2206401|NCT01620983|3845004|FG001|Overall Study|Lost to Follow-up|4
2206402|NCT01620983|3845005|FG002|Overall Study|Lost to Follow-up|9
2206403|NCT01620983|3845003|FG000|Overall Study|Withdrawal by Subject|6
2206404|NCT01620983|3845004|FG001|Overall Study|Withdrawal by Subject|8
2206405|NCT01620983|3845005|FG002|Overall Study|Withdrawal by Subject|1
2206406|NCT01620983|3845003|FG000|Overall Study|Death|2
2206407|NCT01620983|3845004|FG001|Overall Study|Death|0
2206408|NCT01620983|3845005|FG002|Overall Study|Death|0
2206409|NCT01620983|3845003|FG000|Overall Study|Physician Decision|3
2206410|NCT01620983|3845004|FG001|Overall Study|Physician Decision|10
2206411|NCT01620983|3845005|FG002|Overall Study|Physician Decision|5
2206412|NCT01621126|3845028|FG000|Overall Study|Physician Decision|6
2206413|NCT01621178|3845035|FG000|Overall Study|Adverse Event|5
2206414|NCT01621178|3845036|FG001|Overall Study|Adverse Event|2
2206415|NCT01621178|3845037|FG002|Overall Study|Adverse Event|8
2206416|NCT01621178|3845035|FG000|Overall Study|Death|6
2206417|NCT01621178|3845036|FG001|Overall Study|Death|7
2206418|NCT01621178|3845037|FG002|Overall Study|Death|2
2206419|NCT01621178|3845035|FG000|Overall Study|Lost to Follow-up|1
2206420|NCT01621178|3845036|FG001|Overall Study|Lost to Follow-up|2
2206421|NCT01621178|3845037|FG002|Overall Study|Lost to Follow-up|1
2206422|NCT01621178|3845035|FG000|Overall Study|Withdrawal by Subject|14
2206423|NCT01621178|3845036|FG001|Overall Study|Withdrawal by Subject|17
2206424|NCT01621178|3845037|FG002|Overall Study|Withdrawal by Subject|18
2206425|NCT01621178|3845035|FG000|Overall Study|Physician Decision|5
2206426|NCT01621178|3845036|FG001|Overall Study|Physician Decision|2
2206427|NCT01621178|3845037|FG002|Overall Study|Physician Decision|7
2206428|NCT01621191|3845049|FG000|Overall Study|Adverse Event|9
2206429|NCT01621191|3845049|FG000|Overall Study|Withdrawal by Subject|8
2206430|NCT01621191|3845049|FG000|Overall Study|Lack of Efficacy|6
2206431|NCT01621191|3845049|FG000|Overall Study|Lost to Follow-up|1
2206432|NCT01621191|3845049|FG000|Overall Study|Site Removed From Study|1
2217433|NCT01708902|3860796|FG004|Overall Study|Adverse Event|7
2217434|NCT01708902|3860797|FG005|Overall Study|Adverse Event|3
2217435|NCT01708902|3860798|FG006|Overall Study|Adverse Event|5
2217436|NCT01708902|3860792|FG000|Overall Study|Lack of Efficacy|3
2206433|NCT01621490|3845079|FG000|Overall Study|Participant completed treatment|4
2206434|NCT01621490|3845080|FG001|Overall Study|Participant completed treatment|4
2206435|NCT01621490|3845081|FG002|Overall Study|Participant completed treatment|1
2206436|NCT01621490|3845082|FG003|Overall Study|Participant completed treatment|0
2206437|NCT01621490|3845083|FG004|Overall Study|Participant completed treatment|0
2206438|NCT01621490|3845084|FG005|Overall Study|Participant completed treatment|0
2206439|NCT01621490|3845085|FG006|Overall Study|Participant completed treatment|0
2206440|NCT01621490|3845086|FG007|Overall Study|Participant completed treatment|1
2206441|NCT01621490|3845087|FG008|Overall Study|Participant completed treatment|0
2206442|NCT01621490|3845079|FG000|Overall Study|Patient could not travel|1
2206443|NCT01621490|3845080|FG001|Overall Study|Patient could not travel|0
2206444|NCT01621490|3845081|FG002|Overall Study|Patient could not travel|0
2206445|NCT01621490|3845082|FG003|Overall Study|Patient could not travel|0
2206446|NCT01621490|3845083|FG004|Overall Study|Patient could not travel|0
2206447|NCT01621490|3845084|FG005|Overall Study|Patient could not travel|0
2206448|NCT01621490|3845085|FG006|Overall Study|Patient could not travel|0
2206449|NCT01621490|3845086|FG007|Overall Study|Patient could not travel|0
2206450|NCT01621490|3845087|FG008|Overall Study|Patient could not travel|0
2206451|NCT01621490|3845079|FG000|Overall Study|Subject no longer meets study criteria|0
2206452|NCT01621490|3845080|FG001|Overall Study|Subject no longer meets study criteria|0
2206453|NCT01621490|3845081|FG002|Overall Study|Subject no longer meets study criteria|0
2206454|NCT01621490|3845082|FG003|Overall Study|Subject no longer meets study criteria|0
2206455|NCT01621490|3845083|FG004|Overall Study|Subject no longer meets study criteria|1
2206456|NCT01621490|3845084|FG005|Overall Study|Subject no longer meets study criteria|0
2206457|NCT01621490|3845085|FG006|Overall Study|Subject no longer meets study criteria|0
2206458|NCT01621490|3845086|FG007|Overall Study|Subject no longer meets study criteria|0
2206459|NCT01621490|3845087|FG008|Overall Study|Subject no longer meets study criteria|0
2206460|NCT01621490|3845079|FG000|Overall Study|Maximum clinical benefit|3
2206461|NCT01621490|3845080|FG001|Overall Study|Maximum clinical benefit|2
2206462|NCT01621490|3845081|FG002|Overall Study|Maximum clinical benefit|0
2206463|NCT01621490|3845082|FG003|Overall Study|Maximum clinical benefit|0
2206464|NCT01621490|3845083|FG004|Overall Study|Maximum clinical benefit|0
2206465|NCT01621490|3845084|FG005|Overall Study|Maximum clinical benefit|0
2206466|NCT01621490|3845085|FG006|Overall Study|Maximum clinical benefit|1
2206467|NCT01621490|3845086|FG007|Overall Study|Maximum clinical benefit|2
2206468|NCT01621490|3845087|FG008|Overall Study|Maximum clinical benefit|0
2206469|NCT01621490|3845079|FG000|Overall Study|Withdrawal by Subject|1
2206470|NCT01621490|3845080|FG001|Overall Study|Withdrawal by Subject|0
2206471|NCT01621490|3845081|FG002|Overall Study|Withdrawal by Subject|0
2206472|NCT01621490|3845082|FG003|Overall Study|Withdrawal by Subject|0
2206473|NCT01621490|3845083|FG004|Overall Study|Withdrawal by Subject|0
2206474|NCT01621490|3845084|FG005|Overall Study|Withdrawal by Subject|3
2206475|NCT01621490|3845085|FG006|Overall Study|Withdrawal by Subject|0
2206476|NCT01621490|3845086|FG007|Overall Study|Withdrawal by Subject|0
2206477|NCT01621490|3845087|FG008|Overall Study|Withdrawal by Subject|0
2206478|NCT01621490|3845079|FG000|Overall Study|Subject request to discontinue study|1
2206479|NCT01621490|3845080|FG001|Overall Study|Subject request to discontinue study|3
2206480|NCT01621490|3845081|FG002|Overall Study|Subject request to discontinue study|1
2206481|NCT01621490|3845082|FG003|Overall Study|Subject request to discontinue study|1
2206482|NCT01621490|3845083|FG004|Overall Study|Subject request to discontinue study|0
2206483|NCT01621490|3845084|FG005|Overall Study|Subject request to discontinue study|2
2206484|NCT01621490|3845085|FG006|Overall Study|Subject request to discontinue study|1
2206485|NCT01621490|3845086|FG007|Overall Study|Subject request to discontinue study|0
2206486|NCT01621490|3845087|FG008|Overall Study|Subject request to discontinue study|1
2206487|NCT01621490|3845079|FG000|Overall Study|Adverse event unrelated to study drug|2
2206488|NCT01621490|3845080|FG001|Overall Study|Adverse event unrelated to study drug|1
2206489|NCT01621490|3845081|FG002|Overall Study|Adverse event unrelated to study drug|0
2206490|NCT01621490|3845082|FG003|Overall Study|Adverse event unrelated to study drug|0
2206491|NCT01621490|3845083|FG004|Overall Study|Adverse event unrelated to study drug|0
2206492|NCT01621490|3845084|FG005|Overall Study|Adverse event unrelated to study drug|0
2206493|NCT01621490|3845085|FG006|Overall Study|Adverse event unrelated to study drug|0
2206494|NCT01621490|3845086|FG007|Overall Study|Adverse event unrelated to study drug|2
2206495|NCT01621490|3845087|FG008|Overall Study|Adverse event unrelated to study drug|1
2206496|NCT01621490|3845079|FG000|Overall Study|Disease progression|27
2206497|NCT01621490|3845080|FG001|Overall Study|Disease progression|28
2206498|NCT01621490|3845081|FG002|Overall Study|Disease progression|1
2206499|NCT01621490|3845082|FG003|Overall Study|Disease progression|5
2206500|NCT01621490|3845083|FG004|Overall Study|Disease progression|3
2206501|NCT01621490|3845084|FG005|Overall Study|Disease progression|8
2206502|NCT01621490|3845085|FG006|Overall Study|Disease progression|7
2206503|NCT01621490|3845086|FG007|Overall Study|Disease progression|0
2206504|NCT01621490|3845087|FG008|Overall Study|Disease progression|4
2206505|NCT01621490|3845079|FG000|Overall Study|Study drug toxicity|1
2206506|NCT01621490|3845080|FG001|Overall Study|Study drug toxicity|4
2206507|NCT01621490|3845081|FG002|Overall Study|Study drug toxicity|5
2206508|NCT01621490|3845082|FG003|Overall Study|Study drug toxicity|3
2206509|NCT01621490|3845083|FG004|Overall Study|Study drug toxicity|1
2206510|NCT01621490|3845084|FG005|Overall Study|Study drug toxicity|10
2206511|NCT01621490|3845085|FG006|Overall Study|Study drug toxicity|1
2206512|NCT01621490|3845086|FG007|Overall Study|Study drug toxicity|4
2206513|NCT01621490|3845087|FG008|Overall Study|Study drug toxicity|1
2206514|NCT01621490|3845079|FG000|Overall Study|Death|0
2206515|NCT01621490|3845080|FG001|Overall Study|Death|0
2206516|NCT01621490|3845081|FG002|Overall Study|Death|0
2206517|NCT01621490|3845082|FG003|Overall Study|Death|0
2206518|NCT01621490|3845083|FG004|Overall Study|Death|0
2206519|NCT01621490|3845084|FG005|Overall Study|Death|0
2206520|NCT01621490|3845085|FG006|Overall Study|Death|0
2206521|NCT01621490|3845086|FG007|Overall Study|Death|1
2283636|NCT02402907|3970849|FG000|Overall Study|Lost to follow up after C-Section|10
2283637|NCT02402907|3970850|FG001|Overall Study|Lost to follow up after C-Section|23
2129546|NCT01026818|3732576|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
2129547|NCT01026818|3732577|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
2129548|NCT01026818|3732574|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0
2129549|NCT01026818|3732575|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0
2129550|NCT01026818|3732576|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0
2129551|NCT01026818|3732577|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1
2129552|NCT01026818|3732574|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
2129553|NCT01026818|3732575|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
2129554|NCT01026818|3732576|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
2129555|NCT01026818|3732577|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
2129556|NCT01026818|3732574|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
2129557|NCT01026818|3732575|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
2129558|NCT01026818|3732576|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
2129559|NCT01026818|3732577|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
2129560|NCT01026818|3732574|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
2129561|NCT01026818|3732575|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
2129562|NCT01026818|3732576|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
2129563|NCT01026818|3732577|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
2129564|NCT01026818|3732574|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
2129565|NCT01026818|3732575|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
2129566|NCT01026818|3732576|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
2129567|NCT01026818|3732577|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
2129568|NCT01026818|3732574|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
2129569|NCT01026818|3732575|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
2129570|NCT01026818|3732576|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
2129571|NCT01026818|3732577|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
2129572|NCT01026831|3732591|FG000|Overall Study|Adverse Event|4
2129573|NCT01026831|3732592|FG001|Overall Study|Adverse Event|3
2129574|NCT01026831|3732591|FG000|Overall Study|Lost to Follow-up|2
2129575|NCT01026831|3732592|FG001|Overall Study|Lost to Follow-up|0
2129576|NCT01026831|3732591|FG000|Overall Study|Physician Decision|1
2129577|NCT01026831|3732592|FG001|Overall Study|Physician Decision|1
2129578|NCT01026831|3732591|FG000|Overall Study|Protocol Violation|0
2129579|NCT01026831|3732592|FG001|Overall Study|Protocol Violation|2
2129580|NCT01026831|3732591|FG000|Overall Study|Withdrawal by Subject|7
2129581|NCT01026831|3732592|FG001|Overall Study|Withdrawal by Subject|5
2129582|NCT01026948|3732616|FG000|Overall Study|Physician Decision|8
2129583|NCT01026974|3732625|FG000|Overall Study|Withdrawal by Subject|0
2129584|NCT01026974|3732626|FG001|Overall Study|Withdrawal by Subject|1
2129585|NCT01026974|3732627|FG002|Overall Study|Withdrawal by Subject|7
2129586|NCT01026974|3732628|FG003|Overall Study|Withdrawal by Subject|2
2129587|NCT01026974|3732625|FG000|Overall Study|Lost to Follow-up|1
2129588|NCT01026974|3732626|FG001|Overall Study|Lost to Follow-up|1
2129589|NCT01026974|3732627|FG002|Overall Study|Lost to Follow-up|4
2283638|NCT02402933|3970856|FG000|Overall Study|Withdrawal by Subject|4
2283639|NCT02402933|3970856|FG000|Overall Study|Discontinued; Site Termination|10
2283640|NCT02403180|3970862|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
2283641|NCT02403180|3970863|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
2283642|NCT02403180|3970862|FG000|Period 2 (5 Days)|Withdrawal by Subject|0
2283643|NCT02403180|3970863|FG001|Period 2 (5 Days)|Withdrawal by Subject|1
2283644|NCT02403206|3970871|FG000|Overall Study|Lost to Follow-up|4
2129590|NCT01026974|3732628|FG003|Overall Study|Lost to Follow-up|0
2129591|NCT01026974|3732625|FG000|Overall Study|Adverse Event|0
2129592|NCT01026974|3732626|FG001|Overall Study|Adverse Event|0
2129593|NCT01026974|3732627|FG002|Overall Study|Adverse Event|0
2129594|NCT01026974|3732628|FG003|Overall Study|Adverse Event|1
2129595|NCT01026974|3732625|FG000|Overall Study|Inappropriate enrollment|0
2129596|NCT01026974|3732626|FG001|Overall Study|Inappropriate enrollment|0
2129597|NCT01026974|3732627|FG002|Overall Study|Inappropriate enrollment|1
2129598|NCT01026974|3732628|FG003|Overall Study|Inappropriate enrollment|0
2129599|NCT01027273|3732658|FG000|Overall Study|Lost to Follow-up|57
2129600|NCT01027273|3732659|FG001|Overall Study|Lost to Follow-up|31
2129601|NCT01027273|3732658|FG000|Overall Study|Death|2
2129602|NCT01027273|3732659|FG001|Overall Study|Death|2
2206522|NCT01621490|3845087|FG008|Overall Study|Death|0
2206523|NCT01621490|3845079|FG000|Overall Study|Grade 4 Lipase elevation|1
2206524|NCT01621490|3845080|FG001|Overall Study|Grade 4 Lipase elevation|0
2283645|NCT02403206|3970872|FG001|Overall Study|Lost to Follow-up|3
2283646|NCT02403206|3970871|FG000|Overall Study|Physician Decision|2
2129603|NCT01027286|3732667|FG000|Overall Study|Unable to Obtain Required Blood Volume|1
2129604|NCT01027286|3732668|FG001|Overall Study|Unable to Obtain Required Blood Volume|0
2129605|NCT01027286|3732667|FG000|Overall Study|Lost to Follow-up|0
2129606|NCT01027286|3732668|FG001|Overall Study|Lost to Follow-up|1
2129607|NCT01027351|3732680|FG000|Overall Study|Withdrawal by Subject|1
2129608|NCT01027351|3732681|FG001|Overall Study|Withdrawal by Subject|0
2129609|NCT01027351|3732682|FG002|Overall Study|Withdrawal by Subject|1
2129610|NCT01027351|3732683|FG003|Overall Study|Withdrawal by Subject|0
2129611|NCT01027351|3732684|FG004|Overall Study|Withdrawal by Subject|3
2129612|NCT01027351|3732685|FG005|Overall Study|Withdrawal by Subject|5
2129613|NCT01027351|3732680|FG000|Overall Study|Lost to Follow-up|1
2129614|NCT01027351|3732681|FG001|Overall Study|Lost to Follow-up|1
2129615|NCT01027351|3732682|FG002|Overall Study|Lost to Follow-up|0
2129616|NCT01027351|3732683|FG003|Overall Study|Lost to Follow-up|1
2129617|NCT01027351|3732684|FG004|Overall Study|Lost to Follow-up|6
2129618|NCT01027351|3732685|FG005|Overall Study|Lost to Follow-up|0
2129619|NCT01027351|3732680|FG000|Overall Study|Inappropriate enrollment|0
2129620|NCT01027351|3732681|FG001|Overall Study|Inappropriate enrollment|0
2129621|NCT01027351|3732682|FG002|Overall Study|Inappropriate enrollment|0
2129622|NCT01027351|3732683|FG003|Overall Study|Inappropriate enrollment|0
2129623|NCT01027351|3732684|FG004|Overall Study|Inappropriate enrollment|1
2129624|NCT01027351|3732685|FG005|Overall Study|Inappropriate enrollment|0
2129625|NCT01027351|3732680|FG000|Overall Study|Protocol Violation|1
2129626|NCT01027351|3732681|FG001|Overall Study|Protocol Violation|0
2129627|NCT01027351|3732682|FG002|Overall Study|Protocol Violation|0
2129628|NCT01027351|3732683|FG003|Overall Study|Protocol Violation|1
2129629|NCT01027351|3732684|FG004|Overall Study|Protocol Violation|1
2129630|NCT01027351|3732685|FG005|Overall Study|Protocol Violation|0
2129631|NCT01027364|3732710|FG000|Overall Study|Adverse Event|1
2129632|NCT01027364|3732711|FG001|Overall Study|Adverse Event|0
2129633|NCT01027364|3732712|FG002|Overall Study|Adverse Event|1
2129634|NCT01027364|3732713|FG003|Overall Study|Adverse Event|0
2129635|NCT01027364|3732710|FG000|Overall Study|Lost to Follow-up|1
2129636|NCT01027364|3732711|FG001|Overall Study|Lost to Follow-up|0
2129637|NCT01027364|3732712|FG002|Overall Study|Lost to Follow-up|0
2129638|NCT01027364|3732713|FG003|Overall Study|Lost to Follow-up|0
2129639|NCT01027364|3732710|FG000|Overall Study|Protocol Violation|1
2129640|NCT01027364|3732711|FG001|Overall Study|Protocol Violation|0
2129641|NCT01027364|3732712|FG002|Overall Study|Protocol Violation|0
2129642|NCT01027364|3732713|FG003|Overall Study|Protocol Violation|1
2129643|NCT01027364|3732710|FG000|Overall Study|Withdrawal by Subject|1
2129644|NCT01027364|3732711|FG001|Overall Study|Withdrawal by Subject|2
2129645|NCT01027364|3732712|FG002|Overall Study|Withdrawal by Subject|0
2129646|NCT01027364|3732713|FG003|Overall Study|Withdrawal by Subject|0
2129647|NCT01027416|3732741|FG000|Overall Study|Withdrawal by Subject|0
2129648|NCT01027416|3732742|FG001|Overall Study|Withdrawal by Subject|1
2129649|NCT01027416|3732741|FG000|Overall Study|Physician Decision|1
2129650|NCT01027416|3732742|FG001|Overall Study|Physician Decision|4
2129651|NCT01027650|3732783|FG000|Overall Study|Personal Reasons|0
2129652|NCT01027650|3732784|FG001|Overall Study|Personal Reasons|0
2129653|NCT01027650|3732785|FG002|Overall Study|Personal Reasons|0
2129654|NCT01027650|3732786|FG003|Overall Study|Personal Reasons|0
2129655|NCT01027650|3732787|FG004|Overall Study|Personal Reasons|2
2129656|NCT01027650|3732788|FG005|Overall Study|Personal Reasons|1
2129657|NCT01027650|3732789|FG006|Overall Study|Personal Reasons|0
2129658|NCT01027650|3732790|FG007|Overall Study|Personal Reasons|0
2129659|NCT01027650|3732783|FG000|Overall Study|Lost to Follow-up|0
2129660|NCT01027650|3732784|FG001|Overall Study|Lost to Follow-up|0
2129661|NCT01027650|3732785|FG002|Overall Study|Lost to Follow-up|0
2206525|NCT01621490|3845081|FG002|Overall Study|Grade 4 Lipase elevation|0
2206526|NCT01621490|3845082|FG003|Overall Study|Grade 4 Lipase elevation|0
2206527|NCT01621490|3845083|FG004|Overall Study|Grade 4 Lipase elevation|0
2206528|NCT01621490|3845084|FG005|Overall Study|Grade 4 Lipase elevation|0
2206529|NCT01621490|3845085|FG006|Overall Study|Grade 4 Lipase elevation|0
2206530|NCT01621490|3845086|FG007|Overall Study|Grade 4 Lipase elevation|0
2283647|NCT02403206|3970872|FG001|Overall Study|Physician Decision|0
2129662|NCT01027650|3732786|FG003|Overall Study|Lost to Follow-up|0
2129663|NCT01027650|3732787|FG004|Overall Study|Lost to Follow-up|0
2129664|NCT01027650|3732788|FG005|Overall Study|Lost to Follow-up|0
2129665|NCT01027650|3732789|FG006|Overall Study|Lost to Follow-up|1
2129666|NCT01027650|3732790|FG007|Overall Study|Lost to Follow-up|0
2129667|NCT01027650|3732783|FG000|Overall Study|Lack of Efficacy|0
2129668|NCT01027650|3732784|FG001|Overall Study|Lack of Efficacy|0
2129669|NCT01027650|3732785|FG002|Overall Study|Lack of Efficacy|0
2129670|NCT01027650|3732786|FG003|Overall Study|Lack of Efficacy|0
2129671|NCT01027650|3732787|FG004|Overall Study|Lack of Efficacy|0
2129672|NCT01027650|3732788|FG005|Overall Study|Lack of Efficacy|1
2129673|NCT01027650|3732789|FG006|Overall Study|Lack of Efficacy|0
2129674|NCT01027650|3732790|FG007|Overall Study|Lack of Efficacy|0
2129675|NCT01027702|3732808|FG000|Overall Study|Received subsequent therapy|1
2129676|NCT01027702|3732809|FG001|Overall Study|Received subsequent therapy|2
2129677|NCT01027702|3732810|FG002|Overall Study|Received subsequent therapy|0
2129678|NCT01027702|3732811|FG003|Overall Study|Received subsequent therapy|4
2129679|NCT01027702|3732812|FG004|Overall Study|Received subsequent therapy|1
2129680|NCT01027702|3732813|FG005|Overall Study|Received subsequent therapy|0
2129681|NCT01027702|3732814|FG006|Overall Study|Received subsequent therapy|1
2129682|NCT01027702|3732808|FG000|Overall Study|Death|0
2129683|NCT01027702|3732809|FG001|Overall Study|Death|0
2129684|NCT01027702|3732810|FG002|Overall Study|Death|1
2129685|NCT01027702|3732811|FG003|Overall Study|Death|0
2129686|NCT01027702|3732812|FG004|Overall Study|Death|0
2129687|NCT01027702|3732813|FG005|Overall Study|Death|0
2129688|NCT01027702|3732814|FG006|Overall Study|Death|0
2129689|NCT01027754|3732827|FG000|Overall Study|withdrew/lost to follow-up after interve|2
2129690|NCT01027754|3732828|FG001|Overall Study|withdrew/lost to follow-up after interve|3
2129691|NCT01027754|3732827|FG000|Overall Study|Withdrawal by Subject|0
2129692|NCT01027754|3732828|FG001|Overall Study|Withdrawal by Subject|5
2129693|NCT01027845|3732873|FG000|Primary Vaccination Phase|Serious Adverse Event|2
2129694|NCT01027845|3732874|FG001|Primary Vaccination Phase|Serious Adverse Event|0
2129695|NCT01027845|3732875|FG002|Primary Vaccination Phase|Serious Adverse Event|0
2129696|NCT01027845|3732876|FG003|Primary Vaccination Phase|Serious Adverse Event|0
2129697|NCT01027845|3732873|FG000|Primary Vaccination Phase|Adverse Event|1
2129698|NCT01027845|3732874|FG001|Primary Vaccination Phase|Adverse Event|0
2129699|NCT01027845|3732875|FG002|Primary Vaccination Phase|Adverse Event|0
2129700|NCT01027845|3732876|FG003|Primary Vaccination Phase|Adverse Event|0
2129701|NCT01027845|3732873|FG000|Primary Vaccination Phase|Protocol Violation|1
2129702|NCT01027845|3732874|FG001|Primary Vaccination Phase|Protocol Violation|0
2129703|NCT01027845|3732875|FG002|Primary Vaccination Phase|Protocol Violation|0
2129704|NCT01027845|3732876|FG003|Primary Vaccination Phase|Protocol Violation|0
2129705|NCT01027845|3732873|FG000|Primary Vaccination Phase|Migrated/moved from study area|0
2129706|NCT01027845|3732874|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
2129707|NCT01027845|3732875|FG002|Primary Vaccination Phase|Migrated/moved from study area|0
2129708|NCT01027845|3732876|FG003|Primary Vaccination Phase|Migrated/moved from study area|0
2129709|NCT01027845|3732873|FG000|Booster Vaccination Phase|Withdrawal by Subject|1
2129710|NCT01027845|3732874|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
2129711|NCT01027845|3732875|FG002|Booster Vaccination Phase|Withdrawal by Subject|0
2129712|NCT01027845|3732876|FG003|Booster Vaccination Phase|Withdrawal by Subject|0
2129713|NCT01027845|3732873|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
2129714|NCT01027845|3732874|FG001|Booster Vaccination Phase|Migrated/moved from study area|0
2129715|NCT01027845|3732875|FG002|Booster Vaccination Phase|Migrated/moved from study area|0
2129716|NCT01027845|3732876|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
2129717|NCT01027871|3732888|FG000|Overall Study|Physician Decision|1
2129718|NCT01027871|3732889|FG001|Overall Study|Physician Decision|5
2129719|NCT01027871|3732890|FG002|Overall Study|Physician Decision|0
2129720|NCT01027871|3732888|FG000|Overall Study|Protocol Violation|0
2129721|NCT01027871|3732889|FG001|Overall Study|Protocol Violation|2
2129722|NCT01027871|3732890|FG002|Overall Study|Protocol Violation|2
2129723|NCT01027871|3732888|FG000|Overall Study|Withdrawal by Subject|1
2129724|NCT01027871|3732889|FG001|Overall Study|Withdrawal by Subject|2
2129725|NCT01027871|3732890|FG002|Overall Study|Withdrawal by Subject|2
2129726|NCT01027871|3732888|FG000|Overall Study|Adverse Event|0
2129727|NCT01027871|3732889|FG001|Overall Study|Adverse Event|2
2129728|NCT01027871|3732890|FG002|Overall Study|Adverse Event|2
2129729|NCT01027871|3732888|FG000|Overall Study|Sponsor Decision|0
2129730|NCT01027871|3732889|FG001|Overall Study|Sponsor Decision|2
2129731|NCT01027871|3732890|FG002|Overall Study|Sponsor Decision|0
2129732|NCT01027871|3732888|FG000|Overall Study|Discontinued Prior to Treatment|0
2129733|NCT01027871|3732889|FG001|Overall Study|Discontinued Prior to Treatment|0
2129734|NCT01027871|3732890|FG002|Overall Study|Discontinued Prior to Treatment|1
2129735|NCT01027884|3732905|FG000|Overall Study|Adverse Event|2
2129736|NCT01027884|3732906|FG001|Overall Study|Adverse Event|1
2129737|NCT01027884|3732905|FG000|Overall Study|Protocol Violation|1
2129738|NCT01027884|3732906|FG001|Overall Study|Protocol Violation|0
2129739|NCT01027884|3732905|FG000|Overall Study|Non-compliance|1
2129740|NCT01027884|3732906|FG001|Overall Study|Non-compliance|1
2129741|NCT01027884|3732905|FG000|Overall Study|Withdrawal by Subject|0
2129742|NCT01027884|3732906|FG001|Overall Study|Withdrawal by Subject|1
2129743|NCT01027884|3732905|FG000|Overall Study|Lost to Follow-up|0
2129744|NCT01027884|3732906|FG001|Overall Study|Lost to Follow-up|1
2283648|NCT02403206|3970871|FG000|Overall Study|Withdrawal by Subject|3
2129745|NCT01027884|3732905|FG000|Overall Study|Spinal fixation surgery|0
2129746|NCT01027884|3732906|FG001|Overall Study|Spinal fixation surgery|3
2129747|NCT01027897|3732914|FG000|Overall Study|Protocol Violation|1
2129748|NCT01027897|3732914|FG000|Overall Study|Withdrawal by Subject|1
2129749|NCT01027949|3732929|FG000|Overall Study|Death|174
2129750|NCT01027949|3732929|FG000|Overall Study|Progressive Disease|163
2129751|NCT01027949|3732929|FG000|Overall Study|Adverse Event|172
2129752|NCT01027949|3732929|FG000|Overall Study|Withdrawal by Subject|113
2129753|NCT01027949|3732929|FG000|Overall Study|Lost to Follow-up|17
2129754|NCT01027949|3732929|FG000|Overall Study|Protocol Violation|13
2129755|NCT01027949|3732929|FG000|Overall Study|PI Decision|8
2129756|NCT01027949|3732929|FG000|Overall Study|Limited Study Drug Effectiveness|7
2129757|NCT01027949|3732929|FG000|Overall Study|Non-compliance with Study Procedures|7
2129758|NCT01027949|3732929|FG000|Overall Study|Lung Transplant|5
2129759|NCT01027949|3732929|FG000|Overall Study|Unable to Tolerate Study Drug|2
2129760|NCT01027949|3732929|FG000|Overall Study|Use of Excluded Medication|2
2129761|NCT01027949|3732929|FG000|Overall Study|Patient Self-discontinuation|1
2129762|NCT01027949|3732929|FG000|Overall Study|Pregnancy|1
2129763|NCT01027949|3732929|FG000|Overall Study|Surgery|1
2283649|NCT02403206|3970872|FG001|Overall Study|Withdrawal by Subject|3
2283650|NCT02403206|3970871|FG000|Overall Study|Reason not given|2
2129764|NCT01028014|3732939|FG000|Overall Study|Lost to Follow-up|1
2129765|NCT01028014|3732940|FG001|Overall Study|Lost to Follow-up|2
2129766|NCT01028014|3732941|FG002|Overall Study|Lost to Follow-up|0
2129767|NCT01028014|3732942|FG003|Overall Study|Lost to Follow-up|1
2129768|NCT01028014|3732943|FG004|Overall Study|Lost to Follow-up|1
2129769|NCT01028014|3732944|FG005|Overall Study|Lost to Follow-up|2
2129770|NCT01028027|3732960|FG000|Overall Study|Lost to Follow-up|4
2129771|NCT01028027|3732961|FG001|Overall Study|Lost to Follow-up|1
2129772|NCT01028027|3732960|FG000|Overall Study|Withdrawal by Subject|5
2129773|NCT01028027|3732961|FG001|Overall Study|Withdrawal by Subject|3
2129774|NCT01028027|3732960|FG000|Overall Study|Adverse Event|4
2129775|NCT01028027|3732961|FG001|Overall Study|Adverse Event|7
2129776|NCT01028027|3732960|FG000|Overall Study|Protocol Violation|3
2129777|NCT01028027|3732961|FG001|Overall Study|Protocol Violation|1
2129778|NCT01028027|3732960|FG000|Overall Study|Lack of Efficacy|0
2129779|NCT01028027|3732961|FG001|Overall Study|Lack of Efficacy|1
2129780|NCT01028053|3732967|FG000|Overall Study|Screen Failure|113
2129781|NCT01028053|3732967|FG000|Overall Study|Patient Request|11
2129782|NCT01028053|3732967|FG000|Overall Study|Protocol Violation|1
2129783|NCT01028053|3732967|FG000|Overall Study|Physician Decision|2
2129784|NCT01028053|3732967|FG000|Overall Study|Technical Problem|1
2129785|NCT01028053|3732967|FG000|Overall Study|Terminated by Sponsor|1
2129786|NCT01028053|3732967|FG000|Overall Study|Various reasons|4
2129787|NCT01028222|3732992|FG000|Overall Study|Protocol deviation|1
2129788|NCT01028222|3732993|FG001|Overall Study|Protocol deviation|0
2129789|NCT01028222|3732992|FG000|Overall Study|Disease progression|33
2129790|NCT01028222|3732993|FG001|Overall Study|Disease progression|9
2129791|NCT01028222|3732992|FG000|Overall Study|Administrative problems|1
2129792|NCT01028222|3732993|FG001|Overall Study|Administrative problems|1
2129793|NCT01028222|3732992|FG000|Overall Study|Lost to Follow-up|0
2129794|NCT01028222|3732993|FG001|Overall Study|Lost to Follow-up|1
2129795|NCT01028222|3732992|FG000|Overall Study|Withdrawal by Subject|1
2129796|NCT01028222|3732993|FG001|Overall Study|Withdrawal by Subject|0
2129797|NCT01028222|3732992|FG000|Overall Study|Crossover to nilotinib w/out progression|0
2129798|NCT01028222|3732993|FG001|Overall Study|Crossover to nilotinib w/out progression|2
2129799|NCT01028222|3732992|FG000|Overall Study|Adverse Event|2
2129800|NCT01028222|3732993|FG001|Overall Study|Adverse Event|0
2129801|NCT01028352|3733000|FG000|Overall Study|Ineligible due to baseline average pain|5
2129802|NCT01028352|3733000|FG000|Overall Study|Withdrawal by Subject|1
2129803|NCT01028378|3733004|FG000|Overall Study|Lost to Follow-up|12
2129804|NCT01028378|3733004|FG000|Overall Study|Withdrawal by Subject|1
2129805|NCT01028378|3733004|FG000|Overall Study|Adminstrative Reasons|4
2129806|NCT01028391|3733010|FG000|Overall Study|Adverse Event|4
2129807|NCT01028391|3733011|FG001|Overall Study|Adverse Event|0
2129808|NCT01028391|3733010|FG000|Overall Study|Lack of Efficacy|0
2129809|NCT01028391|3733011|FG001|Overall Study|Lack of Efficacy|2
2129810|NCT01028391|3733010|FG000|Overall Study|Lost to Follow-up|3
2129811|NCT01028391|3733011|FG001|Overall Study|Lost to Follow-up|4
2129812|NCT01028391|3733010|FG000|Overall Study|Physician Decision|0
2129813|NCT01028391|3733011|FG001|Overall Study|Physician Decision|1
2129814|NCT01028391|3733010|FG000|Overall Study|Withdrawal by Subject|6
2129815|NCT01028391|3733011|FG001|Overall Study|Withdrawal by Subject|3
2129816|NCT01028391|3733010|FG000|Overall Study|Needed excluded medication|1
2129817|NCT01028391|3733011|FG001|Overall Study|Needed excluded medication|1
2129818|NCT01028560|3733019|FG000|Overall Study|Lack of Efficacy|3
2129819|NCT01028560|3733020|FG001|Overall Study|Lack of Efficacy|6
2129820|NCT01028560|3733019|FG000|Overall Study|Withdrawal by Subject|7
2129821|NCT01028560|3733020|FG001|Overall Study|Withdrawal by Subject|12
2129822|NCT01028651|3733027|FG000|Overall Study|Death|2
2129823|NCT01028651|3733027|FG000|Overall Study|Adverse Event|1
2129824|NCT01029262|3733068|FG000|Overall Study|Adverse Event|9
2129825|NCT01029262|3733069|FG001|Overall Study|Adverse Event|52
2129826|NCT01029262|3733068|FG000|Overall Study|Lack of therapeutic effect|57
2129827|NCT01029262|3733069|FG001|Overall Study|Lack of therapeutic effect|76
2129828|NCT01029262|3733068|FG000|Overall Study|Withdrawal by Subject|10
2129829|NCT01029262|3733069|FG001|Overall Study|Withdrawal by Subject|17
2129830|NCT01029262|3733068|FG000|Overall Study|Protocol Violation|2
2129831|NCT01029262|3733069|FG001|Overall Study|Protocol Violation|3
2129832|NCT01029262|3733068|FG000|Overall Study|Miscellaneous|1
2129833|NCT01029262|3733069|FG001|Overall Study|Miscellaneous|9
2129834|NCT01029262|3733068|FG000|Overall Study|Death|0
2129835|NCT01029262|3733069|FG001|Overall Study|Death|3
2129836|NCT01029340|3733085|FG000|Part B Treatment Period|Withdrawal by Subject|0
2129837|NCT01029340|3733086|FG001|Part B Treatment Period|Withdrawal by Subject|0
2129838|NCT01029340|3733087|FG002|Part B Treatment Period|Withdrawal by Subject|1
2129839|NCT01029340|3733088|FG003|Part B Treatment Period|Withdrawal by Subject|0
2129840|NCT01029340|3733089|FG004|Part B Treatment Period|Withdrawal by Subject|0
2129841|NCT01029340|3733090|FG005|Part B Treatment Period|Withdrawal by Subject|0
2129842|NCT01029340|3733085|FG000|Part B Treatment Period|Protocol Violation|0
2129843|NCT01029340|3733086|FG001|Part B Treatment Period|Protocol Violation|0
2129844|NCT01029340|3733087|FG002|Part B Treatment Period|Protocol Violation|1
2129845|NCT01029340|3733088|FG003|Part B Treatment Period|Protocol Violation|0
2129846|NCT01029340|3733089|FG004|Part B Treatment Period|Protocol Violation|0
2129847|NCT01029340|3733090|FG005|Part B Treatment Period|Protocol Violation|0
2129848|NCT01029340|3733085|FG000|Extension Period|Adverse Event|0
2129849|NCT01029340|3733086|FG001|Extension Period|Adverse Event|0
2129850|NCT01029340|3733087|FG002|Extension Period|Adverse Event|0
2129851|NCT01029340|3733088|FG003|Extension Period|Adverse Event|0
2129852|NCT01029340|3733089|FG004|Extension Period|Adverse Event|0
2129853|NCT01029340|3733090|FG005|Extension Period|Adverse Event|1
2129854|NCT01029340|3733085|FG000|Extension Period|starting another study|0
2129855|NCT01029340|3733086|FG001|Extension Period|starting another study|0
2129856|NCT01029340|3733087|FG002|Extension Period|starting another study|0
2129857|NCT01029340|3733088|FG003|Extension Period|starting another study|0
2129858|NCT01029340|3733089|FG004|Extension Period|starting another study|0
2129859|NCT01029340|3733090|FG005|Extension Period|starting another study|8
2129860|NCT01029340|3733085|FG000|Extension Period|non-compliance|0
2129861|NCT01029340|3733086|FG001|Extension Period|non-compliance|0
2129862|NCT01029340|3733087|FG002|Extension Period|non-compliance|0
2129863|NCT01029340|3733088|FG003|Extension Period|non-compliance|0
2129864|NCT01029340|3733089|FG004|Extension Period|non-compliance|0
2129865|NCT01029340|3733090|FG005|Extension Period|non-compliance|1
2129866|NCT01029340|3733085|FG000|Extension Period|Withdrawal by Subject|0
2129867|NCT01029340|3733086|FG001|Extension Period|Withdrawal by Subject|0
2129868|NCT01029340|3733087|FG002|Extension Period|Withdrawal by Subject|0
2129869|NCT01029340|3733088|FG003|Extension Period|Withdrawal by Subject|0
2129870|NCT01029340|3733089|FG004|Extension Period|Withdrawal by Subject|0
2129871|NCT01029340|3733090|FG005|Extension Period|Withdrawal by Subject|1
2129872|NCT01029340|3733085|FG000|Extension Period|Physician Decision|0
2129873|NCT01029340|3733086|FG001|Extension Period|Physician Decision|0
2129874|NCT01029340|3733087|FG002|Extension Period|Physician Decision|0
2129875|NCT01029340|3733088|FG003|Extension Period|Physician Decision|0
2129876|NCT01029340|3733089|FG004|Extension Period|Physician Decision|0
2129877|NCT01029340|3733090|FG005|Extension Period|Physician Decision|1
2129878|NCT01029353|3733107|FG000|Overall Study|Lost to Follow-up|4
2129879|NCT01029353|3733108|FG001|Overall Study|Lost to Follow-up|5
2129880|NCT01029353|3733109|FG002|Overall Study|Lost to Follow-up|5
2129881|NCT01029353|3733110|FG003|Overall Study|Lost to Follow-up|4
2129882|NCT01029353|3733107|FG000|Overall Study|Consent Withdrawn|2
2129883|NCT01029353|3733108|FG001|Overall Study|Consent Withdrawn|0
2129884|NCT01029353|3733109|FG002|Overall Study|Consent Withdrawn|0
2129885|NCT01029353|3733110|FG003|Overall Study|Consent Withdrawn|0
2129886|NCT01029353|3733107|FG000|Overall Study|Primary Outcome Indeterminate|1
2129887|NCT01029353|3733108|FG001|Overall Study|Primary Outcome Indeterminate|3
2129888|NCT01029353|3733109|FG002|Overall Study|Primary Outcome Indeterminate|2
2129889|NCT01029353|3733110|FG003|Overall Study|Primary Outcome Indeterminate|0
2129890|NCT01029366|3733122|FG000|Overall Study|Withdrawal by Subject|1
2129891|NCT01029366|3733123|FG001|Overall Study|Withdrawal by Subject|0
2129892|NCT01029366|3733122|FG000|Overall Study|Death|1
2129893|NCT01029366|3733123|FG001|Overall Study|Death|1
2129894|NCT01029366|3733122|FG000|Overall Study|disease progression|2
2129895|NCT01029366|3733123|FG001|Overall Study|disease progression|0
2129896|NCT01029366|3733122|FG000|Overall Study|manufacturing failure|0
2129897|NCT01029366|3733123|FG001|Overall Study|manufacturing failure|1
2129898|NCT01029392|3733132|FG000|Overall Study|Withdrawal by Subject|18
2129899|NCT01029392|3733133|FG001|Overall Study|Withdrawal by Subject|11
2129900|NCT01029392|3733132|FG000|Overall Study|Physician Decision|2
2129901|NCT01029392|3733133|FG001|Overall Study|Physician Decision|0
2129902|NCT01029405|3733145|FG000|Overall Study|Withdrawal by Subject|0
2129903|NCT01029405|3733146|FG001|Overall Study|Withdrawal by Subject|1
2129904|NCT01029405|3733147|FG002|Overall Study|Withdrawal by Subject|2
2206531|NCT01621490|3845087|FG008|Overall Study|Grade 4 Lipase elevation|0
2206532|NCT01621490|3845079|FG000|Overall Study|BMS informed of patient status|0
2206533|NCT01621490|3845080|FG001|Overall Study|BMS informed of patient status|0
2206534|NCT01621490|3845081|FG002|Overall Study|BMS informed of patient status|1
2206535|NCT01621490|3845082|FG003|Overall Study|BMS informed of patient status|0
2206536|NCT01621490|3845083|FG004|Overall Study|BMS informed of patient status|0
2206537|NCT01621490|3845084|FG005|Overall Study|BMS informed of patient status|0
2129905|NCT01029405|3733148|FG003|Overall Study|Withdrawal by Subject|0
2129906|NCT01029405|3733145|FG000|Overall Study|Protocol Violation|0
2129907|NCT01029405|3733146|FG001|Overall Study|Protocol Violation|0
2129908|NCT01029405|3733147|FG002|Overall Study|Protocol Violation|0
2129909|NCT01029405|3733148|FG003|Overall Study|Protocol Violation|1
2129910|NCT01029405|3733145|FG000|Overall Study|Adverse Event|0
2129911|NCT01029405|3733146|FG001|Overall Study|Adverse Event|0
2129912|NCT01029405|3733147|FG002|Overall Study|Adverse Event|1
2129913|NCT01029405|3733148|FG003|Overall Study|Adverse Event|1
2129914|NCT01029405|3733145|FG000|Overall Study|Lost to Follow-up|2
2129915|NCT01029405|3733146|FG001|Overall Study|Lost to Follow-up|1
2129916|NCT01029405|3733147|FG002|Overall Study|Lost to Follow-up|1
2129917|NCT01029405|3733148|FG003|Overall Study|Lost to Follow-up|2
2129918|NCT01029405|3733145|FG000|Overall Study|Other|0
2129919|NCT01029405|3733146|FG001|Overall Study|Other|1
2129920|NCT01029405|3733147|FG002|Overall Study|Other|0
2129921|NCT01029405|3733148|FG003|Overall Study|Other|1
2129922|NCT01029535|3733158|FG000|Overall Study|Lost to Follow-up|24
2129923|NCT01029535|3733158|FG000|Overall Study|Protocol Violation|2
2129924|NCT01029535|3733158|FG000|Overall Study|Participant Withdrew Consent|2
2129925|NCT01029535|3733158|FG000|Overall Study|Adverse Event|1
2129926|NCT01029535|3733158|FG000|Overall Study|Use of Another Treatment|1
2129927|NCT01029535|3733158|FG000|Overall Study|Death|1
2129928|NCT01029652|3733169|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
2129929|NCT01029652|3733170|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
2283651|NCT02403206|3970872|FG001|Overall Study|Reason not given|4
2283652|NCT02403271|3970879|FG000|Period 1|Other varied reasons|1
2283653|NCT02403271|3970880|FG001|Period 1|Other varied reasons|0
2283654|NCT02403271|3970879|FG000|Period 2|Withdrawal by Subject|0
2129930|NCT01029652|3733169|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
2129931|NCT01029652|3733170|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
2129932|NCT01029652|3733169|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3
2129933|NCT01029652|3733170|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1
2129934|NCT01029652|3733169|FG000|Core Study (0-12 Weeks)|Administrative problems|2
2129935|NCT01029652|3733170|FG001|Core Study (0-12 Weeks)|Administrative problems|1
2129936|NCT01029652|3733169|FG000|Core Study (0-12 Weeks)|Death|0
2129937|NCT01029652|3733170|FG001|Core Study (0-12 Weeks)|Death|1
2129938|NCT01029652|3733169|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
2129939|NCT01029652|3733170|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
2129940|NCT01029652|3733169|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
2129941|NCT01029652|3733170|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
2129942|NCT01029652|3733169|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
2129943|NCT01029652|3733170|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
2129944|NCT01029652|3733169|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
2129945|NCT01029652|3733170|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
2129946|NCT01029652|3733169|FG000|Extension Study 2 (25-72 Weeks)|Death|1
2129947|NCT01029652|3733170|FG001|Extension Study 2 (25-72 Weeks)|Death|1
2129948|NCT01029652|3733169|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
2129949|NCT01029652|3733170|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
2129950|NCT01029652|3733169|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
2129951|NCT01029652|3733170|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
2129952|NCT01029691|3733197|FG000|Continued APAP to Delivery|Death|0
2129953|NCT01029691|3733198|FG001|Continued APAP to Delivery|Death|0
2129954|NCT01029691|3733199|FG002|Continued APAP to Delivery|Death|1
2129955|NCT01029704|3733217|FG000|Overall Study|Adverse Event|0
2129956|NCT01029704|3733218|FG001|Overall Study|Adverse Event|0
2129957|NCT01029704|3733219|FG002|Overall Study|Adverse Event|0
2129958|NCT01029704|3733220|FG003|Overall Study|Adverse Event|0
2129959|NCT01029704|3733221|FG004|Overall Study|Adverse Event|0
2129960|NCT01029704|3733222|FG005|Overall Study|Adverse Event|0
2129961|NCT01029704|3733223|FG006|Overall Study|Adverse Event|1
2129962|NCT01029704|3733224|FG007|Overall Study|Adverse Event|1
2283655|NCT02403271|3970880|FG001|Period 2|Withdrawal by Subject|14
2283656|NCT02403271|3970879|FG000|Period 2|Death|0
2283657|NCT02403271|3970880|FG001|Period 2|Death|84
2283658|NCT02403271|3970879|FG000|Period 2|Lost to Follow-up|0
2283659|NCT02403271|3970880|FG001|Period 2|Lost to Follow-up|2
2283660|NCT02403271|3970879|FG000|Period 2|Study Terminated by Sponsor|0
2283661|NCT02403271|3970880|FG001|Period 2|Study Terminated by Sponsor|14
2283662|NCT02403271|3970879|FG000|Period 2|Other varied reasons|0
2283663|NCT02403271|3970880|FG001|Period 2|Other varied reasons|10
2283664|NCT02403635|3970901|FG000|Overall Study|Not eligible|9
2283665|NCT02403674|3970923|FG000|Overall Study|Adverse Event|10
2283666|NCT02403674|3970924|FG001|Overall Study|Adverse Event|23
2283667|NCT02403674|3970923|FG000|Overall Study|Death|1
2283668|NCT02403674|3970924|FG001|Overall Study|Death|3
2283669|NCT02403674|3970923|FG000|Overall Study|Lack of Efficacy|18
2283670|NCT02403674|3970924|FG001|Overall Study|Lack of Efficacy|10
2283671|NCT02403674|3970923|FG000|Overall Study|Lost to Follow-up|6
2283672|NCT02403674|3970924|FG001|Overall Study|Lost to Follow-up|7
2283673|NCT02403674|3970923|FG000|Overall Study|Noncompliance with study drug|1
2283674|NCT02403674|3970924|FG001|Overall Study|Noncompliance with study drug|2
2283675|NCT02403674|3970923|FG000|Overall Study|Withdrawal by Subject|8
2283676|NCT02403674|3970924|FG001|Overall Study|Withdrawal by Subject|11
2283677|NCT02403674|3970923|FG000|Overall Study|Physician Decision|2
2283678|NCT02403674|3970924|FG001|Overall Study|Physician Decision|2
2283679|NCT02403674|3970923|FG000|Overall Study|Not treated with study drug|4
2283680|NCT02403674|3970924|FG001|Overall Study|Not treated with study drug|2
2283681|NCT02403674|3970923|FG000|Overall Study|Pregnancy|1
2283682|NCT02403674|3970924|FG001|Overall Study|Pregnancy|1
2283683|NCT02403674|3970923|FG000|Overall Study|Protocol Violation|4
2283684|NCT02403674|3970924|FG001|Overall Study|Protocol Violation|2
2283685|NCT02403817|3970941|FG000|Overall Study|Withdrawal by Subject|5
2283686|NCT02403817|3970942|FG001|Overall Study|Withdrawal by Subject|0
2283687|NCT02404025|3970981|FG000|Overall Study|Adverse Event|1
2283688|NCT02404025|3970981|FG000|Overall Study|Lack of Efficacy|3
2129963|NCT01029704|3733225|FG008|Overall Study|Adverse Event|0
2129964|NCT01029704|3733217|FG000|Overall Study|Withdrawal by Subject|0
2129965|NCT01029704|3733218|FG001|Overall Study|Withdrawal by Subject|0
2129966|NCT01029704|3733219|FG002|Overall Study|Withdrawal by Subject|0
2129967|NCT01029704|3733220|FG003|Overall Study|Withdrawal by Subject|0
2129968|NCT01029704|3733221|FG004|Overall Study|Withdrawal by Subject|2
2129969|NCT01029704|3733222|FG005|Overall Study|Withdrawal by Subject|1
2129970|NCT01029704|3733223|FG006|Overall Study|Withdrawal by Subject|1
2129971|NCT01029704|3733224|FG007|Overall Study|Withdrawal by Subject|1
2129972|NCT01029704|3733225|FG008|Overall Study|Withdrawal by Subject|0
2129973|NCT01029704|3733217|FG000|Overall Study|Lost to Follow-up|0
2129974|NCT01029704|3733218|FG001|Overall Study|Lost to Follow-up|0
2129975|NCT01029704|3733219|FG002|Overall Study|Lost to Follow-up|0
2129976|NCT01029704|3733220|FG003|Overall Study|Lost to Follow-up|0
2129977|NCT01029704|3733221|FG004|Overall Study|Lost to Follow-up|0
2129978|NCT01029704|3733222|FG005|Overall Study|Lost to Follow-up|0
2129979|NCT01029704|3733223|FG006|Overall Study|Lost to Follow-up|1
2129980|NCT01029704|3733224|FG007|Overall Study|Lost to Follow-up|1
2129981|NCT01029704|3733225|FG008|Overall Study|Lost to Follow-up|1
2129982|NCT01029704|3733217|FG000|Overall Study|Lack of Efficacy|0
2129983|NCT01029704|3733218|FG001|Overall Study|Lack of Efficacy|0
2129984|NCT01029704|3733219|FG002|Overall Study|Lack of Efficacy|0
2041558|NCT00439777|3612296|FG000|Observational Period|Death|27
2041559|NCT00439777|3612297|FG001|Observational Period|Death|20
2041560|NCT00439777|3612296|FG000|Observational Period|Study terminated by sponsor|3
2041561|NCT00439777|3612297|FG001|Observational Period|Study terminated by sponsor|1
2041562|NCT00439777|3612296|FG000|Observational Period|Protocol driven decision point|0
2041563|NCT00439777|3612297|FG001|Observational Period|Protocol driven decision point|1
2041564|NCT00439777|3612296|FG000|Observational Period|Lack of Efficacy|1
2041565|NCT00439777|3612297|FG001|Observational Period|Lack of Efficacy|0
2041566|NCT00439777|3612296|FG000|Observational Period|Technical problems|0
2041567|NCT00439777|3612297|FG001|Observational Period|Technical problems|1
2041568|NCT00440011|3612309|FG000|Overall Study|Adverse Event|2
2041569|NCT00440011|3612310|FG001|Overall Study|Adverse Event|0
2041570|NCT00440011|3612309|FG000|Overall Study|Lost to Follow-up|0
2041571|NCT00440011|3612310|FG001|Overall Study|Lost to Follow-up|2
2129985|NCT01029704|3733220|FG003|Overall Study|Lack of Efficacy|0
2129986|NCT01029704|3733221|FG004|Overall Study|Lack of Efficacy|2
2129987|NCT01029704|3733222|FG005|Overall Study|Lack of Efficacy|3
2129988|NCT01029704|3733223|FG006|Overall Study|Lack of Efficacy|1
2129989|NCT01029704|3733224|FG007|Overall Study|Lack of Efficacy|2
2129990|NCT01029704|3733225|FG008|Overall Study|Lack of Efficacy|0
2206538|NCT01621490|3845085|FG006|Overall Study|BMS informed of patient status|0
2206539|NCT01621490|3845086|FG007|Overall Study|BMS informed of patient status|0
2206540|NCT01621490|3845087|FG008|Overall Study|BMS informed of patient status|0
2206541|NCT01621490|3845079|FG000|Overall Study|Investigator decision|0
2206542|NCT01621490|3845080|FG001|Overall Study|Investigator decision|0
2206543|NCT01621490|3845081|FG002|Overall Study|Investigator decision|1
2206544|NCT01621490|3845082|FG003|Overall Study|Investigator decision|0
2206545|NCT01621490|3845083|FG004|Overall Study|Investigator decision|1
2206546|NCT01621490|3845084|FG005|Overall Study|Investigator decision|0
2206547|NCT01621490|3845085|FG006|Overall Study|Investigator decision|1
2206548|NCT01621490|3845086|FG007|Overall Study|Investigator decision|0
2206549|NCT01621490|3845087|FG008|Overall Study|Investigator decision|0
2206550|NCT01621490|3845079|FG000|Overall Study|Documented disease progression|0
2206551|NCT01621490|3845080|FG001|Overall Study|Documented disease progression|0
2206552|NCT01621490|3845081|FG002|Overall Study|Documented disease progression|1
2206553|NCT01621490|3845082|FG003|Overall Study|Documented disease progression|0
2206554|NCT01621490|3845083|FG004|Overall Study|Documented disease progression|0
2206555|NCT01621490|3845084|FG005|Overall Study|Documented disease progression|0
2206556|NCT01621490|3845085|FG006|Overall Study|Documented disease progression|0
2206557|NCT01621490|3845086|FG007|Overall Study|Documented disease progression|0
2206558|NCT01621490|3845087|FG008|Overall Study|Documented disease progression|0
2206559|NCT01621490|3845079|FG000|Overall Study|Patient reached treatment 2 yr limit|0
2206560|NCT01621490|3845080|FG001|Overall Study|Patient reached treatment 2 yr limit|1
2206561|NCT01621490|3845081|FG002|Overall Study|Patient reached treatment 2 yr limit|0
2206562|NCT01621490|3845082|FG003|Overall Study|Patient reached treatment 2 yr limit|0
2206563|NCT01621490|3845083|FG004|Overall Study|Patient reached treatment 2 yr limit|0
2206564|NCT01621490|3845084|FG005|Overall Study|Patient reached treatment 2 yr limit|0
2206565|NCT01621490|3845085|FG006|Overall Study|Patient reached treatment 2 yr limit|0
2206566|NCT01621490|3845086|FG007|Overall Study|Patient reached treatment 2 yr limit|0
2206567|NCT01621490|3845087|FG008|Overall Study|Patient reached treatment 2 yr limit|0
2283689|NCT02404103|3970987|FG000|Overall Study|Adverse Event|1
2041572|NCT00440011|3612309|FG000|Overall Study|Protocol Violation|1
2129991|NCT01029704|3733217|FG000|Overall Study|Withdrawn due to major protocol violation|0
2129992|NCT01029704|3733218|FG001|Overall Study|Withdrawn due to major protocol violation|0
2129993|NCT01029704|3733219|FG002|Overall Study|Withdrawn due to major protocol violation|0
2129994|NCT01029704|3733220|FG003|Overall Study|Withdrawn due to major protocol violation|0
2129995|NCT01029704|3733221|FG004|Overall Study|Withdrawn due to major protocol violation|1
2129996|NCT01029704|3733222|FG005|Overall Study|Withdrawn due to major protocol violation|0
2129997|NCT01029704|3733223|FG006|Overall Study|Withdrawn due to major protocol violation|0
2206568|NCT01621490|3845079|FG000|Overall Study|Clinical deterioration|0
2206569|NCT01621490|3845080|FG001|Overall Study|Clinical deterioration|1
2206570|NCT01621490|3845081|FG002|Overall Study|Clinical deterioration|0
2206571|NCT01621490|3845082|FG003|Overall Study|Clinical deterioration|0
2206572|NCT01621490|3845083|FG004|Overall Study|Clinical deterioration|0
2206573|NCT01621490|3845084|FG005|Overall Study|Clinical deterioration|0
2206574|NCT01621490|3845085|FG006|Overall Study|Clinical deterioration|0
2206575|NCT01621490|3845086|FG007|Overall Study|Clinical deterioration|0
2206576|NCT01621490|3845087|FG008|Overall Study|Clinical deterioration|0
2206577|NCT01621490|3845079|FG000|Overall Study|Complete response|0
2206578|NCT01621490|3845080|FG001|Overall Study|Complete response|0
2206579|NCT01621490|3845081|FG002|Overall Study|Complete response|0
2206580|NCT01621490|3845082|FG003|Overall Study|Complete response|0
2206581|NCT01621490|3845083|FG004|Overall Study|Complete response|0
2206582|NCT01621490|3845084|FG005|Overall Study|Complete response|0
2129998|NCT01029704|3733224|FG007|Overall Study|Withdrawn due to major protocol violation|1
2129999|NCT01029704|3733225|FG008|Overall Study|Withdrawn due to major protocol violation|0
2130000|NCT01029782|3733251|FG000|Overall Study|Lost to Follow-up|2
2130001|NCT01029782|3733252|FG001|Overall Study|Lost to Follow-up|2
2130002|NCT01029782|3733251|FG000|Overall Study|Diagnosis changed|1
2130003|NCT01029782|3733252|FG001|Overall Study|Diagnosis changed|1
2130004|NCT01029782|3733251|FG000|Overall Study|Adverse Event|0
2130005|NCT01029782|3733252|FG001|Overall Study|Adverse Event|1
2130006|NCT01029782|3733251|FG000|Overall Study|Physician Decision|0
2130007|NCT01029782|3733252|FG001|Overall Study|Physician Decision|1
2130008|NCT01029782|3733251|FG000|Overall Study|Protocol Violation|0
2130009|NCT01029782|3733252|FG001|Overall Study|Protocol Violation|2
2130010|NCT01029782|3733251|FG000|Overall Study|Withdrawal by Subject|0
2130011|NCT01029782|3733252|FG001|Overall Study|Withdrawal by Subject|1
2130012|NCT01029795|3733260|FG000|Overall Study|Entry Criteria Not Met|2
2130013|NCT01029795|3733261|FG001|Overall Study|Entry Criteria Not Met|1
2130014|NCT01029795|3733260|FG000|Overall Study|Physician Decision|2
2130015|NCT01029795|3733261|FG001|Overall Study|Physician Decision|1
2130016|NCT01029795|3733260|FG000|Overall Study|Sponsor Decision|11
2130017|NCT01029795|3733261|FG001|Overall Study|Sponsor Decision|17
2130018|NCT01029795|3733260|FG000|Overall Study|Withdrawal by Subject|1
2130019|NCT01029795|3733261|FG001|Overall Study|Withdrawal by Subject|3
2130020|NCT01029886|3733269|FG000|Overall Study|Adverse Event|12
2130021|NCT01029886|3733270|FG001|Overall Study|Adverse Event|25
2130022|NCT01029886|3733269|FG000|Overall Study|Lost to Follow-up|1
2130023|NCT01029886|3733270|FG001|Overall Study|Lost to Follow-up|0
2130024|NCT01029886|3733269|FG000|Overall Study|Physician Decision|2
2130025|NCT01029886|3733270|FG001|Overall Study|Physician Decision|6
2130026|NCT01029886|3733269|FG000|Overall Study|Protocol Violation|17
2130027|NCT01029886|3733270|FG001|Overall Study|Protocol Violation|5
2130028|NCT01029886|3733269|FG000|Overall Study|Withdrawal by Subject|8
2130029|NCT01029886|3733270|FG001|Overall Study|Withdrawal by Subject|18
2130030|NCT01029886|3733269|FG000|Overall Study|Entry Criteria Not Met|13
2130031|NCT01029886|3733270|FG001|Overall Study|Entry Criteria Not Met|5
2130032|NCT01029886|3733269|FG000|Overall Study|Sponsor Decision|1
2130033|NCT01029886|3733270|FG001|Overall Study|Sponsor Decision|0
2130034|NCT01029886|3733269|FG000|Overall Study|Loss Glucose Control|7
2130035|NCT01029886|3733270|FG001|Overall Study|Loss Glucose Control|1
2130036|NCT01029925|3733289|FG000|Completion of Cycle 1 (28 Days)|Death|2
2130037|NCT01029925|3733289|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
2130038|NCT01029925|3733289|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
2130039|NCT01030133|3733295|FG000|Overall Study|failed to experience pain at level 7/10|2
2130040|NCT01030133|3733296|FG001|Overall Study|failed to experience pain at level 7/10|2
2130041|NCT01030458|3733337|FG000|Overall Study|Lost to Follow-up|9
2130042|NCT01030458|3733338|FG001|Overall Study|Lost to Follow-up|10
2130043|NCT01030458|3733337|FG000|Overall Study|Withdrawal by Subject|2
2130044|NCT01030458|3733338|FG001|Overall Study|Withdrawal by Subject|3
2130045|NCT01030458|3733337|FG000|Overall Study|Logistical reasons|9
2130046|NCT01030458|3733338|FG001|Overall Study|Logistical reasons|5
2130047|NCT01030458|3733337|FG000|Overall Study|Moved or changed job|6
2130048|NCT01030458|3733338|FG001|Overall Study|Moved or changed job|13
2130049|NCT01030458|3733337|FG000|Overall Study|Side effect of medication|1
2130050|NCT01030458|3733338|FG001|Overall Study|Side effect of medication|1
2130051|NCT01030523|3733346|FG000|Overall Study|Death|1
2130052|NCT01030523|3733347|FG001|Overall Study|Death|0
2130053|NCT01030523|3733346|FG000|Overall Study|Lost to Follow-up|4
2130054|NCT01030523|3733347|FG001|Overall Study|Lost to Follow-up|4
2130055|NCT01030523|3733346|FG000|Overall Study|Implant failure|1
2130056|NCT01030523|3733347|FG001|Overall Study|Implant failure|0
2130057|NCT01030523|3733346|FG000|Overall Study|Withdrawal by Subject|0
2130058|NCT01030523|3733347|FG001|Overall Study|Withdrawal by Subject|1
2130059|NCT01030536|3733358|FG000|Overall Study|Withdrawal by Subject|0
2206583|NCT01621490|3845085|FG006|Overall Study|Complete response|0
2130060|NCT01030536|3733359|FG001|Overall Study|Withdrawal by Subject|0
2130061|NCT01030536|3733360|FG002|Overall Study|Withdrawal by Subject|1
2130062|NCT01030536|3733361|FG003|Overall Study|Withdrawal by Subject|0
2130063|NCT01030536|3733362|FG004|Overall Study|Withdrawal by Subject|0
2130064|NCT01030536|3733358|FG000|Overall Study|undefined|1
2130065|NCT01030536|3733359|FG001|Overall Study|undefined|0
2130066|NCT01030536|3733360|FG002|Overall Study|undefined|1
2130067|NCT01030536|3733361|FG003|Overall Study|undefined|1
2130068|NCT01030536|3733362|FG004|Overall Study|undefined|0
2130069|NCT01030536|3733358|FG000|Overall Study|Adverse Event|0
2130070|NCT01030536|3733359|FG001|Overall Study|Adverse Event|3
2130071|NCT01030536|3733360|FG002|Overall Study|Adverse Event|1
2130072|NCT01030536|3733361|FG003|Overall Study|Adverse Event|0
2130073|NCT01030536|3733362|FG004|Overall Study|Adverse Event|1
2130074|NCT01030536|3733358|FG000|Overall Study|Progressive disease|6
2130075|NCT01030536|3733359|FG001|Overall Study|Progressive disease|2
2130076|NCT01030536|3733360|FG002|Overall Study|Progressive disease|3
2130077|NCT01030536|3733361|FG003|Overall Study|Progressive disease|2
2130078|NCT01030536|3733362|FG004|Overall Study|Progressive disease|0
2130079|NCT01030536|3733358|FG000|Overall Study|Death|0
2130080|NCT01030536|3733359|FG001|Overall Study|Death|1
2130081|NCT01030536|3733360|FG002|Overall Study|Death|0
2130082|NCT01030536|3733361|FG003|Overall Study|Death|0
2130083|NCT01030536|3733362|FG004|Overall Study|Death|0
2130084|NCT01030666|3733404|FG000|Overall Study|Lost to Follow-up|3
2130085|NCT01030666|3733405|FG001|Overall Study|Lost to Follow-up|2
2130086|NCT01030718|3733415|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1
2130087|NCT01030718|3733416|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1
2130088|NCT01030718|3733417|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11
2130089|NCT01030718|3733415|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3
2130090|NCT01030718|3733416|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5
2130091|NCT01030718|3733417|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1
2130092|NCT01030718|3733415|FG000|Studies CA180-031 and -036 Combined|Death|0
2130093|NCT01030718|3733416|FG001|Studies CA180-031 and -036 Combined|Death|1
2130094|NCT01030718|3733417|FG002|Studies CA180-031 and -036 Combined|Death|0
2130095|NCT01030718|3733415|FG000|Studies CA180-031 and -036 Combined|other reasons|0
2130096|NCT01030718|3733416|FG001|Studies CA180-031 and -036 Combined|other reasons|2
2130097|NCT01030718|3733417|FG002|Studies CA180-031 and -036 Combined|other reasons|0
2130098|NCT01030718|3733415|FG000|Study CA180-036 Only|insufficient effect|1
2130099|NCT01030718|3733416|FG001|Study CA180-036 Only|insufficient effect|1
2130100|NCT01030718|3733417|FG002|Study CA180-036 Only|insufficient effect|5
2130101|NCT01030718|3733415|FG000|Study CA180-036 Only|Adverse Event|2
2130102|NCT01030718|3733416|FG001|Study CA180-036 Only|Adverse Event|3
2130103|NCT01030718|3733417|FG002|Study CA180-036 Only|Adverse Event|0
2130104|NCT01030718|3733415|FG000|Study CA180-036 Only|Death|0
2130105|NCT01030718|3733416|FG001|Study CA180-036 Only|Death|1
2130106|NCT01030718|3733417|FG002|Study CA180-036 Only|Death|0
2130107|NCT01030718|3733415|FG000|Study CA180-036 Only|Other Reasons|0
2130108|NCT01030718|3733416|FG001|Study CA180-036 Only|Other Reasons|2
2130109|NCT01030718|3733417|FG002|Study CA180-036 Only|Other Reasons|0
2130110|NCT01030822|3733447|FG000|Overall Study|Moved/migrated from study area|6
2130111|NCT01030822|3733448|FG001|Overall Study|Moved/migrated from study area|7
2130112|NCT01030822|3733449|FG002|Overall Study|Moved/migrated from study area|3
2130113|NCT01030822|3733447|FG000|Overall Study|Withdrawal by Subject|16
2130114|NCT01030822|3733448|FG001|Overall Study|Withdrawal by Subject|13
2130115|NCT01030822|3733449|FG002|Overall Study|Withdrawal by Subject|16
2130116|NCT01030822|3733447|FG000|Overall Study|Lost to Follow-up|9
2130117|NCT01030822|3733448|FG001|Overall Study|Lost to Follow-up|4
2130118|NCT01030822|3733449|FG002|Overall Study|Lost to Follow-up|7
2130119|NCT01030874|3733469|FG000|Overall Study|Withdrawal by Subject|1
2130120|NCT01030874|3733470|FG001|Overall Study|Withdrawal by Subject|0
2130121|NCT01030874|3733469|FG000|Overall Study|Discharged in first 2 weeks|17
2130122|NCT01030874|3733470|FG001|Overall Study|Discharged in first 2 weeks|16
2130123|NCT01030952|3733478|FG000|Overall Study|Protocol Violation|0
2130124|NCT01030952|3733479|FG001|Overall Study|Protocol Violation|1
2130125|NCT01030952|3733478|FG000|Overall Study|Informed consent withdrawal|1
2130126|NCT01030952|3733479|FG001|Overall Study|Informed consent withdrawal|0
2130127|NCT01030952|3733478|FG000|Overall Study|Lost to Follow-up|0
2130128|NCT01030952|3733479|FG001|Overall Study|Lost to Follow-up|1
2130129|NCT01030952|3733478|FG000|Overall Study|Unexplained|1
2130130|NCT01030952|3733479|FG001|Overall Study|Unexplained|1
2130131|NCT01030965|3733491|FG000|Overall Study|Lack of Efficacy|3
2130132|NCT01030965|3733492|FG001|Overall Study|Lack of Efficacy|2
2130133|NCT01030965|3733493|FG002|Overall Study|Lack of Efficacy|0
2130134|NCT01030965|3733494|FG003|Overall Study|Lack of Efficacy|3
2130135|NCT01030965|3733491|FG000|Overall Study|Protocol Violation|1
2130136|NCT01030965|3733492|FG001|Overall Study|Protocol Violation|1
2130137|NCT01030965|3733493|FG002|Overall Study|Protocol Violation|1
2130138|NCT01030965|3733494|FG003|Overall Study|Protocol Violation|1
2130139|NCT01030965|3733491|FG000|Overall Study|Adverse Event|0
2130140|NCT01030965|3733492|FG001|Overall Study|Adverse Event|1
2130141|NCT01030965|3733493|FG002|Overall Study|Adverse Event|2
2130142|NCT01030965|3733494|FG003|Overall Study|Adverse Event|1
2130143|NCT01030965|3733491|FG000|Overall Study|Protocol-defined Stopping Criteria|0
2130144|NCT01030965|3733492|FG001|Overall Study|Protocol-defined Stopping Criteria|1
2130145|NCT01030965|3733493|FG002|Overall Study|Protocol-defined Stopping Criteria|1
2130146|NCT01030965|3733494|FG003|Overall Study|Protocol-defined Stopping Criteria|0
2283690|NCT02404103|3970988|FG001|Overall Study|Adverse Event|0
2283691|NCT02404103|3970987|FG000|Overall Study|Lost to Follow-up|3
2283692|NCT02404103|3970988|FG001|Overall Study|Lost to Follow-up|3
2283693|NCT02404220|3971014|FG000|Overall Study|Adverse Event|0
2283694|NCT02404220|3971015|FG001|Overall Study|Adverse Event|0
2283695|NCT02404220|3971016|FG002|Overall Study|Adverse Event|1
2130147|NCT01030965|3733491|FG000|Overall Study|Withdrawal by Subject|0
2130148|NCT01030965|3733492|FG001|Overall Study|Withdrawal by Subject|1
2130149|NCT01030965|3733493|FG002|Overall Study|Withdrawal by Subject|0
2130150|NCT01030965|3733494|FG003|Overall Study|Withdrawal by Subject|2
2130151|NCT01031004|3733506|FG000|Overall Study|Protocol Violation|0
2130152|NCT01031004|3733507|FG001|Overall Study|Protocol Violation|1
2130153|NCT01031004|3733506|FG000|Overall Study|Lost to Follow-up|1
2130154|NCT01031004|3733507|FG001|Overall Study|Lost to Follow-up|0
2283696|NCT02404220|3971017|FG003|Overall Study|Adverse Event|0
2283697|NCT02404220|3971014|FG000|Overall Study|Death|5
2283698|NCT02404220|3971015|FG001|Overall Study|Death|5
2283699|NCT02404220|3971016|FG002|Overall Study|Death|3
2283700|NCT02404220|3971017|FG003|Overall Study|Death|8
2283701|NCT02404220|3971014|FG000|Overall Study|Progressive Disease|0
2283702|NCT02404220|3971015|FG001|Overall Study|Progressive Disease|0
2283703|NCT02404220|3971016|FG002|Overall Study|Progressive Disease|1
2283704|NCT02404220|3971017|FG003|Overall Study|Progressive Disease|1
2283705|NCT02404220|3971014|FG000|Overall Study|Study Terminated by Sponsor|0
2283706|NCT02404220|3971015|FG001|Overall Study|Study Terminated by Sponsor|0
2283707|NCT02404220|3971016|FG002|Overall Study|Study Terminated by Sponsor|2
2283708|NCT02404220|3971017|FG003|Overall Study|Study Terminated by Sponsor|1
2283709|NCT02404220|3971014|FG000|Overall Study|Withdrawal by Subject|0
2283710|NCT02404220|3971015|FG001|Overall Study|Withdrawal by Subject|1
2283711|NCT02404220|3971016|FG002|Overall Study|Withdrawal by Subject|0
2283712|NCT02404220|3971017|FG003|Overall Study|Withdrawal by Subject|0
2283713|NCT02404220|3971014|FG000|Overall Study|Enrolled but Never Treated|0
2283714|NCT02404220|3971015|FG001|Overall Study|Enrolled but Never Treated|2
2283715|NCT02404220|3971016|FG002|Overall Study|Enrolled but Never Treated|0
2283716|NCT02404220|3971017|FG003|Overall Study|Enrolled but Never Treated|0
2283717|NCT02404311|3971047|FG000|Part A: Month 0-18|Death|2
2283718|NCT02404311|3971048|FG001|Part A: Month 0-18|Death|0
2283719|NCT02404311|3971049|FG002|Part A: Month 0-18|Death|0
2283720|NCT02404311|3971050|FG003|Part A: Month 0-18|Death|0
2283721|NCT02404311|3971051|FG004|Part A: Month 0-18|Death|0
2283722|NCT02404311|3971047|FG000|Part A: Month 0-18|Physician Decision|1
2283723|NCT02404311|3971048|FG001|Part A: Month 0-18|Physician Decision|0
2283724|NCT02404311|3971049|FG002|Part A: Month 0-18|Physician Decision|0
2283725|NCT02404311|3971050|FG003|Part A: Month 0-18|Physician Decision|0
2283726|NCT02404311|3971051|FG004|Part A: Month 0-18|Physician Decision|0
2283727|NCT02404311|3971047|FG000|Part A: Month 0-18|Lost to Follow-up|4
2283728|NCT02404311|3971048|FG001|Part A: Month 0-18|Lost to Follow-up|2
2283729|NCT02404311|3971049|FG002|Part A: Month 0-18|Lost to Follow-up|0
2283730|NCT02404311|3971050|FG003|Part A: Month 0-18|Lost to Follow-up|0
2283731|NCT02404311|3971051|FG004|Part A: Month 0-18|Lost to Follow-up|0
2283732|NCT02404311|3971047|FG000|Part A: Month 0-18|Withdrawal by Subject|6
2283733|NCT02404311|3971048|FG001|Part A: Month 0-18|Withdrawal by Subject|2
2283734|NCT02404311|3971049|FG002|Part A: Month 0-18|Withdrawal by Subject|0
2283735|NCT02404311|3971050|FG003|Part A: Month 0-18|Withdrawal by Subject|0
2283736|NCT02404311|3971051|FG004|Part A: Month 0-18|Withdrawal by Subject|0
2283737|NCT02404311|3971047|FG000|Part A: Month 0-18|HIV Infection|6
2283738|NCT02404311|3971048|FG001|Part A: Month 0-18|HIV Infection|2
2283739|NCT02404311|3971049|FG002|Part A: Month 0-18|HIV Infection|0
2283740|NCT02404311|3971050|FG003|Part A: Month 0-18|HIV Infection|0
2283741|NCT02404311|3971051|FG004|Part A: Month 0-18|HIV Infection|0
2283742|NCT02404311|3971047|FG000|Part A: Month 0-18|Participant unable to adhere|7
2283743|NCT02404311|3971048|FG001|Part A: Month 0-18|Participant unable to adhere|0
2283744|NCT02404311|3971049|FG002|Part A: Month 0-18|Participant unable to adhere|0
2283745|NCT02404311|3971050|FG003|Part A: Month 0-18|Participant unable to adhere|0
2283746|NCT02404311|3971051|FG004|Part A: Month 0-18|Participant unable to adhere|0
2283747|NCT02404350|3971067|FG000|Overall Study|Adverse Event|2
2283748|NCT02404350|3971068|FG001|Overall Study|Adverse Event|2
2283749|NCT02404350|3971069|FG002|Overall Study|Adverse Event|3
2283750|NCT02404350|3971070|FG003|Overall Study|Adverse Event|9
2283751|NCT02404350|3971067|FG000|Overall Study|Lack of Efficacy|3
2283752|NCT02404350|3971068|FG001|Overall Study|Lack of Efficacy|1
2130155|NCT01031069|3733521|FG000|Overall Study|Serious Adverse Event|0
2283753|NCT02404350|3971069|FG002|Overall Study|Lack of Efficacy|0
2283754|NCT02404350|3971070|FG003|Overall Study|Lack of Efficacy|3
2283755|NCT02404350|3971067|FG000|Overall Study|Lost to Follow-up|2
2283756|NCT02404350|3971068|FG001|Overall Study|Lost to Follow-up|0
2283757|NCT02404350|3971069|FG002|Overall Study|Lost to Follow-up|0
2283758|NCT02404350|3971070|FG003|Overall Study|Lost to Follow-up|1
2283759|NCT02404350|3971067|FG000|Overall Study|Physician Decision|1
2283760|NCT02404350|3971068|FG001|Overall Study|Physician Decision|0
2283761|NCT02404350|3971069|FG002|Overall Study|Physician Decision|0
2283762|NCT02404350|3971070|FG003|Overall Study|Physician Decision|2
2283763|NCT02404350|3971067|FG000|Overall Study|Pregnancy|0
2283764|NCT02404350|3971068|FG001|Overall Study|Pregnancy|0
2283765|NCT02404350|3971069|FG002|Overall Study|Pregnancy|0
2283766|NCT02404350|3971070|FG003|Overall Study|Pregnancy|1
2130156|NCT01031069|3733522|FG001|Overall Study|Serious Adverse Event|1
2130157|NCT01031069|3733523|FG002|Overall Study|Serious Adverse Event|0
2130158|NCT01031069|3733524|FG003|Overall Study|Serious Adverse Event|0
2130159|NCT01031069|3733521|FG000|Overall Study|Withdrawal by Subject|2
2130160|NCT01031069|3733522|FG001|Overall Study|Withdrawal by Subject|3
2130161|NCT01031069|3733523|FG002|Overall Study|Withdrawal by Subject|18
2130162|NCT01031069|3733524|FG003|Overall Study|Withdrawal by Subject|18
2130163|NCT01031069|3733521|FG000|Overall Study|Migrated/moved from study area|1
2130164|NCT01031069|3733522|FG001|Overall Study|Migrated/moved from study area|2
2130165|NCT01031069|3733523|FG002|Overall Study|Migrated/moved from study area|1
2130166|NCT01031069|3733524|FG003|Overall Study|Migrated/moved from study area|1
2130167|NCT01031069|3733521|FG000|Overall Study|Lost to Follow-up|9
2130168|NCT01031069|3733522|FG001|Overall Study|Lost to Follow-up|5
2130169|NCT01031069|3733523|FG002|Overall Study|Lost to Follow-up|21
2130170|NCT01031069|3733524|FG003|Overall Study|Lost to Follow-up|15
2130171|NCT01031069|3733521|FG000|Overall Study|Other|0
2130172|NCT01031069|3733522|FG001|Overall Study|Other|0
2130173|NCT01031069|3733523|FG002|Overall Study|Other|1
2130174|NCT01031069|3733524|FG003|Overall Study|Other|0
2130175|NCT01031381|3733554|FG000|Overall Study|Physician Decision|3
2130176|NCT01031381|3733554|FG000|Overall Study|Withdrawal by Subject|6
2283767|NCT02404350|3971067|FG000|Overall Study|Withdrawal by Subject|7
2283768|NCT02404350|3971068|FG001|Overall Study|Withdrawal by Subject|3
2283769|NCT02404350|3971069|FG002|Overall Study|Withdrawal by Subject|3
2283770|NCT02404350|3971070|FG003|Overall Study|Withdrawal by Subject|19
2283771|NCT02404350|3971067|FG000|Overall Study|Due to Non-compliance with treatment|0
2283772|NCT02404350|3971068|FG001|Overall Study|Due to Non-compliance with treatment|0
2283773|NCT02404350|3971069|FG002|Overall Study|Due to Non-compliance with treatment|0
2283774|NCT02404350|3971070|FG003|Overall Study|Due to Non-compliance with treatment|1
2283775|NCT02404350|3971067|FG000|Overall Study|Due to Technical problems|0
2283776|NCT02404350|3971068|FG001|Overall Study|Due to Technical problems|0
2283777|NCT02404350|3971069|FG002|Overall Study|Due to Technical problems|0
2283778|NCT02404350|3971070|FG003|Overall Study|Due to Technical problems|1
2320834|NCT02952820|4035041|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
2320835|NCT02952820|4035039|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0
2320836|NCT02952820|4035040|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14
2320837|NCT02952820|4035041|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13
2320838|NCT02952820|4035039|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
2320839|NCT02952820|4035040|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
2320840|NCT02952820|4035041|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
2320841|NCT02952820|4035039|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4
2320842|NCT02952820|4035040|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4
2320843|NCT02952820|4035041|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4
2320844|NCT02952820|4035039|FG000|Active Treatment Period (6 Months)|Adverse Event|0
2320845|NCT02952820|4035040|FG001|Active Treatment Period (6 Months)|Adverse Event|6
2320846|NCT02952820|4035041|FG002|Active Treatment Period (6 Months)|Adverse Event|5
2320847|NCT02952820|4035039|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0
2320848|NCT02952820|4035040|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4
2320849|NCT02952820|4035041|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6
2320850|NCT02952820|4035039|FG000|Active Treatment Period (6 Months)|Subject choice|0
2320851|NCT02952820|4035040|FG001|Active Treatment Period (6 Months)|Subject choice|10
2320852|NCT02952820|4035041|FG002|Active Treatment Period (6 Months)|Subject choice|7
2320853|NCT02952820|4035039|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
2320854|NCT02952820|4035040|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
2320855|NCT02952820|4035041|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
2320856|NCT02952820|4035039|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0
2320857|NCT02952820|4035040|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6
2320858|NCT02952820|4035041|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8
2320859|NCT02952820|4035039|FG000|Active Treatment Period (6 Months)|Other than specified|0
2320860|NCT02952820|4035040|FG001|Active Treatment Period (6 Months)|Other than specified|6
2320861|NCT02952820|4035041|FG002|Active Treatment Period (6 Months)|Other than specified|2
2320862|NCT02952820|4035039|FG000|Active Treatment Period (6 Months)|Not treated|0
2320863|NCT02952820|4035040|FG001|Active Treatment Period (6 Months)|Not treated|0
2320864|NCT02952820|4035041|FG002|Active Treatment Period (6 Months)|Not treated|1
2320865|NCT02952898|4035120|FG000|Overall Study|Withdrawal by Subject|10
2320866|NCT02952898|4035121|FG001|Overall Study|Withdrawal by Subject|8
2320867|NCT02952898|4035122|FG002|Overall Study|Withdrawal by Subject|8
2320868|NCT02952898|4035120|FG000|Overall Study|Adverse Event|8
2320869|NCT02952898|4035121|FG001|Overall Study|Adverse Event|8
2320870|NCT02952898|4035122|FG002|Overall Study|Adverse Event|3
2130177|NCT01031446|3733563|FG000|Overall Study|Disease Progression|38
2320871|NCT02952898|4035120|FG000|Overall Study|Lost to Follow-up|3
2320872|NCT02952898|4035121|FG001|Overall Study|Lost to Follow-up|2
2320873|NCT02952898|4035122|FG002|Overall Study|Lost to Follow-up|2
2320874|NCT02952898|4035120|FG000|Overall Study|Non-compliance with study drug|1
2320875|NCT02952898|4035121|FG001|Overall Study|Non-compliance with study drug|1
2130178|NCT01031446|3733563|FG000|Overall Study|Adverse Event|9
2130179|NCT01031446|3733563|FG000|Overall Study|Physician Decision|4
2130180|NCT01031446|3733563|FG000|Overall Study|Withdrawal by Subject|3
2130181|NCT01031446|3733563|FG000|Overall Study|Still on treatment|1
2178099|NCT01380093|3802584|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0
2178100|NCT01380093|3802585|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0
2178101|NCT01380093|3802586|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0
2178102|NCT01380093|3802587|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0
2178103|NCT01380093|3802588|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0
2178104|NCT01380093|3802580|FG000|Treatment Phase: Second Intervention|Other|0
2178105|NCT01380093|3802581|FG001|Treatment Phase: Second Intervention|Other|0
2178106|NCT01380093|3802582|FG002|Treatment Phase: Second Intervention|Other|0
2178107|NCT01380093|3802583|FG003|Treatment Phase: Second Intervention|Other|1
2178108|NCT01380093|3802584|FG004|Treatment Phase: Second Intervention|Other|0
2178109|NCT01380093|3802585|FG005|Treatment Phase: Second Intervention|Other|0
2178110|NCT01380093|3802586|FG006|Treatment Phase: Second Intervention|Other|0
2178111|NCT01380093|3802587|FG007|Treatment Phase: Second Intervention|Other|0
2178112|NCT01380093|3802588|FG008|Treatment Phase: Second Intervention|Other|0
2178113|NCT01380093|3802580|FG000|Treatment Phase: Third Intervention|Non-compliance|0
2178114|NCT01380093|3802581|FG001|Treatment Phase: Third Intervention|Non-compliance|0
2178115|NCT01380093|3802582|FG002|Treatment Phase: Third Intervention|Non-compliance|0
2178116|NCT01380093|3802583|FG003|Treatment Phase: Third Intervention|Non-compliance|0
2178117|NCT01380093|3802584|FG004|Treatment Phase: Third Intervention|Non-compliance|0
2178118|NCT01380093|3802585|FG005|Treatment Phase: Third Intervention|Non-compliance|0
2178119|NCT01380093|3802586|FG006|Treatment Phase: Third Intervention|Non-compliance|0
2178120|NCT01380093|3802587|FG007|Treatment Phase: Third Intervention|Non-compliance|0
2178121|NCT01380093|3802588|FG008|Treatment Phase: Third Intervention|Non-compliance|1
2283779|NCT02404389|3971086|FG000|Overall Study|Adverse Event|1
2283780|NCT02404389|3971087|FG001|Overall Study|Adverse Event|0
2178122|NCT01380093|3802580|FG000|Treatment Phase: Third Intervention|Other|0
2178123|NCT01380093|3802581|FG001|Treatment Phase: Third Intervention|Other|0
2178124|NCT01380093|3802582|FG002|Treatment Phase: Third Intervention|Other|0
2178125|NCT01380093|3802583|FG003|Treatment Phase: Third Intervention|Other|0
2178126|NCT01380093|3802584|FG004|Treatment Phase: Third Intervention|Other|0
2178127|NCT01380093|3802585|FG005|Treatment Phase: Third Intervention|Other|0
2178128|NCT01380093|3802586|FG006|Treatment Phase: Third Intervention|Other|0
2178129|NCT01380093|3802587|FG007|Treatment Phase: Third Intervention|Other|0
2178130|NCT01380093|3802588|FG008|Treatment Phase: Third Intervention|Other|1
2178131|NCT01380145|3802611|FG000|Overall Study|Progressive disease|4
2178132|NCT01380184|3802617|FG000|Part 1 (19 Days)|Adverse Event|1
2178133|NCT01380184|3802617|FG000|Part 2|Adverse Event|5
2178134|NCT01380184|3802617|FG000|Part 2|Disease Progression|8
2178135|NCT01380184|3802617|FG000|Part 2|Lost to Follow-up|1
2178136|NCT01380327|3802633|FG000|Overall Study|Lost to Follow-up|0
2178137|NCT01380327|3802634|FG001|Overall Study|Lost to Follow-up|1
2178138|NCT01380327|3802635|FG002|Overall Study|Lost to Follow-up|1
2178139|NCT01380327|3802633|FG000|Overall Study|Protocol Violation|3
2178140|NCT01380327|3802634|FG001|Overall Study|Protocol Violation|2
2178141|NCT01380327|3802635|FG002|Overall Study|Protocol Violation|3
2178142|NCT01380327|3802633|FG000|Overall Study|Withdrawal by Subject|0
2178143|NCT01380327|3802634|FG001|Overall Study|Withdrawal by Subject|0
2178144|NCT01380327|3802635|FG002|Overall Study|Withdrawal by Subject|1
2178145|NCT01380327|3802633|FG000|Overall Study|Housing situation precluded ability to k|0
2178146|NCT01380327|3802634|FG001|Overall Study|Housing situation precluded ability to k|0
2178147|NCT01380327|3802635|FG002|Overall Study|Housing situation precluded ability to k|1
2178148|NCT01380327|3802633|FG000|Overall Study|Questionable onset of epilepsy|0
2178149|NCT01380327|3802634|FG001|Overall Study|Questionable onset of epilepsy|0
2178150|NCT01380327|3802635|FG002|Overall Study|Questionable onset of epilepsy|1
2178151|NCT01380379|3802648|FG000|Overall Study|Pregnancy|1
2178152|NCT01380535|3802654|FG000|Overall Study|Adverse Event|3
2178153|NCT01380535|3802655|FG001|Overall Study|Adverse Event|3
2178154|NCT01380535|3802654|FG000|Overall Study|Death|3
2178155|NCT01380535|3802655|FG001|Overall Study|Death|0
2178156|NCT01380535|3802654|FG000|Overall Study|Study site closed|0
2178157|NCT01380535|3802655|FG001|Overall Study|Study site closed|5
2178158|NCT01380535|3802654|FG000|Overall Study|Withdrawal by Subject|1
2178159|NCT01380535|3802655|FG001|Overall Study|Withdrawal by Subject|2
2178160|NCT01380535|3802654|FG000|Overall Study|Protocol Violation|0
2178161|NCT01380535|3802655|FG001|Overall Study|Protocol Violation|2
2178162|NCT01380535|3802654|FG000|Overall Study|Lack of Efficacy|0
2178163|NCT01380535|3802655|FG001|Overall Study|Lack of Efficacy|3
2178164|NCT01380691|3802670|FG000|Washout (7 Days)|Protocol Violation|0
2178165|NCT01380691|3802671|FG001|Washout (7 Days)|Protocol Violation|0
2178166|NCT01380691|3802672|FG002|Washout (7 Days)|Protocol Violation|0
2178167|NCT01380691|3802673|FG003|Washout (7 Days)|Protocol Violation|1
2178168|NCT01380691|3802670|FG000|Washout (7 Days)|Withdrawal by Subject|0
2178169|NCT01380691|3802671|FG001|Washout (7 Days)|Withdrawal by Subject|0
2178170|NCT01380691|3802672|FG002|Washout (7 Days)|Withdrawal by Subject|1
2178171|NCT01380691|3802673|FG003|Washout (7 Days)|Withdrawal by Subject|0
2283781|NCT02404389|3971088|FG002|Overall Study|Adverse Event|1
2130182|NCT01031537|3733582|FG000|Overall Study|medical reasons not related to study|3
2130183|NCT01031537|3733582|FG000|Overall Study|Lack of Efficacy|1
2130184|NCT01031537|3733582|FG000|Overall Study|retired from NIH, met exclusion criteria|1
2130185|NCT01031537|3733582|FG000|Overall Study|moved, met exclusion criteria|10
2130186|NCT01031537|3733582|FG000|Overall Study|Withdrawal by Subject|5
2130187|NCT01031537|3733582|FG000|Overall Study|PI removal, no longer met eligibility|12
2130188|NCT01031680|3733588|FG000|Overall Study|Adverse Event|8
2130189|NCT01031680|3733589|FG001|Overall Study|Adverse Event|3
2130190|NCT01031680|3733588|FG000|Overall Study|Lost to Follow-up|2
2130191|NCT01031680|3733589|FG001|Overall Study|Lost to Follow-up|10
2130192|NCT01031680|3733588|FG000|Overall Study|Withdrawal by Subject|12
2130193|NCT01031680|3733589|FG001|Overall Study|Withdrawal by Subject|16
2130194|NCT01031680|3733588|FG000|Overall Study|Death|2
2130195|NCT01031680|3733589|FG001|Overall Study|Death|1
2130196|NCT01031680|3733588|FG000|Overall Study|Subject No Longer Meets Study Criteria|26
2130197|NCT01031680|3733589|FG001|Overall Study|Subject No Longer Meets Study Criteria|17
2283782|NCT02404389|3971089|FG003|Overall Study|Adverse Event|0
2283783|NCT02404389|3971090|FG004|Overall Study|Adverse Event|2
2283784|NCT02404389|3971086|FG000|Overall Study|Subject/guardian decision|1
2283785|NCT02404389|3971087|FG001|Overall Study|Subject/guardian decision|0
2283786|NCT02404389|3971088|FG002|Overall Study|Subject/guardian decision|0
2283787|NCT02404389|3971089|FG003|Overall Study|Subject/guardian decision|1
2283788|NCT02404389|3971090|FG004|Overall Study|Subject/guardian decision|1
2283789|NCT02404441|3971114|FG000|Phase 1 Part|Adverse Event|1
2130198|NCT01031680|3733588|FG000|Overall Study|Poor/Non-compliance|5
2130199|NCT01031680|3733589|FG001|Overall Study|Poor/Non-compliance|6
2130200|NCT01031680|3733588|FG000|Overall Study|Safety|1
2130201|NCT01031680|3733589|FG001|Overall Study|Safety|0
2130202|NCT01031680|3733588|FG000|Overall Study|Incorrect Enrolment|1
2130203|NCT01031680|3733589|FG001|Overall Study|Incorrect Enrolment|2
2130204|NCT01031680|3733588|FG000|Overall Study|Administrative Reason by Sponsor|0
2130205|NCT01031680|3733589|FG001|Overall Study|Administrative Reason by Sponsor|1
2130206|NCT01031680|3733588|FG000|Overall Study|Various|0
2130207|NCT01031680|3733589|FG001|Overall Study|Various|2
2130208|NCT01031706|3733597|FG000|Overall Study|Adverse Event|1
2130209|NCT01031706|3733598|FG001|Overall Study|Adverse Event|0
2130210|NCT01031706|3733597|FG000|Overall Study|Withdrawal by Subject|1
2130211|NCT01031706|3733598|FG001|Overall Study|Withdrawal by Subject|1
2130212|NCT01031836|3733616|FG000|Stage I|Adverse Event|1
2130213|NCT01031836|3733617|FG001|Stage I|Adverse Event|1
2130214|NCT01031836|3733618|FG002|Stage I|Adverse Event|0
2130215|NCT01031836|3733619|FG003|Stage I|Adverse Event|0
2130216|NCT01031836|3733620|FG004|Stage I|Adverse Event|0
2130217|NCT01031836|3733621|FG005|Stage I|Adverse Event|0
2130218|NCT01031836|3733616|FG000|Stage I|Other|0
2130219|NCT01031836|3733617|FG001|Stage I|Other|1
2130220|NCT01031836|3733618|FG002|Stage I|Other|0
2130221|NCT01031836|3733619|FG003|Stage I|Other|0
2130222|NCT01031836|3733620|FG004|Stage I|Other|0
2130223|NCT01031836|3733621|FG005|Stage I|Other|1
2130224|NCT01031836|3733616|FG000|Stage II|Adverse Event|0
2130225|NCT01031836|3733617|FG001|Stage II|Adverse Event|0
2130226|NCT01031836|3733618|FG002|Stage II|Adverse Event|2
2130227|NCT01031836|3733619|FG003|Stage II|Adverse Event|2
2130228|NCT01031836|3733620|FG004|Stage II|Adverse Event|1
2130229|NCT01031836|3733621|FG005|Stage II|Adverse Event|1
2130230|NCT01031836|3733616|FG000|Stage II|Other|2
2130231|NCT01031836|3733617|FG001|Stage II|Other|0
2130232|NCT01031836|3733618|FG002|Stage II|Other|0
2130233|NCT01031836|3733619|FG003|Stage II|Other|1
2130234|NCT01031836|3733620|FG004|Stage II|Other|1
2130235|NCT01031836|3733621|FG005|Stage II|Other|0
2130236|NCT01031979|3733651|FG000|Overall Study|Lost to Follow-up|5
2130237|NCT01031979|3733652|FG001|Overall Study|Lost to Follow-up|4
2130238|NCT01032018|3733660|FG000|Overall Study|Lost to Follow-up|6
2130239|NCT01032018|3733661|FG001|Overall Study|Lost to Follow-up|5
2130240|NCT01032018|3733660|FG000|Overall Study|Death|0
2130241|NCT01032018|3733661|FG001|Overall Study|Death|1
2130242|NCT01032044|3733669|FG000|Overall Study|Protocol Violation|14
2130243|NCT01032044|3733670|FG001|Overall Study|Protocol Violation|8
2130244|NCT01032044|3733669|FG000|Overall Study|Adverse Event|0
2130245|NCT01032044|3733670|FG001|Overall Study|Adverse Event|1
2130246|NCT01032044|3733669|FG000|Overall Study|Lost to Follow-up|11
2130247|NCT01032044|3733670|FG001|Overall Study|Lost to Follow-up|11
2130248|NCT01032070|3733678|FG000|Overall Study|Disease progression|13
2130249|NCT01032070|3733679|FG001|Overall Study|Disease progression|8
2130250|NCT01032070|3733678|FG000|Overall Study|Medical or ethical reasons|0
2130251|NCT01032070|3733679|FG001|Overall Study|Medical or ethical reasons|2
2130252|NCT01032070|3733678|FG000|Overall Study|Withdrawal by Subject|0
2130253|NCT01032070|3733679|FG001|Overall Study|Withdrawal by Subject|2
2130254|NCT01032174|3733712|FG000|Overall Study|Adverse Event|0
2130255|NCT01032174|3733713|FG001|Overall Study|Adverse Event|1
2130256|NCT01032200|3733721|FG000|Overall Study|Death|1
2130257|NCT01032200|3733722|FG001|Overall Study|Death|1
2130258|NCT01032200|3733721|FG000|Overall Study|Withdrawal by Subject|1
2130259|NCT01032200|3733722|FG001|Overall Study|Withdrawal by Subject|3
2130260|NCT01032200|3733721|FG000|Overall Study|Toxicity|0
2130261|NCT01032200|3733722|FG001|Overall Study|Toxicity|2
2283790|NCT02404441|3971115|FG001|Phase 1 Part|Adverse Event|0
2130262|NCT01032200|3733721|FG000|Overall Study|Progression|1
2130263|NCT01032200|3733722|FG001|Overall Study|Progression|0
2130264|NCT01032200|3733721|FG000|Overall Study|Multiple|1
2130265|NCT01032200|3733722|FG001|Overall Study|Multiple|1
2130266|NCT01032239|3733730|FG000|Overall Study|Lost to Follow-up|3
2130267|NCT01032239|3733731|FG001|Overall Study|Lost to Follow-up|2
2130268|NCT01032239|3733730|FG000|Overall Study|Withdrawal by Subject|2
2130269|NCT01032239|3733731|FG001|Overall Study|Withdrawal by Subject|3
2130270|NCT01032239|3733730|FG000|Overall Study|Death|1
2130271|NCT01032239|3733731|FG001|Overall Study|Death|0
2130272|NCT01032239|3733730|FG000|Overall Study|Protocol Violation|1
2130273|NCT01032239|3733731|FG001|Overall Study|Protocol Violation|0
2130274|NCT01032291|3733749|FG000|Safety Lead-in|Adverse Event|1
2130275|NCT01032291|3733750|FG001|Safety Lead-in|Adverse Event|0
2130276|NCT01032291|3733751|FG002|Safety Lead-in|Adverse Event|0
2130277|NCT01032291|3733749|FG000|Safety Lead-in|Death|1
2130278|NCT01032291|3733750|FG001|Safety Lead-in|Death|0
2130279|NCT01032291|3733751|FG002|Safety Lead-in|Death|0
2130280|NCT01032291|3733749|FG000|Proof of Concept|Adverse Event|0
2130281|NCT01032291|3733750|FG001|Proof of Concept|Adverse Event|5
2130282|NCT01032291|3733751|FG002|Proof of Concept|Adverse Event|1
2130283|NCT01032291|3733749|FG000|Proof of Concept|Death|0
2130284|NCT01032291|3733750|FG001|Proof of Concept|Death|1
2130285|NCT01032291|3733751|FG002|Proof of Concept|Death|2
2130286|NCT01032291|3733749|FG000|Proof of Concept|Lack of Efficacy|0
2130287|NCT01032291|3733750|FG001|Proof of Concept|Lack of Efficacy|1
2130288|NCT01032291|3733751|FG002|Proof of Concept|Lack of Efficacy|0
2130289|NCT01032291|3733749|FG000|Proof of Concept|Never Received Study Drug|0
2130290|NCT01032291|3733750|FG001|Proof of Concept|Never Received Study Drug|1
2130291|NCT01032291|3733751|FG002|Proof of Concept|Never Received Study Drug|0
2130292|NCT01032382|3733789|FG000|Overall Study|Disease dissemination|1
2130293|NCT01032382|3733790|FG001|Overall Study|Disease dissemination|1
2130294|NCT01032382|3733789|FG000|Overall Study|Treatment failure|3
2130295|NCT01032382|3733790|FG001|Overall Study|Treatment failure|1
2130296|NCT01032382|3733789|FG000|Overall Study|Index lesion relapse|1
2130297|NCT01032382|3733790|FG001|Overall Study|Index lesion relapse|3
2130298|NCT01032629|3733814|FG000|Overall Study|Closed Site|21
2130299|NCT01032629|3733815|FG001|Overall Study|Closed Site|18
2130300|NCT01032629|3733816|FG002|Overall Study|Closed Site|16
2130301|NCT01032629|3733814|FG000|Overall Study|Withdrawal by Subject|50
2130302|NCT01032629|3733815|FG001|Overall Study|Withdrawal by Subject|36
2130303|NCT01032629|3733816|FG002|Overall Study|Withdrawal by Subject|35
2130304|NCT01032629|3733814|FG000|Overall Study|Lost to Follow-up|74
2130305|NCT01032629|3733815|FG001|Overall Study|Lost to Follow-up|47
2130306|NCT01032629|3733816|FG002|Overall Study|Lost to Follow-up|37
2130307|NCT01032837|3733857|FG000|Overall Study|Adverse event/internal illness|0
2130308|NCT01032837|3733858|FG001|Overall Study|Adverse event/internal illness|1
2130309|NCT01032837|3733859|FG002|Overall Study|Adverse event/internal illness|0
2130310|NCT01032837|3733860|FG003|Overall Study|Adverse event/internal illness|1
2130311|NCT01032837|3733857|FG000|Overall Study|Withdrew consent|0
2130312|NCT01032837|3733858|FG001|Overall Study|Withdrew consent|2
2130313|NCT01032837|3733859|FG002|Overall Study|Withdrew consent|0
2130314|NCT01032837|3733860|FG003|Overall Study|Withdrew consent|1
2130315|NCT01032837|3733857|FG000|Overall Study|Failed to return|0
2130316|NCT01032837|3733858|FG001|Overall Study|Failed to return|0
2130317|NCT01032837|3733859|FG002|Overall Study|Failed to return|1
2130318|NCT01032837|3733860|FG003|Overall Study|Failed to return|0
2130319|NCT01032837|3733857|FG000|Overall Study|Refused treatment|0
2130320|NCT01032837|3733858|FG001|Overall Study|Refused treatment|0
2130321|NCT01032837|3733859|FG002|Overall Study|Refused treatment|0
2283791|NCT02404441|3971116|FG002|Phase 1 Part|Adverse Event|0
2283792|NCT02404441|3971117|FG003|Phase 1 Part|Adverse Event|0
2283793|NCT02404441|3971118|FG004|Phase 1 Part|Adverse Event|0
2283794|NCT02404441|3971119|FG005|Phase 1 Part|Adverse Event|0
2283795|NCT02404441|3971120|FG006|Phase 1 Part|Adverse Event|0
2283796|NCT02404441|3971121|FG007|Phase 1 Part|Adverse Event|0
2283797|NCT02404441|3971122|FG008|Phase 1 Part|Adverse Event|0
2283798|NCT02404441|3971123|FG009|Phase 1 Part|Adverse Event|0
2283799|NCT02404441|3971114|FG000|Phase 1 Part|Physician Decision|0
2283800|NCT02404441|3971115|FG001|Phase 1 Part|Physician Decision|1
2283801|NCT02404441|3971116|FG002|Phase 1 Part|Physician Decision|0
2283802|NCT02404441|3971117|FG003|Phase 1 Part|Physician Decision|0
2283803|NCT02404441|3971118|FG004|Phase 1 Part|Physician Decision|0
2283804|NCT02404441|3971119|FG005|Phase 1 Part|Physician Decision|0
2130322|NCT01032837|3733860|FG003|Overall Study|Refused treatment|1
2130323|NCT01032889|3733877|FG000|Overall Study|Adverse Event|2
2130324|NCT01032889|3733878|FG001|Overall Study|Adverse Event|2
2130325|NCT01032889|3733879|FG002|Overall Study|Adverse Event|0
2130326|NCT01032889|3733877|FG000|Overall Study|Withdrawal of Consent|1
2130327|NCT01032889|3733878|FG001|Overall Study|Withdrawal of Consent|2
2130328|NCT01032889|3733879|FG002|Overall Study|Withdrawal of Consent|1
2130329|NCT01032889|3733877|FG000|Overall Study|Patient Request|0
2130330|NCT01032889|3733878|FG001|Overall Study|Patient Request|1
2130331|NCT01032889|3733879|FG002|Overall Study|Patient Request|0
2130332|NCT01032889|3733877|FG000|Overall Study|Lost to Follow-up|1
2283805|NCT02404441|3971120|FG006|Phase 1 Part|Physician Decision|0
2283806|NCT02404441|3971121|FG007|Phase 1 Part|Physician Decision|0
2130333|NCT01032889|3733878|FG001|Overall Study|Lost to Follow-up|1
2130334|NCT01032889|3733879|FG002|Overall Study|Lost to Follow-up|0
2130335|NCT01032889|3733877|FG000|Overall Study|Lack of Submental Fat|2
2130336|NCT01032889|3733878|FG001|Overall Study|Lack of Submental Fat|8
2130337|NCT01032889|3733879|FG002|Overall Study|Lack of Submental Fat|1
2130338|NCT01032889|3733877|FG000|Overall Study|Miscellaneous Reasons|2
2130339|NCT01032889|3733878|FG001|Overall Study|Miscellaneous Reasons|1
2130340|NCT01032889|3733879|FG002|Overall Study|Miscellaneous Reasons|1
2130341|NCT01032915|3733891|FG000|Overall Study|Adverse Event|2
2130342|NCT01032915|3733892|FG001|Overall Study|Adverse Event|2
2130343|NCT01032915|3733893|FG002|Overall Study|Adverse Event|1
2130344|NCT01032915|3733894|FG003|Overall Study|Adverse Event|1
2130345|NCT01032915|3733891|FG000|Overall Study|Abnormal test procedure result|0
2130346|NCT01032915|3733892|FG001|Overall Study|Abnormal test procedure result|0
2130347|NCT01032915|3733893|FG002|Overall Study|Abnormal test procedure result|1
2130348|NCT01032915|3733894|FG003|Overall Study|Abnormal test procedure result|0
2130349|NCT01032915|3733891|FG000|Overall Study|Withdrawal by Subject|0
2130350|NCT01032915|3733892|FG001|Overall Study|Withdrawal by Subject|3
2130351|NCT01032915|3733893|FG002|Overall Study|Withdrawal by Subject|1
2130352|NCT01032915|3733894|FG003|Overall Study|Withdrawal by Subject|1
2130353|NCT01032915|3733891|FG000|Overall Study|Administrative reasons|5
2130354|NCT01032915|3733892|FG001|Overall Study|Administrative reasons|6
2130355|NCT01032915|3733893|FG002|Overall Study|Administrative reasons|4
2130356|NCT01032915|3733894|FG003|Overall Study|Administrative reasons|4
2130357|NCT01032915|3733891|FG000|Overall Study|Protocol Violation|1
2130358|NCT01032915|3733892|FG001|Overall Study|Protocol Violation|0
2206584|NCT01621490|3845086|FG007|Overall Study|Complete response|0
2206585|NCT01621490|3845087|FG008|Overall Study|Complete response|1
2206586|NCT01621490|3845079|FG000|Overall Study|Patient delayed due to toxicity|0
2206587|NCT01621490|3845080|FG001|Overall Study|Patient delayed due to toxicity|0
2206588|NCT01621490|3845081|FG002|Overall Study|Patient delayed due to toxicity|0
2206589|NCT01621490|3845082|FG003|Overall Study|Patient delayed due to toxicity|0
2206590|NCT01621490|3845083|FG004|Overall Study|Patient delayed due to toxicity|0
2206591|NCT01621490|3845084|FG005|Overall Study|Patient delayed due to toxicity|1
2206592|NCT01621490|3845085|FG006|Overall Study|Patient delayed due to toxicity|0
2206593|NCT01621490|3845086|FG007|Overall Study|Patient delayed due to toxicity|0
2206594|NCT01621490|3845087|FG008|Overall Study|Patient delayed due to toxicity|0
2206595|NCT01621542|3845206|FG000|Overall Study|Adverse Event|0
2206596|NCT01621542|3845207|FG001|Overall Study|Adverse Event|0
2206597|NCT01621542|3845208|FG002|Overall Study|Adverse Event|1
2206598|NCT01621542|3845209|FG003|Overall Study|Adverse Event|3
2206599|NCT01621542|3845210|FG004|Overall Study|Adverse Event|0
2206600|NCT01621542|3845211|FG005|Overall Study|Adverse Event|0
2130359|NCT01032915|3733893|FG002|Overall Study|Protocol Violation|0
2130360|NCT01032915|3733894|FG003|Overall Study|Protocol Violation|1
2130361|NCT01033019|3733936|FG000|Overall Study|Withdrawal by Subject|1
2130362|NCT01033019|3733937|FG001|Overall Study|Withdrawal by Subject|0
2130363|NCT01033071|3733954|FG000|Overall Study|Adverse Event|28
2130364|NCT01033071|3733955|FG001|Overall Study|Adverse Event|51
2130365|NCT01033071|3733956|FG002|Overall Study|Adverse Event|26
2130366|NCT01033071|3733954|FG000|Overall Study|Protocol Violation|0
2130367|NCT01033071|3733955|FG001|Overall Study|Protocol Violation|2
2130368|NCT01033071|3733956|FG002|Overall Study|Protocol Violation|1
2130369|NCT01033071|3733954|FG000|Overall Study|Lost to Follow-up|4
2130370|NCT01033071|3733955|FG001|Overall Study|Lost to Follow-up|5
2130371|NCT01033071|3733956|FG002|Overall Study|Lost to Follow-up|5
2130372|NCT01033071|3733954|FG000|Overall Study|Withdrawal by Subject|17
2130373|NCT01033071|3733955|FG001|Overall Study|Withdrawal by Subject|14
2130374|NCT01033071|3733956|FG002|Overall Study|Withdrawal by Subject|11
2130375|NCT01033071|3733954|FG000|Overall Study|Lack of Efficacy|0
2130376|NCT01033071|3733955|FG001|Overall Study|Lack of Efficacy|1
2130377|NCT01033071|3733956|FG002|Overall Study|Lack of Efficacy|1
2130378|NCT01033071|3733954|FG000|Overall Study|Other|6
2130379|NCT01033071|3733955|FG001|Overall Study|Other|4
2130380|NCT01033071|3733956|FG002|Overall Study|Other|3
2130381|NCT01033136|3733966|FG000|Follow-Up (3 Month)|Lost to Follow-up|2
2130382|NCT01033136|3733967|FG001|Follow-Up (3 Month)|Lost to Follow-up|2
2130383|NCT01033240|3733989|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10
2130384|NCT01033240|3733990|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8
2130385|NCT01033240|3733991|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6
2130386|NCT01033240|3733989|FG000|Overall Study|Death|2
2130387|NCT01033240|3733990|FG001|Overall Study|Death|0
2130388|NCT01033240|3733991|FG002|Overall Study|Death|0
2130389|NCT01033240|3733989|FG000|Overall Study|Withdrew Consent|2
2130390|NCT01033240|3733990|FG001|Overall Study|Withdrew Consent|9
2130391|NCT01033240|3733991|FG002|Overall Study|Withdrew Consent|2
2130392|NCT01033240|3733989|FG000|Overall Study|Disease Progression|35
2130393|NCT01033240|3733990|FG001|Overall Study|Disease Progression|32
2130394|NCT01033240|3733991|FG002|Overall Study|Disease Progression|41
2130395|NCT01033240|3733989|FG000|Overall Study|Investigator Discretion|0
2130396|NCT01033240|3733990|FG001|Overall Study|Investigator Discretion|0
2130397|NCT01033240|3733991|FG002|Overall Study|Investigator Discretion|2
2130398|NCT01033240|3733989|FG000|Overall Study|Other|0
2130399|NCT01033240|3733990|FG001|Overall Study|Other|1
2130400|NCT01033240|3733991|FG002|Overall Study|Other|2
2130401|NCT01033448|3734029|FG000|Overall Study|Withdrawal by Subject|4
2130402|NCT01033448|3734029|FG000|Overall Study|Positive HCV-RNA at week 48|1
2130403|NCT01033448|3734029|FG000|Overall Study|Lost to Follow-up|3
2130404|NCT01033448|3734029|FG000|Overall Study|Withdrew due to other reasons|3
2130405|NCT01033448|3734029|FG000|Overall Study|Unknown disposition|1
2130406|NCT01033487|3734035|FG000|Fourth Intervention Period|Adverse Event|0
2130407|NCT01033487|3734036|FG001|Fourth Intervention Period|Adverse Event|0
2130408|NCT01033487|3734037|FG002|Fourth Intervention Period|Adverse Event|0
2130409|NCT01033487|3734038|FG003|Fourth Intervention Period|Adverse Event|0
2130410|NCT01033487|3734039|FG004|Fourth Intervention Period|Adverse Event|0
2130411|NCT01033487|3734040|FG005|Fourth Intervention Period|Adverse Event|0
2130412|NCT01033487|3734041|FG006|Fourth Intervention Period|Adverse Event|0
2130413|NCT01033487|3734042|FG007|Fourth Intervention Period|Adverse Event|0
2130414|NCT01033487|3734043|FG008|Fourth Intervention Period|Adverse Event|1
2130415|NCT01033487|3734044|FG009|Fourth Intervention Period|Adverse Event|0
2130416|NCT01033643|3734067|FG000|Overall Study|Withdrew Consent|0
2130417|NCT01033643|3734068|FG001|Overall Study|Withdrew Consent|3
2130418|NCT01033643|3734069|FG002|Overall Study|Withdrew Consent|0
2130419|NCT01033643|3734070|FG003|Overall Study|Withdrew Consent|0
2130420|NCT01033643|3734071|FG004|Overall Study|Withdrew Consent|0
2130421|NCT01033643|3734072|FG005|Overall Study|Withdrew Consent|1
2130422|NCT01033734|3734086|FG000|Overall Study|Withdrawal by Subject|1
2130423|NCT01033747|3734101|FG000|Overall Study|Adverse Event|9
2130424|NCT01033747|3734102|FG001|Overall Study|Adverse Event|4
2130425|NCT01033747|3734101|FG000|Overall Study|Abnormal Laboratory Value|1
2130426|NCT01033747|3734102|FG001|Overall Study|Abnormal Laboratory Value|0
2130427|NCT01033747|3734101|FG000|Overall Study|Abnormal test procedure|0
2130428|NCT01033747|3734102|FG001|Overall Study|Abnormal test procedure|1
2130429|NCT01033747|3734101|FG000|Overall Study|Unsatisfactory therapeutic effect|14
2130430|NCT01033747|3734102|FG001|Overall Study|Unsatisfactory therapeutic effect|4
2130431|NCT01033747|3734101|FG000|Overall Study|Protocol Violation|1
2130432|NCT01033747|3734102|FG001|Overall Study|Protocol Violation|0
2130433|NCT01033747|3734101|FG000|Overall Study|Withdrawal by Subject|9
2130434|NCT01033747|3734102|FG001|Overall Study|Withdrawal by Subject|6
2130435|NCT01033747|3734101|FG000|Overall Study|Stopped at end of prolongation visit 1|1
2130436|NCT01033747|3734102|FG001|Overall Study|Stopped at end of prolongation visit 1|0
2130437|NCT01033747|3734101|FG000|Overall Study|Stopped at end of Extension 1|2
2130438|NCT01033747|3734102|FG001|Overall Study|Stopped at end of Extension 1|0
2130439|NCT01033825|3734119|FG000|Overall Study|Withdrawal by Subject|2
2130440|NCT01033825|3734120|FG001|Overall Study|Withdrawal by Subject|3
2130441|NCT01033825|3734121|FG002|Overall Study|Withdrawal by Subject|2
2130442|NCT01033825|3734122|FG003|Overall Study|Withdrawal by Subject|1
2283807|NCT02404441|3971122|FG008|Phase 1 Part|Physician Decision|0
2283808|NCT02404441|3971123|FG009|Phase 1 Part|Physician Decision|0
2283809|NCT02404441|3971114|FG000|Phase 1 Part|Progressive Disease|14
2283810|NCT02404441|3971115|FG001|Phase 1 Part|Progressive Disease|11
2283811|NCT02404441|3971116|FG002|Phase 1 Part|Progressive Disease|7
2283812|NCT02404441|3971117|FG003|Phase 1 Part|Progressive Disease|6
2283813|NCT02404441|3971118|FG004|Phase 1 Part|Progressive Disease|9
2283814|NCT02404441|3971119|FG005|Phase 1 Part|Progressive Disease|0
2283815|NCT02404441|3971120|FG006|Phase 1 Part|Progressive Disease|0
2283816|NCT02404441|3971121|FG007|Phase 1 Part|Progressive Disease|0
2283817|NCT02404441|3971122|FG008|Phase 1 Part|Progressive Disease|0
2283818|NCT02404441|3971123|FG009|Phase 1 Part|Progressive Disease|0
2283819|NCT02404441|3971114|FG000|Phase 1 Part|Subject/Guardian Decision|0
2283820|NCT02404441|3971115|FG001|Phase 1 Part|Subject/Guardian Decision|2
2283821|NCT02404441|3971116|FG002|Phase 1 Part|Subject/Guardian Decision|3
2283822|NCT02404441|3971117|FG003|Phase 1 Part|Subject/Guardian Decision|0
2283823|NCT02404441|3971118|FG004|Phase 1 Part|Subject/Guardian Decision|0
2283824|NCT02404441|3971119|FG005|Phase 1 Part|Subject/Guardian Decision|0
2283825|NCT02404441|3971120|FG006|Phase 1 Part|Subject/Guardian Decision|0
2283826|NCT02404441|3971121|FG007|Phase 1 Part|Subject/Guardian Decision|0
2283827|NCT02404441|3971122|FG008|Phase 1 Part|Subject/Guardian Decision|0
2283828|NCT02404441|3971123|FG009|Phase 1 Part|Subject/Guardian Decision|0
2283829|NCT02404441|3971114|FG000|Phase 1 Part|Death|1
2283830|NCT02404441|3971115|FG001|Phase 1 Part|Death|1
2283831|NCT02404441|3971116|FG002|Phase 1 Part|Death|1
2283832|NCT02404441|3971117|FG003|Phase 1 Part|Death|0
2283833|NCT02404441|3971118|FG004|Phase 1 Part|Death|1
2283834|NCT02404441|3971119|FG005|Phase 1 Part|Death|0
2283835|NCT02404441|3971120|FG006|Phase 1 Part|Death|0
2283836|NCT02404441|3971121|FG007|Phase 1 Part|Death|0
2283837|NCT02404441|3971122|FG008|Phase 1 Part|Death|0
2283838|NCT02404441|3971123|FG009|Phase 1 Part|Death|0
2283839|NCT02404441|3971114|FG000|Phase 2 Part|Adverse Event|0
2283840|NCT02404441|3971115|FG001|Phase 2 Part|Adverse Event|0
2283841|NCT02404441|3971116|FG002|Phase 2 Part|Adverse Event|0
2283842|NCT02404441|3971117|FG003|Phase 2 Part|Adverse Event|0
2283843|NCT02404441|3971118|FG004|Phase 2 Part|Adverse Event|0
2283844|NCT02404441|3971119|FG005|Phase 2 Part|Adverse Event|2
2283845|NCT02404441|3971120|FG006|Phase 2 Part|Adverse Event|3
2283846|NCT02404441|3971121|FG007|Phase 2 Part|Adverse Event|3
2283847|NCT02404441|3971122|FG008|Phase 2 Part|Adverse Event|6
2283848|NCT02404441|3971123|FG009|Phase 2 Part|Adverse Event|1
2130443|NCT01033825|3734123|FG004|Overall Study|Withdrawal by Subject|1
2130444|NCT01033825|3734124|FG005|Overall Study|Withdrawal by Subject|0
2130445|NCT01033825|3734125|FG006|Overall Study|Withdrawal by Subject|0
2130446|NCT01033825|3734119|FG000|Overall Study|Adverse Event|0
2130447|NCT01033825|3734120|FG001|Overall Study|Adverse Event|0
2130448|NCT01033825|3734121|FG002|Overall Study|Adverse Event|0
2130449|NCT01033825|3734122|FG003|Overall Study|Adverse Event|1
2130450|NCT01033825|3734123|FG004|Overall Study|Adverse Event|0
2130451|NCT01033825|3734124|FG005|Overall Study|Adverse Event|0
2130452|NCT01033825|3734125|FG006|Overall Study|Adverse Event|0
2130453|NCT01033825|3734119|FG000|Overall Study|Protocol Violation|1
2130454|NCT01033825|3734120|FG001|Overall Study|Protocol Violation|0
2283849|NCT02404441|3971114|FG000|Phase 2 Part|Physician Decision|0
2283850|NCT02404441|3971115|FG001|Phase 2 Part|Physician Decision|0
2283851|NCT02404441|3971116|FG002|Phase 2 Part|Physician Decision|0
2283852|NCT02404441|3971117|FG003|Phase 2 Part|Physician Decision|0
2283853|NCT02404441|3971118|FG004|Phase 2 Part|Physician Decision|0
2283854|NCT02404441|3971119|FG005|Phase 2 Part|Physician Decision|7
2283855|NCT02404441|3971120|FG006|Phase 2 Part|Physician Decision|9
2283856|NCT02404441|3971121|FG007|Phase 2 Part|Physician Decision|2
2283857|NCT02404441|3971122|FG008|Phase 2 Part|Physician Decision|1
2283858|NCT02404441|3971123|FG009|Phase 2 Part|Physician Decision|3
2130455|NCT01033825|3734121|FG002|Overall Study|Protocol Violation|0
2130456|NCT01033825|3734122|FG003|Overall Study|Protocol Violation|0
2130457|NCT01033825|3734123|FG004|Overall Study|Protocol Violation|0
2130458|NCT01033825|3734124|FG005|Overall Study|Protocol Violation|0
2130459|NCT01033825|3734125|FG006|Overall Study|Protocol Violation|0
2130460|NCT01033825|3734119|FG000|Overall Study|Other|0
2130461|NCT01033825|3734120|FG001|Overall Study|Other|0
2130462|NCT01033825|3734121|FG002|Overall Study|Other|0
2130463|NCT01033825|3734122|FG003|Overall Study|Other|0
2130464|NCT01033825|3734123|FG004|Overall Study|Other|1
2130465|NCT01033825|3734124|FG005|Overall Study|Other|0
2130466|NCT01033825|3734125|FG006|Overall Study|Other|0
2130467|NCT01033851|3734145|FG000|Overall Study|Withdrawal by Subject|3
2130468|NCT01033851|3734146|FG001|Overall Study|Withdrawal by Subject|7
2130469|NCT01033942|3734164|FG000|Overall Study|Withdrawal by Subject|1
2283859|NCT02404441|3971114|FG000|Phase 2 Part|Progressive disease|0
2283860|NCT02404441|3971115|FG001|Phase 2 Part|Progressive disease|0
2283861|NCT02404441|3971116|FG002|Phase 2 Part|Progressive disease|0
2283862|NCT02404441|3971117|FG003|Phase 2 Part|Progressive disease|0
2283863|NCT02404441|3971118|FG004|Phase 2 Part|Progressive disease|0
2283864|NCT02404441|3971119|FG005|Phase 2 Part|Progressive disease|43
2283865|NCT02404441|3971120|FG006|Phase 2 Part|Progressive disease|32
2283866|NCT02404441|3971121|FG007|Phase 2 Part|Progressive disease|31
2283867|NCT02404441|3971122|FG008|Phase 2 Part|Progressive disease|39
2283868|NCT02404441|3971123|FG009|Phase 2 Part|Progressive disease|27
2283869|NCT02404441|3971114|FG000|Phase 2 Part|Subject/guardian decision|0
2283870|NCT02404441|3971115|FG001|Phase 2 Part|Subject/guardian decision|0
2283871|NCT02404441|3971116|FG002|Phase 2 Part|Subject/guardian decision|0
2283872|NCT02404441|3971117|FG003|Phase 2 Part|Subject/guardian decision|0
2283873|NCT02404441|3971118|FG004|Phase 2 Part|Subject/guardian decision|0
2283874|NCT02404441|3971119|FG005|Phase 2 Part|Subject/guardian decision|3
2283875|NCT02404441|3971120|FG006|Phase 2 Part|Subject/guardian decision|9
2283876|NCT02404441|3971121|FG007|Phase 2 Part|Subject/guardian decision|0
2283877|NCT02404441|3971122|FG008|Phase 2 Part|Subject/guardian decision|3
2283878|NCT02404441|3971123|FG009|Phase 2 Part|Subject/guardian decision|2
2283879|NCT02404441|3971114|FG000|Phase 2 Part|Death|0
2283880|NCT02404441|3971115|FG001|Phase 2 Part|Death|0
2283881|NCT02404441|3971116|FG002|Phase 2 Part|Death|0
2283882|NCT02404441|3971117|FG003|Phase 2 Part|Death|0
2283883|NCT02404441|3971118|FG004|Phase 2 Part|Death|0
2283884|NCT02404441|3971119|FG005|Phase 2 Part|Death|4
2283885|NCT02404441|3971120|FG006|Phase 2 Part|Death|8
2283886|NCT02404441|3971121|FG007|Phase 2 Part|Death|4
2283887|NCT02404441|3971122|FG008|Phase 2 Part|Death|10
2283888|NCT02404441|3971123|FG009|Phase 2 Part|Death|9
2283889|NCT02404493|3971169|FG000|Overall Study|Adverse Event|1
2283890|NCT02404493|3971170|FG001|Overall Study|Adverse Event|1
2283891|NCT02404649|3971196|FG000|Overall Study|Adverse Event|1
2283892|NCT02404649|3971197|FG001|Overall Study|Adverse Event|2
2283893|NCT02404805|3971220|FG000|Overall Study|Withdrawal by Subject|1
2283894|NCT02404805|3971221|FG001|Overall Study|Withdrawal by Subject|0
2130470|NCT01033942|3734165|FG001|Overall Study|Withdrawal by Subject|1
2130471|NCT01033942|3734166|FG002|Overall Study|Withdrawal by Subject|1
2283895|NCT02404805|3971222|FG002|Overall Study|Withdrawal by Subject|0
2283896|NCT02404805|3971223|FG003|Overall Study|Withdrawal by Subject|0
2283897|NCT02404805|3971224|FG004|Overall Study|Withdrawal by Subject|0
2283898|NCT02404805|3971225|FG005|Overall Study|Withdrawal by Subject|0
2283899|NCT02405091|3971237|FG000|Overall Study|Adverse Event|16
2283900|NCT02405091|3971238|FG001|Overall Study|Adverse Event|10
2283901|NCT02405091|3971239|FG002|Overall Study|Adverse Event|0
2283902|NCT02405091|3971237|FG000|Overall Study|Protocol Violation|1
2283903|NCT02405091|3971238|FG001|Overall Study|Protocol Violation|0
2283904|NCT02405091|3971239|FG002|Overall Study|Protocol Violation|0
2283905|NCT02405091|3971237|FG000|Overall Study|Noncompliance|1
2283906|NCT02405091|3971238|FG001|Overall Study|Noncompliance|6
2283907|NCT02405091|3971239|FG002|Overall Study|Noncompliance|2
2130472|NCT01033942|3734164|FG000|Overall Study|Lost to Follow-up|1
2130473|NCT01033942|3734165|FG001|Overall Study|Lost to Follow-up|0
2130474|NCT01033942|3734166|FG002|Overall Study|Lost to Follow-up|0
2130475|NCT01033942|3734164|FG000|Overall Study|Enrolled in Extension Study|0
2130476|NCT01033942|3734165|FG001|Overall Study|Enrolled in Extension Study|3
2130477|NCT01033942|3734166|FG002|Overall Study|Enrolled in Extension Study|0
2130478|NCT01034137|3734183|FG000|Overall Study|Adverse Event|9
2130479|NCT01034137|3734184|FG001|Overall Study|Adverse Event|10
2130480|NCT01034137|3734185|FG002|Overall Study|Adverse Event|8
2130481|NCT01034137|3734183|FG000|Overall Study|Withdrawal by Subject|4
2130482|NCT01034137|3734184|FG001|Overall Study|Withdrawal by Subject|3
2130483|NCT01034137|3734185|FG002|Overall Study|Withdrawal by Subject|3
2130484|NCT01034137|3734183|FG000|Overall Study|Lack of Efficacy|9
2130485|NCT01034137|3734184|FG001|Overall Study|Lack of Efficacy|4
2130486|NCT01034137|3734185|FG002|Overall Study|Lack of Efficacy|13
2130487|NCT01034137|3734183|FG000|Overall Study|Protocol Violation|2
2130488|NCT01034137|3734184|FG001|Overall Study|Protocol Violation|2
2130489|NCT01034137|3734185|FG002|Overall Study|Protocol Violation|1
2130490|NCT01034137|3734183|FG000|Overall Study|Refused treatment or did not cooperate|2
2130491|NCT01034137|3734184|FG001|Overall Study|Refused treatment or did not cooperate|0
2283908|NCT02405091|3971237|FG000|Overall Study|Withdrawal by Subject|4
2283909|NCT02405091|3971238|FG001|Overall Study|Withdrawal by Subject|8
2283910|NCT02405091|3971239|FG002|Overall Study|Withdrawal by Subject|0
2283911|NCT02405091|3971237|FG000|Overall Study|Death|0
2283912|NCT02405091|3971238|FG001|Overall Study|Death|1
2283913|NCT02405091|3971239|FG002|Overall Study|Death|0
2283914|NCT02405091|3971237|FG000|Overall Study|Lost to Follow-up|5
2283915|NCT02405091|3971238|FG001|Overall Study|Lost to Follow-up|6
2283916|NCT02405091|3971239|FG002|Overall Study|Lost to Follow-up|0
2283917|NCT02405091|3971237|FG000|Overall Study|Physician Decision|2
2283918|NCT02405091|3971238|FG001|Overall Study|Physician Decision|2
2283919|NCT02405091|3971239|FG002|Overall Study|Physician Decision|0
2283920|NCT02405442|3971280|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0
2283921|NCT02405442|3971281|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2
2283922|NCT02405442|3971282|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4
2283923|NCT02405442|3971283|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1
2283924|NCT02405442|3971280|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
2283925|NCT02405442|3971281|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
2283926|NCT02405442|3971282|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
2283927|NCT02405442|3971283|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
2283928|NCT02405442|3971280|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
2283929|NCT02405442|3971281|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
2283930|NCT02405442|3971282|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
2283931|NCT02405442|3971283|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
2283932|NCT02405442|3971280|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
2283933|NCT02405442|3971281|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
2283934|NCT02405442|3971282|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
2283935|NCT02405442|3971283|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
2283936|NCT02405442|3971280|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
2283937|NCT02405442|3971281|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
2283938|NCT02405442|3971282|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
2283939|NCT02405442|3971283|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
2283940|NCT02405442|3971280|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
2283941|NCT02405442|3971281|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
2283942|NCT02405442|3971282|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
2283943|NCT02405442|3971283|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
2283944|NCT02405442|3971280|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6
2283945|NCT02405442|3971281|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1
2283946|NCT02405442|3971282|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2
2283947|NCT02405442|3971283|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6
2283948|NCT02405442|3971280|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
2283949|NCT02405442|3971281|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
2283950|NCT02405442|3971282|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
2283951|NCT02405442|3971283|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
2283952|NCT02405442|3971280|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1
2041573|NCT00440011|3612310|FG001|Overall Study|Protocol Violation|1
2041574|NCT00440011|3612309|FG000|Overall Study|Withdrawal by Subject|1
2283953|NCT02405442|3971281|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2
2283954|NCT02405442|3971282|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1
2283955|NCT02405442|3971283|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1
2283956|NCT02405442|3971280|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
2041575|NCT00440011|3612310|FG001|Overall Study|Withdrawal by Subject|0
2130492|NCT01034137|3734185|FG002|Overall Study|Refused treatment or did not cooperate|1
2130493|NCT01034137|3734183|FG000|Overall Study|Administrative or other|2
2130494|NCT01034137|3734184|FG001|Overall Study|Administrative or other|3
2130495|NCT01034137|3734185|FG002|Overall Study|Administrative or other|4
2130496|NCT01034163|3734196|FG000|Overall Study|Treatment completed as per protocol|8
2130497|NCT01034163|3734197|FG001|Overall Study|Treatment completed as per protocol|7
2130498|NCT01034163|3734196|FG000|Overall Study|Withdrawal by Subject|8
2130499|NCT01034163|3734197|FG001|Overall Study|Withdrawal by Subject|2
2130500|NCT01034163|3734196|FG000|Overall Study|Protocol deviation|1
2130501|NCT01034163|3734197|FG001|Overall Study|Protocol deviation|0
2283957|NCT02405442|3971281|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
2283958|NCT02405442|3971282|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
2283959|NCT02405442|3971283|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
2283960|NCT02405442|3971280|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
2283961|NCT02405442|3971281|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
2283962|NCT02405442|3971282|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
2283963|NCT02405442|3971283|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
2283964|NCT02405442|3971280|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
2283965|NCT02405442|3971281|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
2283966|NCT02405442|3971282|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
2283967|NCT02405442|3971283|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
2283968|NCT02405442|3971280|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
2283969|NCT02405442|3971281|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
2283970|NCT02405442|3971282|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
2283971|NCT02405442|3971283|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
2283972|NCT02405442|3971280|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
2283973|NCT02405442|3971281|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
2283974|NCT02405442|3971282|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
2283975|NCT02405442|3971283|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
2283976|NCT02405780|3971301|FG000|Period I|Adverse Event|8
2283977|NCT02405780|3971302|FG001|Period I|Adverse Event|0
2283978|NCT02405780|3971303|FG002|Period I|Adverse Event|3
2283979|NCT02405780|3971304|FG003|Period I|Adverse Event|7
2283980|NCT02405780|3971301|FG000|Period I|Medical reasons|1
2283981|NCT02405780|3971302|FG001|Period I|Medical reasons|1
2283982|NCT02405780|3971303|FG002|Period I|Medical reasons|0
2283983|NCT02405780|3971304|FG003|Period I|Medical reasons|1
2283984|NCT02405780|3971301|FG000|Period I|Screening Failure|1
2283985|NCT02405780|3971302|FG001|Period I|Screening Failure|0
2283986|NCT02405780|3971303|FG002|Period I|Screening Failure|1
2283987|NCT02405780|3971304|FG003|Period I|Screening Failure|0
2283988|NCT02405780|3971301|FG000|Period I|Withdrawal by Subject|9
2283989|NCT02405780|3971302|FG001|Period I|Withdrawal by Subject|1
2283990|NCT02405780|3971303|FG002|Period I|Withdrawal by Subject|3
2283991|NCT02405780|3971304|FG003|Period I|Withdrawal by Subject|4
2283992|NCT02405780|3971301|FG000|Period I|Non-compliance with study procedures|8
2283993|NCT02405780|3971302|FG001|Period I|Non-compliance with study procedures|6
2283994|NCT02405780|3971303|FG002|Period I|Non-compliance with study procedures|8
2283995|NCT02405780|3971304|FG003|Period I|Non-compliance with study procedures|11
2283996|NCT02405780|3971301|FG000|Period II|Adverse Event|3
2283997|NCT02405780|3971302|FG001|Period II|Adverse Event|5
2283998|NCT02405780|3971303|FG002|Period II|Adverse Event|4
2283999|NCT02405780|3971304|FG003|Period II|Adverse Event|11
2284000|NCT02405780|3971301|FG000|Period II|Medical reason|0
2284001|NCT02405780|3971302|FG001|Period II|Medical reason|1
2284002|NCT02405780|3971303|FG002|Period II|Medical reason|0
2284003|NCT02405780|3971304|FG003|Period II|Medical reason|0
2284004|NCT02405780|3971301|FG000|Period II|Pregnancy|0
2284005|NCT02405780|3971302|FG001|Period II|Pregnancy|0
2284006|NCT02405780|3971303|FG002|Period II|Pregnancy|1
2284007|NCT02405780|3971304|FG003|Period II|Pregnancy|0
2284008|NCT02405780|3971301|FG000|Period II|Withdrawal by Subject|7
2284009|NCT02405780|3971302|FG001|Period II|Withdrawal by Subject|4
2284010|NCT02405780|3971303|FG002|Period II|Withdrawal by Subject|0
2284011|NCT02405780|3971304|FG003|Period II|Withdrawal by Subject|3
2284012|NCT02405780|3971301|FG000|Period II|Non-compliance with study procedures|5
2284013|NCT02405780|3971302|FG001|Period II|Non-compliance with study procedures|2
2284014|NCT02405780|3971303|FG002|Period II|Non-compliance with study procedures|7
2284015|NCT02405780|3971304|FG003|Period II|Non-compliance with study procedures|4
2284016|NCT02405962|3971331|FG000|Overall Study|Lost to Follow-up|1
2284017|NCT02405962|3971332|FG001|Overall Study|Lost to Follow-up|4
2284018|NCT02405962|3971331|FG000|Overall Study|A participant has moved to another place|0
2284019|NCT02405962|3971332|FG001|Overall Study|A participant has moved to another place|1
2284020|NCT02406027|3971341|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2284021|NCT02406027|3971342|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2
2284022|NCT02406027|3971343|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1
2284023|NCT02406027|3971344|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2284024|NCT02406027|3971345|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2284025|NCT02406027|3971346|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2284026|NCT02406027|3971347|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2284027|NCT02406027|3971341|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3
2130502|NCT01034163|3734196|FG000|Overall Study|Disease progression|3
2130503|NCT01034163|3734197|FG001|Overall Study|Disease progression|4
2130504|NCT01034163|3734196|FG000|Overall Study|Adverse Event|6
2130505|NCT01034163|3734197|FG001|Overall Study|Adverse Event|0
2130506|NCT01034163|3734196|FG000|Overall Study|Administrative problems|0
2130507|NCT01034163|3734197|FG001|Overall Study|Administrative problems|1
2130508|NCT01034163|3734196|FG000|Overall Study|Abnormal laboratory value|1
2130509|NCT01034163|3734197|FG001|Overall Study|Abnormal laboratory value|0
2130510|NCT01034176|3734205|FG000|Overall Study|Physician Decision|2
2130511|NCT01034176|3734206|FG001|Overall Study|Physician Decision|0
2130512|NCT01034176|3734205|FG000|Overall Study|Withdrawal by Subject|0
2130513|NCT01034176|3734206|FG001|Overall Study|Withdrawal by Subject|1
2130514|NCT01034176|3734205|FG000|Overall Study|Lost to Follow-up|0
2130515|NCT01034176|3734206|FG001|Overall Study|Lost to Follow-up|1
2130516|NCT01034306|3734214|FG000|Overall Study|Adverse Event|1
2130517|NCT01034306|3734215|FG001|Overall Study|Adverse Event|0
2130518|NCT01034306|3734214|FG000|Overall Study|Lost to Follow-up|0
2130519|NCT01034306|3734215|FG001|Overall Study|Lost to Follow-up|1
2130520|NCT01034306|3734214|FG000|Overall Study|Withdrawal by Subject|2
2130521|NCT01034306|3734215|FG001|Overall Study|Withdrawal by Subject|2
2130522|NCT01034306|3734214|FG000|Overall Study|hospitalized and decided to stop|1
2130523|NCT01034306|3734215|FG001|Overall Study|hospitalized and decided to stop|0
2130524|NCT01034306|3734214|FG000|Overall Study|Noncomplience|1
2130525|NCT01034306|3734215|FG001|Overall Study|Noncomplience|0
2130526|NCT01034358|3734221|FG000|Overall Study|Withdrawal by Subject|1
2130527|NCT01034358|3734221|FG000|Overall Study|Protocol Violation|1
2130528|NCT01034397|3734227|FG000|Overall Study|Lack of compliance|0
2130529|NCT01034397|3734228|FG001|Overall Study|Lack of compliance|1
2130530|NCT01034397|3734227|FG000|Overall Study|Lack of Efficacy|3
2130531|NCT01034397|3734228|FG001|Overall Study|Lack of Efficacy|0
2130532|NCT01034397|3734227|FG000|Overall Study|Adverse Event|4
2130533|NCT01034397|3734228|FG001|Overall Study|Adverse Event|0
2130534|NCT01034397|3734227|FG000|Overall Study|Other|0
2130535|NCT01034397|3734228|FG001|Overall Study|Other|1
2130536|NCT01034462|3734245|FG000|Overall Study|Adverse Event|7
2130537|NCT01034462|3734246|FG001|Overall Study|Adverse Event|17
2130538|NCT01034462|3734245|FG000|Overall Study|Lack of Efficacy|4
2130539|NCT01034462|3734246|FG001|Overall Study|Lack of Efficacy|4
2130540|NCT01034462|3734245|FG000|Overall Study|Protocol Violation|10
2206601|NCT01621542|3845206|FG000|Overall Study|Death|0
2206602|NCT01621542|3845207|FG001|Overall Study|Death|1
2206603|NCT01621542|3845208|FG002|Overall Study|Death|0
2206604|NCT01621542|3845209|FG003|Overall Study|Death|0
2206605|NCT01621542|3845210|FG004|Overall Study|Death|0
2206606|NCT01621542|3845211|FG005|Overall Study|Death|0
2206607|NCT01621542|3845206|FG000|Overall Study|Physician Decision|1
2206608|NCT01621542|3845207|FG001|Overall Study|Physician Decision|0
2206609|NCT01621542|3845208|FG002|Overall Study|Physician Decision|1
2206610|NCT01621542|3845209|FG003|Overall Study|Physician Decision|13
2130541|NCT01034462|3734246|FG001|Overall Study|Protocol Violation|7
2130542|NCT01034462|3734245|FG000|Overall Study|Withdrawal by Subject|9
2130543|NCT01034462|3734246|FG001|Overall Study|Withdrawal by Subject|8
2130544|NCT01034462|3734245|FG000|Overall Study|Lost to Follow-up|14
2130545|NCT01034462|3734246|FG001|Overall Study|Lost to Follow-up|16
2130546|NCT01034462|3734245|FG000|Overall Study|Other reasons|1
2130547|NCT01034462|3734246|FG001|Overall Study|Other reasons|2
2130548|NCT01034540|3734265|FG000|Overall Study|Adverse Event|0
2130549|NCT01034540|3734266|FG001|Overall Study|Adverse Event|1
2130550|NCT01034631|3734310|FG000|Phase I|Symptomatic Deterioration before Treatme|3
2130551|NCT01034631|3734311|FG001|Phase I|Symptomatic Deterioration before Treatme|0
2130552|NCT01034631|3734312|FG002|Phase I|Symptomatic Deterioration before Treatme|0
2130553|NCT01034631|3734310|FG000|Phase II|Not Evaluable per protocol|0
2130554|NCT01034631|3734311|FG001|Phase II|Not Evaluable per protocol|0
2130555|NCT01034631|3734312|FG002|Phase II|Not Evaluable per protocol|2
2130556|NCT01034631|3734310|FG000|Phase II|Determined Ineligible per protocol|0
2130557|NCT01034631|3734311|FG001|Phase II|Determined Ineligible per protocol|1
2130558|NCT01034631|3734312|FG002|Phase II|Determined Ineligible per protocol|0
2130559|NCT01034657|3734322|FG000|Core Phase|Withdrawal by Subject|1
2130560|NCT01034657|3734323|FG001|Core Phase|Withdrawal by Subject|0
2130561|NCT01034657|3734324|FG002|Core Phase|Withdrawal by Subject|0
2130562|NCT01034657|3734322|FG000|Core Phase|Lack of Efficacy|2
2130563|NCT01034657|3734323|FG001|Core Phase|Lack of Efficacy|0
2130564|NCT01034657|3734324|FG002|Core Phase|Lack of Efficacy|0
2130565|NCT01034657|3734322|FG000|Core Phase|Abnormal laboratory value|1
2130566|NCT01034657|3734323|FG001|Core Phase|Abnormal laboratory value|0
2130567|NCT01034657|3734324|FG002|Core Phase|Abnormal laboratory value|0
2130568|NCT01034657|3734322|FG000|Core Phase|Adverse Event|8
2130569|NCT01034657|3734323|FG001|Core Phase|Adverse Event|0
2130570|NCT01034657|3734324|FG002|Core Phase|Adverse Event|0
2130571|NCT01034657|3734322|FG000|Core Phase|Protocol Violation|2
2206611|NCT01621542|3845210|FG004|Overall Study|Physician Decision|3
2130572|NCT01034657|3734323|FG001|Core Phase|Protocol Violation|0
2130573|NCT01034657|3734324|FG002|Core Phase|Protocol Violation|0
2130574|NCT01034657|3734322|FG000|Randomized Phase|Withdrawal by Subject|0
2130575|NCT01034657|3734323|FG001|Randomized Phase|Withdrawal by Subject|2
2206612|NCT01621542|3845211|FG005|Overall Study|Physician Decision|1
2206613|NCT01621542|3845206|FG000|Overall Study|Withdrawal by Subject|2
2130576|NCT01034657|3734324|FG002|Randomized Phase|Withdrawal by Subject|0
2284028|NCT02406027|3971342|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2284029|NCT02406027|3971343|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1
2284030|NCT02406027|3971344|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2284031|NCT02406027|3971345|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2284032|NCT02406027|3971346|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2284033|NCT02406027|3971347|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2284034|NCT02406027|3971341|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
2284035|NCT02406027|3971342|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
2284036|NCT02406027|3971343|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
2284037|NCT02406027|3971344|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2284038|NCT02406027|3971345|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2284039|NCT02406027|3971346|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2284040|NCT02406027|3971347|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2284041|NCT02406027|3971341|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
2284042|NCT02406027|3971342|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2284043|NCT02406027|3971343|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
2284044|NCT02406027|3971344|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2284045|NCT02406027|3971345|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2284046|NCT02406027|3971346|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2284047|NCT02406027|3971347|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2284048|NCT02406027|3971341|FG000|Open-label Phase (Period 2)|Adverse Event|0
2284049|NCT02406027|3971342|FG001|Open-label Phase (Period 2)|Adverse Event|0
2284050|NCT02406027|3971343|FG002|Open-label Phase (Period 2)|Adverse Event|0
2284051|NCT02406027|3971344|FG003|Open-label Phase (Period 2)|Adverse Event|2
2284052|NCT02406027|3971345|FG004|Open-label Phase (Period 2)|Adverse Event|2
2284053|NCT02406027|3971346|FG005|Open-label Phase (Period 2)|Adverse Event|0
2284054|NCT02406027|3971347|FG006|Open-label Phase (Period 2)|Adverse Event|0
2284055|NCT02406027|3971341|FG000|Open-label Phase (Period 2)|Physician Decision|0
2284056|NCT02406027|3971342|FG001|Open-label Phase (Period 2)|Physician Decision|0
2284057|NCT02406027|3971343|FG002|Open-label Phase (Period 2)|Physician Decision|0
2284058|NCT02406027|3971344|FG003|Open-label Phase (Period 2)|Physician Decision|0
2284059|NCT02406027|3971345|FG004|Open-label Phase (Period 2)|Physician Decision|0
2284060|NCT02406027|3971346|FG005|Open-label Phase (Period 2)|Physician Decision|1
2284061|NCT02406027|3971347|FG006|Open-label Phase (Period 2)|Physician Decision|1
2284062|NCT02406027|3971341|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0
2284063|NCT02406027|3971342|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0
2284064|NCT02406027|3971343|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0
2284065|NCT02406027|3971344|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2
2284066|NCT02406027|3971345|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4
2284067|NCT02406027|3971346|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0
2284068|NCT02406027|3971347|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2
2284069|NCT02406027|3971341|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
2284070|NCT02406027|3971342|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
2284071|NCT02406027|3971343|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
2284072|NCT02406027|3971344|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
2284073|NCT02406027|3971345|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
2284074|NCT02406027|3971346|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
2284075|NCT02406027|3971347|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
2284076|NCT02406027|3971341|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2284077|NCT02406027|3971342|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2284078|NCT02406027|3971343|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2284079|NCT02406027|3971344|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2284080|NCT02406027|3971345|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2284081|NCT02406027|3971346|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
2284082|NCT02406027|3971347|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2284083|NCT02406027|3971341|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2284084|NCT02406027|3971342|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2284085|NCT02406027|3971343|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2284086|NCT02406027|3971344|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2284087|NCT02406027|3971345|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
2284088|NCT02406027|3971346|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2284089|NCT02406027|3971347|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2284090|NCT02406248|3971363|FG000|Overall Study|Death|7
2284091|NCT02406248|3971363|FG000|Overall Study|Withdrawal by Subject|2
2284092|NCT02406261|3971369|FG000|Period 1|Lost to Follow-up|2
2284093|NCT02406261|3971370|FG001|Period 1|Lost to Follow-up|0
2284094|NCT02406261|3971369|FG000|Period 1|Adverse Event|1
2284095|NCT02406261|3971370|FG001|Period 1|Adverse Event|0
2130577|NCT01034657|3734322|FG000|Randomized Phase|Lack of Efficacy|5
2130578|NCT01034657|3734323|FG001|Randomized Phase|Lack of Efficacy|1
2130579|NCT01034657|3734324|FG002|Randomized Phase|Lack of Efficacy|0
2130580|NCT01034657|3734322|FG000|Randomized Phase|Abnormal laboratory value|0
2130581|NCT01034657|3734323|FG001|Randomized Phase|Abnormal laboratory value|1
2130582|NCT01034657|3734324|FG002|Randomized Phase|Abnormal laboratory value|0
2130583|NCT01034657|3734322|FG000|Randomized Phase|Adverse Event|0
2130584|NCT01034657|3734323|FG001|Randomized Phase|Adverse Event|2
2130585|NCT01034657|3734324|FG002|Randomized Phase|Adverse Event|1
2130586|NCT01034709|3734336|FG000|Overall Study|Protocol Violation|9
2130587|NCT01034709|3734337|FG001|Overall Study|Protocol Violation|16
2130588|NCT01035060|3734354|FG000|Overall Study|Lost to Follow-up|0
2130589|NCT01035060|3734355|FG001|Overall Study|Lost to Follow-up|7
2130590|NCT01035060|3734354|FG000|Overall Study|Did not quality after 2nd screening|14
2130591|NCT01035060|3734355|FG001|Overall Study|Did not quality after 2nd screening|1
2130592|NCT01035060|3734354|FG000|Overall Study|Withdrawal by Subject|8
2130593|NCT01035060|3734355|FG001|Overall Study|Withdrawal by Subject|6
2130594|NCT01035060|3734354|FG000|Overall Study|Physician Decision|2
2130595|NCT01035060|3734355|FG001|Overall Study|Physician Decision|0
2130596|NCT01035138|3734374|FG000|Overall Study|Adverse Event|4
2130597|NCT01035138|3734375|FG001|Overall Study|Adverse Event|0
2130598|NCT01035138|3734376|FG002|Overall Study|Adverse Event|2
2130599|NCT01035138|3734374|FG000|Overall Study|Caregiver Decision|2
2130600|NCT01035138|3734375|FG001|Overall Study|Caregiver Decision|0
2130601|NCT01035138|3734376|FG002|Overall Study|Caregiver Decision|1
2130602|NCT01035138|3734374|FG000|Overall Study|Withdrawal by Subject|1
2130603|NCT01035138|3734375|FG001|Overall Study|Withdrawal by Subject|0
2130604|NCT01035138|3734376|FG002|Overall Study|Withdrawal by Subject|0
2130605|NCT01035138|3734374|FG000|Overall Study|Physician Decision|0
2130606|NCT01035138|3734375|FG001|Overall Study|Physician Decision|0
2130607|NCT01035138|3734376|FG002|Overall Study|Physician Decision|1
2130608|NCT01035138|3734374|FG000|Overall Study|Sponsor Decision|66
2130609|NCT01035138|3734375|FG001|Overall Study|Sponsor Decision|60
2130610|NCT01035138|3734376|FG002|Overall Study|Sponsor Decision|42
2130611|NCT01035138|3734374|FG000|Overall Study|Lost to Follow-up|0
2130612|NCT01035138|3734375|FG001|Overall Study|Lost to Follow-up|0
2130613|NCT01035138|3734376|FG002|Overall Study|Lost to Follow-up|1
2130614|NCT01035229|3734397|FG000|Overall Study|Adverse Event|61
2130615|NCT01035229|3734398|FG001|Overall Study|Adverse Event|14
2130616|NCT01035229|3734397|FG000|Overall Study|Withdrawal by Subject|20
2130617|NCT01035229|3734398|FG001|Overall Study|Withdrawal by Subject|7
2130618|NCT01035229|3734397|FG000|Overall Study|Lost to Follow-up|1
2130619|NCT01035229|3734398|FG001|Overall Study|Lost to Follow-up|0
2130620|NCT01035229|3734397|FG000|Overall Study|Administrative problems|1
2130621|NCT01035229|3734398|FG001|Overall Study|Administrative problems|1
2130622|NCT01035229|3734397|FG000|Overall Study|Death|13
2130623|NCT01035229|3734398|FG001|Overall Study|Death|5
2130624|NCT01035229|3734397|FG000|Overall Study|New cancer therapy|2
2130625|NCT01035229|3734398|FG001|Overall Study|New cancer therapy|0
2130626|NCT01035229|3734397|FG000|Overall Study|Protocol Violation|0
2130627|NCT01035229|3734398|FG001|Overall Study|Protocol Violation|2
2130628|NCT01035229|3734397|FG000|Overall Study|Sponsor's decision to end study|3
2130629|NCT01035229|3734398|FG001|Overall Study|Sponsor's decision to end study|3
2130630|NCT01035229|3734397|FG000|Overall Study|Disease Progression|261
2130631|NCT01035229|3734398|FG001|Overall Study|Disease Progression|152
2130632|NCT01035255|3734408|FG000|Overall Study|Death|724
2130633|NCT01035255|3734409|FG001|Overall Study|Death|844
2130634|NCT01035255|3734408|FG000|Overall Study|Lost to Follow-up|2
2130635|NCT01035255|3734409|FG001|Overall Study|Lost to Follow-up|5
2130636|NCT01035255|3734408|FG000|Overall Study|patient's request|15
2130637|NCT01035255|3734409|FG001|Overall Study|patient's request|13
2130638|NCT01035463|3734430|FG000|Overall Study|Adverse Event|0
2130639|NCT01035463|3734431|FG001|Overall Study|Adverse Event|0
2130640|NCT01035463|3734432|FG002|Overall Study|Adverse Event|4
2130641|NCT01035463|3734433|FG003|Overall Study|Adverse Event|1
2130642|NCT01035463|3734434|FG004|Overall Study|Adverse Event|5
2130643|NCT01035463|3734435|FG005|Overall Study|Adverse Event|7
2130644|NCT01035463|3734430|FG000|Overall Study|Withdrawal by Subject|0
2130645|NCT01035463|3734431|FG001|Overall Study|Withdrawal by Subject|2
2130646|NCT01035463|3734432|FG002|Overall Study|Withdrawal by Subject|1
2130647|NCT01035463|3734433|FG003|Overall Study|Withdrawal by Subject|0
2130648|NCT01035463|3734434|FG004|Overall Study|Withdrawal by Subject|1
2130649|NCT01035463|3734435|FG005|Overall Study|Withdrawal by Subject|4
2130650|NCT01035463|3734430|FG000|Overall Study|Disease progression|0
2130651|NCT01035463|3734431|FG001|Overall Study|Disease progression|0
2130652|NCT01035463|3734432|FG002|Overall Study|Disease progression|0
2130653|NCT01035463|3734433|FG003|Overall Study|Disease progression|0
2130654|NCT01035463|3734434|FG004|Overall Study|Disease progression|0
2130655|NCT01035463|3734435|FG005|Overall Study|Disease progression|3
2130656|NCT01035463|3734430|FG000|Overall Study|Other Malignancy|0
2130657|NCT01035463|3734431|FG001|Overall Study|Other Malignancy|0
2130658|NCT01035463|3734432|FG002|Overall Study|Other Malignancy|0
2130659|NCT01035463|3734433|FG003|Overall Study|Other Malignancy|0
2130660|NCT01035463|3734434|FG004|Overall Study|Other Malignancy|0
2130661|NCT01035463|3734435|FG005|Overall Study|Other Malignancy|2
2130662|NCT01035463|3734430|FG000|Overall Study|Other|0
2130663|NCT01035463|3734431|FG001|Overall Study|Other|0
2130664|NCT01035463|3734432|FG002|Overall Study|Other|0
2130665|NCT01035463|3734433|FG003|Overall Study|Other|1
2130666|NCT01035463|3734434|FG004|Overall Study|Other|0
2130667|NCT01035463|3734435|FG005|Overall Study|Other|2
2130668|NCT01035606|3734445|FG000|Overall Study|change in health, job demands,family|3
2130669|NCT01035606|3734446|FG001|Overall Study|change in health, job demands,family|3
2130670|NCT01035606|3734447|FG002|Overall Study|change in health, job demands,family|4
2130671|NCT01035905|3734503|FG000|Overall Study|Lack of Efficacy|1
2130672|NCT01035905|3734504|FG001|Overall Study|Lack of Efficacy|1
2130673|NCT01036022|3734526|FG000|Overall Study|Adverse Event|1
2130674|NCT01036022|3734527|FG001|Overall Study|Adverse Event|3
2130675|NCT01036022|3734528|FG002|Overall Study|Adverse Event|2
2130676|NCT01036022|3734529|FG003|Overall Study|Adverse Event|1
2130677|NCT01036022|3734530|FG004|Overall Study|Adverse Event|0
2130678|NCT01036022|3734531|FG005|Overall Study|Adverse Event|2
2130679|NCT01036022|3734526|FG000|Overall Study|Lack of Efficacy|1
2130680|NCT01036022|3734527|FG001|Overall Study|Lack of Efficacy|1
2130681|NCT01036022|3734528|FG002|Overall Study|Lack of Efficacy|1
2130682|NCT01036022|3734529|FG003|Overall Study|Lack of Efficacy|0
2130683|NCT01036022|3734530|FG004|Overall Study|Lack of Efficacy|1
2130684|NCT01036022|3734531|FG005|Overall Study|Lack of Efficacy|1
2130685|NCT01036022|3734526|FG000|Overall Study|Physician Decision|0
2130686|NCT01036022|3734527|FG001|Overall Study|Physician Decision|0
2130687|NCT01036022|3734528|FG002|Overall Study|Physician Decision|1
2130688|NCT01036022|3734529|FG003|Overall Study|Physician Decision|0
2130689|NCT01036022|3734530|FG004|Overall Study|Physician Decision|0
2130690|NCT01036022|3734531|FG005|Overall Study|Physician Decision|0
2130691|NCT01036022|3734526|FG000|Overall Study|Withdrawal by Subject|0
2130692|NCT01036022|3734527|FG001|Overall Study|Withdrawal by Subject|0
2130693|NCT01036022|3734528|FG002|Overall Study|Withdrawal by Subject|0
2130694|NCT01036022|3734529|FG003|Overall Study|Withdrawal by Subject|1
2130695|NCT01036022|3734530|FG004|Overall Study|Withdrawal by Subject|2
2130696|NCT01036022|3734531|FG005|Overall Study|Withdrawal by Subject|0
2130697|NCT01036165|3734553|FG000|Overall Study|Adverse Event|6
2130698|NCT01036165|3734553|FG000|Overall Study|Lost to Follow-up|2
2130699|NCT01036165|3734553|FG000|Overall Study|Withdrawal by Subject|3
2130700|NCT01036165|3734553|FG000|Overall Study|Device Related Issues|3
2130701|NCT01036165|3734553|FG000|Overall Study|Problems finding proper area to inject|1
2284096|NCT02406261|3971369|FG000|Period 2|Physician Decision|0
2284097|NCT02406261|3971370|FG001|Period 2|Physician Decision|1
2284098|NCT02406261|3971369|FG000|Period 2|Protocol Violation|0
2284099|NCT02406261|3971370|FG001|Period 2|Protocol Violation|1
2284100|NCT02406261|3971369|FG000|Period 2|Withdrawal by Subject|0
2284101|NCT02406261|3971370|FG001|Period 2|Withdrawal by Subject|1
2284102|NCT02406586|3971406|FG000|Overall Study|Lost to Follow-up|0
2284103|NCT02406586|3971407|FG001|Overall Study|Lost to Follow-up|4
2284104|NCT02406586|3971408|FG002|Overall Study|Lost to Follow-up|2
2284105|NCT02406586|3971406|FG000|Overall Study|Withdrawal by Subject|1
2284106|NCT02406586|3971407|FG001|Overall Study|Withdrawal by Subject|0
2284107|NCT02406586|3971408|FG002|Overall Study|Withdrawal by Subject|0
2284108|NCT02406612|3971421|FG000|Overall Study|Screening Failure|3
2284109|NCT02406612|3971422|FG001|Overall Study|Screening Failure|0
2284110|NCT02406612|3971421|FG000|Overall Study|Intra-procedural Exclusion|1
2284111|NCT02406612|3971422|FG001|Overall Study|Intra-procedural Exclusion|3
2284112|NCT02406612|3971421|FG000|Overall Study|Guidewire Failure|0
2284113|NCT02406612|3971422|FG001|Overall Study|Guidewire Failure|1
2284114|NCT02406651|3971428|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3
2284115|NCT02406677|3971435|FG000|Overall Study|Death|16
2284116|NCT02406677|3971436|FG001|Overall Study|Death|8
2284117|NCT02406677|3971435|FG000|Overall Study|Discharged without P2Y12|1
2284118|NCT02406677|3971436|FG001|Overall Study|Discharged without P2Y12|3
2284119|NCT02406677|3971435|FG000|Overall Study|Discharged on prasugrel|283
2284120|NCT02406677|3971436|FG001|Overall Study|Discharged on prasugrel|587
2284121|NCT02406677|3971435|FG000|Overall Study|Withdrawal by Subject|1
2284122|NCT02406677|3971436|FG001|Overall Study|Withdrawal by Subject|0
2284123|NCT02406742|3971449|FG000|Overall Study|Progression of Disease|5
2284124|NCT02406742|3971450|FG001|Overall Study|Progression of Disease|1
2284125|NCT02406742|3971451|FG002|Overall Study|Progression of Disease|6
2284126|NCT02406742|3971449|FG000|Overall Study|Adverse Event|3
2284127|NCT02406742|3971450|FG001|Overall Study|Adverse Event|0
2284128|NCT02406742|3971451|FG002|Overall Study|Adverse Event|2
2284129|NCT02406742|3971449|FG000|Overall Study|Death|1
2284130|NCT02406742|3971450|FG001|Overall Study|Death|0
2284131|NCT02406742|3971451|FG002|Overall Study|Death|0
2284132|NCT02406742|3971449|FG000|Overall Study|Lack of Efficacy|0
2284133|NCT02406742|3971450|FG001|Overall Study|Lack of Efficacy|0
2284134|NCT02406742|3971451|FG002|Overall Study|Lack of Efficacy|1
2130702|NCT01036321|3734559|FG000|Overall Study|Ineligible after randomization|0
2130703|NCT01036321|3734560|FG001|Overall Study|Ineligible after randomization|1
2130704|NCT01036321|3734559|FG000|Overall Study|Withdrawal by Subject|3
2130705|NCT01036321|3734560|FG001|Overall Study|Withdrawal by Subject|2
2284135|NCT02406742|3971449|FG000|Overall Study|Withdrawal by Participant|1
2284136|NCT02406742|3971450|FG001|Overall Study|Withdrawal by Participant|2
2284137|NCT02406742|3971451|FG002|Overall Study|Withdrawal by Participant|0
2130706|NCT01036321|3734559|FG000|Overall Study|Adverse Event|2
2130707|NCT01036321|3734560|FG001|Overall Study|Adverse Event|1
2130708|NCT01036438|3734568|FG000|Overall Study|Adverse Event|7
2130709|NCT01036438|3734569|FG001|Overall Study|Adverse Event|8
2130710|NCT01036438|3734568|FG000|Overall Study|Death|0
2130711|NCT01036438|3734569|FG001|Overall Study|Death|1
2130712|NCT01036438|3734568|FG000|Overall Study|No effect of study treatment|3
2130713|NCT01036438|3734569|FG001|Overall Study|No effect of study treatment|1
2130714|NCT01036529|3734586|FG000|Overall Study|Adverse Event|0
2130715|NCT01036529|3734587|FG001|Overall Study|Adverse Event|1
2130716|NCT01036529|3734586|FG000|Overall Study|Lost to Follow-up|0
2130717|NCT01036529|3734587|FG001|Overall Study|Lost to Follow-up|1
2130718|NCT01036529|3734586|FG000|Overall Study|Physician Decision|1
2130719|NCT01036529|3734587|FG001|Overall Study|Physician Decision|0
2130720|NCT01036529|3734586|FG000|Overall Study|Withdrawal by Subject|1
2130721|NCT01036529|3734587|FG001|Overall Study|Withdrawal by Subject|1
2130722|NCT01036529|3734586|FG000|Overall Study|Sponsor study termination|11
2130723|NCT01036529|3734587|FG001|Overall Study|Sponsor study termination|12
2130724|NCT01036594|3734593|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1
2130725|NCT01036594|3734594|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0
2130726|NCT01036594|3734593|FG000|First Treatment Regimen|Withdrawal by Subject|1
2130727|NCT01036594|3734594|FG001|First Treatment Regimen|Withdrawal by Subject|0
2130728|NCT01036594|3734593|FG000|Week 12 Evaluation|Adverse Event|5
2130729|NCT01036594|3734594|FG001|Week 12 Evaluation|Adverse Event|0
2130730|NCT01036594|3734593|FG000|Week 12 Evaluation|Physician Decision|1
2130731|NCT01036594|3734594|FG001|Week 12 Evaluation|Physician Decision|0
2130732|NCT01036594|3734593|FG000|Treatment Regiments Post Week 12|Physician Decision|1
2130733|NCT01036594|3734594|FG001|Treatment Regiments Post Week 12|Physician Decision|1
2130734|NCT01036594|3734593|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1
2130735|NCT01036594|3734594|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
2130736|NCT01036594|3734593|FG000|Treatment Regiments Post Week 12|Adverse Event|0
2130737|NCT01036594|3734594|FG001|Treatment Regiments Post Week 12|Adverse Event|1
2130738|NCT01036594|3734593|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0
2130739|NCT01036594|3734594|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1
2130740|NCT01036594|3734593|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0
2130741|NCT01036594|3734594|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1
2130742|NCT01036724|3734602|FG000|Overall Study|Adverse Event|1
2130743|NCT01036724|3734603|FG001|Overall Study|Adverse Event|2
2130744|NCT01036724|3734602|FG000|Overall Study|Lack of Efficacy|1
2130745|NCT01036724|3734603|FG001|Overall Study|Lack of Efficacy|1
2130746|NCT01036724|3734602|FG000|Overall Study|Protocol Violation|4
2130747|NCT01036724|3734603|FG001|Overall Study|Protocol Violation|5
2130748|NCT01036763|3734609|FG000|Overall Study|Adverse Event|25
2130749|NCT01036763|3734609|FG000|Overall Study|Lost to Follow-up|28
2130750|NCT01036763|3734609|FG000|Overall Study|Other reason (not specified)|40
2130751|NCT01037088|3734623|FG000|Overall Study|Withdrawal by Subject|3
2130752|NCT01037114|3734632|FG000|Year 20|Others|1
2130753|NCT01037127|3734638|FG000|Overall Study|Lost to Follow-up|2
2130754|NCT01037127|3734639|FG001|Overall Study|Lost to Follow-up|4
2130755|NCT01037127|3734638|FG000|Overall Study|Physician Decision|1
2130756|NCT01037127|3734639|FG001|Overall Study|Physician Decision|0
2130757|NCT01037127|3734638|FG000|Overall Study|Study Closed Terminated|2
2130758|NCT01037127|3734639|FG001|Overall Study|Study Closed Terminated|17
2130759|NCT01037218|3734670|FG000|Overall Study|Adverse Event|4
2130760|NCT01037218|3734671|FG001|Overall Study|Adverse Event|2
2130761|NCT01037218|3734672|FG002|Overall Study|Adverse Event|2
2130762|NCT01037218|3734673|FG003|Overall Study|Adverse Event|1
2130763|NCT01037218|3734670|FG000|Overall Study|Lack of Efficacy|0
2130764|NCT01037218|3734671|FG001|Overall Study|Lack of Efficacy|2
2130765|NCT01037218|3734672|FG002|Overall Study|Lack of Efficacy|1
2130766|NCT01037218|3734673|FG003|Overall Study|Lack of Efficacy|5
2130767|NCT01037218|3734670|FG000|Overall Study|Lost to Follow-up|3
2130768|NCT01037218|3734671|FG001|Overall Study|Lost to Follow-up|5
2130769|NCT01037218|3734672|FG002|Overall Study|Lost to Follow-up|4
2130770|NCT01037218|3734673|FG003|Overall Study|Lost to Follow-up|2
2130771|NCT01037218|3734670|FG000|Overall Study|Withdrawal by Subject|6
2130772|NCT01037218|3734671|FG001|Overall Study|Withdrawal by Subject|7
2130773|NCT01037218|3734672|FG002|Overall Study|Withdrawal by Subject|7
2130774|NCT01037218|3734673|FG003|Overall Study|Withdrawal by Subject|4
2130775|NCT01037218|3734670|FG000|Overall Study|Partner Withdrew Consent|0
2130776|NCT01037218|3734671|FG001|Overall Study|Partner Withdrew Consent|3
2130777|NCT01037218|3734672|FG002|Overall Study|Partner Withdrew Consent|2
2130778|NCT01037218|3734673|FG003|Overall Study|Partner Withdrew Consent|1
2130779|NCT01037218|3734670|FG000|Overall Study|Protocol Violation|0
2130780|NCT01037218|3734671|FG001|Overall Study|Protocol Violation|0
2130781|NCT01037218|3734672|FG002|Overall Study|Protocol Violation|2
2130782|NCT01037218|3734673|FG003|Overall Study|Protocol Violation|2
2130783|NCT01037218|3734670|FG000|Overall Study|Various|3
2130784|NCT01037218|3734671|FG001|Overall Study|Various|2
2130785|NCT01037218|3734672|FG002|Overall Study|Various|3
2130786|NCT01037218|3734673|FG003|Overall Study|Various|1
2130787|NCT01037244|3734687|FG000|Overall Study|Adverse Event|3
2130788|NCT01037244|3734688|FG001|Overall Study|Adverse Event|2
2130789|NCT01037244|3734689|FG002|Overall Study|Adverse Event|6
2130790|NCT01037244|3734690|FG003|Overall Study|Adverse Event|3
2130791|NCT01037244|3734687|FG000|Overall Study|Lack of Efficacy|1
2130792|NCT01037244|3734688|FG001|Overall Study|Lack of Efficacy|1
2130793|NCT01037244|3734689|FG002|Overall Study|Lack of Efficacy|0
2130794|NCT01037244|3734690|FG003|Overall Study|Lack of Efficacy|1
2130795|NCT01037244|3734687|FG000|Overall Study|Lost to Follow-up|3
2130796|NCT01037244|3734688|FG001|Overall Study|Lost to Follow-up|3
2130797|NCT01037244|3734689|FG002|Overall Study|Lost to Follow-up|4
2130798|NCT01037244|3734690|FG003|Overall Study|Lost to Follow-up|4
2130799|NCT01037244|3734687|FG000|Overall Study|Withdrawal by Subject|1
2130800|NCT01037244|3734688|FG001|Overall Study|Withdrawal by Subject|5
2130801|NCT01037244|3734689|FG002|Overall Study|Withdrawal by Subject|3
2130802|NCT01037244|3734690|FG003|Overall Study|Withdrawal by Subject|5
2130803|NCT01037244|3734687|FG000|Overall Study|Partner Withdrew Consent|2
2130804|NCT01037244|3734688|FG001|Overall Study|Partner Withdrew Consent|1
2284138|NCT02406742|3971449|FG000|Overall Study|Physician Decision|1
2284139|NCT02406742|3971450|FG001|Overall Study|Physician Decision|2
2284140|NCT02406742|3971451|FG002|Overall Study|Physician Decision|1
2284141|NCT02406742|3971449|FG000|Overall Study|Transition to other treatment|2
2284142|NCT02406742|3971450|FG001|Overall Study|Transition to other treatment|0
2284143|NCT02406742|3971451|FG002|Overall Study|Transition to other treatment|1
2284144|NCT02406742|3971449|FG000|Overall Study|Other Reasons|1
2284145|NCT02406742|3971450|FG001|Overall Study|Other Reasons|11
2284146|NCT02406742|3971451|FG002|Overall Study|Other Reasons|5
2284147|NCT02407054|3971513|FG000|Overall Study|Adverse Event|1
2284148|NCT02407054|3971514|FG001|Overall Study|Adverse Event|4
2284149|NCT02407054|3971515|FG002|Overall Study|Adverse Event|1
2284150|NCT02407054|3971513|FG000|Overall Study|Non-compliance with Study|0
2284151|NCT02407054|3971514|FG001|Overall Study|Non-compliance with Study|2
2284152|NCT02407054|3971515|FG002|Overall Study|Non-compliance with Study|1
2284153|NCT02407054|3971513|FG000|Overall Study|Physician Decision|1
2284154|NCT02407054|3971514|FG001|Overall Study|Physician Decision|3
2284155|NCT02407054|3971515|FG002|Overall Study|Physician Decision|3
2284156|NCT02407054|3971513|FG000|Overall Study|Withdrawal by Subject|5
2284157|NCT02407054|3971514|FG001|Overall Study|Withdrawal by Subject|9
2284158|NCT02407054|3971515|FG002|Overall Study|Withdrawal by Subject|2
2284159|NCT02407223|3971536|FG000|Overall Study|Adverse Event|1
2284160|NCT02407223|3971537|FG001|Overall Study|Adverse Event|0
2284161|NCT02407223|3971538|FG002|Overall Study|Adverse Event|1
2284162|NCT02407223|3971536|FG000|Overall Study|Lack of Efficacy|6
2284163|NCT02407223|3971537|FG001|Overall Study|Lack of Efficacy|6
2284164|NCT02407223|3971538|FG002|Overall Study|Lack of Efficacy|4
2284165|NCT02407223|3971536|FG000|Overall Study|Lost to Follow-up|1
2284166|NCT02407223|3971537|FG001|Overall Study|Lost to Follow-up|0
2284167|NCT02407223|3971538|FG002|Overall Study|Lost to Follow-up|2
2284168|NCT02407223|3971536|FG000|Overall Study|Withdrawal by Subject|2
2284169|NCT02407223|3971537|FG001|Overall Study|Withdrawal by Subject|4
2284170|NCT02407223|3971538|FG002|Overall Study|Withdrawal by Subject|4
2284171|NCT02407223|3971536|FG000|Overall Study|Study Terminated by Sponsor|77
2284172|NCT02407223|3971537|FG001|Overall Study|Study Terminated by Sponsor|80
2284173|NCT02407223|3971538|FG002|Overall Study|Study Terminated by Sponsor|86
2284174|NCT02407223|3971536|FG000|Overall Study|Subject Refused Further Study Treatment|0
2284175|NCT02407223|3971537|FG001|Overall Study|Subject Refused Further Study Treatment|1
2284176|NCT02407223|3971538|FG002|Overall Study|Subject Refused Further Study Treatment|0
2284177|NCT02407223|3971536|FG000|Overall Study|Other|29
2284178|NCT02407223|3971537|FG001|Overall Study|Other|27
2284179|NCT02407223|3971538|FG002|Overall Study|Other|25
2284180|NCT02407249|3971548|FG000|Overall Study|Did not complete 12-month follow-up|13
2284181|NCT02407249|3971548|FG000|Overall Study|Not treated|13
2284182|NCT02407457|3971554|FG000|1 Month|Death|3
2284183|NCT02407457|3971555|FG001|1 Month|Death|0
2284184|NCT02407457|3971554|FG000|1 Month|Lost to Follow-up|1
2284185|NCT02407457|3971555|FG001|1 Month|Lost to Follow-up|1
2284186|NCT02407457|3971554|FG000|1 Month|missed visit|2
2284187|NCT02407457|3971555|FG001|1 Month|missed visit|6
2284188|NCT02407457|3971554|FG000|6-Month|Death|2
2284189|NCT02407457|3971555|FG001|6-Month|Death|8
2284190|NCT02407457|3971554|FG000|6-Month|Lost to Follow-up|2
2284191|NCT02407457|3971555|FG001|6-Month|Lost to Follow-up|2
2284192|NCT02407457|3971554|FG000|6-Month|missed visit|15
2284193|NCT02407457|3971555|FG001|6-Month|missed visit|12
2284194|NCT02407457|3971554|FG000|6-Month|Over Due|1
2284195|NCT02407457|3971555|FG001|6-Month|Over Due|2
2284196|NCT02407457|3971554|FG000|6-Month|Open Repair|0
2284197|NCT02407457|3971555|FG001|6-Month|Open Repair|1
2284198|NCT02407457|3971554|FG000|1 Year|Death|6
2284199|NCT02407457|3971555|FG001|1 Year|Death|11
2284200|NCT02407457|3971554|FG000|1 Year|Lost to Follow-up|3
2284201|NCT02407457|3971555|FG001|1 Year|Lost to Follow-up|2
2130805|NCT01037244|3734689|FG002|Overall Study|Partner Withdrew Consent|0
2130806|NCT01037244|3734690|FG003|Overall Study|Partner Withdrew Consent|0
2284202|NCT02407457|3971554|FG000|1 Year|Missed Visit|18
2284203|NCT02407457|3971555|FG001|1 Year|Missed Visit|10
2284204|NCT02407457|3971554|FG000|1 Year|Over Due|6
2284205|NCT02407457|3971555|FG001|1 Year|Over Due|4
2284206|NCT02407457|3971554|FG000|1 Year|Open Repair|0
2284207|NCT02407457|3971555|FG001|1 Year|Open Repair|1
2284208|NCT02407457|3971554|FG000|2-year|Death|14
2284209|NCT02407457|3971555|FG001|2-year|Death|8
2130807|NCT01037244|3734687|FG000|Overall Study|Various|3
2130808|NCT01037244|3734688|FG001|Overall Study|Various|2
2130809|NCT01037244|3734689|FG002|Overall Study|Various|1
2130810|NCT01037244|3734690|FG003|Overall Study|Various|1
2178172|NCT01380730|3802692|FG000|Overall Study|Death|0
2178173|NCT01380730|3802693|FG001|Overall Study|Death|0
2178174|NCT01380730|3802694|FG002|Overall Study|Death|0
2178175|NCT01380730|3802695|FG003|Overall Study|Death|0
2178176|NCT01380730|3802696|FG004|Overall Study|Death|1
2178177|NCT01380730|3802697|FG005|Overall Study|Death|0
2178178|NCT01380730|3802698|FG006|Overall Study|Death|0
2178179|NCT01380730|3802699|FG007|Overall Study|Death|0
2178180|NCT01380769|3802736|FG000|Overall Study|Withdrawal by Subject|7
2178181|NCT01380769|3802737|FG001|Overall Study|Withdrawal by Subject|11
2178182|NCT01380769|3802736|FG000|Overall Study|Physician Decision|1
2178183|NCT01380769|3802737|FG001|Overall Study|Physician Decision|1
2178184|NCT01380769|3802736|FG000|Overall Study|Adverse Event|1
2178185|NCT01380769|3802737|FG001|Overall Study|Adverse Event|1
2178186|NCT01380769|3802736|FG000|Overall Study|Protocol Violation|0
2178187|NCT01380769|3802737|FG001|Overall Study|Protocol Violation|1
2178188|NCT01380782|3802745|FG000|Overall Study|Adverse Event|0
2178189|NCT01380782|3802746|FG001|Overall Study|Adverse Event|1
2178190|NCT01380782|3802747|FG002|Overall Study|Adverse Event|0
2178191|NCT01380782|3802748|FG003|Overall Study|Adverse Event|0
2178192|NCT01380782|3802745|FG000|Overall Study|Death|1
2178193|NCT01380782|3802746|FG001|Overall Study|Death|0
2178194|NCT01380782|3802747|FG002|Overall Study|Death|0
2178195|NCT01380782|3802748|FG003|Overall Study|Death|0
2178196|NCT01380782|3802745|FG000|Overall Study|Lack of Efficacy|10
2284210|NCT02407457|3971554|FG000|2-year|Lost to Follow-up|6
2284211|NCT02407457|3971555|FG001|2-year|Lost to Follow-up|9
2284212|NCT02407457|3971554|FG000|2-year|Missed Visit|13
2284213|NCT02407457|3971555|FG001|2-year|Missed Visit|11
2284214|NCT02407457|3971554|FG000|2-year|Over Due|1
2284215|NCT02407457|3971555|FG001|2-year|Over Due|5
2284216|NCT02407457|3971554|FG000|2-year|Open Repair|0
2284217|NCT02407457|3971555|FG001|2-year|Open Repair|2
2284218|NCT02407457|3971554|FG000|3-year|Death|11
2284219|NCT02407457|3971555|FG001|3-year|Death|10
2284220|NCT02407457|3971554|FG000|3-year|Lost to Follow-up|6
2284221|NCT02407457|3971555|FG001|3-year|Lost to Follow-up|9
2284222|NCT02407457|3971554|FG000|3-year|Missed Visit|21
2284223|NCT02407457|3971555|FG001|3-year|Missed Visit|16
2284224|NCT02407457|3971554|FG000|3-year|Over Due|4
2284225|NCT02407457|3971555|FG001|3-year|Over Due|3
2284226|NCT02407457|3971554|FG000|4-year|Death|14
2284227|NCT02407457|3971555|FG001|4-year|Death|7
2284228|NCT02407457|3971554|FG000|4-year|Lost to Follow-up|9
2284229|NCT02407457|3971555|FG001|4-year|Lost to Follow-up|12
2284230|NCT02407457|3971554|FG000|4-year|Over Due|10
2284231|NCT02407457|3971555|FG001|4-year|Over Due|5
2284232|NCT02407457|3971554|FG000|4-year|Missed Visit|13
2284233|NCT02407457|3971555|FG001|4-year|Missed Visit|13
2284234|NCT02407457|3971554|FG000|4-year|Pending visit|19
2284235|NCT02407457|3971555|FG001|4-year|Pending visit|14
2284236|NCT02407457|3971554|FG000|4-year|Not Due|16
2284237|NCT02407457|3971555|FG001|4-year|Not Due|10
2284238|NCT02407457|3971554|FG000|5-year|Death|6
2284239|NCT02407457|3971555|FG001|5-year|Death|1
2284240|NCT02407457|3971554|FG000|5-year|Lost to Follow-up|4
2284241|NCT02407457|3971555|FG001|5-year|Lost to Follow-up|4
2284242|NCT02407457|3971554|FG000|5-year|Missed Visit|10
2284243|NCT02407457|3971555|FG001|5-year|Missed Visit|9
2284244|NCT02407457|3971554|FG000|5-year|Pending Visit|18
2284245|NCT02407457|3971555|FG001|5-year|Pending Visit|17
2284246|NCT02407457|3971554|FG000|5-year|Not Due|54
2284247|NCT02407457|3971555|FG001|5-year|Not Due|46
2284248|NCT02407704|3971565|FG000|Overall Study|Lost to Follow-up|0
2284249|NCT02407704|3971566|FG001|Overall Study|Lost to Follow-up|0
2284250|NCT02407704|3971567|FG002|Overall Study|Lost to Follow-up|0
2284251|NCT02407704|3971568|FG003|Overall Study|Lost to Follow-up|2
2284252|NCT02407704|3971565|FG000|Overall Study|Protocol Violation|0
2284253|NCT02407704|3971566|FG001|Overall Study|Protocol Violation|0
2178197|NCT01380782|3802746|FG001|Overall Study|Lack of Efficacy|9
2178198|NCT01380782|3802747|FG002|Overall Study|Lack of Efficacy|10
2178199|NCT01380782|3802748|FG003|Overall Study|Lack of Efficacy|3
2178200|NCT01380782|3802745|FG000|Overall Study|Physician Decision|1
2178201|NCT01380782|3802746|FG001|Overall Study|Physician Decision|0
2178202|NCT01380782|3802747|FG002|Overall Study|Physician Decision|0
2178203|NCT01380782|3802748|FG003|Overall Study|Physician Decision|0
2178204|NCT01380782|3802745|FG000|Overall Study|Withdrawal by Subject|0
2178205|NCT01380782|3802746|FG001|Overall Study|Withdrawal by Subject|0
2178206|NCT01380782|3802747|FG002|Overall Study|Withdrawal by Subject|1
2178207|NCT01380782|3802748|FG003|Overall Study|Withdrawal by Subject|1
2284254|NCT02407704|3971567|FG002|Overall Study|Protocol Violation|0
2284255|NCT02407704|3971568|FG003|Overall Study|Protocol Violation|1
2284256|NCT02407704|3971565|FG000|Overall Study|Withdrawal by Subject|0
2284257|NCT02407704|3971566|FG001|Overall Study|Withdrawal by Subject|0
2284258|NCT02407704|3971567|FG002|Overall Study|Withdrawal by Subject|1
2284259|NCT02407704|3971568|FG003|Overall Study|Withdrawal by Subject|0
2284260|NCT02407990|3971607|FG000|Overall Study|Death|2
2284261|NCT02407990|3971608|FG001|Overall Study|Death|22
2284262|NCT02407990|3971609|FG002|Overall Study|Death|23
2284263|NCT02407990|3971610|FG003|Overall Study|Death|7
2130811|NCT01037413|3734737|FG000|Part A: Skin Testing|Adverse Event|1
2130812|NCT01037413|3734738|FG001|Part A: Skin Testing|Adverse Event|0
2130813|NCT01037413|3734737|FG000|Part A: Skin Testing|Protocol Violation|1
2130814|NCT01037413|3734738|FG001|Part A: Skin Testing|Protocol Violation|0
2130815|NCT01037413|3734737|FG000|Part B: Scar Revision|Withdrawal by Subject|0
2130816|NCT01037413|3734738|FG001|Part B: Scar Revision|Withdrawal by Subject|1
2130817|NCT01037413|3734737|FG000|Part B: Scar Revision|Assigned But Not Treated|0
2130818|NCT01037413|3734738|FG001|Part B: Scar Revision|Assigned But Not Treated|1
2130819|NCT01037985|3734827|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3
2130820|NCT01037985|3734828|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0
2130821|NCT01037985|3734827|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1
2130822|NCT01037985|3734828|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0
2130823|NCT01037985|3734827|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0
2130824|NCT01037985|3734828|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1
2130825|NCT01037985|3734827|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0
2284264|NCT02407990|3971611|FG004|Overall Study|Death|17
2284265|NCT02407990|3971612|FG005|Overall Study|Death|16
2284266|NCT02407990|3971613|FG006|Overall Study|Death|10
2284267|NCT02407990|3971614|FG007|Overall Study|Death|248
2284268|NCT02407990|3971607|FG000|Overall Study|Lost to Follow-up|0
2284269|NCT02407990|3971608|FG001|Overall Study|Lost to Follow-up|1
2284270|NCT02407990|3971609|FG002|Overall Study|Lost to Follow-up|0
2284271|NCT02407990|3971610|FG003|Overall Study|Lost to Follow-up|0
2284272|NCT02407990|3971611|FG004|Overall Study|Lost to Follow-up|0
2284273|NCT02407990|3971612|FG005|Overall Study|Lost to Follow-up|0
2284274|NCT02407990|3971613|FG006|Overall Study|Lost to Follow-up|0
2284275|NCT02407990|3971614|FG007|Overall Study|Lost to Follow-up|17
2284276|NCT02407990|3971607|FG000|Overall Study|Progressive Disease|0
2284277|NCT02407990|3971608|FG001|Overall Study|Progressive Disease|0
2284278|NCT02407990|3971609|FG002|Overall Study|Progressive Disease|0
2284279|NCT02407990|3971610|FG003|Overall Study|Progressive Disease|0
2284280|NCT02407990|3971611|FG004|Overall Study|Progressive Disease|0
2284281|NCT02407990|3971612|FG005|Overall Study|Progressive Disease|0
2284282|NCT02407990|3971613|FG006|Overall Study|Progressive Disease|0
2284283|NCT02407990|3971614|FG007|Overall Study|Progressive Disease|1
2284284|NCT02407990|3971607|FG000|Overall Study|Withdrawal by Subject|0
2284285|NCT02407990|3971608|FG001|Overall Study|Withdrawal by Subject|0
2284286|NCT02407990|3971609|FG002|Overall Study|Withdrawal by Subject|0
2284287|NCT02407990|3971610|FG003|Overall Study|Withdrawal by Subject|0
2284288|NCT02407990|3971611|FG004|Overall Study|Withdrawal by Subject|1
2284289|NCT02407990|3971612|FG005|Overall Study|Withdrawal by Subject|0
2284290|NCT02407990|3971613|FG006|Overall Study|Withdrawal by Subject|0
2284291|NCT02407990|3971614|FG007|Overall Study|Withdrawal by Subject|30
2284292|NCT02407990|3971607|FG000|Overall Study|Study Terminated by Sponsor|1
2284293|NCT02407990|3971608|FG001|Overall Study|Study Terminated by Sponsor|3
2284294|NCT02407990|3971609|FG002|Overall Study|Study Terminated by Sponsor|3
2284295|NCT02407990|3971610|FG003|Overall Study|Study Terminated by Sponsor|0
2284296|NCT02407990|3971611|FG004|Overall Study|Study Terminated by Sponsor|3
2284297|NCT02407990|3971612|FG005|Overall Study|Study Terminated by Sponsor|4
2284298|NCT02407990|3971613|FG006|Overall Study|Study Terminated by Sponsor|3
2284299|NCT02407990|3971614|FG007|Overall Study|Study Terminated by Sponsor|37
2284300|NCT02407990|3971607|FG000|Overall Study|Logistics|0
2284301|NCT02407990|3971608|FG001|Overall Study|Logistics|0
2284302|NCT02407990|3971609|FG002|Overall Study|Logistics|0
2284303|NCT02407990|3971610|FG003|Overall Study|Logistics|0
2284304|NCT02407990|3971611|FG004|Overall Study|Logistics|0
2284305|NCT02407990|3971612|FG005|Overall Study|Logistics|0
2284306|NCT02407990|3971613|FG006|Overall Study|Logistics|0
2284307|NCT02407990|3971614|FG007|Overall Study|Logistics|1
2284308|NCT02407990|3971607|FG000|Overall Study|Rolled into long-term extension study|0
2284309|NCT02407990|3971608|FG001|Overall Study|Rolled into long-term extension study|0
2284310|NCT02407990|3971609|FG002|Overall Study|Rolled into long-term extension study|0
2284311|NCT02407990|3971610|FG003|Overall Study|Rolled into long-term extension study|0
2284312|NCT02407990|3971611|FG004|Overall Study|Rolled into long-term extension study|0
2284313|NCT02407990|3971612|FG005|Overall Study|Rolled into long-term extension study|0
2284314|NCT02407990|3971613|FG006|Overall Study|Rolled into long-term extension study|0
2284315|NCT02407990|3971614|FG007|Overall Study|Rolled into long-term extension study|1
2284316|NCT02408016|3971641|FG000|Overall Study|Death|6
2284317|NCT02408016|3971642|FG001|Overall Study|Death|1
2284318|NCT02408016|3971643|FG002|Overall Study|Death|0
2130826|NCT01037985|3734828|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4
2130827|NCT01038128|3734838|FG000|Overall Study|Lack of Efficacy|1
2130828|NCT01038128|3734838|FG000|Overall Study|Lost to Follow-up|1
2130829|NCT01038128|3734838|FG000|Overall Study|Withdrawal by Subject|2
2130830|NCT01038297|3734847|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1
2130831|NCT01038297|3734848|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
2130832|NCT01038297|3734849|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
2130833|NCT01038323|3734869|FG000|Overall Study|Withdrawal by Subject|3
2284319|NCT02408016|3971641|FG000|Overall Study|Physician Decision|0
2284320|NCT02408016|3971642|FG001|Overall Study|Physician Decision|2
2284321|NCT02408016|3971643|FG002|Overall Study|Physician Decision|0
2206614|NCT01621542|3845207|FG001|Overall Study|Withdrawal by Subject|0
2206615|NCT01621542|3845208|FG002|Overall Study|Withdrawal by Subject|1
2206616|NCT01621542|3845209|FG003|Overall Study|Withdrawal by Subject|3
2206617|NCT01621542|3845210|FG004|Overall Study|Withdrawal by Subject|3
2206618|NCT01621542|3845211|FG005|Overall Study|Withdrawal by Subject|3
2206619|NCT01621542|3845206|FG000|Overall Study|progression/treatment failure|2
2206620|NCT01621542|3845207|FG001|Overall Study|progression/treatment failure|4
2206621|NCT01621542|3845208|FG002|Overall Study|progression/treatment failure|3
2206622|NCT01621542|3845209|FG003|Overall Study|progression/treatment failure|7
2206623|NCT01621542|3845210|FG004|Overall Study|progression/treatment failure|3
2206624|NCT01621542|3845211|FG005|Overall Study|progression/treatment failure|5
2206625|NCT01621542|3845206|FG000|Overall Study|Protocol Violation|0
2206626|NCT01621542|3845207|FG001|Overall Study|Protocol Violation|0
2206627|NCT01621542|3845208|FG002|Overall Study|Protocol Violation|0
2206628|NCT01621542|3845209|FG003|Overall Study|Protocol Violation|1
2206629|NCT01621542|3845210|FG004|Overall Study|Protocol Violation|0
2206630|NCT01621542|3845211|FG005|Overall Study|Protocol Violation|0
2206631|NCT01621542|3845206|FG000|Overall Study|study stopped by sponsor|0
2206632|NCT01621542|3845207|FG001|Overall Study|study stopped by sponsor|0
2206633|NCT01621542|3845208|FG002|Overall Study|study stopped by sponsor|0
2206634|NCT01621542|3845209|FG003|Overall Study|study stopped by sponsor|1
2206635|NCT01621542|3845210|FG004|Overall Study|study stopped by sponsor|0
2206636|NCT01621542|3845211|FG005|Overall Study|study stopped by sponsor|0
2206637|NCT01621802|3845270|FG000|Overall Study|Protocol Violation|0
2206638|NCT01621802|3845271|FG001|Overall Study|Protocol Violation|0
2206639|NCT01621802|3845272|FG002|Overall Study|Protocol Violation|0
2206640|NCT01621802|3845273|FG003|Overall Study|Protocol Violation|0
2206641|NCT01621802|3845274|FG004|Overall Study|Protocol Violation|0
2206642|NCT01621802|3845275|FG005|Overall Study|Protocol Violation|1
2206643|NCT01621802|3845270|FG000|Overall Study|Withdrawal by Subject|8
2206644|NCT01621802|3845271|FG001|Overall Study|Withdrawal by Subject|4
2284322|NCT02408068|3971651|FG000|Treatment 3 (1.5 Days)|Adverse Event|0
2284323|NCT02408068|3971652|FG001|Treatment 3 (1.5 Days)|Adverse Event|0
2284324|NCT02408068|3971653|FG002|Treatment 3 (1.5 Days)|Adverse Event|1
2284325|NCT02408068|3971654|FG003|Treatment 3 (1.5 Days)|Adverse Event|0
2284326|NCT02408068|3971655|FG004|Treatment 3 (1.5 Days)|Adverse Event|0
2130834|NCT01038323|3734870|FG001|Overall Study|Withdrawal by Subject|2
2130835|NCT01038323|3734871|FG002|Overall Study|Withdrawal by Subject|4
2130836|NCT01038427|3734900|FG000|Overall Study|Lost to follow up|1
2130837|NCT01038427|3734901|FG001|Overall Study|Lost to follow up|1
2130838|NCT01038427|3734902|FG002|Overall Study|Lost to follow up|0
2130839|NCT01038427|3734900|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
2130840|NCT01038427|3734901|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0
2130841|NCT01038427|3734902|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1
2284327|NCT02408068|3971656|FG005|Treatment 3 (1.5 Days)|Adverse Event|0
2284328|NCT02408120|3971669|FG000|Overall Study|Withdrawal by Subject|0
2284329|NCT02408120|3971670|FG001|Overall Study|Withdrawal by Subject|1
2284330|NCT02408120|3971669|FG000|Overall Study|Treatment Refusal|1
2284331|NCT02408120|3971670|FG001|Overall Study|Treatment Refusal|0
2284332|NCT02408120|3971669|FG000|Overall Study|Received Steroids|1
2284333|NCT02408120|3971670|FG001|Overall Study|Received Steroids|1
2284334|NCT02408120|3971669|FG000|Overall Study|Discharged same day|1
2284335|NCT02408120|3971670|FG001|Overall Study|Discharged same day|1
2284336|NCT02408120|3971669|FG000|Overall Study|Did not receive insulin|1
2284337|NCT02408120|3971670|FG001|Overall Study|Did not receive insulin|2
2284338|NCT02408484|3971708|FG000|Overall Study|Withdrawal by Subject|3
2284339|NCT02408484|3971708|FG000|Overall Study|Not treated during study period|1
2284340|NCT02408523|3971730|FG000|Overall Study|Adverse Event|4
2284341|NCT02408523|3971731|FG001|Overall Study|Adverse Event|10
2284342|NCT02408523|3971730|FG000|Overall Study|Lack of Efficacy|0
2284343|NCT02408523|3971731|FG001|Overall Study|Lack of Efficacy|1
2284344|NCT02408523|3971730|FG000|Overall Study|Protocol Violation|1
2284345|NCT02408523|3971731|FG001|Overall Study|Protocol Violation|2
2284346|NCT02408523|3971730|FG000|Overall Study|Lost to Follow-up|2
2284347|NCT02408523|3971731|FG001|Overall Study|Lost to Follow-up|3
2284348|NCT02408523|3971730|FG000|Overall Study|Withdrawal by Subject|3
2284349|NCT02408523|3971731|FG001|Overall Study|Withdrawal by Subject|1
2284350|NCT02408523|3971730|FG000|Overall Study|Sponsor request|1
2284351|NCT02408523|3971731|FG001|Overall Study|Sponsor request|0
2284352|NCT02408523|3971730|FG000|Overall Study|Did not satisfy extension conditions|0
2284353|NCT02408523|3971731|FG001|Overall Study|Did not satisfy extension conditions|1
2284354|NCT02409667|3971824|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
2284355|NCT02409667|3971825|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2284356|NCT02409667|3971826|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2284357|NCT02409667|3971827|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2284358|NCT02409667|3971828|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2284359|NCT02409667|3971824|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
2322389|NCT02971670|4037402|FG003|Overall Study|Withdrawal by Subject|2
2206645|NCT01621802|3845272|FG002|Overall Study|Withdrawal by Subject|4
2206646|NCT01621802|3845273|FG003|Overall Study|Withdrawal by Subject|2
2130842|NCT01038427|3734900|FG000|Overall Study|Withdrew consent|0
2130843|NCT01038427|3734901|FG001|Overall Study|Withdrew consent|0
2130844|NCT01038427|3734902|FG002|Overall Study|Withdrew consent|1
2130845|NCT01038427|3734900|FG000|Overall Study|Adverse Event|2
2130846|NCT01038427|3734901|FG001|Overall Study|Adverse Event|2
2130847|NCT01038427|3734902|FG002|Overall Study|Adverse Event|1
2130848|NCT01038427|3734900|FG000|Overall Study|Enrolled in error|0
2130849|NCT01038427|3734901|FG001|Overall Study|Enrolled in error|1
2130850|NCT01038427|3734902|FG002|Overall Study|Enrolled in error|1
2130851|NCT01038427|3734900|FG000|Overall Study|Other|0
2130852|NCT01038427|3734901|FG001|Overall Study|Other|2
2130853|NCT01038427|3734902|FG002|Overall Study|Other|0
2130854|NCT01038609|3734928|FG000|Overall Study|Adverse Event|0
2130855|NCT01038609|3734929|FG001|Overall Study|Adverse Event|0
2130856|NCT01038609|3734930|FG002|Overall Study|Adverse Event|1
2130857|NCT01038609|3734931|FG003|Overall Study|Adverse Event|0
2130858|NCT01038609|3734932|FG004|Overall Study|Adverse Event|0
2130859|NCT01038609|3734928|FG000|Overall Study|Dosing Error|0
2130860|NCT01038609|3734929|FG001|Overall Study|Dosing Error|0
2130861|NCT01038609|3734930|FG002|Overall Study|Dosing Error|0
2130862|NCT01038609|3734931|FG003|Overall Study|Dosing Error|1
2130863|NCT01038609|3734932|FG004|Overall Study|Dosing Error|1
2130864|NCT01038609|3734928|FG000|Overall Study|Death in the Family|1
2130865|NCT01038609|3734929|FG001|Overall Study|Death in the Family|0
2130866|NCT01038609|3734930|FG002|Overall Study|Death in the Family|0
2130867|NCT01038609|3734931|FG003|Overall Study|Death in the Family|0
2130868|NCT01038609|3734932|FG004|Overall Study|Death in the Family|0
2130869|NCT01038609|3734928|FG000|Overall Study|Refusal of Blood Draws|0
2130870|NCT01038609|3734929|FG001|Overall Study|Refusal of Blood Draws|1
2130871|NCT01038609|3734930|FG002|Overall Study|Refusal of Blood Draws|0
2130872|NCT01038609|3734931|FG003|Overall Study|Refusal of Blood Draws|0
2130873|NCT01038609|3734932|FG004|Overall Study|Refusal of Blood Draws|0
2130874|NCT01038635|3734953|FG000|Overall Study|Disease Progression|2
2130875|NCT01038635|3734954|FG001|Overall Study|Disease Progression|0
2206647|NCT01621802|3845274|FG004|Overall Study|Withdrawal by Subject|2
2206648|NCT01621802|3845275|FG005|Overall Study|Withdrawal by Subject|0
2206649|NCT01621802|3845270|FG000|Overall Study|Migrated/moved from study area|0
2206650|NCT01621802|3845271|FG001|Overall Study|Migrated/moved from study area|0
2206651|NCT01621802|3845272|FG002|Overall Study|Migrated/moved from study area|2
2206652|NCT01621802|3845273|FG003|Overall Study|Migrated/moved from study area|0
2206653|NCT01621802|3845274|FG004|Overall Study|Migrated/moved from study area|1
2284360|NCT02409667|3971825|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2130876|NCT01038635|3734955|FG002|Overall Study|Disease Progression|0
2130877|NCT01038635|3734956|FG003|Overall Study|Disease Progression|0
2130878|NCT01038635|3734957|FG004|Overall Study|Disease Progression|0
2130879|NCT01038635|3734958|FG005|Overall Study|Disease Progression|0
2130880|NCT01038635|3734959|FG006|Overall Study|Disease Progression|1
2130881|NCT01038635|3734960|FG007|Overall Study|Disease Progression|4
2130882|NCT01038635|3734961|FG008|Overall Study|Disease Progression|0
2130883|NCT01038635|3734953|FG000|Overall Study|Death|0
2130884|NCT01038635|3734954|FG001|Overall Study|Death|0
2130885|NCT01038635|3734955|FG002|Overall Study|Death|0
2130886|NCT01038635|3734956|FG003|Overall Study|Death|0
2130887|NCT01038635|3734957|FG004|Overall Study|Death|1
2130888|NCT01038635|3734958|FG005|Overall Study|Death|0
2130889|NCT01038635|3734959|FG006|Overall Study|Death|1
2130890|NCT01038635|3734960|FG007|Overall Study|Death|1
2130891|NCT01038635|3734961|FG008|Overall Study|Death|2
2130892|NCT01038687|3734985|FG000|Overall Study|Adverse Event|0
2130893|NCT01038687|3734986|FG001|Overall Study|Adverse Event|2
2130894|NCT01038687|3734987|FG002|Overall Study|Adverse Event|1
2130895|NCT01038713|3734998|FG000|Overall Study|Patient to hospice|1
2130896|NCT01038713|3734999|FG001|Overall Study|Patient to hospice|1
2130897|NCT01038713|3735000|FG002|Overall Study|Patient to hospice|1
2130898|NCT01038713|3734998|FG000|Overall Study|Lost to Follow-up|3
2130899|NCT01038713|3734999|FG001|Overall Study|Lost to Follow-up|0
2130900|NCT01038713|3735000|FG002|Overall Study|Lost to Follow-up|0
2284361|NCT02409667|3971826|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2284362|NCT02409667|3971827|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2284363|NCT02409667|3971828|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2284364|NCT02409667|3971824|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
2284365|NCT02409667|3971825|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2284366|NCT02409667|3971826|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2284367|NCT02409667|3971827|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2284368|NCT02409667|3971828|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2284369|NCT02409667|3971824|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1
2284370|NCT02409667|3971825|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2130901|NCT01038713|3734998|FG000|Overall Study|Neuroendocrine Tumor|0
2130902|NCT01038713|3734999|FG001|Overall Study|Neuroendocrine Tumor|1
2130903|NCT01038713|3735000|FG002|Overall Study|Neuroendocrine Tumor|0
2130904|NCT01038713|3734998|FG000|Overall Study|died from PEP|0
2130905|NCT01038713|3734999|FG001|Overall Study|died from PEP|1
2130906|NCT01038713|3735000|FG002|Overall Study|died from PEP|0
2130907|NCT01038713|3734998|FG000|Overall Study|Autoimmune Pancreatitis|1
2130908|NCT01038713|3734999|FG001|Overall Study|Autoimmune Pancreatitis|0
2130909|NCT01038713|3735000|FG002|Overall Study|Autoimmune Pancreatitis|0
2130910|NCT01038778|3735010|FG000|Overall Study|Withdrawal by Subject|0
2130911|NCT01038778|3735011|FG001|Overall Study|Withdrawal by Subject|2
2130912|NCT01038778|3735012|FG002|Overall Study|Withdrawal by Subject|3
2130913|NCT01038856|3735019|FG000|Overall Study|Adverse Event|2
2130914|NCT01038869|3735025|FG000|Overall Study|Withdrawal by Subject|1
2130915|NCT01038869|3735025|FG000|Overall Study|Lost to Follow-up|6
2130916|NCT01038921|3735035|FG000|Overall Study|Withdrawal by Subject|1
2130917|NCT01038921|3735036|FG001|Overall Study|Withdrawal by Subject|0
2130918|NCT01038921|3735035|FG000|Overall Study|Physician Decision|1
2130919|NCT01038921|3735036|FG001|Overall Study|Physician Decision|0
2130920|NCT01039376|3735048|FG000|Overall Study|Lost to Follow-up|5
2130921|NCT01039376|3735049|FG001|Overall Study|Lost to Follow-up|12
2130922|NCT01039376|3735048|FG000|Overall Study|Physician Decision|15
2130923|NCT01039376|3735049|FG001|Overall Study|Physician Decision|10
2130924|NCT01039376|3735048|FG000|Overall Study|Withdrawal by Subject|20
2130925|NCT01039376|3735049|FG001|Overall Study|Withdrawal by Subject|32
2130926|NCT01039376|3735048|FG000|Overall Study|Study terminated by Sponsor|90
2130927|NCT01039376|3735049|FG001|Overall Study|Study terminated by Sponsor|72
2130928|NCT01039428|3735058|FG000|Overall Study|Protocol Violation|1
2130929|NCT01039428|3735059|FG001|Overall Study|Protocol Violation|0
2130930|NCT01039428|3735058|FG000|Overall Study|Withdrawal by Subject|1
2130931|NCT01039428|3735059|FG001|Overall Study|Withdrawal by Subject|0
2130932|NCT01039519|3735076|FG000|Treatment|Progressive disease|20
2130933|NCT01039519|3735076|FG000|Treatment|Treatment failure|2
2130934|NCT01039519|3735076|FG000|Treatment|Adverse Event|3
2130935|NCT01039519|3735076|FG000|Treatment|Physician Decision|2
2130936|NCT01039519|3735076|FG000|Survival Follow-up|Death|23
2130937|NCT01039519|3735076|FG000|Survival Follow-up|Sponsor decision|4
2130938|NCT01039584|3735083|FG000|Overall Study|Withdrawal by Subject|4
2130939|NCT01039584|3735084|FG001|Overall Study|Withdrawal by Subject|2
2130940|NCT01039584|3735085|FG002|Overall Study|Withdrawal by Subject|1
2206654|NCT01621802|3845275|FG005|Overall Study|Migrated/moved from study area|0
2206655|NCT01621802|3845270|FG000|Overall Study|Others|3
2206656|NCT01621802|3845271|FG001|Overall Study|Others|3
2206657|NCT01621802|3845272|FG002|Overall Study|Others|3
2206658|NCT01621802|3845273|FG003|Overall Study|Others|2
2206659|NCT01621802|3845274|FG004|Overall Study|Others|1
2206660|NCT01621802|3845275|FG005|Overall Study|Others|0
2206661|NCT01621802|3845270|FG000|Overall Study|Lost to Follow-up|36
2206662|NCT01621802|3845271|FG001|Overall Study|Lost to Follow-up|16
2206663|NCT01621802|3845272|FG002|Overall Study|Lost to Follow-up|24
2206664|NCT01621802|3845273|FG003|Overall Study|Lost to Follow-up|7
2206665|NCT01621802|3845274|FG004|Overall Study|Lost to Follow-up|31
2206666|NCT01621802|3845275|FG005|Overall Study|Lost to Follow-up|11
2206667|NCT01621880|3845294|FG000|Overall Study|Adverse Event|5
2206668|NCT01621880|3845295|FG001|Overall Study|Adverse Event|1
2284371|NCT02409667|3971826|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2284372|NCT02409667|3971827|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2284373|NCT02409667|3971828|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2284374|NCT02409667|3971824|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4
2284375|NCT02409667|3971825|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2284376|NCT02409667|3971826|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2284377|NCT02409667|3971827|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2284378|NCT02409667|3971828|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2284379|NCT02409667|3971824|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
2284380|NCT02409667|3971825|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2284381|NCT02409667|3971826|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2284382|NCT02409667|3971827|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2284383|NCT02409667|3971828|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2284384|NCT02409667|3971824|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
2284385|NCT02409667|3971825|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2284386|NCT02409667|3971826|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2284387|NCT02409667|3971827|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2284388|NCT02409667|3971828|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2284389|NCT02409667|3971824|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
2284390|NCT02409667|3971825|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2284391|NCT02409667|3971826|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2284392|NCT02409667|3971827|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2284393|NCT02409667|3971828|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2284394|NCT02409667|3971824|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25
2284395|NCT02409667|3971825|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2284396|NCT02409667|3971826|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2284397|NCT02409667|3971827|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2284398|NCT02409667|3971828|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2130941|NCT01039584|3735083|FG000|Overall Study|Protocol Violation|10
2206669|NCT01621880|3845294|FG000|Overall Study|Withdrawal by Subject|5
2130942|NCT01039584|3735084|FG001|Overall Study|Protocol Violation|4
2130943|NCT01039584|3735085|FG002|Overall Study|Protocol Violation|6
2130944|NCT01039584|3735083|FG000|Overall Study|Lost to Follow-up|5
2130945|NCT01039584|3735084|FG001|Overall Study|Lost to Follow-up|3
2130946|NCT01039584|3735085|FG002|Overall Study|Lost to Follow-up|4
2130947|NCT01039584|3735083|FG000|Overall Study|Negative Baseline culture for Candida|59
2130948|NCT01039584|3735084|FG001|Overall Study|Negative Baseline culture for Candida|59
2130949|NCT01039584|3735085|FG002|Overall Study|Negative Baseline culture for Candida|24
2130950|NCT01039584|3735083|FG000|Overall Study|Lack of Efficacy|7
2130951|NCT01039584|3735084|FG001|Overall Study|Lack of Efficacy|6
2130952|NCT01039584|3735085|FG002|Overall Study|Lack of Efficacy|10
2130953|NCT01039584|3735083|FG000|Overall Study|other|1
2130954|NCT01039584|3735084|FG001|Overall Study|other|3
2130955|NCT01039584|3735085|FG002|Overall Study|other|1
2130956|NCT01039584|3735083|FG000|Overall Study|Pap smear with significant pathology|10
2130957|NCT01039584|3735084|FG001|Overall Study|Pap smear with significant pathology|10
2130958|NCT01039584|3735085|FG002|Overall Study|Pap smear with significant pathology|3
2130959|NCT01039584|3735083|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7
2130960|NCT01039584|3735084|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10
2130961|NCT01039584|3735085|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8
2130962|NCT01039675|3735095|FG000|Overall Study|Adverse Event|0
2130963|NCT01039675|3735096|FG001|Overall Study|Adverse Event|2
2130964|NCT01039675|3735095|FG000|Overall Study|Lack of Efficacy|0
2130965|NCT01039675|3735096|FG001|Overall Study|Lack of Efficacy|2
2130966|NCT01039675|3735095|FG000|Overall Study|Withdrawal by Subject|0
2130967|NCT01039675|3735096|FG001|Overall Study|Withdrawal by Subject|1
2130968|NCT01039675|3735095|FG000|Overall Study|Lost to Follow-up|0
2130969|NCT01039675|3735096|FG001|Overall Study|Lost to Follow-up|1
2130970|NCT01039675|3735095|FG000|Overall Study|Physician Decision|0
2130971|NCT01039675|3735096|FG001|Overall Study|Physician Decision|1
2130972|NCT01039688|3735105|FG000|Overall Study|Adverse Event|38
2130973|NCT01039688|3735106|FG001|Overall Study|Adverse Event|39
2130974|NCT01039688|3735107|FG002|Overall Study|Adverse Event|24
2130975|NCT01039688|3735105|FG000|Overall Study|Lack of Efficacy|20
2130976|NCT01039688|3735106|FG001|Overall Study|Lack of Efficacy|11
2130977|NCT01039688|3735107|FG002|Overall Study|Lack of Efficacy|26
2130978|NCT01039688|3735105|FG000|Overall Study|Lost to Follow-up|11
2130979|NCT01039688|3735106|FG001|Overall Study|Lost to Follow-up|9
2130980|NCT01039688|3735107|FG002|Overall Study|Lost to Follow-up|5
2130981|NCT01039688|3735105|FG000|Overall Study|Other|13
2130982|NCT01039688|3735106|FG001|Overall Study|Other|25
2130983|NCT01039688|3735107|FG002|Overall Study|Other|12
2130984|NCT01039688|3735105|FG000|Overall Study|Withdrawal by Subject|23
2130985|NCT01039688|3735106|FG001|Overall Study|Withdrawal by Subject|27
2130986|NCT01039688|3735107|FG002|Overall Study|Withdrawal by Subject|13
2130987|NCT01039688|3735105|FG000|Overall Study|Death|2
2130988|NCT01039688|3735106|FG001|Overall Study|Death|0
2284399|NCT02409667|3971824|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
2284400|NCT02409667|3971825|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
2284401|NCT02409667|3971826|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
2284402|NCT02409667|3971827|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
2284403|NCT02409667|3971828|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
2284404|NCT02409667|3971824|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2284405|NCT02409667|3971825|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2284406|NCT02409667|3971826|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2284407|NCT02409667|3971827|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
2284408|NCT02409667|3971828|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2284409|NCT02409667|3971824|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
2284410|NCT02409667|3971825|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
2284411|NCT02409667|3971826|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
2284412|NCT02409667|3971827|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
2284413|NCT02409667|3971828|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
2284414|NCT02409667|3971824|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
2284415|NCT02409667|3971825|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
2284416|NCT02409667|3971826|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
2284417|NCT02409667|3971827|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
2284418|NCT02409667|3971828|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
2284419|NCT02409667|3971824|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
2284420|NCT02409667|3971825|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
2284421|NCT02409667|3971826|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
2284422|NCT02409667|3971827|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
2284423|NCT02409667|3971828|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
2284424|NCT02409667|3971824|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
2284425|NCT02409667|3971825|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
2284426|NCT02409667|3971826|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
2284427|NCT02409667|3971827|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
2130989|NCT01039688|3735107|FG002|Overall Study|Death|0
2130990|NCT01040130|3735131|FG000|Overall Study|Adverse Event|1
2130991|NCT01040130|3735132|FG001|Overall Study|Adverse Event|1
2130992|NCT01040130|3735133|FG002|Overall Study|Adverse Event|0
2130993|NCT01040130|3735134|FG003|Overall Study|Adverse Event|5
2284428|NCT02409667|3971828|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
2284429|NCT02409667|3971824|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2284430|NCT02409667|3971825|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2284431|NCT02409667|3971826|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
2284432|NCT02409667|3971827|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2284433|NCT02409667|3971828|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2284434|NCT02409680|3971841|FG000|Overall Study|Lost to Follow-up|15
2284435|NCT02409680|3971842|FG001|Overall Study|Lost to Follow-up|30
2284436|NCT02409719|3971850|FG000|Overall Study|Lost to Follow-up|3
2284437|NCT02409719|3971851|FG001|Overall Study|Lost to Follow-up|3
2284438|NCT02409732|3971857|FG000|Overall Study|Withdrawal by Subject|4
2284439|NCT02409732|3971857|FG000|Overall Study|Lost to Follow-up|2
2284440|NCT02410200|3971893|FG000|Overall Study|Adverse Event|2
2284441|NCT02410252|3971904|FG000|Overall Study|Withdrawal by Subject|4
2284442|NCT02410252|3971904|FG000|Overall Study|Physician Decision|2
2284443|NCT02410278|3971912|FG000|Run-in Period|Adverse Event|5
2284444|NCT02410278|3971913|FG001|Run-in Period|Adverse Event|0
2284445|NCT02410278|3971914|FG002|Run-in Period|Adverse Event|0
2284446|NCT02410278|3971912|FG000|Run-in Period|GSRS Threshold Not Met|30
2284447|NCT02410278|3971913|FG001|Run-in Period|GSRS Threshold Not Met|0
2284448|NCT02410278|3971914|FG002|Run-in Period|GSRS Threshold Not Met|0
2284449|NCT02410278|3971912|FG000|Run-in Period|Lost to Follow-up|1
2284450|NCT02410278|3971913|FG001|Run-in Period|Lost to Follow-up|0
2284451|NCT02410278|3971914|FG002|Run-in Period|Lost to Follow-up|0
2284452|NCT02410278|3971912|FG000|Run-in Period|Withdrawal by Subject|1
2284453|NCT02410278|3971913|FG001|Run-in Period|Withdrawal by Subject|0
2284454|NCT02410278|3971914|FG002|Run-in Period|Withdrawal by Subject|0
2284455|NCT02410278|3971912|FG000|Run-in Period|Pregnancy|1
2284456|NCT02410278|3971913|FG001|Run-in Period|Pregnancy|0
2284457|NCT02410278|3971914|FG002|Run-in Period|Pregnancy|0
2284458|NCT02410278|3971912|FG000|Study Treatment Period|Adverse Event|0
2284459|NCT02410278|3971913|FG001|Study Treatment Period|Adverse Event|6
2284460|NCT02410278|3971914|FG002|Study Treatment Period|Adverse Event|3
2284461|NCT02410278|3971912|FG000|Study Treatment Period|Physician Decision|0
2284462|NCT02410278|3971913|FG001|Study Treatment Period|Physician Decision|0
2284463|NCT02410278|3971914|FG002|Study Treatment Period|Physician Decision|1
2284464|NCT02410278|3971912|FG000|Study Treatment Period|Withdrawal by Subject|0
2284465|NCT02410278|3971913|FG001|Study Treatment Period|Withdrawal by Subject|1
2284466|NCT02410278|3971914|FG002|Study Treatment Period|Withdrawal by Subject|0
2284467|NCT02410278|3971912|FG000|Study Treatment Period|Other|0
2284468|NCT02410278|3971913|FG001|Study Treatment Period|Other|3
2284469|NCT02410278|3971914|FG002|Study Treatment Period|Other|0
2284470|NCT02410278|3971912|FG000|Study Treatment Period|GSRS Threshold Not Met|0
2284471|NCT02410278|3971913|FG001|Study Treatment Period|GSRS Threshold Not Met|1
2284472|NCT02410278|3971914|FG002|Study Treatment Period|GSRS Threshold Not Met|0
2284473|NCT02410629|3971941|FG000|Overall Study|Family cannot commit to the study|2
2284474|NCT02410629|3971942|FG001|Overall Study|Family cannot commit to the study|1
2284475|NCT02410629|3971941|FG000|Overall Study|Subject returned to work|1
2284476|NCT02410629|3971942|FG001|Overall Study|Subject returned to work|0
2284477|NCT02410629|3971941|FG000|Overall Study|Subject moved back to home country|0
2284478|NCT02410629|3971942|FG001|Overall Study|Subject moved back to home country|1
2284479|NCT02410629|3971941|FG000|Overall Study|Subject underwent heart surgery|0
2284480|NCT02410629|3971942|FG001|Overall Study|Subject underwent heart surgery|1
2284481|NCT02410772|3971957|FG000|Overall Study|Death|3
2284482|NCT02410772|3971958|FG001|Overall Study|Death|4
2284483|NCT02410772|3971959|FG002|Overall Study|Death|8
2284484|NCT02410772|3971957|FG000|Overall Study|Lost to Follow-up|31
2284485|NCT02410772|3971958|FG001|Overall Study|Lost to Follow-up|23
2284486|NCT02410772|3971959|FG002|Overall Study|Lost to Follow-up|22
2284487|NCT02410772|3971957|FG000|Overall Study|Pregnancy|8
2284488|NCT02410772|3971958|FG001|Overall Study|Pregnancy|4
2284489|NCT02410772|3971959|FG002|Overall Study|Pregnancy|5
2284490|NCT02410772|3971957|FG000|Overall Study|Protocol Violation|8
2284491|NCT02410772|3971958|FG001|Overall Study|Protocol Violation|8
2284492|NCT02410772|3971959|FG002|Overall Study|Protocol Violation|4
2284493|NCT02410772|3971957|FG000|Overall Study|Baseline Drug Resistance|49
2284494|NCT02410772|3971958|FG001|Overall Study|Baseline Drug Resistance|40
2284495|NCT02410772|3971959|FG002|Overall Study|Baseline Drug Resistance|51
2284496|NCT02410772|3971957|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4
2284497|NCT02410772|3971958|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6
2284498|NCT02410772|3971959|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3
2130994|NCT01040130|3735135|FG004|Overall Study|Adverse Event|0
2284499|NCT02410772|3971957|FG000|Overall Study|Reinfection with a new strain of MTB|0
2284500|NCT02410772|3971958|FG001|Overall Study|Reinfection with a new strain of MTB|1
2284501|NCT02410772|3971959|FG002|Overall Study|Reinfection with a new strain of MTB|0
2284502|NCT02410811|3971976|FG000|Overall Study|Withdrawal by Subject|0
2284503|NCT02410811|3971977|FG001|Overall Study|Withdrawal by Subject|0
2284504|NCT02410811|3971978|FG002|Overall Study|Withdrawal by Subject|1
2130995|NCT01040130|3735136|FG005|Overall Study|Adverse Event|3
2130996|NCT01040130|3735131|FG000|Overall Study|Protocol Violation|0
2130997|NCT01040130|3735132|FG001|Overall Study|Protocol Violation|0
2130998|NCT01040130|3735133|FG002|Overall Study|Protocol Violation|2
2130999|NCT01040130|3735134|FG003|Overall Study|Protocol Violation|0
2131000|NCT01040130|3735135|FG004|Overall Study|Protocol Violation|0
2131001|NCT01040130|3735136|FG005|Overall Study|Protocol Violation|0
2131002|NCT01040130|3735131|FG000|Overall Study|Withdrawal by Subject|0
2131003|NCT01040130|3735132|FG001|Overall Study|Withdrawal by Subject|2
2131004|NCT01040130|3735133|FG002|Overall Study|Withdrawal by Subject|0
2131005|NCT01040130|3735134|FG003|Overall Study|Withdrawal by Subject|0
2131006|NCT01040130|3735135|FG004|Overall Study|Withdrawal by Subject|0
2131007|NCT01040130|3735136|FG005|Overall Study|Withdrawal by Subject|1
2131008|NCT01040130|3735131|FG000|Overall Study|Other reasons not listed above|2
2131009|NCT01040130|3735132|FG001|Overall Study|Other reasons not listed above|0
2131010|NCT01040130|3735133|FG002|Overall Study|Other reasons not listed above|0
2131011|NCT01040130|3735134|FG003|Overall Study|Other reasons not listed above|0
2131012|NCT01040130|3735135|FG004|Overall Study|Other reasons not listed above|0
2131013|NCT01040130|3735136|FG005|Overall Study|Other reasons not listed above|0
2131014|NCT01040169|3735148|FG000|Overall Study|Lost to Follow-up|3
2131015|NCT01040169|3735149|FG001|Overall Study|Lost to Follow-up|8
2131016|NCT01040260|3735175|FG000|Overall Study|Withdrawal by Subject|12
2131017|NCT01040260|3735176|FG001|Overall Study|Withdrawal by Subject|6
2131018|NCT01040260|3735175|FG000|Overall Study|Lost to Follow-up|3
2131019|NCT01040260|3735176|FG001|Overall Study|Lost to Follow-up|5
2131020|NCT01040351|3735184|FG000|Overall Study|poor ovarian response|1
2131021|NCT01040351|3735185|FG001|Overall Study|poor ovarian response|2
2131022|NCT01040403|3735191|FG000|Overall Study|Adverse Event|10
2131023|NCT01040403|3735191|FG000|Overall Study|Protocol Violation|2
2131024|NCT01040403|3735191|FG000|Overall Study|Lost to Follow-up|1
2131025|NCT01040403|3735191|FG000|Overall Study|Not treated|1
2131026|NCT01040403|3735191|FG000|Overall Study|Other reason not defined above|6
2131027|NCT01040689|3735210|FG000|Overall Study|Adverse Event|0
2284505|NCT02410811|3971979|FG003|Overall Study|Withdrawal by Subject|0
2284506|NCT02410824|3971989|FG000|First Intervention (One Week)|Headache|0
2284507|NCT02410824|3971990|FG001|First Intervention (One Week)|Headache|1
2284508|NCT02410837|3971997|FG000|Overall Study|Death|387
2284509|NCT02410837|3971997|FG000|Overall Study|Lost to Follow-up|50
2284510|NCT02410837|3971997|FG000|Overall Study|Withdrawal by Subject|44
2284511|NCT02410837|3971997|FG000|Overall Study|Physician Decision|6
2284512|NCT02410837|3971997|FG000|Overall Study|Moved to nursing home, cannot communicat|1
2284513|NCT02411084|3972012|FG000|Overall Study|Lack of Efficacy|6
2284514|NCT02411084|3972013|FG001|Overall Study|Lack of Efficacy|3
2284515|NCT02411084|3972012|FG000|Overall Study|Death|5
2284516|NCT02411084|3972013|FG001|Overall Study|Death|4
2284517|NCT02411084|3972012|FG000|Overall Study|Adverse Event|2
2284518|NCT02411084|3972013|FG001|Overall Study|Adverse Event|1
2284519|NCT02411084|3972012|FG000|Overall Study|Other reasons|0
2284520|NCT02411084|3972013|FG001|Overall Study|Other reasons|5
2284521|NCT02411110|3972021|FG000|Treatment Period 1|Adverse Event|4
2284522|NCT02411110|3972022|FG001|Treatment Period 1|Adverse Event|2
2284523|NCT02411110|3972021|FG000|Treatment Period 1|Lost to Follow-up|1
2284524|NCT02411110|3972022|FG001|Treatment Period 1|Lost to Follow-up|0
2284525|NCT02411110|3972021|FG000|Treatment Period 1|Personal Reasons|2
2284526|NCT02411110|3972022|FG001|Treatment Period 1|Personal Reasons|5
2284527|NCT02411110|3972021|FG000|Treatment Period 1|Other Miscellaneous Reasons|2
2284528|NCT02411110|3972022|FG001|Treatment Period 1|Other Miscellaneous Reasons|0
2284529|NCT02411110|3972021|FG000|Treatment Period 2|Adverse Event|1
2284530|NCT02411110|3972022|FG001|Treatment Period 2|Adverse Event|0
2284531|NCT02411110|3972021|FG000|Treatment Period 2|Lost to Follow-up|0
2284532|NCT02411110|3972022|FG001|Treatment Period 2|Lost to Follow-up|2
2284533|NCT02411110|3972021|FG000|Treatment Period 2|Personal Reasons|0
2284534|NCT02411110|3972022|FG001|Treatment Period 2|Personal Reasons|2
2284535|NCT02411201|3972030|FG000|Overall Study|Adverse Event|2
2284536|NCT02411201|3972030|FG000|Overall Study|Withdrawal by Subject|2
2284537|NCT02411201|3972030|FG000|Overall Study|Age group completed|2
2284538|NCT02411292|3972036|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16
2284539|NCT02411292|3972036|FG000|Overall Study|Death|2
2284540|NCT02411292|3972036|FG000|Overall Study|Lost to Follow-up|3
2284541|NCT02411396|3972042|FG000|Overall Study|Lost to Follow-up|31
2284542|NCT02411396|3972042|FG000|Overall Study|Death|10
2284543|NCT02411448|3972054|FG000|Overall Study|Withdrawal by Subject|1
2284544|NCT02411448|3972055|FG001|Overall Study|Withdrawal by Subject|14
2284545|NCT02411448|3972056|FG002|Overall Study|Withdrawal by Subject|9
2284546|NCT02411448|3972054|FG000|Overall Study|Other|0
2284547|NCT02411448|3972055|FG001|Overall Study|Other|2
2284548|NCT02411448|3972056|FG002|Overall Study|Other|0
2284549|NCT02411448|3972054|FG000|Overall Study|Did not receive study treatment|0
2284550|NCT02411448|3972055|FG001|Overall Study|Did not receive study treatment|3
2284551|NCT02411448|3972056|FG002|Overall Study|Did not receive study treatment|0
2284552|NCT02411448|3972054|FG000|Overall Study|Alive on study treatment|3
2284553|NCT02411448|3972055|FG001|Overall Study|Alive on study treatment|64
2284554|NCT02411448|3972056|FG002|Overall Study|Alive on study treatment|43
2131028|NCT01040689|3735211|FG001|Overall Study|Adverse Event|0
2131029|NCT01040689|3735212|FG002|Overall Study|Adverse Event|2
2131030|NCT01040689|3735213|FG003|Overall Study|Adverse Event|4
2131031|NCT01040689|3735210|FG000|Overall Study|Lack of Efficacy|0
2131032|NCT01040689|3735211|FG001|Overall Study|Lack of Efficacy|0
2131033|NCT01040689|3735212|FG002|Overall Study|Lack of Efficacy|1
2131034|NCT01040689|3735213|FG003|Overall Study|Lack of Efficacy|0
2131035|NCT01040689|3735210|FG000|Overall Study|Lost to Follow-up|1
2131036|NCT01040689|3735211|FG001|Overall Study|Lost to Follow-up|0
2131037|NCT01040689|3735212|FG002|Overall Study|Lost to Follow-up|0
2131038|NCT01040689|3735213|FG003|Overall Study|Lost to Follow-up|0
2131039|NCT01040689|3735210|FG000|Overall Study|Withdrawal by Subject|2
2131040|NCT01040689|3735211|FG001|Overall Study|Withdrawal by Subject|1
2284555|NCT02411539|3972083|FG000|Overall Study|Lost to Follow-up|2
2284556|NCT02411539|3972084|FG001|Overall Study|Lost to Follow-up|0
2284557|NCT02411539|3972083|FG000|Overall Study|Confounding medical condition|0
2284558|NCT02411539|3972084|FG001|Overall Study|Confounding medical condition|1
2284559|NCT02411578|3972104|FG000|Crossover Trial Phase|Pregnancy|0
2284560|NCT02411578|3972105|FG001|Crossover Trial Phase|Pregnancy|1
2284561|NCT02411591|3972116|FG000|Overall Study|Adverse Event|0
2284562|NCT02411591|3972117|FG001|Overall Study|Adverse Event|4
2284563|NCT02411591|3972118|FG002|Overall Study|Adverse Event|2
2284564|NCT02411591|3972116|FG000|Overall Study|Withdrawal by Subject|0
2284565|NCT02411591|3972117|FG001|Overall Study|Withdrawal by Subject|3
2284566|NCT02411591|3972118|FG002|Overall Study|Withdrawal by Subject|0
2284567|NCT02411591|3972116|FG000|Overall Study|Physician Decision|0
2284568|NCT02411591|3972117|FG001|Overall Study|Physician Decision|3
2284569|NCT02411591|3972118|FG002|Overall Study|Physician Decision|1
2284570|NCT02411747|3972136|FG000|Overall Study|Withdrawal by Subject|1
2284571|NCT02411747|3972137|FG001|Overall Study|Withdrawal by Subject|0
2284572|NCT02411747|3972136|FG000|Overall Study|Protocol Violation|2
2284573|NCT02411747|3972137|FG001|Overall Study|Protocol Violation|4
2284574|NCT02412111|3972180|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
2284575|NCT02412111|3972181|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
2284576|NCT02412111|3972182|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
2284577|NCT02412111|3972180|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
2284578|NCT02412111|3972181|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
2284579|NCT02412111|3972182|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
2284580|NCT02412111|3972180|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0
2284581|NCT02412111|3972181|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0
2284582|NCT02412111|3972182|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2
2284583|NCT02412111|3972180|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
2284584|NCT02412111|3972181|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
2284585|NCT02412111|3972182|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
2284586|NCT02412111|3972180|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
2284587|NCT02412111|3972181|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
2284588|NCT02412111|3972182|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
2284589|NCT02412111|3972180|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0
2284590|NCT02412111|3972181|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1
2284591|NCT02412111|3972182|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0
2284592|NCT02412111|3972180|FG000|Active Comparator Period (8 Weeks)|Other|0
2284593|NCT02412111|3972181|FG001|Active Comparator Period (8 Weeks)|Other|0
2284594|NCT02412111|3972182|FG002|Active Comparator Period (8 Weeks)|Other|2
2284595|NCT02412306|3972201|FG000|Overall Study|Lost to Follow-up|0
2284596|NCT02412306|3972202|FG001|Overall Study|Lost to Follow-up|1
2284597|NCT02412306|3972203|FG002|Overall Study|Lost to Follow-up|0
2284598|NCT02412306|3972204|FG003|Overall Study|Lost to Follow-up|0
2284599|NCT02412306|3972205|FG004|Overall Study|Lost to Follow-up|0
2284600|NCT02412306|3972201|FG000|Overall Study|Withdrawal by Subject|0
2284601|NCT02412306|3972202|FG001|Overall Study|Withdrawal by Subject|0
2284602|NCT02412306|3972203|FG002|Overall Study|Withdrawal by Subject|1
2284603|NCT02412306|3972204|FG003|Overall Study|Withdrawal by Subject|0
2284604|NCT02412306|3972205|FG004|Overall Study|Withdrawal by Subject|0
2284605|NCT02412306|3972201|FG000|Overall Study|Death|5
2284606|NCT02412306|3972202|FG001|Overall Study|Death|7
2284607|NCT02412306|3972203|FG002|Overall Study|Death|15
2284608|NCT02412306|3972204|FG003|Overall Study|Death|0
2284609|NCT02412306|3972205|FG004|Overall Study|Death|2
2284610|NCT02412371|3972232|FG000|Overall Study|Withdrawal by Subject|0
2284611|NCT02412371|3972233|FG001|Overall Study|Withdrawal by Subject|2
2284612|NCT02412371|3972234|FG002|Overall Study|Withdrawal by Subject|0
2284613|NCT02412371|3972235|FG003|Overall Study|Withdrawal by Subject|1
2284614|NCT02412371|3972236|FG004|Overall Study|Withdrawal by Subject|1
2284615|NCT02412371|3972237|FG005|Overall Study|Withdrawal by Subject|0
2284616|NCT02412371|3972232|FG000|Overall Study|Sponsor Discontinued Study|1
2284617|NCT02412371|3972233|FG001|Overall Study|Sponsor Discontinued Study|4
2284618|NCT02412371|3972234|FG002|Overall Study|Sponsor Discontinued Study|6
2284619|NCT02412371|3972235|FG003|Overall Study|Sponsor Discontinued Study|4
2284620|NCT02412371|3972236|FG004|Overall Study|Sponsor Discontinued Study|5
2131041|NCT01040689|3735212|FG002|Overall Study|Withdrawal by Subject|1
2131042|NCT01040689|3735213|FG003|Overall Study|Withdrawal by Subject|0
2131043|NCT01040689|3735210|FG000|Overall Study|Other reasons not listed above|0
2206670|NCT01621880|3845295|FG001|Overall Study|Withdrawal by Subject|4
2284621|NCT02412371|3972237|FG005|Overall Study|Sponsor Discontinued Study|0
2284622|NCT02412371|3972232|FG000|Overall Study|Death|4
2284623|NCT02412371|3972233|FG001|Overall Study|Death|2
2284624|NCT02412371|3972234|FG002|Overall Study|Death|1
2284625|NCT02412371|3972235|FG003|Overall Study|Death|3
2284626|NCT02412371|3972236|FG004|Overall Study|Death|5
2284627|NCT02412371|3972237|FG005|Overall Study|Death|2
2284628|NCT02412371|3972232|FG000|Overall Study|Other|2
2284629|NCT02412371|3972233|FG001|Overall Study|Other|1
2284630|NCT02412371|3972234|FG002|Overall Study|Other|0
2284631|NCT02412371|3972235|FG003|Overall Study|Other|0
2284632|NCT02412371|3972236|FG004|Overall Study|Other|1
2284633|NCT02412371|3972237|FG005|Overall Study|Other|3
2284634|NCT02412436|3972252|FG000|Overall Study|Protocol-mandated Discontinuation|7
2284635|NCT02412436|3972252|FG000|Overall Study|Lost to Follow-up|6
2284636|NCT02412436|3972252|FG000|Overall Study|Unable to get to clinic|3
2284637|NCT02412436|3972252|FG000|Overall Study|Death|1
2284638|NCT02412436|3972252|FG000|Overall Study|Not Willing to Adhere to Requirements|1
2284639|NCT02412488|3972256|FG000|Overall Study|Lost to Follow-up|10
2284640|NCT02412488|3972256|FG000|Overall Study|Withdrawal by Subject|5
2284641|NCT02412488|3972256|FG000|Overall Study|Physician Decision|1
2284642|NCT02412488|3972256|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1
2284643|NCT02412488|3972256|FG000|Overall Study|Reveal LINQ explant|1
2284644|NCT02412631|3972267|FG000|Overall Study|Adverse Event|1
2284645|NCT02412631|3972268|FG001|Overall Study|Adverse Event|2
2284646|NCT02412631|3972267|FG000|Overall Study|Lost to Follow-up|5
2284647|NCT02412631|3972268|FG001|Overall Study|Lost to Follow-up|9
2284648|NCT02412631|3972267|FG000|Overall Study|Withdrawal by Subject|9
2284649|NCT02412631|3972268|FG001|Overall Study|Withdrawal by Subject|3
2284650|NCT02412631|3972267|FG000|Overall Study|Early stop by FDA|5
2284651|NCT02412631|3972268|FG001|Overall Study|Early stop by FDA|2
2284652|NCT02412631|3972267|FG000|Overall Study|Unspecified reason|6
2284653|NCT02412631|3972268|FG001|Overall Study|Unspecified reason|8
2320876|NCT02952898|4035122|FG002|Overall Study|Non-compliance with study drug|2
2320877|NCT02953262|4035134|FG000|Overall Study|Used portal during 6 months prior to randomization|3
2320878|NCT02953262|4035135|FG001|Overall Study|Used portal during 6 months prior to randomization|6
2320879|NCT02953262|4035136|FG002|Overall Study|Used portal during 6 months prior to randomization|3
2320880|NCT02953262|4035137|FG003|Overall Study|Used portal during 6 months prior to randomization|3
2320881|NCT02953314|4035153|FG000|Overall Study|Adverse Event|0
2320882|NCT02953314|4035154|FG001|Overall Study|Adverse Event|1
2320883|NCT02953314|4035153|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
2320884|NCT02953314|4035154|FG001|Overall Study|Withdrawal of consent (not due to AE)|2
2320885|NCT02953639|4035179|FG000|Overall Study|Adverse Event|2
2320886|NCT02953639|4035180|FG001|Overall Study|Adverse Event|0
2320887|NCT02953639|4035181|FG002|Overall Study|Adverse Event|1
2320888|NCT02953639|4035179|FG000|Overall Study|Lost to Follow-up|8
2320889|NCT02953639|4035180|FG001|Overall Study|Lost to Follow-up|4
2320890|NCT02953639|4035181|FG002|Overall Study|Lost to Follow-up|3
2320891|NCT02953639|4035179|FG000|Overall Study|Non-Compliance With Study Drug|0
2320892|NCT02953639|4035180|FG001|Overall Study|Non-Compliance With Study Drug|2
2320893|NCT02953639|4035181|FG002|Overall Study|Non-Compliance With Study Drug|1
2320894|NCT02953639|4035179|FG000|Overall Study|Multiple Reasons|1
2320895|NCT02953639|4035180|FG001|Overall Study|Multiple Reasons|0
2320896|NCT02953639|4035181|FG002|Overall Study|Multiple Reasons|1
2320897|NCT02953639|4035179|FG000|Overall Study|Physician Decision|1
2320898|NCT02953639|4035180|FG001|Overall Study|Physician Decision|0
2320899|NCT02953639|4035181|FG002|Overall Study|Physician Decision|0
2320900|NCT02953639|4035179|FG000|Overall Study|Withdrawal by Subject|7
2320901|NCT02953639|4035180|FG001|Overall Study|Withdrawal by Subject|8
2320902|NCT02953639|4035181|FG002|Overall Study|Withdrawal by Subject|10
2320903|NCT02953639|4035179|FG000|Overall Study|Completed or Discontinued information is missing|1
2320904|NCT02953639|4035180|FG001|Overall Study|Completed or Discontinued information is missing|0
2320905|NCT02953639|4035181|FG002|Overall Study|Completed or Discontinued information is missing|0
2131044|NCT01040689|3735211|FG001|Overall Study|Other reasons not listed above|1
2131045|NCT01040689|3735212|FG002|Overall Study|Other reasons not listed above|0
2131046|NCT01040689|3735213|FG003|Overall Study|Other reasons not listed above|0
2131047|NCT01040728|3735228|FG000|Overall Study|Adverse Event|4
2131048|NCT01040728|3735229|FG001|Overall Study|Adverse Event|8
2131049|NCT01040728|3735230|FG002|Overall Study|Adverse Event|0
2131050|NCT01040728|3735231|FG003|Overall Study|Adverse Event|4
2131051|NCT01040728|3735228|FG000|Overall Study|Withdrawal by Subject|0
2131052|NCT01040728|3735229|FG001|Overall Study|Withdrawal by Subject|1
2206671|NCT01622231|3845313|FG000|Overall Study|Physician Decision|1
2206672|NCT01622231|3845313|FG000|Overall Study|Withdrawal by Subject|1
2206673|NCT01622348|3845339|FG000|Overall Study|Withdrawal by Subject|1
2206674|NCT01622348|3845340|FG001|Overall Study|Withdrawal by Subject|0
2206675|NCT01622348|3845341|FG002|Overall Study|Withdrawal by Subject|1
2206676|NCT01622569|3845362|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
2206677|NCT01622569|3845363|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
2206678|NCT01622569|3845364|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
2206679|NCT01622569|3845365|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
2206680|NCT01622569|3845362|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
2206681|NCT01622569|3845363|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
2284654|NCT02412657|3972290|FG000|Overall Study|Lost to Follow-up|1
2284655|NCT02412657|3972291|FG001|Overall Study|Lost to Follow-up|0
2284656|NCT02412657|3972292|FG002|Overall Study|Lost to Follow-up|0
2284657|NCT02412657|3972290|FG000|Overall Study|Protocol Violation|0
2284658|NCT02412657|3972291|FG001|Overall Study|Protocol Violation|2
2284659|NCT02412657|3972292|FG002|Overall Study|Protocol Violation|3
2284660|NCT02412722|3972306|FG000|Overall Study|Adverse Event|0
2284661|NCT02412722|3972307|FG001|Overall Study|Adverse Event|2
2284662|NCT02412722|3972308|FG002|Overall Study|Adverse Event|0
2284663|NCT02412722|3972309|FG003|Overall Study|Adverse Event|3
2284664|NCT02412722|3972310|FG004|Overall Study|Adverse Event|0
2284665|NCT02412722|3972311|FG005|Overall Study|Adverse Event|3
2284666|NCT02412722|3972306|FG000|Overall Study|Progressive Disease|6
2284667|NCT02412722|3972307|FG001|Overall Study|Progressive Disease|4
2284668|NCT02412722|3972308|FG002|Overall Study|Progressive Disease|4
2284669|NCT02412722|3972309|FG003|Overall Study|Progressive Disease|9
2284670|NCT02412722|3972310|FG004|Overall Study|Progressive Disease|3
2284671|NCT02412722|3972311|FG005|Overall Study|Progressive Disease|3
2284672|NCT02412722|3972306|FG000|Overall Study|Withdrawal by Subject|2
2284673|NCT02412722|3972307|FG001|Overall Study|Withdrawal by Subject|0
2284674|NCT02412722|3972308|FG002|Overall Study|Withdrawal by Subject|1
2284675|NCT02412722|3972309|FG003|Overall Study|Withdrawal by Subject|2
2284676|NCT02412722|3972310|FG004|Overall Study|Withdrawal by Subject|1
2284677|NCT02412722|3972311|FG005|Overall Study|Withdrawal by Subject|1
2284678|NCT02412722|3972306|FG000|Overall Study|Lost to Follow-up|0
2284679|NCT02412722|3972307|FG001|Overall Study|Lost to Follow-up|0
2284680|NCT02412722|3972308|FG002|Overall Study|Lost to Follow-up|0
2284681|NCT02412722|3972309|FG003|Overall Study|Lost to Follow-up|0
2284682|NCT02412722|3972310|FG004|Overall Study|Lost to Follow-up|1
2284683|NCT02412722|3972311|FG005|Overall Study|Lost to Follow-up|0
2284684|NCT02412722|3972306|FG000|Overall Study|Received drug in run-in and discontinued|0
2284685|NCT02412722|3972307|FG001|Overall Study|Received drug in run-in and discontinued|2
2284686|NCT02412722|3972308|FG002|Overall Study|Received drug in run-in and discontinued|0
2284687|NCT02412722|3972309|FG003|Overall Study|Received drug in run-in and discontinued|0
2284688|NCT02412722|3972310|FG004|Overall Study|Received drug in run-in and discontinued|0
2284689|NCT02412722|3972311|FG005|Overall Study|Received drug in run-in and discontinued|0
2284690|NCT02412722|3972306|FG000|Overall Study|Reason not Specified|3
2284691|NCT02412722|3972307|FG001|Overall Study|Reason not Specified|0
2284692|NCT02412722|3972308|FG002|Overall Study|Reason not Specified|2
2284693|NCT02412722|3972309|FG003|Overall Study|Reason not Specified|1
2284694|NCT02412722|3972310|FG004|Overall Study|Reason not Specified|2
2284695|NCT02412722|3972311|FG005|Overall Study|Reason not Specified|6
2284696|NCT02412761|3972345|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
2284697|NCT02412761|3972346|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
2284698|NCT02412761|3972347|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1
2284699|NCT02412761|3972348|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0
2284700|NCT02412761|3972349|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0
2284701|NCT02412761|3972350|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1
2284702|NCT02412852|3972362|FG000|Overall Study|Withdrawal by Subject|0
2284703|NCT02412852|3972363|FG001|Overall Study|Withdrawal by Subject|1
2284704|NCT02412852|3972364|FG002|Overall Study|Withdrawal by Subject|0
2284705|NCT02412852|3972365|FG003|Overall Study|Withdrawal by Subject|0
2284706|NCT02412852|3972362|FG000|Overall Study|Physician Decision|0
2284707|NCT02412852|3972363|FG001|Overall Study|Physician Decision|0
2284708|NCT02412852|3972364|FG002|Overall Study|Physician Decision|0
2284709|NCT02412852|3972365|FG003|Overall Study|Physician Decision|1
2284710|NCT02412878|3972375|FG000|Overall Study|Withdrawal by Subject|19
2284711|NCT02412878|3972376|FG001|Overall Study|Withdrawal by Subject|10
2284712|NCT02412878|3972375|FG000|Overall Study|Lost to Follow-up|2
2206682|NCT01622569|3845364|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
2206683|NCT01622569|3845365|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
2206684|NCT01622569|3845362|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
2206685|NCT01622569|3845363|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
2206686|NCT01622569|3845364|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
2206687|NCT01622569|3845365|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
2206688|NCT01622569|3845362|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2206689|NCT01622569|3845363|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
2206690|NCT01622569|3845364|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2206691|NCT01622569|3845365|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
2206692|NCT01622569|3845362|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
2206693|NCT01622569|3845363|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
2206694|NCT01622569|3845364|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
2206695|NCT01622569|3845365|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
2206696|NCT01622569|3845362|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
2206697|NCT01622569|3845363|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
2206698|NCT01622569|3845364|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2206699|NCT01622569|3845365|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
2206700|NCT01622569|3845362|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
2131053|NCT01040728|3735230|FG002|Overall Study|Withdrawal by Subject|1
2131054|NCT01040728|3735231|FG003|Overall Study|Withdrawal by Subject|0
2131055|NCT01040728|3735228|FG000|Overall Study|Protocol Violation|0
2131056|NCT01040728|3735229|FG001|Overall Study|Protocol Violation|0
2131057|NCT01040728|3735230|FG002|Overall Study|Protocol Violation|0
2131058|NCT01040728|3735231|FG003|Overall Study|Protocol Violation|1
2206701|NCT01622569|3845363|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2206702|NCT01622569|3845364|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
2206703|NCT01622569|3845365|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
2284713|NCT02412878|3972376|FG001|Overall Study|Lost to Follow-up|3
2284714|NCT02413229|3972453|FG000|Overall Study|Adverse Event|0
2284715|NCT02413229|3972454|FG001|Overall Study|Adverse Event|0
2284716|NCT02413229|3972455|FG002|Overall Study|Adverse Event|0
2284717|NCT02413229|3972456|FG003|Overall Study|Adverse Event|1
2284718|NCT02413229|3972457|FG004|Overall Study|Adverse Event|0
2284719|NCT02413229|3972458|FG005|Overall Study|Adverse Event|0
2284720|NCT02413229|3972459|FG006|Overall Study|Adverse Event|0
2284721|NCT02413229|3972460|FG007|Overall Study|Adverse Event|1
2284722|NCT02413229|3972453|FG000|Overall Study|Lost to Follow-up|0
2284723|NCT02413229|3972454|FG001|Overall Study|Lost to Follow-up|0
2284724|NCT02413229|3972455|FG002|Overall Study|Lost to Follow-up|1
2284725|NCT02413229|3972456|FG003|Overall Study|Lost to Follow-up|0
2284726|NCT02413229|3972457|FG004|Overall Study|Lost to Follow-up|2
2284727|NCT02413229|3972458|FG005|Overall Study|Lost to Follow-up|0
2284728|NCT02413229|3972459|FG006|Overall Study|Lost to Follow-up|0
2284729|NCT02413229|3972460|FG007|Overall Study|Lost to Follow-up|0
2284730|NCT02413229|3972453|FG000|Overall Study|Withdrawal by Subject|1
2284731|NCT02413229|3972454|FG001|Overall Study|Withdrawal by Subject|1
2284732|NCT02413229|3972455|FG002|Overall Study|Withdrawal by Subject|0
2284733|NCT02413229|3972456|FG003|Overall Study|Withdrawal by Subject|0
2284734|NCT02413229|3972457|FG004|Overall Study|Withdrawal by Subject|1
2284735|NCT02413229|3972458|FG005|Overall Study|Withdrawal by Subject|0
2284736|NCT02413229|3972459|FG006|Overall Study|Withdrawal by Subject|0
2284737|NCT02413229|3972460|FG007|Overall Study|Withdrawal by Subject|2
2284738|NCT02413229|3972453|FG000|Overall Study|Progressive Disease|0
2284739|NCT02413229|3972454|FG001|Overall Study|Progressive Disease|0
2284740|NCT02413229|3972455|FG002|Overall Study|Progressive Disease|0
2284741|NCT02413229|3972456|FG003|Overall Study|Progressive Disease|0
2284742|NCT02413229|3972457|FG004|Overall Study|Progressive Disease|0
2284743|NCT02413229|3972458|FG005|Overall Study|Progressive Disease|0
2284744|NCT02413229|3972459|FG006|Overall Study|Progressive Disease|0
2284745|NCT02413229|3972460|FG007|Overall Study|Progressive Disease|1
2284746|NCT02413255|3972495|FG000|Overall Study|Voluntary Withdrawal|0
2284747|NCT02413255|3972496|FG001|Overall Study|Voluntary Withdrawal|0
2284748|NCT02413255|3972497|FG002|Overall Study|Voluntary Withdrawal|0
2284749|NCT02413255|3972498|FG003|Overall Study|Voluntary Withdrawal|0
2284750|NCT02413255|3972499|FG004|Overall Study|Voluntary Withdrawal|0
2284751|NCT02413255|3972500|FG005|Overall Study|Voluntary Withdrawal|0
2284752|NCT02413255|3972501|FG006|Overall Study|Voluntary Withdrawal|0
2284753|NCT02413255|3972502|FG007|Overall Study|Voluntary Withdrawal|0
2284754|NCT02413255|3972503|FG008|Overall Study|Voluntary Withdrawal|0
2284755|NCT02413255|3972504|FG009|Overall Study|Voluntary Withdrawal|0
2284756|NCT02413255|3972505|FG010|Overall Study|Voluntary Withdrawal|0
2284757|NCT02413255|3972506|FG011|Overall Study|Voluntary Withdrawal|0
2284758|NCT02413255|3972507|FG012|Overall Study|Voluntary Withdrawal|0
2284759|NCT02413255|3972508|FG013|Overall Study|Voluntary Withdrawal|0
2284760|NCT02413255|3972509|FG014|Overall Study|Voluntary Withdrawal|1
2284761|NCT02413255|3972510|FG015|Overall Study|Voluntary Withdrawal|0
2284762|NCT02413255|3972511|FG016|Overall Study|Voluntary Withdrawal|0
2284763|NCT02413294|3972562|FG000|Overall Study|Withdrawal by Subject|1
2284764|NCT02413333|3972579|FG000|Period 1|Adverse Event|1
2284765|NCT02413333|3972580|FG001|Period 1|Adverse Event|0
2284766|NCT02413333|3972579|FG000|Period 1|Reason Not Specified|0
2284767|NCT02413333|3972580|FG001|Period 1|Reason Not Specified|1
2284768|NCT02413333|3972579|FG000|Period 2|Protocol Deviation|1
2284769|NCT02413333|3972580|FG001|Period 2|Protocol Deviation|0
2284770|NCT02413346|3972588|FG000|Overall Study|Adverse Event|6
2284771|NCT02413346|3972589|FG001|Overall Study|Adverse Event|6
2284772|NCT02413346|3972588|FG000|Overall Study|Withdrawal by Subject|30
2284773|NCT02413346|3972589|FG001|Overall Study|Withdrawal by Subject|40
2284774|NCT02413346|3972588|FG000|Overall Study|Lost to Follow-up|17
2284775|NCT02413346|3972589|FG001|Overall Study|Lost to Follow-up|21
2284776|NCT02413346|3972588|FG000|Overall Study|Protocol Violation|2
2284777|NCT02413346|3972589|FG001|Overall Study|Protocol Violation|0
2284778|NCT02413346|3972588|FG000|Overall Study|Other Miscellaneous Reasons|4
2284779|NCT02413346|3972589|FG001|Overall Study|Other Miscellaneous Reasons|3
2131059|NCT01040728|3735228|FG000|Overall Study|Lack of Efficacy|0
2131060|NCT01040728|3735229|FG001|Overall Study|Lack of Efficacy|1
2131061|NCT01040728|3735230|FG002|Overall Study|Lack of Efficacy|0
2131062|NCT01040728|3735231|FG003|Overall Study|Lack of Efficacy|1
2206704|NCT01622569|3845362|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2206705|NCT01622569|3845363|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2206706|NCT01622569|3845364|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2206707|NCT01622569|3845365|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
2206708|NCT01622660|3845385|FG000|Overall Study|Adverse Event|1
2206709|NCT01622673|3845395|FG000|Treatment Period 1|Withdrawal by Subject|0
2206710|NCT01622673|3845396|FG001|Treatment Period 1|Withdrawal by Subject|0
2206711|NCT01622673|3845397|FG002|Treatment Period 1|Withdrawal by Subject|0
2206712|NCT01622673|3845398|FG003|Treatment Period 1|Withdrawal by Subject|1
2206713|NCT01622673|3845399|FG004|Treatment Period 1|Withdrawal by Subject|0
2206714|NCT01622673|3845400|FG005|Treatment Period 1|Withdrawal by Subject|0
2206715|NCT01622673|3845395|FG000|Treatment Period 1|Protocol Violation|0
2206716|NCT01622673|3845396|FG001|Treatment Period 1|Protocol Violation|1
2206717|NCT01622673|3845397|FG002|Treatment Period 1|Protocol Violation|0
2131063|NCT01040728|3735228|FG000|Overall Study|Other reasons not listed above|0
2131064|NCT01040728|3735229|FG001|Overall Study|Other reasons not listed above|1
2131065|NCT01040728|3735230|FG002|Overall Study|Other reasons not listed above|0
2131066|NCT01040728|3735231|FG003|Overall Study|Other reasons not listed above|0
2131067|NCT01040780|3735249|FG000|Overall Study|Protocol Violation|1
2131068|NCT01040780|3735250|FG001|Overall Study|Protocol Violation|3
2131069|NCT01040793|3735259|FG000|Overall Study|Adverse Event|5
2131070|NCT01040793|3735260|FG001|Overall Study|Adverse Event|3
2131071|NCT01040793|3735261|FG002|Overall Study|Adverse Event|0
2131072|NCT01040793|3735262|FG003|Overall Study|Adverse Event|2
2131073|NCT01040793|3735263|FG004|Overall Study|Adverse Event|2
2206718|NCT01622673|3845398|FG003|Treatment Period 1|Protocol Violation|0
2284780|NCT02413372|3972598|FG000|Treatment|Lost to Follow-up|0
2284781|NCT02413372|3972599|FG001|Treatment|Lost to Follow-up|2
2284782|NCT02413372|3972600|FG002|Treatment|Lost to Follow-up|1
2284783|NCT02413372|3972598|FG000|Treatment|Withdrawal by Subject|1
2284784|NCT02413372|3972599|FG001|Treatment|Withdrawal by Subject|0
2284785|NCT02413372|3972600|FG002|Treatment|Withdrawal by Subject|0
2284786|NCT02413372|3972598|FG000|Follow-up|Lost to Follow-up|1
2284787|NCT02413372|3972599|FG001|Follow-up|Lost to Follow-up|1
2284788|NCT02413372|3972600|FG002|Follow-up|Lost to Follow-up|0
2284789|NCT02413372|3972598|FG000|Follow-up|Subject Withdrew Consent|1
2284790|NCT02413372|3972599|FG001|Follow-up|Subject Withdrew Consent|0
2284791|NCT02413372|3972600|FG002|Follow-up|Subject Withdrew Consent|1
2284792|NCT02413372|3972598|FG000|Follow-up|Subject unable to return for visit|0
2284793|NCT02413372|3972599|FG001|Follow-up|Subject unable to return for visit|0
2284794|NCT02413372|3972600|FG002|Follow-up|Subject unable to return for visit|1
2284795|NCT02413398|3972610|FG000|Overall Study|Lost to Follow-up|2
2284796|NCT02413398|3972611|FG001|Overall Study|Lost to Follow-up|4
2284797|NCT02413398|3972610|FG000|Overall Study|Withdrawal by Subject|1
2284798|NCT02413398|3972611|FG001|Overall Study|Withdrawal by Subject|1
2284799|NCT02413398|3972610|FG000|Overall Study|Other Eligibility criteria|1
2284800|NCT02413398|3972611|FG001|Overall Study|Other Eligibility criteria|2
2284801|NCT02413489|3972629|FG000|Overall Study|Death|11
2284802|NCT02413489|3972630|FG001|Overall Study|Death|3
2284803|NCT02413489|3972631|FG002|Overall Study|Death|4
2284804|NCT02413489|3972629|FG000|Overall Study|Withdrawal by Subject|2
2284805|NCT02413489|3972630|FG001|Overall Study|Withdrawal by Subject|0
2284806|NCT02413489|3972631|FG002|Overall Study|Withdrawal by Subject|0
2284807|NCT02413489|3972629|FG000|Overall Study|Study Terminated By Sponsor|2
2284808|NCT02413489|3972630|FG001|Overall Study|Study Terminated By Sponsor|13
2284809|NCT02413489|3972631|FG002|Overall Study|Study Terminated By Sponsor|1
2284810|NCT02413593|3972643|FG000|Overall Study|Lost to Follow-up|3
2284811|NCT02413593|3972643|FG000|Overall Study|Adverse Event|1
2284812|NCT02413996|3972664|FG000|Overall Study|not comfortable with the intervention|9
2284813|NCT02413996|3972665|FG001|Overall Study|not comfortable with the intervention|2
2284814|NCT02414828|3972698|FG000|Overall Study|Lost to Follow-up|0
2284815|NCT02414828|3972699|FG001|Overall Study|Lost to Follow-up|1
2284816|NCT02414828|3972700|FG002|Overall Study|Lost to Follow-up|1
2284817|NCT02414828|3972701|FG003|Overall Study|Lost to Follow-up|2
2284818|NCT02414841|3972714|FG000|Overall Study|Withdrawal by Subject|7
2284819|NCT02414841|3972715|FG001|Overall Study|Withdrawal by Subject|5
2284820|NCT02414841|3972714|FG000|Overall Study|Lost to Follow-up|13
2284821|NCT02414841|3972715|FG001|Overall Study|Lost to Follow-up|6
2284822|NCT02414841|3972714|FG000|Overall Study|Death|17
2284823|NCT02414841|3972715|FG001|Overall Study|Death|14
2284824|NCT02414841|3972714|FG000|Overall Study|Received a Kidney Transplant|13
2284825|NCT02414841|3972715|FG001|Overall Study|Received a Kidney Transplant|4
2284826|NCT02414841|3972714|FG000|Overall Study|Randomized But Not Treated|6
2284827|NCT02414841|3972715|FG001|Overall Study|Randomized But Not Treated|4
2284828|NCT02414854|3972727|FG000|Overall Study|Adverse Event|9
2284829|NCT02414854|3972728|FG001|Overall Study|Adverse Event|7
2284830|NCT02414854|3972729|FG002|Overall Study|Adverse Event|1
2131074|NCT01040793|3735264|FG005|Overall Study|Adverse Event|1
2131075|NCT01040793|3735259|FG000|Overall Study|Protocol Violation|1
2206719|NCT01622673|3845399|FG004|Treatment Period 1|Protocol Violation|0
2284831|NCT02414854|3972730|FG003|Overall Study|Adverse Event|12
2284832|NCT02414854|3972727|FG000|Overall Study|Poor compliance to protocol|1
2284833|NCT02414854|3972728|FG001|Overall Study|Poor compliance to protocol|1
2206720|NCT01622673|3845400|FG005|Treatment Period 1|Protocol Violation|0
2206721|NCT01622673|3845395|FG000|Treatment Period 2|Withdrawal by Subject|0
2131076|NCT01040793|3735260|FG001|Overall Study|Protocol Violation|1
2131077|NCT01040793|3735261|FG002|Overall Study|Protocol Violation|1
2131078|NCT01040793|3735262|FG003|Overall Study|Protocol Violation|0
2131079|NCT01040793|3735263|FG004|Overall Study|Protocol Violation|1
2131080|NCT01040793|3735264|FG005|Overall Study|Protocol Violation|0
2131081|NCT01040793|3735259|FG000|Overall Study|Lost to Follow-up|0
2131082|NCT01040793|3735260|FG001|Overall Study|Lost to Follow-up|1
2131083|NCT01040793|3735261|FG002|Overall Study|Lost to Follow-up|1
2131084|NCT01040793|3735262|FG003|Overall Study|Lost to Follow-up|0
2131085|NCT01040793|3735263|FG004|Overall Study|Lost to Follow-up|0
2131086|NCT01040793|3735264|FG005|Overall Study|Lost to Follow-up|0
2131087|NCT01040793|3735259|FG000|Overall Study|Withdrawal by Subject|0
2131088|NCT01040793|3735260|FG001|Overall Study|Withdrawal by Subject|0
2131089|NCT01040793|3735261|FG002|Overall Study|Withdrawal by Subject|0
2131090|NCT01040793|3735262|FG003|Overall Study|Withdrawal by Subject|2
2131091|NCT01040793|3735263|FG004|Overall Study|Withdrawal by Subject|0
2131092|NCT01040793|3735264|FG005|Overall Study|Withdrawal by Subject|0
2131093|NCT01040793|3735259|FG000|Overall Study|Other reasons not listed above|0
2131094|NCT01040793|3735260|FG001|Overall Study|Other reasons not listed above|0
2131095|NCT01040793|3735261|FG002|Overall Study|Other reasons not listed above|1
2131096|NCT01040793|3735262|FG003|Overall Study|Other reasons not listed above|0
2131097|NCT01040793|3735263|FG004|Overall Study|Other reasons not listed above|1
2131098|NCT01040793|3735264|FG005|Overall Study|Other reasons not listed above|0
2131099|NCT01040832|3735285|FG000|Overall Study|Adverse Event|4
2131100|NCT01040832|3735286|FG001|Overall Study|Adverse Event|5
2131101|NCT01040832|3735285|FG000|Overall Study|Death|4
2131102|NCT01040832|3735286|FG001|Overall Study|Death|6
2131103|NCT01040832|3735285|FG000|Overall Study|Withdrawal by Subject|2
2131104|NCT01040832|3735286|FG001|Overall Study|Withdrawal by Subject|3
2131105|NCT01040832|3735285|FG000|Overall Study|Progressive disease|32
2131106|NCT01040832|3735286|FG001|Overall Study|Progressive disease|17
2131107|NCT01040832|3735285|FG000|Overall Study|Symptomatic deterioration|2
2131108|NCT01040832|3735286|FG001|Overall Study|Symptomatic deterioration|5
2131109|NCT01040832|3735285|FG000|Overall Study|Other|2
2131110|NCT01040832|3735286|FG001|Overall Study|Other|1
2131111|NCT01040845|3735294|FG000|Overall Study|Withdrawal by Subject|1
2131112|NCT01040845|3735295|FG001|Overall Study|Withdrawal by Subject|1
2131113|NCT01040845|3735294|FG000|Overall Study|Physician Decision|1
2284834|NCT02414854|3972729|FG002|Overall Study|Poor compliance to protocol|2
2284835|NCT02414854|3972730|FG003|Overall Study|Poor compliance to protocol|2
2284836|NCT02414854|3972727|FG000|Overall Study|Other than specified above|12
2284837|NCT02414854|3972728|FG001|Overall Study|Other than specified above|37
2284838|NCT02414854|3972729|FG002|Overall Study|Other than specified above|17
2284839|NCT02414854|3972730|FG003|Overall Study|Other than specified above|37
2284840|NCT02414932|3972742|FG000|Overall Study|Withdrawal by Subject|2
2284841|NCT02414932|3972743|FG001|Overall Study|Withdrawal by Subject|3
2284842|NCT02414932|3972742|FG000|Overall Study|Adverse Event|1
2284843|NCT02414932|3972743|FG001|Overall Study|Adverse Event|0
2284844|NCT02414958|3972752|FG000|Overall Study|Adverse Event|6
2284845|NCT02414958|3972753|FG001|Overall Study|Adverse Event|6
2284846|NCT02414958|3972754|FG002|Overall Study|Adverse Event|3
2284847|NCT02414958|3972752|FG000|Overall Study|Protocol Violation|10
2284848|NCT02414958|3972753|FG001|Overall Study|Protocol Violation|3
2284849|NCT02414958|3972754|FG002|Overall Study|Protocol Violation|1
2284850|NCT02414958|3972752|FG000|Overall Study|Lost to Follow-up|7
2284851|NCT02414958|3972753|FG001|Overall Study|Lost to Follow-up|4
2284852|NCT02414958|3972754|FG002|Overall Study|Lost to Follow-up|0
2284853|NCT02414958|3972752|FG000|Overall Study|Withdrawal by Subject|5
2284854|NCT02414958|3972753|FG001|Overall Study|Withdrawal by Subject|3
2284855|NCT02414958|3972754|FG002|Overall Study|Withdrawal by Subject|5
2284856|NCT02414958|3972752|FG000|Overall Study|Other than specified|4
2284857|NCT02414958|3972753|FG001|Overall Study|Other than specified|4
2284858|NCT02414958|3972754|FG002|Overall Study|Other than specified|5
2284859|NCT02415127|3972764|FG000|Overall Study|Adverse Event|1
2284860|NCT02415127|3972765|FG001|Overall Study|Adverse Event|0
2284861|NCT02415400|3972784|FG000|Overall Study|Adverse Event|0
2284862|NCT02415400|3972785|FG001|Overall Study|Adverse Event|1
2284863|NCT02415400|3972786|FG002|Overall Study|Adverse Event|1
2284864|NCT02415400|3972787|FG003|Overall Study|Adverse Event|2
2131114|NCT01040845|3735295|FG001|Overall Study|Physician Decision|0
2131115|NCT01040871|3735317|FG000|Overall Study|Adverse Event|6
2131116|NCT01040871|3735318|FG001|Overall Study|Adverse Event|2
2131117|NCT01040871|3735317|FG000|Overall Study|Withdrawal by Subject|2
2131118|NCT01040871|3735318|FG001|Overall Study|Withdrawal by Subject|0
2131119|NCT01040871|3735317|FG000|Overall Study|Death|1
2206722|NCT01622673|3845396|FG001|Treatment Period 2|Withdrawal by Subject|0
2206723|NCT01622673|3845397|FG002|Treatment Period 2|Withdrawal by Subject|0
2206724|NCT01622673|3845398|FG003|Treatment Period 2|Withdrawal by Subject|1
2206725|NCT01622673|3845399|FG004|Treatment Period 2|Withdrawal by Subject|0
2206726|NCT01622673|3845400|FG005|Treatment Period 2|Withdrawal by Subject|0
2206727|NCT01622673|3845395|FG000|Treatment Period 3|Protocol Violation|0
2206728|NCT01622673|3845396|FG001|Treatment Period 3|Protocol Violation|1
2284865|NCT02415400|3972784|FG000|Overall Study|Participant request to stop therapy|4
2284866|NCT02415400|3972785|FG001|Overall Study|Participant request to stop therapy|3
2284867|NCT02415400|3972786|FG002|Overall Study|Participant request to stop therapy|8
2284868|NCT02415400|3972787|FG003|Overall Study|Participant request to stop therapy|6
2284869|NCT02415400|3972784|FG000|Overall Study|Participant withdrew consent|14
2284870|NCT02415400|3972785|FG001|Overall Study|Participant withdrew consent|12
2284871|NCT02415400|3972786|FG002|Overall Study|Participant withdrew consent|30
2284872|NCT02415400|3972787|FG003|Overall Study|Participant withdrew consent|21
2284873|NCT02415400|3972784|FG000|Overall Study|Death|39
2284874|NCT02415400|3972785|FG001|Overall Study|Death|41
2284875|NCT02415400|3972786|FG002|Overall Study|Death|35
2284876|NCT02415400|3972787|FG003|Overall Study|Death|42
2284877|NCT02415400|3972784|FG000|Overall Study|Lost to Follow-up|3
2284878|NCT02415400|3972785|FG001|Overall Study|Lost to Follow-up|3
2284879|NCT02415400|3972786|FG002|Overall Study|Lost to Follow-up|2
2284880|NCT02415400|3972787|FG003|Overall Study|Lost to Follow-up|5
2284881|NCT02415400|3972784|FG000|Overall Study|Poor/Non-Compliance|0
2284882|NCT02415400|3972785|FG001|Overall Study|Poor/Non-Compliance|1
2284883|NCT02415400|3972786|FG002|Overall Study|Poor/Non-Compliance|3
2284884|NCT02415400|3972787|FG003|Overall Study|Poor/Non-Compliance|4
2284885|NCT02415400|3972784|FG000|Overall Study|Participant no longer meets criteria|2
2284886|NCT02415400|3972785|FG001|Overall Study|Participant no longer meets criteria|0
2284887|NCT02415400|3972786|FG002|Overall Study|Participant no longer meets criteria|0
2284888|NCT02415400|3972787|FG003|Overall Study|Participant no longer meets criteria|1
2284889|NCT02415400|3972784|FG000|Overall Study|Participant doesn't answer phone|1
2284890|NCT02415400|3972785|FG001|Overall Study|Participant doesn't answer phone|0
2284891|NCT02415400|3972786|FG002|Overall Study|Participant doesn't answer phone|0
2284892|NCT02415400|3972787|FG003|Overall Study|Participant doesn't answer phone|0
2284893|NCT02415400|3972784|FG000|Overall Study|Participant wanted home visits|1
2284894|NCT02415400|3972785|FG001|Overall Study|Participant wanted home visits|0
2284895|NCT02415400|3972786|FG002|Overall Study|Participant wanted home visits|0
2284896|NCT02415400|3972787|FG003|Overall Study|Participant wanted home visits|0
2284897|NCT02415400|3972784|FG000|Overall Study|Randomized in error|2
2284898|NCT02415400|3972785|FG001|Overall Study|Randomized in error|0
2284899|NCT02415400|3972786|FG002|Overall Study|Randomized in error|0
2284900|NCT02415400|3972787|FG003|Overall Study|Randomized in error|0
2284901|NCT02415400|3972784|FG000|Overall Study|No study drug on site|0
2284902|NCT02415400|3972785|FG001|Overall Study|No study drug on site|1
2284903|NCT02415400|3972786|FG002|Overall Study|No study drug on site|0
2284904|NCT02415400|3972787|FG003|Overall Study|No study drug on site|0
2284905|NCT02415400|3972784|FG000|Overall Study|Stroke and stroke rehabilitation|0
2284906|NCT02415400|3972785|FG001|Overall Study|Stroke and stroke rehabilitation|0
2284907|NCT02415400|3972786|FG002|Overall Study|Stroke and stroke rehabilitation|1
2284908|NCT02415400|3972787|FG003|Overall Study|Stroke and stroke rehabilitation|0
2284909|NCT02415400|3972784|FG000|Overall Study|Coagulation values cannot be set|0
2284910|NCT02415400|3972785|FG001|Overall Study|Coagulation values cannot be set|0
2284911|NCT02415400|3972786|FG002|Overall Study|Coagulation values cannot be set|1
2284912|NCT02415400|3972787|FG003|Overall Study|Coagulation values cannot be set|0
2284913|NCT02415400|3972784|FG000|Overall Study|State regulations prevent participation|0
2284914|NCT02415400|3972785|FG001|Overall Study|State regulations prevent participation|0
2284915|NCT02415400|3972786|FG002|Overall Study|State regulations prevent participation|1
2284916|NCT02415400|3972787|FG003|Overall Study|State regulations prevent participation|0
2284917|NCT02415400|3972784|FG000|Overall Study|Poor treatment monitoring|0
2284918|NCT02415400|3972785|FG001|Overall Study|Poor treatment monitoring|0
2284919|NCT02415400|3972786|FG002|Overall Study|Poor treatment monitoring|1
2284920|NCT02415400|3972787|FG003|Overall Study|Poor treatment monitoring|0
2284921|NCT02415400|3972784|FG000|Overall Study|Participant in jail|0
2284922|NCT02415400|3972785|FG001|Overall Study|Participant in jail|0
2284923|NCT02415400|3972786|FG002|Overall Study|Participant in jail|1
2284924|NCT02415400|3972787|FG003|Overall Study|Participant in jail|0
2284925|NCT02415400|3972784|FG000|Overall Study|Investigator decision|0
2284926|NCT02415400|3972785|FG001|Overall Study|Investigator decision|0
2284927|NCT02415400|3972786|FG002|Overall Study|Investigator decision|1
2284928|NCT02415400|3972787|FG003|Overall Study|Investigator decision|1
2284929|NCT02415400|3972784|FG000|Overall Study|Site closure; participant won't transfer|0
2284930|NCT02415400|3972785|FG001|Overall Study|Site closure; participant won't transfer|0
2284931|NCT02415400|3972786|FG002|Overall Study|Site closure; participant won't transfer|0
2284932|NCT02415400|3972787|FG003|Overall Study|Site closure; participant won't transfer|1
2284933|NCT02415556|3972860|FG000|Overall Study|Adverse Event|3
2284934|NCT02415556|3972861|FG001|Overall Study|Adverse Event|4
2284935|NCT02415556|3972862|FG002|Overall Study|Adverse Event|2
2284936|NCT02415556|3972863|FG003|Overall Study|Adverse Event|4
2284937|NCT02415556|3972860|FG000|Overall Study|Lost to Follow-up|4
2284938|NCT02415556|3972861|FG001|Overall Study|Lost to Follow-up|5
2284939|NCT02415556|3972862|FG002|Overall Study|Lost to Follow-up|4
2284940|NCT02415556|3972863|FG003|Overall Study|Lost to Follow-up|1
2284941|NCT02415556|3972860|FG000|Overall Study|Withdrawal by Subject|13
2284942|NCT02415556|3972861|FG001|Overall Study|Withdrawal by Subject|4
2284943|NCT02415556|3972862|FG002|Overall Study|Withdrawal by Subject|14
2284944|NCT02415556|3972863|FG003|Overall Study|Withdrawal by Subject|12
2131120|NCT01040871|3735318|FG001|Overall Study|Death|3
2131121|NCT01040871|3735317|FG000|Overall Study|Lack of Efficacy|1
2131122|NCT01040871|3735318|FG001|Overall Study|Lack of Efficacy|1
2131123|NCT01040871|3735317|FG000|Overall Study|drug supply issue|1
2131124|NCT01040871|3735318|FG001|Overall Study|drug supply issue|0
2131125|NCT01040871|3735317|FG000|Overall Study|Randomized and Not Treated|2
2131126|NCT01040871|3735318|FG001|Overall Study|Randomized and Not Treated|1
2131127|NCT01041287|3735350|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3
2131128|NCT01041287|3735351|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3
2131129|NCT01041287|3735350|FG000|Treatment Period 2 (3 Months)|Adverse Event|0
2131130|NCT01041287|3735351|FG001|Treatment Period 2 (3 Months)|Adverse Event|2
2131131|NCT01041404|3735359|FG000|Overall Study|Adverse Event|45
2206729|NCT01622673|3845397|FG002|Treatment Period 3|Protocol Violation|0
2206730|NCT01622673|3845398|FG003|Treatment Period 3|Protocol Violation|0
2206731|NCT01622673|3845399|FG004|Treatment Period 3|Protocol Violation|0
2206732|NCT01622673|3845400|FG005|Treatment Period 3|Protocol Violation|0
2284945|NCT02415556|3972860|FG000|Overall Study|Physician Decision|1
2284946|NCT02415556|3972861|FG001|Overall Study|Physician Decision|3
2284947|NCT02415556|3972862|FG002|Overall Study|Physician Decision|1
2284948|NCT02415556|3972863|FG003|Overall Study|Physician Decision|2
2284949|NCT02415556|3972860|FG000|Overall Study|Censored - study completion|4
2284950|NCT02415556|3972861|FG001|Overall Study|Censored - study completion|5
2284951|NCT02415556|3972862|FG002|Overall Study|Censored - study completion|1
2284952|NCT02415556|3972863|FG003|Overall Study|Censored - study completion|0
2284953|NCT02415556|3972860|FG000|Overall Study|Family-related issues|0
2284954|NCT02415556|3972861|FG001|Overall Study|Family-related issues|0
2284955|NCT02415556|3972862|FG002|Overall Study|Family-related issues|0
2284956|NCT02415556|3972863|FG003|Overall Study|Family-related issues|1
2284957|NCT02415595|3972877|FG000|Overall Study|Administrative reason by sponsor|39
2284958|NCT02415595|3972878|FG001|Overall Study|Administrative reason by sponsor|40
2284959|NCT02415595|3972879|FG002|Overall Study|Administrative reason by sponsor|41
2284960|NCT02415595|3972880|FG003|Overall Study|Administrative reason by sponsor|39
2284961|NCT02415595|3972877|FG000|Overall Study|Adverse Event|1
2284962|NCT02415595|3972878|FG001|Overall Study|Adverse Event|3
2284963|NCT02415595|3972879|FG002|Overall Study|Adverse Event|5
2284964|NCT02415595|3972880|FG003|Overall Study|Adverse Event|10
2284965|NCT02415595|3972877|FG000|Overall Study|Lack of Efficacy|4
2284966|NCT02415595|3972878|FG001|Overall Study|Lack of Efficacy|4
2284967|NCT02415595|3972879|FG002|Overall Study|Lack of Efficacy|0
2284968|NCT02415595|3972880|FG003|Overall Study|Lack of Efficacy|0
2284969|NCT02415595|3972877|FG000|Overall Study|Lost to Follow-up|1
2284970|NCT02415595|3972878|FG001|Overall Study|Lost to Follow-up|3
2284971|NCT02415595|3972879|FG002|Overall Study|Lost to Follow-up|1
2284972|NCT02415595|3972880|FG003|Overall Study|Lost to Follow-up|1
2284973|NCT02415595|3972877|FG000|Overall Study|Poor/Non-compliance|1
2284974|NCT02415595|3972878|FG001|Overall Study|Poor/Non-compliance|0
2284975|NCT02415595|3972879|FG002|Overall Study|Poor/Non-compliance|1
2284976|NCT02415595|3972880|FG003|Overall Study|Poor/Non-compliance|0
2284977|NCT02415595|3972877|FG000|Overall Study|Reached stopping criteria|0
2284978|NCT02415595|3972878|FG001|Overall Study|Reached stopping criteria|1
2284979|NCT02415595|3972879|FG002|Overall Study|Reached stopping criteria|1
2284980|NCT02415595|3972880|FG003|Overall Study|Reached stopping criteria|0
2284981|NCT02415595|3972877|FG000|Overall Study|Withdrawal by Subject|4
2284982|NCT02415595|3972878|FG001|Overall Study|Withdrawal by Subject|0
2284983|NCT02415595|3972879|FG002|Overall Study|Withdrawal by Subject|1
2284984|NCT02415595|3972880|FG003|Overall Study|Withdrawal by Subject|3
2284985|NCT02415595|3972877|FG000|Overall Study|Other|0
2284986|NCT02415595|3972878|FG001|Overall Study|Other|1
2284987|NCT02415595|3972879|FG002|Overall Study|Other|1
2284988|NCT02415595|3972880|FG003|Overall Study|Other|0
2284989|NCT02415959|3972984|FG000|Overall Study|Adverse Event|0
2206733|NCT01623050|3845434|FG000|Overall Study|Lost to Follow-up|9
2206734|NCT01623115|3845440|FG000|Overall Study|Randomized but not treated|0
2206735|NCT01623115|3845441|FG001|Overall Study|Randomized but not treated|1
2206736|NCT01623115|3845440|FG000|Overall Study|Physician Decision|1
2206737|NCT01623115|3845441|FG001|Overall Study|Physician Decision|0
2206738|NCT01623115|3845440|FG000|Overall Study|Participants moved|1
2206739|NCT01623115|3845441|FG001|Overall Study|Participants moved|5
2206740|NCT01623115|3845440|FG000|Overall Study|Adverse Event|10
2206741|NCT01623115|3845441|FG001|Overall Study|Adverse Event|13
2206742|NCT01623115|3845440|FG000|Overall Study|Poor compliance to protocol|4
2206743|NCT01623115|3845441|FG001|Overall Study|Poor compliance to protocol|10
2206744|NCT01623115|3845440|FG000|Overall Study|Consent withdrawn by participant|2
2206745|NCT01623115|3845441|FG001|Overall Study|Consent withdrawn by participant|6
2206746|NCT01623115|3845440|FG000|Overall Study|Related to study drug administration|0
2206747|NCT01623115|3845441|FG001|Overall Study|Related to study drug administration|2
2206748|NCT01623115|3845440|FG000|Overall Study|Last visit outside protocol visit window|14
2206749|NCT01623115|3845441|FG001|Overall Study|Last visit outside protocol visit window|26
2206750|NCT01623115|3845440|FG000|Overall Study|Site closure|1
2206751|NCT01623115|3845441|FG001|Overall Study|Site closure|7
2206752|NCT01623115|3845440|FG000|Overall Study|Death|0
2206753|NCT01623115|3845441|FG001|Overall Study|Death|4
2206754|NCT01623115|3845440|FG000|Overall Study|Other than specified above|0
2206755|NCT01623115|3845441|FG001|Overall Study|Other than specified above|3
2206756|NCT01623154|3845447|FG000|Overall Study|Did not drink Pranactin Citric|4
2206757|NCT01623271|3845466|FG000|Overall Study|Withdrawal by Subject|2
2206758|NCT01623310|3845470|FG000|Overall Study|Adverse Event|21
2206759|NCT01623310|3845470|FG000|Overall Study|Lost to Follow-up|18
2206760|NCT01623310|3845470|FG000|Overall Study|Lack of Efficacy|6
2284990|NCT02415959|3972985|FG001|Overall Study|Adverse Event|1
2284991|NCT02415959|3972986|FG002|Overall Study|Adverse Event|0
2284992|NCT02415959|3972987|FG003|Overall Study|Adverse Event|0
2284993|NCT02415959|3972988|FG004|Overall Study|Adverse Event|0
2284994|NCT02415959|3972984|FG000|Overall Study|Protocol Violation|0
2284995|NCT02415959|3972985|FG001|Overall Study|Protocol Violation|0
2284996|NCT02415959|3972986|FG002|Overall Study|Protocol Violation|0
2284997|NCT02415959|3972987|FG003|Overall Study|Protocol Violation|1
2284998|NCT02415959|3972988|FG004|Overall Study|Protocol Violation|0
2284999|NCT02416180|3973017|FG000|Overall Study|Withdrawal by Subject|1
2285000|NCT02416453|3973041|FG000|Overall Study|Adverse Event|0
2285001|NCT02416453|3973042|FG001|Overall Study|Adverse Event|0
2285002|NCT02416453|3973043|FG002|Overall Study|Adverse Event|0
2285003|NCT02416453|3973044|FG003|Overall Study|Adverse Event|2
2285004|NCT02416453|3973045|FG004|Overall Study|Adverse Event|0
2285005|NCT02416453|3973046|FG005|Overall Study|Adverse Event|1
2285006|NCT02416453|3973047|FG006|Overall Study|Adverse Event|0
2285007|NCT02416453|3973048|FG007|Overall Study|Adverse Event|0
2285008|NCT02416453|3973049|FG008|Overall Study|Adverse Event|0
2285009|NCT02416453|3973050|FG009|Overall Study|Adverse Event|0
2285010|NCT02416453|3973051|FG010|Overall Study|Adverse Event|0
2285011|NCT02416453|3973041|FG000|Overall Study|Lost to Follow-up|1
2285012|NCT02416453|3973042|FG001|Overall Study|Lost to Follow-up|3
2285013|NCT02416453|3973043|FG002|Overall Study|Lost to Follow-up|0
2285014|NCT02416453|3973044|FG003|Overall Study|Lost to Follow-up|8
2285015|NCT02416453|3973045|FG004|Overall Study|Lost to Follow-up|0
2285016|NCT02416453|3973046|FG005|Overall Study|Lost to Follow-up|5
2285017|NCT02416453|3973047|FG006|Overall Study|Lost to Follow-up|1
2285018|NCT02416453|3973048|FG007|Overall Study|Lost to Follow-up|3
2285019|NCT02416453|3973049|FG008|Overall Study|Lost to Follow-up|1
2285020|NCT02416453|3973050|FG009|Overall Study|Lost to Follow-up|0
2285021|NCT02416453|3973051|FG010|Overall Study|Lost to Follow-up|0
2285022|NCT02416453|3973041|FG000|Overall Study|Physician Decision|0
2285023|NCT02416453|3973042|FG001|Overall Study|Physician Decision|0
2285024|NCT02416453|3973043|FG002|Overall Study|Physician Decision|0
2285025|NCT02416453|3973044|FG003|Overall Study|Physician Decision|0
2285026|NCT02416453|3973045|FG004|Overall Study|Physician Decision|0
2285027|NCT02416453|3973046|FG005|Overall Study|Physician Decision|1
2285028|NCT02416453|3973047|FG006|Overall Study|Physician Decision|1
2285029|NCT02416453|3973048|FG007|Overall Study|Physician Decision|1
2285030|NCT02416453|3973049|FG008|Overall Study|Physician Decision|0
2285031|NCT02416453|3973050|FG009|Overall Study|Physician Decision|0
2285032|NCT02416453|3973051|FG010|Overall Study|Physician Decision|0
2285033|NCT02416453|3973041|FG000|Overall Study|Withdrawal by Subject|2
2285034|NCT02416453|3973042|FG001|Overall Study|Withdrawal by Subject|0
2285035|NCT02416453|3973043|FG002|Overall Study|Withdrawal by Subject|0
2285036|NCT02416453|3973044|FG003|Overall Study|Withdrawal by Subject|5
2285037|NCT02416453|3973045|FG004|Overall Study|Withdrawal by Subject|1
2285038|NCT02416453|3973046|FG005|Overall Study|Withdrawal by Subject|8
2285039|NCT02416453|3973047|FG006|Overall Study|Withdrawal by Subject|0
2285040|NCT02416453|3973048|FG007|Overall Study|Withdrawal by Subject|8
2285041|NCT02416453|3973049|FG008|Overall Study|Withdrawal by Subject|4
2285042|NCT02416453|3973050|FG009|Overall Study|Withdrawal by Subject|0
2285043|NCT02416453|3973051|FG010|Overall Study|Withdrawal by Subject|0
2285044|NCT02416453|3973041|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
2285045|NCT02416453|3973042|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
2285046|NCT02416453|3973043|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1
2285047|NCT02416453|3973044|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
2285048|NCT02416453|3973045|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
2285049|NCT02416453|3973046|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
2285050|NCT02416453|3973047|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
2285051|NCT02416453|3973048|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
2285052|NCT02416453|3973049|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
2285053|NCT02416453|3973050|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
2285054|NCT02416453|3973051|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
2285055|NCT02416453|3973041|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
2285056|NCT02416453|3973042|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
2285057|NCT02416453|3973043|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
2285058|NCT02416453|3973044|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
2285059|NCT02416453|3973045|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
2285060|NCT02416453|3973046|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1
2206761|NCT01623310|3845470|FG000|Overall Study|Protocol Violation|6
2285061|NCT02416453|3973047|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
2285062|NCT02416453|3973048|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
2285063|NCT02416453|3973049|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
2285064|NCT02416453|3973050|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
2206762|NCT01623310|3845470|FG000|Overall Study|Withdrawal by Subject|25
2206763|NCT01623310|3845470|FG000|Overall Study|Became potentially child-bearing|1
2206764|NCT01623310|3845470|FG000|Overall Study|Diagnoses of bilateral cateracts|1
2206765|NCT01623310|3845470|FG000|Overall Study|Investigators Discretion-Noncompliant|1
2206766|NCT01623531|3845493|FG000|Overall Study|Death|1
2206767|NCT01623531|3845494|FG001|Overall Study|Death|0
2206768|NCT01623531|3845493|FG000|Overall Study|Protocol Violation|2
2206769|NCT01623531|3845494|FG001|Overall Study|Protocol Violation|1
2206770|NCT01623531|3845493|FG000|Overall Study|Missing data at primary outcome time poi|1
2206771|NCT01623531|3845494|FG001|Overall Study|Missing data at primary outcome time poi|1
2206772|NCT01623596|3845505|FG000|Overall Study|Abnormal laboratory values|2
2285065|NCT02416453|3973051|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
2285066|NCT02416791|3973114|FG000|6 Months|Lost to Follow-up|0
2285067|NCT02416791|3973115|FG001|6 Months|Lost to Follow-up|0
2285068|NCT02416791|3973116|FG002|6 Months|Lost to Follow-up|1
2285069|NCT02416908|3973127|FG000|Dose Escalation Phase|Adverse Event|0
2285070|NCT02416908|3973128|FG001|Dose Escalation Phase|Adverse Event|0
2206773|NCT01623596|3845506|FG001|Overall Study|Abnormal laboratory values|0
2206774|NCT01623596|3845505|FG000|Overall Study|Administrative problems|9
2206775|NCT01623596|3845506|FG001|Overall Study|Administrative problems|13
2206776|NCT01623596|3845505|FG000|Overall Study|Adverse Event|20
2285071|NCT02416908|3973129|FG002|Dose Escalation Phase|Adverse Event|3
2285072|NCT02416908|3973130|FG003|Dose Escalation Phase|Adverse Event|0
2285073|NCT02416908|3973127|FG000|Dose Escalation Phase|Withdrawal by Subject|0
2285074|NCT02416908|3973128|FG001|Dose Escalation Phase|Withdrawal by Subject|0
2320906|NCT02953678|4035191|FG000|Overall Study|Adverse Event|20
2131132|NCT01041404|3735360|FG001|Overall Study|Adverse Event|35
2131133|NCT01041404|3735359|FG000|Overall Study|Lack of Efficacy|200
2131134|NCT01041404|3735360|FG001|Overall Study|Lack of Efficacy|210
2131135|NCT01041404|3735359|FG000|Overall Study|Violation of Selection Criteria|0
2131136|NCT01041404|3735360|FG001|Overall Study|Violation of Selection Criteria|1
2131137|NCT01041404|3735359|FG000|Overall Study|Protocol Violation|4
2131138|NCT01041404|3735360|FG001|Overall Study|Protocol Violation|0
2131139|NCT01041404|3735359|FG000|Overall Study|Withdrawal by Subject|29
2131140|NCT01041404|3735360|FG001|Overall Study|Withdrawal by Subject|23
2131141|NCT01041404|3735359|FG000|Overall Study|Failure to Return|1
2131142|NCT01041404|3735360|FG001|Overall Study|Failure to Return|2
2131143|NCT01041404|3735359|FG000|Overall Study|Other|11
2131144|NCT01041404|3735360|FG001|Overall Study|Other|23
2131145|NCT01041417|3735371|FG000|Overall Study|Adverse Event|5
2131146|NCT01041417|3735372|FG001|Overall Study|Adverse Event|2
2131147|NCT01041417|3735371|FG000|Overall Study|Lost to Follow-up|1
2131148|NCT01041417|3735372|FG001|Overall Study|Lost to Follow-up|1
2131149|NCT01041417|3735371|FG000|Overall Study|Death|1
2131150|NCT01041417|3735372|FG001|Overall Study|Death|0
2131151|NCT01041495|3735382|FG000|Overall Study|Withdrawal by Subject|2
2131152|NCT01041495|3735383|FG001|Overall Study|Withdrawal by Subject|5
2131153|NCT01041495|3735382|FG000|Overall Study|Adverse Event|2
2131154|NCT01041495|3735383|FG001|Overall Study|Adverse Event|1
2131155|NCT01041495|3735382|FG000|Overall Study|Lost to Follow-up|0
2131156|NCT01041495|3735383|FG001|Overall Study|Lost to Follow-up|1
2131157|NCT01041573|3735402|FG000|Overall Study|Withdrawal by Subject|2
2131158|NCT01041573|3735403|FG001|Overall Study|Withdrawal by Subject|5
2131159|NCT01041573|3735404|FG002|Overall Study|Withdrawal by Subject|2
2131160|NCT01041573|3735405|FG003|Overall Study|Withdrawal by Subject|0
2131161|NCT01041573|3735402|FG000|Overall Study|Death|1
2131162|NCT01041573|3735403|FG001|Overall Study|Death|0
2131163|NCT01041573|3735404|FG002|Overall Study|Death|0
2131164|NCT01041573|3735405|FG003|Overall Study|Death|0
2131165|NCT01041573|3735402|FG000|Overall Study|Lost to Follow-up|0
2131166|NCT01041573|3735403|FG001|Overall Study|Lost to Follow-up|1
2131167|NCT01041573|3735404|FG002|Overall Study|Lost to Follow-up|2
2131168|NCT01041573|3735405|FG003|Overall Study|Lost to Follow-up|1
2131169|NCT01041573|3735402|FG000|Overall Study|Adverse Event|0
2131170|NCT01041573|3735403|FG001|Overall Study|Adverse Event|2
2131171|NCT01041573|3735404|FG002|Overall Study|Adverse Event|0
2131172|NCT01041573|3735405|FG003|Overall Study|Adverse Event|0
2131173|NCT01041573|3735402|FG000|Overall Study|relocation|1
2131174|NCT01041573|3735403|FG001|Overall Study|relocation|4
2131175|NCT01041573|3735404|FG002|Overall Study|relocation|3
2131176|NCT01041573|3735405|FG003|Overall Study|relocation|1
2131177|NCT01041573|3735402|FG000|Overall Study|further blood extraction|0
2131178|NCT01041573|3735403|FG001|Overall Study|further blood extraction|1
2131179|NCT01041573|3735404|FG002|Overall Study|further blood extraction|0
2131180|NCT01041573|3735405|FG003|Overall Study|further blood extraction|0
2131181|NCT01041573|3735402|FG000|Overall Study|positive to anti-HCV|1
2131182|NCT01041573|3735403|FG001|Overall Study|positive to anti-HCV|0
2131183|NCT01041573|3735404|FG002|Overall Study|positive to anti-HCV|0
2131184|NCT01041573|3735405|FG003|Overall Study|positive to anti-HCV|0
2131185|NCT01041638|3735424|FG000|Overall Study|Adverse Event|4
2206777|NCT01623596|3845506|FG001|Overall Study|Adverse Event|29
2206778|NCT01623596|3845505|FG000|Overall Study|Death|0
2206779|NCT01623596|3845506|FG001|Overall Study|Death|2
2206780|NCT01623596|3845505|FG000|Overall Study|Lost to Follow-up|12
2131186|NCT01041638|3735424|FG000|Overall Study|Death|1
2131187|NCT01041638|3735424|FG000|Overall Study|Lack of Efficacy|7
2131188|NCT01041638|3735424|FG000|Overall Study|Physician Decision|4
2131189|NCT01041638|3735424|FG000|Overall Study|Withdrawal by Subject|11
2131190|NCT01041859|3735447|FG000|Open-Label Titration|Adverse Event|69
2131191|NCT01041859|3735448|FG001|Open-Label Titration|Adverse Event|0
2131192|NCT01041859|3735449|FG002|Open-Label Titration|Adverse Event|0
2131193|NCT01041859|3735447|FG000|Open-Label Titration|Lack of Efficacy|3
2131194|NCT01041859|3735448|FG001|Open-Label Titration|Lack of Efficacy|0
2131195|NCT01041859|3735449|FG002|Open-Label Titration|Lack of Efficacy|0
2131196|NCT01041859|3735447|FG000|Open-Label Titration|Lost to Follow-up|1
2131197|NCT01041859|3735448|FG001|Open-Label Titration|Lost to Follow-up|0
2131198|NCT01041859|3735449|FG002|Open-Label Titration|Lost to Follow-up|0
2131199|NCT01041859|3735447|FG000|Open-Label Titration|Physician Decision|1
2131200|NCT01041859|3735448|FG001|Open-Label Titration|Physician Decision|0
2131201|NCT01041859|3735449|FG002|Open-Label Titration|Physician Decision|0
2131202|NCT01041859|3735447|FG000|Open-Label Titration|Protocol Violation|1
2131203|NCT01041859|3735448|FG001|Open-Label Titration|Protocol Violation|0
2131204|NCT01041859|3735449|FG002|Open-Label Titration|Protocol Violation|0
2131205|NCT01041859|3735447|FG000|Open-Label Titration|Other|7
2131206|NCT01041859|3735448|FG001|Open-Label Titration|Other|0
2131207|NCT01041859|3735449|FG002|Open-Label Titration|Other|0
2131208|NCT01041859|3735447|FG000|Open-Label Titration|Noncompliance With Study Drug|8
2131209|NCT01041859|3735448|FG001|Open-Label Titration|Noncompliance With Study Drug|0
2131210|NCT01041859|3735449|FG002|Open-Label Titration|Noncompliance With Study Drug|0
2131211|NCT01041859|3735447|FG000|Open-Label Titration|Withdrawal by Subject|11
2131212|NCT01041859|3735448|FG001|Open-Label Titration|Withdrawal by Subject|0
2131213|NCT01041859|3735449|FG002|Open-Label Titration|Withdrawal by Subject|0
2131214|NCT01041859|3735447|FG000|Double-Blind Maintenance|Adverse Event|0
2131215|NCT01041859|3735448|FG001|Double-Blind Maintenance|Adverse Event|23
2131216|NCT01041859|3735449|FG002|Double-Blind Maintenance|Adverse Event|13
2131217|NCT01041859|3735447|FG000|Double-Blind Maintenance|Lack of Efficacy|0
2131218|NCT01041859|3735448|FG001|Double-Blind Maintenance|Lack of Efficacy|3
2131219|NCT01041859|3735449|FG002|Double-Blind Maintenance|Lack of Efficacy|11
2131220|NCT01041859|3735447|FG000|Double-Blind Maintenance|Lost to Follow-up|0
2131221|NCT01041859|3735448|FG001|Double-Blind Maintenance|Lost to Follow-up|1
2131222|NCT01041859|3735449|FG002|Double-Blind Maintenance|Lost to Follow-up|0
2131223|NCT01041859|3735447|FG000|Double-Blind Maintenance|Physician Decision|0
2131224|NCT01041859|3735448|FG001|Double-Blind Maintenance|Physician Decision|2
2131225|NCT01041859|3735449|FG002|Double-Blind Maintenance|Physician Decision|1
2131226|NCT01041859|3735447|FG000|Double-Blind Maintenance|Protocol Violation|0
2131227|NCT01041859|3735448|FG001|Double-Blind Maintenance|Protocol Violation|1
2131228|NCT01041859|3735449|FG002|Double-Blind Maintenance|Protocol Violation|3
2131229|NCT01041859|3735447|FG000|Double-Blind Maintenance|Other|0
2131230|NCT01041859|3735448|FG001|Double-Blind Maintenance|Other|6
2131231|NCT01041859|3735449|FG002|Double-Blind Maintenance|Other|2
2131232|NCT01041859|3735447|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0
2131233|NCT01041859|3735448|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2
2131234|NCT01041859|3735449|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6
2131235|NCT01041859|3735447|FG000|Double-Blind Maintenance|Withdrawal by Subject|0
2131236|NCT01041859|3735448|FG001|Double-Blind Maintenance|Withdrawal by Subject|8
2131237|NCT01041859|3735449|FG002|Double-Blind Maintenance|Withdrawal by Subject|9
2131238|NCT01041976|3735458|FG000|Overall Study|Withdrawal by Subject|3
2131239|NCT01041976|3735459|FG001|Overall Study|Withdrawal by Subject|0
2131240|NCT01041976|3735458|FG000|Overall Study|Incarceration|2
2131241|NCT01041976|3735459|FG001|Overall Study|Incarceration|0
2131242|NCT01041976|3735458|FG000|Overall Study|Death|0
2131243|NCT01041976|3735459|FG001|Overall Study|Death|4
2131244|NCT01042093|3735469|FG000|Overall Study|Protocol Violation|2
2131245|NCT01042093|3735470|FG001|Overall Study|Protocol Violation|2
2131246|NCT01042093|3735471|FG002|Overall Study|Protocol Violation|2
2131247|NCT01042093|3735472|FG003|Overall Study|Protocol Violation|3
2131248|NCT01042093|3735469|FG000|Overall Study|Withdrawal by Subject|0
2131249|NCT01042093|3735470|FG001|Overall Study|Withdrawal by Subject|0
2131250|NCT01042093|3735471|FG002|Overall Study|Withdrawal by Subject|0
2131251|NCT01042093|3735472|FG003|Overall Study|Withdrawal by Subject|1
2131252|NCT01042158|3735494|FG000|Overall Study|Physician Decision|1
2131253|NCT01042236|3735498|FG000|Treatment Period 1|Adverse Event|0
2131254|NCT01042236|3735499|FG001|Treatment Period 1|Adverse Event|1
2131255|NCT01042236|3735500|FG002|Treatment Period 1|Adverse Event|0
2131256|NCT01042236|3735501|FG003|Treatment Period 1|Adverse Event|0
2131257|NCT01042236|3735502|FG004|Treatment Period 1|Adverse Event|1
2131258|NCT01042236|3735503|FG005|Treatment Period 1|Adverse Event|0
2131259|NCT01042236|3735498|FG000|Treatment Period 3|Adverse Event|0
2131260|NCT01042236|3735499|FG001|Treatment Period 3|Adverse Event|0
2131261|NCT01042236|3735500|FG002|Treatment Period 3|Adverse Event|0
2131262|NCT01042236|3735501|FG003|Treatment Period 3|Adverse Event|1
2131263|NCT01042236|3735502|FG004|Treatment Period 3|Adverse Event|0
2131264|NCT01042236|3735503|FG005|Treatment Period 3|Adverse Event|0
2131265|NCT01042236|3735498|FG000|Treatment Period 3|Protocol Violation|0
2131266|NCT01042236|3735499|FG001|Treatment Period 3|Protocol Violation|0
2131267|NCT01042236|3735500|FG002|Treatment Period 3|Protocol Violation|0
2131268|NCT01042236|3735501|FG003|Treatment Period 3|Protocol Violation|1
2131269|NCT01042236|3735502|FG004|Treatment Period 3|Protocol Violation|0
2131270|NCT01042236|3735503|FG005|Treatment Period 3|Protocol Violation|0
2131271|NCT01042392|3735528|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
2131272|NCT01042392|3735529|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
2131273|NCT01042392|3735530|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
2131274|NCT01042392|3735531|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
2131275|NCT01042392|3735528|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
2131276|NCT01042392|3735529|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
2131277|NCT01042392|3735530|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
2131278|NCT01042392|3735531|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
2131279|NCT01042392|3735528|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
2131280|NCT01042392|3735529|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
2131281|NCT01042392|3735530|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
2206781|NCT01623596|3845506|FG001|Overall Study|Lost to Follow-up|16
2206782|NCT01623596|3845505|FG000|Overall Study|Withdrawal by Subject|13
2131282|NCT01042392|3735531|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
2131283|NCT01042392|3735528|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
2131284|NCT01042392|3735529|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
2131285|NCT01042392|3735530|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
2131286|NCT01042392|3735531|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
2131287|NCT01042392|3735528|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
2131288|NCT01042392|3735529|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
2131289|NCT01042392|3735530|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
2131290|NCT01042392|3735531|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
2131291|NCT01042392|3735528|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
2131292|NCT01042392|3735529|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
2131293|NCT01042392|3735530|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
2131294|NCT01042392|3735531|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
2131295|NCT01042392|3735528|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
2131296|NCT01042392|3735529|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
2131297|NCT01042392|3735530|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
2131298|NCT01042392|3735531|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
2131299|NCT01042392|3735528|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
2131300|NCT01042392|3735529|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
2131301|NCT01042392|3735530|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
2131302|NCT01042392|3735531|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
2131303|NCT01042392|3735528|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
2131304|NCT01042392|3735529|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
2131305|NCT01042392|3735530|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
2131306|NCT01042392|3735531|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
2131307|NCT01042535|3735560|FG000|Overall Study|disease progression prior to treatment|3
2131308|NCT01042535|3735560|FG000|Overall Study|disease progression during treatment|3
2131309|NCT01042535|3735560|FG000|Overall Study|complications from other disease|2
2131310|NCT01042600|3735566|FG000|Overall Study|Ineligible|1
2131311|NCT01042600|3735567|FG001|Overall Study|Ineligible|0
2131312|NCT01042678|3735586|FG000|Overall Study|Physician Decision|1
2131313|NCT01042678|3735587|FG001|Overall Study|Physician Decision|0
2131314|NCT01042678|3735588|FG002|Overall Study|Physician Decision|0
2131315|NCT01042678|3735589|FG003|Overall Study|Physician Decision|0
2131316|NCT01042678|3735590|FG004|Overall Study|Physician Decision|0
2131317|NCT01042678|3735591|FG005|Overall Study|Physician Decision|0
2131318|NCT01042938|3735605|FG000|Overall Study|Withdrawal by Subject|1
2131319|NCT01042938|3735606|FG001|Overall Study|Withdrawal by Subject|1
2131320|NCT01042938|3735605|FG000|Overall Study|Protocol Violation|1
2131321|NCT01042938|3735606|FG001|Overall Study|Protocol Violation|1
2131322|NCT01042938|3735605|FG000|Overall Study|Ineligible: RTOG study conflict|1
2131323|NCT01042938|3735606|FG001|Overall Study|Ineligible: RTOG study conflict|0
2131324|NCT01042977|3735616|FG000|Overall Study|Adverse Event|4
2131325|NCT01042977|3735617|FG001|Overall Study|Adverse Event|12
2131326|NCT01042977|3735616|FG000|Overall Study|Death|2
2131327|NCT01042977|3735617|FG001|Overall Study|Death|1
2131328|NCT01042977|3735616|FG000|Overall Study|Withdrawal by Subject|8
2131329|NCT01042977|3735617|FG001|Overall Study|Withdrawal by Subject|16
2131330|NCT01042977|3735616|FG000|Overall Study|Lost to Follow-up|0
2206783|NCT01623596|3845506|FG001|Overall Study|Withdrawal by Subject|31
2131331|NCT01042977|3735617|FG001|Overall Study|Lost to Follow-up|2
2131332|NCT01042977|3735616|FG000|Overall Study|Poor/non-compliance|3
2131333|NCT01042977|3735617|FG001|Overall Study|Poor/non-compliance|4
2131334|NCT01042977|3735616|FG000|Overall Study|Subject no longer meets study criteria|15
2131335|NCT01042977|3735617|FG001|Overall Study|Subject no longer meets study criteria|13
2206784|NCT01623596|3845505|FG000|Overall Study|Patient no longer requires study drug|1
2285075|NCT02416908|3973129|FG002|Dose Escalation Phase|Withdrawal by Subject|1
2285076|NCT02416908|3973130|FG003|Dose Escalation Phase|Withdrawal by Subject|0
2285077|NCT02416934|3973139|FG000|Overall Study|given steroids|1
2285078|NCT02416934|3973140|FG001|Overall Study|given steroids|2
2285079|NCT02416934|3973139|FG000|Overall Study|Lost to Follow-up|0
2285080|NCT02416934|3973140|FG001|Overall Study|Lost to Follow-up|2
2285081|NCT02416934|3973139|FG000|Overall Study|Withdrawal by Subject|1
2285082|NCT02416934|3973140|FG001|Overall Study|Withdrawal by Subject|0
2285083|NCT02416934|3973139|FG000|Overall Study|recruited during continuing renewal proc|0
2285084|NCT02416934|3973140|FG001|Overall Study|recruited during continuing renewal proc|1
2285085|NCT02416934|3973139|FG000|Overall Study|Protocol Violation|0
2285086|NCT02416934|3973140|FG001|Overall Study|Protocol Violation|1
2285087|NCT02416934|3973139|FG000|Overall Study|surgery started late|0
2285088|NCT02416934|3973140|FG001|Overall Study|surgery started late|1
2285089|NCT02416934|3973139|FG000|Overall Study|re-operation|1
2285090|NCT02416934|3973140|FG001|Overall Study|re-operation|0
2285091|NCT02417064|3973168|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
2285092|NCT02417064|3973169|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
2285093|NCT02417064|3973170|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
2285094|NCT02417064|3973168|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
2285095|NCT02417064|3973169|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
2285096|NCT02417064|3973170|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
2285097|NCT02417064|3973168|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
2285098|NCT02417064|3973169|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
2285099|NCT02417064|3973170|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
2285100|NCT02417064|3973168|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
2285101|NCT02417064|3973169|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
2285102|NCT02417064|3973170|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
2285103|NCT02417064|3973168|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
2285104|NCT02417064|3973169|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
2285105|NCT02417064|3973170|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
2285106|NCT02417064|3973168|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
2285107|NCT02417064|3973169|FG001|Double-blind Induction Phase (4 Weeks)|Other|4
2285108|NCT02417064|3973170|FG002|Double-blind Induction Phase (4 Weeks)|Other|2
2285109|NCT02417064|3973168|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
2285110|NCT02417064|3973169|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
2285111|NCT02417064|3973170|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
2285112|NCT02417064|3973168|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0
2285113|NCT02417064|3973169|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0
2285114|NCT02417064|3973170|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1
2285115|NCT02417064|3973168|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
2285116|NCT02417064|3973169|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
2285117|NCT02417064|3973170|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
2285118|NCT02417064|3973168|FG000|Follow-up Phase (24 Weeks)|PI Decision|34
2285119|NCT02417064|3973169|FG001|Follow-up Phase (24 Weeks)|PI Decision|29
2285120|NCT02417064|3973170|FG002|Follow-up Phase (24 Weeks)|PI Decision|44
2285121|NCT02417064|3973168|FG000|Follow-up Phase (24 Weeks)|Other|2
2285122|NCT02417064|3973169|FG001|Follow-up Phase (24 Weeks)|Other|2
2285123|NCT02417064|3973170|FG002|Follow-up Phase (24 Weeks)|Other|3
2285124|NCT02417233|3973191|FG000|Overall Study|Death|4
2131336|NCT01042977|3735616|FG000|Overall Study|Incorrect enrollment|6
2131337|NCT01042977|3735617|FG001|Overall Study|Incorrect enrollment|4
2131338|NCT01042977|3735616|FG000|Overall Study|Safety|0
2131339|NCT01042977|3735617|FG001|Overall Study|Safety|2
2131340|NCT01042977|3735616|FG000|Overall Study|Administrative reason by sponsor|0
2131341|NCT01042977|3735617|FG001|Overall Study|Administrative reason by sponsor|1
2131342|NCT01042977|3735616|FG000|Overall Study|Various|3
2131343|NCT01042977|3735617|FG001|Overall Study|Various|0
2131344|NCT01043185|3735666|FG000|Period 6 - Third Washout Period|Protocol Violation|0
2131345|NCT01043185|3735667|FG001|Period 6 - Third Washout Period|Protocol Violation|0
2131346|NCT01043185|3735668|FG002|Period 6 - Third Washout Period|Protocol Violation|0
2131347|NCT01043185|3735669|FG003|Period 6 - Third Washout Period|Protocol Violation|0
2131348|NCT01043185|3735670|FG004|Period 6 - Third Washout Period|Protocol Violation|0
2131349|NCT01043185|3735671|FG005|Period 6 - Third Washout Period|Protocol Violation|0
2131350|NCT01043185|3735672|FG006|Period 6 - Third Washout Period|Protocol Violation|0
2131351|NCT01043185|3735673|FG007|Period 6 - Third Washout Period|Protocol Violation|0
2131352|NCT01043185|3735674|FG008|Period 6 - Third Washout Period|Protocol Violation|1
2131353|NCT01043185|3735675|FG009|Period 6 - Third Washout Period|Protocol Violation|0
2131354|NCT01043705|3735736|FG000|Overall Study|Death|28
2131355|NCT01043705|3735737|FG001|Overall Study|Death|60
2131356|NCT01043705|3735738|FG002|Overall Study|Death|26
2131357|NCT01043705|3735736|FG000|Overall Study|Lost to Follow-up|27
2131358|NCT01043705|3735737|FG001|Overall Study|Lost to Follow-up|12
2131359|NCT01043705|3735738|FG002|Overall Study|Lost to Follow-up|0
2131360|NCT01043705|3735736|FG000|Overall Study|Multiple Reasons|4
2131361|NCT01043705|3735737|FG001|Overall Study|Multiple Reasons|7
2131362|NCT01043705|3735738|FG002|Overall Study|Multiple Reasons|0
2131363|NCT01043705|3735736|FG000|Overall Study|Protocol Violation|2
2131364|NCT01043705|3735737|FG001|Overall Study|Protocol Violation|1
2131365|NCT01043705|3735738|FG002|Overall Study|Protocol Violation|0
2131366|NCT01043705|3735736|FG000|Overall Study|Withdrawal by Subject|8
2131367|NCT01043705|3735737|FG001|Overall Study|Withdrawal by Subject|6
2131368|NCT01043705|3735738|FG002|Overall Study|Withdrawal by Subject|0
2131369|NCT01043705|3735736|FG000|Overall Study|Site Closure|8
2131370|NCT01043705|3735737|FG001|Overall Study|Site Closure|0
2131371|NCT01043705|3735738|FG002|Overall Study|Site Closure|0
2131372|NCT01043705|3735736|FG000|Overall Study|Subsequent Procedure|9
2131373|NCT01043705|3735737|FG001|Overall Study|Subsequent Procedure|24
2131374|NCT01043705|3735738|FG002|Overall Study|Subsequent Procedure|29
2131375|NCT01043705|3735736|FG000|Overall Study|Adverse Event|0
2131376|NCT01043705|3735737|FG001|Overall Study|Adverse Event|2
2131377|NCT01043705|3735738|FG002|Overall Study|Adverse Event|0
2131378|NCT01043705|3735736|FG000|Overall Study|Screen Fail|21
2131379|NCT01043705|3735737|FG001|Overall Study|Screen Fail|0
2131380|NCT01043705|3735738|FG002|Overall Study|Screen Fail|0
2131381|NCT01043705|3735736|FG000|Overall Study|Other|0
2131382|NCT01043705|3735737|FG001|Overall Study|Other|19
2131383|NCT01043705|3735738|FG002|Overall Study|Other|25
2131384|NCT01043874|3735746|FG000|Overall Study|Adverse Event|3
2131385|NCT01043874|3735746|FG000|Overall Study|Withdrawal by Subject|1
2131386|NCT01043874|3735746|FG000|Overall Study|Lack of Efficacy|1
2131387|NCT01043874|3735746|FG000|Overall Study|Administrative Problems|1
2131388|NCT01044290|3735805|FG000|Follow-up 1|Death|3
2131389|NCT01044290|3735806|FG001|Follow-up 1|Death|3
2131390|NCT01044290|3735807|FG002|Follow-up 1|Death|1
2131391|NCT01044290|3735805|FG000|Follow-up 1|Withdrawal by Subject|2
2131392|NCT01044290|3735806|FG001|Follow-up 1|Withdrawal by Subject|2
2131393|NCT01044290|3735807|FG002|Follow-up 1|Withdrawal by Subject|0
2131394|NCT01044290|3735805|FG000|Follow-Up 2|Death|0
2131395|NCT01044290|3735806|FG001|Follow-Up 2|Death|1
2131396|NCT01044290|3735807|FG002|Follow-Up 2|Death|1
2131397|NCT01044290|3735805|FG000|Follow-Up 2|Withdrawal by Subject|0
2131398|NCT01044290|3735806|FG001|Follow-Up 2|Withdrawal by Subject|1
2131399|NCT01044290|3735807|FG002|Follow-Up 2|Withdrawal by Subject|1
2131400|NCT01044303|3735825|FG000|Overall Study|Lost to Follow-up|2
2131401|NCT01044433|3735832|FG000|Overall Study|Lost to Follow-up|3
2131402|NCT01044433|3735832|FG000|Overall Study|Withdrawal by Subject|3
2131403|NCT01044459|3735839|FG000|Overall Study|Withdrawal by Subject|21
2131404|NCT01044459|3735840|FG001|Overall Study|Withdrawal by Subject|28
2131405|NCT01044459|3735839|FG000|Overall Study|Terminated by Sponsor|22
2131406|NCT01044459|3735840|FG001|Overall Study|Terminated by Sponsor|21
2131407|NCT01044459|3735839|FG000|Overall Study|Adverse Event|22
2131408|NCT01044459|3735840|FG001|Overall Study|Adverse Event|20
2131409|NCT01044459|3735839|FG000|Overall Study|Lack of Efficacy|23
2131410|NCT01044459|3735840|FG001|Overall Study|Lack of Efficacy|12
2131411|NCT01044459|3735839|FG000|Overall Study|Protocol Violation|11
2131412|NCT01044459|3735840|FG001|Overall Study|Protocol Violation|16
2131413|NCT01044459|3735839|FG000|Overall Study|Other Reason|7
2131414|NCT01044459|3735840|FG001|Overall Study|Other Reason|14
2131415|NCT01044459|3735839|FG000|Overall Study|COPD exacerbation|9
2131416|NCT01044459|3735840|FG001|Overall Study|COPD exacerbation|8
2131417|NCT01044459|3735839|FG000|Overall Study|Lost to Follow-up|18
2131418|NCT01044459|3735840|FG001|Overall Study|Lost to Follow-up|12
2131419|NCT01044498|3735848|FG000|Overall Study|Withdrew consent|1
2131420|NCT01044498|3735849|FG001|Overall Study|Withdrew consent|1
2131421|NCT01044498|3735848|FG000|Overall Study|Adverse Event|1
2131422|NCT01044498|3735849|FG001|Overall Study|Adverse Event|1
2131423|NCT01044498|3735848|FG000|Overall Study|Other|1
2131424|NCT01044498|3735849|FG001|Overall Study|Other|0
2178208|NCT01380834|3802762|FG000|Overall Study|Physician Decision|1
2178209|NCT01380834|3802763|FG001|Overall Study|Physician Decision|0
2178210|NCT01380990|3802784|FG000|Overall Study|Treatment Failure|1
2178211|NCT01380990|3802785|FG001|Overall Study|Treatment Failure|0
2178212|NCT01380990|3802784|FG000|Overall Study|Death|0
2178213|NCT01380990|3802785|FG001|Overall Study|Death|1
2178214|NCT01381016|3802797|FG000|Overall Study|Lost to Follow-up|1
2178215|NCT01381016|3802798|FG001|Overall Study|Lost to Follow-up|1
2178216|NCT01381016|3802797|FG000|Overall Study|Screen Failure|2
2178217|NCT01381016|3802798|FG001|Overall Study|Screen Failure|2
2206785|NCT01623596|3845506|FG001|Overall Study|Patient no longer requires study drug|0
2206786|NCT01623596|3845505|FG000|Overall Study|Protocol Violation|0
2206787|NCT01623596|3845506|FG001|Overall Study|Protocol Violation|6
2178218|NCT01381016|3802797|FG000|Overall Study|Withdrawal by Subject|0
2206788|NCT01623596|3845505|FG000|Overall Study|Lack of Efficacy|5
2178219|NCT01381016|3802798|FG001|Overall Study|Withdrawal by Subject|1
2178220|NCT01381016|3802797|FG000|Overall Study|Physician Decision|0
2178221|NCT01381016|3802798|FG001|Overall Study|Physician Decision|2
2178222|NCT01381068|3802808|FG000|Overall Study|Death|1
2178223|NCT01381068|3802809|FG001|Overall Study|Death|0
2178224|NCT01381549|3802849|FG000|Overall Study|Ineligible: No organisms isolated|0
2178225|NCT01381549|3802850|FG001|Overall Study|Ineligible: No organisms isolated|0
2178226|NCT01381549|3802851|FG002|Overall Study|Ineligible: No organisms isolated|1
2178227|NCT01381562|3802863|FG000|Overall Study|Adverse Event|0
2178228|NCT01381562|3802864|FG001|Overall Study|Adverse Event|1
2178229|NCT01381562|3802865|FG002|Overall Study|Adverse Event|0
2206789|NCT01623596|3845506|FG001|Overall Study|Lack of Efficacy|3
2285125|NCT02417233|3973192|FG001|Overall Study|Death|10
2285126|NCT02417233|3973193|FG002|Overall Study|Death|14
2285127|NCT02417233|3973191|FG000|Overall Study|Lost to Follow-up|27
2285128|NCT02417233|3973192|FG001|Overall Study|Lost to Follow-up|39
2285129|NCT02417233|3973193|FG002|Overall Study|Lost to Follow-up|34
2285130|NCT02417233|3973191|FG000|Overall Study|Protocol Violation|2
2285131|NCT02417233|3973192|FG001|Overall Study|Protocol Violation|0
2285132|NCT02417233|3973193|FG002|Overall Study|Protocol Violation|2
2285133|NCT02417233|3973191|FG000|Overall Study|Withdrawal by Subject|2
2285134|NCT02417233|3973192|FG001|Overall Study|Withdrawal by Subject|1
2285135|NCT02417233|3973193|FG002|Overall Study|Withdrawal by Subject|8
2285136|NCT02417233|3973191|FG000|Overall Study|Relocation out of study area|1
2285137|NCT02417233|3973192|FG001|Overall Study|Relocation out of study area|0
2285138|NCT02417233|3973193|FG002|Overall Study|Relocation out of study area|1
2285139|NCT02417233|3973191|FG000|Overall Study|Mentally unstable|0
2285140|NCT02417233|3973192|FG001|Overall Study|Mentally unstable|1
2285141|NCT02417233|3973193|FG002|Overall Study|Mentally unstable|0
2131425|NCT01044732|3735933|FG000|Overall Study|Lost to Follow-up|2
2131426|NCT01044732|3735934|FG001|Overall Study|Lost to Follow-up|1
2131427|NCT01044732|3735933|FG000|Overall Study|Physician Decision|5
2131428|NCT01044732|3735934|FG001|Overall Study|Physician Decision|3
2131429|NCT01044732|3735933|FG000|Overall Study|Protocol Violation|11
2131430|NCT01044732|3735934|FG001|Overall Study|Protocol Violation|12
2131431|NCT01044732|3735933|FG000|Overall Study|Withdrawal by Subject|0
2131432|NCT01044732|3735934|FG001|Overall Study|Withdrawal by Subject|1
2131433|NCT01044732|3735933|FG000|Overall Study|Inadequate bowel preparation|11
2131434|NCT01044732|3735934|FG001|Overall Study|Inadequate bowel preparation|17
2131435|NCT01044732|3735933|FG000|Overall Study|Inability to reach cecum|5
2131436|NCT01044732|3735934|FG001|Overall Study|Inability to reach cecum|2
2131437|NCT01044732|3735933|FG000|Overall Study|Technical error or malfunction|15
2131438|NCT01044732|3735934|FG001|Overall Study|Technical error or malfunction|14
2131439|NCT01044745|3735942|FG000|Overall Study|Ineiligible|2
2131440|NCT01045096|3736024|FG000|Overall Study|Withdrawal by Subject|2
2131441|NCT01045096|3736025|FG001|Overall Study|Withdrawal by Subject|0
2131442|NCT01045096|3736026|FG002|Overall Study|Withdrawal by Subject|0
2131443|NCT01045096|3736024|FG000|Overall Study|Other|1
2131444|NCT01045096|3736025|FG001|Overall Study|Other|0
2131445|NCT01045096|3736026|FG002|Overall Study|Other|0
2131446|NCT01045161|3736050|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
2131447|NCT01045161|3736051|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
2131448|NCT01045161|3736052|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
2131449|NCT01045161|3736050|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
2131450|NCT01045161|3736051|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
2131451|NCT01045161|3736052|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
2131452|NCT01045161|3736050|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
2131453|NCT01045161|3736051|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
2131454|NCT01045161|3736052|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
2131455|NCT01045161|3736050|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
2131456|NCT01045161|3736051|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
2131457|NCT01045161|3736052|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
2131458|NCT01045161|3736050|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
2131459|NCT01045161|3736051|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
2131460|NCT01045161|3736052|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
2131461|NCT01045161|3736050|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
2131462|NCT01045161|3736051|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
2131463|NCT01045161|3736052|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
2131464|NCT01045161|3736050|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
2131465|NCT01045161|3736051|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
2131466|NCT01045161|3736052|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
2131467|NCT01045161|3736050|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
2131468|NCT01045161|3736051|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
2131469|NCT01045161|3736052|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
2131470|NCT01045161|3736050|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10
2131471|NCT01045161|3736051|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10
2131472|NCT01045161|3736052|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7
2131473|NCT01045161|3736050|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
2131474|NCT01045161|3736051|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
2131475|NCT01045161|3736052|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
2131476|NCT01045161|3736050|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
2131477|NCT01045161|3736051|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
2131478|NCT01045161|3736052|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
2131479|NCT01045161|3736050|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4
2131480|NCT01045161|3736051|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2
2131481|NCT01045161|3736052|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1
2285142|NCT02417246|3973204|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
2206790|NCT01623752|3845527|FG000|Phase 1 (78 Weeks)|No Data|249
2206791|NCT01623752|3845528|FG001|Phase 1 (78 Weeks)|No Data|66
2131482|NCT01045161|3736050|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
2131483|NCT01045161|3736051|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
2131484|NCT01045161|3736052|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
2131485|NCT01045161|3736050|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
2131486|NCT01045161|3736051|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
2131487|NCT01045161|3736052|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
2131488|NCT01045421|3736092|FG000|Phase 1|Progressive Disease|0
2131489|NCT01045421|3736093|FG001|Phase 1|Progressive Disease|0
2131490|NCT01045421|3736094|FG002|Phase 1|Progressive Disease|0
2131491|NCT01045421|3736095|FG003|Phase 1|Progressive Disease|0
2131492|NCT01045421|3736096|FG004|Phase 1|Progressive Disease|1
2131493|NCT01045421|3736097|FG005|Phase 1|Progressive Disease|0
2131494|NCT01045421|3736098|FG006|Phase 1|Progressive Disease|0
2131495|NCT01045421|3736099|FG007|Phase 1|Progressive Disease|0
2131496|NCT01045421|3736100|FG008|Phase 1|Progressive Disease|0
2131497|NCT01045421|3736101|FG009|Phase 1|Progressive Disease|0
2131498|NCT01045421|3736102|FG010|Phase 1|Progressive Disease|0
2131499|NCT01045421|3736092|FG000|Phase 1|Withdrawal by Subject|0
2131500|NCT01045421|3736093|FG001|Phase 1|Withdrawal by Subject|0
2131501|NCT01045421|3736094|FG002|Phase 1|Withdrawal by Subject|0
2131502|NCT01045421|3736095|FG003|Phase 1|Withdrawal by Subject|1
2131503|NCT01045421|3736096|FG004|Phase 1|Withdrawal by Subject|0
2131504|NCT01045421|3736097|FG005|Phase 1|Withdrawal by Subject|0
2131505|NCT01045421|3736098|FG006|Phase 1|Withdrawal by Subject|0
2131506|NCT01045421|3736099|FG007|Phase 1|Withdrawal by Subject|0
2131507|NCT01045421|3736100|FG008|Phase 1|Withdrawal by Subject|0
2131508|NCT01045421|3736101|FG009|Phase 1|Withdrawal by Subject|0
2131509|NCT01045421|3736102|FG010|Phase 1|Withdrawal by Subject|0
2131510|NCT01045421|3736092|FG000|Phase 2|Progressive Disease|0
2131511|NCT01045421|3736093|FG001|Phase 2|Progressive Disease|0
2131512|NCT01045421|3736094|FG002|Phase 2|Progressive Disease|0
2131513|NCT01045421|3736095|FG003|Phase 2|Progressive Disease|0
2131514|NCT01045421|3736096|FG004|Phase 2|Progressive Disease|0
2131515|NCT01045421|3736097|FG005|Phase 2|Progressive Disease|0
2131516|NCT01045421|3736098|FG006|Phase 2|Progressive Disease|0
2131517|NCT01045421|3736099|FG007|Phase 2|Progressive Disease|1
2131518|NCT01045421|3736100|FG008|Phase 2|Progressive Disease|1
2131519|NCT01045421|3736101|FG009|Phase 2|Progressive Disease|1
2131520|NCT01045421|3736102|FG010|Phase 2|Progressive Disease|1
2131521|NCT01045421|3736092|FG000|Phase 2|Death|0
2131522|NCT01045421|3736093|FG001|Phase 2|Death|0
2131523|NCT01045421|3736094|FG002|Phase 2|Death|0
2131524|NCT01045421|3736095|FG003|Phase 2|Death|0
2131525|NCT01045421|3736096|FG004|Phase 2|Death|0
2131526|NCT01045421|3736097|FG005|Phase 2|Death|0
2131527|NCT01045421|3736098|FG006|Phase 2|Death|0
2131528|NCT01045421|3736099|FG007|Phase 2|Death|1
2131529|NCT01045421|3736100|FG008|Phase 2|Death|1
2131530|NCT01045421|3736101|FG009|Phase 2|Death|2
2131531|NCT01045421|3736102|FG010|Phase 2|Death|0
2131532|NCT01045421|3736092|FG000|Phase 2|Other|0
2131533|NCT01045421|3736093|FG001|Phase 2|Other|0
2131534|NCT01045421|3736094|FG002|Phase 2|Other|0
2131535|NCT01045421|3736095|FG003|Phase 2|Other|0
2131536|NCT01045421|3736096|FG004|Phase 2|Other|0
2131537|NCT01045421|3736097|FG005|Phase 2|Other|0
2131538|NCT01045421|3736098|FG006|Phase 2|Other|0
2131539|NCT01045421|3736099|FG007|Phase 2|Other|3
2131540|NCT01045421|3736100|FG008|Phase 2|Other|0
2131541|NCT01045421|3736101|FG009|Phase 2|Other|0
2131542|NCT01045421|3736102|FG010|Phase 2|Other|1
2131543|NCT01045447|3736125|FG000|Overall Study|Adverse Event|0
2131544|NCT01045447|3736126|FG001|Overall Study|Adverse Event|1
2131545|NCT01045447|3736125|FG000|Overall Study|Lack of Efficacy|3
2131546|NCT01045447|3736126|FG001|Overall Study|Lack of Efficacy|1
2131547|NCT01045447|3736125|FG000|Overall Study|Protocol Violation|6
2131548|NCT01045447|3736126|FG001|Overall Study|Protocol Violation|3
2131549|NCT01045447|3736125|FG000|Overall Study|Withdrawal Criteria|10
2131550|NCT01045447|3736126|FG001|Overall Study|Withdrawal Criteria|10
2131551|NCT01045447|3736125|FG000|Overall Study|Unclassified|17
2131552|NCT01045447|3736126|FG001|Overall Study|Unclassified|13
2131553|NCT01045460|3736134|FG000|Overall Study|Physician Decision|3
2131554|NCT01045460|3736135|FG001|Overall Study|Physician Decision|2
2131555|NCT01045460|3736134|FG000|Overall Study|Lost to Follow-up|0
2131556|NCT01045460|3736135|FG001|Overall Study|Lost to Follow-up|1
2131557|NCT01045460|3736134|FG000|Overall Study|Lack of Efficacy|3
2131558|NCT01045460|3736135|FG001|Overall Study|Lack of Efficacy|0
2131559|NCT01045707|3736154|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
2131560|NCT01045707|3736155|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
2131561|NCT01045707|3736154|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
2131562|NCT01045707|3736155|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
2131563|NCT01045707|3736154|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
2131564|NCT01045707|3736155|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
2131565|NCT01045707|3736154|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
2131566|NCT01045707|3736155|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
2131567|NCT01045707|3736154|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
2131568|NCT01045707|3736155|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
2131569|NCT01045707|3736154|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
2131570|NCT01045707|3736155|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
2131571|NCT01045707|3736154|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
2131572|NCT01045707|3736155|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
2131573|NCT01045707|3736154|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
2131574|NCT01045707|3736155|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
2131575|NCT01045707|3736154|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
2131576|NCT01045707|3736155|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
2131577|NCT01045798|3736163|FG000|Overall Study|Changed to Open-Label Caspofungin|1
2131578|NCT01045798|3736164|FG001|Overall Study|Changed to Open-Label Caspofungin|0
2131579|NCT01045798|3736163|FG000|Overall Study|Invasive Fungal Infection at Baseline|0
2131580|NCT01045798|3736164|FG001|Overall Study|Invasive Fungal Infection at Baseline|1
2131581|NCT01045798|3736163|FG000|Overall Study|Changed to Other Antifungal Therapy|1
2131582|NCT01045798|3736164|FG001|Overall Study|Changed to Other Antifungal Therapy|2
2131583|NCT01045798|3736163|FG000|Overall Study|Received Systemic Antifungal Prestudy|0
2131584|NCT01045798|3736164|FG001|Overall Study|Received Systemic Antifungal Prestudy|1
2131585|NCT01045967|3736172|FG000|Second Intervention|Protocol Violation|0
2131586|NCT01045967|3736173|FG001|Second Intervention|Protocol Violation|1
2131587|NCT01045993|3736183|FG000|Overall Study|Treated-later found eligibility not met|0
2131588|NCT01045993|3736184|FG001|Overall Study|Treated-later found eligibility not met|1
2131589|NCT01045993|3736185|FG002|Overall Study|Treated-later found eligibility not met|0
2131590|NCT01045993|3736186|FG003|Overall Study|Treated-later found eligibility not met|0
2131591|NCT01046084|3736198|FG000|Third Washout of 7 Days|Withdrawal by Subject|2
2131592|NCT01046084|3736199|FG001|Third Washout of 7 Days|Withdrawal by Subject|0
2131593|NCT01046110|3736207|FG000|Overall Study|Adverse Event|9
2131594|NCT01046110|3736208|FG001|Overall Study|Adverse Event|2
2131595|NCT01046110|3736207|FG000|Overall Study|Lack of Efficacy|0
2131596|NCT01046110|3736208|FG001|Overall Study|Lack of Efficacy|1
2131597|NCT01046110|3736207|FG000|Overall Study|Protocol Violation|7
2131598|NCT01046110|3736208|FG001|Overall Study|Protocol Violation|12
2131599|NCT01046110|3736207|FG000|Overall Study|Withdrawal Criteria|3
2131600|NCT01046110|3736208|FG001|Overall Study|Withdrawal Criteria|5
2131601|NCT01046110|3736207|FG000|Overall Study|Unclassified|36
2131602|NCT01046110|3736208|FG001|Overall Study|Unclassified|35
2131603|NCT01046136|3736216|FG000|Overall Study|Withdrawal by Subject|0
2131604|NCT01046136|3736217|FG001|Overall Study|Withdrawal by Subject|4
2131605|NCT01046136|3736216|FG000|Overall Study|Physician Decision|1
2131606|NCT01046136|3736217|FG001|Overall Study|Physician Decision|1
2131607|NCT01046136|3736216|FG000|Overall Study|Lost to Follow-up|3
2131608|NCT01046136|3736217|FG001|Overall Study|Lost to Follow-up|3
2131609|NCT01046253|3736227|FG000|Second Intervention|Adverse Event|0
2131610|NCT01046253|3736228|FG001|Second Intervention|Adverse Event|1
2131611|NCT01046253|3736227|FG000|Second Intervention|Protocol Violation|0
2131612|NCT01046253|3736228|FG001|Second Intervention|Protocol Violation|1
2131613|NCT01046396|3736234|FG000|Overall Study|Withdrawal by Subject|5
2131614|NCT01046565|3736241|FG000|Overall Study|Adverse Event|2
2131615|NCT01046565|3736241|FG000|Overall Study|Withdrawal by Subject|7
2131616|NCT01046643|3736252|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0
2131617|NCT01046643|3736253|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1
2131618|NCT01046643|3736254|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0
2131619|NCT01046643|3736255|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0
2131620|NCT01046682|3736276|FG000|Overall Study|Adverse Event|2
2131621|NCT01046682|3736277|FG001|Overall Study|Adverse Event|0
2206792|NCT01623752|3845529|FG002|Phase 1 (78 Weeks)|No Data|2
2206793|NCT01623752|3845527|FG000|Phase 1 (78 Weeks)|Other|33
2206794|NCT01623752|3845528|FG001|Phase 1 (78 Weeks)|Other|20
2131622|NCT01046695|3736285|FG000|Overall Study|Subject had a pacemaker|0
2131623|NCT01046695|3736286|FG001|Overall Study|Subject had a pacemaker|1
2131624|NCT01046695|3736285|FG000|Overall Study|TENS interfered with the cardiac monitor|0
2131625|NCT01046695|3736286|FG001|Overall Study|TENS interfered with the cardiac monitor|1
2131626|NCT01046877|3736292|FG000|Overall Study|Exited voluntarily before tube extrusion|7
2131627|NCT01046877|3736292|FG000|Overall Study|Exited voluntarily after tube extrusion|11
2131628|NCT01046903|3736296|FG000|Overall Study|Lost to Follow-up|16
2131629|NCT01046903|3736296|FG000|Overall Study|Adverse Event|4
2131630|NCT01046903|3736296|FG000|Overall Study|Withdrawal by Subject|3
2131631|NCT01046903|3736296|FG000|Overall Study|Other|5
2131632|NCT01047007|3736304|FG000|Overall Study|Adverse Event|0
2131633|NCT01047007|3736305|FG001|Overall Study|Adverse Event|2
2131634|NCT01047007|3736306|FG002|Overall Study|Adverse Event|1
2131635|NCT01047007|3736307|FG003|Overall Study|Adverse Event|0
2131636|NCT01047007|3736304|FG000|Overall Study|Progressive Disease|2
2131637|NCT01047007|3736305|FG001|Overall Study|Progressive Disease|4
2131638|NCT01047007|3736306|FG002|Overall Study|Progressive Disease|1
2131639|NCT01047007|3736307|FG003|Overall Study|Progressive Disease|0
2131640|NCT01047293|3736333|FG000|Overall Study|DLT criteria not fulfilled|1
2131641|NCT01047293|3736334|FG001|Overall Study|DLT criteria not fulfilled|1
2131642|NCT01047293|3736335|FG002|Overall Study|DLT criteria not fulfilled|0
2206795|NCT01623752|3845529|FG002|Phase 1 (78 Weeks)|Other|0
2206796|NCT01623752|3845527|FG000|Phase 1 (78 Weeks)|Adverse Event|122
2206797|NCT01623752|3845528|FG001|Phase 1 (78 Weeks)|Adverse Event|39
2206798|NCT01623752|3845529|FG002|Phase 1 (78 Weeks)|Adverse Event|0
2206799|NCT01623752|3845527|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227
2206800|NCT01623752|3845528|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82
2206801|NCT01623752|3845529|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0
2206802|NCT01623752|3845527|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14
2206803|NCT01623752|3845528|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2
2206804|NCT01623752|3845529|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0
2206805|NCT01623752|3845527|FG000|Phase 2 (78 Weeks)|Other|5
2206806|NCT01623752|3845528|FG001|Phase 2 (78 Weeks)|Other|1
2206807|NCT01623752|3845529|FG002|Phase 2 (78 Weeks)|Other|0
2206808|NCT01623752|3845527|FG000|Phase 2 (78 Weeks)|No Data|43
2206809|NCT01623752|3845528|FG001|Phase 2 (78 Weeks)|No Data|11
2206810|NCT01623752|3845529|FG002|Phase 2 (78 Weeks)|No Data|0
2206811|NCT01623752|3845527|FG000|Phase 2 (78 Weeks)|Adverse Event|4
2206812|NCT01623752|3845528|FG001|Phase 2 (78 Weeks)|Adverse Event|4
2206813|NCT01623752|3845529|FG002|Phase 2 (78 Weeks)|Adverse Event|0
2131643|NCT01047293|3736336|FG003|Overall Study|DLT criteria not fulfilled|0
2131644|NCT01047306|3736345|FG000|Overall Study|Withdrawal by Subject|2
2131645|NCT01047306|3736346|FG001|Overall Study|Withdrawal by Subject|0
2131646|NCT01047306|3736345|FG000|Overall Study|Lost to Follow-up|1
2131647|NCT01047306|3736346|FG001|Overall Study|Lost to Follow-up|0
2131648|NCT01047332|3736356|FG000|Overall Study|SEMS Obstruction|11
2131649|NCT01047332|3736357|FG001|Overall Study|SEMS Obstruction|20
2131650|NCT01047332|3736356|FG000|Overall Study|Died Unobstructed|38
2285143|NCT02417246|3973205|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
2285144|NCT02417246|3973204|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
2285145|NCT02417246|3973205|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
2285146|NCT02417246|3973204|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
2285147|NCT02417246|3973205|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
2285148|NCT02417246|3973204|FG000|Phase 2 1st Generic Administered|Physician Decision|1
2285149|NCT02417246|3973205|FG001|Phase 2 1st Generic Administered|Physician Decision|0
2285150|NCT02417441|3973224|FG000|Overall Study|Inconclusive due to missing data|52
2285151|NCT02417441|3973225|FG001|Overall Study|Inconclusive due to missing data|19
2285152|NCT02417753|3973238|FG000|Overall Study|Death|1
2285153|NCT02417935|3973258|FG000|Treatment Period|Adverse Event|12
2285154|NCT02417935|3973259|FG001|Treatment Period|Adverse Event|10
2285155|NCT02417935|3973258|FG000|Treatment Period|Lost to Follow-up|1
2285156|NCT02417935|3973259|FG001|Treatment Period|Lost to Follow-up|0
2285157|NCT02417935|3973258|FG000|Treatment Period|Entry Criteria not met|0
2285158|NCT02417935|3973259|FG001|Treatment Period|Entry Criteria not met|1
2285159|NCT02417935|3973258|FG000|Treatment Period|Protocol Violation|2
2285160|NCT02417935|3973259|FG001|Treatment Period|Protocol Violation|1
2285161|NCT02417935|3973258|FG000|Treatment Period|Withdrawal by Subject|3
2285162|NCT02417935|3973259|FG001|Treatment Period|Withdrawal by Subject|3
2285163|NCT02417935|3973258|FG000|Treatment Period|Physician Decision|3
2285164|NCT02417935|3973259|FG001|Treatment Period|Physician Decision|1
2285165|NCT02417961|3973265|FG000|Overall Study|Adverse Event|1
2285166|NCT02417961|3973265|FG000|Overall Study|Lost to Follow-up|1
2285167|NCT02417961|3973265|FG000|Overall Study|Withdrawal by Subject|2
2285168|NCT02418000|3973274|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
2285169|NCT02418000|3973275|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2285170|NCT02418000|3973276|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2285171|NCT02418000|3973277|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2285172|NCT02418000|3973278|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2285173|NCT02418000|3973274|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
2285174|NCT02418000|3973275|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2285175|NCT02418000|3973276|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2285176|NCT02418000|3973277|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2285177|NCT02418000|3973278|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2285178|NCT02418000|3973274|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
2285179|NCT02418000|3973275|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2285180|NCT02418000|3973276|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2285181|NCT02418000|3973277|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2285182|NCT02418000|3973278|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2285183|NCT02418000|3973274|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2285184|NCT02418000|3973275|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
2285185|NCT02418000|3973276|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2285186|NCT02418000|3973277|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2285187|NCT02418000|3973278|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2285188|NCT02418000|3973274|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2285189|NCT02418000|3973275|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
2285190|NCT02418000|3973276|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2285191|NCT02418000|3973277|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2131651|NCT01047332|3736357|FG001|Overall Study|Died Unobstructed|41
2206814|NCT01623830|3845540|FG000|Overall Study|Withdrawal by Subject|6
2206815|NCT01623830|3845541|FG001|Overall Study|Withdrawal by Subject|7
2131652|NCT01047332|3736356|FG000|Overall Study|Lost to Follow-up|8
2131653|NCT01047332|3736357|FG001|Overall Study|Lost to Follow-up|3
2131654|NCT01047345|3736365|FG000|Base Study|Adverse Event|3
2131655|NCT01047345|3736366|FG001|Base Study|Adverse Event|0
2131656|NCT01047345|3736367|FG002|Base Study|Adverse Event|0
2131657|NCT01047345|3736365|FG000|Base Study|Lost to Follow-up|4
2131658|NCT01047345|3736366|FG001|Base Study|Lost to Follow-up|1
2131659|NCT01047345|3736367|FG002|Base Study|Lost to Follow-up|0
2131660|NCT01047345|3736365|FG000|Base Study|Protocol Violation|3
2131661|NCT01047345|3736366|FG001|Base Study|Protocol Violation|1
2131662|NCT01047345|3736367|FG002|Base Study|Protocol Violation|0
2131663|NCT01047345|3736365|FG000|Base Study|Withdrawal by Subject|12
2131664|NCT01047345|3736366|FG001|Base Study|Withdrawal by Subject|4
2131665|NCT01047345|3736367|FG002|Base Study|Withdrawal by Subject|0
2131666|NCT01047345|3736365|FG000|Extension|Withdrawal by Subject|0
2131667|NCT01047345|3736366|FG001|Extension|Withdrawal by Subject|0
2131668|NCT01047345|3736367|FG002|Extension|Withdrawal by Subject|1
2131669|NCT01047345|3736365|FG000|Extension|Lost to Follow-up|0
2131670|NCT01047345|3736366|FG001|Extension|Lost to Follow-up|0
2131671|NCT01047345|3736367|FG002|Extension|Lost to Follow-up|5
2131672|NCT01047436|3736382|FG000|Overall Study|Protocol Violation|1
2131673|NCT01047436|3736383|FG001|Overall Study|Protocol Violation|0
2131674|NCT01047553|3736414|FG000|Overall Study|Adverse Event|10
2131675|NCT01047553|3736415|FG001|Overall Study|Adverse Event|5
2131676|NCT01047553|3736414|FG000|Overall Study|Withdrawal by Subject|4
2131677|NCT01047553|3736415|FG001|Overall Study|Withdrawal by Subject|2
2285192|NCT02418000|3973278|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2131678|NCT01047553|3736414|FG000|Overall Study|Development of Study-Specific Withdrawal|1
2131679|NCT01047553|3736415|FG001|Overall Study|Development of Study-Specific Withdrawal|1
2131680|NCT01047553|3736414|FG000|Overall Study|Lost to Follow-up|1
2131681|NCT01047553|3736415|FG001|Overall Study|Lost to Follow-up|0
2131682|NCT01047553|3736414|FG000|Overall Study|Sever Non-Compliance to Protocol|1
2131683|NCT01047553|3736415|FG001|Overall Study|Sever Non-Compliance to Protocol|0
2131684|NCT01047553|3736414|FG000|Overall Study|PI's decision|0
2131685|NCT01047553|3736415|FG001|Overall Study|PI's decision|1
2131686|NCT01048099|3736448|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
2131687|NCT01048099|3736448|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
2131688|NCT01048242|3736456|FG000|Overall Study|See study flow chart|4
2131689|NCT01048242|3736457|FG001|Overall Study|See study flow chart|2
2131690|NCT01048333|3736463|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2131691|NCT01048333|3736464|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
2131692|NCT01048333|3736465|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2131693|NCT01048333|3736466|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2206816|NCT01623830|3845540|FG000|Overall Study|Exclusion from Study|1
2206817|NCT01623830|3845541|FG001|Overall Study|Exclusion from Study|2
2206818|NCT01624090|3845555|FG000|Overall Study|DLT, taken off therapy|0
2206819|NCT01624090|3845556|FG001|Overall Study|DLT, taken off therapy|1
2206820|NCT01624090|3845557|FG002|Overall Study|DLT, taken off therapy|0
2206821|NCT01624090|3845558|FG003|Overall Study|DLT, taken off therapy|0
2206822|NCT01624090|3845555|FG000|Overall Study|Withdrew prior to treatment|0
2285193|NCT02418000|3973274|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285194|NCT02418000|3973275|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285195|NCT02418000|3973276|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
2285196|NCT02418000|3973277|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285197|NCT02418000|3973278|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285198|NCT02418000|3973274|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285199|NCT02418000|3973275|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285200|NCT02418000|3973276|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285201|NCT02418000|3973277|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
2285202|NCT02418000|3973278|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285203|NCT02418000|3973274|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2285204|NCT02418000|3973275|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2285205|NCT02418000|3973276|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2285206|NCT02418000|3973277|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2285207|NCT02418000|3973278|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
2285208|NCT02418000|3973274|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285209|NCT02418000|3973275|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285210|NCT02418000|3973276|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285211|NCT02418000|3973277|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2285212|NCT02418000|3973278|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
2285213|NCT02418156|3973311|FG000|Overall Study|Lost to Follow-up|12
2285214|NCT02418156|3973311|FG000|Overall Study|Death|2
2285215|NCT02418156|3973311|FG000|Overall Study|Physician Decision|1
2285216|NCT02418156|3973311|FG000|Overall Study|Withdrawal by Subject|1
2285217|NCT02418156|3973311|FG000|Overall Study|Subject refused to return|1
2285218|NCT02418182|3973317|FG000|Overall Study|Unable to re-consent|18
2285219|NCT02418182|3973318|FG001|Overall Study|Unable to re-consent|15
2285220|NCT02418182|3973317|FG000|Overall Study|Lost to Follow-up|0
2285221|NCT02418182|3973318|FG001|Overall Study|Lost to Follow-up|2
2206823|NCT01624090|3845556|FG001|Overall Study|Withdrew prior to treatment|1
2206824|NCT01624090|3845557|FG002|Overall Study|Withdrew prior to treatment|0
2206825|NCT01624090|3845558|FG003|Overall Study|Withdrew prior to treatment|0
2285222|NCT02418455|3973341|FG000|48-Week Treatment Period|Other- Not Specified|1
2131694|NCT01048333|3736467|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2131695|NCT01048333|3736468|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2131696|NCT01048502|3736490|FG000|Overall Study|Lost to Follow-up|2
2131697|NCT01048502|3736491|FG001|Overall Study|Lost to Follow-up|0
2131698|NCT01048502|3736492|FG002|Overall Study|Lost to Follow-up|0
2131699|NCT01048502|3736493|FG003|Overall Study|Lost to Follow-up|0
2131700|NCT01048502|3736490|FG000|Overall Study|Adverse Event|1
2131701|NCT01048502|3736491|FG001|Overall Study|Adverse Event|0
2131702|NCT01048502|3736492|FG002|Overall Study|Adverse Event|0
2131703|NCT01048502|3736493|FG003|Overall Study|Adverse Event|0
2131704|NCT01048502|3736490|FG000|Overall Study|Withdrawal by Subject|1
2131705|NCT01048502|3736491|FG001|Overall Study|Withdrawal by Subject|4
2131706|NCT01048502|3736492|FG002|Overall Study|Withdrawal by Subject|5
2131707|NCT01048502|3736493|FG003|Overall Study|Withdrawal by Subject|3
2131708|NCT01048502|3736490|FG000|Overall Study|Physician Decision|0
2131709|NCT01048502|3736491|FG001|Overall Study|Physician Decision|3
2131710|NCT01048502|3736492|FG002|Overall Study|Physician Decision|0
2131711|NCT01048502|3736493|FG003|Overall Study|Physician Decision|1
2131712|NCT01048541|3736504|FG000|Overall Study|Withdrawal by Subject|1
2131713|NCT01048541|3736505|FG001|Overall Study|Withdrawal by Subject|0
2131714|NCT01048671|3736553|FG000|Overall Study|Protocol Violation|0
2131715|NCT01048671|3736554|FG001|Overall Study|Protocol Violation|1
2131716|NCT01048671|3736555|FG002|Overall Study|Protocol Violation|1
2131717|NCT01048788|3736570|FG000|Overall Study|Adverse Event|5
2131718|NCT01048788|3736571|FG001|Overall Study|Adverse Event|1
2131719|NCT01048788|3736572|FG002|Overall Study|Adverse Event|1
2131720|NCT01048788|3736570|FG000|Overall Study|Lack of Efficacy|0
2131721|NCT01048788|3736571|FG001|Overall Study|Lack of Efficacy|0
2131722|NCT01048788|3736572|FG002|Overall Study|Lack of Efficacy|1
2131723|NCT01048788|3736570|FG000|Overall Study|Withdrawal by Subject|0
2131724|NCT01048788|3736571|FG001|Overall Study|Withdrawal by Subject|1
2131725|NCT01048788|3736572|FG002|Overall Study|Withdrawal by Subject|0
2131726|NCT01048866|3736582|FG000|Overall Study|Adverse Event|1
2131727|NCT01048866|3736583|FG001|Overall Study|Adverse Event|0
2131728|NCT01048866|3736582|FG000|Overall Study|Protocol Violation|1
2285223|NCT02418455|3973341|FG000|Continuation Period|Sponsor Decision|7
2285224|NCT02418468|3973349|FG000|Overall Study|Adverse Event|1
2285225|NCT02418468|3973350|FG001|Overall Study|Adverse Event|0
2131729|NCT01048866|3736583|FG001|Overall Study|Protocol Violation|0
2131730|NCT01048866|3736582|FG000|Overall Study|Physician Decision|1
2131731|NCT01048866|3736583|FG001|Overall Study|Physician Decision|0
2131732|NCT01048866|3736582|FG000|Overall Study|Withdrawal by Subject|0
2131733|NCT01048866|3736583|FG001|Overall Study|Withdrawal by Subject|2
2131734|NCT01048866|3736582|FG000|Overall Study|Lost to Follow-up|0
2131735|NCT01048866|3736583|FG001|Overall Study|Lost to Follow-up|2
2131736|NCT01048866|3736582|FG000|Overall Study|Other|1
2131737|NCT01048866|3736583|FG001|Overall Study|Other|1
2131738|NCT01048944|3736610|FG000|Overall Study|Protocol Violation|8
2131739|NCT01048944|3736611|FG001|Overall Study|Protocol Violation|10
2131740|NCT01048944|3736612|FG002|Overall Study|Protocol Violation|10
2131741|NCT01048944|3736613|FG003|Overall Study|Protocol Violation|2
2131742|NCT01049009|3736625|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2131743|NCT01049009|3736626|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2131744|NCT01049009|3736625|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2131745|NCT01049009|3736626|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2131746|NCT01049009|3736625|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
2131747|NCT01049009|3736626|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
2131748|NCT01049009|3736625|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8
2131749|NCT01049009|3736626|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7
2131750|NCT01049217|3736634|FG000|Overall Study|Adverse Event|2
2131751|NCT01049217|3736635|FG001|Overall Study|Adverse Event|1
2131752|NCT01049217|3736634|FG000|Overall Study|Lack of Efficacy|1
2131753|NCT01049217|3736635|FG001|Overall Study|Lack of Efficacy|1
2131754|NCT01049217|3736634|FG000|Overall Study|Lost to Follow-up|3
2131755|NCT01049217|3736635|FG001|Overall Study|Lost to Follow-up|8
2131756|NCT01049217|3736634|FG000|Overall Study|Withdrawal by Subject|4
2131757|NCT01049217|3736635|FG001|Overall Study|Withdrawal by Subject|3
2131758|NCT01049217|3736634|FG000|Overall Study|Protocol Violation|1
2131759|NCT01049217|3736635|FG001|Overall Study|Protocol Violation|3
2131760|NCT01049217|3736634|FG000|Overall Study|Pregnancy|1
2131761|NCT01049217|3736635|FG001|Overall Study|Pregnancy|0
2131762|NCT01049217|3736634|FG000|Overall Study|Study Terminated by Sponsor|43
2131763|NCT01049217|3736635|FG001|Overall Study|Study Terminated by Sponsor|43
2131764|NCT01049217|3736634|FG000|Overall Study|Other|1
2131765|NCT01049217|3736635|FG001|Overall Study|Other|2
2131766|NCT01049217|3736634|FG000|Overall Study|Randomized but not Treated|0
2131767|NCT01049217|3736635|FG001|Overall Study|Randomized but not Treated|2
2131768|NCT01049308|3736646|FG000|Pill Counts|Withdrawal by Subject|83
2131769|NCT01049334|3736655|FG000|Overall Study|Withdrawal by Subject|5
2131770|NCT01049334|3736656|FG001|Overall Study|Withdrawal by Subject|3
2285226|NCT02418468|3973349|FG000|Overall Study|Withdrawal of informed consent|1
2131771|NCT01049334|3736655|FG000|Overall Study|Adverse Event|2
2285227|NCT02418468|3973350|FG001|Overall Study|Withdrawal of informed consent|1
2285228|NCT02418585|3973371|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
2285229|NCT02418585|3973372|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
2285230|NCT02418585|3973371|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
2285231|NCT02418585|3973372|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
2285232|NCT02418585|3973371|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
2285233|NCT02418585|3973372|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
2285234|NCT02418585|3973371|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
2285235|NCT02418585|3973372|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
2285236|NCT02418585|3973371|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
2285237|NCT02418585|3973372|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
2285238|NCT02418585|3973371|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0
2131772|NCT01049334|3736656|FG001|Overall Study|Adverse Event|3
2131773|NCT01049334|3736655|FG000|Overall Study|Physician Decision|2
2131774|NCT01049334|3736656|FG001|Overall Study|Physician Decision|0
2131775|NCT01049334|3736655|FG000|Overall Study|Protocol Violation|0
2131776|NCT01049334|3736656|FG001|Overall Study|Protocol Violation|1
2131777|NCT01049360|3736662|FG000|Period 1|Adverse Event|0
2131778|NCT01049360|3736663|FG001|Period 1|Adverse Event|1
2131779|NCT01049360|3736664|FG002|Period 1|Adverse Event|0
2131780|NCT01049360|3736665|FG003|Period 1|Adverse Event|1
2131781|NCT01049360|3736666|FG004|Period 1|Adverse Event|0
2131782|NCT01049360|3736667|FG005|Period 1|Adverse Event|0
2131783|NCT01049360|3736668|FG006|Period 1|Adverse Event|0
2131784|NCT01049360|3736669|FG007|Period 1|Adverse Event|1
2131785|NCT01049360|3736670|FG008|Period 1|Adverse Event|0
2131786|NCT01049360|3736671|FG009|Period 1|Adverse Event|0
2131787|NCT01049360|3736672|FG010|Period 1|Adverse Event|0
2131788|NCT01049360|3736673|FG011|Period 1|Adverse Event|0
2131789|NCT01049360|3736674|FG012|Period 1|Adverse Event|1
2131790|NCT01049360|3736675|FG013|Period 1|Adverse Event|1
2131791|NCT01049360|3736676|FG014|Period 1|Adverse Event|0
2131792|NCT01049360|3736677|FG015|Period 1|Adverse Event|0
2131793|NCT01049360|3736678|FG016|Period 1|Adverse Event|1
2131794|NCT01049360|3736679|FG017|Period 1|Adverse Event|0
2131795|NCT01049360|3736680|FG018|Period 1|Adverse Event|1
2285239|NCT02418585|3973372|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1
2285240|NCT02418585|3973371|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
2285241|NCT02418585|3973372|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
2285242|NCT02418585|3973371|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
2285243|NCT02418585|3973372|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
2285244|NCT02418585|3973371|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6
2285245|NCT02418585|3973372|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17
2285246|NCT02418585|3973371|FG000|Follow-up Phase (24 Weeks)|Other|3
2285247|NCT02418585|3973372|FG001|Follow-up Phase (24 Weeks)|Other|2
2285248|NCT02418754|3973396|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0
2285249|NCT02418754|3973397|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2
2285250|NCT02418754|3973398|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0
2285251|NCT02418754|3973399|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0
2285252|NCT02418754|3973400|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0
2285253|NCT02418754|3973396|FG000|Period 1 (Day 1 to Week 12)|Death|1
2285254|NCT02418754|3973397|FG001|Period 1 (Day 1 to Week 12)|Death|0
2285255|NCT02418754|3973398|FG002|Period 1 (Day 1 to Week 12)|Death|0
2285256|NCT02418754|3973399|FG003|Period 1 (Day 1 to Week 12)|Death|0
2285257|NCT02418754|3973400|FG004|Period 1 (Day 1 to Week 12)|Death|0
2285258|NCT02418754|3973396|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1
2285259|NCT02418754|3973397|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0
2285260|NCT02418754|3973398|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0
2285261|NCT02418754|3973399|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0
2285262|NCT02418754|3973400|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0
2285263|NCT02418754|3973396|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
2285264|NCT02418754|3973397|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2
2285265|NCT02418754|3973398|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1
2285266|NCT02418754|3973399|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
2285267|NCT02418754|3973400|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
2285268|NCT02418754|3973396|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
2285269|NCT02418754|3973397|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
2285270|NCT02418754|3973398|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1
2285271|NCT02418754|3973399|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
2285272|NCT02418754|3973400|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
2285273|NCT02418754|3973396|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3
2285274|NCT02418754|3973397|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7
2285275|NCT02418754|3973398|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6
2131796|NCT01049360|3736681|FG019|Period 1|Adverse Event|0
2131797|NCT01049360|3736662|FG000|Period 1|Did not meet inc/exc criteria|0
2131798|NCT01049360|3736663|FG001|Period 1|Did not meet inc/exc criteria|0
2131799|NCT01049360|3736664|FG002|Period 1|Did not meet inc/exc criteria|0
2131800|NCT01049360|3736665|FG003|Period 1|Did not meet inc/exc criteria|0
2131801|NCT01049360|3736666|FG004|Period 1|Did not meet inc/exc criteria|0
2131802|NCT01049360|3736667|FG005|Period 1|Did not meet inc/exc criteria|0
2320907|NCT02953678|4035191|FG000|Overall Study|Death|7
2131803|NCT01049360|3736668|FG006|Period 1|Did not meet inc/exc criteria|0
2131804|NCT01049360|3736669|FG007|Period 1|Did not meet inc/exc criteria|1
2131805|NCT01049360|3736670|FG008|Period 1|Did not meet inc/exc criteria|1
2131806|NCT01049360|3736671|FG009|Period 1|Did not meet inc/exc criteria|0
2131807|NCT01049360|3736672|FG010|Period 1|Did not meet inc/exc criteria|0
2131808|NCT01049360|3736673|FG011|Period 1|Did not meet inc/exc criteria|0
2131809|NCT01049360|3736674|FG012|Period 1|Did not meet inc/exc criteria|0
2131810|NCT01049360|3736675|FG013|Period 1|Did not meet inc/exc criteria|0
2131811|NCT01049360|3736676|FG014|Period 1|Did not meet inc/exc criteria|0
2131812|NCT01049360|3736677|FG015|Period 1|Did not meet inc/exc criteria|0
2131813|NCT01049360|3736678|FG016|Period 1|Did not meet inc/exc criteria|0
2131814|NCT01049360|3736679|FG017|Period 1|Did not meet inc/exc criteria|0
2131815|NCT01049360|3736680|FG018|Period 1|Did not meet inc/exc criteria|0
2131816|NCT01049360|3736681|FG019|Period 1|Did not meet inc/exc criteria|0
2131817|NCT01049360|3736662|FG000|Period 1|Withdrawal by Subject|0
2131818|NCT01049360|3736663|FG001|Period 1|Withdrawal by Subject|0
2131819|NCT01049360|3736664|FG002|Period 1|Withdrawal by Subject|0
2131820|NCT01049360|3736665|FG003|Period 1|Withdrawal by Subject|0
2131821|NCT01049360|3736666|FG004|Period 1|Withdrawal by Subject|0
2131822|NCT01049360|3736667|FG005|Period 1|Withdrawal by Subject|0
2131823|NCT01049360|3736668|FG006|Period 1|Withdrawal by Subject|0
2131824|NCT01049360|3736669|FG007|Period 1|Withdrawal by Subject|0
2131825|NCT01049360|3736670|FG008|Period 1|Withdrawal by Subject|1
2131826|NCT01049360|3736671|FG009|Period 1|Withdrawal by Subject|0
2131827|NCT01049360|3736672|FG010|Period 1|Withdrawal by Subject|1
2131828|NCT01049360|3736673|FG011|Period 1|Withdrawal by Subject|0
2131829|NCT01049360|3736674|FG012|Period 1|Withdrawal by Subject|1
2131830|NCT01049360|3736675|FG013|Period 1|Withdrawal by Subject|0
2131831|NCT01049360|3736676|FG014|Period 1|Withdrawal by Subject|0
2131832|NCT01049360|3736677|FG015|Period 1|Withdrawal by Subject|0
2131833|NCT01049360|3736678|FG016|Period 1|Withdrawal by Subject|0
2131834|NCT01049360|3736679|FG017|Period 1|Withdrawal by Subject|0
2131835|NCT01049360|3736680|FG018|Period 1|Withdrawal by Subject|0
2131836|NCT01049360|3736681|FG019|Period 1|Withdrawal by Subject|0
2131837|NCT01049360|3736662|FG000|Period 2|Protocol Violation|0
2131838|NCT01049360|3736663|FG001|Period 2|Protocol Violation|0
2131839|NCT01049360|3736664|FG002|Period 2|Protocol Violation|0
2131840|NCT01049360|3736665|FG003|Period 2|Protocol Violation|1
2131841|NCT01049360|3736666|FG004|Period 2|Protocol Violation|0
2131842|NCT01049360|3736667|FG005|Period 2|Protocol Violation|0
2131843|NCT01049360|3736668|FG006|Period 2|Protocol Violation|0
2131844|NCT01049360|3736669|FG007|Period 2|Protocol Violation|0
2131845|NCT01049360|3736670|FG008|Period 2|Protocol Violation|0
2131846|NCT01049360|3736671|FG009|Period 2|Protocol Violation|0
2131847|NCT01049360|3736672|FG010|Period 2|Protocol Violation|0
2131848|NCT01049360|3736673|FG011|Period 2|Protocol Violation|0
2131849|NCT01049360|3736674|FG012|Period 2|Protocol Violation|0
2131850|NCT01049360|3736675|FG013|Period 2|Protocol Violation|0
2131851|NCT01049360|3736676|FG014|Period 2|Protocol Violation|1
2131852|NCT01049360|3736677|FG015|Period 2|Protocol Violation|1
2131853|NCT01049360|3736678|FG016|Period 2|Protocol Violation|0
2131854|NCT01049360|3736679|FG017|Period 2|Protocol Violation|0
2131855|NCT01049360|3736680|FG018|Period 2|Protocol Violation|0
2131856|NCT01049360|3736681|FG019|Period 2|Protocol Violation|0
2131857|NCT01049360|3736662|FG000|Period 2|Adverse Event|0
2131858|NCT01049360|3736663|FG001|Period 2|Adverse Event|1
2131859|NCT01049360|3736664|FG002|Period 2|Adverse Event|0
2131860|NCT01049360|3736665|FG003|Period 2|Adverse Event|0
2131861|NCT01049360|3736666|FG004|Period 2|Adverse Event|0
2131862|NCT01049360|3736667|FG005|Period 2|Adverse Event|0
2131863|NCT01049360|3736668|FG006|Period 2|Adverse Event|0
2131864|NCT01049360|3736669|FG007|Period 2|Adverse Event|0
2131865|NCT01049360|3736670|FG008|Period 2|Adverse Event|1
2131866|NCT01049360|3736671|FG009|Period 2|Adverse Event|0
2131867|NCT01049360|3736672|FG010|Period 2|Adverse Event|0
2131868|NCT01049360|3736673|FG011|Period 2|Adverse Event|0
2131869|NCT01049360|3736674|FG012|Period 2|Adverse Event|0
2131870|NCT01049360|3736675|FG013|Period 2|Adverse Event|0
2131871|NCT01049360|3736676|FG014|Period 2|Adverse Event|0
2131872|NCT01049360|3736677|FG015|Period 2|Adverse Event|0
2131873|NCT01049360|3736678|FG016|Period 2|Adverse Event|0
2131874|NCT01049360|3736679|FG017|Period 2|Adverse Event|0
2131875|NCT01049360|3736680|FG018|Period 2|Adverse Event|0
2131876|NCT01049360|3736681|FG019|Period 2|Adverse Event|1
2131877|NCT01049360|3736662|FG000|Period 2|Withdrawal by Subject|0
2131878|NCT01049360|3736663|FG001|Period 2|Withdrawal by Subject|0
2131879|NCT01049360|3736664|FG002|Period 2|Withdrawal by Subject|0
2131880|NCT01049360|3736665|FG003|Period 2|Withdrawal by Subject|1
2131881|NCT01049360|3736666|FG004|Period 2|Withdrawal by Subject|0
2131882|NCT01049360|3736667|FG005|Period 2|Withdrawal by Subject|0
2131883|NCT01049360|3736668|FG006|Period 2|Withdrawal by Subject|0
2131884|NCT01049360|3736669|FG007|Period 2|Withdrawal by Subject|0
2131885|NCT01049360|3736670|FG008|Period 2|Withdrawal by Subject|0
2131886|NCT01049360|3736671|FG009|Period 2|Withdrawal by Subject|0
2131887|NCT01049360|3736672|FG010|Period 2|Withdrawal by Subject|0
2131888|NCT01049360|3736673|FG011|Period 2|Withdrawal by Subject|0
2131889|NCT01049360|3736674|FG012|Period 2|Withdrawal by Subject|0
2131890|NCT01049360|3736675|FG013|Period 2|Withdrawal by Subject|0
2131891|NCT01049360|3736676|FG014|Period 2|Withdrawal by Subject|1
2131892|NCT01049360|3736677|FG015|Period 2|Withdrawal by Subject|0
2131893|NCT01049360|3736678|FG016|Period 2|Withdrawal by Subject|0
2131894|NCT01049360|3736679|FG017|Period 2|Withdrawal by Subject|0
2131895|NCT01049360|3736680|FG018|Period 2|Withdrawal by Subject|0
2131896|NCT01049360|3736681|FG019|Period 2|Withdrawal by Subject|1
2131897|NCT01049360|3736662|FG000|Period 2|Lack of Efficacy|0
2131898|NCT01049360|3736663|FG001|Period 2|Lack of Efficacy|0
2131899|NCT01049360|3736664|FG002|Period 2|Lack of Efficacy|0
2131900|NCT01049360|3736665|FG003|Period 2|Lack of Efficacy|0
2131901|NCT01049360|3736666|FG004|Period 2|Lack of Efficacy|0
2131902|NCT01049360|3736667|FG005|Period 2|Lack of Efficacy|1
2131903|NCT01049360|3736668|FG006|Period 2|Lack of Efficacy|0
2131904|NCT01049360|3736669|FG007|Period 2|Lack of Efficacy|0
2131905|NCT01049360|3736670|FG008|Period 2|Lack of Efficacy|0
2131906|NCT01049360|3736671|FG009|Period 2|Lack of Efficacy|0
2131907|NCT01049360|3736672|FG010|Period 2|Lack of Efficacy|0
2131908|NCT01049360|3736673|FG011|Period 2|Lack of Efficacy|0
2131909|NCT01049360|3736674|FG012|Period 2|Lack of Efficacy|0
2131910|NCT01049360|3736675|FG013|Period 2|Lack of Efficacy|0
2131911|NCT01049360|3736676|FG014|Period 2|Lack of Efficacy|0
2131912|NCT01049360|3736677|FG015|Period 2|Lack of Efficacy|0
2131913|NCT01049360|3736678|FG016|Period 2|Lack of Efficacy|0
2131914|NCT01049360|3736679|FG017|Period 2|Lack of Efficacy|0
2131915|NCT01049360|3736680|FG018|Period 2|Lack of Efficacy|0
2131916|NCT01049360|3736681|FG019|Period 2|Lack of Efficacy|0
2131917|NCT01049360|3736662|FG000|Period 4|Protocol Violation|0
2131918|NCT01049360|3736663|FG001|Period 4|Protocol Violation|0
2131919|NCT01049360|3736664|FG002|Period 4|Protocol Violation|0
2131920|NCT01049360|3736665|FG003|Period 4|Protocol Violation|0
2131921|NCT01049360|3736666|FG004|Period 4|Protocol Violation|0
2131922|NCT01049360|3736667|FG005|Period 4|Protocol Violation|0
2131923|NCT01049360|3736668|FG006|Period 4|Protocol Violation|0
2131924|NCT01049360|3736669|FG007|Period 4|Protocol Violation|0
2131925|NCT01049360|3736670|FG008|Period 4|Protocol Violation|0
2131926|NCT01049360|3736671|FG009|Period 4|Protocol Violation|0
2131927|NCT01049360|3736672|FG010|Period 4|Protocol Violation|0
2131928|NCT01049360|3736673|FG011|Period 4|Protocol Violation|0
2131929|NCT01049360|3736674|FG012|Period 4|Protocol Violation|0
2131930|NCT01049360|3736675|FG013|Period 4|Protocol Violation|0
2131931|NCT01049360|3736676|FG014|Period 4|Protocol Violation|0
2131932|NCT01049360|3736677|FG015|Period 4|Protocol Violation|0
2131933|NCT01049360|3736678|FG016|Period 4|Protocol Violation|0
2131934|NCT01049360|3736679|FG017|Period 4|Protocol Violation|1
2131935|NCT01049360|3736680|FG018|Period 4|Protocol Violation|0
2131936|NCT01049360|3736681|FG019|Period 4|Protocol Violation|0
2131937|NCT01049360|3736662|FG000|Period 4|Withdrawal by Subject|0
2131938|NCT01049360|3736663|FG001|Period 4|Withdrawal by Subject|0
2131939|NCT01049360|3736664|FG002|Period 4|Withdrawal by Subject|0
2131940|NCT01049360|3736665|FG003|Period 4|Withdrawal by Subject|1
2131941|NCT01049360|3736666|FG004|Period 4|Withdrawal by Subject|0
2131942|NCT01049360|3736667|FG005|Period 4|Withdrawal by Subject|0
2131943|NCT01049360|3736668|FG006|Period 4|Withdrawal by Subject|0
2131944|NCT01049360|3736669|FG007|Period 4|Withdrawal by Subject|0
2131945|NCT01049360|3736670|FG008|Period 4|Withdrawal by Subject|0
2131946|NCT01049360|3736671|FG009|Period 4|Withdrawal by Subject|0
2131947|NCT01049360|3736672|FG010|Period 4|Withdrawal by Subject|0
2206826|NCT01624090|3845555|FG000|Overall Study|Died on study|0
2206827|NCT01624090|3845556|FG001|Overall Study|Died on study|0
2206828|NCT01624090|3845557|FG002|Overall Study|Died on study|2
2206829|NCT01624090|3845558|FG003|Overall Study|Died on study|0
2206830|NCT01624090|3845555|FG000|Overall Study|Did not complete 1 crse of therapy|0
2206831|NCT01624090|3845556|FG001|Overall Study|Did not complete 1 crse of therapy|0
2206832|NCT01624090|3845557|FG002|Overall Study|Did not complete 1 crse of therapy|2
2206833|NCT01624090|3845558|FG003|Overall Study|Did not complete 1 crse of therapy|0
2206834|NCT01624090|3845555|FG000|Overall Study|Dose escalated|0
2206835|NCT01624090|3845556|FG001|Overall Study|Dose escalated|0
2206836|NCT01624090|3845557|FG002|Overall Study|Dose escalated|3
2206837|NCT01624090|3845558|FG003|Overall Study|Dose escalated|0
2206838|NCT01624142|3845570|FG000|Overall Study|Withdrawal by Subject|14
2206839|NCT01624142|3845571|FG001|Overall Study|Withdrawal by Subject|4
2206840|NCT01624142|3845570|FG000|Overall Study|Death|3
2206841|NCT01624142|3845571|FG001|Overall Study|Death|6
2131948|NCT01049360|3736673|FG011|Period 4|Withdrawal by Subject|0
2131949|NCT01049360|3736674|FG012|Period 4|Withdrawal by Subject|0
2131950|NCT01049360|3736675|FG013|Period 4|Withdrawal by Subject|0
2131951|NCT01049360|3736676|FG014|Period 4|Withdrawal by Subject|0
2206842|NCT01624142|3845570|FG000|Overall Study|Study Closure|12
2206843|NCT01624142|3845571|FG001|Overall Study|Study Closure|6
2131952|NCT01049360|3736677|FG015|Period 4|Withdrawal by Subject|0
2131953|NCT01049360|3736678|FG016|Period 4|Withdrawal by Subject|0
2206844|NCT01624142|3845570|FG000|Overall Study|Lost to Follow-up|2
2206845|NCT01624142|3845571|FG001|Overall Study|Lost to Follow-up|0
2206846|NCT01624142|3845570|FG000|Overall Study|Other|1
2131954|NCT01049360|3736679|FG017|Period 4|Withdrawal by Subject|0
2131955|NCT01049360|3736680|FG018|Period 4|Withdrawal by Subject|0
2131956|NCT01049360|3736681|FG019|Period 4|Withdrawal by Subject|0
2131957|NCT01049373|3736695|FG000|Overall Study|Protocol Violation|9
2206847|NCT01624142|3845571|FG001|Overall Study|Other|0
2206848|NCT01624194|3845593|FG000|Overall Study|Lost to Follow-up|1
2206849|NCT01624194|3845594|FG001|Overall Study|Lost to Follow-up|0
2285276|NCT02418754|3973399|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
2285277|NCT02418754|3973400|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
2285278|NCT02418754|3973396|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1
2285279|NCT02418754|3973397|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0
2285280|NCT02418754|3973398|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0
2285281|NCT02418754|3973399|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0
2285282|NCT02418754|3973400|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0
2285283|NCT02418754|3973396|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
2285284|NCT02418754|3973397|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28
2285285|NCT02418754|3973398|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
2285286|NCT02418754|3973399|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21
2131958|NCT01049373|3736696|FG001|Overall Study|Protocol Violation|9
2131959|NCT01049373|3736695|FG000|Overall Study|Withdrawal by Subject|8
2131960|NCT01049373|3736696|FG001|Overall Study|Withdrawal by Subject|5
2131961|NCT01049373|3736695|FG000|Overall Study|Adverse Event|3
2131962|NCT01049373|3736696|FG001|Overall Study|Adverse Event|3
2131963|NCT01049373|3736695|FG000|Overall Study|Lost to Follow-up|9
2131964|NCT01049373|3736696|FG001|Overall Study|Lost to Follow-up|4
2131965|NCT01049373|3736695|FG000|Overall Study|no evaluable study values|9
2131966|NCT01049373|3736696|FG001|Overall Study|no evaluable study values|21
2131967|NCT01049373|3736695|FG000|Overall Study|Other|1
2131968|NCT01049373|3736696|FG001|Overall Study|Other|1
2131969|NCT01049373|3736695|FG000|Overall Study|Non-cooperation|0
2131970|NCT01049373|3736696|FG001|Overall Study|Non-cooperation|1
2131971|NCT01049412|3736706|FG000|Period I|Withdrawal by Subject|4
2131972|NCT01049412|3736707|FG001|Period I|Withdrawal by Subject|6
2131973|NCT01049412|3736706|FG000|Period I|Lost to Follow-up|2
2131974|NCT01049412|3736707|FG001|Period I|Lost to Follow-up|2
2131975|NCT01049412|3736706|FG000|Period I|Physician Decision|0
2131976|NCT01049412|3736707|FG001|Period I|Physician Decision|3
2131977|NCT01049412|3736706|FG000|Period I|Protocol Violation|1
2131978|NCT01049412|3736707|FG001|Period I|Protocol Violation|2
2131979|NCT01049412|3736706|FG000|Period I|Adverse Event|1
2131980|NCT01049412|3736707|FG001|Period I|Adverse Event|0
2131981|NCT01049412|3736706|FG000|Period II|Withdrawal by Subject|2
2131982|NCT01049412|3736707|FG001|Period II|Withdrawal by Subject|3
2131983|NCT01049412|3736706|FG000|Period II|Adverse Event|1
2131984|NCT01049412|3736707|FG001|Period II|Adverse Event|0
2131985|NCT01049412|3736706|FG000|Period II|Lost to Follow-up|1
2131986|NCT01049412|3736707|FG001|Period II|Lost to Follow-up|0
2131987|NCT01049503|3736721|FG000|Overall Study|Lost to Follow-up|11
2131988|NCT01049503|3736722|FG001|Overall Study|Lost to Follow-up|12
2131989|NCT01049503|3736723|FG002|Overall Study|Lost to Follow-up|24
2131990|NCT01049503|3736724|FG003|Overall Study|Lost to Follow-up|26
2131991|NCT01049503|3736725|FG004|Overall Study|Lost to Follow-up|27
2131992|NCT01049503|3736726|FG005|Overall Study|Lost to Follow-up|8
2131993|NCT01049581|3736751|FG000|Overall Study|Lost to Follow-up|2
2131994|NCT01049581|3736752|FG001|Overall Study|Lost to Follow-up|1
2131995|NCT01049919|3736776|FG000|Overall Study|Met study endpoint (major amputation, death)|36
2131996|NCT01049919|3736777|FG001|Overall Study|Met study endpoint (major amputation, death)|16
2131997|NCT01049919|3736776|FG000|Overall Study|Withdrawal by Subject|5
2131998|NCT01049919|3736777|FG001|Overall Study|Withdrawal by Subject|0
2131999|NCT01049919|3736776|FG000|Overall Study|Lost to Follow-up|6
2132000|NCT01049919|3736777|FG001|Overall Study|Lost to Follow-up|1
2132001|NCT01049919|3736776|FG000|Overall Study|Physician Decision|2
2132002|NCT01049919|3736777|FG001|Overall Study|Physician Decision|0
2132003|NCT01049919|3736776|FG000|Overall Study|Received 2nd treatment via compassionate use|1
2132004|NCT01049919|3736777|FG001|Overall Study|Received 2nd treatment via compassionate use|0
2132005|NCT01049919|3736776|FG000|Overall Study|Early study termination by sponsor.|2
2132006|NCT01049919|3736777|FG001|Overall Study|Early study termination by sponsor.|0
2132007|NCT01049984|3736806|FG000|Overall Study|Withdrawal by Subject|1
2132008|NCT01049984|3736807|FG001|Overall Study|Withdrawal by Subject|5
2132009|NCT01049984|3736806|FG000|Overall Study|Protocol Violation|3
2132010|NCT01049984|3736807|FG001|Overall Study|Protocol Violation|4
2132011|NCT01049984|3736806|FG000|Overall Study|Lost to Follow-up|2
2132012|NCT01049984|3736807|FG001|Overall Study|Lost to Follow-up|1
2132013|NCT01049984|3736806|FG000|Overall Study|Adverse Event|13
2132014|NCT01049984|3736807|FG001|Overall Study|Adverse Event|7
2132015|NCT01049984|3736806|FG000|Overall Study|Treatment failure|0
2132016|NCT01049984|3736807|FG001|Overall Study|Treatment failure|2
2132017|NCT01050062|3736815|FG000|Overall Study|Adverse Event|75
2132018|NCT01050062|3736816|FG001|Overall Study|Adverse Event|22
2132019|NCT01050062|3736815|FG000|Overall Study|Lost to Follow-up|83
2132020|NCT01050062|3736816|FG001|Overall Study|Lost to Follow-up|35
2132021|NCT01050062|3736815|FG000|Overall Study|Lack of Efficacy|22
2132022|NCT01050062|3736816|FG001|Overall Study|Lack of Efficacy|35
2132023|NCT01050062|3736815|FG000|Overall Study|Physician Decision|74
2132024|NCT01050062|3736816|FG001|Overall Study|Physician Decision|9
2132025|NCT01050062|3736815|FG000|Overall Study|Others|17
2132026|NCT01050062|3736816|FG001|Overall Study|Others|11
2132027|NCT01050205|3736835|FG000|Overall Study|Lost to Follow-up|7
2132028|NCT01050205|3736836|FG001|Overall Study|Lost to Follow-up|1
2132029|NCT01050205|3736835|FG000|Overall Study|Withdrawal by Subject|1
2132030|NCT01050205|3736836|FG001|Overall Study|Withdrawal by Subject|1
2132031|NCT01050205|3736835|FG000|Overall Study|Relocated from area|1
2132032|NCT01050205|3736836|FG001|Overall Study|Relocated from area|2
2132033|NCT01050205|3736835|FG000|Overall Study|Discontinued Intervention|2
2132034|NCT01050205|3736836|FG001|Overall Study|Discontinued Intervention|0
2132035|NCT01050257|3736854|FG000|Overall Study|Adverse Event|4
2132036|NCT01050257|3736855|FG001|Overall Study|Adverse Event|4
2132037|NCT01050257|3736856|FG002|Overall Study|Adverse Event|2
2132038|NCT01050257|3736854|FG000|Overall Study|Admin/Other (did not switch to oral)|6
2132039|NCT01050257|3736855|FG001|Overall Study|Admin/Other (did not switch to oral)|2
2132040|NCT01050257|3736856|FG002|Overall Study|Admin/Other (did not switch to oral)|2
2132041|NCT01050257|3736854|FG000|Overall Study|Withdrawal by Subject|0
2132042|NCT01050257|3736855|FG001|Overall Study|Withdrawal by Subject|3
2132043|NCT01050257|3736856|FG002|Overall Study|Withdrawal by Subject|0
2132044|NCT01050257|3736854|FG000|Overall Study|No reason specified|0
2132045|NCT01050257|3736855|FG001|Overall Study|No reason specified|0
2132046|NCT01050257|3736856|FG002|Overall Study|No reason specified|2
2132047|NCT01050257|3736854|FG000|Overall Study|Refused treatment/ Did not Cooperate|1
2132048|NCT01050257|3736855|FG001|Overall Study|Refused treatment/ Did not Cooperate|1
2132049|NCT01050257|3736856|FG002|Overall Study|Refused treatment/ Did not Cooperate|0
2132050|NCT01050257|3736854|FG000|Overall Study|Violation criteria|0
2132051|NCT01050257|3736855|FG001|Overall Study|Violation criteria|1
2132052|NCT01050257|3736856|FG002|Overall Study|Violation criteria|0
2132053|NCT01050257|3736854|FG000|Overall Study|Failure to return|0
2132054|NCT01050257|3736855|FG001|Overall Study|Failure to return|2
2132055|NCT01050257|3736856|FG002|Overall Study|Failure to return|0
2132056|NCT01050257|3736854|FG000|Overall Study|Death|0
2132057|NCT01050257|3736855|FG001|Overall Study|Death|0
2132058|NCT01050257|3736856|FG002|Overall Study|Death|1
2132059|NCT01050530|3736866|FG000|Overall Study|Adverse Event|6
2132060|NCT01050530|3736867|FG001|Overall Study|Adverse Event|3
2132061|NCT01050530|3736866|FG000|Overall Study|Lack of Efficacy|1
2132062|NCT01050530|3736867|FG001|Overall Study|Lack of Efficacy|4
2132063|NCT01050530|3736866|FG000|Overall Study|Withdrawal by Subject|0
2132064|NCT01050530|3736867|FG001|Overall Study|Withdrawal by Subject|3
2132065|NCT01050530|3736866|FG000|Overall Study|Protocol Violation|1
2132066|NCT01050530|3736867|FG001|Overall Study|Protocol Violation|0
2132067|NCT01050543|3736875|FG000|Overall Study|Withdrawal by Subject|0
2132068|NCT01050543|3736876|FG001|Overall Study|Withdrawal by Subject|2
2132069|NCT01050543|3736875|FG000|Overall Study|Protocol Violation|0
2132070|NCT01050543|3736876|FG001|Overall Study|Protocol Violation|1
2132071|NCT01050543|3736875|FG000|Overall Study|Administrative|4
2132072|NCT01050543|3736876|FG001|Overall Study|Administrative|1
2132073|NCT01050569|3736885|FG000|Overall Study|Lost to Follow-up|20
2132074|NCT01050569|3736886|FG001|Overall Study|Lost to Follow-up|14
2132075|NCT01050569|3736887|FG002|Overall Study|Lost to Follow-up|16
2132076|NCT01050569|3736885|FG000|Overall Study|Withdrawal by Subject|9
2132077|NCT01050569|3736886|FG001|Overall Study|Withdrawal by Subject|3
2132078|NCT01050569|3736887|FG002|Overall Study|Withdrawal by Subject|11
2132079|NCT01050569|3736885|FG000|Overall Study|Lack of Efficacy|5
2132080|NCT01050569|3736886|FG001|Overall Study|Lack of Efficacy|4
2132081|NCT01050569|3736887|FG002|Overall Study|Lack of Efficacy|3
2132082|NCT01050569|3736885|FG000|Overall Study|Adverse Event|1
2132083|NCT01050569|3736886|FG001|Overall Study|Adverse Event|0
2132084|NCT01050569|3736887|FG002|Overall Study|Adverse Event|0
2132085|NCT01050569|3736885|FG000|Overall Study|Physician Decision|3
2132086|NCT01050569|3736886|FG001|Overall Study|Physician Decision|3
2132087|NCT01050569|3736887|FG002|Overall Study|Physician Decision|3
2132088|NCT01050634|3736908|FG000|Overall Study|Enrolled, but Not Treated|56
2206850|NCT01624194|3845593|FG000|Overall Study|Withdrawal by Subject|1
2132089|NCT01050634|3736908|FG000|Overall Study|Death|2
2132090|NCT01050634|3736908|FG000|Overall Study|Adverse Event|42
2132091|NCT01050634|3736908|FG000|Overall Study|Lost to Follow-up|2
2132092|NCT01050634|3736908|FG000|Overall Study|Other|21
2132093|NCT01050634|3736908|FG000|Overall Study|Ongoing at Date of Cut-Off|5
2132094|NCT01050673|3736932|FG000|Overall Study|Physician Decision|4
2132095|NCT01050673|3736933|FG001|Overall Study|Physician Decision|5
2132096|NCT01050764|3736939|FG000|Overall Study|Death, before HSCT|1
2132097|NCT01050764|3736939|FG000|Overall Study|Donor mobilization failure, death|1
2132098|NCT01050764|3736939|FG000|Overall Study|Death after HSCT, before T-cell infusion|1
2132099|NCT01050790|3736943|FG000|Overall Study|Adverse Event|1
2132100|NCT01050816|3736948|FG000|Overall Study|Lost to Follow-up|2
2132101|NCT01050816|3736948|FG000|Overall Study|patient's refusal|2
2178230|NCT01381575|3802876|FG000|Overall Study|Serious Adverse Event|1
2178231|NCT01381575|3802877|FG001|Overall Study|Serious Adverse Event|0
2178232|NCT01381575|3802878|FG002|Overall Study|Serious Adverse Event|0
2178233|NCT01381575|3802876|FG000|Overall Study|Non-Serious Adverse Event|0
2178234|NCT01381575|3802877|FG001|Overall Study|Non-Serious Adverse Event|0
2178235|NCT01381575|3802878|FG002|Overall Study|Non-Serious Adverse Event|1
2178236|NCT01381575|3802876|FG000|Overall Study|Protocol Violation|0
2178237|NCT01381575|3802877|FG001|Overall Study|Protocol Violation|1
2178238|NCT01381575|3802878|FG002|Overall Study|Protocol Violation|1
2178239|NCT01381575|3802876|FG000|Overall Study|Withdrawal by Subject|15
2178240|NCT01381575|3802877|FG001|Overall Study|Withdrawal by Subject|9
2132102|NCT01050998|3736966|FG000|Overall Study|Adverse Event|1
2132103|NCT01050998|3736967|FG001|Overall Study|Adverse Event|0
2132104|NCT01050998|3736968|FG002|Overall Study|Adverse Event|1
2132105|NCT01050998|3736969|FG003|Overall Study|Adverse Event|0
2132106|NCT01050998|3736970|FG004|Overall Study|Adverse Event|2
2132107|NCT01050998|3736966|FG000|Overall Study|Withdrawal by Subject|0
2132108|NCT01050998|3736967|FG001|Overall Study|Withdrawal by Subject|0
2132109|NCT01050998|3736968|FG002|Overall Study|Withdrawal by Subject|0
2132110|NCT01050998|3736969|FG003|Overall Study|Withdrawal by Subject|1
2132111|NCT01050998|3736970|FG004|Overall Study|Withdrawal by Subject|3
2132112|NCT01050998|3736966|FG000|Overall Study|Other|3
2132113|NCT01050998|3736967|FG001|Overall Study|Other|2
2132114|NCT01050998|3736968|FG002|Overall Study|Other|1
2132115|NCT01050998|3736969|FG003|Overall Study|Other|1
2132116|NCT01050998|3736970|FG004|Overall Study|Other|5
2132117|NCT01050998|3736966|FG000|Overall Study|Data integrity issues|0
2132118|NCT01050998|3736967|FG001|Overall Study|Data integrity issues|0
2132119|NCT01050998|3736968|FG002|Overall Study|Data integrity issues|1
2285287|NCT02418754|3973400|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24
2285288|NCT02418754|3973396|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3
2132120|NCT01050998|3736969|FG003|Overall Study|Data integrity issues|1
2132121|NCT01050998|3736970|FG004|Overall Study|Data integrity issues|4
2132122|NCT01051063|3736988|FG000|Overall Study|Death|2
2132123|NCT01051063|3736989|FG001|Overall Study|Death|2
2132124|NCT01051063|3736988|FG000|Overall Study|Withdrawal by Subject|1
2132125|NCT01051063|3736989|FG001|Overall Study|Withdrawal by Subject|1
2132126|NCT01051063|3736988|FG000|Overall Study|Termination of the study|5
2132127|NCT01051063|3736989|FG001|Overall Study|Termination of the study|0
2132128|NCT01051063|3736988|FG000|Overall Study|Moved from the study site area|1
2132129|NCT01051063|3736989|FG001|Overall Study|Moved from the study site area|0
2132130|NCT01051063|3736988|FG000|Overall Study|Other|1
2132131|NCT01051063|3736989|FG001|Overall Study|Other|0
2206851|NCT01624194|3845594|FG001|Overall Study|Withdrawal by Subject|0
2206852|NCT01624233|3845601|FG000|Period 2 - Induction|Adverse Event|1
2285289|NCT02418754|3973397|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
2132132|NCT01051063|3736988|FG000|Overall Study|Lost to Follow-up|0
2132133|NCT01051063|3736989|FG001|Overall Study|Lost to Follow-up|1
2132134|NCT01051323|3737002|FG000|Overall Study|Discontinuation of treatment|103
2132135|NCT01051323|3737002|FG000|Overall Study|Transplantation|28
2132136|NCT01051323|3737002|FG000|Overall Study|Dialysis dependency|22
2132137|NCT01051323|3737002|FG000|Overall Study|Withdrawal by Subject|13
2132138|NCT01051323|3737002|FG000|Overall Study|Lost to Follow-up|31
2132139|NCT01051323|3737002|FG000|Overall Study|Death|129
2132140|NCT01051323|3737002|FG000|Overall Study|Hospitalization|28
2132141|NCT01051323|3737002|FG000|Overall Study|Other|148
2132142|NCT01051323|3737002|FG000|Overall Study|Missing|37
2132143|NCT01051349|3737010|FG000|Overall Study|Adverse Event|88
2132144|NCT01051349|3737010|FG000|Overall Study|Consent Withdrawn|54
2132145|NCT01051349|3737010|FG000|Overall Study|Investigator Decision|6
2132146|NCT01051349|3737010|FG000|Overall Study|Lost to Follow-up|6
2285290|NCT02418754|3973398|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
2285291|NCT02418754|3973399|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1
2285292|NCT02418754|3973400|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0
2285293|NCT02418754|3973396|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0
2285294|NCT02418754|3973397|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
2285295|NCT02418754|3973398|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
2285296|NCT02418754|3973399|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
2285297|NCT02418754|3973400|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
2285298|NCT02418754|3973396|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
2285299|NCT02418754|3973397|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
2285300|NCT02418754|3973398|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
2132147|NCT01051349|3737010|FG000|Overall Study|Subject non-compliance|7
2132148|NCT01051349|3737010|FG000|Overall Study|Reason not Specified|12
2132149|NCT01051466|3737028|FG000|Overall Study|Adverse Event|1
2132150|NCT01051466|3737029|FG001|Overall Study|Adverse Event|0
2206853|NCT01624233|3845601|FG000|Period 3 - Maintenance|Adverse Event|2
2206854|NCT01624233|3845601|FG000|Period 3 - Maintenance|Lack of Efficacy|1
2206855|NCT01624233|3845601|FG000|Period 3 - Maintenance|Physician Decision|2
2206856|NCT01624233|3845601|FG000|Period 3 - Maintenance|Withdrawal by Subject|2
2206857|NCT01624233|3845601|FG000|Period 4 - Drug Free Period|Relapsed|61
2206858|NCT01624233|3845601|FG000|Period 5 - Retreatment Period|Adverse Event|5
2206859|NCT01624233|3845601|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1
2206860|NCT01624233|3845601|FG000|Period 5 - Retreatment Period|Physician Decision|1
2206861|NCT01624233|3845601|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3
2206862|NCT01624233|3845601|FG000|Period 6: Follow-up|Adverse Event|3
2206863|NCT01624233|3845601|FG000|Period 6: Follow-up|Lack of Efficacy|2
2206864|NCT01624233|3845601|FG000|Period 6: Follow-up|Physician Decision|1
2206865|NCT01624233|3845601|FG000|Period 6: Follow-up|Withdrawal by Subject|3
2206866|NCT01624259|3845611|FG000|Overall Study|Adverse Event|18
2206867|NCT01624259|3845612|FG001|Overall Study|Adverse Event|18
2132151|NCT01051466|3737028|FG000|Overall Study|Lost to Follow-up|1
2132152|NCT01051466|3737029|FG001|Overall Study|Lost to Follow-up|1
2132153|NCT01051466|3737028|FG000|Overall Study|Withdrawal by Subject|5
2132154|NCT01051466|3737029|FG001|Overall Study|Withdrawal by Subject|1
2132155|NCT01051466|3737028|FG000|Overall Study|Entry Criteria Not Met|0
2132156|NCT01051466|3737029|FG001|Overall Study|Entry Criteria Not Met|3
2132157|NCT01051466|3737028|FG000|Overall Study|Physician Decision|1
2132158|NCT01051466|3737029|FG001|Overall Study|Physician Decision|0
2132159|NCT01051557|3737055|FG000|Overall Study|Physician Decision|1
2132160|NCT01051557|3737056|FG001|Overall Study|Physician Decision|0
2132161|NCT01051557|3737057|FG002|Overall Study|Physician Decision|0
2132162|NCT01051557|3737058|FG003|Overall Study|Physician Decision|0
2132163|NCT01051557|3737059|FG004|Overall Study|Physician Decision|0
2132164|NCT01051557|3737060|FG005|Overall Study|Physician Decision|0
2132165|NCT01051557|3737061|FG006|Overall Study|Physician Decision|0
2132166|NCT01051557|3737055|FG000|Overall Study|disease progression|3
2132167|NCT01051557|3737056|FG001|Overall Study|disease progression|3
2132168|NCT01051557|3737057|FG002|Overall Study|disease progression|5
2132169|NCT01051557|3737058|FG003|Overall Study|disease progression|2
2132170|NCT01051557|3737059|FG004|Overall Study|disease progression|4
2132171|NCT01051557|3737060|FG005|Overall Study|disease progression|3
2132172|NCT01051557|3737061|FG006|Overall Study|disease progression|1
2132173|NCT01051557|3737055|FG000|Overall Study|Withdrawal by Subject|0
2132174|NCT01051557|3737056|FG001|Overall Study|Withdrawal by Subject|0
2132175|NCT01051557|3737057|FG002|Overall Study|Withdrawal by Subject|1
2132176|NCT01051557|3737058|FG003|Overall Study|Withdrawal by Subject|0
2132177|NCT01051557|3737059|FG004|Overall Study|Withdrawal by Subject|2
2132178|NCT01051557|3737060|FG005|Overall Study|Withdrawal by Subject|0
2132179|NCT01051557|3737061|FG006|Overall Study|Withdrawal by Subject|1
2132180|NCT01051557|3737055|FG000|Overall Study|Adverse Event|0
2132181|NCT01051557|3737056|FG001|Overall Study|Adverse Event|0
2132182|NCT01051557|3737057|FG002|Overall Study|Adverse Event|0
2132183|NCT01051557|3737058|FG003|Overall Study|Adverse Event|1
2132184|NCT01051557|3737059|FG004|Overall Study|Adverse Event|1
2132185|NCT01051557|3737060|FG005|Overall Study|Adverse Event|3
2132186|NCT01051557|3737061|FG006|Overall Study|Adverse Event|4
2132187|NCT01051661|3737092|FG000|Overall Study|Adverse Event|1
2132188|NCT01051661|3737093|FG001|Overall Study|Adverse Event|1
2132189|NCT01051661|3737094|FG002|Overall Study|Adverse Event|1
2132190|NCT01051661|3737095|FG003|Overall Study|Adverse Event|1
2132191|NCT01051661|3737096|FG004|Overall Study|Adverse Event|0
2132192|NCT01051661|3737097|FG005|Overall Study|Adverse Event|0
2132193|NCT01051661|3737092|FG000|Overall Study|Lost to Follow-up|13
2132194|NCT01051661|3737093|FG001|Overall Study|Lost to Follow-up|22
2132195|NCT01051661|3737094|FG002|Overall Study|Lost to Follow-up|15
2132196|NCT01051661|3737095|FG003|Overall Study|Lost to Follow-up|17
2132197|NCT01051661|3737096|FG004|Overall Study|Lost to Follow-up|10
2132198|NCT01051661|3737097|FG005|Overall Study|Lost to Follow-up|24
2132199|NCT01051661|3737092|FG000|Overall Study|Migrated/moved from study area|1
2132200|NCT01051661|3737093|FG001|Overall Study|Migrated/moved from study area|6
2132201|NCT01051661|3737094|FG002|Overall Study|Migrated/moved from study area|6
2132202|NCT01051661|3737095|FG003|Overall Study|Migrated/moved from study area|8
2132203|NCT01051661|3737096|FG004|Overall Study|Migrated/moved from study area|7
2132204|NCT01051661|3737097|FG005|Overall Study|Migrated/moved from study area|3
2132205|NCT01051661|3737092|FG000|Overall Study|Refused blood sampling|0
2132206|NCT01051661|3737093|FG001|Overall Study|Refused blood sampling|0
2132207|NCT01051661|3737094|FG002|Overall Study|Refused blood sampling|0
2132208|NCT01051661|3737095|FG003|Overall Study|Refused blood sampling|0
2132209|NCT01051661|3737096|FG004|Overall Study|Refused blood sampling|0
2132210|NCT01051661|3737097|FG005|Overall Study|Refused blood sampling|1
2132211|NCT01051661|3737092|FG000|Overall Study|Data not reliable|1
2132212|NCT01051661|3737093|FG001|Overall Study|Data not reliable|0
2132213|NCT01051661|3737094|FG002|Overall Study|Data not reliable|0
2132214|NCT01051661|3737095|FG003|Overall Study|Data not reliable|0
2132215|NCT01051661|3737096|FG004|Overall Study|Data not reliable|0
2132216|NCT01051661|3737097|FG005|Overall Study|Data not reliable|1
2132217|NCT01051661|3737092|FG000|Overall Study|Unable to attend visit(s)|2
2132218|NCT01051661|3737093|FG001|Overall Study|Unable to attend visit(s)|4
2132219|NCT01051661|3737094|FG002|Overall Study|Unable to attend visit(s)|2
2132220|NCT01051661|3737095|FG003|Overall Study|Unable to attend visit(s)|1
2132221|NCT01051661|3737096|FG004|Overall Study|Unable to attend visit(s)|3
2132222|NCT01051661|3737097|FG005|Overall Study|Unable to attend visit(s)|2
2132223|NCT01051661|3737092|FG000|Overall Study|Consent not received from both parents|0
2132224|NCT01051661|3737093|FG001|Overall Study|Consent not received from both parents|0
2132225|NCT01051661|3737094|FG002|Overall Study|Consent not received from both parents|0
2132226|NCT01051661|3737095|FG003|Overall Study|Consent not received from both parents|0
2132227|NCT01051661|3737096|FG004|Overall Study|Consent not received from both parents|0
2132228|NCT01051661|3737097|FG005|Overall Study|Consent not received from both parents|1
2132229|NCT01051661|3737092|FG000|Overall Study|Failure to comply with protocol|0
2132230|NCT01051661|3737093|FG001|Overall Study|Failure to comply with protocol|0
2132231|NCT01051661|3737094|FG002|Overall Study|Failure to comply with protocol|2
2132232|NCT01051661|3737095|FG003|Overall Study|Failure to comply with protocol|0
2178241|NCT01381575|3802878|FG002|Overall Study|Withdrawal by Subject|7
2132233|NCT01051661|3737096|FG004|Overall Study|Failure to comply with protocol|0
2132234|NCT01051661|3737097|FG005|Overall Study|Failure to comply with protocol|0
2132235|NCT01051661|3737092|FG000|Overall Study|Subject lost legal representation|0
2132236|NCT01051661|3737093|FG001|Overall Study|Subject lost legal representation|0
2132237|NCT01051661|3737094|FG002|Overall Study|Subject lost legal representation|0
2132238|NCT01051661|3737095|FG003|Overall Study|Subject lost legal representation|0
2132239|NCT01051661|3737096|FG004|Overall Study|Subject lost legal representation|1
2132240|NCT01051661|3737097|FG005|Overall Study|Subject lost legal representation|0
2132241|NCT01051661|3737092|FG000|Overall Study|Protocol Violation|0
2132242|NCT01051661|3737093|FG001|Overall Study|Protocol Violation|0
2132243|NCT01051661|3737094|FG002|Overall Study|Protocol Violation|0
2132244|NCT01051661|3737095|FG003|Overall Study|Protocol Violation|1
2132245|NCT01051661|3737096|FG004|Overall Study|Protocol Violation|2
2132246|NCT01051661|3737097|FG005|Overall Study|Protocol Violation|1
2132247|NCT01051661|3737092|FG000|Overall Study|Withdrawal by Subject|16
2132248|NCT01051661|3737093|FG001|Overall Study|Withdrawal by Subject|30
2132249|NCT01051661|3737094|FG002|Overall Study|Withdrawal by Subject|13
2132250|NCT01051661|3737095|FG003|Overall Study|Withdrawal by Subject|28
2132251|NCT01051661|3737096|FG004|Overall Study|Withdrawal by Subject|12
2132252|NCT01051661|3737097|FG005|Overall Study|Withdrawal by Subject|34
2132253|NCT01051739|3737134|FG000|Overall Study|Death|3
2132254|NCT01051739|3737135|FG001|Overall Study|Death|3
2132255|NCT01051739|3737134|FG000|Overall Study|Withdrawal by Subject|25
2132256|NCT01051739|3737135|FG001|Overall Study|Withdrawal by Subject|10
2132257|NCT01051791|3737150|FG000|Overall Study|Failed screening|3
2132258|NCT01051791|3737150|FG000|Overall Study|Withdrawal by Subject|1
2132259|NCT01051817|3737157|FG000|Overall Study|Adverse Event|0
2132260|NCT01051817|3737158|FG001|Overall Study|Adverse Event|2
2132261|NCT01051817|3737157|FG000|Overall Study|Abnormal Test Proceedure reults|0
2132262|NCT01051817|3737158|FG001|Overall Study|Abnormal Test Proceedure reults|1
2132263|NCT01051817|3737157|FG000|Overall Study|Withdrawal by Subject|3
2132264|NCT01051817|3737158|FG001|Overall Study|Withdrawal by Subject|5
2132265|NCT01051817|3737157|FG000|Overall Study|Protocol Violation|0
2132266|NCT01051817|3737158|FG001|Overall Study|Protocol Violation|1
2132267|NCT01051856|3737166|FG000|Overall Study|Withdrawal by Subject|1
2132268|NCT01051856|3737167|FG001|Overall Study|Withdrawal by Subject|0
2132269|NCT01051960|3737173|FG000|Overall Study|Adverse Event|1
2132270|NCT01051986|3737179|FG000|Overall Study|Death|1
2132271|NCT01051986|3737180|FG001|Overall Study|Death|0
2132272|NCT01051986|3737179|FG000|Overall Study|Withdrawal by Subject|2
2132273|NCT01051986|3737180|FG001|Overall Study|Withdrawal by Subject|1
2132274|NCT01051986|3737179|FG000|Overall Study|Protocol Violation|2
2132275|NCT01051986|3737180|FG001|Overall Study|Protocol Violation|3
2132276|NCT01052012|3737192|FG000|Overall Study|Not treated|2
2132277|NCT01052012|3737193|FG001|Overall Study|Not treated|5
2132278|NCT01052012|3737194|FG002|Overall Study|Not treated|0
2132279|NCT01052012|3737195|FG003|Overall Study|Not treated|0
2132280|NCT01052012|3737196|FG004|Overall Study|Not treated|11
2132281|NCT01052012|3737197|FG005|Overall Study|Not treated|8
2132282|NCT01052012|3737192|FG000|Overall Study|Adverse Event|1
2132283|NCT01052012|3737193|FG001|Overall Study|Adverse Event|0
2132284|NCT01052012|3737194|FG002|Overall Study|Adverse Event|0
2132285|NCT01052012|3737195|FG003|Overall Study|Adverse Event|1
2132286|NCT01052012|3737196|FG004|Overall Study|Adverse Event|0
2132287|NCT01052012|3737197|FG005|Overall Study|Adverse Event|0
2132288|NCT01052012|3737192|FG000|Overall Study|Lost to Follow-up|0
2132289|NCT01052012|3737193|FG001|Overall Study|Lost to Follow-up|0
2132290|NCT01052012|3737194|FG002|Overall Study|Lost to Follow-up|0
2132291|NCT01052012|3737195|FG003|Overall Study|Lost to Follow-up|0
2132292|NCT01052012|3737196|FG004|Overall Study|Lost to Follow-up|1
2132293|NCT01052012|3737197|FG005|Overall Study|Lost to Follow-up|0
2132294|NCT01052012|3737192|FG000|Overall Study|Withdrawal by Subject|1
2132295|NCT01052012|3737193|FG001|Overall Study|Withdrawal by Subject|1
2132296|NCT01052012|3737194|FG002|Overall Study|Withdrawal by Subject|0
2132297|NCT01052012|3737195|FG003|Overall Study|Withdrawal by Subject|0
2132298|NCT01052012|3737196|FG004|Overall Study|Withdrawal by Subject|3
2132299|NCT01052012|3737197|FG005|Overall Study|Withdrawal by Subject|1
2132300|NCT01052012|3737192|FG000|Overall Study|Physician Decision|0
2132301|NCT01052012|3737193|FG001|Overall Study|Physician Decision|0
2132302|NCT01052012|3737194|FG002|Overall Study|Physician Decision|0
2132303|NCT01052012|3737195|FG003|Overall Study|Physician Decision|0
2132304|NCT01052012|3737196|FG004|Overall Study|Physician Decision|0
2132305|NCT01052012|3737197|FG005|Overall Study|Physician Decision|1
2132306|NCT01052012|3737192|FG000|Overall Study|Other|0
2132307|NCT01052012|3737193|FG001|Overall Study|Other|0
2132308|NCT01052012|3737194|FG002|Overall Study|Other|0
2132309|NCT01052012|3737195|FG003|Overall Study|Other|0
2132310|NCT01052012|3737196|FG004|Overall Study|Other|1
2132311|NCT01052012|3737197|FG005|Overall Study|Other|0
2132312|NCT01052038|3737214|FG000|Overall Study|Lost to Follow-up|2
2132313|NCT01052038|3737215|FG001|Overall Study|Lost to Follow-up|3
2132314|NCT01052038|3737216|FG002|Overall Study|Lost to Follow-up|1
2132315|NCT01052038|3737214|FG000|Overall Study|Protocol Violation|2
2132316|NCT01052038|3737215|FG001|Overall Study|Protocol Violation|3
2132317|NCT01052038|3737216|FG002|Overall Study|Protocol Violation|3
2132318|NCT01052077|3737226|FG000|Phase A|Lost to Follow-up|22
2132319|NCT01052077|3737227|FG001|Phase A|Lost to Follow-up|0
2132320|NCT01052077|3737228|FG002|Phase A|Lost to Follow-up|0
2132321|NCT01052077|3737229|FG003|Phase A|Lost to Follow-up|0
2132322|NCT01052077|3737226|FG000|Phase A|Adverse Event|32
2132323|NCT01052077|3737227|FG001|Phase A|Adverse Event|0
2132324|NCT01052077|3737228|FG002|Phase A|Adverse Event|0
2132325|NCT01052077|3737229|FG003|Phase A|Adverse Event|0
2132326|NCT01052077|3737226|FG000|Phase A|Met Withdrawal Criteria|26
2132327|NCT01052077|3737227|FG001|Phase A|Met Withdrawal Criteria|0
2132328|NCT01052077|3737228|FG002|Phase A|Met Withdrawal Criteria|0
2132329|NCT01052077|3737229|FG003|Phase A|Met Withdrawal Criteria|0
2132330|NCT01052077|3737226|FG000|Phase A|Physician Decision|10
2132331|NCT01052077|3737227|FG001|Phase A|Physician Decision|0
2132332|NCT01052077|3737228|FG002|Phase A|Physician Decision|0
2132333|NCT01052077|3737229|FG003|Phase A|Physician Decision|0
2132334|NCT01052077|3737226|FG000|Phase A|Withdrawal by Subject|29
2132335|NCT01052077|3737227|FG001|Phase A|Withdrawal by Subject|0
2132336|NCT01052077|3737228|FG002|Phase A|Withdrawal by Subject|0
2132337|NCT01052077|3737229|FG003|Phase A|Withdrawal by Subject|0
2132338|NCT01052077|3737226|FG000|Phase A|Protocol Deviation|27
2132339|NCT01052077|3737227|FG001|Phase A|Protocol Deviation|0
2132340|NCT01052077|3737228|FG002|Phase A|Protocol Deviation|0
2132341|NCT01052077|3737229|FG003|Phase A|Protocol Deviation|0
2132342|NCT01052077|3737226|FG000|Phase B|Lost to Follow-up|0
2132343|NCT01052077|3737227|FG001|Phase B|Lost to Follow-up|2
2132344|NCT01052077|3737228|FG002|Phase B|Lost to Follow-up|3
2132345|NCT01052077|3737229|FG003|Phase B|Lost to Follow-up|0
2132346|NCT01052077|3737226|FG000|Phase B|Adverse Event|0
2132347|NCT01052077|3737227|FG001|Phase B|Adverse Event|9
2132348|NCT01052077|3737228|FG002|Phase B|Adverse Event|2
2132349|NCT01052077|3737229|FG003|Phase B|Adverse Event|0
2132350|NCT01052077|3737226|FG000|Phase B|Met Withdrawal Criteria|0
2132351|NCT01052077|3737227|FG001|Phase B|Met Withdrawal Criteria|2
2132352|NCT01052077|3737228|FG002|Phase B|Met Withdrawal Criteria|1
2132353|NCT01052077|3737229|FG003|Phase B|Met Withdrawal Criteria|0
2132354|NCT01052077|3737226|FG000|Phase B|Physician Decision|0
2132355|NCT01052077|3737227|FG001|Phase B|Physician Decision|1
2132356|NCT01052077|3737228|FG002|Phase B|Physician Decision|1
2132357|NCT01052077|3737229|FG003|Phase B|Physician Decision|0
2132358|NCT01052077|3737226|FG000|Phase B|Withdrawal by Subject|0
2132359|NCT01052077|3737227|FG001|Phase B|Withdrawal by Subject|0
2132360|NCT01052077|3737228|FG002|Phase B|Withdrawal by Subject|5
2132361|NCT01052077|3737229|FG003|Phase B|Withdrawal by Subject|0
2132362|NCT01052077|3737226|FG000|Phase B|Protocol Deviation|0
2132363|NCT01052077|3737227|FG001|Phase B|Protocol Deviation|3
2132364|NCT01052077|3737228|FG002|Phase B|Protocol Deviation|4
2132365|NCT01052077|3737229|FG003|Phase B|Protocol Deviation|0
2132366|NCT01052077|3737226|FG000|Phase B|Lack of Efficacy|0
2132367|NCT01052077|3737227|FG001|Phase B|Lack of Efficacy|1
2132368|NCT01052077|3737228|FG002|Phase B|Lack of Efficacy|0
2285301|NCT02418754|3973399|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
2285302|NCT02418754|3973400|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
2285303|NCT02418819|3973414|FG000|Overall Study|Adverse Event|0
2285304|NCT02418819|3973415|FG001|Overall Study|Adverse Event|0
2132369|NCT01052077|3737229|FG003|Phase B|Lack of Efficacy|0
2132370|NCT01052077|3737226|FG000|Phase A+|Lost to Follow-up|0
2132371|NCT01052077|3737227|FG001|Phase A+|Lost to Follow-up|0
2132372|NCT01052077|3737228|FG002|Phase A+|Lost to Follow-up|0
2132373|NCT01052077|3737229|FG003|Phase A+|Lost to Follow-up|8
2132374|NCT01052077|3737226|FG000|Phase A+|Adverse Event|0
2132375|NCT01052077|3737227|FG001|Phase A+|Adverse Event|0
2132376|NCT01052077|3737228|FG002|Phase A+|Adverse Event|0
2132377|NCT01052077|3737229|FG003|Phase A+|Adverse Event|4
2132378|NCT01052077|3737226|FG000|Phase A+|Met Withdrawal Criteria|0
2132379|NCT01052077|3737227|FG001|Phase A+|Met Withdrawal Criteria|0
2132380|NCT01052077|3737228|FG002|Phase A+|Met Withdrawal Criteria|0
2132381|NCT01052077|3737229|FG003|Phase A+|Met Withdrawal Criteria|2
2132382|NCT01052077|3737226|FG000|Phase A+|Withdrawal by Subject|0
2132383|NCT01052077|3737227|FG001|Phase A+|Withdrawal by Subject|0
2132384|NCT01052077|3737228|FG002|Phase A+|Withdrawal by Subject|0
2132385|NCT01052077|3737229|FG003|Phase A+|Withdrawal by Subject|7
2132386|NCT01052103|3737237|FG000|Overall Study|Adverse Event|10
2285305|NCT02418819|3973416|FG002|Overall Study|Adverse Event|1
2285306|NCT02418819|3973417|FG003|Overall Study|Adverse Event|0
2285307|NCT02418819|3973414|FG000|Overall Study|Lost to Follow-up|1
2285308|NCT02418819|3973415|FG001|Overall Study|Lost to Follow-up|0
2132387|NCT01052103|3737238|FG001|Overall Study|Adverse Event|6
2132388|NCT01052103|3737237|FG000|Overall Study|Entry Criteria Not Met|3
2132389|NCT01052103|3737238|FG001|Overall Study|Entry Criteria Not Met|1
2132390|NCT01052103|3737237|FG000|Overall Study|Lost to Follow-up|3
2132391|NCT01052103|3737238|FG001|Overall Study|Lost to Follow-up|5
2132392|NCT01052103|3737237|FG000|Overall Study|Protocol Violation|10
2132393|NCT01052103|3737238|FG001|Overall Study|Protocol Violation|4
2132394|NCT01052103|3737237|FG000|Overall Study|Scheduling conflict|2
2132395|NCT01052103|3737238|FG001|Overall Study|Scheduling conflict|1
2132396|NCT01052103|3737237|FG000|Overall Study|Sponsor Decision|2
2132397|NCT01052103|3737238|FG001|Overall Study|Sponsor Decision|0
2132398|NCT01052103|3737237|FG000|Overall Study|Withdrawal by Subject|3
2132399|NCT01052103|3737238|FG001|Overall Study|Withdrawal by Subject|6
2132400|NCT01052103|3737237|FG000|Overall Study|Perceived Lack of Efficacy|1
2132401|NCT01052103|3737238|FG001|Overall Study|Perceived Lack of Efficacy|0
2132402|NCT01052116|3737247|FG000|Overall Study|Lost to Follow-up|11
2132403|NCT01052116|3737248|FG001|Overall Study|Lost to Follow-up|17
2132404|NCT01052116|3737247|FG000|Overall Study|Withdrawal by Subject|3
2132405|NCT01052116|3737248|FG001|Overall Study|Withdrawal by Subject|6
2132406|NCT01052116|3737247|FG000|Overall Study|Spirometry not performed|0
2132407|NCT01052116|3737248|FG001|Overall Study|Spirometry not performed|4
2132408|NCT01052272|3737267|FG000|Overall Study|Death|0
2132409|NCT01052272|3737268|FG001|Overall Study|Death|0
2132410|NCT01052272|3737269|FG002|Overall Study|Death|1
2132411|NCT01052272|3737270|FG003|Overall Study|Death|1
2132412|NCT01052272|3737267|FG000|Overall Study|Physician Decision|0
2132413|NCT01052272|3737268|FG001|Overall Study|Physician Decision|1
2132414|NCT01052272|3737269|FG002|Overall Study|Physician Decision|0
2132415|NCT01052272|3737270|FG003|Overall Study|Physician Decision|0
2132416|NCT01052272|3737267|FG000|Overall Study|patient refuses follow-up|5
2132417|NCT01052272|3737268|FG001|Overall Study|patient refuses follow-up|4
2132418|NCT01052272|3737269|FG002|Overall Study|patient refuses follow-up|2
2132419|NCT01052272|3737270|FG003|Overall Study|patient refuses follow-up|4
2132420|NCT01052272|3737267|FG000|Overall Study|Withdrawal by Subject|0
2132421|NCT01052272|3737268|FG001|Overall Study|Withdrawal by Subject|2
2132422|NCT01052272|3737269|FG002|Overall Study|Withdrawal by Subject|3
2132423|NCT01052272|3737270|FG003|Overall Study|Withdrawal by Subject|2
2132424|NCT01052272|3737267|FG000|Overall Study|placed in long-term care|0
2132425|NCT01052272|3737268|FG001|Overall Study|placed in long-term care|0
2132426|NCT01052272|3737269|FG002|Overall Study|placed in long-term care|1
2132427|NCT01052272|3737270|FG003|Overall Study|placed in long-term care|0
2132428|NCT01052272|3737267|FG000|Overall Study|decline in health|0
2132429|NCT01052272|3737268|FG001|Overall Study|decline in health|0
2132430|NCT01052272|3737269|FG002|Overall Study|decline in health|1
2132431|NCT01052272|3737270|FG003|Overall Study|decline in health|0
2132432|NCT01052428|3737282|FG000|Overall Study|Death|1
2132433|NCT01052428|3737283|FG001|Overall Study|Death|0
2132434|NCT01052428|3737282|FG000|Overall Study|Withdrawal by Subject|0
2132435|NCT01052428|3737283|FG001|Overall Study|Withdrawal by Subject|1
2132436|NCT01052480|3737291|FG000|Overall Study|Lost to Follow-up|3
2132437|NCT01052480|3737292|FG001|Overall Study|Lost to Follow-up|3
2132438|NCT01052480|3737291|FG000|Overall Study|Protocol Violation|1
2132439|NCT01052480|3737292|FG001|Overall Study|Protocol Violation|0
2132440|NCT01052480|3737291|FG000|Overall Study|Withdrawal by Subject|3
2132441|NCT01052480|3737292|FG001|Overall Study|Withdrawal by Subject|7
2132442|NCT01052480|3737291|FG000|Overall Study|Physician Decision|0
2132443|NCT01052480|3737292|FG001|Overall Study|Physician Decision|2
2132444|NCT01052480|3737291|FG000|Overall Study|Death|1
2132445|NCT01052480|3737292|FG001|Overall Study|Death|5
2132446|NCT01052493|3737298|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1
2132447|NCT01052493|3737299|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
2132448|NCT01052493|3737300|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
2132449|NCT01052662|3737337|FG000|Overall Study|Lost to Follow-up|15
2132450|NCT01052662|3737338|FG001|Overall Study|Lost to Follow-up|13
2132451|NCT01052662|3737339|FG002|Overall Study|Lost to Follow-up|18
2132452|NCT01052662|3737337|FG000|Overall Study|Withdrawal by Subject|3
2132453|NCT01052662|3737338|FG001|Overall Study|Withdrawal by Subject|2
2132454|NCT01052662|3737339|FG002|Overall Study|Withdrawal by Subject|1
2132455|NCT01052662|3737337|FG000|Overall Study|Pharmacy issue|1
2132456|NCT01052662|3737338|FG001|Overall Study|Pharmacy issue|3
2132457|NCT01052662|3737339|FG002|Overall Study|Pharmacy issue|3
2132458|NCT01052662|3737337|FG000|Overall Study|Adverse Event|1
2132459|NCT01052662|3737338|FG001|Overall Study|Adverse Event|1
2285309|NCT02418819|3973416|FG002|Overall Study|Lost to Follow-up|0
2285310|NCT02418819|3973417|FG003|Overall Study|Lost to Follow-up|0
2285311|NCT02418819|3973414|FG000|Overall Study|No longer meets eligibility criteria|0
2285312|NCT02418819|3973415|FG001|Overall Study|No longer meets eligibility criteria|0
2285313|NCT02418819|3973416|FG002|Overall Study|No longer meets eligibility criteria|1
2285314|NCT02418819|3973417|FG003|Overall Study|No longer meets eligibility criteria|0
2285315|NCT02418819|3973414|FG000|Overall Study|No longer willing to participate|0
2285316|NCT02418819|3973415|FG001|Overall Study|No longer willing to participate|0
2285317|NCT02418819|3973416|FG002|Overall Study|No longer willing to participate|2
2285318|NCT02418819|3973417|FG003|Overall Study|No longer willing to participate|1
2285319|NCT02418845|3973429|FG000|Overall Study|Lost to Follow-up|7
2285320|NCT02418845|3973430|FG001|Overall Study|Lost to Follow-up|2
2285321|NCT02418845|3973429|FG000|Overall Study|Lack of Efficacy|0
2285322|NCT02418845|3973430|FG001|Overall Study|Lack of Efficacy|3
2285323|NCT02418845|3973429|FG000|Overall Study|Physician Decision|5
2285324|NCT02418845|3973430|FG001|Overall Study|Physician Decision|5
2132460|NCT01052662|3737339|FG002|Overall Study|Adverse Event|0
2132461|NCT01052662|3737337|FG000|Overall Study|Legal Problem|2
2132462|NCT01052662|3737338|FG001|Overall Study|Legal Problem|0
2132463|NCT01052662|3737339|FG002|Overall Study|Legal Problem|0
2132464|NCT01052662|3737337|FG000|Overall Study|Administrative|0
2132465|NCT01052662|3737338|FG001|Overall Study|Administrative|3
2132466|NCT01052662|3737339|FG002|Overall Study|Administrative|0
2132467|NCT01052714|3737358|FG000|Overall Study|Adverse Event|6
2132468|NCT01052714|3737359|FG001|Overall Study|Adverse Event|3
2132469|NCT01052714|3737360|FG002|Overall Study|Adverse Event|0
2132470|NCT01052714|3737358|FG000|Overall Study|Death|1
2132471|NCT01052714|3737359|FG001|Overall Study|Death|2
2132472|NCT01052714|3737360|FG002|Overall Study|Death|0
2206868|NCT01624259|3845611|FG000|Overall Study|Protocol Violation|1
2132473|NCT01052714|3737358|FG000|Overall Study|Lost to Follow-up|2
2132474|NCT01052714|3737359|FG001|Overall Study|Lost to Follow-up|3
2132475|NCT01052714|3737360|FG002|Overall Study|Lost to Follow-up|0
2132476|NCT01052714|3737358|FG000|Overall Study|Physician Decision|9
2132477|NCT01052714|3737359|FG001|Overall Study|Physician Decision|9
2132478|NCT01052714|3737360|FG002|Overall Study|Physician Decision|1
2132479|NCT01052714|3737358|FG000|Overall Study|Withdrawal by Subject|7
2132480|NCT01052714|3737359|FG001|Overall Study|Withdrawal by Subject|12
2132481|NCT01052714|3737360|FG002|Overall Study|Withdrawal by Subject|1
2132482|NCT01052779|3737368|FG000|Overall Study|Adverse Event|1
2132483|NCT01052779|3737369|FG001|Overall Study|Adverse Event|4
2132484|NCT01052779|3737368|FG000|Overall Study|Withdrawal by Subject|1
2132485|NCT01052779|3737369|FG001|Overall Study|Withdrawal by Subject|2
2132486|NCT01052779|3737368|FG000|Overall Study|Other-Protocol Violation|1
2132487|NCT01052779|3737369|FG001|Overall Study|Other-Protocol Violation|1
2132488|NCT01052779|3737368|FG000|Overall Study|Other-Surgery|0
2132489|NCT01052779|3737369|FG001|Overall Study|Other-Surgery|2
2132490|NCT01052779|3737368|FG000|Overall Study|Other-Missed Week 5 Visit|2
2132491|NCT01052779|3737369|FG001|Overall Study|Other-Missed Week 5 Visit|0
2132492|NCT01052844|3737386|FG000|Overall Study|Adverse Event|0
2132493|NCT01052844|3737387|FG001|Overall Study|Adverse Event|1
2132494|NCT01053247|3737548|FG000|Overall Study|Withdrawal by Subject|9
2132495|NCT01053247|3737549|FG001|Overall Study|Withdrawal by Subject|4
2132496|NCT01053247|3737550|FG002|Overall Study|Withdrawal by Subject|15
2132497|NCT01053247|3737548|FG000|Overall Study|Lack of Efficacy|1
2132498|NCT01053247|3737549|FG001|Overall Study|Lack of Efficacy|0
2132499|NCT01053247|3737550|FG002|Overall Study|Lack of Efficacy|1
2132500|NCT01053247|3737548|FG000|Overall Study|Protocol Violation|2
2132501|NCT01053247|3737549|FG001|Overall Study|Protocol Violation|1
2132502|NCT01053247|3737550|FG002|Overall Study|Protocol Violation|2
2132503|NCT01053247|3737548|FG000|Overall Study|Lost to Follow-up|8
2132504|NCT01053247|3737549|FG001|Overall Study|Lost to Follow-up|5
2285325|NCT02418845|3973429|FG000|Overall Study|Protocol Violation|1
2285326|NCT02418845|3973430|FG001|Overall Study|Protocol Violation|0
2285327|NCT02418845|3973429|FG000|Overall Study|Withdrawal by Subject|3
2285328|NCT02418845|3973430|FG001|Overall Study|Withdrawal by Subject|2
2285329|NCT02418910|3973436|FG000|Overall Study|Lost to Follow-up|3
2285330|NCT02418910|3973436|FG000|Overall Study|Withdrawal by Subject|4
2285331|NCT02418949|3973444|FG000|Overall Study|Withdrawal by Subject|1
2285332|NCT02418949|3973445|FG001|Overall Study|Withdrawal by Subject|0
2285333|NCT02418949|3973446|FG002|Overall Study|Withdrawal by Subject|1
2285334|NCT02418949|3973447|FG003|Overall Study|Withdrawal by Subject|1
2285335|NCT02418949|3973444|FG000|Overall Study|Lost to Follow-up|1
2285336|NCT02418949|3973445|FG001|Overall Study|Lost to Follow-up|0
2285337|NCT02418949|3973446|FG002|Overall Study|Lost to Follow-up|1
2285338|NCT02418949|3973447|FG003|Overall Study|Lost to Follow-up|0
2285339|NCT02418949|3973444|FG000|Overall Study|Physician Decision|1
2285340|NCT02418949|3973445|FG001|Overall Study|Physician Decision|1
2285341|NCT02418949|3973446|FG002|Overall Study|Physician Decision|1
2285342|NCT02418949|3973447|FG003|Overall Study|Physician Decision|0
2285343|NCT02419001|3973459|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
2285344|NCT02419001|3973460|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
2285345|NCT02419313|3973466|FG000|First Intervention|Lost to Follow-up|2
2285346|NCT02419313|3973467|FG001|First Intervention|Lost to Follow-up|0
2285347|NCT02419313|3973466|FG000|Second Intervention|Lost to Follow-up|1
2285348|NCT02419313|3973467|FG001|Second Intervention|Lost to Follow-up|0
2285349|NCT02419469|3973473|FG000|Overall Study|Withdrawal by Subject|1
2285350|NCT02419508|3973479|FG000|Overall Study|Adverse Event|9
2285351|NCT02419508|3973480|FG001|Overall Study|Adverse Event|3
2285352|NCT02419508|3973479|FG000|Overall Study|Withdrawal by Subject|1
2285353|NCT02419508|3973480|FG001|Overall Study|Withdrawal by Subject|0
2285354|NCT02419508|3973479|FG000|Overall Study|Other - Reason not specified|0
2285355|NCT02419508|3973480|FG001|Overall Study|Other - Reason not specified|1
2285356|NCT02419573|3973496|FG000|Overall Study|Lost to Follow-up|3
2285357|NCT02419573|3973497|FG001|Overall Study|Lost to Follow-up|0
2132505|NCT01053247|3737550|FG002|Overall Study|Lost to Follow-up|7
2132506|NCT01053247|3737548|FG000|Overall Study|Adverse Event|0
2132507|NCT01053247|3737549|FG001|Overall Study|Adverse Event|9
2132508|NCT01053247|3737550|FG002|Overall Study|Adverse Event|3
2132509|NCT01053429|3737576|FG000|Overall Study|Adverse Event|64
2206869|NCT01624259|3845612|FG001|Overall Study|Protocol Violation|2
2206870|NCT01624259|3845611|FG000|Overall Study|Withdrawal by Subject|5
2206871|NCT01624259|3845612|FG001|Overall Study|Withdrawal by Subject|7
2206872|NCT01624259|3845611|FG000|Overall Study|Physician Decision|1
2206873|NCT01624259|3845612|FG001|Overall Study|Physician Decision|1
2206874|NCT01624259|3845611|FG000|Overall Study|Lost to Follow-up|2
2206875|NCT01624259|3845612|FG001|Overall Study|Lost to Follow-up|3
2206876|NCT01624259|3845611|FG000|Overall Study|Abnormal laboratory measure|3
2132510|NCT01053429|3737576|FG000|Overall Study|Other|309
2132511|NCT01053663|3737592|FG000|Overall Study|Death|2
2132512|NCT01053663|3737592|FG000|Overall Study|Lost to Follow-up|1
2132513|NCT01053663|3737592|FG000|Overall Study|Poor IV Access|1
2132514|NCT01053663|3737592|FG000|Overall Study|Transferred to Another Hospital|1
2132515|NCT01053663|3737592|FG000|Overall Study|Negative Influenza Diagnosis|1
2132516|NCT01053741|3737604|FG000|2nd Study Intervention|Physician Decision|0
2132517|NCT01053741|3737605|FG001|2nd Study Intervention|Physician Decision|1
2132518|NCT01053962|3737631|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0
2132519|NCT01053962|3737632|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0
2132520|NCT01053962|3737633|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0
2132521|NCT01053962|3737634|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1
2132522|NCT01053962|3737635|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2
2132523|NCT01053962|3737631|FG000|Pretreatment Period|Venipuncture Failure|0
2132524|NCT01053962|3737632|FG001|Pretreatment Period|Venipuncture Failure|0
2132525|NCT01053962|3737633|FG002|Pretreatment Period|Venipuncture Failure|1
2132526|NCT01053962|3737634|FG003|Pretreatment Period|Venipuncture Failure|0
2132527|NCT01053962|3737635|FG004|Pretreatment Period|Venipuncture Failure|0
2132528|NCT01053962|3737631|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0
2132529|NCT01053962|3737632|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1
2132530|NCT01053962|3737633|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0
2132531|NCT01053962|3737634|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0
2132532|NCT01053962|3737635|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0
2132533|NCT01053962|3737631|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0
2132534|NCT01053962|3737632|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0
2132535|NCT01053962|3737633|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0
2132536|NCT01053962|3737634|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1
2132537|NCT01053962|3737635|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0
2132538|NCT01053962|3737631|FG000|Treatment Period|Lack of Efficacy|0
2132539|NCT01053962|3737632|FG001|Treatment Period|Lack of Efficacy|0
2132540|NCT01053962|3737633|FG002|Treatment Period|Lack of Efficacy|0
2132541|NCT01053962|3737634|FG003|Treatment Period|Lack of Efficacy|0
2132542|NCT01053962|3737635|FG004|Treatment Period|Lack of Efficacy|1
2132543|NCT01053962|3737631|FG000|Treatment Period|Adverse Event|0
2132544|NCT01053962|3737632|FG001|Treatment Period|Adverse Event|0
2132545|NCT01053962|3737633|FG002|Treatment Period|Adverse Event|0
2132546|NCT01053962|3737634|FG003|Treatment Period|Adverse Event|0
2132547|NCT01053962|3737635|FG004|Treatment Period|Adverse Event|1
2132548|NCT01053962|3737631|FG000|Treatment Period|Withdrawal by Subject|0
2132549|NCT01053962|3737632|FG001|Treatment Period|Withdrawal by Subject|0
2132550|NCT01053962|3737633|FG002|Treatment Period|Withdrawal by Subject|0
2132551|NCT01053962|3737634|FG003|Treatment Period|Withdrawal by Subject|0
2132552|NCT01053962|3737635|FG004|Treatment Period|Withdrawal by Subject|1
2132553|NCT01053962|3737631|FG000|Treatment Period|Noncompliance with protocol|1
2132554|NCT01053962|3737632|FG001|Treatment Period|Noncompliance with protocol|0
2132555|NCT01053962|3737633|FG002|Treatment Period|Noncompliance with protocol|0
2132556|NCT01053962|3737634|FG003|Treatment Period|Noncompliance with protocol|0
2132557|NCT01053962|3737635|FG004|Treatment Period|Noncompliance with protocol|0
2132558|NCT01053988|3737657|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
2132559|NCT01053988|3737658|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2132560|NCT01053988|3737659|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2132561|NCT01053988|3737660|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2132562|NCT01053988|3737661|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2132563|NCT01053988|3737662|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2132564|NCT01053988|3737657|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
2132565|NCT01053988|3737658|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2132566|NCT01053988|3737659|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2132567|NCT01053988|3737660|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2132568|NCT01053988|3737661|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2132569|NCT01053988|3737662|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2132570|NCT01053988|3737657|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
2132571|NCT01053988|3737658|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2132572|NCT01053988|3737659|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2132573|NCT01053988|3737660|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2132574|NCT01053988|3737661|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2132575|NCT01053988|3737662|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2132576|NCT01053988|3737657|FG000|2-week, Single-blind Run-In Period|Adverse Event|6
2132577|NCT01053988|3737658|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
2132578|NCT01053988|3737659|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
2132579|NCT01053988|3737660|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
2132580|NCT01053988|3737661|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
2132581|NCT01053988|3737662|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
2132582|NCT01053988|3737657|FG000|2-week, Single-blind Run-In Period|Physician Decision|5
2132583|NCT01053988|3737658|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
2285358|NCT02419573|3973496|FG000|Overall Study|Withdrawal by Subject|1
2132584|NCT01053988|3737659|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
2132585|NCT01053988|3737660|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
2132586|NCT01053988|3737661|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
2132587|NCT01053988|3737662|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
2132588|NCT01053988|3737657|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
2132589|NCT01053988|3737658|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2132590|NCT01053988|3737659|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2132591|NCT01053988|3737660|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2132592|NCT01053988|3737661|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2132593|NCT01053988|3737662|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2132594|NCT01053988|3737657|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
2132595|NCT01053988|3737658|FG001|24-week, Double-blind Treatment Period|Adverse Event|15
2132596|NCT01053988|3737659|FG002|24-week, Double-blind Treatment Period|Adverse Event|23
2132597|NCT01053988|3737660|FG003|24-week, Double-blind Treatment Period|Adverse Event|24
2132598|NCT01053988|3737661|FG004|24-week, Double-blind Treatment Period|Adverse Event|17
2132599|NCT01053988|3737662|FG005|24-week, Double-blind Treatment Period|Adverse Event|14
2132600|NCT01053988|3737657|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2132601|NCT01053988|3737658|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
2132602|NCT01053988|3737659|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
2132603|NCT01053988|3737660|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
2132604|NCT01053988|3737661|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
2132605|NCT01053988|3737662|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2132606|NCT01053988|3737657|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
2132607|NCT01053988|3737658|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
2285359|NCT02419573|3973497|FG001|Overall Study|Withdrawal by Subject|0
2285360|NCT02419612|3973505|FG000|Short-term Treatment Period|Adverse Event|1
2285361|NCT02419612|3973506|FG001|Short-term Treatment Period|Adverse Event|1
2285362|NCT02419612|3973505|FG000|Short-term Treatment Period|Death|0
2132608|NCT01053988|3737659|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
2132609|NCT01053988|3737660|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
2132610|NCT01053988|3737661|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
2132611|NCT01053988|3737662|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
2132612|NCT01053988|3737657|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
2132613|NCT01053988|3737658|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3
2132614|NCT01053988|3737659|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4
2132615|NCT01053988|3737660|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
2132616|NCT01053988|3737661|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
2132617|NCT01053988|3737662|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4
2132618|NCT01053988|3737657|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2132619|NCT01053988|3737658|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
2132620|NCT01053988|3737659|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
2132621|NCT01053988|3737660|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
2132622|NCT01053988|3737661|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
2132623|NCT01053988|3737662|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
2132624|NCT01053988|3737657|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2132625|NCT01053988|3737658|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4
2132626|NCT01053988|3737659|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2132627|NCT01053988|3737660|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2132628|NCT01053988|3737661|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2132629|NCT01053988|3737662|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3
2132630|NCT01053988|3737657|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
2132631|NCT01053988|3737658|FG001|24-week, Double-blind Treatment Period|Physician Decision|5
2132632|NCT01053988|3737659|FG002|24-week, Double-blind Treatment Period|Physician Decision|2
2132633|NCT01053988|3737660|FG003|24-week, Double-blind Treatment Period|Physician Decision|5
2132634|NCT01053988|3737661|FG004|24-week, Double-blind Treatment Period|Physician Decision|5
2132635|NCT01053988|3737662|FG005|24-week, Double-blind Treatment Period|Physician Decision|4
2132636|NCT01053988|3737657|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2132637|NCT01053988|3737658|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
2132638|NCT01053988|3737659|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2132639|NCT01053988|3737660|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
2132640|NCT01053988|3737661|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
2132641|NCT01053988|3737662|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2132642|NCT01054144|3737678|FG000|Overall Study|Death|2
2132643|NCT01054170|3737687|FG000|Overall Study|Protocol Violation|1
2132644|NCT01054170|3737688|FG001|Overall Study|Protocol Violation|0
2132645|NCT01054170|3737687|FG000|Overall Study|Withdrawal by Subject|3
2132646|NCT01054170|3737688|FG001|Overall Study|Withdrawal by Subject|2
2132647|NCT01054170|3737687|FG000|Overall Study|Adverse Event|0
2132648|NCT01054170|3737688|FG001|Overall Study|Adverse Event|4
2132649|NCT01054222|3737712|FG000|Overall Study|Lack of Efficacy|1
2132650|NCT01054222|3737712|FG000|Overall Study|Lost to Follow-up|4
2132651|NCT01054222|3737712|FG000|Overall Study|Withdrawal by Subject|6
2132652|NCT01054300|3737718|FG000|Period 1|Adverse Event|1
2132653|NCT01054300|3737719|FG001|Period 1|Adverse Event|0
2132654|NCT01054300|3737720|FG002|Period 1|Adverse Event|0
2132655|NCT01054300|3737721|FG003|Period 1|Adverse Event|0
2132656|NCT01054300|3737718|FG000|Period 2|Withdrawal by Subject|0
2132657|NCT01054300|3737719|FG001|Period 2|Withdrawal by Subject|0
2132658|NCT01054300|3737720|FG002|Period 2|Withdrawal by Subject|1
2132659|NCT01054300|3737721|FG003|Period 2|Withdrawal by Subject|0
2132660|NCT01054443|3737759|FG000|Overall Study|Withdrawal by Subject|0
2132661|NCT01054443|3737760|FG001|Overall Study|Withdrawal by Subject|0
2132662|NCT01054443|3737761|FG002|Overall Study|Withdrawal by Subject|0
2132663|NCT01054443|3737762|FG003|Overall Study|Withdrawal by Subject|1
2132664|NCT01054456|3737775|FG000|Overall Study|Other|1
2132665|NCT01054560|3737781|FG000|Overall Study|Death|10
2132666|NCT01054560|3737782|FG001|Overall Study|Death|21
2132667|NCT01054560|3737781|FG000|Overall Study|Lost to Follow-up|2
2132668|NCT01054560|3737782|FG001|Overall Study|Lost to Follow-up|5
2132669|NCT01054560|3737781|FG000|Overall Study|Withdrawal by Subject|0
2132670|NCT01054560|3737782|FG001|Overall Study|Withdrawal by Subject|2
2132671|NCT01054560|3737781|FG000|Overall Study|Physician Decision|1
2132672|NCT01054560|3737782|FG001|Overall Study|Physician Decision|0
2132673|NCT01054573|3737794|FG000|Overall Study|Adverse Event|1
2132674|NCT01054573|3737795|FG001|Overall Study|Adverse Event|0
2132675|NCT01054573|3737796|FG002|Overall Study|Adverse Event|1
2132676|NCT01054573|3737797|FG003|Overall Study|Adverse Event|1
2132677|NCT01054573|3737794|FG000|Overall Study|Lost to Follow-up|0
2132678|NCT01054573|3737795|FG001|Overall Study|Lost to Follow-up|2
2132679|NCT01054573|3737796|FG002|Overall Study|Lost to Follow-up|0
2132680|NCT01054573|3737797|FG003|Overall Study|Lost to Follow-up|0
2132681|NCT01054573|3737794|FG000|Overall Study|Withdrawal by Subject|0
2132682|NCT01054573|3737795|FG001|Overall Study|Withdrawal by Subject|2
2132683|NCT01054573|3737796|FG002|Overall Study|Withdrawal by Subject|2
2132684|NCT01054573|3737797|FG003|Overall Study|Withdrawal by Subject|1
2132685|NCT01054599|3737845|FG000|Overall Study|Dizziness due to phenytoin toxicity|1
2132686|NCT01054599|3737846|FG001|Overall Study|Dizziness due to phenytoin toxicity|0
2285363|NCT02419612|3973506|FG001|Short-term Treatment Period|Death|2
2285364|NCT02419612|3973505|FG000|Short-term Treatment Period|Lost to Follow-up|6
2285365|NCT02419612|3973506|FG001|Short-term Treatment Period|Lost to Follow-up|6
2285366|NCT02419612|3973505|FG000|Short-term Treatment Period|Withdrawal by Subject|9
2285367|NCT02419612|3973506|FG001|Short-term Treatment Period|Withdrawal by Subject|9
2285368|NCT02419612|3973505|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
2285369|NCT02419612|3973506|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
2285370|NCT02419612|3973505|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0
2285371|NCT02419612|3973506|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2
2285372|NCT02419612|3973505|FG000|Short-term Treatment Period|Worsening of liver function|0
2285373|NCT02419612|3973506|FG001|Short-term Treatment Period|Worsening of liver function|1
2285374|NCT02419612|3973505|FG000|Short-term Treatment Period|Subject moved out of state|0
2285375|NCT02419612|3973506|FG001|Short-term Treatment Period|Subject moved out of state|1
2285376|NCT02419612|3973505|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1
2285377|NCT02419612|3973506|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1
2285378|NCT02419612|3973505|FG000|Long-term Treatment Period|Lost to Follow-up|6
2285379|NCT02419612|3973506|FG001|Long-term Treatment Period|Lost to Follow-up|4
2285380|NCT02419612|3973505|FG000|Long-term Treatment Period|Lack of Efficacy|1
2285381|NCT02419612|3973506|FG001|Long-term Treatment Period|Lack of Efficacy|1
2285382|NCT02419612|3973505|FG000|Long-term Treatment Period|Death|0
2285383|NCT02419612|3973506|FG001|Long-term Treatment Period|Death|1
2285384|NCT02419612|3973505|FG000|Long-term Treatment Period|Adverse Event|0
2285385|NCT02419612|3973506|FG001|Long-term Treatment Period|Adverse Event|5
2285386|NCT02419612|3973505|FG000|Long-term Treatment Period|Other|4
2285387|NCT02419612|3973506|FG001|Long-term Treatment Period|Other|4
2285388|NCT02419612|3973505|FG000|Long-term Treatment Period|Subject Decision|2
2285389|NCT02419612|3973506|FG001|Long-term Treatment Period|Subject Decision|4
2285390|NCT02419612|3973505|FG000|Long-term Treatment Period|Withdrawal by Subject|8
2285391|NCT02419612|3973506|FG001|Long-term Treatment Period|Withdrawal by Subject|2
2285392|NCT02419755|3973523|FG000|Overall Study|Death|1
2285393|NCT02419755|3973524|FG001|Overall Study|Death|3
2285394|NCT02419755|3973523|FG000|Overall Study|Relapse|0
2285395|NCT02419755|3973524|FG001|Overall Study|Relapse|1
2285396|NCT02419755|3973523|FG000|Overall Study|Ineligible|1
2285397|NCT02419755|3973524|FG001|Overall Study|Ineligible|0
2285398|NCT02419755|3973523|FG000|Overall Study|Withdrawal by Subject|1
2132687|NCT01054599|3737845|FG000|Overall Study|Protocol Violation|1
2132688|NCT01054599|3737846|FG001|Overall Study|Protocol Violation|0
2132689|NCT01054599|3737845|FG000|Overall Study|Spells/seizure-like episodes|1
2132690|NCT01054599|3737846|FG001|Overall Study|Spells/seizure-like episodes|1
2132691|NCT01054599|3737845|FG000|Overall Study|Timing/scheduling difficulties|1
2180157|NCT01399190|3806115|FG000|Overall Study|Physician Decision|2
2132692|NCT01054599|3737846|FG001|Overall Study|Timing/scheduling difficulties|1
2132693|NCT01054599|3737845|FG000|Overall Study|Visual impairment, WTAR <80|0
2132694|NCT01054599|3737846|FG001|Overall Study|Visual impairment, WTAR <80|1
2132695|NCT01054599|3737845|FG000|Overall Study|Lost to Follow-up|0
2132696|NCT01054599|3737846|FG001|Overall Study|Lost to Follow-up|2
2132697|NCT01054599|3737845|FG000|Overall Study|Adverse Event|0
2132698|NCT01054599|3737846|FG001|Overall Study|Adverse Event|1
2132699|NCT01054599|3737845|FG000|Overall Study|Withdrawal by Subject|0
2132700|NCT01054599|3737846|FG001|Overall Study|Withdrawal by Subject|1
2132701|NCT01054729|3737873|FG000|Overall Study|Randomized but Not Treated|0
2132702|NCT01054729|3737874|FG001|Overall Study|Randomized but Not Treated|1
2132703|NCT01054729|3737875|FG002|Overall Study|Randomized but Not Treated|0
2132704|NCT01054729|3737876|FG003|Overall Study|Randomized but Not Treated|0
2132705|NCT01054729|3737873|FG000|Overall Study|Adverse Event|1
2132706|NCT01054729|3737874|FG001|Overall Study|Adverse Event|1
2132707|NCT01054729|3737875|FG002|Overall Study|Adverse Event|2
2206877|NCT01624259|3845612|FG001|Overall Study|Abnormal laboratory measure|0
2206878|NCT01624467|3845644|FG000|Overall Study|Withdrawal by Subject|2
2206879|NCT01624467|3845644|FG000|Overall Study|Lost to Follow-up|1
2206880|NCT01624467|3845644|FG000|Overall Study|Adverse Event|7
2206881|NCT01624467|3845644|FG000|Overall Study|Progressive Disease|19
2206882|NCT01624467|3845644|FG000|Overall Study|Per Sponsor Requirement|1
2206883|NCT01624467|3845644|FG000|Overall Study|Subject Withdrew from Treatment|1
2206884|NCT01624506|3845652|FG000|Overall Study|Lost to Follow-up|29
2206885|NCT01624506|3845653|FG001|Overall Study|Lost to Follow-up|15
2206886|NCT01624506|3845652|FG000|Overall Study|Withdrawal by Subject|9
2206887|NCT01624506|3845653|FG001|Overall Study|Withdrawal by Subject|2
2206888|NCT01624506|3845652|FG000|Overall Study|Death|1
2206889|NCT01624506|3845653|FG001|Overall Study|Death|0
2206890|NCT01624506|3845652|FG000|Overall Study|LINX explants|23
2206891|NCT01624506|3845653|FG001|Overall Study|LINX explants|0
2206892|NCT01624506|3845652|FG000|Overall Study|Adverse Event|3
2206893|NCT01624506|3845653|FG001|Overall Study|Adverse Event|0
2206894|NCT01624662|3845663|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
2132708|NCT01054729|3737876|FG003|Overall Study|Adverse Event|1
2132709|NCT01054729|3737873|FG000|Overall Study|Withdrawal by Subject|1
2132710|NCT01054729|3737874|FG001|Overall Study|Withdrawal by Subject|0
2132711|NCT01054729|3737875|FG002|Overall Study|Withdrawal by Subject|1
2132712|NCT01054729|3737876|FG003|Overall Study|Withdrawal by Subject|0
2132713|NCT01054729|3737873|FG000|Overall Study|Lost to Follow-up|0
2132714|NCT01054729|3737874|FG001|Overall Study|Lost to Follow-up|1
2132715|NCT01054729|3737875|FG002|Overall Study|Lost to Follow-up|0
2132716|NCT01054729|3737876|FG003|Overall Study|Lost to Follow-up|0
2132717|NCT01054729|3737873|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0
2132718|NCT01054729|3737874|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1
2132719|NCT01054729|3737875|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0
2132720|NCT01054729|3737876|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0
2132721|NCT01054729|3737873|FG000|Overall Study|Non-responder|1
2132722|NCT01054729|3737874|FG001|Overall Study|Non-responder|0
2132723|NCT01054729|3737875|FG002|Overall Study|Non-responder|1
2132724|NCT01054729|3737876|FG003|Overall Study|Non-responder|1
2132725|NCT01054729|3737873|FG000|Overall Study|PEG/RBV Non-responder|1
2132726|NCT01054729|3737874|FG001|Overall Study|PEG/RBV Non-responder|0
2132727|NCT01054729|3737875|FG002|Overall Study|PEG/RBV Non-responder|1
2132728|NCT01054729|3737876|FG003|Overall Study|PEG/RBV Non-responder|0
2132729|NCT01054729|3737873|FG000|Overall Study|Personal/Obligations|0
2132730|NCT01054729|3737874|FG001|Overall Study|Personal/Obligations|1
2132731|NCT01054729|3737875|FG002|Overall Study|Personal/Obligations|0
2132732|NCT01054729|3737876|FG003|Overall Study|Personal/Obligations|0
2132733|NCT01054729|3737873|FG000|Overall Study|Subject moved|0
2132734|NCT01054729|3737874|FG001|Overall Study|Subject moved|0
2132735|NCT01054729|3737875|FG002|Overall Study|Subject moved|1
2132736|NCT01054729|3737876|FG003|Overall Study|Subject moved|0
2132737|NCT01054729|3737873|FG000|Overall Study|Lack of Efficacy|0
2132738|NCT01054729|3737874|FG001|Overall Study|Lack of Efficacy|0
2132739|NCT01054729|3737875|FG002|Overall Study|Lack of Efficacy|0
2132740|NCT01054729|3737876|FG003|Overall Study|Lack of Efficacy|1
2132741|NCT01054820|3737899|FG000|Overall Study|Withdrawal by Subject|2
2132742|NCT01054846|3737905|FG000|Overall Study|Lost to Follow-up|76
2132743|NCT01054846|3737906|FG001|Overall Study|Lost to Follow-up|17
2132744|NCT01054885|3737917|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
2132745|NCT01054885|3737918|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2132746|NCT01054885|3737919|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2132747|NCT01054885|3737920|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2132748|NCT01054885|3737921|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2132749|NCT01054885|3737922|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2132750|NCT01054885|3737923|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2206895|NCT01624662|3845664|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
2206896|NCT01624662|3845665|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
2206897|NCT01624662|3845666|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
2132751|NCT01054885|3737917|FG000|2-week, Single-blind Run-In Period|Physician Decision|6
2132752|NCT01054885|3737918|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
2132753|NCT01054885|3737919|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
2132754|NCT01054885|3737920|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
2132755|NCT01054885|3737921|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
2132756|NCT01054885|3737922|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
2132757|NCT01054885|3737923|FG006|2-week, Single-blind Run-In Period|Physician Decision|0
2132758|NCT01054885|3737917|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
2132759|NCT01054885|3737918|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2132760|NCT01054885|3737919|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2132761|NCT01054885|3737920|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2132762|NCT01054885|3737921|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2132763|NCT01054885|3737922|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2132764|NCT01054885|3737923|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2132765|NCT01054885|3737917|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
2132766|NCT01054885|3737918|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2132767|NCT01054885|3737919|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2132768|NCT01054885|3737920|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2132769|NCT01054885|3737921|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2132770|NCT01054885|3737922|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2132771|NCT01054885|3737923|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2132772|NCT01054885|3737917|FG000|2-week, Single-blind Run-In Period|Adverse Event|7
2132773|NCT01054885|3737918|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
2132774|NCT01054885|3737919|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
2132775|NCT01054885|3737920|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
2132776|NCT01054885|3737921|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
2132777|NCT01054885|3737922|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
2132778|NCT01054885|3737923|FG006|2-week, Single-blind Run-In Period|Adverse Event|0
2132779|NCT01054885|3737917|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
2132780|NCT01054885|3737918|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2132781|NCT01054885|3737919|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2132782|NCT01054885|3737920|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2132783|NCT01054885|3737921|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2132784|NCT01054885|3737922|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2132785|NCT01054885|3737923|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2132786|NCT01054885|3737917|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
2132787|NCT01054885|3737918|FG001|24-week, Double-blind Treatment Period|Adverse Event|18
2132788|NCT01054885|3737919|FG002|24-week, Double-blind Treatment Period|Adverse Event|12
2132789|NCT01054885|3737920|FG003|24-week, Double-blind Treatment Period|Adverse Event|15
2132790|NCT01054885|3737921|FG004|24-week, Double-blind Treatment Period|Adverse Event|15
2132791|NCT01054885|3737922|FG005|24-week, Double-blind Treatment Period|Adverse Event|17
2132792|NCT01054885|3737923|FG006|24-week, Double-blind Treatment Period|Adverse Event|19
2132793|NCT01054885|3737917|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2132794|NCT01054885|3737918|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2132795|NCT01054885|3737919|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
2132796|NCT01054885|3737920|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
2132797|NCT01054885|3737921|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2132798|NCT01054885|3737922|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
2132799|NCT01054885|3737923|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2132800|NCT01054885|3737917|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
2132801|NCT01054885|3737918|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
2132802|NCT01054885|3737919|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
2132803|NCT01054885|3737920|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
2132804|NCT01054885|3737921|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
2132805|NCT01054885|3737922|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
2132806|NCT01054885|3737923|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
2132807|NCT01054885|3737917|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
2132808|NCT01054885|3737918|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7
2132809|NCT01054885|3737919|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7
2132810|NCT01054885|3737920|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
2132811|NCT01054885|3737921|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3
2132812|NCT01054885|3737922|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8
2132813|NCT01054885|3737923|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4
2132814|NCT01054885|3737917|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
2132815|NCT01054885|3737918|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
2132816|NCT01054885|3737919|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
2180158|NCT01399372|3806136|FG000|Overall Study|Protocol Violation|3
2132817|NCT01054885|3737920|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
2132818|NCT01054885|3737921|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
2132819|NCT01054885|3737922|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
2132820|NCT01054885|3737923|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
2132821|NCT01054885|3737917|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2132822|NCT01054885|3737918|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2132823|NCT01054885|3737919|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
2132824|NCT01054885|3737920|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2132825|NCT01054885|3737921|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2132826|NCT01054885|3737922|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2206898|NCT01624662|3845663|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
2132827|NCT01054885|3737923|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
2132828|NCT01054885|3737917|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2132829|NCT01054885|3737918|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
2132830|NCT01054885|3737919|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2206899|NCT01624662|3845664|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
2206900|NCT01624662|3845665|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
2206901|NCT01624662|3845666|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
2206902|NCT01624662|3845663|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2206903|NCT01624662|3845664|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
2206904|NCT01624662|3845665|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2206905|NCT01624662|3845666|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2206906|NCT01624662|3845663|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
2206907|NCT01624662|3845664|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
2206908|NCT01624662|3845665|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
2206909|NCT01624662|3845666|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
2206910|NCT01624662|3845663|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2206911|NCT01624662|3845664|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2206912|NCT01624662|3845665|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
2206913|NCT01624662|3845666|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2206914|NCT01624662|3845663|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2206915|NCT01624662|3845664|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
2206916|NCT01624662|3845665|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2206917|NCT01624662|3845666|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2285399|NCT02419755|3973524|FG001|Overall Study|Withdrawal by Subject|0
2285400|NCT02419807|3973530|FG000|Overall Study|Withdrawal by Subject|4
2285401|NCT02419807|3973530|FG000|Overall Study|Physician Decision|1
2132831|NCT01054885|3737920|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2132832|NCT01054885|3737921|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2132833|NCT01054885|3737922|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2132834|NCT01054885|3737923|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2132835|NCT01054885|3737917|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
2132836|NCT01054885|3737918|FG001|24-week, Double-blind Treatment Period|Physician Decision|4
2132837|NCT01054885|3737919|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
2132838|NCT01054885|3737920|FG003|24-week, Double-blind Treatment Period|Physician Decision|6
2132839|NCT01054885|3737921|FG004|24-week, Double-blind Treatment Period|Physician Decision|3
2132840|NCT01054885|3737922|FG005|24-week, Double-blind Treatment Period|Physician Decision|1
2132841|NCT01054885|3737923|FG006|24-week, Double-blind Treatment Period|Physician Decision|1
2132842|NCT01054885|3737917|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2132843|NCT01054885|3737918|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
2132844|NCT01054885|3737919|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2132845|NCT01054885|3737920|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
2132846|NCT01054885|3737921|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
2132847|NCT01054885|3737922|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2132848|NCT01054885|3737923|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
2132849|NCT01054976|3737944|FG000|Overall Study|Adverse Event|16
2132850|NCT01054976|3737944|FG000|Overall Study|Uncooperative participations to study|7
2132851|NCT01054976|3737944|FG000|Overall Study|Withdrawal by Subject|4
2132852|NCT01054976|3737944|FG000|Overall Study|Other|8
2132853|NCT01055028|3737950|FG000|Screening|Screen Failure|1
2285402|NCT02419807|3973530|FG000|Overall Study|Protocol Violation|5
2285403|NCT02419937|3973540|FG000|Overall Study|Lost to Follow-up|1
2285404|NCT02419937|3973541|FG001|Overall Study|Lost to Follow-up|0
2320908|NCT02953678|4035191|FG000|Overall Study|Physician Decision|23
2320909|NCT02953678|4035191|FG000|Overall Study|Progressive Disease of GVHD|7
2320910|NCT02953678|4035191|FG000|Overall Study|Relapse of Underlying Malignancy|3
2320911|NCT02953678|4035191|FG000|Overall Study|Withdrawal by participant|3
2320912|NCT02953678|4035191|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5
2320913|NCT02953678|4035191|FG000|Overall Study|Participants were transferred to commercial product.|3
2132854|NCT01055028|3737951|FG001|Screening|Screen Failure|1
2132855|NCT01055028|3737950|FG000|Treatment Cycles 1 to 3|Adverse Event|0
2132856|NCT01055028|3737951|FG001|Treatment Cycles 1 to 3|Adverse Event|1
2132857|NCT01055028|3737950|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
2132858|NCT01055028|3737951|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
2132859|NCT01055028|3737950|FG000|Inter-treatment Period|Did not start Cycle 4|0
2132860|NCT01055028|3737951|FG001|Inter-treatment Period|Did not start Cycle 4|3
2285405|NCT02420093|3973567|FG000|Overall Study|Withdrawal by Subject|1
2285406|NCT02420093|3973568|FG001|Overall Study|Withdrawal by Subject|1
2285407|NCT02420223|3973580|FG000|Overall Study|Adverse Event|1
2285408|NCT02420223|3973581|FG001|Overall Study|Adverse Event|0
2285409|NCT02420223|3973580|FG000|Overall Study|Physician Decision|0
2285410|NCT02420223|3973581|FG001|Overall Study|Physician Decision|2
2285411|NCT02420262|3973589|FG000|Overall Study|Adverse Event|1
2285412|NCT02420262|3973590|FG001|Overall Study|Adverse Event|0
2285413|NCT02420262|3973589|FG000|Overall Study|Withdrawal by Subject|1
2285414|NCT02420262|3973590|FG001|Overall Study|Withdrawal by Subject|4
2285415|NCT02420262|3973589|FG000|Overall Study|Unclassified|0
2285416|NCT02420262|3973590|FG001|Overall Study|Unclassified|1
2285417|NCT02420327|3973596|FG000|Overall Study|Adverse Event|7
2285418|NCT02420327|3973596|FG000|Overall Study|Pregnancy|1
2285419|NCT02420327|3973596|FG000|Overall Study|Withdrawal by Subject|6
2285420|NCT02420327|3973596|FG000|Overall Study|Lost to Follow-up|1
2285421|NCT02420327|3973596|FG000|Overall Study|Protocol Violation|1
2285422|NCT02420353|3973608|FG000|Overall Study|Withdrawal by Subject|0
2132861|NCT01055132|3737967|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
2132862|NCT01055132|3737968|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
2132863|NCT01055132|3737967|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
2132864|NCT01055132|3737968|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
2132865|NCT01055197|3737993|FG000|Overall Study|Protocol Violation|7
2132866|NCT01055197|3737994|FG001|Overall Study|Protocol Violation|2
2132867|NCT01055197|3737993|FG000|Overall Study|Withdrawal by Subject|2
2132868|NCT01055197|3737994|FG001|Overall Study|Withdrawal by Subject|0
2132869|NCT01055262|3738013|FG000|Overall Study|Adverse Event|5
2132870|NCT01055262|3738013|FG000|Overall Study|Protocol Violation|3
2132871|NCT01055262|3738013|FG000|Overall Study|Uncooperativeness|1
2132872|NCT01055314|3738019|FG000|Overall Study|Adverse Event|7
2132873|NCT01055314|3738020|FG001|Overall Study|Adverse Event|4
2132874|NCT01055314|3738019|FG000|Overall Study|Death|2
2132875|NCT01055314|3738020|FG001|Overall Study|Death|1
2132876|NCT01055314|3738019|FG000|Overall Study|Lack of Efficacy|11
2132877|NCT01055314|3738020|FG001|Overall Study|Lack of Efficacy|19
2132878|NCT01055314|3738019|FG000|Overall Study|Physician Decision|10
2132879|NCT01055314|3738020|FG001|Overall Study|Physician Decision|5
2132880|NCT01055314|3738019|FG000|Overall Study|Withdrawal by Subject|1
2132881|NCT01055314|3738020|FG001|Overall Study|Withdrawal by Subject|0
2132882|NCT01055314|3738019|FG000|Overall Study|Ineligible|3
2132883|NCT01055314|3738020|FG001|Overall Study|Ineligible|5
2132884|NCT01055314|3738019|FG000|Overall Study|Refusal of further protocol therapy|10
2132885|NCT01055314|3738020|FG001|Overall Study|Refusal of further protocol therapy|4
2132886|NCT01055314|3738019|FG000|Overall Study|No treatment|1
2132887|NCT01055314|3738020|FG001|Overall Study|No treatment|0
2132888|NCT01055457|3738037|FG000|Overall Study|Lost to Follow-up|0
2132889|NCT01055457|3738038|FG001|Overall Study|Lost to Follow-up|1
2132890|NCT01055457|3738039|FG002|Overall Study|Lost to Follow-up|0
2132891|NCT01055457|3738040|FG003|Overall Study|Lost to Follow-up|0
2132892|NCT01055457|3738041|FG004|Overall Study|Lost to Follow-up|0
2132893|NCT01055457|3738042|FG005|Overall Study|Lost to Follow-up|1
2132894|NCT01055457|3738043|FG006|Overall Study|Lost to Follow-up|0
2132895|NCT01055457|3738044|FG007|Overall Study|Lost to Follow-up|0
2132896|NCT01055457|3738045|FG008|Overall Study|Lost to Follow-up|0
2132897|NCT01055457|3738046|FG009|Overall Study|Lost to Follow-up|0
2132898|NCT01055457|3738037|FG000|Overall Study|Protocol Violation|0
2206918|NCT01624662|3845663|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2206919|NCT01624662|3845664|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2206920|NCT01624662|3845665|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
2206921|NCT01624662|3845666|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2206922|NCT01624870|3845687|FG000|Overall Study|Death|19
2206923|NCT01624870|3845687|FG000|Overall Study|Withdrawal by Subject|1
2206924|NCT01624870|3845687|FG000|Overall Study|CoreValve not implanted|6
2132899|NCT01055457|3738038|FG001|Overall Study|Protocol Violation|0
2132900|NCT01055457|3738039|FG002|Overall Study|Protocol Violation|1
2132901|NCT01055457|3738040|FG003|Overall Study|Protocol Violation|1
2132902|NCT01055457|3738041|FG004|Overall Study|Protocol Violation|1
2132903|NCT01055457|3738042|FG005|Overall Study|Protocol Violation|2
2132904|NCT01055457|3738043|FG006|Overall Study|Protocol Violation|1
2132905|NCT01055457|3738044|FG007|Overall Study|Protocol Violation|0
2206925|NCT01624870|3845687|FG000|Overall Study|Lost to follow up|1
2206926|NCT01624974|3845718|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
2285423|NCT02420353|3973609|FG001|Overall Study|Withdrawal by Subject|1
2285424|NCT02420379|3973617|FG000|Overall Study|Withdrawal by Subject|0
2285425|NCT02420379|3973618|FG001|Overall Study|Withdrawal by Subject|3
2285426|NCT02420379|3973617|FG000|Overall Study|Unable to complete due to schooling|0
2206927|NCT01624974|3845719|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
2206928|NCT01624974|3845718|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
2206929|NCT01624974|3845719|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
2206930|NCT01624974|3845718|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5
2206931|NCT01624974|3845719|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3
2206932|NCT01624974|3845718|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1
2206933|NCT01624974|3845719|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0
2206934|NCT01624974|3845718|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0
2206935|NCT01624974|3845719|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1
2206936|NCT01624974|3845718|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1
2206937|NCT01624974|3845719|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1
2206938|NCT01624974|3845718|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
2132906|NCT01055457|3738045|FG008|Overall Study|Protocol Violation|0
2132907|NCT01055457|3738046|FG009|Overall Study|Protocol Violation|1
2132908|NCT01055457|3738037|FG000|Overall Study|Subject Disinterest|0
2132909|NCT01055457|3738038|FG001|Overall Study|Subject Disinterest|0
2132910|NCT01055457|3738039|FG002|Overall Study|Subject Disinterest|0
2132911|NCT01055457|3738040|FG003|Overall Study|Subject Disinterest|0
2132912|NCT01055457|3738041|FG004|Overall Study|Subject Disinterest|0
2132913|NCT01055457|3738042|FG005|Overall Study|Subject Disinterest|0
2132914|NCT01055457|3738043|FG006|Overall Study|Subject Disinterest|0
2132915|NCT01055457|3738044|FG007|Overall Study|Subject Disinterest|1
2132916|NCT01055457|3738045|FG008|Overall Study|Subject Disinterest|0
2132917|NCT01055457|3738046|FG009|Overall Study|Subject Disinterest|0
2132918|NCT01055457|3738037|FG000|Overall Study|Subject Ineligible|1
2132919|NCT01055457|3738038|FG001|Overall Study|Subject Ineligible|0
2132920|NCT01055457|3738039|FG002|Overall Study|Subject Ineligible|1
2132921|NCT01055457|3738040|FG003|Overall Study|Subject Ineligible|0
2132922|NCT01055457|3738041|FG004|Overall Study|Subject Ineligible|1
2132923|NCT01055457|3738042|FG005|Overall Study|Subject Ineligible|0
2132924|NCT01055457|3738043|FG006|Overall Study|Subject Ineligible|0
2132925|NCT01055457|3738044|FG007|Overall Study|Subject Ineligible|0
2132926|NCT01055457|3738045|FG008|Overall Study|Subject Ineligible|0
2132927|NCT01055457|3738046|FG009|Overall Study|Subject Ineligible|0
2132928|NCT01055457|3738037|FG000|Overall Study|Discomfort|0
2132929|NCT01055457|3738038|FG001|Overall Study|Discomfort|0
2132930|NCT01055457|3738039|FG002|Overall Study|Discomfort|0
2132931|NCT01055457|3738040|FG003|Overall Study|Discomfort|0
2132932|NCT01055457|3738041|FG004|Overall Study|Discomfort|1
2132933|NCT01055457|3738042|FG005|Overall Study|Discomfort|0
2132934|NCT01055457|3738043|FG006|Overall Study|Discomfort|0
2132935|NCT01055457|3738044|FG007|Overall Study|Discomfort|0
2132936|NCT01055457|3738045|FG008|Overall Study|Discomfort|0
2132937|NCT01055457|3738046|FG009|Overall Study|Discomfort|0
2132938|NCT01055457|3738037|FG000|Overall Study|Pregnancy|0
2132939|NCT01055457|3738038|FG001|Overall Study|Pregnancy|0
2132940|NCT01055457|3738039|FG002|Overall Study|Pregnancy|0
2132941|NCT01055457|3738040|FG003|Overall Study|Pregnancy|1
2132942|NCT01055457|3738041|FG004|Overall Study|Pregnancy|0
2132943|NCT01055457|3738042|FG005|Overall Study|Pregnancy|0
2132944|NCT01055457|3738043|FG006|Overall Study|Pregnancy|0
2132945|NCT01055457|3738044|FG007|Overall Study|Pregnancy|0
2132946|NCT01055457|3738045|FG008|Overall Study|Pregnancy|0
2132947|NCT01055457|3738046|FG009|Overall Study|Pregnancy|0
2132948|NCT01055457|3738037|FG000|Overall Study|Adverse Event|0
2132949|NCT01055457|3738038|FG001|Overall Study|Adverse Event|0
2132950|NCT01055457|3738039|FG002|Overall Study|Adverse Event|0
2132951|NCT01055457|3738040|FG003|Overall Study|Adverse Event|1
2132952|NCT01055457|3738041|FG004|Overall Study|Adverse Event|0
2132953|NCT01055457|3738042|FG005|Overall Study|Adverse Event|0
2132954|NCT01055457|3738043|FG006|Overall Study|Adverse Event|0
2132955|NCT01055457|3738044|FG007|Overall Study|Adverse Event|0
2132956|NCT01055457|3738045|FG008|Overall Study|Adverse Event|0
2132957|NCT01055457|3738046|FG009|Overall Study|Adverse Event|0
2132958|NCT01055496|3738070|FG000|Overall Study|Withdrawal by Subject|2
2132959|NCT01055496|3738071|FG001|Overall Study|Withdrawal by Subject|4
2132960|NCT01055496|3738070|FG000|Overall Study|Death|13
2132961|NCT01055496|3738071|FG001|Overall Study|Death|23
2132962|NCT01055496|3738070|FG000|Overall Study|Lost to Follow-up|0
2132963|NCT01055496|3738071|FG001|Overall Study|Lost to Follow-up|2
2132964|NCT01055496|3738070|FG000|Overall Study|Other - Unspecified|0
2132965|NCT01055496|3738071|FG001|Overall Study|Other - Unspecified|1
2132966|NCT01055613|3738100|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
2132967|NCT01055613|3738101|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
2132968|NCT01055613|3738100|FG000|Overall Study|Unacceptable lens fit|1
2132969|NCT01055613|3738101|FG001|Overall Study|Unacceptable lens fit|0
2132970|NCT01055613|3738100|FG000|Overall Study|Discomfort|2
2132971|NCT01055613|3738101|FG001|Overall Study|Discomfort|1
2132972|NCT01055613|3738100|FG000|Overall Study|Lost to Follow-up|1
2132973|NCT01055613|3738101|FG001|Overall Study|Lost to Follow-up|1
2132974|NCT01055613|3738100|FG000|Overall Study|Protocol Violation|1
2132975|NCT01055613|3738101|FG001|Overall Study|Protocol Violation|1
2132976|NCT01055613|3738100|FG000|Overall Study|Subject Disinterest|1
2132977|NCT01055613|3738101|FG001|Overall Study|Subject Disinterest|1
2132978|NCT01055639|3738109|FG000|Overall Study|Adverse Event|0
2132979|NCT01055639|3738110|FG001|Overall Study|Adverse Event|1
2132980|NCT01055639|3738109|FG000|Overall Study|Lack of Efficacy|0
2132981|NCT01055639|3738110|FG001|Overall Study|Lack of Efficacy|1
2132982|NCT01055639|3738109|FG000|Overall Study|Lost to Follow-up|8
2132983|NCT01055639|3738110|FG001|Overall Study|Lost to Follow-up|11
2132984|NCT01055639|3738109|FG000|Overall Study|Protocol Violation|5
2132985|NCT01055639|3738110|FG001|Overall Study|Protocol Violation|5
2132986|NCT01055639|3738109|FG000|Overall Study|Withdrawal by Subject|8
2132987|NCT01055639|3738110|FG001|Overall Study|Withdrawal by Subject|11
2132988|NCT01055834|3738154|FG000|Treatment Period I|Adverse Event|1
2132989|NCT01055834|3738155|FG001|Treatment Period I|Adverse Event|0
2132990|NCT01055886|3738166|FG000|Overall Study|Withdrawal by Subject|4
2132991|NCT01055886|3738167|FG001|Overall Study|Withdrawal by Subject|9
2132992|NCT01055886|3738166|FG000|Overall Study|Lost to Follow-up|1
2132993|NCT01055886|3738167|FG001|Overall Study|Lost to Follow-up|1
2132994|NCT01055886|3738166|FG000|Overall Study|Withdrawal by PI|0
2132995|NCT01055886|3738167|FG001|Overall Study|Withdrawal by PI|1
2132996|NCT01056107|3738186|FG000|Overall Study|Withdrawal by Subject|0
2132997|NCT01056107|3738187|FG001|Overall Study|Withdrawal by Subject|1
2132998|NCT01056107|3738188|FG002|Overall Study|Withdrawal by Subject|3
2132999|NCT01056107|3738189|FG003|Overall Study|Withdrawal by Subject|0
2133000|NCT01056263|3738210|FG000|Overall Study|Adverse Event|12
2133001|NCT01056263|3738210|FG000|Overall Study|Death|1
2133002|NCT01056263|3738210|FG000|Overall Study|Withdrawal by Subject|1
2133003|NCT01056263|3738210|FG000|Overall Study|Lack of Efficacy|29
2133004|NCT01056263|3738210|FG000|Overall Study|Progressive disease|2
2133005|NCT01056263|3738210|FG000|Overall Study|Neoplasm progression|1
2133006|NCT01056263|3738210|FG000|Overall Study|Objective progression or relapse|1
2133007|NCT01056263|3738210|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
2133008|NCT01056276|3738216|FG000|Treatment Period-Cycles 1-8|Toxicity|2
2133009|NCT01056276|3738217|FG001|Treatment Period-Cycles 1-8|Toxicity|1
2133010|NCT01056276|3738216|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
2133011|NCT01056276|3738217|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
2133012|NCT01056276|3738216|FG000|Treatment Period-Cycles 1-8|Disease Progression|2
2133013|NCT01056276|3738217|FG001|Treatment Period-Cycles 1-8|Disease Progression|2
2133014|NCT01056276|3738216|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1
2133015|NCT01056276|3738217|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2
2133016|NCT01056276|3738216|FG000|Treatment Period-Cycles 1-8|Physician Decision|3
2133017|NCT01056276|3738217|FG001|Treatment Period-Cycles 1-8|Physician Decision|0
2133018|NCT01056276|3738216|FG000|Treatment Period-Cycles 1-8|Death|3
2133019|NCT01056276|3738217|FG001|Treatment Period-Cycles 1-8|Death|1
2133020|NCT01056276|3738216|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1
2133021|NCT01056276|3738217|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0
2133022|NCT01056276|3738216|FG000|Maintenance Therapy|Toxicity|0
2133023|NCT01056276|3738217|FG001|Maintenance Therapy|Toxicity|2
2133024|NCT01056276|3738216|FG000|Maintenance Therapy|Progressive Disease|0
2133025|NCT01056276|3738217|FG001|Maintenance Therapy|Progressive Disease|9
2133026|NCT01056276|3738216|FG000|Maintenance Therapy|Physician Decision|0
2133027|NCT01056276|3738217|FG001|Maintenance Therapy|Physician Decision|1
2133028|NCT01056276|3738216|FG000|Maintenance Therapy|Withdrawal by Subject|0
2133029|NCT01056276|3738217|FG001|Maintenance Therapy|Withdrawal by Subject|1
2133030|NCT01056276|3738216|FG000|Maintenance Therapy|Intercurrent Illness|0
2133031|NCT01056276|3738217|FG001|Maintenance Therapy|Intercurrent Illness|1
2133032|NCT01056276|3738216|FG000|Maintenance Therapy|Continuing maintenance therapy|0
2133033|NCT01056276|3738217|FG001|Maintenance Therapy|Continuing maintenance therapy|14
2133034|NCT01056289|3738228|FG000|Open-label Phase|Adverse Event|29
2133035|NCT01056289|3738229|FG001|Open-label Phase|Adverse Event|0
2133036|NCT01056289|3738230|FG002|Open-label Phase|Adverse Event|0
2133037|NCT01056289|3738231|FG003|Open-label Phase|Adverse Event|0
2133038|NCT01056289|3738228|FG000|Open-label Phase|Lost to Follow-up|30
2133039|NCT01056289|3738229|FG001|Open-label Phase|Lost to Follow-up|0
2133040|NCT01056289|3738230|FG002|Open-label Phase|Lost to Follow-up|0
2133041|NCT01056289|3738231|FG003|Open-label Phase|Lost to Follow-up|0
2133042|NCT01056289|3738228|FG000|Open-label Phase|Other|9
2133043|NCT01056289|3738229|FG001|Open-label Phase|Other|0
2133044|NCT01056289|3738230|FG002|Open-label Phase|Other|0
2133045|NCT01056289|3738231|FG003|Open-label Phase|Other|0
2133046|NCT01056289|3738228|FG000|Open-label Phase|Protocol Violation|6
2133047|NCT01056289|3738229|FG001|Open-label Phase|Protocol Violation|0
2133048|NCT01056289|3738230|FG002|Open-label Phase|Protocol Violation|0
2133049|NCT01056289|3738231|FG003|Open-label Phase|Protocol Violation|0
2133050|NCT01056289|3738228|FG000|Open-label Phase|Withdrawal by Subject|26
2133051|NCT01056289|3738229|FG001|Open-label Phase|Withdrawal by Subject|0
2133052|NCT01056289|3738230|FG002|Open-label Phase|Withdrawal by Subject|0
2133053|NCT01056289|3738231|FG003|Open-label Phase|Withdrawal by Subject|0
2133054|NCT01056289|3738228|FG000|Open-label Phase|Lack of Efficacy|18
2133055|NCT01056289|3738229|FG001|Open-label Phase|Lack of Efficacy|0
2133056|NCT01056289|3738230|FG002|Open-label Phase|Lack of Efficacy|0
2133057|NCT01056289|3738231|FG003|Open-label Phase|Lack of Efficacy|0
2133058|NCT01056289|3738228|FG000|Open-label Phase|Not randomized to Double-blind phase|1
2133059|NCT01056289|3738229|FG001|Open-label Phase|Not randomized to Double-blind phase|0
2133060|NCT01056289|3738230|FG002|Open-label Phase|Not randomized to Double-blind phase|0
2133061|NCT01056289|3738231|FG003|Open-label Phase|Not randomized to Double-blind phase|0
2133062|NCT01056289|3738228|FG000|Double-blind Phase|Adverse Event|0
2133063|NCT01056289|3738229|FG001|Double-blind Phase|Adverse Event|1
2133064|NCT01056289|3738230|FG002|Double-blind Phase|Adverse Event|2
2133065|NCT01056289|3738231|FG003|Double-blind Phase|Adverse Event|1
2133066|NCT01056289|3738228|FG000|Double-blind Phase|Lost to Follow-up|0
2133067|NCT01056289|3738229|FG001|Double-blind Phase|Lost to Follow-up|2
2133068|NCT01056289|3738230|FG002|Double-blind Phase|Lost to Follow-up|2
2133069|NCT01056289|3738231|FG003|Double-blind Phase|Lost to Follow-up|2
2133070|NCT01056289|3738228|FG000|Double-blind Phase|Other|0
2133071|NCT01056289|3738229|FG001|Double-blind Phase|Other|0
2133072|NCT01056289|3738230|FG002|Double-blind Phase|Other|1
2133073|NCT01056289|3738231|FG003|Double-blind Phase|Other|2
2133074|NCT01056289|3738228|FG000|Double-blind Phase|Protocol Violation|0
2133075|NCT01056289|3738229|FG001|Double-blind Phase|Protocol Violation|0
2133076|NCT01056289|3738230|FG002|Double-blind Phase|Protocol Violation|1
2133077|NCT01056289|3738231|FG003|Double-blind Phase|Protocol Violation|1
2133078|NCT01056289|3738228|FG000|Double-blind Phase|Withdrawal by Subject|0
2133079|NCT01056289|3738229|FG001|Double-blind Phase|Withdrawal by Subject|0
2133080|NCT01056289|3738230|FG002|Double-blind Phase|Withdrawal by Subject|4
2133081|NCT01056289|3738231|FG003|Double-blind Phase|Withdrawal by Subject|2
2133082|NCT01056289|3738228|FG000|Double-blind Phase|Discontinuation symptom|0
2133083|NCT01056289|3738229|FG001|Double-blind Phase|Discontinuation symptom|1
2133084|NCT01056289|3738230|FG002|Double-blind Phase|Discontinuation symptom|2
2133085|NCT01056289|3738231|FG003|Double-blind Phase|Discontinuation symptom|2
2133086|NCT01056289|3738228|FG000|Double-blind Phase|Physician Decision|0
2133087|NCT01056289|3738229|FG001|Double-blind Phase|Physician Decision|0
2133088|NCT01056289|3738230|FG002|Double-blind Phase|Physician Decision|1
2133089|NCT01056289|3738231|FG003|Double-blind Phase|Physician Decision|0
2178242|NCT01381575|3802876|FG000|Overall Study|Migrated/moved from study area|2
2178243|NCT01381575|3802877|FG001|Overall Study|Migrated/moved from study area|12
2178244|NCT01381575|3802878|FG002|Overall Study|Migrated/moved from study area|2
2178245|NCT01381575|3802876|FG000|Overall Study|Lost to Follow-up|8
2178246|NCT01381575|3802877|FG001|Overall Study|Lost to Follow-up|17
2178247|NCT01381575|3802878|FG002|Overall Study|Lost to Follow-up|9
2178248|NCT01381692|3802889|FG000|Overall Study|Adverse Event|1
2178249|NCT01381692|3802890|FG001|Overall Study|Adverse Event|0
2178250|NCT01381692|3802891|FG002|Overall Study|Adverse Event|0
2178251|NCT01381692|3802892|FG003|Overall Study|Adverse Event|0
2178252|NCT01381692|3802893|FG004|Overall Study|Adverse Event|0
2178253|NCT01381692|3802894|FG005|Overall Study|Adverse Event|0
2178254|NCT01381718|3802904|FG000|Overall Study|Withdrawal by Subject|2
2178255|NCT01381718|3802905|FG001|Overall Study|Withdrawal by Subject|5
2178256|NCT01381718|3802904|FG000|Overall Study|Lost to Follow-up|3
2178257|NCT01381718|3802905|FG001|Overall Study|Lost to Follow-up|5
2178258|NCT01381718|3802904|FG000|Overall Study|Toxicity, side effects or complications related to study|0
2178259|NCT01381718|3802905|FG001|Overall Study|Toxicity, side effects or complications related to study|3
2178260|NCT01381874|3802918|FG000|Overall Study|Lost to Follow-up|1
2178261|NCT01381874|3802919|FG001|Overall Study|Lost to Follow-up|1
2178262|NCT01381874|3802920|FG002|Overall Study|Lost to Follow-up|0
2178263|NCT01381874|3802918|FG000|Overall Study|Withdrawal by Subject|9
2178264|NCT01381874|3802919|FG001|Overall Study|Withdrawal by Subject|10
2178265|NCT01381874|3802920|FG002|Overall Study|Withdrawal by Subject|9
2178266|NCT01381874|3802918|FG000|Overall Study|Other|67
2178267|NCT01381874|3802919|FG001|Overall Study|Other|52
2178268|NCT01381874|3802920|FG002|Overall Study|Other|67
2178269|NCT01381900|3802931|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2
2178270|NCT01381900|3802932|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0
2178271|NCT01381900|3802933|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0
2285427|NCT02420379|3973618|FG001|Overall Study|Unable to complete due to schooling|1
2285428|NCT02420379|3973617|FG000|Overall Study|Transitioned to commercial drug|1
2285429|NCT02420379|3973618|FG001|Overall Study|Transitioned to commercial drug|0
2285430|NCT02420691|3973628|FG000|Overall Study|Adverse Event|3
2285431|NCT02420691|3973628|FG000|Overall Study|Withdrawal by Subject|3
2285432|NCT02421120|3973676|FG000|Overall Study|Adverse Event|1
2285433|NCT02421172|3973699|FG000|Period 1|Adverse Event|1
2285434|NCT02421172|3973700|FG001|Period 1|Adverse Event|0
2285435|NCT02421172|3973701|FG002|Period 1|Adverse Event|0
2285436|NCT02421172|3973702|FG003|Period 1|Adverse Event|0
2285437|NCT02421172|3973703|FG004|Period 1|Adverse Event|0
2285438|NCT02421172|3973699|FG000|Period 1|Lost to Follow-up|3
2285439|NCT02421172|3973700|FG001|Period 1|Lost to Follow-up|1
2285440|NCT02421172|3973701|FG002|Period 1|Lost to Follow-up|0
2285441|NCT02421172|3973702|FG003|Period 1|Lost to Follow-up|0
2285442|NCT02421172|3973703|FG004|Period 1|Lost to Follow-up|0
2285443|NCT02421172|3973699|FG000|Period 1|Patient/guardian decision|0
2285444|NCT02421172|3973700|FG001|Period 1|Patient/guardian decision|1
2285445|NCT02421172|3973701|FG002|Period 1|Patient/guardian decision|0
2285446|NCT02421172|3973702|FG003|Period 1|Patient/guardian decision|0
2285447|NCT02421172|3973703|FG004|Period 1|Patient/guardian decision|0
2285448|NCT02421172|3973699|FG000|Period 2|Adverse Event|0
2285449|NCT02421172|3973700|FG001|Period 2|Adverse Event|0
2285450|NCT02421172|3973701|FG002|Period 2|Adverse Event|4
2285451|NCT02421172|3973702|FG003|Period 2|Adverse Event|0
2285452|NCT02421172|3973703|FG004|Period 2|Adverse Event|0
2285453|NCT02421172|3973699|FG000|Period 2|Lost to Follow-up|0
2133090|NCT01056341|3738263|FG000|Overall Study|Treatment Intolerance|0
2133091|NCT01056341|3738264|FG001|Overall Study|Treatment Intolerance|2
2133092|NCT01056341|3738265|FG002|Overall Study|Treatment Intolerance|0
2133093|NCT01056341|3738266|FG003|Overall Study|Treatment Intolerance|2
2133094|NCT01056341|3738267|FG004|Overall Study|Treatment Intolerance|0
2133095|NCT01056341|3738263|FG000|Overall Study|Lack of Efficacy|32
2133096|NCT01056341|3738264|FG001|Overall Study|Lack of Efficacy|30
2133097|NCT01056341|3738265|FG002|Overall Study|Lack of Efficacy|7
2133098|NCT01056341|3738266|FG003|Overall Study|Lack of Efficacy|25
2133099|NCT01056341|3738267|FG004|Overall Study|Lack of Efficacy|9
2133100|NCT01056341|3738263|FG000|Overall Study|Other reasons|4
2133101|NCT01056341|3738264|FG001|Overall Study|Other reasons|4
2133102|NCT01056341|3738265|FG002|Overall Study|Other reasons|8
2133103|NCT01056341|3738266|FG003|Overall Study|Other reasons|9
2133104|NCT01056341|3738267|FG004|Overall Study|Other reasons|5
2133105|NCT01056380|3738287|FG000|Overall Study|Lost to Follow-up|2
2133106|NCT01056380|3738288|FG001|Overall Study|Lost to Follow-up|3
2133107|NCT01056484|3738298|FG000|Randomized Controlled Trial|Withdrawal by Subject|6
2133108|NCT01056484|3738299|FG001|Randomized Controlled Trial|Withdrawal by Subject|1
2133109|NCT01056484|3738298|FG000|Randomized Controlled Trial|Physician Decision|1
2133110|NCT01056484|3738299|FG001|Randomized Controlled Trial|Physician Decision|0
2133111|NCT01056484|3738298|FG000|Follow up - Non-randomized|Withdrawal by Subject|0
2133112|NCT01056484|3738299|FG001|Follow up - Non-randomized|Withdrawal by Subject|2
2133113|NCT01056510|3738308|FG000|Overall Study|Dropout Before Start of Treatment|1
2133114|NCT01056510|3738309|FG001|Overall Study|Dropout Before Start of Treatment|1
2133115|NCT01056510|3738308|FG000|Overall Study|Withdrawal by Subject|4
2133116|NCT01056510|3738309|FG001|Overall Study|Withdrawal by Subject|2
2133117|NCT01056510|3738308|FG000|Overall Study|Death|29
2133118|NCT01056510|3738309|FG001|Overall Study|Death|34
2133119|NCT01056510|3738308|FG000|Overall Study|Noncompliance|1
2133120|NCT01056510|3738309|FG001|Overall Study|Noncompliance|3
2133121|NCT01056510|3738308|FG000|Overall Study|Physician Decision|4
2133122|NCT01056510|3738309|FG001|Overall Study|Physician Decision|5
2133123|NCT01056510|3738308|FG000|Overall Study|Lost to Follow-up|5
2133124|NCT01056510|3738309|FG001|Overall Study|Lost to Follow-up|6
2133125|NCT01056510|3738308|FG000|Overall Study|Other|10
2133126|NCT01056510|3738309|FG001|Overall Study|Other|12
2133127|NCT01056510|3738308|FG000|Overall Study|Missing|0
2133128|NCT01056510|3738309|FG001|Overall Study|Missing|1
2133129|NCT01056523|3738315|FG000|Overall Study|Death|1
2133130|NCT01056523|3738316|FG001|Overall Study|Death|0
2133131|NCT01056523|3738317|FG002|Overall Study|Death|2
2133132|NCT01056523|3738318|FG003|Overall Study|Death|3
2133133|NCT01056523|3738319|FG004|Overall Study|Death|0
2133134|NCT01056523|3738320|FG005|Overall Study|Death|0
2133135|NCT01056523|3738321|FG006|Overall Study|Death|1
2133136|NCT01056536|3738329|FG000|Overall Study|Lost to Follow-up|202
2133137|NCT01056536|3738330|FG001|Overall Study|Lost to Follow-up|116
2133138|NCT01056536|3738331|FG002|Overall Study|Lost to Follow-up|248
2133139|NCT01056640|3738345|FG000|Overall Study|Withdrawal by Subject|11
2133140|NCT01056640|3738346|FG001|Overall Study|Withdrawal by Subject|8
2133141|NCT01056640|3738345|FG000|Overall Study|Death|15
2133142|NCT01056640|3738346|FG001|Overall Study|Death|4
2133143|NCT01056653|3738355|FG000|Overall Study|Lost to Follow-up|0
2133144|NCT01056653|3738356|FG001|Overall Study|Lost to Follow-up|0
2133145|NCT01056653|3738357|FG002|Overall Study|Lost to Follow-up|2
2133146|NCT01056718|3738366|FG000|Overall Study|Withdrawal by Subject|2
2133147|NCT01056718|3738366|FG000|Overall Study|Ischemia on baseline stress test|1
2133148|NCT01056822|3738373|FG000|Overall Study|Adverse Event|0
2133149|NCT01056822|3738374|FG001|Overall Study|Adverse Event|1
2133150|NCT01056822|3738373|FG000|Overall Study|Protocol Violation|6
2133151|NCT01056822|3738374|FG001|Overall Study|Protocol Violation|5
2133152|NCT01056822|3738373|FG000|Overall Study|Withdrawal by Subject|1
2133153|NCT01056822|3738374|FG001|Overall Study|Withdrawal by Subject|1
2133154|NCT01056822|3738373|FG000|Overall Study|Lost to Follow-up|1
2133155|NCT01056822|3738374|FG001|Overall Study|Lost to Follow-up|0
2133156|NCT01057251|3738409|FG000|Overall Study|Did not meet InclusionExclusion criteria|4
2133157|NCT01057251|3738410|FG001|Overall Study|Did not meet InclusionExclusion criteria|2
2133158|NCT01057251|3738409|FG000|Overall Study|Adverse Event|4
2133159|NCT01057251|3738410|FG001|Overall Study|Adverse Event|2
2133160|NCT01057251|3738409|FG000|Overall Study|Lack of Efficacy|2
2133161|NCT01057251|3738410|FG001|Overall Study|Lack of Efficacy|11
2133162|NCT01057251|3738409|FG000|Overall Study|Protocol Violation|6
2133163|NCT01057251|3738410|FG001|Overall Study|Protocol Violation|2
2133164|NCT01057251|3738409|FG000|Overall Study|Withdrawal by Subject|4
2133165|NCT01057251|3738410|FG001|Overall Study|Withdrawal by Subject|5
2133166|NCT01057251|3738409|FG000|Overall Study|Lost to Follow-up|7
2133167|NCT01057251|3738410|FG001|Overall Study|Lost to Follow-up|6
2133168|NCT01057251|3738409|FG000|Overall Study|Other Reason|1
2133169|NCT01057251|3738410|FG001|Overall Study|Other Reason|1
2133170|NCT01057394|3738437|FG000|Overall Study|Not eligible|0
2133171|NCT01057394|3738438|FG001|Overall Study|Not eligible|2
2133172|NCT01057433|3738442|FG000|Overall Study|Adverse Event|1
2133173|NCT01057589|3738446|FG000|Overall Study|Disease Progression|35
2133174|NCT01057589|3738446|FG000|Overall Study|Adverse Event|10
2133175|NCT01057589|3738446|FG000|Overall Study|Physician Decision|8
2206939|NCT01624974|3845719|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
2206940|NCT01624974|3845718|FG000|Period IV Washout (4 Weeks)|Adverse Event|2
2206941|NCT01624974|3845719|FG001|Period IV Washout (4 Weeks)|Adverse Event|0
2206942|NCT01624974|3845718|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
2285454|NCT02421172|3973700|FG001|Period 2|Lost to Follow-up|0
2285455|NCT02421172|3973701|FG002|Period 2|Lost to Follow-up|0
2133176|NCT01057589|3738446|FG000|Overall Study|Withdrawal by Subject|3
2133177|NCT01057589|3738446|FG000|Overall Study|Sponsor Decision|1
2133178|NCT01057589|3738446|FG000|Overall Study|Death|8
2133179|NCT01057589|3738446|FG000|Overall Study|Lost to Follow-up|1
2133180|NCT01057693|3738450|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45
2206943|NCT01624974|3845719|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
2285456|NCT02421172|3973702|FG003|Period 2|Lost to Follow-up|1
2285457|NCT02421172|3973703|FG004|Period 2|Lost to Follow-up|0
2285458|NCT02421172|3973699|FG000|Period 2|Patient/guardian decision|0
2285459|NCT02421172|3973700|FG001|Period 2|Patient/guardian decision|0
2285460|NCT02421172|3973701|FG002|Period 2|Patient/guardian decision|3
2285461|NCT02421172|3973702|FG003|Period 2|Patient/guardian decision|2
2285462|NCT02421172|3973703|FG004|Period 2|Patient/guardian decision|1
2285463|NCT02421419|3973771|FG000|Overall Study|Physician Decision|0
2285464|NCT02421419|3973772|FG001|Overall Study|Physician Decision|0
2285465|NCT02421419|3973773|FG002|Overall Study|Physician Decision|1
2285466|NCT02421510|3973784|FG000|Overall Study|Other|4
2285467|NCT02421510|3973785|FG001|Overall Study|Other|2
2285468|NCT02421510|3973786|FG002|Overall Study|Other|3
2285469|NCT02421510|3973784|FG000|Overall Study|Protocol Violation|1
2285470|NCT02421510|3973785|FG001|Overall Study|Protocol Violation|2
2285471|NCT02421510|3973786|FG002|Overall Study|Protocol Violation|0
2285472|NCT02421510|3973784|FG000|Overall Study|Death|1
2285473|NCT02421510|3973785|FG001|Overall Study|Death|0
2285474|NCT02421510|3973786|FG002|Overall Study|Death|0
2285475|NCT02421510|3973784|FG000|Overall Study|Noncompliance with study drug|1
2285476|NCT02421510|3973785|FG001|Overall Study|Noncompliance with study drug|0
2285477|NCT02421510|3973786|FG002|Overall Study|Noncompliance with study drug|0
2285478|NCT02421510|3973784|FG000|Overall Study|Physician Decision|1
2285479|NCT02421510|3973785|FG001|Overall Study|Physician Decision|1
2285480|NCT02421510|3973786|FG002|Overall Study|Physician Decision|3
2285481|NCT02421510|3973784|FG000|Overall Study|Adverse Event|9
2285482|NCT02421510|3973785|FG001|Overall Study|Adverse Event|10
2285483|NCT02421510|3973786|FG002|Overall Study|Adverse Event|18
2285484|NCT02421510|3973784|FG000|Overall Study|Pregnancy|1
2285485|NCT02421510|3973785|FG001|Overall Study|Pregnancy|1
2285486|NCT02421510|3973786|FG002|Overall Study|Pregnancy|0
2285487|NCT02421510|3973784|FG000|Overall Study|Withdrawal by Subject|14
2285488|NCT02421510|3973785|FG001|Overall Study|Withdrawal by Subject|18
2285489|NCT02421510|3973786|FG002|Overall Study|Withdrawal by Subject|12
2285490|NCT02421510|3973784|FG000|Overall Study|Lost to Follow-up|1
2285491|NCT02421510|3973785|FG001|Overall Study|Lost to Follow-up|1
2285492|NCT02421510|3973786|FG002|Overall Study|Lost to Follow-up|0
2285493|NCT02421588|3973796|FG000|Overall Study|Non-treatment-related AE|8
2285494|NCT02421588|3973797|FG001|Overall Study|Non-treatment-related AE|8
2285495|NCT02421588|3973796|FG000|Overall Study|Progressive disease|152
2285496|NCT02421588|3973797|FG001|Overall Study|Progressive disease|135
2285497|NCT02421588|3973796|FG000|Overall Study|Death|11
2285498|NCT02421588|3973797|FG001|Overall Study|Death|3
2285499|NCT02421588|3973796|FG000|Overall Study|Physician Decision|8
2285500|NCT02421588|3973797|FG001|Overall Study|Physician Decision|17
2285501|NCT02421588|3973796|FG000|Overall Study|Other reason not specified|3
2285502|NCT02421588|3973797|FG001|Overall Study|Other reason not specified|1
2285503|NCT02421588|3973796|FG000|Overall Study|Symptomatic deterioration|13
2285504|NCT02421588|3973797|FG001|Overall Study|Symptomatic deterioration|19
2285505|NCT02421588|3973796|FG000|Overall Study|Treatment-related AE|10
2041576|NCT00440037|3612316|FG000|Overall Study|Withdrawal by Subject|6
2041577|NCT00440037|3612316|FG000|Overall Study|Administrative decision|3
2041578|NCT00440115|3612332|FG000|Overall Study|Death|7
2041579|NCT00440115|3612333|FG001|Overall Study|Death|9
2041580|NCT00440115|3612334|FG002|Overall Study|Death|5
2041581|NCT00440115|3612332|FG000|Overall Study|Incarceration|0
2041582|NCT00440115|3612333|FG001|Overall Study|Incarceration|2
2041583|NCT00440115|3612334|FG002|Overall Study|Incarceration|1
2041584|NCT00440193|3612353|FG000|Treatment Period|Adverse Event|74
2041585|NCT00440193|3612354|FG001|Treatment Period|Adverse Event|67
2041586|NCT00440193|3612353|FG000|Treatment Period|Death|19
2041587|NCT00440193|3612354|FG001|Treatment Period|Death|22
2041588|NCT00440193|3612353|FG000|Treatment Period|Lack of Efficacy|0
2041589|NCT00440193|3612354|FG001|Treatment Period|Lack of Efficacy|1
2041590|NCT00440193|3612353|FG000|Treatment Period|Lost to Follow-up|12
2041591|NCT00440193|3612354|FG001|Treatment Period|Lost to Follow-up|18
2041592|NCT00440193|3612353|FG000|Treatment Period|Physician Decision|3
2041593|NCT00440193|3612354|FG001|Treatment Period|Physician Decision|6
2041594|NCT00440193|3612353|FG000|Treatment Period|Protocol Violation|16
2041595|NCT00440193|3612354|FG001|Treatment Period|Protocol Violation|19
2041596|NCT00440193|3612353|FG000|Treatment Period|Withdrawal by Subject|36
2285506|NCT02421588|3973797|FG001|Overall Study|Treatment-related AE|14
2041597|NCT00440193|3612354|FG001|Treatment Period|Withdrawal by Subject|77
2041598|NCT00440193|3612353|FG000|Treatment Period|Clinical endpoint reached|28
2041599|NCT00440193|3612354|FG001|Treatment Period|Clinical endpoint reached|25
2041600|NCT00440193|3612353|FG000|Treatment Period|Study terminated by sponsor|102
2041601|NCT00440193|3612354|FG001|Treatment Period|Study terminated by sponsor|94
2041602|NCT00440193|3612353|FG000|Treatment Period|Protocol driven decision point|2
2133181|NCT01057693|3738451|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0
2133182|NCT01057693|3738452|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0
2133183|NCT01057693|3738450|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
2133184|NCT01057693|3738451|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
2133185|NCT01057693|3738452|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
2133186|NCT01057693|3738450|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
2133187|NCT01057693|3738451|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
2133188|NCT01057693|3738452|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
2133189|NCT01057693|3738450|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
2133190|NCT01057693|3738451|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
2133191|NCT01057693|3738452|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
2133192|NCT01057693|3738450|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
2133193|NCT01057693|3738451|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
2133194|NCT01057693|3738452|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
2133195|NCT01057693|3738450|FG000|Single-Blind Phase (Up to Week 6)|Other|2
2133196|NCT01057693|3738451|FG001|Single-Blind Phase (Up to Week 6)|Other|0
2133197|NCT01057693|3738452|FG002|Single-Blind Phase (Up to Week 6)|Other|0
2206944|NCT01624974|3845718|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
2206945|NCT01624974|3845719|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
2206946|NCT01624974|3845718|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3
2206947|NCT01624974|3845719|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0
2206948|NCT01624974|3845718|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1
2206949|NCT01624974|3845719|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0
2206950|NCT01625000|3845731|FG000|Overall Study|Physician Decision|15
2206951|NCT01625000|3845732|FG001|Overall Study|Physician Decision|7
2206952|NCT01625000|3845733|FG002|Overall Study|Physician Decision|7
2206953|NCT01625000|3845734|FG003|Overall Study|Physician Decision|2
2206954|NCT01625000|3845735|FG004|Overall Study|Physician Decision|15
2206955|NCT01625000|3845731|FG000|Overall Study|Protocol Violation|3
2206956|NCT01625000|3845732|FG001|Overall Study|Protocol Violation|10
2206957|NCT01625000|3845733|FG002|Overall Study|Protocol Violation|4
2206958|NCT01625000|3845734|FG003|Overall Study|Protocol Violation|1
2206959|NCT01625000|3845735|FG004|Overall Study|Protocol Violation|2
2206960|NCT01625000|3845731|FG000|Overall Study|Withdrawal by Subject|19
2206961|NCT01625000|3845732|FG001|Overall Study|Withdrawal by Subject|16
2206962|NCT01625000|3845733|FG002|Overall Study|Withdrawal by Subject|11
2206963|NCT01625000|3845734|FG003|Overall Study|Withdrawal by Subject|9
2133198|NCT01057693|3738450|FG000|Between Single-Blind and Double-Blind|Adverse Event|5
2133199|NCT01057693|3738451|FG001|Between Single-Blind and Double-Blind|Adverse Event|0
2133200|NCT01057693|3738452|FG002|Between Single-Blind and Double-Blind|Adverse Event|0
2133201|NCT01057693|3738450|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247
2133202|NCT01057693|3738451|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0
2133203|NCT01057693|3738452|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0
2133204|NCT01057693|3738450|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1
2041603|NCT00440193|3612354|FG001|Treatment Period|Protocol driven decision point|2
2041604|NCT00440193|3612353|FG000|Treatment Period|Switch to commercial drug|0
2041605|NCT00440193|3612354|FG001|Treatment Period|Switch to commercial drug|2
2041606|NCT00440193|3612353|FG000|Treatment Period|Technical problems|1
2041607|NCT00440193|3612354|FG001|Treatment Period|Technical problems|1
2041608|NCT00440193|3612353|FG000|Treatment Period|Participant convenience|5
2041609|NCT00440193|3612354|FG001|Treatment Period|Participant convenience|2
2041610|NCT00440193|3612353|FG000|Treatment Period|Participant did not receive treatment|7
2041611|NCT00440193|3612354|FG001|Treatment Period|Participant did not receive treatment|13
2041612|NCT00440193|3612353|FG000|Treatment Period|Site closed by investigator|0
2041613|NCT00440193|3612354|FG001|Treatment Period|Site closed by investigator|2
2041614|NCT00440193|3612353|FG000|Observational Period|Adverse Event|2
2041615|NCT00440193|3612354|FG001|Observational Period|Adverse Event|2
2041616|NCT00440193|3612353|FG000|Observational Period|Death|15
2041617|NCT00440193|3612354|FG001|Observational Period|Death|20
2041618|NCT00440193|3612353|FG000|Observational Period|Lost to Follow-up|12
2041619|NCT00440193|3612354|FG001|Observational Period|Lost to Follow-up|8
2041620|NCT00440193|3612353|FG000|Observational Period|Protocol Violation|1
2041621|NCT00440193|3612354|FG001|Observational Period|Protocol Violation|0
2041622|NCT00440193|3612353|FG000|Observational Period|Withdrawal by Subject|11
2041623|NCT00440193|3612354|FG001|Observational Period|Withdrawal by Subject|8
2041624|NCT00440193|3612353|FG000|Observational Period|Physician Decision|1
2041625|NCT00440193|3612354|FG001|Observational Period|Physician Decision|0
2041626|NCT00440193|3612353|FG000|Observational Period|Clinical endpoint reached|1
2041627|NCT00440193|3612354|FG001|Observational Period|Clinical endpoint reached|0
2041628|NCT00440193|3612353|FG000|Observational Period|Participant convenience|2
2041629|NCT00440193|3612354|FG001|Observational Period|Participant convenience|0
2133205|NCT01057693|3738451|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0
2133206|NCT01057693|3738452|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0
2133207|NCT01057693|3738450|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7
2133208|NCT01057693|3738451|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0
2133209|NCT01057693|3738452|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0
2133210|NCT01057693|3738450|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
2133211|NCT01057693|3738451|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
2133212|NCT01057693|3738452|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
2133213|NCT01057693|3738450|FG000|Between Single-Blind and Double-Blind|Other|6
2133214|NCT01057693|3738451|FG001|Between Single-Blind and Double-Blind|Other|0
2133215|NCT01057693|3738452|FG002|Between Single-Blind and Double-Blind|Other|0
2133216|NCT01057693|3738450|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
2133217|NCT01057693|3738451|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
2133218|NCT01057693|3738452|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
2133219|NCT01057693|3738450|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
2133220|NCT01057693|3738451|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
2133221|NCT01057693|3738452|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
2133222|NCT01057693|3738450|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
2133223|NCT01057693|3738451|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
2133224|NCT01057693|3738452|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
2133225|NCT01057693|3738450|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
2133226|NCT01057693|3738451|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
2133227|NCT01057693|3738452|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
2133228|NCT01057693|3738450|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
2133229|NCT01057693|3738451|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
2133230|NCT01057693|3738452|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
2133231|NCT01057693|3738450|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0
2133232|NCT01057693|3738451|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1
2133233|NCT01057693|3738452|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0
2133234|NCT01057693|3738450|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
2133235|NCT01057693|3738451|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
2133236|NCT01057693|3738452|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
2133237|NCT01057810|3738462|FG000|Overall Study|Disease progression|156
2133238|NCT01057810|3738463|FG001|Overall Study|Disease progression|197
2133239|NCT01057810|3738462|FG000|Overall Study|Study drug toxicity|5
2133240|NCT01057810|3738463|FG001|Overall Study|Study drug toxicity|114
2133241|NCT01057810|3738462|FG000|Overall Study|Adverse event unrelated to study drug|13
2133242|NCT01057810|3738463|FG001|Overall Study|Adverse event unrelated to study drug|29
2133243|NCT01057810|3738462|FG000|Overall Study|Withdrawal by Subject|10
2133244|NCT01057810|3738463|FG001|Overall Study|Withdrawal by Subject|25
2133245|NCT01057810|3738462|FG000|Overall Study|Death|2
2133246|NCT01057810|3738463|FG001|Overall Study|Death|12
2133247|NCT01057810|3738462|FG000|Overall Study|Maximum clinical benefit|5
2133248|NCT01057810|3738463|FG001|Overall Study|Maximum clinical benefit|5
2133249|NCT01057810|3738462|FG000|Overall Study|Poor/non-compliance|0
2133250|NCT01057810|3738463|FG001|Overall Study|Poor/non-compliance|1
2133251|NCT01057810|3738462|FG000|Overall Study|No longer met study criteria|0
2133252|NCT01057810|3738463|FG001|Overall Study|No longer met study criteria|1
2133253|NCT01057810|3738462|FG000|Overall Study|Other|7
2133254|NCT01057810|3738463|FG001|Overall Study|Other|14
2133255|NCT01057862|3738471|FG000|Overall Study|Withdrawal by Subject|1
2133256|NCT01057862|3738472|FG001|Overall Study|Withdrawal by Subject|2
2133257|NCT01058005|3738501|FG000|Overall Study|Adverse Event|0
2133258|NCT01058005|3738502|FG001|Overall Study|Adverse Event|2
2133259|NCT01058005|3738503|FG002|Overall Study|Adverse Event|1
2133260|NCT01058005|3738501|FG000|Overall Study|Physician Decision|2
2133261|NCT01058005|3738502|FG001|Overall Study|Physician Decision|2
2133262|NCT01058005|3738503|FG002|Overall Study|Physician Decision|0
2133263|NCT01058005|3738501|FG000|Overall Study|Withdrawal by Subject|4
2133264|NCT01058005|3738502|FG001|Overall Study|Withdrawal by Subject|5
2133265|NCT01058005|3738503|FG002|Overall Study|Withdrawal by Subject|11
2133266|NCT01058005|3738501|FG000|Overall Study|Withdrawn Due to Study Termination|27
2206964|NCT01625000|3845735|FG004|Overall Study|Withdrawal by Subject|17
2206965|NCT01625000|3845731|FG000|Overall Study|Adverse Event (including Death)|15
2206966|NCT01625000|3845732|FG001|Overall Study|Adverse Event (including Death)|19
2206967|NCT01625000|3845733|FG002|Overall Study|Adverse Event (including Death)|11
2206968|NCT01625000|3845734|FG003|Overall Study|Adverse Event (including Death)|7
2206969|NCT01625000|3845735|FG004|Overall Study|Adverse Event (including Death)|21
2206970|NCT01625091|3845754|FG000|Intervention|Death|1
2206971|NCT01625091|3845755|FG001|Intervention|Death|1
2206972|NCT01625091|3845754|FG000|Intervention|Withdrawal by Subject|4
2206973|NCT01625091|3845755|FG001|Intervention|Withdrawal by Subject|1
2206974|NCT01625091|3845754|FG000|Intervention|Adverse Event|0
2206975|NCT01625091|3845755|FG001|Intervention|Adverse Event|2
2206976|NCT01625091|3845754|FG000|Intervention|Lost to Follow-up|4
2206977|NCT01625091|3845755|FG001|Intervention|Lost to Follow-up|4
2206978|NCT01625091|3845754|FG000|Intervention|Study termination|2
2206979|NCT01625091|3845755|FG001|Intervention|Study termination|3
2206980|NCT01625091|3845754|FG000|Post-intervention|Death|0
2206981|NCT01625091|3845755|FG001|Post-intervention|Death|1
2206982|NCT01625091|3845754|FG000|Post-intervention|Lost to Follow-up|2
2206983|NCT01625091|3845755|FG001|Post-intervention|Lost to Follow-up|0
2206984|NCT01625091|3845754|FG000|Post-intervention|Study termination|2
2206985|NCT01625091|3845755|FG001|Post-intervention|Study termination|1
2206986|NCT01625182|3845776|FG000|Overall Study|Administrative problems|1
2206987|NCT01625182|3845777|FG001|Overall Study|Administrative problems|0
2206988|NCT01625182|3845776|FG000|Overall Study|Protocol deviation|0
2206989|NCT01625182|3845777|FG001|Overall Study|Protocol deviation|2
2206990|NCT01625182|3845776|FG000|Overall Study|Adverse Event|2
2206991|NCT01625182|3845777|FG001|Overall Study|Adverse Event|0
2206992|NCT01625182|3845776|FG000|Overall Study|Withdrawal by Subject|5
2206993|NCT01625182|3845777|FG001|Overall Study|Withdrawal by Subject|1
2206994|NCT01625182|3845776|FG000|Overall Study|Lack of Efficacy|12
2206995|NCT01625182|3845777|FG001|Overall Study|Lack of Efficacy|8
2206996|NCT01625338|3845791|FG000|Overall Study|Enrolled but not Treated|0
2206997|NCT01625338|3845792|FG001|Overall Study|Enrolled but not Treated|0
2206998|NCT01625338|3845793|FG002|Overall Study|Enrolled but not Treated|1
2206999|NCT01625338|3845791|FG000|Overall Study|Efficacy Failure|27
2207000|NCT01625338|3845792|FG001|Overall Study|Efficacy Failure|39
2207001|NCT01625338|3845793|FG002|Overall Study|Efficacy Failure|31
2207002|NCT01625338|3845791|FG000|Overall Study|Lost to Follow-up|3
2207003|NCT01625338|3845792|FG001|Overall Study|Lost to Follow-up|3
2207004|NCT01625338|3845793|FG002|Overall Study|Lost to Follow-up|2
2207005|NCT01625338|3845791|FG000|Overall Study|Investigator Decision|0
2207006|NCT01625338|3845792|FG001|Overall Study|Investigator Decision|2
2207007|NCT01625338|3845793|FG002|Overall Study|Investigator Decision|1
2207008|NCT01625338|3845791|FG000|Overall Study|Subject Withdrew Consent|1
2207009|NCT01625338|3845792|FG001|Overall Study|Subject Withdrew Consent|0
2207010|NCT01625338|3845793|FG002|Overall Study|Subject Withdrew Consent|2
2207011|NCT01625338|3845791|FG000|Overall Study|Adverse Event|1
2207012|NCT01625338|3845792|FG001|Overall Study|Adverse Event|0
2207013|NCT01625338|3845793|FG002|Overall Study|Adverse Event|1
2207014|NCT01625338|3845791|FG000|Overall Study|Study Discontinued by Sponsor|0
2207015|NCT01625338|3845792|FG001|Overall Study|Study Discontinued by Sponsor|0
2207016|NCT01625338|3845793|FG002|Overall Study|Study Discontinued by Sponsor|1
2207017|NCT01625377|3845803|FG000|Overall Study|Death|1
2207018|NCT01625377|3845804|FG001|Overall Study|Death|1
2207019|NCT01625377|3845803|FG000|Overall Study|Administrative Problem|1
2207020|NCT01625377|3845804|FG001|Overall Study|Administrative Problem|1
2207021|NCT01625377|3845803|FG000|Overall Study|Protocol Violation|0
2207022|NCT01625377|3845804|FG001|Overall Study|Protocol Violation|3
2207023|NCT01625377|3845803|FG000|Overall Study|Adverse Event|3
2133267|NCT01058005|3738502|FG001|Overall Study|Withdrawn Due to Study Termination|13
2133268|NCT01058005|3738503|FG002|Overall Study|Withdrawn Due to Study Termination|7
2133269|NCT01058005|3738501|FG000|Overall Study|Reason Missing|5
2133270|NCT01058005|3738502|FG001|Overall Study|Reason Missing|3
2133271|NCT01058005|3738503|FG002|Overall Study|Reason Missing|1
2133272|NCT01058096|3738518|FG000|Double-blind Treatment Phase|Adverse Event|11
2133273|NCT01058096|3738519|FG001|Double-blind Treatment Phase|Adverse Event|15
2133274|NCT01058096|3738518|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
2133275|NCT01058096|3738519|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
2133276|NCT01058096|3738518|FG000|Double-blind Treatment Phase|Protocol Violation|2
2133277|NCT01058096|3738519|FG001|Double-blind Treatment Phase|Protocol Violation|1
2133278|NCT01058096|3738518|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17
2133279|NCT01058096|3738519|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26
2133280|NCT01058096|3738518|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
2133281|NCT01058096|3738519|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
2133282|NCT01058096|3738518|FG000|Double-blind Treatment Phase|Other Unspecified|2
2133283|NCT01058096|3738519|FG001|Double-blind Treatment Phase|Other Unspecified|0
2207024|NCT01625377|3845804|FG001|Overall Study|Adverse Event|16
2041630|NCT00440232|3612362|FG000|Overall Study|Lost to Follow-up|1
2285507|NCT02421588|3973796|FG000|Overall Study|Withdrawal by Subject|14
2285508|NCT02421588|3973797|FG001|Overall Study|Withdrawal by Subject|16
2285509|NCT02421588|3973796|FG000|Overall Study|Not treated|2
2285510|NCT02421588|3973797|FG001|Overall Study|Not treated|8
2285511|NCT02421601|3973803|FG000|Overall Study|Adverse Event|4
2285512|NCT02421601|3973803|FG000|Overall Study|Lack of Efficacy|5
2285513|NCT02421601|3973803|FG000|Overall Study|Physician Decision|1
2285514|NCT02421601|3973803|FG000|Overall Study|Withdrawal by Subject|31
2285515|NCT02421601|3973803|FG000|Overall Study|Others|41
2285516|NCT02421666|3973809|FG000|6-month Follow-up|Lost to Follow-up|8
2285517|NCT02421666|3973810|FG001|6-month Follow-up|Lost to Follow-up|7
2285518|NCT02421666|3973809|FG000|6-month Follow-up|Withdrawal by Subject|5
2285519|NCT02421666|3973810|FG001|6-month Follow-up|Withdrawal by Subject|6
2285520|NCT02421666|3973809|FG000|12-month Follow-up|Lost to Follow-up|5
2285521|NCT02421666|3973810|FG001|12-month Follow-up|Lost to Follow-up|5
2285522|NCT02421666|3973809|FG000|12-month Follow-up|Withdrawal by Subject|6
2285523|NCT02421666|3973810|FG001|12-month Follow-up|Withdrawal by Subject|11
2207025|NCT01625377|3845803|FG000|Overall Study|Graft loss|1
2207026|NCT01625377|3845804|FG001|Overall Study|Graft loss|0
2207027|NCT01625377|3845803|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2207028|NCT01625377|3845804|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2207029|NCT01625377|3845803|FG000|Overall Study|Abnormal laboratory values|1
2207030|NCT01625377|3845804|FG001|Overall Study|Abnormal laboratory values|0
2207031|NCT01625689|3845836|FG000|Overall Study|Migration|2
2207032|NCT01625689|3845837|FG001|Overall Study|Migration|1
2207033|NCT01625845|3845845|FG000|Overall Study|Adverse Event|1
2207034|NCT01625845|3845846|FG001|Overall Study|Adverse Event|2
2207035|NCT01625845|3845845|FG000|Overall Study|Lost to Follow-up|2
2207036|NCT01625845|3845846|FG001|Overall Study|Lost to Follow-up|1
2207037|NCT01625845|3845845|FG000|Overall Study|Withdrawal by Subject|2
2207038|NCT01625845|3845846|FG001|Overall Study|Withdrawal by Subject|0
2207039|NCT01625897|3845854|FG000|Overall Study|Adverse Event|27
2207040|NCT01625897|3845855|FG001|Overall Study|Adverse Event|10
2207041|NCT01625897|3845854|FG000|Overall Study|Physician Decision|0
2207042|NCT01625897|3845855|FG001|Overall Study|Physician Decision|1
2133284|NCT01058265|3738531|FG000|Overall Study|Lost to Follow-up|11
2133285|NCT01058265|3738532|FG001|Overall Study|Lost to Follow-up|12
2133286|NCT01058304|3738540|FG000|Overall Study|Withdrawal by Subject|8
2133287|NCT01058304|3738541|FG001|Overall Study|Withdrawal by Subject|5
2133288|NCT01058304|3738540|FG000|Overall Study|Lost to Follow-up|13
2133289|NCT01058304|3738541|FG001|Overall Study|Lost to Follow-up|16
2133290|NCT01058304|3738540|FG000|Overall Study|Developed exclusion criterion|6
2285524|NCT02421887|3973827|FG000|Overall Study|Lost to Follow-up|5
2285525|NCT02421887|3973828|FG001|Overall Study|Lost to Follow-up|0
2285526|NCT02421887|3973827|FG000|Overall Study|Withdrawal by Subject|8
2285527|NCT02421887|3973828|FG001|Overall Study|Withdrawal by Subject|5
2285528|NCT02421887|3973827|FG000|Overall Study|Physician Decision|2
2285529|NCT02421887|3973828|FG001|Overall Study|Physician Decision|4
2285530|NCT02421887|3973827|FG000|Overall Study|Adverse Event|2
2133291|NCT01058304|3738541|FG001|Overall Study|Developed exclusion criterion|12
2133292|NCT01058356|3738547|FG000|Overall Study|Adverse Event|5
2133293|NCT01058356|3738547|FG000|Overall Study|Administration of contraindicated drugs|12
2133294|NCT01058356|3738547|FG000|Overall Study|Withdrawal by Subject|21
2133295|NCT01058356|3738547|FG000|Overall Study|Lost to Follow-up|4
2133296|NCT01058395|3738553|FG000|Overall Study|Death|2
2133297|NCT01058395|3738554|FG001|Overall Study|Death|1
2133298|NCT01058395|3738553|FG000|Overall Study|Lost to Follow-up|1
2133299|NCT01058395|3738554|FG001|Overall Study|Lost to Follow-up|0
2133300|NCT01058421|3738562|FG000|1 Month Outcomes|Death|10
2133301|NCT01058421|3738563|FG001|1 Month Outcomes|Death|6
2133302|NCT01058421|3738562|FG000|1 Month Outcomes|Lost to Follow-up|8
2133303|NCT01058421|3738563|FG001|1 Month Outcomes|Lost to Follow-up|7
2133304|NCT01058421|3738562|FG000|1 Month Outcomes|Remained in Hospital|5
2133305|NCT01058421|3738563|FG001|1 Month Outcomes|Remained in Hospital|12
2133306|NCT01058421|3738562|FG000|1 Month Outcomes|Remained in Other Facility|16
2133307|NCT01058421|3738563|FG001|1 Month Outcomes|Remained in Other Facility|17
2133308|NCT01058421|3738562|FG000|3 Month Outcomes|Death|3
2133309|NCT01058421|3738563|FG001|3 Month Outcomes|Death|5
2133310|NCT01058421|3738562|FG000|3 Month Outcomes|Lost to Follow-up|12
2133311|NCT01058421|3738563|FG001|3 Month Outcomes|Lost to Follow-up|11
2133312|NCT01058421|3738562|FG000|3 Month Outcomes|Remained in Hospital|0
2133313|NCT01058421|3738563|FG001|3 Month Outcomes|Remained in Hospital|2
2133314|NCT01058421|3738562|FG000|3 Month Outcomes|Remained in Other Facility|5
2133315|NCT01058421|3738563|FG001|3 Month Outcomes|Remained in Other Facility|8
2133316|NCT01058421|3738562|FG000|6 Month Outcomes|Death|2
2133317|NCT01058421|3738563|FG001|6 Month Outcomes|Death|2
2207043|NCT01625897|3845854|FG000|Overall Study|Withdrawal by Subject|25
2207044|NCT01625897|3845855|FG001|Overall Study|Withdrawal by Subject|3
2133318|NCT01058421|3738562|FG000|6 Month Outcomes|Lost to Follow-up|16
2133319|NCT01058421|3738563|FG001|6 Month Outcomes|Lost to Follow-up|21
2133320|NCT01058421|3738562|FG000|6 Month Outcomes|Remained in Other Facility|1
2133321|NCT01058421|3738563|FG001|6 Month Outcomes|Remained in Other Facility|3
2285531|NCT02421887|3973828|FG001|Overall Study|Adverse Event|0
2285532|NCT02421952|3973834|FG000|Overall Study|Diary Not Returned|93
2285533|NCT02421952|3973834|FG000|Overall Study|Failed seriation task|13
2285534|NCT02421952|3973834|FG000|Overall Study|Subject uncooperative for baseline test|2
2285535|NCT02421952|3973834|FG000|Overall Study|Surgery cancelled|1
2285536|NCT02422186|3973843|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
2285537|NCT02422186|3973844|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
2285538|NCT02422186|3973843|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
2285539|NCT02422186|3973844|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
2285540|NCT02422186|3973843|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
2285541|NCT02422186|3973844|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
2285542|NCT02422186|3973843|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
2285543|NCT02422186|3973844|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
2285544|NCT02422186|3973843|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
2285545|NCT02422186|3973844|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
2285546|NCT02422186|3973843|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
2133322|NCT01058655|3738573|FG000|Overall Study|Withdrawal by Subject|1
2133323|NCT01058655|3738574|FG001|Overall Study|Withdrawal by Subject|0
2133324|NCT01058655|3738575|FG002|Overall Study|Withdrawal by Subject|3
2133325|NCT01058655|3738576|FG003|Overall Study|Withdrawal by Subject|4
2133326|NCT01058655|3738573|FG000|Overall Study|Prolonged Treatment Delay|0
2133327|NCT01058655|3738574|FG001|Overall Study|Prolonged Treatment Delay|0
2207045|NCT01625910|3845863|FG000|Overall Study|Lost to Follow-up|3
2207046|NCT01625910|3845864|FG001|Overall Study|Lost to Follow-up|4
2207047|NCT01625988|3845879|FG000|Overall Study|Lost to Follow-up|5
2207048|NCT01625988|3845880|FG001|Overall Study|Lost to Follow-up|6
2133328|NCT01058655|3738575|FG002|Overall Study|Prolonged Treatment Delay|0
2133329|NCT01058655|3738576|FG003|Overall Study|Prolonged Treatment Delay|2
2133330|NCT01058655|3738573|FG000|Overall Study|Symptomatic Deterioration|0
2133331|NCT01058655|3738574|FG001|Overall Study|Symptomatic Deterioration|0
2133332|NCT01058655|3738575|FG002|Overall Study|Symptomatic Deterioration|0
2133333|NCT01058655|3738576|FG003|Overall Study|Symptomatic Deterioration|1
2133334|NCT01058655|3738573|FG000|Overall Study|Clinical Progression (non-RECIST)|1
2133335|NCT01058655|3738574|FG001|Overall Study|Clinical Progression (non-RECIST)|0
2133336|NCT01058655|3738575|FG002|Overall Study|Clinical Progression (non-RECIST)|0
2133337|NCT01058655|3738576|FG003|Overall Study|Clinical Progression (non-RECIST)|7
2133338|NCT01058655|3738573|FG000|Overall Study|Death|0
2133339|NCT01058655|3738574|FG001|Overall Study|Death|1
2133340|NCT01058655|3738575|FG002|Overall Study|Death|1
2133341|NCT01058655|3738576|FG003|Overall Study|Death|0
2133342|NCT01058655|3738573|FG000|Overall Study|Disease Progression|1
2133343|NCT01058655|3738574|FG001|Overall Study|Disease Progression|2
2133344|NCT01058655|3738575|FG002|Overall Study|Disease Progression|4
2133345|NCT01058655|3738576|FG003|Overall Study|Disease Progression|24
2133346|NCT01058655|3738573|FG000|Overall Study|Other|0
2133347|NCT01058655|3738574|FG001|Overall Study|Other|0
2133348|NCT01058655|3738575|FG002|Overall Study|Other|0
2133349|NCT01058655|3738576|FG003|Overall Study|Other|4
2133350|NCT01058668|3738590|FG000|Double-blind Treatment Phase|Adverse Event|8
2133351|NCT01058668|3738591|FG001|Double-blind Treatment Phase|Adverse Event|15
2133352|NCT01058668|3738592|FG002|Double-blind Treatment Phase|Adverse Event|25
2133353|NCT01058668|3738590|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
2133354|NCT01058668|3738591|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
2133355|NCT01058668|3738592|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
2133356|NCT01058668|3738590|FG000|Double-blind Treatment Phase|Protocol Violation|1
2133357|NCT01058668|3738591|FG001|Double-blind Treatment Phase|Protocol Violation|1
2133358|NCT01058668|3738592|FG002|Double-blind Treatment Phase|Protocol Violation|2
2133359|NCT01058668|3738590|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14
2133360|NCT01058668|3738591|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18
2207049|NCT01625988|3845879|FG000|Overall Study|Withdrawal by Subject|8
2207050|NCT01625988|3845880|FG001|Overall Study|Withdrawal by Subject|3
2207051|NCT01625988|3845879|FG000|Overall Study|Adverse Event|0
2207052|NCT01625988|3845880|FG001|Overall Study|Adverse Event|1
2207053|NCT01625988|3845879|FG000|Overall Study|Lack of Efficacy|0
2207054|NCT01625988|3845880|FG001|Overall Study|Lack of Efficacy|1
2207055|NCT01625988|3845879|FG000|Overall Study|Randomized Inappropriately|1
2207056|NCT01625988|3845880|FG001|Overall Study|Randomized Inappropriately|0
2207057|NCT01625988|3845879|FG000|Overall Study|Protocol Violation|0
2207058|NCT01625988|3845880|FG001|Overall Study|Protocol Violation|2
2207059|NCT01626079|3845891|FG000|Overall Study|Death|78
2207060|NCT01626079|3845892|FG001|Overall Study|Death|115
2207061|NCT01626079|3845891|FG000|Overall Study|Withdrawal by Subject|12
2207062|NCT01626079|3845892|FG001|Overall Study|Withdrawal by Subject|29
2207063|NCT01626079|3845891|FG000|Overall Study|Lost to Follow-up|3
2207064|NCT01626079|3845892|FG001|Overall Study|Lost to Follow-up|3
2207065|NCT01626079|3845891|FG000|Overall Study|Visits Expected or Not Due|74
2207066|NCT01626079|3845892|FG001|Overall Study|Visits Expected or Not Due|69
2207067|NCT01626118|3845907|FG000|Overall Study|Lack of Efficacy|1
2207068|NCT01626118|3845908|FG001|Overall Study|Lack of Efficacy|0
2207069|NCT01626118|3845909|FG002|Overall Study|Lack of Efficacy|1
2207070|NCT01626118|3845910|FG003|Overall Study|Lack of Efficacy|3
2207071|NCT01626118|3845907|FG000|Overall Study|Lost to Follow-up|1
2207072|NCT01626118|3845908|FG001|Overall Study|Lost to Follow-up|0
2207073|NCT01626118|3845909|FG002|Overall Study|Lost to Follow-up|0
2207074|NCT01626118|3845910|FG003|Overall Study|Lost to Follow-up|0
2207075|NCT01626118|3845907|FG000|Overall Study|Adverse Event|0
2207076|NCT01626118|3845908|FG001|Overall Study|Adverse Event|1
2207077|NCT01626118|3845909|FG002|Overall Study|Adverse Event|1
2207078|NCT01626118|3845910|FG003|Overall Study|Adverse Event|0
2285547|NCT02422186|3973844|FG001|Double-blind Induction Phase (4 Weeks)|Other|0
2285548|NCT02422186|3973843|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
2285549|NCT02422186|3973844|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
2285550|NCT02422186|3973843|FG000|Follow-up Phase (2 Weeks)|Other|3
2285551|NCT02422186|3973844|FG001|Follow-up Phase (2 Weeks)|Other|0
2133361|NCT01058668|3738592|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17
2133362|NCT01058668|3738590|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
2133363|NCT01058668|3738591|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
2133364|NCT01058668|3738592|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
2133365|NCT01058668|3738590|FG000|Double-blind Treatment Phase|Other Unspecified|1
2207079|NCT01626118|3845907|FG000|Overall Study|Investigator Decision|0
2207080|NCT01626118|3845908|FG001|Overall Study|Investigator Decision|1
2285552|NCT02422264|3973854|FG000|Overall Study|Serious Adverse Event|1
2133366|NCT01058668|3738591|FG001|Double-blind Treatment Phase|Other Unspecified|1
2133367|NCT01058668|3738592|FG002|Double-blind Treatment Phase|Other Unspecified|0
2133368|NCT01058707|3738607|FG000|Overall Study|Disease Progression|15
2133369|NCT01058707|3738608|FG001|Overall Study|Disease Progression|20
2133370|NCT01058707|3738609|FG002|Overall Study|Disease Progression|20
2133371|NCT01058707|3738610|FG003|Overall Study|Disease Progression|15
2133372|NCT01058707|3738611|FG004|Overall Study|Disease Progression|23
2133373|NCT01058707|3738612|FG005|Overall Study|Disease Progression|10
2133374|NCT01058707|3738613|FG006|Overall Study|Disease Progression|12
2285553|NCT02422264|3973855|FG001|Overall Study|Serious Adverse Event|0
2285554|NCT02422264|3973854|FG000|Overall Study|Withdrawal by Subject|1
2285555|NCT02422264|3973855|FG001|Overall Study|Withdrawal by Subject|2
2285556|NCT02422264|3973854|FG000|Overall Study|Migrated/moved from study area|3
2285557|NCT02422264|3973855|FG001|Overall Study|Migrated/moved from study area|1
2285558|NCT02422264|3973854|FG000|Overall Study|Subject vaccinated outside of the study|0
2285559|NCT02422264|3973855|FG001|Overall Study|Subject vaccinated outside of the study|1
2285560|NCT02423109|3973916|FG000|Lens 1|Adverse Event|1
2285561|NCT02423109|3973917|FG001|Lens 1|Adverse Event|0
2285562|NCT02423291|3973944|FG000|Overall Study|Lack of Efficacy|14
2285563|NCT02423291|3973944|FG000|Overall Study|Adverse Event|1
2285564|NCT02423343|3973963|FG000|Overall Study|Withdrawal by Subject|0
2285565|NCT02423343|3973964|FG001|Overall Study|Withdrawal by Subject|1
2285566|NCT02423343|3973965|FG002|Overall Study|Withdrawal by Subject|0
2285567|NCT02423343|3973966|FG003|Overall Study|Withdrawal by Subject|0
2285568|NCT02423343|3973967|FG004|Overall Study|Withdrawal by Subject|0
2285569|NCT02423343|3973968|FG005|Overall Study|Withdrawal by Subject|0
2285570|NCT02423343|3973963|FG000|Overall Study|Progressive Disease|0
2285571|NCT02423343|3973964|FG001|Overall Study|Progressive Disease|0
2285572|NCT02423343|3973965|FG002|Overall Study|Progressive Disease|0
2285573|NCT02423343|3973966|FG003|Overall Study|Progressive Disease|0
2285574|NCT02423343|3973967|FG004|Overall Study|Progressive Disease|2
2285575|NCT02423343|3973968|FG005|Overall Study|Progressive Disease|0
2285576|NCT02423343|3973963|FG000|Overall Study|Adverse Event|0
2285577|NCT02423343|3973964|FG001|Overall Study|Adverse Event|0
2285578|NCT02423343|3973965|FG002|Overall Study|Adverse Event|0
2285579|NCT02423343|3973966|FG003|Overall Study|Adverse Event|0
2285580|NCT02423343|3973967|FG004|Overall Study|Adverse Event|2
2285581|NCT02423343|3973968|FG005|Overall Study|Adverse Event|0
2285582|NCT02423343|3973963|FG000|Overall Study|Death|0
2285583|NCT02423343|3973964|FG001|Overall Study|Death|0
2285584|NCT02423343|3973965|FG002|Overall Study|Death|0
2285585|NCT02423343|3973966|FG003|Overall Study|Death|0
2285586|NCT02423343|3973967|FG004|Overall Study|Death|1
2285587|NCT02423343|3973968|FG005|Overall Study|Death|0
2285588|NCT02423798|3974024|FG000|Overall Study|Withdrawal by Subject|3
2285589|NCT02424097|3974054|FG000|Overall Study|Lost to Follow-up|1
2285590|NCT02424097|3974055|FG001|Overall Study|Lost to Follow-up|2
2285591|NCT02424149|3974063|FG000|Overall Study|surgery cancelled|2
2285592|NCT02424149|3974064|FG001|Overall Study|surgery cancelled|0
2285593|NCT02424149|3974063|FG000|Overall Study|Withdrawal by Subject|0
2285594|NCT02424149|3974064|FG001|Overall Study|Withdrawal by Subject|1
2285595|NCT02424253|3974076|FG000|Overall Study|Other, unspecified|1
2285596|NCT02424253|3974077|FG001|Overall Study|Other, unspecified|0
2285597|NCT02424253|3974076|FG000|Overall Study|Compliance problems|1
2285598|NCT02424253|3974077|FG001|Overall Study|Compliance problems|0
2285599|NCT02424253|3974076|FG000|Overall Study|Physician Decision|2
2285600|NCT02424253|3974077|FG001|Overall Study|Physician Decision|0
2285601|NCT02424253|3974076|FG000|Overall Study|Lack of Efficacy|0
2285602|NCT02424253|3974077|FG001|Overall Study|Lack of Efficacy|7
2285603|NCT02424253|3974076|FG000|Overall Study|Adverse Event|2
2285604|NCT02424253|3974077|FG001|Overall Study|Adverse Event|0
2285605|NCT02424253|3974076|FG000|Overall Study|Consent withdrawn by subject|4
2285606|NCT02424253|3974077|FG001|Overall Study|Consent withdrawn by subject|1
2285607|NCT02424253|3974076|FG000|Overall Study|Lost to Follow-up|1
2285608|NCT02424253|3974077|FG001|Overall Study|Lost to Follow-up|1
2285609|NCT02424344|3974085|FG000|Overall Study|Lack of Efficacy|0
2285610|NCT02424344|3974086|FG001|Overall Study|Lack of Efficacy|1
2285611|NCT02424344|3974085|FG000|Overall Study|Withdrawal by Subject|2
2285612|NCT02424344|3974086|FG001|Overall Study|Withdrawal by Subject|1
2285613|NCT02424344|3974085|FG000|Overall Study|Lost to Follow-up|1
2285614|NCT02424344|3974086|FG001|Overall Study|Lost to Follow-up|0
2285615|NCT02424344|3974085|FG000|Overall Study|Adverse Event|4
2285616|NCT02424344|3974086|FG001|Overall Study|Adverse Event|8
2285617|NCT02424383|3974103|FG000|Overall Study|Withdrawal by Subject|32
2285618|NCT02424383|3974103|FG000|Overall Study|Death|170
2285619|NCT02424383|3974103|FG000|Overall Study|Sponsor's decision|3
2285620|NCT02424383|3974103|FG000|Overall Study|Investigator's decision|44
2285621|NCT02424383|3974103|FG000|Overall Study|Lost to Follow-up|81
2285622|NCT02424383|3974103|FG000|Overall Study|Other|7
2285623|NCT02424383|3974103|FG000|Overall Study|Ineligible for Major Protocol Deviation|39
2133375|NCT01058707|3738607|FG000|Overall Study|Adverse Event|11
2285624|NCT02424539|3974121|FG000|Overall Study|Adverse Event|0
2285625|NCT02424539|3974122|FG001|Overall Study|Adverse Event|0
2285626|NCT02424539|3974123|FG002|Overall Study|Adverse Event|1
2285627|NCT02424539|3974121|FG000|Overall Study|Physician Decision|0
2285628|NCT02424539|3974122|FG001|Overall Study|Physician Decision|0
2133376|NCT01058707|3738608|FG001|Overall Study|Adverse Event|4
2133377|NCT01058707|3738609|FG002|Overall Study|Adverse Event|7
2133378|NCT01058707|3738610|FG003|Overall Study|Adverse Event|6
2133379|NCT01058707|3738611|FG004|Overall Study|Adverse Event|7
2133380|NCT01058707|3738612|FG005|Overall Study|Adverse Event|3
2133381|NCT01058707|3738613|FG006|Overall Study|Adverse Event|1
2133382|NCT01058707|3738607|FG000|Overall Study|Subject Decision|5
2207081|NCT01626118|3845909|FG002|Overall Study|Investigator Decision|0
2207082|NCT01626118|3845910|FG003|Overall Study|Investigator Decision|0
2207083|NCT01626352|3845920|FG000|Overall Study|Disease Progression|3
2207084|NCT01626352|3845920|FG000|Overall Study|Intercurrent Illness|2
2207085|NCT01626352|3845920|FG000|Overall Study|Death|2
2207086|NCT01626352|3845920|FG000|Overall Study|Withdrawal by Subject|1
2133383|NCT01058707|3738608|FG001|Overall Study|Subject Decision|3
2133384|NCT01058707|3738609|FG002|Overall Study|Subject Decision|3
2133385|NCT01058707|3738610|FG003|Overall Study|Subject Decision|1
2133386|NCT01058707|3738611|FG004|Overall Study|Subject Decision|2
2133387|NCT01058707|3738612|FG005|Overall Study|Subject Decision|3
2133388|NCT01058707|3738613|FG006|Overall Study|Subject Decision|6
2133389|NCT01058707|3738607|FG000|Overall Study|Lost to Follow-up|0
2133390|NCT01058707|3738608|FG001|Overall Study|Lost to Follow-up|0
2133391|NCT01058707|3738609|FG002|Overall Study|Lost to Follow-up|1
2133392|NCT01058707|3738610|FG003|Overall Study|Lost to Follow-up|0
2133393|NCT01058707|3738611|FG004|Overall Study|Lost to Follow-up|0
2133394|NCT01058707|3738612|FG005|Overall Study|Lost to Follow-up|0
2133395|NCT01058707|3738613|FG006|Overall Study|Lost to Follow-up|0
2133396|NCT01058707|3738607|FG000|Overall Study|Reason Not Specified|0
2133397|NCT01058707|3738608|FG001|Overall Study|Reason Not Specified|3
2133398|NCT01058707|3738609|FG002|Overall Study|Reason Not Specified|2
2133399|NCT01058707|3738610|FG003|Overall Study|Reason Not Specified|0
2133400|NCT01058707|3738611|FG004|Overall Study|Reason Not Specified|7
2133401|NCT01058707|3738612|FG005|Overall Study|Reason Not Specified|1
2133402|NCT01058707|3738613|FG006|Overall Study|Reason Not Specified|7
2133403|NCT01058863|3738651|FG000|Overall Study|Lost to Follow-up|1
2133404|NCT01058863|3738651|FG000|Overall Study|Withdrawal by Subject|1
2133405|NCT01058863|3738651|FG000|Overall Study|Sponsor requested withdrawal|1
2133406|NCT01058863|3738651|FG000|Overall Study|Randomized in error|1
2133407|NCT01059071|3738677|FG000|Overall Study|Lack of Efficacy|1
2133408|NCT01059071|3738678|FG001|Overall Study|Lack of Efficacy|4
2133409|NCT01059071|3738679|FG002|Overall Study|Lack of Efficacy|2
2133410|NCT01059071|3738680|FG003|Overall Study|Lack of Efficacy|3
2133411|NCT01059071|3738677|FG000|Overall Study|Withdrawal by Subject|1
2133412|NCT01059071|3738678|FG001|Overall Study|Withdrawal by Subject|0
2133413|NCT01059071|3738679|FG002|Overall Study|Withdrawal by Subject|0
2133414|NCT01059071|3738680|FG003|Overall Study|Withdrawal by Subject|2
2133415|NCT01059071|3738677|FG000|Overall Study|Physician Decision|0
2133416|NCT01059071|3738678|FG001|Overall Study|Physician Decision|0
2133417|NCT01059071|3738679|FG002|Overall Study|Physician Decision|0
2133418|NCT01059071|3738680|FG003|Overall Study|Physician Decision|1
2133419|NCT01059175|3738690|FG000|Overall Study|Death|17
2133420|NCT01059175|3738691|FG001|Overall Study|Death|17
2133421|NCT01059175|3738690|FG000|Overall Study|Adverse Event|4
2133422|NCT01059175|3738691|FG001|Overall Study|Adverse Event|2
2133423|NCT01059175|3738690|FG000|Overall Study|Lost to Follow-up|0
2285629|NCT02424539|3974123|FG002|Overall Study|Physician Decision|1
2285630|NCT02424539|3974121|FG000|Overall Study|Withdrawal by Subject|3
2285631|NCT02424539|3974122|FG001|Overall Study|Withdrawal by Subject|1
2285632|NCT02424539|3974123|FG002|Overall Study|Withdrawal by Subject|0
2285633|NCT02424539|3974121|FG000|Overall Study|Other: Reached stopping criteria|11
2285634|NCT02424539|3974122|FG001|Overall Study|Other: Reached stopping criteria|7
2285635|NCT02424539|3974123|FG002|Overall Study|Other: Reached stopping criteria|6
2285636|NCT02424578|3974133|FG000|Overall Study|Withdrawal by Subject|0
2285637|NCT02424578|3974134|FG001|Overall Study|Withdrawal by Subject|1
2285638|NCT02424591|3974142|FG000|Overall Study|Protocol Violation|2
2285639|NCT02424591|3974143|FG001|Overall Study|Protocol Violation|3
2285640|NCT02424630|3974151|FG000|Overall Study|No rotator cuff tear|1
2285641|NCT02424630|3974152|FG001|Overall Study|No rotator cuff tear|2
2285642|NCT02424630|3974151|FG000|Overall Study|Open procedure|0
2285643|NCT02424630|3974152|FG001|Overall Study|Open procedure|1
2285644|NCT02424734|3974161|FG000|Overall Study|Treatment stopped to be discharged home|2
2285645|NCT02424734|3974162|FG001|Overall Study|Treatment stopped to be discharged home|2
2285646|NCT02424734|3974163|FG002|Overall Study|Treatment stopped to be discharged home|0
2285647|NCT02425098|3974221|FG000|Overall Study|Lost to Follow-up|7
2285648|NCT02425098|3974222|FG001|Overall Study|Lost to Follow-up|7
2285649|NCT02425098|3974221|FG000|Overall Study|Withdrawal by Subject|4
2285650|NCT02425098|3974222|FG001|Overall Study|Withdrawal by Subject|8
2285651|NCT02425098|3974221|FG000|Overall Study|Pregnancy|2
2285652|NCT02425098|3974222|FG001|Overall Study|Pregnancy|0
2285653|NCT02425098|3974221|FG000|Overall Study|Reason not Specified|0
2285654|NCT02425098|3974222|FG001|Overall Study|Reason not Specified|1
2285655|NCT02425111|3974228|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
2133424|NCT01059175|3738691|FG001|Overall Study|Lost to Follow-up|1
2133425|NCT01059318|3738701|FG000|Core Study (26 Week)|Adverse Event|3
2133426|NCT01059318|3738701|FG000|Core Study (26 Week)|Withdrawal by Subject|1
2133427|NCT01059318|3738701|FG000|Extension (36 Week)|Adverse Event|3
2133428|NCT01059344|3738710|FG000|Overall Study|Adverse Event|12
2133429|NCT01059344|3738711|FG001|Overall Study|Adverse Event|30
2133430|NCT01059344|3738710|FG000|Overall Study|Withdrawal by Subject|6
2133431|NCT01059344|3738711|FG001|Overall Study|Withdrawal by Subject|9
2133432|NCT01059344|3738710|FG000|Overall Study|Lost to Follow-up|1
2133433|NCT01059344|3738711|FG001|Overall Study|Lost to Follow-up|1
2133434|NCT01059344|3738710|FG000|Overall Study|Other|3
2133435|NCT01059344|3738711|FG001|Overall Study|Other|6
2133436|NCT01059526|3738776|FG000|Overall Study|Patient enrolled but not treated|20
2133437|NCT01059526|3738777|FG001|Overall Study|Patient enrolled but not treated|17
2133438|NCT01059526|3738776|FG000|Overall Study|Adverse Event|2
2133439|NCT01059526|3738777|FG001|Overall Study|Adverse Event|2
2133440|NCT01059526|3738776|FG000|Overall Study|Protocol Violation|0
2133441|NCT01059526|3738777|FG001|Overall Study|Protocol Violation|1
2133442|NCT01059526|3738776|FG000|Overall Study|Withdrawal by Subject|3
2133443|NCT01059526|3738777|FG001|Overall Study|Withdrawal by Subject|1
2133444|NCT01059526|3738776|FG000|Overall Study|Lost to Follow-up|4
2133445|NCT01059526|3738777|FG001|Overall Study|Lost to Follow-up|1
2133446|NCT01059526|3738776|FG000|Overall Study|Patient found to be dermatographic|1
2133447|NCT01059526|3738777|FG001|Overall Study|Patient found to be dermatographic|0
2133448|NCT01059539|3738783|FG000|Overall Study|Adverse Event|66
2133449|NCT01059539|3738783|FG000|Overall Study|Insufficient Therapeutic Response|26
2133450|NCT01059539|3738783|FG000|Overall Study|Protocol Violation|55
2133451|NCT01059539|3738783|FG000|Overall Study|Withdrawal of Consent|80
2133452|NCT01059539|3738783|FG000|Overall Study|Lost to Follow-up|42
2133453|NCT01059539|3738783|FG000|Overall Study|Reason Not Specified|2
2133454|NCT01059565|3738789|FG000|24-Week Randomized Phase|Randomized but not treated|1
2133455|NCT01059565|3738790|FG001|24-Week Randomized Phase|Randomized but not treated|0
2133456|NCT01059565|3738789|FG000|24-Week Randomized Phase|Adverse Event|5
2133457|NCT01059565|3738790|FG001|24-Week Randomized Phase|Adverse Event|0
2133458|NCT01059565|3738789|FG000|24-Week Randomized Phase|Withdrawal by Subject|3
2133459|NCT01059565|3738790|FG001|24-Week Randomized Phase|Withdrawal by Subject|1
2133460|NCT01059565|3738789|FG000|24-Week Randomized Phase|Lost to Follow-up|0
2133461|NCT01059565|3738790|FG001|24-Week Randomized Phase|Lost to Follow-up|1
2133462|NCT01059565|3738789|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
2133463|NCT01059565|3738790|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
2133464|NCT01059565|3738789|FG000|24-Week Open-Label Phase|Adverse Event|2
2133465|NCT01059565|3738790|FG001|24-Week Open-Label Phase|Adverse Event|0
2133466|NCT01059565|3738789|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1
2133467|NCT01059565|3738790|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1
2133468|NCT01059565|3738789|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1
2133469|NCT01059565|3738790|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0
2133470|NCT01059565|3738789|FG000|24-Week Open-Label Phase|Subject noncompliance|1
2133471|NCT01059565|3738790|FG001|24-Week Open-Label Phase|Subject noncompliance|0
2133472|NCT01059565|3738789|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
2133473|NCT01059565|3738790|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
2133474|NCT01059565|3738789|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0
2133475|NCT01059565|3738790|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1
2133476|NCT01059617|3738802|FG000|Overall Study|Other|7
2133477|NCT01059617|3738803|FG001|Overall Study|Other|1
2133478|NCT01059617|3738804|FG002|Overall Study|Other|8
2133479|NCT01059617|3738805|FG003|Overall Study|Other|6
2133480|NCT01059630|3738825|FG000|Overall Study|Death|100
2133481|NCT01059630|3738826|FG001|Overall Study|Death|84
2133482|NCT01059630|3738825|FG000|Overall Study|Lost to Follow-up|4
2133483|NCT01059630|3738826|FG001|Overall Study|Lost to Follow-up|1
2133484|NCT01059630|3738825|FG000|Overall Study|Physician Decision|2
2207087|NCT01626352|3845920|FG000|Overall Study|Non-Compliance|1
2207088|NCT01626352|3845920|FG000|Overall Study|Never Treated|1
2207089|NCT01626391|3845929|FG000|Overall Study|Physician Decision|1
2207090|NCT01626391|3845930|FG001|Overall Study|Physician Decision|0
2285656|NCT02425111|3974228|FG000|Part A: Treatment Period|Lack of Efficacy|15
2285657|NCT02425111|3974228|FG000|Part A: Treatment Period|Voluntary Withdrawal|4
2285658|NCT02425111|3974228|FG000|Part A: Treatment Period|Lost to Follow-up|2
2285659|NCT02425111|3974228|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
2285660|NCT02425111|3974228|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7
2285661|NCT02425826|3974273|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
2285662|NCT02425826|3974274|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
2285663|NCT02425826|3974275|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
2285664|NCT02425826|3974273|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
2285665|NCT02425826|3974274|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
2285666|NCT02425826|3974275|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
2285667|NCT02425826|3974273|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
2285668|NCT02425826|3974274|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
2285669|NCT02425826|3974275|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
2285670|NCT02425826|3974273|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
2207091|NCT01626391|3845929|FG000|Overall Study|Withdrawal by Subject|1
2207092|NCT01626391|3845930|FG001|Overall Study|Withdrawal by Subject|0
2207093|NCT01626456|3845938|FG000|Overall Study|Withdrawal by Subject|21
2207094|NCT01626456|3845939|FG001|Overall Study|Withdrawal by Subject|46
2207095|NCT01626456|3845938|FG000|Overall Study|Adverse Event|2
2207096|NCT01626456|3845939|FG001|Overall Study|Adverse Event|27
2207097|NCT01626456|3845938|FG000|Overall Study|Lost to Follow-up|2
2207098|NCT01626456|3845939|FG001|Overall Study|Lost to Follow-up|27
2207099|NCT01626456|3845938|FG000|Overall Study|Lack of Efficacy|6
2285671|NCT02425826|3974274|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
2285672|NCT02425826|3974275|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
2285673|NCT02425826|3974273|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3
2285674|NCT02425826|3974274|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1
2285675|NCT02425826|3974275|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0
2285676|NCT02425826|3974273|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
2285677|NCT02425826|3974274|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
2285678|NCT02425826|3974275|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
2133485|NCT01059630|3738826|FG001|Overall Study|Physician Decision|4
2285679|NCT02425826|3974273|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
2285680|NCT02425826|3974274|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
2285681|NCT02425826|3974275|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
2285682|NCT02425826|3974273|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
2285683|NCT02425826|3974274|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
2285684|NCT02425826|3974275|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
2285685|NCT02425826|3974273|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
2285686|NCT02425826|3974274|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
2285687|NCT02425826|3974275|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
2285688|NCT02425826|3974273|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
2285689|NCT02425826|3974274|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
2285690|NCT02425826|3974275|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
2285691|NCT02425891|3974287|FG000|Overall Study|Death|332
2285692|NCT02425891|3974288|FG001|Overall Study|Death|314
2285693|NCT02425891|3974287|FG000|Overall Study|Lost to Follow-up|4
2285694|NCT02425891|3974288|FG001|Overall Study|Lost to Follow-up|6
2285695|NCT02425891|3974287|FG000|Overall Study|Non-Compliance|1
2285696|NCT02425891|3974288|FG001|Overall Study|Non-Compliance|0
2285697|NCT02425891|3974287|FG000|Overall Study|Accidentally randomized screen failure participant|0
2285698|NCT02425891|3974288|FG001|Overall Study|Accidentally randomized screen failure participant|1
2285699|NCT02425891|3974287|FG000|Overall Study|Physician Decision|0
2285700|NCT02425891|3974288|FG001|Overall Study|Physician Decision|1
2285701|NCT02425891|3974287|FG000|Overall Study|Protocol Violation|1
2285702|NCT02425891|3974288|FG001|Overall Study|Protocol Violation|1
2285703|NCT02425891|3974287|FG000|Overall Study|Study Terminated By Sponsor|1
2285704|NCT02425891|3974288|FG001|Overall Study|Study Terminated By Sponsor|0
2285705|NCT02425891|3974287|FG000|Overall Study|Withdrawal by Subject|27
2285706|NCT02425891|3974288|FG001|Overall Study|Withdrawal by Subject|32
2285707|NCT02425891|3974287|FG000|Overall Study|On-going in Study|79
2285708|NCT02425891|3974288|FG001|Overall Study|On-going in Study|90
2285709|NCT02425891|3974287|FG000|Overall Study|Not treated|6
2285710|NCT02425891|3974288|FG001|Overall Study|Not treated|6
2285711|NCT02426086|3974301|FG000|Overall Study|Death|33
2285712|NCT02426086|3974302|FG001|Overall Study|Death|36
2285713|NCT02426086|3974301|FG000|Overall Study|Lost to Follow-up|2
2285714|NCT02426086|3974302|FG001|Overall Study|Lost to Follow-up|0
2285715|NCT02426086|3974301|FG000|Overall Study|Study Terminated by Sponsor|5
2285716|NCT02426086|3974302|FG001|Overall Study|Study Terminated by Sponsor|14
2285717|NCT02426086|3974301|FG000|Overall Study|Withdrawal by Subject|8
2285718|NCT02426086|3974302|FG001|Overall Study|Withdrawal by Subject|9
2285719|NCT02426138|3974315|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
2285720|NCT02426138|3974316|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
2285721|NCT02426541|3974337|FG000|Overall Study|Protocol Violation|1
2285722|NCT02426541|3974338|FG001|Overall Study|Protocol Violation|0
2285723|NCT02426580|3974346|FG000|Overall Study|Death|2
2285724|NCT02426580|3974347|FG001|Overall Study|Death|2
2285725|NCT02426580|3974346|FG000|Overall Study|Lost to Follow-up|0
2285726|NCT02426580|3974347|FG001|Overall Study|Lost to Follow-up|9
2285727|NCT02426580|3974346|FG000|Overall Study|transfer to hemodialysis|5
2285728|NCT02426580|3974347|FG001|Overall Study|transfer to hemodialysis|5
2285729|NCT02426580|3974346|FG000|Overall Study|Kidney transplant|3
2285730|NCT02426580|3974347|FG001|Overall Study|Kidney transplant|0
2285731|NCT02426580|3974346|FG000|Overall Study|Allergic to egg white|1
2285732|NCT02426580|3974347|FG001|Overall Study|Allergic to egg white|0
2285733|NCT02426658|3974353|FG000|Overall Study|Withdrawal by Subject|1
2285734|NCT02426658|3974353|FG000|Overall Study|Patient expired before treatment|2
2133486|NCT01059630|3738825|FG000|Overall Study|Withdrawal by Subject|21
2133487|NCT01059630|3738826|FG001|Overall Study|Withdrawal by Subject|14
2133488|NCT01059643|3738832|FG000|Overall Study|Adverse Event|3
2133489|NCT01059643|3738832|FG000|Overall Study|Withdrawal by Subject|2
2133490|NCT01059643|3738832|FG000|Overall Study|Physician Decision|1
2133491|NCT01059773|3738860|FG000|Overall Study|Adverse Event|2
2133492|NCT01059773|3738861|FG001|Overall Study|Adverse Event|2
2133493|NCT01059773|3738860|FG000|Overall Study|Withdrawal by Subject|1
2133494|NCT01059773|3738861|FG001|Overall Study|Withdrawal by Subject|5
2133495|NCT01059773|3738860|FG000|Overall Study|Lost to Follow-up|1
2133496|NCT01059773|3738861|FG001|Overall Study|Lost to Follow-up|1
2133497|NCT01059773|3738860|FG000|Overall Study|Pregnancy|1
2133498|NCT01059773|3738861|FG001|Overall Study|Pregnancy|1
2133499|NCT01059773|3738860|FG000|Overall Study|Protocol Violation|6
2133500|NCT01059773|3738861|FG001|Overall Study|Protocol Violation|2
2133501|NCT01059773|3738860|FG000|Overall Study|Physician Decision|5
2133502|NCT01059773|3738861|FG001|Overall Study|Physician Decision|4
2133503|NCT01059773|3738860|FG000|Overall Study|Lack of Efficacy|3
2133504|NCT01059773|3738861|FG001|Overall Study|Lack of Efficacy|3
2133505|NCT01059773|3738860|FG000|Overall Study|Death|0
2133506|NCT01059773|3738861|FG001|Overall Study|Death|1
2133507|NCT01059773|3738860|FG000|Overall Study|Malignancy including squamous cell skin|0
2133508|NCT01059773|3738861|FG001|Overall Study|Malignancy including squamous cell skin|1
2133509|NCT01059773|3738860|FG000|Overall Study|Ineligible follow TB screening criteria|0
2207100|NCT01626456|3845939|FG001|Overall Study|Lack of Efficacy|7
2207101|NCT01626456|3845938|FG000|Overall Study|Physician Decision|1
2207102|NCT01626456|3845939|FG001|Overall Study|Physician Decision|4
2207103|NCT01626456|3845938|FG000|Overall Study|Protocol Violation|1
2207104|NCT01626456|3845939|FG001|Overall Study|Protocol Violation|1
2285735|NCT02426918|3974371|FG000|Overall Study|Adverse Event|2
2285736|NCT02426918|3974372|FG001|Overall Study|Adverse Event|2
2285737|NCT02426918|3974373|FG002|Overall Study|Adverse Event|0
2285738|NCT02426918|3974371|FG000|Overall Study|Physician Decision|1
2285739|NCT02426918|3974372|FG001|Overall Study|Physician Decision|1
2285740|NCT02426918|3974373|FG002|Overall Study|Physician Decision|1
2285741|NCT02426918|3974371|FG000|Overall Study|Withdrawal by Subject|5
2285742|NCT02426918|3974372|FG001|Overall Study|Withdrawal by Subject|5
2285743|NCT02426918|3974373|FG002|Overall Study|Withdrawal by Subject|4
2285744|NCT02426918|3974371|FG000|Overall Study|Other|9
2285745|NCT02426918|3974372|FG001|Overall Study|Other|11
2285746|NCT02426918|3974373|FG002|Overall Study|Other|9
2285747|NCT02427100|3974383|FG000|Overall Study|Lost to Follow-up|0
2285748|NCT02427100|3974384|FG001|Overall Study|Lost to Follow-up|2
2285749|NCT02427399|3974395|FG000|Overall Study|Protocol Violation|14
2285750|NCT02427399|3974396|FG001|Overall Study|Protocol Violation|16
2285751|NCT02427399|3974397|FG002|Overall Study|Protocol Violation|12
2285752|NCT02427399|3974398|FG003|Overall Study|Protocol Violation|18
2285753|NCT02427399|3974399|FG004|Overall Study|Protocol Violation|15
2285754|NCT02427477|3974413|FG000|Period 1|Adverse Event|1
2285755|NCT02427477|3974414|FG001|Period 1|Adverse Event|0
2285756|NCT02427607|3974420|FG000|Overall Study|Withdrawal by Subject|1
2285757|NCT02427646|3974426|FG000|Overall Study|Lack of Efficacy|2
2285758|NCT02427646|3974427|FG001|Overall Study|Lack of Efficacy|3
2285759|NCT02427646|3974426|FG000|Overall Study|Physician Decision|1
2285760|NCT02427646|3974427|FG001|Overall Study|Physician Decision|4
2285761|NCT02427646|3974426|FG000|Overall Study|Protocol Violation|3
2285762|NCT02427646|3974427|FG001|Overall Study|Protocol Violation|3
2285763|NCT02427646|3974426|FG000|Overall Study|Bothersome hand weakness|2
2285764|NCT02427646|3974427|FG001|Overall Study|Bothersome hand weakness|4
2285765|NCT02427802|3974474|FG000|Overall Study|Adverse Event|11
2285766|NCT02427802|3974475|FG001|Overall Study|Adverse Event|3
2285767|NCT02427802|3974476|FG002|Overall Study|Adverse Event|7
2285768|NCT02427802|3974474|FG000|Overall Study|Death|0
2285769|NCT02427802|3974475|FG001|Overall Study|Death|4
2285770|NCT02427802|3974476|FG002|Overall Study|Death|1
2285771|NCT02427802|3974474|FG000|Overall Study|Lost to Follow-up|13
2285772|NCT02427802|3974475|FG001|Overall Study|Lost to Follow-up|8
2285773|NCT02427802|3974476|FG002|Overall Study|Lost to Follow-up|8
2285774|NCT02427802|3974474|FG000|Overall Study|Physician Decision|4
2285775|NCT02427802|3974475|FG001|Overall Study|Physician Decision|2
2285776|NCT02427802|3974476|FG002|Overall Study|Physician Decision|4
2285777|NCT02427802|3974474|FG000|Overall Study|Withdrawal by Subject|10
2285778|NCT02427802|3974475|FG001|Overall Study|Withdrawal by Subject|5
2285779|NCT02427802|3974476|FG002|Overall Study|Withdrawal by Subject|11
2285780|NCT02427802|3974474|FG000|Overall Study|Protocol Violation|3
2285781|NCT02427802|3974475|FG001|Overall Study|Protocol Violation|1
2285782|NCT02427802|3974476|FG002|Overall Study|Protocol Violation|1
2285783|NCT02427802|3974474|FG000|Overall Study|protocol specific treatment unrelated|18
2285784|NCT02427802|3974475|FG001|Overall Study|protocol specific treatment unrelated|11
2285785|NCT02427802|3974476|FG002|Overall Study|protocol specific treatment unrelated|11
2285786|NCT02427841|3974484|FG000|Overall Study|Physician Decision|8
2285787|NCT02427958|3974488|FG000|Overall Study|Pretreatment Event (PTE) or AE|3
2133510|NCT01059773|3738861|FG001|Overall Study|Ineligible follow TB screening criteria|1
2133511|NCT01059773|3738860|FG000|Overall Study|Other|1
2285788|NCT02427958|3974488|FG000|Overall Study|Lost to Follow-up|6
2285789|NCT02427958|3974488|FG000|Overall Study|Withdrawal by Subject|14
2285790|NCT02427958|3974488|FG000|Overall Study|Lack of Efficacy|1
2285791|NCT02427984|3974495|FG000|Overall Study|Lost to Follow-up|13
2285792|NCT02427984|3974496|FG001|Overall Study|Lost to Follow-up|5
2285793|NCT02427984|3974497|FG002|Overall Study|Lost to Follow-up|18
2285794|NCT02428296|3974516|FG000|Overall Study|Adverse Event|7
2285795|NCT02428296|3974516|FG000|Overall Study|Withdrawal by Subject|2
2285796|NCT02428413|3974530|FG000|Overall Study|Device to measure WAG malfunctioned|3
2207105|NCT01626456|3845938|FG000|Overall Study|Site Closure|2
2207106|NCT01626456|3845939|FG001|Overall Study|Site Closure|3
2207107|NCT01626456|3845938|FG000|Overall Study|Incarceration|0
2207108|NCT01626456|3845939|FG001|Overall Study|Incarceration|2
2207109|NCT01626495|3845954|FG000|Overall Study|Adverse Event|3
2207110|NCT01626495|3845954|FG000|Overall Study|Disease progression|27
2207111|NCT01626495|3845954|FG000|Overall Study|Withdrawal by Subject|1
2207112|NCT01626495|3845954|FG000|Overall Study|Administrative problem|1
2207113|NCT01626495|3845954|FG000|Overall Study|Death|2
2207114|NCT01626495|3845954|FG000|Overall Study|Physician Decision|1
2207115|NCT01626495|3845954|FG000|Overall Study|New cancer therapy|16
2207116|NCT01626495|3845954|FG000|Overall Study|Manufacturing failure|1
2207117|NCT01626690|3845971|FG000|Overall Study|Protocol Violation|1
2207118|NCT01626690|3845972|FG001|Overall Study|Protocol Violation|0
2207119|NCT01626690|3845971|FG000|Overall Study|Adverse Event|1
2207120|NCT01626690|3845972|FG001|Overall Study|Adverse Event|0
2207121|NCT01626859|3845993|FG000|Overall Study|Adverse Event|1
2207122|NCT01626859|3845994|FG001|Overall Study|Adverse Event|3
2207123|NCT01626859|3845995|FG002|Overall Study|Adverse Event|2
2207124|NCT01626859|3845993|FG000|Overall Study|Physician Decision|0
2207125|NCT01626859|3845994|FG001|Overall Study|Physician Decision|1
2207126|NCT01626859|3845995|FG002|Overall Study|Physician Decision|0
2207127|NCT01626859|3845993|FG000|Overall Study|Withdrawal by Subject|1
2207128|NCT01626859|3845994|FG001|Overall Study|Withdrawal by Subject|4
2207129|NCT01626859|3845995|FG002|Overall Study|Withdrawal by Subject|2
2207130|NCT01626872|3846006|FG000|Overall Study|Physician Decision|13
2207131|NCT01626872|3846007|FG001|Overall Study|Physician Decision|9
2207132|NCT01626872|3846008|FG002|Overall Study|Physician Decision|6
2207133|NCT01626872|3846006|FG000|Overall Study|Withdrawal by Subject|19
2207134|NCT01626872|3846007|FG001|Overall Study|Withdrawal by Subject|27
2207135|NCT01626872|3846008|FG002|Overall Study|Withdrawal by Subject|8
2207136|NCT01626872|3846006|FG000|Overall Study|Adverse Event (including Death)|20
2207137|NCT01626872|3846007|FG001|Overall Study|Adverse Event (including Death)|28
2207138|NCT01626872|3846008|FG002|Overall Study|Adverse Event (including Death)|8
2207139|NCT01626872|3846006|FG000|Overall Study|Protocol Violation (including Pregnancy)|0
2207140|NCT01626872|3846007|FG001|Overall Study|Protocol Violation (including Pregnancy)|2
2285797|NCT02428413|3974531|FG001|Overall Study|Device to measure WAG malfunctioned|5
2285798|NCT02428413|3974530|FG000|Overall Study|Protocol Violation|1
2285799|NCT02428413|3974531|FG001|Overall Study|Protocol Violation|2
2285800|NCT02428413|3974530|FG000|Overall Study|Case Cancelled|2
2285801|NCT02428413|3974531|FG001|Overall Study|Case Cancelled|0
2285802|NCT02428413|3974530|FG000|Overall Study|Missed Cases|1
2285803|NCT02428413|3974531|FG001|Overall Study|Missed Cases|2
2285804|NCT02428413|3974530|FG000|Overall Study|Nurse Refusal|1
2285805|NCT02428413|3974531|FG001|Overall Study|Nurse Refusal|0
2285806|NCT02428608|3974557|FG000|Overall Study|Pregnancy|2
2285807|NCT02428608|3974557|FG000|Overall Study|Lost to Follow-up|37
2285808|NCT02428608|3974557|FG000|Overall Study|Withdrawal by Subject|2
2285809|NCT02428608|3974557|FG000|Overall Study|scheduling conflicts|15
2285810|NCT02428608|3974557|FG000|Overall Study|moved away|10
2285811|NCT02428608|3974557|FG000|Overall Study|Death|1
2285812|NCT02428608|3974557|FG000|Overall Study|various|16
2285813|NCT02428699|3974562|FG000|Washout Period 1|Screen Failure|1
2285814|NCT02428699|3974563|FG001|Washout Period 1|Screen Failure|2
2285815|NCT02428855|3974574|FG000|Overall Study|Withdrawal by Subject|2
2285816|NCT02429258|3974605|FG000|Overall Study|Withdrawal by Subject|2
2207141|NCT01626872|3846008|FG002|Overall Study|Protocol Violation (including Pregnancy)|2
2207142|NCT01626885|3846016|FG000|Overall Study|Adverse Event|8
2207143|NCT01626885|3846016|FG000|Overall Study|Withdrawal by Subject|4
2207144|NCT01626989|3846020|FG000|Screening Period|Screen Failure|15
2207145|NCT01626989|3846021|FG001|Screening Period|Screen Failure|0
2207146|NCT01626989|3846022|FG002|Screening Period|Screen Failure|0
2207147|NCT01626989|3846020|FG000|Screening Period|Withdrawal by Subject|2
2207148|NCT01626989|3846021|FG001|Screening Period|Withdrawal by Subject|0
2207149|NCT01626989|3846022|FG002|Screening Period|Withdrawal by Subject|0
2207150|NCT01627067|3846068|FG000|Overall Study|Screen Failure|1
2207151|NCT01627249|3846077|FG000|Overall Study|Death|3
2207152|NCT01627249|3846078|FG001|Overall Study|Death|5
2207153|NCT01627249|3846079|FG002|Overall Study|Death|3
2207154|NCT01627249|3846077|FG000|Overall Study|Withdrawal by Subject|12
2207155|NCT01627249|3846078|FG001|Overall Study|Withdrawal by Subject|6
2207156|NCT01627249|3846079|FG002|Overall Study|Withdrawal by Subject|9
2207157|NCT01627249|3846077|FG000|Overall Study|Missed Visit|1
2285817|NCT02429258|3974606|FG001|Overall Study|Withdrawal by Subject|0
2285818|NCT02429258|3974605|FG000|Overall Study|Protocol Violation|0
2285819|NCT02429258|3974606|FG001|Overall Study|Protocol Violation|1
2285820|NCT02429310|3974614|FG000|Overall Study|Lost to Follow-up|1
2285821|NCT02429310|3974615|FG001|Overall Study|Lost to Follow-up|2
2285822|NCT02429310|3974614|FG000|Overall Study|Protocol Violation|1
2285823|NCT02429310|3974615|FG001|Overall Study|Protocol Violation|1
2320914|NCT02953782|4035204|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5
2207158|NCT01627249|3846078|FG001|Overall Study|Missed Visit|1
2207159|NCT01627249|3846079|FG002|Overall Study|Missed Visit|0
2207160|NCT01627327|3846108|FG000|Overall Study|Adverse Event|6
2320915|NCT02953782|4035205|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2
2207161|NCT01627327|3846109|FG001|Overall Study|Adverse Event|12
2207162|NCT01627327|3846108|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0
2207163|NCT01627327|3846109|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2
2207164|NCT01627327|3846108|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
2207165|NCT01627327|3846109|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
2207166|NCT01627327|3846108|FG000|Overall Study|Protocol Violation|4
2207167|NCT01627327|3846109|FG001|Overall Study|Protocol Violation|10
2207168|NCT01627327|3846108|FG000|Overall Study|Lost to Follow-up|1
2207169|NCT01627327|3846109|FG001|Overall Study|Lost to Follow-up|3
2207170|NCT01627327|3846108|FG000|Overall Study|Physician Decision|1
2207171|NCT01627327|3846109|FG001|Overall Study|Physician Decision|0
2207172|NCT01627327|3846108|FG000|Overall Study|Withdrawal by Subject|3
2207173|NCT01627327|3846109|FG001|Overall Study|Withdrawal by Subject|3
2207174|NCT01627340|3846117|FG000|Overall Study|Adverse Event|1
2207175|NCT01627340|3846118|FG001|Overall Study|Adverse Event|0
2207176|NCT01627340|3846117|FG000|Overall Study|Lost to Follow-up|8
2207177|NCT01627340|3846118|FG001|Overall Study|Lost to Follow-up|4
2207178|NCT01627340|3846117|FG000|Overall Study|Pregnancy|1
2207179|NCT01627340|3846118|FG001|Overall Study|Pregnancy|0
2207180|NCT01627340|3846117|FG000|Overall Study|Withdrawal by Subject|2
2207181|NCT01627340|3846118|FG001|Overall Study|Withdrawal by Subject|0
2207182|NCT01627574|3846128|FG000|Overall Study|Withdrawal by Subject|8
2207183|NCT01627574|3846129|FG001|Overall Study|Withdrawal by Subject|5
2207184|NCT01627574|3846128|FG000|Overall Study|Lost to Follow-up|13
2207185|NCT01627574|3846129|FG001|Overall Study|Lost to Follow-up|13
2207186|NCT01627691|3846135|FG000|Overall Study|Death|11
2207187|NCT01627691|3846135|FG000|Overall Study|Lost to Follow-up|3
2207188|NCT01627691|3846135|FG000|Overall Study|Withdrawal by Subject|1
2207189|NCT01627691|3846135|FG000|Overall Study|Missed the visit|3
2207190|NCT01627782|3846143|FG000|Overall Study|Adverse Event|1
2207191|NCT01627782|3846144|FG001|Overall Study|Adverse Event|2
2207192|NCT01627782|3846145|FG002|Overall Study|Adverse Event|0
2207193|NCT01627782|3846146|FG003|Overall Study|Adverse Event|1
2133512|NCT01059773|3738861|FG001|Overall Study|Other|3
2133513|NCT01059799|3738874|FG000|Overall Study|Adverse Event|2
2133514|NCT01059799|3738875|FG001|Overall Study|Adverse Event|3
2133515|NCT01059799|3738874|FG000|Overall Study|Lack of Efficacy|1
2133516|NCT01059799|3738875|FG001|Overall Study|Lack of Efficacy|0
2133517|NCT01059799|3738874|FG000|Overall Study|Protocol Violation|3
2133518|NCT01059799|3738875|FG001|Overall Study|Protocol Violation|2
2133519|NCT01059799|3738874|FG000|Overall Study|Withdrawal criteria|13
2133520|NCT01059799|3738875|FG001|Overall Study|Withdrawal criteria|2
2133521|NCT01059799|3738874|FG000|Overall Study|Other|12
2133522|NCT01059799|3738875|FG001|Overall Study|Other|3
2133523|NCT01059812|3738883|FG000|Overall Study|Adverse Event|9
2133524|NCT01059812|3738884|FG001|Overall Study|Adverse Event|5
2133525|NCT01059812|3738883|FG000|Overall Study|Lack of Efficacy|2
2133526|NCT01059812|3738884|FG001|Overall Study|Lack of Efficacy|2
2133527|NCT01059812|3738883|FG000|Overall Study|Protocol Violation|3
2133528|NCT01059812|3738884|FG001|Overall Study|Protocol Violation|1
2133529|NCT01059812|3738883|FG000|Overall Study|Withdrawal Criteria|9
2133530|NCT01059812|3738884|FG001|Overall Study|Withdrawal Criteria|4
2133531|NCT01059812|3738883|FG000|Overall Study|Unclassified|14
2133532|NCT01059812|3738884|FG001|Overall Study|Unclassified|4
2133533|NCT01059825|3738896|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0
2133534|NCT01059825|3738897|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0
2133535|NCT01059825|3738898|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0
2133536|NCT01059825|3738899|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0
2133537|NCT01059825|3738900|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0
2133538|NCT01059825|3738901|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0
2133539|NCT01059825|3738902|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3
2133540|NCT01059825|3738896|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0
2133541|NCT01059825|3738897|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0
2133542|NCT01059825|3738898|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0
2133543|NCT01059825|3738899|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0
2133544|NCT01059825|3738900|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0
2133545|NCT01059825|3738901|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0
2207194|NCT01627782|3846143|FG000|Overall Study|Lack of Efficacy|11
2207195|NCT01627782|3846144|FG001|Overall Study|Lack of Efficacy|1
2207196|NCT01627782|3846145|FG002|Overall Study|Lack of Efficacy|15
2207197|NCT01627782|3846146|FG003|Overall Study|Lack of Efficacy|2
2207198|NCT01627782|3846143|FG000|Overall Study|Protocol Violation|1
2207199|NCT01627782|3846144|FG001|Overall Study|Protocol Violation|0
2207200|NCT01627782|3846145|FG002|Overall Study|Protocol Violation|0
2207201|NCT01627782|3846146|FG003|Overall Study|Protocol Violation|0
2207202|NCT01627782|3846143|FG000|Overall Study|Withdrawal by Subject|2
2207203|NCT01627782|3846144|FG001|Overall Study|Withdrawal by Subject|1
2207204|NCT01627782|3846145|FG002|Overall Study|Withdrawal by Subject|0
2207205|NCT01627782|3846146|FG003|Overall Study|Withdrawal by Subject|0
2207206|NCT01627782|3846143|FG000|Overall Study|Other|0
2207207|NCT01627782|3846144|FG001|Overall Study|Other|2
2207208|NCT01627782|3846145|FG002|Overall Study|Other|0
2207209|NCT01627782|3846146|FG003|Overall Study|Other|3
2207210|NCT01627782|3846143|FG000|Overall Study|Randomized But Not Treated|1
2207211|NCT01627782|3846144|FG001|Overall Study|Randomized But Not Treated|0
2207212|NCT01627782|3846145|FG002|Overall Study|Randomized But Not Treated|0
2207213|NCT01627782|3846146|FG003|Overall Study|Randomized But Not Treated|0
2207214|NCT01627860|3846160|FG000|Overall Study|Adverse Event|9
2207215|NCT01627860|3846161|FG001|Overall Study|Adverse Event|4
2207216|NCT01627860|3846160|FG000|Overall Study|Withdrawal by Subject|2
2207217|NCT01627860|3846161|FG001|Overall Study|Withdrawal by Subject|1
2207218|NCT01627860|3846160|FG000|Overall Study|Seizure frequency doubled|0
2207219|NCT01627860|3846161|FG001|Overall Study|Seizure frequency doubled|1
2207220|NCT01627860|3846160|FG000|Overall Study|Protocol Violation|1
2207221|NCT01627860|3846161|FG001|Overall Study|Protocol Violation|0
2207222|NCT01628107|3846199|FG000|Overall Study|Withdrawal by Subject|17
2207223|NCT01628107|3846199|FG000|Overall Study|Lost to Follow-up|4
2207224|NCT01628107|3846199|FG000|Overall Study|Adverse Event|33
2207225|NCT01628107|3846199|FG000|Overall Study|Physician Decision|2
2207226|NCT01628107|3846199|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1
2207227|NCT01628107|3846199|FG000|Overall Study|Non-compliant with Study Procedures|10
2207228|NCT01628107|3846199|FG000|Overall Study|Not Treated|8
2207229|NCT01628107|3846199|FG000|Overall Study|Sponsor Decision|11
2207230|NCT01628107|3846199|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7
2207231|NCT01628107|3846199|FG000|Overall Study|Relocated|8
2207232|NCT01628107|3846199|FG000|Overall Study|Kidney Transplant|9
2207233|NCT01628107|3846199|FG000|Overall Study|Use of Standard of Care|9
2133546|NCT01059825|3738902|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14
2133547|NCT01059825|3738896|FG000|Enrolled, Run-in Period|Lost to Follow-up|0
2133548|NCT01059825|3738897|FG001|Enrolled, Run-in Period|Lost to Follow-up|0
2133549|NCT01059825|3738898|FG002|Enrolled, Run-in Period|Lost to Follow-up|0
2133550|NCT01059825|3738899|FG003|Enrolled, Run-in Period|Lost to Follow-up|0
2133551|NCT01059825|3738900|FG004|Enrolled, Run-in Period|Lost to Follow-up|0
2133552|NCT01059825|3738901|FG005|Enrolled, Run-in Period|Lost to Follow-up|0
2133553|NCT01059825|3738902|FG006|Enrolled, Run-in Period|Lost to Follow-up|5
2133554|NCT01059825|3738896|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0
2133555|NCT01059825|3738897|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0
2133556|NCT01059825|3738898|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0
2133557|NCT01059825|3738899|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0
2133558|NCT01059825|3738900|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0
2133559|NCT01059825|3738901|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0
2133560|NCT01059825|3738902|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13
2133561|NCT01059825|3738896|FG000|Enrolled, Run-in Period|Other reason not specified|0
2133562|NCT01059825|3738897|FG001|Enrolled, Run-in Period|Other reason not specified|0
2133563|NCT01059825|3738898|FG002|Enrolled, Run-in Period|Other reason not specified|0
2133564|NCT01059825|3738899|FG003|Enrolled, Run-in Period|Other reason not specified|0
2133565|NCT01059825|3738900|FG004|Enrolled, Run-in Period|Other reason not specified|0
2133566|NCT01059825|3738901|FG005|Enrolled, Run-in Period|Other reason not specified|0
2133567|NCT01059825|3738902|FG006|Enrolled, Run-in Period|Other reason not specified|7
2133568|NCT01059825|3738896|FG000|Enrolled, Run-in Period|Protocol Violation|0
2133569|NCT01059825|3738897|FG001|Enrolled, Run-in Period|Protocol Violation|0
2133570|NCT01059825|3738898|FG002|Enrolled, Run-in Period|Protocol Violation|0
2133571|NCT01059825|3738899|FG003|Enrolled, Run-in Period|Protocol Violation|0
2285824|NCT02429427|3974623|FG000|Overall Study|Adverse Event|220
2285825|NCT02429427|3974624|FG001|Overall Study|Adverse Event|92
2285826|NCT02429427|3974623|FG000|Overall Study|Protocol Violation|10
2285827|NCT02429427|3974624|FG001|Overall Study|Protocol Violation|6
2285828|NCT02429427|3974623|FG000|Overall Study|Lost to Follow-up|15
2285829|NCT02429427|3974624|FG001|Overall Study|Lost to Follow-up|6
2285830|NCT02429427|3974623|FG000|Overall Study|Withdrawal by Subject|64
2285831|NCT02429427|3974624|FG001|Overall Study|Withdrawal by Subject|34
2285832|NCT02429427|3974623|FG000|Overall Study|Other|62
2285833|NCT02429427|3974624|FG001|Overall Study|Other|41
2285834|NCT02429778|3974632|FG000|Overall Study|Lost to Follow-up|2
2285835|NCT02429778|3974633|FG001|Overall Study|Lost to Follow-up|0
2285836|NCT02429778|3974632|FG000|Overall Study|Withdrawal by Subject|5
2285837|NCT02429778|3974633|FG001|Overall Study|Withdrawal by Subject|0
2285838|NCT02429856|3974641|FG000|Overall Study|Death|12
2285839|NCT02429856|3974642|FG001|Overall Study|Death|13
2285840|NCT02429856|3974641|FG000|Overall Study|Lost to Follow-up|6
2285841|NCT02429856|3974642|FG001|Overall Study|Lost to Follow-up|5
2285842|NCT02429856|3974641|FG000|Overall Study|Withdrawal by Subject|1
2285843|NCT02429856|3974642|FG001|Overall Study|Withdrawal by Subject|1
2285844|NCT02429934|3974656|FG000|Overall Study|Withdrawal by Subject|0
2285845|NCT02429934|3974657|FG001|Overall Study|Withdrawal by Subject|2
2285846|NCT02429934|3974656|FG000|Overall Study|Adverse Event|2
2285847|NCT02429934|3974657|FG001|Overall Study|Adverse Event|0
2285848|NCT02429934|3974656|FG000|Overall Study|Lost to Follow-up|1
2285849|NCT02429934|3974657|FG001|Overall Study|Lost to Follow-up|1
2285850|NCT02429934|3974656|FG000|Overall Study|Physician Decision|1
2133572|NCT01059825|3738900|FG004|Enrolled, Run-in Period|Protocol Violation|0
2207234|NCT01628120|3846203|FG000|Overall Study|Withdrawal by Subject|7
2207235|NCT01628120|3846203|FG000|Overall Study|Adverse Event|12
2207236|NCT01628120|3846203|FG000|Overall Study|Lost to Follow-up|1
2285851|NCT02429934|3974657|FG001|Overall Study|Physician Decision|0
2133573|NCT01059825|3738901|FG005|Enrolled, Run-in Period|Protocol Violation|0
2133574|NCT01059825|3738902|FG006|Enrolled, Run-in Period|Protocol Violation|5
2133575|NCT01059825|3738896|FG000|Treatment Period|Lost to Follow-up|2
2133576|NCT01059825|3738897|FG001|Treatment Period|Lost to Follow-up|1
2133577|NCT01059825|3738898|FG002|Treatment Period|Lost to Follow-up|0
2133578|NCT01059825|3738899|FG003|Treatment Period|Lost to Follow-up|1
2133579|NCT01059825|3738900|FG004|Treatment Period|Lost to Follow-up|2
2133580|NCT01059825|3738901|FG005|Treatment Period|Lost to Follow-up|0
2133581|NCT01059825|3738902|FG006|Treatment Period|Lost to Follow-up|0
2285852|NCT02430311|3974680|FG000|Part A|Adverse Event|0
2285853|NCT02430311|3974681|FG001|Part A|Adverse Event|1
2285854|NCT02430311|3974680|FG000|Part A|Withdrawal by Subject|1
2285855|NCT02430311|3974681|FG001|Part A|Withdrawal by Subject|0
2285856|NCT02430311|3974680|FG000|Part B|Meet study-specific withdrawal criteria|6
2285857|NCT02430311|3974681|FG001|Part B|Meet study-specific withdrawal criteria|6
2285858|NCT02430311|3974680|FG000|Part B|Withdrawal by Subject|2
2285859|NCT02430311|3974681|FG001|Part B|Withdrawal by Subject|2
2285860|NCT02430311|3974680|FG000|Part B|Adverse Event|1
2285861|NCT02430311|3974681|FG001|Part B|Adverse Event|0
2285862|NCT02430311|3974680|FG000|Part B|Death|1
2285863|NCT02430311|3974681|FG001|Part B|Death|0
2285864|NCT02430480|3974718|FG000|Overall Study|Death|1
2285865|NCT02430480|3974718|FG000|Overall Study|Anesthesia concerns|1
2285866|NCT02430480|3974718|FG000|Overall Study|Progressed on treatment|1
2285867|NCT02430870|3974746|FG000|Part 2|Voluntary Withdrawal|0
2285868|NCT02430870|3974747|FG001|Part 2|Voluntary Withdrawal|0
2285869|NCT02430870|3974748|FG002|Part 2|Voluntary Withdrawal|0
2285870|NCT02430870|3974749|FG003|Part 2|Voluntary Withdrawal|0
2285871|NCT02430870|3974750|FG004|Part 2|Voluntary Withdrawal|0
2285872|NCT02430870|3974751|FG005|Part 2|Voluntary Withdrawal|0
2285873|NCT02430870|3974752|FG006|Part 2|Voluntary Withdrawal|1
2285874|NCT02430870|3974753|FG007|Part 2|Voluntary Withdrawal|0
2285875|NCT02430870|3974746|FG000|Part 2|Other Reason Not Specified|0
2285876|NCT02430870|3974747|FG001|Part 2|Other Reason Not Specified|0
2285877|NCT02430870|3974748|FG002|Part 2|Other Reason Not Specified|0
2285878|NCT02430870|3974749|FG003|Part 2|Other Reason Not Specified|0
2285879|NCT02430870|3974750|FG004|Part 2|Other Reason Not Specified|0
2285880|NCT02430870|3974751|FG005|Part 2|Other Reason Not Specified|0
2285881|NCT02430870|3974752|FG006|Part 2|Other Reason Not Specified|0
2285882|NCT02430870|3974753|FG007|Part 2|Other Reason Not Specified|1
2285883|NCT02431260|3974811|FG000|Overall Study|Subject Decision|0
2285884|NCT02431260|3974812|FG001|Overall Study|Subject Decision|1
2285885|NCT02431260|3974813|FG002|Overall Study|Subject Decision|1
2285886|NCT02431260|3974814|FG003|Overall Study|Subject Decision|0
2285887|NCT02431260|3974815|FG004|Overall Study|Subject Decision|0
2285888|NCT02431260|3974816|FG005|Overall Study|Subject Decision|0
2285889|NCT02431260|3974817|FG006|Overall Study|Subject Decision|0
2285890|NCT02431260|3974818|FG007|Overall Study|Subject Decision|0
2285891|NCT02431260|3974819|FG008|Overall Study|Subject Decision|1
2285892|NCT02431260|3974820|FG009|Overall Study|Subject Decision|1
2285893|NCT02431260|3974821|FG010|Overall Study|Subject Decision|0
2285894|NCT02431260|3974822|FG011|Overall Study|Subject Decision|1
2285895|NCT02431260|3974823|FG012|Overall Study|Subject Decision|0
2285896|NCT02431260|3974824|FG013|Overall Study|Subject Decision|0
2285897|NCT02431260|3974811|FG000|Overall Study|Death|4
2285898|NCT02431260|3974812|FG001|Overall Study|Death|4
2285899|NCT02431260|3974813|FG002|Overall Study|Death|3
2285900|NCT02431260|3974814|FG003|Overall Study|Death|4
2285901|NCT02431260|3974815|FG004|Overall Study|Death|2
2285902|NCT02431260|3974816|FG005|Overall Study|Death|2
2285903|NCT02431260|3974817|FG006|Overall Study|Death|3
2285904|NCT02431260|3974818|FG007|Overall Study|Death|1
2285905|NCT02431260|3974819|FG008|Overall Study|Death|6
2285906|NCT02431260|3974820|FG009|Overall Study|Death|6
2285907|NCT02431260|3974821|FG010|Overall Study|Death|3
2285908|NCT02431260|3974822|FG011|Overall Study|Death|2
2285909|NCT02431260|3974823|FG012|Overall Study|Death|5
2285910|NCT02431260|3974824|FG013|Overall Study|Death|1
2285911|NCT02431260|3974811|FG000|Overall Study|Lost to Follow-up|0
2285912|NCT02431260|3974812|FG001|Overall Study|Lost to Follow-up|0
2285913|NCT02431260|3974813|FG002|Overall Study|Lost to Follow-up|0
2285914|NCT02431260|3974814|FG003|Overall Study|Lost to Follow-up|0
2285915|NCT02431260|3974815|FG004|Overall Study|Lost to Follow-up|0
2285916|NCT02431260|3974816|FG005|Overall Study|Lost to Follow-up|1
2285917|NCT02431260|3974817|FG006|Overall Study|Lost to Follow-up|0
2285918|NCT02431260|3974818|FG007|Overall Study|Lost to Follow-up|0
2285919|NCT02431260|3974819|FG008|Overall Study|Lost to Follow-up|0
2285920|NCT02431260|3974820|FG009|Overall Study|Lost to Follow-up|0
2285921|NCT02431260|3974821|FG010|Overall Study|Lost to Follow-up|0
2285922|NCT02431260|3974822|FG011|Overall Study|Lost to Follow-up|0
2285923|NCT02431260|3974823|FG012|Overall Study|Lost to Follow-up|0
2285924|NCT02431260|3974824|FG013|Overall Study|Lost to Follow-up|0
2285925|NCT02431260|3974811|FG000|Overall Study|Study Terminated by the Sponsor|0
2133582|NCT01059825|3738896|FG000|Treatment Period|Withdrawal by Subject|3
2285926|NCT02431260|3974812|FG001|Overall Study|Study Terminated by the Sponsor|0
2285927|NCT02431260|3974813|FG002|Overall Study|Study Terminated by the Sponsor|2
2285928|NCT02431260|3974814|FG003|Overall Study|Study Terminated by the Sponsor|1
2285929|NCT02431260|3974815|FG004|Overall Study|Study Terminated by the Sponsor|1
2133583|NCT01059825|3738897|FG001|Treatment Period|Withdrawal by Subject|0
2133584|NCT01059825|3738898|FG002|Treatment Period|Withdrawal by Subject|1
2133585|NCT01059825|3738899|FG003|Treatment Period|Withdrawal by Subject|5
2133586|NCT01059825|3738900|FG004|Treatment Period|Withdrawal by Subject|4
2133587|NCT01059825|3738901|FG005|Treatment Period|Withdrawal by Subject|1
2133588|NCT01059825|3738902|FG006|Treatment Period|Withdrawal by Subject|0
2133589|NCT01059825|3738896|FG000|Treatment Period|Other reason not specified|1
2133590|NCT01059825|3738897|FG001|Treatment Period|Other reason not specified|2
2133591|NCT01059825|3738898|FG002|Treatment Period|Other reason not specified|1
2133592|NCT01059825|3738899|FG003|Treatment Period|Other reason not specified|2
2133593|NCT01059825|3738900|FG004|Treatment Period|Other reason not specified|0
2133594|NCT01059825|3738901|FG005|Treatment Period|Other reason not specified|0
2133595|NCT01059825|3738902|FG006|Treatment Period|Other reason not specified|0
2133596|NCT01059825|3738896|FG000|Treatment Period|Protocol Violation|0
2133597|NCT01059825|3738897|FG001|Treatment Period|Protocol Violation|0
2133598|NCT01059825|3738898|FG002|Treatment Period|Protocol Violation|1
2133599|NCT01059825|3738899|FG003|Treatment Period|Protocol Violation|1
2133600|NCT01059825|3738900|FG004|Treatment Period|Protocol Violation|1
2133601|NCT01059825|3738901|FG005|Treatment Period|Protocol Violation|1
2133602|NCT01059825|3738902|FG006|Treatment Period|Protocol Violation|0
2133603|NCT01059825|3738896|FG000|Treatment Period|Adverse event related to study drug|1
2133604|NCT01059825|3738897|FG001|Treatment Period|Adverse event related to study drug|0
2285930|NCT02431260|3974816|FG005|Overall Study|Study Terminated by the Sponsor|0
2285931|NCT02431260|3974817|FG006|Overall Study|Study Terminated by the Sponsor|1
2285932|NCT02431260|3974818|FG007|Overall Study|Study Terminated by the Sponsor|2
2285933|NCT02431260|3974819|FG008|Overall Study|Study Terminated by the Sponsor|1
2285934|NCT02431260|3974820|FG009|Overall Study|Study Terminated by the Sponsor|1
2285935|NCT02431260|3974821|FG010|Overall Study|Study Terminated by the Sponsor|1
2285936|NCT02431260|3974822|FG011|Overall Study|Study Terminated by the Sponsor|0
2285937|NCT02431260|3974823|FG012|Overall Study|Study Terminated by the Sponsor|4
2285938|NCT02431260|3974824|FG013|Overall Study|Study Terminated by the Sponsor|0
2285939|NCT02431260|3974811|FG000|Overall Study|Physician Decision|0
2285940|NCT02431260|3974812|FG001|Overall Study|Physician Decision|0
2285941|NCT02431260|3974813|FG002|Overall Study|Physician Decision|0
2285942|NCT02431260|3974814|FG003|Overall Study|Physician Decision|0
2285943|NCT02431260|3974815|FG004|Overall Study|Physician Decision|0
2285944|NCT02431260|3974816|FG005|Overall Study|Physician Decision|1
2285945|NCT02431260|3974817|FG006|Overall Study|Physician Decision|0
2285946|NCT02431260|3974818|FG007|Overall Study|Physician Decision|0
2285947|NCT02431260|3974819|FG008|Overall Study|Physician Decision|0
2285948|NCT02431260|3974820|FG009|Overall Study|Physician Decision|0
2285949|NCT02431260|3974821|FG010|Overall Study|Physician Decision|0
2285950|NCT02431260|3974822|FG011|Overall Study|Physician Decision|0
2285951|NCT02431260|3974823|FG012|Overall Study|Physician Decision|0
2285952|NCT02431260|3974824|FG013|Overall Study|Physician Decision|0
2285953|NCT02431260|3974811|FG000|Overall Study|Other Unspecified|0
2285954|NCT02431260|3974812|FG001|Overall Study|Other Unspecified|0
2285955|NCT02431260|3974813|FG002|Overall Study|Other Unspecified|0
2285956|NCT02431260|3974814|FG003|Overall Study|Other Unspecified|0
2285957|NCT02431260|3974815|FG004|Overall Study|Other Unspecified|0
2285958|NCT02431260|3974816|FG005|Overall Study|Other Unspecified|0
2285959|NCT02431260|3974817|FG006|Overall Study|Other Unspecified|0
2285960|NCT02431260|3974818|FG007|Overall Study|Other Unspecified|0
2285961|NCT02431260|3974819|FG008|Overall Study|Other Unspecified|0
2285962|NCT02431260|3974820|FG009|Overall Study|Other Unspecified|0
2285963|NCT02431260|3974821|FG010|Overall Study|Other Unspecified|0
2285964|NCT02431260|3974822|FG011|Overall Study|Other Unspecified|1
2285965|NCT02431260|3974823|FG012|Overall Study|Other Unspecified|1
2285966|NCT02431260|3974824|FG013|Overall Study|Other Unspecified|0
2285967|NCT02431364|3974889|FG000|Overall Study|Adverse Event|0
2285968|NCT02431364|3974890|FG001|Overall Study|Adverse Event|1
2285969|NCT02431364|3974891|FG002|Overall Study|Adverse Event|0
2285970|NCT02431364|3974892|FG003|Overall Study|Adverse Event|0
2285971|NCT02431364|3974893|FG004|Overall Study|Adverse Event|0
2285972|NCT02431364|3974889|FG000|Overall Study|Randomized but never treated|0
2285973|NCT02431364|3974890|FG001|Overall Study|Randomized but never treated|0
2285974|NCT02431364|3974891|FG002|Overall Study|Randomized but never treated|0
2285975|NCT02431364|3974892|FG003|Overall Study|Randomized but never treated|1
2285976|NCT02431364|3974893|FG004|Overall Study|Randomized but never treated|0
2285977|NCT02431468|3974921|FG000|Overall Study|Adverse Event|2
2285978|NCT02431468|3974922|FG001|Overall Study|Adverse Event|4
2285979|NCT02431468|3974923|FG002|Overall Study|Adverse Event|5
2285980|NCT02431468|3974921|FG000|Overall Study|Withdrawal by Subject|4
2285981|NCT02431468|3974922|FG001|Overall Study|Withdrawal by Subject|12
2285982|NCT02431468|3974923|FG002|Overall Study|Withdrawal by Subject|2
2285983|NCT02431468|3974921|FG000|Overall Study|noncompliance, investigator termination,|2
2285984|NCT02431468|3974922|FG001|Overall Study|noncompliance, investigator termination,|2
2285985|NCT02431468|3974923|FG002|Overall Study|noncompliance, investigator termination,|2
2285986|NCT02431533|3974939|FG000|Overall Study|Withdrawal by Subject|1
2285987|NCT02431533|3974940|FG001|Overall Study|Withdrawal by Subject|3
2133605|NCT01059825|3738898|FG002|Treatment Period|Adverse event related to study drug|1
2133606|NCT01059825|3738899|FG003|Treatment Period|Adverse event related to study drug|1
2133607|NCT01059825|3738900|FG004|Treatment Period|Adverse event related to study drug|0
2133608|NCT01059825|3738901|FG005|Treatment Period|Adverse event related to study drug|0
2133609|NCT01059825|3738902|FG006|Treatment Period|Adverse event related to study drug|0
2207237|NCT01628120|3846203|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2
2207238|NCT01628120|3846203|FG000|Overall Study|Non-compliant with Study Procedures|1
2285988|NCT02431533|3974939|FG000|Overall Study|Developed Exclusionary criteria|1
2285989|NCT02431533|3974940|FG001|Overall Study|Developed Exclusionary criteria|0
2285990|NCT02431559|3974950|FG000|Overall Study|Adverse Event|0
2285991|NCT02431559|3974951|FG001|Overall Study|Adverse Event|1
2285992|NCT02431559|3974952|FG002|Overall Study|Adverse Event|0
2285993|NCT02431559|3974953|FG003|Overall Study|Adverse Event|4
2285994|NCT02431559|3974950|FG000|Overall Study|Progressive disease|2
2285995|NCT02431559|3974951|FG001|Overall Study|Progressive disease|1
2285996|NCT02431559|3974952|FG002|Overall Study|Progressive disease|4
2285997|NCT02431559|3974953|FG003|Overall Study|Progressive disease|22
2285998|NCT02431559|3974950|FG000|Overall Study|Withdrawal by Subject|0
2285999|NCT02431559|3974951|FG001|Overall Study|Withdrawal by Subject|1
2286000|NCT02431559|3974952|FG002|Overall Study|Withdrawal by Subject|0
2286001|NCT02431559|3974953|FG003|Overall Study|Withdrawal by Subject|4
2286002|NCT02431559|3974950|FG000|Overall Study|Physician Decision|0
2286003|NCT02431559|3974951|FG001|Overall Study|Physician Decision|0
2286004|NCT02431559|3974952|FG002|Overall Study|Physician Decision|0
2286005|NCT02431559|3974953|FG003|Overall Study|Physician Decision|1
2286006|NCT02431676|3975014|FG000|Overall Study|no lab obtained|0
2286007|NCT02431676|3975015|FG001|Overall Study|no lab obtained|1
2286008|NCT02431676|3975016|FG002|Overall Study|no lab obtained|2
2286009|NCT02431793|3975042|FG000|Overall Study|Ineligible doe to not filling Rx|11
2286010|NCT02431793|3975043|FG001|Overall Study|Ineligible doe to not filling Rx|7
2286011|NCT02431793|3975044|FG002|Overall Study|Ineligible doe to not filling Rx|8
2286012|NCT02431793|3975042|FG000|Overall Study|Withdrawal by Subject|7
2286013|NCT02431793|3975043|FG001|Overall Study|Withdrawal by Subject|5
2286014|NCT02431793|3975044|FG002|Overall Study|Withdrawal by Subject|5
2286015|NCT02431793|3975042|FG000|Overall Study|Lost to Follow-up|101
2286016|NCT02431793|3975043|FG001|Overall Study|Lost to Follow-up|122
2286017|NCT02431793|3975044|FG002|Overall Study|Lost to Follow-up|104
2286018|NCT02431806|3975056|FG000|Double-blind Treatment Period|Did not Receive Treatment|1
2286019|NCT02431806|3975057|FG001|Double-blind Treatment Period|Did not Receive Treatment|2
2286020|NCT02431806|3975058|FG002|Double-blind Treatment Period|Did not Receive Treatment|1
2286021|NCT02431806|3975059|FG003|Double-blind Treatment Period|Did not Receive Treatment|1
2286022|NCT02431806|3975056|FG000|Double-blind Treatment Period|Adverse Event|4
2286023|NCT02431806|3975057|FG001|Double-blind Treatment Period|Adverse Event|7
2286024|NCT02431806|3975058|FG002|Double-blind Treatment Period|Adverse Event|11
2286025|NCT02431806|3975059|FG003|Double-blind Treatment Period|Adverse Event|7
2286026|NCT02431806|3975056|FG000|Double-blind Treatment Period|Lack of Efficacy|2
2286027|NCT02431806|3975057|FG001|Double-blind Treatment Period|Lack of Efficacy|0
2286028|NCT02431806|3975058|FG002|Double-blind Treatment Period|Lack of Efficacy|2
2286029|NCT02431806|3975059|FG003|Double-blind Treatment Period|Lack of Efficacy|2
2286030|NCT02431806|3975056|FG000|Double-blind Treatment Period|Withdrawal of Consent|10
2286031|NCT02431806|3975057|FG001|Double-blind Treatment Period|Withdrawal of Consent|7
2286032|NCT02431806|3975058|FG002|Double-blind Treatment Period|Withdrawal of Consent|5
2286033|NCT02431806|3975059|FG003|Double-blind Treatment Period|Withdrawal of Consent|5
2286034|NCT02431806|3975056|FG000|Double-blind Treatment Period|Lost to Follow-up|7
2286035|NCT02431806|3975057|FG001|Double-blind Treatment Period|Lost to Follow-up|4
2286036|NCT02431806|3975058|FG002|Double-blind Treatment Period|Lost to Follow-up|5
2286037|NCT02431806|3975059|FG003|Double-blind Treatment Period|Lost to Follow-up|8
2286038|NCT02431806|3975056|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1
2286039|NCT02431806|3975057|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0
2286040|NCT02431806|3975058|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3
2286041|NCT02431806|3975059|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1
2286042|NCT02431806|3975056|FG000|Double-blind Treatment Period|Reason Not Specified|0
2286043|NCT02431806|3975057|FG001|Double-blind Treatment Period|Reason Not Specified|1
2286044|NCT02431806|3975058|FG002|Double-blind Treatment Period|Reason Not Specified|5
2286045|NCT02431806|3975059|FG003|Double-blind Treatment Period|Reason Not Specified|2
2286046|NCT02432040|3975071|FG000|Overall Study|Lack of Efficacy|3
2286047|NCT02432040|3975072|FG001|Overall Study|Lack of Efficacy|0
2286048|NCT02432040|3975071|FG000|Overall Study|Lost to Follow-up|4
2286049|NCT02432040|3975072|FG001|Overall Study|Lost to Follow-up|5
2286050|NCT02432040|3975071|FG000|Overall Study|Physician Decision|1
2286051|NCT02432040|3975072|FG001|Overall Study|Physician Decision|1
2286052|NCT02432105|3975081|FG000|Overall Study|Lost to Follow-up|1
2286053|NCT02432105|3975082|FG001|Overall Study|Lost to Follow-up|1
2286054|NCT02432105|3975083|FG002|Overall Study|Lost to Follow-up|0
2133610|NCT01059825|3738896|FG000|Treatment Period|Insufficient clinical response|3
2133611|NCT01059825|3738897|FG001|Treatment Period|Insufficient clinical response|0
2133612|NCT01059825|3738898|FG002|Treatment Period|Insufficient clinical response|0
2133613|NCT01059825|3738899|FG003|Treatment Period|Insufficient clinical response|0
2207239|NCT01628120|3846203|FG000|Overall Study|Not Treated|3
2207240|NCT01628120|3846203|FG000|Overall Study|Sponsor Decision|5
2207241|NCT01628120|3846203|FG000|Overall Study|Switched Dialysis Method|2
2207242|NCT01628120|3846203|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3
2207243|NCT01628120|3846203|FG000|Overall Study|Moved or Relocated|5
2207244|NCT01628120|3846203|FG000|Overall Study|Kidney Transplant|2
2207245|NCT01628120|3846203|FG000|Overall Study|Use of Standard of Care|1
2207246|NCT01628198|3846211|FG000|Overall Study|Lost to Follow-up|7
2207247|NCT01628198|3846211|FG000|Overall Study|Withdrawal by Subject|10
2207248|NCT01628198|3846211|FG000|Overall Study|Screen failure|1
2207249|NCT01628367|3846226|FG000|Overall Study|Adverse Event|1
2207250|NCT01628367|3846227|FG001|Overall Study|Adverse Event|0
2207251|NCT01628393|3846236|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1
2207252|NCT01628393|3846237|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0
2207253|NCT01628393|3846238|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0
2207254|NCT01628393|3846239|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0
2207255|NCT01628393|3846240|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0
2207256|NCT01628393|3846236|FG000|Placebo-controlled Treatment Period|Protocol Violation|0
2286055|NCT02432105|3975081|FG000|Overall Study|Withdrawal by Subject|1
2286056|NCT02432105|3975082|FG001|Overall Study|Withdrawal by Subject|0
2286057|NCT02432105|3975083|FG002|Overall Study|Withdrawal by Subject|1
2286058|NCT02432105|3975081|FG000|Overall Study|Culture positive for yeast|0
2286059|NCT02432105|3975082|FG001|Overall Study|Culture positive for yeast|1
2286060|NCT02432105|3975083|FG002|Overall Study|Culture positive for yeast|0
2286061|NCT02432105|3975081|FG000|Overall Study|Randomized in error|0
2286062|NCT02432105|3975082|FG001|Overall Study|Randomized in error|0
2286063|NCT02432105|3975083|FG002|Overall Study|Randomized in error|2
2286064|NCT02432144|3975092|FG000|Overall Study|Participant Non-Compliance|1
2286065|NCT02432235|3975125|FG000|Overall Study|Death|1
2286066|NCT02432235|3975126|FG001|Overall Study|Death|1
2286067|NCT02432235|3975127|FG002|Overall Study|Death|2
2286068|NCT02432235|3975128|FG003|Overall Study|Death|2
2286069|NCT02432235|3975129|FG004|Overall Study|Death|1
2286070|NCT02432235|3975130|FG005|Overall Study|Death|3
2286071|NCT02432235|3975131|FG006|Overall Study|Death|11
2286072|NCT02432235|3975132|FG007|Overall Study|Death|15
2286073|NCT02432235|3975133|FG008|Overall Study|Death|15
2286074|NCT02432235|3975134|FG009|Overall Study|Death|3
2286075|NCT02432235|3975135|FG010|Overall Study|Death|1
2286076|NCT02432235|3975136|FG011|Overall Study|Death|0
2286077|NCT02432235|3975125|FG000|Overall Study|Withdrawal by Subject|0
2286078|NCT02432235|3975126|FG001|Overall Study|Withdrawal by Subject|1
2207257|NCT01628393|3846237|FG001|Placebo-controlled Treatment Period|Protocol Violation|1
2207258|NCT01628393|3846238|FG002|Placebo-controlled Treatment Period|Protocol Violation|0
2207259|NCT01628393|3846239|FG003|Placebo-controlled Treatment Period|Protocol Violation|0
2207260|NCT01628393|3846240|FG004|Placebo-controlled Treatment Period|Protocol Violation|0
2286079|NCT02432235|3975127|FG002|Overall Study|Withdrawal by Subject|0
2286080|NCT02432235|3975128|FG003|Overall Study|Withdrawal by Subject|0
2286081|NCT02432235|3975129|FG004|Overall Study|Withdrawal by Subject|0
2286082|NCT02432235|3975130|FG005|Overall Study|Withdrawal by Subject|2
2286083|NCT02432235|3975131|FG006|Overall Study|Withdrawal by Subject|5
2286084|NCT02432235|3975132|FG007|Overall Study|Withdrawal by Subject|3
2286085|NCT02432235|3975133|FG008|Overall Study|Withdrawal by Subject|1
2286086|NCT02432235|3975134|FG009|Overall Study|Withdrawal by Subject|0
2286087|NCT02432235|3975135|FG010|Overall Study|Withdrawal by Subject|0
2286088|NCT02432235|3975136|FG011|Overall Study|Withdrawal by Subject|0
2286089|NCT02432235|3975125|FG000|Overall Study|Lost to Follow-up|0
2286090|NCT02432235|3975126|FG001|Overall Study|Lost to Follow-up|0
2286091|NCT02432235|3975127|FG002|Overall Study|Lost to Follow-up|0
2286092|NCT02432235|3975128|FG003|Overall Study|Lost to Follow-up|0
2286093|NCT02432235|3975129|FG004|Overall Study|Lost to Follow-up|0
2286094|NCT02432235|3975130|FG005|Overall Study|Lost to Follow-up|1
2286095|NCT02432235|3975131|FG006|Overall Study|Lost to Follow-up|0
2286096|NCT02432235|3975132|FG007|Overall Study|Lost to Follow-up|0
2286097|NCT02432235|3975133|FG008|Overall Study|Lost to Follow-up|1
2286098|NCT02432235|3975134|FG009|Overall Study|Lost to Follow-up|0
2286099|NCT02432235|3975135|FG010|Overall Study|Lost to Follow-up|0
2286100|NCT02432235|3975136|FG011|Overall Study|Lost to Follow-up|0
2286101|NCT02432235|3975125|FG000|Overall Study|Miscellaneous|0
2286102|NCT02432235|3975126|FG001|Overall Study|Miscellaneous|0
2286103|NCT02432235|3975127|FG002|Overall Study|Miscellaneous|0
2286104|NCT02432235|3975128|FG003|Overall Study|Miscellaneous|0
2286105|NCT02432235|3975129|FG004|Overall Study|Miscellaneous|1
2286106|NCT02432235|3975130|FG005|Overall Study|Miscellaneous|6
2286107|NCT02432235|3975131|FG006|Overall Study|Miscellaneous|2
2286108|NCT02432235|3975132|FG007|Overall Study|Miscellaneous|2
2286109|NCT02432235|3975133|FG008|Overall Study|Miscellaneous|4
2286110|NCT02432235|3975134|FG009|Overall Study|Miscellaneous|0
2286111|NCT02432235|3975135|FG010|Overall Study|Miscellaneous|0
2286112|NCT02432235|3975136|FG011|Overall Study|Miscellaneous|1
2286113|NCT02432274|3975172|FG000|Overall Study|Radiological Disease Progression|3
2286114|NCT02432274|3975173|FG001|Overall Study|Radiological Disease Progression|4
2286115|NCT02432274|3975174|FG002|Overall Study|Radiological Disease Progression|7
2286116|NCT02432274|3975175|FG003|Overall Study|Radiological Disease Progression|0
2207261|NCT01628393|3846236|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2
2286117|NCT02432274|3975176|FG004|Overall Study|Radiological Disease Progression|24
2286118|NCT02432274|3975177|FG005|Overall Study|Radiological Disease Progression|6
2286119|NCT02432274|3975178|FG006|Overall Study|Radiological Disease Progression|11
2286120|NCT02432274|3975179|FG007|Overall Study|Radiological Disease Progression|9
2286121|NCT02432274|3975172|FG000|Overall Study|Clinical Disease Progression|0
2286122|NCT02432274|3975173|FG001|Overall Study|Clinical Disease Progression|4
2286123|NCT02432274|3975174|FG002|Overall Study|Clinical Disease Progression|1
2286124|NCT02432274|3975175|FG003|Overall Study|Clinical Disease Progression|0
2286125|NCT02432274|3975176|FG004|Overall Study|Clinical Disease Progression|1
2286126|NCT02432274|3975177|FG005|Overall Study|Clinical Disease Progression|0
2286127|NCT02432274|3975178|FG006|Overall Study|Clinical Disease Progression|0
2286128|NCT02432274|3975179|FG007|Overall Study|Clinical Disease Progression|1
2286129|NCT02432274|3975172|FG000|Overall Study|Adverse Event|0
2286130|NCT02432274|3975173|FG001|Overall Study|Adverse Event|0
2286131|NCT02432274|3975174|FG002|Overall Study|Adverse Event|1
2286132|NCT02432274|3975175|FG003|Overall Study|Adverse Event|0
2286133|NCT02432274|3975176|FG004|Overall Study|Adverse Event|1
2286134|NCT02432274|3975177|FG005|Overall Study|Adverse Event|0
2286135|NCT02432274|3975178|FG006|Overall Study|Adverse Event|2
2286136|NCT02432274|3975179|FG007|Overall Study|Adverse Event|0
2286137|NCT02432274|3975172|FG000|Overall Study|Withdrawal by Subject|0
2286138|NCT02432274|3975173|FG001|Overall Study|Withdrawal by Subject|0
2286139|NCT02432274|3975174|FG002|Overall Study|Withdrawal by Subject|0
2286140|NCT02432274|3975175|FG003|Overall Study|Withdrawal by Subject|0
2286141|NCT02432274|3975176|FG004|Overall Study|Withdrawal by Subject|2
2286142|NCT02432274|3975177|FG005|Overall Study|Withdrawal by Subject|0
2286143|NCT02432274|3975178|FG006|Overall Study|Withdrawal by Subject|1
2286144|NCT02432274|3975179|FG007|Overall Study|Withdrawal by Subject|2
2286145|NCT02432274|3975172|FG000|Overall Study|Participant Choice|0
2286146|NCT02432274|3975173|FG001|Overall Study|Participant Choice|0
2286147|NCT02432274|3975174|FG002|Overall Study|Participant Choice|1
2286148|NCT02432274|3975175|FG003|Overall Study|Participant Choice|0
2286149|NCT02432274|3975176|FG004|Overall Study|Participant Choice|0
2286150|NCT02432274|3975177|FG005|Overall Study|Participant Choice|0
2286151|NCT02432274|3975178|FG006|Overall Study|Participant Choice|1
2286152|NCT02432274|3975179|FG007|Overall Study|Participant Choice|0
2286153|NCT02432274|3975172|FG000|Overall Study|Other than specified|0
2286154|NCT02432274|3975173|FG001|Overall Study|Other than specified|1
2286155|NCT02432274|3975174|FG002|Overall Study|Other than specified|0
2286156|NCT02432274|3975175|FG003|Overall Study|Other than specified|0
2286157|NCT02432274|3975176|FG004|Overall Study|Other than specified|0
2286158|NCT02432274|3975177|FG005|Overall Study|Other than specified|1
2286159|NCT02432274|3975178|FG006|Overall Study|Other than specified|0
2286160|NCT02432274|3975179|FG007|Overall Study|Other than specified|1
2286161|NCT02432274|3975172|FG000|Overall Study|Ongoing|0
2286162|NCT02432274|3975173|FG001|Overall Study|Ongoing|0
2286163|NCT02432274|3975174|FG002|Overall Study|Ongoing|1
2286164|NCT02432274|3975175|FG003|Overall Study|Ongoing|1
2286165|NCT02432274|3975176|FG004|Overall Study|Ongoing|3
2286166|NCT02432274|3975177|FG005|Overall Study|Ongoing|0
2286167|NCT02432274|3975178|FG006|Overall Study|Ongoing|0
2286168|NCT02432274|3975179|FG007|Overall Study|Ongoing|7
2286169|NCT02432703|3975235|FG000|Overall Study|Adverse Event|1
2286170|NCT02432703|3975236|FG001|Overall Study|Adverse Event|4
2286171|NCT02432703|3975235|FG000|Overall Study|Lack of Efficacy|1
2286172|NCT02432703|3975236|FG001|Overall Study|Lack of Efficacy|0
2286173|NCT02432703|3975235|FG000|Overall Study|Lost to Follow-up|5
2286174|NCT02432703|3975236|FG001|Overall Study|Lost to Follow-up|3
2286175|NCT02432703|3975235|FG000|Overall Study|Withdrawal by Subject|9
2286176|NCT02432703|3975236|FG001|Overall Study|Withdrawal by Subject|6
2286177|NCT02432703|3975235|FG000|Overall Study|Other|6
2286178|NCT02432703|3975236|FG001|Overall Study|Other|5
2286179|NCT02433080|3975263|FG000|Overall Study|Lost to Follow-up|1
2286180|NCT02433080|3975264|FG001|Overall Study|Lost to Follow-up|2
2286181|NCT02433080|3975263|FG000|Overall Study|Withdrawal by Subject|0
2286182|NCT02433080|3975264|FG001|Overall Study|Withdrawal by Subject|2
2286183|NCT02433288|3975273|FG000|Overall Study|Severe non-compliance to protocol|13
2286184|NCT02433288|3975274|FG001|Overall Study|Severe non-compliance to protocol|7
2286185|NCT02433288|3975273|FG000|Overall Study|Eligibility criteria not fullfilled|7
2286186|NCT02433288|3975274|FG001|Overall Study|Eligibility criteria not fullfilled|3
2286187|NCT02433288|3975273|FG000|Overall Study|Withdrawal by Subject|101
2286188|NCT02433288|3975274|FG001|Overall Study|Withdrawal by Subject|99
2286189|NCT02433288|3975273|FG000|Overall Study|Lost to Follow-up|2
2286190|NCT02433288|3975274|FG001|Overall Study|Lost to Follow-up|14
2286191|NCT02433288|3975273|FG000|Overall Study|Death|0
2286192|NCT02433288|3975274|FG001|Overall Study|Death|3
2286193|NCT02433340|3975284|FG000|Overall Study|Adverse Event|0
2286194|NCT02433340|3975285|FG001|Overall Study|Adverse Event|0
2207262|NCT01628393|3846237|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1
2286195|NCT02433340|3975286|FG002|Overall Study|Adverse Event|1
2286196|NCT02433340|3975287|FG003|Overall Study|Adverse Event|0
2286197|NCT02433340|3975284|FG000|Overall Study|Withdrawal by Subject|1
2286198|NCT02433340|3975285|FG001|Overall Study|Withdrawal by Subject|0
2207263|NCT01628393|3846238|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1
2207264|NCT01628393|3846239|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0
2207265|NCT01628393|3846240|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0
2207266|NCT01628393|3846236|FG000|Blinded Active Extension Period|Adverse Event|0
2207267|NCT01628393|3846237|FG001|Blinded Active Extension Period|Adverse Event|1
2207268|NCT01628393|3846238|FG002|Blinded Active Extension Period|Adverse Event|0
2207269|NCT01628393|3846239|FG003|Blinded Active Extension Period|Adverse Event|2
2207270|NCT01628393|3846240|FG004|Blinded Active Extension Period|Adverse Event|2
2207271|NCT01628393|3846236|FG000|Blinded Active Extension Period|Lack of Efficacy|0
2207272|NCT01628393|3846237|FG001|Blinded Active Extension Period|Lack of Efficacy|0
2207273|NCT01628393|3846238|FG002|Blinded Active Extension Period|Lack of Efficacy|2
2207274|NCT01628393|3846239|FG003|Blinded Active Extension Period|Lack of Efficacy|0
2207275|NCT01628393|3846240|FG004|Blinded Active Extension Period|Lack of Efficacy|2
2133614|NCT01059825|3738900|FG004|Treatment Period|Insufficient clinical response|0
2133615|NCT01059825|3738901|FG005|Treatment Period|Insufficient clinical response|0
2133616|NCT01059825|3738902|FG006|Treatment Period|Insufficient clinical response|0
2133617|NCT01059825|3738896|FG000|Treatment Period|Adverse event not related to study drug|0
2133618|NCT01059825|3738897|FG001|Treatment Period|Adverse event not related to study drug|1
2133619|NCT01059825|3738898|FG002|Treatment Period|Adverse event not related to study drug|2
2133620|NCT01059825|3738899|FG003|Treatment Period|Adverse event not related to study drug|1
2133621|NCT01059825|3738900|FG004|Treatment Period|Adverse event not related to study drug|1
2133622|NCT01059825|3738901|FG005|Treatment Period|Adverse event not related to study drug|1
2133623|NCT01059825|3738902|FG006|Treatment Period|Adverse event not related to study drug|0
2133624|NCT01059864|3738935|FG000|Open-Label Run-In Phase|Adverse Event|7
2133625|NCT01059864|3738936|FG001|Open-Label Run-In Phase|Adverse Event|0
2133626|NCT01059864|3738937|FG002|Open-Label Run-In Phase|Adverse Event|0
2133627|NCT01059864|3738935|FG000|Open-Label Run-In Phase|Lack of Efficacy|1
2133628|NCT01059864|3738936|FG001|Open-Label Run-In Phase|Lack of Efficacy|0
2133629|NCT01059864|3738937|FG002|Open-Label Run-In Phase|Lack of Efficacy|0
2133630|NCT01059864|3738935|FG000|Open-Label Run-In Phase|Lost to Follow-up|2
2133631|NCT01059864|3738936|FG001|Open-Label Run-In Phase|Lost to Follow-up|0
2133632|NCT01059864|3738937|FG002|Open-Label Run-In Phase|Lost to Follow-up|0
2133633|NCT01059864|3738935|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1
2133634|NCT01059864|3738936|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0
2133635|NCT01059864|3738937|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0
2041631|NCT00440232|3612363|FG001|Overall Study|Lost to Follow-up|1
2041632|NCT00440232|3612362|FG000|Overall Study|Unable to treat within allowed time|0
2041633|NCT00440232|3612363|FG001|Overall Study|Unable to treat within allowed time|1
2207276|NCT01628393|3846236|FG000|Blinded Active Extension Period|Physician Decision|0
2207277|NCT01628393|3846237|FG001|Blinded Active Extension Period|Physician Decision|3
2207278|NCT01628393|3846238|FG002|Blinded Active Extension Period|Physician Decision|0
2207279|NCT01628393|3846239|FG003|Blinded Active Extension Period|Physician Decision|1
2207280|NCT01628393|3846240|FG004|Blinded Active Extension Period|Physician Decision|0
2207281|NCT01628393|3846236|FG000|Blinded Active Extension Period|Protocol Violation|0
2207282|NCT01628393|3846237|FG001|Blinded Active Extension Period|Protocol Violation|0
2207283|NCT01628393|3846238|FG002|Blinded Active Extension Period|Protocol Violation|2
2207284|NCT01628393|3846239|FG003|Blinded Active Extension Period|Protocol Violation|1
2207285|NCT01628393|3846240|FG004|Blinded Active Extension Period|Protocol Violation|0
2207286|NCT01628393|3846236|FG000|Blinded Active Extension Period|Withdrawal by Subject|0
2207287|NCT01628393|3846237|FG001|Blinded Active Extension Period|Withdrawal by Subject|6
2041634|NCT00440232|3612362|FG000|Overall Study|Onset of headache within 4 hours of fast|2
2041635|NCT00440232|3612363|FG001|Overall Study|Onset of headache within 4 hours of fast|2
2041636|NCT00440297|3612371|FG000|Overall Study|Adverse Event|8
2041637|NCT00440297|3612372|FG001|Overall Study|Adverse Event|5
2041638|NCT00440297|3612371|FG000|Overall Study|Lost to Follow-up|1
2041639|NCT00440297|3612372|FG001|Overall Study|Lost to Follow-up|0
2041640|NCT00440297|3612371|FG000|Overall Study|Physician Decision|1
2041641|NCT00440297|3612372|FG001|Overall Study|Physician Decision|0
2041642|NCT00440297|3612371|FG000|Overall Study|Protocol Violation|11
2041643|NCT00440297|3612372|FG001|Overall Study|Protocol Violation|7
2041644|NCT00440297|3612371|FG000|Overall Study|Withdrawal by Subject|1
2041645|NCT00440297|3612372|FG001|Overall Study|Withdrawal by Subject|6
2041646|NCT00440297|3612371|FG000|Overall Study|Randomized by mistake|1
2041647|NCT00440297|3612372|FG001|Overall Study|Randomized by mistake|0
2041648|NCT00440310|3612380|FG000|Overall Study|Lost to Follow-up|4
2041649|NCT00440310|3612381|FG001|Overall Study|Lost to Follow-up|5
2041650|NCT00440310|3612380|FG000|Overall Study|Protocol Violation|0
2041651|NCT00440310|3612381|FG001|Overall Study|Protocol Violation|1
2133636|NCT01059864|3738935|FG000|Open-Label Run-In Phase|Protocol Violation|2
2133637|NCT01059864|3738936|FG001|Open-Label Run-In Phase|Protocol Violation|0
2133638|NCT01059864|3738937|FG002|Open-Label Run-In Phase|Protocol Violation|0
2133639|NCT01059864|3738935|FG000|Double-Blind Treatment Phase|Adverse Event|0
2133640|NCT01059864|3738936|FG001|Double-Blind Treatment Phase|Adverse Event|3
2133641|NCT01059864|3738937|FG002|Double-Blind Treatment Phase|Adverse Event|3
2133642|NCT01059903|3738955|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1
2133643|NCT01059903|3738956|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1
2133644|NCT01060007|3738988|FG000|Overall Study|Withdrawal by Subject|1
2207288|NCT01628393|3846238|FG002|Blinded Active Extension Period|Withdrawal by Subject|2
2207289|NCT01628393|3846239|FG003|Blinded Active Extension Period|Withdrawal by Subject|0
2207290|NCT01628393|3846240|FG004|Blinded Active Extension Period|Withdrawal by Subject|2
2207291|NCT01628510|3846256|FG000|Overall Study|Withdrawal by Subject|0
2207292|NCT01628510|3846257|FG001|Overall Study|Withdrawal by Subject|4
2207293|NCT01628510|3846256|FG000|Overall Study|Death|3
2207294|NCT01628510|3846257|FG001|Overall Study|Death|1
2217437|NCT01708902|3860793|FG001|Overall Study|Lack of Efficacy|1
2217438|NCT01708902|3860794|FG002|Overall Study|Lack of Efficacy|0
2217439|NCT01708902|3860795|FG003|Overall Study|Lack of Efficacy|0
2217440|NCT01708902|3860796|FG004|Overall Study|Lack of Efficacy|0
2217441|NCT01708902|3860797|FG005|Overall Study|Lack of Efficacy|1
2217442|NCT01708902|3860798|FG006|Overall Study|Lack of Efficacy|0
2217443|NCT01708902|3860792|FG000|Overall Study|Non compliance with protocol|0
2217444|NCT01708902|3860793|FG001|Overall Study|Non compliance with protocol|2
2217445|NCT01708902|3860794|FG002|Overall Study|Non compliance with protocol|1
2217446|NCT01708902|3860795|FG003|Overall Study|Non compliance with protocol|3
2217447|NCT01708902|3860796|FG004|Overall Study|Non compliance with protocol|0
2217448|NCT01708902|3860797|FG005|Overall Study|Non compliance with protocol|0
2217449|NCT01708902|3860798|FG006|Overall Study|Non compliance with protocol|0
2217450|NCT01708902|3860792|FG000|Overall Study|Lost to Follow-up|2
2217451|NCT01708902|3860793|FG001|Overall Study|Lost to Follow-up|1
2217452|NCT01708902|3860794|FG002|Overall Study|Lost to Follow-up|2
2217453|NCT01708902|3860795|FG003|Overall Study|Lost to Follow-up|2
2217454|NCT01708902|3860796|FG004|Overall Study|Lost to Follow-up|0
2217455|NCT01708902|3860797|FG005|Overall Study|Lost to Follow-up|0
2217456|NCT01708902|3860798|FG006|Overall Study|Lost to Follow-up|1
2133645|NCT01060007|3738988|FG000|Overall Study|Inevaluable for response at surgery|3
2133646|NCT01060059|3739002|FG000|Overall Study|Adverse Event|1
2133647|NCT01060059|3739003|FG001|Overall Study|Adverse Event|1
2133648|NCT01060059|3739002|FG000|Overall Study|Death|2
2133649|NCT01060059|3739003|FG001|Overall Study|Death|3
2133650|NCT01060059|3739002|FG000|Overall Study|Lost to Follow-up|18
2133651|NCT01060059|3739003|FG001|Overall Study|Lost to Follow-up|34
2133652|NCT01060059|3739002|FG000|Overall Study|entry criteria not met|4
2133653|NCT01060059|3739003|FG001|Overall Study|entry criteria not met|3
2133654|NCT01060059|3739002|FG000|Overall Study|Withdrawal by Subject|35
2133655|NCT01060059|3739003|FG001|Overall Study|Withdrawal by Subject|23
2133656|NCT01060059|3739002|FG000|Overall Study|lack of glycemic control|2
2133657|NCT01060059|3739003|FG001|Overall Study|lack of glycemic control|1
2133658|NCT01060059|3739002|FG000|Overall Study|lack of compliance|5
2133659|NCT01060059|3739003|FG001|Overall Study|lack of compliance|2
2133660|NCT01060072|3739013|FG000|Overall Study|Adverse Event|1
2133661|NCT01060072|3739014|FG001|Overall Study|Adverse Event|1
2133662|NCT01060072|3739013|FG000|Overall Study|Physician Decision|0
2133663|NCT01060072|3739014|FG001|Overall Study|Physician Decision|2
2133664|NCT01060072|3739013|FG000|Overall Study|Protocol Violation|0
2133665|NCT01060072|3739014|FG001|Overall Study|Protocol Violation|1
2133666|NCT01060072|3739013|FG000|Overall Study|Acute cholecystitis|1
2133667|NCT01060072|3739014|FG001|Overall Study|Acute cholecystitis|0
2133668|NCT01060072|3739013|FG000|Overall Study|Excluded Medications|0
2133669|NCT01060072|3739014|FG001|Overall Study|Excluded Medications|1
2133670|NCT01060111|3739036|FG000|Overall Study|Adverse Event|9
2133671|NCT01060111|3739037|FG001|Overall Study|Adverse Event|5
2133672|NCT01060111|3739038|FG002|Overall Study|Adverse Event|18
2133673|NCT01060111|3739036|FG000|Overall Study|Lack of Efficacy|2
2133674|NCT01060111|3739037|FG001|Overall Study|Lack of Efficacy|1
2133675|NCT01060111|3739038|FG002|Overall Study|Lack of Efficacy|0
2133676|NCT01060111|3739036|FG000|Overall Study|Inappropriate participant|5
2133677|NCT01060111|3739037|FG001|Overall Study|Inappropriate participant|4
2133678|NCT01060111|3739038|FG002|Overall Study|Inappropriate participant|5
2133679|NCT01060111|3739036|FG000|Overall Study|Participants' evasion for hospital visit|0
2133680|NCT01060111|3739037|FG001|Overall Study|Participants' evasion for hospital visit|3
2133681|NCT01060111|3739038|FG002|Overall Study|Participants' evasion for hospital visit|2
2133682|NCT01060111|3739036|FG000|Overall Study|Participants' non-cooperation|8
2133683|NCT01060111|3739037|FG001|Overall Study|Participants' non-cooperation|6
2133684|NCT01060111|3739038|FG002|Overall Study|Participants' non-cooperation|6
2133685|NCT01060111|3739036|FG000|Overall Study|Adverse event and insufficient effect|0
2133686|NCT01060111|3739037|FG001|Overall Study|Adverse event and insufficient effect|1
2133687|NCT01060111|3739038|FG002|Overall Study|Adverse event and insufficient effect|0
2133688|NCT01060111|3739036|FG000|Overall Study|Participants' non-cooperation|1
2133689|NCT01060111|3739037|FG001|Overall Study|Participants' non-cooperation|0
2133690|NCT01060111|3739038|FG002|Overall Study|Participants' non-cooperation|0
2133691|NCT01060111|3739036|FG000|Overall Study|Other|2
2133692|NCT01060111|3739037|FG001|Overall Study|Other|3
2133693|NCT01060111|3739038|FG002|Overall Study|Other|4
2133694|NCT01060124|3739049|FG000|Overall Study|Other|16
2133695|NCT01060124|3739049|FG000|Overall Study|Adverse Event|14
2133696|NCT01060124|3739049|FG000|Overall Study|Withdrawal by Subject|7
2133697|NCT01060150|3739053|FG000|Overall Study|Adverse Event|6
2133698|NCT01060150|3739053|FG000|Overall Study|Lost to Follow-up|1
2133699|NCT01060150|3739053|FG000|Overall Study|Protocol Violation|6
2133700|NCT01060150|3739053|FG000|Overall Study|Withdrawal by Subject|8
2133701|NCT01060150|3739053|FG000|Overall Study|Enrolled, but not treated|2
2133702|NCT01060384|3739061|FG000|Overall Study|Withdrawal by Subject|0
2133703|NCT01060384|3739062|FG001|Overall Study|Withdrawal by Subject|1
2133704|NCT01060384|3739063|FG002|Overall Study|Withdrawal by Subject|0
2133705|NCT01060384|3739064|FG003|Overall Study|Withdrawal by Subject|0
2133706|NCT01060384|3739065|FG004|Overall Study|Withdrawal by Subject|0
2133707|NCT01060384|3739061|FG000|Overall Study|Death|0
2133708|NCT01060384|3739062|FG001|Overall Study|Death|0
2133709|NCT01060384|3739063|FG002|Overall Study|Death|0
2133710|NCT01060384|3739064|FG003|Overall Study|Death|0
2133711|NCT01060384|3739065|FG004|Overall Study|Death|1
2133712|NCT01060384|3739061|FG000|Overall Study|Intercurrent illness|0
2133713|NCT01060384|3739062|FG001|Overall Study|Intercurrent illness|0
2133714|NCT01060384|3739063|FG002|Overall Study|Intercurrent illness|0
2133715|NCT01060384|3739064|FG003|Overall Study|Intercurrent illness|0
2133716|NCT01060384|3739065|FG004|Overall Study|Intercurrent illness|1
2133717|NCT01060540|3739076|FG000|Overall Study|Withdrawal by Subject|10
2133718|NCT01060540|3739077|FG001|Overall Study|Withdrawal by Subject|20
2133719|NCT01060540|3739076|FG000|Overall Study|Lost to Follow-up|52
2133720|NCT01060540|3739077|FG001|Overall Study|Lost to Follow-up|43
2133721|NCT01060540|3739076|FG000|Overall Study|Death|2
2133722|NCT01060540|3739077|FG001|Overall Study|Death|1
2133723|NCT01060540|3739076|FG000|Overall Study|Physician Decision|0
2133724|NCT01060540|3739077|FG001|Overall Study|Physician Decision|1
2133725|NCT01060553|3739085|FG000|Overall Study|Lost to Follow-up|3
2133726|NCT01060553|3739086|FG001|Overall Study|Lost to Follow-up|5
2133727|NCT01060553|3739085|FG000|Overall Study|Withdrawal by Subject|5
2133728|NCT01060553|3739086|FG001|Overall Study|Withdrawal by Subject|5
2133729|NCT01060553|3739085|FG000|Overall Study|Lack of Efficacy|1
2133730|NCT01060553|3739086|FG001|Overall Study|Lack of Efficacy|0
2133731|NCT01060670|3739102|FG000|Run In|screen failure|0
2133732|NCT01060670|3739103|FG001|Run In|screen failure|238
2133733|NCT01061008|3739113|FG000|Overall Study|Badiocephalic fistula failed|3
2133734|NCT01061008|3739114|FG001|Overall Study|Badiocephalic fistula failed|2
2286199|NCT02433340|3975286|FG002|Overall Study|Withdrawal by Subject|1
2286200|NCT02433340|3975287|FG003|Overall Study|Withdrawal by Subject|2
2286201|NCT02433340|3975284|FG000|Overall Study|Lost to Follow-up|0
2286202|NCT02433340|3975285|FG001|Overall Study|Lost to Follow-up|1
2286203|NCT02433340|3975286|FG002|Overall Study|Lost to Follow-up|0
2133735|NCT01061008|3739113|FG000|Overall Study|Death|1
2133736|NCT01061008|3739114|FG001|Overall Study|Death|0
2133737|NCT01061008|3739113|FG000|Overall Study|Withdrawal by Subject|1
2133738|NCT01061008|3739114|FG001|Overall Study|Withdrawal by Subject|3
2133739|NCT01061008|3739113|FG000|Overall Study|Unable to exercise following surgery|1
2133740|NCT01061008|3739114|FG001|Overall Study|Unable to exercise following surgery|0
2133741|NCT01061008|3739113|FG000|Overall Study|Adverse Event|0
2133742|NCT01061008|3739114|FG001|Overall Study|Adverse Event|1
2133743|NCT01061177|3739124|FG000|Overall Study|Adverse Event|117
2133744|NCT01061177|3739124|FG000|Overall Study|Withdrawal by Subject|27
2133745|NCT01061177|3739124|FG000|Overall Study|Disease progression|17
2133746|NCT01061177|3739124|FG000|Overall Study|Protocol Violation|11
2133747|NCT01061177|3739124|FG000|Overall Study|Lost to Follow-up|9
2133748|NCT01061177|3739124|FG000|Overall Study|New cancer therapy|9
2133749|NCT01061177|3739124|FG000|Overall Study|Abnormal laboratory values|6
2133750|NCT01061177|3739124|FG000|Overall Study|Abnormal test procedure results|4
2133751|NCT01061177|3739124|FG000|Overall Study|Administratie problems|4
2133752|NCT01061177|3739124|FG000|Overall Study|Death|4
2133753|NCT01061333|3739128|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0
2133754|NCT01061333|3739129|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1
2133755|NCT01061359|3739140|FG000|Overall Study|Death|32
2133756|NCT01061359|3739140|FG000|Overall Study|Lost to Follow-up|1072
2133757|NCT01061359|3739140|FG000|Overall Study|Relapse|187
2133758|NCT01061359|3739140|FG000|Overall Study|Secondary neoplasm|11
2133759|NCT01061385|3739146|FG000|Overall Study|Lost to Follow-up|1
2133760|NCT01061385|3739147|FG001|Overall Study|Lost to Follow-up|0
2133761|NCT01061385|3739146|FG000|Overall Study|subject decision not related to AE|0
2133762|NCT01061385|3739147|FG001|Overall Study|subject decision not related to AE|1
2133763|NCT01061567|3739167|FG000|Overall Study|Adverse Event|32
2133764|NCT01061567|3739167|FG000|Overall Study|Death|2
2133765|NCT01061567|3739167|FG000|Overall Study|Lack of Efficacy|3
2133766|NCT01061567|3739167|FG000|Overall Study|Lost to Follow-up|24
2133767|NCT01061567|3739167|FG000|Overall Study|Protocol Violation|1
2133768|NCT01061567|3739167|FG000|Overall Study|Withdrawal by Subject|11
2133769|NCT01061567|3739167|FG000|Overall Study|Other reason than stated above|3
2133770|NCT01061606|3739171|FG000|Overall Study|Adverse Event|1
2133771|NCT01061606|3739171|FG000|Overall Study|Death|1
2133772|NCT01061606|3739171|FG000|Overall Study|Disease Progression|4
2133773|NCT01061606|3739171|FG000|Overall Study|alternative therapy|2
2133774|NCT01061671|3739177|FG000|Overall Study|Withdrawal by Subject|16
2133775|NCT01061671|3739178|FG001|Overall Study|Withdrawal by Subject|20
2133776|NCT01061671|3739177|FG000|Overall Study|Lost to Follow-up|3
2133777|NCT01061671|3739178|FG001|Overall Study|Lost to Follow-up|5
2133778|NCT01061671|3739177|FG000|Overall Study|Death|28
2133779|NCT01061671|3739178|FG001|Overall Study|Death|30
2133780|NCT01061710|3739184|FG000|Overall Study|Protocol Violation|14
2133781|NCT01061723|3739194|FG000|Overall Study|Adverse Event|0
2133782|NCT01061723|3739195|FG001|Overall Study|Adverse Event|2
2133783|NCT01061723|3739196|FG002|Overall Study|Adverse Event|5
2133784|NCT01061723|3739197|FG003|Overall Study|Adverse Event|5
2133785|NCT01061723|3739198|FG004|Overall Study|Adverse Event|2
2133786|NCT01061723|3739199|FG005|Overall Study|Adverse Event|6
2133787|NCT01061723|3739194|FG000|Overall Study|Lack of Efficacy|2
2133788|NCT01061723|3739195|FG001|Overall Study|Lack of Efficacy|3
2133789|NCT01061723|3739196|FG002|Overall Study|Lack of Efficacy|4
2133790|NCT01061723|3739197|FG003|Overall Study|Lack of Efficacy|2
2133791|NCT01061723|3739198|FG004|Overall Study|Lack of Efficacy|1
2133792|NCT01061723|3739199|FG005|Overall Study|Lack of Efficacy|1
2133793|NCT01061723|3739194|FG000|Overall Study|Randomized but not treated|0
2133794|NCT01061723|3739195|FG001|Overall Study|Randomized but not treated|0
2133795|NCT01061723|3739196|FG002|Overall Study|Randomized but not treated|0
2133796|NCT01061723|3739197|FG003|Overall Study|Randomized but not treated|0
2133797|NCT01061723|3739198|FG004|Overall Study|Randomized but not treated|0
2133798|NCT01061723|3739199|FG005|Overall Study|Randomized but not treated|1
2133799|NCT01061723|3739194|FG000|Overall Study|Other than specified above|2
2133800|NCT01061723|3739195|FG001|Overall Study|Other than specified above|1
2133801|NCT01061723|3739196|FG002|Overall Study|Other than specified above|1
2133802|NCT01061723|3739197|FG003|Overall Study|Other than specified above|1
2133803|NCT01061723|3739198|FG004|Overall Study|Other than specified above|0
2133804|NCT01061723|3739199|FG005|Overall Study|Other than specified above|1
2133805|NCT01061736|3739228|FG000|Overall Study|Dose regimen not selected|0
2133806|NCT01061736|3739229|FG001|Overall Study|Dose regimen not selected|0
2133807|NCT01061736|3739230|FG002|Overall Study|Dose regimen not selected|0
2133808|NCT01061736|3739231|FG003|Overall Study|Dose regimen not selected|0
2133809|NCT01061736|3739232|FG004|Overall Study|Dose regimen not selected|0
2133810|NCT01061736|3739233|FG005|Overall Study|Dose regimen not selected|0
2133811|NCT01061736|3739234|FG006|Overall Study|Dose regimen not selected|79
2133812|NCT01061736|3739235|FG007|Overall Study|Dose regimen not selected|0
2133813|NCT01061736|3739236|FG008|Overall Study|Dose regimen not selected|0
2133814|NCT01061736|3739237|FG009|Overall Study|Dose regimen not selected|0
2133815|NCT01061736|3739228|FG000|Overall Study|Adverse Event|13
2133816|NCT01061736|3739229|FG001|Overall Study|Adverse Event|1
2133817|NCT01061736|3739230|FG002|Overall Study|Adverse Event|3
2133818|NCT01061736|3739231|FG003|Overall Study|Adverse Event|2
2133819|NCT01061736|3739232|FG004|Overall Study|Adverse Event|4
2133820|NCT01061736|3739233|FG005|Overall Study|Adverse Event|1
2133821|NCT01061736|3739234|FG006|Overall Study|Adverse Event|4
2133822|NCT01061736|3739235|FG007|Overall Study|Adverse Event|63
2133823|NCT01061736|3739236|FG008|Overall Study|Adverse Event|67
2133824|NCT01061736|3739237|FG009|Overall Study|Adverse Event|34
2133825|NCT01061736|3739228|FG000|Overall Study|Lack of Efficacy|0
2133826|NCT01061736|3739229|FG001|Overall Study|Lack of Efficacy|2
2133827|NCT01061736|3739230|FG002|Overall Study|Lack of Efficacy|1
2133828|NCT01061736|3739231|FG003|Overall Study|Lack of Efficacy|1
2133829|NCT01061736|3739232|FG004|Overall Study|Lack of Efficacy|1
2133830|NCT01061736|3739233|FG005|Overall Study|Lack of Efficacy|2
2133831|NCT01061736|3739234|FG006|Overall Study|Lack of Efficacy|1
2133832|NCT01061736|3739235|FG007|Overall Study|Lack of Efficacy|9
2133833|NCT01061736|3739236|FG008|Overall Study|Lack of Efficacy|9
2133834|NCT01061736|3739237|FG009|Overall Study|Lack of Efficacy|10
2133835|NCT01061736|3739228|FG000|Overall Study|Poor compliance to protocol|0
2133836|NCT01061736|3739229|FG001|Overall Study|Poor compliance to protocol|0
2133837|NCT01061736|3739230|FG002|Overall Study|Poor compliance to protocol|0
2133838|NCT01061736|3739231|FG003|Overall Study|Poor compliance to protocol|0
2133839|NCT01061736|3739232|FG004|Overall Study|Poor compliance to protocol|0
2133840|NCT01061736|3739233|FG005|Overall Study|Poor compliance to protocol|0
2133841|NCT01061736|3739234|FG006|Overall Study|Poor compliance to protocol|0
2133842|NCT01061736|3739235|FG007|Overall Study|Poor compliance to protocol|2
2133843|NCT01061736|3739236|FG008|Overall Study|Poor compliance to protocol|5
2133844|NCT01061736|3739237|FG009|Overall Study|Poor compliance to protocol|9
2133845|NCT01061736|3739228|FG000|Overall Study|Not treated|0
2133846|NCT01061736|3739229|FG001|Overall Study|Not treated|0
2133847|NCT01061736|3739230|FG002|Overall Study|Not treated|0
2133848|NCT01061736|3739231|FG003|Overall Study|Not treated|0
2133849|NCT01061736|3739232|FG004|Overall Study|Not treated|1
2133850|NCT01061736|3739233|FG005|Overall Study|Not treated|0
2133851|NCT01061736|3739234|FG006|Overall Study|Not treated|0
2133852|NCT01061736|3739235|FG007|Overall Study|Not treated|2
2133853|NCT01061736|3739236|FG008|Overall Study|Not treated|1
2133854|NCT01061736|3739237|FG009|Overall Study|Not treated|0
2133855|NCT01061736|3739228|FG000|Overall Study|Other than specified above|0
2133856|NCT01061736|3739229|FG001|Overall Study|Other than specified above|1
2133857|NCT01061736|3739230|FG002|Overall Study|Other than specified above|2
2133858|NCT01061736|3739231|FG003|Overall Study|Other than specified above|0
2133859|NCT01061736|3739232|FG004|Overall Study|Other than specified above|1
2133860|NCT01061736|3739233|FG005|Overall Study|Other than specified above|0
2133861|NCT01061736|3739234|FG006|Overall Study|Other than specified above|0
2133862|NCT01061736|3739235|FG007|Overall Study|Other than specified above|18
2133863|NCT01061736|3739236|FG008|Overall Study|Other than specified above|15
2133864|NCT01061736|3739237|FG009|Overall Study|Other than specified above|21
2133865|NCT01061775|3739262|FG000|Overall Study|Physician Decision|2
2133866|NCT01061775|3739262|FG000|Overall Study|Lost to Follow-up|1
2133867|NCT01061866|3739267|FG000|Overall Study|Adverse Event|2
2133868|NCT01062061|3739288|FG000|Overall Study|Enrolled more than once|2
2133869|NCT01062061|3739288|FG000|Overall Study|Investigated before study start|13
2133870|NCT01062061|3739288|FG000|Overall Study|Outside chief indications|10
2133871|NCT01062061|3739288|FG000|Overall Study|Failed to meet inclusion criteria|2
2178272|NCT01381900|3802931|FG000|Overall Study|Adverse Event|4
2178273|NCT01381900|3802932|FG001|Overall Study|Adverse Event|6
2178274|NCT01381900|3802933|FG002|Overall Study|Adverse Event|7
2178275|NCT01381900|3802931|FG000|Overall Study|Noncompliance with study drug|0
2178276|NCT01381900|3802932|FG001|Overall Study|Noncompliance with study drug|0
2178277|NCT01381900|3802933|FG002|Overall Study|Noncompliance with study drug|1
2178278|NCT01381900|3802931|FG000|Overall Study|Physician Decision|0
2178279|NCT01381900|3802932|FG001|Overall Study|Physician Decision|1
2178280|NCT01381900|3802933|FG002|Overall Study|Physician Decision|1
2178281|NCT01381900|3802931|FG000|Overall Study|Protocol Violation|0
2178282|NCT01381900|3802932|FG001|Overall Study|Protocol Violation|1
2178283|NCT01381900|3802933|FG002|Overall Study|Protocol Violation|1
2178284|NCT01381900|3802931|FG000|Overall Study|Withdrawal by Subject|0
2178285|NCT01381900|3802932|FG001|Overall Study|Withdrawal by Subject|0
2178286|NCT01381900|3802933|FG002|Overall Study|Withdrawal by Subject|1
2178287|NCT01381900|3802931|FG000|Overall Study|Early withdraw|3
2178288|NCT01381900|3802932|FG001|Overall Study|Early withdraw|1
2178289|NCT01381900|3802933|FG002|Overall Study|Early withdraw|1
2178290|NCT01381926|3802943|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
2178291|NCT01381926|3802944|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
2178292|NCT01381926|3802943|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
2178293|NCT01381926|3802944|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
2178294|NCT01382212|3802980|FG000|Overall Study|Kidney transplant|1
2178295|NCT01382212|3802980|FG000|Overall Study|Withdrew consent|1
2178296|NCT01382225|3802986|FG000|Overall Study|Adverse Event|3
2178297|NCT01382225|3802987|FG001|Overall Study|Adverse Event|2
2178298|NCT01382225|3802986|FG000|Overall Study|Protocol Violation|2
2178299|NCT01382225|3802987|FG001|Overall Study|Protocol Violation|1
2178300|NCT01382225|3802986|FG000|Overall Study|Subject Withdrew Consent|5
2178301|NCT01382225|3802987|FG001|Overall Study|Subject Withdrew Consent|2
2178302|NCT01382225|3802986|FG000|Overall Study|Other|4
2178303|NCT01382225|3802987|FG001|Overall Study|Other|2
2178304|NCT01382251|3802995|FG000|Overall Study|Surgeries cancelled or delayed|16
2178305|NCT01382251|3802996|FG001|Overall Study|Surgeries cancelled or delayed|16
2178306|NCT01382251|3802995|FG000|Overall Study|Lost to Follow-up|4
2178307|NCT01382251|3802996|FG001|Overall Study|Lost to Follow-up|4
2286204|NCT02433340|3975287|FG003|Overall Study|Lost to Follow-up|0
2286205|NCT02433340|3975284|FG000|Overall Study|Required Alternative/Prohibited Therapy|1
2286206|NCT02433340|3975285|FG001|Overall Study|Required Alternative/Prohibited Therapy|0
2286207|NCT02433340|3975286|FG002|Overall Study|Required Alternative/Prohibited Therapy|0
2286208|NCT02433340|3975287|FG003|Overall Study|Required Alternative/Prohibited Therapy|0
2286209|NCT02433340|3975284|FG000|Overall Study|Other|0
2286210|NCT02433340|3975285|FG001|Overall Study|Other|1
2286211|NCT02433340|3975286|FG002|Overall Study|Other|0
2286212|NCT02433340|3975287|FG003|Overall Study|Other|0
2286213|NCT02433379|3975308|FG000|Overall Study|Screen Failures|55
2286214|NCT02433379|3975308|FG000|Overall Study|Death|57
2286215|NCT02433379|3975308|FG000|Overall Study|Total Withdrawals|209
2286216|NCT02433483|3975314|FG000|Overall Study|Unacceptable toxicity|1
2286217|NCT02433483|3975314|FG000|Overall Study|Other antineoplastic therapy/HSCT|1
2286218|NCT02433678|3975345|FG000|Overall Study|Lost to Follow-up|1
2286219|NCT02433678|3975346|FG001|Overall Study|Lost to Follow-up|2
2286220|NCT02433834|3975352|FG000|Overall Study|Protocol-specified criteria|7
2286221|NCT02433834|3975352|FG000|Overall Study|Protocol Violation|3
2286222|NCT02433834|3975352|FG000|Overall Study|Lost to Follow-up|6
2286223|NCT02433834|3975352|FG000|Overall Study|Withdrawal by Subject|14
2286224|NCT02433834|3975352|FG000|Overall Study|Adverse Event|6
2286225|NCT02433834|3975352|FG000|Overall Study|Physician Decision|1
2286226|NCT02434081|3975372|FG000|Overall Study|Death (never started treatment)|2
2286227|NCT02434081|3975372|FG000|Overall Study|Death|2
2178308|NCT01382251|3802995|FG000|Overall Study|Contacted after study closed|1
2178309|NCT01382251|3802996|FG001|Overall Study|Contacted after study closed|1
2178310|NCT01382446|3803012|FG000|Overall Study|Withdrawal by Subject|0
2178311|NCT01382446|3803013|FG001|Overall Study|Withdrawal by Subject|1
2178312|NCT01382446|3803012|FG000|Overall Study|Removal from Mechanical Ventilation|3
2178313|NCT01382446|3803013|FG001|Overall Study|Removal from Mechanical Ventilation|3
2178314|NCT01382602|3803021|FG000|Overall Study|Protocol Violation|0
2286228|NCT02434081|3975372|FG000|Overall Study|Progression|20
2178315|NCT01382602|3803022|FG001|Overall Study|Protocol Violation|3
2178316|NCT01382602|3803021|FG000|Overall Study|Withdrawal by Subject|0
2178317|NCT01382602|3803022|FG001|Overall Study|Withdrawal by Subject|1
2178318|NCT01382940|3803054|FG000|Overall Study|Adverse Event|19
2178319|NCT01382940|3803054|FG000|Overall Study|Lost to Follow-up|4
2178320|NCT01382940|3803054|FG000|Overall Study|Physician Decision|7
2178321|NCT01382940|3803054|FG000|Overall Study|Withdrawal by Subject|23
2286229|NCT02434081|3975372|FG000|Overall Study|Adverse Event|20
2133872|NCT01062113|3739303|FG000|Overall Study|Adverse Event|1
2133873|NCT01062113|3739304|FG001|Overall Study|Adverse Event|0
2133874|NCT01062113|3739305|FG002|Overall Study|Adverse Event|0
2133875|NCT01062113|3739303|FG000|Overall Study|Lack of Efficacy|38
2133876|NCT01062113|3739304|FG001|Overall Study|Lack of Efficacy|22
2133877|NCT01062113|3739305|FG002|Overall Study|Lack of Efficacy|31
2133878|NCT01062113|3739303|FG000|Overall Study|Withdrawal by Subject|1
2133879|NCT01062113|3739304|FG001|Overall Study|Withdrawal by Subject|0
2133880|NCT01062113|3739305|FG002|Overall Study|Withdrawal by Subject|0
2133881|NCT01062126|3739313|FG000|Overall Study|Death|209
2133882|NCT01062126|3739313|FG000|Overall Study|All Withdrawals|324
2133883|NCT01062256|3739328|FG000|Overall Study|Adverse Event|1
2133884|NCT01062256|3739329|FG001|Overall Study|Adverse Event|0
2133885|NCT01062256|3739330|FG002|Overall Study|Adverse Event|0
2133886|NCT01062256|3739328|FG000|Overall Study|Withdrawal by Subject|1
2133887|NCT01062256|3739329|FG001|Overall Study|Withdrawal by Subject|1
2133888|NCT01062256|3739330|FG002|Overall Study|Withdrawal by Subject|1
2133889|NCT01062256|3739328|FG000|Overall Study|Ineligible|1
2133890|NCT01062256|3739329|FG001|Overall Study|Ineligible|4
2133891|NCT01062256|3739330|FG002|Overall Study|Ineligible|3
2133892|NCT01062256|3739328|FG000|Overall Study|Administrative|0
2133893|NCT01062256|3739329|FG001|Overall Study|Administrative|2
2133894|NCT01062256|3739330|FG002|Overall Study|Administrative|0
2133895|NCT01062399|3739360|FG000|Overall Study|Protocol Violation|0
2133896|NCT01062399|3739361|FG001|Overall Study|Protocol Violation|1
2133897|NCT01062399|3739362|FG002|Overall Study|Protocol Violation|0
2133898|NCT01062399|3739363|FG003|Overall Study|Protocol Violation|6
2133899|NCT01062399|3739364|FG004|Overall Study|Protocol Violation|4
2133900|NCT01062555|3739378|FG000|Phase 1|Death|10
2133901|NCT01062555|3739379|FG001|Phase 1|Death|17
2133902|NCT01062555|3739380|FG002|Phase 1|Death|0
2133903|NCT01062555|3739381|FG003|Phase 1|Death|0
2133904|NCT01062555|3739378|FG000|Phase 1|Graft Failure|12
2133905|NCT01062555|3739379|FG001|Phase 1|Graft Failure|8
2133906|NCT01062555|3739380|FG002|Phase 1|Graft Failure|0
2133907|NCT01062555|3739381|FG003|Phase 1|Graft Failure|0
2133908|NCT01062555|3739378|FG000|Phase 1|Withdrawal by Subject|1
2133909|NCT01062555|3739379|FG001|Phase 1|Withdrawal by Subject|1
2133910|NCT01062555|3739380|FG002|Phase 1|Withdrawal by Subject|0
2133911|NCT01062555|3739381|FG003|Phase 1|Withdrawal by Subject|0
2133912|NCT01062555|3739378|FG000|Phase 2|Death|0
2133913|NCT01062555|3739379|FG001|Phase 2|Death|0
2133914|NCT01062555|3739380|FG002|Phase 2|Death|8
2133915|NCT01062555|3739381|FG003|Phase 2|Death|3
2133916|NCT01062555|3739378|FG000|Phase 2|Graft failure|0
2133917|NCT01062555|3739379|FG001|Phase 2|Graft failure|0
2133918|NCT01062555|3739380|FG002|Phase 2|Graft failure|7
2133919|NCT01062555|3739381|FG003|Phase 2|Graft failure|4
2133920|NCT01062555|3739378|FG000|Phase 2|Withdrawal by Subject|0
2133921|NCT01062555|3739379|FG001|Phase 2|Withdrawal by Subject|0
2133922|NCT01062555|3739380|FG002|Phase 2|Withdrawal by Subject|0
2133923|NCT01062555|3739381|FG003|Phase 2|Withdrawal by Subject|7
2133924|NCT01062555|3739378|FG000|Phase 2|Protocol Violation|0
2133925|NCT01062555|3739379|FG001|Phase 2|Protocol Violation|0
2133926|NCT01062555|3739380|FG002|Phase 2|Protocol Violation|0
2133927|NCT01062555|3739381|FG003|Phase 2|Protocol Violation|3
2133928|NCT01062555|3739378|FG000|Phase 2|Physician Decision|0
2133929|NCT01062555|3739379|FG001|Phase 2|Physician Decision|0
2133930|NCT01062555|3739380|FG002|Phase 2|Physician Decision|0
2133931|NCT01062555|3739381|FG003|Phase 2|Physician Decision|17
2133932|NCT01062763|3739407|FG000|Overall Study|Adverse Event|3
2133933|NCT01062763|3739408|FG001|Overall Study|Adverse Event|4
2133934|NCT01062841|3739416|FG000|Overall Study|Indwelling Device Removed|41
2133935|NCT01062841|3739417|FG001|Overall Study|Indwelling Device Removed|48
2133936|NCT01062841|3739416|FG000|Overall Study|Death|3
2133937|NCT01062841|3739417|FG001|Overall Study|Death|5
2133938|NCT01062841|3739416|FG000|Overall Study|Withdrawal by Subject|2
2133939|NCT01062841|3739417|FG001|Overall Study|Withdrawal by Subject|0
2133940|NCT01062841|3739416|FG000|Overall Study|Withdrawal by Study|3
2133941|NCT01062841|3739417|FG001|Overall Study|Withdrawal by Study|0
2133942|NCT01062971|3739434|FG000|Overall Study|Protocol Violation|1
2133943|NCT01062971|3739435|FG001|Overall Study|Protocol Violation|3
2133944|NCT01062971|3739434|FG000|Overall Study|Lost to Follow-up|3
2133945|NCT01062971|3739435|FG001|Overall Study|Lost to Follow-up|4
2133946|NCT01063036|3739441|FG000|Participants Treated With Study Drug|Adverse Event|1
2133947|NCT01063036|3739441|FG000|Participants Treated With Study Drug|Protocol Violation|1
2133948|NCT01063036|3739441|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2
2133949|NCT01063036|3739441|FG000|Participants Treated With Study Drug|Lost to Follow-up|1
2133950|NCT01063036|3739441|FG000|Participants Treated With Study Drug|Pregnancy|1
2133951|NCT01063036|3739441|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
2133952|NCT01063036|3739441|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
2133953|NCT01063036|3739441|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
2133954|NCT01063062|3739460|FG000|Overall Study|Patient withdrew consent|0
2133955|NCT01063062|3739461|FG001|Overall Study|Patient withdrew consent|1
2133956|NCT01063062|3739460|FG000|Overall Study|Adverse Event|2
2133957|NCT01063062|3739461|FG001|Overall Study|Adverse Event|4
2133958|NCT01063062|3739460|FG000|Overall Study|Protocol Violation|5
2133959|NCT01063062|3739461|FG001|Overall Study|Protocol Violation|4
2133960|NCT01063062|3739460|FG000|Overall Study|Investigator's request|1
2133961|NCT01063062|3739461|FG001|Overall Study|Investigator's request|0
2133962|NCT01063062|3739460|FG000|Overall Study|Lost to Follow-up|0
2133963|NCT01063062|3739461|FG001|Overall Study|Lost to Follow-up|2
2133964|NCT01063062|3739460|FG000|Overall Study|Miscellaneous reason|0
2133965|NCT01063062|3739461|FG001|Overall Study|Miscellaneous reason|1
2133966|NCT01063153|3739483|FG000|Overall Study|Found Ineligible During Screening|2
2133967|NCT01063153|3739484|FG001|Overall Study|Found Ineligible During Screening|0
2133968|NCT01063153|3739483|FG000|Overall Study|Lost to Follow-up|0
2133969|NCT01063153|3739484|FG001|Overall Study|Lost to Follow-up|7
2133970|NCT01063153|3739483|FG000|Overall Study|Withdrawal by Subject|0
2133971|NCT01063153|3739484|FG001|Overall Study|Withdrawal by Subject|1
2133972|NCT01063153|3739483|FG000|Overall Study|Physician Decision|0
2133973|NCT01063153|3739484|FG001|Overall Study|Physician Decision|4
2133974|NCT01063283|3739496|FG000|Cycle 1|Adverse Event|2
2133975|NCT01063283|3739497|FG001|Cycle 1|Adverse Event|0
2133976|NCT01063283|3739498|FG002|Cycle 1|Adverse Event|0
2133977|NCT01063283|3739496|FG000|Cycle 1|Technical failure in data collection|1
2133978|NCT01063283|3739497|FG001|Cycle 1|Technical failure in data collection|0
2133979|NCT01063283|3739498|FG002|Cycle 1|Technical failure in data collection|0
2133980|NCT01063348|3739506|FG000|Overall Study|Lost to Follow-up|3
2133981|NCT01063348|3739507|FG001|Overall Study|Lost to Follow-up|10
2133982|NCT01063595|3739513|FG000|Enrolled in Study and Randomized|Reason not Specified|1
2133983|NCT01063595|3739514|FG001|Enrolled in Study and Randomized|Reason not Specified|0
2133984|NCT01063595|3739513|FG000|Enrolled in Study and Randomized|Adverse Event|0
2133985|NCT01063595|3739514|FG001|Enrolled in Study and Randomized|Adverse Event|1
2133986|NCT01063595|3739513|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
2133987|NCT01063595|3739514|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
2133988|NCT01063595|3739513|FG000|First Intervention|Adverse Event|1
2133989|NCT01063595|3739514|FG001|First Intervention|Adverse Event|4
2133990|NCT01063595|3739513|FG000|First Intervention|Withdrawal by Subject|1
2133991|NCT01063595|3739514|FG001|First Intervention|Withdrawal by Subject|0
2133992|NCT01063595|3739513|FG000|First Intervention|Reason not Specified|0
2133993|NCT01063595|3739514|FG001|First Intervention|Reason not Specified|1
2133994|NCT01063764|3739525|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4
2133995|NCT01063764|3739525|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
2133996|NCT01063764|3739525|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
2133997|NCT01063764|3739525|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3
2133998|NCT01063764|3739525|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
2133999|NCT01063764|3739525|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
2134000|NCT01063764|3739525|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
2134001|NCT01063855|3739548|FG000|Overall Study|Adverse Event|4
2134002|NCT01063855|3739549|FG001|Overall Study|Adverse Event|4
2134003|NCT01063855|3739548|FG000|Overall Study|Death|0
2134004|NCT01063855|3739549|FG001|Overall Study|Death|1
2134005|NCT01063855|3739548|FG000|Overall Study|Lost to Follow-up|8
2134006|NCT01063855|3739549|FG001|Overall Study|Lost to Follow-up|4
2134007|NCT01063855|3739548|FG000|Overall Study|Pregnancy|1
2134008|NCT01063855|3739549|FG001|Overall Study|Pregnancy|0
2134009|NCT01063855|3739548|FG000|Overall Study|Lack of Efficacy|0
2134010|NCT01063855|3739549|FG001|Overall Study|Lack of Efficacy|1
2134011|NCT01063855|3739548|FG000|Overall Study|Withdrawal by Subject|11
2134012|NCT01063855|3739549|FG001|Overall Study|Withdrawal by Subject|8
2134013|NCT01063855|3739548|FG000|Overall Study|Reason not specified|13
2134014|NCT01063855|3739549|FG001|Overall Study|Reason not specified|11
2134015|NCT01063868|3739561|FG000|Overall Study|Adverse Event|9
2134016|NCT01063868|3739562|FG001|Overall Study|Adverse Event|7
2134017|NCT01063868|3739561|FG000|Overall Study|Withdrawal by Subject|3
2134018|NCT01063868|3739562|FG001|Overall Study|Withdrawal by Subject|1
2134019|NCT01063868|3739561|FG000|Overall Study|Study Terminated By Sponsor|23
2134020|NCT01063868|3739562|FG001|Overall Study|Study Terminated By Sponsor|4
2134021|NCT01063881|3739571|FG000|Overall Study|Adverse Event|12
2134022|NCT01063881|3739572|FG001|Overall Study|Adverse Event|2
2134023|NCT01063881|3739573|FG002|Overall Study|Adverse Event|0
2134024|NCT01063881|3739571|FG000|Overall Study|Lost to Follow-up|13
2134025|NCT01063881|3739572|FG001|Overall Study|Lost to Follow-up|7
2134026|NCT01063881|3739573|FG002|Overall Study|Lost to Follow-up|1
2134027|NCT01063881|3739571|FG000|Overall Study|Withdrawal by Subject|25
2134028|NCT01063881|3739572|FG001|Overall Study|Withdrawal by Subject|1
2134029|NCT01063881|3739573|FG002|Overall Study|Withdrawal by Subject|0
2134030|NCT01063881|3739571|FG000|Overall Study|Reason for not completed not specified|5
2134031|NCT01063881|3739572|FG001|Overall Study|Reason for not completed not specified|1
2134032|NCT01063881|3739573|FG002|Overall Study|Reason for not completed not specified|0
2134033|NCT01063972|3739613|FG000|Overall Study|Death|12
2134034|NCT01063972|3739614|FG001|Overall Study|Death|11
2134035|NCT01063972|3739613|FG000|Overall Study|Incarcerated|2
2134036|NCT01063972|3739614|FG001|Overall Study|Incarcerated|1
2134037|NCT01064167|3739627|FG000|Overall Study|Protocol Violation|14
2134038|NCT01064167|3739628|FG001|Overall Study|Protocol Violation|15
2134039|NCT01064297|3739647|FG000|Overall Study|Lost to Follow-up|791
2207295|NCT01628549|3846274|FG000|Overall Study|Adverse Event|1
2207296|NCT01628549|3846275|FG001|Overall Study|Adverse Event|1
2207297|NCT01628549|3846276|FG002|Overall Study|Adverse Event|0
2207298|NCT01628549|3846277|FG003|Overall Study|Adverse Event|4
2134040|NCT01064297|3739648|FG001|Overall Study|Lost to Follow-up|48
2134041|NCT01064297|3739649|FG002|Overall Study|Lost to Follow-up|133
2134042|NCT01064310|3739666|FG000|Period 1|Adverse Event|7
2134043|NCT01064310|3739667|FG001|Period 1|Adverse Event|10
2134044|NCT01064310|3739668|FG002|Period 1|Adverse Event|0
2134045|NCT01064310|3739666|FG000|Period 1|Physician Decision|1
2134046|NCT01064310|3739667|FG001|Period 1|Physician Decision|0
2134047|NCT01064310|3739668|FG002|Period 1|Physician Decision|0
2134048|NCT01064310|3739666|FG000|Period 1|Withdrawal by Subject|2
2134049|NCT01064310|3739667|FG001|Period 1|Withdrawal by Subject|2
2134050|NCT01064310|3739668|FG002|Period 1|Withdrawal by Subject|0
2134051|NCT01064310|3739666|FG000|Period 1|Lack of Efficacy|3
2134052|NCT01064310|3739667|FG001|Period 1|Lack of Efficacy|5
2134053|NCT01064310|3739668|FG002|Period 1|Lack of Efficacy|0
2134054|NCT01064310|3739666|FG000|Period 1|Entered Open-label Period|1
2134055|NCT01064310|3739667|FG001|Period 1|Entered Open-label Period|1
2134056|NCT01064310|3739668|FG002|Period 1|Entered Open-label Period|0
2134057|NCT01064310|3739666|FG000|Period 2|Adverse Event|2
2134058|NCT01064310|3739667|FG001|Period 2|Adverse Event|1
2134059|NCT01064310|3739668|FG002|Period 2|Adverse Event|0
2134060|NCT01064310|3739666|FG000|Period 2|Physician Decision|0
2134061|NCT01064310|3739667|FG001|Period 2|Physician Decision|1
2134062|NCT01064310|3739668|FG002|Period 2|Physician Decision|0
2134063|NCT01064310|3739666|FG000|Period 2|Entered Open-label Period|1
2134064|NCT01064310|3739667|FG001|Period 2|Entered Open-label Period|0
2207299|NCT01628549|3846274|FG000|Overall Study|Lost to Follow-up|3
2207300|NCT01628549|3846275|FG001|Overall Study|Lost to Follow-up|4
2207301|NCT01628549|3846276|FG002|Overall Study|Lost to Follow-up|3
2207302|NCT01628549|3846277|FG003|Overall Study|Lost to Follow-up|3
2207303|NCT01628549|3846274|FG000|Overall Study|Withdrawal by Subject|3
2207304|NCT01628549|3846275|FG001|Overall Study|Withdrawal by Subject|4
2207305|NCT01628549|3846276|FG002|Overall Study|Withdrawal by Subject|4
2207306|NCT01628549|3846277|FG003|Overall Study|Withdrawal by Subject|1
2134065|NCT01064310|3739668|FG002|Period 2|Entered Open-label Period|0
2134066|NCT01064310|3739666|FG000|Period 2|Lack of Efficacy|1
2134067|NCT01064310|3739667|FG001|Period 2|Lack of Efficacy|4
2207307|NCT01628549|3846274|FG000|Overall Study|Protocol Violation|2
2207308|NCT01628549|3846275|FG001|Overall Study|Protocol Violation|1
2207309|NCT01628549|3846276|FG002|Overall Study|Protocol Violation|1
2207310|NCT01628549|3846277|FG003|Overall Study|Protocol Violation|0
2207311|NCT01628549|3846274|FG000|Overall Study|withdrawn for noncompliance|0
2207312|NCT01628549|3846275|FG001|Overall Study|withdrawn for noncompliance|2
2207313|NCT01628549|3846276|FG002|Overall Study|withdrawn for noncompliance|1
2207314|NCT01628549|3846277|FG003|Overall Study|withdrawn for noncompliance|0
2207315|NCT01628549|3846274|FG000|Overall Study|abnormal laboratory test results|0
2207316|NCT01628549|3846275|FG001|Overall Study|abnormal laboratory test results|0
2207317|NCT01628549|3846276|FG002|Overall Study|abnormal laboratory test results|1
2207318|NCT01628549|3846277|FG003|Overall Study|abnormal laboratory test results|0
2207319|NCT01628549|3846274|FG000|Overall Study|positive pregnancy test|0
2207320|NCT01628549|3846275|FG001|Overall Study|positive pregnancy test|0
2207321|NCT01628549|3846276|FG002|Overall Study|positive pregnancy test|0
2207322|NCT01628549|3846277|FG003|Overall Study|positive pregnancy test|1
2207323|NCT01628692|3846305|FG000|Overall Study|Lack of Efficacy|4
2207324|NCT01628692|3846306|FG001|Overall Study|Lack of Efficacy|4
2207325|NCT01628692|3846307|FG002|Overall Study|Lack of Efficacy|5
2207326|NCT01628692|3846308|FG003|Overall Study|Lack of Efficacy|1
2207327|NCT01628692|3846309|FG004|Overall Study|Lack of Efficacy|4
2207328|NCT01628692|3846310|FG005|Overall Study|Lack of Efficacy|7
2134068|NCT01064310|3739668|FG002|Period 2|Lack of Efficacy|0
2134069|NCT01064310|3739666|FG000|Open Label Pazopinib|Withdrawal by Subject|0
2134070|NCT01064310|3739667|FG001|Open Label Pazopinib|Withdrawal by Subject|0
2134071|NCT01064310|3739668|FG002|Open Label Pazopinib|Withdrawal by Subject|1
2134072|NCT01064310|3739666|FG000|Open Label Pazopinib|Adverse Event|0
2134073|NCT01064310|3739667|FG001|Open Label Pazopinib|Adverse Event|0
2134074|NCT01064310|3739668|FG002|Open Label Pazopinib|Adverse Event|12
2134075|NCT01064310|3739666|FG000|Open Label Pazopinib|Lack of Efficacy|0
2134076|NCT01064310|3739667|FG001|Open Label Pazopinib|Lack of Efficacy|0
2134077|NCT01064310|3739668|FG002|Open Label Pazopinib|Lack of Efficacy|51
2207329|NCT01628692|3846305|FG000|Overall Study|Adverse Event|2
2207330|NCT01628692|3846306|FG001|Overall Study|Adverse Event|0
2207331|NCT01628692|3846307|FG002|Overall Study|Adverse Event|2
2207332|NCT01628692|3846308|FG003|Overall Study|Adverse Event|0
2134078|NCT01064310|3739666|FG000|Open Label Pazopinib|Physician Decision|0
2134079|NCT01064310|3739667|FG001|Open Label Pazopinib|Physician Decision|0
2134080|NCT01064310|3739668|FG002|Open Label Pazopinib|Physician Decision|20
2134081|NCT01064401|3739692|FG000|Overall Study|Adverse Event|47
2134082|NCT01064401|3739693|FG001|Overall Study|Adverse Event|56
2134083|NCT01064401|3739692|FG000|Overall Study|Lack of Efficacy|46
2207333|NCT01628692|3846309|FG004|Overall Study|Adverse Event|0
2207334|NCT01628692|3846310|FG005|Overall Study|Adverse Event|0
2207335|NCT01628692|3846305|FG000|Overall Study|Withdrawal by Subject|0
2207336|NCT01628692|3846306|FG001|Overall Study|Withdrawal by Subject|1
2207337|NCT01628692|3846307|FG002|Overall Study|Withdrawal by Subject|1
2207338|NCT01628692|3846308|FG003|Overall Study|Withdrawal by Subject|0
2134084|NCT01064401|3739693|FG001|Overall Study|Lack of Efficacy|23
2134085|NCT01064401|3739692|FG000|Overall Study|Lost to Follow-up|12
2207339|NCT01628692|3846309|FG004|Overall Study|Withdrawal by Subject|0
2207340|NCT01628692|3846310|FG005|Overall Study|Withdrawal by Subject|0
2207341|NCT01628692|3846305|FG000|Overall Study|Death|0
2207342|NCT01628692|3846306|FG001|Overall Study|Death|1
2207343|NCT01628692|3846307|FG002|Overall Study|Death|0
2207344|NCT01628692|3846308|FG003|Overall Study|Death|0
2207345|NCT01628692|3846309|FG004|Overall Study|Death|0
2207346|NCT01628692|3846310|FG005|Overall Study|Death|0
2207347|NCT01628692|3846305|FG000|Overall Study|Poor compliance/noncompliance|1
2134086|NCT01064401|3739693|FG001|Overall Study|Lost to Follow-up|9
2134087|NCT01064401|3739692|FG000|Overall Study|Consent Withdrawn|98
2134088|NCT01064401|3739693|FG001|Overall Study|Consent Withdrawn|80
2134089|NCT01064401|3739692|FG000|Overall Study|Investigator Decision|4
2134090|NCT01064401|3739693|FG001|Overall Study|Investigator Decision|6
2134091|NCT01064401|3739692|FG000|Overall Study|Death|4
2134092|NCT01064401|3739693|FG001|Overall Study|Death|0
2134093|NCT01064401|3739692|FG000|Overall Study|Pregnancy|4
2134094|NCT01064401|3739693|FG001|Overall Study|Pregnancy|7
2134095|NCT01064401|3739692|FG000|Overall Study|Noncompliance|7
2134096|NCT01064401|3739693|FG001|Overall Study|Noncompliance|8
2134097|NCT01064401|3739692|FG000|Overall Study|Site Closure|4
2134098|NCT01064401|3739693|FG001|Overall Study|Site Closure|5
2134099|NCT01064401|3739692|FG000|Overall Study|Other|2
2134100|NCT01064401|3739693|FG001|Overall Study|Other|1
2134101|NCT01064414|3739703|FG000|Core Period: Baseline to Week 26|Adverse Event|4
2134102|NCT01064414|3739704|FG001|Core Period: Baseline to Week 26|Adverse Event|4
2134103|NCT01064414|3739705|FG002|Core Period: Baseline to Week 26|Adverse Event|2
2134104|NCT01064414|3739703|FG000|Core Period: Baseline to Week 26|Death|0
2134105|NCT01064414|3739704|FG001|Core Period: Baseline to Week 26|Death|1
2134106|NCT01064414|3739705|FG002|Core Period: Baseline to Week 26|Death|0
2134107|NCT01064414|3739703|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
2134108|NCT01064414|3739704|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
2134109|NCT01064414|3739705|FG002|Core Period: Baseline to Week 26|Protocol Violation|1
2134110|NCT01064414|3739703|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
2134111|NCT01064414|3739704|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2
2134112|NCT01064414|3739705|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2
2134113|NCT01064414|3739703|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2134114|NCT01064414|3739704|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2134115|NCT01064414|3739705|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2134116|NCT01064414|3739703|FG000|Core Period: Baseline to Week 26|Other|4
2134117|NCT01064414|3739704|FG001|Core Period: Baseline to Week 26|Other|7
2134118|NCT01064414|3739705|FG002|Core Period: Baseline to Week 26|Other|2
2134119|NCT01064414|3739703|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
2134120|NCT01064414|3739704|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
2134121|NCT01064414|3739705|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2
2134122|NCT01064414|3739703|FG000|Extension Period: Week 26 to Week 52|Death|0
2134123|NCT01064414|3739704|FG001|Extension Period: Week 26 to Week 52|Death|1
2134124|NCT01064414|3739705|FG002|Extension Period: Week 26 to Week 52|Death|0
2134125|NCT01064414|3739703|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
2134126|NCT01064414|3739704|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2134127|NCT01064414|3739705|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2134128|NCT01064414|3739703|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1
2134129|NCT01064414|3739704|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
2134130|NCT01064414|3739705|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
2134131|NCT01064414|3739703|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2134132|NCT01064414|3739704|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2134133|NCT01064414|3739705|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2134134|NCT01064414|3739703|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
2134135|NCT01064414|3739704|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2134136|NCT01064414|3739705|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2134137|NCT01064414|3739703|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
2134138|NCT01064414|3739704|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
2134139|NCT01064414|3739705|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1
2134140|NCT01064414|3739703|FG000|Extension Period: Week 26 to Week 52|Other|5
2134141|NCT01064414|3739704|FG001|Extension Period: Week 26 to Week 52|Other|2
2134142|NCT01064414|3739705|FG002|Extension Period: Week 26 to Week 52|Other|1
2134143|NCT01064531|3739718|FG000|Overall Study|Lost to Follow-up|0
2134144|NCT01064531|3739719|FG001|Overall Study|Lost to Follow-up|2
2134145|NCT01064531|3739718|FG000|Overall Study|Physician Decision|0
2134146|NCT01064531|3739719|FG001|Overall Study|Physician Decision|1
2134147|NCT01064531|3739718|FG000|Overall Study|Withdrawal by Subject|2
2134148|NCT01064531|3739719|FG001|Overall Study|Withdrawal by Subject|2
2134149|NCT01064531|3739718|FG000|Overall Study|Revision due to femoral stem loosening|1
2207348|NCT01628692|3846306|FG001|Overall Study|Poor compliance/noncompliance|0
2134150|NCT01064531|3739719|FG001|Overall Study|Revision due to femoral stem loosening|0
2134151|NCT01064531|3739718|FG000|Overall Study|Revision due to dislocation|0
2286230|NCT02434081|3975372|FG000|Overall Study|Physician Decision|2
2286231|NCT02434081|3975372|FG000|Overall Study|Withdrawal by Subject|1
2286232|NCT02434081|3975372|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1
2286233|NCT02434328|3975378|FG000|Overall Study|Adverse Event|9
2286234|NCT02434328|3975379|FG001|Overall Study|Adverse Event|4
2286235|NCT02434328|3975378|FG000|Overall Study|Lack of Efficacy|0
2286236|NCT02434328|3975379|FG001|Overall Study|Lack of Efficacy|2
2286237|NCT02434328|3975378|FG000|Overall Study|Physician Decision|0
2134152|NCT01064531|3739719|FG001|Overall Study|Revision due to dislocation|1
2134153|NCT01064531|3739718|FG000|Overall Study|Death|0
2134154|NCT01064531|3739719|FG001|Overall Study|Death|1
2134155|NCT01064622|3739728|FG000|Randomized Phase II|Withdrawal by Subject|2
2134156|NCT01064622|3739729|FG001|Randomized Phase II|Withdrawal by Subject|2
2134157|NCT01064622|3739728|FG000|Randomized Phase II|Protocol Violation|0
2134158|NCT01064622|3739729|FG001|Randomized Phase II|Protocol Violation|1
2134159|NCT01064687|3739742|FG000|Overall Study|Adverse Event|9
2134160|NCT01064687|3739743|FG001|Overall Study|Adverse Event|4
2207349|NCT01628692|3846307|FG002|Overall Study|Poor compliance/noncompliance|0
2207350|NCT01628692|3846308|FG003|Overall Study|Poor compliance/noncompliance|0
2207351|NCT01628692|3846309|FG004|Overall Study|Poor compliance/noncompliance|0
2207352|NCT01628692|3846310|FG005|Overall Study|Poor compliance/noncompliance|0
2207353|NCT01628692|3846305|FG000|Overall Study|Administrative reason by sponsor|0
2207354|NCT01628692|3846306|FG001|Overall Study|Administrative reason by sponsor|0
2207355|NCT01628692|3846307|FG002|Overall Study|Administrative reason by sponsor|0
2207356|NCT01628692|3846308|FG003|Overall Study|Administrative reason by sponsor|0
2207357|NCT01628692|3846309|FG004|Overall Study|Administrative reason by sponsor|0
2207358|NCT01628692|3846310|FG005|Overall Study|Administrative reason by sponsor|1
2207359|NCT01628692|3846305|FG000|Overall Study|Completed 12 Week only|0
2207360|NCT01628692|3846306|FG001|Overall Study|Completed 12 Week only|0
2207361|NCT01628692|3846307|FG002|Overall Study|Completed 12 Week only|0
2207362|NCT01628692|3846308|FG003|Overall Study|Completed 12 Week only|0
2207363|NCT01628692|3846309|FG004|Overall Study|Completed 12 Week only|0
2207364|NCT01628692|3846310|FG005|Overall Study|Completed 12 Week only|1
2207365|NCT01628848|3846338|FG000|Overall Study|Adverse Event|9
2207366|NCT01628848|3846339|FG001|Overall Study|Adverse Event|7
2207367|NCT01628848|3846338|FG000|Overall Study|Lack of Efficacy|0
2207368|NCT01628848|3846339|FG001|Overall Study|Lack of Efficacy|4
2207369|NCT01628848|3846338|FG000|Overall Study|Withdrawal by Subject|0
2207370|NCT01628848|3846339|FG001|Overall Study|Withdrawal by Subject|2
2207371|NCT01628848|3846338|FG000|Overall Study|Physician Decision|3
2207372|NCT01628848|3846339|FG001|Overall Study|Physician Decision|1
2207373|NCT01628874|3846347|FG000|Overall Study|Physician Decision|1
2207374|NCT01628874|3846348|FG001|Overall Study|Physician Decision|1
2207375|NCT01628874|3846347|FG000|Overall Study|Age >4 months|4
2207376|NCT01628874|3846348|FG001|Overall Study|Age >4 months|2
2207377|NCT01628913|3846356|FG000|Overall Study|Adverse Event|12
2207378|NCT01628913|3846357|FG001|Overall Study|Adverse Event|5
2207379|NCT01628913|3846356|FG000|Overall Study|Disease Progression|11
2207380|NCT01628913|3846357|FG001|Overall Study|Disease Progression|14
2207381|NCT01628913|3846356|FG000|Overall Study|Protocol Violation|1
2207382|NCT01628913|3846357|FG001|Overall Study|Protocol Violation|0
2207383|NCT01628913|3846356|FG000|Overall Study|Death|1
2207384|NCT01628913|3846357|FG001|Overall Study|Death|0
2207385|NCT01628913|3846356|FG000|Overall Study|study terminated by Sponsor|4
2207386|NCT01628913|3846357|FG001|Overall Study|study terminated by Sponsor|9
2207387|NCT01628913|3846356|FG000|Overall Study|Withdrawal by Subject|1
2207388|NCT01628913|3846357|FG001|Overall Study|Withdrawal by Subject|0
2207389|NCT01628913|3846356|FG000|Overall Study|Physician Decision|1
2207390|NCT01628913|3846357|FG001|Overall Study|Physician Decision|3
2286238|NCT02434328|3975379|FG001|Overall Study|Physician Decision|1
2286239|NCT02434328|3975378|FG000|Overall Study|Withdrawal by Subject|12
2286240|NCT02434328|3975379|FG001|Overall Study|Withdrawal by Subject|21
2286241|NCT02434328|3975378|FG000|Overall Study|Death|4
2286242|NCT02434328|3975379|FG001|Overall Study|Death|7
2286243|NCT02434328|3975378|FG000|Overall Study|Lost to Follow-up|1
2286244|NCT02434328|3975379|FG001|Overall Study|Lost to Follow-up|6
2286245|NCT02434328|3975378|FG000|Overall Study|Other|4
2286246|NCT02434328|3975379|FG001|Overall Study|Other|1
2286247|NCT02434471|3975386|FG000|Overall Study|Physician Decision|9
2286248|NCT02434770|3975411|FG000|Week 1 to Week 18|Lost to Follow-up|0
2286249|NCT02434770|3975412|FG001|Week 1 to Week 18|Lost to Follow-up|0
2286250|NCT02434770|3975413|FG002|Week 1 to Week 18|Lost to Follow-up|2
2286251|NCT02434770|3975411|FG000|Week 1 to Week 18|Withdrawal by Subject|6
2286252|NCT02434770|3975412|FG001|Week 1 to Week 18|Withdrawal by Subject|12
2286253|NCT02434770|3975413|FG002|Week 1 to Week 18|Withdrawal by Subject|5
2286254|NCT02434770|3975411|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8
2286255|NCT02434770|3975412|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10
2286256|NCT02434770|3975413|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9
2286257|NCT02434770|3975411|FG000|Week 1 to Week 18|Relocated Out of Study Area|0
2134161|NCT01064687|3739744|FG002|Overall Study|Adverse Event|10
2286258|NCT02434770|3975412|FG001|Week 1 to Week 18|Relocated Out of Study Area|0
2207391|NCT01628926|3846366|FG000|Overall Study|Adverse Event|13
2207392|NCT01628926|3846367|FG001|Overall Study|Adverse Event|11
2134162|NCT01064687|3739745|FG003|Overall Study|Adverse Event|3
2134163|NCT01064687|3739742|FG000|Overall Study|Death|1
2286259|NCT02434770|3975413|FG002|Week 1 to Week 18|Relocated Out of Study Area|1
2286260|NCT02434770|3975411|FG000|Week 1 to Week 18|Death|1
2286261|NCT02434770|3975412|FG001|Week 1 to Week 18|Death|0
2286262|NCT02434770|3975413|FG002|Week 1 to Week 18|Death|0
2286263|NCT02434770|3975411|FG000|Week 18 to Week|Lost to Follow-up|2
2286264|NCT02434770|3975412|FG001|Week 18 to Week|Lost to Follow-up|2
2286265|NCT02434770|3975413|FG002|Week 18 to Week|Lost to Follow-up|1
2286266|NCT02434770|3975411|FG000|Week 18 to Week|Withdrawal by Subject|0
2286267|NCT02434770|3975412|FG001|Week 18 to Week|Withdrawal by Subject|0
2286268|NCT02434770|3975413|FG002|Week 18 to Week|Withdrawal by Subject|2
2286269|NCT02434770|3975411|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6
2286270|NCT02434770|3975412|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6
2134164|NCT01064687|3739743|FG001|Overall Study|Death|1
2134165|NCT01064687|3739744|FG002|Overall Study|Death|0
2134166|NCT01064687|3739745|FG003|Overall Study|Death|0
2134167|NCT01064687|3739742|FG000|Overall Study|Entry Criteria Not Met|3
2207393|NCT01628926|3846368|FG002|Overall Study|Adverse Event|9
2207394|NCT01628926|3846366|FG000|Overall Study|Lack of Efficacy|2
2134168|NCT01064687|3739743|FG001|Overall Study|Entry Criteria Not Met|0
2134169|NCT01064687|3739744|FG002|Overall Study|Entry Criteria Not Met|0
2134170|NCT01064687|3739745|FG003|Overall Study|Entry Criteria Not Met|0
2134171|NCT01064687|3739742|FG000|Overall Study|Lack of Efficacy|1
2134172|NCT01064687|3739743|FG001|Overall Study|Lack of Efficacy|0
2134173|NCT01064687|3739744|FG002|Overall Study|Lack of Efficacy|2
2134174|NCT01064687|3739745|FG003|Overall Study|Lack of Efficacy|3
2134175|NCT01064687|3739742|FG000|Overall Study|Lost to Follow-up|7
2134176|NCT01064687|3739743|FG001|Overall Study|Lost to Follow-up|10
2134177|NCT01064687|3739744|FG002|Overall Study|Lost to Follow-up|13
2134178|NCT01064687|3739745|FG003|Overall Study|Lost to Follow-up|5
2134179|NCT01064687|3739742|FG000|Overall Study|Physician Decision|2
2134180|NCT01064687|3739743|FG001|Overall Study|Physician Decision|2
2134181|NCT01064687|3739744|FG002|Overall Study|Physician Decision|0
2134182|NCT01064687|3739745|FG003|Overall Study|Physician Decision|0
2134183|NCT01064687|3739742|FG000|Overall Study|Protocol Violation|1
2134184|NCT01064687|3739743|FG001|Overall Study|Protocol Violation|1
2134185|NCT01064687|3739744|FG002|Overall Study|Protocol Violation|0
2134186|NCT01064687|3739745|FG003|Overall Study|Protocol Violation|1
2134187|NCT01064687|3739742|FG000|Overall Study|Sponsor Decision|0
2134188|NCT01064687|3739743|FG001|Overall Study|Sponsor Decision|0
2134189|NCT01064687|3739744|FG002|Overall Study|Sponsor Decision|3
2134190|NCT01064687|3739745|FG003|Overall Study|Sponsor Decision|0
2134191|NCT01064687|3739742|FG000|Overall Study|Withdrawal by Subject|9
2134192|NCT01064687|3739743|FG001|Overall Study|Withdrawal by Subject|7
2134193|NCT01064687|3739744|FG002|Overall Study|Withdrawal by Subject|12
2134194|NCT01064687|3739745|FG003|Overall Study|Withdrawal by Subject|5
2134195|NCT01064687|3739742|FG000|Overall Study|Treatment Noncompliance|1
2134196|NCT01064687|3739743|FG001|Overall Study|Treatment Noncompliance|1
2134197|NCT01064687|3739744|FG002|Overall Study|Treatment Noncompliance|1
2134198|NCT01064687|3739745|FG003|Overall Study|Treatment Noncompliance|0
2134199|NCT01064739|3739775|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1
2134200|NCT01064817|3739787|FG000|Study Completion|Physician Decision|1
2134201|NCT01064817|3739788|FG001|Study Completion|Physician Decision|0
2134202|NCT01064817|3739787|FG000|Study Completion|Withdrawal by Subject|1
2134203|NCT01064817|3739788|FG001|Study Completion|Withdrawal by Subject|0
2134204|NCT01064856|3739807|FG000|Double-blind (DB) Period|Adverse Event|1
2134205|NCT01064856|3739808|FG001|Double-blind (DB) Period|Adverse Event|0
2134206|NCT01064856|3739809|FG002|Double-blind (DB) Period|Adverse Event|0
2134207|NCT01064856|3739810|FG003|Double-blind (DB) Period|Adverse Event|0
2134208|NCT01064856|3739807|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1
2134209|NCT01064856|3739808|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0
2134210|NCT01064856|3739809|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0
2134211|NCT01064856|3739810|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0
2134212|NCT01064856|3739807|FG000|Open-label (OL) Period|Adverse Event|0
2134213|NCT01064856|3739808|FG001|Open-label (OL) Period|Adverse Event|0
2134214|NCT01064856|3739809|FG002|Open-label (OL) Period|Adverse Event|12
2134215|NCT01064856|3739810|FG003|Open-label (OL) Period|Adverse Event|6
2134216|NCT01064856|3739807|FG000|Open-label (OL) Period|Consent withdrawn by participant|0
2134217|NCT01064856|3739808|FG001|Open-label (OL) Period|Consent withdrawn by participant|0
2134218|NCT01064856|3739809|FG002|Open-label (OL) Period|Consent withdrawn by participant|5
2134219|NCT01064856|3739810|FG003|Open-label (OL) Period|Consent withdrawn by participant|6
2134220|NCT01064856|3739807|FG000|Open-label (OL) Period|Lost to Follow-up|0
2134221|NCT01064856|3739808|FG001|Open-label (OL) Period|Lost to Follow-up|0
2134222|NCT01064856|3739809|FG002|Open-label (OL) Period|Lost to Follow-up|2
2134223|NCT01064856|3739810|FG003|Open-label (OL) Period|Lost to Follow-up|1
2134224|NCT01064856|3739807|FG000|Open-label (OL) Period|Other|0
2286271|NCT02434770|3975413|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3
2286272|NCT02434939|3975425|FG000|Overall Study|Lack of Efficacy|34
2286273|NCT02434939|3975426|FG001|Overall Study|Lack of Efficacy|48
2134225|NCT01064856|3739808|FG001|Open-label (OL) Period|Other|0
2134226|NCT01064856|3739809|FG002|Open-label (OL) Period|Other|7
2134227|NCT01064856|3739810|FG003|Open-label (OL) Period|Other|7
2134228|NCT01064947|3739830|FG000|Overall Study|negative culture|41
2134229|NCT01065350|3739840|FG000|Overall Study|Received incorrect drug allocation|0
2134230|NCT01065350|3739841|FG001|Overall Study|Received incorrect drug allocation|1
2134231|NCT01065597|3739889|FG000|Overall Study|Adverse Event|1
2134232|NCT01065766|3739900|FG000|Overall Study|Assessed before the contracted date|1
2134233|NCT01065766|3739900|FG000|Overall Study|Contraindication to administration|6
2134234|NCT01065766|3739900|FG000|Overall Study|Violated dosage/administration|25
2134235|NCT01065844|3739904|FG000|Overall Study|Adverse Event|5
2134236|NCT01066000|3739908|FG000|Overall Study|Protocol Violation|4
2134237|NCT01066000|3739908|FG000|Overall Study|Death|3
2134238|NCT01066000|3739908|FG000|Overall Study|Withdrawal by Subject|1
2134239|NCT01066000|3739908|FG000|Overall Study|Adverse Event|1
2134240|NCT01066039|3739918|FG000|Overall Study|Adverse Event|6
2134241|NCT01066039|3739918|FG000|Overall Study|Withdrawal by Subject|17
2134242|NCT01066039|3739918|FG000|Overall Study|Protocol Violation|2
2134243|NCT01066039|3739918|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9
2134244|NCT01066039|3739918|FG000|Overall Study|Investigator's Request|1
2134245|NCT01066039|3739918|FG000|Overall Study|Dropout due to Insulin Administration|1
2134246|NCT01066039|3739918|FG000|Overall Study|Additional Antihypertensive Required|4
2134247|NCT01066039|3739918|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2
2134248|NCT01066039|3739918|FG000|Overall Study|Failure to Control Blood Pressure|1
2134249|NCT01066039|3739918|FG000|Overall Study|Drug/Dose Adjustment Required|1
2134250|NCT01066052|3739924|FG000|Overall Study|Enrolled But Not Treated|3
2134251|NCT01066052|3739925|FG001|Overall Study|Enrolled But Not Treated|0
2134252|NCT01066104|3739932|FG000|Overall Study|Adverse Event|1
2134253|NCT01066104|3739933|FG001|Overall Study|Adverse Event|1
2134254|NCT01066104|3739932|FG000|Overall Study|Protocol Violation|1
2134255|NCT01066104|3739933|FG001|Overall Study|Protocol Violation|0
2134256|NCT01066143|3739939|FG000|Overall Study|ineligible for the study|8
2134257|NCT01066156|3739943|FG000|Overall Study|ineligible|2
2134258|NCT01066156|3739943|FG000|Overall Study|Lost to Follow-up|7
2134259|NCT01066156|3739943|FG000|Overall Study|Withdrawal by Subject|1
2134260|NCT01066546|3739969|FG000|Overall Study|Study terminated by sponsor|5
2134261|NCT01066585|3739975|FG000|Overall Study|Protocol Violation|1
2134262|NCT01066585|3739976|FG001|Overall Study|Protocol Violation|0
2134263|NCT01066585|3739975|FG000|Overall Study|Withdrawal by Subject|0
2134264|NCT01066585|3739976|FG001|Overall Study|Withdrawal by Subject|3
2134265|NCT01066780|3739995|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1
2134266|NCT01066780|3739996|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1
2134267|NCT01066793|3740006|FG000|Overall Study|Death|4
2134268|NCT01066793|3740007|FG001|Overall Study|Death|1
2134269|NCT01066793|3740008|FG002|Overall Study|Death|1
2134270|NCT01066793|3740009|FG003|Overall Study|Death|0
2134271|NCT01066793|3740010|FG004|Overall Study|Death|0
2134272|NCT01066793|3740011|FG005|Overall Study|Death|0
2134273|NCT01066793|3740006|FG000|Overall Study|Lack of Efficacy|2
2134274|NCT01066793|3740007|FG001|Overall Study|Lack of Efficacy|1
2134275|NCT01066793|3740008|FG002|Overall Study|Lack of Efficacy|0
2134276|NCT01066793|3740009|FG003|Overall Study|Lack of Efficacy|0
2134277|NCT01066793|3740010|FG004|Overall Study|Lack of Efficacy|0
2134278|NCT01066793|3740011|FG005|Overall Study|Lack of Efficacy|0
2134279|NCT01066793|3740006|FG000|Overall Study|Lost to Follow-up|180
2134280|NCT01066793|3740007|FG001|Overall Study|Lost to Follow-up|39
2134281|NCT01066793|3740008|FG002|Overall Study|Lost to Follow-up|82
2134282|NCT01066793|3740009|FG003|Overall Study|Lost to Follow-up|16
2134283|NCT01066793|3740010|FG004|Overall Study|Lost to Follow-up|0
2134284|NCT01066793|3740011|FG005|Overall Study|Lost to Follow-up|1
2134285|NCT01066793|3740006|FG000|Overall Study|Physician Decision|3
2134286|NCT01066793|3740007|FG001|Overall Study|Physician Decision|0
2134287|NCT01066793|3740008|FG002|Overall Study|Physician Decision|0
2134288|NCT01066793|3740009|FG003|Overall Study|Physician Decision|0
2134289|NCT01066793|3740010|FG004|Overall Study|Physician Decision|0
2134290|NCT01066793|3740011|FG005|Overall Study|Physician Decision|0
2134291|NCT01066793|3740006|FG000|Overall Study|Protocol Violation|3
2134292|NCT01066793|3740007|FG001|Overall Study|Protocol Violation|2
2134293|NCT01066793|3740008|FG002|Overall Study|Protocol Violation|2
2134294|NCT01066793|3740009|FG003|Overall Study|Protocol Violation|0
2134295|NCT01066793|3740010|FG004|Overall Study|Protocol Violation|0
2134296|NCT01066793|3740011|FG005|Overall Study|Protocol Violation|0
2134297|NCT01066793|3740006|FG000|Overall Study|Withdrawal by Subject|7
2134298|NCT01066793|3740007|FG001|Overall Study|Withdrawal by Subject|4
2134299|NCT01066793|3740008|FG002|Overall Study|Withdrawal by Subject|1
2134300|NCT01066793|3740009|FG003|Overall Study|Withdrawal by Subject|0
2134301|NCT01066793|3740010|FG004|Overall Study|Withdrawal by Subject|0
2134302|NCT01066793|3740011|FG005|Overall Study|Withdrawal by Subject|0
2134303|NCT01066793|3740006|FG000|Overall Study|Early Termination|3
2134304|NCT01066793|3740007|FG001|Overall Study|Early Termination|0
2134305|NCT01066793|3740008|FG002|Overall Study|Early Termination|0
2134306|NCT01066793|3740009|FG003|Overall Study|Early Termination|0
2134307|NCT01066793|3740010|FG004|Overall Study|Early Termination|0
2134308|NCT01066793|3740011|FG005|Overall Study|Early Termination|0
2134309|NCT01066793|3740006|FG000|Overall Study|Lab test not done|7
2134310|NCT01066793|3740007|FG001|Overall Study|Lab test not done|0
2134311|NCT01066793|3740008|FG002|Overall Study|Lab test not done|0
2134312|NCT01066793|3740009|FG003|Overall Study|Lab test not done|1
2134313|NCT01066793|3740010|FG004|Overall Study|Lab test not done|0
2134314|NCT01066793|3740011|FG005|Overall Study|Lab test not done|0
2134315|NCT01066793|3740006|FG000|Overall Study|Miscellaneous|4
2134316|NCT01066793|3740007|FG001|Overall Study|Miscellaneous|5
2134317|NCT01066793|3740008|FG002|Overall Study|Miscellaneous|6
2134318|NCT01066793|3740009|FG003|Overall Study|Miscellaneous|0
2134319|NCT01066793|3740010|FG004|Overall Study|Miscellaneous|0
2134320|NCT01066793|3740011|FG005|Overall Study|Miscellaneous|0
2134321|NCT01066793|3740006|FG000|Overall Study|Non-responders|104
2134322|NCT01066793|3740007|FG001|Overall Study|Non-responders|5
2134323|NCT01066793|3740008|FG002|Overall Study|Non-responders|11
2134324|NCT01066793|3740009|FG003|Overall Study|Non-responders|25
2134325|NCT01066793|3740010|FG004|Overall Study|Non-responders|0
2134326|NCT01066793|3740011|FG005|Overall Study|Non-responders|0
2134327|NCT01066793|3740006|FG000|Overall Study|Other|15
2134328|NCT01066793|3740007|FG001|Overall Study|Other|5
2134329|NCT01066793|3740008|FG002|Overall Study|Other|6
2134330|NCT01066793|3740009|FG003|Overall Study|Other|2
2134331|NCT01066793|3740010|FG004|Overall Study|Other|0
2134332|NCT01066793|3740011|FG005|Overall Study|Other|0
2134333|NCT01066793|3740006|FG000|Overall Study|Relapse|20
2134334|NCT01066793|3740007|FG001|Overall Study|Relapse|8
2134335|NCT01066793|3740008|FG002|Overall Study|Relapse|2
2134336|NCT01066793|3740009|FG003|Overall Study|Relapse|3
2134337|NCT01066793|3740010|FG004|Overall Study|Relapse|0
2207395|NCT01628926|3846367|FG001|Overall Study|Lack of Efficacy|1
2207396|NCT01628926|3846368|FG002|Overall Study|Lack of Efficacy|5
2207397|NCT01628926|3846366|FG000|Overall Study|Withdrawal by Subject|6
2134338|NCT01066793|3740011|FG005|Overall Study|Relapse|0
2134339|NCT01066793|3740006|FG000|Overall Study|Result Not Available|1
2134340|NCT01066793|3740007|FG001|Overall Study|Result Not Available|0
2134341|NCT01066793|3740008|FG002|Overall Study|Result Not Available|0
2134342|NCT01066793|3740009|FG003|Overall Study|Result Not Available|0
2134343|NCT01066793|3740010|FG004|Overall Study|Result Not Available|0
2134344|NCT01066793|3740011|FG005|Overall Study|Result Not Available|0
2134345|NCT01066793|3740006|FG000|Overall Study|Treatment Interrupted|1
2134346|NCT01066793|3740007|FG001|Overall Study|Treatment Interrupted|1
2134347|NCT01066793|3740008|FG002|Overall Study|Treatment Interrupted|0
2134348|NCT01066793|3740009|FG003|Overall Study|Treatment Interrupted|0
2134349|NCT01066793|3740010|FG004|Overall Study|Treatment Interrupted|0
2134350|NCT01066793|3740011|FG005|Overall Study|Treatment Interrupted|0
2134351|NCT01066793|3740006|FG000|Overall Study|Treatment Never Started|18
2134352|NCT01066793|3740007|FG001|Overall Study|Treatment Never Started|5
2134353|NCT01066793|3740008|FG002|Overall Study|Treatment Never Started|4
2134354|NCT01066793|3740009|FG003|Overall Study|Treatment Never Started|1
2134355|NCT01066793|3740010|FG004|Overall Study|Treatment Never Started|0
2134356|NCT01066793|3740011|FG005|Overall Study|Treatment Never Started|0
2134357|NCT01066793|3740006|FG000|Overall Study|Treatment Stopped|2
2134358|NCT01066793|3740007|FG001|Overall Study|Treatment Stopped|1
2134359|NCT01066793|3740008|FG002|Overall Study|Treatment Stopped|0
2134360|NCT01066793|3740009|FG003|Overall Study|Treatment Stopped|1
2134361|NCT01066793|3740010|FG004|Overall Study|Treatment Stopped|0
2134362|NCT01066793|3740011|FG005|Overall Study|Treatment Stopped|0
2134363|NCT01066819|3740032|FG000|Overall Study|Adverse Event|18
2134364|NCT01066819|3740033|FG001|Overall Study|Adverse Event|1
2134365|NCT01066819|3740034|FG002|Overall Study|Adverse Event|6
2134366|NCT01066819|3740035|FG003|Overall Study|Adverse Event|0
2134367|NCT01066819|3740036|FG004|Overall Study|Adverse Event|0
2134368|NCT01066819|3740037|FG005|Overall Study|Adverse Event|0
2134369|NCT01066819|3740032|FG000|Overall Study|Death|5
2134370|NCT01066819|3740033|FG001|Overall Study|Death|0
2134371|NCT01066819|3740034|FG002|Overall Study|Death|1
2134372|NCT01066819|3740035|FG003|Overall Study|Death|0
2134373|NCT01066819|3740036|FG004|Overall Study|Death|0
2134374|NCT01066819|3740037|FG005|Overall Study|Death|0
2134375|NCT01066819|3740032|FG000|Overall Study|Lack of Efficacy|22
2134376|NCT01066819|3740033|FG001|Overall Study|Lack of Efficacy|1
2134377|NCT01066819|3740034|FG002|Overall Study|Lack of Efficacy|2
2134378|NCT01066819|3740035|FG003|Overall Study|Lack of Efficacy|1
2134379|NCT01066819|3740036|FG004|Overall Study|Lack of Efficacy|0
2134380|NCT01066819|3740037|FG005|Overall Study|Lack of Efficacy|0
2134381|NCT01066819|3740032|FG000|Overall Study|Physician Decision|6
2134382|NCT01066819|3740033|FG001|Overall Study|Physician Decision|2
2134383|NCT01066819|3740034|FG002|Overall Study|Physician Decision|3
2134384|NCT01066819|3740035|FG003|Overall Study|Physician Decision|0
2134385|NCT01066819|3740036|FG004|Overall Study|Physician Decision|0
2134386|NCT01066819|3740037|FG005|Overall Study|Physician Decision|0
2134387|NCT01066819|3740032|FG000|Overall Study|Protocol Violation|12
2134388|NCT01066819|3740033|FG001|Overall Study|Protocol Violation|6
2134389|NCT01066819|3740034|FG002|Overall Study|Protocol Violation|0
2134390|NCT01066819|3740035|FG003|Overall Study|Protocol Violation|0
2134391|NCT01066819|3740036|FG004|Overall Study|Protocol Violation|0
2134392|NCT01066819|3740037|FG005|Overall Study|Protocol Violation|0
2134393|NCT01066819|3740032|FG000|Overall Study|Withdrawal by Subject|29
2134394|NCT01066819|3740033|FG001|Overall Study|Withdrawal by Subject|11
2134395|NCT01066819|3740034|FG002|Overall Study|Withdrawal by Subject|6
2134396|NCT01066819|3740035|FG003|Overall Study|Withdrawal by Subject|0
2134397|NCT01066819|3740036|FG004|Overall Study|Withdrawal by Subject|0
2134398|NCT01066819|3740037|FG005|Overall Study|Withdrawal by Subject|0
2134399|NCT01066819|3740032|FG000|Overall Study|Administrative|6
2134400|NCT01066819|3740033|FG001|Overall Study|Administrative|4
2134401|NCT01066819|3740034|FG002|Overall Study|Administrative|2
2134402|NCT01066819|3740035|FG003|Overall Study|Administrative|0
2134403|NCT01066819|3740036|FG004|Overall Study|Administrative|0
2134404|NCT01066819|3740037|FG005|Overall Study|Administrative|0
2134405|NCT01066819|3740032|FG000|Overall Study|Not met inclusion/exclusion criteria|1
2134406|NCT01066819|3740033|FG001|Overall Study|Not met inclusion/exclusion criteria|0
2134407|NCT01066819|3740034|FG002|Overall Study|Not met inclusion/exclusion criteria|0
2134408|NCT01066819|3740035|FG003|Overall Study|Not met inclusion/exclusion criteria|0
2134409|NCT01066819|3740036|FG004|Overall Study|Not met inclusion/exclusion criteria|0
2134410|NCT01066819|3740037|FG005|Overall Study|Not met inclusion/exclusion criteria|0
2134411|NCT01066819|3740032|FG000|Overall Study|Early termination|2
2134412|NCT01066819|3740033|FG001|Overall Study|Early termination|0
2134413|NCT01066819|3740034|FG002|Overall Study|Early termination|0
2134414|NCT01066819|3740035|FG003|Overall Study|Early termination|0
2134415|NCT01066819|3740036|FG004|Overall Study|Early termination|0
2134416|NCT01066819|3740037|FG005|Overall Study|Early termination|0
2134417|NCT01066819|3740032|FG000|Overall Study|Failed to return|298
2134418|NCT01066819|3740033|FG001|Overall Study|Failed to return|107
2134419|NCT01066819|3740034|FG002|Overall Study|Failed to return|68
2134420|NCT01066819|3740035|FG003|Overall Study|Failed to return|7
2134421|NCT01066819|3740036|FG004|Overall Study|Failed to return|2
2134422|NCT01066819|3740037|FG005|Overall Study|Failed to return|3
2134423|NCT01066819|3740032|FG000|Overall Study|Lab test not done|9
2134424|NCT01066819|3740033|FG001|Overall Study|Lab test not done|0
2134425|NCT01066819|3740034|FG002|Overall Study|Lab test not done|2
2134426|NCT01066819|3740035|FG003|Overall Study|Lab test not done|1
2134427|NCT01066819|3740036|FG004|Overall Study|Lab test not done|0
2134428|NCT01066819|3740037|FG005|Overall Study|Lab test not done|0
2134429|NCT01066819|3740032|FG000|Overall Study|Miscellaneous|28
2134430|NCT01066819|3740033|FG001|Overall Study|Miscellaneous|10
2286274|NCT02434939|3975425|FG000|Overall Study|Withdrawal by Subject|3
2286275|NCT02434939|3975426|FG001|Overall Study|Withdrawal by Subject|0
2286276|NCT02434939|3975425|FG000|Overall Study|Adverse Event|0
2286277|NCT02434939|3975426|FG001|Overall Study|Adverse Event|1
2286278|NCT02435069|3975433|FG000|Dose Response - First Intervention|Adverse Event|0
2286279|NCT02435069|3975434|FG001|Dose Response - First Intervention|Adverse Event|1
2286280|NCT02435069|3975435|FG002|Dose Response - First Intervention|Adverse Event|1
2286281|NCT02435069|3975436|FG003|Dose Response - First Intervention|Adverse Event|0
2286282|NCT02435069|3975437|FG004|Dose Response - First Intervention|Adverse Event|0
2286283|NCT02435069|3975433|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0
2286284|NCT02435069|3975434|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0
2286285|NCT02435069|3975435|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0
2286286|NCT02435069|3975436|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0
2286287|NCT02435069|3975437|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1
2286288|NCT02435147|3975457|FG000|Overall Study|non-evaluable DXA scan|11
2286289|NCT02435277|3975465|FG000|Overall Study|Adverse Event|1
2286290|NCT02435277|3975466|FG001|Overall Study|Adverse Event|1
2286291|NCT02435277|3975467|FG002|Overall Study|Adverse Event|0
2286292|NCT02435277|3975468|FG003|Overall Study|Adverse Event|0
2286293|NCT02435277|3975465|FG000|Overall Study|Withdrawal by Subject|1
2286294|NCT02435277|3975466|FG001|Overall Study|Withdrawal by Subject|0
2286295|NCT02435277|3975467|FG002|Overall Study|Withdrawal by Subject|0
2286296|NCT02435277|3975468|FG003|Overall Study|Withdrawal by Subject|0
2286297|NCT02435381|3975478|FG000|Overall Study|Lost to Follow-up|2
2286298|NCT02435381|3975479|FG001|Overall Study|Lost to Follow-up|1
2286299|NCT02435680|3975516|FG000|Overall Study|Physician Decision|3
2286300|NCT02435680|3975517|FG001|Overall Study|Physician Decision|0
2286301|NCT02435680|3975518|FG002|Overall Study|Physician Decision|0
2286302|NCT02435680|3975516|FG000|Overall Study|subject / guardian decision|0
2286303|NCT02435680|3975517|FG001|Overall Study|subject / guardian decision|3
2286304|NCT02435680|3975518|FG002|Overall Study|subject / guardian decision|2
2286305|NCT02435680|3975516|FG000|Overall Study|Adverse Event|8
2286306|NCT02435680|3975517|FG001|Overall Study|Adverse Event|3
2286307|NCT02435680|3975518|FG002|Overall Study|Adverse Event|2
2286308|NCT02435680|3975516|FG000|Overall Study|progressive disease|10
2286309|NCT02435680|3975517|FG001|Overall Study|progressive disease|7
2286310|NCT02435680|3975518|FG002|Overall Study|progressive disease|11
2134431|NCT01066819|3740034|FG002|Overall Study|Miscellaneous|18
2134432|NCT01066819|3740035|FG003|Overall Study|Miscellaneous|1
2134433|NCT01066819|3740036|FG004|Overall Study|Miscellaneous|0
2134434|NCT01066819|3740037|FG005|Overall Study|Miscellaneous|0
2134435|NCT01066819|3740032|FG000|Overall Study|Non responders|123
2134436|NCT01066819|3740033|FG001|Overall Study|Non responders|2
2134437|NCT01066819|3740034|FG002|Overall Study|Non responders|7
2134438|NCT01066819|3740035|FG003|Overall Study|Non responders|2
2134439|NCT01066819|3740036|FG004|Overall Study|Non responders|0
2134440|NCT01066819|3740037|FG005|Overall Study|Non responders|1
2134441|NCT01066819|3740032|FG000|Overall Study|Not categorised|9
2286311|NCT02435680|3975516|FG000|Overall Study|not treated|0
2286312|NCT02435680|3975517|FG001|Overall Study|not treated|0
2286313|NCT02435680|3975518|FG002|Overall Study|not treated|1
2286314|NCT02435836|3975539|FG000|Overall Study|Lost to Follow-up|21
2286315|NCT02435836|3975539|FG000|Overall Study|Lack of Efficacy|1
2286316|NCT02435836|3975539|FG000|Overall Study|Withdrawal by Subject|236
2286317|NCT02435836|3975539|FG000|Overall Study|Insufficient Clinical Response|26
2286318|NCT02435836|3975539|FG000|Overall Study|Adverse Event|44
2286319|NCT02435836|3975539|FG000|Overall Study|Sponsor discontinued trial|167
2286320|NCT02435836|3975539|FG000|Overall Study|Noncompliance|27
2286321|NCT02435836|3975539|FG000|Overall Study|Protocol Violation|6
2286322|NCT02435836|3975539|FG000|Overall Study|Met Withdrawal Criteria|7
2286323|NCT02435836|3975539|FG000|Overall Study|AE of Worsening Schizophrenia|96
2286324|NCT02435849|3975543|FG000|Overall Study|Enrolled but not infused|18
2286325|NCT02435849|3975543|FG000|Overall Study|Death|16
2286326|NCT02435849|3975543|FG000|Overall Study|Lack of Efficacy|9
2286327|NCT02435849|3975543|FG000|Overall Study|New therapy for study indication|7
2286328|NCT02435849|3975543|FG000|Overall Study|Subject/guardian decision|2
2286329|NCT02435849|3975543|FG000|Overall Study|Study follow-up ongoing|45
2286330|NCT02435914|3975556|FG000|Overall Study|Ocular Adverse Event|1
2286331|NCT02435914|3975557|FG001|Overall Study|Ocular Adverse Event|0
2286332|NCT02435914|3975558|FG002|Overall Study|Ocular Adverse Event|0
2286333|NCT02435914|3975559|FG003|Overall Study|Ocular Adverse Event|0
2286334|NCT02435914|3975556|FG000|Overall Study|Withdrawal by Subject|0
2286335|NCT02435914|3975557|FG001|Overall Study|Withdrawal by Subject|1
2286336|NCT02435914|3975558|FG002|Overall Study|Withdrawal by Subject|0
2286337|NCT02435914|3975559|FG003|Overall Study|Withdrawal by Subject|0
2286338|NCT02435914|3975556|FG000|Overall Study|Other Miscellaneous Reason|0
2286339|NCT02435914|3975557|FG001|Overall Study|Other Miscellaneous Reason|0
2286340|NCT02435914|3975558|FG002|Overall Study|Other Miscellaneous Reason|1
2286341|NCT02435914|3975559|FG003|Overall Study|Other Miscellaneous Reason|0
2286342|NCT02435966|3975572|FG000|Overall Study|Withdrawal by Subject|0
2286343|NCT02435966|3975573|FG001|Overall Study|Withdrawal by Subject|1
2286344|NCT02435966|3975574|FG002|Overall Study|Withdrawal by Subject|0
2286345|NCT02435992|3975587|FG000|Overall Study|non compliance with protocol|2
2286346|NCT02435992|3975588|FG001|Overall Study|non compliance with protocol|0
2286347|NCT02435992|3975589|FG002|Overall Study|non compliance with protocol|1
2286348|NCT02435992|3975590|FG003|Overall Study|non compliance with protocol|0
2286349|NCT02435992|3975591|FG004|Overall Study|non compliance with protocol|0
2286350|NCT02435992|3975587|FG000|Overall Study|Adverse Event|11
2286351|NCT02435992|3975588|FG001|Overall Study|Adverse Event|6
2286352|NCT02435992|3975589|FG002|Overall Study|Adverse Event|12
2286353|NCT02435992|3975590|FG003|Overall Study|Adverse Event|0
2286354|NCT02435992|3975591|FG004|Overall Study|Adverse Event|0
2134442|NCT01066819|3740033|FG001|Overall Study|Not categorised|2
2134443|NCT01066819|3740034|FG002|Overall Study|Not categorised|6
2134444|NCT01066819|3740035|FG003|Overall Study|Not categorised|1
2134445|NCT01066819|3740036|FG004|Overall Study|Not categorised|0
2134446|NCT01066819|3740037|FG005|Overall Study|Not categorised|0
2134447|NCT01066819|3740032|FG000|Overall Study|Relapse|16
2134448|NCT01066819|3740033|FG001|Overall Study|Relapse|4
2134449|NCT01066819|3740034|FG002|Overall Study|Relapse|3
2134450|NCT01066819|3740035|FG003|Overall Study|Relapse|0
2134451|NCT01066819|3740036|FG004|Overall Study|Relapse|0
2134452|NCT01066819|3740037|FG005|Overall Study|Relapse|0
2134453|NCT01066819|3740032|FG000|Overall Study|Results not available|1
2134454|NCT01066819|3740033|FG001|Overall Study|Results not available|0
2134455|NCT01066819|3740034|FG002|Overall Study|Results not available|0
2134456|NCT01066819|3740035|FG003|Overall Study|Results not available|0
2134457|NCT01066819|3740036|FG004|Overall Study|Results not available|0
2134458|NCT01066819|3740037|FG005|Overall Study|Results not available|0
2134459|NCT01066819|3740032|FG000|Overall Study|Screen failure|1
2134460|NCT01066819|3740033|FG001|Overall Study|Screen failure|0
2134461|NCT01066819|3740034|FG002|Overall Study|Screen failure|0
2134462|NCT01066819|3740035|FG003|Overall Study|Screen failure|0
2134463|NCT01066819|3740036|FG004|Overall Study|Screen failure|0
2134464|NCT01066819|3740037|FG005|Overall Study|Screen failure|0
2134465|NCT01066819|3740032|FG000|Overall Study|Spontaneous cure|1
2134466|NCT01066819|3740033|FG001|Overall Study|Spontaneous cure|0
2134467|NCT01066819|3740034|FG002|Overall Study|Spontaneous cure|0
2134468|NCT01066819|3740035|FG003|Overall Study|Spontaneous cure|0
2134469|NCT01066819|3740036|FG004|Overall Study|Spontaneous cure|0
2134470|NCT01066819|3740037|FG005|Overall Study|Spontaneous cure|0
2286355|NCT02435992|3975587|FG000|Overall Study|Lack of Efficacy|4
2286356|NCT02435992|3975588|FG001|Overall Study|Lack of Efficacy|10
2286357|NCT02435992|3975589|FG002|Overall Study|Lack of Efficacy|9
2286358|NCT02435992|3975590|FG003|Overall Study|Lack of Efficacy|0
2286359|NCT02435992|3975591|FG004|Overall Study|Lack of Efficacy|0
2286360|NCT02435992|3975587|FG000|Overall Study|Withdrawal by Subject|10
2286361|NCT02435992|3975588|FG001|Overall Study|Withdrawal by Subject|8
2286362|NCT02435992|3975589|FG002|Overall Study|Withdrawal by Subject|20
2134471|NCT01066819|3740032|FG000|Overall Study|Treatment never started|85
2134472|NCT01066819|3740033|FG001|Overall Study|Treatment never started|19
2134473|NCT01066819|3740034|FG002|Overall Study|Treatment never started|19
2286363|NCT02435992|3975590|FG003|Overall Study|Withdrawal by Subject|0
2207398|NCT01628926|3846367|FG001|Overall Study|Withdrawal by Subject|4
2207399|NCT01628926|3846368|FG002|Overall Study|Withdrawal by Subject|2
2207400|NCT01628926|3846366|FG000|Overall Study|Protocol Violation|0
2207401|NCT01628926|3846367|FG001|Overall Study|Protocol Violation|1
2207402|NCT01628926|3846368|FG002|Overall Study|Protocol Violation|0
2207403|NCT01628926|3846366|FG000|Overall Study|Discontinuation criteria|3
2207404|NCT01628926|3846367|FG001|Overall Study|Discontinuation criteria|4
2207405|NCT01628926|3846368|FG002|Overall Study|Discontinuation criteria|0
2207406|NCT01628926|3846366|FG000|Overall Study|Physician Decision|2
2207407|NCT01628926|3846367|FG001|Overall Study|Physician Decision|2
2207408|NCT01628926|3846368|FG002|Overall Study|Physician Decision|1
2207409|NCT01628965|3846377|FG000|Overall Study|Adverse Event|30
2207410|NCT01628965|3846377|FG000|Overall Study|Lack of Efficacy|7
2207411|NCT01628965|3846377|FG000|Overall Study|Withdrawal by Subject|3
2207412|NCT01628965|3846377|FG000|Overall Study|Lost to Follow-up|1
2207413|NCT01628965|3846377|FG000|Overall Study|Discontinuation criteria|8
2207414|NCT01629381|3846397|FG000|Overall Study|Withdrawal by Subject|2
2207415|NCT01629381|3846398|FG001|Overall Study|Withdrawal by Subject|5
2207416|NCT01629563|3846410|FG000|Overall Study|Adverse Event|16
2207417|NCT01629563|3846411|FG001|Overall Study|Adverse Event|16
2207418|NCT01629563|3846410|FG000|Overall Study|Death|2
2207419|NCT01629563|3846411|FG001|Overall Study|Death|0
2207420|NCT01629563|3846410|FG000|Overall Study|Lack of Efficacy|2
2207421|NCT01629563|3846411|FG001|Overall Study|Lack of Efficacy|3
2207422|NCT01629563|3846410|FG000|Overall Study|Lost to Follow-up|1
2207423|NCT01629563|3846411|FG001|Overall Study|Lost to Follow-up|0
2207424|NCT01629563|3846410|FG000|Overall Study|Pregnancy|1
2207425|NCT01629563|3846411|FG001|Overall Study|Pregnancy|2
2207426|NCT01629563|3846410|FG000|Overall Study|Protocol Violation|0
2207427|NCT01629563|3846411|FG001|Overall Study|Protocol Violation|1
2134474|NCT01066819|3740035|FG003|Overall Study|Treatment never started|3
2134475|NCT01066819|3740036|FG004|Overall Study|Treatment never started|2
2134476|NCT01066819|3740037|FG005|Overall Study|Treatment never started|2
2134477|NCT01066819|3740032|FG000|Overall Study|Treatment stopped|12
2134478|NCT01066819|3740033|FG001|Overall Study|Treatment stopped|1
2134479|NCT01066819|3740034|FG002|Overall Study|Treatment stopped|2
2134480|NCT01066819|3740035|FG003|Overall Study|Treatment stopped|1
2134481|NCT01066819|3740036|FG004|Overall Study|Treatment stopped|0
2134482|NCT01066819|3740037|FG005|Overall Study|Treatment stopped|0
2134483|NCT01066819|3740032|FG000|Overall Study|Other|5
2134484|NCT01066819|3740033|FG001|Overall Study|Other|1
2134485|NCT01066819|3740034|FG002|Overall Study|Other|1
2134486|NCT01066819|3740035|FG003|Overall Study|Other|0
2134487|NCT01066819|3740036|FG004|Overall Study|Other|0
2134488|NCT01066819|3740037|FG005|Overall Study|Other|0
2134489|NCT01066871|3740053|FG000|Overall Study|Lost to Follow-up|0
2134490|NCT01066871|3740054|FG001|Overall Study|Lost to Follow-up|2
2134491|NCT01066871|3740055|FG002|Overall Study|Lost to Follow-up|2
2134492|NCT01066871|3740056|FG003|Overall Study|Lost to Follow-up|0
2134493|NCT01066871|3740053|FG000|Overall Study|Protocol Violation|1
2134494|NCT01066871|3740054|FG001|Overall Study|Protocol Violation|0
2134495|NCT01066871|3740055|FG002|Overall Study|Protocol Violation|3
2134496|NCT01066871|3740056|FG003|Overall Study|Protocol Violation|2
2134497|NCT01066871|3740053|FG000|Overall Study|Lack of Efficacy|0
2134498|NCT01066871|3740054|FG001|Overall Study|Lack of Efficacy|0
2134499|NCT01066871|3740055|FG002|Overall Study|Lack of Efficacy|0
2134500|NCT01066871|3740056|FG003|Overall Study|Lack of Efficacy|1
2134501|NCT01066871|3740053|FG000|Overall Study|Withdrawal by Subject|3
2134502|NCT01066871|3740054|FG001|Overall Study|Withdrawal by Subject|1
2134503|NCT01066871|3740055|FG002|Overall Study|Withdrawal by Subject|0
2134504|NCT01066871|3740056|FG003|Overall Study|Withdrawal by Subject|0
2134505|NCT01066871|3740053|FG000|Overall Study|Other|0
2134506|NCT01066871|3740054|FG001|Overall Study|Other|2
2134507|NCT01066871|3740055|FG002|Overall Study|Other|1
2134508|NCT01066871|3740056|FG003|Overall Study|Other|2
2134509|NCT01066897|3740073|FG000|Overall Study|Withdrawal by Subject|1
2134510|NCT01066897|3740074|FG001|Overall Study|Withdrawal by Subject|0
2134511|NCT01066897|3740073|FG000|Overall Study|stopped study after developing the flu.|1
2134512|NCT01066897|3740074|FG001|Overall Study|stopped study after developing the flu.|0
2134513|NCT01066923|3740085|FG000|Overall Study|Withdrawal by Subject|3
2134514|NCT01066923|3740086|FG001|Overall Study|Withdrawal by Subject|3
2134515|NCT01066923|3740087|FG002|Overall Study|Withdrawal by Subject|8
2134516|NCT01066923|3740088|FG003|Overall Study|Withdrawal by Subject|8
2134517|NCT01066936|3740098|FG000|Overall Study|Death|2
2134518|NCT01066936|3740098|FG000|Overall Study|Device revised/removed|1
2134519|NCT01066936|3740098|FG000|Overall Study|Lost to Follow-up|3
2134520|NCT01066936|3740098|FG000|Overall Study|Withdrawal by Subject|4
2207428|NCT01629563|3846410|FG000|Overall Study|Withdrawal by Subject|27
2207429|NCT01629563|3846411|FG001|Overall Study|Withdrawal by Subject|20
2207430|NCT01629563|3846410|FG000|Overall Study|surgery|0
2207431|NCT01629563|3846411|FG001|Overall Study|surgery|3
2207432|NCT01629563|3846410|FG000|Overall Study|Lack of return of menses|12
2207433|NCT01629563|3846411|FG001|Overall Study|Lack of return of menses|7
2207434|NCT01629563|3846410|FG000|Overall Study|Protocol Violation|0
2134521|NCT01067105|3740104|FG000|Overall Study|Adverse Event|14
2207435|NCT01629563|3846411|FG001|Overall Study|Protocol Violation|1
2207436|NCT01629589|3846419|FG000|Overall Study|Protocol Violation|4
2134522|NCT01067105|3740104|FG000|Overall Study|Protocol Violation|48
2134523|NCT01067105|3740104|FG000|Overall Study|Withdrawal by Subject|36
2134524|NCT01067105|3740104|FG000|Overall Study|Lost to Follow-up|6
2134525|NCT01067105|3740104|FG000|Overall Study|Physician Decision|6
2134526|NCT01067105|3740104|FG000|Overall Study|Other|31
2134527|NCT01067144|3740110|FG000|Treatment|Did not receive allocated intervention|4
2134528|NCT01067144|3740111|FG001|Treatment|Did not receive allocated intervention|7
2134529|NCT01067144|3740110|FG000|Follow-up|Lost to Follow-up|22
2134530|NCT01067144|3740111|FG001|Follow-up|Lost to Follow-up|12
2134531|NCT01067144|3740110|FG000|Follow-up|Censored owing to second surgery|19
2134532|NCT01067144|3740111|FG001|Follow-up|Censored owing to second surgery|28
2134533|NCT01067144|3740110|FG000|Follow-up|Withdrawal by Subject|18
2134534|NCT01067144|3740111|FG001|Follow-up|Withdrawal by Subject|14
2134535|NCT01067144|3740110|FG000|Follow-up|Surgery cancelled|0
2134536|NCT01067144|3740111|FG001|Follow-up|Surgery cancelled|1
2134537|NCT01067144|3740110|FG000|Follow-up|Death|0
2134538|NCT01067144|3740111|FG001|Follow-up|Death|1
2134539|NCT01067326|3740119|FG000|Overall Study|Adverse Event|0
2134540|NCT01067326|3740120|FG001|Overall Study|Adverse Event|2
2134541|NCT01067326|3740119|FG000|Overall Study|Withdrawal by Subject|1
2134542|NCT01067326|3740120|FG001|Overall Study|Withdrawal by Subject|0
2134543|NCT01067326|3740119|FG000|Overall Study|Early Study Termination|1
2134544|NCT01067326|3740120|FG001|Overall Study|Early Study Termination|1
2134545|NCT01067339|3740128|FG000|Overall Study|Withdrawal by Subject|6
2134546|NCT01067339|3740129|FG001|Overall Study|Withdrawal by Subject|5
2134547|NCT01067352|3740138|FG000|Overall Study|Withdrawal by Subject|1
2134548|NCT01067352|3740139|FG001|Overall Study|Withdrawal by Subject|2
2134549|NCT01067352|3740140|FG002|Overall Study|Withdrawal by Subject|1
2134550|NCT01067352|3740138|FG000|Overall Study|Physician Decision|0
2134551|NCT01067352|3740139|FG001|Overall Study|Physician Decision|1
2134552|NCT01067352|3740140|FG002|Overall Study|Physician Decision|0
2134553|NCT01067469|3740161|FG000|Overall Study|Withdrawal by Subject|0
2134554|NCT01067469|3740162|FG001|Overall Study|Withdrawal by Subject|1
2134555|NCT01067469|3740161|FG000|Overall Study|Disease Progression|0
2134556|NCT01067469|3740162|FG001|Overall Study|Disease Progression|1
2134557|NCT01067508|3740170|FG000|Overall Study|Physician Decision|0
2134558|NCT01067508|3740171|FG001|Overall Study|Physician Decision|1
2134559|NCT01067508|3740170|FG000|Overall Study|Withdrawal by Subject|0
2134560|NCT01067508|3740171|FG001|Overall Study|Withdrawal by Subject|1
2134561|NCT01067846|3740220|FG000|Overall Study|Lost to Follow-up|17
2134562|NCT01067846|3740221|FG001|Overall Study|Lost to Follow-up|19
2134563|NCT01067846|3740220|FG000|Overall Study|Withdrawal by Subject|1
2134564|NCT01067846|3740221|FG001|Overall Study|Withdrawal by Subject|0
2134565|NCT01067846|3740220|FG000|Overall Study|participation in other tx study|1
2134566|NCT01067846|3740221|FG001|Overall Study|participation in other tx study|0
2134567|NCT01067976|3740227|FG000|Overall Study|Study drug never administered|20
2134568|NCT01067976|3740227|FG000|Overall Study|Study prematurely discontinued|2
2134569|NCT01068158|3740247|FG000|Overall Study|Withdrawal by Subject|1
2134570|NCT01068158|3740248|FG001|Overall Study|Withdrawal by Subject|2
2134571|NCT01068158|3740247|FG000|Overall Study|Lost to Follow-up|7
2134572|NCT01068158|3740248|FG001|Overall Study|Lost to Follow-up|0
2134573|NCT01068158|3740247|FG000|Overall Study|Protocol Violation|0
2134574|NCT01068158|3740248|FG001|Overall Study|Protocol Violation|2
2134575|NCT01068262|3740258|FG000|Overall Study|Adverse Event|2
2134576|NCT01068262|3740259|FG001|Overall Study|Adverse Event|0
2134577|NCT01068262|3740260|FG002|Overall Study|Adverse Event|1
2134578|NCT01068262|3740261|FG003|Overall Study|Adverse Event|0
2134579|NCT01068262|3740258|FG000|Overall Study|Protocol Violation|1
2134580|NCT01068262|3740259|FG001|Overall Study|Protocol Violation|0
2134581|NCT01068262|3740260|FG002|Overall Study|Protocol Violation|0
2134582|NCT01068262|3740261|FG003|Overall Study|Protocol Violation|0
2134583|NCT01068262|3740258|FG000|Overall Study|Withdrawal by Subject|0
2134584|NCT01068262|3740259|FG001|Overall Study|Withdrawal by Subject|1
2134585|NCT01068262|3740260|FG002|Overall Study|Withdrawal by Subject|0
2134586|NCT01068262|3740261|FG003|Overall Study|Withdrawal by Subject|0
2134587|NCT01068418|3740274|FG000|Overall Study|Physician Decision|12
2134588|NCT01068509|3740281|FG000|Overall Study|Death|0
2134589|NCT01068509|3740282|FG001|Overall Study|Death|0
2134590|NCT01068509|3740283|FG002|Overall Study|Death|1
2134591|NCT01068509|3740281|FG000|Overall Study|Disease Progression|5
2134592|NCT01068509|3740282|FG001|Overall Study|Disease Progression|20
2134593|NCT01068509|3740283|FG002|Overall Study|Disease Progression|18
2134594|NCT01068509|3740281|FG000|Overall Study|Lost to Follow-up|1
2134595|NCT01068509|3740282|FG001|Overall Study|Lost to Follow-up|0
2134596|NCT01068509|3740283|FG002|Overall Study|Lost to Follow-up|0
2134597|NCT01068509|3740281|FG000|Overall Study|Withdrew Consent|0
2134598|NCT01068509|3740282|FG001|Overall Study|Withdrew Consent|1
2134599|NCT01068509|3740283|FG002|Overall Study|Withdrew Consent|2
2134600|NCT01068509|3740281|FG000|Overall Study|Reason Not Specified|0
2134601|NCT01068509|3740282|FG001|Overall Study|Reason Not Specified|1
2134602|NCT01068509|3740283|FG002|Overall Study|Reason Not Specified|0
2134603|NCT01068600|3740302|FG000|Overall Study|Withdrawal by Subject|5
2134604|NCT01068600|3740303|FG001|Overall Study|Withdrawal by Subject|6
2134605|NCT01068600|3740302|FG000|Overall Study|Adverse Event|3
2134606|NCT01068600|3740303|FG001|Overall Study|Adverse Event|3
2286364|NCT02435992|3975591|FG004|Overall Study|Withdrawal by Subject|0
2286365|NCT02435992|3975587|FG000|Overall Study|Other Reason|1
2286366|NCT02435992|3975588|FG001|Overall Study|Other Reason|0
2286367|NCT02435992|3975589|FG002|Overall Study|Other Reason|0
2286368|NCT02435992|3975590|FG003|Overall Study|Other Reason|0
2286369|NCT02435992|3975591|FG004|Overall Study|Other Reason|0
2134607|NCT01068600|3740302|FG000|Overall Study|Abnormal laboratory value(s)|1
2134608|NCT01068600|3740303|FG001|Overall Study|Abnormal laboratory value(s)|0
2134609|NCT01068600|3740302|FG000|Overall Study|Lost to Follow-up|1
2134610|NCT01068600|3740303|FG001|Overall Study|Lost to Follow-up|2
2134611|NCT01068600|3740302|FG000|Overall Study|Protocol deviation|1
2134612|NCT01068600|3740303|FG001|Overall Study|Protocol deviation|1
2134613|NCT01068600|3740302|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2134614|NCT01068600|3740303|FG001|Overall Study|Unsatisfactory therapeutic effect|4
2134615|NCT01068600|3740302|FG000|Overall Study|Administrative problems|0
2134616|NCT01068600|3740303|FG001|Overall Study|Administrative problems|1
2134617|NCT01068626|3740311|FG000|Overall Study|Adverse Event|3
2134618|NCT01068626|3740312|FG001|Overall Study|Adverse Event|0
2134619|NCT01068626|3740311|FG000|Overall Study|Withdrawal by Subject|0
2134620|NCT01068626|3740312|FG001|Overall Study|Withdrawal by Subject|2
2134621|NCT01068652|3740320|FG000|Overall Study|Adverse Event|4
2134622|NCT01068652|3740321|FG001|Overall Study|Adverse Event|0
2134623|NCT01068652|3740320|FG000|Overall Study|Lack of Efficacy|0
2134624|NCT01068652|3740321|FG001|Overall Study|Lack of Efficacy|2
2134625|NCT01068652|3740320|FG000|Overall Study|Lost to Follow-up|2
2134626|NCT01068652|3740321|FG001|Overall Study|Lost to Follow-up|1
2134627|NCT01068652|3740320|FG000|Overall Study|Protocol Violation|3
2286370|NCT02435992|3975587|FG000|Overall Study|Physician Decision|0
2286371|NCT02435992|3975588|FG001|Overall Study|Physician Decision|0
2286372|NCT02435992|3975589|FG002|Overall Study|Physician Decision|1
2286373|NCT02435992|3975590|FG003|Overall Study|Physician Decision|0
2286374|NCT02435992|3975591|FG004|Overall Study|Physician Decision|0
2286375|NCT02436005|3975603|FG000|Second Intervention|Adverse Event|0
2286376|NCT02436005|3975604|FG001|Second Intervention|Adverse Event|1
2286377|NCT02436135|3975619|FG000|Overall Study|Progressive Disease|3
2286378|NCT02436135|3975620|FG001|Overall Study|Progressive Disease|1
2286379|NCT02436135|3975619|FG000|Overall Study|Investigator Discretion|1
2286380|NCT02436135|3975620|FG001|Overall Study|Investigator Discretion|2
2286381|NCT02436135|3975619|FG000|Overall Study|Adverse Event|1
2286382|NCT02436135|3975620|FG001|Overall Study|Adverse Event|0
2286383|NCT02436135|3975619|FG000|Overall Study|Withdrawal by Participant|1
2286384|NCT02436135|3975620|FG001|Overall Study|Withdrawal by Participant|0
2286385|NCT02436135|3975619|FG000|Overall Study|Study Terminated By Sponsor|0
2286386|NCT02436135|3975620|FG001|Overall Study|Study Terminated By Sponsor|1
2286387|NCT02436200|3975626|FG000|Overall Study|Significant outlier|1
2286388|NCT02436239|3975634|FG000|Open-Lable Treatment Period|Adverse Event|12
2286389|NCT02436239|3975635|FG001|Open-Lable Treatment Period|Adverse Event|3
2286390|NCT02436239|3975636|FG002|Open-Lable Treatment Period|Adverse Event|4
2286391|NCT02436239|3975637|FG003|Open-Lable Treatment Period|Adverse Event|2
2286392|NCT02436239|3975634|FG000|Open-Lable Treatment Period|Lack of Efficacy|1
2286393|NCT02436239|3975635|FG001|Open-Lable Treatment Period|Lack of Efficacy|6
2286394|NCT02436239|3975636|FG002|Open-Lable Treatment Period|Lack of Efficacy|6
2286395|NCT02436239|3975637|FG003|Open-Lable Treatment Period|Lack of Efficacy|1
2286396|NCT02436239|3975634|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10
2286397|NCT02436239|3975635|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15
2286398|NCT02436239|3975636|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9
2286399|NCT02436239|3975637|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0
2286400|NCT02436239|3975634|FG000|Open-Lable Treatment Period|Lost to Follow-up|4
2286401|NCT02436239|3975635|FG001|Open-Lable Treatment Period|Lost to Follow-up|2
2286402|NCT02436239|3975636|FG002|Open-Lable Treatment Period|Lost to Follow-up|4
2286403|NCT02436239|3975637|FG003|Open-Lable Treatment Period|Lost to Follow-up|1
2286404|NCT02436239|3975634|FG000|Open-Lable Treatment Period|Protocol Violation|0
2286405|NCT02436239|3975635|FG001|Open-Lable Treatment Period|Protocol Violation|1
2286406|NCT02436239|3975636|FG002|Open-Lable Treatment Period|Protocol Violation|1
2286407|NCT02436239|3975637|FG003|Open-Lable Treatment Period|Protocol Violation|0
2286408|NCT02436239|3975634|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5
2286409|NCT02436239|3975635|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6
2286410|NCT02436239|3975636|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3
2286411|NCT02436239|3975637|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1
2286412|NCT02436239|3975634|FG000|Open-Lable Treatment Period|Other Reason|1
2286413|NCT02436239|3975635|FG001|Open-Lable Treatment Period|Other Reason|1
2134628|NCT01068652|3740321|FG001|Overall Study|Protocol Violation|6
2134629|NCT01068652|3740320|FG000|Overall Study|Withdrawal criteria|1
2134630|NCT01068652|3740321|FG001|Overall Study|Withdrawal criteria|2
2134631|NCT01068652|3740320|FG000|Overall Study|Patient was not eligible|1
2134632|NCT01068652|3740321|FG001|Overall Study|Patient was not eligible|0
2134633|NCT01068652|3740320|FG000|Overall Study|Unclassified|7
2134634|NCT01068652|3740321|FG001|Overall Study|Unclassified|4
2134635|NCT01068665|3740329|FG000|Overall Study|Adverse Event|5
2134636|NCT01068665|3740330|FG001|Overall Study|Adverse Event|4
2286414|NCT02436239|3975636|FG002|Open-Lable Treatment Period|Other Reason|0
2286415|NCT02436239|3975637|FG003|Open-Lable Treatment Period|Other Reason|0
2134637|NCT01068665|3740329|FG000|Overall Study|Lack of Efficacy|0
2134638|NCT01068665|3740330|FG001|Overall Study|Lack of Efficacy|2
2134639|NCT01068665|3740329|FG000|Overall Study|Protocol Violation|5
2134640|NCT01068665|3740330|FG001|Overall Study|Protocol Violation|2
2134641|NCT01068665|3740329|FG000|Overall Study|Withdrawal Criteria|3
2134642|NCT01068665|3740330|FG001|Overall Study|Withdrawal Criteria|9
2134643|NCT01068665|3740329|FG000|Overall Study|Other|17
2134644|NCT01068665|3740330|FG001|Overall Study|Other|12
2178322|NCT01382940|3803054|FG000|Overall Study|Protocol Violation|20
2178323|NCT01383018|3803067|FG000|Overall Study|Adverse Event|14
2178324|NCT01383018|3803067|FG000|Overall Study|Death|10
2178325|NCT01383018|3803067|FG000|Overall Study|Lost to Follow-up|5
2178326|NCT01383018|3803067|FG000|Overall Study|Physician Decision|5
2178327|NCT01383018|3803067|FG000|Overall Study|Withdrawal by Subject|9
2178328|NCT01383018|3803067|FG000|Overall Study|Subject not implanted|76
2178329|NCT01383018|3803067|FG000|Overall Study|Missed Visit|247
2178330|NCT01383018|3803067|FG000|Overall Study|Site closed early-not compliance related|7
2178331|NCT01383018|3803067|FG000|Overall Study|Patient moved away from site|1
2178332|NCT01383018|3803067|FG000|Overall Study|Subject Incarcerated|1
2180119|NCT01398514|3806031|FG000|Overall Study|Non-compliance with study procedures|2
2180120|NCT01398514|3806032|FG001|Overall Study|Non-compliance with study procedures|0
2180121|NCT01398514|3806031|FG000|Overall Study|Physiologic non-responsiveness|1
2180122|NCT01398514|3806032|FG001|Overall Study|Physiologic non-responsiveness|3
2180123|NCT01398514|3806031|FG000|Overall Study|Failure to show a conditioned response|4
2180124|NCT01398514|3806032|FG001|Overall Study|Failure to show a conditioned response|3
2286416|NCT02436239|3975634|FG000|Down-Taper Period|Withdrawal by Subject|4
2286417|NCT02436239|3975635|FG001|Down-Taper Period|Withdrawal by Subject|4
2286418|NCT02436239|3975636|FG002|Down-Taper Period|Withdrawal by Subject|1
2286419|NCT02436239|3975637|FG003|Down-Taper Period|Withdrawal by Subject|2
2286420|NCT02436304|3975650|FG000|Overall Study|Lost to Follow-up|0
2286421|NCT02436304|3975651|FG001|Overall Study|Lost to Follow-up|1
2286422|NCT02436304|3975652|FG002|Overall Study|Lost to Follow-up|0
2286423|NCT02436304|3975650|FG000|Overall Study|Withdrawal by Subject|0
2286424|NCT02436304|3975651|FG001|Overall Study|Withdrawal by Subject|1
2286425|NCT02436304|3975652|FG002|Overall Study|Withdrawal by Subject|0
2286426|NCT02436304|3975650|FG000|Overall Study|Randomized in error didn't meet I/E crit|0
2286427|NCT02436304|3975651|FG001|Overall Study|Randomized in error didn't meet I/E crit|0
2286428|NCT02436304|3975652|FG002|Overall Study|Randomized in error didn't meet I/E crit|1
2286429|NCT02436330|3975663|FG000|Cohort 1|Lost to Follow-up|5
2286430|NCT02436330|3975664|FG001|Cohort 1|Lost to Follow-up|2
2286431|NCT02436330|3975663|FG000|Cohort 1|Withdrawal by Subject|0
2286432|NCT02436330|3975664|FG001|Cohort 1|Withdrawal by Subject|1
2286433|NCT02436330|3975663|FG000|Cohort 2|Lost to Follow-up|2
2286434|NCT02436330|3975664|FG001|Cohort 2|Lost to Follow-up|0
2286435|NCT02436330|3975663|FG000|Cohort 2|Withdrawal by Subject|2
2286436|NCT02436330|3975664|FG001|Cohort 2|Withdrawal by Subject|3
2286437|NCT02436330|3975663|FG000|Cohort 3|Lost to Follow-up|1
2286438|NCT02436330|3975664|FG001|Cohort 3|Lost to Follow-up|0
2286439|NCT02436330|3975663|FG000|Cohort 3|Withdrawal by Subject|4
2286440|NCT02436330|3975664|FG001|Cohort 3|Withdrawal by Subject|0
2286441|NCT02436330|3975663|FG000|Cohort 4|Lost to Follow-up|1
2286442|NCT02436330|3975664|FG001|Cohort 4|Lost to Follow-up|0
2286443|NCT02436330|3975663|FG000|Cohort 4|Withdrawal by Subject|1
2286444|NCT02436330|3975664|FG001|Cohort 4|Withdrawal by Subject|0
2286445|NCT02436330|3975663|FG000|Cohort 5|Lost to Follow-up|3
2286446|NCT02436330|3975664|FG001|Cohort 5|Lost to Follow-up|2
2286447|NCT02436330|3975663|FG000|Cohort 5|Withdrawal by Subject|3
2286448|NCT02436330|3975664|FG001|Cohort 5|Withdrawal by Subject|2
2286449|NCT02436330|3975663|FG000|Cohort 6|Lost to Follow-up|2
2286450|NCT02436330|3975664|FG001|Cohort 6|Lost to Follow-up|0
2286451|NCT02436330|3975663|FG000|Cohort 6|Withdrawal by Subject|1
2286452|NCT02436330|3975664|FG001|Cohort 6|Withdrawal by Subject|1
2286453|NCT02436356|3975679|FG000|Overall Study|Excluded by MRI Screening|0
2286454|NCT02436356|3975680|FG001|Overall Study|Excluded by MRI Screening|0
2286455|NCT02436356|3975681|FG002|Overall Study|Excluded by MRI Screening|2
2286456|NCT02436356|3975679|FG000|Overall Study|Lost to Follow-up|0
2286457|NCT02436356|3975680|FG001|Overall Study|Lost to Follow-up|1
2286458|NCT02436356|3975681|FG002|Overall Study|Lost to Follow-up|0
2286459|NCT02436356|3975679|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1
2286460|NCT02436356|3975680|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0
2286461|NCT02436356|3975681|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0
2286462|NCT02436356|3975679|FG000|Overall Study|Excluded due to other medical conditions|3
2286463|NCT02436356|3975680|FG001|Overall Study|Excluded due to other medical conditions|0
2180125|NCT01398787|3806044|FG000|Overall Study|Adverse Event|1
2180126|NCT01398956|3806063|FG000|Overall Study|Withdrawal by Subject|4
2180127|NCT01398956|3806063|FG000|Overall Study|AE, non-serious non-fatal|4
2180128|NCT01398956|3806063|FG000|Overall Study|Withdrawal Criteria No.3|1
2180129|NCT01398956|3806063|FG000|Overall Study|Subject moved a long distance|1
2180130|NCT01399047|3806092|FG000|Overall Study|Withdrawal by Subject|0
2286464|NCT02436356|3975681|FG002|Overall Study|Excluded due to other medical conditions|0
2286465|NCT02436356|3975679|FG000|Overall Study|Withdrawal by Subject|1
2286466|NCT02436356|3975680|FG001|Overall Study|Withdrawal by Subject|0
2134645|NCT01068678|3740338|FG000|Overall Study|Lack of Efficacy|3
2134646|NCT01068678|3740339|FG001|Overall Study|Lack of Efficacy|2
2286467|NCT02436356|3975681|FG002|Overall Study|Withdrawal by Subject|0
2286468|NCT02436408|3975694|FG000|Overall Study|Death|1
2286469|NCT02436577|3975704|FG000|Overall Study|Protocol Deviation|0
2286470|NCT02436577|3975705|FG001|Overall Study|Protocol Deviation|1
2286471|NCT02436577|3975706|FG002|Overall Study|Protocol Deviation|0
2286472|NCT02436577|3975707|FG003|Overall Study|Protocol Deviation|0
2207437|NCT01629589|3846420|FG001|Overall Study|Protocol Violation|2
2207438|NCT01629589|3846419|FG000|Overall Study|Lost to Follow-up|2
2207439|NCT01629589|3846420|FG001|Overall Study|Lost to Follow-up|1
2207440|NCT01629589|3846419|FG000|Overall Study|Withdrawal by Subject|2
2207441|NCT01629589|3846420|FG001|Overall Study|Withdrawal by Subject|3
2207442|NCT01629589|3846419|FG000|Overall Study|Did not receive study vaccine|0
2134647|NCT01068678|3740338|FG000|Overall Study|Protocol Violation|5
2134648|NCT01068678|3740339|FG001|Overall Study|Protocol Violation|1
2134649|NCT01068678|3740338|FG000|Overall Study|Withdrawal criteria|12
2134650|NCT01068678|3740339|FG001|Overall Study|Withdrawal criteria|6
2134651|NCT01068678|3740338|FG000|Overall Study|Unclassified|18
2134652|NCT01068678|3740339|FG001|Overall Study|Unclassified|15
2286473|NCT02436577|3975708|FG004|Overall Study|Protocol Deviation|0
2286474|NCT02436577|3975709|FG005|Overall Study|Protocol Deviation|0
2286475|NCT02436681|3975729|FG000|Overall Study|Lost to Follow-up|10
2286476|NCT02436681|3975729|FG000|Overall Study|Withdrawal by Subject|2
2286477|NCT02436681|3975729|FG000|Overall Study|Death|2
2286478|NCT02436759|3975735|FG000|Overall Study|Adverse Event|3
2286479|NCT02436759|3975736|FG001|Overall Study|Adverse Event|0
2286480|NCT02436759|3975735|FG000|Overall Study|Protocol Violation|1
2286481|NCT02436759|3975736|FG001|Overall Study|Protocol Violation|0
2286482|NCT02436759|3975735|FG000|Overall Study|Withdrawal by Subject|0
2286483|NCT02436759|3975736|FG001|Overall Study|Withdrawal by Subject|1
2286484|NCT02436811|3975745|FG000|Overall Study|Lost to Follow-up|2
2286485|NCT02436811|3975746|FG001|Overall Study|Lost to Follow-up|9
2286486|NCT02436811|3975747|FG002|Overall Study|Lost to Follow-up|7
2286487|NCT02436876|3975759|FG000|Overall Study|Lost to Follow-up|0
2286488|NCT02436876|3975760|FG001|Overall Study|Lost to Follow-up|1
2286489|NCT02436876|3975761|FG002|Overall Study|Lost to Follow-up|1
2286490|NCT02436876|3975762|FG003|Overall Study|Lost to Follow-up|1
2286491|NCT02436876|3975759|FG000|Overall Study|Withdrawal by Subject|1
2286492|NCT02436876|3975760|FG001|Overall Study|Withdrawal by Subject|0
2286493|NCT02436876|3975761|FG002|Overall Study|Withdrawal by Subject|0
2286494|NCT02436876|3975762|FG003|Overall Study|Withdrawal by Subject|1
2286495|NCT02436876|3975759|FG000|Overall Study|Physician Decision|0
2286496|NCT02436876|3975760|FG001|Overall Study|Physician Decision|2
2286497|NCT02436876|3975761|FG002|Overall Study|Physician Decision|1
2286498|NCT02436876|3975762|FG003|Overall Study|Physician Decision|0
2286499|NCT02436876|3975759|FG000|Overall Study|Inadequate amount of study drug available for randomization|0
2286500|NCT02436876|3975760|FG001|Overall Study|Inadequate amount of study drug available for randomization|1
2286501|NCT02436876|3975761|FG002|Overall Study|Inadequate amount of study drug available for randomization|0
2286502|NCT02436876|3975762|FG003|Overall Study|Inadequate amount of study drug available for randomization|0
2286503|NCT02436889|3975779|FG000|Overall Study|No improvement in symptoms|1
2286504|NCT02436889|3975780|FG001|Overall Study|No improvement in symptoms|0
2286505|NCT02436889|3975779|FG000|Overall Study|Does not like/could not tolerate medicat|0
2286506|NCT02436889|3975780|FG001|Overall Study|Does not like/could not tolerate medicat|1
2286507|NCT02436915|3975788|FG000|Overall Study|Withdrawal by Subject|0
2286508|NCT02436915|3975789|FG001|Overall Study|Withdrawal by Subject|1
2134653|NCT01068717|3740345|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
2134654|NCT01068717|3740346|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
2134655|NCT01068717|3740347|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
2134656|NCT01068717|3740348|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
2134657|NCT01068730|3740362|FG000|Period 3|Personal reason|1
2134658|NCT01068730|3740363|FG001|Period 3|Personal reason|0
2134659|NCT01068730|3740364|FG002|Period 3|Personal reason|0
2134660|NCT01068730|3740365|FG003|Period 3|Personal reason|0
2134661|NCT01068730|3740362|FG000|Period 4|Family emergency|0
2134662|NCT01068730|3740363|FG001|Period 4|Family emergency|1
2134663|NCT01068730|3740364|FG002|Period 4|Family emergency|0
2134664|NCT01068730|3740365|FG003|Period 4|Family emergency|0
2134665|NCT01068743|3740382|FG000|Period 3|Adverse Event|0
2134666|NCT01068743|3740383|FG001|Period 3|Adverse Event|1
2134667|NCT01068743|3740384|FG002|Period 3|Adverse Event|0
2134668|NCT01068743|3740385|FG003|Period 3|Adverse Event|0
2286509|NCT02437084|3975797|FG000|Overall Study|Withdrawal by Subject|2
2286510|NCT02437084|3975797|FG000|Overall Study|Physician Decision|1
2286511|NCT02437162|3975804|FG000|Overall Study|Protocol Violation|0
2286512|NCT02437162|3975805|FG001|Overall Study|Protocol Violation|1
2134669|NCT01068769|3740398|FG000|Overall Study|Ineligible|1
2134670|NCT01068860|3740421|FG000|Overall Study|Withdrawal by Subject|0
2134671|NCT01068860|3740422|FG001|Overall Study|Withdrawal by Subject|0
2134672|NCT01068860|3740423|FG002|Overall Study|Withdrawal by Subject|0
2134673|NCT01068860|3740424|FG003|Overall Study|Withdrawal by Subject|0
2207443|NCT01629589|3846420|FG001|Overall Study|Did not receive study vaccine|1
2207444|NCT01629667|3846433|FG000|Overall Study|Lost to Follow-up|0
2134674|NCT01068860|3740425|FG004|Overall Study|Withdrawal by Subject|0
2134675|NCT01068860|3740426|FG005|Overall Study|Withdrawal by Subject|2
2134676|NCT01068860|3740427|FG006|Overall Study|Withdrawal by Subject|0
2134677|NCT01068860|3740428|FG007|Overall Study|Withdrawal by Subject|0
2134678|NCT01068860|3740429|FG008|Overall Study|Withdrawal by Subject|0
2134679|NCT01068860|3740430|FG009|Overall Study|Withdrawal by Subject|3
2134680|NCT01068860|3740421|FG000|Overall Study|Administrative problems; misrandomized|0
2134681|NCT01068860|3740422|FG001|Overall Study|Administrative problems; misrandomized|0
2134682|NCT01068860|3740423|FG002|Overall Study|Administrative problems; misrandomized|0
2134683|NCT01068860|3740424|FG003|Overall Study|Administrative problems; misrandomized|1
2134684|NCT01068860|3740425|FG004|Overall Study|Administrative problems; misrandomized|0
2134685|NCT01068860|3740426|FG005|Overall Study|Administrative problems; misrandomized|0
2134686|NCT01068860|3740427|FG006|Overall Study|Administrative problems; misrandomized|0
2134687|NCT01068860|3740428|FG007|Overall Study|Administrative problems; misrandomized|0
2134688|NCT01068860|3740429|FG008|Overall Study|Administrative problems; misrandomized|0
2134689|NCT01068860|3740430|FG009|Overall Study|Administrative problems; misrandomized|1
2134690|NCT01068860|3740421|FG000|Overall Study|Lost to Follow-up|0
2134691|NCT01068860|3740422|FG001|Overall Study|Lost to Follow-up|1
2134692|NCT01068860|3740423|FG002|Overall Study|Lost to Follow-up|0
2134693|NCT01068860|3740424|FG003|Overall Study|Lost to Follow-up|0
2134694|NCT01068860|3740425|FG004|Overall Study|Lost to Follow-up|0
2134695|NCT01068860|3740426|FG005|Overall Study|Lost to Follow-up|0
2134696|NCT01068860|3740427|FG006|Overall Study|Lost to Follow-up|0
2134697|NCT01068860|3740428|FG007|Overall Study|Lost to Follow-up|0
2134698|NCT01068860|3740429|FG008|Overall Study|Lost to Follow-up|0
2134699|NCT01068860|3740430|FG009|Overall Study|Lost to Follow-up|0
2134700|NCT01068912|3740459|FG000|Overall Study|Adverse Event|2
2134701|NCT01068912|3740460|FG001|Overall Study|Adverse Event|3
2207445|NCT01629667|3846434|FG001|Overall Study|Lost to Follow-up|1
2207446|NCT01629667|3846435|FG002|Overall Study|Lost to Follow-up|1
2207447|NCT01629667|3846433|FG000|Overall Study|Withdrawal by Subject|31
2207448|NCT01629667|3846434|FG001|Overall Study|Withdrawal by Subject|20
2207449|NCT01629667|3846435|FG002|Overall Study|Withdrawal by Subject|28
2207450|NCT01629667|3846433|FG000|Overall Study|Death|1
2134702|NCT01068912|3740461|FG002|Overall Study|Adverse Event|2
2134703|NCT01068912|3740459|FG000|Overall Study|Withdrawal by Subject|5
2134704|NCT01068912|3740460|FG001|Overall Study|Withdrawal by Subject|6
2134705|NCT01068912|3740461|FG002|Overall Study|Withdrawal by Subject|6
2134706|NCT01068912|3740459|FG000|Overall Study|Lost to Follow-up|3
2134707|NCT01068912|3740460|FG001|Overall Study|Lost to Follow-up|7
2134708|NCT01068912|3740461|FG002|Overall Study|Lost to Follow-up|3
2134709|NCT01068912|3740459|FG000|Overall Study|Protocol Violation|0
2134710|NCT01068912|3740460|FG001|Overall Study|Protocol Violation|2
2134711|NCT01068912|3740461|FG002|Overall Study|Protocol Violation|0
2134712|NCT01068912|3740459|FG000|Overall Study|aggravation influenza|1
2134713|NCT01068912|3740460|FG001|Overall Study|aggravation influenza|1
2134714|NCT01068912|3740461|FG002|Overall Study|aggravation influenza|1
2134715|NCT01068912|3740459|FG000|Overall Study|other underlying illness|0
2134716|NCT01068912|3740460|FG001|Overall Study|other underlying illness|3
2134717|NCT01068912|3740461|FG002|Overall Study|other underlying illness|3
2134718|NCT01069172|3740493|FG000|Overall Study|Withdrawal by Subject|1
2134719|NCT01069172|3740494|FG001|Overall Study|Withdrawal by Subject|0
2134720|NCT01069289|3740512|FG000|Overall Study|Withdrawal by Subject|15
2134721|NCT01069289|3740513|FG001|Overall Study|Withdrawal by Subject|26
2134722|NCT01069289|3740512|FG000|Overall Study|Adverse Event|21
2134723|NCT01069289|3740513|FG001|Overall Study|Adverse Event|28
2134724|NCT01069289|3740512|FG000|Overall Study|Eligibility criteria not fulfilled|2
2134725|NCT01069289|3740513|FG001|Overall Study|Eligibility criteria not fulfilled|0
2134726|NCT01069289|3740512|FG000|Overall Study|Severe non-compliance to protocol|3
2134727|NCT01069289|3740513|FG001|Overall Study|Severe non-compliance to protocol|2
2134728|NCT01069289|3740512|FG000|Overall Study|Due to deteriorating health condition|1
2134729|NCT01069289|3740513|FG001|Overall Study|Due to deteriorating health condition|0
2134730|NCT01069341|3740540|FG000|Overall Study|Lost to Follow-up|1
2134731|NCT01069419|3740552|FG000|Overall Study|Adverse Event|233
2134732|NCT01069419|3740552|FG000|Overall Study|Lack of Efficacy|332
2134733|NCT01069419|3740552|FG000|Overall Study|Lost to Follow-up|49
2134734|NCT01069419|3740552|FG000|Overall Study|Remission of disease|11
2134735|NCT01069419|3740552|FG000|Overall Study|Withdrawal by Subject|34
2134736|NCT01069419|3740552|FG000|Overall Study|Other Reason|43
2134737|NCT01069419|3740552|FG000|Overall Study|Missing termination information|13
2134738|NCT01069484|3740558|FG000|Overall Study|Death-in-near-family|1
2134739|NCT01069484|3740559|FG001|Overall Study|Death-in-near-family|0
2134740|NCT01069484|3740558|FG000|Overall Study|No specific reason|8
2134741|NCT01069484|3740559|FG001|Overall Study|No specific reason|2
2134742|NCT01069484|3740558|FG000|Overall Study|Illness mother or child|3
2134743|NCT01069484|3740559|FG001|Overall Study|Illness mother or child|1
2134744|NCT01069523|3740577|FG000|Overall Study|Withdrawal by Subject|4
2134745|NCT01069523|3740578|FG001|Overall Study|Withdrawal by Subject|7
2134746|NCT01069627|3740595|FG000|Overall Study|Disease progression|7
2134747|NCT01069627|3740595|FG000|Overall Study|Adverse Event|12
2134748|NCT01069627|3740595|FG000|Overall Study|Protocol Violation|1
2134749|NCT01069705|3740599|FG000|Overall Study|Adverse Event|1
2134750|NCT01069705|3740599|FG000|Overall Study|Withdrawal by Subject|2
2134751|NCT01069900|3740605|FG000|Overall Study|Technical problems|0
2134752|NCT01069900|3740606|FG001|Overall Study|Technical problems|1
2134753|NCT01069900|3740605|FG000|Overall Study|Lost to Follow-up|7
2134754|NCT01069900|3740606|FG001|Overall Study|Lost to Follow-up|1
2134755|NCT01069900|3740605|FG000|Overall Study|Withdrawal by Subject|6
2134756|NCT01069900|3740606|FG001|Overall Study|Withdrawal by Subject|1
2134757|NCT01069900|3740605|FG000|Overall Study|Protocol Violation|4
2134758|NCT01069900|3740606|FG001|Overall Study|Protocol Violation|1
2134759|NCT01069900|3740605|FG000|Overall Study|Insufficient Therapeutic effect|1
2134760|NCT01069900|3740606|FG001|Overall Study|Insufficient Therapeutic effect|0
2134761|NCT01069939|3740614|FG000|Randomised and Included in the Analyses|Adverse Event|17
2134762|NCT01069939|3740615|FG001|Randomised and Included in the Analyses|Adverse Event|22
2134763|NCT01069939|3740614|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15
2134764|NCT01069939|3740615|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12
2134765|NCT01069939|3740614|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1
2134766|NCT01069939|3740615|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1
2134767|NCT01069939|3740614|FG000|Randomised and Included in the Analyses|Protocol Violation|0
2134768|NCT01069939|3740615|FG001|Randomised and Included in the Analyses|Protocol Violation|1
2134769|NCT01069939|3740614|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0
2134770|NCT01069939|3740615|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1
2134771|NCT01069939|3740614|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
2134772|NCT01069939|3740615|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
2134773|NCT01069939|3740614|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
2134774|NCT01069939|3740615|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
2134775|NCT01069939|3740614|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
2134776|NCT01069939|3740615|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
2134777|NCT01069939|3740614|FG000|Randomised and Included in the Analyses|Physician Decision|0
2134778|NCT01069939|3740615|FG001|Randomised and Included in the Analyses|Physician Decision|2
2134779|NCT01069939|3740614|FG000|Randomised and Included in the Analyses|Removal|1
2134780|NCT01069939|3740615|FG001|Randomised and Included in the Analyses|Removal|0
2134781|NCT01070043|3740623|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18
2134782|NCT01070043|3740624|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0
2134783|NCT01070043|3740625|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0
2134784|NCT01070043|3740623|FG000|Double-Blind Treatment|Adverse Event|0
2134785|NCT01070043|3740624|FG001|Double-Blind Treatment|Adverse Event|0
2134786|NCT01070043|3740625|FG002|Double-Blind Treatment|Adverse Event|2
2134787|NCT01070303|3740654|FG000|Overall Study|Adverse Event|39
2134788|NCT01070303|3740654|FG000|Overall Study|Withdrawal by Subject|20
2134789|NCT01070303|3740654|FG000|Overall Study|Lost to Follow-up|9
2134790|NCT01070303|3740654|FG000|Overall Study|Protocol Violation|0
2134791|NCT01070303|3740654|FG000|Overall Study|Lack of Efficacy|2
2134792|NCT01070303|3740654|FG000|Overall Study|Administrative Reason|1
2134793|NCT01070303|3740654|FG000|Overall Study|Other|18
2134794|NCT01070316|3740664|FG000|Extension Phase|Lack of Efficacy|3
2134795|NCT01070316|3740664|FG000|Extension Phase|Withdrawal by Subject|1
2134796|NCT01070329|3740670|FG000|Overall Study|Adverse Event|13
2134797|NCT01070329|3740671|FG001|Overall Study|Adverse Event|10
2134798|NCT01070329|3740670|FG000|Overall Study|Lost to Follow-up|22
2134799|NCT01070329|3740671|FG001|Overall Study|Lost to Follow-up|12
2134800|NCT01070329|3740670|FG000|Overall Study|Withdrawal by Subject|9
2134801|NCT01070329|3740671|FG001|Overall Study|Withdrawal by Subject|11
2134802|NCT01070329|3740670|FG000|Overall Study|Protocol Violation|3
2134803|NCT01070329|3740671|FG001|Overall Study|Protocol Violation|8
2134804|NCT01070329|3740670|FG000|Overall Study|Lack of Efficacy|2
2134805|NCT01070329|3740671|FG001|Overall Study|Lack of Efficacy|6
2134806|NCT01070329|3740670|FG000|Overall Study|Physician Decision|2
2134807|NCT01070329|3740671|FG001|Overall Study|Physician Decision|1
2134808|NCT01070329|3740670|FG000|Overall Study|Entry Criteria Not Met|1
2134809|NCT01070329|3740671|FG001|Overall Study|Entry Criteria Not Met|0
2134810|NCT01070329|3740670|FG000|Overall Study|Sponsor Decision|0
2134811|NCT01070329|3740671|FG001|Overall Study|Sponsor Decision|1
2134812|NCT01070381|3740677|FG000|Period 2, 1 Week of Wear|Handling|0
2134813|NCT01070381|3740678|FG001|Period 2, 1 Week of Wear|Handling|1
2134814|NCT01070381|3740677|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1
2134815|NCT01070381|3740678|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0
2134816|NCT01070394|3740684|FG000|Overall Study|Adverse Event|6
2134817|NCT01070394|3740684|FG000|Overall Study|Withdrawal by Subject|1
2134818|NCT01070550|3740696|FG000|Overall Study|Adverse Event|43
2134819|NCT01070550|3740697|FG001|Overall Study|Adverse Event|1
2134820|NCT01070550|3740698|FG002|Overall Study|Adverse Event|3
2134821|NCT01070550|3740699|FG003|Overall Study|Adverse Event|0
2134822|NCT01070550|3740700|FG004|Overall Study|Adverse Event|0
2134823|NCT01070550|3740701|FG005|Overall Study|Adverse Event|0
2134824|NCT01070550|3740696|FG000|Overall Study|Death|20
2134825|NCT01070550|3740697|FG001|Overall Study|Death|4
2134826|NCT01070550|3740698|FG002|Overall Study|Death|3
2134827|NCT01070550|3740699|FG003|Overall Study|Death|0
2134828|NCT01070550|3740700|FG004|Overall Study|Death|0
2134829|NCT01070550|3740701|FG005|Overall Study|Death|0
2134830|NCT01070550|3740696|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2
2134831|NCT01070550|3740697|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
2134832|NCT01070550|3740698|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1
2134833|NCT01070550|3740699|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0
2134834|NCT01070550|3740700|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0
2134835|NCT01070550|3740701|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0
2134836|NCT01070550|3740696|FG000|Overall Study|Early termination|3
2134837|NCT01070550|3740697|FG001|Overall Study|Early termination|0
2134838|NCT01070550|3740698|FG002|Overall Study|Early termination|0
2134839|NCT01070550|3740699|FG003|Overall Study|Early termination|0
2134840|NCT01070550|3740700|FG004|Overall Study|Early termination|0
2134841|NCT01070550|3740701|FG005|Overall Study|Early termination|0
2134842|NCT01070550|3740696|FG000|Overall Study|Failed to return|450
2134843|NCT01070550|3740697|FG001|Overall Study|Failed to return|33
2134844|NCT01070550|3740698|FG002|Overall Study|Failed to return|144
2134845|NCT01070550|3740699|FG003|Overall Study|Failed to return|40
2134846|NCT01070550|3740700|FG004|Overall Study|Failed to return|1
2134847|NCT01070550|3740701|FG005|Overall Study|Failed to return|2
2134848|NCT01070550|3740696|FG000|Overall Study|Incomplete treatment|2
2134849|NCT01070550|3740697|FG001|Overall Study|Incomplete treatment|0
2134850|NCT01070550|3740698|FG002|Overall Study|Incomplete treatment|0
2134851|NCT01070550|3740699|FG003|Overall Study|Incomplete treatment|0
2134852|NCT01070550|3740700|FG004|Overall Study|Incomplete treatment|0
2134853|NCT01070550|3740701|FG005|Overall Study|Incomplete treatment|0
2134854|NCT01070550|3740696|FG000|Overall Study|Lab test not done|22
2134855|NCT01070550|3740697|FG001|Overall Study|Lab test not done|3
2134856|NCT01070550|3740698|FG002|Overall Study|Lab test not done|4
2134857|NCT01070550|3740699|FG003|Overall Study|Lab test not done|1
2134858|NCT01070550|3740700|FG004|Overall Study|Lab test not done|0
2134859|NCT01070550|3740701|FG005|Overall Study|Lab test not done|1
2134860|NCT01070550|3740696|FG000|Overall Study|Lack of Efficacy|65
2134861|NCT01070550|3740697|FG001|Overall Study|Lack of Efficacy|1
2134862|NCT01070550|3740698|FG002|Overall Study|Lack of Efficacy|5
2134863|NCT01070550|3740699|FG003|Overall Study|Lack of Efficacy|5
2134864|NCT01070550|3740700|FG004|Overall Study|Lack of Efficacy|0
2134865|NCT01070550|3740701|FG005|Overall Study|Lack of Efficacy|1
2134866|NCT01070550|3740696|FG000|Overall Study|Miscellaneous|12
2134867|NCT01070550|3740697|FG001|Overall Study|Miscellaneous|2
2134868|NCT01070550|3740698|FG002|Overall Study|Miscellaneous|3
2134869|NCT01070550|3740699|FG003|Overall Study|Miscellaneous|1
2134870|NCT01070550|3740700|FG004|Overall Study|Miscellaneous|0
2134871|NCT01070550|3740701|FG005|Overall Study|Miscellaneous|0
2134872|NCT01070550|3740696|FG000|Overall Study|New treatment started|3
2134873|NCT01070550|3740697|FG001|Overall Study|New treatment started|1
2134874|NCT01070550|3740698|FG002|Overall Study|New treatment started|0
2134875|NCT01070550|3740699|FG003|Overall Study|New treatment started|2
2134876|NCT01070550|3740700|FG004|Overall Study|New treatment started|0
2134877|NCT01070550|3740701|FG005|Overall Study|New treatment started|0
2134878|NCT01070550|3740696|FG000|Overall Study|Non-responders|493
2134879|NCT01070550|3740697|FG001|Overall Study|Non-responders|4
2134880|NCT01070550|3740698|FG002|Overall Study|Non-responders|21
2134881|NCT01070550|3740699|FG003|Overall Study|Non-responders|20
2134882|NCT01070550|3740700|FG004|Overall Study|Non-responders|0
2134883|NCT01070550|3740701|FG005|Overall Study|Non-responders|2
2134884|NCT01070550|3740696|FG000|Overall Study|Not categorized|33
2134885|NCT01070550|3740697|FG001|Overall Study|Not categorized|2
2134886|NCT01070550|3740698|FG002|Overall Study|Not categorized|6
2134887|NCT01070550|3740699|FG003|Overall Study|Not categorized|1
2134888|NCT01070550|3740700|FG004|Overall Study|Not categorized|0
2134889|NCT01070550|3740701|FG005|Overall Study|Not categorized|1
2134890|NCT01070550|3740696|FG000|Overall Study|Protocol Violation|15
2134891|NCT01070550|3740697|FG001|Overall Study|Protocol Violation|1
2134892|NCT01070550|3740698|FG002|Overall Study|Protocol Violation|1
2134893|NCT01070550|3740699|FG003|Overall Study|Protocol Violation|1
2134894|NCT01070550|3740700|FG004|Overall Study|Protocol Violation|0
2134895|NCT01070550|3740701|FG005|Overall Study|Protocol Violation|0
2134896|NCT01070550|3740696|FG000|Overall Study|Relapse|44
2134897|NCT01070550|3740697|FG001|Overall Study|Relapse|5
2134898|NCT01070550|3740698|FG002|Overall Study|Relapse|14
2134899|NCT01070550|3740699|FG003|Overall Study|Relapse|4
2134900|NCT01070550|3740700|FG004|Overall Study|Relapse|0
2134901|NCT01070550|3740701|FG005|Overall Study|Relapse|0
2134902|NCT01070550|3740696|FG000|Overall Study|Result not available|3
2134903|NCT01070550|3740697|FG001|Overall Study|Result not available|1
2134904|NCT01070550|3740698|FG002|Overall Study|Result not available|3
2134905|NCT01070550|3740699|FG003|Overall Study|Result not available|0
2134906|NCT01070550|3740700|FG004|Overall Study|Result not available|0
2134907|NCT01070550|3740701|FG005|Overall Study|Result not available|0
2134908|NCT01070550|3740696|FG000|Overall Study|Screen failure|1
2134909|NCT01070550|3740697|FG001|Overall Study|Screen failure|0
2134910|NCT01070550|3740698|FG002|Overall Study|Screen failure|0
2134911|NCT01070550|3740699|FG003|Overall Study|Screen failure|0
2134912|NCT01070550|3740700|FG004|Overall Study|Screen failure|0
2134913|NCT01070550|3740701|FG005|Overall Study|Screen failure|0
2286513|NCT02437162|3975806|FG002|Overall Study|Protocol Violation|0
2286514|NCT02437162|3975804|FG000|Overall Study|Randomized but not treated|0
2286515|NCT02437162|3975805|FG001|Overall Study|Randomized but not treated|0
2286516|NCT02437162|3975806|FG002|Overall Study|Randomized but not treated|1
2286517|NCT02437162|3975804|FG000|Overall Study|Study discontinued by Sponsor|93
2286518|NCT02437162|3975805|FG001|Overall Study|Study discontinued by Sponsor|98
2286519|NCT02437162|3975806|FG002|Overall Study|Study discontinued by Sponsor|97
2286520|NCT02437162|3975804|FG000|Overall Study|Withdrawal by Subject|13
2286521|NCT02437162|3975805|FG001|Overall Study|Withdrawal by Subject|7
2286522|NCT02437162|3975806|FG002|Overall Study|Withdrawal by Subject|9
2286523|NCT02437162|3975804|FG000|Overall Study|Adverse Event|0
2286524|NCT02437162|3975805|FG001|Overall Study|Adverse Event|1
2286525|NCT02437162|3975806|FG002|Overall Study|Adverse Event|0
2286526|NCT02437162|3975804|FG000|Overall Study|Lost to Follow-up|1
2286527|NCT02437162|3975805|FG001|Overall Study|Lost to Follow-up|0
2134914|NCT01070550|3740696|FG000|Overall Study|Sponsor decision|1
2134915|NCT01070550|3740697|FG001|Overall Study|Sponsor decision|0
2134916|NCT01070550|3740698|FG002|Overall Study|Sponsor decision|0
2134917|NCT01070550|3740699|FG003|Overall Study|Sponsor decision|0
2134918|NCT01070550|3740700|FG004|Overall Study|Sponsor decision|0
2134919|NCT01070550|3740701|FG005|Overall Study|Sponsor decision|0
2134920|NCT01070550|3740696|FG000|Overall Study|Treatment duration shortened|1
2134921|NCT01070550|3740697|FG001|Overall Study|Treatment duration shortened|0
2134922|NCT01070550|3740698|FG002|Overall Study|Treatment duration shortened|0
2134923|NCT01070550|3740699|FG003|Overall Study|Treatment duration shortened|0
2134924|NCT01070550|3740700|FG004|Overall Study|Treatment duration shortened|0
2134925|NCT01070550|3740701|FG005|Overall Study|Treatment duration shortened|0
2134926|NCT01070550|3740696|FG000|Overall Study|Treatment interrupted|7
2134927|NCT01070550|3740697|FG001|Overall Study|Treatment interrupted|0
2134928|NCT01070550|3740698|FG002|Overall Study|Treatment interrupted|1
2134929|NCT01070550|3740699|FG003|Overall Study|Treatment interrupted|1
2134930|NCT01070550|3740700|FG004|Overall Study|Treatment interrupted|0
2134931|NCT01070550|3740701|FG005|Overall Study|Treatment interrupted|0
2134932|NCT01070550|3740696|FG000|Overall Study|Treatment not started|14
2134933|NCT01070550|3740697|FG001|Overall Study|Treatment not started|2
2134934|NCT01070550|3740698|FG002|Overall Study|Treatment not started|4
2134935|NCT01070550|3740699|FG003|Overall Study|Treatment not started|0
2134936|NCT01070550|3740700|FG004|Overall Study|Treatment not started|0
2134937|NCT01070550|3740701|FG005|Overall Study|Treatment not started|0
2134938|NCT01070550|3740696|FG000|Overall Study|Treatment restarted|0
2134939|NCT01070550|3740697|FG001|Overall Study|Treatment restarted|1
2134940|NCT01070550|3740698|FG002|Overall Study|Treatment restarted|0
2134941|NCT01070550|3740699|FG003|Overall Study|Treatment restarted|0
2134942|NCT01070550|3740700|FG004|Overall Study|Treatment restarted|0
2134943|NCT01070550|3740701|FG005|Overall Study|Treatment restarted|0
2134944|NCT01070550|3740696|FG000|Overall Study|Treatment stopped|3
2134945|NCT01070550|3740697|FG001|Overall Study|Treatment stopped|0
2134946|NCT01070550|3740698|FG002|Overall Study|Treatment stopped|0
2134947|NCT01070550|3740699|FG003|Overall Study|Treatment stopped|0
2134948|NCT01070550|3740700|FG004|Overall Study|Treatment stopped|0
2134949|NCT01070550|3740701|FG005|Overall Study|Treatment stopped|0
2134950|NCT01070550|3740696|FG000|Overall Study|Treatment unavailable|1
2134951|NCT01070550|3740697|FG001|Overall Study|Treatment unavailable|0
2134952|NCT01070550|3740698|FG002|Overall Study|Treatment unavailable|0
2134953|NCT01070550|3740699|FG003|Overall Study|Treatment unavailable|0
2134954|NCT01070550|3740700|FG004|Overall Study|Treatment unavailable|0
2134955|NCT01070550|3740701|FG005|Overall Study|Treatment unavailable|0
2134956|NCT01070550|3740696|FG000|Overall Study|Treatment was stopped early|7
2134957|NCT01070550|3740697|FG001|Overall Study|Treatment was stopped early|0
2134958|NCT01070550|3740698|FG002|Overall Study|Treatment was stopped early|0
2134959|NCT01070550|3740699|FG003|Overall Study|Treatment was stopped early|0
2134960|NCT01070550|3740700|FG004|Overall Study|Treatment was stopped early|0
2134961|NCT01070550|3740701|FG005|Overall Study|Treatment was stopped early|0
2134962|NCT01070550|3740696|FG000|Overall Study|Other|5
2134963|NCT01070550|3740697|FG001|Overall Study|Other|0
2134964|NCT01070550|3740698|FG002|Overall Study|Other|0
2134965|NCT01070550|3740699|FG003|Overall Study|Other|1
2134966|NCT01070550|3740700|FG004|Overall Study|Other|0
2134967|NCT01070550|3740701|FG005|Overall Study|Other|0
2134968|NCT01070550|3740696|FG000|Overall Study|Withdrawal by Subject|35
2134969|NCT01070550|3740697|FG001|Overall Study|Withdrawal by Subject|0
2134970|NCT01070550|3740698|FG002|Overall Study|Withdrawal by Subject|3
2134971|NCT01070550|3740699|FG003|Overall Study|Withdrawal by Subject|0
2134972|NCT01070550|3740700|FG004|Overall Study|Withdrawal by Subject|0
2134973|NCT01070550|3740701|FG005|Overall Study|Withdrawal by Subject|0
2134974|NCT01070771|3740725|FG000|Overall Study|Adverse Event|2
2134975|NCT01070771|3740725|FG000|Overall Study|Protocol Violation|1
2134976|NCT01070784|3740732|FG000|Overall Study|Withdrawal by Subject|6
2134977|NCT01070784|3740733|FG001|Overall Study|Withdrawal by Subject|9
2134978|NCT01070784|3740732|FG000|Overall Study|Adverse Event|14
2134979|NCT01070784|3740733|FG001|Overall Study|Adverse Event|9
2134980|NCT01070888|3740752|FG000|First Intervention (14 Days)|Adverse Event|0
2286528|NCT02437162|3975806|FG002|Overall Study|Lost to Follow-up|1
2286529|NCT02437162|3975804|FG000|Overall Study|Death|0
2134981|NCT01070888|3740753|FG001|First Intervention (14 Days)|Adverse Event|1
2134982|NCT01070888|3740752|FG000|First Intervention (14 Days)|Lost to Follow-up|0
2134983|NCT01070888|3740753|FG001|First Intervention (14 Days)|Lost to Follow-up|1
2134984|NCT01070888|3740752|FG000|Washout (14 Days)|Physician Decision|1
2134985|NCT01070888|3740753|FG001|Washout (14 Days)|Physician Decision|0
2134986|NCT01070979|3740762|FG000|Overall Study|Adverse Event|2
2134987|NCT01070979|3740763|FG001|Overall Study|Adverse Event|3
2134988|NCT01070979|3740764|FG002|Overall Study|Adverse Event|3
2134989|NCT01070979|3740762|FG000|Overall Study|Lost to Follow-up|2
2134990|NCT01070979|3740763|FG001|Overall Study|Lost to Follow-up|1
2134991|NCT01070979|3740764|FG002|Overall Study|Lost to Follow-up|1
2134992|NCT01070979|3740762|FG000|Overall Study|Protocol Violation|0
2134993|NCT01070979|3740763|FG001|Overall Study|Protocol Violation|2
2134994|NCT01070979|3740764|FG002|Overall Study|Protocol Violation|6
2134995|NCT01070979|3740762|FG000|Overall Study|Surgery, moving, personal, abn. labs|4
2134996|NCT01070979|3740763|FG001|Overall Study|Surgery, moving, personal, abn. labs|4
2134997|NCT01070979|3740764|FG002|Overall Study|Surgery, moving, personal, abn. labs|2
2134998|NCT01070979|3740762|FG000|Overall Study|Withdrawal by Subject|3
2134999|NCT01070979|3740763|FG001|Overall Study|Withdrawal by Subject|1
2135000|NCT01070979|3740764|FG002|Overall Study|Withdrawal by Subject|1
2135001|NCT01070979|3740762|FG000|Overall Study|No study drug taken|0
2135002|NCT01070979|3740763|FG001|Overall Study|No study drug taken|1
2135003|NCT01070979|3740764|FG002|Overall Study|No study drug taken|0
2135004|NCT01071070|3740786|FG000|Overall Study|Adverse Event|0
2135005|NCT01071070|3740787|FG001|Overall Study|Adverse Event|3
2135006|NCT01071070|3740786|FG000|Overall Study|Withdrawal by Subject|1
2135007|NCT01071070|3740787|FG001|Overall Study|Withdrawal by Subject|0
2135008|NCT01071070|3740786|FG000|Overall Study|Missed 3 consecutive doses of study drug|2
2135009|NCT01071070|3740787|FG001|Overall Study|Missed 3 consecutive doses of study drug|0
2135010|NCT01071070|3740786|FG000|Overall Study|Hypercalcemia|1
2135011|NCT01071070|3740787|FG001|Overall Study|Hypercalcemia|0
2135012|NCT01071083|3740798|FG000|Overall Study|Adverse Event|1
2135013|NCT01071083|3740799|FG001|Overall Study|Adverse Event|0
2135014|NCT01071083|3740800|FG002|Overall Study|Adverse Event|1
2286530|NCT02437162|3975805|FG001|Overall Study|Death|1
2286531|NCT02437162|3975806|FG002|Overall Study|Death|0
2286532|NCT02437162|3975804|FG000|Overall Study|Other|0
2286533|NCT02437162|3975805|FG001|Overall Study|Other|0
2286534|NCT02437162|3975806|FG002|Overall Study|Other|1
2286535|NCT02437188|3975821|FG000|Overall Study|Randomized but did not receive surgery|4
2286536|NCT02437188|3975822|FG001|Overall Study|Randomized but did not receive surgery|8
2286537|NCT02437188|3975821|FG000|Overall Study|Adverse Event|0
2135015|NCT01071083|3740801|FG003|Overall Study|Adverse Event|0
2135016|NCT01071083|3740802|FG004|Overall Study|Adverse Event|1
2135017|NCT01071083|3740798|FG000|Overall Study|Withdrawal by Subject|3
2135018|NCT01071083|3740799|FG001|Overall Study|Withdrawal by Subject|0
2135019|NCT01071083|3740800|FG002|Overall Study|Withdrawal by Subject|2
2135020|NCT01071083|3740801|FG003|Overall Study|Withdrawal by Subject|0
2135021|NCT01071083|3740802|FG004|Overall Study|Withdrawal by Subject|3
2135022|NCT01071083|3740798|FG000|Overall Study|Physician Decision|1
2135023|NCT01071083|3740799|FG001|Overall Study|Physician Decision|0
2135024|NCT01071083|3740800|FG002|Overall Study|Physician Decision|0
2135025|NCT01071083|3740801|FG003|Overall Study|Physician Decision|1
2135026|NCT01071083|3740802|FG004|Overall Study|Physician Decision|1
2135027|NCT01071083|3740798|FG000|Overall Study|Early Rescue|1
2135028|NCT01071083|3740799|FG001|Overall Study|Early Rescue|0
2135029|NCT01071083|3740800|FG002|Overall Study|Early Rescue|0
2135030|NCT01071083|3740801|FG003|Overall Study|Early Rescue|0
2135031|NCT01071083|3740802|FG004|Overall Study|Early Rescue|1
2135032|NCT01071083|3740798|FG000|Overall Study|Subject Moved|0
2135033|NCT01071083|3740799|FG001|Overall Study|Subject Moved|1
2135034|NCT01071083|3740800|FG002|Overall Study|Subject Moved|0
2135035|NCT01071083|3740801|FG003|Overall Study|Subject Moved|0
2135036|NCT01071083|3740802|FG004|Overall Study|Subject Moved|0
2135037|NCT01071083|3740798|FG000|Overall Study|Images Not Usable (Motion)|0
2135038|NCT01071083|3740799|FG001|Overall Study|Images Not Usable (Motion)|1
2135039|NCT01071083|3740800|FG002|Overall Study|Images Not Usable (Motion)|0
2135040|NCT01071083|3740801|FG003|Overall Study|Images Not Usable (Motion)|0
2135041|NCT01071083|3740802|FG004|Overall Study|Images Not Usable (Motion)|0
2135042|NCT01071083|3740798|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
2135043|NCT01071083|3740799|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
2135044|NCT01071083|3740800|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
2135045|NCT01071083|3740801|FG003|Overall Study|Did Not Meet Eligibility Criteria|1
2135046|NCT01071083|3740802|FG004|Overall Study|Did Not Meet Eligibility Criteria|1
2286538|NCT02437188|3975822|FG001|Overall Study|Adverse Event|1
2286539|NCT02437305|3975844|FG000|Overall Study|Lost to Follow-up|18
2286540|NCT02437305|3975845|FG001|Overall Study|Lost to Follow-up|12
2320916|NCT02953782|4035206|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
2320917|NCT02953782|4035207|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
2320918|NCT02953782|4035208|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4
2320919|NCT02953782|4035209|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
2320920|NCT02953782|4035210|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
2320921|NCT02953782|4035211|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
2135047|NCT01071083|3740798|FG000|Overall Study|Did Not Want Per Protocol Treatment|0
2135048|NCT01071083|3740799|FG001|Overall Study|Did Not Want Per Protocol Treatment|0
2135049|NCT01071083|3740800|FG002|Overall Study|Did Not Want Per Protocol Treatment|1
2135050|NCT01071083|3740801|FG003|Overall Study|Did Not Want Per Protocol Treatment|0
2135051|NCT01071083|3740802|FG004|Overall Study|Did Not Want Per Protocol Treatment|1
2135052|NCT01071083|3740798|FG000|Overall Study|Subject Refused to Continue|1
2135053|NCT01071083|3740799|FG001|Overall Study|Subject Refused to Continue|0
2135054|NCT01071083|3740800|FG002|Overall Study|Subject Refused to Continue|0
2135055|NCT01071083|3740801|FG003|Overall Study|Subject Refused to Continue|0
2135056|NCT01071083|3740802|FG004|Overall Study|Subject Refused to Continue|0
2135057|NCT01071096|3740814|FG000|First Intervention (90 Days)|Lost to Follow-up|1
2135058|NCT01071096|3740815|FG001|First Intervention (90 Days)|Lost to Follow-up|0
2135059|NCT01071200|3740834|FG000|Overall Study|Lack of ovarian response|1
2135060|NCT01071200|3740835|FG001|Overall Study|Lack of ovarian response|1
2135061|NCT01071200|3740834|FG000|Overall Study|No fertilization|4
2135062|NCT01071200|3740835|FG001|Overall Study|No fertilization|0
2135063|NCT01071200|3740834|FG000|Overall Study|No oocytes retrieved|1
2135064|NCT01071200|3740835|FG001|Overall Study|No oocytes retrieved|1
2135065|NCT01071200|3740834|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1
2135066|NCT01071200|3740835|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0
2135067|NCT01071200|3740834|FG000|Overall Study|No viable embryos|0
2135068|NCT01071200|3740835|FG001|Overall Study|No viable embryos|1
2135069|NCT01071252|3740846|FG000|Overall Study|unsatisfactory therapeutic effect|4
2135070|NCT01071252|3740847|FG001|Overall Study|unsatisfactory therapeutic effect|6
2135071|NCT01071252|3740848|FG002|Overall Study|unsatisfactory therapeutic effect|2
2135072|NCT01071252|3740849|FG003|Overall Study|unsatisfactory therapeutic effect|0
2135073|NCT01071252|3740850|FG004|Overall Study|unsatisfactory therapeutic effect|6
2135074|NCT01071252|3740846|FG000|Overall Study|Withdrawal by Subject|8
2135075|NCT01071252|3740847|FG001|Overall Study|Withdrawal by Subject|2
2135076|NCT01071252|3740848|FG002|Overall Study|Withdrawal by Subject|1
2135077|NCT01071252|3740849|FG003|Overall Study|Withdrawal by Subject|2
2135078|NCT01071252|3740850|FG004|Overall Study|Withdrawal by Subject|3
2135079|NCT01071252|3740846|FG000|Overall Study|administrative problems|1
2135080|NCT01071252|3740847|FG001|Overall Study|administrative problems|1
2135081|NCT01071252|3740848|FG002|Overall Study|administrative problems|0
2135082|NCT01071252|3740849|FG003|Overall Study|administrative problems|2
2135083|NCT01071252|3740850|FG004|Overall Study|administrative problems|1
2135084|NCT01071252|3740846|FG000|Overall Study|Lost to Follow-up|1
2135085|NCT01071252|3740847|FG001|Overall Study|Lost to Follow-up|0
2135086|NCT01071252|3740848|FG002|Overall Study|Lost to Follow-up|1
2135087|NCT01071252|3740849|FG003|Overall Study|Lost to Follow-up|2
2135088|NCT01071252|3740850|FG004|Overall Study|Lost to Follow-up|0
2135089|NCT01071252|3740846|FG000|Overall Study|Adverse Event|1
2135090|NCT01071252|3740847|FG001|Overall Study|Adverse Event|1
2135091|NCT01071252|3740848|FG002|Overall Study|Adverse Event|0
2135092|NCT01071252|3740849|FG003|Overall Study|Adverse Event|1
2135093|NCT01071252|3740850|FG004|Overall Study|Adverse Event|0
2135094|NCT01071252|3740846|FG000|Overall Study|Death|0
2135095|NCT01071252|3740847|FG001|Overall Study|Death|0
2135096|NCT01071252|3740848|FG002|Overall Study|Death|0
2135097|NCT01071252|3740849|FG003|Overall Study|Death|0
2135098|NCT01071252|3740850|FG004|Overall Study|Death|1
2135099|NCT01071278|3740862|FG000|Overall Study|Premature Discontinuation|254
2135100|NCT01071278|3740862|FG000|Overall Study|Completion Status Unknown|459
2135101|NCT01071317|3740870|FG000|Overall Study|Lost to Follow-up|2
2135102|NCT01071317|3740871|FG001|Overall Study|Lost to Follow-up|2
2135103|NCT01071395|3740888|FG000|Overall Study|Withdrawal by Subject|2
2207451|NCT01629667|3846434|FG001|Overall Study|Death|5
2207452|NCT01629667|3846435|FG002|Overall Study|Death|3
2207453|NCT01629667|3846433|FG000|Overall Study|Randomized, not treated|2
2207454|NCT01629667|3846434|FG001|Overall Study|Randomized, not treated|1
2207455|NCT01629667|3846435|FG002|Overall Study|Randomized, not treated|0
2207456|NCT01629667|3846433|FG000|Overall Study|Ongoing AE worsening right heart failure|0
2207457|NCT01629667|3846434|FG001|Overall Study|Ongoing AE worsening right heart failure|1
2207458|NCT01629667|3846435|FG002|Overall Study|Ongoing AE worsening right heart failure|0
2207459|NCT01629667|3846433|FG000|Overall Study|Requiring lung transplant|2
2207460|NCT01629667|3846434|FG001|Overall Study|Requiring lung transplant|1
2207461|NCT01629667|3846435|FG002|Overall Study|Requiring lung transplant|3
2207462|NCT01629667|3846433|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
2207463|NCT01629667|3846434|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
2135104|NCT01071395|3740889|FG001|Overall Study|Withdrawal by Subject|1
2135105|NCT01071395|3740888|FG000|Overall Study|Adverse Event|3
2135106|NCT01071395|3740889|FG001|Overall Study|Adverse Event|1
2135107|NCT01071512|3740895|FG000|Overall Study|Adverse Event|1
2135108|NCT01071512|3740895|FG000|Overall Study|Development of antibodies to drug|2
2135109|NCT01071512|3740895|FG000|Overall Study|positive anti-JC virus antibody test|2
2135110|NCT01071798|3740903|FG000|Participants Who Received One Cycle|Lack of Efficacy|18
2135111|NCT01071798|3740903|FG000|Participants Who Received One Cycle|Lack of tolerability|14
2135112|NCT01071798|3740903|FG000|Participants Who Received One Cycle|Patient requirement|20
2135113|NCT01071798|3740903|FG000|Participants Who Received One Cycle|Death|5
2207464|NCT01629667|3846435|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
2135114|NCT01071798|3740903|FG000|Participants Who Received One Cycle|Change of therapy|6
2135115|NCT01071798|3740903|FG000|Participants Who Received One Cycle|Severe concomitant disease|2
2135116|NCT01071798|3740903|FG000|Subpopulation Who Received Two Cycles|Remission|1
2135117|NCT01071798|3740903|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
2135118|NCT01071798|3740903|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
2135119|NCT01071798|3740903|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7
2135120|NCT01071915|3740917|FG000|Overall Study|Adverse Event|3
2135121|NCT01071915|3740917|FG000|Overall Study|Physician Decision|2
2135122|NCT01071915|3740917|FG000|Overall Study|Withdrawal by Subject|2
2135123|NCT01071915|3740917|FG000|Overall Study|Miscellaneous Reasons|2
2135124|NCT01071954|3740921|FG000|Overall Study|Noncompliance|4
2135125|NCT01071954|3740921|FG000|Overall Study|Adverse Event|1
2135126|NCT01071954|3740921|FG000|Overall Study|Withdrawal by Subject|11
2135127|NCT01071954|3740921|FG000|Overall Study|Requirement for Alternative Therapy|5
2135128|NCT01071954|3740921|FG000|Overall Study|Administrative Decision|5
2135129|NCT01071954|3740921|FG000|Overall Study|Protocol Specified Criteria|1
2135130|NCT01072149|3740965|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135131|NCT01072149|3740966|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135132|NCT01072149|3740967|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2135133|NCT01072149|3740968|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135134|NCT01072149|3740969|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135135|NCT01072149|3740970|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135136|NCT01072149|3740971|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135137|NCT01072149|3740972|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135138|NCT01072149|3740973|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135139|NCT01072149|3740974|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135140|NCT01072149|3740975|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135141|NCT01072149|3740976|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135142|NCT01072149|3740977|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135143|NCT01072149|3740978|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135144|NCT01072149|3740979|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135145|NCT01072149|3740980|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135146|NCT01072149|3740981|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135147|NCT01072149|3740982|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2135148|NCT01072149|3740965|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0
2135149|NCT01072149|3740966|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0
2135150|NCT01072149|3740967|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0
2135151|NCT01072149|3740968|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0
2135152|NCT01072149|3740969|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0
2135153|NCT01072149|3740970|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0
2135154|NCT01072149|3740971|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0
2135155|NCT01072149|3740972|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0
2135156|NCT01072149|3740973|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0
2135157|NCT01072149|3740974|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0
2135158|NCT01072149|3740975|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0
2135159|NCT01072149|3740976|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0
2135160|NCT01072149|3740977|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0
2135161|NCT01072149|3740978|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0
2135162|NCT01072149|3740979|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0
2135163|NCT01072149|3740980|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0
2135164|NCT01072149|3740981|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0
2135165|NCT01072149|3740982|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1
2135166|NCT01072149|3740965|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135167|NCT01072149|3740966|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2207465|NCT01629667|3846433|FG000|Overall Study|Started other medicine|1
2207466|NCT01629667|3846434|FG001|Overall Study|Started other medicine|0
2207467|NCT01629667|3846435|FG002|Overall Study|Started other medicine|1
2207468|NCT01629667|3846433|FG000|Overall Study|Site error in safety follow-up|0
2207469|NCT01629667|3846434|FG001|Overall Study|Site error in safety follow-up|0
2207470|NCT01629667|3846435|FG002|Overall Study|Site error in safety follow-up|1
2207471|NCT01629667|3846433|FG000|Overall Study|Enrolled in another clinical study|0
2207472|NCT01629667|3846434|FG001|Overall Study|Enrolled in another clinical study|1
2207473|NCT01629667|3846435|FG002|Overall Study|Enrolled in another clinical study|0
2207474|NCT01629667|3846433|FG000|Overall Study|Code break|1
2207475|NCT01629667|3846434|FG001|Overall Study|Code break|0
2207476|NCT01629667|3846435|FG002|Overall Study|Code break|0
2207477|NCT01629693|3846447|FG000|Overall Study|Lost to Follow-up|2
2207478|NCT01629693|3846448|FG001|Overall Study|Lost to Follow-up|4
2207479|NCT01629693|3846447|FG000|Overall Study|Withdrawal by Subject|2
2135168|NCT01072149|3740967|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135169|NCT01072149|3740968|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135170|NCT01072149|3740969|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135171|NCT01072149|3740970|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135172|NCT01072149|3740971|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135173|NCT01072149|3740972|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135174|NCT01072149|3740973|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135175|NCT01072149|3740974|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135176|NCT01072149|3740975|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1
2135177|NCT01072149|3740976|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135178|NCT01072149|3740977|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135179|NCT01072149|3740978|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135180|NCT01072149|3740979|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135181|NCT01072149|3740980|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135182|NCT01072149|3740981|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135183|NCT01072149|3740982|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2135184|NCT01072149|3740965|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135185|NCT01072149|3740966|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1
2135186|NCT01072149|3740967|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135187|NCT01072149|3740968|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135188|NCT01072149|3740969|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135189|NCT01072149|3740970|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135190|NCT01072149|3740971|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135191|NCT01072149|3740972|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135192|NCT01072149|3740973|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135193|NCT01072149|3740974|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135194|NCT01072149|3740975|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135195|NCT01072149|3740976|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135196|NCT01072149|3740977|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135197|NCT01072149|3740978|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135198|NCT01072149|3740979|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135199|NCT01072149|3740980|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135200|NCT01072149|3740981|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135201|NCT01072149|3740982|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2135202|NCT01072149|3740965|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135203|NCT01072149|3740966|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135204|NCT01072149|3740967|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
2135205|NCT01072149|3740968|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135206|NCT01072149|3740969|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135207|NCT01072149|3740970|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135208|NCT01072149|3740971|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135209|NCT01072149|3740972|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135210|NCT01072149|3740973|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135211|NCT01072149|3740974|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135212|NCT01072149|3740975|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135213|NCT01072149|3740976|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135214|NCT01072149|3740977|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135215|NCT01072149|3740978|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135216|NCT01072149|3740979|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135217|NCT01072149|3740980|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135218|NCT01072149|3740981|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135219|NCT01072149|3740982|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2135220|NCT01072149|3740965|FG000|Treatment Period 2 (28 Days)|Physician Decision|0
2135221|NCT01072149|3740966|FG001|Treatment Period 2 (28 Days)|Physician Decision|0
2135222|NCT01072149|3740967|FG002|Treatment Period 2 (28 Days)|Physician Decision|0
2135223|NCT01072149|3740968|FG003|Treatment Period 2 (28 Days)|Physician Decision|0
2135224|NCT01072149|3740969|FG004|Treatment Period 2 (28 Days)|Physician Decision|0
2135225|NCT01072149|3740970|FG005|Treatment Period 2 (28 Days)|Physician Decision|0
2135226|NCT01072149|3740971|FG006|Treatment Period 2 (28 Days)|Physician Decision|0
2135227|NCT01072149|3740972|FG007|Treatment Period 2 (28 Days)|Physician Decision|1
2135228|NCT01072149|3740973|FG008|Treatment Period 2 (28 Days)|Physician Decision|0
2135229|NCT01072149|3740974|FG009|Treatment Period 2 (28 Days)|Physician Decision|0
2135230|NCT01072149|3740975|FG010|Treatment Period 2 (28 Days)|Physician Decision|0
2135231|NCT01072149|3740976|FG011|Treatment Period 2 (28 Days)|Physician Decision|0
2135232|NCT01072149|3740977|FG012|Treatment Period 2 (28 Days)|Physician Decision|0
2135233|NCT01072149|3740978|FG013|Treatment Period 2 (28 Days)|Physician Decision|0
2135234|NCT01072149|3740979|FG014|Treatment Period 2 (28 Days)|Physician Decision|0
2135235|NCT01072149|3740980|FG015|Treatment Period 2 (28 Days)|Physician Decision|0
2135236|NCT01072149|3740981|FG016|Treatment Period 2 (28 Days)|Physician Decision|0
2135237|NCT01072149|3740982|FG017|Treatment Period 2 (28 Days)|Physician Decision|0
2135238|NCT01072149|3740965|FG000|Washout Period 2 (14 Days)|Physician Decision|1
2135239|NCT01072149|3740966|FG001|Washout Period 2 (14 Days)|Physician Decision|0
2135240|NCT01072149|3740967|FG002|Washout Period 2 (14 Days)|Physician Decision|0
2135241|NCT01072149|3740968|FG003|Washout Period 2 (14 Days)|Physician Decision|0
2135242|NCT01072149|3740969|FG004|Washout Period 2 (14 Days)|Physician Decision|0
2135243|NCT01072149|3740970|FG005|Washout Period 2 (14 Days)|Physician Decision|0
2135244|NCT01072149|3740971|FG006|Washout Period 2 (14 Days)|Physician Decision|0
2135245|NCT01072149|3740972|FG007|Washout Period 2 (14 Days)|Physician Decision|0
2135246|NCT01072149|3740973|FG008|Washout Period 2 (14 Days)|Physician Decision|0
2135247|NCT01072149|3740974|FG009|Washout Period 2 (14 Days)|Physician Decision|0
2135248|NCT01072149|3740975|FG010|Washout Period 2 (14 Days)|Physician Decision|0
2135249|NCT01072149|3740976|FG011|Washout Period 2 (14 Days)|Physician Decision|0
2135250|NCT01072149|3740977|FG012|Washout Period 2 (14 Days)|Physician Decision|0
2135251|NCT01072149|3740978|FG013|Washout Period 2 (14 Days)|Physician Decision|0
2135252|NCT01072149|3740979|FG014|Washout Period 2 (14 Days)|Physician Decision|0
2135253|NCT01072149|3740980|FG015|Washout Period 2 (14 Days)|Physician Decision|0
2135254|NCT01072149|3740981|FG016|Washout Period 2 (14 Days)|Physician Decision|0
2135255|NCT01072149|3740982|FG017|Washout Period 2 (14 Days)|Physician Decision|0
2135256|NCT01072149|3740965|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135257|NCT01072149|3740966|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135258|NCT01072149|3740967|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135259|NCT01072149|3740968|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135260|NCT01072149|3740969|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135261|NCT01072149|3740970|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135262|NCT01072149|3740971|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135263|NCT01072149|3740972|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135264|NCT01072149|3740973|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135265|NCT01072149|3740974|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135266|NCT01072149|3740975|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135267|NCT01072149|3740976|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135268|NCT01072149|3740977|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135269|NCT01072149|3740978|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135270|NCT01072149|3740979|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135271|NCT01072149|3740980|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1
2135272|NCT01072149|3740981|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135273|NCT01072149|3740982|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2135274|NCT01072149|3740965|FG000|Washout Period 2 (14 Days)|Adverse Event|0
2135275|NCT01072149|3740966|FG001|Washout Period 2 (14 Days)|Adverse Event|0
2135276|NCT01072149|3740967|FG002|Washout Period 2 (14 Days)|Adverse Event|0
2135277|NCT01072149|3740968|FG003|Washout Period 2 (14 Days)|Adverse Event|0
2135278|NCT01072149|3740969|FG004|Washout Period 2 (14 Days)|Adverse Event|0
2135279|NCT01072149|3740970|FG005|Washout Period 2 (14 Days)|Adverse Event|0
2135280|NCT01072149|3740971|FG006|Washout Period 2 (14 Days)|Adverse Event|0
2135281|NCT01072149|3740972|FG007|Washout Period 2 (14 Days)|Adverse Event|0
2135282|NCT01072149|3740973|FG008|Washout Period 2 (14 Days)|Adverse Event|0
2135283|NCT01072149|3740974|FG009|Washout Period 2 (14 Days)|Adverse Event|0
2135284|NCT01072149|3740975|FG010|Washout Period 2 (14 Days)|Adverse Event|0
2135285|NCT01072149|3740976|FG011|Washout Period 2 (14 Days)|Adverse Event|0
2135286|NCT01072149|3740977|FG012|Washout Period 2 (14 Days)|Adverse Event|0
2135287|NCT01072149|3740978|FG013|Washout Period 2 (14 Days)|Adverse Event|0
2135288|NCT01072149|3740979|FG014|Washout Period 2 (14 Days)|Adverse Event|0
2135289|NCT01072149|3740980|FG015|Washout Period 2 (14 Days)|Adverse Event|1
2135290|NCT01072149|3740981|FG016|Washout Period 2 (14 Days)|Adverse Event|0
2135291|NCT01072149|3740982|FG017|Washout Period 2 (14 Days)|Adverse Event|0
2135292|NCT01072149|3740965|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135293|NCT01072149|3740966|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135294|NCT01072149|3740967|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135295|NCT01072149|3740968|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135296|NCT01072149|3740969|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135297|NCT01072149|3740970|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135298|NCT01072149|3740971|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135299|NCT01072149|3740972|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135300|NCT01072149|3740973|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0
2207480|NCT01629693|3846448|FG001|Overall Study|Withdrawal by Subject|2
2207481|NCT01629693|3846447|FG000|Overall Study|Adverse Event|1
2207482|NCT01629693|3846448|FG001|Overall Study|Adverse Event|0
2207483|NCT01629693|3846447|FG000|Overall Study|Investigator decision|0
2207484|NCT01629693|3846448|FG001|Overall Study|Investigator decision|1
2135301|NCT01072149|3740974|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135302|NCT01072149|3740975|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135303|NCT01072149|3740976|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135304|NCT01072149|3740977|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1
2135305|NCT01072149|3740978|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135306|NCT01072149|3740979|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135307|NCT01072149|3740980|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135308|NCT01072149|3740981|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0
2135309|NCT01072149|3740982|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0
2286541|NCT02437409|3975864|FG000|Overall Study|Withdrawal by Subject|3
2286542|NCT02437409|3975864|FG000|Overall Study|Screening failure|12
2286543|NCT02437513|3975878|FG000|Overall Study|Withdrawal by Subject|2
2286544|NCT02437864|3975889|FG000|Overall Study|Protocol Violation|4
2286545|NCT02437864|3975890|FG001|Overall Study|Protocol Violation|0
2286546|NCT02437890|3975901|FG000|Overall Study|Non-compliance to study drug|0
2286547|NCT02437890|3975902|FG001|Overall Study|Non-compliance to study drug|1
2286548|NCT02437890|3975903|FG002|Overall Study|Non-compliance to study drug|0
2135310|NCT01072149|3740965|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135311|NCT01072149|3740966|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135312|NCT01072149|3740967|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
2135313|NCT01072149|3740968|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135314|NCT01072149|3740969|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135315|NCT01072149|3740970|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135316|NCT01072149|3740971|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135317|NCT01072149|3740972|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135318|NCT01072149|3740973|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135319|NCT01072149|3740974|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135320|NCT01072149|3740975|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135321|NCT01072149|3740976|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135322|NCT01072149|3740977|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135323|NCT01072149|3740978|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
2135324|NCT01072149|3740979|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135325|NCT01072149|3740980|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135326|NCT01072149|3740981|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135327|NCT01072149|3740982|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2135328|NCT01072201|3741003|FG000|Overall Study|Lost to Follow-up|0
2135329|NCT01072201|3741004|FG001|Overall Study|Lost to Follow-up|1
2135330|NCT01072344|3741025|FG000|Overall Study|Relasped-reached end point|7
2135331|NCT01072344|3741026|FG001|Overall Study|Relasped-reached end point|12
2135332|NCT01072344|3741025|FG000|Overall Study|Protocol Violation|1
2135333|NCT01072344|3741026|FG001|Overall Study|Protocol Violation|2
2135334|NCT01072344|3741025|FG000|Overall Study|Lost to Follow-up|3
2135335|NCT01072344|3741026|FG001|Overall Study|Lost to Follow-up|4
2135336|NCT01072357|3741034|FG000|Overall Study|Lost to Follow-up|0
2135337|NCT01072357|3741035|FG001|Overall Study|Lost to Follow-up|1
2135338|NCT01072396|3741043|FG000|Period One|Adverse Event|1
2135339|NCT01072396|3741044|FG001|Period One|Adverse Event|1
2135340|NCT01072396|3741043|FG000|Period One|Protocol Violation|2
2135341|NCT01072396|3741044|FG001|Period One|Protocol Violation|1
2135342|NCT01072396|3741043|FG000|Period One|Withdrawal by Subject|2
2135343|NCT01072396|3741044|FG001|Period One|Withdrawal by Subject|0
2135344|NCT01072396|3741043|FG000|Washout Period|Missing termination information|0
2135345|NCT01072396|3741044|FG001|Washout Period|Missing termination information|1
2135346|NCT01072396|3741043|FG000|Period Two|Adverse Event|0
2135347|NCT01072396|3741044|FG001|Period Two|Adverse Event|3
2135348|NCT01072396|3741043|FG000|Period Two|Lost to Follow-up|1
2135349|NCT01072396|3741044|FG001|Period Two|Lost to Follow-up|0
2135350|NCT01072448|3741056|FG000|Overall Study|Adverse Event|9
2135351|NCT01072448|3741057|FG001|Overall Study|Adverse Event|10
2135352|NCT01072448|3741056|FG000|Overall Study|Subject withdrew consent|4
2135353|NCT01072448|3741057|FG001|Overall Study|Subject withdrew consent|9
2135354|NCT01072448|3741056|FG000|Overall Study|Protocol deviation|3
2135355|NCT01072448|3741057|FG001|Overall Study|Protocol deviation|4
2135356|NCT01072448|3741056|FG000|Overall Study|Abnormal test procedure result(s)|1
2135357|NCT01072448|3741057|FG001|Overall Study|Abnormal test procedure result(s)|0
2135358|NCT01072448|3741056|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2135359|NCT01072448|3741057|FG001|Overall Study|Unsatisfactory therapeutic effect|3
2135360|NCT01072448|3741056|FG000|Overall Study|Lost to Follow-up|1
2135361|NCT01072448|3741057|FG001|Overall Study|Lost to Follow-up|1
2135362|NCT01072448|3741056|FG000|Overall Study|Abnormal laboratory value(s)|0
2135363|NCT01072448|3741057|FG001|Overall Study|Abnormal laboratory value(s)|1
2135364|NCT01072448|3741056|FG000|Overall Study|Death|0
2135365|NCT01072448|3741057|FG001|Overall Study|Death|2
2135366|NCT01072500|3741065|FG000|Overall Study|Death|2
2135367|NCT01072500|3741066|FG001|Overall Study|Death|2
2135368|NCT01072500|3741065|FG000|Overall Study|Lost to Follow-up|5
2135369|NCT01072500|3741066|FG001|Overall Study|Lost to Follow-up|2
2135370|NCT01072500|3741065|FG000|Overall Study|Withdrawal by Subject|17
2135371|NCT01072500|3741066|FG001|Overall Study|Withdrawal by Subject|10
2135372|NCT01072539|3741074|FG000|Overall Study|Treated prior to the Site Initiation|1
2135373|NCT01072539|3741074|FG000|Overall Study|Protocol Violation|2
2135374|NCT01072630|3741086|FG000|Overall Study|Adverse Event|11
2135375|NCT01072630|3741087|FG001|Overall Study|Adverse Event|19
2135376|NCT01072630|3741088|FG002|Overall Study|Adverse Event|2
2135377|NCT01072630|3741086|FG000|Overall Study|Lack of Efficacy|10
2135378|NCT01072630|3741087|FG001|Overall Study|Lack of Efficacy|10
2135379|NCT01072630|3741088|FG002|Overall Study|Lack of Efficacy|1
2135380|NCT01072630|3741086|FG000|Overall Study|Withdrawal by Subject|8
2135381|NCT01072630|3741087|FG001|Overall Study|Withdrawal by Subject|7
2135382|NCT01072630|3741088|FG002|Overall Study|Withdrawal by Subject|2
2135383|NCT01072630|3741086|FG000|Overall Study|Protocol Violation|10
2135384|NCT01072630|3741087|FG001|Overall Study|Protocol Violation|8
2135385|NCT01072630|3741088|FG002|Overall Study|Protocol Violation|4
2135386|NCT01072630|3741086|FG000|Overall Study|Lost to Follow-up|11
2135387|NCT01072630|3741087|FG001|Overall Study|Lost to Follow-up|11
2135388|NCT01072630|3741088|FG002|Overall Study|Lost to Follow-up|1
2135389|NCT01072630|3741086|FG000|Overall Study|Noncompliance with study medication|1
2135390|NCT01072630|3741087|FG001|Overall Study|Noncompliance with study medication|1
2135391|NCT01072630|3741088|FG002|Overall Study|Noncompliance with study medication|1
2135392|NCT01072630|3741086|FG000|Overall Study|Noncompliance with study procedures|1
2135393|NCT01072630|3741087|FG001|Overall Study|Noncompliance with study procedures|2
2135394|NCT01072630|3741088|FG002|Overall Study|Noncompliance with study procedures|1
2135395|NCT01072630|3741086|FG000|Overall Study|Other|3
2135396|NCT01072630|3741087|FG001|Overall Study|Other|2
2135397|NCT01072630|3741088|FG002|Overall Study|Other|1
2135398|NCT01072877|3741148|FG000|Overall Study|Lost to Follow-up|1
2135399|NCT01072877|3741149|FG001|Overall Study|Lost to Follow-up|1
2135400|NCT01072877|3741150|FG002|Overall Study|Lost to Follow-up|0
2135401|NCT01072877|3741151|FG003|Overall Study|Lost to Follow-up|2
2135402|NCT01072877|3741152|FG004|Overall Study|Lost to Follow-up|0
2135403|NCT01072929|3741169|FG000|Overall Study|Adverse Event|8
2135404|NCT01072929|3741170|FG001|Overall Study|Adverse Event|11
2135405|NCT01072929|3741171|FG002|Overall Study|Adverse Event|2
2135406|NCT01072929|3741169|FG000|Overall Study|Lack of Efficacy|7
2135407|NCT01072929|3741170|FG001|Overall Study|Lack of Efficacy|4
2135408|NCT01072929|3741171|FG002|Overall Study|Lack of Efficacy|0
2135409|NCT01072929|3741169|FG000|Overall Study|Withdrawal by Subject|7
2286549|NCT02437890|3975904|FG003|Overall Study|Non-compliance to study drug|0
2286550|NCT02437890|3975905|FG004|Overall Study|Non-compliance to study drug|1
2286551|NCT02437890|3975901|FG000|Overall Study|Sponsor's decision|1
2286552|NCT02437890|3975902|FG001|Overall Study|Sponsor's decision|1
2286553|NCT02437890|3975903|FG002|Overall Study|Sponsor's decision|4
2286554|NCT02437890|3975904|FG003|Overall Study|Sponsor's decision|0
2286555|NCT02437890|3975905|FG004|Overall Study|Sponsor's decision|2
2286556|NCT02437890|3975901|FG000|Overall Study|Physician Decision|0
2286557|NCT02437890|3975902|FG001|Overall Study|Physician Decision|0
2286558|NCT02437890|3975903|FG002|Overall Study|Physician Decision|0
2286559|NCT02437890|3975904|FG003|Overall Study|Physician Decision|1
2286560|NCT02437890|3975905|FG004|Overall Study|Physician Decision|0
2286561|NCT02437890|3975901|FG000|Overall Study|Unable to attend visit(s)|1
2286562|NCT02437890|3975902|FG001|Overall Study|Unable to attend visit(s)|0
2286563|NCT02437890|3975903|FG002|Overall Study|Unable to attend visit(s)|0
2286564|NCT02437890|3975904|FG003|Overall Study|Unable to attend visit(s)|0
2286565|NCT02437890|3975905|FG004|Overall Study|Unable to attend visit(s)|0
2286566|NCT02437890|3975901|FG000|Overall Study|Lack of Efficacy|1
2286567|NCT02437890|3975902|FG001|Overall Study|Lack of Efficacy|3
2286568|NCT02437890|3975903|FG002|Overall Study|Lack of Efficacy|0
2286569|NCT02437890|3975904|FG003|Overall Study|Lack of Efficacy|3
2286570|NCT02437890|3975905|FG004|Overall Study|Lack of Efficacy|1
2286571|NCT02437890|3975901|FG000|Overall Study|Adverse Event|4
2286572|NCT02437890|3975902|FG001|Overall Study|Adverse Event|9
2286573|NCT02437890|3975903|FG002|Overall Study|Adverse Event|5
2286574|NCT02437890|3975904|FG003|Overall Study|Adverse Event|11
2286575|NCT02437890|3975905|FG004|Overall Study|Adverse Event|7
2286576|NCT02437890|3975901|FG000|Overall Study|Withdrawal by Subject|1
2286577|NCT02437890|3975902|FG001|Overall Study|Withdrawal by Subject|2
2286578|NCT02437890|3975903|FG002|Overall Study|Withdrawal by Subject|6
2286579|NCT02437890|3975904|FG003|Overall Study|Withdrawal by Subject|5
2286580|NCT02437890|3975905|FG004|Overall Study|Withdrawal by Subject|5
2286581|NCT02437890|3975901|FG000|Overall Study|Death|0
2286582|NCT02437890|3975902|FG001|Overall Study|Death|0
2286583|NCT02437890|3975903|FG002|Overall Study|Death|0
2286584|NCT02437890|3975904|FG003|Overall Study|Death|2
2286585|NCT02437890|3975905|FG004|Overall Study|Death|0
2286586|NCT02437903|3975921|FG000|Overall Study|Adverse Event|1
2286587|NCT02437903|3975921|FG000|Overall Study|Withdrawal by Subject|1
2286588|NCT02437903|3975921|FG000|Overall Study|Lost to Follow-up|3
2286589|NCT02438137|3975928|FG000|Overall Study|Lost to Follow-up|3
2286590|NCT02438137|3975929|FG001|Overall Study|Lost to Follow-up|2
2286591|NCT02438137|3975928|FG000|Overall Study|Adverse Event|1
2286592|NCT02438137|3975929|FG001|Overall Study|Adverse Event|0
2286593|NCT02438137|3975928|FG000|Overall Study|Withdrawal by Subject|4
2286594|NCT02438137|3975929|FG001|Overall Study|Withdrawal by Subject|3
2286595|NCT02438137|3975928|FG000|Overall Study|Physician Decision|0
2286596|NCT02438137|3975929|FG001|Overall Study|Physician Decision|1
2286597|NCT02438280|3975939|FG000|Overall Study|Physician Decision|1
2286598|NCT02438280|3975940|FG001|Overall Study|Physician Decision|0
2286599|NCT02438371|3975949|FG000|Overall Study|Lost to Follow-up|3
2286600|NCT02438371|3975950|FG001|Overall Study|Lost to Follow-up|2
2286601|NCT02438371|3975949|FG000|Overall Study|Withdrawal by Subject|1
2286602|NCT02438371|3975950|FG001|Overall Study|Withdrawal by Subject|1
2286603|NCT02438384|3975959|FG000|Overall Study|Lost to Follow-up|8
2135410|NCT01072929|3741170|FG001|Overall Study|Withdrawal by Subject|15
2286604|NCT02438384|3975960|FG001|Overall Study|Lost to Follow-up|6
2286605|NCT02438384|3975961|FG002|Overall Study|Lost to Follow-up|4
2286606|NCT02438722|3976009|FG000|Overall Study|Adverse Event|12
2286607|NCT02438722|3976010|FG001|Overall Study|Adverse Event|9
2286608|NCT02438722|3976009|FG000|Overall Study|Refusal unrelated to AE|2
2286609|NCT02438722|3976010|FG001|Overall Study|Refusal unrelated to AE|5
2286610|NCT02438722|3976009|FG000|Overall Study|Disease progression/relapse|46
2286611|NCT02438722|3976010|FG001|Overall Study|Disease progression/relapse|51
2286612|NCT02438722|3976009|FG000|Overall Study|Death|0
2286613|NCT02438722|3976010|FG001|Overall Study|Death|3
2286614|NCT02438722|3976009|FG000|Overall Study|Physician Decision|2
2286615|NCT02438722|3976010|FG001|Overall Study|Physician Decision|2
2135411|NCT01072929|3741171|FG002|Overall Study|Withdrawal by Subject|3
2135412|NCT01072929|3741169|FG000|Overall Study|Protocol Violation|13
2207485|NCT01629693|3846447|FG000|Overall Study|Poor comfort of study lenses|0
2207486|NCT01629693|3846448|FG001|Overall Study|Poor comfort of study lenses|2
2207487|NCT01629693|3846447|FG000|Overall Study|Subject decision unrelated to AE|0
2135413|NCT01072929|3741170|FG001|Overall Study|Protocol Violation|11
2135414|NCT01072929|3741171|FG002|Overall Study|Protocol Violation|2
2135415|NCT01072929|3741169|FG000|Overall Study|Lost to Follow-up|8
2135416|NCT01072929|3741170|FG001|Overall Study|Lost to Follow-up|4
2135417|NCT01072929|3741171|FG002|Overall Study|Lost to Follow-up|1
2135418|NCT01072929|3741169|FG000|Overall Study|Noncompliance with study medication|0
2135419|NCT01072929|3741170|FG001|Overall Study|Noncompliance with study medication|3
2135420|NCT01072929|3741171|FG002|Overall Study|Noncompliance with study medication|0
2135421|NCT01072929|3741169|FG000|Overall Study|Noncompliance with study procedures|1
2135422|NCT01072929|3741170|FG001|Overall Study|Noncompliance with study procedures|0
2135423|NCT01072929|3741171|FG002|Overall Study|Noncompliance with study procedures|1
2135424|NCT01072929|3741169|FG000|Overall Study|Other|0
2207488|NCT01629693|3846448|FG001|Overall Study|Subject decision unrelated to AE|1
2207489|NCT01629706|3846454|FG000|Phase 1 PureVision|Screen Failure|4
2207490|NCT01629706|3846454|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
2207491|NCT01629706|3846454|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1
2207492|NCT01629706|3846454|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
2207493|NCT01629706|3846454|FG000|Phase 2 Habitual|Screen Failure|6
2207494|NCT01629706|3846454|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
2207495|NCT01629706|3846454|FG000|Phase 2 Habitual|Relocation prior to Dispense|1
2207496|NCT01629706|3846454|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
2207497|NCT01629706|3846454|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1
2207498|NCT01629823|3846488|FG000|Trial Period|Missed visit|11
2207499|NCT01629823|3846489|FG001|Trial Period|Missed visit|9
2207500|NCT01629823|3846490|FG002|Trial Period|Missed visit|8
2207501|NCT01629823|3846488|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1
2207502|NCT01629823|3846489|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1
2207503|NCT01629823|3846490|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1
2207504|NCT01629823|3846488|FG000|Trial Period|Pregnancy|1
2207505|NCT01629823|3846489|FG001|Trial Period|Pregnancy|0
2135425|NCT01072929|3741170|FG001|Overall Study|Other|3
2135426|NCT01072929|3741171|FG002|Overall Study|Other|0
2135427|NCT01073020|3741184|FG000|Overall Study|Withdrawal by Subject|6
2135428|NCT01073020|3741185|FG001|Overall Study|Withdrawal by Subject|4
2135429|NCT01073020|3741186|FG002|Overall Study|Withdrawal by Subject|1
2135430|NCT01073020|3741187|FG003|Overall Study|Withdrawal by Subject|2
2135431|NCT01073020|3741184|FG000|Overall Study|Physician Decision|1
2207506|NCT01629823|3846490|FG002|Trial Period|Pregnancy|0
2207507|NCT01629823|3846488|FG000|Trial Period|Adverse Event|0
2207508|NCT01629823|3846489|FG001|Trial Period|Adverse Event|1
2207509|NCT01629823|3846490|FG002|Trial Period|Adverse Event|0
2207510|NCT01629823|3846488|FG000|Trial Period|Out-of-window visit|0
2207511|NCT01629823|3846489|FG001|Trial Period|Out-of-window visit|2
2207512|NCT01629823|3846490|FG002|Trial Period|Out-of-window visit|0
2207513|NCT01629823|3846488|FG000|Trial Period|Failed to hold medication|0
2207514|NCT01629823|3846489|FG001|Trial Period|Failed to hold medication|0
2207515|NCT01629823|3846490|FG002|Trial Period|Failed to hold medication|1
2207516|NCT01629823|3846488|FG000|Washout Period|Safety|2
2207517|NCT01629823|3846489|FG001|Washout Period|Safety|5
2135432|NCT01073020|3741185|FG001|Overall Study|Physician Decision|0
2135433|NCT01073020|3741186|FG002|Overall Study|Physician Decision|2
2135434|NCT01073020|3741187|FG003|Overall Study|Physician Decision|0
2135435|NCT01073020|3741184|FG000|Overall Study|Death|0
2135436|NCT01073020|3741185|FG001|Overall Study|Death|1
2135437|NCT01073020|3741186|FG002|Overall Study|Death|0
2135438|NCT01073020|3741187|FG003|Overall Study|Death|0
2135439|NCT01073163|3741197|FG000|Overall Study|Adverse Event|1
2135440|NCT01073163|3741197|FG000|Overall Study|Disease Progression|1
2135441|NCT01073163|3741197|FG000|Overall Study|Early termination|1
2135442|NCT01073267|3741205|FG000|Overall Study|Disease Progression|3
2135443|NCT01073293|3741211|FG000|Overall Study|Lost to Follow-up|0
2135444|NCT01073293|3741212|FG001|Overall Study|Lost to Follow-up|1
2135445|NCT01073293|3741211|FG000|Overall Study|Withdrawal by Subject|5
2135446|NCT01073293|3741212|FG001|Overall Study|Withdrawal by Subject|10
2135447|NCT01073462|3741222|FG000|Overall Study|Death|14
2135448|NCT01073462|3741222|FG000|Overall Study|Kidney transplant|10
2135449|NCT01073462|3741222|FG000|Overall Study|Low parathyroid hormone levels|8
2135450|NCT01073462|3741222|FG000|Overall Study|Serious adverse event|2
2135451|NCT01073462|3741222|FG000|Overall Study|Lost to Follow-up|7
2135452|NCT01073566|3741228|FG000|Period 2 (6 Weeks)|Adverse Event|1
2135453|NCT01073566|3741229|FG001|Period 2 (6 Weeks)|Adverse Event|0
2135454|NCT01073605|3741238|FG000|Overall Study|Ongoing at Cutoff Date|1
2135455|NCT01073605|3741239|FG001|Overall Study|Ongoing at Cutoff Date|1
2135456|NCT01073605|3741240|FG002|Overall Study|Ongoing at Cutoff Date|0
2135457|NCT01073605|3741238|FG000|Overall Study|Adverse Event|2
2135458|NCT01073605|3741239|FG001|Overall Study|Adverse Event|1
2135459|NCT01073605|3741240|FG002|Overall Study|Adverse Event|0
2135460|NCT01073605|3741238|FG000|Overall Study|Lost to Follow-up|3
2135461|NCT01073605|3741239|FG001|Overall Study|Lost to Follow-up|4
2135462|NCT01073605|3741240|FG002|Overall Study|Lost to Follow-up|9
2135463|NCT01073605|3741238|FG000|Overall Study|Other|25
2135464|NCT01073605|3741239|FG001|Overall Study|Other|21
2135465|NCT01073605|3741240|FG002|Overall Study|Other|29
2135466|NCT01073605|3741238|FG000|Overall Study|Withdrawal by Subject|31
2135467|NCT01073605|3741239|FG001|Overall Study|Withdrawal by Subject|39
2135468|NCT01073605|3741240|FG002|Overall Study|Withdrawal by Subject|22
2135469|NCT01073605|3741238|FG000|Overall Study|Randomized But Not Treated|0
2135470|NCT01073605|3741239|FG001|Overall Study|Randomized But Not Treated|1
2135471|NCT01073605|3741240|FG002|Overall Study|Randomized But Not Treated|1
2135472|NCT01073618|3741248|FG000|Overall Study|Death|208
2135473|NCT01073618|3741248|FG000|Overall Study|Adverse Event|19
2135474|NCT01073618|3741248|FG000|Overall Study|Other|80
2135475|NCT01073631|3741252|FG000|Overall Study|Death|82
2135476|NCT01073631|3741252|FG000|Overall Study|Adverse Event|24
2135477|NCT01073631|3741252|FG000|Overall Study|Other|63
2135478|NCT01073865|3741267|FG000|Overall Study|Reasons other than below|19
2135479|NCT01073865|3741268|FG001|Overall Study|Reasons other than below|31
2135480|NCT01073865|3741267|FG000|Overall Study|Lost to Follow-up|1
2135481|NCT01073865|3741268|FG001|Overall Study|Lost to Follow-up|1
2135482|NCT01073865|3741267|FG000|Overall Study|Death|3
2135483|NCT01073865|3741268|FG001|Overall Study|Death|2
2135484|NCT01073865|3741267|FG000|Overall Study|Withdrawal by Subject|5
2135485|NCT01073865|3741268|FG001|Overall Study|Withdrawal by Subject|5
2135486|NCT01073930|3741276|FG000|Overall Study|Withdrawal by Subject|3
2135487|NCT01073930|3741277|FG001|Overall Study|Withdrawal by Subject|2
2135488|NCT01073930|3741276|FG000|Overall Study|Lost to Follow-up|0
2135489|NCT01073930|3741277|FG001|Overall Study|Lost to Follow-up|1
2135490|NCT01073930|3741276|FG000|Overall Study|Adverse Event|0
2135491|NCT01073930|3741277|FG001|Overall Study|Adverse Event|1
2135492|NCT01073930|3741276|FG000|Overall Study|Noncompliance with study drug|0
2135493|NCT01073930|3741277|FG001|Overall Study|Noncompliance with study drug|1
2135494|NCT01073930|3741276|FG000|Overall Study|Inadequate prep; unable to do procedure|0
2135495|NCT01073930|3741277|FG001|Overall Study|Inadequate prep; unable to do procedure|1
2135496|NCT01073943|3741285|FG000|Overall Study|Withdrawal by Subject|8
2135497|NCT01073943|3741286|FG001|Overall Study|Withdrawal by Subject|2
2135498|NCT01073943|3741285|FG000|Overall Study|Protocol Violation|2
2135499|NCT01073943|3741286|FG001|Overall Study|Protocol Violation|1
2135500|NCT01073943|3741285|FG000|Overall Study|Adverse Event|1
2135501|NCT01073943|3741286|FG001|Overall Study|Adverse Event|1
2207518|NCT01629823|3846490|FG002|Washout Period|Safety|0
2207519|NCT01629823|3846488|FG000|Washout Period|Pregnancy|1
2207520|NCT01629823|3846489|FG001|Washout Period|Pregnancy|0
2207521|NCT01629823|3846490|FG002|Washout Period|Pregnancy|0
2207522|NCT01629823|3846488|FG000|Washout Period|Protocol Violation|0
2207523|NCT01629823|3846489|FG001|Washout Period|Protocol Violation|1
2207524|NCT01629823|3846490|FG002|Washout Period|Protocol Violation|0
2207525|NCT01629953|3846509|FG000|Overall Study|Death|3
2207526|NCT01629953|3846510|FG001|Overall Study|Death|1
2207527|NCT01629953|3846509|FG000|Overall Study|Lost to Follow-up|10
2135502|NCT01073943|3741285|FG000|Overall Study|Lost to Follow-up|0
2135503|NCT01073943|3741286|FG001|Overall Study|Lost to Follow-up|2
2207528|NCT01629953|3846510|FG001|Overall Study|Lost to Follow-up|14
2207529|NCT01629966|3846519|FG000|Overall Study|Pregnancy|0
2207530|NCT01629966|3846520|FG001|Overall Study|Pregnancy|1
2135504|NCT01073943|3741285|FG000|Overall Study|Power outage; colonoscopy not done|1
2135505|NCT01073943|3741286|FG001|Overall Study|Power outage; colonoscopy not done|0
2135506|NCT01073943|3741285|FG000|Overall Study|Subject forgot|0
2135507|NCT01073943|3741286|FG001|Overall Study|Subject forgot|1
2135508|NCT01073943|3741285|FG000|Overall Study|Unable to return for follow-up|0
2135509|NCT01073943|3741286|FG001|Overall Study|Unable to return for follow-up|1
2135510|NCT01073943|3741285|FG000|Overall Study|Could not tolerate prep|1
2135511|NCT01073943|3741286|FG001|Overall Study|Could not tolerate prep|0
2135512|NCT01074008|3741301|FG000|Overall Study|Adverse Event|0
2135513|NCT01074008|3741302|FG001|Overall Study|Adverse Event|1
2135514|NCT01074008|3741303|FG002|Overall Study|Adverse Event|0
2135515|NCT01074008|3741304|FG003|Overall Study|Adverse Event|0
2135516|NCT01074008|3741305|FG004|Overall Study|Adverse Event|0
2135517|NCT01074008|3741306|FG005|Overall Study|Adverse Event|0
2135518|NCT01074008|3741307|FG006|Overall Study|Adverse Event|0
2135519|NCT01074008|3741308|FG007|Overall Study|Adverse Event|0
2135520|NCT01074008|3741309|FG008|Overall Study|Adverse Event|0
2135521|NCT01074008|3741301|FG000|Overall Study|Withdrawal by Subject|1
2135522|NCT01074008|3741302|FG001|Overall Study|Withdrawal by Subject|1
2135523|NCT01074008|3741303|FG002|Overall Study|Withdrawal by Subject|1
2135524|NCT01074008|3741304|FG003|Overall Study|Withdrawal by Subject|0
2135525|NCT01074008|3741305|FG004|Overall Study|Withdrawal by Subject|1
2135526|NCT01074008|3741306|FG005|Overall Study|Withdrawal by Subject|0
2135527|NCT01074008|3741307|FG006|Overall Study|Withdrawal by Subject|0
2135528|NCT01074008|3741308|FG007|Overall Study|Withdrawal by Subject|0
2135529|NCT01074008|3741309|FG008|Overall Study|Withdrawal by Subject|0
2135530|NCT01074008|3741301|FG000|Overall Study|Lost to Follow-up|0
2135531|NCT01074008|3741302|FG001|Overall Study|Lost to Follow-up|1
2135532|NCT01074008|3741303|FG002|Overall Study|Lost to Follow-up|1
2207531|NCT01629966|3846521|FG002|Overall Study|Pregnancy|0
2207532|NCT01629966|3846519|FG000|Overall Study|Lost to Follow-up|10
2135533|NCT01074008|3741304|FG003|Overall Study|Lost to Follow-up|1
2135534|NCT01074008|3741305|FG004|Overall Study|Lost to Follow-up|1
2135535|NCT01074008|3741306|FG005|Overall Study|Lost to Follow-up|0
2135536|NCT01074008|3741307|FG006|Overall Study|Lost to Follow-up|1
2135537|NCT01074008|3741308|FG007|Overall Study|Lost to Follow-up|0
2135538|NCT01074008|3741309|FG008|Overall Study|Lost to Follow-up|4
2135539|NCT01074047|3741345|FG000|Treatment Phase|Adverse Event|89
2135540|NCT01074047|3741346|FG001|Treatment Phase|Adverse Event|66
2135541|NCT01074047|3741345|FG000|Treatment Phase|Disease Progression|16
2135542|NCT01074047|3741346|FG001|Treatment Phase|Disease Progression|21
2135543|NCT01074047|3741345|FG000|Treatment Phase|Withdrawal by Subject|27
2135544|NCT01074047|3741346|FG001|Treatment Phase|Withdrawal by Subject|48
2135545|NCT01074047|3741345|FG000|Treatment Phase|Death|53
2135546|NCT01074047|3741346|FG001|Treatment Phase|Death|58
2135547|NCT01074047|3741345|FG000|Treatment Phase|Lost to Follow-up|0
2135548|NCT01074047|3741346|FG001|Treatment Phase|Lost to Follow-up|1
2135549|NCT01074047|3741345|FG000|Treatment Phase|Protocol Violation|0
2135550|NCT01074047|3741346|FG001|Treatment Phase|Protocol Violation|1
2135551|NCT01074047|3741345|FG000|Treatment Phase|Miscellaneous|32
2135552|NCT01074047|3741346|FG001|Treatment Phase|Miscellaneous|39
2135553|NCT01074047|3741345|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5
2135554|NCT01074047|3741346|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8
2135555|NCT01074047|3741345|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
2135556|NCT01074047|3741346|FG001|Survival Follow-Up Phase|Lost to Follow-up|1
2135557|NCT01074047|3741345|FG000|Survival Follow-Up Phase|Death|116
2135558|NCT01074047|3741346|FG001|Survival Follow-Up Phase|Death|124
2135559|NCT01074047|3741345|FG000|Survival Follow-Up Phase|Alive at study closure|1
2135560|NCT01074047|3741346|FG001|Survival Follow-Up Phase|Alive at study closure|3
2135561|NCT01074047|3741345|FG000|Extension Phase|Physician Decision|1
2135562|NCT01074047|3741346|FG001|Extension Phase|Physician Decision|0
2135563|NCT01074047|3741345|FG000|Extension Phase|Adverse Event|5
2135564|NCT01074047|3741346|FG001|Extension Phase|Adverse Event|0
2135565|NCT01074047|3741345|FG000|Extension Phase|Disease Progression|9
2135566|NCT01074047|3741346|FG001|Extension Phase|Disease Progression|0
2135567|NCT01074047|3741345|FG000|Extension Phase|Withdrawal by Subject|2
2135568|NCT01074047|3741346|FG001|Extension Phase|Withdrawal by Subject|0
2135569|NCT01074047|3741345|FG000|Extension Phase|Death|5
2135570|NCT01074047|3741346|FG001|Extension Phase|Death|0
2135571|NCT01074216|3741397|FG000|Overall Study|Physician Decision|1
2135572|NCT01074216|3741397|FG000|Overall Study|Not Treated|12
2178333|NCT01383096|3803084|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
2178334|NCT01383096|3803085|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
2178335|NCT01383096|3803086|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
2178336|NCT01383096|3803084|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
2178337|NCT01383096|3803085|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
2178338|NCT01383096|3803086|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
2178339|NCT01383096|3803084|FG000|Third Intervention (8 Days)|Elevated AST|0
2178340|NCT01383096|3803085|FG001|Third Intervention (8 Days)|Elevated AST|1
2178341|NCT01383096|3803086|FG002|Third Intervention (8 Days)|Elevated AST|0
2178342|NCT01383096|3803084|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
2178343|NCT01383096|3803085|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
2178344|NCT01383096|3803086|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
2178345|NCT01383096|3803084|FG000|Third Intervention (8 Days)|Adverse Event|1
2178346|NCT01383096|3803085|FG001|Third Intervention (8 Days)|Adverse Event|0
2178347|NCT01383096|3803086|FG002|Third Intervention (8 Days)|Adverse Event|0
2178348|NCT01383096|3803084|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1
2178349|NCT01383096|3803085|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0
2178350|NCT01383096|3803086|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0
2178351|NCT01383096|3803084|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
2178352|NCT01383096|3803085|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
2178353|NCT01383096|3803086|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
2178354|NCT01383096|3803084|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
2178355|NCT01383096|3803085|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
2178356|NCT01383096|3803086|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
2178357|NCT01383096|3803084|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
2178358|NCT01383096|3803085|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
2178359|NCT01383096|3803086|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
2178360|NCT01383096|3803084|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1
2178361|NCT01383096|3803085|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0
2178362|NCT01383096|3803086|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0
2178363|NCT01383096|3803084|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
2178364|NCT01383096|3803085|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
2178365|NCT01383096|3803086|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
2178366|NCT01383161|3803125|FG000|Overall Study|Adverse Event|5
2178367|NCT01383161|3803126|FG001|Overall Study|Adverse Event|1
2178368|NCT01383161|3803125|FG000|Overall Study|Withdrawal by Subject|0
2178369|NCT01383161|3803126|FG001|Overall Study|Withdrawal by Subject|2
2178370|NCT01383161|3803125|FG000|Overall Study|Lack of Efficacy|0
2286616|NCT02438722|3976009|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1
2286617|NCT02438722|3976010|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0
2286618|NCT02438722|3976009|FG000|Overall Study|Withdrawal by Subject|0
2286619|NCT02438722|3976010|FG001|Overall Study|Withdrawal by Subject|1
2286620|NCT02438722|3976009|FG000|Overall Study|On protocol treatment|15
2135573|NCT01074229|3741404|FG000|Overall Study|Lost to Follow-up|1
2135574|NCT01074229|3741405|FG001|Overall Study|Lost to Follow-up|0
2135575|NCT01074229|3741406|FG002|Overall Study|Lost to Follow-up|0
2135576|NCT01074229|3741404|FG000|Overall Study|Change to open surgical procedure|1
2135577|NCT01074229|3741405|FG001|Overall Study|Change to open surgical procedure|3
2135578|NCT01074229|3741406|FG002|Overall Study|Change to open surgical procedure|4
2135579|NCT01074242|3741416|FG000|Overall Study|Case report before date of contract|40
2135580|NCT01074242|3741416|FG000|Overall Study|Lost to Follow-up|1
2135581|NCT01074242|3741416|FG000|Overall Study|Case report unclear|6
2135582|NCT01074242|3741416|FG000|Overall Study|Violation of vaccine dose or dosage|351
2135583|NCT01074242|3741416|FG000|Overall Study|Duplicate Case Report Form|5
2135584|NCT01074255|3741420|FG000|Overall Study|Did not receive EMEND|2
2135585|NCT01074268|3741426|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
2135586|NCT01074268|3741427|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
2135587|NCT01074268|3741426|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
2135588|NCT01074268|3741427|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
2135589|NCT01074268|3741426|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
2135590|NCT01074268|3741427|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
2135591|NCT01074268|3741426|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
2135592|NCT01074268|3741427|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
2135593|NCT01074268|3741426|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
2135594|NCT01074268|3741427|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
2135595|NCT01074268|3741426|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
2135596|NCT01074268|3741427|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
2135597|NCT01074268|3741426|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
2135598|NCT01074268|3741427|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
2135599|NCT01074268|3741426|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
2135600|NCT01074268|3741427|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
2135601|NCT01074268|3741426|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
2135602|NCT01074268|3741427|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
2135603|NCT01074307|3741435|FG000|Overall Study|No primary endpoint evaluation|14
2135604|NCT01074307|3741436|FG001|Overall Study|No primary endpoint evaluation|6
2135605|NCT01074307|3741435|FG000|Overall Study|Exclusion criterion|0
2135606|NCT01074307|3741436|FG001|Overall Study|Exclusion criterion|1
2135607|NCT01074307|3741435|FG000|Overall Study|Protocol Violation|8
2135608|NCT01074307|3741436|FG001|Overall Study|Protocol Violation|5
2135609|NCT01074450|3741444|FG000|First Intervention|Emesis in Dosing Interval|0
2135610|NCT01074450|3741445|FG001|First Intervention|Emesis in Dosing Interval|2
2135611|NCT01074450|3741444|FG000|Second Intervention|Protocol Violation|1
2135612|NCT01074450|3741445|FG001|Second Intervention|Protocol Violation|0
2135613|NCT01074450|3741444|FG000|Second Intervention|Physician Decision|0
2135614|NCT01074450|3741445|FG001|Second Intervention|Physician Decision|1
2135615|NCT01074554|3741462|FG000|Overall Study|Adverse Event|3
2135616|NCT01074554|3741463|FG001|Overall Study|Adverse Event|3
2135617|NCT01074554|3741462|FG000|Overall Study|Lost to Follow-up|0
2135618|NCT01074554|3741463|FG001|Overall Study|Lost to Follow-up|1
2135619|NCT01074658|3741469|FG000|Overall Study|No implant attempted|19
2135620|NCT01074931|3741473|FG000|Overall Study|Economic reasons|1
2135621|NCT01074931|3741473|FG000|Overall Study|Death|5
2135622|NCT01074944|3741481|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2
2135623|NCT01074944|3741482|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2135624|NCT01074944|3741483|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2135625|NCT01074944|3741484|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2135626|NCT01074944|3741485|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2135627|NCT01074944|3741481|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
2135628|NCT01074944|3741482|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2135629|NCT01074944|3741483|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2135630|NCT01074944|3741484|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2135631|NCT01074944|3741485|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2135632|NCT01074944|3741481|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4
2135633|NCT01074944|3741482|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2135634|NCT01074944|3741483|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2135635|NCT01074944|3741484|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2135636|NCT01074944|3741485|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2135637|NCT01074944|3741481|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
2135638|NCT01074944|3741482|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2135639|NCT01074944|3741483|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2135640|NCT01074944|3741484|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2135641|NCT01074944|3741485|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2135642|NCT01074944|3741481|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
2178371|NCT01383161|3803126|FG001|Overall Study|Lack of Efficacy|1
2135643|NCT01074944|3741482|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
2135644|NCT01074944|3741483|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
2135645|NCT01074944|3741484|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
2135646|NCT01074944|3741485|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
2135647|NCT01074944|3741481|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
2135648|NCT01074944|3741482|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
2135649|NCT01074944|3741483|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
2135650|NCT01074944|3741484|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
2135651|NCT01074944|3741485|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
2135652|NCT01074944|3741481|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
2135653|NCT01074944|3741482|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
2135654|NCT01074944|3741483|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
2135655|NCT01074944|3741484|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
2135656|NCT01074944|3741485|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
2135657|NCT01074944|3741481|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2135658|NCT01074944|3741482|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
2135659|NCT01074944|3741483|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2135660|NCT01074944|3741484|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2135661|NCT01074944|3741485|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2135662|NCT01074944|3741481|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
2135663|NCT01074944|3741482|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
2135664|NCT01074944|3741483|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
2135665|NCT01074944|3741484|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
2135666|NCT01074944|3741485|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
2135667|NCT01074944|3741481|FG000|Long Term Treatment|Adverse Event|0
2135668|NCT01074944|3741482|FG001|Long Term Treatment|Adverse Event|0
2135669|NCT01074944|3741483|FG002|Long Term Treatment|Adverse Event|0
2135670|NCT01074944|3741484|FG003|Long Term Treatment|Adverse Event|3
2135671|NCT01074944|3741485|FG004|Long Term Treatment|Adverse Event|0
2135672|NCT01074944|3741481|FG000|Long Term Treatment|Lost to Follow-up|0
2135673|NCT01074944|3741482|FG001|Long Term Treatment|Lost to Follow-up|0
2135674|NCT01074944|3741483|FG002|Long Term Treatment|Lost to Follow-up|0
2135675|NCT01074944|3741484|FG003|Long Term Treatment|Lost to Follow-up|2
2135676|NCT01074944|3741485|FG004|Long Term Treatment|Lost to Follow-up|0
2135677|NCT01074944|3741481|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2135678|NCT01074944|3741482|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2135679|NCT01074944|3741483|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2135680|NCT01074944|3741484|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18
2135681|NCT01074944|3741485|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2135682|NCT01074944|3741481|FG000|Long Term Treatment|Entered in Period, But Not Treated|0
2135683|NCT01074944|3741482|FG001|Long Term Treatment|Entered in Period, But Not Treated|0
2135684|NCT01074944|3741483|FG002|Long Term Treatment|Entered in Period, But Not Treated|0
2135685|NCT01074944|3741484|FG003|Long Term Treatment|Entered in Period, But Not Treated|1
2135686|NCT01074944|3741485|FG004|Long Term Treatment|Entered in Period, But Not Treated|0
2135687|NCT01074944|3741481|FG000|Long Term Treatment|Withdrawal by Subject|0
2135688|NCT01074944|3741482|FG001|Long Term Treatment|Withdrawal by Subject|0
2135689|NCT01074944|3741483|FG002|Long Term Treatment|Withdrawal by Subject|0
2286621|NCT02438722|3976010|FG001|Overall Study|On protocol treatment|14
2286622|NCT02438722|3976009|FG000|Overall Study|Did not receive protocol treatment|5
2286623|NCT02438722|3976010|FG001|Overall Study|Did not receive protocol treatment|0
2286624|NCT02438787|3976019|FG000|Overall Study|Adverse Event|1
2286625|NCT02438787|3976020|FG001|Overall Study|Adverse Event|0
2286626|NCT02438787|3976021|FG002|Overall Study|Adverse Event|2
2286627|NCT02438787|3976019|FG000|Overall Study|Lack of Efficacy|1
2286628|NCT02438787|3976020|FG001|Overall Study|Lack of Efficacy|2
2286629|NCT02438787|3976021|FG002|Overall Study|Lack of Efficacy|0
2286630|NCT02438787|3976019|FG000|Overall Study|Lost to Follow-up|0
2286631|NCT02438787|3976020|FG001|Overall Study|Lost to Follow-up|1
2286632|NCT02438787|3976021|FG002|Overall Study|Lost to Follow-up|0
2286633|NCT02438787|3976019|FG000|Overall Study|Protocol Violation|0
2286634|NCT02438787|3976020|FG001|Overall Study|Protocol Violation|0
2286635|NCT02438787|3976021|FG002|Overall Study|Protocol Violation|1
2286636|NCT02438787|3976019|FG000|Overall Study|Withdrawal by Subject|15
2286637|NCT02438787|3976020|FG001|Overall Study|Withdrawal by Subject|7
2286638|NCT02438787|3976021|FG002|Overall Study|Withdrawal by Subject|10
2286639|NCT02438787|3976019|FG000|Overall Study|Study discontinued by sponsor|64
2286640|NCT02438787|3976020|FG001|Overall Study|Study discontinued by sponsor|72
2286641|NCT02438787|3976021|FG002|Overall Study|Study discontinued by sponsor|69
2286642|NCT02438787|3976019|FG000|Overall Study|Other|0
2286643|NCT02438787|3976020|FG001|Overall Study|Other|1
2286644|NCT02438787|3976021|FG002|Overall Study|Other|0
2286645|NCT02438787|3976019|FG000|Overall Study|Site terminated by sponsor|0
2286646|NCT02438787|3976020|FG001|Overall Study|Site terminated by sponsor|0
2286647|NCT02438787|3976021|FG002|Overall Study|Site terminated by sponsor|1
2286648|NCT02438813|3976034|FG000|Overall Study|Patient Decision|59
2135690|NCT01074944|3741484|FG003|Long Term Treatment|Withdrawal by Subject|2
2135691|NCT01074944|3741485|FG004|Long Term Treatment|Withdrawal by Subject|0
2135692|NCT01074944|3741481|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0
2135693|NCT01074944|3741482|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0
2135694|NCT01074944|3741483|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0
2135695|NCT01074944|3741484|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0
2286649|NCT02438813|3976034|FG000|Overall Study|Patient Lost to Follow-Up|137
2286650|NCT02438813|3976034|FG000|Overall Study|Study Ended by Sponsor|80
2286651|NCT02438813|3976034|FG000|Overall Study|Patients Not Treated/No EOT Visit|249
2286652|NCT02438826|3976050|FG000|Double-Blind Treatment Phase|Adverse Event|1
2286653|NCT02438826|3976051|FG001|Double-Blind Treatment Phase|Adverse Event|1
2286654|NCT02438826|3976052|FG002|Double-Blind Treatment Phase|Adverse Event|0
2286655|NCT02438826|3976053|FG003|Double-Blind Treatment Phase|Adverse Event|0
2286656|NCT02438826|3976050|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1
2286657|NCT02438826|3976051|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0
2286658|NCT02438826|3976052|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0
2286659|NCT02438826|3976053|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0
2286660|NCT02438826|3976050|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1
2286661|NCT02438826|3976051|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1
2286662|NCT02438826|3976052|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0
2286663|NCT02438826|3976053|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0
2286664|NCT02438826|3976050|FG000|Double-Blind Treatment Phase|Protocol Violation|1
2286665|NCT02438826|3976051|FG001|Double-Blind Treatment Phase|Protocol Violation|2
2286666|NCT02438826|3976052|FG002|Double-Blind Treatment Phase|Protocol Violation|0
2286667|NCT02438826|3976053|FG003|Double-Blind Treatment Phase|Protocol Violation|0
2286668|NCT02438826|3976050|FG000|Double-Blind Treatment Phase|Screen Failure|2
2286669|NCT02438826|3976051|FG001|Double-Blind Treatment Phase|Screen Failure|0
2286670|NCT02438826|3976052|FG002|Double-Blind Treatment Phase|Screen Failure|0
2286671|NCT02438826|3976053|FG003|Double-Blind Treatment Phase|Screen Failure|0
2286672|NCT02438826|3976050|FG000|Open-Label Treatment Phase|Adverse Event|11
2286673|NCT02438826|3976051|FG001|Open-Label Treatment Phase|Adverse Event|6
2286674|NCT02438826|3976052|FG002|Open-Label Treatment Phase|Adverse Event|0
2286675|NCT02438826|3976053|FG003|Open-Label Treatment Phase|Adverse Event|0
2286676|NCT02438826|3976050|FG000|Open-Label Treatment Phase|Lack of Efficacy|27
2286677|NCT02438826|3976051|FG001|Open-Label Treatment Phase|Lack of Efficacy|18
2286678|NCT02438826|3976052|FG002|Open-Label Treatment Phase|Lack of Efficacy|0
2286679|NCT02438826|3976053|FG003|Open-Label Treatment Phase|Lack of Efficacy|0
2286680|NCT02438826|3976050|FG000|Open-Label Treatment Phase|Lost to Follow-up|0
2286681|NCT02438826|3976051|FG001|Open-Label Treatment Phase|Lost to Follow-up|2
2286682|NCT02438826|3976052|FG002|Open-Label Treatment Phase|Lost to Follow-up|0
2286683|NCT02438826|3976053|FG003|Open-Label Treatment Phase|Lost to Follow-up|0
2286684|NCT02438826|3976050|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6
2286685|NCT02438826|3976051|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7
2286686|NCT02438826|3976052|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0
2286687|NCT02438826|3976053|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0
2286688|NCT02438826|3976050|FG000|Post-Treatment Phase|Adverse Event|3
2286689|NCT02438826|3976051|FG001|Post-Treatment Phase|Adverse Event|0
2286690|NCT02438826|3976052|FG002|Post-Treatment Phase|Adverse Event|0
2286691|NCT02438826|3976053|FG003|Post-Treatment Phase|Adverse Event|0
2286692|NCT02438826|3976050|FG000|Post-Treatment Phase|Lack of Efficacy|4
2286693|NCT02438826|3976051|FG001|Post-Treatment Phase|Lack of Efficacy|0
2286694|NCT02438826|3976052|FG002|Post-Treatment Phase|Lack of Efficacy|0
2286695|NCT02438826|3976053|FG003|Post-Treatment Phase|Lack of Efficacy|0
2286696|NCT02438826|3976050|FG000|Post-Treatment Phase|Physician Decision|1
2286697|NCT02438826|3976051|FG001|Post-Treatment Phase|Physician Decision|0
2286698|NCT02438826|3976052|FG002|Post-Treatment Phase|Physician Decision|0
2286699|NCT02438826|3976053|FG003|Post-Treatment Phase|Physician Decision|0
2286700|NCT02438826|3976050|FG000|Post-Treatment Phase|Withdrawal by Subject|1
2286701|NCT02438826|3976051|FG001|Post-Treatment Phase|Withdrawal by Subject|1
2286702|NCT02438826|3976052|FG002|Post-Treatment Phase|Withdrawal by Subject|0
2286703|NCT02438826|3976053|FG003|Post-Treatment Phase|Withdrawal by Subject|0
2286704|NCT02439138|3976068|FG000|Overall Study|Adverse Event|1
2286705|NCT02439138|3976068|FG000|Overall Study|PI decision to terminate the study|2
2286706|NCT02439320|3976096|FG000|Overall Study|Adverse Event|0
2286707|NCT02439320|3976097|FG001|Overall Study|Adverse Event|2
2286708|NCT02439320|3976098|FG002|Overall Study|Adverse Event|0
2286709|NCT02439320|3976096|FG000|Overall Study|Lost to Follow-up|37
2286710|NCT02439320|3976097|FG001|Overall Study|Lost to Follow-up|34
2286711|NCT02439320|3976098|FG002|Overall Study|Lost to Follow-up|42
2286712|NCT02439320|3976096|FG000|Overall Study|Death|0
2286713|NCT02439320|3976097|FG001|Overall Study|Death|1
2286714|NCT02439320|3976098|FG002|Overall Study|Death|0
2286715|NCT02439320|3976096|FG000|Overall Study|Noncompliance with Protocol|10
2286716|NCT02439320|3976097|FG001|Overall Study|Noncompliance with Protocol|11
2286717|NCT02439320|3976098|FG002|Overall Study|Noncompliance with Protocol|7
2286718|NCT02439320|3976096|FG000|Overall Study|Pregnancy|0
2286719|NCT02439320|3976097|FG001|Overall Study|Pregnancy|1
2286720|NCT02439320|3976098|FG002|Overall Study|Pregnancy|1
2286721|NCT02439320|3976096|FG000|Overall Study|Withdrawal by Subject|12
2135696|NCT01074944|3741485|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2
2135697|NCT01074944|3741481|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2135698|NCT01074944|3741482|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2286722|NCT02439320|3976097|FG001|Overall Study|Withdrawal by Subject|16
2135699|NCT01074944|3741483|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2135700|NCT01074944|3741484|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2135701|NCT01074944|3741485|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
2135702|NCT01075048|3741496|FG000|Overall Study|Death|4
2135703|NCT01075048|3741497|FG001|Overall Study|Death|17
2135704|NCT01075048|3741498|FG002|Overall Study|Death|12
2135705|NCT01075048|3741496|FG000|Overall Study|Start of other or new therapy|4
2135706|NCT01075048|3741497|FG001|Overall Study|Start of other or new therapy|36
2135707|NCT01075048|3741498|FG002|Overall Study|Start of other or new therapy|46
2135708|NCT01075048|3741496|FG000|Overall Study|Withdrawal by Subject|1
2135709|NCT01075048|3741497|FG001|Overall Study|Withdrawal by Subject|6
2286723|NCT02439320|3976098|FG002|Overall Study|Withdrawal by Subject|14
2286724|NCT02439320|3976096|FG000|Overall Study|Physician Decision|2
2286725|NCT02439320|3976097|FG001|Overall Study|Physician Decision|1
2286726|NCT02439320|3976098|FG002|Overall Study|Physician Decision|0
2286727|NCT02439320|3976096|FG000|Overall Study|Sponsor Request|0
2286728|NCT02439320|3976097|FG001|Overall Study|Sponsor Request|2
2286729|NCT02439320|3976098|FG002|Overall Study|Sponsor Request|1
2286730|NCT02439320|3976096|FG000|Overall Study|Randomization Failure|35
2286731|NCT02439320|3976097|FG001|Overall Study|Randomization Failure|46
2286732|NCT02439320|3976098|FG002|Overall Study|Randomization Failure|34
2286733|NCT02440425|3976187|FG000|Overall Study|Death likely due to disease progression|1
2286734|NCT02440425|3976187|FG000|Overall Study|Withdrawal by Subject|2
2286735|NCT02440425|3976187|FG000|Overall Study|Adverse Event|1
2286736|NCT02440425|3976187|FG000|Overall Study|Adverse Event/Ineligible|1
2286737|NCT02440568|3976199|FG000|Overall Study|Death|1
2286738|NCT02440568|3976200|FG001|Overall Study|Death|3
2286739|NCT02440568|3976201|FG002|Overall Study|Death|4
2286740|NCT02440568|3976202|FG003|Overall Study|Death|2
2286741|NCT02440568|3976199|FG000|Overall Study|Lack of Efficacy|2
2286742|NCT02440568|3976200|FG001|Overall Study|Lack of Efficacy|0
2286743|NCT02440568|3976201|FG002|Overall Study|Lack of Efficacy|1
2286744|NCT02440568|3976202|FG003|Overall Study|Lack of Efficacy|0
2286745|NCT02440568|3976199|FG000|Overall Study|Lost to Follow-up|1
2286746|NCT02440568|3976200|FG001|Overall Study|Lost to Follow-up|0
2286747|NCT02440568|3976201|FG002|Overall Study|Lost to Follow-up|0
2286748|NCT02440568|3976202|FG003|Overall Study|Lost to Follow-up|0
2286749|NCT02440594|3976221|FG000|Overall Study|Lost to Follow-up|34
2286750|NCT02440594|3976222|FG001|Overall Study|Lost to Follow-up|33
2286751|NCT02440594|3976223|FG002|Overall Study|Lost to Follow-up|54
2286752|NCT02440594|3976224|FG003|Overall Study|Lost to Follow-up|47
2286753|NCT02440594|3976225|FG004|Overall Study|Lost to Follow-up|5
2286754|NCT02440594|3976226|FG005|Overall Study|Lost to Follow-up|4
2286755|NCT02440594|3976227|FG006|Overall Study|Lost to Follow-up|28
2286756|NCT02440594|3976228|FG007|Overall Study|Lost to Follow-up|48
2286757|NCT02440594|3976221|FG000|Overall Study|Cognitive Impairment/Communication Issue|14
2286758|NCT02440594|3976222|FG001|Overall Study|Cognitive Impairment/Communication Issue|6
2286759|NCT02440594|3976223|FG002|Overall Study|Cognitive Impairment/Communication Issue|4
2286760|NCT02440594|3976224|FG003|Overall Study|Cognitive Impairment/Communication Issue|4
2286761|NCT02440594|3976225|FG004|Overall Study|Cognitive Impairment/Communication Issue|2
2286762|NCT02440594|3976226|FG005|Overall Study|Cognitive Impairment/Communication Issue|1
2286763|NCT02440594|3976227|FG006|Overall Study|Cognitive Impairment/Communication Issue|0
2286764|NCT02440594|3976228|FG007|Overall Study|Cognitive Impairment/Communication Issue|0
2286765|NCT02440594|3976221|FG000|Overall Study|Withdrawal by Subject|81
2286766|NCT02440594|3976222|FG001|Overall Study|Withdrawal by Subject|67
2286767|NCT02440594|3976223|FG002|Overall Study|Withdrawal by Subject|59
2286768|NCT02440594|3976224|FG003|Overall Study|Withdrawal by Subject|38
2286769|NCT02440594|3976225|FG004|Overall Study|Withdrawal by Subject|2
2286770|NCT02440594|3976226|FG005|Overall Study|Withdrawal by Subject|2
2286771|NCT02440594|3976227|FG006|Overall Study|Withdrawal by Subject|7
2286772|NCT02440594|3976228|FG007|Overall Study|Withdrawal by Subject|7
2286773|NCT02440594|3976221|FG000|Overall Study|Administratively w/drawn|3
2286774|NCT02440594|3976222|FG001|Overall Study|Administratively w/drawn|2
2286775|NCT02440594|3976223|FG002|Overall Study|Administratively w/drawn|0
2286776|NCT02440594|3976224|FG003|Overall Study|Administratively w/drawn|0
2286777|NCT02440594|3976225|FG004|Overall Study|Administratively w/drawn|0
2286778|NCT02440594|3976226|FG005|Overall Study|Administratively w/drawn|0
2286779|NCT02440594|3976227|FG006|Overall Study|Administratively w/drawn|2
2286780|NCT02440594|3976228|FG007|Overall Study|Administratively w/drawn|1
2286781|NCT02440789|3976270|FG000|Overall Study|Withdrawal by Subject|3
2286782|NCT02440789|3976270|FG000|Overall Study|Not willing to adhere to reqs|1
2286783|NCT02441114|3976278|FG000|Washout2|Withdrawal by Subject|4
2286784|NCT02441179|3976284|FG000|Overall Study|Withdrawal by Subject|1
2286785|NCT02441179|3976285|FG001|Overall Study|Withdrawal by Subject|1
2286786|NCT02441218|3976294|FG000|Overall Study|Death|503
2286787|NCT02441218|3976295|FG001|Overall Study|Death|553
2286788|NCT02441218|3976294|FG000|Overall Study|Withdrawal by Subject|73
2286789|NCT02441218|3976295|FG001|Overall Study|Withdrawal by Subject|58
2286790|NCT02441218|3976294|FG000|Overall Study|Lost to Follow-up|2
2286791|NCT02441218|3976295|FG001|Overall Study|Lost to Follow-up|1
2286792|NCT02441283|3976301|FG000|Overall Study|Withdrew consent|15
2286793|NCT02441283|3976301|FG000|Overall Study|Lost to Follow-up|42
2286794|NCT02441283|3976301|FG000|Overall Study|Death|1
2286795|NCT02441283|3976301|FG000|Overall Study|Other, not specified|32
2286796|NCT02441309|3976308|FG000|Overall Study|Disease progression|2
2286797|NCT02441309|3976309|FG001|Overall Study|Disease progression|1
2286798|NCT02441309|3976310|FG002|Overall Study|Disease progression|2
2286799|NCT02441309|3976308|FG000|Overall Study|Adverse Event|0
2286800|NCT02441309|3976309|FG001|Overall Study|Adverse Event|1
2286801|NCT02441309|3976310|FG002|Overall Study|Adverse Event|0
2286802|NCT02441309|3976308|FG000|Overall Study|Withdrawal by Subject|1
2286803|NCT02441309|3976309|FG001|Overall Study|Withdrawal by Subject|0
2286804|NCT02441309|3976310|FG002|Overall Study|Withdrawal by Subject|1
2286805|NCT02441517|3976321|FG000|Overall Study|Lost to Follow-up|1
2286806|NCT02441517|3976321|FG000|Overall Study|Withdrawal by Subject|2
2286807|NCT02441517|3976321|FG000|Overall Study|Study Terminated by Sponsor|1
2286808|NCT02441946|3976328|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
2286809|NCT02441946|3976329|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
2286810|NCT02441946|3976330|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
2286811|NCT02441946|3976328|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
2286812|NCT02441946|3976329|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
2286813|NCT02441946|3976330|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
2286814|NCT02441946|3976328|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
2286815|NCT02441946|3976329|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
2286816|NCT02441946|3976330|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
2286817|NCT02441946|3976328|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
2286818|NCT02441946|3976329|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
2286819|NCT02441946|3976330|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
2286820|NCT02441946|3976328|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
2286821|NCT02441946|3976329|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
2286822|NCT02441946|3976330|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
2286823|NCT02441946|3976328|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
2286824|NCT02441946|3976329|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
2286825|NCT02441946|3976330|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
2286826|NCT02441946|3976328|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
2286827|NCT02441946|3976329|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
2286828|NCT02441946|3976330|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
2286829|NCT02441946|3976328|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
2286830|NCT02441946|3976329|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
2286831|NCT02441946|3976330|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
2286832|NCT02441946|3976328|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
2286833|NCT02441946|3976329|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
2286834|NCT02441946|3976330|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
2286835|NCT02441946|3976328|FG000|Extension Period (8 Weeks)|Adverse Event|1
2286836|NCT02441946|3976329|FG001|Extension Period (8 Weeks)|Adverse Event|0
2286837|NCT02441946|3976330|FG002|Extension Period (8 Weeks)|Adverse Event|0
2286838|NCT02441946|3976328|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1
2286839|NCT02441946|3976329|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0
2135710|NCT01075048|3741498|FG002|Overall Study|Withdrawal by Subject|3
2135711|NCT01075048|3741496|FG000|Overall Study|Lost to Follow-up|0
2135712|NCT01075048|3741497|FG001|Overall Study|Lost to Follow-up|1
2135713|NCT01075048|3741498|FG002|Overall Study|Lost to Follow-up|1
2135714|NCT01075074|3741512|FG000|Overall Study|Surgeon changed to open incisional case|1
2135715|NCT01075074|3741513|FG001|Overall Study|Surgeon changed to open incisional case|2
2135716|NCT01075074|3741514|FG002|Overall Study|Surgeon changed to open incisional case|2
2135717|NCT01075100|3741537|FG000|Overall Study|Adverse Event|15
2135718|NCT01075100|3741538|FG001|Overall Study|Adverse Event|18
2135719|NCT01075100|3741537|FG000|Overall Study|Patient Request|4
2135720|NCT01075100|3741538|FG001|Overall Study|Patient Request|4
2135721|NCT01075100|3741537|FG000|Overall Study|Investigator Request|2
2135722|NCT01075100|3741538|FG001|Overall Study|Investigator Request|1
2135723|NCT01075100|3741537|FG000|Overall Study|Disease Progression|25
2135724|NCT01075100|3741538|FG001|Overall Study|Disease Progression|29
2135725|NCT01075100|3741537|FG000|Overall Study|Other|3
2135726|NCT01075100|3741538|FG001|Overall Study|Other|1
2135727|NCT01075152|3741548|FG000|Overall Study|Withdrawal by Subject|1
2135728|NCT01075152|3741549|FG001|Overall Study|Withdrawal by Subject|0
2135729|NCT01075178|3741559|FG000|Subject Matching|eligible but not matched|130
2135730|NCT01075178|3741560|FG001|Subject Matching|eligible but not matched|403
2135731|NCT01075178|3741559|FG000|Subject Chart Review|died before chart review period|0
2135732|NCT01075178|3741560|FG001|Subject Chart Review|died before chart review period|2
2135733|NCT01075178|3741559|FG000|Subject Chart Review|no data collected due to site closure|3
2135734|NCT01075178|3741560|FG001|Subject Chart Review|no data collected due to site closure|4
2135735|NCT01075178|3741559|FG000|Subject Chart Review|matched partner excluded (reasons above)|6
2135736|NCT01075178|3741560|FG001|Subject Chart Review|matched partner excluded (reasons above)|3
2135737|NCT01075191|3741566|FG000|Overall Study|Death|1
2135738|NCT01075191|3741566|FG000|Overall Study|Intensification|3
2207533|NCT01629966|3846520|FG001|Overall Study|Lost to Follow-up|13
2207534|NCT01629966|3846521|FG002|Overall Study|Lost to Follow-up|9
2135739|NCT01075191|3741566|FG000|Overall Study|Co-morbidities|1
2135740|NCT01075191|3741566|FG000|Overall Study|Adverse Event|4
2135741|NCT01075191|3741566|FG000|Overall Study|Noncompliance|3
2135742|NCT01075191|3741566|FG000|Overall Study|Therapy Break|3
2135743|NCT01075191|3741566|FG000|Overall Study|Patient's Wish|2
2135744|NCT01075191|3741566|FG000|Overall Study|Unknown Reasons|1
2135745|NCT01075217|3741576|FG000|Overall Study|Adverse Event|1
2135746|NCT01075217|3741577|FG001|Overall Study|Adverse Event|1
2135747|NCT01075217|3741576|FG000|Overall Study|Physician Decision|1
2135748|NCT01075217|3741577|FG001|Overall Study|Physician Decision|0
2135749|NCT01075243|3741594|FG000|Overall Study|Lost to Follow-up|5
2135750|NCT01075243|3741595|FG001|Overall Study|Lost to Follow-up|2
2135751|NCT01075243|3741596|FG002|Overall Study|Lost to Follow-up|0
2135752|NCT01075243|3741594|FG000|Overall Study|Withdrawal by Subject|1
2135753|NCT01075243|3741595|FG001|Overall Study|Withdrawal by Subject|1
2135754|NCT01075243|3741596|FG002|Overall Study|Withdrawal by Subject|0
2135755|NCT01075256|3741609|FG000|Overall Study|Withdrawal by Subject|1
2135756|NCT01075256|3741610|FG001|Overall Study|Withdrawal by Subject|0
2135757|NCT01075256|3741611|FG002|Overall Study|Withdrawal by Subject|0
2135758|NCT01075282|3741627|FG000|Overall Study|Withdrawal by Subject|11
2135759|NCT01075282|3741628|FG001|Overall Study|Withdrawal by Subject|7
2135760|NCT01075282|3741629|FG002|Overall Study|Withdrawal by Subject|11
2207535|NCT01629966|3846519|FG000|Overall Study|Withdrawal by Subject|8
2207536|NCT01629966|3846520|FG001|Overall Study|Withdrawal by Subject|9
2286840|NCT02441946|3976330|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0
2286841|NCT02442206|3976343|FG000|Period 1|Adverse Event|1
2286842|NCT02442206|3976344|FG001|Period 1|Adverse Event|1
2286843|NCT02442206|3976343|FG000|Period 1|withdrew consent|0
2286844|NCT02442206|3976344|FG001|Period 1|withdrew consent|1
2286845|NCT02442206|3976343|FG000|Period 1|COPD exacerbation|0
2286846|NCT02442206|3976344|FG001|Period 1|COPD exacerbation|1
2286847|NCT02442206|3976343|FG000|Period 2|Adverse Event|1
2286848|NCT02442206|3976344|FG001|Period 2|Adverse Event|0
2286849|NCT02442271|3976351|FG000|Overall Study|Adverse Event|1
2286850|NCT02442271|3976351|FG000|Overall Study|Withdrew Consent|1
2286851|NCT02442271|3976351|FG000|Overall Study|Lost to Follow-up|1
2286852|NCT02442271|3976351|FG000|Overall Study|Other|1
2286853|NCT02442284|3976369|FG000|Overall Study|Adverse Event|1
2286854|NCT02442284|3976369|FG000|Overall Study|Withdrew Consent|2
2286855|NCT02442284|3976369|FG000|Overall Study|Lost to Follow-up|3
2286856|NCT02442284|3976369|FG000|Overall Study|Other|1
2286857|NCT02442310|3976373|FG000|Overall Study|Adverse Event|2
2286858|NCT02442310|3976373|FG000|Overall Study|Withdrawal by Subject|1
2286859|NCT02442336|3976383|FG000|Overall Study|6 patients assisted with the intervention development only.|6
2286860|NCT02442336|3976383|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19
2286861|NCT02442336|3976383|FG000|Overall Study|Lost to Follow-up|11
2286862|NCT02442622|3976389|FG000|Overall Study|Withdrawal by Subject|3
2286863|NCT02442622|3976390|FG001|Overall Study|Withdrawal by Subject|1
2286864|NCT02442804|3976421|FG000|Overall Study|Withdrawal by Subject|0
2286865|NCT02442804|3976422|FG001|Overall Study|Withdrawal by Subject|1
2286866|NCT02442804|3976421|FG000|Overall Study|Adverse Event|1
2286867|NCT02442804|3976422|FG001|Overall Study|Adverse Event|0
2286868|NCT02442830|3976430|FG000|Overall Study|Technical Failure|0
2286869|NCT02442830|3976431|FG001|Overall Study|Technical Failure|1
2286870|NCT02443103|3976477|FG000|Overall Study|Adverse Event|2
2286871|NCT02443103|3976477|FG000|Overall Study|Noncompliance|1
2286872|NCT02443155|3976485|FG000|Overall Study|Adverse Event|3
2286873|NCT02443155|3976486|FG001|Overall Study|Adverse Event|4
2286874|NCT02443155|3976487|FG002|Overall Study|Adverse Event|1
2286875|NCT02443155|3976488|FG003|Overall Study|Adverse Event|2
2286876|NCT02443155|3976485|FG000|Overall Study|Unclassified|0
2286877|NCT02443155|3976486|FG001|Overall Study|Unclassified|0
2135761|NCT01075282|3741627|FG000|Overall Study|Adverse Event|9
2135762|NCT01075282|3741628|FG001|Overall Study|Adverse Event|8
2207537|NCT01629966|3846521|FG002|Overall Study|Withdrawal by Subject|16
2207538|NCT01629966|3846519|FG000|Overall Study|Protocol Violation|7
2207539|NCT01629966|3846520|FG001|Overall Study|Protocol Violation|9
2207540|NCT01629966|3846521|FG002|Overall Study|Protocol Violation|7
2207541|NCT01629966|3846519|FG000|Overall Study|Lack of Efficacy|5
2207542|NCT01629966|3846520|FG001|Overall Study|Lack of Efficacy|2
2207543|NCT01629966|3846521|FG002|Overall Study|Lack of Efficacy|4
2207544|NCT01629966|3846519|FG000|Overall Study|Adverse Event|11
2207545|NCT01629966|3846520|FG001|Overall Study|Adverse Event|18
2207546|NCT01629966|3846521|FG002|Overall Study|Adverse Event|30
2207547|NCT01630135|3846550|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0
2207548|NCT01630135|3846551|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2
2207549|NCT01630616|3846572|FG000|Overall Study|Adverse Event|0
2207550|NCT01630616|3846573|FG001|Overall Study|Adverse Event|0
2207551|NCT01630616|3846574|FG002|Overall Study|Adverse Event|0
2207552|NCT01630616|3846575|FG003|Overall Study|Adverse Event|1
2286878|NCT02443155|3976487|FG002|Overall Study|Unclassified|2
2135763|NCT01075282|3741629|FG002|Overall Study|Adverse Event|5
2135764|NCT01075282|3741627|FG000|Overall Study|Entry Criteria Not Met|3
2135765|NCT01075282|3741628|FG001|Overall Study|Entry Criteria Not Met|2
2135766|NCT01075282|3741629|FG002|Overall Study|Entry Criteria Not Met|0
2135767|NCT01075282|3741627|FG000|Overall Study|Lost to Follow-up|3
2286879|NCT02443155|3976488|FG003|Overall Study|Unclassified|1
2286880|NCT02443155|3976485|FG000|Overall Study|Withdrawal by Subject|4
2286881|NCT02443155|3976486|FG001|Overall Study|Withdrawal by Subject|7
2286882|NCT02443155|3976487|FG002|Overall Study|Withdrawal by Subject|3
2286883|NCT02443155|3976488|FG003|Overall Study|Withdrawal by Subject|9
2286884|NCT02443155|3976485|FG000|Overall Study|Pregnancy|3
2286885|NCT02443155|3976486|FG001|Overall Study|Pregnancy|1
2286886|NCT02443155|3976487|FG002|Overall Study|Pregnancy|1
2286887|NCT02443155|3976488|FG003|Overall Study|Pregnancy|2
2286888|NCT02443155|3976485|FG000|Overall Study|Lost to Follow-up|1
2286889|NCT02443155|3976486|FG001|Overall Study|Lost to Follow-up|2
2286890|NCT02443155|3976487|FG002|Overall Study|Lost to Follow-up|0
2286891|NCT02443155|3976488|FG003|Overall Study|Lost to Follow-up|1
2286892|NCT02443155|3976485|FG000|Overall Study|Protocol Violation|1
2286893|NCT02443155|3976486|FG001|Overall Study|Protocol Violation|0
2286894|NCT02443155|3976487|FG002|Overall Study|Protocol Violation|1
2286895|NCT02443155|3976488|FG003|Overall Study|Protocol Violation|1
2286896|NCT02443155|3976485|FG000|Overall Study|Death|0
2286897|NCT02443155|3976486|FG001|Overall Study|Death|0
2286898|NCT02443155|3976487|FG002|Overall Study|Death|1
2286899|NCT02443155|3976488|FG003|Overall Study|Death|0
2286900|NCT02443298|3976501|FG000|Overall Study|Adverse Event|3
2286901|NCT02443298|3976502|FG001|Overall Study|Adverse Event|3
2286902|NCT02443298|3976501|FG000|Overall Study|Withdrawal by Subject|1
2286903|NCT02443298|3976502|FG001|Overall Study|Withdrawal by Subject|2
2286904|NCT02443337|3976510|FG000|Overall Study|Adverse Event|0
2286905|NCT02443337|3976511|FG001|Overall Study|Adverse Event|1
2286906|NCT02443337|3976510|FG000|Overall Study|Clinical Progressive Disease|3
2286907|NCT02443337|3976511|FG001|Overall Study|Clinical Progressive Disease|0
2286908|NCT02443337|3976510|FG000|Overall Study|Withdrawal by Subject|2
2286909|NCT02443337|3976511|FG001|Overall Study|Withdrawal by Subject|1
2286910|NCT02443402|3976524|FG000|Overall Study|Withdrawal by Subject|3
2286911|NCT02443402|3976525|FG001|Overall Study|Withdrawal by Subject|1
2286912|NCT02443402|3976524|FG000|Overall Study|Screen Failure|1
2286913|NCT02443402|3976525|FG001|Overall Study|Screen Failure|2
2286914|NCT02443688|3976556|FG000|Overall Study|Adverse Event|2
2286915|NCT02443688|3976557|FG001|Overall Study|Adverse Event|3
2286916|NCT02443688|3976558|FG002|Overall Study|Adverse Event|2
2286917|NCT02443688|3976556|FG000|Overall Study|Lost to Follow-up|1
2286918|NCT02443688|3976557|FG001|Overall Study|Lost to Follow-up|0
2286919|NCT02443688|3976558|FG002|Overall Study|Lost to Follow-up|0
2286920|NCT02443688|3976556|FG000|Overall Study|Physician Decision|3
2286921|NCT02443688|3976557|FG001|Overall Study|Physician Decision|0
2286922|NCT02443688|3976558|FG002|Overall Study|Physician Decision|1
2286923|NCT02443688|3976556|FG000|Overall Study|Pregnancy|0
2286924|NCT02443688|3976557|FG001|Overall Study|Pregnancy|0
2286925|NCT02443688|3976558|FG002|Overall Study|Pregnancy|1
2286926|NCT02443688|3976556|FG000|Overall Study|Withdrawal by Subject|3
2286927|NCT02443688|3976557|FG001|Overall Study|Withdrawal by Subject|3
2286928|NCT02443688|3976558|FG002|Overall Study|Withdrawal by Subject|4
2286929|NCT02443688|3976556|FG000|Overall Study|Non-compliance with study drug|1
2286930|NCT02443688|3976557|FG001|Overall Study|Non-compliance with study drug|2
2286931|NCT02443688|3976558|FG002|Overall Study|Non-compliance with study drug|4
2286932|NCT02443688|3976556|FG000|Overall Study|Sponsor Request|2
2286933|NCT02443688|3976557|FG001|Overall Study|Sponsor Request|1
2286934|NCT02443688|3976558|FG002|Overall Study|Sponsor Request|0
2286935|NCT02443740|3976574|FG000|Intervention Period 1 (3 Days)|Adverse Event|0
2286936|NCT02443740|3976575|FG001|Intervention Period 1 (3 Days)|Adverse Event|0
2286937|NCT02443740|3976576|FG002|Intervention Period 1 (3 Days)|Adverse Event|0
2286938|NCT02443740|3976577|FG003|Intervention Period 1 (3 Days)|Adverse Event|0
2286939|NCT02443740|3976578|FG004|Intervention Period 1 (3 Days)|Adverse Event|0
2286940|NCT02443740|3976579|FG005|Intervention Period 1 (3 Days)|Adverse Event|1
2286941|NCT02443740|3976580|FG006|Intervention Period 1 (3 Days)|Adverse Event|0
2286942|NCT02443740|3976581|FG007|Intervention Period 1 (3 Days)|Adverse Event|0
2286943|NCT02443740|3976582|FG008|Intervention Period 1 (3 Days)|Adverse Event|0
2286944|NCT02443740|3976583|FG009|Intervention Period 1 (3 Days)|Adverse Event|0
2286945|NCT02443740|3976584|FG010|Intervention Period 1 (3 Days)|Adverse Event|0
2286946|NCT02443740|3976574|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1
2286947|NCT02443740|3976575|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0
2286948|NCT02443740|3976576|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0
2286949|NCT02443740|3976577|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0
2286950|NCT02443740|3976578|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0
2286951|NCT02443740|3976579|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0
2286952|NCT02443740|3976580|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1
2286953|NCT02443740|3976581|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0
2286954|NCT02443740|3976582|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0
2286955|NCT02443740|3976583|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0
2286956|NCT02443740|3976584|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0
2135768|NCT01075282|3741628|FG001|Overall Study|Lost to Follow-up|3
2135769|NCT01075282|3741629|FG002|Overall Study|Lost to Follow-up|3
2135770|NCT01075282|3741627|FG000|Overall Study|Physician Decision|3
2135771|NCT01075282|3741628|FG001|Overall Study|Physician Decision|3
2135772|NCT01075282|3741629|FG002|Overall Study|Physician Decision|3
2135773|NCT01075282|3741627|FG000|Overall Study|Lack of Efficacy|1
2135774|NCT01075282|3741628|FG001|Overall Study|Lack of Efficacy|1
2135775|NCT01075282|3741629|FG002|Overall Study|Lack of Efficacy|0
2135776|NCT01075282|3741627|FG000|Overall Study|Treatment Non-compliance|1
2135777|NCT01075282|3741628|FG001|Overall Study|Treatment Non-compliance|2
2135778|NCT01075282|3741629|FG002|Overall Study|Treatment Non-compliance|2
2135779|NCT01075282|3741627|FG000|Overall Study|Protocol Violation|0
2135780|NCT01075282|3741628|FG001|Overall Study|Protocol Violation|2
2135781|NCT01075282|3741629|FG002|Overall Study|Protocol Violation|1
2135782|NCT01075282|3741627|FG000|Overall Study|Death|0
2135783|NCT01075282|3741628|FG001|Overall Study|Death|1
2135784|NCT01075282|3741629|FG002|Overall Study|Death|2
2135785|NCT01075321|3741638|FG000|Overall Study|Withdrawal by Subject|0
2135786|NCT01075321|3741639|FG001|Overall Study|Withdrawal by Subject|0
2135787|NCT01075321|3741640|FG002|Overall Study|Withdrawal by Subject|1
2135788|NCT01075321|3741641|FG003|Overall Study|Withdrawal by Subject|1
2135789|NCT01075321|3741638|FG000|Overall Study|Protocol Violation|0
2135790|NCT01075321|3741639|FG001|Overall Study|Protocol Violation|0
2135791|NCT01075321|3741640|FG002|Overall Study|Protocol Violation|1
2135792|NCT01075321|3741641|FG003|Overall Study|Protocol Violation|0
2135793|NCT01075321|3741638|FG000|Overall Study|Treatment Incomplete due to progression|1
2135794|NCT01075321|3741639|FG001|Overall Study|Treatment Incomplete due to progression|0
2135795|NCT01075321|3741640|FG002|Overall Study|Treatment Incomplete due to progression|0
2135796|NCT01075321|3741641|FG003|Overall Study|Treatment Incomplete due to progression|0
2135797|NCT01075321|3741638|FG000|Overall Study|Ineligible (miscalculated lab value)|0
2135798|NCT01075321|3741639|FG001|Overall Study|Ineligible (miscalculated lab value)|0
2135799|NCT01075321|3741640|FG002|Overall Study|Ineligible (miscalculated lab value)|0
2135800|NCT01075321|3741641|FG003|Overall Study|Ineligible (miscalculated lab value)|1
2135801|NCT01075412|3741668|FG000|Overall Study|Withdrawal by Subject|0
2135802|NCT01075412|3741669|FG001|Overall Study|Withdrawal by Subject|1
2135803|NCT01075516|3741676|FG000|Overall Study|Death|5
2135804|NCT01075516|3741677|FG001|Overall Study|Death|9
2135805|NCT01075516|3741676|FG000|Overall Study|Lost to Follow-up|10
2135806|NCT01075516|3741677|FG001|Overall Study|Lost to Follow-up|2
2135807|NCT01075516|3741676|FG000|Overall Study|Withdrawal by Subject|3
2135808|NCT01075516|3741677|FG001|Overall Study|Withdrawal by Subject|5
2135809|NCT01075646|3741687|FG000|Overall Study|Lost to Follow-up|4
2135810|NCT01075646|3741688|FG001|Overall Study|Lost to Follow-up|3
2135811|NCT01075646|3741689|FG002|Overall Study|Lost to Follow-up|1
2135812|NCT01075646|3741690|FG003|Overall Study|Lost to Follow-up|2
2135813|NCT01075685|3741702|FG000|Overall Study|Protocol Violation|9
2135814|NCT01075685|3741703|FG001|Overall Study|Protocol Violation|1
2135815|NCT01075685|3741702|FG000|Overall Study|Withdrawal by Subject|20
2135816|NCT01075685|3741703|FG001|Overall Study|Withdrawal by Subject|5
2135817|NCT01075685|3741702|FG000|Overall Study|Lost to Follow-up|563
2135818|NCT01075685|3741703|FG001|Overall Study|Lost to Follow-up|220
2135819|NCT01075763|3741711|FG000|Overall Study|Lost to Follow-up|2
2135820|NCT01075763|3741712|FG001|Overall Study|Lost to Follow-up|1
2135821|NCT01075763|3741711|FG000|Overall Study|Lack of Efficacy|0
2135822|NCT01075763|3741712|FG001|Overall Study|Lack of Efficacy|1
2135823|NCT01075763|3741711|FG000|Overall Study|Withdrawal by Subject|2
2135824|NCT01075763|3741712|FG001|Overall Study|Withdrawal by Subject|2
2135825|NCT01075815|3741720|FG000|Overall Study|Withdrawal before r-hCG administration|6
2135826|NCT01075815|3741721|FG001|Overall Study|Withdrawal before r-hCG administration|1
2135827|NCT01075815|3741720|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
2135828|NCT01075815|3741721|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
2135829|NCT01075815|3741720|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3
2135830|NCT01075815|3741721|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
2135831|NCT01075958|3741727|FG000|Overall Study|Blood sample could not be obtained|44
2135832|NCT01075984|3741740|FG000|Treatment Phase|Adverse Event|0
2135833|NCT01075984|3741741|FG001|Treatment Phase|Adverse Event|1
2135834|NCT01075984|3741742|FG002|Treatment Phase|Adverse Event|3
2135835|NCT01075984|3741743|FG003|Treatment Phase|Adverse Event|7
2135836|NCT01075984|3741744|FG004|Treatment Phase|Adverse Event|35
2135837|NCT01075984|3741740|FG000|Treatment Phase|Protocol Violation|0
2135838|NCT01075984|3741741|FG001|Treatment Phase|Protocol Violation|0
2135839|NCT01075984|3741742|FG002|Treatment Phase|Protocol Violation|1
2135840|NCT01075984|3741743|FG003|Treatment Phase|Protocol Violation|0
2135841|NCT01075984|3741744|FG004|Treatment Phase|Protocol Violation|3
2135842|NCT01075984|3741740|FG000|Treatment Phase|Withdrawal by Subject|0
2135843|NCT01075984|3741741|FG001|Treatment Phase|Withdrawal by Subject|0
2135844|NCT01075984|3741742|FG002|Treatment Phase|Withdrawal by Subject|2
2135845|NCT01075984|3741743|FG003|Treatment Phase|Withdrawal by Subject|0
2135846|NCT01075984|3741744|FG004|Treatment Phase|Withdrawal by Subject|15
2135847|NCT01075984|3741740|FG000|Treatment Phase|Treatment Failure|0
2135848|NCT01075984|3741741|FG001|Treatment Phase|Treatment Failure|0
2135849|NCT01075984|3741742|FG002|Treatment Phase|Treatment Failure|1
2135850|NCT01075984|3741743|FG003|Treatment Phase|Treatment Failure|0
2135851|NCT01075984|3741744|FG004|Treatment Phase|Treatment Failure|5
2135852|NCT01075984|3741740|FG000|Treatment Phase|Progression of disease|0
2135853|NCT01075984|3741741|FG001|Treatment Phase|Progression of disease|0
2135854|NCT01075984|3741742|FG002|Treatment Phase|Progression of disease|0
2135855|NCT01075984|3741743|FG003|Treatment Phase|Progression of disease|0
2135856|NCT01075984|3741744|FG004|Treatment Phase|Progression of disease|2
2135857|NCT01075984|3741740|FG000|Follow-up Phase|Protocol Violation|0
2135858|NCT01075984|3741741|FG001|Follow-up Phase|Protocol Violation|0
2135859|NCT01075984|3741742|FG002|Follow-up Phase|Protocol Violation|1
2135860|NCT01075984|3741743|FG003|Follow-up Phase|Protocol Violation|0
2135861|NCT01075984|3741744|FG004|Follow-up Phase|Protocol Violation|3
2135862|NCT01075984|3741740|FG000|Follow-up Phase|Adverse Event|0
2135863|NCT01075984|3741741|FG001|Follow-up Phase|Adverse Event|0
2135864|NCT01075984|3741742|FG002|Follow-up Phase|Adverse Event|0
2135865|NCT01075984|3741743|FG003|Follow-up Phase|Adverse Event|2
2135866|NCT01075984|3741744|FG004|Follow-up Phase|Adverse Event|27
2135867|NCT01075984|3741740|FG000|Follow-up Phase|Administrative|0
2135868|NCT01075984|3741741|FG001|Follow-up Phase|Administrative|0
2135869|NCT01075984|3741742|FG002|Follow-up Phase|Administrative|0
2135870|NCT01075984|3741743|FG003|Follow-up Phase|Administrative|0
2135871|NCT01075984|3741744|FG004|Follow-up Phase|Administrative|1
2135872|NCT01075984|3741740|FG000|Follow-up Phase|Withdrawal by Subject|0
2135873|NCT01075984|3741741|FG001|Follow-up Phase|Withdrawal by Subject|0
2135874|NCT01075984|3741742|FG002|Follow-up Phase|Withdrawal by Subject|0
2135875|NCT01075984|3741743|FG003|Follow-up Phase|Withdrawal by Subject|0
2135876|NCT01075984|3741744|FG004|Follow-up Phase|Withdrawal by Subject|10
2135877|NCT01075984|3741740|FG000|Follow-up Phase|Progression of disease|0
2135878|NCT01075984|3741741|FG001|Follow-up Phase|Progression of disease|0
2135879|NCT01075984|3741742|FG002|Follow-up Phase|Progression of disease|0
2135880|NCT01075984|3741743|FG003|Follow-up Phase|Progression of disease|0
2135881|NCT01075984|3741744|FG004|Follow-up Phase|Progression of disease|2
2135882|NCT01075984|3741740|FG000|Follow-up Phase|Treatment failure|0
2135883|NCT01075984|3741741|FG001|Follow-up Phase|Treatment failure|0
2135884|NCT01075984|3741742|FG002|Follow-up Phase|Treatment failure|0
2135885|NCT01075984|3741743|FG003|Follow-up Phase|Treatment failure|0
2135886|NCT01075984|3741744|FG004|Follow-up Phase|Treatment failure|4
2135887|NCT01076010|3741759|FG000|Overall Study|Death|15
2135888|NCT01076010|3741760|FG001|Overall Study|Death|1
2135889|NCT01076010|3741761|FG002|Overall Study|Death|0
2135890|NCT01076010|3741759|FG000|Overall Study|Adverse Event|7
2135891|NCT01076010|3741760|FG001|Overall Study|Adverse Event|2
2135892|NCT01076010|3741761|FG002|Overall Study|Adverse Event|0
2135893|NCT01076010|3741759|FG000|Overall Study|Progressive disease|90
2135894|NCT01076010|3741760|FG001|Overall Study|Progressive disease|30
2135895|NCT01076010|3741761|FG002|Overall Study|Progressive disease|1
2135896|NCT01076010|3741759|FG000|Overall Study|Lack of Efficacy|4
2135897|NCT01076010|3741760|FG001|Overall Study|Lack of Efficacy|0
2135898|NCT01076010|3741761|FG002|Overall Study|Lack of Efficacy|0
2135899|NCT01076010|3741759|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0
2135900|NCT01076010|3741760|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1
2135901|NCT01076010|3741761|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0
2135902|NCT01076010|3741759|FG000|Overall Study|Significant Surgical Procedure|0
2135903|NCT01076010|3741760|FG001|Overall Study|Significant Surgical Procedure|1
2135904|NCT01076010|3741761|FG002|Overall Study|Significant Surgical Procedure|0
2135905|NCT01076010|3741759|FG000|Overall Study|Protocol Violation|0
2135906|NCT01076010|3741760|FG001|Overall Study|Protocol Violation|1
2135907|NCT01076010|3741761|FG002|Overall Study|Protocol Violation|0
2135908|NCT01076010|3741759|FG000|Overall Study|Noncompliance|1
2135909|NCT01076010|3741760|FG001|Overall Study|Noncompliance|1
2135910|NCT01076010|3741761|FG002|Overall Study|Noncompliance|0
2135911|NCT01076010|3741759|FG000|Overall Study|Withdrawal by Subject|3
2135912|NCT01076010|3741760|FG001|Overall Study|Withdrawal by Subject|0
2135913|NCT01076010|3741761|FG002|Overall Study|Withdrawal by Subject|1
2135914|NCT01076010|3741759|FG000|Overall Study|Other|5
2135915|NCT01076010|3741760|FG001|Overall Study|Other|2
2135916|NCT01076010|3741761|FG002|Overall Study|Other|0
2135917|NCT01076036|3741769|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2
2135918|NCT01076075|3741790|FG000|Overall Study|Adverse Event|3
2135919|NCT01076075|3741791|FG001|Overall Study|Adverse Event|9
2135920|NCT01076075|3741790|FG000|Overall Study|Lack of Efficacy|5
2135921|NCT01076075|3741791|FG001|Overall Study|Lack of Efficacy|4
2135922|NCT01076075|3741790|FG000|Overall Study|Lost to Follow-up|6
2135923|NCT01076075|3741791|FG001|Overall Study|Lost to Follow-up|5
2135924|NCT01076075|3741790|FG000|Overall Study|other|19
2135925|NCT01076075|3741791|FG001|Overall Study|other|9
2135926|NCT01076075|3741790|FG000|Overall Study|Protocol Violation|0
2135927|NCT01076075|3741791|FG001|Overall Study|Protocol Violation|1
2135928|NCT01076075|3741790|FG000|Overall Study|Withdrawal by Subject|8
2135929|NCT01076075|3741791|FG001|Overall Study|Withdrawal by Subject|19
2135930|NCT01076088|3741806|FG000|Overall Study|Adverse Event|1
2135931|NCT01076088|3741807|FG001|Overall Study|Adverse Event|6
2135932|NCT01076088|3741808|FG002|Overall Study|Adverse Event|3
2135933|NCT01076088|3741809|FG003|Overall Study|Adverse Event|2
2135934|NCT01076088|3741810|FG004|Overall Study|Adverse Event|3
2135935|NCT01076088|3741811|FG005|Overall Study|Adverse Event|3
2135936|NCT01076088|3741806|FG000|Overall Study|Lost to Follow-up|1
2135937|NCT01076088|3741807|FG001|Overall Study|Lost to Follow-up|1
2135938|NCT01076088|3741808|FG002|Overall Study|Lost to Follow-up|0
2135939|NCT01076088|3741809|FG003|Overall Study|Lost to Follow-up|1
2135940|NCT01076088|3741810|FG004|Overall Study|Lost to Follow-up|1
2135941|NCT01076088|3741811|FG005|Overall Study|Lost to Follow-up|2
2135942|NCT01076088|3741806|FG000|Overall Study|Non-compliance with study drug|0
2135943|NCT01076088|3741807|FG001|Overall Study|Non-compliance with study drug|0
2135944|NCT01076088|3741808|FG002|Overall Study|Non-compliance with study drug|0
2135945|NCT01076088|3741809|FG003|Overall Study|Non-compliance with study drug|1
2135946|NCT01076088|3741810|FG004|Overall Study|Non-compliance with study drug|0
2135947|NCT01076088|3741811|FG005|Overall Study|Non-compliance with study drug|0
2135948|NCT01076088|3741806|FG000|Overall Study|Physician Decision|1
2135949|NCT01076088|3741807|FG001|Overall Study|Physician Decision|3
2135950|NCT01076088|3741808|FG002|Overall Study|Physician Decision|0
2135951|NCT01076088|3741809|FG003|Overall Study|Physician Decision|1
2135952|NCT01076088|3741810|FG004|Overall Study|Physician Decision|1
2135953|NCT01076088|3741811|FG005|Overall Study|Physician Decision|0
2135954|NCT01076088|3741806|FG000|Overall Study|Withdrawal by Subject|8
2135955|NCT01076088|3741807|FG001|Overall Study|Withdrawal by Subject|8
2135956|NCT01076088|3741808|FG002|Overall Study|Withdrawal by Subject|14
2135957|NCT01076088|3741809|FG003|Overall Study|Withdrawal by Subject|10
2135958|NCT01076088|3741810|FG004|Overall Study|Withdrawal by Subject|11
2135959|NCT01076088|3741811|FG005|Overall Study|Withdrawal by Subject|17
2135960|NCT01076088|3741806|FG000|Overall Study|Other protocol specified criteria|0
2135961|NCT01076088|3741807|FG001|Overall Study|Other protocol specified criteria|0
2135962|NCT01076088|3741808|FG002|Overall Study|Other protocol specified criteria|0
2135963|NCT01076088|3741809|FG003|Overall Study|Other protocol specified criteria|0
2135964|NCT01076088|3741810|FG004|Overall Study|Other protocol specified criteria|0
2135965|NCT01076088|3741811|FG005|Overall Study|Other protocol specified criteria|1
2135966|NCT01076153|3741826|FG000|Overall Study|Symptoms improved/resolved|10
2135967|NCT01076153|3741826|FG000|Overall Study|Adverse Event|1
2135968|NCT01076166|3741834|FG000|Overall Study|Adverse Event|3
2135969|NCT01076166|3741834|FG000|Overall Study|Symptoms improved/resolved|6
2135970|NCT01076179|3741841|FG000|Overall Study|Withdrawal by Subject|1
2135971|NCT01076192|3741846|FG000|Overall Study|Other|197
2135972|NCT01076205|3741851|FG000|Overall Study|Adverse Drug Reaction|299
2135973|NCT01076205|3741851|FG000|Overall Study|Lack of Effectiveness|1423
2135974|NCT01076205|3741851|FG000|Overall Study|Other Reason|1075
2135975|NCT01076205|3741851|FG000|Overall Study|Unknown Reason|71
2135976|NCT01076205|3741851|FG000|Overall Study|Lost to Follow-up|3151
2135977|NCT01076335|3741917|FG000|Overall Study|Withdrawal by Subject|3
2135978|NCT01076335|3741917|FG000|Overall Study|Withdrawal without treatment|1
2135979|NCT01076361|3741925|FG000|Overall Study|22 leads were excluded from analysis|21
2135980|NCT01076400|3741929|FG000|Overall Study|Adverse Event|2
2135981|NCT01076400|3741930|FG001|Overall Study|Adverse Event|0
2135982|NCT01076400|3741931|FG002|Overall Study|Adverse Event|0
2135983|NCT01076400|3741929|FG000|Overall Study|Progressive Disease|5
2135984|NCT01076400|3741930|FG001|Overall Study|Progressive Disease|0
2135985|NCT01076400|3741931|FG002|Overall Study|Progressive Disease|0
2135986|NCT01076543|3741954|FG000|Overall Study|Withdrawal by Subject|2
2135987|NCT01076543|3741955|FG001|Overall Study|Withdrawal by Subject|0
2135988|NCT01076543|3741956|FG002|Overall Study|Withdrawal by Subject|0
2135989|NCT01076543|3741957|FG003|Overall Study|Withdrawal by Subject|0
2135990|NCT01076543|3741958|FG004|Overall Study|Withdrawal by Subject|0
2135991|NCT01076543|3741959|FG005|Overall Study|Withdrawal by Subject|0
2286957|NCT02443740|3976574|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2286958|NCT02443740|3976575|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2286959|NCT02443740|3976576|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2286960|NCT02443740|3976577|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2286961|NCT02443740|3976578|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2286962|NCT02443740|3976579|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
2286963|NCT02443740|3976580|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2286964|NCT02443740|3976581|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2286965|NCT02443740|3976582|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2286966|NCT02443740|3976583|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2286967|NCT02443740|3976584|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2286968|NCT02443805|3976625|FG000|Overall Study|Adverse Event|100
2286969|NCT02443805|3976626|FG001|Overall Study|Adverse Event|18
2286970|NCT02443805|3976625|FG000|Overall Study|Withdrawal by Subject|73
2286971|NCT02443805|3976626|FG001|Overall Study|Withdrawal by Subject|74
2286972|NCT02443805|3976625|FG000|Overall Study|Lost to Follow-up|19
2286973|NCT02443805|3976626|FG001|Overall Study|Lost to Follow-up|14
2286974|NCT02443805|3976625|FG000|Overall Study|Pregnancy|6
2286975|NCT02443805|3976626|FG001|Overall Study|Pregnancy|5
2286976|NCT02443805|3976625|FG000|Overall Study|Protocol Violation|2
2286977|NCT02443805|3976626|FG001|Overall Study|Protocol Violation|4
2286978|NCT02443805|3976625|FG000|Overall Study|Lack of Efficacy|1
2286979|NCT02443805|3976626|FG001|Overall Study|Lack of Efficacy|1
2286980|NCT02443805|3976625|FG000|Overall Study|Non-compliance with study drug|6
2286981|NCT02443805|3976626|FG001|Overall Study|Non-compliance with study drug|4
2135992|NCT01076647|3741976|FG000|Overall Study|Adverse Event|4
2135993|NCT01076647|3741977|FG001|Overall Study|Adverse Event|1
2041652|NCT00440310|3612380|FG000|Overall Study|Withdrawal by Subject|15
2041653|NCT00440310|3612381|FG001|Overall Study|Withdrawal by Subject|14
2041654|NCT00440310|3612380|FG000|Overall Study|No Reply at EOS|7
2286982|NCT02443805|3976625|FG000|Overall Study|Withdrawal by parent/guardian|3
2286983|NCT02443805|3976626|FG001|Overall Study|Withdrawal by parent/guardian|5
2286984|NCT02443805|3976625|FG000|Overall Study|Any other reason not above-mentioned|3
2286985|NCT02443805|3976626|FG001|Overall Study|Any other reason not above-mentioned|2
2286986|NCT02443883|3976636|FG000|Overall Study|Adverse Event|0
2286987|NCT02443883|3976637|FG001|Overall Study|Adverse Event|1
2286988|NCT02443883|3976638|FG002|Overall Study|Adverse Event|0
2286989|NCT02443883|3976639|FG003|Overall Study|Adverse Event|0
2286990|NCT02443883|3976636|FG000|Overall Study|Lost to Follow-up|3
2286991|NCT02443883|3976637|FG001|Overall Study|Lost to Follow-up|2
2286992|NCT02443883|3976638|FG002|Overall Study|Lost to Follow-up|1
2286993|NCT02443883|3976639|FG003|Overall Study|Lost to Follow-up|0
2286994|NCT02443883|3976636|FG000|Overall Study|Physician Decision|1
2286995|NCT02443883|3976637|FG001|Overall Study|Physician Decision|1
2286996|NCT02443883|3976638|FG002|Overall Study|Physician Decision|0
2286997|NCT02443883|3976639|FG003|Overall Study|Physician Decision|3
2286998|NCT02443883|3976636|FG000|Overall Study|Withdrawal by Subject|1
2286999|NCT02443883|3976637|FG001|Overall Study|Withdrawal by Subject|0
2287000|NCT02443883|3976638|FG002|Overall Study|Withdrawal by Subject|0
2287001|NCT02443883|3976639|FG003|Overall Study|Withdrawal by Subject|2
2287002|NCT02443883|3976636|FG000|Overall Study|Randomized, but never treated|1
2287003|NCT02443883|3976637|FG001|Overall Study|Randomized, but never treated|0
2287004|NCT02443883|3976638|FG002|Overall Study|Randomized, but never treated|0
2287005|NCT02443883|3976639|FG003|Overall Study|Randomized, but never treated|0
2287006|NCT02444182|3976662|FG000|Overall Study|non-compliance|2
2287007|NCT02444182|3976663|FG001|Overall Study|non-compliance|1
2287008|NCT02444182|3976662|FG000|Overall Study|Lost to Follow-up|0
2287009|NCT02444182|3976663|FG001|Overall Study|Lost to Follow-up|4
2287010|NCT02444533|3976680|FG000|Overall Study|Not able to complete forms|0
2287011|NCT02444533|3976681|FG001|Overall Study|Not able to complete forms|2
2287012|NCT02444533|3976680|FG000|Overall Study|Only gave post-procedure complications|2
2287013|NCT02444533|3976681|FG001|Overall Study|Only gave post-procedure complications|2
2287014|NCT02444793|3976723|FG000|Overall Study|Lost to Follow-up|2
2287015|NCT02444793|3976724|FG001|Overall Study|Lost to Follow-up|2
2287016|NCT02444793|3976725|FG002|Overall Study|Lost to Follow-up|0
2287017|NCT02444793|3976726|FG003|Overall Study|Lost to Follow-up|0
2287018|NCT02444793|3976723|FG000|Overall Study|Death|0
2287019|NCT02444793|3976724|FG001|Overall Study|Death|3
2287020|NCT02444793|3976725|FG002|Overall Study|Death|0
2287021|NCT02444793|3976726|FG003|Overall Study|Death|0
2287022|NCT02444793|3976723|FG000|Overall Study|Other|0
2287023|NCT02444793|3976724|FG001|Overall Study|Other|0
2287024|NCT02444793|3976725|FG002|Overall Study|Other|2
2287025|NCT02444793|3976726|FG003|Overall Study|Other|0
2287026|NCT02444793|3976723|FG000|Overall Study|Objective progression or relapse|9
2287027|NCT02444793|3976724|FG001|Overall Study|Objective progression or relapse|1
2287028|NCT02444793|3976725|FG002|Overall Study|Objective progression or relapse|2
2287029|NCT02444793|3976726|FG003|Overall Study|Objective progression or relapse|3
2287030|NCT02445573|3976797|FG000|Overall Study|Withdrawal by Subject|1
2287031|NCT02445573|3976798|FG001|Overall Study|Withdrawal by Subject|1
2287032|NCT02445573|3976797|FG000|Overall Study|Lost to Follow-up|0
2287033|NCT02445573|3976798|FG001|Overall Study|Lost to Follow-up|1
2287034|NCT02445586|3976804|FG000|Overall Study|Death|14
2287035|NCT02445586|3976804|FG000|Overall Study|Withdrawal by Subject|13
2287036|NCT02445586|3976804|FG000|Overall Study|Disease Progression|10
2287037|NCT02445586|3976804|FG000|Overall Study|Protocol Violation|1
2287038|NCT02445586|3976804|FG000|Overall Study|Medical Condition|1
2287039|NCT02445755|3976813|FG000|Overall Study|Withdrawal by Subject|2
2287040|NCT02445755|3976813|FG000|Overall Study|Protocol Violation|6
2287041|NCT02445755|3976813|FG000|Overall Study|Screen Failure|5
2287042|NCT02445794|3976824|FG000|Overall Study|Adverse Event|0
2287043|NCT02445794|3976825|FG001|Overall Study|Adverse Event|0
2287044|NCT02445794|3976826|FG002|Overall Study|Adverse Event|2
2287045|NCT02445794|3976827|FG003|Overall Study|Adverse Event|0
2287046|NCT02445963|3976881|FG000|Overall Study|Lost to Follow-up|1
2287047|NCT02445963|3976882|FG001|Overall Study|Lost to Follow-up|0
2287048|NCT02445963|3976883|FG002|Overall Study|Lost to Follow-up|0
2287049|NCT02445963|3976884|FG003|Overall Study|Lost to Follow-up|0
2287050|NCT02445963|3976881|FG000|Overall Study|Change in employment|1
2287051|NCT02445963|3976882|FG001|Overall Study|Change in employment|0
2287052|NCT02445963|3976883|FG002|Overall Study|Change in employment|0
2287053|NCT02445963|3976884|FG003|Overall Study|Change in employment|0
2287054|NCT02445963|3976881|FG000|Overall Study|Symptoms post-vaccination|0
2287055|NCT02445963|3976882|FG001|Overall Study|Symptoms post-vaccination|0
2287056|NCT02445963|3976883|FG002|Overall Study|Symptoms post-vaccination|1
2287057|NCT02445963|3976884|FG003|Overall Study|Symptoms post-vaccination|0
2287058|NCT02446015|3976898|FG000|Overall Study|Adverse Event|0
2287059|NCT02446015|3976899|FG001|Overall Study|Adverse Event|1
2287060|NCT02446015|3976898|FG000|Overall Study|Withdrawal by Subject|1
2041655|NCT00440310|3612381|FG001|Overall Study|No Reply at EOS|7
2041656|NCT00440310|3612380|FG000|Overall Study|Other|1
2041657|NCT00440310|3612381|FG001|Overall Study|Other|0
2041658|NCT00440310|3612380|FG000|Overall Study|Status Unknown|1
2041659|NCT00440310|3612381|FG001|Overall Study|Status Unknown|3
2041660|NCT00440401|3612389|FG000|Overall Study|Adverse Event|2
2041661|NCT00440401|3612390|FG001|Overall Study|Adverse Event|1
2041662|NCT00440401|3612389|FG000|Overall Study|Other|2
2041663|NCT00440401|3612390|FG001|Overall Study|Other|5
2041664|NCT00440466|3612399|FG000|Overall Study|Death|3
2041665|NCT00440466|3612400|FG001|Overall Study|Death|2
2041666|NCT00440466|3612401|FG002|Overall Study|Death|9
2041667|NCT00440466|3612399|FG000|Overall Study|Adverse Event|3
2041668|NCT00440466|3612400|FG001|Overall Study|Adverse Event|4
2041669|NCT00440466|3612401|FG002|Overall Study|Adverse Event|11
2041670|NCT00440466|3612399|FG000|Overall Study|Lost to Follow-up|1
2041671|NCT00440466|3612400|FG001|Overall Study|Lost to Follow-up|0
2041672|NCT00440466|3612401|FG002|Overall Study|Lost to Follow-up|2
2135994|NCT01076647|3741976|FG000|Overall Study|Lack of Efficacy|0
2135995|NCT01076647|3741977|FG001|Overall Study|Lack of Efficacy|1
2135996|NCT01076647|3741976|FG000|Overall Study|Protocol Violation|7
2135997|NCT01076647|3741977|FG001|Overall Study|Protocol Violation|9
2135998|NCT01076647|3741976|FG000|Overall Study|Withdrawal criteria|2
2207553|NCT01630616|3846576|FG004|Overall Study|Adverse Event|0
2207554|NCT01630616|3846577|FG005|Overall Study|Adverse Event|0
2207555|NCT01630616|3846572|FG000|Overall Study|Withdrawal by Subject|0
2207556|NCT01630616|3846573|FG001|Overall Study|Withdrawal by Subject|0
2207557|NCT01630616|3846574|FG002|Overall Study|Withdrawal by Subject|0
2207558|NCT01630616|3846575|FG003|Overall Study|Withdrawal by Subject|2
2207559|NCT01630616|3846576|FG004|Overall Study|Withdrawal by Subject|0
2207560|NCT01630616|3846577|FG005|Overall Study|Withdrawal by Subject|0
2207561|NCT01630811|3846603|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
2207562|NCT01630811|3846604|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
2207563|NCT01630889|3846612|FG000|Overall Study|Death|2
2207564|NCT01630889|3846612|FG000|Overall Study|Withdrawal by Subject|1
2207565|NCT01630889|3846612|FG000|Overall Study|Other than Specified|2
2207566|NCT01630889|3846612|FG000|Overall Study|Lost to Follow-up|4
2207567|NCT01630889|3846612|FG000|Overall Study|Other|1
2207568|NCT01631188|3846643|FG000|Overall Study|Physician Decision|75
2207569|NCT01631214|3846649|FG000|Overall Study|Withdrawal by Subject|276
2207570|NCT01631214|3846650|FG001|Overall Study|Withdrawal by Subject|290
2207571|NCT01631214|3846649|FG000|Overall Study|Death|113
2207572|NCT01631214|3846650|FG001|Overall Study|Death|106
2207573|NCT01631214|3846649|FG000|Overall Study|Lost to Follow-up|54
2207574|NCT01631214|3846650|FG001|Overall Study|Lost to Follow-up|40
2207575|NCT01631214|3846649|FG000|Overall Study|Adverse Event|45
2207576|NCT01631214|3846650|FG001|Overall Study|Adverse Event|45
2207577|NCT01631214|3846649|FG000|Overall Study|Other|22
2207578|NCT01631214|3846650|FG001|Overall Study|Other|19
2207579|NCT01631214|3846649|FG000|Overall Study|Noncompliance|16
2207580|NCT01631214|3846650|FG001|Overall Study|Noncompliance|15
2207581|NCT01631214|3846649|FG000|Overall Study|Requirement for Alternative Therapy|8
2207582|NCT01631214|3846650|FG001|Overall Study|Requirement for Alternative Therapy|3
2207583|NCT01631214|3846649|FG000|Overall Study|Protocol Deviation|4
2207584|NCT01631214|3846650|FG001|Overall Study|Protocol Deviation|3
2207585|NCT01631214|3846649|FG000|Overall Study|Ineligibility determined|5
2207586|NCT01631214|3846650|FG001|Overall Study|Ineligibility determined|2
2207587|NCT01631214|3846649|FG000|Overall Study|Administrative Decision|1
2207588|NCT01631214|3846650|FG001|Overall Study|Administrative Decision|0
2207589|NCT01631227|3846660|FG000|Overall Study|withdrawn consent|27
2287061|NCT02446015|3976899|FG001|Overall Study|Withdrawal by Subject|0
2287062|NCT02446171|3976910|FG000|Overall Study|Withdrawal by Subject|0
2287063|NCT02446171|3976911|FG001|Overall Study|Withdrawal by Subject|0
2287064|NCT02446171|3976912|FG002|Overall Study|Withdrawal by Subject|2
2287065|NCT02446171|3976913|FG003|Overall Study|Withdrawal by Subject|0
2287066|NCT02446418|3976952|FG000|Overall Study|Adverse Event|4
2287067|NCT02446418|3976953|FG001|Overall Study|Adverse Event|8
2287068|NCT02446418|3976952|FG000|Overall Study|Physician Decision|5
2287069|NCT02446418|3976953|FG001|Overall Study|Physician Decision|1
2287070|NCT02446418|3976952|FG000|Overall Study|Withdrawal by Subject|3
2287071|NCT02446418|3976953|FG001|Overall Study|Withdrawal by Subject|3
2287072|NCT02446418|3976952|FG000|Overall Study|Lost to Follow-up|2
2287073|NCT02446418|3976953|FG001|Overall Study|Lost to Follow-up|2
2287074|NCT02446418|3976952|FG000|Overall Study|Protocol Violation|1
2287075|NCT02446418|3976953|FG001|Overall Study|Protocol Violation|2
2287076|NCT02446418|3976952|FG000|Overall Study|Lack of Efficacy|2
2287077|NCT02446418|3976953|FG001|Overall Study|Lack of Efficacy|0
2287078|NCT02446418|3976952|FG000|Overall Study|Protocol defined stopping criteria reach|1
2135999|NCT01076647|3741977|FG001|Overall Study|Withdrawal criteria|2
2041673|NCT00440466|3612399|FG000|Overall Study|Physician Decision|2
2041674|NCT00440466|3612400|FG001|Overall Study|Physician Decision|0
2136000|NCT01076647|3741976|FG000|Overall Study|Unclassified|12
2136001|NCT01076647|3741977|FG001|Overall Study|Unclassified|12
2136002|NCT01076959|3742000|FG000|Overall Study|Adverse Event|767
2136003|NCT01076959|3742000|FG000|Overall Study|Lack of Efficacy|849
2136004|NCT01076959|3742000|FG000|Overall Study|Non-compliance|274
2207590|NCT01631227|3846661|FG001|Overall Study|withdrawn consent|21
2207591|NCT01631227|3846660|FG000|Overall Study|Adverse Event|1
2207592|NCT01631227|3846661|FG001|Overall Study|Adverse Event|0
2207593|NCT01631227|3846660|FG000|Overall Study|administrative|2
2207594|NCT01631227|3846661|FG001|Overall Study|administrative|1
2207595|NCT01631435|3846672|FG000|Overall Study|Adverse Event|2
2207596|NCT01631435|3846672|FG000|Overall Study|Withdrawal by Subject|2
2287079|NCT02446418|3976953|FG001|Overall Study|Protocol defined stopping criteria reach|0
2320922|NCT02953782|4035204|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
2320923|NCT02953782|4035205|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
2320924|NCT02953782|4035206|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2
2320925|NCT02953782|4035207|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
2320926|NCT02953782|4035208|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
2320927|NCT02953782|4035209|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
2320928|NCT02953782|4035210|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
2320929|NCT02953782|4035211|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
2320930|NCT02953782|4035204|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
2320931|NCT02953782|4035205|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
2320932|NCT02953782|4035206|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
2320933|NCT02953782|4035207|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
2320934|NCT02953782|4035208|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
2320935|NCT02953782|4035209|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
2320936|NCT02953782|4035210|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
2320937|NCT02953782|4035211|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
2320938|NCT02953782|4035204|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
2320939|NCT02953782|4035205|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
2320940|NCT02953782|4035206|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
2320941|NCT02953782|4035207|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
2320942|NCT02953782|4035208|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
2320943|NCT02953782|4035209|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
2320944|NCT02953782|4035210|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
2320945|NCT02953782|4035211|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
2320946|NCT02953782|4035204|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
2320947|NCT02953782|4035205|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
2320948|NCT02953782|4035206|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
2320949|NCT02953782|4035207|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
2320950|NCT02953782|4035208|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
2320951|NCT02953782|4035209|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14
2320952|NCT02953782|4035210|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11
2320953|NCT02953782|4035211|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8
2320954|NCT02953782|4035204|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
2320955|NCT02953782|4035205|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
2320956|NCT02953782|4035206|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
2320957|NCT02953782|4035207|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
2320958|NCT02953782|4035208|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
2320959|NCT02953782|4035209|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1
2320960|NCT02953782|4035210|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2
2320961|NCT02953782|4035211|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3
2320962|NCT02953782|4035204|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
2320963|NCT02953782|4035205|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
2320964|NCT02953782|4035206|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
2320965|NCT02953782|4035207|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
2320966|NCT02953782|4035208|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
2320967|NCT02953782|4035209|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
2320968|NCT02953782|4035210|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
2320969|NCT02953782|4035211|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4
2320970|NCT02953782|4035204|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
2320971|NCT02953782|4035205|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
2320972|NCT02953782|4035206|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
2320973|NCT02953782|4035207|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
2320974|NCT02953782|4035208|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
2320975|NCT02953782|4035209|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
2320976|NCT02953782|4035210|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1
2320977|NCT02953782|4035211|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
2320978|NCT02953821|4035234|FG000|Overall Study|Adverse Event|0
2320979|NCT02953821|4035235|FG001|Overall Study|Adverse Event|4
2320980|NCT02953821|4035234|FG000|Overall Study|Death|1
2320981|NCT02953821|4035235|FG001|Overall Study|Death|0
2207597|NCT01631435|3846672|FG000|Overall Study|incomplete study procedure|5
2207598|NCT01631474|3846682|FG000|Overall Study|Lost to Follow-up|8
2207599|NCT01631474|3846683|FG001|Overall Study|Lost to Follow-up|5
2207600|NCT01631474|3846684|FG002|Overall Study|Lost to Follow-up|7
2207601|NCT01631474|3846685|FG003|Overall Study|Lost to Follow-up|5
2207602|NCT01631474|3846686|FG004|Overall Study|Lost to Follow-up|5
2207603|NCT01631474|3846682|FG000|Overall Study|Withdrawal by Subject|4
2207604|NCT01631474|3846683|FG001|Overall Study|Withdrawal by Subject|4
2207605|NCT01631474|3846684|FG002|Overall Study|Withdrawal by Subject|2
2207606|NCT01631474|3846685|FG003|Overall Study|Withdrawal by Subject|6
2207607|NCT01631474|3846686|FG004|Overall Study|Withdrawal by Subject|5
2207608|NCT01631474|3846682|FG000|Overall Study|Lack of Efficacy|2
2207609|NCT01631474|3846683|FG001|Overall Study|Lack of Efficacy|2
2207610|NCT01631474|3846684|FG002|Overall Study|Lack of Efficacy|0
2207611|NCT01631474|3846685|FG003|Overall Study|Lack of Efficacy|0
2207612|NCT01631474|3846686|FG004|Overall Study|Lack of Efficacy|2
2207613|NCT01631474|3846682|FG000|Overall Study|Noncompliance with Study Drug|0
2207614|NCT01631474|3846683|FG001|Overall Study|Noncompliance with Study Drug|0
2207615|NCT01631474|3846684|FG002|Overall Study|Noncompliance with Study Drug|0
2207616|NCT01631474|3846685|FG003|Overall Study|Noncompliance with Study Drug|0
2207617|NCT01631474|3846686|FG004|Overall Study|Noncompliance with Study Drug|1
2207618|NCT01631474|3846682|FG000|Overall Study|Adverse Event|0
2207619|NCT01631474|3846683|FG001|Overall Study|Adverse Event|1
2207620|NCT01631474|3846684|FG002|Overall Study|Adverse Event|0
2207621|NCT01631474|3846685|FG003|Overall Study|Adverse Event|0
2207622|NCT01631474|3846686|FG004|Overall Study|Adverse Event|0
2207623|NCT01631747|3846754|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1
2207624|NCT01631747|3846755|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0
2207625|NCT01631747|3846754|FG000|Live Birth|Pregnancy Termination|1
2207626|NCT01631747|3846755|FG001|Live Birth|Pregnancy Termination|0
2207627|NCT01631747|3846754|FG000|Live Birth|MIscarriage|2
2207628|NCT01631747|3846755|FG001|Live Birth|MIscarriage|0
2207629|NCT01631747|3846754|FG000|Live Birth|Stillbirth|1
2207630|NCT01631747|3846755|FG001|Live Birth|Stillbirth|1
2287080|NCT02446691|3976985|FG000|Overall Study|Withdrawal by Subject|2
2287081|NCT02446691|3976985|FG000|Overall Study|Lost to Follow-up|8
2287082|NCT02446691|3976985|FG000|Overall Study|Protocol Violation|1
2287083|NCT02446717|3976994|FG000|Overall Study|Adverse Event|0
2287084|NCT02446717|3976995|FG001|Overall Study|Adverse Event|0
2287085|NCT02446717|3976996|FG002|Overall Study|Adverse Event|1
2287086|NCT02446717|3976997|FG003|Overall Study|Adverse Event|0
2287087|NCT02446717|3976998|FG004|Overall Study|Adverse Event|0
2287088|NCT02446717|3976994|FG000|Overall Study|Lost to Follow-up|0
2287089|NCT02446717|3976995|FG001|Overall Study|Lost to Follow-up|1
2287090|NCT02446717|3976996|FG002|Overall Study|Lost to Follow-up|1
2287091|NCT02446717|3976997|FG003|Overall Study|Lost to Follow-up|0
2287092|NCT02446717|3976998|FG004|Overall Study|Lost to Follow-up|1
2287093|NCT02446717|3976994|FG000|Overall Study|Withdrew consent|0
2287094|NCT02446717|3976995|FG001|Overall Study|Withdrew consent|0
2287095|NCT02446717|3976996|FG002|Overall Study|Withdrew consent|0
2287096|NCT02446717|3976997|FG003|Overall Study|Withdrew consent|1
2287097|NCT02446717|3976998|FG004|Overall Study|Withdrew consent|0
2287098|NCT02446743|3977012|FG000|Overall Study|Withdrawal by Subject|1
2287099|NCT02446743|3977013|FG001|Overall Study|Withdrawal by Subject|1
2287100|NCT02446743|3977012|FG000|Overall Study|Lost to Follow-up|1
2287101|NCT02446743|3977013|FG001|Overall Study|Lost to Follow-up|0
2287102|NCT02446743|3977012|FG000|Overall Study|Adverse Event|1
2287103|NCT02446743|3977013|FG001|Overall Study|Adverse Event|1
2287104|NCT02446743|3977012|FG000|Overall Study|Other|2
2287105|NCT02446743|3977013|FG001|Overall Study|Other|3
2287106|NCT02446769|3977028|FG000|Screening Period|Screen Failure|11
2287107|NCT02446769|3977029|FG001|Screening Period|Screen Failure|0
2287108|NCT02446769|3977030|FG002|Screening Period|Screen Failure|0
2287109|NCT02446769|3977028|FG000|Study Period|Randomized in Error|0
2287110|NCT02446769|3977029|FG001|Study Period|Randomized in Error|2
2287111|NCT02446769|3977030|FG002|Study Period|Randomized in Error|0
2287112|NCT02446886|3977048|FG000|Overall Study|Adverse Event|1
2287113|NCT02446886|3977049|FG001|Overall Study|Adverse Event|3
2287114|NCT02446886|3977048|FG000|Overall Study|Withdrawal by Subject|1
2287115|NCT02446886|3977049|FG001|Overall Study|Withdrawal by Subject|1
2287116|NCT02446899|3977058|FG000|Overall Study|Adverse Event|4
2287117|NCT02446899|3977059|FG001|Overall Study|Adverse Event|7
2287118|NCT02446899|3977058|FG000|Overall Study|Condition Under Investigation Worsened|1
2287119|NCT02446899|3977059|FG001|Overall Study|Condition Under Investigation Worsened|4
2287120|NCT02446899|3977058|FG000|Overall Study|Study Specific Withdrawal Criteria|1
2287121|NCT02446899|3977059|FG001|Overall Study|Study Specific Withdrawal Criteria|0
2287122|NCT02446899|3977058|FG000|Overall Study|Lack of Efficacy|2
2287123|NCT02446899|3977059|FG001|Overall Study|Lack of Efficacy|8
2287124|NCT02446899|3977058|FG000|Overall Study|Lost to Follow-up|1
2287125|NCT02446899|3977059|FG001|Overall Study|Lost to Follow-up|3
2287126|NCT02446899|3977058|FG000|Overall Study|Severe Non-Compliance to Protocol|0
2287127|NCT02446899|3977059|FG001|Overall Study|Severe Non-Compliance to Protocol|1
2287128|NCT02446899|3977058|FG000|Overall Study|Withdrawal by Subject|11
2287129|NCT02446899|3977059|FG001|Overall Study|Withdrawal by Subject|19
2287130|NCT02446899|3977058|FG000|Overall Study|Miscellaneous|5
2207631|NCT01631747|3846754|FG000|One Year Infant Outcomes|Patient Refused|13
2207632|NCT01631747|3846755|FG001|One Year Infant Outcomes|Patient Refused|9
2207633|NCT01631812|3846762|FG000|Overall Study|Adverse Event|25
2207634|NCT01631812|3846762|FG000|Overall Study|Lack of Efficacy|5
2207635|NCT01631812|3846762|FG000|Overall Study|Withdrawal by Subject|4
2207636|NCT01631812|3846762|FG000|Overall Study|Physician Decision|3
2207637|NCT01631825|3846766|FG000|Overall Study|Adverse Event|42
2207638|NCT01631825|3846766|FG000|Overall Study|Lack of Efficacy|7
2207639|NCT01631825|3846766|FG000|Overall Study|Withdrawal by Subject|9
2207640|NCT01631825|3846766|FG000|Overall Study|Protocol Violation|4
2207641|NCT01631825|3846766|FG000|Overall Study|Discontinuation criteria|1
2207642|NCT01631825|3846766|FG000|Overall Study|Physician Decision|2
2207643|NCT01631864|3846772|FG000|Overall Study|Withdrawal by Subject|0
2207644|NCT01631864|3846773|FG001|Overall Study|Withdrawal by Subject|1
2207645|NCT01631864|3846772|FG000|Overall Study|Adverse Event|2
2136005|NCT01076959|3742000|FG000|Overall Study|Lost to Follow-up|241
2136006|NCT01076959|3742000|FG000|Overall Study|Other|119
2136007|NCT01077024|3742039|FG000|Overall Study|Lost to Follow-up|20
2136008|NCT01077024|3742040|FG001|Overall Study|Lost to Follow-up|14
2136009|NCT01077024|3742039|FG000|Overall Study|Withdrawal by Subject|0
2136010|NCT01077024|3742040|FG001|Overall Study|Withdrawal by Subject|2
2136011|NCT01077024|3742039|FG000|Overall Study|Incarcerated|7
2136012|NCT01077024|3742040|FG001|Overall Study|Incarcerated|8
2136013|NCT01077024|3742039|FG000|Overall Study|Other|4
2136014|NCT01077024|3742040|FG001|Overall Study|Other|4
2136015|NCT01077050|3742046|FG000|Overall Study|Subjects signed ICF could not be located|1
2136016|NCT01077050|3742046|FG000|Overall Study|Screen failure|8
2287131|NCT02446899|3977059|FG001|Overall Study|Miscellaneous|4
2287132|NCT02446899|3977058|FG000|Overall Study|Failure to Meet Randomization Criteria|0
2287133|NCT02446899|3977059|FG001|Overall Study|Failure to Meet Randomization Criteria|2
2287134|NCT02446912|3977068|FG000|Overall Study|Adverse Event|3
2287135|NCT02446912|3977069|FG001|Overall Study|Adverse Event|13
2287136|NCT02446912|3977070|FG002|Overall Study|Adverse Event|5
2287137|NCT02446912|3977068|FG000|Overall Study|Condition under investigation worsened|0
2287138|NCT02446912|3977069|FG001|Overall Study|Condition under investigation worsened|1
2287139|NCT02446912|3977070|FG002|Overall Study|Condition under investigation worsened|1
2287140|NCT02446912|3977068|FG000|Overall Study|Study-specific withdrawal criteria|1
2287141|NCT02446912|3977069|FG001|Overall Study|Study-specific withdrawal criteria|0
2287142|NCT02446912|3977070|FG002|Overall Study|Study-specific withdrawal criteria|0
2287143|NCT02446912|3977068|FG000|Overall Study|Lack of Efficacy|1
2287144|NCT02446912|3977069|FG001|Overall Study|Lack of Efficacy|4
2287145|NCT02446912|3977070|FG002|Overall Study|Lack of Efficacy|7
2287146|NCT02446912|3977068|FG000|Overall Study|Lost to Follow-up|0
2287147|NCT02446912|3977069|FG001|Overall Study|Lost to Follow-up|0
2287148|NCT02446912|3977070|FG002|Overall Study|Lost to Follow-up|2
2287149|NCT02446912|3977068|FG000|Overall Study|Severe non-compliance to protocol|1
2287150|NCT02446912|3977069|FG001|Overall Study|Severe non-compliance to protocol|0
2287151|NCT02446912|3977070|FG002|Overall Study|Severe non-compliance to protocol|1
2287152|NCT02446912|3977068|FG000|Overall Study|Withdrawal by Subject|10
2287153|NCT02446912|3977069|FG001|Overall Study|Withdrawal by Subject|15
2287154|NCT02446912|3977070|FG002|Overall Study|Withdrawal by Subject|15
2287155|NCT02446912|3977068|FG000|Overall Study|Miscellaneous|2
2287156|NCT02446912|3977069|FG001|Overall Study|Miscellaneous|2
2287157|NCT02446912|3977070|FG002|Overall Study|Miscellaneous|4
2287158|NCT02446990|3977080|FG000|Overall Study|Death|485
2287159|NCT02446990|3977081|FG001|Overall Study|Death|458
2287160|NCT02446990|3977080|FG000|Overall Study|Lost to Follow-up|3
2287161|NCT02446990|3977081|FG001|Overall Study|Lost to Follow-up|1
2287162|NCT02446990|3977080|FG000|Overall Study|Physician Decision|1
2287163|NCT02446990|3977081|FG001|Overall Study|Physician Decision|0
2287164|NCT02446990|3977080|FG000|Overall Study|Withdrawal by Subject|231
2287165|NCT02446990|3977081|FG001|Overall Study|Withdrawal by Subject|199
2287166|NCT02447003|3977089|FG000|Overall Study|Other|0
2287167|NCT02447003|3977090|FG001|Overall Study|Other|4
2287168|NCT02447003|3977089|FG000|Overall Study|Site discontinued|0
2287169|NCT02447003|3977090|FG001|Overall Study|Site discontinued|2
2287170|NCT02447003|3977089|FG000|Overall Study|Physician Decision|0
2287171|NCT02447003|3977090|FG001|Overall Study|Physician Decision|1
2287172|NCT02447003|3977089|FG000|Overall Study|Withdrawal by Subject|4
2287173|NCT02447003|3977090|FG001|Overall Study|Withdrawal by Subject|3
2136017|NCT01077063|3742052|FG000|Overall Study|Adverse Event|3
2136018|NCT01077063|3742053|FG001|Overall Study|Adverse Event|0
2136019|NCT01077063|3742052|FG000|Overall Study|Death|1
2136020|NCT01077063|3742053|FG001|Overall Study|Death|1
2136021|NCT01077063|3742052|FG000|Overall Study|Withdrawal by Subject|0
2287174|NCT02447003|3977089|FG000|Overall Study|Sponsor Decision|6
2287175|NCT02447003|3977090|FG001|Overall Study|Sponsor Decision|11
2287176|NCT02447003|3977089|FG000|Overall Study|Progressive Disease|1
2136022|NCT01077063|3742053|FG001|Overall Study|Withdrawal by Subject|2
2207646|NCT01631864|3846773|FG001|Overall Study|Adverse Event|3
2287177|NCT02447003|3977090|FG001|Overall Study|Progressive Disease|0
2287178|NCT02447003|3977089|FG000|Overall Study|Lost to Follow-up|5
2287179|NCT02447003|3977090|FG001|Overall Study|Lost to Follow-up|0
2287180|NCT02447003|3977089|FG000|Overall Study|Death|154
2287181|NCT02447003|3977090|FG001|Overall Study|Death|63
2136023|NCT01077076|3742059|FG000|First Intervention|Withdrawal by Subject|1
2136024|NCT01077076|3742060|FG001|First Intervention|Withdrawal by Subject|0
2136025|NCT01077076|3742061|FG002|First Intervention|Withdrawal by Subject|0
2136026|NCT01077076|3742062|FG003|First Intervention|Withdrawal by Subject|0
2136027|NCT01077076|3742063|FG004|First Intervention|Withdrawal by Subject|0
2136028|NCT01077076|3742064|FG005|First Intervention|Withdrawal by Subject|0
2136029|NCT01077076|3742059|FG000|Third Intervention|Death in the participant's family|0
2136030|NCT01077076|3742060|FG001|Third Intervention|Death in the participant's family|0
2136031|NCT01077076|3742061|FG002|Third Intervention|Death in the participant's family|0
2136032|NCT01077076|3742062|FG003|Third Intervention|Death in the participant's family|0
2136033|NCT01077076|3742063|FG004|Third Intervention|Death in the participant's family|0
2136034|NCT01077076|3742064|FG005|Third Intervention|Death in the participant's family|1
2136035|NCT01077128|3742072|FG000|Overall Study|Adverse Event|8
2136036|NCT01077128|3742072|FG000|Overall Study|Lack of Efficacy|1
2136037|NCT01077128|3742072|FG000|Overall Study|Disease exacerbation|1
2136038|NCT01077128|3742072|FG000|Overall Study|Adverse event and consent withdrawal|1
2136039|NCT01077128|3742072|FG000|Overall Study|Adverse event and disease exacerbation|1
2136040|NCT01077128|3742072|FG000|Overall Study|Lack of efficacy/disease exacerbation|1
2136041|NCT01077128|3742072|FG000|Overall Study|Other|54
2136042|NCT01077154|3742128|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524
2136043|NCT01077154|3742129|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514
2136044|NCT01077154|3742128|FG000|Overall Study|Withdrawal by Subject|369
2136045|NCT01077154|3742129|FG001|Overall Study|Withdrawal by Subject|385
2136046|NCT01077154|3742128|FG000|Overall Study|Death|215
2136047|NCT01077154|3742129|FG001|Overall Study|Death|214
2136048|NCT01077154|3742128|FG000|Overall Study|Lost to Follow-up|43
2136049|NCT01077154|3742129|FG001|Overall Study|Lost to Follow-up|35
2136050|NCT01077154|3742128|FG000|Overall Study|Noncompliance|22
2136051|NCT01077154|3742129|FG001|Overall Study|Noncompliance|20
2136052|NCT01077154|3742128|FG000|Overall Study|Disease Progression|18
2136053|NCT01077154|3742129|FG001|Overall Study|Disease Progression|20
2136054|NCT01077154|3742128|FG000|Overall Study|Ineligibility Determined|10
2136055|NCT01077154|3742129|FG001|Overall Study|Ineligibility Determined|14
2136056|NCT01077154|3742128|FG000|Overall Study|Other|14
2136057|NCT01077154|3742129|FG001|Overall Study|Other|11
2136058|NCT01077154|3742128|FG000|Overall Study|Adverse Event|9
2136059|NCT01077154|3742129|FG001|Overall Study|Adverse Event|9
2136060|NCT01077154|3742128|FG000|Overall Study|Administrative Decision|1
2136061|NCT01077154|3742129|FG001|Overall Study|Administrative Decision|6
2136062|NCT01077154|3742128|FG000|Overall Study|Protocol Deviation|1
2136063|NCT01077154|3742129|FG001|Overall Study|Protocol Deviation|0
2136064|NCT01077193|3742135|FG000|Overall Study|Lost to Follow-up|1
2136065|NCT01077193|3742135|FG000|Overall Study|Withdrawal by Subject|2
2136066|NCT01077193|3742135|FG000|Overall Study|Lack of Efficacy|1
2136067|NCT01077193|3742135|FG000|Overall Study|Study Terminated by Sponsor|40
2287182|NCT02447029|3977100|FG000|Overall Study|Withdrawal by Subject|3
2287183|NCT02447029|3977101|FG001|Overall Study|Withdrawal by Subject|2
2287184|NCT02447081|3977107|FG000|Overall Study|Death|161
2287185|NCT02447081|3977107|FG000|Overall Study|Lost to Follow-up|36
2287186|NCT02447081|3977107|FG000|Overall Study|Visit not completed|17
2287187|NCT02447081|3977107|FG000|Overall Study|unsuccessful implant procedure|10
2287188|NCT02447172|3977114|FG000|Overall Study|Adverse Event|11
2287189|NCT02447172|3977115|FG001|Overall Study|Adverse Event|8
2287190|NCT02447172|3977116|FG002|Overall Study|Adverse Event|7
2287191|NCT02447172|3977114|FG000|Overall Study|Death|3
2287192|NCT02447172|3977115|FG001|Overall Study|Death|1
2287193|NCT02447172|3977116|FG002|Overall Study|Death|0
2287194|NCT02447172|3977114|FG000|Overall Study|Protocol Violation|2
2287195|NCT02447172|3977115|FG001|Overall Study|Protocol Violation|1
2287196|NCT02447172|3977116|FG002|Overall Study|Protocol Violation|2
2287197|NCT02447172|3977114|FG000|Overall Study|Lost to Follow-up|7
2287198|NCT02447172|3977115|FG001|Overall Study|Lost to Follow-up|4
2287199|NCT02447172|3977116|FG002|Overall Study|Lost to Follow-up|4
2287200|NCT02447172|3977114|FG000|Overall Study|Withdrawal by Subject|5
2287201|NCT02447172|3977115|FG001|Overall Study|Withdrawal by Subject|1
2287202|NCT02447172|3977116|FG002|Overall Study|Withdrawal by Subject|3
2287203|NCT02447172|3977114|FG000|Overall Study|protocol specific treatment unrelated|3
2287204|NCT02447172|3977115|FG001|Overall Study|protocol specific treatment unrelated|0
2287205|NCT02447172|3977116|FG002|Overall Study|protocol specific treatment unrelated|2
2287206|NCT02447250|3977124|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
2287207|NCT02447250|3977124|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
2287208|NCT02447250|3977124|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
2287209|NCT02447302|3977132|FG000|Overall Study|Physician Decision|1
2287210|NCT02447302|3977133|FG001|Overall Study|Physician Decision|0
2287211|NCT02447302|3977134|FG002|Overall Study|Physician Decision|0
2287212|NCT02447302|3977132|FG000|Overall Study|Adverse Event|4
2287213|NCT02447302|3977133|FG001|Overall Study|Adverse Event|3
2287214|NCT02447302|3977134|FG002|Overall Study|Adverse Event|0
2287215|NCT02447302|3977132|FG000|Overall Study|Withdrawal by Subject|0
2287216|NCT02447302|3977133|FG001|Overall Study|Withdrawal by Subject|1
2287217|NCT02447302|3977134|FG002|Overall Study|Withdrawal by Subject|5
2287218|NCT02447302|3977132|FG000|Overall Study|Sponsor Decision|0
2136068|NCT01077258|3742139|FG000|Overall Study|Lost to Follow-up|1390
2136069|NCT01077258|3742139|FG000|Overall Study|Adverse drug reaction|218
2136070|NCT01077258|3742139|FG000|Overall Study|Lack of Efficacy|663
2136071|NCT01077258|3742139|FG000|Overall Study|Clinical remission|37
2136072|NCT01077258|3742139|FG000|Overall Study|Other reasons|260
2136073|NCT01077271|3742156|FG000|Overall Study|Parental desire|8
2136074|NCT01077271|3742156|FG000|Overall Study|Screen failure, did not take palivizumab|4
2136075|NCT01077271|3742156|FG000|Overall Study|Noncompliance|2
2136076|NCT01077271|3742156|FG000|Overall Study|Quota used up (insurance reimb issue)|2
2136077|NCT01077271|3742156|FG000|Overall Study|Changed doctors|2
2136078|NCT01077271|3742156|FG000|Overall Study|Parents thought too many injections|2
2136079|NCT01077271|3742156|FG000|Overall Study|End of RSV season nearly reached|1
2136080|NCT01077271|3742156|FG000|Overall Study|Mother unconvinced of the necessity|1
2136081|NCT01077284|3742171|FG000|Overall Study|Adverse Event|2
2136082|NCT01077284|3742172|FG001|Overall Study|Adverse Event|0
2136083|NCT01077284|3742173|FG002|Overall Study|Adverse Event|1
2136084|NCT01077284|3742171|FG000|Overall Study|Lost to Follow-up|1
2287219|NCT02447302|3977133|FG001|Overall Study|Sponsor Decision|0
2287220|NCT02447302|3977134|FG002|Overall Study|Sponsor Decision|1
2287221|NCT02447328|3977142|FG000|Overall Study|Withdrawal by Subject|1
2287222|NCT02447432|3977148|FG000|Epoch 001|Adverse Event|1
2287223|NCT02447432|3977149|FG001|Epoch 001|Adverse Event|1
2287224|NCT02447432|3977148|FG000|Epoch 001|Withdrawal by Subject|0
2287225|NCT02447432|3977149|FG001|Epoch 001|Withdrawal by Subject|4
2287226|NCT02447432|3977148|FG000|Epoch 001|Migrated/moved from study area|3
2287227|NCT02447432|3977149|FG001|Epoch 001|Migrated/moved from study area|5
2287228|NCT02447432|3977148|FG000|Epoch 001|Lost to Follow-up|1
2287229|NCT02447432|3977149|FG001|Epoch 001|Lost to Follow-up|3
2287230|NCT02447458|3977161|FG000|Overall Study|Other|0
2287231|NCT02447458|3977162|FG001|Overall Study|Other|0
2287232|NCT02447458|3977163|FG002|Overall Study|Other|1
2287233|NCT02447458|3977164|FG003|Overall Study|Other|0
2287234|NCT02447458|3977165|FG004|Overall Study|Other|0
2287235|NCT02447458|3977166|FG005|Overall Study|Other|0
2287236|NCT02447497|3977189|FG000|Overall Study|Did not meet treatment day baseline.|6
2287237|NCT02447497|3977190|FG001|Overall Study|Did not meet treatment day baseline.|5
2287238|NCT02447497|3977191|FG002|Overall Study|Did not meet treatment day baseline.|2
2287239|NCT02447497|3977192|FG003|Overall Study|Did not meet treatment day baseline.|2
2287240|NCT02447497|3977189|FG000|Overall Study|Dressing was compromised|0
2287241|NCT02447497|3977190|FG001|Overall Study|Dressing was compromised|1
2287242|NCT02447497|3977191|FG002|Overall Study|Dressing was compromised|0
2287243|NCT02447497|3977192|FG003|Overall Study|Dressing was compromised|0
2287244|NCT02447718|3977216|FG000|Overall Study|Lost to Follow-up|8
2287245|NCT02447718|3977217|FG001|Overall Study|Lost to Follow-up|0
2287246|NCT02447718|3977216|FG000|Overall Study|Withdrawal by Subject|3
2287247|NCT02447718|3977217|FG001|Overall Study|Withdrawal by Subject|0
2287248|NCT02447718|3977216|FG000|Overall Study|Screen Failure|1
2287249|NCT02447718|3977217|FG001|Overall Study|Screen Failure|0
2287250|NCT02447744|3977226|FG000|Overall Study|Withdrawal by Subject|3
2287251|NCT02447744|3977227|FG001|Overall Study|Withdrawal by Subject|1
2287252|NCT02447744|3977226|FG000|Overall Study|Data not collected b/c logistic reasons|3
2287253|NCT02447744|3977227|FG001|Overall Study|Data not collected b/c logistic reasons|0
2287254|NCT02447848|3977233|FG000|Overall Study|Patient discharged|3
2287255|NCT02447848|3977233|FG000|Overall Study|Lack of Efficacy|4
2287256|NCT02447848|3977233|FG000|Overall Study|Withdrawal by Subject|4
2287257|NCT02447952|3977241|FG000|Overall Study|Adverse Event|2
2287258|NCT02447952|3977241|FG000|Overall Study|Physician Decision|1
2287259|NCT02447952|3977241|FG000|Overall Study|Withdrawal by Subject|4
2287260|NCT02447991|3977247|FG000|Overall Study|Withdrawn by subject - no data|0
2287261|NCT02447991|3977248|FG001|Overall Study|Withdrawn by subject - no data|2
2287262|NCT02447991|3977247|FG000|Overall Study|Withdrawn by Subject - with data|4
2287263|NCT02447991|3977248|FG001|Overall Study|Withdrawn by Subject - with data|4
2287264|NCT02447991|3977247|FG000|Overall Study|Lost to Follow-up - no data|3
2287265|NCT02447991|3977248|FG001|Overall Study|Lost to Follow-up - no data|6
2287266|NCT02447991|3977247|FG000|Overall Study|Lost to follow-up - with data|0
2287267|NCT02447991|3977248|FG001|Overall Study|Lost to follow-up - with data|3
2287268|NCT02447991|3977247|FG000|Overall Study|End of study - no treatment results|3
2287269|NCT02447991|3977248|FG001|Overall Study|End of study - no treatment results|6
2287270|NCT02447991|3977247|FG000|Overall Study|End of study - partial treatment results|0
2287271|NCT02447991|3977248|FG001|Overall Study|End of study - partial treatment results|9
2287272|NCT02448043|3977260|FG000|Overall Study|Withdrawal by Subject|2
2287273|NCT02448043|3977261|FG001|Overall Study|Withdrawal by Subject|2
2287274|NCT02448043|3977260|FG000|Overall Study|Protocol Violation|1
2287275|NCT02448043|3977261|FG001|Overall Study|Protocol Violation|2
2287276|NCT02448446|3977320|FG000|Overall Study|Withdrawal by Subject|1
2287277|NCT02448446|3977321|FG001|Overall Study|Withdrawal by Subject|0
2287278|NCT02448537|3977330|FG000|Overall Study|Withdrawal by Subject|1
2287279|NCT02448537|3977331|FG001|Overall Study|Withdrawal by Subject|1
2287280|NCT02448537|3977332|FG002|Overall Study|Withdrawal by Subject|1
2287281|NCT02448563|3977344|FG000|Overall Study|Lost to Follow-up|16
2287282|NCT02448563|3977345|FG001|Overall Study|Lost to Follow-up|10
2287283|NCT02448563|3977344|FG000|Overall Study|Withdrawal by Subject|0
2136085|NCT01077284|3742172|FG001|Overall Study|Lost to Follow-up|2
2136086|NCT01077284|3742173|FG002|Overall Study|Lost to Follow-up|0
2136087|NCT01077284|3742171|FG000|Overall Study|Withdrawal by Subject|2
2136088|NCT01077284|3742172|FG001|Overall Study|Withdrawal by Subject|3
2136089|NCT01077284|3742173|FG002|Overall Study|Withdrawal by Subject|1
2136090|NCT01077284|3742171|FG000|Overall Study|Other|0
2136091|NCT01077284|3742172|FG001|Overall Study|Other|0
2136092|NCT01077284|3742173|FG002|Overall Study|Other|1
2136093|NCT01077323|3742198|FG000|Overall Study|<9 months enroll before drug dispensed|11226
2136094|NCT01077323|3742199|FG001|Overall Study|<9 months enroll before drug dispensed|263954
2136095|NCT01077323|3742200|FG002|Overall Study|<9 months enroll before drug dispensed|11655523
2136096|NCT01077323|3742198|FG000|Overall Study|Dispensing of drug in baseline period|0
2136097|NCT01077323|3742199|FG001|Overall Study|Dispensing of drug in baseline period|120229
2136098|NCT01077323|3742200|FG002|Overall Study|Dispensing of drug in baseline period|256446
2136099|NCT01077323|3742198|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152
2136100|NCT01077323|3742199|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080
2136101|NCT01077323|3742200|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120
2136102|NCT01077362|3742211|FG000|Overall Study|Lack of Efficacy|13
2136103|NCT01077362|3742212|FG001|Overall Study|Lack of Efficacy|8
2136104|NCT01077362|3742213|FG002|Overall Study|Lack of Efficacy|10
2136105|NCT01077362|3742211|FG000|Overall Study|Lost to Follow-up|1
2136106|NCT01077362|3742212|FG001|Overall Study|Lost to Follow-up|0
2136107|NCT01077362|3742213|FG002|Overall Study|Lost to Follow-up|3
2136108|NCT01077362|3742211|FG000|Overall Study|Adverse Event|12
2136109|NCT01077362|3742212|FG001|Overall Study|Adverse Event|7
2136110|NCT01077362|3742213|FG002|Overall Study|Adverse Event|4
2136111|NCT01077362|3742211|FG000|Overall Study|Withdrawal by Subject|5
2136112|NCT01077362|3742212|FG001|Overall Study|Withdrawal by Subject|3
2136113|NCT01077362|3742213|FG002|Overall Study|Withdrawal by Subject|5
2136114|NCT01077362|3742211|FG000|Overall Study|Other|0
2136115|NCT01077362|3742212|FG001|Overall Study|Other|1
2136116|NCT01077362|3742213|FG002|Overall Study|Other|2
2287284|NCT02448563|3977345|FG001|Overall Study|Withdrawal by Subject|1
2287285|NCT02448706|3977384|FG000|Overall Study|Withdrawal by Subject|4
2287286|NCT02448706|3977385|FG001|Overall Study|Withdrawal by Subject|3
2287287|NCT02448706|3977384|FG000|Overall Study|Protocol Violation|1
2287288|NCT02448706|3977385|FG001|Overall Study|Protocol Violation|1
2287289|NCT02448719|3977404|FG000|Overall Study|Withdrawal by Subject|0
2287290|NCT02448719|3977405|FG001|Overall Study|Withdrawal by Subject|0
2287291|NCT02448719|3977406|FG002|Overall Study|Withdrawal by Subject|0
2287292|NCT02448719|3977407|FG003|Overall Study|Withdrawal by Subject|0
2287293|NCT02448719|3977408|FG004|Overall Study|Withdrawal by Subject|1
2287294|NCT02448719|3977409|FG005|Overall Study|Withdrawal by Subject|0
2287295|NCT02448719|3977410|FG006|Overall Study|Withdrawal by Subject|0
2287296|NCT02448719|3977411|FG007|Overall Study|Withdrawal by Subject|0
2287297|NCT02448719|3977412|FG008|Overall Study|Withdrawal by Subject|0
2287298|NCT02448719|3977413|FG009|Overall Study|Withdrawal by Subject|0
2287299|NCT02448719|3977414|FG010|Overall Study|Withdrawal by Subject|0
2287300|NCT02448771|3977475|FG000|Overall Study|Disease Progression|30
2287301|NCT02448771|3977475|FG000|Overall Study|Unacceptable Toxicity|1
2287302|NCT02448771|3977475|FG000|Overall Study|Physician Decision|3
2287303|NCT02448771|3977475|FG000|Overall Study|Started new therapy|2
2287304|NCT02448810|3977488|FG000|Overall Study|Adverse Event|0
2287305|NCT02448810|3977489|FG001|Overall Study|Adverse Event|0
2287306|NCT02448810|3977490|FG002|Overall Study|Adverse Event|1
2287307|NCT02448810|3977491|FG003|Overall Study|Adverse Event|0
2287308|NCT02448810|3977492|FG004|Overall Study|Adverse Event|0
2287309|NCT02448810|3977493|FG005|Overall Study|Adverse Event|0
2287310|NCT02448810|3977494|FG006|Overall Study|Adverse Event|0
2287311|NCT02448810|3977495|FG007|Overall Study|Adverse Event|0
2287312|NCT02448810|3977488|FG000|Overall Study|Withdrawal by Subject|0
2287313|NCT02448810|3977489|FG001|Overall Study|Withdrawal by Subject|0
2287314|NCT02448810|3977490|FG002|Overall Study|Withdrawal by Subject|1
2287315|NCT02448810|3977491|FG003|Overall Study|Withdrawal by Subject|0
2287316|NCT02448810|3977492|FG004|Overall Study|Withdrawal by Subject|3
2287317|NCT02448810|3977493|FG005|Overall Study|Withdrawal by Subject|5
2287318|NCT02448810|3977494|FG006|Overall Study|Withdrawal by Subject|0
2287319|NCT02448810|3977495|FG007|Overall Study|Withdrawal by Subject|2
2287320|NCT02448810|3977488|FG000|Overall Study|Other (study terminated by sponsor)|0
2287321|NCT02448810|3977489|FG001|Overall Study|Other (study terminated by sponsor)|0
2287322|NCT02448810|3977490|FG002|Overall Study|Other (study terminated by sponsor)|0
2287323|NCT02448810|3977491|FG003|Overall Study|Other (study terminated by sponsor)|0
2287324|NCT02448810|3977492|FG004|Overall Study|Other (study terminated by sponsor)|4
2287325|NCT02448810|3977493|FG005|Overall Study|Other (study terminated by sponsor)|2
2287326|NCT02448810|3977494|FG006|Overall Study|Other (study terminated by sponsor)|2
2136117|NCT01077375|3742228|FG000|Overall Study|Adverse Event|2
2287327|NCT02448810|3977495|FG007|Overall Study|Other (study terminated by sponsor)|1
2287328|NCT02448810|3977488|FG000|Overall Study|Death|1
2287329|NCT02448810|3977489|FG001|Overall Study|Death|0
2287330|NCT02448810|3977490|FG002|Overall Study|Death|1
2287331|NCT02448810|3977491|FG003|Overall Study|Death|0
2287332|NCT02448810|3977492|FG004|Overall Study|Death|1
2287333|NCT02448810|3977493|FG005|Overall Study|Death|0
2136118|NCT01077375|3742229|FG001|Overall Study|Adverse Event|15
2136119|NCT01077375|3742228|FG000|Overall Study|Lack of Efficacy|6
2136120|NCT01077375|3742229|FG001|Overall Study|Lack of Efficacy|8
2207647|NCT01632150|3846788|FG000|Overall Study|Disease progression|27
2207648|NCT01632150|3846788|FG000|Overall Study|Study drug toxicity|1
2287334|NCT02448810|3977494|FG006|Overall Study|Death|0
2287335|NCT02448810|3977495|FG007|Overall Study|Death|0
2287336|NCT02448810|3977488|FG000|Overall Study|Other (Progressive disease)|2
2287337|NCT02448810|3977489|FG001|Overall Study|Other (Progressive disease)|2
2287338|NCT02448810|3977490|FG002|Overall Study|Other (Progressive disease)|0
2287339|NCT02448810|3977491|FG003|Overall Study|Other (Progressive disease)|3
2287340|NCT02448810|3977492|FG004|Overall Study|Other (Progressive disease)|23
2287341|NCT02448810|3977493|FG005|Overall Study|Other (Progressive disease)|9
2287342|NCT02448810|3977494|FG006|Overall Study|Other (Progressive disease)|14
2287343|NCT02448810|3977495|FG007|Overall Study|Other (Progressive disease)|5
2287344|NCT02448810|3977488|FG000|Overall Study|Lost to Follow-up|0
2287345|NCT02448810|3977489|FG001|Overall Study|Lost to Follow-up|1
2287346|NCT02448810|3977490|FG002|Overall Study|Lost to Follow-up|0
2287347|NCT02448810|3977491|FG003|Overall Study|Lost to Follow-up|0
2287348|NCT02448810|3977492|FG004|Overall Study|Lost to Follow-up|0
2287349|NCT02448810|3977493|FG005|Overall Study|Lost to Follow-up|0
2287350|NCT02448810|3977494|FG006|Overall Study|Lost to Follow-up|0
2287351|NCT02448810|3977495|FG007|Overall Study|Lost to Follow-up|0
2287352|NCT02448810|3977488|FG000|Overall Study|Other (unspecified)|0
2287353|NCT02448810|3977489|FG001|Overall Study|Other (unspecified)|0
2287354|NCT02448810|3977490|FG002|Overall Study|Other (unspecified)|0
2287355|NCT02448810|3977491|FG003|Overall Study|Other (unspecified)|0
2287356|NCT02448810|3977492|FG004|Overall Study|Other (unspecified)|0
2287357|NCT02448810|3977493|FG005|Overall Study|Other (unspecified)|0
2287358|NCT02448810|3977494|FG006|Overall Study|Other (unspecified)|2
2287359|NCT02448810|3977495|FG007|Overall Study|Other (unspecified)|0
2287360|NCT02448875|3977529|FG000|Overall Study|Adverse Event|2
2287361|NCT02448875|3977530|FG001|Overall Study|Adverse Event|1
2287362|NCT02448875|3977531|FG002|Overall Study|Adverse Event|0
2287363|NCT02448875|3977529|FG000|Overall Study|Lost to Follow-up|1
2287364|NCT02448875|3977530|FG001|Overall Study|Lost to Follow-up|0
2287365|NCT02448875|3977531|FG002|Overall Study|Lost to Follow-up|0
2287366|NCT02448875|3977529|FG000|Overall Study|Investigator Decision|3
2287367|NCT02448875|3977530|FG001|Overall Study|Investigator Decision|0
2287368|NCT02448875|3977531|FG002|Overall Study|Investigator Decision|1
2287369|NCT02448875|3977529|FG000|Overall Study|Withdrawal by Subject|1
2287370|NCT02448875|3977530|FG001|Overall Study|Withdrawal by Subject|0
2287371|NCT02448875|3977531|FG002|Overall Study|Withdrawal by Subject|0
2287372|NCT02449018|3977552|FG000|Overall Study|Abnormal laboratory value|0
2287373|NCT02449018|3977553|FG001|Overall Study|Abnormal laboratory value|1
2287374|NCT02449018|3977552|FG000|Overall Study|Administrative problems|1
2287375|NCT02449018|3977553|FG001|Overall Study|Administrative problems|0
2287376|NCT02449018|3977552|FG000|Overall Study|Adverse Event|5
2287377|NCT02449018|3977553|FG001|Overall Study|Adverse Event|1
2287378|NCT02449018|3977552|FG000|Overall Study|Protocol deviation|4
2287379|NCT02449018|3977553|FG001|Overall Study|Protocol deviation|0
2287380|NCT02449018|3977552|FG000|Overall Study|Patient decision|2
2287381|NCT02449018|3977553|FG001|Overall Study|Patient decision|0
2287382|NCT02449044|3977559|FG000|Overall Study|Lost to Follow-up|2
2287383|NCT02449044|3977559|FG000|Overall Study|Withdrawal by Subject|13
2287384|NCT02449044|3977559|FG000|Overall Study|Adverse Event|30
2287385|NCT02449044|3977559|FG000|Overall Study|Met Withdrawal Criteria|7
2287386|NCT02449044|3977559|FG000|Overall Study|Physician Decision|9
2287387|NCT02449044|3977559|FG000|Overall Study|Sponsor Discontinued Trial|3
2287388|NCT02449889|3977624|FG000|Overall Study|Adverse Event|1
2287389|NCT02449889|3977625|FG001|Overall Study|Adverse Event|2
2207649|NCT01632150|3846788|FG000|Overall Study|Unrelated adverse event|7
2207650|NCT01632150|3846788|FG000|Overall Study|Withdrawal by Subject|2
2207651|NCT01632150|3846788|FG000|Overall Study|Patient underwent autologous transplant|1
2207652|NCT01632150|3846788|FG000|Overall Study|Moved to compassionate program|2
2207653|NCT01632241|3846815|FG000|Double-blinded (Up to Week 52)|Site Closed|3
2207654|NCT01632241|3846816|FG001|Double-blinded (Up to Week 52)|Site Closed|5
2207655|NCT01632241|3846815|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2
2207656|NCT01632241|3846816|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6
2207657|NCT01632241|3846815|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1
2207658|NCT01632241|3846816|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8
2207659|NCT01632241|3846815|FG000|Double-blinded (Up to Week 52)|Physician Decision|9
2207660|NCT01632241|3846816|FG001|Double-blinded (Up to Week 52)|Physician Decision|12
2207661|NCT01632241|3846815|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9
2207662|NCT01632241|3846816|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15
2287390|NCT02449889|3977626|FG002|Overall Study|Adverse Event|0
2287391|NCT02449889|3977624|FG000|Overall Study|Protocol Violation|0
2287392|NCT02449889|3977625|FG001|Overall Study|Protocol Violation|4
2287393|NCT02449889|3977626|FG002|Overall Study|Protocol Violation|1
2287394|NCT02449902|3977636|FG000|Overall Study|Adverse Event|0
2287395|NCT02449902|3977637|FG001|Overall Study|Adverse Event|1
2287396|NCT02449902|3977636|FG000|Overall Study|Withdrawal by Subject|0
2287397|NCT02449902|3977637|FG001|Overall Study|Withdrawal by Subject|1
2287398|NCT02449915|3977647|FG000|Overall Study|Exclusion criteria - drug use|1
2287399|NCT02449915|3977648|FG001|Overall Study|Exclusion criteria - drug use|0
2287400|NCT02449915|3977647|FG000|Overall Study|Withdrawal by Subject|0
2287401|NCT02449915|3977648|FG001|Overall Study|Withdrawal by Subject|2
2287402|NCT02449915|3977647|FG000|Overall Study|Intraoperative surgical findings|1
2287403|NCT02449915|3977648|FG001|Overall Study|Intraoperative surgical findings|1
2136121|NCT01077375|3742228|FG000|Overall Study|Withdrawal by Subject|0
2136122|NCT01077375|3742229|FG001|Overall Study|Withdrawal by Subject|6
2287404|NCT02449915|3977647|FG000|Overall Study|Abnormal preop lab|0
2287405|NCT02449915|3977648|FG001|Overall Study|Abnormal preop lab|1
2287406|NCT02450487|3977663|FG000|Overall Study|Lost to Follow-up|3
2287407|NCT02450526|3977672|FG000|DB Period (Cycle 1)|Adverse Event|0
2287408|NCT02450526|3977673|FG001|DB Period (Cycle 1)|Adverse Event|0
2287409|NCT02450526|3977674|FG002|DB Period (Cycle 1)|Adverse Event|2
2287410|NCT02450526|3977675|FG003|DB Period (Cycle 1)|Adverse Event|0
2287411|NCT02450526|3977676|FG004|DB Period (Cycle 1)|Adverse Event|0
2287412|NCT02450526|3977672|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28
2287413|NCT02450526|3977673|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3
2287414|NCT02450526|3977674|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8
2287415|NCT02450526|3977675|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1
2287416|NCT02450526|3977676|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0
2287417|NCT02450526|3977672|FG000|DB Period (Cycle 1)|Lost to Follow-up|1
2287418|NCT02450526|3977673|FG001|DB Period (Cycle 1)|Lost to Follow-up|0
2287419|NCT02450526|3977674|FG002|DB Period (Cycle 1)|Lost to Follow-up|0
2287420|NCT02450526|3977675|FG003|DB Period (Cycle 1)|Lost to Follow-up|0
2287421|NCT02450526|3977676|FG004|DB Period (Cycle 1)|Lost to Follow-up|0
2287422|NCT02450526|3977672|FG000|DB Period (Cycle 1)|Protocol Violation|2
2287423|NCT02450526|3977673|FG001|DB Period (Cycle 1)|Protocol Violation|0
2287424|NCT02450526|3977674|FG002|DB Period (Cycle 1)|Protocol Violation|0
2287425|NCT02450526|3977675|FG003|DB Period (Cycle 1)|Protocol Violation|1
2287426|NCT02450526|3977676|FG004|DB Period (Cycle 1)|Protocol Violation|0
2287427|NCT02450526|3977672|FG000|OL Period (Cycles 2-5)|Adverse Event|0
2287428|NCT02450526|3977673|FG001|OL Period (Cycles 2-5)|Adverse Event|0
2287429|NCT02450526|3977674|FG002|OL Period (Cycles 2-5)|Adverse Event|0
2287430|NCT02450526|3977675|FG003|OL Period (Cycles 2-5)|Adverse Event|0
2287431|NCT02450526|3977676|FG004|OL Period (Cycles 2-5)|Adverse Event|2
2287432|NCT02450526|3977672|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2287433|NCT02450526|3977673|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2287434|NCT02450526|3977674|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2287435|NCT02450526|3977675|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2287436|NCT02450526|3977676|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31
2287437|NCT02450526|3977672|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0
2287438|NCT02450526|3977673|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0
2287439|NCT02450526|3977674|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0
2287440|NCT02450526|3977675|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0
2287441|NCT02450526|3977676|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1
2287442|NCT02450526|3977672|FG000|OL Period (Cycles 2-5)|Protocol Violation|0
2287443|NCT02450526|3977673|FG001|OL Period (Cycles 2-5)|Protocol Violation|0
2287444|NCT02450526|3977674|FG002|OL Period (Cycles 2-5)|Protocol Violation|0
2287445|NCT02450526|3977675|FG003|OL Period (Cycles 2-5)|Protocol Violation|0
2287446|NCT02450526|3977676|FG004|OL Period (Cycles 2-5)|Protocol Violation|7
2287447|NCT02450539|3977698|FG000|Overall Study|Withdrawal by Subject|12
2287448|NCT02450539|3977699|FG001|Overall Study|Withdrawal by Subject|6
2287449|NCT02450539|3977698|FG000|Overall Study|Lost to Follow-up|4
2287450|NCT02450539|3977699|FG001|Overall Study|Lost to Follow-up|1
2287451|NCT02450552|3977711|FG000|Overall Study|Withdrawal by Subject|4
2287452|NCT02450552|3977712|FG001|Overall Study|Withdrawal by Subject|0
2287453|NCT02450552|3977713|FG002|Overall Study|Withdrawal by Subject|4
2287454|NCT02450552|3977711|FG000|Overall Study|Physician Decision|1
2287455|NCT02450552|3977712|FG001|Overall Study|Physician Decision|0
2287456|NCT02450552|3977713|FG002|Overall Study|Physician Decision|1
2287457|NCT02450578|3977725|FG000|Overall Study|ECG abnormality so not treated|1
2287458|NCT02450578|3977726|FG001|Overall Study|ECG abnormality so not treated|0
2287459|NCT02450578|3977727|FG002|Overall Study|ECG abnormality so not treated|0
2287460|NCT02450578|3977728|FG003|Overall Study|ECG abnormality so not treated|0
2136123|NCT01077375|3742228|FG000|Overall Study|Lost to Follow-up|2
2136124|NCT01077375|3742229|FG001|Overall Study|Lost to Follow-up|5
2136125|NCT01077375|3742228|FG000|Overall Study|Other Reason|0
2136126|NCT01077375|3742229|FG001|Overall Study|Other Reason|1
2136127|NCT01077518|3742248|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
2287461|NCT02450903|3977766|FG000|Overall Study|Adverse Event|3
2287462|NCT02450903|3977766|FG000|Overall Study|Progressive disease|15
2287463|NCT02450903|3977766|FG000|Overall Study|Switched to commercial drug|1
2287464|NCT02450903|3977766|FG000|Overall Study|Subject/guardian decision|1
2287465|NCT02451007|3977770|FG000|Overall Study|Withdrawal by Subject|4
2287466|NCT02451007|3977770|FG000|Overall Study|Adverse Event|1
2287467|NCT02451007|3977770|FG000|Overall Study|Disease Progression|2
2287468|NCT02451124|3977774|FG000|Overall Study|Withdrawal by Subject|1
2287469|NCT02451137|3977784|FG000|Overall Study|Randomized but not treated|19
2287470|NCT02451137|3977785|FG001|Overall Study|Randomized but not treated|27
2287471|NCT02451137|3977784|FG000|Overall Study|Adverse Event|43
2207663|NCT01632241|3846815|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
2207664|NCT01632241|3846816|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
2136128|NCT01077518|3742249|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
2136129|NCT01077518|3742250|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
2136130|NCT01077518|3742248|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10
2136131|NCT01077518|3742249|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11
2136132|NCT01077518|3742250|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0
2136133|NCT01077518|3742248|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
2207665|NCT01632241|3846815|FG000|Double-blinded (Up to Week 52)|Adverse Event|10
2287472|NCT02451137|3977785|FG001|Overall Study|Adverse Event|42
2287473|NCT02451137|3977784|FG000|Overall Study|Lack of Efficacy|4
2287474|NCT02451137|3977785|FG001|Overall Study|Lack of Efficacy|9
2287475|NCT02451137|3977784|FG000|Overall Study|Participant decision:discontinue insulin|41
2287476|NCT02451137|3977785|FG001|Overall Study|Participant decision:discontinue insulin|43
2287477|NCT02451137|3977784|FG000|Overall Study|Hypoglycemia|2
2287478|NCT02451137|3977785|FG001|Overall Study|Hypoglycemia|1
2287479|NCT02451137|3977784|FG000|Overall Study|Investigator's decision|23
2287480|NCT02451137|3977785|FG001|Overall Study|Investigator's decision|19
2287481|NCT02451137|3977784|FG000|Overall Study|Lost to Follow-up|53
2287482|NCT02451137|3977785|FG001|Overall Study|Lost to Follow-up|61
2287483|NCT02451137|3977784|FG000|Overall Study|Physician Decision|6
2287484|NCT02451137|3977785|FG001|Overall Study|Physician Decision|5
2287485|NCT02451137|3977784|FG000|Overall Study|Sponsor decision|13
2287486|NCT02451137|3977785|FG001|Overall Study|Sponsor decision|25
2287487|NCT02451137|3977784|FG000|Overall Study|Withdrawal by Subject|40
2287488|NCT02451137|3977785|FG001|Overall Study|Withdrawal by Subject|63
2287489|NCT02451137|3977784|FG000|Overall Study|Other than specified above|2
2207666|NCT01632241|3846816|FG001|Double-blinded (Up to Week 52)|Adverse Event|19
2207667|NCT01632241|3846815|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
2207668|NCT01632241|3846816|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
2207669|NCT01632241|3846815|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1
2207670|NCT01632241|3846816|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4
2207671|NCT01632241|3846815|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
2207672|NCT01632241|3846816|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
2207673|NCT01632241|3846815|FG000|Open-label (Week 52 to Week 76)|Site Closed|2
2207674|NCT01632241|3846816|FG001|Open-label (Week 52 to Week 76)|Site Closed|8
2207675|NCT01632241|3846815|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0
2207676|NCT01632241|3846816|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2
2207677|NCT01632241|3846815|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
2207678|NCT01632241|3846816|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
2207679|NCT01632241|3846815|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1
2207680|NCT01632241|3846816|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0
2207681|NCT01632280|3846834|FG000|Overall Study|Withdrawal by Subject|1
2207682|NCT01632280|3846835|FG001|Overall Study|Withdrawal by Subject|0
2207683|NCT01632306|3846843|FG000|Overall Study|Protocol Violation|1
2207684|NCT01632306|3846844|FG001|Overall Study|Protocol Violation|0
2207685|NCT01632306|3846845|FG002|Overall Study|Protocol Violation|0
2207686|NCT01632345|3846856|FG000|Treatment: Part I|Adverse Event|1
2207687|NCT01632345|3846857|FG001|Treatment: Part I|Adverse Event|4
2207688|NCT01632345|3846858|FG002|Treatment: Part I|Adverse Event|2
2207689|NCT01632345|3846859|FG003|Treatment: Part I|Adverse Event|1
2207690|NCT01632345|3846860|FG004|Treatment: Part I|Adverse Event|3
2207691|NCT01632345|3846861|FG005|Treatment: Part I|Adverse Event|0
2207692|NCT01632345|3846862|FG006|Treatment: Part I|Adverse Event|0
2207693|NCT01632345|3846856|FG000|Treatment: Part I|Lack of Efficacy|0
2207694|NCT01632345|3846857|FG001|Treatment: Part I|Lack of Efficacy|1
2207695|NCT01632345|3846858|FG002|Treatment: Part I|Lack of Efficacy|0
2207696|NCT01632345|3846859|FG003|Treatment: Part I|Lack of Efficacy|1
2207697|NCT01632345|3846860|FG004|Treatment: Part I|Lack of Efficacy|1
2207698|NCT01632345|3846861|FG005|Treatment: Part I|Lack of Efficacy|0
2207699|NCT01632345|3846862|FG006|Treatment: Part I|Lack of Efficacy|0
2207700|NCT01632345|3846856|FG000|Treatment: Part I|Lost to Follow-up|3
2207701|NCT01632345|3846857|FG001|Treatment: Part I|Lost to Follow-up|2
2207702|NCT01632345|3846858|FG002|Treatment: Part I|Lost to Follow-up|1
2207703|NCT01632345|3846859|FG003|Treatment: Part I|Lost to Follow-up|3
2207704|NCT01632345|3846860|FG004|Treatment: Part I|Lost to Follow-up|4
2207705|NCT01632345|3846861|FG005|Treatment: Part I|Lost to Follow-up|0
2207706|NCT01632345|3846862|FG006|Treatment: Part I|Lost to Follow-up|0
2207707|NCT01632345|3846856|FG000|Treatment: Part I|Non-Compliance with Study Drug|3
2207708|NCT01632345|3846857|FG001|Treatment: Part I|Non-Compliance with Study Drug|2
2207709|NCT01632345|3846858|FG002|Treatment: Part I|Non-Compliance with Study Drug|2
2207710|NCT01632345|3846859|FG003|Treatment: Part I|Non-Compliance with Study Drug|1
2207711|NCT01632345|3846860|FG004|Treatment: Part I|Non-Compliance with Study Drug|0
2207712|NCT01632345|3846861|FG005|Treatment: Part I|Non-Compliance with Study Drug|0
2207713|NCT01632345|3846862|FG006|Treatment: Part I|Non-Compliance with Study Drug|0
2287490|NCT02451137|3977785|FG001|Overall Study|Other than specified above|3
2287491|NCT02451358|3977815|FG000|Overall Study|Withdrawal by Subject|1
2136134|NCT01077518|3742249|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
2136135|NCT01077518|3742250|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
2136136|NCT01077518|3742248|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
2136137|NCT01077518|3742249|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
2136138|NCT01077518|3742250|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
2136139|NCT01077518|3742248|FG000|Optional Ofa Phase|Physician Decision|0
2136140|NCT01077518|3742249|FG001|Optional Ofa Phase|Physician Decision|0
2207714|NCT01632345|3846856|FG000|Treatment: Part I|Physician Decision|2
2207715|NCT01632345|3846857|FG001|Treatment: Part I|Physician Decision|1
2207716|NCT01632345|3846858|FG002|Treatment: Part I|Physician Decision|0
2287492|NCT02451358|3977816|FG001|Overall Study|Withdrawal by Subject|1
2287493|NCT02451358|3977817|FG002|Overall Study|Withdrawal by Subject|0
2287494|NCT02451358|3977818|FG003|Overall Study|Withdrawal by Subject|0
2287495|NCT02451358|3977815|FG000|Overall Study|Protocol Violation|0
2287496|NCT02451358|3977816|FG001|Overall Study|Protocol Violation|1
2287497|NCT02451358|3977817|FG002|Overall Study|Protocol Violation|1
2287498|NCT02451358|3977818|FG003|Overall Study|Protocol Violation|0
2287499|NCT02451670|3977860|FG000|Overall Study|Did not have qualifying follow-up visit.|714
2287500|NCT02451670|3977861|FG001|Overall Study|Did not have qualifying follow-up visit.|696
2287501|NCT02451696|3977869|FG000|Overall Study|Surgery postponed|1
2287502|NCT02451696|3977870|FG001|Overall Study|Surgery postponed|0
2287503|NCT02451917|3977890|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2
2287504|NCT02451917|3977891|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0
2287505|NCT02451917|3977890|FG000|First Intervention (24 Weeks)|Death|0
2287506|NCT02451917|3977891|FG001|First Intervention (24 Weeks)|Death|1
2287507|NCT02451917|3977890|FG000|First Intervention (24 Weeks)|Adverse Event|0
2287508|NCT02451917|3977891|FG001|First Intervention (24 Weeks)|Adverse Event|2
2287509|NCT02451930|3977903|FG000|Overall Study|Death|0
2287510|NCT02451930|3977904|FG001|Overall Study|Death|15
2207717|NCT01632345|3846859|FG003|Treatment: Part I|Physician Decision|0
2207718|NCT01632345|3846860|FG004|Treatment: Part I|Physician Decision|1
2207719|NCT01632345|3846861|FG005|Treatment: Part I|Physician Decision|0
2207720|NCT01632345|3846862|FG006|Treatment: Part I|Physician Decision|0
2207721|NCT01632345|3846856|FG000|Treatment: Part I|Pregnancy|0
2207722|NCT01632345|3846857|FG001|Treatment: Part I|Pregnancy|1
2207723|NCT01632345|3846858|FG002|Treatment: Part I|Pregnancy|0
2207724|NCT01632345|3846859|FG003|Treatment: Part I|Pregnancy|0
2207725|NCT01632345|3846860|FG004|Treatment: Part I|Pregnancy|0
2207726|NCT01632345|3846861|FG005|Treatment: Part I|Pregnancy|0
2207727|NCT01632345|3846862|FG006|Treatment: Part I|Pregnancy|0
2207728|NCT01632345|3846856|FG000|Treatment: Part I|Protocol Deviation|0
2207729|NCT01632345|3846857|FG001|Treatment: Part I|Protocol Deviation|0
2207730|NCT01632345|3846858|FG002|Treatment: Part I|Protocol Deviation|1
2207731|NCT01632345|3846859|FG003|Treatment: Part I|Protocol Deviation|1
2207732|NCT01632345|3846860|FG004|Treatment: Part I|Protocol Deviation|0
2207733|NCT01632345|3846861|FG005|Treatment: Part I|Protocol Deviation|0
2207734|NCT01632345|3846862|FG006|Treatment: Part I|Protocol Deviation|0
2207735|NCT01632345|3846856|FG000|Treatment: Part I|Withdrawal by Subject|3
2207736|NCT01632345|3846857|FG001|Treatment: Part I|Withdrawal by Subject|4
2207737|NCT01632345|3846858|FG002|Treatment: Part I|Withdrawal by Subject|4
2207738|NCT01632345|3846859|FG003|Treatment: Part I|Withdrawal by Subject|1
2207739|NCT01632345|3846860|FG004|Treatment: Part I|Withdrawal by Subject|4
2207740|NCT01632345|3846861|FG005|Treatment: Part I|Withdrawal by Subject|0
2207741|NCT01632345|3846862|FG006|Treatment: Part I|Withdrawal by Subject|0
2207742|NCT01632345|3846856|FG000|Treatment: Part II|Adverse Event|0
2207743|NCT01632345|3846857|FG001|Treatment: Part II|Adverse Event|0
2207744|NCT01632345|3846858|FG002|Treatment: Part II|Adverse Event|0
2207745|NCT01632345|3846859|FG003|Treatment: Part II|Adverse Event|0
2207746|NCT01632345|3846860|FG004|Treatment: Part II|Adverse Event|0
2207747|NCT01632345|3846861|FG005|Treatment: Part II|Adverse Event|3
2207748|NCT01632345|3846862|FG006|Treatment: Part II|Adverse Event|8
2207749|NCT01632345|3846856|FG000|Treatment: Part II|Lost to Follow-up|0
2207750|NCT01632345|3846857|FG001|Treatment: Part II|Lost to Follow-up|0
2207751|NCT01632345|3846858|FG002|Treatment: Part II|Lost to Follow-up|0
2207752|NCT01632345|3846859|FG003|Treatment: Part II|Lost to Follow-up|0
2207753|NCT01632345|3846860|FG004|Treatment: Part II|Lost to Follow-up|0
2207754|NCT01632345|3846861|FG005|Treatment: Part II|Lost to Follow-up|3
2207755|NCT01632345|3846862|FG006|Treatment: Part II|Lost to Follow-up|1
2207756|NCT01632345|3846856|FG000|Treatment: Part II|Non-Compliance with Study Drug|0
2207757|NCT01632345|3846857|FG001|Treatment: Part II|Non-Compliance with Study Drug|0
2207758|NCT01632345|3846858|FG002|Treatment: Part II|Non-Compliance with Study Drug|0
2287511|NCT02451930|3977903|FG000|Overall Study|Lost to Follow-up|0
2287512|NCT02451930|3977904|FG001|Overall Study|Lost to Follow-up|3
2287513|NCT02451930|3977903|FG000|Overall Study|Sponsor Decision|2
2287514|NCT02451930|3977904|FG001|Overall Study|Sponsor Decision|10
2287515|NCT02451930|3977903|FG000|Overall Study|Withdrawal by Subject|0
2287516|NCT02451930|3977904|FG001|Overall Study|Withdrawal by Subject|1
2287517|NCT02451930|3977903|FG000|Overall Study|Other|0
2287518|NCT02451930|3977904|FG001|Overall Study|Other|1
2287519|NCT02451943|3977922|FG000|Overall Study|On Treatment|4
2287520|NCT02451943|3977923|FG001|Overall Study|On Treatment|4
2287521|NCT02451943|3977922|FG000|Overall Study|Withdrawal by Subject|13
2136141|NCT01077518|3742250|FG002|Optional Ofa Phase|Physician Decision|1
2136142|NCT01077518|3742248|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0
2136143|NCT01077518|3742249|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0
2136144|NCT01077518|3742250|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12
2136145|NCT01077518|3742248|FG000|Optional Ofa Phase|Withdrawal by Subject|0
2136146|NCT01077518|3742249|FG001|Optional Ofa Phase|Withdrawal by Subject|0
2136147|NCT01077518|3742250|FG002|Optional Ofa Phase|Withdrawal by Subject|3
2136148|NCT01077544|3742261|FG000|Overall Study|New Cancer Therapy|3
2136149|NCT01077544|3742262|FG001|Overall Study|New Cancer Therapy|3
2136150|NCT01077544|3742261|FG000|Overall Study|Adverse Event|0
2136151|NCT01077544|3742262|FG001|Overall Study|Adverse Event|1
2136152|NCT01077544|3742261|FG000|Overall Study|Disease Progression|0
2136153|NCT01077544|3742262|FG001|Overall Study|Disease Progression|1
2136154|NCT01077622|3742312|FG000|Overall Study|Physician Decision|2
2136155|NCT01077622|3742312|FG000|Overall Study|Withdrawal by Subject|1
2136156|NCT01077713|3742318|FG000|Overall Study|Withdrawal by Subject|1
2136157|NCT01077713|3742319|FG001|Overall Study|Withdrawal by Subject|2
2136158|NCT01077713|3742318|FG000|Overall Study|Progressive Disease (PD)|0
2136159|NCT01077713|3742319|FG001|Overall Study|Progressive Disease (PD)|1
2136160|NCT01077713|3742318|FG000|Overall Study|Death|28
2136161|NCT01077713|3742319|FG001|Overall Study|Death|29
2136162|NCT01077713|3742318|FG000|Overall Study|Lost to Follow-up|1
2136163|NCT01077713|3742319|FG001|Overall Study|Lost to Follow-up|1
2136164|NCT01077713|3742318|FG000|Overall Study|Adverse Event|2
2136165|NCT01077713|3742319|FG001|Overall Study|Adverse Event|1
2136166|NCT01077713|3742318|FG000|Overall Study|Other|4
2136167|NCT01077713|3742319|FG001|Overall Study|Other|2
2136168|NCT01077739|3742327|FG000|Overall Study|Premature withdrawal|1
2136169|NCT01077739|3742328|FG001|Overall Study|Premature withdrawal|3
2136170|NCT01077739|3742327|FG000|Overall Study|Withdrawal by Subject|1
2136171|NCT01077739|3742328|FG001|Overall Study|Withdrawal by Subject|0
2136172|NCT01077739|3742327|FG000|Overall Study|Death|0
2136173|NCT01077739|3742328|FG001|Overall Study|Death|3
2136174|NCT01077739|3742327|FG000|Overall Study|Unacceptable toxicity|1
2136175|NCT01077739|3742328|FG001|Overall Study|Unacceptable toxicity|2
2136176|NCT01077739|3742327|FG000|Overall Study|Other|2
2136177|NCT01077739|3742328|FG001|Overall Study|Other|2
2136178|NCT01077804|3742334|FG000|Overall Study|Unreachable|102
2136179|NCT01077804|3742334|FG000|Overall Study|Refused to continue|79
2136180|NCT01077804|3742334|FG000|Overall Study|Other|18
2136181|NCT01077960|3742393|FG000|Overall Study|Adverse Event|6
2136182|NCT01077960|3742393|FG000|Overall Study|Protocol Violation|3
2136183|NCT01077960|3742393|FG000|Overall Study|Lost to Follow-up|5
2287522|NCT02451943|3977923|FG001|Overall Study|Withdrawal by Subject|16
2287523|NCT02451943|3977922|FG000|Overall Study|Lost to Follow-up|3
2287524|NCT02451943|3977923|FG001|Overall Study|Lost to Follow-up|4
2287525|NCT02452034|3977944|FG000|Overall Study|Adverse Event|0
2287526|NCT02452034|3977945|FG001|Overall Study|Adverse Event|0
2287527|NCT02452034|3977946|FG002|Overall Study|Adverse Event|0
2287528|NCT02452034|3977947|FG003|Overall Study|Adverse Event|0
2287529|NCT02452034|3977948|FG004|Overall Study|Adverse Event|0
2287530|NCT02452034|3977949|FG005|Overall Study|Adverse Event|1
2287531|NCT02452034|3977944|FG000|Overall Study|Death|0
2287532|NCT02452034|3977945|FG001|Overall Study|Death|0
2287533|NCT02452034|3977946|FG002|Overall Study|Death|0
2287534|NCT02452034|3977947|FG003|Overall Study|Death|0
2287535|NCT02452034|3977948|FG004|Overall Study|Death|1
2287536|NCT02452034|3977949|FG005|Overall Study|Death|1
2287537|NCT02452034|3977944|FG000|Overall Study|Physician Decision|0
2287538|NCT02452034|3977945|FG001|Overall Study|Physician Decision|1
2287539|NCT02452034|3977946|FG002|Overall Study|Physician Decision|1
2287540|NCT02452034|3977947|FG003|Overall Study|Physician Decision|0
2287541|NCT02452034|3977948|FG004|Overall Study|Physician Decision|0
2287542|NCT02452034|3977949|FG005|Overall Study|Physician Decision|0
2287543|NCT02452034|3977944|FG000|Overall Study|Protocol Violation|0
2287544|NCT02452034|3977945|FG001|Overall Study|Protocol Violation|0
2287545|NCT02452034|3977946|FG002|Overall Study|Protocol Violation|0
2287546|NCT02452034|3977947|FG003|Overall Study|Protocol Violation|0
2287547|NCT02452034|3977948|FG004|Overall Study|Protocol Violation|0
2287548|NCT02452034|3977949|FG005|Overall Study|Protocol Violation|1
2287549|NCT02452034|3977944|FG000|Overall Study|Screen Failure|1
2287550|NCT02452034|3977945|FG001|Overall Study|Screen Failure|0
2287551|NCT02452034|3977946|FG002|Overall Study|Screen Failure|0
2287552|NCT02452034|3977947|FG003|Overall Study|Screen Failure|1
2287553|NCT02452034|3977948|FG004|Overall Study|Screen Failure|0
2287554|NCT02452034|3977949|FG005|Overall Study|Screen Failure|0
2287555|NCT02452034|3977944|FG000|Overall Study|Withdrawn by Parent/Guardian|1
2287556|NCT02452034|3977945|FG001|Overall Study|Withdrawn by Parent/Guardian|0
2287557|NCT02452034|3977946|FG002|Overall Study|Withdrawn by Parent/Guardian|0
2287558|NCT02452034|3977947|FG003|Overall Study|Withdrawn by Parent/Guardian|0
2287559|NCT02452034|3977948|FG004|Overall Study|Withdrawn by Parent/Guardian|0
2136184|NCT01077960|3742393|FG000|Overall Study|Subject decision|1
2136185|NCT01077960|3742393|FG000|Overall Study|Reason unspecified|1
2136186|NCT01078090|3742412|FG000|Overall Study|Lost to Follow-up|2363
2136187|NCT01078090|3742412|FG000|Overall Study|Adverse drug reaction (ADR)|453
2136188|NCT01078090|3742412|FG000|Overall Study|Lack of Efficacy|1193
2287560|NCT02452034|3977949|FG005|Overall Study|Withdrawn by Parent/Guardian|0
2136189|NCT01078090|3742412|FG000|Overall Study|ADR and lack of efficacy|61
2136190|NCT01078090|3742412|FG000|Overall Study|Other|523
2136191|NCT01078116|3742430|FG000|Overall Study|Lost to Follow-up|17
2136192|NCT01078116|3742430|FG000|Overall Study|Adverse Event|5
2136193|NCT01078116|3742430|FG000|Overall Study|Withdrawal by Subject|8
2136194|NCT01078116|3742430|FG000|Overall Study|Lack of effectiveness|15
2136195|NCT01078116|3742430|FG000|Overall Study|Case report form not completed|3
2136196|NCT01078155|3742434|FG000|Overall Study|Adverse Event|7
2136197|NCT01078155|3742434|FG000|Overall Study|Lack of Efficacy|16
2136198|NCT01078155|3742434|FG000|Overall Study|Participant's Decision|6
2136199|NCT01078155|3742434|FG000|Overall Study|Lost to Follow-up|15
2136200|NCT01078168|3742440|FG000|Overall Study|Physician Decision|0
2136201|NCT01078168|3742441|FG001|Overall Study|Physician Decision|1
2136202|NCT01078298|3742500|FG000|Overall Study|Lost to Follow-up|12
2136203|NCT01078298|3742501|FG001|Overall Study|Lost to Follow-up|13
2136204|NCT01078298|3742500|FG000|Overall Study|Withdrawal by Subject|31
2136205|NCT01078298|3742501|FG001|Overall Study|Withdrawal by Subject|33
2136206|NCT01078298|3742500|FG000|Overall Study|Protocol Violation|6
2136207|NCT01078298|3742501|FG001|Overall Study|Protocol Violation|6
2136208|NCT01078298|3742500|FG000|Overall Study|Adverse Event|6
2136209|NCT01078298|3742501|FG001|Overall Study|Adverse Event|5
2136210|NCT01078298|3742500|FG000|Overall Study|Death|2
2136211|NCT01078298|3742501|FG001|Overall Study|Death|0
2136212|NCT01078298|3742500|FG000|Overall Study|Did not meet entrance criteria|0
2136213|NCT01078298|3742501|FG001|Overall Study|Did not meet entrance criteria|1
2136214|NCT01078298|3742500|FG000|Overall Study|Other|24
2136215|NCT01078298|3742501|FG001|Overall Study|Other|32
2136216|NCT01078389|3742540|FG000|Overall Study|Adverse Event|10
2136217|NCT01078389|3742541|FG001|Overall Study|Adverse Event|6
2136218|NCT01078389|3742540|FG000|Overall Study|Major Protocol Deviation|2
2136219|NCT01078389|3742541|FG001|Overall Study|Major Protocol Deviation|0
2287561|NCT02452047|3977966|FG000|Overall Study|Adverse Event|0
2287562|NCT02452047|3977967|FG001|Overall Study|Adverse Event|1
2287563|NCT02452047|3977968|FG002|Overall Study|Adverse Event|1
2287564|NCT02452047|3977966|FG000|Overall Study|Death|1
2287565|NCT02452047|3977967|FG001|Overall Study|Death|3
2287566|NCT02452047|3977968|FG002|Overall Study|Death|1
2287567|NCT02452047|3977966|FG000|Overall Study|Physician Decision|1
2287568|NCT02452047|3977967|FG001|Overall Study|Physician Decision|0
2287569|NCT02452047|3977968|FG002|Overall Study|Physician Decision|0
2287570|NCT02452047|3977966|FG000|Overall Study|Lost to Follow-up|1
2287571|NCT02452047|3977967|FG001|Overall Study|Lost to Follow-up|1
2287572|NCT02452047|3977968|FG002|Overall Study|Lost to Follow-up|0
2287573|NCT02452047|3977966|FG000|Overall Study|Withdrawal by Subject|1
2287574|NCT02452047|3977967|FG001|Overall Study|Withdrawal by Subject|0
2287575|NCT02452047|3977968|FG002|Overall Study|Withdrawal by Subject|0
2287576|NCT02452190|3977987|FG000|Overall Study|Withdrawal by Sponsor|1
2287577|NCT02452190|3977988|FG001|Overall Study|Withdrawal by Sponsor|3
2287578|NCT02452190|3977987|FG000|Overall Study|Pregnancy|1
2287579|NCT02452190|3977988|FG001|Overall Study|Pregnancy|0
2287580|NCT02452190|3977987|FG000|Overall Study|Investigator's Decision|2
2287581|NCT02452190|3977988|FG001|Overall Study|Investigator's Decision|0
2287582|NCT02452190|3977987|FG000|Overall Study|Lack of Efficacy|3
2287583|NCT02452190|3977988|FG001|Overall Study|Lack of Efficacy|1
2287584|NCT02452190|3977987|FG000|Overall Study|Lost to Follow-up|4
2287585|NCT02452190|3977988|FG001|Overall Study|Lost to Follow-up|3
2287586|NCT02452190|3977987|FG000|Overall Study|Adverse Event|2
2287587|NCT02452190|3977988|FG001|Overall Study|Adverse Event|5
2287588|NCT02452190|3977987|FG000|Overall Study|Withdrawal by Subject|20
2287589|NCT02452190|3977988|FG001|Overall Study|Withdrawal by Subject|11
2287590|NCT02452190|3977987|FG000|Overall Study|Noncompliance with study drug|1
2287591|NCT02452190|3977988|FG001|Overall Study|Noncompliance with study drug|0
2287592|NCT02452190|3977987|FG000|Overall Study|Participant traveled abroad|1
2287593|NCT02452190|3977988|FG001|Overall Study|Participant traveled abroad|0
2287594|NCT02452190|3977987|FG000|Overall Study|Death|0
2287595|NCT02452190|3977988|FG001|Overall Study|Death|1
2287596|NCT02452320|3977996|FG000|Overall Study|Adverse Event|0
2287597|NCT02452320|3977997|FG001|Overall Study|Adverse Event|1
2287598|NCT02452424|3978018|FG000|Overall Study|Death|2
2287599|NCT02452424|3978019|FG001|Overall Study|Death|2
2287600|NCT02452424|3978020|FG002|Overall Study|Death|2
2287601|NCT02452424|3978021|FG003|Overall Study|Death|6
2287602|NCT02452424|3978022|FG004|Overall Study|Death|2
2287603|NCT02452424|3978023|FG005|Overall Study|Death|0
2287604|NCT02452424|3978024|FG006|Overall Study|Death|5
2287605|NCT02452424|3978025|FG007|Overall Study|Death|1
2287606|NCT02452424|3978026|FG008|Overall Study|Death|3
2287607|NCT02452424|3978027|FG009|Overall Study|Death|1
2136220|NCT01078389|3742540|FG000|Overall Study|Lost to Follow-up|23
2136221|NCT01078389|3742541|FG001|Overall Study|Lost to Follow-up|23
2136222|NCT01078389|3742540|FG000|Overall Study|Voluntary Withdrawal|20
2136223|NCT01078389|3742541|FG001|Overall Study|Voluntary Withdrawal|36
2136224|NCT01078389|3742540|FG000|Overall Study|Other|9
2136225|NCT01078389|3742541|FG001|Overall Study|Other|2
2178372|NCT01383174|3803134|FG000|3 Month Assessment|Death|0
2178373|NCT01383174|3803135|FG001|3 Month Assessment|Death|1
2287608|NCT02452424|3978028|FG010|Overall Study|Death|0
2287609|NCT02452424|3978018|FG000|Overall Study|Lost to Follow-up|0
2136226|NCT01078441|3742564|FG000|Overall Study|Withdrawal by Subject|1
2136227|NCT01078545|3742568|FG000|Overall Study|Lost to Follow-up|13
2136228|NCT01078545|3742568|FG000|Overall Study|Physician Decision|6
2136229|NCT01078545|3742568|FG000|Overall Study|Withdrawal by Subject|3
2136230|NCT01078545|3742568|FG000|Overall Study|Death|3
2287610|NCT02452424|3978019|FG001|Overall Study|Lost to Follow-up|1
2287611|NCT02452424|3978020|FG002|Overall Study|Lost to Follow-up|1
2287612|NCT02452424|3978021|FG003|Overall Study|Lost to Follow-up|0
2287613|NCT02452424|3978022|FG004|Overall Study|Lost to Follow-up|0
2287614|NCT02452424|3978023|FG005|Overall Study|Lost to Follow-up|0
2287615|NCT02452424|3978024|FG006|Overall Study|Lost to Follow-up|0
2287616|NCT02452424|3978025|FG007|Overall Study|Lost to Follow-up|0
2287617|NCT02452424|3978026|FG008|Overall Study|Lost to Follow-up|0
2287618|NCT02452424|3978027|FG009|Overall Study|Lost to Follow-up|0
2287619|NCT02452424|3978028|FG010|Overall Study|Lost to Follow-up|0
2287620|NCT02452424|3978018|FG000|Overall Study|Withdrawal by Subject|0
2287621|NCT02452424|3978019|FG001|Overall Study|Withdrawal by Subject|0
2287622|NCT02452424|3978020|FG002|Overall Study|Withdrawal by Subject|3
2287623|NCT02452424|3978021|FG003|Overall Study|Withdrawal by Subject|2
2287624|NCT02452424|3978022|FG004|Overall Study|Withdrawal by Subject|0
2287625|NCT02452424|3978023|FG005|Overall Study|Withdrawal by Subject|0
2287626|NCT02452424|3978024|FG006|Overall Study|Withdrawal by Subject|1
2287627|NCT02452424|3978025|FG007|Overall Study|Withdrawal by Subject|0
2287628|NCT02452424|3978026|FG008|Overall Study|Withdrawal by Subject|1
2287629|NCT02452424|3978027|FG009|Overall Study|Withdrawal by Subject|1
2287630|NCT02452424|3978028|FG010|Overall Study|Withdrawal by Subject|0
2287631|NCT02452424|3978018|FG000|Overall Study|Other|0
2287632|NCT02452424|3978019|FG001|Overall Study|Other|0
2287633|NCT02452424|3978020|FG002|Overall Study|Other|1
2287634|NCT02452424|3978021|FG003|Overall Study|Other|0
2287635|NCT02452424|3978022|FG004|Overall Study|Other|0
2287636|NCT02452424|3978023|FG005|Overall Study|Other|1
2287637|NCT02452424|3978024|FG006|Overall Study|Other|4
2287638|NCT02452424|3978025|FG007|Overall Study|Other|3
2287639|NCT02452424|3978026|FG008|Overall Study|Other|0
2287640|NCT02452424|3978027|FG009|Overall Study|Other|0
2287641|NCT02452424|3978028|FG010|Overall Study|Other|1
2287642|NCT02452424|3978018|FG000|Overall Study|Progressive disease (per RECIST)|0
2287643|NCT02452424|3978019|FG001|Overall Study|Progressive disease (per RECIST)|0
2287644|NCT02452424|3978020|FG002|Overall Study|Progressive disease (per RECIST)|0
2287645|NCT02452424|3978021|FG003|Overall Study|Progressive disease (per RECIST)|0
2287646|NCT02452424|3978022|FG004|Overall Study|Progressive disease (per RECIST)|0
2287647|NCT02452424|3978023|FG005|Overall Study|Progressive disease (per RECIST)|0
2287648|NCT02452424|3978024|FG006|Overall Study|Progressive disease (per RECIST)|0
2287649|NCT02452424|3978025|FG007|Overall Study|Progressive disease (per RECIST)|0
2287650|NCT02452424|3978026|FG008|Overall Study|Progressive disease (per RECIST)|2
2287651|NCT02452424|3978027|FG009|Overall Study|Progressive disease (per RECIST)|0
2287652|NCT02452424|3978028|FG010|Overall Study|Progressive disease (per RECIST)|0
2287653|NCT02452424|3978018|FG000|Overall Study|Adverse Event|0
2287654|NCT02452424|3978019|FG001|Overall Study|Adverse Event|0
2287655|NCT02452424|3978020|FG002|Overall Study|Adverse Event|0
2287656|NCT02452424|3978021|FG003|Overall Study|Adverse Event|0
2287657|NCT02452424|3978022|FG004|Overall Study|Adverse Event|0
2287658|NCT02452424|3978023|FG005|Overall Study|Adverse Event|0
2287659|NCT02452424|3978024|FG006|Overall Study|Adverse Event|0
2287660|NCT02452424|3978025|FG007|Overall Study|Adverse Event|0
2287661|NCT02452424|3978026|FG008|Overall Study|Adverse Event|0
2287662|NCT02452424|3978027|FG009|Overall Study|Adverse Event|0
2287663|NCT02452424|3978028|FG010|Overall Study|Adverse Event|1
2287664|NCT02452463|3978057|FG000|Overall Study|Death|1
2287665|NCT02452463|3978058|FG001|Overall Study|Death|0
2287666|NCT02452463|3978059|FG002|Overall Study|Death|0
2287667|NCT02452463|3978057|FG000|Overall Study|Study Suspended|1
2287668|NCT02452463|3978058|FG001|Overall Study|Study Suspended|0
2287669|NCT02452463|3978059|FG002|Overall Study|Study Suspended|0
2287670|NCT02452463|3978057|FG000|Overall Study|Recommended by DSMB|0
2287671|NCT02452463|3978058|FG001|Overall Study|Recommended by DSMB|1
2287672|NCT02452463|3978059|FG002|Overall Study|Recommended by DSMB|0
2287673|NCT02452463|3978057|FG000|Overall Study|Withdrawal by Subject|0
2287674|NCT02452463|3978058|FG001|Overall Study|Withdrawal by Subject|1
2287675|NCT02452463|3978059|FG002|Overall Study|Withdrawal by Subject|0
2287676|NCT02452476|3978069|FG000|Overall Study|Death|4
2287677|NCT02452476|3978070|FG001|Overall Study|Death|7
2287678|NCT02452476|3978069|FG000|Overall Study|Lost to Follow-up|1
2287679|NCT02452476|3978070|FG001|Overall Study|Lost to Follow-up|1
2287680|NCT02452476|3978069|FG000|Overall Study|Physician Decision|1
2287681|NCT02452476|3978070|FG001|Overall Study|Physician Decision|1
2287682|NCT02452476|3978069|FG000|Overall Study|Not treated|5
2287683|NCT02452476|3978070|FG001|Overall Study|Not treated|1
2287684|NCT02452762|3978087|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4
2287685|NCT02452762|3978088|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3
2287686|NCT02452762|3978087|FG000|Overall Study|Withdrawal by Subject|1
2287687|NCT02452762|3978088|FG001|Overall Study|Withdrawal by Subject|0
2287688|NCT02452892|3978103|FG000|Week 1 Initial Randommization|Adverse Event|1
2287689|NCT02452892|3978104|FG001|Week 1 Initial Randommization|Adverse Event|0
2136231|NCT01078545|3742568|FG000|Overall Study|Participant moved to another physician|1
2136232|NCT01078571|3742585|FG000|Overall Study|Adverse Event|36
2136233|NCT01078571|3742585|FG000|Overall Study|Lack of effectiveness|36
2287690|NCT02452892|3978105|FG002|Week 1 Initial Randommization|Adverse Event|0
2287691|NCT02452892|3978106|FG003|Week 1 Initial Randommization|Adverse Event|0
2287692|NCT02452892|3978103|FG000|Week 1 Initial Randommization|Lost to Follow-up|0
2287693|NCT02452892|3978104|FG001|Week 1 Initial Randommization|Lost to Follow-up|0
2287694|NCT02452892|3978105|FG002|Week 1 Initial Randommization|Lost to Follow-up|1
2287695|NCT02452892|3978106|FG003|Week 1 Initial Randommization|Lost to Follow-up|0
2287696|NCT02452892|3978103|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
2287697|NCT02452892|3978104|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
2287698|NCT02452892|3978105|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
2287699|NCT02452892|3978106|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
2287700|NCT02452892|3978103|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
2287701|NCT02452892|3978104|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
2287702|NCT02452892|3978105|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
2287703|NCT02452892|3978106|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
2287704|NCT02452892|3978103|FG000|Follow-up|Withdrawal by Subject|0
2287705|NCT02452892|3978104|FG001|Follow-up|Withdrawal by Subject|0
2287706|NCT02452892|3978105|FG002|Follow-up|Withdrawal by Subject|0
2287707|NCT02452892|3978106|FG003|Follow-up|Withdrawal by Subject|1
2287708|NCT02452892|3978103|FG000|Follow-up|Subject left town on Day 42|1
2287709|NCT02452892|3978104|FG001|Follow-up|Subject left town on Day 42|0
2287710|NCT02452892|3978105|FG002|Follow-up|Subject left town on Day 42|0
2287711|NCT02452892|3978106|FG003|Follow-up|Subject left town on Day 42|0
2287712|NCT02453048|3978139|FG000|Overall Study|Only part of initial 6 mo. study|0
2287713|NCT02453048|3978140|FG001|Overall Study|Only part of initial 6 mo. study|0
2287714|NCT02453048|3978141|FG002|Overall Study|Only part of initial 6 mo. study|0
2287715|NCT02453048|3978142|FG003|Overall Study|Only part of initial 6 mo. study|0
2287716|NCT02453048|3978143|FG004|Overall Study|Only part of initial 6 mo. study|6
2287717|NCT02453048|3978139|FG000|Overall Study|Lost to Follow-up|0
2287718|NCT02453048|3978140|FG001|Overall Study|Lost to Follow-up|1
2287719|NCT02453048|3978141|FG002|Overall Study|Lost to Follow-up|2
2287720|NCT02453048|3978142|FG003|Overall Study|Lost to Follow-up|0
2287721|NCT02453048|3978143|FG004|Overall Study|Lost to Follow-up|0
2287722|NCT02453191|3978159|FG000|Overall Study|Withdrawal by Subject|1
2287723|NCT02453256|3978165|FG000|Double Blind Period|Death|1
2287724|NCT02453256|3978166|FG001|Double Blind Period|Death|1
2287725|NCT02453256|3978165|FG000|Double Blind Period|Adverse Event|3
2287726|NCT02453256|3978166|FG001|Double Blind Period|Adverse Event|2
2287727|NCT02453256|3978165|FG000|Double Blind Period|Withdrawal by Subject|9
2287728|NCT02453256|3978166|FG001|Double Blind Period|Withdrawal by Subject|5
2287729|NCT02453256|3978165|FG000|Double Blind Period|Other|0
2287730|NCT02453256|3978166|FG001|Double Blind Period|Other|1
2287731|NCT02453256|3978165|FG000|Open Label Period|Adverse Event|1
2287732|NCT02453256|3978166|FG001|Open Label Period|Adverse Event|3
2287733|NCT02453256|3978165|FG000|Open Label Period|Death|0
2287734|NCT02453256|3978166|FG001|Open Label Period|Death|1
2287735|NCT02453256|3978165|FG000|Open Label Period|Lost to Follow-up|1
2287736|NCT02453256|3978166|FG001|Open Label Period|Lost to Follow-up|0
2287737|NCT02453256|3978165|FG000|Open Label Period|Other|0
2287738|NCT02453256|3978166|FG001|Open Label Period|Other|2
2287739|NCT02453256|3978165|FG000|Open Label Period|Withdrawal by Subject|5
2287740|NCT02453256|3978166|FG001|Open Label Period|Withdrawal by Subject|1
2287741|NCT02453282|3978182|FG000|Overall Study|Death|275
2287742|NCT02453282|3978183|FG001|Overall Study|Death|277
2287743|NCT02453282|3978184|FG002|Overall Study|Death|296
2287744|NCT02453282|3978182|FG000|Overall Study|Lost to Follow-up|1
2287745|NCT02453282|3978183|FG001|Overall Study|Lost to Follow-up|0
2287746|NCT02453282|3978184|FG002|Overall Study|Lost to Follow-up|2
2287747|NCT02453282|3978182|FG000|Overall Study|Withdrawal by Subject|12
2287748|NCT02453282|3978183|FG001|Overall Study|Withdrawal by Subject|10
2287749|NCT02453282|3978184|FG002|Overall Study|Withdrawal by Subject|11
2287750|NCT02453282|3978182|FG000|Overall Study|Participants ongoing at data cut-off|85
2287751|NCT02453282|3978183|FG001|Overall Study|Participants ongoing at data cut-off|84
2287752|NCT02453282|3978184|FG002|Overall Study|Participants ongoing at data cut-off|62
2287753|NCT02453282|3978182|FG000|Overall Study|Other|1
2287754|NCT02453282|3978183|FG001|Overall Study|Other|1
2287755|NCT02453282|3978184|FG002|Overall Study|Other|1
2287756|NCT02453321|3978197|FG000|Overall Study|Weakness|1
2287757|NCT02453321|3978198|FG001|Overall Study|Weakness|1
2287758|NCT02453321|3978199|FG002|Overall Study|Weakness|2
2287759|NCT02453321|3978197|FG000|Overall Study|Deep Venous Thrombosis|0
2287760|NCT02453321|3978198|FG001|Overall Study|Deep Venous Thrombosis|1
2287761|NCT02453321|3978199|FG002|Overall Study|Deep Venous Thrombosis|0
2287762|NCT02453334|3978212|FG000|Overall Study|Death|15
2287763|NCT02453334|3978213|FG001|Overall Study|Death|13
2287764|NCT02453334|3978212|FG000|Overall Study|Adverse Event|2
2287765|NCT02453334|3978213|FG001|Overall Study|Adverse Event|1
2287766|NCT02453334|3978212|FG000|Overall Study|Lost to Follow-up|5
2287767|NCT02453334|3978213|FG001|Overall Study|Lost to Follow-up|9
2287768|NCT02453334|3978212|FG000|Overall Study|Physician Decision|1
2287769|NCT02453334|3978213|FG001|Overall Study|Physician Decision|0
2136234|NCT01078571|3742585|FG000|Overall Study|Reason not reported|21
2136235|NCT01078571|3742585|FG000|Overall Study|Withdrawal by Subject|12
2136236|NCT01078571|3742585|FG000|Overall Study|Lost to Follow-up|8
2136237|NCT01078571|3742585|FG000|Overall Study|Protocol Violation|2
2136238|NCT01078584|3742594|FG000|Overall Study|Final Status Unknown|1073
2136239|NCT01078584|3742594|FG000|Overall Study|Lost to Follow-up|670
2136240|NCT01078584|3742594|FG000|Overall Study|Non-serious Adverse Event|577
2136241|NCT01078584|3742594|FG000|Overall Study|Withdrawal of Consent|244
2136242|NCT01078584|3742594|FG000|Overall Study|Physician Withdrew from Study|90
2136243|NCT01078584|3742594|FG000|Overall Study|Non-compliance|67
2136244|NCT01078584|3742594|FG000|Overall Study|Blood Pressure Controlled|49
2136245|NCT01078584|3742594|FG000|Overall Study|Physician Switched Medication|26
2207759|NCT01632345|3846859|FG003|Treatment: Part II|Non-Compliance with Study Drug|0
2207760|NCT01632345|3846860|FG004|Treatment: Part II|Non-Compliance with Study Drug|0
2207761|NCT01632345|3846861|FG005|Treatment: Part II|Non-Compliance with Study Drug|3
2207762|NCT01632345|3846862|FG006|Treatment: Part II|Non-Compliance with Study Drug|0
2207763|NCT01632345|3846856|FG000|Treatment: Part II|Withdrawal by Subject|0
2207764|NCT01632345|3846857|FG001|Treatment: Part II|Withdrawal by Subject|0
2207765|NCT01632345|3846858|FG002|Treatment: Part II|Withdrawal by Subject|0
2207766|NCT01632345|3846859|FG003|Treatment: Part II|Withdrawal by Subject|0
2207767|NCT01632345|3846860|FG004|Treatment: Part II|Withdrawal by Subject|0
2207768|NCT01632345|3846861|FG005|Treatment: Part II|Withdrawal by Subject|2
2207769|NCT01632345|3846862|FG006|Treatment: Part II|Withdrawal by Subject|2
2207770|NCT01632566|3846886|FG000|Overall Study|Withdrawal by Subject|0
2207771|NCT01632566|3846887|FG001|Overall Study|Withdrawal by Subject|1
2207772|NCT01632566|3846888|FG002|Overall Study|Withdrawal by Subject|0
2207773|NCT01632566|3846889|FG003|Overall Study|Withdrawal by Subject|0
2207774|NCT01632566|3846890|FG004|Overall Study|Withdrawal by Subject|0
2207775|NCT01632566|3846886|FG000|Overall Study|Sponsor Decision|0
2207776|NCT01632566|3846887|FG001|Overall Study|Sponsor Decision|2
2207777|NCT01632566|3846888|FG002|Overall Study|Sponsor Decision|9
2207778|NCT01632566|3846889|FG003|Overall Study|Sponsor Decision|2
2207779|NCT01632566|3846890|FG004|Overall Study|Sponsor Decision|2
2207780|NCT01632579|3846906|FG000|Washout Period|Adverse Event|1
2136246|NCT01078584|3742594|FG000|Overall Study|Physician Discontinued Patient|12
2136247|NCT01078584|3742594|FG000|Overall Study|Lack of Efficacy|98
2136248|NCT01078584|3742594|FG000|Overall Study|Protocol Violation|75
2136249|NCT01078584|3742594|FG000|Overall Study|Serious Adverse Event|27
2136250|NCT01078584|3742594|FG000|Overall Study|Multiple Reasons|2
2136251|NCT01078623|3742611|FG000|Treatment Period 1|Adverse Event|1
2136252|NCT01078623|3742612|FG001|Treatment Period 1|Adverse Event|1
2207781|NCT01632579|3846907|FG001|Washout Period|Adverse Event|0
2207782|NCT01632579|3846908|FG002|Washout Period|Adverse Event|0
2136253|NCT01078623|3742613|FG002|Treatment Period 1|Adverse Event|1
2136254|NCT01078623|3742614|FG003|Treatment Period 1|Adverse Event|0
2136255|NCT01078623|3742615|FG004|Treatment Period 1|Adverse Event|0
2136256|NCT01078623|3742616|FG005|Treatment Period 1|Adverse Event|0
2136257|NCT01078623|3742617|FG006|Treatment Period 1|Adverse Event|1
2136258|NCT01078623|3742618|FG007|Treatment Period 1|Adverse Event|0
2136259|NCT01078623|3742619|FG008|Treatment Period 1|Adverse Event|1
2136260|NCT01078623|3742620|FG009|Treatment Period 1|Adverse Event|1
2136261|NCT01078623|3742621|FG010|Treatment Period 1|Adverse Event|0
2136262|NCT01078623|3742622|FG011|Treatment Period 1|Adverse Event|0
2136263|NCT01078623|3742623|FG012|Treatment Period 1|Adverse Event|0
2136264|NCT01078623|3742624|FG013|Treatment Period 1|Adverse Event|0
2136265|NCT01078623|3742625|FG014|Treatment Period 1|Adverse Event|0
2136266|NCT01078623|3742626|FG015|Treatment Period 1|Adverse Event|0
2136267|NCT01078623|3742627|FG016|Treatment Period 1|Adverse Event|0
2136268|NCT01078623|3742628|FG017|Treatment Period 1|Adverse Event|0
2136269|NCT01078623|3742629|FG018|Treatment Period 1|Adverse Event|0
2136270|NCT01078623|3742630|FG019|Treatment Period 1|Adverse Event|0
2287770|NCT02453334|3978212|FG000|Overall Study|Withdrawal by Subject|17
2287771|NCT02453334|3978213|FG001|Overall Study|Withdrawal by Subject|13
2287772|NCT02453334|3978212|FG000|Overall Study|Other reason|1
2287773|NCT02453334|3978213|FG001|Overall Study|Other reason|4
2320982|NCT02953821|4035234|FG000|Overall Study|Progressive Disease|5
2320983|NCT02953821|4035235|FG001|Overall Study|Progressive Disease|1
2320984|NCT02953821|4035234|FG000|Overall Study|Lost to Follow-up|2
2320985|NCT02953821|4035235|FG001|Overall Study|Lost to Follow-up|0
2320986|NCT02953821|4035234|FG000|Overall Study|Physician Decision|1
2320987|NCT02953821|4035235|FG001|Overall Study|Physician Decision|1
2320988|NCT02953821|4035234|FG000|Overall Study|Withdrawal by Subject|3
2320989|NCT02953821|4035235|FG001|Overall Study|Withdrawal by Subject|3
2136271|NCT01078623|3742611|FG000|Treatment Period 1|Withdrawal by Subject|0
2136272|NCT01078623|3742612|FG001|Treatment Period 1|Withdrawal by Subject|0
2136273|NCT01078623|3742613|FG002|Treatment Period 1|Withdrawal by Subject|0
2136274|NCT01078623|3742614|FG003|Treatment Period 1|Withdrawal by Subject|0
2136275|NCT01078623|3742615|FG004|Treatment Period 1|Withdrawal by Subject|0
2136276|NCT01078623|3742616|FG005|Treatment Period 1|Withdrawal by Subject|0
2136277|NCT01078623|3742617|FG006|Treatment Period 1|Withdrawal by Subject|0
2136278|NCT01078623|3742618|FG007|Treatment Period 1|Withdrawal by Subject|1
2136279|NCT01078623|3742619|FG008|Treatment Period 1|Withdrawal by Subject|0
2136280|NCT01078623|3742620|FG009|Treatment Period 1|Withdrawal by Subject|0
2207783|NCT01632579|3846909|FG003|Washout Period|Adverse Event|0
2136281|NCT01078623|3742621|FG010|Treatment Period 1|Withdrawal by Subject|1
2136282|NCT01078623|3742622|FG011|Treatment Period 1|Withdrawal by Subject|0
2136283|NCT01078623|3742623|FG012|Treatment Period 1|Withdrawal by Subject|0
2136284|NCT01078623|3742624|FG013|Treatment Period 1|Withdrawal by Subject|0
2136285|NCT01078623|3742625|FG014|Treatment Period 1|Withdrawal by Subject|0
2136286|NCT01078623|3742626|FG015|Treatment Period 1|Withdrawal by Subject|0
2136287|NCT01078623|3742627|FG016|Treatment Period 1|Withdrawal by Subject|0
2136288|NCT01078623|3742628|FG017|Treatment Period 1|Withdrawal by Subject|0
2136289|NCT01078623|3742629|FG018|Treatment Period 1|Withdrawal by Subject|0
2136290|NCT01078623|3742630|FG019|Treatment Period 1|Withdrawal by Subject|0
2136291|NCT01078623|3742611|FG000|Treatment Period 1|Protocol Violation|0
2136292|NCT01078623|3742612|FG001|Treatment Period 1|Protocol Violation|0
2136293|NCT01078623|3742613|FG002|Treatment Period 1|Protocol Violation|0
2136294|NCT01078623|3742614|FG003|Treatment Period 1|Protocol Violation|0
2136295|NCT01078623|3742615|FG004|Treatment Period 1|Protocol Violation|0
2136296|NCT01078623|3742616|FG005|Treatment Period 1|Protocol Violation|1
2136297|NCT01078623|3742617|FG006|Treatment Period 1|Protocol Violation|0
2136298|NCT01078623|3742618|FG007|Treatment Period 1|Protocol Violation|0
2136299|NCT01078623|3742619|FG008|Treatment Period 1|Protocol Violation|0
2136300|NCT01078623|3742620|FG009|Treatment Period 1|Protocol Violation|0
2136301|NCT01078623|3742621|FG010|Treatment Period 1|Protocol Violation|0
2136302|NCT01078623|3742622|FG011|Treatment Period 1|Protocol Violation|0
2136303|NCT01078623|3742623|FG012|Treatment Period 1|Protocol Violation|0
2136304|NCT01078623|3742624|FG013|Treatment Period 1|Protocol Violation|0
2136305|NCT01078623|3742625|FG014|Treatment Period 1|Protocol Violation|0
2136306|NCT01078623|3742626|FG015|Treatment Period 1|Protocol Violation|0
2136307|NCT01078623|3742627|FG016|Treatment Period 1|Protocol Violation|0
2136308|NCT01078623|3742628|FG017|Treatment Period 1|Protocol Violation|0
2136309|NCT01078623|3742629|FG018|Treatment Period 1|Protocol Violation|0
2136310|NCT01078623|3742630|FG019|Treatment Period 1|Protocol Violation|0
2136311|NCT01078623|3742611|FG000|Treatment Period 2|Adverse Event|0
2136312|NCT01078623|3742612|FG001|Treatment Period 2|Adverse Event|0
2136313|NCT01078623|3742613|FG002|Treatment Period 2|Adverse Event|0
2136314|NCT01078623|3742614|FG003|Treatment Period 2|Adverse Event|0
2136315|NCT01078623|3742615|FG004|Treatment Period 2|Adverse Event|0
2136316|NCT01078623|3742616|FG005|Treatment Period 2|Adverse Event|0
2136317|NCT01078623|3742617|FG006|Treatment Period 2|Adverse Event|1
2136318|NCT01078623|3742618|FG007|Treatment Period 2|Adverse Event|0
2136319|NCT01078623|3742619|FG008|Treatment Period 2|Adverse Event|0
2136320|NCT01078623|3742620|FG009|Treatment Period 2|Adverse Event|0
2136321|NCT01078623|3742621|FG010|Treatment Period 2|Adverse Event|0
2136322|NCT01078623|3742622|FG011|Treatment Period 2|Adverse Event|0
2136323|NCT01078623|3742623|FG012|Treatment Period 2|Adverse Event|0
2136324|NCT01078623|3742624|FG013|Treatment Period 2|Adverse Event|0
2136325|NCT01078623|3742625|FG014|Treatment Period 2|Adverse Event|0
2136326|NCT01078623|3742626|FG015|Treatment Period 2|Adverse Event|0
2136327|NCT01078623|3742627|FG016|Treatment Period 2|Adverse Event|0
2136328|NCT01078623|3742628|FG017|Treatment Period 2|Adverse Event|0
2136329|NCT01078623|3742629|FG018|Treatment Period 2|Adverse Event|1
2136330|NCT01078623|3742630|FG019|Treatment Period 2|Adverse Event|0
2136331|NCT01078623|3742611|FG000|Treatment Period 2|Withdrawal by Subject|0
2136332|NCT01078623|3742612|FG001|Treatment Period 2|Withdrawal by Subject|0
2136333|NCT01078623|3742613|FG002|Treatment Period 2|Withdrawal by Subject|0
2136334|NCT01078623|3742614|FG003|Treatment Period 2|Withdrawal by Subject|0
2136335|NCT01078623|3742615|FG004|Treatment Period 2|Withdrawal by Subject|0
2136336|NCT01078623|3742616|FG005|Treatment Period 2|Withdrawal by Subject|1
2136337|NCT01078623|3742617|FG006|Treatment Period 2|Withdrawal by Subject|0
2136338|NCT01078623|3742618|FG007|Treatment Period 2|Withdrawal by Subject|0
2136339|NCT01078623|3742619|FG008|Treatment Period 2|Withdrawal by Subject|0
2136340|NCT01078623|3742620|FG009|Treatment Period 2|Withdrawal by Subject|0
2136341|NCT01078623|3742621|FG010|Treatment Period 2|Withdrawal by Subject|0
2136342|NCT01078623|3742622|FG011|Treatment Period 2|Withdrawal by Subject|0
2136343|NCT01078623|3742623|FG012|Treatment Period 2|Withdrawal by Subject|0
2136344|NCT01078623|3742624|FG013|Treatment Period 2|Withdrawal by Subject|0
2136345|NCT01078623|3742625|FG014|Treatment Period 2|Withdrawal by Subject|0
2136346|NCT01078623|3742626|FG015|Treatment Period 2|Withdrawal by Subject|0
2136347|NCT01078623|3742627|FG016|Treatment Period 2|Withdrawal by Subject|0
2136348|NCT01078623|3742628|FG017|Treatment Period 2|Withdrawal by Subject|0
2136349|NCT01078623|3742629|FG018|Treatment Period 2|Withdrawal by Subject|0
2136350|NCT01078623|3742630|FG019|Treatment Period 2|Withdrawal by Subject|0
2136351|NCT01078623|3742611|FG000|Treatment Period 3|Adverse Event|0
2136352|NCT01078623|3742612|FG001|Treatment Period 3|Adverse Event|0
2136353|NCT01078623|3742613|FG002|Treatment Period 3|Adverse Event|0
2136354|NCT01078623|3742614|FG003|Treatment Period 3|Adverse Event|0
2136355|NCT01078623|3742615|FG004|Treatment Period 3|Adverse Event|1
2136356|NCT01078623|3742616|FG005|Treatment Period 3|Adverse Event|0
2136357|NCT01078623|3742617|FG006|Treatment Period 3|Adverse Event|0
2136358|NCT01078623|3742618|FG007|Treatment Period 3|Adverse Event|0
2136359|NCT01078623|3742619|FG008|Treatment Period 3|Adverse Event|0
2136360|NCT01078623|3742620|FG009|Treatment Period 3|Adverse Event|0
2136361|NCT01078623|3742621|FG010|Treatment Period 3|Adverse Event|0
2136362|NCT01078623|3742622|FG011|Treatment Period 3|Adverse Event|0
2136363|NCT01078623|3742623|FG012|Treatment Period 3|Adverse Event|0
2136364|NCT01078623|3742624|FG013|Treatment Period 3|Adverse Event|1
2136365|NCT01078623|3742625|FG014|Treatment Period 3|Adverse Event|0
2136366|NCT01078623|3742626|FG015|Treatment Period 3|Adverse Event|0
2136367|NCT01078623|3742627|FG016|Treatment Period 3|Adverse Event|0
2136368|NCT01078623|3742628|FG017|Treatment Period 3|Adverse Event|0
2136369|NCT01078623|3742629|FG018|Treatment Period 3|Adverse Event|0
2136370|NCT01078623|3742630|FG019|Treatment Period 3|Adverse Event|0
2136371|NCT01078623|3742611|FG000|Treatment Period 4|Adverse Event|0
2136372|NCT01078623|3742612|FG001|Treatment Period 4|Adverse Event|0
2136373|NCT01078623|3742613|FG002|Treatment Period 4|Adverse Event|1
2136374|NCT01078623|3742614|FG003|Treatment Period 4|Adverse Event|0
2136375|NCT01078623|3742615|FG004|Treatment Period 4|Adverse Event|0
2136376|NCT01078623|3742616|FG005|Treatment Period 4|Adverse Event|0
2136377|NCT01078623|3742617|FG006|Treatment Period 4|Adverse Event|0
2136378|NCT01078623|3742618|FG007|Treatment Period 4|Adverse Event|0
2136379|NCT01078623|3742619|FG008|Treatment Period 4|Adverse Event|0
2136380|NCT01078623|3742620|FG009|Treatment Period 4|Adverse Event|0
2136381|NCT01078623|3742621|FG010|Treatment Period 4|Adverse Event|0
2136382|NCT01078623|3742622|FG011|Treatment Period 4|Adverse Event|0
2136383|NCT01078623|3742623|FG012|Treatment Period 4|Adverse Event|0
2136384|NCT01078623|3742624|FG013|Treatment Period 4|Adverse Event|0
2136385|NCT01078623|3742625|FG014|Treatment Period 4|Adverse Event|0
2136386|NCT01078623|3742626|FG015|Treatment Period 4|Adverse Event|0
2136387|NCT01078623|3742627|FG016|Treatment Period 4|Adverse Event|0
2136388|NCT01078623|3742628|FG017|Treatment Period 4|Adverse Event|0
2136389|NCT01078623|3742629|FG018|Treatment Period 4|Adverse Event|0
2136390|NCT01078623|3742630|FG019|Treatment Period 4|Adverse Event|0
2136391|NCT01078623|3742611|FG000|Treatment Period 4|Withdrawal by Subject|0
2136392|NCT01078623|3742612|FG001|Treatment Period 4|Withdrawal by Subject|0
2136393|NCT01078623|3742613|FG002|Treatment Period 4|Withdrawal by Subject|0
2136394|NCT01078623|3742614|FG003|Treatment Period 4|Withdrawal by Subject|0
2136395|NCT01078623|3742615|FG004|Treatment Period 4|Withdrawal by Subject|0
2136396|NCT01078623|3742616|FG005|Treatment Period 4|Withdrawal by Subject|0
2136397|NCT01078623|3742617|FG006|Treatment Period 4|Withdrawal by Subject|0
2136398|NCT01078623|3742618|FG007|Treatment Period 4|Withdrawal by Subject|0
2136399|NCT01078623|3742619|FG008|Treatment Period 4|Withdrawal by Subject|0
2136400|NCT01078623|3742620|FG009|Treatment Period 4|Withdrawal by Subject|0
2136401|NCT01078623|3742621|FG010|Treatment Period 4|Withdrawal by Subject|0
2136402|NCT01078623|3742622|FG011|Treatment Period 4|Withdrawal by Subject|0
2136403|NCT01078623|3742623|FG012|Treatment Period 4|Withdrawal by Subject|0
2136404|NCT01078623|3742624|FG013|Treatment Period 4|Withdrawal by Subject|0
2136405|NCT01078623|3742625|FG014|Treatment Period 4|Withdrawal by Subject|0
2136406|NCT01078623|3742626|FG015|Treatment Period 4|Withdrawal by Subject|1
2136407|NCT01078623|3742627|FG016|Treatment Period 4|Withdrawal by Subject|0
2136408|NCT01078623|3742628|FG017|Treatment Period 4|Withdrawal by Subject|0
2136409|NCT01078623|3742629|FG018|Treatment Period 4|Withdrawal by Subject|0
2136410|NCT01078623|3742630|FG019|Treatment Period 4|Withdrawal by Subject|0
2136411|NCT01078662|3742647|FG000|Overall Study|Death|41
2136412|NCT01078662|3742648|FG001|Overall Study|Death|103
2136413|NCT01078662|3742649|FG002|Overall Study|Death|18
2136414|NCT01078662|3742650|FG003|Overall Study|Death|5
2136415|NCT01078662|3742651|FG004|Overall Study|Death|8
2136416|NCT01078662|3742647|FG000|Overall Study|Patients reached data cut-off|12
2136417|NCT01078662|3742648|FG001|Overall Study|Patients reached data cut-off|53
2136418|NCT01078662|3742649|FG002|Overall Study|Patients reached data cut-off|2
2136419|NCT01078662|3742650|FG003|Overall Study|Patients reached data cut-off|2
2136420|NCT01078662|3742651|FG004|Overall Study|Patients reached data cut-off|3
2136421|NCT01078662|3742647|FG000|Overall Study|Withdrawal by Subject|4
2136422|NCT01078662|3742648|FG001|Overall Study|Withdrawal by Subject|11
2136423|NCT01078662|3742649|FG002|Overall Study|Withdrawal by Subject|1
2136424|NCT01078662|3742650|FG003|Overall Study|Withdrawal by Subject|0
2136425|NCT01078662|3742651|FG004|Overall Study|Withdrawal by Subject|0
2136426|NCT01078662|3742647|FG000|Overall Study|Protocol Violation|0
2136427|NCT01078662|3742648|FG001|Overall Study|Protocol Violation|1
2136428|NCT01078662|3742649|FG002|Overall Study|Protocol Violation|0
2136429|NCT01078662|3742650|FG003|Overall Study|Protocol Violation|0
2136430|NCT01078662|3742651|FG004|Overall Study|Protocol Violation|0
2136431|NCT01078662|3742647|FG000|Overall Study|Lost to Follow-up|1
2136432|NCT01078662|3742648|FG001|Overall Study|Lost to Follow-up|0
2136433|NCT01078662|3742649|FG002|Overall Study|Lost to Follow-up|0
2136434|NCT01078662|3742650|FG003|Overall Study|Lost to Follow-up|0
2136435|NCT01078662|3742651|FG004|Overall Study|Lost to Follow-up|0
2136436|NCT01078675|3742662|FG000|Overall Study|Withdrawal by Subject|7
2136437|NCT01078675|3742663|FG001|Overall Study|Withdrawal by Subject|3
2136438|NCT01078675|3742662|FG000|Overall Study|Protocol Violation|56
2136439|NCT01078675|3742663|FG001|Overall Study|Protocol Violation|0
2136440|NCT01078675|3742662|FG000|Overall Study|Provided in CRF for specific reasons|2
2136441|NCT01078675|3742663|FG001|Overall Study|Provided in CRF for specific reasons|3
2136442|NCT01078675|3742662|FG000|Overall Study|Adverse Event|3
2136443|NCT01078675|3742663|FG001|Overall Study|Adverse Event|0
2136444|NCT01078805|3742678|FG000|Overall Study|Clinically significant abnormal lab|5
2136445|NCT01078805|3742678|FG000|Overall Study|Death|134
2136446|NCT01078805|3742678|FG000|Overall Study|Lost to Follow-up|676
2136447|NCT01078805|3742678|FG000|Overall Study|Physician Decision|169
2136448|NCT01078805|3742678|FG000|Overall Study|Serious adverse event|26
2136449|NCT01078805|3742678|FG000|Overall Study|Sponsor decision|46
2136450|NCT01078805|3742678|FG000|Overall Study|Withdrawal by Subject|739
2136451|NCT01078805|3742678|FG000|Overall Study|Other|173
2136452|NCT01078805|3742678|FG000|Overall Study|Didn't take study drug|82
2136453|NCT01078922|3742703|FG000|Overall Study|Adverse Event|1
2136454|NCT01078974|3742708|FG000|Overall Study|Adverse Event|3
2136455|NCT01079130|3742718|FG000|Overall Study|Adverse Event|1
2136456|NCT01079130|3742719|FG001|Overall Study|Adverse Event|1
2136457|NCT01079130|3742720|FG002|Overall Study|Adverse Event|0
2136458|NCT01079130|3742721|FG003|Overall Study|Adverse Event|1
2136459|NCT01079130|3742722|FG004|Overall Study|Adverse Event|5
2136460|NCT01079130|3742723|FG005|Overall Study|Adverse Event|1
2136461|NCT01079130|3742718|FG000|Overall Study|Administrative problems|1
2136462|NCT01079130|3742719|FG001|Overall Study|Administrative problems|3
2136463|NCT01079130|3742720|FG002|Overall Study|Administrative problems|0
2136464|NCT01079130|3742721|FG003|Overall Study|Administrative problems|0
2136465|NCT01079130|3742722|FG004|Overall Study|Administrative problems|0
2207784|NCT01632579|3846910|FG004|Washout Period|Adverse Event|0
2207785|NCT01632579|3846911|FG005|Washout Period|Adverse Event|0
2136466|NCT01079130|3742723|FG005|Overall Study|Administrative problems|1
2136467|NCT01079130|3742718|FG000|Overall Study|Withdrawal by Subject|0
2136468|NCT01079130|3742719|FG001|Overall Study|Withdrawal by Subject|1
2136469|NCT01079130|3742720|FG002|Overall Study|Withdrawal by Subject|0
2136470|NCT01079130|3742721|FG003|Overall Study|Withdrawal by Subject|0
2136471|NCT01079130|3742722|FG004|Overall Study|Withdrawal by Subject|1
2136472|NCT01079130|3742723|FG005|Overall Study|Withdrawal by Subject|3
2136473|NCT01079130|3742718|FG000|Overall Study|Protocol deviation|0
2136474|NCT01079130|3742719|FG001|Overall Study|Protocol deviation|2
2136475|NCT01079130|3742720|FG002|Overall Study|Protocol deviation|1
2136476|NCT01079130|3742721|FG003|Overall Study|Protocol deviation|2
2136477|NCT01079130|3742722|FG004|Overall Study|Protocol deviation|0
2136478|NCT01079130|3742723|FG005|Overall Study|Protocol deviation|0
2136479|NCT01079130|3742718|FG000|Overall Study|Abnormal test procedure result(s)|0
2136480|NCT01079130|3742719|FG001|Overall Study|Abnormal test procedure result(s)|0
2136481|NCT01079130|3742720|FG002|Overall Study|Abnormal test procedure result(s)|0
2136482|NCT01079130|3742721|FG003|Overall Study|Abnormal test procedure result(s)|0
2136483|NCT01079130|3742722|FG004|Overall Study|Abnormal test procedure result(s)|1
2136484|NCT01079130|3742723|FG005|Overall Study|Abnormal test procedure result(s)|0
2136485|NCT01079130|3742718|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2136486|NCT01079130|3742719|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2136487|NCT01079130|3742720|FG002|Overall Study|Unsatisfactory therapeutic effect|0
2136488|NCT01079130|3742721|FG003|Overall Study|Unsatisfactory therapeutic effect|2
2136489|NCT01079130|3742722|FG004|Overall Study|Unsatisfactory therapeutic effect|0
2136490|NCT01079130|3742723|FG005|Overall Study|Unsatisfactory therapeutic effect|0
2136491|NCT01079130|3742718|FG000|Overall Study|Lost to Follow-up|0
2136492|NCT01079130|3742719|FG001|Overall Study|Lost to Follow-up|0
2136493|NCT01079130|3742720|FG002|Overall Study|Lost to Follow-up|0
2136494|NCT01079130|3742721|FG003|Overall Study|Lost to Follow-up|0
2136495|NCT01079130|3742722|FG004|Overall Study|Lost to Follow-up|1
2136496|NCT01079130|3742723|FG005|Overall Study|Lost to Follow-up|0
2136497|NCT01079182|3742758|FG000|Overall Study|Lost to Follow-up|1634
2136498|NCT01079182|3742758|FG000|Overall Study|Adverse Drug Reaction (ADR)|261
2136499|NCT01079182|3742758|FG000|Overall Study|Lack of Efficacy|514
2207786|NCT01632579|3846912|FG006|Washout Period|Adverse Event|0
2136500|NCT01079182|3742758|FG000|Overall Study|ADR and Lack of Effectiveness|39
2136501|NCT01079182|3742758|FG000|Overall Study|Reasons not Evaluated|271
2136502|NCT01079195|3742762|FG000|Overall Study|No Documentation of Tarka Therapy|739
2136503|NCT01079195|3742762|FG000|Overall Study|No Documentation Available|437
2136504|NCT01079195|3742762|FG000|Overall Study|Adverse Event|157
2136505|NCT01079195|3742762|FG000|Overall Study|Reason Unknown|39
2136506|NCT01079195|3742762|FG000|Overall Study|Withdrawal by Subject|18
2136507|NCT01079195|3742762|FG000|Overall Study|Financial Reasons|15
2136508|NCT01079195|3742762|FG000|Overall Study|Lack of Effectiveness|12
2136509|NCT01079195|3742762|FG000|Overall Study|Physician Decision|4
2136510|NCT01079195|3742762|FG000|Overall Study|Improved Status of Participant|4
2136511|NCT01079195|3742762|FG000|Overall Study|No Follow-up Documentation Available|4
2136512|NCT01079195|3742762|FG000|Overall Study|Non-compliance|2
2136513|NCT01079234|3742769|FG000|Main: Week 0 to 26|Adverse Event|5
2136514|NCT01079234|3742770|FG001|Main: Week 0 to 26|Adverse Event|4
2136515|NCT01079234|3742771|FG002|Main: Week 0 to 26|Adverse Event|1
2136516|NCT01079234|3742772|FG003|Main: Week 0 to 26|Adverse Event|0
2136517|NCT01079234|3742769|FG000|Main: Week 0 to 26|Lack of Efficacy|2
2136518|NCT01079234|3742770|FG001|Main: Week 0 to 26|Lack of Efficacy|1
2136519|NCT01079234|3742771|FG002|Main: Week 0 to 26|Lack of Efficacy|1
2136520|NCT01079234|3742772|FG003|Main: Week 0 to 26|Lack of Efficacy|0
2136521|NCT01079234|3742769|FG000|Main: Week 0 to 26|Protocol Violation|6
2136522|NCT01079234|3742770|FG001|Main: Week 0 to 26|Protocol Violation|2
2136523|NCT01079234|3742771|FG002|Main: Week 0 to 26|Protocol Violation|4
2136524|NCT01079234|3742772|FG003|Main: Week 0 to 26|Protocol Violation|0
2136525|NCT01079234|3742769|FG000|Main: Week 0 to 26|Withdrawal criteria|6
2136526|NCT01079234|3742770|FG001|Main: Week 0 to 26|Withdrawal criteria|6
2136527|NCT01079234|3742771|FG002|Main: Week 0 to 26|Withdrawal criteria|2
2136528|NCT01079234|3742772|FG003|Main: Week 0 to 26|Withdrawal criteria|0
2136529|NCT01079234|3742769|FG000|Main: Week 0 to 26|Unclassified|7
2136530|NCT01079234|3742770|FG001|Main: Week 0 to 26|Unclassified|13
2136531|NCT01079234|3742771|FG002|Main: Week 0 to 26|Unclassified|4
2136532|NCT01079234|3742772|FG003|Main: Week 0 to 26|Unclassified|0
2136533|NCT01079234|3742769|FG000|Extension: Week 27 to 52|Adverse Event|0
2136534|NCT01079234|3742770|FG001|Extension: Week 27 to 52|Adverse Event|0
2136535|NCT01079234|3742771|FG002|Extension: Week 27 to 52|Adverse Event|1
2136536|NCT01079234|3742772|FG003|Extension: Week 27 to 52|Adverse Event|0
2136537|NCT01079234|3742769|FG000|Extension: Week 27 to 52|Lack of Efficacy|0
2136538|NCT01079234|3742770|FG001|Extension: Week 27 to 52|Lack of Efficacy|0
2136539|NCT01079234|3742771|FG002|Extension: Week 27 to 52|Lack of Efficacy|0
2136540|NCT01079234|3742772|FG003|Extension: Week 27 to 52|Lack of Efficacy|2
2136541|NCT01079234|3742769|FG000|Extension: Week 27 to 52|Protocol Violation|0
2136542|NCT01079234|3742770|FG001|Extension: Week 27 to 52|Protocol Violation|0
2136543|NCT01079234|3742771|FG002|Extension: Week 27 to 52|Protocol Violation|2
2136544|NCT01079234|3742772|FG003|Extension: Week 27 to 52|Protocol Violation|5
2136545|NCT01079234|3742769|FG000|Extension: Week 27 to 52|Withdrawal criteria|0
2136546|NCT01079234|3742770|FG001|Extension: Week 27 to 52|Withdrawal criteria|0
2136547|NCT01079234|3742771|FG002|Extension: Week 27 to 52|Withdrawal criteria|4
2136548|NCT01079234|3742772|FG003|Extension: Week 27 to 52|Withdrawal criteria|2
2136549|NCT01079234|3742769|FG000|Extension: Week 27 to 52|Unclassified|0
2136550|NCT01079234|3742770|FG001|Extension: Week 27 to 52|Unclassified|0
2136551|NCT01079234|3742771|FG002|Extension: Week 27 to 52|Unclassified|4
2136552|NCT01079234|3742772|FG003|Extension: Week 27 to 52|Unclassified|7
2136553|NCT01079663|3742807|FG000|Overall Study|Adverse Event|0
2136554|NCT01079663|3742808|FG001|Overall Study|Adverse Event|2
2136555|NCT01079663|3742807|FG000|Overall Study|Protocol Violation|0
2136556|NCT01079663|3742808|FG001|Overall Study|Protocol Violation|2
2136557|NCT01079741|3742819|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2136558|NCT01079741|3742820|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
2136559|NCT01079741|3742821|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2136560|NCT01079741|3742822|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2136561|NCT01079741|3742823|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2136562|NCT01079741|3742819|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2136563|NCT01079741|3742820|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2136564|NCT01079741|3742821|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2136565|NCT01079741|3742822|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2136566|NCT01079741|3742823|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
2136567|NCT01079806|3742837|FG000|Day 1 to Week 96|Adverse Event|0
2136568|NCT01079806|3742838|FG001|Day 1 to Week 96|Adverse Event|3
2136569|NCT01079806|3742837|FG000|Day 1 to Week 96|Withdrawal by Subject|3
2136570|NCT01079806|3742838|FG001|Day 1 to Week 96|Withdrawal by Subject|2
2136571|NCT01079806|3742837|FG000|Day 1 to Week 96|Pregnancy|0
2136572|NCT01079806|3742838|FG001|Day 1 to Week 96|Pregnancy|1
2136573|NCT01079806|3742837|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2
2136574|NCT01079806|3742838|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0
2136575|NCT01079806|3742837|FG000|Day 1 to Week 96|Lost to Follow-up|1
2136576|NCT01079806|3742838|FG001|Day 1 to Week 96|Lost to Follow-up|0
2136577|NCT01079806|3742837|FG000|Day 1 to Week 96|Subject request to stop study treatment|1
2136578|NCT01079806|3742838|FG001|Day 1 to Week 96|Subject request to stop study treatment|0
2136579|NCT01079806|3742837|FG000|Day 1 to Week 96|Removal by Medical Monitor|0
2136580|NCT01079806|3742838|FG001|Day 1 to Week 96|Removal by Medical Monitor|1
2136581|NCT01079806|3742837|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
2136582|NCT01079806|3742838|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
2136583|NCT01079806|3742837|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
2136584|NCT01079806|3742838|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
2136585|NCT01079806|3742837|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
2136586|NCT01079806|3742838|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
2136587|NCT01079832|3742846|FG000|Overall Study|Withdrawal by Subject|1
2136588|NCT01079936|3742854|FG000|Phase I: MTD|First Remission Status|2
2136589|NCT01079936|3742855|FG001|Phase I: MTD|First Remission Status|0
2136590|NCT01079936|3742856|FG002|Phase I: MTD|First Remission Status|0
2136591|NCT01079936|3742857|FG003|Phase I: MTD|First Remission Status|0
2136592|NCT01079936|3742858|FG004|Phase I: MTD|First Remission Status|0
2136593|NCT01079936|3742854|FG000|Phase I: MTD|No Stem Cell Transplantation|2
2136594|NCT01079936|3742855|FG001|Phase I: MTD|No Stem Cell Transplantation|0
2136595|NCT01079936|3742856|FG002|Phase I: MTD|No Stem Cell Transplantation|0
2136596|NCT01079936|3742857|FG003|Phase I: MTD|No Stem Cell Transplantation|0
2136597|NCT01079936|3742858|FG004|Phase I: MTD|No Stem Cell Transplantation|0
2136598|NCT01079936|3742854|FG000|Phase II|Adverse Event|0
2136599|NCT01079936|3742855|FG001|Phase II|Adverse Event|0
2136600|NCT01079936|3742856|FG002|Phase II|Adverse Event|1
2136601|NCT01079936|3742857|FG003|Phase II|Adverse Event|0
2136602|NCT01079936|3742858|FG004|Phase II|Adverse Event|0
2207787|NCT01632579|3846913|FG007|Washout Period|Adverse Event|0
2207788|NCT01632579|3846914|FG008|Washout Period|Adverse Event|0
2207789|NCT01632579|3846906|FG000|Period 2 (Second Intervention)|Adverse Event|1
2136603|NCT01079936|3742854|FG000|Phase II|Insurance Issue|0
2136604|NCT01079936|3742855|FG001|Phase II|Insurance Issue|0
2136605|NCT01079936|3742856|FG002|Phase II|Insurance Issue|0
2136606|NCT01079936|3742857|FG003|Phase II|Insurance Issue|0
2136607|NCT01079936|3742858|FG004|Phase II|Insurance Issue|1
2136608|NCT01079949|3742871|FG000|Overall Study|Withdrawal before r-hCG administration|2
2136609|NCT01079949|3742872|FG001|Overall Study|Withdrawal before r-hCG administration|3
2136610|NCT01079949|3742871|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
2136611|NCT01079949|3742872|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
2136612|NCT01079949|3742871|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8
2136613|NCT01079949|3742872|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
2136614|NCT01079949|3742871|FG000|Overall Study|Randomized but not treated|1
2136615|NCT01079949|3742872|FG001|Overall Study|Randomized but not treated|0
2136616|NCT01079962|3742880|FG000|Overall Study|Adverse Event|2
2136617|NCT01079962|3742881|FG001|Overall Study|Adverse Event|2
2136618|NCT01079962|3742880|FG000|Overall Study|Withdrawal by Subject|5
2136619|NCT01079962|3742881|FG001|Overall Study|Withdrawal by Subject|7
2136620|NCT01079962|3742880|FG000|Overall Study|Protocol Violation|2
2136621|NCT01079962|3742881|FG001|Overall Study|Protocol Violation|2
2136622|NCT01079962|3742880|FG000|Overall Study|No blood pressure (BP) control|3
2136623|NCT01079962|3742881|FG001|Overall Study|No blood pressure (BP) control|0
2136624|NCT01079962|3742880|FG000|Overall Study|Inclusion/exclusion criteria|1
2136625|NCT01079962|3742881|FG001|Overall Study|Inclusion/exclusion criteria|3
2136626|NCT01079962|3742880|FG000|Overall Study|Participant not returning for next visit|1
2136627|NCT01079962|3742881|FG001|Overall Study|Participant not returning for next visit|0
2136628|NCT01079962|3742880|FG000|Overall Study|Due to arrhythmia/bradycardia|1
2136629|NCT01079962|3742881|FG001|Overall Study|Due to arrhythmia/bradycardia|1
2136630|NCT01079988|3742892|FG000|Overall Study|Lost to Follow-up|0
2136631|NCT01079988|3742893|FG001|Overall Study|Lost to Follow-up|0
2136632|NCT01079988|3742894|FG002|Overall Study|Lost to Follow-up|0
2136633|NCT01079988|3742895|FG003|Overall Study|Lost to Follow-up|1
2136634|NCT01079988|3742896|FG004|Overall Study|Lost to Follow-up|0
2136635|NCT01079988|3742892|FG000|Overall Study|Lack of Efficacy|1
2136636|NCT01079988|3742893|FG001|Overall Study|Lack of Efficacy|0
2136637|NCT01079988|3742894|FG002|Overall Study|Lack of Efficacy|0
2136638|NCT01079988|3742895|FG003|Overall Study|Lack of Efficacy|0
2136639|NCT01079988|3742896|FG004|Overall Study|Lack of Efficacy|0
2136640|NCT01079988|3742892|FG000|Overall Study|Other|0
2136641|NCT01079988|3742893|FG001|Overall Study|Other|0
2136642|NCT01079988|3742894|FG002|Overall Study|Other|0
2136643|NCT01079988|3742895|FG003|Overall Study|Other|2
2136644|NCT01079988|3742896|FG004|Overall Study|Other|1
2136645|NCT01080131|3742921|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
2207790|NCT01632579|3846907|FG001|Period 2 (Second Intervention)|Adverse Event|0
2207791|NCT01632579|3846908|FG002|Period 2 (Second Intervention)|Adverse Event|0
2207792|NCT01632579|3846909|FG003|Period 2 (Second Intervention)|Adverse Event|0
2207793|NCT01632579|3846910|FG004|Period 2 (Second Intervention)|Adverse Event|0
2207794|NCT01632579|3846911|FG005|Period 2 (Second Intervention)|Adverse Event|0
2207795|NCT01632579|3846912|FG006|Period 2 (Second Intervention)|Adverse Event|0
2207796|NCT01632579|3846913|FG007|Period 2 (Second Intervention)|Adverse Event|0
2136646|NCT01080131|3742922|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
2136647|NCT01080131|3742921|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6
2136648|NCT01080131|3742922|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4
2136649|NCT01080131|3742921|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5
2136650|NCT01080131|3742922|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3
2136651|NCT01080131|3742921|FG000|Core Study (0- 12 Weeks)|Administrative problems|0
2136652|NCT01080131|3742922|FG001|Core Study (0- 12 Weeks)|Administrative problems|1
2136653|NCT01080131|3742921|FG000|Core Study (0- 12 Weeks)|Death|1
2136654|NCT01080131|3742922|FG001|Core Study (0- 12 Weeks)|Death|0
2136655|NCT01080131|3742921|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0
2136656|NCT01080131|3742922|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2
2136657|NCT01080131|3742921|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
2136658|NCT01080131|3742922|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
2136659|NCT01080131|3742921|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
2136660|NCT01080131|3742922|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
2136661|NCT01080131|3742921|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
2136662|NCT01080131|3742922|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
2136663|NCT01080131|3742921|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
2136664|NCT01080131|3742922|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
2136665|NCT01080131|3742921|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1
2136666|NCT01080131|3742922|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2
2136667|NCT01080131|3742921|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
2136668|NCT01080131|3742922|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
2136669|NCT01080131|3742921|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
2136670|NCT01080131|3742922|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
2136671|NCT01080300|3742996|FG000|Overall Study|Adverse Event|49
2136672|NCT01080300|3742997|FG001|Overall Study|Adverse Event|35
2136673|NCT01080300|3742996|FG000|Overall Study|Lack of Efficacy|12
2136674|NCT01080300|3742997|FG001|Overall Study|Lack of Efficacy|15
2207797|NCT01632579|3846914|FG008|Period 2 (Second Intervention)|Adverse Event|0
2207798|NCT01632800|3846971|FG000|Overall Study|Subject did not fit in apparatus|1
2207799|NCT01632878|3846977|FG000|Screening|Physician Decision|268
2207800|NCT01632878|3846977|FG000|Treatment|Lost to Follow-up|41
2207801|NCT01632878|3846977|FG000|Treatment|Withdrawal by Subject|36
2207802|NCT01632878|3846977|FG000|Treatment|Physician Decision|34
2207803|NCT01632878|3846977|FG000|Treatment|missing information|4
2136675|NCT01080300|3742996|FG000|Overall Study|Protocol Violation|7
2136676|NCT01080300|3742997|FG001|Overall Study|Protocol Violation|13
2136677|NCT01080300|3742996|FG000|Overall Study|Lost to Follow-up|10
2136678|NCT01080300|3742997|FG001|Overall Study|Lost to Follow-up|6
2136679|NCT01080300|3742996|FG000|Overall Study|Death|0
2136680|NCT01080300|3742997|FG001|Overall Study|Death|1
2136681|NCT01080300|3742996|FG000|Overall Study|Withdrawal by Subject|12
2136682|NCT01080300|3742997|FG001|Overall Study|Withdrawal by Subject|28
2136683|NCT01080300|3742996|FG000|Overall Study|Reasons not specified|4
2136684|NCT01080300|3742997|FG001|Overall Study|Reasons not specified|6
2136685|NCT01080326|3743005|FG000|Overall Study|Patient deterioration prior to procedure|3
2136686|NCT01080326|3743005|FG000|Overall Study|Surgeon decision|1
2136687|NCT01080391|3743011|FG000|Overall Study|Randomized but not treated|7
2136688|NCT01080391|3743012|FG001|Overall Study|Randomized but not treated|4
2136689|NCT01080625|3743021|FG000|Overall Study|Physician Decision|0
2136690|NCT01080625|3743022|FG001|Overall Study|Physician Decision|2
2136691|NCT01080625|3743023|FG002|Overall Study|Physician Decision|1
2136692|NCT01080716|3743048|FG000|Part 1|Physician Decision|1
2207804|NCT01632878|3846977|FG000|Treatment|no information on study completion|43
2136693|NCT01080716|3743049|FG001|Part 1|Physician Decision|0
2136694|NCT01080716|3743050|FG002|Part 1|Physician Decision|0
2136695|NCT01080716|3743051|FG003|Part 1|Physician Decision|0
2136696|NCT01080807|3743084|FG000|Overall Study|Adverse Event|9
2136697|NCT01080807|3743085|FG001|Overall Study|Adverse Event|1
2136698|NCT01080807|3743084|FG000|Overall Study|Lack of Efficacy|0
2136699|NCT01080807|3743085|FG001|Overall Study|Lack of Efficacy|1
2136700|NCT01080807|3743084|FG000|Overall Study|Withdrawal by Subject|7
2136701|NCT01080807|3743085|FG001|Overall Study|Withdrawal by Subject|2
2136702|NCT01080807|3743084|FG000|Overall Study|Protocol Violation|7
2136703|NCT01080807|3743085|FG001|Overall Study|Protocol Violation|6
2136704|NCT01080807|3743084|FG000|Overall Study|Lost to Follow-up|6
2136705|NCT01080807|3743085|FG001|Overall Study|Lost to Follow-up|4
2136706|NCT01080807|3743084|FG000|Overall Study|Noncompliance with drug administration|1
2136707|NCT01080807|3743085|FG001|Overall Study|Noncompliance with drug administration|1
2136708|NCT01080807|3743084|FG000|Overall Study|Noncompliance to study procedures|1
2136709|NCT01080807|3743085|FG001|Overall Study|Noncompliance to study procedures|1
2136710|NCT01080807|3743084|FG000|Overall Study|Began working day shift|0
2136711|NCT01080807|3743085|FG001|Overall Study|Began working day shift|2
2136712|NCT01080807|3743084|FG000|Overall Study|Laid off or terminated from job|1
2136713|NCT01080807|3743085|FG001|Overall Study|Laid off or terminated from job|2
2136714|NCT01080807|3743084|FG000|Overall Study|Stopped working consistent night shifts|0
2136715|NCT01080807|3743085|FG001|Overall Study|Stopped working consistent night shifts|1
2136716|NCT01080807|3743084|FG000|Overall Study|Work schedule changing|1
2136717|NCT01080807|3743085|FG001|Overall Study|Work schedule changing|1
2136718|NCT01080807|3743084|FG000|Overall Study|Work schedule and travel|0
2136719|NCT01080807|3743085|FG001|Overall Study|Work schedule and travel|1
2136720|NCT01080807|3743084|FG000|Overall Study|Switched to first shift|1
2136721|NCT01080807|3743085|FG001|Overall Study|Switched to first shift|0
2136722|NCT01080807|3743084|FG000|Overall Study|Moved away without notifying center|1
2136723|NCT01080807|3743085|FG001|Overall Study|Moved away without notifying center|0
2136724|NCT01081132|3743120|FG000|Overall Study|Lack of Efficacy|25
2136725|NCT01081132|3743121|FG001|Overall Study|Lack of Efficacy|9
2136726|NCT01081132|3743120|FG000|Overall Study|Withdrawal by Subject|13
2136727|NCT01081132|3743121|FG001|Overall Study|Withdrawal by Subject|16
2136728|NCT01081132|3743120|FG000|Overall Study|Lost to Follow-up|4
2136729|NCT01081132|3743121|FG001|Overall Study|Lost to Follow-up|11
2136730|NCT01081132|3743120|FG000|Overall Study|Adverse Event|3
2136731|NCT01081132|3743121|FG001|Overall Study|Adverse Event|9
2136732|NCT01081132|3743120|FG000|Overall Study|Non Compliance|4
2136733|NCT01081132|3743121|FG001|Overall Study|Non Compliance|2
2136734|NCT01081132|3743120|FG000|Overall Study|Lack Of Compliance|0
2136735|NCT01081132|3743121|FG001|Overall Study|Lack Of Compliance|1
2136736|NCT01081132|3743120|FG000|Overall Study|Missed Visits|1
2136737|NCT01081132|3743121|FG001|Overall Study|Missed Visits|1
2136738|NCT01081132|3743120|FG000|Overall Study|Stopped Taking Meds|2
2136739|NCT01081132|3743121|FG001|Overall Study|Stopped Taking Meds|0
2136740|NCT01081132|3743120|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0
2136741|NCT01081132|3743121|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1
2136742|NCT01081132|3743120|FG000|Overall Study|Declined Taper Phase|0
2136743|NCT01081132|3743121|FG001|Overall Study|Declined Taper Phase|1
2136744|NCT01081132|3743120|FG000|Overall Study|Protocol Violation|3
2136745|NCT01081132|3743121|FG001|Overall Study|Protocol Violation|1
2136746|NCT01081145|3743127|FG000|Open-Label Phase|Lack of Efficacy|56
2136747|NCT01081145|3743128|FG001|Open-Label Phase|Lack of Efficacy|0
2136748|NCT01081145|3743127|FG000|Open-Label Phase|Response criteria not met|46
2136749|NCT01081145|3743128|FG001|Open-Label Phase|Response criteria not met|0
2136750|NCT01081145|3743127|FG000|Open-Label Phase|Adverse Event|42
2136751|NCT01081145|3743128|FG001|Open-Label Phase|Adverse Event|0
2207805|NCT01632891|3846983|FG000|Overall Study|Lost to Follow-up|0
2136752|NCT01081145|3743127|FG000|Open-Label Phase|Withdrawal by Subject|41
2136753|NCT01081145|3743128|FG001|Open-Label Phase|Withdrawal by Subject|0
2136754|NCT01081145|3743127|FG000|Open-Label Phase|Other|12
2136755|NCT01081145|3743128|FG001|Open-Label Phase|Other|0
2136756|NCT01081145|3743127|FG000|Open-Label Phase|Lost to Follow-up|11
2136757|NCT01081145|3743128|FG001|Open-Label Phase|Lost to Follow-up|0
2136758|NCT01081145|3743127|FG000|Open-Label Phase|Protocol Violation|4
2136759|NCT01081145|3743128|FG001|Open-Label Phase|Protocol Violation|0
2136760|NCT01081145|3743127|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
2136761|NCT01081145|3743128|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
2136762|NCT01081145|3743127|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
2136763|NCT01081145|3743128|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
2136764|NCT01081145|3743127|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
2136765|NCT01081145|3743128|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
2136766|NCT01081145|3743127|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
2136767|NCT01081145|3743128|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
2136768|NCT01081145|3743127|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
2136769|NCT01081145|3743128|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
2136770|NCT01081145|3743127|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
2136771|NCT01081145|3743128|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
2136772|NCT01081145|3743127|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4
2136773|NCT01081145|3743128|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3
2136774|NCT01081249|3743136|FG000|Overall Study|Diagnosed with Bipolar Disorder|0
2136775|NCT01081249|3743137|FG001|Overall Study|Diagnosed with Bipolar Disorder|1
2136776|NCT01081301|3743143|FG000|Overall Study|Bereaved|3
2136777|NCT01081301|3743143|FG000|Overall Study|Too busy|5
2136778|NCT01081301|3743143|FG000|Overall Study|Patient too ill|2
2136779|NCT01081301|3743143|FG000|Overall Study|Lost to Follow-up|4
2136780|NCT01081626|3743166|FG000|Overall Study|Dosing error|1
2136781|NCT01081626|3743167|FG001|Overall Study|Dosing error|1
2136782|NCT01081626|3743166|FG000|Overall Study|Missing Estradiol|25
2136783|NCT01081626|3743167|FG001|Overall Study|Missing Estradiol|28
2136784|NCT01081626|3743166|FG000|Overall Study|Low antral follicle count|1
2136785|NCT01081626|3743167|FG001|Overall Study|Low antral follicle count|0
2136786|NCT01081626|3743166|FG000|Overall Study|Overstimulation|0
2136787|NCT01081626|3743167|FG001|Overall Study|Overstimulation|1
2136788|NCT01081626|3743166|FG000|Overall Study|Lost to Follow-up|0
2136789|NCT01081626|3743167|FG001|Overall Study|Lost to Follow-up|1
2136790|NCT01081626|3743166|FG000|Overall Study|Other|33
2136791|NCT01081626|3743167|FG001|Overall Study|Other|30
2287774|NCT02453386|3978239|FG000|Overall Study|Adverse Event|22
2287775|NCT02453386|3978240|FG001|Overall Study|Adverse Event|30
2287776|NCT02453386|3978241|FG002|Overall Study|Adverse Event|15
2287777|NCT02453386|3978239|FG000|Overall Study|Protocol Violation|1
2287778|NCT02453386|3978240|FG001|Overall Study|Protocol Violation|0
2287779|NCT02453386|3978241|FG002|Overall Study|Protocol Violation|1
2287780|NCT02453386|3978239|FG000|Overall Study|Withdrawal by Subject|10
2287781|NCT02453386|3978240|FG001|Overall Study|Withdrawal by Subject|9
2287782|NCT02453386|3978241|FG002|Overall Study|Withdrawal by Subject|9
2287783|NCT02453386|3978239|FG000|Overall Study|Sponsor Terminated Study|14
2287784|NCT02453386|3978240|FG001|Overall Study|Sponsor Terminated Study|8
2287785|NCT02453386|3978241|FG002|Overall Study|Sponsor Terminated Study|11
2287786|NCT02453386|3978239|FG000|Overall Study|Subject Terminated by Sponsor|1
2287787|NCT02453386|3978240|FG001|Overall Study|Subject Terminated by Sponsor|1
2287788|NCT02453386|3978241|FG002|Overall Study|Subject Terminated by Sponsor|1
2287789|NCT02453386|3978239|FG000|Overall Study|Sponsor Terminated by Investigator|0
2287790|NCT02453386|3978240|FG001|Overall Study|Sponsor Terminated by Investigator|1
2287791|NCT02453386|3978241|FG002|Overall Study|Sponsor Terminated by Investigator|2
2287792|NCT02453386|3978239|FG000|Overall Study|Lost to Follow-up|0
2287793|NCT02453386|3978240|FG001|Overall Study|Lost to Follow-up|0
2287794|NCT02453386|3978241|FG002|Overall Study|Lost to Follow-up|1
2136792|NCT01081665|3743173|FG000|Overall Study|Death|41
2136793|NCT01081665|3743173|FG000|Overall Study|Lost to Follow-up|18
2136794|NCT01081665|3743173|FG000|Overall Study|Withdrawal by Subject|17
2136795|NCT01081665|3743173|FG000|Overall Study|Change of dialysis unit|10
2136796|NCT01081665|3743173|FG000|Overall Study|Regulation of iPTH|5
2136797|NCT01081665|3743173|FG000|Overall Study|Change in renal replacement therapy|2
2136798|NCT01081665|3743173|FG000|Overall Study|Adverse Event|1
2136799|NCT01081665|3743173|FG000|Overall Study|Lack of Efficacy|1
2136800|NCT01081678|3743181|FG000|Overall Study|Ineligibility Determined|0
2136801|NCT01081678|3743182|FG001|Overall Study|Ineligibility Determined|0
2136802|NCT01081678|3743183|FG002|Overall Study|Ineligibility Determined|1
2136803|NCT01081678|3743184|FG003|Overall Study|Ineligibility Determined|1
2136804|NCT01081678|3743181|FG000|Overall Study|Noncompliance|3
2136805|NCT01081678|3743182|FG001|Overall Study|Noncompliance|4
2136806|NCT01081678|3743183|FG002|Overall Study|Noncompliance|5
2136807|NCT01081678|3743184|FG003|Overall Study|Noncompliance|2
2136808|NCT01081678|3743181|FG000|Overall Study|Adverse Event|2
2136809|NCT01081678|3743182|FG001|Overall Study|Adverse Event|1
2136810|NCT01081678|3743183|FG002|Overall Study|Adverse Event|2
2136811|NCT01081678|3743184|FG003|Overall Study|Adverse Event|2
2136812|NCT01081678|3743181|FG000|Overall Study|Withdrawal by Subject|15
2136813|NCT01081678|3743182|FG001|Overall Study|Withdrawal by Subject|7
2136814|NCT01081678|3743183|FG002|Overall Study|Withdrawal by Subject|17
2136815|NCT01081678|3743184|FG003|Overall Study|Withdrawal by Subject|14
2136816|NCT01081678|3743181|FG000|Overall Study|Administrative Decision|1
2136817|NCT01081678|3743182|FG001|Overall Study|Administrative Decision|0
2136818|NCT01081678|3743183|FG002|Overall Study|Administrative Decision|0
2136819|NCT01081678|3743184|FG003|Overall Study|Administrative Decision|1
2136820|NCT01081678|3743181|FG000|Overall Study|Lost to Follow-up|4
2136821|NCT01081678|3743182|FG001|Overall Study|Lost to Follow-up|1
2136822|NCT01081678|3743183|FG002|Overall Study|Lost to Follow-up|4
2136823|NCT01081678|3743184|FG003|Overall Study|Lost to Follow-up|3
2136824|NCT01081678|3743181|FG000|Overall Study|Death|2
2136825|NCT01081678|3743182|FG001|Overall Study|Death|2
2136826|NCT01081678|3743183|FG002|Overall Study|Death|2
2136827|NCT01081678|3743184|FG003|Overall Study|Death|6
2136828|NCT01081678|3743181|FG000|Overall Study|Other|0
2136829|NCT01081678|3743182|FG001|Overall Study|Other|1
2136830|NCT01081678|3743183|FG002|Overall Study|Other|0
2136831|NCT01081678|3743184|FG003|Overall Study|Other|0
2136832|NCT01081769|3743196|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10
2136833|NCT01081769|3743197|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12
2136834|NCT01081769|3743196|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
2136835|NCT01081769|3743197|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
2136836|NCT01081769|3743196|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
2136837|NCT01081769|3743197|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
2136838|NCT01081769|3743196|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
2136839|NCT01081769|3743197|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
2136840|NCT01081769|3743196|FG000|CORE Intent-To-Treat|Adverse Event|14
2136841|NCT01081769|3743197|FG001|CORE Intent-To-Treat|Adverse Event|11
2136842|NCT01081769|3743196|FG000|CORE Intent-To-Treat|Death|1
2136843|NCT01081769|3743197|FG001|CORE Intent-To-Treat|Death|1
2136844|NCT01081769|3743196|FG000|CORE Intent-To-Treat|Lack of Efficacy|2
2136845|NCT01081769|3743197|FG001|CORE Intent-To-Treat|Lack of Efficacy|6
2136846|NCT01081769|3743196|FG000|CORE Intent-To-Treat|Lost to Follow-up|4
2136847|NCT01081769|3743197|FG001|CORE Intent-To-Treat|Lost to Follow-up|5
2136848|NCT01081769|3743196|FG000|CORE Intent-To-Treat|Pregnancy|1
2136849|NCT01081769|3743197|FG001|CORE Intent-To-Treat|Pregnancy|0
2136850|NCT01081769|3743196|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52
2136851|NCT01081769|3743197|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60
2136852|NCT01081769|3743196|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0
2136853|NCT01081769|3743197|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5
2136854|NCT01081769|3743196|FG000|CORE Intent-To-Treat|Other|0
2136855|NCT01081769|3743197|FG001|CORE Intent-To-Treat|Other|1
2136856|NCT01081769|3743196|FG000|CORE Intent-To-Treat|Ineligibility|3
2136857|NCT01081769|3743197|FG001|CORE Intent-To-Treat|Ineligibility|4
2136858|NCT01081769|3743196|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1
2136859|NCT01081769|3743197|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2
2136860|NCT01081769|3743196|FG000|CORE Intent-To-Treat|Patient Moved|2
2136861|NCT01081769|3743197|FG001|CORE Intent-To-Treat|Patient Moved|2
2136862|NCT01081795|3743206|FG000|Overall Study|Adverse Event|18
2136863|NCT01081795|3743207|FG001|Overall Study|Adverse Event|23
2136864|NCT01081795|3743208|FG002|Overall Study|Adverse Event|6
2136865|NCT01081795|3743206|FG000|Overall Study|Lack of Efficacy|7
2136866|NCT01081795|3743207|FG001|Overall Study|Lack of Efficacy|5
2136867|NCT01081795|3743208|FG002|Overall Study|Lack of Efficacy|19
2136868|NCT01081795|3743206|FG000|Overall Study|Subject's schedule|1
2136869|NCT01081795|3743207|FG001|Overall Study|Subject's schedule|1
2136870|NCT01081795|3743208|FG002|Overall Study|Subject's schedule|2
2136871|NCT01081795|3743206|FG000|Overall Study|Revocation of informed consent|2
2136872|NCT01081795|3743207|FG001|Overall Study|Revocation of informed consent|0
2136873|NCT01081795|3743208|FG002|Overall Study|Revocation of informed consent|0
2136874|NCT01081795|3743206|FG000|Overall Study|Ineligible for participation|1
2136875|NCT01081795|3743207|FG001|Overall Study|Ineligible for participation|0
2136876|NCT01081795|3743208|FG002|Overall Study|Ineligible for participation|0
2136877|NCT01081795|3743206|FG000|Overall Study|Use of a prohibited concomitant drug|1
2136878|NCT01081795|3743207|FG001|Overall Study|Use of a prohibited concomitant drug|1
2136879|NCT01081795|3743208|FG002|Overall Study|Use of a prohibited concomitant drug|1
2136880|NCT01081795|3743206|FG000|Overall Study|Using drug with restricted days of use|2
2136881|NCT01081795|3743207|FG001|Overall Study|Using drug with restricted days of use|3
2136882|NCT01081795|3743208|FG002|Overall Study|Using drug with restricted days of use|2
2136883|NCT01081795|3743206|FG000|Overall Study|Other|1
2136884|NCT01081795|3743207|FG001|Overall Study|Other|2
2136885|NCT01081795|3743208|FG002|Overall Study|Other|0
2136886|NCT01081834|3743221|FG000|Core Period: Baseline to Week 26|Pregnancy|1
2136887|NCT01081834|3743222|FG001|Core Period: Baseline to Week 26|Pregnancy|0
2136888|NCT01081834|3743223|FG002|Core Period: Baseline to Week 26|Pregnancy|0
2136889|NCT01081834|3743224|FG003|Core Period: Baseline to Week 26|Pregnancy|0
2136890|NCT01081834|3743225|FG004|Core Period: Baseline to Week 26|Pregnancy|0
2136891|NCT01081834|3743221|FG000|Core Period: Baseline to Week 26|Adverse Event|2
2136892|NCT01081834|3743222|FG001|Core Period: Baseline to Week 26|Adverse Event|5
2136893|NCT01081834|3743223|FG002|Core Period: Baseline to Week 26|Adverse Event|3
2136894|NCT01081834|3743224|FG003|Core Period: Baseline to Week 26|Adverse Event|1
2136895|NCT01081834|3743225|FG004|Core Period: Baseline to Week 26|Adverse Event|1
2136896|NCT01081834|3743221|FG000|Core Period: Baseline to Week 26|Death|1
2136897|NCT01081834|3743222|FG001|Core Period: Baseline to Week 26|Death|0
2136898|NCT01081834|3743223|FG002|Core Period: Baseline to Week 26|Death|0
2136899|NCT01081834|3743224|FG003|Core Period: Baseline to Week 26|Death|0
2136900|NCT01081834|3743225|FG004|Core Period: Baseline to Week 26|Death|0
2136901|NCT01081834|3743221|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2
2136902|NCT01081834|3743222|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2
2136903|NCT01081834|3743223|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5
2136904|NCT01081834|3743224|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0
2136905|NCT01081834|3743225|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0
2136906|NCT01081834|3743221|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
2136907|NCT01081834|3743222|FG001|Core Period: Baseline to Week 26|Protocol Violation|4
2136908|NCT01081834|3743223|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
2136909|NCT01081834|3743224|FG003|Core Period: Baseline to Week 26|Protocol Violation|0
2136910|NCT01081834|3743225|FG004|Core Period: Baseline to Week 26|Protocol Violation|2
2136911|NCT01081834|3743221|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15
2136912|NCT01081834|3743222|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
2136913|NCT01081834|3743223|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9
2136914|NCT01081834|3743224|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3
2136915|NCT01081834|3743225|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1
2136916|NCT01081834|3743221|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3
2136917|NCT01081834|3743222|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4
2136918|NCT01081834|3743223|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2
2136919|NCT01081834|3743224|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2
2136920|NCT01081834|3743225|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2136921|NCT01081834|3743221|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
2136922|NCT01081834|3743222|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2136923|NCT01081834|3743223|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2136924|NCT01081834|3743224|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2136925|NCT01081834|3743225|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2136926|NCT01081834|3743221|FG000|Core Period: Baseline to Week 26|Other|4
2136927|NCT01081834|3743222|FG001|Core Period: Baseline to Week 26|Other|4
2136928|NCT01081834|3743223|FG002|Core Period: Baseline to Week 26|Other|3
2136929|NCT01081834|3743224|FG003|Core Period: Baseline to Week 26|Other|1
2136930|NCT01081834|3743225|FG004|Core Period: Baseline to Week 26|Other|0
2136931|NCT01081834|3743221|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
2136932|NCT01081834|3743222|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
2136933|NCT01081834|3743223|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2136934|NCT01081834|3743224|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2136935|NCT01081834|3743225|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2136936|NCT01081834|3743221|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
2136937|NCT01081834|3743222|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0
2136938|NCT01081834|3743223|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
2136939|NCT01081834|3743224|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0
2136940|NCT01081834|3743225|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0
2136941|NCT01081834|3743221|FG000|Extension Period: Week 26 to Week 52|Death|1
2136942|NCT01081834|3743222|FG001|Extension Period: Week 26 to Week 52|Death|0
2136943|NCT01081834|3743223|FG002|Extension Period: Week 26 to Week 52|Death|0
2136944|NCT01081834|3743224|FG003|Extension Period: Week 26 to Week 52|Death|0
2136945|NCT01081834|3743225|FG004|Extension Period: Week 26 to Week 52|Death|0
2136946|NCT01081834|3743221|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
2136947|NCT01081834|3743222|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
2136948|NCT01081834|3743223|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2178374|NCT01383174|3803134|FG000|3 Month Assessment|Lost to Follow-up|2
2287795|NCT02453386|3978239|FG000|Overall Study|Other|1
2287796|NCT02453386|3978240|FG001|Overall Study|Other|0
2287797|NCT02453386|3978241|FG002|Overall Study|Other|1
2287798|NCT02453555|3978258|FG000|24-week Double-blind Treatment Period|Adverse Event|2
2287799|NCT02453555|3978259|FG001|24-week Double-blind Treatment Period|Adverse Event|0
2287800|NCT02453555|3978260|FG002|24-week Double-blind Treatment Period|Adverse Event|0
2287801|NCT02453555|3978261|FG003|24-week Double-blind Treatment Period|Adverse Event|0
2287802|NCT02453555|3978262|FG004|24-week Double-blind Treatment Period|Adverse Event|0
2287803|NCT02453555|3978263|FG005|24-week Double-blind Treatment Period|Adverse Event|0
2287804|NCT02453555|3978258|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1
2287805|NCT02453555|3978259|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0
2287806|NCT02453555|3978260|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0
2287807|NCT02453555|3978261|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0
2136949|NCT01081834|3743224|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2136950|NCT01081834|3743225|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2136951|NCT01081834|3743221|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
2136952|NCT01081834|3743222|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
2136953|NCT01081834|3743223|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
2136954|NCT01081834|3743224|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
2136955|NCT01081834|3743225|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0
2136956|NCT01081834|3743221|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2136957|NCT01081834|3743222|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
2136958|NCT01081834|3743223|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2136959|NCT01081834|3743224|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2136960|NCT01081834|3743225|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2136961|NCT01081834|3743221|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2136962|NCT01081834|3743222|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2136963|NCT01081834|3743223|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2136964|NCT01081834|3743224|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2136965|NCT01081834|3743225|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2136966|NCT01081834|3743221|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
2136967|NCT01081834|3743222|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
2136968|NCT01081834|3743223|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
2136969|NCT01081834|3743224|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
2136970|NCT01081834|3743225|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
2136971|NCT01081834|3743221|FG000|Extension Period: Week 26 to Week 52|Other|4
2136972|NCT01081834|3743222|FG001|Extension Period: Week 26 to Week 52|Other|5
2136973|NCT01081834|3743223|FG002|Extension Period: Week 26 to Week 52|Other|4
2136974|NCT01081834|3743224|FG003|Extension Period: Week 26 to Week 52|Other|0
2136975|NCT01081834|3743225|FG004|Extension Period: Week 26 to Week 52|Other|0
2136976|NCT01081834|3743221|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
2136977|NCT01081834|3743222|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
2136978|NCT01081834|3743223|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
2136979|NCT01081834|3743224|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
2136980|NCT01081834|3743225|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
2136981|NCT01081834|3743221|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
2136982|NCT01081834|3743222|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1
2136983|NCT01081834|3743223|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
2136984|NCT01081834|3743224|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0
2136985|NCT01081834|3743225|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0
2136986|NCT01081873|3743244|FG000|Overall Study|Death|86
2136987|NCT01081873|3743244|FG000|Overall Study|Withdrawal by Subject|10
2136988|NCT01081873|3743244|FG000|Overall Study|Lost to Follow-up|142
2136989|NCT01081873|3743244|FG000|Overall Study|Progression of prostate cancer|13
2136990|NCT01081873|3743244|FG000|Overall Study|Other|47
2136991|NCT01081912|3743273|FG000|Conversion/Titration|Adverse Event|47
2136992|NCT01081912|3743274|FG001|Conversion/Titration|Adverse Event|0
2136993|NCT01081912|3743275|FG002|Conversion/Titration|Adverse Event|0
2136994|NCT01081912|3743273|FG000|Conversion/Titration|Lack of Efficacy|17
2136995|NCT01081912|3743274|FG001|Conversion/Titration|Lack of Efficacy|0
2136996|NCT01081912|3743275|FG002|Conversion/Titration|Lack of Efficacy|0
2136997|NCT01081912|3743273|FG000|Conversion/Titration|Lost to Follow-up|5
2136998|NCT01081912|3743274|FG001|Conversion/Titration|Lost to Follow-up|0
2136999|NCT01081912|3743275|FG002|Conversion/Titration|Lost to Follow-up|0
2137000|NCT01081912|3743273|FG000|Conversion/Titration|Physician Decision|2
2137001|NCT01081912|3743274|FG001|Conversion/Titration|Physician Decision|0
2137002|NCT01081912|3743275|FG002|Conversion/Titration|Physician Decision|0
2137003|NCT01081912|3743273|FG000|Conversion/Titration|Protocol Violation|67
2137004|NCT01081912|3743274|FG001|Conversion/Titration|Protocol Violation|0
2137005|NCT01081912|3743275|FG002|Conversion/Titration|Protocol Violation|0
2137006|NCT01081912|3743273|FG000|Conversion/Titration|Withdrawal by Subject|23
2137007|NCT01081912|3743274|FG001|Conversion/Titration|Withdrawal by Subject|0
2137008|NCT01081912|3743275|FG002|Conversion/Titration|Withdrawal by Subject|0
2137009|NCT01081912|3743273|FG000|Conversion/Titration|Non-Compliance|47
2137010|NCT01081912|3743274|FG001|Conversion/Titration|Non-Compliance|0
2137011|NCT01081912|3743275|FG002|Conversion/Titration|Non-Compliance|0
2137012|NCT01081912|3743273|FG000|Maintenance Treatment|Adverse Event|0
2137013|NCT01081912|3743274|FG001|Maintenance Treatment|Adverse Event|2
2137014|NCT01081912|3743275|FG002|Maintenance Treatment|Adverse Event|12
2137015|NCT01081912|3743273|FG000|Maintenance Treatment|Lack of Efficacy|0
2137016|NCT01081912|3743274|FG001|Maintenance Treatment|Lack of Efficacy|14
2137017|NCT01081912|3743275|FG002|Maintenance Treatment|Lack of Efficacy|64
2137018|NCT01081912|3743273|FG000|Maintenance Treatment|Lost to Follow-up|0
2137019|NCT01081912|3743274|FG001|Maintenance Treatment|Lost to Follow-up|1
2137020|NCT01081912|3743275|FG002|Maintenance Treatment|Lost to Follow-up|0
2137021|NCT01081912|3743273|FG000|Maintenance Treatment|Physician Decision|0
2137022|NCT01081912|3743274|FG001|Maintenance Treatment|Physician Decision|0
2137023|NCT01081912|3743275|FG002|Maintenance Treatment|Physician Decision|1
2137024|NCT01081912|3743273|FG000|Maintenance Treatment|Protocol Violation|0
2137025|NCT01081912|3743274|FG001|Maintenance Treatment|Protocol Violation|1
2137026|NCT01081912|3743275|FG002|Maintenance Treatment|Protocol Violation|2
2207806|NCT01632891|3846984|FG001|Overall Study|Lost to Follow-up|1
2207807|NCT01632891|3846983|FG000|Overall Study|Withdrawal by Subject|1
2207808|NCT01632891|3846984|FG001|Overall Study|Withdrawal by Subject|0
2207809|NCT01632904|3846996|FG000|Overall Study|Adverse Event|4
2207810|NCT01632904|3846997|FG001|Overall Study|Adverse Event|1
2207811|NCT01632904|3846996|FG000|Overall Study|Physician Decision|0
2207812|NCT01632904|3846997|FG001|Overall Study|Physician Decision|1
2207813|NCT01632904|3846996|FG000|Overall Study|Subject decision|3
2207814|NCT01632904|3846997|FG001|Overall Study|Subject decision|2
2207815|NCT01632904|3846996|FG000|Overall Study|Disease Progression|0
2207816|NCT01632904|3846997|FG001|Overall Study|Disease Progression|1
2207817|NCT01632904|3846996|FG000|Overall Study|Reason for discontinuation not available|0
2207818|NCT01632904|3846997|FG001|Overall Study|Reason for discontinuation not available|1
2207819|NCT01633060|3847011|FG000|Randomization Phase|Protocol deviation|1
2137027|NCT01081912|3743273|FG000|Maintenance Treatment|Withdrawal by Subject|0
2207820|NCT01633060|3847012|FG001|Randomization Phase|Protocol deviation|2
2207821|NCT01633060|3847011|FG000|Randomization Phase|Technical problem|0
2207822|NCT01633060|3847012|FG001|Randomization Phase|Technical problem|1
2207823|NCT01633060|3847011|FG000|Treatment Phase|Adverse Event|24
2287808|NCT02453555|3978262|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0
2287809|NCT02453555|3978263|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0
2137028|NCT01081912|3743274|FG001|Maintenance Treatment|Withdrawal by Subject|5
2137029|NCT01081912|3743275|FG002|Maintenance Treatment|Withdrawal by Subject|5
2137030|NCT01081912|3743273|FG000|Maintenance Treatment|Non-Compliance|0
2137031|NCT01081912|3743274|FG001|Maintenance Treatment|Non-Compliance|4
2137032|NCT01081912|3743275|FG002|Maintenance Treatment|Non-Compliance|7
2137033|NCT01081912|3743273|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0
2137034|NCT01081912|3743274|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0
2137035|NCT01081912|3743275|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1
2137036|NCT01081951|3743284|FG000|Overall Study|Death|54
2137037|NCT01081951|3743285|FG001|Overall Study|Death|47
2137038|NCT01081951|3743284|FG000|Overall Study|Withdrawal by Subject|2
2137039|NCT01081951|3743285|FG001|Overall Study|Withdrawal by Subject|6
2137040|NCT01081951|3743284|FG000|Overall Study|Allocated treatment but did not take it|0
2137041|NCT01081951|3743285|FG001|Overall Study|Allocated treatment but did not take it|1
2137042|NCT01081951|3743284|FG000|Overall Study|Lost to Follow-up|0
2137043|NCT01081951|3743285|FG001|Overall Study|Lost to Follow-up|1
2137044|NCT01082081|3743294|FG000|Overall Study|Lost to Follow-up|0
2137045|NCT01082081|3743295|FG001|Overall Study|Lost to Follow-up|0
2137046|NCT01082081|3743296|FG002|Overall Study|Lost to Follow-up|1
2137047|NCT01082081|3743294|FG000|Overall Study|Withdrawal by Subject|0
2137048|NCT01082081|3743295|FG001|Overall Study|Withdrawal by Subject|0
2137049|NCT01082081|3743296|FG002|Overall Study|Withdrawal by Subject|1
2137050|NCT01082081|3743294|FG000|Overall Study|Other Reason|0
2137051|NCT01082081|3743295|FG001|Overall Study|Other Reason|1
2137052|NCT01082081|3743296|FG002|Overall Study|Other Reason|0
2137053|NCT01082211|3743309|FG000|Overall Study|Protocol Violation|4
2137054|NCT01082211|3743309|FG000|Overall Study|No protocol treatment received|3
2137055|NCT01082328|3743316|FG000|Overall Study|Adverse Event|1
2137056|NCT01082367|3743322|FG000|Double-blind Period|Administrative problems|0
2137057|NCT01082367|3743323|FG001|Double-blind Period|Administrative problems|1
2137058|NCT01082367|3743322|FG000|Double-blind Period|Lack of Efficacy|5
2137059|NCT01082367|3743323|FG001|Double-blind Period|Lack of Efficacy|11
2137060|NCT01082367|3743322|FG000|Double-blind Period|Adverse Event|0
2137061|NCT01082367|3743323|FG001|Double-blind Period|Adverse Event|1
2137062|NCT01082367|3743322|FG000|Follow-up (F-U) Period|Administrative problems|1
2137063|NCT01082367|3743323|FG001|Follow-up (F-U) Period|Administrative problems|0
2137064|NCT01082367|3743322|FG000|Follow-up (F-U) Period|Abnormal lab values|1
2137065|NCT01082367|3743323|FG001|Follow-up (F-U) Period|Abnormal lab values|0
2137066|NCT01082367|3743322|FG000|Follow-up (F-U) Period|Adverse Event|0
2137067|NCT01082367|3743323|FG001|Follow-up (F-U) Period|Adverse Event|1
2137068|NCT01082614|3743352|FG000|Overall Study|Adverse Event|1
2207824|NCT01633060|3847012|FG001|Treatment Phase|Adverse Event|3
2207825|NCT01633060|3847011|FG000|Treatment Phase|Lost to Follow-up|1
2287810|NCT02453555|3978258|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2
2287811|NCT02453555|3978259|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4
2287812|NCT02453555|3978260|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2287813|NCT02453555|3978261|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2287814|NCT02453555|3978262|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2287815|NCT02453555|3978263|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2287816|NCT02453555|3978258|FG000|24-week Double-blind Treatment Period|Other than specified above|0
2287817|NCT02453555|3978259|FG001|24-week Double-blind Treatment Period|Other than specified above|3
2287818|NCT02453555|3978260|FG002|24-week Double-blind Treatment Period|Other than specified above|0
2137069|NCT01082614|3743353|FG001|Overall Study|Adverse Event|4
2137070|NCT01082614|3743352|FG000|Overall Study|Equipment Malfunction|0
2137071|NCT01082614|3743353|FG001|Overall Study|Equipment Malfunction|1
2137072|NCT01082614|3743352|FG000|Overall Study|Physician Decision|2
2137073|NCT01082614|3743353|FG001|Overall Study|Physician Decision|0
2137074|NCT01082640|3743362|FG000|Overall Study|Adverse Event|9
2137075|NCT01082640|3743363|FG001|Overall Study|Adverse Event|5
2137076|NCT01082640|3743364|FG002|Overall Study|Adverse Event|3
2137077|NCT01082640|3743362|FG000|Overall Study|Withdrawal by Subject|3
2137078|NCT01082640|3743363|FG001|Overall Study|Withdrawal by Subject|3
2137079|NCT01082640|3743364|FG002|Overall Study|Withdrawal by Subject|2
2137080|NCT01082640|3743362|FG000|Overall Study|Major protocol deviation|3
2137081|NCT01082640|3743363|FG001|Overall Study|Major protocol deviation|3
2137082|NCT01082640|3743364|FG002|Overall Study|Major protocol deviation|0
2137083|NCT01082640|3743362|FG000|Overall Study|Lost to Follow-up|0
2137084|NCT01082640|3743363|FG001|Overall Study|Lost to Follow-up|3
2137085|NCT01082640|3743364|FG002|Overall Study|Lost to Follow-up|0
2137086|NCT01082640|3743362|FG000|Overall Study|Other|2
2137087|NCT01082640|3743363|FG001|Overall Study|Other|1
2137088|NCT01082640|3743364|FG002|Overall Study|Other|3
2137089|NCT01082874|3743379|FG000|Overall Study|Lost to Follow-up|10
2137090|NCT01082874|3743380|FG001|Overall Study|Lost to Follow-up|10
2137091|NCT01082874|3743381|FG002|Overall Study|Lost to Follow-up|6
2137092|NCT01082874|3743382|FG003|Overall Study|Lost to Follow-up|10
2137093|NCT01082874|3743379|FG000|Overall Study|Withdrawal by Subject|1
2137094|NCT01082874|3743380|FG001|Overall Study|Withdrawal by Subject|2
2137095|NCT01082874|3743381|FG002|Overall Study|Withdrawal by Subject|5
2137096|NCT01082874|3743382|FG003|Overall Study|Withdrawal by Subject|3
2137097|NCT01082965|3743407|FG000|Overall Study|Protocol Violation|0
2137098|NCT01082965|3743408|FG001|Overall Study|Protocol Violation|1
2137099|NCT01082965|3743407|FG000|Overall Study|Other|1
2137100|NCT01082965|3743408|FG001|Overall Study|Other|1
2137101|NCT01083121|3743414|FG000|Overall Study|Use of Humira outside the approved label|81
2137102|NCT01083160|3743422|FG000|Overall Study|Adverse Event|1
2137103|NCT01083173|3743426|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
2137104|NCT01083173|3743427|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
2137105|NCT01083173|3743426|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1
2137106|NCT01083173|3743427|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0
2137107|NCT01083173|3743426|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
2137108|NCT01083173|3743427|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
2137109|NCT01083173|3743426|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
2137110|NCT01083173|3743427|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
2137111|NCT01083173|3743426|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
2137112|NCT01083173|3743427|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
2137113|NCT01083173|3743426|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
2137114|NCT01083173|3743427|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
2137115|NCT01083173|3743426|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0
2137116|NCT01083173|3743427|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1
2287819|NCT02453555|3978261|FG003|24-week Double-blind Treatment Period|Other than specified above|0
2287820|NCT02453555|3978262|FG004|24-week Double-blind Treatment Period|Other than specified above|0
2287821|NCT02453555|3978263|FG005|24-week Double-blind Treatment Period|Other than specified above|0
2287822|NCT02453555|3978258|FG000|Extension Period|Adverse Event|0
2287823|NCT02453555|3978259|FG001|Extension Period|Adverse Event|0
2287824|NCT02453555|3978260|FG002|Extension Period|Adverse Event|1
2287825|NCT02453555|3978261|FG003|Extension Period|Adverse Event|2
2287826|NCT02453555|3978262|FG004|Extension Period|Adverse Event|1
2287827|NCT02453555|3978263|FG005|Extension Period|Adverse Event|1
2287828|NCT02453555|3978258|FG000|Extension Period|Protocol Violation|0
2287829|NCT02453555|3978259|FG001|Extension Period|Protocol Violation|0
2287830|NCT02453555|3978260|FG002|Extension Period|Protocol Violation|1
2287831|NCT02453555|3978261|FG003|Extension Period|Protocol Violation|0
2287832|NCT02453555|3978262|FG004|Extension Period|Protocol Violation|0
2287833|NCT02453555|3978263|FG005|Extension Period|Protocol Violation|0
2287834|NCT02453555|3978258|FG000|Extension Period|Withdrawal by Subject|0
2287835|NCT02453555|3978259|FG001|Extension Period|Withdrawal by Subject|0
2287836|NCT02453555|3978260|FG002|Extension Period|Withdrawal by Subject|1
2287837|NCT02453555|3978261|FG003|Extension Period|Withdrawal by Subject|0
2287838|NCT02453555|3978262|FG004|Extension Period|Withdrawal by Subject|0
2287839|NCT02453555|3978263|FG005|Extension Period|Withdrawal by Subject|0
2287840|NCT02453685|3978307|FG000|Overall Study|Adverse Event|0
2287841|NCT02453685|3978308|FG001|Overall Study|Adverse Event|1
2287842|NCT02453685|3978307|FG000|Overall Study|Protocol Violation|7
2287843|NCT02453685|3978308|FG001|Overall Study|Protocol Violation|4
2287844|NCT02453685|3978307|FG000|Overall Study|Lost to Follow-up|0
2287845|NCT02453685|3978308|FG001|Overall Study|Lost to Follow-up|1
2287846|NCT02453685|3978307|FG000|Overall Study|Withdrawal by Subject|8
2287847|NCT02453685|3978308|FG001|Overall Study|Withdrawal by Subject|4
2287848|NCT02453685|3978307|FG000|Overall Study|Unclassified|4
2287849|NCT02453685|3978308|FG001|Overall Study|Unclassified|2
2137117|NCT01083173|3743426|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
2137118|NCT01083173|3743427|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
2137119|NCT01083173|3743426|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
2137120|NCT01083173|3743427|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
2137121|NCT01083173|3743426|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
2137122|NCT01083173|3743427|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
2137123|NCT01083173|3743426|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
2137124|NCT01083173|3743427|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
2137125|NCT01083186|3743436|FG000|Overall Study|Lost to Follow-up|48
2137126|NCT01083186|3743436|FG000|Overall Study|Consent Withdrawal|7
2137127|NCT01083186|3743436|FG000|Overall Study|Death|3
2137128|NCT01083186|3743436|FG000|Overall Study|Adverse Event|3
2137129|NCT01083186|3743436|FG000|Overall Study|Lack of Efficacy|2
2137130|NCT01083186|3743436|FG000|Overall Study|Hemodialysis Initiation|28
2137131|NCT01083186|3743436|FG000|Overall Study|Administrative Reasons|2
2137132|NCT01083186|3743436|FG000|Overall Study|Non-compliance to Study Treatment|1
2137133|NCT01083316|3743465|FG000|Overall Study|Adverse Event|2
2137134|NCT01083316|3743465|FG000|Overall Study|Withdrawal by Subject|1
2137135|NCT01083485|3743485|FG000|Overall Study|Adverse Event|0
2137136|NCT01083485|3743486|FG001|Overall Study|Adverse Event|1
2137137|NCT01083485|3743485|FG000|Overall Study|Protocol Violation|1
2137138|NCT01083485|3743486|FG001|Overall Study|Protocol Violation|0
2137139|NCT01083485|3743485|FG000|Overall Study|Withdrawal by Subject|5
2207826|NCT01633060|3847012|FG001|Treatment Phase|Lost to Follow-up|0
2287850|NCT02453711|3978323|FG000|Overall Study|Withdrawal by Subject|5
2287851|NCT02453711|3978324|FG001|Overall Study|Withdrawal by Subject|4
2287852|NCT02453711|3978325|FG002|Overall Study|Withdrawal by Subject|6
2287853|NCT02453711|3978326|FG003|Overall Study|Withdrawal by Subject|4
2287854|NCT02453711|3978327|FG004|Overall Study|Withdrawal by Subject|1
2287855|NCT02453711|3978328|FG005|Overall Study|Withdrawal by Subject|1
2287856|NCT02453711|3978329|FG006|Overall Study|Withdrawal by Subject|0
2287857|NCT02453711|3978330|FG007|Overall Study|Withdrawal by Subject|1
2207827|NCT01633060|3847011|FG000|Treatment Phase|Physician Decision|16
2207828|NCT01633060|3847012|FG001|Treatment Phase|Physician Decision|7
2207829|NCT01633060|3847011|FG000|Treatment Phase|Progressive Disease|210
2207830|NCT01633060|3847012|FG001|Treatment Phase|Progressive Disease|120
2207831|NCT01633060|3847011|FG000|Treatment Phase|Protocol Deviation|1
2207832|NCT01633060|3847012|FG001|Treatment Phase|Protocol Deviation|0
2207833|NCT01633060|3847011|FG000|Treatment Phase|Study Terminated by sponsor|7
2207834|NCT01633060|3847012|FG001|Treatment Phase|Study Terminated by sponsor|3
2207835|NCT01633060|3847011|FG000|Treatment Phase|Subject/guardian decision|25
2207836|NCT01633060|3847012|FG001|Treatment Phase|Subject/guardian decision|4
2287858|NCT02453711|3978331|FG008|Overall Study|Withdrawal by Subject|7
2287859|NCT02453711|3978323|FG000|Overall Study|Lost to Follow-up|5
2287860|NCT02453711|3978324|FG001|Overall Study|Lost to Follow-up|3
2287861|NCT02453711|3978325|FG002|Overall Study|Lost to Follow-up|2
2287862|NCT02453711|3978326|FG003|Overall Study|Lost to Follow-up|3
2287863|NCT02453711|3978327|FG004|Overall Study|Lost to Follow-up|1
2287864|NCT02453711|3978328|FG005|Overall Study|Lost to Follow-up|5
2287865|NCT02453711|3978329|FG006|Overall Study|Lost to Follow-up|2
2287866|NCT02453711|3978330|FG007|Overall Study|Lost to Follow-up|6
2287867|NCT02453711|3978331|FG008|Overall Study|Lost to Follow-up|6
2287868|NCT02453711|3978323|FG000|Overall Study|Death|0
2287869|NCT02453711|3978324|FG001|Overall Study|Death|0
2287870|NCT02453711|3978325|FG002|Overall Study|Death|0
2287871|NCT02453711|3978326|FG003|Overall Study|Death|0
2137140|NCT01083485|3743486|FG001|Overall Study|Withdrawal by Subject|2
2207837|NCT01633060|3847011|FG000|Treatment Phase|Death|4
2137141|NCT01083485|3743485|FG000|Overall Study|Other|1
2137142|NCT01083485|3743486|FG001|Overall Study|Other|0
2137143|NCT01083576|3743496|FG000|Overall Study|Treatment Failure|6
2137144|NCT01083576|3743497|FG001|Overall Study|Treatment Failure|1
2137145|NCT01083602|3743504|FG000|Overall Study|Adverse Event|11
2137146|NCT01083602|3743504|FG000|Overall Study|New Cancer Therapy|2
2137147|NCT01083602|3743504|FG000|Overall Study|Death|1
2137148|NCT01083602|3743504|FG000|Overall Study|Withdrawal by Subject|5
2137149|NCT01083602|3743504|FG000|Overall Study|Lack of Efficacy|36
2137150|NCT01083641|3743517|FG000|Overall Study|Withdrawal by Subject|2
2137151|NCT01083680|3743534|FG000|Overall Study|Lost to Follow-up|2758
2137152|NCT01083680|3743534|FG000|Overall Study|Withdrawal by Subject|1086
2137153|NCT01083693|3743541|FG000|Overall Study|Adverse Event|1
2137154|NCT01083693|3743542|FG001|Overall Study|Adverse Event|1
2137155|NCT01083693|3743543|FG002|Overall Study|Adverse Event|0
2137156|NCT01083693|3743541|FG000|Overall Study|Lost to Follow-up|2
2137157|NCT01083693|3743542|FG001|Overall Study|Lost to Follow-up|0
2137158|NCT01083693|3743543|FG002|Overall Study|Lost to Follow-up|2
2207838|NCT01633060|3847012|FG001|Treatment Phase|Death|3
2207839|NCT01633060|3847011|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
2207840|NCT01633060|3847012|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
2207841|NCT01633060|3847011|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
2287872|NCT02453711|3978327|FG004|Overall Study|Death|0
2287873|NCT02453711|3978328|FG005|Overall Study|Death|0
2137159|NCT01083693|3743541|FG000|Overall Study|Lack of effectiveness|13
2137160|NCT01083693|3743542|FG001|Overall Study|Lack of effectiveness|2
2137161|NCT01083693|3743543|FG002|Overall Study|Lack of effectiveness|2
2137162|NCT01083693|3743541|FG000|Overall Study|Patient Moved|0
2137163|NCT01083693|3743542|FG001|Overall Study|Patient Moved|1
2137164|NCT01083693|3743543|FG002|Overall Study|Patient Moved|0
2137165|NCT01083693|3743541|FG000|Overall Study|Complete remission|0
2137166|NCT01083693|3743542|FG001|Overall Study|Complete remission|1
2137167|NCT01083693|3743543|FG002|Overall Study|Complete remission|0
2137168|NCT01083693|3743541|FG000|Overall Study|Other medical condition/surgery|1
2137169|NCT01083693|3743542|FG001|Overall Study|Other medical condition/surgery|1
2137170|NCT01083693|3743543|FG002|Overall Study|Other medical condition/surgery|0
2137171|NCT01083693|3743541|FG000|Overall Study|Withdrawal by Subject|3
2137172|NCT01083693|3743542|FG001|Overall Study|Withdrawal by Subject|0
2137173|NCT01083693|3743543|FG002|Overall Study|Withdrawal by Subject|2
2137174|NCT01083693|3743541|FG000|Overall Study|Reason unknown|0
2137175|NCT01083693|3743542|FG001|Overall Study|Reason unknown|0
2137176|NCT01083693|3743543|FG002|Overall Study|Reason unknown|1
2137177|NCT01083771|3743579|FG000|Overall Study|non-compliant|2
2137178|NCT01083771|3743579|FG000|Overall Study|Withdrawal by Subject|3
2137179|NCT01083810|3743586|FG000|Overall Study|Lost to Follow-up|23
2137180|NCT01083810|3743587|FG001|Overall Study|Lost to Follow-up|11
2137181|NCT01083810|3743588|FG002|Overall Study|Lost to Follow-up|4
2137182|NCT01083810|3743586|FG000|Overall Study|Adverse Event|15
2137183|NCT01083810|3743587|FG001|Overall Study|Adverse Event|11
2137184|NCT01083810|3743588|FG002|Overall Study|Adverse Event|4
2137185|NCT01083810|3743586|FG000|Overall Study|Withdrawal by Subject|7
2137186|NCT01083810|3743587|FG001|Overall Study|Withdrawal by Subject|2
2137187|NCT01083810|3743588|FG002|Overall Study|Withdrawal by Subject|4
2137188|NCT01083810|3743586|FG000|Overall Study|Reason not reported|6
2137189|NCT01083810|3743587|FG001|Overall Study|Reason not reported|1
2137190|NCT01083810|3743588|FG002|Overall Study|Reason not reported|1
2207842|NCT01633060|3847012|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
2207843|NCT01633060|3847011|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
2207844|NCT01633060|3847012|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
2137191|NCT01083810|3743586|FG000|Overall Study|Non-compliance|4
2137192|NCT01083810|3743587|FG001|Overall Study|Non-compliance|7
2137193|NCT01083810|3743588|FG002|Overall Study|Non-compliance|2
2137194|NCT01083810|3743586|FG000|Overall Study|Simplification|4
2137195|NCT01083810|3743587|FG001|Overall Study|Simplification|1
2137196|NCT01083810|3743588|FG002|Overall Study|Simplification|0
2137197|NCT01083810|3743586|FG000|Overall Study|Death|2
2137198|NCT01083810|3743587|FG001|Overall Study|Death|2
2137199|NCT01083810|3743588|FG002|Overall Study|Death|3
2137200|NCT01083810|3743586|FG000|Overall Study|Co-morbidities|1
2137201|NCT01083810|3743587|FG001|Overall Study|Co-morbidities|0
2287874|NCT02453711|3978329|FG006|Overall Study|Death|1
2287875|NCT02453711|3978330|FG007|Overall Study|Death|0
2287876|NCT02453711|3978331|FG008|Overall Study|Death|0
2287877|NCT02453711|3978323|FG000|Overall Study|Unclassified|1
2287878|NCT02453711|3978324|FG001|Overall Study|Unclassified|0
2287879|NCT02453711|3978325|FG002|Overall Study|Unclassified|1
2287880|NCT02453711|3978326|FG003|Overall Study|Unclassified|0
2137202|NCT01083810|3743588|FG002|Overall Study|Co-morbidities|0
2137203|NCT01083810|3743586|FG000|Overall Study|Participation in study|1
2137204|NCT01083810|3743587|FG001|Overall Study|Participation in study|0
2137205|NCT01083810|3743588|FG002|Overall Study|Participation in study|0
2137206|NCT01083810|3743586|FG000|Overall Study|Therapy break|1
2137207|NCT01083810|3743587|FG001|Overall Study|Therapy break|2
2137208|NCT01083810|3743588|FG002|Overall Study|Therapy break|2
2137209|NCT01083810|3743586|FG000|Overall Study|Virologic failure|1
2137210|NCT01083810|3743587|FG001|Overall Study|Virologic failure|8
2137211|NCT01083810|3743588|FG002|Overall Study|Virologic failure|0
2137212|NCT01084005|3743625|FG000|Overall Study|Adverse Event|1
2137213|NCT01084005|3743626|FG001|Overall Study|Adverse Event|8
2137214|NCT01084005|3743625|FG000|Overall Study|Protocol Violation|3
2137215|NCT01084005|3743626|FG001|Overall Study|Protocol Violation|7
2137216|NCT01084005|3743625|FG000|Overall Study|Withdrawal by Subject|1
2137217|NCT01084005|3743626|FG001|Overall Study|Withdrawal by Subject|1
2137218|NCT01084083|3743632|FG000|Overall Study|Adverse Event|5
2137219|NCT01084083|3743632|FG000|Overall Study|Death|1
2137220|NCT01084083|3743632|FG000|Overall Study|Withdrawal by Subject|2
2207845|NCT01633060|3847011|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
2207846|NCT01633060|3847012|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
2217662|NCT01709305|3860932|FG004|Phase 1|Travel, moving, etc.|0
2217663|NCT01709305|3860928|FG000|Phase 1|Physician Decision|13
2137221|NCT01084083|3743632|FG000|Overall Study|Complicating disease|1
2137222|NCT01084083|3743632|FG000|Overall Study|Other|2
2137223|NCT01084083|3743632|FG000|Overall Study|Never started assigned therapy|1
2217664|NCT01709305|3860929|FG001|Phase 1|Physician Decision|0
2217665|NCT01709305|3860930|FG002|Phase 1|Physician Decision|0
2217666|NCT01709305|3860931|FG003|Phase 1|Physician Decision|0
2217667|NCT01709305|3860932|FG004|Phase 1|Physician Decision|0
2217668|NCT01709305|3860928|FG000|Phase 1|Protocol Violation|118
2217669|NCT01709305|3860929|FG001|Phase 1|Protocol Violation|0
2287881|NCT02453711|3978327|FG004|Overall Study|Unclassified|0
2287882|NCT02453711|3978328|FG005|Overall Study|Unclassified|0
2287883|NCT02453711|3978329|FG006|Overall Study|Unclassified|0
2137224|NCT01084135|3743641|FG000|20 Week|Physician Decision|0
2137225|NCT01084135|3743642|FG001|20 Week|Physician Decision|1
2178375|NCT01383174|3803135|FG001|3 Month Assessment|Lost to Follow-up|0
2178376|NCT01383174|3803134|FG000|3 Month Assessment|Refused to complete|4
2178377|NCT01383174|3803135|FG001|3 Month Assessment|Refused to complete|0
2178378|NCT01383174|3803134|FG000|6 Month Assessment|Lost to Follow-up|1
2178379|NCT01383174|3803135|FG001|6 Month Assessment|Lost to Follow-up|1
2178380|NCT01383174|3803134|FG000|6 Month Assessment|Refused to complete|4
2178381|NCT01383174|3803135|FG001|6 Month Assessment|Refused to complete|0
2178382|NCT01383317|3803161|FG000|Overall Study|Lost to Follow-up|2
2178383|NCT01383317|3803162|FG001|Overall Study|Lost to Follow-up|1
2178384|NCT01383317|3803161|FG000|Overall Study|Death|1
2178385|NCT01383317|3803162|FG001|Overall Study|Death|0
2178386|NCT01383317|3803161|FG000|Overall Study|Adverse Event|0
2178387|NCT01383317|3803162|FG001|Overall Study|Adverse Event|1
2178388|NCT01383356|3803168|FG000|Period 1|Adverse Event|5
2178389|NCT01383356|3803169|FG001|Period 1|Adverse Event|3
2178390|NCT01383356|3803168|FG000|Period 1|Non-compliance|3
2178391|NCT01383356|3803169|FG001|Period 1|Non-compliance|0
2178392|NCT01383356|3803168|FG000|Period 1|Out of Range Mid-study-Test|0
2178393|NCT01383356|3803169|FG001|Period 1|Out of Range Mid-study-Test|1
2178394|NCT01383356|3803168|FG000|Period 1|Personal|0
2178395|NCT01383356|3803169|FG001|Period 1|Personal|2
2178396|NCT01383486|3803183|FG000|Overall Study|Lost to Follow-up|10
2178397|NCT01383486|3803183|FG000|Overall Study|Incomplete information for analysis|2
2178398|NCT01383486|3803183|FG000|Overall Study|Did not take any product|6
2178399|NCT01383499|3803188|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1
2178400|NCT01383499|3803189|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0
2178401|NCT01383499|3803190|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
2178402|NCT01383499|3803191|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
2178403|NCT01383707|3803217|FG000|Overall Study|Consent withdrawal|6
2178404|NCT01383707|3803217|FG000|Overall Study|Death|19
2178405|NCT01383707|3803217|FG000|Overall Study|Other|8
2178406|NCT01383707|3803217|FG000|Overall Study|Sponsor's decision|2
2178407|NCT01383707|3803217|FG000|Overall Study|Adverse Event|14
2178408|NCT01383707|3803217|FG000|Overall Study|Progressive disease|23
2178409|NCT01383928|3803237|FG000|Overall Study|Initiation of ASCT|2
2178410|NCT01383928|3803238|FG001|Overall Study|Initiation of ASCT|1
2178411|NCT01383928|3803239|FG002|Overall Study|Initiation of ASCT|18
2178412|NCT01383928|3803237|FG000|Overall Study|Adverse Event|1
2178413|NCT01383928|3803238|FG001|Overall Study|Adverse Event|2
2178414|NCT01383928|3803239|FG002|Overall Study|Adverse Event|8
2178415|NCT01383928|3803237|FG000|Overall Study|Other|1
2178416|NCT01383928|3803238|FG001|Overall Study|Other|3
2178417|NCT01383928|3803239|FG002|Overall Study|Other|4
2178418|NCT01383928|3803237|FG000|Overall Study|Progressive Disease|1
2178419|NCT01383928|3803238|FG001|Overall Study|Progressive Disease|1
2178420|NCT01383928|3803239|FG002|Overall Study|Progressive Disease|5
2178421|NCT01383928|3803237|FG000|Overall Study|Withdrawal by Subject|0
2178422|NCT01383928|3803238|FG001|Overall Study|Withdrawal by Subject|0
2178423|NCT01383928|3803239|FG002|Overall Study|Withdrawal by Subject|4
2178424|NCT01383928|3803237|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
2178425|NCT01383928|3803238|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
2178426|NCT01383928|3803239|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
2178427|NCT01383954|3803249|FG000|Overall Study|Lack of Efficacy|2
2178428|NCT01383954|3803249|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2
2287884|NCT02453711|3978330|FG007|Overall Study|Unclassified|0
2287885|NCT02453711|3978331|FG008|Overall Study|Unclassified|0
2287886|NCT02453841|3978358|FG000|Overall Study|Protocol Violation|1
2287887|NCT02453841|3978358|FG000|Overall Study|Unable to obtain blood samples|2
2287888|NCT02454101|3978370|FG000|Overall Study|Adverse Event|2
2287889|NCT02454101|3978371|FG001|Overall Study|Adverse Event|3
2287890|NCT02454101|3978370|FG000|Overall Study|Lost to Follow-up|3
2287891|NCT02454101|3978371|FG001|Overall Study|Lost to Follow-up|4
2287892|NCT02454478|3978433|FG000|Overall Study|Incomplete DLT Evaluation|1
2287893|NCT02454530|3978439|FG000|Overall Study|Other|8
2287894|NCT02454530|3978440|FG001|Overall Study|Other|13
2287895|NCT02454530|3978439|FG000|Overall Study|Missing information|56
2287896|NCT02454530|3978440|FG001|Overall Study|Missing information|69
2287897|NCT02454530|3978439|FG000|Overall Study|Death|2
2287898|NCT02454530|3978440|FG001|Overall Study|Death|41
2287899|NCT02454530|3978439|FG000|Overall Study|Lost to Follow-up|4
2287900|NCT02454530|3978440|FG001|Overall Study|Lost to Follow-up|4
2287901|NCT02454608|3978450|FG000|Double-Blind Period|Lack of Efficacy|0
2287902|NCT02454608|3978451|FG001|Double-Blind Period|Lack of Efficacy|2
2178429|NCT01383954|3803249|FG000|Overall Study|Adverse Event|1
2178430|NCT01383954|3803249|FG000|Overall Study|Reason Not Specified|9
2178431|NCT01383993|3803256|FG000|Overall Study|Adverse Event|1
2178432|NCT01383993|3803257|FG001|Overall Study|Adverse Event|1
2178433|NCT01383993|3803258|FG002|Overall Study|Adverse Event|0
2178434|NCT01383993|3803256|FG000|Overall Study|Withdrawal by Subject|0
2178435|NCT01383993|3803257|FG001|Overall Study|Withdrawal by Subject|0
2287903|NCT02454608|3978452|FG002|Double-Blind Period|Lack of Efficacy|0
2207847|NCT01633060|3847011|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
2207848|NCT01633060|3847012|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
2207849|NCT01633060|3847011|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1
2207850|NCT01633060|3847012|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0
2207851|NCT01633112|3847022|FG000|Overall Study|Lack of Efficacy|1
2207852|NCT01633112|3847023|FG001|Overall Study|Lack of Efficacy|6
2137226|NCT01084174|3743663|FG000|Overall Study|gastrointestinal symptoms|1
2137227|NCT01084174|3743664|FG001|Overall Study|gastrointestinal symptoms|1
2137228|NCT01084174|3743663|FG000|Overall Study|Eosinophilic esophagitis|0
2137229|NCT01084174|3743664|FG001|Overall Study|Eosinophilic esophagitis|1
2137230|NCT01084174|3743663|FG000|Overall Study|Anaphylaxis|0
2137231|NCT01084174|3743664|FG001|Overall Study|Anaphylaxis|1
2137232|NCT01084174|3743663|FG000|Overall Study|Participant noncompliance|0
2137233|NCT01084174|3743664|FG001|Overall Study|Participant noncompliance|1
2207853|NCT01633112|3847024|FG002|Overall Study|Lack of Efficacy|13
2207854|NCT01633112|3847022|FG000|Overall Study|Abnormal laboratory value(s)|3
2207855|NCT01633112|3847023|FG001|Overall Study|Abnormal laboratory value(s)|1
2207856|NCT01633112|3847024|FG002|Overall Study|Abnormal laboratory value(s)|0
2137234|NCT01084239|3743672|FG000|28-Day Follow-up|Lost to Follow-up|4
2137235|NCT01084239|3743673|FG001|28-Day Follow-up|Lost to Follow-up|9
2137236|NCT01084252|3743695|FG000|Phase 1 (120 Weeks)|Adverse Event|0
2137237|NCT01084252|3743696|FG001|Phase 1 (120 Weeks)|Adverse Event|0
2137238|NCT01084252|3743697|FG002|Phase 1 (120 Weeks)|Adverse Event|1
2137239|NCT01084252|3743698|FG003|Phase 1 (120 Weeks)|Adverse Event|1
2137240|NCT01084252|3743699|FG004|Phase 1 (120 Weeks)|Adverse Event|1
2137241|NCT01084252|3743700|FG005|Phase 1 (120 Weeks)|Adverse Event|0
2137242|NCT01084252|3743701|FG006|Phase 1 (120 Weeks)|Adverse Event|1
2137243|NCT01084252|3743702|FG007|Phase 1 (120 Weeks)|Adverse Event|0
2137244|NCT01084252|3743703|FG008|Phase 1 (120 Weeks)|Adverse Event|0
2137245|NCT01084252|3743704|FG009|Phase 1 (120 Weeks)|Adverse Event|0
2137246|NCT01084252|3743705|FG010|Phase 1 (120 Weeks)|Adverse Event|0
2137247|NCT01084252|3743706|FG011|Phase 1 (120 Weeks)|Adverse Event|0
2137248|NCT01084252|3743707|FG012|Phase 1 (120 Weeks)|Adverse Event|0
2137249|NCT01084252|3743708|FG013|Phase 1 (120 Weeks)|Adverse Event|0
2137250|NCT01084252|3743695|FG000|Phase 1 (120 Weeks)|Progressive disease|15
2137251|NCT01084252|3743696|FG001|Phase 1 (120 Weeks)|Progressive disease|5
2137252|NCT01084252|3743697|FG002|Phase 1 (120 Weeks)|Progressive disease|2
2137253|NCT01084252|3743698|FG003|Phase 1 (120 Weeks)|Progressive disease|22
2137254|NCT01084252|3743699|FG004|Phase 1 (120 Weeks)|Progressive disease|16
2137255|NCT01084252|3743700|FG005|Phase 1 (120 Weeks)|Progressive disease|6
2137256|NCT01084252|3743701|FG006|Phase 1 (120 Weeks)|Progressive disease|5
2137257|NCT01084252|3743702|FG007|Phase 1 (120 Weeks)|Progressive disease|6
2137258|NCT01084252|3743703|FG008|Phase 1 (120 Weeks)|Progressive disease|0
2137259|NCT01084252|3743704|FG009|Phase 1 (120 Weeks)|Progressive disease|0
2137260|NCT01084252|3743705|FG010|Phase 1 (120 Weeks)|Progressive disease|0
2137261|NCT01084252|3743706|FG011|Phase 1 (120 Weeks)|Progressive disease|0
2137262|NCT01084252|3743707|FG012|Phase 1 (120 Weeks)|Progressive disease|0
2137263|NCT01084252|3743708|FG013|Phase 1 (120 Weeks)|Progressive disease|0
2137264|NCT01084252|3743695|FG000|Phase 1 (120 Weeks)|Other than specified above|1
2137265|NCT01084252|3743696|FG001|Phase 1 (120 Weeks)|Other than specified above|1
2137266|NCT01084252|3743697|FG002|Phase 1 (120 Weeks)|Other than specified above|0
2137267|NCT01084252|3743698|FG003|Phase 1 (120 Weeks)|Other than specified above|3
2137268|NCT01084252|3743699|FG004|Phase 1 (120 Weeks)|Other than specified above|1
2137269|NCT01084252|3743700|FG005|Phase 1 (120 Weeks)|Other than specified above|0
2137270|NCT01084252|3743701|FG006|Phase 1 (120 Weeks)|Other than specified above|1
2137271|NCT01084252|3743702|FG007|Phase 1 (120 Weeks)|Other than specified above|1
2137272|NCT01084252|3743703|FG008|Phase 1 (120 Weeks)|Other than specified above|0
2137273|NCT01084252|3743704|FG009|Phase 1 (120 Weeks)|Other than specified above|0
2137274|NCT01084252|3743705|FG010|Phase 1 (120 Weeks)|Other than specified above|0
2137275|NCT01084252|3743706|FG011|Phase 1 (120 Weeks)|Other than specified above|0
2137276|NCT01084252|3743707|FG012|Phase 1 (120 Weeks)|Other than specified above|0
2137277|NCT01084252|3743708|FG013|Phase 1 (120 Weeks)|Other than specified above|0
2137278|NCT01084252|3743695|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2137279|NCT01084252|3743696|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2137280|NCT01084252|3743697|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2137281|NCT01084252|3743698|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2137282|NCT01084252|3743699|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2137283|NCT01084252|3743700|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2137284|NCT01084252|3743701|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2137285|NCT01084252|3743702|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2137286|NCT01084252|3743703|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2137287|NCT01084252|3743704|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
2137288|NCT01084252|3743705|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
2137289|NCT01084252|3743706|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
2137290|NCT01084252|3743707|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2137291|NCT01084252|3743708|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2137292|NCT01084252|3743695|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2178436|NCT01383993|3803258|FG002|Overall Study|Withdrawal by Subject|1
2287904|NCT02454608|3978450|FG000|Open Label Period|Lost to Follow-up|0
2137293|NCT01084252|3743696|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2137294|NCT01084252|3743697|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2137295|NCT01084252|3743698|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2137296|NCT01084252|3743699|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2137297|NCT01084252|3743700|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2137298|NCT01084252|3743701|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2137299|NCT01084252|3743702|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2217670|NCT01709305|3860930|FG002|Phase 1|Protocol Violation|0
2137300|NCT01084252|3743703|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
2137301|NCT01084252|3743704|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
2137302|NCT01084252|3743705|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
2137303|NCT01084252|3743706|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
2137304|NCT01084252|3743707|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2137305|NCT01084252|3743708|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2137306|NCT01084252|3743695|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2137307|NCT01084252|3743696|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2137308|NCT01084252|3743697|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2137309|NCT01084252|3743698|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2137310|NCT01084252|3743699|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2137311|NCT01084252|3743700|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2137312|NCT01084252|3743701|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2137313|NCT01084252|3743702|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2137314|NCT01084252|3743703|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
2137315|NCT01084252|3743704|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2137316|NCT01084252|3743705|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
2137317|NCT01084252|3743706|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
2137318|NCT01084252|3743707|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2137319|NCT01084252|3743708|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2137320|NCT01084252|3743695|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2137321|NCT01084252|3743696|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2137322|NCT01084252|3743697|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2137323|NCT01084252|3743698|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2137324|NCT01084252|3743699|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2137325|NCT01084252|3743700|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2137326|NCT01084252|3743701|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2137327|NCT01084252|3743702|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2137328|NCT01084252|3743703|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
2137329|NCT01084252|3743704|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
2137330|NCT01084252|3743705|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
2137331|NCT01084252|3743706|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
2137332|NCT01084252|3743707|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2137333|NCT01084252|3743708|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2137334|NCT01084252|3743695|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137335|NCT01084252|3743696|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137336|NCT01084252|3743697|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137337|NCT01084252|3743698|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137338|NCT01084252|3743699|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137339|NCT01084252|3743700|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137340|NCT01084252|3743701|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137341|NCT01084252|3743702|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137342|NCT01084252|3743703|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137343|NCT01084252|3743704|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137344|NCT01084252|3743705|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137345|NCT01084252|3743706|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2137346|NCT01084252|3743707|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
2137347|NCT01084252|3743708|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
2137348|NCT01084252|3743695|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137349|NCT01084252|3743696|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137350|NCT01084252|3743697|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137351|NCT01084252|3743698|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137352|NCT01084252|3743699|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137353|NCT01084252|3743700|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137354|NCT01084252|3743701|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137355|NCT01084252|3743702|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137356|NCT01084252|3743703|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137357|NCT01084252|3743704|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137358|NCT01084252|3743705|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137359|NCT01084252|3743706|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2137360|NCT01084252|3743707|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
2137361|NCT01084252|3743708|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
2137362|NCT01084252|3743695|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137363|NCT01084252|3743696|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137364|NCT01084252|3743697|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137365|NCT01084252|3743698|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137366|NCT01084252|3743699|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137367|NCT01084252|3743700|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137368|NCT01084252|3743701|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137369|NCT01084252|3743702|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137370|NCT01084252|3743703|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137371|NCT01084252|3743704|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137372|NCT01084252|3743705|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137373|NCT01084252|3743706|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137374|NCT01084252|3743707|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
2137375|NCT01084252|3743708|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2137376|NCT01084252|3743695|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137377|NCT01084252|3743696|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137378|NCT01084252|3743697|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137379|NCT01084252|3743698|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137380|NCT01084252|3743699|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137381|NCT01084252|3743700|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137382|NCT01084252|3743701|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137383|NCT01084252|3743702|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137384|NCT01084252|3743703|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137385|NCT01084252|3743704|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137386|NCT01084252|3743705|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137387|NCT01084252|3743706|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2137388|NCT01084252|3743707|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
2137389|NCT01084252|3743708|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
2137390|NCT01084252|3743695|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2137391|NCT01084252|3743696|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2137392|NCT01084252|3743697|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2137393|NCT01084252|3743698|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2137394|NCT01084252|3743699|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2287905|NCT02454608|3978451|FG001|Open Label Period|Lost to Follow-up|0
2287906|NCT02454608|3978452|FG002|Open Label Period|Lost to Follow-up|11
2287907|NCT02454608|3978450|FG000|Open Label Period|Withdrawal by Subject|0
2287908|NCT02454608|3978451|FG001|Open Label Period|Withdrawal by Subject|0
2287909|NCT02454608|3978452|FG002|Open Label Period|Withdrawal by Subject|8
2287910|NCT02454959|3978460|FG000|Overall Study|Protocol-Specified Criteria|3
2287911|NCT02454959|3978460|FG000|Overall Study|Physician Decision|1
2137395|NCT01084252|3743700|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2137396|NCT01084252|3743701|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2137397|NCT01084252|3743702|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2137398|NCT01084252|3743703|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2137399|NCT01084252|3743704|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2137400|NCT01084252|3743705|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2137401|NCT01084252|3743706|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2137402|NCT01084252|3743707|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
2137403|NCT01084252|3743708|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
2137404|NCT01084252|3743695|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137405|NCT01084252|3743696|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137406|NCT01084252|3743697|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137407|NCT01084252|3743698|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137408|NCT01084252|3743699|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137409|NCT01084252|3743700|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137410|NCT01084252|3743701|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137411|NCT01084252|3743702|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137412|NCT01084252|3743703|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137413|NCT01084252|3743704|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2180131|NCT01399047|3806093|FG001|Overall Study|Withdrawal by Subject|1
2207857|NCT01633112|3847022|FG000|Overall Study|Abnormal test procedure result(s)|0
2207858|NCT01633112|3847023|FG001|Overall Study|Abnormal test procedure result(s)|1
2207859|NCT01633112|3847024|FG002|Overall Study|Abnormal test procedure result(s)|0
2207860|NCT01633112|3847022|FG000|Overall Study|Administrative problems|1
2207861|NCT01633112|3847023|FG001|Overall Study|Administrative problems|2
2207862|NCT01633112|3847024|FG002|Overall Study|Administrative problems|5
2207863|NCT01633112|3847022|FG000|Overall Study|Adverse Event|16
2207864|NCT01633112|3847023|FG001|Overall Study|Adverse Event|18
2207865|NCT01633112|3847024|FG002|Overall Study|Adverse Event|20
2207866|NCT01633112|3847022|FG000|Overall Study|Lost to Follow-up|7
2207867|NCT01633112|3847023|FG001|Overall Study|Lost to Follow-up|19
2137414|NCT01084252|3743705|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137415|NCT01084252|3743706|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137416|NCT01084252|3743707|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
2137417|NCT01084252|3743708|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2137418|NCT01084538|3743808|FG000|Overall Study|Drug not available|30
2137419|NCT01084538|3743808|FG000|Overall Study|Adverse Event|9
2137420|NCT01084538|3743808|FG000|Overall Study|Kidney transplant|6
2137421|NCT01084538|3743808|FG000|Overall Study|Serious Adverse Event|3
2137422|NCT01084538|3743808|FG000|Overall Study|Lack of effectiveness|2
2137423|NCT01084538|3743808|FG000|Overall Study|Patient noncompliance|2
2137424|NCT01084538|3743808|FG000|Overall Study|Hyperphosphatemia|2
2137425|NCT01084538|3743808|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2
2137426|NCT01084538|3743808|FG000|Overall Study|Change of residence|2
2137427|NCT01084538|3743808|FG000|Overall Study|Over-suppression of parathyroid gland|2
2137428|NCT01084538|3743808|FG000|Overall Study|Reason unknown|8
2137429|NCT01084551|3743815|FG000|Overall Study|Adverse Event|2
2137430|NCT01084551|3743816|FG001|Overall Study|Adverse Event|9
2137431|NCT01084551|3743817|FG002|Overall Study|Adverse Event|4
2137432|NCT01084551|3743815|FG000|Overall Study|Lack of Efficacy|2
2137433|NCT01084551|3743816|FG001|Overall Study|Lack of Efficacy|0
2137434|NCT01084551|3743817|FG002|Overall Study|Lack of Efficacy|1
2137435|NCT01084551|3743815|FG000|Overall Study|Withdrawal by Subject|2
2137436|NCT01084551|3743816|FG001|Overall Study|Withdrawal by Subject|1
2137437|NCT01084551|3743817|FG002|Overall Study|Withdrawal by Subject|0
2137438|NCT01084551|3743815|FG000|Overall Study|Protocol Violation|2
2137439|NCT01084551|3743816|FG001|Overall Study|Protocol Violation|4
2137440|NCT01084551|3743817|FG002|Overall Study|Protocol Violation|0
2137441|NCT01084551|3743815|FG000|Overall Study|Lost to Follow-up|0
2137442|NCT01084551|3743816|FG001|Overall Study|Lost to Follow-up|0
2137443|NCT01084551|3743817|FG002|Overall Study|Lost to Follow-up|3
2137444|NCT01084551|3743815|FG000|Overall Study|Physician Decision|1
2137445|NCT01084551|3743816|FG001|Overall Study|Physician Decision|0
2137446|NCT01084551|3743817|FG002|Overall Study|Physician Decision|0
2137447|NCT01084603|3743825|FG000|Baseline|Withdrawal by Subject|2
2137448|NCT01084603|3743825|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1
2137449|NCT01084603|3743825|FG000|Nicorette® Gum|Withdrawal by Subject|1
2137450|NCT01084603|3743825|FG000|Oral Nicotine 1|Withdrawal by Subject|1
2137451|NCT01084603|3743825|FG000|Washout Period 4|Adverse Event|1
2137452|NCT01084655|3743841|FG000|Overall Study|Radiographic disease progression|3
2137453|NCT01084655|3743842|FG001|Overall Study|Radiographic disease progression|2
2137454|NCT01084655|3743843|FG002|Overall Study|Radiographic disease progression|8
2137455|NCT01084655|3743841|FG000|Overall Study|Withdrawal by Subject|1
2137456|NCT01084655|3743842|FG001|Overall Study|Withdrawal by Subject|0
2137457|NCT01084655|3743843|FG002|Overall Study|Withdrawal by Subject|4
2137458|NCT01084655|3743841|FG000|Overall Study|Adverse Event|2
2137459|NCT01084655|3743842|FG001|Overall Study|Adverse Event|1
2137460|NCT01084655|3743843|FG002|Overall Study|Adverse Event|2
2137461|NCT01084655|3743841|FG000|Overall Study|Other|0
2137462|NCT01084655|3743842|FG001|Overall Study|Other|3
2137463|NCT01084655|3743843|FG002|Overall Study|Other|2
2137464|NCT01084655|3743841|FG000|Overall Study|Symptomatic deterioration|0
2137465|NCT01084655|3743842|FG001|Overall Study|Symptomatic deterioration|0
2137466|NCT01084655|3743843|FG002|Overall Study|Symptomatic deterioration|2
2137467|NCT01084655|3743841|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0
2137468|NCT01084655|3743842|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0
2137469|NCT01084655|3743843|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1
2137470|NCT01084668|3743855|FG000|Overall Study|Lack of Efficacy|5
2137471|NCT01084668|3743855|FG000|Overall Study|Withdrawal by Subject|2
2137472|NCT01084668|3743855|FG000|Overall Study|Pregnancy|1
2137473|NCT01084668|3743855|FG000|Overall Study|Non-compliance|1
2137474|NCT01084694|3743863|FG000|Overall Study|Withdrawal by Subject|2
2137475|NCT01084694|3743864|FG001|Overall Study|Withdrawal by Subject|1
2137476|NCT01084694|3743863|FG000|Overall Study|Death|2
2137477|NCT01084694|3743864|FG001|Overall Study|Death|12
2137478|NCT01084694|3743863|FG000|Overall Study|eligibility not maintained|2
2137479|NCT01084694|3743864|FG001|Overall Study|eligibility not maintained|7
2137480|NCT01084707|3743878|FG000|Overall Study|Withdrawal by Subject|6
2137481|NCT01084772|3743896|FG000|Baseline|Withdrawal by Subject|7
2137482|NCT01084772|3743897|FG001|Baseline|Withdrawal by Subject|6
2137483|NCT01084772|3743896|FG000|3 Months|Death|1
2137484|NCT01084772|3743897|FG001|3 Months|Death|0
2137485|NCT01084772|3743896|FG000|3 Months|Study Termination|2
2137486|NCT01084772|3743897|FG001|3 Months|Study Termination|2
2137487|NCT01084772|3743896|FG000|1 Year|Withdrawal by Subject|0
2137488|NCT01084772|3743897|FG001|1 Year|Withdrawal by Subject|1
2137489|NCT01084772|3743896|FG000|1 Year|Lost to Follow-up|3
2137490|NCT01084772|3743897|FG001|1 Year|Lost to Follow-up|0
2137491|NCT01084772|3743896|FG000|1 Year|Study Termination|0
2137492|NCT01084772|3743897|FG001|1 Year|Study Termination|7
2137493|NCT01084772|3743896|FG000|2 Years|Withdrawal by Subject|1
2137494|NCT01084772|3743897|FG001|2 Years|Withdrawal by Subject|0
2137495|NCT01084772|3743896|FG000|2 Years|Lost to Follow-up|5
2137496|NCT01084772|3743897|FG001|2 Years|Lost to Follow-up|2
2137497|NCT01084772|3743896|FG000|2 Years|Study Termination|3
2137498|NCT01084772|3743897|FG001|2 Years|Study Termination|2
2137499|NCT01085045|3743912|FG000|Part A|Withdrawal by Subject|4
2137500|NCT01085045|3743912|FG000|Part A|Adverse Event|6
2137501|NCT01085045|3743912|FG000|Part A|Protocol Violation|1
2137502|NCT01085045|3743912|FG000|Part A|Protocol Specified Criteria|7
2137503|NCT01085045|3743912|FG000|Part B|Withdrawal by Subject|2
2137504|NCT01085045|3743912|FG000|Part B|Protocol Specified Criteria|6
2137505|NCT01085045|3743912|FG000|Part B|Lost to Follow-up|1
2137506|NCT01085045|3743912|FG000|Part B|Adverse Event|6
2137507|NCT01085136|3743932|FG000|Part A|Other Adverse event|223
2137508|NCT01085136|3743933|FG001|Part A|Other Adverse event|0
2137509|NCT01085136|3743934|FG002|Part A|Other Adverse event|0
2137510|NCT01085136|3743932|FG000|Part A|Protocol Violation|3
2137511|NCT01085136|3743933|FG001|Part A|Protocol Violation|0
2137512|NCT01085136|3743934|FG002|Part A|Protocol Violation|0
2137513|NCT01085136|3743932|FG000|Part A|Lost to Follow-up|3
2137514|NCT01085136|3743933|FG001|Part A|Lost to Follow-up|0
2137515|NCT01085136|3743934|FG002|Part A|Lost to Follow-up|0
2137516|NCT01085136|3743932|FG000|Part A|Refusal to continue trial medication|64
2137517|NCT01085136|3743933|FG001|Part A|Refusal to continue trial medication|0
2137518|NCT01085136|3743934|FG002|Part A|Refusal to continue trial medication|0
2137519|NCT01085136|3743932|FG000|Part A|Other reason not defined above|30
2137520|NCT01085136|3743933|FG001|Part A|Other reason not defined above|0
2137521|NCT01085136|3743934|FG002|Part A|Other reason not defined above|0
2137522|NCT01085136|3743932|FG000|Part B|Other AE|0
2137523|NCT01085136|3743933|FG001|Part B|Other AE|29
2137524|NCT01085136|3743934|FG002|Part B|Other AE|8
2137525|NCT01085136|3743932|FG000|Part B|Refusal to continue trial medication|0
2137526|NCT01085136|3743933|FG001|Part B|Refusal to continue trial medication|12
2137527|NCT01085136|3743934|FG002|Part B|Refusal to continue trial medication|7
2137528|NCT01085136|3743932|FG000|Part B|Not treated|0
2137529|NCT01085136|3743933|FG001|Part B|Not treated|4
2137530|NCT01085136|3743934|FG002|Part B|Not treated|8
2137531|NCT01085136|3743932|FG000|Part B|Other reason not defined above|0
2137532|NCT01085136|3743933|FG001|Part B|Other reason not defined above|6
2137533|NCT01085136|3743934|FG002|Part B|Other reason not defined above|3
2137534|NCT01085201|3743949|FG000|Overall Study|Scheduling conflict|1
2137535|NCT01085201|3743950|FG001|Overall Study|Scheduling conflict|0
2137536|NCT01085201|3743951|FG002|Overall Study|Scheduling conflict|1
2137537|NCT01085201|3743952|FG003|Overall Study|Scheduling conflict|0
2137538|NCT01085201|3743953|FG004|Overall Study|Scheduling conflict|0
2137539|NCT01085201|3743949|FG000|Overall Study|Unknown- no study drug|2
2137540|NCT01085201|3743950|FG001|Overall Study|Unknown- no study drug|0
2137541|NCT01085201|3743951|FG002|Overall Study|Unknown- no study drug|0
2137542|NCT01085201|3743952|FG003|Overall Study|Unknown- no study drug|0
2137543|NCT01085201|3743953|FG004|Overall Study|Unknown- no study drug|0
2137544|NCT01085201|3743949|FG000|Overall Study|Fond ineligible after consent|0
2137545|NCT01085201|3743950|FG001|Overall Study|Fond ineligible after consent|1
2137546|NCT01085201|3743951|FG002|Overall Study|Fond ineligible after consent|1
2137547|NCT01085201|3743952|FG003|Overall Study|Fond ineligible after consent|0
2137548|NCT01085201|3743953|FG004|Overall Study|Fond ineligible after consent|0
2137549|NCT01085214|3743970|FG000|Overall Study|Alternate treatment required|1
2137550|NCT01085357|3744002|FG000|Overall Study|Adverse Event|1
2137551|NCT01085357|3744003|FG001|Overall Study|Adverse Event|1
2137552|NCT01085357|3744002|FG000|Overall Study|Subject Decision|4
2137553|NCT01085357|3744003|FG001|Overall Study|Subject Decision|3
2137554|NCT01085357|3744002|FG000|Overall Study|Investigator Decision|1
2137555|NCT01085357|3744003|FG001|Overall Study|Investigator Decision|1
2137556|NCT01085357|3744002|FG000|Overall Study|Death|11
2137557|NCT01085357|3744003|FG001|Overall Study|Death|1
2137558|NCT01085357|3744002|FG000|Overall Study|Lost to Follow-up|2
2137559|NCT01085357|3744003|FG001|Overall Study|Lost to Follow-up|0
2137560|NCT01085591|3744034|FG000|Overall Study|Adverse Event|0
2137561|NCT01085591|3744035|FG001|Overall Study|Adverse Event|1
2137562|NCT01085591|3744036|FG002|Overall Study|Adverse Event|3
2137563|NCT01085591|3744034|FG000|Overall Study|Physician Decision|1
2137564|NCT01085591|3744035|FG001|Overall Study|Physician Decision|0
2137565|NCT01085591|3744036|FG002|Overall Study|Physician Decision|1
2137566|NCT01085591|3744034|FG000|Overall Study|Withdrawal by Subject|0
2137567|NCT01085591|3744035|FG001|Overall Study|Withdrawal by Subject|2
2137568|NCT01085591|3744036|FG002|Overall Study|Withdrawal by Subject|1
2137569|NCT01085591|3744034|FG000|Overall Study|Lost to Follow-up|0
2137570|NCT01085591|3744035|FG001|Overall Study|Lost to Follow-up|1
2137571|NCT01085591|3744036|FG002|Overall Study|Lost to Follow-up|1
2137572|NCT01085591|3744034|FG000|Overall Study|Protocol Violation|1
2137573|NCT01085591|3744035|FG001|Overall Study|Protocol Violation|1
2137574|NCT01085591|3744036|FG002|Overall Study|Protocol Violation|1
2137575|NCT01085591|3744034|FG000|Overall Study|Other|0
2137576|NCT01085591|3744035|FG001|Overall Study|Other|1
2137577|NCT01085591|3744036|FG002|Overall Study|Other|0
2137578|NCT01085591|3744034|FG000|Overall Study|Not Properly Consented|1
2137579|NCT01085591|3744035|FG001|Overall Study|Not Properly Consented|0
2137580|NCT01085591|3744036|FG002|Overall Study|Not Properly Consented|0
2137581|NCT01085630|3744047|FG000|Overall Study|Insufficient data|1
2137582|NCT01085630|3744048|FG001|Overall Study|Insufficient data|0
2137583|NCT01085630|3744047|FG000|Overall Study|Ineligible|3
2137584|NCT01085630|3744048|FG001|Overall Study|Ineligible|0
2137585|NCT01085682|3744056|FG000|Overall Study|Withdrawal by Subject|25
2137586|NCT01085682|3744057|FG001|Overall Study|Withdrawal by Subject|25
2137587|NCT01085734|3744065|FG000|Overall Study|Adverse Event|0
2137588|NCT01085734|3744066|FG001|Overall Study|Adverse Event|2
2137589|NCT01085734|3744065|FG000|Overall Study|Death|1
2137590|NCT01085734|3744066|FG001|Overall Study|Death|0
2137591|NCT01085734|3744065|FG000|Overall Study|Lost to Follow-up|0
2137592|NCT01085734|3744066|FG001|Overall Study|Lost to Follow-up|1
2137593|NCT01085734|3744065|FG000|Overall Study|Withdrawal by Subject|0
2137594|NCT01085734|3744066|FG001|Overall Study|Withdrawal by Subject|1
2137595|NCT01085812|3744099|FG000|Open-Label Period|Adverse Event|0
2137596|NCT01085812|3744100|FG001|Open-Label Period|Adverse Event|80
2137597|NCT01085812|3744099|FG000|Open-Label Period|Lack of Efficacy|0
2137598|NCT01085812|3744100|FG001|Open-Label Period|Lack of Efficacy|26
2137599|NCT01085812|3744099|FG000|Open-Label Period|Protocol Violation|0
2137600|NCT01085812|3744100|FG001|Open-Label Period|Protocol Violation|39
2137601|NCT01085812|3744099|FG000|Open-Label Period|Withdrawal by Subject|0
2137602|NCT01085812|3744100|FG001|Open-Label Period|Withdrawal by Subject|53
2137603|NCT01085812|3744099|FG000|Open-Label Period|Lost to Follow-up|0
2137604|NCT01085812|3744100|FG001|Open-Label Period|Lost to Follow-up|42
2137605|NCT01085812|3744099|FG000|Double-Blind Period|Adverse Event|3
2207868|NCT01633112|3847024|FG002|Overall Study|Lost to Follow-up|6
2207869|NCT01633112|3847022|FG000|Overall Study|Protocol Violation|4
2207870|NCT01633112|3847023|FG001|Overall Study|Protocol Violation|0
2207871|NCT01633112|3847024|FG002|Overall Study|Protocol Violation|2
2207872|NCT01633112|3847022|FG000|Overall Study|Subject no longer requires study drug|0
2207873|NCT01633112|3847023|FG001|Overall Study|Subject no longer requires study drug|0
2207874|NCT01633112|3847024|FG002|Overall Study|Subject no longer requires study drug|1
2207875|NCT01633112|3847022|FG000|Overall Study|Withdrawal by Subject|20
2207876|NCT01633112|3847023|FG001|Overall Study|Withdrawal by Subject|12
2207877|NCT01633112|3847024|FG002|Overall Study|Withdrawal by Subject|41
2207878|NCT01633112|3847022|FG000|Overall Study|missing Study Completion CRF|1
2137606|NCT01085812|3744100|FG001|Double-Blind Period|Adverse Event|8
2137607|NCT01085812|3744099|FG000|Double-Blind Period|Protocol Violation|2
2137608|NCT01085812|3744100|FG001|Double-Blind Period|Protocol Violation|7
2137609|NCT01085812|3744099|FG000|Double-Blind Period|Withdrawal by Subject|11
2137610|NCT01085812|3744100|FG001|Double-Blind Period|Withdrawal by Subject|24
2137611|NCT01085812|3744099|FG000|Double-Blind Period|Lost to Follow-up|5
2137612|NCT01085812|3744100|FG001|Double-Blind Period|Lost to Follow-up|17
2137613|NCT01085812|3744099|FG000|Double-Blind Period|Other Reasons|0
2137614|NCT01085812|3744100|FG001|Double-Blind Period|Other Reasons|2
2137615|NCT01085812|3744099|FG000|Double-blind Intent-to-treat Population|Adverse Event|3
2137616|NCT01085812|3744100|FG001|Double-blind Intent-to-treat Population|Adverse Event|8
2137617|NCT01085812|3744099|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2
2137618|NCT01085812|3744100|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7
2137619|NCT01085812|3744099|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
2137620|NCT01085812|3744100|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
2137621|NCT01085812|3744099|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4
2137622|NCT01085812|3744100|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17
2137623|NCT01085812|3744099|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
2137624|NCT01085812|3744100|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
2137625|NCT01086033|3744148|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86
2137626|NCT01086033|3744148|FG000|Overall Study|Lost to Follow-up|86
2137627|NCT01086033|3744148|FG000|Overall Study|Adverse Event|42
2137628|NCT01086033|3744148|FG000|Overall Study|Withdrawal by Subject|41
2137629|NCT01086033|3744148|FG000|Overall Study|Other|14
2137630|NCT01086033|3744148|FG000|Overall Study|Other|13
2137631|NCT01086033|3744148|FG000|Overall Study|AE and Withdrew Consent|5
2137632|NCT01086033|3744148|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5
2137633|NCT01086033|3744148|FG000|Overall Study|Withdrew consent and Other Reason|4
2137634|NCT01086033|3744148|FG000|Overall Study|AE and Lack of Efficacy|4
2137635|NCT01086033|3744148|FG000|Overall Study|Death|1
2137636|NCT01086033|3744148|FG000|Overall Study|AE and Lost to Follow-up|1
2137637|NCT01086033|3744148|FG000|Overall Study|AE and Other Reason|1
2137638|NCT01086033|3744148|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
2137639|NCT01086150|3744158|FG000|Overall Study|Withdrawal by Subject|0
2137640|NCT01086150|3744159|FG001|Overall Study|Withdrawal by Subject|4
2137641|NCT01086150|3744160|FG002|Overall Study|Withdrawal by Subject|1
2137642|NCT01086150|3744158|FG000|Overall Study|Lost to Follow-up|0
2137643|NCT01086150|3744159|FG001|Overall Study|Lost to Follow-up|1
2137644|NCT01086150|3744160|FG002|Overall Study|Lost to Follow-up|0
2137645|NCT01086150|3744158|FG000|Overall Study|Screen Failure|0
2137646|NCT01086150|3744159|FG001|Overall Study|Screen Failure|1
2137647|NCT01086150|3744160|FG002|Overall Study|Screen Failure|0
2137648|NCT01086215|3744172|FG000|Overall Study|Death|14
2137649|NCT01086215|3744173|FG001|Overall Study|Death|8
2137650|NCT01086215|3744174|FG002|Overall Study|Death|8
2137651|NCT01086215|3744175|FG003|Overall Study|Death|1
2137652|NCT01086215|3744172|FG000|Overall Study|Lost to Follow-up|22
2137653|NCT01086215|3744173|FG001|Overall Study|Lost to Follow-up|39
2137654|NCT01086215|3744174|FG002|Overall Study|Lost to Follow-up|18
2137655|NCT01086215|3744175|FG003|Overall Study|Lost to Follow-up|2
2287912|NCT02454959|3978460|FG000|Overall Study|Withdrawal by Subject|3
2287913|NCT02454959|3978460|FG000|Overall Study|Adverse Event|2
2287914|NCT02454972|3978475|FG000|Overall Study|Progressive disease|17
2287915|NCT02454972|3978476|FG001|Overall Study|Progressive disease|16
2287916|NCT02454972|3978477|FG002|Overall Study|Progressive disease|59
2287917|NCT02454972|3978478|FG003|Overall Study|Progressive disease|23
2287918|NCT02454972|3978479|FG004|Overall Study|Progressive disease|16
2287919|NCT02454972|3978480|FG005|Overall Study|Progressive disease|12
2287920|NCT02454972|3978481|FG006|Overall Study|Progressive disease|19
2287921|NCT02454972|3978482|FG007|Overall Study|Progressive disease|27
2287922|NCT02454972|3978483|FG008|Overall Study|Progressive disease|84
2287923|NCT02454972|3978475|FG000|Overall Study|Death|0
2287924|NCT02454972|3978476|FG001|Overall Study|Death|0
2287925|NCT02454972|3978477|FG002|Overall Study|Death|5
2287926|NCT02454972|3978478|FG003|Overall Study|Death|1
2287927|NCT02454972|3978479|FG004|Overall Study|Death|0
2287928|NCT02454972|3978480|FG005|Overall Study|Death|0
2287929|NCT02454972|3978481|FG006|Overall Study|Death|0
2287930|NCT02454972|3978482|FG007|Overall Study|Death|0
2287931|NCT02454972|3978483|FG008|Overall Study|Death|2
2137656|NCT01086358|3744189|FG000|First Intervention|Lost to Follow-up|9
2137657|NCT01086358|3744190|FG001|First Intervention|Lost to Follow-up|4
2137658|NCT01086358|3744189|FG000|First Intervention|Withdrawal by Subject|0
2137659|NCT01086358|3744190|FG001|First Intervention|Withdrawal by Subject|1
2137660|NCT01086358|3744189|FG000|Second Intervention|Lost to Follow-up|4
2137661|NCT01086358|3744190|FG001|Second Intervention|Lost to Follow-up|4
2137662|NCT01086384|3744198|FG000|2-week Run-in Period|Adverse Event|1
2137663|NCT01086384|3744199|FG001|2-week Run-in Period|Adverse Event|0
2137664|NCT01086384|3744200|FG002|2-week Run-in Period|Adverse Event|0
2137665|NCT01086384|3744198|FG000|2-week Run-in Period|Protocol Violation|1
2137666|NCT01086384|3744199|FG001|2-week Run-in Period|Protocol Violation|0
2137667|NCT01086384|3744200|FG002|2-week Run-in Period|Protocol Violation|0
2137668|NCT01086384|3744198|FG000|2-week Run-in Period|Lost to Follow-up|1
2137669|NCT01086384|3744199|FG001|2-week Run-in Period|Lost to Follow-up|0
2137670|NCT01086384|3744200|FG002|2-week Run-in Period|Lost to Follow-up|0
2137671|NCT01086384|3744198|FG000|2-week Run-in Period|Physician Decision|6
2137672|NCT01086384|3744199|FG001|2-week Run-in Period|Physician Decision|0
2137673|NCT01086384|3744200|FG002|2-week Run-in Period|Physician Decision|0
2137674|NCT01086384|3744198|FG000|2-week Run-in Period|Withdrawal by Subject|19
2137675|NCT01086384|3744199|FG001|2-week Run-in Period|Withdrawal by Subject|0
2137676|NCT01086384|3744200|FG002|2-week Run-in Period|Withdrawal by Subject|0
2137677|NCT01086384|3744198|FG000|2-week Run-in Period|Study Closed/Terminated|42
2137678|NCT01086384|3744199|FG001|2-week Run-in Period|Study Closed/Terminated|0
2137679|NCT01086384|3744200|FG002|2-week Run-in Period|Study Closed/Terminated|0
2137680|NCT01086384|3744198|FG000|2-week Run-in Period|Continuation Criteria Not Met|92
2137681|NCT01086384|3744199|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
2137682|NCT01086384|3744200|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
2137683|NCT01086384|3744198|FG000|2-week Run-in Period|Randomized in Error|1
2137684|NCT01086384|3744199|FG001|2-week Run-in Period|Randomized in Error|0
2137685|NCT01086384|3744200|FG002|2-week Run-in Period|Randomized in Error|0
2137686|NCT01086384|3744198|FG000|Treatment Period|Withdrawal by Subject|0
2137687|NCT01086384|3744199|FG001|Treatment Period|Withdrawal by Subject|53
2137688|NCT01086384|3744200|FG002|Treatment Period|Withdrawal by Subject|55
2137689|NCT01086384|3744198|FG000|Treatment Period|Protocol Violation|0
2137690|NCT01086384|3744199|FG001|Treatment Period|Protocol Violation|26
2137691|NCT01086384|3744200|FG002|Treatment Period|Protocol Violation|17
2137692|NCT01086384|3744198|FG000|Treatment Period|Lack of Efficacy|0
2137693|NCT01086384|3744199|FG001|Treatment Period|Lack of Efficacy|22
2137694|NCT01086384|3744200|FG002|Treatment Period|Lack of Efficacy|13
2137695|NCT01086384|3744198|FG000|Treatment Period|Adverse Event|0
2137696|NCT01086384|3744199|FG001|Treatment Period|Adverse Event|19
2137697|NCT01086384|3744200|FG002|Treatment Period|Adverse Event|15
2137698|NCT01086384|3744198|FG000|Treatment Period|Lost to Follow-up|0
2137699|NCT01086384|3744199|FG001|Treatment Period|Lost to Follow-up|11
2137700|NCT01086384|3744200|FG002|Treatment Period|Lost to Follow-up|9
2207879|NCT01633112|3847023|FG001|Overall Study|missing Study Completion CRF|1
2207880|NCT01633112|3847024|FG002|Overall Study|missing Study Completion CRF|4
2207881|NCT01633788|3847055|FG000|Overall Study|Adverse Event|1
2207882|NCT01633788|3847056|FG001|Overall Study|Adverse Event|3
2207883|NCT01633788|3847057|FG002|Overall Study|Adverse Event|3
2287932|NCT02454972|3978475|FG000|Overall Study|Physician Decision|0
2287933|NCT02454972|3978476|FG001|Overall Study|Physician Decision|1
2287934|NCT02454972|3978477|FG002|Overall Study|Physician Decision|2
2287935|NCT02454972|3978478|FG003|Overall Study|Physician Decision|1
2207884|NCT01633788|3847058|FG003|Overall Study|Adverse Event|3
2287936|NCT02454972|3978479|FG004|Overall Study|Physician Decision|2
2287937|NCT02454972|3978480|FG005|Overall Study|Physician Decision|0
2287938|NCT02454972|3978481|FG006|Overall Study|Physician Decision|0
2287939|NCT02454972|3978482|FG007|Overall Study|Physician Decision|1
2287940|NCT02454972|3978483|FG008|Overall Study|Physician Decision|4
2287941|NCT02454972|3978475|FG000|Overall Study|Non treatment-related adverse event|2
2287942|NCT02454972|3978476|FG001|Overall Study|Non treatment-related adverse event|0
2287943|NCT02454972|3978477|FG002|Overall Study|Non treatment-related adverse event|1
2137701|NCT01086384|3744198|FG000|Treatment Period|Physician Decision|0
2137702|NCT01086384|3744199|FG001|Treatment Period|Physician Decision|9
2137703|NCT01086384|3744200|FG002|Treatment Period|Physician Decision|6
2137704|NCT01086384|3744198|FG000|Treatment Period|Study Closed/Terminated|0
2137705|NCT01086384|3744199|FG001|Treatment Period|Study Closed/Terminated|7
2137706|NCT01086384|3744200|FG002|Treatment Period|Study Closed/Terminated|8
2137707|NCT01086384|3744198|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0
2137708|NCT01086384|3744199|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0
2137709|NCT01086384|3744200|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1
2137710|NCT01086384|3744198|FG000|Treatment Period|Received Treatment in Error|0
2137711|NCT01086384|3744199|FG001|Treatment Period|Received Treatment in Error|1
2137712|NCT01086384|3744200|FG002|Treatment Period|Received Treatment in Error|0
2137713|NCT01086410|3744210|FG000|Overall Study|Adverse Event|1
2137714|NCT01086410|3744211|FG001|Overall Study|Adverse Event|0
2137715|NCT01086410|3744212|FG002|Overall Study|Adverse Event|0
2137716|NCT01086410|3744213|FG003|Overall Study|Adverse Event|2
2137717|NCT01086410|3744210|FG000|Overall Study|Lack of Efficacy|1
2137718|NCT01086410|3744211|FG001|Overall Study|Lack of Efficacy|1
2137719|NCT01086410|3744212|FG002|Overall Study|Lack of Efficacy|0
2137720|NCT01086410|3744213|FG003|Overall Study|Lack of Efficacy|0
2137721|NCT01086410|3744210|FG000|Overall Study|Protocol Violation|1
2137722|NCT01086410|3744211|FG001|Overall Study|Protocol Violation|1
2137723|NCT01086410|3744212|FG002|Overall Study|Protocol Violation|0
2137724|NCT01086410|3744213|FG003|Overall Study|Protocol Violation|0
2137725|NCT01086410|3744210|FG000|Overall Study|Lost to Follow-up|0
2137726|NCT01086410|3744211|FG001|Overall Study|Lost to Follow-up|0
2137727|NCT01086410|3744212|FG002|Overall Study|Lost to Follow-up|1
2137728|NCT01086410|3744213|FG003|Overall Study|Lost to Follow-up|0
2137729|NCT01086423|3744226|FG000|Overall Study|Protocol Violation|0
2137730|NCT01086423|3744227|FG001|Overall Study|Protocol Violation|0
2137731|NCT01086423|3744228|FG002|Overall Study|Protocol Violation|1
2137732|NCT01086423|3744226|FG000|Overall Study|Migrated/moved from study area|2
2137733|NCT01086423|3744227|FG001|Overall Study|Migrated/moved from study area|0
2137734|NCT01086423|3744228|FG002|Overall Study|Migrated/moved from study area|4
2137735|NCT01086423|3744226|FG000|Overall Study|Adverse event, fatal|1
2137736|NCT01086423|3744227|FG001|Overall Study|Adverse event, fatal|1
2137737|NCT01086423|3744228|FG002|Overall Study|Adverse event, fatal|0
2137738|NCT01086423|3744226|FG000|Overall Study|Adverse event, non-fatal|2
2137739|NCT01086423|3744227|FG001|Overall Study|Adverse event, non-fatal|1
2137740|NCT01086423|3744228|FG002|Overall Study|Adverse event, non-fatal|0
2137741|NCT01086423|3744226|FG000|Overall Study|Withdrawal by Subject|5
2137742|NCT01086423|3744227|FG001|Overall Study|Withdrawal by Subject|1
2137743|NCT01086423|3744228|FG002|Overall Study|Withdrawal by Subject|3
2137744|NCT01086423|3744226|FG000|Overall Study|Lost to Follow-up|0
2137745|NCT01086423|3744227|FG001|Overall Study|Lost to Follow-up|0
2137746|NCT01086423|3744228|FG002|Overall Study|Lost to Follow-up|1
2137747|NCT01086540|3744247|FG000|Overall Study|Death|3
2137748|NCT01086540|3744248|FG001|Overall Study|Death|1
2137749|NCT01086540|3744247|FG000|Overall Study|Physician Decision|2
2137750|NCT01086540|3744248|FG001|Overall Study|Physician Decision|1
2137751|NCT01086540|3744247|FG000|Overall Study|Addition of new therapy for PAH|1
2137752|NCT01086540|3744248|FG001|Overall Study|Addition of new therapy for PAH|0
2137753|NCT01086969|3744295|FG000|Overall Study|Withdrawal by Subject|1
2137754|NCT01086969|3744296|FG001|Overall Study|Withdrawal by Subject|2
2137755|NCT01086969|3744297|FG002|Overall Study|Withdrawal by Subject|0
2137756|NCT01087489|3744305|FG000|Overall Study|enrolled in another VA study|0
2137757|NCT01087489|3744306|FG001|Overall Study|enrolled in another VA study|1
2137758|NCT01087489|3744305|FG000|Overall Study|Death|0
2137759|NCT01087489|3744306|FG001|Overall Study|Death|1
2207885|NCT01633788|3847055|FG000|Overall Study|Lost to Follow-up|2
2207886|NCT01633788|3847056|FG001|Overall Study|Lost to Follow-up|2
2207887|NCT01633788|3847057|FG002|Overall Study|Lost to Follow-up|2
2207888|NCT01633788|3847058|FG003|Overall Study|Lost to Follow-up|0
2137760|NCT01087489|3744305|FG000|Overall Study|unable to survey by telephone|0
2137761|NCT01087489|3744306|FG001|Overall Study|unable to survey by telephone|1
2137762|NCT01087502|3744314|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5
2137763|NCT01087502|3744315|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4
2137764|NCT01087502|3744314|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1
2137765|NCT01087502|3744315|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1
2137766|NCT01087502|3744314|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
2137767|NCT01087502|3744315|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
2137768|NCT01087502|3744314|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
2137769|NCT01087502|3744315|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
2137770|NCT01087502|3744314|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1
2137771|NCT01087502|3744315|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2
2137772|NCT01087502|3744314|FG000|Up to Final Analysis (Week 52)|Adverse Event|17
2137773|NCT01087502|3744315|FG001|Up to Final Analysis (Week 52)|Adverse Event|10
2137774|NCT01087502|3744314|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1
2137775|NCT01087502|3744315|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2
2207889|NCT01633788|3847055|FG000|Overall Study|Personal Reasons|3
2137776|NCT01087502|3744314|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4
2137777|NCT01087502|3744315|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0
2137778|NCT01087502|3744314|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2
2137779|NCT01087502|3744315|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0
2137780|NCT01087502|3744314|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
2137781|NCT01087502|3744315|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
2137782|NCT01087502|3744314|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
2137783|NCT01087502|3744315|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
2137784|NCT01087502|3744314|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5
2137785|NCT01087502|3744315|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4
2137786|NCT01087528|3744323|FG000|Overall Study|Withdrawal by Subject|1
2137787|NCT01087528|3744323|FG000|Overall Study|Incomplete CE procedure|6
2137788|NCT01087723|3744340|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0
2137789|NCT01087723|3744341|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1
2287944|NCT02454972|3978478|FG003|Overall Study|Non treatment-related adverse event|0
2287945|NCT02454972|3978479|FG004|Overall Study|Non treatment-related adverse event|0
2137790|NCT01087723|3744340|FG000|Overall Study|Withdrawal by Subject|10
2137791|NCT01087723|3744341|FG001|Overall Study|Withdrawal by Subject|13
2137792|NCT01087723|3744340|FG000|Overall Study|Physician Decision|2
2137793|NCT01087723|3744341|FG001|Overall Study|Physician Decision|0
2137794|NCT01087723|3744340|FG000|Overall Study|Lost to Follow-up|1
2137795|NCT01087723|3744341|FG001|Overall Study|Lost to Follow-up|4
2137796|NCT01087723|3744340|FG000|Overall Study|Reason Not Specified|1
2137797|NCT01087723|3744341|FG001|Overall Study|Reason Not Specified|2
2137798|NCT01087736|3744349|FG000|Overall Study|Lost to Follow-up|1
2137799|NCT01087736|3744350|FG001|Overall Study|Lost to Follow-up|0
2137800|NCT01087736|3744349|FG000|Overall Study|Death|0
2137801|NCT01087736|3744350|FG001|Overall Study|Death|1
2137802|NCT01087736|3744349|FG000|Overall Study|Withdrawal by Subject|0
2137803|NCT01087736|3744350|FG001|Overall Study|Withdrawal by Subject|1
2137804|NCT01087762|3744359|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
2137805|NCT01087762|3744360|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
2137806|NCT01087762|3744361|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
2137807|NCT01087762|3744362|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
2137808|NCT01087762|3744363|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
2137809|NCT01087762|3744359|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6
2137810|NCT01087762|3744360|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0
2137811|NCT01087762|3744361|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1
2137812|NCT01087762|3744362|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0
2137813|NCT01087762|3744363|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0
2137814|NCT01087762|3744359|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
2137815|NCT01087762|3744360|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
2137816|NCT01087762|3744361|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
2137817|NCT01087762|3744362|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
2137818|NCT01087762|3744363|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
2137819|NCT01087762|3744359|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
2137820|NCT01087762|3744360|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
2180132|NCT01399099|3806101|FG000|Overall Study|Lost to Follow-up|11
2287946|NCT02454972|3978480|FG005|Overall Study|Non treatment-related adverse event|1
2287947|NCT02454972|3978481|FG006|Overall Study|Non treatment-related adverse event|0
2287948|NCT02454972|3978482|FG007|Overall Study|Non treatment-related adverse event|1
2287949|NCT02454972|3978483|FG008|Overall Study|Non treatment-related adverse event|0
2287950|NCT02454972|3978475|FG000|Overall Study|Treatment-related adverse events|0
2287951|NCT02454972|3978476|FG001|Overall Study|Treatment-related adverse events|1
2287952|NCT02454972|3978477|FG002|Overall Study|Treatment-related adverse events|1
2287953|NCT02454972|3978478|FG003|Overall Study|Treatment-related adverse events|0
2287954|NCT02454972|3978479|FG004|Overall Study|Treatment-related adverse events|2
2287955|NCT02454972|3978480|FG005|Overall Study|Treatment-related adverse events|0
2287956|NCT02454972|3978481|FG006|Overall Study|Treatment-related adverse events|0
2287957|NCT02454972|3978482|FG007|Overall Study|Treatment-related adverse events|2
2287958|NCT02454972|3978483|FG008|Overall Study|Treatment-related adverse events|2
2287959|NCT02454972|3978475|FG000|Overall Study|Patient moves to compassionate use|0
2287960|NCT02454972|3978476|FG001|Overall Study|Patient moves to compassionate use|0
2287961|NCT02454972|3978477|FG002|Overall Study|Patient moves to compassionate use|0
2287962|NCT02454972|3978478|FG003|Overall Study|Patient moves to compassionate use|0
2287963|NCT02454972|3978479|FG004|Overall Study|Patient moves to compassionate use|0
2287964|NCT02454972|3978480|FG005|Overall Study|Patient moves to compassionate use|0
2287965|NCT02454972|3978481|FG006|Overall Study|Patient moves to compassionate use|2
2287966|NCT02454972|3978482|FG007|Overall Study|Patient moves to compassionate use|0
2287967|NCT02454972|3978483|FG008|Overall Study|Patient moves to compassionate use|11
2287968|NCT02454972|3978475|FG000|Overall Study|Withdrawal by Subject|0
2287969|NCT02454972|3978476|FG001|Overall Study|Withdrawal by Subject|1
2287970|NCT02454972|3978477|FG002|Overall Study|Withdrawal by Subject|5
2287971|NCT02454972|3978478|FG003|Overall Study|Withdrawal by Subject|2
2287972|NCT02454972|3978479|FG004|Overall Study|Withdrawal by Subject|3
2287973|NCT02454972|3978480|FG005|Overall Study|Withdrawal by Subject|2
2137821|NCT01087762|3744361|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
2137822|NCT01087762|3744362|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
2137823|NCT01087762|3744363|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
2137824|NCT01087762|3744359|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
2137825|NCT01087762|3744360|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
2137826|NCT01087762|3744361|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
2137827|NCT01087762|3744362|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
2137828|NCT01087762|3744363|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
2137829|NCT01087762|3744359|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
2137830|NCT01087762|3744360|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
2137831|NCT01087762|3744361|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
2137832|NCT01087762|3744362|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
2137833|NCT01087762|3744363|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
2137834|NCT01087762|3744359|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0
2137835|NCT01087762|3744360|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0
2137836|NCT01087762|3744361|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0
2137837|NCT01087762|3744362|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1
2137838|NCT01087762|3744363|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1
2137839|NCT01087762|3744359|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
2137840|NCT01087762|3744360|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
2137841|NCT01087762|3744361|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
2137842|NCT01087762|3744362|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
2137843|NCT01087762|3744363|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
2137844|NCT01087762|3744359|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
2137845|NCT01087762|3744360|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
2137846|NCT01087762|3744361|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
2137847|NCT01087762|3744362|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
2137848|NCT01087762|3744363|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
2137849|NCT01087762|3744359|FG000|Open-Label Period (Weeks 48-204)|Other|0
2137850|NCT01087762|3744360|FG001|Open-Label Period (Weeks 48-204)|Other|0
2137851|NCT01087762|3744361|FG002|Open-Label Period (Weeks 48-204)|Other|0
2137852|NCT01087762|3744362|FG003|Open-Label Period (Weeks 48-204)|Other|2
2137853|NCT01087762|3744363|FG004|Open-Label Period (Weeks 48-204)|Other|4
2137854|NCT01087762|3744359|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
2137855|NCT01087762|3744360|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
2137856|NCT01087762|3744361|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
2137857|NCT01087762|3744362|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
2137858|NCT01087762|3744363|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
2137859|NCT01087762|3744359|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
2137860|NCT01087762|3744360|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
2137861|NCT01087762|3744361|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
2137862|NCT01087762|3744362|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
2137863|NCT01087762|3744363|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
2137864|NCT01087762|3744359|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
2137865|NCT01087762|3744360|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
2137866|NCT01087762|3744361|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
2137867|NCT01087762|3744362|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
2137868|NCT01087762|3744363|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
2137869|NCT01087775|3744373|FG000|Overall Study|failed inclusion criteria|2
2137870|NCT01087788|3744381|FG000|24-weeks Double-blind Period|Lack of Efficacy|2
2137871|NCT01087788|3744382|FG001|24-weeks Double-blind Period|Lack of Efficacy|0
2137872|NCT01087788|3744383|FG002|24-weeks Double-blind Period|Lack of Efficacy|1
2137873|NCT01087788|3744381|FG000|24-weeks Double-blind Period|Protocol Violation|0
2137874|NCT01087788|3744382|FG001|24-weeks Double-blind Period|Protocol Violation|1
2137875|NCT01087788|3744383|FG002|24-weeks Double-blind Period|Protocol Violation|0
2137876|NCT01087788|3744381|FG000|24-weeks Double-blind Period|Lost to Follow-up|4
2137877|NCT01087788|3744382|FG001|24-weeks Double-blind Period|Lost to Follow-up|1
2137878|NCT01087788|3744383|FG002|24-weeks Double-blind Period|Lost to Follow-up|1
2137879|NCT01087788|3744381|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7
2137880|NCT01087788|3744382|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2
2137881|NCT01087788|3744383|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5
2137882|NCT01087788|3744381|FG000|24-weeks Double-blind Period|AE, serious fatal|0
2137883|NCT01087788|3744382|FG001|24-weeks Double-blind Period|AE, serious fatal|1
2137884|NCT01087788|3744383|FG002|24-weeks Double-blind Period|AE, serious fatal|1
2137885|NCT01087788|3744381|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0
2137886|NCT01087788|3744382|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2
2137887|NCT01087788|3744383|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3
2137888|NCT01087788|3744381|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2
2137889|NCT01087788|3744382|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1
2137890|NCT01087788|3744383|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2
2137891|NCT01087788|3744381|FG000|24-weeks Double-blind Period|AE, unknown type|0
2137892|NCT01087788|3744382|FG001|24-weeks Double-blind Period|AE, unknown type|0
2137893|NCT01087788|3744383|FG002|24-weeks Double-blind Period|AE, unknown type|1
2137894|NCT01087788|3744381|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1
2137895|NCT01087788|3744382|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0
2137896|NCT01087788|3744383|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0
2137897|NCT01087788|3744381|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
2137898|NCT01087788|3744382|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
2137899|NCT01087788|3744383|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
2137900|NCT01087788|3744381|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0
2137901|NCT01087788|3744382|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1
2137902|NCT01087788|3744383|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0
2137903|NCT01087788|3744381|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
2137904|NCT01087788|3744382|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
2137905|NCT01087788|3744383|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
2137906|NCT01087788|3744381|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0
2137907|NCT01087788|3744382|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2
2137908|NCT01087788|3744383|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1
2137909|NCT01087788|3744381|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1
2137910|NCT01087788|3744382|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0
2137911|NCT01087788|3744383|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1
2137912|NCT01087788|3744381|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1
2137913|NCT01087788|3744382|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0
2137914|NCT01087788|3744383|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0
2137915|NCT01087788|3744381|FG000|24-weeks Dose-blind Period|AE, serious fatal|0
2137916|NCT01087788|3744382|FG001|24-weeks Dose-blind Period|AE, serious fatal|1
2137917|NCT01087788|3744383|FG002|24-weeks Dose-blind Period|AE, serious fatal|0
2137918|NCT01087788|3744381|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2
2137919|NCT01087788|3744382|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1
2137920|NCT01087788|3744383|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2
2137921|NCT01087788|3744381|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
2137922|NCT01087788|3744382|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
2137923|NCT01087788|3744383|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
2137924|NCT01087788|3744381|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
2137925|NCT01087788|3744382|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
2137926|NCT01087788|3744383|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
2137927|NCT01087788|3744381|FG000|24-weeks Dose-blind Period|Patient moved|0
2137928|NCT01087788|3744382|FG001|24-weeks Dose-blind Period|Patient moved|0
2137929|NCT01087788|3744383|FG002|24-weeks Dose-blind Period|Patient moved|1
2137930|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4
2137931|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2
2137932|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3
2137933|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|Protocol Violation|2
2137934|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|Protocol Violation|1
2137935|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|Protocol Violation|0
2137936|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0
2137937|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4
2137938|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2
2137939|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13
2137940|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8
2207890|NCT01633788|3847056|FG001|Overall Study|Personal Reasons|1
2207891|NCT01633788|3847057|FG002|Overall Study|Personal Reasons|1
2207892|NCT01633788|3847058|FG003|Overall Study|Personal Reasons|3
2287974|NCT02454972|3978481|FG006|Overall Study|Withdrawal by Subject|0
2287975|NCT02454972|3978482|FG007|Overall Study|Withdrawal by Subject|1
2287976|NCT02454972|3978483|FG008|Overall Study|Withdrawal by Subject|2
2287977|NCT02454972|3978475|FG000|Overall Study|Multiple delay/holds on treatment|0
2287978|NCT02454972|3978476|FG001|Overall Study|Multiple delay/holds on treatment|0
2320990|NCT02953821|4035234|FG000|Overall Study|Change of address|0
2207893|NCT01633788|3847055|FG000|Overall Study|Protocol Violation|1
2207894|NCT01633788|3847056|FG001|Overall Study|Protocol Violation|0
2207895|NCT01633788|3847057|FG002|Overall Study|Protocol Violation|1
2207896|NCT01633788|3847058|FG003|Overall Study|Protocol Violation|0
2207897|NCT01633788|3847055|FG000|Overall Study|Other Reasons|0
2207898|NCT01633788|3847056|FG001|Overall Study|Other Reasons|2
2207899|NCT01633788|3847057|FG002|Overall Study|Other Reasons|3
2207900|NCT01633788|3847058|FG003|Overall Study|Other Reasons|7
2207901|NCT01633944|3847098|FG000|Open-label Titration Phase|Adverse Event|109
2207902|NCT01633944|3847099|FG001|Open-label Titration Phase|Adverse Event|0
2207903|NCT01633944|3847100|FG002|Open-label Titration Phase|Adverse Event|0
2207904|NCT01633944|3847098|FG000|Open-label Titration Phase|Lack of Efficacy|33
2207905|NCT01633944|3847099|FG001|Open-label Titration Phase|Lack of Efficacy|0
2207906|NCT01633944|3847100|FG002|Open-label Titration Phase|Lack of Efficacy|0
2207907|NCT01633944|3847098|FG000|Open-label Titration Phase|Withdrawal by Subject|34
2207908|NCT01633944|3847099|FG001|Open-label Titration Phase|Withdrawal by Subject|0
2137941|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10
2137942|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|AE, serious fatal|2
2137943|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|AE, serious fatal|0
2137944|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|AE, serious fatal|1
2137945|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1
2137946|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3
2137947|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4
2137948|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
2137949|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
2137950|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
2137951|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
2137952|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
2137953|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
2137954|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1
2137955|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0
2137956|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0
2137957|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|Sponsor request|1
2137958|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|Sponsor request|0
2137959|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|Sponsor request|0
2207909|NCT01633944|3847100|FG002|Open-label Titration Phase|Withdrawal by Subject|0
2137960|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|Principal investigator decision|0
2137961|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|Principal investigator decision|1
2137962|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|Principal investigator decision|2
2137963|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|No participation in study extension|0
2137964|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|No participation in study extension|0
2137965|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|No participation in study extension|1
2137966|NCT01087788|3744381|FG000|Open-Label Period (OL-P)|Personal reasons|0
2137967|NCT01087788|3744382|FG001|Open-Label Period (OL-P)|Personal reasons|0
2137968|NCT01087788|3744383|FG002|Open-Label Period (OL-P)|Personal reasons|1
2137969|NCT01087814|3744403|FG000|First Intervention (5 Days)|Withdrawal by Subject|3
2137970|NCT01087814|3744404|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
2137971|NCT01087814|3744403|FG000|Second Intervention (5 Days)|Physician Decision|1
2137972|NCT01087814|3744404|FG001|Second Intervention (5 Days)|Physician Decision|0
2137973|NCT01087905|3744418|FG000|Overall Study|Lost to Follow-up|24
2137974|NCT01087905|3744419|FG001|Overall Study|Lost to Follow-up|28
2137975|NCT01087905|3744420|FG002|Overall Study|Lost to Follow-up|18
2137976|NCT01087905|3744421|FG003|Overall Study|Lost to Follow-up|31
2137977|NCT01087905|3744422|FG004|Overall Study|Lost to Follow-up|27
2137978|NCT01087905|3744423|FG005|Overall Study|Lost to Follow-up|25
2137979|NCT01087905|3744424|FG006|Overall Study|Lost to Follow-up|20
2137980|NCT01087905|3744425|FG007|Overall Study|Lost to Follow-up|24
2137981|NCT01087905|3744418|FG000|Overall Study|Withdrawal by Subject|5
2137982|NCT01087905|3744419|FG001|Overall Study|Withdrawal by Subject|4
2137983|NCT01087905|3744420|FG002|Overall Study|Withdrawal by Subject|4
2137984|NCT01087905|3744421|FG003|Overall Study|Withdrawal by Subject|5
2137985|NCT01087905|3744422|FG004|Overall Study|Withdrawal by Subject|4
2137986|NCT01087905|3744423|FG005|Overall Study|Withdrawal by Subject|3
2137987|NCT01087905|3744424|FG006|Overall Study|Withdrawal by Subject|3
2137988|NCT01087905|3744425|FG007|Overall Study|Withdrawal by Subject|5
2137989|NCT01087944|3744463|FG000|Period 1 (Week 1-3)|Adverse Event|1
2137990|NCT01087944|3744464|FG001|Period 1 (Week 1-3)|Adverse Event|0
2137991|NCT01087944|3744463|FG000|Period 2 (Week 4-6)|Adverse Event|0
2137992|NCT01087944|3744464|FG001|Period 2 (Week 4-6)|Adverse Event|2
2137993|NCT01087957|3744472|FG000|Overall Study|Death|2
2137994|NCT01087957|3744473|FG001|Overall Study|Death|2
2137995|NCT01087957|3744472|FG000|Overall Study|Lost to Follow-up|3
2137996|NCT01087957|3744473|FG001|Overall Study|Lost to Follow-up|4
2137997|NCT01087957|3744472|FG000|Overall Study|Protocol Violation|13
2137998|NCT01087957|3744473|FG001|Overall Study|Protocol Violation|25
2137999|NCT01087957|3744472|FG000|Overall Study|Withdrawal by Subject|18
2138000|NCT01087957|3744473|FG001|Overall Study|Withdrawal by Subject|15
2138001|NCT01087957|3744472|FG000|Overall Study|Physician Decision|5
2138002|NCT01087957|3744473|FG001|Overall Study|Physician Decision|9
2138003|NCT01087970|3744479|FG000|Overall Study|Protocol Violation|2
2138004|NCT01088048|3744503|FG000|Overall Study|Adverse Event|7
2138005|NCT01088048|3744504|FG001|Overall Study|Adverse Event|9
2138006|NCT01088048|3744505|FG002|Overall Study|Adverse Event|7
2138007|NCT01088048|3744506|FG003|Overall Study|Adverse Event|5
2138008|NCT01088048|3744507|FG004|Overall Study|Adverse Event|6
2138009|NCT01088048|3744508|FG005|Overall Study|Adverse Event|3
2138010|NCT01088048|3744509|FG006|Overall Study|Adverse Event|3
2138011|NCT01088048|3744510|FG007|Overall Study|Adverse Event|0
2138012|NCT01088048|3744511|FG008|Overall Study|Adverse Event|2
2138013|NCT01088048|3744512|FG009|Overall Study|Adverse Event|2
2138014|NCT01088048|3744503|FG000|Overall Study|Withdrew Consent|1
2138015|NCT01088048|3744504|FG001|Overall Study|Withdrew Consent|1
2138016|NCT01088048|3744505|FG002|Overall Study|Withdrew Consent|1
2207910|NCT01633944|3847098|FG000|Open-label Titration Phase|Protocol Violation|24
2287979|NCT02454972|3978477|FG002|Overall Study|Multiple delay/holds on treatment|0
2287980|NCT02454972|3978478|FG003|Overall Study|Multiple delay/holds on treatment|1
2138017|NCT01088048|3744506|FG003|Overall Study|Withdrew Consent|1
2138018|NCT01088048|3744507|FG004|Overall Study|Withdrew Consent|2
2138019|NCT01088048|3744508|FG005|Overall Study|Withdrew Consent|1
2138020|NCT01088048|3744509|FG006|Overall Study|Withdrew Consent|0
2138021|NCT01088048|3744510|FG007|Overall Study|Withdrew Consent|2
2138022|NCT01088048|3744511|FG008|Overall Study|Withdrew Consent|2
2138023|NCT01088048|3744512|FG009|Overall Study|Withdrew Consent|1
2138024|NCT01088048|3744503|FG000|Overall Study|Concomitant Medication Prohibited|1
2138025|NCT01088048|3744504|FG001|Overall Study|Concomitant Medication Prohibited|0
2138026|NCT01088048|3744505|FG002|Overall Study|Concomitant Medication Prohibited|0
2138027|NCT01088048|3744506|FG003|Overall Study|Concomitant Medication Prohibited|0
2138028|NCT01088048|3744507|FG004|Overall Study|Concomitant Medication Prohibited|0
2138029|NCT01088048|3744508|FG005|Overall Study|Concomitant Medication Prohibited|0
2138030|NCT01088048|3744509|FG006|Overall Study|Concomitant Medication Prohibited|0
2138031|NCT01088048|3744510|FG007|Overall Study|Concomitant Medication Prohibited|0
2138032|NCT01088048|3744511|FG008|Overall Study|Concomitant Medication Prohibited|0
2138033|NCT01088048|3744512|FG009|Overall Study|Concomitant Medication Prohibited|0
2138034|NCT01088048|3744503|FG000|Overall Study|Investigator Request|2
2138035|NCT01088048|3744504|FG001|Overall Study|Investigator Request|2
2138036|NCT01088048|3744505|FG002|Overall Study|Investigator Request|0
2138037|NCT01088048|3744506|FG003|Overall Study|Investigator Request|0
2138038|NCT01088048|3744507|FG004|Overall Study|Investigator Request|3
2138039|NCT01088048|3744508|FG005|Overall Study|Investigator Request|1
2138040|NCT01088048|3744509|FG006|Overall Study|Investigator Request|1
2138041|NCT01088048|3744510|FG007|Overall Study|Investigator Request|0
2138042|NCT01088048|3744511|FG008|Overall Study|Investigator Request|0
2138043|NCT01088048|3744512|FG009|Overall Study|Investigator Request|0
2138044|NCT01088048|3744503|FG000|Overall Study|Patient Non-compliance|0
2138045|NCT01088048|3744504|FG001|Overall Study|Patient Non-compliance|1
2138046|NCT01088048|3744505|FG002|Overall Study|Patient Non-compliance|0
2138047|NCT01088048|3744506|FG003|Overall Study|Patient Non-compliance|0
2138048|NCT01088048|3744507|FG004|Overall Study|Patient Non-compliance|0
2138049|NCT01088048|3744508|FG005|Overall Study|Patient Non-compliance|0
2138050|NCT01088048|3744509|FG006|Overall Study|Patient Non-compliance|0
2138051|NCT01088048|3744510|FG007|Overall Study|Patient Non-compliance|0
2138052|NCT01088048|3744511|FG008|Overall Study|Patient Non-compliance|0
2138053|NCT01088048|3744512|FG009|Overall Study|Patient Non-compliance|0
2138054|NCT01088048|3744503|FG000|Overall Study|Disease Progression|7
2138055|NCT01088048|3744504|FG001|Overall Study|Disease Progression|4
2138056|NCT01088048|3744505|FG002|Overall Study|Disease Progression|3
2138057|NCT01088048|3744506|FG003|Overall Study|Disease Progression|5
2138058|NCT01088048|3744507|FG004|Overall Study|Disease Progression|3
2138059|NCT01088048|3744508|FG005|Overall Study|Disease Progression|3
2138060|NCT01088048|3744509|FG006|Overall Study|Disease Progression|2
2138061|NCT01088048|3744510|FG007|Overall Study|Disease Progression|1
2138062|NCT01088048|3744511|FG008|Overall Study|Disease Progression|0
2138063|NCT01088048|3744512|FG009|Overall Study|Disease Progression|0
2138064|NCT01088048|3744503|FG000|Overall Study|Death|1
2138065|NCT01088048|3744504|FG001|Overall Study|Death|5
2138066|NCT01088048|3744505|FG002|Overall Study|Death|3
2138067|NCT01088048|3744506|FG003|Overall Study|Death|3
2138068|NCT01088048|3744507|FG004|Overall Study|Death|1
2138069|NCT01088048|3744508|FG005|Overall Study|Death|3
2138070|NCT01088048|3744509|FG006|Overall Study|Death|0
2138071|NCT01088048|3744510|FG007|Overall Study|Death|0
2138072|NCT01088048|3744511|FG008|Overall Study|Death|3
2138073|NCT01088048|3744512|FG009|Overall Study|Death|1
2138074|NCT01088048|3744503|FG000|Overall Study|Other|3
2138075|NCT01088048|3744504|FG001|Overall Study|Other|5
2138076|NCT01088048|3744505|FG002|Overall Study|Other|0
2138077|NCT01088048|3744506|FG003|Overall Study|Other|0
2138078|NCT01088048|3744507|FG004|Overall Study|Other|2
2138079|NCT01088048|3744508|FG005|Overall Study|Other|0
2138080|NCT01088048|3744509|FG006|Overall Study|Other|0
2138081|NCT01088048|3744510|FG007|Overall Study|Other|2
2138082|NCT01088048|3744511|FG008|Overall Study|Other|0
2138083|NCT01088048|3744512|FG009|Overall Study|Other|0
2138084|NCT01088243|3744547|FG000|Overall Study|Adverse Event|1
2138085|NCT01088243|3744548|FG001|Overall Study|Adverse Event|0
2138086|NCT01088399|3744561|FG000|Overall Study|Adverse Event|211
2138087|NCT01088399|3744562|FG001|Overall Study|Adverse Event|16
2138088|NCT01088399|3744563|FG002|Overall Study|Adverse Event|0
2138089|NCT01088399|3744561|FG000|Overall Study|Death|204
2138090|NCT01088399|3744562|FG001|Overall Study|Death|45
2138091|NCT01088399|3744563|FG002|Overall Study|Death|0
2138092|NCT01088399|3744561|FG000|Overall Study|Lack of Efficacy|298
2138093|NCT01088399|3744562|FG001|Overall Study|Lack of Efficacy|7
2138094|NCT01088399|3744563|FG002|Overall Study|Lack of Efficacy|5
2138095|NCT01088399|3744561|FG000|Overall Study|Lost to Follow-up|1070
2138096|NCT01088399|3744562|FG001|Overall Study|Lost to Follow-up|278
2138097|NCT01088399|3744563|FG002|Overall Study|Lost to Follow-up|58
2138098|NCT01088399|3744561|FG000|Overall Study|Physician Decision|531
2138099|NCT01088399|3744562|FG001|Overall Study|Physician Decision|88
2138100|NCT01088399|3744563|FG002|Overall Study|Physician Decision|16
2138101|NCT01088399|3744561|FG000|Overall Study|Withdrawal by Subject|544
2138102|NCT01088399|3744562|FG001|Overall Study|Withdrawal by Subject|195
2138103|NCT01088399|3744563|FG002|Overall Study|Withdrawal by Subject|33
2138104|NCT01088399|3744561|FG000|Overall Study|Change to or start of somatropin therapy|234
2138105|NCT01088399|3744562|FG001|Overall Study|Change to or start of somatropin therapy|17
2138106|NCT01088399|3744563|FG002|Overall Study|Change to or start of somatropin therapy|12
2138107|NCT01088399|3744561|FG000|Overall Study|Sponsor decision|1573
2138108|NCT01088399|3744562|FG001|Overall Study|Sponsor decision|298
2138109|NCT01088399|3744563|FG002|Overall Study|Sponsor decision|7
2138110|NCT01088399|3744561|FG000|Overall Study|Protocol Violation|10
2138111|NCT01088399|3744562|FG001|Overall Study|Protocol Violation|1
2138112|NCT01088399|3744563|FG002|Overall Study|Protocol Violation|0
2138113|NCT01088399|3744561|FG000|Overall Study|Enrollment criteria not met|48
2138114|NCT01088399|3744562|FG001|Overall Study|Enrollment criteria not met|119
2138115|NCT01088399|3744563|FG002|Overall Study|Enrollment criteria not met|70
2138116|NCT01088399|3744561|FG000|Overall Study|Study summary visit not completed|2398
2138117|NCT01088399|3744562|FG001|Overall Study|Study summary visit not completed|283
2138118|NCT01088399|3744563|FG002|Overall Study|Study summary visit not completed|80
2138119|NCT01088412|3744574|FG000|Overall Study|Adverse Event|38
2138120|NCT01088412|3744575|FG001|Overall Study|Adverse Event|0
2138121|NCT01088412|3744576|FG002|Overall Study|Adverse Event|0
2138122|NCT01088412|3744574|FG000|Overall Study|Death|42
2207911|NCT01633944|3847099|FG001|Open-label Titration Phase|Protocol Violation|0
2138123|NCT01088412|3744575|FG001|Overall Study|Death|6
2138124|NCT01088412|3744576|FG002|Overall Study|Death|0
2138125|NCT01088412|3744574|FG000|Overall Study|Other Reason per Case Report Form|2089
2138126|NCT01088412|3744575|FG001|Overall Study|Other Reason per Case Report Form|103
2138127|NCT01088412|3744576|FG002|Overall Study|Other Reason per Case Report Form|9
2138128|NCT01088412|3744574|FG000|Overall Study|Withdrawal by Subject|1761
2138129|NCT01088412|3744575|FG001|Overall Study|Withdrawal by Subject|25
2138130|NCT01088412|3744576|FG002|Overall Study|Withdrawal by Subject|1
2138131|NCT01088412|3744574|FG000|Overall Study|Received Another GH Product|79
2138132|NCT01088412|3744575|FG001|Overall Study|Received Another GH Product|0
2138133|NCT01088412|3744576|FG002|Overall Study|Received Another GH Product|0
2138134|NCT01088412|3744574|FG000|Overall Study|Participant Moved|601
2138135|NCT01088412|3744575|FG001|Overall Study|Participant Moved|21
2138136|NCT01088412|3744576|FG002|Overall Study|Participant Moved|2
2138137|NCT01088412|3744574|FG000|Overall Study|Physician Decision|1041
2138138|NCT01088412|3744575|FG001|Overall Study|Physician Decision|8
2138139|NCT01088412|3744576|FG002|Overall Study|Physician Decision|4
2138140|NCT01088412|3744574|FG000|Overall Study|Sponsor Decision|4467
2138141|NCT01088412|3744575|FG001|Overall Study|Sponsor Decision|79
2138142|NCT01088412|3744576|FG002|Overall Study|Sponsor Decision|23
2138143|NCT01088412|3744574|FG000|Overall Study|Third Party Required to Change Brand|487
2138144|NCT01088412|3744575|FG001|Overall Study|Third Party Required to Change Brand|0
2138145|NCT01088412|3744576|FG002|Overall Study|Third Party Required to Change Brand|0
2138146|NCT01088412|3744574|FG000|Overall Study|Lost to Follow-up|3052
2138147|NCT01088412|3744575|FG001|Overall Study|Lost to Follow-up|130
2138148|NCT01088412|3744576|FG002|Overall Study|Lost to Follow-up|11
2138149|NCT01088412|3744574|FG000|Overall Study|Study Summary Not Completed|4360
2138150|NCT01088412|3744575|FG001|Overall Study|Study Summary Not Completed|64
2138151|NCT01088412|3744576|FG002|Overall Study|Study Summary Not Completed|22
2138152|NCT01088438|3744589|FG000|Overall Study|Withdrawal by Subject|11
2138153|NCT01088438|3744590|FG001|Overall Study|Withdrawal by Subject|6
2138154|NCT01088438|3744589|FG000|Overall Study|Lost to Follow-up|18
2138155|NCT01088438|3744590|FG001|Overall Study|Lost to Follow-up|30
2138156|NCT01088503|3744612|FG000|Overall Study|Withdrawal by Subject|118
2138157|NCT01088503|3744613|FG001|Overall Study|Withdrawal by Subject|327
2138158|NCT01088503|3744614|FG002|Overall Study|Withdrawal by Subject|10
2138159|NCT01088503|3744612|FG000|Overall Study|Death|64
2138160|NCT01088503|3744613|FG001|Overall Study|Death|358
2138161|NCT01088503|3744614|FG002|Overall Study|Death|7
2138162|NCT01088529|3744622|FG000|Overall Study|Did not receive study treatment|0
2138163|NCT01088529|3744623|FG001|Overall Study|Did not receive study treatment|1
2138164|NCT01088984|3744659|FG000|Phase 1|Death|2
2138165|NCT01088984|3744660|FG001|Phase 1|Death|1
2138166|NCT01088984|3744659|FG000|Phase 1|Disease Progression|2
2138167|NCT01088984|3744660|FG001|Phase 1|Disease Progression|4
2138168|NCT01088984|3744659|FG000|Phase 1|Other|1
2138169|NCT01088984|3744660|FG001|Phase 1|Other|1
2138170|NCT01088984|3744659|FG000|Phase 2|Death|0
2138171|NCT01088984|3744660|FG001|Phase 2|Death|5
2138172|NCT01088984|3744659|FG000|Phase 2|Withdrawal by Subject|0
2138173|NCT01088984|3744660|FG001|Phase 2|Withdrawal by Subject|1
2138174|NCT01088984|3744659|FG000|Phase 2|DIsease Progression|0
2138175|NCT01088984|3744660|FG001|Phase 2|DIsease Progression|25
2138176|NCT01088984|3744659|FG000|Phase 2|Other|0
2138177|NCT01088984|3744660|FG001|Phase 2|Other|1
2138178|NCT01088997|3744671|FG000|Overall Study|Physician Decision|1
2138179|NCT01088997|3744672|FG001|Overall Study|Physician Decision|1
2138180|NCT01088997|3744671|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1
2138181|NCT01088997|3744672|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1
2138182|NCT01088997|3744671|FG000|Overall Study|Excluded prior to receiving drug|1
2138183|NCT01088997|3744672|FG001|Overall Study|Excluded prior to receiving drug|1
2138184|NCT01089023|3744681|FG000|Overall Study|Lost to Follow-up|3
2138185|NCT01089023|3744681|FG000|Overall Study|Adverse Event|1
2138186|NCT01089023|3744681|FG000|Overall Study|Withdrawal by Subject|1
2138187|NCT01089023|3744681|FG000|Overall Study|Protocol Violation|1
2138188|NCT01089023|3744681|FG000|Overall Study|Lack of Efficacy|1
2138189|NCT01089127|3744711|FG000|Overall Study|Adverse Event|5
2138190|NCT01089127|3744712|FG001|Overall Study|Adverse Event|1
2138191|NCT01089127|3744713|FG002|Overall Study|Adverse Event|1
2138192|NCT01089127|3744714|FG003|Overall Study|Adverse Event|0
2138193|NCT01089127|3744715|FG004|Overall Study|Adverse Event|0
2138194|NCT01089127|3744716|FG005|Overall Study|Adverse Event|1
2138195|NCT01089127|3744711|FG000|Overall Study|Subject withdrew consent|0
2138196|NCT01089127|3744712|FG001|Overall Study|Subject withdrew consent|1
2138197|NCT01089127|3744713|FG002|Overall Study|Subject withdrew consent|1
2138198|NCT01089127|3744714|FG003|Overall Study|Subject withdrew consent|1
2287981|NCT02454972|3978479|FG004|Overall Study|Multiple delay/holds on treatment|0
2287982|NCT02454972|3978480|FG005|Overall Study|Multiple delay/holds on treatment|0
2138199|NCT01089127|3744715|FG004|Overall Study|Subject withdrew consent|0
2207912|NCT01633944|3847100|FG002|Open-label Titration Phase|Protocol Violation|0
2207913|NCT01633944|3847098|FG000|Open-label Titration Phase|Lost to Follow-up|22
2207914|NCT01633944|3847099|FG001|Open-label Titration Phase|Lost to Follow-up|0
2207915|NCT01633944|3847100|FG002|Open-label Titration Phase|Lost to Follow-up|0
2207916|NCT01633944|3847098|FG000|Open-label Titration Phase|Other|68
2207917|NCT01633944|3847099|FG001|Open-label Titration Phase|Other|0
2207918|NCT01633944|3847100|FG002|Open-label Titration Phase|Other|0
2207919|NCT01633944|3847098|FG000|Double-blind Treatment Phase|Adverse Event|0
2207920|NCT01633944|3847099|FG001|Double-blind Treatment Phase|Adverse Event|13
2207921|NCT01633944|3847100|FG002|Double-blind Treatment Phase|Adverse Event|7
2207922|NCT01633944|3847098|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
2138200|NCT01089127|3744716|FG005|Overall Study|Subject withdrew consent|2
2138201|NCT01089127|3744711|FG000|Overall Study|Abnormal test procedure result(s)|2
2138202|NCT01089127|3744712|FG001|Overall Study|Abnormal test procedure result(s)|1
2138203|NCT01089127|3744713|FG002|Overall Study|Abnormal test procedure result(s)|0
2138204|NCT01089127|3744714|FG003|Overall Study|Abnormal test procedure result(s)|0
2138205|NCT01089127|3744715|FG004|Overall Study|Abnormal test procedure result(s)|0
2138206|NCT01089127|3744716|FG005|Overall Study|Abnormal test procedure result(s)|0
2138207|NCT01089127|3744711|FG000|Overall Study|Lost to Follow-up|1
2138208|NCT01089127|3744712|FG001|Overall Study|Lost to Follow-up|1
2138209|NCT01089127|3744713|FG002|Overall Study|Lost to Follow-up|0
2138210|NCT01089127|3744714|FG003|Overall Study|Lost to Follow-up|0
2138211|NCT01089127|3744715|FG004|Overall Study|Lost to Follow-up|1
2138212|NCT01089127|3744716|FG005|Overall Study|Lost to Follow-up|0
2138213|NCT01089127|3744711|FG000|Overall Study|Protocol deviation|0
2138214|NCT01089127|3744712|FG001|Overall Study|Protocol deviation|1
2138215|NCT01089127|3744713|FG002|Overall Study|Protocol deviation|0
2138216|NCT01089127|3744714|FG003|Overall Study|Protocol deviation|0
2138217|NCT01089127|3744715|FG004|Overall Study|Protocol deviation|1
2138218|NCT01089127|3744716|FG005|Overall Study|Protocol deviation|0
2138219|NCT01089361|3744749|FG000|Overall Study|Death|1
2138220|NCT01089361|3744750|FG001|Overall Study|Death|0
2138221|NCT01089413|3744761|FG000|Overall Study|Lost to Follow-up|1
2138222|NCT01089413|3744761|FG000|Overall Study|Progressive Disease|93
2138223|NCT01089413|3744761|FG000|Overall Study|Participant Withdrew Consent|1
2138224|NCT01089413|3744761|FG000|Overall Study|Unacceptable Toxicity|12
2138225|NCT01089413|3744761|FG000|Overall Study|Death|10
2138226|NCT01089413|3744761|FG000|Overall Study|Metastasectomy|13
2138227|NCT01089413|3744761|FG000|Overall Study|Other|71
2138228|NCT01089504|3744773|FG000|Overall Study|Lost to Follow-up|1
2138229|NCT01089504|3744774|FG001|Overall Study|Lost to Follow-up|1
2138230|NCT01089504|3744773|FG000|Overall Study|Withdrawal by Subject|2
2138231|NCT01089504|3744774|FG001|Overall Study|Withdrawal by Subject|0
2138232|NCT01089543|3744797|FG000|Overall Study|Withdrawal by Subject|2
2138233|NCT01089543|3744798|FG001|Overall Study|Withdrawal by Subject|3
2138234|NCT01089543|3744799|FG002|Overall Study|Withdrawal by Subject|3
2138235|NCT01089543|3744800|FG003|Overall Study|Withdrawal by Subject|1
2138236|NCT01089543|3744797|FG000|Overall Study|Physician Decision|1
2138237|NCT01089543|3744798|FG001|Overall Study|Physician Decision|0
2138238|NCT01089543|3744799|FG002|Overall Study|Physician Decision|0
2138239|NCT01089543|3744800|FG003|Overall Study|Physician Decision|1
2138240|NCT01089543|3744797|FG000|Overall Study|Adverse Event|0
2138241|NCT01089543|3744798|FG001|Overall Study|Adverse Event|1
2138242|NCT01089543|3744799|FG002|Overall Study|Adverse Event|0
2138243|NCT01089543|3744800|FG003|Overall Study|Adverse Event|0
2138244|NCT01089556|3744812|FG000|Study Period II (Weeks 1-8)|Adverse Event|35
2138245|NCT01089556|3744813|FG001|Study Period II (Weeks 1-8)|Adverse Event|39
2138246|NCT01089556|3744814|FG002|Study Period II (Weeks 1-8)|Adverse Event|0
2138247|NCT01089556|3744815|FG003|Study Period II (Weeks 1-8)|Adverse Event|0
2138248|NCT01089556|3744816|FG004|Study Period II (Weeks 1-8)|Adverse Event|0
2138249|NCT01089556|3744817|FG005|Study Period II (Weeks 1-8)|Adverse Event|0
2138250|NCT01089556|3744812|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
2138251|NCT01089556|3744813|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
2138252|NCT01089556|3744814|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2138253|NCT01089556|3744815|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2138254|NCT01089556|3744816|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2207923|NCT01633944|3847099|FG001|Double-blind Treatment Phase|Lack of Efficacy|8
2138255|NCT01089556|3744817|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2138256|NCT01089556|3744812|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1
2138257|NCT01089556|3744813|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2
2138258|NCT01089556|3744814|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2138259|NCT01089556|3744815|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2138260|NCT01089556|3744816|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2138261|NCT01089556|3744817|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2138262|NCT01089556|3744812|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2138263|NCT01089556|3744813|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3
2138264|NCT01089556|3744814|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2138265|NCT01089556|3744815|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2138266|NCT01089556|3744816|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2138267|NCT01089556|3744817|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2138268|NCT01089556|3744812|FG000|Study Period II (Weeks 1-8)|Physician Decision|4
2138269|NCT01089556|3744813|FG001|Study Period II (Weeks 1-8)|Physician Decision|0
2138270|NCT01089556|3744814|FG002|Study Period II (Weeks 1-8)|Physician Decision|0
2138271|NCT01089556|3744815|FG003|Study Period II (Weeks 1-8)|Physician Decision|0
2138272|NCT01089556|3744816|FG004|Study Period II (Weeks 1-8)|Physician Decision|0
2138273|NCT01089556|3744817|FG005|Study Period II (Weeks 1-8)|Physician Decision|0
2138274|NCT01089556|3744812|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4
2138275|NCT01089556|3744813|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4
2138276|NCT01089556|3744814|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0
2138277|NCT01089556|3744815|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0
2138278|NCT01089556|3744816|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0
2138279|NCT01089556|3744817|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0
2138280|NCT01089556|3744812|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
2138281|NCT01089556|3744813|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
2138282|NCT01089556|3744814|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2138283|NCT01089556|3744815|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2138284|NCT01089556|3744816|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2138285|NCT01089556|3744817|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2138286|NCT01089556|3744812|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3
2138287|NCT01089556|3744813|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4
2138288|NCT01089556|3744814|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0
2138289|NCT01089556|3744815|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0
2138290|NCT01089556|3744816|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0
2138291|NCT01089556|3744817|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0
2138292|NCT01089556|3744812|FG000|Study Period III (Weeks 9-16)|Adverse Event|0
2138293|NCT01089556|3744813|FG001|Study Period III (Weeks 9-16)|Adverse Event|0
2138294|NCT01089556|3744814|FG002|Study Period III (Weeks 9-16)|Adverse Event|4
2138295|NCT01089556|3744815|FG003|Study Period III (Weeks 9-16)|Adverse Event|2
2138296|NCT01089556|3744816|FG004|Study Period III (Weeks 9-16)|Adverse Event|4
2138297|NCT01089556|3744817|FG005|Study Period III (Weeks 9-16)|Adverse Event|3
2138298|NCT01089556|3744812|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
2138299|NCT01089556|3744813|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
2138300|NCT01089556|3744814|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2138301|NCT01089556|3744815|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2138302|NCT01089556|3744816|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2138303|NCT01089556|3744817|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2138304|NCT01089556|3744812|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2138305|NCT01089556|3744813|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2138306|NCT01089556|3744814|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2138307|NCT01089556|3744815|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2
2138308|NCT01089556|3744816|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1
2138309|NCT01089556|3744817|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2138310|NCT01089556|3744812|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2138311|NCT01089556|3744813|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2138312|NCT01089556|3744814|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1
2138313|NCT01089556|3744815|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2138314|NCT01089556|3744816|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2138315|NCT01089556|3744817|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2138316|NCT01089556|3744812|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0
2138317|NCT01089556|3744813|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0
2138318|NCT01089556|3744814|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1
2138319|NCT01089556|3744815|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1
2138320|NCT01089556|3744816|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1
2138321|NCT01089556|3744817|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0
2138322|NCT01089556|3744812|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0
2138323|NCT01089556|3744813|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0
2138324|NCT01089556|3744814|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4
2138325|NCT01089556|3744815|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3
2138326|NCT01089556|3744816|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4
2180133|NCT01399099|3806101|FG000|Overall Study|Physician Decision|1
2320991|NCT02953821|4035235|FG001|Overall Study|Change of address|1
2138327|NCT01089556|3744817|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1
2138328|NCT01089556|3744812|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
2138329|NCT01089556|3744813|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
2138330|NCT01089556|3744814|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
2138331|NCT01089556|3744815|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
2138332|NCT01089556|3744816|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
2138333|NCT01089556|3744817|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
2287983|NCT02454972|3978481|FG006|Overall Study|Multiple delay/holds on treatment|0
2287984|NCT02454972|3978482|FG007|Overall Study|Multiple delay/holds on treatment|0
2287985|NCT02454972|3978483|FG008|Overall Study|Multiple delay/holds on treatment|0
2287986|NCT02454972|3978475|FG000|Overall Study|Never treated|0
2287987|NCT02454972|3978476|FG001|Overall Study|Never treated|0
2287988|NCT02454972|3978477|FG002|Overall Study|Never treated|3
2287989|NCT02454972|3978478|FG003|Overall Study|Never treated|1
2287990|NCT02454972|3978479|FG004|Overall Study|Never treated|1
2287991|NCT02454972|3978480|FG005|Overall Study|Never treated|0
2287992|NCT02454972|3978481|FG006|Overall Study|Never treated|0
2287993|NCT02454972|3978482|FG007|Overall Study|Never treated|0
2287994|NCT02454972|3978483|FG008|Overall Study|Never treated|5
2287995|NCT02455050|3978499|FG000|Treatment Period 1|Lost to Follow-up|1
2287996|NCT02455050|3978500|FG001|Treatment Period 1|Lost to Follow-up|1
2287997|NCT02455050|3978501|FG002|Treatment Period 1|Lost to Follow-up|1
2287998|NCT02455050|3978502|FG003|Treatment Period 1|Lost to Follow-up|2
2287999|NCT02455050|3978499|FG000|Treatment Period 2|Lost to Follow-up|1
2288000|NCT02455050|3978500|FG001|Treatment Period 2|Lost to Follow-up|0
2288001|NCT02455050|3978501|FG002|Treatment Period 2|Lost to Follow-up|2
2288002|NCT02455050|3978502|FG003|Treatment Period 2|Lost to Follow-up|1
2138334|NCT01089582|3744842|FG000|Overall Study|Death|2
2138335|NCT01089582|3744842|FG000|Overall Study|Adverse Event|15
2138336|NCT01089582|3744842|FG000|Overall Study|Lost to Follow-up|8
2138337|NCT01089582|3744842|FG000|Overall Study|Other|4
2138338|NCT01089582|3744842|FG000|Overall Study|Withdrawal by Subject|1
2138339|NCT01089608|3744859|FG000|Overall Study|Adverse Event|0
2138340|NCT01089608|3744860|FG001|Overall Study|Adverse Event|4
2138341|NCT01089608|3744859|FG000|Overall Study|Lost to Follow-up|0
2138342|NCT01089608|3744860|FG001|Overall Study|Lost to Follow-up|2
2138343|NCT01089647|3744868|FG000|Overall Study|Lost to Follow-up|2
2138344|NCT01089647|3744869|FG001|Overall Study|Lost to Follow-up|2
2138345|NCT01089647|3744868|FG000|Overall Study|Withdrawal by Subject|2
2138346|NCT01089647|3744869|FG001|Overall Study|Withdrawal by Subject|1
2138347|NCT01089647|3744868|FG000|Overall Study|Adverse Event|0
2138348|NCT01089647|3744869|FG001|Overall Study|Adverse Event|1
2138349|NCT01089725|3744880|FG000|Overall Study|Adverse Event|1
2138350|NCT01089725|3744881|FG001|Overall Study|Adverse Event|1
2138351|NCT01089725|3744882|FG002|Overall Study|Adverse Event|0
2138352|NCT01089725|3744883|FG003|Overall Study|Adverse Event|0
2138353|NCT01089725|3744884|FG004|Overall Study|Adverse Event|2
2138354|NCT01089725|3744880|FG000|Overall Study|Lack of Efficacy|4
2138355|NCT01089725|3744881|FG001|Overall Study|Lack of Efficacy|3
2138356|NCT01089725|3744882|FG002|Overall Study|Lack of Efficacy|1
2138357|NCT01089725|3744883|FG003|Overall Study|Lack of Efficacy|0
2138358|NCT01089725|3744884|FG004|Overall Study|Lack of Efficacy|4
2138359|NCT01089725|3744880|FG000|Overall Study|Lost to Follow-up|2
2138360|NCT01089725|3744881|FG001|Overall Study|Lost to Follow-up|2
2138361|NCT01089725|3744882|FG002|Overall Study|Lost to Follow-up|0
2138362|NCT01089725|3744883|FG003|Overall Study|Lost to Follow-up|3
2138363|NCT01089725|3744884|FG004|Overall Study|Lost to Follow-up|0
2138364|NCT01089725|3744880|FG000|Overall Study|Protocol Violation|0
2138365|NCT01089725|3744881|FG001|Overall Study|Protocol Violation|0
2138366|NCT01089725|3744882|FG002|Overall Study|Protocol Violation|1
2138367|NCT01089725|3744883|FG003|Overall Study|Protocol Violation|1
2138368|NCT01089725|3744884|FG004|Overall Study|Protocol Violation|0
2288003|NCT02455076|3978527|FG000|Inpatient|Withdrawal by Subject|1
2288004|NCT02455076|3978528|FG001|Inpatient|Withdrawal by Subject|0
2288005|NCT02455076|3978529|FG002|Inpatient|Withdrawal by Subject|0
2138369|NCT01089725|3744880|FG000|Overall Study|Withdrawal by Subject|5
2138370|NCT01089725|3744881|FG001|Overall Study|Withdrawal by Subject|5
2138371|NCT01089725|3744882|FG002|Overall Study|Withdrawal by Subject|4
2138372|NCT01089725|3744883|FG003|Overall Study|Withdrawal by Subject|5
2138373|NCT01089725|3744884|FG004|Overall Study|Withdrawal by Subject|4
2138374|NCT01089725|3744880|FG000|Overall Study|Study Terminated by Sponsor|51
2138375|NCT01089725|3744881|FG001|Overall Study|Study Terminated by Sponsor|56
2138376|NCT01089725|3744882|FG002|Overall Study|Study Terminated by Sponsor|53
2138377|NCT01089725|3744883|FG003|Overall Study|Study Terminated by Sponsor|68
2138378|NCT01089725|3744884|FG004|Overall Study|Study Terminated by Sponsor|68
2138379|NCT01089725|3744880|FG000|Overall Study|Randomized, but not treated|0
2138380|NCT01089725|3744881|FG001|Overall Study|Randomized, but not treated|1
2138381|NCT01089725|3744882|FG002|Overall Study|Randomized, but not treated|2
2138382|NCT01089725|3744883|FG003|Overall Study|Randomized, but not treated|1
2138383|NCT01089725|3744884|FG004|Overall Study|Randomized, but not treated|2
2138384|NCT01089725|3744880|FG000|Overall Study|Other|3
2138385|NCT01089725|3744881|FG001|Overall Study|Other|0
2138386|NCT01089725|3744882|FG002|Overall Study|Other|0
2288006|NCT02455076|3978530|FG003|Inpatient|Withdrawal by Subject|0
2288007|NCT02455076|3978531|FG004|Inpatient|Withdrawal by Subject|0
2138387|NCT01089725|3744883|FG003|Overall Study|Other|1
2138388|NCT01089725|3744884|FG004|Overall Study|Other|0
2178437|NCT01383993|3803256|FG000|Overall Study|Marketed voriconazole in post-therapy|2
2178438|NCT01383993|3803257|FG001|Overall Study|Marketed voriconazole in post-therapy|0
2178439|NCT01383993|3803258|FG002|Overall Study|Marketed voriconazole in post-therapy|0
2178440|NCT01384019|3803269|FG000|Overall Study|Withdrawal by Subject|3
2178441|NCT01384019|3803270|FG001|Overall Study|Withdrawal by Subject|0
2178442|NCT01384019|3803269|FG000|Overall Study|Death|1
2178443|NCT01384019|3803270|FG001|Overall Study|Death|0
2178444|NCT01384019|3803269|FG000|Overall Study|MRI refusal|6
2178445|NCT01384019|3803270|FG001|Overall Study|MRI refusal|6
2178446|NCT01384292|3803279|FG000|Part B|Severe non-compliance to protocol|1
2178447|NCT01384292|3803280|FG001|Part B|Severe non-compliance to protocol|0
2178448|NCT01384292|3803281|FG002|Part B|Severe non-compliance to protocol|0
2178449|NCT01384734|3803318|FG000|Overall Study|Adverse Event|0
2178450|NCT01384734|3803319|FG001|Overall Study|Adverse Event|3
2178451|NCT01384734|3803320|FG002|Overall Study|Adverse Event|0
2178452|NCT01384734|3803321|FG003|Overall Study|Adverse Event|2
2178453|NCT01384734|3803322|FG004|Overall Study|Adverse Event|7
2178454|NCT01384734|3803318|FG000|Overall Study|Death|1
2178455|NCT01384734|3803319|FG001|Overall Study|Death|0
2178456|NCT01384734|3803320|FG002|Overall Study|Death|1
2178457|NCT01384734|3803321|FG003|Overall Study|Death|0
2178458|NCT01384734|3803322|FG004|Overall Study|Death|0
2178459|NCT01384734|3803318|FG000|Overall Study|Continuation criteria not met|0
2178460|NCT01384734|3803319|FG001|Overall Study|Continuation criteria not met|0
2178461|NCT01384734|3803320|FG002|Overall Study|Continuation criteria not met|1
2178462|NCT01384734|3803321|FG003|Overall Study|Continuation criteria not met|1
2288008|NCT02455076|3978527|FG000|Inpatient|Discharged <24 h after admission|0
2288009|NCT02455076|3978528|FG001|Inpatient|Discharged <24 h after admission|1
2288010|NCT02455076|3978529|FG002|Inpatient|Discharged <24 h after admission|0
2288011|NCT02455076|3978530|FG003|Inpatient|Discharged <24 h after admission|0
2288012|NCT02455076|3978531|FG004|Inpatient|Discharged <24 h after admission|0
2288013|NCT02455076|3978527|FG000|Inpatient|Adverse Event|3
2288014|NCT02455076|3978528|FG001|Inpatient|Adverse Event|0
2288015|NCT02455076|3978529|FG002|Inpatient|Adverse Event|0
2288016|NCT02455076|3978530|FG003|Inpatient|Adverse Event|0
2288017|NCT02455076|3978531|FG004|Inpatient|Adverse Event|0
2288018|NCT02455076|3978527|FG000|Outpatient|Adverse Event|0
2288019|NCT02455076|3978528|FG001|Outpatient|Adverse Event|0
2288020|NCT02455076|3978529|FG002|Outpatient|Adverse Event|0
2288021|NCT02455076|3978530|FG003|Outpatient|Adverse Event|5
2288022|NCT02455076|3978531|FG004|Outpatient|Adverse Event|0
2288023|NCT02455076|3978527|FG000|Outpatient|Lost to Follow-up|0
2288024|NCT02455076|3978528|FG001|Outpatient|Lost to Follow-up|0
2288025|NCT02455076|3978529|FG002|Outpatient|Lost to Follow-up|0
2288026|NCT02455076|3978530|FG003|Outpatient|Lost to Follow-up|1
2288027|NCT02455076|3978531|FG004|Outpatient|Lost to Follow-up|12
2288028|NCT02455336|3978549|FG000|Overall Study|Withdrawal by Subject|0
2288029|NCT02455336|3978550|FG001|Overall Study|Withdrawal by Subject|2
2288030|NCT02455336|3978549|FG000|Overall Study|Adverse Event|3
2288031|NCT02455336|3978550|FG001|Overall Study|Adverse Event|0
2288032|NCT02455336|3978549|FG000|Overall Study|Non-responder to treatment|2
2288033|NCT02455336|3978550|FG001|Overall Study|Non-responder to treatment|0
2288034|NCT02455388|3978558|FG000|Overall Study|Protocol Violation|1
2288035|NCT02455388|3978559|FG001|Overall Study|Protocol Violation|0
2288036|NCT02455388|3978560|FG002|Overall Study|Protocol Violation|4
2288037|NCT02455388|3978558|FG000|Overall Study|Withdrawal by Subject|0
2288038|NCT02455388|3978559|FG001|Overall Study|Withdrawal by Subject|0
2288039|NCT02455388|3978560|FG002|Overall Study|Withdrawal by Subject|7
2288040|NCT02455518|3978576|FG000|Overall Study|Protocol Violation|0
2288041|NCT02455518|3978577|FG001|Overall Study|Protocol Violation|1
2288042|NCT02455518|3978578|FG002|Overall Study|Protocol Violation|1
2288043|NCT02455518|3978579|FG003|Overall Study|Protocol Violation|3
2288044|NCT02455557|3978589|FG000|Overall Study|Withdrawal by Subject|2
2288045|NCT02456103|3978593|FG000|Overall Study|Study Closure|207
2288046|NCT02456103|3978593|FG000|Overall Study|Physician Decision|1
2288047|NCT02456103|3978593|FG000|Overall Study|Required prohibited medications|5
2288048|NCT02456103|3978593|FG000|Overall Study|Protocol Violation|1
2288049|NCT02456103|3978593|FG000|Overall Study|Adverse Event|5
2288050|NCT02456103|3978593|FG000|Overall Study|Abnormal Laboratory Value|2
2288051|NCT02456103|3978593|FG000|Overall Study|Lost to Follow-up|1
2288052|NCT02456103|3978593|FG000|Overall Study|Withdrawal by Subject|24
2288053|NCT02456636|3978600|FG000|Overall Study|Death|0
2288054|NCT02456636|3978601|FG001|Overall Study|Death|3
2288055|NCT02456636|3978602|FG002|Overall Study|Death|0
2288056|NCT02456636|3978600|FG000|Overall Study|Pregnancy|1
2288057|NCT02456636|3978601|FG001|Overall Study|Pregnancy|3
2288058|NCT02456636|3978602|FG002|Overall Study|Pregnancy|5
2178463|NCT01384734|3803322|FG004|Overall Study|Continuation criteria not met|0
2178464|NCT01384734|3803318|FG000|Overall Study|Lack of Efficacy|3
2178465|NCT01384734|3803319|FG001|Overall Study|Lack of Efficacy|7
2288059|NCT02456636|3978600|FG000|Overall Study|Physician Decision|4
2288060|NCT02456636|3978601|FG001|Overall Study|Physician Decision|5
2138389|NCT01090011|3744909|FG000|Overall Study|Progressive disease|128
2138390|NCT01090011|3744909|FG000|Overall Study|Adverse Event|32
2138391|NCT01090011|3744909|FG000|Overall Study|Protocol Violation|1
2138392|NCT01090011|3744909|FG000|Overall Study|Refusal to start/continue medication|5
2138393|NCT01090011|3744909|FG000|Overall Study|Other reason not defined above|5
2138394|NCT01090050|3744923|FG000|Overall Study|Lost to Follow-up|0
2138395|NCT01090050|3744924|FG001|Overall Study|Lost to Follow-up|1
2138396|NCT01090050|3744923|FG000|Overall Study|Lack of Efficacy|1
2138397|NCT01090050|3744924|FG001|Overall Study|Lack of Efficacy|5
2138398|NCT01090050|3744923|FG000|Overall Study|Physician Decision|0
2138399|NCT01090050|3744924|FG001|Overall Study|Physician Decision|1
2138400|NCT01090063|3744934|FG000|Screen|Screen Failed|4
2138401|NCT01090063|3744934|FG000|Treatment|Withdrawal by Subject|4
2138402|NCT01090076|3744950|FG000|Overall Study|Death|1
2138403|NCT01090076|3744951|FG001|Overall Study|Death|1
2138404|NCT01090076|3744950|FG000|Overall Study|Withdrawal by Subject|0
2138405|NCT01090076|3744951|FG001|Overall Study|Withdrawal by Subject|1
2138406|NCT01090102|3744961|FG000|First 12 Weeks|Withdrawal by Subject|1
2138407|NCT01090102|3744962|FG001|First 12 Weeks|Withdrawal by Subject|1
2138408|NCT01090102|3744961|FG000|First 12 Weeks|Adverse Event|2
2138409|NCT01090102|3744962|FG001|First 12 Weeks|Adverse Event|0
2138410|NCT01090102|3744961|FG000|First 12 Weeks|Death|1
2138411|NCT01090102|3744962|FG001|First 12 Weeks|Death|1
2138412|NCT01090102|3744961|FG000|Second 12 Weeks|Withdrawal by Subject|0
2138413|NCT01090102|3744962|FG001|Second 12 Weeks|Withdrawal by Subject|1
2138414|NCT01090310|3744981|FG000|Core Study|Adverse Event|2
2138415|NCT01090310|3744982|FG001|Core Study|Adverse Event|2
2138416|NCT01090310|3744983|FG002|Core Study|Adverse Event|1
2138417|NCT01090310|3744984|FG003|Core Study|Adverse Event|1
2138418|NCT01090310|3744981|FG000|Core Study|Subject withdrew consent|0
2138419|NCT01090310|3744982|FG001|Core Study|Subject withdrew consent|3
2138420|NCT01090310|3744983|FG002|Core Study|Subject withdrew consent|1
2138421|NCT01090310|3744984|FG003|Core Study|Subject withdrew consent|1
2138422|NCT01090310|3744981|FG000|Core Study|Abnormal test procedure result|0
2138423|NCT01090310|3744982|FG001|Core Study|Abnormal test procedure result|0
2138424|NCT01090310|3744983|FG002|Core Study|Abnormal test procedure result|1
2138425|NCT01090310|3744984|FG003|Core Study|Abnormal test procedure result|0
2138426|NCT01090310|3744981|FG000|Core Study|Administrative reasons|5
2138427|NCT01090310|3744982|FG001|Core Study|Administrative reasons|6
2138428|NCT01090310|3744983|FG002|Core Study|Administrative reasons|4
2138429|NCT01090310|3744984|FG003|Core Study|Administrative reasons|4
2138430|NCT01090310|3744981|FG000|Core Study|Protocol deviation|1
2138431|NCT01090310|3744982|FG001|Core Study|Protocol deviation|0
2138432|NCT01090310|3744983|FG002|Core Study|Protocol deviation|0
2138433|NCT01090310|3744984|FG003|Core Study|Protocol deviation|1
2138434|NCT01090310|3744981|FG000|Extension Study|Aministrative problems|13
2138435|NCT01090310|3744982|FG001|Extension Study|Aministrative problems|15
2138436|NCT01090310|3744983|FG002|Extension Study|Aministrative problems|14
2138437|NCT01090310|3744984|FG003|Extension Study|Aministrative problems|18
2138438|NCT01090310|3744981|FG000|Extension Study|Adverse Event|0
2138439|NCT01090310|3744982|FG001|Extension Study|Adverse Event|0
2138440|NCT01090310|3744983|FG002|Extension Study|Adverse Event|0
2138441|NCT01090310|3744984|FG003|Extension Study|Adverse Event|1
2138442|NCT01090310|3744981|FG000|Extension Study|Unsatisfactory therapeutic effect|1
2138443|NCT01090310|3744982|FG001|Extension Study|Unsatisfactory therapeutic effect|0
2138444|NCT01090310|3744983|FG002|Extension Study|Unsatisfactory therapeutic effect|1
2138445|NCT01090310|3744984|FG003|Extension Study|Unsatisfactory therapeutic effect|1
2138446|NCT01090310|3744981|FG000|Extension Study|Subject withdrew consent|0
2138447|NCT01090310|3744982|FG001|Extension Study|Subject withdrew consent|1
2138448|NCT01090310|3744983|FG002|Extension Study|Subject withdrew consent|0
2138449|NCT01090310|3744984|FG003|Extension Study|Subject withdrew consent|0
2138450|NCT01090323|3744996|FG000|Overall Study|Adverse Event|12
2138451|NCT01090323|3744997|FG001|Overall Study|Adverse Event|2
2138452|NCT01090323|3744996|FG000|Overall Study|Abnormal Lab Values|3
2138453|NCT01090323|3744997|FG001|Overall Study|Abnormal Lab Values|1
2138454|NCT01090323|3744996|FG000|Overall Study|Abnormal Test Procedure Results|2
2138455|NCT01090323|3744997|FG001|Overall Study|Abnormal Test Procedure Results|0
2138456|NCT01090323|3744996|FG000|Overall Study|Unsatisfactory therapeutic effect|4
2138457|NCT01090323|3744997|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2138458|NCT01090323|3744996|FG000|Overall Study|Condition no longer requires drug|5
2138459|NCT01090323|3744997|FG001|Overall Study|Condition no longer requires drug|4
2138460|NCT01090323|3744996|FG000|Overall Study|Protocol Violation|2
2138461|NCT01090323|3744997|FG001|Overall Study|Protocol Violation|1
2138462|NCT01090323|3744996|FG000|Overall Study|Withdrew consent|33
2138463|NCT01090323|3744997|FG001|Overall Study|Withdrew consent|11
2138464|NCT01090323|3744996|FG000|Overall Study|Lost to Follow-up|11
2138465|NCT01090323|3744997|FG001|Overall Study|Lost to Follow-up|6
2138466|NCT01090323|3744996|FG000|Overall Study|Administrative problems|6
2138467|NCT01090323|3744997|FG001|Overall Study|Administrative problems|4
2138468|NCT01090323|3744996|FG000|Overall Study|Death|1
2138469|NCT01090323|3744997|FG001|Overall Study|Death|2
2138470|NCT01090323|3744996|FG000|Overall Study|Stopped end of core|7
2138471|NCT01090323|3744997|FG001|Overall Study|Stopped end of core|0
2138472|NCT01090323|3744996|FG000|Overall Study|Stopped end of extension 1#|3
2138473|NCT01090323|3744997|FG001|Overall Study|Stopped end of extension 1#|1
2138474|NCT01090414|3745007|FG000|Study 101-99|Progressive Disease|28
2138475|NCT01090414|3745008|FG001|Study 101-99|Progressive Disease|48
2138476|NCT01090414|3745009|FG002|Study 101-99|Progressive Disease|10
2138477|NCT01090414|3745010|FG003|Study 101-99|Progressive Disease|4
2138478|NCT01090414|3745007|FG000|Study 101-99|Adverse Event|10
2138479|NCT01090414|3745008|FG001|Study 101-99|Adverse Event|28
2138480|NCT01090414|3745009|FG002|Study 101-99|Adverse Event|18
2138481|NCT01090414|3745010|FG003|Study 101-99|Adverse Event|0
2138482|NCT01090414|3745007|FG000|Study 101-99|Investigator Request|1
2138483|NCT01090414|3745008|FG001|Study 101-99|Investigator Request|11
2138484|NCT01090414|3745009|FG002|Study 101-99|Investigator Request|4
2138485|NCT01090414|3745010|FG003|Study 101-99|Investigator Request|0
2138486|NCT01090414|3745007|FG000|Study 101-99|Death|3
2138487|NCT01090414|3745008|FG001|Study 101-99|Death|8
2138488|NCT01090414|3745009|FG002|Study 101-99|Death|1
2138489|NCT01090414|3745010|FG003|Study 101-99|Death|0
2138490|NCT01090414|3745007|FG000|Study 101-99|Sponsor Discontinued Study|0
2138491|NCT01090414|3745008|FG001|Study 101-99|Sponsor Discontinued Study|7
2138492|NCT01090414|3745009|FG002|Study 101-99|Sponsor Discontinued Study|5
2138493|NCT01090414|3745010|FG003|Study 101-99|Sponsor Discontinued Study|0
2138494|NCT01090414|3745007|FG000|Study 101-99|Other (Unknown Reasons)|3
2138495|NCT01090414|3745008|FG001|Study 101-99|Other (Unknown Reasons)|3
2138496|NCT01090414|3745009|FG002|Study 101-99|Other (Unknown Reasons)|0
2138497|NCT01090414|3745010|FG003|Study 101-99|Other (Unknown Reasons)|0
2138498|NCT01090414|3745007|FG000|Study 101-99|Withdrew Consent|0
2138499|NCT01090414|3745008|FG001|Study 101-99|Withdrew Consent|2
2138500|NCT01090414|3745009|FG002|Study 101-99|Withdrew Consent|3
2138501|NCT01090414|3745010|FG003|Study 101-99|Withdrew Consent|1
2138502|NCT01090414|3745007|FG000|Study 101-99|Participant Request|3
2138503|NCT01090414|3745008|FG001|Study 101-99|Participant Request|1
2138504|NCT01090414|3745009|FG002|Study 101-99|Participant Request|0
2138505|NCT01090414|3745010|FG003|Study 101-99|Participant Request|0
2138506|NCT01090427|3745035|FG000|After Controlled Period|Death|0
2138507|NCT01090427|3745036|FG001|After Controlled Period|Death|0
2138508|NCT01090427|3745037|FG002|After Controlled Period|Death|0
2138509|NCT01090427|3745038|FG003|After Controlled Period|Death|0
2138510|NCT01090427|3745039|FG004|After Controlled Period|Death|0
2138511|NCT01090427|3745040|FG005|After Controlled Period|Death|1
2138512|NCT01090427|3745041|FG006|After Controlled Period|Death|0
2138513|NCT01090427|3745035|FG000|After Controlled Period|Lack of Efficacy|0
2138514|NCT01090427|3745036|FG001|After Controlled Period|Lack of Efficacy|0
2138515|NCT01090427|3745037|FG002|After Controlled Period|Lack of Efficacy|0
2138516|NCT01090427|3745038|FG003|After Controlled Period|Lack of Efficacy|0
2138517|NCT01090427|3745039|FG004|After Controlled Period|Lack of Efficacy|0
2138518|NCT01090427|3745040|FG005|After Controlled Period|Lack of Efficacy|3
2138519|NCT01090427|3745041|FG006|After Controlled Period|Lack of Efficacy|2
2138520|NCT01090427|3745035|FG000|After Controlled Period|Adverse Event|0
2138521|NCT01090427|3745036|FG001|After Controlled Period|Adverse Event|0
2138522|NCT01090427|3745037|FG002|After Controlled Period|Adverse Event|0
2138523|NCT01090427|3745038|FG003|After Controlled Period|Adverse Event|2
2138524|NCT01090427|3745039|FG004|After Controlled Period|Adverse Event|0
2138525|NCT01090427|3745040|FG005|After Controlled Period|Adverse Event|1
2138526|NCT01090427|3745041|FG006|After Controlled Period|Adverse Event|0
2138527|NCT01090453|3745055|FG000|Overall Study|Withdrawal by Subject|1
2138528|NCT01090453|3745056|FG001|Overall Study|Withdrawal by Subject|2
2138529|NCT01090453|3745055|FG000|Overall Study|Lost to Follow-up|7
2138530|NCT01090453|3745056|FG001|Overall Study|Lost to Follow-up|7
2138531|NCT01090453|3745055|FG000|Overall Study|Non serious AEs|1
2138532|NCT01090453|3745056|FG001|Overall Study|Non serious AEs|0
2138533|NCT01090453|3745055|FG000|Overall Study|Protocol Violation|2
2138534|NCT01090453|3745056|FG001|Overall Study|Protocol Violation|0
2138535|NCT01090453|3745055|FG000|Overall Study|Other|2
2138536|NCT01090453|3745056|FG001|Overall Study|Other|4
2138537|NCT01090453|3745055|FG000|Overall Study|Eligibility Criteria|0
2138538|NCT01090453|3745056|FG001|Overall Study|Eligibility Criteria|1
2138539|NCT01090492|3745079|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1
2138540|NCT01090492|3745080|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1
2138541|NCT01090492|3745081|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1
2138542|NCT01090492|3745082|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2
2138543|NCT01090492|3745083|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0
2138544|NCT01090492|3745084|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0
2138545|NCT01090492|3745085|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1
2138546|NCT01090492|3745086|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0
2138547|NCT01090492|3745079|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2138548|NCT01090492|3745080|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
2138549|NCT01090492|3745081|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2138550|NCT01090492|3745082|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2138551|NCT01090492|3745083|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2138552|NCT01090492|3745084|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2138553|NCT01090492|3745085|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2138554|NCT01090492|3745086|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
2138555|NCT01090492|3745079|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2138556|NCT01090492|3745080|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2138557|NCT01090492|3745081|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1
2138558|NCT01090492|3745082|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2138559|NCT01090492|3745083|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2138560|NCT01090492|3745084|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2138561|NCT01090492|3745085|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2138562|NCT01090492|3745086|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2138563|NCT01090492|3745079|FG000|First Intervention Period (4 Weeks)|Other|0
2138564|NCT01090492|3745080|FG001|First Intervention Period (4 Weeks)|Other|0
2138565|NCT01090492|3745081|FG002|First Intervention Period (4 Weeks)|Other|1
2138566|NCT01090492|3745082|FG003|First Intervention Period (4 Weeks)|Other|1
2138567|NCT01090492|3745083|FG004|First Intervention Period (4 Weeks)|Other|2
2138568|NCT01090492|3745084|FG005|First Intervention Period (4 Weeks)|Other|0
2138569|NCT01090492|3745085|FG006|First Intervention Period (4 Weeks)|Other|0
2138570|NCT01090492|3745086|FG007|First Intervention Period (4 Weeks)|Other|0
2138571|NCT01090492|3745079|FG000|First Intervention Period (4 Weeks)|Pregnancy|0
2138572|NCT01090492|3745080|FG001|First Intervention Period (4 Weeks)|Pregnancy|0
2138573|NCT01090492|3745081|FG002|First Intervention Period (4 Weeks)|Pregnancy|0
2138574|NCT01090492|3745082|FG003|First Intervention Period (4 Weeks)|Pregnancy|0
2138575|NCT01090492|3745083|FG004|First Intervention Period (4 Weeks)|Pregnancy|1
2138576|NCT01090492|3745084|FG005|First Intervention Period (4 Weeks)|Pregnancy|0
2138577|NCT01090492|3745085|FG006|First Intervention Period (4 Weeks)|Pregnancy|0
2138578|NCT01090492|3745086|FG007|First Intervention Period (4 Weeks)|Pregnancy|0
2138579|NCT01090492|3745079|FG000|First Intervention Period (4 Weeks)|Adverse Event|0
2138580|NCT01090492|3745080|FG001|First Intervention Period (4 Weeks)|Adverse Event|2
2138581|NCT01090492|3745081|FG002|First Intervention Period (4 Weeks)|Adverse Event|0
2138582|NCT01090492|3745082|FG003|First Intervention Period (4 Weeks)|Adverse Event|3
2138583|NCT01090492|3745083|FG004|First Intervention Period (4 Weeks)|Adverse Event|1
2138584|NCT01090492|3745084|FG005|First Intervention Period (4 Weeks)|Adverse Event|2
2138585|NCT01090492|3745085|FG006|First Intervention Period (4 Weeks)|Adverse Event|0
2138586|NCT01090492|3745086|FG007|First Intervention Period (4 Weeks)|Adverse Event|5
2138587|NCT01090492|3745079|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1
2138588|NCT01090492|3745080|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0
2138589|NCT01090492|3745081|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0
2138590|NCT01090492|3745082|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0
2138591|NCT01090492|3745083|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1
2138592|NCT01090492|3745084|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0
2138593|NCT01090492|3745085|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1
2138594|NCT01090492|3745086|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1
2138595|NCT01090492|3745079|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0
2138596|NCT01090492|3745080|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1
2138597|NCT01090492|3745081|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0
2138598|NCT01090492|3745082|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0
2138599|NCT01090492|3745083|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0
2138600|NCT01090492|3745084|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0
2138601|NCT01090492|3745085|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0
2138602|NCT01090492|3745086|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0
2138603|NCT01090492|3745079|FG000|Second Intervention Period (4 Weeks)|Other|0
2138604|NCT01090492|3745080|FG001|Second Intervention Period (4 Weeks)|Other|1
2138605|NCT01090492|3745081|FG002|Second Intervention Period (4 Weeks)|Other|1
2138606|NCT01090492|3745082|FG003|Second Intervention Period (4 Weeks)|Other|0
2138607|NCT01090492|3745083|FG004|Second Intervention Period (4 Weeks)|Other|0
2138608|NCT01090492|3745084|FG005|Second Intervention Period (4 Weeks)|Other|0
2138609|NCT01090492|3745085|FG006|Second Intervention Period (4 Weeks)|Other|0
2138610|NCT01090492|3745086|FG007|Second Intervention Period (4 Weeks)|Other|0
2138611|NCT01090492|3745079|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0
2138612|NCT01090492|3745080|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0
2138613|NCT01090492|3745081|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1
2138614|NCT01090492|3745082|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0
2138615|NCT01090492|3745083|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1
2138616|NCT01090492|3745084|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1
2138617|NCT01090492|3745085|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7
2138618|NCT01090492|3745086|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1
2138619|NCT01090492|3745079|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2138620|NCT01090492|3745080|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2138621|NCT01090492|3745081|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2138622|NCT01090492|3745082|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2138623|NCT01090492|3745083|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2138624|NCT01090492|3745084|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2138625|NCT01090492|3745085|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
2138626|NCT01090492|3745086|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2138627|NCT01090739|3745105|FG000|Enrollment|Withdrawal by Subject|24
2138628|NCT01090739|3745105|FG000|Enrollment|Protocol Violation|14
2138629|NCT01090739|3745105|FG000|Enrollment|Lost to Follow-up|5
2138630|NCT01090739|3745105|FG000|Enrollment|Physician Decision|5
2138631|NCT01090739|3745105|FG000|Enrollment|Sponsor termination of site|4
2138632|NCT01090739|3745105|FG000|Enrollment|Study implant limit reached|2
2138633|NCT01090739|3745105|FG000|Enrollment|Adverse Event|1
2138634|NCT01090739|3745105|FG000|12 Month Follow-up|Withdrawal by Subject|2
2138635|NCT01090739|3745105|FG000|12 Month Follow-up|Lost to Follow-up|1
2138636|NCT01090739|3745105|FG000|12 Month Follow-up|Physician Decision|1
2138637|NCT01090739|3745105|FG000|12 Month Follow-up|Death|1
2138638|NCT01090739|3745105|FG000|24 Month Follow-up|Withdrawal by Subject|7
2138639|NCT01090739|3745105|FG000|24 Month Follow-up|Lost to Follow-up|1
2138640|NCT01090739|3745105|FG000|24 Month Follow-up|Death|1
2138641|NCT01090739|3745105|FG000|36 Month Follow-up|Withdrawal by Subject|6
2138642|NCT01090739|3745105|FG000|36 Month Follow-up|Visit still pending|17
2138643|NCT01090765|3745125|FG000|Overall Study|Patient withdrew consent|0
2138644|NCT01090765|3745126|FG001|Overall Study|Patient withdrew consent|0
2138645|NCT01090765|3745127|FG002|Overall Study|Patient withdrew consent|0
2138646|NCT01090765|3745128|FG003|Overall Study|Patient withdrew consent|0
2138647|NCT01090765|3745129|FG004|Overall Study|Patient withdrew consent|1
2138648|NCT01090765|3745130|FG005|Overall Study|Patient withdrew consent|1
2138649|NCT01090765|3745125|FG000|Overall Study|Developed a DVT, needed anticoagulation|0
2288061|NCT02456636|3978602|FG002|Overall Study|Physician Decision|4
2288062|NCT02456636|3978600|FG000|Overall Study|Withdrawal by Subject|13
2288063|NCT02456636|3978601|FG001|Overall Study|Withdrawal by Subject|14
2288064|NCT02456636|3978602|FG002|Overall Study|Withdrawal by Subject|16
2288065|NCT02456636|3978600|FG000|Overall Study|Lost to Follow-up|50
2288066|NCT02456636|3978601|FG001|Overall Study|Lost to Follow-up|44
2288067|NCT02456636|3978602|FG002|Overall Study|Lost to Follow-up|50
2288068|NCT02456662|3978612|FG000|Overall Study|Lost to Follow-up|2
2288069|NCT02456662|3978613|FG001|Overall Study|Lost to Follow-up|1
2288070|NCT02456727|3978621|FG000|Overall Study|Lost to Follow-up|63
2288071|NCT02456727|3978622|FG001|Overall Study|Lost to Follow-up|65
2288072|NCT02456727|3978621|FG000|Overall Study|Death|2
2288073|NCT02456727|3978622|FG001|Overall Study|Death|1
2288074|NCT02456727|3978621|FG000|Overall Study|Withdrawal by Subject|1
2288075|NCT02456727|3978622|FG001|Overall Study|Withdrawal by Subject|10
2288076|NCT02456727|3978621|FG000|Overall Study|Never Initiated Treatment|43
2288077|NCT02456727|3978622|FG001|Overall Study|Never Initiated Treatment|30
2288078|NCT02456740|3978647|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
2288079|NCT02456740|3978648|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
2288080|NCT02456740|3978649|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
2288081|NCT02456740|3978650|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2288082|NCT02456740|3978651|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2288083|NCT02456740|3978652|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2288084|NCT02456740|3978653|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2288085|NCT02456740|3978654|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2288086|NCT02456740|3978655|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2288087|NCT02456740|3978647|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
2288088|NCT02456740|3978648|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
2288089|NCT02456740|3978649|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
2288090|NCT02456740|3978650|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2288091|NCT02456740|3978651|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2288092|NCT02456740|3978652|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2288093|NCT02456740|3978653|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2288094|NCT02456740|3978654|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2288095|NCT02456740|3978655|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2288096|NCT02456740|3978647|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
2288097|NCT02456740|3978648|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
2288098|NCT02456740|3978649|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
2288099|NCT02456740|3978650|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2288100|NCT02456740|3978651|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2288101|NCT02456740|3978652|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2288102|NCT02456740|3978653|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2288103|NCT02456740|3978654|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2288104|NCT02456740|3978655|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2288105|NCT02456740|3978647|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2288106|NCT02456740|3978648|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2288107|NCT02456740|3978649|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2288108|NCT02456740|3978650|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
2138650|NCT01090765|3745126|FG001|Overall Study|Developed a DVT, needed anticoagulation|0
2178466|NCT01384734|3803320|FG002|Overall Study|Lack of Efficacy|4
2288109|NCT02456740|3978651|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
2288110|NCT02456740|3978652|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2138651|NCT01090765|3745127|FG002|Overall Study|Developed a DVT, needed anticoagulation|0
2138652|NCT01090765|3745128|FG003|Overall Study|Developed a DVT, needed anticoagulation|1
2138653|NCT01090765|3745129|FG004|Overall Study|Developed a DVT, needed anticoagulation|0
2138654|NCT01090765|3745130|FG005|Overall Study|Developed a DVT, needed anticoagulation|0
2138655|NCT01090765|3745125|FG000|Overall Study|Vasovagal reaction with first infusion|0
2138656|NCT01090765|3745126|FG001|Overall Study|Vasovagal reaction with first infusion|0
2138657|NCT01090765|3745127|FG002|Overall Study|Vasovagal reaction with first infusion|0
2138658|NCT01090765|3745128|FG003|Overall Study|Vasovagal reaction with first infusion|0
2138659|NCT01090765|3745129|FG004|Overall Study|Vasovagal reaction with first infusion|1
2138660|NCT01090765|3745130|FG005|Overall Study|Vasovagal reaction with first infusion|0
2138661|NCT01090973|3745149|FG000|Overall Study|Disease progression|1
2138662|NCT01091103|3745153|FG000|Overall Study|Adverse Event|1
2138663|NCT01091103|3745153|FG000|Overall Study|Progressive Disease|3
2138664|NCT01091168|3745186|FG000|Overall Study|Progressive disease|250
2138665|NCT01091168|3745187|FG001|Overall Study|Progressive disease|234
2138666|NCT01091168|3745186|FG000|Overall Study|Adverse Event|21
2138667|NCT01091168|3745187|FG001|Overall Study|Adverse Event|24
2138668|NCT01091168|3745186|FG000|Overall Study|Lost to Follow-up|0
2138669|NCT01091168|3745187|FG001|Overall Study|Lost to Follow-up|1
2138670|NCT01091168|3745186|FG000|Overall Study|Physician, patient's decision, other|27
2138671|NCT01091168|3745187|FG001|Overall Study|Physician, patient's decision, other|37
2138672|NCT01091246|3745196|FG000|Overall Study|Lost to Follow-up|23
2138673|NCT01091246|3745197|FG001|Overall Study|Lost to Follow-up|11
2138674|NCT01091246|3745198|FG002|Overall Study|Lost to Follow-up|7
2138675|NCT01091246|3745196|FG000|Overall Study|Adverse Event|1
2138676|NCT01091246|3745197|FG001|Overall Study|Adverse Event|0
2138677|NCT01091246|3745198|FG002|Overall Study|Adverse Event|1
2138678|NCT01091246|3745196|FG000|Overall Study|Withdrawal by Subject|9
2138679|NCT01091246|3745197|FG001|Overall Study|Withdrawal by Subject|5
2138680|NCT01091246|3745198|FG002|Overall Study|Withdrawal by Subject|4
2138681|NCT01091246|3745196|FG000|Overall Study|Subject not dosed|2
2138682|NCT01091246|3745197|FG001|Overall Study|Subject not dosed|0
2138683|NCT01091246|3745198|FG002|Overall Study|Subject not dosed|1
2138684|NCT01091259|3745208|FG000|Overall Study|Adverse Event|3
2138685|NCT01091259|3745208|FG000|Overall Study|Lack of Efficacy|2
2138686|NCT01091363|3745214|FG000|Overall Study|Withdrawal by Subject|11
2138687|NCT01091363|3745215|FG001|Overall Study|Withdrawal by Subject|15
2138688|NCT01091363|3745214|FG000|Overall Study|Lost to Follow-up|2
2138689|NCT01091363|3745215|FG001|Overall Study|Lost to Follow-up|2
2138690|NCT01091428|3745225|FG000|Phase 1|Progressive Disease|24
2138691|NCT01091428|3745226|FG001|Phase 1|Progressive Disease|8
2138692|NCT01091428|3745227|FG002|Phase 1|Progressive Disease|0
2138693|NCT01091428|3745228|FG003|Phase 1|Progressive Disease|0
2138694|NCT01091428|3745225|FG000|Phase 1|Symptomatic Deterioration|3
2288111|NCT02456740|3978653|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2288112|NCT02456740|3978654|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2288113|NCT02456740|3978655|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
2288114|NCT02456740|3978647|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2288115|NCT02456740|3978648|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2288116|NCT02456740|3978649|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2288117|NCT02456740|3978650|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
2288118|NCT02456740|3978651|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
2288119|NCT02456740|3978652|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
2288120|NCT02456740|3978653|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
2288121|NCT02456740|3978654|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
2288122|NCT02456740|3978655|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
2288123|NCT02456740|3978647|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0
2288124|NCT02456740|3978648|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0
2288125|NCT02456740|3978649|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0
2288126|NCT02456740|3978650|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0
2288127|NCT02456740|3978651|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0
2288128|NCT02456740|3978652|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0
2288129|NCT02456740|3978653|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0
2288130|NCT02456740|3978654|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1
2288131|NCT02456740|3978655|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0
2288132|NCT02456740|3978647|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2288133|NCT02456740|3978648|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2288134|NCT02456740|3978649|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2288135|NCT02456740|3978650|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
2288136|NCT02456740|3978651|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
2288137|NCT02456740|3978652|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
2288138|NCT02456740|3978653|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
2288139|NCT02456740|3978654|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
2288140|NCT02456740|3978655|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
2288141|NCT02456909|3978676|FG000|Overall Study|Did not receive allocated intervention|24
2138695|NCT01091428|3745226|FG001|Phase 1|Symptomatic Deterioration|2
2138696|NCT01091428|3745227|FG002|Phase 1|Symptomatic Deterioration|0
2138697|NCT01091428|3745228|FG003|Phase 1|Symptomatic Deterioration|0
2138698|NCT01091428|3745225|FG000|Phase 1|Adverse Event|2
2138699|NCT01091428|3745226|FG001|Phase 1|Adverse Event|0
2138700|NCT01091428|3745227|FG002|Phase 1|Adverse Event|0
2288142|NCT02456909|3978677|FG001|Overall Study|Did not receive allocated intervention|26
2288143|NCT02456909|3978676|FG000|Overall Study|Did not complete the primary outcome|0
2288144|NCT02456909|3978677|FG001|Overall Study|Did not complete the primary outcome|1
2288145|NCT02457065|3978685|FG000|Overall Study|Lost to Follow-up|9
2288146|NCT02457065|3978686|FG001|Overall Study|Lost to Follow-up|11
2288147|NCT02457182|3978694|FG000|Overall Study|Lost to Follow-up|1
2288148|NCT02457182|3978695|FG001|Overall Study|Lost to Follow-up|0
2288149|NCT02457195|3978701|FG000|Overall Study|Adverse Event|3
2288150|NCT02457195|3978701|FG000|Overall Study|Protocol Violation|2
2288151|NCT02457195|3978701|FG000|Overall Study|Withdrawal by Subject|4
2288152|NCT02457247|3978709|FG000|Period 1|Pretreatment Event/Adverse Event|0
2288153|NCT02457247|3978710|FG001|Period 1|Pretreatment Event/Adverse Event|1
2288154|NCT02457247|3978711|FG002|Period 1|Pretreatment Event/Adverse Event|0
2288155|NCT02457247|3978712|FG003|Period 1|Pretreatment Event/Adverse Event|0
2288156|NCT02457247|3978709|FG000|Period 1|Significant Protocol Deviation|1
2288157|NCT02457247|3978710|FG001|Period 1|Significant Protocol Deviation|1
2288158|NCT02457247|3978711|FG002|Period 1|Significant Protocol Deviation|0
2288159|NCT02457247|3978712|FG003|Period 1|Significant Protocol Deviation|0
2288160|NCT02457247|3978709|FG000|Period 1|Voluntary Withdrawal|1
2288161|NCT02457247|3978710|FG001|Period 1|Voluntary Withdrawal|0
2288162|NCT02457247|3978711|FG002|Period 1|Voluntary Withdrawal|0
2288163|NCT02457247|3978712|FG003|Period 1|Voluntary Withdrawal|0
2288164|NCT02457247|3978709|FG000|Period 2|Pretreatment Event/Adverse Event|0
2288165|NCT02457247|3978710|FG001|Period 2|Pretreatment Event/Adverse Event|1
2288166|NCT02457247|3978711|FG002|Period 2|Pretreatment Event/Adverse Event|0
2288167|NCT02457247|3978712|FG003|Period 2|Pretreatment Event/Adverse Event|0
2288168|NCT02457247|3978709|FG000|Period 2|Significant Protocol Deviation|1
2288169|NCT02457247|3978710|FG001|Period 2|Significant Protocol Deviation|0
2288170|NCT02457247|3978711|FG002|Period 2|Significant Protocol Deviation|0
2288171|NCT02457247|3978712|FG003|Period 2|Significant Protocol Deviation|0
2288172|NCT02457247|3978709|FG000|Period 2|Lost to Follow-up|0
2288173|NCT02457247|3978710|FG001|Period 2|Lost to Follow-up|1
2288174|NCT02457247|3978711|FG002|Period 2|Lost to Follow-up|0
2288175|NCT02457247|3978712|FG003|Period 2|Lost to Follow-up|0
2288176|NCT02457247|3978709|FG000|Period 2|Voluntary Withdrawal|1
2288177|NCT02457247|3978710|FG001|Period 2|Voluntary Withdrawal|1
2288178|NCT02457247|3978711|FG002|Period 2|Voluntary Withdrawal|0
2288179|NCT02457247|3978712|FG003|Period 2|Voluntary Withdrawal|0
2288180|NCT02457325|3978744|FG000|First Intervention (1 Day)|Lost to Follow-up|2
2288181|NCT02457325|3978745|FG001|First Intervention (1 Day)|Lost to Follow-up|2
2288182|NCT02457520|3978762|FG000|Active Treatment Phase|Adverse Event|10
2288183|NCT02457520|3978762|FG000|Active Treatment Phase|Lost to Follow-up|8
2288184|NCT02457520|3978762|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3
2288185|NCT02457520|3978762|FG000|Active Treatment Phase|other|4
2288186|NCT02457520|3978762|FG000|Active Treatment Phase|Physician Decision|1
2288187|NCT02457520|3978762|FG000|Active Treatment Phase|Protocol Violation|1
2288188|NCT02457520|3978762|FG000|Active Treatment Phase|Withdrawal by Subject|7
2288189|NCT02457520|3978762|FG000|Post-treatment Period|Other: Retreatment Required|7
2288190|NCT02457520|3978762|FG000|Post-treatment Period|Lost to Follow-up|23
2288191|NCT02457520|3978762|FG000|Post-treatment Period|Other|3
2288192|NCT02457520|3978762|FG000|Post-treatment Period|Physician Decision|1
2288193|NCT02457520|3978762|FG000|Post-treatment Period|Withdrawal by Subject|14
2288194|NCT02457546|3978794|FG000|Overall Study|Other reasons|4
2288195|NCT02457546|3978795|FG001|Overall Study|Other reasons|1
2288196|NCT02457546|3978794|FG000|Overall Study|Refused to complete study/procedures|1
2288197|NCT02457546|3978795|FG001|Overall Study|Refused to complete study/procedures|1
2288198|NCT02457546|3978794|FG000|Overall Study|Lost to Follow-up|4
2288199|NCT02457546|3978795|FG001|Overall Study|Lost to Follow-up|1
2288200|NCT02457546|3978794|FG000|Overall Study|Adverse Event|0
2288201|NCT02457546|3978795|FG001|Overall Study|Adverse Event|1
2288202|NCT02457611|3978801|FG000|Overall Study|Lost to Follow-up|3
2138701|NCT01091428|3745228|FG003|Phase 1|Adverse Event|0
2288203|NCT02457637|3978805|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71
2288204|NCT02457793|3978820|FG000|Overall Study|Reason not specified|0
2288205|NCT02457793|3978821|FG001|Overall Study|Reason not specified|0
2288206|NCT02457793|3978822|FG002|Overall Study|Reason not specified|0
2288207|NCT02457793|3978823|FG003|Overall Study|Reason not specified|1
2288208|NCT02457793|3978824|FG004|Overall Study|Reason not specified|1
2288209|NCT02457793|3978825|FG005|Overall Study|Reason not specified|1
2288210|NCT02457793|3978820|FG000|Overall Study|Withdrawal by Subject|0
2288211|NCT02457793|3978821|FG001|Overall Study|Withdrawal by Subject|4
2288212|NCT02457793|3978822|FG002|Overall Study|Withdrawal by Subject|2
2288213|NCT02457793|3978823|FG003|Overall Study|Withdrawal by Subject|2
2288214|NCT02457793|3978824|FG004|Overall Study|Withdrawal by Subject|2
2288215|NCT02457793|3978825|FG005|Overall Study|Withdrawal by Subject|2
2288216|NCT02457793|3978820|FG000|Overall Study|Adverse Event|0
2288217|NCT02457793|3978821|FG001|Overall Study|Adverse Event|0
2138702|NCT01091428|3745225|FG000|Phase 1|Withdrawal by Subject|7
2138703|NCT01091428|3745226|FG001|Phase 1|Withdrawal by Subject|0
2138704|NCT01091428|3745227|FG002|Phase 1|Withdrawal by Subject|0
2138705|NCT01091428|3745228|FG003|Phase 1|Withdrawal by Subject|0
2138706|NCT01091428|3745225|FG000|Phase 1|Reason not specified|0
2138707|NCT01091428|3745226|FG001|Phase 1|Reason not specified|1
2138708|NCT01091428|3745227|FG002|Phase 1|Reason not specified|0
2138709|NCT01091428|3745228|FG003|Phase 1|Reason not specified|0
2138710|NCT01091428|3745225|FG000|Phase 1|Single-Patient IND|2
2138711|NCT01091428|3745226|FG001|Phase 1|Single-Patient IND|0
2138712|NCT01091428|3745227|FG002|Phase 1|Single-Patient IND|0
2138713|NCT01091428|3745228|FG003|Phase 1|Single-Patient IND|0
2138714|NCT01091428|3745225|FG000|Phase 2|Progressive Disease|0
2138715|NCT01091428|3745226|FG001|Phase 2|Progressive Disease|0
2138716|NCT01091428|3745227|FG002|Phase 2|Progressive Disease|44
2138717|NCT01091428|3745228|FG003|Phase 2|Progressive Disease|46
2138718|NCT01091428|3745225|FG000|Phase 2|Symptomatic Deterioration|0
2138719|NCT01091428|3745226|FG001|Phase 2|Symptomatic Deterioration|0
2138720|NCT01091428|3745227|FG002|Phase 2|Symptomatic Deterioration|1
2138721|NCT01091428|3745228|FG003|Phase 2|Symptomatic Deterioration|6
2138722|NCT01091428|3745225|FG000|Phase 2|Adverse Event|0
2138723|NCT01091428|3745226|FG001|Phase 2|Adverse Event|0
2138724|NCT01091428|3745227|FG002|Phase 2|Adverse Event|12
2138725|NCT01091428|3745228|FG003|Phase 2|Adverse Event|5
2138726|NCT01091428|3745225|FG000|Phase 2|Withdrawal by Subject|0
2138727|NCT01091428|3745226|FG001|Phase 2|Withdrawal by Subject|0
2138728|NCT01091428|3745227|FG002|Phase 2|Withdrawal by Subject|9
2288218|NCT02457793|3978822|FG002|Overall Study|Adverse Event|0
2288219|NCT02457793|3978823|FG003|Overall Study|Adverse Event|1
2288220|NCT02457793|3978824|FG004|Overall Study|Adverse Event|0
2288221|NCT02457793|3978825|FG005|Overall Study|Adverse Event|0
2288222|NCT02457793|3978820|FG000|Overall Study|Physician Decision|1
2288223|NCT02457793|3978821|FG001|Overall Study|Physician Decision|0
2288224|NCT02457793|3978822|FG002|Overall Study|Physician Decision|1
2288225|NCT02457793|3978823|FG003|Overall Study|Physician Decision|1
2288226|NCT02457793|3978824|FG004|Overall Study|Physician Decision|1
2288227|NCT02457793|3978825|FG005|Overall Study|Physician Decision|3
2288228|NCT02457819|3978840|FG000|Overall Study|reason not given|8
2288229|NCT02457819|3978840|FG000|Overall Study|Withdrawal by Subject|24
2288230|NCT02457819|3978840|FG000|Overall Study|Protocol Violation|1
2288231|NCT02457819|3978840|FG000|Overall Study|non compliance with study drug|4
2288232|NCT02457819|3978840|FG000|Overall Study|Lost to Follow-up|10
2288233|NCT02457819|3978840|FG000|Overall Study|Lack of Efficacy|19
2288234|NCT02457819|3978840|FG000|Overall Study|Adverse Event|33
2288235|NCT02458092|3978850|FG000|Overall Study|Withdrawal by Subject|1
2288236|NCT02458092|3978851|FG001|Overall Study|Withdrawal by Subject|0
2288237|NCT02458287|3978866|FG000|Overall Study|Adverse Event|0
2288238|NCT02458287|3978867|FG001|Overall Study|Adverse Event|0
2288239|NCT02458287|3978868|FG002|Overall Study|Adverse Event|0
2288240|NCT02458287|3978869|FG003|Overall Study|Adverse Event|1
2288241|NCT02458287|3978866|FG000|Overall Study|Lost to Follow-up|0
2288242|NCT02458287|3978867|FG001|Overall Study|Lost to Follow-up|1
2288243|NCT02458287|3978868|FG002|Overall Study|Lost to Follow-up|1
2288244|NCT02458287|3978869|FG003|Overall Study|Lost to Follow-up|0
2288245|NCT02458287|3978866|FG000|Overall Study|Protocol Violation|0
2288246|NCT02458287|3978867|FG001|Overall Study|Protocol Violation|1
2288247|NCT02458287|3978868|FG002|Overall Study|Protocol Violation|0
2288248|NCT02458287|3978869|FG003|Overall Study|Protocol Violation|0
2288249|NCT02458287|3978866|FG000|Overall Study|Withdrawal by Subject|0
2288250|NCT02458287|3978867|FG001|Overall Study|Withdrawal by Subject|2
2288251|NCT02458287|3978868|FG002|Overall Study|Withdrawal by Subject|2
2288252|NCT02458287|3978869|FG003|Overall Study|Withdrawal by Subject|1
2288253|NCT02458287|3978866|FG000|Overall Study|Relocated Out of State|0
2288254|NCT02458287|3978867|FG001|Overall Study|Relocated Out of State|0
2288255|NCT02458287|3978868|FG002|Overall Study|Relocated Out of State|0
2288256|NCT02458287|3978869|FG003|Overall Study|Relocated Out of State|1
2288257|NCT02458469|3978901|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0
2288258|NCT02458469|3978902|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
2288259|NCT02458469|3978903|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1
2288260|NCT02458469|3978904|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0
2288261|NCT02458469|3978905|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0
2288262|NCT02458469|3978906|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0
2288263|NCT02458469|3978901|FG000|First Intervention (2 Weeks)|Physician Decision|1
2138729|NCT01091428|3745228|FG003|Phase 2|Withdrawal by Subject|8
2138730|NCT01091428|3745225|FG000|Phase 2|Unsatisfactory Therapeutic Response|0
2288264|NCT02458469|3978902|FG001|First Intervention (2 Weeks)|Physician Decision|0
2288265|NCT02458469|3978903|FG002|First Intervention (2 Weeks)|Physician Decision|0
2288266|NCT02458469|3978904|FG003|First Intervention (2 Weeks)|Physician Decision|0
2288267|NCT02458469|3978905|FG004|First Intervention (2 Weeks)|Physician Decision|0
2288268|NCT02458469|3978906|FG005|First Intervention (2 Weeks)|Physician Decision|0
2288269|NCT02458469|3978901|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2288270|NCT02458469|3978902|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2288271|NCT02458469|3978903|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2288272|NCT02458469|3978904|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2138731|NCT01091428|3745226|FG001|Phase 2|Unsatisfactory Therapeutic Response|0
2138732|NCT01091428|3745227|FG002|Phase 2|Unsatisfactory Therapeutic Response|1
2138733|NCT01091428|3745228|FG003|Phase 2|Unsatisfactory Therapeutic Response|1
2138734|NCT01091428|3745225|FG000|Phase 2|Reason not specified|0
2138735|NCT01091428|3745226|FG001|Phase 2|Reason not specified|0
2138736|NCT01091428|3745227|FG002|Phase 2|Reason not specified|4
2138737|NCT01091428|3745228|FG003|Phase 2|Reason not specified|3
2138738|NCT01091428|3745225|FG000|Phase 2|Physician Decision|0
2138739|NCT01091428|3745226|FG001|Phase 2|Physician Decision|0
2138740|NCT01091428|3745227|FG002|Phase 2|Physician Decision|2
2138741|NCT01091428|3745228|FG003|Phase 2|Physician Decision|0
2138742|NCT01091454|3745247|FG000|Overall Study|Ineligible|1
2138743|NCT01091519|3745253|FG000|Overall Study|Adverse Event|12
2138744|NCT01091519|3745254|FG001|Overall Study|Adverse Event|16
2138745|NCT01091519|3745253|FG000|Overall Study|Death|1
2138746|NCT01091519|3745254|FG001|Overall Study|Death|0
2138747|NCT01091519|3745253|FG000|Overall Study|Lack of Efficacy|16
2138748|NCT01091519|3745254|FG001|Overall Study|Lack of Efficacy|19
2138749|NCT01091519|3745253|FG000|Overall Study|Lost to Follow-up|14
2138750|NCT01091519|3745254|FG001|Overall Study|Lost to Follow-up|24
2138751|NCT01091519|3745253|FG000|Overall Study|Withdrawal by Subject|2
2138752|NCT01091519|3745254|FG001|Overall Study|Withdrawal by Subject|2
2138753|NCT01091519|3745253|FG000|Overall Study|Other|6
2138754|NCT01091519|3745254|FG001|Overall Study|Other|8
2138755|NCT01091519|3745253|FG000|Overall Study|Randomized not treated|4
2138756|NCT01091519|3745254|FG001|Overall Study|Randomized not treated|4
2138757|NCT01091662|3745262|FG000|Overall Study|Adverse Event|1
2138758|NCT01091662|3745263|FG001|Overall Study|Adverse Event|9
2138759|NCT01091662|3745262|FG000|Overall Study|Physician Decision|1
2138760|NCT01091662|3745263|FG001|Overall Study|Physician Decision|1
2138761|NCT01091662|3745262|FG000|Overall Study|Withdrawal by Subject|7
2288273|NCT02458469|3978905|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2288274|NCT02458469|3978906|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1
2288275|NCT02458638|3978914|FG000|Overall Study|Death|309
2288276|NCT02458638|3978914|FG000|Overall Study|End of Cohort/End of Study|67
2288277|NCT02458638|3978914|FG000|Overall Study|Lost to Follow-up|31
2288278|NCT02458638|3978914|FG000|Overall Study|Other Reasons|4
2288279|NCT02458638|3978914|FG000|Overall Study|Physician Decision|1
2288280|NCT02458638|3978914|FG000|Overall Study|Withdrawal by Subject|47
2288281|NCT02459093|3978938|FG000|Overall Study|Protocol Violation|6
2288282|NCT02459093|3978939|FG001|Overall Study|Protocol Violation|11
2288283|NCT02459093|3978938|FG000|Overall Study|Lost to Follow-up|6
2288284|NCT02459093|3978939|FG001|Overall Study|Lost to Follow-up|7
2288285|NCT02459262|3978969|FG000|Overall Study|Withdrawal by Subject|0
2288286|NCT02459262|3978970|FG001|Overall Study|Withdrawal by Subject|0
2288287|NCT02459262|3978971|FG002|Overall Study|Withdrawal by Subject|0
2288288|NCT02459262|3978972|FG003|Overall Study|Withdrawal by Subject|0
2288289|NCT02459262|3978973|FG004|Overall Study|Withdrawal by Subject|0
2288290|NCT02459262|3978974|FG005|Overall Study|Withdrawal by Subject|0
2288291|NCT02459262|3978975|FG006|Overall Study|Withdrawal by Subject|0
2288292|NCT02459262|3978976|FG007|Overall Study|Withdrawal by Subject|0
2288293|NCT02459262|3978977|FG008|Overall Study|Withdrawal by Subject|0
2288294|NCT02459262|3978978|FG009|Overall Study|Withdrawal by Subject|1
2288295|NCT02459262|3978979|FG010|Overall Study|Withdrawal by Subject|0
2288296|NCT02459418|3979014|FG000|Overall Study|Exclusion Criteria|4
2288297|NCT02459418|3979015|FG001|Overall Study|Exclusion Criteria|0
2288298|NCT02459418|3979014|FG000|Overall Study|Protocol Violation|0
2288299|NCT02459418|3979015|FG001|Overall Study|Protocol Violation|2
2288300|NCT02459418|3979014|FG000|Overall Study|Physician Decision|0
2288301|NCT02459418|3979015|FG001|Overall Study|Physician Decision|2
2288302|NCT02459418|3979014|FG000|Overall Study|Endometrial thickness of >5 mm|1
2288303|NCT02459418|3979015|FG001|Overall Study|Endometrial thickness of >5 mm|0
2288304|NCT02459418|3979014|FG000|Overall Study|Adverse Event|0
2288305|NCT02459418|3979015|FG001|Overall Study|Adverse Event|1
2288306|NCT02459418|3979014|FG000|Overall Study|Withdrawal by Subject|1
2288307|NCT02459418|3979015|FG001|Overall Study|Withdrawal by Subject|1
2288308|NCT02459418|3979014|FG000|Overall Study|Elevated Creatine Kinase|1
2288309|NCT02459418|3979015|FG001|Overall Study|Elevated Creatine Kinase|0
2288310|NCT02459418|3979014|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1
2288311|NCT02459418|3979015|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0
2288312|NCT02459587|3979026|FG000|3-Month Follow-up Assessment|Death|0
2288313|NCT02459587|3979027|FG001|3-Month Follow-up Assessment|Death|2
2288314|NCT02459587|3979026|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3
2138762|NCT01091662|3745263|FG001|Overall Study|Withdrawal by Subject|6
2138763|NCT01091662|3745262|FG000|Overall Study|met exit criteria|7
2288315|NCT02459587|3979027|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3
2288316|NCT02459587|3979026|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27
2288317|NCT02459587|3979027|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22
2288318|NCT02459587|3979026|FG000|3-Month Follow-up Assessment|Researcher withdrew|2
2288319|NCT02459587|3979027|FG001|3-Month Follow-up Assessment|Researcher withdrew|4
2288320|NCT02459587|3979026|FG000|6-month Follow-up Assessment|Death|2
2288321|NCT02459587|3979027|FG001|6-month Follow-up Assessment|Death|1
2288322|NCT02459587|3979026|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1
2138764|NCT01091662|3745263|FG001|Overall Study|met exit criteria|13
2138765|NCT01091662|3745262|FG000|Overall Study|met exclusion criteria|1
2138766|NCT01091662|3745263|FG001|Overall Study|met exclusion criteria|0
2138767|NCT01091662|3745262|FG000|Overall Study|Lost to Follow-up|0
2138768|NCT01091662|3745263|FG001|Overall Study|Lost to Follow-up|1
2138769|NCT01091662|3745262|FG000|Overall Study|Pregnancy|0
2138770|NCT01091662|3745263|FG001|Overall Study|Pregnancy|1
2138771|NCT01091662|3745262|FG000|Overall Study|Protocol Violation|0
2138772|NCT01091662|3745263|FG001|Overall Study|Protocol Violation|2
2138773|NCT01091662|3745262|FG000|Overall Study|unable to swallow capsule|0
2138774|NCT01091662|3745263|FG001|Overall Study|unable to swallow capsule|1
2138775|NCT01091675|3745274|FG000|Overall Study|Adverse Event|7
2138776|NCT01091675|3745274|FG000|Overall Study|Lack of Efficacy|27
2138777|NCT01091974|3745292|FG000|Overall Study|Did not start intervention|3
2138778|NCT01091974|3745293|FG001|Overall Study|Did not start intervention|1
2138779|NCT01091974|3745294|FG002|Overall Study|Did not start intervention|3
2138780|NCT01091974|3745295|FG003|Overall Study|Did not start intervention|1
2138781|NCT01091974|3745292|FG000|Overall Study|resumed sleep medication|0
2138782|NCT01091974|3745293|FG001|Overall Study|resumed sleep medication|0
2138783|NCT01091974|3745294|FG002|Overall Study|resumed sleep medication|1
2138784|NCT01091974|3745295|FG003|Overall Study|resumed sleep medication|2
2138785|NCT01091974|3745292|FG000|Overall Study|Withdrawal by Subject|1
2138786|NCT01091974|3745293|FG001|Overall Study|Withdrawal by Subject|3
2138787|NCT01091974|3745294|FG002|Overall Study|Withdrawal by Subject|2
2138788|NCT01091974|3745295|FG003|Overall Study|Withdrawal by Subject|2
2138789|NCT01091974|3745292|FG000|Overall Study|side-effects|1
2138790|NCT01091974|3745293|FG001|Overall Study|side-effects|1
2138791|NCT01091974|3745294|FG002|Overall Study|side-effects|0
2138792|NCT01091974|3745295|FG003|Overall Study|side-effects|2
2138793|NCT01092182|3745308|FG000|Overall Study|Death|0
2138794|NCT01092182|3745309|FG001|Overall Study|Death|5
2138795|NCT01092182|3745310|FG002|Overall Study|Death|3
2138796|NCT01092182|3745308|FG000|Overall Study|participant safety|1
2138797|NCT01092182|3745309|FG001|Overall Study|participant safety|2
2138798|NCT01092182|3745310|FG002|Overall Study|participant safety|0
2138799|NCT01092182|3745308|FG000|Overall Study|Physician Decision|0
2138800|NCT01092182|3745309|FG001|Overall Study|Physician Decision|6
2138801|NCT01092182|3745310|FG002|Overall Study|Physician Decision|0
2138802|NCT01092182|3745308|FG000|Overall Study|Did not meet criteria|0
2138803|NCT01092182|3745309|FG001|Overall Study|Did not meet criteria|0
2138804|NCT01092182|3745310|FG002|Overall Study|Did not meet criteria|25
2138805|NCT01092182|3745308|FG000|Overall Study|Non-compliance|0
2138806|NCT01092182|3745309|FG001|Overall Study|Non-compliance|3
2138807|NCT01092182|3745310|FG002|Overall Study|Non-compliance|0
2138808|NCT01092182|3745308|FG000|Overall Study|Participant refused follow-up|0
2138809|NCT01092182|3745309|FG001|Overall Study|Participant refused follow-up|2
2138810|NCT01092182|3745310|FG002|Overall Study|Participant refused follow-up|0
2138811|NCT01092416|3745353|FG000|Enrollment|Atherectomy device not inserted|3
2138812|NCT01092416|3745353|FG000|30-Day Follow-up|Death|2
2138813|NCT01092416|3745353|FG000|30-Day Follow-up|Missed 30-day follow-up|3
2138814|NCT01092416|3745353|FG000|30-Day Follow-up|Data collected after close of 30D window|5
2138815|NCT01092416|3745353|FG000|12-Month Follow-up|Death|16
2138816|NCT01092416|3745353|FG000|12-Month Follow-up|Lost to Follow-up|4
2138817|NCT01092416|3745353|FG000|12-Month Follow-up|Withdrawal by Subject|2
2138818|NCT01092416|3745353|FG000|12-Month Follow-up|Missed 1-year follow-up|1
2138819|NCT01092416|3745353|FG000|12-Month Follow-up|Data collected after close of 1Y window|2
2138820|NCT01092507|3745376|FG000|Overall Study|Withdrawal by Subject|2
2138821|NCT01092507|3745377|FG001|Overall Study|Withdrawal by Subject|0
2138822|NCT01092546|3745383|FG000|Overall Study|Subjects withdrawn prior to dosing|4
2207924|NCT01633944|3847100|FG002|Double-blind Treatment Phase|Lack of Efficacy|23
2138823|NCT01092637|3745393|FG000|Overall Study|Death|47
2138824|NCT01092637|3745394|FG001|Overall Study|Death|49
2138825|NCT01092663|3745403|FG000|Overall Study|Withdrawal by Subject|3
2138826|NCT01092663|3745404|FG001|Overall Study|Withdrawal by Subject|2
2138827|NCT01092663|3745403|FG000|Overall Study|Glucose >300mg/dL|1
2138828|NCT01092663|3745404|FG001|Overall Study|Glucose >300mg/dL|0
2138829|NCT01092663|3745403|FG000|Overall Study|High fasting triglyceride|2
2288323|NCT02459587|3979027|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2
2288324|NCT02459587|3979026|FG000|6-month Follow-up Assessment|Lost to Follow-up|21
2288325|NCT02459587|3979027|FG001|6-month Follow-up Assessment|Lost to Follow-up|22
2138830|NCT01092663|3745404|FG001|Overall Study|High fasting triglyceride|0
2138831|NCT01092663|3745403|FG000|Overall Study|Adverse Event|1
2138832|NCT01092663|3745404|FG001|Overall Study|Adverse Event|1
2138833|NCT01092663|3745403|FG000|Overall Study|Protocol Violation|0
2138834|NCT01092663|3745404|FG001|Overall Study|Protocol Violation|1
2138835|NCT01092702|3745424|FG000|Overall Study|Withdrawal by Subject|7
2138836|NCT01092702|3745424|FG000|Overall Study|Lost to Follow-up|2
2138837|NCT01092728|3745430|FG000|Overall Study|Withdrawal by Subject|2
2138838|NCT01092728|3745431|FG001|Overall Study|Withdrawal by Subject|0
2138839|NCT01092728|3745430|FG000|Overall Study|Adverse Event|0
2138840|NCT01092728|3745431|FG001|Overall Study|Adverse Event|1
2217671|NCT01709305|3860931|FG003|Phase 1|Protocol Violation|0
2138841|NCT01092728|3745430|FG000|Overall Study|Disease Progression|1
2138842|NCT01092728|3745431|FG001|Overall Study|Disease Progression|13
2138843|NCT01092728|3745430|FG000|Overall Study|Prohibited Concomitant Medications|1
2138844|NCT01092728|3745431|FG001|Overall Study|Prohibited Concomitant Medications|0
2138845|NCT01092780|3745441|FG000|Washout Period 1|Adverse Event|0
2138846|NCT01092780|3745442|FG001|Washout Period 1|Adverse Event|1
2138847|NCT01092780|3745443|FG002|Washout Period 1|Adverse Event|0
2138848|NCT01092780|3745444|FG003|Washout Period 1|Adverse Event|0
2138849|NCT01092780|3745441|FG000|Washout Period 1|Noncompliance with nCPAP|1
2138850|NCT01092780|3745442|FG001|Washout Period 1|Noncompliance with nCPAP|0
2138851|NCT01092780|3745443|FG002|Washout Period 1|Noncompliance with nCPAP|0
2138852|NCT01092780|3745444|FG003|Washout Period 1|Noncompliance with nCPAP|0
2138853|NCT01092780|3745441|FG000|Washout Period 2|Adverse Event|0
2138854|NCT01092780|3745442|FG001|Washout Period 2|Adverse Event|1
2138855|NCT01092780|3745443|FG002|Washout Period 2|Adverse Event|1
2138856|NCT01092780|3745444|FG003|Washout Period 2|Adverse Event|0
2138857|NCT01092832|3745456|FG000|Overall Study|Other|1
2138858|NCT01092832|3745457|FG001|Overall Study|Other|0
2138859|NCT01093222|3745508|FG000|Overall Study|Ineligible|6
2138860|NCT01093222|3745508|FG000|Overall Study|Adverse Event|7
2138861|NCT01093222|3745508|FG000|Overall Study|Progression/relapse|24
2138862|NCT01093222|3745508|FG000|Overall Study|Death|2
2138863|NCT01093222|3745508|FG000|Overall Study|Not protocol specified|1
2138864|NCT01093534|3745547|FG000|Overall Study|Adverse Event|2
2138865|NCT01093534|3745548|FG001|Overall Study|Adverse Event|5
2138866|NCT01093534|3745549|FG002|Overall Study|Adverse Event|2
2138867|NCT01093534|3745547|FG000|Overall Study|Lack of Efficacy|2
2138868|NCT01093534|3745548|FG001|Overall Study|Lack of Efficacy|1
2138869|NCT01093534|3745549|FG002|Overall Study|Lack of Efficacy|1
2138870|NCT01093534|3745547|FG000|Overall Study|Withdrawal by Subject|5
2138871|NCT01093534|3745548|FG001|Overall Study|Withdrawal by Subject|7
2138872|NCT01093534|3745549|FG002|Overall Study|Withdrawal by Subject|2
2138873|NCT01093534|3745547|FG000|Overall Study|Other|1
2288326|NCT02459587|3979026|FG000|12-month Follow-up Assessment|Death|2
2288327|NCT02459587|3979027|FG001|12-month Follow-up Assessment|Death|0
2288328|NCT02459587|3979026|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2
2288329|NCT02459587|3979027|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4
2288330|NCT02459587|3979026|FG000|12-month Follow-up Assessment|Lost to Follow-up|18
2288331|NCT02459587|3979027|FG001|12-month Follow-up Assessment|Lost to Follow-up|22
2288332|NCT02459587|3979026|FG000|12-month Follow-up Assessment|Researcher withdrew|0
2288333|NCT02459587|3979027|FG001|12-month Follow-up Assessment|Researcher withdrew|1
2288334|NCT02459665|3979038|FG000|Overall Study|Withdrawal by Subject|0
2288335|NCT02459665|3979039|FG001|Overall Study|Withdrawal by Subject|1
2288336|NCT02459665|3979040|FG002|Overall Study|Withdrawal by Subject|1
2288337|NCT02459665|3979041|FG003|Overall Study|Withdrawal by Subject|2
2288338|NCT02459899|3979075|FG000|Overall Study|Adverse Event|1
2288339|NCT02459899|3979076|FG001|Overall Study|Adverse Event|1
2288340|NCT02459899|3979077|FG002|Overall Study|Adverse Event|0
2288341|NCT02459899|3979078|FG003|Overall Study|Adverse Event|0
2288342|NCT02459899|3979075|FG000|Overall Study|Lost to Follow-up|1
2288343|NCT02459899|3979076|FG001|Overall Study|Lost to Follow-up|2
2288344|NCT02459899|3979077|FG002|Overall Study|Lost to Follow-up|0
2288345|NCT02459899|3979078|FG003|Overall Study|Lost to Follow-up|1
2288346|NCT02459899|3979075|FG000|Overall Study|Non-compliance with the treatment|0
2288347|NCT02459899|3979076|FG001|Overall Study|Non-compliance with the treatment|0
2288348|NCT02459899|3979077|FG002|Overall Study|Non-compliance with the treatment|0
2288349|NCT02459899|3979078|FG003|Overall Study|Non-compliance with the treatment|1
2288350|NCT02459899|3979075|FG000|Overall Study|Withdrawal by Subject|1
2288351|NCT02459899|3979076|FG001|Overall Study|Withdrawal by Subject|3
2288352|NCT02459899|3979077|FG002|Overall Study|Withdrawal by Subject|0
2288353|NCT02459899|3979078|FG003|Overall Study|Withdrawal by Subject|0
2288354|NCT02459951|3979088|FG000|Overall Study|Unable to meet holding requirement|1
2288355|NCT02459964|3979096|FG000|Overall Study|Withdrawal by Subject|0
2288356|NCT02459964|3979097|FG001|Overall Study|Withdrawal by Subject|0
2288357|NCT02459964|3979098|FG002|Overall Study|Withdrawal by Subject|1
2288358|NCT02459964|3979096|FG000|Overall Study|Abnormal EKG changes|0
2288359|NCT02459964|3979097|FG001|Overall Study|Abnormal EKG changes|0
2288360|NCT02459964|3979098|FG002|Overall Study|Abnormal EKG changes|1
2288361|NCT02460198|3979113|FG000|Overall Study|Adverse Event|1
2288362|NCT02460198|3979114|FG001|Overall Study|Adverse Event|3
2288363|NCT02460198|3979113|FG000|Overall Study|Death|32
2288364|NCT02460198|3979114|FG001|Overall Study|Death|25
2288365|NCT02460198|3979113|FG000|Overall Study|Lost to Follow-up|1
2288366|NCT02460198|3979114|FG001|Overall Study|Lost to Follow-up|1
2288367|NCT02460198|3979113|FG000|Overall Study|Withdrawal by Subject|2
2138874|NCT01093534|3745548|FG001|Overall Study|Other|3
2138875|NCT01093534|3745549|FG002|Overall Study|Other|4
2138876|NCT01093573|3745561|FG000|Overall Study|Physician Decision|0
2288368|NCT02460198|3979114|FG001|Overall Study|Withdrawal by Subject|4
2288369|NCT02460198|3979113|FG000|Overall Study|Ongoing|25
2288370|NCT02460198|3979114|FG001|Overall Study|Ongoing|30
2288371|NCT02460263|3979120|FG000|Transition Period|Withdrawal by Subject|1
2288372|NCT02460263|3979120|FG000|Transition Period|Death|1
2288373|NCT02460380|3979130|FG000|Overall Study|Withdrawal by Subject|10
2288374|NCT02460380|3979131|FG001|Overall Study|Withdrawal by Subject|5
2288375|NCT02460458|3979138|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47
2138877|NCT01093573|3745562|FG001|Overall Study|Physician Decision|0
2138878|NCT01093573|3745563|FG002|Overall Study|Physician Decision|1
2138879|NCT01093573|3745561|FG000|Overall Study|Insurance Denied|0
2138880|NCT01093573|3745562|FG001|Overall Study|Insurance Denied|0
2138881|NCT01093573|3745563|FG002|Overall Study|Insurance Denied|1
2138882|NCT01093586|3745574|FG000|Overall Study|Failed to engraft|3
2138883|NCT01093599|3745580|FG000|Overall Study|Lost to Follow-up|32
2138884|NCT01093599|3745581|FG001|Overall Study|Lost to Follow-up|46
2138885|NCT01093625|3745589|FG000|Baseline and Dispensed|Withdrawal by Subject|2
2138886|NCT01093625|3745590|FG001|Baseline and Dispensed|Withdrawal by Subject|0
2138887|NCT01093625|3745589|FG000|2-Week Visit|Withdrawal by Subject|1
2138888|NCT01093625|3745590|FG001|2-Week Visit|Withdrawal by Subject|0
2138889|NCT01093625|3745589|FG000|1-Month Visit|Lost to Follow-up|2
2138890|NCT01093625|3745590|FG001|1-Month Visit|Lost to Follow-up|0
2138891|NCT01093625|3745589|FG000|3-Month Visit|Lost to Follow-up|2
2138892|NCT01093625|3745590|FG001|3-Month Visit|Lost to Follow-up|0
2138893|NCT01093625|3745589|FG000|6-Month Visit|Withdrawal by Subject|6
2138894|NCT01093625|3745590|FG001|6-Month Visit|Withdrawal by Subject|7
2138895|NCT01093625|3745589|FG000|6-Month Visit|Lost to Follow-up|2
2138896|NCT01093625|3745590|FG001|6-Month Visit|Lost to Follow-up|2
2138897|NCT01093625|3745589|FG000|1-Year Visit|Lost to Follow-up|5
2138898|NCT01093625|3745590|FG001|1-Year Visit|Lost to Follow-up|3
2138899|NCT01093755|3745616|FG000|Overall Study|Withdrawal by Subject|3
2138900|NCT01093755|3745617|FG001|Overall Study|Withdrawal by Subject|4
2138901|NCT01093885|3745636|FG000|Overall Study|Adverse Event|4
2138902|NCT01093885|3745636|FG000|Overall Study|Lost to Follow-up|1
2138903|NCT01094119|3745656|FG000|Overall Study|Lack of Efficacy|2
2138904|NCT01094119|3745657|FG001|Overall Study|Lack of Efficacy|4
2138905|NCT01094171|3745663|FG000|Overall Study|Lost to Follow-up|2
2138906|NCT01094171|3745663|FG000|Overall Study|Informed consent withdrawal|4
2138907|NCT01094171|3745663|FG000|Overall Study|Migration from the study area|3
2138908|NCT01094171|3745663|FG000|Overall Study|Other|1
2138909|NCT01094184|3745669|FG000|Overall Study|Death|35
2138910|NCT01094184|3745670|FG001|Overall Study|Death|11
2138911|NCT01094288|3745684|FG000|Overall Study|Adverse Event|0
2138912|NCT01094288|3745685|FG001|Overall Study|Adverse Event|3
2138913|NCT01094288|3745686|FG002|Overall Study|Adverse Event|1
2138914|NCT01094288|3745687|FG003|Overall Study|Adverse Event|1
2138915|NCT01094288|3745688|FG004|Overall Study|Adverse Event|0
2138916|NCT01094288|3745689|FG005|Overall Study|Adverse Event|0
2138917|NCT01094288|3745690|FG006|Overall Study|Adverse Event|0
2138918|NCT01094288|3745691|FG007|Overall Study|Adverse Event|0
2138919|NCT01094288|3745684|FG000|Overall Study|Withdrawal by Subject|0
2138920|NCT01094288|3745685|FG001|Overall Study|Withdrawal by Subject|1
2138921|NCT01094288|3745686|FG002|Overall Study|Withdrawal by Subject|2
2138922|NCT01094288|3745687|FG003|Overall Study|Withdrawal by Subject|0
2138923|NCT01094288|3745688|FG004|Overall Study|Withdrawal by Subject|0
2138924|NCT01094288|3745689|FG005|Overall Study|Withdrawal by Subject|0
2138925|NCT01094288|3745690|FG006|Overall Study|Withdrawal by Subject|0
2138926|NCT01094288|3745691|FG007|Overall Study|Withdrawal by Subject|2
2138927|NCT01094288|3745684|FG000|Overall Study|Initiation of Alternative Therapy|0
2138928|NCT01094288|3745685|FG001|Overall Study|Initiation of Alternative Therapy|0
2138929|NCT01094288|3745686|FG002|Overall Study|Initiation of Alternative Therapy|1
2138930|NCT01094288|3745687|FG003|Overall Study|Initiation of Alternative Therapy|0
2138931|NCT01094288|3745688|FG004|Overall Study|Initiation of Alternative Therapy|0
2138932|NCT01094288|3745689|FG005|Overall Study|Initiation of Alternative Therapy|0
2288376|NCT02460458|3979138|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27
2288377|NCT02460458|3979138|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14
2288378|NCT02460458|3979138|FG000|First Prospective Phase|Lost to Follow-up|16
2288379|NCT02460458|3979138|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9
2288380|NCT02460562|3979144|FG000|Overall Study|Lost to Follow-up|15
2288381|NCT02460562|3979145|FG001|Overall Study|Lost to Follow-up|16
2288382|NCT02460575|3979153|FG000|Overall Study|Lost to Follow-up|1
2288383|NCT02460575|3979154|FG001|Overall Study|Lost to Follow-up|0
2288384|NCT02460679|3979169|FG000|Overall Study|Investigator Decision|1
2288385|NCT02460679|3979169|FG000|Overall Study|Withdrawal by Subject|4
2288386|NCT02460822|3979173|FG000|Overall Study|Withdrawal by Subject|1
2288387|NCT02460978|3979180|FG000|Overall Study|Adverse Event|17
2288388|NCT02460978|3979181|FG001|Overall Study|Adverse Event|11
2288389|NCT02460978|3979182|FG002|Overall Study|Adverse Event|11
2288390|NCT02460978|3979180|FG000|Overall Study|Withdrawal by Subject|5
2288391|NCT02460978|3979181|FG001|Overall Study|Withdrawal by Subject|5
2288392|NCT02460978|3979182|FG002|Overall Study|Withdrawal by Subject|14
2288393|NCT02460978|3979180|FG000|Overall Study|Lost to Follow-up|2
2288394|NCT02460978|3979181|FG001|Overall Study|Lost to Follow-up|3
2138933|NCT01094288|3745690|FG006|Overall Study|Initiation of Alternative Therapy|0
2138934|NCT01094288|3745691|FG007|Overall Study|Initiation of Alternative Therapy|0
2138935|NCT01094288|3745684|FG000|Overall Study|Reason not Specified|2
2138936|NCT01094288|3745685|FG001|Overall Study|Reason not Specified|3
2138937|NCT01094288|3745686|FG002|Overall Study|Reason not Specified|0
2288395|NCT02460978|3979182|FG002|Overall Study|Lost to Follow-up|1
2288396|NCT02460978|3979180|FG000|Overall Study|Protocol Violation|1
2288397|NCT02460978|3979181|FG001|Overall Study|Protocol Violation|1
2138938|NCT01094288|3745687|FG003|Overall Study|Reason not Specified|1
2138939|NCT01094288|3745688|FG004|Overall Study|Reason not Specified|0
2138940|NCT01094288|3745689|FG005|Overall Study|Reason not Specified|0
2138941|NCT01094288|3745690|FG006|Overall Study|Reason not Specified|0
2138942|NCT01094288|3745691|FG007|Overall Study|Reason not Specified|0
2138943|NCT01094288|3745684|FG000|Overall Study|Ongoing Participants|0
2138944|NCT01094288|3745685|FG001|Overall Study|Ongoing Participants|3
2138945|NCT01094288|3745686|FG002|Overall Study|Ongoing Participants|0
2138946|NCT01094288|3745687|FG003|Overall Study|Ongoing Participants|0
2138947|NCT01094288|3745688|FG004|Overall Study|Ongoing Participants|0
2138948|NCT01094288|3745689|FG005|Overall Study|Ongoing Participants|0
2138949|NCT01094288|3745690|FG006|Overall Study|Ongoing Participants|0
2138950|NCT01094288|3745691|FG007|Overall Study|Ongoing Participants|0
2138951|NCT01094301|3745713|FG000|Trial Stage|Withdrawal by Subject|1
2138952|NCT01094301|3745713|FG000|Implant Stage|Adverse Event|1
2138953|NCT01094301|3745713|FG000|Implant Stage|Protocol Violation|1
2138954|NCT01094301|3745713|FG000|Implant Stage|Withdrawal by Subject|2
2138955|NCT01094301|3745713|FG000|Implant Stage|No return of pain|4
2138956|NCT01094730|3745790|FG000|Period 1 (14 Days)|Lost to Follow-up|0
2138957|NCT01094730|3745791|FG001|Period 1 (14 Days)|Lost to Follow-up|1
2138958|NCT01094730|3745790|FG000|Period 1 (14 Days)|Withdrawal by Subject|0
2138959|NCT01094730|3745791|FG001|Period 1 (14 Days)|Withdrawal by Subject|1
2138960|NCT01094730|3745790|FG000|Period 1 (14 Days)|No time for the follow-up visit|1
2138961|NCT01094730|3745791|FG001|Period 1 (14 Days)|No time for the follow-up visit|0
2138962|NCT01094730|3745790|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1
2138963|NCT01094730|3745791|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0
2138964|NCT01094730|3745790|FG000|Period 2 (14 Days)|Protocol Violation|2
2138965|NCT01094730|3745791|FG001|Period 2 (14 Days)|Protocol Violation|0
2138966|NCT01094730|3745790|FG000|Period 2 (14 Days)|No time for the follow-up visit|1
2138967|NCT01094730|3745791|FG001|Period 2 (14 Days)|No time for the follow-up visit|0
2138968|NCT01094730|3745790|FG000|Period 2 (14 Days)|Adverse Event|0
2138969|NCT01094730|3745791|FG001|Period 2 (14 Days)|Adverse Event|1
2138970|NCT01094730|3745790|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0
2138971|NCT01094730|3745791|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1
2138972|NCT01094743|3745798|FG000|Period 1|Unsatisfactory comfort at lens fitting|2
2138973|NCT01094782|3745809|FG000|Overall Study|Withdrawal by Subject|5
2138974|NCT01094782|3745810|FG001|Overall Study|Withdrawal by Subject|5
2138975|NCT01094782|3745811|FG002|Overall Study|Withdrawal by Subject|1
2138976|NCT01094782|3745812|FG003|Overall Study|Withdrawal by Subject|5
2138977|NCT01094782|3745813|FG004|Overall Study|Withdrawal by Subject|5
2138978|NCT01094782|3745814|FG005|Overall Study|Withdrawal by Subject|0
2138979|NCT01094782|3745809|FG000|Overall Study|Lost to Follow-up|1
2138980|NCT01094782|3745810|FG001|Overall Study|Lost to Follow-up|0
2138981|NCT01094782|3745811|FG002|Overall Study|Lost to Follow-up|0
2138982|NCT01094782|3745812|FG003|Overall Study|Lost to Follow-up|2
2138983|NCT01094782|3745813|FG004|Overall Study|Lost to Follow-up|1
2138984|NCT01094782|3745814|FG005|Overall Study|Lost to Follow-up|4
2138985|NCT01094782|3745809|FG000|Overall Study|Positive Drug Screen|2
2138986|NCT01094782|3745810|FG001|Overall Study|Positive Drug Screen|2
2138987|NCT01094782|3745811|FG002|Overall Study|Positive Drug Screen|1
2138988|NCT01094782|3745812|FG003|Overall Study|Positive Drug Screen|1
2138989|NCT01094782|3745813|FG004|Overall Study|Positive Drug Screen|3
2138990|NCT01094782|3745814|FG005|Overall Study|Positive Drug Screen|2
2138991|NCT01094782|3745809|FG000|Overall Study|Sensory Deficit at Site of QST|0
2138992|NCT01094782|3745810|FG001|Overall Study|Sensory Deficit at Site of QST|1
2138993|NCT01094782|3745811|FG002|Overall Study|Sensory Deficit at Site of QST|0
2138994|NCT01094782|3745812|FG003|Overall Study|Sensory Deficit at Site of QST|0
2288398|NCT02460978|3979182|FG002|Overall Study|Protocol Violation|1
2288399|NCT02460978|3979180|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2
2288400|NCT02460978|3979181|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5
2288401|NCT02460978|3979182|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4
2288402|NCT02460978|3979180|FG000|Overall Study|Pregnancy|0
2288403|NCT02460978|3979181|FG001|Overall Study|Pregnancy|0
2288404|NCT02460978|3979182|FG002|Overall Study|Pregnancy|2
2288405|NCT02460991|3979192|FG000|Overall Study|Withdrawal by Subject|0
2288406|NCT02460991|3979193|FG001|Overall Study|Withdrawal by Subject|2
2288407|NCT02461134|3979204|FG000|Overall Study|Adverse Event|1
2288408|NCT02461160|3979221|FG000|Overall Study|Lost to Follow-up|0
2288409|NCT02461160|3979222|FG001|Overall Study|Lost to Follow-up|0
2288410|NCT02461160|3979223|FG002|Overall Study|Lost to Follow-up|0
2138995|NCT01094782|3745813|FG004|Overall Study|Sensory Deficit at Site of QST|0
2138996|NCT01094782|3745814|FG005|Overall Study|Sensory Deficit at Site of QST|0
2138997|NCT01094782|3745809|FG000|Overall Study|Unable to Complete Questionnaires|0
2138998|NCT01094782|3745810|FG001|Overall Study|Unable to Complete Questionnaires|1
2138999|NCT01094782|3745811|FG002|Overall Study|Unable to Complete Questionnaires|0
2139000|NCT01094782|3745812|FG003|Overall Study|Unable to Complete Questionnaires|0
2139001|NCT01094782|3745813|FG004|Overall Study|Unable to Complete Questionnaires|0
2139002|NCT01094782|3745814|FG005|Overall Study|Unable to Complete Questionnaires|0
2139003|NCT01094782|3745809|FG000|Overall Study|Healthy Subject Had Pain|0
2288411|NCT02461160|3979224|FG003|Overall Study|Lost to Follow-up|0
2288412|NCT02461160|3979225|FG004|Overall Study|Lost to Follow-up|0
2139004|NCT01094782|3745810|FG001|Overall Study|Healthy Subject Had Pain|1
2139005|NCT01094782|3745811|FG002|Overall Study|Healthy Subject Had Pain|0
2139006|NCT01094782|3745812|FG003|Overall Study|Healthy Subject Had Pain|0
2139007|NCT01094782|3745813|FG004|Overall Study|Healthy Subject Had Pain|0
2139008|NCT01094782|3745814|FG005|Overall Study|Healthy Subject Had Pain|0
2139009|NCT01094782|3745809|FG000|Overall Study|Hypertension|0
2139010|NCT01094782|3745810|FG001|Overall Study|Hypertension|0
2139011|NCT01094782|3745811|FG002|Overall Study|Hypertension|1
2139012|NCT01094782|3745812|FG003|Overall Study|Hypertension|0
2139013|NCT01094782|3745813|FG004|Overall Study|Hypertension|0
2139014|NCT01094782|3745814|FG005|Overall Study|Hypertension|0
2139015|NCT01094782|3745809|FG000|Overall Study|Wrong Pain Condition|0
2139016|NCT01094782|3745810|FG001|Overall Study|Wrong Pain Condition|0
2139017|NCT01094782|3745811|FG002|Overall Study|Wrong Pain Condition|0
2139018|NCT01094782|3745812|FG003|Overall Study|Wrong Pain Condition|2
2139019|NCT01094782|3745813|FG004|Overall Study|Wrong Pain Condition|1
2139020|NCT01094782|3745814|FG005|Overall Study|Wrong Pain Condition|1
2139021|NCT01094782|3745809|FG000|Overall Study|Recent Interventional Injection|0
2139022|NCT01094782|3745810|FG001|Overall Study|Recent Interventional Injection|0
2139023|NCT01094782|3745811|FG002|Overall Study|Recent Interventional Injection|0
2139024|NCT01094782|3745812|FG003|Overall Study|Recent Interventional Injection|0
2139025|NCT01094782|3745813|FG004|Overall Study|Recent Interventional Injection|0
2139026|NCT01094782|3745814|FG005|Overall Study|Recent Interventional Injection|1
2139027|NCT01094782|3745809|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0
2139028|NCT01094782|3745810|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0
2139029|NCT01094782|3745811|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0
2139030|NCT01094782|3745812|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0
2139031|NCT01094782|3745813|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1
2139032|NCT01094782|3745814|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0
2139033|NCT01094782|3745809|FG000|Overall Study|Noncompliance With Study Schedule|0
2139034|NCT01094782|3745810|FG001|Overall Study|Noncompliance With Study Schedule|0
2139035|NCT01094782|3745811|FG002|Overall Study|Noncompliance With Study Schedule|0
2139036|NCT01094782|3745812|FG003|Overall Study|Noncompliance With Study Schedule|1
2139037|NCT01094782|3745813|FG004|Overall Study|Noncompliance With Study Schedule|0
2139038|NCT01094782|3745814|FG005|Overall Study|Noncompliance With Study Schedule|0
2139039|NCT01094808|3745831|FG000|Overall Study|Withdrawal by Subject|1
2139040|NCT01094808|3745832|FG001|Overall Study|Withdrawal by Subject|1
2139041|NCT01094808|3745833|FG002|Overall Study|Withdrawal by Subject|0
2139042|NCT01094886|3745841|FG000|Overall Study|Adverse Event|2
2139043|NCT01094886|3745841|FG000|Overall Study|Withdrawal by Subject|5
2288413|NCT02461160|3979226|FG005|Overall Study|Lost to Follow-up|0
2288414|NCT02461160|3979227|FG006|Overall Study|Lost to Follow-up|0
2288415|NCT02461160|3979228|FG007|Overall Study|Lost to Follow-up|1
2288416|NCT02461160|3979229|FG008|Overall Study|Lost to Follow-up|0
2288417|NCT02461160|3979230|FG009|Overall Study|Lost to Follow-up|0
2288418|NCT02461160|3979231|FG010|Overall Study|Lost to Follow-up|0
2288419|NCT02461160|3979232|FG011|Overall Study|Lost to Follow-up|0
2288420|NCT02461160|3979233|FG012|Overall Study|Lost to Follow-up|0
2288421|NCT02461290|3979282|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7
2288422|NCT02461290|3979282|FG000|Overall Study|Lost to Follow-up|3
2288423|NCT02461589|3979328|FG000|Overall Study|Withdrawal by Subject|5
2288424|NCT02461589|3979329|FG001|Overall Study|Withdrawal by Subject|1
2288425|NCT02461589|3979330|FG002|Overall Study|Withdrawal by Subject|3
2288426|NCT02461589|3979331|FG003|Overall Study|Withdrawal by Subject|2
2288427|NCT02461589|3979332|FG004|Overall Study|Withdrawal by Subject|1
2288428|NCT02461589|3979333|FG005|Overall Study|Withdrawal by Subject|2
2288429|NCT02461589|3979334|FG006|Overall Study|Withdrawal by Subject|1
2288430|NCT02461589|3979335|FG007|Overall Study|Withdrawal by Subject|3
2288431|NCT02461589|3979336|FG008|Overall Study|Withdrawal by Subject|3
2288432|NCT02461589|3979337|FG009|Overall Study|Withdrawal by Subject|1
2288433|NCT02461589|3979328|FG000|Overall Study|Lost to Follow-up|0
2288434|NCT02461589|3979329|FG001|Overall Study|Lost to Follow-up|0
2288435|NCT02461589|3979330|FG002|Overall Study|Lost to Follow-up|2
2288436|NCT02461589|3979331|FG003|Overall Study|Lost to Follow-up|3
2288437|NCT02461589|3979332|FG004|Overall Study|Lost to Follow-up|1
2288438|NCT02461589|3979333|FG005|Overall Study|Lost to Follow-up|1
2288439|NCT02461589|3979334|FG006|Overall Study|Lost to Follow-up|3
2288440|NCT02461589|3979335|FG007|Overall Study|Lost to Follow-up|1
2288441|NCT02461589|3979336|FG008|Overall Study|Lost to Follow-up|3
2288442|NCT02461589|3979337|FG009|Overall Study|Lost to Follow-up|1
2288443|NCT02461589|3979328|FG000|Overall Study|Death|0
2288444|NCT02461589|3979329|FG001|Overall Study|Death|0
2288445|NCT02461589|3979330|FG002|Overall Study|Death|0
2288446|NCT02461589|3979331|FG003|Overall Study|Death|0
2139044|NCT01095094|3745856|FG000|Overall Study|Withdrawal by Subject|1
2139045|NCT01095094|3745856|FG000|Overall Study|Death|1
2139046|NCT01095094|3745856|FG000|Overall Study|Physician Decision|1
2288447|NCT02461589|3979332|FG004|Overall Study|Death|0
2288448|NCT02461589|3979333|FG005|Overall Study|Death|0
2288449|NCT02461589|3979334|FG006|Overall Study|Death|0
2288450|NCT02461589|3979335|FG007|Overall Study|Death|1
2288451|NCT02461589|3979336|FG008|Overall Study|Death|0
2288452|NCT02461589|3979337|FG009|Overall Study|Death|0
2139047|NCT01095653|3745891|FG000|Overall Study|Lack of Efficacy|3
2139048|NCT01095653|3745892|FG001|Overall Study|Lack of Efficacy|0
2139049|NCT01095653|3745893|FG002|Overall Study|Lack of Efficacy|0
2139050|NCT01095653|3745891|FG000|Overall Study|Adverse Event|1
2139051|NCT01095653|3745892|FG001|Overall Study|Adverse Event|4
2139052|NCT01095653|3745893|FG002|Overall Study|Adverse Event|4
2139053|NCT01095653|3745891|FG000|Overall Study|Lost to Follow-up|1
2139054|NCT01095653|3745892|FG001|Overall Study|Lost to Follow-up|0
2139055|NCT01095653|3745893|FG002|Overall Study|Lost to Follow-up|4
2139056|NCT01095653|3745891|FG000|Overall Study|Withdrawal by Subject|4
2139057|NCT01095653|3745892|FG001|Overall Study|Withdrawal by Subject|5
2139058|NCT01095653|3745893|FG002|Overall Study|Withdrawal by Subject|3
2139059|NCT01095653|3745891|FG000|Overall Study|non-compliance, not met criteria, etc.|10
2139060|NCT01095653|3745892|FG001|Overall Study|non-compliance, not met criteria, etc.|6
2139061|NCT01095653|3745893|FG002|Overall Study|non-compliance, not met criteria, etc.|5
2207925|NCT01633944|3847098|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
2207926|NCT01633944|3847099|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
2207927|NCT01633944|3847100|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8
2139062|NCT01095666|3745904|FG000|Overall Study|Lack of Efficacy|0
2139063|NCT01095666|3745905|FG001|Overall Study|Lack of Efficacy|0
2139064|NCT01095666|3745906|FG002|Overall Study|Lack of Efficacy|1
2139065|NCT01095666|3745904|FG000|Overall Study|Adverse Event|2
2139066|NCT01095666|3745905|FG001|Overall Study|Adverse Event|1
2139067|NCT01095666|3745906|FG002|Overall Study|Adverse Event|3
2139068|NCT01095666|3745904|FG000|Overall Study|Lost to Follow-up|2
2139069|NCT01095666|3745905|FG001|Overall Study|Lost to Follow-up|2
2139070|NCT01095666|3745906|FG002|Overall Study|Lost to Follow-up|0
2207928|NCT01633944|3847098|FG000|Double-blind Treatment Phase|Protocol Violation|0
2207929|NCT01633944|3847099|FG001|Double-blind Treatment Phase|Protocol Violation|7
2288453|NCT02461589|3979328|FG000|Overall Study|Unclassified|0
2139071|NCT01095666|3745904|FG000|Overall Study|Withdrawal by Subject|6
2139072|NCT01095666|3745905|FG001|Overall Study|Withdrawal by Subject|6
2139073|NCT01095666|3745906|FG002|Overall Study|Withdrawal by Subject|1
2139074|NCT01095666|3745904|FG000|Overall Study|Non-compliance, not met criteria etc.|7
2139075|NCT01095666|3745905|FG001|Overall Study|Non-compliance, not met criteria etc.|2
2139076|NCT01095666|3745906|FG002|Overall Study|Non-compliance, not met criteria etc.|2
2139077|NCT01095796|3745921|FG000|Overall Study|Randomized but Not Treated|5
2139078|NCT01095796|3745922|FG001|Overall Study|Randomized but Not Treated|2
2139079|NCT01095796|3745921|FG000|Overall Study|Adverse Event|9
2139080|NCT01095796|3745922|FG001|Overall Study|Adverse Event|19
2139081|NCT01095796|3745921|FG000|Overall Study|Death|3
2139082|NCT01095796|3745922|FG001|Overall Study|Death|2
2139083|NCT01095796|3745921|FG000|Overall Study|Pregnancy|2
2139084|NCT01095796|3745922|FG001|Overall Study|Pregnancy|0
2139085|NCT01095796|3745921|FG000|Overall Study|Lack of Efficacy|5
2139086|NCT01095796|3745922|FG001|Overall Study|Lack of Efficacy|3
2139087|NCT01095796|3745921|FG000|Overall Study|Investigator's Discretion|7
2139088|NCT01095796|3745922|FG001|Overall Study|Investigator's Discretion|2
2139089|NCT01095796|3745921|FG000|Overall Study|Withdrew Consent|16
2139090|NCT01095796|3745922|FG001|Overall Study|Withdrew Consent|22
2139091|NCT01095796|3745921|FG000|Overall Study|Lost to Follow-up|27
2139092|NCT01095796|3745922|FG001|Overall Study|Lost to Follow-up|29
2139093|NCT01095796|3745921|FG000|Overall Study|Participant Noncompliance|5
2139094|NCT01095796|3745922|FG001|Overall Study|Participant Noncompliance|10
2139095|NCT01095796|3745921|FG000|Overall Study|Protocol Violation|1
2139096|NCT01095796|3745922|FG001|Overall Study|Protocol Violation|0
2139097|NCT01095796|3745921|FG000|Overall Study|Participant Transferred to Another Study|215
2139098|NCT01095796|3745922|FG001|Overall Study|Participant Transferred to Another Study|200
2139099|NCT01095835|3745931|FG000|Overall Study|Adverse Event|8
2139100|NCT01095835|3745932|FG001|Overall Study|Adverse Event|6
2139101|NCT01095835|3745933|FG002|Overall Study|Adverse Event|6
2139102|NCT01095835|3745931|FG000|Overall Study|Lack of Efficacy|0
2139103|NCT01095835|3745932|FG001|Overall Study|Lack of Efficacy|1
2139104|NCT01095835|3745933|FG002|Overall Study|Lack of Efficacy|0
2139105|NCT01095835|3745931|FG000|Overall Study|Physician Decision|0
2139106|NCT01095835|3745932|FG001|Overall Study|Physician Decision|0
2139107|NCT01095835|3745933|FG002|Overall Study|Physician Decision|1
2139108|NCT01095835|3745931|FG000|Overall Study|Withdrawal by Subject|1
2139109|NCT01095835|3745932|FG001|Overall Study|Withdrawal by Subject|3
2139110|NCT01095835|3745933|FG002|Overall Study|Withdrawal by Subject|0
2139111|NCT01095835|3745931|FG000|Overall Study|Non study compliance|0
2207930|NCT01633944|3847100|FG002|Double-blind Treatment Phase|Protocol Violation|10
2207931|NCT01633944|3847098|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
2207932|NCT01633944|3847099|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
2207933|NCT01633944|3847100|FG002|Double-blind Treatment Phase|Lost to Follow-up|9
2207934|NCT01633944|3847098|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
2288454|NCT02461589|3979329|FG001|Overall Study|Unclassified|0
2288455|NCT02461589|3979330|FG002|Overall Study|Unclassified|0
2139112|NCT01095835|3745932|FG001|Overall Study|Non study compliance|0
2139113|NCT01095835|3745933|FG002|Overall Study|Non study compliance|1
2139114|NCT01095835|3745931|FG000|Overall Study|Protocol Violation|1
2207935|NCT01633944|3847099|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
2139115|NCT01095835|3745932|FG001|Overall Study|Protocol Violation|2
2139116|NCT01095835|3745933|FG002|Overall Study|Protocol Violation|0
2139117|NCT01095978|3745946|FG000|Overall Study|Did not take Klacid SR|2
2139118|NCT01095978|3745946|FG000|Overall Study|Adverse Event|1
2139119|NCT01096017|3745952|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1
2139120|NCT01096017|3745953|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1
2139121|NCT01096056|3745961|FG000|Overall Study|Lost to Follow-up|0
2139122|NCT01096056|3745962|FG001|Overall Study|Lost to Follow-up|1
2139123|NCT01096160|3745978|FG000|Overall Study|Adverse Event|0
2139124|NCT01096160|3745979|FG001|Overall Study|Adverse Event|0
2139125|NCT01096160|3745980|FG002|Overall Study|Adverse Event|1
2139126|NCT01096160|3745981|FG003|Overall Study|Adverse Event|0
2139127|NCT01096160|3745982|FG004|Overall Study|Adverse Event|0
2139128|NCT01096160|3745983|FG005|Overall Study|Adverse Event|0
2139129|NCT01096160|3745984|FG006|Overall Study|Adverse Event|0
2288456|NCT02461589|3979331|FG003|Overall Study|Unclassified|0
2288457|NCT02461589|3979332|FG004|Overall Study|Unclassified|0
2288458|NCT02461589|3979333|FG005|Overall Study|Unclassified|0
2288459|NCT02461589|3979334|FG006|Overall Study|Unclassified|1
2288460|NCT02461589|3979335|FG007|Overall Study|Unclassified|0
2288461|NCT02461589|3979336|FG008|Overall Study|Unclassified|0
2288462|NCT02461589|3979337|FG009|Overall Study|Unclassified|2
2288463|NCT02461589|3979328|FG000|Overall Study|Missing follow-up information|1
2288464|NCT02461589|3979329|FG001|Overall Study|Missing follow-up information|1
2288465|NCT02461589|3979330|FG002|Overall Study|Missing follow-up information|0
2288466|NCT02461589|3979331|FG003|Overall Study|Missing follow-up information|0
2288467|NCT02461589|3979332|FG004|Overall Study|Missing follow-up information|0
2288468|NCT02461589|3979333|FG005|Overall Study|Missing follow-up information|0
2288469|NCT02461589|3979334|FG006|Overall Study|Missing follow-up information|1
2288470|NCT02461589|3979335|FG007|Overall Study|Missing follow-up information|0
2288471|NCT02461589|3979336|FG008|Overall Study|Missing follow-up information|0
2288472|NCT02461589|3979337|FG009|Overall Study|Missing follow-up information|0
2288473|NCT02461589|3979328|FG000|Overall Study|Withdrawal from trial before exposure|0
2288474|NCT02461589|3979329|FG001|Overall Study|Withdrawal from trial before exposure|0
2288475|NCT02461589|3979330|FG002|Overall Study|Withdrawal from trial before exposure|0
2288476|NCT02461589|3979331|FG003|Overall Study|Withdrawal from trial before exposure|0
2288477|NCT02461589|3979332|FG004|Overall Study|Withdrawal from trial before exposure|0
2288478|NCT02461589|3979333|FG005|Overall Study|Withdrawal from trial before exposure|0
2288479|NCT02461589|3979334|FG006|Overall Study|Withdrawal from trial before exposure|0
2288480|NCT02461589|3979335|FG007|Overall Study|Withdrawal from trial before exposure|0
2288481|NCT02461589|3979336|FG008|Overall Study|Withdrawal from trial before exposure|0
2288482|NCT02461589|3979337|FG009|Overall Study|Withdrawal from trial before exposure|1
2288483|NCT02461628|3979361|FG000|Overall Study|Refused to complete survey|4
2288484|NCT02461628|3979362|FG001|Overall Study|Refused to complete survey|7
2288485|NCT02461745|3979379|FG000|Overall Study|Lack of Efficacy|9
2288486|NCT02461745|3979380|FG001|Overall Study|Lack of Efficacy|1
2288487|NCT02461745|3979379|FG000|Overall Study|Lost to Follow-up|2
2288488|NCT02461745|3979380|FG001|Overall Study|Lost to Follow-up|2
2288489|NCT02461745|3979379|FG000|Overall Study|Withdrawal by Subject|3
2288490|NCT02461745|3979380|FG001|Overall Study|Withdrawal by Subject|1
2288491|NCT02461758|3979392|FG000|Overall Study|Lost to Follow-up|0
2288492|NCT02461758|3979393|FG001|Overall Study|Lost to Follow-up|1
2288493|NCT02461758|3979394|FG002|Overall Study|Lost to Follow-up|1
2288494|NCT02461758|3979395|FG003|Overall Study|Lost to Follow-up|0
2288495|NCT02462057|3979443|FG000|Overall Study|Left Vitality|32
2288496|NCT02462057|3979444|FG001|Overall Study|Left Vitality|27
2288497|NCT02462057|3979445|FG002|Overall Study|Left Vitality|23
2288498|NCT02462057|3979446|FG003|Overall Study|Left Vitality|35
2288499|NCT02462057|3979447|FG004|Overall Study|Left Vitality|33
2288500|NCT02462057|3979443|FG000|Overall Study|Joined HealthyFood Before Intervention|22
2288501|NCT02462057|3979444|FG001|Overall Study|Joined HealthyFood Before Intervention|13
2288502|NCT02462057|3979445|FG002|Overall Study|Joined HealthyFood Before Intervention|23
2288503|NCT02462057|3979446|FG003|Overall Study|Joined HealthyFood Before Intervention|16
2288504|NCT02462057|3979447|FG004|Overall Study|Joined HealthyFood Before Intervention|17
2320992|NCT02953821|4035234|FG000|Overall Study|Lack of Efficacy|1
2320993|NCT02953821|4035235|FG001|Overall Study|Lack of Efficacy|0
2320994|NCT02953821|4035234|FG000|Overall Study|Out of state for indeterminate time|0
2320995|NCT02953821|4035235|FG001|Overall Study|Out of state for indeterminate time|1
2320996|NCT02953821|4035234|FG000|Overall Study|No improvement|0
2320997|NCT02953821|4035235|FG001|Overall Study|No improvement|1
2320998|NCT02953821|4035234|FG000|Overall Study|Refused follow-up visit|2
2320999|NCT02953821|4035235|FG001|Overall Study|Refused follow-up visit|1
2321000|NCT02953938|4035257|FG000|Overall Study|Adverse Event|0
2321001|NCT02953938|4035258|FG001|Overall Study|Adverse Event|1
2321002|NCT02953938|4035257|FG000|Overall Study|Withdrawal by Subject|1
2321003|NCT02953938|4035258|FG001|Overall Study|Withdrawal by Subject|1
2321004|NCT02954172|4035267|FG000|Overall Study|Protocol Violation|3
2321005|NCT02954172|4035268|FG001|Overall Study|Protocol Violation|0
2321006|NCT02954172|4035267|FG000|Overall Study|allergic reaction|2
2321007|NCT02954172|4035268|FG001|Overall Study|allergic reaction|1
2321008|NCT02954172|4035267|FG000|Overall Study|non-measurable lesions at baseline|1
2139130|NCT01096160|3745985|FG007|Overall Study|Adverse Event|0
2139131|NCT01096160|3745986|FG008|Overall Study|Adverse Event|0
2139132|NCT01096160|3745987|FG009|Overall Study|Adverse Event|1
2139133|NCT01096160|3745978|FG000|Overall Study|Met stopping criteria per protocol|0
2139134|NCT01096160|3745979|FG001|Overall Study|Met stopping criteria per protocol|0
2139135|NCT01096160|3745980|FG002|Overall Study|Met stopping criteria per protocol|0
2139136|NCT01096160|3745981|FG003|Overall Study|Met stopping criteria per protocol|0
2139137|NCT01096160|3745982|FG004|Overall Study|Met stopping criteria per protocol|1
2139138|NCT01096160|3745983|FG005|Overall Study|Met stopping criteria per protocol|0
2139139|NCT01096160|3745984|FG006|Overall Study|Met stopping criteria per protocol|2
2139140|NCT01096160|3745985|FG007|Overall Study|Met stopping criteria per protocol|0
2139141|NCT01096160|3745986|FG008|Overall Study|Met stopping criteria per protocol|2
2139142|NCT01096160|3745987|FG009|Overall Study|Met stopping criteria per protocol|0
2178467|NCT01384734|3803321|FG003|Overall Study|Lack of Efficacy|4
2178468|NCT01384734|3803322|FG004|Overall Study|Lack of Efficacy|2
2178469|NCT01384734|3803318|FG000|Overall Study|Lost to Follow-up|5
2178470|NCT01384734|3803319|FG001|Overall Study|Lost to Follow-up|3
2178471|NCT01384734|3803320|FG002|Overall Study|Lost to Follow-up|3
2178472|NCT01384734|3803321|FG003|Overall Study|Lost to Follow-up|8
2178473|NCT01384734|3803322|FG004|Overall Study|Lost to Follow-up|5
2178474|NCT01384734|3803318|FG000|Overall Study|Non-compliance with study drug|1
2178475|NCT01384734|3803319|FG001|Overall Study|Non-compliance with study drug|2
2178476|NCT01384734|3803320|FG002|Overall Study|Non-compliance with study drug|6
2178477|NCT01384734|3803321|FG003|Overall Study|Non-compliance with study drug|0
2178478|NCT01384734|3803322|FG004|Overall Study|Non-compliance with study drug|2
2178479|NCT01384734|3803318|FG000|Overall Study|Pregnancy|0
2178480|NCT01384734|3803319|FG001|Overall Study|Pregnancy|1
2178481|NCT01384734|3803320|FG002|Overall Study|Pregnancy|0
2178482|NCT01384734|3803321|FG003|Overall Study|Pregnancy|0
2178483|NCT01384734|3803322|FG004|Overall Study|Pregnancy|1
2178484|NCT01384734|3803318|FG000|Overall Study|Sponsor terminated|0
2178485|NCT01384734|3803319|FG001|Overall Study|Sponsor terminated|0
2178486|NCT01384734|3803320|FG002|Overall Study|Sponsor terminated|0
2178487|NCT01384734|3803321|FG003|Overall Study|Sponsor terminated|0
2178488|NCT01384734|3803322|FG004|Overall Study|Sponsor terminated|1
2178489|NCT01384734|3803318|FG000|Overall Study|Withdrawal by Subject|5
2178490|NCT01384734|3803319|FG001|Overall Study|Withdrawal by Subject|5
2178491|NCT01384734|3803320|FG002|Overall Study|Withdrawal by Subject|6
2178492|NCT01384734|3803321|FG003|Overall Study|Withdrawal by Subject|7
2178493|NCT01384734|3803322|FG004|Overall Study|Withdrawal by Subject|9
2178494|NCT01384734|3803318|FG000|Overall Study|Investigator relocating|0
2178495|NCT01384734|3803319|FG001|Overall Study|Investigator relocating|2
2178496|NCT01384734|3803320|FG002|Overall Study|Investigator relocating|0
2178497|NCT01384734|3803321|FG003|Overall Study|Investigator relocating|3
2178498|NCT01384734|3803322|FG004|Overall Study|Investigator relocating|1
2178499|NCT01384734|3803318|FG000|Overall Study|Unable to come back for visit|1
2178500|NCT01384734|3803319|FG001|Overall Study|Unable to come back for visit|0
2178501|NCT01384734|3803320|FG002|Overall Study|Unable to come back for visit|1
2178502|NCT01384734|3803321|FG003|Overall Study|Unable to come back for visit|1
2178503|NCT01384734|3803322|FG004|Overall Study|Unable to come back for visit|0
2178504|NCT01384734|3803318|FG000|Overall Study|Prison|0
2178505|NCT01384734|3803319|FG001|Overall Study|Prison|0
2178506|NCT01384734|3803320|FG002|Overall Study|Prison|1
2178507|NCT01384734|3803321|FG003|Overall Study|Prison|0
2178508|NCT01384734|3803322|FG004|Overall Study|Prison|0
2178509|NCT01384734|3803318|FG000|Overall Study|As per Exclusion criteria|0
2178510|NCT01384734|3803319|FG001|Overall Study|As per Exclusion criteria|1
2178511|NCT01384734|3803320|FG002|Overall Study|As per Exclusion criteria|0
2178512|NCT01384734|3803321|FG003|Overall Study|As per Exclusion criteria|0
2178513|NCT01384734|3803322|FG004|Overall Study|As per Exclusion criteria|0
2178514|NCT01384734|3803318|FG000|Overall Study|Missed End of treatment visit|0
2178515|NCT01384734|3803319|FG001|Overall Study|Missed End of treatment visit|0
2178516|NCT01384734|3803320|FG002|Overall Study|Missed End of treatment visit|0
2288505|NCT02462083|3979468|FG000|Overall Study|Sponsor request|39
2288506|NCT02462083|3979468|FG000|Overall Study|Withdrawal by Subject|87
2288507|NCT02462083|3979468|FG000|Overall Study|Lost to Follow-up|41
2288508|NCT02462083|3979468|FG000|Overall Study|Lack of Efficacy|151
2288509|NCT02462083|3979468|FG000|Overall Study|Pregnancy|1
2288510|NCT02462083|3979468|FG000|Overall Study|Protocol Violation|6
2288511|NCT02462083|3979468|FG000|Overall Study|Adverse Event|33
2288512|NCT02462083|3979468|FG000|Overall Study|Worsening condition|16
2288513|NCT02462083|3979468|FG000|Overall Study|Other than specified|45
2288514|NCT02462473|3979517|FG000|Overall Study|Death|1
2288515|NCT02462473|3979517|FG000|Overall Study|Other|3
2288516|NCT02462486|3979524|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
2288517|NCT02462486|3979525|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
2288518|NCT02462486|3979526|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3
2288519|NCT02462486|3979524|FG000|Overall Study|Adverse Event|53
2288520|NCT02462486|3979525|FG001|Overall Study|Adverse Event|48
2288521|NCT02462486|3979526|FG002|Overall Study|Adverse Event|21
2288522|NCT02462486|3979524|FG000|Overall Study|Lack of Efficacy|6
2288523|NCT02462486|3979525|FG001|Overall Study|Lack of Efficacy|12
2288524|NCT02462486|3979526|FG002|Overall Study|Lack of Efficacy|3
2139143|NCT01096186|3746022|FG000|Overall Study|Adverse Event|16
2139144|NCT01096186|3746022|FG000|Overall Study|Death|4
2139145|NCT01096186|3746022|FG000|Overall Study|Lack of Efficacy|4
2139146|NCT01096186|3746022|FG000|Overall Study|Lost to Follow-up|2
2139147|NCT01096186|3746022|FG000|Overall Study|Withdrawal by Subject|22
2139148|NCT01096186|3746022|FG000|Overall Study|Physician Decision|1
2139149|NCT01096186|3746022|FG000|Overall Study|Noncompliance with study drug|1
2139150|NCT01096316|3746037|FG000|Overall Study|Lost to Follow-up|15
2139151|NCT01096316|3746038|FG001|Overall Study|Lost to Follow-up|9
2139152|NCT01096342|3746044|FG000|Overall Study|Protocol Violation|1
2139153|NCT01096446|3746050|FG000|Overall Study|Death|1
2139154|NCT01096446|3746051|FG001|Overall Study|Death|0
2139155|NCT01096446|3746050|FG000|Overall Study|Protocol Violation|2
2139156|NCT01096446|3746051|FG001|Overall Study|Protocol Violation|0
2139157|NCT01096550|3746058|FG000|Overall Study|discontinued site|10
2139158|NCT01096550|3746059|FG001|Overall Study|discontinued site|11
2139159|NCT01096550|3746058|FG000|Overall Study|non-regular treatment track at clinic|1
2139160|NCT01096550|3746059|FG001|Overall Study|non-regular treatment track at clinic|1
2139161|NCT01096550|3746058|FG000|Overall Study|clinic readmission|1
2139162|NCT01096550|3746059|FG001|Overall Study|clinic readmission|1
2139163|NCT01096550|3746058|FG000|Overall Study|Withdrawal by Subject|0
2139164|NCT01096550|3746059|FG001|Overall Study|Withdrawal by Subject|1
2139165|NCT01096550|3746058|FG000|Overall Study|non-African American participant|13
2139166|NCT01096550|3746059|FG001|Overall Study|non-African American participant|6
2139167|NCT01096550|3746058|FG000|Overall Study|Lost to Follow-up|12
2139168|NCT01096550|3746059|FG001|Overall Study|Lost to Follow-up|9
2139169|NCT01096589|3746069|FG000|Overall Study|Adverse Event|2
2139170|NCT01096589|3746070|FG001|Overall Study|Adverse Event|1
2139171|NCT01096589|3746071|FG002|Overall Study|Adverse Event|2
2139172|NCT01096589|3746072|FG003|Overall Study|Adverse Event|1
2139173|NCT01096589|3746069|FG000|Overall Study|Withdrawal by Subject|2
2139174|NCT01096589|3746070|FG001|Overall Study|Withdrawal by Subject|1
2139175|NCT01096589|3746071|FG002|Overall Study|Withdrawal by Subject|1
2139176|NCT01096589|3746072|FG003|Overall Study|Withdrawal by Subject|1
2139177|NCT01096589|3746069|FG000|Overall Study|Compliance with protocol|0
2139178|NCT01096589|3746070|FG001|Overall Study|Compliance with protocol|0
2139179|NCT01096589|3746071|FG002|Overall Study|Compliance with protocol|1
2139180|NCT01096589|3746072|FG003|Overall Study|Compliance with protocol|0
2139181|NCT01096589|3746069|FG000|Overall Study|found treatment exhausting|0
2139182|NCT01096589|3746070|FG001|Overall Study|found treatment exhausting|0
2139183|NCT01096589|3746071|FG002|Overall Study|found treatment exhausting|0
2139184|NCT01096589|3746072|FG003|Overall Study|found treatment exhausting|1
2139185|NCT01096667|3746091|FG000|Overall Study|Lost to Follow-up|1
2139186|NCT01096667|3746092|FG001|Overall Study|Lost to Follow-up|1
2139187|NCT01096667|3746093|FG002|Overall Study|Lost to Follow-up|1
2139188|NCT01096667|3746094|FG003|Overall Study|Lost to Follow-up|0
2139189|NCT01096667|3746095|FG004|Overall Study|Lost to Follow-up|0
2139190|NCT01096667|3746091|FG000|Overall Study|Withdrawal by Subject|1
2139191|NCT01096667|3746092|FG001|Overall Study|Withdrawal by Subject|0
2139192|NCT01096667|3746093|FG002|Overall Study|Withdrawal by Subject|0
2139193|NCT01096667|3746094|FG003|Overall Study|Withdrawal by Subject|1
2139194|NCT01096667|3746095|FG004|Overall Study|Withdrawal by Subject|0
2288525|NCT02462486|3979524|FG000|Overall Study|Lost to Follow-up|3
2288526|NCT02462486|3979525|FG001|Overall Study|Lost to Follow-up|4
2288527|NCT02462486|3979526|FG002|Overall Study|Lost to Follow-up|2
2288528|NCT02462486|3979524|FG000|Overall Study|Withdrawal by Subject|25
2288529|NCT02462486|3979525|FG001|Overall Study|Withdrawal by Subject|22
2288530|NCT02462486|3979526|FG002|Overall Study|Withdrawal by Subject|19
2288531|NCT02462486|3979524|FG000|Overall Study|Protocol Violation|3
2288532|NCT02462486|3979525|FG001|Overall Study|Protocol Violation|1
2288533|NCT02462486|3979526|FG002|Overall Study|Protocol Violation|1
2288534|NCT02462486|3979524|FG000|Overall Study|Reason not Specified|3
2288535|NCT02462486|3979525|FG001|Overall Study|Reason not Specified|4
2288536|NCT02462486|3979526|FG002|Overall Study|Reason not Specified|3
2288537|NCT02462720|3979534|FG000|Part 2|Withdrawal by Subject|1
2288538|NCT02462720|3979535|FG001|Part 2|Withdrawal by Subject|0
2288539|NCT02462720|3979534|FG000|Part 2|Protocol Violation|0
2288540|NCT02462720|3979535|FG001|Part 2|Protocol Violation|1
2288541|NCT02462759|3979545|FG000|Part 1: Double Blind|Death|1
2288542|NCT02462759|3979546|FG001|Part 1: Double Blind|Death|0
2288543|NCT02462759|3979547|FG002|Part 1: Double Blind|Death|0
2288544|NCT02462928|3979561|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
2139195|NCT01096667|3746091|FG000|Overall Study|Reason not available|0
2139196|NCT01096667|3746092|FG001|Overall Study|Reason not available|1
2139197|NCT01096667|3746093|FG002|Overall Study|Reason not available|1
2139198|NCT01096667|3746094|FG003|Overall Study|Reason not available|1
2139199|NCT01096667|3746095|FG004|Overall Study|Reason not available|0
2139200|NCT01096667|3746091|FG000|Overall Study|Protocol Violation|0
2139201|NCT01096667|3746092|FG001|Overall Study|Protocol Violation|0
2139202|NCT01096667|3746093|FG002|Overall Study|Protocol Violation|0
2139203|NCT01096667|3746094|FG003|Overall Study|Protocol Violation|1
2139204|NCT01096667|3746095|FG004|Overall Study|Protocol Violation|0
2139205|NCT01096667|3746091|FG000|Overall Study|Not treated|1
2288545|NCT02462928|3979562|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
2139206|NCT01096667|3746092|FG001|Overall Study|Not treated|0
2139207|NCT01096667|3746093|FG002|Overall Study|Not treated|0
2139208|NCT01096667|3746094|FG003|Overall Study|Not treated|0
2139209|NCT01096667|3746095|FG004|Overall Study|Not treated|0
2139210|NCT01096784|3746140|FG000|Overall Study|Withdrawal by Subject|2
2139211|NCT01096784|3746141|FG001|Overall Study|Withdrawal by Subject|1
2139212|NCT01096784|3746140|FG000|Overall Study|Adverse Event|11
2139213|NCT01096784|3746141|FG001|Overall Study|Adverse Event|9
2139214|NCT01096784|3746140|FG000|Overall Study|Protocol Deviation|2
2139215|NCT01096784|3746141|FG001|Overall Study|Protocol Deviation|2
2139216|NCT01096784|3746140|FG000|Overall Study|Administrative Decision|0
2139217|NCT01096784|3746141|FG001|Overall Study|Administrative Decision|1
2139218|NCT01096784|3746140|FG000|Overall Study|Other Unspecified|0
2139219|NCT01096784|3746141|FG001|Overall Study|Other Unspecified|1
2139220|NCT01096849|3746165|FG000|Overall Study|Consent Withdrawn|1
2139221|NCT01096849|3746166|FG001|Overall Study|Consent Withdrawn|4
2139222|NCT01096849|3746167|FG002|Overall Study|Consent Withdrawn|2
2139223|NCT01096849|3746165|FG000|Overall Study|Lack of Efficacy|0
2139224|NCT01096849|3746166|FG001|Overall Study|Lack of Efficacy|2
2139225|NCT01096849|3746167|FG002|Overall Study|Lack of Efficacy|0
2139226|NCT01096849|3746165|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0
2139227|NCT01096849|3746166|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1
2139228|NCT01096849|3746167|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1
2139229|NCT01096849|3746165|FG000|Overall Study|Investigator or Medical Monitor Decision|0
2139230|NCT01096849|3746166|FG001|Overall Study|Investigator or Medical Monitor Decision|1
2139231|NCT01096849|3746167|FG002|Overall Study|Investigator or Medical Monitor Decision|0
2139232|NCT01096849|3746165|FG000|Overall Study|Administrative Reasons|0
2139233|NCT01096849|3746166|FG001|Overall Study|Administrative Reasons|1
2139234|NCT01096849|3746167|FG002|Overall Study|Administrative Reasons|2
2139235|NCT01096849|3746165|FG000|Overall Study|Lost to Follow-up|1
2139236|NCT01096849|3746166|FG001|Overall Study|Lost to Follow-up|3
2139237|NCT01096849|3746167|FG002|Overall Study|Lost to Follow-up|1
2139238|NCT01097005|3746208|FG000|Overall Study|Case Report Form not collected|18
2139239|NCT01097005|3746208|FG000|Overall Study|Subjects cannot visit the hospital|1
2139240|NCT01097005|3746208|FG000|Overall Study|Poor medication compliance|1
2139241|NCT01097005|3746208|FG000|Overall Study|No examination data available|244
2288546|NCT02462928|3979563|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2
2288547|NCT02462928|3979561|FG000|Overall Study|Adverse Event|47
2288548|NCT02462928|3979562|FG001|Overall Study|Adverse Event|51
2288549|NCT02462928|3979563|FG002|Overall Study|Adverse Event|25
2288550|NCT02462928|3979561|FG000|Overall Study|Lack of Efficacy|3
2288551|NCT02462928|3979562|FG001|Overall Study|Lack of Efficacy|8
2288552|NCT02462928|3979563|FG002|Overall Study|Lack of Efficacy|3
2288553|NCT02462928|3979561|FG000|Overall Study|Lost to Follow-up|4
2288554|NCT02462928|3979562|FG001|Overall Study|Lost to Follow-up|4
2288555|NCT02462928|3979563|FG002|Overall Study|Lost to Follow-up|1
2288556|NCT02462928|3979561|FG000|Overall Study|Withdrawal by Patient|31
2288557|NCT02462928|3979562|FG001|Overall Study|Withdrawal by Patient|21
2288558|NCT02462928|3979563|FG002|Overall Study|Withdrawal by Patient|21
2288559|NCT02462928|3979561|FG000|Overall Study|Protocol Violation|0
2288560|NCT02462928|3979562|FG001|Overall Study|Protocol Violation|1
2288561|NCT02462928|3979563|FG002|Overall Study|Protocol Violation|0
2288562|NCT02462928|3979561|FG000|Overall Study|Reason not Specified|4
2288563|NCT02462928|3979562|FG001|Overall Study|Reason not Specified|6
2288564|NCT02462928|3979563|FG002|Overall Study|Reason not Specified|5
2288565|NCT02463032|3979586|FG000|Overall Study|Lack of Efficacy|61
2288566|NCT02463032|3979587|FG001|Overall Study|Lack of Efficacy|50
2288567|NCT02463032|3979586|FG000|Overall Study|Death|8
2288568|NCT02463032|3979587|FG001|Overall Study|Death|8
2288569|NCT02463032|3979586|FG000|Overall Study|Adverse Event|2
2288570|NCT02463032|3979587|FG001|Overall Study|Adverse Event|6
2288571|NCT02463071|3979596|FG000|Overall Study|Adverse Event|3
2288572|NCT02463071|3979597|FG001|Overall Study|Adverse Event|5
2288573|NCT02463071|3979598|FG002|Overall Study|Adverse Event|1
2288574|NCT02463071|3979596|FG000|Overall Study|Death|1
2288575|NCT02463071|3979597|FG001|Overall Study|Death|0
2288576|NCT02463071|3979598|FG002|Overall Study|Death|0
2288577|NCT02463071|3979596|FG000|Overall Study|Eligibility criteria not fulfilled|1
2288578|NCT02463071|3979597|FG001|Overall Study|Eligibility criteria not fulfilled|0
2288579|NCT02463071|3979598|FG002|Overall Study|Eligibility criteria not fulfilled|0
2288580|NCT02463071|3979596|FG000|Overall Study|Reason not specified|7
2288581|NCT02463071|3979597|FG001|Overall Study|Reason not specified|9
2288582|NCT02463071|3979598|FG002|Overall Study|Reason not specified|4
2139242|NCT01097005|3746208|FG000|Overall Study|Deviation from exclusion criteria|37
2139243|NCT01097005|3746208|FG000|Overall Study|Adverse Event|14
2139244|NCT01097005|3746208|FG000|Overall Study|Discontinuance by complication|50
2139245|NCT01097044|3746216|FG000|Overall Study|Withdrawal by Subject|4
2139246|NCT01097044|3746217|FG001|Overall Study|Withdrawal by Subject|4
2139247|NCT01097044|3746216|FG000|Overall Study|Lost to Follow-up|1
2139248|NCT01097044|3746217|FG001|Overall Study|Lost to Follow-up|0
2139249|NCT01097044|3746216|FG000|Overall Study|Withdrawal by Sponsor|0
2139250|NCT01097044|3746217|FG001|Overall Study|Withdrawal by Sponsor|1
2139251|NCT01097057|3746225|FG000|Overall Study|Physician Decision|3
2288583|NCT02463071|3979596|FG000|Overall Study|Protocol Violation|0
2139252|NCT01097330|3746236|FG000|Overall Study|Study terminated early|7
2139253|NCT01097330|3746237|FG001|Overall Study|Study terminated early|5
2139254|NCT01097421|3746259|FG000|Overall Study|Adverse Event|8
2139255|NCT01097421|3746259|FG000|Overall Study|Protocol Violation|2
2139256|NCT01097421|3746259|FG000|Overall Study|Lost to Follow-up|1
2139257|NCT01097421|3746259|FG000|Overall Study|Withdrawal by Subject|3
2139258|NCT01097577|3746269|FG000|Overall Study|Adverse Event|0
2139259|NCT01097577|3746270|FG001|Overall Study|Adverse Event|1
2139260|NCT01097616|3746279|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
2288584|NCT02463071|3979597|FG001|Overall Study|Protocol Violation|2
2288585|NCT02463071|3979598|FG002|Overall Study|Protocol Violation|0
2288586|NCT02463071|3979596|FG000|Overall Study|Lost to Follow-up|0
2288587|NCT02463071|3979597|FG001|Overall Study|Lost to Follow-up|0
2288588|NCT02463071|3979598|FG002|Overall Study|Lost to Follow-up|1
2288589|NCT02463097|3979606|FG000|Overall Study|Withdrawal by Subject|1
2288590|NCT02463331|3979616|FG000|Overall Study|Adverse Event|4
2288591|NCT02463331|3979617|FG001|Overall Study|Adverse Event|2
2288592|NCT02463331|3979616|FG000|Overall Study|Lost to Follow-up|1
2288593|NCT02463331|3979617|FG001|Overall Study|Lost to Follow-up|1
2288594|NCT02463331|3979616|FG000|Overall Study|Pregnancy|2
2288595|NCT02463331|3979617|FG001|Overall Study|Pregnancy|3
2288596|NCT02463331|3979616|FG000|Overall Study|Lack of Efficacy|6
2288597|NCT02463331|3979617|FG001|Overall Study|Lack of Efficacy|0
2288598|NCT02463331|3979616|FG000|Overall Study|Physician Decision|3
2288599|NCT02463331|3979617|FG001|Overall Study|Physician Decision|0
2288600|NCT02463357|3979628|FG000|Overall Study|Withdrawal by Subject|1
2288601|NCT02463357|3979629|FG001|Overall Study|Withdrawal by Subject|0
2288602|NCT02463357|3979630|FG002|Overall Study|Withdrawal by Subject|0
2288603|NCT02463357|3979631|FG003|Overall Study|Withdrawal by Subject|0
2288604|NCT02463357|3979632|FG004|Overall Study|Withdrawal by Subject|0
2288605|NCT02463357|3979628|FG000|Overall Study|Withdrawal by Subject|0
2288606|NCT02463357|3979629|FG001|Overall Study|Withdrawal by Subject|0
2288607|NCT02463357|3979630|FG002|Overall Study|Withdrawal by Subject|0
2288608|NCT02463357|3979631|FG003|Overall Study|Withdrawal by Subject|0
2288609|NCT02463357|3979632|FG004|Overall Study|Withdrawal by Subject|1
2288610|NCT02463409|3979644|FG000|Overall Study|Withdrawal by Subject|1
2288611|NCT02463409|3979644|FG000|Overall Study|Screen failure|1
2288612|NCT02464059|3979671|FG000|Overall Study|Lost to Follow-up|6
2288613|NCT02465034|3979746|FG000|Overall Study|Withdrawal by Subject|1
2288614|NCT02465034|3979747|FG001|Overall Study|Withdrawal by Subject|1
2288615|NCT02465034|3979746|FG000|Overall Study|Screen fail|2
2288616|NCT02465034|3979747|FG001|Overall Study|Screen fail|0
2288617|NCT02465034|3979746|FG000|Overall Study|Could not be scheduled for study visit|0
2288618|NCT02465034|3979747|FG001|Overall Study|Could not be scheduled for study visit|5
2288619|NCT02465203|3979786|FG000|Overall Study|Protocol Violation|1
2288620|NCT02465203|3979787|FG001|Overall Study|Protocol Violation|1
2288621|NCT02465203|3979788|FG002|Overall Study|Protocol Violation|1
2288622|NCT02465203|3979786|FG000|Overall Study|Study terminated by sponsor|50
2288623|NCT02465203|3979787|FG001|Overall Study|Study terminated by sponsor|34
2288624|NCT02465203|3979788|FG002|Overall Study|Study terminated by sponsor|11
2288625|NCT02465203|3979786|FG000|Overall Study|New therapy for study indication|4
2288626|NCT02465203|3979787|FG001|Overall Study|New therapy for study indication|0
2288627|NCT02465203|3979788|FG002|Overall Study|New therapy for study indication|0
2288628|NCT02465203|3979786|FG000|Overall Study|Patient/guardian decision|1
2288629|NCT02465203|3979787|FG001|Overall Study|Patient/guardian decision|1
2288630|NCT02465203|3979788|FG002|Overall Study|Patient/guardian decision|1
2288631|NCT02465437|3979829|FG000|Overall Study|Physician Decision|0
2288632|NCT02465437|3979830|FG001|Overall Study|Physician Decision|0
2288633|NCT02465437|3979831|FG002|Overall Study|Physician Decision|1
2288634|NCT02465437|3979832|FG003|Overall Study|Physician Decision|0
2288635|NCT02465437|3979829|FG000|Overall Study|Withdrawal by Subject|1
2288636|NCT02465437|3979830|FG001|Overall Study|Withdrawal by Subject|0
2288637|NCT02465437|3979831|FG002|Overall Study|Withdrawal by Subject|0
2288638|NCT02465437|3979832|FG003|Overall Study|Withdrawal by Subject|1
2288639|NCT02465437|3979829|FG000|Overall Study|Adverse Event|0
2288640|NCT02465437|3979830|FG001|Overall Study|Adverse Event|1
2288641|NCT02465437|3979831|FG002|Overall Study|Adverse Event|0
2288642|NCT02465437|3979832|FG003|Overall Study|Adverse Event|0
2288643|NCT02465463|3979868|FG000|Overall Study|Lost to Follow-up|2
2288644|NCT02465463|3979869|FG001|Overall Study|Lost to Follow-up|1
2288645|NCT02465463|3979868|FG000|Overall Study|Death|1
2288646|NCT02465463|3979869|FG001|Overall Study|Death|0
2288647|NCT02465463|3979868|FG000|Overall Study|Protocol Violation|1
2288648|NCT02465463|3979869|FG001|Overall Study|Protocol Violation|0
2288649|NCT02465489|3979876|FG000|Overall Study|Adverse Event|5
2288650|NCT02465515|3979890|FG000|Overall Study|Investigator site closed|4
2288651|NCT02465515|3979891|FG001|Overall Study|Investigator site closed|5
2288652|NCT02465515|3979890|FG000|Overall Study|Withdrawal by Subject|74
2139261|NCT01097616|3746280|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
2288653|NCT02465515|3979891|FG001|Overall Study|Withdrawal by Subject|43
2288654|NCT02465515|3979890|FG000|Overall Study|Physician Decision|8
2288655|NCT02465515|3979891|FG001|Overall Study|Physician Decision|12
2288656|NCT02465515|3979890|FG000|Overall Study|Lost to Follow-up|68
2288657|NCT02465515|3979891|FG001|Overall Study|Lost to Follow-up|51
2288658|NCT02465528|3979901|FG000|Overall Study|Progressive disease|0
2139262|NCT01097616|3746281|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
2139263|NCT01097616|3746282|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2139264|NCT01097616|3746283|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2139265|NCT01097616|3746284|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2139266|NCT01097616|3746285|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2139267|NCT01097616|3746286|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2139268|NCT01097616|3746279|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
2139269|NCT01097616|3746280|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
2139270|NCT01097616|3746281|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
2139271|NCT01097616|3746282|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2139272|NCT01097616|3746283|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2139273|NCT01097616|3746284|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2139274|NCT01097616|3746285|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2139275|NCT01097616|3746286|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2139276|NCT01097616|3746279|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
2139277|NCT01097616|3746280|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
2139278|NCT01097616|3746281|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
2139279|NCT01097616|3746282|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2139280|NCT01097616|3746283|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2139281|NCT01097616|3746284|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2139282|NCT01097616|3746285|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2139283|NCT01097616|3746286|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2180134|NCT01399099|3806101|FG000|Overall Study|Protocol Violation|1
2288659|NCT02465528|3979902|FG001|Overall Study|Progressive disease|2
2288660|NCT02465528|3979903|FG002|Overall Study|Progressive disease|9
2288661|NCT02465528|3979904|FG003|Overall Study|Progressive disease|4
2288662|NCT02465528|3979901|FG000|Overall Study|Study terminated by sponsor|1
2288663|NCT02465528|3979902|FG001|Overall Study|Study terminated by sponsor|2
2288664|NCT02465528|3979903|FG002|Overall Study|Study terminated by sponsor|0
2288665|NCT02465528|3979904|FG003|Overall Study|Study terminated by sponsor|0
2288666|NCT02465528|3979901|FG000|Overall Study|Withdrawal by Subject|0
2288667|NCT02465528|3979902|FG001|Overall Study|Withdrawal by Subject|0
2288668|NCT02465528|3979903|FG002|Overall Study|Withdrawal by Subject|2
2288669|NCT02465528|3979904|FG003|Overall Study|Withdrawal by Subject|0
2288670|NCT02465528|3979901|FG000|Overall Study|Adverse Event|0
2288671|NCT02465528|3979902|FG001|Overall Study|Adverse Event|0
2288672|NCT02465528|3979903|FG002|Overall Study|Adverse Event|0
2288673|NCT02465528|3979904|FG003|Overall Study|Adverse Event|1
2288674|NCT02465528|3979901|FG000|Overall Study|Physician Decision|0
2288675|NCT02465528|3979902|FG001|Overall Study|Physician Decision|0
2288676|NCT02465528|3979903|FG002|Overall Study|Physician Decision|1
2288677|NCT02465528|3979904|FG003|Overall Study|Physician Decision|0
2288678|NCT02465567|3979920|FG000|Overall Study|Adverse Event|118
2288679|NCT02465567|3979921|FG001|Overall Study|Adverse Event|113
2288680|NCT02465567|3979922|FG002|Overall Study|Adverse Event|147
2288681|NCT02465567|3979923|FG003|Overall Study|Adverse Event|138
2288682|NCT02465567|3979920|FG000|Overall Study|Lack of Efficacy|103
2288683|NCT02465567|3979921|FG001|Overall Study|Lack of Efficacy|102
2288684|NCT02465567|3979922|FG002|Overall Study|Lack of Efficacy|171
2288685|NCT02465567|3979923|FG003|Overall Study|Lack of Efficacy|135
2288686|NCT02465567|3979920|FG000|Overall Study|Withdrawal by Subject|104
2288687|NCT02465567|3979921|FG001|Overall Study|Withdrawal by Subject|94
2288688|NCT02465567|3979922|FG002|Overall Study|Withdrawal by Subject|123
2288689|NCT02465567|3979923|FG003|Overall Study|Withdrawal by Subject|130
2288690|NCT02465567|3979920|FG000|Overall Study|Physician Decision|23
2288691|NCT02465567|3979921|FG001|Overall Study|Physician Decision|33
2288692|NCT02465567|3979922|FG002|Overall Study|Physician Decision|38
2288693|NCT02465567|3979923|FG003|Overall Study|Physician Decision|28
2288694|NCT02465567|3979920|FG000|Overall Study|Major Protocol Deviation|24
2288695|NCT02465567|3979921|FG001|Overall Study|Major Protocol Deviation|26
2288696|NCT02465567|3979922|FG002|Overall Study|Major Protocol Deviation|22
2288697|NCT02465567|3979923|FG003|Overall Study|Major Protocol Deviation|25
2288698|NCT02465567|3979920|FG000|Overall Study|Lost to Follow-up|25
2288699|NCT02465567|3979921|FG001|Overall Study|Lost to Follow-up|21
2288700|NCT02465567|3979922|FG002|Overall Study|Lost to Follow-up|19
2288701|NCT02465567|3979923|FG003|Overall Study|Lost to Follow-up|15
2288702|NCT02465567|3979920|FG000|Overall Study|Protocol Specified Criteria|20
2288703|NCT02465567|3979921|FG001|Overall Study|Protocol Specified Criteria|10
2288704|NCT02465567|3979922|FG002|Overall Study|Protocol Specified Criteria|9
2288705|NCT02465567|3979923|FG003|Overall Study|Protocol Specified Criteria|12
2288706|NCT02465567|3979920|FG000|Overall Study|Administrative Reasons|12
2288707|NCT02465567|3979921|FG001|Overall Study|Administrative Reasons|9
2288708|NCT02465567|3979922|FG002|Overall Study|Administrative Reasons|11
2288709|NCT02465567|3979923|FG003|Overall Study|Administrative Reasons|5
2288710|NCT02465567|3979920|FG000|Overall Study|Randomized but not treated|1
2288711|NCT02465567|3979921|FG001|Overall Study|Randomized but not treated|5
2288712|NCT02465567|3979922|FG002|Overall Study|Randomized but not treated|4
2288713|NCT02465567|3979923|FG003|Overall Study|Randomized but not treated|5
2139284|NCT01097616|3746279|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
2139285|NCT01097616|3746280|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
2139286|NCT01097616|3746281|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2139287|NCT01097616|3746282|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2139288|NCT01097616|3746283|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2139289|NCT01097616|3746284|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2139290|NCT01097616|3746285|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2139291|NCT01097616|3746286|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2139292|NCT01097616|3746279|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
2139293|NCT01097616|3746280|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
2139294|NCT01097616|3746281|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
2139295|NCT01097616|3746282|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2139296|NCT01097616|3746283|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2139297|NCT01097616|3746284|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2139298|NCT01097616|3746285|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2139299|NCT01097616|3746286|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2139300|NCT01097616|3746279|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
2139301|NCT01097616|3746280|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
2139302|NCT01097616|3746281|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2139303|NCT01097616|3746282|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2139304|NCT01097616|3746283|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2139305|NCT01097616|3746284|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2139306|NCT01097616|3746285|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2139307|NCT01097616|3746286|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2139308|NCT01097616|3746279|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
2139309|NCT01097616|3746280|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
2139310|NCT01097616|3746281|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139311|NCT01097616|3746282|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139312|NCT01097616|3746283|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139313|NCT01097616|3746284|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139314|NCT01097616|3746285|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139315|NCT01097616|3746286|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139316|NCT01097616|3746279|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139317|NCT01097616|3746280|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139318|NCT01097616|3746281|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
2139319|NCT01097616|3746282|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139320|NCT01097616|3746283|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139321|NCT01097616|3746284|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139322|NCT01097616|3746285|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139323|NCT01097616|3746286|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139324|NCT01097616|3746279|FG000|Optional DB EXT Phase|Adverse Event|0
2139325|NCT01097616|3746280|FG001|Optional DB EXT Phase|Adverse Event|7
2139326|NCT01097616|3746281|FG002|Optional DB EXT Phase|Adverse Event|2
2139327|NCT01097616|3746282|FG003|Optional DB EXT Phase|Adverse Event|0
2288714|NCT02465567|3979920|FG000|Overall Study|enrolled in >1 studies|18
2288715|NCT02465567|3979921|FG001|Overall Study|enrolled in >1 studies|11
2288716|NCT02465567|3979922|FG002|Overall Study|enrolled in >1 studies|19
2288717|NCT02465567|3979923|FG003|Overall Study|enrolled in >1 studies|15
2288718|NCT02465567|3979920|FG000|Overall Study|missing PI Signature|1
2288719|NCT02465567|3979921|FG001|Overall Study|missing PI Signature|0
2288720|NCT02465567|3979922|FG002|Overall Study|missing PI Signature|0
2288721|NCT02465567|3979923|FG003|Overall Study|missing PI Signature|0
2288722|NCT02465866|3979947|FG000|Period 3|Withdrawal by Subject|0
2288723|NCT02465866|3979948|FG001|Period 3|Withdrawal by Subject|1
2288724|NCT02465866|3979949|FG002|Period 3|Withdrawal by Subject|0
2288725|NCT02465866|3979950|FG003|Period 3|Withdrawal by Subject|0
2288726|NCT02465931|3979962|FG000|Overall Study|Lost to Follow-up|9
2288727|NCT02465931|3979963|FG001|Overall Study|Lost to Follow-up|11
2288728|NCT02465931|3979962|FG000|Overall Study|Protocol Violation|1
2288729|NCT02465931|3979963|FG001|Overall Study|Protocol Violation|0
2288730|NCT02465931|3979962|FG000|Overall Study|Withdrawal by Subject|1
2288731|NCT02465931|3979963|FG001|Overall Study|Withdrawal by Subject|0
2288732|NCT02466386|3979994|FG000|Overall Study|Adverse Event|5
2288733|NCT02466386|3979994|FG000|Overall Study|Protocol Violation|2
2288734|NCT02466386|3979994|FG000|Overall Study|Withdrawal by Subject|14
2288735|NCT02466386|3979994|FG000|Overall Study|Lost to Follow-up|5
2288736|NCT02466386|3979994|FG000|Overall Study|Lack of Efficacy|8
2288737|NCT02466386|3979994|FG000|Overall Study|Other|10
2288738|NCT02466399|3980000|FG000|Overall Study|Adverse Event|1
2288739|NCT02466399|3980001|FG001|Overall Study|Adverse Event|0
2288740|NCT02466399|3980000|FG000|Overall Study|Early exit due to family emergency|1
2288741|NCT02466399|3980001|FG001|Overall Study|Early exit due to family emergency|0
2288742|NCT02466425|3980019|FG000|Overall Study|Adverse Event|3
2288743|NCT02466425|3980020|FG001|Overall Study|Adverse Event|11
2288744|NCT02466425|3980019|FG000|Overall Study|Lack of Efficacy|4
2288745|NCT02466425|3980020|FG001|Overall Study|Lack of Efficacy|1
2139328|NCT01097616|3746283|FG004|Optional DB EXT Phase|Adverse Event|0
2139329|NCT01097616|3746284|FG005|Optional DB EXT Phase|Adverse Event|0
2139330|NCT01097616|3746285|FG006|Optional DB EXT Phase|Adverse Event|0
2139331|NCT01097616|3746286|FG007|Optional DB EXT Phase|Adverse Event|0
2139332|NCT01097616|3746279|FG000|Optional DB EXT Phase|Withdrawal by Subject|12
2139333|NCT01097616|3746280|FG001|Optional DB EXT Phase|Withdrawal by Subject|6
2139334|NCT01097616|3746281|FG002|Optional DB EXT Phase|Withdrawal by Subject|3
2139335|NCT01097616|3746282|FG003|Optional DB EXT Phase|Withdrawal by Subject|0
2288746|NCT02466425|3980019|FG000|Overall Study|Lost to Follow-up|3
2288747|NCT02466425|3980020|FG001|Overall Study|Lost to Follow-up|0
2288748|NCT02466425|3980019|FG000|Overall Study|Protocol Violation|1
2288749|NCT02466425|3980020|FG001|Overall Study|Protocol Violation|0
2288750|NCT02466425|3980019|FG000|Overall Study|Withdrawal by Subject|0
2288751|NCT02466425|3980020|FG001|Overall Study|Withdrawal by Subject|1
2288752|NCT02466425|3980019|FG000|Overall Study|Other|1
2288753|NCT02466425|3980020|FG001|Overall Study|Other|3
2288754|NCT02466425|3980019|FG000|Overall Study|Withdrawal by Parent/Guardian|2
2288755|NCT02466425|3980020|FG001|Overall Study|Withdrawal by Parent/Guardian|0
2288756|NCT02466516|3980031|FG000|Overall Study|Adverse Event|1
2288757|NCT02466516|3980032|FG001|Overall Study|Adverse Event|1
2288758|NCT02466516|3980033|FG002|Overall Study|Adverse Event|0
2288759|NCT02466516|3980034|FG003|Overall Study|Adverse Event|0
2288760|NCT02466516|3980035|FG004|Overall Study|Adverse Event|0
2288761|NCT02466516|3980031|FG000|Overall Study|Withdrew Consent|1
2288762|NCT02466516|3980032|FG001|Overall Study|Withdrew Consent|0
2288763|NCT02466516|3980033|FG002|Overall Study|Withdrew Consent|0
2288764|NCT02466516|3980034|FG003|Overall Study|Withdrew Consent|0
2288765|NCT02466516|3980035|FG004|Overall Study|Withdrew Consent|0
2288766|NCT02466516|3980031|FG000|Overall Study|Lost to Follow-up|2
2288767|NCT02466516|3980032|FG001|Overall Study|Lost to Follow-up|0
2288768|NCT02466516|3980033|FG002|Overall Study|Lost to Follow-up|1
2288769|NCT02466516|3980034|FG003|Overall Study|Lost to Follow-up|0
2288770|NCT02466516|3980035|FG004|Overall Study|Lost to Follow-up|0
2288771|NCT02466555|3980047|FG000|Overall Study|Lost to Follow-up|2
2288772|NCT02466659|3980070|FG000|Overall Study|Lost to Follow-up|5
2288773|NCT02466659|3980071|FG001|Overall Study|Lost to Follow-up|2
2288774|NCT02467192|3980110|FG000|Overall Study|Death|1
2288775|NCT02467192|3980110|FG000|Overall Study|revealed to have pneumonia before|2
2288776|NCT02468193|3980193|FG000|Overall Study|Adverse Event|4
2288777|NCT02468193|3980193|FG000|Overall Study|Subject/ Guardian decision|2
2288778|NCT02468414|3980215|FG000|Overall Study|Early Study Termination by Sponsor|1
2288779|NCT02468414|3980216|FG001|Overall Study|Early Study Termination by Sponsor|0
2288780|NCT02468414|3980215|FG000|Overall Study|Poor in-vitro secreting TARGTs|1
2288781|NCT02468414|3980216|FG001|Overall Study|Poor in-vitro secreting TARGTs|0
2288782|NCT02468414|3980215|FG000|Overall Study|Screen Failure|1
2288783|NCT02468414|3980216|FG001|Overall Study|Screen Failure|0
2288784|NCT02468557|3980222|FG000|Overall Study|Adverse Event|1
2288785|NCT02468557|3980222|FG000|Overall Study|Death|1
2288786|NCT02468557|3980222|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10
2288787|NCT02468557|3980222|FG000|Overall Study|All Enrolled but Never Dosed|4
2288788|NCT02468648|3980239|FG000|Overall Study|Death|1
2288789|NCT02468674|3980252|FG000|Overall Study|Adverse Event|0
2288790|NCT02468674|3980253|FG001|Overall Study|Adverse Event|0
2288791|NCT02468674|3980254|FG002|Overall Study|Adverse Event|0
2288792|NCT02468674|3980255|FG003|Overall Study|Adverse Event|1
2288793|NCT02468674|3980256|FG004|Overall Study|Adverse Event|0
2288794|NCT02468674|3980257|FG005|Overall Study|Adverse Event|1
2288795|NCT02468674|3980258|FG006|Overall Study|Adverse Event|0
2288796|NCT02468674|3980259|FG007|Overall Study|Adverse Event|0
2288797|NCT02468674|3980260|FG008|Overall Study|Adverse Event|0
2288798|NCT02468674|3980252|FG000|Overall Study|Lost to Follow-up|1
2288799|NCT02468674|3980253|FG001|Overall Study|Lost to Follow-up|0
2288800|NCT02468674|3980254|FG002|Overall Study|Lost to Follow-up|0
2288801|NCT02468674|3980255|FG003|Overall Study|Lost to Follow-up|0
2288802|NCT02468674|3980256|FG004|Overall Study|Lost to Follow-up|0
2288803|NCT02468674|3980257|FG005|Overall Study|Lost to Follow-up|0
2288804|NCT02468674|3980258|FG006|Overall Study|Lost to Follow-up|0
2288805|NCT02468674|3980259|FG007|Overall Study|Lost to Follow-up|1
2288806|NCT02468674|3980260|FG008|Overall Study|Lost to Follow-up|1
2288807|NCT02468674|3980252|FG000|Overall Study|Physician Decision|0
2288808|NCT02468674|3980253|FG001|Overall Study|Physician Decision|0
2288809|NCT02468674|3980254|FG002|Overall Study|Physician Decision|0
2288810|NCT02468674|3980255|FG003|Overall Study|Physician Decision|0
2288811|NCT02468674|3980256|FG004|Overall Study|Physician Decision|0
2288812|NCT02468674|3980257|FG005|Overall Study|Physician Decision|0
2288813|NCT02468674|3980258|FG006|Overall Study|Physician Decision|1
2288814|NCT02468674|3980259|FG007|Overall Study|Physician Decision|0
2288815|NCT02468674|3980260|FG008|Overall Study|Physician Decision|0
2288816|NCT02468674|3980252|FG000|Overall Study|Patient/Guardian Decision|0
2288817|NCT02468674|3980253|FG001|Overall Study|Patient/Guardian Decision|0
2288818|NCT02468674|3980254|FG002|Overall Study|Patient/Guardian Decision|0
2288819|NCT02468674|3980255|FG003|Overall Study|Patient/Guardian Decision|0
2288820|NCT02468674|3980256|FG004|Overall Study|Patient/Guardian Decision|1
2288821|NCT02468674|3980257|FG005|Overall Study|Patient/Guardian Decision|0
2139336|NCT01097616|3746283|FG004|Optional DB EXT Phase|Withdrawal by Subject|0
2139337|NCT01097616|3746284|FG005|Optional DB EXT Phase|Withdrawal by Subject|0
2139338|NCT01097616|3746285|FG006|Optional DB EXT Phase|Withdrawal by Subject|0
2139339|NCT01097616|3746286|FG007|Optional DB EXT Phase|Withdrawal by Subject|0
2139340|NCT01097616|3746279|FG000|Optional DB EXT Phase|Protocol Violation|0
2139341|NCT01097616|3746280|FG001|Optional DB EXT Phase|Protocol Violation|2
2139342|NCT01097616|3746281|FG002|Optional DB EXT Phase|Protocol Violation|3
2139343|NCT01097616|3746282|FG003|Optional DB EXT Phase|Protocol Violation|0
2139344|NCT01097616|3746283|FG004|Optional DB EXT Phase|Protocol Violation|0
2139345|NCT01097616|3746284|FG005|Optional DB EXT Phase|Protocol Violation|0
2288822|NCT02468674|3980258|FG006|Overall Study|Patient/Guardian Decision|0
2288823|NCT02468674|3980259|FG007|Overall Study|Patient/Guardian Decision|2
2288824|NCT02468674|3980260|FG008|Overall Study|Patient/Guardian Decision|1
2288825|NCT02468674|3980252|FG000|Overall Study|Protocol Deviation|0
2288826|NCT02468674|3980253|FG001|Overall Study|Protocol Deviation|0
2288827|NCT02468674|3980254|FG002|Overall Study|Protocol Deviation|0
2288828|NCT02468674|3980255|FG003|Overall Study|Protocol Deviation|0
2288829|NCT02468674|3980256|FG004|Overall Study|Protocol Deviation|0
2288830|NCT02468674|3980257|FG005|Overall Study|Protocol Deviation|0
2288831|NCT02468674|3980258|FG006|Overall Study|Protocol Deviation|0
2288832|NCT02468674|3980259|FG007|Overall Study|Protocol Deviation|1
2288833|NCT02468674|3980260|FG008|Overall Study|Protocol Deviation|1
2288834|NCT02468934|3980302|FG000|Overall Study|Withdrawal by Subject|4
2288835|NCT02468934|3980302|FG000|Overall Study|Screen Failure|3
2288836|NCT02469038|3980310|FG000|Overall Study|Physician Decision|4
2288837|NCT02469038|3980311|FG001|Overall Study|Physician Decision|5
2288838|NCT02469064|3980319|FG000|Overall Study|Request not to receive intervention.|1
2288839|NCT02469064|3980320|FG001|Overall Study|Request not to receive intervention.|3
2288840|NCT02469077|3980328|FG000|Post Randomization/Intervention Period|Scheduling issues|3
2288841|NCT02469077|3980329|FG001|Post Randomization/Intervention Period|Scheduling issues|2
2288842|NCT02469077|3980328|FG000|Post Randomization/Intervention Period|Relocated|1
2288843|NCT02469077|3980329|FG001|Post Randomization/Intervention Period|Relocated|1
2288844|NCT02469077|3980328|FG000|Post Randomization/Intervention Period|Conflicting health issues|0
2288845|NCT02469077|3980329|FG001|Post Randomization/Intervention Period|Conflicting health issues|1
2288846|NCT02469077|3980328|FG000|Post Intervention /Followup|Withdrawal by Subject|2
2288847|NCT02469077|3980329|FG001|Post Intervention /Followup|Withdrawal by Subject|1
2288848|NCT02469090|3980341|FG000|Period 1: Dose Titration Phase|Adverse Event|12
2288849|NCT02469090|3980342|FG001|Period 1: Dose Titration Phase|Adverse Event|0
2288850|NCT02469090|3980343|FG002|Period 1: Dose Titration Phase|Adverse Event|0
2288851|NCT02469090|3980341|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8
2288852|NCT02469090|3980342|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0
2288853|NCT02469090|3980343|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0
2288854|NCT02469090|3980341|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1
2288855|NCT02469090|3980342|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0
2288856|NCT02469090|3980343|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0
2288857|NCT02469090|3980341|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11
2288858|NCT02469090|3980342|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0
2288859|NCT02469090|3980343|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0
2288860|NCT02469090|3980341|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0
2288861|NCT02469090|3980342|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5
2288862|NCT02469090|3980343|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15
2288863|NCT02469090|3980341|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0
2288864|NCT02469090|3980342|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3
2288865|NCT02469090|3980343|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4
2288866|NCT02469090|3980341|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
2288867|NCT02469090|3980342|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1
2288868|NCT02469090|3980343|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
2288869|NCT02469090|3980341|FG000|Period 2: Maintenance Treatment Phase|Death|0
2288870|NCT02469090|3980342|FG001|Period 2: Maintenance Treatment Phase|Death|0
2288871|NCT02469090|3980343|FG002|Period 2: Maintenance Treatment Phase|Death|1
2288872|NCT02469168|3980356|FG000|Overall Study|Trial closed|1
2288873|NCT02469168|3980357|FG001|Overall Study|Trial closed|0
2288874|NCT02469246|3980365|FG000|Double-Blind Phase|Randomized and Never Treated|5
2288875|NCT02469246|3980366|FG001|Double-Blind Phase|Randomized and Never Treated|6
2288876|NCT02469246|3980365|FG000|Double-Blind Phase|Adverse Event|12
2288877|NCT02469246|3980366|FG001|Double-Blind Phase|Adverse Event|9
2288878|NCT02469246|3980365|FG000|Double-Blind Phase|Death|2
2288879|NCT02469246|3980366|FG001|Double-Blind Phase|Death|0
2288880|NCT02469246|3980365|FG000|Double-Blind Phase|Lack of Efficacy|2
2288881|NCT02469246|3980366|FG001|Double-Blind Phase|Lack of Efficacy|1
2288882|NCT02469246|3980365|FG000|Double-Blind Phase|Investigator's Discretion|8
2288883|NCT02469246|3980366|FG001|Double-Blind Phase|Investigator's Discretion|8
2288884|NCT02469246|3980365|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
2288885|NCT02469246|3980366|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
2288886|NCT02469246|3980365|FG000|Double-Blind Phase|Protocol Violation|1
2288887|NCT02469246|3980366|FG001|Double-Blind Phase|Protocol Violation|1
2139346|NCT01097616|3746285|FG006|Optional DB EXT Phase|Protocol Violation|0
2139347|NCT01097616|3746286|FG007|Optional DB EXT Phase|Protocol Violation|0
2139348|NCT01097616|3746279|FG000|Optional DB EXT Phase|Lost to Follow-up|1
2139349|NCT01097616|3746280|FG001|Optional DB EXT Phase|Lost to Follow-up|5
2139350|NCT01097616|3746281|FG002|Optional DB EXT Phase|Lost to Follow-up|1
2139351|NCT01097616|3746282|FG003|Optional DB EXT Phase|Lost to Follow-up|0
2139352|NCT01097616|3746283|FG004|Optional DB EXT Phase|Lost to Follow-up|0
2139353|NCT01097616|3746284|FG005|Optional DB EXT Phase|Lost to Follow-up|0
2139354|NCT01097616|3746285|FG006|Optional DB EXT Phase|Lost to Follow-up|0
2139355|NCT01097616|3746286|FG007|Optional DB EXT Phase|Lost to Follow-up|0
2139356|NCT01097616|3746279|FG000|Optional DB EXT Phase|Lack of Efficacy|1
2139357|NCT01097616|3746280|FG001|Optional DB EXT Phase|Lack of Efficacy|1
2139358|NCT01097616|3746281|FG002|Optional DB EXT Phase|Lack of Efficacy|1
2139359|NCT01097616|3746282|FG003|Optional DB EXT Phase|Lack of Efficacy|0
2139360|NCT01097616|3746283|FG004|Optional DB EXT Phase|Lack of Efficacy|0
2139361|NCT01097616|3746284|FG005|Optional DB EXT Phase|Lack of Efficacy|0
2139362|NCT01097616|3746285|FG006|Optional DB EXT Phase|Lack of Efficacy|0
2139363|NCT01097616|3746286|FG007|Optional DB EXT Phase|Lack of Efficacy|0
2139364|NCT01097616|3746279|FG000|Optional DB EXT Phase|Physician Decision|1
2139365|NCT01097616|3746280|FG001|Optional DB EXT Phase|Physician Decision|0
2139366|NCT01097616|3746281|FG002|Optional DB EXT Phase|Physician Decision|0
2139367|NCT01097616|3746282|FG003|Optional DB EXT Phase|Physician Decision|0
2139368|NCT01097616|3746283|FG004|Optional DB EXT Phase|Physician Decision|0
2139369|NCT01097616|3746284|FG005|Optional DB EXT Phase|Physician Decision|0
2139370|NCT01097616|3746285|FG006|Optional DB EXT Phase|Physician Decision|0
2288888|NCT02469246|3980365|FG000|Double-Blind Phase|Withdrew Consent|25
2288889|NCT02469246|3980366|FG001|Double-Blind Phase|Withdrew Consent|25
2288890|NCT02469246|3980365|FG000|Double-Blind Phase|Lost to Follow-up|9
2288891|NCT02469246|3980366|FG001|Double-Blind Phase|Lost to Follow-up|5
2288892|NCT02469298|3980378|FG000|Overall Study|Protocol Violation|0
2288893|NCT02469298|3980379|FG001|Overall Study|Protocol Violation|1
2288894|NCT02469298|3980380|FG002|Overall Study|Protocol Violation|1
2288895|NCT02469298|3980381|FG003|Overall Study|Protocol Violation|0
2288896|NCT02469298|3980378|FG000|Overall Study|Lost to Follow-up|1
2288897|NCT02469298|3980379|FG001|Overall Study|Lost to Follow-up|0
2288898|NCT02469298|3980380|FG002|Overall Study|Lost to Follow-up|1
2288899|NCT02469298|3980381|FG003|Overall Study|Lost to Follow-up|0
2288900|NCT02469298|3980378|FG000|Overall Study|Physician Decision|0
2288901|NCT02469298|3980379|FG001|Overall Study|Physician Decision|0
2288902|NCT02469298|3980380|FG002|Overall Study|Physician Decision|0
2288903|NCT02469298|3980381|FG003|Overall Study|Physician Decision|1
2288904|NCT02469298|3980378|FG000|Overall Study|Withdrawal by Subject|0
2288905|NCT02469298|3980379|FG001|Overall Study|Withdrawal by Subject|0
2288906|NCT02469298|3980380|FG002|Overall Study|Withdrawal by Subject|0
2288907|NCT02469298|3980381|FG003|Overall Study|Withdrawal by Subject|1
2288908|NCT02469610|3980418|FG000|Overall Study|Death|1
2288909|NCT02469610|3980419|FG001|Overall Study|Death|0
2288910|NCT02469610|3980418|FG000|Overall Study|Lost to Follow-up|1
2288911|NCT02469610|3980419|FG001|Overall Study|Lost to Follow-up|0
2288912|NCT02469610|3980418|FG000|Overall Study|exclusion criteria|2
2288913|NCT02469610|3980419|FG001|Overall Study|exclusion criteria|1
2288914|NCT02469623|3980425|FG000|Overall Study|Not consented for long-term follow-up|4
2288915|NCT02469623|3980425|FG000|Overall Study|Lost to Follow-up|4
2288916|NCT02469623|3980425|FG000|Overall Study|Withdrawal by Subject|2
2288917|NCT02469623|3980425|FG000|Overall Study|Death|3
2288918|NCT02469857|3980445|FG000|Overall Study|Death|24
2288919|NCT02469857|3980446|FG001|Overall Study|Death|29
2288920|NCT02469857|3980445|FG000|Overall Study|Discontinuation|1
2288921|NCT02469857|3980446|FG001|Overall Study|Discontinuation|3
2288922|NCT02469896|3980468|FG000|Overall Study|Withdrawal by Subject|2
2288923|NCT02469896|3980469|FG001|Overall Study|Withdrawal by Subject|0
2288924|NCT02469961|3980481|FG000|Overall Study|Physician Decision|4
2288925|NCT02469961|3980482|FG001|Overall Study|Physician Decision|1
2288926|NCT02470091|3980495|FG000|Overall Study|Withdrawal by Subject|1
2288927|NCT02470091|3980496|FG001|Overall Study|Withdrawal by Subject|0
2288928|NCT02470091|3980495|FG000|Overall Study|Ineligible|0
2288929|NCT02470091|3980496|FG001|Overall Study|Ineligible|2
2321009|NCT02954172|4035268|FG001|Overall Study|non-measurable lesions at baseline|2
2321010|NCT02954354|4035287|FG000|Overall Study|Adverse Event|2
2321011|NCT02954354|4035288|FG001|Overall Study|Adverse Event|2
2321012|NCT02954354|4035289|FG002|Overall Study|Adverse Event|4
2321013|NCT02954354|4035287|FG000|Overall Study|Failure to Meet Eligibility Criteria|1
2321014|NCT02954354|4035288|FG001|Overall Study|Failure to Meet Eligibility Criteria|0
2321015|NCT02954354|4035289|FG002|Overall Study|Failure to Meet Eligibility Criteria|0
2321016|NCT02954354|4035287|FG000|Overall Study|Lack of Efficacy|0
2139371|NCT01097616|3746286|FG007|Optional DB EXT Phase|Physician Decision|0
2321017|NCT02954354|4035288|FG001|Overall Study|Lack of Efficacy|2
2321018|NCT02954354|4035289|FG002|Overall Study|Lack of Efficacy|0
2321019|NCT02954354|4035287|FG000|Overall Study|Withdrawal by Subject|17
2321020|NCT02954354|4035288|FG001|Overall Study|Withdrawal by Subject|9
2321021|NCT02954354|4035289|FG002|Overall Study|Withdrawal by Subject|11
2321022|NCT02954354|4035287|FG000|Overall Study|Lost to Follow-up|12
2321023|NCT02954354|4035288|FG001|Overall Study|Lost to Follow-up|5
2321024|NCT02954354|4035289|FG002|Overall Study|Lost to Follow-up|0
2321025|NCT02954354|4035287|FG000|Overall Study|Miscellaneous|2
2139372|NCT01097616|3746279|FG000|DB RO Phase|Adverse Event|0
2139373|NCT01097616|3746280|FG001|DB RO Phase|Adverse Event|0
2139374|NCT01097616|3746281|FG002|DB RO Phase|Adverse Event|0
2139375|NCT01097616|3746282|FG003|DB RO Phase|Adverse Event|0
2139376|NCT01097616|3746283|FG004|DB RO Phase|Adverse Event|0
2139377|NCT01097616|3746284|FG005|DB RO Phase|Adverse Event|0
2139378|NCT01097616|3746285|FG006|DB RO Phase|Adverse Event|1
2139379|NCT01097616|3746286|FG007|DB RO Phase|Adverse Event|0
2139380|NCT01097616|3746279|FG000|DB RO Phase|Withdrawal by Subject|0
2139381|NCT01097616|3746280|FG001|DB RO Phase|Withdrawal by Subject|0
2139382|NCT01097616|3746281|FG002|DB RO Phase|Withdrawal by Subject|0
2139383|NCT01097616|3746282|FG003|DB RO Phase|Withdrawal by Subject|0
2139384|NCT01097616|3746283|FG004|DB RO Phase|Withdrawal by Subject|0
2139385|NCT01097616|3746284|FG005|DB RO Phase|Withdrawal by Subject|1
2139386|NCT01097616|3746285|FG006|DB RO Phase|Withdrawal by Subject|0
2139387|NCT01097616|3746286|FG007|DB RO Phase|Withdrawal by Subject|0
2139388|NCT01097616|3746279|FG000|DB RO Phase|Lost to Follow-up|0
2139389|NCT01097616|3746280|FG001|DB RO Phase|Lost to Follow-up|0
2139390|NCT01097616|3746281|FG002|DB RO Phase|Lost to Follow-up|0
2139391|NCT01097616|3746282|FG003|DB RO Phase|Lost to Follow-up|1
2139392|NCT01097616|3746283|FG004|DB RO Phase|Lost to Follow-up|1
2139393|NCT01097616|3746284|FG005|DB RO Phase|Lost to Follow-up|0
2139394|NCT01097616|3746285|FG006|DB RO Phase|Lost to Follow-up|0
2139395|NCT01097616|3746286|FG007|DB RO Phase|Lost to Follow-up|1
2139396|NCT01097616|3746279|FG000|DB RO Phase|Not Treated in RO|0
2139397|NCT01097616|3746280|FG001|DB RO Phase|Not Treated in RO|0
2139398|NCT01097616|3746281|FG002|DB RO Phase|Not Treated in RO|0
2139399|NCT01097616|3746282|FG003|DB RO Phase|Not Treated in RO|0
2139400|NCT01097616|3746283|FG004|DB RO Phase|Not Treated in RO|0
2139401|NCT01097616|3746284|FG005|DB RO Phase|Not Treated in RO|1
2139402|NCT01097616|3746285|FG006|DB RO Phase|Not Treated in RO|0
2139403|NCT01097616|3746286|FG007|DB RO Phase|Not Treated in RO|0
2139404|NCT01097629|3746315|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
2139405|NCT01097629|3746316|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
2139406|NCT01097629|3746317|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
2139407|NCT01097629|3746318|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2139408|NCT01097629|3746319|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2139409|NCT01097629|3746320|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2139410|NCT01097629|3746321|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2139411|NCT01097629|3746322|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2139412|NCT01097629|3746315|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
2139413|NCT01097629|3746316|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
2139414|NCT01097629|3746317|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
2139415|NCT01097629|3746318|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2139416|NCT01097629|3746319|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2139417|NCT01097629|3746320|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2139418|NCT01097629|3746321|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2139419|NCT01097629|3746322|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2139420|NCT01097629|3746315|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
2139421|NCT01097629|3746316|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
2139422|NCT01097629|3746317|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
2139423|NCT01097629|3746318|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2139424|NCT01097629|3746319|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2139425|NCT01097629|3746320|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2139426|NCT01097629|3746321|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2139427|NCT01097629|3746322|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2139428|NCT01097629|3746315|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
2139429|NCT01097629|3746316|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
2139430|NCT01097629|3746317|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
2288930|NCT02470403|3980547|FG000|Overall Study|Adverse Event|1
2288931|NCT02470403|3980548|FG001|Overall Study|Adverse Event|0
2288932|NCT02470403|3980549|FG002|Overall Study|Adverse Event|0
2288933|NCT02470403|3980550|FG003|Overall Study|Adverse Event|0
2288934|NCT02470403|3980551|FG004|Overall Study|Adverse Event|0
2288935|NCT02470403|3980547|FG000|Overall Study|Lost to Follow-up|0
2288936|NCT02470403|3980548|FG001|Overall Study|Lost to Follow-up|1
2288937|NCT02470403|3980549|FG002|Overall Study|Lost to Follow-up|0
2288938|NCT02470403|3980550|FG003|Overall Study|Lost to Follow-up|0
2288939|NCT02470403|3980551|FG004|Overall Study|Lost to Follow-up|0
2288940|NCT02470403|3980547|FG000|Overall Study|Subject/guardian decision|1
2288941|NCT02470403|3980548|FG001|Overall Study|Subject/guardian decision|0
2288942|NCT02470403|3980549|FG002|Overall Study|Subject/guardian decision|0
2288943|NCT02470403|3980550|FG003|Overall Study|Subject/guardian decision|4
2288944|NCT02470403|3980551|FG004|Overall Study|Subject/guardian decision|0
2288945|NCT02470429|3980568|FG000|Overall Study|Adverse Event|1
2288946|NCT02470429|3980569|FG001|Overall Study|Adverse Event|0
2288947|NCT02470429|3980568|FG000|Overall Study|Withdrawal by Subject|1
2288948|NCT02470429|3980569|FG001|Overall Study|Withdrawal by Subject|0
2288949|NCT02470585|3980583|FG000|Overall Study|Death|82
2288950|NCT02470585|3980584|FG001|Overall Study|Death|87
2139431|NCT01097629|3746318|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2139432|NCT01097629|3746319|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2139433|NCT01097629|3746320|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2139434|NCT01097629|3746321|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2139435|NCT01097629|3746322|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2139436|NCT01097629|3746315|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
2139437|NCT01097629|3746316|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
2139438|NCT01097629|3746317|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
2139439|NCT01097629|3746318|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2139440|NCT01097629|3746319|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2139441|NCT01097629|3746320|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2139442|NCT01097629|3746321|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2139443|NCT01097629|3746322|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2139444|NCT01097629|3746315|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
2139445|NCT01097629|3746316|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
2139446|NCT01097629|3746317|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139447|NCT01097629|3746318|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139448|NCT01097629|3746319|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139449|NCT01097629|3746320|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139450|NCT01097629|3746321|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139451|NCT01097629|3746322|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2139452|NCT01097629|3746315|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
2139453|NCT01097629|3746316|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
2139454|NCT01097629|3746317|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
2139455|NCT01097629|3746318|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139456|NCT01097629|3746319|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139457|NCT01097629|3746320|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139458|NCT01097629|3746321|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139459|NCT01097629|3746322|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2139460|NCT01097629|3746315|FG000|DB RO Phase|Withdrawal by Subject|0
2139461|NCT01097629|3746316|FG001|DB RO Phase|Withdrawal by Subject|0
2139462|NCT01097629|3746317|FG002|DB RO Phase|Withdrawal by Subject|0
2139463|NCT01097629|3746318|FG003|DB RO Phase|Withdrawal by Subject|0
2139464|NCT01097629|3746319|FG004|DB RO Phase|Withdrawal by Subject|0
2139465|NCT01097629|3746320|FG005|DB RO Phase|Withdrawal by Subject|0
2139466|NCT01097629|3746321|FG006|DB RO Phase|Withdrawal by Subject|0
2139467|NCT01097629|3746322|FG007|DB RO Phase|Withdrawal by Subject|1
2139468|NCT01097629|3746315|FG000|DB RO Phase|Protocol Violation|0
2139469|NCT01097629|3746316|FG001|DB RO Phase|Protocol Violation|0
2139470|NCT01097629|3746317|FG002|DB RO Phase|Protocol Violation|0
2139471|NCT01097629|3746318|FG003|DB RO Phase|Protocol Violation|1
2139472|NCT01097629|3746319|FG004|DB RO Phase|Protocol Violation|0
2139473|NCT01097629|3746320|FG005|DB RO Phase|Protocol Violation|1
2139474|NCT01097629|3746321|FG006|DB RO Phase|Protocol Violation|1
2139475|NCT01097629|3746322|FG007|DB RO Phase|Protocol Violation|0
2139476|NCT01097629|3746315|FG000|DB RO Phase|Lost to Follow-up|0
2139477|NCT01097629|3746316|FG001|DB RO Phase|Lost to Follow-up|0
2139478|NCT01097629|3746317|FG002|DB RO Phase|Lost to Follow-up|0
2139479|NCT01097629|3746318|FG003|DB RO Phase|Lost to Follow-up|0
2139480|NCT01097629|3746319|FG004|DB RO Phase|Lost to Follow-up|0
2139481|NCT01097629|3746320|FG005|DB RO Phase|Lost to Follow-up|0
2139482|NCT01097629|3746321|FG006|DB RO Phase|Lost to Follow-up|2
2139483|NCT01097629|3746322|FG007|DB RO Phase|Lost to Follow-up|0
2139484|NCT01097655|3746354|FG000|Overall Study|Withdrawal by Subject|1
2139485|NCT01097655|3746354|FG000|Overall Study|Subject Documented Twice|1
2139486|NCT01097655|3746354|FG000|Overall Study|Did Not Meet Inclusion Criteria|8
2139487|NCT01097668|3746360|FG000|Overall Study|Withdrawal by Subject|1
2139488|NCT01097668|3746361|FG001|Overall Study|Withdrawal by Subject|2
2139489|NCT01097668|3746360|FG000|Overall Study|Lost to Follow-up|1
2139490|NCT01097668|3746361|FG001|Overall Study|Lost to Follow-up|0
2139491|NCT01097694|3746373|FG000|Overall Study|Adverse Event|5
2139492|NCT01097694|3746374|FG001|Overall Study|Adverse Event|0
2139493|NCT01097694|3746373|FG000|Overall Study|Lost to Follow-up|0
2139494|NCT01097694|3746374|FG001|Overall Study|Lost to Follow-up|3
2139495|NCT01097694|3746373|FG000|Overall Study|Withdrawal by Subject|3
2139496|NCT01097694|3746374|FG001|Overall Study|Withdrawal by Subject|1
2139497|NCT01097707|3746385|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2139498|NCT01097707|3746386|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2139499|NCT01097707|3746387|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2139500|NCT01097707|3746388|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2139501|NCT01097707|3746389|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2139502|NCT01097707|3746385|FG000|Overall Study|Adverse Event|4
2139503|NCT01097707|3746386|FG001|Overall Study|Adverse Event|2
2139504|NCT01097707|3746387|FG002|Overall Study|Adverse Event|3
2139505|NCT01097707|3746388|FG003|Overall Study|Adverse Event|1
2139506|NCT01097707|3746389|FG004|Overall Study|Adverse Event|3
2139507|NCT01097707|3746385|FG000|Overall Study|Entry Criteria Not Met|2
2139508|NCT01097707|3746386|FG001|Overall Study|Entry Criteria Not Met|1
2139509|NCT01097707|3746387|FG002|Overall Study|Entry Criteria Not Met|1
2139510|NCT01097707|3746388|FG003|Overall Study|Entry Criteria Not Met|0
2139511|NCT01097707|3746389|FG004|Overall Study|Entry Criteria Not Met|1
2139512|NCT01097707|3746385|FG000|Overall Study|Lack of Efficacy|1
2139513|NCT01097707|3746386|FG001|Overall Study|Lack of Efficacy|0
2139514|NCT01097707|3746387|FG002|Overall Study|Lack of Efficacy|0
2139515|NCT01097707|3746388|FG003|Overall Study|Lack of Efficacy|1
2139516|NCT01097707|3746389|FG004|Overall Study|Lack of Efficacy|0
2139517|NCT01097707|3746385|FG000|Overall Study|Lost to Follow-up|1
2139518|NCT01097707|3746386|FG001|Overall Study|Lost to Follow-up|1
2207936|NCT01633944|3847100|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
2207937|NCT01633944|3847098|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0
2207938|NCT01633944|3847099|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1
2207939|NCT01633944|3847100|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0
2207940|NCT01633944|3847098|FG000|Double-blind Treatment Phase|Other|0
2207941|NCT01633944|3847099|FG001|Double-blind Treatment Phase|Other|7
2207942|NCT01633944|3847100|FG002|Double-blind Treatment Phase|Other|0
2288951|NCT02470585|3980585|FG002|Overall Study|Death|86
2139519|NCT01097707|3746387|FG002|Overall Study|Lost to Follow-up|2
2139520|NCT01097707|3746388|FG003|Overall Study|Lost to Follow-up|0
2139521|NCT01097707|3746389|FG004|Overall Study|Lost to Follow-up|3
2139522|NCT01097707|3746385|FG000|Overall Study|Protocol Violation|2
2139523|NCT01097707|3746386|FG001|Overall Study|Protocol Violation|2
2139524|NCT01097707|3746387|FG002|Overall Study|Protocol Violation|3
2139525|NCT01097707|3746388|FG003|Overall Study|Protocol Violation|2
2139526|NCT01097707|3746389|FG004|Overall Study|Protocol Violation|2
2139527|NCT01097707|3746385|FG000|Overall Study|Sponsor Decision|31
2139528|NCT01097707|3746386|FG001|Overall Study|Sponsor Decision|31
2139529|NCT01097707|3746387|FG002|Overall Study|Sponsor Decision|34
2139530|NCT01097707|3746388|FG003|Overall Study|Sponsor Decision|35
2139531|NCT01097707|3746389|FG004|Overall Study|Sponsor Decision|36
2139532|NCT01097707|3746385|FG000|Overall Study|Withdrawal by Subject|3
2139533|NCT01097707|3746386|FG001|Overall Study|Withdrawal by Subject|6
2139534|NCT01097707|3746387|FG002|Overall Study|Withdrawal by Subject|1
2139535|NCT01097707|3746388|FG003|Overall Study|Withdrawal by Subject|4
2139536|NCT01097707|3746389|FG004|Overall Study|Withdrawal by Subject|3
2139537|NCT01097707|3746385|FG000|Overall Study|Reason unknown|0
2139538|NCT01097707|3746386|FG001|Overall Study|Reason unknown|0
2139539|NCT01097707|3746387|FG002|Overall Study|Reason unknown|0
2139540|NCT01097707|3746388|FG003|Overall Study|Reason unknown|0
2139541|NCT01097707|3746389|FG004|Overall Study|Reason unknown|1
2139542|NCT01097863|3746414|FG000|Overall Study|Discomfort|1
2139543|NCT01097863|3746415|FG001|Overall Study|Discomfort|0
2139544|NCT01097863|3746416|FG002|Overall Study|Discomfort|1
2139545|NCT01097863|3746414|FG000|Overall Study|Did not return for final visit|0
2288952|NCT02470585|3980583|FG000|Overall Study|Withdrawal by Subject|19
2288953|NCT02470585|3980584|FG001|Overall Study|Withdrawal by Subject|21
2288954|NCT02470585|3980585|FG002|Overall Study|Withdrawal by Subject|29
2288955|NCT02470585|3980583|FG000|Overall Study|Lost to Follow-up|2
2288956|NCT02470585|3980584|FG001|Overall Study|Lost to Follow-up|5
2288957|NCT02470585|3980585|FG002|Overall Study|Lost to Follow-up|4
2288958|NCT02470585|3980583|FG000|Overall Study|Other|4
2288959|NCT02470585|3980584|FG001|Overall Study|Other|4
2288960|NCT02470585|3980585|FG002|Overall Study|Other|6
2288961|NCT02470806|3980611|FG000|Overall Study|Lost to Follow-up|1
2288962|NCT02470806|3980612|FG001|Overall Study|Lost to Follow-up|1
2288963|NCT02470806|3980611|FG000|Overall Study|Adverse Event|5
2288964|NCT02470806|3980612|FG001|Overall Study|Adverse Event|2
2288965|NCT02470806|3980611|FG000|Overall Study|Protocol Violation|4
2139546|NCT01097863|3746415|FG001|Overall Study|Did not return for final visit|0
2139547|NCT01097863|3746416|FG002|Overall Study|Did not return for final visit|1
2139548|NCT01098032|3746463|FG000|Overall Study|Withdrawal by Subject|1
2139549|NCT01098032|3746464|FG001|Overall Study|Withdrawal by Subject|1
2139550|NCT01098097|3746470|FG000|Overall Study|Adverse Event|17
2139551|NCT01098097|3746470|FG000|Overall Study|Lost to Follow-up|18
2139552|NCT01098097|3746470|FG000|Overall Study|Status unknown|16
2139553|NCT01098097|3746470|FG000|Overall Study|No reason reported|31
2139554|NCT01098162|3746474|FG000|Overall Study|Adverse Event|37
2139555|NCT01098162|3746474|FG000|Overall Study|Lack of Efficacy|4
2139556|NCT01098162|3746474|FG000|Overall Study|Wish of Patient|7
2139557|NCT01098162|3746474|FG000|Overall Study|Lost to Follow-up|9
2139558|NCT01098162|3746474|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5
2139559|NCT01098162|3746474|FG000|Overall Study|Adverse Event & Lack of Efficacy|6
2139560|NCT01098162|3746474|FG000|Overall Study|Adverse Event & Wish of Patient|13
2139561|NCT01098162|3746474|FG000|Overall Study|Adverse Event & Lost to Follow-up|2
2288966|NCT02470806|3980612|FG001|Overall Study|Protocol Violation|11
2288967|NCT02470806|3980611|FG000|Overall Study|Physician Decision|0
2288968|NCT02470806|3980612|FG001|Overall Study|Physician Decision|3
2288969|NCT02470806|3980611|FG000|Overall Study|Withdrawal by Subject|3
2139562|NCT01098162|3746474|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
2139563|NCT01098162|3746474|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1
2139564|NCT01098162|3746474|FG000|Overall Study|Other Reason|1
2139565|NCT01098162|3746474|FG000|Overall Study|Reason Unknown|26
2139566|NCT01098240|3746478|FG000|Open-Label Phase|Study Terminated by Sponsor|27
2139567|NCT01098240|3746479|FG001|Open-Label Phase|Study Terminated by Sponsor|0
2139568|NCT01098240|3746480|FG002|Open-Label Phase|Study Terminated by Sponsor|0
2139569|NCT01098240|3746478|FG000|Open-Label Phase|Protocol Violation|4
2139570|NCT01098240|3746479|FG001|Open-Label Phase|Protocol Violation|0
2139571|NCT01098240|3746480|FG002|Open-Label Phase|Protocol Violation|0
2139572|NCT01098240|3746478|FG000|Open-Label Phase|Lost to Follow-up|13
2139573|NCT01098240|3746479|FG001|Open-Label Phase|Lost to Follow-up|0
2139574|NCT01098240|3746480|FG002|Open-Label Phase|Lost to Follow-up|0
2139575|NCT01098240|3746478|FG000|Open-Label Phase|Other|19
2139576|NCT01098240|3746479|FG001|Open-Label Phase|Other|0
2139577|NCT01098240|3746480|FG002|Open-Label Phase|Other|0
2139578|NCT01098240|3746478|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50
2139579|NCT01098240|3746479|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
2139580|NCT01098240|3746480|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
2139581|NCT01098240|3746478|FG000|Open-Label Phase|Pregnancy|1
2139582|NCT01098240|3746479|FG001|Open-Label Phase|Pregnancy|0
2139583|NCT01098240|3746480|FG002|Open-Label Phase|Pregnancy|0
2139584|NCT01098240|3746478|FG000|Open-Label Phase|Withdrawal by Subject|9
2139585|NCT01098240|3746479|FG001|Open-Label Phase|Withdrawal by Subject|0
2139586|NCT01098240|3746480|FG002|Open-Label Phase|Withdrawal by Subject|0
2139587|NCT01098240|3746478|FG000|Open-Label Phase|Adverse Event|12
2139588|NCT01098240|3746479|FG001|Open-Label Phase|Adverse Event|0
2139589|NCT01098240|3746480|FG002|Open-Label Phase|Adverse Event|0
2139590|NCT01098240|3746478|FG000|Double-Blind Phase|Study Terminated by Sponsor|0
2139591|NCT01098240|3746479|FG001|Double-Blind Phase|Study Terminated by Sponsor|5
2139592|NCT01098240|3746480|FG002|Double-Blind Phase|Study Terminated by Sponsor|8
2139593|NCT01098240|3746478|FG000|Double-Blind Phase|Protocol Violation|0
2139594|NCT01098240|3746479|FG001|Double-Blind Phase|Protocol Violation|2
2139595|NCT01098240|3746480|FG002|Double-Blind Phase|Protocol Violation|4
2139596|NCT01098240|3746478|FG000|Double-Blind Phase|Lost to Follow-up|0
2139597|NCT01098240|3746479|FG001|Double-Blind Phase|Lost to Follow-up|2
2139598|NCT01098240|3746480|FG002|Double-Blind Phase|Lost to Follow-up|0
2139599|NCT01098240|3746478|FG000|Double-Blind Phase|Other|0
2139600|NCT01098240|3746479|FG001|Double-Blind Phase|Other|2
2139601|NCT01098240|3746480|FG002|Double-Blind Phase|Other|2
2139602|NCT01098240|3746478|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0
2139603|NCT01098240|3746479|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1
2139604|NCT01098240|3746480|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0
2139605|NCT01098240|3746478|FG000|Double-Blind Phase|Insufficient Clinical Response|0
2139606|NCT01098240|3746479|FG001|Double-Blind Phase|Insufficient Clinical Response|1
2139607|NCT01098240|3746480|FG002|Double-Blind Phase|Insufficient Clinical Response|2
2288970|NCT02470806|3980612|FG001|Overall Study|Withdrawal by Subject|10
2139608|NCT01098240|3746478|FG000|Double-Blind Phase|Withdrawal by Subject|0
2139609|NCT01098240|3746479|FG001|Double-Blind Phase|Withdrawal by Subject|1
2139610|NCT01098240|3746480|FG002|Double-Blind Phase|Withdrawal by Subject|3
2139611|NCT01098240|3746478|FG000|Double-Blind Phase|Adverse Event|0
2139612|NCT01098240|3746479|FG001|Double-Blind Phase|Adverse Event|3
2139613|NCT01098240|3746480|FG002|Double-Blind Phase|Adverse Event|3
2139614|NCT01098266|3746498|FG000|Overall Study|Physician Decision|1
2139615|NCT01098266|3746499|FG001|Overall Study|Physician Decision|0
2139616|NCT01098266|3746498|FG000|Overall Study|Death|3
2139617|NCT01098266|3746499|FG001|Overall Study|Death|2
2139618|NCT01098266|3746498|FG000|Overall Study|Withdrawal by Subject|3
2139619|NCT01098266|3746499|FG001|Overall Study|Withdrawal by Subject|5
2139620|NCT01098305|3746507|FG000|Overall Study|Lost to Follow-up|31
2139621|NCT01098305|3746508|FG001|Overall Study|Lost to Follow-up|33
2139622|NCT01098461|3746535|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
2139623|NCT01098461|3746536|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
2139624|NCT01098461|3746537|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
2139625|NCT01098461|3746538|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
2139626|NCT01098461|3746535|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1
2139627|NCT01098461|3746536|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2
2139628|NCT01098461|3746537|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1
2139629|NCT01098461|3746538|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3
2139630|NCT01098461|3746535|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
2139631|NCT01098461|3746536|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
2139632|NCT01098461|3746537|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
2139633|NCT01098461|3746538|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
2139634|NCT01098461|3746535|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
2139635|NCT01098461|3746536|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
2139636|NCT01098461|3746537|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
2139637|NCT01098461|3746538|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
2139638|NCT01098461|3746535|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
2139639|NCT01098461|3746536|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
2139640|NCT01098461|3746537|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
2139641|NCT01098461|3746538|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
2139642|NCT01098461|3746535|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
2180135|NCT01399099|3806101|FG000|Overall Study|Skin Irritation|13
2139643|NCT01098461|3746536|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
2139644|NCT01098461|3746537|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
2139645|NCT01098461|3746538|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
2139646|NCT01098461|3746535|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
2139647|NCT01098461|3746536|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
2139648|NCT01098461|3746537|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
2139649|NCT01098461|3746538|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
2139650|NCT01098474|3746555|FG000|Active Phase|Other|0
2139651|NCT01098474|3746556|FG001|Active Phase|Other|0
2139652|NCT01098474|3746557|FG002|Active Phase|Other|3
2139653|NCT01098474|3746558|FG003|Active Phase|Other|0
2139654|NCT01098474|3746559|FG004|Active Phase|Other|0
2139655|NCT01098474|3746560|FG005|Active Phase|Other|0
2139656|NCT01098474|3746555|FG000|Active Phase|Withdrawal by Subject|1
2139657|NCT01098474|3746556|FG001|Active Phase|Withdrawal by Subject|1
2139658|NCT01098474|3746557|FG002|Active Phase|Withdrawal by Subject|2
2139659|NCT01098474|3746558|FG003|Active Phase|Withdrawal by Subject|0
2139660|NCT01098474|3746559|FG004|Active Phase|Withdrawal by Subject|0
2139661|NCT01098474|3746560|FG005|Active Phase|Withdrawal by Subject|0
2139662|NCT01098474|3746555|FG000|Active Phase|Lost to Follow-up|1
2139663|NCT01098474|3746556|FG001|Active Phase|Lost to Follow-up|0
2139664|NCT01098474|3746557|FG002|Active Phase|Lost to Follow-up|0
2139665|NCT01098474|3746558|FG003|Active Phase|Lost to Follow-up|0
2139666|NCT01098474|3746559|FG004|Active Phase|Lost to Follow-up|0
2139667|NCT01098474|3746560|FG005|Active Phase|Lost to Follow-up|0
2139668|NCT01098474|3746555|FG000|Follow Up Phase|Travelled out of study area|0
2139669|NCT01098474|3746556|FG001|Follow Up Phase|Travelled out of study area|0
2139670|NCT01098474|3746557|FG002|Follow Up Phase|Travelled out of study area|0
2139671|NCT01098474|3746558|FG003|Follow Up Phase|Travelled out of study area|0
2139672|NCT01098474|3746559|FG004|Follow Up Phase|Travelled out of study area|1
2139673|NCT01098474|3746560|FG005|Follow Up Phase|Travelled out of study area|0
2139674|NCT01098474|3746555|FG000|Follow Up Phase|Other|0
2139675|NCT01098474|3746556|FG001|Follow Up Phase|Other|0
2139676|NCT01098474|3746557|FG002|Follow Up Phase|Other|0
2139677|NCT01098474|3746558|FG003|Follow Up Phase|Other|0
2139678|NCT01098474|3746559|FG004|Follow Up Phase|Other|0
2139679|NCT01098474|3746560|FG005|Follow Up Phase|Other|4
2139680|NCT01098474|3746555|FG000|Follow Up Phase|Withdrawal by Subject|0
2139681|NCT01098474|3746556|FG001|Follow Up Phase|Withdrawal by Subject|0
2139682|NCT01098474|3746557|FG002|Follow Up Phase|Withdrawal by Subject|0
2139683|NCT01098474|3746558|FG003|Follow Up Phase|Withdrawal by Subject|2
2139684|NCT01098474|3746559|FG004|Follow Up Phase|Withdrawal by Subject|0
2139685|NCT01098474|3746560|FG005|Follow Up Phase|Withdrawal by Subject|1
2139686|NCT01098474|3746555|FG000|Follow Up Phase|Lost to Follow-up|0
2139687|NCT01098474|3746556|FG001|Follow Up Phase|Lost to Follow-up|0
2139688|NCT01098474|3746557|FG002|Follow Up Phase|Lost to Follow-up|0
2139689|NCT01098474|3746558|FG003|Follow Up Phase|Lost to Follow-up|0
2139690|NCT01098474|3746559|FG004|Follow Up Phase|Lost to Follow-up|1
2139691|NCT01098474|3746560|FG005|Follow Up Phase|Lost to Follow-up|0
2139692|NCT01098487|3746584|FG000|Overall Study|Adverse Event|22
2139693|NCT01098487|3746584|FG000|Overall Study|Lack of Efficacy|11
2139694|NCT01098487|3746584|FG000|Overall Study|Withdrawal by Subject|7
2139695|NCT01098487|3746584|FG000|Overall Study|Lost to Follow-up|3
2139696|NCT01098487|3746584|FG000|Overall Study|Physician Decision|1
2139697|NCT01098539|3746594|FG000|Overall Study|Adverse Event|26
2139698|NCT01098539|3746595|FG001|Overall Study|Adverse Event|26
2139699|NCT01098539|3746594|FG000|Overall Study|Protocol Violation|1
2139700|NCT01098539|3746595|FG001|Overall Study|Protocol Violation|4
2139701|NCT01098539|3746594|FG000|Overall Study|Noncompliance|3
2139702|NCT01098539|3746595|FG001|Overall Study|Noncompliance|5
2139703|NCT01098539|3746594|FG000|Overall Study|Lost to Follow-up|4
2139704|NCT01098539|3746595|FG001|Overall Study|Lost to Follow-up|4
2139705|NCT01098539|3746594|FG000|Overall Study|Withdrawal by Subject|12
2139706|NCT01098539|3746595|FG001|Overall Study|Withdrawal by Subject|26
2139707|NCT01098539|3746594|FG000|Overall Study|Physician Decision|5
2139708|NCT01098539|3746595|FG001|Overall Study|Physician Decision|3
2139709|NCT01098812|3746626|FG000|Overall Study|Death|2
2139710|NCT01098812|3746627|FG001|Overall Study|Death|0
2139711|NCT01098812|3746628|FG002|Overall Study|Death|1
2139712|NCT01098812|3746626|FG000|Overall Study|Lost to Follow-up|0
2139713|NCT01098812|3746627|FG001|Overall Study|Lost to Follow-up|1
2139714|NCT01098812|3746628|FG002|Overall Study|Lost to Follow-up|0
2139715|NCT01098851|3746637|FG000|Overall Study|Equipment failure|1
2139716|NCT01098851|3746638|FG001|Overall Study|Equipment failure|0
2139717|NCT01099215|3746677|FG000|Overall Study|Withdrawal by Subject|1
2139718|NCT01099215|3746678|FG001|Overall Study|Withdrawal by Subject|0
2139719|NCT01099215|3746677|FG000|Overall Study|Adverse Event|0
2139720|NCT01099215|3746678|FG001|Overall Study|Adverse Event|1
2139721|NCT01099267|3746684|FG000|MDS-003 Study|Adverse Event|37
2139722|NCT01099267|3746684|FG000|MDS-003 Study|Lack of Efficacy|52
2139723|NCT01099267|3746684|FG000|MDS-003 Study|Withdrawal by Subject|8
2139724|NCT01099267|3746684|FG000|MDS-003 Study|Lost to Follow-up|1
2139725|NCT01099267|3746684|FG000|MDS-003 Study|Death|11
2139726|NCT01099267|3746684|FG000|MDS-003 Study|Study Closed by Sponsor|2
2139727|NCT01099267|3746684|FG000|MDS-003 Study|Disease Progression|7
2139728|NCT01099267|3746684|FG000|MDS-003 Study|Investigator Decision|2
2139729|NCT01099267|3746684|FG000|MDS-003 Study|Non-Compliance|2
2139730|NCT01099267|3746684|FG000|MDS-003 Study|Loss of Response|1
2139731|NCT01099267|3746684|FG000|MDS-003 Study|Secondary Malign Disease|1
2139732|NCT01099397|3746702|FG000|Overall Study|Lost to Follow-up|4
2139733|NCT01099397|3746702|FG000|Overall Study|Protocol Violation|4
2139734|NCT01099397|3746702|FG000|Overall Study|Withdrawal by Subject|5
2139735|NCT01099579|3746745|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4
2139736|NCT01099579|3746746|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1
2139737|NCT01099579|3746747|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0
2139738|NCT01099579|3746745|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
2139739|NCT01099579|3746746|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
2139740|NCT01099579|3746747|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
2139741|NCT01099579|3746745|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
2139742|NCT01099579|3746746|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
2139743|NCT01099579|3746747|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
2139744|NCT01099579|3746745|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
2139745|NCT01099579|3746746|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
2139746|NCT01099579|3746747|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
2139747|NCT01099579|3746745|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2
2139748|NCT01099579|3746746|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2
2139749|NCT01099579|3746747|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1
2139750|NCT01099579|3746745|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1
2139751|NCT01099579|3746746|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1
2139752|NCT01099579|3746747|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1
2139753|NCT01099579|3746745|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0
2139754|NCT01099579|3746746|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0
2139755|NCT01099579|3746747|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2
2139756|NCT01099579|3746745|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
2139757|NCT01099579|3746746|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
2139758|NCT01099579|3746747|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
2139759|NCT01099579|3746745|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
2139760|NCT01099579|3746746|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
2139761|NCT01099579|3746747|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
2139762|NCT01099579|3746745|FG000|Stage 2 (ATV Capsule)|Adverse Event|0
2139763|NCT01099579|3746746|FG001|Stage 2 (ATV Capsule)|Adverse Event|1
2139764|NCT01099579|3746747|FG002|Stage 2 (ATV Capsule)|Adverse Event|0
2139765|NCT01099709|3746801|FG000|Period 1|Withdrawal by Subject|0
2139766|NCT01099709|3746802|FG001|Period 1|Withdrawal by Subject|1
2139767|NCT01099709|3746801|FG000|Period 1|Positive cotinine test|0
2139768|NCT01099709|3746802|FG001|Period 1|Positive cotinine test|1
2139769|NCT01099709|3746801|FG000|Period 1|Adverse Event|1
2139770|NCT01099709|3746802|FG001|Period 1|Adverse Event|0
2139771|NCT01099917|3746834|FG000|Overall Study|Adverse Event|3
2139772|NCT01099917|3746834|FG000|Overall Study|Not Treated|24
2139773|NCT01100034|3746855|FG000|Overall Study|Lost to Follow-up|11
2139774|NCT01100034|3746855|FG000|Overall Study|Withdrawal of parent/guardian consent|1
2139775|NCT01100034|3746855|FG000|Overall Study|Withdrawal by Subject|4
2139776|NCT01100034|3746855|FG000|Overall Study|Sponsor decision|21
2139777|NCT01100034|3746855|FG000|Overall Study|Participated in another clinical trial|1
2139778|NCT01100034|3746855|FG000|Overall Study|Participants moved to another hospital|4
2139779|NCT01100034|3746855|FG000|Overall Study|Site closed due to non-responsiveness|1
2139780|NCT01100073|3746859|FG000|Overall Study|Lack of Efficacy|4
2139781|NCT01100073|3746859|FG000|Overall Study|Insufficient Tolerability|21
2139782|NCT01100073|3746859|FG000|Overall Study|Withdrawal by Subject|13
2139783|NCT01100073|3746859|FG000|Overall Study|Lost to Follow-up|39
2139784|NCT01100073|3746859|FG000|Overall Study|Lack of effect + patient's wish|2
2139785|NCT01100073|3746859|FG000|Overall Study|Insufficient tolerability +patients wish|8
2139786|NCT01100073|3746859|FG000|Overall Study|Other|8
2139787|NCT01100073|3746859|FG000|Overall Study|Missing|5
2288971|NCT02470806|3980611|FG000|Overall Study|Lack of Efficacy|5
2288972|NCT02470806|3980612|FG001|Overall Study|Lack of Efficacy|15
2288973|NCT02471014|3980636|FG000|Overall Study|Lost to Follow-up|2
2288974|NCT02471014|3980637|FG001|Overall Study|Lost to Follow-up|2
2288975|NCT02471183|3980643|FG000|Main Treatment Period|Adverse Event|1
2288976|NCT02471183|3980643|FG000|Main Treatment Period|Withdrawal by Subject|1
2288977|NCT02471183|3980643|FG000|Extended Treatment Period|Lack of Efficacy|1
2288978|NCT02471404|3980658|FG000|Overall Study|Adverse Event|7
2288979|NCT02471404|3980659|FG001|Overall Study|Adverse Event|1
2288980|NCT02471404|3980660|FG002|Overall Study|Adverse Event|2
2288981|NCT02471404|3980658|FG000|Overall Study|Developed Study Withdrawal Criteria|4
2288982|NCT02471404|3980659|FG001|Overall Study|Developed Study Withdrawal Criteria|1
2288983|NCT02471404|3980660|FG002|Overall Study|Developed Study Withdrawal Criteria|2
2288984|NCT02471404|3980658|FG000|Overall Study|Failure to Meet Randomization Criteria|2
2288985|NCT02471404|3980659|FG001|Overall Study|Failure to Meet Randomization Criteria|0
2288986|NCT02471404|3980660|FG002|Overall Study|Failure to Meet Randomization Criteria|1
2288987|NCT02471404|3980658|FG000|Overall Study|Lost to Follow-up|1
2288988|NCT02471404|3980659|FG001|Overall Study|Lost to Follow-up|1
2139788|NCT01100086|3746863|FG000|Period 1|Withdrawal by Subject|1
2139789|NCT01100086|3746864|FG001|Period 1|Withdrawal by Subject|0
2139790|NCT01100307|3746893|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
2139791|NCT01100307|3746894|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
2139792|NCT01100307|3746893|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
2139793|NCT01100307|3746894|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
2139794|NCT01100307|3746893|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5
2139795|NCT01100307|3746894|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2
2139796|NCT01100307|3746893|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
2139797|NCT01100307|3746894|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
2139798|NCT01100307|3746893|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
2139799|NCT01100307|3746894|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
2139800|NCT01100307|3746893|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3
2139801|NCT01100307|3746894|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8
2139802|NCT01100320|3746902|FG000|Period 1|Withdrawal by Subject|2
2139803|NCT01100320|3746903|FG001|Period 1|Withdrawal by Subject|4
2139804|NCT01100320|3746902|FG000|Period 1|Positive Drug Screen|1
2139805|NCT01100320|3746903|FG001|Period 1|Positive Drug Screen|1
2139806|NCT01100320|3746902|FG000|Period 1|Adverse Event|2
2139807|NCT01100320|3746903|FG001|Period 1|Adverse Event|2
2139808|NCT01100320|3746902|FG000|Period 2|Withdrawal by Subject|1
2139809|NCT01100320|3746903|FG001|Period 2|Withdrawal by Subject|1
2139810|NCT01100437|3746909|FG000|Titration/Stabilization|Adverse Event|0
2139811|NCT01100437|3746910|FG001|Titration/Stabilization|Adverse Event|0
2139812|NCT01100437|3746911|FG002|Titration/Stabilization|Adverse Event|4
2139813|NCT01100437|3746909|FG000|Titration/Stabilization|Non-compliance|0
2139814|NCT01100437|3746910|FG001|Titration/Stabilization|Non-compliance|0
2139815|NCT01100437|3746911|FG002|Titration/Stabilization|Non-compliance|1
2139816|NCT01100437|3746909|FG000|Titration/Stabilization|Sponsor canceled study|0
2139817|NCT01100437|3746910|FG001|Titration/Stabilization|Sponsor canceled study|0
2139818|NCT01100437|3746911|FG002|Titration/Stabilization|Sponsor canceled study|1
2139819|NCT01100437|3746909|FG000|Maintenance|Withdrawal by Subject|0
2139820|NCT01100437|3746910|FG001|Maintenance|Withdrawal by Subject|0
2139821|NCT01100437|3746911|FG002|Maintenance|Withdrawal by Subject|1
2139822|NCT01100437|3746909|FG000|Maintenance|Sponsor termination of study|0
2139823|NCT01100437|3746910|FG001|Maintenance|Sponsor termination of study|0
2139824|NCT01100437|3746911|FG002|Maintenance|Sponsor termination of study|1
2139825|NCT01100502|3746922|FG000|Overall Study|Withdrawal by Subject|18
2139826|NCT01100502|3746923|FG001|Overall Study|Withdrawal by Subject|25
2139827|NCT01100502|3746922|FG000|Overall Study|Lost to Follow-up|13
2139828|NCT01100502|3746923|FG001|Overall Study|Lost to Follow-up|28
2139829|NCT01100502|3746922|FG000|Overall Study|Site request to end participation in study|0
2139830|NCT01100502|3746923|FG001|Overall Study|Site request to end participation in study|1
2139831|NCT01100502|3746922|FG000|Overall Study|Death|45
2139832|NCT01100502|3746923|FG001|Overall Study|Death|40
2139833|NCT01100528|3746929|FG000|Overall Study|Death|1
2139834|NCT01100528|3746929|FG000|Overall Study|Withdrawal by Subject|2
2139835|NCT01100567|3746935|FG000|Overall Study|Withdrawal by Subject|5
2139836|NCT01100567|3746936|FG001|Overall Study|Withdrawal by Subject|8
2139837|NCT01100567|3746935|FG000|Overall Study|Early Hospital Discharge|6
2139838|NCT01100567|3746936|FG001|Overall Study|Early Hospital Discharge|4
2139839|NCT01100567|3746935|FG000|Overall Study|Lost to Follow-up|1
2139840|NCT01100567|3746936|FG001|Overall Study|Lost to Follow-up|2
2139841|NCT01100567|3746935|FG000|Overall Study|Physician Decision|0
2139842|NCT01100567|3746936|FG001|Overall Study|Physician Decision|1
2139843|NCT01100567|3746935|FG000|Overall Study|Deemed ineligible after consent|0
2139844|NCT01100567|3746936|FG001|Overall Study|Deemed ineligible after consent|1
2139845|NCT01100853|3746966|FG000|Overall Study|Lost to Follow-up|11
2139846|NCT01100853|3746967|FG001|Overall Study|Lost to Follow-up|6
2139847|NCT01100853|3746966|FG000|Overall Study|Received <4 study injections|10
2139848|NCT01100853|3746967|FG001|Overall Study|Received <4 study injections|13
2139849|NCT01100853|3746966|FG000|Overall Study|Withdrawal by Subject|6
2139850|NCT01100853|3746967|FG001|Overall Study|Withdrawal by Subject|4
2139851|NCT01100944|3746983|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
2139852|NCT01100944|3746984|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
2139853|NCT01100944|3746985|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
2139854|NCT01100944|3746983|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
2139855|NCT01100944|3746984|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
2139856|NCT01100944|3746985|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
2139857|NCT01100944|3746983|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
2139858|NCT01100944|3746984|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
2139859|NCT01100944|3746985|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
2139860|NCT01100944|3746983|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
2139861|NCT01100944|3746984|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
2139862|NCT01100944|3746985|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
2139863|NCT01101022|3747008|FG000|Overall Study|Adverse Event|6
2139864|NCT01101022|3747009|FG001|Overall Study|Adverse Event|2
2139865|NCT01101022|3747008|FG000|Overall Study|Protocol Violation|4
2139866|NCT01101022|3747009|FG001|Overall Study|Protocol Violation|3
2139867|NCT01101022|3747008|FG000|Overall Study|Withdrawal by Subject|3
2139868|NCT01101022|3747009|FG001|Overall Study|Withdrawal by Subject|8
2139869|NCT01101022|3747008|FG000|Overall Study|Lost to Follow-up|1
2139870|NCT01101022|3747009|FG001|Overall Study|Lost to Follow-up|4
2139871|NCT01101022|3747008|FG000|Overall Study|Lack of Efficacy|0
2139872|NCT01101022|3747009|FG001|Overall Study|Lack of Efficacy|7
2139873|NCT01101022|3747008|FG000|Overall Study|Sponsor decision|1
2139874|NCT01101022|3747009|FG001|Overall Study|Sponsor decision|1
2139875|NCT01101022|3747008|FG000|Overall Study|Non-compliance|1
2139876|NCT01101022|3747009|FG001|Overall Study|Non-compliance|0
2139877|NCT01101022|3747008|FG000|Overall Study|Work schedule|1
2139878|NCT01101022|3747009|FG001|Overall Study|Work schedule|1
2139879|NCT01101022|3747008|FG000|Overall Study|Vacation|0
2139880|NCT01101022|3747009|FG001|Overall Study|Vacation|1
2139881|NCT01101035|3747017|FG000|Overall Study|Adverse Event|191
2139882|NCT01101035|3747018|FG001|Overall Study|Adverse Event|172
2139883|NCT01101035|3747017|FG000|Overall Study|Major Protocol Deviation|52
2139884|NCT01101035|3747018|FG001|Overall Study|Major Protocol Deviation|46
2139885|NCT01101035|3747017|FG000|Overall Study|Lost to Follow-up|226
2139886|NCT01101035|3747018|FG001|Overall Study|Lost to Follow-up|223
2139887|NCT01101035|3747017|FG000|Overall Study|Voluntary Withdrawal|595
2139888|NCT01101035|3747018|FG001|Overall Study|Voluntary Withdrawal|587
2139889|NCT01101035|3747017|FG000|Overall Study|Reason not Specified|333
2139890|NCT01101035|3747018|FG001|Overall Study|Reason not Specified|363
2139891|NCT01101061|3747030|FG000|Overall Study|Adverse Event|0
2139892|NCT01101061|3747031|FG001|Overall Study|Adverse Event|0
2139893|NCT01101061|3747032|FG002|Overall Study|Adverse Event|1
2139894|NCT01101061|3747033|FG003|Overall Study|Adverse Event|0
2139895|NCT01101061|3747034|FG004|Overall Study|Adverse Event|0
2139896|NCT01101061|3747035|FG005|Overall Study|Adverse Event|0
2139897|NCT01101165|3747058|FG000|Period 1|Adverse Event|1
2139898|NCT01101165|3747059|FG001|Period 1|Adverse Event|2
2139899|NCT01101165|3747058|FG000|Period 1|Withdrawal by Subject|0
2139900|NCT01101165|3747059|FG001|Period 1|Withdrawal by Subject|2
2139901|NCT01101165|3747058|FG000|Period 1|Positive Drug Screen|0
2139902|NCT01101165|3747059|FG001|Period 1|Positive Drug Screen|1
2139903|NCT01101165|3747058|FG000|Period 1|Lost to Follow-up|1
2139904|NCT01101165|3747059|FG001|Period 1|Lost to Follow-up|0
2139905|NCT01101165|3747058|FG000|Period 2|Withdrawal by Subject|3
2139906|NCT01101165|3747059|FG001|Period 2|Withdrawal by Subject|1
2139907|NCT01101165|3747058|FG000|Period 2|Adverse Event|1
2139908|NCT01101165|3747059|FG001|Period 2|Adverse Event|0
2139909|NCT01101178|3747065|FG000|Period 1|Withdrawal by Subject|1
2139910|NCT01101178|3747066|FG001|Period 1|Withdrawal by Subject|2
2139911|NCT01101178|3747065|FG000|Period 1|Positive drug screen|1
2139912|NCT01101178|3747066|FG001|Period 1|Positive drug screen|1
2139913|NCT01101178|3747065|FG000|Period 1|Adverse Event|2
2139914|NCT01101178|3747066|FG001|Period 1|Adverse Event|1
2139915|NCT01101178|3747065|FG000|Period 2|Withdrawal by Subject|0
2139916|NCT01101178|3747066|FG001|Period 2|Withdrawal by Subject|1
2139917|NCT01101191|3747073|FG000|Period 1|Withdrawal by Subject|1
2139918|NCT01101191|3747074|FG001|Period 1|Withdrawal by Subject|0
2139919|NCT01101191|3747073|FG000|Period 1|Adverse Event|1
2139920|NCT01101191|3747074|FG001|Period 1|Adverse Event|2
2139921|NCT01101308|3747081|FG000|Period 1|Adverse Event|2
2139922|NCT01101308|3747082|FG001|Period 1|Adverse Event|1
2139923|NCT01101308|3747081|FG000|Period 1|Positive for cotinine|1
2139924|NCT01101308|3747082|FG001|Period 1|Positive for cotinine|0
2139925|NCT01101321|3747089|FG000|Period 1|Withdrawal by Subject|1
2139926|NCT01101321|3747090|FG001|Period 1|Withdrawal by Subject|1
2139927|NCT01101321|3747089|FG000|Period 1|Adverse Event|3
2139928|NCT01101321|3747090|FG001|Period 1|Adverse Event|3
2139929|NCT01101334|3747098|FG000|Overall Study|Adverse Event|9
2139930|NCT01101334|3747099|FG001|Overall Study|Adverse Event|4
2139931|NCT01101334|3747098|FG000|Overall Study|Death|7
2139932|NCT01101334|3747099|FG001|Overall Study|Death|1
2139933|NCT01101334|3747098|FG000|Overall Study|Withdrawal by Subject|4
2139934|NCT01101334|3747099|FG001|Overall Study|Withdrawal by Subject|3
2139935|NCT01101334|3747098|FG000|Overall Study|Withdrawal by Sponsor|1
2139936|NCT01101334|3747099|FG001|Overall Study|Withdrawal by Sponsor|1
2139937|NCT01101334|3747098|FG000|Overall Study|Progressive Disease|22
2139938|NCT01101334|3747099|FG001|Overall Study|Progressive Disease|35
2139939|NCT01101334|3747098|FG000|Overall Study|Other|2
2139940|NCT01101334|3747099|FG001|Overall Study|Other|1
2178517|NCT01384734|3803321|FG003|Overall Study|Missed End of treatment visit|1
2178518|NCT01384734|3803322|FG004|Overall Study|Missed End of treatment visit|0
2178519|NCT01384734|3803318|FG000|Overall Study|Adhesion problem|0
2178520|NCT01384734|3803319|FG001|Overall Study|Adhesion problem|0
2178521|NCT01384734|3803320|FG002|Overall Study|Adhesion problem|0
2178522|NCT01384734|3803321|FG003|Overall Study|Adhesion problem|1
2178523|NCT01384734|3803322|FG004|Overall Study|Adhesion problem|0
2178524|NCT01384734|3803318|FG000|Overall Study|Early termination|0
2178525|NCT01384734|3803319|FG001|Overall Study|Early termination|0
2178526|NCT01384734|3803320|FG002|Overall Study|Early termination|0
2178527|NCT01384734|3803321|FG003|Overall Study|Early termination|0
2178528|NCT01384734|3803322|FG004|Overall Study|Early termination|1
2178529|NCT01384734|3803318|FG000|Overall Study|Physician Decision|1
2178530|NCT01384734|3803319|FG001|Overall Study|Physician Decision|0
2139941|NCT01101477|3747108|FG000|Overall Study|Protocol Violation|5
2139942|NCT01101477|3747109|FG001|Overall Study|Protocol Violation|3
2139943|NCT01101477|3747110|FG002|Overall Study|Protocol Violation|1
2139944|NCT01101542|3747118|FG000|Year 3 Surveillance Period|Lost to Follow-up|7
2139945|NCT01101542|3747118|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4
2139946|NCT01101542|3747118|FG000|Year 4 Surveillance Period|Other|287
2139947|NCT01101542|3747118|FG000|Year 5 Surveillance Period|Lost to Follow-up|140
2139948|NCT01101542|3747118|FG000|Year 5 Surveillance Period|Pregnancy|1
2139949|NCT01101542|3747118|FG000|Year 6 Surveillance Period|Lost to Follow-up|986
2139950|NCT01101542|3747118|FG000|Year 6 Surveillance Period|Pregnancy|1
2139951|NCT01101542|3747118|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4
2139952|NCT01101841|3747128|FG000|Overall Study|Adverse Event|15
2139953|NCT01101841|3747129|FG001|Overall Study|Adverse Event|15
2139954|NCT01101841|3747128|FG000|Overall Study|Lost to Follow-up|9
2139955|NCT01101841|3747129|FG001|Overall Study|Lost to Follow-up|3
2139956|NCT01101841|3747128|FG000|Overall Study|Withdrawal by Subject|21
2139957|NCT01101841|3747129|FG001|Overall Study|Withdrawal by Subject|40
2139958|NCT01101841|3747128|FG000|Overall Study|Protocol Violation|1
2139959|NCT01101841|3747129|FG001|Overall Study|Protocol Violation|1
2139960|NCT01101841|3747128|FG000|Overall Study|Physician Decision|0
2139961|NCT01101841|3747129|FG001|Overall Study|Physician Decision|2
2139962|NCT01101841|3747128|FG000|Overall Study|Lack of Efficacy|0
2139963|NCT01101841|3747129|FG001|Overall Study|Lack of Efficacy|2
2139964|NCT01101841|3747128|FG000|Overall Study|Other|0
2139965|NCT01101841|3747129|FG001|Overall Study|Other|1
2139966|NCT01101841|3747128|FG000|Overall Study|Suicidality Tracking Scale|3
2139967|NCT01101841|3747129|FG001|Overall Study|Suicidality Tracking Scale|1
2139968|NCT01101841|3747128|FG000|Overall Study|Eligibility Criteria|1
2139969|NCT01101841|3747129|FG001|Overall Study|Eligibility Criteria|2
2139970|NCT01101997|3747166|FG000|Overall Study|Withdrawal by Subject|2
2139971|NCT01102231|3747181|FG000|Overall Study|Protocol Violation|3
2139972|NCT01102231|3747181|FG000|Overall Study|Lack of Efficacy|2
2139973|NCT01102231|3747181|FG000|Overall Study|Death|2
2139974|NCT01102231|3747181|FG000|Overall Study|Adverse Event|3
2139975|NCT01102231|3747181|FG000|Overall Study|Withdrawal by Subject|1
2139976|NCT01102231|3747181|FG000|Overall Study|Did not received the treatment|4
2139977|NCT01102257|3747188|FG000|Overall Study|Adverse Event|1
2139978|NCT01102257|3747189|FG001|Overall Study|Adverse Event|0
2139979|NCT01102257|3747188|FG000|Overall Study|Adverse Event|1
2139980|NCT01102257|3747189|FG001|Overall Study|Adverse Event|0
2139981|NCT01102374|3747204|FG000|Overall Study|Death|9
2139982|NCT01102374|3747205|FG001|Overall Study|Death|13
2139983|NCT01102374|3747204|FG000|Overall Study|Lost to Follow-up|7
2139984|NCT01102374|3747205|FG001|Overall Study|Lost to Follow-up|6
2139985|NCT01102426|3747222|FG000|Overall Study|Randomized but not treated|4
2139986|NCT01102426|3747223|FG001|Overall Study|Randomized but not treated|1
2139987|NCT01102426|3747222|FG000|Overall Study|Adverse Events (treatment-related)|15
2139988|NCT01102426|3747223|FG001|Overall Study|Adverse Events (treatment-related)|8
2139989|NCT01102426|3747222|FG000|Overall Study|Physician Decision|9
2139990|NCT01102426|3747223|FG001|Overall Study|Physician Decision|6
2139991|NCT01102426|3747222|FG000|Overall Study|Progressive Disease|85
2139992|NCT01102426|3747223|FG001|Overall Study|Progressive Disease|44
2139993|NCT01102426|3747222|FG000|Overall Study|Adverse Events (unrelated to|9
2139994|NCT01102426|3747223|FG001|Overall Study|Adverse Events (unrelated to|1
2139995|NCT01102426|3747222|FG000|Overall Study|Patient Refusal|24
2288989|NCT02471404|3980660|FG002|Overall Study|Lost to Follow-up|3
2288990|NCT02471404|3980658|FG000|Overall Study|Protocol Violation|1
2288991|NCT02471404|3980659|FG001|Overall Study|Protocol Violation|0
2288992|NCT02471404|3980660|FG002|Overall Study|Protocol Violation|0
2288993|NCT02471404|3980658|FG000|Overall Study|Withdrawal by Subject|8
2288994|NCT02471404|3980659|FG001|Overall Study|Withdrawal by Subject|4
2288995|NCT02471404|3980660|FG002|Overall Study|Withdrawal by Subject|5
2288996|NCT02471404|3980658|FG000|Overall Study|Other reasons not specified|10
2288997|NCT02471404|3980659|FG001|Overall Study|Other reasons not specified|7
2288998|NCT02471404|3980660|FG002|Overall Study|Other reasons not specified|12
2288999|NCT02471586|3980680|FG000|Overall Study|Lost to Follow-up|3
2289000|NCT02471586|3980681|FG001|Overall Study|Lost to Follow-up|8
2289001|NCT02471586|3980682|FG002|Overall Study|Lost to Follow-up|4
2289002|NCT02471586|3980680|FG000|Overall Study|Death|2
2289003|NCT02471586|3980681|FG001|Overall Study|Death|2
2289004|NCT02471586|3980682|FG002|Overall Study|Death|0
2289005|NCT02471612|3980692|FG000|Overall Study|Lost to Follow-up|2
2289006|NCT02471716|3980723|FG000|Overall Study|Withdrawal by Subject|0
2289007|NCT02471716|3980724|FG001|Overall Study|Withdrawal by Subject|1
2289008|NCT02471716|3980725|FG002|Overall Study|Withdrawal by Subject|0
2289009|NCT02471716|3980726|FG003|Overall Study|Withdrawal by Subject|2
2289010|NCT02471716|3980727|FG004|Overall Study|Withdrawal by Subject|5
2289011|NCT02471716|3980723|FG000|Overall Study|Study Terminiated by sponsor|0
2289012|NCT02471716|3980724|FG001|Overall Study|Study Terminiated by sponsor|0
2289013|NCT02471716|3980725|FG002|Overall Study|Study Terminiated by sponsor|0
2289014|NCT02471716|3980726|FG003|Overall Study|Study Terminiated by sponsor|1
2139996|NCT01102426|3747223|FG001|Overall Study|Patient Refusal|12
2139997|NCT01102426|3747222|FG000|Overall Study|Death (due to adverse events|0
2178531|NCT01384734|3803320|FG002|Overall Study|Physician Decision|0
2139998|NCT01102426|3747223|FG001|Overall Study|Death (due to adverse events|1
2139999|NCT01102426|3747222|FG000|Overall Study|Death (non-related to the study|19
2140000|NCT01102426|3747223|FG001|Overall Study|Death (non-related to the study|8
2140001|NCT01102491|3747231|FG000|Overall Study|Protocol Violation|11
2140002|NCT01102491|3747232|FG001|Overall Study|Protocol Violation|12
2140003|NCT01102777|3747253|FG000|Overall Study|Death|2
2140004|NCT01102777|3747254|FG001|Overall Study|Death|6
2140005|NCT01102777|3747253|FG000|Overall Study|Lost to Follow-up|7
2140006|NCT01102777|3747254|FG001|Overall Study|Lost to Follow-up|10
2140007|NCT01102803|3747263|FG000|Baseline to Post-Treatment|Lost to Follow-up|3
2140008|NCT01102803|3747264|FG001|Baseline to Post-Treatment|Lost to Follow-up|0
2140009|NCT01102803|3747263|FG000|Post to Follow-Up|Lost to Follow-up|1
2140010|NCT01102803|3747264|FG001|Post to Follow-Up|Lost to Follow-up|3
2140011|NCT01102972|3747280|FG000|Overall Study|Adverse Event|8
2140012|NCT01102972|3747281|FG001|Overall Study|Adverse Event|2
2140013|NCT01102972|3747280|FG000|Overall Study|Lack of Efficacy|2
2140014|NCT01102972|3747281|FG001|Overall Study|Lack of Efficacy|1
2140015|NCT01102972|3747280|FG000|Overall Study|Protocol Violation|1
2140016|NCT01102972|3747281|FG001|Overall Study|Protocol Violation|0
2140017|NCT01102972|3747280|FG000|Overall Study|Lost to Follow-up|10
2140018|NCT01102972|3747281|FG001|Overall Study|Lost to Follow-up|5
2140019|NCT01102972|3747280|FG000|Overall Study|Investigator Discretion|2
2140020|NCT01102972|3747281|FG001|Overall Study|Investigator Discretion|0
2140021|NCT01102972|3747280|FG000|Overall Study|Withdrawal by Subject|6
2140022|NCT01102972|3747281|FG001|Overall Study|Withdrawal by Subject|6
2140023|NCT01103063|3747289|FG000|Overall Study|Adverse Event|3
2140024|NCT01103063|3747290|FG001|Overall Study|Adverse Event|1
2140025|NCT01103063|3747289|FG000|Overall Study|Lost to Follow-up|68
2140026|NCT01103063|3747290|FG001|Overall Study|Lost to Follow-up|51
2140027|NCT01103063|3747289|FG000|Overall Study|Withdrawal by Subject|60
2140028|NCT01103063|3747290|FG001|Overall Study|Withdrawal by Subject|15
2140029|NCT01103063|3747289|FG000|Overall Study|Other|16
2140030|NCT01103063|3747290|FG001|Overall Study|Other|11
2140031|NCT01103063|3747289|FG000|Overall Study|Protocol Violation|1
2140032|NCT01103063|3747290|FG001|Overall Study|Protocol Violation|0
2140033|NCT01103063|3747289|FG000|Overall Study|Study terminated by Sponsor|326
2140034|NCT01103063|3747290|FG001|Overall Study|Study terminated by Sponsor|342
2140035|NCT01103063|3747289|FG000|Overall Study|Death|3
2140036|NCT01103063|3747290|FG001|Overall Study|Death|1
2140037|NCT01103141|3747300|FG000|Overall Study|Death|0
2140038|NCT01103141|3747301|FG001|Overall Study|Death|1
2140039|NCT01103141|3747300|FG000|Overall Study|Lost to Follow-up|2
2140040|NCT01103141|3747301|FG001|Overall Study|Lost to Follow-up|1
2140041|NCT01103232|3747309|FG000|Overall Study|Withdrawal by Subject|1
2140042|NCT01103232|3747310|FG001|Overall Study|Withdrawal by Subject|1
2140043|NCT01103232|3747309|FG000|Overall Study|Protocol Violation|0
2140044|NCT01103232|3747310|FG001|Overall Study|Protocol Violation|1
2140045|NCT01103245|3747320|FG000|Overall Study|Withdrawal by Subject|1
2140046|NCT01103245|3747321|FG001|Overall Study|Withdrawal by Subject|0
2140047|NCT01103245|3747322|FG002|Overall Study|Withdrawal by Subject|3
2140048|NCT01103245|3747323|FG003|Overall Study|Withdrawal by Subject|0
2140049|NCT01103245|3747320|FG000|Overall Study|Inadequate IV access|1
2140050|NCT01103245|3747321|FG001|Overall Study|Inadequate IV access|0
2140051|NCT01103245|3747322|FG002|Overall Study|Inadequate IV access|0
2140052|NCT01103245|3747323|FG003|Overall Study|Inadequate IV access|0
2140053|NCT01103245|3747320|FG000|Overall Study|Adverse Event|0
2140054|NCT01103245|3747321|FG001|Overall Study|Adverse Event|2
2140055|NCT01103245|3747322|FG002|Overall Study|Adverse Event|1
2140056|NCT01103245|3747323|FG003|Overall Study|Adverse Event|0
2140057|NCT01103245|3747320|FG000|Overall Study|Physician Decision|1
2140058|NCT01103245|3747321|FG001|Overall Study|Physician Decision|0
2140059|NCT01103245|3747322|FG002|Overall Study|Physician Decision|0
2140060|NCT01103245|3747323|FG003|Overall Study|Physician Decision|0
2140061|NCT01103284|3747345|FG000|Overall Study|Death|2
2140062|NCT01103284|3747346|FG001|Overall Study|Death|0
2140063|NCT01103284|3747345|FG000|Overall Study|Lost to Follow-up|9
2140064|NCT01103284|3747346|FG001|Overall Study|Lost to Follow-up|10
2140065|NCT01103284|3747345|FG000|Overall Study|Pregnancy|3
2140066|NCT01103284|3747346|FG001|Overall Study|Pregnancy|1
2140067|NCT01103284|3747345|FG000|Overall Study|Protocol Violation|12
2140068|NCT01103284|3747346|FG001|Overall Study|Protocol Violation|5
2140069|NCT01103284|3747345|FG000|Overall Study|Adverse Event|0
2140070|NCT01103284|3747346|FG001|Overall Study|Adverse Event|5
2140071|NCT01103284|3747345|FG000|Overall Study|Withdrawal by Subject|14
2140072|NCT01103284|3747346|FG001|Overall Study|Withdrawal by Subject|18
2140073|NCT01103284|3747345|FG000|Overall Study|Dermal Hypersensitivity|0
2140074|NCT01103284|3747346|FG001|Overall Study|Dermal Hypersensitivity|1
2140075|NCT01103284|3747345|FG000|Overall Study|Termination by the Sponsor|0
2140076|NCT01103284|3747346|FG001|Overall Study|Termination by the Sponsor|1
2140077|NCT01103284|3747345|FG000|Overall Study|Not described|2
2140078|NCT01103284|3747346|FG001|Overall Study|Not described|1
2140079|NCT01103284|3747345|FG000|Overall Study|Missing CRF entries for study completion|0
2140080|NCT01103284|3747346|FG001|Overall Study|Missing CRF entries for study completion|2
2140081|NCT01103323|3747354|FG000|Without/Before Drug Switch|Adverse Event|50
2140082|NCT01103323|3747355|FG001|Without/Before Drug Switch|Adverse Event|7
2140083|NCT01103323|3747354|FG000|Without/Before Drug Switch|Withdrawal by Subject|17
2140084|NCT01103323|3747355|FG001|Without/Before Drug Switch|Withdrawal by Subject|5
2140085|NCT01103323|3747354|FG000|Without/Before Drug Switch|Protocol Violation|2
2140086|NCT01103323|3747355|FG001|Without/Before Drug Switch|Protocol Violation|0
2140087|NCT01103323|3747354|FG000|Without/Before Drug Switch|Physician Decision|2
2140088|NCT01103323|3747355|FG001|Without/Before Drug Switch|Physician Decision|0
2140089|NCT01103323|3747354|FG000|Without/Before Drug Switch|did not receive study treatment|5
2140090|NCT01103323|3747355|FG001|Without/Before Drug Switch|did not receive study treatment|2
2140091|NCT01103323|3747354|FG000|Without/Before Drug Switch|Switch to Regorafenib|0
2140092|NCT01103323|3747355|FG001|Without/Before Drug Switch|Switch to Regorafenib|4
2140093|NCT01103323|3747354|FG000|Switched From Placebo to Regorafenib|Adverse Event|0
2140094|NCT01103323|3747355|FG001|Switched From Placebo to Regorafenib|Adverse Event|1
2207943|NCT01634100|3847117|FG000|Overall Study|Withdrawal by Subject|1
2207944|NCT01634100|3847118|FG001|Overall Study|Withdrawal by Subject|0
2140095|NCT01103362|3747362|FG000|Overall Study|study terminated|596
2140096|NCT01103466|3747396|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2
2140097|NCT01103466|3747397|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0
2140098|NCT01103466|3747398|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0
2140099|NCT01103466|3747396|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2
2140100|NCT01103466|3747397|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1
2140101|NCT01103466|3747398|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0
2140102|NCT01103466|3747396|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
2140103|NCT01103466|3747397|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
2140104|NCT01103466|3747398|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
2140105|NCT01103466|3747396|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1
2140106|NCT01103466|3747397|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0
2140107|NCT01103466|3747398|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0
2140108|NCT01103466|3747396|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
2140109|NCT01103466|3747397|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
2140110|NCT01103466|3747398|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
2140111|NCT01103466|3747396|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0
2140112|NCT01103466|3747397|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0
2140113|NCT01103466|3747398|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1
2140114|NCT01103479|3747409|FG000|Overall Study|Up to date with CRC screening|1
2140115|NCT01103479|3747410|FG001|Overall Study|Up to date with CRC screening|9
2140116|NCT01103479|3747411|FG002|Overall Study|Up to date with CRC screening|12
2140117|NCT01103479|3747409|FG000|Overall Study|Family history of CRC|1
2140118|NCT01103479|3747410|FG001|Overall Study|Family history of CRC|0
2140119|NCT01103479|3747411|FG002|Overall Study|Family history of CRC|2
2140120|NCT01103479|3747409|FG000|Overall Study|Active cancer|1
2140121|NCT01103479|3747410|FG001|Overall Study|Active cancer|0
2140122|NCT01103479|3747411|FG002|Overall Study|Active cancer|0
2140123|NCT01103479|3747409|FG000|Overall Study|Saw non-study physician|2
2140124|NCT01103479|3747410|FG001|Overall Study|Saw non-study physician|0
2140125|NCT01103479|3747411|FG002|Overall Study|Saw non-study physician|0
2140126|NCT01103713|3747441|FG000|Overall Study|Lost to Follow-up|2
2140127|NCT01103713|3747441|FG000|Overall Study|Withdrawal by Subject|8
2140128|NCT01103713|3747441|FG000|Overall Study|Study terminated by sponsor|2
2140129|NCT01103713|3747441|FG000|Overall Study|Other|1
2140130|NCT01103778|3747448|FG000|Overall Study|Lost to Follow-up|1
2140131|NCT01103778|3747448|FG000|Overall Study|Proteinuria improved prior to enrollment|1
2140132|NCT01103778|3747448|FG000|Overall Study|Screen failure|1
2140133|NCT01103960|3747465|FG000|Overall Study|Adverse Event|2
2140134|NCT01103960|3747466|FG001|Overall Study|Adverse Event|1
2289015|NCT02471716|3980727|FG004|Overall Study|Study Terminiated by sponsor|0
2289016|NCT02471716|3980723|FG000|Overall Study|Lost to Follow-up|0
2289017|NCT02471716|3980724|FG001|Overall Study|Lost to Follow-up|0
2289018|NCT02471716|3980725|FG002|Overall Study|Lost to Follow-up|0
2289019|NCT02471716|3980726|FG003|Overall Study|Lost to Follow-up|3
2289020|NCT02471716|3980727|FG004|Overall Study|Lost to Follow-up|2
2289021|NCT02471716|3980723|FG000|Overall Study|Death|0
2289022|NCT02471716|3980724|FG001|Overall Study|Death|0
2289023|NCT02471716|3980725|FG002|Overall Study|Death|0
2289024|NCT02471716|3980726|FG003|Overall Study|Death|1
2289025|NCT02471716|3980727|FG004|Overall Study|Death|0
2289026|NCT02471716|3980723|FG000|Overall Study|Other|0
2289027|NCT02471716|3980724|FG001|Overall Study|Other|0
2289028|NCT02471716|3980725|FG002|Overall Study|Other|0
2289029|NCT02471716|3980726|FG003|Overall Study|Other|8
2289030|NCT02471716|3980727|FG004|Overall Study|Other|9
2289031|NCT02471755|3980743|FG000|Overall Study|Withdrawal by Subject|1
2289032|NCT02471755|3980744|FG001|Overall Study|Withdrawal by Subject|0
2289033|NCT02471755|3980743|FG000|Overall Study|Lost to Follow-up|0
2289034|NCT02471755|3980744|FG001|Overall Study|Lost to Follow-up|1
2289035|NCT02472145|3980753|FG000|Overall Study|Death|10
2289036|NCT02472145|3980754|FG001|Overall Study|Death|101
2289037|NCT02472145|3980755|FG002|Overall Study|Death|99
2289038|NCT02472145|3980753|FG000|Overall Study|Lost to Follow-up|0
2289039|NCT02472145|3980754|FG001|Overall Study|Lost to Follow-up|1
2289040|NCT02472145|3980755|FG002|Overall Study|Lost to Follow-up|0
2289041|NCT02472145|3980753|FG000|Overall Study|Withdrawal by Subject|0
2140135|NCT01103960|3747465|FG000|Overall Study|Withdrawal by Subject|2
2140136|NCT01103960|3747466|FG001|Overall Study|Withdrawal by Subject|1
2140137|NCT01103960|3747465|FG000|Overall Study|Other|1
2140138|NCT01103960|3747466|FG001|Overall Study|Other|0
2140139|NCT01104155|3747507|FG000|Overall Study|Adverse Event|15
2140140|NCT01104155|3747508|FG001|Overall Study|Adverse Event|8
2140141|NCT01104155|3747507|FG000|Overall Study|Participant choice|6
2140142|NCT01104155|3747508|FG001|Overall Study|Participant choice|5
2140143|NCT01104155|3747507|FG000|Overall Study|Withdrawal of consent|1
2140144|NCT01104155|3747508|FG001|Overall Study|Withdrawal of consent|1
2140145|NCT01104155|3747507|FG000|Overall Study|Other|3
2140146|NCT01104155|3747508|FG001|Overall Study|Other|4
2140147|NCT01104246|3747523|FG000|Overall Study|Withdrawal by Subject|1
2140148|NCT01104246|3747523|FG000|Overall Study|did not meet inclusion criteria|4
2140149|NCT01104311|3747538|FG000|Overall Study|Withdrawal by Subject|6
2140150|NCT01104311|3747539|FG001|Overall Study|Withdrawal by Subject|6
2140151|NCT01104311|3747538|FG000|Overall Study|Protocol Violation|0
2140152|NCT01104311|3747539|FG001|Overall Study|Protocol Violation|1
2140153|NCT01104311|3747538|FG000|Overall Study|Physician Decision|2
2140154|NCT01104311|3747539|FG001|Overall Study|Physician Decision|2
2140155|NCT01104311|3747538|FG000|Overall Study|low compliance|1
2140156|NCT01104311|3747539|FG001|Overall Study|low compliance|1
2140157|NCT01104311|3747538|FG000|Overall Study|Adverse Event|1
2140158|NCT01104311|3747539|FG001|Overall Study|Adverse Event|2
2140159|NCT01104376|3747549|FG000|Overall Study|Withdrawal by Subject|15
2140160|NCT01104376|3747549|FG000|Overall Study|Consented but excluded after labs|13
2140161|NCT01104415|3747562|FG000|Core Phase|Consent withdrawn by subjects|1
2140162|NCT01104415|3747563|FG001|Core Phase|Consent withdrawn by subjects|0
2140163|NCT01104415|3747562|FG000|Extension Period|Progressive disease|0
2140164|NCT01104415|3747563|FG001|Extension Period|Progressive disease|4
2140165|NCT01104415|3747562|FG000|Extension Period|Death|0
2140166|NCT01104415|3747563|FG001|Extension Period|Death|1
2140167|NCT01104415|3747562|FG000|Extension Period|Physician Decision|0
2140168|NCT01104415|3747563|FG001|Extension Period|Physician Decision|1
2140169|NCT01104415|3747562|FG000|Extension Period|Transition to Study LX1606.302|0
2140170|NCT01104415|3747563|FG001|Extension Period|Transition to Study LX1606.302|4
2140171|NCT01104415|3747562|FG000|Extension Period|Heart surgery/feeling miserable|0
2140172|NCT01104415|3747563|FG001|Extension Period|Heart surgery/feeling miserable|1
2140173|NCT01104493|3747572|FG000|Overall Study|Lost to Follow-up|0
2140174|NCT01104493|3747573|FG001|Overall Study|Lost to Follow-up|2
2140175|NCT01104545|3747582|FG000|Overall Study|Adverse Event|0
2140176|NCT01104545|3747583|FG001|Overall Study|Adverse Event|1
2140177|NCT01104545|3747584|FG002|Overall Study|Adverse Event|2
2140178|NCT01104558|3747629|FG000|Overall Study|Protocol Violation|6
2140179|NCT01104558|3747629|FG000|Overall Study|Missing of primary efficacy assessment|10
2140180|NCT01104558|3747629|FG000|Overall Study|Missing of genetic analysis results|1
2140181|NCT01104584|3747633|FG000|Overall Study|Study drug never administered|21
2140182|NCT01104584|3747633|FG000|Overall Study|Study prematurely discontinued|2
2140183|NCT01104636|3747655|FG000|Overall Study|Lack of Efficacy|43
2140184|NCT01104636|3747655|FG000|Overall Study|Lost to Follow-up|24
2140185|NCT01104636|3747655|FG000|Overall Study|Withdrawal by Subject|4
2140186|NCT01104636|3747655|FG000|Overall Study|Other|43
2140187|NCT01104636|3747655|FG000|Overall Study|Study terminated by sponsor|1
2140188|NCT01104636|3747655|FG000|Overall Study|Pregnancy|2
2140189|NCT01104636|3747655|FG000|Overall Study|Adverse Event|40
2140190|NCT01104636|3747655|FG000|Overall Study|Ongoing|21
2140191|NCT01104662|3747667|FG000|Overall Study|Adverse Event|2
2140192|NCT01104662|3747668|FG001|Overall Study|Adverse Event|2
2140193|NCT01104662|3747669|FG002|Overall Study|Adverse Event|0
2140194|NCT01104662|3747670|FG003|Overall Study|Adverse Event|1
2140195|NCT01104662|3747671|FG004|Overall Study|Adverse Event|1
2140196|NCT01104662|3747672|FG005|Overall Study|Adverse Event|1
2140197|NCT01104662|3747673|FG006|Overall Study|Adverse Event|0
2140198|NCT01104662|3747674|FG007|Overall Study|Adverse Event|0
2140199|NCT01104662|3747667|FG000|Overall Study|Clinical Failure|1
2140200|NCT01104662|3747668|FG001|Overall Study|Clinical Failure|0
2140201|NCT01104662|3747669|FG002|Overall Study|Clinical Failure|0
2140202|NCT01104662|3747670|FG003|Overall Study|Clinical Failure|0
2140203|NCT01104662|3747671|FG004|Overall Study|Clinical Failure|0
2140204|NCT01104662|3747672|FG005|Overall Study|Clinical Failure|1
2140205|NCT01104662|3747673|FG006|Overall Study|Clinical Failure|0
2140206|NCT01104662|3747674|FG007|Overall Study|Clinical Failure|0
2140207|NCT01104662|3747667|FG000|Overall Study|Participant left investigator's care|1
2140208|NCT01104662|3747668|FG001|Overall Study|Participant left investigator's care|1
2140209|NCT01104662|3747669|FG002|Overall Study|Participant left investigator's care|0
2140210|NCT01104662|3747670|FG003|Overall Study|Participant left investigator's care|0
2140211|NCT01104662|3747671|FG004|Overall Study|Participant left investigator's care|0
2140212|NCT01104662|3747672|FG005|Overall Study|Participant left investigator's care|0
2140213|NCT01104662|3747673|FG006|Overall Study|Participant left investigator's care|0
2140214|NCT01104662|3747674|FG007|Overall Study|Participant left investigator's care|0
2207945|NCT01634100|3847119|FG002|Overall Study|Withdrawal by Subject|1
2207946|NCT01634100|3847120|FG003|Overall Study|Withdrawal by Subject|0
2207947|NCT01634100|3847121|FG004|Overall Study|Withdrawal by Subject|0
2140215|NCT01104662|3747667|FG000|Overall Study|Reason not specified|3
2140216|NCT01104662|3747668|FG001|Overall Study|Reason not specified|3
2140217|NCT01104662|3747669|FG002|Overall Study|Reason not specified|0
2140218|NCT01104662|3747670|FG003|Overall Study|Reason not specified|0
2140219|NCT01104662|3747671|FG004|Overall Study|Reason not specified|0
2140220|NCT01104662|3747672|FG005|Overall Study|Reason not specified|1
2140221|NCT01104662|3747673|FG006|Overall Study|Reason not specified|0
2140222|NCT01104662|3747674|FG007|Overall Study|Reason not specified|0
2140223|NCT01104662|3747667|FG000|Overall Study|Randomized but not treated|3
2140224|NCT01104662|3747668|FG001|Overall Study|Randomized but not treated|4
2140225|NCT01104662|3747669|FG002|Overall Study|Randomized but not treated|1
2140226|NCT01104662|3747670|FG003|Overall Study|Randomized but not treated|0
2140227|NCT01104662|3747671|FG004|Overall Study|Randomized but not treated|0
2140228|NCT01104662|3747672|FG005|Overall Study|Randomized but not treated|1
2140229|NCT01104662|3747673|FG006|Overall Study|Randomized but not treated|0
2140230|NCT01104662|3747674|FG007|Overall Study|Randomized but not treated|0
2140231|NCT01104701|3747697|FG000|Overall Study|Withdrawal by Subject|0
2140232|NCT01104701|3747698|FG001|Overall Study|Withdrawal by Subject|1
2140233|NCT01104701|3747699|FG002|Overall Study|Withdrawal by Subject|2
2140234|NCT01104701|3747700|FG003|Overall Study|Withdrawal by Subject|1
2289042|NCT02472145|3980754|FG001|Overall Study|Withdrawal by Subject|9
2289043|NCT02472145|3980755|FG002|Overall Study|Withdrawal by Subject|13
2289044|NCT02472145|3980753|FG000|Overall Study|Sponsor decision|0
2289045|NCT02472145|3980754|FG001|Overall Study|Sponsor decision|3
2140235|NCT01104701|3747697|FG000|Overall Study|Adverse Event|0
2140236|NCT01104701|3747698|FG001|Overall Study|Adverse Event|0
2140237|NCT01104701|3747699|FG002|Overall Study|Adverse Event|0
2140238|NCT01104701|3747700|FG003|Overall Study|Adverse Event|1
2140239|NCT01104701|3747697|FG000|Overall Study|Physician Decision|0
2140240|NCT01104701|3747698|FG001|Overall Study|Physician Decision|2
2140241|NCT01104701|3747699|FG002|Overall Study|Physician Decision|0
2140242|NCT01104701|3747700|FG003|Overall Study|Physician Decision|0
2140243|NCT01104766|3747714|FG000|Overall Study|Did not meet inc/exc criteria|1
2140244|NCT01104766|3747715|FG001|Overall Study|Did not meet inc/exc criteria|0
2140245|NCT01104766|3747716|FG002|Overall Study|Did not meet inc/exc criteria|0
2140246|NCT01104766|3747717|FG003|Overall Study|Did not meet inc/exc criteria|0
2140247|NCT01104766|3747714|FG000|Overall Study|Adverse Event|17
2140248|NCT01104766|3747715|FG001|Overall Study|Adverse Event|15
2140249|NCT01104766|3747716|FG002|Overall Study|Adverse Event|20
2140250|NCT01104766|3747717|FG003|Overall Study|Adverse Event|14
2140251|NCT01104766|3747714|FG000|Overall Study|Lack of Efficacy|20
2140252|NCT01104766|3747715|FG001|Overall Study|Lack of Efficacy|15
2140253|NCT01104766|3747716|FG002|Overall Study|Lack of Efficacy|14
2140254|NCT01104766|3747717|FG003|Overall Study|Lack of Efficacy|8
2140255|NCT01104766|3747714|FG000|Overall Study|Protocol Violation|2
2140256|NCT01104766|3747715|FG001|Overall Study|Protocol Violation|0
2140257|NCT01104766|3747716|FG002|Overall Study|Protocol Violation|0
2140258|NCT01104766|3747717|FG003|Overall Study|Protocol Violation|0
2140259|NCT01104766|3747714|FG000|Overall Study|Withdrawal by Subject|17
2140260|NCT01104766|3747715|FG001|Overall Study|Withdrawal by Subject|19
2140261|NCT01104766|3747716|FG002|Overall Study|Withdrawal by Subject|25
2140262|NCT01104766|3747717|FG003|Overall Study|Withdrawal by Subject|15
2140263|NCT01104766|3747714|FG000|Overall Study|Lost to Follow-up|1
2140264|NCT01104766|3747715|FG001|Overall Study|Lost to Follow-up|2
2140265|NCT01104766|3747716|FG002|Overall Study|Lost to Follow-up|1
2140266|NCT01104766|3747717|FG003|Overall Study|Lost to Follow-up|1
2140267|NCT01104779|3747730|FG000|Overall Study|Protocol Violation|1
2140268|NCT01104779|3747731|FG001|Overall Study|Protocol Violation|2
2140269|NCT01104779|3747732|FG002|Overall Study|Protocol Violation|2
2140270|NCT01104779|3747730|FG000|Overall Study|Lack of Efficacy|26
2140271|NCT01104779|3747731|FG001|Overall Study|Lack of Efficacy|12
2140272|NCT01104779|3747732|FG002|Overall Study|Lack of Efficacy|13
2140273|NCT01104779|3747730|FG000|Overall Study|Adverse Event|13
2140274|NCT01104779|3747731|FG001|Overall Study|Adverse Event|14
2140275|NCT01104779|3747732|FG002|Overall Study|Adverse Event|13
2140276|NCT01104779|3747730|FG000|Overall Study|Did not meet inc/exc criteria|1
2140277|NCT01104779|3747731|FG001|Overall Study|Did not meet inc/exc criteria|1
2140278|NCT01104779|3747732|FG002|Overall Study|Did not meet inc/exc criteria|1
2140279|NCT01104779|3747730|FG000|Overall Study|Other reasons|0
2140280|NCT01104779|3747731|FG001|Overall Study|Other reasons|1
2140281|NCT01104779|3747732|FG002|Overall Study|Other reasons|0
2140282|NCT01104779|3747730|FG000|Overall Study|Lost to Follow-up|2
2140283|NCT01104779|3747731|FG001|Overall Study|Lost to Follow-up|0
2140284|NCT01104779|3747732|FG002|Overall Study|Lost to Follow-up|1
2140285|NCT01104779|3747730|FG000|Overall Study|Withdrawal by Subject|16
2140286|NCT01104779|3747731|FG001|Overall Study|Withdrawal by Subject|25
2140287|NCT01104779|3747732|FG002|Overall Study|Withdrawal by Subject|32
2140288|NCT01104792|3747740|FG000|Overall Study|Adverse Event|77
2140289|NCT01104792|3747740|FG000|Overall Study|Insufficient Therapeutic Response|22
2140290|NCT01104792|3747740|FG000|Overall Study|Protocol Violation|45
2140291|NCT01104792|3747740|FG000|Overall Study|Withdrawal of Consent|179
2289046|NCT02472145|3980755|FG002|Overall Study|Sponsor decision|2
2140292|NCT01104792|3747740|FG000|Overall Study|Lost to Follow-up|43
2140293|NCT01104792|3747740|FG000|Overall Study|Reasons Not Specified|27
2140294|NCT01104792|3747740|FG000|Overall Study|Did Not Meet Eligibility Criteria|133
2140295|NCT01104870|3747747|FG000|Overall Study|Adverse Event|1
2140296|NCT01104870|3747748|FG001|Overall Study|Adverse Event|1
2140297|NCT01104870|3747749|FG002|Overall Study|Adverse Event|0
2140298|NCT01104870|3747747|FG000|Overall Study|Death|0
2140299|NCT01104870|3747748|FG001|Overall Study|Death|0
2140300|NCT01104870|3747749|FG002|Overall Study|Death|1
2140301|NCT01104870|3747747|FG000|Overall Study|Withdrawal by Subject|0
2140302|NCT01104870|3747748|FG001|Overall Study|Withdrawal by Subject|0
2140303|NCT01104870|3747749|FG002|Overall Study|Withdrawal by Subject|1
2140304|NCT01105065|3747757|FG000|Overall Study|Adverse Event|5
2140305|NCT01105065|3747757|FG000|Overall Study|Technical Problems|1
2140306|NCT01105091|3747765|FG000|Overall Study|Death|2
2140307|NCT01105091|3747766|FG001|Overall Study|Death|0
2140308|NCT01105130|3747786|FG000|Overall Study|Withdrawal by Subject|4
2140309|NCT01105130|3747787|FG001|Overall Study|Withdrawal by Subject|6
2140310|NCT01105130|3747788|FG002|Overall Study|Withdrawal by Subject|2
2140311|NCT01105130|3747786|FG000|Overall Study|Never Started|2
2140312|NCT01105130|3747787|FG001|Overall Study|Never Started|2
2140313|NCT01105130|3747788|FG002|Overall Study|Never Started|4
2140314|NCT01105130|3747786|FG000|Overall Study|Toxicity|1
2140315|NCT01105130|3747787|FG001|Overall Study|Toxicity|3
2140316|NCT01105130|3747788|FG002|Overall Study|Toxicity|2
2140317|NCT01105130|3747786|FG000|Overall Study|Multiple Reasons|3
2140318|NCT01105130|3747787|FG001|Overall Study|Multiple Reasons|0
2140319|NCT01105130|3747788|FG002|Overall Study|Multiple Reasons|2
2140320|NCT01105377|3747825|FG000|Overall Study|Withdrawal by Subject|0
2140321|NCT01105377|3747826|FG001|Overall Study|Withdrawal by Subject|1
2140322|NCT01105533|3747832|FG000|Overall Study|Death|0
2140323|NCT01105533|3747833|FG001|Overall Study|Death|0
2140324|NCT01105533|3747834|FG002|Overall Study|Death|0
2140325|NCT01105533|3747835|FG003|Overall Study|Death|0
2140326|NCT01105533|3747836|FG004|Overall Study|Death|1
2140327|NCT01105533|3747837|FG005|Overall Study|Death|0
2140328|NCT01105533|3747838|FG006|Overall Study|Death|0
2140329|NCT01105533|3747839|FG007|Overall Study|Death|0
2140330|NCT01105533|3747840|FG008|Overall Study|Death|0
2140331|NCT01105533|3747832|FG000|Overall Study|Lack of Efficacy|1
2140332|NCT01105533|3747833|FG001|Overall Study|Lack of Efficacy|1
2140333|NCT01105533|3747834|FG002|Overall Study|Lack of Efficacy|3
2140334|NCT01105533|3747835|FG003|Overall Study|Lack of Efficacy|3
2140335|NCT01105533|3747836|FG004|Overall Study|Lack of Efficacy|4
2140336|NCT01105533|3747837|FG005|Overall Study|Lack of Efficacy|5
2140337|NCT01105533|3747838|FG006|Overall Study|Lack of Efficacy|3
2140338|NCT01105533|3747839|FG007|Overall Study|Lack of Efficacy|2
2140339|NCT01105533|3747840|FG008|Overall Study|Lack of Efficacy|9
2140340|NCT01105533|3747832|FG000|Overall Study|Adverse Event|0
2140341|NCT01105533|3747833|FG001|Overall Study|Adverse Event|0
2140342|NCT01105533|3747834|FG002|Overall Study|Adverse Event|0
2140343|NCT01105533|3747835|FG003|Overall Study|Adverse Event|0
2140344|NCT01105533|3747836|FG004|Overall Study|Adverse Event|1
2140345|NCT01105533|3747837|FG005|Overall Study|Adverse Event|2
2140346|NCT01105533|3747838|FG006|Overall Study|Adverse Event|2
2140347|NCT01105533|3747839|FG007|Overall Study|Adverse Event|0
2140348|NCT01105533|3747840|FG008|Overall Study|Adverse Event|1
2140349|NCT01105533|3747832|FG000|Overall Study|Other|0
2140350|NCT01105533|3747833|FG001|Overall Study|Other|0
2140351|NCT01105533|3747834|FG002|Overall Study|Other|0
2140352|NCT01105533|3747835|FG003|Overall Study|Other|0
2140353|NCT01105533|3747836|FG004|Overall Study|Other|1
2140354|NCT01105533|3747837|FG005|Overall Study|Other|0
2140355|NCT01105533|3747838|FG006|Overall Study|Other|3
2140356|NCT01105533|3747839|FG007|Overall Study|Other|1
2140357|NCT01105533|3747840|FG008|Overall Study|Other|2
2140358|NCT01105533|3747832|FG000|Overall Study|Physician Decision|0
2140359|NCT01105533|3747833|FG001|Overall Study|Physician Decision|0
2140360|NCT01105533|3747834|FG002|Overall Study|Physician Decision|0
2140361|NCT01105533|3747835|FG003|Overall Study|Physician Decision|0
2140362|NCT01105533|3747836|FG004|Overall Study|Physician Decision|0
2140363|NCT01105533|3747837|FG005|Overall Study|Physician Decision|0
2140364|NCT01105533|3747838|FG006|Overall Study|Physician Decision|0
2140365|NCT01105533|3747839|FG007|Overall Study|Physician Decision|1
2140366|NCT01105533|3747840|FG008|Overall Study|Physician Decision|0
2140367|NCT01105767|3747885|FG000|Overall Study|Lost to Follow-up|1160
2140368|NCT01105767|3747886|FG001|Overall Study|Lost to Follow-up|1614
2140369|NCT01105767|3747887|FG002|Overall Study|Lost to Follow-up|1184
2140370|NCT01105936|3747895|FG000|Period 1|Adverse Event|0
2140371|NCT01105936|3747896|FG001|Period 1|Adverse Event|0
2140372|NCT01105936|3747897|FG002|Period 1|Adverse Event|0
2140373|NCT01105936|3747898|FG003|Period 1|Adverse Event|1
2140374|NCT01105936|3747895|FG000|Period 2|Adverse Event|1
2140375|NCT01105936|3747896|FG001|Period 2|Adverse Event|0
2140376|NCT01105936|3747897|FG002|Period 2|Adverse Event|0
2140377|NCT01105936|3747898|FG003|Period 2|Adverse Event|0
2140378|NCT01105936|3747895|FG000|Period 3|Protocol Violation|0
2140379|NCT01105936|3747896|FG001|Period 3|Protocol Violation|2
2140380|NCT01105936|3747897|FG002|Period 3|Protocol Violation|0
2140381|NCT01105936|3747898|FG003|Period 3|Protocol Violation|0
2140382|NCT01105975|3747917|FG000|Overall Study|Adverse Event|2
2140383|NCT01105975|3747918|FG001|Overall Study|Adverse Event|1
2140384|NCT01105975|3747919|FG002|Overall Study|Adverse Event|5
2140385|NCT01105975|3747920|FG003|Overall Study|Adverse Event|1
2140386|NCT01105975|3747921|FG004|Overall Study|Adverse Event|0
2140387|NCT01105975|3747922|FG005|Overall Study|Adverse Event|1
2140388|NCT01105975|3747923|FG006|Overall Study|Adverse Event|2
2140389|NCT01105975|3747924|FG007|Overall Study|Adverse Event|4
2140390|NCT01105975|3747925|FG008|Overall Study|Adverse Event|1
2140391|NCT01105975|3747926|FG009|Overall Study|Adverse Event|4
2140392|NCT01105975|3747917|FG000|Overall Study|Withdrawal by Subject|2
2140393|NCT01105975|3747918|FG001|Overall Study|Withdrawal by Subject|2
2140394|NCT01105975|3747919|FG002|Overall Study|Withdrawal by Subject|2
2140395|NCT01105975|3747920|FG003|Overall Study|Withdrawal by Subject|0
2140396|NCT01105975|3747921|FG004|Overall Study|Withdrawal by Subject|4
2140397|NCT01105975|3747922|FG005|Overall Study|Withdrawal by Subject|1
2140398|NCT01105975|3747923|FG006|Overall Study|Withdrawal by Subject|2
2140399|NCT01105975|3747924|FG007|Overall Study|Withdrawal by Subject|1
2140400|NCT01105975|3747925|FG008|Overall Study|Withdrawal by Subject|0
2140401|NCT01105975|3747926|FG009|Overall Study|Withdrawal by Subject|3
2140402|NCT01105975|3747917|FG000|Overall Study|Lost to Follow-up|1
2140403|NCT01105975|3747918|FG001|Overall Study|Lost to Follow-up|0
2140404|NCT01105975|3747919|FG002|Overall Study|Lost to Follow-up|0
2140405|NCT01105975|3747920|FG003|Overall Study|Lost to Follow-up|1
2140406|NCT01105975|3747921|FG004|Overall Study|Lost to Follow-up|1
2140407|NCT01105975|3747922|FG005|Overall Study|Lost to Follow-up|0
2140408|NCT01105975|3747923|FG006|Overall Study|Lost to Follow-up|0
2140409|NCT01105975|3747924|FG007|Overall Study|Lost to Follow-up|0
2140410|NCT01105975|3747925|FG008|Overall Study|Lost to Follow-up|1
2140411|NCT01105975|3747926|FG009|Overall Study|Lost to Follow-up|0
2140412|NCT01105975|3747917|FG000|Overall Study|Physician Decision|0
2140413|NCT01105975|3747918|FG001|Overall Study|Physician Decision|0
2140414|NCT01105975|3747919|FG002|Overall Study|Physician Decision|0
2140415|NCT01105975|3747920|FG003|Overall Study|Physician Decision|0
2140416|NCT01105975|3747921|FG004|Overall Study|Physician Decision|0
2140417|NCT01105975|3747922|FG005|Overall Study|Physician Decision|0
2140418|NCT01105975|3747923|FG006|Overall Study|Physician Decision|2
2140419|NCT01105975|3747924|FG007|Overall Study|Physician Decision|0
2140420|NCT01105975|3747925|FG008|Overall Study|Physician Decision|0
2140421|NCT01105975|3747926|FG009|Overall Study|Physician Decision|0
2140422|NCT01105975|3747917|FG000|Overall Study|Protocol Violation|0
2140423|NCT01105975|3747918|FG001|Overall Study|Protocol Violation|2
2140424|NCT01105975|3747919|FG002|Overall Study|Protocol Violation|2
2140425|NCT01105975|3747920|FG003|Overall Study|Protocol Violation|0
2140426|NCT01105975|3747921|FG004|Overall Study|Protocol Violation|1
2140427|NCT01105975|3747922|FG005|Overall Study|Protocol Violation|1
2140428|NCT01105975|3747923|FG006|Overall Study|Protocol Violation|1
2140429|NCT01105975|3747924|FG007|Overall Study|Protocol Violation|1
2140430|NCT01105975|3747925|FG008|Overall Study|Protocol Violation|2
2207948|NCT01634100|3847122|FG005|Overall Study|Withdrawal by Subject|0
2140431|NCT01105975|3747926|FG009|Overall Study|Protocol Violation|2
2207949|NCT01634113|3847133|FG000|Overall Study|Not treated|0
2207950|NCT01634113|3847134|FG001|Overall Study|Not treated|0
2289047|NCT02472145|3980753|FG000|Overall Study|Other|0
2289048|NCT02472145|3980754|FG001|Overall Study|Other|45
2289049|NCT02472145|3980755|FG002|Overall Study|Other|43
2289050|NCT02472353|3980795|FG000|Overall Study|Lost to Follow-up|1
2289051|NCT02472353|3980796|FG001|Overall Study|Lost to Follow-up|1
2289052|NCT02472353|3980795|FG000|Overall Study|Withdrawal by Subject|2
2289053|NCT02472353|3980796|FG001|Overall Study|Withdrawal by Subject|1
2289054|NCT02472353|3980795|FG000|Overall Study|Study Termination|1
2289055|NCT02472353|3980796|FG001|Overall Study|Study Termination|4
2289056|NCT02472366|3980804|FG000|Overall Study|Lost to Follow-up|1
2289057|NCT02472366|3980805|FG001|Overall Study|Lost to Follow-up|0
2289058|NCT02472405|3980811|FG000|Overall Study|Lost to Follow-up|9
2289059|NCT02472405|3980811|FG000|Overall Study|Adverse Event|1
2289060|NCT02472652|3980837|FG000|Overall Study|Lost to Follow-up|1
2289061|NCT02472756|3980850|FG000|Induction (Approximately 6 Months)|Adverse Event|1
2289062|NCT02472756|3980850|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
2289063|NCT02472756|3980850|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7
2289064|NCT02472756|3980850|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2
2289065|NCT02472756|3980850|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1
2289066|NCT02472795|3980859|FG000|Overall Study|Adverse Event|0
2289067|NCT02472795|3980860|FG001|Overall Study|Adverse Event|1
2289068|NCT02472795|3980861|FG002|Overall Study|Adverse Event|0
2289069|NCT02472795|3980862|FG003|Overall Study|Adverse Event|0
2289070|NCT02472795|3980863|FG004|Overall Study|Adverse Event|2
2289071|NCT02472795|3980859|FG000|Overall Study|Withdrawal by Subject|0
2289072|NCT02472795|3980860|FG001|Overall Study|Withdrawal by Subject|0
2140432|NCT01105975|3747917|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2140433|NCT01105975|3747918|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2207951|NCT01634113|3847135|FG002|Overall Study|Not treated|1
2207952|NCT01634139|3847146|FG000|Overall Study|Non compliant with protocol|1
2207953|NCT01634139|3847147|FG001|Overall Study|Non compliant with protocol|0
2207954|NCT01634139|3847148|FG002|Overall Study|Non compliant with protocol|0
2207955|NCT01634139|3847146|FG000|Overall Study|Consent withdrawn not due to AE|4
2207956|NCT01634139|3847147|FG001|Overall Study|Consent withdrawn not due to AE|3
2140434|NCT01105975|3747919|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2140435|NCT01105975|3747920|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2140436|NCT01105975|3747921|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2140437|NCT01105975|3747922|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2
2140438|NCT01105975|3747923|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2140439|NCT01105975|3747924|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2140440|NCT01105975|3747925|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2
2140441|NCT01105975|3747926|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2140442|NCT01106014|3747969|FG000|Overall Study|Morbidity or Mortality primary endpoint|155
2140443|NCT01106014|3747970|FG001|Overall Study|Morbidity or Mortality primary endpoint|242
2140444|NCT01106014|3747969|FG000|Overall Study|Adverse Event|78
2140445|NCT01106014|3747970|FG001|Overall Study|Adverse Event|42
2140446|NCT01106014|3747969|FG000|Overall Study|Withdrawal by Subject|43
2140447|NCT01106014|3747970|FG001|Overall Study|Withdrawal by Subject|37
2140448|NCT01106014|3747969|FG000|Overall Study|Administrative reason|7
2140449|NCT01106014|3747970|FG001|Overall Study|Administrative reason|6
2140450|NCT01106014|3747969|FG000|Overall Study|Lost to Follow-up|2
2140451|NCT01106014|3747970|FG001|Overall Study|Lost to Follow-up|3
2140452|NCT01106027|3747976|FG000|Overall Study|Lost graft early, discontinued|1
2207957|NCT01634139|3847148|FG002|Overall Study|Consent withdrawn not due to AE|2
2207958|NCT01634139|3847146|FG000|Overall Study|Other|4
2207959|NCT01634139|3847147|FG001|Overall Study|Other|0
2207960|NCT01634139|3847148|FG002|Overall Study|Other|3
2207961|NCT01634139|3847146|FG000|Overall Study|Lost to Follow-up|0
2207962|NCT01634139|3847147|FG001|Overall Study|Lost to Follow-up|2
2207963|NCT01634139|3847148|FG002|Overall Study|Lost to Follow-up|0
2207964|NCT01634139|3847146|FG000|Overall Study|Not treated|1
2207965|NCT01634139|3847147|FG001|Overall Study|Not treated|1
2207966|NCT01634139|3847148|FG002|Overall Study|Not treated|0
2207967|NCT01634152|3847159|FG000|Overall Study|Adverse Event|2
2207968|NCT01634152|3847160|FG001|Overall Study|Adverse Event|0
2207969|NCT01634152|3847161|FG002|Overall Study|Adverse Event|2
2207970|NCT01634152|3847159|FG000|Overall Study|Consent withdrawn not due to AE|1
2207971|NCT01634152|3847160|FG001|Overall Study|Consent withdrawn not due to AE|0
2207972|NCT01634152|3847161|FG002|Overall Study|Consent withdrawn not due to AE|1
2207973|NCT01634152|3847159|FG000|Overall Study|Not treated|0
2207974|NCT01634152|3847160|FG001|Overall Study|Not treated|1
2207975|NCT01634152|3847161|FG002|Overall Study|Not treated|0
2207976|NCT01634152|3847159|FG000|Overall Study|Other reason not defined above|1
2289073|NCT02472795|3980861|FG002|Overall Study|Withdrawal by Subject|0
2289074|NCT02472795|3980862|FG003|Overall Study|Withdrawal by Subject|0
2289075|NCT02472795|3980863|FG004|Overall Study|Withdrawal by Subject|1
2289076|NCT02472847|3980877|FG000|Overall Study|Withdrawal by Subject|1
2289077|NCT02472847|3980878|FG001|Overall Study|Withdrawal by Subject|5
2140453|NCT01106092|3747989|FG000|Overall Study|Withdrawal by Subject|0
2140454|NCT01106092|3747990|FG001|Overall Study|Withdrawal by Subject|0
2140455|NCT01106092|3747991|FG002|Overall Study|Withdrawal by Subject|0
2140456|NCT01106092|3747992|FG003|Overall Study|Withdrawal by Subject|1
2140457|NCT01106157|3748004|FG000|Overall Study|Withdrawal by Subject|1
2140458|NCT01106157|3748005|FG001|Overall Study|Withdrawal by Subject|0
2207977|NCT01634152|3847160|FG001|Overall Study|Other reason not defined above|0
2207978|NCT01634152|3847161|FG002|Overall Study|Other reason not defined above|1
2289078|NCT02472886|3980887|FG000|Overall Study|Lack of Efficacy|0
2289079|NCT02472886|3980888|FG001|Overall Study|Lack of Efficacy|2
2289080|NCT02472886|3980889|FG002|Overall Study|Lack of Efficacy|1
2289081|NCT02472977|3980905|FG000|Overall Study|Disease progression|4
2289082|NCT02472977|3980906|FG001|Overall Study|Disease progression|25
2289083|NCT02472977|3980907|FG002|Overall Study|Disease progression|6
2289084|NCT02472977|3980905|FG000|Overall Study|Withdrawal by Subject|0
2289085|NCT02472977|3980906|FG001|Overall Study|Withdrawal by Subject|1
2289086|NCT02472977|3980907|FG002|Overall Study|Withdrawal by Subject|0
2289087|NCT02472977|3980905|FG000|Overall Study|Study drug toxicity|2
2289088|NCT02472977|3980906|FG001|Overall Study|Study drug toxicity|0
2289089|NCT02472977|3980907|FG002|Overall Study|Study drug toxicity|2
2289090|NCT02472977|3980905|FG000|Overall Study|Subject request to discontinue treatment|0
2289091|NCT02472977|3980906|FG001|Overall Study|Subject request to discontinue treatment|1
2289092|NCT02472977|3980907|FG002|Overall Study|Subject request to discontinue treatment|0
2289093|NCT02473250|3980915|FG000|Overall Study|Lost to Follow-up|10
2289094|NCT02473250|3980915|FG000|Overall Study|Physician Decision|5
2289095|NCT02473250|3980915|FG000|Overall Study|Did not tolerate medication washout|3
2289096|NCT02473250|3980915|FG000|Overall Study|Antidepressant effect of divalproex|2
2289097|NCT02473289|3980922|FG000|Overall Study|Adverse Event|2
2289098|NCT02473289|3980923|FG001|Overall Study|Adverse Event|3
2289099|NCT02473289|3980922|FG000|Overall Study|Lost to Follow-up|1
2289100|NCT02473289|3980923|FG001|Overall Study|Lost to Follow-up|1
2289101|NCT02473289|3980922|FG000|Overall Study|Protocol Violation|0
2289102|NCT02473289|3980923|FG001|Overall Study|Protocol Violation|1
2289103|NCT02473289|3980922|FG000|Overall Study|Withdrawal of consent|6
2289104|NCT02473289|3980923|FG001|Overall Study|Withdrawal of consent|7
2207979|NCT01634165|3847169|FG000|Period 2|Adverse Event|0
2207980|NCT01634165|3847170|FG001|Period 2|Adverse Event|1
2207981|NCT01634165|3847171|FG002|Period 2|Adverse Event|0
2140459|NCT01106248|3748011|FG000|Overall Study|Adverse Event|1
2140460|NCT01106248|3748011|FG000|Overall Study|Administrative|2
2140461|NCT01106287|3748019|FG000|Overall Study|Adverse Event|1
2140462|NCT01106287|3748020|FG001|Overall Study|Adverse Event|0
2140463|NCT01106287|3748021|FG002|Overall Study|Adverse Event|0
2140464|NCT01106287|3748022|FG003|Overall Study|Adverse Event|0
2140465|NCT01106352|3748047|FG000|Overall Study|Subjects untreated|0
2140466|NCT01106352|3748048|FG001|Overall Study|Subjects untreated|0
2140467|NCT01106352|3748049|FG002|Overall Study|Subjects untreated|0
2140468|NCT01106352|3748050|FG003|Overall Study|Subjects untreated|3
2140469|NCT01106352|3748051|FG004|Overall Study|Subjects untreated|4
2140470|NCT01106352|3748047|FG000|Overall Study|Sponsor Decision|1
2140471|NCT01106352|3748048|FG001|Overall Study|Sponsor Decision|0
2140472|NCT01106352|3748049|FG002|Overall Study|Sponsor Decision|0
2140473|NCT01106352|3748050|FG003|Overall Study|Sponsor Decision|0
2140474|NCT01106352|3748051|FG004|Overall Study|Sponsor Decision|0
2140475|NCT01106352|3748047|FG000|Overall Study|Too ill to come in for the visit|0
2140476|NCT01106352|3748048|FG001|Overall Study|Too ill to come in for the visit|0
2140477|NCT01106352|3748049|FG002|Overall Study|Too ill to come in for the visit|1
2140478|NCT01106352|3748050|FG003|Overall Study|Too ill to come in for the visit|0
2140479|NCT01106352|3748051|FG004|Overall Study|Too ill to come in for the visit|0
2140480|NCT01106352|3748047|FG000|Overall Study|Lost to Follow-up|0
2140481|NCT01106352|3748048|FG001|Overall Study|Lost to Follow-up|0
2140482|NCT01106352|3748049|FG002|Overall Study|Lost to Follow-up|0
2140483|NCT01106352|3748050|FG003|Overall Study|Lost to Follow-up|0
2140484|NCT01106352|3748051|FG004|Overall Study|Lost to Follow-up|1
2140485|NCT01106352|3748047|FG000|Overall Study|Death|0
2140486|NCT01106352|3748048|FG001|Overall Study|Death|0
2140487|NCT01106352|3748049|FG002|Overall Study|Death|1
2140488|NCT01106352|3748050|FG003|Overall Study|Death|3
2140489|NCT01106352|3748051|FG004|Overall Study|Death|1
2140490|NCT01106352|3748047|FG000|Overall Study|Disease progression|0
2140491|NCT01106352|3748048|FG001|Overall Study|Disease progression|0
2140492|NCT01106352|3748049|FG002|Overall Study|Disease progression|0
2140493|NCT01106352|3748050|FG003|Overall Study|Disease progression|1
2140494|NCT01106352|3748051|FG004|Overall Study|Disease progression|0
2140495|NCT01106352|3748047|FG000|Overall Study|Withdrawal by Subject|0
2140496|NCT01106352|3748048|FG001|Overall Study|Withdrawal by Subject|0
2140497|NCT01106352|3748049|FG002|Overall Study|Withdrawal by Subject|0
2140498|NCT01106352|3748050|FG003|Overall Study|Withdrawal by Subject|3
2140499|NCT01106352|3748051|FG004|Overall Study|Withdrawal by Subject|2
2140500|NCT01106352|3748047|FG000|Overall Study|Went on hospice|0
2140501|NCT01106352|3748048|FG001|Overall Study|Went on hospice|0
2140502|NCT01106352|3748049|FG002|Overall Study|Went on hospice|0
2140503|NCT01106352|3748050|FG003|Overall Study|Went on hospice|1
2140504|NCT01106352|3748051|FG004|Overall Study|Went on hospice|0
2140505|NCT01106352|3748047|FG000|Overall Study|Subject entered hospice|0
2140506|NCT01106352|3748048|FG001|Overall Study|Subject entered hospice|0
2140507|NCT01106352|3748049|FG002|Overall Study|Subject entered hospice|0
2140508|NCT01106352|3748050|FG003|Overall Study|Subject entered hospice|1
2140509|NCT01106352|3748051|FG004|Overall Study|Subject entered hospice|0
2140510|NCT01106352|3748047|FG000|Overall Study|Home hospice since July 2013|0
2140511|NCT01106352|3748048|FG001|Overall Study|Home hospice since July 2013|0
2140512|NCT01106352|3748049|FG002|Overall Study|Home hospice since July 2013|0
2140513|NCT01106352|3748050|FG003|Overall Study|Home hospice since July 2013|1
2140514|NCT01106352|3748051|FG004|Overall Study|Home hospice since July 2013|0
2140515|NCT01106404|3748073|FG000|Period I (First 6 Weeks)|Adverse Event|2
2140516|NCT01106404|3748074|FG001|Period I (First 6 Weeks)|Adverse Event|0
2140517|NCT01106404|3748073|FG000|Period I (First 6 Weeks)|Physician Decision|1
2140518|NCT01106404|3748074|FG001|Period I (First 6 Weeks)|Physician Decision|0
2140519|NCT01106404|3748073|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0
2140520|NCT01106404|3748074|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1
2140521|NCT01106404|3748073|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0
2140522|NCT01106404|3748074|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1
2140523|NCT01106430|3748088|FG000|Overall Study|Adverse Event|8
2140524|NCT01106430|3748089|FG001|Overall Study|Adverse Event|10
2140525|NCT01106430|3748088|FG000|Overall Study|Lack of Efficacy|2
2140526|NCT01106430|3748089|FG001|Overall Study|Lack of Efficacy|13
2140527|NCT01106430|3748088|FG000|Overall Study|Lost to Follow-up|5
2140528|NCT01106430|3748089|FG001|Overall Study|Lost to Follow-up|1
2140529|NCT01106430|3748088|FG000|Overall Study|Early Termination Requested By Sponsor|1
2140530|NCT01106430|3748089|FG001|Overall Study|Early Termination Requested By Sponsor|0
2140531|NCT01106430|3748088|FG000|Overall Study|Moved Out Of State|0
2140532|NCT01106430|3748089|FG001|Overall Study|Moved Out Of State|1
2140533|NCT01106430|3748088|FG000|Overall Study|Refused To Take Medication|0
2140534|NCT01106430|3748089|FG001|Overall Study|Refused To Take Medication|1
2140535|NCT01106430|3748088|FG000|Overall Study|Noncompliance|0
2140536|NCT01106430|3748089|FG001|Overall Study|Noncompliance|1
2140537|NCT01106430|3748088|FG000|Overall Study|Hard Time Swallowing The Pills|1
2140538|NCT01106430|3748089|FG001|Overall Study|Hard Time Swallowing The Pills|0
2140539|NCT01106430|3748088|FG000|Overall Study|Previous Use Of Marijuana|1
2140540|NCT01106430|3748089|FG001|Overall Study|Previous Use Of Marijuana|0
2140541|NCT01106430|3748088|FG000|Overall Study|Protocol Violation|7
2140542|NCT01106430|3748089|FG001|Overall Study|Protocol Violation|2
2140543|NCT01106430|3748088|FG000|Overall Study|Withdrawal by Subject|8
2140544|NCT01106430|3748089|FG001|Overall Study|Withdrawal by Subject|4
2140545|NCT01106586|3748106|FG000|Overall Study|Adverse Event|9
2140546|NCT01106586|3748107|FG001|Overall Study|Adverse Event|15
2140547|NCT01106586|3748106|FG000|Overall Study|Death|1
2140548|NCT01106586|3748107|FG001|Overall Study|Death|3
2140549|NCT01106586|3748106|FG000|Overall Study|Pregnancy|2
2140550|NCT01106586|3748107|FG001|Overall Study|Pregnancy|2
2140551|NCT01106586|3748106|FG000|Overall Study|Lack of Efficacy|1
2140552|NCT01106586|3748107|FG001|Overall Study|Lack of Efficacy|0
2140553|NCT01106586|3748106|FG000|Overall Study|Investigator's Discretion|5
2140554|NCT01106586|3748107|FG001|Overall Study|Investigator's Discretion|8
2140555|NCT01106586|3748106|FG000|Overall Study|Withdrew Consent|18
2140556|NCT01106586|3748107|FG001|Overall Study|Withdrew Consent|30
2140557|NCT01106586|3748106|FG000|Overall Study|Lost to Follow-up|24
2140558|NCT01106586|3748107|FG001|Overall Study|Lost to Follow-up|20
2140559|NCT01106586|3748106|FG000|Overall Study|Participant Noncompliance|12
2140560|NCT01106586|3748107|FG001|Overall Study|Participant Noncompliance|10
2140561|NCT01106586|3748106|FG000|Overall Study|Protocol Violation|1
2140562|NCT01106586|3748107|FG001|Overall Study|Protocol Violation|0
2140563|NCT01106586|3748106|FG000|Overall Study|Participant Transferred to Another Study|212
2140564|NCT01106586|3748107|FG001|Overall Study|Participant Transferred to Another Study|197
2140565|NCT01106625|3748116|FG000|Core Period: Baseline to Week 26|Adverse Event|6
2140566|NCT01106625|3748117|FG001|Core Period: Baseline to Week 26|Adverse Event|8
2140567|NCT01106625|3748118|FG002|Core Period: Baseline to Week 26|Adverse Event|8
2140568|NCT01106625|3748116|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5
2140569|NCT01106625|3748117|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0
2140570|NCT01106625|3748118|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4
2140571|NCT01106625|3748116|FG000|Core Period: Baseline to Week 26|Physician Decision|1
2140572|NCT01106625|3748117|FG001|Core Period: Baseline to Week 26|Physician Decision|0
2140573|NCT01106625|3748118|FG002|Core Period: Baseline to Week 26|Physician Decision|0
2140574|NCT01106625|3748116|FG000|Core Period: Baseline to Week 26|Protocol Violation|2
2140575|NCT01106625|3748117|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
2140576|NCT01106625|3748118|FG002|Core Period: Baseline to Week 26|Protocol Violation|3
2140577|NCT01106625|3748116|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6
2140578|NCT01106625|3748117|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9
2140579|NCT01106625|3748118|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7
2140580|NCT01106625|3748116|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
2140581|NCT01106625|3748117|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
2140582|NCT01106625|3748118|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2140583|NCT01106625|3748116|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
2140584|NCT01106625|3748117|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
2140585|NCT01106625|3748118|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
2140586|NCT01106625|3748116|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2140587|NCT01106625|3748117|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2140588|NCT01106625|3748118|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2140589|NCT01106625|3748116|FG000|Core Period: Baseline to Week 26|Other|8
2140590|NCT01106625|3748117|FG001|Core Period: Baseline to Week 26|Other|7
2140591|NCT01106625|3748118|FG002|Core Period: Baseline to Week 26|Other|4
2140592|NCT01106625|3748116|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
2140593|NCT01106625|3748117|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2
2140594|NCT01106625|3748118|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3
2140595|NCT01106625|3748116|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
2140596|NCT01106625|3748117|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
2140597|NCT01106625|3748118|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2140598|NCT01106625|3748116|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
2140599|NCT01106625|3748117|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
2140600|NCT01106625|3748118|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1
2140601|NCT01106625|3748116|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
2140602|NCT01106625|3748117|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
2140603|NCT01106625|3748118|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
2140604|NCT01106625|3748116|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
2140605|NCT01106625|3748117|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2140606|NCT01106625|3748118|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2140607|NCT01106625|3748116|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
2140608|NCT01106625|3748117|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
2140609|NCT01106625|3748118|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
2140610|NCT01106625|3748116|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
2140611|NCT01106625|3748117|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
2140612|NCT01106625|3748118|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
2140613|NCT01106625|3748116|FG000|Extension Period: Week 26 to Week 52|Other|5
2140614|NCT01106625|3748117|FG001|Extension Period: Week 26 to Week 52|Other|5
2140615|NCT01106625|3748118|FG002|Extension Period: Week 26 to Week 52|Other|4
2140616|NCT01106651|3748132|FG000|Overall Study|Adverse Event|17
2140617|NCT01106651|3748133|FG001|Overall Study|Adverse Event|9
2140618|NCT01106651|3748134|FG002|Overall Study|Adverse Event|23
2140619|NCT01106651|3748132|FG000|Overall Study|Lost to Follow-up|8
2140620|NCT01106651|3748133|FG001|Overall Study|Lost to Follow-up|2
2140621|NCT01106651|3748134|FG002|Overall Study|Lost to Follow-up|6
2140622|NCT01106651|3748132|FG000|Overall Study|Physician Decision|4
2140623|NCT01106651|3748133|FG001|Overall Study|Physician Decision|3
2140624|NCT01106651|3748134|FG002|Overall Study|Physician Decision|1
2289105|NCT02473289|3980922|FG000|Overall Study|Treatment Unblinded + Adverse event|0
2289106|NCT02473289|3980923|FG001|Overall Study|Treatment Unblinded + Adverse event|1
2289107|NCT02473289|3980922|FG000|Overall Study|Other|2
2289108|NCT02473289|3980923|FG001|Overall Study|Other|0
2289109|NCT02473367|3980929|FG000|Wait 1|Withdrawal by Subject|1
2289110|NCT02473367|3980929|FG000|Period 4|Lost to Follow-up|1
2289111|NCT02473393|3980943|FG000|Overall Study|Adverse Event|0
2289112|NCT02473393|3980944|FG001|Overall Study|Adverse Event|0
2289113|NCT02473393|3980945|FG002|Overall Study|Adverse Event|1
2289114|NCT02473393|3980946|FG003|Overall Study|Adverse Event|0
2140625|NCT01106651|3748132|FG000|Overall Study|Protocol Violation|1
2140626|NCT01106651|3748133|FG001|Overall Study|Protocol Violation|2
2140627|NCT01106651|3748134|FG002|Overall Study|Protocol Violation|1
2140628|NCT01106651|3748132|FG000|Overall Study|Withdrawal by Subject|14
2140629|NCT01106651|3748133|FG001|Overall Study|Withdrawal by Subject|7
2140630|NCT01106651|3748134|FG002|Overall Study|Withdrawal by Subject|4
2140631|NCT01106651|3748132|FG000|Overall Study|Noncompliance with study drug|1
2140632|NCT01106651|3748133|FG001|Overall Study|Noncompliance with study drug|0
2140633|NCT01106651|3748134|FG002|Overall Study|Noncompliance with study drug|2
2140634|NCT01106651|3748132|FG000|Overall Study|Other|34
2140635|NCT01106651|3748133|FG001|Overall Study|Other|31
2140636|NCT01106651|3748134|FG002|Overall Study|Other|21
2140637|NCT01106651|3748132|FG000|Overall Study|Death|0
2140638|NCT01106651|3748133|FG001|Overall Study|Death|3
2140639|NCT01106651|3748134|FG002|Overall Study|Death|0
2140640|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Adverse Event|7
2140641|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Adverse Event|18
2140642|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Adverse Event|6
2140643|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Adverse Event|8
2140644|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Death|0
2140645|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Death|0
2140646|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Death|1
2140647|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Death|0
2140648|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1
2140649|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0
2140650|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0
2140651|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0
2140652|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3
2140653|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
2140654|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6
2140655|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3
2140656|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Physician Decision|2
2140657|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Physician Decision|1
2140658|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Physician Decision|3
2140659|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Physician Decision|1
2140660|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
2140661|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
2140662|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
2140663|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Protocol Violation|3
2140664|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5
2140665|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
2140666|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15
2140667|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6
2140668|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
2140669|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
2140670|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
2140671|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
2140672|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2140673|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3
2140674|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2140675|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2140676|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0
2289115|NCT02473393|3980943|FG000|Overall Study|Withdrawal by Subject|0
2289116|NCT02473393|3980944|FG001|Overall Study|Withdrawal by Subject|0
2140677|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1
2140678|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2
2140679|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0
2140680|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Product quality complaint|0
2140681|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Product quality complaint|1
2140682|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Product quality complaint|1
2140683|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Product quality complaint|0
2140684|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Other|8
2140685|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Other|14
2140686|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Other|8
2140687|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Other|23
2140688|NCT01106677|3748149|FG000|Core Period: Baseline to Week 26|Pregnancy|0
2140689|NCT01106677|3748150|FG001|Core Period: Baseline to Week 26|Pregnancy|1
2140690|NCT01106677|3748151|FG002|Core Period: Baseline to Week 26|Pregnancy|0
2140691|NCT01106677|3748152|FG003|Core Period: Baseline to Week 26|Pregnancy|0
2140692|NCT01106677|3748149|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
2140693|NCT01106677|3748150|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
2140694|NCT01106677|3748151|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5
2140695|NCT01106677|3748152|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9
2140696|NCT01106677|3748149|FG000|Extension Period: Week 26 to Week 52|Death|0
2140697|NCT01106677|3748150|FG001|Extension Period: Week 26 to Week 52|Death|0
2140698|NCT01106677|3748151|FG002|Extension Period: Week 26 to Week 52|Death|0
2140699|NCT01106677|3748152|FG003|Extension Period: Week 26 to Week 52|Death|1
2140700|NCT01106677|3748149|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
2140701|NCT01106677|3748150|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
2140702|NCT01106677|3748151|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
2140703|NCT01106677|3748152|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
2140704|NCT01106677|3748149|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2140705|NCT01106677|3748150|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2140706|NCT01106677|3748151|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2140707|NCT01106677|3748152|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2140708|NCT01106677|3748149|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
2140709|NCT01106677|3748150|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3
2140710|NCT01106677|3748151|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
2140711|NCT01106677|3748152|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3
2140712|NCT01106677|3748149|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
2140713|NCT01106677|3748150|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0
2140714|NCT01106677|3748151|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
2140715|NCT01106677|3748152|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
2140716|NCT01106677|3748149|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2140717|NCT01106677|3748150|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
2140718|NCT01106677|3748151|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
2140719|NCT01106677|3748152|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2140720|NCT01106677|3748149|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
2140721|NCT01106677|3748150|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
2140722|NCT01106677|3748151|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
2140723|NCT01106677|3748152|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
2140724|NCT01106677|3748149|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2140725|NCT01106677|3748150|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2140726|NCT01106677|3748151|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2140727|NCT01106677|3748152|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2140728|NCT01106677|3748149|FG000|Extension Period: Week 26 to Week 52|Other|6
2140729|NCT01106677|3748150|FG001|Extension Period: Week 26 to Week 52|Other|5
2140730|NCT01106677|3748151|FG002|Extension Period: Week 26 to Week 52|Other|8
2140731|NCT01106677|3748152|FG003|Extension Period: Week 26 to Week 52|Other|5
2140732|NCT01106690|3748172|FG000|Core Period: Baseline to Week 26|Adverse Event|6
2140733|NCT01106690|3748173|FG001|Core Period: Baseline to Week 26|Adverse Event|1
2140734|NCT01106690|3748174|FG002|Core Period: Baseline to Week 26|Adverse Event|4
2140735|NCT01106690|3748172|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1
2140736|NCT01106690|3748173|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
2140737|NCT01106690|3748174|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2
2140738|NCT01106690|3748172|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
2140739|NCT01106690|3748173|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
2140740|NCT01106690|3748174|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
2140741|NCT01106690|3748172|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
2140742|NCT01106690|3748173|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1
2140743|NCT01106690|3748174|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0
2140744|NCT01106690|3748172|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
2140745|NCT01106690|3748173|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
2140746|NCT01106690|3748174|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
2140747|NCT01106690|3748172|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2178532|NCT01384734|3803321|FG003|Overall Study|Physician Decision|0
2140748|NCT01106690|3748173|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2140749|NCT01106690|3748174|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2140750|NCT01106690|3748172|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
2140751|NCT01106690|3748173|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2140752|NCT01106690|3748174|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2140753|NCT01106690|3748172|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
2140754|NCT01106690|3748173|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2140755|NCT01106690|3748174|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2140756|NCT01106690|3748172|FG000|Core Period: Baseline to Week 26|Other|10
2140757|NCT01106690|3748173|FG001|Core Period: Baseline to Week 26|Other|2
2140758|NCT01106690|3748174|FG002|Core Period: Baseline to Week 26|Other|6
2140759|NCT01106690|3748172|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
2140760|NCT01106690|3748173|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
2140761|NCT01106690|3748174|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
2140762|NCT01106690|3748172|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2140763|NCT01106690|3748173|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2140764|NCT01106690|3748174|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2140765|NCT01106690|3748172|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
2140766|NCT01106690|3748173|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2
2140767|NCT01106690|3748174|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
2140768|NCT01106690|3748172|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2140769|NCT01106690|3748173|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2140770|NCT01106690|3748174|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
2140771|NCT01106690|3748172|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2140772|NCT01106690|3748173|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2140773|NCT01106690|3748174|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2140774|NCT01106690|3748172|FG000|Extension Period: Week 26 to Week 52|Other|8
2140775|NCT01106690|3748173|FG001|Extension Period: Week 26 to Week 52|Other|3
2140776|NCT01106690|3748174|FG002|Extension Period: Week 26 to Week 52|Other|4
2140777|NCT01106690|3748172|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
2140778|NCT01106690|3748173|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2140779|NCT01106690|3748174|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2140780|NCT01106846|3748196|FG000|Overall Study|Change in surgical procedure|0
2140781|NCT01106846|3748197|FG001|Overall Study|Change in surgical procedure|1
2140782|NCT01106898|3748214|FG000|Overall Study|Adverse Event|6
2178533|NCT01384734|3803322|FG004|Overall Study|Physician Decision|0
2178534|NCT01384760|3803333|FG000|Overall Study|Lost to Follow-up|0
2178535|NCT01384760|3803334|FG001|Overall Study|Lost to Follow-up|6
2178536|NCT01384760|3803333|FG000|Overall Study|Protocol Violation|16
2178537|NCT01384760|3803334|FG001|Overall Study|Protocol Violation|0
2178538|NCT01384877|3803342|FG000|Treatment 2|Lost to Follow-up|2
2178539|NCT01384877|3803343|FG001|Treatment 2|Lost to Follow-up|2
2178540|NCT01385098|3803349|FG000|Overall Study|Adverse Event|10
2178541|NCT01385098|3803349|FG000|Overall Study|Lost to Follow-up|4
2178542|NCT01385202|3803392|FG000|Overall Study|Lost to Follow-up|6
2178543|NCT01385202|3803392|FG000|Overall Study|Not Eligible|11
2178544|NCT01385202|3803392|FG000|Overall Study|Withdrawn|1
2178545|NCT01385371|3803408|FG000|Overall Study|Adverse Event|54
2178546|NCT01385371|3803409|FG001|Overall Study|Adverse Event|19
2178547|NCT01385371|3803408|FG000|Overall Study|Lost to Follow-up|16
2178548|NCT01385371|3803409|FG001|Overall Study|Lost to Follow-up|16
2178549|NCT01385371|3803408|FG000|Overall Study|Withdrawal by Subject|52
2289117|NCT02473393|3980945|FG002|Overall Study|Withdrawal by Subject|1
2289118|NCT02473393|3980946|FG003|Overall Study|Withdrawal by Subject|1
2289119|NCT02473471|3980956|FG000|Overall Study|poor oral hygiene|2
2289120|NCT02473471|3980956|FG000|Overall Study|Lost to Follow-up|1
2289121|NCT02473510|3980968|FG000|Overall Study|Lost to Follow-up|1
2289122|NCT02473510|3980969|FG001|Overall Study|Lost to Follow-up|2
2289123|NCT02473614|3980975|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1
2289124|NCT02473614|3980976|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0
2289125|NCT02473640|3980983|FG000|Treatment Period 1|Adverse Event|1
2289126|NCT02473913|3981011|FG000|Overall Study|Lost to Follow-up|3
2289127|NCT02473913|3981012|FG001|Overall Study|Lost to Follow-up|3
2289128|NCT02473952|3981020|FG000|Overall Study|Adverse Event|2
2289129|NCT02473952|3981021|FG001|Overall Study|Adverse Event|2
2289130|NCT02473952|3981020|FG000|Overall Study|Withdrawal by Subject|0
2289131|NCT02473952|3981021|FG001|Overall Study|Withdrawal by Subject|6
2289132|NCT02473965|3981029|FG000|Overall Study|Adverse Event|6
2289133|NCT02473965|3981030|FG001|Overall Study|Adverse Event|4
2289134|NCT02473965|3981029|FG000|Overall Study|MG worsening|4
2289135|NCT02473965|3981030|FG001|Overall Study|MG worsening|1
2289136|NCT02473965|3981029|FG000|Overall Study|Withdrawal by Subject|2
2289137|NCT02473965|3981030|FG001|Overall Study|Withdrawal by Subject|3
2289138|NCT02473965|3981029|FG000|Overall Study|Physician Decision|0
2289139|NCT02473965|3981030|FG001|Overall Study|Physician Decision|2
2289140|NCT02474069|3981040|FG000|Selection Phase (SP)|Adverse Event|8
2140783|NCT01106911|3748218|FG000|Overall Study|Physician Decision|2
2140784|NCT01106911|3748218|FG000|Overall Study|deemed ineligible after screening|3
2140785|NCT01106976|3748228|FG000|Overall Study|Lost to Follow-up|8
2140786|NCT01107197|3748251|FG000|Overall Study|Death|12
2140787|NCT01107197|3748252|FG001|Overall Study|Death|10
2140788|NCT01107197|3748251|FG000|Overall Study|Lost to Follow-up|5
2140789|NCT01107197|3748252|FG001|Overall Study|Lost to Follow-up|8
2140790|NCT01107197|3748251|FG000|Overall Study|Withdrawal by Subject|3
2140791|NCT01107197|3748252|FG001|Overall Study|Withdrawal by Subject|5
2140792|NCT01107353|3748260|FG000|Overall Study|Positive Drug Screen|1
2140793|NCT01107353|3748261|FG001|Overall Study|Positive Drug Screen|0
2140794|NCT01107379|3748267|FG000|Overall Study|Withdrawal by Subject|18
2140795|NCT01107379|3748267|FG000|Overall Study|Lost to Follow-up|3
2140796|NCT01107392|3748273|FG000|Overall Study|Adverse Event|2
2140797|NCT01107392|3748274|FG001|Overall Study|Adverse Event|0
2140798|NCT01107392|3748273|FG000|Overall Study|Personal Reasons|2
2140799|NCT01107392|3748274|FG001|Overall Study|Personal Reasons|3
2140800|NCT01107392|3748273|FG000|Overall Study|Administrative decision|1
2140801|NCT01107392|3748274|FG001|Overall Study|Administrative decision|0
2140802|NCT01107405|3748285|FG000|Overall Study|Adverse Event|1
2140803|NCT01107405|3748286|FG001|Overall Study|Adverse Event|1
2140804|NCT01107405|3748287|FG002|Overall Study|Adverse Event|0
2140805|NCT01107405|3748288|FG003|Overall Study|Adverse Event|0
2140806|NCT01107405|3748289|FG004|Overall Study|Adverse Event|2
2140807|NCT01107405|3748285|FG000|Overall Study|Withdrawal by Subject|1
2140808|NCT01107405|3748286|FG001|Overall Study|Withdrawal by Subject|0
2140809|NCT01107405|3748287|FG002|Overall Study|Withdrawal by Subject|1
2140810|NCT01107405|3748288|FG003|Overall Study|Withdrawal by Subject|2
2140811|NCT01107405|3748289|FG004|Overall Study|Withdrawal by Subject|1
2140812|NCT01107405|3748285|FG000|Overall Study|Protocol Violation|0
2140813|NCT01107405|3748286|FG001|Overall Study|Protocol Violation|0
2140814|NCT01107405|3748287|FG002|Overall Study|Protocol Violation|1
2140815|NCT01107405|3748288|FG003|Overall Study|Protocol Violation|1
2140816|NCT01107405|3748289|FG004|Overall Study|Protocol Violation|0
2140817|NCT01107418|3748305|FG000|Overall Study|Disease Progression|45
2140818|NCT01107418|3748305|FG000|Overall Study|Adverse Event|3
2140819|NCT01107418|3748305|FG000|Overall Study|Withdrawal by Subject|1
2140820|NCT01107418|3748305|FG000|Overall Study|Study Closing|1
2207982|NCT01634165|3847172|FG003|Period 2|Adverse Event|0
2207983|NCT01634178|3847182|FG000|Treatment Period 1|Adverse Event|0
2140821|NCT01107418|3748305|FG000|Overall Study|Started Other Therapy|1
2140822|NCT01107418|3748305|FG000|Overall Study|Entered Extension Study|1
2140823|NCT01107444|3748322|FG000|Overall Study|Withdrawal by Subject|8
2140824|NCT01107444|3748323|FG001|Overall Study|Withdrawal by Subject|12
2140825|NCT01107444|3748322|FG000|Overall Study|Protocol Entry Criteria Not Met|0
2140826|NCT01107444|3748323|FG001|Overall Study|Protocol Entry Criteria Not Met|1
2140827|NCT01107457|3748337|FG000|Part A|Adverse Event|1
2140828|NCT01107457|3748338|FG001|Part A|Adverse Event|2
2140829|NCT01107457|3748339|FG002|Part A|Adverse Event|1
2140830|NCT01107457|3748340|FG003|Part A|Adverse Event|0
2140831|NCT01107457|3748341|FG004|Part A|Adverse Event|0
2207984|NCT01634178|3847183|FG001|Treatment Period 1|Adverse Event|1
2207985|NCT01634178|3847182|FG000|Treatment Period 2|Adverse Event|1
2207986|NCT01634178|3847183|FG001|Treatment Period 2|Adverse Event|0
2207987|NCT01634243|3847214|FG000|Overall Study|Adverse Event|5
2207988|NCT01634243|3847215|FG001|Overall Study|Adverse Event|5
2289141|NCT02474069|3981041|FG001|Selection Phase (SP)|Adverse Event|0
2289142|NCT02474069|3981042|FG002|Selection Phase (SP)|Adverse Event|0
2289143|NCT02474069|3981040|FG000|Selection Phase (SP)|Lack of Efficacy|1
2289144|NCT02474069|3981041|FG001|Selection Phase (SP)|Lack of Efficacy|0
2289145|NCT02474069|3981042|FG002|Selection Phase (SP)|Lack of Efficacy|0
2289146|NCT02474069|3981040|FG000|Selection Phase (SP)|Lost to Follow-up|4
2289147|NCT02474069|3981041|FG001|Selection Phase (SP)|Lost to Follow-up|0
2289148|NCT02474069|3981042|FG002|Selection Phase (SP)|Lost to Follow-up|0
2289149|NCT02474069|3981040|FG000|Selection Phase (SP)|Physician Decision|1
2289150|NCT02474069|3981041|FG001|Selection Phase (SP)|Physician Decision|0
2289151|NCT02474069|3981042|FG002|Selection Phase (SP)|Physician Decision|0
2289152|NCT02474069|3981040|FG000|Selection Phase (SP)|Protocol Violation|1
2289153|NCT02474069|3981041|FG001|Selection Phase (SP)|Protocol Violation|0
2289154|NCT02474069|3981042|FG002|Selection Phase (SP)|Protocol Violation|0
2289155|NCT02474069|3981040|FG000|Selection Phase (SP)|No longer requires treatment|1
2289156|NCT02474069|3981041|FG001|Selection Phase (SP)|No longer requires treatment|0
2321026|NCT02954354|4035288|FG001|Overall Study|Miscellaneous|2
2140832|NCT01107457|3748342|FG005|Part A|Adverse Event|0
2140833|NCT01107457|3748337|FG000|Part A|Withdrawal by Subject|3
2140834|NCT01107457|3748338|FG001|Part A|Withdrawal by Subject|3
2140835|NCT01107457|3748339|FG002|Part A|Withdrawal by Subject|0
2140836|NCT01107457|3748340|FG003|Part A|Withdrawal by Subject|3
2140837|NCT01107457|3748341|FG004|Part A|Withdrawal by Subject|1
2140838|NCT01107457|3748342|FG005|Part A|Withdrawal by Subject|0
2140839|NCT01107457|3748337|FG000|Part A|Lost to Follow-up|0
2140840|NCT01107457|3748338|FG001|Part A|Lost to Follow-up|1
2140841|NCT01107457|3748339|FG002|Part A|Lost to Follow-up|0
2207989|NCT01634243|3847214|FG000|Overall Study|Lack of Efficacy|1
2207990|NCT01634243|3847215|FG001|Overall Study|Lack of Efficacy|0
2207991|NCT01634360|3847242|FG000|Overall Study|Adverse Event|10
2140842|NCT01107457|3748340|FG003|Part A|Lost to Follow-up|0
2140843|NCT01107457|3748341|FG004|Part A|Lost to Follow-up|0
2140844|NCT01107457|3748342|FG005|Part A|Lost to Follow-up|0
2140845|NCT01107457|3748337|FG000|Part A|Lack of Efficacy|1
2140846|NCT01107457|3748338|FG001|Part A|Lack of Efficacy|0
2140847|NCT01107457|3748339|FG002|Part A|Lack of Efficacy|0
2140848|NCT01107457|3748340|FG003|Part A|Lack of Efficacy|0
2140849|NCT01107457|3748341|FG004|Part A|Lack of Efficacy|0
2140850|NCT01107457|3748342|FG005|Part A|Lack of Efficacy|0
2140851|NCT01107457|3748337|FG000|Part A|Protocol Violation|0
2140852|NCT01107457|3748338|FG001|Part A|Protocol Violation|1
2140853|NCT01107457|3748339|FG002|Part A|Protocol Violation|0
2140854|NCT01107457|3748340|FG003|Part A|Protocol Violation|0
2140855|NCT01107457|3748341|FG004|Part A|Protocol Violation|0
2140856|NCT01107457|3748342|FG005|Part A|Protocol Violation|0
2140857|NCT01107457|3748337|FG000|Part B and C|Adverse Event|0
2140858|NCT01107457|3748338|FG001|Part B and C|Adverse Event|0
2140859|NCT01107457|3748339|FG002|Part B and C|Adverse Event|0
2140860|NCT01107457|3748340|FG003|Part B and C|Adverse Event|0
2140861|NCT01107457|3748341|FG004|Part B and C|Adverse Event|0
2140862|NCT01107457|3748342|FG005|Part B and C|Adverse Event|12
2140863|NCT01107457|3748337|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2140864|NCT01107457|3748338|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2140865|NCT01107457|3748339|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2140866|NCT01107457|3748340|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2140867|NCT01107457|3748341|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2140868|NCT01107457|3748342|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1
2140869|NCT01107457|3748337|FG000|Part B and C|Physician Decision|0
2140870|NCT01107457|3748338|FG001|Part B and C|Physician Decision|0
2140871|NCT01107457|3748339|FG002|Part B and C|Physician Decision|0
2140872|NCT01107457|3748340|FG003|Part B and C|Physician Decision|0
2140873|NCT01107457|3748341|FG004|Part B and C|Physician Decision|0
2140874|NCT01107457|3748342|FG005|Part B and C|Physician Decision|3
2140875|NCT01107457|3748337|FG000|Part B and C|Lack of Efficacy|0
2140876|NCT01107457|3748338|FG001|Part B and C|Lack of Efficacy|0
2140877|NCT01107457|3748339|FG002|Part B and C|Lack of Efficacy|0
2140878|NCT01107457|3748340|FG003|Part B and C|Lack of Efficacy|0
2140879|NCT01107457|3748341|FG004|Part B and C|Lack of Efficacy|0
2140880|NCT01107457|3748342|FG005|Part B and C|Lack of Efficacy|7
2140881|NCT01107457|3748337|FG000|Part B and C|Lost to Follow-up|0
2140882|NCT01107457|3748338|FG001|Part B and C|Lost to Follow-up|0
2140883|NCT01107457|3748339|FG002|Part B and C|Lost to Follow-up|0
2140884|NCT01107457|3748340|FG003|Part B and C|Lost to Follow-up|0
2140885|NCT01107457|3748341|FG004|Part B and C|Lost to Follow-up|0
2140886|NCT01107457|3748342|FG005|Part B and C|Lost to Follow-up|10
2140887|NCT01107457|3748337|FG000|Part B and C|Protocol Violation|0
2140888|NCT01107457|3748338|FG001|Part B and C|Protocol Violation|0
2140889|NCT01107457|3748339|FG002|Part B and C|Protocol Violation|0
2140890|NCT01107457|3748340|FG003|Part B and C|Protocol Violation|0
2140891|NCT01107457|3748341|FG004|Part B and C|Protocol Violation|0
2140892|NCT01107457|3748342|FG005|Part B and C|Protocol Violation|1
2140893|NCT01107457|3748337|FG000|Part B and C|Sponsor Decision|0
2140894|NCT01107457|3748338|FG001|Part B and C|Sponsor Decision|0
2140895|NCT01107457|3748339|FG002|Part B and C|Sponsor Decision|0
2140896|NCT01107457|3748340|FG003|Part B and C|Sponsor Decision|0
2140897|NCT01107457|3748341|FG004|Part B and C|Sponsor Decision|0
2140898|NCT01107457|3748342|FG005|Part B and C|Sponsor Decision|66
2140899|NCT01107457|3748337|FG000|Part B and C|Withdrawal by Subject|0
2140900|NCT01107457|3748338|FG001|Part B and C|Withdrawal by Subject|0
2140901|NCT01107457|3748339|FG002|Part B and C|Withdrawal by Subject|0
2140902|NCT01107457|3748340|FG003|Part B and C|Withdrawal by Subject|0
2140903|NCT01107457|3748341|FG004|Part B and C|Withdrawal by Subject|0
2140904|NCT01107457|3748342|FG005|Part B and C|Withdrawal by Subject|16
2140905|NCT01107457|3748337|FG000|Part B and C|Clinical Relapse|0
2140906|NCT01107457|3748338|FG001|Part B and C|Clinical Relapse|0
2140907|NCT01107457|3748339|FG002|Part B and C|Clinical Relapse|0
2140908|NCT01107457|3748340|FG003|Part B and C|Clinical Relapse|0
2140909|NCT01107457|3748341|FG004|Part B and C|Clinical Relapse|0
2140910|NCT01107457|3748342|FG005|Part B and C|Clinical Relapse|4
2140911|NCT01107535|3748360|FG000|Overall Study|Death|5
2140912|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Lack of Efficacy|167
2140913|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Lack of Efficacy|0
2140914|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Lack of Efficacy|0
2140915|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Lack of Efficacy|0
2140916|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Adverse Event|198
2140917|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Adverse Event|0
2140918|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Adverse Event|0
2140919|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Adverse Event|0
2140920|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Death|62
2140921|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Death|0
2140922|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Death|0
2140923|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Death|0
2140924|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54
2140925|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0
2140926|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0
2140927|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0
2140928|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Complicating disease|13
2140929|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Complicating disease|0
2140930|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Complicating disease|0
2140931|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Complicating disease|0
2140932|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Alternative therapy|12
2140933|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Alternative therapy|0
2140934|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Alternative therapy|0
2140935|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Alternative therapy|0
2140936|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10
2140937|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0
2140938|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0
2140939|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0
2140940|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Non-compliance|4
2140941|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Non-compliance|0
2140942|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Non-compliance|0
2140943|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Non-compliance|0
2140944|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Pain|4
2140945|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Pain|0
2140946|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Pain|0
2140947|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Pain|0
2140948|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Protocol Violation|1
2140949|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Protocol Violation|0
2140950|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Protocol Violation|0
2140951|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Protocol Violation|0
2140952|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Hospice care|1
2140953|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Hospice care|0
2140954|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Hospice care|0
2140955|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Hospice care|0
2140956|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Physician Decision|1
2140957|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Physician Decision|0
2140958|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Physician Decision|0
2140959|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Physician Decision|0
2140960|NCT01107626|3748368|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50
2140961|NCT01107626|3748369|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0
2140962|NCT01107626|3748370|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0
2140963|NCT01107626|3748371|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0
2140964|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0
2140965|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217
2140966|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217
2140967|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170
2140968|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Adverse Event|0
2140969|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Adverse Event|32
2140970|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Adverse Event|29
2140971|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Adverse Event|46
2140972|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Death|0
2140973|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Death|8
2140974|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Death|2
2140975|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Death|13
2140976|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0
2140977|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11
2140978|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21
2140979|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27
2140980|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Alternative therapy|0
2140981|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Alternative therapy|2
2140982|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Alternative therapy|4
2140983|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Alternative therapy|5
2140984|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Other complicating disease|0
2140985|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Other complicating disease|2
2140986|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Other complicating disease|5
2140987|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Other complicating disease|9
2140988|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0
2140989|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2
2140990|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4
2140991|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3
2140992|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0
2140993|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
2140994|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
2140995|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3
2140996|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
2140997|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
2140998|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
2140999|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
2141000|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Financial reason|0
2141001|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Financial reason|2
2141002|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Financial reason|0
2141003|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Financial reason|0
2141004|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Physician Decision|0
2141005|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Physician Decision|2
2141006|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Physician Decision|3
2141007|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Physician Decision|3
2141008|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Hospice care|0
2141009|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Hospice care|1
2141010|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Hospice care|2
2141011|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Hospice care|0
2141012|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Non-compliance|0
2141013|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Non-compliance|0
2141014|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Non-compliance|0
2141015|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Non-compliance|2
2141016|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Pain|0
2141017|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Pain|0
2141018|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Pain|0
2141019|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Pain|1
2141020|NCT01107626|3748368|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0
2141021|NCT01107626|3748369|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4
2141022|NCT01107626|3748370|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4
2141023|NCT01107626|3748371|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10
2141024|NCT01107743|3748399|FG000|Overall Study|Protocol Violation|46
2141025|NCT01107886|3748459|FG000|Overall Study|Lost to Follow-up|15
2141026|NCT01107886|3748460|FG001|Overall Study|Lost to Follow-up|13
2141027|NCT01107886|3748459|FG000|Overall Study|Withdrawal by Subject|180
2141028|NCT01107886|3748460|FG001|Overall Study|Withdrawal by Subject|196
2141029|NCT01107886|3748459|FG000|Overall Study|Administrative withdrawal of consent|7
2141030|NCT01107886|3748460|FG001|Overall Study|Administrative withdrawal of consent|5
2141031|NCT01107899|3748469|FG000|Overall Study|Physician Decision|5
2141032|NCT01107899|3748470|FG001|Overall Study|Physician Decision|0
2141033|NCT01107899|3748471|FG002|Overall Study|Physician Decision|3
2141034|NCT01107899|3748469|FG000|Overall Study|Withdrawal by Subject|0
2141035|NCT01107899|3748470|FG001|Overall Study|Withdrawal by Subject|0
2141036|NCT01107899|3748471|FG002|Overall Study|Withdrawal by Subject|1
2141037|NCT01107912|3748486|FG000|Period 1|Adverse Event|0
2141038|NCT01107912|3748487|FG001|Period 1|Adverse Event|0
2141039|NCT01107912|3748488|FG002|Period 1|Adverse Event|0
2141040|NCT01107912|3748489|FG003|Period 1|Adverse Event|0
2141041|NCT01107912|3748490|FG004|Period 1|Adverse Event|2
2141042|NCT01107912|3748491|FG005|Period 1|Adverse Event|0
2141043|NCT01107912|3748486|FG000|Period 1|Physician Decision|0
2141044|NCT01107912|3748487|FG001|Period 1|Physician Decision|0
2141045|NCT01107912|3748488|FG002|Period 1|Physician Decision|0
2141046|NCT01107912|3748489|FG003|Period 1|Physician Decision|0
2141047|NCT01107912|3748490|FG004|Period 1|Physician Decision|1
2141048|NCT01107912|3748491|FG005|Period 1|Physician Decision|0
2141049|NCT01107912|3748486|FG000|Period 1|Withdrawal by Subject|1
2141050|NCT01107912|3748487|FG001|Period 1|Withdrawal by Subject|0
2141051|NCT01107912|3748488|FG002|Period 1|Withdrawal by Subject|0
2141052|NCT01107912|3748489|FG003|Period 1|Withdrawal by Subject|0
2141053|NCT01107912|3748490|FG004|Period 1|Withdrawal by Subject|0
2141054|NCT01107912|3748491|FG005|Period 1|Withdrawal by Subject|0
2141055|NCT01107912|3748486|FG000|Period 2|Physician Decision|0
2141056|NCT01107912|3748487|FG001|Period 2|Physician Decision|0
2141057|NCT01107912|3748488|FG002|Period 2|Physician Decision|1
2141058|NCT01107912|3748489|FG003|Period 2|Physician Decision|0
2141059|NCT01107912|3748490|FG004|Period 2|Physician Decision|0
2141060|NCT01107912|3748491|FG005|Period 2|Physician Decision|0
2141061|NCT01107912|3748486|FG000|Period 3|Adverse Event|0
2141062|NCT01107912|3748487|FG001|Period 3|Adverse Event|1
2141063|NCT01107912|3748488|FG002|Period 3|Adverse Event|1
2141064|NCT01107912|3748489|FG003|Period 3|Adverse Event|0
2141065|NCT01107912|3748490|FG004|Period 3|Adverse Event|0
2141066|NCT01107912|3748491|FG005|Period 3|Adverse Event|0
2141067|NCT01107912|3748486|FG000|Period 3|Withdrawal by Subject|0
2141068|NCT01107912|3748487|FG001|Period 3|Withdrawal by Subject|0
2141069|NCT01107912|3748488|FG002|Period 3|Withdrawal by Subject|0
2141070|NCT01107912|3748489|FG003|Period 3|Withdrawal by Subject|1
2141071|NCT01107912|3748490|FG004|Period 3|Withdrawal by Subject|0
2141072|NCT01107912|3748491|FG005|Period 3|Withdrawal by Subject|0
2141073|NCT01107925|3748510|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
2141074|NCT01107925|3748511|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2141075|NCT01107925|3748512|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2141076|NCT01107925|3748513|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2141077|NCT01107925|3748514|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
2141078|NCT01107925|3748515|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2141079|NCT01107925|3748510|FG000|Period 2|Withdrawal by Subject|0
2141080|NCT01107925|3748511|FG001|Period 2|Withdrawal by Subject|1
2141081|NCT01107925|3748512|FG002|Period 2|Withdrawal by Subject|0
2141082|NCT01107925|3748513|FG003|Period 2|Withdrawal by Subject|0
2141083|NCT01107925|3748514|FG004|Period 2|Withdrawal by Subject|0
2141084|NCT01107925|3748515|FG005|Period 2|Withdrawal by Subject|1
2141085|NCT01108068|3748563|FG000|Overall Study|5 not started, 1 stop due to side effect|6
2141086|NCT01108068|3748564|FG001|Overall Study|5 not started, 1 stop due to side effect|0
2141087|NCT01108094|3748592|FG000|Overall Study|Adverse Event|2
2141088|NCT01108094|3748593|FG001|Overall Study|Adverse Event|0
2141089|NCT01108094|3748594|FG002|Overall Study|Adverse Event|0
2141090|NCT01108094|3748595|FG003|Overall Study|Adverse Event|0
2141091|NCT01108094|3748592|FG000|Overall Study|Withdrawal by Subject|1
2141092|NCT01108094|3748593|FG001|Overall Study|Withdrawal by Subject|0
2141093|NCT01108094|3748594|FG002|Overall Study|Withdrawal by Subject|0
2141094|NCT01108094|3748595|FG003|Overall Study|Withdrawal by Subject|0
2141095|NCT01108185|3748608|FG000|Overall Study|Non-compliance|15
2141096|NCT01108185|3748608|FG000|Overall Study|Lost to Follow-up|12
2141097|NCT01108237|3748614|FG000|Overall Study|No alignment data|2
2141098|NCT01108237|3748615|FG001|Overall Study|No alignment data|17
2141099|NCT01108237|3748614|FG000|Overall Study|Did not meet criteria for analysis|7
2141100|NCT01108237|3748615|FG001|Overall Study|Did not meet criteria for analysis|0
2141101|NCT01108263|3748623|FG000|Overall Study|Adverse Event|0
2141102|NCT01108263|3748624|FG001|Overall Study|Adverse Event|1
2141103|NCT01108341|3748630|FG000|Overall Study|Death|2
2141104|NCT01108341|3748630|FG000|Overall Study|Withdrawal by Subject|1
2141105|NCT01108341|3748630|FG000|Overall Study|Lost to Follow-up|1
2141106|NCT01108341|3748630|FG000|Overall Study|Other|1
2141107|NCT01108458|3748649|FG000|Overall Study|Withdrawal by Subject|1
2141108|NCT01108510|3748655|FG000|Overall Study|Randomized but Not Treated|5
2141109|NCT01108510|3748656|FG001|Overall Study|Randomized but Not Treated|1
2141110|NCT01108510|3748655|FG000|Overall Study|Joined Another Gilead-sponsored Study|186
2141111|NCT01108510|3748656|FG001|Overall Study|Joined Another Gilead-sponsored Study|195
2141112|NCT01108510|3748655|FG000|Overall Study|Adverse Event|26
2141113|NCT01108510|3748656|FG001|Overall Study|Adverse Event|19
2141114|NCT01108510|3748655|FG000|Overall Study|Lost to Follow-up|20
2141115|NCT01108510|3748656|FG001|Overall Study|Lost to Follow-up|17
2141116|NCT01108510|3748655|FG000|Overall Study|Withdrew Consent|21
2141117|NCT01108510|3748656|FG001|Overall Study|Withdrew Consent|15
2141118|NCT01108510|3748655|FG000|Overall Study|Investigator's Discretion|12
2141119|NCT01108510|3748656|FG001|Overall Study|Investigator's Discretion|10
2141120|NCT01108510|3748655|FG000|Overall Study|Participant Noncompliance|5
2141121|NCT01108510|3748656|FG001|Overall Study|Participant Noncompliance|7
2141122|NCT01108510|3748655|FG000|Overall Study|Lack of Efficacy|3
2141123|NCT01108510|3748656|FG001|Overall Study|Lack of Efficacy|0
2141124|NCT01108510|3748655|FG000|Overall Study|Pregnancy|0
2141125|NCT01108510|3748656|FG001|Overall Study|Pregnancy|3
2141126|NCT01108510|3748655|FG000|Overall Study|Death|1
2141127|NCT01108510|3748656|FG001|Overall Study|Death|1
2141128|NCT01108718|3748664|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1
2141129|NCT01108718|3748665|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0
2141130|NCT01108731|3748672|FG000|Overall Study|Withdrawal by Subject|1
2141131|NCT01108731|3748673|FG001|Overall Study|Withdrawal by Subject|1
2141132|NCT01108731|3748672|FG000|Overall Study|Adverse Event|3
2141133|NCT01108731|3748673|FG001|Overall Study|Adverse Event|3
2141134|NCT01108796|3748692|FG000|Overall Study|Adverse Event|0
2141135|NCT01108796|3748693|FG001|Overall Study|Adverse Event|1
2141136|NCT01108796|3748692|FG000|Overall Study|Lost to Follow-up|7
2141137|NCT01108796|3748693|FG001|Overall Study|Lost to Follow-up|6
2141138|NCT01108809|3748701|FG000|Overall Study|Adverse Event|3
2141139|NCT01108809|3748701|FG000|Overall Study|Lost to Follow-up|1
2141140|NCT01109173|3748756|FG000|Overall Study|Adverse Event|15
2141141|NCT01109173|3748757|FG001|Overall Study|Adverse Event|17
2141142|NCT01109173|3748758|FG002|Overall Study|Adverse Event|9
2141143|NCT01109173|3748759|FG003|Overall Study|Adverse Event|6
2141144|NCT01109173|3748756|FG000|Overall Study|Lost to Follow-up|0
2141145|NCT01109173|3748757|FG001|Overall Study|Lost to Follow-up|1
2141146|NCT01109173|3748758|FG002|Overall Study|Lost to Follow-up|0
2141147|NCT01109173|3748759|FG003|Overall Study|Lost to Follow-up|0
2141148|NCT01109173|3748756|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
2141149|NCT01109173|3748757|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
2141150|NCT01109173|3748758|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
2141151|NCT01109173|3748759|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
2141152|NCT01109173|3748756|FG000|Overall Study|Noncompliance|0
2141153|NCT01109173|3748757|FG001|Overall Study|Noncompliance|1
2141154|NCT01109173|3748758|FG002|Overall Study|Noncompliance|0
2141155|NCT01109173|3748759|FG003|Overall Study|Noncompliance|0
2141156|NCT01109173|3748756|FG000|Overall Study|Treatment Failure|25
2141157|NCT01109173|3748757|FG001|Overall Study|Treatment Failure|32
2141158|NCT01109173|3748758|FG002|Overall Study|Treatment Failure|69
2141159|NCT01109173|3748759|FG003|Overall Study|Treatment Failure|64
2141160|NCT01109173|3748756|FG000|Overall Study|Protocol Violation|4
2141161|NCT01109173|3748757|FG001|Overall Study|Protocol Violation|5
2141162|NCT01109173|3748758|FG002|Overall Study|Protocol Violation|1
2141163|NCT01109173|3748759|FG003|Overall Study|Protocol Violation|2
2141164|NCT01109173|3748756|FG000|Overall Study|Patient Did Not Use Study Medication|34
2141165|NCT01109173|3748757|FG001|Overall Study|Patient Did Not Use Study Medication|26
2141166|NCT01109173|3748758|FG002|Overall Study|Patient Did Not Use Study Medication|11
2141167|NCT01109173|3748759|FG003|Overall Study|Patient Did Not Use Study Medication|7
2141168|NCT01109173|3748756|FG000|Overall Study|Not Specifiied|5
2141169|NCT01109173|3748757|FG001|Overall Study|Not Specifiied|4
2141170|NCT01109173|3748758|FG002|Overall Study|Not Specifiied|9
2141171|NCT01109173|3748759|FG003|Overall Study|Not Specifiied|14
2141172|NCT01109316|3748775|FG000|Study Period 1|Adverse Event|0
2141173|NCT01109316|3748776|FG001|Study Period 1|Adverse Event|0
2141174|NCT01109316|3748777|FG002|Study Period 1|Adverse Event|1
2141175|NCT01109316|3748778|FG003|Study Period 1|Adverse Event|0
2141176|NCT01109316|3748779|FG004|Study Period 1|Adverse Event|0
2141177|NCT01109316|3748780|FG005|Study Period 1|Adverse Event|0
2141178|NCT01109316|3748775|FG000|Study Period 1|Lost to Follow-up|0
2141179|NCT01109316|3748776|FG001|Study Period 1|Lost to Follow-up|0
2141180|NCT01109316|3748777|FG002|Study Period 1|Lost to Follow-up|1
2141181|NCT01109316|3748778|FG003|Study Period 1|Lost to Follow-up|1
2141182|NCT01109316|3748779|FG004|Study Period 1|Lost to Follow-up|0
2141183|NCT01109316|3748780|FG005|Study Period 1|Lost to Follow-up|0
2141184|NCT01109316|3748775|FG000|Study Period 1|Withdrawal by Subject|0
2141185|NCT01109316|3748776|FG001|Study Period 1|Withdrawal by Subject|0
2141186|NCT01109316|3748777|FG002|Study Period 1|Withdrawal by Subject|1
2289157|NCT02474069|3981042|FG002|Selection Phase (SP)|No longer requires treatment|0
2289158|NCT02474069|3981040|FG000|Selection Phase (SP)|Technical Problem|1
2141187|NCT01109316|3748778|FG003|Study Period 1|Withdrawal by Subject|0
2141188|NCT01109316|3748779|FG004|Study Period 1|Withdrawal by Subject|2
2141189|NCT01109316|3748780|FG005|Study Period 1|Withdrawal by Subject|0
2141190|NCT01109316|3748775|FG000|Study Period 1|Sponsor Decision|0
2141191|NCT01109316|3748776|FG001|Study Period 1|Sponsor Decision|0
2141192|NCT01109316|3748777|FG002|Study Period 1|Sponsor Decision|0
2141193|NCT01109316|3748778|FG003|Study Period 1|Sponsor Decision|0
2141194|NCT01109316|3748779|FG004|Study Period 1|Sponsor Decision|0
2141195|NCT01109316|3748780|FG005|Study Period 1|Sponsor Decision|2
2141196|NCT01109316|3748775|FG000|Study Period 2|Entry Criteria Not Met|0
2141197|NCT01109316|3748776|FG001|Study Period 2|Entry Criteria Not Met|1
2141198|NCT01109316|3748777|FG002|Study Period 2|Entry Criteria Not Met|0
2141199|NCT01109316|3748778|FG003|Study Period 2|Entry Criteria Not Met|0
2141200|NCT01109316|3748779|FG004|Study Period 2|Entry Criteria Not Met|0
2141201|NCT01109316|3748780|FG005|Study Period 2|Entry Criteria Not Met|0
2141202|NCT01109316|3748775|FG000|Study Period 2|Physician Decision|0
2141203|NCT01109316|3748776|FG001|Study Period 2|Physician Decision|0
2141204|NCT01109316|3748777|FG002|Study Period 2|Physician Decision|0
2141205|NCT01109316|3748778|FG003|Study Period 2|Physician Decision|1
2141206|NCT01109316|3748779|FG004|Study Period 2|Physician Decision|0
2141207|NCT01109316|3748780|FG005|Study Period 2|Physician Decision|0
2141208|NCT01109316|3748775|FG000|Study Period 2|Protocol Violation|1
2141209|NCT01109316|3748776|FG001|Study Period 2|Protocol Violation|0
2141210|NCT01109316|3748777|FG002|Study Period 2|Protocol Violation|0
2141211|NCT01109316|3748778|FG003|Study Period 2|Protocol Violation|0
2141212|NCT01109316|3748779|FG004|Study Period 2|Protocol Violation|0
2141213|NCT01109316|3748780|FG005|Study Period 2|Protocol Violation|0
2141214|NCT01109316|3748775|FG000|Study Period 2|Withdrawal by Subject|0
2141215|NCT01109316|3748776|FG001|Study Period 2|Withdrawal by Subject|0
2141216|NCT01109316|3748777|FG002|Study Period 2|Withdrawal by Subject|1
2141217|NCT01109316|3748778|FG003|Study Period 2|Withdrawal by Subject|0
2141218|NCT01109316|3748779|FG004|Study Period 2|Withdrawal by Subject|0
2141219|NCT01109316|3748780|FG005|Study Period 2|Withdrawal by Subject|1
2141220|NCT01109316|3748775|FG000|Study Period 3|Lost to Follow-up|0
2141221|NCT01109316|3748776|FG001|Study Period 3|Lost to Follow-up|0
2141222|NCT01109316|3748777|FG002|Study Period 3|Lost to Follow-up|0
2141223|NCT01109316|3748778|FG003|Study Period 3|Lost to Follow-up|0
2141224|NCT01109316|3748779|FG004|Study Period 3|Lost to Follow-up|1
2141225|NCT01109316|3748780|FG005|Study Period 3|Lost to Follow-up|0
2141226|NCT01109316|3748775|FG000|Study Period 3|Withdrawal by Subject|1
2141227|NCT01109316|3748776|FG001|Study Period 3|Withdrawal by Subject|0
2141228|NCT01109316|3748777|FG002|Study Period 3|Withdrawal by Subject|0
2141229|NCT01109316|3748778|FG003|Study Period 3|Withdrawal by Subject|0
2141230|NCT01109316|3748779|FG004|Study Period 3|Withdrawal by Subject|1
2141231|NCT01109316|3748780|FG005|Study Period 3|Withdrawal by Subject|0
2141232|NCT01109524|3748794|FG000|Overall Study|Disease Progression|29
2141233|NCT01109524|3748794|FG000|Overall Study|Study Drug toxicity|6
2141234|NCT01109524|3748794|FG000|Overall Study|Adverse Event|4
2141235|NCT01109524|3748794|FG000|Overall Study|Withdrawal by Subject|2
2141236|NCT01109524|3748794|FG000|Overall Study|Maximum clinical benefit|3
2141237|NCT01109524|3748794|FG000|Overall Study|Death|2
2141238|NCT01109524|3748794|FG000|Overall Study|No longer meets criteria|2
2141239|NCT01109524|3748794|FG000|Overall Study|Participant requested to end treatment|4
2141240|NCT01109524|3748794|FG000|Overall Study|Other|5
2141241|NCT01109849|3748816|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
2141242|NCT01109849|3748817|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
2141243|NCT01109849|3748818|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
2141244|NCT01109849|3748819|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
2141245|NCT01109849|3748820|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
2141246|NCT01109849|3748816|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1
2141247|NCT01109849|3748817|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0
2178550|NCT01385371|3803409|FG001|Overall Study|Withdrawal by Subject|39
2141248|NCT01109849|3748818|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0
2141249|NCT01109849|3748819|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0
2141250|NCT01109849|3748820|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0
2141251|NCT01109849|3748816|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
2141252|NCT01109849|3748817|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
2141253|NCT01109849|3748818|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
2141254|NCT01109849|3748819|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
2141255|NCT01109849|3748820|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
2141256|NCT01109849|3748816|FG000|Initial Randomization: ADHD Treatment|move away|2
2141257|NCT01109849|3748817|FG001|Initial Randomization: ADHD Treatment|move away|7
2141258|NCT01109849|3748818|FG002|Initial Randomization: ADHD Treatment|move away|0
2141259|NCT01109849|3748819|FG003|Initial Randomization: ADHD Treatment|move away|0
2141260|NCT01109849|3748820|FG004|Initial Randomization: ADHD Treatment|move away|0
2141261|NCT01109849|3748816|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
2141262|NCT01109849|3748817|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
2141263|NCT01109849|3748818|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
2141264|NCT01109849|3748819|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
2141265|NCT01109849|3748820|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
2141266|NCT01109849|3748816|FG000|Adaptive Randomization: Weight Recovery|moved away|0
2141267|NCT01109849|3748817|FG001|Adaptive Randomization: Weight Recovery|moved away|0
2141268|NCT01109849|3748818|FG002|Adaptive Randomization: Weight Recovery|moved away|0
2141269|NCT01109849|3748819|FG003|Adaptive Randomization: Weight Recovery|moved away|2
2141270|NCT01109849|3748820|FG004|Adaptive Randomization: Weight Recovery|moved away|0
2141271|NCT01109940|3748844|FG000|Overall Study|Administrative problems|2
2141272|NCT01109940|3748845|FG001|Overall Study|Administrative problems|0
2141273|NCT01109940|3748846|FG002|Overall Study|Administrative problems|0
2141274|NCT01109940|3748847|FG003|Overall Study|Administrative problems|0
2141275|NCT01109940|3748844|FG000|Overall Study|Serious Adverse Event|2
2141276|NCT01109940|3748845|FG001|Overall Study|Serious Adverse Event|1
2141277|NCT01109940|3748846|FG002|Overall Study|Serious Adverse Event|0
2141278|NCT01109940|3748847|FG003|Overall Study|Serious Adverse Event|0
2141279|NCT01109940|3748844|FG000|Overall Study|Lost to Follow-up|1
2141280|NCT01109940|3748845|FG001|Overall Study|Lost to Follow-up|0
2141281|NCT01109940|3748846|FG002|Overall Study|Lost to Follow-up|0
2141282|NCT01109940|3748847|FG003|Overall Study|Lost to Follow-up|0
2141283|NCT01109940|3748844|FG000|Overall Study|Patient withdrew consent|1
2141284|NCT01109940|3748845|FG001|Overall Study|Patient withdrew consent|1
2141285|NCT01109940|3748846|FG002|Overall Study|Patient withdrew consent|0
2141286|NCT01109940|3748847|FG003|Overall Study|Patient withdrew consent|0
2141287|NCT01109940|3748844|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2141288|NCT01109940|3748845|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2141289|NCT01109940|3748846|FG002|Overall Study|Unsatisfactory therapeutic effect|1
2141290|NCT01109940|3748847|FG003|Overall Study|Unsatisfactory therapeutic effect|0
2141291|NCT01109979|3748859|FG000|Overall Study|Physician Decision|2
2141292|NCT01109979|3748860|FG001|Overall Study|Physician Decision|0
2141293|NCT01109979|3748859|FG000|Overall Study|Withdrawal by Subject|0
2141294|NCT01109979|3748860|FG001|Overall Study|Withdrawal by Subject|1
2141295|NCT01109992|3748868|FG000|Overall Study|Withdrawal by Subject|0
2141296|NCT01109992|3748869|FG001|Overall Study|Withdrawal by Subject|1
2141297|NCT01109992|3748868|FG000|Overall Study|Movement during rest scan.|0
2141298|NCT01109992|3748869|FG001|Overall Study|Movement during rest scan.|1
2141299|NCT01110005|3748880|FG000|Overall Study|ineligible|1
2141300|NCT01110005|3748881|FG001|Overall Study|ineligible|2
2141301|NCT01110005|3748880|FG000|Overall Study|missing consent|3
2141302|NCT01110005|3748881|FG001|Overall Study|missing consent|2
2141303|NCT01110005|3748880|FG000|Overall Study|Withdrawal by Subject|0
2141304|NCT01110005|3748881|FG001|Overall Study|Withdrawal by Subject|1
2141305|NCT01110200|3748904|FG000|Overall Study|Adverse Event|28
2141306|NCT01110200|3748905|FG001|Overall Study|Adverse Event|28
2141307|NCT01110200|3748904|FG000|Overall Study|Withdrawal by Subject|25
2141308|NCT01110200|3748905|FG001|Overall Study|Withdrawal by Subject|32
2141309|NCT01110200|3748904|FG000|Overall Study|Lack of Efficacy|16
2141310|NCT01110200|3748905|FG001|Overall Study|Lack of Efficacy|25
2141311|NCT01110200|3748904|FG000|Overall Study|Protocol Violation|14
2141312|NCT01110200|3748905|FG001|Overall Study|Protocol Violation|12
2141313|NCT01110200|3748904|FG000|Overall Study|Physician Decision|13
2141314|NCT01110200|3748905|FG001|Overall Study|Physician Decision|17
2141315|NCT01110200|3748904|FG000|Overall Study|Lost to Follow-up|10
2141316|NCT01110200|3748905|FG001|Overall Study|Lost to Follow-up|7
2141317|NCT01110239|3748915|FG000|Sham Preconditioning|Withdrawal by Subject|0
2141318|NCT01110239|3748916|FG001|Sham Preconditioning|Withdrawal by Subject|0
2141319|NCT01110239|3748917|FG002|Sham Preconditioning|Withdrawal by Subject|1
2141320|NCT01110239|3748918|FG003|Sham Preconditioning|Withdrawal by Subject|0
2141321|NCT01110239|3748915|FG000|7.5 Min Ischemia|Withdrawal by Subject|0
2141322|NCT01110239|3748916|FG001|7.5 Min Ischemia|Withdrawal by Subject|0
2141323|NCT01110239|3748917|FG002|7.5 Min Ischemia|Withdrawal by Subject|1
2141324|NCT01110239|3748918|FG003|7.5 Min Ischemia|Withdrawal by Subject|0
2141325|NCT01110330|3748937|FG000|Overall Study|Adverse Event|0
2141326|NCT01110330|3748938|FG001|Overall Study|Adverse Event|4
2141327|NCT01110330|3748939|FG002|Overall Study|Adverse Event|3
2141328|NCT01110330|3748937|FG000|Overall Study|Lack of Efficacy|3
2141329|NCT01110330|3748938|FG001|Overall Study|Lack of Efficacy|1
2141330|NCT01110330|3748939|FG002|Overall Study|Lack of Efficacy|1
2141331|NCT01110330|3748937|FG000|Overall Study|Lost to Follow-up|9
2141332|NCT01110330|3748938|FG001|Overall Study|Lost to Follow-up|10
2141333|NCT01110330|3748939|FG002|Overall Study|Lost to Follow-up|15
2141334|NCT01110330|3748937|FG000|Overall Study|Physician Decision|0
2141335|NCT01110330|3748938|FG001|Overall Study|Physician Decision|1
2141336|NCT01110330|3748939|FG002|Overall Study|Physician Decision|0
2141337|NCT01110330|3748937|FG000|Overall Study|Protocol Violation|2
2141338|NCT01110330|3748938|FG001|Overall Study|Protocol Violation|0
2141339|NCT01110330|3748939|FG002|Overall Study|Protocol Violation|4
2141340|NCT01110330|3748937|FG000|Overall Study|Withdrawal by Subject|0
2141341|NCT01110330|3748938|FG001|Overall Study|Withdrawal by Subject|6
2141342|NCT01110330|3748939|FG002|Overall Study|Withdrawal by Subject|2
2141343|NCT01110330|3748937|FG000|Overall Study|Other|1
2141344|NCT01110330|3748938|FG001|Overall Study|Other|1
2141345|NCT01110330|3748939|FG002|Overall Study|Other|1
2178551|NCT01385371|3803408|FG000|Overall Study|Protocol Violation|25
2178552|NCT01385371|3803409|FG001|Overall Study|Protocol Violation|21
2178553|NCT01385371|3803408|FG000|Overall Study|Administrative|2
2178554|NCT01385371|3803409|FG001|Overall Study|Administrative|2
2178555|NCT01385566|3803421|FG000|Overall Study|Lost to Follow-up|1
2178556|NCT01385566|3803422|FG001|Overall Study|Lost to Follow-up|0
2178557|NCT01385566|3803423|FG002|Overall Study|Lost to Follow-up|0
2178558|NCT01385566|3803424|FG003|Overall Study|Lost to Follow-up|0
2178559|NCT01385566|3803425|FG004|Overall Study|Lost to Follow-up|0
2178560|NCT01385566|3803426|FG005|Overall Study|Lost to Follow-up|0
2178561|NCT01385566|3803421|FG000|Overall Study|Withdrawal by Subject|0
2178562|NCT01385566|3803422|FG001|Overall Study|Withdrawal by Subject|0
2178563|NCT01385566|3803423|FG002|Overall Study|Withdrawal by Subject|0
2178564|NCT01385566|3803424|FG003|Overall Study|Withdrawal by Subject|1
2178565|NCT01385566|3803425|FG004|Overall Study|Withdrawal by Subject|0
2178566|NCT01385566|3803426|FG005|Overall Study|Withdrawal by Subject|0
2178567|NCT01385748|3803471|FG000|Overall Study|Withdrawal by Subject|7
2178568|NCT01385748|3803472|FG001|Overall Study|Withdrawal by Subject|4
2178569|NCT01385748|3803473|FG002|Overall Study|Withdrawal by Subject|5
2178570|NCT01385748|3803471|FG000|Overall Study|Noncompliance|3
2178571|NCT01385748|3803472|FG001|Overall Study|Noncompliance|1
2178572|NCT01385748|3803473|FG002|Overall Study|Noncompliance|6
2178573|NCT01385748|3803471|FG000|Overall Study|Other|1
2178574|NCT01385748|3803472|FG001|Overall Study|Other|7
2178575|NCT01385748|3803473|FG002|Overall Study|Other|1
2178576|NCT01385748|3803471|FG000|Overall Study|Adverse Event|4
2178577|NCT01385748|3803472|FG001|Overall Study|Adverse Event|2
2178578|NCT01385748|3803473|FG002|Overall Study|Adverse Event|1
2178579|NCT01385995|3803487|FG000|Period 1, 2 Months|Physician Decision|1
2178580|NCT01385995|3803488|FG001|Period 1, 2 Months|Physician Decision|0
2178581|NCT01386008|3803496|FG000|Overall Study|exited w/o incident /study discontinued|17
2178582|NCT01386008|3803496|FG000|Overall Study|Adverse Event|3
2178583|NCT01386554|3803507|FG000|Overall Study|Lost to Follow-up|0
2178584|NCT01386554|3803508|FG001|Overall Study|Lost to Follow-up|0
2178585|NCT01386554|3803509|FG002|Overall Study|Lost to Follow-up|1
2178586|NCT01386554|3803507|FG000|Overall Study|Adverse Event|2
2178587|NCT01386554|3803508|FG001|Overall Study|Adverse Event|5
2178588|NCT01386554|3803509|FG002|Overall Study|Adverse Event|2
2178589|NCT01386554|3803507|FG000|Overall Study|Progressive disease|1
2178590|NCT01386554|3803508|FG001|Overall Study|Progressive disease|2
2178591|NCT01386554|3803509|FG002|Overall Study|Progressive disease|2
2178592|NCT01386554|3803507|FG000|Overall Study|Administration of live vaccines|0
2178593|NCT01386554|3803508|FG001|Overall Study|Administration of live vaccines|1
2178594|NCT01386554|3803509|FG002|Overall Study|Administration of live vaccines|0
2178595|NCT01386554|3803507|FG000|Overall Study|Investigator discretion|0
2178596|NCT01386554|3803508|FG001|Overall Study|Investigator discretion|0
2178597|NCT01386554|3803509|FG002|Overall Study|Investigator discretion|1
2178598|NCT01386554|3803507|FG000|Overall Study|Reason not collected|0
2178599|NCT01386554|3803508|FG001|Overall Study|Reason not collected|1
2178600|NCT01386554|3803509|FG002|Overall Study|Reason not collected|0
2178601|NCT01386606|3803523|FG000|Overall Study|Adverse Event|0
2178602|NCT01386606|3803524|FG001|Overall Study|Adverse Event|1
2178603|NCT01386606|3803525|FG002|Overall Study|Adverse Event|0
2178604|NCT01386606|3803526|FG003|Overall Study|Adverse Event|0
2289159|NCT02474069|3981041|FG001|Selection Phase (SP)|Technical Problem|0
2289160|NCT02474069|3981042|FG002|Selection Phase (SP)|Technical Problem|0
2289161|NCT02474069|3981040|FG000|Selection Phase (SP)|Withdrawal by Subject|3
2289162|NCT02474069|3981041|FG001|Selection Phase (SP)|Withdrawal by Subject|0
2289163|NCT02474069|3981042|FG002|Selection Phase (SP)|Withdrawal by Subject|0
2289164|NCT02474069|3981040|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3
2321027|NCT02954354|4035289|FG002|Overall Study|Miscellaneous|1
2178605|NCT01386606|3803523|FG000|Overall Study|Withdrawal by Subject|0
2178606|NCT01386606|3803524|FG001|Overall Study|Withdrawal by Subject|1
2178607|NCT01386606|3803525|FG002|Overall Study|Withdrawal by Subject|1
2178608|NCT01386606|3803526|FG003|Overall Study|Withdrawal by Subject|0
2178609|NCT01386606|3803523|FG000|Overall Study|Protocol Violation|1
2141346|NCT01110382|3748949|FG000|Overall Study|Withdrawal by Subject|0
2141347|NCT01110382|3748950|FG001|Overall Study|Withdrawal by Subject|1
2141348|NCT01110382|3748949|FG000|Overall Study|Protocol Violation|0
2141349|NCT01110382|3748950|FG001|Overall Study|Protocol Violation|1
2141350|NCT01110408|3748962|FG000|Overall Study|Protocol Violation|1
2141351|NCT01110408|3748963|FG001|Overall Study|Protocol Violation|0
2141352|NCT01110707|3749028|FG000|Overall Study|Protocol Violation|0
2141353|NCT01110707|3749029|FG001|Overall Study|Protocol Violation|3
2141354|NCT01110915|3749048|FG000|Overall Study|Death|2
2141355|NCT01110915|3749049|FG001|Overall Study|Death|1
2141356|NCT01110915|3749048|FG000|Overall Study|Lost to Follow-up|1
2141357|NCT01110915|3749049|FG001|Overall Study|Lost to Follow-up|0
2141358|NCT01110915|3749048|FG000|Overall Study|Withdrawal by Subject|7
2141359|NCT01110915|3749049|FG001|Overall Study|Withdrawal by Subject|1
2141360|NCT01111123|3749080|FG000|Open- Label Phase|Failed to be clear or almost cleared|14
2141361|NCT01111123|3749081|FG001|Open- Label Phase|Failed to be clear or almost cleared|0
2141362|NCT01111123|3749080|FG000|Maintenance Phase|Lost to Follow-up|0
2141363|NCT01111123|3749081|FG001|Maintenance Phase|Lost to Follow-up|2
2141364|NCT01111149|3749092|FG000|Overall Study|Protocol Violation|1
2141365|NCT01111149|3749093|FG001|Overall Study|Protocol Violation|1
2141366|NCT01111149|3749094|FG002|Overall Study|Protocol Violation|2
2141367|NCT01111149|3749092|FG000|Overall Study|Withdrawal by Subject|1
2141368|NCT01111149|3749093|FG001|Overall Study|Withdrawal by Subject|0
2141369|NCT01111149|3749094|FG002|Overall Study|Withdrawal by Subject|2
2141370|NCT01111240|3749107|FG000|Overall Study|Adverse Event|190
2141371|NCT01111240|3749107|FG000|Overall Study|Lack of Efficacy|545
2141372|NCT01111240|3749107|FG000|Overall Study|Lack of Efficacy and Adverse Event|19
2141373|NCT01111240|3749107|FG000|Overall Study|Other|312
2141374|NCT01111292|3749113|FG000|Treatment|Physician Decision|1
2141375|NCT01111292|3749114|FG001|Treatment|Physician Decision|1
2141376|NCT01111461|3749152|FG000|Overall Study|Adverse Event|32
2141377|NCT01111461|3749152|FG000|Overall Study|Participant choice|11
2141378|NCT01111461|3749152|FG000|Overall Study|Lost to Follow-up|1
2141379|NCT01111461|3749152|FG000|Overall Study|Withdrawal by Subject|1
2141380|NCT01111461|3749152|FG000|Overall Study|Other|6
2141381|NCT01111474|3749156|FG000|Overall Study|Lost to Follow-up|12
2141382|NCT01111526|3749162|FG000|Overall Study|GVHD Disease Progression|0
2141383|NCT01111526|3749163|FG001|Overall Study|GVHD Disease Progression|1
2141384|NCT01111526|3749164|FG002|Overall Study|GVHD Disease Progression|2
2141385|NCT01111539|3749168|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6
2141386|NCT01111539|3749169|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
2141387|NCT01111539|3749170|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
2141388|NCT01111539|3749171|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
2141389|NCT01111539|3749172|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
2141390|NCT01111539|3749168|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5
2141391|NCT01111539|3749169|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
2141392|NCT01111539|3749170|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
2141393|NCT01111539|3749171|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
2141394|NCT01111539|3749172|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
2141395|NCT01111539|3749168|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60
2141396|NCT01111539|3749169|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
2141397|NCT01111539|3749170|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
2141398|NCT01111539|3749171|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
2141399|NCT01111539|3749172|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
2141400|NCT01111539|3749168|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1
2141401|NCT01111539|3749169|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
2141402|NCT01111539|3749170|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
2141403|NCT01111539|3749171|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
2141404|NCT01111539|3749172|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
2141405|NCT01111539|3749168|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7
2141406|NCT01111539|3749169|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
2141407|NCT01111539|3749170|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
2141408|NCT01111539|3749171|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
2141409|NCT01111539|3749172|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
2141410|NCT01111539|3749168|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2
2141411|NCT01111539|3749169|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
2141412|NCT01111539|3749170|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
2141413|NCT01111539|3749171|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
2141414|NCT01111539|3749172|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
2141415|NCT01111539|3749168|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1
2141416|NCT01111539|3749169|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
2141417|NCT01111539|3749170|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
2289165|NCT02474069|3981041|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0
2289166|NCT02474069|3981042|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0
2289167|NCT02474069|3981040|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0
2289168|NCT02474069|3981041|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3
2289169|NCT02474069|3981042|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2
2141418|NCT01111539|3749171|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
2141419|NCT01111539|3749172|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
2141420|NCT01111539|3749168|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
2141421|NCT01111539|3749169|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
2141422|NCT01111539|3749170|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
2141423|NCT01111539|3749171|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
2141424|NCT01111539|3749172|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
2141425|NCT01111539|3749168|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
2141426|NCT01111539|3749169|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
2141427|NCT01111539|3749170|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
2141428|NCT01111539|3749171|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
2141429|NCT01111539|3749172|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2
2141430|NCT01111539|3749168|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
2141431|NCT01111539|3749169|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
2141432|NCT01111539|3749170|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
2141433|NCT01111539|3749171|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
2141434|NCT01111539|3749172|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
2141435|NCT01111539|3749168|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
2141436|NCT01111539|3749169|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
2141437|NCT01111539|3749170|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
2141438|NCT01111539|3749171|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
2141439|NCT01111539|3749172|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1
2141440|NCT01111539|3749168|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
2141441|NCT01111539|3749169|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
2141442|NCT01111539|3749170|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
2141443|NCT01111539|3749171|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1
2141444|NCT01111539|3749172|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
2141445|NCT01111539|3749168|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
2141446|NCT01111539|3749169|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
2141447|NCT01111539|3749170|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
2141448|NCT01111539|3749171|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2
2141449|NCT01111539|3749172|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
2141450|NCT01111539|3749168|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
2141451|NCT01111539|3749169|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
2141452|NCT01111539|3749170|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
2141453|NCT01111539|3749171|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
2141454|NCT01111539|3749172|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
2141455|NCT01111552|3749182|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9
2141456|NCT01111552|3749183|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
2141457|NCT01111552|3749184|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
2141458|NCT01111552|3749185|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
2141459|NCT01111552|3749186|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
2141460|NCT01111552|3749182|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4
2141461|NCT01111552|3749183|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
2141462|NCT01111552|3749184|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
2289170|NCT02474069|3981040|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
2289171|NCT02474069|3981041|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
2289172|NCT02474069|3981042|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
2289173|NCT02474069|3981040|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
2289174|NCT02474069|3981041|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
2289175|NCT02474069|3981042|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
2289176|NCT02474069|3981040|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
2289177|NCT02474069|3981041|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
2289178|NCT02474069|3981042|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
2289179|NCT02474082|3981054|FG000|Overall Study|Adverse Event|2
2289180|NCT02474082|3981055|FG001|Overall Study|Adverse Event|32
2289181|NCT02474082|3981054|FG000|Overall Study|Withdrawal of informed consent|1
2289182|NCT02474082|3981055|FG001|Overall Study|Withdrawal of informed consent|11
2289183|NCT02474082|3981054|FG000|Overall Study|Lost to Follow-up|2
2289184|NCT02474082|3981055|FG001|Overall Study|Lost to Follow-up|2
2289185|NCT02474082|3981054|FG000|Overall Study|Dose tapering not achieved|0
2289186|NCT02474082|3981055|FG001|Overall Study|Dose tapering not achieved|4
2289187|NCT02474082|3981054|FG000|Overall Study|Participant/guardian decision|1
2289188|NCT02474082|3981055|FG001|Overall Study|Participant/guardian decision|2
2289189|NCT02474082|3981054|FG000|Overall Study|Non-compliance with study treatment|0
2289190|NCT02474082|3981055|FG001|Overall Study|Non-compliance with study treatment|2
2289191|NCT02474082|3981054|FG000|Overall Study|Protocol deviation|0
2289192|NCT02474082|3981055|FG001|Overall Study|Protocol deviation|1
2289193|NCT02474199|3981063|FG000|Overall Study|Lost to Follow-up|1
2289194|NCT02474199|3981064|FG001|Overall Study|Lost to Follow-up|0
2141463|NCT01111552|3749185|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
2141464|NCT01111552|3749186|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
2141465|NCT01111552|3749182|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89
2141466|NCT01111552|3749183|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
2141467|NCT01111552|3749184|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
2141468|NCT01111552|3749185|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
2141469|NCT01111552|3749186|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
2141470|NCT01111552|3749182|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3
2141471|NCT01111552|3749183|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
2141472|NCT01111552|3749184|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
2141473|NCT01111552|3749185|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
2141474|NCT01111552|3749186|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
2141475|NCT01111552|3749182|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3
2141476|NCT01111552|3749183|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
2141477|NCT01111552|3749184|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
2141478|NCT01111552|3749185|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
2141479|NCT01111552|3749186|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
2141480|NCT01111552|3749182|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7
2141481|NCT01111552|3749183|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
2141482|NCT01111552|3749184|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
2141483|NCT01111552|3749185|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
2141484|NCT01111552|3749186|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
2141485|NCT01111552|3749182|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1
2141486|NCT01111552|3749183|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
2141487|NCT01111552|3749184|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
2141488|NCT01111552|3749185|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
2141489|NCT01111552|3749186|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
2141490|NCT01111552|3749182|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1
2141491|NCT01111552|3749183|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
2141492|NCT01111552|3749184|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
2141493|NCT01111552|3749185|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
2141494|NCT01111552|3749186|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
2141495|NCT01111552|3749182|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
2141496|NCT01111552|3749183|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
2141497|NCT01111552|3749184|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
2141498|NCT01111552|3749185|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
2141499|NCT01111552|3749186|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
2141500|NCT01111552|3749182|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
2141501|NCT01111552|3749183|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
2141502|NCT01111552|3749184|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
2141503|NCT01111552|3749185|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
2141504|NCT01111552|3749186|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
2141505|NCT01111552|3749182|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
2141506|NCT01111552|3749183|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2
2141507|NCT01111552|3749184|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
2141508|NCT01111552|3749185|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
2141509|NCT01111552|3749186|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
2141510|NCT01111552|3749182|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
2141511|NCT01111552|3749183|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1
2141512|NCT01111552|3749184|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
2141513|NCT01111552|3749185|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
2141514|NCT01111552|3749186|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
2141515|NCT01111552|3749182|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
2141516|NCT01111552|3749183|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1
2141517|NCT01111552|3749184|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
2141518|NCT01111552|3749185|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
2289195|NCT02474199|3981065|FG002|Overall Study|Lost to Follow-up|0
2289196|NCT02474199|3981066|FG003|Overall Study|Lost to Follow-up|0
2289197|NCT02474199|3981063|FG000|Overall Study|Withdrawal by Subject|1
2289198|NCT02474199|3981064|FG001|Overall Study|Withdrawal by Subject|2
2289199|NCT02474199|3981065|FG002|Overall Study|Withdrawal by Subject|0
2289200|NCT02474199|3981066|FG003|Overall Study|Withdrawal by Subject|1
2289201|NCT02474199|3981063|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0
2289202|NCT02474199|3981064|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1
2289203|NCT02474199|3981065|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0
2289204|NCT02474199|3981066|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0
2289205|NCT02474199|3981063|FG000|Overall Study|Did not meet eligibility criteria|0
2141519|NCT01111552|3749186|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
2141520|NCT01111552|3749182|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
2141521|NCT01111552|3749183|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
2141522|NCT01111552|3749184|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
2141523|NCT01111552|3749185|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
2141524|NCT01111552|3749186|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
2141525|NCT01111604|3749199|FG000|Overall Study|Lost to Follow-up|0
2141526|NCT01111604|3749200|FG001|Overall Study|Lost to Follow-up|0
2141527|NCT01111604|3749201|FG002|Overall Study|Lost to Follow-up|1
2141528|NCT01111604|3749199|FG000|Overall Study|Withdrew Consent|3
2141529|NCT01111604|3749200|FG001|Overall Study|Withdrew Consent|0
2141530|NCT01111604|3749201|FG002|Overall Study|Withdrew Consent|2
2141531|NCT01111604|3749199|FG000|Overall Study|Withdrawal by Subject|2
2141532|NCT01111604|3749200|FG001|Overall Study|Withdrawal by Subject|0
2141533|NCT01111604|3749201|FG002|Overall Study|Withdrawal by Subject|0
2141534|NCT01111604|3749199|FG000|Overall Study|Death|1
2141535|NCT01111604|3749200|FG001|Overall Study|Death|0
2141536|NCT01111604|3749201|FG002|Overall Study|Death|0
2141537|NCT01111604|3749199|FG000|Overall Study|Met Exclusion Criteria|2
2141538|NCT01111604|3749200|FG001|Overall Study|Met Exclusion Criteria|0
2141539|NCT01111604|3749201|FG002|Overall Study|Met Exclusion Criteria|0
2141540|NCT01111825|3749231|FG000|Overall Study|Withdrawal by Subject|0
2141541|NCT01111825|3749232|FG001|Overall Study|Withdrawal by Subject|0
2141542|NCT01111825|3749233|FG002|Overall Study|Withdrawal by Subject|1
2141543|NCT01111825|3749234|FG003|Overall Study|Withdrawal by Subject|0
2141544|NCT01111825|3749231|FG000|Overall Study|Lost to Follow-up|0
2141545|NCT01111825|3749232|FG001|Overall Study|Lost to Follow-up|0
2141546|NCT01111825|3749233|FG002|Overall Study|Lost to Follow-up|3
2141547|NCT01111825|3749234|FG003|Overall Study|Lost to Follow-up|1
2141548|NCT01111825|3749231|FG000|Overall Study|Adverse Event|2
2141549|NCT01111825|3749232|FG001|Overall Study|Adverse Event|1
2141550|NCT01111825|3749233|FG002|Overall Study|Adverse Event|4
2141551|NCT01111825|3749234|FG003|Overall Study|Adverse Event|0
2141552|NCT01111825|3749231|FG000|Overall Study|Disease Progression|1
2141553|NCT01111825|3749232|FG001|Overall Study|Disease Progression|0
2141554|NCT01111825|3749233|FG002|Overall Study|Disease Progression|0
2141555|NCT01111825|3749234|FG003|Overall Study|Disease Progression|0
2141556|NCT01111825|3749231|FG000|Overall Study|Discontinuation by Sponsor|0
2141557|NCT01111825|3749232|FG001|Overall Study|Discontinuation by Sponsor|0
2141558|NCT01111825|3749233|FG002|Overall Study|Discontinuation by Sponsor|0
2141559|NCT01111825|3749234|FG003|Overall Study|Discontinuation by Sponsor|20
2141560|NCT01111838|3749244|FG000|Overall Study|Patient Ineligible|2
2141561|NCT01111838|3749244|FG000|Overall Study|Not Treated|3
2141562|NCT01111838|3749244|FG000|Overall Study|Clinical deterioration|1
2141563|NCT01111838|3749244|FG000|Overall Study|Other Complicating Disease|1
2141564|NCT01111851|3749250|FG000|Overall Study|All planned PET scans were not obtained.|2
2141565|NCT01111851|3749251|FG001|Overall Study|All planned PET scans were not obtained.|0
2141566|NCT01112059|3749259|FG000|Overall Study|Withdrawal by Subject|1
2141567|NCT01112059|3749260|FG001|Overall Study|Withdrawal by Subject|0
2141568|NCT01112267|3749281|FG000|Overall Study|Adverse Event|24
2141569|NCT01112267|3749282|FG001|Overall Study|Adverse Event|6
2141570|NCT01112267|3749281|FG000|Overall Study|Withdrawal by Subject|3
2141571|NCT01112267|3749282|FG001|Overall Study|Withdrawal by Subject|5
2141572|NCT01112267|3749281|FG000|Overall Study|Protocol Violation|5
2141573|NCT01112267|3749282|FG001|Overall Study|Protocol Violation|3
2141574|NCT01112267|3749281|FG000|Overall Study|Participants not compliant|1
2141575|NCT01112267|3749282|FG001|Overall Study|Participants not compliant|2
2141576|NCT01112267|3749281|FG000|Overall Study|Participants not receive any study drug|1
2141577|NCT01112267|3749282|FG001|Overall Study|Participants not receive any study drug|2
2141578|NCT01112514|3749301|FG000|Overall Study|Lost to Follow-up|1
2141579|NCT01112579|3749307|FG000|Overall Study|Missed Visit|1
2141580|NCT01112579|3749308|FG001|Overall Study|Missed Visit|1
2141581|NCT01112579|3749307|FG000|Overall Study|Death|0
2141582|NCT01112579|3749308|FG001|Overall Study|Death|2
2178610|NCT01386606|3803524|FG001|Overall Study|Protocol Violation|0
2178611|NCT01386606|3803525|FG002|Overall Study|Protocol Violation|1
2178612|NCT01386606|3803526|FG003|Overall Study|Protocol Violation|1
2178613|NCT01386606|3803523|FG000|Overall Study|Lost to Follow-up|2
2178614|NCT01386606|3803524|FG001|Overall Study|Lost to Follow-up|0
2178615|NCT01386606|3803525|FG002|Overall Study|Lost to Follow-up|0
2178616|NCT01386606|3803526|FG003|Overall Study|Lost to Follow-up|0
2178617|NCT01386606|3803523|FG000|Overall Study|Subject incarcerated|0
2178618|NCT01386606|3803524|FG001|Overall Study|Subject incarcerated|1
2178619|NCT01386606|3803525|FG002|Overall Study|Subject incarcerated|0
2178620|NCT01386606|3803526|FG003|Overall Study|Subject incarcerated|0
2178621|NCT01386606|3803523|FG000|Overall Study|Unable to draw PK|1
2178622|NCT01386606|3803524|FG001|Overall Study|Unable to draw PK|0
2178623|NCT01386606|3803525|FG002|Overall Study|Unable to draw PK|0
2178624|NCT01386606|3803526|FG003|Overall Study|Unable to draw PK|0
2178625|NCT01386606|3803523|FG000|Overall Study|T levels too high|0
2178626|NCT01386606|3803524|FG001|Overall Study|T levels too high|1
2178627|NCT01386606|3803525|FG002|Overall Study|T levels too high|1
2178628|NCT01386606|3803526|FG003|Overall Study|T levels too high|0
2178629|NCT01386645|3803552|FG000|Overall Study|Physician Decision|0
2141583|NCT01112917|3749356|FG000|Overall Study|Death|2
2141584|NCT01112917|3749357|FG001|Overall Study|Death|11
2141585|NCT01112917|3749356|FG000|Overall Study|Lost to Follow-up|1
2141586|NCT01112917|3749357|FG001|Overall Study|Lost to Follow-up|1
2141587|NCT01112917|3749356|FG000|Overall Study|Withdrawal by Subject|1
2141588|NCT01112917|3749357|FG001|Overall Study|Withdrawal by Subject|3
2141589|NCT01112917|3749356|FG000|Overall Study|Unable to Convert Filter|3
2141590|NCT01112917|3749357|FG001|Overall Study|Unable to Convert Filter|0
2141591|NCT01112982|3749361|FG000|Overall Study|Withdrawal by Subject|1
2141592|NCT01112982|3749361|FG000|Overall Study|exceeded weight limit to complete MRI|1
2141593|NCT01113463|3749385|FG000|Overall Study|Physician Decision|5
2141594|NCT01113502|3749394|FG000|Overall Study|Withdrawal by Subject|1
2141595|NCT01113502|3749395|FG001|Overall Study|Withdrawal by Subject|0
2141596|NCT01113502|3749396|FG002|Overall Study|Withdrawal by Subject|1
2141597|NCT01113502|3749397|FG003|Overall Study|Withdrawal by Subject|1
2141598|NCT01113502|3749398|FG004|Overall Study|Withdrawal by Subject|0
2141599|NCT01113502|3749394|FG000|Overall Study|Adverse Event|0
2141600|NCT01113502|3749395|FG001|Overall Study|Adverse Event|0
2141601|NCT01113502|3749396|FG002|Overall Study|Adverse Event|3
2141602|NCT01113502|3749397|FG003|Overall Study|Adverse Event|2
2141603|NCT01113502|3749398|FG004|Overall Study|Adverse Event|0
2141604|NCT01113541|3749411|FG000|Overall Study|Withdrawal by Subject|1
2141605|NCT01113541|3749411|FG000|Overall Study|Protocol Violation|1
2141606|NCT01113541|3749411|FG000|Overall Study|Study Terminated by Sponsor|7
2141607|NCT01113541|3749411|FG000|Overall Study|Adverse Event|4
2141608|NCT01113580|3749417|FG000|Overall Study|Protocol Violation|1
2141609|NCT01113580|3749418|FG001|Overall Study|Protocol Violation|0
2141610|NCT01113710|3749433|FG000|Overall Study|Adverse Event|64
2141611|NCT01113710|3749433|FG000|Overall Study|Lack of Efficacy|41
2141612|NCT01113710|3749433|FG000|Overall Study|No Information Available|40
2141613|NCT01113710|3749433|FG000|Overall Study|Withdrawal by Subject|28
2141614|NCT01113710|3749433|FG000|Overall Study|Lost to Follow-up|20
2141615|NCT01113710|3749433|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
2141616|NCT01113710|3749433|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11
2141617|NCT01113710|3749433|FG000|Overall Study|Lack of Patient's Compliance|8
2141618|NCT01113710|3749433|FG000|Overall Study|Other|7
2141619|NCT01113710|3749433|FG000|Overall Study|Adverse Event/Other|5
2141620|NCT01113710|3749433|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5
2141621|NCT01113710|3749433|FG000|Overall Study|Lack of Efficacy/Other|4
2141622|NCT01113710|3749433|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4
2141623|NCT01113710|3749433|FG000|Overall Study|Lack of Efficacy/Adverse Event|3
2141624|NCT01113710|3749433|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2
2141625|NCT01113710|3749433|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
2141626|NCT01113710|3749433|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2
2141627|NCT01113710|3749433|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1
2141628|NCT01113710|3749433|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1
2141629|NCT01113710|3749433|FG000|Overall Study|Compliance/Efficacy/AE/Other|1
2141630|NCT01113710|3749433|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
2141631|NCT01113710|3749433|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
2141632|NCT01113710|3749433|FG000|Overall Study|Lack of Patient's Compliance/Other|1
2141633|NCT01113710|3749433|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1
2141634|NCT01113710|3749433|FG000|Overall Study|Subject Did Not Receive Neupro|3
2141635|NCT01113749|3749450|FG000|Overall Study|Lost to Follow-up|1
2141636|NCT01113749|3749451|FG001|Overall Study|Lost to Follow-up|2
2141637|NCT01113801|3749461|FG000|Overall Study|Adverse Event|4
2141638|NCT01113801|3749462|FG001|Overall Study|Adverse Event|0
2141639|NCT01113801|3749463|FG002|Overall Study|Adverse Event|2
2141640|NCT01113801|3749464|FG003|Overall Study|Adverse Event|6
2141641|NCT01113801|3749461|FG000|Overall Study|Death|4
2141642|NCT01113801|3749462|FG001|Overall Study|Death|5
2141643|NCT01113801|3749463|FG002|Overall Study|Death|3
2141644|NCT01113801|3749464|FG003|Overall Study|Death|4
2141645|NCT01113801|3749461|FG000|Overall Study|Protocol Violation|0
2141646|NCT01113801|3749462|FG001|Overall Study|Protocol Violation|1
2141647|NCT01113801|3749463|FG002|Overall Study|Protocol Violation|0
2141648|NCT01113801|3749464|FG003|Overall Study|Protocol Violation|0
2141649|NCT01113801|3749461|FG000|Overall Study|Withdrawal by Subject|9
2141650|NCT01113801|3749462|FG001|Overall Study|Withdrawal by Subject|7
2141651|NCT01113801|3749463|FG002|Overall Study|Withdrawal by Subject|7
2141652|NCT01113801|3749464|FG003|Overall Study|Withdrawal by Subject|8
2141653|NCT01113801|3749461|FG000|Overall Study|Physician Decision|2
2141654|NCT01113801|3749462|FG001|Overall Study|Physician Decision|2
2141655|NCT01113801|3749463|FG002|Overall Study|Physician Decision|3
2141656|NCT01113801|3749464|FG003|Overall Study|Physician Decision|3
2141657|NCT01113801|3749461|FG000|Overall Study|Sponsor Decision|15
2141658|NCT01113801|3749462|FG001|Overall Study|Sponsor Decision|21
2141659|NCT01113801|3749463|FG002|Overall Study|Sponsor Decision|20
2141660|NCT01113801|3749464|FG003|Overall Study|Sponsor Decision|15
2141661|NCT01113801|3749461|FG000|Overall Study|Clinical Endpoint (ESRD)|7
2141662|NCT01113801|3749462|FG001|Overall Study|Clinical Endpoint (ESRD)|4
2141663|NCT01113801|3749463|FG002|Overall Study|Clinical Endpoint (ESRD)|2
2141664|NCT01113801|3749464|FG003|Overall Study|Clinical Endpoint (ESRD)|5
2141665|NCT01113879|3749476|FG000|Period 1: Block 1|Withdrawal by Subject|2
2141666|NCT01113879|3749477|FG001|Period 1: Block 1|Withdrawal by Subject|0
2141667|NCT01113892|3749487|FG000|Overall Study|Lost to Follow-up|2
2141668|NCT01113892|3749488|FG001|Overall Study|Lost to Follow-up|2
2141669|NCT01113892|3749487|FG000|Overall Study|Withdrawal by Subject|1
2141670|NCT01113892|3749488|FG001|Overall Study|Withdrawal by Subject|1
2141671|NCT01113892|3749487|FG000|Overall Study|Death|2
2141672|NCT01113892|3749488|FG001|Overall Study|Death|4
2141673|NCT01113892|3749487|FG000|Overall Study|Graft no longer evaluable|9
2141674|NCT01113892|3749488|FG001|Overall Study|Graft no longer evaluable|9
2141675|NCT01113931|3749496|FG000|Overall Study|Adverse Event|2
2141676|NCT01113931|3749497|FG001|Overall Study|Adverse Event|2
2141677|NCT01113931|3749496|FG000|Overall Study|Physician Decision|0
2141678|NCT01113931|3749497|FG001|Overall Study|Physician Decision|2
2141679|NCT01113931|3749496|FG000|Overall Study|Lost to Follow-up|12
2141680|NCT01113931|3749497|FG001|Overall Study|Lost to Follow-up|9
2141681|NCT01113931|3749496|FG000|Overall Study|Various|2
2141682|NCT01113931|3749497|FG001|Overall Study|Various|4
2141683|NCT01113931|3749496|FG000|Overall Study|Withdrawal by Subject|3
2141684|NCT01113931|3749497|FG001|Overall Study|Withdrawal by Subject|0
2141685|NCT01114139|3749514|FG000|Overall Study|Adverse Event|3
2141686|NCT01114139|3749515|FG001|Overall Study|Adverse Event|2
2141687|NCT01114139|3749514|FG000|Overall Study|Lost to Follow-up|15
2141688|NCT01114139|3749515|FG001|Overall Study|Lost to Follow-up|3
2141689|NCT01114139|3749514|FG000|Overall Study|Withdrawal by Subject|17
2141690|NCT01114139|3749515|FG001|Overall Study|Withdrawal by Subject|6
2141691|NCT01114139|3749514|FG000|Overall Study|Other-Missed 1 visit|1
2141692|NCT01114139|3749515|FG001|Overall Study|Other-Missed 1 visit|0
2141693|NCT01114139|3749514|FG000|Overall Study|Other-Protocol Violation|1
2141694|NCT01114139|3749515|FG001|Overall Study|Other-Protocol Violation|0
2141695|NCT01114139|3749514|FG000|Overall Study|Other-Out of window for study drug dose|1
2141696|NCT01114139|3749515|FG001|Overall Study|Other-Out of window for study drug dose|0
2141697|NCT01114139|3749514|FG000|Overall Study|Other-Participant falsified records|0
2141698|NCT01114139|3749515|FG001|Overall Study|Other-Participant falsified records|1
2141699|NCT01114139|3749514|FG000|Overall Study|Other-Participant went on hospice|0
2141700|NCT01114139|3749515|FG001|Overall Study|Other-Participant went on hospice|1
2141701|NCT01114139|3749514|FG000|Overall Study|Other-Physician changed treatment|1
2141702|NCT01114139|3749515|FG001|Overall Study|Other-Physician changed treatment|0
2141703|NCT01114139|3749514|FG000|Overall Study|Other-Withdrew prior to receiving dose|1
2141704|NCT01114139|3749515|FG001|Overall Study|Other-Withdrew prior to receiving dose|3
2141705|NCT01114204|3749523|FG000|Overall Study|Adverse Event|3
2141706|NCT01114204|3749524|FG001|Overall Study|Adverse Event|2
2141707|NCT01114204|3749523|FG000|Overall Study|Lost to Follow-up|1
2289206|NCT02474199|3981064|FG001|Overall Study|Did not meet eligibility criteria|0
2289207|NCT02474199|3981065|FG002|Overall Study|Did not meet eligibility criteria|2
2289208|NCT02474199|3981066|FG003|Overall Study|Did not meet eligibility criteria|2
2289209|NCT02474355|3981073|FG000|Overall Study|Other|43
2289210|NCT02474355|3981073|FG000|Overall Study|Eligibility Criteria not Fulfilled|2
2289211|NCT02474355|3981073|FG000|Overall Study|Lost to Follow-up|98
2289212|NCT02474355|3981073|FG000|Overall Study|Withdrawal by Subject|124
2289213|NCT02474355|3981073|FG000|Overall Study|Death|1361
2289214|NCT02474589|3981123|FG000|Overall Study|Adverse Event|6
2289215|NCT02474589|3981124|FG001|Overall Study|Adverse Event|2
2289216|NCT02474589|3981123|FG000|Overall Study|Lost to Follow-up|6
2289217|NCT02474589|3981124|FG001|Overall Study|Lost to Follow-up|1
2289218|NCT02474589|3981123|FG000|Overall Study|Protocol Violation|4
2289219|NCT02474589|3981124|FG001|Overall Study|Protocol Violation|1
2289220|NCT02474589|3981123|FG000|Overall Study|Withdrawal by Subject|4
2289221|NCT02474589|3981124|FG001|Overall Study|Withdrawal by Subject|0
2289222|NCT02474589|3981123|FG000|Overall Study|Inability to complete study procedures|5
2289223|NCT02474589|3981124|FG001|Overall Study|Inability to complete study procedures|1
2289224|NCT02475265|3981160|FG000|Overall Study|Physician Decision|1
2289225|NCT02475265|3981160|FG000|Overall Study|Withdrawal by Subject|2
2289226|NCT02475278|3981164|FG000|Overall Study|Lost to Follow-up|1
2289227|NCT02475278|3981164|FG000|Overall Study|Reason Not Specified|1
2289228|NCT02475369|3981168|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7
2289229|NCT02475369|3981169|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2
2289230|NCT02475395|3981182|FG000|Overall Study|Protocol Violation|30
2289231|NCT02475395|3981183|FG001|Overall Study|Protocol Violation|3
2289232|NCT02475564|3981191|FG000|Overall Study|Withdrawal by Subject|1
2289233|NCT02475564|3981192|FG001|Overall Study|Withdrawal by Subject|0
2289234|NCT02475564|3981191|FG000|Overall Study|Lost to Follow-up|2
2289235|NCT02475564|3981192|FG001|Overall Study|Lost to Follow-up|1
2289236|NCT02475564|3981191|FG000|Overall Study|Intense Menstrual bleeding|1
2289237|NCT02475564|3981192|FG001|Overall Study|Intense Menstrual bleeding|0
2289238|NCT02475629|3981198|FG000|Overall Study|Adverse Event|1
2289239|NCT02475629|3981198|FG000|Overall Study|Death|4
2289240|NCT02475629|3981198|FG000|Overall Study|Physician Decision|1
2289241|NCT02475629|3981198|FG000|Overall Study|Withdrawal by Subject|1
2289242|NCT02475629|3981198|FG000|Overall Study|Lost to Follow-up|1
2289243|NCT02475629|3981198|FG000|Overall Study|Subject non-compliance|1
2289244|NCT02475655|3981204|FG000|Overall Study|Lost to Follow-up|0
2141708|NCT01114204|3749524|FG001|Overall Study|Lost to Follow-up|0
2141709|NCT01114204|3749523|FG000|Overall Study|Withdrawal by Subject|10
2141710|NCT01114204|3749524|FG001|Overall Study|Withdrawal by Subject|6
2141711|NCT01114204|3749523|FG000|Overall Study|Death|1
2141712|NCT01114204|3749524|FG001|Overall Study|Death|0
2141713|NCT01114204|3749523|FG000|Overall Study|Other-Personal reasons|2
2141714|NCT01114204|3749524|FG001|Overall Study|Other-Personal reasons|0
2141715|NCT01114204|3749523|FG000|Overall Study|Other-Medical monitor request|1
2141716|NCT01114204|3749524|FG001|Overall Study|Other-Medical monitor request|0
2141717|NCT01114204|3749523|FG000|Overall Study|Other-Participant request|2
2141718|NCT01114204|3749524|FG001|Overall Study|Other-Participant request|0
2141719|NCT01114204|3749523|FG000|Overall Study|Other-Protocol Violation|1
2141720|NCT01114204|3749524|FG001|Overall Study|Other-Protocol Violation|0
2141721|NCT01114217|3749532|FG000|Overall Study|Adverse Event|5
2141722|NCT01114217|3749533|FG001|Overall Study|Adverse Event|3
2141723|NCT01114217|3749532|FG000|Overall Study|Lost to Follow-up|17
2141724|NCT01114217|3749533|FG001|Overall Study|Lost to Follow-up|33
2141725|NCT01114217|3749532|FG000|Overall Study|Withdrawal by Subject|21
2141726|NCT01114217|3749533|FG001|Overall Study|Withdrawal by Subject|28
2141727|NCT01114217|3749532|FG000|Overall Study|Other-Clerical Error|3
2141728|NCT01114217|3749533|FG001|Overall Study|Other-Clerical Error|0
2141729|NCT01114217|3749532|FG000|Overall Study|Other-Early termination|6
2141730|NCT01114217|3749533|FG001|Overall Study|Other-Early termination|10
2141731|NCT01114217|3749532|FG000|Overall Study|Other-Procedure|1
2141732|NCT01114217|3749533|FG001|Overall Study|Other-Procedure|1
2141733|NCT01114217|3749532|FG000|Overall Study|Other-Pregnancy|2
2141734|NCT01114217|3749533|FG001|Overall Study|Other-Pregnancy|4
2141735|NCT01114217|3749532|FG000|Overall Study|Other-Protocol Violation|1
2141736|NCT01114217|3749533|FG001|Overall Study|Other-Protocol Violation|3
2289245|NCT02475655|3981205|FG001|Overall Study|Lost to Follow-up|1
2289246|NCT02475733|3981213|FG000|Overall Study|Withdrawal by Subject|1
2289247|NCT02475733|3981214|FG001|Overall Study|Withdrawal by Subject|0
2289248|NCT02475733|3981213|FG000|Overall Study|Physician Decision|1
2289249|NCT02475733|3981214|FG001|Overall Study|Physician Decision|0
2289250|NCT02475850|3981231|FG000|Overall Study|Death|155
2289251|NCT02475850|3981232|FG001|Overall Study|Death|141
2289252|NCT02475850|3981231|FG000|Overall Study|Lost to Follow-up|217
2289253|NCT02475850|3981232|FG001|Overall Study|Lost to Follow-up|188
2289254|NCT02475850|3981231|FG000|Overall Study|Withdrawal by Subject|221
2289255|NCT02475850|3981232|FG001|Overall Study|Withdrawal by Subject|155
2289256|NCT02475954|3981241|FG000|Overall Study|Withdrawal by Subject|2
2289257|NCT02475954|3981242|FG001|Overall Study|Withdrawal by Subject|2
2289258|NCT02475954|3981241|FG000|Overall Study|Lost to Follow-up|11
2289259|NCT02475954|3981242|FG001|Overall Study|Lost to Follow-up|9
2289260|NCT02475954|3981241|FG000|Overall Study|Death|1
2289261|NCT02475954|3981242|FG001|Overall Study|Death|1
2289262|NCT02475980|3981249|FG000|Overall Study|Lost to Follow-up|4
2289263|NCT02475980|3981249|FG000|Overall Study|Withdrawal by Subject|1
2289264|NCT02476006|3981253|FG000|Overall Study|Death|4
2289265|NCT02476006|3981253|FG000|Overall Study|Lack of treatment efficacy|2
2289266|NCT02476006|3981253|FG000|Overall Study|Pregnancy|1
2289267|NCT02476006|3981253|FG000|Overall Study|Participant did not wish to continue|39
2289268|NCT02476006|3981253|FG000|Overall Study|Adverse Event|41
2289269|NCT02476006|3981253|FG000|Overall Study|Poor compliance to study protocol|3
2289270|NCT02476006|3981253|FG000|Overall Study|Sponsor decision|6
2289271|NCT02476006|3981253|FG000|Overall Study|Lost to Follow-up|5
2289272|NCT02476006|3981253|FG000|Overall Study|Physician Decision|5
2289273|NCT02476006|3981253|FG000|Overall Study|Study ended treatment not available|4
2289274|NCT02476006|3981253|FG000|Overall Study|Switched to commercial drug|4
2289275|NCT02476006|3981253|FG000|Overall Study|Excluded from study|1
2289276|NCT02476006|3981253|FG000|Overall Study|Protocol Violation|1
2289277|NCT02476006|3981253|FG000|Overall Study|Enrolled but not treated|4
2289278|NCT02476175|3981273|FG000|Overall Study|Adverse Event|2
2289279|NCT02476201|3981277|FG000|Overall Study|Unable to program MPP|9
2289280|NCT02476201|3981277|FG000|Overall Study|Study echo not performed|5
2289281|NCT02476201|3981277|FG000|Overall Study|Adverse Event|4
2289282|NCT02476201|3981277|FG000|Overall Study|Death|2
2289283|NCT02476201|3981277|FG000|Overall Study|Lost to Follow-up|2
2289284|NCT02476201|3981277|FG000|Overall Study|MPP programmed to OFF|2
2289285|NCT02476201|3981277|FG000|Overall Study|Withdrawal by Subject|1
2289286|NCT02476201|3981277|FG000|Overall Study|Unsuccessful implant|1
2141737|NCT01114217|3749532|FG000|Overall Study|Other-Lack of Efficacy|1
2141738|NCT01114217|3749533|FG001|Overall Study|Other-Lack of Efficacy|0
2141739|NCT01114217|3749532|FG000|Overall Study|Other-Non Compliance|2
2141740|NCT01114217|3749533|FG001|Overall Study|Other-Non Compliance|0
2141741|NCT01114217|3749532|FG000|Overall Study|Other-Physician Decision|1
2141742|NCT01114217|3749533|FG001|Overall Study|Other-Physician Decision|1
2141743|NCT01114217|3749532|FG000|Overall Study|Other-Sponsor Decision|10
2141744|NCT01114217|3749533|FG001|Overall Study|Other-Sponsor Decision|12
2289287|NCT02476422|3981295|FG000|Overall Study|Subject/guardian decision|0
2289288|NCT02476422|3981296|FG001|Overall Study|Subject/guardian decision|1
2289289|NCT02476578|3981330|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35
2289290|NCT02476578|3981331|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43
2289291|NCT02476578|3981330|FG000|Overall Study|Lost to Follow-up|6
2289292|NCT02476578|3981331|FG001|Overall Study|Lost to Follow-up|13
2141745|NCT01114217|3749532|FG000|Overall Study|Other-Study Termination|0
2141746|NCT01114217|3749533|FG001|Overall Study|Other-Study Termination|1
2141747|NCT01114217|3749532|FG000|Overall Study|Other-Study Withdrawn|1
2141748|NCT01114217|3749533|FG001|Overall Study|Other-Study Withdrawn|1
2141749|NCT01114217|3749532|FG000|Overall Study|Other-Site Stopped Communicating|2
2141750|NCT01114217|3749533|FG001|Overall Study|Other-Site Stopped Communicating|0
2141751|NCT01114217|3749532|FG000|Overall Study|Other-Lost to Follow-up|1
2141752|NCT01114217|3749533|FG001|Overall Study|Other-Lost to Follow-up|0
2141753|NCT01114217|3749532|FG000|Overall Study|Other-Withdrawal by Subject|1
2141754|NCT01114217|3749533|FG001|Overall Study|Other-Withdrawal by Subject|1
2141755|NCT01114360|3749547|FG000|Intervention 1 (4 Weeks)|Physician Decision|0
2141756|NCT01114360|3749548|FG001|Intervention 1 (4 Weeks)|Physician Decision|1
2141757|NCT01114373|3749568|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1
2141758|NCT01114373|3749569|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0
2141759|NCT01114373|3749568|FG000|Intervention 1 (4 Weeks)|Incarceration|1
2141760|NCT01114373|3749569|FG001|Intervention 1 (4 Weeks)|Incarceration|0
2141761|NCT01114373|3749568|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
2141762|NCT01114373|3749569|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
2141763|NCT01114373|3749568|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0
2141764|NCT01114373|3749569|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1
2141765|NCT01114438|3749579|FG000|Overall Study|Adverse Event|10
2141766|NCT01114438|3749579|FG000|Overall Study|concomitant medication|1
2141767|NCT01114438|3749579|FG000|Overall Study|Physician Decision|1
2141768|NCT01114438|3749579|FG000|Overall Study|Withdrawal by Subject|2
2141769|NCT01114516|3749594|FG000|Overall Study|Lost to Follow-up|2
2141770|NCT01114516|3749595|FG001|Overall Study|Lost to Follow-up|1
2141771|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Adverse Event|87
2141772|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Adverse Event|18
2141773|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Adverse Event|17
2141774|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
2141775|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
2141776|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
2141777|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
2141778|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
2141779|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
2141780|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2
2141781|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1
2141782|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2
2141783|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1
2141784|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1
2141785|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1
2141786|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18
2141787|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8
2141788|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2
2141789|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1
2141790|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4
2141791|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2
2141792|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Administrative problems|2
2141793|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Administrative problems|1
2141794|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Administrative problems|2
2141795|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Death|2
2141796|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Death|1
2141797|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Death|2
2141798|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Graft loss|0
2141799|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Graft loss|2
2141800|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Graft loss|0
2141801|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Protocol Violation|0
2141802|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Protocol Violation|5
2141803|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Protocol Violation|2
2141804|NCT01114529|3749604|FG000|Completed Study Medication at Month 24|Missing|2
2141805|NCT01114529|3749605|FG001|Completed Study Medication at Month 24|Missing|0
2141806|NCT01114529|3749606|FG002|Completed Study Medication at Month 24|Missing|0
2141807|NCT01114529|3749604|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18
2141808|NCT01114529|3749605|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6
2141809|NCT01114529|3749606|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3
2141810|NCT01114529|3749604|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10
2141811|NCT01114529|3749605|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5
2141812|NCT01114529|3749606|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7
2141813|NCT01114529|3749604|FG000|Completed Study Phase at Month 24|Death|8
2141814|NCT01114529|3749605|FG001|Completed Study Phase at Month 24|Death|5
2141815|NCT01114529|3749606|FG002|Completed Study Phase at Month 24|Death|4
2141816|NCT01114529|3749604|FG000|Completed Study Phase at Month 24|Other|2
2141817|NCT01114529|3749605|FG001|Completed Study Phase at Month 24|Other|0
2141818|NCT01114529|3749606|FG002|Completed Study Phase at Month 24|Other|0
2141819|NCT01114529|3749604|FG000|Completed Study Phase at Month 24|Missing|2
2141820|NCT01114529|3749605|FG001|Completed Study Phase at Month 24|Missing|0
2141821|NCT01114529|3749606|FG002|Completed Study Phase at Month 24|Missing|0
2141822|NCT01114646|3749635|FG000|Overall Study|Withdrawal by Subject|3
2141823|NCT01114646|3749636|FG001|Overall Study|Withdrawal by Subject|2
2141824|NCT01114672|3749644|FG000|Overall Study|Death|0
2141825|NCT01114672|3749645|FG001|Overall Study|Death|1
2141826|NCT01114672|3749644|FG000|Overall Study|Withdrawal by Subject|2
2141827|NCT01114672|3749645|FG001|Overall Study|Withdrawal by Subject|1
2141828|NCT01114672|3749644|FG000|Overall Study|Lost to Follow-up|1
2141829|NCT01114672|3749645|FG001|Overall Study|Lost to Follow-up|0
2141830|NCT01114672|3749644|FG000|Overall Study|transplanted|1
2141831|NCT01114672|3749645|FG001|Overall Study|transplanted|0
2141832|NCT01114724|3749651|FG000|Overall Study|Death|8
2141833|NCT01114724|3749651|FG000|Overall Study|Lost to Follow-up|1
2141834|NCT01114724|3749651|FG000|Overall Study|Withdrawal by Subject|1
2141835|NCT01114737|3749658|FG000|Randomized Treatment Period|Withdrawal by Subject|1
2141836|NCT01114737|3749659|FG001|Randomized Treatment Period|Withdrawal by Subject|0
2141837|NCT01114737|3749658|FG000|Randomized Treatment Period|Lost to Follow-up|1
2141838|NCT01114737|3749659|FG001|Randomized Treatment Period|Lost to Follow-up|1
2141839|NCT01114737|3749658|FG000|Randomized Treatment Period|Pregnancy|1
2141840|NCT01114737|3749659|FG001|Randomized Treatment Period|Pregnancy|0
2141841|NCT01114737|3749658|FG000|Open-Label Treatment Period|Withdrawal by Subject|1
2141842|NCT01114737|3749659|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
2141843|NCT01114737|3749658|FG000|Open-Label Treatment Period|Lost to Follow-up|3
2141844|NCT01114737|3749659|FG001|Open-Label Treatment Period|Lost to Follow-up|1
2141845|NCT01114737|3749658|FG000|Open-Label Treatment Period|Difficult Personal Events|1
2141846|NCT01114737|3749659|FG001|Open-Label Treatment Period|Difficult Personal Events|0
2141847|NCT01114828|3749678|FG000|Overall Study|Adverse Event|1
2141848|NCT01114828|3749679|FG001|Overall Study|Adverse Event|1
2141849|NCT01114828|3749678|FG000|Overall Study|Lack of Efficacy|0
2141850|NCT01114828|3749679|FG001|Overall Study|Lack of Efficacy|2
2141851|NCT01114828|3749678|FG000|Overall Study|Protocol Violation|2
2141852|NCT01114828|3749679|FG001|Overall Study|Protocol Violation|0
2141853|NCT01114828|3749678|FG000|Overall Study|Withdrawal by Subject|0
2141854|NCT01114828|3749679|FG001|Overall Study|Withdrawal by Subject|1
2141855|NCT01114880|3749687|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4
2141856|NCT01114880|3749688|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0
2141857|NCT01114880|3749687|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
2141858|NCT01114880|3749688|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
2141859|NCT01114880|3749687|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
2141860|NCT01114880|3749688|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
2141861|NCT01114880|3749687|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
2141862|NCT01114880|3749688|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
2141863|NCT01114880|3749687|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3
2141864|NCT01114880|3749688|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0
2141865|NCT01114880|3749687|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
2141866|NCT01114880|3749688|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
2141867|NCT01115309|3749785|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2
2141868|NCT01115309|3749785|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1
2141869|NCT01115309|3749785|FG000|Long-term Follow-up|Lost to Follow-up|6
2141870|NCT01115491|3749798|FG000|Overall Study|Death|22
2141871|NCT01115491|3749798|FG000|Overall Study|Adverse Event|3
2141872|NCT01115491|3749798|FG000|Overall Study|Lost to Follow-up|3
2141873|NCT01115491|3749798|FG000|Overall Study|Withdrawal by Subject|1
2141874|NCT01115491|3749798|FG000|Overall Study|Physician Decision|1
2141875|NCT01115569|3749822|FG000|Conversion/Titration Phase|Adverse Event|59
2141876|NCT01115569|3749823|FG001|Conversion/Titration Phase|Adverse Event|0
2141877|NCT01115569|3749822|FG000|Conversion/Titration Phase|Lost to Follow-up|3
2141878|NCT01115569|3749823|FG001|Conversion/Titration Phase|Lost to Follow-up|0
2141879|NCT01115569|3749822|FG000|Conversion/Titration Phase|Physician Decision|5
2141880|NCT01115569|3749823|FG001|Conversion/Titration Phase|Physician Decision|0
2141881|NCT01115569|3749822|FG000|Conversion/Titration Phase|Protocol Violation|68
2141882|NCT01115569|3749823|FG001|Conversion/Titration Phase|Protocol Violation|0
2141883|NCT01115569|3749822|FG000|Conversion/Titration Phase|Withdrawal by Subject|26
2141884|NCT01115569|3749823|FG001|Conversion/Titration Phase|Withdrawal by Subject|0
2141885|NCT01115569|3749822|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53
2141886|NCT01115569|3749823|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0
2141887|NCT01115569|3749822|FG000|Maintenance Phase|Adverse Event|0
2141888|NCT01115569|3749823|FG001|Maintenance Phase|Adverse Event|43
2141889|NCT01115569|3749822|FG000|Maintenance Phase|Lost to Follow-up|0
2141890|NCT01115569|3749823|FG001|Maintenance Phase|Lost to Follow-up|8
2141891|NCT01115569|3749822|FG000|Maintenance Phase|Physician Decision|0
2141892|NCT01115569|3749823|FG001|Maintenance Phase|Physician Decision|3
2141893|NCT01115569|3749822|FG000|Maintenance Phase|Protocol Violation|0
2141894|NCT01115569|3749823|FG001|Maintenance Phase|Protocol Violation|9
2141895|NCT01115569|3749822|FG000|Maintenance Phase|Withdrawal by Subject|0
2141896|NCT01115569|3749823|FG001|Maintenance Phase|Withdrawal by Subject|27
2141897|NCT01115569|3749822|FG000|Maintenance Phase|Non-Compliance with Study Drug|0
2141898|NCT01115569|3749823|FG001|Maintenance Phase|Non-Compliance with Study Drug|48
2141899|NCT01115569|3749822|FG000|Maintenance Phase|Administrative|0
2141900|NCT01115569|3749823|FG001|Maintenance Phase|Administrative|1
2141901|NCT01115738|3749857|FG000|Overall Study|Death|1
2141902|NCT01115738|3749858|FG001|Overall Study|Death|0
2141903|NCT01115738|3749859|FG002|Overall Study|Death|0
2141904|NCT01115738|3749857|FG000|Overall Study|Lost to Follow-up|0
2141905|NCT01115738|3749858|FG001|Overall Study|Lost to Follow-up|0
2141906|NCT01115738|3749859|FG002|Overall Study|Lost to Follow-up|1
2141907|NCT01115738|3749857|FG000|Overall Study|Physician Decision|18
2141908|NCT01115738|3749858|FG001|Overall Study|Physician Decision|15
2141909|NCT01115738|3749859|FG002|Overall Study|Physician Decision|17
2141910|NCT01115738|3749857|FG000|Overall Study|Withdrawal by Subject|6
2141911|NCT01115738|3749858|FG001|Overall Study|Withdrawal by Subject|6
2141912|NCT01115738|3749859|FG002|Overall Study|Withdrawal by Subject|9
2141913|NCT01115803|3749882|FG000|Overall Study|Withdrawal by Subject|0
2141914|NCT01115803|3749883|FG001|Overall Study|Withdrawal by Subject|0
2141915|NCT01115803|3749884|FG002|Overall Study|Withdrawal by Subject|0
2141916|NCT01115803|3749885|FG003|Overall Study|Withdrawal by Subject|0
2141917|NCT01115803|3749886|FG004|Overall Study|Withdrawal by Subject|0
2141918|NCT01115803|3749887|FG005|Overall Study|Withdrawal by Subject|0
2141919|NCT01115803|3749888|FG006|Overall Study|Withdrawal by Subject|1
2141920|NCT01115803|3749882|FG000|Overall Study|Lost to Follow-up|0
2141921|NCT01115803|3749883|FG001|Overall Study|Lost to Follow-up|0
2141922|NCT01115803|3749884|FG002|Overall Study|Lost to Follow-up|1
2141923|NCT01115803|3749885|FG003|Overall Study|Lost to Follow-up|0
2141924|NCT01115803|3749886|FG004|Overall Study|Lost to Follow-up|0
2141925|NCT01115803|3749887|FG005|Overall Study|Lost to Follow-up|0
2141926|NCT01115803|3749888|FG006|Overall Study|Lost to Follow-up|0
2141927|NCT01115803|3749882|FG000|Overall Study|Progressive Disease during Cycle1|0
2141928|NCT01115803|3749883|FG001|Overall Study|Progressive Disease during Cycle1|0
2141929|NCT01115803|3749884|FG002|Overall Study|Progressive Disease during Cycle1|0
2289293|NCT02476617|3981337|FG000|Overall Study|Adverse Event|1
2289294|NCT02476617|3981337|FG000|Overall Study|Lost to Follow-up|1
2289295|NCT02477020|3981362|FG000|Overall Study|Pretreatment Event/Adverse Event|6
2289296|NCT02477020|3981363|FG001|Overall Study|Pretreatment Event/Adverse Event|6
2289297|NCT02477020|3981362|FG000|Overall Study|Voluntary Withdrawal|7
2289298|NCT02477020|3981363|FG001|Overall Study|Voluntary Withdrawal|16
2289299|NCT02477020|3981362|FG000|Overall Study|Reason not Specified|3
2289300|NCT02477020|3981363|FG001|Overall Study|Reason not Specified|1
2289301|NCT02477020|3981362|FG000|Overall Study|Lack of Efficacy|14
2289302|NCT02477020|3981363|FG001|Overall Study|Lack of Efficacy|5
2289303|NCT02477111|3981369|FG000|Overall Study|Death|5
2289304|NCT02477111|3981369|FG000|Overall Study|Withdrawal by Subject|2
2289305|NCT02477111|3981369|FG000|Overall Study|missed visit|4
2289306|NCT02477215|3981379|FG000|Dose Escalation Phase|Physician Decision|1
2289307|NCT02477215|3981380|FG001|Dose Escalation Phase|Physician Decision|2
2289308|NCT02477215|3981381|FG002|Dose Escalation Phase|Physician Decision|0
2289309|NCT02477215|3981379|FG000|Fixed Dose Phase|Physician Decision|0
2289310|NCT02477215|3981380|FG001|Fixed Dose Phase|Physician Decision|7
2289311|NCT02477215|3981381|FG002|Fixed Dose Phase|Physician Decision|0
2289312|NCT02477332|3981412|FG000|Overall Study|Adverse Event|0
2289313|NCT02477332|3981413|FG001|Overall Study|Adverse Event|1
2289314|NCT02477332|3981414|FG002|Overall Study|Adverse Event|1
2289315|NCT02477332|3981415|FG003|Overall Study|Adverse Event|2
2289316|NCT02477332|3981416|FG004|Overall Study|Adverse Event|1
2289317|NCT02477332|3981417|FG005|Overall Study|Adverse Event|2
2289318|NCT02477332|3981412|FG000|Overall Study|Lack of Efficacy|1
2289319|NCT02477332|3981413|FG001|Overall Study|Lack of Efficacy|2
2289320|NCT02477332|3981414|FG002|Overall Study|Lack of Efficacy|1
2289321|NCT02477332|3981415|FG003|Overall Study|Lack of Efficacy|2
2289322|NCT02477332|3981416|FG004|Overall Study|Lack of Efficacy|1
2289323|NCT02477332|3981417|FG005|Overall Study|Lack of Efficacy|1
2289324|NCT02477332|3981412|FG000|Overall Study|Non-compliance with study treatment|0
2289325|NCT02477332|3981413|FG001|Overall Study|Non-compliance with study treatment|1
2289326|NCT02477332|3981414|FG002|Overall Study|Non-compliance with study treatment|2
2289327|NCT02477332|3981415|FG003|Overall Study|Non-compliance with study treatment|0
2289328|NCT02477332|3981416|FG004|Overall Study|Non-compliance with study treatment|0
2289329|NCT02477332|3981417|FG005|Overall Study|Non-compliance with study treatment|0
2289330|NCT02477332|3981412|FG000|Overall Study|Pregnancy|0
2141930|NCT01115803|3749885|FG003|Overall Study|Progressive Disease during Cycle1|0
2141931|NCT01115803|3749886|FG004|Overall Study|Progressive Disease during Cycle1|0
2141932|NCT01115803|3749887|FG005|Overall Study|Progressive Disease during Cycle1|0
2141933|NCT01115803|3749888|FG006|Overall Study|Progressive Disease during Cycle1|1
2141934|NCT01115855|3749911|FG000|Overall Study|Adverse Event|16
2141935|NCT01115855|3749912|FG001|Overall Study|Adverse Event|18
2289331|NCT02477332|3981413|FG001|Overall Study|Pregnancy|0
2141936|NCT01115855|3749911|FG000|Overall Study|Death|6
2141937|NCT01115855|3749912|FG001|Overall Study|Death|5
2141938|NCT01115855|3749911|FG000|Overall Study|Lab Abnormality|1
2141939|NCT01115855|3749912|FG001|Overall Study|Lab Abnormality|1
2289332|NCT02477332|3981414|FG002|Overall Study|Pregnancy|0
2141940|NCT01115855|3749911|FG000|Overall Study|Protocol Violation|0
2141941|NCT01115855|3749912|FG001|Overall Study|Protocol Violation|1
2141942|NCT01115855|3749911|FG000|Overall Study|Withdrawal by Subject|5
2141943|NCT01115855|3749912|FG001|Overall Study|Withdrawal by Subject|5
2141944|NCT01115855|3749911|FG000|Overall Study|Other|8
2141945|NCT01115855|3749912|FG001|Overall Study|Other|6
2141946|NCT01115933|3749918|FG000|Overall Study|Did not receive XIENCE PRIME SV|1
2141947|NCT01115998|3749977|FG000|Overall Study|Lost to Follow-up|6
2141948|NCT01115998|3749978|FG001|Overall Study|Lost to Follow-up|6
2141949|NCT01116427|3750053|FG000|Core Phase|Adverse Event|0
2141950|NCT01116427|3750054|FG001|Core Phase|Adverse Event|1
2141951|NCT01116427|3750053|FG000|Core Phase|Lost to Follow-up|1
2141952|NCT01116427|3750054|FG001|Core Phase|Lost to Follow-up|0
2141953|NCT01116427|3750053|FG000|Core Phase|Withdrawal by Subject|3
2141954|NCT01116427|3750054|FG001|Core Phase|Withdrawal by Subject|0
2289333|NCT02477332|3981415|FG003|Overall Study|Pregnancy|1
2289334|NCT02477332|3981416|FG004|Overall Study|Pregnancy|0
2141955|NCT01116427|3750053|FG000|Core Phase|Worsening Multiple Sclerosis|1
2141956|NCT01116427|3750054|FG001|Core Phase|Worsening Multiple Sclerosis|0
2141957|NCT01116427|3750053|FG000|Extension Phase|Adverse Event|1
2141958|NCT01116427|3750054|FG001|Extension Phase|Adverse Event|1
2141959|NCT01116427|3750053|FG000|Extension Phase|Lost to Follow-up|2
2141960|NCT01116427|3750054|FG001|Extension Phase|Lost to Follow-up|0
2141961|NCT01116427|3750053|FG000|Extension Phase|Withdrawal by Subject|5
2141962|NCT01116427|3750054|FG001|Extension Phase|Withdrawal by Subject|1
2141963|NCT01116427|3750053|FG000|Extension Phase|Not using appropriate birth control|1
2141964|NCT01116427|3750054|FG001|Extension Phase|Not using appropriate birth control|0
2141965|NCT01116440|3750066|FG000|Treatment|Withdrawal by Subject|2
2141966|NCT01116440|3750067|FG001|Treatment|Withdrawal by Subject|2
2141967|NCT01116440|3750066|FG000|Treatment|Lost to Follow-up|1
2141968|NCT01116440|3750067|FG001|Treatment|Lost to Follow-up|1
2141969|NCT01116440|3750066|FG000|Treatment|Protocol Violation|0
2141970|NCT01116440|3750067|FG001|Treatment|Protocol Violation|2
2141971|NCT01116440|3750066|FG000|Treatment|Lack of Efficacy|0
2141972|NCT01116440|3750067|FG001|Treatment|Lack of Efficacy|1
2141973|NCT01116440|3750066|FG000|Treatment|Adverse Event|0
2141974|NCT01116440|3750067|FG001|Treatment|Adverse Event|1
2141975|NCT01116440|3750066|FG000|Withdrawal|Withdrawal by Subject|0
2141976|NCT01116440|3750067|FG001|Withdrawal|Withdrawal by Subject|1
2141977|NCT01116440|3750066|FG000|Withdrawal|Lost to Follow-up|0
2141978|NCT01116440|3750067|FG001|Withdrawal|Lost to Follow-up|1
2141979|NCT01116440|3750066|FG000|Follow-up|Lost to Follow-up|0
2141980|NCT01116440|3750067|FG001|Follow-up|Lost to Follow-up|1
2141981|NCT01116440|3750066|FG000|Follow-up|Withdrawal by Subject|0
2141982|NCT01116440|3750067|FG001|Follow-up|Withdrawal by Subject|1
2141983|NCT01116544|3750082|FG000|Overall Study|Protocol Violation|1
2141984|NCT01116544|3750083|FG001|Overall Study|Protocol Violation|0
2141985|NCT01116544|3750082|FG000|Overall Study|Withdrawal by Subject|1
2141986|NCT01116544|3750083|FG001|Overall Study|Withdrawal by Subject|1
2141987|NCT01116687|3750093|FG000|Overall Study|Withdrawal by Subject|4
2141988|NCT01116739|3750099|FG000|Overall Study|Child had 2 years of HS|110
2141989|NCT01116739|3750100|FG001|Overall Study|Child had 2 years of HS|128
2141990|NCT01116739|3750099|FG000|Overall Study|Withdrawal by Subject|6
2141991|NCT01116739|3750100|FG001|Overall Study|Withdrawal by Subject|0
2141992|NCT01116739|3750099|FG000|Overall Study|child too young|2
2141993|NCT01116739|3750100|FG001|Overall Study|child too young|6
2141994|NCT01116739|3750099|FG000|Overall Study|child not enrolled in head start|10
2141995|NCT01116739|3750100|FG001|Overall Study|child not enrolled in head start|2
2141996|NCT01116739|3750099|FG000|Overall Study|enrolled caregiver not legal guardian|2
2141997|NCT01116739|3750100|FG001|Overall Study|enrolled caregiver not legal guardian|0
2141998|NCT01116882|3750108|FG000|30-day|Lost to Follow-up|50
2141999|NCT01116882|3750109|FG001|30-day|Lost to Follow-up|21
2142000|NCT01116882|3750108|FG000|30-day|Withdrawal by Subject|2
2142001|NCT01116882|3750109|FG001|30-day|Withdrawal by Subject|4
2142002|NCT01116882|3750108|FG000|30-day|Other Reasons|16
2142003|NCT01116882|3750109|FG001|30-day|Other Reasons|6
2142004|NCT01116882|3750108|FG000|12-month|Lost to Follow-up|111
2142005|NCT01116882|3750109|FG001|12-month|Lost to Follow-up|42
2142006|NCT01116882|3750108|FG000|12-month|Other Reasons|151
2142007|NCT01116882|3750109|FG001|12-month|Other Reasons|49
2142008|NCT01116882|3750108|FG000|12-month|Withdrawal by Subject|5
2142009|NCT01116882|3750109|FG001|12-month|Withdrawal by Subject|8
2142010|NCT01117012|3750238|FG000|Overall Study|Adverse Event|0
2142011|NCT01117012|3750239|FG001|Overall Study|Adverse Event|1
2142012|NCT01117012|3750238|FG000|Overall Study|Death|1
2142013|NCT01117012|3750239|FG001|Overall Study|Death|1
2142014|NCT01117012|3750238|FG000|Overall Study|Withdrawal by Subject|3
2142015|NCT01117012|3750239|FG001|Overall Study|Withdrawal by Subject|0
2142016|NCT01117012|3750238|FG000|Overall Study|Undefined|4
2142017|NCT01117012|3750239|FG001|Overall Study|Undefined|3
2142018|NCT01117051|3750247|FG000|Overall Study|Withdrawal by Subject|5
2142019|NCT01117051|3750248|FG001|Overall Study|Withdrawal by Subject|3
2142020|NCT01117051|3750247|FG000|Overall Study|Adverse Event|4
2142021|NCT01117051|3750248|FG001|Overall Study|Adverse Event|3
2142022|NCT01117051|3750247|FG000|Overall Study|Lost to Follow-up|0
2142023|NCT01117051|3750248|FG001|Overall Study|Lost to Follow-up|1
2289335|NCT02477332|3981417|FG005|Overall Study|Pregnancy|0
2142024|NCT01117051|3750247|FG000|Overall Study|Did not meet in-/exclusion criteria|0
2142025|NCT01117051|3750248|FG001|Overall Study|Did not meet in-/exclusion criteria|1
2142026|NCT01117051|3750247|FG000|Overall Study|Sponsor's decision|3
2142027|NCT01117051|3750248|FG001|Overall Study|Sponsor's decision|1
2142028|NCT01117051|3750247|FG000|Overall Study|Surgical procedure|0
2142029|NCT01117051|3750248|FG001|Overall Study|Surgical procedure|1
2142030|NCT01117051|3750247|FG000|Overall Study|Randomized by mistake|0
2142031|NCT01117051|3750248|FG001|Overall Study|Randomized by mistake|1
2142032|NCT01117051|3750247|FG000|Overall Study|Convenience issue|1
2142033|NCT01117051|3750248|FG001|Overall Study|Convenience issue|0
2142034|NCT01117181|3750268|FG000|Overall Study|Lost to Follow-up|1
2142035|NCT01117181|3750269|FG001|Overall Study|Lost to Follow-up|0
2142036|NCT01117181|3750268|FG000|Overall Study|Withdrawal by Subject|0
2142037|NCT01117181|3750269|FG001|Overall Study|Withdrawal by Subject|2
2142038|NCT01117337|3750286|FG000|Overall Study|Lost to Follow-up|4
2142039|NCT01117337|3750287|FG001|Overall Study|Lost to Follow-up|0
2142040|NCT01117350|3750295|FG000|Comparative Period|Not Treated|5
2142041|NCT01117350|3750296|FG001|Comparative Period|Not Treated|8
2142042|NCT01117350|3750295|FG000|Comparative Period|Adverse Event|6
2142043|NCT01117350|3750296|FG001|Comparative Period|Adverse Event|33
2142044|NCT01117350|3750295|FG000|Comparative Period|Lost to Follow-up|11
2142045|NCT01117350|3750296|FG001|Comparative Period|Lost to Follow-up|7
2142046|NCT01117350|3750295|FG000|Comparative Period|Withdrawal by Subject|9
2142047|NCT01117350|3750296|FG001|Comparative Period|Withdrawal by Subject|13
2142048|NCT01117350|3750295|FG000|Comparative Period|Protocol Violation|8
2142049|NCT01117350|3750296|FG001|Comparative Period|Protocol Violation|12
2142050|NCT01117350|3750295|FG000|Comparative Period|Lack of Efficacy|1
2142051|NCT01117350|3750296|FG001|Comparative Period|Lack of Efficacy|0
2142052|NCT01117350|3750295|FG000|Comparative Period|Physician Decision|0
2142053|NCT01117350|3750296|FG001|Comparative Period|Physician Decision|1
2142054|NCT01117350|3750295|FG000|Comparative Period|Move to another city/country|2
2142055|NCT01117350|3750296|FG001|Comparative Period|Move to another city/country|1
2142056|NCT01117350|3750295|FG000|Extension Period|Not included in extension, not treated|0
2142057|NCT01117350|3750296|FG001|Extension Period|Not included in extension, not treated|50
2142058|NCT01117350|3750295|FG000|Extension Period|Adverse Event|0
2142059|NCT01117350|3750296|FG001|Extension Period|Adverse Event|2
2207992|NCT01634360|3847243|FG001|Overall Study|Adverse Event|34
2207993|NCT01634360|3847242|FG000|Overall Study|subject withdrew consent|13
2207994|NCT01634360|3847243|FG001|Overall Study|subject withdrew consent|23
2207995|NCT01634360|3847242|FG000|Overall Study|Protocol Violation|1
2142060|NCT01117350|3750295|FG000|Extension Period|Protocol Violation|0
2142061|NCT01117350|3750296|FG001|Extension Period|Protocol Violation|2
2142062|NCT01117350|3750295|FG000|Extension Period|Lost to Follow-up|0
2142063|NCT01117350|3750296|FG001|Extension Period|Lost to Follow-up|2
2289336|NCT02477332|3981412|FG000|Overall Study|Protocol Violation|2
2289337|NCT02477332|3981413|FG001|Overall Study|Protocol Violation|0
2289338|NCT02477332|3981414|FG002|Overall Study|Protocol Violation|3
2289339|NCT02477332|3981415|FG003|Overall Study|Protocol Violation|3
2289340|NCT02477332|3981416|FG004|Overall Study|Protocol Violation|1
2289341|NCT02477332|3981417|FG005|Overall Study|Protocol Violation|1
2289342|NCT02477332|3981412|FG000|Overall Study|Technical problems|0
2289343|NCT02477332|3981413|FG001|Overall Study|Technical problems|0
2289344|NCT02477332|3981414|FG002|Overall Study|Technical problems|1
2289345|NCT02477332|3981415|FG003|Overall Study|Technical problems|0
2289346|NCT02477332|3981416|FG004|Overall Study|Technical problems|0
2289347|NCT02477332|3981417|FG005|Overall Study|Technical problems|0
2289348|NCT02477332|3981412|FG000|Overall Study|Lost to Follow-up|0
2289349|NCT02477332|3981413|FG001|Overall Study|Lost to Follow-up|0
2289350|NCT02477332|3981414|FG002|Overall Study|Lost to Follow-up|2
2289351|NCT02477332|3981415|FG003|Overall Study|Lost to Follow-up|0
2289352|NCT02477332|3981416|FG004|Overall Study|Lost to Follow-up|0
2289353|NCT02477332|3981417|FG005|Overall Study|Lost to Follow-up|0
2289354|NCT02477332|3981412|FG000|Overall Study|Physician Decision|0
2289355|NCT02477332|3981413|FG001|Overall Study|Physician Decision|0
2142064|NCT01117350|3750295|FG000|Extension Period|Withdrawal by Subject|0
2207996|NCT01634360|3847243|FG001|Overall Study|Protocol Violation|1
2207997|NCT01634360|3847242|FG000|Overall Study|Lack of Efficacy|4
2289356|NCT02477332|3981414|FG002|Overall Study|Physician Decision|1
2289357|NCT02477332|3981415|FG003|Overall Study|Physician Decision|3
2289358|NCT02477332|3981416|FG004|Overall Study|Physician Decision|0
2289359|NCT02477332|3981417|FG005|Overall Study|Physician Decision|1
2289360|NCT02477332|3981412|FG000|Overall Study|Withdrawal by Subject|0
2289361|NCT02477332|3981413|FG001|Overall Study|Withdrawal by Subject|3
2289362|NCT02477332|3981414|FG002|Overall Study|Withdrawal by Subject|1
2289363|NCT02477332|3981415|FG003|Overall Study|Withdrawal by Subject|2
2289364|NCT02477332|3981416|FG004|Overall Study|Withdrawal by Subject|1
2289365|NCT02477332|3981417|FG005|Overall Study|Withdrawal by Subject|0
2289366|NCT02477527|3981442|FG000|Overall Study|Lost to Follow-up|2
2142065|NCT01117350|3750296|FG001|Extension Period|Withdrawal by Subject|3
2142066|NCT01117350|3750295|FG000|Extension Period|Lack of Efficacy|0
2207998|NCT01634360|3847243|FG001|Overall Study|Lack of Efficacy|14
2207999|NCT01634360|3847242|FG000|Overall Study|Other|3
2208000|NCT01634360|3847243|FG001|Overall Study|Other|20
2208001|NCT01634360|3847242|FG000|Overall Study|Study termination by sponsor|18
2142067|NCT01117350|3750296|FG001|Extension Period|Lack of Efficacy|2
2142068|NCT01117350|3750295|FG000|Extension Period|Inclusion criteria not respected|0
2142069|NCT01117350|3750296|FG001|Extension Period|Inclusion criteria not respected|1
2142070|NCT01117350|3750295|FG000|Extension Period|Prohibited medication|0
2142071|NCT01117350|3750296|FG001|Extension Period|Prohibited medication|1
2142072|NCT01117428|3750311|FG000|Overall Study|Lack of Efficacy|1
2142073|NCT01117428|3750312|FG001|Overall Study|Lack of Efficacy|0
2142074|NCT01117428|3750313|FG002|Overall Study|Lack of Efficacy|0
2142075|NCT01117428|3750314|FG003|Overall Study|Lack of Efficacy|0
2142076|NCT01117428|3750315|FG004|Overall Study|Lack of Efficacy|0
2142077|NCT01117428|3750316|FG005|Overall Study|Lack of Efficacy|0
2142078|NCT01117428|3750311|FG000|Overall Study|Adverse Event|4
2142079|NCT01117428|3750312|FG001|Overall Study|Adverse Event|0
2142080|NCT01117428|3750313|FG002|Overall Study|Adverse Event|0
2142081|NCT01117428|3750314|FG003|Overall Study|Adverse Event|0
2142082|NCT01117428|3750315|FG004|Overall Study|Adverse Event|1
2142083|NCT01117428|3750316|FG005|Overall Study|Adverse Event|2
2142084|NCT01117428|3750311|FG000|Overall Study|Death|0
2142085|NCT01117428|3750312|FG001|Overall Study|Death|1
2142086|NCT01117428|3750313|FG002|Overall Study|Death|2
2142087|NCT01117428|3750314|FG003|Overall Study|Death|0
2142088|NCT01117428|3750315|FG004|Overall Study|Death|0
2142089|NCT01117428|3750316|FG005|Overall Study|Death|1
2142090|NCT01117428|3750311|FG000|Overall Study|Physician Decision|0
2142091|NCT01117428|3750312|FG001|Overall Study|Physician Decision|1
2142092|NCT01117428|3750313|FG002|Overall Study|Physician Decision|0
2142093|NCT01117428|3750314|FG003|Overall Study|Physician Decision|0
2142094|NCT01117428|3750315|FG004|Overall Study|Physician Decision|0
2142095|NCT01117428|3750316|FG005|Overall Study|Physician Decision|0
2142096|NCT01117428|3750311|FG000|Overall Study|Withdrawal by Subject|0
2142097|NCT01117428|3750312|FG001|Overall Study|Withdrawal by Subject|0
2142098|NCT01117428|3750313|FG002|Overall Study|Withdrawal by Subject|1
2142099|NCT01117428|3750314|FG003|Overall Study|Withdrawal by Subject|0
2142100|NCT01117428|3750315|FG004|Overall Study|Withdrawal by Subject|0
2142101|NCT01117428|3750316|FG005|Overall Study|Withdrawal by Subject|0
2142102|NCT01117428|3750311|FG000|Overall Study|Progressive disease|15
2142103|NCT01117428|3750312|FG001|Overall Study|Progressive disease|27
2142104|NCT01117428|3750313|FG002|Overall Study|Progressive disease|10
2142105|NCT01117428|3750314|FG003|Overall Study|Progressive disease|12
2142106|NCT01117428|3750315|FG004|Overall Study|Progressive disease|16
2142107|NCT01117428|3750316|FG005|Overall Study|Progressive disease|17
2142108|NCT01117454|3750334|FG000|Overall Study|Pregnancy|0
2142109|NCT01117454|3750335|FG001|Overall Study|Pregnancy|1
2142110|NCT01117480|3750341|FG000|Overall Study|Protocol Violation|8
2142111|NCT01117480|3750341|FG000|Overall Study|Did Not Start Adalimumab Therapy|20
2142112|NCT01117623|3750353|FG000|Overall Study|Adverse Event|0
2142113|NCT01117623|3750354|FG001|Overall Study|Adverse Event|2
2142114|NCT01117623|3750355|FG002|Overall Study|Adverse Event|4
2142115|NCT01117623|3750356|FG003|Overall Study|Adverse Event|0
2142116|NCT01117623|3750357|FG004|Overall Study|Adverse Event|2
2142117|NCT01117623|3750358|FG005|Overall Study|Adverse Event|0
2142118|NCT01117623|3750359|FG006|Overall Study|Adverse Event|0
2142119|NCT01117623|3750360|FG007|Overall Study|Adverse Event|2
2142120|NCT01117623|3750353|FG000|Overall Study|Disease progression, recurrence, relapse|3
2142121|NCT01117623|3750354|FG001|Overall Study|Disease progression, recurrence, relapse|6
2142122|NCT01117623|3750355|FG002|Overall Study|Disease progression, recurrence, relapse|5
2142123|NCT01117623|3750356|FG003|Overall Study|Disease progression, recurrence, relapse|6
2142124|NCT01117623|3750357|FG004|Overall Study|Disease progression, recurrence, relapse|8
2142125|NCT01117623|3750358|FG005|Overall Study|Disease progression, recurrence, relapse|14
2142126|NCT01117623|3750359|FG006|Overall Study|Disease progression, recurrence, relapse|5
2142127|NCT01117623|3750360|FG007|Overall Study|Disease progression, recurrence, relapse|22
2142128|NCT01117623|3750353|FG000|Overall Study|Withdrawal by Subject|0
2142129|NCT01117623|3750354|FG001|Overall Study|Withdrawal by Subject|0
2142130|NCT01117623|3750355|FG002|Overall Study|Withdrawal by Subject|2
2142131|NCT01117623|3750356|FG003|Overall Study|Withdrawal by Subject|0
2142132|NCT01117623|3750357|FG004|Overall Study|Withdrawal by Subject|0
2142133|NCT01117623|3750358|FG005|Overall Study|Withdrawal by Subject|1
2142134|NCT01117623|3750359|FG006|Overall Study|Withdrawal by Subject|1
2142135|NCT01117623|3750360|FG007|Overall Study|Withdrawal by Subject|1
2142136|NCT01117623|3750353|FG000|Overall Study|Non-compliance with study medication|0
2142137|NCT01117623|3750354|FG001|Overall Study|Non-compliance with study medication|0
2142138|NCT01117623|3750355|FG002|Overall Study|Non-compliance with study medication|0
2142139|NCT01117623|3750356|FG003|Overall Study|Non-compliance with study medication|0
2142140|NCT01117623|3750357|FG004|Overall Study|Non-compliance with study medication|0
2142141|NCT01117623|3750358|FG005|Overall Study|Non-compliance with study medication|0
2142142|NCT01117623|3750359|FG006|Overall Study|Non-compliance with study medication|0
2142143|NCT01117623|3750360|FG007|Overall Study|Non-compliance with study medication|1
2142144|NCT01117623|3750353|FG000|Overall Study|Invest. text: completed all planned txs|0
2142145|NCT01117623|3750354|FG001|Overall Study|Invest. text: completed all planned txs|0
2142146|NCT01117623|3750355|FG002|Overall Study|Invest. text: completed all planned txs|0
2142147|NCT01117623|3750356|FG003|Overall Study|Invest. text: completed all planned txs|0
2142148|NCT01117623|3750357|FG004|Overall Study|Invest. text: completed all planned txs|0
2142149|NCT01117623|3750358|FG005|Overall Study|Invest. text: completed all planned txs|1
2142150|NCT01117623|3750359|FG006|Overall Study|Invest. text: completed all planned txs|0
2142151|NCT01117623|3750360|FG007|Overall Study|Invest. text: completed all planned txs|0
2142152|NCT01117766|3750385|FG000|First Intervention|Adverse Event|0
2142153|NCT01117766|3750386|FG001|First Intervention|Adverse Event|1
2142154|NCT01117766|3750385|FG000|First Intervention|Protocol Violation|1
2142155|NCT01117766|3750386|FG001|First Intervention|Protocol Violation|0
2142156|NCT01117766|3750385|FG000|Washout Period|Protocol Violation|0
2142157|NCT01117766|3750386|FG001|Washout Period|Protocol Violation|2
2142158|NCT01117766|3750385|FG000|Second Intervention|Lost to Follow-up|1
2142159|NCT01117766|3750386|FG001|Second Intervention|Lost to Follow-up|0
2142160|NCT01117766|3750385|FG000|Second Intervention|Other|1
2142161|NCT01117766|3750386|FG001|Second Intervention|Other|2
2142162|NCT01117766|3750385|FG000|Second Intervention|Adverse Event|0
2142163|NCT01117766|3750386|FG001|Second Intervention|Adverse Event|2
2142164|NCT01117766|3750385|FG000|Second Intervention|Withdrawal by Subject|0
2142165|NCT01117766|3750386|FG001|Second Intervention|Withdrawal by Subject|1
2142166|NCT01117792|3750392|FG000|Overall Study|Death|1
2142167|NCT01117792|3750392|FG000|Overall Study|Adverse Event|3
2142168|NCT01117857|3750396|FG000|Overall Study|Lost to Follow-up|4
2142169|NCT01117857|3750396|FG000|Overall Study|Withdrawal by Subject|4
2142170|NCT01117857|3750396|FG000|Overall Study|Physician Decision|1
2142171|NCT01117870|3750402|FG000|Overall Study|Inability to place needle|1
2142172|NCT01117870|3750403|FG001|Overall Study|Inability to place needle|0
2142173|NCT01117987|3750424|FG000|Overall Study|Protocol deviation|0
2142174|NCT01117987|3750425|FG001|Overall Study|Protocol deviation|1
2142175|NCT01117987|3750424|FG000|Overall Study|Subject no longer requires study drug|1
2142176|NCT01117987|3750425|FG001|Overall Study|Subject no longer requires study drug|0
2142177|NCT01117987|3750424|FG000|Overall Study|Lost to Follow-up|1
2142178|NCT01117987|3750425|FG001|Overall Study|Lost to Follow-up|1
2142179|NCT01117987|3750424|FG000|Overall Study|Abnormal test procedure result|2
2142180|NCT01117987|3750425|FG001|Overall Study|Abnormal test procedure result|0
2142181|NCT01117987|3750424|FG000|Overall Study|Lack of Efficacy|3
2142182|NCT01117987|3750425|FG001|Overall Study|Lack of Efficacy|4
2142183|NCT01117987|3750424|FG000|Overall Study|Death|5
2142184|NCT01117987|3750425|FG001|Overall Study|Death|10
2142185|NCT01117987|3750424|FG000|Overall Study|Withdrawal by Subject|5
2142186|NCT01117987|3750425|FG001|Overall Study|Withdrawal by Subject|10
2142187|NCT01117987|3750424|FG000|Overall Study|Adverse Event|19
2142188|NCT01117987|3750425|FG001|Overall Study|Adverse Event|26
2142189|NCT01117987|3750424|FG000|Overall Study|Administrative problems|25
2142190|NCT01117987|3750425|FG001|Overall Study|Administrative problems|22
2142191|NCT01118052|3750431|FG000|Overall Study|Never treated|2
2142192|NCT01118117|3750452|FG000|Overall Study|Death|8
2142193|NCT01118117|3750453|FG001|Overall Study|Death|0
2142194|NCT01118117|3750452|FG000|Overall Study|Lost to Follow-up|6
2142195|NCT01118117|3750453|FG001|Overall Study|Lost to Follow-up|0
2142196|NCT01118117|3750452|FG000|Overall Study|Missed 12 Month Visit|7
2142197|NCT01118117|3750453|FG001|Overall Study|Missed 12 Month Visit|0
2178630|NCT01386645|3803553|FG001|Overall Study|Physician Decision|0
2178631|NCT01386645|3803554|FG002|Overall Study|Physician Decision|1
2178632|NCT01386645|3803552|FG000|Overall Study|Withdrawal by Subject|0
2178633|NCT01386645|3803553|FG001|Overall Study|Withdrawal by Subject|1
2178634|NCT01386645|3803554|FG002|Overall Study|Withdrawal by Subject|1
2178635|NCT01386788|3803562|FG000|Overall Study|Lost to Follow-up|2
2178636|NCT01386944|3803566|FG000|Overall Study|Adverse Event|26
2178637|NCT01386944|3803566|FG000|Overall Study|Lack of Efficacy|14
2178638|NCT01386944|3803566|FG000|Overall Study|Lost to Follow-up|8
2178639|NCT01386944|3803566|FG000|Overall Study|Unspecified reason|8
2178640|NCT01386970|3803572|FG000|Overall Study|Withdrawal by Subject|0
2178641|NCT01386970|3803573|FG001|Overall Study|Withdrawal by Subject|1
2178642|NCT01386970|3803572|FG000|Overall Study|Adverse Event|4
2178643|NCT01386970|3803573|FG001|Overall Study|Adverse Event|1
2178644|NCT01387022|3803592|FG000|Overall Study|Death|1
2178645|NCT01387022|3803593|FG001|Overall Study|Death|1
2178646|NCT01387022|3803592|FG000|Overall Study|Lost to Follow-up|0
2178647|NCT01387022|3803593|FG001|Overall Study|Lost to Follow-up|3
2178648|NCT01387074|3803599|FG000|Overall Study|Lost to Follow-up|7
2178649|NCT01387074|3803599|FG000|Overall Study|Lack of Efficacy|1
2208002|NCT01634360|3847243|FG001|Overall Study|Study termination by sponsor|44
2208003|NCT01634555|3847249|FG000|Overall Study|Adverse Event|3
2208004|NCT01634555|3847249|FG000|Overall Study|Physician Decision|1
2208005|NCT01634659|3847265|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2
2208006|NCT01634659|3847266|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0
2289367|NCT02477527|3981442|FG000|Overall Study|Withdrawal by Subject|1
2178650|NCT01387230|3803625|FG000|Overall Study|Adverse Event|0
2178651|NCT01387230|3803626|FG001|Overall Study|Adverse Event|1
2178652|NCT01387230|3803627|FG002|Overall Study|Adverse Event|3
2208007|NCT01634659|3847265|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1
2208008|NCT01634659|3847266|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0
2178653|NCT01387230|3803625|FG000|Overall Study|Lack of Efficacy|8
2178654|NCT01387230|3803626|FG001|Overall Study|Lack of Efficacy|5
2208009|NCT01634854|3847274|FG000|Overall Study|Cesarean delivery|2
2142198|NCT01118143|3750461|FG000|Overall Study|Withdrawal by Subject|2
2142199|NCT01118143|3750462|FG001|Overall Study|Withdrawal by Subject|5
2142200|NCT01118299|3750510|FG000|Overall Study|Death|7
2142201|NCT01118299|3750511|FG001|Overall Study|Death|5
2142202|NCT01118299|3750510|FG000|Overall Study|Withdrawal by Subject|8
2142203|NCT01118299|3750511|FG001|Overall Study|Withdrawal by Subject|8
2142204|NCT01118299|3750510|FG000|Overall Study|Lost to Follow-up|2
2142205|NCT01118299|3750511|FG001|Overall Study|Lost to Follow-up|1
2142206|NCT01118299|3750510|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6
2142207|NCT01118299|3750511|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15
2142208|NCT01118312|3750518|FG000|Overall Study|Lost to Follow-up|33
2142209|NCT01118312|3750519|FG001|Overall Study|Lost to Follow-up|32
2142210|NCT01118312|3750518|FG000|Overall Study|Withdrawal by Subject|1
2142211|NCT01118312|3750519|FG001|Overall Study|Withdrawal by Subject|3
2142212|NCT01118325|3750528|FG000|Overall Study|Adverse Event|1
2142213|NCT01118325|3750529|FG001|Overall Study|Adverse Event|0
2142214|NCT01118325|3750530|FG002|Overall Study|Adverse Event|1
2142215|NCT01118351|3750560|FG000|Overall Study|Adverse Event|3
2142216|NCT01118351|3750560|FG000|Overall Study|Withdrawal by Subject|1
2142217|NCT01118377|3750564|FG000|Overall Study|Did Not Receive Study Medication|1
2142218|NCT01118377|3750564|FG000|Overall Study|Death|38
2142219|NCT01118377|3750564|FG000|Overall Study|Failure to Return|3
2142220|NCT01118455|3750570|FG000|Baseline [Visits 1 & 2]|Adverse Event|1
2142221|NCT01118455|3750571|FG001|Baseline [Visits 1 & 2]|Adverse Event|0
2142222|NCT01118520|3750588|FG000|Overall Study|AAA repair|9
2142223|NCT01118520|3750589|FG001|Overall Study|AAA repair|7
2142224|NCT01118520|3750590|FG002|Overall Study|AAA repair|9
2142225|NCT01118520|3750588|FG000|Overall Study|Adverse Event|3
2142226|NCT01118520|3750589|FG001|Overall Study|Adverse Event|3
2142227|NCT01118520|3750590|FG002|Overall Study|Adverse Event|3
2142228|NCT01118520|3750588|FG000|Overall Study|Withdrawal by Subject|8
2142229|NCT01118520|3750589|FG001|Overall Study|Withdrawal by Subject|13
2142230|NCT01118520|3750590|FG002|Overall Study|Withdrawal by Subject|8
2142231|NCT01118663|3750604|FG000|Overall Study|Adverse Event|2
2142232|NCT01118663|3750605|FG001|Overall Study|Adverse Event|1
2142233|NCT01118663|3750604|FG000|Overall Study|Withdrawal by Subject|0
2142234|NCT01118663|3750605|FG001|Overall Study|Withdrawal by Subject|1
2142235|NCT01118728|3750641|FG000|Overall Study|Adverse Event|17
2142236|NCT01118728|3750641|FG000|Overall Study|Lack of Efficacy|27
2142237|NCT01118728|3750641|FG000|Overall Study|Sponsor's decision to discontinue study|172
2142238|NCT01118728|3750641|FG000|Overall Study|Withdrawal by Subject|3
2142239|NCT01118728|3750641|FG000|Overall Study|Lost to Follow-up|4
2142240|NCT01118780|3750658|FG000|Overall Study|Adverse Event|15
2142241|NCT01118780|3750659|FG001|Overall Study|Adverse Event|15
2142242|NCT01118780|3750658|FG000|Overall Study|Death|1
2142243|NCT01118780|3750659|FG001|Overall Study|Death|0
2142244|NCT01118780|3750658|FG000|Overall Study|Lack of Efficacy|2
2289368|NCT02477527|3981442|FG000|Overall Study|Screen Failure|3
2289369|NCT02477553|3981448|FG000|Overall Study|Screening up-to-date|12
2289370|NCT02477553|3981449|FG001|Overall Study|Screening up-to-date|13
2289371|NCT02477553|3981448|FG000|Overall Study|No MD visit|1
2289372|NCT02477553|3981449|FG001|Overall Study|No MD visit|1
2289373|NCT02477553|3981448|FG000|Overall Study|Workup consistent w/CRC|1
2289374|NCT02477553|3981449|FG001|Overall Study|Workup consistent w/CRC|1
2289375|NCT02477553|3981448|FG000|Overall Study|Technical issues with intervention|2
2289376|NCT02477553|3981449|FG001|Overall Study|Technical issues with intervention|0
2289377|NCT02477553|3981448|FG000|Overall Study|Elevated risk for CRC|2
2289378|NCT02477553|3981449|FG001|Overall Study|Elevated risk for CRC|2
2289379|NCT02477553|3981448|FG000|Overall Study|MD advised against screening|1
2289380|NCT02477553|3981449|FG001|Overall Study|MD advised against screening|3
2289381|NCT02477553|3981448|FG000|Overall Study|patient deceased|1
2289382|NCT02477553|3981449|FG001|Overall Study|patient deceased|0
2289383|NCT02477605|3981457|FG000|Overall Study|Discontinued prior to treatment|1
2289384|NCT02477605|3981458|FG001|Overall Study|Discontinued prior to treatment|0
2289385|NCT02477605|3981457|FG000|Overall Study|Lost to Follow-up|0
2289386|NCT02477605|3981458|FG001|Overall Study|Lost to Follow-up|2
2289387|NCT02477605|3981457|FG000|Overall Study|Withdrawal by Subject|0
2289388|NCT02477605|3981458|FG001|Overall Study|Withdrawal by Subject|1
2289389|NCT02477605|3981457|FG000|Overall Study|Administered gas during surgery|0
2289390|NCT02477605|3981458|FG001|Overall Study|Administered gas during surgery|1
2289391|NCT02477670|3981470|FG000|Stage 1|Adverse Event|2
2289392|NCT02477670|3981471|FG001|Stage 1|Adverse Event|7
2289393|NCT02477670|3981472|FG002|Stage 1|Adverse Event|0
2289394|NCT02477670|3981473|FG003|Stage 1|Adverse Event|0
2289395|NCT02477670|3981474|FG004|Stage 1|Adverse Event|0
2289396|NCT02477670|3981475|FG005|Stage 1|Adverse Event|0
2289397|NCT02477670|3981476|FG006|Stage 1|Adverse Event|0
2289398|NCT02477670|3981470|FG000|Stage 1|Lost to Follow-up|0
2289399|NCT02477670|3981471|FG001|Stage 1|Lost to Follow-up|2
2289400|NCT02477670|3981472|FG002|Stage 1|Lost to Follow-up|0
2289401|NCT02477670|3981473|FG003|Stage 1|Lost to Follow-up|0
2142245|NCT01118780|3750659|FG001|Overall Study|Lack of Efficacy|6
2142246|NCT01118780|3750658|FG000|Overall Study|Physician Decision|2
2142247|NCT01118780|3750659|FG001|Overall Study|Physician Decision|0
2289402|NCT02477670|3981474|FG004|Stage 1|Lost to Follow-up|0
2289403|NCT02477670|3981475|FG005|Stage 1|Lost to Follow-up|0
2142248|NCT01118780|3750658|FG000|Overall Study|Protocol Violation|3
2142249|NCT01118780|3750659|FG001|Overall Study|Protocol Violation|6
2142250|NCT01118780|3750658|FG000|Overall Study|Withdrawal by Subject|13
2142251|NCT01118780|3750659|FG001|Overall Study|Withdrawal by Subject|8
2142252|NCT01118949|3750672|FG000|Overall Study|Adverse Event|5
2142253|NCT01118949|3750672|FG000|Overall Study|Withdrawal by Subject|4
2142254|NCT01118962|3750676|FG000|Overall Study|Adverse Event|2
2142255|NCT01118962|3750676|FG000|Overall Study|Lack of Efficacy|1
2142256|NCT01118962|3750676|FG000|Overall Study|Protocol Violation|1
2142257|NCT01118962|3750676|FG000|Overall Study|Withdrawal by Subject|4
2142258|NCT01118962|3750676|FG000|Overall Study|Pregnancy|1
2142259|NCT01118962|3750676|FG000|Overall Study|Non-compliance with Medicinal Product|1
2142260|NCT01118975|3750682|FG000|Overall Study|Adverse Event|0
2142261|NCT01118975|3750683|FG001|Overall Study|Adverse Event|1
2142262|NCT01119001|3750701|FG000|Overall Study|Withdrawal by Subject|2
2142263|NCT01119105|3750714|FG000|Overall Study|Withdrawal by Subject|1
2142264|NCT01119105|3750715|FG001|Overall Study|Withdrawal by Subject|1
2142265|NCT01119105|3750716|FG002|Overall Study|Withdrawal by Subject|1
2142266|NCT01119105|3750714|FG000|Overall Study|Lost to Follow-up|0
2142267|NCT01119105|3750715|FG001|Overall Study|Lost to Follow-up|2
2142268|NCT01119105|3750716|FG002|Overall Study|Lost to Follow-up|5
2142269|NCT01119105|3750714|FG000|Overall Study|Adverse Event|1
2142270|NCT01119105|3750715|FG001|Overall Study|Adverse Event|0
2142271|NCT01119105|3750716|FG002|Overall Study|Adverse Event|1
2142272|NCT01119105|3750714|FG000|Overall Study|study drug missed on 2 consecutive days|1
2142273|NCT01119105|3750715|FG001|Overall Study|study drug missed on 2 consecutive days|2
2142274|NCT01119105|3750716|FG002|Overall Study|study drug missed on 2 consecutive days|1
2142275|NCT01119105|3750714|FG000|Overall Study|Other|1
2142276|NCT01119105|3750715|FG001|Overall Study|Other|1
2142277|NCT01119105|3750716|FG002|Overall Study|Other|0
2142278|NCT01119118|3750724|FG000|Overall Study|Adverse Event|1
2142279|NCT01119131|3750731|FG000|Overall Study|Adverse Event|1
2142280|NCT01119131|3750732|FG001|Overall Study|Adverse Event|1
2142281|NCT01119131|3750733|FG002|Overall Study|Adverse Event|1
2142282|NCT01119131|3750731|FG000|Overall Study|Non-Compliance|1
2142283|NCT01119131|3750732|FG001|Overall Study|Non-Compliance|0
2142284|NCT01119131|3750733|FG002|Overall Study|Non-Compliance|4
2142285|NCT01119131|3750731|FG000|Overall Study|Physician Decision|0
2142286|NCT01119131|3750732|FG001|Overall Study|Physician Decision|0
2142287|NCT01119131|3750733|FG002|Overall Study|Physician Decision|1
2142288|NCT01119248|3750757|FG000|Overall Study|Physician Decision|5
2142289|NCT01119287|3750768|FG000|Overall Study|Patient Decision, not related to AE|0
2142290|NCT01119287|3750769|FG001|Overall Study|Patient Decision, not related to AE|0
2142291|NCT01119287|3750770|FG002|Overall Study|Patient Decision, not related to AE|2
2142292|NCT01119287|3750771|FG003|Overall Study|Patient Decision, not related to AE|2
2142293|NCT01119287|3750772|FG004|Overall Study|Patient Decision, not related to AE|1
2142294|NCT01119287|3750773|FG005|Overall Study|Patient Decision, not related to AE|0
2142295|NCT01119443|3750787|FG000|Crossover Period 1 (5 Days)|Adverse Event|0
2142296|NCT01119443|3750788|FG001|Crossover Period 1 (5 Days)|Adverse Event|1
2142297|NCT01119508|3750837|FG000|Overall Study|Adverse Event|56
2142298|NCT01119508|3750837|FG000|Overall Study|Withdrawal by Subject|2
2142299|NCT01119508|3750837|FG000|Overall Study|Died before tumor response evaluation|1
2142300|NCT01119625|3750843|FG000|Overall Study|Lost to Follow-up|1
2142301|NCT01119625|3750844|FG001|Overall Study|Lost to Follow-up|2
2142302|NCT01119625|3750843|FG000|Overall Study|Withdrawal by Subject|2
2142303|NCT01119625|3750844|FG001|Overall Study|Withdrawal by Subject|1
2142304|NCT01119625|3750843|FG000|Overall Study|Other|0
2142305|NCT01119625|3750844|FG001|Overall Study|Other|1
2142306|NCT01119703|3750852|FG000|Overall Study|Adverse Event|0
2142307|NCT01119703|3750853|FG001|Overall Study|Adverse Event|1
2142308|NCT01119768|3750872|FG000|Treatment Period|Lack of Efficacy|18
2142309|NCT01119768|3750873|FG001|Treatment Period|Lack of Efficacy|25
2142310|NCT01119846|3750886|FG000|Overall Study|Adverse Event|1
2142311|NCT01119846|3750887|FG001|Overall Study|Adverse Event|0
2142312|NCT01119846|3750888|FG002|Overall Study|Adverse Event|6
2142313|NCT01119846|3750886|FG000|Overall Study|Physician Decision|1
2142314|NCT01119846|3750887|FG001|Overall Study|Physician Decision|0
2142315|NCT01119846|3750888|FG002|Overall Study|Physician Decision|0
2142316|NCT01119846|3750886|FG000|Overall Study|Protocol Violation|0
2142317|NCT01119846|3750887|FG001|Overall Study|Protocol Violation|0
2142318|NCT01119846|3750888|FG002|Overall Study|Protocol Violation|1
2142319|NCT01119846|3750886|FG000|Overall Study|Withdrawal by Subject|0
2142320|NCT01119846|3750887|FG001|Overall Study|Withdrawal by Subject|0
2142321|NCT01119846|3750888|FG002|Overall Study|Withdrawal by Subject|4
2142322|NCT01119859|3750925|FG000|Overall Study|Adverse Event|9
2142323|NCT01119859|3750926|FG001|Overall Study|Adverse Event|10
2289404|NCT02477670|3981476|FG006|Stage 1|Lost to Follow-up|0
2289405|NCT02477670|3981470|FG000|Stage 1|Withdrawal by Subject|1
2289406|NCT02477670|3981471|FG001|Stage 1|Withdrawal by Subject|2
2289407|NCT02477670|3981472|FG002|Stage 1|Withdrawal by Subject|0
2142324|NCT01119859|3750925|FG000|Overall Study|Death|2
2142325|NCT01119859|3750926|FG001|Overall Study|Death|0
2142326|NCT01119859|3750925|FG000|Overall Study|Insufficient therapeutic response|7
2142327|NCT01119859|3750926|FG001|Overall Study|Insufficient therapeutic response|14
2142328|NCT01119859|3750925|FG000|Overall Study|Refused treatment|3
2142329|NCT01119859|3750926|FG001|Overall Study|Refused treatment|6
2142330|NCT01119859|3750925|FG000|Overall Study|Failure to return|3
2142331|NCT01119859|3750926|FG001|Overall Study|Failure to return|0
2142332|NCT01119898|3750934|FG000|Overall Study|Adverse Event|4
2142333|NCT01119898|3750935|FG001|Overall Study|Adverse Event|5
2142334|NCT01119898|3750934|FG000|Overall Study|Withdrawal by Subject|1
2142335|NCT01119898|3750935|FG001|Overall Study|Withdrawal by Subject|4
2142336|NCT01119898|3750934|FG000|Overall Study|Lack of Efficacy|0
2142337|NCT01119898|3750935|FG001|Overall Study|Lack of Efficacy|2
2142338|NCT01119898|3750934|FG000|Overall Study|Protocol Violation|1
2142339|NCT01119898|3750935|FG001|Overall Study|Protocol Violation|1
2142340|NCT01119898|3750934|FG000|Overall Study|Medical procedure|1
2142341|NCT01119898|3750935|FG001|Overall Study|Medical procedure|0
2142342|NCT01119898|3750934|FG000|Overall Study|Randomized in error did not participate|1
2142343|NCT01119898|3750935|FG001|Overall Study|Randomized in error did not participate|0
2142344|NCT01119937|3750943|FG000|Overall Study|Adverse Event|11
2142345|NCT01119937|3750944|FG001|Overall Study|Adverse Event|5
2142346|NCT01119937|3750943|FG000|Overall Study|Protocol deviation|3
2142347|NCT01119937|3750944|FG001|Overall Study|Protocol deviation|1
2142348|NCT01119937|3750943|FG000|Overall Study|Unsatisfactory therapeutic effect|3
2142349|NCT01119937|3750944|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2142350|NCT01119937|3750943|FG000|Overall Study|Withdrawal by Subject|2
2142351|NCT01119937|3750944|FG001|Overall Study|Withdrawal by Subject|1
2142352|NCT01119950|3750950|FG000|Overall Study|Adverse Event|25
2142353|NCT01119950|3750950|FG000|Overall Study|Withdrawal by Subject|9
2142354|NCT01119950|3750950|FG000|Overall Study|Protocol Violation|5
2142355|NCT01119950|3750950|FG000|Overall Study|Lost to Follow-up|4
2142356|NCT01119950|3750950|FG000|Overall Study|Administrative|2
2142357|NCT01119950|3750950|FG000|Overall Study|Abnormal lab value|1
2142358|NCT01119950|3750950|FG000|Overall Study|Death|1
2142359|NCT01119963|3750978|FG000|Overall Study|Lost to Follow-up|1
2142360|NCT01119963|3750979|FG001|Overall Study|Lost to Follow-up|1
2142361|NCT01120028|3750991|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
2142362|NCT01120028|3750992|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
2142363|NCT01120028|3750993|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
2142364|NCT01120028|3750994|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
2142365|NCT01120028|3750991|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
2142366|NCT01120028|3750992|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
2142367|NCT01120028|3750993|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
2142368|NCT01120028|3750994|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
2142369|NCT01120067|3751007|FG000|Overall Study|Lost to Follow-up|3
2142370|NCT01120067|3751008|FG001|Overall Study|Lost to Follow-up|1
2142371|NCT01120067|3751007|FG000|Overall Study|fail to engage >3 sessions|2
2142372|NCT01120067|3751008|FG001|Overall Study|fail to engage >3 sessions|0
2142373|NCT01120093|3751014|FG000|Treatment Period 1|Adverse Event|0
2142374|NCT01120093|3751015|FG001|Treatment Period 1|Adverse Event|0
2142375|NCT01120093|3751016|FG002|Treatment Period 1|Adverse Event|1
2142376|NCT01120093|3751017|FG003|Treatment Period 1|Adverse Event|0
2142377|NCT01120093|3751018|FG004|Treatment Period 1|Adverse Event|1
2142378|NCT01120093|3751014|FG000|Treatment Period 1|Withdrawal by Subject|0
2142379|NCT01120093|3751015|FG001|Treatment Period 1|Withdrawal by Subject|1
2142380|NCT01120093|3751016|FG002|Treatment Period 1|Withdrawal by Subject|0
2142381|NCT01120093|3751017|FG003|Treatment Period 1|Withdrawal by Subject|0
2142382|NCT01120093|3751018|FG004|Treatment Period 1|Withdrawal by Subject|0
2142383|NCT01120093|3751014|FG000|Treatment Period 2|Adverse Event|0
2142384|NCT01120093|3751015|FG001|Treatment Period 2|Adverse Event|0
2142385|NCT01120093|3751016|FG002|Treatment Period 2|Adverse Event|0
2142386|NCT01120093|3751017|FG003|Treatment Period 2|Adverse Event|1
2142387|NCT01120093|3751018|FG004|Treatment Period 2|Adverse Event|0
2142388|NCT01120093|3751014|FG000|Treatment Period 2|Withdrawal by Subject|0
2142389|NCT01120093|3751015|FG001|Treatment Period 2|Withdrawal by Subject|0
2142390|NCT01120093|3751016|FG002|Treatment Period 2|Withdrawal by Subject|0
2142391|NCT01120093|3751017|FG003|Treatment Period 2|Withdrawal by Subject|0
2142392|NCT01120093|3751018|FG004|Treatment Period 2|Withdrawal by Subject|1
2142393|NCT01120093|3751014|FG000|Treatment Period 3|Lack of Efficacy|0
2142394|NCT01120093|3751015|FG001|Treatment Period 3|Lack of Efficacy|0
2142395|NCT01120093|3751016|FG002|Treatment Period 3|Lack of Efficacy|0
2142396|NCT01120093|3751017|FG003|Treatment Period 3|Lack of Efficacy|1
2142397|NCT01120093|3751018|FG004|Treatment Period 3|Lack of Efficacy|0
2142398|NCT01120093|3751014|FG000|Treatment Period 3|Adverse Event|0
2142399|NCT01120093|3751015|FG001|Treatment Period 3|Adverse Event|0
2142400|NCT01120093|3751016|FG002|Treatment Period 3|Adverse Event|0
2142401|NCT01120093|3751017|FG003|Treatment Period 3|Adverse Event|0
2142402|NCT01120093|3751018|FG004|Treatment Period 3|Adverse Event|1
2142403|NCT01120093|3751014|FG000|Treatment Period 3|Withdrawal by Subject|0
2142404|NCT01120093|3751015|FG001|Treatment Period 3|Withdrawal by Subject|0
2142405|NCT01120093|3751016|FG002|Treatment Period 3|Withdrawal by Subject|1
2142406|NCT01120093|3751017|FG003|Treatment Period 3|Withdrawal by Subject|0
2142407|NCT01120093|3751018|FG004|Treatment Period 3|Withdrawal by Subject|0
2142408|NCT01120093|3751014|FG000|Treatment Period 4|Adverse Event|1
2142409|NCT01120093|3751015|FG001|Treatment Period 4|Adverse Event|0
2142410|NCT01120093|3751016|FG002|Treatment Period 4|Adverse Event|0
2142411|NCT01120093|3751017|FG003|Treatment Period 4|Adverse Event|0
2142412|NCT01120093|3751018|FG004|Treatment Period 4|Adverse Event|0
2142413|NCT01120093|3751014|FG000|Treatment Period 5|Adverse Event|0
2142414|NCT01120093|3751015|FG001|Treatment Period 5|Adverse Event|1
2142415|NCT01120093|3751016|FG002|Treatment Period 5|Adverse Event|0
2142416|NCT01120093|3751017|FG003|Treatment Period 5|Adverse Event|1
2142417|NCT01120093|3751018|FG004|Treatment Period 5|Adverse Event|0
2142418|NCT01120184|3751033|FG000|Overall Study|Adverse Event|0
2142419|NCT01120184|3751034|FG001|Overall Study|Adverse Event|1
2142420|NCT01120184|3751035|FG002|Overall Study|Adverse Event|0
2142421|NCT01120184|3751033|FG000|Overall Study|Lost to Follow-up|13
2142422|NCT01120184|3751034|FG001|Overall Study|Lost to Follow-up|13
2142423|NCT01120184|3751035|FG002|Overall Study|Lost to Follow-up|11
2142424|NCT01120184|3751033|FG000|Overall Study|Physician Decision|9
2142425|NCT01120184|3751034|FG001|Overall Study|Physician Decision|1
2142426|NCT01120184|3751035|FG002|Overall Study|Physician Decision|3
2142427|NCT01120184|3751033|FG000|Overall Study|Reason not Specified|8
2142428|NCT01120184|3751034|FG001|Overall Study|Reason not Specified|3
2142429|NCT01120184|3751035|FG002|Overall Study|Reason not Specified|12
2142430|NCT01120184|3751033|FG000|Overall Study|Sponsor Decision to Terminate Study|133
2142431|NCT01120184|3751034|FG001|Overall Study|Sponsor Decision to Terminate Study|144
2142432|NCT01120184|3751035|FG002|Overall Study|Sponsor Decision to Terminate Study|143
2142433|NCT01120184|3751033|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32
2142434|NCT01120184|3751034|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29
2142435|NCT01120184|3751035|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25
2142436|NCT01120184|3751033|FG000|Overall Study|Death|170
2142437|NCT01120184|3751034|FG001|Overall Study|Death|176
2142438|NCT01120184|3751035|FG002|Overall Study|Death|169
2142439|NCT01120210|3751055|FG000|MAIN INFUSION|Adverse Event|1
2142440|NCT01120210|3751056|FG001|MAIN INFUSION|Adverse Event|0
2142441|NCT01120210|3751055|FG000|MAIN INFUSION|Withdrawal by Subject|0
2142442|NCT01120210|3751056|FG001|MAIN INFUSION|Withdrawal by Subject|1
2142443|NCT01120275|3751083|FG000|Overall Study|Adverse Event|3
2142444|NCT01120275|3751083|FG000|Overall Study|Progression|27
2142445|NCT01120275|3751083|FG000|Overall Study|Ineligible|3
2142446|NCT01120275|3751083|FG000|Overall Study|Withdrawal by Subject|1
2142447|NCT01120275|3751083|FG000|Overall Study|Refusal|1
2142448|NCT01120275|3751083|FG000|Overall Study|Not specific|1
2142449|NCT01120379|3751088|FG000|One Year Timepoint|Withdrawal by Subject|41
2142450|NCT01120379|3751088|FG000|One Year Timepoint|Lost to Follow-up|115
2142451|NCT01120379|3751088|FG000|One Year Timepoint|Death|108
2142452|NCT01120379|3751088|FG000|One Year Timepoint|Physician Decision|9
2142453|NCT01120379|3751088|FG000|One Year Timepoint|Any other reason for early termination|5
2142454|NCT01120379|3751088|FG000|Two Year Timepoint|Withdrawal by Subject|11
2142455|NCT01120379|3751088|FG000|Two Year Timepoint|Lost to Follow-up|87
2142456|NCT01120379|3751088|FG000|Two Year Timepoint|Death|123
2142457|NCT01120379|3751088|FG000|Two Year Timepoint|Physician Decision|12
2142458|NCT01120379|3751088|FG000|Two Year Timepoint|Any other reason for early termination|4
2142459|NCT01120379|3751088|FG000|Three Year Timepoint|Withdrawal by Subject|25
2142460|NCT01120379|3751088|FG000|Three Year Timepoint|Lost to Follow-up|43
2142461|NCT01120379|3751088|FG000|Three Year Timepoint|Death|120
2142462|NCT01120379|3751088|FG000|Three Year Timepoint|Physician Decision|9
2142463|NCT01120379|3751088|FG000|Three Year Timepoint|Any other reason for early termination|17
2142464|NCT01120379|3751088|FG000|Four Year Timepoint|Withdrawal by Subject|5
2142465|NCT01120379|3751088|FG000|Four Year Timepoint|Lost to Follow-up|10
2142466|NCT01120379|3751088|FG000|Four Year Timepoint|Death|131
2142467|NCT01120379|3751088|FG000|Four Year Timepoint|Physician Decision|5
2142468|NCT01120379|3751088|FG000|Four Year Timepoint|Any other reason for early termination|217
2142469|NCT01120600|3751105|FG000|Overall Study|Adverse Event|7
2142470|NCT01120600|3751106|FG001|Overall Study|Adverse Event|7
2142471|NCT01120600|3751105|FG000|Overall Study|Excessive Bone Loss|0
2142472|NCT01120600|3751106|FG001|Overall Study|Excessive Bone Loss|4
2142473|NCT01120600|3751105|FG000|Overall Study|Lost to Follow-up|1
2289408|NCT02477670|3981473|FG003|Stage 1|Withdrawal by Subject|0
2289409|NCT02477670|3981474|FG004|Stage 1|Withdrawal by Subject|0
2289410|NCT02477670|3981475|FG005|Stage 1|Withdrawal by Subject|0
2289411|NCT02477670|3981476|FG006|Stage 1|Withdrawal by Subject|0
2289412|NCT02477670|3981470|FG000|Stage 1|Non-compliance with Study Drug|1
2289413|NCT02477670|3981471|FG001|Stage 1|Non-compliance with Study Drug|2
2289414|NCT02477670|3981472|FG002|Stage 1|Non-compliance with Study Drug|0
2289415|NCT02477670|3981473|FG003|Stage 1|Non-compliance with Study Drug|0
2289416|NCT02477670|3981474|FG004|Stage 1|Non-compliance with Study Drug|0
2289417|NCT02477670|3981475|FG005|Stage 1|Non-compliance with Study Drug|0
2289418|NCT02477670|3981476|FG006|Stage 1|Non-compliance with Study Drug|0
2289419|NCT02477670|3981470|FG000|Stage 2|Adverse Event|0
2289420|NCT02477670|3981471|FG001|Stage 2|Adverse Event|0
2289421|NCT02477670|3981472|FG002|Stage 2|Adverse Event|1
2289422|NCT02477670|3981473|FG003|Stage 2|Adverse Event|0
2289423|NCT02477670|3981474|FG004|Stage 2|Adverse Event|0
2142474|NCT01120600|3751106|FG001|Overall Study|Lost to Follow-up|3
2142475|NCT01120600|3751105|FG000|Overall Study|Physician Decision|1
2142476|NCT01120600|3751106|FG001|Overall Study|Physician Decision|3
2289424|NCT02477670|3981475|FG005|Stage 2|Adverse Event|0
2142477|NCT01120600|3751105|FG000|Overall Study|Protocol Violation|0
2142478|NCT01120600|3751106|FG001|Overall Study|Protocol Violation|4
2289425|NCT02477670|3981476|FG006|Stage 2|Adverse Event|0
2142479|NCT01120600|3751105|FG000|Overall Study|Withdrawal by Subject|10
2142480|NCT01120600|3751106|FG001|Overall Study|Withdrawal by Subject|11
2142481|NCT01120626|3751114|FG000|Overall Study|Withdrawal by Subject|1
2142482|NCT01120626|3751115|FG001|Overall Study|Withdrawal by Subject|0
2142483|NCT01120691|3751141|FG000|Overall Study|Adverse Event|59
2142484|NCT01120691|3751142|FG001|Overall Study|Adverse Event|67
2142485|NCT01120691|3751143|FG002|Overall Study|Adverse Event|47
2142486|NCT01120691|3751141|FG000|Overall Study|Subject withdrew consent|33
2142487|NCT01120691|3751142|FG001|Overall Study|Subject withdrew consent|50
2142488|NCT01120691|3751143|FG002|Overall Study|Subject withdrew consent|44
2142489|NCT01120691|3751141|FG000|Overall Study|Death|21
2142490|NCT01120691|3751142|FG001|Overall Study|Death|22
2142491|NCT01120691|3751143|FG002|Overall Study|Death|24
2142492|NCT01120691|3751141|FG000|Overall Study|Unsatisfactory therapeutic effect|18
2142493|NCT01120691|3751142|FG001|Overall Study|Unsatisfactory therapeutic effect|32
2142494|NCT01120691|3751143|FG002|Overall Study|Unsatisfactory therapeutic effect|38
2142495|NCT01120691|3751141|FG000|Overall Study|Administrative problems|15
2142496|NCT01120691|3751142|FG001|Overall Study|Administrative problems|8
2142497|NCT01120691|3751143|FG002|Overall Study|Administrative problems|9
2142498|NCT01120691|3751141|FG000|Overall Study|Protocol deviation|13
2142499|NCT01120691|3751142|FG001|Overall Study|Protocol deviation|12
2142500|NCT01120691|3751143|FG002|Overall Study|Protocol deviation|12
2142501|NCT01120691|3751141|FG000|Overall Study|Lost to Follow-up|5
2142502|NCT01120691|3751142|FG001|Overall Study|Lost to Follow-up|6
2142503|NCT01120691|3751143|FG002|Overall Study|Lost to Follow-up|4
2142504|NCT01120691|3751141|FG000|Overall Study|Abnormal test procedure result(s)|3
2289426|NCT02477670|3981470|FG000|Stage 2|Antipsychotic Medication Changed|0
2289427|NCT02477670|3981471|FG001|Stage 2|Antipsychotic Medication Changed|0
2289428|NCT02477670|3981472|FG002|Stage 2|Antipsychotic Medication Changed|1
2289429|NCT02477670|3981473|FG003|Stage 2|Antipsychotic Medication Changed|0
2289430|NCT02477670|3981474|FG004|Stage 2|Antipsychotic Medication Changed|0
2289431|NCT02477670|3981475|FG005|Stage 2|Antipsychotic Medication Changed|0
2289432|NCT02477670|3981476|FG006|Stage 2|Antipsychotic Medication Changed|0
2289433|NCT02477670|3981470|FG000|Stage 2|Withdrawal by Subject|0
2289434|NCT02477670|3981471|FG001|Stage 2|Withdrawal by Subject|0
2289435|NCT02477670|3981472|FG002|Stage 2|Withdrawal by Subject|0
2289436|NCT02477670|3981473|FG003|Stage 2|Withdrawal by Subject|1
2289437|NCT02477670|3981474|FG004|Stage 2|Withdrawal by Subject|0
2289438|NCT02477670|3981475|FG005|Stage 2|Withdrawal by Subject|0
2289439|NCT02477670|3981476|FG006|Stage 2|Withdrawal by Subject|0
2289440|NCT02477800|3981494|FG000|Placebo-Controlled Period|Adverse Event|16
2289441|NCT02477800|3981495|FG001|Placebo-Controlled Period|Adverse Event|25
2289442|NCT02477800|3981496|FG002|Placebo-Controlled Period|Adverse Event|28
2289443|NCT02477800|3981497|FG003|Placebo-Controlled Period|Adverse Event|0
2289444|NCT02477800|3981498|FG004|Placebo-Controlled Period|Adverse Event|0
2289445|NCT02477800|3981499|FG005|Placebo-Controlled Period|Adverse Event|0
2289446|NCT02477800|3981500|FG006|Placebo-Controlled Period|Adverse Event|0
2289447|NCT02477800|3981494|FG000|Placebo-Controlled Period|Change of Treatment|1
2289448|NCT02477800|3981495|FG001|Placebo-Controlled Period|Change of Treatment|2
2289449|NCT02477800|3981496|FG002|Placebo-Controlled Period|Change of Treatment|1
2289450|NCT02477800|3981497|FG003|Placebo-Controlled Period|Change of Treatment|0
2289451|NCT02477800|3981498|FG004|Placebo-Controlled Period|Change of Treatment|0
2289452|NCT02477800|3981499|FG005|Placebo-Controlled Period|Change of Treatment|0
2289453|NCT02477800|3981500|FG006|Placebo-Controlled Period|Change of Treatment|0
2289454|NCT02477800|3981494|FG000|Placebo-Controlled Period|Consent Withdrawn|26
2289455|NCT02477800|3981495|FG001|Placebo-Controlled Period|Consent Withdrawn|16
2289456|NCT02477800|3981496|FG002|Placebo-Controlled Period|Consent Withdrawn|27
2289457|NCT02477800|3981497|FG003|Placebo-Controlled Period|Consent Withdrawn|0
2289458|NCT02477800|3981498|FG004|Placebo-Controlled Period|Consent Withdrawn|0
2289459|NCT02477800|3981499|FG005|Placebo-Controlled Period|Consent Withdrawn|0
2289460|NCT02477800|3981500|FG006|Placebo-Controlled Period|Consent Withdrawn|0
2289461|NCT02477800|3981494|FG000|Placebo-Controlled Period|Death|0
2289462|NCT02477800|3981495|FG001|Placebo-Controlled Period|Death|3
2289463|NCT02477800|3981496|FG002|Placebo-Controlled Period|Death|2
2289464|NCT02477800|3981497|FG003|Placebo-Controlled Period|Death|0
2289465|NCT02477800|3981498|FG004|Placebo-Controlled Period|Death|0
2289466|NCT02477800|3981499|FG005|Placebo-Controlled Period|Death|0
2289467|NCT02477800|3981500|FG006|Placebo-Controlled Period|Death|0
2289468|NCT02477800|3981494|FG000|Placebo-Controlled Period|Disease Progression|1
2289469|NCT02477800|3981495|FG001|Placebo-Controlled Period|Disease Progression|0
2289470|NCT02477800|3981496|FG002|Placebo-Controlled Period|Disease Progression|1
2289471|NCT02477800|3981497|FG003|Placebo-Controlled Period|Disease Progression|0
2289472|NCT02477800|3981498|FG004|Placebo-Controlled Period|Disease Progression|0
2289473|NCT02477800|3981499|FG005|Placebo-Controlled Period|Disease Progression|0
2289474|NCT02477800|3981500|FG006|Placebo-Controlled Period|Disease Progression|0
2289475|NCT02477800|3981494|FG000|Placebo-Controlled Period|Investigator Decision|3
2289476|NCT02477800|3981495|FG001|Placebo-Controlled Period|Investigator Decision|2
2289477|NCT02477800|3981496|FG002|Placebo-Controlled Period|Investigator Decision|1
2289478|NCT02477800|3981497|FG003|Placebo-Controlled Period|Investigator Decision|0
2289479|NCT02477800|3981498|FG004|Placebo-Controlled Period|Investigator Decision|0
2142505|NCT01120691|3751142|FG001|Overall Study|Abnormal test procedure result(s)|2
2142506|NCT01120691|3751143|FG002|Overall Study|Abnormal test procedure result(s)|1
2142507|NCT01120691|3751141|FG000|Overall Study|Patient's inability to use the device|3
2142508|NCT01120691|3751142|FG001|Overall Study|Patient's inability to use the device|1
2142509|NCT01120691|3751143|FG002|Overall Study|Patient's inability to use the device|0
2142510|NCT01120691|3751141|FG000|Overall Study|Abnormal laboratory value(s)|1
2142511|NCT01120691|3751142|FG001|Overall Study|Abnormal laboratory value(s)|3
2142512|NCT01120691|3751143|FG002|Overall Study|Abnormal laboratory value(s)|4
2142513|NCT01120717|3751234|FG000|Overall Study|Withdrawal by Subject|11
2142514|NCT01120717|3751235|FG001|Overall Study|Withdrawal by Subject|6
2142515|NCT01120717|3751234|FG000|Overall Study|Adverse Event|10
2142516|NCT01120717|3751235|FG001|Overall Study|Adverse Event|6
2142517|NCT01120717|3751234|FG000|Overall Study|Protocol Deviation|2
2142518|NCT01120717|3751235|FG001|Overall Study|Protocol Deviation|5
2142519|NCT01120717|3751234|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
2142520|NCT01120717|3751235|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
2142521|NCT01120717|3751234|FG000|Overall Study|Lost to Follow-up|2
2142522|NCT01120717|3751235|FG001|Overall Study|Lost to Follow-up|3
2142523|NCT01120717|3751234|FG000|Overall Study|Death|3
2142524|NCT01120717|3751235|FG001|Overall Study|Death|1
2142525|NCT01120717|3751234|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
2142526|NCT01120717|3751235|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
2142527|NCT01120756|3751243|FG000|Overall Study|Withdrawal by Subject|1
2142528|NCT01120756|3751244|FG001|Overall Study|Withdrawal by Subject|1
2142529|NCT01120782|3751250|FG000|Overall Study|Test article shipping error|11
2142530|NCT01120899|3751262|FG000|Overall Study|Withdrawal by Subject|3
2142531|NCT01121146|3751272|FG000|Overall Study|Death|17
2142532|NCT01121146|3751273|FG001|Overall Study|Death|15
2142533|NCT01121146|3751272|FG000|Overall Study|Adverse Event|2
2142534|NCT01121146|3751273|FG001|Overall Study|Adverse Event|11
2142535|NCT01121146|3751272|FG000|Overall Study|Lost to Follow-up|7
2142536|NCT01121146|3751273|FG001|Overall Study|Lost to Follow-up|16
2142537|NCT01121185|3751292|FG000|Overall Study|Not infused|0
2142538|NCT01121185|3751293|FG001|Overall Study|Not infused|1
2142539|NCT01121185|3751292|FG000|Overall Study|Not transplanted|1
2142540|NCT01121185|3751293|FG001|Overall Study|Not transplanted|0
2142541|NCT01121263|3751334|FG000|Overall Study|Death|3
2142542|NCT01121263|3751335|FG001|Overall Study|Death|2
2142543|NCT01121263|3751334|FG000|Overall Study|Lost to Follow-up|22
2142544|NCT01121263|3751335|FG001|Overall Study|Lost to Follow-up|12
2142545|NCT01121263|3751334|FG000|Overall Study|Withdrawal by Subject|0
2142546|NCT01121263|3751335|FG001|Overall Study|Withdrawal by Subject|1
2142547|NCT01121393|3751345|FG000|Overall Study|Progressive disease|201
2142548|NCT01121393|3751346|FG001|Overall Study|Progressive disease|20
2142549|NCT01121393|3751345|FG000|Overall Study|Other Adverse events|24
2142550|NCT01121393|3751346|FG001|Overall Study|Other Adverse events|45
2142551|NCT01121393|3751345|FG000|Overall Study|Non-compliant with protocol|0
2142552|NCT01121393|3751346|FG001|Overall Study|Non-compliant with protocol|3
2142553|NCT01121393|3751345|FG000|Overall Study|Lost to Follow-up|1
2142554|NCT01121393|3751346|FG001|Overall Study|Lost to Follow-up|0
2142555|NCT01121393|3751345|FG000|Overall Study|Refused cont. medication|7
2142556|NCT01121393|3751346|FG001|Overall Study|Refused cont. medication|7
2142557|NCT01121393|3751345|FG000|Overall Study|Not treated|3
2142558|NCT01121393|3751346|FG001|Overall Study|Not treated|9
2142559|NCT01121393|3751345|FG000|Overall Study|Other than listed|6
2142560|NCT01121393|3751346|FG001|Overall Study|Other than listed|0
2142561|NCT01121406|3751360|FG000|Overall Study|Progressive disease RECIST|44
2142562|NCT01121406|3751361|FG001|Overall Study|Progressive disease RECIST|28
2142563|NCT01121406|3751360|FG000|Overall Study|Wors. or AE of underlying cancer disease|4
2178655|NCT01387230|3803627|FG002|Overall Study|Lack of Efficacy|4
2289480|NCT02477800|3981499|FG005|Placebo-Controlled Period|Investigator Decision|0
2289481|NCT02477800|3981500|FG006|Placebo-Controlled Period|Investigator Decision|0
2289482|NCT02477800|3981494|FG000|Placebo-Controlled Period|Lost to Follow-up|1
2289483|NCT02477800|3981495|FG001|Placebo-Controlled Period|Lost to Follow-up|3
2289484|NCT02477800|3981496|FG002|Placebo-Controlled Period|Lost to Follow-up|3
2289485|NCT02477800|3981497|FG003|Placebo-Controlled Period|Lost to Follow-up|0
2289486|NCT02477800|3981498|FG004|Placebo-Controlled Period|Lost to Follow-up|0
2289487|NCT02477800|3981499|FG005|Placebo-Controlled Period|Lost to Follow-up|0
2289488|NCT02477800|3981500|FG006|Placebo-Controlled Period|Lost to Follow-up|0
2289489|NCT02477800|3981494|FG000|Placebo-Controlled Period|Relocation|2
2289490|NCT02477800|3981495|FG001|Placebo-Controlled Period|Relocation|0
2289491|NCT02477800|3981496|FG002|Placebo-Controlled Period|Relocation|0
2289492|NCT02477800|3981497|FG003|Placebo-Controlled Period|Relocation|0
2289493|NCT02477800|3981498|FG004|Placebo-Controlled Period|Relocation|0
2289494|NCT02477800|3981499|FG005|Placebo-Controlled Period|Relocation|0
2289495|NCT02477800|3981500|FG006|Placebo-Controlled Period|Relocation|0
2289496|NCT02477800|3981494|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1
2289497|NCT02477800|3981495|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1
2289498|NCT02477800|3981496|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1
2289499|NCT02477800|3981497|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0
2289500|NCT02477800|3981498|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0
2289501|NCT02477800|3981499|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0
2142564|NCT01121406|3751361|FG001|Overall Study|Wors. or AE of underlying cancer disease|6
2142565|NCT01121406|3751360|FG000|Overall Study|Other AE|3
2142566|NCT01121406|3751361|FG001|Overall Study|Other AE|10
2142567|NCT01121406|3751360|FG000|Overall Study|Non-compliant with protocol|0
2142568|NCT01121406|3751361|FG001|Overall Study|Non-compliant with protocol|2
2142569|NCT01121406|3751360|FG000|Overall Study|Lost to Follow-up|0
2142570|NCT01121406|3751361|FG001|Overall Study|Lost to Follow-up|1
2142571|NCT01121406|3751360|FG000|Overall Study|Refused continuation of study med.|1
2142572|NCT01121406|3751361|FG001|Overall Study|Refused continuation of study med.|2
2142573|NCT01121406|3751360|FG000|Overall Study|Reason other than specified above|2
2142574|NCT01121406|3751361|FG001|Overall Study|Reason other than specified above|6
2142575|NCT01121406|3751360|FG000|Overall Study|Not treated|1
2142576|NCT01121406|3751361|FG001|Overall Study|Not treated|0
2142577|NCT01121484|3751372|FG000|Overall Study|Adverse Event|12
2142578|NCT01121484|3751373|FG001|Overall Study|Adverse Event|5
2142579|NCT01121484|3751372|FG000|Overall Study|Lack of Efficacy|3
2142580|NCT01121484|3751373|FG001|Overall Study|Lack of Efficacy|11
2142581|NCT01121484|3751372|FG000|Overall Study|Lost to Follow-up|5
2142582|NCT01121484|3751373|FG001|Overall Study|Lost to Follow-up|9
2142583|NCT01121484|3751372|FG000|Overall Study|Physician Decision|0
2142584|NCT01121484|3751373|FG001|Overall Study|Physician Decision|3
2142585|NCT01121484|3751372|FG000|Overall Study|Protocol Violation|1
2142586|NCT01121484|3751373|FG001|Overall Study|Protocol Violation|0
2142587|NCT01121484|3751372|FG000|Overall Study|Withdrawal by Subject|8
2142588|NCT01121484|3751373|FG001|Overall Study|Withdrawal by Subject|7
2142589|NCT01121484|3751372|FG000|Overall Study|Discontinuation of study by sponsor|0
2142590|NCT01121484|3751373|FG001|Overall Study|Discontinuation of study by sponsor|1
2142591|NCT01121484|3751372|FG000|Overall Study|Other|3
2142592|NCT01121484|3751373|FG001|Overall Study|Other|3
2142593|NCT01121484|3751372|FG000|Overall Study|Randomized, not treated|1
2142594|NCT01121484|3751373|FG001|Overall Study|Randomized, not treated|4
2142595|NCT01121536|3751379|FG000|Overall Study|Adverse Event|63
2142596|NCT01121536|3751379|FG000|Overall Study|Lack of Efficacy|35
2142597|NCT01121536|3751379|FG000|Overall Study|Withdrawal by Subject|65
2142598|NCT01121536|3751379|FG000|Overall Study|Protocol Violation|20
2142599|NCT01121536|3751379|FG000|Overall Study|Noncompliance with study medication|12
2142600|NCT01121536|3751379|FG000|Overall Study|Noncompliance with study procedures|9
2142601|NCT01121536|3751379|FG000|Overall Study|Lost to Follow-up|39
2142602|NCT01121536|3751379|FG000|Overall Study|Other|118
2142603|NCT01121549|3751383|FG000|Overall Study|Adverse Event|10
2142604|NCT01121549|3751383|FG000|Overall Study|Lack of Efficacy|11
2142605|NCT01121549|3751383|FG000|Overall Study|Lost to Follow-up|12
2142606|NCT01121549|3751383|FG000|Overall Study|Did not meet entrance criteria|9
2142607|NCT01121549|3751383|FG000|Overall Study|Study terminated by sponsor|197
2142608|NCT01121549|3751383|FG000|Overall Study|Pregnancy|1
2142609|NCT01121549|3751383|FG000|Overall Study|Protocol Violation|33
2142610|NCT01121549|3751383|FG000|Overall Study|Withdrawal by Subject|16
2142611|NCT01121549|3751383|FG000|Overall Study|Other|58
2142612|NCT01121562|3751387|FG000|Overall Study|Objective progression or relapse|8
2142613|NCT01121562|3751387|FG000|Overall Study|Withdrawal by Subject|1
2142614|NCT01121562|3751387|FG000|Overall Study|Adverse Event|1
2142615|NCT01121562|3751387|FG000|Overall Study|Sponsor Decision|1
2142616|NCT01121562|3751387|FG000|Overall Study|Met study discontinuation criteria|1
2142617|NCT01121575|3751397|FG000|Overall Study|Participant Refused Further Follow-Up|0
2142618|NCT01121575|3751398|FG001|Overall Study|Participant Refused Further Follow-Up|0
2142619|NCT01121575|3751399|FG002|Overall Study|Participant Refused Further Follow-Up|0
2142620|NCT01121575|3751400|FG003|Overall Study|Participant Refused Further Follow-Up|0
2142621|NCT01121575|3751401|FG004|Overall Study|Participant Refused Further Follow-Up|5
2142622|NCT01121575|3751402|FG005|Overall Study|Participant Refused Further Follow-Up|1
2142623|NCT01121575|3751397|FG000|Overall Study|Unspecified Reasons|8
2142624|NCT01121575|3751398|FG001|Overall Study|Unspecified Reasons|6
2142625|NCT01121575|3751399|FG002|Overall Study|Unspecified Reasons|7
2142626|NCT01121575|3751400|FG003|Overall Study|Unspecified Reasons|5
2142627|NCT01121575|3751401|FG004|Overall Study|Unspecified Reasons|13
2142628|NCT01121575|3751402|FG005|Overall Study|Unspecified Reasons|10
2142629|NCT01121575|3751397|FG000|Overall Study|Death|6
2142630|NCT01121575|3751398|FG001|Overall Study|Death|0
2142631|NCT01121575|3751399|FG002|Overall Study|Death|0
2142632|NCT01121575|3751400|FG003|Overall Study|Death|1
2142633|NCT01121575|3751401|FG004|Overall Study|Death|7
2142634|NCT01121575|3751402|FG005|Overall Study|Death|1
2142635|NCT01121666|3751423|FG000|Overall Study|Protocol Violation|29
2142636|NCT01121666|3751424|FG001|Overall Study|Protocol Violation|10
2142637|NCT01121757|3751432|FG000|First Drug|Death|1
2142638|NCT01121757|3751433|FG001|First Drug|Death|0
2142639|NCT01121757|3751432|FG000|First Drug|Disease Progression|0
2142640|NCT01121757|3751433|FG001|First Drug|Disease Progression|2
2142641|NCT01121757|3751432|FG000|Combination|Physician Decision|0
2142642|NCT01121757|3751433|FG001|Combination|Physician Decision|1
2142643|NCT01121757|3751432|FG000|Combination|Disease Progression|2
2142644|NCT01121757|3751433|FG001|Combination|Disease Progression|0
2142645|NCT01121900|3751441|FG000|First Intervention Period|Adverse Event|1
2142646|NCT01121900|3751442|FG001|First Intervention Period|Adverse Event|1
2142647|NCT01121900|3751441|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
2142648|NCT01121900|3751442|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
2142649|NCT01121913|3751448|FG000|First Intervention Period|Adverse Event|0
2142650|NCT01121913|3751449|FG001|First Intervention Period|Adverse Event|0
2142651|NCT01121913|3751450|FG002|First Intervention Period|Adverse Event|1
2142652|NCT01121913|3751451|FG003|First Intervention Period|Adverse Event|0
2142653|NCT01121913|3751448|FG000|First Washout Period|Withdrawal by Subject|1
2142654|NCT01121913|3751449|FG001|First Washout Period|Withdrawal by Subject|0
2142655|NCT01121913|3751450|FG002|First Washout Period|Withdrawal by Subject|0
2142656|NCT01121913|3751451|FG003|First Washout Period|Withdrawal by Subject|0
2142657|NCT01121913|3751448|FG000|Second Intervention Period|Adverse Event|0
2142658|NCT01121913|3751449|FG001|Second Intervention Period|Adverse Event|0
2142659|NCT01121913|3751450|FG002|Second Intervention Period|Adverse Event|1
2142660|NCT01121913|3751451|FG003|Second Intervention Period|Adverse Event|0
2142661|NCT01121913|3751448|FG000|Second Washout Period|Withdrawal by Subject|0
2142662|NCT01121913|3751449|FG001|Second Washout Period|Withdrawal by Subject|0
2142663|NCT01121913|3751450|FG002|Second Washout Period|Withdrawal by Subject|1
2142664|NCT01121913|3751451|FG003|Second Washout Period|Withdrawal by Subject|0
2142665|NCT01121913|3751448|FG000|Third Washout Period|Adverse Event|1
2142666|NCT01121913|3751449|FG001|Third Washout Period|Adverse Event|0
2142667|NCT01121913|3751450|FG002|Third Washout Period|Adverse Event|0
2142668|NCT01121913|3751451|FG003|Third Washout Period|Adverse Event|0
2142669|NCT01121926|3751461|FG000|First Intervention Period|Adverse Event|1
2142670|NCT01121926|3751462|FG001|First Intervention Period|Adverse Event|0
2142671|NCT01121926|3751461|FG000|Washout Period|Adverse Event|0
2142672|NCT01121926|3751462|FG001|Washout Period|Adverse Event|1
2142673|NCT01121926|3751461|FG000|Washout Period|Positive pregnancy test|0
2142674|NCT01121926|3751462|FG001|Washout Period|Positive pregnancy test|1
2142675|NCT01121991|3751475|FG000|Overall Study|Lack of Ovarian Response|2
2142676|NCT01121991|3751475|FG000|Overall Study|No Oocytes Retrieved|3
2142677|NCT01121991|3751475|FG000|Overall Study|No Fertilization|1
2142678|NCT01122173|3751530|FG000|Overall Study|Lost to Follow-up|3
2142679|NCT01122173|3751530|FG000|Overall Study|Withdrawal by Subject|3
2142680|NCT01122173|3751530|FG000|Overall Study|Left study for other reasons|3
2142681|NCT01122264|3751583|FG000|Overall Study|Adverse Event|6
2142682|NCT01122264|3751584|FG001|Overall Study|Adverse Event|5
2142683|NCT01122264|3751585|FG002|Overall Study|Adverse Event|7
2142684|NCT01122264|3751583|FG000|Overall Study|Death|1
2142685|NCT01122264|3751584|FG001|Overall Study|Death|0
2142686|NCT01122264|3751585|FG002|Overall Study|Death|0
2142687|NCT01122264|3751583|FG000|Overall Study|Lost to Follow-up|5
2142688|NCT01122264|3751584|FG001|Overall Study|Lost to Follow-up|9
2142689|NCT01122264|3751585|FG002|Overall Study|Lost to Follow-up|13
2142690|NCT01122264|3751583|FG000|Overall Study|Entry Criteria Not Met|1
2142691|NCT01122264|3751584|FG001|Overall Study|Entry Criteria Not Met|0
2142692|NCT01122264|3751585|FG002|Overall Study|Entry Criteria Not Met|0
2142693|NCT01122264|3751583|FG000|Overall Study|Protocol Violation|7
2142694|NCT01122264|3751584|FG001|Overall Study|Protocol Violation|7
2142695|NCT01122264|3751585|FG002|Overall Study|Protocol Violation|9
2142696|NCT01122264|3751583|FG000|Overall Study|Withdrawal by Subject|6
2142697|NCT01122264|3751584|FG001|Overall Study|Withdrawal by Subject|6
2142698|NCT01122264|3751585|FG002|Overall Study|Withdrawal by Subject|16
2142699|NCT01122264|3751583|FG000|Overall Study|Physician Decision|3
2142700|NCT01122264|3751584|FG001|Overall Study|Physician Decision|1
2142701|NCT01122264|3751585|FG002|Overall Study|Physician Decision|1
2142702|NCT01122264|3751583|FG000|Overall Study|Lack of Efficacy|3
2142703|NCT01122264|3751584|FG001|Overall Study|Lack of Efficacy|1
2142704|NCT01122264|3751585|FG002|Overall Study|Lack of Efficacy|1
2142705|NCT01122394|3751603|FG000|Overall Study|Withdrawal by Subject|1
2142706|NCT01122394|3751604|FG001|Overall Study|Withdrawal by Subject|1
2142707|NCT01122394|3751603|FG000|Overall Study|Lost to Follow-up|2
2142708|NCT01122394|3751604|FG001|Overall Study|Lost to Follow-up|2
2142709|NCT01122394|3751603|FG000|Overall Study|Adverse Event|0
2142710|NCT01122394|3751604|FG001|Overall Study|Adverse Event|1
2142711|NCT01122576|3751624|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0
2289502|NCT02477800|3981500|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0
2289503|NCT02477800|3981494|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2
2289504|NCT02477800|3981495|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1
2289505|NCT02477800|3981496|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0
2289506|NCT02477800|3981497|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0
2289507|NCT02477800|3981498|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0
2289508|NCT02477800|3981499|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0
2289509|NCT02477800|3981500|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0
2289510|NCT02477800|3981494|FG000|Placebo-Controlled Period|Study Visit Burden|5
2289511|NCT02477800|3981495|FG001|Placebo-Controlled Period|Study Visit Burden|3
2289512|NCT02477800|3981496|FG002|Placebo-Controlled Period|Study Visit Burden|11
2142712|NCT01122576|3751625|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1
2142713|NCT01122576|3751626|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2
2142714|NCT01122576|3751624|FG000|Post-Cataract Surgery|Central Macular Edema|0
2142715|NCT01122576|3751625|FG001|Post-Cataract Surgery|Central Macular Edema|0
2142716|NCT01122576|3751626|FG002|Post-Cataract Surgery|Central Macular Edema|1
2142717|NCT01122576|3751624|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0
2289513|NCT02477800|3981497|FG003|Placebo-Controlled Period|Study Visit Burden|0
2289514|NCT02477800|3981498|FG004|Placebo-Controlled Period|Study Visit Burden|0
2289515|NCT02477800|3981499|FG005|Placebo-Controlled Period|Study Visit Burden|0
2142718|NCT01122576|3751625|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0
2142719|NCT01122576|3751626|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1
2142720|NCT01122680|3751637|FG000|Period 1 (4 Weeks)|Adverse Event|1
2142721|NCT01122680|3751638|FG001|Period 1 (4 Weeks)|Adverse Event|0
2142722|NCT01122680|3751639|FG002|Period 1 (4 Weeks)|Adverse Event|0
2142723|NCT01122680|3751640|FG003|Period 1 (4 Weeks)|Adverse Event|0
2142724|NCT01122680|3751637|FG000|Period 1 (4 Weeks)|Protocol Violation|1
2142725|NCT01122680|3751638|FG001|Period 1 (4 Weeks)|Protocol Violation|0
2142726|NCT01122680|3751639|FG002|Period 1 (4 Weeks)|Protocol Violation|0
2142727|NCT01122680|3751640|FG003|Period 1 (4 Weeks)|Protocol Violation|0
2142728|NCT01122680|3751637|FG000|Period 1 (4 Weeks)|Other|1
2142729|NCT01122680|3751638|FG001|Period 1 (4 Weeks)|Other|1
2142730|NCT01122680|3751639|FG002|Period 1 (4 Weeks)|Other|0
2142731|NCT01122680|3751640|FG003|Period 1 (4 Weeks)|Other|0
2142732|NCT01122680|3751637|FG000|Period 2 (4 Weeks)|Protocol Violation|0
2142733|NCT01122680|3751638|FG001|Period 2 (4 Weeks)|Protocol Violation|0
2142734|NCT01122680|3751639|FG002|Period 2 (4 Weeks)|Protocol Violation|0
2142735|NCT01122680|3751640|FG003|Period 2 (4 Weeks)|Protocol Violation|1
2142736|NCT01122680|3751637|FG000|Period 2 (4 Weeks)|Other|1
2142737|NCT01122680|3751638|FG001|Period 2 (4 Weeks)|Other|0
2142738|NCT01122680|3751639|FG002|Period 2 (4 Weeks)|Other|0
2142739|NCT01122680|3751640|FG003|Period 2 (4 Weeks)|Other|0
2289516|NCT02477800|3981500|FG006|Placebo-Controlled Period|Study Visit Burden|0
2289517|NCT02477800|3981494|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
2289518|NCT02477800|3981495|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5
2289519|NCT02477800|3981496|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3
2289520|NCT02477800|3981497|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
2289521|NCT02477800|3981498|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
2289522|NCT02477800|3981499|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
2289523|NCT02477800|3981500|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
2289524|NCT02477800|3981494|FG000|Placebo-Controlled Period|Reason not Specified|161
2289525|NCT02477800|3981495|FG001|Placebo-Controlled Period|Reason not Specified|161
2289526|NCT02477800|3981496|FG002|Placebo-Controlled Period|Reason not Specified|189
2289527|NCT02477800|3981497|FG003|Placebo-Controlled Period|Reason not Specified|0
2289528|NCT02477800|3981498|FG004|Placebo-Controlled Period|Reason not Specified|0
2289529|NCT02477800|3981499|FG005|Placebo-Controlled Period|Reason not Specified|0
2289530|NCT02477800|3981500|FG006|Placebo-Controlled Period|Reason not Specified|0
2289531|NCT02477800|3981494|FG000|Long Term Extension Period|Adverse Event|0
2289532|NCT02477800|3981495|FG001|Long Term Extension Period|Adverse Event|0
2289533|NCT02477800|3981496|FG002|Long Term Extension Period|Adverse Event|0
2289534|NCT02477800|3981497|FG003|Long Term Extension Period|Adverse Event|6
2289535|NCT02477800|3981498|FG004|Long Term Extension Period|Adverse Event|2
2289536|NCT02477800|3981499|FG005|Long Term Extension Period|Adverse Event|4
2289537|NCT02477800|3981500|FG006|Long Term Extension Period|Adverse Event|3
2289538|NCT02477800|3981494|FG000|Long Term Extension Period|Death|0
2289539|NCT02477800|3981495|FG001|Long Term Extension Period|Death|0
2289540|NCT02477800|3981496|FG002|Long Term Extension Period|Death|0
2289541|NCT02477800|3981497|FG003|Long Term Extension Period|Death|1
2289542|NCT02477800|3981498|FG004|Long Term Extension Period|Death|1
2289543|NCT02477800|3981499|FG005|Long Term Extension Period|Death|1
2289544|NCT02477800|3981500|FG006|Long Term Extension Period|Death|2
2289545|NCT02477800|3981494|FG000|Long Term Extension Period|Consent Withdrawn|0
2289546|NCT02477800|3981495|FG001|Long Term Extension Period|Consent Withdrawn|0
2289547|NCT02477800|3981496|FG002|Long Term Extension Period|Consent Withdrawn|0
2289548|NCT02477800|3981497|FG003|Long Term Extension Period|Consent Withdrawn|10
2289549|NCT02477800|3981498|FG004|Long Term Extension Period|Consent Withdrawn|4
2289550|NCT02477800|3981499|FG005|Long Term Extension Period|Consent Withdrawn|13
2289551|NCT02477800|3981500|FG006|Long Term Extension Period|Consent Withdrawn|16
2289552|NCT02477800|3981494|FG000|Long Term Extension Period|Disease Progression|0
2289553|NCT02477800|3981495|FG001|Long Term Extension Period|Disease Progression|0
2289554|NCT02477800|3981496|FG002|Long Term Extension Period|Disease Progression|0
2289555|NCT02477800|3981497|FG003|Long Term Extension Period|Disease Progression|3
2289556|NCT02477800|3981498|FG004|Long Term Extension Period|Disease Progression|1
2289557|NCT02477800|3981499|FG005|Long Term Extension Period|Disease Progression|1
2289558|NCT02477800|3981500|FG006|Long Term Extension Period|Disease Progression|0
2289559|NCT02477800|3981494|FG000|Long Term Extension Period|Investigator Decision|0
2289560|NCT02477800|3981495|FG001|Long Term Extension Period|Investigator Decision|0
2289561|NCT02477800|3981496|FG002|Long Term Extension Period|Investigator Decision|0
2289562|NCT02477800|3981497|FG003|Long Term Extension Period|Investigator Decision|0
2289563|NCT02477800|3981498|FG004|Long Term Extension Period|Investigator Decision|0
2289564|NCT02477800|3981499|FG005|Long Term Extension Period|Investigator Decision|0
2289565|NCT02477800|3981500|FG006|Long Term Extension Period|Investigator Decision|2
2289566|NCT02477800|3981494|FG000|Long Term Extension Period|Lost to Follow-up|0
2142740|NCT01122680|3751637|FG000|Period 3 (4 Weeks)|Adverse Event|1
2142741|NCT01122680|3751638|FG001|Period 3 (4 Weeks)|Adverse Event|0
2142742|NCT01122680|3751639|FG002|Period 3 (4 Weeks)|Adverse Event|0
2142743|NCT01122680|3751640|FG003|Period 3 (4 Weeks)|Adverse Event|0
2289567|NCT02477800|3981495|FG001|Long Term Extension Period|Lost to Follow-up|0
2289568|NCT02477800|3981496|FG002|Long Term Extension Period|Lost to Follow-up|0
2289569|NCT02477800|3981497|FG003|Long Term Extension Period|Lost to Follow-up|0
2289570|NCT02477800|3981498|FG004|Long Term Extension Period|Lost to Follow-up|1
2289571|NCT02477800|3981499|FG005|Long Term Extension Period|Lost to Follow-up|3
2289572|NCT02477800|3981500|FG006|Long Term Extension Period|Lost to Follow-up|0
2289573|NCT02477800|3981494|FG000|Long Term Extension Period|Site Terminated By Sponsor|0
2289574|NCT02477800|3981495|FG001|Long Term Extension Period|Site Terminated By Sponsor|0
2289575|NCT02477800|3981496|FG002|Long Term Extension Period|Site Terminated By Sponsor|0
2289576|NCT02477800|3981497|FG003|Long Term Extension Period|Site Terminated By Sponsor|0
2289577|NCT02477800|3981498|FG004|Long Term Extension Period|Site Terminated By Sponsor|0
2289578|NCT02477800|3981499|FG005|Long Term Extension Period|Site Terminated By Sponsor|2
2289579|NCT02477800|3981500|FG006|Long Term Extension Period|Site Terminated By Sponsor|1
2289580|NCT02477800|3981494|FG000|Long Term Extension Period|Study Visit Burden|0
2289581|NCT02477800|3981495|FG001|Long Term Extension Period|Study Visit Burden|0
2289582|NCT02477800|3981496|FG002|Long Term Extension Period|Study Visit Burden|0
2289583|NCT02477800|3981497|FG003|Long Term Extension Period|Study Visit Burden|3
2289584|NCT02477800|3981498|FG004|Long Term Extension Period|Study Visit Burden|0
2289585|NCT02477800|3981499|FG005|Long Term Extension Period|Study Visit Burden|2
2289586|NCT02477800|3981500|FG006|Long Term Extension Period|Study Visit Burden|2
2289587|NCT02477800|3981494|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0
2289588|NCT02477800|3981495|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0
2289589|NCT02477800|3981496|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0
2289590|NCT02477800|3981497|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1
2289591|NCT02477800|3981498|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3
2289592|NCT02477800|3981499|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3
2289593|NCT02477800|3981500|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1
2289594|NCT02477800|3981494|FG000|Long Term Extension Period|Reason not Specified|0
2289595|NCT02477800|3981495|FG001|Long Term Extension Period|Reason not Specified|0
2289596|NCT02477800|3981496|FG002|Long Term Extension Period|Reason not Specified|0
2289597|NCT02477800|3981497|FG003|Long Term Extension Period|Reason not Specified|126
2289598|NCT02477800|3981498|FG004|Long Term Extension Period|Reason not Specified|140
2289599|NCT02477800|3981499|FG005|Long Term Extension Period|Reason not Specified|270
2289600|NCT02477800|3981500|FG006|Long Term Extension Period|Reason not Specified|224
2289601|NCT02477839|3981514|FG000|Overall Study|Adverse Event|0
2289602|NCT02477839|3981515|FG001|Overall Study|Adverse Event|1
2289603|NCT02477839|3981514|FG000|Overall Study|Protocol Violation|0
2289604|NCT02477839|3981515|FG001|Overall Study|Protocol Violation|2
2289605|NCT02477839|3981514|FG000|Overall Study|Withdrawal by Subject|3
2289606|NCT02477839|3981515|FG001|Overall Study|Withdrawal by Subject|3
2289607|NCT02477839|3981514|FG000|Overall Study|Participant had PGS during V6|0
2289608|NCT02477839|3981515|FG001|Overall Study|Participant had PGS during V6|1
2289609|NCT02477839|3981514|FG000|Overall Study|Parents decided to stop medication|0
2289610|NCT02477839|3981515|FG001|Overall Study|Parents decided to stop medication|1
2289611|NCT02477839|3981514|FG000|Overall Study|Lack of tolerability|0
2289612|NCT02477839|3981515|FG001|Overall Study|Lack of tolerability|1
2289613|NCT02477839|3981514|FG000|Overall Study|Exclusion criterion|0
2289614|NCT02477839|3981515|FG001|Overall Study|Exclusion criterion|1
2289615|NCT02478164|3981523|FG000|Overall Study|Lack of Efficacy|13
2289616|NCT02478164|3981523|FG000|Overall Study|Adverse Event|1
2289617|NCT02478164|3981523|FG000|Overall Study|Withdrawal by Subject|1
2289618|NCT02478359|3981529|FG000|Overall Study|Disenrolled from health plan|106
2289619|NCT02478359|3981530|FG001|Overall Study|Disenrolled from health plan|65
2289620|NCT02478372|3981540|FG000|Overall Study|Protocol Violation|12
2289621|NCT02478372|3981541|FG001|Overall Study|Protocol Violation|8
2289622|NCT02478372|3981540|FG000|Overall Study|Lost to Follow-up|1
2289623|NCT02478372|3981541|FG001|Overall Study|Lost to Follow-up|4
2289624|NCT02478372|3981540|FG000|Overall Study|Death|0
2289625|NCT02478372|3981541|FG001|Overall Study|Death|2
2321028|NCT02954458|4035303|FG000|Overall Study|Adverse Event|0
2321029|NCT02954458|4035304|FG001|Overall Study|Adverse Event|0
2321030|NCT02954458|4035305|FG002|Overall Study|Adverse Event|0
2321031|NCT02954458|4035306|FG003|Overall Study|Adverse Event|1
2321032|NCT02954458|4035303|FG000|Overall Study|Withdrawal by Subject|0
2321033|NCT02954458|4035304|FG001|Overall Study|Withdrawal by Subject|0
2321034|NCT02954458|4035305|FG002|Overall Study|Withdrawal by Subject|0
2321035|NCT02954458|4035306|FG003|Overall Study|Withdrawal by Subject|1
2321036|NCT02954458|4035303|FG000|Overall Study|Physician Decision|0
2321037|NCT02954458|4035304|FG001|Overall Study|Physician Decision|0
2321038|NCT02954458|4035305|FG002|Overall Study|Physician Decision|1
2321039|NCT02954458|4035306|FG003|Overall Study|Physician Decision|1
2321040|NCT02954458|4035303|FG000|Overall Study|Lost to Follow-up|1
2321041|NCT02954458|4035304|FG001|Overall Study|Lost to Follow-up|0
2321042|NCT02954458|4035305|FG002|Overall Study|Lost to Follow-up|0
2321043|NCT02954458|4035306|FG003|Overall Study|Lost to Follow-up|1
2321044|NCT02954458|4035303|FG000|Overall Study|Death|0
2321045|NCT02954458|4035304|FG001|Overall Study|Death|0
2321046|NCT02954458|4035305|FG002|Overall Study|Death|0
2321047|NCT02954458|4035306|FG003|Overall Study|Death|1
2142744|NCT01122680|3751637|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
2142745|NCT01122680|3751638|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1
2142746|NCT01122680|3751639|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0
2142747|NCT01122680|3751640|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
2178656|NCT01387230|3803625|FG000|Overall Study|Protocol-defined Stopping Criteria|6
2178657|NCT01387230|3803626|FG001|Overall Study|Protocol-defined Stopping Criteria|0
2178658|NCT01387230|3803627|FG002|Overall Study|Protocol-defined Stopping Criteria|5
2178659|NCT01387230|3803625|FG000|Overall Study|Lost to Follow-up|0
2178660|NCT01387230|3803626|FG001|Overall Study|Lost to Follow-up|0
2178661|NCT01387230|3803627|FG002|Overall Study|Lost to Follow-up|1
2178662|NCT01387230|3803625|FG000|Overall Study|Withdrawal by Subject|4
2178663|NCT01387230|3803626|FG001|Overall Study|Withdrawal by Subject|1
2178664|NCT01387230|3803627|FG002|Overall Study|Withdrawal by Subject|0
2178665|NCT01387269|3803637|FG000|Overall Study|Death|38
2178666|NCT01387269|3803638|FG001|Overall Study|Death|20
2178667|NCT01387269|3803637|FG000|Overall Study|Other|8
2178668|NCT01387269|3803638|FG001|Overall Study|Other|7
2178669|NCT01387269|3803637|FG000|Overall Study|Unrelated AE|12
2178670|NCT01387269|3803638|FG001|Overall Study|Unrelated AE|3
2178671|NCT01387269|3803637|FG000|Overall Study|Withdrawal by patient|32
2178672|NCT01387269|3803638|FG001|Overall Study|Withdrawal by patient|10
2178673|NCT01387269|3803637|FG000|Overall Study|Study drug-related AE|1
2178674|NCT01387269|3803638|FG001|Overall Study|Study drug-related AE|0
2178675|NCT01387269|3803637|FG000|Overall Study|Lost to Follow-up|1
2178676|NCT01387269|3803638|FG001|Overall Study|Lost to Follow-up|0
2178677|NCT01387282|3803646|FG000|Overall Study|Death|47
2178678|NCT01387282|3803647|FG001|Overall Study|Death|16
2178679|NCT01387282|3803646|FG000|Overall Study|Other|5
2178680|NCT01387282|3803647|FG001|Overall Study|Other|1
2178681|NCT01387282|3803646|FG000|Overall Study|Unrelated AE|6
2178682|NCT01387282|3803647|FG001|Overall Study|Unrelated AE|4
2178683|NCT01387282|3803646|FG000|Overall Study|Withdrawal by patient|33
2289626|NCT02478398|3981549|FG000|Overall Study|Adverse Event|20
2289627|NCT02478398|3981550|FG001|Overall Study|Adverse Event|5
2289628|NCT02478398|3981549|FG000|Overall Study|Lost to Follow-up|5
2289629|NCT02478398|3981550|FG001|Overall Study|Lost to Follow-up|4
2289630|NCT02478398|3981549|FG000|Overall Study|Non-Compliance With Study Drug|5
2289631|NCT02478398|3981550|FG001|Overall Study|Non-Compliance With Study Drug|1
2289632|NCT02478398|3981549|FG000|Overall Study|Protocol Violation|3
2289633|NCT02478398|3981550|FG001|Overall Study|Protocol Violation|1
2289634|NCT02478398|3981549|FG000|Overall Study|Withdrawal By Parent/Guardian|9
2289635|NCT02478398|3981550|FG001|Overall Study|Withdrawal By Parent/Guardian|6
2289636|NCT02478398|3981549|FG000|Overall Study|Withdrawal By Participant|10
2289637|NCT02478398|3981550|FG001|Overall Study|Withdrawal By Participant|4
2289638|NCT02478463|3981557|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1
2289639|NCT02478463|3981557|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1
2289640|NCT02478463|3981557|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1
2289641|NCT02478632|3981585|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
2289642|NCT02478632|3981586|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
2289643|NCT02478632|3981585|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
2289644|NCT02478632|3981586|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
2289645|NCT02478632|3981585|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
2289646|NCT02478632|3981586|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
2289647|NCT02479139|3981606|FG000|Overall Study|Lost to Follow-up|2
2289648|NCT02479139|3981607|FG001|Overall Study|Lost to Follow-up|4
2289649|NCT02479139|3981608|FG002|Overall Study|Lost to Follow-up|4
2289650|NCT02479139|3981609|FG003|Overall Study|Lost to Follow-up|2
2289651|NCT02479139|3981610|FG004|Overall Study|Lost to Follow-up|3
2289652|NCT02479139|3981611|FG005|Overall Study|Lost to Follow-up|5
2289653|NCT02479139|3981606|FG000|Overall Study|Withdrew Consent|5
2289654|NCT02479139|3981607|FG001|Overall Study|Withdrew Consent|6
2289655|NCT02479139|3981608|FG002|Overall Study|Withdrew Consent|1
2289656|NCT02479139|3981609|FG003|Overall Study|Withdrew Consent|4
2289657|NCT02479139|3981610|FG004|Overall Study|Withdrew Consent|1
2289658|NCT02479139|3981611|FG005|Overall Study|Withdrew Consent|1
2289659|NCT02479139|3981606|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0
2289660|NCT02479139|3981607|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0
2289661|NCT02479139|3981608|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1
2289662|NCT02479139|3981609|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0
2289663|NCT02479139|3981610|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0
2289664|NCT02479139|3981611|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0
2289665|NCT02479139|3981606|FG000|Overall Study|Other Miscellaneous Reasons|1
2289666|NCT02479139|3981607|FG001|Overall Study|Other Miscellaneous Reasons|0
2289667|NCT02479139|3981608|FG002|Overall Study|Other Miscellaneous Reasons|1
2289668|NCT02479139|3981609|FG003|Overall Study|Other Miscellaneous Reasons|1
2178684|NCT01387282|3803647|FG001|Overall Study|Withdrawal by patient|23
2178685|NCT01387282|3803646|FG000|Overall Study|Study drug-related AE|2
2178686|NCT01387282|3803647|FG001|Overall Study|Study drug-related AE|2
2178687|NCT01387282|3803646|FG000|Overall Study|Lost to Follow-up|4
2178688|NCT01387282|3803647|FG001|Overall Study|Lost to Follow-up|1
2178689|NCT01387347|3803655|FG000|Overall Study|Lost to Follow-up|2
2178690|NCT01387347|3803656|FG001|Overall Study|Lost to Follow-up|1
2142748|NCT01122862|3751673|FG000|Period 1|Protocol Violation|0
2142749|NCT01122862|3751674|FG001|Period 1|Protocol Violation|1
2142750|NCT01122862|3751675|FG002|Period 1|Protocol Violation|0
2142751|NCT01122862|3751673|FG000|Period 2|Adverse Event|0
2142752|NCT01122862|3751674|FG001|Period 2|Adverse Event|0
2142753|NCT01122862|3751675|FG002|Period 2|Adverse Event|1
2142754|NCT01122927|3751698|FG000|Period 1 - Conversion Phase|Adverse Event|3
2142755|NCT01122927|3751699|FG001|Period 1 - Conversion Phase|Adverse Event|0
2142756|NCT01122927|3751698|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
2142757|NCT01122927|3751699|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2142758|NCT01122927|3751698|FG000|Period 1 - Conversion Phase|Physician Decision|2
2142759|NCT01122927|3751699|FG001|Period 1 - Conversion Phase|Physician Decision|0
2142760|NCT01122927|3751698|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
2142761|NCT01122927|3751699|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
2142762|NCT01122927|3751698|FG000|Period 1 - Conversion Phase|Protocol Deviation|1
2142763|NCT01122927|3751699|FG001|Period 1 - Conversion Phase|Protocol Deviation|0
2142764|NCT01122927|3751698|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
2142765|NCT01122927|3751699|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
2142766|NCT01122927|3751698|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0
2142767|NCT01122927|3751699|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33
2142768|NCT01122927|3751698|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
2142769|NCT01122927|3751699|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
2142770|NCT01122927|3751698|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
2142771|NCT01122927|3751699|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
2142772|NCT01122927|3751698|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0
2142773|NCT01122927|3751699|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12
2142774|NCT01122927|3751698|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
2142775|NCT01122927|3751699|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
2142776|NCT01122927|3751698|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
2142777|NCT01122927|3751699|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
2142778|NCT01123070|3751713|FG000|Part B Double Blind Period|Protocol Violation|0
2142779|NCT01123070|3751714|FG001|Part B Double Blind Period|Protocol Violation|0
2142780|NCT01123070|3751715|FG002|Part B Double Blind Period|Protocol Violation|0
2142781|NCT01123070|3751716|FG003|Part B Double Blind Period|Protocol Violation|1
2142782|NCT01123070|3751713|FG000|Part B Double Blind Period|Adverse Event|0
2142783|NCT01123070|3751714|FG001|Part B Double Blind Period|Adverse Event|0
2289669|NCT02479139|3981610|FG004|Overall Study|Other Miscellaneous Reasons|1
2289670|NCT02479139|3981611|FG005|Overall Study|Other Miscellaneous Reasons|0
2289671|NCT02479412|3981634|FG000|Overall Study|Adverse Event|0
2289672|NCT02479412|3981635|FG001|Overall Study|Adverse Event|0
2289673|NCT02479412|3981636|FG002|Overall Study|Adverse Event|1
2289674|NCT02479412|3981637|FG003|Overall Study|Adverse Event|0
2289675|NCT02479412|3981638|FG004|Overall Study|Adverse Event|0
2289676|NCT02479412|3981639|FG005|Overall Study|Adverse Event|0
2289677|NCT02479412|3981640|FG006|Overall Study|Adverse Event|0
2289678|NCT02479412|3981641|FG007|Overall Study|Adverse Event|0
2289679|NCT02479412|3981642|FG008|Overall Study|Adverse Event|0
2289680|NCT02479412|3981634|FG000|Overall Study|Study-specific withdrawal criteria|0
2289681|NCT02479412|3981635|FG001|Overall Study|Study-specific withdrawal criteria|0
2289682|NCT02479412|3981636|FG002|Overall Study|Study-specific withdrawal criteria|1
2289683|NCT02479412|3981637|FG003|Overall Study|Study-specific withdrawal criteria|1
2289684|NCT02479412|3981638|FG004|Overall Study|Study-specific withdrawal criteria|0
2289685|NCT02479412|3981639|FG005|Overall Study|Study-specific withdrawal criteria|0
2289686|NCT02479412|3981640|FG006|Overall Study|Study-specific withdrawal criteria|0
2289687|NCT02479412|3981641|FG007|Overall Study|Study-specific withdrawal criteria|1
2289688|NCT02479412|3981642|FG008|Overall Study|Study-specific withdrawal criteria|1
2289689|NCT02479412|3981634|FG000|Overall Study|Randomization to wrong PK sampling group|0
2289690|NCT02479412|3981635|FG001|Overall Study|Randomization to wrong PK sampling group|0
2289691|NCT02479412|3981636|FG002|Overall Study|Randomization to wrong PK sampling group|0
2289692|NCT02479412|3981637|FG003|Overall Study|Randomization to wrong PK sampling group|0
2289693|NCT02479412|3981638|FG004|Overall Study|Randomization to wrong PK sampling group|1
2289694|NCT02479412|3981639|FG005|Overall Study|Randomization to wrong PK sampling group|0
2289695|NCT02479412|3981640|FG006|Overall Study|Randomization to wrong PK sampling group|0
2289696|NCT02479412|3981641|FG007|Overall Study|Randomization to wrong PK sampling group|0
2289697|NCT02479412|3981642|FG008|Overall Study|Randomization to wrong PK sampling group|0
2289698|NCT02479802|3981667|FG000|Overall Study|Lost to Follow-up|1
2289699|NCT02479802|3981667|FG000|Overall Study|Adverse Event|1
2289700|NCT02479880|3981673|FG000|Overall Study|Study Terminated by Sponsor|13
2289701|NCT02479880|3981674|FG001|Overall Study|Study Terminated by Sponsor|12
2289702|NCT02479880|3981673|FG000|Overall Study|Pregnancy|0
2289703|NCT02479880|3981674|FG001|Overall Study|Pregnancy|1
2289704|NCT02480010|3981682|FG000|Overall Study|Adverse Event|3
2289705|NCT02480010|3981683|FG001|Overall Study|Adverse Event|1
2289706|NCT02480010|3981682|FG000|Overall Study|Death|1
2289707|NCT02480010|3981683|FG001|Overall Study|Death|0
2289708|NCT02480010|3981682|FG000|Overall Study|Insufficient therapeutic response|31
2289709|NCT02480010|3981683|FG001|Overall Study|Insufficient therapeutic response|29
2142784|NCT01123070|3751715|FG002|Part B Double Blind Period|Adverse Event|2
2142785|NCT01123070|3751716|FG003|Part B Double Blind Period|Adverse Event|0
2142786|NCT01123070|3751713|FG000|Part B Double Blind Period|Sponsor's Decision|0
2142787|NCT01123070|3751714|FG001|Part B Double Blind Period|Sponsor's Decision|0
2142788|NCT01123070|3751715|FG002|Part B Double Blind Period|Sponsor's Decision|2
2142789|NCT01123070|3751716|FG003|Part B Double Blind Period|Sponsor's Decision|2
2142790|NCT01123083|3751729|FG000|Overall Study|Investigator recommendation|1
2142791|NCT01123083|3751730|FG001|Overall Study|Investigator recommendation|1
2142792|NCT01123083|3751729|FG000|Overall Study|Administrative reasons|0
2142793|NCT01123083|3751730|FG001|Overall Study|Administrative reasons|4
2142794|NCT01123083|3751729|FG000|Overall Study|Lost to Follow-up|2
2142795|NCT01123083|3751730|FG001|Overall Study|Lost to Follow-up|6
2142796|NCT01123083|3751729|FG000|Overall Study|Adverse Event|1
2142797|NCT01123083|3751730|FG001|Overall Study|Adverse Event|0
2142798|NCT01123083|3751729|FG000|Overall Study|Withdrew for another reason not covered|0
2142799|NCT01123083|3751730|FG001|Overall Study|Withdrew for another reason not covered|1
2142800|NCT01123083|3751729|FG000|Overall Study|Participant/legal representative request|7
2142801|NCT01123083|3751730|FG001|Overall Study|Participant/legal representative request|3
2142802|NCT01123148|3751736|FG000|Overall Study|Coughing caused unacceptable EEG quality|1
2142803|NCT01123148|3751736|FG000|Overall Study|Didn't meet milestone criteria|1
2142804|NCT01123161|3751742|FG000|Overall Study|Lost to Follow-up|1
2142805|NCT01123161|3751743|FG001|Overall Study|Lost to Follow-up|0
2142806|NCT01123161|3751742|FG000|Overall Study|Withdrawal by Subject|1
2142807|NCT01123161|3751743|FG001|Overall Study|Withdrawal by Subject|0
2142808|NCT01123200|3751752|FG000|Overall Study|Withdrawal by Subject|1
2142809|NCT01123356|3751756|FG000|Overall Study|Adverse Event|2
2142810|NCT01123356|3751756|FG000|Overall Study|Lack of Efficacy|4
2142811|NCT01123356|3751756|FG000|Overall Study|Withdrawal by Subject|1
2142812|NCT01123382|3751763|FG000|Overall Study|Withdrawal by Subject|1
2142813|NCT01123382|3751764|FG001|Overall Study|Withdrawal by Subject|4
2142814|NCT01123382|3751763|FG000|Overall Study|Lost to Follow-up|1
2142815|NCT01123382|3751764|FG001|Overall Study|Lost to Follow-up|2
2142816|NCT01123395|3751770|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
2142817|NCT01123395|3751771|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
2142818|NCT01123642|3751786|FG000|Overall Study|Lost to Follow-up|23
2142819|NCT01123642|3751786|FG000|Overall Study|Withdrawal by Subject|9
2142820|NCT01123642|3751786|FG000|Overall Study|ineligible at baseline assessment|36
2142821|NCT01123655|3751793|FG000|Overall Study|Medication for RA had to be changed|1
2142822|NCT01123655|3751794|FG001|Overall Study|Medication for RA had to be changed|0
2142823|NCT01123655|3751795|FG002|Overall Study|Medication for RA had to be changed|0
2142824|NCT01123655|3751793|FG000|Overall Study|new illness|0
2142825|NCT01123655|3751794|FG001|Overall Study|new illness|1
2142826|NCT01123655|3751795|FG002|Overall Study|new illness|0
2142827|NCT01123655|3751793|FG000|Overall Study|began prohibitive drug|0
2142828|NCT01123655|3751794|FG001|Overall Study|began prohibitive drug|0
2142829|NCT01123655|3751795|FG002|Overall Study|began prohibitive drug|1
2142830|NCT01123889|3751803|FG000|Overall Study|Lost to Follow-up|3
2142831|NCT01123889|3751804|FG001|Overall Study|Lost to Follow-up|1
2142832|NCT01123941|3751821|FG000|Overall Study|Lost to Follow-up|2
2142833|NCT01123941|3751822|FG001|Overall Study|Lost to Follow-up|1
2142834|NCT01123980|3751830|FG000|Overall Study|Adverse Event|1
2142835|NCT01123980|3751831|FG001|Overall Study|Adverse Event|1
2142836|NCT01123980|3751830|FG000|Overall Study|Lack of Efficacy|1
2142837|NCT01123980|3751831|FG001|Overall Study|Lack of Efficacy|0
2142838|NCT01123980|3751830|FG000|Overall Study|Physician Decision|0
2142839|NCT01123980|3751831|FG001|Overall Study|Physician Decision|1
2142840|NCT01123980|3751830|FG000|Overall Study|Lost to Follow-up|0
2142841|NCT01123980|3751831|FG001|Overall Study|Lost to Follow-up|6
2142842|NCT01123980|3751830|FG000|Overall Study|Protocol Violation|6
2142843|NCT01123980|3751831|FG001|Overall Study|Protocol Violation|6
2142844|NCT01123980|3751830|FG000|Overall Study|Withdrawal by Subject|5
2142845|NCT01123980|3751831|FG001|Overall Study|Withdrawal by Subject|3
2142846|NCT01123980|3751830|FG000|Overall Study|Unclassified|6
2142847|NCT01123980|3751831|FG001|Overall Study|Unclassified|7
2142848|NCT01124006|3751840|FG000|Overall Study|Withdrawal by Subject|2
2142849|NCT01124006|3751841|FG001|Overall Study|Withdrawal by Subject|2
2142850|NCT01124006|3751842|FG002|Overall Study|Withdrawal by Subject|0
2142851|NCT01124006|3751840|FG000|Overall Study|Lost to Follow-up|1
2142852|NCT01124006|3751841|FG001|Overall Study|Lost to Follow-up|0
2142853|NCT01124006|3751842|FG002|Overall Study|Lost to Follow-up|1
2142854|NCT01124006|3751840|FG000|Overall Study|Other|0
2142855|NCT01124006|3751841|FG001|Overall Study|Other|0
2142856|NCT01124006|3751842|FG002|Overall Study|Other|1
2142857|NCT01124045|3751852|FG000|Overall Study|Lost to Follow-up|0
2142858|NCT01124045|3751853|FG001|Overall Study|Lost to Follow-up|1
2142859|NCT01124045|3751852|FG000|Overall Study|Physician Decision|0
2142860|NCT01124045|3751853|FG001|Overall Study|Physician Decision|2
2142861|NCT01124097|3751863|FG000|Overall Study|Withdrawal by Subject|4
2142862|NCT01124097|3751864|FG001|Overall Study|Withdrawal by Subject|3
2142863|NCT01124097|3751865|FG002|Overall Study|Withdrawal by Subject|2
2142864|NCT01124097|3751866|FG003|Overall Study|Withdrawal by Subject|3
2142865|NCT01124097|3751863|FG000|Overall Study|Lack of Efficacy|2
2142866|NCT01124097|3751864|FG001|Overall Study|Lack of Efficacy|3
2142867|NCT01124097|3751865|FG002|Overall Study|Lack of Efficacy|1
2142868|NCT01124097|3751866|FG003|Overall Study|Lack of Efficacy|3
2142869|NCT01124097|3751863|FG000|Overall Study|Adverse Event|24
2142870|NCT01124097|3751864|FG001|Overall Study|Adverse Event|15
2142871|NCT01124097|3751865|FG002|Overall Study|Adverse Event|15
2142872|NCT01124097|3751866|FG003|Overall Study|Adverse Event|7
2142873|NCT01124097|3751863|FG000|Overall Study|Protocol Violation|2
2142874|NCT01124097|3751864|FG001|Overall Study|Protocol Violation|0
2142875|NCT01124097|3751865|FG002|Overall Study|Protocol Violation|2
2142876|NCT01124097|3751866|FG003|Overall Study|Protocol Violation|1
2142877|NCT01124097|3751863|FG000|Overall Study|Physician Decision|2
2142878|NCT01124097|3751864|FG001|Overall Study|Physician Decision|1
2142879|NCT01124097|3751865|FG002|Overall Study|Physician Decision|0
2142880|NCT01124097|3751866|FG003|Overall Study|Physician Decision|0
2142881|NCT01124149|3751876|FG000|Acute Phase|Withdrawal by Subject|22
2142882|NCT01124149|3751876|FG000|Acute Phase|Adverse Event|21
2142883|NCT01124149|3751876|FG000|Acute Phase|Lack of Efficacy|17
2142884|NCT01124149|3751876|FG000|Acute Phase|Protocol Violation|14
2142885|NCT01124149|3751876|FG000|Acute Phase|Lost to Follow-up|2
2142886|NCT01124149|3751876|FG000|Acute Phase|Prolonged antibiotic therapy|1
2142887|NCT01124149|3751876|FG000|Acute Phase|Sponsor request|1
2142888|NCT01124149|3751876|FG000|Acute Phase|UC symptoms not ameliorated|1
2142889|NCT01124149|3751876|FG000|Acute Phase|Non-compliance|1
2142890|NCT01124149|3751876|FG000|Acute Phase|Low hemoglobin|1
2142891|NCT01124149|3751876|FG000|Acute Phase|Travelling to another country|1
2289710|NCT02480010|3981682|FG000|Overall Study|Refused Treatment|0
2289711|NCT02480010|3981683|FG001|Overall Study|Refused Treatment|3
2289712|NCT02480114|3981691|FG000|Overall Study|Not completing surveys|3
2289713|NCT02480114|3981692|FG001|Overall Study|Not completing surveys|2
2289714|NCT02480114|3981691|FG000|Overall Study|Withdrawal by Subject|2
2289715|NCT02480114|3981692|FG001|Overall Study|Withdrawal by Subject|4
2289716|NCT02480114|3981691|FG000|Overall Study|Disease progression|3
2289717|NCT02480114|3981692|FG001|Overall Study|Disease progression|0
2289718|NCT02480114|3981691|FG000|Overall Study|Improper completion of survey|1
2289719|NCT02480114|3981692|FG001|Overall Study|Improper completion of survey|1
2289720|NCT02480114|3981691|FG000|Overall Study|Not eligible|0
2289721|NCT02480114|3981692|FG001|Overall Study|Not eligible|1
2289722|NCT02480153|3981700|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
2289723|NCT02480153|3981701|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
2289724|NCT02480153|3981702|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
2289725|NCT02480153|3981700|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
2289726|NCT02480153|3981701|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
2289727|NCT02480153|3981702|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
2289728|NCT02480153|3981700|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
2289729|NCT02480153|3981701|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
2289730|NCT02480153|3981702|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
2289731|NCT02480153|3981700|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
2289732|NCT02480153|3981701|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
2289733|NCT02480153|3981702|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
2289734|NCT02480153|3981700|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0
2289735|NCT02480153|3981701|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1
2289736|NCT02480153|3981702|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0
2289737|NCT02480153|3981700|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0
2289738|NCT02480153|3981701|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1
2289739|NCT02480153|3981702|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0
2289740|NCT02480153|3981700|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
2289741|NCT02480153|3981701|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
2289742|NCT02480153|3981702|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
2289743|NCT02480153|3981700|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
2289744|NCT02480153|3981701|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
2289745|NCT02480153|3981702|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
2289746|NCT02480153|3981700|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
2289747|NCT02480153|3981701|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
2289748|NCT02480153|3981702|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
2289749|NCT02480153|3981700|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
2289750|NCT02480153|3981701|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
2289751|NCT02480153|3981702|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
2289752|NCT02480153|3981700|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
2289753|NCT02480153|3981701|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
2289754|NCT02480153|3981702|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
2142892|NCT01124149|3751876|FG000|Acute Phase|Sponsor decision|1
2142893|NCT01124149|3751876|FG000|Maintenance Phase|Lack of Efficacy|40
2142894|NCT01124149|3751876|FG000|Maintenance Phase|Adverse Event|24
2142895|NCT01124149|3751876|FG000|Maintenance Phase|Lost to Follow-up|15
2142896|NCT01124149|3751876|FG000|Maintenance Phase|Withdrawal by Subject|10
2142897|NCT01124149|3751876|FG000|Maintenance Phase|Protocol Violation|5
2142898|NCT01124149|3751876|FG000|Maintenance Phase|Coordinator error|1
2142899|NCT01124149|3751876|FG000|Maintenance Phase|Non-compliance|1
2142900|NCT01124162|3751885|FG000|First Intervention|Adverse Event|2
2142901|NCT01124162|3751886|FG001|First Intervention|Adverse Event|0
2142902|NCT01124162|3751885|FG000|Washout of 7 Days|Withdrawal by Subject|1
2142903|NCT01124162|3751886|FG001|Washout of 7 Days|Withdrawal by Subject|0
2142904|NCT01124175|3751894|FG000|Washout of 7 Days|Withdrawal by Subject|0
2142905|NCT01124175|3751895|FG001|Washout of 7 Days|Withdrawal by Subject|2
2142906|NCT01124292|3751913|FG000|Overall Study|Lost to Follow-up|2
2142907|NCT01124292|3751914|FG001|Overall Study|Lost to Follow-up|4
2142908|NCT01124292|3751915|FG002|Overall Study|Lost to Follow-up|3
2142909|NCT01124292|3751913|FG000|Overall Study|Physician Decision|0
2142910|NCT01124292|3751914|FG001|Overall Study|Physician Decision|3
2142911|NCT01124292|3751915|FG002|Overall Study|Physician Decision|2
2142912|NCT01124292|3751913|FG000|Overall Study|Withdrawal by Subject|0
2142913|NCT01124292|3751914|FG001|Overall Study|Withdrawal by Subject|6
2142914|NCT01124292|3751915|FG002|Overall Study|Withdrawal by Subject|2
2142915|NCT01124292|3751913|FG000|Overall Study|medical issue unrelated to the study|0
2142916|NCT01124292|3751914|FG001|Overall Study|medical issue unrelated to the study|0
2142917|NCT01124292|3751915|FG002|Overall Study|medical issue unrelated to the study|2
2142918|NCT01124292|3751913|FG000|Overall Study|piercing track closed|0
2142919|NCT01124292|3751914|FG001|Overall Study|piercing track closed|2
2142920|NCT01124292|3751915|FG002|Overall Study|piercing track closed|1
2142921|NCT01124422|3751941|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
2142922|NCT01124422|3751942|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
2142923|NCT01124422|3751943|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
2142924|NCT01124422|3751941|FG000|4-Week Open-label Run-in Phase|Adverse Event|7
2142925|NCT01124422|3751942|FG001|4-Week Open-label Run-in Phase|Adverse Event|0
2142926|NCT01124422|3751943|FG002|4-Week Open-label Run-in Phase|Adverse Event|0
2142927|NCT01124422|3751941|FG000|4-Week Open-label Run-in Phase|Physician Decision|4
2142928|NCT01124422|3751942|FG001|4-Week Open-label Run-in Phase|Physician Decision|0
2142929|NCT01124422|3751943|FG002|4-Week Open-label Run-in Phase|Physician Decision|0
2142930|NCT01124422|3751941|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1
2142931|NCT01124422|3751942|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0
2142932|NCT01124422|3751943|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0
2142933|NCT01124422|3751941|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
2142934|NCT01124422|3751942|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
2142935|NCT01124422|3751943|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
2142936|NCT01124422|3751941|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5
2142937|NCT01124422|3751942|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0
2142938|NCT01124422|3751943|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0
2142939|NCT01124422|3751941|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
2142940|NCT01124422|3751942|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
2142941|NCT01124422|3751943|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
2142942|NCT01124422|3751941|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0
2142943|NCT01124422|3751942|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6
2142944|NCT01124422|3751943|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3
2142945|NCT01124422|3751941|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0
2142946|NCT01124422|3751942|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5
2142947|NCT01124422|3751943|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2
2142948|NCT01124422|3751941|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
2142949|NCT01124422|3751942|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
2142950|NCT01124422|3751943|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
2142951|NCT01124448|3751952|FG000|Overall Study|Lost to Follow-up|0
2142952|NCT01124448|3751953|FG001|Overall Study|Lost to Follow-up|3
2142953|NCT01124448|3751952|FG000|Overall Study|Protocol Violation|2
2142954|NCT01124448|3751953|FG001|Overall Study|Protocol Violation|0
2142955|NCT01124604|3751961|FG000|Overall Study|Adverse Event|10
2142956|NCT01124604|3751962|FG001|Overall Study|Adverse Event|1
2142957|NCT01124604|3751961|FG000|Overall Study|Lack of Efficacy|1
2142958|NCT01124604|3751962|FG001|Overall Study|Lack of Efficacy|0
2142959|NCT01124604|3751961|FG000|Overall Study|Withdrawal by Subject|4
2142960|NCT01124604|3751962|FG001|Overall Study|Withdrawal by Subject|0
2142961|NCT01124604|3751961|FG000|Overall Study|Disease Progression|0
2142962|NCT01124604|3751962|FG001|Overall Study|Disease Progression|1
2142963|NCT01124617|3751970|FG000|Overall Study|Adverse Event|5
2142964|NCT01124617|3751971|FG001|Overall Study|Adverse Event|2
2142965|NCT01124617|3751970|FG000|Overall Study|Lack of Efficacy|2
2142966|NCT01124617|3751971|FG001|Overall Study|Lack of Efficacy|1
2142967|NCT01124617|3751970|FG000|Overall Study|Protocol Violation|1
2142968|NCT01124617|3751971|FG001|Overall Study|Protocol Violation|1
2142969|NCT01124617|3751970|FG000|Overall Study|Withdrawal by Subject|9
2142970|NCT01124617|3751971|FG001|Overall Study|Withdrawal by Subject|1
2142971|NCT01124617|3751970|FG000|Overall Study|Other|2
2142972|NCT01124617|3751971|FG001|Overall Study|Other|1
2142973|NCT01124643|3751977|FG000|Overall Study|Death|1
2142974|NCT01124734|3751981|FG000|Overall Study|Disease progression|13
2142975|NCT01124734|3751981|FG000|Overall Study|Adverse Event|1
2142976|NCT01124734|3751981|FG000|Overall Study|Withdrawal by Subject|1
2142977|NCT01124734|3751981|FG000|Overall Study|Elected for alternative treatment|2
2142978|NCT01124838|3752001|FG000|Overall Study|Miscellaneous|4
2142979|NCT01124838|3752002|FG001|Overall Study|Miscellaneous|2
2142980|NCT01124838|3752001|FG000|Overall Study|Adverse Event|7
2142981|NCT01124838|3752002|FG001|Overall Study|Adverse Event|11
2142982|NCT01124838|3752001|FG000|Overall Study|Lack of Efficacy|2
2142983|NCT01124838|3752002|FG001|Overall Study|Lack of Efficacy|0
2142984|NCT01124838|3752001|FG000|Overall Study|Withdrawal by Subject|3
2142985|NCT01124838|3752002|FG001|Overall Study|Withdrawal by Subject|2
2142986|NCT01124838|3752001|FG000|Overall Study|Lost to Follow-up|2
2142987|NCT01124838|3752002|FG001|Overall Study|Lost to Follow-up|0
2142988|NCT01124864|3752016|FG000|Overall Study|Follow up phase competed as per protocol|18
2142989|NCT01124864|3752017|FG001|Overall Study|Follow up phase competed as per protocol|22
2142990|NCT01124864|3752018|FG002|Overall Study|Follow up phase competed as per protocol|24
2142991|NCT01124864|3752019|FG003|Overall Study|Follow up phase competed as per protocol|18
2142992|NCT01124864|3752020|FG004|Overall Study|Follow up phase competed as per protocol|26
2142993|NCT01124864|3752021|FG005|Overall Study|Follow up phase competed as per protocol|2
2142994|NCT01124864|3752016|FG000|Overall Study|Death|6
2142995|NCT01124864|3752017|FG001|Overall Study|Death|9
2142996|NCT01124864|3752018|FG002|Overall Study|Death|6
2142997|NCT01124864|3752019|FG003|Overall Study|Death|2
2142998|NCT01124864|3752020|FG004|Overall Study|Death|1
2142999|NCT01124864|3752021|FG005|Overall Study|Death|0
2143000|NCT01124864|3752016|FG000|Overall Study|Withdrawal by Subject|2
2143001|NCT01124864|3752017|FG001|Overall Study|Withdrawal by Subject|3
2143002|NCT01124864|3752018|FG002|Overall Study|Withdrawal by Subject|4
2143003|NCT01124864|3752019|FG003|Overall Study|Withdrawal by Subject|0
2143004|NCT01124864|3752020|FG004|Overall Study|Withdrawal by Subject|2
2143005|NCT01124864|3752021|FG005|Overall Study|Withdrawal by Subject|1
2143006|NCT01124864|3752016|FG000|Overall Study|Lost to Follow-up|1
2143007|NCT01124864|3752017|FG001|Overall Study|Lost to Follow-up|1
2143008|NCT01124864|3752018|FG002|Overall Study|Lost to Follow-up|0
2143009|NCT01124864|3752019|FG003|Overall Study|Lost to Follow-up|1
2143010|NCT01124864|3752020|FG004|Overall Study|Lost to Follow-up|0
2143011|NCT01124864|3752021|FG005|Overall Study|Lost to Follow-up|0
2143012|NCT01124864|3752016|FG000|Overall Study|Protocol Violation|1
2143013|NCT01124864|3752017|FG001|Overall Study|Protocol Violation|0
2143014|NCT01124864|3752018|FG002|Overall Study|Protocol Violation|0
2143015|NCT01124864|3752019|FG003|Overall Study|Protocol Violation|0
2143016|NCT01124864|3752020|FG004|Overall Study|Protocol Violation|1
2143017|NCT01124864|3752021|FG005|Overall Study|Protocol Violation|0
2143018|NCT01124916|3752039|FG000|Overall Study|Lost to Follow-up|3
2143019|NCT01124916|3752040|FG001|Overall Study|Lost to Follow-up|2
2143020|NCT01125046|3752055|FG000|First 6 Months of Treatment|Death|1
2143021|NCT01125046|3752055|FG000|First 6 Months of Treatment|Withdrawal by Subject|2
2143022|NCT01125046|3752055|FG000|First 6 Months of Treatment|Non-compliance|1
2143023|NCT01125046|3752055|FG000|First 6 Months of Treatment|Surgery|1
2143024|NCT01125046|3752055|FG000|First 6 Months of Treatment|Progressive Disease|7
2143025|NCT01125046|3752055|FG000|First 6 Months of Treatment|Adverse Event|2
2143026|NCT01125046|3752055|FG000|Continued Treatment After 6 Months|Progressive Disease|2
2143027|NCT01125046|3752055|FG000|Continued Treatment After 6 Months|Adverse Event|1
2143028|NCT01125046|3752055|FG000|Follow-up/Data Cut Off Point|Death|29
2143029|NCT01125046|3752055|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4
2143030|NCT01125189|3752081|FG000|Treatment Period|Lack of Efficacy|15
2143031|NCT01125189|3752082|FG001|Treatment Period|Lack of Efficacy|18
2143032|NCT01125189|3752083|FG002|Treatment Period|Lack of Efficacy|25
2143033|NCT01125189|3752081|FG000|Treatment Period|Adverse Event|7
2143034|NCT01125189|3752082|FG001|Treatment Period|Adverse Event|8
2143035|NCT01125189|3752083|FG002|Treatment Period|Adverse Event|8
2143036|NCT01125189|3752081|FG000|Treatment Period|Withdrawal by Subject|3
2143037|NCT01125189|3752082|FG001|Treatment Period|Withdrawal by Subject|1
2143038|NCT01125189|3752083|FG002|Treatment Period|Withdrawal by Subject|1
2143039|NCT01125189|3752081|FG000|Treatment Period|Death|1
2143040|NCT01125189|3752082|FG001|Treatment Period|Death|0
2143041|NCT01125189|3752083|FG002|Treatment Period|Death|0
2143042|NCT01125189|3752081|FG000|Treatment Period|Lost to Follow-up|1
2143043|NCT01125189|3752082|FG001|Treatment Period|Lost to Follow-up|2
2143044|NCT01125189|3752083|FG002|Treatment Period|Lost to Follow-up|1
2143045|NCT01125189|3752081|FG000|Treatment Period|Poor compliance/noncompliance|0
2143046|NCT01125189|3752082|FG001|Treatment Period|Poor compliance/noncompliance|1
2143047|NCT01125189|3752083|FG002|Treatment Period|Poor compliance/noncompliance|0
2143048|NCT01125189|3752081|FG000|Treatment Period|Participants requested to discontinue|1
2143049|NCT01125189|3752082|FG001|Treatment Period|Participants requested to discontinue|3
2143050|NCT01125189|3752083|FG002|Treatment Period|Participants requested to discontinue|4
2143051|NCT01125189|3752081|FG000|Treatment Period|Other reasons|1
2143052|NCT01125189|3752082|FG001|Treatment Period|Other reasons|1
2143053|NCT01125189|3752083|FG002|Treatment Period|Other reasons|0
2143054|NCT01125189|3752081|FG000|Treatment Period|Completed 24 week treatment period only|2
2143055|NCT01125189|3752082|FG001|Treatment Period|Completed 24 week treatment period only|1
2143056|NCT01125189|3752083|FG002|Treatment Period|Completed 24 week treatment period only|2
2143057|NCT01125189|3752081|FG000|Follow up Period|Withdrawal by Subject|3
2143058|NCT01125189|3752082|FG001|Follow up Period|Withdrawal by Subject|2
2143059|NCT01125189|3752083|FG002|Follow up Period|Withdrawal by Subject|5
2143060|NCT01125189|3752081|FG000|Follow up Period|Death|1
2143061|NCT01125189|3752082|FG001|Follow up Period|Death|0
2143062|NCT01125189|3752083|FG002|Follow up Period|Death|0
2143063|NCT01125189|3752081|FG000|Follow up Period|Lost to Follow-up|12
2143064|NCT01125189|3752082|FG001|Follow up Period|Lost to Follow-up|9
2143065|NCT01125189|3752083|FG002|Follow up Period|Lost to Follow-up|6
2143066|NCT01125189|3752081|FG000|Follow up Period|Other reasons|4
2143067|NCT01125189|3752082|FG001|Follow up Period|Other reasons|4
2143068|NCT01125189|3752083|FG002|Follow up Period|Other reasons|5
2143069|NCT01125293|3752109|FG000|Overall Study|Disease Progression|1
2143070|NCT01125293|3752110|FG001|Overall Study|Disease Progression|3
2143071|NCT01125293|3752111|FG002|Overall Study|Disease Progression|4
2143072|NCT01125293|3752112|FG003|Overall Study|Disease Progression|3
2143073|NCT01125293|3752113|FG004|Overall Study|Disease Progression|5
2143074|NCT01125293|3752114|FG005|Overall Study|Disease Progression|12
2143075|NCT01125293|3752109|FG000|Overall Study|Adverse Event|1
2143076|NCT01125293|3752110|FG001|Overall Study|Adverse Event|0
2143077|NCT01125293|3752111|FG002|Overall Study|Adverse Event|0
2143078|NCT01125293|3752112|FG003|Overall Study|Adverse Event|0
2143079|NCT01125293|3752113|FG004|Overall Study|Adverse Event|2
2143080|NCT01125293|3752114|FG005|Overall Study|Adverse Event|8
2143081|NCT01125293|3752109|FG000|Overall Study|Symptomatic Deterioration|1
2143082|NCT01125293|3752110|FG001|Overall Study|Symptomatic Deterioration|0
2143083|NCT01125293|3752111|FG002|Overall Study|Symptomatic Deterioration|0
2289755|NCT02480153|3981700|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2
2289756|NCT02480153|3981701|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0
2289757|NCT02480153|3981702|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0
2289758|NCT02480153|3981700|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
2289759|NCT02480153|3981701|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
2289760|NCT02480153|3981702|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
2289761|NCT02480153|3981700|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
2289762|NCT02480153|3981701|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
2289763|NCT02480153|3981702|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
2289764|NCT02480153|3981700|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
2289765|NCT02480153|3981701|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
2289766|NCT02480153|3981702|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
2289767|NCT02480153|3981700|FG000|Period 3: Week 52 Dosing to Week 78|Other|0
2289768|NCT02480153|3981701|FG001|Period 3: Week 52 Dosing to Week 78|Other|0
2289769|NCT02480153|3981702|FG002|Period 3: Week 52 Dosing to Week 78|Other|1
2289770|NCT02480153|3981700|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
2289771|NCT02480153|3981701|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
2289772|NCT02480153|3981702|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
2289773|NCT02480153|3981700|FG000|Period 3: Week 52 Dosing to Week 78|Death|0
2289774|NCT02480153|3981701|FG001|Period 3: Week 52 Dosing to Week 78|Death|1
2289775|NCT02480153|3981702|FG002|Period 3: Week 52 Dosing to Week 78|Death|0
2289776|NCT02480621|3981772|FG000|Randomization|Withdrawal by Subject|1
2289777|NCT02480621|3981773|FG001|Randomization|Withdrawal by Subject|0
2289778|NCT02480621|3981772|FG000|Randomization|Surgeon did not give intervention|0
2289779|NCT02480621|3981773|FG001|Randomization|Surgeon did not give intervention|1
2289780|NCT02480621|3981772|FG000|Follow Up|Lost to Follow-up|4
2143084|NCT01125293|3752112|FG003|Overall Study|Symptomatic Deterioration|0
2143085|NCT01125293|3752113|FG004|Overall Study|Symptomatic Deterioration|0
2143086|NCT01125293|3752114|FG005|Overall Study|Symptomatic Deterioration|0
2143087|NCT01125293|3752109|FG000|Overall Study|Death|0
2143088|NCT01125293|3752110|FG001|Overall Study|Death|0
2208010|NCT01634854|3847275|FG001|Overall Study|Cesarean delivery|7
2208011|NCT01635153|3847312|FG000|Overall Study|Lost to Follow-up|40
2208012|NCT01635153|3847313|FG001|Overall Study|Lost to Follow-up|43
2143089|NCT01125293|3752111|FG002|Overall Study|Death|0
2217457|NCT01708902|3860792|FG000|Overall Study|Refused to continue trial medication|8
2217458|NCT01708902|3860793|FG001|Overall Study|Refused to continue trial medication|0
2217459|NCT01708902|3860794|FG002|Overall Study|Refused to continue trial medication|4
2217460|NCT01708902|3860795|FG003|Overall Study|Refused to continue trial medication|2
2217461|NCT01708902|3860796|FG004|Overall Study|Refused to continue trial medication|8
2217462|NCT01708902|3860797|FG005|Overall Study|Refused to continue trial medication|1
2217463|NCT01708902|3860798|FG006|Overall Study|Refused to continue trial medication|1
2217464|NCT01708902|3860792|FG000|Overall Study|Other Reason|1
2217465|NCT01708902|3860793|FG001|Overall Study|Other Reason|0
2217466|NCT01708902|3860794|FG002|Overall Study|Other Reason|1
2217467|NCT01708902|3860795|FG003|Overall Study|Other Reason|1
2217468|NCT01708902|3860796|FG004|Overall Study|Other Reason|1
2217469|NCT01708902|3860797|FG005|Overall Study|Other Reason|2
2217470|NCT01708902|3860798|FG006|Overall Study|Other Reason|0
2217471|NCT01708915|3860821|FG000|Overall Study|Adverse Event|1
2217472|NCT01708915|3860822|FG001|Overall Study|Adverse Event|0
2217473|NCT01708915|3860823|FG002|Overall Study|Adverse Event|9
2217474|NCT01708915|3860824|FG003|Overall Study|Adverse Event|13
2217475|NCT01708915|3860821|FG000|Overall Study|Lack of Efficacy|84
2217476|NCT01708915|3860822|FG001|Overall Study|Lack of Efficacy|60
2143090|NCT01125293|3752112|FG003|Overall Study|Death|0
2143091|NCT01125293|3752113|FG004|Overall Study|Death|1
2143092|NCT01125293|3752114|FG005|Overall Study|Death|0
2143093|NCT01125293|3752109|FG000|Overall Study|Withdrawal by Subject|0
2143094|NCT01125293|3752110|FG001|Overall Study|Withdrawal by Subject|0
2143095|NCT01125293|3752111|FG002|Overall Study|Withdrawal by Subject|0
2143096|NCT01125293|3752112|FG003|Overall Study|Withdrawal by Subject|0
2143097|NCT01125293|3752113|FG004|Overall Study|Withdrawal by Subject|2
2143098|NCT01125293|3752114|FG005|Overall Study|Withdrawal by Subject|1
2143099|NCT01125293|3752109|FG000|Overall Study|Physician Decision|0
2143100|NCT01125293|3752110|FG001|Overall Study|Physician Decision|0
2143101|NCT01125293|3752111|FG002|Overall Study|Physician Decision|0
2143102|NCT01125293|3752112|FG003|Overall Study|Physician Decision|0
2143103|NCT01125293|3752113|FG004|Overall Study|Physician Decision|0
2143104|NCT01125293|3752114|FG005|Overall Study|Physician Decision|2
2143105|NCT01125358|3752135|FG000|Overall Study|Adverse Event|3
2143106|NCT01125358|3752136|FG001|Overall Study|Adverse Event|0
2143107|NCT01125358|3752137|FG002|Overall Study|Adverse Event|0
2143108|NCT01125358|3752138|FG003|Overall Study|Adverse Event|2
2143109|NCT01125358|3752135|FG000|Overall Study|Perceived Lack of Efficacy|6
2143110|NCT01125358|3752136|FG001|Overall Study|Perceived Lack of Efficacy|3
2143111|NCT01125358|3752137|FG002|Overall Study|Perceived Lack of Efficacy|7
2143112|NCT01125358|3752138|FG003|Overall Study|Perceived Lack of Efficacy|4
2143113|NCT01125358|3752135|FG000|Overall Study|Protocol Violation|1
2143114|NCT01125358|3752136|FG001|Overall Study|Protocol Violation|0
2143115|NCT01125358|3752137|FG002|Overall Study|Protocol Violation|0
2143116|NCT01125358|3752138|FG003|Overall Study|Protocol Violation|0
2143117|NCT01125358|3752135|FG000|Overall Study|Sponsor Decision|0
2143118|NCT01125358|3752136|FG001|Overall Study|Sponsor Decision|0
2143119|NCT01125358|3752137|FG002|Overall Study|Sponsor Decision|1
2143120|NCT01125358|3752138|FG003|Overall Study|Sponsor Decision|1
2143121|NCT01125358|3752135|FG000|Overall Study|Withdrawal by Subject|2
2143122|NCT01125358|3752136|FG001|Overall Study|Withdrawal by Subject|1
2143123|NCT01125358|3752137|FG002|Overall Study|Withdrawal by Subject|1
2143124|NCT01125358|3752138|FG003|Overall Study|Withdrawal by Subject|1
2143125|NCT01125514|3752148|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
2143126|NCT01125514|3752148|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
2143127|NCT01125514|3752148|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
2143128|NCT01125514|3752148|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
2143129|NCT01125514|3752148|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
2143130|NCT01125514|3752148|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
2143131|NCT01125566|3752164|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
2143132|NCT01125566|3752165|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
2143133|NCT01125566|3752166|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
2143134|NCT01125566|3752164|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
2143135|NCT01125566|3752165|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
2143136|NCT01125566|3752166|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
2143137|NCT01125566|3752164|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25
2143138|NCT01125566|3752165|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5
2143139|NCT01125566|3752166|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0
2143140|NCT01125566|3752164|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0
2143141|NCT01125566|3752165|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2
2143142|NCT01125566|3752166|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0
2143143|NCT01125566|3752164|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
2143144|NCT01125566|3752165|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
2143145|NCT01125566|3752166|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
2143146|NCT01125566|3752164|FG000|Patients Before the Switch (26Apr2013)|Not treated|2
2143147|NCT01125566|3752165|FG001|Patients Before the Switch (26Apr2013)|Not treated|0
2143148|NCT01125566|3752166|FG002|Patients Before the Switch (26Apr2013)|Not treated|0
2143149|NCT01125566|3752164|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25
2143150|NCT01125566|3752165|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13
2143151|NCT01125566|3752166|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0
2143152|NCT01125566|3752164|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
2143153|NCT01125566|3752165|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
2143154|NCT01125566|3752166|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
2143155|NCT01125566|3752164|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
2143156|NCT01125566|3752165|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
2143157|NCT01125566|3752166|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
2143158|NCT01125566|3752164|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0
2143159|NCT01125566|3752165|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0
2143160|NCT01125566|3752166|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7
2143161|NCT01125566|3752164|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
2178691|NCT01387516|3803679|FG000|Overall Study|Lost to Follow-up|4
2143162|NCT01125566|3752165|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
2143163|NCT01125566|3752166|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
2143164|NCT01125566|3752164|FG000|Patients Who Switched From AV to TV|Other than listed above|0
2143165|NCT01125566|3752165|FG001|Patients Who Switched From AV to TV|Other than listed above|0
2143166|NCT01125566|3752166|FG002|Patients Who Switched From AV to TV|Other than listed above|4
2143167|NCT01125722|3752192|FG000|Overall Study|Withdrawal by Subject|2
2143168|NCT01125722|3752193|FG001|Overall Study|Withdrawal by Subject|1
2143169|NCT01125722|3752192|FG000|Overall Study|Lost to Follow-up|1
2143170|NCT01125722|3752193|FG001|Overall Study|Lost to Follow-up|0
2143171|NCT01125748|3752201|FG000|Overall Study|Adverse Event|0
2143172|NCT01125748|3752202|FG001|Overall Study|Adverse Event|2
2143173|NCT01125748|3752201|FG000|Overall Study|Lost to Follow-up|0
2143174|NCT01125748|3752202|FG001|Overall Study|Lost to Follow-up|1
2143175|NCT01125748|3752201|FG000|Overall Study|Physician Decision|8
2143176|NCT01125748|3752202|FG001|Overall Study|Physician Decision|7
2143177|NCT01125748|3752201|FG000|Overall Study|Patient Decision to Withdraw|2
2143178|NCT01125748|3752202|FG001|Overall Study|Patient Decision to Withdraw|4
2143179|NCT01125800|3752224|FG000|Phase I|Protocol Violation|0
2143180|NCT01125800|3752225|FG001|Phase I|Protocol Violation|3
2143181|NCT01125800|3752226|FG002|Phase I|Protocol Violation|1
2143182|NCT01125800|3752227|FG003|Phase I|Protocol Violation|1
2143183|NCT01125800|3752228|FG004|Phase I|Protocol Violation|0
2143184|NCT01125800|3752224|FG000|Phase I|Adverse Event|2
2143185|NCT01125800|3752225|FG001|Phase I|Adverse Event|2
2143186|NCT01125800|3752226|FG002|Phase I|Adverse Event|1
2143187|NCT01125800|3752227|FG003|Phase I|Adverse Event|7
2143188|NCT01125800|3752228|FG004|Phase I|Adverse Event|0
2143189|NCT01125800|3752224|FG000|Phase I|Administrative problems|1
2289781|NCT02480621|3981773|FG001|Follow Up|Lost to Follow-up|2
2289782|NCT02480712|3981779|FG000|Overall Study|Enrolled but Never Treated|1
2289783|NCT02480712|3981779|FG000|Overall Study|Lost to Follow-up|5
2289784|NCT02480712|3981779|FG000|Overall Study|Withdrew Consent|3
2289785|NCT02480712|3981779|FG000|Overall Study|Death|1
2289786|NCT02480712|3981779|FG000|Overall Study|Lack of Efficacy|1
2289787|NCT02480764|3981792|FG000|Overall Study|Pretreatment Event/Adverse Event|3
2289788|NCT02480764|3981793|FG001|Overall Study|Pretreatment Event/Adverse Event|6
2289789|NCT02480764|3981794|FG002|Overall Study|Pretreatment Event/Adverse Event|3
2289790|NCT02480764|3981792|FG000|Overall Study|Major Protocol Deviation|1
2289791|NCT02480764|3981793|FG001|Overall Study|Major Protocol Deviation|4
2289792|NCT02480764|3981794|FG002|Overall Study|Major Protocol Deviation|3
2289793|NCT02480764|3981792|FG000|Overall Study|Lost to Follow-up|0
2289794|NCT02480764|3981793|FG001|Overall Study|Lost to Follow-up|1
2289795|NCT02480764|3981794|FG002|Overall Study|Lost to Follow-up|2
2289796|NCT02480764|3981792|FG000|Overall Study|Voluntary Withdrawal|6
2289797|NCT02480764|3981793|FG001|Overall Study|Voluntary Withdrawal|5
2289798|NCT02480764|3981794|FG002|Overall Study|Voluntary Withdrawal|10
2289799|NCT02480764|3981792|FG000|Overall Study|Lack of Efficacy|0
2289800|NCT02480764|3981793|FG001|Overall Study|Lack of Efficacy|3
2289801|NCT02480764|3981794|FG002|Overall Study|Lack of Efficacy|3
2289802|NCT02480764|3981792|FG000|Overall Study|Reason not Specified|0
2289803|NCT02480764|3981793|FG001|Overall Study|Reason not Specified|1
2289804|NCT02480764|3981794|FG002|Overall Study|Reason not Specified|0
2289805|NCT02481050|3981817|FG000|Overall Study|Adverse Event|1
2289806|NCT02481050|3981817|FG000|Overall Study|Disease Progression|47
2289807|NCT02481050|3981817|FG000|Overall Study|Withdrawal by Subject|7
2289808|NCT02481050|3981817|FG000|Overall Study|Other|3
2289809|NCT02481869|3981962|FG000|Overall Study|Lost to Follow-up|3
2289810|NCT02481869|3981963|FG001|Overall Study|Lost to Follow-up|4
2289811|NCT02481869|3981962|FG000|Overall Study|Withdrawal by Subject|2
2289812|NCT02481869|3981963|FG001|Overall Study|Withdrawal by Subject|0
2289813|NCT02481934|3981970|FG000|Overall Study|Death|2
2289814|NCT02481947|3981976|FG000|Overall Study|Withdrawal by Subject|24
2289815|NCT02481947|3981977|FG001|Overall Study|Withdrawal by Subject|10
2289816|NCT02481947|3981976|FG000|Overall Study|Lost to Follow-up|11
2289817|NCT02481947|3981977|FG001|Overall Study|Lost to Follow-up|5
2289818|NCT02481947|3981976|FG000|Overall Study|Adverse Event|6
2289819|NCT02481947|3981977|FG001|Overall Study|Adverse Event|11
2289820|NCT02481947|3981976|FG000|Overall Study|Physician Decision|4
2289821|NCT02481947|3981977|FG001|Overall Study|Physician Decision|5
2289822|NCT02481947|3981976|FG000|Overall Study|Protocol Violation|1
2289823|NCT02481947|3981977|FG001|Overall Study|Protocol Violation|5
2289824|NCT02482129|3981994|FG000|Overall Study|Adverse Event-prior to treatment|0
2289825|NCT02482129|3981995|FG001|Overall Study|Adverse Event-prior to treatment|1
2289826|NCT02482129|3981994|FG000|Overall Study|Withdrawal by subject-prior to treatment|0
2289827|NCT02482129|3981995|FG001|Overall Study|Withdrawal by subject-prior to treatment|1
2289828|NCT02482129|3981994|FG000|Overall Study|Unable to draw blood-prior to treatment|1
2289829|NCT02482129|3981995|FG001|Overall Study|Unable to draw blood-prior to treatment|0
2289830|NCT02482129|3981994|FG000|Overall Study|Criteria not met-prior to treatment|1
2289831|NCT02482129|3981995|FG001|Overall Study|Criteria not met-prior to treatment|0
2289832|NCT02482129|3981994|FG000|Overall Study|Adverse Event|1
2289833|NCT02482129|3981995|FG001|Overall Study|Adverse Event|0
2289834|NCT02482129|3981994|FG000|Overall Study|Withdrawal by Subject|2
2143190|NCT01125800|3752225|FG001|Phase I|Administrative problems|0
2143191|NCT01125800|3752226|FG002|Phase I|Administrative problems|0
2143192|NCT01125800|3752227|FG003|Phase I|Administrative problems|0
2289835|NCT02482129|3981995|FG001|Overall Study|Withdrawal by Subject|0
2289836|NCT02482129|3981994|FG000|Overall Study|Criteria not met|1
2289837|NCT02482129|3981995|FG001|Overall Study|Criteria not met|0
2289838|NCT02482233|3982005|FG000|Overall Study|Lost to Follow-up|1
2289839|NCT02482233|3982006|FG001|Overall Study|Lost to Follow-up|1
2289840|NCT02482298|3982017|FG000|Overall Study|Withdrawal by Subject|2
2289841|NCT02482298|3982018|FG001|Overall Study|Withdrawal by Subject|1
2289842|NCT02482298|3982019|FG002|Overall Study|Withdrawal by Subject|2
2289843|NCT02482298|3982017|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0
2289844|NCT02482298|3982018|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1
2289845|NCT02482298|3982019|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0
2289846|NCT02482298|3982017|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
2289847|NCT02482298|3982018|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
2289848|NCT02482298|3982019|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
2289849|NCT02482298|3982017|FG000|Overall Study|Lost to Follow-up|0
2289850|NCT02482298|3982018|FG001|Overall Study|Lost to Follow-up|1
2289851|NCT02482298|3982019|FG002|Overall Study|Lost to Follow-up|0
2289852|NCT02482428|3982032|FG000|Overall Study|Lost to Follow-up|4
2289853|NCT02482428|3982033|FG001|Overall Study|Lost to Follow-up|9
2289854|NCT02482428|3982034|FG002|Overall Study|Lost to Follow-up|1
2289855|NCT02482428|3982035|FG003|Overall Study|Lost to Follow-up|2
2289856|NCT02482428|3982036|FG004|Overall Study|Lost to Follow-up|4
2289857|NCT02482428|3982032|FG000|Overall Study|Physician Decision|0
2289858|NCT02482428|3982033|FG001|Overall Study|Physician Decision|0
2289859|NCT02482428|3982034|FG002|Overall Study|Physician Decision|0
2289860|NCT02482428|3982035|FG003|Overall Study|Physician Decision|0
2289861|NCT02482428|3982036|FG004|Overall Study|Physician Decision|1
2289862|NCT02482428|3982032|FG000|Overall Study|protocol deviation|1
2289863|NCT02482428|3982033|FG001|Overall Study|protocol deviation|1
2289864|NCT02482428|3982034|FG002|Overall Study|protocol deviation|0
2289865|NCT02482428|3982035|FG003|Overall Study|protocol deviation|0
2289866|NCT02482428|3982036|FG004|Overall Study|protocol deviation|0
2289867|NCT02482428|3982032|FG000|Overall Study|subject/guardian decision|4
2289868|NCT02482428|3982033|FG001|Overall Study|subject/guardian decision|2
2289869|NCT02482428|3982034|FG002|Overall Study|subject/guardian decision|0
2289870|NCT02482428|3982035|FG003|Overall Study|subject/guardian decision|0
2289871|NCT02482428|3982036|FG004|Overall Study|subject/guardian decision|2
2289872|NCT02482571|3982050|FG000|Overall Study|Adverse Event|1
2289873|NCT02482571|3982050|FG000|Overall Study|Scanner or Respiract failure|3
2289874|NCT02482571|3982050|FG000|Overall Study|Withdrawal by Subject|4
2289875|NCT02482805|3982106|FG000|Overall Study|Lost to Follow-up|4
2289876|NCT02482805|3982107|FG001|Overall Study|Lost to Follow-up|4
2289877|NCT02482805|3982108|FG002|Overall Study|Lost to Follow-up|0
2289878|NCT02482935|3982131|FG000|Period 1|Withdrawal by Subject|1
2289879|NCT02482935|3982132|FG001|Period 1|Withdrawal by Subject|0
2289880|NCT02483416|3982147|FG000|Overall Study|Other reason|0
2289881|NCT02483416|3982148|FG001|Overall Study|Other reason|1
2289882|NCT02483416|3982147|FG000|Overall Study|Treatment stop|3
2289883|NCT02483416|3982148|FG001|Overall Study|Treatment stop|0
2289884|NCT02483520|3982157|FG000|Overall Study|Lost to Follow-up|3
2289885|NCT02483520|3982158|FG001|Overall Study|Lost to Follow-up|4
2289886|NCT02483520|3982157|FG000|Overall Study|Withdrawal by Subject|4
2289887|NCT02483520|3982158|FG001|Overall Study|Withdrawal by Subject|14
2289888|NCT02483520|3982157|FG000|Overall Study|Hospitalized|2
2289889|NCT02483520|3982158|FG001|Overall Study|Hospitalized|3
2143193|NCT01125800|3752228|FG004|Phase I|Administrative problems|0
2143194|NCT01125800|3752224|FG000|Phase I|Withdrawal by Subject|0
2143195|NCT01125800|3752225|FG001|Phase I|Withdrawal by Subject|0
2143196|NCT01125800|3752226|FG002|Phase I|Withdrawal by Subject|1
2143197|NCT01125800|3752227|FG003|Phase I|Withdrawal by Subject|0
2143198|NCT01125800|3752228|FG004|Phase I|Withdrawal by Subject|0
2143199|NCT01125800|3752224|FG000|Phase I|Disease progression|5
2143200|NCT01125800|3752225|FG001|Phase I|Disease progression|4
2143201|NCT01125800|3752226|FG002|Phase I|Disease progression|1
2143202|NCT01125800|3752227|FG003|Phase I|Disease progression|3
2143203|NCT01125800|3752228|FG004|Phase I|Disease progression|0
2143204|NCT01125800|3752224|FG000|Phase II|Protocol Violation|0
2143205|NCT01125800|3752225|FG001|Phase II|Protocol Violation|0
2143206|NCT01125800|3752226|FG002|Phase II|Protocol Violation|0
2143207|NCT01125800|3752227|FG003|Phase II|Protocol Violation|0
2143208|NCT01125800|3752228|FG004|Phase II|Protocol Violation|1
2143209|NCT01125800|3752224|FG000|Phase II|Adverse Event|0
2289890|NCT02483520|3982157|FG000|Overall Study|Moved to LTC|2
2289891|NCT02483520|3982158|FG001|Overall Study|Moved to LTC|3
2289892|NCT02483572|3982166|FG000|Overall Study|Withdrawal by Subject|1
2289893|NCT02483572|3982167|FG001|Overall Study|Withdrawal by Subject|0
2289894|NCT02483572|3982166|FG000|Overall Study|Lost to Follow-up|1
2289895|NCT02483572|3982167|FG001|Overall Study|Lost to Follow-up|0
2143210|NCT01125800|3752225|FG001|Phase II|Adverse Event|0
2289896|NCT02483572|3982166|FG000|Overall Study|Physician Decision|0
2289897|NCT02483572|3982167|FG001|Overall Study|Physician Decision|1
2289898|NCT02483585|3982175|FG000|Double-blind Treatment Phase|Decision by Sponsor|1
2143211|NCT01125800|3752226|FG002|Phase II|Adverse Event|0
2143212|NCT01125800|3752227|FG003|Phase II|Adverse Event|0
2143213|NCT01125800|3752228|FG004|Phase II|Adverse Event|2
2143214|NCT01125800|3752224|FG000|Phase II|Disease progression|0
2143215|NCT01125800|3752225|FG001|Phase II|Disease progression|0
2143216|NCT01125800|3752226|FG002|Phase II|Disease progression|0
2143217|NCT01125800|3752227|FG003|Phase II|Disease progression|1
2143218|NCT01125800|3752228|FG004|Phase II|Disease progression|8
2143219|NCT01125813|3752243|FG000|Overall Study|Death|1
2143220|NCT01125813|3752243|FG000|Overall Study|Withdrawal by Subject|1
2143221|NCT01125813|3752243|FG000|Overall Study|Screen Failures|4
2143222|NCT01125917|3752247|FG000|Overall Study|Adverse Event|43
2143223|NCT01125917|3752247|FG000|Overall Study|Lost to Follow-up|23
2143224|NCT01125917|3752247|FG000|Overall Study|Withdrawal by Subject|31
2143225|NCT01125917|3752247|FG000|Overall Study|Administrative|223
2143226|NCT01125917|3752247|FG000|Overall Study|Lack of Efficacy|19
2143227|NCT01125930|3752253|FG000|Overall Study|Adverse Event|0
2143228|NCT01125930|3752254|FG001|Overall Study|Adverse Event|1
2143229|NCT01125930|3752253|FG000|Overall Study|Withdrawal by Subject|1
2143230|NCT01125930|3752254|FG001|Overall Study|Withdrawal by Subject|6
2143231|NCT01125930|3752253|FG000|Overall Study|Protocol Violation|0
2143232|NCT01125930|3752254|FG001|Overall Study|Protocol Violation|1
2143233|NCT01125930|3752253|FG000|Overall Study|Lost to Follow-up|0
2143234|NCT01125930|3752254|FG001|Overall Study|Lost to Follow-up|2
2143235|NCT01126060|3752278|FG000|Overall Study|Protocol Violation|0
2143236|NCT01126060|3752279|FG001|Overall Study|Protocol Violation|2
2143237|NCT01126268|3752294|FG000|Overall Study|Adverse Event|1
2143238|NCT01126359|3752298|FG000|First Intervention (20-minutes)|Physician Decision|0
2143239|NCT01126359|3752299|FG001|First Intervention (20-minutes)|Physician Decision|1
2143240|NCT01126424|3752315|FG000|Overall Study|Adverse Event|0
2143241|NCT01126424|3752316|FG001|Overall Study|Adverse Event|0
2143242|NCT01126424|3752317|FG002|Overall Study|Adverse Event|0
2143243|NCT01126424|3752318|FG003|Overall Study|Adverse Event|0
2143244|NCT01126424|3752319|FG004|Overall Study|Adverse Event|1
2143245|NCT01126424|3752320|FG005|Overall Study|Adverse Event|0
2143246|NCT01126424|3752315|FG000|Overall Study|Withdrawal by Subject|0
2143247|NCT01126424|3752316|FG001|Overall Study|Withdrawal by Subject|0
2143248|NCT01126424|3752317|FG002|Overall Study|Withdrawal by Subject|1
2143249|NCT01126424|3752318|FG003|Overall Study|Withdrawal by Subject|3
2143250|NCT01126424|3752319|FG004|Overall Study|Withdrawal by Subject|1
2143251|NCT01126424|3752320|FG005|Overall Study|Withdrawal by Subject|0
2143252|NCT01126437|3752331|FG000|Overall Study|Not treated|11
2143253|NCT01126437|3752332|FG001|Overall Study|Not treated|18
2143254|NCT01126437|3752333|FG002|Overall Study|Not treated|19
2143255|NCT01126437|3752331|FG000|Overall Study|Sites with data irregularities/fraud|6
2143256|NCT01126437|3752332|FG001|Overall Study|Sites with data irregularities/fraud|6
2143257|NCT01126437|3752333|FG002|Overall Study|Sites with data irregularities/fraud|7
2143258|NCT01126437|3752331|FG000|Overall Study|Adverse Event|602
2143259|NCT01126437|3752332|FG001|Overall Study|Adverse Event|606
2143260|NCT01126437|3752333|FG002|Overall Study|Adverse Event|635
2143261|NCT01126437|3752331|FG000|Overall Study|Lack of Efficacy|65
2143262|NCT01126437|3752332|FG001|Overall Study|Lack of Efficacy|60
2143263|NCT01126437|3752333|FG002|Overall Study|Lack of Efficacy|59
2143264|NCT01126437|3752331|FG000|Overall Study|Protocol Violation|64
2143265|NCT01126437|3752332|FG001|Overall Study|Protocol Violation|66
2143266|NCT01126437|3752333|FG002|Overall Study|Protocol Violation|41
2143267|NCT01126437|3752331|FG000|Overall Study|Lost to Follow-up|52
2143268|NCT01126437|3752332|FG001|Overall Study|Lost to Follow-up|63
2143269|NCT01126437|3752333|FG002|Overall Study|Lost to Follow-up|55
2143270|NCT01126437|3752331|FG000|Overall Study|Withdrawal by Subject|331
2143271|NCT01126437|3752332|FG001|Overall Study|Withdrawal by Subject|335
2143272|NCT01126437|3752333|FG002|Overall Study|Withdrawal by Subject|319
2143273|NCT01126437|3752331|FG000|Overall Study|Other reason not specified|210
2143274|NCT01126437|3752332|FG001|Overall Study|Other reason not specified|176
2143275|NCT01126437|3752333|FG002|Overall Study|Other reason not specified|178
2143276|NCT01126541|3752344|FG000|Overall Study|Adverse Event|0
2143277|NCT01126541|3752345|FG001|Overall Study|Adverse Event|2
2143278|NCT01126541|3752346|FG002|Overall Study|Adverse Event|4
2143279|NCT01126541|3752344|FG000|Overall Study|Death|0
2143280|NCT01126541|3752345|FG001|Overall Study|Death|1
2143281|NCT01126541|3752346|FG002|Overall Study|Death|0
2143282|NCT01126541|3752344|FG000|Overall Study|Lack of Efficacy|6
2143283|NCT01126541|3752345|FG001|Overall Study|Lack of Efficacy|1
2143284|NCT01126541|3752346|FG002|Overall Study|Lack of Efficacy|11
2143285|NCT01126541|3752344|FG000|Overall Study|Lost to Follow-up|1
2143286|NCT01126541|3752345|FG001|Overall Study|Lost to Follow-up|2
2143287|NCT01126541|3752346|FG002|Overall Study|Lost to Follow-up|2
2143288|NCT01126541|3752344|FG000|Overall Study|Withdrawal by Subject|2
2143289|NCT01126541|3752345|FG001|Overall Study|Withdrawal by Subject|5
2143290|NCT01126541|3752346|FG002|Overall Study|Withdrawal by Subject|6
2143291|NCT01126541|3752344|FG000|Overall Study|Protocol Violation|0
2143292|NCT01126541|3752345|FG001|Overall Study|Protocol Violation|0
2143293|NCT01126541|3752346|FG002|Overall Study|Protocol Violation|1
2143294|NCT01126541|3752344|FG000|Overall Study|Administrative reason or other|1
2143295|NCT01126541|3752345|FG001|Overall Study|Administrative reason or other|1
2143296|NCT01126541|3752346|FG002|Overall Study|Administrative reason or other|2
2143297|NCT01126580|3752359|FG000|Overall Study|Adverse Event|14
2143298|NCT01126580|3752360|FG001|Overall Study|Adverse Event|8
2143299|NCT01126580|3752361|FG002|Overall Study|Adverse Event|12
2143300|NCT01126580|3752359|FG000|Overall Study|Withdrawal by Subject|11
2143301|NCT01126580|3752360|FG001|Overall Study|Withdrawal by Subject|19
2143302|NCT01126580|3752361|FG002|Overall Study|Withdrawal by Subject|14
2143303|NCT01126580|3752359|FG000|Overall Study|Sponsor Decision|5
2143304|NCT01126580|3752360|FG001|Overall Study|Sponsor Decision|4
2143305|NCT01126580|3752361|FG002|Overall Study|Sponsor Decision|7
2143306|NCT01126580|3752359|FG000|Overall Study|Physician Decision|1
2143307|NCT01126580|3752360|FG001|Overall Study|Physician Decision|1
2143308|NCT01126580|3752361|FG002|Overall Study|Physician Decision|2
2143309|NCT01126580|3752359|FG000|Overall Study|Entry Criteria Not Met|1
2143310|NCT01126580|3752360|FG001|Overall Study|Entry Criteria Not Met|1
2143311|NCT01126580|3752361|FG002|Overall Study|Entry Criteria Not Met|2
2143312|NCT01126580|3752359|FG000|Overall Study|Lack of Efficacy|2
2143313|NCT01126580|3752360|FG001|Overall Study|Lack of Efficacy|3
2143314|NCT01126580|3752361|FG002|Overall Study|Lack of Efficacy|4
2143315|NCT01126580|3752359|FG000|Overall Study|Protocol Violation|0
2143316|NCT01126580|3752360|FG001|Overall Study|Protocol Violation|1
2143317|NCT01126580|3752361|FG002|Overall Study|Protocol Violation|2
2143318|NCT01126580|3752359|FG000|Overall Study|Lost to Follow-up|15
2143319|NCT01126580|3752360|FG001|Overall Study|Lost to Follow-up|13
2143320|NCT01126580|3752361|FG002|Overall Study|Lost to Follow-up|9
2143321|NCT01126580|3752359|FG000|Overall Study|Treatment Non-compliance|0
2143322|NCT01126580|3752360|FG001|Overall Study|Treatment Non-compliance|2
2143323|NCT01126580|3752361|FG002|Overall Study|Treatment Non-compliance|3
2143324|NCT01126619|3752383|FG000|Overall Study|Not eligible for the study|2
2143325|NCT01126619|3752383|FG000|Overall Study|Investigator decision|4
2143326|NCT01126619|3752383|FG000|Overall Study|Serious adverse event|1
2143327|NCT01126619|3752383|FG000|Overall Study|Withdrawal by Subject|9
2143328|NCT01126619|3752383|FG000|Overall Study|Non-compliance|1
2143329|NCT01127061|3752411|FG000|Overall Study|Lost to Follow-up|7
2143330|NCT01127061|3752412|FG001|Overall Study|Lost to Follow-up|10
2143331|NCT01127061|3752411|FG000|Overall Study|Physician Decision|3
2143332|NCT01127061|3752412|FG001|Overall Study|Physician Decision|3
2143333|NCT01127139|3752429|FG000|Overall Study|Adverse Event|40
2143334|NCT01127139|3752429|FG000|Overall Study|Incompliance|12
2143335|NCT01127139|3752429|FG000|Overall Study|Lack of Efficacy|4
2143336|NCT01127139|3752429|FG000|Overall Study|Reason not specified|1
2143337|NCT01127165|3752438|FG000|Overall Study|Adverse Event|2
2143338|NCT01127165|3752439|FG001|Overall Study|Adverse Event|2
2143339|NCT01127165|3752438|FG000|Overall Study|Lack of Efficacy|10
2143340|NCT01127165|3752439|FG001|Overall Study|Lack of Efficacy|8
2143341|NCT01127165|3752438|FG000|Overall Study|Lost to Follow-up|3
2143342|NCT01127165|3752439|FG001|Overall Study|Lost to Follow-up|5
2143343|NCT01127165|3752438|FG000|Overall Study|Withdrawal by Subject|1
2143344|NCT01127165|3752439|FG001|Overall Study|Withdrawal by Subject|3
2143345|NCT01127165|3752438|FG000|Overall Study|Protocol Violation|0
2143346|NCT01127165|3752439|FG001|Overall Study|Protocol Violation|1
2143347|NCT01127373|3752466|FG000|Overall Study|Not Treated|3
2143348|NCT01127373|3752466|FG000|Overall Study|Lost to Follow-up|7
2143349|NCT01127373|3752466|FG000|Overall Study|Withdrawal by Subject|1
2143350|NCT01127373|3752466|FG000|Overall Study|Disease progression|1
2143351|NCT01127607|3752502|FG000|Phase II (Between Subjects)|Lost to Follow-up|0
2143352|NCT01127607|3752503|FG001|Phase II (Between Subjects)|Lost to Follow-up|2
2143353|NCT01127607|3752502|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1
2143354|NCT01127607|3752503|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0
2143355|NCT01127633|3752528|FG000|Overall Study|Adverse Event|74
2143356|NCT01127633|3752529|FG001|Overall Study|Adverse Event|73
2143357|NCT01127633|3752528|FG000|Overall Study|Death|40
2143358|NCT01127633|3752529|FG001|Overall Study|Death|43
2143359|NCT01127633|3752528|FG000|Overall Study|Lost to Follow-up|4
2143360|NCT01127633|3752529|FG001|Overall Study|Lost to Follow-up|0
2143361|NCT01127633|3752528|FG000|Overall Study|Parent/Caregiver Decision|246
2143362|NCT01127633|3752529|FG001|Overall Study|Parent/Caregiver Decision|228
2143363|NCT01127633|3752528|FG000|Overall Study|Physician Decision|60
2143364|NCT01127633|3752529|FG001|Overall Study|Physician Decision|45
2143365|NCT01127633|3752528|FG000|Overall Study|Withdrawal by Subject|57
2143366|NCT01127633|3752529|FG001|Overall Study|Withdrawal by Subject|72
2143367|NCT01127633|3752528|FG000|Overall Study|Sponsor Decision|163
2143368|NCT01127633|3752529|FG001|Overall Study|Sponsor Decision|195
2143369|NCT01127633|3752528|FG000|Overall Study|Protocol Violation|8
2143370|NCT01127633|3752529|FG001|Overall Study|Protocol Violation|16
2143371|NCT01127633|3752528|FG000|Overall Study|Abnormal Lab/ECG Result|0
2143372|NCT01127633|3752529|FG001|Overall Study|Abnormal Lab/ECG Result|1
2143373|NCT01127633|3752528|FG000|Overall Study|Not treated|1
2143374|NCT01127633|3752529|FG001|Overall Study|Not treated|0
2143375|NCT01127646|3752537|FG000|Overall Study|Entry Criteria Not Met|1
2143376|NCT01127646|3752538|FG001|Overall Study|Entry Criteria Not Met|0
2143377|NCT01127646|3752537|FG000|Overall Study|Protocol Violation|0
2143378|NCT01127646|3752538|FG001|Overall Study|Protocol Violation|1
2143379|NCT01127763|3752580|FG000|Overall Study|Adverse Event|2
2143380|NCT01127763|3752580|FG000|Overall Study|Withdrawal by Subject|1
2143381|NCT01127763|3752580|FG000|Overall Study|Physician Decision|2
2178692|NCT01387516|3803680|FG001|Overall Study|Lost to Follow-up|4
2143382|NCT01127893|3752588|FG000|Overall Study|Study Termination by the Sponsor|1
2143383|NCT01128153|3752607|FG000|Overall Study|Adverse Event|1
2143384|NCT01128153|3752608|FG001|Overall Study|Adverse Event|3
2143385|NCT01128153|3752607|FG000|Overall Study|Condition under investigation worsened|8
2143386|NCT01128153|3752608|FG001|Overall Study|Condition under investigation worsened|7
2143387|NCT01128153|3752607|FG000|Overall Study|Withdrawal by Subject|2
2143388|NCT01128153|3752608|FG001|Overall Study|Withdrawal by Subject|3
2143389|NCT01128153|3752607|FG000|Overall Study|Incorrect enrolment to study|2
2143390|NCT01128153|3752608|FG001|Overall Study|Incorrect enrolment to study|1
2143391|NCT01128153|3752607|FG000|Overall Study|Protocol Violation|2
2143392|NCT01128153|3752608|FG001|Overall Study|Protocol Violation|0
2143393|NCT01128153|3752607|FG000|Overall Study|Developed discontinuation criteria|1
2143394|NCT01128153|3752608|FG001|Overall Study|Developed discontinuation criteria|1
2143395|NCT01128179|3752616|FG000|Overall Study|Death|1
2143396|NCT01128179|3752617|FG001|Overall Study|Death|0
2143397|NCT01128179|3752616|FG000|Overall Study|Protocol Violation|1
2143398|NCT01128179|3752617|FG001|Overall Study|Protocol Violation|0
2143399|NCT01128244|3752638|FG000|Overall Study|Adverse Event|1
2143400|NCT01128244|3752638|FG000|Overall Study|Scheduling conflict|2
2143401|NCT01128296|3752658|FG000|Overall Study|Physician Decision|0
2143402|NCT01128296|3752659|FG001|Overall Study|Physician Decision|0
2143403|NCT01128296|3752660|FG002|Overall Study|Physician Decision|0
2143404|NCT01128296|3752661|FG003|Overall Study|Physician Decision|0
2143405|NCT01128296|3752662|FG004|Overall Study|Physician Decision|0
2143406|NCT01128296|3752663|FG005|Overall Study|Physician Decision|3
2143407|NCT01128296|3752658|FG000|Overall Study|Withdrawal by Subject|0
2143408|NCT01128296|3752659|FG001|Overall Study|Withdrawal by Subject|0
2143409|NCT01128296|3752660|FG002|Overall Study|Withdrawal by Subject|0
2143410|NCT01128296|3752661|FG003|Overall Study|Withdrawal by Subject|0
2143411|NCT01128296|3752662|FG004|Overall Study|Withdrawal by Subject|0
2143412|NCT01128296|3752663|FG005|Overall Study|Withdrawal by Subject|2
2143413|NCT01128361|3752676|FG000|Overall Study|Lost to Follow-up|0
2143414|NCT01128361|3752677|FG001|Overall Study|Lost to Follow-up|1
2143415|NCT01128361|3752676|FG000|Overall Study|Withdrawal by Subject|5
2143416|NCT01128361|3752677|FG001|Overall Study|Withdrawal by Subject|2
2143417|NCT01128387|3752685|FG000|Overall Study|Physician Decision|0
2143418|NCT01128387|3752686|FG001|Overall Study|Physician Decision|1
2143419|NCT01128400|3752695|FG000|Overall Study|Lost to Follow-up|1
2143420|NCT01128400|3752696|FG001|Overall Study|Lost to Follow-up|0
2143421|NCT01128400|3752697|FG002|Overall Study|Lost to Follow-up|1
2143422|NCT01128400|3752695|FG000|Overall Study|Screening failure|1
2143423|NCT01128400|3752696|FG001|Overall Study|Screening failure|0
2143424|NCT01128400|3752697|FG002|Overall Study|Screening failure|0
2143425|NCT01128400|3752695|FG000|Overall Study|were not invited to participate on taste|0
2143426|NCT01128400|3752696|FG001|Overall Study|were not invited to participate on taste|0
2143427|NCT01128400|3752697|FG002|Overall Study|were not invited to participate on taste|15
2143428|NCT01128400|3752695|FG000|Overall Study|Excluded due to sinus problems|0
2143429|NCT01128400|3752696|FG001|Overall Study|Excluded due to sinus problems|1
2143430|NCT01128400|3752697|FG002|Overall Study|Excluded due to sinus problems|0
2143431|NCT01128413|3752707|FG000|Overall Study|Withdrawal by Subject|1
2143432|NCT01128413|3752708|FG001|Overall Study|Withdrawal by Subject|0
2143433|NCT01128413|3752707|FG000|Overall Study|NICOM Monitor Problems|2
2143434|NCT01128413|3752708|FG001|Overall Study|NICOM Monitor Problems|1
2143435|NCT01128413|3752707|FG000|Overall Study|Pt made DNR|1
2143436|NCT01128413|3752708|FG001|Overall Study|Pt made DNR|0
2143437|NCT01128543|3752720|FG000|Overall Study|Withdrawal by Subject|3
2143438|NCT01128543|3752720|FG000|Overall Study|Protocol Violation|1
2143439|NCT01128569|3752724|FG000|Washout Period 1|Adverse Event|0
2143440|NCT01128569|3752725|FG001|Washout Period 1|Adverse Event|0
2143441|NCT01128569|3752726|FG002|Washout Period 1|Adverse Event|1
2289899|NCT02483585|3982176|FG001|Double-blind Treatment Phase|Decision by Sponsor|1
2289900|NCT02483585|3982175|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12
2289901|NCT02483585|3982176|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12
2289902|NCT02483585|3982175|FG000|Double-blind Treatment Phase|Lost to Follow-up|3
2289903|NCT02483585|3982176|FG001|Double-blind Treatment Phase|Lost to Follow-up|2
2289904|NCT02483585|3982175|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6
2289905|NCT02483585|3982176|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5
2289906|NCT02483585|3982175|FG000|Open-label Treatment Phase|Decision by Sponsor|0
2289907|NCT02483585|3982176|FG001|Open-label Treatment Phase|Decision by Sponsor|1
2289908|NCT02483585|3982175|FG000|Open-label Treatment Phase|Withdrawal by Subject|18
2289909|NCT02483585|3982176|FG001|Open-label Treatment Phase|Withdrawal by Subject|14
2289910|NCT02483585|3982175|FG000|Open-label Treatment Phase|Lost to Follow-up|3
2289911|NCT02483585|3982176|FG001|Open-label Treatment Phase|Lost to Follow-up|5
2289912|NCT02483611|3982189|FG000|Overall Study|Protocol Violation|0
2289913|NCT02483611|3982190|FG001|Overall Study|Protocol Violation|0
2289914|NCT02483611|3982191|FG002|Overall Study|Protocol Violation|1
2289915|NCT02483975|3982210|FG000|Overall Study|Adverse Event|0
2143442|NCT01128569|3752727|FG003|Washout Period 1|Adverse Event|0
2143443|NCT01128569|3752728|FG004|Washout Period 1|Adverse Event|0
2143444|NCT01128569|3752729|FG005|Washout Period 1|Adverse Event|0
2289916|NCT02483975|3982211|FG001|Overall Study|Adverse Event|1
2289917|NCT02483975|3982210|FG000|Overall Study|Lost to Follow-up|0
2289918|NCT02483975|3982211|FG001|Overall Study|Lost to Follow-up|1
2289919|NCT02483975|3982210|FG000|Overall Study|Physician Decision|2
2289920|NCT02483975|3982211|FG001|Overall Study|Physician Decision|0
2289921|NCT02484443|3982230|FG000|Overall Study|Lack of Efficacy|28
2289922|NCT02484443|3982230|FG000|Overall Study|Physician Decision|2
2289923|NCT02484443|3982230|FG000|Overall Study|Ineligible|2
2289924|NCT02484547|3982237|FG000|Placebo-Controlled Period|Adverse Event|10
2289925|NCT02484547|3982238|FG001|Placebo-Controlled Period|Adverse Event|13
2289926|NCT02484547|3982239|FG002|Placebo-Controlled Period|Adverse Event|20
2289927|NCT02484547|3982240|FG003|Placebo-Controlled Period|Adverse Event|0
2289928|NCT02484547|3982241|FG004|Placebo-Controlled Period|Adverse Event|0
2289929|NCT02484547|3982242|FG005|Placebo-Controlled Period|Adverse Event|0
2289930|NCT02484547|3982243|FG006|Placebo-Controlled Period|Adverse Event|0
2289931|NCT02484547|3982237|FG000|Placebo-Controlled Period|Change of Treatment|0
2289932|NCT02484547|3982238|FG001|Placebo-Controlled Period|Change of Treatment|0
2289933|NCT02484547|3982239|FG002|Placebo-Controlled Period|Change of Treatment|1
2289934|NCT02484547|3982240|FG003|Placebo-Controlled Period|Change of Treatment|0
2289935|NCT02484547|3982241|FG004|Placebo-Controlled Period|Change of Treatment|0
2289936|NCT02484547|3982242|FG005|Placebo-Controlled Period|Change of Treatment|0
2289937|NCT02484547|3982243|FG006|Placebo-Controlled Period|Change of Treatment|0
2289938|NCT02484547|3982237|FG000|Placebo-Controlled Period|Consent Withdrawn|15
2289939|NCT02484547|3982238|FG001|Placebo-Controlled Period|Consent Withdrawn|32
2289940|NCT02484547|3982239|FG002|Placebo-Controlled Period|Consent Withdrawn|26
2289941|NCT02484547|3982240|FG003|Placebo-Controlled Period|Consent Withdrawn|0
2289942|NCT02484547|3982241|FG004|Placebo-Controlled Period|Consent Withdrawn|0
2289943|NCT02484547|3982242|FG005|Placebo-Controlled Period|Consent Withdrawn|0
2289944|NCT02484547|3982243|FG006|Placebo-Controlled Period|Consent Withdrawn|0
2289945|NCT02484547|3982237|FG000|Placebo-Controlled Period|Death|5
2289946|NCT02484547|3982238|FG001|Placebo-Controlled Period|Death|0
2289947|NCT02484547|3982239|FG002|Placebo-Controlled Period|Death|6
2289948|NCT02484547|3982240|FG003|Placebo-Controlled Period|Death|0
2289949|NCT02484547|3982241|FG004|Placebo-Controlled Period|Death|0
2289950|NCT02484547|3982242|FG005|Placebo-Controlled Period|Death|0
2289951|NCT02484547|3982243|FG006|Placebo-Controlled Period|Death|0
2289952|NCT02484547|3982237|FG000|Placebo-Controlled Period|Disease Progression|2
2289953|NCT02484547|3982238|FG001|Placebo-Controlled Period|Disease Progression|0
2289954|NCT02484547|3982239|FG002|Placebo-Controlled Period|Disease Progression|1
2289955|NCT02484547|3982240|FG003|Placebo-Controlled Period|Disease Progression|0
2289956|NCT02484547|3982241|FG004|Placebo-Controlled Period|Disease Progression|0
2289957|NCT02484547|3982242|FG005|Placebo-Controlled Period|Disease Progression|0
2289958|NCT02484547|3982243|FG006|Placebo-Controlled Period|Disease Progression|0
2289959|NCT02484547|3982237|FG000|Placebo-Controlled Period|Investigator Decision|2
2289960|NCT02484547|3982238|FG001|Placebo-Controlled Period|Investigator Decision|2
2289961|NCT02484547|3982239|FG002|Placebo-Controlled Period|Investigator Decision|5
2289962|NCT02484547|3982240|FG003|Placebo-Controlled Period|Investigator Decision|0
2289963|NCT02484547|3982241|FG004|Placebo-Controlled Period|Investigator Decision|0
2289964|NCT02484547|3982242|FG005|Placebo-Controlled Period|Investigator Decision|0
2289965|NCT02484547|3982243|FG006|Placebo-Controlled Period|Investigator Decision|0
2289966|NCT02484547|3982237|FG000|Placebo-Controlled Period|Lost to Follow-up|3
2289967|NCT02484547|3982238|FG001|Placebo-Controlled Period|Lost to Follow-up|1
2289968|NCT02484547|3982239|FG002|Placebo-Controlled Period|Lost to Follow-up|3
2289969|NCT02484547|3982240|FG003|Placebo-Controlled Period|Lost to Follow-up|0
2289970|NCT02484547|3982241|FG004|Placebo-Controlled Period|Lost to Follow-up|0
2289971|NCT02484547|3982242|FG005|Placebo-Controlled Period|Lost to Follow-up|0
2289972|NCT02484547|3982243|FG006|Placebo-Controlled Period|Lost to Follow-up|0
2289973|NCT02484547|3982237|FG000|Placebo-Controlled Period|Relocation|1
2289974|NCT02484547|3982238|FG001|Placebo-Controlled Period|Relocation|1
2289975|NCT02484547|3982239|FG002|Placebo-Controlled Period|Relocation|1
2289976|NCT02484547|3982240|FG003|Placebo-Controlled Period|Relocation|0
2289977|NCT02484547|3982241|FG004|Placebo-Controlled Period|Relocation|0
2289978|NCT02484547|3982242|FG005|Placebo-Controlled Period|Relocation|0
2289979|NCT02484547|3982243|FG006|Placebo-Controlled Period|Relocation|0
2289980|NCT02484547|3982237|FG000|Placebo-Controlled Period|Study Visit Burden|2
2289981|NCT02484547|3982238|FG001|Placebo-Controlled Period|Study Visit Burden|8
2289982|NCT02484547|3982239|FG002|Placebo-Controlled Period|Study Visit Burden|5
2289983|NCT02484547|3982240|FG003|Placebo-Controlled Period|Study Visit Burden|0
2289984|NCT02484547|3982241|FG004|Placebo-Controlled Period|Study Visit Burden|0
2289985|NCT02484547|3982242|FG005|Placebo-Controlled Period|Study Visit Burden|0
2289986|NCT02484547|3982243|FG006|Placebo-Controlled Period|Study Visit Burden|0
2289987|NCT02484547|3982237|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4
2289988|NCT02484547|3982238|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
2289989|NCT02484547|3982239|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
2289990|NCT02484547|3982240|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
2289991|NCT02484547|3982241|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
2289992|NCT02484547|3982242|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
2289993|NCT02484547|3982243|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
2289994|NCT02484547|3982237|FG000|Placebo-Controlled Period|Reason not Specified|216
2289995|NCT02484547|3982238|FG001|Placebo-Controlled Period|Reason not Specified|194
2143445|NCT01128569|3752724|FG000|Treatment Period 2|Withdrawal by Subject|0
2143446|NCT01128569|3752725|FG001|Treatment Period 2|Withdrawal by Subject|1
2143447|NCT01128569|3752726|FG002|Treatment Period 2|Withdrawal by Subject|0
2143448|NCT01128569|3752727|FG003|Treatment Period 2|Withdrawal by Subject|0
2143449|NCT01128569|3752728|FG004|Treatment Period 2|Withdrawal by Subject|0
2143450|NCT01128569|3752729|FG005|Treatment Period 2|Withdrawal by Subject|0
2143451|NCT01128595|3752737|FG000|Treatment Period 3|Withdrawal by Subject|0
2143452|NCT01128595|3752738|FG001|Treatment Period 3|Withdrawal by Subject|1
2143453|NCT01128595|3752739|FG002|Treatment Period 3|Withdrawal by Subject|0
2143454|NCT01128595|3752740|FG003|Treatment Period 3|Withdrawal by Subject|0
2143455|NCT01128621|3752753|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
2143456|NCT01128621|3752754|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
2178693|NCT01387516|3803681|FG002|Overall Study|Lost to Follow-up|2
2178694|NCT01387516|3803682|FG003|Overall Study|Lost to Follow-up|3
2178695|NCT01387516|3803679|FG000|Overall Study|Withdrawal by Subject|1
2178696|NCT01387516|3803680|FG001|Overall Study|Withdrawal by Subject|1
2178697|NCT01387516|3803681|FG002|Overall Study|Withdrawal by Subject|2
2178698|NCT01387516|3803682|FG003|Overall Study|Withdrawal by Subject|0
2178699|NCT01387516|3803679|FG000|Overall Study|Death|0
2178700|NCT01387516|3803680|FG001|Overall Study|Death|0
2178701|NCT01387516|3803681|FG002|Overall Study|Death|0
2178702|NCT01387516|3803682|FG003|Overall Study|Death|1
2178703|NCT01387542|3803692|FG000|Overall Study|Adverse Event|3
2178704|NCT01387542|3803692|FG000|Overall Study|Withdrawal by Subject|1
2178705|NCT01387542|3803692|FG000|Overall Study|Changed diagnosis|1
2178706|NCT01387542|3803692|FG000|Overall Study|Insufficient response|1
2178707|NCT01387542|3803692|FG000|Overall Study|Non-compliant|1
2178708|NCT01387542|3803692|FG000|Overall Study|Lost to Follow-up|1
2178709|NCT01387594|3803711|FG000|Overall Study|Withdrawal by Subject|0
2178710|NCT01387594|3803712|FG001|Overall Study|Withdrawal by Subject|2
2178711|NCT01387594|3803711|FG000|Overall Study|Lost to Follow-up|0
2178712|NCT01387594|3803712|FG001|Overall Study|Lost to Follow-up|1
2178713|NCT01387607|3803723|FG000|Overall Study|Adverse Event|23
2178714|NCT01387607|3803724|FG001|Overall Study|Adverse Event|11
2178715|NCT01387607|3803723|FG000|Overall Study|Lack of Efficacy|8
2178716|NCT01387607|3803724|FG001|Overall Study|Lack of Efficacy|6
2178717|NCT01387607|3803723|FG000|Overall Study|Lost to Follow-up|2
2178718|NCT01387607|3803724|FG001|Overall Study|Lost to Follow-up|1
2178719|NCT01387607|3803723|FG000|Overall Study|No longer meets eligibility criteria|0
2178720|NCT01387607|3803724|FG001|Overall Study|No longer meets eligibility criteria|1
2178721|NCT01387607|3803723|FG000|Overall Study|Protocol Violation|1
2178722|NCT01387607|3803724|FG001|Overall Study|Protocol Violation|5
2178723|NCT01387607|3803723|FG000|Overall Study|Withdrawal by Subject|13
2178724|NCT01387607|3803724|FG001|Overall Study|Withdrawal by Subject|14
2178725|NCT01387607|3803723|FG000|Overall Study|Other|1
2178726|NCT01387607|3803724|FG001|Overall Study|Other|1
2178727|NCT01387607|3803723|FG000|Overall Study|Randomized, not treated|3
2178728|NCT01387607|3803724|FG001|Overall Study|Randomized, not treated|6
2178729|NCT01387737|3803758|FG000|Overall Study|Adverse Event|20
2178730|NCT01387737|3803759|FG001|Overall Study|Adverse Event|30
2178731|NCT01387737|3803758|FG000|Overall Study|Lack of Efficacy|1
2178732|NCT01387737|3803759|FG001|Overall Study|Lack of Efficacy|0
2178733|NCT01387737|3803758|FG000|Overall Study|Physician Decision|3
2178734|NCT01387737|3803759|FG001|Overall Study|Physician Decision|10
2178735|NCT01387737|3803758|FG000|Overall Study|Withdrawal by Subject|27
2178736|NCT01387737|3803759|FG001|Overall Study|Withdrawal by Subject|31
2178737|NCT01387737|3803758|FG000|Overall Study|Clearly not eligible for the study|1
2178738|NCT01387737|3803759|FG001|Overall Study|Clearly not eligible for the study|3
2178739|NCT01387789|3803765|FG000|Overall Study|Adverse Event|5
2178740|NCT01387789|3803765|FG000|Overall Study|Lack of Efficacy|2
2178741|NCT01387789|3803765|FG000|Overall Study|Lost to Follow-up|1
2178742|NCT01387932|3803780|FG000|Randomized and Treated|Physician Decision|3
2178743|NCT01387932|3803781|FG001|Randomized and Treated|Physician Decision|2
2178744|NCT01387932|3803780|FG000|Randomized and Treated|Withdrawal by Subject|4
2178745|NCT01387932|3803781|FG001|Randomized and Treated|Withdrawal by Subject|2
2178746|NCT01387932|3803780|FG000|Survival Follow-up|Liver Transplant|24
2178747|NCT01387932|3803781|FG001|Survival Follow-up|Liver Transplant|28
2178748|NCT01387932|3803780|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52
2178749|NCT01387932|3803781|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53
2178750|NCT01387932|3803780|FG000|Survival Follow-up|Withdrawal by Subject|2
2178751|NCT01387932|3803781|FG001|Survival Follow-up|Withdrawal by Subject|4
2178752|NCT01387932|3803780|FG000|Survival Follow-up|Lost to Follow-up|6
2178753|NCT01387932|3803781|FG001|Survival Follow-up|Lost to Follow-up|5
2178754|NCT01388166|3803789|FG000|Overall Study|Adverse Event|16
2178755|NCT01388166|3803789|FG000|Overall Study|Lost to Follow-up|30
2178756|NCT01388166|3803789|FG000|Overall Study|Others than specified above|13
2178757|NCT01388335|3803793|FG000|Period 1|Progressive Disease|1
2178758|NCT01388335|3803793|FG000|Period 2|Progressive Disease|2
2178759|NCT01388335|3803793|FG000|Period 2|Sponsor Decision|1
2178760|NCT01388335|3803793|FG000|Safety Extension|Progressive Disease|7
2178761|NCT01388361|3803808|FG000|Overall Study|Adverse Event|0
2143457|NCT01128738|3752778|FG000|First Treatment Phase (TP)|Lost to Follow-up|1
2143458|NCT01128738|3752779|FG001|First Treatment Phase (TP)|Lost to Follow-up|0
2143459|NCT01128738|3752778|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3
2143460|NCT01128738|3752779|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1
2143461|NCT01128738|3752778|FG000|Second TP|Lost to Follow-up|0
2143462|NCT01128738|3752779|FG001|Second TP|Lost to Follow-up|1
2143463|NCT01128738|3752778|FG000|Second TP|Withdrawal by Subject|0
2143464|NCT01128738|3752779|FG001|Second TP|Withdrawal by Subject|2
2143465|NCT01128842|3752791|FG000|Overall Study|Adverse Event|1
2143466|NCT01128842|3752791|FG000|Overall Study|Disease Progression|6
2143467|NCT01128894|3752798|FG000|Overall Study|Adverse Event|31
2143468|NCT01128894|3752799|FG001|Overall Study|Adverse Event|41
2143469|NCT01128894|3752798|FG000|Overall Study|Protocol Violation|2
2143470|NCT01128894|3752799|FG001|Overall Study|Protocol Violation|1
2143471|NCT01128894|3752798|FG000|Overall Study|Noncompliance|4
2143472|NCT01128894|3752799|FG001|Overall Study|Noncompliance|5
2143473|NCT01128894|3752798|FG000|Overall Study|Lost to Follow-up|8
2143474|NCT01128894|3752799|FG001|Overall Study|Lost to Follow-up|8
2143475|NCT01128894|3752798|FG000|Overall Study|Withdrawal by Subject|10
2143476|NCT01128894|3752799|FG001|Overall Study|Withdrawal by Subject|12
2143477|NCT01128894|3752798|FG000|Overall Study|Physician Decision|2
2143478|NCT01128894|3752799|FG001|Overall Study|Physician Decision|1
2143479|NCT01128894|3752798|FG000|Overall Study|Conflicting HbA1c Results at Screening|1
2143480|NCT01128894|3752799|FG001|Overall Study|Conflicting HbA1c Results at Screening|0
2143481|NCT01128946|3752805|FG000|Period I|Protocol Violation|0
2143482|NCT01128946|3752806|FG001|Period I|Protocol Violation|1
2143483|NCT01128946|3752807|FG002|Period I|Protocol Violation|0
2143484|NCT01128946|3752808|FG003|Period I|Protocol Violation|0
2143485|NCT01128946|3752805|FG000|Period I|Withdrawal by Subject|0
2143486|NCT01128946|3752806|FG001|Period I|Withdrawal by Subject|0
2143487|NCT01128946|3752807|FG002|Period I|Withdrawal by Subject|1
2143488|NCT01128946|3752808|FG003|Period I|Withdrawal by Subject|1
2143489|NCT01128946|3752805|FG000|Period II|Protocol Violation|0
2143490|NCT01128946|3752806|FG001|Period II|Protocol Violation|1
2143491|NCT01128946|3752807|FG002|Period II|Protocol Violation|0
2143492|NCT01128946|3752808|FG003|Period II|Protocol Violation|0
2143493|NCT01128946|3752805|FG000|Period II|Withdrawal by Subject|0
2143494|NCT01128946|3752806|FG001|Period II|Withdrawal by Subject|0
2143495|NCT01128946|3752807|FG002|Period II|Withdrawal by Subject|0
2143496|NCT01128946|3752808|FG003|Period II|Withdrawal by Subject|1
2143497|NCT01128946|3752805|FG000|Period III|Protocol Violation|1
2143498|NCT01128946|3752806|FG001|Period III|Protocol Violation|0
2143499|NCT01128946|3752807|FG002|Period III|Protocol Violation|0
2143500|NCT01128946|3752808|FG003|Period III|Protocol Violation|0
2143501|NCT01128959|3752819|FG000|Lead in Period|Adverse Event|3
2143502|NCT01128959|3752819|FG000|Treatment Period|Adverse Event|3
2143503|NCT01128959|3752819|FG000|Treatment Period|Withdrawal by Subject|1
2143504|NCT01129011|3752849|FG000|Overall Study|Adverse Event|20
2143505|NCT01129011|3752850|FG001|Overall Study|Adverse Event|30
2143506|NCT01129011|3752849|FG000|Overall Study|Withdrawal by Subject|24
2143507|NCT01129011|3752850|FG001|Overall Study|Withdrawal by Subject|8
2143508|NCT01129011|3752849|FG000|Overall Study|Lost to Follow-up|6
2143509|NCT01129011|3752850|FG001|Overall Study|Lost to Follow-up|7
2143510|NCT01129011|3752849|FG000|Overall Study|Duodenal Ulcer|2
2143511|NCT01129011|3752850|FG001|Overall Study|Duodenal Ulcer|8
2143512|NCT01129011|3752849|FG000|Overall Study|misc|7
2143513|NCT01129011|3752850|FG001|Overall Study|misc|4
2143514|NCT01129024|3752856|FG000|Overall Study|Physician Decision|5
2143515|NCT01129024|3752856|FG000|Overall Study|Study Terminated by Sponsor|8
2143516|NCT01129024|3752856|FG000|Overall Study|Withdrawal by Subject|2
2143517|NCT01129024|3752856|FG000|Overall Study|Lack of Efficacy|3
2143518|NCT01129024|3752856|FG000|Overall Study|Needed a Platelet Transfusion|1
2143519|NCT01129102|3752863|FG000|Overall Study|No study drug treatment|2
2143520|NCT01129102|3752864|FG001|Overall Study|No study drug treatment|3
2143521|NCT01129102|3752865|FG002|Overall Study|No study drug treatment|1
2143522|NCT01129102|3752863|FG000|Overall Study|Withdrawal by Subject|2
2143523|NCT01129102|3752864|FG001|Overall Study|Withdrawal by Subject|0
2143524|NCT01129102|3752865|FG002|Overall Study|Withdrawal by Subject|3
2143525|NCT01129102|3752863|FG000|Overall Study|Protocol Violation|0
2143526|NCT01129102|3752864|FG001|Overall Study|Protocol Violation|1
2143527|NCT01129102|3752865|FG002|Overall Study|Protocol Violation|1
2143528|NCT01129102|3752863|FG000|Overall Study|Pregnancy|0
2143529|NCT01129102|3752864|FG001|Overall Study|Pregnancy|0
2143530|NCT01129102|3752865|FG002|Overall Study|Pregnancy|1
2143531|NCT01129102|3752863|FG000|Overall Study|Adverse Event|2
2143532|NCT01129102|3752864|FG001|Overall Study|Adverse Event|2
2143533|NCT01129102|3752865|FG002|Overall Study|Adverse Event|1
2143534|NCT01129102|3752863|FG000|Overall Study|Lost to Follow-up|2
2143535|NCT01129102|3752864|FG001|Overall Study|Lost to Follow-up|0
2143536|NCT01129102|3752865|FG002|Overall Study|Lost to Follow-up|0
2143537|NCT01129115|3752876|FG000|Overall Study|Adverse Event|1
2143538|NCT01129115|3752877|FG001|Overall Study|Adverse Event|2
2143539|NCT01129115|3752878|FG002|Overall Study|Adverse Event|3
2143540|NCT01129115|3752879|FG003|Overall Study|Adverse Event|3
2143541|NCT01129115|3752876|FG000|Overall Study|Withdrawal by Subject|1
2143542|NCT01129115|3752877|FG001|Overall Study|Withdrawal by Subject|3
2143543|NCT01129115|3752878|FG002|Overall Study|Withdrawal by Subject|1
2143544|NCT01129115|3752879|FG003|Overall Study|Withdrawal by Subject|4
2143545|NCT01129115|3752876|FG000|Overall Study|Protocol Violation|0
2143546|NCT01129115|3752877|FG001|Overall Study|Protocol Violation|2
2143547|NCT01129115|3752878|FG002|Overall Study|Protocol Violation|2
2143548|NCT01129115|3752879|FG003|Overall Study|Protocol Violation|2
2143549|NCT01129128|3752892|FG000|Overall Study|Lost to Follow-up|2
2143550|NCT01129128|3752893|FG001|Overall Study|Lost to Follow-up|2
2143551|NCT01129128|3752894|FG002|Overall Study|Lost to Follow-up|1
2143552|NCT01129128|3752892|FG000|Overall Study|Protocol Violation|0
2143553|NCT01129128|3752893|FG001|Overall Study|Protocol Violation|1
2143554|NCT01129128|3752894|FG002|Overall Study|Protocol Violation|0
2143555|NCT01129128|3752892|FG000|Overall Study|Withdrawal by Subject|0
2143556|NCT01129128|3752893|FG001|Overall Study|Withdrawal by Subject|1
2143557|NCT01129128|3752894|FG002|Overall Study|Withdrawal by Subject|3
2143558|NCT01129128|3752892|FG000|Overall Study|Physician Decision|1
2143559|NCT01129128|3752893|FG001|Overall Study|Physician Decision|0
2143560|NCT01129128|3752894|FG002|Overall Study|Physician Decision|0
2143561|NCT01129284|3752933|FG000|Overall Study|Adverse Event|2
2143562|NCT01129284|3752934|FG001|Overall Study|Adverse Event|0
2143563|NCT01129284|3752935|FG002|Overall Study|Adverse Event|1
2143564|NCT01129336|3752945|FG000|Overall Study|Protocol Violation|1
2143565|NCT01129336|3752946|FG001|Overall Study|Protocol Violation|0
2143566|NCT01129336|3752945|FG000|Overall Study|Disease Progression|1
2143567|NCT01129336|3752946|FG001|Overall Study|Disease Progression|4
2143568|NCT01129336|3752945|FG000|Overall Study|Lost to Follow-up|1
2143569|NCT01129336|3752946|FG001|Overall Study|Lost to Follow-up|0
2143570|NCT01129336|3752945|FG000|Overall Study|Withdrawal by Subject|7
2143571|NCT01129336|3752946|FG001|Overall Study|Withdrawal by Subject|4
2143572|NCT01129336|3752945|FG000|Overall Study|Adverse Event|0
2143573|NCT01129336|3752946|FG001|Overall Study|Adverse Event|1
2143574|NCT01129336|3752945|FG000|Overall Study|Missing Study Completion Status|2
2143575|NCT01129336|3752946|FG001|Overall Study|Missing Study Completion Status|3
2143576|NCT01129336|3752945|FG000|Overall Study|Death|0
2143577|NCT01129336|3752946|FG001|Overall Study|Death|4
2143578|NCT01129557|3752982|FG000|Overall Study|Adverse Event|1
2143579|NCT01129557|3752983|FG001|Overall Study|Adverse Event|2
2143580|NCT01129557|3752984|FG002|Overall Study|Adverse Event|2
2143581|NCT01129557|3752982|FG000|Overall Study|Novartis terminated study early|3
2143582|NCT01129557|3752983|FG001|Overall Study|Novartis terminated study early|3
2143583|NCT01129557|3752984|FG002|Overall Study|Novartis terminated study early|2
2143584|NCT01129583|3753005|FG000|Overall Study|Death|1
2143585|NCT01129583|3753006|FG001|Overall Study|Death|0
2143586|NCT01129583|3753005|FG000|Overall Study|Lost to Follow-up|1
2143587|NCT01129583|3753006|FG001|Overall Study|Lost to Follow-up|1
2143588|NCT01129583|3753005|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1
2143589|NCT01129583|3753006|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1
2143590|NCT01129622|3753016|FG000|Overall Study|Withdrawal by Subject|2
2143591|NCT01129882|3753038|FG000|Overall Study|Adverse Event|39
2143592|NCT01129882|3753038|FG000|Overall Study|Death|6
2143593|NCT01129882|3753038|FG000|Overall Study|Lack of Efficacy|5
2143594|NCT01129882|3753038|FG000|Overall Study|Lost to Follow-up|13
2143595|NCT01129882|3753038|FG000|Overall Study|Physician Decision|27
2143596|NCT01129882|3753038|FG000|Overall Study|Protocol Deviation|3
2143597|NCT01129882|3753038|FG000|Overall Study|Withdrawal Criteria Met|19
2143598|NCT01129882|3753038|FG000|Overall Study|Trial Termination by Sponsor|6
2143599|NCT01129882|3753038|FG000|Overall Study|Withdrawal by Subject|160
2143600|NCT01129921|3753044|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
2143601|NCT01129921|3753045|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
2143602|NCT01129921|3753044|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
2143603|NCT01129921|3753045|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
2143604|NCT01129921|3753044|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
2143605|NCT01129921|3753045|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
2143606|NCT01129921|3753044|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
2143607|NCT01129921|3753045|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
2143608|NCT01129960|3753059|FG000|Overall Study|Withdrawal by Subject|3
2143609|NCT01129960|3753060|FG001|Overall Study|Withdrawal by Subject|0
2143610|NCT01129960|3753061|FG002|Overall Study|Withdrawal by Subject|3
2143611|NCT01129960|3753062|FG003|Overall Study|Withdrawal by Subject|2
2143612|NCT01129960|3753059|FG000|Overall Study|Lack of Efficacy|1
2143613|NCT01129960|3753060|FG001|Overall Study|Lack of Efficacy|1
2143614|NCT01129960|3753061|FG002|Overall Study|Lack of Efficacy|1
2143615|NCT01129960|3753062|FG003|Overall Study|Lack of Efficacy|1
2143616|NCT01129960|3753059|FG000|Overall Study|Adverse Event|23
2143617|NCT01129960|3753060|FG001|Overall Study|Adverse Event|16
2143618|NCT01129960|3753061|FG002|Overall Study|Adverse Event|16
2143619|NCT01129960|3753062|FG003|Overall Study|Adverse Event|7
2143620|NCT01129960|3753059|FG000|Overall Study|Protocol Violation|1
2143621|NCT01129960|3753060|FG001|Overall Study|Protocol Violation|2
2143622|NCT01129960|3753061|FG002|Overall Study|Protocol Violation|3
2143623|NCT01129960|3753062|FG003|Overall Study|Protocol Violation|0
2143624|NCT01129960|3753059|FG000|Overall Study|Lost to Follow-up|0
2143625|NCT01129960|3753060|FG001|Overall Study|Lost to Follow-up|2
2143626|NCT01129960|3753061|FG002|Overall Study|Lost to Follow-up|3
2143627|NCT01129960|3753062|FG003|Overall Study|Lost to Follow-up|3
2143628|NCT01129960|3753059|FG000|Overall Study|Discontinuation of the study by Sponsor|0
2143629|NCT01129960|3753060|FG001|Overall Study|Discontinuation of the study by Sponsor|1
2143630|NCT01129960|3753061|FG002|Overall Study|Discontinuation of the study by Sponsor|0
2143631|NCT01129960|3753062|FG003|Overall Study|Discontinuation of the study by Sponsor|0
2143632|NCT01129960|3753059|FG000|Overall Study|Physician Decision|1
2143633|NCT01129960|3753060|FG001|Overall Study|Physician Decision|0
2143634|NCT01129960|3753061|FG002|Overall Study|Physician Decision|0
2143635|NCT01129960|3753062|FG003|Overall Study|Physician Decision|0
2143636|NCT01129960|3753059|FG000|Overall Study|Pregnancy|1
2143637|NCT01129960|3753060|FG001|Overall Study|Pregnancy|0
2143638|NCT01129960|3753061|FG002|Overall Study|Pregnancy|0
2143639|NCT01129960|3753062|FG003|Overall Study|Pregnancy|0
2143640|NCT01130051|3753072|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
2143641|NCT01130051|3753073|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
2143642|NCT01130051|3753072|FG000|Washout Period of 14 Days|Protocol Violation|1
2143643|NCT01130051|3753073|FG001|Washout Period of 14 Days|Protocol Violation|1
2143644|NCT01130103|3753081|FG000|Randomized Treatment|Adverse Event|1
2143645|NCT01130103|3753082|FG001|Randomized Treatment|Adverse Event|1
2143646|NCT01130103|3753081|FG000|Randomized Treatment|Lost to Follow-up|1
2143647|NCT01130103|3753082|FG001|Randomized Treatment|Lost to Follow-up|0
2143648|NCT01130103|3753081|FG000|Randomized Treatment|Protocol Violation|3
2143649|NCT01130103|3753082|FG001|Randomized Treatment|Protocol Violation|2
2143650|NCT01130103|3753081|FG000|Randomized Treatment|Withdrawal by Subject|1
2143651|NCT01130103|3753082|FG001|Randomized Treatment|Withdrawal by Subject|2
2143652|NCT01130103|3753081|FG000|Maintenance Treatment|Lack of Efficacy|0
2143653|NCT01130103|3753082|FG001|Maintenance Treatment|Lack of Efficacy|1
2143654|NCT01130103|3753081|FG000|Maintenance Treatment|Lost to Follow-up|1
2143655|NCT01130103|3753082|FG001|Maintenance Treatment|Lost to Follow-up|1
2143656|NCT01130103|3753081|FG000|Maintenance Treatment|Withdrawal by Subject|1
2143657|NCT01130103|3753082|FG001|Maintenance Treatment|Withdrawal by Subject|0
2143658|NCT01130168|3753088|FG000|Period 1|Withdrawal by Subject|0
2143659|NCT01130168|3753089|FG001|Period 1|Withdrawal by Subject|1
2143660|NCT01130168|3753090|FG002|Period 1|Withdrawal by Subject|0
2143661|NCT01130168|3753091|FG003|Period 1|Withdrawal by Subject|1
2143662|NCT01130168|3753092|FG004|Period 1|Withdrawal by Subject|0
2143663|NCT01130168|3753093|FG005|Period 1|Withdrawal by Subject|0
2143664|NCT01130168|3753088|FG000|Period 1|Discontinued For Other Reason|0
2143665|NCT01130168|3753089|FG001|Period 1|Discontinued For Other Reason|0
2143666|NCT01130168|3753090|FG002|Period 1|Discontinued For Other Reason|1
2143667|NCT01130168|3753091|FG003|Period 1|Discontinued For Other Reason|1
2143668|NCT01130168|3753092|FG004|Period 1|Discontinued For Other Reason|0
2143669|NCT01130168|3753093|FG005|Period 1|Discontinued For Other Reason|0
2143670|NCT01130168|3753088|FG000|Period 1|Adverse Event|0
2143671|NCT01130168|3753089|FG001|Period 1|Adverse Event|0
2143672|NCT01130168|3753090|FG002|Period 1|Adverse Event|0
2143673|NCT01130168|3753091|FG003|Period 1|Adverse Event|1
2143674|NCT01130168|3753092|FG004|Period 1|Adverse Event|0
2143675|NCT01130168|3753093|FG005|Period 1|Adverse Event|0
2143676|NCT01130272|3753107|FG000|Overall Study|Adverse Event|2
2143677|NCT01130272|3753108|FG001|Overall Study|Adverse Event|5
2143678|NCT01130272|3753109|FG002|Overall Study|Adverse Event|6
2143679|NCT01130272|3753110|FG003|Overall Study|Adverse Event|22
2143680|NCT01130272|3753111|FG004|Overall Study|Adverse Event|7
2143681|NCT01130272|3753107|FG000|Overall Study|IVRS-confirmed constipation|0
2143682|NCT01130272|3753108|FG001|Overall Study|IVRS-confirmed constipation|1
2143683|NCT01130272|3753109|FG002|Overall Study|IVRS-confirmed constipation|1
2143684|NCT01130272|3753110|FG003|Overall Study|IVRS-confirmed constipation|2
2143685|NCT01130272|3753111|FG004|Overall Study|IVRS-confirmed constipation|0
2143686|NCT01130272|3753107|FG000|Overall Study|Rescue medications due to diarrhea|3
2143687|NCT01130272|3753108|FG001|Overall Study|Rescue medications due to diarrhea|5
2143688|NCT01130272|3753109|FG002|Overall Study|Rescue medications due to diarrhea|8
2143689|NCT01130272|3753110|FG003|Overall Study|Rescue medications due to diarrhea|8
2143690|NCT01130272|3753111|FG004|Overall Study|Rescue medications due to diarrhea|6
2143691|NCT01130272|3753107|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
2143692|NCT01130272|3753108|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
2143693|NCT01130272|3753109|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
2143694|NCT01130272|3753110|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
2143695|NCT01130272|3753111|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
2143696|NCT01130272|3753107|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2143697|NCT01130272|3753108|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2143698|NCT01130272|3753109|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2143699|NCT01130272|3753110|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
2143700|NCT01130272|3753111|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2143701|NCT01130272|3753107|FG000|Overall Study|Protocol Violation|0
2143702|NCT01130272|3753108|FG001|Overall Study|Protocol Violation|0
2143703|NCT01130272|3753109|FG002|Overall Study|Protocol Violation|3
2143704|NCT01130272|3753110|FG003|Overall Study|Protocol Violation|5
2143705|NCT01130272|3753111|FG004|Overall Study|Protocol Violation|5
2143706|NCT01130272|3753107|FG000|Overall Study|Lost to Follow-up|4
2143707|NCT01130272|3753108|FG001|Overall Study|Lost to Follow-up|3
2143708|NCT01130272|3753109|FG002|Overall Study|Lost to Follow-up|4
2143709|NCT01130272|3753110|FG003|Overall Study|Lost to Follow-up|7
2143710|NCT01130272|3753111|FG004|Overall Study|Lost to Follow-up|6
2143711|NCT01130272|3753107|FG000|Overall Study|Withdrawal by Subject|4
2143712|NCT01130272|3753108|FG001|Overall Study|Withdrawal by Subject|11
2143713|NCT01130272|3753109|FG002|Overall Study|Withdrawal by Subject|10
2143714|NCT01130272|3753110|FG003|Overall Study|Withdrawal by Subject|9
2143715|NCT01130272|3753111|FG004|Overall Study|Withdrawal by Subject|8
2143716|NCT01130272|3753107|FG000|Overall Study|Physician Decision|1
2143717|NCT01130272|3753108|FG001|Overall Study|Physician Decision|1
2143718|NCT01130272|3753109|FG002|Overall Study|Physician Decision|0
2143719|NCT01130272|3753110|FG003|Overall Study|Physician Decision|1
2143720|NCT01130272|3753111|FG004|Overall Study|Physician Decision|2
2143721|NCT01130272|3753107|FG000|Overall Study|Sponsor decision|6
2143722|NCT01130272|3753108|FG001|Overall Study|Sponsor decision|15
2143723|NCT01130272|3753109|FG002|Overall Study|Sponsor decision|16
2143724|NCT01130272|3753110|FG003|Overall Study|Sponsor decision|13
2143725|NCT01130272|3753111|FG004|Overall Study|Sponsor decision|16
2143726|NCT01130272|3753107|FG000|Overall Study|Study arm discontinued|38
2143727|NCT01130272|3753108|FG001|Overall Study|Study arm discontinued|0
2143728|NCT01130272|3753109|FG002|Overall Study|Study arm discontinued|0
2143729|NCT01130272|3753110|FG003|Overall Study|Study arm discontinued|0
2143730|NCT01130272|3753111|FG004|Overall Study|Study arm discontinued|0
2143731|NCT01130337|3753123|FG000|Overall Study|Withdrawal by Subject|3
2143732|NCT01130337|3753123|FG000|Overall Study|Principal investigator decision|1
2143733|NCT01130337|3753123|FG000|Overall Study|Death|1
2143734|NCT01130337|3753123|FG000|Overall Study|Disease progression|1
2143735|NCT01130337|3753123|FG000|Overall Study|Toxicity, AE/intercurrent disease|7
2143736|NCT01130337|3753123|FG000|Overall Study|Surgical resection (R2)|1
2143737|NCT01130493|3753127|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1
2143738|NCT01130493|3753128|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0
2143739|NCT01130493|3753129|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0
2143740|NCT01130493|3753127|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3
2143741|NCT01130493|3753128|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0
2143742|NCT01130493|3753129|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0
2143743|NCT01130493|3753127|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
2143744|NCT01130493|3753128|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
2143745|NCT01130493|3753129|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
2143746|NCT01130493|3753127|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
2143747|NCT01130493|3753128|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
2143748|NCT01130493|3753129|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
2143749|NCT01130493|3753127|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1
2143750|NCT01130493|3753128|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0
2143751|NCT01130493|3753129|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0
2143752|NCT01130493|3753127|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
2143753|NCT01130493|3753128|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
2143754|NCT01130493|3753129|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
2143755|NCT01130493|3753127|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
2143756|NCT01130493|3753128|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
2143757|NCT01130493|3753129|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
2143758|NCT01130493|3753127|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
2143759|NCT01130493|3753128|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
2143760|NCT01130493|3753129|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
2143761|NCT01130493|3753127|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0
2143762|NCT01130493|3753128|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0
2143763|NCT01130493|3753129|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1
2143764|NCT01130493|3753127|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
2143765|NCT01130493|3753128|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
2143766|NCT01130493|3753129|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
2143767|NCT01130493|3753127|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
2143768|NCT01130493|3753128|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
2143769|NCT01130493|3753129|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
2143770|NCT01130493|3753127|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0
2143771|NCT01130493|3753128|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0
2143772|NCT01130493|3753129|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1
2143773|NCT01130493|3753127|FG000|Part 2: OLE|Adverse Event|0
2143774|NCT01130493|3753128|FG001|Part 2: OLE|Adverse Event|2
2143775|NCT01130493|3753129|FG002|Part 2: OLE|Adverse Event|1
2143776|NCT01130493|3753127|FG000|Part 2: OLE|Withdrawal by Subject|0
2143777|NCT01130493|3753128|FG001|Part 2: OLE|Withdrawal by Subject|1
2143778|NCT01130493|3753129|FG002|Part 2: OLE|Withdrawal by Subject|4
2143779|NCT01130532|3753143|FG000|Period III (Weeks 0-12)|Adverse Event|3
2143780|NCT01130532|3753144|FG001|Period III (Weeks 0-12)|Adverse Event|3
2143781|NCT01130532|3753145|FG002|Period III (Weeks 0-12)|Adverse Event|2
2143782|NCT01130532|3753146|FG003|Period III (Weeks 0-12)|Adverse Event|0
2143783|NCT01130532|3753143|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4
2143784|NCT01130532|3753144|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2
2143785|NCT01130532|3753145|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4
2143786|NCT01130532|3753146|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0
2143787|NCT01130532|3753143|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2
2143788|NCT01130532|3753144|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0
2143789|NCT01130532|3753145|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1
2143790|NCT01130532|3753146|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0
2143791|NCT01130532|3753143|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2
2143792|NCT01130532|3753144|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2
2143793|NCT01130532|3753145|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3
2143794|NCT01130532|3753146|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0
2143795|NCT01130532|3753143|FG000|Period III (Weeks 0-12)|Protocol Violation|0
2143796|NCT01130532|3753144|FG001|Period III (Weeks 0-12)|Protocol Violation|0
2143797|NCT01130532|3753145|FG002|Period III (Weeks 0-12)|Protocol Violation|1
2143798|NCT01130532|3753146|FG003|Period III (Weeks 0-12)|Protocol Violation|0
2143799|NCT01130532|3753143|FG000|Period III (Weeks 0-12)|Sponsor Decision|3
2143800|NCT01130532|3753144|FG001|Period III (Weeks 0-12)|Sponsor Decision|4
2143801|NCT01130532|3753145|FG002|Period III (Weeks 0-12)|Sponsor Decision|2
2143802|NCT01130532|3753146|FG003|Period III (Weeks 0-12)|Sponsor Decision|0
2143803|NCT01130532|3753143|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7
2143804|NCT01130532|3753144|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7
2143805|NCT01130532|3753145|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6
2143806|NCT01130532|3753146|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0
2143807|NCT01130532|3753143|FG000|Period IV (Weeks 13-16)|Adverse Event|0
2143808|NCT01130532|3753144|FG001|Period IV (Weeks 13-16)|Adverse Event|0
2143809|NCT01130532|3753145|FG002|Period IV (Weeks 13-16)|Adverse Event|0
2143810|NCT01130532|3753146|FG003|Period IV (Weeks 13-16)|Adverse Event|1
2143811|NCT01130532|3753143|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
2143812|NCT01130532|3753144|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
2143813|NCT01130532|3753145|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
2143814|NCT01130532|3753146|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
2143815|NCT01130532|3753143|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0
2143816|NCT01130532|3753144|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0
2143817|NCT01130532|3753145|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0
2143818|NCT01130532|3753146|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5
2143819|NCT01130532|3753143|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0
2143820|NCT01130532|3753144|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0
2143821|NCT01130532|3753145|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0
2143822|NCT01130532|3753146|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3
2143823|NCT01130597|3753158|FG000|Overall Study|Protocol-specified (High K+)|1
2143824|NCT01130597|3753158|FG000|Overall Study|Adverse Event|4
2143825|NCT01130597|3753158|FG000|Overall Study|Death|1
2208013|NCT01635218|3847322|FG000|Overall Study|Lost to Follow-up|3
2208014|NCT01635218|3847323|FG001|Overall Study|Lost to Follow-up|7
2208015|NCT01635218|3847324|FG002|Overall Study|Lost to Follow-up|6
2208016|NCT01635283|3847345|FG000|Overall Study|Tumor Progression|3
2208017|NCT01635283|3847345|FG000|Overall Study|Lost to Follow-up|1
2289996|NCT02484547|3982239|FG002|Placebo-Controlled Period|Reason not Specified|183
2289997|NCT02484547|3982240|FG003|Placebo-Controlled Period|Reason not Specified|0
2289998|NCT02484547|3982241|FG004|Placebo-Controlled Period|Reason not Specified|0
2289999|NCT02484547|3982242|FG005|Placebo-Controlled Period|Reason not Specified|0
2290000|NCT02484547|3982243|FG006|Placebo-Controlled Period|Reason not Specified|0
2290001|NCT02484547|3982237|FG000|Long-Term Extension Period|Adverse Event|0
2290002|NCT02484547|3982238|FG001|Long-Term Extension Period|Adverse Event|0
2290003|NCT02484547|3982239|FG002|Long-Term Extension Period|Adverse Event|0
2290004|NCT02484547|3982240|FG003|Long-Term Extension Period|Adverse Event|0
2290005|NCT02484547|3982241|FG004|Long-Term Extension Period|Adverse Event|1
2290006|NCT02484547|3982242|FG005|Long-Term Extension Period|Adverse Event|3
2290007|NCT02484547|3982243|FG006|Long-Term Extension Period|Adverse Event|2
2290008|NCT02484547|3982237|FG000|Long-Term Extension Period|Death|0
2290009|NCT02484547|3982238|FG001|Long-Term Extension Period|Death|0
2290010|NCT02484547|3982239|FG002|Long-Term Extension Period|Death|0
2290011|NCT02484547|3982240|FG003|Long-Term Extension Period|Death|0
2290012|NCT02484547|3982241|FG004|Long-Term Extension Period|Death|0
2290013|NCT02484547|3982242|FG005|Long-Term Extension Period|Death|3
2290014|NCT02484547|3982243|FG006|Long-Term Extension Period|Death|0
2290015|NCT02484547|3982237|FG000|Long-Term Extension Period|Disease Progression|0
2290016|NCT02484547|3982238|FG001|Long-Term Extension Period|Disease Progression|0
2290017|NCT02484547|3982239|FG002|Long-Term Extension Period|Disease Progression|0
2290018|NCT02484547|3982240|FG003|Long-Term Extension Period|Disease Progression|0
2290019|NCT02484547|3982241|FG004|Long-Term Extension Period|Disease Progression|2
2290020|NCT02484547|3982242|FG005|Long-Term Extension Period|Disease Progression|4
2290021|NCT02484547|3982243|FG006|Long-Term Extension Period|Disease Progression|0
2290022|NCT02484547|3982237|FG000|Long-Term Extension Period|Lost to Follow-up|0
2290023|NCT02484547|3982238|FG001|Long-Term Extension Period|Lost to Follow-up|0
2290024|NCT02484547|3982239|FG002|Long-Term Extension Period|Lost to Follow-up|0
2290025|NCT02484547|3982240|FG003|Long-Term Extension Period|Lost to Follow-up|1
2290026|NCT02484547|3982241|FG004|Long-Term Extension Period|Lost to Follow-up|1
2143826|NCT01130597|3753158|FG000|Overall Study|Protocol Violation|1
2143827|NCT01130831|3753171|FG000|Overall Study|Withdrawal by Subject|7
2143828|NCT01130831|3753171|FG000|Overall Study|Death|4
2143829|NCT01130831|3753171|FG000|Overall Study|Information was missing|3
2143830|NCT01130883|3753203|FG000|Overall Study|Patient Noncompliance|6
2143831|NCT01130883|3753203|FG000|Overall Study|Reason Unknown|1
2143832|NCT01130883|3753203|FG000|Overall Study|Adverse Event|3
2143833|NCT01130974|3753213|FG000|Overall Study|Protocol Violation|10
2143834|NCT01130974|3753214|FG001|Overall Study|Protocol Violation|10
2143835|NCT01130974|3753213|FG000|Overall Study|Withdrawal by Subject|0
2143836|NCT01130974|3753214|FG001|Overall Study|Withdrawal by Subject|1
2143837|NCT01130974|3753213|FG000|Overall Study|Ineligibility criteria|5
2143838|NCT01130974|3753214|FG001|Overall Study|Ineligibility criteria|2
2143839|NCT01131078|3753237|FG000|Overall Study|Adverse Event|22
2143840|NCT01131078|3753238|FG001|Overall Study|Adverse Event|12
2143841|NCT01131078|3753239|FG002|Overall Study|Adverse Event|17
2143842|NCT01131078|3753237|FG000|Overall Study|Progressive Disease|58
2143843|NCT01131078|3753238|FG001|Overall Study|Progressive Disease|77
2143844|NCT01131078|3753239|FG002|Overall Study|Progressive Disease|71
2143845|NCT01131078|3753237|FG000|Overall Study|Protocol Violation|1
2143846|NCT01131078|3753238|FG001|Overall Study|Protocol Violation|0
2143847|NCT01131078|3753239|FG002|Overall Study|Protocol Violation|0
2143848|NCT01131078|3753237|FG000|Overall Study|Lost to Follow-up|1
2143849|NCT01131078|3753238|FG001|Overall Study|Lost to Follow-up|1
2143850|NCT01131078|3753239|FG002|Overall Study|Lost to Follow-up|1
2143851|NCT01131078|3753237|FG000|Overall Study|Withdrawal by Subject|2
2143852|NCT01131078|3753238|FG001|Overall Study|Withdrawal by Subject|4
2143853|NCT01131078|3753239|FG002|Overall Study|Withdrawal by Subject|3
2143854|NCT01131078|3753237|FG000|Overall Study|Non-compliance|3
2143855|NCT01131078|3753238|FG001|Overall Study|Non-compliance|0
2143856|NCT01131078|3753239|FG002|Overall Study|Non-compliance|0
2143857|NCT01131078|3753237|FG000|Overall Study|Physician Decision|10
2143858|NCT01131078|3753238|FG001|Overall Study|Physician Decision|6
2143859|NCT01131078|3753239|FG002|Overall Study|Physician Decision|8
2143860|NCT01131078|3753237|FG000|Overall Study|Death|4
2143861|NCT01131078|3753238|FG001|Overall Study|Death|0
2143862|NCT01131078|3753239|FG002|Overall Study|Death|2
2143863|NCT01131078|3753237|FG000|Overall Study|Other|0
2143864|NCT01131078|3753238|FG001|Overall Study|Other|1
2143865|NCT01131078|3753239|FG002|Overall Study|Other|0
2143866|NCT01131104|3753249|FG000|Overall Study|Withdrawal by Subject|3
2143867|NCT01131104|3753249|FG000|Overall Study|Physician Decision|4
2143868|NCT01131104|3753249|FG000|Overall Study|Information Not Available|5
2143869|NCT01131104|3753249|FG000|Overall Study|No Information on Index Date of Onset|1
2143870|NCT01131130|3753253|FG000|Period 1 - Baseline|Pregnancy|1
2143871|NCT01131130|3753253|FG000|Period 3- Crossover|+ Slit lamp finding|1
2143872|NCT01131182|3753263|FG000|Overall Study|Withdrawal by Subject|1
2143873|NCT01131182|3753264|FG001|Overall Study|Withdrawal by Subject|1
2143874|NCT01131182|3753263|FG000|Overall Study|Lost to Follow-up|14
2143875|NCT01131182|3753264|FG001|Overall Study|Lost to Follow-up|15
2143876|NCT01131182|3753263|FG000|Overall Study|Other Reason|1
2143877|NCT01131182|3753264|FG001|Overall Study|Other Reason|0
2143878|NCT01131260|3753272|FG000|Overall Study|Randomization error|5
2143879|NCT01131260|3753273|FG001|Overall Study|Randomization error|1
2143880|NCT01131260|3753272|FG000|Overall Study|Declined to continue participation|8
2143881|NCT01131260|3753273|FG001|Overall Study|Declined to continue participation|13
2143882|NCT01131260|3753272|FG000|Overall Study|Physician Decision|22
2143883|NCT01131260|3753273|FG001|Overall Study|Physician Decision|24
2143884|NCT01131260|3753272|FG000|Overall Study|Technical problems|7
2143885|NCT01131260|3753273|FG001|Overall Study|Technical problems|6
2143886|NCT01131260|3753272|FG000|Overall Study|Staff error|2
2143887|NCT01131260|3753273|FG001|Overall Study|Staff error|1
2143888|NCT01131260|3753272|FG000|Overall Study|Ineligible|0
2143889|NCT01131260|3753273|FG001|Overall Study|Ineligible|2
2143890|NCT01131299|3753281|FG000|Overall Study|Withdrawal by Subject|4
2143891|NCT01131299|3753282|FG001|Overall Study|Withdrawal by Subject|7
2143892|NCT01131312|3753290|FG000|Overall Study|Lost to Follow-up|425
2143893|NCT01131312|3753291|FG001|Overall Study|Lost to Follow-up|229
2143894|NCT01131312|3753292|FG002|Overall Study|Lost to Follow-up|351
2143895|NCT01131325|3753300|FG000|Overall Study|Adverse Event|1
2143896|NCT01131325|3753300|FG000|Overall Study|The participants discontinued the study as the study got terminated|2
2143897|NCT01131351|3753306|FG000|Overall Study|Adverse Event|0
2143898|NCT01131351|3753307|FG001|Overall Study|Adverse Event|2
2143899|NCT01131351|3753306|FG000|Overall Study|Protocol Deviation|0
2143900|NCT01131351|3753307|FG001|Overall Study|Protocol Deviation|1
2143901|NCT01131494|3753313|FG000|Overall Study|Withdrawal by Subject|2
2143902|NCT01131507|3753318|FG000|Overall Study|Adverse Event|1
2143903|NCT01131507|3753318|FG000|Overall Study|Lost to Follow-up|1
2143904|NCT01131507|3753318|FG000|Overall Study|Withdrawal by Subject|1
2143905|NCT01131520|3753324|FG000|Overall Study|Computer problem|1
2143906|NCT01131520|3753325|FG001|Overall Study|Computer problem|0
2143907|NCT01131520|3753324|FG000|Overall Study|Counselor not available|0
2143908|NCT01131520|3753325|FG001|Overall Study|Counselor not available|3
2143909|NCT01131520|3753324|FG000|Overall Study|Subject changed history after enrollment|0
2143910|NCT01131520|3753325|FG001|Overall Study|Subject changed history after enrollment|1
2143911|NCT01131585|3753333|FG000|Overall Study|Adverse Event|0
2143912|NCT01131585|3753334|FG001|Overall Study|Adverse Event|2
2143913|NCT01131585|3753333|FG000|Overall Study|Abnormal laboratory value|1
2143914|NCT01131585|3753334|FG001|Overall Study|Abnormal laboratory value|0
2143915|NCT01131585|3753333|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2143916|NCT01131585|3753334|FG001|Overall Study|Unsatisfactory therapeutic effect|3
2143917|NCT01131585|3753333|FG000|Overall Study|Protocol Violation|2
2143918|NCT01131585|3753334|FG001|Overall Study|Protocol Violation|1
2143919|NCT01131585|3753333|FG000|Overall Study|Withdrawal by Subject|3
2143920|NCT01131585|3753334|FG001|Overall Study|Withdrawal by Subject|3
2143921|NCT01131585|3753333|FG000|Overall Study|Lost to Follow-up|0
2143922|NCT01131585|3753334|FG001|Overall Study|Lost to Follow-up|1
2143923|NCT01131585|3753333|FG000|Overall Study|Administrative problems|1
2143924|NCT01131585|3753334|FG001|Overall Study|Administrative problems|1
2143925|NCT01131585|3753333|FG000|Overall Study|Study termination|78
2143926|NCT01131585|3753334|FG001|Overall Study|Study termination|32
2143927|NCT01131676|3753343|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5
2143928|NCT01131676|3753344|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3
2143929|NCT01131676|3753345|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4
2143930|NCT01131676|3753343|FG000|Discontinuation From Treatment|Not treated|4
2143931|NCT01131676|3753344|FG001|Discontinuation From Treatment|Not treated|2
2143932|NCT01131676|3753345|FG002|Discontinuation From Treatment|Not treated|2
2143933|NCT01131676|3753343|FG000|Discontinuation From Treatment|Lack of Efficacy|11
2143934|NCT01131676|3753344|FG001|Discontinuation From Treatment|Lack of Efficacy|1
2143935|NCT01131676|3753345|FG002|Discontinuation From Treatment|Lack of Efficacy|0
2143936|NCT01131676|3753343|FG000|Discontinuation From Treatment|Non compliant with protocol|15
2143937|NCT01131676|3753344|FG001|Discontinuation From Treatment|Non compliant with protocol|15
2143938|NCT01131676|3753345|FG002|Discontinuation From Treatment|Non compliant with protocol|12
2143939|NCT01131676|3753343|FG000|Discontinuation From Treatment|Lost to Follow-up|15
2143940|NCT01131676|3753344|FG001|Discontinuation From Treatment|Lost to Follow-up|9
2143941|NCT01131676|3753345|FG002|Discontinuation From Treatment|Lost to Follow-up|6
2143942|NCT01131676|3753343|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172
2143943|NCT01131676|3753344|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118
2143944|NCT01131676|3753345|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122
2143945|NCT01131676|3753343|FG000|Discontinuation From Treatment|Other than those specified|162
2143946|NCT01131676|3753344|FG001|Discontinuation From Treatment|Other than those specified|142
2143947|NCT01131676|3753345|FG002|Discontinuation From Treatment|Other than those specified|125
2143948|NCT01131676|3753343|FG000|Discontinuation From Treatment|Adverse Event|303
2143949|NCT01131676|3753344|FG001|Discontinuation From Treatment|Adverse Event|267
2143950|NCT01131676|3753345|FG002|Discontinuation From Treatment|Adverse Event|273
2143951|NCT01131676|3753343|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
2143952|NCT01131676|3753344|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
2143953|NCT01131676|3753345|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
2143954|NCT01131676|3753343|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
2143955|NCT01131676|3753344|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
2143956|NCT01131676|3753345|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
2143957|NCT01131676|3753343|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
2143958|NCT01131676|3753344|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
2143959|NCT01131676|3753345|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
2143960|NCT01131676|3753343|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
2143961|NCT01131676|3753344|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
2143962|NCT01131676|3753345|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
2143963|NCT01131676|3753343|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
2143964|NCT01131676|3753344|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
2143965|NCT01131676|3753345|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
2143966|NCT01131676|3753343|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
2143967|NCT01131676|3753344|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
2143968|NCT01131676|3753345|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
2143969|NCT01132118|3753356|FG000|First Intervention (8 Weeks)|Adverse Event|1
2143970|NCT01132118|3753357|FG001|First Intervention (8 Weeks)|Adverse Event|0
2143971|NCT01132118|3753356|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
2143972|NCT01132118|3753357|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3
2143973|NCT01132118|3753356|FG000|Second Intervention (8 Weeks)|Adverse Event|0
2143974|NCT01132118|3753357|FG001|Second Intervention (8 Weeks)|Adverse Event|1
2143975|NCT01132313|3753386|FG000|Overall Study|Lack of Efficacy|1
2143976|NCT01132313|3753387|FG001|Overall Study|Lack of Efficacy|0
2143977|NCT01132313|3753388|FG002|Overall Study|Lack of Efficacy|0
2143978|NCT01132313|3753389|FG003|Overall Study|Lack of Efficacy|0
2143979|NCT01132313|3753390|FG004|Overall Study|Lack of Efficacy|0
2143980|NCT01132313|3753391|FG005|Overall Study|Lack of Efficacy|0
2143981|NCT01132313|3753392|FG006|Overall Study|Lack of Efficacy|0
2143982|NCT01132313|3753393|FG007|Overall Study|Lack of Efficacy|3
2143983|NCT01132313|3753394|FG008|Overall Study|Lack of Efficacy|14
2143984|NCT01132313|3753395|FG009|Overall Study|Lack of Efficacy|16
2143985|NCT01132313|3753396|FG010|Overall Study|Lack of Efficacy|0
2143986|NCT01132313|3753397|FG011|Overall Study|Lack of Efficacy|0
2143987|NCT01132313|3753386|FG000|Overall Study|Not treated|2
2143988|NCT01132313|3753387|FG001|Overall Study|Not treated|0
2143989|NCT01132313|3753388|FG002|Overall Study|Not treated|0
2143990|NCT01132313|3753389|FG003|Overall Study|Not treated|0
2143991|NCT01132313|3753390|FG004|Overall Study|Not treated|2
2143992|NCT01132313|3753391|FG005|Overall Study|Not treated|1
2143993|NCT01132313|3753392|FG006|Overall Study|Not treated|3
2143994|NCT01132313|3753393|FG007|Overall Study|Not treated|0
2143995|NCT01132313|3753394|FG008|Overall Study|Not treated|0
2143996|NCT01132313|3753395|FG009|Overall Study|Not treated|0
2143997|NCT01132313|3753396|FG010|Overall Study|Not treated|0
2143998|NCT01132313|3753397|FG011|Overall Study|Not treated|0
2143999|NCT01132313|3753386|FG000|Overall Study|Adverse Event|0
2144000|NCT01132313|3753387|FG001|Overall Study|Adverse Event|0
2144001|NCT01132313|3753388|FG002|Overall Study|Adverse Event|4
2144002|NCT01132313|3753389|FG003|Overall Study|Adverse Event|10
2144003|NCT01132313|3753390|FG004|Overall Study|Adverse Event|19
2144004|NCT01132313|3753391|FG005|Overall Study|Adverse Event|6
2144005|NCT01132313|3753392|FG006|Overall Study|Adverse Event|5
2144006|NCT01132313|3753393|FG007|Overall Study|Adverse Event|3
2144007|NCT01132313|3753394|FG008|Overall Study|Adverse Event|7
2144008|NCT01132313|3753395|FG009|Overall Study|Adverse Event|2
2144009|NCT01132313|3753396|FG010|Overall Study|Adverse Event|0
2144010|NCT01132313|3753397|FG011|Overall Study|Adverse Event|0
2144011|NCT01132313|3753386|FG000|Overall Study|Protocol Violation|0
2144012|NCT01132313|3753387|FG001|Overall Study|Protocol Violation|0
2144013|NCT01132313|3753388|FG002|Overall Study|Protocol Violation|0
2144014|NCT01132313|3753389|FG003|Overall Study|Protocol Violation|1
2144015|NCT01132313|3753390|FG004|Overall Study|Protocol Violation|0
2144016|NCT01132313|3753391|FG005|Overall Study|Protocol Violation|0
2144017|NCT01132313|3753392|FG006|Overall Study|Protocol Violation|0
2144018|NCT01132313|3753393|FG007|Overall Study|Protocol Violation|0
2144019|NCT01132313|3753394|FG008|Overall Study|Protocol Violation|0
2144020|NCT01132313|3753395|FG009|Overall Study|Protocol Violation|0
2144021|NCT01132313|3753396|FG010|Overall Study|Protocol Violation|0
2144022|NCT01132313|3753397|FG011|Overall Study|Protocol Violation|0
2144023|NCT01132313|3753386|FG000|Overall Study|Lost to Follow-up|0
2144024|NCT01132313|3753387|FG001|Overall Study|Lost to Follow-up|0
2144025|NCT01132313|3753388|FG002|Overall Study|Lost to Follow-up|1
2144026|NCT01132313|3753389|FG003|Overall Study|Lost to Follow-up|0
2144027|NCT01132313|3753390|FG004|Overall Study|Lost to Follow-up|0
2144028|NCT01132313|3753391|FG005|Overall Study|Lost to Follow-up|0
2144029|NCT01132313|3753392|FG006|Overall Study|Lost to Follow-up|0
2144030|NCT01132313|3753393|FG007|Overall Study|Lost to Follow-up|1
2144031|NCT01132313|3753394|FG008|Overall Study|Lost to Follow-up|0
2144032|NCT01132313|3753395|FG009|Overall Study|Lost to Follow-up|0
2144033|NCT01132313|3753396|FG010|Overall Study|Lost to Follow-up|0
2144034|NCT01132313|3753397|FG011|Overall Study|Lost to Follow-up|0
2144035|NCT01132313|3753386|FG000|Overall Study|Withdrawal by Subject|0
2144036|NCT01132313|3753387|FG001|Overall Study|Withdrawal by Subject|0
2144037|NCT01132313|3753388|FG002|Overall Study|Withdrawal by Subject|3
2144038|NCT01132313|3753389|FG003|Overall Study|Withdrawal by Subject|3
2144039|NCT01132313|3753390|FG004|Overall Study|Withdrawal by Subject|6
2144040|NCT01132313|3753391|FG005|Overall Study|Withdrawal by Subject|0
2144041|NCT01132313|3753392|FG006|Overall Study|Withdrawal by Subject|1
2144042|NCT01132313|3753393|FG007|Overall Study|Withdrawal by Subject|0
2144043|NCT01132313|3753394|FG008|Overall Study|Withdrawal by Subject|0
2144044|NCT01132313|3753395|FG009|Overall Study|Withdrawal by Subject|2
2144045|NCT01132313|3753396|FG010|Overall Study|Withdrawal by Subject|0
2144046|NCT01132313|3753397|FG011|Overall Study|Withdrawal by Subject|0
2144047|NCT01132313|3753386|FG000|Overall Study|Lack of antiviral response|0
2144048|NCT01132313|3753387|FG001|Overall Study|Lack of antiviral response|0
2144049|NCT01132313|3753388|FG002|Overall Study|Lack of antiviral response|12
2144050|NCT01132313|3753389|FG003|Overall Study|Lack of antiviral response|18
2144051|NCT01132313|3753390|FG004|Overall Study|Lack of antiviral response|18
2144052|NCT01132313|3753391|FG005|Overall Study|Lack of antiviral response|18
2144053|NCT01132313|3753392|FG006|Overall Study|Lack of antiviral response|21
2144054|NCT01132313|3753393|FG007|Overall Study|Lack of antiviral response|0
2144055|NCT01132313|3753394|FG008|Overall Study|Lack of antiviral response|0
2144056|NCT01132313|3753395|FG009|Overall Study|Lack of antiviral response|0
2290027|NCT02484547|3982242|FG005|Long-Term Extension Period|Lost to Follow-up|2
2290028|NCT02484547|3982243|FG006|Long-Term Extension Period|Lost to Follow-up|0
2290029|NCT02484547|3982237|FG000|Long-Term Extension Period|Loss of Capacity|0
2290030|NCT02484547|3982238|FG001|Long-Term Extension Period|Loss of Capacity|0
2290031|NCT02484547|3982239|FG002|Long-Term Extension Period|Loss of Capacity|0
2290032|NCT02484547|3982240|FG003|Long-Term Extension Period|Loss of Capacity|0
2290033|NCT02484547|3982241|FG004|Long-Term Extension Period|Loss of Capacity|1
2290034|NCT02484547|3982242|FG005|Long-Term Extension Period|Loss of Capacity|0
2144057|NCT01132313|3753396|FG010|Overall Study|Lack of antiviral response|1
2144058|NCT01132313|3753397|FG011|Overall Study|Lack of antiviral response|0
2144059|NCT01132313|3753386|FG000|Overall Study|Other reason not defined above|0
2144060|NCT01132313|3753387|FG001|Overall Study|Other reason not defined above|0
2144061|NCT01132313|3753388|FG002|Overall Study|Other reason not defined above|0
2144062|NCT01132313|3753389|FG003|Overall Study|Other reason not defined above|0
2144063|NCT01132313|3753390|FG004|Overall Study|Other reason not defined above|0
2144064|NCT01132313|3753391|FG005|Overall Study|Other reason not defined above|0
2144065|NCT01132313|3753392|FG006|Overall Study|Other reason not defined above|0
2144066|NCT01132313|3753393|FG007|Overall Study|Other reason not defined above|1
2144067|NCT01132313|3753394|FG008|Overall Study|Other reason not defined above|0
2144068|NCT01132313|3753395|FG009|Overall Study|Other reason not defined above|0
2144069|NCT01132313|3753396|FG010|Overall Study|Other reason not defined above|0
2144070|NCT01132313|3753397|FG011|Overall Study|Other reason not defined above|0
2144071|NCT01132326|3753428|FG000|Overall Study|Lack of Efficacy|25
2144072|NCT01132326|3753428|FG000|Overall Study|Adverse Event|37
2144073|NCT01132326|3753428|FG000|Overall Study|Protocol Violation|1
2144074|NCT01132326|3753428|FG000|Overall Study|Lost to Follow-up|16
2144075|NCT01132326|3753428|FG000|Overall Study|Withdrawal by Subject|40
2144076|NCT01132326|3753428|FG000|Overall Study|Physician Decision|10
2144077|NCT01132326|3753428|FG000|Overall Study|Study Termination|80
2144078|NCT01132326|3753428|FG000|Overall Study|Declining Health|1
2144079|NCT01132326|3753428|FG000|Overall Study|Pregnancy|1
2144080|NCT01132326|3753428|FG000|Overall Study|Caregiver Withdrew Consent|1
2144081|NCT01132326|3753428|FG000|Overall Study|Death|5
2144082|NCT01132326|3753428|FG000|Overall Study|Subject Unable to Come To Visits|1
2144083|NCT01132482|3753439|FG000|Overall Study|Adverse Event|1
2144084|NCT01132482|3753440|FG001|Overall Study|Adverse Event|0
2144085|NCT01132495|3753450|FG000|Overall Study|Various reasons|40
2144086|NCT01132495|3753451|FG001|Overall Study|Various reasons|38
2144087|NCT01132495|3753452|FG002|Overall Study|Various reasons|20
2144088|NCT01132495|3753453|FG003|Overall Study|Various reasons|12
2144089|NCT01132547|3753470|FG000|Overall Study|Withdrawal by Subject|3
2144090|NCT01132547|3753471|FG001|Overall Study|Withdrawal by Subject|1
2144091|NCT01132547|3753470|FG000|Overall Study|Death|1
2144092|NCT01132547|3753471|FG001|Overall Study|Death|0
2144093|NCT01132612|3753480|FG000|Overall Study|Death|0
2144094|NCT01132612|3753481|FG001|Overall Study|Death|0
2144095|NCT01132612|3753482|FG002|Overall Study|Death|1
2144096|NCT01132612|3753480|FG000|Overall Study|Protocol deviation|0
2144097|NCT01132612|3753481|FG001|Overall Study|Protocol deviation|0
2144098|NCT01132612|3753482|FG002|Overall Study|Protocol deviation|3
2144099|NCT01132612|3753480|FG000|Overall Study|Lost to Follow-up|2
2144100|NCT01132612|3753481|FG001|Overall Study|Lost to Follow-up|2
2144101|NCT01132612|3753482|FG002|Overall Study|Lost to Follow-up|7
2144102|NCT01132612|3753480|FG000|Overall Study|Adverse Event|5
2144103|NCT01132612|3753481|FG001|Overall Study|Adverse Event|2
2144104|NCT01132612|3753482|FG002|Overall Study|Adverse Event|15
2144105|NCT01132612|3753480|FG000|Overall Study|Withdrawal by Subject|5
2144106|NCT01132612|3753481|FG001|Overall Study|Withdrawal by Subject|8
2144107|NCT01132612|3753482|FG002|Overall Study|Withdrawal by Subject|19
2144108|NCT01132612|3753480|FG000|Overall Study|Administrative problems|5
2144109|NCT01132612|3753481|FG001|Overall Study|Administrative problems|1
2144110|NCT01132612|3753482|FG002|Overall Study|Administrative problems|52
2144111|NCT01132612|3753480|FG000|Overall Study|Lack of Efficacy|23
2144112|NCT01132612|3753481|FG001|Overall Study|Lack of Efficacy|22
2144113|NCT01132612|3753482|FG002|Overall Study|Lack of Efficacy|73
2144114|NCT01132651|3753492|FG000|Overall Study|Lost to Follow-up|1
2144115|NCT01132651|3753493|FG001|Overall Study|Lost to Follow-up|1
2144116|NCT01132664|3753504|FG000|Phase lb|Adverse Event|0
2144117|NCT01132664|3753505|FG001|Phase lb|Adverse Event|1
2144118|NCT01132664|3753506|FG002|Phase lb|Adverse Event|0
2144119|NCT01132664|3753507|FG003|Phase lb|Adverse Event|0
2144120|NCT01132664|3753508|FG004|Phase lb|Adverse Event|0
2144121|NCT01132664|3753504|FG000|Phase lb|Withdrawal by Subject|1
2144122|NCT01132664|3753505|FG001|Phase lb|Withdrawal by Subject|2
2144123|NCT01132664|3753506|FG002|Phase lb|Withdrawal by Subject|0
2144124|NCT01132664|3753507|FG003|Phase lb|Withdrawal by Subject|0
2144125|NCT01132664|3753508|FG004|Phase lb|Withdrawal by Subject|0
2144126|NCT01132664|3753504|FG000|Phase lb|Disease Progression|4
2144127|NCT01132664|3753505|FG001|Phase lb|Disease Progression|9
2144128|NCT01132664|3753506|FG002|Phase lb|Disease Progression|0
2144129|NCT01132664|3753507|FG003|Phase lb|Disease Progression|0
2144130|NCT01132664|3753508|FG004|Phase lb|Disease Progression|0
2144131|NCT01132664|3753504|FG000|Phase ll|Death|0
2144132|NCT01132664|3753505|FG001|Phase ll|Death|0
2144133|NCT01132664|3753506|FG002|Phase ll|Death|2
2144134|NCT01132664|3753507|FG003|Phase ll|Death|0
2144135|NCT01132664|3753508|FG004|Phase ll|Death|0
2144136|NCT01132664|3753504|FG000|Phase ll|Adverse Event|0
2144137|NCT01132664|3753505|FG001|Phase ll|Adverse Event|0
2144138|NCT01132664|3753506|FG002|Phase ll|Adverse Event|10
2144139|NCT01132664|3753507|FG003|Phase ll|Adverse Event|0
2144140|NCT01132664|3753508|FG004|Phase ll|Adverse Event|0
2144141|NCT01132664|3753504|FG000|Phase ll|Withdrawal by Subject|0
2208018|NCT01635764|3847370|FG000|Overall Study|Adverse Event|46
2144142|NCT01132664|3753505|FG001|Phase ll|Withdrawal by Subject|0
2144143|NCT01132664|3753506|FG002|Phase ll|Withdrawal by Subject|3
2144144|NCT01132664|3753507|FG003|Phase ll|Withdrawal by Subject|0
2144145|NCT01132664|3753508|FG004|Phase ll|Withdrawal by Subject|0
2144146|NCT01132664|3753504|FG000|Phase ll|Disease progression|0
2144147|NCT01132664|3753505|FG001|Phase ll|Disease progression|0
2144148|NCT01132664|3753506|FG002|Phase ll|Disease progression|35
2144149|NCT01132664|3753507|FG003|Phase ll|Disease progression|0
2144150|NCT01132664|3753508|FG004|Phase ll|Disease progression|0
2144151|NCT01132664|3753504|FG000|BM Cohort|Disease progression|0
2144152|NCT01132664|3753505|FG001|BM Cohort|Disease progression|0
2144153|NCT01132664|3753506|FG002|BM Cohort|Disease progression|0
2144154|NCT01132664|3753507|FG003|BM Cohort|Disease progression|3
2144155|NCT01132664|3753508|FG004|BM Cohort|Disease progression|4
2144156|NCT01132664|3753504|FG000|BM Cohort|Adverse Event|0
2144157|NCT01132664|3753505|FG001|BM Cohort|Adverse Event|0
2144158|NCT01132664|3753506|FG002|BM Cohort|Adverse Event|0
2144159|NCT01132664|3753507|FG003|BM Cohort|Adverse Event|0
2144160|NCT01132664|3753508|FG004|BM Cohort|Adverse Event|1
2144161|NCT01132664|3753504|FG000|BM Cohort|Withdrawal by Subject|0
2144162|NCT01132664|3753505|FG001|BM Cohort|Withdrawal by Subject|0
2144163|NCT01132664|3753506|FG002|BM Cohort|Withdrawal by Subject|0
2144164|NCT01132664|3753507|FG003|BM Cohort|Withdrawal by Subject|0
2144165|NCT01132664|3753508|FG004|BM Cohort|Withdrawal by Subject|1
2144166|NCT01132755|3753529|FG000|Overall Study|Procedure not done due to medical reason|23
2144167|NCT01132755|3753529|FG000|Overall Study|Protocol Violation|15
2144168|NCT01132755|3753529|FG000|Overall Study|Withdrawal by Subject|4
2144169|NCT01132807|3753533|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9
2144170|NCT01132807|3753534|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
2144171|NCT01132807|3753535|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
2144172|NCT01132807|3753533|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6
2144173|NCT01132807|3753534|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0
2144174|NCT01132807|3753535|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0
2144175|NCT01132820|3753543|FG000|Overall Study|Ineligible: wrong cell type|1
2144176|NCT01132820|3753543|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1
2144177|NCT01132820|3753543|FG000|Overall Study|Ineligible:Inadequate pathology|1
2144178|NCT01132820|3753543|FG000|Overall Study|Never treated|1
2144179|NCT01132820|3753543|FG000|Overall Study|Inadequate data|1
2144180|NCT01133067|3753562|FG000|Overall Study|Death|136
2144181|NCT01133067|3753562|FG000|Overall Study|Lost to Follow-up|3
2144182|NCT01133171|3753575|FG000|Overall Study|Withdrawal by Subject|1
2144183|NCT01133171|3753576|FG001|Overall Study|Withdrawal by Subject|2
2144184|NCT01133171|3753577|FG002|Overall Study|Withdrawal by Subject|0
2144185|NCT01133275|3753585|FG000|Overall Study|Withdrawal by Subject|1
2144186|NCT01133275|3753585|FG000|Overall Study|Cerebrovascular accident (CVA)|1
2144187|NCT01133379|3753592|FG000|Overall Study|Withdrawal by Subject|0
2144188|NCT01133379|3753593|FG001|Overall Study|Withdrawal by Subject|1
2144189|NCT01133379|3753594|FG002|Overall Study|Withdrawal by Subject|1
2144190|NCT01133379|3753592|FG000|Overall Study|Lost to Follow-up|1
2144191|NCT01133379|3753593|FG001|Overall Study|Lost to Follow-up|1
2144192|NCT01133379|3753594|FG002|Overall Study|Lost to Follow-up|1
2144193|NCT01133392|3753604|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
2144194|NCT01133392|3753605|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
2144195|NCT01133392|3753604|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0
2144196|NCT01133392|3753605|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1
2144197|NCT01133405|3753621|FG000|Period 1|Withdrawal by Subject|0
2144198|NCT01133405|3753622|FG001|Period 1|Withdrawal by Subject|1
2144199|NCT01133405|3753623|FG002|Period 1|Withdrawal by Subject|0
2144200|NCT01133405|3753624|FG003|Period 1|Withdrawal by Subject|1
2144201|NCT01133405|3753625|FG004|Period 1|Withdrawal by Subject|0
2144202|NCT01133405|3753626|FG005|Period 1|Withdrawal by Subject|1
2144203|NCT01133405|3753627|FG006|Period 1|Withdrawal by Subject|0
2144204|NCT01133405|3753628|FG007|Period 1|Withdrawal by Subject|0
2144205|NCT01133405|3753629|FG008|Period 1|Withdrawal by Subject|0
2144206|NCT01133405|3753630|FG009|Period 1|Withdrawal by Subject|0
2144207|NCT01133405|3753621|FG000|Period 1|Physician Decision|0
2144208|NCT01133405|3753622|FG001|Period 1|Physician Decision|0
2144209|NCT01133405|3753623|FG002|Period 1|Physician Decision|0
2144210|NCT01133405|3753624|FG003|Period 1|Physician Decision|1
2144211|NCT01133405|3753625|FG004|Period 1|Physician Decision|0
2144212|NCT01133405|3753626|FG005|Period 1|Physician Decision|0
2144213|NCT01133405|3753627|FG006|Period 1|Physician Decision|0
2144214|NCT01133405|3753628|FG007|Period 1|Physician Decision|0
2144215|NCT01133405|3753629|FG008|Period 1|Physician Decision|0
2144216|NCT01133405|3753630|FG009|Period 1|Physician Decision|0
2144217|NCT01133405|3753621|FG000|Period 1|Discontinued after randomization|1
2144218|NCT01133405|3753622|FG001|Period 1|Discontinued after randomization|0
2144219|NCT01133405|3753623|FG002|Period 1|Discontinued after randomization|0
2144220|NCT01133405|3753624|FG003|Period 1|Discontinued after randomization|0
2144221|NCT01133405|3753625|FG004|Period 1|Discontinued after randomization|0
2144222|NCT01133405|3753626|FG005|Period 1|Discontinued after randomization|0
2144223|NCT01133405|3753627|FG006|Period 1|Discontinued after randomization|1
2144224|NCT01133405|3753628|FG007|Period 1|Discontinued after randomization|0
2144225|NCT01133405|3753629|FG008|Period 1|Discontinued after randomization|0
2144226|NCT01133405|3753630|FG009|Period 1|Discontinued after randomization|0
2144227|NCT01133405|3753621|FG000|Period 1|Received drug only in period 2|0
2144228|NCT01133405|3753622|FG001|Period 1|Received drug only in period 2|1
2144229|NCT01133405|3753623|FG002|Period 1|Received drug only in period 2|0
2144230|NCT01133405|3753624|FG003|Period 1|Received drug only in period 2|2
2144231|NCT01133405|3753625|FG004|Period 1|Received drug only in period 2|0
2144232|NCT01133405|3753626|FG005|Period 1|Received drug only in period 2|1
2144233|NCT01133405|3753627|FG006|Period 1|Received drug only in period 2|0
2144234|NCT01133405|3753628|FG007|Period 1|Received drug only in period 2|0
2144235|NCT01133405|3753629|FG008|Period 1|Received drug only in period 2|0
2144236|NCT01133405|3753630|FG009|Period 1|Received drug only in period 2|0
2144237|NCT01133405|3753621|FG000|Period 1|Received drug only in period 3|0
2144238|NCT01133405|3753622|FG001|Period 1|Received drug only in period 3|1
2144239|NCT01133405|3753623|FG002|Period 1|Received drug only in period 3|1
2144240|NCT01133405|3753624|FG003|Period 1|Received drug only in period 3|0
2144241|NCT01133405|3753625|FG004|Period 1|Received drug only in period 3|0
2144242|NCT01133405|3753626|FG005|Period 1|Received drug only in period 3|0
2144243|NCT01133405|3753627|FG006|Period 1|Received drug only in period 3|0
2144244|NCT01133405|3753628|FG007|Period 1|Received drug only in period 3|0
2144245|NCT01133405|3753629|FG008|Period 1|Received drug only in period 3|0
2144246|NCT01133405|3753630|FG009|Period 1|Received drug only in period 3|0
2144247|NCT01133405|3753621|FG000|Period 2|Adverse Event|0
2144248|NCT01133405|3753622|FG001|Period 2|Adverse Event|0
2144249|NCT01133405|3753623|FG002|Period 2|Adverse Event|1
2144250|NCT01133405|3753624|FG003|Period 2|Adverse Event|0
2144251|NCT01133405|3753625|FG004|Period 2|Adverse Event|0
2144252|NCT01133405|3753626|FG005|Period 2|Adverse Event|0
2144253|NCT01133405|3753627|FG006|Period 2|Adverse Event|0
2144254|NCT01133405|3753628|FG007|Period 2|Adverse Event|0
2144255|NCT01133405|3753629|FG008|Period 2|Adverse Event|0
2144256|NCT01133405|3753630|FG009|Period 2|Adverse Event|0
2144257|NCT01133405|3753621|FG000|Period 2|Withdrawal by Subject|0
2144258|NCT01133405|3753622|FG001|Period 2|Withdrawal by Subject|0
2144259|NCT01133405|3753623|FG002|Period 2|Withdrawal by Subject|0
2144260|NCT01133405|3753624|FG003|Period 2|Withdrawal by Subject|1
2144261|NCT01133405|3753625|FG004|Period 2|Withdrawal by Subject|0
2144262|NCT01133405|3753626|FG005|Period 2|Withdrawal by Subject|1
2144263|NCT01133405|3753627|FG006|Period 2|Withdrawal by Subject|0
2144264|NCT01133405|3753628|FG007|Period 2|Withdrawal by Subject|0
2144265|NCT01133405|3753629|FG008|Period 2|Withdrawal by Subject|0
2144266|NCT01133405|3753630|FG009|Period 2|Withdrawal by Subject|0
2144267|NCT01133405|3753621|FG000|Period 2|Entry Criteria Not Met|0
2144268|NCT01133405|3753622|FG001|Period 2|Entry Criteria Not Met|1
2144269|NCT01133405|3753623|FG002|Period 2|Entry Criteria Not Met|0
2144270|NCT01133405|3753624|FG003|Period 2|Entry Criteria Not Met|0
2144271|NCT01133405|3753625|FG004|Period 2|Entry Criteria Not Met|0
2144272|NCT01133405|3753626|FG005|Period 2|Entry Criteria Not Met|0
2144273|NCT01133405|3753627|FG006|Period 2|Entry Criteria Not Met|0
2144274|NCT01133405|3753628|FG007|Period 2|Entry Criteria Not Met|0
2144275|NCT01133405|3753629|FG008|Period 2|Entry Criteria Not Met|0
2144276|NCT01133405|3753630|FG009|Period 2|Entry Criteria Not Met|0
2144277|NCT01133405|3753621|FG000|Period 2|Physician Decision|0
2144278|NCT01133405|3753622|FG001|Period 2|Physician Decision|0
2144279|NCT01133405|3753623|FG002|Period 2|Physician Decision|0
2144280|NCT01133405|3753624|FG003|Period 2|Physician Decision|0
2144281|NCT01133405|3753625|FG004|Period 2|Physician Decision|0
2144282|NCT01133405|3753626|FG005|Period 2|Physician Decision|1
2144283|NCT01133405|3753627|FG006|Period 2|Physician Decision|0
2144284|NCT01133405|3753628|FG007|Period 2|Physician Decision|0
2144285|NCT01133405|3753629|FG008|Period 2|Physician Decision|0
2144286|NCT01133405|3753630|FG009|Period 2|Physician Decision|0
2144287|NCT01133418|3753662|FG000|Overall Study|Lost to Follow-up|5
2144288|NCT01133418|3753663|FG001|Overall Study|Lost to Follow-up|6
2144289|NCT01133522|3753679|FG000|Overall Study|Withdrawal by Subject|0
2144290|NCT01133522|3753680|FG001|Overall Study|Withdrawal by Subject|1
2144291|NCT01133522|3753681|FG002|Overall Study|Withdrawal by Subject|0
2144292|NCT01133522|3753682|FG003|Overall Study|Withdrawal by Subject|1
2144293|NCT01133522|3753683|FG004|Overall Study|Withdrawal by Subject|0
2144294|NCT01133522|3753684|FG005|Overall Study|Withdrawal by Subject|0
2144295|NCT01133522|3753685|FG006|Overall Study|Withdrawal by Subject|0
2144296|NCT01133522|3753686|FG007|Overall Study|Withdrawal by Subject|0
2144297|NCT01133522|3753687|FG008|Overall Study|Withdrawal by Subject|0
2144298|NCT01133522|3753688|FG009|Overall Study|Withdrawal by Subject|0
2144299|NCT01133522|3753679|FG000|Overall Study|Physician Decision|0
2144300|NCT01133522|3753680|FG001|Overall Study|Physician Decision|0
2144301|NCT01133522|3753681|FG002|Overall Study|Physician Decision|0
2144302|NCT01133522|3753682|FG003|Overall Study|Physician Decision|0
2144303|NCT01133522|3753683|FG004|Overall Study|Physician Decision|1
2144304|NCT01133522|3753684|FG005|Overall Study|Physician Decision|0
2144305|NCT01133522|3753685|FG006|Overall Study|Physician Decision|0
2144306|NCT01133522|3753686|FG007|Overall Study|Physician Decision|0
2144307|NCT01133522|3753687|FG008|Overall Study|Physician Decision|0
2144308|NCT01133522|3753688|FG009|Overall Study|Physician Decision|0
2144309|NCT01133626|3753720|FG000|Overall Study|Adverse Event|0
2144310|NCT01133626|3753721|FG001|Overall Study|Adverse Event|1
2144311|NCT01133626|3753722|FG002|Overall Study|Adverse Event|0
2144312|NCT01133626|3753720|FG000|Overall Study|Withdrawal by Subject|1
2144313|NCT01133626|3753721|FG001|Overall Study|Withdrawal by Subject|2
2144314|NCT01133626|3753722|FG002|Overall Study|Withdrawal by Subject|2
2144315|NCT01133626|3753720|FG000|Overall Study|Other|0
2144316|NCT01133626|3753721|FG001|Overall Study|Other|2
2144317|NCT01133626|3753722|FG002|Overall Study|Other|0
2144318|NCT01133665|3753730|FG000|Overall Study|Physician Decision|2
2144319|NCT01133678|3753736|FG000|Overall Study|Death|1
2144320|NCT01133678|3753737|FG001|Overall Study|Death|1
2144321|NCT01133704|3753745|FG000|Overall Study|Death|44
2144322|NCT01133704|3753746|FG001|Overall Study|Death|26
2144323|NCT01133704|3753745|FG000|Overall Study|Patient refused to continue|4
2144324|NCT01133704|3753746|FG001|Overall Study|Patient refused to continue|0
2144325|NCT01133704|3753745|FG000|Overall Study|Study Closure|1
2144326|NCT01133704|3753746|FG001|Overall Study|Study Closure|0
2144327|NCT01133756|3753755|FG000|Overall Study|Adverse Event|1
2144328|NCT01133756|3753756|FG001|Overall Study|Adverse Event|2
2144329|NCT01133756|3753757|FG002|Overall Study|Adverse Event|1
2144330|NCT01133756|3753755|FG000|Overall Study|Investigator Decision|1
2144331|NCT01133756|3753756|FG001|Overall Study|Investigator Decision|0
2144332|NCT01133756|3753757|FG002|Overall Study|Investigator Decision|0
2144333|NCT01133756|3753755|FG000|Overall Study|Withdrawal by Subject|0
2144334|NCT01133756|3753756|FG001|Overall Study|Withdrawal by Subject|1
2144335|NCT01133756|3753757|FG002|Overall Study|Withdrawal by Subject|0
2144336|NCT01133756|3753755|FG000|Overall Study|Progression of Disease|0
2144337|NCT01133756|3753756|FG001|Overall Study|Progression of Disease|0
2144338|NCT01133756|3753757|FG002|Overall Study|Progression of Disease|1
2144339|NCT01133821|3753767|FG000|Overall Study|Lost to Follow-up|8
2144340|NCT01133821|3753768|FG001|Overall Study|Lost to Follow-up|11
2144341|NCT01133821|3753767|FG000|Overall Study|Withdrawal by Subject|8
2144342|NCT01133821|3753768|FG001|Overall Study|Withdrawal by Subject|3
2144343|NCT01133821|3753767|FG000|Overall Study|preferred other treatment|1
2144344|NCT01133821|3753768|FG001|Overall Study|preferred other treatment|1
2144345|NCT01133821|3753767|FG000|Overall Study|Protocol Violation|0
2144346|NCT01133821|3753768|FG001|Overall Study|Protocol Violation|1
2144347|NCT01133821|3753767|FG000|Overall Study|Refused participation|1
2144348|NCT01133821|3753768|FG001|Overall Study|Refused participation|3
2144349|NCT01133847|3753777|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
2144350|NCT01133847|3753778|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
2144351|NCT01133847|3753779|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
2144352|NCT01133847|3753777|FG000|Follow-Up Phase|Lost to Follow-up|1
2144353|NCT01133847|3753778|FG001|Follow-Up Phase|Lost to Follow-up|3
2144354|NCT01133847|3753779|FG002|Follow-Up Phase|Lost to Follow-up|7
2144355|NCT01133977|3753798|FG000|Overall Study|Adverse Event|0
2144356|NCT01133977|3753799|FG001|Overall Study|Adverse Event|0
2144357|NCT01133977|3753800|FG002|Overall Study|Adverse Event|1
2144358|NCT01133977|3753801|FG003|Overall Study|Adverse Event|0
2144359|NCT01133977|3753802|FG004|Overall Study|Adverse Event|0
2144360|NCT01133977|3753798|FG000|Overall Study|Death|1
2144361|NCT01133977|3753799|FG001|Overall Study|Death|1
2144362|NCT01133977|3753800|FG002|Overall Study|Death|1
2144363|NCT01133977|3753801|FG003|Overall Study|Death|7
2144364|NCT01133977|3753802|FG004|Overall Study|Death|3
2144365|NCT01133977|3753798|FG000|Overall Study|Started a New Line of Therapy|2
2144366|NCT01133977|3753799|FG001|Overall Study|Started a New Line of Therapy|6
2144367|NCT01133977|3753800|FG002|Overall Study|Started a New Line of Therapy|4
2144368|NCT01133977|3753801|FG003|Overall Study|Started a New Line of Therapy|25
2144369|NCT01133977|3753802|FG004|Overall Study|Started a New Line of Therapy|33
2144370|NCT01133977|3753798|FG000|Overall Study|Lost to Follow-up|0
2144371|NCT01133977|3753799|FG001|Overall Study|Lost to Follow-up|0
2144372|NCT01133977|3753800|FG002|Overall Study|Lost to Follow-up|0
2144373|NCT01133977|3753801|FG003|Overall Study|Lost to Follow-up|2
2144374|NCT01133977|3753802|FG004|Overall Study|Lost to Follow-up|1
2144375|NCT01133977|3753798|FG000|Overall Study|Withdrawal by Subject|0
2144376|NCT01133977|3753799|FG001|Overall Study|Withdrawal by Subject|0
2144377|NCT01133977|3753800|FG002|Overall Study|Withdrawal by Subject|0
2144378|NCT01133977|3753801|FG003|Overall Study|Withdrawal by Subject|5
2144379|NCT01133977|3753802|FG004|Overall Study|Withdrawal by Subject|1
2144380|NCT01134042|3753853|FG000|Overall Study|Adverse Event|3
2144381|NCT01134042|3753854|FG001|Overall Study|Adverse Event|7
2144382|NCT01134042|3753855|FG002|Overall Study|Adverse Event|2
2144383|NCT01134042|3753853|FG000|Overall Study|Lack of Efficacy|21
2144384|NCT01134042|3753854|FG001|Overall Study|Lack of Efficacy|6
2144385|NCT01134042|3753855|FG002|Overall Study|Lack of Efficacy|18
2144386|NCT01134042|3753853|FG000|Overall Study|Protocol Violation|5
2144387|NCT01134042|3753854|FG001|Overall Study|Protocol Violation|3
2144388|NCT01134042|3753855|FG002|Overall Study|Protocol Violation|5
2144389|NCT01134042|3753853|FG000|Overall Study|Lost to Follow-up|2
2144390|NCT01134042|3753854|FG001|Overall Study|Lost to Follow-up|0
2144391|NCT01134042|3753855|FG002|Overall Study|Lost to Follow-up|1
2144392|NCT01134042|3753853|FG000|Overall Study|Physician Decision|4
2144393|NCT01134042|3753854|FG001|Overall Study|Physician Decision|8
2144394|NCT01134042|3753855|FG002|Overall Study|Physician Decision|1
2144395|NCT01134042|3753853|FG000|Overall Study|Withdrawal by Subject|13
2144396|NCT01134042|3753854|FG001|Overall Study|Withdrawal by Subject|4
2144397|NCT01134042|3753855|FG002|Overall Study|Withdrawal by Subject|7
2144398|NCT01134055|3753871|FG000|Overall Study|Adverse Event|5
2144399|NCT01134055|3753872|FG001|Overall Study|Adverse Event|2
2144400|NCT01134055|3753873|FG002|Overall Study|Adverse Event|2
2144401|NCT01134055|3753874|FG003|Overall Study|Adverse Event|2
2144402|NCT01134055|3753875|FG004|Overall Study|Adverse Event|5
2144403|NCT01134055|3753876|FG005|Overall Study|Adverse Event|7
2144404|NCT01134055|3753877|FG006|Overall Study|Adverse Event|2
2144405|NCT01134055|3753871|FG000|Overall Study|Lost to Follow-up|0
2144406|NCT01134055|3753872|FG001|Overall Study|Lost to Follow-up|1
2144407|NCT01134055|3753873|FG002|Overall Study|Lost to Follow-up|0
2144408|NCT01134055|3753874|FG003|Overall Study|Lost to Follow-up|1
2144409|NCT01134055|3753875|FG004|Overall Study|Lost to Follow-up|0
2144410|NCT01134055|3753876|FG005|Overall Study|Lost to Follow-up|0
2144411|NCT01134055|3753877|FG006|Overall Study|Lost to Follow-up|0
2144412|NCT01134055|3753871|FG000|Overall Study|Withdrawal by Subject|3
2144413|NCT01134055|3753872|FG001|Overall Study|Withdrawal by Subject|3
2144414|NCT01134055|3753873|FG002|Overall Study|Withdrawal by Subject|1
2144415|NCT01134055|3753874|FG003|Overall Study|Withdrawal by Subject|2
2144416|NCT01134055|3753875|FG004|Overall Study|Withdrawal by Subject|0
2144417|NCT01134055|3753876|FG005|Overall Study|Withdrawal by Subject|0
2144418|NCT01134055|3753877|FG006|Overall Study|Withdrawal by Subject|8
2144419|NCT01134055|3753871|FG000|Overall Study|Protocol Violation|0
2144420|NCT01134055|3753872|FG001|Overall Study|Protocol Violation|0
2144421|NCT01134055|3753873|FG002|Overall Study|Protocol Violation|0
2144422|NCT01134055|3753874|FG003|Overall Study|Protocol Violation|1
2144423|NCT01134055|3753875|FG004|Overall Study|Protocol Violation|1
2144424|NCT01134055|3753876|FG005|Overall Study|Protocol Violation|0
2144425|NCT01134055|3753877|FG006|Overall Study|Protocol Violation|0
2144426|NCT01134055|3753871|FG000|Overall Study|Physician Decision|0
2144427|NCT01134055|3753872|FG001|Overall Study|Physician Decision|0
2144428|NCT01134055|3753873|FG002|Overall Study|Physician Decision|0
2144429|NCT01134055|3753874|FG003|Overall Study|Physician Decision|0
2144430|NCT01134055|3753875|FG004|Overall Study|Physician Decision|0
2144431|NCT01134055|3753876|FG005|Overall Study|Physician Decision|0
2144432|NCT01134055|3753877|FG006|Overall Study|Physician Decision|1
2144433|NCT01134107|3753909|FG000|Period 1-First Treatment Intervention|Adverse Event|1
2144434|NCT01134107|3753910|FG001|Period 1-First Treatment Intervention|Adverse Event|0
2144435|NCT01134107|3753909|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
2144436|NCT01134107|3753910|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
2144437|NCT01134107|3753909|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3
2290035|NCT02484547|3982243|FG006|Long-Term Extension Period|Loss of Capacity|0
2290036|NCT02484547|3982237|FG000|Long-Term Extension Period|Change of Treatment|0
2290037|NCT02484547|3982238|FG001|Long-Term Extension Period|Change of Treatment|0
2290038|NCT02484547|3982239|FG002|Long-Term Extension Period|Change of Treatment|0
2290039|NCT02484547|3982240|FG003|Long-Term Extension Period|Change of Treatment|0
2290040|NCT02484547|3982241|FG004|Long-Term Extension Period|Change of Treatment|0
2290041|NCT02484547|3982242|FG005|Long-Term Extension Period|Change of Treatment|0
2290042|NCT02484547|3982243|FG006|Long-Term Extension Period|Change of Treatment|1
2290043|NCT02484547|3982237|FG000|Long-Term Extension Period|Consent Withdrawn|0
2290044|NCT02484547|3982238|FG001|Long-Term Extension Period|Consent Withdrawn|0
2290045|NCT02484547|3982239|FG002|Long-Term Extension Period|Consent Withdrawn|0
2290046|NCT02484547|3982240|FG003|Long-Term Extension Period|Consent Withdrawn|6
2290047|NCT02484547|3982241|FG004|Long-Term Extension Period|Consent Withdrawn|7
2290048|NCT02484547|3982242|FG005|Long-Term Extension Period|Consent Withdrawn|13
2290049|NCT02484547|3982243|FG006|Long-Term Extension Period|Consent Withdrawn|17
2290050|NCT02484547|3982237|FG000|Long-Term Extension Period|Investigator Decision|0
2290051|NCT02484547|3982238|FG001|Long-Term Extension Period|Investigator Decision|0
2290052|NCT02484547|3982239|FG002|Long-Term Extension Period|Investigator Decision|0
2290053|NCT02484547|3982240|FG003|Long-Term Extension Period|Investigator Decision|2
2290054|NCT02484547|3982241|FG004|Long-Term Extension Period|Investigator Decision|1
2290055|NCT02484547|3982242|FG005|Long-Term Extension Period|Investigator Decision|0
2290056|NCT02484547|3982243|FG006|Long-Term Extension Period|Investigator Decision|1
2290057|NCT02484547|3982237|FG000|Long-Term Extension Period|Relocation|0
2290058|NCT02484547|3982238|FG001|Long-Term Extension Period|Relocation|0
2290059|NCT02484547|3982239|FG002|Long-Term Extension Period|Relocation|0
2290060|NCT02484547|3982240|FG003|Long-Term Extension Period|Relocation|1
2290061|NCT02484547|3982241|FG004|Long-Term Extension Period|Relocation|1
2290062|NCT02484547|3982242|FG005|Long-Term Extension Period|Relocation|0
2290063|NCT02484547|3982243|FG006|Long-Term Extension Period|Relocation|0
2290064|NCT02484547|3982237|FG000|Long-Term Extension Period|Study Visit Burden|0
2290065|NCT02484547|3982238|FG001|Long-Term Extension Period|Study Visit Burden|0
2290066|NCT02484547|3982239|FG002|Long-Term Extension Period|Study Visit Burden|0
2290067|NCT02484547|3982240|FG003|Long-Term Extension Period|Study Visit Burden|2
2290068|NCT02484547|3982241|FG004|Long-Term Extension Period|Study Visit Burden|0
2290069|NCT02484547|3982242|FG005|Long-Term Extension Period|Study Visit Burden|0
2290070|NCT02484547|3982243|FG006|Long-Term Extension Period|Study Visit Burden|3
2290071|NCT02484547|3982237|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
2290072|NCT02484547|3982238|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
2290073|NCT02484547|3982239|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
2290074|NCT02484547|3982240|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
2321048|NCT02954458|4035303|FG000|Overall Study|Other|0
2144438|NCT01134107|3753910|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4
2144439|NCT01134107|3753909|FG000|Period 1-First Treatment Intervention|Physician Decision|1
2144440|NCT01134107|3753910|FG001|Period 1-First Treatment Intervention|Physician Decision|0
2144441|NCT01134107|3753909|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
2144442|NCT01134107|3753910|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
2144443|NCT01134107|3753909|FG000|Period 2-Second Treatment Intervention|Physician Decision|1
2144444|NCT01134107|3753910|FG001|Period 2-Second Treatment Intervention|Physician Decision|0
2144445|NCT01134107|3753909|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1
2144446|NCT01134107|3753910|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0
2178762|NCT01388361|3803809|FG001|Overall Study|Adverse Event|5
2178763|NCT01388361|3803810|FG002|Overall Study|Adverse Event|1
2178764|NCT01388361|3803808|FG000|Overall Study|Protocol Violation|0
2178765|NCT01388361|3803809|FG001|Overall Study|Protocol Violation|0
2178766|NCT01388361|3803810|FG002|Overall Study|Protocol Violation|2
2178767|NCT01388361|3803808|FG000|Overall Study|Withdrawal criteria|12
2178768|NCT01388361|3803809|FG001|Overall Study|Withdrawal criteria|7
2178769|NCT01388361|3803810|FG002|Overall Study|Withdrawal criteria|10
2178770|NCT01388361|3803808|FG000|Overall Study|Unclassified|0
2178771|NCT01388361|3803809|FG001|Overall Study|Unclassified|0
2178772|NCT01388361|3803810|FG002|Overall Study|Unclassified|1
2178773|NCT01388478|3803818|FG000|Overall Study|Adverse Event|4
2178774|NCT01388478|3803818|FG000|Overall Study|Withdrawal by Subject|1
2178775|NCT01388530|3803822|FG000|Overall Study|Lost to Follow-up|5
2178776|NCT01388543|3803828|FG000|Day 14|Adverse Event|1
2178777|NCT01388543|3803829|FG001|Day 14|Adverse Event|4
2178778|NCT01388647|3803837|FG000|Overall Study|Adverse Event|1
2178779|NCT01388647|3803838|FG001|Overall Study|Adverse Event|2
2178780|NCT01388790|3803849|FG000|Overall Study|Ongoing at data cut-off date|8
2178781|NCT01388816|3803857|FG000|Overall Study|Adverse Event|0
2178782|NCT01388816|3803858|FG001|Overall Study|Adverse Event|2
2178783|NCT01388816|3803859|FG002|Overall Study|Adverse Event|0
2178784|NCT01388816|3803860|FG003|Overall Study|Adverse Event|0
2178785|NCT01388816|3803857|FG000|Overall Study|Lost to Follow-up|0
2178786|NCT01388816|3803858|FG001|Overall Study|Lost to Follow-up|1
2178787|NCT01388816|3803859|FG002|Overall Study|Lost to Follow-up|0
2178788|NCT01388816|3803860|FG003|Overall Study|Lost to Follow-up|0
2178789|NCT01388816|3803857|FG000|Overall Study|Withdrawal by Subject|2
2178790|NCT01388816|3803858|FG001|Overall Study|Withdrawal by Subject|1
2178791|NCT01388816|3803859|FG002|Overall Study|Withdrawal by Subject|1
2178792|NCT01388816|3803860|FG003|Overall Study|Withdrawal by Subject|0
2178793|NCT01388816|3803857|FG000|Overall Study|Protocol Violation|0
2178794|NCT01388816|3803858|FG001|Overall Study|Protocol Violation|0
2178795|NCT01388816|3803859|FG002|Overall Study|Protocol Violation|2
2178796|NCT01388816|3803860|FG003|Overall Study|Protocol Violation|0
2178797|NCT01388907|3803875|FG000|Overall Study|Adverse Event|2
2178798|NCT01388907|3803876|FG001|Overall Study|Adverse Event|0
2178799|NCT01388985|3803895|FG000|Overall Study|Death|0
2178800|NCT01388985|3803896|FG001|Overall Study|Death|1
2178801|NCT01388985|3803895|FG000|Overall Study|Lost to Follow-up|30
2178802|NCT01388985|3803896|FG001|Overall Study|Lost to Follow-up|30
2178803|NCT01388985|3803895|FG000|Overall Study|Withdrawal by Subject|13
2178804|NCT01388985|3803896|FG001|Overall Study|Withdrawal by Subject|4
2178805|NCT01388985|3803895|FG000|Overall Study|Subject unavailable|1
2178806|NCT01388985|3803896|FG001|Overall Study|Subject unavailable|1
2178807|NCT01388985|3803895|FG000|Overall Study|Other (no reason)|0
2178808|NCT01388985|3803896|FG001|Overall Study|Other (no reason)|1
2178809|NCT01388985|3803895|FG000|Overall Study|Error of nurse|5
2178810|NCT01388985|3803896|FG001|Overall Study|Error of nurse|1
2178811|NCT01389102|3803912|FG000|Overall Study|Adverse Event|1
2178812|NCT01389102|3803913|FG001|Overall Study|Adverse Event|3
2178813|NCT01389102|3803914|FG002|Overall Study|Adverse Event|2
2178814|NCT01389102|3803915|FG003|Overall Study|Adverse Event|2
2178815|NCT01389102|3803916|FG004|Overall Study|Adverse Event|2
2178816|NCT01389102|3803917|FG005|Overall Study|Adverse Event|2
2178817|NCT01389102|3803912|FG000|Overall Study|Hurricane Katrina|4
2178818|NCT01389102|3803913|FG001|Overall Study|Hurricane Katrina|2
2178819|NCT01389102|3803914|FG002|Overall Study|Hurricane Katrina|3
2178820|NCT01389102|3803915|FG003|Overall Study|Hurricane Katrina|0
2178821|NCT01389102|3803916|FG004|Overall Study|Hurricane Katrina|3
2178822|NCT01389102|3803917|FG005|Overall Study|Hurricane Katrina|1
2178823|NCT01389102|3803912|FG000|Overall Study|Lost to Follow-up|4
2178824|NCT01389102|3803913|FG001|Overall Study|Lost to Follow-up|1
2178825|NCT01389102|3803914|FG002|Overall Study|Lost to Follow-up|1
2178826|NCT01389102|3803915|FG003|Overall Study|Lost to Follow-up|2
2178827|NCT01389102|3803916|FG004|Overall Study|Lost to Follow-up|4
2178828|NCT01389102|3803917|FG005|Overall Study|Lost to Follow-up|1
2178829|NCT01389102|3803912|FG000|Overall Study|Protocol Violation|0
2178830|NCT01389102|3803913|FG001|Overall Study|Protocol Violation|0
2178831|NCT01389102|3803914|FG002|Overall Study|Protocol Violation|3
2178832|NCT01389102|3803915|FG003|Overall Study|Protocol Violation|0
2178833|NCT01389102|3803916|FG004|Overall Study|Protocol Violation|1
2178834|NCT01389102|3803917|FG005|Overall Study|Protocol Violation|1
2178835|NCT01389102|3803912|FG000|Overall Study|Withdrawal by Subject|7
2178836|NCT01389102|3803913|FG001|Overall Study|Withdrawal by Subject|4
2208019|NCT01635764|3847370|FG000|Overall Study|Lack of Efficacy|76
2178837|NCT01389102|3803914|FG002|Overall Study|Withdrawal by Subject|9
2144447|NCT01134263|3753930|FG000|Overall Study|Serious adverse event|2
2144448|NCT01134263|3753931|FG001|Overall Study|Serious adverse event|1
2144449|NCT01134263|3753932|FG002|Overall Study|Serious adverse event|1
2144450|NCT01134263|3753933|FG003|Overall Study|Serious adverse event|1
2144451|NCT01134263|3753934|FG004|Overall Study|Serious adverse event|1
2144452|NCT01134263|3753930|FG000|Overall Study|Other adverse event|1
2144453|NCT01134263|3753931|FG001|Overall Study|Other adverse event|2
2144454|NCT01134263|3753932|FG002|Overall Study|Other adverse event|5
2144455|NCT01134263|3753933|FG003|Overall Study|Other adverse event|3
2144456|NCT01134263|3753934|FG004|Overall Study|Other adverse event|0
2144457|NCT01134263|3753930|FG000|Overall Study|Protocol Violation|8
2144458|NCT01134263|3753931|FG001|Overall Study|Protocol Violation|7
2144459|NCT01134263|3753932|FG002|Overall Study|Protocol Violation|2
2144460|NCT01134263|3753933|FG003|Overall Study|Protocol Violation|4
2144461|NCT01134263|3753934|FG004|Overall Study|Protocol Violation|2
2144462|NCT01134263|3753930|FG000|Overall Study|Lost to Follow-up|4
2144463|NCT01134263|3753931|FG001|Overall Study|Lost to Follow-up|3
2144464|NCT01134263|3753932|FG002|Overall Study|Lost to Follow-up|5
2144465|NCT01134263|3753933|FG003|Overall Study|Lost to Follow-up|3
2144466|NCT01134263|3753934|FG004|Overall Study|Lost to Follow-up|1
2144467|NCT01134263|3753930|FG000|Overall Study|Withdrawal by Subject|8
2144468|NCT01134263|3753931|FG001|Overall Study|Withdrawal by Subject|6
2144469|NCT01134263|3753932|FG002|Overall Study|Withdrawal by Subject|16
2144470|NCT01134263|3753933|FG003|Overall Study|Withdrawal by Subject|7
2144471|NCT01134263|3753934|FG004|Overall Study|Withdrawal by Subject|5
2144472|NCT01134263|3753930|FG000|Overall Study|Enrolled, but not treated|1
2144473|NCT01134263|3753931|FG001|Overall Study|Enrolled, but not treated|1
2144474|NCT01134263|3753932|FG002|Overall Study|Enrolled, but not treated|0
2144475|NCT01134263|3753933|FG003|Overall Study|Enrolled, but not treated|1
2144476|NCT01134263|3753934|FG004|Overall Study|Enrolled, but not treated|0
2144477|NCT01134315|3753966|FG000|Overall Study|Adverse Event|1
2144478|NCT01134315|3753967|FG001|Overall Study|Adverse Event|2
2144479|NCT01134315|3753966|FG000|Overall Study|Other Reason|8
2144480|NCT01134315|3753967|FG001|Overall Study|Other Reason|17
2144481|NCT01134393|3753990|FG000|Overall Study|Adverse Event|18
2144482|NCT01134393|3753990|FG000|Overall Study|Lack of Efficacy|2
2144483|NCT01134393|3753990|FG000|Overall Study|Protocol Violation|12
2144484|NCT01134393|3753990|FG000|Overall Study|Lost to Follow-up|3
2144485|NCT01134393|3753990|FG000|Overall Study|Withdrawal by Subject|11
2144486|NCT01134393|3753990|FG000|Overall Study|Other|6
2144487|NCT01134562|3754038|FG000|Overall Study|Adverse Event|0
2144488|NCT01134562|3754039|FG001|Overall Study|Adverse Event|1
2144489|NCT01134562|3754040|FG002|Overall Study|Adverse Event|0
2144490|NCT01134562|3754041|FG003|Overall Study|Adverse Event|0
2144491|NCT01134562|3754042|FG004|Overall Study|Adverse Event|0
2144492|NCT01134614|3754077|FG000|Overall Study|Still on treatment as of March 2013|21
2144493|NCT01134614|3754078|FG001|Overall Study|Still on treatment as of March 2013|13
2144494|NCT01134614|3754077|FG000|Overall Study|Progressive disease|60
2144495|NCT01134614|3754078|FG001|Overall Study|Progressive disease|54
2144496|NCT01134614|3754077|FG000|Overall Study|Adverse Event|26
2144497|NCT01134614|3754078|FG001|Overall Study|Adverse Event|39
2144498|NCT01134614|3754077|FG000|Overall Study|Death|5
2144499|NCT01134614|3754078|FG001|Overall Study|Death|8
2144500|NCT01134614|3754077|FG000|Overall Study|Withdrawal by Subject|3
2144501|NCT01134614|3754078|FG001|Overall Study|Withdrawal by Subject|2
2144502|NCT01134614|3754077|FG000|Overall Study|Alternative therapy|2
2144503|NCT01134614|3754078|FG001|Overall Study|Alternative therapy|0
2144504|NCT01134614|3754077|FG000|Overall Study|Complicating disease|2
2144505|NCT01134614|3754078|FG001|Overall Study|Complicating disease|1
2144506|NCT01134614|3754077|FG000|Overall Study|Physician's decision|0
2144507|NCT01134614|3754078|FG001|Overall Study|Physician's decision|1
2144508|NCT01134614|3754077|FG000|Overall Study|Never started treatment|4
2144509|NCT01134614|3754078|FG001|Overall Study|Never started treatment|1
2144510|NCT01134614|3754077|FG000|Overall Study|Pt received tx not allowed on study|0
2144511|NCT01134614|3754078|FG001|Overall Study|Pt received tx not allowed on study|1
2144512|NCT01134614|3754077|FG000|Overall Study|Symptomatic deterioration|0
2144513|NCT01134614|3754078|FG001|Overall Study|Symptomatic deterioration|1
2144514|NCT01134614|3754077|FG000|Overall Study|Patient in hospice care|0
2144515|NCT01134614|3754078|FG001|Overall Study|Patient in hospice care|1
2144516|NCT01134627|3754086|FG000|Overall Study|Adverse Event|47
2144517|NCT01134627|3754087|FG001|Overall Study|Adverse Event|31
2144518|NCT01134627|3754086|FG000|Overall Study|Lost to Follow-up|1
2144519|NCT01134627|3754087|FG001|Overall Study|Lost to Follow-up|2
2144520|NCT01134627|3754086|FG000|Overall Study|Protocol Violation|3
2144521|NCT01134627|3754087|FG001|Overall Study|Protocol Violation|5
2144522|NCT01134627|3754086|FG000|Overall Study|Lack of Efficacy|2
2144523|NCT01134627|3754087|FG001|Overall Study|Lack of Efficacy|12
2144524|NCT01134627|3754086|FG000|Overall Study|Withdrawal by Subject|4
2144525|NCT01134627|3754087|FG001|Overall Study|Withdrawal by Subject|3
2144526|NCT01134627|3754086|FG000|Overall Study|Planning to become pregnant/pregnancy|1
2144527|NCT01134627|3754087|FG001|Overall Study|Planning to become pregnant/pregnancy|0
2144528|NCT01134627|3754086|FG000|Overall Study|Other|11
2144529|NCT01134627|3754087|FG001|Overall Study|Other|14
2144530|NCT01134705|3754095|FG000|Overall Study|Adverse Event|1
2144531|NCT01134705|3754096|FG001|Overall Study|Adverse Event|7
2144532|NCT01134705|3754095|FG000|Overall Study|Withdrawal by Subject|6
2144533|NCT01134705|3754096|FG001|Overall Study|Withdrawal by Subject|6
2144534|NCT01134705|3754095|FG000|Overall Study|Pregnancy|1
2144535|NCT01134705|3754096|FG001|Overall Study|Pregnancy|0
2144536|NCT01134705|3754095|FG000|Overall Study|Lost to Follow-up|5
2144537|NCT01134705|3754096|FG001|Overall Study|Lost to Follow-up|2
2144538|NCT01134705|3754095|FG000|Overall Study|Protocol Violation|1
2144539|NCT01134705|3754096|FG001|Overall Study|Protocol Violation|1
2144540|NCT01134705|3754095|FG000|Overall Study|Other|1
2144541|NCT01134705|3754096|FG001|Overall Study|Other|6
2144542|NCT01134731|3754105|FG000|Overall Study|Adverse Event|3
2144543|NCT01134731|3754106|FG001|Overall Study|Adverse Event|2
2144544|NCT01134731|3754107|FG002|Overall Study|Adverse Event|1
2144545|NCT01134731|3754105|FG000|Overall Study|Physician Decision|2
2208020|NCT01635764|3847370|FG000|Overall Study|Exceed Protocol-specified Interventions|2
2144546|NCT01134731|3754106|FG001|Overall Study|Physician Decision|2
2144547|NCT01134731|3754107|FG002|Overall Study|Physician Decision|2
2144548|NCT01134731|3754105|FG000|Overall Study|Lack of Efficacy|0
2144549|NCT01134731|3754106|FG001|Overall Study|Lack of Efficacy|0
2144550|NCT01134731|3754107|FG002|Overall Study|Lack of Efficacy|1
2144551|NCT01134731|3754105|FG000|Overall Study|Withdrawal by Subject|3
2144552|NCT01134731|3754106|FG001|Overall Study|Withdrawal by Subject|3
2144553|NCT01134731|3754107|FG002|Overall Study|Withdrawal by Subject|1
2144554|NCT01134731|3754105|FG000|Overall Study|Lost to Follow-up|5
2144555|NCT01134731|3754106|FG001|Overall Study|Lost to Follow-up|4
2144556|NCT01134731|3754107|FG002|Overall Study|Lost to Follow-up|3
2144557|NCT01134783|3754118|FG000|Overall Study|Pregnancy|16
2144558|NCT01134783|3754119|FG001|Overall Study|Pregnancy|8
2144559|NCT01134783|3754118|FG000|Overall Study|Withdrawal by Subject|15
2144560|NCT01134783|3754119|FG001|Overall Study|Withdrawal by Subject|9
2144561|NCT01134783|3754118|FG000|Overall Study|Lost to Follow-up|5
2144562|NCT01134783|3754119|FG001|Overall Study|Lost to Follow-up|20
2144563|NCT01134939|3754161|FG000|Overall Study|Adverse Event|9
2144564|NCT01134939|3754162|FG001|Overall Study|Adverse Event|3
2144565|NCT01134939|3754163|FG002|Overall Study|Adverse Event|4
2144566|NCT01134939|3754164|FG003|Overall Study|Adverse Event|5
2144567|NCT01134939|3754165|FG004|Overall Study|Adverse Event|5
2144568|NCT01134939|3754166|FG005|Overall Study|Adverse Event|5
2144569|NCT01134939|3754167|FG006|Overall Study|Adverse Event|1
2144570|NCT01134939|3754168|FG007|Overall Study|Adverse Event|0
2144571|NCT01134939|3754161|FG000|Overall Study|Lack of Efficacy|2
2144572|NCT01134939|3754162|FG001|Overall Study|Lack of Efficacy|5
2144573|NCT01134939|3754163|FG002|Overall Study|Lack of Efficacy|1
2144574|NCT01134939|3754164|FG003|Overall Study|Lack of Efficacy|0
2144575|NCT01134939|3754165|FG004|Overall Study|Lack of Efficacy|3
2144576|NCT01134939|3754166|FG005|Overall Study|Lack of Efficacy|0
2144577|NCT01134939|3754167|FG006|Overall Study|Lack of Efficacy|1
2144578|NCT01134939|3754168|FG007|Overall Study|Lack of Efficacy|0
2144579|NCT01134939|3754161|FG000|Overall Study|Lost to Follow-up|2
2144580|NCT01134939|3754162|FG001|Overall Study|Lost to Follow-up|3
2144581|NCT01134939|3754163|FG002|Overall Study|Lost to Follow-up|0
2144582|NCT01134939|3754164|FG003|Overall Study|Lost to Follow-up|1
2144583|NCT01134939|3754165|FG004|Overall Study|Lost to Follow-up|2
2144584|NCT01134939|3754166|FG005|Overall Study|Lost to Follow-up|1
2144585|NCT01134939|3754167|FG006|Overall Study|Lost to Follow-up|0
2144586|NCT01134939|3754168|FG007|Overall Study|Lost to Follow-up|0
2290075|NCT02484547|3982241|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1
2290076|NCT02484547|3982242|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3
2290077|NCT02484547|3982243|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2
2290078|NCT02484547|3982237|FG000|Long-Term Extension Period|Reason not Specified|0
2290079|NCT02484547|3982238|FG001|Long-Term Extension Period|Reason not Specified|0
2290080|NCT02484547|3982239|FG002|Long-Term Extension Period|Reason not Specified|0
2290081|NCT02484547|3982240|FG003|Long-Term Extension Period|Reason not Specified|119
2290082|NCT02484547|3982241|FG004|Long-Term Extension Period|Reason not Specified|117
2290083|NCT02484547|3982242|FG005|Long-Term Extension Period|Reason not Specified|223
2290084|NCT02484547|3982243|FG006|Long-Term Extension Period|Reason not Specified|231
2290085|NCT02484651|3982257|FG000|Overall Study|Patients' data files were corrupted.|1
2290086|NCT02484651|3982258|FG001|Overall Study|Patients' data files were corrupted.|1
2290087|NCT02484651|3982257|FG000|Overall Study|BIS monitoring failed.|1
2290088|NCT02484651|3982258|FG001|Overall Study|BIS monitoring failed.|1
2144587|NCT01134939|3754161|FG000|Overall Study|Death|0
2144588|NCT01134939|3754162|FG001|Overall Study|Death|1
2144589|NCT01134939|3754163|FG002|Overall Study|Death|0
2144590|NCT01134939|3754164|FG003|Overall Study|Death|0
2144591|NCT01134939|3754165|FG004|Overall Study|Death|0
2144592|NCT01134939|3754166|FG005|Overall Study|Death|0
2144593|NCT01134939|3754167|FG006|Overall Study|Death|0
2144594|NCT01134939|3754168|FG007|Overall Study|Death|0
2208021|NCT01635764|3847370|FG000|Overall Study|Protocol Deviation|1
2208022|NCT01635764|3847370|FG000|Overall Study|Withdrew Consent|67
2208023|NCT01635764|3847370|FG000|Overall Study|Lost to Follow-up|53
2208024|NCT01635764|3847370|FG000|Overall Study|Other|28
2208025|NCT01635855|3847381|FG000|Overall Study|Withdrawal by Subject|4
2208026|NCT01635920|3847391|FG000|Overall Study|Adverse Event|1
2208027|NCT01635920|3847392|FG001|Overall Study|Adverse Event|0
2208028|NCT01635920|3847391|FG000|Overall Study|Lost to Follow-up|0
2144595|NCT01134939|3754161|FG000|Overall Study|Termination page not available|4
2144596|NCT01134939|3754162|FG001|Overall Study|Termination page not available|6
2144597|NCT01134939|3754163|FG002|Overall Study|Termination page not available|5
2144598|NCT01134939|3754164|FG003|Overall Study|Termination page not available|8
2144599|NCT01134939|3754165|FG004|Overall Study|Termination page not available|0
2144600|NCT01134939|3754166|FG005|Overall Study|Termination page not available|3
2144601|NCT01134939|3754167|FG006|Overall Study|Termination page not available|7
2144602|NCT01134939|3754168|FG007|Overall Study|Termination page not available|0
2144603|NCT01135017|3754192|FG000|Overall Study|Adverse Event|3
2144604|NCT01135017|3754193|FG001|Overall Study|Adverse Event|8
2144605|NCT01135017|3754192|FG000|Overall Study|Other than above|3
2144606|NCT01135017|3754193|FG001|Overall Study|Other than above|4
2144607|NCT01135394|3754282|FG000|Screening|Lost to Follow-up|2
2144608|NCT01135394|3754282|FG000|Screening|Withdrawal by Subject|10
2144609|NCT01135394|3754282|FG000|Screening|Screening failure|16
2144610|NCT01135394|3754282|FG000|Screening|Physician Decision|5
2144611|NCT01135394|3754282|FG000|Baseline Assessment|Withdrawal by Subject|9
2144612|NCT01135394|3754282|FG000|Baseline Assessment|Physician Decision|3
2144613|NCT01135394|3754282|FG000|Baseline Assessment|Lost to Follow-up|2
2144614|NCT01135394|3754282|FG000|Baseline Assessment|Adverse Event|1
2144615|NCT01135394|3754282|FG000|Study Treatment|Withdrawal by Subject|1
2144616|NCT01135394|3754282|FG000|Study Treatment|Physician Decision|1
2144617|NCT01135394|3754282|FG000|Study Treatment|Adverse Event|2
2144618|NCT01135498|3754295|FG000|Overall Study|Adverse Event|20
2144619|NCT01135498|3754295|FG000|Overall Study|Progressive disease|38
2144620|NCT01135498|3754295|FG000|Overall Study|Investigator judgement|25
2144621|NCT01135498|3754295|FG000|Overall Study|Withdrawal by Subject|4
2144622|NCT01135498|3754295|FG000|Overall Study|Death|1
2144623|NCT01135498|3754295|FG000|Overall Study|Ongoing at time of analysis|2
2144624|NCT01135511|3754309|FG000|Overall Study|Adverse Event|0
2144625|NCT01135511|3754310|FG001|Overall Study|Adverse Event|1
2144626|NCT01135511|3754311|FG002|Overall Study|Adverse Event|2
2144627|NCT01135511|3754312|FG003|Overall Study|Adverse Event|0
2144628|NCT01135511|3754313|FG004|Overall Study|Adverse Event|0
2144629|NCT01135511|3754314|FG005|Overall Study|Adverse Event|1
2144630|NCT01135511|3754315|FG006|Overall Study|Adverse Event|0
2144631|NCT01135511|3754316|FG007|Overall Study|Adverse Event|1
2144632|NCT01135511|3754317|FG008|Overall Study|Adverse Event|0
2144633|NCT01135511|3754309|FG000|Overall Study|Lack of Efficacy|0
2144634|NCT01135511|3754310|FG001|Overall Study|Lack of Efficacy|1
2144635|NCT01135511|3754311|FG002|Overall Study|Lack of Efficacy|1
2144636|NCT01135511|3754312|FG003|Overall Study|Lack of Efficacy|2
2144637|NCT01135511|3754313|FG004|Overall Study|Lack of Efficacy|0
2144638|NCT01135511|3754314|FG005|Overall Study|Lack of Efficacy|0
2144639|NCT01135511|3754315|FG006|Overall Study|Lack of Efficacy|0
2144640|NCT01135511|3754316|FG007|Overall Study|Lack of Efficacy|0
2144641|NCT01135511|3754317|FG008|Overall Study|Lack of Efficacy|0
2144642|NCT01135511|3754309|FG000|Overall Study|Protocol Violation|0
2144643|NCT01135511|3754310|FG001|Overall Study|Protocol Violation|0
2144644|NCT01135511|3754311|FG002|Overall Study|Protocol Violation|3
2144645|NCT01135511|3754312|FG003|Overall Study|Protocol Violation|0
2144646|NCT01135511|3754313|FG004|Overall Study|Protocol Violation|0
2144647|NCT01135511|3754314|FG005|Overall Study|Protocol Violation|0
2144648|NCT01135511|3754315|FG006|Overall Study|Protocol Violation|0
2144649|NCT01135511|3754316|FG007|Overall Study|Protocol Violation|0
2144650|NCT01135511|3754317|FG008|Overall Study|Protocol Violation|0
2144651|NCT01135511|3754309|FG000|Overall Study|Pregnancy|0
2144652|NCT01135511|3754310|FG001|Overall Study|Pregnancy|0
2144653|NCT01135511|3754311|FG002|Overall Study|Pregnancy|0
2144654|NCT01135511|3754312|FG003|Overall Study|Pregnancy|1
2144655|NCT01135511|3754313|FG004|Overall Study|Pregnancy|0
2144656|NCT01135511|3754314|FG005|Overall Study|Pregnancy|0
2144657|NCT01135511|3754315|FG006|Overall Study|Pregnancy|0
2144658|NCT01135511|3754316|FG007|Overall Study|Pregnancy|0
2144659|NCT01135511|3754317|FG008|Overall Study|Pregnancy|0
2144660|NCT01135511|3754309|FG000|Overall Study|could not visit the clinic|0
2144661|NCT01135511|3754310|FG001|Overall Study|could not visit the clinic|1
2144662|NCT01135511|3754311|FG002|Overall Study|could not visit the clinic|2
2144663|NCT01135511|3754312|FG003|Overall Study|could not visit the clinic|0
2144664|NCT01135511|3754313|FG004|Overall Study|could not visit the clinic|0
2144665|NCT01135511|3754314|FG005|Overall Study|could not visit the clinic|0
2144666|NCT01135511|3754315|FG006|Overall Study|could not visit the clinic|0
2144667|NCT01135511|3754316|FG007|Overall Study|could not visit the clinic|0
2144668|NCT01135511|3754317|FG008|Overall Study|could not visit the clinic|0
2144669|NCT01135511|3754309|FG000|Overall Study|noncompliance with study drug taken|0
2144670|NCT01135511|3754310|FG001|Overall Study|noncompliance with study drug taken|0
2144671|NCT01135511|3754311|FG002|Overall Study|noncompliance with study drug taken|0
2144672|NCT01135511|3754312|FG003|Overall Study|noncompliance with study drug taken|0
2144673|NCT01135511|3754313|FG004|Overall Study|noncompliance with study drug taken|1
2144674|NCT01135511|3754314|FG005|Overall Study|noncompliance with study drug taken|0
2144675|NCT01135511|3754315|FG006|Overall Study|noncompliance with study drug taken|0
2144676|NCT01135511|3754316|FG007|Overall Study|noncompliance with study drug taken|0
2144677|NCT01135511|3754317|FG008|Overall Study|noncompliance with study drug taken|0
2144678|NCT01135511|3754309|FG000|Overall Study|Withdrawal by Subject|0
2144679|NCT01135511|3754310|FG001|Overall Study|Withdrawal by Subject|0
2144680|NCT01135511|3754311|FG002|Overall Study|Withdrawal by Subject|0
2144681|NCT01135511|3754312|FG003|Overall Study|Withdrawal by Subject|0
2144682|NCT01135511|3754313|FG004|Overall Study|Withdrawal by Subject|0
2144683|NCT01135511|3754314|FG005|Overall Study|Withdrawal by Subject|0
2144684|NCT01135511|3754315|FG006|Overall Study|Withdrawal by Subject|1
2144685|NCT01135511|3754316|FG007|Overall Study|Withdrawal by Subject|0
2144686|NCT01135511|3754317|FG008|Overall Study|Withdrawal by Subject|1
2144687|NCT01135524|3754337|FG000|Overall Study|Withdrawal by Subject|14
2144688|NCT01135524|3754337|FG000|Overall Study|Adverse Event|20
2144689|NCT01135524|3754337|FG000|Overall Study|Lost to Follow-up|3
2144690|NCT01135524|3754337|FG000|Overall Study|Administrative|151
2144691|NCT01135524|3754337|FG000|Overall Study|Lack of Efficacy|8
2144692|NCT01135914|3754348|FG000|Overall Study|Withdrawal by Subject|1
2144693|NCT01135914|3754349|FG001|Overall Study|Withdrawal by Subject|3
2144694|NCT01135914|3754350|FG002|Overall Study|Withdrawal by Subject|6
2144695|NCT01135914|3754348|FG000|Overall Study|Lost to Follow-up|1
2144696|NCT01135914|3754349|FG001|Overall Study|Lost to Follow-up|0
2144697|NCT01135914|3754350|FG002|Overall Study|Lost to Follow-up|1
2144698|NCT01135914|3754348|FG000|Overall Study|Protocol Violation|0
2144699|NCT01135914|3754349|FG001|Overall Study|Protocol Violation|0
2144700|NCT01135914|3754350|FG002|Overall Study|Protocol Violation|3
2144701|NCT01135914|3754348|FG000|Overall Study|Lack of Efficacy|2
2144702|NCT01135914|3754349|FG001|Overall Study|Lack of Efficacy|1
2144703|NCT01135914|3754350|FG002|Overall Study|Lack of Efficacy|10
2144704|NCT01135914|3754348|FG000|Overall Study|Adverse Event|0
2144705|NCT01135914|3754349|FG001|Overall Study|Adverse Event|1
2144706|NCT01135914|3754350|FG002|Overall Study|Adverse Event|2
2144707|NCT01135992|3754358|FG000|Overall Study|Adverse Event|1
2144708|NCT01135992|3754358|FG000|Overall Study|Lack of Efficacy|1
2144709|NCT01135992|3754358|FG000|Overall Study|Protocol Violation|2
2144710|NCT01135992|3754358|FG000|Overall Study|Withdrawal criteria|10
2144711|NCT01135992|3754358|FG000|Overall Study|Unclassified|7
2144712|NCT01136174|3754366|FG000|Overall Study|Adverse Event|0
2144713|NCT01136174|3754367|FG001|Overall Study|Adverse Event|0
2144714|NCT01136174|3754368|FG002|Overall Study|Adverse Event|0
2144715|NCT01136174|3754369|FG003|Overall Study|Adverse Event|4
2144716|NCT01136291|3754395|FG000|Overall Study|Lost to Follow-up|1
2144717|NCT01136291|3754396|FG001|Overall Study|Lost to Follow-up|1
2144718|NCT01136356|3754402|FG000|First 18-day Withdrawal|Withdrawal by Subject|3
2144719|NCT01136356|3754403|FG001|First 18-day Withdrawal|Withdrawal by Subject|0
2144720|NCT01136356|3754402|FG000|First 18-day Withdrawal|Physician Decision|1
2144721|NCT01136356|3754403|FG001|First 18-day Withdrawal|Physician Decision|0
2144722|NCT01136356|3754402|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0
2144723|NCT01136356|3754403|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1
2144724|NCT01136382|3754410|FG000|Overall Study|Other|8
2144725|NCT01136382|3754411|FG001|Overall Study|Other|3
2144726|NCT01136382|3754410|FG000|Overall Study|Study-Specific Withdrawal Criteria|48
2144727|NCT01136382|3754411|FG001|Overall Study|Study-Specific Withdrawal Criteria|25
2144728|NCT01136382|3754410|FG000|Overall Study|Severe Non-Compliance to Protocol|0
2144729|NCT01136382|3754411|FG001|Overall Study|Severe Non-Compliance to Protocol|2
2144730|NCT01136382|3754410|FG000|Overall Study|Withdrawal by Subject|4
2144731|NCT01136382|3754411|FG001|Overall Study|Withdrawal by Subject|1
2144732|NCT01136408|3754420|FG000|Overall Study|Adverse Event|4
2144733|NCT01136408|3754421|FG001|Overall Study|Adverse Event|8
2144734|NCT01136408|3754422|FG002|Overall Study|Adverse Event|4
2144735|NCT01136408|3754420|FG000|Overall Study|Protocol Violation|1
2144736|NCT01136408|3754421|FG001|Overall Study|Protocol Violation|1
2144737|NCT01136408|3754422|FG002|Overall Study|Protocol Violation|1
2144738|NCT01136655|3754438|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
2144739|NCT01136655|3754438|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
2144740|NCT01136655|3754438|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
2144741|NCT01136655|3754438|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
2208029|NCT01635920|3847392|FG001|Overall Study|Lost to Follow-up|1
2208030|NCT01635920|3847391|FG000|Overall Study|Subject decision|2
2290089|NCT02484651|3982257|FG000|Overall Study|Time of the procedure less than 90 min.|1
2144742|NCT01136733|3754458|FG000|Phase 1b|Adverse Event|0
2144743|NCT01136733|3754459|FG001|Phase 1b|Adverse Event|3
2144744|NCT01136733|3754460|FG002|Phase 1b|Adverse Event|1
2144745|NCT01136733|3754461|FG003|Phase 1b|Adverse Event|0
2144746|NCT01136733|3754462|FG004|Phase 1b|Adverse Event|0
2144747|NCT01136733|3754463|FG005|Phase 1b|Adverse Event|0
2144748|NCT01136733|3754464|FG006|Phase 1b|Adverse Event|0
2144749|NCT01136733|3754458|FG000|Phase 1b|Participant Choice|0
2144750|NCT01136733|3754459|FG001|Phase 1b|Participant Choice|0
2144751|NCT01136733|3754460|FG002|Phase 1b|Participant Choice|1
2144752|NCT01136733|3754461|FG003|Phase 1b|Participant Choice|0
2144753|NCT01136733|3754462|FG004|Phase 1b|Participant Choice|0
2144754|NCT01136733|3754463|FG005|Phase 1b|Participant Choice|0
2144755|NCT01136733|3754464|FG006|Phase 1b|Participant Choice|0
2144756|NCT01136733|3754458|FG000|Phase 1b|Administrative-Withdrew Consent|0
2144757|NCT01136733|3754459|FG001|Phase 1b|Administrative-Withdrew Consent|1
2144758|NCT01136733|3754460|FG002|Phase 1b|Administrative-Withdrew Consent|0
2144759|NCT01136733|3754461|FG003|Phase 1b|Administrative-Withdrew Consent|0
2144760|NCT01136733|3754462|FG004|Phase 1b|Administrative-Withdrew Consent|0
2144761|NCT01136733|3754463|FG005|Phase 1b|Administrative-Withdrew Consent|0
2144762|NCT01136733|3754464|FG006|Phase 1b|Administrative-Withdrew Consent|0
2144763|NCT01136733|3754458|FG000|Phase 1b|Clinical Progression|1
2144764|NCT01136733|3754459|FG001|Phase 1b|Clinical Progression|1
2144765|NCT01136733|3754460|FG002|Phase 1b|Clinical Progression|0
2144766|NCT01136733|3754461|FG003|Phase 1b|Clinical Progression|0
2144767|NCT01136733|3754462|FG004|Phase 1b|Clinical Progression|0
2144768|NCT01136733|3754463|FG005|Phase 1b|Clinical Progression|0
2144769|NCT01136733|3754464|FG006|Phase 1b|Clinical Progression|0
2144770|NCT01136733|3754458|FG000|Phase 2|Disease Progression|0
2144771|NCT01136733|3754459|FG001|Phase 2|Disease Progression|0
2144772|NCT01136733|3754460|FG002|Phase 2|Disease Progression|0
2144773|NCT01136733|3754461|FG003|Phase 2|Disease Progression|0
2144774|NCT01136733|3754462|FG004|Phase 2|Disease Progression|30
2144775|NCT01136733|3754463|FG005|Phase 2|Disease Progression|32
2144776|NCT01136733|3754464|FG006|Phase 2|Disease Progression|38
2144777|NCT01136733|3754458|FG000|Phase 2|Adverse Event|0
2144778|NCT01136733|3754459|FG001|Phase 2|Adverse Event|0
2144779|NCT01136733|3754460|FG002|Phase 2|Adverse Event|0
2144780|NCT01136733|3754461|FG003|Phase 2|Adverse Event|0
2144781|NCT01136733|3754462|FG004|Phase 2|Adverse Event|11
2290090|NCT02484651|3982258|FG001|Overall Study|Time of the procedure less than 90 min.|2
2290091|NCT02484690|3982270|FG000|Overall Study|Adverse Event|1
2290092|NCT02484690|3982271|FG001|Overall Study|Adverse Event|3
2144782|NCT01136733|3754463|FG005|Phase 2|Adverse Event|13
2144783|NCT01136733|3754464|FG006|Phase 2|Adverse Event|5
2144784|NCT01136733|3754458|FG000|Phase 2|Participant Choice|0
2144785|NCT01136733|3754459|FG001|Phase 2|Participant Choice|0
2144786|NCT01136733|3754460|FG002|Phase 2|Participant Choice|0
2144787|NCT01136733|3754461|FG003|Phase 2|Participant Choice|0
2144788|NCT01136733|3754462|FG004|Phase 2|Participant Choice|3
2144789|NCT01136733|3754463|FG005|Phase 2|Participant Choice|0
2290093|NCT02484690|3982272|FG002|Overall Study|Adverse Event|0
2144790|NCT01136733|3754464|FG006|Phase 2|Participant Choice|1
2144791|NCT01136733|3754458|FG000|Phase 2|Administrative-Withdrew Consent|0
2144792|NCT01136733|3754459|FG001|Phase 2|Administrative-Withdrew Consent|0
2144793|NCT01136733|3754460|FG002|Phase 2|Administrative-Withdrew Consent|0
2144794|NCT01136733|3754461|FG003|Phase 2|Administrative-Withdrew Consent|0
2144795|NCT01136733|3754462|FG004|Phase 2|Administrative-Withdrew Consent|1
2144796|NCT01136733|3754463|FG005|Phase 2|Administrative-Withdrew Consent|0
2144797|NCT01136733|3754464|FG006|Phase 2|Administrative-Withdrew Consent|0
2144798|NCT01136733|3754458|FG000|Phase 2|Other|0
2144799|NCT01136733|3754459|FG001|Phase 2|Other|0
2144800|NCT01136733|3754460|FG002|Phase 2|Other|0
2144801|NCT01136733|3754461|FG003|Phase 2|Other|0
2144802|NCT01136733|3754462|FG004|Phase 2|Other|6
2144803|NCT01136733|3754463|FG005|Phase 2|Other|7
2144804|NCT01136733|3754464|FG006|Phase 2|Other|6
2144805|NCT01136746|3754496|FG000|Overall Study|Lost to Follow-up|0
2144806|NCT01136746|3754497|FG001|Overall Study|Lost to Follow-up|2
2144807|NCT01136746|3754496|FG000|Overall Study|Protocol Violation|2
2144808|NCT01136746|3754497|FG001|Overall Study|Protocol Violation|1
2144809|NCT01136746|3754496|FG000|Overall Study|Death|1
2144810|NCT01136746|3754497|FG001|Overall Study|Death|0
2144811|NCT01136772|3754505|FG000|Overall Study|Adverse Event|15
2144812|NCT01136772|3754506|FG001|Overall Study|Adverse Event|14
2144813|NCT01136772|3754505|FG000|Overall Study|Lack of Efficacy|42
2144814|NCT01136772|3754506|FG001|Overall Study|Lack of Efficacy|39
2144815|NCT01136772|3754505|FG000|Overall Study|Administrative|14
2144816|NCT01136772|3754506|FG001|Overall Study|Administrative|12
2144817|NCT01136772|3754505|FG000|Overall Study|Withdrawal by Subject|33
2144818|NCT01136772|3754506|FG001|Overall Study|Withdrawal by Subject|36
2144819|NCT01136772|3754505|FG000|Overall Study|Did not receive injection|10
2144820|NCT01136772|3754506|FG001|Overall Study|Did not receive injection|7
2144821|NCT01136772|3754505|FG000|Overall Study|Did not follow up after first injection|2
2144822|NCT01136772|3754506|FG001|Overall Study|Did not follow up after first injection|2
2144823|NCT01136785|3754514|FG000|Overall Study|Protocol Violation|2
2144824|NCT01136785|3754515|FG001|Overall Study|Protocol Violation|1
2144825|NCT01136876|3754536|FG000|Overall Study|Lost to Follow-up|0
2144826|NCT01136876|3754537|FG001|Overall Study|Lost to Follow-up|1
2144827|NCT01136876|3754536|FG000|Overall Study|Physician Decision|3
2144828|NCT01136876|3754537|FG001|Overall Study|Physician Decision|5
2144829|NCT01136876|3754536|FG000|Overall Study|Missing NGAL measurement|2
2144830|NCT01136876|3754537|FG001|Overall Study|Missing NGAL measurement|5
2144831|NCT01136915|3754547|FG000|Overall Study|Lost to Follow-up|2
2144832|NCT01136915|3754548|FG001|Overall Study|Lost to Follow-up|0
2144833|NCT01136915|3754547|FG000|Overall Study|Exclusion criterion met|0
2144834|NCT01136915|3754548|FG001|Overall Study|Exclusion criterion met|1
2144835|NCT01136954|3754558|FG000|Overall Study|Adverse Event|3
2144836|NCT01136954|3754559|FG001|Overall Study|Adverse Event|2
2144837|NCT01136954|3754558|FG000|Overall Study|Withdrawal by Subject|6
2290094|NCT02484690|3982273|FG003|Overall Study|Adverse Event|0
2144838|NCT01136954|3754559|FG001|Overall Study|Withdrawal by Subject|2
2144839|NCT01136954|3754558|FG000|Overall Study|Lack of Efficacy|14
2144840|NCT01136954|3754559|FG001|Overall Study|Lack of Efficacy|13
2144841|NCT01136954|3754558|FG000|Overall Study|Physician Decision|0
2290095|NCT02484690|3982274|FG004|Overall Study|Adverse Event|5
2144842|NCT01136954|3754559|FG001|Overall Study|Physician Decision|1
2144843|NCT01136954|3754558|FG000|Overall Study|Other|1
2144844|NCT01136954|3754559|FG001|Overall Study|Other|3
2290096|NCT02484690|3982270|FG000|Overall Study|Death|0
2290097|NCT02484690|3982271|FG001|Overall Study|Death|0
2290098|NCT02484690|3982272|FG002|Overall Study|Death|0
2290099|NCT02484690|3982273|FG003|Overall Study|Death|0
2290100|NCT02484690|3982274|FG004|Overall Study|Death|1
2290101|NCT02484690|3982270|FG000|Overall Study|Withdrawal by Subject|1
2144845|NCT01137071|3754600|FG000|Overall Study|Disease Progression|11
2144846|NCT01137071|3754600|FG000|Overall Study|Withdrawal by Subject|2
2144847|NCT01137071|3754600|FG000|Overall Study|Wrongly Included|1
2144848|NCT01137110|3754611|FG000|Overall Study|Protocol Violation|1
2144849|NCT01137110|3754612|FG001|Overall Study|Protocol Violation|0
2144850|NCT01137292|3754618|FG000|Overall Study|Death|30
2144851|NCT01137292|3754618|FG000|Overall Study|Adverse Event|3
2144852|NCT01137292|3754618|FG000|Overall Study|Lack of Efficacy|13
2144853|NCT01137292|3754618|FG000|Overall Study|Lost to Follow-up|1
2144854|NCT01137292|3754618|FG000|Overall Study|Other|7
2144855|NCT01137435|3754640|FG000|Overall Study|Lost to Follow-up|24
2144856|NCT01137435|3754640|FG000|Overall Study|Off label usage|4
2144857|NCT01137474|3754648|FG000|Overall Study|Adverse Event|3
2144858|NCT01137474|3754649|FG001|Overall Study|Adverse Event|5
2144859|NCT01137474|3754650|FG002|Overall Study|Adverse Event|1
2144860|NCT01137474|3754651|FG003|Overall Study|Adverse Event|3
2144861|NCT01137474|3754648|FG000|Overall Study|Withdrawal by Subject|7
2144862|NCT01137474|3754649|FG001|Overall Study|Withdrawal by Subject|2
2144863|NCT01137474|3754650|FG002|Overall Study|Withdrawal by Subject|6
2144864|NCT01137474|3754651|FG003|Overall Study|Withdrawal by Subject|9
2144865|NCT01137474|3754648|FG000|Overall Study|No longer met study criteria|6
2144866|NCT01137474|3754649|FG001|Overall Study|No longer met study criteria|1
2144867|NCT01137474|3754650|FG002|Overall Study|No longer met study criteria|0
2144868|NCT01137474|3754651|FG003|Overall Study|No longer met study criteria|5
2144869|NCT01137474|3754648|FG000|Overall Study|Lost to Follow-up|5
2144870|NCT01137474|3754649|FG001|Overall Study|Lost to Follow-up|1
2144871|NCT01137474|3754650|FG002|Overall Study|Lost to Follow-up|0
2144872|NCT01137474|3754651|FG003|Overall Study|Lost to Follow-up|2
2144873|NCT01137474|3754648|FG000|Overall Study|Lack of Efficacy|0
2144874|NCT01137474|3754649|FG001|Overall Study|Lack of Efficacy|0
2144875|NCT01137474|3754650|FG002|Overall Study|Lack of Efficacy|0
2144876|NCT01137474|3754651|FG003|Overall Study|Lack of Efficacy|2
2144877|NCT01137474|3754648|FG000|Overall Study|Other|3
2144878|NCT01137474|3754649|FG001|Overall Study|Other|1
2144879|NCT01137474|3754650|FG002|Overall Study|Other|0
2144880|NCT01137474|3754651|FG003|Overall Study|Other|0
2144881|NCT01137474|3754648|FG000|Overall Study|Pregnancy|0
2144882|NCT01137474|3754649|FG001|Overall Study|Pregnancy|1
2144883|NCT01137474|3754650|FG002|Overall Study|Pregnancy|0
2144884|NCT01137474|3754651|FG003|Overall Study|Pregnancy|0
2144885|NCT01137474|3754648|FG000|Overall Study|Administrative reason by sponsor|0
2144886|NCT01137474|3754649|FG001|Overall Study|Administrative reason by sponsor|1
2144887|NCT01137474|3754650|FG002|Overall Study|Administrative reason by sponsor|0
2144888|NCT01137474|3754651|FG003|Overall Study|Administrative reason by sponsor|0
2144889|NCT01137578|3754665|FG000|Overall Study|Participant requested to Discontinue|3
2144890|NCT01137578|3754666|FG001|Overall Study|Participant requested to Discontinue|0
2144891|NCT01137578|3754667|FG002|Overall Study|Participant requested to Discontinue|0
2144892|NCT01137578|3754665|FG000|Overall Study|Withdrawal by Subject|1
2144893|NCT01137578|3754666|FG001|Overall Study|Withdrawal by Subject|0
2144894|NCT01137578|3754667|FG002|Overall Study|Withdrawal by Subject|0
2144895|NCT01137578|3754665|FG000|Overall Study|Other|12
2144896|NCT01137578|3754666|FG001|Overall Study|Other|2
2144897|NCT01137578|3754667|FG002|Overall Study|Other|6
2144898|NCT01137604|3754699|FG000|Overall Study|Adverse Event|1
2144899|NCT01137604|3754700|FG001|Overall Study|Adverse Event|6
2144900|NCT01137604|3754701|FG002|Overall Study|Adverse Event|9
2144901|NCT01137604|3754702|FG003|Overall Study|Adverse Event|9
2144902|NCT01137604|3754699|FG000|Overall Study|Withdrawal by Subject|0
2144903|NCT01137604|3754700|FG001|Overall Study|Withdrawal by Subject|2
2144904|NCT01137604|3754701|FG002|Overall Study|Withdrawal by Subject|2
2144905|NCT01137604|3754702|FG003|Overall Study|Withdrawal by Subject|1
2144906|NCT01137604|3754699|FG000|Overall Study|Clinical Progression|0
2144907|NCT01137604|3754700|FG001|Overall Study|Clinical Progression|2
2144908|NCT01137604|3754701|FG002|Overall Study|Clinical Progression|1
2144909|NCT01137604|3754702|FG003|Overall Study|Clinical Progression|0
2144910|NCT01137604|3754699|FG000|Overall Study|Participant's Decision|1
2144911|NCT01137604|3754700|FG001|Overall Study|Participant's Decision|0
2144912|NCT01137604|3754701|FG002|Overall Study|Participant's Decision|0
2144913|NCT01137604|3754702|FG003|Overall Study|Participant's Decision|0
2144914|NCT01137604|3754699|FG000|Overall Study|Clinical Decline|0
2144915|NCT01137604|3754700|FG001|Overall Study|Clinical Decline|0
2144916|NCT01137604|3754701|FG002|Overall Study|Clinical Decline|1
2144917|NCT01137604|3754702|FG003|Overall Study|Clinical Decline|1
2144918|NCT01137682|3754715|FG000|Overall Study|Adverse Event-CORE|2
2144919|NCT01137682|3754716|FG001|Overall Study|Adverse Event-CORE|4
2144920|NCT01137682|3754717|FG002|Overall Study|Adverse Event-CORE|0
2290102|NCT02484690|3982271|FG001|Overall Study|Withdrawal by Subject|3
2144921|NCT01137682|3754715|FG000|Overall Study|Withdrawal by Subject-CORE|2
2144922|NCT01137682|3754716|FG001|Overall Study|Withdrawal by Subject-CORE|2
2144923|NCT01137682|3754717|FG002|Overall Study|Withdrawal by Subject-CORE|2
2144924|NCT01137682|3754715|FG000|Overall Study|Administrative problems-CORE|2
2144925|NCT01137682|3754716|FG001|Overall Study|Administrative problems-CORE|1
2144926|NCT01137682|3754717|FG002|Overall Study|Administrative problems-CORE|0
2144927|NCT01137682|3754715|FG000|Overall Study|Protocol Violation-CORE|0
2144928|NCT01137682|3754716|FG001|Overall Study|Protocol Violation-CORE|1
2144929|NCT01137682|3754717|FG002|Overall Study|Protocol Violation-CORE|1
2290103|NCT02484690|3982272|FG002|Overall Study|Withdrawal by Subject|1
2290104|NCT02484690|3982273|FG003|Overall Study|Withdrawal by Subject|2
2290105|NCT02484690|3982274|FG004|Overall Study|Withdrawal by Subject|0
2290106|NCT02484690|3982270|FG000|Overall Study|Physician Decision|2
2290107|NCT02484690|3982271|FG001|Overall Study|Physician Decision|0
2290108|NCT02484690|3982272|FG002|Overall Study|Physician Decision|1
2290109|NCT02484690|3982273|FG003|Overall Study|Physician Decision|0
2290110|NCT02484690|3982274|FG004|Overall Study|Physician Decision|0
2290111|NCT02484690|3982270|FG000|Overall Study|Lost to Follow-up|0
2290112|NCT02484690|3982271|FG001|Overall Study|Lost to Follow-up|0
2144930|NCT01137682|3754715|FG000|Overall Study|Adverse Event-Extension|4
2144931|NCT01137682|3754716|FG001|Overall Study|Adverse Event-Extension|8
2144932|NCT01137682|3754717|FG002|Overall Study|Adverse Event-Extension|7
2144933|NCT01137682|3754715|FG000|Overall Study|Lack of Efficacy-Extension|15
2144934|NCT01137682|3754716|FG001|Overall Study|Lack of Efficacy-Extension|9
2144935|NCT01137682|3754717|FG002|Overall Study|Lack of Efficacy-Extension|13
2144936|NCT01137682|3754715|FG000|Overall Study|Withdrawal by Subject-Extension|6
2144937|NCT01137682|3754716|FG001|Overall Study|Withdrawal by Subject-Extension|8
2144938|NCT01137682|3754717|FG002|Overall Study|Withdrawal by Subject-Extension|8
2144939|NCT01137682|3754715|FG000|Overall Study|Lost to Follow Up-Extension|0
2144940|NCT01137682|3754716|FG001|Overall Study|Lost to Follow Up-Extension|1
2144941|NCT01137682|3754717|FG002|Overall Study|Lost to Follow Up-Extension|0
2144942|NCT01137682|3754715|FG000|Overall Study|Administrative problems-Extension|0
2144943|NCT01137682|3754716|FG001|Overall Study|Administrative problems-Extension|2
2144944|NCT01137682|3754717|FG002|Overall Study|Administrative problems-Extension|0
2144945|NCT01137682|3754715|FG000|Overall Study|Death-Extension|2
2144946|NCT01137682|3754716|FG001|Overall Study|Death-Extension|0
2144947|NCT01137682|3754717|FG002|Overall Study|Death-Extension|0
2144948|NCT01137682|3754715|FG000|Overall Study|Protocol Violation-Extension|2
2144949|NCT01137682|3754716|FG001|Overall Study|Protocol Violation-Extension|1
2144950|NCT01137682|3754717|FG002|Overall Study|Protocol Violation-Extension|0
2144951|NCT01137682|3754715|FG000|Overall Study|Did not enter extension|2
2144952|NCT01137682|3754716|FG001|Overall Study|Did not enter extension|3
2144953|NCT01137682|3754717|FG002|Overall Study|Did not enter extension|2
2144954|NCT01137682|3754715|FG000|Overall Study|Did not receive treatment in extension|0
2144955|NCT01137682|3754716|FG001|Overall Study|Did not receive treatment in extension|0
2144956|NCT01137682|3754717|FG002|Overall Study|Did not receive treatment in extension|1
2144957|NCT01137786|3754731|FG000|Overall Study|Lost to Follow-up|0
2144958|NCT01137786|3754732|FG001|Overall Study|Lost to Follow-up|2
2144959|NCT01137786|3754731|FG000|Overall Study|Withdrawal by Subject|1
2144960|NCT01137786|3754732|FG001|Overall Study|Withdrawal by Subject|1
2144961|NCT01137812|3754742|FG000|Overall Study|Adverse Event|21
2144962|NCT01137812|3754743|FG001|Overall Study|Adverse Event|14
2144963|NCT01137812|3754742|FG000|Overall Study|Lost to Follow-up|6
2144964|NCT01137812|3754743|FG001|Overall Study|Lost to Follow-up|8
2144965|NCT01137812|3754742|FG000|Overall Study|Physician Decision|25
2290113|NCT02484690|3982272|FG002|Overall Study|Lost to Follow-up|1
2290114|NCT02484690|3982273|FG003|Overall Study|Lost to Follow-up|0
2290115|NCT02484690|3982274|FG004|Overall Study|Lost to Follow-up|0
2290116|NCT02484729|3982297|FG000|Overall Study|Failure of IntelliCap Error|0
2290117|NCT02484729|3982298|FG001|Overall Study|Failure of IntelliCap Error|0
2290118|NCT02484729|3982299|FG002|Overall Study|Failure of IntelliCap Error|0
2290119|NCT02484729|3982300|FG003|Overall Study|Failure of IntelliCap Error|0
2290120|NCT02484729|3982301|FG004|Overall Study|Failure of IntelliCap Error|0
2290121|NCT02484729|3982302|FG005|Overall Study|Failure of IntelliCap Error|0
2290122|NCT02484729|3982303|FG006|Overall Study|Failure of IntelliCap Error|0
2290123|NCT02484729|3982304|FG007|Overall Study|Failure of IntelliCap Error|0
2290124|NCT02484729|3982305|FG008|Overall Study|Failure of IntelliCap Error|0
2290125|NCT02484729|3982306|FG009|Overall Study|Failure of IntelliCap Error|1
2290126|NCT02484911|3982383|FG000|Overall Study|Withdrawal by Subject|2
2290127|NCT02484911|3982384|FG001|Overall Study|Withdrawal by Subject|1
2290128|NCT02484911|3982383|FG000|Overall Study|Protocol Violation|2
2290129|NCT02484911|3982384|FG001|Overall Study|Protocol Violation|1
2290130|NCT02485158|3982391|FG000|Overall Study|Withdrawal by Subject|3
2290131|NCT02485158|3982391|FG000|Overall Study|expected drug side effect|1
2290132|NCT02485301|3982402|FG000|Overall Study|Serious Adverse Events|2
2290133|NCT02485301|3982403|FG001|Overall Study|Serious Adverse Events|1
2290134|NCT02485301|3982402|FG000|Overall Study|Protocol Violation|0
2290135|NCT02485301|3982403|FG001|Overall Study|Protocol Violation|1
2290136|NCT02485301|3982402|FG000|Overall Study|Withdrawal by Subject|6
2290137|NCT02485301|3982403|FG001|Overall Study|Withdrawal by Subject|7
2290138|NCT02485301|3982402|FG000|Overall Study|Migrated/moved from study area|10
2144966|NCT01137812|3754743|FG001|Overall Study|Physician Decision|17
2144967|NCT01137812|3754742|FG000|Overall Study|Protocol Violation|5
2144968|NCT01137812|3754743|FG001|Overall Study|Protocol Violation|4
2144969|NCT01137812|3754742|FG000|Overall Study|Withdrawal by Subject|5
2144970|NCT01137812|3754743|FG001|Overall Study|Withdrawal by Subject|13
2144971|NCT01137812|3754742|FG000|Overall Study|Death|2
2144972|NCT01137812|3754743|FG001|Overall Study|Death|0
2144973|NCT01137812|3754742|FG000|Overall Study|Patient met glycemic withdrawal criteria|40
2144974|NCT01137812|3754743|FG001|Overall Study|Patient met glycemic withdrawal criteria|85
2144975|NCT01137812|3754742|FG000|Overall Study|Other|19
2290139|NCT02485301|3982403|FG001|Overall Study|Migrated/moved from study area|19
2290140|NCT02485301|3982402|FG000|Overall Study|Lost to Follow-up|17
2290141|NCT02485301|3982403|FG001|Overall Study|Lost to Follow-up|17
2290142|NCT02485301|3982402|FG000|Overall Study|Other|3
2144976|NCT01137812|3754743|FG001|Overall Study|Other|27
2144977|NCT01138007|3754807|FG000|Overall Study|Adverse Event|4
2144978|NCT01138007|3754808|FG001|Overall Study|Adverse Event|12
2144979|NCT01138007|3754809|FG002|Overall Study|Adverse Event|9
2144980|NCT01138007|3754807|FG000|Overall Study|Lack of Efficacy|2
2144981|NCT01138007|3754808|FG001|Overall Study|Lack of Efficacy|0
2144982|NCT01138007|3754809|FG002|Overall Study|Lack of Efficacy|6
2144983|NCT01138007|3754807|FG000|Overall Study|Protocol Violation|2
2144984|NCT01138007|3754808|FG001|Overall Study|Protocol Violation|3
2144985|NCT01138007|3754809|FG002|Overall Study|Protocol Violation|2
2144986|NCT01138007|3754807|FG000|Overall Study|Protocol-Defined Stopping Criteria|6
2144987|NCT01138007|3754808|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
2144988|NCT01138007|3754809|FG002|Overall Study|Protocol-Defined Stopping Criteria|8
2144989|NCT01138007|3754807|FG000|Overall Study|Lost to Follow-up|3
2144990|NCT01138007|3754808|FG001|Overall Study|Lost to Follow-up|3
2144991|NCT01138007|3754809|FG002|Overall Study|Lost to Follow-up|5
2144992|NCT01138007|3754807|FG000|Overall Study|Physician Decision|0
2144993|NCT01138007|3754808|FG001|Overall Study|Physician Decision|5
2144994|NCT01138007|3754809|FG002|Overall Study|Physician Decision|3
2144995|NCT01138007|3754807|FG000|Overall Study|Withdrawal by Subject|5
2144996|NCT01138007|3754808|FG001|Overall Study|Withdrawal by Subject|6
2144997|NCT01138007|3754809|FG002|Overall Study|Withdrawal by Subject|15
2144998|NCT01138046|3754819|FG000|Overall Study|Withdrawal due to death|6
2144999|NCT01138111|3754832|FG000|Overall Study|Withdrawal by Subject|5
2145000|NCT01138111|3754832|FG000|Overall Study|Adverse Event|1
2145001|NCT01138111|3754832|FG000|Overall Study|Death|1
2145002|NCT01138111|3754832|FG000|Overall Study|Lost to Follow-up|2
2290143|NCT02485301|3982403|FG001|Overall Study|Other|4
2290144|NCT02485353|3982409|FG000|Overall Study|Death|1
2290145|NCT02485353|3982409|FG000|Overall Study|Disease Progression|1
2290146|NCT02485483|3982415|FG000|Overall Study|Depression at baseline|15
2290147|NCT02485483|3982416|FG001|Overall Study|Depression at baseline|0
2290148|NCT02485483|3982415|FG000|Overall Study|Discontinued after baseline|39
2290149|NCT02485483|3982416|FG001|Overall Study|Discontinued after baseline|0
2290150|NCT02485704|3982437|FG000|Overall Study|Lost to Follow-up|4
2290151|NCT02485704|3982438|FG001|Overall Study|Lost to Follow-up|5
2290152|NCT02485704|3982437|FG000|Overall Study|Withdrawal by Subject|0
2290153|NCT02485704|3982438|FG001|Overall Study|Withdrawal by Subject|3
2290154|NCT02485704|3982437|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1
2290155|NCT02485704|3982438|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0
2290156|NCT02485717|3982447|FG000|Overall Study|Lost to Follow-up|6
2290157|NCT02485717|3982448|FG001|Overall Study|Lost to Follow-up|0
2290158|NCT02485717|3982449|FG002|Overall Study|Lost to Follow-up|0
2290159|NCT02485717|3982447|FG000|Overall Study|Withdrawal by Subject|0
2290160|NCT02485717|3982448|FG001|Overall Study|Withdrawal by Subject|0
2290161|NCT02485717|3982449|FG002|Overall Study|Withdrawal by Subject|1
2290162|NCT02485717|3982447|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0
2290163|NCT02485717|3982448|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1
2290164|NCT02485717|3982449|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0
2290165|NCT02485717|3982447|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0
2290166|NCT02485717|3982448|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1
2290167|NCT02485717|3982449|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0
2290168|NCT02485925|3982472|FG000|Overall Study|Withdrawal by Subject|3
2290169|NCT02485925|3982472|FG000|Overall Study|Death|1
2290170|NCT02485925|3982472|FG000|Overall Study|Lost to Follow-up|11
2290171|NCT02486302|3982509|FG000|Overall Study|Discontinued prematurely|410
2290172|NCT02486302|3982509|FG000|Overall Study|Documentation not completed|255
2290173|NCT02486302|3982509|FG000|Overall Study|Excluded due to legal reasons|8
2290174|NCT02486302|3982509|FG000|Overall Study|Not treated|3
2290175|NCT02486406|3982535|FG000|Overall Study|Withdrew consent|1
2290176|NCT02486406|3982536|FG001|Overall Study|Withdrew consent|0
2290177|NCT02486406|3982537|FG002|Overall Study|Withdrew consent|0
2290178|NCT02486406|3982538|FG003|Overall Study|Withdrew consent|1
2290179|NCT02486406|3982535|FG000|Overall Study|Lost to Follow-up|1
2290180|NCT02486406|3982536|FG001|Overall Study|Lost to Follow-up|3
2290181|NCT02486406|3982537|FG002|Overall Study|Lost to Follow-up|1
2290182|NCT02486406|3982538|FG003|Overall Study|Lost to Follow-up|3
2145003|NCT01138150|3754878|FG000|Overall Study|blood unable to be processed|0
2290183|NCT02486406|3982535|FG000|Overall Study|Other, not specified|0
2290184|NCT02486406|3982536|FG001|Overall Study|Other, not specified|0
2145004|NCT01138150|3754879|FG001|Overall Study|blood unable to be processed|1
2145005|NCT01138150|3754878|FG000|Overall Study|Physician Decision|1
2145006|NCT01138150|3754879|FG001|Overall Study|Physician Decision|0
2145007|NCT01138501|3754914|FG000|Overall Study|Protocol Violation|2
2145008|NCT01138501|3754914|FG000|Overall Study|Withdrawal by Subject|3
2145009|NCT01138657|3754934|FG000|Overall Study|Adverse Event|3
2145010|NCT01138657|3754935|FG001|Overall Study|Adverse Event|10
2145011|NCT01138657|3754934|FG000|Overall Study|Lack of Efficacy|2
2145012|NCT01138657|3754935|FG001|Overall Study|Lack of Efficacy|1
2145013|NCT01138657|3754934|FG000|Overall Study|Lost to Follow-up|0
2145014|NCT01138657|3754935|FG001|Overall Study|Lost to Follow-up|3
2145015|NCT01138657|3754934|FG000|Overall Study|Miscellaneous Reasons|3
2145016|NCT01138657|3754935|FG001|Overall Study|Miscellaneous Reasons|4
2145017|NCT01138826|3754952|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1
2145018|NCT01138826|3754953|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1
2145019|NCT01138826|3754954|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0
2145020|NCT01138826|3754955|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0
2145021|NCT01138826|3754956|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1
2145022|NCT01138826|3754957|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0
2145023|NCT01139008|3754992|FG000|Overall Study|Withdrawal by Subject|5
2145024|NCT01139008|3754992|FG000|Overall Study|Non-compliant, lost product|1
2145025|NCT01139021|3755005|FG000|Overall Study|Adverse Event|0
2145026|NCT01139021|3755006|FG001|Overall Study|Adverse Event|0
2145027|NCT01139021|3755007|FG002|Overall Study|Adverse Event|0
2145028|NCT01139021|3755008|FG003|Overall Study|Adverse Event|0
2145029|NCT01139021|3755009|FG004|Overall Study|Adverse Event|1
2145030|NCT01139021|3755010|FG005|Overall Study|Adverse Event|0
2145031|NCT01139021|3755005|FG000|Overall Study|Lost to Follow-up|0
2145032|NCT01139021|3755006|FG001|Overall Study|Lost to Follow-up|0
2145033|NCT01139021|3755007|FG002|Overall Study|Lost to Follow-up|0
2145034|NCT01139021|3755008|FG003|Overall Study|Lost to Follow-up|0
2145035|NCT01139021|3755009|FG004|Overall Study|Lost to Follow-up|2
2145036|NCT01139021|3755010|FG005|Overall Study|Lost to Follow-up|0
2145037|NCT01139021|3755005|FG000|Overall Study|Protocol Violation|1
2145038|NCT01139021|3755006|FG001|Overall Study|Protocol Violation|0
2145039|NCT01139021|3755007|FG002|Overall Study|Protocol Violation|0
2145040|NCT01139021|3755008|FG003|Overall Study|Protocol Violation|0
2145041|NCT01139021|3755009|FG004|Overall Study|Protocol Violation|2
2145042|NCT01139021|3755010|FG005|Overall Study|Protocol Violation|0
2145043|NCT01139021|3755005|FG000|Overall Study|Withdrawal by Subject|0
2145044|NCT01139021|3755006|FG001|Overall Study|Withdrawal by Subject|0
2145045|NCT01139021|3755007|FG002|Overall Study|Withdrawal by Subject|0
2145046|NCT01139021|3755008|FG003|Overall Study|Withdrawal by Subject|1
2145047|NCT01139021|3755009|FG004|Overall Study|Withdrawal by Subject|4
2145048|NCT01139021|3755010|FG005|Overall Study|Withdrawal by Subject|0
2145049|NCT01139047|3755025|FG000|Overall Study|Withdrawal by Subject|1
2145050|NCT01139164|3755035|FG000|Overall Study|Withdrawn prior to study start|0
2145051|NCT01139164|3755036|FG001|Overall Study|Withdrawn prior to study start|2
2145052|NCT01139164|3755037|FG002|Overall Study|Withdrawn prior to study start|0
2145053|NCT01139450|3755068|FG000|Overall Study|Withdrawal by Subject|7
2145054|NCT01139450|3755069|FG001|Overall Study|Withdrawal by Subject|10
2145055|NCT01139450|3755070|FG002|Overall Study|Withdrawal by Subject|13
2145056|NCT01139450|3755068|FG000|Overall Study|Lack of Efficacy|3
2145057|NCT01139450|3755069|FG001|Overall Study|Lack of Efficacy|1
2145058|NCT01139450|3755070|FG002|Overall Study|Lack of Efficacy|8
2145059|NCT01139450|3755068|FG000|Overall Study|Protocol Violation|6
2145060|NCT01139450|3755069|FG001|Overall Study|Protocol Violation|5
2145061|NCT01139450|3755070|FG002|Overall Study|Protocol Violation|2
2145062|NCT01139450|3755068|FG000|Overall Study|Lost to Follow-up|9
2145063|NCT01139450|3755069|FG001|Overall Study|Lost to Follow-up|7
2145064|NCT01139450|3755070|FG002|Overall Study|Lost to Follow-up|11
2145065|NCT01139450|3755068|FG000|Overall Study|Administrative|0
2145066|NCT01139450|3755069|FG001|Overall Study|Administrative|0
2145067|NCT01139450|3755070|FG002|Overall Study|Administrative|1
2145068|NCT01139450|3755068|FG000|Overall Study|Adverse Event|2
2145069|NCT01139450|3755069|FG001|Overall Study|Adverse Event|2
2145070|NCT01139450|3755070|FG002|Overall Study|Adverse Event|3
2145071|NCT01139580|3755093|FG000|Overall Study|Adverse Event|5
2145072|NCT01139580|3755094|FG001|Overall Study|Adverse Event|4
2145073|NCT01139580|3755093|FG000|Overall Study|Lost to Follow-up|9
2145074|NCT01139580|3755094|FG001|Overall Study|Lost to Follow-up|1
2145075|NCT01139580|3755093|FG000|Overall Study|Lack of Efficacy|0
2145076|NCT01139580|3755094|FG001|Overall Study|Lack of Efficacy|2
2145077|NCT01139580|3755093|FG000|Overall Study|Withdrawal by Subject|6
2145078|NCT01139580|3755094|FG001|Overall Study|Withdrawal by Subject|9
2145079|NCT01139580|3755093|FG000|Overall Study|Used Excluded Medicine After Enrollment|1
2145080|NCT01139580|3755094|FG001|Overall Study|Used Excluded Medicine After Enrollment|0
2290185|NCT02486406|3982537|FG002|Overall Study|Other, not specified|1
2145081|NCT01139580|3755093|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
2145082|NCT01139580|3755094|FG001|Overall Study|Did Not Meet Exclusion Criteria|0
2145083|NCT01139580|3755093|FG000|Overall Study|Misrandomized|1
2145084|NCT01139580|3755094|FG001|Overall Study|Misrandomized|0
2145085|NCT01139580|3755093|FG000|Overall Study|Beginning Study Exclusion Treatment|0
2145086|NCT01139580|3755094|FG001|Overall Study|Beginning Study Exclusion Treatment|1
2145087|NCT01139580|3755093|FG000|Overall Study|Participant Randomization in Error|0
2145088|NCT01139580|3755094|FG001|Overall Study|Participant Randomization in Error|1
2145089|NCT01139658|3755102|FG000|Overall Study|Adverse Event|10
2145090|NCT01139658|3755103|FG001|Overall Study|Adverse Event|27
2145091|NCT01139658|3755102|FG000|Overall Study|Lack of Efficacy|15
2145092|NCT01139658|3755103|FG001|Overall Study|Lack of Efficacy|7
2145093|NCT01139658|3755102|FG000|Overall Study|Withdrawal by Subject|2
2145094|NCT01139658|3755103|FG001|Overall Study|Withdrawal by Subject|4
2145095|NCT01139658|3755102|FG000|Overall Study|No documentation of treatment|1
2145096|NCT01139658|3755103|FG001|Overall Study|No documentation of treatment|0
2290186|NCT02486406|3982538|FG003|Overall Study|Other, not specified|0
2290187|NCT02486588|3982576|FG000|Overall Study|Randomized in error- ineligible|738
2290188|NCT02486588|3982577|FG001|Overall Study|Randomized in error- ineligible|750
2290189|NCT02486588|3982578|FG002|Overall Study|Randomized in error- ineligible|755
2290190|NCT02486588|3982579|FG003|Overall Study|Randomized in error- ineligible|738
2290191|NCT02486588|3982580|FG004|Overall Study|Randomized in error- ineligible|746
2145097|NCT01139658|3755102|FG000|Overall Study|Other|28
2145098|NCT01139658|3755103|FG001|Overall Study|Other|75
2145099|NCT01139762|3755111|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
2145100|NCT01139762|3755112|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
2145101|NCT01139762|3755113|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
2145102|NCT01139762|3755111|FG000|Washout and Placebo Lead-In Period|Adverse Event|1
2145103|NCT01139762|3755112|FG001|Washout and Placebo Lead-In Period|Adverse Event|0
2145104|NCT01139762|3755113|FG002|Washout and Placebo Lead-In Period|Adverse Event|0
2145105|NCT01139762|3755111|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
2145106|NCT01139762|3755112|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
2145107|NCT01139762|3755113|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
2145108|NCT01139762|3755111|FG000|Washout and Placebo Lead-In Period|Physician Decision|12
2145109|NCT01139762|3755112|FG001|Washout and Placebo Lead-In Period|Physician Decision|0
2145110|NCT01139762|3755113|FG002|Washout and Placebo Lead-In Period|Physician Decision|0
2145111|NCT01139762|3755111|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10
2145112|NCT01139762|3755112|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0
2145113|NCT01139762|3755113|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0
2145114|NCT01139762|3755111|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10
2145115|NCT01139762|3755112|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0
2145116|NCT01139762|3755113|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0
2145117|NCT01139762|3755111|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0
2145118|NCT01139762|3755112|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4
2290192|NCT02486588|3982581|FG005|Overall Study|Randomized in error- ineligible|746
2290193|NCT02486627|3982602|FG000|Overall Study|Death|1
2290194|NCT02486627|3982603|FG001|Overall Study|Death|0
2290195|NCT02486627|3982602|FG000|Overall Study|Other Unspecified|0
2290196|NCT02486627|3982603|FG001|Overall Study|Other Unspecified|2
2290197|NCT02486627|3982602|FG000|Overall Study|Consent Withdrawn by Participant|4
2290198|NCT02486627|3982603|FG001|Overall Study|Consent Withdrawn by Participant|3
2290199|NCT02486627|3982602|FG000|Overall Study|Significant Participant Noncompliance|1
2290200|NCT02486627|3982603|FG001|Overall Study|Significant Participant Noncompliance|1
2290201|NCT02486627|3982602|FG000|Overall Study|Lost to Follow-up|1
2290202|NCT02486627|3982603|FG001|Overall Study|Lost to Follow-up|3
2290203|NCT02486653|3982611|FG000|Overall Study|Withdrawal by Subject|1
2290204|NCT02486653|3982612|FG001|Overall Study|Withdrawal by Subject|3
2290205|NCT02486653|3982611|FG000|Overall Study|Protocol Violation|1
2290206|NCT02486653|3982612|FG001|Overall Study|Protocol Violation|0
2290207|NCT02486653|3982611|FG000|Overall Study|surgery cancelled|4
2290208|NCT02486653|3982612|FG001|Overall Study|surgery cancelled|1
2290209|NCT02486692|3982620|FG000|Overall Study|did not login for randomization|4
2290210|NCT02486692|3982621|FG001|Overall Study|did not login for randomization|7
2290211|NCT02486757|3982627|FG000|Overall Study|Lost to Follow-up|1
2290212|NCT02486796|3982633|FG000|Overall Study|Withdrawal by Subject|1
2290213|NCT02486796|3982634|FG001|Overall Study|Withdrawal by Subject|1
2290214|NCT02486796|3982633|FG000|Overall Study|Physician Decision|1
2290215|NCT02486796|3982634|FG001|Overall Study|Physician Decision|0
2290216|NCT02486952|3982649|FG000|Overall Study|Not Started Induction Therapy|3
2290217|NCT02486952|3982649|FG000|Overall Study|Adverse Event|1
2290218|NCT02486952|3982649|FG000|Overall Study|Death|15
2290219|NCT02486952|3982649|FG000|Overall Study|Lack of Efficacy|3
2290220|NCT02486952|3982649|FG000|Overall Study|Lost to Follow-up|26
2290221|NCT02486952|3982649|FG000|Overall Study|Other|2
2290222|NCT02487030|3982660|FG000|Overall Study|Lack of Efficacy|2
2290223|NCT02487030|3982661|FG001|Overall Study|Lack of Efficacy|4
2290224|NCT02487030|3982662|FG002|Overall Study|Lack of Efficacy|1
2290225|NCT02487030|3982663|FG003|Overall Study|Lack of Efficacy|0
2290226|NCT02487030|3982664|FG004|Overall Study|Lack of Efficacy|1
2290227|NCT02487030|3982665|FG005|Overall Study|Lack of Efficacy|0
2290228|NCT02487030|3982666|FG006|Overall Study|Lack of Efficacy|0
2290229|NCT02487030|3982660|FG000|Overall Study|Lost to Follow-up|0
2290230|NCT02487030|3982661|FG001|Overall Study|Lost to Follow-up|0
2290231|NCT02487030|3982662|FG002|Overall Study|Lost to Follow-up|1
2290232|NCT02487030|3982663|FG003|Overall Study|Lost to Follow-up|1
2290233|NCT02487030|3982664|FG004|Overall Study|Lost to Follow-up|0
2145119|NCT01139762|3755113|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10
2145120|NCT01139762|3755111|FG000|Double-Blind Randomized Active Treatment|Death|0
2145121|NCT01139762|3755112|FG001|Double-Blind Randomized Active Treatment|Death|1
2145122|NCT01139762|3755113|FG002|Double-Blind Randomized Active Treatment|Death|1
2145123|NCT01139762|3755111|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
2145124|NCT01139762|3755112|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
2145125|NCT01139762|3755113|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
2145126|NCT01139762|3755111|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0
2145127|NCT01139762|3755112|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2
2145128|NCT01139762|3755113|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8
2145129|NCT01139762|3755111|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
2145130|NCT01139762|3755112|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
2145131|NCT01139762|3755113|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
2145132|NCT01139762|3755111|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0
2145133|NCT01139762|3755112|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2
2145134|NCT01139762|3755113|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0
2145135|NCT01139762|3755111|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0
2145136|NCT01139762|3755112|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5
2145137|NCT01139762|3755113|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6
2145138|NCT01139762|3755111|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
2145139|NCT01139762|3755112|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
2145140|NCT01139762|3755113|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
2145141|NCT01139762|3755111|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
2145142|NCT01139762|3755112|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
2145143|NCT01139762|3755113|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
2145144|NCT01139775|3755123|FG000|Overall Study|Adverse Event|0
2145145|NCT01139775|3755124|FG001|Overall Study|Adverse Event|6
2145146|NCT01139775|3755125|FG002|Overall Study|Adverse Event|2
2145147|NCT01139775|3755123|FG000|Overall Study|Protocol Violation|0
2145148|NCT01139775|3755124|FG001|Overall Study|Protocol Violation|5
2145149|NCT01139775|3755125|FG002|Overall Study|Protocol Violation|0
2145150|NCT01139775|3755123|FG000|Overall Study|Withdrawal by Subject|1
2145151|NCT01139775|3755124|FG001|Overall Study|Withdrawal by Subject|0
2145152|NCT01139775|3755125|FG002|Overall Study|Withdrawal by Subject|2
2145153|NCT01139775|3755123|FG000|Overall Study|Physician Decision|0
2145154|NCT01139775|3755124|FG001|Overall Study|Physician Decision|2
2145155|NCT01139775|3755125|FG002|Overall Study|Physician Decision|2
2145156|NCT01140061|3755165|FG000|Part I|Adverse Event|1
2145157|NCT01140061|3755166|FG001|Part I|Adverse Event|0
2145158|NCT01140061|3755167|FG002|Part I|Adverse Event|0
2145159|NCT01140061|3755168|FG003|Part I|Adverse Event|0
2145160|NCT01140061|3755169|FG004|Part I|Adverse Event|0
2145161|NCT01140061|3755170|FG005|Part I|Adverse Event|0
2145162|NCT01140061|3755171|FG006|Part I|Adverse Event|0
2145163|NCT01140061|3755172|FG007|Part I|Adverse Event|0
2145164|NCT01140061|3755173|FG008|Part I|Adverse Event|0
2145165|NCT01140061|3755174|FG009|Part I|Adverse Event|0
2145166|NCT01140061|3755165|FG000|Extension|Laboratory Adverse Event|0
2145167|NCT01140061|3755166|FG001|Extension|Laboratory Adverse Event|0
2145168|NCT01140061|3755167|FG002|Extension|Laboratory Adverse Event|0
2145169|NCT01140061|3755168|FG003|Extension|Laboratory Adverse Event|0
2145170|NCT01140061|3755169|FG004|Extension|Laboratory Adverse Event|0
2145171|NCT01140061|3755170|FG005|Extension|Laboratory Adverse Event|0
2145172|NCT01140061|3755171|FG006|Extension|Laboratory Adverse Event|0
2145173|NCT01140061|3755172|FG007|Extension|Laboratory Adverse Event|0
2145174|NCT01140061|3755173|FG008|Extension|Laboratory Adverse Event|0
2145175|NCT01140061|3755174|FG009|Extension|Laboratory Adverse Event|1
2145176|NCT01140347|3755206|FG000|Overall Study|Lost to Follow-up|5
2145177|NCT01140347|3755207|FG001|Overall Study|Lost to Follow-up|6
2145178|NCT01140347|3755206|FG000|Overall Study|Withdrawal by Subject|13
2145179|NCT01140347|3755207|FG001|Overall Study|Withdrawal by Subject|8
2178838|NCT01389102|3803915|FG003|Overall Study|Withdrawal by Subject|2
2178839|NCT01389102|3803916|FG004|Overall Study|Withdrawal by Subject|3
2178840|NCT01389102|3803917|FG005|Overall Study|Withdrawal by Subject|3
2178841|NCT01389102|3803912|FG000|Overall Study|Subject Traveling Out of Country|0
2178842|NCT01389102|3803913|FG001|Overall Study|Subject Traveling Out of Country|0
2178843|NCT01389102|3803914|FG002|Overall Study|Subject Traveling Out of Country|0
2178844|NCT01389102|3803915|FG003|Overall Study|Subject Traveling Out of Country|1
2178845|NCT01389102|3803916|FG004|Overall Study|Subject Traveling Out of Country|0
2178846|NCT01389102|3803917|FG005|Overall Study|Subject Traveling Out of Country|0
2178847|NCT01389102|3803912|FG000|Overall Study|Subject Moved|2
2178848|NCT01389102|3803913|FG001|Overall Study|Subject Moved|0
2178849|NCT01389102|3803914|FG002|Overall Study|Subject Moved|1
2178850|NCT01389102|3803915|FG003|Overall Study|Subject Moved|0
2178851|NCT01389102|3803916|FG004|Overall Study|Subject Moved|0
2178852|NCT01389102|3803917|FG005|Overall Study|Subject Moved|0
2178853|NCT01389102|3803912|FG000|Overall Study|Unavailable due to husband's illness|0
2178854|NCT01389102|3803913|FG001|Overall Study|Unavailable due to husband's illness|1
2145180|NCT01140477|3755219|FG000|Overall Study|Lost to Follow-up|4
2145181|NCT01140477|3755220|FG001|Overall Study|Lost to Follow-up|0
2145182|NCT01140477|3755219|FG000|Overall Study|Withdrawal by Subject|1
2145183|NCT01140477|3755220|FG001|Overall Study|Withdrawal by Subject|4
2145184|NCT01140477|3755219|FG000|Overall Study|Surgical complication preventing implant|2
2145185|NCT01140477|3755220|FG001|Overall Study|Surgical complication preventing implant|0
2145186|NCT01140477|3755219|FG000|Overall Study|Death|1
2145187|NCT01140477|3755220|FG001|Overall Study|Death|1
2145188|NCT01140477|3755219|FG000|Overall Study|Subject explanted|0
2145189|NCT01140477|3755220|FG001|Overall Study|Subject explanted|1
2145190|NCT01140503|3755226|FG000|Overall Study|Withdrawal by Subject|1
2145191|NCT01140568|3755230|FG000|Overall Study|disease progression|31
2145192|NCT01140568|3755230|FG000|Overall Study|Withdrawal by Subject|1
2145193|NCT01140568|3755230|FG000|Overall Study|Screen Fail|4
2145194|NCT01140646|3755234|FG000|Overall Study|Adverse Event|4
2145195|NCT01140646|3755234|FG000|Overall Study|Refused Further Treatment|5
2145196|NCT01140880|3755251|FG000|Overall Study|Death|0
2145197|NCT01140880|3755252|FG001|Overall Study|Death|1
2145198|NCT01140880|3755251|FG000|Overall Study|Withdrawal by Subject|6
2145199|NCT01140880|3755252|FG001|Overall Study|Withdrawal by Subject|3
2145200|NCT01140880|3755251|FG000|Overall Study|Lost to Follow-up|8
2145201|NCT01140880|3755252|FG001|Overall Study|Lost to Follow-up|10
2145202|NCT01140880|3755251|FG000|Overall Study|Protocol Violation|0
2145203|NCT01140880|3755252|FG001|Overall Study|Protocol Violation|30
2145204|NCT01140906|3755262|FG000|Overall Study|Adverse Event|7
2145205|NCT01140906|3755263|FG001|Overall Study|Adverse Event|10
2145206|NCT01140906|3755264|FG002|Overall Study|Adverse Event|17
2145207|NCT01140906|3755265|FG003|Overall Study|Adverse Event|7
2145208|NCT01140906|3755262|FG000|Overall Study|Lack of Efficacy|6
2145209|NCT01140906|3755263|FG001|Overall Study|Lack of Efficacy|8
2145210|NCT01140906|3755264|FG002|Overall Study|Lack of Efficacy|2
2145211|NCT01140906|3755265|FG003|Overall Study|Lack of Efficacy|1
2145212|NCT01140906|3755262|FG000|Overall Study|Non-compliance|0
2145213|NCT01140906|3755263|FG001|Overall Study|Non-compliance|1
2145214|NCT01140906|3755264|FG002|Overall Study|Non-compliance|0
2145215|NCT01140906|3755265|FG003|Overall Study|Non-compliance|1
2145216|NCT01140906|3755262|FG000|Overall Study|Protocol Violation|5
2145217|NCT01140906|3755263|FG001|Overall Study|Protocol Violation|3
2145218|NCT01140906|3755264|FG002|Overall Study|Protocol Violation|2
2145219|NCT01140906|3755265|FG003|Overall Study|Protocol Violation|1
2145220|NCT01140906|3755262|FG000|Overall Study|Withdrawal of consent|6
2145221|NCT01140906|3755263|FG001|Overall Study|Withdrawal of consent|6
2145222|NCT01140906|3755264|FG002|Overall Study|Withdrawal of consent|2
2145223|NCT01140906|3755265|FG003|Overall Study|Withdrawal of consent|2
2145224|NCT01140906|3755262|FG000|Overall Study|Lost to Follow-up|1
2145225|NCT01140906|3755263|FG001|Overall Study|Lost to Follow-up|1
2145226|NCT01140906|3755264|FG002|Overall Study|Lost to Follow-up|0
2145227|NCT01140906|3755265|FG003|Overall Study|Lost to Follow-up|2
2145228|NCT01140906|3755262|FG000|Overall Study|Administrative or other reason|0
2145229|NCT01140906|3755263|FG001|Overall Study|Administrative or other reason|5
2145230|NCT01140906|3755264|FG002|Overall Study|Administrative or other reason|3
2145231|NCT01140906|3755265|FG003|Overall Study|Administrative or other reason|2
2145232|NCT01141205|3755290|FG000|Overall Study|Physician Decision|1
2145233|NCT01141205|3755291|FG001|Overall Study|Physician Decision|1
2145234|NCT01141205|3755290|FG000|Overall Study|Lost to Follow-up|1
2145235|NCT01141205|3755291|FG001|Overall Study|Lost to Follow-up|0
2145236|NCT01141205|3755290|FG000|Overall Study|Withdrawal by Subject|1
2145237|NCT01141205|3755291|FG001|Overall Study|Withdrawal by Subject|1
2145238|NCT01141283|3755301|FG000|Overall Study|Adverse Event|56
2145239|NCT01141283|3755301|FG000|Overall Study|Lost to Follow-up|4
2145240|NCT01141283|3755301|FG000|Overall Study|Withdrawal by Subject|14
2145241|NCT01141283|3755301|FG000|Overall Study|Administrative|4
2145242|NCT01141283|3755301|FG000|Overall Study|Lack of Efficacy|10
2145243|NCT01141478|3755322|FG000|Overall Study|Withdrawal by Subject|1
2145244|NCT01141478|3755323|FG001|Overall Study|Withdrawal by Subject|1
2145245|NCT01141660|3755366|FG000|Overall Study|Physician Decision|0
2145246|NCT01141660|3755367|FG001|Overall Study|Physician Decision|12
2145247|NCT01142089|3755393|FG000|Overall Study|Physician Decision|1
2145248|NCT01142089|3755394|FG001|Overall Study|Physician Decision|0
2145249|NCT01142089|3755393|FG000|Overall Study|Withdrawal by Subject|1
2145250|NCT01142089|3755394|FG001|Overall Study|Withdrawal by Subject|2
2145251|NCT01142089|3755393|FG000|Overall Study|Use of prohibited medications|0
2145252|NCT01142089|3755394|FG001|Overall Study|Use of prohibited medications|1
2145253|NCT01142089|3755393|FG000|Overall Study|Noncompliance with study procedures|2
2145254|NCT01142089|3755394|FG001|Overall Study|Noncompliance with study procedures|1
2145255|NCT01142089|3755393|FG000|Overall Study|Patient required rescue medication|8
2145256|NCT01142089|3755394|FG001|Overall Study|Patient required rescue medication|17
2145257|NCT01142115|3755400|FG000|First Intervention|Lack of Efficacy|1
2145258|NCT01142115|3755401|FG001|First Intervention|Lack of Efficacy|1
2145259|NCT01142115|3755400|FG000|First Intervention|Adverse Event|1
2145260|NCT01142115|3755401|FG001|First Intervention|Adverse Event|0
2145261|NCT01142193|3755408|FG000|Overall Study|Adverse Event|12
2145262|NCT01142193|3755409|FG001|Overall Study|Adverse Event|4
2145263|NCT01142193|3755408|FG000|Overall Study|Lack of Efficacy|2
2145264|NCT01142193|3755409|FG001|Overall Study|Lack of Efficacy|1
2145265|NCT01142193|3755408|FG000|Overall Study|Physician Decision|1
2145266|NCT01142193|3755409|FG001|Overall Study|Physician Decision|1
2145267|NCT01142193|3755408|FG000|Overall Study|Withdrawal by Subject|4
2145268|NCT01142193|3755409|FG001|Overall Study|Withdrawal by Subject|3
2145269|NCT01142193|3755408|FG000|Overall Study|Protocol Discontinuation Criterion Met|1
2145270|NCT01142193|3755409|FG001|Overall Study|Protocol Discontinuation Criterion Met|0
2145271|NCT01142193|3755408|FG000|Overall Study|Other|1
2145272|NCT01142193|3755409|FG001|Overall Study|Other|2
2145273|NCT01142232|3755420|FG000|Overall Study|Adverse Event|1
2145274|NCT01142232|3755421|FG001|Overall Study|Adverse Event|2
2145275|NCT01142232|3755422|FG002|Overall Study|Adverse Event|1
2145276|NCT01142232|3755423|FG003|Overall Study|Adverse Event|0
2145277|NCT01142232|3755424|FG004|Overall Study|Adverse Event|4
2145278|NCT01142232|3755420|FG000|Overall Study|Death|0
2145279|NCT01142232|3755421|FG001|Overall Study|Death|0
2145280|NCT01142232|3755422|FG002|Overall Study|Death|0
2145281|NCT01142232|3755423|FG003|Overall Study|Death|0
2145282|NCT01142232|3755424|FG004|Overall Study|Death|1
2145283|NCT01142232|3755420|FG000|Overall Study|Disease Progression|2
2290234|NCT02487030|3982665|FG005|Overall Study|Lost to Follow-up|1
2290235|NCT02487030|3982666|FG006|Overall Study|Lost to Follow-up|0
2290236|NCT02487030|3982660|FG000|Overall Study|Adverse Event|0
2290237|NCT02487030|3982661|FG001|Overall Study|Adverse Event|0
2290238|NCT02487030|3982662|FG002|Overall Study|Adverse Event|0
2290239|NCT02487030|3982663|FG003|Overall Study|Adverse Event|1
2290240|NCT02487030|3982664|FG004|Overall Study|Adverse Event|0
2145284|NCT01142232|3755421|FG001|Overall Study|Disease Progression|0
2145285|NCT01142232|3755422|FG002|Overall Study|Disease Progression|1
2145286|NCT01142232|3755423|FG003|Overall Study|Disease Progression|2
2145287|NCT01142232|3755424|FG004|Overall Study|Disease Progression|12
2145288|NCT01142232|3755420|FG000|Overall Study|Withdrawal by Subject|0
2145289|NCT01142232|3755421|FG001|Overall Study|Withdrawal by Subject|0
2145290|NCT01142232|3755422|FG002|Overall Study|Withdrawal by Subject|0
2145291|NCT01142232|3755423|FG003|Overall Study|Withdrawal by Subject|1
2145292|NCT01142232|3755424|FG004|Overall Study|Withdrawal by Subject|3
2145293|NCT01142232|3755420|FG000|Overall Study|Physician Decision|0
2145294|NCT01142232|3755421|FG001|Overall Study|Physician Decision|1
2145295|NCT01142232|3755422|FG002|Overall Study|Physician Decision|0
2145296|NCT01142232|3755423|FG003|Overall Study|Physician Decision|2
2145297|NCT01142232|3755424|FG004|Overall Study|Physician Decision|10
2145298|NCT01142232|3755420|FG000|Overall Study|Alternative Therapy|0
2145299|NCT01142232|3755421|FG001|Overall Study|Alternative Therapy|1
2145300|NCT01142232|3755422|FG002|Overall Study|Alternative Therapy|1
2145301|NCT01142232|3755423|FG003|Overall Study|Alternative Therapy|0
2145302|NCT01142232|3755424|FG004|Overall Study|Alternative Therapy|1
2145303|NCT01142232|3755420|FG000|Overall Study|Off Trt for other complicating disease|0
2145304|NCT01142232|3755421|FG001|Overall Study|Off Trt for other complicating disease|0
2145305|NCT01142232|3755422|FG002|Overall Study|Off Trt for other complicating disease|0
2145306|NCT01142232|3755423|FG003|Overall Study|Off Trt for other complicating disease|0
2145307|NCT01142232|3755424|FG004|Overall Study|Off Trt for other complicating disease|1
2145308|NCT01142232|3755420|FG000|Overall Study|Noncompliance|0
2145309|NCT01142232|3755421|FG001|Overall Study|Noncompliance|0
2145310|NCT01142232|3755422|FG002|Overall Study|Noncompliance|0
2145311|NCT01142232|3755423|FG003|Overall Study|Noncompliance|0
2145312|NCT01142232|3755424|FG004|Overall Study|Noncompliance|2
2145313|NCT01142336|3755460|FG000|Overall Study|Adverse Event|1
2145314|NCT01142336|3755461|FG001|Overall Study|Adverse Event|1
2145315|NCT01142336|3755460|FG000|Overall Study|Lost to Follow-up|0
2145316|NCT01142336|3755461|FG001|Overall Study|Lost to Follow-up|1
2145317|NCT01142388|3755472|FG000|Overall Study|Lack of Efficacy|21
2145318|NCT01142388|3755473|FG001|Overall Study|Lack of Efficacy|31
2145319|NCT01142388|3755472|FG000|Overall Study|Adverse Event|9
2145320|NCT01142388|3755473|FG001|Overall Study|Adverse Event|5
2145321|NCT01142388|3755472|FG000|Overall Study|Death|3
2145322|NCT01142388|3755473|FG001|Overall Study|Death|2
2145323|NCT01142388|3755472|FG000|Overall Study|Withdrawal by Subject|5
2145324|NCT01142388|3755473|FG001|Overall Study|Withdrawal by Subject|3
2145325|NCT01142388|3755472|FG000|Overall Study|Alternative therapy|1
2145326|NCT01142388|3755473|FG001|Overall Study|Alternative therapy|0
2145327|NCT01142388|3755472|FG000|Overall Study|Other complications|0
2145328|NCT01142388|3755473|FG001|Overall Study|Other complications|2
2145329|NCT01142388|3755472|FG000|Overall Study|Other|1
2145330|NCT01142388|3755473|FG001|Overall Study|Other|1
2145331|NCT01142388|3755472|FG000|Overall Study|Never started therapy|7
2145332|NCT01142388|3755473|FG001|Overall Study|Never started therapy|3
2145333|NCT01142466|3755481|FG000|Overall Study|Adverse Event|2
2145334|NCT01142466|3755482|FG001|Overall Study|Adverse Event|1
2145335|NCT01142466|3755481|FG000|Overall Study|Withdrawal by Subject|1
2145336|NCT01142466|3755482|FG001|Overall Study|Withdrawal by Subject|1
2145337|NCT01142661|3755488|FG000|Overall Study|Adverse Event|2
2145338|NCT01142661|3755488|FG000|Overall Study|Withdrawal by Subject|1
2145339|NCT01142661|3755488|FG000|Overall Study|Physician Decision|1
2145340|NCT01142726|3755495|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
2145341|NCT01142726|3755496|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
2145342|NCT01142726|3755497|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
2145343|NCT01142726|3755495|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
2145344|NCT01142726|3755496|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
2145345|NCT01142726|3755497|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
2145346|NCT01142726|3755495|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
2145347|NCT01142726|3755496|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
2145348|NCT01142726|3755497|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
2145349|NCT01142726|3755495|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
2145350|NCT01142726|3755496|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
2145351|NCT01142726|3755497|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
2145352|NCT01142726|3755495|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
2145353|NCT01142726|3755496|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
2145354|NCT01142726|3755497|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
2145355|NCT01142726|3755495|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
2145356|NCT01142726|3755496|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
2145357|NCT01142726|3755497|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
2145358|NCT01142726|3755495|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
2145359|NCT01142726|3755496|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
2145360|NCT01142726|3755497|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
2145361|NCT01142726|3755495|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
2145362|NCT01142726|3755496|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
2145363|NCT01142726|3755497|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
2145364|NCT01142726|3755495|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
2145365|NCT01142726|3755496|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
2145366|NCT01142726|3755497|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
2145367|NCT01142726|3755495|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
2145368|NCT01142726|3755496|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
2145369|NCT01142726|3755497|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
2145370|NCT01142726|3755495|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
2145371|NCT01142726|3755496|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
2145372|NCT01142726|3755497|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
2145373|NCT01142726|3755495|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0
2145374|NCT01142726|3755496|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1
2145375|NCT01142726|3755497|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1
2145376|NCT01142726|3755495|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
2145377|NCT01142726|3755496|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
2145378|NCT01142726|3755497|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
2145379|NCT01142726|3755495|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
2145380|NCT01142726|3755496|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
2145381|NCT01142726|3755497|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
2145382|NCT01142726|3755495|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
2145383|NCT01142726|3755496|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
2145384|NCT01142726|3755497|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
2145385|NCT01142726|3755495|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
2145386|NCT01142726|3755496|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
2145387|NCT01142726|3755497|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
2145388|NCT01142791|3755513|FG000|Overall Study|Alternative Treatment|1
2145389|NCT01142791|3755514|FG001|Overall Study|Alternative Treatment|0
2208031|NCT01635920|3847392|FG001|Overall Study|Subject decision|0
2208032|NCT01635933|3847401|FG000|Overall Study|Adverse Event|1
2145390|NCT01142791|3755513|FG000|Overall Study|Lost to Follow-up|1
2145391|NCT01142791|3755514|FG001|Overall Study|Lost to Follow-up|0
2145392|NCT01142791|3755513|FG000|Overall Study|Withdrawal by Subject|5
2145393|NCT01142791|3755514|FG001|Overall Study|Withdrawal by Subject|0
2145394|NCT01142791|3755513|FG000|Overall Study|Received only 1 sonication|0
2145395|NCT01142791|3755514|FG001|Overall Study|Received only 1 sonication|6
2145396|NCT01142908|3755520|FG000|Overall Study|Lost to Follow-up|19
2145397|NCT01142908|3755521|FG001|Overall Study|Lost to Follow-up|13
2145398|NCT01142908|3755520|FG000|Overall Study|Death|1
2145399|NCT01142908|3755521|FG001|Overall Study|Death|4
2145400|NCT01142908|3755520|FG000|Overall Study|Excluded - did not meet criteria|9
2145401|NCT01142908|3755521|FG001|Overall Study|Excluded - did not meet criteria|5
2145402|NCT01142908|3755520|FG000|Overall Study|Withdrawal by Subject|3
2145403|NCT01142908|3755521|FG001|Overall Study|Withdrawal by Subject|0
2145404|NCT01143038|3755531|FG000|Overall Study|Withdrawal by Subject|4
2145405|NCT01143038|3755531|FG000|Overall Study|Requirement for alternative therapy|5
2145406|NCT01143038|3755531|FG000|Overall Study|Adverse Event|3
2145407|NCT01143038|3755531|FG000|Overall Study|Lost to Follow-up|2
2145408|NCT01143038|3755531|FG000|Overall Study|Protocol Deviation|1
2145409|NCT01143038|3755531|FG000|Overall Study|Death|1
2145410|NCT01143051|3755541|FG000|3-14 Day Washout|Withdrawal by Subject|0
2145411|NCT01143051|3755542|FG001|3-14 Day Washout|Withdrawal by Subject|0
2145412|NCT01143051|3755543|FG002|3-14 Day Washout|Withdrawal by Subject|1
2145413|NCT01143051|3755544|FG003|3-14 Day Washout|Withdrawal by Subject|0
2145414|NCT01143051|3755545|FG004|3-14 Day Washout|Withdrawal by Subject|0
2145415|NCT01143051|3755546|FG005|3-14 Day Washout|Withdrawal by Subject|0
2145416|NCT01143051|3755541|FG000|3-14 Day Washout|Withdrawal by Subject|0
2145417|NCT01143051|3755542|FG001|3-14 Day Washout|Withdrawal by Subject|0
2145418|NCT01143051|3755543|FG002|3-14 Day Washout|Withdrawal by Subject|0
2145419|NCT01143051|3755544|FG003|3-14 Day Washout|Withdrawal by Subject|0
2145420|NCT01143051|3755545|FG004|3-14 Day Washout|Withdrawal by Subject|0
2145421|NCT01143051|3755546|FG005|3-14 Day Washout|Withdrawal by Subject|1
2145422|NCT01143077|3755559|FG000|Overall Study|Lack of Efficacy|0
2145423|NCT01143077|3755560|FG001|Overall Study|Lack of Efficacy|2
2145424|NCT01143077|3755561|FG002|Overall Study|Lack of Efficacy|1
2145425|NCT01143077|3755559|FG000|Overall Study|Adverse Event|5
2145426|NCT01143077|3755560|FG001|Overall Study|Adverse Event|6
2145427|NCT01143077|3755561|FG002|Overall Study|Adverse Event|5
2145428|NCT01143077|3755559|FG000|Overall Study|Lost to Follow-up|2
2145429|NCT01143077|3755560|FG001|Overall Study|Lost to Follow-up|3
2145430|NCT01143077|3755561|FG002|Overall Study|Lost to Follow-up|4
2145431|NCT01143077|3755559|FG000|Overall Study|Protocol Violation|2
2145432|NCT01143077|3755560|FG001|Overall Study|Protocol Violation|0
2145433|NCT01143077|3755561|FG002|Overall Study|Protocol Violation|0
2145434|NCT01143077|3755559|FG000|Overall Study|Withdrawal by Subject|4
2145435|NCT01143077|3755560|FG001|Overall Study|Withdrawal by Subject|3
2145436|NCT01143077|3755561|FG002|Overall Study|Withdrawal by Subject|3
2145437|NCT01143077|3755559|FG000|Overall Study|Non-compliance with study drug|0
2145438|NCT01143077|3755560|FG001|Overall Study|Non-compliance with study drug|1
2145439|NCT01143077|3755561|FG002|Overall Study|Non-compliance with study drug|1
2145440|NCT01143077|3755559|FG000|Overall Study|Administrative|1
2145441|NCT01143077|3755560|FG001|Overall Study|Administrative|0
2145442|NCT01143077|3755561|FG002|Overall Study|Administrative|0
2145443|NCT01143077|3755559|FG000|Overall Study|Principal Investigator Decision|2
2145444|NCT01143077|3755560|FG001|Overall Study|Principal Investigator Decision|0
2145445|NCT01143077|3755561|FG002|Overall Study|Principal Investigator Decision|1
2145446|NCT01143090|3755569|FG000|Overall Study|Lack of Efficacy|2
2145447|NCT01143090|3755569|FG000|Overall Study|Adverse Event|17
2145448|NCT01143090|3755569|FG000|Overall Study|Lost to Follow-up|9
2145449|NCT01143090|3755569|FG000|Overall Study|Protocol Violation|2
2145450|NCT01143090|3755569|FG000|Overall Study|Withdrawal by Subject|18
2145451|NCT01143090|3755569|FG000|Overall Study|Non-compliance with study drug|1
2145452|NCT01143090|3755569|FG000|Overall Study|Failure to meet eligibility criteria|1
2145453|NCT01143090|3755569|FG000|Overall Study|Administrative|1
2145454|NCT01143207|3755599|FG000|Overall Study|Lost to Follow-up|2
2145455|NCT01143259|3755605|FG000|Overall Study|Withdrawal by Subject|3
2145456|NCT01143259|3755606|FG001|Overall Study|Withdrawal by Subject|2
2145457|NCT01143259|3755605|FG000|Overall Study|Protocol Violation|13
2145458|NCT01143259|3755606|FG001|Overall Study|Protocol Violation|9
2145459|NCT01143259|3755605|FG000|Overall Study|Screen Failure|7
2145460|NCT01143259|3755606|FG001|Overall Study|Screen Failure|9
2145461|NCT01143324|3755621|FG000|Overall Study|Lost to Follow-up|11
2145462|NCT01143324|3755621|FG000|Overall Study|Withdrawal by Subject|4
2145463|NCT01143324|3755621|FG000|Overall Study|Explant of the device|4
2145464|NCT01143337|3755627|FG000|Overall Study|Adverse Event|3
2145465|NCT01143337|3755628|FG001|Overall Study|Adverse Event|9
2145466|NCT01143337|3755629|FG002|Overall Study|Adverse Event|5
2145467|NCT01143337|3755627|FG000|Overall Study|Lack of Efficacy|6
2290241|NCT02487030|3982665|FG005|Overall Study|Adverse Event|0
2145468|NCT01143337|3755628|FG001|Overall Study|Lack of Efficacy|2
2145469|NCT01143337|3755629|FG002|Overall Study|Lack of Efficacy|1
2145470|NCT01143337|3755627|FG000|Overall Study|Protocol Violation|1
2145471|NCT01143337|3755628|FG001|Overall Study|Protocol Violation|0
2145472|NCT01143337|3755629|FG002|Overall Study|Protocol Violation|0
2145473|NCT01143337|3755627|FG000|Overall Study|Withdrawal by Subject|0
2145474|NCT01143337|3755628|FG001|Overall Study|Withdrawal by Subject|0
2145475|NCT01143337|3755629|FG002|Overall Study|Withdrawal by Subject|1
2145476|NCT01143337|3755627|FG000|Overall Study|Other reason|0
2145477|NCT01143337|3755628|FG001|Overall Study|Other reason|0
2145478|NCT01143337|3755629|FG002|Overall Study|Other reason|5
2208033|NCT01635933|3847402|FG001|Overall Study|Adverse Event|0
2290242|NCT02487030|3982666|FG006|Overall Study|Adverse Event|0
2145479|NCT01143389|3755637|FG000|Overall Study|Lost to Follow-up|26
2145480|NCT01143389|3755638|FG001|Overall Study|Lost to Follow-up|25
2145481|NCT01143402|3755647|FG000|Overall Study|Rapid clinical decline|1
2145482|NCT01143402|3755648|FG001|Overall Study|Rapid clinical decline|1
2145483|NCT01143402|3755649|FG002|Overall Study|Rapid clinical decline|0
2145484|NCT01143402|3755647|FG000|Overall Study|Not Treated|0
2145485|NCT01143402|3755648|FG001|Overall Study|Not Treated|0
2145486|NCT01143402|3755649|FG002|Overall Study|Not Treated|1
2145487|NCT01143714|3755726|FG000|Overall Study|Adverse Event|4
2145488|NCT01143714|3755727|FG001|Overall Study|Adverse Event|2
2145489|NCT01143714|3755726|FG000|Overall Study|Withdrawal by Subject|1
2145490|NCT01143714|3755727|FG001|Overall Study|Withdrawal by Subject|0
2145491|NCT01143714|3755726|FG000|Overall Study|Subject non-compliance|0
2145492|NCT01143714|3755727|FG001|Overall Study|Subject non-compliance|1
2145493|NCT01143714|3755726|FG000|Overall Study|wound closed = deemed healed|1
2290243|NCT02487030|3982660|FG000|Overall Study|Death|0
2145494|NCT01143714|3755727|FG001|Overall Study|wound closed = deemed healed|0
2145495|NCT01143714|3755726|FG000|Overall Study|wound size increased|1
2145496|NCT01143714|3755727|FG001|Overall Study|wound size increased|0
2145497|NCT01143896|3755805|FG000|Overall Study|Did not complete Baseline Interview|5
2145498|NCT01143896|3755806|FG001|Overall Study|Did not complete Baseline Interview|4
2145499|NCT01143896|3755805|FG000|Overall Study|Lost to Follow-up|18
2145500|NCT01143896|3755806|FG001|Overall Study|Lost to Follow-up|13
2145501|NCT01143896|3755805|FG000|Overall Study|Withdrawal by Subject|13
2145502|NCT01143896|3755806|FG001|Overall Study|Withdrawal by Subject|5
2145503|NCT01143896|3755805|FG000|Overall Study|Death|6
2145504|NCT01143896|3755806|FG001|Overall Study|Death|3
2145505|NCT01144052|3755824|FG000|Overall Study|Withdrawal by Subject|1
2145506|NCT01144052|3755825|FG001|Overall Study|Withdrawal by Subject|1
2145507|NCT01144182|3755852|FG000|Overall Study|Death|5
2145508|NCT01144182|3755853|FG001|Overall Study|Death|6
2145509|NCT01144182|3755852|FG000|Overall Study|Withdrawal by Subject|3
2145510|NCT01144182|3755853|FG001|Overall Study|Withdrawal by Subject|6
2145511|NCT01144182|3755852|FG000|Overall Study|Lost to Follow-up|9
2145512|NCT01144182|3755853|FG001|Overall Study|Lost to Follow-up|9
2145513|NCT01144299|3755879|FG000|Overall Study|Lost to Follow-up|1
2145514|NCT01144299|3755880|FG001|Overall Study|Lost to Follow-up|0
2145515|NCT01144299|3755879|FG000|Overall Study|Withdrawal by Subject|1
2145516|NCT01144299|3755880|FG001|Overall Study|Withdrawal by Subject|0
2145517|NCT01144364|3755897|FG000|Induction Phase|Disease progression|14
2145518|NCT01144364|3755898|FG001|Induction Phase|Disease progression|0
2145519|NCT01144364|3755899|FG002|Induction Phase|Disease progression|0
2145520|NCT01144364|3755897|FG000|Induction Phase|Adverse Event|9
2145521|NCT01144364|3755898|FG001|Induction Phase|Adverse Event|0
2145522|NCT01144364|3755899|FG002|Induction Phase|Adverse Event|0
2145523|NCT01144364|3755897|FG000|Induction Phase|Death|1
2145524|NCT01144364|3755898|FG001|Induction Phase|Death|0
2145525|NCT01144364|3755899|FG002|Induction Phase|Death|0
2145526|NCT01144364|3755897|FG000|Induction Phase|Withdrawal by Subject|1
2145527|NCT01144364|3755898|FG001|Induction Phase|Withdrawal by Subject|0
2145528|NCT01144364|3755899|FG002|Induction Phase|Withdrawal by Subject|0
2145529|NCT01144364|3755897|FG000|Induction Phase|Lost to Follow-up|2
2145530|NCT01144364|3755898|FG001|Induction Phase|Lost to Follow-up|0
2145531|NCT01144364|3755899|FG002|Induction Phase|Lost to Follow-up|0
2145532|NCT01144364|3755897|FG000|Induction Phase|Physician Decision|1
2145533|NCT01144364|3755898|FG001|Induction Phase|Physician Decision|0
2145534|NCT01144364|3755899|FG002|Induction Phase|Physician Decision|0
2145535|NCT01144364|3755897|FG000|Induction Phase|Stable disease|2
2145536|NCT01144364|3755898|FG001|Induction Phase|Stable disease|0
2145537|NCT01144364|3755899|FG002|Induction Phase|Stable disease|0
2145538|NCT01144364|3755897|FG000|Induction Phase|Secondary neoplasia|1
2145539|NCT01144364|3755898|FG001|Induction Phase|Secondary neoplasia|0
2145540|NCT01144364|3755899|FG002|Induction Phase|Secondary neoplasia|0
2290244|NCT02487030|3982661|FG001|Overall Study|Death|0
2290245|NCT02487030|3982662|FG002|Overall Study|Death|0
2145541|NCT01144364|3755897|FG000|Induction Phase|Protocol Violation|1
2145542|NCT01144364|3755898|FG001|Induction Phase|Protocol Violation|0
2145543|NCT01144364|3755899|FG002|Induction Phase|Protocol Violation|0
2145544|NCT01144364|3755897|FG000|Follow-Up/Maintenance Phase|Disease progression|0
2145545|NCT01144364|3755898|FG001|Follow-Up/Maintenance Phase|Disease progression|23
2145546|NCT01144364|3755899|FG002|Follow-Up/Maintenance Phase|Disease progression|29
2145547|NCT01144364|3755897|FG000|Follow-Up/Maintenance Phase|Adverse Event|0
2145548|NCT01144364|3755898|FG001|Follow-Up/Maintenance Phase|Adverse Event|3
2145549|NCT01144364|3755899|FG002|Follow-Up/Maintenance Phase|Adverse Event|1
2145550|NCT01144364|3755897|FG000|Follow-Up/Maintenance Phase|Death|0
2145551|NCT01144364|3755898|FG001|Follow-Up/Maintenance Phase|Death|2
2145552|NCT01144364|3755899|FG002|Follow-Up/Maintenance Phase|Death|0
2145553|NCT01144364|3755897|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
2145554|NCT01144364|3755898|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
2145555|NCT01144364|3755899|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
2145556|NCT01144364|3755897|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0
2145557|NCT01144364|3755898|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1
2145558|NCT01144364|3755899|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4
2145559|NCT01144364|3755897|FG000|Follow-Up/Maintenance Phase|Relapse|0
2145560|NCT01144364|3755898|FG001|Follow-Up/Maintenance Phase|Relapse|5
2145561|NCT01144364|3755899|FG002|Follow-Up/Maintenance Phase|Relapse|5
2145562|NCT01144364|3755897|FG000|Follow-Up/Maintenance Phase|Physician Decision|0
2145563|NCT01144364|3755898|FG001|Follow-Up/Maintenance Phase|Physician Decision|0
2145564|NCT01144364|3755899|FG002|Follow-Up/Maintenance Phase|Physician Decision|1
2145565|NCT01144377|3755914|FG000|52 Week Treatment Period|Adverse Event|0
2145566|NCT01144377|3755915|FG001|52 Week Treatment Period|Adverse Event|0
2145567|NCT01144377|3755916|FG002|52 Week Treatment Period|Adverse Event|3
2145568|NCT01144377|3755917|FG003|52 Week Treatment Period|Adverse Event|2
2145569|NCT01144377|3755918|FG004|52 Week Treatment Period|Adverse Event|1
2145570|NCT01144377|3755914|FG000|52 Week Treatment Period|Entry Criteria Not Met|0
2145571|NCT01144377|3755915|FG001|52 Week Treatment Period|Entry Criteria Not Met|0
2145572|NCT01144377|3755916|FG002|52 Week Treatment Period|Entry Criteria Not Met|1
2290246|NCT02487030|3982663|FG003|Overall Study|Death|0
2290247|NCT02487030|3982664|FG004|Overall Study|Death|1
2145573|NCT01144377|3755917|FG003|52 Week Treatment Period|Entry Criteria Not Met|1
2145574|NCT01144377|3755918|FG004|52 Week Treatment Period|Entry Criteria Not Met|0
2145575|NCT01144377|3755914|FG000|52 Week Treatment Period|Protocol Violation|0
2145576|NCT01144377|3755915|FG001|52 Week Treatment Period|Protocol Violation|0
2145577|NCT01144377|3755916|FG002|52 Week Treatment Period|Protocol Violation|0
2145578|NCT01144377|3755917|FG003|52 Week Treatment Period|Protocol Violation|0
2145579|NCT01144377|3755918|FG004|52 Week Treatment Period|Protocol Violation|1
2145580|NCT01144377|3755914|FG000|52 Week Treatment Period|Lost to Follow-up|1
2145581|NCT01144377|3755915|FG001|52 Week Treatment Period|Lost to Follow-up|0
2145582|NCT01144377|3755916|FG002|52 Week Treatment Period|Lost to Follow-up|0
2145583|NCT01144377|3755917|FG003|52 Week Treatment Period|Lost to Follow-up|0
2145584|NCT01144377|3755918|FG004|52 Week Treatment Period|Lost to Follow-up|0
2145585|NCT01144377|3755914|FG000|52 Week Treatment Period|Withdrawal by Subject|4
2145586|NCT01144377|3755915|FG001|52 Week Treatment Period|Withdrawal by Subject|1
2145587|NCT01144377|3755916|FG002|52 Week Treatment Period|Withdrawal by Subject|1
2145588|NCT01144377|3755917|FG003|52 Week Treatment Period|Withdrawal by Subject|1
2145589|NCT01144377|3755918|FG004|52 Week Treatment Period|Withdrawal by Subject|0
2145590|NCT01144377|3755914|FG000|52 Week Treatment Period|Sponsor Decision|0
2145591|NCT01144377|3755915|FG001|52 Week Treatment Period|Sponsor Decision|0
2145592|NCT01144377|3755916|FG002|52 Week Treatment Period|Sponsor Decision|0
2145593|NCT01144377|3755917|FG003|52 Week Treatment Period|Sponsor Decision|0
2145594|NCT01144377|3755918|FG004|52 Week Treatment Period|Sponsor Decision|1
2145595|NCT01144377|3755914|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0
2145596|NCT01144377|3755915|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1
2145597|NCT01144377|3755916|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0
2145598|NCT01144377|3755917|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0
2145599|NCT01144377|3755918|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1
2145600|NCT01144377|3755914|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2145601|NCT01144377|3755915|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2145602|NCT01144377|3755916|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2145603|NCT01144377|3755917|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2290248|NCT02487030|3982665|FG005|Overall Study|Death|0
2290249|NCT02487030|3982666|FG006|Overall Study|Death|0
2290250|NCT02487199|3982690|FG000|Overall Study|Withdrew Consent|0
2290251|NCT02487199|3982691|FG001|Overall Study|Withdrew Consent|1
2290252|NCT02487446|3982722|FG000|Period 1|Physician Decision|0
2290253|NCT02487446|3982723|FG001|Period 1|Physician Decision|1
2145604|NCT01144377|3755918|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
2145605|NCT01144377|3755914|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
2145606|NCT01144377|3755915|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2145607|NCT01144377|3755916|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2145608|NCT01144377|3755917|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2145609|NCT01144377|3755918|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2145610|NCT01144403|3755932|FG000|Overall Study|Lost to Follow-up|3
2145611|NCT01144403|3755932|FG000|Overall Study|Death|1
2145612|NCT01144403|3755932|FG000|Overall Study|Adverse Event|1
2145613|NCT01144663|3756004|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2
2145614|NCT01144663|3756005|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0
2145615|NCT01144663|3756006|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1
2145616|NCT01144663|3756007|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0
2145617|NCT01144663|3756004|FG000|Primary Vaccination Phase|Adverse Event|1
2145618|NCT01144663|3756005|FG001|Primary Vaccination Phase|Adverse Event|0
2145619|NCT01144663|3756006|FG002|Primary Vaccination Phase|Adverse Event|0
2145620|NCT01144663|3756007|FG003|Primary Vaccination Phase|Adverse Event|1
2145621|NCT01144663|3756004|FG000|Primary Vaccination Phase|Protocol Violation|2
2145622|NCT01144663|3756005|FG001|Primary Vaccination Phase|Protocol Violation|0
2145623|NCT01144663|3756006|FG002|Primary Vaccination Phase|Protocol Violation|1
2145624|NCT01144663|3756007|FG003|Primary Vaccination Phase|Protocol Violation|0
2145625|NCT01144663|3756004|FG000|Primary Vaccination Phase|Withdrawal by Subject|9
2145626|NCT01144663|3756005|FG001|Primary Vaccination Phase|Withdrawal by Subject|5
2145627|NCT01144663|3756006|FG002|Primary Vaccination Phase|Withdrawal by Subject|3
2145628|NCT01144663|3756007|FG003|Primary Vaccination Phase|Withdrawal by Subject|10
2145629|NCT01144663|3756004|FG000|Primary Vaccination Phase|Migrated/moved from study area|4
2145630|NCT01144663|3756005|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
2145631|NCT01144663|3756006|FG002|Primary Vaccination Phase|Migrated/moved from study area|2
2145632|NCT01144663|3756007|FG003|Primary Vaccination Phase|Migrated/moved from study area|3
2145633|NCT01144663|3756004|FG000|Primary Vaccination Phase|Lost to Follow-up|2
2290254|NCT02487446|3982722|FG000|Period 1|Lack of Efficacy|1
2290255|NCT02487446|3982723|FG001|Period 1|Lack of Efficacy|0
2290256|NCT02487446|3982722|FG000|Period 1|Protocol deviation|3
2290257|NCT02487446|3982723|FG001|Period 1|Protocol deviation|2
2290258|NCT02487446|3982722|FG000|Period 1|Lost to Follow-up|2
2290259|NCT02487446|3982723|FG001|Period 1|Lost to Follow-up|0
2290260|NCT02487446|3982722|FG000|Period 1|Withdrawal by Subject|2
2290261|NCT02487446|3982723|FG001|Period 1|Withdrawal by Subject|0
2290262|NCT02487446|3982722|FG000|Period 1|Adverse Event|5
2290263|NCT02487446|3982723|FG001|Period 1|Adverse Event|5
2145634|NCT01144663|3756005|FG001|Primary Vaccination Phase|Lost to Follow-up|0
2145635|NCT01144663|3756006|FG002|Primary Vaccination Phase|Lost to Follow-up|1
2145636|NCT01144663|3756007|FG003|Primary Vaccination Phase|Lost to Follow-up|2
2145637|NCT01144663|3756004|FG000|Primary Vaccination Phase|Other|0
2145638|NCT01144663|3756005|FG001|Primary Vaccination Phase|Other|1
2145639|NCT01144663|3756006|FG002|Primary Vaccination Phase|Other|0
2145640|NCT01144663|3756007|FG003|Primary Vaccination Phase|Other|2
2145641|NCT01144663|3756004|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
2145642|NCT01144663|3756005|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
2145643|NCT01144663|3756006|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
2145644|NCT01144663|3756007|FG003|Booster Vaccination Phase|Withdrawal by Subject|1
2145645|NCT01144663|3756004|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
2145646|NCT01144663|3756005|FG001|Booster Vaccination Phase|Migrated/moved from study area|1
2145647|NCT01144663|3756006|FG002|Booster Vaccination Phase|Migrated/moved from study area|1
2145648|NCT01144663|3756007|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
2145649|NCT01144663|3756004|FG000|Booster Vaccination Phase|Lost to Follow-up|2
2145650|NCT01144663|3756005|FG001|Booster Vaccination Phase|Lost to Follow-up|1
2145651|NCT01144663|3756006|FG002|Booster Vaccination Phase|Lost to Follow-up|3
2145652|NCT01144663|3756007|FG003|Booster Vaccination Phase|Lost to Follow-up|0
2145653|NCT01144663|3756004|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
2145654|NCT01144663|3756005|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
2145655|NCT01144663|3756006|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
2145656|NCT01144663|3756007|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
2145657|NCT01144663|3756004|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
2145658|NCT01144663|3756005|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
2145659|NCT01144663|3756006|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
2145660|NCT01144663|3756007|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
2145661|NCT01144663|3756004|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
2145662|NCT01144663|3756005|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
2145663|NCT01144663|3756006|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
2145664|NCT01144663|3756007|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
2145665|NCT01144715|3756019|FG000|Overall Study|Lost to Follow-up|2
2145666|NCT01144715|3756020|FG001|Overall Study|Lost to Follow-up|1
2145667|NCT01144715|3756019|FG000|Overall Study|Withdrawal by Subject|2
2145668|NCT01144715|3756020|FG001|Overall Study|Withdrawal by Subject|1
2145669|NCT01144715|3756019|FG000|Overall Study|Adverse Event|0
2145670|NCT01144715|3756020|FG001|Overall Study|Adverse Event|1
2145671|NCT01145053|3756052|FG000|Overall Study|Adverse Event|22
2145672|NCT01145053|3756052|FG000|Overall Study|Lost to Follow-up|28
2145673|NCT01145053|3756052|FG000|Overall Study|Withdrawal by Subject|25
2145674|NCT01145053|3756052|FG000|Overall Study|Other|18
2145675|NCT01145066|3756059|FG000|Overall Study|To resume NSAIDs|2
2145676|NCT01145066|3756060|FG001|Overall Study|To resume NSAIDs|2
2145677|NCT01145066|3756061|FG002|Overall Study|To resume NSAIDs|1
2145678|NCT01145066|3756059|FG000|Overall Study|Non-related surgery|0
2145679|NCT01145066|3756060|FG001|Overall Study|Non-related surgery|0
2145680|NCT01145066|3756061|FG002|Overall Study|Non-related surgery|1
2145681|NCT01145066|3756059|FG000|Overall Study|Withdrawal by Subject|0
2145682|NCT01145066|3756060|FG001|Overall Study|Withdrawal by Subject|0
2145683|NCT01145066|3756061|FG002|Overall Study|Withdrawal by Subject|2
2145684|NCT01145066|3756059|FG000|Overall Study|To start new med|1
2145685|NCT01145066|3756060|FG001|Overall Study|To start new med|0
2208034|NCT01635933|3847401|FG000|Overall Study|Lost to Follow-up|0
2208035|NCT01635933|3847402|FG001|Overall Study|Lost to Follow-up|5
2208036|NCT01635933|3847401|FG000|Overall Study|Subject decision|1
2208037|NCT01635933|3847402|FG001|Overall Study|Subject decision|1
2208038|NCT01635933|3847401|FG000|Overall Study|Noncompliance|0
2208039|NCT01635933|3847402|FG001|Overall Study|Noncompliance|1
2208040|NCT01635933|3847401|FG000|Overall Study|No longer had transportation|0
2290264|NCT02487446|3982722|FG000|Washout|Lost to Follow-up|0
2290265|NCT02487446|3982723|FG001|Washout|Lost to Follow-up|2
2290266|NCT02487446|3982722|FG000|Washout|Withdrawal by Subject|1
2290267|NCT02487446|3982723|FG001|Washout|Withdrawal by Subject|4
2290268|NCT02487446|3982722|FG000|Washout|Adverse Event|2
2290269|NCT02487446|3982723|FG001|Washout|Adverse Event|2
2290270|NCT02487446|3982722|FG000|Period 2|Protocol deviation|0
2290271|NCT02487446|3982723|FG001|Period 2|Protocol deviation|1
2290272|NCT02487446|3982722|FG000|Period 2|Lost to Follow-up|1
2290273|NCT02487446|3982723|FG001|Period 2|Lost to Follow-up|1
2290274|NCT02487446|3982722|FG000|Period 2|Withdrawal by Subject|1
2290275|NCT02487446|3982723|FG001|Period 2|Withdrawal by Subject|1
2290276|NCT02487446|3982722|FG000|Period 2|Adverse Event|6
2290277|NCT02487446|3982723|FG001|Period 2|Adverse Event|2
2290278|NCT02487472|3982730|FG000|Overall Study|Did not complete telephonic interviews|9
2290279|NCT02487472|3982730|FG000|Overall Study|Other|2
2321049|NCT02954458|4035304|FG001|Overall Study|Other|0
2321050|NCT02954458|4035305|FG002|Overall Study|Other|0
2208041|NCT01635933|3847402|FG001|Overall Study|No longer had transportation|1
2208042|NCT01635998|3847410|FG000|Overall Study|Death|1
2208043|NCT01635998|3847411|FG001|Overall Study|Death|1
2208044|NCT01635998|3847410|FG000|Overall Study|Lost to Follow-up|2
2145686|NCT01145066|3756061|FG002|Overall Study|To start new med|0
2145687|NCT01145066|3756059|FG000|Overall Study|problems swallowing capsule|1
2145688|NCT01145066|3756060|FG001|Overall Study|problems swallowing capsule|0
2145689|NCT01145066|3756061|FG002|Overall Study|problems swallowing capsule|0
2145690|NCT01145066|3756059|FG000|Overall Study|Abdominal discomfort|0
2145691|NCT01145066|3756060|FG001|Overall Study|Abdominal discomfort|1
2145692|NCT01145066|3756061|FG002|Overall Study|Abdominal discomfort|0
2145693|NCT01145066|3756059|FG000|Overall Study|Low platelet count|0
2145694|NCT01145066|3756060|FG001|Overall Study|Low platelet count|1
2145695|NCT01145066|3756061|FG002|Overall Study|Low platelet count|0
2145696|NCT01145222|3756099|FG000|Overall Study|Procedure not done (no anesthesiologist)|0
2145697|NCT01145222|3756100|FG001|Overall Study|Procedure not done (no anesthesiologist)|0
2145698|NCT01145222|3756101|FG002|Overall Study|Procedure not done (no anesthesiologist)|1
2145699|NCT01145222|3756102|FG003|Overall Study|Procedure not done (no anesthesiologist)|0
2145700|NCT01145222|3756099|FG000|Overall Study|Poor bowel preparation|0
2145701|NCT01145222|3756100|FG001|Overall Study|Poor bowel preparation|0
2145702|NCT01145222|3756101|FG002|Overall Study|Poor bowel preparation|0
2145703|NCT01145222|3756102|FG003|Overall Study|Poor bowel preparation|1
2145704|NCT01145352|3756112|FG000|Overall Study|Found to have been registered twice|6
2145705|NCT01145352|3756112|FG000|Overall Study|Treated before marketing approval|4
2145706|NCT01145352|3756112|FG000|Overall Study|Syringe formulation was used|1
2145707|NCT01145417|3756129|FG000|Overall Study|Death|1
2145708|NCT01145417|3756130|FG001|Overall Study|Death|0
2145709|NCT01145417|3756129|FG000|Overall Study|Lost to Follow-up|2
2145710|NCT01145417|3756130|FG001|Overall Study|Lost to Follow-up|1
2145711|NCT01145417|3756129|FG000|Overall Study|Withdrawal by Subject|1
2145712|NCT01145417|3756130|FG001|Overall Study|Withdrawal by Subject|2
2145713|NCT01145417|3756129|FG000|Overall Study|Pregnancy|1
2145714|NCT01145417|3756130|FG001|Overall Study|Pregnancy|0
2145715|NCT01145417|3756129|FG000|Overall Study|Adverse Event|0
2145716|NCT01145417|3756130|FG001|Overall Study|Adverse Event|1
2145717|NCT01145417|3756129|FG000|Overall Study|Study terminated by sponsor|35
2145718|NCT01145417|3756130|FG001|Overall Study|Study terminated by sponsor|43
2145719|NCT01145417|3756129|FG000|Overall Study|Other|1
2145720|NCT01145417|3756130|FG001|Overall Study|Other|0
2145721|NCT01145482|3756138|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
2145722|NCT01145482|3756139|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
2145723|NCT01145508|3756147|FG000|Overall Study|Adverse Event|1
2145724|NCT01145508|3756148|FG001|Overall Study|Adverse Event|0
2145725|NCT01145508|3756147|FG000|Overall Study|Death|1
2145726|NCT01145508|3756148|FG001|Overall Study|Death|0
2145727|NCT01145508|3756147|FG000|Overall Study|Physician Decision|2
2145728|NCT01145508|3756148|FG001|Overall Study|Physician Decision|1
2145729|NCT01145508|3756147|FG000|Overall Study|Never started treatment|1
2145730|NCT01145508|3756148|FG001|Overall Study|Never started treatment|1
2145731|NCT01145560|3756164|FG000|Overall Study|Withdrawal by Subject|2
2145732|NCT01145560|3756165|FG001|Overall Study|Withdrawal by Subject|1
2145733|NCT01145560|3756166|FG002|Overall Study|Withdrawal by Subject|0
2145734|NCT01145560|3756164|FG000|Overall Study|Lost to Follow-up|1
2145735|NCT01145560|3756165|FG001|Overall Study|Lost to Follow-up|1
2145736|NCT01145560|3756166|FG002|Overall Study|Lost to Follow-up|1
2145737|NCT01145560|3756164|FG000|Overall Study|No study drug by 24h after organ failure|1
2145738|NCT01145560|3756165|FG001|Overall Study|No study drug by 24h after organ failure|0
2145739|NCT01145560|3756166|FG002|Overall Study|No study drug by 24h after organ failure|0
2145740|NCT01145560|3756164|FG000|Overall Study|Accidental unblinding of study treatment|0
2145741|NCT01145560|3756165|FG001|Overall Study|Accidental unblinding of study treatment|1
2145742|NCT01145560|3756166|FG002|Overall Study|Accidental unblinding of study treatment|0
2145743|NCT01145560|3756164|FG000|Overall Study|False insurance information|0
2145744|NCT01145560|3756165|FG001|Overall Study|False insurance information|1
2145745|NCT01145560|3756166|FG002|Overall Study|False insurance information|0
2145746|NCT01145560|3756164|FG000|Overall Study|Withdrawal of therapy|0
2145747|NCT01145560|3756165|FG001|Overall Study|Withdrawal of therapy|0
2145748|NCT01145560|3756166|FG002|Overall Study|Withdrawal of therapy|1
2145749|NCT01145625|3756176|FG000|Overall Study|Lost to Follow-up|8
2145750|NCT01145625|3756177|FG001|Overall Study|Lost to Follow-up|9
2145751|NCT01145625|3756176|FG000|Overall Study|Adverse Event|6
2145752|NCT01145625|3756177|FG001|Overall Study|Adverse Event|4
2145753|NCT01145625|3756176|FG000|Overall Study|Protocol Violation|3
2145754|NCT01145625|3756177|FG001|Overall Study|Protocol Violation|1
2145755|NCT01145625|3756176|FG000|Overall Study|Withdrawal by Subject|7
2145756|NCT01145625|3756177|FG001|Overall Study|Withdrawal by Subject|16
2145757|NCT01145625|3756176|FG000|Overall Study|Pregnancy|0
2145758|NCT01145625|3756177|FG001|Overall Study|Pregnancy|1
2145759|NCT01145755|3756195|FG000|Overall Study|Adverse Event|2
2208045|NCT01635998|3847411|FG001|Overall Study|Lost to Follow-up|1
2145760|NCT01145755|3756196|FG001|Overall Study|Adverse Event|4
2145761|NCT01145755|3756197|FG002|Overall Study|Adverse Event|2
2145762|NCT01145755|3756195|FG000|Overall Study|Withdrawal by Subject|2
2145763|NCT01145755|3756196|FG001|Overall Study|Withdrawal by Subject|2
2145764|NCT01145755|3756197|FG002|Overall Study|Withdrawal by Subject|2
2145765|NCT01145755|3756195|FG000|Overall Study|Lost to Follow-up|2
2145766|NCT01145755|3756196|FG001|Overall Study|Lost to Follow-up|3
2145767|NCT01145755|3756197|FG002|Overall Study|Lost to Follow-up|1
2145768|NCT01145755|3756195|FG000|Overall Study|Protocol Violation|0
2145769|NCT01145755|3756196|FG001|Overall Study|Protocol Violation|3
2145770|NCT01145755|3756197|FG002|Overall Study|Protocol Violation|1
2145771|NCT01145755|3756195|FG000|Overall Study|Study Closure|14
2145772|NCT01145755|3756196|FG001|Overall Study|Study Closure|14
2290280|NCT02487498|3982745|FG000|Period: Period 1|Adverse Event|2
2290281|NCT02487498|3982746|FG001|Period: Period 1|Adverse Event|4
2145773|NCT01145755|3756197|FG002|Overall Study|Study Closure|17
2145774|NCT01145755|3756195|FG000|Overall Study|Lack of Efficacy|0
2145775|NCT01145755|3756196|FG001|Overall Study|Lack of Efficacy|1
2145776|NCT01145755|3756197|FG002|Overall Study|Lack of Efficacy|0
2145777|NCT01145755|3756195|FG000|Overall Study|Patient could not swollow medication|0
2145778|NCT01145755|3756196|FG001|Overall Study|Patient could not swollow medication|0
2145779|NCT01145755|3756197|FG002|Overall Study|Patient could not swollow medication|1
2145780|NCT01145755|3756195|FG000|Overall Study|Withdrawal by Subject|0
2145781|NCT01145755|3756196|FG001|Overall Study|Withdrawal by Subject|0
2145782|NCT01145755|3756197|FG002|Overall Study|Withdrawal by Subject|1
2145783|NCT01145755|3756195|FG000|Overall Study|Positive urine ethanol|0
2145784|NCT01145755|3756196|FG001|Overall Study|Positive urine ethanol|1
2145785|NCT01145755|3756197|FG002|Overall Study|Positive urine ethanol|0
2145786|NCT01145885|3756214|FG000|Overall Study|Progressive Disease|7
2145787|NCT01145898|3756226|FG000|3-year Treatment|medication change by treating physician|3
2145788|NCT01145898|3756227|FG001|3-year Treatment|medication change by treating physician|16
2178855|NCT01389102|3803914|FG002|Overall Study|Unavailable due to husband's illness|0
2178856|NCT01389102|3803915|FG003|Overall Study|Unavailable due to husband's illness|0
2178857|NCT01389102|3803916|FG004|Overall Study|Unavailable due to husband's illness|0
2178858|NCT01389102|3803917|FG005|Overall Study|Unavailable due to husband's illness|0
2178859|NCT01389102|3803912|FG000|Overall Study|Investigator Judgement|0
2178860|NCT01389102|3803913|FG001|Overall Study|Investigator Judgement|1
2178861|NCT01389102|3803914|FG002|Overall Study|Investigator Judgement|0
2178862|NCT01389102|3803915|FG003|Overall Study|Investigator Judgement|0
2178863|NCT01389102|3803916|FG004|Overall Study|Investigator Judgement|0
2178864|NCT01389102|3803917|FG005|Overall Study|Investigator Judgement|0
2178865|NCT01389128|3803939|FG000|Overall Study|Fetal distress|1
2178866|NCT01389128|3803940|FG001|Overall Study|Fetal distress|0
2178867|NCT01389128|3803939|FG000|Overall Study|Cervix dilation stop|1
2178868|NCT01389128|3803940|FG001|Overall Study|Cervix dilation stop|2
2290282|NCT02487498|3982745|FG000|Period: Period 1|Subject/guardian decision|2
2290283|NCT02487498|3982746|FG001|Period: Period 1|Subject/guardian decision|4
2290284|NCT02487498|3982745|FG000|Period: Period 1|Lost to Follow-up|0
2290285|NCT02487498|3982746|FG001|Period: Period 1|Lost to Follow-up|2
2290286|NCT02487498|3982745|FG000|Period: Period 1|Lack of Efficacy|1
2290287|NCT02487498|3982746|FG001|Period: Period 1|Lack of Efficacy|0
2178869|NCT01389128|3803939|FG000|Overall Study|Rapid labor evolution|3
2178870|NCT01389128|3803940|FG001|Overall Study|Rapid labor evolution|2
2178871|NCT01389128|3803939|FG000|Overall Study|Intolerance to procedure|0
2178872|NCT01389128|3803940|FG001|Overall Study|Intolerance to procedure|2
2178873|NCT01389232|3803950|FG000|Overall Study|Had scaffold removed|15
2178874|NCT01389232|3803950|FG000|Overall Study|Personal reasons|2
2178875|NCT01389232|3803950|FG000|Overall Study|Adverse Event|1
2178876|NCT01389232|3803950|FG000|Overall Study|Death|1
2290288|NCT02487498|3982745|FG000|Period: Period 1|Physician Decision|0
2290289|NCT02487498|3982746|FG001|Period: Period 1|Physician Decision|1
2290290|NCT02487498|3982745|FG000|Period: Period 1|Protocol deviation|1
2290291|NCT02487498|3982746|FG001|Period: Period 1|Protocol deviation|0
2290292|NCT02487498|3982745|FG000|Period: Washout|Subject/guardian decision|0
2290293|NCT02487498|3982746|FG001|Period: Washout|Subject/guardian decision|5
2290294|NCT02487498|3982745|FG000|Period: Washout|Lack of Efficacy|1
2290295|NCT02487498|3982746|FG001|Period: Washout|Lack of Efficacy|1
2290296|NCT02487498|3982745|FG000|Period: Washout|Physician Decision|1
2290297|NCT02487498|3982746|FG001|Period: Washout|Physician Decision|0
2290298|NCT02487498|3982745|FG000|Period: Washout|Non-compliance with study treatment|0
2290299|NCT02487498|3982746|FG001|Period: Washout|Non-compliance with study treatment|1
2290300|NCT02487498|3982745|FG000|Period: Period 2|Adverse Event|2
2290301|NCT02487498|3982746|FG001|Period: Period 2|Adverse Event|2
2290302|NCT02487498|3982745|FG000|Period: Period 2|Subject/guardian decision|2
2290303|NCT02487498|3982746|FG001|Period: Period 2|Subject/guardian decision|1
2290304|NCT02487498|3982745|FG000|Period: Period 2|Lost to Follow-up|1
2290305|NCT02487498|3982746|FG001|Period: Period 2|Lost to Follow-up|1
2290306|NCT02487498|3982745|FG000|Period: Period 2|Death|0
2290307|NCT02487498|3982746|FG001|Period: Period 2|Death|1
2290308|NCT02487498|3982745|FG000|Period: Period 2|Physician Decision|1
2290309|NCT02487498|3982746|FG001|Period: Period 2|Physician Decision|0
2178877|NCT01389245|3803964|FG000|Overall Study|Protocol Violation|10
2178878|NCT01389245|3803964|FG000|Overall Study|Lost to Follow-up|3
2178879|NCT01389245|3803964|FG000|Overall Study|Withdrawal by Subject|2
2178880|NCT01389258|3803968|FG000|Overall Study|Lost to Follow-up|5
2178881|NCT01389323|3803985|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
2178882|NCT01389323|3803985|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24
2180136|NCT01399099|3806101|FG000|Overall Study|Infection|1
2145789|NCT01146054|3756232|FG000|Overall Study|Did not meet dose constraints for SBRT|5
2145790|NCT01146054|3756232|FG000|Overall Study|Rapid tumor progression|2
2145791|NCT01146054|3756232|FG000|Overall Study|Other illness precluded treatment|2
2145792|NCT01146054|3756232|FG000|Overall Study|Lost to Follow-up|1
2145793|NCT01146288|3756243|FG000|First Intervention(1 Day)|Adverse Event|0
2145794|NCT01146288|3756244|FG001|First Intervention(1 Day)|Adverse Event|1
2145795|NCT01146561|3756299|FG000|Overall Study|Withdrawal by Subject|1
2145796|NCT01146561|3756299|FG000|Overall Study|Lost to Follow-up|1
2145797|NCT01146613|3756315|FG000|Overall Study|Lost to Follow-up|3
2145798|NCT01146613|3756316|FG001|Overall Study|Lost to Follow-up|8
2145799|NCT01146613|3756315|FG000|Overall Study|Lack of Efficacy|0
2145800|NCT01146613|3756316|FG001|Overall Study|Lack of Efficacy|1
2145801|NCT01146613|3756315|FG000|Overall Study|Death|1
2145802|NCT01146613|3756316|FG001|Overall Study|Death|0
2145803|NCT01146613|3756315|FG000|Overall Study|Physician Decision|1
2145804|NCT01146613|3756316|FG001|Overall Study|Physician Decision|0
2145805|NCT01146613|3756315|FG000|Overall Study|Withdrawal by Subject|0
2145806|NCT01146613|3756316|FG001|Overall Study|Withdrawal by Subject|3
2145807|NCT01146613|3756315|FG000|Overall Study|schedule conflict|1
2145808|NCT01146613|3756316|FG001|Overall Study|schedule conflict|0
2145809|NCT01146613|3756315|FG000|Overall Study|Outpatient detox|1
2145810|NCT01146613|3756316|FG001|Overall Study|Outpatient detox|0
2145811|NCT01146665|3756324|FG000|Overall Study|Withdrawal by Subject|10
2145812|NCT01146665|3756325|FG001|Overall Study|Withdrawal by Subject|16
2145813|NCT01146782|3756349|FG000|Screening Cohort|Screen Failure|187
2145814|NCT01146782|3756349|FG000|Screening Cohort|Lost to Follow-up|4
2145815|NCT01146782|3756349|FG000|Screening Cohort|Physician Decision|1
2145816|NCT01146782|3756349|FG000|Screening Cohort|Withdrawal by Subject|29
2145817|NCT01146782|3756349|FG000|Safety Cohort|Screen Failure|61
2145818|NCT01146782|3756349|FG000|Safety Cohort|Withdrawal by Subject|4
2145819|NCT01146782|3756349|FG000|Safety Cohort|Control AHI <5|4
2145820|NCT01146782|3756349|FG000|Safety Cohort|TST <4 hrs|14
2145821|NCT01146782|3756349|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5
2145822|NCT01146782|3756349|FG000|Primary Endpoint Cohort|Physician Decision|1
2145823|NCT01146795|3756354|FG000|Overall Study|Withdrawal by Subject|4
2145824|NCT01146795|3756354|FG000|Overall Study|Adverse Event|6
2145825|NCT01146795|3756354|FG000|Overall Study|Still in treatment at study closure|10
2145826|NCT01146860|3756385|FG000|Overall Study|Withdrawal by Subject|0
2145827|NCT01146860|3756386|FG001|Overall Study|Withdrawal by Subject|1
2145828|NCT01146873|3756394|FG000|Overall Study|Transfer out|0
2145829|NCT01146873|3756395|FG001|Overall Study|Transfer out|6
2145830|NCT01146912|3756408|FG000|Overall Study|Already received influenza vaccination|817
2145831|NCT01146912|3756409|FG001|Overall Study|Already received influenza vaccination|822
2145832|NCT01146912|3756410|FG002|Overall Study|Already received influenza vaccination|13
2145833|NCT01146912|3756411|FG003|Overall Study|Already received influenza vaccination|15
2145834|NCT01146912|3756412|FG004|Overall Study|Already received influenza vaccination|41
2145835|NCT01146912|3756413|FG005|Overall Study|Already received influenza vaccination|61
2145836|NCT01146912|3756414|FG006|Overall Study|Already received influenza vaccination|56
2145837|NCT01146912|3756415|FG007|Overall Study|Already received influenza vaccination|0
2145838|NCT01146912|3756408|FG000|Overall Study|< 14 weeks gestational age|0
2145839|NCT01146912|3756409|FG001|Overall Study|< 14 weeks gestational age|0
2145840|NCT01146912|3756410|FG002|Overall Study|< 14 weeks gestational age|3
2145841|NCT01146912|3756411|FG003|Overall Study|< 14 weeks gestational age|2
2145842|NCT01146912|3756412|FG004|Overall Study|< 14 weeks gestational age|0
2145843|NCT01146912|3756413|FG005|Overall Study|< 14 weeks gestational age|0
2145844|NCT01146912|3756414|FG006|Overall Study|< 14 weeks gestational age|0
2145845|NCT01146912|3756415|FG007|Overall Study|< 14 weeks gestational age|0
2145846|NCT01146912|3756408|FG000|Overall Study|Duplicate patient|0
2145847|NCT01146912|3756409|FG001|Overall Study|Duplicate patient|0
2145848|NCT01146912|3756410|FG002|Overall Study|Duplicate patient|1
2145849|NCT01146912|3756411|FG003|Overall Study|Duplicate patient|0
2145850|NCT01146912|3756412|FG004|Overall Study|Duplicate patient|0
2145851|NCT01146912|3756413|FG005|Overall Study|Duplicate patient|0
2145852|NCT01146912|3756414|FG006|Overall Study|Duplicate patient|0
2145853|NCT01146912|3756415|FG007|Overall Study|Duplicate patient|0
2145854|NCT01146951|3756436|FG000|Overall Study|Adverse Event|4
2145855|NCT01146951|3756437|FG001|Overall Study|Adverse Event|1
2145856|NCT01147055|3756443|FG000|First Intervention Period|Lost to Follow-up|1
2145857|NCT01147055|3756444|FG001|First Intervention Period|Lost to Follow-up|0
2145858|NCT01147068|3756457|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1
2145859|NCT01147068|3756458|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0
2145860|NCT01147068|3756459|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0
2145861|NCT01147068|3756460|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0
2145862|NCT01147068|3756461|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0
2145863|NCT01147068|3756462|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1
2145864|NCT01147068|3756463|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0
2145865|NCT01147068|3756457|FG000|Subjects That Received 2nd Dose|Ineligible|0
2145866|NCT01147068|3756458|FG001|Subjects That Received 2nd Dose|Ineligible|1
2145867|NCT01147068|3756459|FG002|Subjects That Received 2nd Dose|Ineligible|0
2145868|NCT01147068|3756460|FG003|Subjects That Received 2nd Dose|Ineligible|0
2145869|NCT01147068|3756461|FG004|Subjects That Received 2nd Dose|Ineligible|0
2145870|NCT01147068|3756462|FG005|Subjects That Received 2nd Dose|Ineligible|0
2145871|NCT01147068|3756463|FG006|Subjects That Received 2nd Dose|Ineligible|0
2145872|NCT01147068|3756457|FG000|Subjects That Received 2nd Dose|Did not complete the study|0
2145873|NCT01147068|3756458|FG001|Subjects That Received 2nd Dose|Did not complete the study|1
2145874|NCT01147068|3756459|FG002|Subjects That Received 2nd Dose|Did not complete the study|0
2145875|NCT01147068|3756460|FG003|Subjects That Received 2nd Dose|Did not complete the study|0
2145876|NCT01147068|3756461|FG004|Subjects That Received 2nd Dose|Did not complete the study|0
2145877|NCT01147068|3756462|FG005|Subjects That Received 2nd Dose|Did not complete the study|1
2145878|NCT01147068|3756463|FG006|Subjects That Received 2nd Dose|Did not complete the study|0
2145879|NCT01147068|3756457|FG000|Subjects That Received 2nd Dose|Other|0
2145880|NCT01147068|3756458|FG001|Subjects That Received 2nd Dose|Other|3
2145881|NCT01147068|3756459|FG002|Subjects That Received 2nd Dose|Other|3
2145882|NCT01147068|3756460|FG003|Subjects That Received 2nd Dose|Other|0
2145883|NCT01147068|3756461|FG004|Subjects That Received 2nd Dose|Other|1
2145884|NCT01147068|3756462|FG005|Subjects That Received 2nd Dose|Other|0
2145885|NCT01147068|3756463|FG006|Subjects That Received 2nd Dose|Other|0
2145886|NCT01147068|3756457|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
2145887|NCT01147068|3756458|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2145888|NCT01147068|3756459|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2145889|NCT01147068|3756460|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2145890|NCT01147068|3756461|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2145891|NCT01147068|3756462|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
2145892|NCT01147068|3756463|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
2145893|NCT01147068|3756457|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2145894|NCT01147068|3756458|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2145895|NCT01147068|3756459|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2145896|NCT01147068|3756460|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
2145897|NCT01147068|3756461|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2145898|NCT01147068|3756462|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2145899|NCT01147068|3756463|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2145900|NCT01147068|3756457|FG000|Subjects That Completed Safety Follow-up|Ineligible|0
2145901|NCT01147068|3756458|FG001|Subjects That Completed Safety Follow-up|Ineligible|1
2145902|NCT01147068|3756459|FG002|Subjects That Completed Safety Follow-up|Ineligible|0
2145903|NCT01147068|3756460|FG003|Subjects That Completed Safety Follow-up|Ineligible|0
2145904|NCT01147068|3756461|FG004|Subjects That Completed Safety Follow-up|Ineligible|0
2145905|NCT01147068|3756462|FG005|Subjects That Completed Safety Follow-up|Ineligible|0
2145906|NCT01147068|3756463|FG006|Subjects That Completed Safety Follow-up|Ineligible|0
2145907|NCT01147107|3756481|FG000|Overall Study|Lack of Efficacy|5
2145908|NCT01147107|3756482|FG001|Overall Study|Lack of Efficacy|0
2145909|NCT01147107|3756481|FG000|Overall Study|Withdrawal by Subject|1
2145910|NCT01147107|3756482|FG001|Overall Study|Withdrawal by Subject|1
2145911|NCT01147172|3756488|FG000|Overall Study|Withdrawal by Subject|2
2145912|NCT01147172|3756488|FG000|Overall Study|Lost to Follow-up|2
2145913|NCT01147250|3756496|FG000|Overall Study|Lost to Follow-up|14
2145914|NCT01147250|3756497|FG001|Overall Study|Lost to Follow-up|11
2145915|NCT01147250|3756496|FG000|Overall Study|Withdrawal by Subject|83
2145916|NCT01147250|3756497|FG001|Overall Study|Withdrawal by Subject|88
2145917|NCT01147250|3756496|FG000|Overall Study|Site termination by sponsor|13
2145918|NCT01147250|3756497|FG001|Overall Study|Site termination by sponsor|5
2145919|NCT01147250|3756496|FG000|Overall Study|Other than specified|0
2145920|NCT01147250|3756497|FG001|Overall Study|Other than specified|1
2145921|NCT01147341|3756514|FG000|Double Blind Period|Lack of Efficacy|1
2145922|NCT01147341|3756515|FG001|Double Blind Period|Lack of Efficacy|1
2145923|NCT01147341|3756514|FG000|Double Blind Period|Withdrawal by Subject|0
2145924|NCT01147341|3756515|FG001|Double Blind Period|Withdrawal by Subject|1
2145925|NCT01147341|3756514|FG000|Open Label Period|Lack of Efficacy|3
2145926|NCT01147341|3756515|FG001|Open Label Period|Lack of Efficacy|0
2145927|NCT01147341|3756514|FG000|Open Label Period|Subject moved|1
2145928|NCT01147341|3756515|FG001|Open Label Period|Subject moved|0
2145929|NCT01147458|3756558|FG000|First Intervention|Study terminated by sponsor|8
2145930|NCT01147458|3756559|FG001|First Intervention|Study terminated by sponsor|8
2208046|NCT01635998|3847410|FG000|Overall Study|Withdrawal by Subject|1
2208047|NCT01635998|3847411|FG001|Overall Study|Withdrawal by Subject|5
2290310|NCT02487771|3982771|FG000|Overall Study|Lost to Follow-up|2
2290311|NCT02487771|3982772|FG001|Overall Study|Lost to Follow-up|3
2290312|NCT02487771|3982771|FG000|Overall Study|Moved out of area|5
2290313|NCT02487771|3982772|FG001|Overall Study|Moved out of area|6
2290314|NCT02487771|3982771|FG000|Overall Study|Withdrawal by Subject|3
2290315|NCT02487771|3982772|FG001|Overall Study|Withdrawal by Subject|5
2290316|NCT02487810|3982780|FG000|Overall Study|Withdrawal by Subject|1
2290317|NCT02487810|3982781|FG001|Overall Study|Withdrawal by Subject|0
2290318|NCT02488005|3982804|FG000|Overall Study|Lost to Follow-up|2
2290319|NCT02488109|3982819|FG000|Treatment in Hospital|Withdrawal by Subject|0
2290320|NCT02488109|3982820|FG001|Treatment in Hospital|Withdrawal by Subject|5
2290321|NCT02488109|3982819|FG000|12-month Follow-Up|Lost to Follow-up|4
2145931|NCT01147458|3756560|FG002|First Intervention|Study terminated by sponsor|7
2145932|NCT01147458|3756561|FG003|First Intervention|Study terminated by sponsor|8
2145933|NCT01147458|3756558|FG000|First Intervention|Protocol Violation|2
2145934|NCT01147458|3756559|FG001|First Intervention|Protocol Violation|3
2145935|NCT01147458|3756560|FG002|First Intervention|Protocol Violation|2
2145936|NCT01147458|3756561|FG003|First Intervention|Protocol Violation|3
2145937|NCT01147458|3756558|FG000|First Intervention|Withdrawal by Subject|3
2145938|NCT01147458|3756559|FG001|First Intervention|Withdrawal by Subject|0
2145939|NCT01147458|3756560|FG002|First Intervention|Withdrawal by Subject|1
2145940|NCT01147458|3756561|FG003|First Intervention|Withdrawal by Subject|0
2145941|NCT01147458|3756558|FG000|First Intervention|Adverse Event|0
2145942|NCT01147458|3756559|FG001|First Intervention|Adverse Event|3
2145943|NCT01147458|3756560|FG002|First Intervention|Adverse Event|2
2145944|NCT01147458|3756561|FG003|First Intervention|Adverse Event|3
2145945|NCT01147458|3756558|FG000|First Intervention|Other|1
2145946|NCT01147458|3756559|FG001|First Intervention|Other|2
2145947|NCT01147458|3756560|FG002|First Intervention|Other|0
2145948|NCT01147458|3756561|FG003|First Intervention|Other|0
2145949|NCT01147458|3756558|FG000|Second Intervention|Study terminated by sponsor|7
2145950|NCT01147458|3756559|FG001|Second Intervention|Study terminated by sponsor|5
2145951|NCT01147458|3756560|FG002|Second Intervention|Study terminated by sponsor|5
2145952|NCT01147458|3756561|FG003|Second Intervention|Study terminated by sponsor|3
2145953|NCT01147458|3756558|FG000|Second Intervention|Protocol Violation|0
2145954|NCT01147458|3756559|FG001|Second Intervention|Protocol Violation|1
2145955|NCT01147458|3756560|FG002|Second Intervention|Protocol Violation|1
2145956|NCT01147458|3756561|FG003|Second Intervention|Protocol Violation|0
2145957|NCT01147458|3756558|FG000|Second Intervention|Withdrawal by Subject|0
2145958|NCT01147458|3756559|FG001|Second Intervention|Withdrawal by Subject|1
2145959|NCT01147458|3756560|FG002|Second Intervention|Withdrawal by Subject|0
2145960|NCT01147458|3756561|FG003|Second Intervention|Withdrawal by Subject|0
2145961|NCT01147458|3756558|FG000|Second Intervention|Adverse Event|2
2145962|NCT01147458|3756559|FG001|Second Intervention|Adverse Event|0
2145963|NCT01147458|3756560|FG002|Second Intervention|Adverse Event|1
2145964|NCT01147458|3756561|FG003|Second Intervention|Adverse Event|1
2145965|NCT01147458|3756558|FG000|Second Intervention|Other|0
2145966|NCT01147458|3756559|FG001|Second Intervention|Other|0
2145967|NCT01147458|3756560|FG002|Second Intervention|Other|1
2145968|NCT01147458|3756561|FG003|Second Intervention|Other|0
2145969|NCT01147471|3756575|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
2145970|NCT01147471|3756576|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
2145971|NCT01147471|3756575|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
2290322|NCT02488109|3982820|FG001|12-month Follow-Up|Lost to Follow-up|7
2290323|NCT02488239|3982828|FG000|Overall Study|Death|3
2290324|NCT02488239|3982828|FG000|Overall Study|Withdrawal by Subject|3
2290325|NCT02488239|3982828|FG000|Overall Study|Physician Decision|2
2290326|NCT02488239|3982828|FG000|Overall Study|Consent ineligible|1
2290327|NCT02488239|3982828|FG000|Overall Study|Did not undergo implant procedure|1
2290328|NCT02488330|3982846|FG000|Overall Study|Adverse Event|1
2290329|NCT02488330|3982846|FG000|Overall Study|Physician Decision|2
2290330|NCT02488330|3982846|FG000|Overall Study|Death|2
2290331|NCT02488330|3982846|FG000|Overall Study|Disease Progression|3
2290332|NCT02488330|3982846|FG000|Overall Study|Study Termination by Sponsor|4
2290333|NCT02488681|3982850|FG000|Overall Study|Implant unsuccessful|7
2290334|NCT02488824|3982856|FG000|Overall Study|Adverse Event|1
2290335|NCT02488824|3982857|FG001|Overall Study|Adverse Event|1
2290336|NCT02488915|3982863|FG000|Overall Study|Death|21
2290337|NCT02488915|3982863|FG000|Overall Study|Lost to Follow-up|4
2290338|NCT02488915|3982863|FG000|Overall Study|Withdrawal by Subject|1
2290339|NCT02488980|3982870|FG000|Overall Study|Protocol Violation|2
2290340|NCT02488980|3982871|FG001|Overall Study|Protocol Violation|2
2290341|NCT02488980|3982872|FG002|Overall Study|Protocol Violation|2
2290342|NCT02489045|3982880|FG000|Overall Study|unable to collect usable data|53
2290343|NCT02489045|3982880|FG000|Follow-up|Lost to Follow-up|10
2290344|NCT02489279|3982914|FG000|Overall Study|Lost to Follow-up|12
2290345|NCT02489279|3982915|FG001|Overall Study|Lost to Follow-up|10
2290346|NCT02489344|3982921|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
2290347|NCT02489344|3982921|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
2290348|NCT02489344|3982921|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1
2290349|NCT02489344|3982921|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
2290350|NCT02489500|3982931|FG000|Overall Study|Death|1
2290351|NCT02489500|3982932|FG001|Overall Study|Death|1
2290352|NCT02489630|3982940|FG000|Overall Study|Oversedation|1
2290353|NCT02489630|3982941|FG001|Overall Study|Oversedation|1
2290354|NCT02489630|3982940|FG000|Overall Study|Time to med. admin. > protocol limit|1
2290355|NCT02489630|3982941|FG001|Overall Study|Time to med. admin. > protocol limit|1
2145972|NCT01147471|3756576|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
2145973|NCT01147471|3756575|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
2145974|NCT01147471|3756576|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
2145975|NCT01147471|3756575|FG000|3 Month Follow Up|Lost to Follow-up|1
2145976|NCT01147471|3756576|FG001|3 Month Follow Up|Lost to Follow-up|1
2145977|NCT01147471|3756575|FG000|3 Month Follow Up|Physician Decision|0
2145978|NCT01147471|3756576|FG001|3 Month Follow Up|Physician Decision|1
2145979|NCT01147471|3756575|FG000|6 Month Follow Up|Lost to Follow-up|4
2145980|NCT01147471|3756576|FG001|6 Month Follow Up|Lost to Follow-up|2
2145981|NCT01147497|3756584|FG000|Overall Study|failed insertion|2
2145982|NCT01147497|3756585|FG001|Overall Study|failed insertion|0
2145983|NCT01147640|3756615|FG000|Overall Study|Adverse Event|2
2145984|NCT01147640|3756616|FG001|Overall Study|Adverse Event|0
2145985|NCT01147640|3756615|FG000|Overall Study|Physician Decision|1
2145986|NCT01147640|3756616|FG001|Overall Study|Physician Decision|0
2145987|NCT01147640|3756615|FG000|Overall Study|Withdrawal by Subject|1
2145988|NCT01147640|3756616|FG001|Overall Study|Withdrawal by Subject|0
2145989|NCT01147640|3756615|FG000|Overall Study|Lost to Follow-up|0
2145990|NCT01147640|3756616|FG001|Overall Study|Lost to Follow-up|1
2145991|NCT01147640|3756615|FG000|Overall Study|Didn't meet eligibility criteria|1
2145992|NCT01147640|3756616|FG001|Overall Study|Didn't meet eligibility criteria|0
2145993|NCT01147744|3756629|FG000|Overall Study|Protocol Violation|1
2145994|NCT01147744|3756630|FG001|Overall Study|Protocol Violation|0
2145995|NCT01147744|3756631|FG002|Overall Study|Protocol Violation|1
2145996|NCT01147744|3756632|FG003|Overall Study|Protocol Violation|0
2145997|NCT01147744|3756633|FG004|Overall Study|Protocol Violation|1
2145998|NCT01147744|3756634|FG005|Overall Study|Protocol Violation|3
2145999|NCT01147744|3756635|FG006|Overall Study|Protocol Violation|1
2146000|NCT01147744|3756629|FG000|Overall Study|Physician Decision|0
2146001|NCT01147744|3756630|FG001|Overall Study|Physician Decision|1
2146002|NCT01147744|3756631|FG002|Overall Study|Physician Decision|1
2146003|NCT01147744|3756632|FG003|Overall Study|Physician Decision|0
2146004|NCT01147744|3756633|FG004|Overall Study|Physician Decision|0
2146005|NCT01147744|3756634|FG005|Overall Study|Physician Decision|0
2146006|NCT01147744|3756635|FG006|Overall Study|Physician Decision|1
2146007|NCT01147744|3756629|FG000|Overall Study|Lack of Efficacy|11
2146008|NCT01147744|3756630|FG001|Overall Study|Lack of Efficacy|11
2146009|NCT01147744|3756631|FG002|Overall Study|Lack of Efficacy|9
2146010|NCT01147744|3756632|FG003|Overall Study|Lack of Efficacy|11
2146011|NCT01147744|3756633|FG004|Overall Study|Lack of Efficacy|13
2146012|NCT01147744|3756634|FG005|Overall Study|Lack of Efficacy|8
2146013|NCT01147744|3756635|FG006|Overall Study|Lack of Efficacy|7
2146014|NCT01147744|3756629|FG000|Overall Study|Adverse Event|1
2146015|NCT01147744|3756630|FG001|Overall Study|Adverse Event|2
2146016|NCT01147744|3756631|FG002|Overall Study|Adverse Event|3
2146017|NCT01147744|3756632|FG003|Overall Study|Adverse Event|0
2146018|NCT01147744|3756633|FG004|Overall Study|Adverse Event|2
2146019|NCT01147744|3756634|FG005|Overall Study|Adverse Event|1
2146020|NCT01147744|3756635|FG006|Overall Study|Adverse Event|2
2146021|NCT01147744|3756629|FG000|Overall Study|Withdrawal by Subject|8
2146022|NCT01147744|3756630|FG001|Overall Study|Withdrawal by Subject|4
2146023|NCT01147744|3756631|FG002|Overall Study|Withdrawal by Subject|2
2146024|NCT01147744|3756632|FG003|Overall Study|Withdrawal by Subject|2
2146025|NCT01147744|3756633|FG004|Overall Study|Withdrawal by Subject|2
2146026|NCT01147744|3756634|FG005|Overall Study|Withdrawal by Subject|5
2146027|NCT01147744|3756635|FG006|Overall Study|Withdrawal by Subject|2
2146028|NCT01147744|3756629|FG000|Overall Study|Lost to Follow-up|0
2146029|NCT01147744|3756630|FG001|Overall Study|Lost to Follow-up|1
2146030|NCT01147744|3756631|FG002|Overall Study|Lost to Follow-up|0
2146031|NCT01147744|3756632|FG003|Overall Study|Lost to Follow-up|0
2146032|NCT01147744|3756633|FG004|Overall Study|Lost to Follow-up|0
2146033|NCT01147744|3756634|FG005|Overall Study|Lost to Follow-up|0
2146034|NCT01147744|3756635|FG006|Overall Study|Lost to Follow-up|0
2146035|NCT01147744|3756629|FG000|Overall Study|Sponsor decision to amend protocol|7
2290356|NCT02489773|3982958|FG000|Overall Study|Lost to Follow-up|4
2290357|NCT02489773|3982959|FG001|Overall Study|Lost to Follow-up|1
2290358|NCT02489773|3982958|FG000|Overall Study|Physician Decision|1
2290359|NCT02489773|3982959|FG001|Overall Study|Physician Decision|0
2290360|NCT02489773|3982958|FG000|Overall Study|Withdrawal by Subject|1
2290361|NCT02489773|3982959|FG001|Overall Study|Withdrawal by Subject|0
2290362|NCT02489773|3982958|FG000|Overall Study|Leave the country or the state|1
2290363|NCT02489773|3982959|FG001|Overall Study|Leave the country or the state|1
2290364|NCT02489799|3982967|FG000|Overall Study|Lost to Follow-up|4
2290365|NCT02489799|3982968|FG001|Overall Study|Lost to Follow-up|1
2290366|NCT02489799|3982967|FG000|Overall Study|Failure to Maintain Eligibility|4
2290367|NCT02489799|3982968|FG001|Overall Study|Failure to Maintain Eligibility|6
2290368|NCT02489799|3982967|FG000|Overall Study|Withdrawal by Subject|1
2290369|NCT02489799|3982968|FG001|Overall Study|Withdrawal by Subject|1
2290370|NCT02489799|3982967|FG000|Overall Study|Death|0
2290371|NCT02489799|3982968|FG001|Overall Study|Death|1
2290372|NCT02489968|3982976|FG000|Open-label Treatment Period|Adverse Event|14
2290373|NCT02489968|3982977|FG001|Open-label Treatment Period|Adverse Event|7
2290374|NCT02489968|3982978|FG002|Open-label Treatment Period|Adverse Event|0
2290375|NCT02489968|3982979|FG003|Open-label Treatment Period|Adverse Event|0
2290376|NCT02489968|3982980|FG004|Open-label Treatment Period|Adverse Event|0
2290377|NCT02489968|3982981|FG005|Open-label Treatment Period|Adverse Event|0
2290378|NCT02489968|3982976|FG000|Open-label Treatment Period|Protocol Violation|2
2146036|NCT01147744|3756630|FG001|Overall Study|Sponsor decision to amend protocol|4
2146037|NCT01147744|3756631|FG002|Overall Study|Sponsor decision to amend protocol|2
2146038|NCT01147744|3756632|FG003|Overall Study|Sponsor decision to amend protocol|5
2146039|NCT01147744|3756633|FG004|Overall Study|Sponsor decision to amend protocol|7
2146040|NCT01147744|3756634|FG005|Overall Study|Sponsor decision to amend protocol|2
2146041|NCT01147744|3756635|FG006|Overall Study|Sponsor decision to amend protocol|6
2146042|NCT01147744|3756629|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
2146043|NCT01147744|3756630|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
2146044|NCT01147744|3756631|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0
2146045|NCT01147744|3756632|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0
2146046|NCT01147744|3756633|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0
2146047|NCT01147744|3756634|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1
2146048|NCT01147744|3756635|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0
2146049|NCT01147809|3756663|FG000|Phase I (168 Days)|Adverse Event|0
2146050|NCT01147809|3756664|FG001|Phase I (168 Days)|Adverse Event|0
2146051|NCT01147809|3756665|FG002|Phase I (168 Days)|Adverse Event|0
2146052|NCT01147809|3756666|FG003|Phase I (168 Days)|Adverse Event|1
2146053|NCT01147809|3756667|FG004|Phase I (168 Days)|Adverse Event|0
2146054|NCT01147809|3756668|FG005|Phase I (168 Days)|Adverse Event|0
2146055|NCT01147809|3756663|FG000|Phase I (168 Days)|Lost to Follow-up|1
2146056|NCT01147809|3756664|FG001|Phase I (168 Days)|Lost to Follow-up|0
2146057|NCT01147809|3756665|FG002|Phase I (168 Days)|Lost to Follow-up|0
2146058|NCT01147809|3756666|FG003|Phase I (168 Days)|Lost to Follow-up|1
2146059|NCT01147809|3756667|FG004|Phase I (168 Days)|Lost to Follow-up|0
2146060|NCT01147809|3756668|FG005|Phase I (168 Days)|Lost to Follow-up|0
2146061|NCT01147809|3756663|FG000|Phase I (168 Days)|Physician Decision|0
2146062|NCT01147809|3756664|FG001|Phase I (168 Days)|Physician Decision|1
2146063|NCT01147809|3756665|FG002|Phase I (168 Days)|Physician Decision|2
2146064|NCT01147809|3756666|FG003|Phase I (168 Days)|Physician Decision|0
2146065|NCT01147809|3756667|FG004|Phase I (168 Days)|Physician Decision|0
2146066|NCT01147809|3756668|FG005|Phase I (168 Days)|Physician Decision|0
2146067|NCT01147809|3756663|FG000|Phase I (168 Days)|Withdrawal by Subject|0
2146068|NCT01147809|3756664|FG001|Phase I (168 Days)|Withdrawal by Subject|0
2146069|NCT01147809|3756665|FG002|Phase I (168 Days)|Withdrawal by Subject|0
2146070|NCT01147809|3756666|FG003|Phase I (168 Days)|Withdrawal by Subject|3
2146071|NCT01147809|3756667|FG004|Phase I (168 Days)|Withdrawal by Subject|0
2146072|NCT01147809|3756668|FG005|Phase I (168 Days)|Withdrawal by Subject|0
2146073|NCT01147809|3756663|FG000|Phase II (168 Days)|Adverse Event|0
2146074|NCT01147809|3756664|FG001|Phase II (168 Days)|Adverse Event|0
2146075|NCT01147809|3756665|FG002|Phase II (168 Days)|Adverse Event|0
2146076|NCT01147809|3756666|FG003|Phase II (168 Days)|Adverse Event|0
2146077|NCT01147809|3756667|FG004|Phase II (168 Days)|Adverse Event|3
2146078|NCT01147809|3756668|FG005|Phase II (168 Days)|Adverse Event|6
2146079|NCT01147809|3756663|FG000|Phase II (168 Days)|Protocol Violation|0
2146080|NCT01147809|3756664|FG001|Phase II (168 Days)|Protocol Violation|0
2146081|NCT01147809|3756665|FG002|Phase II (168 Days)|Protocol Violation|0
2146082|NCT01147809|3756666|FG003|Phase II (168 Days)|Protocol Violation|0
2146083|NCT01147809|3756667|FG004|Phase II (168 Days)|Protocol Violation|0
2146084|NCT01147809|3756668|FG005|Phase II (168 Days)|Protocol Violation|1
2146085|NCT01147809|3756663|FG000|Phase II (168 Days)|Physician Decision|0
2146086|NCT01147809|3756664|FG001|Phase II (168 Days)|Physician Decision|0
2146087|NCT01147809|3756665|FG002|Phase II (168 Days)|Physician Decision|0
2146088|NCT01147809|3756666|FG003|Phase II (168 Days)|Physician Decision|0
2290379|NCT02489968|3982977|FG001|Open-label Treatment Period|Protocol Violation|2
2290380|NCT02489968|3982978|FG002|Open-label Treatment Period|Protocol Violation|0
2290381|NCT02489968|3982979|FG003|Open-label Treatment Period|Protocol Violation|0
2290382|NCT02489968|3982980|FG004|Open-label Treatment Period|Protocol Violation|0
2290383|NCT02489968|3982981|FG005|Open-label Treatment Period|Protocol Violation|0
2290384|NCT02489968|3982976|FG000|Open-label Treatment Period|Lost to Follow-up|0
2290385|NCT02489968|3982977|FG001|Open-label Treatment Period|Lost to Follow-up|3
2290386|NCT02489968|3982978|FG002|Open-label Treatment Period|Lost to Follow-up|0
2290387|NCT02489968|3982979|FG003|Open-label Treatment Period|Lost to Follow-up|0
2290388|NCT02489968|3982980|FG004|Open-label Treatment Period|Lost to Follow-up|0
2290389|NCT02489968|3982981|FG005|Open-label Treatment Period|Lost to Follow-up|0
2290390|NCT02489968|3982976|FG000|Open-label Treatment Period|Withdrawal by Subject|4
2290391|NCT02489968|3982977|FG001|Open-label Treatment Period|Withdrawal by Subject|7
2290392|NCT02489968|3982978|FG002|Open-label Treatment Period|Withdrawal by Subject|0
2290393|NCT02489968|3982979|FG003|Open-label Treatment Period|Withdrawal by Subject|0
2290394|NCT02489968|3982980|FG004|Open-label Treatment Period|Withdrawal by Subject|0
2290395|NCT02489968|3982981|FG005|Open-label Treatment Period|Withdrawal by Subject|0
2290396|NCT02489968|3982976|FG000|Open-label Treatment Period|Other than specified above|204
2290397|NCT02489968|3982977|FG001|Open-label Treatment Period|Other than specified above|189
2290398|NCT02489968|3982978|FG002|Open-label Treatment Period|Other than specified above|0
2290399|NCT02489968|3982979|FG003|Open-label Treatment Period|Other than specified above|0
2290400|NCT02489968|3982980|FG004|Open-label Treatment Period|Other than specified above|0
2290401|NCT02489968|3982981|FG005|Open-label Treatment Period|Other than specified above|0
2290402|NCT02489968|3982976|FG000|Double-blind Treatment Period|Adverse Event|0
2290403|NCT02489968|3982977|FG001|Double-blind Treatment Period|Adverse Event|0
2290404|NCT02489968|3982978|FG002|Double-blind Treatment Period|Adverse Event|2
2146089|NCT01147809|3756667|FG004|Phase II (168 Days)|Physician Decision|5
2146090|NCT01147809|3756668|FG005|Phase II (168 Days)|Physician Decision|11
2146091|NCT01147809|3756663|FG000|Phase II (168 Days)|Withdrawal by Subject|0
2146092|NCT01147809|3756664|FG001|Phase II (168 Days)|Withdrawal by Subject|0
2146093|NCT01147809|3756665|FG002|Phase II (168 Days)|Withdrawal by Subject|0
2146094|NCT01147809|3756666|FG003|Phase II (168 Days)|Withdrawal by Subject|0
2146095|NCT01147809|3756667|FG004|Phase II (168 Days)|Withdrawal by Subject|7
2146096|NCT01147809|3756668|FG005|Phase II (168 Days)|Withdrawal by Subject|15
2146097|NCT01147809|3756663|FG000|Phase II (168 Days)|Ongoing|0
2146098|NCT01147809|3756664|FG001|Phase II (168 Days)|Ongoing|0
2146099|NCT01147809|3756665|FG002|Phase II (168 Days)|Ongoing|0
2146100|NCT01147809|3756666|FG003|Phase II (168 Days)|Ongoing|0
2146101|NCT01147809|3756667|FG004|Phase II (168 Days)|Ongoing|1
2146102|NCT01147809|3756668|FG005|Phase II (168 Days)|Ongoing|0
2146103|NCT01147848|3756685|FG000|Run-in Period|Screen Failure|623
2146104|NCT01147848|3756686|FG001|Run-in Period|Screen Failure|0
2146105|NCT01147848|3756687|FG002|Run-in Period|Screen Failure|0
2146106|NCT01147848|3756685|FG000|Run-in Period|Run-in Failure|135
2146107|NCT01147848|3756686|FG001|Run-in Period|Run-in Failure|0
2146108|NCT01147848|3756687|FG002|Run-in Period|Run-in Failure|0
2146109|NCT01147848|3756685|FG000|Randomized Phase|Adverse Event|0
2146110|NCT01147848|3756686|FG001|Randomized Phase|Adverse Event|6
2146111|NCT01147848|3756687|FG002|Randomized Phase|Adverse Event|8
2146112|NCT01147848|3756685|FG000|Randomized Phase|Lack of Efficacy|0
2146113|NCT01147848|3756686|FG001|Randomized Phase|Lack of Efficacy|20
2146114|NCT01147848|3756687|FG002|Randomized Phase|Lack of Efficacy|11
2146115|NCT01147848|3756685|FG000|Randomized Phase|Protocol Violation|0
2146116|NCT01147848|3756686|FG001|Randomized Phase|Protocol Violation|7
2146117|NCT01147848|3756687|FG002|Randomized Phase|Protocol Violation|10
2146118|NCT01147848|3756685|FG000|Randomized Phase|Lost to Follow-up|0
2146119|NCT01147848|3756686|FG001|Randomized Phase|Lost to Follow-up|5
2146120|NCT01147848|3756687|FG002|Randomized Phase|Lost to Follow-up|7
2146121|NCT01147848|3756685|FG000|Randomized Phase|Physician Decision|0
2146122|NCT01147848|3756686|FG001|Randomized Phase|Physician Decision|0
2146123|NCT01147848|3756687|FG002|Randomized Phase|Physician Decision|1
2146124|NCT01147848|3756685|FG000|Randomized Phase|Withdrawal by Subject|0
2146125|NCT01147848|3756686|FG001|Randomized Phase|Withdrawal by Subject|7
2146126|NCT01147848|3756687|FG002|Randomized Phase|Withdrawal by Subject|9
2146127|NCT01147874|3756694|FG000|Overall Study|Adverse Event|5
2146128|NCT01147874|3756694|FG000|Overall Study|Investigator's Request|1
2146129|NCT01147874|3756694|FG000|Overall Study|Lost to Follow-up|25
2146130|NCT01147874|3756694|FG000|Overall Study|Other|5
2146131|NCT01147874|3756694|FG000|Overall Study|Protocol Violation|5
2146132|NCT01147874|3756694|FG000|Overall Study|Sponsor's Decision|2
2146133|NCT01147874|3756694|FG000|Overall Study|Withdrawal by Subject|24
2146134|NCT01147900|3756701|FG000|At Year 10|Lost to Follow-up|0
2146135|NCT01147900|3756702|FG001|At Year 10|Lost to Follow-up|1
2146136|NCT01147900|3756703|FG002|At Year 10|Lost to Follow-up|0
2146137|NCT01147926|3756713|FG000|Overall Study|Subject Withdrew Consent|9
2146138|NCT01147926|3756714|FG001|Overall Study|Subject Withdrew Consent|10
2146139|NCT01147926|3756713|FG000|Overall Study|Adverse Event|7
2146140|NCT01147926|3756714|FG001|Overall Study|Adverse Event|6
2146141|NCT01147926|3756713|FG000|Overall Study|Subject Non-Compliant|5
2146142|NCT01147926|3756714|FG001|Overall Study|Subject Non-Compliant|4
2146143|NCT01147926|3756713|FG000|Overall Study|Principal investigator left hospital|1
2146144|NCT01147926|3756714|FG001|Overall Study|Principal investigator left hospital|3
2146145|NCT01147926|3756713|FG000|Overall Study|Selection criteria not met|3
2146146|NCT01147926|3756714|FG001|Overall Study|Selection criteria not met|1
2146147|NCT01147926|3756713|FG000|Overall Study|Lost to Follow-up|0
2146148|NCT01147926|3756714|FG001|Overall Study|Lost to Follow-up|2
2146149|NCT01147926|3756713|FG000|Overall Study|Sponsor's Decision|0
2146150|NCT01147926|3756714|FG001|Overall Study|Sponsor's Decision|1
2146151|NCT01147926|3756713|FG000|Overall Study|Lack of Efficacy|1
2146152|NCT01147926|3756714|FG001|Overall Study|Lack of Efficacy|0
2146153|NCT01147926|3756713|FG000|Overall Study|Too busy, no time for study|1
2146154|NCT01147926|3756714|FG001|Overall Study|Too busy, no time for study|0
2146155|NCT01147926|3756713|FG000|Overall Study|Went on holiday|0
2146156|NCT01147926|3756714|FG001|Overall Study|Went on holiday|1
2146157|NCT01147926|3756713|FG000|Overall Study|Colonoscopy result|0
2146158|NCT01147926|3756714|FG001|Overall Study|Colonoscopy result|1
2146159|NCT01148017|3756724|FG000|Overall Study|Withdrawal by Subject|31
2146160|NCT01148017|3756725|FG001|Overall Study|Withdrawal by Subject|14
2146161|NCT01148017|3756726|FG002|Overall Study|Withdrawal by Subject|0
2146162|NCT01148017|3756727|FG003|Overall Study|Withdrawal by Subject|0
2146163|NCT01148017|3756724|FG000|Overall Study|Lost to Follow-up|23
2146164|NCT01148017|3756725|FG001|Overall Study|Lost to Follow-up|10
2146165|NCT01148017|3756726|FG002|Overall Study|Lost to Follow-up|0
2146166|NCT01148017|3756727|FG003|Overall Study|Lost to Follow-up|0
2146167|NCT01148017|3756724|FG000|Overall Study|Inappropriate enrollment|1
2146168|NCT01148017|3756725|FG001|Overall Study|Inappropriate enrollment|0
2146169|NCT01148017|3756726|FG002|Overall Study|Inappropriate enrollment|0
2146170|NCT01148017|3756727|FG003|Overall Study|Inappropriate enrollment|0
2146171|NCT01148017|3756724|FG000|Overall Study|Administrative reason|22
2146172|NCT01148017|3756725|FG001|Overall Study|Administrative reason|9
2146173|NCT01148017|3756726|FG002|Overall Study|Administrative reason|0
2146174|NCT01148017|3756727|FG003|Overall Study|Administrative reason|0
2146175|NCT01148017|3756724|FG000|Overall Study|Unable to classify|3
2146176|NCT01148017|3756725|FG001|Overall Study|Unable to classify|1
2146177|NCT01148017|3756726|FG002|Overall Study|Unable to classify|0
2146178|NCT01148017|3756727|FG003|Overall Study|Unable to classify|0
2146179|NCT01148225|3756738|FG000|Overall Study|Other|185
2146180|NCT01148459|3756752|FG000|Overall Study|Serious Adverse Event|5
2146181|NCT01148459|3756753|FG001|Overall Study|Serious Adverse Event|4
2146182|NCT01148459|3756752|FG000|Overall Study|Withdrawal by Subject|1
2146183|NCT01148459|3756753|FG001|Overall Study|Withdrawal by Subject|0
2146184|NCT01148459|3756752|FG000|Overall Study|Migrated/moved from study area|3
2146185|NCT01148459|3756753|FG001|Overall Study|Migrated/moved from study area|6
2146186|NCT01148459|3756752|FG000|Overall Study|Lost to Follow-up|2
2146187|NCT01148459|3756753|FG001|Overall Study|Lost to Follow-up|0
2146188|NCT01148459|3756752|FG000|Overall Study|Refusal|1
2146189|NCT01148459|3756753|FG001|Overall Study|Refusal|0
2146190|NCT01148459|3756752|FG000|Overall Study|Failure to comply with study procedures|0
2146191|NCT01148459|3756753|FG001|Overall Study|Failure to comply with study procedures|1
2146192|NCT01148511|3756761|FG000|Exposed to Study Drug|Protocol Violation|2
2146193|NCT01148511|3756762|FG001|Exposed to Study Drug|Protocol Violation|0
2146194|NCT01148511|3756763|FG002|Exposed to Study Drug|Protocol Violation|0
2146195|NCT01148511|3756761|FG000|Exposed to Study Drug|Lost to Follow-up|4
2146196|NCT01148511|3756762|FG001|Exposed to Study Drug|Lost to Follow-up|0
2146197|NCT01148511|3756763|FG002|Exposed to Study Drug|Lost to Follow-up|0
2146198|NCT01148511|3756761|FG000|Randomized|Adverse Event|0
2146199|NCT01148511|3756762|FG001|Randomized|Adverse Event|1
2146200|NCT01148511|3756763|FG002|Randomized|Adverse Event|0
2146201|NCT01148511|3756761|FG000|Randomized|Protocol Violation|0
2146202|NCT01148511|3756762|FG001|Randomized|Protocol Violation|2
2146203|NCT01148511|3756763|FG002|Randomized|Protocol Violation|1
2146204|NCT01148511|3756761|FG000|Randomized|Lost to Follow-up|0
2146205|NCT01148511|3756762|FG001|Randomized|Lost to Follow-up|1
2146206|NCT01148511|3756763|FG002|Randomized|Lost to Follow-up|1
2146207|NCT01148511|3756761|FG000|Randomized|Consent withdrawal|0
2146208|NCT01148511|3756762|FG001|Randomized|Consent withdrawal|5
2146209|NCT01148511|3756763|FG002|Randomized|Consent withdrawal|3
2146210|NCT01148511|3756761|FG000|Randomized|Other|0
2146211|NCT01148511|3756762|FG001|Randomized|Other|1
2146212|NCT01148511|3756763|FG002|Randomized|Other|1
2146213|NCT01148537|3756810|FG000|Overall Study|Withdrawal by Subject|1
2146214|NCT01148537|3756811|FG001|Overall Study|Withdrawal by Subject|0
2146215|NCT01148537|3756812|FG002|Overall Study|Withdrawal by Subject|2
2146216|NCT01148537|3756810|FG000|Overall Study|Adverse Event|2
2146217|NCT01148537|3756811|FG001|Overall Study|Adverse Event|0
2146218|NCT01148537|3756812|FG002|Overall Study|Adverse Event|1
2146219|NCT01148693|3756833|FG000|Overall Study|Attempts for cannulation were failed|13
2146220|NCT01148693|3756834|FG001|Overall Study|Attempts for cannulation were failed|10
2146221|NCT01148771|3756848|FG000|Washout Period|Withdrawal by Subject|0
2146222|NCT01148771|3756849|FG001|Washout Period|Withdrawal by Subject|1
2146223|NCT01148810|3756861|FG000|Overall Study|Adverse Event|0
2146224|NCT01148810|3756862|FG001|Overall Study|Adverse Event|2
2146225|NCT01148810|3756861|FG000|Overall Study|Lack of Efficacy|0
2146226|NCT01148810|3756862|FG001|Overall Study|Lack of Efficacy|1
2146227|NCT01148810|3756861|FG000|Overall Study|Withdrawal by Subject|0
2146228|NCT01148810|3756862|FG001|Overall Study|Withdrawal by Subject|2
2146229|NCT01148810|3756861|FG000|Overall Study|Protocol Violation|1
2146230|NCT01148810|3756862|FG001|Overall Study|Protocol Violation|0
2146231|NCT01148862|3756878|FG000|Second Intervention|Withdrawal by Subject|0
2146232|NCT01148862|3756879|FG001|Second Intervention|Withdrawal by Subject|2
2146233|NCT01148979|3756899|FG000|Overall Study|Lost to Follow-up|0
2146234|NCT01148979|3756900|FG001|Overall Study|Lost to Follow-up|1
2146235|NCT01149057|3756906|FG000|Overall Study|Lack of Efficacy|16
2146236|NCT01149057|3756906|FG000|Overall Study|Adverse Event|13
2146237|NCT01149057|3756906|FG000|Overall Study|Withdrawal by Subject|9
2146238|NCT01149057|3756906|FG000|Overall Study|Positive Hepatitis B Core Antibody|5
2146239|NCT01149057|3756906|FG000|Overall Study|B Cell Depletion|4
2146240|NCT01149057|3756906|FG000|Overall Study|Participant Non-Compliance|2
2146241|NCT01149057|3756906|FG000|Overall Study|Lost to Follow-up|1
2146242|NCT01149057|3756906|FG000|Overall Study|High Parathyroid Hormone Value|1
2146243|NCT01149057|3756906|FG000|Overall Study|Other|6
2146244|NCT01149096|3756912|FG000|Overall Study|Lost to Follow-up|0
2146245|NCT01149096|3756913|FG001|Overall Study|Lost to Follow-up|1
2146246|NCT01149148|3756922|FG000|Overall Study|Lost to Follow-up|1
2146247|NCT01149148|3756923|FG001|Overall Study|Lost to Follow-up|2
2208048|NCT01636076|3847428|FG000|Overall Study|Terminated by sponsor|1
2146248|NCT01149148|3756922|FG000|Overall Study|Death|1
2146249|NCT01149148|3756923|FG001|Overall Study|Death|0
2146250|NCT01149343|3756934|FG000|Overall Study|Withdrawal by Subject|1
2146251|NCT01149343|3756935|FG001|Overall Study|Withdrawal by Subject|1
2146252|NCT01149343|3756936|FG002|Overall Study|Withdrawal by Subject|1
2146253|NCT01149343|3756937|FG003|Overall Study|Withdrawal by Subject|5
2146254|NCT01149343|3756934|FG000|Overall Study|Death|10
2146255|NCT01149343|3756935|FG001|Overall Study|Death|13
2146256|NCT01149343|3756936|FG002|Overall Study|Death|18
2146257|NCT01149343|3756937|FG003|Overall Study|Death|18
2146258|NCT01149343|3756934|FG000|Overall Study|Lost to Follow-up|1
2146259|NCT01149343|3756935|FG001|Overall Study|Lost to Follow-up|0
2146260|NCT01149343|3756936|FG002|Overall Study|Lost to Follow-up|0
2146261|NCT01149343|3756937|FG003|Overall Study|Lost to Follow-up|1
2146262|NCT01149343|3756934|FG000|Overall Study|Other|8
2146263|NCT01149343|3756935|FG001|Overall Study|Other|10
2146264|NCT01149343|3756936|FG002|Overall Study|Other|2
2146265|NCT01149343|3756937|FG003|Overall Study|Other|14
2146266|NCT01149343|3756934|FG000|Overall Study|Sponsor study termination|0
2146267|NCT01149343|3756935|FG001|Overall Study|Sponsor study termination|0
2146268|NCT01149343|3756936|FG002|Overall Study|Sponsor study termination|0
2146269|NCT01149343|3756937|FG003|Overall Study|Sponsor study termination|2
2146270|NCT01149343|3756934|FG000|Overall Study|Recurrence / Progressive disease|0
2146271|NCT01149343|3756935|FG001|Overall Study|Recurrence / Progressive disease|0
2146272|NCT01149343|3756936|FG002|Overall Study|Recurrence / Progressive disease|1
2146273|NCT01149343|3756937|FG003|Overall Study|Recurrence / Progressive disease|0
2146274|NCT01149369|3756953|FG000|Overall Study|Adverse Event|6
2146275|NCT01149369|3756954|FG001|Overall Study|Adverse Event|3
2146276|NCT01149421|3756963|FG000|Overall Study|Adverse Event|22
2146277|NCT01149421|3756964|FG001|Overall Study|Adverse Event|6
2146278|NCT01149421|3756965|FG002|Overall Study|Adverse Event|11
2146279|NCT01149421|3756963|FG000|Overall Study|Withdrawal by Subject|20
2146280|NCT01149421|3756964|FG001|Overall Study|Withdrawal by Subject|12
2146281|NCT01149421|3756965|FG002|Overall Study|Withdrawal by Subject|13
2146282|NCT01149421|3756963|FG000|Overall Study|Sponsor Decision|0
2146283|NCT01149421|3756964|FG001|Overall Study|Sponsor Decision|1
2146284|NCT01149421|3756965|FG002|Overall Study|Sponsor Decision|1
2146285|NCT01149421|3756963|FG000|Overall Study|Lost to Follow-up|2
2146286|NCT01149421|3756964|FG001|Overall Study|Lost to Follow-up|4
2146287|NCT01149421|3756965|FG002|Overall Study|Lost to Follow-up|5
2146288|NCT01149421|3756963|FG000|Overall Study|Physician Decision|5
2146289|NCT01149421|3756964|FG001|Overall Study|Physician Decision|3
2146290|NCT01149421|3756965|FG002|Overall Study|Physician Decision|6
2146291|NCT01149421|3756963|FG000|Overall Study|Entry Criteria Not Met|1
2146292|NCT01149421|3756964|FG001|Overall Study|Entry Criteria Not Met|1
2146293|NCT01149421|3756965|FG002|Overall Study|Entry Criteria Not Met|2
2146294|NCT01149421|3756963|FG000|Overall Study|Protocol Violation|2
2146295|NCT01149421|3756964|FG001|Overall Study|Protocol Violation|2
2146296|NCT01149421|3756965|FG002|Overall Study|Protocol Violation|6
2146297|NCT01149460|3756985|FG000|Overall Study|Withdrawal by Subject|0
2146298|NCT01149460|3756986|FG001|Overall Study|Withdrawal by Subject|2
2146299|NCT01149473|3756994|FG000|First Intervention|Adverse Event|1
2146300|NCT01149473|3756995|FG001|First Intervention|Adverse Event|1
2146301|NCT01149473|3756994|FG000|Washout of 7 Days|Withdrawal by Subject|1
2146302|NCT01149473|3756995|FG001|Washout of 7 Days|Withdrawal by Subject|1
2146303|NCT01149486|3757003|FG000|First Intervention|Adverse Event|0
2146304|NCT01149486|3757004|FG001|First Intervention|Adverse Event|1
2146305|NCT01149538|3757016|FG000|Overall Study|Lost to Follow-up|0
2146306|NCT01149538|3757017|FG001|Overall Study|Lost to Follow-up|1
2146307|NCT01149538|3757016|FG000|Overall Study|Withdrawal by Subject|5
2146308|NCT01149538|3757017|FG001|Overall Study|Withdrawal by Subject|3
2146309|NCT01149655|3757036|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1
2146310|NCT01149655|3757037|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0
2146311|NCT01149655|3757038|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0
2146312|NCT01149655|3757039|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0
2146313|NCT01149655|3757036|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
2146314|NCT01149655|3757037|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
2146315|NCT01149655|3757038|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
2146316|NCT01149655|3757039|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
2146317|NCT01149655|3757036|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
2146318|NCT01149655|3757037|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2146319|NCT01149655|3757038|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2146320|NCT01149655|3757039|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2146321|NCT01149655|3757036|FG000|Period 1 - Conversion Phase|Physician Decision|2
2146322|NCT01149655|3757037|FG001|Period 1 - Conversion Phase|Physician Decision|0
2146323|NCT01149655|3757038|FG002|Period 1 - Conversion Phase|Physician Decision|0
2146324|NCT01149655|3757039|FG003|Period 1 - Conversion Phase|Physician Decision|0
2146325|NCT01149655|3757036|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
2146326|NCT01149655|3757037|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
2146327|NCT01149655|3757038|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0
2146328|NCT01149655|3757039|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0
2146329|NCT01149655|3757036|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
2146330|NCT01149655|3757037|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
2146331|NCT01149655|3757038|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
2146332|NCT01149655|3757039|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
2146333|NCT01149655|3757036|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
2146334|NCT01149655|3757037|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
2146335|NCT01149655|3757038|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
2146336|NCT01149655|3757039|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
2146337|NCT01149655|3757036|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
2146338|NCT01149655|3757037|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
2146339|NCT01149655|3757038|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
2146340|NCT01149655|3757039|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
2146341|NCT01149655|3757036|FG000|Period 2-Stabilization Phase|Physician Decision|0
2146342|NCT01149655|3757037|FG001|Period 2-Stabilization Phase|Physician Decision|3
2146343|NCT01149655|3757038|FG002|Period 2-Stabilization Phase|Physician Decision|0
2146344|NCT01149655|3757039|FG003|Period 2-Stabilization Phase|Physician Decision|0
2146345|NCT01149655|3757036|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0
2146346|NCT01149655|3757037|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5
2146347|NCT01149655|3757038|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0
2146348|NCT01149655|3757039|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0
2146349|NCT01149655|3757036|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
2146350|NCT01149655|3757037|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
2146351|NCT01149655|3757038|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
2146352|NCT01149655|3757039|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
2146353|NCT01149655|3757036|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
2146354|NCT01149655|3757037|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
2146355|NCT01149655|3757038|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
2146356|NCT01149655|3757039|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
2146357|NCT01149655|3757036|FG000|Period 3-DB Maintenance Phase|Physician Decision|0
2146358|NCT01149655|3757037|FG001|Period 3-DB Maintenance Phase|Physician Decision|0
2146359|NCT01149655|3757038|FG002|Period 3-DB Maintenance Phase|Physician Decision|1
2146360|NCT01149655|3757039|FG003|Period 3-DB Maintenance Phase|Physician Decision|0
2146361|NCT01149655|3757036|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
2146362|NCT01149655|3757037|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
2146363|NCT01149655|3757038|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
2146364|NCT01149655|3757039|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
2146365|NCT01149655|3757036|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
2146366|NCT01149655|3757037|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
2146367|NCT01149655|3757038|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
2146368|NCT01149655|3757039|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
2146369|NCT01149655|3757036|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0
2146370|NCT01149655|3757037|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0
2146371|NCT01149655|3757038|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19
2146372|NCT01149655|3757039|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18
2146373|NCT01149681|3757047|FG000|Overall Study|Withdrawal by Subject|7
2146374|NCT01149681|3757047|FG000|Overall Study|Progressive disease|1
2208049|NCT01636076|3847429|FG001|Overall Study|Terminated by sponsor|1
2208050|NCT01636076|3847428|FG000|Overall Study|Lack of Efficacy|0
2208051|NCT01636076|3847429|FG001|Overall Study|Lack of Efficacy|1
2208052|NCT01636076|3847428|FG000|Overall Study|Lost to Follow-up|1
2208053|NCT01636076|3847429|FG001|Overall Study|Lost to Follow-up|0
2208054|NCT01636076|3847428|FG000|Overall Study|Physician Decision|1
2208055|NCT01636076|3847429|FG001|Overall Study|Physician Decision|1
2208056|NCT01636076|3847428|FG000|Overall Study|Non-compliance with study treatment|1
2208057|NCT01636076|3847429|FG001|Overall Study|Non-compliance with study treatment|1
2208058|NCT01636076|3847428|FG000|Overall Study|Adverse Event|6
2208059|NCT01636076|3847429|FG001|Overall Study|Adverse Event|11
2208060|NCT01636076|3847428|FG000|Overall Study|Withdrawal by Subject|7
2208061|NCT01636076|3847429|FG001|Overall Study|Withdrawal by Subject|10
2208062|NCT01636258|3847463|FG000|Overall Study|Lost to Follow-up|1
2208063|NCT01636258|3847464|FG001|Overall Study|Lost to Follow-up|0
2208064|NCT01636362|3847490|FG000|Overall Study|Physician Decision|6
2290405|NCT02489968|3982979|FG003|Double-blind Treatment Period|Adverse Event|6
2290406|NCT02489968|3982980|FG004|Double-blind Treatment Period|Adverse Event|4
2146375|NCT01149681|3757047|FG000|Overall Study|Physician Decision|2
2146376|NCT01149681|3757047|FG000|Overall Study|adverse events nonrelated study drug|2
2146377|NCT01149863|3757083|FG000|Overall Study|Missing data or Not receiveing studydrug|3
2146378|NCT01150045|3757109|FG000|Overall Study|Protocol Violation|0
2146379|NCT01150045|3757110|FG001|Overall Study|Protocol Violation|1
2146380|NCT01150045|3757111|FG002|Overall Study|Protocol Violation|0
2146381|NCT01150045|3757112|FG003|Overall Study|Protocol Violation|1
2146382|NCT01150097|3757123|FG000|Months 24 to 36 Post-transplantation|Death|2
2146383|NCT01150097|3757124|FG001|Months 24 to 36 Post-transplantation|Death|0
2146384|NCT01150097|3757125|FG002|Months 24 to 36 Post-transplantation|Death|0
2146385|NCT01150097|3757123|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5
2146386|NCT01150097|3757124|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2
2146387|NCT01150097|3757125|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2
2146388|NCT01150097|3757123|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
2146389|NCT01150097|3757124|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
2146390|NCT01150097|3757125|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
2146391|NCT01150097|3757123|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
2146392|NCT01150097|3757124|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
2146393|NCT01150097|3757125|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
2208065|NCT01636362|3847490|FG000|Overall Study|Subject healed, not returning|1
2208066|NCT01636362|3847490|FG000|Overall Study|Withdrawal by Subject|1
2146394|NCT01150097|3757123|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5
2146395|NCT01150097|3757124|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4
2146396|NCT01150097|3757125|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0
2146397|NCT01150097|3757123|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
2146398|NCT01150097|3757124|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
2146399|NCT01150097|3757125|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
2146400|NCT01150097|3757123|FG000|Months 24 to 48 Post-transplantation|Death|2
2146401|NCT01150097|3757124|FG001|Months 24 to 48 Post-transplantation|Death|0
2146402|NCT01150097|3757125|FG002|Months 24 to 48 Post-transplantation|Death|0
2146403|NCT01150123|3757153|FG000|Overall Study|Withdrawal by Subject|1
2146404|NCT01150123|3757154|FG001|Overall Study|Withdrawal by Subject|1
2146405|NCT01150123|3757155|FG002|Overall Study|Withdrawal by Subject|2
2146406|NCT01150123|3757156|FG003|Overall Study|Withdrawal by Subject|1
2146407|NCT01150123|3757157|FG004|Overall Study|Withdrawal by Subject|1
2146408|NCT01150123|3757158|FG005|Overall Study|Withdrawal by Subject|1
2146409|NCT01150123|3757159|FG006|Overall Study|Withdrawal by Subject|0
2146410|NCT01150123|3757160|FG007|Overall Study|Withdrawal by Subject|3
2146411|NCT01150123|3757161|FG008|Overall Study|Withdrawal by Subject|2
2146412|NCT01150123|3757162|FG009|Overall Study|Withdrawal by Subject|0
2146413|NCT01150123|3757163|FG010|Overall Study|Withdrawal by Subject|1
2146414|NCT01150123|3757164|FG011|Overall Study|Withdrawal by Subject|0
2146415|NCT01150123|3757165|FG012|Overall Study|Withdrawal by Subject|1
2146416|NCT01150123|3757166|FG013|Overall Study|Withdrawal by Subject|0
2146417|NCT01150123|3757167|FG014|Overall Study|Withdrawal by Subject|0
2146418|NCT01150123|3757168|FG015|Overall Study|Withdrawal by Subject|1
2146419|NCT01150123|3757169|FG016|Overall Study|Withdrawal by Subject|0
2146420|NCT01150123|3757170|FG017|Overall Study|Withdrawal by Subject|1
2146421|NCT01150123|3757153|FG000|Overall Study|Lost to Follow-up|2
2146422|NCT01150123|3757154|FG001|Overall Study|Lost to Follow-up|1
2146423|NCT01150123|3757155|FG002|Overall Study|Lost to Follow-up|2
2146424|NCT01150123|3757156|FG003|Overall Study|Lost to Follow-up|2
2146425|NCT01150123|3757157|FG004|Overall Study|Lost to Follow-up|2
2146426|NCT01150123|3757158|FG005|Overall Study|Lost to Follow-up|5
2146427|NCT01150123|3757159|FG006|Overall Study|Lost to Follow-up|0
2146428|NCT01150123|3757160|FG007|Overall Study|Lost to Follow-up|0
2146429|NCT01150123|3757161|FG008|Overall Study|Lost to Follow-up|3
2146430|NCT01150123|3757162|FG009|Overall Study|Lost to Follow-up|1
2146431|NCT01150123|3757163|FG010|Overall Study|Lost to Follow-up|1
2146432|NCT01150123|3757164|FG011|Overall Study|Lost to Follow-up|1
2146433|NCT01150123|3757165|FG012|Overall Study|Lost to Follow-up|2
2146434|NCT01150123|3757166|FG013|Overall Study|Lost to Follow-up|0
2146435|NCT01150123|3757167|FG014|Overall Study|Lost to Follow-up|0
2146436|NCT01150123|3757168|FG015|Overall Study|Lost to Follow-up|0
2146437|NCT01150123|3757169|FG016|Overall Study|Lost to Follow-up|0
2146438|NCT01150123|3757170|FG017|Overall Study|Lost to Follow-up|0
2146439|NCT01150357|3757230|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0
2146440|NCT01150357|3757231|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1
2290407|NCT02489968|3982981|FG005|Double-blind Treatment Period|Adverse Event|5
2290408|NCT02489968|3982976|FG000|Double-blind Treatment Period|Protocol Violation|0
2290409|NCT02489968|3982977|FG001|Double-blind Treatment Period|Protocol Violation|0
2290410|NCT02489968|3982978|FG002|Double-blind Treatment Period|Protocol Violation|0
2290411|NCT02489968|3982979|FG003|Double-blind Treatment Period|Protocol Violation|0
2290412|NCT02489968|3982980|FG004|Double-blind Treatment Period|Protocol Violation|1
2290413|NCT02489968|3982981|FG005|Double-blind Treatment Period|Protocol Violation|1
2290414|NCT02489968|3982976|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
2290415|NCT02489968|3982977|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
2290416|NCT02489968|3982978|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
2290417|NCT02489968|3982979|FG003|Double-blind Treatment Period|Withdrawal by Subject|2
2290418|NCT02489968|3982980|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
2290419|NCT02489968|3982981|FG005|Double-blind Treatment Period|Withdrawal by Subject|2
2290420|NCT02489968|3982976|FG000|Double-blind Treatment Period|Other than specified above|0
2290421|NCT02489968|3982977|FG001|Double-blind Treatment Period|Other than specified above|0
2290422|NCT02489968|3982978|FG002|Double-blind Treatment Period|Other than specified above|0
2290423|NCT02489968|3982979|FG003|Double-blind Treatment Period|Other than specified above|0
2290424|NCT02489968|3982980|FG004|Double-blind Treatment Period|Other than specified above|1
2290425|NCT02489968|3982981|FG005|Double-blind Treatment Period|Other than specified above|0
2290426|NCT02489981|3982993|FG000|Overall Study|Adverse Event|21
2290427|NCT02489981|3982993|FG000|Overall Study|Insufficient effectiveness|16
2290428|NCT02489981|3982993|FG000|Overall Study|Improved|31
2290429|NCT02489981|3982993|FG000|Overall Study|Lost to Follow-up|31
2290430|NCT02489981|3982993|FG000|Overall Study|Other than listed|28
2290431|NCT02490371|3983008|FG000|Overall Study|Lost to Follow-up|1
2290432|NCT02490371|3983009|FG001|Overall Study|Lost to Follow-up|1
2290433|NCT02490475|3983019|FG000|Period 1: First 6 Cycles|Adverse Event|2
2290434|NCT02490475|3983020|FG001|Period 1: First 6 Cycles|Adverse Event|1
2146441|NCT01150357|3757232|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1
2146442|NCT01150357|3757230|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
2146443|NCT01150357|3757231|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
2146444|NCT01150357|3757232|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
2146445|NCT01150357|3757230|FG000|Dose Response Phase (Phase 1)|Adverse Event|0
2146446|NCT01150357|3757231|FG001|Dose Response Phase (Phase 1)|Adverse Event|0
2146447|NCT01150357|3757232|FG002|Dose Response Phase (Phase 1)|Adverse Event|1
2146448|NCT01150357|3757230|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
2146449|NCT01150357|3757231|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
2146450|NCT01150357|3757232|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
2146451|NCT01150357|3757230|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
2146452|NCT01150357|3757231|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
2146453|NCT01150357|3757232|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
2146454|NCT01150357|3757230|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
2146455|NCT01150357|3757231|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
2146456|NCT01150357|3757232|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
2146457|NCT01150357|3757230|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
2146458|NCT01150357|3757231|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
2146459|NCT01150357|3757232|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
2146460|NCT01150474|3757263|FG000|Overall Study|Withdrawal by Subject|5
2146461|NCT01150474|3757264|FG001|Overall Study|Withdrawal by Subject|2
2290435|NCT02490475|3983021|FG002|Period 1: First 6 Cycles|Adverse Event|0
2290436|NCT02490475|3983022|FG003|Period 1: First 6 Cycles|Adverse Event|1
2290437|NCT02490475|3983019|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
2290438|NCT02490475|3983020|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
2290439|NCT02490475|3983021|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
2290440|NCT02490475|3983022|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
2290441|NCT02490475|3983019|FG000|Period 1: First 6 Cycles|Refused Treatment|1
2290442|NCT02490475|3983020|FG001|Period 1: First 6 Cycles|Refused Treatment|0
2290443|NCT02490475|3983021|FG002|Period 1: First 6 Cycles|Refused Treatment|0
2290444|NCT02490475|3983022|FG003|Period 1: First 6 Cycles|Refused Treatment|0
2290445|NCT02490475|3983019|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
2290446|NCT02490475|3983020|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
2290447|NCT02490475|3983021|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
2290448|NCT02490475|3983022|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
2290449|NCT02490475|3983019|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1
2290450|NCT02490475|3983020|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0
2290451|NCT02490475|3983021|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2
2290452|NCT02490475|3983022|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0
2290453|NCT02490475|3983019|FG000|Period 2: Extension Phase|Refused Treatment|0
2290454|NCT02490475|3983020|FG001|Period 2: Extension Phase|Refused Treatment|0
2290455|NCT02490475|3983021|FG002|Period 2: Extension Phase|Refused Treatment|0
2290456|NCT02490475|3983022|FG003|Period 2: Extension Phase|Refused Treatment|1
2290457|NCT02490475|3983019|FG000|Period 2: Extension Phase|Adverse Event|0
2290458|NCT02490475|3983020|FG001|Period 2: Extension Phase|Adverse Event|0
2290459|NCT02490475|3983021|FG002|Period 2: Extension Phase|Adverse Event|1
2290460|NCT02490475|3983022|FG003|Period 2: Extension Phase|Adverse Event|0
2290461|NCT02490878|3983063|FG000|Overall Study|deemed ineligible|0
2290462|NCT02490878|3983064|FG001|Overall Study|deemed ineligible|1
2290463|NCT02490878|3983063|FG000|Overall Study|progression prior to treatment|0
2290464|NCT02490878|3983064|FG001|Overall Study|progression prior to treatment|1
2290465|NCT02490878|3983063|FG000|Overall Study|only submitted baseline QOL|0
2290466|NCT02490878|3983064|FG001|Overall Study|only submitted baseline QOL|1
2290467|NCT02491073|3983072|FG000|Overall Study|screen failure|1
2290468|NCT02491073|3983073|FG001|Overall Study|screen failure|0
2290469|NCT02491463|3983116|FG000|Overall Study|Withdrawal by Subject|1
2290470|NCT02491463|3983117|FG001|Overall Study|Withdrawal by Subject|2
2290471|NCT02491463|3983118|FG002|Overall Study|Withdrawal by Subject|0
2290472|NCT02491463|3983119|FG003|Overall Study|Withdrawal by Subject|0
2290473|NCT02491463|3983116|FG000|Overall Study|Migrated/moved from study area|1
2290474|NCT02491463|3983117|FG001|Overall Study|Migrated/moved from study area|5
2290475|NCT02491463|3983118|FG002|Overall Study|Migrated/moved from study area|1
2290476|NCT02491463|3983119|FG003|Overall Study|Migrated/moved from study area|1
2290477|NCT02491463|3983116|FG000|Overall Study|Lost to Follow-up|0
2290478|NCT02491463|3983117|FG001|Overall Study|Lost to Follow-up|3
2290479|NCT02491463|3983118|FG002|Overall Study|Lost to Follow-up|3
2290480|NCT02491463|3983119|FG003|Overall Study|Lost to Follow-up|0
2290481|NCT02491671|3983131|FG000|Overall Study|Adverse Event|6
2290482|NCT02491671|3983132|FG001|Overall Study|Adverse Event|8
2290483|NCT02491671|3983131|FG000|Overall Study|Death|0
2290484|NCT02491671|3983132|FG001|Overall Study|Death|2
2290485|NCT02491671|3983131|FG000|Overall Study|Use of sealants other than Hemopatch|5
2290486|NCT02491671|3983132|FG001|Overall Study|Use of sealants other than Hemopatch|3
2290487|NCT02491684|3983140|FG000|Treatment Phase|Adverse Event|2
2290488|NCT02491684|3983141|FG001|Treatment Phase|Adverse Event|2
2290489|NCT02491684|3983140|FG000|Treatment Phase|Incorrect randomisation|1
2290490|NCT02491684|3983141|FG001|Treatment Phase|Incorrect randomisation|0
2290491|NCT02491684|3983140|FG000|Treatment Phase|Investigator and Sponsor decision|0
2146462|NCT01150474|3757263|FG000|Overall Study|Cancer found|1
2146463|NCT01150474|3757264|FG001|Overall Study|Cancer found|0
2146464|NCT01150474|3757263|FG000|Overall Study|Multiple Studies|0
2146465|NCT01150474|3757264|FG001|Overall Study|Multiple Studies|1
2146466|NCT01150474|3757263|FG000|Overall Study|Rectotomy|1
2146467|NCT01150474|3757264|FG001|Overall Study|Rectotomy|0
2146468|NCT01150474|3757263|FG000|Overall Study|Drug did not arrive in time|1
2146469|NCT01150474|3757264|FG001|Overall Study|Drug did not arrive in time|0
2146470|NCT01150474|3757263|FG000|Overall Study|Drug not administered|1
2146471|NCT01150474|3757264|FG001|Overall Study|Drug not administered|0
2146472|NCT01150474|3757263|FG000|Overall Study|Surgery Changed|1
2146473|NCT01150474|3757264|FG001|Overall Study|Surgery Changed|0
2146474|NCT01151020|3757319|FG000|Overall Study|Death|25
2146475|NCT01151020|3757319|FG000|Overall Study|Conversion to open repair|1
2146476|NCT01151020|3757319|FG000|Overall Study|Lost to Follow-up|4
2146477|NCT01151020|3757319|FG000|Overall Study|Withdrawal by Subject|22
2146478|NCT01151020|3757319|FG000|Overall Study|Patients did not receive the device|2
2146479|NCT01151085|3757336|FG000|Overall Study|Lost to Follow-up|31
2146480|NCT01151085|3757336|FG000|Overall Study|Protocol Violation|25
2146481|NCT01151098|3757347|FG000|Overall Study|Adverse Event|82
2146482|NCT01151098|3757347|FG000|Overall Study|Lost to Follow-up|6
2146483|NCT01151098|3757347|FG000|Overall Study|Lack of Efficacy|15
2146484|NCT01151098|3757347|FG000|Overall Study|Protocol Violation|1
2146485|NCT01151098|3757347|FG000|Overall Study|Miscellaneous|13
2146486|NCT01151137|3757353|FG000|Overall Study|Death|15
2146487|NCT01151137|3757354|FG001|Overall Study|Death|27
2146488|NCT01151137|3757353|FG000|Overall Study|Lost to Follow-up|1
2146489|NCT01151137|3757354|FG001|Overall Study|Lost to Follow-up|1
2146490|NCT01151215|3757372|FG000|Overall Study|Worsening of condition under study|1
2146491|NCT01151215|3757373|FG001|Overall Study|Worsening of condition under study|1
2146492|NCT01151215|3757374|FG002|Overall Study|Worsening of condition under study|1
2146493|NCT01151215|3757372|FG000|Overall Study|Death|16
2146494|NCT01151215|3757373|FG001|Overall Study|Death|20
2146495|NCT01151215|3757374|FG002|Overall Study|Death|11
2146496|NCT01151215|3757372|FG000|Overall Study|Lost to Follow-up|0
2146497|NCT01151215|3757373|FG001|Overall Study|Lost to Follow-up|0
2146498|NCT01151215|3757374|FG002|Overall Study|Lost to Follow-up|3
2146499|NCT01151215|3757372|FG000|Overall Study|Withdrawal by Subject|3
2146500|NCT01151215|3757373|FG001|Overall Study|Withdrawal by Subject|1
2146501|NCT01151215|3757374|FG002|Overall Study|Withdrawal by Subject|2
2146502|NCT01151215|3757372|FG000|Overall Study|Disease progression|0
2146503|NCT01151215|3757373|FG001|Overall Study|Disease progression|1
2146504|NCT01151215|3757374|FG002|Overall Study|Disease progression|1
2146505|NCT01151215|3757372|FG000|Overall Study|Safety as judged by the investigator|0
2146506|NCT01151215|3757373|FG001|Overall Study|Safety as judged by the investigator|0
2146507|NCT01151215|3757374|FG002|Overall Study|Safety as judged by the investigator|1
2146508|NCT01151280|3757382|FG000|Overall Study|Adverse Event|1
2146509|NCT01151280|3757382|FG000|Overall Study|Lack of Efficacy|3
2146510|NCT01151345|3757386|FG000|First Intervention Period|Protocol Violation|0
2146511|NCT01151345|3757387|FG001|First Intervention Period|Protocol Violation|1
2146512|NCT01151410|3757408|FG000|Overall Study|Withdrawal by Subject|3
2146513|NCT01151410|3757409|FG001|Overall Study|Withdrawal by Subject|5
2146514|NCT01151410|3757408|FG000|Overall Study|Lost to Follow-up|3
2146515|NCT01151410|3757409|FG001|Overall Study|Lost to Follow-up|4
2146516|NCT01151410|3757408|FG000|Overall Study|Adverse Event|1
2146517|NCT01151410|3757409|FG001|Overall Study|Adverse Event|2
2146518|NCT01151410|3757408|FG000|Overall Study|Protocol deviation|2
2146519|NCT01151410|3757409|FG001|Overall Study|Protocol deviation|1
2146520|NCT01151410|3757408|FG000|Overall Study|Administrative problems|1
2146521|NCT01151410|3757409|FG001|Overall Study|Administrative problems|1
2146522|NCT01151410|3757408|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2146523|NCT01151410|3757409|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2146524|NCT01151410|3757408|FG000|Overall Study|Abnormal laboratory value(s)|0
2146525|NCT01151410|3757409|FG001|Overall Study|Abnormal laboratory value(s)|1
2146526|NCT01151423|3757417|FG000|Overall Study|Study terminated by Sponsor|9
2146527|NCT01151423|3757418|FG001|Overall Study|Study terminated by Sponsor|10
2146528|NCT01151423|3757417|FG000|Overall Study|Protocol Violation|0
2146529|NCT01151423|3757418|FG001|Overall Study|Protocol Violation|1
2146530|NCT01151423|3757417|FG000|Overall Study|Physician Decision|1
2146531|NCT01151423|3757418|FG001|Overall Study|Physician Decision|1
2146532|NCT01151423|3757417|FG000|Overall Study|Pregnancy|0
2146533|NCT01151423|3757418|FG001|Overall Study|Pregnancy|1
2146534|NCT01151423|3757417|FG000|Overall Study|Death|0
2146535|NCT01151423|3757418|FG001|Overall Study|Death|1
2146536|NCT01151423|3757417|FG000|Overall Study|Adverse Event|3
2146537|NCT01151423|3757418|FG001|Overall Study|Adverse Event|0
2146538|NCT01151423|3757417|FG000|Overall Study|Withdrawal by Subject|1
2146539|NCT01151423|3757418|FG001|Overall Study|Withdrawal by Subject|3
2146540|NCT01151423|3757417|FG000|Overall Study|Lost to Follow-up|1
2146541|NCT01151423|3757418|FG001|Overall Study|Lost to Follow-up|0
2290492|NCT02491684|3983141|FG001|Treatment Phase|Investigator and Sponsor decision|1
2146542|NCT01151423|3757417|FG000|Overall Study|Diagnosed as non-TTP patient|0
2146543|NCT01151423|3757418|FG001|Overall Study|Diagnosed as non-TTP patient|1
2146544|NCT01151423|3757417|FG000|Overall Study|Participated in other clinical trial|1
2146545|NCT01151423|3757418|FG001|Overall Study|Participated in other clinical trial|0
2178883|NCT01389323|3803985|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
2178884|NCT01389323|3803985|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
2178885|NCT01389323|3803985|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
2178886|NCT01389323|3803985|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
2178887|NCT01389323|3803985|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
2178888|NCT01389323|3803985|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
2178889|NCT01389323|3803985|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
2178890|NCT01389323|3803985|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
2178891|NCT01389323|3803985|FG000|Follow-up Period (up to 48 Weeks)|Other|3
2178892|NCT01389596|3803999|FG000|Overall Study|Protocol Violation|3
2178893|NCT01389596|3804000|FG001|Overall Study|Protocol Violation|4
2178894|NCT01389596|3804001|FG002|Overall Study|Protocol Violation|3
2178895|NCT01389596|3803999|FG000|Overall Study|Withdrawal by Subject|1
2178896|NCT01389596|3804000|FG001|Overall Study|Withdrawal by Subject|2
2178897|NCT01389596|3804001|FG002|Overall Study|Withdrawal by Subject|2
2178898|NCT01389596|3803999|FG000|Overall Study|Insufficient Clinical Response|3
2178899|NCT01389596|3804000|FG001|Overall Study|Insufficient Clinical Response|4
2178900|NCT01389596|3804001|FG002|Overall Study|Insufficient Clinical Response|5
2178901|NCT01389596|3803999|FG000|Overall Study|Adverse Event|1
2178902|NCT01389596|3804000|FG001|Overall Study|Adverse Event|4
2178903|NCT01389596|3804001|FG002|Overall Study|Adverse Event|0
2178904|NCT01389596|3803999|FG000|Overall Study|Death|0
2178905|NCT01389596|3804000|FG001|Overall Study|Death|1
2178906|NCT01389596|3804001|FG002|Overall Study|Death|0
2178907|NCT01389596|3803999|FG000|Overall Study|Other Unspecified|2
2178908|NCT01389596|3804000|FG001|Overall Study|Other Unspecified|1
2178909|NCT01389596|3804001|FG002|Overall Study|Other Unspecified|0
2178910|NCT01389752|3804009|FG000|Study Period 1|Sponsor decision|0
2178911|NCT01389752|3804010|FG001|Study Period 1|Sponsor decision|2
2178912|NCT01389752|3804009|FG000|Study Period 2|Sponsor decision|1
2178913|NCT01389752|3804010|FG001|Study Period 2|Sponsor decision|0
2178914|NCT01389882|3804035|FG000|Overall Study|Respiratory rate > 80/min during study|1
2178915|NCT01389882|3804036|FG001|Overall Study|Respiratory rate > 80/min during study|3
2178916|NCT01389882|3804035|FG000|Overall Study|Withdrawal by Subject|0
2178917|NCT01389882|3804036|FG001|Overall Study|Withdrawal by Subject|1
2178918|NCT01389973|3804042|FG000|Overall Study|Lost to Follow-up|1
2178919|NCT01389973|3804042|FG000|Overall Study|Trial Stopped by Sponsor|9
2178920|NCT01389973|3804042|FG000|Overall Study|Other|10
2178921|NCT01390038|3804046|FG000|Overall Study|Death|1
2178922|NCT01390038|3804046|FG000|Overall Study|Lost to Follow-up|1
2178923|NCT01390038|3804046|FG000|Overall Study|Withdrawal by Subject|4
2178924|NCT01390038|3804046|FG000|Overall Study|Simpliciti System Removal|2
2178925|NCT01390220|3804068|FG000|Test Dose Phase|Adverse Event|17
2178926|NCT01390220|3804069|FG001|Test Dose Phase|Adverse Event|0
2178927|NCT01390220|3804070|FG002|Test Dose Phase|Adverse Event|0
2178928|NCT01390220|3804068|FG000|Test Dose Phase|Withdrawal by Subject|8
2178929|NCT01390220|3804069|FG001|Test Dose Phase|Withdrawal by Subject|0
2178930|NCT01390220|3804070|FG002|Test Dose Phase|Withdrawal by Subject|0
2178931|NCT01390220|3804068|FG000|Test Dose Phase|Lost to Follow-up|2
2178932|NCT01390220|3804069|FG001|Test Dose Phase|Lost to Follow-up|0
2178933|NCT01390220|3804070|FG002|Test Dose Phase|Lost to Follow-up|0
2178934|NCT01390220|3804068|FG000|Test Dose Phase|Protocol Violation|8
2178935|NCT01390220|3804069|FG001|Test Dose Phase|Protocol Violation|0
2178936|NCT01390220|3804070|FG002|Test Dose Phase|Protocol Violation|0
2178937|NCT01390220|3804068|FG000|Test Dose Phase|No treated seizure cluster episode|37
2178938|NCT01390220|3804069|FG001|Test Dose Phase|No treated seizure cluster episode|0
2178939|NCT01390220|3804070|FG002|Test Dose Phase|No treated seizure cluster episode|0
2178940|NCT01390220|3804068|FG000|Test Dose Phase|Study/Site closure|6
2178941|NCT01390220|3804069|FG001|Test Dose Phase|Study/Site closure|0
2178942|NCT01390220|3804070|FG002|Test Dose Phase|Study/Site closure|0
2178943|NCT01390220|3804068|FG000|Test Dose Phase|Caregiver no longer available|5
2178944|NCT01390220|3804069|FG001|Test Dose Phase|Caregiver no longer available|0
2178945|NCT01390220|3804070|FG002|Test Dose Phase|Caregiver no longer available|0
2178946|NCT01390220|3804068|FG000|Test Dose Phase|Noncompliance|2
2178947|NCT01390220|3804069|FG001|Test Dose Phase|Noncompliance|0
2178948|NCT01390220|3804070|FG002|Test Dose Phase|Noncompliance|0
2178949|NCT01390220|3804068|FG000|Test Dose Phase|Logistical|6
2178950|NCT01390220|3804069|FG001|Test Dose Phase|Logistical|0
2178951|NCT01390220|3804070|FG002|Test Dose Phase|Logistical|0
2178952|NCT01390220|3804068|FG000|Comparative Phase|Withdrawal by Subject|0
2178953|NCT01390220|3804069|FG001|Comparative Phase|Withdrawal by Subject|1
2178954|NCT01390220|3804070|FG002|Comparative Phase|Withdrawal by Subject|0
2180137|NCT01399099|3806101|FG000|Overall Study|Miscellaneous|4
2180138|NCT01399125|3806108|FG000|Overall Study|Adverse Event|32
2180139|NCT01399125|3806109|FG001|Overall Study|Adverse Event|30
2180140|NCT01399125|3806108|FG000|Overall Study|Abnormal Lab values|0
2180141|NCT01399125|3806109|FG001|Overall Study|Abnormal Lab values|1
2180142|NCT01399125|3806108|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
2180143|NCT01399125|3806109|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4
2180144|NCT01399125|3806108|FG000|Overall Study|Withdrawal by Subject|5
2146546|NCT01151540|3757432|FG000|Overall Study|Other|2
2146547|NCT01151540|3757432|FG000|Overall Study|Adverse event, non-fatal|4
2146548|NCT01151540|3757432|FG000|Overall Study|Withdrawal by Subject|7
2146549|NCT01151579|3757438|FG000|Overall Study|Physician Decision|3
2146550|NCT01151579|3757439|FG001|Overall Study|Physician Decision|1
2146551|NCT01151579|3757438|FG000|Overall Study|Withdrawal by Subject|3
2146552|NCT01151579|3757439|FG001|Overall Study|Withdrawal by Subject|2
2146553|NCT01151579|3757438|FG000|Overall Study|Not meet inclusion criteria|6
2146554|NCT01151579|3757439|FG001|Overall Study|Not meet inclusion criteria|4
2146555|NCT01151618|3757445|FG000|Overall Study|Adverse Event|2
2146556|NCT01151618|3757445|FG000|Overall Study|Withdrawal by Subject|7
2146557|NCT01152021|3757472|FG000|Overall Study|Adverse Event|4
2146558|NCT01152021|3757473|FG001|Overall Study|Adverse Event|4
2146559|NCT01152021|3757472|FG000|Overall Study|Study drug had expired|1
2146560|NCT01152021|3757473|FG001|Overall Study|Study drug had expired|0
2146561|NCT01152021|3757472|FG000|Overall Study|Physician Decision|1
2146562|NCT01152021|3757473|FG001|Overall Study|Physician Decision|1
2146563|NCT01152021|3757472|FG000|Overall Study|No access to study drug in Pharmacy|0
2146564|NCT01152021|3757473|FG001|Overall Study|No access to study drug in Pharmacy|1
2146565|NCT01152190|3757492|FG000|Overall Study|Adverse Event|2
2146566|NCT01152190|3757493|FG001|Overall Study|Adverse Event|4
2146567|NCT01152190|3757492|FG000|Overall Study|Death|1
2146568|NCT01152190|3757493|FG001|Overall Study|Death|0
2146569|NCT01152190|3757492|FG000|Overall Study|Protocol Violation|1
2146570|NCT01152190|3757493|FG001|Overall Study|Protocol Violation|1
2146571|NCT01152190|3757492|FG000|Overall Study|Withdrawal by Subject|1
2146572|NCT01152190|3757493|FG001|Overall Study|Withdrawal by Subject|3
2146573|NCT01152385|3757530|FG000|Overall Study|Withdrawal by Subject|3
2146574|NCT01152385|3757531|FG001|Overall Study|Withdrawal by Subject|1
2146575|NCT01152385|3757532|FG002|Overall Study|Withdrawal by Subject|1
2146576|NCT01152385|3757533|FG003|Overall Study|Withdrawal by Subject|1
2146577|NCT01152385|3757530|FG000|Overall Study|Protocol Violation|0
2146578|NCT01152385|3757531|FG001|Overall Study|Protocol Violation|0
2146579|NCT01152385|3757532|FG002|Overall Study|Protocol Violation|0
2146580|NCT01152385|3757533|FG003|Overall Study|Protocol Violation|1
2146581|NCT01152385|3757530|FG000|Overall Study|Adverse Event|1
2146582|NCT01152385|3757531|FG001|Overall Study|Adverse Event|1
2146583|NCT01152385|3757532|FG002|Overall Study|Adverse Event|0
2146584|NCT01152385|3757533|FG003|Overall Study|Adverse Event|0
2146585|NCT01152385|3757530|FG000|Overall Study|Study-specific withdrawal criteria|1
2146586|NCT01152385|3757531|FG001|Overall Study|Study-specific withdrawal criteria|1
2146587|NCT01152385|3757532|FG002|Overall Study|Study-specific withdrawal criteria|2
2146588|NCT01152385|3757533|FG003|Overall Study|Study-specific withdrawal criteria|0
2146589|NCT01152385|3757530|FG000|Overall Study|Other|4
2146590|NCT01152385|3757531|FG001|Overall Study|Other|3
2146591|NCT01152385|3757532|FG002|Overall Study|Other|2
2146592|NCT01152385|3757533|FG003|Overall Study|Other|3
2146593|NCT01152437|3757550|FG000|Overall Study|Other Adverse Event|8
2146594|NCT01152437|3757551|FG001|Overall Study|Other Adverse Event|1
2146595|NCT01152437|3757552|FG002|Overall Study|Other Adverse Event|7
2146596|NCT01152437|3757550|FG000|Overall Study|Not treated|0
2146597|NCT01152437|3757551|FG001|Overall Study|Not treated|1
2290493|NCT02491892|3983158|FG000|Overall Study|Adverse Event|1
2290494|NCT02491892|3983159|FG001|Overall Study|Adverse Event|1
2290495|NCT02491892|3983158|FG000|Overall Study|Death|1
2290496|NCT02491892|3983159|FG001|Overall Study|Death|1
2290497|NCT02491892|3983158|FG000|Overall Study|Lack of Efficacy|37
2290498|NCT02491892|3983159|FG001|Overall Study|Lack of Efficacy|36
2290499|NCT02491892|3983158|FG000|Overall Study|Refused Treatment|1
2290500|NCT02491892|3983159|FG001|Overall Study|Refused Treatment|0
2290501|NCT02491892|3983158|FG000|Overall Study|Lost to Follow-up|1
2290502|NCT02491892|3983159|FG001|Overall Study|Lost to Follow-up|0
2290503|NCT02492100|3983169|FG000|Overall Study|Death|1
2290504|NCT02492165|3983178|FG000|Overall Study|Withdrawal by Subject|0
2290505|NCT02492165|3983179|FG001|Overall Study|Withdrawal by Subject|1
2290506|NCT02492165|3983180|FG002|Overall Study|Withdrawal by Subject|0
2290507|NCT02492165|3983181|FG003|Overall Study|Withdrawal by Subject|0
2290508|NCT02492763|3983221|FG000|Overall Study|Withdrawal by Subject|0
2290509|NCT02492763|3983222|FG001|Overall Study|Withdrawal by Subject|2
2290510|NCT02492763|3983223|FG002|Overall Study|Withdrawal by Subject|1
2290511|NCT02492763|3983224|FG003|Overall Study|Withdrawal by Subject|0
2290512|NCT02492763|3983221|FG000|Overall Study|Adverse Event|3
2290513|NCT02492763|3983222|FG001|Overall Study|Adverse Event|1
2290514|NCT02492763|3983223|FG002|Overall Study|Adverse Event|1
2290515|NCT02492763|3983224|FG003|Overall Study|Adverse Event|2
2290516|NCT02492763|3983221|FG000|Overall Study|Death|0
2290517|NCT02492763|3983222|FG001|Overall Study|Death|0
2290518|NCT02492763|3983223|FG002|Overall Study|Death|1
2290519|NCT02492763|3983224|FG003|Overall Study|Death|0
2290520|NCT02492763|3983221|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0
2146598|NCT01152437|3757552|FG002|Overall Study|Not treated|2
2146599|NCT01152437|3757550|FG000|Overall Study|Progressive disease|27
2146600|NCT01152437|3757551|FG001|Overall Study|Progressive disease|13
2146601|NCT01152437|3757552|FG002|Overall Study|Progressive disease|32
2290521|NCT02492763|3983222|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1
2290522|NCT02492763|3983223|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0
2146602|NCT01152437|3757550|FG000|Overall Study|Refusal to continue taking trial medicat|1
2146603|NCT01152437|3757551|FG001|Overall Study|Refusal to continue taking trial medicat|0
2146604|NCT01152437|3757552|FG002|Overall Study|Refusal to continue taking trial medicat|2
2146605|NCT01152450|3757562|FG000|Period 1 (4 Weeks)|Adverse Event|0
2146606|NCT01152450|3757563|FG001|Period 1 (4 Weeks)|Adverse Event|0
2146607|NCT01152450|3757564|FG002|Period 1 (4 Weeks)|Adverse Event|0
2146608|NCT01152450|3757565|FG003|Period 1 (4 Weeks)|Adverse Event|0
2146609|NCT01152450|3757566|FG004|Period 1 (4 Weeks)|Adverse Event|1
2146610|NCT01152450|3757567|FG005|Period 1 (4 Weeks)|Adverse Event|1
2146611|NCT01152450|3757562|FG000|Period 1 (4 Weeks)|Protocol Violation|0
2146612|NCT01152450|3757563|FG001|Period 1 (4 Weeks)|Protocol Violation|0
2146613|NCT01152450|3757564|FG002|Period 1 (4 Weeks)|Protocol Violation|0
2146614|NCT01152450|3757565|FG003|Period 1 (4 Weeks)|Protocol Violation|0
2146615|NCT01152450|3757566|FG004|Period 1 (4 Weeks)|Protocol Violation|1
2146616|NCT01152450|3757567|FG005|Period 1 (4 Weeks)|Protocol Violation|0
2146617|NCT01152450|3757562|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0
2146618|NCT01152450|3757563|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1
2146619|NCT01152450|3757564|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1
2146620|NCT01152450|3757565|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
2146621|NCT01152450|3757566|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
2146622|NCT01152450|3757567|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0
2146623|NCT01152554|3757586|FG000|Overall Study|Withdrawal by Subject|73
2146624|NCT01152554|3757587|FG001|Overall Study|Withdrawal by Subject|28
2146625|NCT01152554|3757586|FG000|Overall Study|Eligiblity criteria not fulfilled|0
2146626|NCT01152554|3757587|FG001|Overall Study|Eligiblity criteria not fulfilled|1
2146627|NCT01152554|3757586|FG000|Overall Study|Adverse Event|67
2146628|NCT01152554|3757587|FG001|Overall Study|Adverse Event|14
2146629|NCT01152554|3757586|FG000|Overall Study|Severe non-compliance to protocol|36
2146630|NCT01152554|3757587|FG001|Overall Study|Severe non-compliance to protocol|14
2146631|NCT01152554|3757586|FG000|Overall Study|Condition under investigation worsened|5
2146632|NCT01152554|3757587|FG001|Overall Study|Condition under investigation worsened|2
2146633|NCT01152554|3757586|FG000|Overall Study|Lack of Efficacy|20
2146634|NCT01152554|3757587|FG001|Overall Study|Lack of Efficacy|3
2146635|NCT01152554|3757586|FG000|Overall Study|Study-specific withdrawal criteria|17
2146636|NCT01152554|3757587|FG001|Overall Study|Study-specific withdrawal criteria|8
2146637|NCT01152554|3757586|FG000|Overall Study|Lost to Follow-up|87
2146638|NCT01152554|3757587|FG001|Overall Study|Lost to Follow-up|32
2146639|NCT01152554|3757586|FG000|Overall Study|Other|28
2146640|NCT01152554|3757587|FG001|Overall Study|Other|8
2146641|NCT01152554|3757586|FG000|Overall Study|Death|1
2146642|NCT01152554|3757587|FG001|Overall Study|Death|1
2146643|NCT01152580|3757595|FG000|Overall Study|Withdrawal by Subject|0
2146644|NCT01152580|3757596|FG001|Overall Study|Withdrawal by Subject|1
2146645|NCT01152788|3757608|FG000|Overall Study|Withdrawal by Subject|0
2146646|NCT01152788|3757609|FG001|Overall Study|Withdrawal by Subject|3
2146647|NCT01152788|3757608|FG000|Overall Study|No treatment|0
2146648|NCT01152788|3757609|FG001|Overall Study|No treatment|1
2146649|NCT01152814|3757615|FG000|Overall Study|Lost to Follow-up|2
2146650|NCT01152996|3757619|FG000|Overall Study|Withdrawal by Subject|142
2146651|NCT01152996|3757619|FG000|Overall Study|Adverse Event|115
2146652|NCT01152996|3757619|FG000|Overall Study|Lost to Follow-up|112
2146653|NCT01152996|3757619|FG000|Overall Study|Lack of Efficacy|68
2146654|NCT01152996|3757619|FG000|Overall Study|Noncompliance|41
2146655|NCT01152996|3757619|FG000|Overall Study|Other|36
2146656|NCT01152996|3757619|FG000|Overall Study|Protocol Violation|22
2146657|NCT01152996|3757619|FG000|Overall Study|Elevated liver enzymes|1
2146658|NCT01153009|3757627|FG000|Overall Study|Adverse Event|4
2146659|NCT01153009|3757628|FG001|Overall Study|Adverse Event|14
2146660|NCT01153009|3757629|FG002|Overall Study|Adverse Event|14
2146661|NCT01153009|3757630|FG003|Overall Study|Adverse Event|10
2146662|NCT01153009|3757627|FG000|Overall Study|Lack of Efficacy|9
2146663|NCT01153009|3757628|FG001|Overall Study|Lack of Efficacy|0
2146664|NCT01153009|3757629|FG002|Overall Study|Lack of Efficacy|2
2146665|NCT01153009|3757630|FG003|Overall Study|Lack of Efficacy|1
2146666|NCT01153009|3757627|FG000|Overall Study|Noncompliance with Study Medication|1
2146667|NCT01153009|3757628|FG001|Overall Study|Noncompliance with Study Medication|3
2146668|NCT01153009|3757629|FG002|Overall Study|Noncompliance with Study Medication|4
2146669|NCT01153009|3757630|FG003|Overall Study|Noncompliance with Study Medication|1
2146670|NCT01153009|3757627|FG000|Overall Study|Protocol Deviations|4
2146671|NCT01153009|3757628|FG001|Overall Study|Protocol Deviations|3
2146672|NCT01153009|3757629|FG002|Overall Study|Protocol Deviations|3
2146673|NCT01153009|3757630|FG003|Overall Study|Protocol Deviations|2
2146674|NCT01153009|3757627|FG000|Overall Study|Withdrawal of Consent|5
2146675|NCT01153009|3757628|FG001|Overall Study|Withdrawal of Consent|5
2146676|NCT01153009|3757629|FG002|Overall Study|Withdrawal of Consent|4
2146677|NCT01153009|3757630|FG003|Overall Study|Withdrawal of Consent|6
2146678|NCT01153009|3757627|FG000|Overall Study|Lost to Follow-up|8
2146679|NCT01153009|3757628|FG001|Overall Study|Lost to Follow-up|8
2146680|NCT01153009|3757629|FG002|Overall Study|Lost to Follow-up|11
2146681|NCT01153009|3757630|FG003|Overall Study|Lost to Follow-up|15
2146682|NCT01153009|3757627|FG000|Overall Study|Other|1
2146683|NCT01153009|3757628|FG001|Overall Study|Other|1
2146684|NCT01153009|3757629|FG002|Overall Study|Other|3
2146685|NCT01153009|3757630|FG003|Overall Study|Other|2
2146686|NCT01153269|3757640|FG000|Overall Study|Withdrawal by Subject|1
2146687|NCT01153269|3757640|FG000|Overall Study|Antiretroviral therapy break|1
2146688|NCT01153321|3757649|FG000|Overall Study|Development of study withdrawal criteria|0
2146689|NCT01153321|3757650|FG001|Overall Study|Development of study withdrawal criteria|1
2146690|NCT01153321|3757649|FG000|Overall Study|Withdrawal by Subject|0
2146691|NCT01153321|3757650|FG001|Overall Study|Withdrawal by Subject|1
2146692|NCT01153321|3757649|FG000|Overall Study|Adverse Event|1
2146693|NCT01153321|3757650|FG001|Overall Study|Adverse Event|1
2146694|NCT01153347|3757660|FG000|Overall Study|Withdrawal by Subject|7
2146695|NCT01153347|3757661|FG001|Overall Study|Withdrawal by Subject|7
2146696|NCT01153347|3757662|FG002|Overall Study|Withdrawal by Subject|7
2146697|NCT01153347|3757663|FG003|Overall Study|Withdrawal by Subject|7
2146698|NCT01153347|3757660|FG000|Overall Study|Eligibility criteria not fulfilled|0
2146699|NCT01153347|3757661|FG001|Overall Study|Eligibility criteria not fulfilled|1
2146700|NCT01153347|3757662|FG002|Overall Study|Eligibility criteria not fulfilled|2
2146701|NCT01153347|3757663|FG003|Overall Study|Eligibility criteria not fulfilled|1
2146702|NCT01153347|3757660|FG000|Overall Study|Adverse Event|3
2146703|NCT01153347|3757661|FG001|Overall Study|Adverse Event|9
2146704|NCT01153347|3757662|FG002|Overall Study|Adverse Event|21
2146705|NCT01153347|3757663|FG003|Overall Study|Adverse Event|7
2146706|NCT01153347|3757660|FG000|Overall Study|Severe non-compliance to protocol|6
2146707|NCT01153347|3757661|FG001|Overall Study|Severe non-compliance to protocol|7
2146708|NCT01153347|3757662|FG002|Overall Study|Severe non-compliance to protocol|4
2146709|NCT01153347|3757663|FG003|Overall Study|Severe non-compliance to protocol|3
2146710|NCT01153347|3757660|FG000|Overall Study|Condition under investigation worsened|1
2146711|NCT01153347|3757661|FG001|Overall Study|Condition under investigation worsened|1
2146712|NCT01153347|3757662|FG002|Overall Study|Condition under investigation worsened|0
2146713|NCT01153347|3757663|FG003|Overall Study|Condition under investigation worsened|0
2146714|NCT01153347|3757660|FG000|Overall Study|Lack of Efficacy|2
2146715|NCT01153347|3757661|FG001|Overall Study|Lack of Efficacy|2
2146716|NCT01153347|3757662|FG002|Overall Study|Lack of Efficacy|0
2146717|NCT01153347|3757663|FG003|Overall Study|Lack of Efficacy|4
2146718|NCT01153347|3757660|FG000|Overall Study|Study-specific withdrawal criteria|4
2146719|NCT01153347|3757661|FG001|Overall Study|Study-specific withdrawal criteria|3
2146720|NCT01153347|3757662|FG002|Overall Study|Study-specific withdrawal criteria|1
2146721|NCT01153347|3757663|FG003|Overall Study|Study-specific withdrawal criteria|2
2146722|NCT01153347|3757660|FG000|Overall Study|Lost to Follow-up|4
2146723|NCT01153347|3757661|FG001|Overall Study|Lost to Follow-up|9
2146724|NCT01153347|3757662|FG002|Overall Study|Lost to Follow-up|11
2146725|NCT01153347|3757663|FG003|Overall Study|Lost to Follow-up|8
2146726|NCT01153347|3757660|FG000|Overall Study|Other|5
2146727|NCT01153347|3757661|FG001|Overall Study|Other|5
2146728|NCT01153347|3757662|FG002|Overall Study|Other|4
2146729|NCT01153347|3757663|FG003|Overall Study|Other|0
2146730|NCT01153347|3757660|FG000|Overall Study|Death|1
2146731|NCT01153347|3757661|FG001|Overall Study|Death|0
2146732|NCT01153347|3757662|FG002|Overall Study|Death|0
2146733|NCT01153347|3757663|FG003|Overall Study|Death|0
2146734|NCT01153425|3757675|FG000|Overall Study|Withdrawal by Subject|3
2146735|NCT01153425|3757676|FG001|Overall Study|Withdrawal by Subject|3
2146736|NCT01153516|3757698|FG000|Overall Study|Both subjects refused surgery|2
2146737|NCT01153516|3757699|FG001|Overall Study|Both subjects refused surgery|0
2146738|NCT01153633|3757726|FG000|Overall Study|Protocol Violation|1
2146739|NCT01153633|3757727|FG001|Overall Study|Protocol Violation|1
2290523|NCT02492763|3983224|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0
2290524|NCT02492763|3983221|FG000|Overall Study|Lost to Follow-up|0
2290525|NCT02492763|3983222|FG001|Overall Study|Lost to Follow-up|0
2290526|NCT02492763|3983223|FG002|Overall Study|Lost to Follow-up|1
2290527|NCT02492763|3983224|FG003|Overall Study|Lost to Follow-up|0
2290528|NCT02492763|3983221|FG000|Overall Study|Non-Compliance With Study Drug|0
2290529|NCT02492763|3983222|FG001|Overall Study|Non-Compliance With Study Drug|1
2290530|NCT02492763|3983223|FG002|Overall Study|Non-Compliance With Study Drug|0
2290531|NCT02492763|3983224|FG003|Overall Study|Non-Compliance With Study Drug|0
2290532|NCT02492763|3983221|FG000|Overall Study|Screen Failure|0
2290533|NCT02492763|3983222|FG001|Overall Study|Screen Failure|0
2290534|NCT02492763|3983223|FG002|Overall Study|Screen Failure|0
2290535|NCT02492763|3983224|FG003|Overall Study|Screen Failure|1
2290536|NCT02492763|3983221|FG000|Overall Study|Study Terminated by Sponsor|13
2290537|NCT02492763|3983222|FG001|Overall Study|Study Terminated by Sponsor|10
2290538|NCT02492763|3983223|FG002|Overall Study|Study Terminated by Sponsor|6
2290539|NCT02492763|3983224|FG003|Overall Study|Study Terminated by Sponsor|10
2290540|NCT02492841|3983241|FG000|Overall Study|Lost to Follow-up|34
2290541|NCT02492841|3983242|FG001|Overall Study|Lost to Follow-up|31
2290542|NCT02492841|3983243|FG002|Overall Study|Lost to Follow-up|35
2290543|NCT02492880|3983263|FG000|Overall Study|Lost to Follow-up|1
2290544|NCT02492880|3983263|FG000|Overall Study|Protocol Violation|1
2290545|NCT02492958|3983271|FG000|Overall Study|Withdrawal by Subject|0
2290546|NCT02492958|3983272|FG001|Overall Study|Withdrawal by Subject|0
2290547|NCT02492958|3983273|FG002|Overall Study|Withdrawal by Subject|1
2290548|NCT02492958|3983274|FG003|Overall Study|Withdrawal by Subject|0
2290549|NCT02492958|3983271|FG000|Overall Study|Adverse Event|1
2290550|NCT02492958|3983272|FG001|Overall Study|Adverse Event|0
2290551|NCT02492958|3983273|FG002|Overall Study|Adverse Event|1
2290552|NCT02492958|3983274|FG003|Overall Study|Adverse Event|0
2290553|NCT02492984|3983286|FG000|Overall Study|Adverse Event|1
2290554|NCT02492984|3983287|FG001|Overall Study|Adverse Event|0
2290555|NCT02492984|3983286|FG000|Overall Study|Protocol Violation|1
2290556|NCT02492984|3983287|FG001|Overall Study|Protocol Violation|0
2290557|NCT02492984|3983286|FG000|Overall Study|Withdrawal by Subject|1
2146740|NCT01153633|3757726|FG000|Overall Study|Therapeutic failure|3
2146741|NCT01153633|3757727|FG001|Overall Study|Therapeutic failure|3
2146742|NCT01153698|3757748|FG000|Overall Study|Adverse Event|12
2146743|NCT01153698|3757748|FG000|Overall Study|Lost to Follow-up|4
2146744|NCT01153698|3757748|FG000|Overall Study|Withdrawal by Subject|2
2146745|NCT01153698|3757748|FG000|Overall Study|Switch to other anticoagulants|4
2146746|NCT01153698|3757748|FG000|Overall Study|Other|2
2146747|NCT01153698|3757748|FG000|Overall Study|Not treated with Pradaxa|5
2146748|NCT01153724|3757759|FG000|Treatment Period 1|Withdrawal by Subject|1
2146749|NCT01153724|3757759|FG000|Treatment Period 2|Adverse Event|1
2146750|NCT01153724|3757759|FG000|Treatment Period 2|Other reason not defined above|1
2146751|NCT01153763|3757765|FG000|Overall Study|Study Closed|16
2146752|NCT01153763|3757765|FG000|Overall Study|Lost to Follow-up|1
2146753|NCT01153763|3757765|FG000|Overall Study|Physician Decision|2
2146754|NCT01153763|3757765|FG000|Overall Study|Withdrawal by Subject|2
2146755|NCT01153815|3757771|FG000|Overall Study|Adverse Event|3
2146756|NCT01153815|3757772|FG001|Overall Study|Adverse Event|1
2146757|NCT01153815|3757771|FG000|Overall Study|Withdrawal by Subject|6
2146758|NCT01153815|3757772|FG001|Overall Study|Withdrawal by Subject|4
2146759|NCT01153841|3757780|FG000|Overall Study|Adverse Event|1
2146760|NCT01153841|3757781|FG001|Overall Study|Adverse Event|0
2146761|NCT01153841|3757780|FG000|Overall Study|Withdrawal by Subject|1
2146762|NCT01153841|3757781|FG001|Overall Study|Withdrawal by Subject|0
2146763|NCT01153841|3757780|FG000|Overall Study|Protocol Violation|2
2146764|NCT01153841|3757781|FG001|Overall Study|Protocol Violation|0
2146765|NCT01153841|3757780|FG000|Overall Study|Lost to Follow-up|2
2146766|NCT01153841|3757781|FG001|Overall Study|Lost to Follow-up|0
2146767|NCT01153893|3757789|FG000|Overall Study|Adverse Event|1
2146768|NCT01153893|3757790|FG001|Overall Study|Adverse Event|0
2146769|NCT01153958|3757798|FG000|Overall Study|Study Terminated|36
2146770|NCT01153958|3757799|FG001|Overall Study|Study Terminated|32
2146771|NCT01153971|3757805|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
2146772|NCT01153971|3757805|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
2146773|NCT01153971|3757805|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
2146774|NCT01153971|3757805|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
2146775|NCT01153971|3757805|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1
2146776|NCT01153971|3757805|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1
2146777|NCT01153971|3757805|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2
2146778|NCT01153984|3757809|FG000|Overall Study|Withdrawal by Subject|1
2146779|NCT01153984|3757809|FG000|Overall Study|Adverse Event|1
2146780|NCT01154010|3757815|FG000|Overall Study|Lost to Follow-up|0
2146781|NCT01154010|3757816|FG001|Overall Study|Lost to Follow-up|1
2290558|NCT02492984|3983287|FG001|Overall Study|Withdrawal by Subject|0
2290559|NCT02492997|3983298|FG000|Overall Study|Withdrawal by Subject|1
2290560|NCT02492997|3983299|FG001|Overall Study|Withdrawal by Subject|0
2290561|NCT02492997|3983298|FG000|Overall Study|Gained Weight|1
2290562|NCT02492997|3983299|FG001|Overall Study|Gained Weight|0
2290563|NCT02492997|3983298|FG000|Overall Study|Lost to Follow-up|0
2290564|NCT02492997|3983299|FG001|Overall Study|Lost to Follow-up|1
2290565|NCT02493062|3983318|FG000|Overall Study|Physician Decision|12
2290566|NCT02493127|3983328|FG000|Overall Study|Lost to Follow-up|1
2290567|NCT02493127|3983329|FG001|Overall Study|Lost to Follow-up|1
2290568|NCT02493361|3983346|FG000|Overall Study|Withdrawal by Subject|3
2290569|NCT02493517|3983365|FG000|Overall Study|Protocol Violation|1
2290570|NCT02493517|3983366|FG001|Overall Study|Protocol Violation|2
2290571|NCT02493517|3983365|FG000|Overall Study|Withdrawal by Subject|1
2290572|NCT02493517|3983366|FG001|Overall Study|Withdrawal by Subject|2
2290573|NCT02493517|3983365|FG000|Overall Study|Adverse Event|0
2290574|NCT02493517|3983366|FG001|Overall Study|Adverse Event|2
2290575|NCT02493517|3983365|FG000|Overall Study|Missed study visit|0
2290576|NCT02493517|3983366|FG001|Overall Study|Missed study visit|1
2290577|NCT02493660|3983394|FG000|Overall Study|Physician Decision|0
2290578|NCT02493660|3983395|FG001|Overall Study|Physician Decision|1
2290579|NCT02493712|3983404|FG000|Overall Study|Withdrawal by Subject|1
2290580|NCT02493712|3983405|FG001|Overall Study|Withdrawal by Subject|0
2290581|NCT02493712|3983406|FG002|Overall Study|Withdrawal by Subject|2
2290582|NCT02493712|3983404|FG000|Overall Study|Protocol Violation|0
2290583|NCT02493712|3983405|FG001|Overall Study|Protocol Violation|0
2290584|NCT02493712|3983406|FG002|Overall Study|Protocol Violation|1
2290585|NCT02493712|3983404|FG000|Overall Study|Lost to Follow-up|1
2290586|NCT02493712|3983405|FG001|Overall Study|Lost to Follow-up|0
2146782|NCT01154088|3757825|FG000|Overall Study|Lost to Follow-up|4
2146783|NCT01154088|3757826|FG001|Overall Study|Lost to Follow-up|6
2146784|NCT01154088|3757827|FG002|Overall Study|Lost to Follow-up|7
2146785|NCT01154101|3757841|FG000|Overall Study|Adverse Event|0
2290587|NCT02493712|3983406|FG002|Overall Study|Lost to Follow-up|0
2290588|NCT02493712|3983404|FG000|Overall Study|Physician Decision|0
2146786|NCT01154101|3757842|FG001|Overall Study|Adverse Event|2
2146787|NCT01154101|3757843|FG002|Overall Study|Adverse Event|1
2146788|NCT01154101|3757844|FG003|Overall Study|Adverse Event|1
2146789|NCT01154101|3757845|FG004|Overall Study|Adverse Event|0
2146790|NCT01154101|3757841|FG000|Overall Study|Lost to Follow-up|0
2146791|NCT01154101|3757842|FG001|Overall Study|Lost to Follow-up|1
2146792|NCT01154101|3757843|FG002|Overall Study|Lost to Follow-up|0
2146793|NCT01154101|3757844|FG003|Overall Study|Lost to Follow-up|1
2146794|NCT01154101|3757845|FG004|Overall Study|Lost to Follow-up|0
2146795|NCT01154101|3757841|FG000|Overall Study|Withdrawal by Subject|0
2146796|NCT01154101|3757842|FG001|Overall Study|Withdrawal by Subject|1
2146797|NCT01154101|3757843|FG002|Overall Study|Withdrawal by Subject|2
2146798|NCT01154101|3757844|FG003|Overall Study|Withdrawal by Subject|0
2146799|NCT01154101|3757845|FG004|Overall Study|Withdrawal by Subject|1
2146800|NCT01154127|3757864|FG000|Period 1 (21 Days)|Adverse Event|3
2146801|NCT01154127|3757865|FG001|Period 1 (21 Days)|Adverse Event|4
2146802|NCT01154127|3757864|FG000|Period 1 (21 Days)|Withdrawal by Subject|0
2146803|NCT01154127|3757865|FG001|Period 1 (21 Days)|Withdrawal by Subject|2
2146804|NCT01154127|3757864|FG000|Washout (14 - 28 Days)|Adverse Event|2
2146805|NCT01154127|3757865|FG001|Washout (14 - 28 Days)|Adverse Event|0
2146806|NCT01154127|3757864|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1
2146807|NCT01154127|3757865|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0
2146808|NCT01154127|3757864|FG000|Period 2 (21 Days)|Protocol Deviation|0
2146809|NCT01154127|3757865|FG001|Period 2 (21 Days)|Protocol Deviation|1
2146810|NCT01154140|3757873|FG000|Overall Study|Death|71
2146811|NCT01154140|3757874|FG001|Overall Study|Death|81
2146812|NCT01154140|3757873|FG000|Overall Study|Lost to Follow-up|4
2146813|NCT01154140|3757874|FG001|Overall Study|Lost to Follow-up|5
2146814|NCT01154140|3757873|FG000|Overall Study|Withdrawal by Subject|12
2146815|NCT01154140|3757874|FG001|Overall Study|Withdrawal by Subject|13
2146816|NCT01154140|3757873|FG000|Overall Study|Other|3
2146817|NCT01154140|3757874|FG001|Overall Study|Other|1
2146818|NCT01154140|3757873|FG000|Overall Study|Randomized but not treated|1
2146819|NCT01154140|3757874|FG001|Overall Study|Randomized but not treated|2
2146820|NCT01154153|3757882|FG000|Overall Study|Poor compliance to protocol|2
2146821|NCT01154153|3757883|FG001|Overall Study|Poor compliance to protocol|0
2146822|NCT01154153|3757882|FG000|Overall Study|Unable to use labs|2
2146823|NCT01154153|3757883|FG001|Overall Study|Unable to use labs|3
2146824|NCT01154153|3757882|FG000|Overall Study|Withdrew consent|1
2146825|NCT01154153|3757883|FG001|Overall Study|Withdrew consent|0
2146826|NCT01154166|3757891|FG000|Overall Study|Adverse Event|14
2146827|NCT01154166|3757892|FG001|Overall Study|Adverse Event|9
2146828|NCT01154166|3757891|FG000|Overall Study|Lost to Follow-up|1
2146829|NCT01154166|3757892|FG001|Overall Study|Lost to Follow-up|1
2146830|NCT01154166|3757891|FG000|Overall Study|Protocol Violation|4
2146831|NCT01154166|3757892|FG001|Overall Study|Protocol Violation|1
2146832|NCT01154166|3757891|FG000|Overall Study|Withdrawal by Subject|10
2146833|NCT01154166|3757892|FG001|Overall Study|Withdrawal by Subject|1
2146834|NCT01154166|3757891|FG000|Overall Study|Lack of Efficacy|3
2290589|NCT02493712|3983405|FG001|Overall Study|Physician Decision|1
2290590|NCT02493712|3983406|FG002|Overall Study|Physician Decision|0
2290591|NCT02493712|3983404|FG000|Overall Study|Lack of Efficacy|0
2290592|NCT02493712|3983405|FG001|Overall Study|Lack of Efficacy|5
2290593|NCT02493712|3983406|FG002|Overall Study|Lack of Efficacy|3
2290594|NCT02493764|3983416|FG000|Overall Study|Adverse Event|2
2290595|NCT02493764|3983417|FG001|Overall Study|Adverse Event|2
2290596|NCT02493764|3983416|FG000|Overall Study|Death|44
2290597|NCT02493764|3983417|FG001|Overall Study|Death|58
2290598|NCT02493764|3983416|FG000|Overall Study|Lost to Follow-up|2
2290599|NCT02493764|3983417|FG001|Overall Study|Lost to Follow-up|1
2290600|NCT02493764|3983416|FG000|Overall Study|Protocol Violation|6
2290601|NCT02493764|3983417|FG001|Overall Study|Protocol Violation|7
2290602|NCT02493764|3983416|FG000|Overall Study|Physician Decision|1
2290603|NCT02493764|3983417|FG001|Overall Study|Physician Decision|1
2290604|NCT02493764|3983416|FG000|Overall Study|Participant moved|17
2290605|NCT02493764|3983417|FG001|Overall Study|Participant moved|5
2290606|NCT02493764|3983416|FG000|Overall Study|Withdrawal parent/guardian|0
2290607|NCT02493764|3983417|FG001|Overall Study|Withdrawal parent/guardian|1
2290608|NCT02493764|3983416|FG000|Overall Study|Withdrawal by Subject|11
2290609|NCT02493764|3983417|FG001|Overall Study|Withdrawal by Subject|7
2290610|NCT02493777|3983425|FG000|Overall Study|Lost to Follow-up|0
2290611|NCT02493777|3983426|FG001|Overall Study|Lost to Follow-up|1
2290612|NCT02493855|3983435|FG000|Overall Study|Non-compliance|1
2290613|NCT02493855|3983436|FG001|Overall Study|Non-compliance|0
2290614|NCT02493855|3983437|FG002|Overall Study|Non-compliance|0
2290615|NCT02493855|3983435|FG000|Overall Study|Adverse Event|0
2290616|NCT02493855|3983436|FG001|Overall Study|Adverse Event|1
2290617|NCT02493855|3983437|FG002|Overall Study|Adverse Event|0
2290618|NCT02493855|3983435|FG000|Overall Study|Withdrawal by Subject|1
2290619|NCT02493855|3983436|FG001|Overall Study|Withdrawal by Subject|0
2290620|NCT02493855|3983437|FG002|Overall Study|Withdrawal by Subject|0
2146835|NCT01154166|3757892|FG001|Overall Study|Lack of Efficacy|0
2290621|NCT02493868|3983445|FG000|Induction Phase: DE Participants|Adverse Event|22
2290622|NCT02493868|3983446|FG001|Induction Phase: DE Participants|Adverse Event|0
2290623|NCT02493868|3983445|FG000|Induction Phase: DE Participants|Lost to Follow-up|1
2146836|NCT01154166|3757891|FG000|Overall Study|Disease Progression|1
2146837|NCT01154166|3757892|FG001|Overall Study|Disease Progression|0
2146838|NCT01154166|3757891|FG000|Overall Study|Poor Compliance|1
2146839|NCT01154166|3757892|FG001|Overall Study|Poor Compliance|0
2146840|NCT01154218|3757912|FG000|Third Intervention Period|Adverse Event|0
2146841|NCT01154218|3757913|FG001|Third Intervention Period|Adverse Event|1
2146842|NCT01154218|3757914|FG002|Third Intervention Period|Adverse Event|0
2146843|NCT01154218|3757915|FG003|Third Intervention Period|Adverse Event|0
2146844|NCT01154218|3757912|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2146845|NCT01154218|3757913|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2146846|NCT01154218|3757914|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2146847|NCT01154218|3757915|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
2146848|NCT01154218|3757912|FG000|Fourth Intervention Period|Withdrawal by Subject|1
2146849|NCT01154218|3757913|FG001|Fourth Intervention Period|Withdrawal by Subject|0
2146850|NCT01154218|3757914|FG002|Fourth Intervention Period|Withdrawal by Subject|0
2146851|NCT01154218|3757915|FG003|Fourth Intervention Period|Withdrawal by Subject|0
2146852|NCT01154231|3757925|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1
2146853|NCT01154231|3757925|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1
2146854|NCT01154283|3757931|FG000|0-6 Weeks|Withdrawal by Subject|7
2146855|NCT01154283|3757932|FG001|0-6 Weeks|Withdrawal by Subject|2
2146856|NCT01154283|3757931|FG000|0-6 Weeks|Death|0
2146857|NCT01154283|3757932|FG001|0-6 Weeks|Death|1
2146858|NCT01154283|3757931|FG000|7-12 Weeks|Death|1
2146859|NCT01154283|3757932|FG001|7-12 Weeks|Death|0
2146860|NCT01154283|3757931|FG000|7-12 Weeks|Withdrawal by Subject|0
2146861|NCT01154283|3757932|FG001|7-12 Weeks|Withdrawal by Subject|1
2146862|NCT01154296|3757940|FG000|Randomization and Intervention|Decided to decline|1
2146863|NCT01154296|3757941|FG001|Randomization and Intervention|Decided to decline|1
2146864|NCT01154296|3757940|FG000|Randomization and Intervention|Declined by staff|1
2146865|NCT01154296|3757941|FG001|Randomization and Intervention|Declined by staff|0
2146866|NCT01154296|3757940|FG000|Randomization and Intervention|Did not return|1
2146867|NCT01154296|3757941|FG001|Randomization and Intervention|Did not return|0
2146868|NCT01154296|3757940|FG000|Randomization and Intervention|Left before test|0
2146869|NCT01154296|3757941|FG001|Randomization and Intervention|Left before test|1
2146870|NCT01154296|3757940|FG000|Randomization and Intervention|Left clinic early|2
2146871|NCT01154296|3757941|FG001|Randomization and Intervention|Left clinic early|0
2146872|NCT01154296|3757940|FG000|6-month Follow-up|Lost contact|269
2146873|NCT01154296|3757941|FG001|6-month Follow-up|Lost contact|275
2146874|NCT01154296|3757940|FG000|6-month Follow-up|Incarcerated|37
2146875|NCT01154296|3757941|FG001|6-month Follow-up|Incarcerated|32
2146876|NCT01154296|3757940|FG000|6-month Follow-up|Withdrew consent|14
2146877|NCT01154296|3757941|FG001|6-month Follow-up|Withdrew consent|15
2146878|NCT01154296|3757940|FG000|6-month Follow-up|Death|3
2146879|NCT01154296|3757941|FG001|6-month Follow-up|Death|2
2146880|NCT01154296|3757940|FG000|6-month Follow-up|Declined by Study Coordinator|5
2146881|NCT01154296|3757941|FG001|6-month Follow-up|Declined by Study Coordinator|4
2146882|NCT01154452|3757968|FG000|Phase Ib|Not Treated|1
2146883|NCT01154452|3757969|FG001|Phase Ib|Not Treated|0
2146884|NCT01154452|3757970|FG002|Phase Ib|Not Treated|0
2146885|NCT01154452|3757971|FG003|Phase Ib|Not Treated|0
2146886|NCT01154452|3757968|FG000|Phase Ib|Adverse Event|2
2146887|NCT01154452|3757969|FG001|Phase Ib|Adverse Event|1
2146888|NCT01154452|3757970|FG002|Phase Ib|Adverse Event|0
2146889|NCT01154452|3757971|FG003|Phase Ib|Adverse Event|0
2146890|NCT01154452|3757968|FG000|Phase II|Withdrawal by Subject|0
2146891|NCT01154452|3757969|FG001|Phase II|Withdrawal by Subject|0
2146892|NCT01154452|3757970|FG002|Phase II|Withdrawal by Subject|1
2146893|NCT01154452|3757971|FG003|Phase II|Withdrawal by Subject|2
2146894|NCT01154452|3757968|FG000|Phase II|Adverse Event|0
2146895|NCT01154452|3757969|FG001|Phase II|Adverse Event|0
2146896|NCT01154452|3757970|FG002|Phase II|Adverse Event|4
2146897|NCT01154452|3757971|FG003|Phase II|Adverse Event|4
2146898|NCT01154673|3758003|FG000|Overall Study|Lost to Follow-up|1
2146899|NCT01154673|3758004|FG001|Overall Study|Lost to Follow-up|0
2146900|NCT01154673|3758003|FG000|Overall Study|moved out of province|1
2146901|NCT01154673|3758004|FG001|Overall Study|moved out of province|0
2146902|NCT01154816|3758037|FG000|Overall Study|Withdrawal by Subject|1
2146903|NCT01154816|3758038|FG001|Overall Study|Withdrawal by Subject|0
2146904|NCT01154816|3758039|FG002|Overall Study|Withdrawal by Subject|0
2146905|NCT01154816|3758040|FG003|Overall Study|Withdrawal by Subject|1
2146906|NCT01154816|3758041|FG004|Overall Study|Withdrawal by Subject|0
2146907|NCT01154816|3758042|FG005|Overall Study|Withdrawal by Subject|0
2146908|NCT01154816|3758043|FG006|Overall Study|Withdrawal by Subject|0
2146909|NCT01154816|3758044|FG007|Overall Study|Withdrawal by Subject|0
2146910|NCT01154816|3758045|FG008|Overall Study|Withdrawal by Subject|1
2146911|NCT01154816|3758046|FG009|Overall Study|Withdrawal by Subject|3
2146912|NCT01154816|3758047|FG010|Overall Study|Withdrawal by Subject|0
2146913|NCT01154816|3758048|FG011|Overall Study|Withdrawal by Subject|0
2146914|NCT01154816|3758037|FG000|Overall Study|Progressive Disease|13
2146915|NCT01154816|3758038|FG001|Overall Study|Progressive Disease|8
2146916|NCT01154816|3758039|FG002|Overall Study|Progressive Disease|9
2146917|NCT01154816|3758040|FG003|Overall Study|Progressive Disease|9
2146918|NCT01154816|3758041|FG004|Overall Study|Progressive Disease|8
2146919|NCT01154816|3758042|FG005|Overall Study|Progressive Disease|8
2146920|NCT01154816|3758043|FG006|Overall Study|Progressive Disease|5
2146921|NCT01154816|3758044|FG007|Overall Study|Progressive Disease|6
2146922|NCT01154816|3758045|FG008|Overall Study|Progressive Disease|8
2146923|NCT01154816|3758046|FG009|Overall Study|Progressive Disease|6
2146924|NCT01154816|3758047|FG010|Overall Study|Progressive Disease|10
2146925|NCT01154816|3758048|FG011|Overall Study|Progressive Disease|3
2146926|NCT01154816|3758037|FG000|Overall Study|Physician Decision|1
2146927|NCT01154816|3758038|FG001|Overall Study|Physician Decision|0
2146928|NCT01154816|3758039|FG002|Overall Study|Physician Decision|1
2146929|NCT01154816|3758040|FG003|Overall Study|Physician Decision|0
2146930|NCT01154816|3758041|FG004|Overall Study|Physician Decision|2
2146931|NCT01154816|3758042|FG005|Overall Study|Physician Decision|0
2146932|NCT01154816|3758043|FG006|Overall Study|Physician Decision|0
2146933|NCT01154816|3758044|FG007|Overall Study|Physician Decision|0
2146934|NCT01154816|3758045|FG008|Overall Study|Physician Decision|0
2146935|NCT01154816|3758046|FG009|Overall Study|Physician Decision|1
2146936|NCT01154816|3758047|FG010|Overall Study|Physician Decision|1
2146937|NCT01154816|3758048|FG011|Overall Study|Physician Decision|1
2146938|NCT01154816|3758037|FG000|Overall Study|Adverse Event|5
2146939|NCT01154816|3758038|FG001|Overall Study|Adverse Event|2
2146940|NCT01154816|3758039|FG002|Overall Study|Adverse Event|0
2146941|NCT01154816|3758040|FG003|Overall Study|Adverse Event|0
2146942|NCT01154816|3758041|FG004|Overall Study|Adverse Event|0
2146943|NCT01154816|3758042|FG005|Overall Study|Adverse Event|0
2146944|NCT01154816|3758043|FG006|Overall Study|Adverse Event|1
2146945|NCT01154816|3758044|FG007|Overall Study|Adverse Event|1
2146946|NCT01154816|3758045|FG008|Overall Study|Adverse Event|0
2146947|NCT01154816|3758046|FG009|Overall Study|Adverse Event|0
2146948|NCT01154816|3758047|FG010|Overall Study|Adverse Event|0
2146949|NCT01154816|3758048|FG011|Overall Study|Adverse Event|0
2146950|NCT01155011|3758091|FG000|Baseline to 6 Months|Withdrawal by Subject|18
2146951|NCT01155011|3758092|FG001|Baseline to 6 Months|Withdrawal by Subject|19
2146952|NCT01155011|3758091|FG000|Baseline to 6 Months|investigator decision, moved|4
2146953|NCT01155011|3758092|FG001|Baseline to 6 Months|investigator decision, moved|5
2146954|NCT01155011|3758091|FG000|Baseline to 6 Months|Death|0
2146955|NCT01155011|3758092|FG001|Baseline to 6 Months|Death|1
2146956|NCT01155011|3758091|FG000|6 to 12 Months|Withdrawal by Subject|8
2146957|NCT01155011|3758092|FG001|6 to 12 Months|Withdrawal by Subject|5
2146958|NCT01155011|3758091|FG000|6 to 12 Months|Death|1
2146959|NCT01155011|3758092|FG001|6 to 12 Months|Death|5
2146960|NCT01155024|3758102|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
2146961|NCT01155024|3758103|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
2146962|NCT01155024|3758102|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
2146963|NCT01155024|3758103|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
2146964|NCT01155024|3758102|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
2146965|NCT01155024|3758103|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
2146966|NCT01155050|3758114|FG000|Overall Study|Lost to Follow-up|15
2146967|NCT01155050|3758115|FG001|Overall Study|Lost to Follow-up|20
2146968|NCT01155050|3758116|FG002|Overall Study|Lost to Follow-up|19
2146969|NCT01155050|3758117|FG003|Overall Study|Lost to Follow-up|22
2146970|NCT01155063|3758127|FG000|Overall Study|Adverse Event|1
2290624|NCT02493868|3983446|FG001|Induction Phase: DE Participants|Lost to Follow-up|0
2290625|NCT02493868|3983445|FG000|Induction Phase: DE Participants|Lack of Efficacy|2
2290626|NCT02493868|3983446|FG001|Induction Phase: DE Participants|Lack of Efficacy|0
2290627|NCT02493868|3983445|FG000|Induction Phase: DE Participants|Protocol Violation|2
2290628|NCT02493868|3983446|FG001|Induction Phase: DE Participants|Protocol Violation|0
2290629|NCT02493868|3983445|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15
2290630|NCT02493868|3983446|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0
2290631|NCT02493868|3983445|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
2290632|NCT02493868|3983446|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
2290633|NCT02493868|3983445|FG000|Induction Phase: DE Participants|Other|8
2290634|NCT02493868|3983446|FG001|Induction Phase: DE Participants|Other|0
2290635|NCT02493868|3983445|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5
2290636|NCT02493868|3983446|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0
2290637|NCT02493868|3983445|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
2290638|NCT02493868|3983446|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
2290639|NCT02493868|3983445|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
2290640|NCT02493868|3983446|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
2290641|NCT02493868|3983445|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4
2290642|NCT02493868|3983446|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1
2290643|NCT02493868|3983445|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
2290644|NCT02493868|3983446|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
2290645|NCT02493868|3983445|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
2290646|NCT02493868|3983446|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
2290647|NCT02493868|3983445|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
2290648|NCT02493868|3983446|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
2146971|NCT01155063|3758127|FG000|Overall Study|Withdrawal by Subject|1
2146972|NCT01155063|3758127|FG000|Overall Study|Study terminated by sponsor|87
2146973|NCT01155141|3758131|FG000|Overall Study|Withdrawal by Subject|1
2146974|NCT01155141|3758131|FG000|Overall Study|Screen Failure|1
2146975|NCT01155167|3758150|FG000|Overall Study|Insufficient ultrasound data|2
2146976|NCT01155167|3758151|FG001|Overall Study|Insufficient ultrasound data|0
2146977|NCT01155167|3758150|FG000|Overall Study|Access site changed to femoral artery|1
2146978|NCT01155167|3758151|FG001|Overall Study|Access site changed to femoral artery|0
2146979|NCT01155219|3758190|FG000|Overall Study|Adverse Event|3
2146980|NCT01155219|3758191|FG001|Overall Study|Adverse Event|1
2146981|NCT01155219|3758190|FG000|Overall Study|non-medical reason|1
2146982|NCT01155219|3758191|FG001|Overall Study|non-medical reason|2
2146983|NCT01155284|3758199|FG000|Overall Study|Withdrawal by Subject|4
2146984|NCT01155284|3758200|FG001|Overall Study|Withdrawal by Subject|3
2146985|NCT01155284|3758199|FG000|Overall Study|Lost to Follow-up|1
2146986|NCT01155284|3758200|FG001|Overall Study|Lost to Follow-up|2
2146987|NCT01155284|3758199|FG000|Overall Study|Physician Decision|1
2146988|NCT01155284|3758200|FG001|Overall Study|Physician Decision|0
2146989|NCT01155284|3758199|FG000|Overall Study|Adverse Event|1
2146990|NCT01155284|3758200|FG001|Overall Study|Adverse Event|0
2146991|NCT01155323|3758208|FG000|First Intervention|exclusion criteria|1
2146992|NCT01155323|3758209|FG001|First Intervention|exclusion criteria|1
2146993|NCT01155323|3758208|FG000|Second Intervention|Lost to Follow-up|1
2146994|NCT01155323|3758209|FG001|Second Intervention|Lost to Follow-up|1
2146995|NCT01155466|3758229|FG000|Overall Study|Adverse Event|13
2146996|NCT01155466|3758230|FG001|Overall Study|Adverse Event|15
2146997|NCT01155466|3758231|FG002|Overall Study|Adverse Event|6
2146998|NCT01155466|3758232|FG003|Overall Study|Adverse Event|17
2146999|NCT01155466|3758233|FG004|Overall Study|Adverse Event|18
2147000|NCT01155466|3758229|FG000|Overall Study|Lost to Follow-up|0
2147001|NCT01155466|3758230|FG001|Overall Study|Lost to Follow-up|0
2147002|NCT01155466|3758231|FG002|Overall Study|Lost to Follow-up|0
2147003|NCT01155466|3758232|FG003|Overall Study|Lost to Follow-up|0
2147004|NCT01155466|3758233|FG004|Overall Study|Lost to Follow-up|2
2147005|NCT01155466|3758229|FG000|Overall Study|Withdrawal by Subject|7
2147006|NCT01155466|3758230|FG001|Overall Study|Withdrawal by Subject|5
2147007|NCT01155466|3758231|FG002|Overall Study|Withdrawal by Subject|9
2147008|NCT01155466|3758232|FG003|Overall Study|Withdrawal by Subject|4
2147009|NCT01155466|3758233|FG004|Overall Study|Withdrawal by Subject|4
2147010|NCT01155466|3758229|FG000|Overall Study|Protocol Violation|0
2147011|NCT01155466|3758230|FG001|Overall Study|Protocol Violation|0
2147012|NCT01155466|3758231|FG002|Overall Study|Protocol Violation|2
2147013|NCT01155466|3758232|FG003|Overall Study|Protocol Violation|0
2290649|NCT02493868|3983445|FG000|Optimization Phase: DE+TE Participants|Other|10
2290650|NCT02493868|3983446|FG001|Optimization Phase: DE+TE Participants|Other|2
2290651|NCT02493868|3983445|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1
2290652|NCT02493868|3983446|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4
2290653|NCT02493868|3983445|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
2290654|NCT02493868|3983446|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
2290655|NCT02493868|3983445|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1
2290656|NCT02493868|3983446|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1
2290657|NCT02493868|3983445|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
2290658|NCT02493868|3983446|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
2290659|NCT02493868|3983445|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1
2290660|NCT02493868|3983446|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0
2290661|NCT02493868|3983445|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
2290662|NCT02493868|3983446|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
2290663|NCT02493868|3983445|FG000|Maintenance Phase: DE+TE Participants|Other|4
2290664|NCT02493868|3983446|FG001|Maintenance Phase: DE+TE Participants|Other|9
2290665|NCT02493868|3983445|FG000|Follow-up Phase|Lost to Follow-up|1
2290666|NCT02493868|3983446|FG001|Follow-up Phase|Lost to Follow-up|0
2290667|NCT02493868|3983445|FG000|Follow-up Phase|Withdrawal by Subject|3
2290668|NCT02493868|3983446|FG001|Follow-up Phase|Withdrawal by Subject|0
2290669|NCT02493868|3983445|FG000|Follow-up Phase|Investigator Decision|5
2290670|NCT02493868|3983446|FG001|Follow-up Phase|Investigator Decision|1
2290671|NCT02493868|3983445|FG000|Follow-up Phase|Other|2
2290672|NCT02493868|3983446|FG001|Follow-up Phase|Other|1
2290673|NCT02493946|3983461|FG000|DB Period|Withdrawal by Subject|8
2290674|NCT02493946|3983462|FG001|DB Period|Withdrawal by Subject|5
2290675|NCT02493946|3983463|FG002|DB Period|Withdrawal by Subject|0
2290676|NCT02493946|3983461|FG000|Open Label Period|Withdrawal by Subject|0
2290677|NCT02493946|3983462|FG001|Open Label Period|Withdrawal by Subject|0
2290678|NCT02493946|3983463|FG002|Open Label Period|Withdrawal by Subject|74
2290679|NCT02493946|3983461|FG000|Open Label Period|Adverse Event|0
2290680|NCT02493946|3983462|FG001|Open Label Period|Adverse Event|0
2290681|NCT02493946|3983463|FG002|Open Label Period|Adverse Event|4
2290682|NCT02493946|3983461|FG000|Open Label Period|Lost to Follow-up|0
2147014|NCT01155466|3758233|FG004|Overall Study|Protocol Violation|1
2147015|NCT01155466|3758229|FG000|Overall Study|Administrative|0
2147016|NCT01155466|3758230|FG001|Overall Study|Administrative|3
2290683|NCT02493946|3983462|FG001|Open Label Period|Lost to Follow-up|0
2290684|NCT02493946|3983463|FG002|Open Label Period|Lost to Follow-up|1
2147017|NCT01155466|3758231|FG002|Overall Study|Administrative|0
2147018|NCT01155466|3758232|FG003|Overall Study|Administrative|0
2147019|NCT01155466|3758233|FG004|Overall Study|Administrative|0
2147020|NCT01155466|3758229|FG000|Overall Study|Randomized not treated|2
2147021|NCT01155466|3758230|FG001|Overall Study|Randomized not treated|2
2147022|NCT01155466|3758231|FG002|Overall Study|Randomized not treated|3
2147023|NCT01155466|3758232|FG003|Overall Study|Randomized not treated|0
2147024|NCT01155466|3758233|FG004|Overall Study|Randomized not treated|2
2147025|NCT01155479|3758250|FG000|Part I|Adverse Event|13
2147026|NCT01155479|3758251|FG001|Part I|Adverse Event|8
2147027|NCT01155479|3758252|FG002|Part I|Adverse Event|18
2147028|NCT01155479|3758253|FG003|Part I|Adverse Event|7
2147029|NCT01155479|3758254|FG004|Part I|Adverse Event|6
2147030|NCT01155479|3758250|FG000|Part I|Administrative|2
2147031|NCT01155479|3758251|FG001|Part I|Administrative|2
2147032|NCT01155479|3758252|FG002|Part I|Administrative|2
2147033|NCT01155479|3758253|FG003|Part I|Administrative|0
2147034|NCT01155479|3758254|FG004|Part I|Administrative|0
2147035|NCT01155479|3758250|FG000|Part I|Did Not Meet Protocol Eligibility|3
2147036|NCT01155479|3758251|FG001|Part I|Did Not Meet Protocol Eligibility|1
2147037|NCT01155479|3758252|FG002|Part I|Did Not Meet Protocol Eligibility|2
2147038|NCT01155479|3758253|FG003|Part I|Did Not Meet Protocol Eligibility|1
2147039|NCT01155479|3758254|FG004|Part I|Did Not Meet Protocol Eligibility|3
2147040|NCT01155479|3758250|FG000|Part I|Withdrawal by Subject|11
2147041|NCT01155479|3758251|FG001|Part I|Withdrawal by Subject|13
2147042|NCT01155479|3758252|FG002|Part I|Withdrawal by Subject|8
2147043|NCT01155479|3758253|FG003|Part I|Withdrawal by Subject|8
2147044|NCT01155479|3758254|FG004|Part I|Withdrawal by Subject|9
2147045|NCT01155479|3758250|FG000|Part I|Lost to Follow-up|0
2147046|NCT01155479|3758251|FG001|Part I|Lost to Follow-up|0
2147047|NCT01155479|3758252|FG002|Part I|Lost to Follow-up|1
2147048|NCT01155479|3758253|FG003|Part I|Lost to Follow-up|1
2147049|NCT01155479|3758254|FG004|Part I|Lost to Follow-up|0
2147050|NCT01155479|3758250|FG000|Part I|Treatment Failure|3
2147051|NCT01155479|3758251|FG001|Part I|Treatment Failure|0
2147052|NCT01155479|3758252|FG002|Part I|Treatment Failure|3
2147053|NCT01155479|3758253|FG003|Part I|Treatment Failure|1
2147054|NCT01155479|3758254|FG004|Part I|Treatment Failure|2
2147055|NCT01155479|3758250|FG000|Part I|Did Not Receive Treatment|4
2147056|NCT01155479|3758251|FG001|Part I|Did Not Receive Treatment|2
2147057|NCT01155479|3758252|FG002|Part I|Did Not Receive Treatment|2
2147058|NCT01155479|3758253|FG003|Part I|Did Not Receive Treatment|6
2147059|NCT01155479|3758254|FG004|Part I|Did Not Receive Treatment|1
2147060|NCT01155479|3758250|FG000|Part I|Non-Compliance with Protocol|2
2147061|NCT01155479|3758251|FG001|Part I|Non-Compliance with Protocol|1
2147062|NCT01155479|3758252|FG002|Part I|Non-Compliance with Protocol|3
2147063|NCT01155479|3758253|FG003|Part I|Non-Compliance with Protocol|3
2147064|NCT01155479|3758254|FG004|Part I|Non-Compliance with Protocol|2
2147065|NCT01155479|3758250|FG000|Part II|Adverse Event|7
2147066|NCT01155479|3758251|FG001|Part II|Adverse Event|6
2147067|NCT01155479|3758252|FG002|Part II|Adverse Event|8
2147068|NCT01155479|3758253|FG003|Part II|Adverse Event|3
2147069|NCT01155479|3758254|FG004|Part II|Adverse Event|4
2147070|NCT01155479|3758250|FG000|Part II|Administrative|43
2147071|NCT01155479|3758251|FG001|Part II|Administrative|49
2147072|NCT01155479|3758252|FG002|Part II|Administrative|36
2147073|NCT01155479|3758253|FG003|Part II|Administrative|38
2147074|NCT01155479|3758254|FG004|Part II|Administrative|46
2147075|NCT01155479|3758250|FG000|Part II|Withdrawal by Subject|8
2147076|NCT01155479|3758251|FG001|Part II|Withdrawal by Subject|4
2147077|NCT01155479|3758252|FG002|Part II|Withdrawal by Subject|12
2147078|NCT01155479|3758253|FG003|Part II|Withdrawal by Subject|7
2147079|NCT01155479|3758254|FG004|Part II|Withdrawal by Subject|3
2147080|NCT01155479|3758250|FG000|Part II|Lost to Follow-up|1
2147081|NCT01155479|3758251|FG001|Part II|Lost to Follow-up|0
2147082|NCT01155479|3758252|FG002|Part II|Lost to Follow-up|0
2147083|NCT01155479|3758253|FG003|Part II|Lost to Follow-up|0
2147084|NCT01155479|3758254|FG004|Part II|Lost to Follow-up|1
2147085|NCT01155479|3758250|FG000|Part II|Treatment Failure|0
2147086|NCT01155479|3758251|FG001|Part II|Treatment Failure|1
2147087|NCT01155479|3758252|FG002|Part II|Treatment Failure|2
2147088|NCT01155479|3758253|FG003|Part II|Treatment Failure|0
2147089|NCT01155479|3758254|FG004|Part II|Treatment Failure|1
2147090|NCT01155479|3758250|FG000|Part II|Non-Compliance with Protocol|0
2147091|NCT01155479|3758251|FG001|Part II|Non-Compliance with Protocol|1
2147092|NCT01155479|3758252|FG002|Part II|Non-Compliance with Protocol|0
2147093|NCT01155479|3758253|FG003|Part II|Non-Compliance with Protocol|2
2147094|NCT01155479|3758254|FG004|Part II|Non-Compliance with Protocol|0
2147095|NCT01155531|3758286|FG000|Overall Study|Adverse Event|0
2147096|NCT01155531|3758287|FG001|Overall Study|Adverse Event|0
2147097|NCT01155531|3758288|FG002|Overall Study|Adverse Event|1
2147098|NCT01155531|3758289|FG003|Overall Study|Adverse Event|0
2147099|NCT01155531|3758286|FG000|Overall Study|Lost to Follow-up|0
2147100|NCT01155531|3758287|FG001|Overall Study|Lost to Follow-up|0
2147101|NCT01155531|3758288|FG002|Overall Study|Lost to Follow-up|0
2147102|NCT01155531|3758289|FG003|Overall Study|Lost to Follow-up|1
2147103|NCT01155531|3758286|FG000|Overall Study|Withdrawal by Subject|1
2147104|NCT01155531|3758287|FG001|Overall Study|Withdrawal by Subject|0
2147105|NCT01155531|3758288|FG002|Overall Study|Withdrawal by Subject|1
2147106|NCT01155531|3758289|FG003|Overall Study|Withdrawal by Subject|0
2147107|NCT01155570|3758299|FG000|Overall Study|Adverse Event|39
2147108|NCT01155570|3758299|FG000|Overall Study|Lack of Efficacy|46
2147109|NCT01155570|3758299|FG000|Overall Study|Participant's Economic Reasons|17
2147110|NCT01155570|3758299|FG000|Overall Study|No Hospital Visits|7
2147111|NCT01155570|3758299|FG000|Overall Study|Adverse Event + Lack of Efficacy|2
2147112|NCT01155570|3758299|FG000|Overall Study|Adverse Event + Other Reasons|7
2147113|NCT01155570|3758299|FG000|Overall Study|Participant's Economic Reasons + Other|1
2147114|NCT01155570|3758299|FG000|Overall Study|Other Reasons|23
2147115|NCT01155583|3758314|FG000|Phase I|Screen failure - did not start treatment|0
2147116|NCT01155583|3758315|FG001|Phase I|Screen failure - did not start treatment|0
2147117|NCT01155583|3758316|FG002|Phase I|Screen failure - did not start treatment|0
2147118|NCT01155583|3758317|FG003|Phase I|Screen failure - did not start treatment|0
2147119|NCT01155583|3758318|FG004|Phase I|Screen failure - did not start treatment|1
2290685|NCT02493946|3983461|FG000|Open Label Period|Investigator decision, non-compliance|0
2290686|NCT02493946|3983462|FG001|Open Label Period|Investigator decision, non-compliance|0
2290687|NCT02493946|3983463|FG002|Open Label Period|Investigator decision, non-compliance|2
2290688|NCT02493946|3983461|FG000|Open Label Period|Investigator decision, non-availability|0
2290689|NCT02493946|3983462|FG001|Open Label Period|Investigator decision, non-availability|0
2290690|NCT02493946|3983463|FG002|Open Label Period|Investigator decision, non-availability|1
2290691|NCT02493946|3983461|FG000|Open Label Period|Pregnancy|0
2290692|NCT02493946|3983462|FG001|Open Label Period|Pregnancy|0
2290693|NCT02493946|3983463|FG002|Open Label Period|Pregnancy|3
2290694|NCT02493946|3983461|FG000|Open Label Period|Site error|0
2290695|NCT02493946|3983462|FG001|Open Label Period|Site error|0
2290696|NCT02493946|3983463|FG002|Open Label Period|Site error|1
2290697|NCT02494401|3983517|FG000|Overall Study|Lost to Follow-up|22
2290698|NCT02494401|3983518|FG001|Overall Study|Lost to Follow-up|25
2290699|NCT02494401|3983517|FG000|Overall Study|Withdrawal by Subject|3
2290700|NCT02494401|3983518|FG001|Overall Study|Withdrawal by Subject|2
2290701|NCT02494583|3983544|FG000|Overall Study|Death|195
2290702|NCT02494583|3983545|FG001|Overall Study|Death|189
2290703|NCT02494583|3983546|FG002|Overall Study|Death|201
2290704|NCT02494583|3983544|FG000|Overall Study|Lost to Follow-up|1
2290705|NCT02494583|3983545|FG001|Overall Study|Lost to Follow-up|0
2290706|NCT02494583|3983546|FG002|Overall Study|Lost to Follow-up|0
2290707|NCT02494583|3983544|FG000|Overall Study|Protocol Violation|1
2290708|NCT02494583|3983545|FG001|Overall Study|Protocol Violation|2
2290709|NCT02494583|3983546|FG002|Overall Study|Protocol Violation|0
2290710|NCT02494583|3983544|FG000|Overall Study|Withdrawal by Subject|3
2290711|NCT02494583|3983545|FG001|Overall Study|Withdrawal by Subject|15
2290712|NCT02494583|3983546|FG002|Overall Study|Withdrawal by Subject|15
2290713|NCT02494583|3983544|FG000|Overall Study|Ongoing in Study|56
2290714|NCT02494583|3983545|FG001|Overall Study|Ongoing in Study|51
2290715|NCT02494583|3983546|FG002|Overall Study|Ongoing in Study|34
2290716|NCT02494596|3983554|FG000|Overall Study|Insufficient Therapeutic Response|3
2290717|NCT02494596|3983555|FG001|Overall Study|Insufficient Therapeutic Response|3
2290718|NCT02494596|3983556|FG002|Overall Study|Insufficient Therapeutic Response|1
2290719|NCT02494596|3983554|FG000|Overall Study|Adverse Event|0
2290720|NCT02494596|3983555|FG001|Overall Study|Adverse Event|1
2290721|NCT02494596|3983556|FG002|Overall Study|Adverse Event|0
2290722|NCT02494596|3983554|FG000|Overall Study|Refused Treatment|0
2290723|NCT02494596|3983555|FG001|Overall Study|Refused Treatment|1
2290724|NCT02494596|3983556|FG002|Overall Study|Refused Treatment|0
2290725|NCT02494778|3983571|FG000|Overall Study|Death|3
2290726|NCT02494778|3983571|FG000|Overall Study|Other|173
2290727|NCT02494778|3983571|FG000|Overall Study|Lack of Efficacy|4
2290728|NCT02494778|3983571|FG000|Overall Study|Adverse Event|18
2290729|NCT02494778|3983571|FG000|Overall Study|Withdrawal by Subject|20
2290730|NCT02494778|3983571|FG000|Overall Study|Lost to Follow-up|2
2290731|NCT02494778|3983571|FG000|Overall Study|Noncompliant with study drug admin.|1
2290732|NCT02495025|3983586|FG000|Overall Study|Lost to Follow-up|21
2290733|NCT02495025|3983587|FG001|Overall Study|Lost to Follow-up|14
2290734|NCT02495025|3983586|FG000|Overall Study|Withdrawal by Subject|5
2290735|NCT02495025|3983587|FG001|Overall Study|Withdrawal by Subject|0
2290736|NCT02495168|3983620|FG000|Overall Study|Other than Specified|18
2290737|NCT02495168|3983621|FG001|Overall Study|Other than Specified|22
2290738|NCT02495168|3983622|FG002|Overall Study|Other than Specified|5
2290739|NCT02495168|3983620|FG000|Overall Study|Did not Complete Final Visit On Time|4
2290740|NCT02495168|3983621|FG001|Overall Study|Did not Complete Final Visit On Time|3
2290741|NCT02495168|3983622|FG002|Overall Study|Did not Complete Final Visit On Time|2
2290742|NCT02495168|3983620|FG000|Overall Study|Physician Decision|1
2290743|NCT02495168|3983621|FG001|Overall Study|Physician Decision|1
2290744|NCT02495168|3983622|FG002|Overall Study|Physician Decision|0
2290745|NCT02495168|3983620|FG000|Overall Study|Lost to Follow-up|10
2290746|NCT02495168|3983621|FG001|Overall Study|Lost to Follow-up|6
2290747|NCT02495168|3983622|FG002|Overall Study|Lost to Follow-up|1
2290748|NCT02495168|3983620|FG000|Overall Study|Withdrawal by Subject|1
2290749|NCT02495168|3983621|FG001|Overall Study|Withdrawal by Subject|4
2290750|NCT02495168|3983622|FG002|Overall Study|Withdrawal by Subject|2
2290751|NCT02495168|3983620|FG000|Overall Study|Protocol Violation|0
2290752|NCT02495168|3983621|FG001|Overall Study|Protocol Violation|10
2290753|NCT02495168|3983622|FG002|Overall Study|Protocol Violation|1
2290754|NCT02495168|3983620|FG000|Overall Study|Adverse Event|4
2147120|NCT01155583|3758319|FG005|Phase I|Screen failure - did not start treatment|0
2147121|NCT01155583|3758320|FG006|Phase I|Screen failure - did not start treatment|0
2147122|NCT01155583|3758321|FG007|Phase I|Screen failure - did not start treatment|2
2147123|NCT01155583|3758322|FG008|Phase I|Screen failure - did not start treatment|0
2147124|NCT01155583|3758314|FG000|Phase I|Withdrawal by Subject|0
2147125|NCT01155583|3758315|FG001|Phase I|Withdrawal by Subject|0
2147126|NCT01155583|3758316|FG002|Phase I|Withdrawal by Subject|0
2147127|NCT01155583|3758317|FG003|Phase I|Withdrawal by Subject|0
2147128|NCT01155583|3758318|FG004|Phase I|Withdrawal by Subject|0
2290755|NCT02495168|3983621|FG001|Overall Study|Adverse Event|8
2290756|NCT02495168|3983622|FG002|Overall Study|Adverse Event|3
2290757|NCT02495168|3983620|FG000|Overall Study|Lack of Efficacy|0
2290758|NCT02495168|3983621|FG001|Overall Study|Lack of Efficacy|0
2290759|NCT02495168|3983622|FG002|Overall Study|Lack of Efficacy|3
2290760|NCT02495233|3983632|FG000|Overall Study|Miscellaneous|0
2290761|NCT02495233|3983633|FG001|Overall Study|Miscellaneous|1
2290762|NCT02495389|3983652|FG000|Overall Study|Withdrawal by Subject|40
2321051|NCT02954458|4035306|FG003|Overall Study|Other|7
2321052|NCT02954575|4035320|FG000|Overall Study|Withdrawal by Subject|2
2321053|NCT02954575|4035320|FG000|Overall Study|Adverse Event|1
2321054|NCT02954601|4035332|FG000|First Intervention (Five Days)|Withdrawal by Subject|0
2321055|NCT02954601|4035333|FG001|First Intervention (Five Days)|Withdrawal by Subject|0
2321056|NCT02954601|4035334|FG002|First Intervention (Five Days)|Withdrawal by Subject|1
2321057|NCT02954601|4035335|FG003|First Intervention (Five Days)|Withdrawal by Subject|0
2321058|NCT02954653|4035347|FG000|Overall Study|Death|3
2321059|NCT02954653|4035348|FG001|Overall Study|Death|1
2321060|NCT02954653|4035349|FG002|Overall Study|Death|0
2321061|NCT02954653|4035350|FG003|Overall Study|Death|0
2321062|NCT02954653|4035351|FG004|Overall Study|Death|0
2321063|NCT02954653|4035352|FG005|Overall Study|Death|0
2321064|NCT02954653|4035353|FG006|Overall Study|Death|0
2321065|NCT02954653|4035354|FG007|Overall Study|Death|0
2321066|NCT02954653|4035355|FG008|Overall Study|Death|0
2321067|NCT02954653|4035347|FG000|Overall Study|Randomized but did not receive treatment|1
2321068|NCT02954653|4035348|FG001|Overall Study|Randomized but did not receive treatment|0
2321069|NCT02954653|4035349|FG002|Overall Study|Randomized but did not receive treatment|0
2321070|NCT02954653|4035350|FG003|Overall Study|Randomized but did not receive treatment|0
2321071|NCT02954653|4035351|FG004|Overall Study|Randomized but did not receive treatment|0
2321072|NCT02954653|4035352|FG005|Overall Study|Randomized but did not receive treatment|0
2321073|NCT02954653|4035353|FG006|Overall Study|Randomized but did not receive treatment|0
2321074|NCT02954653|4035354|FG007|Overall Study|Randomized but did not receive treatment|0
2321075|NCT02954653|4035355|FG008|Overall Study|Randomized but did not receive treatment|0
2321076|NCT02954653|4035347|FG000|Overall Study|Started another anti-cancer therapy|0
2321077|NCT02954653|4035348|FG001|Overall Study|Started another anti-cancer therapy|1
2321078|NCT02954653|4035349|FG002|Overall Study|Started another anti-cancer therapy|0
2321079|NCT02954653|4035350|FG003|Overall Study|Started another anti-cancer therapy|0
2321080|NCT02954653|4035351|FG004|Overall Study|Started another anti-cancer therapy|0
2321081|NCT02954653|4035352|FG005|Overall Study|Started another anti-cancer therapy|0
2321082|NCT02954653|4035353|FG006|Overall Study|Started another anti-cancer therapy|0
2321083|NCT02954653|4035354|FG007|Overall Study|Started another anti-cancer therapy|0
2321084|NCT02954653|4035355|FG008|Overall Study|Started another anti-cancer therapy|0
2321085|NCT02954653|4035347|FG000|Overall Study|Treatment failure and consent withdrawal|0
2321086|NCT02954653|4035348|FG001|Overall Study|Treatment failure and consent withdrawal|1
2321087|NCT02954653|4035349|FG002|Overall Study|Treatment failure and consent withdrawal|0
2321088|NCT02954653|4035350|FG003|Overall Study|Treatment failure and consent withdrawal|0
2321089|NCT02954653|4035351|FG004|Overall Study|Treatment failure and consent withdrawal|0
2321090|NCT02954653|4035352|FG005|Overall Study|Treatment failure and consent withdrawal|0
2321091|NCT02954653|4035353|FG006|Overall Study|Treatment failure and consent withdrawal|0
2321092|NCT02954653|4035354|FG007|Overall Study|Treatment failure and consent withdrawal|0
2321093|NCT02954653|4035355|FG008|Overall Study|Treatment failure and consent withdrawal|0
2321094|NCT02954848|4035369|FG000|Overall Study|Randomized but Not Treated|0
2321095|NCT02954848|4035370|FG001|Overall Study|Randomized but Not Treated|1
2321096|NCT02954848|4035369|FG000|Overall Study|Adverse Event|2
2321097|NCT02954848|4035370|FG001|Overall Study|Adverse Event|3
2321098|NCT02954848|4035369|FG000|Overall Study|Withdrawal by Participant|0
2321099|NCT02954848|4035370|FG001|Overall Study|Withdrawal by Participant|1
2321100|NCT02954887|4035376|FG000|Overall Study|Withdrawal by Subject|3
2321101|NCT02954887|4035376|FG000|Overall Study|Lack of Efficacy|3
2321102|NCT02954887|4035376|FG000|Overall Study|Other|1
2321103|NCT02955069|4035382|FG000|Overall Study|Adverse Event|7
2321104|NCT02955069|4035383|FG001|Overall Study|Adverse Event|2
2321105|NCT02955069|4035382|FG000|Overall Study|Death|7
2321106|NCT02955069|4035383|FG001|Overall Study|Death|3
2321107|NCT02955069|4035382|FG000|Overall Study|Physician Decision|10
2321108|NCT02955069|4035383|FG001|Overall Study|Physician Decision|2
2321109|NCT02955069|4035382|FG000|Overall Study|Progressive disease|64
2321110|NCT02955069|4035383|FG001|Overall Study|Progressive disease|13
2321111|NCT02955069|4035382|FG000|Overall Study|Study terminated by sponsor|4
2321112|NCT02955069|4035383|FG001|Overall Study|Study terminated by sponsor|0
2147129|NCT01155583|3758319|FG005|Phase I|Withdrawal by Subject|0
2147130|NCT01155583|3758320|FG006|Phase I|Withdrawal by Subject|0
2147131|NCT01155583|3758321|FG007|Phase I|Withdrawal by Subject|1
2147132|NCT01155583|3758322|FG008|Phase I|Withdrawal by Subject|0
2147133|NCT01155661|3758338|FG000|Overall Study|Adverse Event|101
2147134|NCT01155661|3758338|FG000|Overall Study|Death|1
2147135|NCT01155661|3758338|FG000|Overall Study|Lack of Efficacy|32
2147136|NCT01155661|3758338|FG000|Overall Study|Lost to Follow-up|22
2147137|NCT01155661|3758338|FG000|Overall Study|Physician Decision|3
2147138|NCT01155661|3758338|FG000|Overall Study|Protocol Violation|35
2147139|NCT01155661|3758338|FG000|Overall Study|Withdrawal by Subject|73
2147140|NCT01155661|3758338|FG000|Overall Study|Sponsor Decision|13
2147141|NCT01155726|3758344|FG000|Period 1, 3 Days (Masked)|Inconvenience|1
2147142|NCT01155726|3758345|FG001|Period 1, 3 Days (Masked)|Inconvenience|0
2147143|NCT01155726|3758346|FG002|Period 1, 3 Days (Masked)|Inconvenience|2
2147144|NCT01155726|3758347|FG003|Period 1, 3 Days (Masked)|Inconvenience|0
2290763|NCT02495844|3983696|FG000|Overall Study|Lack of Efficacy|1
2290764|NCT02495844|3983697|FG001|Overall Study|Lack of Efficacy|2
2290765|NCT02495844|3983696|FG000|Overall Study|AE, non-fatal|0
2290766|NCT02495844|3983697|FG001|Overall Study|AE, non-fatal|1
2290767|NCT02495844|3983696|FG000|Overall Study|Hepatitis Positivity|0
2290768|NCT02495844|3983697|FG001|Overall Study|Hepatitis Positivity|1
2290769|NCT02495857|3983708|FG000|Overall Study|Adverse Event|5
2290770|NCT02495857|3983709|FG001|Overall Study|Adverse Event|0
2290771|NCT02495857|3983710|FG002|Overall Study|Adverse Event|1
2290772|NCT02495857|3983708|FG000|Overall Study|Withdrawal by Subject|9
2290773|NCT02495857|3983709|FG001|Overall Study|Withdrawal by Subject|6
2290774|NCT02495857|3983710|FG002|Overall Study|Withdrawal by Subject|10
2290775|NCT02495857|3983708|FG000|Overall Study|Physician Decision|0
2290776|NCT02495857|3983709|FG001|Overall Study|Physician Decision|1
2290777|NCT02495857|3983710|FG002|Overall Study|Physician Decision|0
2290778|NCT02495857|3983708|FG000|Overall Study|Protocol Violation|1
2290779|NCT02495857|3983709|FG001|Overall Study|Protocol Violation|1
2290780|NCT02495857|3983710|FG002|Overall Study|Protocol Violation|2
2290781|NCT02495857|3983708|FG000|Overall Study|Lost to Follow-up|4
2290782|NCT02495857|3983709|FG001|Overall Study|Lost to Follow-up|5
2290783|NCT02495857|3983710|FG002|Overall Study|Lost to Follow-up|3
2290784|NCT02495857|3983708|FG000|Overall Study|Other|3
2290785|NCT02495857|3983709|FG001|Overall Study|Other|3
2290786|NCT02495857|3983710|FG002|Overall Study|Other|2
2290787|NCT02495883|3983720|FG000|Overall Study|Excessive head motion|1
2290788|NCT02495883|3983721|FG001|Overall Study|Excessive head motion|0
2290789|NCT02495948|3983726|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
2290790|NCT02495948|3983727|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
2290791|NCT02495948|3983726|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
2290792|NCT02495948|3983727|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
2290793|NCT02496000|3983737|FG000|Overall Study|Withdrawal by Subject|1
2290794|NCT02496000|3983738|FG001|Overall Study|Withdrawal by Subject|2
2290795|NCT02496000|3983739|FG002|Overall Study|Withdrawal by Subject|0
2290796|NCT02496000|3983737|FG000|Overall Study|Lost to Follow-up|1
2290797|NCT02496000|3983738|FG001|Overall Study|Lost to Follow-up|0
2290798|NCT02496000|3983739|FG002|Overall Study|Lost to Follow-up|1
2290799|NCT02496000|3983737|FG000|Overall Study|Protocol Violation|0
2290800|NCT02496000|3983738|FG001|Overall Study|Protocol Violation|0
2290801|NCT02496000|3983739|FG002|Overall Study|Protocol Violation|1
2290802|NCT02496000|3983737|FG000|Overall Study|Non-compliance or lack of cooperation|0
2290803|NCT02496000|3983738|FG001|Overall Study|Non-compliance or lack of cooperation|2
2290804|NCT02496000|3983739|FG002|Overall Study|Non-compliance or lack of cooperation|0
2290805|NCT02496000|3983737|FG000|Overall Study|undetermined|0
2290806|NCT02496000|3983738|FG001|Overall Study|undetermined|1
2290807|NCT02496000|3983739|FG002|Overall Study|undetermined|0
2290808|NCT02496091|3983748|FG000|Overall Study|Eligibility criteria not fulfilled|2
2290809|NCT02496221|3983753|FG000|Treatment Period 2 - 4 Days|Adverse Event|0
2290810|NCT02496221|3983754|FG001|Treatment Period 2 - 4 Days|Adverse Event|1
2290811|NCT02496221|3983753|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1
2290812|NCT02496221|3983754|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0
2290813|NCT02496221|3983753|FG000|Treatment Period 2 - 4 Days|Physician Decision|1
2290814|NCT02496221|3983754|FG001|Treatment Period 2 - 4 Days|Physician Decision|0
2290815|NCT02496533|3983764|FG000|Overall Study|Lack of data on outcome|3
2290816|NCT02496533|3983765|FG001|Overall Study|Lack of data on outcome|0
2290817|NCT02496533|3983764|FG000|Overall Study|Patient did not complete all measures|0
2290818|NCT02496533|3983765|FG001|Overall Study|Patient did not complete all measures|4
2290819|NCT02496533|3983764|FG000|Overall Study|Late for radiologic testing|0
2147145|NCT01155869|3758397|FG000|Overall Study|Lost to Follow-up|3
2147146|NCT01155869|3758398|FG001|Overall Study|Lost to Follow-up|1
2147147|NCT01156012|3758415|FG000|Overall Study|Adverse Event|3
2147148|NCT01156012|3758416|FG001|Overall Study|Adverse Event|1
2290820|NCT02496533|3983765|FG001|Overall Study|Late for radiologic testing|2
2290821|NCT02496702|3983773|FG000|Overall Study|Lost to Follow-up|8
2290822|NCT02496702|3983774|FG001|Overall Study|Lost to Follow-up|6
2290823|NCT02496702|3983773|FG000|Overall Study|Only partially tested|0
2290824|NCT02496702|3983774|FG001|Overall Study|Only partially tested|2
2290825|NCT02496767|3983784|FG000|Open-label Lead-in Phase|Adverse Event|176
2290826|NCT02496767|3983785|FG001|Open-label Lead-in Phase|Adverse Event|0
2147149|NCT01156012|3758415|FG000|Overall Study|Lost to Follow-up|1
2147150|NCT01156012|3758416|FG001|Overall Study|Lost to Follow-up|0
2147151|NCT01156012|3758415|FG000|Overall Study|Withdrawal by Subject|1
2147152|NCT01156012|3758416|FG001|Overall Study|Withdrawal by Subject|0
2147153|NCT01156012|3758415|FG000|Overall Study|use of commercial drug instead of study|0
2147154|NCT01156012|3758416|FG001|Overall Study|use of commercial drug instead of study|1
2147155|NCT01156012|3758415|FG000|Overall Study|Non respect of one of inclusion criteria|2
2147156|NCT01156012|3758416|FG001|Overall Study|Non respect of one of inclusion criteria|1
2147157|NCT01156051|3758424|FG000|Overall Study|Lost to Follow-up|1
2147158|NCT01156051|3758425|FG001|Overall Study|Lost to Follow-up|0
2147159|NCT01156051|3758424|FG000|Overall Study|patient not compliant with protocol|0
2147160|NCT01156051|3758425|FG001|Overall Study|patient not compliant with protocol|1
2147161|NCT01156116|3758433|FG000|Overall Study|Withdrawal by Subject|3
2147162|NCT01156116|3758434|FG001|Overall Study|Withdrawal by Subject|1
2147163|NCT01156116|3758433|FG000|Overall Study|CPAP intolerance|2
2147164|NCT01156116|3758434|FG001|Overall Study|CPAP intolerance|0
2147165|NCT01156142|3758442|FG000|Overall Study|Withdrawal by Subject|8
2147166|NCT01156142|3758443|FG001|Overall Study|Withdrawal by Subject|6
2147167|NCT01156142|3758442|FG000|Overall Study|Ineligible|0
2147168|NCT01156142|3758443|FG001|Overall Study|Ineligible|1
2147169|NCT01156311|3758451|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1
2147170|NCT01156311|3758452|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1
2147171|NCT01156311|3758453|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0
2147172|NCT01156311|3758454|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0
2147173|NCT01156311|3758451|FG000|2-Month Monotherapy Period|Physician Decision|0
2147174|NCT01156311|3758452|FG001|2-Month Monotherapy Period|Physician Decision|1
2147175|NCT01156311|3758453|FG002|2-Month Monotherapy Period|Physician Decision|0
2147176|NCT01156311|3758454|FG003|2-Month Monotherapy Period|Physician Decision|0
2147177|NCT01156311|3758451|FG000|2-Month Monotherapy Period|Other|1
2147178|NCT01156311|3758452|FG001|2-Month Monotherapy Period|Other|0
2147179|NCT01156311|3758453|FG002|2-Month Monotherapy Period|Other|0
2147180|NCT01156311|3758454|FG003|2-Month Monotherapy Period|Other|0
2147181|NCT01156311|3758451|FG000|6-month Add-on Therapy Period|Adverse Event|0
2147182|NCT01156311|3758452|FG001|6-month Add-on Therapy Period|Adverse Event|0
2147183|NCT01156311|3758453|FG002|6-month Add-on Therapy Period|Adverse Event|7
2147184|NCT01156311|3758454|FG003|6-month Add-on Therapy Period|Adverse Event|6
2147185|NCT01156311|3758451|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0
2147186|NCT01156311|3758452|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0
2147187|NCT01156311|3758453|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2
2290827|NCT02496767|3983786|FG002|Open-label Lead-in Phase|Adverse Event|0
2290828|NCT02496767|3983787|FG003|Open-label Lead-in Phase|Adverse Event|0
2290829|NCT02496767|3983788|FG004|Open-label Lead-in Phase|Adverse Event|0
2290830|NCT02496767|3983789|FG005|Open-label Lead-in Phase|Adverse Event|0
2290831|NCT02496767|3983790|FG006|Open-label Lead-in Phase|Adverse Event|0
2290832|NCT02496767|3983791|FG007|Open-label Lead-in Phase|Adverse Event|0
2290833|NCT02496767|3983784|FG000|Open-label Lead-in Phase|Protocol Violation|2
2290834|NCT02496767|3983785|FG001|Open-label Lead-in Phase|Protocol Violation|0
2290835|NCT02496767|3983786|FG002|Open-label Lead-in Phase|Protocol Violation|0
2290836|NCT02496767|3983787|FG003|Open-label Lead-in Phase|Protocol Violation|0
2290837|NCT02496767|3983788|FG004|Open-label Lead-in Phase|Protocol Violation|0
2290838|NCT02496767|3983789|FG005|Open-label Lead-in Phase|Protocol Violation|0
2290839|NCT02496767|3983790|FG006|Open-label Lead-in Phase|Protocol Violation|0
2290840|NCT02496767|3983791|FG007|Open-label Lead-in Phase|Protocol Violation|0
2290841|NCT02496767|3983784|FG000|Open-label Lead-in Phase|Lost to Follow-up|1
2290842|NCT02496767|3983785|FG001|Open-label Lead-in Phase|Lost to Follow-up|0
2290843|NCT02496767|3983786|FG002|Open-label Lead-in Phase|Lost to Follow-up|0
2290844|NCT02496767|3983787|FG003|Open-label Lead-in Phase|Lost to Follow-up|0
2290845|NCT02496767|3983788|FG004|Open-label Lead-in Phase|Lost to Follow-up|0
2290846|NCT02496767|3983789|FG005|Open-label Lead-in Phase|Lost to Follow-up|0
2290847|NCT02496767|3983790|FG006|Open-label Lead-in Phase|Lost to Follow-up|0
2290848|NCT02496767|3983791|FG007|Open-label Lead-in Phase|Lost to Follow-up|0
2290849|NCT02496767|3983784|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
2290850|NCT02496767|3983785|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13
2290851|NCT02496767|3983786|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23
2290852|NCT02496767|3983787|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43
2290853|NCT02496767|3983788|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43
2290854|NCT02496767|3983789|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0
2147188|NCT01156311|3758454|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0
2147189|NCT01156311|3758451|FG000|6-month Add-on Therapy Period|Disease Activity|0
2147190|NCT01156311|3758452|FG001|6-month Add-on Therapy Period|Disease Activity|0
2147191|NCT01156311|3758453|FG002|6-month Add-on Therapy Period|Disease Activity|1
2147192|NCT01156311|3758454|FG003|6-month Add-on Therapy Period|Disease Activity|2
2147193|NCT01156311|3758451|FG000|6-month Add-on Therapy Period|Physician Decision|0
2290855|NCT02496767|3983790|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0
2290856|NCT02496767|3983791|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0
2290857|NCT02496767|3983784|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0
2321113|NCT02955069|4035382|FG000|Overall Study|Subject/Guardian decision|3
2147194|NCT01156311|3758452|FG001|6-month Add-on Therapy Period|Physician Decision|0
2147195|NCT01156311|3758453|FG002|6-month Add-on Therapy Period|Physician Decision|1
2147196|NCT01156311|3758454|FG003|6-month Add-on Therapy Period|Physician Decision|0
2147197|NCT01156311|3758451|FG000|6-month Add-on Therapy Period|Other|0
2147198|NCT01156311|3758452|FG001|6-month Add-on Therapy Period|Other|0
2147199|NCT01156311|3758453|FG002|6-month Add-on Therapy Period|Other|1
2147200|NCT01156311|3758454|FG003|6-month Add-on Therapy Period|Other|2
2147201|NCT01156363|3758465|FG000|Overall Study|Adverse Event|6
2147202|NCT01156363|3758465|FG000|Overall Study|Insufficient Therapeutic Response|5
2147203|NCT01156363|3758465|FG000|Overall Study|Failure to Return|1
2147204|NCT01156363|3758465|FG000|Overall Study|Refused Treatment|4
2147205|NCT01156363|3758465|FG000|Overall Study|Other|6
2147206|NCT01156376|3758479|FG000|Overall Study|Adverse Event|1
2290858|NCT02496767|3983785|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13
2290859|NCT02496767|3983786|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9
2290860|NCT02496767|3983787|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8
2290861|NCT02496767|3983788|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14
2290862|NCT02496767|3983789|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0
2290863|NCT02496767|3983790|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0
2290864|NCT02496767|3983791|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0
2290865|NCT02496767|3983784|FG000|Double-blind, Placebo-controlled Phase|Death|0
2290866|NCT02496767|3983785|FG001|Double-blind, Placebo-controlled Phase|Death|10
2290867|NCT02496767|3983786|FG002|Double-blind, Placebo-controlled Phase|Death|6
2290868|NCT02496767|3983787|FG003|Double-blind, Placebo-controlled Phase|Death|2
2290869|NCT02496767|3983788|FG004|Double-blind, Placebo-controlled Phase|Death|4
2290870|NCT02496767|3983789|FG005|Double-blind, Placebo-controlled Phase|Death|0
2290871|NCT02496767|3983790|FG006|Double-blind, Placebo-controlled Phase|Death|0
2290872|NCT02496767|3983791|FG007|Double-blind, Placebo-controlled Phase|Death|0
2290873|NCT02496767|3983784|FG000|Double-blind, Placebo-controlled Phase|Various|0
2290874|NCT02496767|3983785|FG001|Double-blind, Placebo-controlled Phase|Various|9
2290875|NCT02496767|3983786|FG002|Double-blind, Placebo-controlled Phase|Various|4
2290876|NCT02496767|3983787|FG003|Double-blind, Placebo-controlled Phase|Various|5
2290877|NCT02496767|3983788|FG004|Double-blind, Placebo-controlled Phase|Various|2
2290878|NCT02496767|3983789|FG005|Double-blind, Placebo-controlled Phase|Various|0
2290879|NCT02496767|3983790|FG006|Double-blind, Placebo-controlled Phase|Various|0
2290880|NCT02496767|3983791|FG007|Double-blind, Placebo-controlled Phase|Various|0
2290881|NCT02496767|3983784|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2290882|NCT02496767|3983785|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4
2290883|NCT02496767|3983786|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3
2290884|NCT02496767|3983787|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1
2290885|NCT02496767|3983788|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2
2290886|NCT02496767|3983789|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2290887|NCT02496767|3983790|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2290888|NCT02496767|3983791|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2290889|NCT02496767|3983784|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
2290890|NCT02496767|3983785|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4
2290891|NCT02496767|3983786|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1
2290892|NCT02496767|3983787|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0
2290893|NCT02496767|3983788|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0
2290894|NCT02496767|3983789|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0
2290895|NCT02496767|3983790|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0
2290896|NCT02496767|3983791|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0
2290897|NCT02496767|3983784|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2290898|NCT02496767|3983785|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
2290899|NCT02496767|3983786|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2290900|NCT02496767|3983787|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
2290901|NCT02496767|3983788|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1
2290902|NCT02496767|3983789|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2290903|NCT02496767|3983790|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2290904|NCT02496767|3983791|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2290905|NCT02496767|3983784|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0
2290906|NCT02496767|3983785|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1
2290907|NCT02496767|3983786|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0
2290908|NCT02496767|3983787|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0
2290909|NCT02496767|3983788|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0
2290910|NCT02496767|3983789|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0
2290911|NCT02496767|3983790|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0
2290912|NCT02496767|3983791|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0
2290913|NCT02496767|3983784|FG000|Double-blind, Withdrawal Phase|Progressive disease|0
2147207|NCT01156376|3758480|FG001|Overall Study|Adverse Event|0
2147208|NCT01156376|3758481|FG002|Overall Study|Adverse Event|1
2147209|NCT01156376|3758479|FG000|Overall Study|Withdrawal by Subject|0
2147210|NCT01156376|3758480|FG001|Overall Study|Withdrawal by Subject|0
2147211|NCT01156376|3758481|FG002|Overall Study|Withdrawal by Subject|3
2147212|NCT01156480|3758491|FG000|Overall Study|change in diagnosis|0
2147213|NCT01156480|3758492|FG001|Overall Study|change in diagnosis|1
2147214|NCT01156532|3758500|FG000|Overall Study|Family Reasons|1
2147215|NCT01156532|3758500|FG000|Overall Study|Lost to Follow-up|1
2178955|NCT01390272|3804109|FG000|Overall Study|Death|3
2178956|NCT01390272|3804110|FG001|Overall Study|Death|2
2178957|NCT01390272|3804109|FG000|Overall Study|Withdrawal by Subject|9
2178958|NCT01390272|3804110|FG001|Overall Study|Withdrawal by Subject|5
2178959|NCT01390272|3804109|FG000|Overall Study|Patient moved, no longer eligible|5
2178960|NCT01390272|3804110|FG001|Overall Study|Patient moved, no longer eligible|8
2178961|NCT01390298|3804116|FG000|Overall Study|Death|1
2178962|NCT01390298|3804116|FG000|Overall Study|long term ICU admission|1
2178963|NCT01390298|3804116|FG000|Overall Study|Withdrawal by Subject|14
2178964|NCT01390298|3804116|FG000|Overall Study|Lost to Follow-up|7
2178965|NCT01390298|3804116|FG000|Overall Study|Surgery cancelled|1
2178966|NCT01390389|3804122|FG000|Overall Study|Withdrawal by Subject|2
2178967|NCT01390389|3804123|FG001|Overall Study|Withdrawal by Subject|0
2178968|NCT01390389|3804122|FG000|Overall Study|Screen Fail|2
2178969|NCT01390389|3804123|FG001|Overall Study|Screen Fail|1
2178970|NCT01390402|3804133|FG000|Overall Study|Death|1
2178971|NCT01390402|3804133|FG000|Overall Study|Disease Progression|4
2178972|NCT01390428|3804143|FG000|Overall Study|Elective Surgery|0
2178973|NCT01390428|3804144|FG001|Overall Study|Elective Surgery|0
2178974|NCT01390428|3804145|FG002|Overall Study|Elective Surgery|0
2290914|NCT02496767|3983785|FG001|Double-blind, Withdrawal Phase|Progressive disease|0
2290915|NCT02496767|3983786|FG002|Double-blind, Withdrawal Phase|Progressive disease|0
2290916|NCT02496767|3983787|FG003|Double-blind, Withdrawal Phase|Progressive disease|0
2290917|NCT02496767|3983788|FG004|Double-blind, Withdrawal Phase|Progressive disease|0
2290918|NCT02496767|3983789|FG005|Double-blind, Withdrawal Phase|Progressive disease|4
2290919|NCT02496767|3983790|FG006|Double-blind, Withdrawal Phase|Progressive disease|0
2290920|NCT02496767|3983791|FG007|Double-blind, Withdrawal Phase|Progressive disease|1
2290921|NCT02496767|3983784|FG000|Double-blind, Withdrawal Phase|Adverse Event|0
2290922|NCT02496767|3983785|FG001|Double-blind, Withdrawal Phase|Adverse Event|0
2290923|NCT02496767|3983786|FG002|Double-blind, Withdrawal Phase|Adverse Event|0
2290924|NCT02496767|3983787|FG003|Double-blind, Withdrawal Phase|Adverse Event|0
2290925|NCT02496767|3983788|FG004|Double-blind, Withdrawal Phase|Adverse Event|0
2290926|NCT02496767|3983789|FG005|Double-blind, Withdrawal Phase|Adverse Event|1
2290927|NCT02496767|3983790|FG006|Double-blind, Withdrawal Phase|Adverse Event|2
2290928|NCT02496767|3983791|FG007|Double-blind, Withdrawal Phase|Adverse Event|1
2290929|NCT02496767|3983784|FG000|Double-blind, Withdrawal Phase|Death|0
2290930|NCT02496767|3983785|FG001|Double-blind, Withdrawal Phase|Death|0
2290931|NCT02496767|3983786|FG002|Double-blind, Withdrawal Phase|Death|0
2290932|NCT02496767|3983787|FG003|Double-blind, Withdrawal Phase|Death|0
2290933|NCT02496767|3983788|FG004|Double-blind, Withdrawal Phase|Death|0
2290934|NCT02496767|3983789|FG005|Double-blind, Withdrawal Phase|Death|0
2290935|NCT02496767|3983790|FG006|Double-blind, Withdrawal Phase|Death|1
2290936|NCT02496767|3983791|FG007|Double-blind, Withdrawal Phase|Death|2
2290937|NCT02496767|3983784|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
2290938|NCT02496767|3983785|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
2290939|NCT02496767|3983786|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
2290940|NCT02496767|3983787|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
2290941|NCT02496767|3983788|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
2290942|NCT02496767|3983789|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
2290943|NCT02496767|3983790|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
2290944|NCT02496767|3983791|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
2290945|NCT02496884|3983809|FG000|Overall Study|Counted twice as enrolled|2
2290946|NCT02496884|3983810|FG001|Overall Study|Counted twice as enrolled|0
2290947|NCT02496884|3983811|FG002|Overall Study|Counted twice as enrolled|0
2290948|NCT02496884|3983812|FG003|Overall Study|Counted twice as enrolled|0
2290949|NCT02496884|3983809|FG000|Overall Study|Withdrawal by Subject|0
2290950|NCT02496884|3983810|FG001|Overall Study|Withdrawal by Subject|3
2290951|NCT02496884|3983811|FG002|Overall Study|Withdrawal by Subject|0
2290952|NCT02496884|3983812|FG003|Overall Study|Withdrawal by Subject|0
2290953|NCT02497001|3983826|FG000|Overall Study|Lost to Follow-up|10
2290954|NCT02497001|3983827|FG001|Overall Study|Lost to Follow-up|2
2290955|NCT02497001|3983828|FG002|Overall Study|Lost to Follow-up|0
2290956|NCT02497001|3983829|FG003|Overall Study|Lost to Follow-up|2
2290957|NCT02497001|3983826|FG000|Overall Study|Adverse Event|28
2290958|NCT02497001|3983827|FG001|Overall Study|Adverse Event|30
2290959|NCT02497001|3983828|FG002|Overall Study|Adverse Event|11
2290960|NCT02497001|3983829|FG003|Overall Study|Adverse Event|11
2290961|NCT02497001|3983826|FG000|Overall Study|Withdrawal by Subject|14
2178975|NCT01390428|3804146|FG003|Overall Study|Elective Surgery|0
2178976|NCT01390428|3804147|FG004|Overall Study|Elective Surgery|1
2178977|NCT01390428|3804148|FG005|Overall Study|Elective Surgery|0
2178978|NCT01390428|3804143|FG000|Overall Study|Withdrawal by Subject|0
2178979|NCT01390428|3804144|FG001|Overall Study|Withdrawal by Subject|0
2178980|NCT01390428|3804145|FG002|Overall Study|Withdrawal by Subject|1
2147216|NCT01156675|3758526|FG000|Overall Study|Death|5
2147217|NCT01156675|3758527|FG001|Overall Study|Death|3
2147218|NCT01156675|3758528|FG002|Overall Study|Death|0
2147219|NCT01156675|3758526|FG000|Overall Study|No data|29
2147220|NCT01156675|3758527|FG001|Overall Study|No data|22
2147221|NCT01156675|3758528|FG002|Overall Study|No data|2
2147222|NCT01156714|3758553|FG000|Overall Study|Withdrawal by Subject|9
2147223|NCT01156714|3758554|FG001|Overall Study|Withdrawal by Subject|4
2147224|NCT01156714|3758555|FG002|Overall Study|Withdrawal by Subject|3
2147225|NCT01156792|3758566|FG000|Overall Study|Adverse Event|1
2147226|NCT01156792|3758566|FG000|Overall Study|Lack of Efficacy|36
2147227|NCT01156792|3758566|FG000|Overall Study|Protocol Violation|6
2147228|NCT01156792|3758566|FG000|Overall Study|Lost to Follow-up|3
2147229|NCT01156792|3758566|FG000|Overall Study|Physician Decision|3
2147230|NCT01156792|3758566|FG000|Overall Study|Withdrawal by Subject|9
2290962|NCT02497001|3983827|FG001|Overall Study|Withdrawal by Subject|37
2290963|NCT02497001|3983828|FG002|Overall Study|Withdrawal by Subject|19
2290964|NCT02497001|3983829|FG003|Overall Study|Withdrawal by Subject|15
2290965|NCT02497001|3983826|FG000|Overall Study|Physician Decision|5
2290966|NCT02497001|3983827|FG001|Overall Study|Physician Decision|11
2290967|NCT02497001|3983828|FG002|Overall Study|Physician Decision|5
2290968|NCT02497001|3983829|FG003|Overall Study|Physician Decision|1
2290969|NCT02497001|3983826|FG000|Overall Study|subjects that were not treated|1
2290970|NCT02497001|3983827|FG001|Overall Study|subjects that were not treated|2
2290971|NCT02497001|3983828|FG002|Overall Study|subjects that were not treated|2
2290972|NCT02497001|3983829|FG003|Overall Study|subjects that were not treated|1
2290973|NCT02497001|3983826|FG000|Overall Study|Major Protocol Deviation|3
2290974|NCT02497001|3983827|FG001|Overall Study|Major Protocol Deviation|4
2290975|NCT02497001|3983828|FG002|Overall Study|Major Protocol Deviation|4
2290976|NCT02497001|3983829|FG003|Overall Study|Major Protocol Deviation|4
2290977|NCT02497001|3983826|FG000|Overall Study|Lack of Efficacy|10
2290978|NCT02497001|3983827|FG001|Overall Study|Lack of Efficacy|16
2290979|NCT02497001|3983828|FG002|Overall Study|Lack of Efficacy|6
2290980|NCT02497001|3983829|FG003|Overall Study|Lack of Efficacy|6
2290981|NCT02497001|3983826|FG000|Overall Study|Protocol Violation|3
2290982|NCT02497001|3983827|FG001|Overall Study|Protocol Violation|1
2290983|NCT02497001|3983828|FG002|Overall Study|Protocol Violation|3
2290984|NCT02497001|3983829|FG003|Overall Study|Protocol Violation|1
2290985|NCT02497287|3983879|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
2290986|NCT02497287|3983879|FG000|Induction Phase (4 Weeks)|Adverse Event|52
2290987|NCT02497287|3983879|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22
2290988|NCT02497287|3983879|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21
2290989|NCT02497287|3983879|FG000|Induction Phase (4 Weeks)|Other|13
2290990|NCT02497287|3983879|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5
2290991|NCT02497287|3983879|FG000|Induction Phase (4 Weeks)|Protocol Violation|1
2290992|NCT02497287|3983879|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
2290993|NCT02497287|3983879|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
2290994|NCT02497287|3983879|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
2290995|NCT02497287|3983879|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25
2290996|NCT02497287|3983879|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
2290997|NCT02497287|3983879|FG000|Optimization/Maintenance (48 Weeks)|Other|21
2290998|NCT02497287|3983879|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
2290999|NCT02497287|3983879|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
2291000|NCT02497287|3983879|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
2291001|NCT02497287|3983879|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2
2291002|NCT02497287|3983879|FG000|Optimization/Maintenance (48 Weeks)|Death|2
2291003|NCT02497287|3983879|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
2291004|NCT02497287|3983879|FG000|Follow-up Phase (4 Week)|PI Decision|12
2291005|NCT02497287|3983879|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10
2291006|NCT02497287|3983879|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5
2291007|NCT02497287|3983879|FG000|Follow-up Phase (4 Week)|Adverse Event|3
2291008|NCT02497287|3983879|FG000|Follow-up Phase (4 Week)|Other|1
2291009|NCT02497391|3983885|FG000|Period 2 (14 Days)|Withdrawal by Subject|1
2291010|NCT02497391|3983886|FG001|Period 2 (14 Days)|Withdrawal by Subject|0
2291011|NCT02497391|3983887|FG002|Period 2 (14 Days)|Withdrawal by Subject|1
2291012|NCT02497391|3983888|FG003|Period 2 (14 Days)|Withdrawal by Subject|0
2291013|NCT02497391|3983889|FG004|Period 2 (14 Days)|Withdrawal by Subject|0
2291014|NCT02497391|3983890|FG005|Period 2 (14 Days)|Withdrawal by Subject|0
2291015|NCT02497391|3983885|FG000|Period 2 (14 Days)|Sponsor Decision|3
2291016|NCT02497391|3983886|FG001|Period 2 (14 Days)|Sponsor Decision|1
2291017|NCT02497391|3983887|FG002|Period 2 (14 Days)|Sponsor Decision|2
2291018|NCT02497391|3983888|FG003|Period 2 (14 Days)|Sponsor Decision|3
2291019|NCT02497391|3983889|FG004|Period 2 (14 Days)|Sponsor Decision|2
2291020|NCT02497391|3983890|FG005|Period 2 (14 Days)|Sponsor Decision|3
2291021|NCT02497391|3983885|FG000|Period 3 (14 Days)|Adverse Event|0
2291022|NCT02497391|3983886|FG001|Period 3 (14 Days)|Adverse Event|1
2291023|NCT02497391|3983887|FG002|Period 3 (14 Days)|Adverse Event|0
2291024|NCT02497391|3983888|FG003|Period 3 (14 Days)|Adverse Event|0
2291025|NCT02497391|3983889|FG004|Period 3 (14 Days)|Adverse Event|0
2291026|NCT02497391|3983890|FG005|Period 3 (14 Days)|Adverse Event|0
2147231|NCT01156792|3758566|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11
2147232|NCT01156844|3758594|FG000|Overall Study|Adverse Event|0
2147233|NCT01156844|3758595|FG001|Overall Study|Adverse Event|0
2147234|NCT01156844|3758596|FG002|Overall Study|Adverse Event|1
2147235|NCT01156844|3758597|FG003|Overall Study|Adverse Event|1
2147236|NCT01156844|3758594|FG000|Overall Study|Abnormal test procedure result(s)|0
2147237|NCT01156844|3758595|FG001|Overall Study|Abnormal test procedure result(s)|1
2147238|NCT01156844|3758596|FG002|Overall Study|Abnormal test procedure result(s)|2
2147239|NCT01156844|3758597|FG003|Overall Study|Abnormal test procedure result(s)|2
2147240|NCT01156844|3758594|FG000|Overall Study|Withdrawal by Subject|0
2147241|NCT01156844|3758595|FG001|Overall Study|Withdrawal by Subject|0
2291027|NCT02497391|3983885|FG000|Period 3 (14 Days)|Sponsor Decision|0
2291028|NCT02497391|3983886|FG001|Period 3 (14 Days)|Sponsor Decision|0
2291029|NCT02497391|3983887|FG002|Period 3 (14 Days)|Sponsor Decision|0
2291030|NCT02497391|3983888|FG003|Period 3 (14 Days)|Sponsor Decision|0
2291031|NCT02497391|3983889|FG004|Period 3 (14 Days)|Sponsor Decision|1
2291032|NCT02497391|3983890|FG005|Period 3 (14 Days)|Sponsor Decision|0
2291033|NCT02497391|3983885|FG000|Period 3 (14 Days)|Withdrawal by Subject|0
2291034|NCT02497391|3983886|FG001|Period 3 (14 Days)|Withdrawal by Subject|0
2291035|NCT02497391|3983887|FG002|Period 3 (14 Days)|Withdrawal by Subject|1
2291036|NCT02497391|3983888|FG003|Period 3 (14 Days)|Withdrawal by Subject|0
2291037|NCT02497391|3983889|FG004|Period 3 (14 Days)|Withdrawal by Subject|0
2291038|NCT02497391|3983890|FG005|Period 3 (14 Days)|Withdrawal by Subject|0
2291039|NCT02497404|3983898|FG000|Overall Study|Adverse Event|1
2291040|NCT02497469|3983904|FG000|Overall Study|Randomized but not Treated|0
2291041|NCT02497469|3983905|FG001|Overall Study|Randomized but not Treated|2
2291042|NCT02497469|3983904|FG000|Overall Study|Pretreatment Event/Adverse Event|18
2291043|NCT02497469|3983905|FG001|Overall Study|Pretreatment Event/Adverse Event|16
2291044|NCT02497469|3983904|FG000|Overall Study|Leukopenia or Lymphopenia|1
2291045|NCT02497469|3983905|FG001|Overall Study|Leukopenia or Lymphopenia|0
2291046|NCT02497469|3983904|FG000|Overall Study|Significant Protocol Deviation|4
2291047|NCT02497469|3983905|FG001|Overall Study|Significant Protocol Deviation|5
2291048|NCT02497469|3983904|FG000|Overall Study|Lost to Follow-up|14
2291049|NCT02497469|3983905|FG001|Overall Study|Lost to Follow-up|4
2291050|NCT02497469|3983904|FG000|Overall Study|Voluntary Withdrawal|39
2291051|NCT02497469|3983905|FG001|Overall Study|Voluntary Withdrawal|41
2291052|NCT02497469|3983904|FG000|Overall Study|Pregnancy|1
2291053|NCT02497469|3983905|FG001|Overall Study|Pregnancy|1
2291054|NCT02497469|3983904|FG000|Overall Study|Lack of Efficacy|86
2291055|NCT02497469|3983905|FG001|Overall Study|Lack of Efficacy|40
2291056|NCT02497469|3983904|FG000|Overall Study|Reason not Specified|6
2291057|NCT02497469|3983905|FG001|Overall Study|Reason not Specified|6
2291058|NCT02497612|3983915|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57
2291059|NCT02497612|3983916|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51
2291060|NCT02497612|3983917|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39
2291061|NCT02497612|3983918|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41
2291062|NCT02497612|3983915|FG000|Overall Study|Participant's request|2
2291063|NCT02497612|3983916|FG001|Overall Study|Participant's request|3
2291064|NCT02497612|3983917|FG002|Overall Study|Participant's request|4
2291065|NCT02497612|3983918|FG003|Overall Study|Participant's request|1
2291066|NCT02497612|3983915|FG000|Overall Study|Investigator's judgement|1
2291067|NCT02497612|3983916|FG001|Overall Study|Investigator's judgement|0
2291068|NCT02497612|3983917|FG002|Overall Study|Investigator's judgement|0
2291069|NCT02497612|3983918|FG003|Overall Study|Investigator's judgement|2
2291070|NCT02497612|3983915|FG000|Overall Study|Adverse Event|3
2291071|NCT02497612|3983916|FG001|Overall Study|Adverse Event|1
2291072|NCT02497612|3983917|FG002|Overall Study|Adverse Event|4
2291073|NCT02497612|3983918|FG003|Overall Study|Adverse Event|1
2291074|NCT02497612|3983915|FG000|Overall Study|Lost to Follow-up|1
2291075|NCT02497612|3983916|FG001|Overall Study|Lost to Follow-up|1
2291076|NCT02497612|3983917|FG002|Overall Study|Lost to Follow-up|0
2291077|NCT02497612|3983918|FG003|Overall Study|Lost to Follow-up|1
2291078|NCT02497612|3983915|FG000|Overall Study|Other unspecified|1
2291079|NCT02497612|3983916|FG001|Overall Study|Other unspecified|1
2291080|NCT02497612|3983917|FG002|Overall Study|Other unspecified|2
2291081|NCT02497612|3983918|FG003|Overall Study|Other unspecified|0
2291082|NCT02497612|3983915|FG000|Overall Study|Not eligible|1
2291083|NCT02497612|3983916|FG001|Overall Study|Not eligible|0
2291084|NCT02497612|3983917|FG002|Overall Study|Not eligible|0
2291085|NCT02497612|3983918|FG003|Overall Study|Not eligible|1
2291086|NCT02497755|3983930|FG000|Overall Study|Protocol Violation|1
2291087|NCT02497755|3983931|FG001|Overall Study|Protocol Violation|0
2291088|NCT02497781|3983940|FG000|Overall Study|Withdrawal by Subject|2
2291089|NCT02497781|3983941|FG001|Overall Study|Withdrawal by Subject|0
2291090|NCT02497781|3983940|FG000|Overall Study|Lack of Efficacy|0
2291091|NCT02497781|3983941|FG001|Overall Study|Lack of Efficacy|1
2291092|NCT02497781|3983940|FG000|Overall Study|Randomised but not treated|1
2147242|NCT01156844|3758596|FG002|Overall Study|Withdrawal by Subject|2
2147243|NCT01156844|3758597|FG003|Overall Study|Withdrawal by Subject|2
2147244|NCT01156844|3758594|FG000|Overall Study|Lost to Follow-up|0
2291093|NCT02497781|3983941|FG001|Overall Study|Randomised but not treated|1
2147245|NCT01156844|3758595|FG001|Overall Study|Lost to Follow-up|0
2291094|NCT02497781|3983940|FG000|Overall Study|Lost to Follow-up|1
2291095|NCT02497781|3983941|FG001|Overall Study|Lost to Follow-up|1
2147246|NCT01156844|3758596|FG002|Overall Study|Lost to Follow-up|1
2147247|NCT01156844|3758597|FG003|Overall Study|Lost to Follow-up|0
2147248|NCT01156844|3758594|FG000|Overall Study|Administrative problems|0
2147249|NCT01156844|3758595|FG001|Overall Study|Administrative problems|1
2147250|NCT01156844|3758596|FG002|Overall Study|Administrative problems|0
2147251|NCT01156844|3758597|FG003|Overall Study|Administrative problems|1
2208067|NCT01636687|3847523|FG000|Induction Period|Withdrawal by Subject|1
2208068|NCT01636687|3847524|FG001|Induction Period|Withdrawal by Subject|0
2208069|NCT01636687|3847525|FG002|Induction Period|Withdrawal by Subject|0
2208070|NCT01636687|3847526|FG003|Induction Period|Withdrawal by Subject|0
2147252|NCT01156844|3758594|FG000|Overall Study|Protocol deviation|2
2147253|NCT01156844|3758595|FG001|Overall Study|Protocol deviation|0
2147254|NCT01156844|3758596|FG002|Overall Study|Protocol deviation|0
2147255|NCT01156844|3758597|FG003|Overall Study|Protocol deviation|0
2147256|NCT01157065|3758621|FG000|Overall Study|Death|0
2147257|NCT01157065|3758622|FG001|Overall Study|Death|1
2147258|NCT01157078|3758630|FG000|Overall Study|Withdrawal by Subject|12
2147259|NCT01157078|3758631|FG001|Overall Study|Withdrawal by Subject|14
2147260|NCT01157078|3758630|FG000|Overall Study|Eligibility criteria not fulfilled|2
2147261|NCT01157078|3758631|FG001|Overall Study|Eligibility criteria not fulfilled|0
2147262|NCT01157078|3758630|FG000|Overall Study|Adverse Event|6
2147263|NCT01157078|3758631|FG001|Overall Study|Adverse Event|6
2147264|NCT01157078|3758630|FG000|Overall Study|Severe non-compliance to protocol|2
2147265|NCT01157078|3758631|FG001|Overall Study|Severe non-compliance to protocol|4
2147266|NCT01157078|3758630|FG000|Overall Study|Condition under investigation worsened|0
2147267|NCT01157078|3758631|FG001|Overall Study|Condition under investigation worsened|1
2147268|NCT01157078|3758630|FG000|Overall Study|Lack of Efficacy|2
2147269|NCT01157078|3758631|FG001|Overall Study|Lack of Efficacy|0
2147270|NCT01157078|3758630|FG000|Overall Study|Study-specific withdrawal criteria|2
2147271|NCT01157078|3758631|FG001|Overall Study|Study-specific withdrawal criteria|2
2147272|NCT01157078|3758630|FG000|Overall Study|Lost to Follow-up|7
2147273|NCT01157078|3758631|FG001|Overall Study|Lost to Follow-up|5
2147274|NCT01157078|3758630|FG000|Overall Study|Other|2
2147275|NCT01157078|3758631|FG001|Overall Study|Other|4
2147276|NCT01157117|3758640|FG000|Overall Study|Dosing Symptoms|0
2147277|NCT01157117|3758641|FG001|Overall Study|Dosing Symptoms|4
2147278|NCT01157117|3758642|FG002|Overall Study|Dosing Symptoms|0
2147279|NCT01157117|3758640|FG000|Overall Study|Withdrawal by Subject|4
2147280|NCT01157117|3758641|FG001|Overall Study|Withdrawal by Subject|1
2147281|NCT01157117|3758642|FG002|Overall Study|Withdrawal by Subject|1
2147282|NCT01157117|3758640|FG000|Overall Study|Lack of Efficacy|1
2147283|NCT01157117|3758641|FG001|Overall Study|Lack of Efficacy|1
2147284|NCT01157117|3758642|FG002|Overall Study|Lack of Efficacy|0
2147285|NCT01157117|3758640|FG000|Overall Study|Lost to Follow-up|0
2147286|NCT01157117|3758641|FG001|Overall Study|Lost to Follow-up|0
2147287|NCT01157117|3758642|FG002|Overall Study|Lost to Follow-up|1
2147288|NCT01157117|3758640|FG000|Overall Study|Unknown (Pending Final Form Submission)|4
2147289|NCT01157117|3758641|FG001|Overall Study|Unknown (Pending Final Form Submission)|5
2147290|NCT01157117|3758642|FG002|Overall Study|Unknown (Pending Final Form Submission)|13
2147291|NCT01157169|3758652|FG000|First Intervention|Emesis Within 4 hrs of Administration|4
2147292|NCT01157169|3758653|FG001|First Intervention|Emesis Within 4 hrs of Administration|2
2147293|NCT01157169|3758652|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0
2147294|NCT01157169|3758653|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1
2147295|NCT01157182|3758661|FG000|Washout of 28 Days|Adverse Event|2
2147296|NCT01157182|3758662|FG001|Washout of 28 Days|Adverse Event|0
2147297|NCT01157234|3758670|FG000|Overall Study|Withdrawal by Subject|1
2147298|NCT01157234|3758671|FG001|Overall Study|Withdrawal by Subject|0
2147299|NCT01157351|3758686|FG000|Overall Study|Adverse Event|5
2147300|NCT01157351|3758687|FG001|Overall Study|Adverse Event|4
2147301|NCT01157351|3758686|FG000|Overall Study|Death|1
2147302|NCT01157351|3758687|FG001|Overall Study|Death|0
2147303|NCT01157351|3758686|FG000|Overall Study|Lost to Follow-up|53
2147304|NCT01157351|3758687|FG001|Overall Study|Lost to Follow-up|55
2147305|NCT01157351|3758686|FG000|Overall Study|Withdrawal by Subject|37
2147306|NCT01157351|3758687|FG001|Overall Study|Withdrawal by Subject|27
2147307|NCT01157351|3758686|FG000|Overall Study|Physician Decision|5
2147308|NCT01157351|3758687|FG001|Overall Study|Physician Decision|4
2147309|NCT01157351|3758686|FG000|Overall Study|Protocol Violation|0
2147310|NCT01157351|3758687|FG001|Overall Study|Protocol Violation|1
2147311|NCT01157351|3758686|FG000|Overall Study|Other|32
2147312|NCT01157351|3758687|FG001|Overall Study|Other|36
2147313|NCT01157351|3758686|FG000|Overall Study|Noncompliance with Study Drug|0
2147314|NCT01157351|3758687|FG001|Overall Study|Noncompliance with Study Drug|3
2147315|NCT01157351|3758686|FG000|Overall Study|Randomized but not Treated|4
2147316|NCT01157351|3758687|FG001|Overall Study|Randomized but not Treated|2
2147317|NCT01157364|3758699|FG000|Overall Study|Other Reasons|1
2147318|NCT01157364|3758700|FG001|Overall Study|Other Reasons|1
2147319|NCT01157364|3758701|FG002|Overall Study|Other Reasons|2
2147320|NCT01157364|3758702|FG003|Overall Study|Other Reasons|1
2147321|NCT01157364|3758703|FG004|Overall Study|Other Reasons|0
2147322|NCT01157364|3758704|FG005|Overall Study|Other Reasons|0
2147323|NCT01157364|3758699|FG000|Overall Study|Personal Reasons|0
2147324|NCT01157364|3758700|FG001|Overall Study|Personal Reasons|2
2147325|NCT01157364|3758701|FG002|Overall Study|Personal Reasons|0
2147326|NCT01157364|3758702|FG003|Overall Study|Personal Reasons|0
2147327|NCT01157364|3758703|FG004|Overall Study|Personal Reasons|1
2147328|NCT01157364|3758704|FG005|Overall Study|Personal Reasons|1
2147329|NCT01157364|3758699|FG000|Overall Study|Lost to Follow-up|1
2147330|NCT01157364|3758700|FG001|Overall Study|Lost to Follow-up|0
2147331|NCT01157364|3758701|FG002|Overall Study|Lost to Follow-up|1
2147332|NCT01157364|3758702|FG003|Overall Study|Lost to Follow-up|0
2147333|NCT01157364|3758703|FG004|Overall Study|Lost to Follow-up|0
2147334|NCT01157364|3758704|FG005|Overall Study|Lost to Follow-up|0
2147335|NCT01157364|3758699|FG000|Overall Study|Lack of Efficacy|0
2147336|NCT01157364|3758700|FG001|Overall Study|Lack of Efficacy|0
2147337|NCT01157364|3758701|FG002|Overall Study|Lack of Efficacy|0
2147338|NCT01157364|3758702|FG003|Overall Study|Lack of Efficacy|1
2147339|NCT01157364|3758703|FG004|Overall Study|Lack of Efficacy|0
2147340|NCT01157364|3758704|FG005|Overall Study|Lack of Efficacy|0
2147341|NCT01157364|3758699|FG000|Overall Study|Adverse Event|0
2147342|NCT01157364|3758700|FG001|Overall Study|Adverse Event|1
2147343|NCT01157364|3758701|FG002|Overall Study|Adverse Event|1
2147344|NCT01157364|3758702|FG003|Overall Study|Adverse Event|0
2147345|NCT01157364|3758703|FG004|Overall Study|Adverse Event|1
2147346|NCT01157364|3758704|FG005|Overall Study|Adverse Event|0
2147347|NCT01157377|3758725|FG000|Overall Study|Lost to Follow-up|0
2147348|NCT01157377|3758726|FG001|Overall Study|Lost to Follow-up|0
2147349|NCT01157377|3758727|FG002|Overall Study|Lost to Follow-up|1
2147350|NCT01157377|3758728|FG003|Overall Study|Lost to Follow-up|0
2147351|NCT01157377|3758729|FG004|Overall Study|Lost to Follow-up|1
2147352|NCT01157377|3758730|FG005|Overall Study|Lost to Follow-up|1
2147353|NCT01157377|3758731|FG006|Overall Study|Lost to Follow-up|0
2147354|NCT01157377|3758725|FG000|Overall Study|Personal Reasons|2
2147355|NCT01157377|3758726|FG001|Overall Study|Personal Reasons|1
2147356|NCT01157377|3758727|FG002|Overall Study|Personal Reasons|0
2147357|NCT01157377|3758728|FG003|Overall Study|Personal Reasons|1
2147358|NCT01157377|3758729|FG004|Overall Study|Personal Reasons|0
2147359|NCT01157377|3758730|FG005|Overall Study|Personal Reasons|0
2147360|NCT01157377|3758731|FG006|Overall Study|Personal Reasons|0
2147361|NCT01157377|3758725|FG000|Overall Study|Protocol Violation|0
2147362|NCT01157377|3758726|FG001|Overall Study|Protocol Violation|0
2147363|NCT01157377|3758727|FG002|Overall Study|Protocol Violation|0
2147364|NCT01157377|3758728|FG003|Overall Study|Protocol Violation|0
2147365|NCT01157377|3758729|FG004|Overall Study|Protocol Violation|0
2147366|NCT01157377|3758730|FG005|Overall Study|Protocol Violation|1
2147367|NCT01157377|3758731|FG006|Overall Study|Protocol Violation|0
2147368|NCT01157377|3758725|FG000|Overall Study|Lack of Efficacy|0
2147369|NCT01157377|3758726|FG001|Overall Study|Lack of Efficacy|0
2147370|NCT01157377|3758727|FG002|Overall Study|Lack of Efficacy|0
2147371|NCT01157377|3758728|FG003|Overall Study|Lack of Efficacy|0
2147372|NCT01157377|3758729|FG004|Overall Study|Lack of Efficacy|0
2147373|NCT01157377|3758730|FG005|Overall Study|Lack of Efficacy|0
2147374|NCT01157377|3758731|FG006|Overall Study|Lack of Efficacy|1
2147375|NCT01157377|3758725|FG000|Overall Study|Other Miscellaneous Reasons|0
2147376|NCT01157377|3758726|FG001|Overall Study|Other Miscellaneous Reasons|2
2147377|NCT01157377|3758727|FG002|Overall Study|Other Miscellaneous Reasons|0
2147378|NCT01157377|3758728|FG003|Overall Study|Other Miscellaneous Reasons|0
2147379|NCT01157377|3758729|FG004|Overall Study|Other Miscellaneous Reasons|1
2147380|NCT01157377|3758730|FG005|Overall Study|Other Miscellaneous Reasons|1
2147381|NCT01157377|3758731|FG006|Overall Study|Other Miscellaneous Reasons|1
2147382|NCT01157676|3758767|FG000|Randomization|Death|1
2147383|NCT01157676|3758768|FG001|Randomization|Death|1
2147384|NCT01157676|3758767|FG000|Randomization|unresectable|2
2147385|NCT01157676|3758768|FG001|Randomization|unresectable|3
2208071|NCT01636687|3847527|FG004|Induction Period|Withdrawal by Subject|0
2208072|NCT01636687|3847523|FG000|Induction Period|Adverse Event|1
2208073|NCT01636687|3847524|FG001|Induction Period|Adverse Event|0
2208074|NCT01636687|3847525|FG002|Induction Period|Adverse Event|0
2208075|NCT01636687|3847526|FG003|Induction Period|Adverse Event|0
2208076|NCT01636687|3847527|FG004|Induction Period|Adverse Event|1
2208077|NCT01636687|3847523|FG000|Induction Period|Lack of Efficacy|0
2208078|NCT01636687|3847524|FG001|Induction Period|Lack of Efficacy|0
2208079|NCT01636687|3847525|FG002|Induction Period|Lack of Efficacy|0
2208080|NCT01636687|3847526|FG003|Induction Period|Lack of Efficacy|0
2208081|NCT01636687|3847527|FG004|Induction Period|Lack of Efficacy|1
2208082|NCT01636687|3847523|FG000|Induction Period|Physician Decision|1
2208083|NCT01636687|3847524|FG001|Induction Period|Physician Decision|0
2208084|NCT01636687|3847525|FG002|Induction Period|Physician Decision|0
2208085|NCT01636687|3847526|FG003|Induction Period|Physician Decision|0
2208086|NCT01636687|3847527|FG004|Induction Period|Physician Decision|0
2147386|NCT01157676|3758767|FG000|Randomization|Withdrawal by Subject|17
2147387|NCT01157676|3758768|FG001|Randomization|Withdrawal by Subject|13
2147388|NCT01157676|3758767|FG000|Randomization|Physician Decision|1
2147389|NCT01157676|3758768|FG001|Randomization|Physician Decision|0
2147390|NCT01157676|3758767|FG000|Surgery|underwent open cystectomy|0
2147391|NCT01157676|3758768|FG001|Surgery|underwent open cystectomy|4
2147392|NCT01157676|3758767|FG000|Surgery|converted to open procedure|0
2147393|NCT01157676|3758768|FG001|Surgery|converted to open procedure|5
2147394|NCT01157676|3758767|FG000|Surgery|underwent robotic cystectomy|1
2147395|NCT01157676|3758768|FG001|Surgery|underwent robotic cystectomy|0
2147396|NCT01157845|3758780|FG000|Overall Study|Lost to Follow-up|5
2147397|NCT01157845|3758780|FG000|Overall Study|Withdrawal by Subject|12
2147398|NCT01157845|3758780|FG000|Overall Study|Physician Decision|3
2147399|NCT01157845|3758780|FG000|Overall Study|Protocol Violation|13
2147400|NCT01157845|3758780|FG000|Overall Study|Study was ended|1
2147401|NCT01157845|3758780|FG000|Overall Study|Device malfunction|1
2147402|NCT01157897|3758788|FG000|Overall Study|Lost to Follow-up|2
2147403|NCT01157897|3758789|FG001|Overall Study|Lost to Follow-up|0
2147404|NCT01157897|3758790|FG002|Overall Study|Lost to Follow-up|0
2147405|NCT01157897|3758791|FG003|Overall Study|Lost to Follow-up|1
2147406|NCT01157897|3758788|FG000|Overall Study|Relocated|0
2147407|NCT01157897|3758789|FG001|Overall Study|Relocated|2
2147408|NCT01157897|3758790|FG002|Overall Study|Relocated|0
2147409|NCT01157897|3758791|FG003|Overall Study|Relocated|0
2147410|NCT01158118|3758803|FG000|Overall Study|Screen failure|1
2147411|NCT01158118|3758804|FG001|Overall Study|Screen failure|0
2147412|NCT01158118|3758803|FG000|Overall Study|Donor match was a screen failure|0
2147413|NCT01158118|3758804|FG001|Overall Study|Donor match was a screen failure|1
2147414|NCT01158118|3758803|FG000|Overall Study|Suffered stroke prior to transplant|0
2147415|NCT01158118|3758804|FG001|Overall Study|Suffered stroke prior to transplant|1
2147416|NCT01158118|3758803|FG000|Overall Study|Death|0
2147417|NCT01158118|3758804|FG001|Overall Study|Death|1
2147418|NCT01158222|3758814|FG000|Overall Study|Not eligible for intermediate phase|17
2147419|NCT01158261|3758818|FG000|Overall Study|Lost to Follow-up|9
2147420|NCT01158261|3758818|FG000|Overall Study|Death|7
2147421|NCT01158261|3758818|FG000|Overall Study|Withdrawal by Subject|1
2147422|NCT01158378|3758824|FG000|Overall Study|Death|4
2147423|NCT01158378|3758825|FG001|Overall Study|Death|5
2147424|NCT01158378|3758824|FG000|Overall Study|Lost to Follow-up|2
2147425|NCT01158378|3758825|FG001|Overall Study|Lost to Follow-up|4
2147426|NCT01158378|3758824|FG000|Overall Study|Withdrawal by Subject|4
2147427|NCT01158378|3758825|FG001|Overall Study|Withdrawal by Subject|0
2147428|NCT01158404|3758840|FG000|Overall Study|Withdrawal by Subject|0
2147429|NCT01158404|3758841|FG001|Overall Study|Withdrawal by Subject|1
2147430|NCT01158404|3758842|FG002|Overall Study|Withdrawal by Subject|0
2147431|NCT01158404|3758843|FG003|Overall Study|Withdrawal by Subject|0
2147432|NCT01158404|3758844|FG004|Overall Study|Withdrawal by Subject|3
2147433|NCT01158404|3758845|FG005|Overall Study|Withdrawal by Subject|1
2147434|NCT01158404|3758846|FG006|Overall Study|Withdrawal by Subject|0
2147435|NCT01158404|3758847|FG007|Overall Study|Withdrawal by Subject|1
2147436|NCT01158404|3758840|FG000|Overall Study|Physician Decision|0
2147437|NCT01158404|3758841|FG001|Overall Study|Physician Decision|0
2147438|NCT01158404|3758842|FG002|Overall Study|Physician Decision|0
2147439|NCT01158404|3758843|FG003|Overall Study|Physician Decision|0
2147440|NCT01158404|3758844|FG004|Overall Study|Physician Decision|0
2147441|NCT01158404|3758845|FG005|Overall Study|Physician Decision|0
2147442|NCT01158404|3758846|FG006|Overall Study|Physician Decision|0
2147443|NCT01158404|3758847|FG007|Overall Study|Physician Decision|1
2147444|NCT01158404|3758840|FG000|Overall Study|Progressive Disease|0
2147445|NCT01158404|3758841|FG001|Overall Study|Progressive Disease|0
2147446|NCT01158404|3758842|FG002|Overall Study|Progressive Disease|0
2147447|NCT01158404|3758843|FG003|Overall Study|Progressive Disease|0
2147448|NCT01158404|3758844|FG004|Overall Study|Progressive Disease|0
2147449|NCT01158404|3758845|FG005|Overall Study|Progressive Disease|0
2147450|NCT01158404|3758846|FG006|Overall Study|Progressive Disease|1
2147451|NCT01158404|3758847|FG007|Overall Study|Progressive Disease|0
2147452|NCT01158534|3758873|FG000|Overall Study|Withdrawal by Subject|1
2147453|NCT01158534|3758873|FG000|Overall Study|Death|1
2147454|NCT01158534|3758873|FG000|Overall Study|Other|1
2147455|NCT01158924|3758932|FG000|Overall Study|Withdrawal by Subject|1
2147456|NCT01158924|3758933|FG001|Overall Study|Withdrawal by Subject|2
2147457|NCT01158924|3758932|FG000|Overall Study|Lost to Follow-up|0
2147458|NCT01158924|3758933|FG001|Overall Study|Lost to Follow-up|1
2147459|NCT01158950|3758939|FG000|1st Intervention (1 Day)|Physician Decision|1
2147460|NCT01158950|3758940|FG001|1st Intervention (1 Day)|Physician Decision|2
2147461|NCT01159171|3758971|FG000|Overall Study|Adverse Event|11
2147462|NCT01159171|3758971|FG000|Overall Study|Progression of Disease|28
2147463|NCT01159171|3758971|FG000|Overall Study|Protocol Violation|1
2147464|NCT01159171|3758971|FG000|Overall Study|Need for Surgery|5
2147465|NCT01159171|3758971|FG000|Overall Study|Medical Decision|4
2147466|NCT01159171|3758971|FG000|Overall Study|Death|1
2147467|NCT01159431|3758991|FG000|Overall Study|Adverse Event|1
2147468|NCT01159431|3758992|FG001|Overall Study|Adverse Event|2
2147469|NCT01159431|3758991|FG000|Overall Study|non-compliance|1
2147470|NCT01159431|3758992|FG001|Overall Study|non-compliance|1
2147471|NCT01159431|3758991|FG000|Overall Study|Lack of Efficacy|0
2147472|NCT01159431|3758992|FG001|Overall Study|Lack of Efficacy|3
2147473|NCT01159574|3759018|FG000|Treatment Phase|non-evaluable/not included in analysis|1
2147474|NCT01159574|3759018|FG000|Treatment Phase|Adverse Event|3
2147475|NCT01159574|3759018|FG000|Treatment Phase|Death|6
2147476|NCT01159574|3759018|FG000|Treatment Phase|Physician Decision|2
2147477|NCT01159574|3759018|FG000|Treatment Phase|Withdrawal by Subject|7
2147478|NCT01159574|3759018|FG000|Treatment Phase|still on treatment|2
2147479|NCT01159574|3759018|FG000|Follow Up Phase|Lost to Follow-up|2
2147480|NCT01159574|3759018|FG000|Follow Up Phase|still being followed for overall surviva|18
2147481|NCT01159600|3759030|FG000|Overall Study|Not treated|0
2291096|NCT02497976|3983957|FG000|Overall Study|Withdrawal by Subject|2
2291097|NCT02497976|3983958|FG001|Overall Study|Withdrawal by Subject|0
2291098|NCT02497976|3983957|FG000|Overall Study|Moved out of area|0
2291099|NCT02497976|3983958|FG001|Overall Study|Moved out of area|1
2291100|NCT02498067|3983964|FG000|Overall Study|Lost to Follow-up|22
2291101|NCT02498067|3983964|FG000|Overall Study|Did not meet inclusion criteria|11
2291102|NCT02498236|3983978|FG000|Overall Study|Did not show for testing|1
2291103|NCT02498236|3983979|FG001|Overall Study|Did not show for testing|0
2291104|NCT02498236|3983980|FG002|Overall Study|Did not show for testing|0
2147482|NCT01159600|3759031|FG001|Overall Study|Not treated|0
2147483|NCT01159600|3759032|FG002|Overall Study|Not treated|1
2147484|NCT01159600|3759033|FG003|Overall Study|Not treated|0
2147485|NCT01159600|3759034|FG004|Overall Study|Not treated|0
2147486|NCT01159600|3759035|FG005|Overall Study|Not treated|1
2147487|NCT01159600|3759036|FG006|Overall Study|Not treated|2
2147488|NCT01159600|3759037|FG007|Overall Study|Not treated|2
2147489|NCT01159600|3759030|FG000|Overall Study|Adverse Event|7
2147490|NCT01159600|3759031|FG001|Overall Study|Adverse Event|2
2147491|NCT01159600|3759032|FG002|Overall Study|Adverse Event|5
2147492|NCT01159600|3759033|FG003|Overall Study|Adverse Event|1
2147493|NCT01159600|3759034|FG004|Overall Study|Adverse Event|8
2147494|NCT01159600|3759035|FG005|Overall Study|Adverse Event|6
2147495|NCT01159600|3759036|FG006|Overall Study|Adverse Event|7
2147496|NCT01159600|3759037|FG007|Overall Study|Adverse Event|5
2147497|NCT01159600|3759030|FG000|Overall Study|Lack of Efficacy|0
2147498|NCT01159600|3759031|FG001|Overall Study|Lack of Efficacy|0
2147499|NCT01159600|3759032|FG002|Overall Study|Lack of Efficacy|0
2147500|NCT01159600|3759033|FG003|Overall Study|Lack of Efficacy|0
2147501|NCT01159600|3759034|FG004|Overall Study|Lack of Efficacy|2
2147502|NCT01159600|3759035|FG005|Overall Study|Lack of Efficacy|0
2147503|NCT01159600|3759036|FG006|Overall Study|Lack of Efficacy|0
2147504|NCT01159600|3759037|FG007|Overall Study|Lack of Efficacy|1
2147505|NCT01159600|3759030|FG000|Overall Study|Non compliant with protocol|2
2147506|NCT01159600|3759031|FG001|Overall Study|Non compliant with protocol|1
2147507|NCT01159600|3759032|FG002|Overall Study|Non compliant with protocol|0
2147508|NCT01159600|3759033|FG003|Overall Study|Non compliant with protocol|0
2147509|NCT01159600|3759034|FG004|Overall Study|Non compliant with protocol|2
2147510|NCT01159600|3759035|FG005|Overall Study|Non compliant with protocol|0
2147511|NCT01159600|3759036|FG006|Overall Study|Non compliant with protocol|2
2147512|NCT01159600|3759037|FG007|Overall Study|Non compliant with protocol|0
2147513|NCT01159600|3759030|FG000|Overall Study|Lost to Follow-up|2
2147514|NCT01159600|3759031|FG001|Overall Study|Lost to Follow-up|3
2147515|NCT01159600|3759032|FG002|Overall Study|Lost to Follow-up|4
2147516|NCT01159600|3759033|FG003|Overall Study|Lost to Follow-up|3
2147517|NCT01159600|3759034|FG004|Overall Study|Lost to Follow-up|3
2147518|NCT01159600|3759035|FG005|Overall Study|Lost to Follow-up|0
2147519|NCT01159600|3759036|FG006|Overall Study|Lost to Follow-up|3
2147520|NCT01159600|3759037|FG007|Overall Study|Lost to Follow-up|2
2147521|NCT01159600|3759030|FG000|Overall Study|Patient refusal to continue,not due toAE|7
2147522|NCT01159600|3759031|FG001|Overall Study|Patient refusal to continue,not due toAE|2
2147523|NCT01159600|3759032|FG002|Overall Study|Patient refusal to continue,not due toAE|4
2147524|NCT01159600|3759033|FG003|Overall Study|Patient refusal to continue,not due toAE|5
2147525|NCT01159600|3759034|FG004|Overall Study|Patient refusal to continue,not due toAE|4
2147526|NCT01159600|3759035|FG005|Overall Study|Patient refusal to continue,not due toAE|4
2147527|NCT01159600|3759036|FG006|Overall Study|Patient refusal to continue,not due toAE|2
2147528|NCT01159600|3759037|FG007|Overall Study|Patient refusal to continue,not due toAE|5
2147529|NCT01159600|3759030|FG000|Overall Study|Other reason not defined above|3
2147530|NCT01159600|3759031|FG001|Overall Study|Other reason not defined above|0
2147531|NCT01159600|3759032|FG002|Overall Study|Other reason not defined above|4
2147532|NCT01159600|3759033|FG003|Overall Study|Other reason not defined above|2
2147533|NCT01159600|3759034|FG004|Overall Study|Other reason not defined above|5
2147534|NCT01159600|3759035|FG005|Overall Study|Other reason not defined above|7
2147535|NCT01159600|3759036|FG006|Overall Study|Other reason not defined above|3
2147536|NCT01159600|3759037|FG007|Overall Study|Other reason not defined above|3
2147537|NCT01159665|3759062|FG000|Overall Study|Withdrawal by Subject|0
2147538|NCT01159665|3759063|FG001|Overall Study|Withdrawal by Subject|1
2147539|NCT01159665|3759064|FG002|Overall Study|Withdrawal by Subject|0
2147540|NCT01159665|3759065|FG003|Overall Study|Withdrawal by Subject|0
2147541|NCT01159665|3759066|FG004|Overall Study|Withdrawal by Subject|0
2147542|NCT01159665|3759067|FG005|Overall Study|Withdrawal by Subject|0
2147543|NCT01159691|3759081|FG000|Overall Study|Lost to Follow-up|2
2147544|NCT01159691|3759081|FG000|Overall Study|Unknown reasons|1
2147545|NCT01159691|3759081|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6
2147546|NCT01159691|3759081|FG000|Overall Study|Discontinued Neupro due to other reasons|1
2147547|NCT01159691|3759081|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2
2147548|NCT01159691|3759081|FG000|Overall Study|Disc. Neupro other & unknown reasons|7
2147549|NCT01159691|3759081|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2
2291105|NCT02498236|3983981|FG003|Overall Study|Did not show for testing|0
2147550|NCT01159691|3759081|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1
2147551|NCT01159769|3759094|FG000|Overall Study|Adverse Event|1
2291106|NCT02498236|3983982|FG004|Overall Study|Did not show for testing|0
2291107|NCT02498236|3983983|FG005|Overall Study|Did not show for testing|0
2147552|NCT01159912|3759101|FG000|Overall Study|Adverse Event|2
2147553|NCT01159912|3759102|FG001|Overall Study|Adverse Event|2
2147554|NCT01159912|3759103|FG002|Overall Study|Adverse Event|3
2147555|NCT01159912|3759101|FG000|Overall Study|Lack of Efficacy|23
2147556|NCT01159912|3759102|FG001|Overall Study|Lack of Efficacy|15
2147557|NCT01159912|3759103|FG002|Overall Study|Lack of Efficacy|14
2147558|NCT01159912|3759101|FG000|Overall Study|Protocol Violation|1
2147559|NCT01159912|3759102|FG001|Overall Study|Protocol Violation|2
2147560|NCT01159912|3759103|FG002|Overall Study|Protocol Violation|3
2147561|NCT01159912|3759101|FG000|Overall Study|Lost to Follow-up|4
2147562|NCT01159912|3759102|FG001|Overall Study|Lost to Follow-up|0
2147563|NCT01159912|3759103|FG002|Overall Study|Lost to Follow-up|0
2147564|NCT01159912|3759101|FG000|Overall Study|Physician Decision|0
2147565|NCT01159912|3759102|FG001|Overall Study|Physician Decision|0
2147566|NCT01159912|3759103|FG002|Overall Study|Physician Decision|3
2147567|NCT01159912|3759101|FG000|Overall Study|Withdrawal by Subject|10
2147568|NCT01159912|3759102|FG001|Overall Study|Withdrawal by Subject|3
2147569|NCT01159912|3759103|FG002|Overall Study|Withdrawal by Subject|3
2147570|NCT01159938|3759114|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0
2147571|NCT01159938|3759115|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0
2147572|NCT01159938|3759116|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1
2147573|NCT01159938|3759117|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0
2147574|NCT01159938|3759118|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0
2147575|NCT01160198|3759142|FG000|Overall Study|Withdrawal by Subject|2
2147576|NCT01160198|3759143|FG001|Overall Study|Withdrawal by Subject|1
2147577|NCT01160198|3759144|FG002|Overall Study|Withdrawal by Subject|0
2147578|NCT01160198|3759142|FG000|Overall Study|Adverse Event|0
2147579|NCT01160198|3759143|FG001|Overall Study|Adverse Event|1
2147580|NCT01160198|3759144|FG002|Overall Study|Adverse Event|0
2147581|NCT01160198|3759142|FG000|Overall Study|Lost to Follow-up|0
2147582|NCT01160198|3759143|FG001|Overall Study|Lost to Follow-up|1
2147583|NCT01160198|3759144|FG002|Overall Study|Lost to Follow-up|0
2147584|NCT01160198|3759142|FG000|Overall Study|Participant lost drug; withdrew consent|0
2147585|NCT01160198|3759143|FG001|Overall Study|Participant lost drug; withdrew consent|0
2147586|NCT01160198|3759144|FG002|Overall Study|Participant lost drug; withdrew consent|1
2147587|NCT01160211|3759155|FG000|Overall Study|ongoing|90
2147588|NCT01160211|3759156|FG001|Overall Study|ongoing|75
2147589|NCT01160211|3759157|FG002|Overall Study|ongoing|79
2147590|NCT01160211|3759155|FG000|Overall Study|Withdrawal by Subject|3
2147591|NCT01160211|3759156|FG001|Overall Study|Withdrawal by Subject|5
2147592|NCT01160211|3759157|FG002|Overall Study|Withdrawal by Subject|3
2147593|NCT01160211|3759155|FG000|Overall Study|Physician Decision|2
2147594|NCT01160211|3759156|FG001|Overall Study|Physician Decision|0
2147595|NCT01160211|3759157|FG002|Overall Study|Physician Decision|0
2291108|NCT02498236|3983984|FG006|Overall Study|Did not show for testing|0
2291109|NCT02498236|3983985|FG007|Overall Study|Did not show for testing|1
2291110|NCT02498236|3983978|FG000|Overall Study|Equipment failure|0
2291111|NCT02498236|3983979|FG001|Overall Study|Equipment failure|0
2291112|NCT02498236|3983980|FG002|Overall Study|Equipment failure|0
2291113|NCT02498236|3983981|FG003|Overall Study|Equipment failure|0
2291114|NCT02498236|3983982|FG004|Overall Study|Equipment failure|0
2291115|NCT02498236|3983983|FG005|Overall Study|Equipment failure|0
2291116|NCT02498236|3983984|FG006|Overall Study|Equipment failure|1
2291117|NCT02498236|3983985|FG007|Overall Study|Equipment failure|0
2291118|NCT02498236|3983978|FG000|Overall Study|Withdrawal by Subject|0
2291119|NCT02498236|3983979|FG001|Overall Study|Withdrawal by Subject|0
2291120|NCT02498236|3983980|FG002|Overall Study|Withdrawal by Subject|0
2291121|NCT02498236|3983981|FG003|Overall Study|Withdrawal by Subject|0
2291122|NCT02498236|3983982|FG004|Overall Study|Withdrawal by Subject|1
2291123|NCT02498236|3983983|FG005|Overall Study|Withdrawal by Subject|0
2291124|NCT02498236|3983984|FG006|Overall Study|Withdrawal by Subject|0
2291125|NCT02498236|3983985|FG007|Overall Study|Withdrawal by Subject|0
2291126|NCT02498418|3984009|FG000|Overall Study|Lack of Efficacy|0
2291127|NCT02498418|3984010|FG001|Overall Study|Lack of Efficacy|0
2291128|NCT02498418|3984011|FG002|Overall Study|Lack of Efficacy|1
2291129|NCT02498418|3984009|FG000|Overall Study|Withdrawal by Subject|2
2291130|NCT02498418|3984010|FG001|Overall Study|Withdrawal by Subject|0
2291131|NCT02498418|3984011|FG002|Overall Study|Withdrawal by Subject|3
2291132|NCT02498418|3984009|FG000|Overall Study|Lost to Follow-up|0
2147596|NCT01160211|3759155|FG000|Overall Study|Lost to Follow-up|4
2147597|NCT01160211|3759156|FG001|Overall Study|Lost to Follow-up|7
2147598|NCT01160211|3759157|FG002|Overall Study|Lost to Follow-up|5
2147599|NCT01160289|3759184|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8
2147600|NCT01160289|3759185|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0
2147601|NCT01160289|3759186|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0
2147602|NCT01160289|3759187|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0
2147603|NCT01160289|3759188|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0
2291133|NCT02498418|3984010|FG001|Overall Study|Lost to Follow-up|1
2291134|NCT02498418|3984011|FG002|Overall Study|Lost to Follow-up|1
2291135|NCT02498418|3984009|FG000|Overall Study|Participant taken prohibited medication|0
2291136|NCT02498418|3984010|FG001|Overall Study|Participant taken prohibited medication|1
2291137|NCT02498418|3984011|FG002|Overall Study|Participant taken prohibited medication|1
2147604|NCT01160289|3759189|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0
2147605|NCT01160289|3759184|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
2147606|NCT01160289|3759185|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2147607|NCT01160289|3759186|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2147608|NCT01160289|3759187|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2147609|NCT01160289|3759188|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2147610|NCT01160289|3759189|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2147611|NCT01160289|3759184|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
2147612|NCT01160289|3759185|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2147613|NCT01160289|3759186|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2147614|NCT01160289|3759187|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2147615|NCT01160289|3759188|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2147616|NCT01160289|3759189|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2147617|NCT01160289|3759184|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
2147618|NCT01160289|3759185|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2147619|NCT01160289|3759186|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2147620|NCT01160289|3759187|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2147621|NCT01160289|3759188|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2147622|NCT01160289|3759189|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2147623|NCT01160289|3759184|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26
2147624|NCT01160289|3759185|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0
2147625|NCT01160289|3759186|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0
2147626|NCT01160289|3759187|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0
2147627|NCT01160289|3759188|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0
2147628|NCT01160289|3759189|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0
2147629|NCT01160289|3759184|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1
2147630|NCT01160289|3759185|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0
2147631|NCT01160289|3759186|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0
2147632|NCT01160289|3759187|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0
2147633|NCT01160289|3759188|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0
2147634|NCT01160289|3759189|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0
2147635|NCT01160289|3759184|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
2147636|NCT01160289|3759185|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2147637|NCT01160289|3759186|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2147638|NCT01160289|3759187|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2147639|NCT01160289|3759188|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2147640|NCT01160289|3759189|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2147641|NCT01160289|3759184|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
2147642|NCT01160289|3759185|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2147643|NCT01160289|3759186|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2147644|NCT01160289|3759187|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2147645|NCT01160289|3759188|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2147646|NCT01160289|3759189|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2147647|NCT01160289|3759184|FG000|Post-Randomization Period|Adverse Event|0
2147648|NCT01160289|3759185|FG001|Post-Randomization Period|Adverse Event|4
2147649|NCT01160289|3759186|FG002|Post-Randomization Period|Adverse Event|4
2147650|NCT01160289|3759187|FG003|Post-Randomization Period|Adverse Event|2
2147651|NCT01160289|3759188|FG004|Post-Randomization Period|Adverse Event|0
2147652|NCT01160289|3759189|FG005|Post-Randomization Period|Adverse Event|0
2147653|NCT01160289|3759184|FG000|Post-Randomization Period|Death|0
2147654|NCT01160289|3759185|FG001|Post-Randomization Period|Death|0
2147655|NCT01160289|3759186|FG002|Post-Randomization Period|Death|0
2147656|NCT01160289|3759187|FG003|Post-Randomization Period|Death|1
2147657|NCT01160289|3759188|FG004|Post-Randomization Period|Death|0
2147658|NCT01160289|3759189|FG005|Post-Randomization Period|Death|0
2147659|NCT01160289|3759184|FG000|Post-Randomization Period|Lack of Efficacy|0
2147660|NCT01160289|3759185|FG001|Post-Randomization Period|Lack of Efficacy|1
2147661|NCT01160289|3759186|FG002|Post-Randomization Period|Lack of Efficacy|0
2147662|NCT01160289|3759187|FG003|Post-Randomization Period|Lack of Efficacy|3
2147663|NCT01160289|3759188|FG004|Post-Randomization Period|Lack of Efficacy|0
2147664|NCT01160289|3759189|FG005|Post-Randomization Period|Lack of Efficacy|0
2147665|NCT01160289|3759184|FG000|Post-Randomization Period|Lost to Follow-up|0
2147666|NCT01160289|3759185|FG001|Post-Randomization Period|Lost to Follow-up|3
2147667|NCT01160289|3759186|FG002|Post-Randomization Period|Lost to Follow-up|2
2147668|NCT01160289|3759187|FG003|Post-Randomization Period|Lost to Follow-up|5
2147669|NCT01160289|3759188|FG004|Post-Randomization Period|Lost to Follow-up|3
2147670|NCT01160289|3759189|FG005|Post-Randomization Period|Lost to Follow-up|4
2147671|NCT01160289|3759184|FG000|Post-Randomization Period|Physician Decision|0
2147672|NCT01160289|3759185|FG001|Post-Randomization Period|Physician Decision|0
2147673|NCT01160289|3759186|FG002|Post-Randomization Period|Physician Decision|1
2147674|NCT01160289|3759187|FG003|Post-Randomization Period|Physician Decision|0
2147675|NCT01160289|3759188|FG004|Post-Randomization Period|Physician Decision|0
2147676|NCT01160289|3759189|FG005|Post-Randomization Period|Physician Decision|0
2147677|NCT01160289|3759184|FG000|Post-Randomization Period|Protocol Violation|0
2147678|NCT01160289|3759185|FG001|Post-Randomization Period|Protocol Violation|4
2147679|NCT01160289|3759186|FG002|Post-Randomization Period|Protocol Violation|2
2147680|NCT01160289|3759187|FG003|Post-Randomization Period|Protocol Violation|0
2147681|NCT01160289|3759188|FG004|Post-Randomization Period|Protocol Violation|1
2147682|NCT01160289|3759189|FG005|Post-Randomization Period|Protocol Violation|3
2147683|NCT01160289|3759184|FG000|Post-Randomization Period|Withdrawal by Subject|0
2147684|NCT01160289|3759185|FG001|Post-Randomization Period|Withdrawal by Subject|5
2147685|NCT01160289|3759186|FG002|Post-Randomization Period|Withdrawal by Subject|13
2147686|NCT01160289|3759187|FG003|Post-Randomization Period|Withdrawal by Subject|8
2147687|NCT01160289|3759188|FG004|Post-Randomization Period|Withdrawal by Subject|5
2147688|NCT01160289|3759189|FG005|Post-Randomization Period|Withdrawal by Subject|7
2147689|NCT01160289|3759184|FG000|Post-Randomization Period|Entry Criteria Not Met|0
2147690|NCT01160289|3759185|FG001|Post-Randomization Period|Entry Criteria Not Met|2
2147691|NCT01160289|3759186|FG002|Post-Randomization Period|Entry Criteria Not Met|2
2147692|NCT01160289|3759187|FG003|Post-Randomization Period|Entry Criteria Not Met|2
2147693|NCT01160289|3759188|FG004|Post-Randomization Period|Entry Criteria Not Met|0
2147694|NCT01160289|3759189|FG005|Post-Randomization Period|Entry Criteria Not Met|0
2147695|NCT01160289|3759184|FG000|Post-Randomization Period|Sponsor Decision|0
2147696|NCT01160289|3759185|FG001|Post-Randomization Period|Sponsor Decision|1
2147697|NCT01160289|3759186|FG002|Post-Randomization Period|Sponsor Decision|0
2147698|NCT01160289|3759187|FG003|Post-Randomization Period|Sponsor Decision|0
2147699|NCT01160289|3759188|FG004|Post-Randomization Period|Sponsor Decision|0
2147700|NCT01160289|3759189|FG005|Post-Randomization Period|Sponsor Decision|0
2147701|NCT01160354|3759205|FG000|Overall Study|Death|0
2147702|NCT01160354|3759206|FG001|Overall Study|Death|1
2147703|NCT01160354|3759207|FG002|Overall Study|Death|1
2147704|NCT01160484|3759237|FG000|Overall Study|Lack of Efficacy|9
2147705|NCT01160484|3759237|FG000|Overall Study|Adverse Event|6
2147706|NCT01160484|3759237|FG000|Overall Study|Withdrawal by Subject|2
2147707|NCT01160484|3759237|FG000|Overall Study|inclusion/exclusion criteria failure|1
2147708|NCT01160614|3759243|FG000|Overall Study|Withdrawal by Subject|0
2147709|NCT01160614|3759244|FG001|Overall Study|Withdrawal by Subject|2
2147710|NCT01160640|3759270|FG000|Overall Study|Physician Decision|3
2147711|NCT01160640|3759271|FG001|Overall Study|Physician Decision|3
2147712|NCT01160640|3759270|FG000|Overall Study|Incarceration|1
2147713|NCT01160640|3759271|FG001|Overall Study|Incarceration|0
2147714|NCT01160640|3759270|FG000|Overall Study|Withdrawal by Subject|0
2147715|NCT01160640|3759271|FG001|Overall Study|Withdrawal by Subject|3
2147716|NCT01160744|3759283|FG000|Overall Study|Withdrawal by Subject|11
2147717|NCT01160744|3759284|FG001|Overall Study|Withdrawal by Subject|5
2147718|NCT01160744|3759285|FG002|Overall Study|Withdrawal by Subject|6
2147719|NCT01160744|3759286|FG003|Overall Study|Withdrawal by Subject|4
2147720|NCT01160744|3759283|FG000|Overall Study|Not meet inclusion/exclusion criteria|0
2147721|NCT01160744|3759284|FG001|Overall Study|Not meet inclusion/exclusion criteria|0
2147722|NCT01160744|3759285|FG002|Overall Study|Not meet inclusion/exclusion criteria|1
2147723|NCT01160744|3759286|FG003|Overall Study|Not meet inclusion/exclusion criteria|0
2147724|NCT01160770|3759298|FG000|Overall Study|Adverse Event|10
2147725|NCT01160770|3759298|FG000|Overall Study|Protocol Violation|2
2147726|NCT01160770|3759298|FG000|Overall Study|Subject/parent/caregiver request|33
2147727|NCT01160770|3759298|FG000|Overall Study|Physician Decision|1
2147728|NCT01160770|3759298|FG000|Overall Study|Lost to Follow-up|7
2147729|NCT01160770|3759298|FG000|Overall Study|Study termination or sponsor request|1
2147730|NCT01160770|3759298|FG000|Overall Study|Death|9
2147731|NCT01160770|3759298|FG000|Overall Study|Lack of Efficacy|15
2147732|NCT01160770|3759298|FG000|Overall Study|Other Reasons|1
2147733|NCT01160822|3759309|FG000|Overall Study|Adverse Event|0
2147734|NCT01160822|3759310|FG001|Overall Study|Adverse Event|0
2147735|NCT01160822|3759311|FG002|Overall Study|Adverse Event|0
2147736|NCT01160822|3759312|FG003|Overall Study|Adverse Event|0
2147737|NCT01160822|3759313|FG004|Overall Study|Adverse Event|1
2147738|NCT01160822|3759314|FG005|Overall Study|Adverse Event|2
2147739|NCT01160822|3759315|FG006|Overall Study|Adverse Event|5
2147740|NCT01160822|3759309|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2147741|NCT01160822|3759310|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2147742|NCT01160822|3759311|FG002|Overall Study|Unsatisfactory therapeutic effect|0
2147743|NCT01160822|3759312|FG003|Overall Study|Unsatisfactory therapeutic effect|0
2147744|NCT01160822|3759313|FG004|Overall Study|Unsatisfactory therapeutic effect|4
2147745|NCT01160822|3759314|FG005|Overall Study|Unsatisfactory therapeutic effect|5
2147746|NCT01160822|3759315|FG006|Overall Study|Unsatisfactory therapeutic effect|3
2147747|NCT01160822|3759309|FG000|Overall Study|Withdrawal by Subject|0
2147748|NCT01160822|3759310|FG001|Overall Study|Withdrawal by Subject|0
2147749|NCT01160822|3759311|FG002|Overall Study|Withdrawal by Subject|0
2147750|NCT01160822|3759312|FG003|Overall Study|Withdrawal by Subject|0
2147751|NCT01160822|3759313|FG004|Overall Study|Withdrawal by Subject|0
2147752|NCT01160822|3759314|FG005|Overall Study|Withdrawal by Subject|0
2147753|NCT01160822|3759315|FG006|Overall Study|Withdrawal by Subject|1
2147754|NCT01160822|3759309|FG000|Overall Study|Lost to Follow-up|0
2147755|NCT01160822|3759310|FG001|Overall Study|Lost to Follow-up|0
2147756|NCT01160822|3759311|FG002|Overall Study|Lost to Follow-up|0
2147757|NCT01160822|3759312|FG003|Overall Study|Lost to Follow-up|0
2147758|NCT01160822|3759313|FG004|Overall Study|Lost to Follow-up|1
2147759|NCT01160822|3759314|FG005|Overall Study|Lost to Follow-up|0
2147760|NCT01160822|3759315|FG006|Overall Study|Lost to Follow-up|0
2147761|NCT01160822|3759309|FG000|Overall Study|Administrative problems|0
2147762|NCT01160822|3759310|FG001|Overall Study|Administrative problems|0
2147763|NCT01160822|3759311|FG002|Overall Study|Administrative problems|0
2147764|NCT01160822|3759312|FG003|Overall Study|Administrative problems|0
2147765|NCT01160822|3759313|FG004|Overall Study|Administrative problems|1
2147766|NCT01160822|3759314|FG005|Overall Study|Administrative problems|0
2147767|NCT01160822|3759315|FG006|Overall Study|Administrative problems|0
2147768|NCT01160822|3759309|FG000|Overall Study|Protocol deviation|0
2147769|NCT01160822|3759310|FG001|Overall Study|Protocol deviation|0
2147770|NCT01160822|3759311|FG002|Overall Study|Protocol deviation|0
2147771|NCT01160822|3759312|FG003|Overall Study|Protocol deviation|0
2147772|NCT01160822|3759313|FG004|Overall Study|Protocol deviation|2
2147773|NCT01160822|3759314|FG005|Overall Study|Protocol deviation|0
2147774|NCT01160822|3759315|FG006|Overall Study|Protocol deviation|0
2147775|NCT01161043|3759345|FG000|Overall Study|Withdrawal by Subject|3
2147776|NCT01161173|3759370|FG000|Overall Study|Protocol Violation|13
2147777|NCT01161173|3759370|FG000|Overall Study|Lost to Follow-up|7
2147778|NCT01161173|3759370|FG000|Overall Study|Progressive Disease|82
2147779|NCT01161173|3759370|FG000|Overall Study|Withdrawal of Consent|5
2147780|NCT01161173|3759370|FG000|Overall Study|Unacceptable Toxicity|21
2147781|NCT01161173|3759370|FG000|Overall Study|Death|194
2147782|NCT01161173|3759370|FG000|Overall Study|End of Study|2
2147783|NCT01161173|3759370|FG000|Overall Study|Reasons Not Specified|23
2147784|NCT01161407|3759403|FG000|Overall Study|Protocol Violation|3
2147785|NCT01161407|3759404|FG001|Overall Study|Protocol Violation|1
2147786|NCT01161446|3759422|FG000|Overall Study|Lost to Follow-up|18
2147787|NCT01161446|3759423|FG001|Overall Study|Lost to Follow-up|14
2147788|NCT01161446|3759422|FG000|Overall Study|Withdrawal by Subject|0
2147789|NCT01161446|3759423|FG001|Overall Study|Withdrawal by Subject|1
2147790|NCT01161472|3759429|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
2147791|NCT01161472|3759430|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
2147792|NCT01161472|3759431|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
2147793|NCT01161472|3759432|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
2147794|NCT01161498|3759444|FG000|Overall Study|Disease Progression|0
2147795|NCT01161498|3759445|FG001|Overall Study|Disease Progression|1
2147796|NCT01161524|3759453|FG000|Core Study (23 Weeks)|Adverse Event|3
2147797|NCT01161524|3759454|FG001|Core Study (23 Weeks)|Adverse Event|0
2147798|NCT01161524|3759455|FG002|Core Study (23 Weeks)|Adverse Event|0
2147799|NCT01161524|3759453|FG000|Core Study (23 Weeks)|Other|1
2147800|NCT01161524|3759454|FG001|Core Study (23 Weeks)|Other|0
2147801|NCT01161524|3759455|FG002|Core Study (23 Weeks)|Other|0
2147802|NCT01161524|3759453|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1
2147803|NCT01161524|3759454|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1
2147804|NCT01161524|3759455|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0
2147805|NCT01161524|3759453|FG000|Core Study (23 Weeks)|Lost to Follow-up|1
2147806|NCT01161524|3759454|FG001|Core Study (23 Weeks)|Lost to Follow-up|2
2147807|NCT01161524|3759455|FG002|Core Study (23 Weeks)|Lost to Follow-up|0
2147808|NCT01161524|3759453|FG000|Core Study (23 Weeks)|Subject Choice|3
2147809|NCT01161524|3759454|FG001|Core Study (23 Weeks)|Subject Choice|2
2147810|NCT01161524|3759455|FG002|Core Study (23 Weeks)|Subject Choice|0
2147811|NCT01161524|3759453|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
2291138|NCT02498652|3984039|FG000|Overall Study|Protocol Violation|0
2291139|NCT02498652|3984040|FG001|Overall Study|Protocol Violation|1
2291140|NCT02498678|3984066|FG000|Overall Study|interference from the surgical team|0
2291141|NCT02498678|3984067|FG001|Overall Study|interference from the surgical team|2
2291142|NCT02498821|3984084|FG000|Overall Study|Screen failure|3
2291143|NCT02498821|3984085|FG001|Overall Study|Screen failure|5
2291144|NCT02499029|3984102|FG000|Overall Study|Lost to Follow-up|2
2147812|NCT01161524|3759454|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
2147813|NCT01161524|3759455|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
2147814|NCT01161524|3759453|FG000|Extension Phase (Approximately 83 Weeks)|Other|0
2147815|NCT01161524|3759454|FG001|Extension Phase (Approximately 83 Weeks)|Other|0
2147816|NCT01161524|3759455|FG002|Extension Phase (Approximately 83 Weeks)|Other|6
2147817|NCT01161524|3759453|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
2147818|NCT01161524|3759454|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
2147819|NCT01161524|3759455|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
2147820|NCT01161524|3759453|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
2147821|NCT01161524|3759454|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
2147822|NCT01161524|3759455|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
2147823|NCT01161524|3759453|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
2147824|NCT01161524|3759454|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
2178981|NCT01390428|3804146|FG003|Overall Study|Withdrawal by Subject|0
2291145|NCT02499029|3984103|FG001|Overall Study|Lost to Follow-up|2
2147825|NCT01161524|3759455|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
2147826|NCT01161537|3759464|FG000|Part B|Withdrawal by Subject|2
2147827|NCT01161628|3759482|FG000|Overall Study|Death|6
2147828|NCT01161628|3759482|FG000|Overall Study|Lack of Efficacy|2
2147829|NCT01162122|3759520|FG000|Overall Study|Withdrawal by Subject|52
2147830|NCT01162122|3759521|FG001|Overall Study|Withdrawal by Subject|43
2147831|NCT01162122|3759520|FG000|Overall Study|Lost to Follow-up|73
2147832|NCT01162122|3759521|FG001|Overall Study|Lost to Follow-up|91
2147833|NCT01162122|3759520|FG000|Overall Study|Adverse Event|3
2147834|NCT01162122|3759521|FG001|Overall Study|Adverse Event|2
2147835|NCT01162122|3759520|FG000|Overall Study|Death|51
2147836|NCT01162122|3759521|FG001|Overall Study|Death|46
2147837|NCT01162122|3759520|FG000|Overall Study|Protocol Violation|2
2147838|NCT01162122|3759521|FG001|Overall Study|Protocol Violation|2
2147839|NCT01162122|3759520|FG000|Overall Study|Inappropriate enrollment|5
2147840|NCT01162122|3759521|FG001|Overall Study|Inappropriate enrollment|4
2147841|NCT01162122|3759520|FG000|Overall Study|Administrative reason|1
2147842|NCT01162122|3759521|FG001|Overall Study|Administrative reason|1
2147843|NCT01162122|3759520|FG000|Overall Study|Unable to classify|3
2147844|NCT01162122|3759521|FG001|Overall Study|Unable to classify|7
2147845|NCT01162122|3759520|FG000|Overall Study|Missing primary reason|1
2147846|NCT01162122|3759521|FG001|Overall Study|Missing primary reason|0
2147847|NCT01162135|3759530|FG000|Overall Study|Withdrawal by Subject|1
2147848|NCT01162135|3759530|FG000|Overall Study|Severe back pain|1
2147849|NCT01162135|3759530|FG000|Overall Study|Ineligible|1
2147850|NCT01162239|3759538|FG000|Treatment Phase|Withdrawal by Subject|1
2147851|NCT01162239|3759539|FG001|Treatment Phase|Withdrawal by Subject|3
2147852|NCT01162239|3759540|FG002|Treatment Phase|Withdrawal by Subject|2
2147853|NCT01162239|3759541|FG003|Treatment Phase|Withdrawal by Subject|3
2147854|NCT01162239|3759538|FG000|Treatment Phase|Death|0
2147855|NCT01162239|3759539|FG001|Treatment Phase|Death|0
2147856|NCT01162239|3759540|FG002|Treatment Phase|Death|0
2147857|NCT01162239|3759541|FG003|Treatment Phase|Death|1
2147858|NCT01162239|3759538|FG000|Treatment Phase|Lost to Follow-up|5
2147859|NCT01162239|3759539|FG001|Treatment Phase|Lost to Follow-up|4
2147860|NCT01162239|3759540|FG002|Treatment Phase|Lost to Follow-up|2
2147861|NCT01162239|3759541|FG003|Treatment Phase|Lost to Follow-up|1
2147862|NCT01162239|3759538|FG000|Extended Follow-up|Lost to Follow-up|8
2147863|NCT01162239|3759539|FG001|Extended Follow-up|Lost to Follow-up|13
2147864|NCT01162239|3759540|FG002|Extended Follow-up|Lost to Follow-up|8
2147865|NCT01162239|3759541|FG003|Extended Follow-up|Lost to Follow-up|6
2147866|NCT01162343|3759561|FG000|Overall Study|Left ED prior to psychiatrist assessment|80
2147867|NCT01162343|3759561|FG000|Overall Study|Refused psychiatrist assessment|12
2147868|NCT01162421|3759567|FG000|Overall Study|Did not receive study drug|2
2147869|NCT01162421|3759568|FG001|Overall Study|Did not receive study drug|1
2147870|NCT01162421|3759567|FG000|Overall Study|Adverse Event|2
2147871|NCT01162421|3759568|FG001|Overall Study|Adverse Event|5
2147872|NCT01162421|3759567|FG000|Overall Study|Lost to Follow-up|0
2147873|NCT01162421|3759568|FG001|Overall Study|Lost to Follow-up|2
2147874|NCT01162421|3759567|FG000|Overall Study|Lack of Efficacy|2
2147875|NCT01162421|3759568|FG001|Overall Study|Lack of Efficacy|2
2147876|NCT01162421|3759567|FG000|Overall Study|Other|2
2147877|NCT01162421|3759568|FG001|Overall Study|Other|3
2147878|NCT01162473|3759576|FG000|Overall Study|Adverse Event|2
2291146|NCT02499029|3984102|FG000|Overall Study|Physician Decision|2
2291147|NCT02499029|3984103|FG001|Overall Study|Physician Decision|1
2291148|NCT02499029|3984102|FG000|Overall Study|Death|1
2291149|NCT02499029|3984103|FG001|Overall Study|Death|0
2291150|NCT02499120|3984115|FG000|Overall Study|Death|45
2291151|NCT02499120|3984116|FG001|Overall Study|Death|42
2291152|NCT02499120|3984115|FG000|Overall Study|Lost to Follow-up|1
2291153|NCT02499120|3984116|FG001|Overall Study|Lost to Follow-up|2
2291154|NCT02499120|3984115|FG000|Overall Study|Participant refused further follow-up|1
2291155|NCT02499120|3984116|FG001|Overall Study|Participant refused further follow-up|0
2291156|NCT02499120|3984115|FG000|Overall Study|Withdrawal by Subject|2
2291157|NCT02499120|3984116|FG001|Overall Study|Withdrawal by Subject|5
2291158|NCT02499120|3984115|FG000|Overall Study|Other|1
2291159|NCT02499120|3984116|FG001|Overall Study|Other|0
2147879|NCT01162473|3759577|FG001|Overall Study|Adverse Event|1
2147880|NCT01162473|3759576|FG000|Overall Study|Withdrawal by Subject|0
2147881|NCT01162473|3759577|FG001|Overall Study|Withdrawal by Subject|4
2147882|NCT01162486|3759588|FG000|Overall Study|low ANC|1
2147883|NCT01162486|3759589|FG001|Overall Study|low ANC|0
2147884|NCT01162486|3759590|FG002|Overall Study|low ANC|0
2147885|NCT01162486|3759591|FG003|Overall Study|low ANC|0
2147886|NCT01162486|3759592|FG004|Overall Study|low ANC|0
2147887|NCT01162486|3759588|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1
2147888|NCT01162486|3759589|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0
2147889|NCT01162486|3759590|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0
2147890|NCT01162486|3759591|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0
2147891|NCT01162486|3759592|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0
2147892|NCT01162486|3759588|FG000|Overall Study|elevated LFTs|0
2291160|NCT02499120|3984115|FG000|Overall Study|Ongoing on study|15
2291161|NCT02499120|3984116|FG001|Overall Study|Ongoing on study|11
2291162|NCT02499146|3984122|FG000|Overall Study|Lost to Follow-up|1
2147893|NCT01162486|3759589|FG001|Overall Study|elevated LFTs|0
2147894|NCT01162486|3759590|FG002|Overall Study|elevated LFTs|1
2147895|NCT01162486|3759591|FG003|Overall Study|elevated LFTs|0
2147896|NCT01162486|3759592|FG004|Overall Study|elevated LFTs|0
2147897|NCT01162486|3759588|FG000|Overall Study|Pregnancy|0
2147898|NCT01162486|3759589|FG001|Overall Study|Pregnancy|0
2147899|NCT01162486|3759590|FG002|Overall Study|Pregnancy|0
2147900|NCT01162486|3759591|FG003|Overall Study|Pregnancy|1
2147901|NCT01162486|3759592|FG004|Overall Study|Pregnancy|0
2147902|NCT01162499|3759608|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0
2147903|NCT01162499|3759609|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1
2178982|NCT01390428|3804147|FG004|Overall Study|Withdrawal by Subject|0
2178983|NCT01390428|3804148|FG005|Overall Study|Withdrawal by Subject|0
2178984|NCT01390441|3804167|FG000|Treatment Period|Protocol Violation|0
2178985|NCT01390441|3804168|FG001|Treatment Period|Protocol Violation|1
2178986|NCT01390441|3804169|FG002|Treatment Period|Protocol Violation|0
2178987|NCT01390441|3804170|FG003|Treatment Period|Protocol Violation|0
2178988|NCT01390441|3804171|FG004|Treatment Period|Protocol Violation|0
2178989|NCT01390441|3804167|FG000|Treatment Period|Physician Decision|0
2178990|NCT01390441|3804168|FG001|Treatment Period|Physician Decision|0
2178991|NCT01390441|3804169|FG002|Treatment Period|Physician Decision|0
2178992|NCT01390441|3804170|FG003|Treatment Period|Physician Decision|1
2178993|NCT01390441|3804171|FG004|Treatment Period|Physician Decision|0
2178994|NCT01390441|3804167|FG000|Treatment Period|Lack of Efficacy|0
2178995|NCT01390441|3804168|FG001|Treatment Period|Lack of Efficacy|0
2178996|NCT01390441|3804169|FG002|Treatment Period|Lack of Efficacy|0
2178997|NCT01390441|3804170|FG003|Treatment Period|Lack of Efficacy|0
2178998|NCT01390441|3804171|FG004|Treatment Period|Lack of Efficacy|1
2178999|NCT01390441|3804167|FG000|Treatment Period|Unknown due to early stopping of study|0
2179000|NCT01390441|3804168|FG001|Treatment Period|Unknown due to early stopping of study|0
2179001|NCT01390441|3804169|FG002|Treatment Period|Unknown due to early stopping of study|8
2179002|NCT01390441|3804170|FG003|Treatment Period|Unknown due to early stopping of study|11
2179003|NCT01390441|3804171|FG004|Treatment Period|Unknown due to early stopping of study|7
2179004|NCT01390441|3804167|FG000|Treatment Period|Adverse Event|0
2179005|NCT01390441|3804168|FG001|Treatment Period|Adverse Event|0
2179006|NCT01390441|3804169|FG002|Treatment Period|Adverse Event|1
2179007|NCT01390441|3804170|FG003|Treatment Period|Adverse Event|1
2179008|NCT01390441|3804171|FG004|Treatment Period|Adverse Event|2
2179009|NCT01390441|3804167|FG000|Treatment Period|Withdrawal by Subject|0
2179010|NCT01390441|3804168|FG001|Treatment Period|Withdrawal by Subject|0
2179011|NCT01390441|3804169|FG002|Treatment Period|Withdrawal by Subject|1
2179012|NCT01390441|3804170|FG003|Treatment Period|Withdrawal by Subject|0
2179013|NCT01390441|3804171|FG004|Treatment Period|Withdrawal by Subject|1
2179014|NCT01390441|3804167|FG000|Treatment Period|Lost to Follow-up|1
2179015|NCT01390441|3804168|FG001|Treatment Period|Lost to Follow-up|0
2179016|NCT01390441|3804169|FG002|Treatment Period|Lost to Follow-up|0
2179017|NCT01390441|3804170|FG003|Treatment Period|Lost to Follow-up|0
2179018|NCT01390441|3804171|FG004|Treatment Period|Lost to Follow-up|0
2179019|NCT01390441|3804167|FG000|Extension Period|Protocol Violation|3
2179020|NCT01390441|3804168|FG001|Extension Period|Protocol Violation|1
2179021|NCT01390441|3804169|FG002|Extension Period|Protocol Violation|0
2179022|NCT01390441|3804170|FG003|Extension Period|Protocol Violation|1
2179023|NCT01390441|3804171|FG004|Extension Period|Protocol Violation|0
2179024|NCT01390584|3804211|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
2179025|NCT01390584|3804212|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
2179026|NCT01390584|3804213|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1
2179027|NCT01390649|3804222|FG000|Overall Study|Physician Decision|1
2179028|NCT01390779|3804226|FG000|Overall Study|Physician Decision|1
2179029|NCT01390844|3804363|FG000|Treatment Phase|Adverse Event|12
2179030|NCT01390844|3804364|FG001|Treatment Phase|Adverse Event|2
2179031|NCT01390844|3804365|FG002|Treatment Phase|Adverse Event|3
2179032|NCT01390844|3804366|FG003|Treatment Phase|Adverse Event|2
2179033|NCT01390844|3804363|FG000|Treatment Phase|Treatment Failure|23
2179034|NCT01390844|3804364|FG001|Treatment Phase|Treatment Failure|25
2179035|NCT01390844|3804365|FG002|Treatment Phase|Treatment Failure|10
2179036|NCT01390844|3804366|FG003|Treatment Phase|Treatment Failure|13
2179037|NCT01390844|3804363|FG000|Treatment Phase|Non-Medical Reasons|5
2179038|NCT01390844|3804364|FG001|Treatment Phase|Non-Medical Reasons|1
2179039|NCT01390844|3804365|FG002|Treatment Phase|Non-Medical Reasons|8
2179040|NCT01390844|3804366|FG003|Treatment Phase|Non-Medical Reasons|1
2179041|NCT01390844|3804363|FG000|Treatment Phase|Non-GCP Compliant|0
2179042|NCT01390844|3804364|FG001|Treatment Phase|Non-GCP Compliant|0
2179043|NCT01390844|3804365|FG002|Treatment Phase|Non-GCP Compliant|10
2179044|NCT01390844|3804366|FG003|Treatment Phase|Non-GCP Compliant|3
2179045|NCT01390844|3804363|FG000|Follow-Up Phase|Non-Medical Reasons|1
2179046|NCT01390844|3804364|FG001|Follow-Up Phase|Non-Medical Reasons|1
2179047|NCT01390844|3804365|FG002|Follow-Up Phase|Non-Medical Reasons|1
2179048|NCT01390844|3804366|FG003|Follow-Up Phase|Non-Medical Reasons|0
2179049|NCT01390857|3804376|FG000|Overall Study|Protocol Violation|2
2179050|NCT01390857|3804376|FG000|Overall Study|Lost to Follow-up|1
2179051|NCT01390857|3804376|FG000|Overall Study|No Visit after the First Visit|7
2179052|NCT01390948|3804416|FG000|Overall Study|End of Study|1
2179053|NCT01390948|3804417|FG001|Overall Study|End of Study|0
2147904|NCT01162863|3759633|FG000|Overall Study|Lack of Efficacy|1
2147905|NCT01162863|3759634|FG001|Overall Study|Lack of Efficacy|0
2147906|NCT01162863|3759635|FG002|Overall Study|Lack of Efficacy|0
2147907|NCT01162863|3759633|FG000|Overall Study|Adverse Event|0
2147908|NCT01162863|3759634|FG001|Overall Study|Adverse Event|1
2147909|NCT01162863|3759635|FG002|Overall Study|Adverse Event|0
2147910|NCT01163032|3759646|FG000|Randomization Phase|Withdrawal by Subject|2
2291163|NCT02499146|3984122|FG000|Overall Study|Withdrawal by Subject|1
2291164|NCT02499146|3984122|FG000|Overall Study|Other|2
2291165|NCT02499146|3984122|FG000|Overall Study|Ongoing at date of cut-off|9
2147911|NCT01163032|3759647|FG001|Randomization Phase|Withdrawal by Subject|3
2147912|NCT01163032|3759648|FG002|Randomization Phase|Withdrawal by Subject|0
2147913|NCT01163032|3759646|FG000|Randomization Phase|Adverse Event|3
2147914|NCT01163032|3759647|FG001|Randomization Phase|Adverse Event|3
2147915|NCT01163032|3759648|FG002|Randomization Phase|Adverse Event|0
2147916|NCT01163032|3759646|FG000|Randomization Phase|Protocol Violation|0
2147917|NCT01163032|3759647|FG001|Randomization Phase|Protocol Violation|1
2147918|NCT01163032|3759648|FG002|Randomization Phase|Protocol Violation|0
2147919|NCT01163032|3759646|FG000|Randomization Phase|Various*|5
2147920|NCT01163032|3759647|FG001|Randomization Phase|Various*|4
2147921|NCT01163032|3759648|FG002|Randomization Phase|Various*|0
2147922|NCT01163032|3759646|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0
2147923|NCT01163032|3759647|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1
2147924|NCT01163032|3759648|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0
2147925|NCT01163032|3759646|FG000|Open Label Extension Phase|Adverse Event|0
2147926|NCT01163032|3759647|FG001|Open Label Extension Phase|Adverse Event|0
2147927|NCT01163032|3759648|FG002|Open Label Extension Phase|Adverse Event|3
2147928|NCT01163032|3759646|FG000|Open Label Extension Phase|Withdrawal by Subject|0
2147929|NCT01163032|3759647|FG001|Open Label Extension Phase|Withdrawal by Subject|0
2147930|NCT01163032|3759648|FG002|Open Label Extension Phase|Withdrawal by Subject|3
2208087|NCT01636687|3847523|FG000|Maintenance Period|Withdrawal by Subject|2
2208088|NCT01636687|3847524|FG001|Maintenance Period|Withdrawal by Subject|0
2208089|NCT01636687|3847525|FG002|Maintenance Period|Withdrawal by Subject|2
2208090|NCT01636687|3847526|FG003|Maintenance Period|Withdrawal by Subject|0
2208091|NCT01636687|3847527|FG004|Maintenance Period|Withdrawal by Subject|0
2208092|NCT01636687|3847523|FG000|Maintenance Period|Adverse Event|1
2208093|NCT01636687|3847524|FG001|Maintenance Period|Adverse Event|0
2208094|NCT01636687|3847525|FG002|Maintenance Period|Adverse Event|0
2147931|NCT01163032|3759646|FG000|Open Label Extension Phase|Protocol Violation|0
2147932|NCT01163032|3759647|FG001|Open Label Extension Phase|Protocol Violation|0
2147933|NCT01163032|3759648|FG002|Open Label Extension Phase|Protocol Violation|1
2147934|NCT01163032|3759646|FG000|Open Label Extension Phase|Study Termination|0
2147935|NCT01163032|3759647|FG001|Open Label Extension Phase|Study Termination|0
2147936|NCT01163032|3759648|FG002|Open Label Extension Phase|Study Termination|7
2147937|NCT01163032|3759646|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
2147938|NCT01163032|3759647|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
2147939|NCT01163032|3759648|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
2147940|NCT01163149|3759674|FG000|Extension Treatment Period|Withdrawal by Subject|2
2147941|NCT01163149|3759675|FG001|Extension Treatment Period|Withdrawal by Subject|0
2147942|NCT01163149|3759676|FG002|Extension Treatment Period|Withdrawal by Subject|1
2147943|NCT01163149|3759674|FG000|Extension Treatment Period|Adverse Event|0
2147944|NCT01163149|3759675|FG001|Extension Treatment Period|Adverse Event|1
2147945|NCT01163149|3759676|FG002|Extension Treatment Period|Adverse Event|0
2147946|NCT01163149|3759674|FG000|Extension Treatment Period|Noncompliance|0
2147947|NCT01163149|3759675|FG001|Extension Treatment Period|Noncompliance|0
2147948|NCT01163149|3759676|FG002|Extension Treatment Period|Noncompliance|1
2147949|NCT01163253|3759713|FG000|Overall Study|Withdrawn Due to Pregnancy|12
2147950|NCT01163253|3759714|FG001|Overall Study|Withdrawn Due to Pregnancy|2
2147951|NCT01163253|3759713|FG000|Overall Study|Study Terminated by Sponsor|978
2147952|NCT01163253|3759714|FG001|Overall Study|Study Terminated by Sponsor|349
2147953|NCT01163253|3759713|FG000|Overall Study|Protocol Violation|43
2147954|NCT01163253|3759714|FG001|Overall Study|Protocol Violation|12
2147955|NCT01163253|3759713|FG000|Overall Study|Withdrawal by Subject|199
2147956|NCT01163253|3759714|FG001|Overall Study|Withdrawal by Subject|50
2147957|NCT01163253|3759713|FG000|Overall Study|Medication Error|1
2147958|NCT01163253|3759714|FG001|Overall Study|Medication Error|0
2147959|NCT01163253|3759713|FG000|Overall Study|Lost to Follow-up|125
2147960|NCT01163253|3759714|FG001|Overall Study|Lost to Follow-up|23
2147961|NCT01163253|3759713|FG000|Overall Study|Insufficient Clinical Response|423
2147962|NCT01163253|3759714|FG001|Overall Study|Insufficient Clinical Response|29
2147963|NCT01163253|3759713|FG000|Overall Study|Adverse Event|300
2147964|NCT01163253|3759714|FG001|Overall Study|Adverse Event|78
2147965|NCT01163253|3759713|FG000|Overall Study|Death|17
2147966|NCT01163253|3759714|FG001|Overall Study|Death|5
2147967|NCT01163253|3759713|FG000|Overall Study|Ongoing|13
2147968|NCT01163253|3759714|FG001|Overall Study|Ongoing|4
2147969|NCT01163253|3759713|FG000|Overall Study|Other Unspecified|170
2147970|NCT01163253|3759714|FG001|Overall Study|Other Unspecified|34
2208095|NCT01636687|3847526|FG003|Maintenance Period|Adverse Event|0
2208096|NCT01636687|3847527|FG004|Maintenance Period|Adverse Event|0
2147971|NCT01163266|3759723|FG000|Overall Study|Pretreatment Event or Adverse Event|2
2321114|NCT02955069|4035383|FG001|Overall Study|Subject/Guardian decision|1
2147972|NCT01163266|3759724|FG001|Overall Study|Pretreatment Event or Adverse Event|9
2147973|NCT01163266|3759725|FG002|Overall Study|Pretreatment Event or Adverse Event|7
2147974|NCT01163266|3759723|FG000|Overall Study|Lack of Efficacy|1
2147975|NCT01163266|3759724|FG001|Overall Study|Lack of Efficacy|3
2147976|NCT01163266|3759725|FG002|Overall Study|Lack of Efficacy|1
2147977|NCT01163266|3759723|FG000|Overall Study|Noncompliance with Study Drug|0
2147978|NCT01163266|3759724|FG001|Overall Study|Noncompliance with Study Drug|2
2147979|NCT01163266|3759725|FG002|Overall Study|Noncompliance with Study Drug|0
2147980|NCT01163266|3759723|FG000|Overall Study|Protocol Deviations|2
2147981|NCT01163266|3759724|FG001|Overall Study|Protocol Deviations|2
2147982|NCT01163266|3759725|FG002|Overall Study|Protocol Deviations|5
2147983|NCT01163266|3759723|FG000|Overall Study|Withdrawal of Consent|5
2147984|NCT01163266|3759724|FG001|Overall Study|Withdrawal of Consent|7
2147985|NCT01163266|3759725|FG002|Overall Study|Withdrawal of Consent|3
2147986|NCT01163266|3759723|FG000|Overall Study|Lost to Follow-up|7
2147987|NCT01163266|3759724|FG001|Overall Study|Lost to Follow-up|7
2147988|NCT01163266|3759725|FG002|Overall Study|Lost to Follow-up|10
2147989|NCT01163266|3759723|FG000|Overall Study|Other|1
2147990|NCT01163266|3759724|FG001|Overall Study|Other|1
2147991|NCT01163266|3759725|FG002|Overall Study|Other|2
2147992|NCT01163279|3759735|FG000|Overall Study|Withdrawal by Subject|2
2147993|NCT01163279|3759736|FG001|Overall Study|Withdrawal by Subject|0
2147994|NCT01163292|3759745|FG000|Overall Study|Lack of Efficacy|9
2147995|NCT01163292|3759746|FG001|Overall Study|Lack of Efficacy|0
2147996|NCT01163292|3759745|FG000|Overall Study|Adverse Event|6
2147997|NCT01163292|3759746|FG001|Overall Study|Adverse Event|0
2147998|NCT01163292|3759745|FG000|Overall Study|Initiation of biological therapy|0
2147999|NCT01163292|3759746|FG001|Overall Study|Initiation of biological therapy|15
2148000|NCT01163292|3759745|FG000|Overall Study|Sufficient response to adalimumab|8
2148001|NCT01163292|3759746|FG001|Overall Study|Sufficient response to adalimumab|0
2148002|NCT01163292|3759745|FG000|Overall Study|Refusal to receive adalimumab|7
2148003|NCT01163292|3759746|FG001|Overall Study|Refusal to receive adalimumab|0
2148004|NCT01163292|3759745|FG000|Overall Study|Economic reasons|6
2148005|NCT01163292|3759746|FG001|Overall Study|Economic reasons|0
2148006|NCT01163292|3759745|FG000|Overall Study|No further visits|5
2148007|NCT01163292|3759746|FG001|Overall Study|No further visits|7
2148008|NCT01163318|3759752|FG000|Overall Study|Off-Label Use of Adalimumab|8
2148009|NCT01163318|3759752|FG000|Overall Study|Did Not Continue Use of Adalimumab|26
2148010|NCT01163318|3759752|FG000|Overall Study|History/comorbidity of malignant tumor|3
2148011|NCT01163318|3759752|FG000|Overall Study|Participants Without Case Report Form|7
2148012|NCT01163318|3759752|FG000|Overall Study|Multiple Reasons Per Participant|224
2148013|NCT01163474|3759761|FG000|Overall Study|Withdrawal by Subject|1
2148014|NCT01163474|3759761|FG000|Overall Study|Tech barriers to videoteleconference vis|12
2148015|NCT01163474|3759761|FG000|Overall Study|Lost to Follow-up|3
2148016|NCT01163617|3759777|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2148017|NCT01163617|3759778|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
2148018|NCT01163617|3759779|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2148019|NCT01163617|3759780|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2148020|NCT01163617|3759781|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2148021|NCT01163617|3759782|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2148022|NCT01163617|3759783|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2148023|NCT01163617|3759784|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2148024|NCT01163617|3759777|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2148025|NCT01163617|3759778|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
2148026|NCT01163617|3759779|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2148027|NCT01163617|3759780|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2148028|NCT01163617|3759781|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2148029|NCT01163617|3759782|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2148030|NCT01163617|3759783|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2148031|NCT01163617|3759784|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2148032|NCT01163617|3759777|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2148033|NCT01163617|3759778|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2148034|NCT01163617|3759779|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
2148035|NCT01163617|3759780|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2148036|NCT01163617|3759781|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2148037|NCT01163617|3759782|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2148038|NCT01163617|3759783|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2148039|NCT01163617|3759784|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2148040|NCT01163721|3759840|FG000|Overall Study|Adverse Event|5
2148041|NCT01163721|3759841|FG001|Overall Study|Adverse Event|6
2148042|NCT01163721|3759840|FG000|Overall Study|Withdrawal by Subject|3
2148043|NCT01163721|3759841|FG001|Overall Study|Withdrawal by Subject|4
2148044|NCT01163721|3759840|FG000|Overall Study|Lost to Follow-up|0
2148045|NCT01163721|3759841|FG001|Overall Study|Lost to Follow-up|1
2148046|NCT01163721|3759840|FG000|Overall Study|Physician Decision|0
2148047|NCT01163721|3759841|FG001|Overall Study|Physician Decision|1
2148048|NCT01163747|3759849|FG000|Overall Study|Adverse Event|0
2148049|NCT01163747|3759850|FG001|Overall Study|Adverse Event|5
2148050|NCT01163747|3759849|FG000|Overall Study|Insufficient Therapeutic Response|0
2148051|NCT01163747|3759850|FG001|Overall Study|Insufficient Therapeutic Response|1
2148052|NCT01163747|3759849|FG000|Overall Study|Protocol Violation|0
2148053|NCT01163747|3759850|FG001|Overall Study|Protocol Violation|1
2148054|NCT01163747|3759849|FG000|Overall Study|Refused Treatment|6
2148055|NCT01163747|3759850|FG001|Overall Study|Refused Treatment|4
2148056|NCT01163786|3759867|FG000|Treatment With Bortezomib|Withdrawal by Subject|1
2148057|NCT01163786|3759867|FG000|Treatment With Bortezomib|Adverse Event|2
2148058|NCT01163786|3759867|FG000|Completed Follow up (Visit 9 and 10)|Other|1
2148059|NCT01163851|3759873|FG000|Overall Study|Site Closure|0
2148060|NCT01163851|3759874|FG001|Overall Study|Site Closure|1
2148061|NCT01163851|3759873|FG000|Overall Study|Enrolled but not treated|1
2148062|NCT01163851|3759874|FG001|Overall Study|Enrolled but not treated|0
2148063|NCT01163916|3759883|FG000|Overall Study|Withdrawal by Subject|2
2148064|NCT01163916|3759884|FG001|Overall Study|Withdrawal by Subject|0
2148065|NCT01163916|3759885|FG002|Overall Study|Withdrawal by Subject|2
2148066|NCT01163916|3759883|FG000|Overall Study|Adverse Event|2
2148067|NCT01163916|3759884|FG001|Overall Study|Adverse Event|0
2148068|NCT01163916|3759885|FG002|Overall Study|Adverse Event|1
2148069|NCT01163916|3759883|FG000|Overall Study|Lack of Efficacy|2
2148070|NCT01163916|3759884|FG001|Overall Study|Lack of Efficacy|0
2148071|NCT01163916|3759885|FG002|Overall Study|Lack of Efficacy|1
2148072|NCT01163916|3759883|FG000|Overall Study|Other|24
2148073|NCT01163916|3759884|FG001|Overall Study|Other|4
2148074|NCT01163916|3759885|FG002|Overall Study|Other|16
2148075|NCT01164007|3759907|FG000|Overall Study|Adverse Event|5
2148076|NCT01164007|3759907|FG000|Overall Study|Progression of Disease|30
2148077|NCT01164007|3759907|FG000|Overall Study|Protocol Violation|1
2148078|NCT01164007|3759907|FG000|Overall Study|Withdrawal by Subject|1
2148079|NCT01164007|3759907|FG000|Overall Study|Medical Decision|3
2148080|NCT01164475|3759931|FG000|Overall Study|Lack of Efficacy|1
2148081|NCT01164475|3759932|FG001|Overall Study|Lack of Efficacy|0
2148082|NCT01164475|3759931|FG000|Overall Study|Other|0
2148083|NCT01164475|3759932|FG001|Overall Study|Other|1
2148084|NCT01164475|3759931|FG000|Overall Study|Progressive disease|0
2148085|NCT01164475|3759932|FG001|Overall Study|Progressive disease|1
2148086|NCT01164475|3759931|FG000|Overall Study|Protocol Violation|1
2148087|NCT01164475|3759932|FG001|Overall Study|Protocol Violation|0
2148088|NCT01164501|3759941|FG000|Overall Study|Not treated|2
2148089|NCT01164501|3759942|FG001|Overall Study|Not treated|0
2148090|NCT01164501|3759943|FG002|Overall Study|Not treated|1
2148091|NCT01164501|3759941|FG000|Overall Study|Adverse Event|18
2148092|NCT01164501|3759942|FG001|Overall Study|Adverse Event|4
2148093|NCT01164501|3759943|FG002|Overall Study|Adverse Event|21
2148094|NCT01164501|3759941|FG000|Overall Study|Lack of Efficacy|0
2148095|NCT01164501|3759942|FG001|Overall Study|Lack of Efficacy|0
2148096|NCT01164501|3759943|FG002|Overall Study|Lack of Efficacy|1
2148097|NCT01164501|3759941|FG000|Overall Study|Non compliant with protocol|1
2148098|NCT01164501|3759942|FG001|Overall Study|Non compliant with protocol|1
2148099|NCT01164501|3759943|FG002|Overall Study|Non compliant with protocol|4
2148100|NCT01164501|3759941|FG000|Overall Study|Lost to Follow-up|3
2148101|NCT01164501|3759942|FG001|Overall Study|Lost to Follow-up|0
2148102|NCT01164501|3759943|FG002|Overall Study|Lost to Follow-up|3
2148103|NCT01164501|3759941|FG000|Overall Study|Patient refusal to continue,not due toAE|10
2148104|NCT01164501|3759942|FG001|Overall Study|Patient refusal to continue,not due toAE|4
2148105|NCT01164501|3759943|FG002|Overall Study|Patient refusal to continue,not due toAE|8
2148106|NCT01164501|3759941|FG000|Overall Study|Other reason not defined above|9
2148107|NCT01164501|3759942|FG001|Overall Study|Other reason not defined above|1
2148108|NCT01164501|3759943|FG002|Overall Study|Other reason not defined above|4
2148109|NCT01164579|3759956|FG000|Overall Study|Lack of Efficacy|0
2148110|NCT01164579|3759957|FG001|Overall Study|Lack of Efficacy|0
2148111|NCT01164579|3759958|FG002|Overall Study|Lack of Efficacy|6
2148112|NCT01164579|3759956|FG000|Overall Study|Lost to Follow-up|1
2148113|NCT01164579|3759957|FG001|Overall Study|Lost to Follow-up|1
2148114|NCT01164579|3759958|FG002|Overall Study|Lost to Follow-up|0
2148115|NCT01164579|3759956|FG000|Overall Study|Withdrawal by Subject|2
2148116|NCT01164579|3759957|FG001|Overall Study|Withdrawal by Subject|5
2148117|NCT01164579|3759958|FG002|Overall Study|Withdrawal by Subject|3
2148118|NCT01164579|3759956|FG000|Overall Study|Protocol Violation|0
2148119|NCT01164579|3759957|FG001|Overall Study|Protocol Violation|1
2148120|NCT01164579|3759958|FG002|Overall Study|Protocol Violation|2
2148121|NCT01164579|3759956|FG000|Overall Study|Adverse Event|4
2148122|NCT01164579|3759957|FG001|Overall Study|Adverse Event|2
2148123|NCT01164579|3759958|FG002|Overall Study|Adverse Event|5
2148124|NCT01164579|3759956|FG000|Overall Study|Reason not specified|1
2148125|NCT01164579|3759957|FG001|Overall Study|Reason not specified|0
2148126|NCT01164579|3759958|FG002|Overall Study|Reason not specified|0
2148127|NCT01164722|3759978|FG000|Overall Study|Adverse Event|0
2148128|NCT01164722|3759979|FG001|Overall Study|Adverse Event|1
2148129|NCT01164722|3759978|FG000|Overall Study|Withdrawal by Subject|3
2148130|NCT01164722|3759979|FG001|Overall Study|Withdrawal by Subject|4
2148131|NCT01164722|3759978|FG000|Overall Study|Lost to Follow-up|3
2148132|NCT01164722|3759979|FG001|Overall Study|Lost to Follow-up|6
2148133|NCT01164722|3759978|FG000|Overall Study|met protocol criteria for non-treatment|11
2148134|NCT01164722|3759979|FG001|Overall Study|met protocol criteria for non-treatment|1
2148135|NCT01164722|3759978|FG000|Overall Study|enrolled on other study, concomitant med|1
2148136|NCT01164722|3759979|FG001|Overall Study|enrolled on other study, concomitant med|3
2148137|NCT01164865|3759987|FG000|Overall Study|Lost to Follow-up|2
2148138|NCT01164865|3759988|FG001|Overall Study|Lost to Follow-up|1
2148139|NCT01164891|3759994|FG000|Overall Study|Disease Progression|5
2148140|NCT01164891|3759994|FG000|Overall Study|Adverse Event|1
2148141|NCT01164956|3759999|FG000|Overall Study|Side Effects|1
2148142|NCT01164956|3760000|FG001|Overall Study|Side Effects|0
2148143|NCT01164956|3760001|FG002|Overall Study|Side Effects|1
2148144|NCT01165021|3760009|FG000|Overall Study|Death|1
2148145|NCT01165138|3760024|FG000|Overall Study|Adverse Event|0
2148146|NCT01165138|3760025|FG001|Overall Study|Adverse Event|1
2148147|NCT01165138|3760026|FG002|Overall Study|Adverse Event|0
2148148|NCT01165138|3760027|FG003|Overall Study|Adverse Event|2
2148149|NCT01165138|3760024|FG000|Overall Study|Lack of Efficacy|0
2148150|NCT01165138|3760025|FG001|Overall Study|Lack of Efficacy|32
2148151|NCT01165138|3760026|FG002|Overall Study|Lack of Efficacy|6
2148152|NCT01165138|3760027|FG003|Overall Study|Lack of Efficacy|7
2148153|NCT01165138|3760024|FG000|Overall Study|Protocol Violation|0
2148154|NCT01165138|3760025|FG001|Overall Study|Protocol Violation|7
2148155|NCT01165138|3760026|FG002|Overall Study|Protocol Violation|0
2148156|NCT01165138|3760027|FG003|Overall Study|Protocol Violation|2
2148157|NCT01165138|3760024|FG000|Overall Study|Lost to Follow-up|0
2148158|NCT01165138|3760025|FG001|Overall Study|Lost to Follow-up|0
2148159|NCT01165138|3760026|FG002|Overall Study|Lost to Follow-up|1
2148160|NCT01165138|3760027|FG003|Overall Study|Lost to Follow-up|2
2148161|NCT01165138|3760024|FG000|Overall Study|Physician Decision|0
2148162|NCT01165138|3760025|FG001|Overall Study|Physician Decision|6
2148163|NCT01165138|3760026|FG002|Overall Study|Physician Decision|7
2148164|NCT01165138|3760027|FG003|Overall Study|Physician Decision|6
2148165|NCT01165138|3760024|FG000|Overall Study|Withdrawal by Subject|0
2148166|NCT01165138|3760025|FG001|Overall Study|Withdrawal by Subject|6
2148167|NCT01165138|3760026|FG002|Overall Study|Withdrawal by Subject|6
2148168|NCT01165138|3760027|FG003|Overall Study|Withdrawal by Subject|3
2148169|NCT01165177|3760037|FG000|Overall Study|Serious Adverse Event|227
2148170|NCT01165177|3760038|FG001|Overall Study|Serious Adverse Event|235
2148171|NCT01165177|3760037|FG000|Overall Study|Withdrawal by Subject|368
2148172|NCT01165177|3760038|FG001|Overall Study|Withdrawal by Subject|354
2148173|NCT01165177|3760037|FG000|Overall Study|Protocol Violation|19
2148174|NCT01165177|3760038|FG001|Overall Study|Protocol Violation|21
2148175|NCT01165177|3760037|FG000|Overall Study|Non-serious adverse event|30
2148176|NCT01165177|3760038|FG001|Overall Study|Non-serious adverse event|18
2148177|NCT01165177|3760037|FG000|Overall Study|Other unspecified reasons|47
2148178|NCT01165177|3760038|FG001|Overall Study|Other unspecified reasons|35
2148179|NCT01165177|3760037|FG000|Overall Study|Suspected HZ episode|0
2148180|NCT01165177|3760038|FG001|Overall Study|Suspected HZ episode|2
2148181|NCT01165177|3760037|FG000|Overall Study|Lost to Follow-up|183
2148182|NCT01165177|3760038|FG001|Overall Study|Lost to Follow-up|194
2148183|NCT01165177|3760037|FG000|Overall Study|Migrated/ moved from study area|48
2148184|NCT01165177|3760038|FG001|Overall Study|Migrated/ moved from study area|43
2148185|NCT01165203|3760054|FG000|Active Phase|Serious Adverse Event|1
2148186|NCT01165203|3760055|FG001|Active Phase|Serious Adverse Event|0
2148187|NCT01165203|3760054|FG000|Active Phase|Withdrawal by Subject|2
2148188|NCT01165203|3760055|FG001|Active Phase|Withdrawal by Subject|1
2148189|NCT01165203|3760054|FG000|Active Phase|Migrated/moved from study area|0
2148190|NCT01165203|3760055|FG001|Active Phase|Migrated/moved from study area|1
2148191|NCT01165203|3760054|FG000|Active Phase|Lost to Follow-up|2
2148192|NCT01165203|3760055|FG001|Active Phase|Lost to Follow-up|0
2148193|NCT01165203|3760054|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1
2148194|NCT01165203|3760055|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0
2208097|NCT01636687|3847523|FG000|Maintenance Period|Lack of Efficacy|4
2208098|NCT01636687|3847524|FG001|Maintenance Period|Lack of Efficacy|1
2148195|NCT01165203|3760054|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2
2148196|NCT01165203|3760055|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2
2148197|NCT01165203|3760054|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2
2148198|NCT01165203|3760055|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1
2148199|NCT01165203|3760054|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2
2148200|NCT01165203|3760055|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0
2148201|NCT01165203|3760054|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0
2148202|NCT01165203|3760055|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1
2148203|NCT01165216|3760070|FG000|Overall Study|Adverse Event|6
2148204|NCT01165216|3760071|FG001|Overall Study|Adverse Event|3
2148205|NCT01165216|3760070|FG000|Overall Study|Withdrawal by Subject|1
2148206|NCT01165216|3760071|FG001|Overall Study|Withdrawal by Subject|1
2148207|NCT01165216|3760070|FG000|Overall Study|Disease progression|1
2148208|NCT01165216|3760071|FG001|Overall Study|Disease progression|3
2148209|NCT01165229|3760081|FG000|Overall Study|Serious Adverse Event|456
2148210|NCT01165229|3760082|FG001|Overall Study|Serious Adverse Event|487
2148211|NCT01165229|3760081|FG000|Overall Study|Non-Serious Adverse Event|47
2148212|NCT01165229|3760082|FG001|Overall Study|Non-Serious Adverse Event|15
2148213|NCT01165229|3760081|FG000|Overall Study|Protocol Violation|6
2148214|NCT01165229|3760082|FG001|Overall Study|Protocol Violation|8
2148215|NCT01165229|3760081|FG000|Overall Study|Withdrawal by Subject|387
2148216|NCT01165229|3760082|FG001|Overall Study|Withdrawal by Subject|396
2148217|NCT01165229|3760081|FG000|Overall Study|Migrated/moved from study area|51
2148218|NCT01165229|3760082|FG001|Overall Study|Migrated/moved from study area|46
2148219|NCT01165229|3760081|FG000|Overall Study|Lost to Follow-up|123
2148220|NCT01165229|3760082|FG001|Overall Study|Lost to Follow-up|133
2148221|NCT01165229|3760081|FG000|Overall Study|Suspected HZ Episode|2
2148222|NCT01165229|3760082|FG001|Overall Study|Suspected HZ Episode|2
2148223|NCT01165229|3760081|FG000|Overall Study|No reason from the subject|108
2148224|NCT01165229|3760082|FG001|Overall Study|No reason from the subject|102
2148225|NCT01165229|3760081|FG000|Overall Study|Unknown completion status|0
2148226|NCT01165229|3760082|FG001|Overall Study|Unknown completion status|1
2148227|NCT01165242|3760121|FG000|Overall Study|Unreachable Subjects|1
2148228|NCT01165242|3760122|FG001|Overall Study|Unreachable Subjects|0
2148229|NCT01165242|3760123|FG002|Overall Study|Unreachable Subjects|0
2148230|NCT01165242|3760121|FG000|Overall Study|Incarcerated Subjects|0
2148231|NCT01165242|3760122|FG001|Overall Study|Incarcerated Subjects|1
2148232|NCT01165242|3760123|FG002|Overall Study|Incarcerated Subjects|0
2148233|NCT01165242|3760121|FG000|Overall Study|Visit 2 Declined by Subject|0
2148234|NCT01165242|3760122|FG001|Overall Study|Visit 2 Declined by Subject|0
2148235|NCT01165242|3760123|FG002|Overall Study|Visit 2 Declined by Subject|1
2148236|NCT01165242|3760121|FG000|Overall Study|Withdrawal by Subject|0
2148237|NCT01165242|3760122|FG001|Overall Study|Withdrawal by Subject|2
2148238|NCT01165242|3760123|FG002|Overall Study|Withdrawal by Subject|2
2148239|NCT01165242|3760121|FG000|Overall Study|Extended Holiday|0
2148240|NCT01165242|3760122|FG001|Overall Study|Extended Holiday|0
2148241|NCT01165242|3760123|FG002|Overall Study|Extended Holiday|1
2148242|NCT01165242|3760121|FG000|Overall Study|Lost to Follow-up|9
2148243|NCT01165242|3760122|FG001|Overall Study|Lost to Follow-up|7
2148244|NCT01165242|3760123|FG002|Overall Study|Lost to Follow-up|10
2148245|NCT01165281|3760135|FG000|Overall Study|Adverse Event|12
2148246|NCT01165281|3760136|FG001|Overall Study|Adverse Event|14
2148247|NCT01165281|3760135|FG000|Overall Study|Death|3
2148248|NCT01165281|3760136|FG001|Overall Study|Death|4
2148249|NCT01165281|3760135|FG000|Overall Study|Lack of Efficacy|4
2148250|NCT01165281|3760136|FG001|Overall Study|Lack of Efficacy|1
2148251|NCT01165281|3760135|FG000|Overall Study|Lost to Follow-up|0
2148252|NCT01165281|3760136|FG001|Overall Study|Lost to Follow-up|1
2148253|NCT01165281|3760135|FG000|Overall Study|Physician Decision|8
2148254|NCT01165281|3760136|FG001|Overall Study|Physician Decision|1
2148255|NCT01165281|3760135|FG000|Overall Study|Protocol Violation|6
2148256|NCT01165281|3760136|FG001|Overall Study|Protocol Violation|5
2148257|NCT01165281|3760135|FG000|Overall Study|Withdrawal by Subject|8
2148258|NCT01165281|3760136|FG001|Overall Study|Withdrawal by Subject|7
2148259|NCT01165281|3760135|FG000|Overall Study|Noncompliance with Study Drug|1
2148260|NCT01165281|3760136|FG001|Overall Study|Noncompliance with Study Drug|4
2148261|NCT01165281|3760135|FG000|Overall Study|Progressive Disease|10
2148262|NCT01165281|3760136|FG001|Overall Study|Progressive Disease|14
2148263|NCT01165281|3760135|FG000|Overall Study|Other|6
2148264|NCT01165281|3760136|FG001|Overall Study|Other|0
2148265|NCT01165307|3760144|FG000|Overall Study|Lost to Follow-up|11
2148266|NCT01165307|3760145|FG001|Overall Study|Lost to Follow-up|3
2148267|NCT01165307|3760144|FG000|Overall Study|Withdrawal by Subject|2
2148268|NCT01165307|3760145|FG001|Overall Study|Withdrawal by Subject|0
2148269|NCT01165307|3760144|FG000|Overall Study|Subject not available for contact|1
2148270|NCT01165307|3760145|FG001|Overall Study|Subject not available for contact|0
2148271|NCT01165320|3760153|FG000|Overall Study|Clinical adverse experience|2
2148272|NCT01165320|3760154|FG001|Overall Study|Clinical adverse experience|1
2148273|NCT01165320|3760155|FG002|Overall Study|Clinical adverse experience|0
2148274|NCT01165320|3760153|FG000|Overall Study|Laboratory adverse experience|1
2148275|NCT01165320|3760154|FG001|Overall Study|Laboratory adverse experience|0
2148276|NCT01165320|3760155|FG002|Overall Study|Laboratory adverse experience|0
2148277|NCT01165320|3760153|FG000|Overall Study|Lack of Efficacy|0
2148278|NCT01165320|3760154|FG001|Overall Study|Lack of Efficacy|2
2148279|NCT01165320|3760155|FG002|Overall Study|Lack of Efficacy|0
2148280|NCT01165320|3760153|FG000|Overall Study|Reason unknown|0
2148281|NCT01165320|3760154|FG001|Overall Study|Reason unknown|1
2148282|NCT01165320|3760155|FG002|Overall Study|Reason unknown|0
2148283|NCT01165554|3760167|FG000|Overall Study|Withdrawal by Subject|23
2148284|NCT01165684|3760176|FG000|Overall Study|Adverse Event|1
2148285|NCT01165684|3760177|FG001|Overall Study|Adverse Event|1
2148286|NCT01165684|3760176|FG000|Overall Study|Lack of Efficacy|2
2148287|NCT01165684|3760177|FG001|Overall Study|Lack of Efficacy|1
2148288|NCT01165684|3760176|FG000|Overall Study|Protocol Violation|7
2148289|NCT01165684|3760177|FG001|Overall Study|Protocol Violation|15
2148290|NCT01165684|3760176|FG000|Overall Study|Withdrawal Criteria|2
2148291|NCT01165684|3760177|FG001|Overall Study|Withdrawal Criteria|13
2148292|NCT01165684|3760176|FG000|Overall Study|Unclassified|16
2148293|NCT01165684|3760177|FG001|Overall Study|Unclassified|22
2148294|NCT01165996|3760206|FG000|Overall Study|Death|1
2148295|NCT01165996|3760206|FG000|Overall Study|Physician Decision|1
2148296|NCT01166282|3760230|FG000|Open-label Period|Adverse Event|0
2148297|NCT01166282|3760231|FG001|Open-label Period|Adverse Event|0
2148298|NCT01166282|3760232|FG002|Open-label Period|Adverse Event|6
2148299|NCT01166282|3760230|FG000|Open-label Period|Withdrawal by Subject|0
2148300|NCT01166282|3760231|FG001|Open-label Period|Withdrawal by Subject|0
2148301|NCT01166282|3760232|FG002|Open-label Period|Withdrawal by Subject|4
2148302|NCT01166282|3760230|FG000|Open-label Period|Lack of Efficacy|0
2148303|NCT01166282|3760231|FG001|Open-label Period|Lack of Efficacy|0
2148304|NCT01166282|3760232|FG002|Open-label Period|Lack of Efficacy|2
2148305|NCT01166282|3760230|FG000|Open-label Period|Remission|0
2148306|NCT01166282|3760231|FG001|Open-label Period|Remission|0
2148307|NCT01166282|3760232|FG002|Open-label Period|Remission|4
2148308|NCT01166282|3760230|FG000|Open-label Period|Irregular Compliance|0
2148309|NCT01166282|3760231|FG001|Open-label Period|Irregular Compliance|0
2148310|NCT01166282|3760232|FG002|Open-label Period|Irregular Compliance|1
2148311|NCT01166373|3760253|FG000|Overall Study|Lost to Follow-up|3
2148312|NCT01166373|3760254|FG001|Overall Study|Lost to Follow-up|2
2148313|NCT01166373|3760255|FG002|Overall Study|Lost to Follow-up|2
2148314|NCT01166373|3760256|FG003|Overall Study|Lost to Follow-up|2
2148315|NCT01166373|3760253|FG000|Overall Study|Withdrawal by Subject|1
2148316|NCT01166373|3760254|FG001|Overall Study|Withdrawal by Subject|2
2148317|NCT01166373|3760255|FG002|Overall Study|Withdrawal by Subject|2
2148318|NCT01166373|3760256|FG003|Overall Study|Withdrawal by Subject|3
2148319|NCT01166373|3760253|FG000|Overall Study|Physician Decision|1
2148320|NCT01166373|3760254|FG001|Overall Study|Physician Decision|0
2148321|NCT01166373|3760255|FG002|Overall Study|Physician Decision|0
2148322|NCT01166373|3760256|FG003|Overall Study|Physician Decision|0
2148323|NCT01166386|3760270|FG000|Overall Study|Withdrawal by Subject|3
2148324|NCT01166386|3760271|FG001|Overall Study|Withdrawal by Subject|5
2148325|NCT01166438|3760279|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
2148326|NCT01166438|3760280|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
2148327|NCT01166438|3760279|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
2148328|NCT01166438|3760280|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
2148329|NCT01166438|3760279|FG000|Double-blind Phase: 1st 6 Months|Not treated|1
2148330|NCT01166438|3760280|FG001|Double-blind Phase: 1st 6 Months|Not treated|1
2148331|NCT01166438|3760279|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1
2148332|NCT01166438|3760280|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2
2148333|NCT01166438|3760279|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4
2148334|NCT01166438|3760280|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2
2148335|NCT01166438|3760279|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29
2148336|NCT01166438|3760280|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52
2148337|NCT01166568|3760290|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0
2148338|NCT01166568|3760291|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0
2148339|NCT01166568|3760292|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1
2148340|NCT01166568|3760290|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
2148341|NCT01166568|3760291|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
2148342|NCT01166568|3760292|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
2148343|NCT01166568|3760290|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
2148344|NCT01166568|3760291|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
2148345|NCT01166568|3760292|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
2148346|NCT01166646|3760300|FG000|Overall Study|Protocol Violation|0
2148347|NCT01166646|3760301|FG001|Overall Study|Protocol Violation|1
2148348|NCT01166646|3760300|FG000|Overall Study|Adverse Event|1
2148349|NCT01166646|3760301|FG001|Overall Study|Adverse Event|0
2148350|NCT01166659|3760307|FG000|Overall Study|Subject Decision|8
2148351|NCT01166659|3760307|FG000|Overall Study|Investigator Decision|2
2148352|NCT01166659|3760307|FG000|Overall Study|Death|1
2148353|NCT01166659|3760307|FG000|Overall Study|Lost to Follow-up|1
2148354|NCT01166659|3760307|FG000|Overall Study|Study Closed at Site|1
2148355|NCT01166750|3760314|FG000|Overall Study|Lost to Follow-up|1
2148356|NCT01166750|3760315|FG001|Overall Study|Lost to Follow-up|0
2148357|NCT01166763|3760321|FG000|Overall Study|Withdrawal by Subject|3
2148358|NCT01166945|3760327|FG000|Randomized|diagnosed with Group A strep|4
2148359|NCT01166945|3760328|FG001|Randomized|diagnosed with Group A strep|4
2148360|NCT01166945|3760327|FG000|Day 10|NonCompliance/Lost to Follow Up|3
2148361|NCT01166945|3760328|FG001|Day 10|NonCompliance/Lost to Follow Up|2
2148362|NCT01166945|3760327|FG000|Day 15|NonCompliance/Lost to Follow Up|2
2148363|NCT01166945|3760328|FG001|Day 15|NonCompliance/Lost to Follow Up|1
2148364|NCT01166945|3760327|FG000|Day 30|Lost to Follow-up|4
2148365|NCT01166945|3760328|FG001|Day 30|Lost to Follow-up|3
2148366|NCT01166958|3760338|FG000|Overall Study|Withdrawal by Subject|1
2148367|NCT01166958|3760339|FG001|Overall Study|Withdrawal by Subject|0
2148368|NCT01167023|3760398|FG000|Overall Study|Lost to Follow-up|0
2148369|NCT01167023|3760399|FG001|Overall Study|Lost to Follow-up|1
2148370|NCT01167023|3760400|FG002|Overall Study|Lost to Follow-up|1
2148371|NCT01167023|3760398|FG000|Overall Study|Screen Failure|0
2148372|NCT01167023|3760399|FG001|Overall Study|Screen Failure|1
2148373|NCT01167023|3760400|FG002|Overall Study|Screen Failure|0
2148374|NCT01167023|3760398|FG000|Overall Study|Sponsor Decision|0
2148375|NCT01167023|3760399|FG001|Overall Study|Sponsor Decision|1
2148376|NCT01167023|3760400|FG002|Overall Study|Sponsor Decision|0
2148377|NCT01167023|3760398|FG000|Overall Study|Withdrawal by Subject|0
2148378|NCT01167023|3760399|FG001|Overall Study|Withdrawal by Subject|0
2148379|NCT01167023|3760400|FG002|Overall Study|Withdrawal by Subject|1
2148380|NCT01167140|3760406|FG000|Overall Study|Withdrawal by Subject|1
2148381|NCT01167153|3760412|FG000|Overall Study|Non-effective therapy|1
2148382|NCT01167153|3760413|FG001|Overall Study|Non-effective therapy|4
2148383|NCT01167153|3760412|FG000|Overall Study|AE including clinical laboratory AE|2
2148384|NCT01167153|3760413|FG001|Overall Study|AE including clinical laboratory AE|8
2148385|NCT01167153|3760412|FG000|Overall Study|Hypotension|1
2148386|NCT01167153|3760413|FG001|Overall Study|Hypotension|0
2148387|NCT01167153|3760412|FG000|Overall Study|Lost to Follow-up|7
2148388|NCT01167153|3760413|FG001|Overall Study|Lost to Follow-up|9
2148389|NCT01167153|3760412|FG000|Overall Study|Non-compliance to concomitant medication|0
2148390|NCT01167153|3760413|FG001|Overall Study|Non-compliance to concomitant medication|2
2148391|NCT01167153|3760412|FG000|Overall Study|Investigator initiation withdrawal,Other|1
2148392|NCT01167153|3760413|FG001|Overall Study|Investigator initiation withdrawal,Other|1
2148393|NCT01167153|3760412|FG000|Overall Study|Withdrawal consent|1
2148394|NCT01167153|3760413|FG001|Overall Study|Withdrawal consent|1
2148395|NCT01167153|3760412|FG000|Overall Study|Subject initiation withdrawal, Other|5
2148396|NCT01167153|3760413|FG001|Overall Study|Subject initiation withdrawal, Other|8
2148397|NCT01167179|3760421|FG000|Overall Study|disease recurrence|4
2148398|NCT01167179|3760422|FG001|Overall Study|disease recurrence|4
2148399|NCT01167179|3760421|FG000|Overall Study|Death|4
2148400|NCT01167179|3760422|FG001|Overall Study|Death|10
2148401|NCT01167179|3760421|FG000|Overall Study|Withdrawal by Subject|1
2148402|NCT01167179|3760422|FG001|Overall Study|Withdrawal by Subject|2
2148403|NCT01167179|3760421|FG000|Overall Study|diverse|6
2148404|NCT01167179|3760422|FG001|Overall Study|diverse|5
2148405|NCT01167192|3760428|FG000|Overall Study|Adverse Event|1
2148406|NCT01167192|3760428|FG000|Overall Study|Death|1
2148407|NCT01167192|3760428|FG000|Overall Study|Withdrawal by Subject|1
2148408|NCT01167192|3760428|FG000|Overall Study|Insurance denial|1
2148409|NCT01167257|3760434|FG000|Overall Study|Lost to Follow-up|2
2148410|NCT01167257|3760435|FG001|Overall Study|Lost to Follow-up|2
2148411|NCT01167257|3760434|FG000|Overall Study|Withdrew consent|1
2148412|NCT01167257|3760435|FG001|Overall Study|Withdrew consent|1
2148413|NCT01167426|3760445|FG000|Overall Study|Lost to Follow-up|6
2148414|NCT01167426|3760445|FG000|Overall Study|Protocol Violation|1
2148415|NCT01167426|3760445|FG000|Overall Study|Withdrawal by Subject|2
2148416|NCT01167426|3760445|FG000|Overall Study|Sponsor Decision|1
2148417|NCT01167582|3760472|FG000|Overall Study|Lost to Follow-up|0
2148418|NCT01167582|3760473|FG001|Overall Study|Lost to Follow-up|1
2148419|NCT01167634|3760497|FG000|Overall Study|Lost to Follow-up|1
2148420|NCT01167634|3760498|FG001|Overall Study|Lost to Follow-up|3
2148421|NCT01167634|3760499|FG002|Overall Study|Lost to Follow-up|3
2148422|NCT01167634|3760500|FG003|Overall Study|Lost to Follow-up|4
2148423|NCT01167634|3760497|FG000|Overall Study|Withdrawal by Subject|1
2148424|NCT01167634|3760498|FG001|Overall Study|Withdrawal by Subject|1
2148425|NCT01167634|3760499|FG002|Overall Study|Withdrawal by Subject|0
2148426|NCT01167634|3760500|FG003|Overall Study|Withdrawal by Subject|0
2148427|NCT01167881|3760527|FG000|Overall Study|Adverse Event|47
2148428|NCT01167881|3760528|FG001|Overall Study|Adverse Event|51
2148429|NCT01167881|3760527|FG000|Overall Study|Lack of Efficacy|4
2148430|NCT01167881|3760528|FG001|Overall Study|Lack of Efficacy|7
2148431|NCT01167881|3760527|FG000|Overall Study|Non compliant with protocol|9
2148432|NCT01167881|3760528|FG001|Overall Study|Non compliant with protocol|18
2148433|NCT01167881|3760527|FG000|Overall Study|Lost to Follow-up|19
2148434|NCT01167881|3760528|FG001|Overall Study|Lost to Follow-up|20
2148435|NCT01167881|3760527|FG000|Overall Study|Patient refusal to cont., not due to AE|45
2148436|NCT01167881|3760528|FG001|Overall Study|Patient refusal to cont., not due to AE|40
2148437|NCT01167881|3760527|FG000|Overall Study|Not treated|4
2148438|NCT01167881|3760528|FG001|Overall Study|Not treated|0
2148439|NCT01167881|3760527|FG000|Overall Study|Other not defined above|31
2148440|NCT01167881|3760528|FG001|Overall Study|Other not defined above|55
2148441|NCT01167907|3760536|FG000|Overall Study|Protocol Violation|1
2148442|NCT01167907|3760537|FG001|Overall Study|Protocol Violation|0
2148443|NCT01167907|3760536|FG000|Overall Study|saphenous catheter dislodged before comp|1
2148444|NCT01167907|3760537|FG001|Overall Study|saphenous catheter dislodged before comp|1
2148445|NCT01168232|3760552|FG000|Overall Study|Ineligible-Second primary cancer site|1
2148446|NCT01168232|3760552|FG000|Overall Study|Ineligible- Wrong cell type|6
2148447|NCT01168232|3760552|FG000|Overall Study|Ineligible-Inadequate pathology|1
2148448|NCT01168349|3760556|FG000|Overall Study|Death|157
2148449|NCT01168349|3760556|FG000|Overall Study|Lost to Follow-up|34
2148450|NCT01168349|3760556|FG000|Overall Study|Withdrawal by Subject|9
2148451|NCT01168349|3760556|FG000|Overall Study|Kidney transplantation|3
2148452|NCT01168349|3760556|FG000|Overall Study|Other|22
2148453|NCT01168349|3760556|FG000|Overall Study|Protocol Violation|76
2148454|NCT01168401|3760587|FG000|Overall Study|Lost to Follow-up|1
2148455|NCT01168401|3760588|FG001|Overall Study|Lost to Follow-up|1
2148456|NCT01168401|3760589|FG002|Overall Study|Lost to Follow-up|2
2148457|NCT01168401|3760590|FG003|Overall Study|Lost to Follow-up|1
2148458|NCT01168401|3760591|FG004|Overall Study|Lost to Follow-up|0
2148459|NCT01168401|3760592|FG005|Overall Study|Lost to Follow-up|0
2148460|NCT01168401|3760593|FG006|Overall Study|Lost to Follow-up|0
2148461|NCT01168401|3760594|FG007|Overall Study|Lost to Follow-up|0
2148462|NCT01168401|3760595|FG008|Overall Study|Lost to Follow-up|0
2148463|NCT01168401|3760596|FG009|Overall Study|Lost to Follow-up|0
2148464|NCT01168401|3760597|FG010|Overall Study|Lost to Follow-up|0
2148465|NCT01168401|3760587|FG000|Overall Study|Withdrawal by Subject|0
2148466|NCT01168401|3760588|FG001|Overall Study|Withdrawal by Subject|0
2148467|NCT01168401|3760589|FG002|Overall Study|Withdrawal by Subject|0
2148468|NCT01168401|3760590|FG003|Overall Study|Withdrawal by Subject|1
2148469|NCT01168401|3760591|FG004|Overall Study|Withdrawal by Subject|0
2148470|NCT01168401|3760592|FG005|Overall Study|Withdrawal by Subject|0
2148471|NCT01168401|3760593|FG006|Overall Study|Withdrawal by Subject|0
2148472|NCT01168401|3760594|FG007|Overall Study|Withdrawal by Subject|0
2148473|NCT01168401|3760595|FG008|Overall Study|Withdrawal by Subject|0
2148474|NCT01168401|3760596|FG009|Overall Study|Withdrawal by Subject|0
2148475|NCT01168401|3760597|FG010|Overall Study|Withdrawal by Subject|0
2148476|NCT01168427|3760621|FG000|Overall Study|Patient exited prior to implant|1
2148477|NCT01168596|3760627|FG000|Overall Study|Withdrawal by Subject|3
2148478|NCT01168596|3760628|FG001|Overall Study|Withdrawal by Subject|1
2148479|NCT01168856|3760666|FG000|Overall Study|Lost to Follow-up|4
2148480|NCT01168856|3760667|FG001|Overall Study|Lost to Follow-up|34
2148481|NCT01168856|3760666|FG000|Overall Study|Withdrawal by Subject|6
2148482|NCT01168856|3760667|FG001|Overall Study|Withdrawal by Subject|8
2148483|NCT01168856|3760666|FG000|Overall Study|Physician Decision|2
2148484|NCT01168856|3760667|FG001|Overall Study|Physician Decision|1
2148485|NCT01168856|3760666|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0
2148486|NCT01168856|3760667|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1
2148487|NCT01168856|3760666|FG000|Overall Study|Participant received anti-HCV treatment|1
2148488|NCT01168856|3760667|FG001|Overall Study|Participant received anti-HCV treatment|0
2148489|NCT01168856|3760666|FG000|Overall Study|Death|0
2148490|NCT01168856|3760667|FG001|Overall Study|Death|2
2148491|NCT01168856|3760666|FG000|Overall Study|Other|1
2148492|NCT01168856|3760667|FG001|Overall Study|Other|291
2148493|NCT01168856|3760666|FG000|Overall Study|Protocol Violation|4
2148494|NCT01168856|3760667|FG001|Overall Study|Protocol Violation|6
2179054|NCT01390948|3804418|FG002|Overall Study|End of Study|0
2179055|NCT01390948|3804416|FG000|Overall Study|Withdrew consent|2
2179056|NCT01390948|3804417|FG001|Overall Study|Withdrew consent|2
2179057|NCT01390948|3804418|FG002|Overall Study|Withdrew consent|0
2179058|NCT01390948|3804416|FG000|Overall Study|Progressive Disease|2
2179059|NCT01390948|3804417|FG001|Overall Study|Progressive Disease|5
2179060|NCT01390948|3804418|FG002|Overall Study|Progressive Disease|0
2179061|NCT01390948|3804416|FG000|Overall Study|Death during follow-up|10
2179062|NCT01390948|3804417|FG001|Overall Study|Death during follow-up|11
2179063|NCT01390948|3804418|FG002|Overall Study|Death during follow-up|1
2179064|NCT01391000|3804427|FG000|Overall Study|Lost to Follow-up|2
2179065|NCT01391000|3804428|FG001|Overall Study|Lost to Follow-up|0
2179066|NCT01391130|3804445|FG000|Overall Study|Withdrawal by Subject|3
2179067|NCT01391130|3804446|FG001|Overall Study|Withdrawal by Subject|2
2179068|NCT01391130|3804445|FG000|Overall Study|Physician Decision|2
2179069|NCT01391130|3804446|FG001|Overall Study|Physician Decision|3
2179070|NCT01391130|3804445|FG000|Overall Study|Did not Receive Drug|1
2179071|NCT01391130|3804446|FG001|Overall Study|Did not Receive Drug|1
2179072|NCT01391507|3804523|FG000|Overall Study|Death|0
2179073|NCT01391507|3804524|FG001|Overall Study|Death|0
2179074|NCT01391507|3804525|FG002|Overall Study|Death|0
2179075|NCT01391507|3804526|FG003|Overall Study|Death|1
2179076|NCT01391507|3804523|FG000|Overall Study|Adverse Event|1
2179077|NCT01391507|3804524|FG001|Overall Study|Adverse Event|1
2179078|NCT01391507|3804525|FG002|Overall Study|Adverse Event|2
2179079|NCT01391507|3804526|FG003|Overall Study|Adverse Event|2
2179080|NCT01391507|3804523|FG000|Overall Study|Withdrawal by Subject|1
2179081|NCT01391507|3804524|FG001|Overall Study|Withdrawal by Subject|2
2179082|NCT01391507|3804525|FG002|Overall Study|Withdrawal by Subject|1
2179083|NCT01391507|3804526|FG003|Overall Study|Withdrawal by Subject|1
2179084|NCT01391507|3804523|FG000|Overall Study|Lack of Efficacy|0
2179085|NCT01391507|3804524|FG001|Overall Study|Lack of Efficacy|0
2179086|NCT01391507|3804525|FG002|Overall Study|Lack of Efficacy|0
2179087|NCT01391507|3804526|FG003|Overall Study|Lack of Efficacy|1
2179088|NCT01391507|3804523|FG000|Overall Study|Protocol Violation|2
2179089|NCT01391507|3804524|FG001|Overall Study|Protocol Violation|1
2179090|NCT01391507|3804525|FG002|Overall Study|Protocol Violation|1
2179091|NCT01391507|3804526|FG003|Overall Study|Protocol Violation|2
2179092|NCT01391546|3804538|FG000|Overall Study|History of Herpes Zoster (HZ)|1
2179093|NCT01391546|3804539|FG001|Overall Study|History of Herpes Zoster (HZ)|0
2179094|NCT01391663|3804561|FG000|Overall Study|Withdrawal by Subject|0
2179095|NCT01391663|3804562|FG001|Overall Study|Withdrawal by Subject|0
2179096|NCT01391663|3804563|FG002|Overall Study|Withdrawal by Subject|1
2179097|NCT01391663|3804564|FG003|Overall Study|Withdrawal by Subject|0
2179098|NCT01391793|3804576|FG000|Overall Study|Ineligible|3
2179099|NCT01391793|3804577|FG001|Overall Study|Ineligible|0
2179100|NCT01391793|3804576|FG000|Overall Study|Urine Culture Negative or Indeterminate|71
2179101|NCT01391793|3804577|FG001|Overall Study|Urine Culture Negative or Indeterminate|87
2179102|NCT01391793|3804576|FG000|Overall Study|No DMSA|73
2179103|NCT01391793|3804577|FG001|Overall Study|No DMSA|57
2148495|NCT01168973|3760697|FG000|Overall Study|Progressive Disease|341
2148496|NCT01168973|3760698|FG001|Overall Study|Progressive Disease|429
2148497|NCT01168973|3760697|FG000|Overall Study|Adverse Event|94
2148498|NCT01168973|3760698|FG001|Overall Study|Adverse Event|55
2148499|NCT01168973|3760697|FG000|Overall Study|Withdrawal by Subject|90
2148500|NCT01168973|3760698|FG001|Overall Study|Withdrawal by Subject|53
2148501|NCT01168973|3760697|FG000|Overall Study|Death|42
2148502|NCT01168973|3760698|FG001|Overall Study|Death|45
2148503|NCT01168973|3760697|FG000|Overall Study|Physician Decision|37
2148504|NCT01168973|3760698|FG001|Overall Study|Physician Decision|19
2148505|NCT01168973|3760697|FG000|Overall Study|Sponsor Decision|2
2148506|NCT01168973|3760698|FG001|Overall Study|Sponsor Decision|1
2148507|NCT01168973|3760697|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7
2148508|NCT01168973|3760698|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9
2148509|NCT01168999|3760721|FG000|Overall Study|Lost to Follow-up|2
2148510|NCT01168999|3760722|FG001|Overall Study|Lost to Follow-up|1
2148511|NCT01168999|3760723|FG002|Overall Study|Lost to Follow-up|0
2148512|NCT01168999|3760724|FG003|Overall Study|Lost to Follow-up|0
2148513|NCT01169038|3760734|FG000|Overall Study|Death|1
2148514|NCT01169038|3760734|FG000|Overall Study|Adverse Event|5
2148515|NCT01169038|3760734|FG000|Overall Study|Required antibiotic administration|1
2148516|NCT01169103|3760751|FG000|Overall Study|Lost to Follow-up|3
2148517|NCT01169103|3760752|FG001|Overall Study|Lost to Follow-up|3
2148518|NCT01169103|3760751|FG000|Overall Study|Withdrawal by Subject|3
2148519|NCT01169103|3760752|FG001|Overall Study|Withdrawal by Subject|1
2148520|NCT01169337|3760785|FG000|Overall Study|Lack of Efficacy|5
2148521|NCT01169337|3760786|FG001|Overall Study|Lack of Efficacy|7
2148522|NCT01169337|3760787|FG002|Overall Study|Lack of Efficacy|0
2148523|NCT01169337|3760785|FG000|Overall Study|Adverse Event|12
2148524|NCT01169337|3760786|FG001|Overall Study|Adverse Event|18
2148525|NCT01169337|3760787|FG002|Overall Study|Adverse Event|0
2148526|NCT01169337|3760785|FG000|Overall Study|Death|2
2148527|NCT01169337|3760786|FG001|Overall Study|Death|0
2148528|NCT01169337|3760787|FG002|Overall Study|Death|0
2148529|NCT01169337|3760785|FG000|Overall Study|Withdrawal by Subject|11
2148530|NCT01169337|3760786|FG001|Overall Study|Withdrawal by Subject|11
2148531|NCT01169337|3760787|FG002|Overall Study|Withdrawal by Subject|6
2148532|NCT01169337|3760785|FG000|Overall Study|Noncompliance|2
2148533|NCT01169337|3760786|FG001|Overall Study|Noncompliance|0
2148534|NCT01169337|3760787|FG002|Overall Study|Noncompliance|0
2148535|NCT01169337|3760785|FG000|Overall Study|Other complicating disease|1
2148536|NCT01169337|3760786|FG001|Overall Study|Other complicating disease|1
2148537|NCT01169337|3760787|FG002|Overall Study|Other complicating disease|0
2148538|NCT01169337|3760785|FG000|Overall Study|Physician Decision|1
2148539|NCT01169337|3760786|FG001|Overall Study|Physician Decision|5
2148540|NCT01169337|3760787|FG002|Overall Study|Physician Decision|0
2148541|NCT01169337|3760785|FG000|Overall Study|Alternative therapy|0
2148542|NCT01169337|3760786|FG001|Overall Study|Alternative therapy|2
2148543|NCT01169337|3760787|FG002|Overall Study|Alternative therapy|0
2148544|NCT01169337|3760785|FG000|Overall Study|Changed hospital|0
2148545|NCT01169337|3760786|FG001|Overall Study|Changed hospital|1
2148546|NCT01169337|3760787|FG002|Overall Study|Changed hospital|0
2148547|NCT01169337|3760785|FG000|Overall Study|Never started treatment|0
2148548|NCT01169337|3760786|FG001|Overall Study|Never started treatment|2
2148549|NCT01169337|3760787|FG002|Overall Study|Never started treatment|0
2148550|NCT01169337|3760785|FG000|Overall Study|Reason not reported|1
2148551|NCT01169337|3760786|FG001|Overall Study|Reason not reported|0
2148552|NCT01169337|3760787|FG002|Overall Study|Reason not reported|0
2148553|NCT01169337|3760785|FG000|Overall Study|Continuing lenalidomide|9
2148554|NCT01169337|3760786|FG001|Overall Study|Continuing lenalidomide|43
2148555|NCT01169337|3760787|FG002|Overall Study|Continuing lenalidomide|0
2148556|NCT01169350|3760795|FG000|Overall Study|Physician Decision|3
2148557|NCT01169350|3760795|FG000|Overall Study|Lost to Follow-up|2
2148558|NCT01169493|3760814|FG000|Period 1 (6 Months)|Withdrawal by Subject|0
2148559|NCT01169493|3760815|FG001|Period 1 (6 Months)|Withdrawal by Subject|1
2148560|NCT01169493|3760816|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
2148561|NCT01169493|3760817|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
2148562|NCT01169493|3760818|FG004|Period 1 (6 Months)|Withdrawal by Subject|0
2148563|NCT01169493|3760819|FG005|Period 1 (6 Months)|Withdrawal by Subject|3
2148564|NCT01169493|3760814|FG000|Period 3 (6 Months)|Adverse Event|0
2148565|NCT01169493|3760815|FG001|Period 3 (6 Months)|Adverse Event|1
2148566|NCT01169493|3760816|FG002|Period 3 (6 Months)|Adverse Event|0
2148567|NCT01169493|3760817|FG003|Period 3 (6 Months)|Adverse Event|0
2148568|NCT01169493|3760818|FG004|Period 3 (6 Months)|Adverse Event|0
2148569|NCT01169493|3760819|FG005|Period 3 (6 Months)|Adverse Event|0
2148570|NCT01169493|3760814|FG000|Period 3 (6 Months)|Physician Decision|0
2148571|NCT01169493|3760815|FG001|Period 3 (6 Months)|Physician Decision|1
2148572|NCT01169493|3760816|FG002|Period 3 (6 Months)|Physician Decision|1
2148573|NCT01169493|3760817|FG003|Period 3 (6 Months)|Physician Decision|0
2148574|NCT01169493|3760818|FG004|Period 3 (6 Months)|Physician Decision|0
2148575|NCT01169493|3760819|FG005|Period 3 (6 Months)|Physician Decision|0
2148576|NCT01169532|3760839|FG000|Overall Study|Withdrawal by Subject|1
2148577|NCT01169558|3760843|FG000|Overall Study|Disease progression|98
2148578|NCT01169558|3760843|FG000|Overall Study|Adverse Event|25
2148579|NCT01169558|3760843|FG000|Overall Study|Withdrawal of Consent|8
2148580|NCT01169558|3760843|FG000|Overall Study|Medical Decision|7
2148581|NCT01169558|3760843|FG000|Overall Study|Stable Disease|4
2148582|NCT01169558|3760843|FG000|Overall Study|Lost to Follow-up|4
2148583|NCT01169558|3760843|FG000|Overall Study|Need for Surgery|4
2148584|NCT01169558|3760843|FG000|Overall Study|Non-compliance|2
2148585|NCT01169558|3760843|FG000|Overall Study|Protocol Violation|2
2148586|NCT01169558|3760843|FG000|Overall Study|Partial response|2
2148587|NCT01169636|3760852|FG000|Overall Study|Adverse Event|0
2148588|NCT01169636|3760853|FG001|Overall Study|Adverse Event|0
2148589|NCT01169636|3760854|FG002|Overall Study|Adverse Event|1
2148590|NCT01169636|3760855|FG003|Overall Study|Adverse Event|1
2148591|NCT01169636|3760856|FG004|Overall Study|Adverse Event|0
2148592|NCT01169636|3760852|FG000|Overall Study|Screen failure|0
2148593|NCT01169636|3760853|FG001|Overall Study|Screen failure|0
2148594|NCT01169636|3760854|FG002|Overall Study|Screen failure|2
2148595|NCT01169636|3760855|FG003|Overall Study|Screen failure|0
2148596|NCT01169636|3760856|FG004|Overall Study|Screen failure|0
2148597|NCT01169636|3760852|FG000|Overall Study|Withdrawal by Subject|0
2148598|NCT01169636|3760853|FG001|Overall Study|Withdrawal by Subject|0
2148599|NCT01169636|3760854|FG002|Overall Study|Withdrawal by Subject|0
2148600|NCT01169636|3760855|FG003|Overall Study|Withdrawal by Subject|0
2148601|NCT01169636|3760856|FG004|Overall Study|Withdrawal by Subject|3
2148602|NCT01169649|3760866|FG000|Overall Study|Patient Not Treated|3
2148603|NCT01169675|3760875|FG000|Overall Study|Progressive disease|13
2148604|NCT01169675|3760876|FG001|Overall Study|Progressive disease|2
2148605|NCT01169675|3760877|FG002|Overall Study|Progressive disease|5
2148606|NCT01169675|3760878|FG003|Overall Study|Progressive disease|15
2148607|NCT01169675|3760879|FG004|Overall Study|Progressive disease|1
2148608|NCT01169675|3760875|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1
2148609|NCT01169675|3760876|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
2148610|NCT01169675|3760877|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
2148611|NCT01169675|3760878|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
2148612|NCT01169675|3760879|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2
2148613|NCT01169675|3760875|FG000|Overall Study|Adverse Event|5
2148614|NCT01169675|3760876|FG001|Overall Study|Adverse Event|1
2148615|NCT01169675|3760877|FG002|Overall Study|Adverse Event|2
2148616|NCT01169675|3760878|FG003|Overall Study|Adverse Event|0
2148617|NCT01169675|3760879|FG004|Overall Study|Adverse Event|0
2148618|NCT01169675|3760875|FG000|Overall Study|Withdrawal by Subject|1
2148619|NCT01169675|3760876|FG001|Overall Study|Withdrawal by Subject|0
2148620|NCT01169675|3760877|FG002|Overall Study|Withdrawal by Subject|0
2148621|NCT01169675|3760878|FG003|Overall Study|Withdrawal by Subject|1
2148622|NCT01169675|3760879|FG004|Overall Study|Withdrawal by Subject|2
2148623|NCT01169675|3760875|FG000|Overall Study|Other Reason Not Defined Above|0
2148624|NCT01169675|3760876|FG001|Overall Study|Other Reason Not Defined Above|0
2148625|NCT01169675|3760877|FG002|Overall Study|Other Reason Not Defined Above|0
2148626|NCT01169675|3760878|FG003|Overall Study|Other Reason Not Defined Above|1
2148627|NCT01169675|3760879|FG004|Overall Study|Other Reason Not Defined Above|1
2148628|NCT01169701|3760893|FG000|Overall Study|Lost to Follow-up|1
2148629|NCT01169701|3760894|FG001|Overall Study|Lost to Follow-up|1
2148630|NCT01169701|3760893|FG000|Overall Study|Withdrawal by Subject|1
2148631|NCT01169701|3760894|FG001|Overall Study|Withdrawal by Subject|3
2148632|NCT01169701|3760893|FG000|Overall Study|Adverse Event|1
2148633|NCT01169701|3760894|FG001|Overall Study|Adverse Event|2
2148634|NCT01169701|3760893|FG000|Overall Study|Exclusion criteria|2
2148635|NCT01169701|3760894|FG001|Overall Study|Exclusion criteria|0
2148636|NCT01169701|3760893|FG000|Overall Study|Death|0
2148637|NCT01169701|3760894|FG001|Overall Study|Death|1
2148638|NCT01169701|3760893|FG000|Overall Study|Administrative problems|0
2148639|NCT01169701|3760894|FG001|Overall Study|Administrative problems|1
2148640|NCT01169701|3760893|FG000|Overall Study|Serious adverse event|0
2148641|NCT01169701|3760894|FG001|Overall Study|Serious adverse event|1
2148642|NCT01169701|3760893|FG000|Overall Study|Sponsor decision|0
2148643|NCT01169701|3760894|FG001|Overall Study|Sponsor decision|1
2148644|NCT01169779|3760902|FG000|Overall Study|Adverse Event|3
2148645|NCT01169779|3760903|FG001|Overall Study|Adverse Event|11
2148646|NCT01169779|3760902|FG000|Overall Study|Lack of Efficacy|1
2148647|NCT01169779|3760903|FG001|Overall Study|Lack of Efficacy|0
2148648|NCT01169779|3760902|FG000|Overall Study|Protocol Violation|1
2148649|NCT01169779|3760903|FG001|Overall Study|Protocol Violation|1
2148650|NCT01169779|3760902|FG000|Overall Study|Withdrawal by Subject|3
2148651|NCT01169779|3760903|FG001|Overall Study|Withdrawal by Subject|2
2148652|NCT01169779|3760902|FG000|Overall Study|Familial and personal reasons|3
2148653|NCT01169779|3760903|FG001|Overall Study|Familial and personal reasons|3
2148654|NCT01169844|3760911|FG000|Overall Study|Adverse Event|0
2148655|NCT01169844|3760912|FG001|Overall Study|Adverse Event|1
2148656|NCT01169844|3760911|FG000|Overall Study|Patient withdrew consent|4
2148657|NCT01169844|3760912|FG001|Overall Study|Patient withdrew consent|0
2148658|NCT01169844|3760911|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2148659|NCT01169844|3760912|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2148660|NCT01169987|3760918|FG000|Overall Study|Withdrawal by Subject|3
2148661|NCT01169987|3760918|FG000|Overall Study|Lost to Follow-up|24
2148662|NCT01169987|3760918|FG000|Overall Study|Other|4
2148663|NCT01170039|3760930|FG000|Overall Study|Withdrawal by Subject|5
2148664|NCT01170039|3760931|FG001|Overall Study|Withdrawal by Subject|3
2148665|NCT01170039|3760930|FG000|Overall Study|Lack of funding, drug not available|3
2148666|NCT01170039|3760931|FG001|Overall Study|Lack of funding, drug not available|3
2148667|NCT01170065|3760940|FG000|Overall Study|Adverse Event|17
2148668|NCT01170065|3760941|FG001|Overall Study|Adverse Event|50
2148669|NCT01170065|3760942|FG002|Overall Study|Adverse Event|10
2148670|NCT01170065|3760940|FG000|Overall Study|Lost to Follow-up|1
2148671|NCT01170065|3760941|FG001|Overall Study|Lost to Follow-up|4
2148672|NCT01170065|3760942|FG002|Overall Study|Lost to Follow-up|1
2148673|NCT01170065|3760940|FG000|Overall Study|Consent withdrawn, not due to AE|2
2148674|NCT01170065|3760941|FG001|Overall Study|Consent withdrawn, not due to AE|4
2148675|NCT01170065|3760942|FG002|Overall Study|Consent withdrawn, not due to AE|2
2148676|NCT01170065|3760940|FG000|Overall Study|Reason other than specified|3
2148677|NCT01170065|3760941|FG001|Overall Study|Reason other than specified|8
2148678|NCT01170065|3760942|FG002|Overall Study|Reason other than specified|3
2148679|NCT01170065|3760940|FG000|Overall Study|Ongoing after planned observation time|5
2148680|NCT01170065|3760941|FG001|Overall Study|Ongoing after planned observation time|26
2148681|NCT01170065|3760942|FG002|Overall Study|Ongoing after planned observation time|10
2148682|NCT01170091|3760950|FG000|Overall Study|Missing efficacy evaluation|3
2148683|NCT01170091|3760950|FG000|Overall Study|Treatment duration is less than 4 weeks|21
2148684|NCT01170208|3760966|FG000|Overall Study|Withdrawal by Subject|5
2148685|NCT01170208|3760967|FG001|Overall Study|Withdrawal by Subject|0
2148686|NCT01170208|3760968|FG002|Overall Study|Withdrawal by Subject|1
2148687|NCT01170208|3760966|FG000|Overall Study|Protocol Violation|1
2148688|NCT01170208|3760967|FG001|Overall Study|Protocol Violation|0
2148689|NCT01170208|3760968|FG002|Overall Study|Protocol Violation|1
2148690|NCT01170221|3760981|FG000|Overall Study|Lost to Follow-up|22
2148691|NCT01170221|3760982|FG001|Overall Study|Lost to Follow-up|21
2148692|NCT01170221|3760981|FG000|Overall Study|Withdrawal by Subject|9
2148693|NCT01170221|3760982|FG001|Overall Study|Withdrawal by Subject|7
2148694|NCT01170221|3760981|FG000|Overall Study|Subject completed only screening and LFU|1
2148695|NCT01170221|3760982|FG001|Overall Study|Subject completed only screening and LFU|0
2148696|NCT01170221|3760981|FG000|Overall Study|Randomized but not treated|1
2148697|NCT01170221|3760982|FG001|Overall Study|Randomized but not treated|0
2148698|NCT01170273|3760999|FG000|Overall Study|Lost to Follow-up|6
2148699|NCT01170273|3761000|FG001|Overall Study|Lost to Follow-up|8
2148700|NCT01170273|3760999|FG000|Overall Study|Protocol Violation|1
2148701|NCT01170273|3761000|FG001|Overall Study|Protocol Violation|0
2148702|NCT01170273|3760999|FG000|Overall Study|Death|1
2148703|NCT01170273|3761000|FG001|Overall Study|Death|0
2148704|NCT01170273|3760999|FG000|Overall Study|Adverse Event|0
2148705|NCT01170273|3761000|FG001|Overall Study|Adverse Event|1
2148706|NCT01170364|3761008|FG000|Overall Study|Protocol Violation|4
2148707|NCT01170364|3761009|FG001|Overall Study|Protocol Violation|1
2148708|NCT01170598|3761055|FG000|Overall Study|Withdrawal by Subject|1
2148709|NCT01170598|3761055|FG000|Overall Study|Death|3
2148710|NCT01170598|3761055|FG000|Overall Study|Lost to Follow-up|1
2148711|NCT01170598|3761055|FG000|Overall Study|Refused|1
2148712|NCT01170663|3761061|FG000|Overall Study|Lost to Follow-up|3
2148713|NCT01170663|3761062|FG001|Overall Study|Lost to Follow-up|9
2148714|NCT01170663|3761061|FG000|Overall Study|Withdrawal of consent without follow-up|11
2148715|NCT01170663|3761062|FG001|Overall Study|Withdrawal of consent without follow-up|11
2148716|NCT01170962|3761104|FG000|Treatment Period|Lack of Efficacy|96
2148717|NCT01170962|3761105|FG001|Treatment Period|Lack of Efficacy|91
2148718|NCT01170962|3761106|FG002|Treatment Period|Lack of Efficacy|7
2148719|NCT01170962|3761104|FG000|Treatment Period|Adverse Event|11
2148720|NCT01170962|3761105|FG001|Treatment Period|Adverse Event|12
2148721|NCT01170962|3761106|FG002|Treatment Period|Adverse Event|3
2148722|NCT01170962|3761104|FG000|Treatment Period|Withdrawal by Subject|2
2148723|NCT01170962|3761105|FG001|Treatment Period|Withdrawal by Subject|1
2148724|NCT01170962|3761106|FG002|Treatment Period|Withdrawal by Subject|0
2148725|NCT01170962|3761104|FG000|Treatment Period|Lost to Follow-up|1
2148726|NCT01170962|3761105|FG001|Treatment Period|Lost to Follow-up|1
2148727|NCT01170962|3761106|FG002|Treatment Period|Lost to Follow-up|1
2148728|NCT01170962|3761104|FG000|Treatment Period|Participant no longer meets criteria|0
2148729|NCT01170962|3761105|FG001|Treatment Period|Participant no longer meets criteria|1
2148730|NCT01170962|3761106|FG002|Treatment Period|Participant no longer meets criteria|0
2148731|NCT01170962|3761104|FG000|Treatment Period|Request to discontinue treatment|7
2148732|NCT01170962|3761105|FG001|Treatment Period|Request to discontinue treatment|3
2148733|NCT01170962|3761106|FG002|Treatment Period|Request to discontinue treatment|1
2148734|NCT01170962|3761104|FG000|Treatment Period|Completed 24 Week treatment period only|10
2148735|NCT01170962|3761105|FG001|Treatment Period|Completed 24 Week treatment period only|2
2148736|NCT01170962|3761106|FG002|Treatment Period|Completed 24 Week treatment period only|0
2148737|NCT01170962|3761104|FG000|Follow up Period|Withdrawal by Subject|14
2148738|NCT01170962|3761105|FG001|Follow up Period|Withdrawal by Subject|10
2148739|NCT01170962|3761106|FG002|Follow up Period|Withdrawal by Subject|2
2148740|NCT01170962|3761104|FG000|Follow up Period|Lost to Follow-up|13
2148741|NCT01170962|3761105|FG001|Follow up Period|Lost to Follow-up|8
2148742|NCT01170962|3761106|FG002|Follow up Period|Lost to Follow-up|1
2148743|NCT01170962|3761104|FG000|Follow up Period|Death|2
2148744|NCT01170962|3761105|FG001|Follow up Period|Death|2
2148745|NCT01170962|3761106|FG002|Follow up Period|Death|0
2148746|NCT01170962|3761104|FG000|Follow up Period|Others|10
2148747|NCT01170962|3761105|FG001|Follow up Period|Others|7
2148748|NCT01170962|3761106|FG002|Follow up Period|Others|3
2148749|NCT01171183|3761135|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
2148750|NCT01171183|3761136|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
2148751|NCT01171183|3761135|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0
2148752|NCT01171183|3761136|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1
2148753|NCT01171183|3761135|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
2148754|NCT01171183|3761136|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
2148755|NCT01171183|3761135|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
2148756|NCT01171183|3761136|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
2148757|NCT01171183|3761135|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
2148758|NCT01171183|3761136|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
2148759|NCT01171183|3761135|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
2148760|NCT01171183|3761136|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
2148761|NCT01171521|3761142|FG000|Overall Study|Lost to Follow-up|5
2148762|NCT01171521|3761142|FG000|Overall Study|screen failure|1
2148763|NCT01171612|3761146|FG000|Overall Study|Lost to Follow-up|51
2148764|NCT01171625|3761153|FG000|Overall Study|On-Protocol|67
2148765|NCT01171625|3761153|FG000|Overall Study|Death|38
2148766|NCT01171625|3761153|FG000|Overall Study|Withdrawal by Subject|31
2148767|NCT01171625|3761153|FG000|Overall Study|Explanted|10
2148768|NCT01171625|3761153|FG000|Overall Study|Lost to Follow-up|5
2148769|NCT01171625|3761153|FG000|Overall Study|Patient received valve-in-valve|3
2148770|NCT01171625|3761153|FG000|Overall Study|Other|1
2148771|NCT01171625|3761153|FG000|Overall Study|Consented but did not receive device|25
2148772|NCT01171677|3761167|FG000|Overall Study|Withdrawal by Subject|0
2148773|NCT01171677|3761168|FG001|Overall Study|Withdrawal by Subject|3
2148774|NCT01171677|3761167|FG000|Overall Study|Adverse Event|1
2148775|NCT01171677|3761168|FG001|Overall Study|Adverse Event|0
2148776|NCT01171677|3761167|FG000|Overall Study|completed <70% IntenSati classes|5
2148777|NCT01171677|3761168|FG001|Overall Study|completed <70% IntenSati classes|0
2148778|NCT01171820|3761194|FG000|Overall Study|Death|3
2148779|NCT01171820|3761195|FG001|Overall Study|Death|3
2148780|NCT01171820|3761194|FG000|Overall Study|Lost to Follow-up|0
2148781|NCT01171820|3761195|FG001|Overall Study|Lost to Follow-up|1
2148782|NCT01171820|3761194|FG000|Overall Study|Withdrawal by Subject|2
2148783|NCT01171820|3761195|FG001|Overall Study|Withdrawal by Subject|0
2148784|NCT01171820|3761194|FG000|Overall Study|Physician Decision|0
2148785|NCT01171820|3761195|FG001|Overall Study|Physician Decision|1
2148786|NCT01171820|3761194|FG000|Overall Study|1-Year Missed Visit|1
2148787|NCT01171820|3761195|FG001|Overall Study|1-Year Missed Visit|1
2148788|NCT01171963|3761212|FG000|Overall Study|Adverse Event|10
2148789|NCT01171963|3761213|FG001|Overall Study|Adverse Event|15
2148790|NCT01171963|3761212|FG000|Overall Study|Lost to Follow-up|23
2148791|NCT01171963|3761213|FG001|Overall Study|Lost to Follow-up|24
2148792|NCT01171963|3761212|FG000|Overall Study|Other - diarrhoea|1
2148793|NCT01171963|3761213|FG001|Overall Study|Other - diarrhoea|0
2148794|NCT01171963|3761212|FG000|Overall Study|Withdrawal by Subject|114
2148795|NCT01171963|3761213|FG001|Overall Study|Withdrawal by Subject|129
2148796|NCT01171976|3761225|FG000|Overall Study|Protocol Violation|0
2148797|NCT01171976|3761226|FG001|Overall Study|Protocol Violation|0
2148798|NCT01171976|3761227|FG002|Overall Study|Protocol Violation|1
2148799|NCT01171976|3761225|FG000|Overall Study|Death|2
2148800|NCT01171976|3761226|FG001|Overall Study|Death|4
2148801|NCT01171976|3761227|FG002|Overall Study|Death|1
2148802|NCT01171976|3761225|FG000|Overall Study|Lost to Follow-up|4
2148803|NCT01171976|3761226|FG001|Overall Study|Lost to Follow-up|0
2148804|NCT01171976|3761227|FG002|Overall Study|Lost to Follow-up|2
2148805|NCT01171976|3761225|FG000|Overall Study|Withdrawal by Subject|1
2148806|NCT01171976|3761226|FG001|Overall Study|Withdrawal by Subject|5
2148807|NCT01171976|3761227|FG002|Overall Study|Withdrawal by Subject|6
2148808|NCT01171976|3761225|FG000|Overall Study|Abnormal test result|1
2148809|NCT01171976|3761226|FG001|Overall Study|Abnormal test result|0
2148810|NCT01171976|3761227|FG002|Overall Study|Abnormal test result|0
2148811|NCT01171976|3761225|FG000|Overall Study|Adverse Event|6
2148812|NCT01171976|3761226|FG001|Overall Study|Adverse Event|2
2148813|NCT01171976|3761227|FG002|Overall Study|Adverse Event|5
2148814|NCT01171989|3761238|FG000|Overall Study|Lost to Follow-up|0
2148815|NCT01171989|3761239|FG001|Overall Study|Lost to Follow-up|0
2291166|NCT02499146|3984122|FG000|Overall Study|Began other treatment/therapy|13
2291167|NCT02499159|3984128|FG000|Randomization|Protocol Violation|1
2291168|NCT02499159|3984129|FG001|Randomization|Protocol Violation|1
2291169|NCT02499159|3984128|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
2291170|NCT02499159|3984129|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
2291171|NCT02499159|3984128|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3
2291172|NCT02499159|3984129|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1
2291173|NCT02499159|3984128|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
2291174|NCT02499159|3984129|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
2148816|NCT01171989|3761240|FG002|Overall Study|Lost to Follow-up|1
2148817|NCT01172275|3761281|FG000|Overall Study|Lost to Follow-up|1
2148818|NCT01172275|3761282|FG001|Overall Study|Lost to Follow-up|0
2291175|NCT02499159|3984128|FG000|30-Day Follow-Up Phone Call|Other|1
2148819|NCT01172275|3761281|FG000|Overall Study|Protocol Violation|1
2148820|NCT01172275|3761282|FG001|Overall Study|Protocol Violation|0
2148821|NCT01172288|3761290|FG000|Overall Study|Adverse Event|1
2148822|NCT01172288|3761291|FG001|Overall Study|Adverse Event|0
2148823|NCT01172288|3761290|FG000|Overall Study|Protocol Violation|0
2148824|NCT01172288|3761291|FG001|Overall Study|Protocol Violation|1
2148825|NCT01172535|3761325|FG000|Overall Study|Death|3
2148826|NCT01172535|3761325|FG000|Overall Study|Withdrawal by Subject|2
2208099|NCT01636687|3847525|FG002|Maintenance Period|Lack of Efficacy|0
2208100|NCT01636687|3847526|FG003|Maintenance Period|Lack of Efficacy|0
2148827|NCT01172535|3761325|FG000|Overall Study|Lost to Follow-up|1
2148828|NCT01172535|3761325|FG000|Overall Study|Ineligible at study entry|1
2148829|NCT01172535|3761325|FG000|Overall Study|Unwilling to adhere to study requirement|1
2148830|NCT01172639|3761346|FG000|Overall Study|Death|1
2148831|NCT01172639|3761347|FG001|Overall Study|Death|1
2148832|NCT01172639|3761348|FG002|Overall Study|Death|0
2148833|NCT01172639|3761349|FG003|Overall Study|Death|0
2148834|NCT01172639|3761350|FG004|Overall Study|Death|0
2148835|NCT01172639|3761346|FG000|Overall Study|Lost to Follow-up|9
2148836|NCT01172639|3761347|FG001|Overall Study|Lost to Follow-up|7
2148837|NCT01172639|3761348|FG002|Overall Study|Lost to Follow-up|11
2148838|NCT01172639|3761349|FG003|Overall Study|Lost to Follow-up|6
2148839|NCT01172639|3761350|FG004|Overall Study|Lost to Follow-up|6
2148840|NCT01172639|3761346|FG000|Overall Study|Withdrawal by Subject|3
2148841|NCT01172639|3761347|FG001|Overall Study|Withdrawal by Subject|3
2148842|NCT01172639|3761348|FG002|Overall Study|Withdrawal by Subject|5
2148843|NCT01172639|3761349|FG003|Overall Study|Withdrawal by Subject|5
2148844|NCT01172639|3761350|FG004|Overall Study|Withdrawal by Subject|0
2148845|NCT01172808|3761366|FG000|Overall Study|Adverse Event|8
2148846|NCT01172808|3761367|FG001|Overall Study|Adverse Event|4
2148847|NCT01172808|3761368|FG002|Overall Study|Adverse Event|8
2148848|NCT01172808|3761369|FG003|Overall Study|Adverse Event|3
2148849|NCT01172808|3761366|FG000|Overall Study|Lack of Efficacy|1
2148850|NCT01172808|3761367|FG001|Overall Study|Lack of Efficacy|0
2148851|NCT01172808|3761368|FG002|Overall Study|Lack of Efficacy|0
2148852|NCT01172808|3761369|FG003|Overall Study|Lack of Efficacy|0
2148853|NCT01172808|3761366|FG000|Overall Study|Protocol Violation|2
2148854|NCT01172808|3761367|FG001|Overall Study|Protocol Violation|2
2148855|NCT01172808|3761368|FG002|Overall Study|Protocol Violation|2
2148856|NCT01172808|3761369|FG003|Overall Study|Protocol Violation|0
2148857|NCT01172808|3761366|FG000|Overall Study|Lost to Follow-up|0
2148858|NCT01172808|3761367|FG001|Overall Study|Lost to Follow-up|1
2148859|NCT01172808|3761368|FG002|Overall Study|Lost to Follow-up|1
2148860|NCT01172808|3761369|FG003|Overall Study|Lost to Follow-up|3
2148861|NCT01172808|3761366|FG000|Overall Study|Withdrawal by Subject|4
2148862|NCT01172808|3761367|FG001|Overall Study|Withdrawal by Subject|1
2148863|NCT01172808|3761368|FG002|Overall Study|Withdrawal by Subject|3
2148864|NCT01172808|3761369|FG003|Overall Study|Withdrawal by Subject|2
2148865|NCT01172808|3761366|FG000|Overall Study|Other|6
2148866|NCT01172808|3761367|FG001|Overall Study|Other|5
2148867|NCT01172808|3761368|FG002|Overall Study|Other|9
2148868|NCT01172808|3761369|FG003|Overall Study|Other|7
2148869|NCT01172821|3761383|FG000|Overall Study|Adverse Event|5
2148870|NCT01172821|3761384|FG001|Overall Study|Adverse Event|2
2148871|NCT01172821|3761385|FG002|Overall Study|Adverse Event|2
2148872|NCT01172821|3761386|FG003|Overall Study|Adverse Event|7
2148873|NCT01172821|3761383|FG000|Overall Study|Protocol Violation|0
2148874|NCT01172821|3761384|FG001|Overall Study|Protocol Violation|2
2148875|NCT01172821|3761385|FG002|Overall Study|Protocol Violation|1
2148876|NCT01172821|3761386|FG003|Overall Study|Protocol Violation|2
2148877|NCT01172821|3761383|FG000|Overall Study|Lost to Follow-up|4
2148878|NCT01172821|3761384|FG001|Overall Study|Lost to Follow-up|1
2148879|NCT01172821|3761385|FG002|Overall Study|Lost to Follow-up|2
2148880|NCT01172821|3761386|FG003|Overall Study|Lost to Follow-up|2
2148881|NCT01172821|3761383|FG000|Overall Study|Withdrawal by Subject|2
2148882|NCT01172821|3761384|FG001|Overall Study|Withdrawal by Subject|3
2148883|NCT01172821|3761385|FG002|Overall Study|Withdrawal by Subject|3
2208101|NCT01636687|3847527|FG004|Maintenance Period|Lack of Efficacy|0
2208102|NCT01636687|3847523|FG000|Maintenance Period|Lost to Follow-up|1
2208103|NCT01636687|3847524|FG001|Maintenance Period|Lost to Follow-up|1
2208104|NCT01636687|3847525|FG002|Maintenance Period|Lost to Follow-up|0
2208105|NCT01636687|3847526|FG003|Maintenance Period|Lost to Follow-up|0
2208106|NCT01636687|3847527|FG004|Maintenance Period|Lost to Follow-up|1
2208107|NCT01636687|3847523|FG000|Maintenance Period|Physician Decision|0
2148884|NCT01172821|3761386|FG003|Overall Study|Withdrawal by Subject|3
2148885|NCT01172821|3761383|FG000|Overall Study|Other|3
2148886|NCT01172821|3761384|FG001|Overall Study|Other|4
2148887|NCT01172821|3761385|FG002|Overall Study|Other|5
2148888|NCT01172821|3761386|FG003|Overall Study|Other|3
2148889|NCT01172847|3761396|FG000|Overall Study|Withdrawal by Subject|3
2148890|NCT01172873|3761408|FG000|Overall Study|Withdrawal by Subject|3
2148891|NCT01172873|3761409|FG001|Overall Study|Withdrawal by Subject|2
2148892|NCT01172938|3761418|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
2208108|NCT01636687|3847524|FG001|Maintenance Period|Physician Decision|0
2148893|NCT01172938|3761419|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
2179104|NCT01391819|3804583|FG000|Overall Study|Withdrawal by Subject|56
2148894|NCT01172938|3761420|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
2148895|NCT01172938|3761421|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2148896|NCT01172938|3761422|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2148897|NCT01172938|3761423|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2148898|NCT01172938|3761424|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2148899|NCT01172938|3761425|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2148900|NCT01172938|3761426|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2148901|NCT01172938|3761418|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
2148902|NCT01172938|3761419|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
2148903|NCT01172938|3761420|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
2148904|NCT01172938|3761421|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2148905|NCT01172938|3761422|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2208109|NCT01636687|3847525|FG002|Maintenance Period|Physician Decision|0
2148906|NCT01172938|3761423|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2148907|NCT01172938|3761424|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2148908|NCT01172938|3761425|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2148909|NCT01172938|3761426|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2148910|NCT01172938|3761418|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2148911|NCT01172938|3761419|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
2148912|NCT01172938|3761420|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
2148913|NCT01172938|3761421|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2148914|NCT01172938|3761422|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2148915|NCT01172938|3761423|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2148916|NCT01172938|3761424|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2148917|NCT01172938|3761425|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2148918|NCT01172938|3761426|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2148919|NCT01172938|3761418|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
2148920|NCT01172938|3761419|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
2148921|NCT01172938|3761420|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
2148922|NCT01172938|3761421|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2148923|NCT01172938|3761422|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2148924|NCT01172938|3761423|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2148925|NCT01172938|3761424|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2148926|NCT01172938|3761425|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2148927|NCT01172938|3761426|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2148928|NCT01172938|3761418|FG000|Placebo-controlled Phase (Week 0-24)|Death|0
2148929|NCT01172938|3761419|FG001|Placebo-controlled Phase (Week 0-24)|Death|1
2148930|NCT01172938|3761420|FG002|Placebo-controlled Phase (Week 0-24)|Death|0
2148931|NCT01172938|3761421|FG003|Placebo-controlled Phase (Week 0-24)|Death|0
2148932|NCT01172938|3761422|FG004|Placebo-controlled Phase (Week 0-24)|Death|0
2148933|NCT01172938|3761423|FG005|Placebo-controlled Phase (Week 0-24)|Death|0
2148934|NCT01172938|3761424|FG006|Placebo-controlled Phase (Week 0-24)|Death|0
2148935|NCT01172938|3761425|FG007|Placebo-controlled Phase (Week 0-24)|Death|0
2148936|NCT01172938|3761426|FG008|Placebo-controlled Phase (Week 0-24)|Death|0
2148937|NCT01172938|3761418|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
2148938|NCT01172938|3761419|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2148939|NCT01172938|3761420|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2148940|NCT01172938|3761421|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2148941|NCT01172938|3761422|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2148942|NCT01172938|3761423|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2148943|NCT01172938|3761424|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2148944|NCT01172938|3761425|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2148945|NCT01172938|3761426|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2148946|NCT01172938|3761418|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
2148947|NCT01172938|3761419|FG001|Placebo-controlled Phase (Week 0-24)|Other|2
2148948|NCT01172938|3761420|FG002|Placebo-controlled Phase (Week 0-24)|Other|1
2148949|NCT01172938|3761421|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
2148950|NCT01172938|3761422|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
2148951|NCT01172938|3761423|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
2148952|NCT01172938|3761424|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
2148953|NCT01172938|3761425|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
2148954|NCT01172938|3761426|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
2148955|NCT01172938|3761418|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2148956|NCT01172938|3761419|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
2148957|NCT01172938|3761420|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
2148958|NCT01172938|3761421|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
2148959|NCT01172938|3761422|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
2148960|NCT01172938|3761423|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
2148961|NCT01172938|3761424|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2148962|NCT01172938|3761425|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2148963|NCT01172938|3761426|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2148964|NCT01172938|3761418|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2148965|NCT01172938|3761419|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
2148966|NCT01172938|3761420|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
2148967|NCT01172938|3761421|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
2148968|NCT01172938|3761422|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
2148969|NCT01172938|3761423|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
2148970|NCT01172938|3761424|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2148971|NCT01172938|3761425|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2148972|NCT01172938|3761426|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2148973|NCT01172938|3761418|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2148974|NCT01172938|3761419|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2148975|NCT01172938|3761420|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
2148976|NCT01172938|3761421|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2148977|NCT01172938|3761422|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2148978|NCT01172938|3761423|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2148979|NCT01172938|3761424|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2148980|NCT01172938|3761425|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2148981|NCT01172938|3761426|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2148982|NCT01172938|3761418|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
2148983|NCT01172938|3761419|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
2148984|NCT01172938|3761420|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
2148985|NCT01172938|3761421|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
2148986|NCT01172938|3761422|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
2148987|NCT01172938|3761423|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
2148988|NCT01172938|3761424|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
2148989|NCT01172938|3761425|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
2148990|NCT01172938|3761426|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
2148991|NCT01172938|3761418|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2148992|NCT01172938|3761419|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
2148993|NCT01172938|3761420|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
2148994|NCT01172938|3761421|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
2148995|NCT01172938|3761422|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2148996|NCT01172938|3761423|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2148997|NCT01172938|3761424|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2148998|NCT01172938|3761425|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2148999|NCT01172938|3761426|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2149000|NCT01172938|3761418|FG000|Active Treatment Phase (Weeks 25-52)|Other|0
2149001|NCT01172938|3761419|FG001|Active Treatment Phase (Weeks 25-52)|Other|0
2149002|NCT01172938|3761420|FG002|Active Treatment Phase (Weeks 25-52)|Other|0
2149003|NCT01172938|3761421|FG003|Active Treatment Phase (Weeks 25-52)|Other|0
2149004|NCT01172938|3761422|FG004|Active Treatment Phase (Weeks 25-52)|Other|0
2149005|NCT01172938|3761423|FG005|Active Treatment Phase (Weeks 25-52)|Other|1
2149006|NCT01172938|3761424|FG006|Active Treatment Phase (Weeks 25-52)|Other|1
2149007|NCT01172938|3761425|FG007|Active Treatment Phase (Weeks 25-52)|Other|0
2149008|NCT01172938|3761426|FG008|Active Treatment Phase (Weeks 25-52)|Other|0
2149009|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2149010|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
2149011|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
2149012|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2149013|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2149014|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2149015|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2149016|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
2149017|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
2149018|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2149019|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
2149020|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
2149021|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2149022|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2149023|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2149024|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2149025|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
2149026|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2149027|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2149028|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2149029|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
2149030|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2149031|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2149032|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2149033|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2149034|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2149035|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2149036|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2149037|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
2149038|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
2149039|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2149040|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2149041|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2149042|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2149043|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
2149044|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
2149045|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0
2149046|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0
2149047|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1
2149048|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0
2149049|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0
2149050|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0
2149051|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0
2149052|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0
2149053|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0
2149054|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2149055|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
2149056|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
2149057|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2149058|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2149059|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2149060|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2149061|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
2149062|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2149063|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2149064|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
2149065|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2149066|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2149067|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2149068|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2149069|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2149070|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2149071|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
2149072|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0
2149073|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1
2149074|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0
2149075|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0
2149076|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0
2149077|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0
2149078|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0
2149079|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0
2149080|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0
2149081|NCT01172938|3761418|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2149082|NCT01172938|3761419|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2149083|NCT01172938|3761420|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2149084|NCT01172938|3761421|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2149085|NCT01172938|3761422|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2149086|NCT01172938|3761423|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2149087|NCT01172938|3761424|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2149088|NCT01172938|3761425|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2149089|NCT01172938|3761426|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
2149090|NCT01172938|3761418|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2149091|NCT01172938|3761419|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
2149092|NCT01172938|3761420|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
2149093|NCT01172938|3761421|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2149094|NCT01172938|3761422|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2149095|NCT01172938|3761423|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2149096|NCT01172938|3761424|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2149097|NCT01172938|3761425|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
2149098|NCT01172938|3761426|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
2149099|NCT01172938|3761418|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2149100|NCT01172938|3761419|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
2149101|NCT01172938|3761420|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
2149102|NCT01172938|3761421|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2149103|NCT01172938|3761422|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2149104|NCT01172938|3761423|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2149105|NCT01172938|3761424|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2149106|NCT01172938|3761425|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
2149107|NCT01172938|3761426|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
2149108|NCT01172938|3761418|FG000|Active-Treatment Phase Weeks (104-156)|Death|0
2149109|NCT01172938|3761419|FG001|Active-Treatment Phase Weeks (104-156)|Death|0
2149110|NCT01172938|3761420|FG002|Active-Treatment Phase Weeks (104-156)|Death|0
2149111|NCT01172938|3761421|FG003|Active-Treatment Phase Weeks (104-156)|Death|0
2149112|NCT01172938|3761422|FG004|Active-Treatment Phase Weeks (104-156)|Death|0
2149113|NCT01172938|3761423|FG005|Active-Treatment Phase Weeks (104-156)|Death|0
2149114|NCT01172938|3761424|FG006|Active-Treatment Phase Weeks (104-156)|Death|0
2149115|NCT01172938|3761425|FG007|Active-Treatment Phase Weeks (104-156)|Death|1
2149116|NCT01172938|3761426|FG008|Active-Treatment Phase Weeks (104-156)|Death|0
2149117|NCT01172938|3761418|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2149118|NCT01172938|3761419|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
2149119|NCT01172938|3761420|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2149120|NCT01172938|3761421|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2149121|NCT01172938|3761422|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2149122|NCT01172938|3761423|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2149123|NCT01172938|3761424|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2149124|NCT01172938|3761425|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2149125|NCT01172938|3761426|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2149126|NCT01172938|3761418|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2149127|NCT01172938|3761419|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2149128|NCT01172938|3761420|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
2149129|NCT01172938|3761421|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2149130|NCT01172938|3761422|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2149131|NCT01172938|3761423|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2149132|NCT01172938|3761424|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2149133|NCT01172938|3761425|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2149134|NCT01172938|3761426|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2149135|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2149136|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
2149137|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
2149138|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2149139|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2149140|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2149141|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2149142|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
2149143|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2149144|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2149145|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
2149146|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
2149147|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2149148|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2149149|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2149150|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2149151|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
2149152|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
2149153|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2149154|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
2149155|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
2149156|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2149157|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2149158|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2149159|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2149160|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
2149161|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
2149162|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2149163|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2149164|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
2149165|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2149166|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2149167|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2208110|NCT01636687|3847526|FG003|Maintenance Period|Physician Decision|0
2208111|NCT01636687|3847527|FG004|Maintenance Period|Physician Decision|1
2149168|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2149169|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2149170|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
2208112|NCT01636687|3847523|FG000|Extension Period|technical problems|0
2208113|NCT01636687|3847524|FG001|Extension Period|technical problems|1
2149171|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2149172|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2149173|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2149174|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2149175|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2149176|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2149177|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2149178|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
2149179|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2149180|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2149181|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2149182|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
2149183|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2149184|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2149185|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2149186|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2149187|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
2149188|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
2149189|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2149190|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2149191|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
2149192|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2149193|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2149194|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2149195|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2149196|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2149197|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2149198|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2149199|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
2149200|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2149201|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2149202|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2149203|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2149204|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2149205|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
2149206|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2149207|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2149208|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
2149209|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
2149210|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2149211|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2149212|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2149213|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2149214|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
2149215|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2149216|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0
2149217|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0
2149218|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1
2149219|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0
2149220|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0
2291176|NCT02499159|3984129|FG001|30-Day Follow-Up Phone Call|Other|0
2291177|NCT02499172|3984139|FG000|Overall Study|Financial reason|0
2291178|NCT02499172|3984140|FG001|Overall Study|Financial reason|0
2291179|NCT02499172|3984141|FG002|Overall Study|Financial reason|523
2291180|NCT02499172|3984142|FG003|Overall Study|Financial reason|436
2291181|NCT02499172|3984139|FG000|Overall Study|Lost to Follow-up|65
2291182|NCT02499172|3984140|FG001|Overall Study|Lost to Follow-up|64
2291183|NCT02499172|3984141|FG002|Overall Study|Lost to Follow-up|0
2291184|NCT02499172|3984142|FG003|Overall Study|Lost to Follow-up|0
2291185|NCT02499263|3984152|FG000|Overall Study|Lost to Follow-up|9
2291186|NCT02499263|3984152|FG000|Overall Study|Participant's withdrawal of consent|4
2291187|NCT02499263|3984152|FG000|Overall Study|Lack of Efficacy|22
2291188|NCT02499263|3984152|FG000|Overall Study|investigator's judgment|12
2291189|NCT02499263|3984152|FG000|Overall Study|Adverse Events/Serious Adverse Events|11
2149221|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0
2149222|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0
2149223|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0
2149224|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0
2149225|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2149226|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2149227|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
2149228|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2149229|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2149230|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2149231|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2149232|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2149233|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2149234|NCT01172938|3761418|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2149235|NCT01172938|3761419|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2149236|NCT01172938|3761420|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2149237|NCT01172938|3761421|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2149238|NCT01172938|3761422|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2149239|NCT01172938|3761423|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2149240|NCT01172938|3761424|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2149241|NCT01172938|3761425|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2149242|NCT01172938|3761426|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
2149243|NCT01173055|3761468|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2
2149244|NCT01173055|3761469|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2
2149245|NCT01173055|3761468|FG000|Period 2 - Day 64 to 112|Adverse Event|0
2149246|NCT01173055|3761469|FG001|Period 2 - Day 64 to 112|Adverse Event|1
2149247|NCT01173120|3761475|FG000|Overall Study|Lack of Efficacy|2
2149248|NCT01173120|3761475|FG000|Overall Study|Lost to Follow-up|1
2149249|NCT01173120|3761475|FG000|Overall Study|Participant Decision|2
2149250|NCT01173120|3761475|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33
2149251|NCT01173120|3761475|FG000|Overall Study|Switch-Participant Decision|12
2149252|NCT01173120|3761475|FG000|Overall Study|Switch-Difficulty With Device|12
2149253|NCT01173471|3761514|FG000|Overall Study|Eligibility criteria not fulfilled|0
2149254|NCT01173471|3761515|FG001|Overall Study|Eligibility criteria not fulfilled|0
2149255|NCT01173471|3761516|FG002|Overall Study|Eligibility criteria not fulfilled|1
2149256|NCT01173471|3761517|FG003|Overall Study|Eligibility criteria not fulfilled|1
2149257|NCT01173471|3761514|FG000|Overall Study|Condition under investigation worsened|2
2149258|NCT01173471|3761515|FG001|Overall Study|Condition under investigation worsened|0
2149259|NCT01173471|3761516|FG002|Overall Study|Condition under investigation worsened|0
2149260|NCT01173471|3761517|FG003|Overall Study|Condition under investigation worsened|0
2149261|NCT01173471|3761514|FG000|Overall Study|Lost to Follow-up|0
2149262|NCT01173471|3761515|FG001|Overall Study|Lost to Follow-up|0
2149263|NCT01173471|3761516|FG002|Overall Study|Lost to Follow-up|1
2149264|NCT01173471|3761517|FG003|Overall Study|Lost to Follow-up|0
2149265|NCT01173471|3761514|FG000|Overall Study|Reason given as Other|0
2149266|NCT01173471|3761515|FG001|Overall Study|Reason given as Other|0
2149267|NCT01173471|3761516|FG002|Overall Study|Reason given as Other|1
2149268|NCT01173471|3761517|FG003|Overall Study|Reason given as Other|0
2149269|NCT01173523|3761529|FG000|Overall Study|Clinical Progression|1
2149270|NCT01173523|3761530|FG001|Overall Study|Clinical Progression|1
2149271|NCT01173523|3761529|FG000|Overall Study|Progressive Disease|10
2149272|NCT01173523|3761530|FG001|Overall Study|Progressive Disease|8
2149273|NCT01173523|3761529|FG000|Overall Study|Other|2
2149274|NCT01173523|3761530|FG001|Overall Study|Other|3
2149275|NCT01173601|3761540|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
2149276|NCT01173601|3761541|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2149277|NCT01173601|3761542|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2149278|NCT01173601|3761543|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2149279|NCT01173601|3761544|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2149280|NCT01173601|3761540|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
2149281|NCT01173601|3761541|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2149282|NCT01173601|3761542|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2149283|NCT01173601|3761543|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2149284|NCT01173601|3761544|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2149285|NCT01173601|3761540|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
2149286|NCT01173601|3761541|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2149287|NCT01173601|3761542|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2149288|NCT01173601|3761543|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2149289|NCT01173601|3761544|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2149290|NCT01173601|3761540|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
2149291|NCT01173601|3761541|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2149292|NCT01173601|3761542|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2149293|NCT01173601|3761543|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2149294|NCT01173601|3761544|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2149295|NCT01173601|3761540|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
2149296|NCT01173601|3761541|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2149297|NCT01173601|3761542|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2149298|NCT01173601|3761543|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2149299|NCT01173601|3761544|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2149300|NCT01173601|3761540|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
2149301|NCT01173601|3761541|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2149302|NCT01173601|3761542|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2149303|NCT01173601|3761543|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2149304|NCT01173601|3761544|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2149305|NCT01173601|3761540|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
2149306|NCT01173601|3761541|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2149307|NCT01173601|3761542|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2149308|NCT01173601|3761543|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2149309|NCT01173601|3761544|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2149310|NCT01173601|3761540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
2149311|NCT01173601|3761541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
2149312|NCT01173601|3761542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
2149313|NCT01173601|3761543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
2149314|NCT01173601|3761544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
2149315|NCT01173601|3761540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
2149316|NCT01173601|3761541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
2149317|NCT01173601|3761542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
2149318|NCT01173601|3761543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
2149319|NCT01173601|3761544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
2149320|NCT01173601|3761540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2149321|NCT01173601|3761541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
2149322|NCT01173601|3761542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2149323|NCT01173601|3761543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
2149324|NCT01173601|3761544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
2149325|NCT01173601|3761540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2149326|NCT01173601|3761541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
2291190|NCT02499263|3984152|FG000|Overall Study|Participant's decision|3
2291191|NCT02499263|3984152|FG000|Overall Study|Pregnancy|1
2149327|NCT01173601|3761542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2149328|NCT01173601|3761543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
2149329|NCT01173601|3761544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2149330|NCT01173601|3761540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
2149331|NCT01173601|3761541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
2149332|NCT01173601|3761542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2149333|NCT01173601|3761543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
2149334|NCT01173601|3761544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2149335|NCT01173601|3761540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
2149336|NCT01173601|3761541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
2149337|NCT01173601|3761542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
2149338|NCT01173601|3761543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
2149339|NCT01173601|3761544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
2291192|NCT02499406|3984160|FG000|Overall Study|missed 3 treatment sessions|4
2291193|NCT02499575|3984183|FG000|Overall Study|Protocol Violation|0
2291194|NCT02499575|3984184|FG001|Overall Study|Protocol Violation|1
2291195|NCT02499770|3984196|FG000|Overall Study|Death|17
2291196|NCT02499770|3984197|FG001|Overall Study|Death|56
2291197|NCT02499770|3984196|FG000|Overall Study|Study completion|1
2291198|NCT02499770|3984197|FG001|Overall Study|Study completion|10
2291199|NCT02499770|3984196|FG000|Overall Study|Withdrawal by Subject|0
2291200|NCT02499770|3984197|FG001|Overall Study|Withdrawal by Subject|7
2291201|NCT02499770|3984196|FG000|Overall Study|Lost to Follow-up|0
2291202|NCT02499770|3984197|FG001|Overall Study|Lost to Follow-up|2
2291203|NCT02499770|3984196|FG000|Overall Study|Subject declined further treatment|1
2291204|NCT02499770|3984197|FG001|Overall Study|Subject declined further treatment|0
2291205|NCT02499770|3984196|FG000|Overall Study|Withdrawn by PI for compassionate reason|0
2291206|NCT02499770|3984197|FG001|Overall Study|Withdrawn by PI for compassionate reason|1
2291207|NCT02499770|3984196|FG000|Overall Study|Randomized but not enrolled|0
2291208|NCT02499770|3984197|FG001|Overall Study|Randomized but not enrolled|1
2291209|NCT02499783|3984211|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
2291210|NCT02499783|3984212|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
2291211|NCT02499783|3984213|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
2291212|NCT02499783|3984211|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
2291213|NCT02499783|3984212|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
2291214|NCT02499783|3984213|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
2291215|NCT02499783|3984211|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
2291216|NCT02499783|3984212|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
2291217|NCT02499783|3984213|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
2149340|NCT01173601|3761540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2149341|NCT01173601|3761541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2149342|NCT01173601|3761542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2149343|NCT01173601|3761543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2149344|NCT01173601|3761544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
2149345|NCT01173653|3761564|FG000|Overall Study|Pts unwilling to provide follow-up|53
2149346|NCT01173653|3761565|FG001|Overall Study|Pts unwilling to provide follow-up|41
2291218|NCT02499783|3984211|FG000|DB Period: Weeks 0-8|Adverse Event|8
2291219|NCT02499783|3984212|FG001|DB Period: Weeks 0-8|Adverse Event|6
2291220|NCT02499783|3984213|FG002|DB Period: Weeks 0-8|Adverse Event|0
2291221|NCT02499783|3984211|FG000|DB Period: Weeks 0-8|Withdrew Consent|1
2149347|NCT01173679|3761571|FG000|Overall Study|Death|1
2149348|NCT01173692|3761578|FG000|Overall Study|Adverse Event|1
2149349|NCT01173692|3761579|FG001|Overall Study|Adverse Event|2
2149350|NCT01173692|3761578|FG000|Overall Study|Withdrawal by Subject|1
2149351|NCT01173692|3761579|FG001|Overall Study|Withdrawal by Subject|3
2149352|NCT01173718|3761585|FG000|Overall Study|Death|17
2149353|NCT01173718|3761585|FG000|Overall Study|Abandonment of study graft|27
2149354|NCT01174004|3761608|FG000|Overall Study|Adverse Event|2
2149355|NCT01174004|3761609|FG001|Overall Study|Adverse Event|10
2149356|NCT01174004|3761608|FG000|Overall Study|Withdrawal by Subject|2
2149357|NCT01174004|3761609|FG001|Overall Study|Withdrawal by Subject|3
2149358|NCT01174004|3761608|FG000|Overall Study|At Discretion of Sponsor|2
2149359|NCT01174004|3761609|FG001|Overall Study|At Discretion of Sponsor|2
2149360|NCT01174004|3761608|FG000|Overall Study|Protocol Violation|0
2149361|NCT01174004|3761609|FG001|Overall Study|Protocol Violation|1
2149362|NCT01174004|3761608|FG000|Overall Study|Physician Decision|1
2149363|NCT01174004|3761609|FG001|Overall Study|Physician Decision|0
2149364|NCT01174043|3761636|FG000|Overall Study|Disease progression|5
2149365|NCT01174043|3761636|FG000|Overall Study|Adverse Event|3
2149366|NCT01174043|3761636|FG000|Overall Study|Death|1
2149367|NCT01174043|3761636|FG000|Overall Study|Withdrawal by Subject|2
2149368|NCT01174160|3761651|FG000|Overall Study|Adverse Event|1
2149369|NCT01174160|3761652|FG001|Overall Study|Adverse Event|0
2149370|NCT01174160|3761651|FG000|Overall Study|Lost to Follow-up|1
2149371|NCT01174160|3761652|FG001|Overall Study|Lost to Follow-up|0
2149372|NCT01174160|3761651|FG000|Overall Study|Physician Decision|1
2149373|NCT01174160|3761652|FG001|Overall Study|Physician Decision|0
2149374|NCT01174160|3761651|FG000|Overall Study|Protocol Violation|4
2149375|NCT01174160|3761652|FG001|Overall Study|Protocol Violation|6
2149376|NCT01174160|3761651|FG000|Overall Study|Withdrawal by Subject|1
2149377|NCT01174160|3761652|FG001|Overall Study|Withdrawal by Subject|0
2149378|NCT01174173|3761658|FG000|Overall Study|drug-drug interaction|1
2149379|NCT01174186|3761665|FG000|Overall Study|Lost to Follow-up|0
2149380|NCT01174186|3761666|FG001|Overall Study|Lost to Follow-up|1
2149381|NCT01174186|3761665|FG000|Overall Study|Withdrawal by Subject|0
2149382|NCT01174186|3761666|FG001|Overall Study|Withdrawal by Subject|2
2149383|NCT01174238|3761672|FG000|Overall Study|Lost to Follow-up|2
2149384|NCT01174264|3761682|FG000|Single Dose Pharmacokinetics|Early progressive disease|1
2149385|NCT01174264|3761683|FG001|Single Dose Pharmacokinetics|Early progressive disease|0
2149386|NCT01174264|3761684|FG002|Single Dose Pharmacokinetics|Early progressive disease|1
2149387|NCT01174264|3761682|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0
2149388|NCT01174264|3761683|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0
2149389|NCT01174264|3761684|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1
2149390|NCT01174264|3761682|FG000|Steady-state Pharmacokinetics|Not evaluable|6
2149391|NCT01174264|3761683|FG001|Steady-state Pharmacokinetics|Not evaluable|0
2149392|NCT01174264|3761684|FG002|Steady-state Pharmacokinetics|Not evaluable|2
2149393|NCT01174342|3761692|FG000|Overall Study|Conversion to cesarean section|4
2149394|NCT01174446|3761696|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
2149395|NCT01174446|3761697|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
2149396|NCT01174446|3761698|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
2149397|NCT01174446|3761699|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
2149398|NCT01174446|3761696|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
2149399|NCT01174446|3761697|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
2149400|NCT01174446|3761698|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
2149401|NCT01174446|3761699|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
2149402|NCT01174446|3761696|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
2149403|NCT01174446|3761697|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
2149404|NCT01174446|3761698|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
2149405|NCT01174446|3761699|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
2149406|NCT01174446|3761696|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
2149407|NCT01174446|3761697|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
2149408|NCT01174446|3761698|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
2149409|NCT01174446|3761699|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
2149410|NCT01174459|3761746|FG000|Overall Study|case report form (CRF) not collected|5
2179105|NCT01391819|3804583|FG000|Overall Study|Migrated/moved from study area|82
2179106|NCT01391819|3804583|FG000|Overall Study|Lost to Follow-up|252
2149411|NCT01174550|3761752|FG000|Overall Study|Death|75
2149412|NCT01174550|3761753|FG001|Overall Study|Death|74
2149413|NCT01174550|3761752|FG000|Overall Study|Lost to Follow-up|652
2149414|NCT01174550|3761753|FG001|Overall Study|Lost to Follow-up|510
2149415|NCT01174550|3761752|FG000|Overall Study|Withdrawal by Subject|543
2149416|NCT01174550|3761753|FG001|Overall Study|Withdrawal by Subject|289
2149417|NCT01174784|3761772|FG000|Overall Study|Screen fails|4
2149418|NCT01175018|3761793|FG000|Overall Study|Adverse Event|3
2149419|NCT01175018|3761794|FG001|Overall Study|Adverse Event|1
2208114|NCT01636687|3847525|FG002|Extension Period|technical problems|2
2291222|NCT02499783|3984212|FG001|DB Period: Weeks 0-8|Withdrew Consent|0
2149420|NCT01175083|3761816|FG000|Primary Epoch|Withdrawal by Subject|0
2149421|NCT01175083|3761817|FG001|Primary Epoch|Withdrawal by Subject|0
2149422|NCT01175083|3761818|FG002|Primary Epoch|Withdrawal by Subject|0
2149423|NCT01175083|3761819|FG003|Primary Epoch|Withdrawal by Subject|0
2149424|NCT01175083|3761820|FG004|Primary Epoch|Withdrawal by Subject|0
2149425|NCT01175083|3761821|FG005|Primary Epoch|Withdrawal by Subject|2
2149426|NCT01175083|3761816|FG000|Primary Epoch|Lost to Follow-up|0
2149427|NCT01175083|3761817|FG001|Primary Epoch|Lost to Follow-up|0
2149428|NCT01175083|3761818|FG002|Primary Epoch|Lost to Follow-up|0
2149429|NCT01175083|3761819|FG003|Primary Epoch|Lost to Follow-up|0
2149430|NCT01175083|3761820|FG004|Primary Epoch|Lost to Follow-up|0
2149431|NCT01175083|3761821|FG005|Primary Epoch|Lost to Follow-up|1
2149432|NCT01175083|3761816|FG000|Booster Epoch|Death|0
2149433|NCT01175083|3761817|FG001|Booster Epoch|Death|0
2149434|NCT01175083|3761818|FG002|Booster Epoch|Death|1
2149435|NCT01175083|3761819|FG003|Booster Epoch|Death|0
2149436|NCT01175083|3761820|FG004|Booster Epoch|Death|0
2149437|NCT01175083|3761821|FG005|Booster Epoch|Death|0
2149438|NCT01175083|3761816|FG000|Booster Epoch|Withdrawal by Subject|0
2149439|NCT01175083|3761817|FG001|Booster Epoch|Withdrawal by Subject|0
2149440|NCT01175083|3761818|FG002|Booster Epoch|Withdrawal by Subject|0
2149441|NCT01175083|3761819|FG003|Booster Epoch|Withdrawal by Subject|1
2149442|NCT01175083|3761820|FG004|Booster Epoch|Withdrawal by Subject|0
2149443|NCT01175083|3761821|FG005|Booster Epoch|Withdrawal by Subject|0
2149444|NCT01175135|3761843|FG000|Overall Study|Adverse Event|2
2149445|NCT01175135|3761844|FG001|Overall Study|Adverse Event|5
2149446|NCT01175135|3761845|FG002|Overall Study|Adverse Event|3
2149447|NCT01175135|3761846|FG003|Overall Study|Adverse Event|4
2149448|NCT01175135|3761843|FG000|Overall Study|Death|1
2291223|NCT02499783|3984213|FG002|DB Period: Weeks 0-8|Withdrew Consent|0
2291224|NCT02499783|3984211|FG000|DB Period: Weeks 0-8|Other|1
2291225|NCT02499783|3984212|FG001|DB Period: Weeks 0-8|Other|1
2291226|NCT02499783|3984213|FG002|DB Period: Weeks 0-8|Other|0
2291227|NCT02499783|3984211|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0
2291228|NCT02499783|3984212|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0
2291229|NCT02499783|3984213|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16
2291230|NCT02499783|3984211|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
2291231|NCT02499783|3984212|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
2291232|NCT02499783|3984213|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
2291233|NCT02499783|3984211|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
2291234|NCT02499783|3984212|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
2291235|NCT02499783|3984213|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
2291236|NCT02499783|3984211|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
2291237|NCT02499783|3984212|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
2291238|NCT02499783|3984213|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
2291239|NCT02499952|3984223|FG000|Overall Study|Lost to Follow-up|1
2291240|NCT02499952|3984223|FG000|Overall Study|Death|9
2291241|NCT02500043|3984229|FG000|Overall Study|Randomized, but not Treated|2
2291242|NCT02500043|3984230|FG001|Overall Study|Randomized, but not Treated|2
2291243|NCT02500043|3984229|FG000|Overall Study|Ongoing at Date of Cut-Off|19
2291244|NCT02500043|3984230|FG001|Overall Study|Ongoing at Date of Cut-Off|3
2291245|NCT02500043|3984229|FG000|Overall Study|Adverse Event|33
2291246|NCT02500043|3984230|FG001|Overall Study|Adverse Event|11
2291247|NCT02500043|3984229|FG000|Overall Study|Clinical Progression|54
2291248|NCT02500043|3984230|FG001|Overall Study|Clinical Progression|35
2291249|NCT02500043|3984229|FG000|Overall Study|Radiological Progression|192
2291250|NCT02500043|3984230|FG001|Overall Study|Radiological Progression|110
2291251|NCT02500043|3984229|FG000|Overall Study|Physician's Decision|11
2291252|NCT02500043|3984230|FG001|Overall Study|Physician's Decision|3
2291253|NCT02500043|3984229|FG000|Overall Study|Withdrawal by Subject|14
2291254|NCT02500043|3984230|FG001|Overall Study|Withdrawal by Subject|4
2291255|NCT02500043|3984229|FG000|Overall Study|Death|11
2291256|NCT02500043|3984230|FG001|Overall Study|Death|2
2291257|NCT02500043|3984229|FG000|Overall Study|Protocol Deviation|1
2291258|NCT02500043|3984230|FG001|Overall Study|Protocol Deviation|0
2149449|NCT01175135|3761844|FG001|Overall Study|Death|0
2149450|NCT01175135|3761845|FG002|Overall Study|Death|0
2149451|NCT01175135|3761846|FG003|Overall Study|Death|0
2149452|NCT01175135|3761843|FG000|Overall Study|Lack of Efficacy|4
2149453|NCT01175135|3761844|FG001|Overall Study|Lack of Efficacy|5
2149454|NCT01175135|3761845|FG002|Overall Study|Lack of Efficacy|0
2149455|NCT01175135|3761846|FG003|Overall Study|Lack of Efficacy|5
2149456|NCT01175135|3761843|FG000|Overall Study|Lost to Follow-up|1
2208115|NCT01636687|3847526|FG003|Extension Period|technical problems|1
2149457|NCT01175135|3761844|FG001|Overall Study|Lost to Follow-up|2
2149458|NCT01175135|3761845|FG002|Overall Study|Lost to Follow-up|0
2149459|NCT01175135|3761846|FG003|Overall Study|Lost to Follow-up|0
2149460|NCT01175135|3761843|FG000|Overall Study|Protocol Violation|1
2149461|NCT01175135|3761844|FG001|Overall Study|Protocol Violation|1
2149462|NCT01175135|3761845|FG002|Overall Study|Protocol Violation|0
2149463|NCT01175135|3761846|FG003|Overall Study|Protocol Violation|0
2149464|NCT01175135|3761843|FG000|Overall Study|Withdrawal by Subject|4
2149465|NCT01175135|3761844|FG001|Overall Study|Withdrawal by Subject|8
2149466|NCT01175135|3761845|FG002|Overall Study|Withdrawal by Subject|5
2149467|NCT01175135|3761846|FG003|Overall Study|Withdrawal by Subject|5
2149468|NCT01175135|3761843|FG000|Overall Study|Other|3
2149469|NCT01175135|3761844|FG001|Overall Study|Other|1
2149470|NCT01175135|3761845|FG002|Overall Study|Other|3
2149471|NCT01175135|3761846|FG003|Overall Study|Other|0
2149472|NCT01175135|3761843|FG000|Overall Study|Randomized But Not Treated|0
2149473|NCT01175135|3761844|FG001|Overall Study|Randomized But Not Treated|0
2149474|NCT01175135|3761845|FG002|Overall Study|Randomized But Not Treated|1
2149475|NCT01175135|3761846|FG003|Overall Study|Randomized But Not Treated|0
2149476|NCT01175213|3761868|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
2149477|NCT01175213|3761869|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
2149478|NCT01175213|3761868|FG000|IGSC, 10%/rHuPH20|Death|1
2149479|NCT01175213|3761869|FG001|IGSC, 10%/rHuPH20|Death|0
2149480|NCT01175213|3761868|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1
2149481|NCT01175213|3761869|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0
2149482|NCT01175213|3761868|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
2149483|NCT01175213|3761869|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
2149484|NCT01175213|3761868|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3
2149485|NCT01175213|3761869|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0
2149486|NCT01175213|3761868|FG000|Safety Follow-up|Adverse Event|1
2149487|NCT01175213|3761869|FG001|Safety Follow-up|Adverse Event|0
2149488|NCT01175356|3761900|FG000|Overall Study|Death|1
2149489|NCT01175356|3761900|FG000|Overall Study|Lack of Efficacy|12
2149490|NCT01175356|3761900|FG000|Overall Study|Lost to Follow-up|1
2149491|NCT01175356|3761900|FG000|Overall Study|Physician Decision|23
2149492|NCT01175356|3761900|FG000|Overall Study|Ineligible|1
2149493|NCT01175356|3761900|FG000|Overall Study|Treatment Slot Not Available|18
2149494|NCT01175356|3761900|FG000|Overall Study|Refusal by patient/parent/guardian|6
2149495|NCT01175356|3761900|FG000|Overall Study|Pts MIBG non-avid after enrollment|2
2149496|NCT01175356|3761900|FG000|Overall Study|On other COG study w/tumor tx intent|7
2149497|NCT01175356|3761900|FG000|Overall Study|Inadequate stem cell for transplant|1
2149498|NCT01175356|3761900|FG000|Overall Study|Initiation other tx prior to completion|9
2149499|NCT01175382|3761916|FG000|Overall Study|Lost to Follow-up|4
2149500|NCT01175382|3761917|FG001|Overall Study|Lost to Follow-up|3
2149501|NCT01175382|3761918|FG002|Overall Study|Lost to Follow-up|1
2149502|NCT01175382|3761916|FG000|Overall Study|Physician Decision|0
2149503|NCT01175382|3761917|FG001|Overall Study|Physician Decision|1
2149504|NCT01175382|3761918|FG002|Overall Study|Physician Decision|0
2149505|NCT01175382|3761916|FG000|Overall Study|Withdrawal by Subject|0
2149506|NCT01175382|3761917|FG001|Overall Study|Withdrawal by Subject|0
2149507|NCT01175382|3761918|FG002|Overall Study|Withdrawal by Subject|1
2149508|NCT01175382|3761916|FG000|Overall Study|No longer having problem|1
2149509|NCT01175382|3761917|FG001|Overall Study|No longer having problem|0
2149510|NCT01175382|3761918|FG002|Overall Study|No longer having problem|1
2149511|NCT01175382|3761916|FG000|Overall Study|Unable/unwilling to attend visits|3
2149512|NCT01175382|3761917|FG001|Overall Study|Unable/unwilling to attend visits|1
2149513|NCT01175382|3761918|FG002|Overall Study|Unable/unwilling to attend visits|2
2149514|NCT01175382|3761916|FG000|Overall Study|Unwilling to follow protocol|0
2149515|NCT01175382|3761917|FG001|Overall Study|Unwilling to follow protocol|1
2149516|NCT01175382|3761918|FG002|Overall Study|Unwilling to follow protocol|0
2149517|NCT01175382|3761916|FG000|Overall Study|Unable to tolerate study meds|0
2149518|NCT01175382|3761917|FG001|Overall Study|Unable to tolerate study meds|1
2149519|NCT01175382|3761918|FG002|Overall Study|Unable to tolerate study meds|1
2149520|NCT01175473|3761941|FG000|Overall Study|Adverse Event|2
2149521|NCT01175473|3761942|FG001|Overall Study|Adverse Event|2
2149522|NCT01175590|3761950|FG000|Overall Study|Lost to Follow-up|1
2149523|NCT01175590|3761951|FG001|Overall Study|Lost to Follow-up|0
2149524|NCT01175590|3761950|FG000|Overall Study|Withdrawal by Subject|0
2149525|NCT01175590|3761951|FG001|Overall Study|Withdrawal by Subject|2
2149526|NCT01175590|3761950|FG000|Overall Study|Adverse Event|4
2149527|NCT01175590|3761951|FG001|Overall Study|Adverse Event|0
2149528|NCT01175590|3761950|FG000|Overall Study|Physician Decision|1
2149529|NCT01175590|3761951|FG001|Overall Study|Physician Decision|4
2149530|NCT01175590|3761950|FG000|Overall Study|Lack of Efficacy|1
2149531|NCT01175590|3761951|FG001|Overall Study|Lack of Efficacy|1
2149532|NCT01175590|3761950|FG000|Overall Study|Residual Bacterial Conjunctivitis|1
2149533|NCT01175590|3761951|FG001|Overall Study|Residual Bacterial Conjunctivitis|0
2149534|NCT01175590|3761950|FG000|Overall Study|Treated not as randomized|3
2291259|NCT02500056|3984238|FG000|Overall Study|Lost to Follow-up|3
2291260|NCT02500056|3984239|FG001|Overall Study|Lost to Follow-up|7
2291261|NCT02500056|3984238|FG000|Overall Study|Recurrence|1
2149535|NCT01175590|3761951|FG001|Overall Study|Treated not as randomized|2
2291262|NCT02500056|3984239|FG001|Overall Study|Recurrence|0
2149536|NCT01175590|3761950|FG000|Overall Study|Herpes Simplex Dermatitis|1
2149537|NCT01175590|3761951|FG001|Overall Study|Herpes Simplex Dermatitis|0
2149538|NCT01175590|3761950|FG000|Overall Study|Protocol Violation|0
2149539|NCT01175590|3761951|FG001|Overall Study|Protocol Violation|1
2149540|NCT01175668|3761960|FG000|Overall Study|Withdrawal by Subject|2
2149541|NCT01175668|3761961|FG001|Overall Study|Withdrawal by Subject|0
2149542|NCT01175707|3761969|FG000|Overall Study|Adverse Event|4
2149543|NCT01175707|3761970|FG001|Overall Study|Adverse Event|6
2149544|NCT01175811|3761988|FG000|Overall Study|Adverse Event|1
2149545|NCT01175811|3761989|FG001|Overall Study|Adverse Event|1
2149546|NCT01175811|3761988|FG000|Overall Study|Entry criteria not met|3
2149547|NCT01175811|3761989|FG001|Overall Study|Entry criteria not met|1
2149548|NCT01175811|3761988|FG000|Overall Study|Lack of Efficacy|1
2149549|NCT01175811|3761989|FG001|Overall Study|Lack of Efficacy|0
2149550|NCT01175811|3761988|FG000|Overall Study|Lost to Follow-up|3
2149551|NCT01175811|3761989|FG001|Overall Study|Lost to Follow-up|2
2149552|NCT01175811|3761988|FG000|Overall Study|Physician Decision|1
2149553|NCT01175811|3761989|FG001|Overall Study|Physician Decision|1
2149554|NCT01175811|3761988|FG000|Overall Study|Protocol Violation|1
2149555|NCT01175811|3761989|FG001|Overall Study|Protocol Violation|2
2149556|NCT01175811|3761988|FG000|Overall Study|Withdrawal by Subject|6
2149557|NCT01175811|3761989|FG001|Overall Study|Withdrawal by Subject|7
2149558|NCT01175824|3761997|FG000|Overall Study|Adverse Event|2
2149559|NCT01175824|3761998|FG001|Overall Study|Adverse Event|1
2149560|NCT01175824|3761997|FG000|Overall Study|Lack of Efficacy|2
2149561|NCT01175824|3761998|FG001|Overall Study|Lack of Efficacy|0
2149562|NCT01175824|3761997|FG000|Overall Study|Lost to Follow-up|0
2149563|NCT01175824|3761998|FG001|Overall Study|Lost to Follow-up|1
2149564|NCT01175824|3761997|FG000|Overall Study|Physician Decision|0
2149565|NCT01175824|3761998|FG001|Overall Study|Physician Decision|4
2149566|NCT01175824|3761997|FG000|Overall Study|Protocol Violation|2
2149567|NCT01175824|3761998|FG001|Overall Study|Protocol Violation|5
2149568|NCT01175824|3761997|FG000|Overall Study|Withdrawal by Subject|3
2149569|NCT01175824|3761998|FG001|Overall Study|Withdrawal by Subject|7
2149570|NCT01175824|3761997|FG000|Overall Study|Sponsor Decision|1
2149571|NCT01175824|3761998|FG001|Overall Study|Sponsor Decision|0
2149572|NCT01175824|3761997|FG000|Overall Study|Entry Criteria Not Met|6
2149573|NCT01175824|3761998|FG001|Overall Study|Entry Criteria Not Met|4
2149574|NCT01176032|3762031|FG000|Overall Study|Adverse Event|1
2149575|NCT01176032|3762032|FG001|Overall Study|Adverse Event|0
2149576|NCT01176032|3762031|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2149577|NCT01176032|3762032|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2149578|NCT01176032|3762031|FG000|Overall Study|Protocol Violation|1
2149579|NCT01176032|3762032|FG001|Overall Study|Protocol Violation|0
2149580|NCT01176032|3762031|FG000|Overall Study|Informed consent withdrawn|3
2149581|NCT01176032|3762032|FG001|Overall Study|Informed consent withdrawn|0
2149582|NCT01176032|3762031|FG000|Overall Study|Other|1
2149583|NCT01176032|3762032|FG001|Overall Study|Other|0
2149584|NCT01176058|3762045|FG000|Overall Study|Adverse Event|1
2149585|NCT01176058|3762046|FG001|Overall Study|Adverse Event|0
2149586|NCT01176058|3762045|FG000|Overall Study|Insufficient clinical response|2
2149587|NCT01176058|3762046|FG001|Overall Study|Insufficient clinical response|2
2149588|NCT01176058|3762045|FG000|Overall Study|Insufficient mycological response|0
2149589|NCT01176058|3762046|FG001|Overall Study|Insufficient mycological response|1
2149590|NCT01176058|3762045|FG000|Overall Study|Withdrawal by Subject|1
2149591|NCT01176058|3762046|FG001|Overall Study|Withdrawal by Subject|0
2149592|NCT01176240|3762056|FG000|Study 306A|Lack of Efficacy|2
2149593|NCT01176240|3762057|FG001|Study 306A|Lack of Efficacy|1
2149594|NCT01176240|3762056|FG000|Study 306A|Protocol Violation|0
2149595|NCT01176240|3762057|FG001|Study 306A|Protocol Violation|1
2149596|NCT01176240|3762056|FG000|Study 306A|Withdrawal by Subject|0
2149597|NCT01176240|3762057|FG001|Study 306A|Withdrawal by Subject|1
2149598|NCT01176240|3762056|FG000|Study 306A|Stop due to diverse problems|1
2149599|NCT01176240|3762057|FG001|Study 306A|Stop due to diverse problems|0
2149600|NCT01176240|3762056|FG000|Study 306B|Lack of Efficacy|5
2149601|NCT01176240|3762057|FG001|Study 306B|Lack of Efficacy|3
2149602|NCT01176240|3762056|FG000|Study 306B|Adverse Event|10
2149603|NCT01176240|3762057|FG001|Study 306B|Adverse Event|5
2149604|NCT01176240|3762056|FG000|Study 306B|Protocol Violation|2
2149605|NCT01176240|3762057|FG001|Study 306B|Protocol Violation|3
2149606|NCT01176240|3762056|FG000|Study 306B|Withdrawal by Subject|4
2149607|NCT01176240|3762057|FG001|Study 306B|Withdrawal by Subject|1
2149608|NCT01176240|3762056|FG000|Study 306B|Physician Decision|2
2149609|NCT01176240|3762057|FG001|Study 306B|Physician Decision|1
2149610|NCT01176240|3762056|FG000|Study 306B|Supine Hypertension|1
2149611|NCT01176240|3762057|FG001|Study 306B|Supine Hypertension|2
2149612|NCT01176240|3762056|FG000|Study 306B|Lost to Follow-up|0
2149613|NCT01176240|3762057|FG001|Study 306B|Lost to Follow-up|1
2149614|NCT01176240|3762056|FG000|Study 306B|withdrew prior to dosing|2
2149615|NCT01176240|3762057|FG001|Study 306B|withdrew prior to dosing|1
2149616|NCT01176266|3762063|FG000|Overall Study|Death|6
2149617|NCT01176266|3762063|FG000|Overall Study|Withdrawal by Subject|3
2149618|NCT01176292|3762073|FG000|Overall Study|Lost to Follow-up|2
2149619|NCT01176292|3762074|FG001|Overall Study|Lost to Follow-up|4
2149620|NCT01176292|3762073|FG000|Overall Study|Adverse Event|1
2149621|NCT01176292|3762074|FG001|Overall Study|Adverse Event|1
2291263|NCT02500056|3984238|FG000|Overall Study|Death|3
2291264|NCT02500056|3984239|FG001|Overall Study|Death|1
2291265|NCT02500537|3984254|FG000|Overall Study|Death|2
2291266|NCT02500537|3984255|FG001|Overall Study|Death|0
2291267|NCT02500537|3984254|FG000|Overall Study|Lost to Follow-up|0
2291268|NCT02500537|3984255|FG001|Overall Study|Lost to Follow-up|1
2291269|NCT02500537|3984254|FG000|Overall Study|Withdrawal by Subject|1
2291270|NCT02500537|3984255|FG001|Overall Study|Withdrawal by Subject|0
2291271|NCT02500550|3984262|FG000|Overall Study|Death|7
2149622|NCT01176292|3762073|FG000|Overall Study|Physician Decision|0
2149623|NCT01176292|3762074|FG001|Overall Study|Physician Decision|2
2149624|NCT01176292|3762073|FG000|Overall Study|Has not scheduled one-year visit yet|2
2149625|NCT01176292|3762074|FG001|Overall Study|Has not scheduled one-year visit yet|2
2149626|NCT01176565|3762103|FG000|Overall Study|Lost to Follow-up|12
2149627|NCT01176565|3762104|FG001|Overall Study|Lost to Follow-up|16
2149628|NCT01176565|3762103|FG000|Overall Study|Withdrawal by Subject|7
2149629|NCT01176565|3762104|FG001|Overall Study|Withdrawal by Subject|1
2149630|NCT01176565|3762103|FG000|Overall Study|Not Analyzed (any other reason)|1
2149631|NCT01176565|3762104|FG001|Overall Study|Not Analyzed (any other reason)|2
2149632|NCT01176773|3762133|FG000|Overall Study|Screen Failure|2
2149633|NCT01176773|3762133|FG000|Overall Study|Withdrew consent|1
2149634|NCT01176916|3762143|FG000|Overall Study|Adverse Event|61
2149635|NCT01176916|3762143|FG000|Overall Study|Death|1
2149636|NCT01176916|3762143|FG000|Overall Study|Lost to Follow-up|15
2149637|NCT01176916|3762143|FG000|Overall Study|Objective progression or relapse|17
2149638|NCT01176916|3762143|FG000|Overall Study|Protocol Violation|24
2149639|NCT01176916|3762143|FG000|Overall Study|Withdrawal by Subject|37
2149640|NCT01176916|3762143|FG000|Overall Study|Other|6
2149641|NCT01176916|3762143|FG000|Overall Study|Withdrawal prior to Treatment|6
2149642|NCT01176968|3762161|FG000|Overall Study|Adverse Event|10
2149643|NCT01176968|3762162|FG001|Overall Study|Adverse Event|11
2149644|NCT01176968|3762161|FG000|Overall Study|Death|2
2149645|NCT01176968|3762162|FG001|Overall Study|Death|3
2149646|NCT01176968|3762161|FG000|Overall Study|Lack of Efficacy|0
2149647|NCT01176968|3762162|FG001|Overall Study|Lack of Efficacy|1
2149648|NCT01176968|3762161|FG000|Overall Study|Lost to Follow-up|16
2149649|NCT01176968|3762162|FG001|Overall Study|Lost to Follow-up|14
2149650|NCT01176968|3762161|FG000|Overall Study|Withdrawal by Subject|48
2149651|NCT01176968|3762162|FG001|Overall Study|Withdrawal by Subject|48
2149652|NCT01176968|3762161|FG000|Overall Study|Protocol Violation|2
2149653|NCT01176968|3762162|FG001|Overall Study|Protocol Violation|1
2149654|NCT01176968|3762161|FG000|Overall Study|Did Not Meet Entrance Criteria|1
2149655|NCT01176968|3762162|FG001|Overall Study|Did Not Meet Entrance Criteria|0
2149656|NCT01176968|3762161|FG000|Overall Study|Study terminated by sponsor|0
2149657|NCT01176968|3762162|FG001|Overall Study|Study terminated by sponsor|1
2149658|NCT01176968|3762161|FG000|Overall Study|Reason not defined|5
2149659|NCT01176968|3762162|FG001|Overall Study|Reason not defined|3
2149660|NCT01177007|3762172|FG000|Overall Study|Lost to Follow-up|2
2149661|NCT01177007|3762172|FG000|Overall Study|Death|4
2149662|NCT01177007|3762172|FG000|Overall Study|Entered hospice care|5
2149663|NCT01177007|3762172|FG000|Overall Study|Required additional Y90 treatment|6
2149664|NCT01177007|3762172|FG000|Overall Study|Change in treatment modality|21
2149665|NCT01177059|3762178|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
2149666|NCT01177059|3762178|FG000|Overall Study|Withdrew consent|2
2149667|NCT01177059|3762178|FG000|Overall Study|Lost to Follow-up|18
2149668|NCT01177137|3762194|FG000|Overall Study|Withdrawal by Subject|10
2149669|NCT01177137|3762195|FG001|Overall Study|Withdrawal by Subject|10
2149670|NCT01177137|3762196|FG002|Overall Study|Withdrawal by Subject|2
2149671|NCT01177228|3762220|FG000|Overall Study|Positive tuberculosis test|0
2149672|NCT01177228|3762221|FG001|Overall Study|Positive tuberculosis test|1
2149673|NCT01177228|3762222|FG002|Overall Study|Positive tuberculosis test|0
2149674|NCT01177228|3762223|FG003|Overall Study|Positive tuberculosis test|0
2149675|NCT01177228|3762220|FG000|Overall Study|Worsening disease activity|1
2149676|NCT01177228|3762221|FG001|Overall Study|Worsening disease activity|0
2149677|NCT01177228|3762222|FG002|Overall Study|Worsening disease activity|0
2149678|NCT01177228|3762223|FG003|Overall Study|Worsening disease activity|0
2149679|NCT01177228|3762220|FG000|Overall Study|Withdrawal by Subject|0
2149680|NCT01177228|3762221|FG001|Overall Study|Withdrawal by Subject|1
2149681|NCT01177228|3762222|FG002|Overall Study|Withdrawal by Subject|0
2149682|NCT01177228|3762223|FG003|Overall Study|Withdrawal by Subject|0
2149683|NCT01177293|3762238|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0
2149684|NCT01177293|3762239|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1
2149685|NCT01177384|3762247|FG000|Overall Study|Adverse Event|6
2149686|NCT01177384|3762248|FG001|Overall Study|Adverse Event|4
2149687|NCT01177384|3762247|FG000|Overall Study|Lack of Efficacy|0
2149688|NCT01177384|3762248|FG001|Overall Study|Lack of Efficacy|1
2149689|NCT01177384|3762247|FG000|Overall Study|Lost to Follow-up|3
2149690|NCT01177384|3762248|FG001|Overall Study|Lost to Follow-up|4
2149691|NCT01177384|3762247|FG000|Overall Study|Physician Decision|0
2149692|NCT01177384|3762248|FG001|Overall Study|Physician Decision|3
2149693|NCT01177384|3762247|FG000|Overall Study|Protocol Violation|0
2149694|NCT01177384|3762248|FG001|Overall Study|Protocol Violation|2
2291272|NCT02500641|3984290|FG000|Overall Study|Adverse Event|0
2291273|NCT02500641|3984291|FG001|Overall Study|Adverse Event|2
2149695|NCT01177384|3762247|FG000|Overall Study|Withdrawal by Subject|5
2149696|NCT01177384|3762248|FG001|Overall Study|Withdrawal by Subject|12
2149697|NCT01177410|3762257|FG000|Overall Study|Adverse Event|0
2149698|NCT01177410|3762258|FG001|Overall Study|Adverse Event|2
2149699|NCT01177410|3762259|FG002|Overall Study|Adverse Event|2
2149700|NCT01177410|3762257|FG000|Overall Study|Withdrawal by Subject|1
2149701|NCT01177410|3762258|FG001|Overall Study|Withdrawal by Subject|4
2149702|NCT01177410|3762259|FG002|Overall Study|Withdrawal by Subject|3
2149703|NCT01177410|3762257|FG000|Overall Study|Lost to Follow-up|0
2149704|NCT01177410|3762258|FG001|Overall Study|Lost to Follow-up|1
2149705|NCT01177410|3762259|FG002|Overall Study|Lost to Follow-up|0
2149706|NCT01177553|3762269|FG000|Overall Study|babies not yet 6 months of age|1
2149707|NCT01177553|3762270|FG001|Overall Study|babies not yet 6 months of age|0
2149708|NCT01177670|3762276|FG000|Overall Study|Study Terminated|115
2149709|NCT01177670|3762276|FG000|Overall Study|Physician Decision|50
2149710|NCT01177670|3762276|FG000|Overall Study|Withdrawal by Subject|4
2149711|NCT01177722|3762288|FG000|Overall Study|Serious Adverse Event|0
2149712|NCT01177722|3762289|FG001|Overall Study|Serious Adverse Event|0
2149713|NCT01177722|3762290|FG002|Overall Study|Serious Adverse Event|1
2149714|NCT01177722|3762291|FG003|Overall Study|Serious Adverse Event|0
2149715|NCT01177722|3762288|FG000|Overall Study|Protocol Violation|0
2149716|NCT01177722|3762289|FG001|Overall Study|Protocol Violation|0
2149717|NCT01177722|3762290|FG002|Overall Study|Protocol Violation|1
2149718|NCT01177722|3762291|FG003|Overall Study|Protocol Violation|0
2149719|NCT01177722|3762288|FG000|Overall Study|Lost to Follow-up|3
2149720|NCT01177722|3762289|FG001|Overall Study|Lost to Follow-up|4
2149721|NCT01177722|3762290|FG002|Overall Study|Lost to Follow-up|3
2149722|NCT01177722|3762291|FG003|Overall Study|Lost to Follow-up|1
2149723|NCT01177722|3762288|FG000|Overall Study|Withdrawal by Subject|10
2149724|NCT01177722|3762289|FG001|Overall Study|Withdrawal by Subject|6
2149725|NCT01177722|3762290|FG002|Overall Study|Withdrawal by Subject|4
2149726|NCT01177722|3762291|FG003|Overall Study|Withdrawal by Subject|6
2149727|NCT01177787|3762306|FG000|Cryolipolysis on Thigh|Protocol Violation|4
2149728|NCT01177787|3762306|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9
2149729|NCT01177787|3762306|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1
2149730|NCT01177800|3762320|FG000|Overall Study|Adverse Event|9
2149731|NCT01177800|3762321|FG001|Overall Study|Adverse Event|3
2149732|NCT01177800|3762320|FG000|Overall Study|Protocol Violation|0
2149733|NCT01177800|3762321|FG001|Overall Study|Protocol Violation|1
2149734|NCT01177800|3762320|FG000|Overall Study|Physician Decision|1
2149735|NCT01177800|3762321|FG001|Overall Study|Physician Decision|0
2149736|NCT01177800|3762320|FG000|Overall Study|Withdrawal of informed consent|0
2149737|NCT01177800|3762321|FG001|Overall Study|Withdrawal of informed consent|1
2149738|NCT01177813|3762332|FG000|Overall Study|Adverse Event|8
2149739|NCT01177813|3762333|FG001|Overall Study|Adverse Event|2
2149740|NCT01177813|3762334|FG002|Overall Study|Adverse Event|4
2149741|NCT01177813|3762335|FG003|Overall Study|Adverse Event|6
2149742|NCT01177813|3762336|FG004|Overall Study|Adverse Event|3
2149743|NCT01177813|3762332|FG000|Overall Study|Lack of Efficacy|1
2149744|NCT01177813|3762333|FG001|Overall Study|Lack of Efficacy|0
2149745|NCT01177813|3762334|FG002|Overall Study|Lack of Efficacy|0
2149746|NCT01177813|3762335|FG003|Overall Study|Lack of Efficacy|0
2149747|NCT01177813|3762336|FG004|Overall Study|Lack of Efficacy|0
2149748|NCT01177813|3762332|FG000|Overall Study|Protocol Violation|3
2149749|NCT01177813|3762333|FG001|Overall Study|Protocol Violation|2
2149750|NCT01177813|3762334|FG002|Overall Study|Protocol Violation|2
2149751|NCT01177813|3762335|FG003|Overall Study|Protocol Violation|0
2149752|NCT01177813|3762336|FG004|Overall Study|Protocol Violation|1
2149753|NCT01177813|3762332|FG000|Overall Study|Lost to Follow-up|12
2149754|NCT01177813|3762333|FG001|Overall Study|Lost to Follow-up|5
2149755|NCT01177813|3762334|FG002|Overall Study|Lost to Follow-up|6
2149756|NCT01177813|3762335|FG003|Overall Study|Lost to Follow-up|3
2149757|NCT01177813|3762336|FG004|Overall Study|Lost to Follow-up|0
2149758|NCT01177813|3762332|FG000|Overall Study|Withdrawal by Subject|12
2149759|NCT01177813|3762333|FG001|Overall Study|Withdrawal by Subject|7
2149760|NCT01177813|3762334|FG002|Overall Study|Withdrawal by Subject|6
2149761|NCT01177813|3762335|FG003|Overall Study|Withdrawal by Subject|5
2149762|NCT01177813|3762336|FG004|Overall Study|Withdrawal by Subject|3
2149763|NCT01177813|3762332|FG000|Overall Study|Other reason not defined above|5
2149764|NCT01177813|3762333|FG001|Overall Study|Other reason not defined above|2
2149765|NCT01177813|3762334|FG002|Overall Study|Other reason not defined above|2
2149766|NCT01177813|3762335|FG003|Overall Study|Other reason not defined above|3
2291274|NCT02500641|3984290|FG000|Overall Study|Withdrawal by Subject|4
2291275|NCT02500641|3984291|FG001|Overall Study|Withdrawal by Subject|5
2149767|NCT01177813|3762336|FG004|Overall Study|Other reason not defined above|2
2149768|NCT01177943|3762350|FG000|First Intervention|Withdrawal by Subject|2
2149769|NCT01177943|3762351|FG001|First Intervention|Withdrawal by Subject|0
2149770|NCT01177969|3762364|FG000|Overall Study|Protocol Violation|2
2149771|NCT01177969|3762365|FG001|Overall Study|Protocol Violation|1
2149772|NCT01177969|3762364|FG000|Overall Study|Withdrawal by Subject|1
2149773|NCT01177969|3762365|FG001|Overall Study|Withdrawal by Subject|2
2149774|NCT01178073|3762374|FG000|Overall Study|Adverse Event|34
2149775|NCT01178073|3762375|FG001|Overall Study|Adverse Event|27
2149776|NCT01178073|3762376|FG002|Overall Study|Adverse Event|24
2149777|NCT01178073|3762374|FG000|Overall Study|Protocol Violation|1
2149778|NCT01178073|3762375|FG001|Overall Study|Protocol Violation|1
2149779|NCT01178073|3762376|FG002|Overall Study|Protocol Violation|1
2149780|NCT01178073|3762374|FG000|Overall Study|Lost to Follow-up|2
2149781|NCT01178073|3762375|FG001|Overall Study|Lost to Follow-up|0
2149782|NCT01178073|3762376|FG002|Overall Study|Lost to Follow-up|3
2149783|NCT01178073|3762374|FG000|Overall Study|Physician Decision|14
2149784|NCT01178073|3762375|FG001|Overall Study|Physician Decision|10
2149785|NCT01178073|3762376|FG002|Overall Study|Physician Decision|10
2149786|NCT01178073|3762374|FG000|Overall Study|Withdrawal by Subject|10
2149787|NCT01178073|3762375|FG001|Overall Study|Withdrawal by Subject|6
2149788|NCT01178073|3762376|FG002|Overall Study|Withdrawal by Subject|8
2149789|NCT01178073|3762374|FG000|Overall Study|Missing Completion Status|1
2149790|NCT01178073|3762375|FG001|Overall Study|Missing Completion Status|0
2149791|NCT01178073|3762376|FG002|Overall Study|Missing Completion Status|0
2149792|NCT01178086|3762387|FG000|Overall Study|Participant refusal|7
2149793|NCT01178086|3762387|FG000|Overall Study|Physician Decision|44
2149794|NCT01178086|3762387|FG000|Overall Study|Switch to other CLL therapy|113
2149795|NCT01178086|3762387|FG000|Overall Study|Death|59
2149796|NCT01178086|3762387|FG000|Overall Study|Other unspecified|89
2149797|NCT01178086|3762387|FG000|Overall Study|Excluded from EAS|20
2149798|NCT01178099|3762397|FG000|Overall Study|Physician Decision|0
2149799|NCT01178099|3762398|FG001|Overall Study|Physician Decision|1
2149800|NCT01178125|3762408|FG000|Overall Study|Lost to Follow-up|397
2149801|NCT01178125|3762408|FG000|Overall Study|Adverse Event|244
2149802|NCT01178125|3762408|FG000|Overall Study|Withdrawal by Subject|209
2149803|NCT01178125|3762408|FG000|Overall Study|Noncompliance|184
2149804|NCT01178125|3762408|FG000|Overall Study|Pregnancy|55
2149805|NCT01178125|3762408|FG000|Overall Study|Other Reason|39
2149806|NCT01178125|3762408|FG000|Overall Study|Sponsor Decision|28
2149807|NCT01178125|3762408|FG000|Overall Study|Protocol Violation|17
2149808|NCT01178125|3762408|FG000|Overall Study|Investigator Decision|5
2149809|NCT01178138|3762417|FG000|Overall Study|Lost to Follow-up|8
2149810|NCT01178138|3762417|FG000|Overall Study|Withdrawal by Subject|7
2149811|NCT01178138|3762417|FG000|Overall Study|Physician Decision|8
2149812|NCT01178294|3762454|FG000|Overall Study|Adverse Event|4
2149813|NCT01178294|3762454|FG000|Overall Study|Lost to Follow-up|2
2149814|NCT01178294|3762454|FG000|Overall Study|Lack of Efficacy|1
2149815|NCT01178294|3762454|FG000|Overall Study|Death|1
2149816|NCT01178294|3762454|FG000|Overall Study|Development of inhibitors to OBI-1|1
2149817|NCT01178294|3762454|FG000|Overall Study|Subject status is terminal|1
2149818|NCT01178294|3762454|FG000|Overall Study|Completion status could not be verified|1
2149819|NCT01178385|3762475|FG000|Overall Study|Withdrawal by Subject|2
2149820|NCT01178385|3762476|FG001|Overall Study|Withdrawal by Subject|0
2149821|NCT01178411|3762482|FG000|Overall Study|Adverse Event|5
2149822|NCT01178411|3762482|FG000|Overall Study|Withdrawal by Subject|4
2149823|NCT01178411|3762482|FG000|Overall Study|Protocol Violation|1
2149824|NCT01178411|3762482|FG000|Overall Study|Progressive disease per RECIST|32
2149825|NCT01178411|3762482|FG000|Overall Study|Progressive disease per clinician|9
2149826|NCT01178411|3762482|FG000|Overall Study|Physician Decision|6
2149827|NCT01178411|3762482|FG000|Overall Study|Death|1
2149828|NCT01178411|3762482|FG000|Overall Study|No reason provided|1
2149829|NCT01178411|3762482|FG000|Overall Study|Drug manufacturing ended|1
2149830|NCT01178671|3762502|FG000|Overall Study|Adverse Event|4
2149831|NCT01178671|3762503|FG001|Overall Study|Adverse Event|6
2149832|NCT01178671|3762502|FG000|Overall Study|Protocol Violation|1
2149833|NCT01178671|3762503|FG001|Overall Study|Protocol Violation|1
2149834|NCT01178671|3762502|FG000|Overall Study|Lack of Efficacy|0
2149835|NCT01178671|3762503|FG001|Overall Study|Lack of Efficacy|1
2149836|NCT01178671|3762502|FG000|Overall Study|Lost to Follow-up|3
2149837|NCT01178671|3762503|FG001|Overall Study|Lost to Follow-up|1
2149838|NCT01178671|3762502|FG000|Overall Study|Physician Decision|4
2149839|NCT01178671|3762503|FG001|Overall Study|Physician Decision|6
2149840|NCT01178762|3762509|FG000|Overall Study|Lost to Follow-up|15
2149841|NCT01178853|3762528|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1
2149842|NCT01178853|3762529|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2
2149843|NCT01178853|3762528|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
2149844|NCT01178853|3762529|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
2149845|NCT01178853|3762528|FG000|Period 3 (Warfarin Titration)|Adverse Event|1
2149846|NCT01178853|3762529|FG001|Period 3 (Warfarin Titration)|Adverse Event|0
2149847|NCT01178853|3762528|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0
2149848|NCT01178853|3762529|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2
2149849|NCT01178853|3762528|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
2149850|NCT01178853|3762529|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
2149851|NCT01179048|3762541|FG000|Overall Study|Withdrawn - does not allow contact|4
2149852|NCT01179048|3762542|FG001|Overall Study|Withdrawn - does not allow contact|8
2149853|NCT01179048|3762541|FG000|Overall Study|Lost to Follow-up|8
2149854|NCT01179048|3762542|FG001|Overall Study|Lost to Follow-up|9
2149855|NCT01179048|3762541|FG000|Overall Study|Alive|127
2149856|NCT01179048|3762542|FG001|Overall Study|Alive|142
2149857|NCT01179191|3762557|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47
2149858|NCT01179191|3762557|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
2149859|NCT01179191|3762557|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30
2179107|NCT01391819|3804583|FG000|Overall Study|Death|3
2149860|NCT01179191|3762557|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
2149861|NCT01179191|3762557|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
2149862|NCT01179191|3762557|FG000|Titration Phase (up to 6 Weeks)|Other|62
2149863|NCT01179191|3762557|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10
2149864|NCT01179191|3762557|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
2149865|NCT01179191|3762557|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3
2149866|NCT01179191|3762557|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
2149867|NCT01179191|3762557|FG000|Maintenance Phase (8 Weeks)|Other|66
2149868|NCT01179334|3762574|FG000|Treatment Period|Adverse Event|1
2149869|NCT01179334|3762575|FG001|Treatment Period|Adverse Event|0
2149870|NCT01179334|3762574|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6
2149871|NCT01179334|3762575|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2
2149872|NCT01179334|3762574|FG000|Long-term Extension (LTE) Period|Death|3
2149873|NCT01179334|3762575|FG001|Long-term Extension (LTE) Period|Death|0
2149874|NCT01179334|3762574|FG000|Long-term Extension (LTE) Period|Adverse Event|2
2149875|NCT01179334|3762575|FG001|Long-term Extension (LTE) Period|Adverse Event|4
2149876|NCT01179347|3762583|FG000|Double-blind Period (12 Weeks)|Adverse Event|2
2149877|NCT01179347|3762584|FG001|Double-blind Period (12 Weeks)|Adverse Event|6
2149878|NCT01179347|3762583|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2
2149879|NCT01179347|3762584|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0
2149880|NCT01179347|3762583|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1
2149881|NCT01179347|3762584|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2
2149882|NCT01179347|3762583|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
2149883|NCT01179347|3762584|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
2149884|NCT01179347|3762583|FG000|Double-blind Period (12 Weeks)|Other|2
2149885|NCT01179347|3762584|FG001|Double-blind Period (12 Weeks)|Other|4
2149886|NCT01179347|3762583|FG000|Open-label Period (12 Weeks)|Adverse Event|5
2149887|NCT01179347|3762584|FG001|Open-label Period (12 Weeks)|Adverse Event|9
2149888|NCT01179347|3762583|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0
2149889|NCT01179347|3762584|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2
2149890|NCT01179347|3762583|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1
2149891|NCT01179347|3762584|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0
2149892|NCT01179347|3762583|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1
2149893|NCT01179347|3762584|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1
2149894|NCT01179347|3762583|FG000|Open-label Period (12 Weeks)|Protocol Violation|1
2149895|NCT01179347|3762584|FG001|Open-label Period (12 Weeks)|Protocol Violation|0
2149896|NCT01179347|3762583|FG000|Open-label Period (12 Weeks)|Other|7
2149897|NCT01179347|3762584|FG001|Open-label Period (12 Weeks)|Other|4
2149898|NCT01179477|3762592|FG000|Overall Study|Death|542
2149899|NCT01179477|3762592|FG000|Overall Study|Unsuccessful implant|80
2149900|NCT01179477|3762592|FG000|Overall Study|Non-death withdrawal|438
2149901|NCT01179477|3762592|FG000|Overall Study|Did not complete final visit|27
2149902|NCT01179516|3762603|FG000|Overall Study|Pretreatment Event or Adverse Event|6
2149903|NCT01179516|3762604|FG001|Overall Study|Pretreatment Event or Adverse Event|8
2149904|NCT01179516|3762605|FG002|Overall Study|Pretreatment Event or Adverse Event|12
2149905|NCT01179516|3762603|FG000|Overall Study|Lack of Efficacy|4
2149906|NCT01179516|3762604|FG001|Overall Study|Lack of Efficacy|2
2149907|NCT01179516|3762605|FG002|Overall Study|Lack of Efficacy|0
2149908|NCT01179516|3762603|FG000|Overall Study|Noncompliance with Study Drug|2
2149909|NCT01179516|3762604|FG001|Overall Study|Noncompliance with Study Drug|0
2149910|NCT01179516|3762605|FG002|Overall Study|Noncompliance with Study Drug|1
2149911|NCT01179516|3762603|FG000|Overall Study|Protocol Deviations|4
2149912|NCT01179516|3762604|FG001|Overall Study|Protocol Deviations|3
2149913|NCT01179516|3762605|FG002|Overall Study|Protocol Deviations|3
2149914|NCT01179516|3762603|FG000|Overall Study|Withdrawal of Consent|2
2149915|NCT01179516|3762604|FG001|Overall Study|Withdrawal of Consent|6
2149916|NCT01179516|3762605|FG002|Overall Study|Withdrawal of Consent|10
2149917|NCT01179516|3762603|FG000|Overall Study|Lost to Follow-up|7
2149918|NCT01179516|3762604|FG001|Overall Study|Lost to Follow-up|7
2149919|NCT01179516|3762605|FG002|Overall Study|Lost to Follow-up|3
2149920|NCT01179516|3762603|FG000|Overall Study|Other|2
2149921|NCT01179516|3762604|FG001|Overall Study|Other|0
2149922|NCT01179516|3762605|FG002|Overall Study|Other|2
2149923|NCT01179672|3762635|FG000|Overall Study|Adverse Event|17
2149924|NCT01179672|3762636|FG001|Overall Study|Adverse Event|8
2149925|NCT01179672|3762635|FG000|Overall Study|Withdrawal by Subject|10
2149926|NCT01179672|3762636|FG001|Overall Study|Withdrawal by Subject|12
2149927|NCT01179672|3762635|FG000|Overall Study|Entry Criteria Not Met|0
2149928|NCT01179672|3762636|FG001|Overall Study|Entry Criteria Not Met|2
2149929|NCT01179672|3762635|FG000|Overall Study|Lost to Follow-up|0
2149930|NCT01179672|3762636|FG001|Overall Study|Lost to Follow-up|1
2149931|NCT01179672|3762635|FG000|Overall Study|Protocol Violation|2
2149932|NCT01179672|3762636|FG001|Overall Study|Protocol Violation|2
2149933|NCT01179672|3762635|FG000|Overall Study|Physician Decision|1
2149934|NCT01179672|3762636|FG001|Overall Study|Physician Decision|1
2149935|NCT01179919|3762646|FG000|Overall Study|Protocol Violation|1
2149936|NCT01179919|3762646|FG000|Overall Study|Adverse Event|1
2149937|NCT01180049|3762668|FG000|Overall Study|Other|9
2149938|NCT01180049|3762669|FG001|Overall Study|Other|7
2149939|NCT01180049|3762668|FG000|Overall Study|Lost to Follow-up|8
2149940|NCT01180049|3762669|FG001|Overall Study|Lost to Follow-up|6
2149941|NCT01180049|3762668|FG000|Overall Study|Death|36
2149942|NCT01180049|3762669|FG001|Overall Study|Death|35
2149943|NCT01180244|3762698|FG000|Overall Study|Lack of Efficacy|0
2149944|NCT01180244|3762699|FG001|Overall Study|Lack of Efficacy|7
2149945|NCT01180244|3762698|FG000|Overall Study|Physician Decision|3
2149946|NCT01180244|3762699|FG001|Overall Study|Physician Decision|0
2149947|NCT01180244|3762698|FG000|Overall Study|Adverse Event|1
2149948|NCT01180244|3762699|FG001|Overall Study|Adverse Event|0
2149949|NCT01180244|3762698|FG000|Overall Study|Withdrawal by Subject|0
2149950|NCT01180244|3762699|FG001|Overall Study|Withdrawal by Subject|1
2149951|NCT01180244|3762698|FG000|Overall Study|Protocol Violation|1
2149952|NCT01180244|3762699|FG001|Overall Study|Protocol Violation|0
2149953|NCT01180244|3762698|FG000|Overall Study|Lost to Follow-up|1
2149954|NCT01180244|3762699|FG001|Overall Study|Lost to Follow-up|0
2179108|NCT01391819|3804583|FG000|Overall Study|Other|9
2179109|NCT01391832|3804592|FG000|Overall Study|Withdrawal by Subject|21
2179110|NCT01391832|3804593|FG001|Overall Study|Withdrawal by Subject|22
2179111|NCT01391832|3804592|FG000|Overall Study|Lost to Follow-up|0
2179112|NCT01391832|3804593|FG001|Overall Study|Lost to Follow-up|1
2179113|NCT01392183|3804619|FG000|First Drug Administration|Adverse Event|3
2179114|NCT01392183|3804620|FG001|First Drug Administration|Adverse Event|2
2179115|NCT01392183|3804619|FG000|First Drug Administration|Death|1
2179116|NCT01392183|3804620|FG001|First Drug Administration|Death|0
2179117|NCT01392183|3804619|FG000|First Drug Administration|Withdrawal by Subject|10
2179118|NCT01392183|3804620|FG001|First Drug Administration|Withdrawal by Subject|17
2179119|NCT01392300|3804630|FG000|Main Period (MP)|Predefined discontinuation criteria|2
2179120|NCT01392300|3804631|FG001|Main Period (MP)|Predefined discontinuation criteria|3
2179121|NCT01392300|3804632|FG002|Main Period (MP)|Predefined discontinuation criteria|0
2179122|NCT01392300|3804630|FG000|Main Period (MP)|Withdrawal by Subject|5
2179123|NCT01392300|3804631|FG001|Main Period (MP)|Withdrawal by Subject|1
2179124|NCT01392300|3804632|FG002|Main Period (MP)|Withdrawal by Subject|0
2179125|NCT01392300|3804630|FG000|Main Period (MP)|Lost to Follow-up|3
2179126|NCT01392300|3804631|FG001|Main Period (MP)|Lost to Follow-up|3
2179127|NCT01392300|3804632|FG002|Main Period (MP)|Lost to Follow-up|0
2179128|NCT01392300|3804630|FG000|Main Period (MP)|Non-compliance|1
2179129|NCT01392300|3804631|FG001|Main Period (MP)|Non-compliance|0
2179130|NCT01392300|3804632|FG002|Main Period (MP)|Non-compliance|0
2179131|NCT01392300|3804630|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0
2179132|NCT01392300|3804631|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0
2179133|NCT01392300|3804632|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13
2179134|NCT01392300|3804630|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0
2179135|NCT01392300|3804631|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0
2179136|NCT01392300|3804632|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3
2179137|NCT01392300|3804630|FG000|Open Label Extension (OLEX) Period|Non-compliance|0
2179138|NCT01392300|3804631|FG001|Open Label Extension (OLEX) Period|Non-compliance|0
2291276|NCT02500641|3984290|FG000|Overall Study|Unable to follow study procedures|3
2291277|NCT02500641|3984291|FG001|Overall Study|Unable to follow study procedures|2
2291278|NCT02500641|3984290|FG000|Overall Study|Protocol Violation|1
2291279|NCT02500641|3984291|FG001|Overall Study|Protocol Violation|2
2291280|NCT02500641|3984290|FG000|Overall Study|Lost to Follow-up|1
2291281|NCT02500641|3984291|FG001|Overall Study|Lost to Follow-up|0
2291282|NCT02500641|3984290|FG000|Overall Study|Sponsor decision|1
2291283|NCT02500641|3984291|FG001|Overall Study|Sponsor decision|0
2291284|NCT02500641|3984290|FG000|Overall Study|Non compliance to study drug|0
2291285|NCT02500641|3984291|FG001|Overall Study|Non compliance to study drug|1
2291286|NCT02500706|3984300|FG000|Overall Study|Adverse Event|0
2291287|NCT02500706|3984301|FG001|Overall Study|Adverse Event|0
2291288|NCT02500706|3984302|FG002|Overall Study|Adverse Event|1
2291289|NCT02500706|3984300|FG000|Overall Study|Lost to Follow-up|0
2291290|NCT02500706|3984301|FG001|Overall Study|Lost to Follow-up|1
2291291|NCT02500706|3984302|FG002|Overall Study|Lost to Follow-up|1
2291292|NCT02500706|3984300|FG000|Overall Study|Withdrawal by Subject|4
2291293|NCT02500706|3984301|FG001|Overall Study|Withdrawal by Subject|6
2291294|NCT02500706|3984302|FG002|Overall Study|Withdrawal by Subject|4
2291295|NCT02500706|3984300|FG000|Overall Study|Unclassified|0
2291296|NCT02500706|3984301|FG001|Overall Study|Unclassified|0
2291297|NCT02500706|3984302|FG002|Overall Study|Unclassified|1
2291298|NCT02500719|3984312|FG000|Overall Study|Lost to Follow-up|2
2291299|NCT02500719|3984313|FG001|Overall Study|Lost to Follow-up|3
2291300|NCT02500719|3984312|FG000|Overall Study|Trauma history|1
2291301|NCT02500719|3984313|FG001|Overall Study|Trauma history|0
2291302|NCT02500719|3984312|FG000|Overall Study|MRI data found to be unusable during analysis|0
2291303|NCT02500719|3984313|FG001|Overall Study|MRI data found to be unusable during analysis|1
2291304|NCT02500719|3984312|FG000|Overall Study|Did not meet criteria for PTSD|0
2291305|NCT02500719|3984313|FG001|Overall Study|Did not meet criteria for PTSD|1
2291306|NCT02500719|3984312|FG000|Overall Study|Claustrophobia|0
2291307|NCT02500719|3984313|FG001|Overall Study|Claustrophobia|1
2291308|NCT02500719|3984312|FG000|Overall Study|History of head trauma|0
2291309|NCT02500719|3984313|FG001|Overall Study|History of head trauma|1
2291310|NCT02500732|3984321|FG000|Overall Study|Physician Decision|0
2291311|NCT02500732|3984322|FG001|Overall Study|Physician Decision|1
2149955|NCT01180296|3762707|FG000|Overall Study|Protocol Violation|1
2149956|NCT01180296|3762708|FG001|Overall Study|Protocol Violation|2
2149957|NCT01180400|3762718|FG000|Overall Study|Withdrawal by Subject|5
2149958|NCT01180400|3762719|FG001|Overall Study|Withdrawal by Subject|6
2149959|NCT01180400|3762718|FG000|Overall Study|Eligibility criteria not fulfilled|0
2149960|NCT01180400|3762719|FG001|Overall Study|Eligibility criteria not fulfilled|2
2149961|NCT01180400|3762718|FG000|Overall Study|Adverse Event|12
2149962|NCT01180400|3762719|FG001|Overall Study|Adverse Event|10
2149963|NCT01180400|3762718|FG000|Overall Study|Severe non-compliance to protocol|1
2149964|NCT01180400|3762719|FG001|Overall Study|Severe non-compliance to protocol|2
2149965|NCT01180400|3762718|FG000|Overall Study|Condition under investigation worsened|2
2149966|NCT01180400|3762719|FG001|Overall Study|Condition under investigation worsened|1
2149967|NCT01180400|3762718|FG000|Overall Study|Lack of Efficacy|2
2149968|NCT01180400|3762719|FG001|Overall Study|Lack of Efficacy|0
2149969|NCT01180400|3762718|FG000|Overall Study|Study-specific withdrawal criteria|1
2149970|NCT01180400|3762719|FG001|Overall Study|Study-specific withdrawal criteria|2
2149971|NCT01180400|3762718|FG000|Overall Study|Lost to Follow-up|2
2149972|NCT01180400|3762719|FG001|Overall Study|Lost to Follow-up|3
2149973|NCT01180400|3762718|FG000|Overall Study|Other|0
2149974|NCT01180400|3762719|FG001|Overall Study|Other|1
2149975|NCT01180647|3762738|FG000|Overall Study|Lost to Follow-up|5
2149976|NCT01180647|3762739|FG001|Overall Study|Lost to Follow-up|6
2149977|NCT01180660|3762747|FG000|Overall Study|Changed to open surgery|1
2149978|NCT01180660|3762748|FG001|Overall Study|Changed to open surgery|0
2149979|NCT01180777|3762754|FG000|Overall Study|Protocol Violation|6
2149980|NCT01180777|3762754|FG000|Overall Study|Poor lens fit|4
2149981|NCT01180777|3762754|FG000|Overall Study|Lost to Follow-up|1
2149982|NCT01180777|3762754|FG000|Overall Study|Adverse Event|1
2149983|NCT01180790|3762767|FG000|Overall Study|Adverse Event|1
2149984|NCT01180790|3762768|FG001|Overall Study|Adverse Event|1
2149985|NCT01180790|3762769|FG002|Overall Study|Adverse Event|2
2149986|NCT01180790|3762770|FG003|Overall Study|Adverse Event|0
2149987|NCT01180790|3762771|FG004|Overall Study|Adverse Event|1
2149988|NCT01180790|3762772|FG005|Overall Study|Adverse Event|3
2149989|NCT01180790|3762773|FG006|Overall Study|Adverse Event|0
2149990|NCT01180790|3762767|FG000|Overall Study|Withdrawal by Subject|3
2149991|NCT01180790|3762768|FG001|Overall Study|Withdrawal by Subject|0
2149992|NCT01180790|3762769|FG002|Overall Study|Withdrawal by Subject|5
2149993|NCT01180790|3762770|FG003|Overall Study|Withdrawal by Subject|0
2149994|NCT01180790|3762771|FG004|Overall Study|Withdrawal by Subject|2
2149995|NCT01180790|3762772|FG005|Overall Study|Withdrawal by Subject|1
2149996|NCT01180790|3762773|FG006|Overall Study|Withdrawal by Subject|0
2149997|NCT01180790|3762767|FG000|Overall Study|Lost to Follow-up|3
2149998|NCT01180790|3762768|FG001|Overall Study|Lost to Follow-up|1
2149999|NCT01180790|3762769|FG002|Overall Study|Lost to Follow-up|0
2150000|NCT01180790|3762770|FG003|Overall Study|Lost to Follow-up|2
2150001|NCT01180790|3762771|FG004|Overall Study|Lost to Follow-up|1
2150002|NCT01180790|3762772|FG005|Overall Study|Lost to Follow-up|0
2150003|NCT01180790|3762773|FG006|Overall Study|Lost to Follow-up|1
2150004|NCT01180790|3762767|FG000|Overall Study|Physician Decision|1
2208116|NCT01636687|3847527|FG004|Extension Period|technical problems|0
2208117|NCT01636687|3847523|FG000|Extension Period|Adverse Event|4
2208118|NCT01636687|3847524|FG001|Extension Period|Adverse Event|3
2150005|NCT01180790|3762768|FG001|Overall Study|Physician Decision|0
2150006|NCT01180790|3762769|FG002|Overall Study|Physician Decision|0
2150007|NCT01180790|3762770|FG003|Overall Study|Physician Decision|1
2150008|NCT01180790|3762771|FG004|Overall Study|Physician Decision|0
2150009|NCT01180790|3762772|FG005|Overall Study|Physician Decision|0
2150010|NCT01180790|3762773|FG006|Overall Study|Physician Decision|0
2150011|NCT01180790|3762767|FG000|Overall Study|Lack of Efficacy|1
2150012|NCT01180790|3762768|FG001|Overall Study|Lack of Efficacy|2
2150013|NCT01180790|3762769|FG002|Overall Study|Lack of Efficacy|5
2150014|NCT01180790|3762770|FG003|Overall Study|Lack of Efficacy|6
2150015|NCT01180790|3762771|FG004|Overall Study|Lack of Efficacy|1
2150016|NCT01180790|3762772|FG005|Overall Study|Lack of Efficacy|3
2150017|NCT01180790|3762773|FG006|Overall Study|Lack of Efficacy|0
2150018|NCT01180790|3762767|FG000|Overall Study|compliance|0
2150019|NCT01180790|3762768|FG001|Overall Study|compliance|1
2150020|NCT01180790|3762769|FG002|Overall Study|compliance|0
2150021|NCT01180790|3762770|FG003|Overall Study|compliance|0
2150022|NCT01180790|3762771|FG004|Overall Study|compliance|0
2150023|NCT01180790|3762772|FG005|Overall Study|compliance|0
2150024|NCT01180790|3762773|FG006|Overall Study|compliance|0
2150025|NCT01180790|3762767|FG000|Overall Study|Severe coronary atherosclerosis (death)|0
2150026|NCT01180790|3762768|FG001|Overall Study|Severe coronary atherosclerosis (death)|0
2208119|NCT01636687|3847525|FG002|Extension Period|Adverse Event|2
2208120|NCT01636687|3847526|FG003|Extension Period|Adverse Event|1
2150027|NCT01180790|3762769|FG002|Overall Study|Severe coronary atherosclerosis (death)|1
2150028|NCT01180790|3762770|FG003|Overall Study|Severe coronary atherosclerosis (death)|0
2150029|NCT01180790|3762771|FG004|Overall Study|Severe coronary atherosclerosis (death)|0
2150030|NCT01180790|3762772|FG005|Overall Study|Severe coronary atherosclerosis (death)|0
2150031|NCT01180790|3762773|FG006|Overall Study|Severe coronary atherosclerosis (death)|0
2150032|NCT01180985|3762828|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
2150033|NCT01180985|3762829|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
2150034|NCT01180998|3762839|FG000|Overall Study|Poor Vision|0
2150035|NCT01180998|3762840|FG001|Overall Study|Poor Vision|2
2150036|NCT01180998|3762841|FG002|Overall Study|Poor Vision|2
2150037|NCT01180998|3762839|FG000|Overall Study|Lost to Follow-up|0
2150038|NCT01180998|3762840|FG001|Overall Study|Lost to Follow-up|0
2150039|NCT01180998|3762841|FG002|Overall Study|Lost to Follow-up|1
2150040|NCT01180998|3762839|FG000|Overall Study|Protocol Violation|1
2150041|NCT01180998|3762840|FG001|Overall Study|Protocol Violation|2
2150042|NCT01180998|3762841|FG002|Overall Study|Protocol Violation|0
2150043|NCT01180998|3762839|FG000|Overall Study|Withdrawal by Subject|0
2150044|NCT01180998|3762840|FG001|Overall Study|Withdrawal by Subject|0
2150045|NCT01180998|3762841|FG002|Overall Study|Withdrawal by Subject|1
2150046|NCT01180998|3762839|FG000|Overall Study|Poor comfort|3
2150047|NCT01180998|3762840|FG001|Overall Study|Poor comfort|0
2150048|NCT01180998|3762841|FG002|Overall Study|Poor comfort|4
2150049|NCT01180998|3762839|FG000|Overall Study|Poor lens handling|0
2150050|NCT01180998|3762840|FG001|Overall Study|Poor lens handling|0
2150051|NCT01180998|3762841|FG002|Overall Study|Poor lens handling|2
2150052|NCT01181011|3762850|FG000|Overall Study|Adverse Event|2
2150053|NCT01181011|3762850|FG000|Overall Study|Lost to Follow-up|1
2150054|NCT01181102|3762879|FG000|Overall Study|Adverse Event|28
2150055|NCT01181102|3762880|FG001|Overall Study|Adverse Event|26
2150056|NCT01181102|3762879|FG000|Overall Study|Lack of Efficacy|3
2150057|NCT01181102|3762880|FG001|Overall Study|Lack of Efficacy|1
2150058|NCT01181102|3762879|FG000|Overall Study|Lost to Follow-up|2
2150059|NCT01181102|3762880|FG001|Overall Study|Lost to Follow-up|0
2150060|NCT01181102|3762879|FG000|Overall Study|Physician Decision|3
2150061|NCT01181102|3762880|FG001|Overall Study|Physician Decision|1
2150062|NCT01181102|3762879|FG000|Overall Study|Protocol Violation|5
2150063|NCT01181102|3762880|FG001|Overall Study|Protocol Violation|6
2150064|NCT01181102|3762879|FG000|Overall Study|Withdrawal by Subject|10
2150065|NCT01181102|3762880|FG001|Overall Study|Withdrawal by Subject|12
2150066|NCT01181128|3762889|FG000|Overall Study|Withdrawal by Subject|2
2150067|NCT01181128|3762890|FG001|Overall Study|Withdrawal by Subject|2
2150068|NCT01181128|3762891|FG002|Overall Study|Withdrawal by Subject|0
2150069|NCT01181128|3762889|FG000|Overall Study|Death|1
2150070|NCT01181128|3762890|FG001|Overall Study|Death|0
2150071|NCT01181128|3762891|FG002|Overall Study|Death|0
2150072|NCT01181128|3762889|FG000|Overall Study|Physician Decision|2
2150073|NCT01181128|3762890|FG001|Overall Study|Physician Decision|0
2150074|NCT01181128|3762891|FG002|Overall Study|Physician Decision|0
2150075|NCT01181128|3762889|FG000|Overall Study|Adverse Event|0
2150076|NCT01181128|3762890|FG001|Overall Study|Adverse Event|2
2150077|NCT01181128|3762891|FG002|Overall Study|Adverse Event|0
2150078|NCT01181128|3762889|FG000|Overall Study|Other|1
2150079|NCT01181128|3762890|FG001|Overall Study|Other|1
2150080|NCT01181128|3762891|FG002|Overall Study|Other|1
2150081|NCT01181141|3762913|FG000|Overall Study|Adverse Event|2
2150082|NCT01181141|3762914|FG001|Overall Study|Adverse Event|1
2150083|NCT01181141|3762913|FG000|Overall Study|Lack of Efficacy|1
2150084|NCT01181141|3762914|FG001|Overall Study|Lack of Efficacy|0
2150085|NCT01181141|3762913|FG000|Overall Study|Lost to Follow-up|1
2150086|NCT01181141|3762914|FG001|Overall Study|Lost to Follow-up|1
2150087|NCT01181141|3762913|FG000|Overall Study|Physician Decision|2
2150088|NCT01181141|3762914|FG001|Overall Study|Physician Decision|0
2150089|NCT01181141|3762913|FG000|Overall Study|Protocol Violation|3
2150090|NCT01181141|3762914|FG001|Overall Study|Protocol Violation|1
2150091|NCT01181141|3762913|FG000|Overall Study|Withdrawal by Subject|3
2150092|NCT01181141|3762914|FG001|Overall Study|Withdrawal by Subject|1
2150093|NCT01181167|3762922|FG000|Overall Study|Adverse Event|11
2150094|NCT01181167|3762923|FG001|Overall Study|Adverse Event|21
2150095|NCT01181167|3762922|FG000|Overall Study|Lost to Follow-up|1
2150096|NCT01181167|3762923|FG001|Overall Study|Lost to Follow-up|0
2150097|NCT01181167|3762922|FG000|Overall Study|Physician Decision|2
2291312|NCT02500758|3984330|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0
2291313|NCT02500758|3984331|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1
2291314|NCT02500758|3984330|FG000|Washout (1 Week)|Lost to Follow-up|2
2291315|NCT02500758|3984331|FG001|Washout (1 Week)|Lost to Follow-up|2
2291316|NCT02500758|3984330|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2
2291317|NCT02500758|3984331|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0
2291318|NCT02500758|3984330|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0
2291319|NCT02500758|3984331|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1
2291320|NCT02500758|3984330|FG000|Second Intervention (2 Minutes)|Protocol Violation|1
2291321|NCT02500758|3984331|FG001|Second Intervention (2 Minutes)|Protocol Violation|1
2291322|NCT02500979|3984353|FG000|Period 1|Hyperglycemia|1
2291323|NCT02500979|3984354|FG001|Period 1|Hyperglycemia|0
2321115|NCT02955186|4035397|FG000|Overall Study|Withdrawal by Subject|6
2150098|NCT01181167|3762923|FG001|Overall Study|Physician Decision|3
2150099|NCT01181167|3762922|FG000|Overall Study|Protocol Violation|3
2150100|NCT01181167|3762923|FG001|Overall Study|Protocol Violation|0
2150101|NCT01181167|3762922|FG000|Overall Study|Withdrawal by Subject|6
2150102|NCT01181167|3762923|FG001|Overall Study|Withdrawal by Subject|8
2150103|NCT01181271|3762933|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
2150104|NCT01181271|3762933|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
2150105|NCT01181271|3762933|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2
2150106|NCT01181271|3762933|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
2150107|NCT01181531|3763003|FG000|Overall Study|Other|17
2150108|NCT01181531|3763004|FG001|Overall Study|Other|12
2150109|NCT01181531|3763003|FG000|Overall Study|Partial consent by subject withdrawn|0
2150110|NCT01181531|3763004|FG001|Overall Study|Partial consent by subject withdrawn|1
2150111|NCT01181531|3763003|FG000|Overall Study|Physician Decision|3
2150112|NCT01181531|3763004|FG001|Overall Study|Physician Decision|1
2150113|NCT01181531|3763003|FG000|Overall Study|Noncompliance|2
2150114|NCT01181531|3763004|FG001|Overall Study|Noncompliance|2
2150115|NCT01181531|3763003|FG000|Overall Study|Ineligibility determined|1
2150116|NCT01181531|3763004|FG001|Overall Study|Ineligibility determined|2
2150117|NCT01181531|3763003|FG000|Overall Study|Protocol Specified Criteria|15
2150118|NCT01181531|3763004|FG001|Overall Study|Protocol Specified Criteria|8
2150119|NCT01181531|3763003|FG000|Overall Study|Pregnancy|0
2150120|NCT01181531|3763004|FG001|Overall Study|Pregnancy|1
2150121|NCT01181531|3763003|FG000|Overall Study|Withdrawal by Subject|8
2150122|NCT01181531|3763004|FG001|Overall Study|Withdrawal by Subject|7
2150123|NCT01181531|3763003|FG000|Overall Study|Protocol Violation|6
2150124|NCT01181531|3763004|FG001|Overall Study|Protocol Violation|6
2150125|NCT01181531|3763003|FG000|Overall Study|Death|9
2150126|NCT01181531|3763004|FG001|Overall Study|Death|12
2150127|NCT01181531|3763003|FG000|Overall Study|Adverse Event|0
2150128|NCT01181531|3763004|FG001|Overall Study|Adverse Event|1
2150129|NCT01181609|3763015|FG000|Overall Study|Adverse Event|1
2150130|NCT01181609|3763015|FG000|Overall Study|Withdrawal by Subject|1
2150131|NCT01181609|3763015|FG000|Overall Study|Lost to Follow-up|1
2150132|NCT01181609|3763015|FG000|Overall Study|Death|50
2150133|NCT01181726|3763034|FG000|First Intervention|Adverse Event|1
2150134|NCT01181726|3763035|FG001|First Intervention|Adverse Event|0
2150135|NCT01181895|3763061|FG000|Overall Study|Adverse Event|3
2150136|NCT01181895|3763062|FG001|Overall Study|Adverse Event|1
2150137|NCT01181895|3763063|FG002|Overall Study|Adverse Event|1
2150138|NCT01181895|3763061|FG000|Overall Study|Lack of Efficacy|8
2150139|NCT01181895|3763062|FG001|Overall Study|Lack of Efficacy|9
2150140|NCT01181895|3763063|FG002|Overall Study|Lack of Efficacy|9
2150141|NCT01181895|3763061|FG000|Overall Study|Protocol Violation|2
2150142|NCT01181895|3763062|FG001|Overall Study|Protocol Violation|1
2150143|NCT01181895|3763063|FG002|Overall Study|Protocol Violation|0
2150144|NCT01181895|3763061|FG000|Overall Study|Lost to Follow-up|0
2150145|NCT01181895|3763062|FG001|Overall Study|Lost to Follow-up|1
2150146|NCT01181895|3763063|FG002|Overall Study|Lost to Follow-up|2
2150147|NCT01181895|3763061|FG000|Overall Study|Investigator Discretion|1
2150148|NCT01181895|3763062|FG001|Overall Study|Investigator Discretion|2
2150149|NCT01181895|3763063|FG002|Overall Study|Investigator Discretion|1
2150150|NCT01181895|3763061|FG000|Overall Study|Withdrawal by Subject|3
2150151|NCT01181895|3763062|FG001|Overall Study|Withdrawal by Subject|0
2150152|NCT01181895|3763063|FG002|Overall Study|Withdrawal by Subject|5
2150153|NCT01181986|3763078|FG000|Phase 1|Lost to Follow-up|0
2150154|NCT01181986|3763079|FG001|Phase 1|Lost to Follow-up|1
2150155|NCT01181986|3763080|FG002|Phase 1|Lost to Follow-up|1
2150156|NCT01181986|3763078|FG000|Phase 1|Adverse Event|0
2150157|NCT01181986|3763079|FG001|Phase 1|Adverse Event|0
2150158|NCT01181986|3763080|FG002|Phase 1|Adverse Event|1
2150159|NCT01181986|3763078|FG000|Phase 1|Protocol Violation|1
2150160|NCT01181986|3763079|FG001|Phase 1|Protocol Violation|0
2150161|NCT01181986|3763080|FG002|Phase 1|Protocol Violation|0
2150162|NCT01181986|3763078|FG000|Phase 2|Adverse Event|0
2150163|NCT01181986|3763079|FG001|Phase 2|Adverse Event|3
2150164|NCT01181986|3763080|FG002|Phase 2|Adverse Event|0
2150165|NCT01181986|3763078|FG000|Phase 2|Medical condition|0
2150166|NCT01181986|3763079|FG001|Phase 2|Medical condition|1
2150167|NCT01181986|3763080|FG002|Phase 2|Medical condition|0
2150168|NCT01182181|3763108|FG000|First Intervention|Adverse Event|1
2150169|NCT01182181|3763109|FG001|First Intervention|Adverse Event|0
2150170|NCT01182181|3763108|FG000|Washout of 21 Days|Withdrawal by Subject|0
2150171|NCT01182181|3763109|FG001|Washout of 21 Days|Withdrawal by Subject|1
2150172|NCT01182194|3763117|FG000|Washout of 28 Days|Withdrawal by Subject|1
2150173|NCT01182194|3763118|FG001|Washout of 28 Days|Withdrawal by Subject|0
2150174|NCT01182207|3763126|FG000|First Intervention|Positive Hepatitis Results|0
2150175|NCT01182207|3763127|FG001|First Intervention|Positive Hepatitis Results|1
2150176|NCT01182207|3763126|FG000|Second Intervention|Emeses within 1 hour of dosing|1
2150177|NCT01182207|3763127|FG001|Second Intervention|Emeses within 1 hour of dosing|0
2150178|NCT01182285|3763133|FG000|First Intervention Week 1-10|Disease progression|1
2150179|NCT01182285|3763134|FG001|First Intervention Week 1-10|Disease progression|0
2150180|NCT01182285|3763135|FG002|First Intervention Week 1-10|Disease progression|0
2150181|NCT01182285|3763133|FG000|First Intervention Week 1-10|Adverse Event|1
2150182|NCT01182285|3763134|FG001|First Intervention Week 1-10|Adverse Event|0
2150183|NCT01182285|3763135|FG002|First Intervention Week 1-10|Adverse Event|0
2150184|NCT01182285|3763133|FG000|First Intervention Week 1-10|Non-compliance|1
2150185|NCT01182285|3763134|FG001|First Intervention Week 1-10|Non-compliance|0
2150186|NCT01182285|3763135|FG002|First Intervention Week 1-10|Non-compliance|0
2150187|NCT01182285|3763133|FG000|Third Intervention Week 11-52|Disease Progression|0
2150188|NCT01182285|3763134|FG001|Third Intervention Week 11-52|Disease Progression|0
2150189|NCT01182285|3763135|FG002|Third Intervention Week 11-52|Disease Progression|6
2150190|NCT01182285|3763133|FG000|Third Intervention Week 11-52|Other|0
2150191|NCT01182285|3763134|FG001|Third Intervention Week 11-52|Other|0
2150192|NCT01182285|3763135|FG002|Third Intervention Week 11-52|Other|2
2150193|NCT01182298|3763142|FG000|Overall Study|Lack of Efficacy|4
2150194|NCT01182298|3763142|FG000|Overall Study|Withdrawal by Subject|2
2150195|NCT01182337|3763148|FG000|Overall Study|Withdrawal by Subject|3
2150196|NCT01182337|3763149|FG001|Overall Study|Withdrawal by Subject|1
2150197|NCT01182337|3763148|FG000|Overall Study|Lost to Follow-up|0
2150198|NCT01182337|3763149|FG001|Overall Study|Lost to Follow-up|1
2150199|NCT01182350|3763156|FG000|Overall Study|Adverse Event|5
2150200|NCT01182350|3763157|FG001|Overall Study|Adverse Event|0
2150201|NCT01182350|3763158|FG002|Overall Study|Adverse Event|0
2150202|NCT01182350|3763159|FG003|Overall Study|Adverse Event|0
2150203|NCT01182350|3763160|FG004|Overall Study|Adverse Event|0
2150204|NCT01182350|3763156|FG000|Overall Study|Disease Progression|15
2150205|NCT01182350|3763157|FG001|Overall Study|Disease Progression|12
2150206|NCT01182350|3763158|FG002|Overall Study|Disease Progression|0
2150207|NCT01182350|3763159|FG003|Overall Study|Disease Progression|1
2150208|NCT01182350|3763160|FG004|Overall Study|Disease Progression|0
2150209|NCT01182350|3763156|FG000|Overall Study|Death|0
2150210|NCT01182350|3763157|FG001|Overall Study|Death|1
2150211|NCT01182350|3763158|FG002|Overall Study|Death|1
2150212|NCT01182350|3763159|FG003|Overall Study|Death|0
2150213|NCT01182350|3763160|FG004|Overall Study|Death|0
2150214|NCT01182350|3763156|FG000|Overall Study|Withdrawal by Subject|3
2150215|NCT01182350|3763157|FG001|Overall Study|Withdrawal by Subject|1
2150216|NCT01182350|3763158|FG002|Overall Study|Withdrawal by Subject|0
2150217|NCT01182350|3763159|FG003|Overall Study|Withdrawal by Subject|1
2150218|NCT01182350|3763160|FG004|Overall Study|Withdrawal by Subject|0
2150219|NCT01182350|3763156|FG000|Overall Study|Alternative Therapy|2
2150220|NCT01182350|3763157|FG001|Overall Study|Alternative Therapy|0
2150221|NCT01182350|3763158|FG002|Overall Study|Alternative Therapy|1
2150222|NCT01182350|3763159|FG003|Overall Study|Alternative Therapy|0
2150223|NCT01182350|3763160|FG004|Overall Study|Alternative Therapy|0
2150224|NCT01182350|3763156|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2
2150225|NCT01182350|3763157|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0
2150226|NCT01182350|3763158|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1
2150227|NCT01182350|3763159|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1
2150228|NCT01182350|3763160|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0
2150229|NCT01182350|3763156|FG000|Overall Study|Unevaluable for Biopsy|0
2150230|NCT01182350|3763157|FG001|Overall Study|Unevaluable for Biopsy|0
2150231|NCT01182350|3763158|FG002|Overall Study|Unevaluable for Biopsy|0
2150232|NCT01182350|3763159|FG003|Overall Study|Unevaluable for Biopsy|0
2150233|NCT01182350|3763160|FG004|Overall Study|Unevaluable for Biopsy|3
2150234|NCT01182415|3763185|FG000|Overall Study|Lost to Follow-up|1
2150235|NCT01182428|3763191|FG000|Overall Study|Physician Decision|1
2150236|NCT01182428|3763192|FG001|Overall Study|Physician Decision|0
2150237|NCT01182428|3763191|FG000|Overall Study|Lost to Follow-up|9
2150238|NCT01182428|3763192|FG001|Overall Study|Lost to Follow-up|1
2150239|NCT01182428|3763191|FG000|Overall Study|Withdrawal by Subject|1
2150240|NCT01182428|3763192|FG001|Overall Study|Withdrawal by Subject|0
2150241|NCT01182441|3763200|FG000|Overall Study|Patient Still in Follow-up|152
2150242|NCT01182441|3763201|FG001|Overall Study|Patient Still in Follow-up|72
2150243|NCT01182441|3763200|FG000|Overall Study|Death|37
2150244|NCT01182441|3763201|FG001|Overall Study|Death|25
2150245|NCT01182441|3763200|FG000|Overall Study|Implant Attempt Unsuccessful|13
2150246|NCT01182441|3763201|FG001|Overall Study|Implant Attempt Unsuccessful|0
2150247|NCT01182441|3763200|FG000|Overall Study|Lost to Follow-up|5
2150248|NCT01182441|3763201|FG001|Overall Study|Lost to Follow-up|8
2150249|NCT01182441|3763200|FG000|Overall Study|Withdrawal by Subject|6
2150250|NCT01182441|3763201|FG001|Overall Study|Withdrawal by Subject|13
2150251|NCT01182441|3763200|FG000|Overall Study|Implant Not Attempted|4
2150252|NCT01182441|3763201|FG001|Overall Study|Implant Not Attempted|0
2150253|NCT01182441|3763200|FG000|Overall Study|Adverse Event|2
2150254|NCT01182441|3763201|FG001|Overall Study|Adverse Event|0
2150255|NCT01182441|3763200|FG000|Overall Study|Physician Decision|1
2150256|NCT01182441|3763201|FG001|Overall Study|Physician Decision|1
2150257|NCT01182844|3763243|FG000|Overall Study|Withdrawal by Subject|0
2150258|NCT01182844|3763244|FG001|Overall Study|Withdrawal by Subject|2
2150259|NCT01183013|3763257|FG000|Overall Study|Adverse Event|6
2150260|NCT01183013|3763258|FG001|Overall Study|Adverse Event|8
2150261|NCT01183013|3763259|FG002|Overall Study|Adverse Event|5
2150262|NCT01183013|3763260|FG003|Overall Study|Adverse Event|5
2150263|NCT01183013|3763261|FG004|Overall Study|Adverse Event|10
2150264|NCT01183013|3763262|FG005|Overall Study|Adverse Event|10
2150265|NCT01183013|3763263|FG006|Overall Study|Adverse Event|6
2150266|NCT01183013|3763257|FG000|Overall Study|Lack of Efficacy|3
2150267|NCT01183013|3763258|FG001|Overall Study|Lack of Efficacy|2
2150268|NCT01183013|3763259|FG002|Overall Study|Lack of Efficacy|1
2150269|NCT01183013|3763260|FG003|Overall Study|Lack of Efficacy|2
2150270|NCT01183013|3763261|FG004|Overall Study|Lack of Efficacy|1
2150271|NCT01183013|3763262|FG005|Overall Study|Lack of Efficacy|2
2150272|NCT01183013|3763263|FG006|Overall Study|Lack of Efficacy|0
2208121|NCT01636687|3847527|FG004|Extension Period|Adverse Event|0
2150273|NCT01183013|3763257|FG000|Overall Study|Protocol Violation|5
2150274|NCT01183013|3763258|FG001|Overall Study|Protocol Violation|2
2150275|NCT01183013|3763259|FG002|Overall Study|Protocol Violation|4
2150276|NCT01183013|3763260|FG003|Overall Study|Protocol Violation|0
2150277|NCT01183013|3763261|FG004|Overall Study|Protocol Violation|4
2150278|NCT01183013|3763262|FG005|Overall Study|Protocol Violation|3
2150279|NCT01183013|3763263|FG006|Overall Study|Protocol Violation|3
2150280|NCT01183013|3763257|FG000|Overall Study|Lost to Follow-up|7
2150281|NCT01183013|3763258|FG001|Overall Study|Lost to Follow-up|3
2150282|NCT01183013|3763259|FG002|Overall Study|Lost to Follow-up|4
2150283|NCT01183013|3763260|FG003|Overall Study|Lost to Follow-up|3
2150284|NCT01183013|3763261|FG004|Overall Study|Lost to Follow-up|2
2150285|NCT01183013|3763262|FG005|Overall Study|Lost to Follow-up|6
2150286|NCT01183013|3763263|FG006|Overall Study|Lost to Follow-up|5
2150287|NCT01183013|3763257|FG000|Overall Study|Withdrawal by Subject|9
2150288|NCT01183013|3763258|FG001|Overall Study|Withdrawal by Subject|13
2150289|NCT01183013|3763259|FG002|Overall Study|Withdrawal by Subject|10
2150290|NCT01183013|3763260|FG003|Overall Study|Withdrawal by Subject|8
2150291|NCT01183013|3763261|FG004|Overall Study|Withdrawal by Subject|7
2150292|NCT01183013|3763262|FG005|Overall Study|Withdrawal by Subject|9
2150293|NCT01183013|3763263|FG006|Overall Study|Withdrawal by Subject|10
2150294|NCT01183013|3763257|FG000|Overall Study|Reasons other than stated above|15
2150295|NCT01183013|3763258|FG001|Overall Study|Reasons other than stated above|11
2150296|NCT01183013|3763259|FG002|Overall Study|Reasons other than stated above|17
2150297|NCT01183013|3763260|FG003|Overall Study|Reasons other than stated above|12
2150298|NCT01183013|3763261|FG004|Overall Study|Reasons other than stated above|12
2150299|NCT01183013|3763262|FG005|Overall Study|Reasons other than stated above|15
2150300|NCT01183013|3763263|FG006|Overall Study|Reasons other than stated above|13
2150301|NCT01183065|3763280|FG000|Overall Study|Patient no longer fits eligibility crite|1
2150302|NCT01183104|3763286|FG000|Overall Study|Adverse Event|8
2150303|NCT01183104|3763287|FG001|Overall Study|Adverse Event|6
2150304|NCT01183104|3763286|FG000|Overall Study|Death|0
2150305|NCT01183104|3763287|FG001|Overall Study|Death|1
2150306|NCT01183104|3763286|FG000|Overall Study|Lost to Follow-up|14
2150307|NCT01183104|3763287|FG001|Overall Study|Lost to Follow-up|7
2150308|NCT01183104|3763286|FG000|Overall Study|Physician Decision|5
2150309|NCT01183104|3763287|FG001|Overall Study|Physician Decision|8
2150310|NCT01183104|3763286|FG000|Overall Study|Withdrawal by Subject|6
2150311|NCT01183104|3763287|FG001|Overall Study|Withdrawal by Subject|11
2150312|NCT01183104|3763286|FG000|Overall Study|Nonparticipation in Extension Study|39
2150313|NCT01183104|3763287|FG001|Overall Study|Nonparticipation in Extension Study|50
2150314|NCT01183104|3763286|FG000|Overall Study|Did not receive study drug|5
2150315|NCT01183104|3763287|FG001|Overall Study|Did not receive study drug|9
2150316|NCT01183143|3763293|FG000|Overall Study|Protocol Violation|115
2150317|NCT01183143|3763293|FG000|Overall Study|Withdrawal by Subject|19
2150318|NCT01183143|3763293|FG000|Overall Study|Subject Questionnaires not returned|5
2150319|NCT01183143|3763293|FG000|Overall Study|Subjects enrolled, but not treated|11
2150320|NCT01183234|3763327|FG000|First Intervention|Adverse Event|1
2150321|NCT01183234|3763328|FG001|First Intervention|Adverse Event|0
2150322|NCT01183260|3763336|FG000|Overall Study|Intraop screen failure|2
2150323|NCT01183260|3763337|FG001|Overall Study|Intraop screen failure|0
2150324|NCT01183260|3763336|FG000|Overall Study|Withdrawal by Subject|1
2150325|NCT01183260|3763337|FG001|Overall Study|Withdrawal by Subject|1
2150326|NCT01183260|3763336|FG000|Overall Study|Revised within 30 days|0
2150327|NCT01183260|3763337|FG001|Overall Study|Revised within 30 days|1
2150328|NCT01183260|3763336|FG000|Overall Study|Death|1
2150329|NCT01183260|3763337|FG001|Overall Study|Death|0
2150330|NCT01183390|3763354|FG000|First Intervention|Adverse Event|0
2150331|NCT01183390|3763355|FG001|First Intervention|Adverse Event|1
2150332|NCT01183780|3763410|FG000|Overall Study|Withdrawal by Subject|25
2150333|NCT01183780|3763411|FG001|Overall Study|Withdrawal by Subject|14
2150334|NCT01183780|3763410|FG000|Overall Study|Lost to Follow-up|6
2150335|NCT01183780|3763411|FG001|Overall Study|Lost to Follow-up|11
2150336|NCT01183858|3763419|FG000|Overall Study|Death not related to Progressive Disease|5
2150337|NCT01183858|3763420|FG001|Overall Study|Death not related to Progressive Disease|6
2150338|NCT01183858|3763419|FG000|Overall Study|Adverse Event|14
2150339|NCT01183858|3763420|FG001|Overall Study|Adverse Event|11
2150340|NCT01183858|3763419|FG000|Overall Study|Investigator's Decision|0
2150341|NCT01183858|3763420|FG001|Overall Study|Investigator's Decision|3
2150342|NCT01183858|3763419|FG000|Overall Study|Insufficient Therapeutic Response|2
2150343|NCT01183858|3763420|FG001|Overall Study|Insufficient Therapeutic Response|0
2150344|NCT01183858|3763419|FG000|Overall Study|Refused Treatment|1
2150345|NCT01183858|3763420|FG001|Overall Study|Refused Treatment|4
2150346|NCT01183858|3763419|FG000|Overall Study|Withdrew Consent|4
2150347|NCT01183858|3763420|FG001|Overall Study|Withdrew Consent|4
2150348|NCT01183858|3763419|FG000|Overall Study|Discontinued Smoking|3
2150349|NCT01183858|3763420|FG001|Overall Study|Discontinued Smoking|1
2150350|NCT01183858|3763419|FG000|Overall Study|Protocol Violation|1
2150351|NCT01183858|3763420|FG001|Overall Study|Protocol Violation|0
2150352|NCT01183858|3763419|FG000|Overall Study|Administrative/Other|6
2150353|NCT01183858|3763420|FG001|Overall Study|Administrative/Other|6
2150354|NCT01183858|3763419|FG000|Overall Study|Progressive Disease|112
2150355|NCT01183858|3763420|FG001|Overall Study|Progressive Disease|115
2150356|NCT01183858|3763419|FG000|Overall Study|Death related to Progressive Disease|4
2150357|NCT01183858|3763420|FG001|Overall Study|Death related to Progressive Disease|5
2291324|NCT02500979|3984353|FG000|Period 1|Severe non-compliance to protocol|0
2291325|NCT02500979|3984354|FG001|Period 1|Severe non-compliance to protocol|1
2291326|NCT02500979|3984353|FG000|Period 1|Adverse Event|1
2291327|NCT02500979|3984354|FG001|Period 1|Adverse Event|0
2291328|NCT02500979|3984353|FG000|Period 1|Subject decision|2
2291329|NCT02500979|3984354|FG001|Period 1|Subject decision|0
2291330|NCT02500979|3984353|FG000|Period 2|Change in risk|1
2291331|NCT02500979|3984354|FG001|Period 2|Change in risk|0
2291332|NCT02501161|3984372|FG000|Overall Study|Adverse Event|2
2291333|NCT02501161|3984373|FG001|Overall Study|Adverse Event|6
2291334|NCT02501161|3984372|FG000|Overall Study|Lost to Follow-up|7
2291335|NCT02501161|3984373|FG001|Overall Study|Lost to Follow-up|4
2291336|NCT02501161|3984372|FG000|Overall Study|Withdrawal by Subject|10
2291337|NCT02501161|3984373|FG001|Overall Study|Withdrawal by Subject|15
2291338|NCT02501161|3984372|FG000|Overall Study|Other|3
2291339|NCT02501161|3984373|FG001|Overall Study|Other|0
2291340|NCT02501473|3984403|FG000|Overall Study|Study Terminated|2
2291341|NCT02501473|3984404|FG001|Overall Study|Study Terminated|3
2291342|NCT02501473|3984405|FG002|Overall Study|Study Terminated|7
2291343|NCT02501473|3984406|FG003|Overall Study|Study Terminated|9
2291344|NCT02501473|3984407|FG004|Overall Study|Study Terminated|2
2291345|NCT02501473|3984408|FG005|Overall Study|Study Terminated|10
2291346|NCT02501473|3984409|FG006|Overall Study|Study Terminated|1
2291347|NCT02501473|3984410|FG007|Overall Study|Study Terminated|0
2291348|NCT02501473|3984403|FG000|Overall Study|Withdrawal by Subject|0
2291349|NCT02501473|3984404|FG001|Overall Study|Withdrawal by Subject|0
2291350|NCT02501473|3984405|FG002|Overall Study|Withdrawal by Subject|3
2150358|NCT01183858|3763419|FG000|Overall Study|Lost to Follow-up|1
2150359|NCT01183858|3763420|FG001|Overall Study|Lost to Follow-up|1
2150360|NCT01183975|3763432|FG000|Overall Study|Lost to Follow-up|73
2150361|NCT01184053|3763445|FG000|Overall Study|progression while on treatment|3
2150362|NCT01184079|3763452|FG000|Overall Study|Lost to Follow-up|14
2150363|NCT01184079|3763453|FG001|Overall Study|Lost to Follow-up|2
2150364|NCT01184118|3763461|FG000|Overall Study|Only asthma step 1 - screen fail|1
2150365|NCT01184118|3763461|FG000|Overall Study|No physiologic confirmation of asthma|8
2150366|NCT01184118|3763461|FG000|Overall Study|FEV1 <60% predicted|2
2150367|NCT01184118|3763461|FG000|Overall Study|Exclusionary medical condition|2
2150368|NCT01184118|3763461|FG000|Overall Study|Withdrawal by Subject|5
2150369|NCT01184326|3763468|FG000|Overall Study|Adverse Event|1
2150370|NCT01184326|3763469|FG001|Overall Study|Adverse Event|2
2150371|NCT01184326|3763470|FG002|Overall Study|Adverse Event|0
2150372|NCT01184326|3763468|FG000|Overall Study|Death|0
2150373|NCT01184326|3763469|FG001|Overall Study|Death|0
2150374|NCT01184326|3763470|FG002|Overall Study|Death|1
2150375|NCT01184326|3763468|FG000|Overall Study|Withdrawal by Subject|0
2150376|NCT01184326|3763469|FG001|Overall Study|Withdrawal by Subject|0
2150377|NCT01184326|3763470|FG002|Overall Study|Withdrawal by Subject|1
2150378|NCT01184326|3763468|FG000|Overall Study|Physician Decision|1
2150379|NCT01184326|3763469|FG001|Overall Study|Physician Decision|1
2150380|NCT01184326|3763470|FG002|Overall Study|Physician Decision|0
2150381|NCT01184326|3763468|FG000|Overall Study|Disease Progression|1
2150382|NCT01184326|3763469|FG001|Overall Study|Disease Progression|3
2150383|NCT01184326|3763470|FG002|Overall Study|Disease Progression|12
2150384|NCT01184508|3763492|FG000|Overall Study|Adverse Event|4
2150385|NCT01184508|3763493|FG001|Overall Study|Adverse Event|6
2150386|NCT01184508|3763492|FG000|Overall Study|Lack of Efficacy|1
2150387|NCT01184508|3763493|FG001|Overall Study|Lack of Efficacy|1
2150388|NCT01184508|3763492|FG000|Overall Study|Lost to Follow-up|1
2150389|NCT01184508|3763493|FG001|Overall Study|Lost to Follow-up|1
2150390|NCT01184508|3763492|FG000|Overall Study|Physician Decision|1
2150391|NCT01184508|3763493|FG001|Overall Study|Physician Decision|0
2291351|NCT02501473|3984406|FG003|Overall Study|Withdrawal by Subject|3
2291352|NCT02501473|3984407|FG004|Overall Study|Withdrawal by Subject|2
2291353|NCT02501473|3984408|FG005|Overall Study|Withdrawal by Subject|2
2291354|NCT02501473|3984409|FG006|Overall Study|Withdrawal by Subject|0
2291355|NCT02501473|3984410|FG007|Overall Study|Withdrawal by Subject|0
2291356|NCT02501473|3984403|FG000|Overall Study|Death|0
2291357|NCT02501473|3984404|FG001|Overall Study|Death|0
2291358|NCT02501473|3984405|FG002|Overall Study|Death|1
2291359|NCT02501473|3984406|FG003|Overall Study|Death|1
2291360|NCT02501473|3984407|FG004|Overall Study|Death|0
2291361|NCT02501473|3984408|FG005|Overall Study|Death|1
2291362|NCT02501473|3984409|FG006|Overall Study|Death|0
2291363|NCT02501473|3984410|FG007|Overall Study|Death|0
2291364|NCT02501473|3984403|FG000|Overall Study|Lost to Follow-up|1
2291365|NCT02501473|3984404|FG001|Overall Study|Lost to Follow-up|0
2291366|NCT02501473|3984405|FG002|Overall Study|Lost to Follow-up|1
2150392|NCT01184508|3763492|FG000|Overall Study|Protocol Violation|3
2150393|NCT01184508|3763493|FG001|Overall Study|Protocol Violation|1
2150394|NCT01184508|3763492|FG000|Overall Study|Sponsor Decision|5
2150395|NCT01184508|3763493|FG001|Overall Study|Sponsor Decision|2
2150396|NCT01184508|3763492|FG000|Overall Study|Withdrawal by Subject|1
2291367|NCT02501473|3984406|FG003|Overall Study|Lost to Follow-up|0
2291368|NCT02501473|3984407|FG004|Overall Study|Lost to Follow-up|0
2291369|NCT02501473|3984408|FG005|Overall Study|Lost to Follow-up|1
2291370|NCT02501473|3984409|FG006|Overall Study|Lost to Follow-up|0
2291371|NCT02501473|3984410|FG007|Overall Study|Lost to Follow-up|0
2150397|NCT01184508|3763493|FG001|Overall Study|Withdrawal by Subject|3
2150398|NCT01184508|3763492|FG000|Overall Study|Randomized, Not Treated|0
2150399|NCT01184508|3763493|FG001|Overall Study|Randomized, Not Treated|1
2150400|NCT01184846|3763513|FG000|Overall Study|Adverse Event|2
2150401|NCT01184846|3763513|FG000|Overall Study|Insufficient response|1
2150402|NCT01184859|3763524|FG000|Period 1: Single Dose|Insufficient urine production|0
2150403|NCT01184859|3763525|FG001|Period 1: Single Dose|Insufficient urine production|1
2150404|NCT01184859|3763526|FG002|Period 1: Single Dose|Insufficient urine production|0
2150405|NCT01184859|3763527|FG003|Period 1: Single Dose|Insufficient urine production|0
2150406|NCT01184859|3763528|FG004|Period 1: Single Dose|Insufficient urine production|0
2150407|NCT01184859|3763524|FG000|Period 1: Single Dose|Protocol Violation|0
2150408|NCT01184859|3763525|FG001|Period 1: Single Dose|Protocol Violation|1
2150409|NCT01184859|3763526|FG002|Period 1: Single Dose|Protocol Violation|0
2208122|NCT01636687|3847523|FG000|Extension Period|Lack of Efficacy|7
2150410|NCT01184859|3763527|FG003|Period 1: Single Dose|Protocol Violation|0
2150411|NCT01184859|3763528|FG004|Period 1: Single Dose|Protocol Violation|0
2150412|NCT01184859|3763524|FG000|Period 1: Single Dose|Adverse Event|0
2150413|NCT01184859|3763525|FG001|Period 1: Single Dose|Adverse Event|0
2150414|NCT01184859|3763526|FG002|Period 1: Single Dose|Adverse Event|0
2150415|NCT01184859|3763527|FG003|Period 1: Single Dose|Adverse Event|0
2150416|NCT01184859|3763528|FG004|Period 1: Single Dose|Adverse Event|1
2150417|NCT01184859|3763524|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2291372|NCT02501473|3984403|FG000|Overall Study|Reason not specified|0
2291373|NCT02501473|3984404|FG001|Overall Study|Reason not specified|0
2291374|NCT02501473|3984405|FG002|Overall Study|Reason not specified|1
2291375|NCT02501473|3984406|FG003|Overall Study|Reason not specified|1
2291376|NCT02501473|3984407|FG004|Overall Study|Reason not specified|0
2291377|NCT02501473|3984408|FG005|Overall Study|Reason not specified|0
2291378|NCT02501473|3984409|FG006|Overall Study|Reason not specified|0
2291379|NCT02501473|3984410|FG007|Overall Study|Reason not specified|0
2291380|NCT02501629|3984444|FG000|Overall Study|Death|0
2291381|NCT02501629|3984445|FG001|Overall Study|Death|1
2291382|NCT02501629|3984444|FG000|Overall Study|Withdrawn from study by sponsor|1
2291383|NCT02501629|3984445|FG001|Overall Study|Withdrawn from study by sponsor|0
2291384|NCT02501629|3984444|FG000|Overall Study|Early termination by sponsor|1
2291385|NCT02501629|3984445|FG001|Overall Study|Early termination by sponsor|0
2291386|NCT02501629|3984444|FG000|Overall Study|Withdrawal by Subject|3
2291387|NCT02501629|3984445|FG001|Overall Study|Withdrawal by Subject|5
2291388|NCT02501629|3984444|FG000|Overall Study|Subject did not return to site|0
2291389|NCT02501629|3984445|FG001|Overall Study|Subject did not return to site|1
2291390|NCT02501642|3984453|FG000|Overall Study|Lost to Follow-up|7
2291391|NCT02501642|3984454|FG001|Overall Study|Lost to Follow-up|11
2291392|NCT02501811|3984464|FG000|Overall Study|Death|1
2291393|NCT02501811|3984465|FG001|Overall Study|Death|3
2291394|NCT02501811|3984466|FG002|Overall Study|Death|2
2291395|NCT02501811|3984467|FG003|Overall Study|Death|3
2291396|NCT02501811|3984464|FG000|Overall Study|Withdrawal by Subject|3
2291397|NCT02501811|3984465|FG001|Overall Study|Withdrawal by Subject|3
2291398|NCT02501811|3984466|FG002|Overall Study|Withdrawal by Subject|2
2291399|NCT02501811|3984467|FG003|Overall Study|Withdrawal by Subject|3
2291400|NCT02501811|3984464|FG000|Overall Study|Lost to Follow-up|0
2291401|NCT02501811|3984465|FG001|Overall Study|Lost to Follow-up|0
2291402|NCT02501811|3984466|FG002|Overall Study|Lost to Follow-up|2
2291403|NCT02501811|3984467|FG003|Overall Study|Lost to Follow-up|1
2291404|NCT02501902|3984485|FG000|Overall Study|Subject Refused Further Follow-up|0
2291405|NCT02501902|3984486|FG001|Overall Study|Subject Refused Further Follow-up|0
2291406|NCT02501902|3984487|FG002|Overall Study|Subject Refused Further Follow-up|0
2291407|NCT02501902|3984488|FG003|Overall Study|Subject Refused Further Follow-up|0
2291408|NCT02501902|3984489|FG004|Overall Study|Subject Refused Further Follow-up|0
2291409|NCT02501902|3984490|FG005|Overall Study|Subject Refused Further Follow-up|0
2291410|NCT02501902|3984491|FG006|Overall Study|Subject Refused Further Follow-up|0
2291411|NCT02501902|3984492|FG007|Overall Study|Subject Refused Further Follow-up|1
2291412|NCT02501902|3984485|FG000|Overall Study|Study Terminated by Sponsor|0
2291413|NCT02501902|3984486|FG001|Overall Study|Study Terminated by Sponsor|3
2291414|NCT02501902|3984487|FG002|Overall Study|Study Terminated by Sponsor|0
2291415|NCT02501902|3984488|FG003|Overall Study|Study Terminated by Sponsor|1
2291416|NCT02501902|3984489|FG004|Overall Study|Study Terminated by Sponsor|1
2291417|NCT02501902|3984490|FG005|Overall Study|Study Terminated by Sponsor|0
2291418|NCT02501902|3984491|FG006|Overall Study|Study Terminated by Sponsor|2
2291419|NCT02501902|3984492|FG007|Overall Study|Study Terminated by Sponsor|4
2291420|NCT02501902|3984485|FG000|Overall Study|Death|3
2291421|NCT02501902|3984486|FG001|Overall Study|Death|4
2291422|NCT02501902|3984487|FG002|Overall Study|Death|4
2291423|NCT02501902|3984488|FG003|Overall Study|Death|10
2291424|NCT02501902|3984489|FG004|Overall Study|Death|10
2291425|NCT02501902|3984490|FG005|Overall Study|Death|11
2291426|NCT02501902|3984491|FG006|Overall Study|Death|7
2291427|NCT02501902|3984492|FG007|Overall Study|Death|15
2291428|NCT02501928|3984518|FG000|Overall Study|Withdrawal By Parent/Guardian|0
2291429|NCT02501928|3984519|FG001|Overall Study|Withdrawal By Parent/Guardian|0
2291430|NCT02501928|3984520|FG002|Overall Study|Withdrawal By Parent/Guardian|0
2291431|NCT02501928|3984521|FG003|Overall Study|Withdrawal By Parent/Guardian|0
2150418|NCT01184859|3763525|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2150419|NCT01184859|3763526|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2150420|NCT01184859|3763527|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2150421|NCT01184859|3763528|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
2150422|NCT01184859|3763524|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1
2150423|NCT01184859|3763525|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0
2150424|NCT01184859|3763526|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0
2150425|NCT01184859|3763527|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0
2150426|NCT01184859|3763528|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0
2150427|NCT01184872|3763547|FG000|Overall Study|Adverse Event|3
2150428|NCT01184872|3763548|FG001|Overall Study|Adverse Event|4
2150429|NCT01184872|3763547|FG000|Overall Study|Unsatisfactory therapeutic effect|3
2150430|NCT01184872|3763548|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2150431|NCT01184872|3763547|FG000|Overall Study|Withdrawal by Subject|2
2150432|NCT01184872|3763548|FG001|Overall Study|Withdrawal by Subject|0
2150433|NCT01184872|3763547|FG000|Overall Study|Lost to Follow-up|0
2150434|NCT01184872|3763548|FG001|Overall Study|Lost to Follow-up|1
2150435|NCT01184872|3763547|FG000|Overall Study|Administrative problems|1
2150436|NCT01184872|3763548|FG001|Overall Study|Administrative problems|1
2150437|NCT01184872|3763547|FG000|Overall Study|Protocol deviation|1
2150438|NCT01184872|3763548|FG001|Overall Study|Protocol deviation|0
2150439|NCT01184989|3763563|FG000|Overall Study|Adverse Event|11
2150440|NCT01184989|3763563|FG000|Overall Study|Withdrawal by Subject|1
2150441|NCT01185080|3763574|FG000|Overall Study|Adverse Event|1
2150442|NCT01185080|3763575|FG001|Overall Study|Adverse Event|1
2150443|NCT01185080|3763576|FG002|Overall Study|Adverse Event|0
2150444|NCT01185080|3763574|FG000|Overall Study|Personal reasons|0
2150445|NCT01185080|3763575|FG001|Overall Study|Personal reasons|0
2150446|NCT01185080|3763576|FG002|Overall Study|Personal reasons|1
2150447|NCT01185171|3763584|FG000|Induction Chemotherapy|Withdrawal by Subject|1
2150448|NCT01185171|3763584|FG000|Induction Chemotherapy|Duodenal Ulcer|1
2150449|NCT01185171|3763584|FG000|Concurrent Chemo and Radiation Treatment|Death|3
2150450|NCT01185171|3763584|FG000|Maintenance|Elevated liver transaminases|3
2150451|NCT01185171|3763584|FG000|Maintenance|Rush|2
2150452|NCT01185171|3763584|FG000|Maintenance|Diarrhea|1
2150453|NCT01185171|3763584|FG000|Maintenance|Xerostomia|1
2150454|NCT01185171|3763584|FG000|Maintenance|Nausea|1
2150455|NCT01185171|3763584|FG000|Maintenance|Comorbid Illness|2
2150456|NCT01185171|3763584|FG000|Maintenance|Withdrawal by Subject|1
2150457|NCT01185171|3763584|FG000|Maintenance|Disease Recurrence|1
2150458|NCT01185249|3763588|FG000|Overall Study|Patients discharged or change in status|42
2150459|NCT01185288|3763595|FG000|Overall Study|Adverse Event|7
2150460|NCT01185288|3763596|FG001|Overall Study|Adverse Event|6
2150461|NCT01185288|3763595|FG000|Overall Study|Withdrawal by Subject|6
2150462|NCT01185288|3763596|FG001|Overall Study|Withdrawal by Subject|4
2150463|NCT01185288|3763595|FG000|Overall Study|Lost to Follow-up|2
2150464|NCT01185288|3763596|FG001|Overall Study|Lost to Follow-up|5
2150465|NCT01185288|3763595|FG000|Overall Study|Lack of Efficacy|2
2150466|NCT01185288|3763596|FG001|Overall Study|Lack of Efficacy|0
2150467|NCT01185288|3763595|FG000|Overall Study|Investigator discretion|1
2150468|NCT01185288|3763596|FG001|Overall Study|Investigator discretion|0
2150469|NCT01185288|3763595|FG000|Overall Study|Did not meet inclusion criteria|1
2150470|NCT01185288|3763596|FG001|Overall Study|Did not meet inclusion criteria|0
2150471|NCT01185288|3763595|FG000|Overall Study|Noncompliance|0
2150472|NCT01185288|3763596|FG001|Overall Study|Noncompliance|1
2150473|NCT01185301|3763606|FG000|Overall Study|Adverse Event|3
2150474|NCT01185301|3763607|FG001|Overall Study|Adverse Event|0
2150475|NCT01185301|3763608|FG002|Overall Study|Adverse Event|2
2150476|NCT01185301|3763609|FG003|Overall Study|Adverse Event|3
2150477|NCT01185301|3763606|FG000|Overall Study|Withdrawal by Subject|7
2150478|NCT01185301|3763607|FG001|Overall Study|Withdrawal by Subject|5
2150479|NCT01185301|3763608|FG002|Overall Study|Withdrawal by Subject|2
2150480|NCT01185301|3763609|FG003|Overall Study|Withdrawal by Subject|3
2150481|NCT01185301|3763606|FG000|Overall Study|Lost to Follow-up|2
2150482|NCT01185301|3763607|FG001|Overall Study|Lost to Follow-up|0
2150483|NCT01185301|3763608|FG002|Overall Study|Lost to Follow-up|0
2150484|NCT01185301|3763609|FG003|Overall Study|Lost to Follow-up|1
2150485|NCT01185301|3763606|FG000|Overall Study|Other Reason|3
2150486|NCT01185301|3763607|FG001|Overall Study|Other Reason|2
2150487|NCT01185301|3763608|FG002|Overall Study|Other Reason|2
2150488|NCT01185301|3763609|FG003|Overall Study|Other Reason|2
2150489|NCT01185340|3763622|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
2150490|NCT01185340|3763623|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2150491|NCT01185340|3763624|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2150492|NCT01185340|3763625|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2150493|NCT01185340|3763622|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
2150494|NCT01185340|3763623|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2150495|NCT01185340|3763624|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2150496|NCT01185340|3763625|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2150497|NCT01185340|3763622|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
2150498|NCT01185340|3763623|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2150499|NCT01185340|3763624|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2150500|NCT01185340|3763625|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2150501|NCT01185340|3763622|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
2150502|NCT01185340|3763623|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2150503|NCT01185340|3763624|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2150504|NCT01185340|3763625|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2150505|NCT01185340|3763622|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
2150506|NCT01185340|3763623|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2150507|NCT01185340|3763624|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2150508|NCT01185340|3763625|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2150509|NCT01185340|3763622|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
2150510|NCT01185340|3763623|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2150511|NCT01185340|3763624|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2150512|NCT01185340|3763625|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2150513|NCT01185340|3763622|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
2150514|NCT01185340|3763623|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2150515|NCT01185340|3763624|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2150516|NCT01185340|3763625|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2150517|NCT01185340|3763622|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
2150518|NCT01185340|3763623|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
2150519|NCT01185340|3763624|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
2150520|NCT01185340|3763625|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
2150521|NCT01185340|3763622|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
2150522|NCT01185340|3763623|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
2150523|NCT01185340|3763624|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
2150524|NCT01185340|3763625|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
2150525|NCT01185340|3763622|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2150526|NCT01185340|3763623|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
2150527|NCT01185340|3763624|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
2150528|NCT01185340|3763625|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
2150529|NCT01185340|3763622|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2150530|NCT01185340|3763623|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2150531|NCT01185340|3763624|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2150532|NCT01185340|3763625|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2150533|NCT01185340|3763622|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
2150534|NCT01185340|3763623|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2150535|NCT01185340|3763624|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
2150536|NCT01185340|3763625|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2150537|NCT01185340|3763622|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
2150538|NCT01185340|3763623|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
2150539|NCT01185340|3763624|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
2150540|NCT01185340|3763625|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
2150541|NCT01185340|3763622|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2150542|NCT01185340|3763623|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2150543|NCT01185340|3763624|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
2150544|NCT01185340|3763625|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
2150545|NCT01185353|3763642|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1
2150546|NCT01185353|3763643|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1
2150547|NCT01185353|3763644|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1
2150548|NCT01185353|3763645|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1
2150549|NCT01185353|3763646|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5
2150550|NCT01185353|3763647|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0
2150551|NCT01185353|3763648|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0
2150552|NCT01185353|3763649|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0
2150553|NCT01185353|3763650|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0
2150554|NCT01185353|3763651|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0
2150555|NCT01185353|3763642|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2150556|NCT01185353|3763643|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2150557|NCT01185353|3763644|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2150558|NCT01185353|3763645|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2150559|NCT01185353|3763646|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
2150560|NCT01185353|3763647|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2150561|NCT01185353|3763648|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2150562|NCT01185353|3763649|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2150563|NCT01185353|3763650|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2150564|NCT01185353|3763651|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2150565|NCT01185353|3763642|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
2150566|NCT01185353|3763643|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2180145|NCT01399125|3806109|FG001|Overall Study|Withdrawal by Subject|8
2291432|NCT02501928|3984522|FG004|Overall Study|Withdrawal By Parent/Guardian|1
2291433|NCT02501928|3984523|FG005|Overall Study|Withdrawal By Parent/Guardian|0
2291434|NCT02502097|3984548|FG000|Period 1|Adverse Event|0
2150567|NCT01185353|3763644|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2150568|NCT01185353|3763645|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2150569|NCT01185353|3763646|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
2150570|NCT01185353|3763647|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2150571|NCT01185353|3763648|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2150572|NCT01185353|3763649|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2150573|NCT01185353|3763650|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2150574|NCT01185353|3763651|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2150575|NCT01185353|3763642|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0
2150576|NCT01185353|3763643|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0
2150577|NCT01185353|3763644|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1
2150578|NCT01185353|3763645|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0
2150579|NCT01185353|3763646|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2
2150580|NCT01185353|3763647|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0
2150581|NCT01185353|3763648|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0
2150582|NCT01185353|3763649|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0
2150583|NCT01185353|3763650|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0
2150584|NCT01185353|3763651|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0
2150585|NCT01185353|3763642|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0
2150586|NCT01185353|3763643|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0
2150587|NCT01185353|3763644|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0
2208123|NCT01636687|3847524|FG001|Extension Period|Lack of Efficacy|0
2208124|NCT01636687|3847525|FG002|Extension Period|Lack of Efficacy|2
2150588|NCT01185353|3763645|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0
2150589|NCT01185353|3763646|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1
2150590|NCT01185353|3763647|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0
2150591|NCT01185353|3763648|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0
2150592|NCT01185353|3763649|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0
2150593|NCT01185353|3763650|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0
2150594|NCT01185353|3763651|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0
2150595|NCT01185353|3763642|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
2150596|NCT01185353|3763643|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2150597|NCT01185353|3763644|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2150598|NCT01185353|3763645|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2150599|NCT01185353|3763646|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
2150600|NCT01185353|3763647|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2150601|NCT01185353|3763648|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2150602|NCT01185353|3763649|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2150603|NCT01185353|3763650|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2150604|NCT01185353|3763651|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2150605|NCT01185353|3763642|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0
2150606|NCT01185353|3763643|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0
2150607|NCT01185353|3763644|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1
2150608|NCT01185353|3763645|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0
2150609|NCT01185353|3763646|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0
2150610|NCT01185353|3763647|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1
2150611|NCT01185353|3763648|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0
2150612|NCT01185353|3763649|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0
2150613|NCT01185353|3763650|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0
2150614|NCT01185353|3763651|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0
2150615|NCT01185353|3763642|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2150616|NCT01185353|3763643|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
2150617|NCT01185353|3763644|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2150618|NCT01185353|3763645|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
2150619|NCT01185353|3763646|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2150620|NCT01185353|3763647|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2291435|NCT02502097|3984549|FG001|Period 1|Adverse Event|0
2291436|NCT02502097|3984550|FG002|Period 1|Adverse Event|1
2291437|NCT02502097|3984551|FG003|Period 1|Adverse Event|0
2291438|NCT02502097|3984548|FG000|Wash Out Period|Adverse Event|0
2291439|NCT02502097|3984549|FG001|Wash Out Period|Adverse Event|1
2291440|NCT02502097|3984550|FG002|Wash Out Period|Adverse Event|1
2291441|NCT02502097|3984551|FG003|Wash Out Period|Adverse Event|1
2291442|NCT02502097|3984548|FG000|Period 2|Adverse Event|0
2291443|NCT02502097|3984549|FG001|Period 2|Adverse Event|0
2291444|NCT02502097|3984550|FG002|Period 2|Adverse Event|1
2291445|NCT02502097|3984551|FG003|Period 2|Adverse Event|0
2291446|NCT02502149|3984558|FG000|Intermediate|Discontinued prematurely|1
2291447|NCT02502149|3984559|FG001|Intermediate|Discontinued prematurely|0
2291448|NCT02502149|3984560|FG002|Intermediate|Discontinued prematurely|0
2291449|NCT02502149|3984561|FG003|Intermediate|Discontinued prematurely|0
2291450|NCT02502149|3984562|FG004|Intermediate|Discontinued prematurely|0
2291451|NCT02502526|3984604|FG000|Overall Study|Lost to Follow-up|2
2291452|NCT02502526|3984605|FG001|Overall Study|Lost to Follow-up|2
2291453|NCT02502526|3984606|FG002|Overall Study|Lost to Follow-up|3
2291454|NCT02502526|3984604|FG000|Overall Study|Withdrawal by Subject|0
2291455|NCT02502526|3984605|FG001|Overall Study|Withdrawal by Subject|1
2291456|NCT02502526|3984606|FG002|Overall Study|Withdrawal by Subject|1
2150621|NCT01185353|3763648|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2150622|NCT01185353|3763649|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2150623|NCT01185353|3763650|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2150624|NCT01185353|3763651|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2150625|NCT01185353|3763642|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2150626|NCT01185353|3763643|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2150627|NCT01185353|3763644|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2150628|NCT01185353|3763645|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
2150629|NCT01185353|3763646|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2150630|NCT01185353|3763647|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2150631|NCT01185353|3763648|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
2150632|NCT01185353|3763649|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2150633|NCT01185353|3763650|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2150634|NCT01185353|3763651|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2150635|NCT01185353|3763642|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2150636|NCT01185353|3763643|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2150637|NCT01185353|3763644|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
2150638|NCT01185353|3763645|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
2150639|NCT01185353|3763646|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2150640|NCT01185353|3763647|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
2150641|NCT01185353|3763648|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
2150642|NCT01185353|3763649|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2150643|NCT01185353|3763650|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2150644|NCT01185353|3763651|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2150645|NCT01185353|3763642|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2150646|NCT01185353|3763643|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2150647|NCT01185353|3763644|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2150648|NCT01185353|3763645|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2150649|NCT01185353|3763646|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2150650|NCT01185353|3763647|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2150651|NCT01185353|3763648|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
2150652|NCT01185353|3763649|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2150653|NCT01185353|3763650|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2150654|NCT01185353|3763651|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2150655|NCT01185353|3763642|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0
2150656|NCT01185353|3763643|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0
2150657|NCT01185353|3763644|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0
2150658|NCT01185353|3763645|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0
2150659|NCT01185353|3763646|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0
2150660|NCT01185353|3763647|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0
2150661|NCT01185353|3763648|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0
2150662|NCT01185353|3763649|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8
2150663|NCT01185353|3763650|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2
2150664|NCT01185353|3763651|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2
2150665|NCT01185353|3763642|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2150666|NCT01185353|3763643|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2291457|NCT02502526|3984604|FG000|Overall Study|Disqualified due to cataract grading|0
2291458|NCT02502526|3984605|FG001|Overall Study|Disqualified due to cataract grading|0
2291459|NCT02502526|3984606|FG002|Overall Study|Disqualified due to cataract grading|1
2291460|NCT02502526|3984604|FG000|Overall Study|Enrollment suspension|4
2291461|NCT02502526|3984605|FG001|Overall Study|Enrollment suspension|1
2291462|NCT02502526|3984606|FG002|Overall Study|Enrollment suspension|1
2291463|NCT02502734|3984615|FG000|Double-blind Treatment Period 1|Adverse Event|1
2291464|NCT02502734|3984616|FG001|Double-blind Treatment Period 1|Adverse Event|0
2291465|NCT02502734|3984615|FG000|Washout Period|Adverse Event|1
2291466|NCT02502734|3984616|FG001|Washout Period|Adverse Event|0
2291467|NCT02502864|3984624|FG000|Overall Study|Withdrawal by Subject|1
2291468|NCT02503085|3984628|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1
2291469|NCT02503085|3984629|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0
2291470|NCT02503085|3984630|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1
2291471|NCT02503085|3984631|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0
2291472|NCT02503202|3984643|FG000|Base Study: Up to Month 6|Death|1
2291473|NCT02503202|3984644|FG001|Base Study: Up to Month 6|Death|1
2291474|NCT02503202|3984645|FG002|Base Study: Up to Month 6|Death|0
2291475|NCT02503202|3984646|FG003|Base Study: Up to Month 6|Death|0
2291476|NCT02503202|3984647|FG004|Base Study: Up to Month 6|Death|0
2291477|NCT02503202|3984643|FG000|Base Study: Up to Month 6|Lost to Follow-up|11
2291478|NCT02503202|3984644|FG001|Base Study: Up to Month 6|Lost to Follow-up|8
2291479|NCT02503202|3984645|FG002|Base Study: Up to Month 6|Lost to Follow-up|10
2291480|NCT02503202|3984646|FG003|Base Study: Up to Month 6|Lost to Follow-up|5
2291481|NCT02503202|3984647|FG004|Base Study: Up to Month 6|Lost to Follow-up|1
2291482|NCT02503202|3984643|FG000|Base Study: Up to Month 6|Physician Decision|0
2291483|NCT02503202|3984644|FG001|Base Study: Up to Month 6|Physician Decision|0
2291484|NCT02503202|3984645|FG002|Base Study: Up to Month 6|Physician Decision|0
2150667|NCT01185353|3763644|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2150668|NCT01185353|3763645|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2150669|NCT01185353|3763646|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2150670|NCT01185353|3763647|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2150671|NCT01185353|3763648|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2150672|NCT01185353|3763649|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
2150673|NCT01185353|3763650|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
2150674|NCT01185353|3763651|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
2150675|NCT01185353|3763642|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2150676|NCT01185353|3763643|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2150677|NCT01185353|3763644|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2150678|NCT01185353|3763645|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2150679|NCT01185353|3763646|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2150680|NCT01185353|3763647|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2150681|NCT01185353|3763648|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2150682|NCT01185353|3763649|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
2150683|NCT01185353|3763650|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
2150684|NCT01185353|3763651|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
2150685|NCT01185353|3763642|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2150686|NCT01185353|3763643|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2150687|NCT01185353|3763644|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2150688|NCT01185353|3763645|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2150689|NCT01185353|3763646|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2150690|NCT01185353|3763647|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2150691|NCT01185353|3763648|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2150692|NCT01185353|3763649|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2150693|NCT01185353|3763650|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
2150694|NCT01185353|3763651|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2150695|NCT01185353|3763642|FG000|Part C (Weeks 24 Through 76)|Death|0
2150696|NCT01185353|3763643|FG001|Part C (Weeks 24 Through 76)|Death|0
2150697|NCT01185353|3763644|FG002|Part C (Weeks 24 Through 76)|Death|0
2150698|NCT01185353|3763645|FG003|Part C (Weeks 24 Through 76)|Death|0
2150699|NCT01185353|3763646|FG004|Part C (Weeks 24 Through 76)|Death|0
2150700|NCT01185353|3763647|FG005|Part C (Weeks 24 Through 76)|Death|0
2150701|NCT01185353|3763648|FG006|Part C (Weeks 24 Through 76)|Death|0
2150702|NCT01185353|3763649|FG007|Part C (Weeks 24 Through 76)|Death|0
2150703|NCT01185353|3763650|FG008|Part C (Weeks 24 Through 76)|Death|0
2150704|NCT01185353|3763651|FG009|Part C (Weeks 24 Through 76)|Death|1
2150705|NCT01185353|3763642|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2150706|NCT01185353|3763643|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2150707|NCT01185353|3763644|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2150708|NCT01185353|3763645|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2150709|NCT01185353|3763646|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2150710|NCT01185353|3763647|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2150711|NCT01185353|3763648|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2150712|NCT01185353|3763649|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2150713|NCT01185353|3763650|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2150714|NCT01185353|3763651|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
2150715|NCT01185353|3763642|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0
2150716|NCT01185353|3763643|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0
2150717|NCT01185353|3763644|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0
2150718|NCT01185353|3763645|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0
2150719|NCT01185353|3763646|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0
2150720|NCT01185353|3763647|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0
2150721|NCT01185353|3763648|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0
2150722|NCT01185353|3763649|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0
2150723|NCT01185353|3763650|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0
2150724|NCT01185353|3763651|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1
2150725|NCT01185353|3763642|FG000|Part C (Weeks 24 Through 76)|Reason missing|0
2150726|NCT01185353|3763643|FG001|Part C (Weeks 24 Through 76)|Reason missing|0
2150727|NCT01185353|3763644|FG002|Part C (Weeks 24 Through 76)|Reason missing|0
2150728|NCT01185353|3763645|FG003|Part C (Weeks 24 Through 76)|Reason missing|0
2150729|NCT01185353|3763646|FG004|Part C (Weeks 24 Through 76)|Reason missing|0
2150730|NCT01185353|3763647|FG005|Part C (Weeks 24 Through 76)|Reason missing|0
2150731|NCT01185353|3763648|FG006|Part C (Weeks 24 Through 76)|Reason missing|0
2150732|NCT01185353|3763649|FG007|Part C (Weeks 24 Through 76)|Reason missing|0
2150733|NCT01185353|3763650|FG008|Part C (Weeks 24 Through 76)|Reason missing|1
2150734|NCT01185353|3763651|FG009|Part C (Weeks 24 Through 76)|Reason missing|0
2150735|NCT01185353|3763642|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2150736|NCT01185353|3763643|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2150737|NCT01185353|3763644|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2150738|NCT01185353|3763645|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2150739|NCT01185353|3763646|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2150740|NCT01185353|3763647|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2150741|NCT01185353|3763648|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2150742|NCT01185353|3763649|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
2150743|NCT01185353|3763650|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
2150744|NCT01185353|3763651|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2150745|NCT01185353|3763642|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2150746|NCT01185353|3763643|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2150747|NCT01185353|3763644|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2150748|NCT01185353|3763645|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2150749|NCT01185353|3763646|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2150750|NCT01185353|3763647|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2150751|NCT01185353|3763648|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2150752|NCT01185353|3763649|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
2150753|NCT01185353|3763650|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
2150754|NCT01185353|3763651|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
2150755|NCT01185353|3763642|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0
2150756|NCT01185353|3763643|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0
2150757|NCT01185353|3763644|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0
2150758|NCT01185353|3763645|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0
2150759|NCT01185353|3763646|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0
2150760|NCT01185353|3763647|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0
2150761|NCT01185353|3763648|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0
2150762|NCT01185353|3763649|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1
2150763|NCT01185353|3763650|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2
2150764|NCT01185353|3763651|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0
2150765|NCT01185366|3763692|FG000|First Line Therapy|Insurance Coverage Denied|1
2150766|NCT01185366|3763693|FG001|First Line Therapy|Insurance Coverage Denied|1
2150767|NCT01185366|3763692|FG000|First Line Therapy|Withdrawal by Subject|1
2150768|NCT01185366|3763693|FG001|First Line Therapy|Withdrawal by Subject|0
2150769|NCT01185366|3763692|FG000|First Line Therapy|Lack of Metastatic Site|1
2150770|NCT01185366|3763693|FG001|First Line Therapy|Lack of Metastatic Site|0
2150771|NCT01185366|3763692|FG000|Crossover to Second Line Therapy|Adverse Event|3
2150772|NCT01185366|3763693|FG001|Crossover to Second Line Therapy|Adverse Event|6
2150773|NCT01185366|3763692|FG000|Crossover to Second Line Therapy|Physician Decision|5
2150774|NCT01185366|3763693|FG001|Crossover to Second Line Therapy|Physician Decision|1
2150775|NCT01185366|3763692|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1
2150776|NCT01185366|3763693|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0
2150777|NCT01185366|3763692|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5
2150778|NCT01185366|3763693|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3
2150779|NCT01185509|3763703|FG000|Overall Study|Progression/Relapse|9
2150780|NCT01185509|3763704|FG001|Overall Study|Progression/Relapse|15
2150781|NCT01185509|3763703|FG000|Overall Study|Physician Decision|2
2150782|NCT01185509|3763704|FG001|Overall Study|Physician Decision|2
2150783|NCT01185509|3763703|FG000|Overall Study|Withdrawal by Subject|0
2150784|NCT01185509|3763704|FG001|Overall Study|Withdrawal by Subject|1
2150785|NCT01185509|3763703|FG000|Overall Study|Death|0
2150786|NCT01185509|3763704|FG001|Overall Study|Death|1
2150787|NCT01185509|3763703|FG000|Overall Study|Intercurrent Illness|0
2291485|NCT02503202|3984646|FG003|Base Study: Up to Month 6|Physician Decision|0
2291486|NCT02503202|3984647|FG004|Base Study: Up to Month 6|Physician Decision|1
2291487|NCT02503202|3984643|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6
2291488|NCT02503202|3984644|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3
2291489|NCT02503202|3984645|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4
2291490|NCT02503202|3984646|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4
2291491|NCT02503202|3984647|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1
2291492|NCT02503202|3984643|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0
2291493|NCT02503202|3984644|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0
2291494|NCT02503202|3984645|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1
2291495|NCT02503202|3984646|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2
2291496|NCT02503202|3984647|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0
2291497|NCT02503202|3984643|FG000|Extension: Month 6 to 24|Protocol Violation|0
2291498|NCT02503202|3984644|FG001|Extension: Month 6 to 24|Protocol Violation|0
2291499|NCT02503202|3984645|FG002|Extension: Month 6 to 24|Protocol Violation|0
2291500|NCT02503202|3984646|FG003|Extension: Month 6 to 24|Protocol Violation|1
2291501|NCT02503202|3984647|FG004|Extension: Month 6 to 24|Protocol Violation|0
2291502|NCT02503202|3984643|FG000|Extension: Month 6 to 24|Death|1
2291503|NCT02503202|3984644|FG001|Extension: Month 6 to 24|Death|0
2291504|NCT02503202|3984645|FG002|Extension: Month 6 to 24|Death|0
2291505|NCT02503202|3984646|FG003|Extension: Month 6 to 24|Death|0
2291506|NCT02503202|3984647|FG004|Extension: Month 6 to 24|Death|0
2291507|NCT02503202|3984643|FG000|Extension: Month 6 to 24|Lost to Follow-up|4
2291508|NCT02503202|3984644|FG001|Extension: Month 6 to 24|Lost to Follow-up|8
2291509|NCT02503202|3984645|FG002|Extension: Month 6 to 24|Lost to Follow-up|6
2291510|NCT02503202|3984646|FG003|Extension: Month 6 to 24|Lost to Follow-up|10
2291511|NCT02503202|3984647|FG004|Extension: Month 6 to 24|Lost to Follow-up|1
2291512|NCT02503202|3984643|FG000|Extension: Month 6 to 24|Physician Decision|1
2321116|NCT02955186|4035398|FG001|Overall Study|Withdrawal by Subject|2
2150788|NCT01185509|3763704|FG001|Overall Study|Intercurrent Illness|1
2150789|NCT01185522|3763711|FG000|Overall Study|Lack of Efficacy|28
2150790|NCT01185522|3763711|FG000|Overall Study|Lost to Follow-up|19
2150791|NCT01185522|3763711|FG000|Overall Study|Withdrawal by Subject|10
2150792|NCT01185522|3763711|FG000|Overall Study|Poor tolerance|39
2150793|NCT01185522|3763711|FG000|Overall Study|Other reasons|12
2150794|NCT01185548|3763716|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
2150795|NCT01185561|3763731|FG000|Overall Study|Lost to Follow-up|0
2150796|NCT01185561|3763732|FG001|Overall Study|Lost to Follow-up|4
2150797|NCT01185561|3763731|FG000|Overall Study|Withdrawal by Subject|2
2150798|NCT01185561|3763732|FG001|Overall Study|Withdrawal by Subject|8
2150799|NCT01185600|3763740|FG000|Overall Study|Adverse Event|1
2150800|NCT01185600|3763741|FG001|Overall Study|Adverse Event|1
2150801|NCT01185600|3763740|FG000|Overall Study|Death|0
2150802|NCT01185600|3763741|FG001|Overall Study|Death|1
2150803|NCT01185600|3763740|FG000|Overall Study|Lost to Follow-up|0
2150804|NCT01185600|3763741|FG001|Overall Study|Lost to Follow-up|5
2150805|NCT01185600|3763740|FG000|Overall Study|Physician Decision|29
2150806|NCT01185600|3763741|FG001|Overall Study|Physician Decision|35
2150807|NCT01185600|3763740|FG000|Overall Study|Withdrawal by Subject|1
2150808|NCT01185600|3763741|FG001|Overall Study|Withdrawal by Subject|1
2150809|NCT01185600|3763740|FG000|Overall Study|Hold by DSMB|1
2150810|NCT01185600|3763741|FG001|Overall Study|Hold by DSMB|2
2150811|NCT01185639|3763750|FG000|Overall Study|Progressed and didn't receive therapy|2
2150812|NCT01185704|3763756|FG000|Overall Study|Randomized but not treated|3
2150813|NCT01185704|3763757|FG001|Overall Study|Randomized but not treated|3
2150814|NCT01185704|3763756|FG000|Overall Study|Lack of ovarian response|5
2150815|NCT01185704|3763757|FG001|Overall Study|Lack of ovarian response|1
2150816|NCT01185704|3763756|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5
2150817|NCT01185704|3763757|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3
2150818|NCT01185704|3763756|FG000|Overall Study|Ectopic pregnancy|0
2150819|NCT01185704|3763757|FG001|Overall Study|Ectopic pregnancy|1
2179139|NCT01392300|3804632|FG002|Open Label Extension (OLEX) Period|Non-compliance|1
2179140|NCT01392300|3804630|FG000|Open Label Extension (OLEX) Period|Death|0
2179141|NCT01392300|3804631|FG001|Open Label Extension (OLEX) Period|Death|0
2179142|NCT01392300|3804632|FG002|Open Label Extension (OLEX) Period|Death|4
2179143|NCT01392300|3804630|FG000|Open Label Extension (OLEX) Period|Adverse Event|0
2179144|NCT01392300|3804631|FG001|Open Label Extension (OLEX) Period|Adverse Event|0
2179145|NCT01392300|3804632|FG002|Open Label Extension (OLEX) Period|Adverse Event|7
2179146|NCT01392300|3804630|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
2179147|NCT01392300|3804631|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
2208125|NCT01636687|3847526|FG003|Extension Period|Lack of Efficacy|1
2208126|NCT01636687|3847527|FG004|Extension Period|Lack of Efficacy|0
2208127|NCT01636687|3847523|FG000|Extension Period|Lost to Follow-up|1
2291513|NCT02503202|3984644|FG001|Extension: Month 6 to 24|Physician Decision|0
2179148|NCT01392300|3804632|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
2179149|NCT01392300|3804630|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0
2179150|NCT01392300|3804631|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0
2179151|NCT01392300|3804632|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6
2179152|NCT01392326|3804642|FG000|Overall Study|Death|2
2179153|NCT01392326|3804643|FG001|Overall Study|Death|0
2179154|NCT01392326|3804644|FG002|Overall Study|Death|0
2179155|NCT01392326|3804642|FG000|Overall Study|Withdrawal by Subject|12
2179156|NCT01392326|3804643|FG001|Overall Study|Withdrawal by Subject|11
2179157|NCT01392326|3804644|FG002|Overall Study|Withdrawal by Subject|15
2179158|NCT01392326|3804642|FG000|Overall Study|Protocol Violation|2
2179159|NCT01392326|3804643|FG001|Overall Study|Protocol Violation|0
2179160|NCT01392326|3804644|FG002|Overall Study|Protocol Violation|0
2291514|NCT02503202|3984645|FG002|Extension: Month 6 to 24|Physician Decision|1
2291515|NCT02503202|3984646|FG003|Extension: Month 6 to 24|Physician Decision|3
2291516|NCT02503202|3984647|FG004|Extension: Month 6 to 24|Physician Decision|0
2291517|NCT02503202|3984643|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5
2291518|NCT02503202|3984644|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8
2291519|NCT02503202|3984645|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2
2291520|NCT02503202|3984646|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4
2291521|NCT02503202|3984647|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0
2291522|NCT02503215|3984659|FG000|Overall Study|Unable to wear compression stockings|1
2291523|NCT02503215|3984659|FG000|Overall Study|Unable to use positive airway pressure|2
2291524|NCT02503332|3984676|FG000|Overall Study|Adverse Event|17
2291525|NCT02503332|3984677|FG001|Overall Study|Adverse Event|5
2291526|NCT02503332|3984678|FG002|Overall Study|Adverse Event|3
2291527|NCT02503332|3984679|FG003|Overall Study|Adverse Event|1
2291528|NCT02503332|3984676|FG000|Overall Study|Investigator's Decision|5
2291529|NCT02503332|3984677|FG001|Overall Study|Investigator's Decision|1
2291530|NCT02503332|3984678|FG002|Overall Study|Investigator's Decision|0
2291531|NCT02503332|3984679|FG003|Overall Study|Investigator's Decision|0
2291532|NCT02503332|3984676|FG000|Overall Study|Sponsor's Decision|1
2291533|NCT02503332|3984677|FG001|Overall Study|Sponsor's Decision|0
2179161|NCT01392326|3804642|FG000|Overall Study|Pregnancy|0
2208128|NCT01636687|3847524|FG001|Extension Period|Lost to Follow-up|0
2291534|NCT02503332|3984678|FG002|Overall Study|Sponsor's Decision|0
2150820|NCT01185782|3763765|FG000|Overall Study|Adverse Event|0
2150821|NCT01185782|3763766|FG001|Overall Study|Adverse Event|1
2150822|NCT01185782|3763765|FG000|Overall Study|Protocol Violation|1
2150823|NCT01185782|3763766|FG001|Overall Study|Protocol Violation|0
2150824|NCT01185782|3763765|FG000|Overall Study|Poor Response to Treatment|3
2150825|NCT01185782|3763766|FG001|Overall Study|Poor Response to Treatment|1
2150826|NCT01185782|3763765|FG000|Overall Study|Other|2
2150827|NCT01185782|3763766|FG001|Overall Study|Other|5
2150828|NCT01185782|3763765|FG000|Overall Study|Randomized but not treated|0
2150829|NCT01185782|3763766|FG001|Overall Study|Randomized but not treated|4
2150830|NCT01185821|3763777|FG000|Overall Study|Abnormal laboratory value(s)|1
2150831|NCT01185821|3763778|FG001|Overall Study|Abnormal laboratory value(s)|2
2150832|NCT01185821|3763779|FG002|Overall Study|Abnormal laboratory value(s)|1
2150833|NCT01185821|3763780|FG003|Overall Study|Abnormal laboratory value(s)|0
2150834|NCT01185821|3763781|FG004|Overall Study|Abnormal laboratory value(s)|0
2150835|NCT01185821|3763777|FG000|Overall Study|Protocol Violation|0
2150836|NCT01185821|3763778|FG001|Overall Study|Protocol Violation|0
2150837|NCT01185821|3763779|FG002|Overall Study|Protocol Violation|0
2150838|NCT01185821|3763780|FG003|Overall Study|Protocol Violation|1
2291535|NCT02503332|3984679|FG003|Overall Study|Sponsor's Decision|1
2291536|NCT02503332|3984676|FG000|Overall Study|Subject Request|6
2291537|NCT02503332|3984677|FG001|Overall Study|Subject Request|5
2291538|NCT02503332|3984678|FG002|Overall Study|Subject Request|2
2291539|NCT02503332|3984679|FG003|Overall Study|Subject Request|1
2291540|NCT02503332|3984676|FG000|Overall Study|Death|0
2291541|NCT02503332|3984677|FG001|Overall Study|Death|2
2291542|NCT02503332|3984678|FG002|Overall Study|Death|2
2291543|NCT02503332|3984679|FG003|Overall Study|Death|0
2291544|NCT02503332|3984676|FG000|Overall Study|Other|5
2291545|NCT02503332|3984677|FG001|Overall Study|Other|6
2291546|NCT02503332|3984678|FG002|Overall Study|Other|1
2291547|NCT02503332|3984679|FG003|Overall Study|Other|1
2291548|NCT02503501|3984709|FG000|Overall Study|Physician Decision|1
2291549|NCT02503501|3984710|FG001|Overall Study|Physician Decision|0
2291550|NCT02503501|3984709|FG000|Overall Study|Protocol Violation|0
2291551|NCT02503501|3984710|FG001|Overall Study|Protocol Violation|1
2291552|NCT02503501|3984709|FG000|Overall Study|Withdrawal by Subject|0
2291553|NCT02503501|3984710|FG001|Overall Study|Withdrawal by Subject|2
2291554|NCT02503540|3984716|FG000|Overall Study|Death|2
2291555|NCT02503540|3984716|FG000|Overall Study|Withdrawal by Subject|1
2291556|NCT02503787|3984730|FG000|Enrollment|Withdrawal by Subject|6
2291557|NCT02503787|3984730|FG000|Enrollment|Inclusion/exclusion criteria not met|4
2291558|NCT02503787|3984730|FG000|Enrollment|Physician Decision|2
2291559|NCT02503787|3984730|FG000|Enrollment|Insurance issue|2
2291560|NCT02503787|3984730|FG000|Enrollment|Lost to Follow-up|1
2291561|NCT02503787|3984730|FG000|Enrollment|Study closure|1
2291562|NCT02503787|3984730|FG000|Enrollment|Adverse Event|1
2291563|NCT02503787|3984730|FG000|Enrollment|Protocol Violation|1
2291564|NCT02503787|3984730|FG000|Enrollment|Inability to implant system|1
2291565|NCT02503787|3984730|FG000|Enrollment|Unable to be programmed|1
2291566|NCT02503787|3984730|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6
2291567|NCT02503787|3984730|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
2291568|NCT02503787|3984730|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
2291569|NCT02503787|3984730|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2
2291570|NCT02503787|3984730|FG000|Implant to 3 Month Endpoint|Adverse Event|2
2291571|NCT02503787|3984730|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1
2291572|NCT02503865|3984754|FG000|Overall Study|Moved out of area|1
2291573|NCT02503865|3984755|FG001|Overall Study|Moved out of area|8
2291574|NCT02503865|3984756|FG002|Overall Study|Moved out of area|0
2291575|NCT02503865|3984754|FG000|Overall Study|Refused treatment|4
2291576|NCT02503865|3984755|FG001|Overall Study|Refused treatment|39
2291577|NCT02503865|3984756|FG002|Overall Study|Refused treatment|2
2291578|NCT02504216|3984776|FG000|Overall Study|Lost to Follow-up|3
2291579|NCT02504216|3984777|FG001|Overall Study|Lost to Follow-up|3
2291580|NCT02504216|3984776|FG000|Overall Study|Withdrawal by Subject|8
2291581|NCT02504216|3984777|FG001|Overall Study|Withdrawal by Subject|12
2291582|NCT02504268|3984786|FG000|Overall Study|Adverse Event|18
2291583|NCT02504268|3984787|FG001|Overall Study|Adverse Event|8
2291584|NCT02504268|3984788|FG002|Overall Study|Adverse Event|14
2291585|NCT02504268|3984789|FG003|Overall Study|Adverse Event|0
2291586|NCT02504268|3984790|FG004|Overall Study|Adverse Event|0
2291587|NCT02504268|3984791|FG005|Overall Study|Adverse Event|0
2291588|NCT02504268|3984792|FG006|Overall Study|Adverse Event|0
2291589|NCT02504268|3984793|FG007|Overall Study|Adverse Event|0
2291590|NCT02504268|3984794|FG008|Overall Study|Adverse Event|0
2150839|NCT01185821|3763781|FG004|Overall Study|Protocol Violation|1
2150840|NCT01185821|3763777|FG000|Overall Study|Abnormal test procedure result|0
2291591|NCT02504268|3984786|FG000|Overall Study|Withdrawal of Consent|11
2291592|NCT02504268|3984787|FG001|Overall Study|Withdrawal of Consent|10
2291593|NCT02504268|3984788|FG002|Overall Study|Withdrawal of Consent|3
2291594|NCT02504268|3984789|FG003|Overall Study|Withdrawal of Consent|0
2291595|NCT02504268|3984790|FG004|Overall Study|Withdrawal of Consent|0
2291596|NCT02504268|3984791|FG005|Overall Study|Withdrawal of Consent|0
2291597|NCT02504268|3984792|FG006|Overall Study|Withdrawal of Consent|0
2291598|NCT02504268|3984793|FG007|Overall Study|Withdrawal of Consent|0
2150841|NCT01185821|3763778|FG001|Overall Study|Abnormal test procedure result|0
2150842|NCT01185821|3763779|FG002|Overall Study|Abnormal test procedure result|0
2150843|NCT01185821|3763780|FG003|Overall Study|Abnormal test procedure result|0
2150844|NCT01185821|3763781|FG004|Overall Study|Abnormal test procedure result|1
2150845|NCT01185821|3763777|FG000|Overall Study|Death|0
2150846|NCT01185821|3763778|FG001|Overall Study|Death|1
2150847|NCT01185821|3763779|FG002|Overall Study|Death|0
2150848|NCT01185821|3763780|FG003|Overall Study|Death|0
2150849|NCT01185821|3763781|FG004|Overall Study|Death|0
2150850|NCT01185821|3763777|FG000|Overall Study|Condition no longer required study drug|0
2150851|NCT01185821|3763778|FG001|Overall Study|Condition no longer required study drug|0
2150852|NCT01185821|3763779|FG002|Overall Study|Condition no longer required study drug|0
2150853|NCT01185821|3763780|FG003|Overall Study|Condition no longer required study drug|0
2150854|NCT01185821|3763781|FG004|Overall Study|Condition no longer required study drug|1
2150855|NCT01185821|3763777|FG000|Overall Study|Adverse Event|2
2150856|NCT01185821|3763778|FG001|Overall Study|Adverse Event|3
2150857|NCT01185821|3763779|FG002|Overall Study|Adverse Event|1
2150858|NCT01185821|3763780|FG003|Overall Study|Adverse Event|2
2150859|NCT01185821|3763781|FG004|Overall Study|Adverse Event|5
2150860|NCT01185821|3763777|FG000|Overall Study|Lack of Efficacy|0
2150861|NCT01185821|3763778|FG001|Overall Study|Lack of Efficacy|0
2150862|NCT01185821|3763779|FG002|Overall Study|Lack of Efficacy|3
2150863|NCT01185821|3763780|FG003|Overall Study|Lack of Efficacy|0
2150864|NCT01185821|3763781|FG004|Overall Study|Lack of Efficacy|9
2150865|NCT01185821|3763777|FG000|Overall Study|Withdrawal by Subject|3
2150866|NCT01185821|3763778|FG001|Overall Study|Withdrawal by Subject|2
2150867|NCT01185821|3763779|FG002|Overall Study|Withdrawal by Subject|2
2150868|NCT01185821|3763780|FG003|Overall Study|Withdrawal by Subject|1
2150869|NCT01185821|3763781|FG004|Overall Study|Withdrawal by Subject|3
2150870|NCT01185821|3763777|FG000|Overall Study|Lost to Follow-up|1
2150871|NCT01185821|3763778|FG001|Overall Study|Lost to Follow-up|1
2150872|NCT01185821|3763779|FG002|Overall Study|Lost to Follow-up|2
2150873|NCT01185821|3763780|FG003|Overall Study|Lost to Follow-up|1
2150874|NCT01185821|3763781|FG004|Overall Study|Lost to Follow-up|2
2150875|NCT01185821|3763777|FG000|Overall Study|Administrative problems|0
2150876|NCT01185821|3763778|FG001|Overall Study|Administrative problems|0
2150877|NCT01185821|3763779|FG002|Overall Study|Administrative problems|1
2150878|NCT01185821|3763780|FG003|Overall Study|Administrative problems|1
2150879|NCT01185821|3763781|FG004|Overall Study|Administrative problems|2
2150880|NCT01185834|3763795|FG000|Overall Study|Lost to Follow-up|2
2150881|NCT01185834|3763795|FG000|Overall Study|Discomfort|4
2150882|NCT01185834|3763795|FG000|Overall Study|Biomicroscopy|4
2150883|NCT01185834|3763795|FG000|Overall Study|Time/Job Conflict|2
2150884|NCT01185834|3763795|FG000|Overall Study|Early exit - Site error|2
2150885|NCT01185964|3763802|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1
2150886|NCT01185964|3763803|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6
2150887|NCT01185964|3763804|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2
2150888|NCT01185964|3763805|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0
2150889|NCT01185964|3763802|FG000|Phase 1b and Phase 2|Other Therapy Started|0
2150890|NCT01185964|3763803|FG001|Phase 1b and Phase 2|Other Therapy Started|3
2150891|NCT01185964|3763804|FG002|Phase 1b and Phase 2|Other Therapy Started|3
2150892|NCT01185964|3763805|FG003|Phase 1b and Phase 2|Other Therapy Started|0
2150893|NCT01185964|3763802|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0
2150894|NCT01185964|3763803|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0
2150895|NCT01185964|3763804|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1
2150896|NCT01185964|3763805|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0
2150897|NCT01185964|3763802|FG000|Phase 1b and Phase 2|Adverse Event|1
2150898|NCT01185964|3763803|FG001|Phase 1b and Phase 2|Adverse Event|0
2150899|NCT01185964|3763804|FG002|Phase 1b and Phase 2|Adverse Event|2
2150900|NCT01185964|3763805|FG003|Phase 1b and Phase 2|Adverse Event|0
2150901|NCT01185964|3763802|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0
2150902|NCT01185964|3763803|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1
2150903|NCT01185964|3763804|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1
2150904|NCT01185964|3763805|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0
2150905|NCT01185964|3763802|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
2150906|NCT01185964|3763803|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
2150907|NCT01185964|3763804|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
2150908|NCT01185964|3763805|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
2150909|NCT01185964|3763802|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
2150910|NCT01185964|3763803|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
2150911|NCT01185964|3763804|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
2150912|NCT01185964|3763805|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
2150913|NCT01185964|3763802|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
2150914|NCT01185964|3763803|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
2150915|NCT01185964|3763804|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
2150916|NCT01185964|3763805|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
2150917|NCT01186328|3763830|FG000|Overall Study|Death|1
2150918|NCT01186328|3763831|FG001|Overall Study|Death|0
2150919|NCT01186328|3763832|FG002|Overall Study|Death|0
2150920|NCT01186419|3763843|FG000|Overall Study|Withdrawal by Subject|5
2150921|NCT01186419|3763844|FG001|Overall Study|Withdrawal by Subject|3
2150922|NCT01186419|3763843|FG000|Overall Study|Adverse Event|1
2150923|NCT01186419|3763844|FG001|Overall Study|Adverse Event|2
2150924|NCT01186419|3763843|FG000|Overall Study|Physician Decision|0
2150925|NCT01186419|3763844|FG001|Overall Study|Physician Decision|3
2150926|NCT01186419|3763843|FG000|Overall Study|Other|1
2150927|NCT01186419|3763844|FG001|Overall Study|Other|1
2150928|NCT01186458|3763849|FG000|Overall Study|Adverse Event|1
2150929|NCT01186692|3763862|FG000|Overall Study|Not Catheterized|11
2150930|NCT01186692|3763862|FG000|Overall Study|Futher testing contraindicated implant|19
2150931|NCT01186692|3763862|FG000|Overall Study|Adverse Event|2
2150932|NCT01186744|3763880|FG000|Overall Study|Lack of Efficacy|156
2150933|NCT01186744|3763881|FG001|Overall Study|Lack of Efficacy|99
2150934|NCT01186744|3763882|FG002|Overall Study|Lack of Efficacy|0
2150935|NCT01186744|3763883|FG003|Overall Study|Lack of Efficacy|2
2150936|NCT01186744|3763884|FG004|Overall Study|Lack of Efficacy|2
2150937|NCT01186744|3763885|FG005|Overall Study|Lack of Efficacy|5
2150938|NCT01186744|3763880|FG000|Overall Study|Protocol Violation|1
2150939|NCT01186744|3763881|FG001|Overall Study|Protocol Violation|2
2150940|NCT01186744|3763882|FG002|Overall Study|Protocol Violation|0
2150941|NCT01186744|3763883|FG003|Overall Study|Protocol Violation|1
2150942|NCT01186744|3763884|FG004|Overall Study|Protocol Violation|1
2150943|NCT01186744|3763885|FG005|Overall Study|Protocol Violation|2
2150944|NCT01186744|3763880|FG000|Overall Study|Lost to Follow-up|15
2150945|NCT01186744|3763881|FG001|Overall Study|Lost to Follow-up|16
2150946|NCT01186744|3763882|FG002|Overall Study|Lost to Follow-up|2
2150947|NCT01186744|3763883|FG003|Overall Study|Lost to Follow-up|1
2150948|NCT01186744|3763884|FG004|Overall Study|Lost to Follow-up|1
2150949|NCT01186744|3763885|FG005|Overall Study|Lost to Follow-up|4
2150950|NCT01186744|3763880|FG000|Overall Study|Screen failure|1
2150951|NCT01186744|3763881|FG001|Overall Study|Screen failure|1
2150952|NCT01186744|3763882|FG002|Overall Study|Screen failure|0
2150953|NCT01186744|3763883|FG003|Overall Study|Screen failure|1
2150954|NCT01186744|3763884|FG004|Overall Study|Screen failure|0
2150955|NCT01186744|3763885|FG005|Overall Study|Screen failure|0
2150956|NCT01186744|3763880|FG000|Overall Study|Withdrawal by Subject|14
2150957|NCT01186744|3763881|FG001|Overall Study|Withdrawal by Subject|10
2150958|NCT01186744|3763882|FG002|Overall Study|Withdrawal by Subject|2
2150959|NCT01186744|3763883|FG003|Overall Study|Withdrawal by Subject|5
2150960|NCT01186744|3763884|FG004|Overall Study|Withdrawal by Subject|0
2150961|NCT01186744|3763885|FG005|Overall Study|Withdrawal by Subject|6
2150962|NCT01186744|3763880|FG000|Overall Study|Study terminated by Sponsor|1
2150963|NCT01186744|3763881|FG001|Overall Study|Study terminated by Sponsor|0
2150964|NCT01186744|3763882|FG002|Overall Study|Study terminated by Sponsor|0
2150965|NCT01186744|3763883|FG003|Overall Study|Study terminated by Sponsor|0
2150966|NCT01186744|3763884|FG004|Overall Study|Study terminated by Sponsor|0
2150967|NCT01186744|3763885|FG005|Overall Study|Study terminated by Sponsor|0
2150968|NCT01186744|3763880|FG000|Overall Study|Other|9
2150969|NCT01186744|3763881|FG001|Overall Study|Other|10
2150970|NCT01186744|3763882|FG002|Overall Study|Other|1
2150971|NCT01186744|3763883|FG003|Overall Study|Other|2
2150972|NCT01186744|3763884|FG004|Overall Study|Other|1
2150973|NCT01186744|3763885|FG005|Overall Study|Other|5
2150974|NCT01186744|3763880|FG000|Overall Study|Adverse Event|10
2150975|NCT01186744|3763881|FG001|Overall Study|Adverse Event|14
2150976|NCT01186744|3763882|FG002|Overall Study|Adverse Event|1
2150977|NCT01186744|3763883|FG003|Overall Study|Adverse Event|0
2150978|NCT01186744|3763884|FG004|Overall Study|Adverse Event|1
2150979|NCT01186744|3763885|FG005|Overall Study|Adverse Event|4
2150980|NCT01186744|3763880|FG000|Overall Study|Death|1
2150981|NCT01186744|3763881|FG001|Overall Study|Death|0
2150982|NCT01186744|3763882|FG002|Overall Study|Death|0
2150983|NCT01186744|3763883|FG003|Overall Study|Death|0
2150984|NCT01186744|3763884|FG004|Overall Study|Death|0
2150985|NCT01186744|3763885|FG005|Overall Study|Death|0
2150986|NCT01186770|3763924|FG000|Overall Study|Ineligibility|0
2150987|NCT01186770|3763925|FG001|Overall Study|Ineligibility|0
2150988|NCT01186770|3763926|FG002|Overall Study|Ineligibility|2
2150989|NCT01186770|3763927|FG003|Overall Study|Ineligibility|0
2150990|NCT01186770|3763924|FG000|Overall Study|Protocol Violation|7
2150991|NCT01186770|3763925|FG001|Overall Study|Protocol Violation|9
2150992|NCT01186770|3763926|FG002|Overall Study|Protocol Violation|12
2150993|NCT01186770|3763927|FG003|Overall Study|Protocol Violation|14
2150994|NCT01186770|3763924|FG000|Overall Study|Adverse Event|2
2150995|NCT01186770|3763925|FG001|Overall Study|Adverse Event|9
2150996|NCT01186770|3763926|FG002|Overall Study|Adverse Event|7
2150997|NCT01186770|3763927|FG003|Overall Study|Adverse Event|9
2150998|NCT01186770|3763924|FG000|Overall Study|Withdrawal by Subject|15
2150999|NCT01186770|3763925|FG001|Overall Study|Withdrawal by Subject|13
2151000|NCT01186770|3763926|FG002|Overall Study|Withdrawal by Subject|11
2151001|NCT01186770|3763927|FG003|Overall Study|Withdrawal by Subject|17
2151002|NCT01186770|3763924|FG000|Overall Study|Lost to Follow-up|10
2151003|NCT01186770|3763925|FG001|Overall Study|Lost to Follow-up|6
2151004|NCT01186770|3763926|FG002|Overall Study|Lost to Follow-up|14
2151005|NCT01186770|3763927|FG003|Overall Study|Lost to Follow-up|9
2151006|NCT01186770|3763924|FG000|Overall Study|Insufficient response to treatment|7
2151007|NCT01186770|3763925|FG001|Overall Study|Insufficient response to treatment|8
2151008|NCT01186770|3763926|FG002|Overall Study|Insufficient response to treatment|5
2151009|NCT01186770|3763927|FG003|Overall Study|Insufficient response to treatment|7
2151010|NCT01186770|3763924|FG000|Overall Study|Other than specified|0
2151011|NCT01186770|3763925|FG001|Overall Study|Other than specified|1
2151012|NCT01186770|3763926|FG002|Overall Study|Other than specified|1
2151013|NCT01186770|3763927|FG003|Overall Study|Other than specified|2
2151014|NCT01186796|3763939|FG000|Overall Study|Adverse Event|3
2151015|NCT01186796|3763940|FG001|Overall Study|Adverse Event|0
2151016|NCT01186796|3763939|FG000|Overall Study|Withdrawal by Subject|1
2151017|NCT01186796|3763940|FG001|Overall Study|Withdrawal by Subject|1
2151018|NCT01186796|3763939|FG000|Overall Study|Protocol Violation|0
2151019|NCT01186796|3763940|FG001|Overall Study|Protocol Violation|1
2151020|NCT01186809|3763946|FG000|Overall Study|Death|30
2151021|NCT01186939|3763950|FG000|Overall Study|Death|7
2151022|NCT01186939|3763950|FG000|Overall Study|Withdrawal by Subject|2
2151023|NCT01186939|3763950|FG000|Overall Study|No longer receiving clinical benefit|17
2151024|NCT01186939|3763950|FG000|Overall Study|Program closed|5
2151025|NCT01186939|3763950|FG000|Overall Study|Sponsor decision|4
2151026|NCT01186939|3763950|FG000|Overall Study|Started additional treatment|1
2151027|NCT01186939|3763950|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
2151028|NCT01186939|3763950|FG000|Overall Study|Myocardial infarction|1
2151029|NCT01186939|3763950|FG000|Overall Study|Bone marrow transplant|1
2151030|NCT01186939|3763950|FG000|Overall Study|Transformation to AML|1
2151031|NCT01186978|3763954|FG000|Overall Study|Withdrawal by Subject|1
2151032|NCT01187043|3763979|FG000|Overall Study|Adverse Event|0
2151033|NCT01187043|3763980|FG001|Overall Study|Adverse Event|0
2151034|NCT01187043|3763981|FG002|Overall Study|Adverse Event|0
2151035|NCT01187043|3763982|FG003|Overall Study|Adverse Event|0
2151036|NCT01187043|3763983|FG004|Overall Study|Adverse Event|1
2151037|NCT01187043|3763979|FG000|Overall Study|Unable to make scheduled visits|1
2151038|NCT01187043|3763980|FG001|Overall Study|Unable to make scheduled visits|0
2151039|NCT01187043|3763981|FG002|Overall Study|Unable to make scheduled visits|4
2151040|NCT01187043|3763982|FG003|Overall Study|Unable to make scheduled visits|0
2151041|NCT01187043|3763983|FG004|Overall Study|Unable to make scheduled visits|1
2151042|NCT01187407|3764030|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
2151043|NCT01187407|3764031|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2151044|NCT01187407|3764032|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2151045|NCT01187407|3764033|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2151046|NCT01187407|3764034|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2291599|NCT02504268|3984794|FG008|Overall Study|Withdrawal of Consent|0
2291600|NCT02504268|3984786|FG000|Overall Study|Pregnancy|2
2291601|NCT02504268|3984787|FG001|Overall Study|Pregnancy|0
2291602|NCT02504268|3984788|FG002|Overall Study|Pregnancy|0
2291603|NCT02504268|3984789|FG003|Overall Study|Pregnancy|0
2291604|NCT02504268|3984790|FG004|Overall Study|Pregnancy|0
2291605|NCT02504268|3984791|FG005|Overall Study|Pregnancy|0
2291606|NCT02504268|3984792|FG006|Overall Study|Pregnancy|0
2291607|NCT02504268|3984793|FG007|Overall Study|Pregnancy|0
2291608|NCT02504268|3984794|FG008|Overall Study|Pregnancy|0
2291609|NCT02504268|3984786|FG000|Overall Study|Lost to Follow-up|3
2291610|NCT02504268|3984787|FG001|Overall Study|Lost to Follow-up|6
2291611|NCT02504268|3984788|FG002|Overall Study|Lost to Follow-up|4
2291612|NCT02504268|3984789|FG003|Overall Study|Lost to Follow-up|0
2291613|NCT02504268|3984790|FG004|Overall Study|Lost to Follow-up|0
2291614|NCT02504268|3984791|FG005|Overall Study|Lost to Follow-up|0
2291615|NCT02504268|3984792|FG006|Overall Study|Lost to Follow-up|0
2291616|NCT02504268|3984793|FG007|Overall Study|Lost to Follow-up|0
2291617|NCT02504268|3984794|FG008|Overall Study|Lost to Follow-up|0
2291618|NCT02504268|3984786|FG000|Overall Study|Death|1
2291619|NCT02504268|3984787|FG001|Overall Study|Death|1
2291620|NCT02504268|3984788|FG002|Overall Study|Death|0
2291621|NCT02504268|3984789|FG003|Overall Study|Death|0
2291622|NCT02504268|3984790|FG004|Overall Study|Death|0
2291623|NCT02504268|3984791|FG005|Overall Study|Death|0
2291624|NCT02504268|3984792|FG006|Overall Study|Death|0
2291625|NCT02504268|3984793|FG007|Overall Study|Death|0
2291626|NCT02504268|3984794|FG008|Overall Study|Death|0
2291627|NCT02504268|3984786|FG000|Overall Study|Subject Request to Discontinue|11
2291628|NCT02504268|3984787|FG001|Overall Study|Subject Request to Discontinue|3
2291629|NCT02504268|3984788|FG002|Overall Study|Subject Request to Discontinue|6
2291630|NCT02504268|3984789|FG003|Overall Study|Subject Request to Discontinue|0
2291631|NCT02504268|3984790|FG004|Overall Study|Subject Request to Discontinue|0
2291632|NCT02504268|3984791|FG005|Overall Study|Subject Request to Discontinue|0
2291633|NCT02504268|3984792|FG006|Overall Study|Subject Request to Discontinue|0
2291634|NCT02504268|3984793|FG007|Overall Study|Subject Request to Discontinue|0
2291635|NCT02504268|3984794|FG008|Overall Study|Subject Request to Discontinue|0
2291636|NCT02504268|3984786|FG000|Overall Study|No Longer Meets Study Criteria|2
2291637|NCT02504268|3984787|FG001|Overall Study|No Longer Meets Study Criteria|3
2291638|NCT02504268|3984788|FG002|Overall Study|No Longer Meets Study Criteria|0
2291639|NCT02504268|3984789|FG003|Overall Study|No Longer Meets Study Criteria|0
2291640|NCT02504268|3984790|FG004|Overall Study|No Longer Meets Study Criteria|0
2291641|NCT02504268|3984791|FG005|Overall Study|No Longer Meets Study Criteria|0
2151047|NCT01187407|3764030|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
2151048|NCT01187407|3764031|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2151049|NCT01187407|3764032|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2151050|NCT01187407|3764033|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2151051|NCT01187407|3764034|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2151052|NCT01187407|3764030|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
2151053|NCT01187407|3764031|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2151054|NCT01187407|3764032|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2151055|NCT01187407|3764033|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2151056|NCT01187407|3764034|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2151057|NCT01187407|3764030|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
2151058|NCT01187407|3764031|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2151059|NCT01187407|3764032|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2151060|NCT01187407|3764033|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2151061|NCT01187407|3764034|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2151062|NCT01187407|3764030|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
2151063|NCT01187407|3764031|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2151064|NCT01187407|3764032|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2151065|NCT01187407|3764033|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2151066|NCT01187407|3764034|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2151067|NCT01187407|3764030|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
2151068|NCT01187407|3764031|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2151069|NCT01187407|3764032|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2151070|NCT01187407|3764033|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2151071|NCT01187407|3764034|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2151072|NCT01187407|3764030|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
2291642|NCT02504268|3984792|FG006|Overall Study|No Longer Meets Study Criteria|0
2291643|NCT02504268|3984793|FG007|Overall Study|No Longer Meets Study Criteria|0
2291644|NCT02504268|3984794|FG008|Overall Study|No Longer Meets Study Criteria|0
2291645|NCT02504268|3984786|FG000|Overall Study|Lack of Efficacy|11
2291646|NCT02504268|3984787|FG001|Overall Study|Lack of Efficacy|35
2291647|NCT02504268|3984788|FG002|Overall Study|Lack of Efficacy|9
2291648|NCT02504268|3984789|FG003|Overall Study|Lack of Efficacy|0
2291649|NCT02504268|3984790|FG004|Overall Study|Lack of Efficacy|0
2291650|NCT02504268|3984791|FG005|Overall Study|Lack of Efficacy|0
2291651|NCT02504268|3984792|FG006|Overall Study|Lack of Efficacy|0
2291652|NCT02504268|3984793|FG007|Overall Study|Lack of Efficacy|0
2291653|NCT02504268|3984794|FG008|Overall Study|Lack of Efficacy|0
2291654|NCT02504268|3984786|FG000|Overall Study|Poor/Non-Compliance|3
2291655|NCT02504268|3984787|FG001|Overall Study|Poor/Non-Compliance|2
2291656|NCT02504268|3984788|FG002|Overall Study|Poor/Non-Compliance|3
2291657|NCT02504268|3984789|FG003|Overall Study|Poor/Non-Compliance|0
2291658|NCT02504268|3984790|FG004|Overall Study|Poor/Non-Compliance|0
2291659|NCT02504268|3984791|FG005|Overall Study|Poor/Non-Compliance|0
2291660|NCT02504268|3984792|FG006|Overall Study|Poor/Non-Compliance|0
2291661|NCT02504268|3984793|FG007|Overall Study|Poor/Non-Compliance|0
2291662|NCT02504268|3984794|FG008|Overall Study|Poor/Non-Compliance|0
2291663|NCT02504268|3984786|FG000|Overall Study|Not Disclosed|1
2291664|NCT02504268|3984787|FG001|Overall Study|Not Disclosed|0
2291665|NCT02504268|3984788|FG002|Overall Study|Not Disclosed|2
2291666|NCT02504268|3984789|FG003|Overall Study|Not Disclosed|0
2291667|NCT02504268|3984790|FG004|Overall Study|Not Disclosed|0
2291668|NCT02504268|3984791|FG005|Overall Study|Not Disclosed|0
2291669|NCT02504268|3984792|FG006|Overall Study|Not Disclosed|0
2291670|NCT02504268|3984793|FG007|Overall Study|Not Disclosed|0
2291671|NCT02504268|3984794|FG008|Overall Study|Not Disclosed|0
2291672|NCT02504294|3984816|FG000|Overall Study|Adverse Event|15
2291673|NCT02504294|3984817|FG001|Overall Study|Adverse Event|12
2291674|NCT02504294|3984816|FG000|Overall Study|Withdrawal by Subject|7
2291675|NCT02504294|3984817|FG001|Overall Study|Withdrawal by Subject|1
2291676|NCT02504294|3984816|FG000|Overall Study|Protocol Violation|27
2291677|NCT02504294|3984817|FG001|Overall Study|Protocol Violation|26
2291678|NCT02504294|3984816|FG000|Overall Study|Physician Decision|1
2291679|NCT02504294|3984817|FG001|Overall Study|Physician Decision|2
2291680|NCT02504294|3984816|FG000|Overall Study|Lost to Follow-up|6
2291681|NCT02504294|3984817|FG001|Overall Study|Lost to Follow-up|7
2291682|NCT02504320|3984827|FG000|Treatment Period 1|Positive Drug Screen|0
2291683|NCT02504320|3984828|FG001|Treatment Period 1|Positive Drug Screen|0
2291684|NCT02504320|3984829|FG002|Treatment Period 1|Positive Drug Screen|1
2291685|NCT02504320|3984830|FG003|Treatment Period 1|Positive Drug Screen|0
2291686|NCT02504320|3984827|FG000|Treatment Period 2|Positive Drug Screen|0
2291687|NCT02504320|3984828|FG001|Treatment Period 2|Positive Drug Screen|1
2291688|NCT02504320|3984829|FG002|Treatment Period 2|Positive Drug Screen|0
2291689|NCT02504320|3984830|FG003|Treatment Period 2|Positive Drug Screen|0
2291690|NCT02504320|3984827|FG000|Treatment Period 3|Positive Drug Screen|0
2291691|NCT02504320|3984828|FG001|Treatment Period 3|Positive Drug Screen|0
2291692|NCT02504320|3984829|FG002|Treatment Period 3|Positive Drug Screen|0
2291693|NCT02504320|3984830|FG003|Treatment Period 3|Positive Drug Screen|1
2291694|NCT02504320|3984827|FG000|Treatment Period 3|Adverse Event|0
2291695|NCT02504320|3984828|FG001|Treatment Period 3|Adverse Event|0
2151073|NCT01187407|3764031|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2151074|NCT01187407|3764032|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2151075|NCT01187407|3764033|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2151076|NCT01187407|3764034|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2151077|NCT01187407|3764030|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
2151078|NCT01187407|3764031|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
2151079|NCT01187407|3764032|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
2151080|NCT01187407|3764033|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
2151081|NCT01187407|3764034|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
2151082|NCT01187407|3764030|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
2151083|NCT01187407|3764031|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
2151084|NCT01187407|3764032|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
2151085|NCT01187407|3764033|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
2151086|NCT01187407|3764034|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
2151087|NCT01187407|3764030|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2151088|NCT01187407|3764031|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
2151089|NCT01187407|3764032|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
2151090|NCT01187407|3764033|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
2151091|NCT01187407|3764034|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
2151092|NCT01187407|3764030|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2151093|NCT01187407|3764031|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2151094|NCT01187407|3764032|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2151095|NCT01187407|3764033|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2151096|NCT01187407|3764034|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
2151097|NCT01187407|3764030|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
2151098|NCT01187407|3764031|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
2151099|NCT01187407|3764032|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2291696|NCT02504320|3984829|FG002|Treatment Period 3|Adverse Event|1
2291697|NCT02504320|3984830|FG003|Treatment Period 3|Adverse Event|0
2291698|NCT02504424|3984840|FG000|Overall Study|Withdrawal by Subject|2
2321117|NCT02955186|4035397|FG000|Overall Study|Protocol Violation|1
2321118|NCT02955186|4035398|FG001|Overall Study|Protocol Violation|0
2321119|NCT02955212|4035406|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4
2321120|NCT02955212|4035407|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7
2321121|NCT02955212|4035406|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8
2321122|NCT02955212|4035407|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3
2321123|NCT02955212|4035406|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1
2321124|NCT02955212|4035407|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0
2321125|NCT02955212|4035406|FG000|Period 1: Double-blind Treatment Period|Other|3
2321126|NCT02955212|4035407|FG001|Period 1: Double-blind Treatment Period|Other|2
2321127|NCT02955212|4035406|FG000|Period 2: Open-label Extension|Adverse Event|11
2321128|NCT02955212|4035407|FG001|Period 2: Open-label Extension|Adverse Event|7
2321129|NCT02955212|4035406|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1
2321130|NCT02955212|4035407|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4
2321131|NCT02955212|4035406|FG000|Period 2: Open-label Extension|Lack of Efficacy|3
2321132|NCT02955212|4035407|FG001|Period 2: Open-label Extension|Lack of Efficacy|2
2321133|NCT02955212|4035406|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0
2321134|NCT02955212|4035407|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1
2321135|NCT02955212|4035406|FG000|Period 2: Open-label Extension|Other|2
2321136|NCT02955212|4035407|FG001|Period 2: Open-label Extension|Other|4
2321137|NCT02955797|4035426|FG000|Overall Study|Protocol Violation|1
2321138|NCT02955797|4035427|FG001|Overall Study|Protocol Violation|0
2321139|NCT02955797|4035428|FG002|Overall Study|Protocol Violation|0
2321140|NCT02955797|4035429|FG003|Overall Study|Protocol Violation|1
2321141|NCT02955797|4035426|FG000|Overall Study|Withdrawal by Subject|2
2321142|NCT02955797|4035427|FG001|Overall Study|Withdrawal by Subject|2
2321143|NCT02955797|4035428|FG002|Overall Study|Withdrawal by Subject|0
2321144|NCT02955797|4035429|FG003|Overall Study|Withdrawal by Subject|1
2321145|NCT02955797|4035426|FG000|Overall Study|Lost to Follow-up|0
2321146|NCT02955797|4035427|FG001|Overall Study|Lost to Follow-up|1
2321147|NCT02955797|4035428|FG002|Overall Study|Lost to Follow-up|0
2321148|NCT02955797|4035429|FG003|Overall Study|Lost to Follow-up|0
2321149|NCT02956057|4035475|FG000|Overall Study|Discontinued intervention|14
2321150|NCT02956057|4035476|FG001|Overall Study|Discontinued intervention|10
2321151|NCT02956057|4035477|FG002|Overall Study|Discontinued intervention|7
2321152|NCT02956057|4035478|FG003|Overall Study|Discontinued intervention|14
2321153|NCT02956057|4035479|FG004|Overall Study|Discontinued intervention|4
2321154|NCT02956057|4035480|FG005|Overall Study|Discontinued intervention|17
2321155|NCT02956057|4035475|FG000|Overall Study|Lost to Follow-up|0
2321156|NCT02956057|4035476|FG001|Overall Study|Lost to Follow-up|2
2321157|NCT02956057|4035477|FG002|Overall Study|Lost to Follow-up|1
2321158|NCT02956057|4035478|FG003|Overall Study|Lost to Follow-up|1
2321159|NCT02956057|4035479|FG004|Overall Study|Lost to Follow-up|1
2321160|NCT02956057|4035480|FG005|Overall Study|Lost to Follow-up|0
2321161|NCT02956278|4035517|FG000|Overall Study|Withdrawal by Subject|6
2151100|NCT01187407|3764033|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
2151101|NCT01187407|3764034|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
2151102|NCT01187407|3764030|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
2151103|NCT01187407|3764031|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
2151104|NCT01187407|3764032|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
2151105|NCT01187407|3764033|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
2151106|NCT01187407|3764034|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
2151107|NCT01187407|3764030|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2151108|NCT01187407|3764031|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2151109|NCT01187407|3764032|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2151110|NCT01187407|3764033|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2151111|NCT01187407|3764034|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
2151112|NCT01187433|3764053|FG000|Overall Study|Protocol Violation|6
2291699|NCT02504502|3984847|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4
2291700|NCT02504502|3984848|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7
2291701|NCT02504502|3984847|FG000|Crossover to Enhanced Report|Lost to Follow-up|5
2291702|NCT02504502|3984848|FG001|Crossover to Enhanced Report|Lost to Follow-up|0
2291703|NCT02504541|3984854|FG000|Overall Study|Adverse Event|4
2291704|NCT02504541|3984854|FG000|Overall Study|Withdrawal by Subject|4
2291705|NCT02504541|3984854|FG000|Overall Study|Lost to Follow-up|1
2291706|NCT02504541|3984854|FG000|Overall Study|Met Stopping Criteria|1
2291707|NCT02504541|3984854|FG000|Overall Study|Protocol Violation|2
2291708|NCT02504541|3984854|FG000|Overall Study|Termination by Sponsor|1
2291709|NCT02504541|3984854|FG000|Overall Study|Other|2
2291710|NCT02504541|3984854|FG000|Overall Study|Multiple|5
2291711|NCT02504671|3984887|FG000|Overall Study|Withdrawal by Subject|1
2291712|NCT02504671|3984888|FG001|Overall Study|Withdrawal by Subject|5
2291713|NCT02504671|3984889|FG002|Overall Study|Withdrawal by Subject|4
2291714|NCT02504671|3984890|FG003|Overall Study|Withdrawal by Subject|4
2291715|NCT02504671|3984891|FG004|Overall Study|Withdrawal by Subject|5
2291716|NCT02504671|3984892|FG005|Overall Study|Withdrawal by Subject|3
2291717|NCT02504671|3984887|FG000|Overall Study|Lack of Efficacy|1
2291718|NCT02504671|3984888|FG001|Overall Study|Lack of Efficacy|3
2291719|NCT02504671|3984889|FG002|Overall Study|Lack of Efficacy|1
2291720|NCT02504671|3984890|FG003|Overall Study|Lack of Efficacy|0
2291721|NCT02504671|3984891|FG004|Overall Study|Lack of Efficacy|4
2291722|NCT02504671|3984892|FG005|Overall Study|Lack of Efficacy|4
2291723|NCT02504671|3984887|FG000|Overall Study|Adverse Event|1
2291724|NCT02504671|3984888|FG001|Overall Study|Adverse Event|1
2291725|NCT02504671|3984889|FG002|Overall Study|Adverse Event|0
2291726|NCT02504671|3984890|FG003|Overall Study|Adverse Event|1
2291727|NCT02504671|3984891|FG004|Overall Study|Adverse Event|0
2291728|NCT02504671|3984892|FG005|Overall Study|Adverse Event|2
2291729|NCT02504671|3984887|FG000|Overall Study|Protocol Violation|2
2291730|NCT02504671|3984888|FG001|Overall Study|Protocol Violation|1
2291731|NCT02504671|3984889|FG002|Overall Study|Protocol Violation|0
2291732|NCT02504671|3984890|FG003|Overall Study|Protocol Violation|0
2291733|NCT02504671|3984891|FG004|Overall Study|Protocol Violation|0
2291734|NCT02504671|3984892|FG005|Overall Study|Protocol Violation|1
2291735|NCT02504671|3984887|FG000|Overall Study|Lost to Follow-up|0
2291736|NCT02504671|3984888|FG001|Overall Study|Lost to Follow-up|0
2291737|NCT02504671|3984889|FG002|Overall Study|Lost to Follow-up|2
2291738|NCT02504671|3984890|FG003|Overall Study|Lost to Follow-up|0
2291739|NCT02504671|3984891|FG004|Overall Study|Lost to Follow-up|0
2291740|NCT02504671|3984892|FG005|Overall Study|Lost to Follow-up|1
2291741|NCT02504671|3984887|FG000|Overall Study|Protocol defined stopping criteria|7
2291742|NCT02504671|3984888|FG001|Overall Study|Protocol defined stopping criteria|4
2291743|NCT02504671|3984889|FG002|Overall Study|Protocol defined stopping criteria|3
2291744|NCT02504671|3984890|FG003|Overall Study|Protocol defined stopping criteria|5
2291745|NCT02504671|3984891|FG004|Overall Study|Protocol defined stopping criteria|3
2291746|NCT02504671|3984892|FG005|Overall Study|Protocol defined stopping criteria|3
2291747|NCT02504827|3984924|FG000|Overall Study|Could not produce sputum|1
2291748|NCT02504892|3984928|FG000|Overall Study|Adverse event-pneumonitis|2
2291749|NCT02505217|3984943|FG000|Overall Study|Withdrawal by Subject|1
2291750|NCT02505217|3984944|FG001|Overall Study|Withdrawal by Subject|2
2291751|NCT02505334|3984956|FG000|Main Treatment Period|Adverse Event|3
2291752|NCT02505334|3984957|FG001|Main Treatment Period|Adverse Event|3
2291753|NCT02505334|3984956|FG000|Main Treatment Period|Lack of Efficacy|7
2291754|NCT02505334|3984957|FG001|Main Treatment Period|Lack of Efficacy|17
2291755|NCT02505334|3984956|FG000|Main Treatment Period|Protocol Violation|0
2291756|NCT02505334|3984957|FG001|Main Treatment Period|Protocol Violation|1
2291757|NCT02505334|3984956|FG000|Main Treatment Period|Withdrawal by Subject|1
2291758|NCT02505334|3984957|FG001|Main Treatment Period|Withdrawal by Subject|8
2291759|NCT02505334|3984956|FG000|Main Treatment Period|Unclassified|4
2291760|NCT02505334|3984957|FG001|Main Treatment Period|Unclassified|10
2291761|NCT02505334|3984956|FG000|Extension Treatment Period|Adverse Event|5
2291762|NCT02505334|3984957|FG001|Extension Treatment Period|Adverse Event|0
2291763|NCT02505334|3984956|FG000|Extension Treatment Period|Lack of Efficacy|4
2291764|NCT02505334|3984957|FG001|Extension Treatment Period|Lack of Efficacy|0
2291765|NCT02505334|3984956|FG000|Extension Treatment Period|Withdrawal by Subject|6
2151113|NCT01187433|3764054|FG001|Overall Study|Protocol Violation|2
2151114|NCT01187433|3764053|FG000|Overall Study|Withdrawal by Subject|5
2151115|NCT01187433|3764054|FG001|Overall Study|Withdrawal by Subject|2
2151116|NCT01187446|3764062|FG000|Overall Study|Patient started non-protocol therapy|0
2151117|NCT01187446|3764063|FG001|Overall Study|Patient started non-protocol therapy|1
2151118|NCT01187550|3764089|FG000|Overall Study|Protocol Violation|3
2151119|NCT01187550|3764090|FG001|Overall Study|Protocol Violation|1
2151120|NCT01187550|3764089|FG000|Overall Study|Other|3
2151121|NCT01187550|3764090|FG001|Overall Study|Other|0
2151122|NCT01187550|3764089|FG000|Overall Study|Randomized but not treated|8
2151123|NCT01187550|3764090|FG001|Overall Study|Randomized but not treated|0
2151124|NCT01187901|3764109|FG000|Overall Study|Protocol Violation|1
2151125|NCT01187901|3764110|FG001|Overall Study|Protocol Violation|0
2151126|NCT01187901|3764109|FG000|Overall Study|Lost to Follow-up|1
2151127|NCT01187901|3764110|FG001|Overall Study|Lost to Follow-up|2
2151128|NCT01187901|3764109|FG000|Overall Study|Unrelated Health Reasons|1
2151129|NCT01187901|3764110|FG001|Overall Study|Unrelated Health Reasons|2
2151130|NCT01187901|3764109|FG000|Overall Study|Suspected Allergic Reaction|1
2151131|NCT01187901|3764110|FG001|Overall Study|Suspected Allergic Reaction|1
2151132|NCT01187901|3764109|FG000|Overall Study|Adverse Event|3
2151133|NCT01187901|3764110|FG001|Overall Study|Adverse Event|0
2151134|NCT01187901|3764109|FG000|Overall Study|No Endpoint due to Early Study Halt|2
2151135|NCT01187901|3764110|FG001|Overall Study|No Endpoint due to Early Study Halt|3
2151136|NCT01187901|3764109|FG000|Overall Study|Pregnancy|0
2151137|NCT01187901|3764110|FG001|Overall Study|Pregnancy|2
2151138|NCT01187953|3764122|FG000|Overall Study|Death|11
2151139|NCT01187953|3764123|FG001|Overall Study|Death|13
2151140|NCT01187953|3764122|FG000|Overall Study|Adverse Event|1
2151141|NCT01187953|3764123|FG001|Overall Study|Adverse Event|2
2151142|NCT01187953|3764122|FG000|Overall Study|Lost to Follow-up|0
2291766|NCT02505334|3984957|FG001|Extension Treatment Period|Withdrawal by Subject|0
2291767|NCT02505334|3984956|FG000|Extension Treatment Period|Unclassified|3
2291768|NCT02505334|3984957|FG001|Extension Treatment Period|Unclassified|0
2291769|NCT02505542|3984963|FG000|Part A: Open-Label Period|Adverse Event|31
2291770|NCT02505542|3984964|FG001|Part A: Open-Label Period|Adverse Event|0
2291771|NCT02505542|3984965|FG002|Part A: Open-Label Period|Adverse Event|0
2291772|NCT02505542|3984966|FG003|Part A: Open-Label Period|Adverse Event|0
2291773|NCT02505542|3984963|FG000|Part A: Open-Label Period|Lack of Efficacy|5
2291774|NCT02505542|3984964|FG001|Part A: Open-Label Period|Lack of Efficacy|0
2291775|NCT02505542|3984965|FG002|Part A: Open-Label Period|Lack of Efficacy|0
2291776|NCT02505542|3984966|FG003|Part A: Open-Label Period|Lack of Efficacy|0
2291777|NCT02505542|3984963|FG000|Part A: Open-Label Period|Protocol Violation|1
2291778|NCT02505542|3984964|FG001|Part A: Open-Label Period|Protocol Violation|0
2291779|NCT02505542|3984965|FG002|Part A: Open-Label Period|Protocol Violation|0
2291780|NCT02505542|3984966|FG003|Part A: Open-Label Period|Protocol Violation|0
2291781|NCT02505542|3984963|FG000|Part A: Open-Label Period|Lost to Follow-up|5
2291782|NCT02505542|3984964|FG001|Part A: Open-Label Period|Lost to Follow-up|0
2291783|NCT02505542|3984965|FG002|Part A: Open-Label Period|Lost to Follow-up|0
2291784|NCT02505542|3984966|FG003|Part A: Open-Label Period|Lost to Follow-up|0
2291785|NCT02505542|3984963|FG000|Part A: Open-Label Period|Withdrawal by Subject|27
2291786|NCT02505542|3984964|FG001|Part A: Open-Label Period|Withdrawal by Subject|0
2291787|NCT02505542|3984965|FG002|Part A: Open-Label Period|Withdrawal by Subject|0
2291788|NCT02505542|3984966|FG003|Part A: Open-Label Period|Withdrawal by Subject|0
2291789|NCT02505542|3984963|FG000|Part A: Open-Label Period|New medical history available|1
2291790|NCT02505542|3984964|FG001|Part A: Open-Label Period|New medical history available|0
2291791|NCT02505542|3984965|FG002|Part A: Open-Label Period|New medical history available|0
2291792|NCT02505542|3984966|FG003|Part A: Open-Label Period|New medical history available|0
2291793|NCT02505542|3984963|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1
2291794|NCT02505542|3984964|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0
2291795|NCT02505542|3984965|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0
2291796|NCT02505542|3984966|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0
2291797|NCT02505542|3984963|FG000|Part A: Open-Label Period|Pregnancy|2
2291798|NCT02505542|3984964|FG001|Part A: Open-Label Period|Pregnancy|0
2291799|NCT02505542|3984965|FG002|Part A: Open-Label Period|Pregnancy|0
2291800|NCT02505542|3984966|FG003|Part A: Open-Label Period|Pregnancy|0
2291801|NCT02505542|3984963|FG000|Part A: Open-Label Period|Sponsor directive|1
2291802|NCT02505542|3984964|FG001|Part A: Open-Label Period|Sponsor directive|0
2291803|NCT02505542|3984965|FG002|Part A: Open-Label Period|Sponsor directive|0
2291804|NCT02505542|3984966|FG003|Part A: Open-Label Period|Sponsor directive|0
2291805|NCT02505542|3984963|FG000|Part A: Open-Label Period|Medical monitor decision|1
2291806|NCT02505542|3984964|FG001|Part A: Open-Label Period|Medical monitor decision|0
2291807|NCT02505542|3984965|FG002|Part A: Open-Label Period|Medical monitor decision|0
2291808|NCT02505542|3984966|FG003|Part A: Open-Label Period|Medical monitor decision|0
2291809|NCT02505542|3984963|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1
2151143|NCT01187953|3764123|FG001|Overall Study|Lost to Follow-up|3
2151144|NCT01187953|3764122|FG000|Overall Study|Withdrawal by Subject|3
2151145|NCT01187953|3764123|FG001|Overall Study|Withdrawal by Subject|3
2151146|NCT01188226|3764133|FG000|Overall Study|Withdrawal by Subject|4
2151147|NCT01188343|3764150|FG000|Overall Study|Not vaccinated|0
2151148|NCT01188343|3764151|FG001|Overall Study|Not vaccinated|2
2151149|NCT01188343|3764152|FG002|Overall Study|Not vaccinated|1
2151150|NCT01188343|3764150|FG000|Overall Study|Withdrawal by Subject|1
2151151|NCT01188343|3764151|FG001|Overall Study|Withdrawal by Subject|24
2151152|NCT01188343|3764152|FG002|Overall Study|Withdrawal by Subject|0
2151153|NCT01188538|3764222|FG000|Overall Study|Lost to Follow-up|0
2151154|NCT01188538|3764223|FG001|Overall Study|Lost to Follow-up|1
2151155|NCT01188551|3764235|FG000|Overall Study|Pharmacy issues|1
2151156|NCT01188551|3764236|FG001|Overall Study|Pharmacy issues|0
2151157|NCT01188551|3764237|FG002|Overall Study|Pharmacy issues|0
2151158|NCT01188551|3764238|FG003|Overall Study|Pharmacy issues|0
2151159|NCT01188564|3764250|FG000|Double-blind Phase|randomized not treated|1
2151160|NCT01188564|3764251|FG001|Double-blind Phase|randomized not treated|0
2151161|NCT01188655|3764270|FG000|Overall Study|Lack of Efficacy|1
2151162|NCT01188655|3764270|FG000|Overall Study|Lost to Follow-up|1
2151163|NCT01188655|3764270|FG000|Overall Study|Other|11
2151164|NCT01188668|3764274|FG000|Period 1: ARIP Alone|Protocol Violation|2
2151165|NCT01188668|3764274|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
2151166|NCT01188668|3764274|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
2151167|NCT01188681|3764285|FG000|Overall Study|bladder cancer|0
2151168|NCT01188681|3764286|FG001|Overall Study|bladder cancer|0
2151169|NCT01188681|3764287|FG002|Overall Study|bladder cancer|1
2151170|NCT01188681|3764288|FG003|Overall Study|bladder cancer|0
2151171|NCT01188681|3764285|FG000|Overall Study|Withdrawal by Subject|0
2151172|NCT01188681|3764286|FG001|Overall Study|Withdrawal by Subject|0
2151173|NCT01188681|3764287|FG002|Overall Study|Withdrawal by Subject|0
2151174|NCT01188681|3764288|FG003|Overall Study|Withdrawal by Subject|1
2151175|NCT01188772|3764319|FG000|Overall Study|Randomized but Not Treated|0
2151176|NCT01188772|3764320|FG001|Overall Study|Randomized but Not Treated|1
2151177|NCT01188772|3764321|FG002|Overall Study|Randomized but Not Treated|0
2151178|NCT01188772|3764322|FG003|Overall Study|Randomized but Not Treated|0
2151179|NCT01188772|3764319|FG000|Overall Study|Adverse Event|0
2151180|NCT01188772|3764320|FG001|Overall Study|Adverse Event|1
2151181|NCT01188772|3764321|FG002|Overall Study|Adverse Event|2
2151182|NCT01188772|3764322|FG003|Overall Study|Adverse Event|0
2151183|NCT01188772|3764319|FG000|Overall Study|Lost to Follow-up|4
2151184|NCT01188772|3764320|FG001|Overall Study|Lost to Follow-up|1
2151185|NCT01188772|3764321|FG002|Overall Study|Lost to Follow-up|1
2151186|NCT01188772|3764322|FG003|Overall Study|Lost to Follow-up|1
2151187|NCT01188772|3764319|FG000|Overall Study|Non-responder|0
2151188|NCT01188772|3764320|FG001|Overall Study|Non-responder|0
2151189|NCT01188772|3764321|FG002|Overall Study|Non-responder|3
2151190|NCT01188772|3764322|FG003|Overall Study|Non-responder|0
2151191|NCT01188772|3764319|FG000|Overall Study|Physician Decision|0
2151192|NCT01188772|3764320|FG001|Overall Study|Physician Decision|0
2151193|NCT01188772|3764321|FG002|Overall Study|Physician Decision|1
2151194|NCT01188772|3764322|FG003|Overall Study|Physician Decision|0
2151195|NCT01188772|3764319|FG000|Overall Study|Terminated by Sponsor|0
2151196|NCT01188772|3764320|FG001|Overall Study|Terminated by Sponsor|0
2291810|NCT02505542|3984964|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0
2291811|NCT02505542|3984965|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0
2291812|NCT02505542|3984966|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0
2291813|NCT02505542|3984963|FG000|Part A: Open-Label Period|Non-compliance|1
2291814|NCT02505542|3984964|FG001|Part A: Open-Label Period|Non-compliance|0
2291815|NCT02505542|3984965|FG002|Part A: Open-Label Period|Non-compliance|0
2291816|NCT02505542|3984966|FG003|Part A: Open-Label Period|Non-compliance|0
2291817|NCT02505542|3984963|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
2291818|NCT02505542|3984964|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
2291819|NCT02505542|3984965|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
2291820|NCT02505542|3984966|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
2291821|NCT02505542|3984963|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
2291822|NCT02505542|3984964|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
2291823|NCT02505542|3984965|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
2291824|NCT02505542|3984966|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
2291825|NCT02505542|3984963|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
2291826|NCT02505542|3984964|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
2291827|NCT02505542|3984965|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
2291828|NCT02505542|3984966|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
2291829|NCT02505542|3984963|FG000|Part B: Double-Blind Period|Adverse Event|0
2291830|NCT02505542|3984964|FG001|Part B: Double-Blind Period|Adverse Event|0
2291831|NCT02505542|3984965|FG002|Part B: Double-Blind Period|Adverse Event|1
2151197|NCT01188772|3764321|FG002|Overall Study|Terminated by Sponsor|1
2151198|NCT01188772|3764322|FG003|Overall Study|Terminated by Sponsor|0
2151199|NCT01188772|3764319|FG000|Overall Study|Treatment Failure|0
2151200|NCT01188772|3764320|FG001|Overall Study|Treatment Failure|0
2151201|NCT01188772|3764321|FG002|Overall Study|Treatment Failure|1
2151202|NCT01188772|3764322|FG003|Overall Study|Treatment Failure|0
2151203|NCT01188772|3764319|FG000|Overall Study|Virologic Failure|1
2151204|NCT01188772|3764320|FG001|Overall Study|Virologic Failure|0
2151205|NCT01188772|3764321|FG002|Overall Study|Virologic Failure|0
2151206|NCT01188772|3764322|FG003|Overall Study|Virologic Failure|0
2151207|NCT01188772|3764319|FG000|Overall Study|Withdrawal by Subject|0
2151208|NCT01188772|3764320|FG001|Overall Study|Withdrawal by Subject|0
2151209|NCT01188772|3764321|FG002|Overall Study|Withdrawal by Subject|2
2151210|NCT01188772|3764322|FG003|Overall Study|Withdrawal by Subject|0
2151211|NCT01188811|3764337|FG000|Overall Study|Withdrawal by Subject|0
2151212|NCT01188811|3764338|FG001|Overall Study|Withdrawal by Subject|2
2151213|NCT01188811|3764337|FG000|Overall Study|Adverse Event|6
2151214|NCT01188811|3764338|FG001|Overall Study|Adverse Event|0
2151215|NCT01188967|3764367|FG000|Overall Study|Withdrawal by Subject|1
2151216|NCT01188967|3764368|FG001|Overall Study|Withdrawal by Subject|1
2151217|NCT01188967|3764367|FG000|Overall Study|Physician Decision|1
2151218|NCT01188967|3764368|FG001|Overall Study|Physician Decision|1
2151219|NCT01188967|3764367|FG000|Overall Study|Lost to Follow-up|3
2151220|NCT01188967|3764368|FG001|Overall Study|Lost to Follow-up|2
2151221|NCT01189032|3764379|FG000|Overall Study|Adverse Event|1
2151222|NCT01189032|3764380|FG001|Overall Study|Adverse Event|3
2151223|NCT01189032|3764381|FG002|Overall Study|Adverse Event|4
2151224|NCT01189032|3764379|FG000|Overall Study|Lack of Efficacy|2
2151225|NCT01189032|3764380|FG001|Overall Study|Lack of Efficacy|3
2151226|NCT01189032|3764381|FG002|Overall Study|Lack of Efficacy|0
2151227|NCT01189032|3764379|FG000|Overall Study|Withdrawal by Subject|1
2151228|NCT01189032|3764380|FG001|Overall Study|Withdrawal by Subject|0
2151229|NCT01189032|3764381|FG002|Overall Study|Withdrawal by Subject|1
2151230|NCT01189032|3764379|FG000|Overall Study|Protocol Violation|1
2151231|NCT01189032|3764380|FG001|Overall Study|Protocol Violation|1
2151232|NCT01189032|3764381|FG002|Overall Study|Protocol Violation|1
2151233|NCT01189201|3764416|FG000|Overall Study|Adverse Event|1
2151234|NCT01189266|3764446|FG000|Overall Study|Adverse Event|1
2151235|NCT01189266|3764447|FG001|Overall Study|Adverse Event|0
2151236|NCT01189266|3764448|FG002|Overall Study|Adverse Event|5
2151237|NCT01189266|3764446|FG000|Overall Study|Death|0
2151238|NCT01189266|3764447|FG001|Overall Study|Death|0
2151239|NCT01189266|3764448|FG002|Overall Study|Death|5
2151240|NCT01189266|3764446|FG000|Overall Study|Lack of Efficacy|4
2151241|NCT01189266|3764447|FG001|Overall Study|Lack of Efficacy|5
2151242|NCT01189266|3764448|FG002|Overall Study|Lack of Efficacy|44
2151243|NCT01189266|3764446|FG000|Overall Study|Physician Decision|0
2151244|NCT01189266|3764447|FG001|Overall Study|Physician Decision|0
2151245|NCT01189266|3764448|FG002|Overall Study|Physician Decision|1
2151246|NCT01189266|3764446|FG000|Overall Study|Protocol Violation|0
2151247|NCT01189266|3764447|FG001|Overall Study|Protocol Violation|1
2151248|NCT01189266|3764448|FG002|Overall Study|Protocol Violation|1
2151249|NCT01189266|3764446|FG000|Overall Study|Withdrawal by Subject|0
2151250|NCT01189266|3764447|FG001|Overall Study|Withdrawal by Subject|0
2151251|NCT01189266|3764448|FG002|Overall Study|Withdrawal by Subject|1
2151252|NCT01189266|3764446|FG000|Overall Study|Patient refuses further therapy|1
2151253|NCT01189266|3764447|FG001|Overall Study|Patient refuses further therapy|0
2151254|NCT01189266|3764448|FG002|Overall Study|Patient refuses further therapy|7
2151255|NCT01189266|3764446|FG000|Overall Study|No treatment|0
2151256|NCT01189266|3764447|FG001|Overall Study|No treatment|0
2151257|NCT01189266|3764448|FG002|Overall Study|No treatment|1
2151258|NCT01189461|3764504|FG000|Overall Study|Lack of Efficacy|13
2151259|NCT01189461|3764504|FG000|Overall Study|Lost to Follow-up|1
2151260|NCT01189461|3764504|FG000|Overall Study|Withdrawal by Subject|6
2151261|NCT01189461|3764504|FG000|Overall Study|Protocol Violation|1
2151262|NCT01189461|3764504|FG000|Overall Study|Adverse Event|2
2151263|NCT01189461|3764504|FG000|Overall Study|Did not meet entrance criteria|3
2151264|NCT01189461|3764504|FG000|Overall Study|Other|8
2151265|NCT01189487|3764508|FG000|Overall Study|Lack of Efficacy|2
2151266|NCT01189487|3764508|FG000|Overall Study|Adverse Event|1
2151267|NCT01189500|3764512|FG000|Period 1: TAMOX Alone|Adverse Event|1
2151268|NCT01189500|3764512|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
2151269|NCT01189604|3764526|FG000|Overall Study|Impossible to visit|0
2151270|NCT01189604|3764527|FG001|Overall Study|Impossible to visit|0
2151271|NCT01189604|3764528|FG002|Overall Study|Impossible to visit|0
2151272|NCT01189604|3764529|FG003|Overall Study|Impossible to visit|0
2151273|NCT01189604|3764530|FG004|Overall Study|Impossible to visit|0
2151274|NCT01189604|3764531|FG005|Overall Study|Impossible to visit|1
2151275|NCT01189604|3764532|FG006|Overall Study|Impossible to visit|0
2151276|NCT01189604|3764526|FG000|Overall Study|Adverse Event|0
2151277|NCT01189604|3764527|FG001|Overall Study|Adverse Event|1
2151278|NCT01189604|3764528|FG002|Overall Study|Adverse Event|0
2151279|NCT01189604|3764529|FG003|Overall Study|Adverse Event|0
2151280|NCT01189604|3764530|FG004|Overall Study|Adverse Event|2
2151281|NCT01189604|3764531|FG005|Overall Study|Adverse Event|0
2151282|NCT01189604|3764532|FG006|Overall Study|Adverse Event|1
2151283|NCT01189604|3764526|FG000|Overall Study|Withdrawal by Subject|1
2208129|NCT01636687|3847525|FG002|Extension Period|Lost to Follow-up|1
2151284|NCT01189604|3764527|FG001|Overall Study|Withdrawal by Subject|0
2151285|NCT01189604|3764528|FG002|Overall Study|Withdrawal by Subject|0
2151286|NCT01189604|3764529|FG003|Overall Study|Withdrawal by Subject|0
2151287|NCT01189604|3764530|FG004|Overall Study|Withdrawal by Subject|0
2151288|NCT01189604|3764531|FG005|Overall Study|Withdrawal by Subject|0
2151289|NCT01189604|3764532|FG006|Overall Study|Withdrawal by Subject|0
2151290|NCT01189812|3764581|FG000|Overall Study|Withdrawal by Subject|2
2151291|NCT01189812|3764582|FG001|Overall Study|Withdrawal by Subject|3
2151292|NCT01189812|3764581|FG000|Overall Study|Adverse Event|1
2151293|NCT01189812|3764582|FG001|Overall Study|Adverse Event|0
2151294|NCT01189812|3764581|FG000|Overall Study|Out of Window|4
2151295|NCT01189812|3764582|FG001|Overall Study|Out of Window|3
2151296|NCT01189812|3764581|FG000|Overall Study|Moved out of State|1
2151297|NCT01189812|3764582|FG001|Overall Study|Moved out of State|2
2151298|NCT01189890|3764590|FG000|Overall Study|Adverse Event|3
2151299|NCT01189890|3764591|FG001|Overall Study|Adverse Event|4
2151300|NCT01189890|3764590|FG000|Overall Study|Lack of Efficacy|7
2151301|NCT01189890|3764591|FG001|Overall Study|Lack of Efficacy|2
2151302|NCT01189890|3764590|FG000|Overall Study|Lost to Follow-up|1
2151303|NCT01189890|3764591|FG001|Overall Study|Lost to Follow-up|7
2151304|NCT01189890|3764590|FG000|Overall Study|Protocol Violation|1
2151305|NCT01189890|3764591|FG001|Overall Study|Protocol Violation|5
2151306|NCT01189890|3764590|FG000|Overall Study|Withdrawal by Subject|15
2151307|NCT01189890|3764591|FG001|Overall Study|Withdrawal by Subject|11
2151308|NCT01189890|3764590|FG000|Overall Study|Non Compliance|0
2151309|NCT01189890|3764591|FG001|Overall Study|Non Compliance|1
2151310|NCT01189890|3764590|FG000|Overall Study|Physician Decision|5
2151311|NCT01189890|3764591|FG001|Overall Study|Physician Decision|4
2151312|NCT01189890|3764590|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5
2151313|NCT01189890|3764591|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5
2151314|NCT01190007|3764597|FG000|Overall Study|Withdrawal by Subject|4
2151315|NCT01190007|3764597|FG000|Overall Study|Adverse Event|8
2151316|NCT01190007|3764597|FG000|Overall Study|Difficulty of visit for complications|1
2151317|NCT01190007|3764597|FG000|Overall Study|Participant was arrested|1
2151318|NCT01190020|3764603|FG000|Overall Study|Adverse Event|2
2151319|NCT01190020|3764604|FG001|Overall Study|Adverse Event|0
2151320|NCT01190020|3764603|FG000|Overall Study|Lost to Follow-up|2
2151321|NCT01190020|3764604|FG001|Overall Study|Lost to Follow-up|0
2151322|NCT01190020|3764603|FG000|Overall Study|Withdrawal by Subject|3
2151323|NCT01190020|3764604|FG001|Overall Study|Withdrawal by Subject|0
2151324|NCT01190098|3764625|FG000|Overall Study|Adverse Event|2
2151325|NCT01190098|3764626|FG001|Overall Study|Adverse Event|0
2151326|NCT01190098|3764625|FG000|Overall Study|Patient coomorbidity|0
2151327|NCT01190098|3764626|FG001|Overall Study|Patient coomorbidity|1
2151328|NCT01190098|3764625|FG000|Overall Study|Lack of transportation|1
2151329|NCT01190098|3764626|FG001|Overall Study|Lack of transportation|0
2151330|NCT01190098|3764625|FG000|Overall Study|Other|0
2151331|NCT01190098|3764626|FG001|Overall Study|Other|1
2151332|NCT01190124|3764635|FG000|Overall Study|Death|3
2151333|NCT01190124|3764636|FG001|Overall Study|Death|0
2151334|NCT01190124|3764637|FG002|Overall Study|Death|0
2151335|NCT01190124|3764635|FG000|Overall Study|Therapeutic Failure|12
2151336|NCT01190124|3764636|FG001|Overall Study|Therapeutic Failure|0
2151337|NCT01190124|3764637|FG002|Overall Study|Therapeutic Failure|1
2151338|NCT01190124|3764635|FG000|Overall Study|Lost to Follow-up|2
2151339|NCT01190124|3764636|FG001|Overall Study|Lost to Follow-up|0
2151340|NCT01190124|3764637|FG002|Overall Study|Lost to Follow-up|0
2151341|NCT01190150|3764650|FG000|First Treatment|Withdrawal by Subject|1
2151342|NCT01190150|3764651|FG001|First Treatment|Withdrawal by Subject|0
2151343|NCT01190150|3764650|FG000|Washout|Withdrawal by Subject|0
2151344|NCT01190150|3764651|FG001|Washout|Withdrawal by Subject|1
2151345|NCT01190150|3764650|FG000|Washout|Difficulty in adherence|0
2151346|NCT01190150|3764651|FG001|Washout|Difficulty in adherence|1
2151347|NCT01190176|3764657|FG000|Overall Study|Withdrawal by Subject|1
2151348|NCT01190176|3764657|FG000|Overall Study|Lost to Follow-up|1
2151349|NCT01190189|3764661|FG000|Overall Study|Lost to Follow-up|4
2151350|NCT01190189|3764661|FG000|Overall Study|Withdrawal by Subject|1
2151351|NCT01190189|3764661|FG000|Overall Study|Migrated/moved from study area|1
2151352|NCT01190215|3764667|FG000|Up to Month 6|Lost to Follow-up|2
2151353|NCT01190215|3764668|FG001|Up to Month 6|Lost to Follow-up|0
2151354|NCT01190228|3764677|FG000|Overall Study|Protocol Violation|4
2151355|NCT01190228|3764678|FG001|Overall Study|Protocol Violation|0
2151356|NCT01190228|3764679|FG002|Overall Study|Protocol Violation|0
2151357|NCT01190228|3764677|FG000|Overall Study|Withdrawal by Subject|1
2151358|NCT01190228|3764678|FG001|Overall Study|Withdrawal by Subject|0
2151359|NCT01190228|3764679|FG002|Overall Study|Withdrawal by Subject|0
2151360|NCT01190410|3764691|FG000|Overall Study|Adverse Event|0
2151361|NCT01190410|3764692|FG001|Overall Study|Adverse Event|3
2151362|NCT01190410|3764691|FG000|Overall Study|Lack of Efficacy|0
2151363|NCT01190410|3764692|FG001|Overall Study|Lack of Efficacy|2
2151364|NCT01190410|3764691|FG000|Overall Study|Withdrawal by Subject|0
2291832|NCT02505542|3984966|FG003|Part B: Double-Blind Period|Adverse Event|3
2291833|NCT02505542|3984963|FG000|Part B: Double-Blind Period|Lost to Follow-up|0
2291834|NCT02505542|3984964|FG001|Part B: Double-Blind Period|Lost to Follow-up|0
2151365|NCT01190410|3764692|FG001|Overall Study|Withdrawal by Subject|2
2151366|NCT01190410|3764691|FG000|Overall Study|Administrative decision|1
2151367|NCT01190410|3764692|FG001|Overall Study|Administrative decision|0
2291835|NCT02505542|3984965|FG002|Part B: Double-Blind Period|Lost to Follow-up|0
2151368|NCT01190410|3764691|FG000|Overall Study|PI discretion|0
2151369|NCT01190410|3764692|FG001|Overall Study|PI discretion|2
2151370|NCT01190436|3764704|FG000|Overall Study|Lost to Follow-up|35
2151371|NCT01190436|3764704|FG000|Overall Study|Other|4
2151372|NCT01190449|3764711|FG000|Overall Study|Ineligible|0
2151373|NCT01190449|3764712|FG001|Overall Study|Ineligible|4
2151374|NCT01190475|3764721|FG000|Overall Study|Withdrawal by Subject|0
2151375|NCT01190475|3764722|FG001|Overall Study|Withdrawal by Subject|0
2151376|NCT01190475|3764723|FG002|Overall Study|Withdrawal by Subject|1
2151377|NCT01190514|3764733|FG000|First Intervention (Period 1)|Adverse Event|1
2151378|NCT01190514|3764734|FG001|First Intervention (Period 1)|Adverse Event|0
2151379|NCT01190514|3764735|FG002|First Intervention (Period 1)|Adverse Event|0
2151380|NCT01190514|3764736|FG003|First Intervention (Period 1)|Adverse Event|0
2151381|NCT01190514|3764733|FG000|Third Intervention (Period 3)|Adverse Event|1
2151382|NCT01190514|3764734|FG001|Third Intervention (Period 3)|Adverse Event|0
2151383|NCT01190514|3764735|FG002|Third Intervention (Period 3)|Adverse Event|0
2151384|NCT01190514|3764736|FG003|Third Intervention (Period 3)|Adverse Event|0
2151385|NCT01190813|3764762|FG000|Overall Study|Lost to Follow-up|1
2151386|NCT01190813|3764763|FG001|Overall Study|Lost to Follow-up|2
2151387|NCT01190813|3764762|FG000|Overall Study|Withdrawal by Subject|2
2151388|NCT01190813|3764763|FG001|Overall Study|Withdrawal by Subject|1
2151389|NCT01190813|3764762|FG000|Overall Study|Refused study treatment after randomized|1
2151390|NCT01190813|3764763|FG001|Overall Study|Refused study treatment after randomized|0
2151391|NCT01190813|3764762|FG000|Overall Study|Adverse Event|0
2151392|NCT01190813|3764763|FG001|Overall Study|Adverse Event|1
2291836|NCT02505542|3984966|FG003|Part B: Double-Blind Period|Lost to Follow-up|1
2291837|NCT02505542|3984963|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0
2291838|NCT02505542|3984964|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8
2291839|NCT02505542|3984965|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7
2291840|NCT02505542|3984966|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2
2291841|NCT02505542|3984963|FG000|Part B: Double-Blind Period|Planning pregnancy|0
2291842|NCT02505542|3984964|FG001|Part B: Double-Blind Period|Planning pregnancy|1
2291843|NCT02505542|3984965|FG002|Part B: Double-Blind Period|Planning pregnancy|0
2291844|NCT02505542|3984966|FG003|Part B: Double-Blind Period|Planning pregnancy|0
2291845|NCT02505542|3984963|FG000|Part B: Double-Blind Period|Week 94 missed|0
2291846|NCT02505542|3984964|FG001|Part B: Double-Blind Period|Week 94 missed|0
2291847|NCT02505542|3984965|FG002|Part B: Double-Blind Period|Week 94 missed|1
2291848|NCT02505542|3984966|FG003|Part B: Double-Blind Period|Week 94 missed|0
2291849|NCT02505542|3984963|FG000|Part B: Double-Blind Period|Patient was moved from the country|0
2291850|NCT02505542|3984964|FG001|Part B: Double-Blind Period|Patient was moved from the country|0
2291851|NCT02505542|3984965|FG002|Part B: Double-Blind Period|Patient was moved from the country|0
2291852|NCT02505542|3984966|FG003|Part B: Double-Blind Period|Patient was moved from the country|1
2291853|NCT02505542|3984963|FG000|Part B: Double-Blind Period|Lack of Efficacy|0
2291854|NCT02505542|3984964|FG001|Part B: Double-Blind Period|Lack of Efficacy|1
2291855|NCT02505542|3984965|FG002|Part B: Double-Blind Period|Lack of Efficacy|0
2291856|NCT02505542|3984966|FG003|Part B: Double-Blind Period|Lack of Efficacy|0
2291857|NCT02505542|3984963|FG000|Part B: Double-Blind Period|Miscalculation|0
2291858|NCT02505542|3984964|FG001|Part B: Double-Blind Period|Miscalculation|1
2291859|NCT02505542|3984965|FG002|Part B: Double-Blind Period|Miscalculation|0
2291860|NCT02505542|3984966|FG003|Part B: Double-Blind Period|Miscalculation|0
2291861|NCT02505542|3984963|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0
2291862|NCT02505542|3984964|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1
2291863|NCT02505542|3984965|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0
2291864|NCT02505542|3984966|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0
2291865|NCT02505867|3984994|FG000|Overall Study|Lack of Efficacy|6
2291866|NCT02505867|3984995|FG001|Overall Study|Lack of Efficacy|6
2291867|NCT02505945|3985012|FG000|Overall Study|Withdrawal by Subject|13
2291868|NCT02505945|3985013|FG001|Overall Study|Withdrawal by Subject|2
2291869|NCT02505945|3985012|FG000|Overall Study|Adverse Event|1
2291870|NCT02505945|3985013|FG001|Overall Study|Adverse Event|0
2291871|NCT02505945|3985012|FG000|Overall Study|Physician Decision|2
2291872|NCT02505945|3985013|FG001|Overall Study|Physician Decision|1
2291873|NCT02505945|3985012|FG000|Overall Study|Lost to Follow-up|6
2291874|NCT02505945|3985013|FG001|Overall Study|Lost to Follow-up|1
2291875|NCT02506036|3985021|FG000|First Intervention (4-6 Weeks)|Death|1
2291876|NCT02506036|3985022|FG001|First Intervention (4-6 Weeks)|Death|0
2291877|NCT02506036|3985021|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0
2291878|NCT02506036|3985022|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1
2291879|NCT02506036|3985021|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
2291880|NCT02506036|3985022|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
2291881|NCT02506257|3985045|FG000|Overall Study|Adverse Event|0
2291882|NCT02506257|3985046|FG001|Overall Study|Adverse Event|2
2291883|NCT02506257|3985047|FG002|Overall Study|Adverse Event|3
2291884|NCT02506257|3985048|FG003|Overall Study|Adverse Event|0
2291885|NCT02506257|3985045|FG000|Overall Study|Protocol Violation|0
2291886|NCT02506257|3985046|FG001|Overall Study|Protocol Violation|0
2291887|NCT02506257|3985047|FG002|Overall Study|Protocol Violation|1
2291888|NCT02506257|3985048|FG003|Overall Study|Protocol Violation|0
2291889|NCT02506816|3985131|FG000|Overall Study|Adverse Event|3
2291890|NCT02506881|3985152|FG000|First Intervention (Day 1)|Protocol Violation|0
2151393|NCT01190839|3764771|FG000|Overall Study|Adverse Event|32
2151394|NCT01190839|3764772|FG001|Overall Study|Adverse Event|41
2151395|NCT01190839|3764771|FG000|Overall Study|Protocol Violation|2
2151396|NCT01190839|3764772|FG001|Overall Study|Protocol Violation|2
2151397|NCT01190839|3764771|FG000|Overall Study|Lost to Follow-up|7
2151398|NCT01190839|3764772|FG001|Overall Study|Lost to Follow-up|1
2151399|NCT01190839|3764771|FG000|Overall Study|Death|1
2151400|NCT01190839|3764772|FG001|Overall Study|Death|0
2151401|NCT01190839|3764771|FG000|Overall Study|Trial stopped by Sponsor|71
2151402|NCT01190839|3764772|FG001|Overall Study|Trial stopped by Sponsor|68
2151403|NCT01190839|3764771|FG000|Overall Study|Undefined|35
2151404|NCT01190839|3764772|FG001|Overall Study|Undefined|31
2151405|NCT01190839|3764771|FG000|Overall Study|Randomized but not treated|2
2151406|NCT01190839|3764772|FG001|Overall Study|Randomized but not treated|4
2151407|NCT01190865|3764780|FG000|Overall Study|Withdrawal by Subject|1
2151408|NCT01190865|3764780|FG000|Overall Study|Non-compliance|2
2151409|NCT01190891|3764803|FG000|Overall Study|Protocol Violation|1
2151410|NCT01190891|3764804|FG001|Overall Study|Protocol Violation|0
2151411|NCT01190891|3764803|FG000|Overall Study|Withdrawal by Subject|5
2151412|NCT01190891|3764804|FG001|Overall Study|Withdrawal by Subject|0
2151413|NCT01190930|3764812|FG000|Induction|Adverse Event|17
2151414|NCT01190930|3764813|FG001|Induction|Adverse Event|0
2151415|NCT01190930|3764814|FG002|Induction|Adverse Event|0
2151416|NCT01190930|3764815|FG003|Induction|Adverse Event|0
2151417|NCT01190930|3764816|FG004|Induction|Adverse Event|0
2151418|NCT01190930|3764817|FG005|Induction|Adverse Event|0
2151419|NCT01190930|3764818|FG006|Induction|Adverse Event|0
2151420|NCT01190930|3764819|FG007|Induction|Adverse Event|0
2151421|NCT01190930|3764820|FG008|Induction|Adverse Event|0
2291891|NCT02506881|3985153|FG001|First Intervention (Day 1)|Protocol Violation|0
2291892|NCT02506881|3985154|FG002|First Intervention (Day 1)|Protocol Violation|1
2291893|NCT02506881|3985155|FG003|First Intervention (Day 1)|Protocol Violation|0
2291894|NCT02506881|3985152|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
2291895|NCT02506881|3985153|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
2291896|NCT02506881|3985154|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
2291897|NCT02506881|3985155|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
2291898|NCT02506881|3985152|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0
2291899|NCT02506881|3985153|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0
2291900|NCT02506881|3985154|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12
2291901|NCT02506881|3985155|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12
2291902|NCT02507219|3985182|FG000|Overall Study|Physician Decision|1
2291903|NCT02507219|3985183|FG001|Overall Study|Physician Decision|0
2291904|NCT02507219|3985184|FG002|Overall Study|Physician Decision|0
2291905|NCT02507219|3985185|FG003|Overall Study|Physician Decision|0
2291906|NCT02507219|3985186|FG004|Overall Study|Physician Decision|0
2291907|NCT02507219|3985187|FG005|Overall Study|Physician Decision|0
2291908|NCT02507219|3985182|FG000|Overall Study|Withdrawal by Subject|0
2291909|NCT02507219|3985183|FG001|Overall Study|Withdrawal by Subject|0
2291910|NCT02507219|3985184|FG002|Overall Study|Withdrawal by Subject|0
2291911|NCT02507219|3985185|FG003|Overall Study|Withdrawal by Subject|0
2291912|NCT02507219|3985186|FG004|Overall Study|Withdrawal by Subject|1
2291913|NCT02507219|3985187|FG005|Overall Study|Withdrawal by Subject|0
2291914|NCT02507297|3985197|FG000|Overall Study|Withdrawal by Subject|1
2291915|NCT02507297|3985198|FG001|Overall Study|Withdrawal by Subject|0
2291916|NCT02507297|3985197|FG000|Overall Study|Lost to Follow-up|0
2291917|NCT02507297|3985198|FG001|Overall Study|Lost to Follow-up|1
2291918|NCT02507349|3985206|FG000|Overall Study|Death|12
2291919|NCT02507349|3985207|FG001|Overall Study|Death|16
2291920|NCT02507349|3985206|FG000|Overall Study|Withdrawal by Subject|1
2291921|NCT02507349|3985207|FG001|Overall Study|Withdrawal by Subject|1
2291922|NCT02507349|3985206|FG000|Overall Study|Lost to Follow-up|174
2291923|NCT02507349|3985207|FG001|Overall Study|Lost to Follow-up|144
2291924|NCT02507375|3985215|FG000|Overall Study|Progressive Disease|4
2291925|NCT02507375|3985216|FG001|Overall Study|Progressive Disease|5
2291926|NCT02507375|3985215|FG000|Overall Study|Death|0
2291927|NCT02507375|3985216|FG001|Overall Study|Death|1
2291928|NCT02507375|3985215|FG000|Overall Study|Refused treatment|0
2291929|NCT02507375|3985216|FG001|Overall Study|Refused treatment|1
2291930|NCT02507375|3985215|FG000|Overall Study|Adverse Event|0
2291931|NCT02507375|3985216|FG001|Overall Study|Adverse Event|1
2291932|NCT02507752|3985236|FG000|Overall Study|Adverse Event|1
2291933|NCT02507752|3985236|FG000|Overall Study|Protocol Violation|6
2291934|NCT02507752|3985236|FG000|Overall Study|Lost to Follow-up|7
2291935|NCT02507752|3985236|FG000|Overall Study|Infusion reaction at first infusion|1
2291936|NCT02507752|3985236|FG000|Overall Study|Participant didn't perform visit Week 12|1
2291937|NCT02507752|3985236|FG000|Overall Study|Participant didn't perform visit Week 24|1
2291938|NCT02508116|3985255|FG000|Overall Study|Lost to Follow-up|2
2291939|NCT02508116|3985256|FG001|Overall Study|Lost to Follow-up|3
2291940|NCT02508116|3985255|FG000|Overall Study|Withdrawal by Subject|3
2291941|NCT02508116|3985256|FG001|Overall Study|Withdrawal by Subject|2
2291942|NCT02508116|3985255|FG000|Overall Study|Protocol Violation|1
2291943|NCT02508116|3985256|FG001|Overall Study|Protocol Violation|2
2291944|NCT02508116|3985255|FG000|Overall Study|Physician Decision|2
2151422|NCT01190930|3764821|FG009|Induction|Adverse Event|0
2151423|NCT01190930|3764812|FG000|Induction|Death|34
2151424|NCT01190930|3764813|FG001|Induction|Death|0
2151425|NCT01190930|3764814|FG002|Induction|Death|0
2151426|NCT01190930|3764815|FG003|Induction|Death|0
2151427|NCT01190930|3764816|FG004|Induction|Death|0
2151428|NCT01190930|3764817|FG005|Induction|Death|0
2151429|NCT01190930|3764818|FG006|Induction|Death|0
2151430|NCT01190930|3764819|FG007|Induction|Death|0
2151431|NCT01190930|3764820|FG008|Induction|Death|0
2151432|NCT01190930|3764821|FG009|Induction|Death|0
2151433|NCT01190930|3764812|FG000|Induction|Lost to Follow-up|1
2151434|NCT01190930|3764813|FG001|Induction|Lost to Follow-up|0
2291945|NCT02508116|3985256|FG001|Overall Study|Physician Decision|0
2291946|NCT02508194|3985264|FG000|Overall Study|Death|5
2291947|NCT02508194|3985265|FG001|Overall Study|Death|3
2291948|NCT02508194|3985264|FG000|Overall Study|Lost to Follow-up|25
2291949|NCT02508194|3985265|FG001|Overall Study|Lost to Follow-up|18
2291950|NCT02508194|3985264|FG000|Overall Study|Withdrawal by Subject|20
2291951|NCT02508194|3985265|FG001|Overall Study|Withdrawal by Subject|18
2291952|NCT02508194|3985264|FG000|Overall Study|Error in Randomization|1
2291953|NCT02508194|3985265|FG001|Overall Study|Error in Randomization|3
2291954|NCT02508194|3985264|FG000|Overall Study|Principal Investigator Decision|1
2291955|NCT02508194|3985265|FG001|Overall Study|Principal Investigator Decision|2
2291956|NCT02508428|3985304|FG000|Overall Study|Death|32
2291957|NCT02508428|3985305|FG001|Overall Study|Death|33
2291958|NCT02508428|3985304|FG000|Overall Study|Liner revised|3
2291959|NCT02508428|3985305|FG001|Overall Study|Liner revised|19
2291960|NCT02508428|3985304|FG000|Overall Study|Incomplete follow-up|17
2291961|NCT02508428|3985305|FG001|Overall Study|Incomplete follow-up|15
2291962|NCT02508532|3985327|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
2291963|NCT02508532|3985328|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
2291964|NCT02508532|3985329|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
2291965|NCT02508532|3985330|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
2291966|NCT02508532|3985331|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
2291967|NCT02508532|3985332|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
2291968|NCT02508532|3985333|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1
2291969|NCT02508532|3985334|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
2291970|NCT02508532|3985335|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
2291971|NCT02508532|3985327|FG000|Part 1 - Dose Determining Period|Not Evaluable|0
2291972|NCT02508532|3985328|FG001|Part 1 - Dose Determining Period|Not Evaluable|0
2291973|NCT02508532|3985329|FG002|Part 1 - Dose Determining Period|Not Evaluable|0
2291974|NCT02508532|3985330|FG003|Part 1 - Dose Determining Period|Not Evaluable|0
2291975|NCT02508532|3985331|FG004|Part 1 - Dose Determining Period|Not Evaluable|0
2291976|NCT02508532|3985332|FG005|Part 1 - Dose Determining Period|Not Evaluable|0
2291977|NCT02508532|3985333|FG006|Part 1 - Dose Determining Period|Not Evaluable|0
2291978|NCT02508532|3985334|FG007|Part 1 - Dose Determining Period|Not Evaluable|1
2291979|NCT02508532|3985335|FG008|Part 1 - Dose Determining Period|Not Evaluable|0
2291980|NCT02508532|3985327|FG000|Part 2 - Treatment|Disease Progression|0
2291981|NCT02508532|3985328|FG001|Part 2 - Treatment|Disease Progression|0
2291982|NCT02508532|3985329|FG002|Part 2 - Treatment|Disease Progression|0
2291983|NCT02508532|3985330|FG003|Part 2 - Treatment|Disease Progression|0
2291984|NCT02508532|3985331|FG004|Part 2 - Treatment|Disease Progression|0
2291985|NCT02508532|3985332|FG005|Part 2 - Treatment|Disease Progression|0
2291986|NCT02508532|3985333|FG006|Part 2 - Treatment|Disease Progression|0
2291987|NCT02508532|3985334|FG007|Part 2 - Treatment|Disease Progression|0
2291988|NCT02508532|3985335|FG008|Part 2 - Treatment|Disease Progression|118
2291989|NCT02508532|3985327|FG000|Part 2 - Treatment|Adverse Event|0
2291990|NCT02508532|3985328|FG001|Part 2 - Treatment|Adverse Event|0
2291991|NCT02508532|3985329|FG002|Part 2 - Treatment|Adverse Event|0
2291992|NCT02508532|3985330|FG003|Part 2 - Treatment|Adverse Event|0
2291993|NCT02508532|3985331|FG004|Part 2 - Treatment|Adverse Event|0
2291994|NCT02508532|3985332|FG005|Part 2 - Treatment|Adverse Event|0
2291995|NCT02508532|3985333|FG006|Part 2 - Treatment|Adverse Event|0
2291996|NCT02508532|3985334|FG007|Part 2 - Treatment|Adverse Event|0
2291997|NCT02508532|3985335|FG008|Part 2 - Treatment|Adverse Event|49
2291998|NCT02508532|3985327|FG000|Part 2 - Treatment|Physician Decision|0
2291999|NCT02508532|3985328|FG001|Part 2 - Treatment|Physician Decision|0
2292000|NCT02508532|3985329|FG002|Part 2 - Treatment|Physician Decision|0
2292001|NCT02508532|3985330|FG003|Part 2 - Treatment|Physician Decision|0
2292002|NCT02508532|3985331|FG004|Part 2 - Treatment|Physician Decision|0
2292003|NCT02508532|3985332|FG005|Part 2 - Treatment|Physician Decision|0
2292004|NCT02508532|3985333|FG006|Part 2 - Treatment|Physician Decision|0
2292005|NCT02508532|3985334|FG007|Part 2 - Treatment|Physician Decision|0
2292006|NCT02508532|3985335|FG008|Part 2 - Treatment|Physician Decision|12
2292007|NCT02508532|3985327|FG000|Part 2 - Treatment|Administrative|0
2292008|NCT02508532|3985328|FG001|Part 2 - Treatment|Administrative|0
2292009|NCT02508532|3985329|FG002|Part 2 - Treatment|Administrative|0
2292010|NCT02508532|3985330|FG003|Part 2 - Treatment|Administrative|0
2292011|NCT02508532|3985331|FG004|Part 2 - Treatment|Administrative|0
2151435|NCT01190930|3764814|FG002|Induction|Lost to Follow-up|0
2151436|NCT01190930|3764815|FG003|Induction|Lost to Follow-up|0
2151437|NCT01190930|3764816|FG004|Induction|Lost to Follow-up|0
2151438|NCT01190930|3764817|FG005|Induction|Lost to Follow-up|0
2151439|NCT01190930|3764818|FG006|Induction|Lost to Follow-up|0
2151440|NCT01190930|3764819|FG007|Induction|Lost to Follow-up|0
2151441|NCT01190930|3764820|FG008|Induction|Lost to Follow-up|0
2151442|NCT01190930|3764821|FG009|Induction|Lost to Follow-up|0
2151443|NCT01190930|3764812|FG000|Induction|Physician Decision|125
2151444|NCT01190930|3764813|FG001|Induction|Physician Decision|3
2151445|NCT01190930|3764814|FG002|Induction|Physician Decision|0
2151446|NCT01190930|3764815|FG003|Induction|Physician Decision|0
2151447|NCT01190930|3764816|FG004|Induction|Physician Decision|0
2151448|NCT01190930|3764817|FG005|Induction|Physician Decision|0
2151449|NCT01190930|3764818|FG006|Induction|Physician Decision|0
2151450|NCT01190930|3764819|FG007|Induction|Physician Decision|0
2151451|NCT01190930|3764820|FG008|Induction|Physician Decision|0
2151452|NCT01190930|3764821|FG009|Induction|Physician Decision|0
2151453|NCT01190930|3764812|FG000|Induction|Withdrawal by Subject|9
2151454|NCT01190930|3764813|FG001|Induction|Withdrawal by Subject|0
2151455|NCT01190930|3764814|FG002|Induction|Withdrawal by Subject|0
2151456|NCT01190930|3764815|FG003|Induction|Withdrawal by Subject|0
2151457|NCT01190930|3764816|FG004|Induction|Withdrawal by Subject|0
2151458|NCT01190930|3764817|FG005|Induction|Withdrawal by Subject|0
2151459|NCT01190930|3764818|FG006|Induction|Withdrawal by Subject|0
2151460|NCT01190930|3764819|FG007|Induction|Withdrawal by Subject|0
2151461|NCT01190930|3764820|FG008|Induction|Withdrawal by Subject|0
2151462|NCT01190930|3764821|FG009|Induction|Withdrawal by Subject|0
2151463|NCT01190930|3764812|FG000|Induction|Refusal|235
2151464|NCT01190930|3764813|FG001|Induction|Refusal|0
2151465|NCT01190930|3764814|FG002|Induction|Refusal|0
2151466|NCT01190930|3764815|FG003|Induction|Refusal|0
2151467|NCT01190930|3764816|FG004|Induction|Refusal|0
2151468|NCT01190930|3764817|FG005|Induction|Refusal|0
2151469|NCT01190930|3764818|FG006|Induction|Refusal|0
2151470|NCT01190930|3764819|FG007|Induction|Refusal|0
2151471|NCT01190930|3764820|FG008|Induction|Refusal|0
2151472|NCT01190930|3764821|FG009|Induction|Refusal|0
2151473|NCT01190930|3764812|FG000|Induction|Inevaluable|23
2151474|NCT01190930|3764813|FG001|Induction|Inevaluable|1
2151475|NCT01190930|3764814|FG002|Induction|Inevaluable|0
2151476|NCT01190930|3764815|FG003|Induction|Inevaluable|0
2151477|NCT01190930|3764816|FG004|Induction|Inevaluable|0
2151478|NCT01190930|3764817|FG005|Induction|Inevaluable|0
2151479|NCT01190930|3764818|FG006|Induction|Inevaluable|0
2151480|NCT01190930|3764819|FG007|Induction|Inevaluable|0
2151481|NCT01190930|3764820|FG008|Induction|Inevaluable|0
2151482|NCT01190930|3764821|FG009|Induction|Inevaluable|0
2151483|NCT01190930|3764812|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61
2151484|NCT01190930|3764813|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
2151485|NCT01190930|3764814|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
2151486|NCT01190930|3764815|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
2151487|NCT01190930|3764816|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
2151488|NCT01190930|3764817|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
2151489|NCT01190930|3764818|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
2151490|NCT01190930|3764819|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
2151491|NCT01190930|3764820|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
2151492|NCT01190930|3764821|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
2151493|NCT01190930|3764812|FG000|Induction|High Risk Downs|80
2151494|NCT01190930|3764813|FG001|Induction|High Risk Downs|0
2151495|NCT01190930|3764814|FG002|Induction|High Risk Downs|0
2151496|NCT01190930|3764815|FG003|Induction|High Risk Downs|0
2151497|NCT01190930|3764816|FG004|Induction|High Risk Downs|0
2151498|NCT01190930|3764817|FG005|Induction|High Risk Downs|0
2151499|NCT01190930|3764818|FG006|Induction|High Risk Downs|0
2151500|NCT01190930|3764819|FG007|Induction|High Risk Downs|0
2151501|NCT01190930|3764820|FG008|Induction|High Risk Downs|0
2151502|NCT01190930|3764821|FG009|Induction|High Risk Downs|0
2151503|NCT01190930|3764812|FG000|Induction|Enrollment onto another COG Protocol|1
2151504|NCT01190930|3764813|FG001|Induction|Enrollment onto another COG Protocol|0
2151505|NCT01190930|3764814|FG002|Induction|Enrollment onto another COG Protocol|0
2151506|NCT01190930|3764815|FG003|Induction|Enrollment onto another COG Protocol|0
2151507|NCT01190930|3764816|FG004|Induction|Enrollment onto another COG Protocol|0
2151508|NCT01190930|3764817|FG005|Induction|Enrollment onto another COG Protocol|0
2151509|NCT01190930|3764818|FG006|Induction|Enrollment onto another COG Protocol|0
2151510|NCT01190930|3764819|FG007|Induction|Enrollment onto another COG Protocol|0
2151511|NCT01190930|3764820|FG008|Induction|Enrollment onto another COG Protocol|0
2151512|NCT01190930|3764821|FG009|Induction|Enrollment onto another COG Protocol|0
2151513|NCT01190930|3764812|FG000|Induction|Average Risk|1847
2151514|NCT01190930|3764813|FG001|Induction|Average Risk|0
2151515|NCT01190930|3764814|FG002|Induction|Average Risk|0
2151516|NCT01190930|3764815|FG003|Induction|Average Risk|0
2151517|NCT01190930|3764816|FG004|Induction|Average Risk|0
2151518|NCT01190930|3764817|FG005|Induction|Average Risk|0
2151519|NCT01190930|3764818|FG006|Induction|Average Risk|0
2151520|NCT01190930|3764819|FG007|Induction|Average Risk|0
2151521|NCT01190930|3764820|FG008|Induction|Average Risk|0
2151522|NCT01190930|3764821|FG009|Induction|Average Risk|0
2151523|NCT01190930|3764812|FG000|Induction|High Risk|1227
2151524|NCT01190930|3764813|FG001|Induction|High Risk|0
2151525|NCT01190930|3764814|FG002|Induction|High Risk|0
2151526|NCT01190930|3764815|FG003|Induction|High Risk|0
2151527|NCT01190930|3764816|FG004|Induction|High Risk|0
2151528|NCT01190930|3764817|FG005|Induction|High Risk|0
2151529|NCT01190930|3764818|FG006|Induction|High Risk|0
2151530|NCT01190930|3764819|FG007|Induction|High Risk|0
2151531|NCT01190930|3764820|FG008|Induction|High Risk|0
2151532|NCT01190930|3764821|FG009|Induction|High Risk|0
2151533|NCT01190930|3764812|FG000|Induction|Low Risk|443
2151534|NCT01190930|3764813|FG001|Induction|Low Risk|0
2151535|NCT01190930|3764814|FG002|Induction|Low Risk|0
2151536|NCT01190930|3764815|FG003|Induction|Low Risk|0
2151537|NCT01190930|3764816|FG004|Induction|Low Risk|0
2151538|NCT01190930|3764817|FG005|Induction|Low Risk|0
2151539|NCT01190930|3764818|FG006|Induction|Low Risk|0
2151540|NCT01190930|3764819|FG007|Induction|Low Risk|0
2151541|NCT01190930|3764820|FG008|Induction|Low Risk|0
2151542|NCT01190930|3764821|FG009|Induction|Low Risk|0
2151543|NCT01190930|3764812|FG000|Induction|Very High Risk|1012
2151544|NCT01190930|3764813|FG001|Induction|Very High Risk|0
2151545|NCT01190930|3764814|FG002|Induction|Very High Risk|0
2151546|NCT01190930|3764815|FG003|Induction|Very High Risk|0
2151547|NCT01190930|3764816|FG004|Induction|Very High Risk|0
2151548|NCT01190930|3764817|FG005|Induction|Very High Risk|0
2151549|NCT01190930|3764818|FG006|Induction|Very High Risk|0
2151550|NCT01190930|3764819|FG007|Induction|Very High Risk|0
2151551|NCT01190930|3764820|FG008|Induction|Very High Risk|0
2151552|NCT01190930|3764821|FG009|Induction|Very High Risk|0
2151553|NCT01190930|3764812|FG000|Induction|Philadelphia chromosome-positive|99
2151554|NCT01190930|3764813|FG001|Induction|Philadelphia chromosome-positive|0
2151555|NCT01190930|3764814|FG002|Induction|Philadelphia chromosome-positive|0
2151556|NCT01190930|3764815|FG003|Induction|Philadelphia chromosome-positive|0
2151557|NCT01190930|3764816|FG004|Induction|Philadelphia chromosome-positive|0
2151558|NCT01190930|3764817|FG005|Induction|Philadelphia chromosome-positive|0
2151559|NCT01190930|3764818|FG006|Induction|Philadelphia chromosome-positive|0
2151560|NCT01190930|3764819|FG007|Induction|Philadelphia chromosome-positive|0
2151561|NCT01190930|3764820|FG008|Induction|Philadelphia chromosome-positive|0
2151562|NCT01190930|3764821|FG009|Induction|Philadelphia chromosome-positive|0
2151563|NCT01190930|3764812|FG000|Induction|Incomplete Induction data|63
2151564|NCT01190930|3764813|FG001|Induction|Incomplete Induction data|0
2151565|NCT01190930|3764814|FG002|Induction|Incomplete Induction data|0
2151566|NCT01190930|3764815|FG003|Induction|Incomplete Induction data|0
2151567|NCT01190930|3764816|FG004|Induction|Incomplete Induction data|0
2151568|NCT01190930|3764817|FG005|Induction|Incomplete Induction data|0
2151569|NCT01190930|3764818|FG006|Induction|Incomplete Induction data|0
2151570|NCT01190930|3764819|FG007|Induction|Incomplete Induction data|0
2151571|NCT01190930|3764820|FG008|Induction|Incomplete Induction data|0
2151572|NCT01190930|3764821|FG009|Induction|Incomplete Induction data|0
2151573|NCT01190930|3764812|FG000|Induction|Progressive disease|0
2151574|NCT01190930|3764813|FG001|Induction|Progressive disease|1
2151575|NCT01190930|3764814|FG002|Induction|Progressive disease|0
2151576|NCT01190930|3764815|FG003|Induction|Progressive disease|0
2151577|NCT01190930|3764816|FG004|Induction|Progressive disease|0
2151578|NCT01190930|3764817|FG005|Induction|Progressive disease|0
2151579|NCT01190930|3764818|FG006|Induction|Progressive disease|0
2151580|NCT01190930|3764819|FG007|Induction|Progressive disease|0
2151581|NCT01190930|3764820|FG008|Induction|Progressive disease|0
2151582|NCT01190930|3764821|FG009|Induction|Progressive disease|0
2151583|NCT01190930|3764812|FG000|Induction|No treatment|3
2151584|NCT01190930|3764813|FG001|Induction|No treatment|0
2151585|NCT01190930|3764814|FG002|Induction|No treatment|0
2151586|NCT01190930|3764815|FG003|Induction|No treatment|0
2151587|NCT01190930|3764816|FG004|Induction|No treatment|0
2151588|NCT01190930|3764817|FG005|Induction|No treatment|0
2151589|NCT01190930|3764818|FG006|Induction|No treatment|0
2151590|NCT01190930|3764819|FG007|Induction|No treatment|0
2151591|NCT01190930|3764820|FG008|Induction|No treatment|0
2151592|NCT01190930|3764821|FG009|Induction|No treatment|0
2151593|NCT01190930|3764812|FG000|Induction|Ineligible|69
2151594|NCT01190930|3764813|FG001|Induction|Ineligible|4
2151595|NCT01190930|3764814|FG002|Induction|Ineligible|0
2151596|NCT01190930|3764815|FG003|Induction|Ineligible|0
2151597|NCT01190930|3764816|FG004|Induction|Ineligible|0
2151598|NCT01190930|3764817|FG005|Induction|Ineligible|0
2151599|NCT01190930|3764818|FG006|Induction|Ineligible|0
2151600|NCT01190930|3764819|FG007|Induction|Ineligible|0
2151601|NCT01190930|3764820|FG008|Induction|Ineligible|0
2151602|NCT01190930|3764821|FG009|Induction|Ineligible|0
2151603|NCT01190930|3764812|FG000|Post Induction Pre-Maintenance|Adverse Event|0
2151604|NCT01190930|3764813|FG001|Post Induction Pre-Maintenance|Adverse Event|0
2151605|NCT01190930|3764814|FG002|Post Induction Pre-Maintenance|Adverse Event|8
2151606|NCT01190930|3764815|FG003|Post Induction Pre-Maintenance|Adverse Event|0
2151607|NCT01190930|3764816|FG004|Post Induction Pre-Maintenance|Adverse Event|0
2151608|NCT01190930|3764817|FG005|Post Induction Pre-Maintenance|Adverse Event|0
2151609|NCT01190930|3764818|FG006|Post Induction Pre-Maintenance|Adverse Event|0
2151610|NCT01190930|3764819|FG007|Post Induction Pre-Maintenance|Adverse Event|0
2151611|NCT01190930|3764820|FG008|Post Induction Pre-Maintenance|Adverse Event|0
2151612|NCT01190930|3764821|FG009|Post Induction Pre-Maintenance|Adverse Event|0
2151613|NCT01190930|3764812|FG000|Post Induction Pre-Maintenance|Death|0
2151614|NCT01190930|3764813|FG001|Post Induction Pre-Maintenance|Death|0
2151615|NCT01190930|3764814|FG002|Post Induction Pre-Maintenance|Death|8
2151616|NCT01190930|3764815|FG003|Post Induction Pre-Maintenance|Death|4
2151617|NCT01190930|3764816|FG004|Post Induction Pre-Maintenance|Death|0
2151618|NCT01190930|3764817|FG005|Post Induction Pre-Maintenance|Death|0
2151619|NCT01190930|3764818|FG006|Post Induction Pre-Maintenance|Death|0
2151620|NCT01190930|3764819|FG007|Post Induction Pre-Maintenance|Death|0
2151621|NCT01190930|3764820|FG008|Post Induction Pre-Maintenance|Death|0
2151622|NCT01190930|3764821|FG009|Post Induction Pre-Maintenance|Death|0
2151623|NCT01190930|3764812|FG000|Post Induction Pre-Maintenance|Physician Decision|0
2151624|NCT01190930|3764813|FG001|Post Induction Pre-Maintenance|Physician Decision|2
2151625|NCT01190930|3764814|FG002|Post Induction Pre-Maintenance|Physician Decision|35
2151626|NCT01190930|3764815|FG003|Post Induction Pre-Maintenance|Physician Decision|7
2151627|NCT01190930|3764816|FG004|Post Induction Pre-Maintenance|Physician Decision|5
2151628|NCT01190930|3764817|FG005|Post Induction Pre-Maintenance|Physician Decision|3
2151629|NCT01190930|3764818|FG006|Post Induction Pre-Maintenance|Physician Decision|0
2151630|NCT01190930|3764819|FG007|Post Induction Pre-Maintenance|Physician Decision|0
2151631|NCT01190930|3764820|FG008|Post Induction Pre-Maintenance|Physician Decision|0
2151632|NCT01190930|3764821|FG009|Post Induction Pre-Maintenance|Physician Decision|0
2151633|NCT01190930|3764812|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0
2151634|NCT01190930|3764813|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1
2151635|NCT01190930|3764814|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5
2151636|NCT01190930|3764815|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2
2151637|NCT01190930|3764816|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0
2151638|NCT01190930|3764817|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0
2151639|NCT01190930|3764818|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0
2151640|NCT01190930|3764819|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0
2151641|NCT01190930|3764820|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0
2151642|NCT01190930|3764821|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0
2151643|NCT01190930|3764812|FG000|Post Induction Pre-Maintenance|Refusal|0
2151644|NCT01190930|3764813|FG001|Post Induction Pre-Maintenance|Refusal|2
2151645|NCT01190930|3764814|FG002|Post Induction Pre-Maintenance|Refusal|694
2151646|NCT01190930|3764815|FG003|Post Induction Pre-Maintenance|Refusal|4
2151647|NCT01190930|3764816|FG004|Post Induction Pre-Maintenance|Refusal|0
2151648|NCT01190930|3764817|FG005|Post Induction Pre-Maintenance|Refusal|3
2151649|NCT01190930|3764818|FG006|Post Induction Pre-Maintenance|Refusal|0
2151650|NCT01190930|3764819|FG007|Post Induction Pre-Maintenance|Refusal|0
2151651|NCT01190930|3764820|FG008|Post Induction Pre-Maintenance|Refusal|0
2151652|NCT01190930|3764821|FG009|Post Induction Pre-Maintenance|Refusal|0
2151653|NCT01190930|3764812|FG000|Post Induction Pre-Maintenance|Inevaluable|0
2151654|NCT01190930|3764813|FG001|Post Induction Pre-Maintenance|Inevaluable|0
2151655|NCT01190930|3764814|FG002|Post Induction Pre-Maintenance|Inevaluable|6
2151656|NCT01190930|3764815|FG003|Post Induction Pre-Maintenance|Inevaluable|0
2151657|NCT01190930|3764816|FG004|Post Induction Pre-Maintenance|Inevaluable|0
2151658|NCT01190930|3764817|FG005|Post Induction Pre-Maintenance|Inevaluable|0
2151659|NCT01190930|3764818|FG006|Post Induction Pre-Maintenance|Inevaluable|0
2151660|NCT01190930|3764819|FG007|Post Induction Pre-Maintenance|Inevaluable|0
2151661|NCT01190930|3764820|FG008|Post Induction Pre-Maintenance|Inevaluable|0
2151662|NCT01190930|3764821|FG009|Post Induction Pre-Maintenance|Inevaluable|0
2151663|NCT01190930|3764812|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
2151664|NCT01190930|3764813|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1
2151665|NCT01190930|3764814|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
2151666|NCT01190930|3764815|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
2151667|NCT01190930|3764816|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
2151668|NCT01190930|3764817|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
2151669|NCT01190930|3764818|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
2151670|NCT01190930|3764819|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
2151671|NCT01190930|3764820|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
2292012|NCT02508532|3985332|FG005|Part 2 - Treatment|Administrative|0
2292013|NCT02508532|3985333|FG006|Part 2 - Treatment|Administrative|0
2292014|NCT02508532|3985334|FG007|Part 2 - Treatment|Administrative|0
2292015|NCT02508532|3985335|FG008|Part 2 - Treatment|Administrative|3
2292016|NCT02508532|3985327|FG000|Part 2 - Treatment|Sponsor Decision|0
2292017|NCT02508532|3985328|FG001|Part 2 - Treatment|Sponsor Decision|0
2292018|NCT02508532|3985329|FG002|Part 2 - Treatment|Sponsor Decision|0
2292019|NCT02508532|3985330|FG003|Part 2 - Treatment|Sponsor Decision|0
2292020|NCT02508532|3985331|FG004|Part 2 - Treatment|Sponsor Decision|0
2292021|NCT02508532|3985332|FG005|Part 2 - Treatment|Sponsor Decision|0
2292022|NCT02508532|3985333|FG006|Part 2 - Treatment|Sponsor Decision|0
2292023|NCT02508532|3985334|FG007|Part 2 - Treatment|Sponsor Decision|0
2292024|NCT02508532|3985335|FG008|Part 2 - Treatment|Sponsor Decision|28
2292025|NCT02508532|3985327|FG000|Part 2 - Treatment|Death|0
2292026|NCT02508532|3985328|FG001|Part 2 - Treatment|Death|0
2292027|NCT02508532|3985329|FG002|Part 2 - Treatment|Death|0
2292028|NCT02508532|3985330|FG003|Part 2 - Treatment|Death|0
2292029|NCT02508532|3985331|FG004|Part 2 - Treatment|Death|0
2292030|NCT02508532|3985332|FG005|Part 2 - Treatment|Death|0
2292031|NCT02508532|3985333|FG006|Part 2 - Treatment|Death|0
2151672|NCT01190930|3764821|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
2151673|NCT01190930|3764812|FG000|Post Induction Pre-Maintenance|Progressive disease|0
2151674|NCT01190930|3764813|FG001|Post Induction Pre-Maintenance|Progressive disease|0
2151675|NCT01190930|3764814|FG002|Post Induction Pre-Maintenance|Progressive disease|1
2151676|NCT01190930|3764815|FG003|Post Induction Pre-Maintenance|Progressive disease|0
2151677|NCT01190930|3764816|FG004|Post Induction Pre-Maintenance|Progressive disease|0
2151678|NCT01190930|3764817|FG005|Post Induction Pre-Maintenance|Progressive disease|0
2151679|NCT01190930|3764818|FG006|Post Induction Pre-Maintenance|Progressive disease|0
2151680|NCT01190930|3764819|FG007|Post Induction Pre-Maintenance|Progressive disease|0
2151681|NCT01190930|3764820|FG008|Post Induction Pre-Maintenance|Progressive disease|0
2151682|NCT01190930|3764821|FG009|Post Induction Pre-Maintenance|Progressive disease|0
2151683|NCT01190930|3764812|FG000|Post Induction Pre-Maintenance|Relapse|0
2151684|NCT01190930|3764813|FG001|Post Induction Pre-Maintenance|Relapse|0
2151685|NCT01190930|3764814|FG002|Post Induction Pre-Maintenance|Relapse|1
2151686|NCT01190930|3764815|FG003|Post Induction Pre-Maintenance|Relapse|0
2151687|NCT01190930|3764816|FG004|Post Induction Pre-Maintenance|Relapse|0
2151688|NCT01190930|3764817|FG005|Post Induction Pre-Maintenance|Relapse|0
2151689|NCT01190930|3764818|FG006|Post Induction Pre-Maintenance|Relapse|0
2151690|NCT01190930|3764819|FG007|Post Induction Pre-Maintenance|Relapse|0
2151691|NCT01190930|3764820|FG008|Post Induction Pre-Maintenance|Relapse|0
2151692|NCT01190930|3764821|FG009|Post Induction Pre-Maintenance|Relapse|0
2151693|NCT01190930|3764812|FG000|Maintenance|Adverse Event|0
2151694|NCT01190930|3764813|FG001|Maintenance|Adverse Event|0
2151695|NCT01190930|3764814|FG002|Maintenance|Adverse Event|0
2151696|NCT01190930|3764815|FG003|Maintenance|Adverse Event|0
2151697|NCT01190930|3764816|FG004|Maintenance|Adverse Event|0
2151698|NCT01190930|3764817|FG005|Maintenance|Adverse Event|1
2151699|NCT01190930|3764818|FG006|Maintenance|Adverse Event|1
2151700|NCT01190930|3764819|FG007|Maintenance|Adverse Event|3
2151701|NCT01190930|3764820|FG008|Maintenance|Adverse Event|3
2151702|NCT01190930|3764821|FG009|Maintenance|Adverse Event|0
2151703|NCT01190930|3764812|FG000|Maintenance|Death|0
2151704|NCT01190930|3764813|FG001|Maintenance|Death|0
2151705|NCT01190930|3764814|FG002|Maintenance|Death|0
2151706|NCT01190930|3764815|FG003|Maintenance|Death|1
2151707|NCT01190930|3764816|FG004|Maintenance|Death|0
2151708|NCT01190930|3764817|FG005|Maintenance|Death|0
2151709|NCT01190930|3764818|FG006|Maintenance|Death|2
2151710|NCT01190930|3764819|FG007|Maintenance|Death|2
2151711|NCT01190930|3764820|FG008|Maintenance|Death|2
2151712|NCT01190930|3764821|FG009|Maintenance|Death|2
2151713|NCT01190930|3764812|FG000|Maintenance|Lost to Follow-up|0
2151714|NCT01190930|3764813|FG001|Maintenance|Lost to Follow-up|0
2151715|NCT01190930|3764814|FG002|Maintenance|Lost to Follow-up|0
2151716|NCT01190930|3764815|FG003|Maintenance|Lost to Follow-up|0
2151717|NCT01190930|3764816|FG004|Maintenance|Lost to Follow-up|0
2151718|NCT01190930|3764817|FG005|Maintenance|Lost to Follow-up|0
2151719|NCT01190930|3764818|FG006|Maintenance|Lost to Follow-up|1
2151720|NCT01190930|3764819|FG007|Maintenance|Lost to Follow-up|1
2151721|NCT01190930|3764820|FG008|Maintenance|Lost to Follow-up|1
2151722|NCT01190930|3764821|FG009|Maintenance|Lost to Follow-up|0
2151723|NCT01190930|3764812|FG000|Maintenance|Physician Decision|0
2151724|NCT01190930|3764813|FG001|Maintenance|Physician Decision|1
2151725|NCT01190930|3764814|FG002|Maintenance|Physician Decision|0
2151726|NCT01190930|3764815|FG003|Maintenance|Physician Decision|5
2151727|NCT01190930|3764816|FG004|Maintenance|Physician Decision|9
2151728|NCT01190930|3764817|FG005|Maintenance|Physician Decision|4
2151729|NCT01190930|3764818|FG006|Maintenance|Physician Decision|8
2151730|NCT01190930|3764819|FG007|Maintenance|Physician Decision|8
2151731|NCT01190930|3764820|FG008|Maintenance|Physician Decision|10
2151732|NCT01190930|3764821|FG009|Maintenance|Physician Decision|17
2151733|NCT01190930|3764812|FG000|Maintenance|Withdrawal by Subject|0
2151734|NCT01190930|3764813|FG001|Maintenance|Withdrawal by Subject|0
2151735|NCT01190930|3764814|FG002|Maintenance|Withdrawal by Subject|0
2151736|NCT01190930|3764815|FG003|Maintenance|Withdrawal by Subject|0
2151737|NCT01190930|3764816|FG004|Maintenance|Withdrawal by Subject|0
2151738|NCT01190930|3764817|FG005|Maintenance|Withdrawal by Subject|0
2151739|NCT01190930|3764818|FG006|Maintenance|Withdrawal by Subject|2
2151740|NCT01190930|3764819|FG007|Maintenance|Withdrawal by Subject|1
2151741|NCT01190930|3764820|FG008|Maintenance|Withdrawal by Subject|4
2151742|NCT01190930|3764821|FG009|Maintenance|Withdrawal by Subject|1
2151743|NCT01190930|3764812|FG000|Maintenance|Refusal|0
2151744|NCT01190930|3764813|FG001|Maintenance|Refusal|1
2151745|NCT01190930|3764814|FG002|Maintenance|Refusal|0
2151746|NCT01190930|3764815|FG003|Maintenance|Refusal|2
2151747|NCT01190930|3764816|FG004|Maintenance|Refusal|0
2151748|NCT01190930|3764817|FG005|Maintenance|Refusal|4
2151749|NCT01190930|3764818|FG006|Maintenance|Refusal|5
2151750|NCT01190930|3764819|FG007|Maintenance|Refusal|17
2151751|NCT01190930|3764820|FG008|Maintenance|Refusal|13
2151752|NCT01190930|3764821|FG009|Maintenance|Refusal|6
2151753|NCT01190930|3764812|FG000|Maintenance|second malignant neoplasm|0
2151754|NCT01190930|3764813|FG001|Maintenance|second malignant neoplasm|0
2151755|NCT01190930|3764814|FG002|Maintenance|second malignant neoplasm|0
2151756|NCT01190930|3764815|FG003|Maintenance|second malignant neoplasm|1
2151757|NCT01190930|3764816|FG004|Maintenance|second malignant neoplasm|0
2151758|NCT01190930|3764817|FG005|Maintenance|second malignant neoplasm|1
2151759|NCT01190930|3764818|FG006|Maintenance|second malignant neoplasm|0
2151760|NCT01190930|3764819|FG007|Maintenance|second malignant neoplasm|0
2151761|NCT01190930|3764820|FG008|Maintenance|second malignant neoplasm|1
2151762|NCT01190930|3764821|FG009|Maintenance|second malignant neoplasm|0
2151763|NCT01190930|3764812|FG000|Maintenance|Inevaluable|0
2151764|NCT01190930|3764813|FG001|Maintenance|Inevaluable|0
2151765|NCT01190930|3764814|FG002|Maintenance|Inevaluable|0
2151766|NCT01190930|3764815|FG003|Maintenance|Inevaluable|0
2151767|NCT01190930|3764816|FG004|Maintenance|Inevaluable|0
2151768|NCT01190930|3764817|FG005|Maintenance|Inevaluable|1
2151769|NCT01190930|3764818|FG006|Maintenance|Inevaluable|1
2151770|NCT01190930|3764819|FG007|Maintenance|Inevaluable|1
2151771|NCT01190930|3764820|FG008|Maintenance|Inevaluable|0
2151772|NCT01190930|3764821|FG009|Maintenance|Inevaluable|0
2151773|NCT01190930|3764812|FG000|Maintenance|Enrollment onto another COG Protocol|0
2151774|NCT01190930|3764813|FG001|Maintenance|Enrollment onto another COG Protocol|0
2151775|NCT01190930|3764814|FG002|Maintenance|Enrollment onto another COG Protocol|0
2151776|NCT01190930|3764815|FG003|Maintenance|Enrollment onto another COG Protocol|0
2151777|NCT01190930|3764816|FG004|Maintenance|Enrollment onto another COG Protocol|0
2151778|NCT01190930|3764817|FG005|Maintenance|Enrollment onto another COG Protocol|0
2151779|NCT01190930|3764818|FG006|Maintenance|Enrollment onto another COG Protocol|0
2151780|NCT01190930|3764819|FG007|Maintenance|Enrollment onto another COG Protocol|0
2151781|NCT01190930|3764820|FG008|Maintenance|Enrollment onto another COG Protocol|1
2151782|NCT01190930|3764821|FG009|Maintenance|Enrollment onto another COG Protocol|0
2151783|NCT01190930|3764812|FG000|Maintenance|Relapse|0
2151784|NCT01190930|3764813|FG001|Maintenance|Relapse|0
2151785|NCT01190930|3764814|FG002|Maintenance|Relapse|0
2151786|NCT01190930|3764815|FG003|Maintenance|Relapse|2
2151787|NCT01190930|3764816|FG004|Maintenance|Relapse|0
2151788|NCT01190930|3764817|FG005|Maintenance|Relapse|1
2151789|NCT01190930|3764818|FG006|Maintenance|Relapse|6
2151790|NCT01190930|3764819|FG007|Maintenance|Relapse|13
2151791|NCT01190930|3764820|FG008|Maintenance|Relapse|11
2151792|NCT01190930|3764821|FG009|Maintenance|Relapse|11
2151793|NCT01190930|3764812|FG000|Maintenance|Still on therapy|0
2151794|NCT01190930|3764813|FG001|Maintenance|Still on therapy|8
2151795|NCT01190930|3764814|FG002|Maintenance|Still on therapy|0
2151796|NCT01190930|3764815|FG003|Maintenance|Still on therapy|29
2151797|NCT01190930|3764816|FG004|Maintenance|Still on therapy|0
2151798|NCT01190930|3764817|FG005|Maintenance|Still on therapy|0
2151799|NCT01190930|3764818|FG006|Maintenance|Still on therapy|0
2151800|NCT01190930|3764819|FG007|Maintenance|Still on therapy|0
2151801|NCT01190930|3764820|FG008|Maintenance|Still on therapy|0
2151802|NCT01190930|3764821|FG009|Maintenance|Still on therapy|0
2179162|NCT01392326|3804643|FG001|Overall Study|Pregnancy|0
2179163|NCT01392326|3804644|FG002|Overall Study|Pregnancy|1
2179164|NCT01392326|3804642|FG000|Overall Study|Physician Decision|7
2179165|NCT01392326|3804643|FG001|Overall Study|Physician Decision|5
2179166|NCT01392326|3804644|FG002|Overall Study|Physician Decision|2
2179167|NCT01392326|3804642|FG000|Overall Study|Lost to Follow-up|1
2179168|NCT01392326|3804643|FG001|Overall Study|Lost to Follow-up|3
2179169|NCT01392326|3804644|FG002|Overall Study|Lost to Follow-up|4
2179170|NCT01392326|3804642|FG000|Overall Study|Lack of Efficacy|14
2179171|NCT01392326|3804643|FG001|Overall Study|Lack of Efficacy|10
2179172|NCT01392326|3804644|FG002|Overall Study|Lack of Efficacy|15
2179173|NCT01392326|3804642|FG000|Overall Study|Adverse Event|9
2179174|NCT01392326|3804643|FG001|Overall Study|Adverse Event|6
2179175|NCT01392326|3804644|FG002|Overall Study|Adverse Event|11
2179176|NCT01392378|3804657|FG000|Infant Series|Adverse Event|0
2179177|NCT01392378|3804658|FG001|Infant Series|Adverse Event|0
2179178|NCT01392378|3804659|FG002|Infant Series|Adverse Event|0
2179179|NCT01392378|3804660|FG003|Infant Series|Adverse Event|1
2179180|NCT01392378|3804661|FG004|Infant Series|Adverse Event|0
2179181|NCT01392378|3804657|FG000|Infant Series|Lost to Follow-up|0
2179182|NCT01392378|3804658|FG001|Infant Series|Lost to Follow-up|0
2179183|NCT01392378|3804659|FG002|Infant Series|Lost to Follow-up|0
2179184|NCT01392378|3804660|FG003|Infant Series|Lost to Follow-up|1
2179185|NCT01392378|3804661|FG004|Infant Series|Lost to Follow-up|0
2179186|NCT01392378|3804657|FG000|Infant Series|Protocol Violation|0
2179187|NCT01392378|3804658|FG001|Infant Series|Protocol Violation|1
2179188|NCT01392378|3804659|FG002|Infant Series|Protocol Violation|0
2179189|NCT01392378|3804660|FG003|Infant Series|Protocol Violation|0
2179190|NCT01392378|3804661|FG004|Infant Series|Protocol Violation|0
2179191|NCT01392378|3804657|FG000|Infant Series|Withdrawal by Parent|4
2179192|NCT01392378|3804658|FG001|Infant Series|Withdrawal by Parent|1
2179193|NCT01392378|3804659|FG002|Infant Series|Withdrawal by Parent|0
2179194|NCT01392378|3804660|FG003|Infant Series|Withdrawal by Parent|0
2179195|NCT01392378|3804661|FG004|Infant Series|Withdrawal by Parent|0
2179196|NCT01392378|3804657|FG000|After Infant Series|Lost to Follow-up|0
2179197|NCT01392378|3804658|FG001|After Infant Series|Lost to Follow-up|0
2179198|NCT01392378|3804659|FG002|After Infant Series|Lost to Follow-up|1
2179199|NCT01392378|3804660|FG003|After Infant Series|Lost to Follow-up|0
2179200|NCT01392378|3804661|FG004|After Infant Series|Lost to Follow-up|0
2179201|NCT01392378|3804657|FG000|After Infant Series|Withdrawal by Parent|0
2179202|NCT01392378|3804658|FG001|After Infant Series|Withdrawal by Parent|1
2179203|NCT01392378|3804659|FG002|After Infant Series|Withdrawal by Parent|1
2179204|NCT01392378|3804660|FG003|After Infant Series|Withdrawal by Parent|0
2151803|NCT01191008|3764845|FG000|Overall Study|Protocol Violation|7
2151804|NCT01191008|3764845|FG000|Overall Study|Lost to Follow-up|8
2151805|NCT01191086|3764849|FG000|Overall Study|Adverse Event|20
2151806|NCT01191086|3764849|FG000|Overall Study|Lack of Efficacy|10
2151807|NCT01191086|3764849|FG000|Overall Study|Lost to Follow-up|4
2151808|NCT01191086|3764849|FG000|Overall Study|Physician Decision|2
2151809|NCT01191086|3764849|FG000|Overall Study|Withdrawal by Subject|24
2151810|NCT01191086|3764849|FG000|Overall Study|Discontinuation criterion met|1
2151811|NCT01191086|3764849|FG000|Overall Study|Other|1
2151812|NCT01191190|3764853|FG000|Overall Study|Withdrawal by Subject|1
2151813|NCT01191268|3764881|FG000|Overall Study|Withdrawal by Subject|19
2151814|NCT01191268|3764882|FG001|Overall Study|Withdrawal by Subject|25
2151815|NCT01191268|3764883|FG002|Overall Study|Withdrawal by Subject|21
2151816|NCT01191268|3764881|FG000|Overall Study|Adverse Event|21
2151817|NCT01191268|3764882|FG001|Overall Study|Adverse Event|13
2151818|NCT01191268|3764883|FG002|Overall Study|Adverse Event|8
2151819|NCT01191268|3764881|FG000|Overall Study|Physician Decision|6
2151820|NCT01191268|3764882|FG001|Overall Study|Physician Decision|8
2292032|NCT02508532|3985334|FG007|Part 2 - Treatment|Death|0
2292033|NCT02508532|3985335|FG008|Part 2 - Treatment|Death|1
2292034|NCT02508532|3985327|FG000|Part 2 - Treatment|Withdrawal by Subject|0
2292035|NCT02508532|3985328|FG001|Part 2 - Treatment|Withdrawal by Subject|0
2292036|NCT02508532|3985329|FG002|Part 2 - Treatment|Withdrawal by Subject|0
2292037|NCT02508532|3985330|FG003|Part 2 - Treatment|Withdrawal by Subject|0
2292038|NCT02508532|3985331|FG004|Part 2 - Treatment|Withdrawal by Subject|0
2292039|NCT02508532|3985332|FG005|Part 2 - Treatment|Withdrawal by Subject|0
2292040|NCT02508532|3985333|FG006|Part 2 - Treatment|Withdrawal by Subject|0
2292041|NCT02508532|3985334|FG007|Part 2 - Treatment|Withdrawal by Subject|0
2292042|NCT02508532|3985335|FG008|Part 2 - Treatment|Withdrawal by Subject|6
2292043|NCT02508532|3985327|FG000|Part 1 and Part 2 End of Study|Disease Progression|2
2292044|NCT02508532|3985328|FG001|Part 1 and Part 2 End of Study|Disease Progression|0
2292045|NCT02508532|3985329|FG002|Part 1 and Part 2 End of Study|Disease Progression|0
2292046|NCT02508532|3985330|FG003|Part 1 and Part 2 End of Study|Disease Progression|0
2292047|NCT02508532|3985331|FG004|Part 1 and Part 2 End of Study|Disease Progression|0
2292048|NCT02508532|3985332|FG005|Part 1 and Part 2 End of Study|Disease Progression|0
2292049|NCT02508532|3985333|FG006|Part 1 and Part 2 End of Study|Disease Progression|0
2292050|NCT02508532|3985334|FG007|Part 1 and Part 2 End of Study|Disease Progression|1
2292051|NCT02508532|3985335|FG008|Part 1 and Part 2 End of Study|Disease Progression|6
2292052|NCT02508532|3985327|FG000|Part 1 and Part 2 End of Study|Adverse Event|1
2292053|NCT02508532|3985328|FG001|Part 1 and Part 2 End of Study|Adverse Event|0
2292054|NCT02508532|3985329|FG002|Part 1 and Part 2 End of Study|Adverse Event|1
2292055|NCT02508532|3985330|FG003|Part 1 and Part 2 End of Study|Adverse Event|0
2292056|NCT02508532|3985331|FG004|Part 1 and Part 2 End of Study|Adverse Event|0
2292057|NCT02508532|3985332|FG005|Part 1 and Part 2 End of Study|Adverse Event|0
2292058|NCT02508532|3985333|FG006|Part 1 and Part 2 End of Study|Adverse Event|0
2292059|NCT02508532|3985334|FG007|Part 1 and Part 2 End of Study|Adverse Event|0
2292060|NCT02508532|3985335|FG008|Part 1 and Part 2 End of Study|Adverse Event|2
2292061|NCT02508532|3985327|FG000|Part 1 and Part 2 End of Study|Death|0
2292062|NCT02508532|3985328|FG001|Part 1 and Part 2 End of Study|Death|4
2292063|NCT02508532|3985329|FG002|Part 1 and Part 2 End of Study|Death|2
2292064|NCT02508532|3985330|FG003|Part 1 and Part 2 End of Study|Death|4
2292065|NCT02508532|3985331|FG004|Part 1 and Part 2 End of Study|Death|3
2292066|NCT02508532|3985332|FG005|Part 1 and Part 2 End of Study|Death|0
2292067|NCT02508532|3985333|FG006|Part 1 and Part 2 End of Study|Death|0
2292068|NCT02508532|3985334|FG007|Part 1 and Part 2 End of Study|Death|1
2292069|NCT02508532|3985335|FG008|Part 1 and Part 2 End of Study|Death|111
2292070|NCT02508532|3985327|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1
2292071|NCT02508532|3985328|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1
2292072|NCT02508532|3985329|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1
2292073|NCT02508532|3985330|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0
2292074|NCT02508532|3985331|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0
2292075|NCT02508532|3985332|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0
2292076|NCT02508532|3985333|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0
2292077|NCT02508532|3985334|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0
2292078|NCT02508532|3985335|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6
2292079|NCT02508532|3985327|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
2292080|NCT02508532|3985328|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
2292081|NCT02508532|3985329|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
2292082|NCT02508532|3985330|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
2292083|NCT02508532|3985331|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
2292084|NCT02508532|3985332|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
2292085|NCT02508532|3985333|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
2292086|NCT02508532|3985334|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
2292087|NCT02508532|3985335|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15
2292088|NCT02508532|3985327|FG000|Part 1 and Part 2 End of Study|Physician Decision|0
2292089|NCT02508532|3985328|FG001|Part 1 and Part 2 End of Study|Physician Decision|0
2151821|NCT01191268|3764883|FG002|Overall Study|Physician Decision|9
2151822|NCT01191268|3764881|FG000|Overall Study|Lost to Follow-up|8
2151823|NCT01191268|3764882|FG001|Overall Study|Lost to Follow-up|5
2151824|NCT01191268|3764883|FG002|Overall Study|Lost to Follow-up|9
2151825|NCT01191268|3764881|FG000|Overall Study|Entry Criteria Not Met|3
2151826|NCT01191268|3764882|FG001|Overall Study|Entry Criteria Not Met|1
2151827|NCT01191268|3764883|FG002|Overall Study|Entry Criteria Not Met|1
2151828|NCT01191268|3764881|FG000|Overall Study|Death|0
2151829|NCT01191268|3764882|FG001|Overall Study|Death|1
2151830|NCT01191268|3764883|FG002|Overall Study|Death|3
2151831|NCT01191268|3764881|FG000|Overall Study|Protocol Violation|1
2151832|NCT01191268|3764882|FG001|Overall Study|Protocol Violation|0
2151833|NCT01191268|3764883|FG002|Overall Study|Protocol Violation|1
2151834|NCT01191268|3764881|FG000|Overall Study|Sponsor Decision|0
2151835|NCT01191268|3764882|FG001|Overall Study|Sponsor Decision|2
2151836|NCT01191268|3764883|FG002|Overall Study|Sponsor Decision|0
2151837|NCT01191762|3765023|FG000|Overall Study|Adverse Event|1
2151838|NCT01191762|3765024|FG001|Overall Study|Adverse Event|0
2151839|NCT01191788|3765032|FG000|Overall Study|Lost to Follow-up|21
2151840|NCT01191788|3765033|FG001|Overall Study|Lost to Follow-up|22
2151841|NCT01191801|3765042|FG000|Overall Study|Death|36
2151842|NCT01191801|3765043|FG001|Overall Study|Death|12
2151843|NCT01191801|3765042|FG000|Overall Study|Lack of Efficacy|176
2151844|NCT01191801|3765043|FG001|Overall Study|Lack of Efficacy|258
2151845|NCT01191801|3765042|FG000|Overall Study|Adverse Event|9
2151846|NCT01191801|3765043|FG001|Overall Study|Adverse Event|8
2292090|NCT02508532|3985329|FG002|Part 1 and Part 2 End of Study|Physician Decision|1
2292091|NCT02508532|3985330|FG003|Part 1 and Part 2 End of Study|Physician Decision|0
2292092|NCT02508532|3985331|FG004|Part 1 and Part 2 End of Study|Physician Decision|1
2292093|NCT02508532|3985332|FG005|Part 1 and Part 2 End of Study|Physician Decision|0
2292094|NCT02508532|3985333|FG006|Part 1 and Part 2 End of Study|Physician Decision|0
2292095|NCT02508532|3985334|FG007|Part 1 and Part 2 End of Study|Physician Decision|0
2292096|NCT02508532|3985335|FG008|Part 1 and Part 2 End of Study|Physician Decision|8
2292097|NCT02508532|3985327|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0
2292098|NCT02508532|3985328|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0
2292099|NCT02508532|3985329|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0
2292100|NCT02508532|3985330|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0
2292101|NCT02508532|3985331|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0
2292102|NCT02508532|3985332|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0
2292103|NCT02508532|3985333|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0
2292104|NCT02508532|3985334|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0
2292105|NCT02508532|3985335|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1
2292106|NCT02508532|3985327|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2
2292107|NCT02508532|3985328|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1
2292108|NCT02508532|3985329|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1
2292109|NCT02508532|3985330|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2
2292110|NCT02508532|3985331|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2
2292111|NCT02508532|3985332|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0
2292112|NCT02508532|3985333|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0
2292113|NCT02508532|3985334|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1
2292114|NCT02508532|3985335|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|67
2292115|NCT02508532|3985327|FG000|Part 1 and Part 2 End of Study|Continuing in study|0
2292116|NCT02508532|3985328|FG001|Part 1 and Part 2 End of Study|Continuing in study|0
2292117|NCT02508532|3985329|FG002|Part 1 and Part 2 End of Study|Continuing in study|0
2292118|NCT02508532|3985330|FG003|Part 1 and Part 2 End of Study|Continuing in study|0
2292119|NCT02508532|3985331|FG004|Part 1 and Part 2 End of Study|Continuing in study|0
2292120|NCT02508532|3985332|FG005|Part 1 and Part 2 End of Study|Continuing in study|0
2292121|NCT02508532|3985333|FG006|Part 1 and Part 2 End of Study|Continuing in study|0
2292122|NCT02508532|3985334|FG007|Part 1 and Part 2 End of Study|Continuing in study|0
2292123|NCT02508532|3985335|FG008|Part 1 and Part 2 End of Study|Continuing in study|1
2292124|NCT02508649|3985372|FG000|Overall Study|Withdrawal by Subject|4
2292125|NCT02508649|3985373|FG001|Overall Study|Withdrawal by Subject|6
2292126|NCT02508649|3985374|FG002|Overall Study|Withdrawal by Subject|5
2292127|NCT02508649|3985375|FG003|Overall Study|Withdrawal by Subject|6
2292128|NCT02508649|3985372|FG000|Overall Study|Investigator withdrew the subject|1
2292129|NCT02508649|3985373|FG001|Overall Study|Investigator withdrew the subject|2
2292130|NCT02508649|3985374|FG002|Overall Study|Investigator withdrew the subject|1
2292131|NCT02508649|3985375|FG003|Overall Study|Investigator withdrew the subject|0
2292132|NCT02508649|3985372|FG000|Overall Study|Post randomization screening failure|12
2292133|NCT02508649|3985373|FG001|Overall Study|Post randomization screening failure|4
2292134|NCT02508649|3985374|FG002|Overall Study|Post randomization screening failure|9
2292135|NCT02508649|3985375|FG003|Overall Study|Post randomization screening failure|3
2292136|NCT02508649|3985372|FG000|Overall Study|Lost to Follow-up|1
2292137|NCT02508649|3985373|FG001|Overall Study|Lost to Follow-up|1
2292138|NCT02508649|3985374|FG002|Overall Study|Lost to Follow-up|0
2292139|NCT02508649|3985375|FG003|Overall Study|Lost to Follow-up|1
2292140|NCT02508701|3985392|FG000|Overall Study|Lost to Follow-up|9
2292141|NCT02508701|3985393|FG001|Overall Study|Lost to Follow-up|5
2151847|NCT01191801|3765042|FG000|Overall Study|Protocol Violation|2
2151848|NCT01191801|3765043|FG001|Overall Study|Protocol Violation|4
2151849|NCT01191801|3765042|FG000|Overall Study|Physician Decision|47
2151850|NCT01191801|3765043|FG001|Overall Study|Physician Decision|24
2151851|NCT01191801|3765042|FG000|Overall Study|Withdrawal by Subject|1
2151852|NCT01191801|3765043|FG001|Overall Study|Withdrawal by Subject|4
2151853|NCT01191801|3765042|FG000|Overall Study|Not Provided|45
2151854|NCT01191801|3765043|FG001|Overall Study|Not Provided|27
2151855|NCT01191840|3765060|FG000|Overall Study|withdrew consent|2
2151856|NCT01191840|3765061|FG001|Overall Study|withdrew consent|1
2151857|NCT01191840|3765060|FG000|Overall Study|Subject discontinued treatment|1
2151858|NCT01191840|3765061|FG001|Overall Study|Subject discontinued treatment|2
2151859|NCT01191840|3765060|FG000|Overall Study|Lost to Follow-up|4
2151860|NCT01191840|3765061|FG001|Overall Study|Lost to Follow-up|6
2151861|NCT01191840|3765060|FG000|Overall Study|Non Staph Infection|4
2151862|NCT01191840|3765061|FG001|Overall Study|Non Staph Infection|3
2151863|NCT01191840|3765060|FG000|Overall Study|ineligible at enrollment|1
2151864|NCT01191840|3765061|FG001|Overall Study|ineligible at enrollment|0
2151865|NCT01191840|3765060|FG000|Overall Study|IRB approval lapse|0
2151866|NCT01191840|3765061|FG001|Overall Study|IRB approval lapse|2
2151867|NCT01191840|3765060|FG000|Overall Study|lab error speciation - non Staph infecti|0
2151868|NCT01191840|3765061|FG001|Overall Study|lab error speciation - non Staph infecti|1
2151869|NCT01191840|3765060|FG000|Overall Study|Withdrawal by Subject|2
2151870|NCT01191840|3765061|FG001|Overall Study|Withdrawal by Subject|0
2151871|NCT01191944|3765069|FG000|Overall Study|Adverse Event|11
2151872|NCT01191944|3765070|FG001|Overall Study|Adverse Event|12
2151873|NCT01191944|3765069|FG000|Overall Study|Protocol Violation|1
2151874|NCT01191944|3765070|FG001|Overall Study|Protocol Violation|2
2151875|NCT01191944|3765069|FG000|Overall Study|Withdrawal by Subject|4
2151876|NCT01191944|3765070|FG001|Overall Study|Withdrawal by Subject|2
2151877|NCT01191944|3765069|FG000|Overall Study|Other|1
2151878|NCT01191944|3765070|FG001|Overall Study|Other|3
2151879|NCT01192022|3765080|FG000|Overall Study|Withdrawal of Consent|3
2151880|NCT01192022|3765081|FG001|Overall Study|Withdrawal of Consent|1
2151881|NCT01192022|3765082|FG002|Overall Study|Withdrawal of Consent|0
2151882|NCT01192022|3765083|FG003|Overall Study|Withdrawal of Consent|0
2151883|NCT01192022|3765084|FG004|Overall Study|Withdrawal of Consent|0
2151884|NCT01192022|3765080|FG000|Overall Study|Lost to Follow-up|4
2151885|NCT01192022|3765081|FG001|Overall Study|Lost to Follow-up|2
2151886|NCT01192022|3765082|FG002|Overall Study|Lost to Follow-up|1
2151887|NCT01192022|3765083|FG003|Overall Study|Lost to Follow-up|1
2151888|NCT01192022|3765084|FG004|Overall Study|Lost to Follow-up|0
2151889|NCT01192022|3765080|FG000|Overall Study|Adverse Event|1
2151890|NCT01192022|3765081|FG001|Overall Study|Adverse Event|0
2151891|NCT01192022|3765082|FG002|Overall Study|Adverse Event|0
2151892|NCT01192022|3765083|FG003|Overall Study|Adverse Event|0
2151893|NCT01192022|3765084|FG004|Overall Study|Adverse Event|0
2151894|NCT01192022|3765080|FG000|Overall Study|Fatal Adverse Event|4
2151895|NCT01192022|3765081|FG001|Overall Study|Fatal Adverse Event|6
2151896|NCT01192022|3765082|FG002|Overall Study|Fatal Adverse Event|0
2151897|NCT01192022|3765083|FG003|Overall Study|Fatal Adverse Event|0
2151898|NCT01192022|3765084|FG004|Overall Study|Fatal Adverse Event|1
2151899|NCT01192022|3765080|FG000|Overall Study|Physician withdrew-patient hardship|1
2151900|NCT01192022|3765081|FG001|Overall Study|Physician withdrew-patient hardship|0
2151901|NCT01192022|3765082|FG002|Overall Study|Physician withdrew-patient hardship|0
2151902|NCT01192022|3765083|FG003|Overall Study|Physician withdrew-patient hardship|0
2151903|NCT01192022|3765084|FG004|Overall Study|Physician withdrew-patient hardship|0
2151904|NCT01192022|3765080|FG000|Overall Study|Patient too sick from chemotherapy|0
2151905|NCT01192022|3765081|FG001|Overall Study|Patient too sick from chemotherapy|1
2151906|NCT01192022|3765082|FG002|Overall Study|Patient too sick from chemotherapy|0
2151907|NCT01192022|3765083|FG003|Overall Study|Patient too sick from chemotherapy|0
2151908|NCT01192022|3765084|FG004|Overall Study|Patient too sick from chemotherapy|0
2151909|NCT01192022|3765080|FG000|Overall Study|Patient needed surgery|0
2151910|NCT01192022|3765081|FG001|Overall Study|Patient needed surgery|1
2151911|NCT01192022|3765082|FG002|Overall Study|Patient needed surgery|0
2151912|NCT01192022|3765083|FG003|Overall Study|Patient needed surgery|0
2292142|NCT02508701|3985394|FG002|Overall Study|Lost to Follow-up|5
2292143|NCT02508701|3985395|FG003|Overall Study|Lost to Follow-up|3
2292144|NCT02508935|3985409|FG000|Overall Study|Withdrawal by Subject|1
2292145|NCT02508935|3985409|FG000|Overall Study|Withdrawal by Caregiver|8
2292146|NCT02508935|3985409|FG000|Overall Study|Pain Score <4|1
2292147|NCT02508935|3985409|FG000|Overall Study|Emesis|3
2292148|NCT02508935|3985409|FG000|Overall Study|Adverse Event|3
2292149|NCT02508935|3985409|FG000|Overall Study|Protocol Violation|1
2292150|NCT02508935|3985409|FG000|Overall Study|Physician Decision|1
2292151|NCT02508935|3985409|FG000|Overall Study|Trial terminated by sponsor|5
2151913|NCT01192022|3765084|FG004|Overall Study|Patient needed surgery|0
2151914|NCT01192022|3765080|FG000|Overall Study|Parents did not allow all follow up|0
2151915|NCT01192022|3765081|FG001|Overall Study|Parents did not allow all follow up|0
2151916|NCT01192022|3765082|FG002|Overall Study|Parents did not allow all follow up|0
2151917|NCT01192022|3765083|FG003|Overall Study|Parents did not allow all follow up|1
2151918|NCT01192022|3765084|FG004|Overall Study|Parents did not allow all follow up|0
2151919|NCT01192100|3765095|FG000|Overall Study|Withdrawal by Subject|0
2151920|NCT01192100|3765096|FG001|Overall Study|Withdrawal by Subject|0
2292152|NCT02509026|3985415|FG000|Induction Period (24 Weeks)|Adverse Event|5
2151921|NCT01192100|3765097|FG002|Overall Study|Withdrawal by Subject|0
2151922|NCT01192100|3765098|FG003|Overall Study|Withdrawal by Subject|0
2151923|NCT01192100|3765099|FG004|Overall Study|Withdrawal by Subject|1
2292153|NCT02509026|3985415|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5
2292154|NCT02509026|3985415|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6
2292155|NCT02509026|3985415|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1
2292156|NCT02509026|3985415|FG000|Induction Period (24 Weeks)|Other|2
2292157|NCT02509026|3985415|FG000|Induction Period (24 Weeks)|Protocol Violation|1
2292158|NCT02509026|3985415|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1
2292159|NCT02509026|3985415|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1
2292160|NCT02509026|3985415|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2
2292161|NCT02509026|3985415|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5
2292162|NCT02509026|3985415|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1
2292163|NCT02509026|3985415|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2
2292164|NCT02509026|3985415|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1
2292165|NCT02509078|3985464|FG000|Overall Study|Protocol Violation|1
2292166|NCT02509078|3985465|FG001|Overall Study|Protocol Violation|1
2292167|NCT02509117|3985483|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2292168|NCT02509117|3985484|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
2292169|NCT02509117|3985485|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2292170|NCT02509117|3985486|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2292171|NCT02509117|3985487|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2292172|NCT02509117|3985488|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2292173|NCT02509117|3985489|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2292174|NCT02509117|3985490|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2292175|NCT02509117|3985491|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2292176|NCT02509117|3985492|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2292177|NCT02509117|3985483|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2292178|NCT02509117|3985484|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2292179|NCT02509117|3985485|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2292180|NCT02509117|3985486|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2292181|NCT02509117|3985487|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2292182|NCT02509117|3985488|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2292183|NCT02509117|3985489|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2292184|NCT02509117|3985490|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2292185|NCT02509117|3985491|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2292186|NCT02509117|3985492|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
2292187|NCT02509117|3985483|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2292188|NCT02509117|3985484|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2292189|NCT02509117|3985485|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2292190|NCT02509117|3985486|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2292191|NCT02509117|3985487|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2292192|NCT02509117|3985488|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2292193|NCT02509117|3985489|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2292194|NCT02509117|3985490|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2292195|NCT02509117|3985491|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2292196|NCT02509117|3985492|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
2292197|NCT02509156|3985532|FG000|Randomized Phase|Death|1
2292198|NCT02509156|3985533|FG001|Randomized Phase|Death|0
2292199|NCT02509156|3985532|FG000|Randomized Phase|Withdrawal by Subject|1
2292200|NCT02509156|3985533|FG001|Randomized Phase|Withdrawal by Subject|1
2292201|NCT02510001|3985602|FG000|Overall Study|Early disease progression|0
2292202|NCT02510001|3985603|FG001|Overall Study|Early disease progression|0
2292203|NCT02510001|3985604|FG002|Overall Study|Early disease progression|0
2292204|NCT02510001|3985605|FG003|Overall Study|Early disease progression|1
2292205|NCT02510001|3985606|FG004|Overall Study|Early disease progression|1
2292206|NCT02510001|3985607|FG005|Overall Study|Early disease progression|1
2292207|NCT02510001|3985608|FG006|Overall Study|Early disease progression|0
2292208|NCT02510001|3985609|FG007|Overall Study|Early disease progression|0
2292209|NCT02510001|3985602|FG000|Overall Study|Adverse Event|0
2292210|NCT02510001|3985603|FG001|Overall Study|Adverse Event|0
2292211|NCT02510001|3985604|FG002|Overall Study|Adverse Event|0
2292212|NCT02510001|3985605|FG003|Overall Study|Adverse Event|1
2292213|NCT02510001|3985606|FG004|Overall Study|Adverse Event|2
2292214|NCT02510001|3985607|FG005|Overall Study|Adverse Event|1
2292215|NCT02510001|3985608|FG006|Overall Study|Adverse Event|2
2292216|NCT02510001|3985609|FG007|Overall Study|Adverse Event|5
2292217|NCT02510001|3985602|FG000|Overall Study|Physician Decision|0
2292218|NCT02510001|3985603|FG001|Overall Study|Physician Decision|0
2292219|NCT02510001|3985604|FG002|Overall Study|Physician Decision|0
2292220|NCT02510001|3985605|FG003|Overall Study|Physician Decision|0
2292221|NCT02510001|3985606|FG004|Overall Study|Physician Decision|1
2292222|NCT02510001|3985607|FG005|Overall Study|Physician Decision|0
2151924|NCT01192100|3765100|FG005|Overall Study|Withdrawal by Subject|0
2292223|NCT02510001|3985608|FG006|Overall Study|Physician Decision|0
2292224|NCT02510001|3985609|FG007|Overall Study|Physician Decision|0
2292225|NCT02510001|3985602|FG000|Overall Study|Withdrawal by Subject|0
2292226|NCT02510001|3985603|FG001|Overall Study|Withdrawal by Subject|0
2292227|NCT02510001|3985604|FG002|Overall Study|Withdrawal by Subject|0
2292228|NCT02510001|3985605|FG003|Overall Study|Withdrawal by Subject|0
2292229|NCT02510001|3985606|FG004|Overall Study|Withdrawal by Subject|0
2292230|NCT02510001|3985607|FG005|Overall Study|Withdrawal by Subject|0
2292231|NCT02510001|3985608|FG006|Overall Study|Withdrawal by Subject|0
2292232|NCT02510001|3985609|FG007|Overall Study|Withdrawal by Subject|2
2292233|NCT02510014|3985647|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1
2292234|NCT02510014|3985648|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1
2292235|NCT02510014|3985647|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
2292236|NCT02510014|3985648|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
2292237|NCT02510014|3985647|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
2292238|NCT02510014|3985648|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
2292239|NCT02510014|3985647|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0
2292240|NCT02510014|3985648|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1
2292241|NCT02510014|3985647|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
2292242|NCT02510014|3985648|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
2292243|NCT02510014|3985647|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
2292244|NCT02510014|3985648|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
2292245|NCT02510014|3985647|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
2292246|NCT02510014|3985648|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
2292247|NCT02510014|3985647|FG000|Run-In Period (Days -14 to Day -1)|Other|19
2292248|NCT02510014|3985648|FG001|Run-In Period (Days -14 to Day -1)|Other|1
2292249|NCT02510014|3985647|FG000|Treatment Period|Adverse Event|11
2292250|NCT02510014|3985648|FG001|Treatment Period|Adverse Event|4
2292251|NCT02510014|3985647|FG000|Treatment Period|Withdrawal symptoms|3
2292252|NCT02510014|3985648|FG001|Treatment Period|Withdrawal symptoms|0
2292253|NCT02510014|3985647|FG000|Treatment Period|Lost to Follow-up|80
2292254|NCT02510014|3985648|FG001|Treatment Period|Lost to Follow-up|19
2292255|NCT02510014|3985647|FG000|Treatment Period|Physician Decision|5
2292256|NCT02510014|3985648|FG001|Treatment Period|Physician Decision|0
2292257|NCT02510014|3985647|FG000|Treatment Period|Withdrawal by Subject|67
2292258|NCT02510014|3985648|FG001|Treatment Period|Withdrawal by Subject|24
2292259|NCT02510014|3985647|FG000|Treatment Period|Withdrawn by the investigator|7
2292260|NCT02510014|3985648|FG001|Treatment Period|Withdrawn by the investigator|1
2292261|NCT02510014|3985647|FG000|Treatment Period|Protocol Violation|4
2292262|NCT02510014|3985648|FG001|Treatment Period|Protocol Violation|4
2292263|NCT02510014|3985647|FG000|Treatment Period|Incarceration, pregnancy, misc|29
2292264|NCT02510014|3985648|FG001|Treatment Period|Incarceration, pregnancy, misc|5
2292265|NCT02510664|3985666|FG000|Overall Study|Transferred Care|9
2292266|NCT02510664|3985667|FG001|Overall Study|Transferred Care|9
2292267|NCT02510664|3985668|FG002|Overall Study|Transferred Care|0
2292268|NCT02510664|3985666|FG000|Overall Study|Provider Retired/No Time to Reschedule|10
2292269|NCT02510664|3985667|FG001|Overall Study|Provider Retired/No Time to Reschedule|10
2292270|NCT02510664|3985668|FG002|Overall Study|Provider Retired/No Time to Reschedule|0
2292271|NCT02510664|3985666|FG000|Overall Study|Time Constraints|1
2292272|NCT02510664|3985667|FG001|Overall Study|Time Constraints|1
2292273|NCT02510664|3985668|FG002|Overall Study|Time Constraints|0
2292274|NCT02510794|3985685|FG000|Overall Study|Adverse Event|0
2292275|NCT02510794|3985686|FG001|Overall Study|Adverse Event|1
2292276|NCT02510794|3985687|FG002|Overall Study|Adverse Event|0
2292277|NCT02510794|3985688|FG003|Overall Study|Adverse Event|0
2292278|NCT02510794|3985685|FG000|Overall Study|Death|1
2292279|NCT02510794|3985686|FG001|Overall Study|Death|2
2292280|NCT02510794|3985687|FG002|Overall Study|Death|1
2292281|NCT02510794|3985688|FG003|Overall Study|Death|1
2292282|NCT02510794|3985685|FG000|Overall Study|Lack of Efficacy|3
2292283|NCT02510794|3985686|FG001|Overall Study|Lack of Efficacy|1
2292284|NCT02510794|3985687|FG002|Overall Study|Lack of Efficacy|1
2292285|NCT02510794|3985688|FG003|Overall Study|Lack of Efficacy|0
2292286|NCT02510794|3985685|FG000|Overall Study|Participant moved out of the area|0
2292287|NCT02510794|3985686|FG001|Overall Study|Participant moved out of the area|0
2292288|NCT02510794|3985687|FG002|Overall Study|Participant moved out of the area|0
2292289|NCT02510794|3985688|FG003|Overall Study|Participant moved out of the area|1
2292290|NCT02510794|3985685|FG000|Overall Study|Physician Decision|3
2292291|NCT02510794|3985686|FG001|Overall Study|Physician Decision|0
2292292|NCT02510794|3985687|FG002|Overall Study|Physician Decision|0
2292293|NCT02510794|3985688|FG003|Overall Study|Physician Decision|0
2292294|NCT02510794|3985685|FG000|Overall Study|Protocol Violation|0
2292295|NCT02510794|3985686|FG001|Overall Study|Protocol Violation|0
2292296|NCT02510794|3985687|FG002|Overall Study|Protocol Violation|1
2292297|NCT02510794|3985688|FG003|Overall Study|Protocol Violation|0
2292298|NCT02510794|3985685|FG000|Overall Study|Withdrawal by Subject|1
2292299|NCT02510794|3985686|FG001|Overall Study|Withdrawal by Subject|2
2292300|NCT02510794|3985687|FG002|Overall Study|Withdrawal by Subject|4
2292301|NCT02510794|3985688|FG003|Overall Study|Withdrawal by Subject|3
2151925|NCT01192100|3765095|FG000|Overall Study|Protocol Violation|0
2151926|NCT01192100|3765096|FG001|Overall Study|Protocol Violation|0
2151927|NCT01192100|3765097|FG002|Overall Study|Protocol Violation|0
2151928|NCT01192100|3765098|FG003|Overall Study|Protocol Violation|1
2151929|NCT01192100|3765099|FG004|Overall Study|Protocol Violation|0
2151930|NCT01192100|3765100|FG005|Overall Study|Protocol Violation|0
2151931|NCT01192126|3765110|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
2151932|NCT01192126|3765111|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
2151933|NCT01192126|3765110|FG000|First Intervention (1 Week)|Lost to Follow-up|1
2151934|NCT01192126|3765111|FG001|First Intervention (1 Week)|Lost to Follow-up|1
2151935|NCT01192152|3765130|FG000|Period 1|left prematurely (while on treatment B)|0
2151936|NCT01192152|3765131|FG001|Period 1|left prematurely (while on treatment B)|1
2151937|NCT01192152|3765130|FG000|Period 3|family emergency|1
2151938|NCT01192152|3765131|FG001|Period 3|family emergency|0
2151939|NCT01192178|3765141|FG000|Overall Study|Withdrawal by Subject|6
2151940|NCT01192178|3765142|FG001|Overall Study|Withdrawal by Subject|10
2151941|NCT01192178|3765141|FG000|Overall Study|Protocol Violation|10
2151942|NCT01192178|3765142|FG001|Overall Study|Protocol Violation|3
2151943|NCT01192178|3765141|FG000|Overall Study|Physician Decision|2
2151944|NCT01192178|3765142|FG001|Overall Study|Physician Decision|4
2151945|NCT01192178|3765141|FG000|Overall Study|Lost to Follow-up|3
2151946|NCT01192178|3765142|FG001|Overall Study|Lost to Follow-up|3
2151947|NCT01192178|3765141|FG000|Overall Study|Adverse Event|2
2151948|NCT01192178|3765142|FG001|Overall Study|Adverse Event|1
2151949|NCT01192178|3765141|FG000|Overall Study|Lack of Efficacy|1
2151950|NCT01192178|3765142|FG001|Overall Study|Lack of Efficacy|2
2151951|NCT01192191|3765152|FG000|Overall Study|Adverse Event|7
2151952|NCT01192191|3765153|FG001|Overall Study|Adverse Event|12
2151953|NCT01192191|3765152|FG000|Overall Study|Participants Reached Stopping Criteria|3
2151954|NCT01192191|3765153|FG001|Overall Study|Participants Reached Stopping Criteria|2
2151955|NCT01192191|3765152|FG000|Overall Study|Lost to Follow-up|0
2151956|NCT01192191|3765153|FG001|Overall Study|Lost to Follow-up|1
2151957|NCT01192191|3765152|FG000|Overall Study|Withdrawal by Subject|1
2151958|NCT01192191|3765153|FG001|Overall Study|Withdrawal by Subject|6
2151959|NCT01192204|3765161|FG000|Overall Study|could not keep recall appointments|1
2151960|NCT01192204|3765162|FG001|Overall Study|could not keep recall appointments|0
2151961|NCT01192295|3765187|FG000|Overall Study|Adverse Event|3
2151962|NCT01192295|3765188|FG001|Overall Study|Adverse Event|7
2151963|NCT01192295|3765187|FG000|Overall Study|Withdrawal by Subject|3
2151964|NCT01192295|3765188|FG001|Overall Study|Withdrawal by Subject|4
2151965|NCT01192295|3765187|FG000|Overall Study|Lost to Follow-up|0
2151966|NCT01192295|3765188|FG001|Overall Study|Lost to Follow-up|1
2151967|NCT01192295|3765187|FG000|Overall Study|Lack of Efficacy|0
2151968|NCT01192295|3765188|FG001|Overall Study|Lack of Efficacy|5
2151969|NCT01192295|3765187|FG000|Overall Study|Administrative|4
2151970|NCT01192295|3765188|FG001|Overall Study|Administrative|6
2151971|NCT01192347|3765196|FG000|Overall Study|Death|3
2151972|NCT01192347|3765196|FG000|Overall Study|Lost to Follow-up|3
2151973|NCT01192347|3765196|FG000|Overall Study|Withdrawal by Subject|1
2151974|NCT01192347|3765196|FG000|Overall Study|Adverse Event|1
2151975|NCT01192347|3765196|FG000|Overall Study|Suspected serious adverse drug reaction|1
2151976|NCT01192347|3765196|FG000|Overall Study|Patient seen in different hospital|1
2151977|NCT01192347|3765196|FG000|Overall Study|Patient not visiting hospital regularly|1
2151978|NCT01192347|3765196|FG000|Overall Study|Patient did not show up for visits|1
2151979|NCT01192399|3765200|FG000|Overall Study|Lack of Efficacy|2
2151980|NCT01192412|3765206|FG000|Overall Study|Lost to Follow-up|2
2151981|NCT01192412|3765207|FG001|Overall Study|Lost to Follow-up|1
2151982|NCT01192412|3765206|FG000|Overall Study|Withdrawal by Subject|2
2151983|NCT01192412|3765207|FG001|Overall Study|Withdrawal by Subject|1
2151984|NCT01192516|3765216|FG000|Overall Study|Lost to Follow-up|7
2151985|NCT01192516|3765217|FG001|Overall Study|Lost to Follow-up|10
2151986|NCT01192516|3765218|FG002|Overall Study|Lost to Follow-up|7
2151987|NCT01192516|3765216|FG000|Overall Study|Withdrawal by Subject|4
2151988|NCT01192516|3765217|FG001|Overall Study|Withdrawal by Subject|4
2151989|NCT01192516|3765218|FG002|Overall Study|Withdrawal by Subject|1
2151990|NCT01192516|3765216|FG000|Overall Study|started new treatment|5
2151991|NCT01192516|3765217|FG001|Overall Study|started new treatment|1
2151992|NCT01192516|3765218|FG002|Overall Study|started new treatment|0
2151993|NCT01192516|3765216|FG000|Overall Study|Unable to follow Actiwatch instructions|4
2208130|NCT01636687|3847526|FG003|Extension Period|Lost to Follow-up|0
2208131|NCT01636687|3847527|FG004|Extension Period|Lost to Follow-up|0
2151994|NCT01192516|3765217|FG001|Overall Study|Unable to follow Actiwatch instructions|2
2151995|NCT01192516|3765218|FG002|Overall Study|Unable to follow Actiwatch instructions|0
2151996|NCT01192776|3765252|FG000|Overall Study|Death|8
2151997|NCT01192776|3765253|FG001|Overall Study|Death|15
2151998|NCT01192776|3765254|FG002|Overall Study|Death|18
2151999|NCT01192776|3765255|FG003|Overall Study|Death|15
2152000|NCT01192776|3765252|FG000|Overall Study|Lost to Follow-up|3
2152001|NCT01192776|3765253|FG001|Overall Study|Lost to Follow-up|6
2152002|NCT01192776|3765254|FG002|Overall Study|Lost to Follow-up|3
2152003|NCT01192776|3765255|FG003|Overall Study|Lost to Follow-up|5
2152004|NCT01192815|3765267|FG000|Overall Study|Withdrawal by Subject|1
2208132|NCT01636687|3847523|FG000|Extension Period|Physician Decision|1
2152005|NCT01192815|3765267|FG000|Overall Study|Lack of Efficacy|1
2152006|NCT01193101|3765297|FG000|Overall Study|Adverse Event|0
2152007|NCT01193101|3765298|FG001|Overall Study|Adverse Event|1
2152008|NCT01193101|3765299|FG002|Overall Study|Adverse Event|1
2152009|NCT01193101|3765300|FG003|Overall Study|Adverse Event|3
2152010|NCT01193101|3765297|FG000|Overall Study|Lack of Efficacy|3
2152011|NCT01193101|3765298|FG001|Overall Study|Lack of Efficacy|1
2152012|NCT01193101|3765299|FG002|Overall Study|Lack of Efficacy|0
2152013|NCT01193101|3765300|FG003|Overall Study|Lack of Efficacy|8
2152014|NCT01193101|3765297|FG000|Overall Study|Withdrawal by Subject|2
2152015|NCT01193101|3765298|FG001|Overall Study|Withdrawal by Subject|4
2152016|NCT01193101|3765299|FG002|Overall Study|Withdrawal by Subject|1
2152017|NCT01193101|3765300|FG003|Overall Study|Withdrawal by Subject|1
2152018|NCT01193101|3765297|FG000|Overall Study|Administrative problems|0
2152019|NCT01193101|3765298|FG001|Overall Study|Administrative problems|0
2152020|NCT01193101|3765299|FG002|Overall Study|Administrative problems|1
2152021|NCT01193101|3765300|FG003|Overall Study|Administrative problems|0
2152022|NCT01193101|3765297|FG000|Overall Study|Abnormal test procedure results|0
2152023|NCT01193101|3765298|FG001|Overall Study|Abnormal test procedure results|1
2152024|NCT01193101|3765299|FG002|Overall Study|Abnormal test procedure results|0
2152025|NCT01193101|3765300|FG003|Overall Study|Abnormal test procedure results|0
2152026|NCT01193127|3765323|FG000|Randomized|Surgery Cancelled|0
2292302|NCT02510820|3985700|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0
2292303|NCT02510820|3985701|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
2292304|NCT02510820|3985700|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2292305|NCT02510820|3985701|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
2292306|NCT02511184|3985710|FG000|Overall Study|Death|1
2292307|NCT02511184|3985711|FG001|Overall Study|Death|0
2152027|NCT01193127|3765324|FG001|Randomized|Surgery Cancelled|0
2152028|NCT01193127|3765325|FG002|Randomized|Surgery Cancelled|0
2152029|NCT01193127|3765326|FG003|Randomized|Surgery Cancelled|1
2152030|NCT01193127|3765323|FG000|Treated|Withdrawal by Subject|0
2152031|NCT01193127|3765324|FG001|Treated|Withdrawal by Subject|0
2152032|NCT01193127|3765325|FG002|Treated|Withdrawal by Subject|0
2152033|NCT01193127|3765326|FG003|Treated|Withdrawal by Subject|1
2152034|NCT01193153|3765338|FG000|Open-label Lead in Period|Lost to Follow-up|32
2152035|NCT01193153|3765339|FG001|Open-label Lead in Period|Lost to Follow-up|0
2152036|NCT01193153|3765338|FG000|Open-label Lead in Period|Pregnancy|1
2152037|NCT01193153|3765339|FG001|Open-label Lead in Period|Pregnancy|0
2152038|NCT01193153|3765338|FG000|Open-label Lead in Period|Withdrawal by Subject|69
2152039|NCT01193153|3765339|FG001|Open-label Lead in Period|Withdrawal by Subject|0
2152040|NCT01193153|3765338|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
2152041|NCT01193153|3765339|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
2152042|NCT01193153|3765338|FG000|Open-label Lead in Period|Other|14
2152043|NCT01193153|3765339|FG001|Open-label Lead in Period|Other|0
2152044|NCT01193153|3765338|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
2152045|NCT01193153|3765339|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
2152046|NCT01193153|3765338|FG000|Open-label Lead in Period|Adverse Event|41
2152047|NCT01193153|3765339|FG001|Open-label Lead in Period|Adverse Event|0
2152048|NCT01193153|3765338|FG000|Open-label Lead in Period|Death|1
2152049|NCT01193153|3765339|FG001|Open-label Lead in Period|Death|0
2152050|NCT01193153|3765338|FG000|Open-label Lead in Period|Lack of Efficacy|26
2152051|NCT01193153|3765339|FG001|Open-label Lead in Period|Lack of Efficacy|0
2152052|NCT01193153|3765338|FG000|Open-label Stabilization Period|Adverse Event|9
2152053|NCT01193153|3765339|FG001|Open-label Stabilization Period|Adverse Event|0
2152054|NCT01193153|3765338|FG000|Open-label Stabilization Period|Death|2
2152055|NCT01193153|3765339|FG001|Open-label Stabilization Period|Death|0
2152056|NCT01193153|3765338|FG000|Open-label Stabilization Period|Lost to Follow-up|10
2152057|NCT01193153|3765339|FG001|Open-label Stabilization Period|Lost to Follow-up|0
2152058|NCT01193153|3765338|FG000|Open-label Stabilization Period|Lack of Efficacy|5
2152059|NCT01193153|3765339|FG001|Open-label Stabilization Period|Lack of Efficacy|0
2152060|NCT01193153|3765338|FG000|Open-label Stabilization Period|Withdrawal by Subject|29
2152061|NCT01193153|3765339|FG001|Open-label Stabilization Period|Withdrawal by Subject|0
2152062|NCT01193153|3765338|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
2152063|NCT01193153|3765339|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
2152064|NCT01193153|3765338|FG000|Open-label Stabilization Period|Other|8
2152065|NCT01193153|3765339|FG001|Open-label Stabilization Period|Other|0
2152066|NCT01193153|3765338|FG000|Double Blind Relapse Prevention Period|Other|2
2152067|NCT01193153|3765339|FG001|Double Blind Relapse Prevention Period|Other|3
2152068|NCT01193153|3765338|FG000|Double Blind Relapse Prevention Period|Adverse Event|12
2152069|NCT01193153|3765339|FG001|Double Blind Relapse Prevention Period|Adverse Event|3
2152070|NCT01193153|3765338|FG000|Double Blind Relapse Prevention Period|Death|2
2292308|NCT02511184|3985710|FG000|Overall Study|Lost to Follow-up|0
2292309|NCT02511184|3985711|FG001|Overall Study|Lost to Follow-up|1
2292310|NCT02511184|3985710|FG000|Overall Study|Study terminated by sponsor|1
2292311|NCT02511184|3985711|FG001|Overall Study|Study terminated by sponsor|5
2292312|NCT02511184|3985710|FG000|Overall Study|Withdrawal by Subject|0
2292313|NCT02511184|3985711|FG001|Overall Study|Withdrawal by Subject|1
2152071|NCT01193153|3765339|FG001|Double Blind Relapse Prevention Period|Death|0
2152072|NCT01193153|3765338|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2
2152073|NCT01193153|3765339|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9
2152074|NCT01193153|3765338|FG000|Double Blind Relapse Prevention Period|Pregnancy|1
2152075|NCT01193153|3765339|FG001|Double Blind Relapse Prevention Period|Pregnancy|0
2152076|NCT01193153|3765338|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
2152077|NCT01193153|3765339|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
2152078|NCT01193153|3765338|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25
2152079|NCT01193153|3765339|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57
2152080|NCT01193153|3765338|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
2152081|NCT01193153|3765339|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
2152082|NCT01193218|3765353|FG000|0-12 Weeks|Adverse Event|6
2152083|NCT01193218|3765354|FG001|0-12 Weeks|Adverse Event|0
2152084|NCT01193218|3765355|FG002|0-12 Weeks|Adverse Event|1
2152085|NCT01193218|3765356|FG003|0-12 Weeks|Adverse Event|0
2152086|NCT01193218|3765357|FG004|0-12 Weeks|Adverse Event|0
2152087|NCT01193218|3765358|FG005|0-12 Weeks|Adverse Event|2
2152088|NCT01193218|3765359|FG006|0-12 Weeks|Adverse Event|2
2152089|NCT01193218|3765360|FG007|0-12 Weeks|Adverse Event|0
2152090|NCT01193218|3765353|FG000|0-12 Weeks|Protocol Violation|0
2152091|NCT01193218|3765354|FG001|0-12 Weeks|Protocol Violation|0
2152092|NCT01193218|3765355|FG002|0-12 Weeks|Protocol Violation|0
2152093|NCT01193218|3765356|FG003|0-12 Weeks|Protocol Violation|0
2152094|NCT01193218|3765357|FG004|0-12 Weeks|Protocol Violation|1
2152095|NCT01193218|3765358|FG005|0-12 Weeks|Protocol Violation|1
2152096|NCT01193218|3765359|FG006|0-12 Weeks|Protocol Violation|0
2152097|NCT01193218|3765360|FG007|0-12 Weeks|Protocol Violation|0
2152098|NCT01193218|3765353|FG000|0-12 Weeks|Withdrawal by Subject|3
2152099|NCT01193218|3765354|FG001|0-12 Weeks|Withdrawal by Subject|0
2152100|NCT01193218|3765355|FG002|0-12 Weeks|Withdrawal by Subject|2
2152101|NCT01193218|3765356|FG003|0-12 Weeks|Withdrawal by Subject|0
2152102|NCT01193218|3765357|FG004|0-12 Weeks|Withdrawal by Subject|0
2152103|NCT01193218|3765358|FG005|0-12 Weeks|Withdrawal by Subject|0
2152104|NCT01193218|3765359|FG006|0-12 Weeks|Withdrawal by Subject|1
2152105|NCT01193218|3765360|FG007|0-12 Weeks|Withdrawal by Subject|0
2152106|NCT01193218|3765353|FG000|12-52 Weeks|Adverse Event|1
2152107|NCT01193218|3765354|FG001|12-52 Weeks|Adverse Event|0
2152108|NCT01193218|3765355|FG002|12-52 Weeks|Adverse Event|1
2152109|NCT01193218|3765356|FG003|12-52 Weeks|Adverse Event|2
2152110|NCT01193218|3765357|FG004|12-52 Weeks|Adverse Event|3
2152111|NCT01193218|3765358|FG005|12-52 Weeks|Adverse Event|3
2152112|NCT01193218|3765359|FG006|12-52 Weeks|Adverse Event|1
2152113|NCT01193218|3765360|FG007|12-52 Weeks|Adverse Event|2
2152114|NCT01193218|3765353|FG000|12-52 Weeks|Lack of Efficacy|0
2152115|NCT01193218|3765354|FG001|12-52 Weeks|Lack of Efficacy|0
2152116|NCT01193218|3765355|FG002|12-52 Weeks|Lack of Efficacy|0
2152117|NCT01193218|3765356|FG003|12-52 Weeks|Lack of Efficacy|0
2152118|NCT01193218|3765357|FG004|12-52 Weeks|Lack of Efficacy|0
2152119|NCT01193218|3765358|FG005|12-52 Weeks|Lack of Efficacy|0
2152120|NCT01193218|3765359|FG006|12-52 Weeks|Lack of Efficacy|1
2292314|NCT02511431|3985737|FG000|Treatment|Lost to Follow-up|0
2292315|NCT02511431|3985738|FG001|Treatment|Lost to Follow-up|0
2292316|NCT02511431|3985739|FG002|Treatment|Lost to Follow-up|1
2292317|NCT02511431|3985740|FG003|Treatment|Lost to Follow-up|0
2292318|NCT02511431|3985741|FG004|Treatment|Lost to Follow-up|0
2292319|NCT02511431|3985742|FG005|Treatment|Lost to Follow-up|1
2292320|NCT02511678|3985793|FG000|Overall Study|Withdrawal by Subject|2
2292321|NCT02511678|3985793|FG000|Overall Study|Lost to Follow-up|4
2292322|NCT02511678|3985793|FG000|Overall Study|Death|19
2292323|NCT02511678|3985793|FG000|Overall Study|Adverse Event|1
2292324|NCT02511678|3985793|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5
2292325|NCT02511678|3985793|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1
2292326|NCT02511678|3985793|FG000|Overall Study|Required Radiofrequency Ablation|1
2292327|NCT02511678|3985793|FG000|Overall Study|Biopsy was Negative|1
2292328|NCT02511678|3985793|FG000|Overall Study|Protocol Violation|1
2292329|NCT02511678|3985793|FG000|Overall Study|Received Radiation Treatment|1
2292330|NCT02511782|3985817|FG000|Overall Study|Withdrawal by Subject|1
2292331|NCT02511782|3985818|FG001|Overall Study|Withdrawal by Subject|0
2292332|NCT02511782|3985819|FG002|Overall Study|Withdrawal by Subject|0
2292333|NCT02512042|3985829|FG000|Overall Study|Adverse Event|0
2292334|NCT02512042|3985830|FG001|Overall Study|Adverse Event|4
2292335|NCT02512042|3985829|FG000|Overall Study|Withdrawal by Subject|6
2292336|NCT02512042|3985830|FG001|Overall Study|Withdrawal by Subject|6
2292337|NCT02512042|3985829|FG000|Overall Study|Non-compliance with study drug|1
2292338|NCT02512042|3985830|FG001|Overall Study|Non-compliance with study drug|2
2292339|NCT02512042|3985829|FG000|Overall Study|Lost to Follow-up|5
2292340|NCT02512042|3985830|FG001|Overall Study|Lost to Follow-up|2
2292341|NCT02512042|3985829|FG000|Overall Study|Other|11
2292342|NCT02512042|3985830|FG001|Overall Study|Other|11
2292343|NCT02512068|3985838|FG000|Overall Study|Pretreatment Event/Adverse Event|8
2292344|NCT02512068|3985839|FG001|Overall Study|Pretreatment Event/Adverse Event|6
2292345|NCT02512068|3985838|FG000|Overall Study|Major Protocol Deviation|1
2292346|NCT02512068|3985839|FG001|Overall Study|Major Protocol Deviation|0
2152121|NCT01193218|3765360|FG007|12-52 Weeks|Lack of Efficacy|0
2152122|NCT01193218|3765353|FG000|12-52 Weeks|Withdrawal by Subject|3
2152123|NCT01193218|3765354|FG001|12-52 Weeks|Withdrawal by Subject|0
2152124|NCT01193218|3765355|FG002|12-52 Weeks|Withdrawal by Subject|3
2152125|NCT01193218|3765356|FG003|12-52 Weeks|Withdrawal by Subject|0
2152126|NCT01193218|3765357|FG004|12-52 Weeks|Withdrawal by Subject|0
2152127|NCT01193218|3765358|FG005|12-52 Weeks|Withdrawal by Subject|2
2152128|NCT01193218|3765359|FG006|12-52 Weeks|Withdrawal by Subject|1
2152129|NCT01193218|3765360|FG007|12-52 Weeks|Withdrawal by Subject|2
2152130|NCT01193218|3765353|FG000|12-52 Weeks|Other reason than above|1
2152131|NCT01193218|3765354|FG001|12-52 Weeks|Other reason than above|0
2152132|NCT01193218|3765355|FG002|12-52 Weeks|Other reason than above|0
2152133|NCT01193218|3765356|FG003|12-52 Weeks|Other reason than above|1
2152134|NCT01193218|3765357|FG004|12-52 Weeks|Other reason than above|1
2152135|NCT01193218|3765358|FG005|12-52 Weeks|Other reason than above|0
2152136|NCT01193218|3765359|FG006|12-52 Weeks|Other reason than above|0
2152137|NCT01193218|3765360|FG007|12-52 Weeks|Other reason than above|0
2152138|NCT01193244|3765378|FG000|Overall Study|Withdrawal by Subject|79
2152139|NCT01193244|3765379|FG001|Overall Study|Withdrawal by Subject|97
2152140|NCT01193244|3765378|FG000|Overall Study|Other|303
2152141|NCT01193244|3765379|FG001|Overall Study|Other|278
2152142|NCT01193244|3765378|FG000|Overall Study|Lost to Follow-up|6
2152143|NCT01193244|3765379|FG001|Overall Study|Lost to Follow-up|15
2152144|NCT01193257|3765387|FG000|Overall Study|Death|202
2152145|NCT01193257|3765388|FG001|Overall Study|Death|391
2152146|NCT01193257|3765387|FG000|Overall Study|Study termination by sponsor|0
2152147|NCT01193257|3765388|FG001|Overall Study|Study termination by sponsor|3
2152148|NCT01193257|3765387|FG000|Overall Study|Withdrawal by Subject|26
2152149|NCT01193257|3765388|FG001|Overall Study|Withdrawal by Subject|86
2152150|NCT01193257|3765387|FG000|Overall Study|Lost to Follow-up|2
2152151|NCT01193257|3765388|FG001|Overall Study|Lost to Follow-up|3
2152152|NCT01193257|3765387|FG000|Overall Study|Unblinded due to futility|135
2152153|NCT01193257|3765388|FG001|Overall Study|Unblinded due to futility|251
2152154|NCT01193283|3765394|FG000|Overall Study|Death|1
2152155|NCT01193335|3765400|FG000|After Infant Series|Lost to Follow-up|1
2152156|NCT01193335|3765401|FG001|After Infant Series|Lost to Follow-up|2
2152157|NCT01193335|3765400|FG000|After Infant Series|No Longer Met Eligibility Criteria|0
2152158|NCT01193335|3765401|FG001|After Infant Series|No Longer Met Eligibility Criteria|1
2152159|NCT01193335|3765400|FG000|1-Year Follow-up|No Longer Willing to Participate|7
2152160|NCT01193335|3765401|FG001|1-Year Follow-up|No Longer Willing to Participate|9
2152161|NCT01193335|3765400|FG000|1-Year Follow-up|Lost to Follow-up|4
2152162|NCT01193335|3765401|FG001|1-Year Follow-up|Lost to Follow-up|0
2152163|NCT01193335|3765400|FG000|2-Year Follow-up|No Longer Willing to Participate|5
2152164|NCT01193335|3765401|FG001|2-Year Follow-up|No Longer Willing to Participate|6
2152165|NCT01193335|3765400|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2
2152166|NCT01193335|3765401|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2
2152167|NCT01193348|3765423|FG000|Screening Period|Screen Failure|5
2152168|NCT01193348|3765423|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
2152169|NCT01193348|3765423|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1
2152170|NCT01193348|3765423|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
2152171|NCT01193348|3765423|FG000|Extension Treatment Period|Physician Decision|1
2152172|NCT01193348|3765423|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
2152173|NCT01193517|3765435|FG000|Overall Study|Early Progression|1
2152174|NCT01193517|3765436|FG001|Overall Study|Early Progression|0
2152175|NCT01193517|3765437|FG002|Overall Study|Early Progression|0
2152176|NCT01193582|3765450|FG000|Vaccination Series|Withdrawal by Subject|11
2152177|NCT01193582|3765451|FG001|Vaccination Series|Withdrawal by Subject|13
2152178|NCT01193582|3765452|FG002|Vaccination Series|Withdrawal by Subject|8
2152179|NCT01193582|3765453|FG003|Vaccination Series|Withdrawal by Subject|3
2152180|NCT01193582|3765450|FG000|12 Month Follow-up|Death|0
2152181|NCT01193582|3765451|FG001|12 Month Follow-up|Death|0
2152182|NCT01193582|3765452|FG002|12 Month Follow-up|Death|1
2152183|NCT01193582|3765453|FG003|12 Month Follow-up|Death|0
2152184|NCT01193582|3765450|FG000|12 Month Follow-up|Withdrawal by Subject|6
2152185|NCT01193582|3765451|FG001|12 Month Follow-up|Withdrawal by Subject|0
2152186|NCT01193582|3765452|FG002|12 Month Follow-up|Withdrawal by Subject|3
2152187|NCT01193582|3765453|FG003|12 Month Follow-up|Withdrawal by Subject|11
2152188|NCT01193608|3765471|FG000|Overall Study|Other|0
2208133|NCT01636687|3847524|FG001|Extension Period|Physician Decision|0
2208134|NCT01636687|3847525|FG002|Extension Period|Physician Decision|0
2152189|NCT01193608|3765472|FG001|Overall Study|Other|1
2152190|NCT01193608|3765473|FG002|Overall Study|Other|0
2152191|NCT01193608|3765474|FG003|Overall Study|Other|0
2152192|NCT01193608|3765475|FG004|Overall Study|Other|0
2152193|NCT01193608|3765476|FG005|Overall Study|Other|0
2152194|NCT01193608|3765471|FG000|Overall Study|Withdrawal by Subject|0
2152195|NCT01193608|3765472|FG001|Overall Study|Withdrawal by Subject|1
2152196|NCT01193608|3765473|FG002|Overall Study|Withdrawal by Subject|2
2152197|NCT01193608|3765474|FG003|Overall Study|Withdrawal by Subject|3
2152198|NCT01193608|3765475|FG004|Overall Study|Withdrawal by Subject|3
2152199|NCT01193608|3765476|FG005|Overall Study|Withdrawal by Subject|0
2152200|NCT01193608|3765471|FG000|Overall Study|Lost to Follow-up|0
2152201|NCT01193608|3765472|FG001|Overall Study|Lost to Follow-up|0
2152202|NCT01193608|3765473|FG002|Overall Study|Lost to Follow-up|0
2152203|NCT01193608|3765474|FG003|Overall Study|Lost to Follow-up|0
2152204|NCT01193608|3765475|FG004|Overall Study|Lost to Follow-up|1
2152205|NCT01193608|3765476|FG005|Overall Study|Lost to Follow-up|2
2152206|NCT01193608|3765471|FG000|Overall Study|Adverse Event|0
2152207|NCT01193608|3765472|FG001|Overall Study|Adverse Event|0
2152208|NCT01193608|3765473|FG002|Overall Study|Adverse Event|0
2152209|NCT01193608|3765474|FG003|Overall Study|Adverse Event|0
2152210|NCT01193608|3765475|FG004|Overall Study|Adverse Event|1
2152211|NCT01193608|3765476|FG005|Overall Study|Adverse Event|0
2152212|NCT01193660|3765498|FG000|Overall Study|Withdrawal by Subject|2
2152213|NCT01193660|3765499|FG001|Overall Study|Withdrawal by Subject|3
2152214|NCT01193660|3765500|FG002|Overall Study|Withdrawal by Subject|1
2152215|NCT01193660|3765498|FG000|Overall Study|Death|1
2152216|NCT01193660|3765499|FG001|Overall Study|Death|0
2152217|NCT01193660|3765500|FG002|Overall Study|Death|0
2152218|NCT01193660|3765498|FG000|Overall Study|Physician Decision|1
2152219|NCT01193660|3765499|FG001|Overall Study|Physician Decision|0
2152220|NCT01193660|3765500|FG002|Overall Study|Physician Decision|1
2152221|NCT01193686|3765510|FG000|Overall Study|Withdrawal by Subject|4
2152222|NCT01193686|3765511|FG001|Overall Study|Withdrawal by Subject|1
2152223|NCT01193686|3765510|FG000|Overall Study|Removed by Investigators; unable to matc|3
2152224|NCT01193686|3765511|FG001|Overall Study|Removed by Investigators; unable to matc|0
2152225|NCT01193920|3765549|FG000|Overall Study|Withdrawal by Subject|1
2152226|NCT01193920|3765550|FG001|Overall Study|Withdrawal by Subject|0
2152227|NCT01193920|3765551|FG002|Overall Study|Withdrawal by Subject|5
2152228|NCT01193920|3765552|FG003|Overall Study|Withdrawal by Subject|1
2152229|NCT01193920|3765553|FG004|Overall Study|Withdrawal by Subject|3
2152230|NCT01193920|3765554|FG005|Overall Study|Withdrawal by Subject|1
2152231|NCT01193920|3765555|FG006|Overall Study|Withdrawal by Subject|3
2152232|NCT01193920|3765556|FG007|Overall Study|Withdrawal by Subject|0
2152233|NCT01193920|3765557|FG008|Overall Study|Withdrawal by Subject|1
2152234|NCT01193920|3765558|FG009|Overall Study|Withdrawal by Subject|0
2152235|NCT01193920|3765549|FG000|Overall Study|Lost to Follow-up|1
2152236|NCT01193920|3765550|FG001|Overall Study|Lost to Follow-up|0
2152237|NCT01193920|3765551|FG002|Overall Study|Lost to Follow-up|1
2152238|NCT01193920|3765552|FG003|Overall Study|Lost to Follow-up|1
2152239|NCT01193920|3765553|FG004|Overall Study|Lost to Follow-up|3
2152240|NCT01193920|3765554|FG005|Overall Study|Lost to Follow-up|3
2152241|NCT01193920|3765555|FG006|Overall Study|Lost to Follow-up|1
2152242|NCT01193920|3765556|FG007|Overall Study|Lost to Follow-up|0
2152243|NCT01193920|3765557|FG008|Overall Study|Lost to Follow-up|2
2152244|NCT01193920|3765558|FG009|Overall Study|Lost to Follow-up|3
2152245|NCT01193920|3765549|FG000|Overall Study|Protocol Violation|1
2152246|NCT01193920|3765550|FG001|Overall Study|Protocol Violation|0
2152247|NCT01193920|3765551|FG002|Overall Study|Protocol Violation|0
2152248|NCT01193920|3765552|FG003|Overall Study|Protocol Violation|0
2152249|NCT01193920|3765553|FG004|Overall Study|Protocol Violation|0
2152250|NCT01193920|3765554|FG005|Overall Study|Protocol Violation|0
2152251|NCT01193920|3765555|FG006|Overall Study|Protocol Violation|0
2152252|NCT01193920|3765556|FG007|Overall Study|Protocol Violation|0
2152253|NCT01193920|3765557|FG008|Overall Study|Protocol Violation|0
2152254|NCT01193920|3765558|FG009|Overall Study|Protocol Violation|0
2152255|NCT01193920|3765549|FG000|Overall Study|Death|0
2152256|NCT01193920|3765550|FG001|Overall Study|Death|0
2152257|NCT01193920|3765551|FG002|Overall Study|Death|0
2152258|NCT01193920|3765552|FG003|Overall Study|Death|1
2152259|NCT01193920|3765553|FG004|Overall Study|Death|0
2152260|NCT01193920|3765554|FG005|Overall Study|Death|0
2152261|NCT01193920|3765555|FG006|Overall Study|Death|2
2152262|NCT01193920|3765556|FG007|Overall Study|Death|3
2152263|NCT01193920|3765557|FG008|Overall Study|Death|2
2152264|NCT01193920|3765558|FG009|Overall Study|Death|4
2152265|NCT01193920|3765549|FG000|Overall Study|Unable to classify|0
2152266|NCT01193920|3765550|FG001|Overall Study|Unable to classify|0
2152267|NCT01193920|3765551|FG002|Overall Study|Unable to classify|0
2152268|NCT01193920|3765552|FG003|Overall Study|Unable to classify|1
2152269|NCT01193920|3765553|FG004|Overall Study|Unable to classify|0
2152270|NCT01193920|3765554|FG005|Overall Study|Unable to classify|0
2152271|NCT01193920|3765555|FG006|Overall Study|Unable to classify|0
2292347|NCT02512068|3985838|FG000|Overall Study|Voluntary Withdrawal|0
2292348|NCT02512068|3985839|FG001|Overall Study|Voluntary Withdrawal|1
2292349|NCT02512068|3985838|FG000|Overall Study|Lack of Efficacy|0
2292350|NCT02512068|3985839|FG001|Overall Study|Lack of Efficacy|1
2292351|NCT02512068|3985838|FG000|Overall Study|Reason Not Specified|3
2292352|NCT02512068|3985839|FG001|Overall Study|Reason Not Specified|5
2292353|NCT02512302|3985867|FG000|Period 1|Adverse Event|0
2292354|NCT02512302|3985868|FG001|Period 1|Adverse Event|1
2292355|NCT02512302|3985869|FG002|Period 1|Adverse Event|0
2292356|NCT02512302|3985870|FG003|Period 1|Adverse Event|0
2292357|NCT02512302|3985871|FG004|Period 1|Adverse Event|0
2292358|NCT02512302|3985872|FG005|Period 1|Adverse Event|0
2292359|NCT02512302|3985873|FG006|Period 1|Adverse Event|0
2292360|NCT02512302|3985874|FG007|Period 1|Adverse Event|0
2292361|NCT02512302|3985875|FG008|Period 1|Adverse Event|0
2292362|NCT02512302|3985876|FG009|Period 1|Adverse Event|0
2152272|NCT01193920|3765556|FG007|Overall Study|Unable to classify|1
2152273|NCT01193920|3765557|FG008|Overall Study|Unable to classify|0
2152274|NCT01193920|3765558|FG009|Overall Study|Unable to classify|0
2292363|NCT02512302|3985867|FG000|Period 2|Adverse Event|0
2152275|NCT01194154|3765592|FG000|Overall Study|Adverse Event|12
2152276|NCT01194154|3765593|FG001|Overall Study|Adverse Event|7
2152277|NCT01194154|3765592|FG000|Overall Study|Lost to Follow-up|2
2152278|NCT01194154|3765593|FG001|Overall Study|Lost to Follow-up|3
2152279|NCT01194154|3765592|FG000|Overall Study|Protocol Violation|0
2152280|NCT01194154|3765593|FG001|Overall Study|Protocol Violation|1
2152281|NCT01194154|3765592|FG000|Overall Study|Withdrawal by Subject|5
2152282|NCT01194154|3765593|FG001|Overall Study|Withdrawal by Subject|6
2152283|NCT01194154|3765592|FG000|Overall Study|Blood pressure increase|5
2152284|NCT01194154|3765593|FG001|Overall Study|Blood pressure increase|3
2152285|NCT01194154|3765592|FG000|Overall Study|Hemoglobin decrease|0
2152286|NCT01194154|3765593|FG001|Overall Study|Hemoglobin decrease|1
2152287|NCT01194154|3765592|FG000|Overall Study|Hemoglobin increase|12
2152288|NCT01194154|3765593|FG001|Overall Study|Hemoglobin increase|3
2152289|NCT01194154|3765592|FG000|Overall Study|Skipping of CERA treatment at two visits|3
2152290|NCT01194154|3765593|FG001|Overall Study|Skipping of CERA treatment at two visits|0
2152291|NCT01194154|3765592|FG000|Overall Study|Treatment with prohibited medication|4
2152292|NCT01194154|3765593|FG001|Overall Study|Treatment with prohibited medication|5
2152293|NCT01194154|3765592|FG000|Overall Study|Other|4
2152294|NCT01194154|3765593|FG001|Overall Study|Other|0
2152295|NCT01194154|3765592|FG000|Overall Study|Did not receive study medication|2
2152296|NCT01194154|3765593|FG001|Overall Study|Did not receive study medication|4
2152297|NCT01194219|3765603|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
2152298|NCT01194219|3765604|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
2152299|NCT01194219|3765605|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2152300|NCT01194219|3765606|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2152301|NCT01194219|3765607|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2152302|NCT01194219|3765608|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2152303|NCT01194219|3765609|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2152304|NCT01194219|3765610|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2152305|NCT01194219|3765611|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2152306|NCT01194219|3765612|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2152307|NCT01194219|3765603|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
2152308|NCT01194219|3765604|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
2152309|NCT01194219|3765605|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2152310|NCT01194219|3765606|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2152311|NCT01194219|3765607|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2152312|NCT01194219|3765608|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2152313|NCT01194219|3765609|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2152314|NCT01194219|3765610|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2152315|NCT01194219|3765611|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2152316|NCT01194219|3765612|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2152317|NCT01194219|3765603|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
2152318|NCT01194219|3765604|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2152319|NCT01194219|3765605|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2152320|NCT01194219|3765606|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2152321|NCT01194219|3765607|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2152322|NCT01194219|3765608|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2152323|NCT01194219|3765609|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2152324|NCT01194219|3765610|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2152325|NCT01194219|3765611|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2152326|NCT01194219|3765612|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2152327|NCT01194219|3765603|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
2152328|NCT01194219|3765604|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
2152329|NCT01194219|3765605|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2152330|NCT01194219|3765606|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2152331|NCT01194219|3765607|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2152332|NCT01194219|3765608|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2152333|NCT01194219|3765609|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2152334|NCT01194219|3765610|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2152335|NCT01194219|3765611|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2152336|NCT01194219|3765612|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2152337|NCT01194219|3765603|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0
2152338|NCT01194219|3765604|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1
2152339|NCT01194219|3765605|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0
2152340|NCT01194219|3765606|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0
2152341|NCT01194219|3765607|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0
2152342|NCT01194219|3765608|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0
2152343|NCT01194219|3765609|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0
2152344|NCT01194219|3765610|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0
2152345|NCT01194219|3765611|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0
2152346|NCT01194219|3765612|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0
2152347|NCT01194219|3765603|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
2152348|NCT01194219|3765604|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
2152349|NCT01194219|3765605|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2152350|NCT01194219|3765606|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2152351|NCT01194219|3765607|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2152352|NCT01194219|3765608|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2152353|NCT01194219|3765609|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2152354|NCT01194219|3765610|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2152355|NCT01194219|3765611|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2152356|NCT01194219|3765612|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2152357|NCT01194219|3765603|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
2152358|NCT01194219|3765604|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
2152359|NCT01194219|3765605|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2152360|NCT01194219|3765606|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2152361|NCT01194219|3765607|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2152362|NCT01194219|3765608|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2152363|NCT01194219|3765609|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2152364|NCT01194219|3765610|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2152365|NCT01194219|3765611|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2152366|NCT01194219|3765612|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2152367|NCT01194219|3765603|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
2152368|NCT01194219|3765604|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
2152369|NCT01194219|3765605|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2152370|NCT01194219|3765606|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2152371|NCT01194219|3765607|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2152372|NCT01194219|3765608|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2152373|NCT01194219|3765609|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2152374|NCT01194219|3765610|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2152375|NCT01194219|3765611|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2152376|NCT01194219|3765612|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2152377|NCT01194219|3765603|FG000|Maintenance Phase Weeks16-32|Adverse Event|0
2152378|NCT01194219|3765604|FG001|Maintenance Phase Weeks16-32|Adverse Event|0
2152379|NCT01194219|3765605|FG002|Maintenance Phase Weeks16-32|Adverse Event|8
2152380|NCT01194219|3765606|FG003|Maintenance Phase Weeks16-32|Adverse Event|9
2152381|NCT01194219|3765607|FG004|Maintenance Phase Weeks16-32|Adverse Event|0
2152382|NCT01194219|3765608|FG005|Maintenance Phase Weeks16-32|Adverse Event|0
2152383|NCT01194219|3765609|FG006|Maintenance Phase Weeks16-32|Adverse Event|0
2152384|NCT01194219|3765610|FG007|Maintenance Phase Weeks16-32|Adverse Event|0
2152385|NCT01194219|3765611|FG008|Maintenance Phase Weeks16-32|Adverse Event|0
2152386|NCT01194219|3765612|FG009|Maintenance Phase Weeks16-32|Adverse Event|0
2152387|NCT01194219|3765603|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2152388|NCT01194219|3765604|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2152389|NCT01194219|3765605|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37
2152390|NCT01194219|3765606|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15
2152391|NCT01194219|3765607|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2152392|NCT01194219|3765608|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2152393|NCT01194219|3765609|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2152394|NCT01194219|3765610|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2152395|NCT01194219|3765611|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2152396|NCT01194219|3765612|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2152397|NCT01194219|3765603|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2152398|NCT01194219|3765604|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2152399|NCT01194219|3765605|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
2152400|NCT01194219|3765606|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
2152401|NCT01194219|3765607|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2152402|NCT01194219|3765608|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2152403|NCT01194219|3765609|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2152404|NCT01194219|3765610|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2152405|NCT01194219|3765611|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2152406|NCT01194219|3765612|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2152407|NCT01194219|3765603|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2152408|NCT01194219|3765604|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2152409|NCT01194219|3765605|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
2152410|NCT01194219|3765606|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
2152411|NCT01194219|3765607|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2152412|NCT01194219|3765608|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2152413|NCT01194219|3765609|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2152414|NCT01194219|3765610|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2152415|NCT01194219|3765611|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2152416|NCT01194219|3765612|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2152417|NCT01194219|3765603|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2152418|NCT01194219|3765604|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2152419|NCT01194219|3765605|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9
2152420|NCT01194219|3765606|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2152421|NCT01194219|3765607|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2152422|NCT01194219|3765608|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2152423|NCT01194219|3765609|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2152424|NCT01194219|3765610|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2152425|NCT01194219|3765611|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2152426|NCT01194219|3765612|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2152427|NCT01194219|3765603|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0
2152428|NCT01194219|3765604|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0
2152429|NCT01194219|3765605|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0
2152430|NCT01194219|3765606|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1
2152431|NCT01194219|3765607|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0
2152432|NCT01194219|3765608|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0
2152433|NCT01194219|3765609|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0
2152434|NCT01194219|3765610|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0
2152435|NCT01194219|3765611|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0
2152436|NCT01194219|3765612|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0
2152437|NCT01194219|3765603|FG000|Maintenance Phase Weeks16-32|Other|0
2152438|NCT01194219|3765604|FG001|Maintenance Phase Weeks16-32|Other|0
2152439|NCT01194219|3765605|FG002|Maintenance Phase Weeks16-32|Other|2
2152440|NCT01194219|3765606|FG003|Maintenance Phase Weeks16-32|Other|1
2152441|NCT01194219|3765607|FG004|Maintenance Phase Weeks16-32|Other|0
2152442|NCT01194219|3765608|FG005|Maintenance Phase Weeks16-32|Other|0
2152443|NCT01194219|3765609|FG006|Maintenance Phase Weeks16-32|Other|0
2152444|NCT01194219|3765610|FG007|Maintenance Phase Weeks16-32|Other|0
2152445|NCT01194219|3765611|FG008|Maintenance Phase Weeks16-32|Other|0
2152446|NCT01194219|3765612|FG009|Maintenance Phase Weeks16-32|Other|0
2152447|NCT01194219|3765603|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2152448|NCT01194219|3765604|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2152449|NCT01194219|3765605|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2152450|NCT01194219|3765606|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2152451|NCT01194219|3765607|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2152452|NCT01194219|3765608|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
2152453|NCT01194219|3765609|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
2152454|NCT01194219|3765610|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
2152455|NCT01194219|3765611|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2152456|NCT01194219|3765612|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2152457|NCT01194219|3765603|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2152458|NCT01194219|3765604|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2152459|NCT01194219|3765605|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2152460|NCT01194219|3765606|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2152461|NCT01194219|3765607|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
2152462|NCT01194219|3765608|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
2152463|NCT01194219|3765609|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
2152464|NCT01194219|3765610|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
2152465|NCT01194219|3765611|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2152466|NCT01194219|3765612|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2152467|NCT01194219|3765603|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2152468|NCT01194219|3765604|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2152469|NCT01194219|3765605|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2152470|NCT01194219|3765606|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2152471|NCT01194219|3765607|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
2152472|NCT01194219|3765608|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2152473|NCT01194219|3765609|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
2152474|NCT01194219|3765610|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2152475|NCT01194219|3765611|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2152476|NCT01194219|3765612|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2152477|NCT01194219|3765603|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2292364|NCT02512302|3985868|FG001|Period 2|Adverse Event|0
2292365|NCT02512302|3985869|FG002|Period 2|Adverse Event|0
2292366|NCT02512302|3985870|FG003|Period 2|Adverse Event|0
2292367|NCT02512302|3985871|FG004|Period 2|Adverse Event|0
2292368|NCT02512302|3985872|FG005|Period 2|Adverse Event|0
2292369|NCT02512302|3985873|FG006|Period 2|Adverse Event|0
2292370|NCT02512302|3985874|FG007|Period 2|Adverse Event|0
2292371|NCT02512302|3985875|FG008|Period 2|Adverse Event|0
2292372|NCT02512302|3985876|FG009|Period 2|Adverse Event|1
2292373|NCT02512302|3985867|FG000|Period 3|Lost to Follow-up|0
2292374|NCT02512302|3985868|FG001|Period 3|Lost to Follow-up|0
2292375|NCT02512302|3985869|FG002|Period 3|Lost to Follow-up|1
2292376|NCT02512302|3985870|FG003|Period 3|Lost to Follow-up|0
2152478|NCT01194219|3765604|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2292377|NCT02512302|3985871|FG004|Period 3|Lost to Follow-up|0
2292378|NCT02512302|3985872|FG005|Period 3|Lost to Follow-up|0
2292379|NCT02512302|3985873|FG006|Period 3|Lost to Follow-up|0
2152479|NCT01194219|3765605|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2152480|NCT01194219|3765606|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2152481|NCT01194219|3765607|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
2152482|NCT01194219|3765608|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2152483|NCT01194219|3765609|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
2152484|NCT01194219|3765610|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
2152485|NCT01194219|3765611|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2152486|NCT01194219|3765612|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2152487|NCT01194219|3765603|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2152488|NCT01194219|3765604|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2152489|NCT01194219|3765605|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2152490|NCT01194219|3765606|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2152491|NCT01194219|3765607|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
2152492|NCT01194219|3765608|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
2152493|NCT01194219|3765609|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
2152494|NCT01194219|3765610|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2152495|NCT01194219|3765611|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2152496|NCT01194219|3765612|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2152497|NCT01194219|3765603|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2152498|NCT01194219|3765604|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2152499|NCT01194219|3765605|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2152500|NCT01194219|3765606|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2152501|NCT01194219|3765607|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2152502|NCT01194219|3765608|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2152503|NCT01194219|3765609|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2152504|NCT01194219|3765610|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
2152505|NCT01194219|3765611|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2152506|NCT01194219|3765612|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2152507|NCT01194219|3765603|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2152508|NCT01194219|3765604|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2152509|NCT01194219|3765605|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2152510|NCT01194219|3765606|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2152511|NCT01194219|3765607|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2152512|NCT01194219|3765608|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2152513|NCT01194219|3765609|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1
2152514|NCT01194219|3765610|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2152515|NCT01194219|3765611|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2152516|NCT01194219|3765612|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2152517|NCT01194219|3765603|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2152518|NCT01194219|3765604|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2152519|NCT01194219|3765605|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2152520|NCT01194219|3765606|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2152521|NCT01194219|3765607|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2152522|NCT01194219|3765608|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2152523|NCT01194219|3765609|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2152524|NCT01194219|3765610|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2152525|NCT01194219|3765611|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25
2152526|NCT01194219|3765612|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14
2152527|NCT01194219|3765603|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2152528|NCT01194219|3765604|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2152529|NCT01194219|3765605|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2152530|NCT01194219|3765606|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2152531|NCT01194219|3765607|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2152532|NCT01194219|3765608|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2152533|NCT01194219|3765609|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2152534|NCT01194219|3765610|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2152535|NCT01194219|3765611|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
2152536|NCT01194219|3765612|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
2152537|NCT01194219|3765603|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2152538|NCT01194219|3765604|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2152539|NCT01194219|3765605|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2152540|NCT01194219|3765606|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2152541|NCT01194219|3765607|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2152542|NCT01194219|3765608|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2152543|NCT01194219|3765609|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2152544|NCT01194219|3765610|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2208135|NCT01636687|3847526|FG003|Extension Period|Physician Decision|1
2152545|NCT01194219|3765611|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
2152546|NCT01194219|3765612|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
2152547|NCT01194219|3765603|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2152548|NCT01194219|3765604|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2152549|NCT01194219|3765605|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2152550|NCT01194219|3765606|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2152551|NCT01194219|3765607|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2152552|NCT01194219|3765608|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2152553|NCT01194219|3765609|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2152554|NCT01194219|3765610|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2152555|NCT01194219|3765611|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
2152556|NCT01194219|3765612|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
2152557|NCT01194219|3765603|FG000|Long-Term Extension Weeks 52 to 260|Death|0
2152558|NCT01194219|3765604|FG001|Long-Term Extension Weeks 52 to 260|Death|0
2152559|NCT01194219|3765605|FG002|Long-Term Extension Weeks 52 to 260|Death|0
2152560|NCT01194219|3765606|FG003|Long-Term Extension Weeks 52 to 260|Death|0
2152561|NCT01194219|3765607|FG004|Long-Term Extension Weeks 52 to 260|Death|0
2152562|NCT01194219|3765608|FG005|Long-Term Extension Weeks 52 to 260|Death|0
2152563|NCT01194219|3765609|FG006|Long-Term Extension Weeks 52 to 260|Death|0
2152564|NCT01194219|3765610|FG007|Long-Term Extension Weeks 52 to 260|Death|0
2152565|NCT01194219|3765611|FG008|Long-Term Extension Weeks 52 to 260|Death|1
2152566|NCT01194219|3765612|FG009|Long-Term Extension Weeks 52 to 260|Death|1
2152567|NCT01194219|3765603|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2152568|NCT01194219|3765604|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2152569|NCT01194219|3765605|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2152570|NCT01194219|3765606|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2152571|NCT01194219|3765607|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2152572|NCT01194219|3765608|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2152573|NCT01194219|3765609|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2152574|NCT01194219|3765610|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2152575|NCT01194219|3765611|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
2152576|NCT01194219|3765612|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
2152577|NCT01194219|3765603|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2152578|NCT01194219|3765604|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2152579|NCT01194219|3765605|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2152580|NCT01194219|3765606|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2152581|NCT01194219|3765607|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2152582|NCT01194219|3765608|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2152583|NCT01194219|3765609|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2152584|NCT01194219|3765610|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2152585|NCT01194219|3765611|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
2152586|NCT01194219|3765612|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2152587|NCT01194219|3765603|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2152588|NCT01194219|3765604|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2152589|NCT01194219|3765605|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2152590|NCT01194219|3765606|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2152591|NCT01194219|3765607|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2152592|NCT01194219|3765608|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2152593|NCT01194219|3765609|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2152594|NCT01194219|3765610|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2152595|NCT01194219|3765611|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
2152596|NCT01194219|3765612|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
2152597|NCT01194245|3765640|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
2152598|NCT01194245|3765641|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2152599|NCT01194245|3765642|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2152600|NCT01194245|3765643|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2152601|NCT01194245|3765644|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2152602|NCT01194245|3765640|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3
2152603|NCT01194245|3765641|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0
2152604|NCT01194245|3765642|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0
2152605|NCT01194245|3765643|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0
2152606|NCT01194245|3765644|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0
2152607|NCT01194245|3765640|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3
2152608|NCT01194245|3765641|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0
2152609|NCT01194245|3765642|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0
2152610|NCT01194245|3765643|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0
2152611|NCT01194245|3765644|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0
2152612|NCT01194245|3765640|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
2152613|NCT01194245|3765641|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2152614|NCT01194245|3765642|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2152615|NCT01194245|3765643|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2152616|NCT01194245|3765644|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2152617|NCT01194245|3765640|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2152618|NCT01194245|3765641|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2152619|NCT01194245|3765642|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2152620|NCT01194245|3765643|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2152621|NCT01194245|3765644|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
2152622|NCT01194245|3765640|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2152623|NCT01194245|3765641|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2152624|NCT01194245|3765642|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
2152625|NCT01194245|3765643|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
2152626|NCT01194245|3765644|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
2152627|NCT01194258|3765653|FG000|Titration Period|Withdrawal by Subject|6
2152628|NCT01194258|3765654|FG001|Titration Period|Withdrawal by Subject|0
2152629|NCT01194258|3765655|FG002|Titration Period|Withdrawal by Subject|0
2152630|NCT01194258|3765656|FG003|Titration Period|Withdrawal by Subject|0
2152631|NCT01194258|3765657|FG004|Titration Period|Withdrawal by Subject|0
2152632|NCT01194258|3765653|FG000|Titration Period|Lost to Follow-up|2
2152633|NCT01194258|3765654|FG001|Titration Period|Lost to Follow-up|0
2152634|NCT01194258|3765655|FG002|Titration Period|Lost to Follow-up|0
2152635|NCT01194258|3765656|FG003|Titration Period|Lost to Follow-up|0
2152636|NCT01194258|3765657|FG004|Titration Period|Lost to Follow-up|0
2152637|NCT01194258|3765653|FG000|Titration Period|Titration failure|3
2152638|NCT01194258|3765654|FG001|Titration Period|Titration failure|0
2152639|NCT01194258|3765655|FG002|Titration Period|Titration failure|0
2152640|NCT01194258|3765656|FG003|Titration Period|Titration failure|0
2152641|NCT01194258|3765657|FG004|Titration Period|Titration failure|0
2152642|NCT01194258|3765653|FG000|Period 1 (12 Weeks)|Death|0
2152643|NCT01194258|3765654|FG001|Period 1 (12 Weeks)|Death|0
2152644|NCT01194258|3765655|FG002|Period 1 (12 Weeks)|Death|0
2152645|NCT01194258|3765656|FG003|Period 1 (12 Weeks)|Death|0
2152646|NCT01194258|3765657|FG004|Period 1 (12 Weeks)|Death|1
2152647|NCT01194258|3765653|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0
2152648|NCT01194258|3765654|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0
2152649|NCT01194258|3765655|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0
2152650|NCT01194258|3765656|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0
2152651|NCT01194258|3765657|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2
2152652|NCT01194258|3765653|FG000|Period 2 (12 Weeks)|Adverse Event|0
2152653|NCT01194258|3765654|FG001|Period 2 (12 Weeks)|Adverse Event|1
2152654|NCT01194258|3765655|FG002|Period 2 (12 Weeks)|Adverse Event|0
2152655|NCT01194258|3765656|FG003|Period 2 (12 Weeks)|Adverse Event|0
2152656|NCT01194258|3765657|FG004|Period 2 (12 Weeks)|Adverse Event|0
2152657|NCT01194258|3765653|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0
2152658|NCT01194258|3765654|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1
2152659|NCT01194258|3765655|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1
2152660|NCT01194258|3765656|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0
2152661|NCT01194258|3765657|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0
2152662|NCT01194271|3765668|FG000|Overall Study|Withdrawal by Subject|1
2152663|NCT01194271|3765668|FG000|Overall Study|Ineligible, Screen Failure|1
2152664|NCT01194271|3765668|FG000|Overall Study|Death|1
2152665|NCT01194414|3765683|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
2152666|NCT01194414|3765684|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
2152667|NCT01194414|3765685|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
2152668|NCT01194414|3765686|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
2152669|NCT01194414|3765683|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
2152670|NCT01194414|3765684|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
2152671|NCT01194414|3765685|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
2152672|NCT01194414|3765686|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
2152673|NCT01194414|3765683|FG000|24 Weeks Double Blind Period|Protocol Violation|5
2152674|NCT01194414|3765684|FG001|24 Weeks Double Blind Period|Protocol Violation|3
2152675|NCT01194414|3765685|FG002|24 Weeks Double Blind Period|Protocol Violation|0
2152676|NCT01194414|3765686|FG003|24 Weeks Double Blind Period|Protocol Violation|0
2152677|NCT01194414|3765683|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
2152678|NCT01194414|3765684|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
2152679|NCT01194414|3765685|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
2152680|NCT01194414|3765686|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
2152681|NCT01194414|3765683|FG000|24 Weeks Double Blind Period|Pregnancy|2
2152682|NCT01194414|3765684|FG001|24 Weeks Double Blind Period|Pregnancy|2
2152683|NCT01194414|3765685|FG002|24 Weeks Double Blind Period|Pregnancy|0
2152684|NCT01194414|3765686|FG003|24 Weeks Double Blind Period|Pregnancy|0
2152685|NCT01194414|3765683|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2
2152686|NCT01194414|3765684|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1
2152687|NCT01194414|3765685|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0
2152688|NCT01194414|3765686|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0
2152689|NCT01194414|3765683|FG000|24 Weeks Double Blind Period|Other|0
2152690|NCT01194414|3765684|FG001|24 Weeks Double Blind Period|Other|1
2152691|NCT01194414|3765685|FG002|24 Weeks Double Blind Period|Other|0
2152692|NCT01194414|3765686|FG003|24 Weeks Double Blind Period|Other|0
2152693|NCT01194414|3765683|FG000|24 Weeks Double Blind Period|Adverse Event|28
2152694|NCT01194414|3765684|FG001|24 Weeks Double Blind Period|Adverse Event|40
2152695|NCT01194414|3765685|FG002|24 Weeks Double Blind Period|Adverse Event|0
2152696|NCT01194414|3765686|FG003|24 Weeks Double Blind Period|Adverse Event|0
2152697|NCT01194414|3765683|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
2152698|NCT01194414|3765684|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
2152699|NCT01194414|3765685|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
2152700|NCT01194414|3765686|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
2152701|NCT01194414|3765683|FG000|24 Weeks Double Blind Period|Death|0
2152702|NCT01194414|3765684|FG001|24 Weeks Double Blind Period|Death|1
2152703|NCT01194414|3765685|FG002|24 Weeks Double Blind Period|Death|0
2152704|NCT01194414|3765686|FG003|24 Weeks Double Blind Period|Death|0
2152705|NCT01194414|3765683|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3
2152706|NCT01194414|3765684|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5
2152707|NCT01194414|3765685|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0
2152708|NCT01194414|3765686|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0
2152709|NCT01194414|3765683|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
2152710|NCT01194414|3765684|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
2152711|NCT01194414|3765685|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
2152712|NCT01194414|3765686|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
2152713|NCT01194414|3765683|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
2152714|NCT01194414|3765684|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
2152715|NCT01194414|3765685|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
2152716|NCT01194414|3765686|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
2152717|NCT01194414|3765683|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4
2152718|NCT01194414|3765684|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3
2152719|NCT01194414|3765685|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2
2152720|NCT01194414|3765686|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1
2152721|NCT01194414|3765683|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
2152722|NCT01194414|3765684|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
2152723|NCT01194414|3765685|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
2152724|NCT01194414|3765686|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
2152725|NCT01194414|3765683|FG000|72 Weeks Open Label Extension|Pregnancy|1
2152726|NCT01194414|3765684|FG001|72 Weeks Open Label Extension|Pregnancy|3
2152727|NCT01194414|3765685|FG002|72 Weeks Open Label Extension|Pregnancy|1
2152728|NCT01194414|3765686|FG003|72 Weeks Open Label Extension|Pregnancy|1
2152729|NCT01194414|3765683|FG000|72 Weeks Open Label Extension|Other|2
2152730|NCT01194414|3765684|FG001|72 Weeks Open Label Extension|Other|1
2152731|NCT01194414|3765685|FG002|72 Weeks Open Label Extension|Other|0
2152732|NCT01194414|3765686|FG003|72 Weeks Open Label Extension|Other|0
2152733|NCT01194414|3765683|FG000|72 Weeks Open Label Extension|Protocol Violation|0
2152734|NCT01194414|3765684|FG001|72 Weeks Open Label Extension|Protocol Violation|0
2152735|NCT01194414|3765685|FG002|72 Weeks Open Label Extension|Protocol Violation|0
2152736|NCT01194414|3765686|FG003|72 Weeks Open Label Extension|Protocol Violation|1
2152737|NCT01194414|3765683|FG000|72 Weeks Open Label Extension|Adverse Event|35
2152738|NCT01194414|3765684|FG001|72 Weeks Open Label Extension|Adverse Event|21
2152739|NCT01194414|3765685|FG002|72 Weeks Open Label Extension|Adverse Event|2
2152740|NCT01194414|3765686|FG003|72 Weeks Open Label Extension|Adverse Event|12
2152741|NCT01194414|3765683|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
2152742|NCT01194414|3765684|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
2152743|NCT01194414|3765685|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
2152744|NCT01194414|3765686|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
2152745|NCT01194414|3765683|FG000|72 Weeks Open Label Extension|Death|1
2152746|NCT01194414|3765684|FG001|72 Weeks Open Label Extension|Death|2
2152747|NCT01194414|3765685|FG002|72 Weeks Open Label Extension|Death|0
2152748|NCT01194414|3765686|FG003|72 Weeks Open Label Extension|Death|2
2152749|NCT01194440|3765698|FG000|Baseline (First Dose)|Reason not specified|4
2152750|NCT01194440|3765698|FG000|Baseline (First Dose)|Lack of Efficacy|1
2152751|NCT01194440|3765698|FG000|Baseline (First Dose)|Change in therapy|1
2152752|NCT01194440|3765698|FG000|Baseline (First Dose)|Adverse Event|1
2152753|NCT01194440|3765698|FG000|6-months (2nd Dose)|Change in therapy|4
2152754|NCT01194531|3765739|FG000|Overall Study|Withdrawal by Subject|1
2152755|NCT01194531|3765740|FG001|Overall Study|Withdrawal by Subject|0
2152756|NCT01194531|3765739|FG000|Overall Study|Protocol Violation|4
2152757|NCT01194531|3765740|FG001|Overall Study|Protocol Violation|1
2152758|NCT01194531|3765739|FG000|Overall Study|Physician Decision|0
2152759|NCT01194531|3765740|FG001|Overall Study|Physician Decision|2
2152760|NCT01194804|3765751|FG000|Overall Study|Withdrawal by Subject|1
2152761|NCT01194830|3765757|FG000|Overall Study|Adverse Event|3
2152762|NCT01194830|3765758|FG001|Overall Study|Adverse Event|2
2152763|NCT01194830|3765757|FG000|Overall Study|Protocol Violation|5
2152764|NCT01194830|3765758|FG001|Overall Study|Protocol Violation|4
2208136|NCT01636687|3847527|FG004|Extension Period|Physician Decision|0
2152765|NCT01194830|3765757|FG000|Overall Study|Lost to Follow-up|9
2152766|NCT01194830|3765758|FG001|Overall Study|Lost to Follow-up|7
2152767|NCT01194830|3765757|FG000|Overall Study|Withdrawal by Subject|2
2152768|NCT01194830|3765758|FG001|Overall Study|Withdrawal by Subject|1
2292380|NCT02512302|3985874|FG007|Period 3|Lost to Follow-up|0
2292381|NCT02512302|3985875|FG008|Period 3|Lost to Follow-up|0
2292382|NCT02512302|3985876|FG009|Period 3|Lost to Follow-up|0
2292383|NCT02512302|3985867|FG000|Period 4|Adverse Event|0
2292384|NCT02512302|3985868|FG001|Period 4|Adverse Event|0
2292385|NCT02512302|3985869|FG002|Period 4|Adverse Event|0
2292386|NCT02512302|3985870|FG003|Period 4|Adverse Event|0
2292387|NCT02512302|3985871|FG004|Period 4|Adverse Event|0
2292388|NCT02512302|3985872|FG005|Period 4|Adverse Event|0
2292389|NCT02512302|3985873|FG006|Period 4|Adverse Event|1
2292390|NCT02512302|3985874|FG007|Period 4|Adverse Event|0
2292391|NCT02512302|3985875|FG008|Period 4|Adverse Event|0
2292392|NCT02512302|3985876|FG009|Period 4|Adverse Event|0
2292393|NCT02512861|3985971|FG000|Overall Study|Protocol Violation|3
2292394|NCT02512861|3985972|FG001|Overall Study|Protocol Violation|7
2292395|NCT02512861|3985971|FG000|Overall Study|Physician Decision|3
2292396|NCT02512861|3985972|FG001|Overall Study|Physician Decision|1
2152769|NCT01194830|3765757|FG000|Overall Study|Lack of Efficacy|1
2152770|NCT01194830|3765758|FG001|Overall Study|Lack of Efficacy|1
2152771|NCT01194830|3765757|FG000|Overall Study|Non-compliance issues|4
2152772|NCT01194830|3765758|FG001|Overall Study|Non-compliance issues|4
2152773|NCT01194830|3765757|FG000|Overall Study|Other Reason|12
2152774|NCT01194830|3765758|FG001|Overall Study|Other Reason|8
2152775|NCT01194869|3765764|FG000|Overall Study|Disease Progression|2
2152776|NCT01194869|3765764|FG000|Overall Study|Toxicity|2
2152777|NCT01194973|3765768|FG000|Screening Period|Screen Failure|3
2152778|NCT01194973|3765768|FG000|26 Week Treatment Period|Adverse Event|1
2152779|NCT01194973|3765768|FG000|26 Week Treatment Period|Lack of Efficacy|1
2152780|NCT01194973|3765768|FG000|26 Week Treatment Period|Pregnancy|1
2152781|NCT01194999|3765772|FG000|Overall Study|Lost to Follow-up|17
2152782|NCT01195090|3765788|FG000|Overall Study|Adverse Event|1
2152783|NCT01195090|3765789|FG001|Overall Study|Adverse Event|2
2152784|NCT01195090|3765788|FG000|Overall Study|Lost to Follow-up|2
2152785|NCT01195090|3765789|FG001|Overall Study|Lost to Follow-up|2
2152786|NCT01195090|3765788|FG000|Overall Study|Protocol Violation|3
2152787|NCT01195090|3765789|FG001|Overall Study|Protocol Violation|4
2152788|NCT01195103|3765798|FG000|Overall Study|Withdrawal by Subject|1
2152789|NCT01195103|3765799|FG001|Overall Study|Withdrawal by Subject|0
2152790|NCT01195103|3765800|FG002|Overall Study|Withdrawal by Subject|0
2152791|NCT01195272|3765817|FG000|Overall Study|Adverse Event|1
2152792|NCT01195272|3765817|FG000|Overall Study|Lack of Efficacy|3
2152793|NCT01195363|3765823|FG000|Overall Study|Lost to Follow-up|7
2152794|NCT01195363|3765824|FG001|Overall Study|Lost to Follow-up|4
2152795|NCT01195363|3765823|FG000|Overall Study|Adverse Event|3
2152796|NCT01195363|3765824|FG001|Overall Study|Adverse Event|1
2152797|NCT01195363|3765823|FG000|Overall Study|Lack of Efficacy|0
2152798|NCT01195363|3765824|FG001|Overall Study|Lack of Efficacy|4
2152799|NCT01195363|3765823|FG000|Overall Study|incarceration|1
2152800|NCT01195363|3765824|FG001|Overall Study|incarceration|0
2152801|NCT01195415|3765830|FG000|Overall Study|No repeat biopsy due to progression|2
2152802|NCT01195545|3765838|FG000|Overall Study|Protocol Violation|4
2152803|NCT01195623|3765863|FG000|Overall Study|Lost to Follow-up|35
2152804|NCT01195623|3765864|FG001|Overall Study|Lost to Follow-up|37
2152805|NCT01195636|3765872|FG000|First Intervention (3 Weeks)|Adverse Event|2
2152806|NCT01195636|3765873|FG001|First Intervention (3 Weeks)|Adverse Event|3
2152807|NCT01195636|3765872|FG000|First Intervention (3 Weeks)|Protocol Violation|1
2152808|NCT01195636|3765873|FG001|First Intervention (3 Weeks)|Protocol Violation|0
2152809|NCT01195636|3765872|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
2152810|NCT01195636|3765873|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0
2152811|NCT01195636|3765872|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
2152812|NCT01195636|3765873|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0
2152813|NCT01195636|3765872|FG000|Washout Period (2 Weeks)|Adverse Event|1
2152814|NCT01195636|3765873|FG001|Washout Period (2 Weeks)|Adverse Event|1
2152815|NCT01195636|3765872|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
2152816|NCT01195636|3765873|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
2152817|NCT01195636|3765872|FG000|Second Intervention (3 Weeks)|Adverse Event|1
2152818|NCT01195636|3765873|FG001|Second Intervention (3 Weeks)|Adverse Event|1
2152819|NCT01195636|3765872|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0
2152820|NCT01195636|3765873|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1
2152821|NCT01195662|3765882|FG000|Double Blind Treatment Period|Adverse Event|4
2152822|NCT01195662|3765883|FG001|Double Blind Treatment Period|Adverse Event|1
2152823|NCT01195662|3765884|FG002|Double Blind Treatment Period|Adverse Event|2
2152824|NCT01195662|3765882|FG000|Double Blind Treatment Period|Withdrawal by Subject|6
2152825|NCT01195662|3765883|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
2152826|NCT01195662|3765884|FG002|Double Blind Treatment Period|Withdrawal by Subject|4
2152827|NCT01195662|3765882|FG000|Double Blind Treatment Period|Lost to Follow-up|3
2152828|NCT01195662|3765883|FG001|Double Blind Treatment Period|Lost to Follow-up|2
2152829|NCT01195662|3765884|FG002|Double Blind Treatment Period|Lost to Follow-up|3
2152830|NCT01195662|3765882|FG000|Double Blind Treatment Period|Administrative reason|2
2292397|NCT02512861|3985971|FG000|Overall Study|Withdrawal by Subject|0
2292398|NCT02512861|3985972|FG001|Overall Study|Withdrawal by Subject|1
2292399|NCT02512965|3985994|FG000|Overall Study|Withdrawal by Subject|0
2292400|NCT02512965|3985995|FG001|Overall Study|Withdrawal by Subject|4
2152831|NCT01195662|3765883|FG001|Double Blind Treatment Period|Administrative reason|1
2152832|NCT01195662|3765884|FG002|Double Blind Treatment Period|Administrative reason|1
2152833|NCT01195662|3765882|FG000|Double Blind Treatment Period|Requested discontinue treatment|1
2152834|NCT01195662|3765883|FG001|Double Blind Treatment Period|Requested discontinue treatment|0
2152835|NCT01195662|3765884|FG002|Double Blind Treatment Period|Requested discontinue treatment|1
2152836|NCT01195662|3765882|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1
2152837|NCT01195662|3765883|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5
2152838|NCT01195662|3765884|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2
2152839|NCT01195662|3765882|FG000|Double Blind Treatment Period|Lack of Efficacy|2
2152840|NCT01195662|3765883|FG001|Double Blind Treatment Period|Lack of Efficacy|0
2152841|NCT01195662|3765884|FG002|Double Blind Treatment Period|Lack of Efficacy|0
2152842|NCT01195662|3765882|FG000|Double Blind Treatment Period|Non-specified|3
2152843|NCT01195662|3765883|FG001|Double Blind Treatment Period|Non-specified|0
2152844|NCT01195662|3765884|FG002|Double Blind Treatment Period|Non-specified|0
2152845|NCT01195662|3765882|FG000|Double Blind Treatment Period|Missing disposition information|0
2152846|NCT01195662|3765883|FG001|Double Blind Treatment Period|Missing disposition information|1
2152847|NCT01195662|3765884|FG002|Double Blind Treatment Period|Missing disposition information|1
2152848|NCT01195662|3765882|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
2152849|NCT01195662|3765883|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
2152850|NCT01195662|3765884|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
2152851|NCT01195662|3765882|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
2152852|NCT01195662|3765883|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
2152853|NCT01195662|3765884|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
2292401|NCT02513160|3986025|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
2152854|NCT01195675|3765893|FG000|Overall Study|Adverse Event|1
2152855|NCT01195675|3765893|FG000|Overall Study|Withdrawal by Subject|2
2152856|NCT01195831|3765976|FG000|Overall Study|Lost to Follow-up|2
2152857|NCT01195831|3765977|FG001|Overall Study|Lost to Follow-up|4
2152858|NCT01195831|3765976|FG000|Overall Study|Withdrawal by Subject|2
2152859|NCT01195831|3765977|FG001|Overall Study|Withdrawal by Subject|2
2152860|NCT01195831|3765976|FG000|Overall Study|Adverse Event|4
2152861|NCT01195831|3765977|FG001|Overall Study|Adverse Event|2
2152862|NCT01195831|3765976|FG000|Overall Study|Protocol Violation|0
2152863|NCT01195831|3765977|FG001|Overall Study|Protocol Violation|2
2152864|NCT01195844|3765983|FG000|Overall Study|Fecal sample not collected|40
2179205|NCT01392378|3804661|FG004|After Infant Series|Withdrawal by Parent|1
2179206|NCT01392378|3804657|FG000|Toddler Dose|Lost to Follow-up|0
2179207|NCT01392378|3804658|FG001|Toddler Dose|Lost to Follow-up|0
2179208|NCT01392378|3804659|FG002|Toddler Dose|Lost to Follow-up|0
2179209|NCT01392378|3804660|FG003|Toddler Dose|Lost to Follow-up|1
2179210|NCT01392378|3804661|FG004|Toddler Dose|Lost to Follow-up|0
2179211|NCT01392378|3804657|FG000|Toddler Dose|Withdrawal by Parent|0
2179212|NCT01392378|3804658|FG001|Toddler Dose|Withdrawal by Parent|1
2179213|NCT01392378|3804659|FG002|Toddler Dose|Withdrawal by Parent|0
2179214|NCT01392378|3804660|FG003|Toddler Dose|Withdrawal by Parent|1
2179215|NCT01392378|3804661|FG004|Toddler Dose|Withdrawal by Parent|1
2179216|NCT01392443|3804683|FG000|Overall Study|Disease progression|30
2179217|NCT01392443|3804683|FG000|Overall Study|Adverse Event|24
2179218|NCT01392443|3804683|FG000|Overall Study|Death|7
2179219|NCT01392443|3804683|FG000|Overall Study|Withdrawal by Subject|5
2179220|NCT01392443|3804683|FG000|Overall Study|Lost to Follow-up|1
2292402|NCT02513160|3986026|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
2292403|NCT02513160|3986027|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
2292404|NCT02513160|3986028|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
2292405|NCT02513160|3986025|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
2292406|NCT02513160|3986026|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
2292407|NCT02513160|3986027|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
2292408|NCT02513160|3986028|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
2292409|NCT02513160|3986025|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
2292410|NCT02513160|3986026|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
2292411|NCT02513160|3986027|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
2179221|NCT01392443|3804683|FG000|Overall Study|Protocol Violation|1
2179222|NCT01392469|3804687|FG000|Overall Study|Adverse Event|2
2179223|NCT01392469|3804687|FG000|Overall Study|Withdrawal by Subject|1
2179224|NCT01392469|3804687|FG000|Overall Study|Protocol Violation|1
2179225|NCT01392495|3804702|FG000|Overall Study|Death|3
2179226|NCT01392495|3804702|FG000|Overall Study|Administrative problems|8
2179227|NCT01392495|3804702|FG000|Overall Study|Withdrawal by Subject|2
2179228|NCT01392495|3804702|FG000|Overall Study|Adverse Event|3
2179229|NCT01392547|3804708|FG000|Overall Study|Adverse Event|2
2179230|NCT01392547|3804708|FG000|Overall Study|Non-compliance|2
2179231|NCT01392547|3804708|FG000|Overall Study|Withdrawal criteria|3
2179232|NCT01392547|3804708|FG000|Overall Study|Unclassified|1
2179233|NCT01392560|3804714|FG000|Overall Study|Adverse Event|2
2179234|NCT01392560|3804714|FG000|Overall Study|not entered|8
2179235|NCT01392560|3804714|FG000|Overall Study|discontinued during placebo run-in|2
2179236|NCT01392573|3804722|FG000|Overall Study|Adverse Event|1
2152865|NCT01195948|3766013|FG000|Overall Study|Lost to Follow-up|0
2152866|NCT01195948|3766014|FG001|Overall Study|Lost to Follow-up|1
2152867|NCT01195948|3766015|FG002|Overall Study|Lost to Follow-up|2
2152868|NCT01196026|3766032|FG000|Overall Study|Withdrawal by Subject|1
2152869|NCT01196026|3766033|FG001|Overall Study|Withdrawal by Subject|4
2152870|NCT01196026|3766034|FG002|Overall Study|Withdrawal by Subject|0
2152871|NCT01196026|3766035|FG003|Overall Study|Withdrawal by Subject|0
2152872|NCT01196026|3766036|FG004|Overall Study|Withdrawal by Subject|0
2152873|NCT01196026|3766037|FG005|Overall Study|Withdrawal by Subject|0
2152874|NCT01196026|3766032|FG000|Overall Study|Lost to Follow-up|0
2152875|NCT01196026|3766033|FG001|Overall Study|Lost to Follow-up|3
2152876|NCT01196026|3766034|FG002|Overall Study|Lost to Follow-up|0
2152877|NCT01196026|3766035|FG003|Overall Study|Lost to Follow-up|0
2152878|NCT01196026|3766036|FG004|Overall Study|Lost to Follow-up|1
2152879|NCT01196026|3766037|FG005|Overall Study|Lost to Follow-up|0
2152880|NCT01196026|3766032|FG000|Overall Study|Other|0
2152881|NCT01196026|3766033|FG001|Overall Study|Other|1
2152882|NCT01196026|3766034|FG002|Overall Study|Other|0
2152883|NCT01196026|3766035|FG003|Overall Study|Other|0
2152884|NCT01196026|3766036|FG004|Overall Study|Other|0
2152885|NCT01196026|3766037|FG005|Overall Study|Other|0
2152886|NCT01196052|3766053|FG000|Overall Study|Adverse Event|9
2152887|NCT01196052|3766053|FG000|Overall Study|Lost to Follow-up|1
2152888|NCT01196052|3766053|FG000|Overall Study|Noncompliance to Protocol Requirements|2
2152889|NCT01196052|3766053|FG000|Overall Study|Reason not Specified|5
2152890|NCT01196052|3766053|FG000|Overall Study|Withdrawal by Subject|6
2152891|NCT01196078|3766059|FG000|Overall Study|Withdrawal by Subject|3
2152892|NCT01196078|3766060|FG001|Overall Study|Withdrawal by Subject|5
2152893|NCT01196078|3766059|FG000|Overall Study|Adverse Event|4
2152894|NCT01196078|3766060|FG001|Overall Study|Adverse Event|4
2152895|NCT01196078|3766059|FG000|Overall Study|Protocol Violation|2
2152896|NCT01196078|3766060|FG001|Overall Study|Protocol Violation|1
2152897|NCT01196078|3766059|FG000|Overall Study|Lack of Efficacy|17
2152898|NCT01196078|3766060|FG001|Overall Study|Lack of Efficacy|23
2152899|NCT01196078|3766059|FG000|Overall Study|Lost to Follow-up|1
2152900|NCT01196078|3766060|FG001|Overall Study|Lost to Follow-up|0
2152901|NCT01196078|3766059|FG000|Overall Study|Death|6
2152902|NCT01196078|3766060|FG001|Overall Study|Death|4
2152903|NCT01196091|3766069|FG000|Overall Study|Adverse Event|22
2152904|NCT01196091|3766070|FG001|Overall Study|Adverse Event|27
2152905|NCT01196091|3766071|FG002|Overall Study|Adverse Event|26
2152906|NCT01196091|3766069|FG000|Overall Study|Death|3
2152907|NCT01196091|3766070|FG001|Overall Study|Death|2
2152908|NCT01196091|3766071|FG002|Overall Study|Death|2
2152909|NCT01196091|3766069|FG000|Overall Study|Entry Criteria Not Met|11
2152910|NCT01196091|3766070|FG001|Overall Study|Entry Criteria Not Met|11
2152911|NCT01196091|3766071|FG002|Overall Study|Entry Criteria Not Met|10
2152912|NCT01196091|3766069|FG000|Overall Study|Lack of Efficacy|15
2152913|NCT01196091|3766070|FG001|Overall Study|Lack of Efficacy|12
2152914|NCT01196091|3766071|FG002|Overall Study|Lack of Efficacy|17
2152915|NCT01196091|3766069|FG000|Overall Study|Lost to Follow-up|5
2152916|NCT01196091|3766070|FG001|Overall Study|Lost to Follow-up|5
2152917|NCT01196091|3766071|FG002|Overall Study|Lost to Follow-up|6
2152918|NCT01196091|3766069|FG000|Overall Study|Parent/Caregiver Decision|0
2152919|NCT01196091|3766070|FG001|Overall Study|Parent/Caregiver Decision|0
2152920|NCT01196091|3766071|FG002|Overall Study|Parent/Caregiver Decision|1
2152921|NCT01196091|3766069|FG000|Overall Study|Withdrawal by Subject|16
2152922|NCT01196091|3766070|FG001|Overall Study|Withdrawal by Subject|19
2152923|NCT01196091|3766071|FG002|Overall Study|Withdrawal by Subject|22
2152924|NCT01196091|3766069|FG000|Overall Study|Physician Decision|3
2152925|NCT01196091|3766070|FG001|Overall Study|Physician Decision|3
2152926|NCT01196091|3766071|FG002|Overall Study|Physician Decision|4
2152927|NCT01196091|3766069|FG000|Overall Study|Protocol Violation|1
2152928|NCT01196091|3766070|FG001|Overall Study|Protocol Violation|3
2152929|NCT01196091|3766071|FG002|Overall Study|Protocol Violation|3
2152930|NCT01196091|3766069|FG000|Overall Study|Sponsor Decision|6
2152931|NCT01196091|3766070|FG001|Overall Study|Sponsor Decision|5
2152932|NCT01196091|3766071|FG002|Overall Study|Sponsor Decision|4
2152933|NCT01196091|3766069|FG000|Overall Study|Excluded Site|5
2152934|NCT01196091|3766070|FG001|Overall Study|Excluded Site|11
2152935|NCT01196091|3766071|FG002|Overall Study|Excluded Site|8
2152936|NCT01196091|3766069|FG000|Overall Study|Randomized, No Study Drug Received|1
2152937|NCT01196091|3766070|FG001|Overall Study|Randomized, No Study Drug Received|0
2152938|NCT01196091|3766071|FG002|Overall Study|Randomized, No Study Drug Received|1
2152939|NCT01196104|3766086|FG000|Overall Study|Lost to Follow-up|1
2152940|NCT01196104|3766087|FG001|Overall Study|Lost to Follow-up|0
2152941|NCT01196104|3766086|FG000|Overall Study|Physician Decision|0
2152942|NCT01196104|3766087|FG001|Overall Study|Physician Decision|1
2152943|NCT01196104|3766086|FG000|Overall Study|Withdrawal by Subject|3
2152944|NCT01196104|3766087|FG001|Overall Study|Withdrawal by Subject|3
2152945|NCT01196104|3766086|FG000|Overall Study|Various|0
2152946|NCT01196104|3766087|FG001|Overall Study|Various|1
2152947|NCT01196416|3766123|FG000|Overall Study|Withdrawal by Subject|2
2152948|NCT01196429|3766129|FG000|Overall Study|Ineligible - inadequate pathology|1
2152949|NCT01196429|3766130|FG001|Overall Study|Ineligible - inadequate pathology|0
2152950|NCT01196429|3766129|FG000|Overall Study|Ineligible - wrong cell type|1
2152951|NCT01196429|3766130|FG001|Overall Study|Ineligible - wrong cell type|0
2152952|NCT01196429|3766129|FG000|Overall Study|Refused - Never Treated|1
2152953|NCT01196429|3766130|FG001|Overall Study|Refused - Never Treated|0
2292412|NCT02513160|3986028|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
2292413|NCT02513160|3986025|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4
2292414|NCT02513160|3986026|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0
2292415|NCT02513160|3986027|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0
2292416|NCT02513160|3986028|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0
2292417|NCT02513160|3986025|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
2292418|NCT02513160|3986026|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
2292419|NCT02513160|3986027|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
2292420|NCT02513160|3986028|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
2292421|NCT02513160|3986025|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
2292422|NCT02513160|3986026|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
2292423|NCT02513160|3986027|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
2292424|NCT02513160|3986028|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
2292425|NCT02513160|3986025|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
2152954|NCT01196741|3766149|FG000|Overall Study|Disease progression|34
2152955|NCT01196741|3766150|FG001|Overall Study|Disease progression|14
2152956|NCT01196741|3766149|FG000|Overall Study|Adverse Event|10
2152957|NCT01196741|3766150|FG001|Overall Study|Adverse Event|6
2152958|NCT01196741|3766149|FG000|Overall Study|Serious Adverse Event|3
2152959|NCT01196741|3766150|FG001|Overall Study|Serious Adverse Event|1
2152960|NCT01196741|3766149|FG000|Overall Study|Dose limiting Adverse Event|2
2152961|NCT01196741|3766150|FG001|Overall Study|Dose limiting Adverse Event|1
2152962|NCT01196741|3766149|FG000|Overall Study|Withdrawal by Subject|3
2152963|NCT01196741|3766150|FG001|Overall Study|Withdrawal by Subject|0
2152964|NCT01196741|3766149|FG000|Overall Study|Other reason|3
2152965|NCT01196741|3766150|FG001|Overall Study|Other reason|3
2152966|NCT01196741|3766149|FG000|Overall Study|Other|3
2152967|NCT01196741|3766150|FG001|Overall Study|Other|2
2152968|NCT01196741|3766149|FG000|Overall Study|Protocol Violation|2
2152969|NCT01196741|3766150|FG001|Overall Study|Protocol Violation|1
2152970|NCT01196975|3766221|FG000|Overall Study|Adverse Event|2
2152971|NCT01196975|3766222|FG001|Overall Study|Adverse Event|2
2152972|NCT01196975|3766223|FG002|Overall Study|Adverse Event|0
2152973|NCT01196975|3766224|FG003|Overall Study|Adverse Event|0
2152974|NCT01196975|3766225|FG004|Overall Study|Adverse Event|2
2152975|NCT01196975|3766221|FG000|Overall Study|Withdrawal by Subject|2
2152976|NCT01196975|3766222|FG001|Overall Study|Withdrawal by Subject|1
2152977|NCT01196975|3766223|FG002|Overall Study|Withdrawal by Subject|0
2152978|NCT01196975|3766224|FG003|Overall Study|Withdrawal by Subject|1
2152979|NCT01196975|3766225|FG004|Overall Study|Withdrawal by Subject|0
2152980|NCT01196975|3766221|FG000|Overall Study|Lost to Follow-up|11
2152981|NCT01196975|3766222|FG001|Overall Study|Lost to Follow-up|6
2152982|NCT01196975|3766223|FG002|Overall Study|Lost to Follow-up|5
2152983|NCT01196975|3766224|FG003|Overall Study|Lost to Follow-up|5
2152984|NCT01196975|3766225|FG004|Overall Study|Lost to Follow-up|11
2152985|NCT01196988|3766264|FG000|Overall Study|Adverse Event|1
2152986|NCT01196988|3766265|FG001|Overall Study|Adverse Event|2
2152987|NCT01196988|3766266|FG002|Overall Study|Adverse Event|0
2152988|NCT01196988|3766267|FG003|Overall Study|Adverse Event|0
2152989|NCT01196988|3766264|FG000|Overall Study|Withdrawal by Subject|5
2152990|NCT01196988|3766265|FG001|Overall Study|Withdrawal by Subject|1
2152991|NCT01196988|3766266|FG002|Overall Study|Withdrawal by Subject|4
2152992|NCT01196988|3766267|FG003|Overall Study|Withdrawal by Subject|0
2152993|NCT01196988|3766264|FG000|Overall Study|Lost to Follow-up|16
2152994|NCT01196988|3766265|FG001|Overall Study|Lost to Follow-up|29
2152995|NCT01196988|3766266|FG002|Overall Study|Lost to Follow-up|21
2152996|NCT01196988|3766267|FG003|Overall Study|Lost to Follow-up|1
2152997|NCT01196988|3766264|FG000|Overall Study|Other|2
2152998|NCT01196988|3766265|FG001|Overall Study|Other|0
2152999|NCT01196988|3766266|FG002|Overall Study|Other|0
2153000|NCT01196988|3766267|FG003|Overall Study|Other|0
2153001|NCT01197300|3766280|FG000|Overall Study|Lost to Follow-up|0
2153002|NCT01197300|3766281|FG001|Overall Study|Lost to Follow-up|1
2153003|NCT01197300|3766280|FG000|Overall Study|Protocol Violation|0
2153004|NCT01197300|3766281|FG001|Overall Study|Protocol Violation|1
2153005|NCT01197378|3766298|FG000|Overall Study|Adverse Event|3
2153006|NCT01197378|3766298|FG000|Overall Study|Withdrawal by Subject|1
2153007|NCT01197378|3766298|FG000|Overall Study|Physician Decision|1
2153008|NCT01197378|3766298|FG000|Overall Study|Other|2
2153009|NCT01197417|3766304|FG000|Overall Study|Physician Decision|3
2153010|NCT01197417|3766305|FG001|Overall Study|Physician Decision|2
2153011|NCT01197417|3766304|FG000|Overall Study|Withdrawal by Subject|2
2153012|NCT01197417|3766305|FG001|Overall Study|Withdrawal by Subject|4
2153013|NCT01197417|3766304|FG000|Overall Study|Site miscommunication|0
2153014|NCT01197417|3766305|FG001|Overall Study|Site miscommunication|1
2153015|NCT01197417|3766304|FG000|Overall Study|Subject transferred to intensive care|0
2153016|NCT01197417|3766305|FG001|Overall Study|Subject transferred to intensive care|1
2153017|NCT01197417|3766304|FG000|Overall Study|Not consented in time to receive drug|0
2153018|NCT01197417|3766305|FG001|Overall Study|Not consented in time to receive drug|1
2153019|NCT01197417|3766304|FG000|Overall Study|Hypotension|1
2153020|NCT01197417|3766305|FG001|Overall Study|Hypotension|2
2153021|NCT01197417|3766304|FG000|Overall Study|Found to be ineligible|2
2153022|NCT01197417|3766305|FG001|Overall Study|Found to be ineligible|5
2153023|NCT01197417|3766304|FG000|Overall Study|No 25-hour magnesium level|0
2153024|NCT01197417|3766305|FG001|Overall Study|No 25-hour magnesium level|2
2153025|NCT01197508|3766333|FG000|Overall Study|Withdrawal by Subject|8
2153026|NCT01197508|3766334|FG001|Overall Study|Withdrawal by Subject|7
2153027|NCT01197508|3766335|FG002|Overall Study|Withdrawal by Subject|15
2153028|NCT01197508|3766336|FG003|Overall Study|Withdrawal by Subject|4
2153029|NCT01197508|3766333|FG000|Overall Study|Eligiblity criteria not fulfilled|0
2153030|NCT01197508|3766334|FG001|Overall Study|Eligiblity criteria not fulfilled|0
2153031|NCT01197508|3766335|FG002|Overall Study|Eligiblity criteria not fulfilled|2
2153032|NCT01197508|3766336|FG003|Overall Study|Eligiblity criteria not fulfilled|0
2153033|NCT01197508|3766333|FG000|Overall Study|Adverse Event|10
2153034|NCT01197508|3766334|FG001|Overall Study|Adverse Event|13
2153035|NCT01197508|3766335|FG002|Overall Study|Adverse Event|23
2153036|NCT01197508|3766336|FG003|Overall Study|Adverse Event|3
2153037|NCT01197508|3766333|FG000|Overall Study|Severe non-compliance to protocol|0
2153038|NCT01197508|3766334|FG001|Overall Study|Severe non-compliance to protocol|3
2153039|NCT01197508|3766335|FG002|Overall Study|Severe non-compliance to protocol|1
2153040|NCT01197508|3766336|FG003|Overall Study|Severe non-compliance to protocol|3
2153041|NCT01197508|3766333|FG000|Overall Study|Condition under investigation worsened|1
2153042|NCT01197508|3766334|FG001|Overall Study|Condition under investigation worsened|1
2153043|NCT01197508|3766335|FG002|Overall Study|Condition under investigation worsened|1
2153044|NCT01197508|3766336|FG003|Overall Study|Condition under investigation worsened|1
2153045|NCT01197508|3766333|FG000|Overall Study|Lack of Efficacy|1
2153046|NCT01197508|3766334|FG001|Overall Study|Lack of Efficacy|2
2153047|NCT01197508|3766335|FG002|Overall Study|Lack of Efficacy|2
2153048|NCT01197508|3766336|FG003|Overall Study|Lack of Efficacy|1
2153049|NCT01197508|3766333|FG000|Overall Study|Study-specific withdrawal criteria|0
2153050|NCT01197508|3766334|FG001|Overall Study|Study-specific withdrawal criteria|0
2153051|NCT01197508|3766335|FG002|Overall Study|Study-specific withdrawal criteria|1
2153052|NCT01197508|3766336|FG003|Overall Study|Study-specific withdrawal criteria|2
2153053|NCT01197508|3766333|FG000|Overall Study|Lost to Follow-up|1
2153054|NCT01197508|3766334|FG001|Overall Study|Lost to Follow-up|1
2153055|NCT01197508|3766335|FG002|Overall Study|Lost to Follow-up|2
2153056|NCT01197508|3766336|FG003|Overall Study|Lost to Follow-up|0
2153057|NCT01197508|3766333|FG000|Overall Study|Other|2
2153058|NCT01197508|3766334|FG001|Overall Study|Other|3
2153059|NCT01197508|3766335|FG002|Overall Study|Other|2
2153060|NCT01197508|3766336|FG003|Overall Study|Other|2
2153061|NCT01197521|3766349|FG000|Overall Study|Not reported|24
2153062|NCT01197521|3766350|FG001|Overall Study|Not reported|25
2153063|NCT01197521|3766351|FG002|Overall Study|Not reported|21
2153064|NCT01197521|3766349|FG000|Overall Study|Enrolment in long term extension|42
2153065|NCT01197521|3766350|FG001|Overall Study|Enrolment in long term extension|36
2153066|NCT01197521|3766351|FG002|Overall Study|Enrolment in long term extension|87
2153067|NCT01197521|3766349|FG000|Overall Study|Severe non-compliance to protocol|1
2153068|NCT01197521|3766350|FG001|Overall Study|Severe non-compliance to protocol|3
2153069|NCT01197521|3766351|FG002|Overall Study|Severe non-compliance to protocol|3
2153070|NCT01197521|3766349|FG000|Overall Study|Lack of therapeutic response|2
2153071|NCT01197521|3766350|FG001|Overall Study|Lack of therapeutic response|3
2153072|NCT01197521|3766351|FG002|Overall Study|Lack of therapeutic response|4
2153073|NCT01197521|3766349|FG000|Overall Study|Dev. of study specific discont. criteria|6
2153074|NCT01197521|3766350|FG001|Overall Study|Dev. of study specific discont. criteria|16
2153075|NCT01197521|3766351|FG002|Overall Study|Dev. of study specific discont. criteria|2
2153076|NCT01197521|3766349|FG000|Overall Study|Lost to Follow-up|3
2153077|NCT01197521|3766350|FG001|Overall Study|Lost to Follow-up|2
2153078|NCT01197521|3766351|FG002|Overall Study|Lost to Follow-up|2
2153079|NCT01197521|3766349|FG000|Overall Study|Adverse Event|25
2153080|NCT01197521|3766350|FG001|Overall Study|Adverse Event|28
2153081|NCT01197521|3766351|FG002|Overall Study|Adverse Event|24
2153082|NCT01197534|3766365|FG000|Overall Study|Not reported|16
2153083|NCT01197534|3766366|FG001|Overall Study|Not reported|10
2153084|NCT01197534|3766367|FG002|Overall Study|Not reported|16
2153085|NCT01197534|3766365|FG000|Overall Study|Enrolment in long term extension|57
2153086|NCT01197534|3766366|FG001|Overall Study|Enrolment in long term extension|66
2153087|NCT01197534|3766367|FG002|Overall Study|Enrolment in long term extension|119
2153088|NCT01197534|3766365|FG000|Overall Study|Severe non-compliance to protocol|3
2153089|NCT01197534|3766366|FG001|Overall Study|Severe non-compliance to protocol|4
2153090|NCT01197534|3766367|FG002|Overall Study|Severe non-compliance to protocol|1
2153091|NCT01197534|3766365|FG000|Overall Study|Lack of therapeutic response|9
2153092|NCT01197534|3766366|FG001|Overall Study|Lack of therapeutic response|4
2153093|NCT01197534|3766367|FG002|Overall Study|Lack of therapeutic response|9
2153094|NCT01197534|3766365|FG000|Overall Study|Dev. of study specific discont. criteria|13
2153095|NCT01197534|3766366|FG001|Overall Study|Dev. of study specific discont. criteria|6
2153096|NCT01197534|3766367|FG002|Overall Study|Dev. of study specific discont. criteria|2
2153097|NCT01197534|3766365|FG000|Overall Study|Lost to Follow-up|1
2153098|NCT01197534|3766366|FG001|Overall Study|Lost to Follow-up|4
2153099|NCT01197534|3766367|FG002|Overall Study|Lost to Follow-up|2
2153100|NCT01197534|3766365|FG000|Overall Study|Adverse Event|35
2153101|NCT01197534|3766366|FG001|Overall Study|Adverse Event|36
2153102|NCT01197534|3766367|FG002|Overall Study|Adverse Event|24
2153103|NCT01197560|3766384|FG000|Overall Study|Adverse Event|6
2153104|NCT01197560|3766385|FG001|Overall Study|Adverse Event|8
2153105|NCT01197560|3766384|FG000|Overall Study|Death|3
2153106|NCT01197560|3766385|FG001|Overall Study|Death|5
2153107|NCT01197560|3766384|FG000|Overall Study|Withdrawal by Subject|1
2153108|NCT01197560|3766385|FG001|Overall Study|Withdrawal by Subject|1
2153109|NCT01197560|3766384|FG000|Overall Study|Disease progression|40
2153110|NCT01197560|3766385|FG001|Overall Study|Disease progression|35
2153111|NCT01197560|3766384|FG000|Overall Study|Miscellaneous|4
2153112|NCT01197560|3766385|FG001|Overall Study|Miscellaneous|3
2153113|NCT01197560|3766384|FG000|Overall Study|Missing|0
2153114|NCT01197560|3766385|FG001|Overall Study|Missing|1
2153115|NCT01197755|3766419|FG000|Overall Study|Adverse Event|8
2153116|NCT01197755|3766420|FG001|Overall Study|Adverse Event|10
2153117|NCT01197755|3766421|FG002|Overall Study|Adverse Event|10
2153118|NCT01197755|3766419|FG000|Overall Study|Study-specific discontinuation criteria|2
2153119|NCT01197755|3766420|FG001|Overall Study|Study-specific discontinuation criteria|1
2153120|NCT01197755|3766421|FG002|Overall Study|Study-specific discontinuation criteria|0
2153121|NCT01197755|3766419|FG000|Overall Study|Entered the long-term extension study|18
2153122|NCT01197755|3766420|FG001|Overall Study|Entered the long-term extension study|21
2153123|NCT01197755|3766421|FG002|Overall Study|Entered the long-term extension study|35
2153124|NCT01197755|3766419|FG000|Overall Study|Lack of therapeutic response|0
2153125|NCT01197755|3766420|FG001|Overall Study|Lack of therapeutic response|7
2153126|NCT01197755|3766421|FG002|Overall Study|Lack of therapeutic response|4
2153127|NCT01197755|3766419|FG000|Overall Study|Severe non-compliance to the protocol|2
2153128|NCT01197755|3766420|FG001|Overall Study|Severe non-compliance to the protocol|1
2153129|NCT01197755|3766421|FG002|Overall Study|Severe non-compliance to the protocol|2
2153130|NCT01197755|3766419|FG000|Overall Study|Withdrawal by Subject|1
2153131|NCT01197755|3766420|FG001|Overall Study|Withdrawal by Subject|0
2153132|NCT01197755|3766421|FG002|Overall Study|Withdrawal by Subject|0
2153133|NCT01197755|3766419|FG000|Overall Study|Lost to Follow-up|0
2153134|NCT01197755|3766420|FG001|Overall Study|Lost to Follow-up|0
2153135|NCT01197755|3766421|FG002|Overall Study|Lost to Follow-up|1
2153136|NCT01197755|3766419|FG000|Overall Study|eg, change in circumstances|7
2153137|NCT01197755|3766420|FG001|Overall Study|eg, change in circumstances|3
2153138|NCT01197755|3766421|FG002|Overall Study|eg, change in circumstances|2
2153139|NCT01197794|3766438|FG000|Overall Study|Adverse Event|3
2153140|NCT01197794|3766439|FG001|Overall Study|Adverse Event|2
2153141|NCT01197794|3766440|FG002|Overall Study|Adverse Event|4
2153142|NCT01197794|3766441|FG003|Overall Study|Adverse Event|4
2153143|NCT01197794|3766442|FG004|Overall Study|Adverse Event|4
2153144|NCT01197794|3766443|FG005|Overall Study|Adverse Event|2
2153145|NCT01197794|3766444|FG006|Overall Study|Adverse Event|3
2153146|NCT01197794|3766438|FG000|Overall Study|Protocol Violation|0
2153147|NCT01197794|3766439|FG001|Overall Study|Protocol Violation|0
2153148|NCT01197794|3766440|FG002|Overall Study|Protocol Violation|0
2153149|NCT01197794|3766441|FG003|Overall Study|Protocol Violation|0
2153150|NCT01197794|3766442|FG004|Overall Study|Protocol Violation|2
2153151|NCT01197794|3766443|FG005|Overall Study|Protocol Violation|0
2153152|NCT01197794|3766444|FG006|Overall Study|Protocol Violation|1
2153153|NCT01197794|3766438|FG000|Overall Study|Development of study withdrawal criteria|3
2153154|NCT01197794|3766439|FG001|Overall Study|Development of study withdrawal criteria|0
2153155|NCT01197794|3766440|FG002|Overall Study|Development of study withdrawal criteria|0
2153156|NCT01197794|3766441|FG003|Overall Study|Development of study withdrawal criteria|1
2153157|NCT01197794|3766442|FG004|Overall Study|Development of study withdrawal criteria|0
2153158|NCT01197794|3766443|FG005|Overall Study|Development of study withdrawal criteria|0
2153159|NCT01197794|3766444|FG006|Overall Study|Development of study withdrawal criteria|1
2153160|NCT01197794|3766438|FG000|Overall Study|Eligibility criteria not fulfilled|5
2153161|NCT01197794|3766439|FG001|Overall Study|Eligibility criteria not fulfilled|8
2153162|NCT01197794|3766440|FG002|Overall Study|Eligibility criteria not fulfilled|2
2153163|NCT01197794|3766441|FG003|Overall Study|Eligibility criteria not fulfilled|5
2153164|NCT01197794|3766442|FG004|Overall Study|Eligibility criteria not fulfilled|5
2153165|NCT01197794|3766443|FG005|Overall Study|Eligibility criteria not fulfilled|9
2153166|NCT01197794|3766444|FG006|Overall Study|Eligibility criteria not fulfilled|6
2153167|NCT01197794|3766438|FG000|Overall Study|Withdrawal by Subject|3
2153168|NCT01197794|3766439|FG001|Overall Study|Withdrawal by Subject|3
2153169|NCT01197794|3766440|FG002|Overall Study|Withdrawal by Subject|4
2153170|NCT01197794|3766441|FG003|Overall Study|Withdrawal by Subject|1
2153171|NCT01197794|3766442|FG004|Overall Study|Withdrawal by Subject|1
2153172|NCT01197794|3766443|FG005|Overall Study|Withdrawal by Subject|5
2153173|NCT01197794|3766444|FG006|Overall Study|Withdrawal by Subject|6
2153174|NCT01197794|3766438|FG000|Overall Study|Lost to Follow-up|1
2153175|NCT01197794|3766439|FG001|Overall Study|Lost to Follow-up|1
2153176|NCT01197794|3766440|FG002|Overall Study|Lost to Follow-up|0
2153177|NCT01197794|3766441|FG003|Overall Study|Lost to Follow-up|1
2153178|NCT01197794|3766442|FG004|Overall Study|Lost to Follow-up|0
2153179|NCT01197794|3766443|FG005|Overall Study|Lost to Follow-up|1
2153180|NCT01197794|3766444|FG006|Overall Study|Lost to Follow-up|0
2153181|NCT01197794|3766438|FG000|Overall Study|Other|1
2153182|NCT01197794|3766439|FG001|Overall Study|Other|1
2153183|NCT01197794|3766440|FG002|Overall Study|Other|3
2153184|NCT01197794|3766441|FG003|Overall Study|Other|0
2153185|NCT01197794|3766442|FG004|Overall Study|Other|2
2153186|NCT01197794|3766443|FG005|Overall Study|Other|2
2153187|NCT01197794|3766444|FG006|Overall Study|Other|4
2153188|NCT01197911|3766486|FG000|Overall Study|Adverse Event|0
2153189|NCT01197911|3766487|FG001|Overall Study|Adverse Event|0
2153190|NCT01197911|3766488|FG002|Overall Study|Adverse Event|1
2153191|NCT01198002|3766500|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
2153192|NCT01198002|3766501|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
2153193|NCT01198002|3766502|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
2153194|NCT01198002|3766500|FG000|Treatment Period 1 (Weeks 0-52)|Death|2
2153195|NCT01198002|3766501|FG001|Treatment Period 1 (Weeks 0-52)|Death|0
2153196|NCT01198002|3766502|FG002|Treatment Period 1 (Weeks 0-52)|Death|1
2153197|NCT01198002|3766500|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
2153198|NCT01198002|3766501|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
2153199|NCT01198002|3766502|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
2153200|NCT01198002|3766500|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
2153201|NCT01198002|3766501|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
2153202|NCT01198002|3766502|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
2153203|NCT01198002|3766500|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
2153204|NCT01198002|3766501|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
2153205|NCT01198002|3766502|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
2153206|NCT01198002|3766500|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
2153207|NCT01198002|3766501|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
2153208|NCT01198002|3766502|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
2153209|NCT01198002|3766500|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
2153210|NCT01198002|3766501|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
2153211|NCT01198002|3766502|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
2153212|NCT01198002|3766500|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
2153213|NCT01198002|3766501|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
2153214|NCT01198002|3766502|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
2153215|NCT01198002|3766500|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
2153216|NCT01198002|3766501|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
2153217|NCT01198002|3766502|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
2153218|NCT01198002|3766500|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
2153219|NCT01198002|3766501|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
2153220|NCT01198002|3766502|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
2153221|NCT01198002|3766500|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
2153222|NCT01198002|3766501|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
2153223|NCT01198002|3766502|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
2153224|NCT01198002|3766500|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
2153225|NCT01198002|3766501|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
2153226|NCT01198002|3766502|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
2153227|NCT01198002|3766500|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
2153228|NCT01198002|3766501|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
2153229|NCT01198002|3766502|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
2153230|NCT01198002|3766500|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
2153231|NCT01198002|3766501|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
2153232|NCT01198002|3766502|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
2153233|NCT01198002|3766500|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
2153234|NCT01198002|3766501|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
2153235|NCT01198002|3766502|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
2153236|NCT01198028|3766532|FG000|Overall Study|Adverse Event|5
2153237|NCT01198028|3766532|FG000|Overall Study|Death|3
2153238|NCT01198028|3766532|FG000|Overall Study|Physician Decision|2
2153239|NCT01198132|3766538|FG000|Overall Study|Withdrawal by Subject|4
2153240|NCT01198132|3766539|FG001|Overall Study|Withdrawal by Subject|5
2292426|NCT02513160|3986026|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
2292427|NCT02513160|3986027|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
2292428|NCT02513160|3986028|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
2292429|NCT02513160|3986025|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
2292430|NCT02513160|3986026|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
2292431|NCT02513160|3986027|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
2292432|NCT02513160|3986028|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
2292433|NCT02513160|3986025|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1
2292434|NCT02513160|3986026|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0
2292435|NCT02513160|3986027|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0
2292436|NCT02513160|3986028|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0
2292437|NCT02513160|3986025|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
2292438|NCT02513160|3986026|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
2292439|NCT02513160|3986027|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
2153241|NCT01198132|3766538|FG000|Overall Study|Physician Decision|5
2153242|NCT01198132|3766539|FG001|Overall Study|Physician Decision|4
2153243|NCT01198132|3766538|FG000|Overall Study|Other Unspecified|3
2153244|NCT01198132|3766539|FG001|Overall Study|Other Unspecified|6
2153245|NCT01198132|3766538|FG000|Overall Study|Lack of Efficacy|2
2153246|NCT01198132|3766539|FG001|Overall Study|Lack of Efficacy|3
2153247|NCT01198132|3766538|FG000|Overall Study|Sign/symptoms of underlying disease|2
2153248|NCT01198132|3766539|FG001|Overall Study|Sign/symptoms of underlying disease|1
2153249|NCT01198132|3766538|FG000|Overall Study|Abnormal/clinically significant biologic|1
2153250|NCT01198132|3766539|FG001|Overall Study|Abnormal/clinically significant biologic|1
2153251|NCT01198132|3766538|FG000|Overall Study|Adverse Event|0
2153252|NCT01198132|3766539|FG001|Overall Study|Adverse Event|1
2153253|NCT01198132|3766538|FG000|Overall Study|Protocol Violation|1
2153254|NCT01198132|3766539|FG001|Overall Study|Protocol Violation|0
2153255|NCT01198145|3766549|FG000|Overall Study|Withdrawal by Subject|1
2153256|NCT01198145|3766550|FG001|Overall Study|Withdrawal by Subject|1
2153257|NCT01198275|3766568|FG000|Overall Study|Adverse Event|2
2153258|NCT01198275|3766569|FG001|Overall Study|Adverse Event|3
2153259|NCT01198275|3766568|FG000|Overall Study|spontaneous return to sinus rhythm|4
2153260|NCT01198275|3766569|FG001|Overall Study|spontaneous return to sinus rhythm|2
2153261|NCT01198470|3766607|FG000|Overall Study|Adverse Event|2
2153262|NCT01198509|3766617|FG000|Overall Study|Withdrawal by Subject|1
2153263|NCT01198509|3766618|FG001|Overall Study|Withdrawal by Subject|0
2153264|NCT01198509|3766619|FG002|Overall Study|Withdrawal by Subject|0
2153265|NCT01198509|3766620|FG003|Overall Study|Withdrawal by Subject|0
2153266|NCT01198509|3766621|FG004|Overall Study|Withdrawal by Subject|0
2153267|NCT01198509|3766622|FG005|Overall Study|Withdrawal by Subject|0
2153268|NCT01198574|3766638|FG000|Overall Study|Resigned from schools|4
2153269|NCT01198574|3766639|FG001|Overall Study|Resigned from schools|1
2153270|NCT01198574|3766640|FG002|Overall Study|Resigned from schools|1
2153271|NCT01198574|3766641|FG003|Overall Study|Resigned from schools|4
2153272|NCT01198587|3766655|FG000|Overall Study|Lost to Follow-up|8
2153273|NCT01198587|3766656|FG001|Overall Study|Lost to Follow-up|0
2153274|NCT01198587|3766657|FG002|Overall Study|Lost to Follow-up|9
2153275|NCT01198587|3766658|FG003|Overall Study|Lost to Follow-up|0
2153276|NCT01198600|3766673|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
2153277|NCT01198600|3766674|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
2153278|NCT01198600|3766675|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
2153279|NCT01198600|3766676|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
2153280|NCT01198600|3766673|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
2153281|NCT01198600|3766674|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
2153282|NCT01198600|3766675|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
2153283|NCT01198600|3766676|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
2153284|NCT01198600|3766673|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
2153285|NCT01198600|3766674|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
2153286|NCT01198600|3766675|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
2153287|NCT01198600|3766676|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
2153288|NCT01198600|3766673|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
2153289|NCT01198600|3766674|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
2153290|NCT01198600|3766675|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
2153291|NCT01198600|3766676|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
2153292|NCT01198600|3766673|FG000|Phase 2: 56 Days of Wear|Inconvenience|0
2153293|NCT01198600|3766674|FG001|Phase 2: 56 Days of Wear|Inconvenience|0
2153294|NCT01198600|3766675|FG002|Phase 2: 56 Days of Wear|Inconvenience|2
2153295|NCT01198600|3766676|FG003|Phase 2: 56 Days of Wear|Inconvenience|0
2153296|NCT01198600|3766673|FG000|Phase 2: 56 Days of Wear|Relocation|0
2153297|NCT01198600|3766674|FG001|Phase 2: 56 Days of Wear|Relocation|0
2153298|NCT01198600|3766675|FG002|Phase 2: 56 Days of Wear|Relocation|2
2153299|NCT01198600|3766676|FG003|Phase 2: 56 Days of Wear|Relocation|0
2153300|NCT01198600|3766673|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
2153301|NCT01198600|3766674|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
2153302|NCT01198600|3766675|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
2153303|NCT01198600|3766676|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
2153304|NCT01198756|3766697|FG000|Overall Study|Adverse Event|0
2153305|NCT01198756|3766698|FG001|Overall Study|Adverse Event|0
2153306|NCT01198756|3766699|FG002|Overall Study|Adverse Event|0
2153307|NCT01198756|3766700|FG003|Overall Study|Adverse Event|1
2153308|NCT01198756|3766697|FG000|Overall Study|Protocol Violation|0
2153309|NCT01198756|3766698|FG001|Overall Study|Protocol Violation|0
2153310|NCT01198756|3766699|FG002|Overall Study|Protocol Violation|0
2153311|NCT01198756|3766700|FG003|Overall Study|Protocol Violation|2
2153312|NCT01198756|3766697|FG000|Overall Study|Withdrawal by Subject|9
2153313|NCT01198756|3766698|FG001|Overall Study|Withdrawal by Subject|4
2153314|NCT01198756|3766699|FG002|Overall Study|Withdrawal by Subject|7
2153315|NCT01198756|3766700|FG003|Overall Study|Withdrawal by Subject|5
2153316|NCT01198756|3766697|FG000|Overall Study|Lost to Follow-up|29
2153317|NCT01198756|3766698|FG001|Overall Study|Lost to Follow-up|36
2153318|NCT01198756|3766699|FG002|Overall Study|Lost to Follow-up|23
2153319|NCT01198756|3766700|FG003|Overall Study|Lost to Follow-up|18
2153320|NCT01198795|3766721|FG000|Overall Study|Did not meet InclusionExclusion criteria|30
2153321|NCT01198795|3766721|FG000|Overall Study|Withdrawal by Subject|17
2153322|NCT01198795|3766721|FG000|Overall Study|Lost to Follow-up|15
2153323|NCT01198795|3766721|FG000|Overall Study|Adverse Event|9
2153324|NCT01198795|3766721|FG000|Overall Study|Lack of Efficacy|5
2153325|NCT01198795|3766721|FG000|Overall Study|Protocol Violation|2
2153326|NCT01198795|3766721|FG000|Overall Study|Other Reason|4
2153327|NCT01198873|3766727|FG000|Overall Study|Adverse Event|4
2153328|NCT01198873|3766728|FG001|Overall Study|Adverse Event|7
2153329|NCT01198873|3766727|FG000|Overall Study|Study closure|29
2153330|NCT01198873|3766728|FG001|Overall Study|Study closure|23
2153331|NCT01198873|3766727|FG000|Overall Study|Other than above|4
2153332|NCT01198873|3766728|FG001|Overall Study|Other than above|2
2153333|NCT01198977|3766736|FG000|Overall Study|Lost to Follow-up|1
2153334|NCT01198977|3766737|FG001|Overall Study|Lost to Follow-up|0
2153335|NCT01199016|3766745|FG000|Overall Study|No longer meets eligibility criteria|4
2153336|NCT01199016|3766745|FG000|Overall Study|Entrance criteria|5
2153337|NCT01199016|3766745|FG000|Overall Study|Protocol Violation|9
2153338|NCT01199016|3766745|FG000|Overall Study|Other|13
2153339|NCT01199016|3766745|FG000|Overall Study|Withdrawal by Subject|21
2153340|NCT01199016|3766745|FG000|Overall Study|Lost to Follow-up|25
2153341|NCT01199042|3766749|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
2153342|NCT01199042|3766749|FG000|At Home (3 Months)|Lost to Follow-up|1
2153343|NCT01199055|3766761|FG000|Overall Study|Death|0
2153344|NCT01199055|3766762|FG001|Overall Study|Death|1
2153345|NCT01199055|3766763|FG002|Overall Study|Death|0
2153346|NCT01199055|3766761|FG000|Overall Study|Physician Decision|0
2153347|NCT01199055|3766762|FG001|Overall Study|Physician Decision|1
2153348|NCT01199055|3766763|FG002|Overall Study|Physician Decision|1
2153349|NCT01199055|3766761|FG000|Overall Study|Progressive disease|2
2153350|NCT01199055|3766762|FG001|Overall Study|Progressive disease|1
2153351|NCT01199055|3766763|FG002|Overall Study|Progressive disease|2
2153352|NCT01199055|3766761|FG000|Overall Study|Withdrawal by Subject|0
2153353|NCT01199055|3766762|FG001|Overall Study|Withdrawal by Subject|0
2153354|NCT01199055|3766763|FG002|Overall Study|Withdrawal by Subject|1
2153355|NCT01199068|3766776|FG000|Overall Study|Unacceptable toxicity|0
2153356|NCT01199068|3766777|FG001|Overall Study|Unacceptable toxicity|0
2153357|NCT01199068|3766778|FG002|Overall Study|Unacceptable toxicity|2
2153358|NCT01199068|3766776|FG000|Overall Study|Progressive disease|3
2153359|NCT01199068|3766777|FG001|Overall Study|Progressive disease|3
2153360|NCT01199068|3766778|FG002|Overall Study|Progressive disease|6
2153361|NCT01199068|3766776|FG000|Overall Study|Withdrawal by Subject|0
2153362|NCT01199068|3766777|FG001|Overall Study|Withdrawal by Subject|0
2153363|NCT01199068|3766778|FG002|Overall Study|Withdrawal by Subject|1
2153364|NCT01199198|3766799|FG000|Overall Study|Adverse Event|3
2153365|NCT01199198|3766800|FG001|Overall Study|Adverse Event|0
2153366|NCT01199198|3766799|FG000|Overall Study|Lost to Follow-up|1
2153367|NCT01199198|3766800|FG001|Overall Study|Lost to Follow-up|5
2153368|NCT01199198|3766799|FG000|Overall Study|Withdrawal by Subject|1
2153369|NCT01199198|3766800|FG001|Overall Study|Withdrawal by Subject|2
2153370|NCT01199198|3766799|FG000|Overall Study|ICU Transfer|1
2153371|NCT01199198|3766800|FG001|Overall Study|ICU Transfer|2
2153372|NCT01199198|3766799|FG000|Overall Study|Hospice-care transfer|1
2153373|NCT01199198|3766800|FG001|Overall Study|Hospice-care transfer|2
2153374|NCT01199263|3766819|FG000|Overall Study|Ineligible|0
2153375|NCT01199263|3766820|FG001|Overall Study|Ineligible|2
2153376|NCT01199263|3766819|FG000|Overall Study|Never Treated|6
2153377|NCT01199263|3766820|FG001|Overall Study|Never Treated|0
2153378|NCT01199289|3766832|FG000|Overall Study|Ineligibility determined|2
2153379|NCT01199289|3766833|FG001|Overall Study|Ineligibility determined|1
2153380|NCT01199289|3766834|FG002|Overall Study|Ineligibility determined|0
2153381|NCT01199289|3766835|FG003|Overall Study|Ineligibility determined|0
2153382|NCT01199289|3766832|FG000|Overall Study|Protocol Violation|1
2153383|NCT01199289|3766833|FG001|Overall Study|Protocol Violation|0
2153384|NCT01199289|3766834|FG002|Overall Study|Protocol Violation|0
2153385|NCT01199289|3766835|FG003|Overall Study|Protocol Violation|1
2153386|NCT01199289|3766832|FG000|Overall Study|Noncompliance|1
2153387|NCT01199289|3766833|FG001|Overall Study|Noncompliance|0
2153388|NCT01199289|3766834|FG002|Overall Study|Noncompliance|2
2153389|NCT01199289|3766835|FG003|Overall Study|Noncompliance|0
2153390|NCT01199289|3766832|FG000|Overall Study|Adverse Event|0
2153391|NCT01199289|3766833|FG001|Overall Study|Adverse Event|3
2153392|NCT01199289|3766834|FG002|Overall Study|Adverse Event|1
2153393|NCT01199289|3766835|FG003|Overall Study|Adverse Event|4
2153394|NCT01199289|3766832|FG000|Overall Study|Full consent withdrawn|2
2153395|NCT01199289|3766833|FG001|Overall Study|Full consent withdrawn|2
2153396|NCT01199289|3766834|FG002|Overall Study|Full consent withdrawn|2
2153397|NCT01199289|3766835|FG003|Overall Study|Full consent withdrawn|3
2153398|NCT01199289|3766832|FG000|Overall Study|Administrative decision|0
2153399|NCT01199289|3766833|FG001|Overall Study|Administrative decision|0
2153400|NCT01199289|3766834|FG002|Overall Study|Administrative decision|0
2153401|NCT01199289|3766835|FG003|Overall Study|Administrative decision|1
2153402|NCT01199289|3766832|FG000|Overall Study|Lost to Follow-up|0
2153403|NCT01199289|3766833|FG001|Overall Study|Lost to Follow-up|0
2153404|NCT01199289|3766834|FG002|Overall Study|Lost to Follow-up|0
2153405|NCT01199289|3766835|FG003|Overall Study|Lost to Follow-up|1
2153406|NCT01199289|3766832|FG000|Overall Study|Protocol-specified criteria|3
2153407|NCT01199289|3766833|FG001|Overall Study|Protocol-specified criteria|0
2153408|NCT01199289|3766834|FG002|Overall Study|Protocol-specified criteria|0
2153409|NCT01199289|3766835|FG003|Overall Study|Protocol-specified criteria|1
2153410|NCT01199289|3766832|FG000|Overall Study|Pregnancy|0
2153411|NCT01199289|3766833|FG001|Overall Study|Pregnancy|1
2153412|NCT01199289|3766834|FG002|Overall Study|Pregnancy|0
2153413|NCT01199289|3766835|FG003|Overall Study|Pregnancy|1
2153414|NCT01199471|3766857|FG000|Overall Study|Protocol Violation|4
2153415|NCT01199471|3766857|FG000|Overall Study|Withdrawal by Subject|1
2153416|NCT01199471|3766857|FG000|Overall Study|Physician Decision|1
2153417|NCT01199575|3766862|FG000|Overall Study|Withdrawal by Subject|5
2153418|NCT01199601|3766869|FG000|Overall Study|Lost to Follow-up|47
2153419|NCT01199601|3766870|FG001|Overall Study|Lost to Follow-up|66
2153420|NCT01199601|3766869|FG000|Overall Study|Withdrawal by Subject|15
2153421|NCT01199601|3766870|FG001|Overall Study|Withdrawal by Subject|3
2153422|NCT01199601|3766869|FG000|Overall Study|Insecurity prevented staff interviewing.|7
2153423|NCT01199601|3766870|FG001|Overall Study|Insecurity prevented staff interviewing.|9
2153424|NCT01199705|3766876|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
2153425|NCT01199731|3766894|FG000|Overall Study|Adverse Event|0
2153426|NCT01199731|3766895|FG001|Overall Study|Adverse Event|1
2153427|NCT01199731|3766896|FG002|Overall Study|Adverse Event|0
2153428|NCT01199731|3766894|FG000|Overall Study|Study closed/terminated|7
2153429|NCT01199731|3766895|FG001|Overall Study|Study closed/terminated|9
2153430|NCT01199731|3766896|FG002|Overall Study|Study closed/terminated|7
2153431|NCT01199731|3766894|FG000|Overall Study|Lost to Follow-up|0
2153432|NCT01199731|3766895|FG001|Overall Study|Lost to Follow-up|0
2153433|NCT01199731|3766896|FG002|Overall Study|Lost to Follow-up|2
2153434|NCT01199731|3766894|FG000|Overall Study|Physician Decision|0
2153435|NCT01199731|3766895|FG001|Overall Study|Physician Decision|1
2153436|NCT01199731|3766896|FG002|Overall Study|Physician Decision|1
2153437|NCT01199731|3766894|FG000|Overall Study|Withdrawal by Subject|2
2153438|NCT01199731|3766895|FG001|Overall Study|Withdrawal by Subject|0
2153439|NCT01199731|3766896|FG002|Overall Study|Withdrawal by Subject|0
2153440|NCT01199822|3766911|FG000|Overall Study|Investigator discontinued therapy|0
2153441|NCT01199822|3766912|FG001|Overall Study|Investigator discontinued therapy|1
2153442|NCT01199822|3766913|FG002|Overall Study|Investigator discontinued therapy|0
2153443|NCT01199861|3766940|FG000|Overall Study|Administrative problems|1
2153444|NCT01199861|3766941|FG001|Overall Study|Administrative problems|0
2153445|NCT01199861|3766940|FG000|Overall Study|Adverse Event|1
2153446|NCT01199861|3766941|FG001|Overall Study|Adverse Event|0
2153447|NCT01199939|3766956|FG000|Overall Study|Adverse Event|4
2153448|NCT01199939|3766956|FG000|Overall Study|Protocol Violation|3
2153449|NCT01199939|3766956|FG000|Overall Study|Lost to Follow-up|2
2153450|NCT01199939|3766956|FG000|Overall Study|Reached a virologic endpoint|4
2153451|NCT01200069|3767002|FG000|Overall Study|Withdrawal by Subject|0
2153452|NCT01200069|3767003|FG001|Overall Study|Withdrawal by Subject|1
2153453|NCT01200238|3767058|FG000|Overall Study|Adverse Event|2
2153454|NCT01200238|3767059|FG001|Overall Study|Adverse Event|1
2153455|NCT01200238|3767058|FG000|Overall Study|Progressive Disease|5
2153456|NCT01200238|3767059|FG001|Overall Study|Progressive Disease|8
2153457|NCT01200238|3767058|FG000|Overall Study|Withdrawal by Subject|0
2153458|NCT01200238|3767059|FG001|Overall Study|Withdrawal by Subject|1
2153459|NCT01200290|3767065|FG000|Treatment Period|Adverse Event|1
2153460|NCT01200290|3767065|FG000|Post-Treatment Follow-Up Period|Death|2
2153461|NCT01200329|3767069|FG000|Overall Study|Lack of financial coverage|2
2153462|NCT01200329|3767069|FG000|Overall Study|Progressive disease|1
2153463|NCT01200342|3767073|FG000|Overall Study|Disease Progression|1
2153464|NCT01200355|3767079|FG000|Overall Study|Death|7
2153465|NCT01200355|3767080|FG001|Overall Study|Death|2
2153466|NCT01200368|3767089|FG000|Infant Series|Adverse Event|2
2153467|NCT01200368|3767090|FG001|Infant Series|Adverse Event|2
2153468|NCT01200368|3767091|FG002|Infant Series|Adverse Event|3
2153469|NCT01200368|3767089|FG000|Infant Series|Withdrawal by Subject|0
2153470|NCT01200368|3767090|FG001|Infant Series|Withdrawal by Subject|2
2153471|NCT01200368|3767091|FG002|Infant Series|Withdrawal by Subject|2
2153472|NCT01200368|3767089|FG000|Infant Series|Did not meet entrance criteria|0
2153473|NCT01200368|3767090|FG001|Infant Series|Did not meet entrance criteria|1
2153474|NCT01200368|3767091|FG002|Infant Series|Did not meet entrance criteria|0
2153475|NCT01200368|3767089|FG000|Infant Series|Randomized, not vaccinated|0
2153476|NCT01200368|3767090|FG001|Infant Series|Randomized, not vaccinated|1
2153477|NCT01200368|3767091|FG002|Infant Series|Randomized, not vaccinated|1
2153478|NCT01200368|3767089|FG000|Infant Series|Other|1
2153479|NCT01200368|3767090|FG001|Infant Series|Other|0
2153480|NCT01200368|3767091|FG002|Infant Series|Other|0
2153481|NCT01200368|3767089|FG000|After Infant Series|Adverse Event|6
2153482|NCT01200368|3767090|FG001|After Infant Series|Adverse Event|6
2153483|NCT01200368|3767091|FG002|After Infant Series|Adverse Event|3
2153484|NCT01200368|3767089|FG000|After Infant Series|Withdrawal by Subject|10
2153485|NCT01200368|3767090|FG001|After Infant Series|Withdrawal by Subject|8
2153486|NCT01200368|3767091|FG002|After Infant Series|Withdrawal by Subject|4
2153487|NCT01200368|3767089|FG000|After Infant Series|Lost to Follow-up|1
2153488|NCT01200368|3767090|FG001|After Infant Series|Lost to Follow-up|0
2153489|NCT01200368|3767091|FG002|After Infant Series|Lost to Follow-up|0
2153490|NCT01200368|3767089|FG000|After Infant Series|Other|1
2153491|NCT01200368|3767090|FG001|After Infant Series|Other|2
2153492|NCT01200368|3767091|FG002|After Infant Series|Other|2
2153493|NCT01200368|3767089|FG000|Toddler Dose|Adverse Event|0
2153494|NCT01200368|3767090|FG001|Toddler Dose|Adverse Event|3
2153495|NCT01200368|3767091|FG002|Toddler Dose|Adverse Event|1
2153496|NCT01200394|3767108|FG000|Overall Study|Adverse Event|0
2153497|NCT01200394|3767109|FG001|Overall Study|Adverse Event|14
2153498|NCT01200394|3767108|FG000|Overall Study|Death|1
2153499|NCT01200394|3767109|FG001|Overall Study|Death|0
2153500|NCT01200394|3767108|FG000|Overall Study|Lost to Follow-up|0
2153501|NCT01200394|3767109|FG001|Overall Study|Lost to Follow-up|1
2153502|NCT01200394|3767108|FG000|Overall Study|Did Not Meet Entrance Criteria|1
2153503|NCT01200394|3767109|FG001|Overall Study|Did Not Meet Entrance Criteria|4
2153504|NCT01200394|3767108|FG000|Overall Study|Protocol Violation|0
2153505|NCT01200394|3767109|FG001|Overall Study|Protocol Violation|3
2153506|NCT01200394|3767108|FG000|Overall Study|Withdrawal by Subject|0
2153507|NCT01200394|3767109|FG001|Overall Study|Withdrawal by Subject|5
2153508|NCT01200394|3767108|FG000|Overall Study|Other|0
2153509|NCT01200394|3767109|FG001|Overall Study|Other|1
2153510|NCT01200407|3767116|FG000|Overall Study|Lost to Follow-up|56
2153511|NCT01200407|3767116|FG000|Overall Study|Adverse Event|3
2153512|NCT01200407|3767116|FG000|Overall Study|Withdrawal by Subject|4
2153513|NCT01200407|3767116|FG000|Overall Study|Other|19
2153514|NCT01200485|3767129|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
2153515|NCT01200485|3767130|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
2153516|NCT01200485|3767131|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
2153517|NCT01200485|3767129|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
2153518|NCT01200485|3767130|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
2153519|NCT01200485|3767131|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
2153520|NCT01200511|3767142|FG000|Overall Study|Lost to Follow-up|3
2153521|NCT01200511|3767142|FG000|Overall Study|Withdrawal by Subject|1
2153522|NCT01200511|3767142|FG000|Overall Study|Adverse Event|1
2153523|NCT01200524|3767151|FG000|Overall Study|Withdrawal by Subject|1
2153524|NCT01200524|3767152|FG001|Overall Study|Withdrawal by Subject|1
2153525|NCT01200524|3767153|FG002|Overall Study|Withdrawal by Subject|3
2153526|NCT01200524|3767151|FG000|Overall Study|Adverse Event|1
2153527|NCT01200524|3767152|FG001|Overall Study|Adverse Event|0
2153528|NCT01200524|3767153|FG002|Overall Study|Adverse Event|0
2153529|NCT01200524|3767151|FG000|Overall Study|Non availability of study nurse|0
2153530|NCT01200524|3767152|FG001|Overall Study|Non availability of study nurse|0
2153531|NCT01200524|3767153|FG002|Overall Study|Non availability of study nurse|1
2153532|NCT01200589|3767163|FG000|Overall Study|Withdrawal by Subject|13
2153533|NCT01200589|3767164|FG001|Overall Study|Withdrawal by Subject|11
2153534|NCT01200589|3767163|FG000|Overall Study|Physician Decision|2
2153535|NCT01200589|3767164|FG001|Overall Study|Physician Decision|2
2153536|NCT01200589|3767163|FG000|Overall Study|Lost to Follow-up|5
2153537|NCT01200589|3767164|FG001|Overall Study|Lost to Follow-up|4
2153538|NCT01200589|3767163|FG000|Overall Study|Study terminated|170
2153539|NCT01200589|3767164|FG001|Overall Study|Study terminated|172
2153540|NCT01200758|3767172|FG000|Stage I|Death|0
2153541|NCT01200758|3767173|FG001|Stage I|Death|1
2153542|NCT01200758|3767174|FG002|Stage I|Death|0
2153543|NCT01200758|3767175|FG003|Stage I|Death|0
2153544|NCT01200758|3767172|FG000|Stage I|Physician Decision|1
2153545|NCT01200758|3767173|FG001|Stage I|Physician Decision|1
2153546|NCT01200758|3767174|FG002|Stage I|Physician Decision|0
2153547|NCT01200758|3767175|FG003|Stage I|Physician Decision|0
2153548|NCT01200758|3767172|FG000|Stage I|Lack of Efficacy|2
2153549|NCT01200758|3767173|FG001|Stage I|Lack of Efficacy|1
2153550|NCT01200758|3767174|FG002|Stage I|Lack of Efficacy|0
2153551|NCT01200758|3767175|FG003|Stage I|Lack of Efficacy|0
2153552|NCT01200758|3767172|FG000|Stage I|Adverse Event|5
2153553|NCT01200758|3767173|FG001|Stage I|Adverse Event|5
2153554|NCT01200758|3767174|FG002|Stage I|Adverse Event|0
2153555|NCT01200758|3767175|FG003|Stage I|Adverse Event|0
2153556|NCT01200758|3767172|FG000|Stage I|Withdrawal by Subject|1
2292440|NCT02513160|3986028|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
2292441|NCT02513160|3986025|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
2292442|NCT02513160|3986026|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
2292443|NCT02513160|3986027|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
2292444|NCT02513160|3986028|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
2292445|NCT02513160|3986025|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
2153557|NCT01200758|3767173|FG001|Stage I|Withdrawal by Subject|2
2153558|NCT01200758|3767174|FG002|Stage I|Withdrawal by Subject|0
2153559|NCT01200758|3767175|FG003|Stage I|Withdrawal by Subject|0
2292446|NCT02513160|3986026|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
2292447|NCT02513160|3986027|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
2153560|NCT01200758|3767172|FG000|Stage I|Disease Progression|9
2153561|NCT01200758|3767173|FG001|Stage I|Disease Progression|7
2153562|NCT01200758|3767174|FG002|Stage I|Disease Progression|0
2153563|NCT01200758|3767175|FG003|Stage I|Disease Progression|0
2292448|NCT02513160|3986028|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
2292449|NCT02513459|3986058|FG000|Overall Study|Adverse Event|7
2292450|NCT02513459|3986058|FG000|Overall Study|Withdrew consent|5
2292451|NCT02513459|3986058|FG000|Overall Study|Loss of efficacy|2
2292452|NCT02513459|3986058|FG000|Overall Study|Pregnancy|2
2292453|NCT02513459|3986058|FG000|Overall Study|Subject decision|2
2292454|NCT02513459|3986058|FG000|Overall Study|Lack of response|1
2153564|NCT01200758|3767172|FG000|Stage 2|Disease Progression|0
2153565|NCT01200758|3767173|FG001|Stage 2|Disease Progression|0
2153566|NCT01200758|3767174|FG002|Stage 2|Disease Progression|16
2153567|NCT01200758|3767175|FG003|Stage 2|Disease Progression|21
2153568|NCT01200758|3767172|FG000|Stage 2|Lack of Efficacy|0
2153569|NCT01200758|3767173|FG001|Stage 2|Lack of Efficacy|0
2153570|NCT01200758|3767174|FG002|Stage 2|Lack of Efficacy|4
2153571|NCT01200758|3767175|FG003|Stage 2|Lack of Efficacy|2
2153572|NCT01200758|3767172|FG000|Stage 2|Physician Decision|0
2153573|NCT01200758|3767173|FG001|Stage 2|Physician Decision|0
2153574|NCT01200758|3767174|FG002|Stage 2|Physician Decision|5
2153575|NCT01200758|3767175|FG003|Stage 2|Physician Decision|7
2153576|NCT01200758|3767172|FG000|Stage 2|Adverse Event|0
2153577|NCT01200758|3767173|FG001|Stage 2|Adverse Event|0
2153578|NCT01200758|3767174|FG002|Stage 2|Adverse Event|5
2153579|NCT01200758|3767175|FG003|Stage 2|Adverse Event|9
2153580|NCT01200758|3767172|FG000|Stage 2|Withdrawal by Subject|0
2153581|NCT01200758|3767173|FG001|Stage 2|Withdrawal by Subject|0
2153582|NCT01200758|3767174|FG002|Stage 2|Withdrawal by Subject|4
2153583|NCT01200758|3767175|FG003|Stage 2|Withdrawal by Subject|1
2153584|NCT01200758|3767172|FG000|Stage 2|Lost to Follow-up|0
2153585|NCT01200758|3767173|FG001|Stage 2|Lost to Follow-up|0
2153586|NCT01200758|3767174|FG002|Stage 2|Lost to Follow-up|3
2153587|NCT01200758|3767175|FG003|Stage 2|Lost to Follow-up|1
2153588|NCT01200758|3767172|FG000|Stage 2|Protocol Violation|0
2153589|NCT01200758|3767173|FG001|Stage 2|Protocol Violation|0
2153590|NCT01200758|3767174|FG002|Stage 2|Protocol Violation|1
2153591|NCT01200758|3767175|FG003|Stage 2|Protocol Violation|4
2153592|NCT01200758|3767172|FG000|Stage 2|Death|0
2153593|NCT01200758|3767173|FG001|Stage 2|Death|0
2153594|NCT01200758|3767174|FG002|Stage 2|Death|3
2153595|NCT01200758|3767175|FG003|Stage 2|Death|5
2153596|NCT01200797|3767187|FG000|Overall Study|symptomatic deterioration|2
2153597|NCT01200797|3767187|FG000|Overall Study|Adverse Event|4
2153598|NCT01200797|3767187|FG000|Overall Study|Disease Progression|13
2153599|NCT01200810|3767194|FG000|Overall Study|Physician Decision|1
2153600|NCT01200810|3767195|FG001|Overall Study|Physician Decision|0
2153601|NCT01200810|3767194|FG000|Overall Study|Withdrawal by Subject|1
2153602|NCT01200810|3767195|FG001|Overall Study|Withdrawal by Subject|2
2153603|NCT01200810|3767194|FG000|Overall Study|Sponsor stopped making study drug|3
2153604|NCT01200810|3767195|FG001|Overall Study|Sponsor stopped making study drug|3
2179237|NCT01392573|3804723|FG001|Overall Study|Adverse Event|3
2179238|NCT01392573|3804722|FG000|Overall Study|Lack of Efficacy|1
2179239|NCT01392573|3804723|FG001|Overall Study|Lack of Efficacy|2
2179240|NCT01392573|3804722|FG000|Overall Study|Protocol Violation|0
2179241|NCT01392573|3804723|FG001|Overall Study|Protocol Violation|2
2179242|NCT01392573|3804722|FG000|Overall Study|Withdrawal Criteria|13
2179243|NCT01392573|3804723|FG001|Overall Study|Withdrawal Criteria|15
2179244|NCT01392573|3804722|FG000|Overall Study|Site closure|8
2179245|NCT01392573|3804723|FG001|Overall Study|Site closure|7
2179246|NCT01392573|3804722|FG000|Overall Study|Unclassified|9
2179247|NCT01392573|3804723|FG001|Overall Study|Unclassified|6
2179248|NCT01392677|3804740|FG000|Overall Study|Adverse Event|3
2179249|NCT01392677|3804741|FG001|Overall Study|Adverse Event|1
2179250|NCT01392677|3804740|FG000|Overall Study|Withdrawal by Subject|0
2179251|NCT01392677|3804741|FG001|Overall Study|Withdrawal by Subject|2
2179252|NCT01392677|3804740|FG000|Overall Study|Incorrect enrollment|2
2179253|NCT01392677|3804741|FG001|Overall Study|Incorrect enrollment|3
2179254|NCT01392677|3804740|FG000|Overall Study|Other reason|3
2179255|NCT01392677|3804741|FG001|Overall Study|Other reason|2
2179256|NCT01392742|3804759|FG000|Overall Study|Premature study termination|42
2179257|NCT01392742|3804759|FG000|Overall Study|Failure to return|35
2179258|NCT01392742|3804759|FG000|Overall Study|No treatment/no cooperation/withdrew|12
2179259|NCT01392742|3804759|FG000|Overall Study|Lost to Follow-up|34
2179260|NCT01392742|3804759|FG000|Overall Study|Insufficient therapeutic response (ITR)|30
2179261|NCT01392742|3804759|FG000|Overall Study|ITR and Protocol deviation|1
2179262|NCT01392742|3804759|FG000|Overall Study|Adverse event/intercurrent illness|17
2179263|NCT01392742|3804759|FG000|Overall Study|Protocol Violation|14
2179264|NCT01392742|3804759|FG000|Overall Study|Other|3
2179265|NCT01392742|3804759|FG000|Overall Study|Missing information|13
2179266|NCT01392963|3804773|FG000|Week 0 (First Intervention)|Lost to Follow-up|0
2179267|NCT01392963|3804774|FG001|Week 0 (First Intervention)|Lost to Follow-up|1
2179268|NCT01392963|3804773|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0
2179269|NCT01392963|3804774|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1
2179270|NCT01392963|3804773|FG000|Week 24 Follow-up|Lost to Follow-up|2
2179271|NCT01392963|3804774|FG001|Week 24 Follow-up|Lost to Follow-up|0
2292455|NCT02513459|3986058|FG000|Overall Study|Reproductive plans|1
2179272|NCT01393106|3804787|FG000|Overall Study|Adverse Event|3
2179273|NCT01393106|3804787|FG000|Overall Study|Withdrawal by Subject|1
2179274|NCT01393106|3804787|FG000|Overall Study|Lack of Efficacy|1
2153605|NCT01200992|3767207|FG000|Overall Study|Study terminated early|35
2153606|NCT01200992|3767208|FG001|Overall Study|Study terminated early|41
2153607|NCT01200992|3767207|FG000|Overall Study|Randomized but not treated|2
2153608|NCT01200992|3767208|FG001|Overall Study|Randomized but not treated|0
2153609|NCT01201265|3767233|FG000|Overall Study|Death|14
2153610|NCT01201265|3767233|FG000|Overall Study|Insufficient Therapeutic Response|3
2153611|NCT01201265|3767233|FG000|Overall Study|Lost to Follow-up|10
2292456|NCT02513459|3986058|FG000|Overall Study|Surgery planned-- not done|1
2292457|NCT02513472|3986069|FG000|Overall Study|Radiological Disease Progression|45
2292458|NCT02513472|3986070|FG001|Overall Study|Radiological Disease Progression|56
2292459|NCT02513472|3986069|FG000|Overall Study|Clinical Disease Progression|5
2292460|NCT02513472|3986070|FG001|Overall Study|Clinical Disease Progression|12
2292461|NCT02513472|3986069|FG000|Overall Study|Adverse Event|7
2292462|NCT02513472|3986070|FG001|Overall Study|Adverse Event|11
2292463|NCT02513472|3986069|FG000|Overall Study|Withdrawal by Subject|0
2292464|NCT02513472|3986070|FG001|Overall Study|Withdrawal by Subject|4
2292465|NCT02513472|3986069|FG000|Overall Study|Subject Choice|2
2292466|NCT02513472|3986070|FG001|Overall Study|Subject Choice|6
2292467|NCT02513472|3986069|FG000|Overall Study|Treatment Completed as per Protocol|3
2292468|NCT02513472|3986070|FG001|Overall Study|Treatment Completed as per Protocol|1
2292469|NCT02513472|3986069|FG000|Overall Study|Other|3
2292470|NCT02513472|3986070|FG001|Overall Study|Other|3
2321162|NCT02956278|4035518|FG001|Overall Study|Withdrawal by Subject|2
2321163|NCT02956278|4035519|FG002|Overall Study|Withdrawal by Subject|0
2321164|NCT02956460|4035529|FG000|Lens 1|Lost to Follow-up|1
2321165|NCT02956460|4035530|FG001|Lens 1|Lost to Follow-up|0
2321166|NCT02956486|4035538|FG000|Core Phase|Adverse Event|51
2321167|NCT02956486|4035539|FG001|Core Phase|Adverse Event|88
2321168|NCT02956486|4035540|FG002|Core Phase|Adverse Event|0
2321169|NCT02956486|4035538|FG000|Core Phase|Lost to Follow-up|8
2321170|NCT02956486|4035539|FG001|Core Phase|Lost to Follow-up|6
2321171|NCT02956486|4035540|FG002|Core Phase|Lost to Follow-up|0
2321172|NCT02956486|4035538|FG000|Core Phase|Inadequate therapeutic effect|4
2321173|NCT02956486|4035539|FG001|Core Phase|Inadequate therapeutic effect|5
2321174|NCT02956486|4035540|FG002|Core Phase|Inadequate therapeutic effect|0
2321175|NCT02956486|4035538|FG000|Core Phase|Withdrawal by Subject|101
2321176|NCT02956486|4035539|FG001|Core Phase|Withdrawal by Subject|104
2321177|NCT02956486|4035540|FG002|Core Phase|Withdrawal by Subject|0
2321178|NCT02956486|4035538|FG000|Core Phase|Study terminated by sponsor|888
2321179|NCT02956486|4035539|FG001|Core Phase|Study terminated by sponsor|848
2321180|NCT02956486|4035540|FG002|Core Phase|Study terminated by sponsor|0
2321181|NCT02956486|4035538|FG000|Core Phase|Other|27
2321182|NCT02956486|4035539|FG001|Core Phase|Other|18
2321183|NCT02956486|4035540|FG002|Core Phase|Other|0
2321184|NCT02956486|4035538|FG000|Core Phase|Not treated|0
2321185|NCT02956486|4035539|FG001|Core Phase|Not treated|3
2321186|NCT02956486|4035540|FG002|Core Phase|Not treated|0
2321187|NCT02956486|4035538|FG000|Extension Phase|Adverse Event|0
2321188|NCT02956486|4035539|FG001|Extension Phase|Adverse Event|0
2321189|NCT02956486|4035540|FG002|Extension Phase|Adverse Event|2
2321190|NCT02956486|4035538|FG000|Extension Phase|Study terminated by sponsor|0
2321191|NCT02956486|4035539|FG001|Extension Phase|Study terminated by sponsor|0
2321192|NCT02956486|4035540|FG002|Extension Phase|Study terminated by sponsor|16
2321193|NCT02956486|4035538|FG000|Extension Phase|Not Treated|0
2321194|NCT02956486|4035539|FG001|Extension Phase|Not Treated|0
2321195|NCT02956486|4035540|FG002|Extension Phase|Not Treated|1
2321196|NCT02956629|4035564|FG000|Overall Study|Adverse Event|0
2321197|NCT02956629|4035565|FG001|Overall Study|Adverse Event|0
2321198|NCT02956629|4035566|FG002|Overall Study|Adverse Event|1
2321199|NCT02956629|4035567|FG003|Overall Study|Adverse Event|0
2321200|NCT02956629|4035568|FG004|Overall Study|Adverse Event|0
2321201|NCT02956629|4035569|FG005|Overall Study|Adverse Event|0
2321202|NCT02956629|4035564|FG000|Overall Study|Lost to Follow-up|2
2321203|NCT02956629|4035565|FG001|Overall Study|Lost to Follow-up|5
2321204|NCT02956629|4035566|FG002|Overall Study|Lost to Follow-up|3
2321205|NCT02956629|4035567|FG003|Overall Study|Lost to Follow-up|1
2321206|NCT02956629|4035568|FG004|Overall Study|Lost to Follow-up|0
2321207|NCT02956629|4035569|FG005|Overall Study|Lost to Follow-up|1
2321208|NCT02956629|4035564|FG000|Overall Study|Withdrawal by Subject|3
2321209|NCT02956629|4035565|FG001|Overall Study|Withdrawal by Subject|1
2321210|NCT02956629|4035566|FG002|Overall Study|Withdrawal by Subject|0
2321211|NCT02956629|4035567|FG003|Overall Study|Withdrawal by Subject|0
2321212|NCT02956629|4035568|FG004|Overall Study|Withdrawal by Subject|0
2321213|NCT02956629|4035569|FG005|Overall Study|Withdrawal by Subject|0
2321214|NCT02956837|4035605|FG000|Overall Study|Serious Adverse Events|0
2321215|NCT02956837|4035606|FG001|Overall Study|Serious Adverse Events|1
2321216|NCT02956837|4035607|FG002|Overall Study|Serious Adverse Events|0
2321217|NCT02956837|4035608|FG003|Overall Study|Serious Adverse Events|0
2321218|NCT02956837|4035605|FG000|Overall Study|Withdrawal by Subject|0
2321219|NCT02956837|4035606|FG001|Overall Study|Withdrawal by Subject|1
2321220|NCT02956837|4035607|FG002|Overall Study|Withdrawal by Subject|0
2321221|NCT02956837|4035608|FG003|Overall Study|Withdrawal by Subject|3
2321222|NCT02956837|4035605|FG000|Overall Study|Lost to Follow-up|0
2321223|NCT02956837|4035606|FG001|Overall Study|Lost to Follow-up|1
2321224|NCT02956837|4035607|FG002|Overall Study|Lost to Follow-up|2
2153612|NCT01201265|3767233|FG000|Overall Study|Withdrawal by Subject|7
2153613|NCT01201265|3767233|FG000|Overall Study|Disease Progression|4
2153614|NCT01201317|3767240|FG000|Overall Study|Withdrawal by Subject|5
2153615|NCT01201317|3767241|FG001|Overall Study|Withdrawal by Subject|0
2153616|NCT01201317|3767242|FG002|Overall Study|Withdrawal by Subject|3
2153617|NCT01201317|3767240|FG000|Overall Study|Adverse Event|2
2153618|NCT01201317|3767241|FG001|Overall Study|Adverse Event|2
2153619|NCT01201317|3767242|FG002|Overall Study|Adverse Event|2
2153620|NCT01201317|3767240|FG000|Overall Study|Screen failure|1
2153621|NCT01201317|3767241|FG001|Overall Study|Screen failure|1
2153622|NCT01201317|3767242|FG002|Overall Study|Screen failure|0
2153623|NCT01201317|3767240|FG000|Overall Study|Protocol Violation|0
2153624|NCT01201317|3767241|FG001|Overall Study|Protocol Violation|1
2153625|NCT01201317|3767242|FG002|Overall Study|Protocol Violation|1
2153626|NCT01201317|3767240|FG000|Overall Study|Death|0
2153627|NCT01201317|3767241|FG001|Overall Study|Death|1
2153628|NCT01201317|3767242|FG002|Overall Study|Death|0
2153629|NCT01201317|3767240|FG000|Overall Study|Study-specific withdrawal criteria|0
2153630|NCT01201317|3767241|FG001|Overall Study|Study-specific withdrawal criteria|0
2153631|NCT01201317|3767242|FG002|Overall Study|Study-specific withdrawal criteria|1
2153632|NCT01201317|3767240|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0
2153633|NCT01201317|3767241|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1
2153634|NCT01201317|3767242|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0
2153635|NCT01201317|3767240|FG000|Overall Study|Decrease in renal function|0
2153636|NCT01201317|3767241|FG001|Overall Study|Decrease in renal function|1
2153637|NCT01201317|3767242|FG002|Overall Study|Decrease in renal function|0
2153638|NCT01201317|3767240|FG000|Overall Study|Lack of Efficacy|1
2153639|NCT01201317|3767241|FG001|Overall Study|Lack of Efficacy|0
2153640|NCT01201317|3767242|FG002|Overall Study|Lack of Efficacy|0
2153641|NCT01201317|3767240|FG000|Overall Study|Safety, possible history of tuberculosis|0
2153642|NCT01201317|3767241|FG001|Overall Study|Safety, possible history of tuberculosis|0
2153643|NCT01201317|3767242|FG002|Overall Study|Safety, possible history of tuberculosis|1
2153644|NCT01201343|3767250|FG000|Overall Study|Adverse Event|6
2153645|NCT01201343|3767250|FG000|Overall Study|Withdrawal by Subject|5
2153646|NCT01201343|3767250|FG000|Overall Study|Lost to Follow-up|2
2153647|NCT01201343|3767250|FG000|Overall Study|Lack of Efficacy|2
2153648|NCT01201343|3767250|FG000|Overall Study|Participant wrongly included in trial|1
2153649|NCT01201343|3767250|FG000|Overall Study|Randomized, not treated|3
2153650|NCT01201356|3767254|FG000|Overall Study|Adverse Event|170
2153651|NCT01201356|3767254|FG000|Overall Study|Abnormal laboratory value(s)|51
2153652|NCT01201356|3767254|FG000|Overall Study|Abnormal test procedure result(s)|3
2153653|NCT01201356|3767254|FG000|Overall Study|Unsatisfactory therapeutic effect|112
2153654|NCT01201356|3767254|FG000|Overall Study|Condition no longer requires study drug|12
2153655|NCT01201356|3767254|FG000|Overall Study|Withdrawal by Subject|144
2153656|NCT01201356|3767254|FG000|Overall Study|Lost to Follow-up|50
2153657|NCT01201356|3767254|FG000|Overall Study|administrative problems|74
2153658|NCT01201356|3767254|FG000|Overall Study|Death|16
2153659|NCT01201356|3767254|FG000|Overall Study|Protocol Violation|12
2153660|NCT01201759|3767273|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
2153661|NCT01201759|3767274|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
2153662|NCT01201759|3767273|FG000|Visit 3 - Washout|Adverse Event|0
2153663|NCT01201759|3767274|FG001|Visit 3 - Washout|Adverse Event|3
2153664|NCT01201759|3767273|FG000|Visit 3 - Washout|Lost to Follow-up|1
2153665|NCT01201759|3767274|FG001|Visit 3 - Washout|Lost to Follow-up|0
2153666|NCT01201759|3767273|FG000|Visit 4 Crossover|Lost to Follow-up|0
2153667|NCT01201759|3767274|FG001|Visit 4 Crossover|Lost to Follow-up|1
2153668|NCT01201785|3767293|FG000|Overall Study|Lost to Follow-up|16
2153669|NCT01201798|3767299|FG000|Overall Study|Adverse Event|2
2153670|NCT01201798|3767300|FG001|Overall Study|Adverse Event|0
2153671|NCT01201798|3767299|FG000|Overall Study|Lost to Follow-up|3
2153672|NCT01201798|3767300|FG001|Overall Study|Lost to Follow-up|5
2153673|NCT01201798|3767299|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
2153674|NCT01201798|3767300|FG001|Overall Study|Decision Unrelated to an Adverse Event|1
2153675|NCT01201798|3767299|FG000|Overall Study|Noncompliance|1
2153676|NCT01201798|3767300|FG001|Overall Study|Noncompliance|0
2153677|NCT01201798|3767299|FG000|Overall Study|Protocol Violation|1
2153678|NCT01201798|3767300|FG001|Overall Study|Protocol Violation|1
2153679|NCT01201798|3767299|FG000|Overall Study|Treatment Failure|1
2153680|NCT01201798|3767300|FG001|Overall Study|Treatment Failure|8
2153681|NCT01201811|3767306|FG000|Overall Study|Adverse Event|6
2153682|NCT01201811|3767306|FG000|Overall Study|Disease progression|3
2153683|NCT01201811|3767306|FG000|Overall Study|Withdrawal by Subject|3
2153684|NCT01201811|3767306|FG000|Overall Study|Death|4
2153685|NCT01201811|3767306|FG000|Overall Study|Treatment Failure|2
2153686|NCT01201811|3767306|FG000|Overall Study|Physician Decision|1
2153687|NCT01201850|3767310|FG000|Overall Study|Tumor progression|4
2153688|NCT01201915|3767330|FG000|Overall Study|Adverse Event|2
2153689|NCT01201915|3767331|FG001|Overall Study|Adverse Event|1
2153690|NCT01201915|3767332|FG002|Overall Study|Adverse Event|1
2153691|NCT01201915|3767330|FG000|Overall Study|Lost to Follow-up|0
2153692|NCT01201915|3767331|FG001|Overall Study|Lost to Follow-up|4
2153693|NCT01201915|3767332|FG002|Overall Study|Lost to Follow-up|0
2153694|NCT01201915|3767330|FG000|Overall Study|Physician Decision|3
2153695|NCT01201915|3767331|FG001|Overall Study|Physician Decision|0
2153696|NCT01201915|3767332|FG002|Overall Study|Physician Decision|0
2153697|NCT01201915|3767330|FG000|Overall Study|Subject Decision|3
2153698|NCT01201915|3767331|FG001|Overall Study|Subject Decision|3
2153699|NCT01201915|3767332|FG002|Overall Study|Subject Decision|5
2153700|NCT01201915|3767330|FG000|Overall Study|Target Lesion Progression|0
2153701|NCT01201915|3767331|FG001|Overall Study|Target Lesion Progression|3
2153702|NCT01201915|3767332|FG002|Overall Study|Target Lesion Progression|0
2153703|NCT01201967|3767342|FG000|Overall Study|Lost to Follow-up|6
2153704|NCT01201967|3767343|FG001|Overall Study|Lost to Follow-up|5
2153705|NCT01202175|3767374|FG000|Overall Study|Lost to Follow-up|2
2153706|NCT01202175|3767374|FG000|Overall Study|Withdrawal by Subject|1
2153707|NCT01202175|3767374|FG000|Overall Study|Adverse Event|2
2153708|NCT01202188|3767384|FG000|Overall Study|Protocol deviation|14
2153709|NCT01202188|3767385|FG001|Overall Study|Protocol deviation|8
2153710|NCT01202188|3767386|FG002|Overall Study|Protocol deviation|12
2153711|NCT01202188|3767387|FG003|Overall Study|Protocol deviation|10
2153712|NCT01202188|3767388|FG004|Overall Study|Protocol deviation|11
2153713|NCT01202188|3767384|FG000|Overall Study|Subject withdrew consent|12
2153714|NCT01202188|3767385|FG001|Overall Study|Subject withdrew consent|13
2153715|NCT01202188|3767386|FG002|Overall Study|Subject withdrew consent|22
2153716|NCT01202188|3767387|FG003|Overall Study|Subject withdrew consent|11
2153717|NCT01202188|3767388|FG004|Overall Study|Subject withdrew consent|13
2153718|NCT01202188|3767384|FG000|Overall Study|Adverse Event|5
2153719|NCT01202188|3767385|FG001|Overall Study|Adverse Event|23
2153720|NCT01202188|3767386|FG002|Overall Study|Adverse Event|13
2153721|NCT01202188|3767387|FG003|Overall Study|Adverse Event|10
2153722|NCT01202188|3767388|FG004|Overall Study|Adverse Event|10
2153723|NCT01202188|3767384|FG000|Overall Study|Administrative problems|3
2153724|NCT01202188|3767385|FG001|Overall Study|Administrative problems|2
2153725|NCT01202188|3767386|FG002|Overall Study|Administrative problems|1
2153726|NCT01202188|3767387|FG003|Overall Study|Administrative problems|1
2153727|NCT01202188|3767388|FG004|Overall Study|Administrative problems|2
2153728|NCT01202188|3767384|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2153729|NCT01202188|3767385|FG001|Overall Study|Unsatisfactory therapeutic effect|8
2153730|NCT01202188|3767386|FG002|Overall Study|Unsatisfactory therapeutic effect|2
2153731|NCT01202188|3767387|FG003|Overall Study|Unsatisfactory therapeutic effect|5
2153732|NCT01202188|3767388|FG004|Overall Study|Unsatisfactory therapeutic effect|8
2153733|NCT01202188|3767384|FG000|Overall Study|Lost to Follow-up|1
2153734|NCT01202188|3767385|FG001|Overall Study|Lost to Follow-up|1
2153735|NCT01202188|3767386|FG002|Overall Study|Lost to Follow-up|0
2153736|NCT01202188|3767387|FG003|Overall Study|Lost to Follow-up|4
2153737|NCT01202188|3767388|FG004|Overall Study|Lost to Follow-up|1
2153738|NCT01202188|3767384|FG000|Overall Study|Death|1
2153739|NCT01202188|3767385|FG001|Overall Study|Death|1
2153740|NCT01202188|3767386|FG002|Overall Study|Death|1
2153741|NCT01202188|3767387|FG003|Overall Study|Death|1
2153742|NCT01202188|3767388|FG004|Overall Study|Death|0
2153743|NCT01202188|3767384|FG000|Overall Study|Abnormal test procedure result (s)|0
2153744|NCT01202188|3767385|FG001|Overall Study|Abnormal test procedure result (s)|0
2153745|NCT01202188|3767386|FG002|Overall Study|Abnormal test procedure result (s)|2
2153746|NCT01202188|3767387|FG003|Overall Study|Abnormal test procedure result (s)|0
2153747|NCT01202188|3767388|FG004|Overall Study|Abnormal test procedure result (s)|0
2153748|NCT01202227|3767406|FG000|Overall Study|Adverse Event|16
2153749|NCT01202227|3767406|FG000|Overall Study|Withdrawal by Subject|2
2153750|NCT01202227|3767406|FG000|Overall Study|Lack of Efficacy|1
2153751|NCT01202279|3767416|FG000|Overall Study|Adverse Event|8
2153752|NCT01202279|3767417|FG001|Overall Study|Adverse Event|6
2153753|NCT01202279|3767416|FG000|Overall Study|Withdrawal by Subject|13
2153754|NCT01202279|3767417|FG001|Overall Study|Withdrawal by Subject|10
2153755|NCT01202279|3767416|FG000|Overall Study|Physician Decision|0
2153756|NCT01202279|3767417|FG001|Overall Study|Physician Decision|1
2153757|NCT01202279|3767416|FG000|Overall Study|Lost to Follow-up|10
2153758|NCT01202279|3767417|FG001|Overall Study|Lost to Follow-up|7
2153759|NCT01202279|3767416|FG000|Overall Study|Protocol Violation|1
2153760|NCT01202279|3767417|FG001|Overall Study|Protocol Violation|1
2153761|NCT01202279|3767416|FG000|Overall Study|study compliance|5
2153762|NCT01202279|3767417|FG001|Overall Study|study compliance|2
2153763|NCT01202409|3767423|FG000|Overall Study|Adverse Event|1
2153764|NCT01202409|3767423|FG000|Overall Study|Ineligible - KRAS mutants|7
2153765|NCT01202591|3767441|FG000|Overall Study|Adverse Event|2
2153766|NCT01202591|3767442|FG001|Overall Study|Adverse Event|1
2153767|NCT01202591|3767443|FG002|Overall Study|Adverse Event|4
2153768|NCT01202591|3767444|FG003|Overall Study|Adverse Event|4
2153769|NCT01202591|3767445|FG004|Overall Study|Adverse Event|0
2153770|NCT01202591|3767446|FG005|Overall Study|Adverse Event|0
2153771|NCT01202591|3767441|FG000|Overall Study|Other reason as per investigator|3
2153772|NCT01202591|3767442|FG001|Overall Study|Other reason as per investigator|4
2153773|NCT01202591|3767443|FG002|Overall Study|Other reason as per investigator|7
2153774|NCT01202591|3767444|FG003|Overall Study|Other reason as per investigator|3
2153775|NCT01202591|3767445|FG004|Overall Study|Other reason as per investigator|1
2153776|NCT01202591|3767446|FG005|Overall Study|Other reason as per investigator|3
2153777|NCT01202591|3767441|FG000|Overall Study|Withdrawal by Subject|0
2153778|NCT01202591|3767442|FG001|Overall Study|Withdrawal by Subject|0
2153779|NCT01202591|3767443|FG002|Overall Study|Withdrawal by Subject|0
2153780|NCT01202591|3767444|FG003|Overall Study|Withdrawal by Subject|0
2153781|NCT01202591|3767445|FG004|Overall Study|Withdrawal by Subject|2
2153782|NCT01202591|3767446|FG005|Overall Study|Withdrawal by Subject|1
2153783|NCT01202591|3767441|FG000|Overall Study|Objective Disease Progression|0
2153784|NCT01202591|3767442|FG001|Overall Study|Objective Disease Progression|0
2153785|NCT01202591|3767443|FG002|Overall Study|Objective Disease Progression|0
2153786|NCT01202591|3767444|FG003|Overall Study|Objective Disease Progression|0
2153787|NCT01202591|3767445|FG004|Overall Study|Objective Disease Progression|2
2153788|NCT01202591|3767446|FG005|Overall Study|Objective Disease Progression|0
2153789|NCT01202747|3767497|FG000|Overall Study|Withdrawal by Subject|1
2153790|NCT01202760|3767504|FG000|Overall Study|Entry Criteria Not Met|0
2153791|NCT01202760|3767505|FG001|Overall Study|Entry Criteria Not Met|3
2153792|NCT01202760|3767506|FG002|Overall Study|Entry Criteria Not Met|1
2153793|NCT01202760|3767504|FG000|Overall Study|Adverse Event|11
2153794|NCT01202760|3767505|FG001|Overall Study|Adverse Event|9
2153795|NCT01202760|3767506|FG002|Overall Study|Adverse Event|10
2153796|NCT01202760|3767504|FG000|Overall Study|Death|2
2153797|NCT01202760|3767505|FG001|Overall Study|Death|1
2153798|NCT01202760|3767506|FG002|Overall Study|Death|0
2153799|NCT01202760|3767504|FG000|Overall Study|Lack of Efficacy|6
2153800|NCT01202760|3767505|FG001|Overall Study|Lack of Efficacy|8
2153801|NCT01202760|3767506|FG002|Overall Study|Lack of Efficacy|7
2153802|NCT01202760|3767504|FG000|Overall Study|Lost to Follow-up|0
2153803|NCT01202760|3767505|FG001|Overall Study|Lost to Follow-up|2
2153804|NCT01202760|3767506|FG002|Overall Study|Lost to Follow-up|1
2153805|NCT01202760|3767504|FG000|Overall Study|Parent / Caregiver Decision|0
2153806|NCT01202760|3767505|FG001|Overall Study|Parent / Caregiver Decision|1
2153807|NCT01202760|3767506|FG002|Overall Study|Parent / Caregiver Decision|0
2153808|NCT01202760|3767504|FG000|Overall Study|Withdrawal by Subject|17
2153809|NCT01202760|3767505|FG001|Overall Study|Withdrawal by Subject|18
2153810|NCT01202760|3767506|FG002|Overall Study|Withdrawal by Subject|14
2153811|NCT01202760|3767504|FG000|Overall Study|Physician Decision|0
2153812|NCT01202760|3767505|FG001|Overall Study|Physician Decision|1
2153813|NCT01202760|3767506|FG002|Overall Study|Physician Decision|0
2153814|NCT01202760|3767504|FG000|Overall Study|Protocol Violation|7
2153815|NCT01202760|3767505|FG001|Overall Study|Protocol Violation|5
2153816|NCT01202760|3767506|FG002|Overall Study|Protocol Violation|2
2153817|NCT01202760|3767504|FG000|Overall Study|Sponsor Decision|4
2153818|NCT01202760|3767505|FG001|Overall Study|Sponsor Decision|4
2153819|NCT01202760|3767506|FG002|Overall Study|Sponsor Decision|0
2153820|NCT01202773|3767529|FG000|Overall Study|Adverse Event|4
2153821|NCT01202773|3767530|FG001|Overall Study|Adverse Event|5
2153822|NCT01202773|3767531|FG002|Overall Study|Adverse Event|5
2153823|NCT01202773|3767529|FG000|Overall Study|Lack of Efficacy|5
2153824|NCT01202773|3767530|FG001|Overall Study|Lack of Efficacy|4
2153825|NCT01202773|3767531|FG002|Overall Study|Lack of Efficacy|9
2153826|NCT01202773|3767529|FG000|Overall Study|Entry Criteria Not Met|2
2153827|NCT01202773|3767530|FG001|Overall Study|Entry Criteria Not Met|0
2153828|NCT01202773|3767531|FG002|Overall Study|Entry Criteria Not Met|1
2153829|NCT01202773|3767529|FG000|Overall Study|Lost to Follow-up|1
2153830|NCT01202773|3767530|FG001|Overall Study|Lost to Follow-up|2
2153831|NCT01202773|3767531|FG002|Overall Study|Lost to Follow-up|2
2153832|NCT01202773|3767529|FG000|Overall Study|Withdrawal by Subject|13
2153833|NCT01202773|3767530|FG001|Overall Study|Withdrawal by Subject|6
2153834|NCT01202773|3767531|FG002|Overall Study|Withdrawal by Subject|5
2153835|NCT01202773|3767529|FG000|Overall Study|Physician Decision|2
2153836|NCT01202773|3767530|FG001|Overall Study|Physician Decision|0
2153837|NCT01202773|3767531|FG002|Overall Study|Physician Decision|0
2153838|NCT01202773|3767529|FG000|Overall Study|Protocol Violation|11
2153839|NCT01202773|3767530|FG001|Overall Study|Protocol Violation|6
2153840|NCT01202773|3767531|FG002|Overall Study|Protocol Violation|10
2153841|NCT01202773|3767529|FG000|Overall Study|Sponsor Decision|19
2153842|NCT01202773|3767530|FG001|Overall Study|Sponsor Decision|20
2153843|NCT01202773|3767531|FG002|Overall Study|Sponsor Decision|23
2153844|NCT01202877|3767552|FG000|Overall Study|Disease Progression|0
2153845|NCT01202877|3767553|FG001|Overall Study|Disease Progression|1
2153846|NCT01202877|3767554|FG002|Overall Study|Disease Progression|2
2153847|NCT01202877|3767552|FG000|Overall Study|Adverse Event|0
2153848|NCT01202877|3767553|FG001|Overall Study|Adverse Event|0
2153849|NCT01202877|3767554|FG002|Overall Study|Adverse Event|2
2153850|NCT01202877|3767552|FG000|Overall Study|Withdrawal by Subject|0
2153851|NCT01202877|3767553|FG001|Overall Study|Withdrawal by Subject|0
2153852|NCT01202877|3767554|FG002|Overall Study|Withdrawal by Subject|1
2153853|NCT01202877|3767552|FG000|Overall Study|Death|0
2153854|NCT01202877|3767553|FG001|Overall Study|Death|0
2153855|NCT01202877|3767554|FG002|Overall Study|Death|1
2153856|NCT01202903|3767564|FG000|Overall Study|Administrative Probelms|1
2153857|NCT01202903|3767565|FG001|Overall Study|Administrative Probelms|4
2153858|NCT01202903|3767564|FG000|Overall Study|Protocol Violation|0
2153859|NCT01202903|3767565|FG001|Overall Study|Protocol Violation|1
2153860|NCT01202903|3767564|FG000|Overall Study|Death|1
2153861|NCT01202903|3767565|FG001|Overall Study|Death|0
2153862|NCT01202903|3767564|FG000|Overall Study|Lost to Follow-up|1
2153863|NCT01202903|3767565|FG001|Overall Study|Lost to Follow-up|1
2153864|NCT01202903|3767564|FG000|Overall Study|Lack of Efficacy|1
2153865|NCT01202903|3767565|FG001|Overall Study|Lack of Efficacy|3
2153866|NCT01202903|3767564|FG000|Overall Study|Adverse Event|3
2153867|NCT01202903|3767565|FG001|Overall Study|Adverse Event|3
2153868|NCT01202903|3767564|FG000|Overall Study|Withdrawal by Subject|4
2153869|NCT01202903|3767565|FG001|Overall Study|Withdrawal by Subject|4
2153870|NCT01202955|3767573|FG000|Period 1: 10 Days|Withdrawal by Subject|0
2153871|NCT01202955|3767574|FG001|Period 1: 10 Days|Withdrawal by Subject|2
2153872|NCT01203072|3767601|FG000|Overall Study|Adverse Event|5
2153873|NCT01203072|3767602|FG001|Overall Study|Adverse Event|3
2153874|NCT01203072|3767603|FG002|Overall Study|Adverse Event|2
2041675|NCT00440466|3612401|FG002|Overall Study|Physician Decision|1
2041676|NCT00440466|3612399|FG000|Overall Study|Protocol Violation|2
2041677|NCT00440466|3612400|FG001|Overall Study|Protocol Violation|0
2041678|NCT00440466|3612401|FG002|Overall Study|Protocol Violation|4
2041679|NCT00440466|3612399|FG000|Overall Study|Withdrawal by Subject|2
2041680|NCT00440466|3612400|FG001|Overall Study|Withdrawal by Subject|5
2153875|NCT01203072|3767604|FG003|Overall Study|Adverse Event|4
2153876|NCT01203072|3767605|FG004|Overall Study|Adverse Event|2
2153877|NCT01203072|3767601|FG000|Overall Study|Lack of Efficacy|1
2153878|NCT01203072|3767602|FG001|Overall Study|Lack of Efficacy|0
2153879|NCT01203072|3767603|FG002|Overall Study|Lack of Efficacy|0
2153880|NCT01203072|3767604|FG003|Overall Study|Lack of Efficacy|0
2153881|NCT01203072|3767605|FG004|Overall Study|Lack of Efficacy|0
2153882|NCT01203072|3767601|FG000|Overall Study|Lost to Follow-up|0
2153883|NCT01203072|3767602|FG001|Overall Study|Lost to Follow-up|1
2153884|NCT01203072|3767603|FG002|Overall Study|Lost to Follow-up|0
2153885|NCT01203072|3767604|FG003|Overall Study|Lost to Follow-up|0
2153886|NCT01203072|3767605|FG004|Overall Study|Lost to Follow-up|0
2153887|NCT01203072|3767601|FG000|Overall Study|Protocol Violation|2
2153888|NCT01203072|3767602|FG001|Overall Study|Protocol Violation|0
2153889|NCT01203072|3767603|FG002|Overall Study|Protocol Violation|0
2153890|NCT01203072|3767604|FG003|Overall Study|Protocol Violation|0
2153891|NCT01203072|3767605|FG004|Overall Study|Protocol Violation|1
2153892|NCT01203072|3767601|FG000|Overall Study|Withdrawal by Subject|2
2153893|NCT01203072|3767602|FG001|Overall Study|Withdrawal by Subject|2
2153894|NCT01203072|3767603|FG002|Overall Study|Withdrawal by Subject|1
2153895|NCT01203072|3767604|FG003|Overall Study|Withdrawal by Subject|2
2153896|NCT01203072|3767605|FG004|Overall Study|Withdrawal by Subject|3
2153897|NCT01203098|3767620|FG000|Overall Study|Adverse Event|3
2153898|NCT01203098|3767621|FG001|Overall Study|Adverse Event|1
2153899|NCT01203098|3767622|FG002|Overall Study|Adverse Event|7
2153900|NCT01203098|3767620|FG000|Overall Study|Lost to Follow-up|0
2153901|NCT01203098|3767621|FG001|Overall Study|Lost to Follow-up|0
2153902|NCT01203098|3767622|FG002|Overall Study|Lost to Follow-up|1
2153903|NCT01203098|3767620|FG000|Overall Study|Physician Decision|2
2153904|NCT01203098|3767621|FG001|Overall Study|Physician Decision|2
2153905|NCT01203098|3767622|FG002|Overall Study|Physician Decision|0
2153906|NCT01203098|3767620|FG000|Overall Study|Withdrawal by Subject|1
2153907|NCT01203098|3767621|FG001|Overall Study|Withdrawal by Subject|1
2153908|NCT01203098|3767622|FG002|Overall Study|Withdrawal by Subject|3
2153909|NCT01203787|3767677|FG000|Overall Study|Death|12
2153910|NCT01203787|3767678|FG001|Overall Study|Death|10
2153911|NCT01203787|3767677|FG000|Overall Study|Withdrawal by Subject|6
2153912|NCT01203787|3767678|FG001|Overall Study|Withdrawal by Subject|2
2153913|NCT01203787|3767677|FG000|Overall Study|Lost to Follow-up|2
2153914|NCT01203787|3767678|FG001|Overall Study|Lost to Follow-up|0
2153915|NCT01203787|3767677|FG000|Overall Study|Adverse Event|11
2153916|NCT01203787|3767678|FG001|Overall Study|Adverse Event|15
2153917|NCT01203852|3767695|FG000|Metoprolol 8 Weeks|Physician Decision|470
2153918|NCT01203852|3767695|FG000|Washout 2 Weeks|Physician Decision|46
2153919|NCT01203878|3767705|FG000|Overall Study|Withdrawal by Subject|0
2153920|NCT01203878|3767706|FG001|Overall Study|Withdrawal by Subject|0
2153921|NCT01203878|3767707|FG002|Overall Study|Withdrawal by Subject|1
2153922|NCT01203878|3767705|FG000|Overall Study|Adverse Event|0
2153923|NCT01203878|3767706|FG001|Overall Study|Adverse Event|0
2153924|NCT01203878|3767707|FG002|Overall Study|Adverse Event|2
2153925|NCT01203917|3767714|FG000|Overall Study|Death|29
2153926|NCT01203917|3767714|FG000|Overall Study|Lost to Follow-up|2
2153927|NCT01203917|3767714|FG000|Overall Study|Withdrawal by Subject|3
2153928|NCT01203917|3767714|FG000|Overall Study|Due to objective disease progression|1
2153929|NCT01203917|3767714|FG000|Overall Study|Due to EGFR M+I patient|1
2153930|NCT01203930|3767720|FG000|Overall Study|Disease Progression|0
2153931|NCT01203930|3767721|FG001|Overall Study|Disease Progression|4
2153932|NCT01203930|3767720|FG000|Overall Study|Death|3
2153933|NCT01203930|3767721|FG001|Overall Study|Death|1
2153934|NCT01203930|3767720|FG000|Overall Study|Withdrew Consent|1
2153935|NCT01203930|3767721|FG001|Overall Study|Withdrew Consent|10
2153936|NCT01203930|3767720|FG000|Overall Study|Investigator Request|0
2153937|NCT01203930|3767721|FG001|Overall Study|Investigator Request|8
2153938|NCT01203930|3767720|FG000|Overall Study|Study Terminated by Sponsor|0
2153939|NCT01203930|3767721|FG001|Overall Study|Study Terminated by Sponsor|12
2153940|NCT01203930|3767720|FG000|Overall Study|Poor tolerance of study drug|0
2153941|NCT01203930|3767721|FG001|Overall Study|Poor tolerance of study drug|1
2041681|NCT00440466|3612401|FG002|Overall Study|Withdrawal by Subject|9
2153942|NCT01203930|3767720|FG000|Overall Study|Adverse Event|17
2153943|NCT01203930|3767721|FG001|Overall Study|Adverse Event|5
2153944|NCT01203956|3767729|FG000|Second Two-week Period|Non-compliant: no evaluable results|5
2153945|NCT01203956|3767730|FG001|Second Two-week Period|Non-compliant: no evaluable results|6
2153946|NCT01204294|3767752|FG000|Overall Study|Adverse Event|2
2153947|NCT01204294|3767753|FG001|Overall Study|Adverse Event|6
2153948|NCT01204294|3767754|FG002|Overall Study|Adverse Event|0
2153949|NCT01204294|3767755|FG003|Overall Study|Adverse Event|7
2153950|NCT01204294|3767756|FG004|Overall Study|Adverse Event|1
2153951|NCT01204294|3767757|FG005|Overall Study|Adverse Event|4
2292471|NCT02513550|3986091|FG000|Double Blind Treatment Period|Withdrawal by Subject|11
2292472|NCT02513550|3986092|FG001|Double Blind Treatment Period|Withdrawal by Subject|11
2292473|NCT02513550|3986093|FG002|Double Blind Treatment Period|Withdrawal by Subject|25
2153952|NCT01204294|3767758|FG006|Overall Study|Adverse Event|0
2153953|NCT01204294|3767752|FG000|Overall Study|Protocol Violation|1
2153954|NCT01204294|3767753|FG001|Overall Study|Protocol Violation|0
2153955|NCT01204294|3767754|FG002|Overall Study|Protocol Violation|2
2153956|NCT01204294|3767755|FG003|Overall Study|Protocol Violation|1
2153957|NCT01204294|3767756|FG004|Overall Study|Protocol Violation|0
2153958|NCT01204294|3767757|FG005|Overall Study|Protocol Violation|0
2153959|NCT01204294|3767758|FG006|Overall Study|Protocol Violation|0
2153960|NCT01204294|3767752|FG000|Overall Study|Withdrawal by Subject|0
2153961|NCT01204294|3767753|FG001|Overall Study|Withdrawal by Subject|2
2153962|NCT01204294|3767754|FG002|Overall Study|Withdrawal by Subject|2
2153963|NCT01204294|3767755|FG003|Overall Study|Withdrawal by Subject|1
2153964|NCT01204294|3767756|FG004|Overall Study|Withdrawal by Subject|1
2153965|NCT01204294|3767757|FG005|Overall Study|Withdrawal by Subject|1
2153966|NCT01204294|3767758|FG006|Overall Study|Withdrawal by Subject|2
2153967|NCT01204294|3767752|FG000|Overall Study|Lack of Efficacy|0
2153968|NCT01204294|3767753|FG001|Overall Study|Lack of Efficacy|0
2153969|NCT01204294|3767754|FG002|Overall Study|Lack of Efficacy|0
2153970|NCT01204294|3767755|FG003|Overall Study|Lack of Efficacy|2
2153971|NCT01204294|3767756|FG004|Overall Study|Lack of Efficacy|0
2153972|NCT01204294|3767757|FG005|Overall Study|Lack of Efficacy|0
2292474|NCT02513550|3986094|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
2292475|NCT02513550|3986095|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
2292476|NCT02513550|3986096|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
2292477|NCT02513550|3986091|FG000|Double Blind Treatment Period|Adverse Event|5
2292478|NCT02513550|3986092|FG001|Double Blind Treatment Period|Adverse Event|13
2292479|NCT02513550|3986093|FG002|Double Blind Treatment Period|Adverse Event|17
2292480|NCT02513550|3986094|FG003|Double Blind Treatment Period|Adverse Event|0
2292481|NCT02513550|3986095|FG004|Double Blind Treatment Period|Adverse Event|1
2292482|NCT02513550|3986096|FG005|Double Blind Treatment Period|Adverse Event|0
2292483|NCT02513550|3986091|FG000|Double Blind Treatment Period|Lost to Follow-up|9
2292484|NCT02513550|3986092|FG001|Double Blind Treatment Period|Lost to Follow-up|7
2292485|NCT02513550|3986093|FG002|Double Blind Treatment Period|Lost to Follow-up|11
2292486|NCT02513550|3986094|FG003|Double Blind Treatment Period|Lost to Follow-up|0
2292487|NCT02513550|3986095|FG004|Double Blind Treatment Period|Lost to Follow-up|0
2292488|NCT02513550|3986096|FG005|Double Blind Treatment Period|Lost to Follow-up|1
2292489|NCT02513550|3986091|FG000|Double Blind Treatment Period|Lack of Efficacy|4
2292490|NCT02513550|3986092|FG001|Double Blind Treatment Period|Lack of Efficacy|5
2292491|NCT02513550|3986093|FG002|Double Blind Treatment Period|Lack of Efficacy|6
2292492|NCT02513550|3986094|FG003|Double Blind Treatment Period|Lack of Efficacy|0
2292493|NCT02513550|3986095|FG004|Double Blind Treatment Period|Lack of Efficacy|0
2292494|NCT02513550|3986096|FG005|Double Blind Treatment Period|Lack of Efficacy|0
2292495|NCT02513550|3986091|FG000|Double Blind Treatment Period|Protocol Violation|1
2292496|NCT02513550|3986092|FG001|Double Blind Treatment Period|Protocol Violation|1
2292497|NCT02513550|3986093|FG002|Double Blind Treatment Period|Protocol Violation|4
2292498|NCT02513550|3986094|FG003|Double Blind Treatment Period|Protocol Violation|0
2292499|NCT02513550|3986095|FG004|Double Blind Treatment Period|Protocol Violation|0
2292500|NCT02513550|3986096|FG005|Double Blind Treatment Period|Protocol Violation|0
2292501|NCT02513550|3986091|FG000|Double Blind Treatment Period|Physician Decision|2
2292502|NCT02513550|3986092|FG001|Double Blind Treatment Period|Physician Decision|0
2292503|NCT02513550|3986093|FG002|Double Blind Treatment Period|Physician Decision|4
2292504|NCT02513550|3986094|FG003|Double Blind Treatment Period|Physician Decision|0
2292505|NCT02513550|3986095|FG004|Double Blind Treatment Period|Physician Decision|0
2292506|NCT02513550|3986096|FG005|Double Blind Treatment Period|Physician Decision|0
2292507|NCT02513550|3986091|FG000|Double Blind Treatment Period|Site terminated by sponsor|1
2292508|NCT02513550|3986092|FG001|Double Blind Treatment Period|Site terminated by sponsor|1
2292509|NCT02513550|3986093|FG002|Double Blind Treatment Period|Site terminated by sponsor|3
2292510|NCT02513550|3986094|FG003|Double Blind Treatment Period|Site terminated by sponsor|0
2292511|NCT02513550|3986095|FG004|Double Blind Treatment Period|Site terminated by sponsor|0
2292512|NCT02513550|3986096|FG005|Double Blind Treatment Period|Site terminated by sponsor|0
2292513|NCT02513550|3986091|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2292514|NCT02513550|3986092|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2292515|NCT02513550|3986093|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
2292516|NCT02513550|3986094|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2292517|NCT02513550|3986095|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2153973|NCT01204294|3767758|FG006|Overall Study|Lack of Efficacy|0
2153974|NCT01204294|3767752|FG000|Overall Study|Other (house moving)|0
2153975|NCT01204294|3767753|FG001|Overall Study|Other (house moving)|0
2153976|NCT01204294|3767754|FG002|Overall Study|Other (house moving)|1
2153977|NCT01204294|3767755|FG003|Overall Study|Other (house moving)|0
2153978|NCT01204294|3767756|FG004|Overall Study|Other (house moving)|0
2153979|NCT01204294|3767757|FG005|Overall Study|Other (house moving)|0
2153980|NCT01204294|3767758|FG006|Overall Study|Other (house moving)|0
2153981|NCT01204398|3767774|FG000|Overall Study|Adverse Event|1
2153982|NCT01204658|3767782|FG000|Primary Phase|Adverse Event|0
2153983|NCT01204658|3767783|FG001|Primary Phase|Adverse Event|0
2153984|NCT01204658|3767784|FG002|Primary Phase|Adverse Event|1
2153985|NCT01204658|3767785|FG003|Primary Phase|Adverse Event|0
2153986|NCT01204671|3767803|FG000|Overall Study|Adverse Event|4
2153987|NCT01204671|3767804|FG001|Overall Study|Adverse Event|3
2153988|NCT01204671|3767805|FG002|Overall Study|Adverse Event|3
2153989|NCT01204671|3767806|FG003|Overall Study|Adverse Event|3
2153990|NCT01204671|3767807|FG004|Overall Study|Adverse Event|1
2153991|NCT01204671|3767803|FG000|Overall Study|Withdrawal by Subject|2
2153992|NCT01204671|3767804|FG001|Overall Study|Withdrawal by Subject|3
2153993|NCT01204671|3767805|FG002|Overall Study|Withdrawal by Subject|4
2153994|NCT01204671|3767806|FG003|Overall Study|Withdrawal by Subject|5
2153995|NCT01204671|3767807|FG004|Overall Study|Withdrawal by Subject|3
2153996|NCT01204671|3767803|FG000|Overall Study|Lost to Follow-up|7
2153997|NCT01204671|3767804|FG001|Overall Study|Lost to Follow-up|8
2153998|NCT01204671|3767805|FG002|Overall Study|Lost to Follow-up|6
2153999|NCT01204671|3767806|FG003|Overall Study|Lost to Follow-up|4
2154000|NCT01204671|3767807|FG004|Overall Study|Lost to Follow-up|0
2154001|NCT01204671|3767803|FG000|Overall Study|Unknown Completion Status|1
2154002|NCT01204671|3767804|FG001|Overall Study|Unknown Completion Status|1
2154003|NCT01204671|3767805|FG002|Overall Study|Unknown Completion Status|0
2154004|NCT01204671|3767806|FG003|Overall Study|Unknown Completion Status|0
2154005|NCT01204671|3767807|FG004|Overall Study|Unknown Completion Status|0
2154006|NCT01204671|3767803|FG000|Overall Study|Physician Decision|0
2154007|NCT01204671|3767804|FG001|Overall Study|Physician Decision|0
2154008|NCT01204671|3767805|FG002|Overall Study|Physician Decision|0
2154009|NCT01204671|3767806|FG003|Overall Study|Physician Decision|1
2154010|NCT01204671|3767807|FG004|Overall Study|Physician Decision|0
2154011|NCT01204697|3767825|FG000|Overall Study|Death|26
2154012|NCT01204697|3767826|FG001|Overall Study|Death|27
2154013|NCT01204697|3767825|FG000|Overall Study|Lost to Follow-up|3
2154014|NCT01204697|3767826|FG001|Overall Study|Lost to Follow-up|4
2154015|NCT01204697|3767825|FG000|Overall Study|Withdrawal by Subject|2
2154016|NCT01204697|3767826|FG001|Overall Study|Withdrawal by Subject|4
2154017|NCT01204697|3767825|FG000|Overall Study|Randomized, but not treated|0
2154018|NCT01204697|3767826|FG001|Overall Study|Randomized, but not treated|1
2154019|NCT01204710|3767834|FG000|Randomization Treatment|Lost to Follow-up|1
2154020|NCT01204710|3767835|FG001|Randomization Treatment|Lost to Follow-up|0
2154021|NCT01204710|3767834|FG000|Randomization Treatment|Withdrawal by Subject|6
2154022|NCT01204710|3767835|FG001|Randomization Treatment|Withdrawal by Subject|5
2154023|NCT01204710|3767834|FG000|Randomization Treatment|Physician Decision|3
2154024|NCT01204710|3767835|FG001|Randomization Treatment|Physician Decision|2
2154025|NCT01204710|3767834|FG000|Randomization Treatment|Entry criteria not met|0
2154026|NCT01204710|3767835|FG001|Randomization Treatment|Entry criteria not met|1
2154027|NCT01204710|3767834|FG000|Randomization Treatment|Adverse Event|4
2154028|NCT01204710|3767835|FG001|Randomization Treatment|Adverse Event|2
2154029|NCT01204710|3767834|FG000|Randomization Treatment|Sponsor Decision|0
2154030|NCT01204710|3767835|FG001|Randomization Treatment|Sponsor Decision|1
2154031|NCT01204710|3767834|FG000|Randomization Treatment|Worsening of General condition|0
2154032|NCT01204710|3767835|FG001|Randomization Treatment|Worsening of General condition|1
2154033|NCT01204710|3767834|FG000|Randomization Treatment|Moved and Followed for Survival|0
2154034|NCT01204710|3767835|FG001|Randomization Treatment|Moved and Followed for Survival|1
2154035|NCT01204710|3767834|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
2154036|NCT01204710|3767835|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
2154037|NCT01204710|3767834|FG000|Optional Olaratumab Monotherapy|Physician Decision|0
2154038|NCT01204710|3767835|FG001|Optional Olaratumab Monotherapy|Physician Decision|1
2154039|NCT01204710|3767834|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
2154040|NCT01204710|3767835|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
2154041|NCT01204775|3767867|FG000|Overall Study|Poor/non-compliance|0
2154042|NCT01204775|3767868|FG001|Overall Study|Poor/non-compliance|1
2154043|NCT01204775|3767867|FG000|Overall Study|Withdrawal by Subject|1
2154044|NCT01204775|3767868|FG001|Overall Study|Withdrawal by Subject|0
2154045|NCT01204918|3767885|FG000|Overall Study|Withdrawal by Subject|4
2154046|NCT01204918|3767886|FG001|Overall Study|Withdrawal by Subject|10
2154047|NCT01204918|3767887|FG002|Overall Study|Withdrawal by Subject|5
2154048|NCT01205035|3767897|FG000|Overall Study|Withdrawal by Subject|1
2154049|NCT01205035|3767898|FG001|Overall Study|Withdrawal by Subject|0
2154050|NCT01205035|3767897|FG000|Overall Study|Physician Decision|1
2154051|NCT01205035|3767898|FG001|Overall Study|Physician Decision|0
2154052|NCT01205126|3767906|FG000|Titration Phase|Adverse Event|5
2154053|NCT01205126|3767907|FG001|Titration Phase|Adverse Event|3
2154054|NCT01205126|3767906|FG000|Titration Phase|Withdrawal by Subject|5
2154055|NCT01205126|3767907|FG001|Titration Phase|Withdrawal by Subject|5
2154056|NCT01205126|3767906|FG000|Titration Phase|Lost to Follow-up|2
2154057|NCT01205126|3767907|FG001|Titration Phase|Lost to Follow-up|2
2154058|NCT01205126|3767906|FG000|Titration Phase|No stable titration dose|1
2154059|NCT01205126|3767907|FG001|Titration Phase|No stable titration dose|0
2154060|NCT01205126|3767906|FG000|Titration Phase|More than maximum dosage required|2
2154061|NCT01205126|3767907|FG001|Titration Phase|More than maximum dosage required|3
2154062|NCT01205126|3767906|FG000|Titration Phase|Other|8
2154063|NCT01205126|3767907|FG001|Titration Phase|Other|6
2154064|NCT01205126|3767906|FG000|Between Titration & Maintenance Phase|Other|0
2154065|NCT01205126|3767907|FG001|Between Titration & Maintenance Phase|Other|4
2154066|NCT01205126|3767906|FG000|Maintenance Phase|Adverse Event|3
2154067|NCT01205126|3767907|FG001|Maintenance Phase|Adverse Event|7
2154068|NCT01205126|3767906|FG000|Maintenance Phase|Death|4
2154069|NCT01205126|3767907|FG001|Maintenance Phase|Death|4
2154070|NCT01205126|3767906|FG000|Maintenance Phase|More than the maximum dosage required|5
2154071|NCT01205126|3767907|FG001|Maintenance Phase|More than the maximum dosage required|5
2154072|NCT01205126|3767906|FG000|Maintenance Phase|Prohibited drugs used|1
2154073|NCT01205126|3767907|FG001|Maintenance Phase|Prohibited drugs used|0
2154074|NCT01205126|3767906|FG000|Maintenance Phase|Other|11
2154075|NCT01205126|3767907|FG001|Maintenance Phase|Other|8
2154076|NCT01205126|3767906|FG000|Maintenance Phase|Lost to Follow-up|5
2154077|NCT01205126|3767907|FG001|Maintenance Phase|Lost to Follow-up|5
2154078|NCT01205126|3767906|FG000|Maintenance Phase|Withdrawal by Subject|8
2154079|NCT01205126|3767907|FG001|Maintenance Phase|Withdrawal by Subject|11
2154080|NCT01205152|3767913|FG000|Overall Study|Death|1
2154081|NCT01205165|3767919|FG000|Overall Study|Lost to Follow-up|2
2154082|NCT01205230|3767926|FG000|Overall Study|Adverse Event|4
2154083|NCT01205230|3767927|FG001|Overall Study|Adverse Event|0
2154084|NCT01205230|3767926|FG000|Overall Study|Physician Decision|1
2154085|NCT01205230|3767927|FG001|Overall Study|Physician Decision|0
2154086|NCT01205269|3767938|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0
2154087|NCT01205269|3767939|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0
2154088|NCT01205269|3767940|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0
2154089|NCT01205269|3767941|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1
2154090|NCT01205269|3767942|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0
2154091|NCT01205269|3767943|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0
2154092|NCT01205438|3767958|FG000|Overall Study|Adverse Event|19
2154093|NCT01205438|3767959|FG001|Overall Study|Adverse Event|17
2154094|NCT01205438|3767960|FG002|Overall Study|Adverse Event|24
2154095|NCT01205438|3767958|FG000|Overall Study|Death|1
2154096|NCT01205438|3767959|FG001|Overall Study|Death|1
2154097|NCT01205438|3767960|FG002|Overall Study|Death|3
2154098|NCT01205438|3767958|FG000|Overall Study|Entry Criteria Not Met|16
2154099|NCT01205438|3767959|FG001|Overall Study|Entry Criteria Not Met|15
2154100|NCT01205438|3767960|FG002|Overall Study|Entry Criteria Not Met|13
2154101|NCT01205438|3767958|FG000|Overall Study|Lack of Efficacy|14
2154102|NCT01205438|3767959|FG001|Overall Study|Lack of Efficacy|11
2154103|NCT01205438|3767960|FG002|Overall Study|Lack of Efficacy|14
2154104|NCT01205438|3767958|FG000|Overall Study|Lost to Follow-up|6
2154105|NCT01205438|3767959|FG001|Overall Study|Lost to Follow-up|7
2154106|NCT01205438|3767960|FG002|Overall Study|Lost to Follow-up|8
2154107|NCT01205438|3767958|FG000|Overall Study|Withdrawal by Subject|19
2154108|NCT01205438|3767959|FG001|Overall Study|Withdrawal by Subject|25
2154109|NCT01205438|3767960|FG002|Overall Study|Withdrawal by Subject|19
2154110|NCT01205438|3767958|FG000|Overall Study|Physician Decision|0
2154111|NCT01205438|3767959|FG001|Overall Study|Physician Decision|3
2154112|NCT01205438|3767960|FG002|Overall Study|Physician Decision|2
2154113|NCT01205438|3767958|FG000|Overall Study|Protocol Violation|2
2154114|NCT01205438|3767959|FG001|Overall Study|Protocol Violation|7
2154115|NCT01205438|3767960|FG002|Overall Study|Protocol Violation|4
2154116|NCT01205438|3767958|FG000|Overall Study|Sponsor Decision|0
2154117|NCT01205438|3767959|FG001|Overall Study|Sponsor Decision|1
2154118|NCT01205438|3767960|FG002|Overall Study|Sponsor Decision|1
2154119|NCT01205451|3767973|FG000|Overall Study|Lost to Follow-up|1
2154120|NCT01205451|3767974|FG001|Overall Study|Lost to Follow-up|1
2154121|NCT01205451|3767973|FG000|Overall Study|Withdrawal by Subject|5
2154122|NCT01205451|3767974|FG001|Overall Study|Withdrawal by Subject|9
2154123|NCT01205529|3767989|FG000|Overall Study|Procedure Cancelled|4
2154124|NCT01205529|3767989|FG000|Overall Study|Withdrawal by Subject|2
2154125|NCT01205529|3767989|FG000|Overall Study|Physician Decision|4
2154126|NCT01205529|3767989|FG000|Overall Study|Unstable post op|15
2154127|NCT01205529|3767989|FG000|Overall Study|No longer met criteria|30
2154128|NCT01205581|3768004|FG000|Overall Study|Withdrawal by Subject|1
2154129|NCT01205581|3768005|FG001|Overall Study|Withdrawal by Subject|0
2154130|NCT01205581|3768006|FG002|Overall Study|Withdrawal by Subject|0
2154131|NCT01205581|3768007|FG003|Overall Study|Withdrawal by Subject|0
2154132|NCT01205581|3768008|FG004|Overall Study|Withdrawal by Subject|0
2154133|NCT01205581|3768009|FG005|Overall Study|Withdrawal by Subject|0
2154134|NCT01205685|3768044|FG000|Overall Study|Disease Progression|10
2154135|NCT01205685|3768044|FG000|Overall Study|Withdrawal by Subject|1
2154136|NCT01205776|3768050|FG000|Overall Study|Lost to Follow-up|53
2154137|NCT01205776|3768051|FG001|Overall Study|Lost to Follow-up|61
2154138|NCT01205776|3768050|FG000|Overall Study|Withdrawal by Subject|11
2154139|NCT01205776|3768051|FG001|Overall Study|Withdrawal by Subject|34
2154140|NCT01206140|3768075|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1
2154141|NCT01206140|3768076|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0
2154142|NCT01206166|3768084|FG000|Overall Study|No evaluable data|2
2154143|NCT01206166|3768085|FG001|Overall Study|No evaluable data|3
2154144|NCT01206322|3768096|FG000|Overall Study|Adverse Event|0
2154145|NCT01206322|3768097|FG001|Overall Study|Adverse Event|0
2154146|NCT01206322|3768098|FG002|Overall Study|Adverse Event|0
2154147|NCT01206322|3768099|FG003|Overall Study|Adverse Event|1
2154148|NCT01206582|3768158|FG000|Overall Study|Withdrew prior to study|1
2154149|NCT01206582|3768159|FG001|Overall Study|Withdrew prior to study|0
2154150|NCT01206582|3768158|FG000|Overall Study|Discontinued intervention before week 8|1
2154151|NCT01206582|3768159|FG001|Overall Study|Discontinued intervention before week 8|2
2154152|NCT01206764|3768209|FG000|Overall Study|Adverse Event|20
2154153|NCT01206764|3768209|FG000|Overall Study|Abnormal laboratory value|2
2154154|NCT01206764|3768209|FG000|Overall Study|Abnormal test procedure result|1
2154155|NCT01206764|3768209|FG000|Overall Study|Patient withdrew consent|5
2154156|NCT01206764|3768209|FG000|Overall Study|Lost to Follow-up|6
2154157|NCT01206764|3768209|FG000|Overall Study|Death|11
2154158|NCT01206764|3768209|FG000|Overall Study|New cancer therapy|2
2154159|NCT01206764|3768209|FG000|Overall Study|Disease progression|88
2154160|NCT01206764|3768209|FG000|Overall Study|Protocol deviation|3
2154161|NCT01206777|3768213|FG000|Overall Study|Death|1
2154162|NCT01206777|3768213|FG000|Overall Study|Adverse Event|1
2292518|NCT02513550|3986096|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2292519|NCT02513550|3986091|FG000|Double Blind Treatment Period|Due to personal business|2
2292520|NCT02513550|3986092|FG001|Double Blind Treatment Period|Due to personal business|0
2292521|NCT02513550|3986093|FG002|Double Blind Treatment Period|Due to personal business|1
2292522|NCT02513550|3986094|FG003|Double Blind Treatment Period|Due to personal business|0
2292523|NCT02513550|3986095|FG004|Double Blind Treatment Period|Due to personal business|0
2292524|NCT02513550|3986096|FG005|Double Blind Treatment Period|Due to personal business|0
2292525|NCT02513550|3986091|FG000|Double Blind Treatment Period|Death|1
2292526|NCT02513550|3986092|FG001|Double Blind Treatment Period|Death|0
2292527|NCT02513550|3986093|FG002|Double Blind Treatment Period|Death|2
2292528|NCT02513550|3986094|FG003|Double Blind Treatment Period|Death|0
2292529|NCT02513550|3986095|FG004|Double Blind Treatment Period|Death|0
2292530|NCT02513550|3986096|FG005|Double Blind Treatment Period|Death|0
2292531|NCT02513550|3986091|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12
2292532|NCT02513550|3986092|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20
2292533|NCT02513550|3986093|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26
2292534|NCT02513550|3986094|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0
2292535|NCT02513550|3986095|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0
2292536|NCT02513550|3986096|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0
2292537|NCT02513550|3986091|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
2292538|NCT02513550|3986092|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
2292539|NCT02513550|3986093|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
2292540|NCT02513550|3986094|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
2292541|NCT02513550|3986095|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
2292542|NCT02513550|3986096|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
2292543|NCT02513550|3986091|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4
2292544|NCT02513550|3986092|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2
2292545|NCT02513550|3986093|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7
2292546|NCT02513550|3986094|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0
2292547|NCT02513550|3986095|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0
2292548|NCT02513550|3986096|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0
2292549|NCT02513550|3986091|FG000|Post-Treatment Follow-up Period|Adverse Event|1
2292550|NCT02513550|3986092|FG001|Post-Treatment Follow-up Period|Adverse Event|1
2292551|NCT02513550|3986093|FG002|Post-Treatment Follow-up Period|Adverse Event|4
2292552|NCT02513550|3986094|FG003|Post-Treatment Follow-up Period|Adverse Event|0
2292553|NCT02513550|3986095|FG004|Post-Treatment Follow-up Period|Adverse Event|0
2292554|NCT02513550|3986096|FG005|Post-Treatment Follow-up Period|Adverse Event|0
2292555|NCT02513550|3986091|FG000|Post-Treatment Follow-up Period|Physician Decision|2
2292556|NCT02513550|3986092|FG001|Post-Treatment Follow-up Period|Physician Decision|0
2292557|NCT02513550|3986093|FG002|Post-Treatment Follow-up Period|Physician Decision|0
2292558|NCT02513550|3986094|FG003|Post-Treatment Follow-up Period|Physician Decision|0
2292559|NCT02513550|3986095|FG004|Post-Treatment Follow-up Period|Physician Decision|0
2292560|NCT02513550|3986096|FG005|Post-Treatment Follow-up Period|Physician Decision|0
2292561|NCT02513550|3986091|FG000|Post-Treatment Follow-up Period|Death|0
2292562|NCT02513550|3986092|FG001|Post-Treatment Follow-up Period|Death|0
2292563|NCT02513550|3986093|FG002|Post-Treatment Follow-up Period|Death|1
2292564|NCT02513550|3986094|FG003|Post-Treatment Follow-up Period|Death|0
2292565|NCT02513550|3986095|FG004|Post-Treatment Follow-up Period|Death|0
2154163|NCT01206816|3768224|FG000|Overall Study|Protocol Violation|0
2154164|NCT01206816|3768225|FG001|Overall Study|Protocol Violation|0
2154165|NCT01206816|3768226|FG002|Overall Study|Protocol Violation|1
2154166|NCT01206816|3768227|FG003|Overall Study|Protocol Violation|0
2154167|NCT01206816|3768228|FG004|Overall Study|Protocol Violation|0
2154168|NCT01206816|3768229|FG005|Overall Study|Protocol Violation|0
2154169|NCT01206816|3768230|FG006|Overall Study|Protocol Violation|0
2154170|NCT01206816|3768224|FG000|Overall Study|Withdrawal by Subject|0
2154171|NCT01206816|3768225|FG001|Overall Study|Withdrawal by Subject|0
2154172|NCT01206816|3768226|FG002|Overall Study|Withdrawal by Subject|1
2154173|NCT01206816|3768227|FG003|Overall Study|Withdrawal by Subject|0
2154174|NCT01206816|3768228|FG004|Overall Study|Withdrawal by Subject|0
2154175|NCT01206816|3768229|FG005|Overall Study|Withdrawal by Subject|0
2154176|NCT01206816|3768230|FG006|Overall Study|Withdrawal by Subject|0
2154177|NCT01206816|3768224|FG000|Overall Study|Progressive disease|3
2154178|NCT01206816|3768225|FG001|Overall Study|Progressive disease|3
2154179|NCT01206816|3768226|FG002|Overall Study|Progressive disease|13
2154180|NCT01206816|3768227|FG003|Overall Study|Progressive disease|3
2154181|NCT01206816|3768228|FG004|Overall Study|Progressive disease|3
2154182|NCT01206816|3768229|FG005|Overall Study|Progressive disease|16
2154183|NCT01206816|3768230|FG006|Overall Study|Progressive disease|3
2154184|NCT01206816|3768224|FG000|Overall Study|Other AE|0
2154185|NCT01206816|3768225|FG001|Overall Study|Other AE|0
2154186|NCT01206816|3768226|FG002|Overall Study|Other AE|4
2154187|NCT01206816|3768227|FG003|Overall Study|Other AE|0
2154188|NCT01206816|3768228|FG004|Overall Study|Other AE|0
2154189|NCT01206816|3768229|FG005|Overall Study|Other AE|3
2154190|NCT01206816|3768230|FG006|Overall Study|Other AE|2
2154191|NCT01206816|3768224|FG000|Overall Study|other than stated above|0
2154192|NCT01206816|3768225|FG001|Overall Study|other than stated above|0
2154193|NCT01206816|3768226|FG002|Overall Study|other than stated above|1
2154194|NCT01206816|3768227|FG003|Overall Study|other than stated above|0
2154195|NCT01206816|3768228|FG004|Overall Study|other than stated above|0
2154196|NCT01206816|3768229|FG005|Overall Study|other than stated above|0
2154197|NCT01206816|3768230|FG006|Overall Study|other than stated above|1
2154198|NCT01207219|3768253|FG000|Overall Study|changed diagnosis during study period|5
2154199|NCT01207219|3768254|FG001|Overall Study|changed diagnosis during study period|3
2154200|NCT01207219|3768255|FG002|Overall Study|changed diagnosis during study period|1
2154201|NCT01207219|3768253|FG000|Overall Study|Lost to Follow-up|6
2154202|NCT01207219|3768254|FG001|Overall Study|Lost to Follow-up|8
2154203|NCT01207219|3768255|FG002|Overall Study|Lost to Follow-up|6
2179275|NCT01393158|3804804|FG000|Overall Study|Adverse Event|1
2179276|NCT01393158|3804805|FG001|Overall Study|Adverse Event|0
2179277|NCT01393301|3804819|FG000|Overall Study|Lost to Follow-up|5
2179278|NCT01393301|3804820|FG001|Overall Study|Lost to Follow-up|3
2179279|NCT01393301|3804819|FG000|Overall Study|Withdrawal by Subject|2
2179280|NCT01393301|3804820|FG001|Overall Study|Withdrawal by Subject|0
2179281|NCT01393301|3804819|FG000|Overall Study|Completed <7 sessions (intervention)|2
2179282|NCT01393301|3804820|FG001|Overall Study|Completed <7 sessions (intervention)|0
2179283|NCT01393405|3804835|FG000|Induction Period (week1-16)|Lack of Efficacy|70
2179284|NCT01393405|3804836|FG001|Induction Period (week1-16)|Lack of Efficacy|0
2179285|NCT01393405|3804837|FG002|Induction Period (week1-16)|Lack of Efficacy|0
2179286|NCT01393405|3804835|FG000|Induction Period (week1-16)|Adverse Event|16
2179287|NCT01393405|3804836|FG001|Induction Period (week1-16)|Adverse Event|0
2179288|NCT01393405|3804837|FG002|Induction Period (week1-16)|Adverse Event|0
2179289|NCT01393405|3804835|FG000|Induction Period (week1-16)|Withdrawal by Subject|9
2179290|NCT01393405|3804836|FG001|Induction Period (week1-16)|Withdrawal by Subject|0
2179291|NCT01393405|3804837|FG002|Induction Period (week1-16)|Withdrawal by Subject|0
2179292|NCT01393405|3804835|FG000|Maintenance Period Week|Lack of Efficacy|0
2179293|NCT01393405|3804836|FG001|Maintenance Period Week|Lack of Efficacy|22
2179294|NCT01393405|3804837|FG002|Maintenance Period Week|Lack of Efficacy|22
2179295|NCT01393405|3804835|FG000|Maintenance Period Week|Adverse Event|0
2179296|NCT01393405|3804836|FG001|Maintenance Period Week|Adverse Event|5
2179297|NCT01393405|3804837|FG002|Maintenance Period Week|Adverse Event|2
2179298|NCT01393405|3804835|FG000|Maintenance Period Week|Withdrawal by Subject|0
2179299|NCT01393405|3804836|FG001|Maintenance Period Week|Withdrawal by Subject|1
2179300|NCT01393405|3804837|FG002|Maintenance Period Week|Withdrawal by Subject|0
2179301|NCT01393405|3804835|FG000|Maintenance Period Week|Lost to Follow-up|0
2179302|NCT01393405|3804836|FG001|Maintenance Period Week|Lost to Follow-up|1
2179303|NCT01393405|3804837|FG002|Maintenance Period Week|Lost to Follow-up|0
2179304|NCT01393444|3804847|FG000|Overall Study|Withdrawal by Subject|1
2179305|NCT01393444|3804847|FG000|Overall Study|Determined ineligible during screening.|2
2179306|NCT01393600|3804868|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
2179307|NCT01393600|3804869|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
2179308|NCT01393600|3804870|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
2179309|NCT01393600|3804871|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
2179310|NCT01393600|3804868|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
2179311|NCT01393600|3804869|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
2179312|NCT01393600|3804870|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
2179313|NCT01393600|3804871|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
2179314|NCT01393600|3804868|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
2179315|NCT01393600|3804869|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
2179316|NCT01393600|3804870|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
2154204|NCT01207388|3768263|FG000|Overall Study|Death|67
2154205|NCT01207388|3768263|FG000|Overall Study|Withdrawal by Subject|1
2154206|NCT01207414|3768286|FG000|Overall Study|Adverse Event|25
2154207|NCT01207414|3768287|FG001|Overall Study|Adverse Event|39
2154208|NCT01207414|3768286|FG000|Overall Study|Abnormal test procedure results|0
2154209|NCT01207414|3768287|FG001|Overall Study|Abnormal test procedure results|1
2154210|NCT01207414|3768286|FG000|Overall Study|Unsatisfactory therapeutic effect|5
2154211|NCT01207414|3768287|FG001|Overall Study|Unsatisfactory therapeutic effect|4
2154212|NCT01207414|3768286|FG000|Overall Study|Patient withdrew consent|14
2154213|NCT01207414|3768287|FG001|Overall Study|Patient withdrew consent|11
2154214|NCT01207414|3768286|FG000|Overall Study|Lost to Follow-up|15
2154215|NCT01207414|3768287|FG001|Overall Study|Lost to Follow-up|17
2154216|NCT01207414|3768286|FG000|Overall Study|Administrative problems|1
2154217|NCT01207414|3768287|FG001|Overall Study|Administrative problems|1
2154218|NCT01207414|3768286|FG000|Overall Study|Protocol deviation|12
2154219|NCT01207414|3768287|FG001|Overall Study|Protocol deviation|9
2154220|NCT01207414|3768286|FG000|Overall Study|Randomized in error|1
2154221|NCT01207414|3768287|FG001|Overall Study|Randomized in error|0
2154222|NCT01207427|3768296|FG000|Double-blind Treatment Period|Adverse Event|0
2154223|NCT01207427|3768297|FG001|Double-blind Treatment Period|Adverse Event|1
2154224|NCT01207427|3768298|FG002|Double-blind Treatment Period|Adverse Event|0
2154225|NCT01207427|3768296|FG000|Double-blind Treatment Period|Lost to Follow-up|0
2154226|NCT01207427|3768297|FG001|Double-blind Treatment Period|Lost to Follow-up|0
2154227|NCT01207427|3768298|FG002|Double-blind Treatment Period|Lost to Follow-up|1
2154228|NCT01207427|3768296|FG000|Double-blind Treatment Period|Protocol Violation|2
2154229|NCT01207427|3768297|FG001|Double-blind Treatment Period|Protocol Violation|1
2154230|NCT01207427|3768298|FG002|Double-blind Treatment Period|Protocol Violation|1
2154231|NCT01207427|3768296|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
2154232|NCT01207427|3768297|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
2154233|NCT01207427|3768298|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
2154234|NCT01207440|3768313|FG000|Overall Study|Adverse Event|46
2154235|NCT01207440|3768314|FG001|Overall Study|Adverse Event|11
2154236|NCT01207440|3768315|FG002|Overall Study|Adverse Event|7
2154237|NCT01207440|3768316|FG003|Overall Study|Adverse Event|2
2154238|NCT01207440|3768317|FG004|Overall Study|Adverse Event|6
2154239|NCT01207440|3768318|FG005|Overall Study|Adverse Event|6
2154240|NCT01207440|3768319|FG006|Overall Study|Adverse Event|2
2154241|NCT01207440|3768313|FG000|Overall Study|Death|6
2154242|NCT01207440|3768314|FG001|Overall Study|Death|3
2154243|NCT01207440|3768315|FG002|Overall Study|Death|2
2154244|NCT01207440|3768316|FG003|Overall Study|Death|2
2154245|NCT01207440|3768317|FG004|Overall Study|Death|7
2154246|NCT01207440|3768318|FG005|Overall Study|Death|5
2154247|NCT01207440|3768319|FG006|Overall Study|Death|1
2154248|NCT01207440|3768313|FG000|Overall Study|Lack of Efficacy|13
2154249|NCT01207440|3768314|FG001|Overall Study|Lack of Efficacy|2
2154250|NCT01207440|3768315|FG002|Overall Study|Lack of Efficacy|5
2154251|NCT01207440|3768316|FG003|Overall Study|Lack of Efficacy|1
2154252|NCT01207440|3768317|FG004|Overall Study|Lack of Efficacy|2
2154253|NCT01207440|3768318|FG005|Overall Study|Lack of Efficacy|3
2154254|NCT01207440|3768319|FG006|Overall Study|Lack of Efficacy|0
2154255|NCT01207440|3768313|FG000|Overall Study|Lost to Follow-up|0
2154256|NCT01207440|3768314|FG001|Overall Study|Lost to Follow-up|0
2154257|NCT01207440|3768315|FG002|Overall Study|Lost to Follow-up|2
2154258|NCT01207440|3768316|FG003|Overall Study|Lost to Follow-up|1
2154259|NCT01207440|3768317|FG004|Overall Study|Lost to Follow-up|0
2154260|NCT01207440|3768318|FG005|Overall Study|Lost to Follow-up|0
2154261|NCT01207440|3768319|FG006|Overall Study|Lost to Follow-up|0
2154262|NCT01207440|3768313|FG000|Overall Study|Non-compliance with Study Drug|3
2154263|NCT01207440|3768314|FG001|Overall Study|Non-compliance with Study Drug|0
2154264|NCT01207440|3768315|FG002|Overall Study|Non-compliance with Study Drug|1
2154265|NCT01207440|3768316|FG003|Overall Study|Non-compliance with Study Drug|0
2154266|NCT01207440|3768317|FG004|Overall Study|Non-compliance with Study Drug|0
2154267|NCT01207440|3768318|FG005|Overall Study|Non-compliance with Study Drug|0
2154268|NCT01207440|3768319|FG006|Overall Study|Non-compliance with Study Drug|0
2154269|NCT01207440|3768313|FG000|Overall Study|Physician Decision|6
2154270|NCT01207440|3768314|FG001|Overall Study|Physician Decision|5
2154271|NCT01207440|3768315|FG002|Overall Study|Physician Decision|5
2154272|NCT01207440|3768316|FG003|Overall Study|Physician Decision|0
2154273|NCT01207440|3768317|FG004|Overall Study|Physician Decision|1
2154274|NCT01207440|3768318|FG005|Overall Study|Physician Decision|0
2154275|NCT01207440|3768319|FG006|Overall Study|Physician Decision|0
2154276|NCT01207440|3768313|FG000|Overall Study|Progressive Disease|19
2154277|NCT01207440|3768314|FG001|Overall Study|Progressive Disease|10
2154278|NCT01207440|3768315|FG002|Overall Study|Progressive Disease|19
2154279|NCT01207440|3768316|FG003|Overall Study|Progressive Disease|7
2154280|NCT01207440|3768317|FG004|Overall Study|Progressive Disease|23
2154281|NCT01207440|3768318|FG005|Overall Study|Progressive Disease|27
2154282|NCT01207440|3768319|FG006|Overall Study|Progressive Disease|0
2154283|NCT01207440|3768313|FG000|Overall Study|Protocol Violation|2
2154284|NCT01207440|3768314|FG001|Overall Study|Protocol Violation|0
2154285|NCT01207440|3768315|FG002|Overall Study|Protocol Violation|0
2154286|NCT01207440|3768316|FG003|Overall Study|Protocol Violation|0
2154287|NCT01207440|3768317|FG004|Overall Study|Protocol Violation|0
2154288|NCT01207440|3768318|FG005|Overall Study|Protocol Violation|0
2154289|NCT01207440|3768319|FG006|Overall Study|Protocol Violation|0
2154290|NCT01207440|3768313|FG000|Overall Study|Site Terminated by Sponsor|69
2154291|NCT01207440|3768314|FG001|Overall Study|Site Terminated by Sponsor|19
2154292|NCT01207440|3768315|FG002|Overall Study|Site Terminated by Sponsor|12
2154293|NCT01207440|3768316|FG003|Overall Study|Site Terminated by Sponsor|2
2154294|NCT01207440|3768317|FG004|Overall Study|Site Terminated by Sponsor|3
2154295|NCT01207440|3768318|FG005|Overall Study|Site Terminated by Sponsor|0
2154296|NCT01207440|3768319|FG006|Overall Study|Site Terminated by Sponsor|2
2154297|NCT01207440|3768313|FG000|Overall Study|Withdrawal by Subject|29
2154298|NCT01207440|3768314|FG001|Overall Study|Withdrawal by Subject|4
2154299|NCT01207440|3768315|FG002|Overall Study|Withdrawal by Subject|5
2154300|NCT01207440|3768316|FG003|Overall Study|Withdrawal by Subject|3
2154301|NCT01207440|3768317|FG004|Overall Study|Withdrawal by Subject|2
2154302|NCT01207440|3768318|FG005|Overall Study|Withdrawal by Subject|2
2154303|NCT01207440|3768319|FG006|Overall Study|Withdrawal by Subject|0
2154304|NCT01207440|3768313|FG000|Overall Study|Reason Not Specified|10
2154305|NCT01207440|3768314|FG001|Overall Study|Reason Not Specified|10
2154306|NCT01207440|3768315|FG002|Overall Study|Reason Not Specified|7
2154307|NCT01207440|3768316|FG003|Overall Study|Reason Not Specified|0
2154308|NCT01207440|3768317|FG004|Overall Study|Reason Not Specified|4
2154309|NCT01207440|3768318|FG005|Overall Study|Reason Not Specified|3
2154310|NCT01207440|3768319|FG006|Overall Study|Reason Not Specified|0
2154311|NCT01207453|3768343|FG000|First Intervention|Adverse Event|2
2154312|NCT01207453|3768344|FG001|First Intervention|Adverse Event|1
2154313|NCT01207453|3768343|FG000|Washout|Adverse Event|1
2154314|NCT01207453|3768344|FG001|Washout|Adverse Event|0
2154315|NCT01207453|3768343|FG000|Washout|Lost to Follow-up|1
2154316|NCT01207453|3768344|FG001|Washout|Lost to Follow-up|0
2154317|NCT01207453|3768343|FG000|2nd Intervention|Adverse Event|1
2154318|NCT01207453|3768344|FG001|2nd Intervention|Adverse Event|2
2154319|NCT01207453|3768343|FG000|2nd Intervention|Lost to Follow-up|1
2154320|NCT01207453|3768344|FG001|2nd Intervention|Lost to Follow-up|0
2154321|NCT01207583|3768374|FG000|Overall Study|Withdrawal by Subject|0
2154322|NCT01207583|3768375|FG001|Overall Study|Withdrawal by Subject|3
2154323|NCT01207583|3768376|FG002|Overall Study|Withdrawal by Subject|1
2154324|NCT01207583|3768374|FG000|Overall Study|Participant failed to return|1
2154325|NCT01207583|3768375|FG001|Overall Study|Participant failed to return|0
2154326|NCT01207583|3768376|FG002|Overall Study|Participant failed to return|0
2154327|NCT01207583|3768374|FG000|Overall Study|Lost to Follow-up|0
2154328|NCT01207583|3768375|FG001|Overall Study|Lost to Follow-up|2
2154329|NCT01207583|3768376|FG002|Overall Study|Lost to Follow-up|0
2154330|NCT01207596|3768397|FG000|Overall Study|Physician Decision|4
2154331|NCT01207596|3768397|FG000|Overall Study|Lack of Efficacy|1
2154332|NCT01207596|3768397|FG000|Overall Study|Adverse Event|3
2154333|NCT01207596|3768397|FG000|Overall Study|Withdrawal by Subject|1
2154334|NCT01207687|3768405|FG000|Overall Study|Adverse Event|1
2154335|NCT01207687|3768405|FG000|Overall Study|Withdrawal by Subject|1
2154336|NCT01208038|3768450|FG000|Overall Study|Withdrawal by Subject|1
2154337|NCT01208051|3768459|FG000|Total Enrollment|Withdrawal by Subject|0
2154338|NCT01208051|3768460|FG001|Total Enrollment|Withdrawal by Subject|1
2154339|NCT01208051|3768461|FG002|Total Enrollment|Withdrawal by Subject|0
2154340|NCT01208051|3768462|FG003|Total Enrollment|Withdrawal by Subject|0
2154341|NCT01208051|3768463|FG004|Total Enrollment|Withdrawal by Subject|2
2154342|NCT01208051|3768459|FG000|Total Enrollment|Brain metastases|0
2154343|NCT01208051|3768460|FG001|Total Enrollment|Brain metastases|0
2154344|NCT01208051|3768461|FG002|Total Enrollment|Brain metastases|1
2154345|NCT01208051|3768462|FG003|Total Enrollment|Brain metastases|0
2154346|NCT01208051|3768463|FG004|Total Enrollment|Brain metastases|0
2154347|NCT01208103|3768479|FG000|Overall Study|Adverse Event|1
2154348|NCT01208103|3768479|FG000|Overall Study|Withdrawal by Subject|1
2154349|NCT01208233|3768499|FG000|Overall Study|Adverse Event|0
2154350|NCT01208233|3768500|FG001|Overall Study|Adverse Event|1
2154351|NCT01208233|3768501|FG002|Overall Study|Adverse Event|2
2154352|NCT01208233|3768502|FG003|Overall Study|Adverse Event|0
2154353|NCT01208233|3768503|FG004|Overall Study|Adverse Event|3
2154354|NCT01208233|3768504|FG005|Overall Study|Adverse Event|5
2154355|NCT01208233|3768499|FG000|Overall Study|Death|0
2154356|NCT01208233|3768500|FG001|Overall Study|Death|0
2154357|NCT01208233|3768501|FG002|Overall Study|Death|0
2154358|NCT01208233|3768502|FG003|Overall Study|Death|0
2154359|NCT01208233|3768503|FG004|Overall Study|Death|3
2154360|NCT01208233|3768504|FG005|Overall Study|Death|5
2154361|NCT01208233|3768499|FG000|Overall Study|Did not meet entrance criteria|2
2154362|NCT01208233|3768500|FG001|Overall Study|Did not meet entrance criteria|1
2154363|NCT01208233|3768501|FG002|Overall Study|Did not meet entrance criteria|1
2154364|NCT01208233|3768502|FG003|Overall Study|Did not meet entrance criteria|0
2154365|NCT01208233|3768503|FG004|Overall Study|Did not meet entrance criteria|1
2154366|NCT01208233|3768504|FG005|Overall Study|Did not meet entrance criteria|0
2154367|NCT01208233|3768499|FG000|Overall Study|Medication error without adverse event|0
2154368|NCT01208233|3768500|FG001|Overall Study|Medication error without adverse event|0
2154369|NCT01208233|3768501|FG002|Overall Study|Medication error without adverse event|0
2154370|NCT01208233|3768502|FG003|Overall Study|Medication error without adverse event|0
2154371|NCT01208233|3768503|FG004|Overall Study|Medication error without adverse event|0
2154372|NCT01208233|3768504|FG005|Overall Study|Medication error without adverse event|1
2154373|NCT01208233|3768499|FG000|Overall Study|Study terminated by sponsor|0
2154374|NCT01208233|3768500|FG001|Overall Study|Study terminated by sponsor|0
2154375|NCT01208233|3768501|FG002|Overall Study|Study terminated by sponsor|0
2154376|NCT01208233|3768502|FG003|Overall Study|Study terminated by sponsor|0
2154377|NCT01208233|3768503|FG004|Overall Study|Study terminated by sponsor|10
2154378|NCT01208233|3768504|FG005|Overall Study|Study terminated by sponsor|7
2154379|NCT01208233|3768499|FG000|Overall Study|Protocol Violation|0
2154380|NCT01208233|3768500|FG001|Overall Study|Protocol Violation|0
2154381|NCT01208233|3768501|FG002|Overall Study|Protocol Violation|0
2154382|NCT01208233|3768502|FG003|Overall Study|Protocol Violation|0
2154383|NCT01208233|3768503|FG004|Overall Study|Protocol Violation|3
2154384|NCT01208233|3768504|FG005|Overall Study|Protocol Violation|0
2154385|NCT01208233|3768499|FG000|Overall Study|Other|2
2154386|NCT01208233|3768500|FG001|Overall Study|Other|1
2154387|NCT01208233|3768501|FG002|Overall Study|Other|0
2154388|NCT01208233|3768502|FG003|Overall Study|Other|0
2154389|NCT01208233|3768503|FG004|Overall Study|Other|0
2154390|NCT01208233|3768504|FG005|Overall Study|Other|1
2154391|NCT01208233|3768499|FG000|Overall Study|Withdrawal by Subject|1
2154392|NCT01208233|3768500|FG001|Overall Study|Withdrawal by Subject|0
2154393|NCT01208233|3768501|FG002|Overall Study|Withdrawal by Subject|1
2154394|NCT01208233|3768502|FG003|Overall Study|Withdrawal by Subject|1
2154395|NCT01208233|3768503|FG004|Overall Study|Withdrawal by Subject|4
2154396|NCT01208233|3768504|FG005|Overall Study|Withdrawal by Subject|2
2154397|NCT01208324|3768528|FG000|Post-randomization of Patch|Withdrawal by Subject|1
2154398|NCT01208324|3768529|FG001|Post-randomization of Patch|Withdrawal by Subject|0
2154399|NCT01208324|3768530|FG002|Post-randomization of Patch|Withdrawal by Subject|0
2154400|NCT01208324|3768531|FG003|Post-randomization of Patch|Withdrawal by Subject|0
2154401|NCT01208337|3768541|FG000|Overall Study|Death|3
2154402|NCT01208402|3768547|FG000|Overall Study|Withdrawal by Subject|1
2154403|NCT01208402|3768548|FG001|Overall Study|Withdrawal by Subject|0
2154404|NCT01208415|3768554|FG000|Overall Study|Death|1
2154405|NCT01208415|3768554|FG000|Overall Study|Lost to Follow-up|2
2154406|NCT01208415|3768554|FG000|Overall Study|Withdrawal by Subject|3
2154407|NCT01208415|3768554|FG000|Overall Study|Device not placed|1
2154408|NCT01208415|3768554|FG000|Overall Study|Still be eligible for follow-up|33
2154409|NCT01208870|3768560|FG000|Overall Study|Lost to Follow-up|2
2154410|NCT01208870|3768561|FG001|Overall Study|Lost to Follow-up|8
2154411|NCT01208961|3768578|FG000|High-Fat Period III|Protocol Violation|1
2154412|NCT01208961|3768579|FG001|High-Fat Period III|Protocol Violation|0
2154413|NCT01209078|3768586|FG000|Overall Study|Adverse Event|5
2154414|NCT01209078|3768587|FG001|Overall Study|Adverse Event|0
2154415|NCT01209078|3768586|FG000|Overall Study|Lost to Follow-up|4
2154416|NCT01209078|3768587|FG001|Overall Study|Lost to Follow-up|0
2154417|NCT01209078|3768586|FG000|Overall Study|Physician Decision|5
2154418|NCT01209078|3768587|FG001|Overall Study|Physician Decision|2
2154419|NCT01209078|3768586|FG000|Overall Study|Withdrawal by Subject|2
2154420|NCT01209078|3768587|FG001|Overall Study|Withdrawal by Subject|1
2154421|NCT01209143|3768597|FG000|Overall Study|Adverse Event|2
2154422|NCT01209143|3768598|FG001|Overall Study|Adverse Event|1
2154423|NCT01209143|3768597|FG000|Overall Study|Death|0
2154424|NCT01209143|3768598|FG001|Overall Study|Death|1
2154425|NCT01209143|3768597|FG000|Overall Study|Physician Decision|3
2154426|NCT01209143|3768598|FG001|Overall Study|Physician Decision|1
2154427|NCT01209143|3768597|FG000|Overall Study|Lost to Follow-up|1
2154428|NCT01209143|3768598|FG001|Overall Study|Lost to Follow-up|0
2154429|NCT01209143|3768597|FG000|Overall Study|Withdrawal by Subject|2
2154430|NCT01209143|3768598|FG001|Overall Study|Withdrawal by Subject|1
2154431|NCT01209143|3768597|FG000|Overall Study|Disease progression|11
2154432|NCT01209143|3768598|FG001|Overall Study|Disease progression|16
2154433|NCT01209286|3768650|FG000|Overall Study|Adverse Event|4
2154434|NCT01209286|3768651|FG001|Overall Study|Adverse Event|3
2154435|NCT01209286|3768652|FG002|Overall Study|Adverse Event|1
2154436|NCT01209286|3768650|FG000|Overall Study|Hematological Relapse After Remission|0
2154437|NCT01209286|3768651|FG001|Overall Study|Hematological Relapse After Remission|1
2154438|NCT01209286|3768652|FG002|Overall Study|Hematological Relapse After Remission|1
2154439|NCT01209286|3768650|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1
2154440|NCT01209286|3768651|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3
2154441|NCT01209286|3768652|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1
2154442|NCT01209286|3768650|FG000|Overall Study|Physician Decision|0
2154443|NCT01209286|3768651|FG001|Overall Study|Physician Decision|2
2154444|NCT01209286|3768652|FG002|Overall Study|Physician Decision|0
2154445|NCT01209286|3768650|FG000|Overall Study|Other|0
2154446|NCT01209286|3768651|FG001|Overall Study|Other|1
2154447|NCT01209286|3768652|FG002|Overall Study|Other|0
2154448|NCT01209325|3768669|FG000|Overall Study|Lost to Follow-up|24
2154449|NCT01209325|3768669|FG000|Overall Study|Adverse Event|1
2154450|NCT01209325|3768669|FG000|Overall Study|Relocated|3
2154451|NCT01209325|3768669|FG000|Overall Study|Refusal after starting therapy|8
2154452|NCT01209325|3768669|FG000|Overall Study|Protocol Violation|4
2154453|NCT01209325|3768669|FG000|Overall Study|Refusal prior to therapy|1
2154454|NCT01209325|3768669|FG000|Overall Study|Incarceration|2
2154455|NCT01209598|3768701|FG000|Overall Study|Withdrawal by Subject|1
2154456|NCT01209598|3768702|FG001|Overall Study|Withdrawal by Subject|0
2154457|NCT01209624|3768709|FG000|Overall Study|Death|2
2154458|NCT01209624|3768709|FG000|Overall Study|Adverse Event|13
2154459|NCT01209624|3768709|FG000|Overall Study|Lack of Efficacy|17
2154460|NCT01209624|3768709|FG000|Overall Study|Lost to Follow-up|290
2154461|NCT01209624|3768709|FG000|Overall Study|Other|4
2154462|NCT01209689|3768715|FG000|Overall Study|Insufficient Therapeutic Response|7
2154463|NCT01209689|3768716|FG001|Overall Study|Insufficient Therapeutic Response|2
2154464|NCT01209689|3768715|FG000|Overall Study|Refused Treatment|8
2154465|NCT01209689|3768716|FG001|Overall Study|Refused Treatment|3
2154466|NCT01209689|3768715|FG000|Overall Study|Adverse Event|4
2154467|NCT01209689|3768716|FG001|Overall Study|Adverse Event|0
2154468|NCT01209689|3768715|FG000|Overall Study|Violation of Selection Criteria at Entry|1
2154469|NCT01209689|3768716|FG001|Overall Study|Violation of Selection Criteria at Entry|0
2154470|NCT01209689|3768715|FG000|Overall Study|Failure to Return|3
2154471|NCT01209689|3768716|FG001|Overall Study|Failure to Return|0
2154472|NCT01209689|3768715|FG000|Overall Study|Sponsor's Decision to Stop the Study|68
2154473|NCT01209689|3768716|FG001|Overall Study|Sponsor's Decision to Stop the Study|17
2154474|NCT01209780|3768750|FG000|Overall Study|Adverse Event|0
2154475|NCT01209780|3768751|FG001|Overall Study|Adverse Event|1
2154476|NCT01209780|3768752|FG002|Overall Study|Adverse Event|0
2154477|NCT01209780|3768753|FG003|Overall Study|Adverse Event|0
2154478|NCT01209780|3768754|FG004|Overall Study|Adverse Event|0
2154479|NCT01209780|3768750|FG000|Overall Study|Withdrawal by Subject|9
2154480|NCT01209780|3768751|FG001|Overall Study|Withdrawal by Subject|2
2154481|NCT01209780|3768752|FG002|Overall Study|Withdrawal by Subject|1
2154482|NCT01209780|3768753|FG003|Overall Study|Withdrawal by Subject|1
2154483|NCT01209780|3768754|FG004|Overall Study|Withdrawal by Subject|0
2154484|NCT01209780|3768750|FG000|Overall Study|Lost to Follow-up|17
2154485|NCT01209780|3768751|FG001|Overall Study|Lost to Follow-up|12
2154486|NCT01209780|3768752|FG002|Overall Study|Lost to Follow-up|3
2154487|NCT01209780|3768753|FG003|Overall Study|Lost to Follow-up|9
2154488|NCT01209780|3768754|FG004|Overall Study|Lost to Follow-up|4
2154489|NCT01209780|3768750|FG000|Overall Study|Protocol Violation|0
2154490|NCT01209780|3768751|FG001|Overall Study|Protocol Violation|1
2154491|NCT01209780|3768752|FG002|Overall Study|Protocol Violation|0
2154492|NCT01209780|3768753|FG003|Overall Study|Protocol Violation|0
2154493|NCT01209780|3768754|FG004|Overall Study|Protocol Violation|0
2154494|NCT01209780|3768750|FG000|Overall Study|Inappropriate enrollment|0
2154495|NCT01209780|3768751|FG001|Overall Study|Inappropriate enrollment|2
2154496|NCT01209780|3768752|FG002|Overall Study|Inappropriate enrollment|0
2154497|NCT01209780|3768753|FG003|Overall Study|Inappropriate enrollment|0
2292566|NCT02513550|3986096|FG005|Post-Treatment Follow-up Period|Death|0
2292567|NCT02513550|3986091|FG000|Post-Treatment Follow-up Period|Subject move out of town|0
2292568|NCT02513550|3986092|FG001|Post-Treatment Follow-up Period|Subject move out of town|0
2292569|NCT02513550|3986093|FG002|Post-Treatment Follow-up Period|Subject move out of town|1
2292570|NCT02513550|3986094|FG003|Post-Treatment Follow-up Period|Subject move out of town|0
2292571|NCT02513550|3986095|FG004|Post-Treatment Follow-up Period|Subject move out of town|0
2292572|NCT02513550|3986096|FG005|Post-Treatment Follow-up Period|Subject move out of town|0
2292573|NCT02513550|3986091|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2292574|NCT02513550|3986092|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2292575|NCT02513550|3986093|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
2292576|NCT02513550|3986094|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2292577|NCT02513550|3986095|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2292578|NCT02513550|3986096|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2292579|NCT02513550|3986091|FG000|Post-Treatment Follow-up Period|Labor Reasons|0
2292580|NCT02513550|3986092|FG001|Post-Treatment Follow-up Period|Labor Reasons|0
2292581|NCT02513550|3986093|FG002|Post-Treatment Follow-up Period|Labor Reasons|1
2292582|NCT02513550|3986094|FG003|Post-Treatment Follow-up Period|Labor Reasons|0
2292583|NCT02513550|3986095|FG004|Post-Treatment Follow-up Period|Labor Reasons|0
2292584|NCT02513550|3986096|FG005|Post-Treatment Follow-up Period|Labor Reasons|0
2292585|NCT02513732|3986126|FG000|Overall Study|Lost to Follow-up|11
2292586|NCT02513732|3986126|FG000|Overall Study|Death|9
2292587|NCT02513732|3986126|FG000|Overall Study|Changing hospital|2
2292588|NCT02513745|3986132|FG000|Overall Study|Criteria at time of surgery not met.|3
2292589|NCT02513745|3986133|FG001|Overall Study|Criteria at time of surgery not met.|3
2292590|NCT02513771|3986141|FG000|Overall Study|Lost to Follow-up|1
2292591|NCT02513771|3986142|FG001|Overall Study|Lost to Follow-up|1
2292592|NCT02513771|3986141|FG000|Overall Study|Not being able to get to clinic|1
2292593|NCT02513771|3986142|FG001|Overall Study|Not being able to get to clinic|0
2292594|NCT02513823|3986148|FG000|Overall Study|Lost to Follow-up|4
2292595|NCT02513823|3986148|FG000|Overall Study|Physician Decision|1
2292596|NCT02514122|3986190|FG000|Overall Study|Withdrawal by Subject|2
2292597|NCT02514122|3986191|FG001|Overall Study|Withdrawal by Subject|0
2292598|NCT02514174|3986197|FG000|Overall Study|Patient refused to continue medication|1
2292599|NCT02514174|3986197|FG000|Overall Study|Adverse Event|2
2292600|NCT02514174|3986197|FG000|Overall Study|Study closed by sponsor|9
2292601|NCT02514174|3986197|FG000|Overall Study|Progressive disease|11
2154498|NCT01209780|3768754|FG004|Overall Study|Inappropriate enrollment|1
2154499|NCT01209832|3768767|FG000|Period 1|Sponsor Decision and was not dosed|1
2154500|NCT01209832|3768767|FG000|Period 2|Sponsor Decision|1
2154501|NCT01209949|3768778|FG000|Overall Study|Lost to Follow-up|3
2154502|NCT01210001|3768785|FG000|Overall Study|Not treated|1
2154503|NCT01210001|3768786|FG001|Overall Study|Not treated|0
2154504|NCT01210001|3768787|FG002|Overall Study|Not treated|0
2154505|NCT01210001|3768785|FG000|Overall Study|Adverse Event|4
2154506|NCT01210001|3768786|FG001|Overall Study|Adverse Event|2
2154507|NCT01210001|3768787|FG002|Overall Study|Adverse Event|5
2154508|NCT01210001|3768785|FG000|Overall Study|Non compliant with protocol|2
2154509|NCT01210001|3768786|FG001|Overall Study|Non compliant with protocol|2
2154510|NCT01210001|3768787|FG002|Overall Study|Non compliant with protocol|3
2154511|NCT01210001|3768785|FG000|Overall Study|Lost to Follow-up|4
2154512|NCT01210001|3768786|FG001|Overall Study|Lost to Follow-up|3
2154513|NCT01210001|3768787|FG002|Overall Study|Lost to Follow-up|2
2154514|NCT01210001|3768785|FG000|Overall Study|Patient refusal to continue,not due toAE|6
2154515|NCT01210001|3768786|FG001|Overall Study|Patient refusal to continue,not due toAE|2
2154516|NCT01210001|3768787|FG002|Overall Study|Patient refusal to continue,not due toAE|1
2154517|NCT01210001|3768785|FG000|Overall Study|Other reason not defined above|2
2154518|NCT01210001|3768786|FG001|Overall Study|Other reason not defined above|2
2154519|NCT01210001|3768787|FG002|Overall Study|Other reason not defined above|1
2154520|NCT01210118|3768806|FG000|Overall Study|Lost to Follow-up|1
2154521|NCT01210118|3768807|FG001|Overall Study|Lost to Follow-up|1
2154522|NCT01210118|3768806|FG000|Overall Study|Protocol Violation|1
2154523|NCT01210118|3768807|FG001|Overall Study|Protocol Violation|1
2154524|NCT01210118|3768806|FG000|Overall Study|Spontaneous abortion|1
2154525|NCT01210118|3768807|FG001|Overall Study|Spontaneous abortion|3
2154526|NCT01210144|3768818|FG000|Overall Study|Lack of ovarian response|1
2154527|NCT01210144|3768819|FG001|Overall Study|Lack of ovarian response|0
2154528|NCT01210144|3768818|FG000|Overall Study|No fertilization|1
2154529|NCT01210144|3768819|FG001|Overall Study|No fertilization|0
2154530|NCT01210144|3768818|FG000|Overall Study|No transfer|1
2154531|NCT01210144|3768819|FG001|Overall Study|No transfer|0
2154532|NCT01210222|3768847|FG000|Overall Study|Ineligible|2
2154533|NCT01210222|3768847|FG000|Overall Study|Never treated|1
2154534|NCT01210352|3768866|FG000|Overall Study|Adverse Event|0
2154535|NCT01210352|3768867|FG001|Overall Study|Adverse Event|0
2154536|NCT01210352|3768868|FG002|Overall Study|Adverse Event|0
2154537|NCT01210352|3768869|FG003|Overall Study|Adverse Event|0
2154538|NCT01210352|3768870|FG004|Overall Study|Adverse Event|0
2154539|NCT01210352|3768871|FG005|Overall Study|Adverse Event|0
2154540|NCT01210352|3768872|FG006|Overall Study|Adverse Event|0
2154541|NCT01210352|3768873|FG007|Overall Study|Adverse Event|2
2154542|NCT01210352|3768874|FG008|Overall Study|Adverse Event|1
2154543|NCT01210352|3768866|FG000|Overall Study|Lack of Efficacy|0
2154544|NCT01210352|3768867|FG001|Overall Study|Lack of Efficacy|0
2154545|NCT01210352|3768868|FG002|Overall Study|Lack of Efficacy|0
2154546|NCT01210352|3768869|FG003|Overall Study|Lack of Efficacy|0
2154547|NCT01210352|3768870|FG004|Overall Study|Lack of Efficacy|0
2154548|NCT01210352|3768871|FG005|Overall Study|Lack of Efficacy|0
2154549|NCT01210352|3768872|FG006|Overall Study|Lack of Efficacy|1
2154550|NCT01210352|3768873|FG007|Overall Study|Lack of Efficacy|0
2154551|NCT01210352|3768874|FG008|Overall Study|Lack of Efficacy|0
2154552|NCT01210352|3768866|FG000|Overall Study|Physician Decision|0
2154553|NCT01210352|3768867|FG001|Overall Study|Physician Decision|0
2154554|NCT01210352|3768868|FG002|Overall Study|Physician Decision|0
2154555|NCT01210352|3768869|FG003|Overall Study|Physician Decision|0
2154556|NCT01210352|3768870|FG004|Overall Study|Physician Decision|0
2154557|NCT01210352|3768871|FG005|Overall Study|Physician Decision|0
2154558|NCT01210352|3768872|FG006|Overall Study|Physician Decision|0
2292602|NCT02514174|3986197|FG000|Overall Study|Treatment change|1
2292603|NCT02514174|3986197|FG000|Overall Study|Treated off study with Afatinib.|1
2292604|NCT02514473|3986203|FG000|Overall Study|Adverse Event|0
2292605|NCT02514473|3986204|FG001|Overall Study|Adverse Event|2
2292606|NCT02514473|3986203|FG000|Overall Study|Withdrawal by Subject|2
2292607|NCT02514473|3986204|FG001|Overall Study|Withdrawal by Subject|1
2292608|NCT02514473|3986203|FG000|Overall Study|Lost to Follow-up|0
2292609|NCT02514473|3986204|FG001|Overall Study|Lost to Follow-up|1
2292610|NCT02514473|3986203|FG000|Overall Study|Other|1
2292611|NCT02514473|3986204|FG001|Overall Study|Other|1
2292612|NCT02514551|3986213|FG000|Overall Study|Lost to Follow-up|0
2292613|NCT02514551|3986214|FG001|Overall Study|Lost to Follow-up|1
2292614|NCT02514551|3986213|FG000|Overall Study|Participant Never Treated|0
2292615|NCT02514551|3986214|FG001|Overall Study|Participant Never Treated|2
2292616|NCT02514577|3986223|FG000|Overall Study|Lost to Follow-up|6
2292617|NCT02514577|3986224|FG001|Overall Study|Lost to Follow-up|6
2292618|NCT02514577|3986223|FG000|Overall Study|Protocol Violation|1
2292619|NCT02514577|3986224|FG001|Overall Study|Protocol Violation|0
2292620|NCT02514577|3986223|FG000|Overall Study|Withdrawal by Subject|6
2292621|NCT02514577|3986224|FG001|Overall Study|Withdrawal by Subject|6
2292622|NCT02514577|3986223|FG000|Overall Study|Adverse Event|1
2154559|NCT01210352|3768873|FG007|Overall Study|Physician Decision|1
2154560|NCT01210352|3768874|FG008|Overall Study|Physician Decision|2
2292623|NCT02514577|3986224|FG001|Overall Study|Adverse Event|1
2154561|NCT01210352|3768866|FG000|Overall Study|Withdrawal by Subject|0
2292624|NCT02514746|3986232|FG000|Overall Study|Chronically Ill|1
2292625|NCT02514746|3986233|FG001|Overall Study|Chronically Ill|2
2292626|NCT02514746|3986232|FG000|Overall Study|Physician Decision|4
2292627|NCT02514746|3986233|FG001|Overall Study|Physician Decision|2
2292628|NCT02514746|3986232|FG000|Overall Study|Withdrawal by Subject|12
2292629|NCT02514746|3986233|FG001|Overall Study|Withdrawal by Subject|10
2292630|NCT02514746|3986232|FG000|Overall Study|Other|5
2292631|NCT02514746|3986233|FG001|Overall Study|Other|1
2292632|NCT02514772|3986243|FG000|Overall Study|Adverse Event|1
2292633|NCT02514772|3986244|FG001|Overall Study|Adverse Event|0
2292634|NCT02514772|3986243|FG000|Overall Study|Death|0
2292635|NCT02514772|3986244|FG001|Overall Study|Death|1
2292636|NCT02514772|3986243|FG000|Overall Study|Withdrawal by Subject|2
2292637|NCT02514772|3986244|FG001|Overall Study|Withdrawal by Subject|1
2292638|NCT02514824|3986254|FG000|Overall Study|Withdrawal by Subject|1
2292639|NCT02514824|3986255|FG001|Overall Study|Withdrawal by Subject|0
2292640|NCT02514824|3986256|FG002|Overall Study|Withdrawal by Subject|0
2292641|NCT02514824|3986257|FG003|Overall Study|Withdrawal by Subject|0
2292642|NCT02514824|3986254|FG000|Overall Study|Dose-Limiting Toxicity|0
2292643|NCT02514824|3986255|FG001|Overall Study|Dose-Limiting Toxicity|1
2292644|NCT02514824|3986256|FG002|Overall Study|Dose-Limiting Toxicity|0
2292645|NCT02514824|3986257|FG003|Overall Study|Dose-Limiting Toxicity|0
2292646|NCT02515045|3986275|FG000|Overall Study|Adverse Event|0
2292647|NCT02515045|3986276|FG001|Overall Study|Adverse Event|3
2292648|NCT02515045|3986277|FG002|Overall Study|Adverse Event|3
2292649|NCT02515045|3986275|FG000|Overall Study|Lost to Follow-up|0
2292650|NCT02515045|3986276|FG001|Overall Study|Lost to Follow-up|1
2292651|NCT02515045|3986277|FG002|Overall Study|Lost to Follow-up|1
2292652|NCT02515097|3986296|FG000|Overall Study|Lost to Follow-up|4
2292653|NCT02515097|3986297|FG001|Overall Study|Lost to Follow-up|2
2292654|NCT02515097|3986296|FG000|Overall Study|Withdrawal by Subject|1
2292655|NCT02515097|3986297|FG001|Overall Study|Withdrawal by Subject|3
2292656|NCT02515097|3986296|FG000|Overall Study|Adverse Event|2
2292657|NCT02515097|3986297|FG001|Overall Study|Adverse Event|1
2292658|NCT02515279|3986312|FG000|Overall Study|Adverse Event|7
2292659|NCT02515279|3986312|FG000|Overall Study|Lack of Efficacy|31
2292660|NCT02515279|3986312|FG000|Overall Study|Lost to Follow-up|9
2292661|NCT02515279|3986312|FG000|Overall Study|Withdrawal by Subject|18
2292662|NCT02515279|3986312|FG000|Overall Study|End-of-treatment visit not attended|17
2292663|NCT02515279|3986312|FG000|Overall Study|Other|22
2292664|NCT02515331|3986332|FG000|Overall Study|Withdrawal by Subject|0
2292665|NCT02515331|3986333|FG001|Overall Study|Withdrawal by Subject|0
2292666|NCT02515331|3986334|FG002|Overall Study|Withdrawal by Subject|1
2292667|NCT02515331|3986332|FG000|Overall Study|Protocol deviation|0
2292668|NCT02515331|3986333|FG001|Overall Study|Protocol deviation|0
2292669|NCT02515331|3986334|FG002|Overall Study|Protocol deviation|3
2292670|NCT02515331|3986332|FG000|Overall Study|Adverse Event|2
2292671|NCT02515331|3986333|FG001|Overall Study|Adverse Event|0
2292672|NCT02515331|3986334|FG002|Overall Study|Adverse Event|0
2292673|NCT02515630|3986344|FG000|Overall Study|Withdrawal by Subject|5
2292674|NCT02515630|3986344|FG000|Overall Study|Adverse Event|4
2292675|NCT02515630|3986344|FG000|Overall Study|Physician Decision|4
2292676|NCT02515630|3986344|FG000|Overall Study|Death|2
2292677|NCT02515630|3986344|FG000|Overall Study|Disease Progression|1
2292678|NCT02515669|3986364|FG000|228 Week Open-Label Phase|Other|0
2292679|NCT02515669|3986365|FG001|228 Week Open-Label Phase|Other|0
2292680|NCT02515669|3986366|FG002|228 Week Open-Label Phase|Other|1
2292681|NCT02515669|3986367|FG003|228 Week Open-Label Phase|Other|4
2292682|NCT02515669|3986364|FG000|228 Week Open-Label Phase|Lack of Efficacy|0
2292683|NCT02515669|3986365|FG001|228 Week Open-Label Phase|Lack of Efficacy|0
2292684|NCT02515669|3986366|FG002|228 Week Open-Label Phase|Lack of Efficacy|1
2292685|NCT02515669|3986367|FG003|228 Week Open-Label Phase|Lack of Efficacy|0
2292686|NCT02515669|3986364|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
2292687|NCT02515669|3986365|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
2292688|NCT02515669|3986366|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2
2292689|NCT02515669|3986367|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3
2154562|NCT01210352|3768867|FG001|Overall Study|Withdrawal by Subject|0
2154563|NCT01210352|3768868|FG002|Overall Study|Withdrawal by Subject|1
2154564|NCT01210352|3768869|FG003|Overall Study|Withdrawal by Subject|0
2154565|NCT01210352|3768870|FG004|Overall Study|Withdrawal by Subject|0
2154566|NCT01210352|3768871|FG005|Overall Study|Withdrawal by Subject|0
2154567|NCT01210352|3768872|FG006|Overall Study|Withdrawal by Subject|1
2154568|NCT01210352|3768873|FG007|Overall Study|Withdrawal by Subject|0
2154569|NCT01210352|3768874|FG008|Overall Study|Withdrawal by Subject|1
2292690|NCT02515669|3986364|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0
2292691|NCT02515669|3986365|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7
2292692|NCT02515669|3986366|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2
2292693|NCT02515669|3986367|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17
2292694|NCT02515669|3986364|FG000|228 Week Open-Label Phase|Missing|0
2292695|NCT02515669|3986365|FG001|228 Week Open-Label Phase|Missing|2
2292696|NCT02515669|3986366|FG002|228 Week Open-Label Phase|Missing|2
2154570|NCT01210352|3768866|FG000|Overall Study|Patient Discharged Early|0
2292697|NCT02515669|3986367|FG003|228 Week Open-Label Phase|Missing|2
2292698|NCT02515942|3986430|FG000|Overall Study|Adverse Event|5
2292699|NCT02515942|3986431|FG001|Overall Study|Adverse Event|0
2292700|NCT02515942|3986432|FG002|Overall Study|Adverse Event|0
2292701|NCT02515942|3986430|FG000|Overall Study|Death|0
2292702|NCT02515942|3986431|FG001|Overall Study|Death|0
2292703|NCT02515942|3986432|FG002|Overall Study|Death|1
2292704|NCT02515942|3986430|FG000|Overall Study|Lack of Efficacy|0
2292705|NCT02515942|3986431|FG001|Overall Study|Lack of Efficacy|0
2292706|NCT02515942|3986432|FG002|Overall Study|Lack of Efficacy|1
2292707|NCT02515942|3986430|FG000|Overall Study|Lost to Follow-up|2
2292708|NCT02515942|3986431|FG001|Overall Study|Lost to Follow-up|0
2292709|NCT02515942|3986432|FG002|Overall Study|Lost to Follow-up|0
2292710|NCT02515942|3986430|FG000|Overall Study|Withdrawal by Subject|0
2292711|NCT02515942|3986431|FG001|Overall Study|Withdrawal by Subject|3
2292712|NCT02515942|3986432|FG002|Overall Study|Withdrawal by Subject|2
2292713|NCT02515994|3986444|FG000|Overall Study|Protocol Violation|3
2292714|NCT02515994|3986445|FG001|Overall Study|Protocol Violation|5
2292715|NCT02515994|3986444|FG000|Overall Study|No Longer Meets Eligibility Criteria|2
2292716|NCT02515994|3986445|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
2292717|NCT02515994|3986444|FG000|Overall Study|Adverse Event|3
2154571|NCT01210352|3768867|FG001|Overall Study|Patient Discharged Early|0
2154572|NCT01210352|3768868|FG002|Overall Study|Patient Discharged Early|1
2154573|NCT01210352|3768869|FG003|Overall Study|Patient Discharged Early|0
2154574|NCT01210352|3768870|FG004|Overall Study|Patient Discharged Early|0
2154575|NCT01210352|3768871|FG005|Overall Study|Patient Discharged Early|0
2154576|NCT01210352|3768872|FG006|Overall Study|Patient Discharged Early|0
2154577|NCT01210352|3768873|FG007|Overall Study|Patient Discharged Early|0
2154578|NCT01210352|3768874|FG008|Overall Study|Patient Discharged Early|0
2154579|NCT01210443|3768979|FG000|Overall Study|Study terminated by sponsor|2
2154580|NCT01210495|3768987|FG000|Overall Study|Participant Refused Further Follow-Up|1
2154581|NCT01210495|3768988|FG001|Overall Study|Participant Refused Further Follow-Up|0
2154582|NCT01210495|3768989|FG002|Overall Study|Participant Refused Further Follow-Up|11
2154583|NCT01210495|3768990|FG003|Overall Study|Participant Refused Further Follow-Up|2
2154584|NCT01210495|3768987|FG000|Overall Study|Death|14
2154585|NCT01210495|3768988|FG001|Overall Study|Death|7
2154586|NCT01210495|3768989|FG002|Overall Study|Death|112
2154587|NCT01210495|3768990|FG003|Overall Study|Death|54
2154588|NCT01210495|3768987|FG000|Overall Study|Study Terminated by Sponsor|0
2154589|NCT01210495|3768988|FG001|Overall Study|Study Terminated by Sponsor|0
2154590|NCT01210495|3768989|FG002|Overall Study|Study Terminated by Sponsor|4
2154591|NCT01210495|3768990|FG003|Overall Study|Study Terminated by Sponsor|11
2154592|NCT01210495|3768987|FG000|Overall Study|Lost to Follow-up|0
2154593|NCT01210495|3768988|FG001|Overall Study|Lost to Follow-up|0
2154594|NCT01210495|3768989|FG002|Overall Study|Lost to Follow-up|1
2154595|NCT01210495|3768990|FG003|Overall Study|Lost to Follow-up|1
2154596|NCT01210495|3768987|FG000|Overall Study|Other unspecified|0
2154597|NCT01210495|3768988|FG001|Overall Study|Other unspecified|0
2154598|NCT01210495|3768989|FG002|Overall Study|Other unspecified|6
2154599|NCT01210495|3768990|FG003|Overall Study|Other unspecified|0
2154600|NCT01210651|3769025|FG000|Overall Study|Lost to Follow-up|1
2154601|NCT01210651|3769026|FG001|Overall Study|Lost to Follow-up|1
2154602|NCT01210651|3769025|FG000|Overall Study|schedule conflicts|1
2154603|NCT01210651|3769026|FG001|Overall Study|schedule conflicts|5
2154604|NCT01210651|3769025|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0
2154605|NCT01210651|3769026|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1
2154606|NCT01210651|3769025|FG000|Overall Study|Withdrawal by Subject|1
2154607|NCT01210651|3769026|FG001|Overall Study|Withdrawal by Subject|1
2154608|NCT01210651|3769025|FG000|Overall Study|Injury outside study|2
2154609|NCT01210651|3769026|FG001|Overall Study|Injury outside study|0
2154610|NCT01210664|3769036|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
2154611|NCT01210664|3769037|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
2154612|NCT01210664|3769038|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
2154613|NCT01210664|3769039|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
2154614|NCT01210664|3769036|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
2154615|NCT01210664|3769037|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
2154616|NCT01210664|3769038|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
2154617|NCT01210664|3769039|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
2154618|NCT01210664|3769036|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
2154619|NCT01210664|3769037|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
2154620|NCT01210664|3769038|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
2154621|NCT01210664|3769039|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
2154622|NCT01210690|3769049|FG000|Overall Study|Adverse Event|7
2154623|NCT01210690|3769049|FG000|Overall Study|Lack of Efficacy|12
2154624|NCT01210690|3769049|FG000|Overall Study|Lost to Follow-up|3
2154625|NCT01210690|3769049|FG000|Overall Study|Disease Remission|1
2154626|NCT01210690|3769049|FG000|Overall Study|Withdrawal by Subject|1
2154627|NCT01210690|3769049|FG000|Overall Study|Patient refused to swallow|1
2154628|NCT01210690|3769049|FG000|Overall Study|Patient could not take glucose|1
2154629|NCT01210807|3769063|FG000|Overall Study|Lost to Follow-up|1
2292718|NCT02515994|3986445|FG001|Overall Study|Adverse Event|1
2154630|NCT01210807|3769064|FG001|Overall Study|Lost to Follow-up|2
2154631|NCT01210807|3769063|FG000|Overall Study|Not implanted bilaterally|2
2154632|NCT01210807|3769064|FG001|Overall Study|Not implanted bilaterally|1
2154633|NCT01211145|3769094|FG000|Overall Study|Reason not specified|3
2154634|NCT01211145|3769095|FG001|Overall Study|Reason not specified|2
2154635|NCT01211145|3769096|FG002|Overall Study|Reason not specified|2
2154636|NCT01211145|3769097|FG003|Overall Study|Reason not specified|1
2154637|NCT01211145|3769094|FG000|Overall Study|Lost to Follow-up|3
2154638|NCT01211145|3769095|FG001|Overall Study|Lost to Follow-up|2
2154639|NCT01211145|3769096|FG002|Overall Study|Lost to Follow-up|1
2154640|NCT01211145|3769097|FG003|Overall Study|Lost to Follow-up|2
2154641|NCT01211145|3769094|FG000|Overall Study|Study-specific withdrawal criteria|1
2154642|NCT01211145|3769095|FG001|Overall Study|Study-specific withdrawal criteria|0
2154643|NCT01211145|3769096|FG002|Overall Study|Study-specific withdrawal criteria|0
2154644|NCT01211145|3769097|FG003|Overall Study|Study-specific withdrawal criteria|0
2154645|NCT01211145|3769094|FG000|Overall Study|Severe noncompliance to protocol|1
2154646|NCT01211145|3769095|FG001|Overall Study|Severe noncompliance to protocol|0
2154647|NCT01211145|3769096|FG002|Overall Study|Severe noncompliance to protocol|0
2154648|NCT01211145|3769097|FG003|Overall Study|Severe noncompliance to protocol|0
2154649|NCT01211145|3769094|FG000|Overall Study|Eligibility criteria not fulfilled|16
2154650|NCT01211145|3769095|FG001|Overall Study|Eligibility criteria not fulfilled|12
2154651|NCT01211145|3769096|FG002|Overall Study|Eligibility criteria not fulfilled|10
2154652|NCT01211145|3769097|FG003|Overall Study|Eligibility criteria not fulfilled|15
2154653|NCT01211145|3769094|FG000|Overall Study|Patient decision|2
2154654|NCT01211145|3769095|FG001|Overall Study|Patient decision|1
2154655|NCT01211145|3769096|FG002|Overall Study|Patient decision|0
2154656|NCT01211145|3769097|FG003|Overall Study|Patient decision|2
2154657|NCT01211184|3769110|FG000|Overall Study|Withdrawal by Subject|0
2154658|NCT01211184|3769111|FG001|Overall Study|Withdrawal by Subject|2
2154659|NCT01211184|3769112|FG002|Overall Study|Withdrawal by Subject|1
2154660|NCT01211197|3769123|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2154661|NCT01211197|3769124|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2154662|NCT01211197|3769125|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2154663|NCT01211197|3769126|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2154664|NCT01211197|3769127|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2154665|NCT01211197|3769128|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2154666|NCT01211197|3769123|FG000|Washout Period 2 (7 Days)|Adverse Event|1
2154667|NCT01211197|3769124|FG001|Washout Period 2 (7 Days)|Adverse Event|0
2154668|NCT01211197|3769125|FG002|Washout Period 2 (7 Days)|Adverse Event|0
2154669|NCT01211197|3769126|FG003|Washout Period 2 (7 Days)|Adverse Event|0
2154670|NCT01211197|3769127|FG004|Washout Period 2 (7 Days)|Adverse Event|0
2154671|NCT01211197|3769128|FG005|Washout Period 2 (7 Days)|Adverse Event|0
2154672|NCT01211262|3769138|FG000|Overall Study|Progressive Disease|18
2154673|NCT01211262|3769139|FG001|Overall Study|Progressive Disease|9
2154674|NCT01211262|3769138|FG000|Overall Study|Adverse Event|4
2154675|NCT01211262|3769139|FG001|Overall Study|Adverse Event|0
2154676|NCT01211262|3769138|FG000|Overall Study|Withdrawal of Consent|1
2154677|NCT01211262|3769139|FG001|Overall Study|Withdrawal of Consent|0
2154678|NCT01211262|3769138|FG000|Overall Study|Other|0
2154679|NCT01211262|3769139|FG001|Overall Study|Other|1
2154680|NCT01211288|3769150|FG000|Overall Study|Lost to Follow-up|1
2154681|NCT01211288|3769151|FG001|Overall Study|Lost to Follow-up|1
2154682|NCT01211483|3769172|FG000|Phase 1b|Death|6
2154683|NCT01211483|3769173|FG001|Phase 1b|Death|0
2154684|NCT01211483|3769174|FG002|Phase 1b|Death|0
2154685|NCT01211483|3769175|FG003|Phase 1b|Death|0
2154686|NCT01211483|3769172|FG000|Phase 1b|Withdrawal by Subject|1
2154687|NCT01211483|3769173|FG001|Phase 1b|Withdrawal by Subject|0
2154688|NCT01211483|3769174|FG002|Phase 1b|Withdrawal by Subject|0
2154689|NCT01211483|3769175|FG003|Phase 1b|Withdrawal by Subject|0
2154690|NCT01211483|3769172|FG000|Phase 2|Lost to Follow-up|0
2154691|NCT01211483|3769173|FG001|Phase 2|Lost to Follow-up|1
2154692|NCT01211483|3769174|FG002|Phase 2|Lost to Follow-up|1
2154693|NCT01211483|3769175|FG003|Phase 2|Lost to Follow-up|2
2154694|NCT01211483|3769172|FG000|Phase 2|Death|0
2154695|NCT01211483|3769173|FG001|Phase 2|Death|64
2154696|NCT01211483|3769174|FG002|Phase 2|Death|53
2154697|NCT01211483|3769175|FG003|Phase 2|Death|53
2154698|NCT01211483|3769172|FG000|Phase 2|Withdrawal by Subject|0
2154699|NCT01211483|3769173|FG001|Phase 2|Withdrawal by Subject|1
2154700|NCT01211483|3769174|FG002|Phase 2|Withdrawal by Subject|10
2154701|NCT01211483|3769175|FG003|Phase 2|Withdrawal by Subject|5
2154702|NCT01211483|3769172|FG000|Phase 2|Study terminated by Sponsor|0
2154703|NCT01211483|3769173|FG001|Phase 2|Study terminated by Sponsor|6
2154704|NCT01211483|3769174|FG002|Phase 2|Study terminated by Sponsor|8
2154705|NCT01211483|3769175|FG003|Phase 2|Study terminated by Sponsor|11
2154706|NCT01211522|3769192|FG000|Overall Study|Withdrawal by Subject|3
2154707|NCT01211522|3769193|FG001|Overall Study|Withdrawal by Subject|7
2154708|NCT01211522|3769194|FG002|Overall Study|Withdrawal by Subject|5
2154709|NCT01211535|3769204|FG000|Overall Study|Adverse Event|0
2154710|NCT01211535|3769205|FG001|Overall Study|Adverse Event|1
2154711|NCT01211613|3769225|FG000|Overall Study|Lost to Follow-up|2
2154712|NCT01211613|3769226|FG001|Overall Study|Lost to Follow-up|2
2154713|NCT01211613|3769227|FG002|Overall Study|Lost to Follow-up|2
2154714|NCT01211613|3769225|FG000|Overall Study|Withdrawal by Subject|1
2154715|NCT01211613|3769226|FG001|Overall Study|Withdrawal by Subject|0
2154716|NCT01211613|3769227|FG002|Overall Study|Withdrawal by Subject|0
2154717|NCT01211665|3769237|FG000|Overall Study|Withdrawal by Subject|1
2154718|NCT01211665|3769238|FG001|Overall Study|Withdrawal by Subject|0
2154719|NCT01211665|3769237|FG000|Overall Study|Death|1
2154720|NCT01211665|3769238|FG001|Overall Study|Death|0
2154721|NCT01211769|3769257|FG000|Overall Study|Lost to Follow-up|7
2154722|NCT01211769|3769258|FG001|Overall Study|Lost to Follow-up|9
2154723|NCT01211769|3769259|FG002|Overall Study|Lost to Follow-up|5
2154724|NCT01211769|3769260|FG003|Overall Study|Lost to Follow-up|9
2154725|NCT01211769|3769257|FG000|Overall Study|Physician Decision|2
2154726|NCT01211769|3769258|FG001|Overall Study|Physician Decision|0
2154727|NCT01211769|3769259|FG002|Overall Study|Physician Decision|2
2154728|NCT01211769|3769260|FG003|Overall Study|Physician Decision|1
2154729|NCT01211769|3769257|FG000|Overall Study|Adverse Event|0
2154730|NCT01211769|3769258|FG001|Overall Study|Adverse Event|1
2154731|NCT01211769|3769259|FG002|Overall Study|Adverse Event|1
2154732|NCT01211769|3769260|FG003|Overall Study|Adverse Event|1
2154733|NCT01212094|3769287|FG000|Year 1: Baseline Monitoring|Study terminated|7
2154734|NCT01212094|3769288|FG001|Year 1: Baseline Monitoring|Study terminated|0
2154735|NCT01212094|3769289|FG002|Year 1: Baseline Monitoring|Study terminated|0
2154736|NCT01212094|3769287|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7
2154737|NCT01212094|3769288|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0
2154738|NCT01212094|3769289|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0
2154739|NCT01212094|3769287|FG000|Year 1: Baseline Monitoring|Started on DMT|2
2154740|NCT01212094|3769288|FG001|Year 1: Baseline Monitoring|Started on DMT|0
2154741|NCT01212094|3769289|FG002|Year 1: Baseline Monitoring|Started on DMT|0
2154742|NCT01212094|3769287|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0
2154743|NCT01212094|3769288|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4
2154744|NCT01212094|3769289|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7
2154745|NCT01212094|3769287|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
2154746|NCT01212094|3769288|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
2154747|NCT01212094|3769289|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
2154748|NCT01212094|3769287|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0
2154749|NCT01212094|3769288|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0
2154750|NCT01212094|3769289|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1
2154751|NCT01212159|3769363|FG000|Overall Study|Withdrawal by Subject|12
2154752|NCT01212159|3769364|FG001|Overall Study|Withdrawal by Subject|12
2154753|NCT01212185|3769381|FG000|Overall Study|Protocol Violation|2
2154754|NCT01212185|3769382|FG001|Overall Study|Protocol Violation|1
2154755|NCT01212588|3769428|FG000|Overall Study|Physician Decision|0
2154756|NCT01212588|3769429|FG001|Overall Study|Physician Decision|1
2154757|NCT01212588|3769428|FG000|Overall Study|Protocol Violation|1
2154758|NCT01212588|3769429|FG001|Overall Study|Protocol Violation|1
2154759|NCT01212744|3769439|FG000|Overall Study|Withdrawal by Subject|1
2154760|NCT01212757|3769448|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
2154761|NCT01212757|3769449|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
2154762|NCT01212757|3769450|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
2154763|NCT01212757|3769451|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2154764|NCT01212757|3769452|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2154765|NCT01212757|3769453|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2154766|NCT01212757|3769454|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2154767|NCT01212757|3769455|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2154768|NCT01212757|3769456|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2154769|NCT01212757|3769448|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
2154770|NCT01212757|3769449|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
2154771|NCT01212757|3769450|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
2154772|NCT01212757|3769451|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2154773|NCT01212757|3769452|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2154774|NCT01212757|3769453|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2154775|NCT01212757|3769454|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2154776|NCT01212757|3769455|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2154777|NCT01212757|3769456|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2154778|NCT01212757|3769448|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
2154779|NCT01212757|3769449|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
2154780|NCT01212757|3769450|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
2154781|NCT01212757|3769451|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2154782|NCT01212757|3769452|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2154783|NCT01212757|3769453|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2154784|NCT01212757|3769454|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2154785|NCT01212757|3769455|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2154786|NCT01212757|3769456|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2154787|NCT01212757|3769448|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
2154788|NCT01212757|3769449|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2154789|NCT01212757|3769450|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
2154790|NCT01212757|3769451|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2154791|NCT01212757|3769452|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2154792|NCT01212757|3769453|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2154793|NCT01212757|3769454|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2154794|NCT01212757|3769455|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2154795|NCT01212757|3769456|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2154796|NCT01212757|3769448|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2154797|NCT01212757|3769449|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2154798|NCT01212757|3769450|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
2154799|NCT01212757|3769451|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2154800|NCT01212757|3769452|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2154801|NCT01212757|3769453|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2154802|NCT01212757|3769454|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2154803|NCT01212757|3769455|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2154804|NCT01212757|3769456|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2154805|NCT01212757|3769448|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2154806|NCT01212757|3769449|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2154807|NCT01212757|3769450|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2154808|NCT01212757|3769451|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2154809|NCT01212757|3769452|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2154810|NCT01212757|3769453|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2154811|NCT01212757|3769454|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2154812|NCT01212757|3769455|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2154813|NCT01212757|3769456|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2154814|NCT01212757|3769448|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
2154815|NCT01212757|3769449|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
2154816|NCT01212757|3769450|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
2154817|NCT01212757|3769451|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
2154818|NCT01212757|3769452|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
2154819|NCT01212757|3769453|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
2154820|NCT01212757|3769454|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
2154821|NCT01212757|3769455|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
2154822|NCT01212757|3769456|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
2154823|NCT01212757|3769448|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2154824|NCT01212757|3769449|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
2154825|NCT01212757|3769450|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
2154826|NCT01212757|3769451|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
2154827|NCT01212757|3769452|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2154828|NCT01212757|3769453|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
2154829|NCT01212757|3769454|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2154830|NCT01212757|3769455|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2154831|NCT01212757|3769456|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2154832|NCT01212757|3769448|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2154833|NCT01212757|3769449|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
2154834|NCT01212757|3769450|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
2154835|NCT01212757|3769451|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
2154836|NCT01212757|3769452|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2154837|NCT01212757|3769453|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
2154838|NCT01212757|3769454|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2154839|NCT01212757|3769455|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2154840|NCT01212757|3769456|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2154841|NCT01212757|3769448|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2154842|NCT01212757|3769449|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2154843|NCT01212757|3769450|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
2154844|NCT01212757|3769451|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2154845|NCT01212757|3769452|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2154846|NCT01212757|3769453|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2154847|NCT01212757|3769454|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2154848|NCT01212757|3769455|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2154849|NCT01212757|3769456|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2154850|NCT01212757|3769448|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2154851|NCT01212757|3769449|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
2154852|NCT01212757|3769450|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
2154853|NCT01212757|3769451|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
2154854|NCT01212757|3769452|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
2154855|NCT01212757|3769453|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
2154856|NCT01212757|3769454|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2154857|NCT01212757|3769455|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2154858|NCT01212757|3769456|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2154859|NCT01212757|3769448|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2154860|NCT01212757|3769449|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
2154861|NCT01212757|3769450|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2154862|NCT01212757|3769451|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2154863|NCT01212757|3769452|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
2154864|NCT01212757|3769453|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2154865|NCT01212757|3769454|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2154866|NCT01212757|3769455|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2154867|NCT01212757|3769456|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2154868|NCT01212757|3769448|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0
2154869|NCT01212757|3769449|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1
2154870|NCT01212757|3769450|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1
2154871|NCT01212757|3769451|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0
2154872|NCT01212757|3769452|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0
2154873|NCT01212757|3769453|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0
2154874|NCT01212757|3769454|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0
2154875|NCT01212757|3769455|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0
2154876|NCT01212757|3769456|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0
2154877|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2154878|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2154879|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2154880|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2154881|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2154882|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2154883|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2154884|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2154885|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1
2154886|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0
2154887|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1
2154888|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1
2154889|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0
2154890|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0
2154891|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0
2154892|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0
2154893|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2
2154894|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2
2154895|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2154896|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
2154897|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
2154898|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2154899|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2154900|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2154901|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2154902|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
2154903|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2154904|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2154905|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
2154906|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
2154907|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2154908|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2154909|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2154910|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2154911|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
2154912|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
2154913|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2154914|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2154915|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
2154916|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2154917|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2154918|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2154919|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2154920|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2154921|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2154922|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0
2154923|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4
2154924|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1
2154925|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0
2154926|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0
2154927|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0
2154928|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0
2154929|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2
2154930|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0
2154931|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2154932|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
2154933|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
2154934|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2154935|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2154936|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2154937|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2154938|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
2154939|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
2154940|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2154941|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2154942|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
2154943|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2154944|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2154945|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2154946|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2154947|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2154948|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2154949|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2154950|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
2154951|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
2154952|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2154953|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2154954|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2154955|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2154956|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
2154957|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
2154958|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2154959|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2154960|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2154961|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2154962|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2154963|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2154964|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2154965|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2154966|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
2154967|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2154968|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1
2154969|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2154970|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2154971|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2154972|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2154973|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2154974|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2154975|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2154976|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2154977|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2154978|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3
2154979|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2154980|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2154981|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2154982|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2154983|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2154984|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2
2154985|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2154986|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2
2154987|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2154988|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2154989|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2154990|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2154991|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2154992|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2154993|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1
2154994|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0
2154995|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1
2154996|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2
2154997|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0
2154998|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0
2154999|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0
2155000|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0
2155001|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1
2155002|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1
2155003|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2155004|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
2155005|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
2155006|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2155007|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2155008|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2155009|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2155010|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
2155011|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
2155012|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2155013|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
2155014|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
2155015|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2155016|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2155017|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2155018|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2155019|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
2155020|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
2155021|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 4)|Death|0
2155022|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 4)|Death|0
2155023|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 4)|Death|1
2155024|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 4)|Death|0
2155025|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 4)|Death|0
2155026|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 4)|Death|0
2155027|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 4)|Death|0
2155028|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 4)|Death|0
2155029|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 4)|Death|1
2155030|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2155031|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2155032|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2155033|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2155034|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2155035|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2155036|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2155037|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
2155038|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2155039|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2155040|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
2155041|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
2155042|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2155043|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2155044|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2155045|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2155046|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
2155047|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
2155048|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0
2155049|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2
2155050|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2
2155051|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0
2155052|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0
2155053|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0
2155054|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0
2155055|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2
2155056|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0
2155057|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2155058|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
2155059|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
2155060|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2155061|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2155062|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2155063|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2155064|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
2155065|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
2155066|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2155067|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
2155068|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2155069|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2155070|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2155071|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2155072|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2155073|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2155074|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2155075|NCT01212757|3769448|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2155076|NCT01212757|3769449|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1
2155077|NCT01212757|3769450|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1
2155078|NCT01212757|3769451|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2155079|NCT01212757|3769452|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2155080|NCT01212757|3769453|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2155081|NCT01212757|3769454|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2155082|NCT01212757|3769455|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2155083|NCT01212757|3769456|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2155084|NCT01212770|3769477|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
2155085|NCT01212770|3769478|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
2155086|NCT01212770|3769479|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
2155087|NCT01212770|3769480|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2155088|NCT01212770|3769481|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2155089|NCT01212770|3769482|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2155090|NCT01212770|3769483|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2155091|NCT01212770|3769484|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2155092|NCT01212770|3769485|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2155093|NCT01212770|3769477|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
2155094|NCT01212770|3769478|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
2155095|NCT01212770|3769479|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
2155096|NCT01212770|3769480|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2155097|NCT01212770|3769481|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2155098|NCT01212770|3769482|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2155099|NCT01212770|3769483|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2155100|NCT01212770|3769484|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2155101|NCT01212770|3769485|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2155102|NCT01212770|3769477|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
2155103|NCT01212770|3769478|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
2155104|NCT01212770|3769479|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
2155105|NCT01212770|3769480|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2155106|NCT01212770|3769481|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2155107|NCT01212770|3769482|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2155108|NCT01212770|3769483|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2155109|NCT01212770|3769484|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2155110|NCT01212770|3769485|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2155111|NCT01212770|3769477|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2155112|NCT01212770|3769478|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2155113|NCT01212770|3769479|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
2155114|NCT01212770|3769480|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2155115|NCT01212770|3769481|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2155116|NCT01212770|3769482|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2155117|NCT01212770|3769483|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2155118|NCT01212770|3769484|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2155119|NCT01212770|3769485|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2155120|NCT01212770|3769477|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2155121|NCT01212770|3769478|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2155122|NCT01212770|3769479|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2155123|NCT01212770|3769480|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2155124|NCT01212770|3769481|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2155125|NCT01212770|3769482|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2155126|NCT01212770|3769483|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2155127|NCT01212770|3769484|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2155128|NCT01212770|3769485|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2155129|NCT01212770|3769477|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
2155130|NCT01212770|3769478|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
2155131|NCT01212770|3769479|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
2155132|NCT01212770|3769480|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2155133|NCT01212770|3769481|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2155134|NCT01212770|3769482|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2155135|NCT01212770|3769483|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2155136|NCT01212770|3769484|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2155137|NCT01212770|3769485|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2155138|NCT01212770|3769477|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2155139|NCT01212770|3769478|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
2155140|NCT01212770|3769479|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
2155141|NCT01212770|3769480|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
2155142|NCT01212770|3769481|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2155143|NCT01212770|3769482|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2180146|NCT01399125|3806108|FG000|Overall Study|Lost to Follow-up|2
2155144|NCT01212770|3769483|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
2155145|NCT01212770|3769484|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2155146|NCT01212770|3769485|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2155147|NCT01212770|3769477|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2155148|NCT01212770|3769478|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
2155149|NCT01212770|3769479|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
2155150|NCT01212770|3769480|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
2155151|NCT01212770|3769481|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
2155152|NCT01212770|3769482|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
2155153|NCT01212770|3769483|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2155154|NCT01212770|3769484|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2155155|NCT01212770|3769485|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2155156|NCT01212770|3769477|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
2155157|NCT01212770|3769478|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
2155158|NCT01212770|3769479|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
2155159|NCT01212770|3769480|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
2155160|NCT01212770|3769481|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
2155161|NCT01212770|3769482|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
2155162|NCT01212770|3769483|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
2155163|NCT01212770|3769484|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
2155164|NCT01212770|3769485|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
2155165|NCT01212770|3769477|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2155166|NCT01212770|3769478|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2155167|NCT01212770|3769479|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
2155168|NCT01212770|3769480|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2155169|NCT01212770|3769481|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2155170|NCT01212770|3769482|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2155171|NCT01212770|3769483|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2155172|NCT01212770|3769484|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2155173|NCT01212770|3769485|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2155174|NCT01212770|3769477|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2155175|NCT01212770|3769478|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2155176|NCT01212770|3769479|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2155177|NCT01212770|3769480|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
2155178|NCT01212770|3769481|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2155179|NCT01212770|3769482|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2155180|NCT01212770|3769483|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2155181|NCT01212770|3769484|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2155182|NCT01212770|3769485|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2155183|NCT01212770|3769477|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2155184|NCT01212770|3769478|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2155185|NCT01212770|3769479|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
2155186|NCT01212770|3769480|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
2155187|NCT01212770|3769481|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2155188|NCT01212770|3769482|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2155189|NCT01212770|3769483|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2155190|NCT01212770|3769484|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2155191|NCT01212770|3769485|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2155192|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
2155193|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3
2155194|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3
2155195|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
2155196|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
2155197|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
2155198|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
2155199|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0
2155200|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2
2155201|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2155202|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
2155203|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
2155204|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2155205|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2155206|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2155207|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2155208|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
2155209|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
2155210|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2155211|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
2155212|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2155213|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2292719|NCT02515994|3986444|FG000|Overall Study|Withdrawal by Subject|2
2292720|NCT02515994|3986445|FG001|Overall Study|Withdrawal by Subject|0
2292721|NCT02516098|3986467|FG000|Period 1|Protocol Violation|1
2292722|NCT02516098|3986468|FG001|Period 1|Protocol Violation|0
2292723|NCT02516098|3986467|FG000|Washout After Period 1|Adverse Event|0
2292724|NCT02516098|3986468|FG001|Washout After Period 1|Adverse Event|1
2292725|NCT02516098|3986467|FG000|Period 2|Withdrawal by Subject|0
2292726|NCT02516098|3986468|FG001|Period 2|Withdrawal by Subject|1
2292727|NCT02516163|3986480|FG000|Overall Study|Withdrawal by Subject|1
2155214|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2155215|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2155216|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2155217|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2155218|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2155219|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2155220|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
2155221|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
2155222|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2155223|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2155224|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2155225|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2155226|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
2155227|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
2155228|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2155229|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
2155230|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
2155231|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2155232|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2155233|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2155234|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2155235|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
2155236|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
2155237|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
2155238|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2
2155239|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1
2155240|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
2155241|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
2155242|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
2155243|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
2155244|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0
2155245|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
2155246|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
2155247|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2
2155248|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
2155249|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
2155250|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
2155251|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
2155252|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
2155253|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2
2155254|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1
2155255|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2155256|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
2155257|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
2155258|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2155259|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2155260|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2155261|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2155262|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2155263|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2155264|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2155265|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
2155266|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
2155267|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2155268|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2155269|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2155270|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2155271|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
2155272|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
2155273|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2155274|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
2155275|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2155276|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2155277|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2321225|NCT02956837|4035608|FG003|Overall Study|Lost to Follow-up|0
2155278|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2155279|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2155280|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2155281|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2155282|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0
2155283|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0
2155284|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0
2155285|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0
2155286|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0
2155287|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0
2155288|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0
2155289|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1
2155290|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0
2155291|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
2155292|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2
2155293|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1
2155294|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
2155295|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
2155296|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
2155297|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
2155298|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
2155299|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1
2155300|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
2155301|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1
2155302|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1
2155303|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
2155304|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
2155305|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
2155306|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
2155307|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
2155308|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1
2155309|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2155310|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
2155311|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
2155312|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2155313|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2155314|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2155315|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2155316|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
2155317|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2155318|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2155319|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
2155320|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
2155321|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2155322|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2155323|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2155324|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2155325|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
2155326|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2155327|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2155328|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
2155329|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
2155330|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2155331|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2155332|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2155333|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2155334|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2155335|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2155336|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2155337|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2155338|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
2155339|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2155340|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2155341|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2155342|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2155343|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2155344|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2155345|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
2155346|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1
2155347|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
2155348|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
2155349|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
2155350|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
2155351|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
2155352|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0
2155353|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1
2155354|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 5)|Missing|0
2155355|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 5)|Missing|0
2155356|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 5)|Missing|1
2155357|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 5)|Missing|0
2155358|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 5)|Missing|0
2155359|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 5)|Missing|0
2155360|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 5)|Missing|0
2155361|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 5)|Missing|0
2155362|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 5)|Missing|0
2155363|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
2155364|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
2155365|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3
2155366|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
2155367|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
2155368|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
2155369|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
2155370|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0
2155371|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0
2155372|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
2155373|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0
2155374|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2
2155375|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
2155376|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
2155377|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
2155378|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
2155379|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
2155380|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
2155381|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2155382|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2155383|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
2155384|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2155385|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2155386|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2155387|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2155388|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2155389|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2155390|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2155391|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
2155392|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
2155393|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2155394|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2155395|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2155396|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2155397|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
2155398|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2155399|NCT01212770|3769477|FG000|Long-term Safety Phase (Year 5)|Death|0
2155400|NCT01212770|3769478|FG001|Long-term Safety Phase (Year 5)|Death|0
2155401|NCT01212770|3769479|FG002|Long-term Safety Phase (Year 5)|Death|0
2155402|NCT01212770|3769480|FG003|Long-term Safety Phase (Year 5)|Death|0
2155403|NCT01212770|3769481|FG004|Long-term Safety Phase (Year 5)|Death|0
2292728|NCT02516163|3986480|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11
2292729|NCT02516163|3986480|FG000|Overall Study|Unfit/delay in surgery|3
2292730|NCT02516163|3986480|FG000|Overall Study|Use of incorrect measurement technique|5
2208137|NCT01636687|3847523|FG000|Extension Period|study terminated by sponsor|33
2292731|NCT02516163|3986480|FG000|Overall Study|Data not recorded|2
2292732|NCT02516163|3986480|FG000|Overall Study|MRI contraindication exclusion|6
2292733|NCT02516202|3986487|FG000|Overall Study|Withdrawal by Subject|1
2292734|NCT02516202|3986488|FG001|Overall Study|Withdrawal by Subject|0
2292735|NCT02516202|3986489|FG002|Overall Study|Withdrawal by Subject|1
2292736|NCT02516202|3986487|FG000|Overall Study|Lost to Follow-up|1
2292737|NCT02516202|3986488|FG001|Overall Study|Lost to Follow-up|1
2292738|NCT02516202|3986489|FG002|Overall Study|Lost to Follow-up|1
2292739|NCT02516202|3986487|FG000|Overall Study|Stopped Follow-up|0
2292740|NCT02516202|3986488|FG001|Overall Study|Stopped Follow-up|0
2292741|NCT02516202|3986489|FG002|Overall Study|Stopped Follow-up|1
2292742|NCT02516306|3986499|FG000|Period 2: Day 8 - 91|Protocol Violation|1
2292743|NCT02516306|3986500|FG001|Period 2: Day 8 - 91|Protocol Violation|2
2292744|NCT02516332|3986509|FG000|Overall Study|Withdrawal by Subject|2
2292745|NCT02516332|3986510|FG001|Overall Study|Withdrawal by Subject|1
2292746|NCT02516332|3986511|FG002|Overall Study|Withdrawal by Subject|2
2155404|NCT01212770|3769482|FG005|Long-term Safety Phase (Year 5)|Death|0
2155405|NCT01212770|3769483|FG006|Long-term Safety Phase (Year 5)|Death|0
2155406|NCT01212770|3769484|FG007|Long-term Safety Phase (Year 5)|Death|1
2155407|NCT01212770|3769485|FG008|Long-term Safety Phase (Year 5)|Death|0
2155408|NCT01212991|3769542|FG000|Double-blind|Lost to Follow-up|8
2155409|NCT01212991|3769543|FG001|Double-blind|Lost to Follow-up|4
2155410|NCT01212991|3769544|FG002|Double-blind|Lost to Follow-up|0
2155411|NCT01212991|3769542|FG000|Double-blind|Death|699
2155412|NCT01212991|3769543|FG001|Double-blind|Death|550
2155413|NCT01212991|3769544|FG002|Double-blind|Death|0
2155414|NCT01212991|3769542|FG000|Double-blind|Withdrawal by Subject|16
2155415|NCT01212991|3769543|FG001|Double-blind|Withdrawal by Subject|19
2155416|NCT01212991|3769544|FG002|Double-blind|Withdrawal by Subject|0
2155417|NCT01212991|3769542|FG000|Double-blind|Other|7
2155418|NCT01212991|3769543|FG001|Double-blind|Other|0
2155419|NCT01212991|3769544|FG002|Double-blind|Other|0
2155420|NCT01212991|3769542|FG000|Double-blind|Sponsor decision|142
2155421|NCT01212991|3769543|FG001|Double-blind|Sponsor decision|38
2155422|NCT01212991|3769544|FG002|Double-blind|Sponsor decision|0
2155423|NCT01212991|3769542|FG000|Open-label|Death|0
2155424|NCT01212991|3769543|FG001|Open-label|Death|0
2155425|NCT01212991|3769544|FG002|Open-label|Death|166
2155426|NCT01212991|3769542|FG000|Open-label|Lost to Follow-up|0
2155427|NCT01212991|3769543|FG001|Open-label|Lost to Follow-up|0
2155428|NCT01212991|3769544|FG002|Open-label|Lost to Follow-up|5
2155429|NCT01212991|3769542|FG000|Open-label|Withdrawal by Subject|0
2155430|NCT01212991|3769543|FG001|Open-label|Withdrawal by Subject|0
2155431|NCT01212991|3769544|FG002|Open-label|Withdrawal by Subject|7
2155432|NCT01212991|3769542|FG000|Open-label|Sponsor decision|0
2155433|NCT01212991|3769543|FG001|Open-label|Sponsor decision|0
2155434|NCT01212991|3769544|FG002|Open-label|Sponsor decision|53
2155435|NCT01212991|3769542|FG000|Open-label|Other|0
2155436|NCT01212991|3769543|FG001|Open-label|Other|0
2155437|NCT01212991|3769544|FG002|Open-label|Other|3
2155438|NCT01213082|3769564|FG000|Overall Study|Lost to Follow-up|6
2155439|NCT01213082|3769565|FG001|Overall Study|Lost to Follow-up|7
2155440|NCT01213082|3769566|FG002|Overall Study|Lost to Follow-up|4
2155441|NCT01213082|3769564|FG000|Overall Study|Physician Decision|0
2155442|NCT01213082|3769565|FG001|Overall Study|Physician Decision|0
2155443|NCT01213082|3769566|FG002|Overall Study|Physician Decision|1
2155444|NCT01213173|3769576|FG000|Overall Study|Protocol Violation|2
2155445|NCT01213173|3769577|FG001|Overall Study|Protocol Violation|0
2155446|NCT01213173|3769576|FG000|Overall Study|Adverse Event|4
2155447|NCT01213173|3769577|FG001|Overall Study|Adverse Event|8
2155448|NCT01213173|3769576|FG000|Overall Study|Withdrawal by Subject|5
2155449|NCT01213173|3769577|FG001|Overall Study|Withdrawal by Subject|5
2155450|NCT01213173|3769576|FG000|Overall Study|Incorrect Enrollment|1
2155451|NCT01213173|3769577|FG001|Overall Study|Incorrect Enrollment|3
2155452|NCT01213251|3769590|FG000|Overall Study|Death|2
2155453|NCT01213251|3769591|FG001|Overall Study|Death|1
2155454|NCT01213251|3769592|FG002|Overall Study|Death|2
2155455|NCT01213251|3769590|FG000|Overall Study|Exit|3
2155456|NCT01213251|3769591|FG001|Overall Study|Exit|2
2155457|NCT01213251|3769592|FG002|Overall Study|Exit|8
2155458|NCT01213251|3769590|FG000|Overall Study|Protocol Violation|1
2155459|NCT01213251|3769591|FG001|Overall Study|Protocol Violation|1
2155460|NCT01213251|3769592|FG002|Overall Study|Protocol Violation|0
2292747|NCT02516410|3986521|FG000|Overall Study|Adverse Event|0
2292748|NCT02516410|3986522|FG001|Overall Study|Adverse Event|1
2292749|NCT02516410|3986521|FG000|Overall Study|Withdrawal by Subject|0
2292750|NCT02516410|3986522|FG001|Overall Study|Withdrawal by Subject|1
2292751|NCT02516592|3986535|FG000|Overall Study|Patient withdrew consent|5
2292752|NCT02516592|3986536|FG001|Overall Study|Patient withdrew consent|2
2292753|NCT02516592|3986535|FG000|Overall Study|Protocol deviation|4
2292754|NCT02516592|3986536|FG001|Overall Study|Protocol deviation|4
2292755|NCT02516592|3986535|FG000|Overall Study|Lost to Follow-up|2
2292756|NCT02516592|3986536|FG001|Overall Study|Lost to Follow-up|3
2292757|NCT02516592|3986535|FG000|Overall Study|Patient/guardian decision|2
2292758|NCT02516592|3986536|FG001|Overall Study|Patient/guardian decision|1
2292759|NCT02516592|3986535|FG000|Overall Study|Adverse Event|1
2292760|NCT02516592|3986536|FG001|Overall Study|Adverse Event|2
2292761|NCT02516592|3986535|FG000|Overall Study|Abnormal test procedure result|1
2292762|NCT02516592|3986536|FG001|Overall Study|Abnormal test procedure result|0
2292763|NCT02516592|3986535|FG000|Overall Study|Death|1
2292764|NCT02516592|3986536|FG001|Overall Study|Death|1
2292765|NCT02516605|3986547|FG000|Overall Study|Protocol Violation|0
2155461|NCT01213251|3769590|FG000|Overall Study|Missed 18-Month Follow-up|0
2155462|NCT01213251|3769591|FG001|Overall Study|Missed 18-Month Follow-up|0
2155463|NCT01213251|3769592|FG002|Overall Study|Missed 18-Month Follow-up|1
2155464|NCT01213264|3769608|FG000|Overall Study|Adverse Event|1
2155465|NCT01213264|3769609|FG001|Overall Study|Adverse Event|0
2155466|NCT01213264|3769610|FG002|Overall Study|Adverse Event|0
2155467|NCT01213264|3769608|FG000|Overall Study|Lost to Follow-up|1
2155468|NCT01213264|3769609|FG001|Overall Study|Lost to Follow-up|2
2292766|NCT02516605|3986548|FG001|Overall Study|Protocol Violation|0
2292767|NCT02516605|3986549|FG002|Overall Study|Protocol Violation|0
2155469|NCT01213264|3769610|FG002|Overall Study|Lost to Follow-up|6
2179317|NCT01393600|3804871|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
2179318|NCT01393600|3804868|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
2180147|NCT01399125|3806109|FG001|Overall Study|Lost to Follow-up|3
2292768|NCT02516605|3986550|FG003|Overall Study|Protocol Violation|0
2155470|NCT01213472|3769629|FG000|Overall Study|Recurrence/Progressive disease|25
2155471|NCT01213472|3769629|FG000|Overall Study|Withdrawal by Subject|1
2155472|NCT01213472|3769629|FG000|Overall Study|Physician Decision|1
2155473|NCT01213524|3769635|FG000|Baseline|Withdrawal by Subject|5
2155474|NCT01213524|3769635|FG000|Baseline|high breath alcohol levels|1
2155475|NCT01213524|3769635|FG000|Baseline|Physician Decision|1
2155476|NCT01213524|3769635|FG000|Session 2|Withdrawal by Subject|5
2155477|NCT01213524|3769635|FG000|Session 3|Withdrawal by Subject|4
2155478|NCT01213524|3769635|FG000|Session 4|Physician Decision|1
2155479|NCT01213524|3769635|FG000|Session 4|Withdrawal by Subject|2
2155480|NCT01213836|3769693|FG000|Period 1, First Intervention|Adverse Event|2
2155481|NCT01213836|3769694|FG001|Period 1, First Intervention|Adverse Event|1
2155482|NCT01213836|3769693|FG000|Period 1, First Intervention|Protocol Violation|0
2155483|NCT01213836|3769694|FG001|Period 1, First Intervention|Protocol Violation|1
2155484|NCT01213836|3769693|FG000|Period 1, First Intervention|Withdrawal by Subject|1
2155485|NCT01213836|3769694|FG001|Period 1, First Intervention|Withdrawal by Subject|1
2155486|NCT01213966|3769716|FG000|Overall Study|Protocol Violation|1
2155487|NCT01213966|3769717|FG001|Overall Study|Protocol Violation|0
2155488|NCT01213966|3769718|FG002|Overall Study|Protocol Violation|3
2155489|NCT01213966|3769719|FG003|Overall Study|Protocol Violation|1
2155490|NCT01214044|3769729|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
2155491|NCT01214044|3769729|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3
2155492|NCT01214044|3769729|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
2155493|NCT01214044|3769729|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
2155494|NCT01214044|3769729|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
2155495|NCT01214044|3769729|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
2155496|NCT01214174|3769789|FG000|Overall Study|Withdrawal by Subject|0
2155497|NCT01214174|3769790|FG001|Overall Study|Withdrawal by Subject|0
2155498|NCT01214174|3769791|FG002|Overall Study|Withdrawal by Subject|1
2155499|NCT01214187|3769801|FG000|Overall Study|Adverse Event|6
2155500|NCT01214187|3769802|FG001|Overall Study|Adverse Event|2
2155501|NCT01214187|3769801|FG000|Overall Study|Death|1
2155502|NCT01214187|3769802|FG001|Overall Study|Death|1
2155503|NCT01214187|3769801|FG000|Overall Study|Withdrawal by Subject|0
2155504|NCT01214187|3769802|FG001|Overall Study|Withdrawal by Subject|3
2155505|NCT01214200|3769808|FG000|Overall Study|Did not meet inclusion/exclusion|9
2155506|NCT01214200|3769808|FG000|Overall Study|Withdrawal by Subject|2
2155507|NCT01214239|3769816|FG000|Overall Study|Adverse Event|3
2155508|NCT01214239|3769817|FG001|Overall Study|Adverse Event|4
2155509|NCT01214239|3769816|FG000|Overall Study|Protocol Violation|2
2155510|NCT01214239|3769817|FG001|Overall Study|Protocol Violation|1
2155511|NCT01214239|3769816|FG000|Overall Study|Lost to Follow-up|1
2155512|NCT01214239|3769817|FG001|Overall Study|Lost to Follow-up|1
2155513|NCT01214239|3769816|FG000|Overall Study|Withdrawal by Subject|4
2155514|NCT01214239|3769817|FG001|Overall Study|Withdrawal by Subject|9
2155515|NCT01214239|3769816|FG000|Overall Study|Lack of Efficacy|1
2155516|NCT01214239|3769817|FG001|Overall Study|Lack of Efficacy|2
2155517|NCT01214239|3769816|FG000|Overall Study|patient's private reason|1
2155518|NCT01214239|3769817|FG001|Overall Study|patient's private reason|1
2155519|NCT01214252|3769823|FG000|Overall Study|Not eligible per protocol|82
2155520|NCT01214395|3769852|FG000|Overall Study|All patients had infection|5
2155521|NCT01214421|3769861|FG000|Overall Study|Lost to Follow-up|7
2155522|NCT01214421|3769862|FG001|Overall Study|Lost to Follow-up|3
2155523|NCT01214421|3769863|FG002|Overall Study|Lost to Follow-up|7
2155524|NCT01214421|3769864|FG003|Overall Study|Lost to Follow-up|3
2155525|NCT01214421|3769861|FG000|Overall Study|Adverse Event|16
2155526|NCT01214421|3769862|FG001|Overall Study|Adverse Event|35
2155527|NCT01214421|3769863|FG002|Overall Study|Adverse Event|14
2155528|NCT01214421|3769864|FG003|Overall Study|Adverse Event|3
2155529|NCT01214421|3769861|FG000|Overall Study|Sponsor Discontinued Site|1
2155530|NCT01214421|3769862|FG001|Overall Study|Sponsor Discontinued Site|2
2155531|NCT01214421|3769863|FG002|Overall Study|Sponsor Discontinued Site|0
2155532|NCT01214421|3769864|FG003|Overall Study|Sponsor Discontinued Site|0
2155533|NCT01214421|3769861|FG000|Overall Study|Withdrawal Criteria Met|3
2155534|NCT01214421|3769862|FG001|Overall Study|Withdrawal Criteria Met|0
2155535|NCT01214421|3769863|FG002|Overall Study|Withdrawal Criteria Met|2
2155536|NCT01214421|3769864|FG003|Overall Study|Withdrawal Criteria Met|1
2155537|NCT01214421|3769861|FG000|Overall Study|Physician Decision|2
2155538|NCT01214421|3769862|FG001|Overall Study|Physician Decision|0
2155539|NCT01214421|3769863|FG002|Overall Study|Physician Decision|4
2155540|NCT01214421|3769864|FG003|Overall Study|Physician Decision|0
2155541|NCT01214421|3769861|FG000|Overall Study|Withdrawal by Subject|21
2155542|NCT01214421|3769862|FG001|Overall Study|Withdrawal by Subject|18
2155543|NCT01214421|3769863|FG002|Overall Study|Withdrawal by Subject|11
2155544|NCT01214421|3769864|FG003|Overall Study|Withdrawal by Subject|2
2155545|NCT01214434|3769876|FG000|Overall Study|Withdrawal by Subject|1
2155546|NCT01214434|3769877|FG001|Overall Study|Withdrawal by Subject|0
2155547|NCT01214434|3769876|FG000|Overall Study|Lost to Follow-up|2
2155548|NCT01214434|3769877|FG001|Overall Study|Lost to Follow-up|2
2155549|NCT01214434|3769876|FG000|Overall Study|Site error|1
2155550|NCT01214434|3769877|FG001|Overall Study|Site error|0
2155551|NCT01214603|3769886|FG000|Overall Study|Adverse Event|0
2155552|NCT01214603|3769887|FG001|Overall Study|Adverse Event|0
2155553|NCT01214603|3769888|FG002|Overall Study|Adverse Event|1
2155554|NCT01214603|3769886|FG000|Overall Study|Death|1
2155555|NCT01214603|3769887|FG001|Overall Study|Death|0
2155556|NCT01214603|3769888|FG002|Overall Study|Death|0
2155557|NCT01214603|3769886|FG000|Overall Study|Progressive Disease|4
2155558|NCT01214603|3769887|FG001|Overall Study|Progressive Disease|1
2155559|NCT01214603|3769888|FG002|Overall Study|Progressive Disease|3
2155560|NCT01214616|3769901|FG000|Overall Study|Progressive disease|2
2155561|NCT01214616|3769902|FG001|Overall Study|Progressive disease|2
2155562|NCT01214616|3769903|FG002|Overall Study|Progressive disease|2
2155563|NCT01214616|3769904|FG003|Overall Study|Progressive disease|4
2155564|NCT01214616|3769901|FG000|Overall Study|Dose limiting toxicity|0
2155565|NCT01214616|3769902|FG001|Overall Study|Dose limiting toxicity|2
2155566|NCT01214616|3769903|FG002|Overall Study|Dose limiting toxicity|0
2155567|NCT01214616|3769904|FG003|Overall Study|Dose limiting toxicity|0
2155568|NCT01214616|3769901|FG000|Overall Study|Other adverse events|0
2155569|NCT01214616|3769902|FG001|Overall Study|Other adverse events|1
2155570|NCT01214616|3769903|FG002|Overall Study|Other adverse events|1
2155571|NCT01214616|3769904|FG003|Overall Study|Other adverse events|1
2155572|NCT01214616|3769901|FG000|Overall Study|Withdrawal by Subject|1
2155573|NCT01214616|3769902|FG001|Overall Study|Withdrawal by Subject|0
2155574|NCT01214616|3769903|FG002|Overall Study|Withdrawal by Subject|0
2155575|NCT01214616|3769904|FG003|Overall Study|Withdrawal by Subject|1
2155576|NCT01214629|3769933|FG000|Overall Study|Progressive Disease|1
2155577|NCT01214629|3769934|FG001|Overall Study|Progressive Disease|1
2155578|NCT01214629|3769935|FG002|Overall Study|Progressive Disease|0
2155579|NCT01214629|3769936|FG003|Overall Study|Progressive Disease|1
2155580|NCT01214629|3769937|FG004|Overall Study|Progressive Disease|2
2155581|NCT01214629|3769938|FG005|Overall Study|Progressive Disease|3
2155582|NCT01214629|3769939|FG006|Overall Study|Progressive Disease|1
2155583|NCT01214629|3769940|FG007|Overall Study|Progressive Disease|1
2155584|NCT01214629|3769941|FG008|Overall Study|Progressive Disease|1
2155585|NCT01214629|3769942|FG009|Overall Study|Progressive Disease|5
2155586|NCT01214629|3769943|FG010|Overall Study|Progressive Disease|1
2155587|NCT01214629|3769933|FG000|Overall Study|Adverse Event|0
2155588|NCT01214629|3769934|FG001|Overall Study|Adverse Event|0
2155589|NCT01214629|3769935|FG002|Overall Study|Adverse Event|0
2155590|NCT01214629|3769936|FG003|Overall Study|Adverse Event|1
2155591|NCT01214629|3769937|FG004|Overall Study|Adverse Event|0
2155592|NCT01214629|3769938|FG005|Overall Study|Adverse Event|1
2155593|NCT01214629|3769939|FG006|Overall Study|Adverse Event|0
2155594|NCT01214629|3769940|FG007|Overall Study|Adverse Event|0
2155595|NCT01214629|3769941|FG008|Overall Study|Adverse Event|0
2155596|NCT01214629|3769942|FG009|Overall Study|Adverse Event|1
2155597|NCT01214629|3769943|FG010|Overall Study|Adverse Event|0
2155598|NCT01214629|3769933|FG000|Overall Study|Physician Decision|0
2155599|NCT01214629|3769934|FG001|Overall Study|Physician Decision|0
2155600|NCT01214629|3769935|FG002|Overall Study|Physician Decision|0
2155601|NCT01214629|3769936|FG003|Overall Study|Physician Decision|0
2155602|NCT01214629|3769937|FG004|Overall Study|Physician Decision|0
2155603|NCT01214629|3769938|FG005|Overall Study|Physician Decision|0
2155604|NCT01214629|3769939|FG006|Overall Study|Physician Decision|0
2155605|NCT01214629|3769940|FG007|Overall Study|Physician Decision|0
2155606|NCT01214629|3769941|FG008|Overall Study|Physician Decision|0
2155607|NCT01214629|3769942|FG009|Overall Study|Physician Decision|0
2155608|NCT01214629|3769943|FG010|Overall Study|Physician Decision|1
2155609|NCT01214629|3769933|FG000|Overall Study|Withdrawal by Subject|0
2155610|NCT01214629|3769934|FG001|Overall Study|Withdrawal by Subject|0
2155611|NCT01214629|3769935|FG002|Overall Study|Withdrawal by Subject|0
2155612|NCT01214629|3769936|FG003|Overall Study|Withdrawal by Subject|0
2155613|NCT01214629|3769937|FG004|Overall Study|Withdrawal by Subject|0
2155614|NCT01214629|3769938|FG005|Overall Study|Withdrawal by Subject|0
2155615|NCT01214629|3769939|FG006|Overall Study|Withdrawal by Subject|0
2155616|NCT01214629|3769940|FG007|Overall Study|Withdrawal by Subject|0
2155617|NCT01214629|3769941|FG008|Overall Study|Withdrawal by Subject|0
2155618|NCT01214629|3769942|FG009|Overall Study|Withdrawal by Subject|1
2155619|NCT01214629|3769943|FG010|Overall Study|Withdrawal by Subject|0
2155620|NCT01214642|3769993|FG000|Overall Study|Progressive Disease|3
2155621|NCT01214642|3769994|FG001|Overall Study|Progressive Disease|2
2155622|NCT01214642|3769995|FG002|Overall Study|Progressive Disease|3
2155623|NCT01214642|3769996|FG003|Overall Study|Progressive Disease|5
2155624|NCT01214642|3769997|FG004|Overall Study|Progressive Disease|5
2155625|NCT01214642|3769998|FG005|Overall Study|Progressive Disease|3
2155626|NCT01214642|3769999|FG006|Overall Study|Progressive Disease|5
2155627|NCT01214642|3770000|FG007|Overall Study|Progressive Disease|3
2155628|NCT01214642|3770001|FG008|Overall Study|Progressive Disease|10
2155629|NCT01214642|3770002|FG009|Overall Study|Progressive Disease|2
2155630|NCT01214642|3770003|FG010|Overall Study|Progressive Disease|1
2155631|NCT01214642|3770004|FG011|Overall Study|Progressive Disease|4
2155632|NCT01214642|3769993|FG000|Overall Study|Adverse Event|0
2155633|NCT01214642|3769994|FG001|Overall Study|Adverse Event|1
2155634|NCT01214642|3769995|FG002|Overall Study|Adverse Event|0
2155635|NCT01214642|3769996|FG003|Overall Study|Adverse Event|0
2155636|NCT01214642|3769997|FG004|Overall Study|Adverse Event|0
2155637|NCT01214642|3769998|FG005|Overall Study|Adverse Event|0
2155638|NCT01214642|3769999|FG006|Overall Study|Adverse Event|1
2155639|NCT01214642|3770000|FG007|Overall Study|Adverse Event|0
2155640|NCT01214642|3770001|FG008|Overall Study|Adverse Event|0
2155641|NCT01214642|3770002|FG009|Overall Study|Adverse Event|1
2155642|NCT01214642|3770003|FG010|Overall Study|Adverse Event|1
2155643|NCT01214642|3770004|FG011|Overall Study|Adverse Event|0
2155644|NCT01214642|3769993|FG000|Overall Study|Death|0
2155645|NCT01214642|3769994|FG001|Overall Study|Death|0
2155646|NCT01214642|3769995|FG002|Overall Study|Death|1
2155647|NCT01214642|3769996|FG003|Overall Study|Death|0
2155648|NCT01214642|3769997|FG004|Overall Study|Death|0
2155649|NCT01214642|3769998|FG005|Overall Study|Death|0
2155650|NCT01214642|3769999|FG006|Overall Study|Death|0
2155651|NCT01214642|3770000|FG007|Overall Study|Death|0
2155652|NCT01214642|3770001|FG008|Overall Study|Death|0
2155653|NCT01214642|3770002|FG009|Overall Study|Death|0
2155654|NCT01214642|3770003|FG010|Overall Study|Death|1
2155655|NCT01214642|3770004|FG011|Overall Study|Death|0
2155656|NCT01214642|3769993|FG000|Overall Study|Withdrawal by Subject|0
2155657|NCT01214642|3769994|FG001|Overall Study|Withdrawal by Subject|0
2155658|NCT01214642|3769995|FG002|Overall Study|Withdrawal by Subject|1
2155659|NCT01214642|3769996|FG003|Overall Study|Withdrawal by Subject|0
2155660|NCT01214642|3769997|FG004|Overall Study|Withdrawal by Subject|0
2155661|NCT01214642|3769998|FG005|Overall Study|Withdrawal by Subject|0
2155662|NCT01214642|3769999|FG006|Overall Study|Withdrawal by Subject|0
2155663|NCT01214642|3770000|FG007|Overall Study|Withdrawal by Subject|0
2155664|NCT01214642|3770001|FG008|Overall Study|Withdrawal by Subject|3
2155665|NCT01214642|3770002|FG009|Overall Study|Withdrawal by Subject|1
2155666|NCT01214642|3770003|FG010|Overall Study|Withdrawal by Subject|1
2155667|NCT01214642|3770004|FG011|Overall Study|Withdrawal by Subject|0
2155668|NCT01214642|3769993|FG000|Overall Study|Physician Decision|0
2155669|NCT01214642|3769994|FG001|Overall Study|Physician Decision|0
2155670|NCT01214642|3769995|FG002|Overall Study|Physician Decision|1
2155671|NCT01214642|3769996|FG003|Overall Study|Physician Decision|1
2155672|NCT01214642|3769997|FG004|Overall Study|Physician Decision|1
2155673|NCT01214642|3769998|FG005|Overall Study|Physician Decision|0
2155674|NCT01214642|3769999|FG006|Overall Study|Physician Decision|0
2155675|NCT01214642|3770000|FG007|Overall Study|Physician Decision|0
2155676|NCT01214642|3770001|FG008|Overall Study|Physician Decision|0
2155677|NCT01214642|3770002|FG009|Overall Study|Physician Decision|0
2155678|NCT01214642|3770003|FG010|Overall Study|Physician Decision|0
2155679|NCT01214642|3770004|FG011|Overall Study|Physician Decision|2
2155680|NCT01214655|3770050|FG000|Part A|Progressive Disease|7
2155681|NCT01214655|3770051|FG001|Part A|Progressive Disease|0
2155682|NCT01214655|3770052|FG002|Part A|Progressive Disease|0
2155683|NCT01214655|3770050|FG000|Part A|Physician Decision|1
2155684|NCT01214655|3770051|FG001|Part A|Physician Decision|0
2155685|NCT01214655|3770052|FG002|Part A|Physician Decision|0
2155686|NCT01214655|3770050|FG000|Part B|Progressive disease|0
2155687|NCT01214655|3770051|FG001|Part B|Progressive disease|10
2155688|NCT01214655|3770052|FG002|Part B|Progressive disease|0
2155689|NCT01214655|3770050|FG000|Part B|Death|0
2155690|NCT01214655|3770051|FG001|Part B|Death|1
2155691|NCT01214655|3770052|FG002|Part B|Death|0
2155692|NCT01214655|3770050|FG000|Part B|Withdrawal by Subject|0
2155693|NCT01214655|3770051|FG001|Part B|Withdrawal by Subject|2
2155694|NCT01214655|3770052|FG002|Part B|Withdrawal by Subject|0
2155695|NCT01214655|3770050|FG000|Part C|Progressive Disease|0
2155696|NCT01214655|3770051|FG001|Part C|Progressive Disease|0
2155697|NCT01214655|3770052|FG002|Part C|Progressive Disease|5
2155698|NCT01214655|3770050|FG000|Part C|Death|0
2155699|NCT01214655|3770051|FG001|Part C|Death|0
2155700|NCT01214655|3770052|FG002|Part C|Death|1
2155701|NCT01214655|3770050|FG000|Part C|Physician Decision|0
2155702|NCT01214655|3770051|FG001|Part C|Physician Decision|0
2155703|NCT01214655|3770052|FG002|Part C|Physician Decision|1
2155704|NCT01214668|3770104|FG000|Overall Study|Adverse Event|0
2155705|NCT01214668|3770105|FG001|Overall Study|Adverse Event|1
2155706|NCT01214668|3770106|FG002|Overall Study|Adverse Event|0
2155707|NCT01214668|3770107|FG003|Overall Study|Adverse Event|2
2155708|NCT01214668|3770108|FG004|Overall Study|Adverse Event|1
2155709|NCT01214668|3770109|FG005|Overall Study|Adverse Event|1
2155710|NCT01214668|3770104|FG000|Overall Study|Death|0
2155711|NCT01214668|3770105|FG001|Overall Study|Death|0
2155712|NCT01214668|3770106|FG002|Overall Study|Death|1
2155713|NCT01214668|3770107|FG003|Overall Study|Death|0
2155714|NCT01214668|3770108|FG004|Overall Study|Death|0
2155715|NCT01214668|3770109|FG005|Overall Study|Death|0
2155716|NCT01214668|3770104|FG000|Overall Study|Progressive Disease|4
2155717|NCT01214668|3770105|FG001|Overall Study|Progressive Disease|2
2155718|NCT01214668|3770106|FG002|Overall Study|Progressive Disease|5
2155719|NCT01214668|3770107|FG003|Overall Study|Progressive Disease|4
2155720|NCT01214668|3770108|FG004|Overall Study|Progressive Disease|4
2155721|NCT01214668|3770109|FG005|Overall Study|Progressive Disease|5
2155722|NCT01214668|3770104|FG000|Overall Study|Withdrawal by Subject|0
2155723|NCT01214668|3770105|FG001|Overall Study|Withdrawal by Subject|0
2155724|NCT01214668|3770106|FG002|Overall Study|Withdrawal by Subject|0
2155725|NCT01214668|3770107|FG003|Overall Study|Withdrawal by Subject|0
2155726|NCT01214668|3770108|FG004|Overall Study|Withdrawal by Subject|1
2155727|NCT01214668|3770109|FG005|Overall Study|Withdrawal by Subject|0
2155728|NCT01214720|3770126|FG000|Overall Study|Alive and still on treatment|34
2155729|NCT01214720|3770127|FG001|Overall Study|Alive and still on treatment|18
2155730|NCT01214720|3770126|FG000|Overall Study|Alive and in follow-up|45
2155731|NCT01214720|3770127|FG001|Overall Study|Alive and in follow-up|48
2155732|NCT01214720|3770126|FG000|Overall Study|Lost to Follow-up|6
2155733|NCT01214720|3770127|FG001|Overall Study|Lost to Follow-up|2
2155734|NCT01214837|3770149|FG000|Overall Study|Death|0
2155735|NCT01214837|3770150|FG001|Overall Study|Death|0
2155736|NCT01214837|3770151|FG002|Overall Study|Death|1
2155737|NCT01214837|3770149|FG000|Overall Study|Adverse Event|1
2155738|NCT01214837|3770150|FG001|Overall Study|Adverse Event|2
2155739|NCT01214837|3770151|FG002|Overall Study|Adverse Event|1
2155740|NCT01214837|3770149|FG000|Overall Study|Withdrawal by Subject|27
2155741|NCT01214837|3770150|FG001|Overall Study|Withdrawal by Subject|36
2155742|NCT01214837|3770151|FG002|Overall Study|Withdrawal by Subject|28
2155743|NCT01214837|3770149|FG000|Overall Study|Lost to Follow-up|20
2155744|NCT01214837|3770150|FG001|Overall Study|Lost to Follow-up|15
2155745|NCT01214837|3770151|FG002|Overall Study|Lost to Follow-up|21
2155746|NCT01214837|3770149|FG000|Overall Study|Inappropriate Enrolment|0
2155747|NCT01214837|3770150|FG001|Overall Study|Inappropriate Enrolment|1
2155748|NCT01214837|3770151|FG002|Overall Study|Inappropriate Enrolment|2
2155749|NCT01214837|3770149|FG000|Overall Study|Administrative Reason|2
2155750|NCT01214837|3770150|FG001|Overall Study|Administrative Reason|6
2155751|NCT01214837|3770151|FG002|Overall Study|Administrative Reason|4
2155752|NCT01214837|3770149|FG000|Overall Study|Protocol Violation|3
2155753|NCT01214837|3770150|FG001|Overall Study|Protocol Violation|1
2155754|NCT01214837|3770151|FG002|Overall Study|Protocol Violation|5
2155755|NCT01214837|3770149|FG000|Overall Study|Unable to Classify|1
2155756|NCT01214837|3770150|FG001|Overall Study|Unable to Classify|3
2155757|NCT01214837|3770151|FG002|Overall Study|Unable to Classify|0
2155758|NCT01214850|3770163|FG000|Overall Study|Withdrawal by Subject|38
2155759|NCT01214850|3770164|FG001|Overall Study|Withdrawal by Subject|31
2155760|NCT01214850|3770165|FG002|Overall Study|Withdrawal by Subject|28
2155761|NCT01214850|3770163|FG000|Overall Study|Lost to Follow-up|124
2155762|NCT01214850|3770164|FG001|Overall Study|Lost to Follow-up|98
2155763|NCT01214850|3770165|FG002|Overall Study|Lost to Follow-up|123
2155764|NCT01214850|3770163|FG000|Overall Study|Protocol Violation|5
2155765|NCT01214850|3770164|FG001|Overall Study|Protocol Violation|5
2155766|NCT01214850|3770165|FG002|Overall Study|Protocol Violation|6
2155767|NCT01214850|3770163|FG000|Overall Study|Adverse event or death|11
2155768|NCT01214850|3770164|FG001|Overall Study|Adverse event or death|8
2155769|NCT01214850|3770165|FG002|Overall Study|Adverse event or death|3
2155770|NCT01214850|3770163|FG000|Overall Study|Inappropriate enrollment|2
2155771|NCT01214850|3770164|FG001|Overall Study|Inappropriate enrollment|1
2155772|NCT01214850|3770165|FG002|Overall Study|Inappropriate enrollment|0
2155773|NCT01214850|3770163|FG000|Overall Study|Administrative reason|1
2155774|NCT01214850|3770164|FG001|Overall Study|Administrative reason|0
2155775|NCT01214850|3770165|FG002|Overall Study|Administrative reason|0
2155776|NCT01214850|3770163|FG000|Overall Study|Unable to classify|2
2155777|NCT01214850|3770164|FG001|Overall Study|Unable to classify|1
2155778|NCT01214850|3770165|FG002|Overall Study|Unable to classify|1
2155779|NCT01214915|3770176|FG000|Overall Study|Adverse Event|8
2155780|NCT01214915|3770176|FG000|Overall Study|Lack of Efficacy|3
2155781|NCT01215032|3770189|FG000|Overall Study|Adverse Event|3
2155782|NCT01215032|3770189|FG000|Overall Study|Lack of Efficacy|17
2155783|NCT01215097|3770197|FG000|Overall Study|Adverse Event|1
2155784|NCT01215097|3770198|FG001|Overall Study|Adverse Event|3
2155785|NCT01215097|3770197|FG000|Overall Study|Protocol Violation|0
2155786|NCT01215097|3770198|FG001|Overall Study|Protocol Violation|2
2155787|NCT01215097|3770197|FG000|Overall Study|Lost to Follow-up|2
2155788|NCT01215097|3770198|FG001|Overall Study|Lost to Follow-up|0
2155789|NCT01215097|3770197|FG000|Overall Study|Withdrawal by Subject|6
2155790|NCT01215097|3770198|FG001|Overall Study|Withdrawal by Subject|3
2155791|NCT01215097|3770197|FG000|Overall Study|Lack of Efficacy|0
2155792|NCT01215097|3770198|FG001|Overall Study|Lack of Efficacy|3
2155793|NCT01215097|3770197|FG000|Overall Study|patient's refusal to come|2
2155794|NCT01215097|3770198|FG001|Overall Study|patient's refusal to come|2
2155795|NCT01215097|3770197|FG000|Overall Study|patient's private reason|1
2155796|NCT01215097|3770198|FG001|Overall Study|patient's private reason|1
2155797|NCT01215175|3770238|FG000|Overall Study|Lost to Follow-up|0
2155798|NCT01215175|3770239|FG001|Overall Study|Lost to Follow-up|1
2155799|NCT01215175|3770240|FG002|Overall Study|Lost to Follow-up|0
2155800|NCT01215175|3770241|FG003|Overall Study|Lost to Follow-up|1
2155801|NCT01215175|3770242|FG004|Overall Study|Lost to Follow-up|0
2155802|NCT01215188|3770257|FG000|Overall Study|Lost to Follow-up|22
2155803|NCT01215188|3770258|FG001|Overall Study|Lost to Follow-up|22
2155804|NCT01215188|3770259|FG002|Overall Study|Lost to Follow-up|16
2155805|NCT01215188|3770257|FG000|Overall Study|Adverse Event|1
2155806|NCT01215188|3770258|FG001|Overall Study|Adverse Event|1
2155807|NCT01215188|3770259|FG002|Overall Study|Adverse Event|3
2155808|NCT01215188|3770257|FG000|Overall Study|Physician Decision|2
2155809|NCT01215188|3770258|FG001|Overall Study|Physician Decision|1
2155810|NCT01215188|3770259|FG002|Overall Study|Physician Decision|0
2155811|NCT01215188|3770257|FG000|Overall Study|Lack of Efficacy|0
2155812|NCT01215188|3770258|FG001|Overall Study|Lack of Efficacy|0
2155813|NCT01215188|3770259|FG002|Overall Study|Lack of Efficacy|1
2155814|NCT01215188|3770257|FG000|Overall Study|Protocol Violation|1
2155815|NCT01215188|3770258|FG001|Overall Study|Protocol Violation|1
2155816|NCT01215188|3770259|FG002|Overall Study|Protocol Violation|1
2155817|NCT01215188|3770257|FG000|Overall Study|Withdrawal by Subject|32
2155818|NCT01215188|3770258|FG001|Overall Study|Withdrawal by Subject|34
2155819|NCT01215188|3770259|FG002|Overall Study|Withdrawal by Subject|31
2155820|NCT01215227|3770273|FG000|Overall Study|Adverse Event|11
2155821|NCT01215227|3770274|FG001|Overall Study|Adverse Event|11
2155822|NCT01215227|3770275|FG002|Overall Study|Adverse Event|4
2155823|NCT01215227|3770276|FG003|Overall Study|Adverse Event|8
2155824|NCT01215227|3770277|FG004|Overall Study|Adverse Event|7
2155825|NCT01215227|3770278|FG005|Overall Study|Adverse Event|6
2155826|NCT01215227|3770273|FG000|Overall Study|Treatment Failure|8
2155827|NCT01215227|3770274|FG001|Overall Study|Treatment Failure|4
2155828|NCT01215227|3770275|FG002|Overall Study|Treatment Failure|1
2155829|NCT01215227|3770276|FG003|Overall Study|Treatment Failure|5
2155830|NCT01215227|3770277|FG004|Overall Study|Treatment Failure|1
2155831|NCT01215227|3770278|FG005|Overall Study|Treatment Failure|1
2155832|NCT01215227|3770273|FG000|Overall Study|Lost to Follow-up|1
2155833|NCT01215227|3770274|FG001|Overall Study|Lost to Follow-up|4
2155834|NCT01215227|3770275|FG002|Overall Study|Lost to Follow-up|1
2155835|NCT01215227|3770276|FG003|Overall Study|Lost to Follow-up|1
2155836|NCT01215227|3770277|FG004|Overall Study|Lost to Follow-up|1
2155837|NCT01215227|3770278|FG005|Overall Study|Lost to Follow-up|2
2155838|NCT01215227|3770273|FG000|Overall Study|Subject Withdrew Consent|16
2155839|NCT01215227|3770274|FG001|Overall Study|Subject Withdrew Consent|20
2155840|NCT01215227|3770275|FG002|Overall Study|Subject Withdrew Consent|7
2155841|NCT01215227|3770276|FG003|Overall Study|Subject Withdrew Consent|10
2155842|NCT01215227|3770277|FG004|Overall Study|Subject Withdrew Consent|11
2155843|NCT01215227|3770278|FG005|Overall Study|Subject Withdrew Consent|8
2155844|NCT01215227|3770273|FG000|Overall Study|Non-Compliance With Protocol|2
2155845|NCT01215227|3770274|FG001|Overall Study|Non-Compliance With Protocol|6
2155846|NCT01215227|3770275|FG002|Overall Study|Non-Compliance With Protocol|1
2155847|NCT01215227|3770276|FG003|Overall Study|Non-Compliance With Protocol|0
2155848|NCT01215227|3770277|FG004|Overall Study|Non-Compliance With Protocol|0
2155849|NCT01215227|3770278|FG005|Overall Study|Non-Compliance With Protocol|0
2292769|NCT02516605|3986551|FG004|Overall Study|Protocol Violation|1
2292770|NCT02516605|3986547|FG000|Overall Study|Withdrawal by Subject|0
2292771|NCT02516605|3986548|FG001|Overall Study|Withdrawal by Subject|0
2292772|NCT02516605|3986549|FG002|Overall Study|Withdrawal by Subject|0
2292773|NCT02516605|3986550|FG003|Overall Study|Withdrawal by Subject|1
2292774|NCT02516605|3986551|FG004|Overall Study|Withdrawal by Subject|0
2292775|NCT02516982|3986571|FG000|Overall Study|Called in to antenatal appointment|32
2292776|NCT02516982|3986572|FG001|Overall Study|Called in to antenatal appointment|35
2292777|NCT02516982|3986573|FG002|Overall Study|Called in to antenatal appointment|0
2292778|NCT02516982|3986574|FG003|Overall Study|Called in to antenatal appointment|0
2292779|NCT02516982|3986571|FG000|Overall Study|Withdrawal by Subject|0
2292780|NCT02516982|3986572|FG001|Overall Study|Withdrawal by Subject|0
2292781|NCT02516982|3986573|FG002|Overall Study|Withdrawal by Subject|1
2292782|NCT02516982|3986574|FG003|Overall Study|Withdrawal by Subject|2
2292783|NCT02516982|3986571|FG000|Overall Study|Protocol Violation|0
2292784|NCT02516982|3986572|FG001|Overall Study|Protocol Violation|0
2292785|NCT02516982|3986573|FG002|Overall Study|Protocol Violation|1
2292786|NCT02516982|3986574|FG003|Overall Study|Protocol Violation|1
2292787|NCT02516982|3986571|FG000|Overall Study|Did not install the app|0
2292788|NCT02516982|3986572|FG001|Overall Study|Did not install the app|0
2292789|NCT02516982|3986573|FG002|Overall Study|Did not install the app|46
2292790|NCT02516982|3986574|FG003|Overall Study|Did not install the app|47
2292791|NCT02517268|3986600|FG000|Overall Study|Withdrawal by Subject|1
2292792|NCT02517268|3986601|FG001|Overall Study|Withdrawal by Subject|0
2292793|NCT02517463|3986609|FG000|Overall Study|Lost to Follow-up|5
2292794|NCT02517463|3986610|FG001|Overall Study|Lost to Follow-up|2
2292795|NCT02517515|3986618|FG000|Overall Study|Adverse Event|0
2292796|NCT02517515|3986619|FG001|Overall Study|Adverse Event|1
2292797|NCT02517515|3986618|FG000|Overall Study|Withdrew Consent|0
2292798|NCT02517515|3986619|FG001|Overall Study|Withdrew Consent|1
2292799|NCT02517515|3986618|FG000|Overall Study|Lost to Follow-up|1
2292800|NCT02517515|3986619|FG001|Overall Study|Lost to Follow-up|0
2292801|NCT02517515|3986618|FG000|Overall Study|Other|1
2292802|NCT02517515|3986619|FG001|Overall Study|Other|0
2292803|NCT02517528|3986626|FG000|Overall Study|Withdrawal by Subject|1
2292804|NCT02517541|3986630|FG000|Baseline Period (Own Product)|Protocol Violation|1
2292805|NCT02517541|3986630|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
2292806|NCT02517541|3986630|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
2292807|NCT02517541|3986630|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
2155850|NCT01215227|3770273|FG000|Overall Study|Administrative|83
2155851|NCT01215227|3770274|FG001|Overall Study|Administrative|73
2155852|NCT01215227|3770275|FG002|Overall Study|Administrative|42
2155853|NCT01215227|3770276|FG003|Overall Study|Administrative|24
2155854|NCT01215227|3770277|FG004|Overall Study|Administrative|28
2155855|NCT01215227|3770278|FG005|Overall Study|Administrative|40
2155856|NCT01215227|3770273|FG000|Overall Study|Missing Status|0
2155857|NCT01215227|3770274|FG001|Overall Study|Missing Status|1
2155858|NCT01215227|3770275|FG002|Overall Study|Missing Status|0
2292808|NCT02517541|3986630|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
2155859|NCT01215227|3770276|FG003|Overall Study|Missing Status|0
2155860|NCT01215227|3770277|FG004|Overall Study|Missing Status|0
2155861|NCT01215227|3770278|FG005|Overall Study|Missing Status|0
2155862|NCT01215227|3770273|FG000|Overall Study|Randomized but not treated|0
2155863|NCT01215227|3770274|FG001|Overall Study|Randomized but not treated|0
2155864|NCT01215227|3770275|FG002|Overall Study|Randomized but not treated|1
2155865|NCT01215227|3770276|FG003|Overall Study|Randomized but not treated|1
2155866|NCT01215227|3770277|FG004|Overall Study|Randomized but not treated|0
2155867|NCT01215227|3770278|FG005|Overall Study|Randomized but not treated|1
2155868|NCT01215253|3770303|FG000|Overall Study|Withdrawal by Subject|57
2155869|NCT01215253|3770304|FG001|Overall Study|Withdrawal by Subject|35
2155870|NCT01215253|3770303|FG000|Overall Study|Physician Decision|9
2155871|NCT01215253|3770304|FG001|Overall Study|Physician Decision|12
2155872|NCT01215253|3770303|FG000|Overall Study|Lost to Follow-up|6
2155873|NCT01215253|3770304|FG001|Overall Study|Lost to Follow-up|4
2155874|NCT01215253|3770303|FG000|Overall Study|Other|14
2155875|NCT01215253|3770304|FG001|Overall Study|Other|12
2155876|NCT01215357|3770371|FG000|Overall Study|Withdrawal by Subject|3
2155877|NCT01215357|3770371|FG000|Overall Study|Protocol Violation|9
2155878|NCT01215422|3770379|FG000|Overall Study|Relocation|1
2155879|NCT01215422|3770380|FG001|Overall Study|Relocation|0
2155880|NCT01215422|3770381|FG002|Overall Study|Relocation|0
2155881|NCT01215422|3770382|FG003|Overall Study|Relocation|0
2155882|NCT01215422|3770379|FG000|Overall Study|Failed intubations|0
2155883|NCT01215422|3770380|FG001|Overall Study|Failed intubations|0
2155884|NCT01215422|3770381|FG002|Overall Study|Failed intubations|3
2155885|NCT01215422|3770382|FG003|Overall Study|Failed intubations|8
2292809|NCT02517541|3986630|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
2292810|NCT02517866|3986665|FG000|Overall Study|Pretreatment Event/Adverse Event|9
2292811|NCT02517866|3986666|FG001|Overall Study|Pretreatment Event/Adverse Event|2
2292812|NCT02517866|3986667|FG002|Overall Study|Pretreatment Event/Adverse Event|0
2292813|NCT02517866|3986665|FG000|Overall Study|Significant Protocol Deviation|4
2292814|NCT02517866|3986666|FG001|Overall Study|Significant Protocol Deviation|1
2292815|NCT02517866|3986667|FG002|Overall Study|Significant Protocol Deviation|0
2292816|NCT02517866|3986665|FG000|Overall Study|Lost to Follow-up|1
2292817|NCT02517866|3986666|FG001|Overall Study|Lost to Follow-up|0
2292818|NCT02517866|3986667|FG002|Overall Study|Lost to Follow-up|0
2292819|NCT02517866|3986665|FG000|Overall Study|Voluntary Withdrawal|2
2292820|NCT02517866|3986666|FG001|Overall Study|Voluntary Withdrawal|2
2292821|NCT02517866|3986667|FG002|Overall Study|Voluntary Withdrawal|0
2292822|NCT02517866|3986665|FG000|Overall Study|Investigator Decision|2
2292823|NCT02517866|3986666|FG001|Overall Study|Investigator Decision|1
2292824|NCT02517866|3986667|FG002|Overall Study|Investigator Decision|0
2292825|NCT02517866|3986665|FG000|Overall Study|Reason not specified|2
2292826|NCT02517866|3986666|FG001|Overall Study|Reason not specified|0
2292827|NCT02517866|3986667|FG002|Overall Study|Reason not specified|0
2292828|NCT02517905|3986679|FG000|Overall Study|Lost to Follow-up|4
2292829|NCT02517905|3986680|FG001|Overall Study|Lost to Follow-up|0
2292830|NCT02517905|3986679|FG000|Overall Study|Withdrawal by Subject|4
2292831|NCT02517905|3986680|FG001|Overall Study|Withdrawal by Subject|0
2292832|NCT02517905|3986679|FG000|Overall Study|Screen failure|2
2292833|NCT02517905|3986680|FG001|Overall Study|Screen failure|2
2292834|NCT02518048|3986695|FG000|Overall Study|Withdrawal by Subject|1
2292835|NCT02518113|3986704|FG000|Overall Study|Adverse Event|1
2292836|NCT02518113|3986705|FG001|Overall Study|Adverse Event|0
2292837|NCT02518113|3986706|FG002|Overall Study|Adverse Event|1
2292838|NCT02518113|3986707|FG003|Overall Study|Adverse Event|0
2292839|NCT02518113|3986704|FG000|Overall Study|Death|1
2292840|NCT02518113|3986705|FG001|Overall Study|Death|2
2292841|NCT02518113|3986706|FG002|Overall Study|Death|0
2292842|NCT02518113|3986707|FG003|Overall Study|Death|0
2292843|NCT02518113|3986704|FG000|Overall Study|Physician Decision|0
2292844|NCT02518113|3986705|FG001|Overall Study|Physician Decision|1
2292845|NCT02518113|3986706|FG002|Overall Study|Physician Decision|0
2292846|NCT02518113|3986707|FG003|Overall Study|Physician Decision|0
2292847|NCT02518113|3986704|FG000|Overall Study|Progressive Disease|1
2292848|NCT02518113|3986705|FG001|Overall Study|Progressive Disease|2
2292849|NCT02518113|3986706|FG002|Overall Study|Progressive Disease|3
2292850|NCT02518113|3986707|FG003|Overall Study|Progressive Disease|0
2292851|NCT02518464|3986741|FG000|Overall Study|Adverse Event|2
2292852|NCT02518490|3986745|FG000|Overall Study|Withdrawal by Subject|1
2292853|NCT02518490|3986746|FG001|Overall Study|Withdrawal by Subject|1
2292854|NCT02518620|3986755|FG000|Overall Study|Adverse Event|23
2292855|NCT02518620|3986756|FG001|Overall Study|Adverse Event|11
2292856|NCT02518620|3986755|FG000|Overall Study|Lack of Efficacy|2
2292857|NCT02518620|3986756|FG001|Overall Study|Lack of Efficacy|0
2292858|NCT02518620|3986755|FG000|Overall Study|Non-Compliance with Study Drug|1
2155886|NCT01215422|3770379|FG000|Overall Study|Did not complete all intubations|7
2155887|NCT01215422|3770380|FG001|Overall Study|Did not complete all intubations|0
2155888|NCT01215422|3770381|FG002|Overall Study|Did not complete all intubations|0
2155889|NCT01215422|3770382|FG003|Overall Study|Did not complete all intubations|0
2155890|NCT01215435|3770406|FG000|Overall Study|Adverse Event|1
2155891|NCT01215435|3770407|FG001|Overall Study|Adverse Event|0
2155892|NCT01215435|3770406|FG000|Overall Study|Protocol Violation|2
2155893|NCT01215435|3770407|FG001|Overall Study|Protocol Violation|0
2155894|NCT01215435|3770406|FG000|Overall Study|Withdrawal Criteria|8
2155895|NCT01215435|3770407|FG001|Overall Study|Withdrawal Criteria|11
2155896|NCT01215435|3770406|FG000|Overall Study|Lost to Follow-up|3
2155897|NCT01215435|3770407|FG001|Overall Study|Lost to Follow-up|0
2155898|NCT01215435|3770406|FG000|Overall Study|Unclassified|5
2155899|NCT01215435|3770407|FG001|Overall Study|Unclassified|5
2155900|NCT01215513|3770413|FG000|Overall Study|Not completed CS42|9
2155901|NCT01215513|3770413|FG000|Overall Study|Not enrolled from CS42 to CS42A|21
2155902|NCT01215513|3770413|FG000|Overall Study|Adverse event (CS42A)|2
2155903|NCT01215513|3770413|FG000|Overall Study|Physician decision (CS42A)|6
2155904|NCT01215513|3770413|FG000|Overall Study|Withdrawal by subject (CS42A)|5
2155905|NCT01215513|3770413|FG000|Overall Study|Miscellaneous reasons (CS42A)|2
2155906|NCT01215721|3770453|FG000|Overall Study|Adverse Event|2
2155907|NCT01215734|3770459|FG000|Overall Study|Death|0
2155908|NCT01215734|3770460|FG001|Overall Study|Death|1
2155909|NCT01215851|3770485|FG000|Treatment Period|Adverse Event|1
2155910|NCT01215851|3770486|FG001|Treatment Period|Adverse Event|1
2155911|NCT01215851|3770487|FG002|Treatment Period|Adverse Event|1
2155912|NCT01215851|3770488|FG003|Treatment Period|Adverse Event|3
2155913|NCT01215851|3770489|FG004|Treatment Period|Adverse Event|0
2155914|NCT01215851|3770490|FG005|Treatment Period|Adverse Event|1
2155915|NCT01215851|3770485|FG000|Follow up Period|Lost to Follow-up|0
2155916|NCT01215851|3770486|FG001|Follow up Period|Lost to Follow-up|0
2155917|NCT01215851|3770487|FG002|Follow up Period|Lost to Follow-up|0
2155918|NCT01215851|3770488|FG003|Follow up Period|Lost to Follow-up|0
2155919|NCT01215851|3770489|FG004|Follow up Period|Lost to Follow-up|0
2292859|NCT02518620|3986756|FG001|Overall Study|Non-Compliance with Study Drug|0
2292860|NCT02518620|3986755|FG000|Overall Study|Physician Decision|1
2292861|NCT02518620|3986756|FG001|Overall Study|Physician Decision|1
2292862|NCT02518620|3986755|FG000|Overall Study|Sponsor's Decision|0
2292863|NCT02518620|3986756|FG001|Overall Study|Sponsor's Decision|3
2292864|NCT02518620|3986755|FG000|Overall Study|Lost to Follow-up|1
2292865|NCT02518620|3986756|FG001|Overall Study|Lost to Follow-up|1
2292866|NCT02518620|3986755|FG000|Overall Study|Withdrawal by Subject|17
2292867|NCT02518620|3986756|FG001|Overall Study|Withdrawal by Subject|9
2292868|NCT02518620|3986755|FG000|Overall Study|Death|1
2292869|NCT02518620|3986756|FG001|Overall Study|Death|0
2292870|NCT02518620|3986755|FG000|Overall Study|Pregnancy Wish|3
2292871|NCT02518620|3986756|FG001|Overall Study|Pregnancy Wish|0
2292872|NCT02518620|3986755|FG000|Overall Study|Pregnancy|1
2292873|NCT02518620|3986756|FG001|Overall Study|Pregnancy|0
2292874|NCT02518620|3986755|FG000|Overall Study|Relocation|2
2292875|NCT02518620|3986756|FG001|Overall Study|Relocation|1
2292876|NCT02518685|3986766|FG000|Overall Study|Adverse Event|29
2292877|NCT02518685|3986767|FG001|Overall Study|Adverse Event|1
2292878|NCT02518685|3986766|FG000|Overall Study|Withdrawal by Subject|10
2292879|NCT02518685|3986767|FG001|Overall Study|Withdrawal by Subject|3
2292880|NCT02518685|3986766|FG000|Overall Study|relocation, study fatigue|7
2292881|NCT02518685|3986767|FG001|Overall Study|relocation, study fatigue|2
2292882|NCT02518685|3986766|FG000|Overall Study|Pregnancy|1
2292883|NCT02518685|3986767|FG001|Overall Study|Pregnancy|0
2292884|NCT02518685|3986766|FG000|Overall Study|Physician Decision|1
2292885|NCT02518685|3986767|FG001|Overall Study|Physician Decision|0
2292886|NCT02518685|3986766|FG000|Overall Study|Lost to Follow-up|1
2292887|NCT02518685|3986767|FG001|Overall Study|Lost to Follow-up|4
2292888|NCT02518919|3986777|FG000|Overall Study|Protocol Violation|1
2292889|NCT02518919|3986778|FG001|Overall Study|Protocol Violation|1
2292890|NCT02518919|3986779|FG002|Overall Study|Protocol Violation|2
2292891|NCT02518971|3986789|FG000|Overall Study|Lost to Follow-up|0
2292892|NCT02518971|3986790|FG001|Overall Study|Lost to Follow-up|1
2292893|NCT02518971|3986789|FG000|Overall Study|Physician Decision|6
2292894|NCT02518971|3986790|FG001|Overall Study|Physician Decision|6
2292895|NCT02518971|3986789|FG000|Overall Study|Protocol Violation|6
2292896|NCT02518971|3986790|FG001|Overall Study|Protocol Violation|4
2292897|NCT02518971|3986789|FG000|Overall Study|Withdrawal by Subject|4
2292898|NCT02518971|3986790|FG001|Overall Study|Withdrawal by Subject|5
2292899|NCT02518971|3986789|FG000|Overall Study|Side effects|1
2292900|NCT02518971|3986790|FG001|Overall Study|Side effects|0
2292901|NCT02518971|3986789|FG000|Overall Study|medication lost in mail|0
2292902|NCT02518971|3986790|FG001|Overall Study|medication lost in mail|1
2292903|NCT02518971|3986789|FG000|Overall Study|eligibility criteria no longer met|6
2292904|NCT02518971|3986790|FG001|Overall Study|eligibility criteria no longer met|3
2155920|NCT01215851|3770490|FG005|Follow up Period|Lost to Follow-up|1
2155921|NCT01215916|3770514|FG000|Overall Study|Progressive Disease|0
2155922|NCT01215916|3770515|FG001|Overall Study|Progressive Disease|2
2155923|NCT01215916|3770516|FG002|Overall Study|Progressive Disease|1
2155924|NCT01215916|3770517|FG003|Overall Study|Progressive Disease|2
2155925|NCT01215916|3770518|FG004|Overall Study|Progressive Disease|5
2155926|NCT01215916|3770519|FG005|Overall Study|Progressive Disease|4
2155927|NCT01215916|3770520|FG006|Overall Study|Progressive Disease|5
2292905|NCT02519231|3986845|FG000|Overall Study|Lost to Follow-up|2
2292906|NCT02519231|3986846|FG001|Overall Study|Lost to Follow-up|5
2292907|NCT02519231|3986845|FG000|Overall Study|Withdrawal by Subject|0
2292908|NCT02519231|3986846|FG001|Overall Study|Withdrawal by Subject|1
2292909|NCT02519504|3986873|FG000|Overall Study|Protocol Violation|6
2155928|NCT01215916|3770521|FG007|Overall Study|Progressive Disease|3
2155929|NCT01215916|3770522|FG008|Overall Study|Progressive Disease|1
2155930|NCT01215916|3770514|FG000|Overall Study|Adverse Event|1
2155931|NCT01215916|3770515|FG001|Overall Study|Adverse Event|1
2155932|NCT01215916|3770516|FG002|Overall Study|Adverse Event|0
2155933|NCT01215916|3770517|FG003|Overall Study|Adverse Event|1
2155934|NCT01215916|3770518|FG004|Overall Study|Adverse Event|0
2155935|NCT01215916|3770519|FG005|Overall Study|Adverse Event|0
2155936|NCT01215916|3770520|FG006|Overall Study|Adverse Event|3
2155937|NCT01215916|3770521|FG007|Overall Study|Adverse Event|0
2155938|NCT01215916|3770522|FG008|Overall Study|Adverse Event|0
2155939|NCT01215916|3770514|FG000|Overall Study|Withdrawal by Subject|0
2155940|NCT01215916|3770515|FG001|Overall Study|Withdrawal by Subject|1
2155941|NCT01215916|3770516|FG002|Overall Study|Withdrawal by Subject|1
2155942|NCT01215916|3770517|FG003|Overall Study|Withdrawal by Subject|2
2155943|NCT01215916|3770518|FG004|Overall Study|Withdrawal by Subject|0
2155944|NCT01215916|3770519|FG005|Overall Study|Withdrawal by Subject|0
2155945|NCT01215916|3770520|FG006|Overall Study|Withdrawal by Subject|1
2155946|NCT01215916|3770521|FG007|Overall Study|Withdrawal by Subject|0
2155947|NCT01215916|3770522|FG008|Overall Study|Withdrawal by Subject|0
2155948|NCT01215916|3770514|FG000|Overall Study|Death|0
2155949|NCT01215916|3770515|FG001|Overall Study|Death|1
2155950|NCT01215916|3770516|FG002|Overall Study|Death|0
2155951|NCT01215916|3770517|FG003|Overall Study|Death|0
2155952|NCT01215916|3770518|FG004|Overall Study|Death|1
2155953|NCT01215916|3770519|FG005|Overall Study|Death|0
2155954|NCT01215916|3770520|FG006|Overall Study|Death|0
2155955|NCT01215916|3770521|FG007|Overall Study|Death|0
2155956|NCT01215916|3770522|FG008|Overall Study|Death|1
2155957|NCT01215916|3770514|FG000|Overall Study|Physician Decision|0
2155958|NCT01215916|3770515|FG001|Overall Study|Physician Decision|0
2155959|NCT01215916|3770516|FG002|Overall Study|Physician Decision|1
2155960|NCT01215916|3770517|FG003|Overall Study|Physician Decision|1
2155961|NCT01215916|3770518|FG004|Overall Study|Physician Decision|0
2155962|NCT01215916|3770519|FG005|Overall Study|Physician Decision|0
2155963|NCT01215916|3770520|FG006|Overall Study|Physician Decision|0
2292910|NCT02519504|3986874|FG001|Overall Study|Protocol Violation|5
2292911|NCT02519504|3986873|FG000|Overall Study|Ineligible for direct testing|12
2292912|NCT02519504|3986874|FG001|Overall Study|Ineligible for direct testing|12
2292913|NCT02519504|3986873|FG000|Overall Study|Did not participate in direct testing|95
2292914|NCT02519504|3986874|FG001|Overall Study|Did not participate in direct testing|86
2292915|NCT02519595|3986883|FG000|Overall Study|Protocol Violation|8
2292916|NCT02519595|3986884|FG001|Overall Study|Protocol Violation|22
2292917|NCT02519595|3986885|FG002|Overall Study|Protocol Violation|16
2292918|NCT02519842|3986908|FG000|Base Study: Cycle 1|Screening Failure|1
2292919|NCT02519842|3986909|FG001|Base Study: Cycle 1|Screening Failure|1
2292920|NCT02519842|3986910|FG002|Base Study: Cycle 1|Screening Failure|0
2292921|NCT02519842|3986908|FG000|Base Study: Cycle 1|Adverse Event|1
2292922|NCT02519842|3986909|FG001|Base Study: Cycle 1|Adverse Event|0
2292923|NCT02519842|3986910|FG002|Base Study: Cycle 1|Adverse Event|0
2292924|NCT02519842|3986908|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
2292925|NCT02519842|3986909|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
2292926|NCT02519842|3986910|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
2292927|NCT02519842|3986908|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0
2292928|NCT02519842|3986909|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1
2292929|NCT02519842|3986910|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0
2292930|NCT02519842|3986908|FG000|Optional Extension: Cycles 2-6|Physician Decision|0
2292931|NCT02519842|3986909|FG001|Optional Extension: Cycles 2-6|Physician Decision|0
2292932|NCT02519842|3986910|FG002|Optional Extension: Cycles 2-6|Physician Decision|5
2292933|NCT02519842|3986908|FG000|Optional Extension: Cycles 2-6|Adverse Event|0
2292934|NCT02519842|3986909|FG001|Optional Extension: Cycles 2-6|Adverse Event|0
2292935|NCT02519842|3986910|FG002|Optional Extension: Cycles 2-6|Adverse Event|1
2292936|NCT02519842|3986908|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
2292937|NCT02519842|3986909|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
2292938|NCT02519842|3986910|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
2292939|NCT02519842|3986908|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
2292940|NCT02519842|3986909|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
2292941|NCT02519842|3986910|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
2292942|NCT02519842|3986908|FG000|Optional Extension: Cycles 2-6|Death|0
2292943|NCT02519842|3986909|FG001|Optional Extension: Cycles 2-6|Death|0
2292944|NCT02519842|3986910|FG002|Optional Extension: Cycles 2-6|Death|1
2292945|NCT02519842|3986908|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
2292946|NCT02519842|3986909|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
2155964|NCT01215916|3770521|FG007|Overall Study|Physician Decision|0
2155965|NCT01215916|3770522|FG008|Overall Study|Physician Decision|0
2155966|NCT01215942|3770557|FG000|Treatment Period|Adverse Event|15
2155967|NCT01215942|3770558|FG001|Treatment Period|Adverse Event|26
2155968|NCT01215942|3770557|FG000|Treatment Period|Death|2
2155969|NCT01215942|3770558|FG001|Treatment Period|Death|4
2155970|NCT01215942|3770557|FG000|Treatment Period|Lack of Efficacy|23
2155971|NCT01215942|3770558|FG001|Treatment Period|Lack of Efficacy|62
2155972|NCT01215942|3770557|FG000|Treatment Period|Lost to Follow-up|3
2155973|NCT01215942|3770558|FG001|Treatment Period|Lost to Follow-up|4
2155974|NCT01215942|3770557|FG000|Treatment Period|Withdrawal by Subject|17
2155975|NCT01215942|3770558|FG001|Treatment Period|Withdrawal by Subject|40
2155976|NCT01215942|3770557|FG000|Treatment Period|Physician Decision|5
2155977|NCT01215942|3770558|FG001|Treatment Period|Physician Decision|5
2155978|NCT01215942|3770557|FG000|Treatment Period|Protocol Violation|0
2155979|NCT01215942|3770558|FG001|Treatment Period|Protocol Violation|1
2155980|NCT01215942|3770557|FG000|Treatment Period|Sponsor Decision|349
2155981|NCT01215942|3770558|FG001|Treatment Period|Sponsor Decision|530
2155982|NCT01215942|3770557|FG000|Post-Treatment Follow-Up Period|Death|0
2155983|NCT01215942|3770558|FG001|Post-Treatment Follow-Up Period|Death|1
2155984|NCT01215942|3770557|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13
2155985|NCT01215942|3770558|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13
2155986|NCT01215942|3770557|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
2155987|NCT01215942|3770558|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
2155988|NCT01215942|3770557|FG000|Post-Treatment Follow-Up Period|Physician Decision|1
2155989|NCT01215942|3770558|FG001|Post-Treatment Follow-Up Period|Physician Decision|2
2155990|NCT01215942|3770557|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28
2155991|NCT01215942|3770558|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61
2155992|NCT01215955|3770579|FG000|Overall Study|Adverse Event|1
2155993|NCT01215955|3770580|FG001|Overall Study|Adverse Event|4
2155994|NCT01215955|3770581|FG002|Overall Study|Adverse Event|2
2155995|NCT01215955|3770582|FG003|Overall Study|Adverse Event|3
2155996|NCT01215955|3770579|FG000|Overall Study|Death|2
2155997|NCT01215955|3770580|FG001|Overall Study|Death|0
2155998|NCT01215955|3770581|FG002|Overall Study|Death|1
2155999|NCT01215955|3770582|FG003|Overall Study|Death|3
2156000|NCT01215955|3770579|FG000|Overall Study|Entry Criteria Not Met|1
2156001|NCT01215955|3770580|FG001|Overall Study|Entry Criteria Not Met|3
2156002|NCT01215955|3770581|FG002|Overall Study|Entry Criteria Not Met|4
2156003|NCT01215955|3770582|FG003|Overall Study|Entry Criteria Not Met|7
2156004|NCT01215955|3770579|FG000|Overall Study|Lack of Efficacy|1
2156005|NCT01215955|3770580|FG001|Overall Study|Lack of Efficacy|2
2156006|NCT01215955|3770581|FG002|Overall Study|Lack of Efficacy|1
2156007|NCT01215955|3770582|FG003|Overall Study|Lack of Efficacy|0
2156008|NCT01215955|3770579|FG000|Overall Study|Lost to Follow-up|4
2156009|NCT01215955|3770580|FG001|Overall Study|Lost to Follow-up|4
2156010|NCT01215955|3770581|FG002|Overall Study|Lost to Follow-up|8
2156011|NCT01215955|3770582|FG003|Overall Study|Lost to Follow-up|9
2156012|NCT01215955|3770579|FG000|Overall Study|Physician Decision|4
2156013|NCT01215955|3770580|FG001|Overall Study|Physician Decision|10
2292947|NCT02519842|3986910|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
2292948|NCT02519842|3986908|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
2292949|NCT02519842|3986909|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
2292950|NCT02519842|3986910|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
2292951|NCT02519842|3986908|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
2292952|NCT02519842|3986909|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
2292953|NCT02519842|3986910|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
2292954|NCT02519842|3986908|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
2292955|NCT02519842|3986909|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
2292956|NCT02519842|3986910|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
2292957|NCT02519855|3986920|FG000|Overall Study|Adverse Event|0
2292958|NCT02519855|3986921|FG001|Overall Study|Adverse Event|1
2292959|NCT02519855|3986920|FG000|Overall Study|Lost to Follow-up|3
2292960|NCT02519855|3986921|FG001|Overall Study|Lost to Follow-up|3
2292961|NCT02520011|3986930|FG000|Overall Study|Adverse Event|0
2292962|NCT02520011|3986931|FG001|Overall Study|Adverse Event|1
2292963|NCT02520011|3986932|FG002|Overall Study|Adverse Event|2
2292964|NCT02520011|3986930|FG000|Overall Study|Death|0
2292965|NCT02520011|3986931|FG001|Overall Study|Death|8
2292966|NCT02520011|3986932|FG002|Overall Study|Death|1
2292967|NCT02520011|3986930|FG000|Overall Study|Lack of Efficacy|4
2292968|NCT02520011|3986931|FG001|Overall Study|Lack of Efficacy|26
2292969|NCT02520011|3986932|FG002|Overall Study|Lack of Efficacy|4
2292970|NCT02520011|3986930|FG000|Overall Study|Physician Decision|0
2292971|NCT02520011|3986931|FG001|Overall Study|Physician Decision|2
2292972|NCT02520011|3986932|FG002|Overall Study|Physician Decision|0
2292973|NCT02520011|3986930|FG000|Overall Study|Withdrawal by Subject|1
2292974|NCT02520011|3986931|FG001|Overall Study|Withdrawal by Subject|3
2292975|NCT02520011|3986932|FG002|Overall Study|Withdrawal by Subject|0
2292976|NCT02520011|3986930|FG000|Overall Study|Protocol Deviation|0
2292977|NCT02520011|3986931|FG001|Overall Study|Protocol Deviation|1
2292978|NCT02520011|3986932|FG002|Overall Study|Protocol Deviation|0
2292979|NCT02520011|3986930|FG000|Overall Study|Patient went to hospice|0
2292980|NCT02520011|3986931|FG001|Overall Study|Patient went to hospice|1
2292981|NCT02520011|3986932|FG002|Overall Study|Patient went to hospice|0
2292982|NCT02520011|3986930|FG000|Overall Study|Progressive disease following response|0
2156014|NCT01215955|3770581|FG002|Overall Study|Physician Decision|8
2156015|NCT01215955|3770582|FG003|Overall Study|Physician Decision|11
2156016|NCT01215955|3770579|FG000|Overall Study|Protocol Violation|17
2156017|NCT01215955|3770580|FG001|Overall Study|Protocol Violation|13
2156018|NCT01215955|3770581|FG002|Overall Study|Protocol Violation|8
2156019|NCT01215955|3770582|FG003|Overall Study|Protocol Violation|8
2156020|NCT01215955|3770579|FG000|Overall Study|Sponsor Decision|1
2156021|NCT01215955|3770580|FG001|Overall Study|Sponsor Decision|2
2156022|NCT01215955|3770581|FG002|Overall Study|Sponsor Decision|0
2156023|NCT01215955|3770582|FG003|Overall Study|Sponsor Decision|1
2156024|NCT01215955|3770579|FG000|Overall Study|Withdrawal by Subject|14
2156025|NCT01215955|3770580|FG001|Overall Study|Withdrawal by Subject|15
2156026|NCT01215955|3770581|FG002|Overall Study|Withdrawal by Subject|13
2156027|NCT01215955|3770582|FG003|Overall Study|Withdrawal by Subject|9
2156028|NCT01215955|3770579|FG000|Overall Study|Quality Issues|0
2156029|NCT01215955|3770580|FG001|Overall Study|Quality Issues|0
2156030|NCT01215955|3770581|FG002|Overall Study|Quality Issues|3
2156031|NCT01215955|3770582|FG003|Overall Study|Quality Issues|2
2156032|NCT01215968|3770597|FG000|Overall Study|Adverse Event|0
2156033|NCT01215968|3770598|FG001|Overall Study|Adverse Event|2
2156034|NCT01215968|3770597|FG000|Overall Study|Protocol Violation|2
2156035|NCT01215968|3770598|FG001|Overall Study|Protocol Violation|4
2156036|NCT01215968|3770597|FG000|Overall Study|Not received study drug|0
2156037|NCT01215968|3770598|FG001|Overall Study|Not received study drug|1
2292983|NCT02520011|3986931|FG001|Overall Study|Progressive disease following response|4
2292984|NCT02520011|3986932|FG002|Overall Study|Progressive disease following response|2
2292985|NCT02520089|3986947|FG000|Overall Study|Lost to Follow-up|3
2292986|NCT02520089|3986948|FG001|Overall Study|Lost to Follow-up|4
2292987|NCT02520284|3986957|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1
2292988|NCT02520284|3986958|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3
2292989|NCT02520284|3986959|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0
2292990|NCT02520284|3986957|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
2292991|NCT02520284|3986958|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
2292992|NCT02520284|3986959|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
2292993|NCT02520284|3986957|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
2292994|NCT02520284|3986958|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
2292995|NCT02520284|3986959|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
2292996|NCT02520284|3986957|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
2292997|NCT02520284|3986958|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
2292998|NCT02520284|3986959|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
2292999|NCT02520284|3986957|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
2293000|NCT02520284|3986958|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
2293001|NCT02520284|3986959|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
2293002|NCT02520284|3986957|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
2293003|NCT02520284|3986958|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
2293004|NCT02520284|3986959|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
2293005|NCT02520284|3986957|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
2293006|NCT02520284|3986958|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
2293007|NCT02520284|3986959|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
2293008|NCT02520284|3986957|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
2293009|NCT02520284|3986958|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
2293010|NCT02520284|3986959|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
2293011|NCT02520284|3986957|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
2293012|NCT02520284|3986958|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
2293013|NCT02520284|3986959|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
2293014|NCT02520284|3986957|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
2293015|NCT02520284|3986958|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
2293016|NCT02520284|3986959|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
2293017|NCT02520284|3986957|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
2293018|NCT02520284|3986958|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
2293019|NCT02520284|3986959|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
2293020|NCT02520310|3986973|FG000|At 6 Months Clinical Follow-up|Death|1
2293021|NCT02520310|3986973|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
2293022|NCT02520310|3986973|FG000|AT 3 Year Clinical Follow-up|Death|2
2293023|NCT02520310|3986973|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
2293024|NCT02520310|3986973|FG000|AT 4 Year Clinical Follow-up|Death|1
2293025|NCT02520310|3986973|FG000|AT 4 Year Clinical Follow-up|missed visit|1
2293026|NCT02520388|3986981|FG000|Overall Study|Physician Decision|1
2293027|NCT02520388|3986982|FG001|Overall Study|Physician Decision|0
2293028|NCT02520388|3986981|FG000|Overall Study|Subject or parent/guardian request|0
2293029|NCT02520388|3986982|FG001|Overall Study|Subject or parent/guardian request|6
2293030|NCT02520388|3986981|FG000|Overall Study|Adverse Event|1
2293031|NCT02520388|3986982|FG001|Overall Study|Adverse Event|4
2293032|NCT02520388|3986981|FG000|Overall Study|Lost to Follow-up|3
2293033|NCT02520388|3986982|FG001|Overall Study|Lost to Follow-up|2
2293034|NCT02520388|3986981|FG000|Overall Study|Other (reason not defined)|4
2293035|NCT02520388|3986982|FG001|Overall Study|Other (reason not defined)|4
2156038|NCT01215981|3770609|FG000|Overall Study|Physician Decision|0
2156039|NCT01215981|3770610|FG001|Overall Study|Physician Decision|1
2156040|NCT01215981|3770609|FG000|Overall Study|Protocol Violation|1
2156041|NCT01215981|3770610|FG001|Overall Study|Protocol Violation|0
2156042|NCT01215981|3770609|FG000|Overall Study|Withdrawal by Subject|1
2156043|NCT01215981|3770610|FG001|Overall Study|Withdrawal by Subject|0
2156044|NCT01216072|3770618|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40
2156045|NCT01216072|3770619|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4
2156046|NCT01216072|3770618|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
2156047|NCT01216072|3770619|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
2156048|NCT01216072|3770618|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
2156049|NCT01216072|3770619|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
2156050|NCT01216072|3770618|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
2156051|NCT01216072|3770619|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
2156052|NCT01216072|3770618|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
2156053|NCT01216072|3770619|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
2156054|NCT01216072|3770618|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
2156055|NCT01216072|3770619|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
2156056|NCT01216072|3770618|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
2156057|NCT01216072|3770619|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
2156058|NCT01216072|3770618|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0
2156059|NCT01216072|3770619|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10
2156060|NCT01216072|3770618|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
2156061|NCT01216072|3770619|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
2156062|NCT01216072|3770618|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
2156063|NCT01216072|3770619|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
2156064|NCT01216163|3770631|FG000|Overall Study|Withdrawal by Subject|1
2156065|NCT01216163|3770632|FG001|Overall Study|Withdrawal by Subject|1
2156066|NCT01216163|3770633|FG002|Overall Study|Withdrawal by Subject|0
2156067|NCT01216176|3770644|FG000|Overall Study|Adverse Event|0
2156068|NCT01216176|3770645|FG001|Overall Study|Adverse Event|8
2156069|NCT01216176|3770646|FG002|Overall Study|Adverse Event|0
2156070|NCT01216176|3770644|FG000|Overall Study|Physician Decision|0
2156071|NCT01216176|3770645|FG001|Overall Study|Physician Decision|0
2156072|NCT01216176|3770646|FG002|Overall Study|Physician Decision|1
2156073|NCT01216189|3770657|FG000|Overall Study|Lost to Follow-up|21
2293036|NCT02520531|3987013|FG000|Overall Study|Revision of study device components|2
2293037|NCT02520531|3987014|FG001|Overall Study|Revision of study device components|2
2293038|NCT02520531|3987013|FG000|Overall Study|Death|1
2293039|NCT02520531|3987014|FG001|Overall Study|Death|2
2293040|NCT02520531|3987013|FG000|Overall Study|Lost to Follow-up|1
2293041|NCT02520531|3987014|FG001|Overall Study|Lost to Follow-up|1
2293042|NCT02520531|3987013|FG000|Overall Study|Meet exclusion criterion|0
2293043|NCT02520531|3987014|FG001|Overall Study|Meet exclusion criterion|1
2293044|NCT02520531|3987013|FG000|Overall Study|Withdrawal by Subject|1
2293045|NCT02520531|3987014|FG001|Overall Study|Withdrawal by Subject|0
2293046|NCT02520531|3987013|FG000|Overall Study|Not study device|1
2293047|NCT02520531|3987014|FG001|Overall Study|Not study device|0
2293048|NCT02521376|3987046|FG000|Overall Study|Enrolled, But Not Treated|1
2293049|NCT02521376|3987047|FG001|Overall Study|Enrolled, But Not Treated|0
2293050|NCT02521376|3987048|FG002|Overall Study|Enrolled, But Not Treated|0
2293051|NCT02521376|3987049|FG003|Overall Study|Enrolled, But Not Treated|0
2293052|NCT02521792|3987087|FG000|Overall Study|Study Terminated|6
2293053|NCT02521870|3987099|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0
2293054|NCT02521870|3987100|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1
2293055|NCT02521870|3987101|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0
2293056|NCT02521870|3987102|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0
2293057|NCT02521870|3987103|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0
2293058|NCT02521870|3987104|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0
2293059|NCT02521870|3987105|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0
2293060|NCT02521870|3987106|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0
2293061|NCT02521870|3987107|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0
2293062|NCT02521870|3987108|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0
2293063|NCT02521870|3987109|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0
2293064|NCT02521870|3987110|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0
2293065|NCT02521870|3987099|FG000|Phase 1: Dose Escalation|Adverse Event|2
2293066|NCT02521870|3987100|FG001|Phase 1: Dose Escalation|Adverse Event|1
2293067|NCT02521870|3987101|FG002|Phase 1: Dose Escalation|Adverse Event|0
2293068|NCT02521870|3987102|FG003|Phase 1: Dose Escalation|Adverse Event|0
2293069|NCT02521870|3987103|FG004|Phase 1: Dose Escalation|Adverse Event|0
2293070|NCT02521870|3987104|FG005|Phase 1: Dose Escalation|Adverse Event|0
2293071|NCT02521870|3987105|FG006|Phase 1: Dose Escalation|Adverse Event|0
2293072|NCT02521870|3987106|FG007|Phase 1: Dose Escalation|Adverse Event|0
2293073|NCT02521870|3987107|FG008|Phase 1: Dose Escalation|Adverse Event|0
2293074|NCT02521870|3987108|FG009|Phase 1: Dose Escalation|Adverse Event|0
2293075|NCT02521870|3987109|FG010|Phase 1: Dose Escalation|Adverse Event|0
2293076|NCT02521870|3987110|FG011|Phase 1: Dose Escalation|Adverse Event|0
2293077|NCT02521870|3987099|FG000|Phase 1: Dose Escalation|Progressive Disease|3
2293078|NCT02521870|3987100|FG001|Phase 1: Dose Escalation|Progressive Disease|2
2156074|NCT01216189|3770658|FG001|Overall Study|Lost to Follow-up|3
2156075|NCT01216189|3770657|FG000|Overall Study|Death|4
2156076|NCT01216189|3770658|FG001|Overall Study|Death|2
2156077|NCT01216202|3770666|FG000|Overall Study|Withdrawal by Subject|8
2156078|NCT01216202|3770667|FG001|Overall Study|Withdrawal by Subject|0
2156079|NCT01216202|3770666|FG000|Overall Study|Death|0
2156080|NCT01216202|3770667|FG001|Overall Study|Death|2
2156081|NCT01216202|3770666|FG000|Overall Study|Lost to Follow-up|14
2156082|NCT01216202|3770667|FG001|Overall Study|Lost to Follow-up|0
2156083|NCT01216319|3770684|FG000|Overall Study|Lost to Follow-up|2
2156084|NCT01216319|3770684|FG000|Overall Study|Unanticipated chemo for breast cancer|2
2156085|NCT01216332|3770690|FG000|Overall Study|Withdrawal by Subject|4
2156086|NCT01216332|3770691|FG001|Overall Study|Withdrawal by Subject|0
2156087|NCT01216683|3770720|FG000|Induction|Never started treatment|0
2156088|NCT01216683|3770721|FG001|Induction|Never started treatment|6
2156089|NCT01216683|3770722|FG002|Induction|Never started treatment|3
2156090|NCT01216683|3770720|FG000|Induction|Lack of Efficacy|4
2156091|NCT01216683|3770721|FG001|Induction|Lack of Efficacy|3
2156092|NCT01216683|3770722|FG002|Induction|Lack of Efficacy|7
2156093|NCT01216683|3770720|FG000|Induction|Adverse Event|0
2156094|NCT01216683|3770721|FG001|Induction|Adverse Event|5
2156095|NCT01216683|3770722|FG002|Induction|Adverse Event|5
2156096|NCT01216683|3770720|FG000|Induction|Death|0
2156097|NCT01216683|3770721|FG001|Induction|Death|0
2156098|NCT01216683|3770722|FG002|Induction|Death|2
2156099|NCT01216683|3770720|FG000|Induction|Withdrawal by Subject|0
2156100|NCT01216683|3770721|FG001|Induction|Withdrawal by Subject|4
2156101|NCT01216683|3770722|FG002|Induction|Withdrawal by Subject|2
2156102|NCT01216683|3770720|FG000|Induction|Other disease|0
2156103|NCT01216683|3770721|FG001|Induction|Other disease|1
2156104|NCT01216683|3770722|FG002|Induction|Other disease|2
2156105|NCT01216683|3770720|FG000|Continuation|Lack of Efficacy|3
2156106|NCT01216683|3770721|FG001|Continuation|Lack of Efficacy|2
2156107|NCT01216683|3770722|FG002|Continuation|Lack of Efficacy|7
2156108|NCT01216683|3770720|FG000|Continuation|Adverse Event|5
2156109|NCT01216683|3770721|FG001|Continuation|Adverse Event|3
2156110|NCT01216683|3770722|FG002|Continuation|Adverse Event|16
2156111|NCT01216683|3770720|FG000|Continuation|Death|1
2156112|NCT01216683|3770721|FG001|Continuation|Death|0
2156113|NCT01216683|3770722|FG002|Continuation|Death|2
2156114|NCT01216683|3770720|FG000|Continuation|Withdrawal by Subject|4
2156115|NCT01216683|3770721|FG001|Continuation|Withdrawal by Subject|5
2156116|NCT01216683|3770722|FG002|Continuation|Withdrawal by Subject|9
2156117|NCT01216683|3770720|FG000|Continuation|Other diseases|0
2156118|NCT01216683|3770721|FG001|Continuation|Other diseases|2
2156119|NCT01216683|3770722|FG002|Continuation|Other diseases|1
2156120|NCT01216683|3770720|FG000|Continuation|Physician Decision|1
2156121|NCT01216683|3770721|FG001|Continuation|Physician Decision|0
2156122|NCT01216683|3770722|FG002|Continuation|Physician Decision|1
2156123|NCT01216683|3770720|FG000|Continuation|Non-compliance|1
2156124|NCT01216683|3770721|FG001|Continuation|Non-compliance|0
2156125|NCT01216683|3770722|FG002|Continuation|Non-compliance|1
2156126|NCT01216683|3770720|FG000|Continuation|Insurance change|0
2156127|NCT01216683|3770721|FG001|Continuation|Insurance change|1
2293079|NCT02521870|3987101|FG002|Phase 1: Dose Escalation|Progressive Disease|4
2293080|NCT02521870|3987102|FG003|Phase 1: Dose Escalation|Progressive Disease|6
2293081|NCT02521870|3987103|FG004|Phase 1: Dose Escalation|Progressive Disease|0
2293082|NCT02521870|3987104|FG005|Phase 1: Dose Escalation|Progressive Disease|0
2293083|NCT02521870|3987105|FG006|Phase 1: Dose Escalation|Progressive Disease|0
2293084|NCT02521870|3987106|FG007|Phase 1: Dose Escalation|Progressive Disease|0
2293085|NCT02521870|3987107|FG008|Phase 1: Dose Escalation|Progressive Disease|0
2293086|NCT02521870|3987108|FG009|Phase 1: Dose Escalation|Progressive Disease|0
2293087|NCT02521870|3987109|FG010|Phase 1: Dose Escalation|Progressive Disease|0
2293088|NCT02521870|3987110|FG011|Phase 1: Dose Escalation|Progressive Disease|0
2293089|NCT02521870|3987099|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0
2293090|NCT02521870|3987100|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0
2293091|NCT02521870|3987101|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0
2293092|NCT02521870|3987102|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0
2293093|NCT02521870|3987103|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5
2293094|NCT02521870|3987104|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1
2293095|NCT02521870|3987105|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1
2293096|NCT02521870|3987106|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0
2293097|NCT02521870|3987107|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1
2156128|NCT01216683|3770722|FG002|Continuation|Insurance change|0
2156129|NCT01216683|3770720|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0
2156130|NCT01216683|3770721|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1
2156131|NCT01216683|3770722|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0
2156132|NCT01216683|3770720|FG000|Continuation|Not reported|0
2156133|NCT01216683|3770721|FG001|Continuation|Not reported|0
2156134|NCT01216683|3770722|FG002|Continuation|Not reported|1
2156135|NCT01216683|3770720|FG000|Continuation|Never started treatment|0
2293098|NCT02521870|3987108|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1
2293099|NCT02521870|3987109|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2
2293100|NCT02521870|3987110|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0
2156136|NCT01216683|3770721|FG001|Continuation|Never started treatment|1
2156137|NCT01216683|3770722|FG002|Continuation|Never started treatment|5
2156138|NCT01217073|3770776|FG000|Base Period|Adverse Event|1
2156139|NCT01217073|3770777|FG001|Base Period|Adverse Event|0
2156140|NCT01217073|3770778|FG002|Base Period|Adverse Event|1
2156141|NCT01217073|3770779|FG003|Base Period|Adverse Event|0
2156142|NCT01217073|3770780|FG004|Base Period|Adverse Event|4
2156143|NCT01217073|3770781|FG005|Base Period|Adverse Event|1
2156144|NCT01217073|3770782|FG006|Base Period|Adverse Event|0
2156145|NCT01217073|3770783|FG007|Base Period|Adverse Event|0
2156146|NCT01217073|3770776|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1
2156147|NCT01217073|3770777|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0
2156148|NCT01217073|3770778|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0
2156149|NCT01217073|3770779|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0
2156150|NCT01217073|3770780|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0
2156151|NCT01217073|3770781|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0
2156152|NCT01217073|3770782|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0
2156153|NCT01217073|3770783|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0
2156154|NCT01217073|3770776|FG000|Base Period|Excluded medication|0
2156155|NCT01217073|3770777|FG001|Base Period|Excluded medication|0
2156156|NCT01217073|3770778|FG002|Base Period|Excluded medication|0
2156157|NCT01217073|3770779|FG003|Base Period|Excluded medication|0
2156158|NCT01217073|3770780|FG004|Base Period|Excluded medication|1
2156159|NCT01217073|3770781|FG005|Base Period|Excluded medication|0
2156160|NCT01217073|3770782|FG006|Base Period|Excluded medication|0
2156161|NCT01217073|3770783|FG007|Base Period|Excluded medication|0
2156162|NCT01217073|3770776|FG000|Base Period|Lack of Efficacy|0
2156163|NCT01217073|3770777|FG001|Base Period|Lack of Efficacy|0
2156164|NCT01217073|3770778|FG002|Base Period|Lack of Efficacy|0
2156165|NCT01217073|3770779|FG003|Base Period|Lack of Efficacy|0
2156166|NCT01217073|3770780|FG004|Base Period|Lack of Efficacy|0
2156167|NCT01217073|3770781|FG005|Base Period|Lack of Efficacy|1
2156168|NCT01217073|3770782|FG006|Base Period|Lack of Efficacy|0
2156169|NCT01217073|3770783|FG007|Base Period|Lack of Efficacy|0
2156170|NCT01217073|3770776|FG000|Base Period|Lost to Follow-up|0
2156171|NCT01217073|3770777|FG001|Base Period|Lost to Follow-up|0
2156172|NCT01217073|3770778|FG002|Base Period|Lost to Follow-up|1
2156173|NCT01217073|3770779|FG003|Base Period|Lost to Follow-up|1
2156174|NCT01217073|3770780|FG004|Base Period|Lost to Follow-up|3
2156175|NCT01217073|3770781|FG005|Base Period|Lost to Follow-up|0
2156176|NCT01217073|3770782|FG006|Base Period|Lost to Follow-up|0
2156177|NCT01217073|3770783|FG007|Base Period|Lost to Follow-up|0
2156178|NCT01217073|3770776|FG000|Base Period|Physician Decision|0
2156179|NCT01217073|3770777|FG001|Base Period|Physician Decision|0
2156180|NCT01217073|3770778|FG002|Base Period|Physician Decision|0
2156181|NCT01217073|3770779|FG003|Base Period|Physician Decision|0
2156182|NCT01217073|3770780|FG004|Base Period|Physician Decision|1
2156183|NCT01217073|3770781|FG005|Base Period|Physician Decision|0
2156184|NCT01217073|3770782|FG006|Base Period|Physician Decision|0
2156185|NCT01217073|3770783|FG007|Base Period|Physician Decision|0
2156186|NCT01217073|3770776|FG000|Base Period|Protocol Violation|1
2156187|NCT01217073|3770777|FG001|Base Period|Protocol Violation|0
2156188|NCT01217073|3770778|FG002|Base Period|Protocol Violation|0
2293101|NCT02521870|3987099|FG000|Phase 2: Dose Expansion|Adverse Event|0
2293102|NCT02521870|3987100|FG001|Phase 2: Dose Expansion|Adverse Event|0
2293103|NCT02521870|3987101|FG002|Phase 2: Dose Expansion|Adverse Event|0
2293104|NCT02521870|3987102|FG003|Phase 2: Dose Expansion|Adverse Event|0
2293105|NCT02521870|3987103|FG004|Phase 2: Dose Expansion|Adverse Event|11
2293106|NCT02521870|3987104|FG005|Phase 2: Dose Expansion|Adverse Event|2
2293107|NCT02521870|3987105|FG006|Phase 2: Dose Expansion|Adverse Event|0
2293108|NCT02521870|3987106|FG007|Phase 2: Dose Expansion|Adverse Event|1
2293109|NCT02521870|3987107|FG008|Phase 2: Dose Expansion|Adverse Event|5
2293110|NCT02521870|3987108|FG009|Phase 2: Dose Expansion|Adverse Event|0
2293111|NCT02521870|3987109|FG010|Phase 2: Dose Expansion|Adverse Event|1
2293112|NCT02521870|3987110|FG011|Phase 2: Dose Expansion|Adverse Event|0
2293113|NCT02521870|3987099|FG000|Phase 2: Dose Expansion|Progressive Disease|0
2293114|NCT02521870|3987100|FG001|Phase 2: Dose Expansion|Progressive Disease|0
2293115|NCT02521870|3987101|FG002|Phase 2: Dose Expansion|Progressive Disease|0
2293116|NCT02521870|3987102|FG003|Phase 2: Dose Expansion|Progressive Disease|0
2293117|NCT02521870|3987103|FG004|Phase 2: Dose Expansion|Progressive Disease|22
2293118|NCT02521870|3987104|FG005|Phase 2: Dose Expansion|Progressive Disease|18
2293119|NCT02521870|3987105|FG006|Phase 2: Dose Expansion|Progressive Disease|17
2293120|NCT02521870|3987106|FG007|Phase 2: Dose Expansion|Progressive Disease|7
2293121|NCT02521870|3987107|FG008|Phase 2: Dose Expansion|Progressive Disease|5
2293122|NCT02521870|3987108|FG009|Phase 2: Dose Expansion|Progressive Disease|17
2156189|NCT01217073|3770779|FG003|Base Period|Protocol Violation|0
2156190|NCT01217073|3770780|FG004|Base Period|Protocol Violation|1
2156191|NCT01217073|3770781|FG005|Base Period|Protocol Violation|2
2156192|NCT01217073|3770782|FG006|Base Period|Protocol Violation|0
2156193|NCT01217073|3770783|FG007|Base Period|Protocol Violation|0
2156194|NCT01217073|3770776|FG000|Base Period|Withdrawal by Subject|4
2156195|NCT01217073|3770777|FG001|Base Period|Withdrawal by Subject|5
2156196|NCT01217073|3770778|FG002|Base Period|Withdrawal by Subject|5
2156197|NCT01217073|3770779|FG003|Base Period|Withdrawal by Subject|1
2321226|NCT02956967|4035621|FG000|Overall Study|Adverse Event|3
2156198|NCT01217073|3770780|FG004|Base Period|Withdrawal by Subject|5
2156199|NCT01217073|3770781|FG005|Base Period|Withdrawal by Subject|5
2156200|NCT01217073|3770782|FG006|Base Period|Withdrawal by Subject|0
2156201|NCT01217073|3770783|FG007|Base Period|Withdrawal by Subject|0
2156202|NCT01217073|3770776|FG000|Extension Period|Adverse Event|0
2156203|NCT01217073|3770777|FG001|Extension Period|Adverse Event|0
2156204|NCT01217073|3770778|FG002|Extension Period|Adverse Event|0
2156205|NCT01217073|3770779|FG003|Extension Period|Adverse Event|0
2156206|NCT01217073|3770780|FG004|Extension Period|Adverse Event|0
2156207|NCT01217073|3770781|FG005|Extension Period|Adverse Event|0
2156208|NCT01217073|3770782|FG006|Extension Period|Adverse Event|19
2156209|NCT01217073|3770783|FG007|Extension Period|Adverse Event|5
2156210|NCT01217073|3770776|FG000|Extension Period|ALT/AST|0
2156211|NCT01217073|3770777|FG001|Extension Period|ALT/AST|0
2156212|NCT01217073|3770778|FG002|Extension Period|ALT/AST|0
2156213|NCT01217073|3770779|FG003|Extension Period|ALT/AST|0
2156214|NCT01217073|3770780|FG004|Extension Period|ALT/AST|0
2156215|NCT01217073|3770781|FG005|Extension Period|ALT/AST|0
2156216|NCT01217073|3770782|FG006|Extension Period|ALT/AST|2
2156217|NCT01217073|3770783|FG007|Extension Period|ALT/AST|0
2156218|NCT01217073|3770776|FG000|Extension Period|Contraindication to study medication|0
2156219|NCT01217073|3770777|FG001|Extension Period|Contraindication to study medication|0
2156220|NCT01217073|3770778|FG002|Extension Period|Contraindication to study medication|0
2156221|NCT01217073|3770779|FG003|Extension Period|Contraindication to study medication|0
2156222|NCT01217073|3770780|FG004|Extension Period|Contraindication to study medication|0
2156223|NCT01217073|3770781|FG005|Extension Period|Contraindication to study medication|0
2156224|NCT01217073|3770782|FG006|Extension Period|Contraindication to study medication|1
2156225|NCT01217073|3770783|FG007|Extension Period|Contraindication to study medication|0
2156226|NCT01217073|3770776|FG000|Extension Period|Creatinine/eGFR|0
2156227|NCT01217073|3770777|FG001|Extension Period|Creatinine/eGFR|0
2156228|NCT01217073|3770778|FG002|Extension Period|Creatinine/eGFR|0
2156229|NCT01217073|3770779|FG003|Extension Period|Creatinine/eGFR|0
2156230|NCT01217073|3770780|FG004|Extension Period|Creatinine/eGFR|0
2156231|NCT01217073|3770781|FG005|Extension Period|Creatinine/eGFR|0
2156232|NCT01217073|3770782|FG006|Extension Period|Creatinine/eGFR|11
2156233|NCT01217073|3770783|FG007|Extension Period|Creatinine/eGFR|1
2156234|NCT01217073|3770776|FG000|Extension Period|Death|0
2156235|NCT01217073|3770777|FG001|Extension Period|Death|0
2156236|NCT01217073|3770778|FG002|Extension Period|Death|0
2156237|NCT01217073|3770779|FG003|Extension Period|Death|0
2156238|NCT01217073|3770780|FG004|Extension Period|Death|0
2156239|NCT01217073|3770781|FG005|Extension Period|Death|0
2156240|NCT01217073|3770782|FG006|Extension Period|Death|1
2293123|NCT02521870|3987109|FG010|Phase 2: Dose Expansion|Progressive Disease|17
2293124|NCT02521870|3987110|FG011|Phase 2: Dose Expansion|Progressive Disease|21
2293125|NCT02521870|3987099|FG000|Phase 2: Dose Expansion|Death|0
2293126|NCT02521870|3987100|FG001|Phase 2: Dose Expansion|Death|0
2293127|NCT02521870|3987101|FG002|Phase 2: Dose Expansion|Death|0
2293128|NCT02521870|3987102|FG003|Phase 2: Dose Expansion|Death|0
2293129|NCT02521870|3987103|FG004|Phase 2: Dose Expansion|Death|1
2293130|NCT02521870|3987104|FG005|Phase 2: Dose Expansion|Death|1
2293131|NCT02521870|3987105|FG006|Phase 2: Dose Expansion|Death|3
2293132|NCT02521870|3987106|FG007|Phase 2: Dose Expansion|Death|1
2293133|NCT02521870|3987107|FG008|Phase 2: Dose Expansion|Death|1
2293134|NCT02521870|3987108|FG009|Phase 2: Dose Expansion|Death|5
2293135|NCT02521870|3987109|FG010|Phase 2: Dose Expansion|Death|2
2293136|NCT02521870|3987110|FG011|Phase 2: Dose Expansion|Death|2
2293137|NCT02521870|3987099|FG000|Phase 2: Dose Expansion|Other|0
2293138|NCT02521870|3987100|FG001|Phase 2: Dose Expansion|Other|0
2293139|NCT02521870|3987101|FG002|Phase 2: Dose Expansion|Other|0
2293140|NCT02521870|3987102|FG003|Phase 2: Dose Expansion|Other|0
2293141|NCT02521870|3987103|FG004|Phase 2: Dose Expansion|Other|10
2293142|NCT02521870|3987104|FG005|Phase 2: Dose Expansion|Other|3
2293143|NCT02521870|3987105|FG006|Phase 2: Dose Expansion|Other|2
2293144|NCT02521870|3987106|FG007|Phase 2: Dose Expansion|Other|0
2293145|NCT02521870|3987107|FG008|Phase 2: Dose Expansion|Other|10
2293146|NCT02521870|3987108|FG009|Phase 2: Dose Expansion|Other|5
2293147|NCT02521870|3987109|FG010|Phase 2: Dose Expansion|Other|1
2293148|NCT02521870|3987110|FG011|Phase 2: Dose Expansion|Other|7
2293149|NCT02521870|3987099|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0
2293150|NCT02521870|3987100|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0
2293151|NCT02521870|3987101|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0
2293152|NCT02521870|3987102|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0
2293153|NCT02521870|3987103|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1
2293154|NCT02521870|3987104|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0
2293155|NCT02521870|3987105|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0
2293156|NCT02521870|3987106|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0
2293157|NCT02521870|3987107|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0
2293158|NCT02521870|3987108|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0
2293159|NCT02521870|3987109|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0
2293160|NCT02521870|3987110|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0
2156241|NCT01217073|3770783|FG007|Extension Period|Death|0
2156242|NCT01217073|3770776|FG000|Extension Period|Excluded medication|0
2156243|NCT01217073|3770777|FG001|Extension Period|Excluded medication|0
2156244|NCT01217073|3770778|FG002|Extension Period|Excluded medication|0
2156245|NCT01217073|3770779|FG003|Extension Period|Excluded medication|0
2156246|NCT01217073|3770780|FG004|Extension Period|Excluded medication|0
2156247|NCT01217073|3770781|FG005|Extension Period|Excluded medication|0
2156248|NCT01217073|3770782|FG006|Extension Period|Excluded medication|2
2156249|NCT01217073|3770783|FG007|Extension Period|Excluded medication|0
2156250|NCT01217073|3770776|FG000|Extension Period|Lack of Efficacy|0
2156251|NCT01217073|3770777|FG001|Extension Period|Lack of Efficacy|0
2156252|NCT01217073|3770778|FG002|Extension Period|Lack of Efficacy|0
2156253|NCT01217073|3770779|FG003|Extension Period|Lack of Efficacy|0
2156254|NCT01217073|3770780|FG004|Extension Period|Lack of Efficacy|0
2156255|NCT01217073|3770781|FG005|Extension Period|Lack of Efficacy|0
2156256|NCT01217073|3770782|FG006|Extension Period|Lack of Efficacy|3
2156257|NCT01217073|3770783|FG007|Extension Period|Lack of Efficacy|0
2156258|NCT01217073|3770776|FG000|Extension Period|Lost to Follow-up|0
2156259|NCT01217073|3770777|FG001|Extension Period|Lost to Follow-up|0
2156260|NCT01217073|3770778|FG002|Extension Period|Lost to Follow-up|0
2156261|NCT01217073|3770779|FG003|Extension Period|Lost to Follow-up|0
2156262|NCT01217073|3770780|FG004|Extension Period|Lost to Follow-up|0
2156263|NCT01217073|3770781|FG005|Extension Period|Lost to Follow-up|0
2156264|NCT01217073|3770782|FG006|Extension Period|Lost to Follow-up|9
2156265|NCT01217073|3770783|FG007|Extension Period|Lost to Follow-up|1
2156266|NCT01217073|3770776|FG000|Extension Period|Non-compliance with study drug|0
2156267|NCT01217073|3770777|FG001|Extension Period|Non-compliance with study drug|0
2156268|NCT01217073|3770778|FG002|Extension Period|Non-compliance with study drug|0
2156269|NCT01217073|3770779|FG003|Extension Period|Non-compliance with study drug|0
2156270|NCT01217073|3770780|FG004|Extension Period|Non-compliance with study drug|0
2156271|NCT01217073|3770781|FG005|Extension Period|Non-compliance with study drug|0
2156272|NCT01217073|3770782|FG006|Extension Period|Non-compliance with study drug|0
2156273|NCT01217073|3770783|FG007|Extension Period|Non-compliance with study drug|1
2156274|NCT01217073|3770776|FG000|Extension Period|Physician Decision|0
2156275|NCT01217073|3770777|FG001|Extension Period|Physician Decision|0
2156276|NCT01217073|3770778|FG002|Extension Period|Physician Decision|0
2156277|NCT01217073|3770779|FG003|Extension Period|Physician Decision|0
2156278|NCT01217073|3770780|FG004|Extension Period|Physician Decision|0
2293161|NCT02521870|3987099|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
2293162|NCT02521870|3987100|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
2293163|NCT02521870|3987101|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
2293164|NCT02521870|3987102|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
2293165|NCT02521870|3987103|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2
2293166|NCT02521870|3987104|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
2293167|NCT02521870|3987105|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
2293168|NCT02521870|3987106|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
2293169|NCT02521870|3987107|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
2293170|NCT02521870|3987108|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
2293171|NCT02521870|3987109|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
2293172|NCT02521870|3987110|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
2293173|NCT02521948|3987140|FG000|Overall Study|Adverse Event|2
2293174|NCT02521948|3987140|FG000|Overall Study|Death|4
2293175|NCT02521948|3987140|FG000|Overall Study|Lost to Follow-up|1
2293176|NCT02521948|3987140|FG000|Overall Study|Did not attend one or both follow-ups|6
2293177|NCT02522286|3987177|FG000|Overall Study|Withdrawal by Subject|3
2293178|NCT02522286|3987178|FG001|Overall Study|Withdrawal by Subject|0
2293179|NCT02522286|3987179|FG002|Overall Study|Withdrawal by Subject|0
2293180|NCT02522286|3987180|FG003|Overall Study|Withdrawal by Subject|3
2293181|NCT02522299|3987192|FG000|Overall Study|Adverse Event|2
2293182|NCT02522299|3987193|FG001|Overall Study|Adverse Event|0
2293183|NCT02522299|3987192|FG000|Overall Study|Physician Decision|0
2293184|NCT02522299|3987193|FG001|Overall Study|Physician Decision|1
2293185|NCT02522299|3987192|FG000|Overall Study|Withdrawal by Subject|2
2293186|NCT02522299|3987193|FG001|Overall Study|Withdrawal by Subject|0
2293187|NCT02522325|3987213|FG000|Overall Study|Adverse Event|0
2293188|NCT02522325|3987214|FG001|Overall Study|Adverse Event|1
2321227|NCT02956967|4035621|FG000|Overall Study|Reason non-related to neutropenia|10
2321228|NCT02956967|4035621|FG000|Overall Study|Lost to Follow-up|5
2321229|NCT02956967|4035621|FG000|Overall Study|Missing|1
2321230|NCT02956967|4035621|FG000|Overall Study|Termination of Nivestim administration|29
2321231|NCT02957136|4035631|FG000|Overall Study|Withdrawal by Subject|2
2321232|NCT02957136|4035632|FG001|Overall Study|Withdrawal by Subject|1
2321233|NCT02957331|4035649|FG000|Overall Study|Protocol Violation|1
2321234|NCT02957331|4035650|FG001|Overall Study|Protocol Violation|0
2322390|NCT02971683|4037414|FG000|Overall Study|Other reasons|0
2322391|NCT02971683|4037415|FG001|Overall Study|Other reasons|1
2322392|NCT02971683|4037414|FG000|Overall Study|Poor/Non-Compliance|0
2322393|NCT02971683|4037415|FG001|Overall Study|Poor/Non-Compliance|1
2322394|NCT02971683|4037414|FG000|Overall Study|Lost to Follow-up|1
2156279|NCT01217073|3770781|FG005|Extension Period|Physician Decision|0
2156280|NCT01217073|3770782|FG006|Extension Period|Physician Decision|4
2156281|NCT01217073|3770783|FG007|Extension Period|Physician Decision|1
2156282|NCT01217073|3770776|FG000|Extension Period|Protocol Violation|0
2156283|NCT01217073|3770777|FG001|Extension Period|Protocol Violation|0
2156284|NCT01217073|3770778|FG002|Extension Period|Protocol Violation|0
2156285|NCT01217073|3770779|FG003|Extension Period|Protocol Violation|0
2156286|NCT01217073|3770780|FG004|Extension Period|Protocol Violation|0
2156287|NCT01217073|3770781|FG005|Extension Period|Protocol Violation|0
2156288|NCT01217073|3770782|FG006|Extension Period|Protocol Violation|2
2156289|NCT01217073|3770783|FG007|Extension Period|Protocol Violation|1
2156290|NCT01217073|3770776|FG000|Extension Period|Site discontinued study participation|0
2156291|NCT01217073|3770777|FG001|Extension Period|Site discontinued study participation|0
2156292|NCT01217073|3770778|FG002|Extension Period|Site discontinued study participation|0
2156293|NCT01217073|3770779|FG003|Extension Period|Site discontinued study participation|0
2156294|NCT01217073|3770780|FG004|Extension Period|Site discontinued study participation|0
2156295|NCT01217073|3770781|FG005|Extension Period|Site discontinued study participation|0
2156296|NCT01217073|3770782|FG006|Extension Period|Site discontinued study participation|7
2156297|NCT01217073|3770783|FG007|Extension Period|Site discontinued study participation|2
2156298|NCT01217073|3770776|FG000|Extension Period|Withdrawal by Subject|0
2156299|NCT01217073|3770777|FG001|Extension Period|Withdrawal by Subject|0
2156300|NCT01217073|3770778|FG002|Extension Period|Withdrawal by Subject|0
2156301|NCT01217073|3770779|FG003|Extension Period|Withdrawal by Subject|0
2156302|NCT01217073|3770780|FG004|Extension Period|Withdrawal by Subject|0
2156303|NCT01217073|3770781|FG005|Extension Period|Withdrawal by Subject|0
2156304|NCT01217073|3770782|FG006|Extension Period|Withdrawal by Subject|30
2156305|NCT01217073|3770783|FG007|Extension Period|Withdrawal by Subject|8
2156306|NCT01217112|3770812|FG000|Overall Study|Adverse Event|0
2156307|NCT01217112|3770813|FG001|Overall Study|Adverse Event|2
2156308|NCT01217112|3770814|FG002|Overall Study|Adverse Event|0
2156309|NCT01217112|3770815|FG003|Overall Study|Adverse Event|2
2156310|NCT01217112|3770816|FG004|Overall Study|Adverse Event|0
2156311|NCT01217112|3770812|FG000|Overall Study|Withdrawal by Subject|0
2156312|NCT01217112|3770813|FG001|Overall Study|Withdrawal by Subject|0
2156313|NCT01217112|3770814|FG002|Overall Study|Withdrawal by Subject|1
2156314|NCT01217112|3770815|FG003|Overall Study|Withdrawal by Subject|0
2156315|NCT01217112|3770816|FG004|Overall Study|Withdrawal by Subject|0
2156316|NCT01217112|3770812|FG000|Overall Study|Physician Decision|0
2156317|NCT01217112|3770813|FG001|Overall Study|Physician Decision|0
2156318|NCT01217112|3770814|FG002|Overall Study|Physician Decision|0
2156319|NCT01217112|3770815|FG003|Overall Study|Physician Decision|0
2156320|NCT01217112|3770816|FG004|Overall Study|Physician Decision|1
2156321|NCT01217190|3770830|FG000|Second Dosing|Withdrawal by Subject|0
2156322|NCT01217190|3770831|FG001|Second Dosing|Withdrawal by Subject|2
2156323|NCT01217229|3770840|FG000|Overall Study|Adverse Event|1
2156324|NCT01217229|3770840|FG000|Overall Study|Disease progression, deterioration|2
2156325|NCT01217229|3770840|FG000|Overall Study|Disease progression, Cheson criteria|14
2156326|NCT01217229|3770840|FG000|Overall Study|Protocol Violation|1
2156327|NCT01217229|3770840|FG000|Overall Study|Disease progression not confirmed|2
2156328|NCT01217307|3770846|FG000|Overall Study|Withdrawal by Subject|0
2156329|NCT01217307|3770847|FG001|Overall Study|Withdrawal by Subject|1
2156330|NCT01217385|3770853|FG000|Overall Study|Withdrawal by Subject|3
2156331|NCT01217385|3770853|FG000|Overall Study|DOSI not performed/not eval|12
2156332|NCT01217385|3770853|FG000|Overall Study|Central Path not Available|1
2156333|NCT01217385|3770853|FG000|Overall Study|Normal Breast TOI not available|10
2156334|NCT01217437|3770876|FG000|Overall Study|Adverse Event|0
2293189|NCT02522377|3987222|FG000|Overall Study|Withdrawal by Subject|1
2293190|NCT02522377|3987223|FG001|Overall Study|Withdrawal by Subject|0
2293191|NCT02522377|3987222|FG000|Overall Study|Remission Achieved|3
2293192|NCT02522377|3987223|FG001|Overall Study|Remission Achieved|0
2293193|NCT02522403|3987231|FG000|Overall Study|Lost to Follow-up|2
2293194|NCT02522403|3987232|FG001|Overall Study|Lost to Follow-up|2
2156335|NCT01217437|3770877|FG001|Overall Study|Adverse Event|8
2156336|NCT01217437|3770876|FG000|Overall Study|Death|5
2156337|NCT01217437|3770877|FG001|Overall Study|Death|0
2156338|NCT01217437|3770876|FG000|Overall Study|Lack of Efficacy|29
2156339|NCT01217437|3770877|FG001|Overall Study|Lack of Efficacy|25
2156340|NCT01217437|3770876|FG000|Overall Study|Physician Decision|8
2156341|NCT01217437|3770877|FG001|Overall Study|Physician Decision|5
2156342|NCT01217437|3770876|FG000|Overall Study|Withdrawal by Subject|0
2156343|NCT01217437|3770877|FG001|Overall Study|Withdrawal by Subject|2
2156344|NCT01217437|3770876|FG000|Overall Study|Ineligible|1
2156345|NCT01217437|3770877|FG001|Overall Study|Ineligible|1
2156346|NCT01217463|3770885|FG000|Overall Study|Adverse Event|8
2156347|NCT01217463|3770886|FG001|Overall Study|Adverse Event|5
2156348|NCT01217463|3770885|FG000|Overall Study|Physician Decision|0
2293195|NCT02522403|3987231|FG000|Overall Study|Withdrawal by Subject|2
2293196|NCT02522403|3987232|FG001|Overall Study|Withdrawal by Subject|4
2293197|NCT02522481|3987247|FG000|Overall Study|discontinued|1
2293198|NCT02522481|3987247|FG000|Overall Study|Not dosed|2
2293199|NCT02522494|3987260|FG000|Overall Study|Lost to Follow-up|6
2293200|NCT02522494|3987261|FG001|Overall Study|Lost to Follow-up|2
2293201|NCT02522494|3987260|FG000|Overall Study|Withdrawal by Subject|1
2293202|NCT02522494|3987261|FG001|Overall Study|Withdrawal by Subject|0
2321235|NCT02957682|4035674|FG000|Overall Study|Adverse Event|64
2156349|NCT01217463|3770886|FG001|Overall Study|Physician Decision|1
2156350|NCT01217463|3770885|FG000|Overall Study|Withdrawal by Subject|3
2156351|NCT01217463|3770886|FG001|Overall Study|Withdrawal by Subject|0
2156352|NCT01217463|3770885|FG000|Overall Study|Surgery on the Target Limb|0
2156353|NCT01217463|3770886|FG001|Overall Study|Surgery on the Target Limb|1
2156354|NCT01217463|3770885|FG000|Overall Study|Patient Non-compliant|1
2156355|NCT01217463|3770886|FG001|Overall Study|Patient Non-compliant|0
2156356|NCT01217463|3770885|FG000|Overall Study|Other|1
2156357|NCT01217463|3770886|FG001|Overall Study|Other|1
2156358|NCT01217476|3770896|FG000|Overall Study|Adverse Event|6
2156359|NCT01217476|3770897|FG001|Overall Study|Adverse Event|1
2156360|NCT01217476|3770896|FG000|Overall Study|Physician Decision|0
2156361|NCT01217476|3770897|FG001|Overall Study|Physician Decision|1
2156362|NCT01217476|3770896|FG000|Overall Study|Withdrawal by Subject|3
2156363|NCT01217476|3770897|FG001|Overall Study|Withdrawal by Subject|3
2156364|NCT01217476|3770896|FG000|Overall Study|Surgery on the Target Limb|0
2156365|NCT01217476|3770897|FG001|Overall Study|Surgery on the Target Limb|2
2156366|NCT01217476|3770896|FG000|Overall Study|Protocol Deviation|1
2156367|NCT01217476|3770897|FG001|Overall Study|Protocol Deviation|0
2156368|NCT01217476|3770896|FG000|Overall Study|Other|2
2156369|NCT01217476|3770897|FG001|Overall Study|Other|0
2156370|NCT01217606|3770918|FG000|Initial Treatment Phase|Other Reasons|0
2156371|NCT01217606|3770919|FG001|Initial Treatment Phase|Other Reasons|2
2156372|NCT01217606|3770918|FG000|Initial Treatment Phase|Protocol Violation|3
2156373|NCT01217606|3770919|FG001|Initial Treatment Phase|Protocol Violation|2
2156374|NCT01217606|3770918|FG000|Initial Treatment Phase|Personal Reasons|0
2156375|NCT01217606|3770919|FG001|Initial Treatment Phase|Personal Reasons|2
2156376|NCT01217606|3770918|FG000|Initial Treatment Phase|Lack of Efficacy|1
2156377|NCT01217606|3770919|FG001|Initial Treatment Phase|Lack of Efficacy|0
2156378|NCT01217606|3770918|FG000|Initial Treatment Phase|Adverse Event|10
2156379|NCT01217606|3770919|FG001|Initial Treatment Phase|Adverse Event|6
2156380|NCT01217606|3770918|FG000|9-Month Masked Extension|Adverse Event|3
2156381|NCT01217606|3770919|FG001|9-Month Masked Extension|Adverse Event|6
2156382|NCT01217606|3770918|FG000|9-Month Masked Extension|Other Reasons|4
2156383|NCT01217606|3770919|FG001|9-Month Masked Extension|Other Reasons|4
2156384|NCT01217606|3770918|FG000|9-Month Masked Extension|Personal Reasons|2
2156385|NCT01217606|3770919|FG001|9-Month Masked Extension|Personal Reasons|1
2156386|NCT01217606|3770918|FG000|9-Month Masked Extension|Lost to Follow-up|1
2156387|NCT01217606|3770919|FG001|9-Month Masked Extension|Lost to Follow-up|0
2156388|NCT01217606|3770918|FG000|9-Month Masked Extension|Pregnancy|1
2156389|NCT01217606|3770919|FG001|9-Month Masked Extension|Pregnancy|0
2156390|NCT01217606|3770918|FG000|9-Month Masked Extension|Lack of Efficacy|2
2156391|NCT01217606|3770919|FG001|9-Month Masked Extension|Lack of Efficacy|0
2156392|NCT01217801|3770942|FG000|Period 1|Protocol Violation|1
2156393|NCT01217801|3770943|FG001|Period 1|Protocol Violation|1
2156394|NCT01217801|3770942|FG000|Period 1|Withdrawal by Subject|0
2293203|NCT02522494|3987260|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6
2293204|NCT02522494|3987261|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2
2293205|NCT02522494|3987260|FG000|Overall Study|Participant did not watch the video|1
2293206|NCT02522494|3987261|FG001|Overall Study|Participant did not watch the video|0
2293207|NCT02522494|3987260|FG000|Overall Study|Death|0
2293208|NCT02522494|3987261|FG001|Overall Study|Death|1
2293209|NCT02522624|3987269|FG000|Overall Study|Technical failure|1
2293210|NCT02522624|3987270|FG001|Overall Study|Technical failure|0
2293211|NCT02522728|3987287|FG000|Overall Study|Withdrawal by Subject|6
2293212|NCT02522728|3987288|FG001|Overall Study|Withdrawal by Subject|6
2293213|NCT02522728|3987287|FG000|Overall Study|Death|4
2293214|NCT02522728|3987288|FG001|Overall Study|Death|3
2293215|NCT02522728|3987287|FG000|Overall Study|Adverse Event|2
2293216|NCT02522728|3987288|FG001|Overall Study|Adverse Event|1
2293217|NCT02522728|3987287|FG000|Overall Study|Did not receive randomized study device|0
2293218|NCT02522728|3987288|FG001|Overall Study|Did not receive randomized study device|1
2293219|NCT02522767|3987296|FG000|Double-blind|Withdrawal by Subject|8
2293220|NCT02522767|3987297|FG001|Double-blind|Withdrawal by Subject|11
2293221|NCT02522767|3987296|FG000|Double-blind|Lost to Follow-up|1
2293222|NCT02522767|3987297|FG001|Double-blind|Lost to Follow-up|0
2293223|NCT02522767|3987296|FG000|Double-blind|Adverse Event|1
2293224|NCT02522767|3987297|FG001|Double-blind|Adverse Event|10
2293225|NCT02522767|3987296|FG000|Double-blind|Protocol Violation|0
2293226|NCT02522767|3987297|FG001|Double-blind|Protocol Violation|1
2293227|NCT02522767|3987296|FG000|Double-blind|Lack of Efficacy|0
2293228|NCT02522767|3987297|FG001|Double-blind|Lack of Efficacy|2
2293229|NCT02522767|3987296|FG000|Double-blind|Protocol Deviation|1
2293230|NCT02522767|3987297|FG001|Double-blind|Protocol Deviation|0
2293231|NCT02522767|3987296|FG000|Open-label|Withdrawal by Subject|2
2293232|NCT02522767|3987297|FG001|Open-label|Withdrawal by Subject|3
2293233|NCT02522767|3987296|FG000|Open-label|Lost to Follow-up|0
2293234|NCT02522767|3987297|FG001|Open-label|Lost to Follow-up|1
2293235|NCT02522767|3987296|FG000|Open-label|Adverse Event|2
2293236|NCT02522767|3987297|FG001|Open-label|Adverse Event|1
2293237|NCT02522767|3987296|FG000|Open-label|Lack of Efficacy|1
2156395|NCT01217801|3770943|FG001|Period 1|Withdrawal by Subject|1
2156396|NCT01217814|3770952|FG000|Overall Study|Adverse Event|1
2156397|NCT01217814|3770953|FG001|Overall Study|Adverse Event|1
2156398|NCT01217814|3770954|FG002|Overall Study|Adverse Event|0
2156399|NCT01217814|3770952|FG000|Overall Study|Lack of Efficacy|0
2156400|NCT01217814|3770953|FG001|Overall Study|Lack of Efficacy|0
2156401|NCT01217814|3770954|FG002|Overall Study|Lack of Efficacy|1
2156402|NCT01217892|3770986|FG000|Overall Study|Adverse Event|1
2156403|NCT01217892|3770987|FG001|Overall Study|Adverse Event|1
2156404|NCT01217892|3770988|FG002|Overall Study|Adverse Event|1
2156405|NCT01217892|3770989|FG003|Overall Study|Adverse Event|0
2156406|NCT01217892|3770986|FG000|Overall Study|Withdrawal by Subject|0
2156407|NCT01217892|3770987|FG001|Overall Study|Withdrawal by Subject|2
2156408|NCT01217892|3770988|FG002|Overall Study|Withdrawal by Subject|1
2156409|NCT01217892|3770989|FG003|Overall Study|Withdrawal by Subject|0
2156410|NCT01217892|3770986|FG000|Overall Study|Lab value|1
2156411|NCT01217892|3770987|FG001|Overall Study|Lab value|0
2156412|NCT01217892|3770988|FG002|Overall Study|Lab value|1
2156413|NCT01217892|3770989|FG003|Overall Study|Lab value|0
2156414|NCT01217892|3770986|FG000|Overall Study|Subject no longer meets study criteria|5
2156415|NCT01217892|3770987|FG001|Overall Study|Subject no longer meets study criteria|2
2156416|NCT01217892|3770988|FG002|Overall Study|Subject no longer meets study criteria|4
2156417|NCT01217892|3770989|FG003|Overall Study|Subject no longer meets study criteria|8
2156418|NCT01217892|3770986|FG000|Overall Study|Incorrect enrollment|0
2156419|NCT01217892|3770987|FG001|Overall Study|Incorrect enrollment|1
2156420|NCT01217892|3770988|FG002|Overall Study|Incorrect enrollment|1
2156421|NCT01217892|3770989|FG003|Overall Study|Incorrect enrollment|0
2156422|NCT01217892|3770986|FG000|Overall Study|Poor/Non-Compliance|0
2156423|NCT01217892|3770987|FG001|Overall Study|Poor/Non-Compliance|0
2156424|NCT01217892|3770988|FG002|Overall Study|Poor/Non-Compliance|1
2156425|NCT01217892|3770989|FG003|Overall Study|Poor/Non-Compliance|0
2156426|NCT01217944|3771002|FG000|Overall Study|Protocol Violation|1
2156427|NCT01217944|3771003|FG001|Overall Study|Protocol Violation|1
2156428|NCT01217944|3771004|FG002|Overall Study|Protocol Violation|0
2156429|NCT01217944|3771002|FG000|Overall Study|Lost to Follow-up|3
2156430|NCT01217944|3771003|FG001|Overall Study|Lost to Follow-up|1
2156431|NCT01217944|3771004|FG002|Overall Study|Lost to Follow-up|0
2156432|NCT01217944|3771002|FG000|Overall Study|Withdrawal by Subject|1
2156433|NCT01217944|3771003|FG001|Overall Study|Withdrawal by Subject|2
2156434|NCT01217944|3771004|FG002|Overall Study|Withdrawal by Subject|0
2156435|NCT01217944|3771002|FG000|Overall Study|Lack of Efficacy|1
2156436|NCT01217944|3771003|FG001|Overall Study|Lack of Efficacy|0
2156437|NCT01217944|3771004|FG002|Overall Study|Lack of Efficacy|0
2156438|NCT01217957|3771019|FG000|Phase 1|Withdrawal by Patient|1
2156439|NCT01217957|3771020|FG001|Phase 1|Withdrawal by Patient|0
2156440|NCT01217957|3771021|FG002|Phase 1|Withdrawal by Patient|1
2156441|NCT01217957|3771022|FG003|Phase 1|Withdrawal by Patient|1
2156442|NCT01217957|3771023|FG004|Phase 1|Withdrawal by Patient|0
2156443|NCT01217957|3771019|FG000|Phase 2|Withdrawal by Patient|0
2156444|NCT01217957|3771020|FG001|Phase 2|Withdrawal by Patient|0
2156445|NCT01217957|3771021|FG002|Phase 2|Withdrawal by Patient|0
2156446|NCT01217957|3771022|FG003|Phase 2|Withdrawal by Patient|0
2156447|NCT01217957|3771023|FG004|Phase 2|Withdrawal by Patient|1
2156448|NCT01218009|3771046|FG000|Overall Study|Protocol Violation|2
2156449|NCT01218009|3771047|FG001|Overall Study|Protocol Violation|1
2156450|NCT01218009|3771046|FG000|Overall Study|Withdrawal by Subject|3
2156451|NCT01218009|3771047|FG001|Overall Study|Withdrawal by Subject|1
2156452|NCT01218009|3771046|FG000|Overall Study|Sponsor terminated study|161
2293238|NCT02522767|3987297|FG001|Open-label|Lack of Efficacy|1
2293239|NCT02522767|3987296|FG000|Open-label|Protocol Violation|0
2293240|NCT02522767|3987297|FG001|Open-label|Protocol Violation|1
2293241|NCT02522780|3987307|FG000|Overall Study|Consent withdrawn by subject|5
2293242|NCT02522780|3987308|FG001|Overall Study|Consent withdrawn by subject|7
2293243|NCT02522780|3987307|FG000|Overall Study|Protocol deviation|1
2293244|NCT02522780|3987308|FG001|Overall Study|Protocol deviation|3
2293245|NCT02522780|3987307|FG000|Overall Study|Subject refused endoscopic procedure|0
2293246|NCT02522780|3987308|FG001|Overall Study|Subject refused endoscopic procedure|1
2293247|NCT02522780|3987307|FG000|Overall Study|Adverse event, non-fatal|11
2293248|NCT02522780|3987308|FG001|Overall Study|Adverse event, non-fatal|16
2293249|NCT02522884|3987324|FG000|Overall Study|Withdrawal by Subject|6
2293250|NCT02522884|3987324|FG000|Overall Study|Death|3
2293251|NCT02522884|3987324|FG000|Overall Study|Missed 12-month Follow-up|9
2293252|NCT02523599|3987360|FG000|Overall Study|Adverse Event|1
2293253|NCT02523599|3987361|FG001|Overall Study|Adverse Event|0
2293254|NCT02523599|3987360|FG000|Overall Study|Physician Decision|1
2293255|NCT02523599|3987361|FG001|Overall Study|Physician Decision|0
2293256|NCT02523599|3987360|FG000|Overall Study|Lost to Follow-up|4
2293257|NCT02523599|3987361|FG001|Overall Study|Lost to Follow-up|1
2293258|NCT02523599|3987360|FG000|Overall Study|Did not return for Day 30 visit|2
2293259|NCT02523599|3987361|FG001|Overall Study|Did not return for Day 30 visit|0
2293260|NCT02524145|3987410|FG000|Overall Study|Withdrawal by Subject|2
2293261|NCT02524145|3987411|FG001|Overall Study|Withdrawal by Subject|2
2293262|NCT02524145|3987412|FG002|Overall Study|Withdrawal by Subject|3
2293263|NCT02524158|3987422|FG000|12-weeks Assessment|Withdrawal by Subject|1
2293264|NCT02524158|3987423|FG001|12-weeks Assessment|Withdrawal by Subject|1
2293265|NCT02524158|3987422|FG000|12-weeks Assessment|Lost to Follow-up|18
2156453|NCT01218009|3771047|FG001|Overall Study|Sponsor terminated study|163
2293266|NCT02524158|3987423|FG001|12-weeks Assessment|Lost to Follow-up|12
2293267|NCT02524158|3987422|FG000|6-month Assessment|Withdrawal by Subject|1
2156454|NCT01218087|3771060|FG000|Overall Study|Death|2
2156455|NCT01218087|3771061|FG001|Overall Study|Death|1
2156456|NCT01218087|3771060|FG000|Overall Study|Withdrawal by Subject|5
2156457|NCT01218087|3771061|FG001|Overall Study|Withdrawal by Subject|0
2156458|NCT01218087|3771060|FG000|Overall Study|Transferred|8
2156459|NCT01218087|3771061|FG001|Overall Study|Transferred|5
2156460|NCT01218100|3771071|FG000|Overall Study|Did not meet InclusionExclusion criteria|1
2156461|NCT01218100|3771072|FG001|Overall Study|Did not meet InclusionExclusion criteria|1
2156462|NCT01218100|3771073|FG002|Overall Study|Did not meet InclusionExclusion criteria|1
2156463|NCT01218100|3771074|FG003|Overall Study|Did not meet InclusionExclusion criteria|2
2156464|NCT01218100|3771071|FG000|Overall Study|Adverse Event|4
2156465|NCT01218100|3771072|FG001|Overall Study|Adverse Event|6
2156466|NCT01218100|3771073|FG002|Overall Study|Adverse Event|6
2156467|NCT01218100|3771074|FG003|Overall Study|Adverse Event|7
2156468|NCT01218100|3771071|FG000|Overall Study|Lack of Efficacy|9
2156469|NCT01218100|3771072|FG001|Overall Study|Lack of Efficacy|6
2156470|NCT01218100|3771073|FG002|Overall Study|Lack of Efficacy|5
2156471|NCT01218100|3771074|FG003|Overall Study|Lack of Efficacy|12
2156472|NCT01218100|3771071|FG000|Overall Study|Protocol Violation|0
2156473|NCT01218100|3771072|FG001|Overall Study|Protocol Violation|0
2156474|NCT01218100|3771073|FG002|Overall Study|Protocol Violation|1
2156475|NCT01218100|3771074|FG003|Overall Study|Protocol Violation|1
2156476|NCT01218100|3771071|FG000|Overall Study|Withdrawal by Subject|5
2156477|NCT01218100|3771072|FG001|Overall Study|Withdrawal by Subject|2
2156478|NCT01218100|3771073|FG002|Overall Study|Withdrawal by Subject|6
2156479|NCT01218100|3771074|FG003|Overall Study|Withdrawal by Subject|7
2156480|NCT01218100|3771071|FG000|Overall Study|Lost to Follow-up|3
2156481|NCT01218100|3771072|FG001|Overall Study|Lost to Follow-up|8
2293268|NCT02524158|3987423|FG001|6-month Assessment|Withdrawal by Subject|1
2293269|NCT02524158|3987422|FG000|6-month Assessment|Lost to Follow-up|21
2293270|NCT02524158|3987423|FG001|6-month Assessment|Lost to Follow-up|20
2293271|NCT02524665|3987452|FG000|Overall Study|Lost to Follow-up|1
2293272|NCT02524730|3987457|FG000|Overall Study|Lost to Follow-up|5
2293273|NCT02524730|3987457|FG000|Overall Study|Withdrawal by Subject|18
2293274|NCT02524730|3987457|FG000|Overall Study|Death|10
2293275|NCT02524730|3987457|FG000|Overall Study|Adverse Event|8
2293276|NCT02524730|3987457|FG000|Overall Study|Protocol Violation|1
2293277|NCT02524730|3987457|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4
2293278|NCT02524847|3987465|FG000|Overall Study|Adverse Event|4
2293279|NCT02524847|3987465|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
2293280|NCT02524847|3987465|FG000|Overall Study|Condition no Longer Requires Treatment|4
2293281|NCT02524847|3987465|FG000|Overall Study|Death|1
2293282|NCT02524847|3987465|FG000|Overall Study|Reason not Specified|1
2293283|NCT02525094|3987508|FG000|Overall Study|Lost to Follow-up|2
2293284|NCT02525094|3987509|FG001|Overall Study|Lost to Follow-up|1
2293285|NCT02525094|3987508|FG000|Overall Study|Withdrawal by Subject|5
2293286|NCT02525094|3987509|FG001|Overall Study|Withdrawal by Subject|6
2293287|NCT02525094|3987508|FG000|Overall Study|Not Treated|1
2293288|NCT02525094|3987509|FG001|Overall Study|Not Treated|1
2293289|NCT02525133|3987518|FG000|Overall Study|Adverse Event|0
2293290|NCT02525133|3987519|FG001|Overall Study|Adverse Event|1
2293291|NCT02525133|3987518|FG000|Overall Study|Death|0
2293292|NCT02525133|3987519|FG001|Overall Study|Death|1
2293293|NCT02525133|3987518|FG000|Overall Study|did not meet randomization criteria|1
2293294|NCT02525133|3987519|FG001|Overall Study|did not meet randomization criteria|0
2293295|NCT02525133|3987518|FG000|Overall Study|Lost to Follow-up|5
2293296|NCT02525133|3987519|FG001|Overall Study|Lost to Follow-up|1
2293297|NCT02525133|3987518|FG000|Overall Study|randomized not enrolled|3
2293298|NCT02525133|3987519|FG001|Overall Study|randomized not enrolled|0
2293299|NCT02525133|3987518|FG000|Overall Study|Withdrawal by Subject|1
2293300|NCT02525133|3987519|FG001|Overall Study|Withdrawal by Subject|0
2293301|NCT02525471|3987531|FG000|Overall Study|Screen Failure|6
2293302|NCT02525471|3987531|FG000|Overall Study|Withdrawal by Subject|4
2293303|NCT02525471|3987531|FG000|Overall Study|Death|1
2293304|NCT02525588|3987577|FG000|Overall Study|Death|3
2293305|NCT02525588|3987578|FG001|Overall Study|Death|1
2293306|NCT02525588|3987577|FG000|Overall Study|Lost to Follow-up|2
2293307|NCT02525588|3987578|FG001|Overall Study|Lost to Follow-up|0
2293308|NCT02525588|3987577|FG000|Overall Study|Withdrawal by Subject|1
2293309|NCT02525588|3987578|FG001|Overall Study|Withdrawal by Subject|1
2293310|NCT02525588|3987577|FG000|Overall Study|Adverse Event|0
2293311|NCT02525588|3987578|FG001|Overall Study|Adverse Event|1
2293312|NCT02525627|3987586|FG000|Overall Study|Revision|1
2293313|NCT02525627|3987587|FG001|Overall Study|Revision|1
2293314|NCT02525627|3987586|FG000|Overall Study|Withdrawal by Subject|1
2293315|NCT02525627|3987587|FG001|Overall Study|Withdrawal by Subject|2
2293316|NCT02525627|3987586|FG000|Overall Study|Death|1
2293317|NCT02525627|3987587|FG001|Overall Study|Death|0
2293318|NCT02525627|3987586|FG000|Overall Study|Site terminated|11
2293319|NCT02525627|3987587|FG001|Overall Study|Site terminated|10
2293320|NCT02525744|3987606|FG000|Period 1|Physician Decision|0
2293321|NCT02525744|3987607|FG001|Period 1|Physician Decision|0
2293322|NCT02525744|3987608|FG002|Period 1|Physician Decision|1
2156482|NCT01218100|3771073|FG002|Overall Study|Lost to Follow-up|2
2156483|NCT01218100|3771074|FG003|Overall Study|Lost to Follow-up|1
2156484|NCT01218100|3771071|FG000|Overall Study|Other Reason|2
2293323|NCT02525744|3987609|FG003|Period 1|Physician Decision|0
2293324|NCT02525744|3987606|FG000|Period 3|Adverse Event|0
2156485|NCT01218100|3771072|FG001|Overall Study|Other Reason|2
2156486|NCT01218100|3771073|FG002|Overall Study|Other Reason|6
2156487|NCT01218100|3771074|FG003|Overall Study|Other Reason|4
2156488|NCT01218113|3771087|FG000|Overall Study|Withdrawal by Subject|1
2156489|NCT01218113|3771088|FG001|Overall Study|Withdrawal by Subject|0
2156490|NCT01218113|3771089|FG002|Overall Study|Withdrawal by Subject|1
2156491|NCT01218113|3771087|FG000|Overall Study|Lost to Follow-up|4
2156492|NCT01218113|3771088|FG001|Overall Study|Lost to Follow-up|1
2156493|NCT01218113|3771089|FG002|Overall Study|Lost to Follow-up|4
2156494|NCT01218113|3771087|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0
2156495|NCT01218113|3771088|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0
2156496|NCT01218113|3771089|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1
2156497|NCT01218126|3771108|FG000|Overall Study|Adverse Event|8
2156498|NCT01218126|3771109|FG001|Overall Study|Adverse Event|10
2156499|NCT01218126|3771110|FG002|Overall Study|Adverse Event|12
2156500|NCT01218126|3771111|FG003|Overall Study|Adverse Event|16
2156501|NCT01218126|3771108|FG000|Overall Study|Lack of Efficacy|7
2156502|NCT01218126|3771109|FG001|Overall Study|Lack of Efficacy|2
2156503|NCT01218126|3771110|FG002|Overall Study|Lack of Efficacy|2
2156504|NCT01218126|3771111|FG003|Overall Study|Lack of Efficacy|6
2156505|NCT01218126|3771108|FG000|Overall Study|Protocol Violation|5
2156506|NCT01218126|3771109|FG001|Overall Study|Protocol Violation|2
2156507|NCT01218126|3771110|FG002|Overall Study|Protocol Violation|2
2156508|NCT01218126|3771111|FG003|Overall Study|Protocol Violation|3
2156509|NCT01218126|3771108|FG000|Overall Study|Protocol-defined stopping criteria|1
2156510|NCT01218126|3771109|FG001|Overall Study|Protocol-defined stopping criteria|1
2156511|NCT01218126|3771110|FG002|Overall Study|Protocol-defined stopping criteria|0
2156512|NCT01218126|3771111|FG003|Overall Study|Protocol-defined stopping criteria|0
2156513|NCT01218126|3771108|FG000|Overall Study|Lost to Follow-up|0
2156514|NCT01218126|3771109|FG001|Overall Study|Lost to Follow-up|0
2156515|NCT01218126|3771110|FG002|Overall Study|Lost to Follow-up|0
2156516|NCT01218126|3771111|FG003|Overall Study|Lost to Follow-up|2
2156517|NCT01218126|3771108|FG000|Overall Study|Physician Decision|1
2156518|NCT01218126|3771109|FG001|Overall Study|Physician Decision|2
2156519|NCT01218126|3771110|FG002|Overall Study|Physician Decision|4
2156520|NCT01218126|3771111|FG003|Overall Study|Physician Decision|2
2156521|NCT01218126|3771108|FG000|Overall Study|Withdrawal by Subject|2
2156522|NCT01218126|3771109|FG001|Overall Study|Withdrawal by Subject|5
2156523|NCT01218126|3771110|FG002|Overall Study|Withdrawal by Subject|4
2156524|NCT01218126|3771111|FG003|Overall Study|Withdrawal by Subject|6
2156525|NCT01218204|3771123|FG000|Part B Washout|Adverse Event|0
2156526|NCT01218204|3771124|FG001|Part B Washout|Adverse Event|1
2156527|NCT01218204|3771125|FG002|Part B Washout|Adverse Event|0
2156528|NCT01218204|3771126|FG003|Part B Washout|Adverse Event|0
2156529|NCT01218204|3771123|FG000|Part B Washout|Lost to Follow-up|0
2156530|NCT01218204|3771124|FG001|Part B Washout|Lost to Follow-up|2
2156531|NCT01218204|3771125|FG002|Part B Washout|Lost to Follow-up|0
2156532|NCT01218204|3771126|FG003|Part B Washout|Lost to Follow-up|0
2156533|NCT01218204|3771123|FG000|Part B Washout|Physician Decision|0
2156534|NCT01218204|3771124|FG001|Part B Washout|Physician Decision|14
2156535|NCT01218204|3771125|FG002|Part B Washout|Physician Decision|0
2156536|NCT01218204|3771126|FG003|Part B Washout|Physician Decision|0
2156537|NCT01218204|3771123|FG000|Part B Washout|Withdrawal by Subject|0
2156538|NCT01218204|3771124|FG001|Part B Washout|Withdrawal by Subject|14
2156539|NCT01218204|3771125|FG002|Part B Washout|Withdrawal by Subject|0
2156540|NCT01218204|3771126|FG003|Part B Washout|Withdrawal by Subject|0
2156541|NCT01218204|3771123|FG000|Part B Washout|Reached defined stopping criteria|0
2156542|NCT01218204|3771124|FG001|Part B Washout|Reached defined stopping criteria|2
2156543|NCT01218204|3771125|FG002|Part B Washout|Reached defined stopping criteria|0
2156544|NCT01218204|3771126|FG003|Part B Washout|Reached defined stopping criteria|0
2156545|NCT01218204|3771123|FG000|Part B Washout|Did not meet continuation criteria|0
2156546|NCT01218204|3771124|FG001|Part B Washout|Did not meet continuation criteria|112
2156547|NCT01218204|3771125|FG002|Part B Washout|Did not meet continuation criteria|0
2156548|NCT01218204|3771126|FG003|Part B Washout|Did not meet continuation criteria|0
2156549|NCT01218204|3771123|FG000|Part B Run-in|Adverse Event|0
2156550|NCT01218204|3771124|FG001|Part B Run-in|Adverse Event|0
2156551|NCT01218204|3771125|FG002|Part B Run-in|Adverse Event|1
2156552|NCT01218204|3771126|FG003|Part B Run-in|Adverse Event|0
2156553|NCT01218204|3771123|FG000|Part B Run-in|Protocol Violation|0
2156554|NCT01218204|3771124|FG001|Part B Run-in|Protocol Violation|0
2156555|NCT01218204|3771125|FG002|Part B Run-in|Protocol Violation|2
2156556|NCT01218204|3771126|FG003|Part B Run-in|Protocol Violation|0
2156557|NCT01218204|3771123|FG000|Part B Run-in|Withdrawal by Subject|0
2156558|NCT01218204|3771124|FG001|Part B Run-in|Withdrawal by Subject|0
2156559|NCT01218204|3771125|FG002|Part B Run-in|Withdrawal by Subject|3
2156560|NCT01218204|3771126|FG003|Part B Run-in|Withdrawal by Subject|0
2156561|NCT01218204|3771123|FG000|Part B Pooled Treatment Arm|Adverse Event|0
2156562|NCT01218204|3771124|FG001|Part B Pooled Treatment Arm|Adverse Event|0
2156563|NCT01218204|3771125|FG002|Part B Pooled Treatment Arm|Adverse Event|0
2156564|NCT01218204|3771126|FG003|Part B Pooled Treatment Arm|Adverse Event|2
2156565|NCT01218204|3771123|FG000|Part B Pooled Treatment Arm|Protocol Violation|0
2156566|NCT01218204|3771124|FG001|Part B Pooled Treatment Arm|Protocol Violation|0
2156567|NCT01218204|3771125|FG002|Part B Pooled Treatment Arm|Protocol Violation|0
2156568|NCT01218204|3771126|FG003|Part B Pooled Treatment Arm|Protocol Violation|1
2156569|NCT01218243|3771175|FG000|Overall Study|Lack of Efficacy|1
2156570|NCT01218243|3771176|FG001|Overall Study|Lack of Efficacy|1
2156571|NCT01218243|3771175|FG000|Overall Study|Lost to Follow-up|3
2156572|NCT01218243|3771176|FG001|Overall Study|Lost to Follow-up|3
2156573|NCT01218243|3771175|FG000|Overall Study|Protocol Violation|5
2156574|NCT01218243|3771176|FG001|Overall Study|Protocol Violation|10
2156575|NCT01218308|3771184|FG000|Overall Study|Adverse Event|1
2156576|NCT01218308|3771185|FG001|Overall Study|Adverse Event|2
2156577|NCT01218308|3771184|FG000|Overall Study|Protocol Violation|0
2156578|NCT01218308|3771185|FG001|Overall Study|Protocol Violation|2
2156579|NCT01218308|3771184|FG000|Overall Study|Withdrawal by Subject|61
2156580|NCT01218308|3771185|FG001|Overall Study|Withdrawal by Subject|64
2156581|NCT01218308|3771184|FG000|Overall Study|Lost to Follow-up|27
2156582|NCT01218308|3771185|FG001|Overall Study|Lost to Follow-up|31
2156583|NCT01218308|3771184|FG000|Overall Study|Other|14
2156584|NCT01218308|3771185|FG001|Overall Study|Other|21
2156585|NCT01218438|3771200|FG000|Epoch 1|Physician Decision|2
2156586|NCT01218438|3771200|FG000|Epoch 1|Adverse Event|1
2156587|NCT01218438|3771200|FG000|Epoch 3|Withdrawal by Subject|3
2156588|NCT01218438|3771200|FG000|Epoch 3|Adverse Event|1
2156589|NCT01218438|3771200|FG000|Epoch 4|Physician Decision|1
2156590|NCT01218438|3771200|FG000|Epoch 4|Withdrawal by Subject|2
2156591|NCT01218477|3771278|FG000|Overall Study|Disease progression|2
2156592|NCT01218477|3771279|FG001|Overall Study|Disease progression|3
2156593|NCT01218477|3771280|FG002|Overall Study|Disease progression|6
2156594|NCT01218477|3771281|FG003|Overall Study|Disease progression|2
2156595|NCT01218477|3771278|FG000|Overall Study|Study drug toxicity|0
2156596|NCT01218477|3771279|FG001|Overall Study|Study drug toxicity|2
2156597|NCT01218477|3771280|FG002|Overall Study|Study drug toxicity|5
2156598|NCT01218477|3771281|FG003|Overall Study|Study drug toxicity|0
2156599|NCT01218477|3771278|FG000|Overall Study|No longer meets study criteria|1
2156600|NCT01218477|3771279|FG001|Overall Study|No longer meets study criteria|0
2156601|NCT01218477|3771280|FG002|Overall Study|No longer meets study criteria|0
2156602|NCT01218477|3771281|FG003|Overall Study|No longer meets study criteria|0
2156603|NCT01218477|3771278|FG000|Overall Study|Withdrawal by Subject|0
2156604|NCT01218477|3771279|FG001|Overall Study|Withdrawal by Subject|0
2156605|NCT01218477|3771280|FG002|Overall Study|Withdrawal by Subject|1
2156606|NCT01218477|3771281|FG003|Overall Study|Withdrawal by Subject|0
2156607|NCT01218477|3771278|FG000|Overall Study|Prepared for cell transplantation|0
2156608|NCT01218477|3771279|FG001|Overall Study|Prepared for cell transplantation|1
2156609|NCT01218477|3771280|FG002|Overall Study|Prepared for cell transplantation|1
2156610|NCT01218477|3771281|FG003|Overall Study|Prepared for cell transplantation|0
2156611|NCT01218477|3771278|FG000|Overall Study|Administrative reason by sponsor|0
2156612|NCT01218477|3771279|FG001|Overall Study|Administrative reason by sponsor|0
2156613|NCT01218477|3771280|FG002|Overall Study|Administrative reason by sponsor|1
2156614|NCT01218477|3771281|FG003|Overall Study|Administrative reason by sponsor|0
2156615|NCT01218477|3771278|FG000|Overall Study|Maximum clinical benefit|0
2156616|NCT01218477|3771279|FG001|Overall Study|Maximum clinical benefit|2
2156617|NCT01218477|3771280|FG002|Overall Study|Maximum clinical benefit|0
2156618|NCT01218477|3771281|FG003|Overall Study|Maximum clinical benefit|0
2156619|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Death|2
2156620|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Death|1
2156621|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Death|0
2156622|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Death|0
2156623|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
2156624|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3
2156625|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
2156626|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
2156627|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2
2156628|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2
2156629|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0
2156630|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0
2156631|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2
2156632|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
2156633|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
2156634|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
2156635|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17
2156636|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15
2156637|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
2156638|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
2156639|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
2156640|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1
2156641|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
2156642|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
2156643|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
2156644|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1
2156645|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
2156646|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
2156647|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
2156648|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3
2156649|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
2156650|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
2156651|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Other|3
2156652|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Other|4
2156653|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Other|0
2156654|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Other|0
2156655|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
2156656|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1
2156657|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
2156658|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
2156659|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2
2156660|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3
2156661|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
2156662|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
2156663|NCT01218516|3771297|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
2156664|NCT01218516|3771298|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
2156665|NCT01218516|3771299|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
2156666|NCT01218516|3771300|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
2156667|NCT01218594|3771315|FG000|Overall Study|Death|1
2156668|NCT01218594|3771315|FG000|Overall Study|Withdrawal by Subject|3
2156669|NCT01218594|3771315|FG000|Overall Study|Adverse Event|2
2156670|NCT01218594|3771315|FG000|Overall Study|Physician Decision|6
2156671|NCT01218646|3771323|FG000|Overall Study|Adverse Event|0
2156672|NCT01218646|3771324|FG001|Overall Study|Adverse Event|0
2156673|NCT01218646|3771325|FG002|Overall Study|Adverse Event|1
2156674|NCT01218646|3771326|FG003|Overall Study|Adverse Event|0
2156675|NCT01218646|3771323|FG000|Overall Study|Lost to Follow-up|1
2156676|NCT01218646|3771324|FG001|Overall Study|Lost to Follow-up|0
2156677|NCT01218646|3771325|FG002|Overall Study|Lost to Follow-up|0
2156678|NCT01218646|3771326|FG003|Overall Study|Lost to Follow-up|0
2156679|NCT01218646|3771323|FG000|Overall Study|Protocol Violation|0
2156680|NCT01218646|3771324|FG001|Overall Study|Protocol Violation|0
2156681|NCT01218646|3771325|FG002|Overall Study|Protocol Violation|1
2156682|NCT01218646|3771326|FG003|Overall Study|Protocol Violation|1
2156683|NCT01218659|3771338|FG000|18-Month Randomized Period|Withdrawal by Subject|2
2156684|NCT01218659|3771339|FG001|18-Month Randomized Period|Withdrawal by Subject|3
2156685|NCT01218659|3771340|FG002|18-Month Randomized Period|Withdrawal by Subject|0
2156686|NCT01218659|3771338|FG000|18-Month Randomized Period|Did not receive study drug|0
2156687|NCT01218659|3771339|FG001|18-Month Randomized Period|Did not receive study drug|3
2156688|NCT01218659|3771340|FG002|18-Month Randomized Period|Did not receive study drug|0
2156689|NCT01218659|3771338|FG000|12-Month OLE|Withdrawal by Subject|0
2156690|NCT01218659|3771339|FG001|12-Month OLE|Withdrawal by Subject|0
2156691|NCT01218659|3771340|FG002|12-Month OLE|Withdrawal by Subject|2
2293325|NCT02525744|3987607|FG001|Period 3|Adverse Event|1
2293326|NCT02525744|3987608|FG002|Period 3|Adverse Event|0
2293327|NCT02525744|3987609|FG003|Period 3|Adverse Event|0
2293328|NCT02525744|3987606|FG000|Period 4|Withdrawal by Subject|1
2293329|NCT02525744|3987607|FG001|Period 4|Withdrawal by Subject|0
2293330|NCT02525744|3987608|FG002|Period 4|Withdrawal by Subject|0
2293331|NCT02525744|3987609|FG003|Period 4|Withdrawal by Subject|0
2293332|NCT02525744|3987606|FG000|Period 5|Physician Decision|1
2293333|NCT02525744|3987607|FG001|Period 5|Physician Decision|0
2293334|NCT02525744|3987608|FG002|Period 5|Physician Decision|0
2293335|NCT02525744|3987609|FG003|Period 5|Physician Decision|0
2293336|NCT02525861|3987621|FG000|Overall Study|Adverse Event|1
2293337|NCT02525861|3987622|FG001|Overall Study|Adverse Event|0
2293338|NCT02525861|3987621|FG000|Overall Study|Withdrawal by Subject|0
2293339|NCT02525861|3987622|FG001|Overall Study|Withdrawal by Subject|1
2293340|NCT02525861|3987621|FG000|Overall Study|Physician Decision|0
2293341|NCT02525861|3987622|FG001|Overall Study|Physician Decision|1
2293342|NCT02525874|3987630|FG000|Overall Study|Other|1
2293343|NCT02525874|3987630|FG000|Overall Study|Investigator Decision|1
2293344|NCT02525874|3987630|FG000|Overall Study|Consent withdrawn|22
2293345|NCT02525874|3987630|FG000|Overall Study|Non-compliance with study drug|3
2293346|NCT02525874|3987630|FG000|Overall Study|Adverse Event|17
2293347|NCT02525874|3987630|FG000|Overall Study|Lost to Follow-up|7
2293348|NCT02525874|3987630|FG000|Overall Study|Disease progression, defined by protocol|2
2293349|NCT02525874|3987630|FG000|Overall Study|Disease relapse|4
2293350|NCT02525874|3987630|FG000|Overall Study|Alternative Treatment for MS|2
2293351|NCT02525874|3987630|FG000|Overall Study|New lesions in Brain|1
2293352|NCT02526160|3987636|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0
2321236|NCT02957682|4035675|FG001|Overall Study|Adverse Event|67
2156692|NCT01218659|3771338|FG000|12-Month OLE|Physician Decision|0
2156693|NCT01218659|3771339|FG001|12-Month OLE|Physician Decision|0
2156694|NCT01218659|3771340|FG002|12-Month OLE|Physician Decision|1
2156695|NCT01218659|3771338|FG000|12-Month OLE|Lost to Follow-up|0
2156696|NCT01218659|3771339|FG001|12-Month OLE|Lost to Follow-up|0
2293353|NCT02526160|3987637|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1
2293354|NCT02526160|3987636|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0
2293355|NCT02526160|3987637|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1
2293356|NCT02526160|3987636|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3
2293357|NCT02526160|3987637|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3
2293358|NCT02526160|3987636|FG000|Open-Label Treatment Extension Period I|Death|0
2293359|NCT02526160|3987637|FG001|Open-Label Treatment Extension Period I|Death|1
2293360|NCT02526160|3987636|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3
2293361|NCT02526160|3987637|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1
2293362|NCT02526160|3987636|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0
2293363|NCT02526160|3987637|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1
2293364|NCT02526160|3987636|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0
2293365|NCT02526160|3987637|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1
2293366|NCT02526160|3987636|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1
2293367|NCT02526160|3987637|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0
2293368|NCT02526212|3987650|FG000|Overall Study|Incarceration|1
2293369|NCT02526212|3987651|FG001|Overall Study|Incarceration|0
2293370|NCT02526212|3987650|FG000|Overall Study|Lost to Follow-up|1
2293371|NCT02526212|3987651|FG001|Overall Study|Lost to Follow-up|0
2293372|NCT02526212|3987650|FG000|Overall Study|Death|0
2293373|NCT02526212|3987651|FG001|Overall Study|Death|1
2293374|NCT02526290|3987677|FG000|Overall Study|Adverse Event|3
2293375|NCT02526290|3987677|FG000|Overall Study|Withdrawal by Subject|4
2293376|NCT02526290|3987677|FG000|Overall Study|Physician Decision|1
2293377|NCT02526524|3987687|FG000|Overall Study|Withdrawal by Subject|3
2293378|NCT02526524|3987688|FG001|Overall Study|Withdrawal by Subject|3
2293379|NCT02526524|3987689|FG002|Overall Study|Withdrawal by Subject|6
2293380|NCT02526524|3987690|FG003|Overall Study|Withdrawal by Subject|1
2293381|NCT02526524|3987691|FG004|Overall Study|Withdrawal by Subject|9
2293382|NCT02526524|3987692|FG005|Overall Study|Withdrawal by Subject|5
2293383|NCT02526524|3987687|FG000|Overall Study|Adverse Event|3
2293384|NCT02526524|3987688|FG001|Overall Study|Adverse Event|2
2293385|NCT02526524|3987689|FG002|Overall Study|Adverse Event|4
2293386|NCT02526524|3987690|FG003|Overall Study|Adverse Event|2
2293387|NCT02526524|3987691|FG004|Overall Study|Adverse Event|6
2293388|NCT02526524|3987692|FG005|Overall Study|Adverse Event|8
2293389|NCT02526524|3987687|FG000|Overall Study|Lost to Follow-up|2
2293390|NCT02526524|3987688|FG001|Overall Study|Lost to Follow-up|3
2293391|NCT02526524|3987689|FG002|Overall Study|Lost to Follow-up|8
2293392|NCT02526524|3987690|FG003|Overall Study|Lost to Follow-up|1
2293393|NCT02526524|3987691|FG004|Overall Study|Lost to Follow-up|2
2293394|NCT02526524|3987692|FG005|Overall Study|Lost to Follow-up|5
2293395|NCT02526524|3987687|FG000|Overall Study|Protocol Violation|3
2293396|NCT02526524|3987688|FG001|Overall Study|Protocol Violation|1
2293397|NCT02526524|3987689|FG002|Overall Study|Protocol Violation|5
2293398|NCT02526524|3987690|FG003|Overall Study|Protocol Violation|3
2293399|NCT02526524|3987691|FG004|Overall Study|Protocol Violation|4
2293400|NCT02526524|3987692|FG005|Overall Study|Protocol Violation|3
2293401|NCT02526524|3987687|FG000|Overall Study|Loss of Glucose Control|0
2293402|NCT02526524|3987688|FG001|Overall Study|Loss of Glucose Control|0
2293403|NCT02526524|3987689|FG002|Overall Study|Loss of Glucose Control|3
2293404|NCT02526524|3987690|FG003|Overall Study|Loss of Glucose Control|0
2293405|NCT02526524|3987691|FG004|Overall Study|Loss of Glucose Control|2
2293406|NCT02526524|3987692|FG005|Overall Study|Loss of Glucose Control|0
2293407|NCT02526524|3987687|FG000|Overall Study|Physician Decision|0
2293408|NCT02526524|3987688|FG001|Overall Study|Physician Decision|0
2293409|NCT02526524|3987689|FG002|Overall Study|Physician Decision|0
2293410|NCT02526524|3987690|FG003|Overall Study|Physician Decision|0
2293411|NCT02526524|3987691|FG004|Overall Study|Physician Decision|1
2293412|NCT02526524|3987692|FG005|Overall Study|Physician Decision|0
2293413|NCT02526524|3987687|FG000|Overall Study|Sponsor Decision|1
2293414|NCT02526524|3987688|FG001|Overall Study|Sponsor Decision|0
2293415|NCT02526524|3987689|FG002|Overall Study|Sponsor Decision|0
2293416|NCT02526524|3987690|FG003|Overall Study|Sponsor Decision|0
2293417|NCT02526524|3987691|FG004|Overall Study|Sponsor Decision|0
2293418|NCT02526524|3987692|FG005|Overall Study|Sponsor Decision|0
2293419|NCT02526550|3987706|FG000|Overall Study|Lost to Follow-up|1
2293420|NCT02526693|3987745|FG000|Overall Study|Physician Decision|3
2293421|NCT02526693|3987746|FG001|Overall Study|Physician Decision|1
2293422|NCT02527148|3987758|FG000|Overall Study|Did not receive study intervention|1
2293423|NCT02527148|3987759|FG001|Overall Study|Did not receive study intervention|0
2293424|NCT02527161|3987767|FG000|Overall Study|Failed MRI|52
2293425|NCT02527161|3987767|FG000|Overall Study|Withdrawal by Subject|19
2293426|NCT02527161|3987767|FG000|Overall Study|Delay in or unfit for surgery|16
2293427|NCT02527161|3987767|FG000|Overall Study|MRI contraindication|6
2293428|NCT02527161|3987767|FG000|Overall Study|Consent violation|4
2293429|NCT02527161|3987767|FG000|Overall Study|Only Recruited to Part A|27
2156697|NCT01218659|3771340|FG002|12-Month OLE|Lost to Follow-up|1
2156698|NCT01218659|3771338|FG000|12-Month OLE|Pregnancy|0
2156699|NCT01218659|3771339|FG001|12-Month OLE|Pregnancy|0
2156700|NCT01218659|3771340|FG002|12-Month OLE|Pregnancy|1
2156701|NCT01218659|3771338|FG000|12-Month OLE|Lack of Efficacy|0
2156702|NCT01218659|3771339|FG001|12-Month OLE|Lack of Efficacy|0
2156703|NCT01218659|3771340|FG002|12-Month OLE|Lack of Efficacy|1
2156704|NCT01218659|3771338|FG000|12-Month OLE|Declined to participate in the OLE|0
2156705|NCT01218659|3771339|FG001|12-Month OLE|Declined to participate in the OLE|0
2156706|NCT01218659|3771340|FG002|12-Month OLE|Declined to participate in the OLE|4
2156707|NCT01218802|3771360|FG000|Overall Study|Lost to Follow-up|5
2156708|NCT01218802|3771361|FG001|Overall Study|Lost to Follow-up|6
2156709|NCT01218802|3771360|FG000|Overall Study|Withdrawal by Subject|3
2156710|NCT01218802|3771361|FG001|Overall Study|Withdrawal by Subject|10
2156711|NCT01218802|3771360|FG000|Overall Study|Adverse Event|0
2156712|NCT01218802|3771361|FG001|Overall Study|Adverse Event|2
2156713|NCT01218802|3771360|FG000|Overall Study|Incarcerated|2
2156714|NCT01218802|3771361|FG001|Overall Study|Incarcerated|0
2156715|NCT01218867|3771378|FG000|Overall Study|Death during treatment|0
2156716|NCT01218867|3771379|FG001|Overall Study|Death during treatment|0
2156717|NCT01218867|3771380|FG002|Overall Study|Death during treatment|0
2156718|NCT01218867|3771381|FG003|Overall Study|Death during treatment|0
2156719|NCT01218867|3771382|FG004|Overall Study|Death during treatment|0
2156720|NCT01218867|3771383|FG005|Overall Study|Death during treatment|0
2156721|NCT01218867|3771384|FG006|Overall Study|Death during treatment|1
2156722|NCT01218867|3771385|FG007|Overall Study|Death during treatment|0
2156723|NCT01218867|3771386|FG008|Overall Study|Death during treatment|0
2156724|NCT01218867|3771387|FG009|Overall Study|Death during treatment|0
2156725|NCT01218867|3771388|FG010|Overall Study|Death during treatment|0
2156726|NCT01219933|3771518|FG000|Overall Study|Adverse Event|8
2156727|NCT01219933|3771518|FG000|Overall Study|No LDA reached|5
2156728|NCT01219933|3771518|FG000|Overall Study|No LDA maintained|7
2156729|NCT01219933|3771518|FG000|Overall Study|Lost to Follow-up|3
2156730|NCT01219933|3771518|FG000|Overall Study|GC free|1
2156731|NCT01219933|3771518|FG000|Overall Study|Withdrawal by Subject|5
2156732|NCT01219933|3771518|FG000|Overall Study|Protocol Violation|8
2156733|NCT01219933|3771518|FG000|Overall Study|Lack of Efficacy|1
2156734|NCT01219959|3771525|FG000|Overall Study|Adverse Event|6
2156735|NCT01219959|3771526|FG001|Overall Study|Adverse Event|14
2156736|NCT01219959|3771525|FG000|Overall Study|Physician Decision|0
2156737|NCT01219959|3771526|FG001|Overall Study|Physician Decision|4
2156738|NCT01219959|3771525|FG000|Overall Study|Withdrawal by Subject|0
2293430|NCT02527161|3987767|FG000|Overall Study|Physician Decision|1
2293431|NCT02527161|3987767|FG000|Overall Study|Adverse Event|1
2293432|NCT02527161|3987767|FG000|Overall Study|Lost to Follow-up|6
2293433|NCT02527343|3987783|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1
2293434|NCT02527343|3987784|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0
2293435|NCT02527343|3987785|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0
2293436|NCT02527343|3987786|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0
2293437|NCT02527343|3987787|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0
2293438|NCT02527343|3987788|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0
2293439|NCT02527343|3987783|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1
2293440|NCT02527343|3987784|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
2293441|NCT02527343|3987785|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
2293442|NCT02527343|3987786|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
2293443|NCT02527343|3987787|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
2293444|NCT02527343|3987788|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
2293445|NCT02527343|3987783|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
2293446|NCT02527343|3987784|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4
2293447|NCT02527343|3987785|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
2293448|NCT02527343|3987786|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
2293449|NCT02527343|3987787|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
2293450|NCT02527343|3987788|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
2293451|NCT02527343|3987783|FG000|RT Period: Weeks 1 to 52|Other|4
2293452|NCT02527343|3987784|FG001|RT Period: Weeks 1 to 52|Other|3
2293453|NCT02527343|3987785|FG002|RT Period: Weeks 1 to 52|Other|0
2293454|NCT02527343|3987786|FG003|RT Period: Weeks 1 to 52|Other|0
2293455|NCT02527343|3987787|FG004|RT Period: Weeks 1 to 52|Other|0
2293456|NCT02527343|3987788|FG005|RT Period: Weeks 1 to 52|Other|0
2293457|NCT02527343|3987783|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
2293458|NCT02527343|3987784|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
2293459|NCT02527343|3987785|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1
2293460|NCT02527343|3987786|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
2293461|NCT02527343|3987787|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
2156739|NCT01219959|3771526|FG001|Overall Study|Withdrawal by Subject|2
2156740|NCT01219959|3771525|FG000|Overall Study|Renal Transplantation|0
2156741|NCT01219959|3771526|FG001|Overall Study|Renal Transplantation|3
2156742|NCT01219959|3771525|FG000|Overall Study|Other|1
2156743|NCT01219959|3771526|FG001|Overall Study|Other|0
2156744|NCT01219985|3771532|FG000|Overall Study|Physician Decision|20
2156745|NCT01220024|3771540|FG000|Overall Study|Lost to Follow-up|1
2156746|NCT01220024|3771541|FG001|Overall Study|Lost to Follow-up|1
2156747|NCT01220128|3771554|FG000|Overall Study|Progressive disease|0
2156748|NCT01220128|3771555|FG001|Overall Study|Progressive disease|0
2156749|NCT01220128|3771556|FG002|Overall Study|Progressive disease|2
2156750|NCT01220128|3771557|FG003|Overall Study|Progressive disease|0
2156751|NCT01220128|3771558|FG004|Overall Study|Progressive disease|0
2156752|NCT01220128|3771559|FG005|Overall Study|Progressive disease|0
2156753|NCT01220128|3771560|FG006|Overall Study|Progressive disease|0
2156754|NCT01220128|3771554|FG000|Overall Study|Sponsor study termination|0
2156755|NCT01220128|3771555|FG001|Overall Study|Sponsor study termination|1
2156756|NCT01220128|3771556|FG002|Overall Study|Sponsor study termination|0
2156757|NCT01220128|3771557|FG003|Overall Study|Sponsor study termination|0
2156758|NCT01220128|3771558|FG004|Overall Study|Sponsor study termination|0
2156759|NCT01220128|3771559|FG005|Overall Study|Sponsor study termination|0
2156760|NCT01220128|3771560|FG006|Overall Study|Sponsor study termination|1
2156761|NCT01220128|3771554|FG000|Overall Study|Adverse event, serious fatal|2
2156762|NCT01220128|3771555|FG001|Overall Study|Adverse event, serious fatal|0
2156763|NCT01220128|3771556|FG002|Overall Study|Adverse event, serious fatal|0
2156764|NCT01220128|3771557|FG003|Overall Study|Adverse event, serious fatal|0
2156765|NCT01220128|3771558|FG004|Overall Study|Adverse event, serious fatal|0
2156766|NCT01220128|3771559|FG005|Overall Study|Adverse event, serious fatal|0
2156767|NCT01220128|3771560|FG006|Overall Study|Adverse event, serious fatal|1
2156768|NCT01220128|3771554|FG000|Overall Study|Adverse event, non-fatal|1
2156769|NCT01220128|3771555|FG001|Overall Study|Adverse event, non-fatal|0
2156770|NCT01220128|3771556|FG002|Overall Study|Adverse event, non-fatal|0
2156771|NCT01220128|3771557|FG003|Overall Study|Adverse event, non-fatal|0
2156772|NCT01220128|3771558|FG004|Overall Study|Adverse event, non-fatal|0
2156773|NCT01220128|3771559|FG005|Overall Study|Adverse event, non-fatal|0
2156774|NCT01220128|3771560|FG006|Overall Study|Adverse event, non-fatal|3
2293462|NCT02527343|3987788|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
2293463|NCT02527343|3987783|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0
2293464|NCT02527343|3987784|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0
2293465|NCT02527343|3987785|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0
2293466|NCT02527343|3987786|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2
2293467|NCT02527343|3987787|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0
2293468|NCT02527343|3987788|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0
2293469|NCT02527343|3987783|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
2293470|NCT02527343|3987784|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
2293471|NCT02527343|3987785|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
2293472|NCT02527343|3987786|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
2293473|NCT02527343|3987787|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1
2293474|NCT02527343|3987788|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
2293475|NCT02527343|3987783|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
2293476|NCT02527343|3987784|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
2293477|NCT02527343|3987785|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
2293478|NCT02527343|3987786|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
2293479|NCT02527343|3987787|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3
2293480|NCT02527343|3987788|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1
2293481|NCT02527343|3987783|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
2293482|NCT02527343|3987784|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
2293483|NCT02527343|3987785|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
2293484|NCT02527343|3987786|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
2293485|NCT02527343|3987787|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2
2293486|NCT02527343|3987788|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1
2293487|NCT02527343|3987783|FG000|OLE Period-Year 1: Week 53 to 104|Other|0
2293488|NCT02527343|3987784|FG001|OLE Period-Year 1: Week 53 to 104|Other|0
2293489|NCT02527343|3987785|FG002|OLE Period-Year 1: Week 53 to 104|Other|0
2293490|NCT02527343|3987786|FG003|OLE Period-Year 1: Week 53 to 104|Other|0
2293491|NCT02527343|3987787|FG004|OLE Period-Year 1: Week 53 to 104|Other|5
2293492|NCT02527343|3987788|FG005|OLE Period-Year 1: Week 53 to 104|Other|7
2293493|NCT02527343|3987783|FG000|OLE Period-Year 2: Week 105 to 156|Other|0
2293494|NCT02527343|3987784|FG001|OLE Period-Year 2: Week 105 to 156|Other|0
2293495|NCT02527343|3987785|FG002|OLE Period-Year 2: Week 105 to 156|Other|0
2293496|NCT02527343|3987786|FG003|OLE Period-Year 2: Week 105 to 156|Other|0
2293497|NCT02527343|3987787|FG004|OLE Period-Year 2: Week 105 to 156|Other|1
2293498|NCT02527343|3987788|FG005|OLE Period-Year 2: Week 105 to 156|Other|2
2293499|NCT02527343|3987783|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
2293500|NCT02527343|3987784|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
2293501|NCT02527343|3987785|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
2293502|NCT02527343|3987786|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
2293503|NCT02527343|3987787|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1
2293504|NCT02527343|3987788|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
2293505|NCT02527343|3987783|FG000|PT Follow-up: Weeks 104 to 169|Other|0
2156775|NCT01220128|3771554|FG000|Overall Study|Other|0
2156776|NCT01220128|3771555|FG001|Overall Study|Other|0
2156777|NCT01220128|3771556|FG002|Overall Study|Other|1
2156778|NCT01220128|3771557|FG003|Overall Study|Other|0
2156779|NCT01220128|3771558|FG004|Overall Study|Other|0
2156780|NCT01220128|3771559|FG005|Overall Study|Other|0
2156781|NCT01220128|3771560|FG006|Overall Study|Other|0
2156782|NCT01220128|3771554|FG000|Overall Study|Consent withdrawn by subject|1
2156783|NCT01220128|3771555|FG001|Overall Study|Consent withdrawn by subject|0
2156784|NCT01220128|3771556|FG002|Overall Study|Consent withdrawn by subject|0
2156785|NCT01220128|3771557|FG003|Overall Study|Consent withdrawn by subject|0
2156786|NCT01220128|3771558|FG004|Overall Study|Consent withdrawn by subject|0
2156787|NCT01220128|3771559|FG005|Overall Study|Consent withdrawn by subject|0
2156788|NCT01220128|3771560|FG006|Overall Study|Consent withdrawn by subject|0
2156789|NCT01220167|3771580|FG000|Period 3|Urine positive for substance abuse|0
2156790|NCT01220167|3771581|FG001|Period 3|Urine positive for substance abuse|1
2156791|NCT01220167|3771582|FG002|Period 3|Urine positive for substance abuse|0
2156792|NCT01220180|3771591|FG000|Overall Study|Lost to Follow-up|76
2156793|NCT01220180|3771591|FG000|Overall Study|Other|72
2156794|NCT01220180|3771591|FG000|Overall Study|Adverse Event|35
2156795|NCT01220180|3771591|FG000|Overall Study|Lack of Efficacy|22
2156796|NCT01220180|3771591|FG000|Overall Study|Death|1
2156797|NCT01220180|3771591|FG000|Overall Study|Randomized but not treated|1
2156798|NCT01220297|3771597|FG000|Overall Study|Death|2
2156799|NCT01220297|3771597|FG000|Overall Study|Lost to Follow-up|1
2156800|NCT01220401|3771603|FG000|Overall Study|Withdrawal by Subject|2
2156801|NCT01220401|3771603|FG000|Overall Study|Protocol Violation|1
2156802|NCT01220414|3771609|FG000|Overall Study|Withdrawal by Subject|1
2156803|NCT01220414|3771610|FG001|Overall Study|Withdrawal by Subject|0
2156804|NCT01220414|3771611|FG002|Overall Study|Withdrawal by Subject|0
2156805|NCT01220414|3771612|FG003|Overall Study|Withdrawal by Subject|1
2156806|NCT01220557|3771634|FG000|Overall Study|Lost to Follow-up|5
2156807|NCT01220557|3771635|FG001|Overall Study|Lost to Follow-up|3
2156808|NCT01220557|3771634|FG000|Overall Study|attended less than 6 lessons|1
2156809|NCT01220557|3771635|FG001|Overall Study|attended less than 6 lessons|2
2156810|NCT01220609|3771641|FG000|Overall Study|Ineligible-Wrong primary cancer site|1
2156811|NCT01220609|3771641|FG000|Overall Study|Ineligible- Wrong cell type|1
2156812|NCT01220609|3771641|FG000|Overall Study|Ineligible-Never treated|1
2156813|NCT01220856|3771680|FG000|Overall Study|graft loss|3
2156814|NCT01220856|3771681|FG001|Overall Study|graft loss|3
2156815|NCT01220856|3771680|FG000|Overall Study|Lost to Follow-up|1
2156816|NCT01220856|3771681|FG001|Overall Study|Lost to Follow-up|0
2156817|NCT01220999|3771703|FG000|Overall Study|Progressive disease|0
2156818|NCT01220999|3771704|FG001|Overall Study|Progressive disease|0
2156819|NCT01220999|3771705|FG002|Overall Study|Progressive disease|1
2156820|NCT01220999|3771706|FG003|Overall Study|Progressive disease|0
2156821|NCT01220999|3771707|FG004|Overall Study|Progressive disease|0
2156822|NCT01221090|3771723|FG000|Overall Study|Non-Compliant or Unable to Contact|15
2156823|NCT01221090|3771724|FG001|Overall Study|Non-Compliant or Unable to Contact|12
2156824|NCT01221090|3771725|FG002|Overall Study|Non-Compliant or Unable to Contact|15
2156825|NCT01221090|3771726|FG003|Overall Study|Non-Compliant or Unable to Contact|20
2156826|NCT01221090|3771723|FG000|Overall Study|Withdrawal by Subject|0
2156827|NCT01221090|3771724|FG001|Overall Study|Withdrawal by Subject|22
2156828|NCT01221090|3771725|FG002|Overall Study|Withdrawal by Subject|27
2293506|NCT02527343|3987784|FG001|PT Follow-up: Weeks 104 to 169|Other|0
2293507|NCT02527343|3987785|FG002|PT Follow-up: Weeks 104 to 169|Other|0
2293508|NCT02527343|3987786|FG003|PT Follow-up: Weeks 104 to 169|Other|0
2293509|NCT02527343|3987787|FG004|PT Follow-up: Weeks 104 to 169|Other|0
2293510|NCT02527343|3987788|FG005|PT Follow-up: Weeks 104 to 169|Other|1
2293511|NCT02527421|3987805|FG000|Overall Study|Withdrawal by Subject|1
2293512|NCT02527421|3987806|FG001|Overall Study|Withdrawal by Subject|0
2293513|NCT02528188|3987843|FG000|Overall Study|Adverse Event|23
2293514|NCT02528188|3987844|FG001|Overall Study|Adverse Event|22
2293515|NCT02528188|3987845|FG002|Overall Study|Adverse Event|8
2293516|NCT02528188|3987843|FG000|Overall Study|Protocol Violation|4
2293517|NCT02528188|3987844|FG001|Overall Study|Protocol Violation|6
2293518|NCT02528188|3987845|FG002|Overall Study|Protocol Violation|4
2293519|NCT02528188|3987843|FG000|Overall Study|Lack of Efficacy|19
2293520|NCT02528188|3987844|FG001|Overall Study|Lack of Efficacy|21
2293521|NCT02528188|3987845|FG002|Overall Study|Lack of Efficacy|22
2293522|NCT02528188|3987843|FG000|Overall Study|Withdrawal by Subject|97
2293523|NCT02528188|3987844|FG001|Overall Study|Withdrawal by Subject|104
2293524|NCT02528188|3987845|FG002|Overall Study|Withdrawal by Subject|100
2293525|NCT02528188|3987843|FG000|Overall Study|Lost to Follow-up|25
2293526|NCT02528188|3987844|FG001|Overall Study|Lost to Follow-up|21
2293527|NCT02528188|3987845|FG002|Overall Study|Lost to Follow-up|31
2293528|NCT02528188|3987843|FG000|Overall Study|Death|4
2293529|NCT02528188|3987844|FG001|Overall Study|Death|4
2293530|NCT02528188|3987845|FG002|Overall Study|Death|0
2293531|NCT02528188|3987843|FG000|Overall Study|Other|89
2293532|NCT02528188|3987844|FG001|Overall Study|Other|91
2293533|NCT02528188|3987845|FG002|Overall Study|Other|74
2156829|NCT01221090|3771726|FG003|Overall Study|Withdrawal by Subject|2
2156830|NCT01221181|3771736|FG000|Overall Study|Lost to Follow-up|1
2156831|NCT01221233|3771764|FG000|Overall Study|Withdrawal by Subject|3
2293534|NCT02528188|3987843|FG000|Overall Study|Randomized but not treated|6
2293535|NCT02528188|3987844|FG001|Overall Study|Randomized but not treated|7
2156832|NCT01221233|3771765|FG001|Overall Study|Withdrawal by Subject|1
2156833|NCT01221272|3771771|FG000|Period 1|Adverse Event|2
2156834|NCT01221272|3771772|FG001|Period 1|Adverse Event|0
2156835|NCT01221272|3771771|FG000|Period 1|Consent Withdrawal|0
2293536|NCT02528188|3987845|FG002|Overall Study|Randomized but not treated|12
2293537|NCT02528214|3987855|FG000|Overall Study|Protocol Violation|0
2293538|NCT02528214|3987856|FG001|Overall Study|Protocol Violation|1
2293539|NCT02528214|3987855|FG000|Overall Study|Adverse Event|0
2293540|NCT02528214|3987856|FG001|Overall Study|Adverse Event|1
2293541|NCT02528214|3987855|FG000|Overall Study|Other than specified above|0
2293542|NCT02528214|3987856|FG001|Overall Study|Other than specified above|1
2293543|NCT02528253|3987868|FG000|Overall Study|Adverse Event|3
2293544|NCT02528253|3987869|FG001|Overall Study|Adverse Event|4
2293545|NCT02528253|3987870|FG002|Overall Study|Adverse Event|4
2293546|NCT02528253|3987871|FG003|Overall Study|Adverse Event|8
2293547|NCT02528253|3987872|FG004|Overall Study|Adverse Event|18
2293548|NCT02528253|3987868|FG000|Overall Study|Death|2
2293549|NCT02528253|3987869|FG001|Overall Study|Death|2
2293550|NCT02528253|3987870|FG002|Overall Study|Death|1
2293551|NCT02528253|3987871|FG003|Overall Study|Death|0
2293552|NCT02528253|3987872|FG004|Overall Study|Death|1
2293553|NCT02528253|3987868|FG000|Overall Study|Insufficient clinical response|7
2293554|NCT02528253|3987869|FG001|Overall Study|Insufficient clinical response|10
2293555|NCT02528253|3987870|FG002|Overall Study|Insufficient clinical response|13
2293556|NCT02528253|3987871|FG003|Overall Study|Insufficient clinical response|12
2293557|NCT02528253|3987872|FG004|Overall Study|Insufficient clinical response|16
2293558|NCT02528253|3987868|FG000|Overall Study|Lost to Follow-up|16
2293559|NCT02528253|3987869|FG001|Overall Study|Lost to Follow-up|9
2293560|NCT02528253|3987870|FG002|Overall Study|Lost to Follow-up|31
2293561|NCT02528253|3987871|FG003|Overall Study|Lost to Follow-up|16
2293562|NCT02528253|3987872|FG004|Overall Study|Lost to Follow-up|34
2293563|NCT02528253|3987868|FG000|Overall Study|Other|21
2293564|NCT02528253|3987869|FG001|Overall Study|Other|22
2293565|NCT02528253|3987870|FG002|Overall Study|Other|58
2293566|NCT02528253|3987871|FG003|Overall Study|Other|52
2293567|NCT02528253|3987872|FG004|Overall Study|Other|76
2293568|NCT02528253|3987868|FG000|Overall Study|Withdrawal by Subject|25
2293569|NCT02528253|3987869|FG001|Overall Study|Withdrawal by Subject|20
2293570|NCT02528253|3987870|FG002|Overall Study|Withdrawal by Subject|29
2293571|NCT02528253|3987871|FG003|Overall Study|Withdrawal by Subject|48
2293572|NCT02528253|3987872|FG004|Overall Study|Withdrawal by Subject|73
2293573|NCT02528253|3987868|FG000|Overall Study|Protocol Violation|1
2293574|NCT02528253|3987869|FG001|Overall Study|Protocol Violation|2
2293575|NCT02528253|3987870|FG002|Overall Study|Protocol Violation|4
2293576|NCT02528253|3987871|FG003|Overall Study|Protocol Violation|0
2293577|NCT02528253|3987872|FG004|Overall Study|Protocol Violation|4
2293578|NCT02528253|3987868|FG000|Overall Study|Withdrawn Due to Pregnancy|0
2293579|NCT02528253|3987869|FG001|Overall Study|Withdrawn Due to Pregnancy|1
2293580|NCT02528253|3987870|FG002|Overall Study|Withdrawn Due to Pregnancy|0
2293581|NCT02528253|3987871|FG003|Overall Study|Withdrawn Due to Pregnancy|0
2293582|NCT02528253|3987872|FG004|Overall Study|Withdrawn Due to Pregnancy|1
2293583|NCT02528305|3987903|FG000|Overall Study|Withdrawal by Subject|1
2293584|NCT02528305|3987903|FG000|Overall Study|Adverse Event|1
2293585|NCT02528305|3987903|FG000|Overall Study|Physician Decision|1
2293586|NCT02528331|3987930|FG000|Overall Study|Withdrawal by Subject|2
2293587|NCT02528357|3987953|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293588|NCT02528357|3987954|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1
2293589|NCT02528357|3987955|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293590|NCT02528357|3987956|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293591|NCT02528357|3987957|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293592|NCT02528357|3987958|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293593|NCT02528357|3987959|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293594|NCT02528357|3987960|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293595|NCT02528357|3987961|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293596|NCT02528357|3987962|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293597|NCT02528357|3987963|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293598|NCT02528357|3987964|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293599|NCT02528357|3987965|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293600|NCT02528357|3987966|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293601|NCT02528357|3987967|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293602|NCT02528357|3987968|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293603|NCT02528357|3987969|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293604|NCT02528357|3987970|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293605|NCT02528357|3987971|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
2293606|NCT02528357|3987953|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293607|NCT02528357|3987954|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293608|NCT02528357|3987955|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293609|NCT02528357|3987956|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
2156836|NCT01221272|3771772|FG001|Period 1|Consent Withdrawal|1
2156837|NCT01221272|3771771|FG000|Period 1|Significant Dosing Noncompliance|0
2156838|NCT01221272|3771772|FG001|Period 1|Significant Dosing Noncompliance|1
2156839|NCT01221272|3771771|FG000|Period 2|Adverse Event|0
2156840|NCT01221272|3771772|FG001|Period 2|Adverse Event|2
2156841|NCT01221285|3771781|FG000|Overall Study|Withdrawal by Subject|1
2156842|NCT01221350|3771800|FG000|Overall Study|Discontinued intervention (GERD)|1
2156843|NCT01221350|3771801|FG001|Overall Study|Discontinued intervention (GERD)|0
2156844|NCT01221350|3771800|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0
2156845|NCT01221350|3771801|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1
2156846|NCT01221350|3771800|FG000|Overall Study|Withdrawal by Subject|4
2156847|NCT01221350|3771801|FG001|Overall Study|Withdrawal by Subject|2
2156848|NCT01221363|3771811|FG000|Overall Study|Pregnancy|1
2156849|NCT01221363|3771812|FG001|Overall Study|Pregnancy|0
2156850|NCT01221363|3771811|FG000|Overall Study|Withdrawal by Subject|11
2156851|NCT01221363|3771812|FG001|Overall Study|Withdrawal by Subject|5
2156852|NCT01221597|3771829|FG000|Overall Study|Adverse Event|4
2156853|NCT01221597|3771830|FG001|Overall Study|Adverse Event|1
2156854|NCT01221597|3771829|FG000|Overall Study|Withdrawal by Subject|20
2156855|NCT01221597|3771830|FG001|Overall Study|Withdrawal by Subject|6
2156856|NCT01221597|3771829|FG000|Overall Study|Lost to Follow-up|6
2156857|NCT01221597|3771830|FG001|Overall Study|Lost to Follow-up|5
2156858|NCT01221597|3771829|FG000|Overall Study|Protocol Violation|1
2156859|NCT01221597|3771830|FG001|Overall Study|Protocol Violation|0
2156860|NCT01221597|3771829|FG000|Overall Study|Other|3
2156861|NCT01221597|3771830|FG001|Overall Study|Other|4
2156862|NCT01221597|3771829|FG000|Overall Study|Death|2
2156863|NCT01221597|3771830|FG001|Overall Study|Death|0
2156864|NCT01221623|3771839|FG000|Overall Study|Withdrawal by Subject|19
2156865|NCT01221623|3771840|FG001|Overall Study|Withdrawal by Subject|8
2156866|NCT01221623|3771839|FG000|Overall Study|Lost to Follow-up|7
2156867|NCT01221623|3771840|FG001|Overall Study|Lost to Follow-up|1
2156868|NCT01221623|3771839|FG000|Overall Study|Adverse Event|6
2156869|NCT01221623|3771840|FG001|Overall Study|Adverse Event|3
2156870|NCT01221623|3771839|FG000|Overall Study|Death|1
2156871|NCT01221623|3771840|FG001|Overall Study|Death|0
2156872|NCT01221623|3771839|FG000|Overall Study|Other|5
2156873|NCT01221623|3771840|FG001|Overall Study|Other|2
2156874|NCT01221727|3771848|FG000|Overall Study|Physician Decision|2
2156875|NCT01221727|3771849|FG001|Overall Study|Physician Decision|0
2156876|NCT01221727|3771848|FG000|Overall Study|Withdrawal by Subject|1
2156877|NCT01221727|3771849|FG001|Overall Study|Withdrawal by Subject|1
2156878|NCT01221753|3771861|FG000|Overall Study|Adverse Event|1
2156879|NCT01221948|3771873|FG000|Overall Study|Physician Decision|5
2156880|NCT01221948|3771873|FG000|Overall Study|Withdrawal by Subject|2
2156881|NCT01221948|3771873|FG000|Overall Study|not disclosed|2
2156882|NCT01221948|3771873|FG000|Overall Study|Death|1
2156883|NCT01221948|3771873|FG000|Overall Study|Protocol Violation|4
2156884|NCT01222078|3771877|FG000|Overall Study|Early termination of the study|1
2156885|NCT01222104|3771889|FG000|Overall Study|Lost to Follow-up|37
2156886|NCT01222104|3771889|FG000|Overall Study|Death|10
2156887|NCT01222403|3772002|FG000|Overall Study|Inappropriate enrollment|0
2156888|NCT01222403|3772003|FG001|Overall Study|Inappropriate enrollment|2
2156889|NCT01222416|3772011|FG000|Overall Study|ineligible;metastasis|3
2156890|NCT01222416|3772012|FG001|Overall Study|ineligible;metastasis|0
2156891|NCT01222416|3772011|FG000|Overall Study|Adverse Event|4
2156892|NCT01222416|3772012|FG001|Overall Study|Adverse Event|0
2156893|NCT01222416|3772011|FG000|Overall Study|Withdrawal by Subject|5
2156894|NCT01222416|3772012|FG001|Overall Study|Withdrawal by Subject|0
2156895|NCT01222416|3772011|FG000|Overall Study|scheduling|6
2156896|NCT01222416|3772012|FG001|Overall Study|scheduling|0
2156897|NCT01222416|3772011|FG000|Overall Study|missed view/scan|1
2156898|NCT01222416|3772012|FG001|Overall Study|missed view/scan|0
2156899|NCT01222416|3772011|FG000|Overall Study|Death|1
2156900|NCT01222416|3772012|FG001|Overall Study|Death|0
2156901|NCT01222507|3772031|FG000|Overall Study|Physician Decision|1
2156902|NCT01222507|3772031|FG000|Overall Study|Withdrawal by Subject|1
2156903|NCT01222520|3772037|FG000|Open-label run-in Period|Withdrawal by Subject|0
2156904|NCT01222520|3772038|FG001|Open-label run-in Period|Withdrawal by Subject|2
2156905|NCT01222520|3772037|FG000|Open-label run-in Period|Blood pressure criteria not met|0
2156906|NCT01222520|3772038|FG001|Open-label run-in Period|Blood pressure criteria not met|18
2156907|NCT01222520|3772037|FG000|Open-label run-in Period|Number of patients fulfilled|0
2156908|NCT01222520|3772038|FG001|Open-label run-in Period|Number of patients fulfilled|3
2156909|NCT01222520|3772037|FG000|Double-blind Period|Adverse Event|0
2156910|NCT01222520|3772038|FG001|Double-blind Period|Adverse Event|1
2156911|NCT01222520|3772037|FG000|Double-blind Period|Lack of Efficacy|0
2156912|NCT01222520|3772038|FG001|Double-blind Period|Lack of Efficacy|1
2156913|NCT01222520|3772037|FG000|Double-blind Period|Study medication stolen|1
2156914|NCT01222520|3772038|FG001|Double-blind Period|Study medication stolen|0
2156915|NCT01222533|3772044|FG000|Overall Study|Adverse Event|5
2156916|NCT01222533|3772044|FG000|Overall Study|Withdrawal by Subject|5
2156917|NCT01222533|3772044|FG000|Overall Study|Other|4
2156918|NCT01222715|3772072|FG000|Overall Study|Adverse Event|0
2156919|NCT01222715|3772073|FG001|Overall Study|Adverse Event|4
2156920|NCT01222715|3772072|FG000|Overall Study|Death|0
2156921|NCT01222715|3772073|FG001|Overall Study|Death|1
2156922|NCT01222715|3772072|FG000|Overall Study|Lack of Efficacy|22
2156923|NCT01222715|3772073|FG001|Overall Study|Lack of Efficacy|14
2156924|NCT01222715|3772072|FG000|Overall Study|Physician Decision|12
2156925|NCT01222715|3772073|FG001|Overall Study|Physician Decision|2
2156926|NCT01222715|3772072|FG000|Overall Study|Refusal of further protocol therapy|0
2156927|NCT01222715|3772073|FG001|Overall Study|Refusal of further protocol therapy|4
2156928|NCT01222715|3772072|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1
2156929|NCT01222715|3772073|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1
2156930|NCT01222715|3772072|FG000|Overall Study|Ineligible|0
2156931|NCT01222715|3772073|FG001|Overall Study|Ineligible|1
2156932|NCT01222715|3772072|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
2156933|NCT01222715|3772073|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
2156934|NCT01222767|3772079|FG000|Overall Study|Progressive disease|13
2156935|NCT01222767|3772079|FG000|Overall Study|Adverse Event|2
2156936|NCT01222767|3772079|FG000|Overall Study|Surgical resection|1
2156937|NCT01222767|3772079|FG000|Overall Study|Never treated|1
2156938|NCT01223027|3772103|FG000|Overall Study|Adverse Event|20
2156939|NCT01223027|3772104|FG001|Overall Study|Adverse Event|10
2156940|NCT01223027|3772103|FG000|Overall Study|Death|42
2156941|NCT01223027|3772104|FG001|Overall Study|Death|42
2156942|NCT01223027|3772103|FG000|Overall Study|Lost to Follow-up|2
2156943|NCT01223027|3772104|FG001|Overall Study|Lost to Follow-up|1
2156944|NCT01223027|3772103|FG000|Overall Study|Physician Decision|4
2156945|NCT01223027|3772104|FG001|Overall Study|Physician Decision|8
2156946|NCT01223027|3772103|FG000|Overall Study|Progressive Disease|167
2156947|NCT01223027|3772104|FG001|Overall Study|Progressive Disease|183
2156948|NCT01223027|3772103|FG000|Overall Study|Protocol Violation|2
2156949|NCT01223027|3772104|FG001|Overall Study|Protocol Violation|1
2156950|NCT01223027|3772103|FG000|Overall Study|Subject/guardian decicion|18
2156951|NCT01223027|3772104|FG001|Overall Study|Subject/guardian decicion|16
2156952|NCT01223027|3772103|FG000|Overall Study|New therapy for study indication|17
2156953|NCT01223027|3772104|FG001|Overall Study|New therapy for study indication|8
2156954|NCT01223027|3772103|FG000|Overall Study|Study terminated by sponsor|2
2156955|NCT01223027|3772104|FG001|Overall Study|Study terminated by sponsor|8
2156956|NCT01223183|3772112|FG000|Imaging Day 1|Physician Decision|0
2156957|NCT01223183|3772113|FG001|Imaging Day 1|Physician Decision|1
2156958|NCT01223183|3772112|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1
2156959|NCT01223183|3772113|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0
2156960|NCT01223183|3772112|FG000|Washout Period (5-24 Days)|Physician Decision|1
2156961|NCT01223183|3772113|FG001|Washout Period (5-24 Days)|Physician Decision|0
2156962|NCT01223196|3772122|FG000|Overall Study|Lost to Follow-up|2
2156963|NCT01223196|3772123|FG001|Overall Study|Lost to Follow-up|0
2156964|NCT01223196|3772122|FG000|Overall Study|Physician Decision|1
2156965|NCT01223196|3772123|FG001|Overall Study|Physician Decision|0
2156966|NCT01223196|3772122|FG000|Overall Study|Withdrawal by Subject|1
2156967|NCT01223196|3772123|FG001|Overall Study|Withdrawal by Subject|0
2156968|NCT01223235|3772131|FG000|Overall Study|Withdrawal by Subject|1
2156969|NCT01223365|3772150|FG000|Open-label Titration Period|Enrolled but not treated|1
2156970|NCT01223365|3772150|FG000|Open-label Titration Period|Adverse Event|23
2156971|NCT01223365|3772150|FG000|Open-label Titration Period|Lack of Efficacy|3
2156972|NCT01223365|3772150|FG000|Open-label Titration Period|Withdrawal by Subject|5
2156973|NCT01223365|3772150|FG000|Open-label Titration Period|Protocol Violation|1
2156974|NCT01223365|3772150|FG000|Open-label Titration Period|Lost to Follow-up|2
2156975|NCT01223365|3772150|FG000|Open-label Titration Period|Noncompliance with study drug admin|1
2156976|NCT01223365|3772150|FG000|Open-label Titration Period|Noncompliance with study procedures|2
2156977|NCT01223365|3772150|FG000|Open-label Titration Period|Starting physical therapy|1
2156978|NCT01223365|3772150|FG000|Open-label Treatment Period|Adverse Event|39
2156979|NCT01223365|3772150|FG000|Open-label Treatment Period|Lack of Efficacy|2
2156980|NCT01223365|3772150|FG000|Open-label Treatment Period|Withdrawal by Subject|19
2156981|NCT01223365|3772150|FG000|Open-label Treatment Period|Protocol Violation|15
2156982|NCT01223365|3772150|FG000|Open-label Treatment Period|Lost to Follow-up|7
2156983|NCT01223365|3772150|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7
2156984|NCT01223365|3772150|FG000|Open-label Treatment Period|Noncompliance with study procedures|6
2156985|NCT01223365|3772150|FG000|Open-label Treatment Period|Moved out of area|2
2156986|NCT01223365|3772150|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1
2156987|NCT01223365|3772150|FG000|Open-label Treatment Period|"Out of window"|1
2156988|NCT01223365|3772150|FG000|Open-label Treatment Period|Starting physical therapy|1
2156989|NCT01223365|3772150|FG000|Open-label Treatment Period|Physician Decision|2
2179319|NCT01393600|3804869|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
2179320|NCT01393600|3804870|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
2179321|NCT01393600|3804871|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
2179322|NCT01393600|3804868|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
2179323|NCT01393600|3804869|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
2179324|NCT01393600|3804870|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
2179325|NCT01393600|3804871|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
2179326|NCT01393600|3804868|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
2179327|NCT01393600|3804869|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
2156990|NCT01223404|3772180|FG000|First Intervention (1 Day)|Adverse Event|0
2156991|NCT01223404|3772181|FG001|First Intervention (1 Day)|Adverse Event|0
2156992|NCT01223404|3772182|FG002|First Intervention (1 Day)|Adverse Event|0
2156993|NCT01223404|3772183|FG003|First Intervention (1 Day)|Adverse Event|1
2156994|NCT01223404|3772184|FG004|First Intervention (1 Day)|Adverse Event|0
2156995|NCT01223404|3772185|FG005|First Intervention (1 Day)|Adverse Event|0
2156996|NCT01223404|3772180|FG000|Second Intervention (1 Day)|Adverse Event|1
2156997|NCT01223404|3772181|FG001|Second Intervention (1 Day)|Adverse Event|0
2156998|NCT01223404|3772182|FG002|Second Intervention (1 Day)|Adverse Event|0
2156999|NCT01223404|3772183|FG003|Second Intervention (1 Day)|Adverse Event|0
2157000|NCT01223404|3772184|FG004|Second Intervention (1 Day)|Adverse Event|0
2157001|NCT01223404|3772185|FG005|Second Intervention (1 Day)|Adverse Event|0
2157002|NCT01223404|3772180|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0
2157003|NCT01223404|3772181|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0
2157004|NCT01223404|3772182|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0
2157005|NCT01223404|3772183|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1
2157006|NCT01223404|3772184|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0
2157007|NCT01223404|3772185|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0
2157008|NCT01223937|3772221|FG000|Overall Study|Withdrawal by Subject|3
2157009|NCT01223937|3772222|FG001|Overall Study|Withdrawal by Subject|2
2157010|NCT01223937|3772221|FG000|Overall Study|Lost to Follow-up|1
2157011|NCT01223937|3772222|FG001|Overall Study|Lost to Follow-up|4
2157012|NCT01223937|3772221|FG000|Overall Study|Adverse Event|1
2157013|NCT01223937|3772222|FG001|Overall Study|Adverse Event|4
2157014|NCT01223937|3772221|FG000|Overall Study|Protocol Violation|8
2157015|NCT01223937|3772222|FG001|Overall Study|Protocol Violation|7
2157016|NCT01223937|3772221|FG000|Overall Study|Other|4
2157017|NCT01223937|3772222|FG001|Overall Study|Other|1
2157018|NCT01224158|3772253|FG000|Overall Study|Withdrawal by Subject|1
2157019|NCT01224158|3772254|FG001|Overall Study|Withdrawal by Subject|0
2157020|NCT01224171|3772262|FG000|Overall Study|Adverse Event|8
2157021|NCT01224171|3772263|FG001|Overall Study|Adverse Event|4
2157022|NCT01224171|3772262|FG000|Overall Study|Protocol Violation|0
2157023|NCT01224171|3772263|FG001|Overall Study|Protocol Violation|1
2157024|NCT01224171|3772262|FG000|Overall Study|Lack of Efficacy|5
2157025|NCT01224171|3772263|FG001|Overall Study|Lack of Efficacy|1
2157026|NCT01224171|3772262|FG000|Overall Study|Withdrawal of Consent|2
2157027|NCT01224171|3772263|FG001|Overall Study|Withdrawal of Consent|4
2157028|NCT01224171|3772262|FG000|Overall Study|Lost to Follow-up|0
2293610|NCT02528357|3987957|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293611|NCT02528357|3987958|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2
2293612|NCT02528357|3987959|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293613|NCT02528357|3987960|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
2293614|NCT02528357|3987961|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293615|NCT02528357|3987962|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293616|NCT02528357|3987963|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293617|NCT02528357|3987964|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293618|NCT02528357|3987965|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293619|NCT02528357|3987966|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293620|NCT02528357|3987967|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293621|NCT02528357|3987968|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293622|NCT02528357|3987969|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293623|NCT02528357|3987970|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293624|NCT02528357|3987971|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
2293625|NCT02528357|3987953|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293626|NCT02528357|3987954|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293627|NCT02528357|3987955|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
2293628|NCT02528357|3987956|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293629|NCT02528357|3987957|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3
2293630|NCT02528357|3987958|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293631|NCT02528357|3987959|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
2157029|NCT01224171|3772263|FG001|Overall Study|Lost to Follow-up|3
2157030|NCT01224431|3772285|FG000|Overall Study|not randomized|0
2157031|NCT01224431|3772286|FG001|Overall Study|not randomized|4
2157032|NCT01224431|3772285|FG000|Overall Study|no video record|0
2157033|NCT01224431|3772286|FG001|Overall Study|no video record|1
2157034|NCT01224639|3772310|FG000|Overall Study|Withdrawal by Subject|0
2157035|NCT01224639|3772311|FG001|Overall Study|Withdrawal by Subject|0
2157036|NCT01224639|3772312|FG002|Overall Study|Withdrawal by Subject|0
2157037|NCT01224639|3772313|FG003|Overall Study|Withdrawal by Subject|0
2157038|NCT01224639|3772314|FG004|Overall Study|Withdrawal by Subject|2
2157039|NCT01224639|3772315|FG005|Overall Study|Withdrawal by Subject|0
2157040|NCT01224639|3772316|FG006|Overall Study|Withdrawal by Subject|1
2157041|NCT01224639|3772317|FG007|Overall Study|Withdrawal by Subject|1
2157042|NCT01224639|3772310|FG000|Overall Study|Adverse Event|0
2157043|NCT01224639|3772311|FG001|Overall Study|Adverse Event|0
2157044|NCT01224639|3772312|FG002|Overall Study|Adverse Event|0
2157045|NCT01224639|3772313|FG003|Overall Study|Adverse Event|0
2157046|NCT01224639|3772314|FG004|Overall Study|Adverse Event|0
2293632|NCT02528357|3987960|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1
2293633|NCT02528357|3987961|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293634|NCT02528357|3987962|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293635|NCT02528357|3987963|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293636|NCT02528357|3987964|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293637|NCT02528357|3987965|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293638|NCT02528357|3987966|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293639|NCT02528357|3987967|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293640|NCT02528357|3987968|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293641|NCT02528357|3987969|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293642|NCT02528357|3987970|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293643|NCT02528357|3987971|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
2293644|NCT02528357|3987953|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293645|NCT02528357|3987954|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293646|NCT02528357|3987955|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293647|NCT02528357|3987956|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293648|NCT02528357|3987957|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1
2293649|NCT02528357|3987958|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293650|NCT02528357|3987959|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293651|NCT02528357|3987960|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293652|NCT02528357|3987961|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293653|NCT02528357|3987962|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293654|NCT02528357|3987963|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293655|NCT02528357|3987964|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293656|NCT02528357|3987965|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293657|NCT02528357|3987966|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293658|NCT02528357|3987967|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293659|NCT02528357|3987968|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293660|NCT02528357|3987969|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293661|NCT02528357|3987970|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293662|NCT02528357|3987971|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293663|NCT02528357|3987953|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293664|NCT02528357|3987954|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293665|NCT02528357|3987955|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293666|NCT02528357|3987956|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293667|NCT02528357|3987957|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293668|NCT02528357|3987958|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293669|NCT02528357|3987959|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293670|NCT02528357|3987960|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293671|NCT02528357|3987961|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293672|NCT02528357|3987962|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293673|NCT02528357|3987963|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293674|NCT02528357|3987964|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293675|NCT02528357|3987965|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293676|NCT02528357|3987966|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1
2293677|NCT02528357|3987967|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5
2293678|NCT02528357|3987968|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293679|NCT02528357|3987969|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293680|NCT02528357|3987970|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293681|NCT02528357|3987971|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
2293682|NCT02528357|3987953|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293683|NCT02528357|3987954|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293684|NCT02528357|3987955|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293685|NCT02528357|3987956|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293686|NCT02528357|3987957|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293687|NCT02528357|3987958|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293688|NCT02528357|3987959|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2157047|NCT01224639|3772315|FG005|Overall Study|Adverse Event|0
2157048|NCT01224639|3772316|FG006|Overall Study|Adverse Event|0
2157049|NCT01224639|3772317|FG007|Overall Study|Adverse Event|1
2157050|NCT01224782|3772344|FG000|Overall Study|Lost to Follow-up|177
2157051|NCT01224782|3772344|FG000|Overall Study|Withdrawal by Subject|16
2157052|NCT01224782|3772344|FG000|Overall Study|Death|14
2157053|NCT01224782|3772344|FG000|Overall Study|Improvement|13
2157054|NCT01224782|3772344|FG000|Overall Study|Adverse Event|12
2157055|NCT01224782|3772344|FG000|Overall Study|Adverse Reaction|11
2157056|NCT01224782|3772344|FG000|Overall Study|Noncompliance|10
2157057|NCT01224782|3772344|FG000|Overall Study|Other|4
2157058|NCT01224782|3772344|FG000|Overall Study|Start of Dialysis|3
2157059|NCT01224782|3772344|FG000|Overall Study|Change of Treatment|1
2157060|NCT01224782|3772344|FG000|Overall Study|Financial Reasons|1
2157061|NCT01224782|3772344|FG000|Overall Study|Deterioration|1
2157062|NCT01224782|3772344|FG000|Overall Study|Transplantation|1
2157063|NCT01224821|3772348|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
2157064|NCT01224821|3772348|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38
2157065|NCT01224821|3772348|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
2157066|NCT01224821|3772348|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
2157067|NCT01224821|3772348|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
2157068|NCT01224821|3772348|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
2157069|NCT01224821|3772348|FG000|Long-Term Follow-Up|Death|2
2157070|NCT01224821|3772348|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
2157071|NCT01224925|3772354|FG000|Overall Study|Lost to Follow-up|3
2157072|NCT01224925|3772355|FG001|Overall Study|Lost to Follow-up|2
2157073|NCT01225146|3772396|FG000|Overall Study|Sponsor discontinued making 2mg drug|0
2157074|NCT01225146|3772397|FG001|Overall Study|Sponsor discontinued making 2mg drug|2
2157075|NCT01225159|3772407|FG000|Overall Study|Change operation|1
2157076|NCT01225159|3772408|FG001|Overall Study|Change operation|0
2157077|NCT01225172|3772416|FG000|Overall Study|Subject decision to stop|1
2157078|NCT01225172|3772417|FG001|Overall Study|Subject decision to stop|0
2157079|NCT01225172|3772416|FG000|Overall Study|Subject request to discontinue treatment|3
2157080|NCT01225172|3772417|FG001|Overall Study|Subject request to discontinue treatment|1
2157081|NCT01225172|3772416|FG000|Overall Study|Subject no longer meets study criteria|1
2157082|NCT01225172|3772417|FG001|Overall Study|Subject no longer meets study criteria|0
2157083|NCT01225172|3772416|FG000|Overall Study|Withdrawal by Subject|1
2157084|NCT01225172|3772417|FG001|Overall Study|Withdrawal by Subject|0
2157085|NCT01225211|3772433|FG000|Overall Study|Adverse Event|0
2157086|NCT01225211|3772434|FG001|Overall Study|Adverse Event|0
2157087|NCT01225211|3772435|FG002|Overall Study|Adverse Event|1
2157088|NCT01225211|3772436|FG003|Overall Study|Adverse Event|0
2157089|NCT01225211|3772437|FG004|Overall Study|Adverse Event|0
2157090|NCT01225211|3772438|FG005|Overall Study|Adverse Event|0
2157091|NCT01225211|3772439|FG006|Overall Study|Adverse Event|0
2157092|NCT01225211|3772440|FG007|Overall Study|Adverse Event|0
2157093|NCT01225211|3772441|FG008|Overall Study|Adverse Event|0
2157094|NCT01225211|3772442|FG009|Overall Study|Adverse Event|1
2157095|NCT01225211|3772433|FG000|Overall Study|Withdrawal by Subject|0
2157096|NCT01225211|3772434|FG001|Overall Study|Withdrawal by Subject|0
2157097|NCT01225211|3772435|FG002|Overall Study|Withdrawal by Subject|0
2157098|NCT01225211|3772436|FG003|Overall Study|Withdrawal by Subject|0
2157099|NCT01225211|3772437|FG004|Overall Study|Withdrawal by Subject|0
2157100|NCT01225211|3772438|FG005|Overall Study|Withdrawal by Subject|0
2157101|NCT01225211|3772439|FG006|Overall Study|Withdrawal by Subject|1
2157102|NCT01225211|3772440|FG007|Overall Study|Withdrawal by Subject|0
2157103|NCT01225211|3772441|FG008|Overall Study|Withdrawal by Subject|1
2157104|NCT01225211|3772442|FG009|Overall Study|Withdrawal by Subject|3
2157105|NCT01225211|3772433|FG000|Overall Study|Other|0
2157106|NCT01225211|3772434|FG001|Overall Study|Other|0
2157107|NCT01225211|3772435|FG002|Overall Study|Other|0
2157108|NCT01225211|3772436|FG003|Overall Study|Other|0
2157109|NCT01225211|3772437|FG004|Overall Study|Other|0
2157110|NCT01225211|3772438|FG005|Overall Study|Other|0
2157111|NCT01225211|3772439|FG006|Overall Study|Other|0
2157112|NCT01225211|3772440|FG007|Overall Study|Other|0
2157113|NCT01225211|3772441|FG008|Overall Study|Other|0
2157114|NCT01225211|3772442|FG009|Overall Study|Other|1
2157115|NCT01225549|3772532|FG000|Period 4 - Washout|Disallowed medication|0
2157116|NCT01225549|3772533|FG001|Period 4 - Washout|Disallowed medication|1
2157117|NCT01225549|3772534|FG002|Period 4 - Washout|Disallowed medication|0
2157118|NCT01225549|3772535|FG003|Period 4 - Washout|Disallowed medication|0
2157119|NCT01225549|3772536|FG004|Period 4 - Washout|Disallowed medication|0
2157120|NCT01225549|3772537|FG005|Period 4 - Washout|Disallowed medication|0
2157121|NCT01225549|3772538|FG006|Period 4 - Washout|Disallowed medication|0
2157122|NCT01225549|3772539|FG007|Period 4 - Washout|Disallowed medication|0
2157123|NCT01225549|3772540|FG008|Period 4 - Washout|Disallowed medication|0
2157124|NCT01225549|3772541|FG009|Period 4 - Washout|Disallowed medication|0
2157125|NCT01225549|3772532|FG000|Period 6 - Washout|Disallowed medication|0
2157126|NCT01225549|3772533|FG001|Period 6 - Washout|Disallowed medication|0
2157127|NCT01225549|3772534|FG002|Period 6 - Washout|Disallowed medication|0
2157128|NCT01225549|3772535|FG003|Period 6 - Washout|Disallowed medication|1
2157129|NCT01225549|3772536|FG004|Period 6 - Washout|Disallowed medication|0
2157130|NCT01225549|3772537|FG005|Period 6 - Washout|Disallowed medication|0
2157131|NCT01225549|3772538|FG006|Period 6 - Washout|Disallowed medication|0
2157132|NCT01225549|3772539|FG007|Period 6 - Washout|Disallowed medication|0
2157133|NCT01225549|3772540|FG008|Period 6 - Washout|Disallowed medication|0
2157134|NCT01225549|3772541|FG009|Period 6 - Washout|Disallowed medication|0
2157135|NCT01225562|3772554|FG000|Overall Study|Withdrawal by Subject|52
2157136|NCT01225562|3772555|FG001|Overall Study|Withdrawal by Subject|50
2157137|NCT01225562|3772556|FG002|Overall Study|Withdrawal by Subject|52
2157138|NCT01225562|3772554|FG000|Overall Study|Lost to Follow-up|3
2157139|NCT01225562|3772555|FG001|Overall Study|Lost to Follow-up|6
2157140|NCT01225562|3772556|FG002|Overall Study|Lost to Follow-up|1
2157141|NCT01225731|3772569|FG000|Part 1|Did not meet eligibility criteria|1
2157142|NCT01225731|3772570|FG001|Part 1|Did not meet eligibility criteria|0
2208138|NCT01636687|3847524|FG001|Extension Period|study terminated by sponsor|50
2208139|NCT01636687|3847525|FG002|Extension Period|study terminated by sponsor|17
2157143|NCT01225731|3772571|FG002|Part 1|Did not meet eligibility criteria|0
2157144|NCT01225731|3772572|FG003|Part 1|Did not meet eligibility criteria|0
2157145|NCT01225731|3772573|FG004|Part 1|Did not meet eligibility criteria|1
2157146|NCT01225731|3772574|FG005|Part 1|Did not meet eligibility criteria|0
2157147|NCT01225731|3772575|FG006|Part 1|Did not meet eligibility criteria|0
2157148|NCT01225731|3772576|FG007|Part 1|Did not meet eligibility criteria|0
2157149|NCT01225731|3772577|FG008|Part 1|Did not meet eligibility criteria|0
2157150|NCT01225731|3772578|FG009|Part 1|Did not meet eligibility criteria|0
2157151|NCT01225731|3772579|FG010|Part 1|Did not meet eligibility criteria|0
2157152|NCT01225731|3772580|FG011|Part 1|Did not meet eligibility criteria|0
2157153|NCT01225731|3772581|FG012|Part 1|Did not meet eligibility criteria|0
2157154|NCT01225731|3772569|FG000|Part 1|Adverse Event|1
2157155|NCT01225731|3772570|FG001|Part 1|Adverse Event|2
2157156|NCT01225731|3772571|FG002|Part 1|Adverse Event|1
2157157|NCT01225731|3772572|FG003|Part 1|Adverse Event|1
2157158|NCT01225731|3772573|FG004|Part 1|Adverse Event|1
2157159|NCT01225731|3772574|FG005|Part 1|Adverse Event|0
2157160|NCT01225731|3772575|FG006|Part 1|Adverse Event|0
2157161|NCT01225731|3772576|FG007|Part 1|Adverse Event|0
2157162|NCT01225731|3772577|FG008|Part 1|Adverse Event|0
2157163|NCT01225731|3772578|FG009|Part 1|Adverse Event|0
2157164|NCT01225731|3772579|FG010|Part 1|Adverse Event|0
2157165|NCT01225731|3772580|FG011|Part 1|Adverse Event|0
2157166|NCT01225731|3772581|FG012|Part 1|Adverse Event|0
2157167|NCT01225731|3772569|FG000|Part 1|Withdrawal by Subject|0
2157168|NCT01225731|3772570|FG001|Part 1|Withdrawal by Subject|3
2157169|NCT01225731|3772571|FG002|Part 1|Withdrawal by Subject|0
2157170|NCT01225731|3772572|FG003|Part 1|Withdrawal by Subject|0
2157171|NCT01225731|3772573|FG004|Part 1|Withdrawal by Subject|4
2157172|NCT01225731|3772574|FG005|Part 1|Withdrawal by Subject|0
2157173|NCT01225731|3772575|FG006|Part 1|Withdrawal by Subject|0
2157174|NCT01225731|3772576|FG007|Part 1|Withdrawal by Subject|0
2157175|NCT01225731|3772577|FG008|Part 1|Withdrawal by Subject|0
2157176|NCT01225731|3772578|FG009|Part 1|Withdrawal by Subject|0
2157177|NCT01225731|3772579|FG010|Part 1|Withdrawal by Subject|0
2157178|NCT01225731|3772580|FG011|Part 1|Withdrawal by Subject|0
2157179|NCT01225731|3772581|FG012|Part 1|Withdrawal by Subject|0
2157180|NCT01225731|3772569|FG000|Part 1|Protocol Violation|0
2157181|NCT01225731|3772570|FG001|Part 1|Protocol Violation|0
2157182|NCT01225731|3772571|FG002|Part 1|Protocol Violation|0
2157183|NCT01225731|3772572|FG003|Part 1|Protocol Violation|1
2157184|NCT01225731|3772573|FG004|Part 1|Protocol Violation|0
2157185|NCT01225731|3772574|FG005|Part 1|Protocol Violation|0
2157186|NCT01225731|3772575|FG006|Part 1|Protocol Violation|0
2157187|NCT01225731|3772576|FG007|Part 1|Protocol Violation|0
2157188|NCT01225731|3772577|FG008|Part 1|Protocol Violation|0
2157189|NCT01225731|3772578|FG009|Part 1|Protocol Violation|0
2157190|NCT01225731|3772579|FG010|Part 1|Protocol Violation|0
2157191|NCT01225731|3772580|FG011|Part 1|Protocol Violation|0
2157192|NCT01225731|3772581|FG012|Part 1|Protocol Violation|0
2157193|NCT01225731|3772569|FG000|Part 2|Protocol Violation|0
2157194|NCT01225731|3772570|FG001|Part 2|Protocol Violation|0
2157195|NCT01225731|3772571|FG002|Part 2|Protocol Violation|0
2157196|NCT01225731|3772572|FG003|Part 2|Protocol Violation|0
2157197|NCT01225731|3772573|FG004|Part 2|Protocol Violation|0
2157198|NCT01225731|3772574|FG005|Part 2|Protocol Violation|1
2157199|NCT01225731|3772575|FG006|Part 2|Protocol Violation|0
2157200|NCT01225731|3772576|FG007|Part 2|Protocol Violation|0
2157201|NCT01225731|3772577|FG008|Part 2|Protocol Violation|1
2157202|NCT01225731|3772578|FG009|Part 2|Protocol Violation|0
2157203|NCT01225731|3772579|FG010|Part 2|Protocol Violation|0
2157204|NCT01225731|3772580|FG011|Part 2|Protocol Violation|0
2157205|NCT01225731|3772581|FG012|Part 2|Protocol Violation|0
2157206|NCT01225731|3772569|FG000|Part 2|Adverse Event|0
2157207|NCT01225731|3772570|FG001|Part 2|Adverse Event|0
2157208|NCT01225731|3772571|FG002|Part 2|Adverse Event|0
2208140|NCT01636687|3847526|FG003|Extension Period|study terminated by sponsor|23
2157209|NCT01225731|3772572|FG003|Part 2|Adverse Event|0
2157210|NCT01225731|3772573|FG004|Part 2|Adverse Event|0
2157211|NCT01225731|3772574|FG005|Part 2|Adverse Event|0
2157212|NCT01225731|3772575|FG006|Part 2|Adverse Event|4
2157213|NCT01225731|3772576|FG007|Part 2|Adverse Event|4
2157214|NCT01225731|3772577|FG008|Part 2|Adverse Event|2
2157215|NCT01225731|3772578|FG009|Part 2|Adverse Event|0
2157216|NCT01225731|3772579|FG010|Part 2|Adverse Event|0
2157217|NCT01225731|3772580|FG011|Part 2|Adverse Event|0
2157218|NCT01225731|3772581|FG012|Part 2|Adverse Event|0
2157219|NCT01225731|3772569|FG000|Part 2|Lack of Efficacy|0
2157220|NCT01225731|3772570|FG001|Part 2|Lack of Efficacy|0
2157221|NCT01225731|3772571|FG002|Part 2|Lack of Efficacy|0
2157222|NCT01225731|3772572|FG003|Part 2|Lack of Efficacy|0
2157223|NCT01225731|3772573|FG004|Part 2|Lack of Efficacy|0
2157224|NCT01225731|3772574|FG005|Part 2|Lack of Efficacy|1
2157225|NCT01225731|3772575|FG006|Part 2|Lack of Efficacy|0
2157226|NCT01225731|3772576|FG007|Part 2|Lack of Efficacy|12
2157227|NCT01225731|3772577|FG008|Part 2|Lack of Efficacy|3
2157228|NCT01225731|3772578|FG009|Part 2|Lack of Efficacy|0
2157229|NCT01225731|3772579|FG010|Part 2|Lack of Efficacy|0
2157230|NCT01225731|3772580|FG011|Part 2|Lack of Efficacy|0
2293689|NCT02528357|3987960|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293690|NCT02528357|3987961|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293691|NCT02528357|3987962|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293692|NCT02528357|3987963|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293693|NCT02528357|3987964|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293694|NCT02528357|3987965|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293695|NCT02528357|3987966|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1
2157231|NCT01225731|3772581|FG012|Part 2|Lack of Efficacy|0
2157232|NCT01225731|3772569|FG000|Part 2|Pregnancy|0
2157233|NCT01225731|3772570|FG001|Part 2|Pregnancy|0
2157234|NCT01225731|3772571|FG002|Part 2|Pregnancy|0
2157235|NCT01225731|3772572|FG003|Part 2|Pregnancy|0
2157236|NCT01225731|3772573|FG004|Part 2|Pregnancy|0
2157237|NCT01225731|3772574|FG005|Part 2|Pregnancy|0
2157238|NCT01225731|3772575|FG006|Part 2|Pregnancy|1
2157239|NCT01225731|3772576|FG007|Part 2|Pregnancy|0
2157240|NCT01225731|3772577|FG008|Part 2|Pregnancy|1
2157241|NCT01225731|3772578|FG009|Part 2|Pregnancy|0
2157242|NCT01225731|3772579|FG010|Part 2|Pregnancy|0
2157243|NCT01225731|3772580|FG011|Part 2|Pregnancy|0
2157244|NCT01225731|3772581|FG012|Part 2|Pregnancy|0
2157245|NCT01225731|3772569|FG000|Part 2|Lost to Follow-up|0
2157246|NCT01225731|3772570|FG001|Part 2|Lost to Follow-up|0
2157247|NCT01225731|3772571|FG002|Part 2|Lost to Follow-up|0
2157248|NCT01225731|3772572|FG003|Part 2|Lost to Follow-up|0
2157249|NCT01225731|3772573|FG004|Part 2|Lost to Follow-up|0
2157250|NCT01225731|3772574|FG005|Part 2|Lost to Follow-up|0
2157251|NCT01225731|3772575|FG006|Part 2|Lost to Follow-up|0
2157252|NCT01225731|3772576|FG007|Part 2|Lost to Follow-up|3
2157253|NCT01225731|3772577|FG008|Part 2|Lost to Follow-up|1
2157254|NCT01225731|3772578|FG009|Part 2|Lost to Follow-up|0
2157255|NCT01225731|3772579|FG010|Part 2|Lost to Follow-up|0
2157256|NCT01225731|3772580|FG011|Part 2|Lost to Follow-up|0
2157257|NCT01225731|3772581|FG012|Part 2|Lost to Follow-up|0
2157258|NCT01225731|3772569|FG000|Part 2|Physician Decision|0
2208141|NCT01636687|3847527|FG004|Extension Period|study terminated by sponsor|0
2157259|NCT01225731|3772570|FG001|Part 2|Physician Decision|0
2157260|NCT01225731|3772571|FG002|Part 2|Physician Decision|0
2157261|NCT01225731|3772572|FG003|Part 2|Physician Decision|0
2157262|NCT01225731|3772573|FG004|Part 2|Physician Decision|0
2157263|NCT01225731|3772574|FG005|Part 2|Physician Decision|0
2157264|NCT01225731|3772575|FG006|Part 2|Physician Decision|0
2157265|NCT01225731|3772576|FG007|Part 2|Physician Decision|2
2157266|NCT01225731|3772577|FG008|Part 2|Physician Decision|2
2157267|NCT01225731|3772578|FG009|Part 2|Physician Decision|0
2157268|NCT01225731|3772579|FG010|Part 2|Physician Decision|0
2157269|NCT01225731|3772580|FG011|Part 2|Physician Decision|0
2157270|NCT01225731|3772581|FG012|Part 2|Physician Decision|0
2157271|NCT01225731|3772569|FG000|Part 2|Withdrawal by Subject|0
2157272|NCT01225731|3772570|FG001|Part 2|Withdrawal by Subject|0
2157273|NCT01225731|3772571|FG002|Part 2|Withdrawal by Subject|0
2157274|NCT01225731|3772572|FG003|Part 2|Withdrawal by Subject|0
2157275|NCT01225731|3772573|FG004|Part 2|Withdrawal by Subject|0
2157276|NCT01225731|3772574|FG005|Part 2|Withdrawal by Subject|1
2157277|NCT01225731|3772575|FG006|Part 2|Withdrawal by Subject|3
2157278|NCT01225731|3772576|FG007|Part 2|Withdrawal by Subject|4
2157279|NCT01225731|3772577|FG008|Part 2|Withdrawal by Subject|1
2157280|NCT01225731|3772578|FG009|Part 2|Withdrawal by Subject|0
2157281|NCT01225731|3772579|FG010|Part 2|Withdrawal by Subject|0
2157282|NCT01225731|3772580|FG011|Part 2|Withdrawal by Subject|0
2157283|NCT01225731|3772581|FG012|Part 2|Withdrawal by Subject|0
2157284|NCT01225731|3772569|FG000|Part 3|Adverse Event|0
2157285|NCT01225731|3772570|FG001|Part 3|Adverse Event|0
2157286|NCT01225731|3772571|FG002|Part 3|Adverse Event|0
2157287|NCT01225731|3772572|FG003|Part 3|Adverse Event|0
2157288|NCT01225731|3772573|FG004|Part 3|Adverse Event|0
2157289|NCT01225731|3772574|FG005|Part 3|Adverse Event|0
2157290|NCT01225731|3772575|FG006|Part 3|Adverse Event|0
2157291|NCT01225731|3772576|FG007|Part 3|Adverse Event|0
2157292|NCT01225731|3772577|FG008|Part 3|Adverse Event|0
2157293|NCT01225731|3772578|FG009|Part 3|Adverse Event|0
2157294|NCT01225731|3772579|FG010|Part 3|Adverse Event|1
2157295|NCT01225731|3772580|FG011|Part 3|Adverse Event|1
2157296|NCT01225731|3772581|FG012|Part 3|Adverse Event|0
2157297|NCT01225731|3772569|FG000|Part 3|Lost to Follow-up|0
2157298|NCT01225731|3772570|FG001|Part 3|Lost to Follow-up|0
2157299|NCT01225731|3772571|FG002|Part 3|Lost to Follow-up|0
2157300|NCT01225731|3772572|FG003|Part 3|Lost to Follow-up|0
2157301|NCT01225731|3772573|FG004|Part 3|Lost to Follow-up|0
2157302|NCT01225731|3772574|FG005|Part 3|Lost to Follow-up|0
2157303|NCT01225731|3772575|FG006|Part 3|Lost to Follow-up|0
2157304|NCT01225731|3772576|FG007|Part 3|Lost to Follow-up|0
2157305|NCT01225731|3772577|FG008|Part 3|Lost to Follow-up|0
2157306|NCT01225731|3772578|FG009|Part 3|Lost to Follow-up|0
2157307|NCT01225731|3772579|FG010|Part 3|Lost to Follow-up|1
2157308|NCT01225731|3772580|FG011|Part 3|Lost to Follow-up|2
2157309|NCT01225731|3772581|FG012|Part 3|Lost to Follow-up|1
2157310|NCT01225731|3772569|FG000|Part 3|Physician Decision|0
2157311|NCT01225731|3772570|FG001|Part 3|Physician Decision|0
2157312|NCT01225731|3772571|FG002|Part 3|Physician Decision|0
2157313|NCT01225731|3772572|FG003|Part 3|Physician Decision|0
2157314|NCT01225731|3772573|FG004|Part 3|Physician Decision|0
2157315|NCT01225731|3772574|FG005|Part 3|Physician Decision|0
2157316|NCT01225731|3772575|FG006|Part 3|Physician Decision|0
2157317|NCT01225731|3772576|FG007|Part 3|Physician Decision|0
2157318|NCT01225731|3772577|FG008|Part 3|Physician Decision|0
2157319|NCT01225731|3772578|FG009|Part 3|Physician Decision|0
2157320|NCT01225731|3772579|FG010|Part 3|Physician Decision|0
2157321|NCT01225731|3772580|FG011|Part 3|Physician Decision|1
2157322|NCT01225731|3772581|FG012|Part 3|Physician Decision|2
2157323|NCT01225731|3772569|FG000|Part 3|Withdrawal by Subject|0
2157324|NCT01225731|3772570|FG001|Part 3|Withdrawal by Subject|0
2157325|NCT01225731|3772571|FG002|Part 3|Withdrawal by Subject|0
2157326|NCT01225731|3772572|FG003|Part 3|Withdrawal by Subject|0
2157327|NCT01225731|3772573|FG004|Part 3|Withdrawal by Subject|0
2157328|NCT01225731|3772574|FG005|Part 3|Withdrawal by Subject|0
2157329|NCT01225731|3772575|FG006|Part 3|Withdrawal by Subject|0
2157330|NCT01225731|3772576|FG007|Part 3|Withdrawal by Subject|0
2157331|NCT01225731|3772577|FG008|Part 3|Withdrawal by Subject|0
2157332|NCT01225731|3772578|FG009|Part 3|Withdrawal by Subject|0
2157333|NCT01225731|3772579|FG010|Part 3|Withdrawal by Subject|4
2157334|NCT01225731|3772580|FG011|Part 3|Withdrawal by Subject|6
2157335|NCT01225731|3772581|FG012|Part 3|Withdrawal by Subject|4
2157336|NCT01225822|3772615|FG000|Overall Study|Adverse Event|13
2157337|NCT01225822|3772616|FG001|Overall Study|Adverse Event|31
2157338|NCT01225822|3772617|FG002|Overall Study|Adverse Event|18
2157339|NCT01225822|3772618|FG003|Overall Study|Adverse Event|23
2157340|NCT01225822|3772619|FG004|Overall Study|Adverse Event|14
2157341|NCT01225822|3772615|FG000|Overall Study|Protocol Violation|6
2157342|NCT01225822|3772616|FG001|Overall Study|Protocol Violation|8
2157343|NCT01225822|3772617|FG002|Overall Study|Protocol Violation|6
2157344|NCT01225822|3772618|FG003|Overall Study|Protocol Violation|7
2157345|NCT01225822|3772619|FG004|Overall Study|Protocol Violation|4
2157346|NCT01225822|3772615|FG000|Overall Study|Lost to Follow-up|0
2157347|NCT01225822|3772616|FG001|Overall Study|Lost to Follow-up|0
2157348|NCT01225822|3772617|FG002|Overall Study|Lost to Follow-up|0
2157349|NCT01225822|3772618|FG003|Overall Study|Lost to Follow-up|1
2157350|NCT01225822|3772619|FG004|Overall Study|Lost to Follow-up|0
2157351|NCT01225822|3772615|FG000|Overall Study|Withdrawal by Subject|6
2157352|NCT01225822|3772616|FG001|Overall Study|Withdrawal by Subject|7
2157353|NCT01225822|3772617|FG002|Overall Study|Withdrawal by Subject|7
2157354|NCT01225822|3772618|FG003|Overall Study|Withdrawal by Subject|11
2157355|NCT01225822|3772619|FG004|Overall Study|Withdrawal by Subject|6
2157356|NCT01225822|3772615|FG000|Overall Study|Other|13
2157357|NCT01225822|3772616|FG001|Overall Study|Other|10
2157358|NCT01225822|3772617|FG002|Overall Study|Other|7
2157359|NCT01225822|3772618|FG003|Overall Study|Other|10
2157360|NCT01225822|3772619|FG004|Overall Study|Other|7
2157361|NCT01225835|3772636|FG000|Overall Study|Completed protocol|2
2157362|NCT01225835|3772637|FG001|Overall Study|Completed protocol|1
2157363|NCT01225835|3772636|FG000|Overall Study|Did not meet hCG criterion|2
2157364|NCT01225835|3772637|FG001|Overall Study|Did not meet hCG criterion|0
2157365|NCT01225835|3772636|FG000|Overall Study|Adverse Event|2
2157366|NCT01225835|3772637|FG001|Overall Study|Adverse Event|1
2157367|NCT01225835|3772636|FG000|Overall Study|Other|1
2157368|NCT01225835|3772637|FG001|Overall Study|Other|1
2157369|NCT01225887|3772649|FG000|Overall Study|Ineligible:required test not done|2
2157370|NCT01225887|3772649|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1
2157371|NCT01225887|3772649|FG000|Overall Study|Ineligible:inadequate pathology|2
2157372|NCT01225952|3772665|FG000|Overall Study|Lost to Follow-up|1
2157373|NCT01225952|3772666|FG001|Overall Study|Lost to Follow-up|0
2157374|NCT01225952|3772667|FG002|Overall Study|Lost to Follow-up|0
2157375|NCT01225952|3772665|FG000|Overall Study|Study Eye Explanted|0
2157376|NCT01225952|3772666|FG001|Overall Study|Study Eye Explanted|0
2157377|NCT01225952|3772667|FG002|Overall Study|Study Eye Explanted|1
2157378|NCT01225952|3772665|FG000|Overall Study|Withdrawal by Subject|4
2157379|NCT01225952|3772666|FG001|Overall Study|Withdrawal by Subject|4
2157380|NCT01225952|3772667|FG002|Overall Study|Withdrawal by Subject|5
2157381|NCT01225952|3772665|FG000|Overall Study|Surgical complications|1
2157382|NCT01225952|3772666|FG001|Overall Study|Surgical complications|0
2157383|NCT01225952|3772667|FG002|Overall Study|Surgical complications|0
2157384|NCT01225991|3772675|FG000|Overall Study|Withdrawal by Subject|6
2157385|NCT01226043|3772681|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1
2157386|NCT01226043|3772682|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2
2157387|NCT01226043|3772683|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0
2157388|NCT01226043|3772684|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0
2157389|NCT01226043|3772681|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0
2157390|NCT01226043|3772682|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1
2157391|NCT01226043|3772683|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0
2157392|NCT01226043|3772684|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0
2157393|NCT01226043|3772681|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
2157394|NCT01226043|3772682|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
2157395|NCT01226043|3772683|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
2157396|NCT01226043|3772684|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
2157397|NCT01226043|3772681|FG000|4-week Crossover Phase - Period 1|Physician Decision|0
2157398|NCT01226043|3772682|FG001|4-week Crossover Phase - Period 1|Physician Decision|6
2157399|NCT01226043|3772683|FG002|4-week Crossover Phase - Period 1|Physician Decision|0
2157400|NCT01226043|3772684|FG003|4-week Crossover Phase - Period 1|Physician Decision|0
2157401|NCT01226043|3772681|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
2157402|NCT01226043|3772682|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
2157403|NCT01226043|3772683|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
2157404|NCT01226043|3772684|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
2157405|NCT01226043|3772681|FG000|4-week Crossover Phase - Period 2|Physician Decision|4
2157406|NCT01226043|3772682|FG001|4-week Crossover Phase - Period 2|Physician Decision|5
2157407|NCT01226043|3772683|FG002|4-week Crossover Phase - Period 2|Physician Decision|0
2157408|NCT01226043|3772684|FG003|4-week Crossover Phase - Period 2|Physician Decision|0
2157409|NCT01226043|3772681|FG000|6-week Re-randomization Phase|Adverse Event|0
2157410|NCT01226043|3772682|FG001|6-week Re-randomization Phase|Adverse Event|0
2157411|NCT01226043|3772683|FG002|6-week Re-randomization Phase|Adverse Event|1
2157412|NCT01226043|3772684|FG003|6-week Re-randomization Phase|Adverse Event|1
2157413|NCT01226043|3772681|FG000|6-week Re-randomization Phase|Protocol Violation|0
2157414|NCT01226043|3772682|FG001|6-week Re-randomization Phase|Protocol Violation|0
2157415|NCT01226043|3772683|FG002|6-week Re-randomization Phase|Protocol Violation|1
2157416|NCT01226043|3772684|FG003|6-week Re-randomization Phase|Protocol Violation|1
2157417|NCT01226043|3772681|FG000|6-week Re-randomization Phase|Lost to Follow-up|0
2157418|NCT01226043|3772682|FG001|6-week Re-randomization Phase|Lost to Follow-up|0
2157419|NCT01226043|3772683|FG002|6-week Re-randomization Phase|Lost to Follow-up|1
2157420|NCT01226043|3772684|FG003|6-week Re-randomization Phase|Lost to Follow-up|3
2157421|NCT01226043|3772681|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0
2157422|NCT01226043|3772682|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0
2157423|NCT01226043|3772683|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1
2157424|NCT01226043|3772684|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3
2157425|NCT01226043|3772681|FG000|6-week Re-randomization Phase|Physician Decision|0
2157426|NCT01226043|3772682|FG001|6-week Re-randomization Phase|Physician Decision|0
2157427|NCT01226043|3772683|FG002|6-week Re-randomization Phase|Physician Decision|3
2157428|NCT01226043|3772684|FG003|6-week Re-randomization Phase|Physician Decision|2
2157429|NCT01226043|3772681|FG000|6-week Re-randomization Phase|completed in error|0
2157430|NCT01226043|3772682|FG001|6-week Re-randomization Phase|completed in error|0
2157431|NCT01226043|3772683|FG002|6-week Re-randomization Phase|completed in error|0
2157432|NCT01226043|3772684|FG003|6-week Re-randomization Phase|completed in error|1
2157433|NCT01226043|3772681|FG000|30-week Observational Phase|Adverse Event|0
2157434|NCT01226043|3772682|FG001|30-week Observational Phase|Adverse Event|0
2157435|NCT01226043|3772683|FG002|30-week Observational Phase|Adverse Event|1
2157436|NCT01226043|3772684|FG003|30-week Observational Phase|Adverse Event|1
2157437|NCT01226043|3772681|FG000|30-week Observational Phase|Protocol Violation|0
2157438|NCT01226043|3772682|FG001|30-week Observational Phase|Protocol Violation|0
2157439|NCT01226043|3772683|FG002|30-week Observational Phase|Protocol Violation|0
2157440|NCT01226043|3772684|FG003|30-week Observational Phase|Protocol Violation|1
2157441|NCT01226043|3772681|FG000|30-week Observational Phase|Lost to Follow-up|0
2157442|NCT01226043|3772682|FG001|30-week Observational Phase|Lost to Follow-up|0
2157443|NCT01226043|3772683|FG002|30-week Observational Phase|Lost to Follow-up|2
2157444|NCT01226043|3772684|FG003|30-week Observational Phase|Lost to Follow-up|2
2157445|NCT01226043|3772681|FG000|30-week Observational Phase|Withdrawal by Subject|0
2157446|NCT01226043|3772682|FG001|30-week Observational Phase|Withdrawal by Subject|0
2157447|NCT01226043|3772683|FG002|30-week Observational Phase|Withdrawal by Subject|1
2157448|NCT01226043|3772684|FG003|30-week Observational Phase|Withdrawal by Subject|7
2157449|NCT01226043|3772681|FG000|30-week Observational Phase|Physician Decision|0
2157450|NCT01226043|3772682|FG001|30-week Observational Phase|Physician Decision|0
2157451|NCT01226043|3772683|FG002|30-week Observational Phase|Physician Decision|2
2157452|NCT01226043|3772684|FG003|30-week Observational Phase|Physician Decision|2
2157453|NCT01226095|3772714|FG000|Overall Study|Poor compliance|1
2157454|NCT01226121|3772728|FG000|Overall Study|Lost to Follow-up|2
2157455|NCT01226121|3772729|FG001|Overall Study|Lost to Follow-up|0
2157456|NCT01226121|3772730|FG002|Overall Study|Lost to Follow-up|1
2157457|NCT01226459|3772744|FG000|Overall Study|Adverse Event|2
2157458|NCT01226459|3772745|FG001|Overall Study|Adverse Event|8
2157459|NCT01226459|3772744|FG000|Overall Study|Protocol Violation|4
2157460|NCT01226459|3772745|FG001|Overall Study|Protocol Violation|3
2157461|NCT01226459|3772744|FG000|Overall Study|Withdrawal by Subject|10
2157462|NCT01226459|3772745|FG001|Overall Study|Withdrawal by Subject|13
2157463|NCT01226459|3772744|FG000|Overall Study|Lost to Follow-up|4
2157464|NCT01226459|3772745|FG001|Overall Study|Lost to Follow-up|8
2157465|NCT01226459|3772744|FG000|Overall Study|Pregnancy|1
2157466|NCT01226459|3772745|FG001|Overall Study|Pregnancy|0
2157467|NCT01226472|3772751|FG000|Overall Study|Progressive Disease|1
2157468|NCT01226511|3772794|FG000|Acute Treatment Period|Adverse Event|7
2157469|NCT01226511|3772795|FG001|Acute Treatment Period|Adverse Event|6
2157470|NCT01226511|3772794|FG000|Acute Treatment Period|Lack of Efficacy|2
2157471|NCT01226511|3772795|FG001|Acute Treatment Period|Lack of Efficacy|1
2157472|NCT01226511|3772794|FG000|Acute Treatment Period|Lost to Follow-up|3
2157473|NCT01226511|3772795|FG001|Acute Treatment Period|Lost to Follow-up|6
2157474|NCT01226511|3772794|FG000|Acute Treatment Period|Parent/caregiver decision|5
2157475|NCT01226511|3772795|FG001|Acute Treatment Period|Parent/caregiver decision|7
2157476|NCT01226511|3772794|FG000|Acute Treatment Period|Protocol Violation|5
2157477|NCT01226511|3772795|FG001|Acute Treatment Period|Protocol Violation|5
2157478|NCT01226511|3772794|FG000|Acute Treatment Period|Withdrawal by Subject|10
2157479|NCT01226511|3772795|FG001|Acute Treatment Period|Withdrawal by Subject|6
2157480|NCT01226511|3772794|FG000|Extension Treatment Period|Adverse Event|8
2157481|NCT01226511|3772795|FG001|Extension Treatment Period|Adverse Event|8
2157482|NCT01226511|3772794|FG000|Extension Treatment Period|Lack of Efficacy|3
2157483|NCT01226511|3772795|FG001|Extension Treatment Period|Lack of Efficacy|2
2157484|NCT01226511|3772794|FG000|Extension Treatment Period|Lost to Follow-up|4
2157485|NCT01226511|3772795|FG001|Extension Treatment Period|Lost to Follow-up|3
2157486|NCT01226511|3772794|FG000|Extension Treatment Period|Protocol Violation|2
2157487|NCT01226511|3772795|FG001|Extension Treatment Period|Protocol Violation|2
2157488|NCT01226511|3772794|FG000|Extension Treatment Period|Withdrawal by Subject|1
2157489|NCT01226511|3772795|FG001|Extension Treatment Period|Withdrawal by Subject|3
2157490|NCT01226511|3772794|FG000|Extension Treatment Period|Parent/Caregiver Decision|8
2157491|NCT01226511|3772795|FG001|Extension Treatment Period|Parent/Caregiver Decision|8
2157492|NCT01226511|3772794|FG000|Extension Treatment Period|Sponsor Decision|1
2157493|NCT01226511|3772795|FG001|Extension Treatment Period|Sponsor Decision|1
2157494|NCT01226511|3772794|FG000|Taper Period|Adverse Event|1
2157495|NCT01226511|3772795|FG001|Taper Period|Adverse Event|0
2157496|NCT01226511|3772794|FG000|Taper Period|Lost to Follow-up|2
2157497|NCT01226511|3772795|FG001|Taper Period|Lost to Follow-up|2
2157498|NCT01226511|3772794|FG000|Taper Period|Protocol Violation|1
2157499|NCT01226511|3772795|FG001|Taper Period|Protocol Violation|0
2157500|NCT01226511|3772794|FG000|Taper Period|Parent/Caregiver Decision|1
2157501|NCT01226511|3772795|FG001|Taper Period|Parent/Caregiver Decision|1
2157502|NCT01226745|3772855|FG000|Overall Study|Did not complete schedule of assessments|8
2157503|NCT01226745|3772856|FG001|Overall Study|Did not complete schedule of assessments|3
2157504|NCT01226745|3772857|FG002|Overall Study|Did not complete schedule of assessments|6
2157505|NCT01226745|3772858|FG003|Overall Study|Did not complete schedule of assessments|0
2157506|NCT01226745|3772859|FG004|Overall Study|Did not complete schedule of assessments|0
2157507|NCT01226745|3772860|FG005|Overall Study|Did not complete schedule of assessments|1
2157508|NCT01226745|3772855|FG000|Overall Study|Lost to Follow-up|2
2157509|NCT01226745|3772856|FG001|Overall Study|Lost to Follow-up|6
2157510|NCT01226745|3772857|FG002|Overall Study|Lost to Follow-up|6
2157511|NCT01226745|3772858|FG003|Overall Study|Lost to Follow-up|1
2157512|NCT01226745|3772859|FG004|Overall Study|Lost to Follow-up|1
2157513|NCT01226745|3772860|FG005|Overall Study|Lost to Follow-up|2
2157514|NCT01226745|3772855|FG000|Overall Study|Death|1
2157515|NCT01226745|3772856|FG001|Overall Study|Death|0
2157516|NCT01226745|3772857|FG002|Overall Study|Death|0
2157517|NCT01226745|3772858|FG003|Overall Study|Death|0
2157518|NCT01226745|3772859|FG004|Overall Study|Death|0
2157519|NCT01226745|3772860|FG005|Overall Study|Death|1
2157520|NCT01226745|3772855|FG000|Overall Study|Other|6
2157521|NCT01226745|3772856|FG001|Overall Study|Other|7
2157522|NCT01226745|3772857|FG002|Overall Study|Other|8
2157523|NCT01226745|3772858|FG003|Overall Study|Other|4
2157524|NCT01226745|3772859|FG004|Overall Study|Other|3
2157525|NCT01226745|3772860|FG005|Overall Study|Other|1
2157526|NCT01227018|3772898|FG000|Overall Study|Disease progression|9
2157527|NCT01227018|3772898|FG000|Overall Study|Toxicity|2
2157528|NCT01227018|3772898|FG000|Overall Study|Withdrew after beginning treatment|4
2157529|NCT01227044|3772904|FG000|Overall Study|Lost to Follow-up|5
2157530|NCT01227044|3772905|FG001|Overall Study|Lost to Follow-up|7
2157531|NCT01227044|3772904|FG000|Overall Study|Discontinued Intervention|1
2157532|NCT01227044|3772905|FG001|Overall Study|Discontinued Intervention|2
2157533|NCT01227252|3772925|FG000|Overall Study|Sponsor Decision|0
2157534|NCT01227252|3772926|FG001|Overall Study|Sponsor Decision|1
2157535|NCT01227252|3772927|FG002|Overall Study|Sponsor Decision|0
2157536|NCT01227252|3772928|FG003|Overall Study|Sponsor Decision|0
2157537|NCT01227252|3772925|FG000|Overall Study|Lost to Follow-up|0
2157538|NCT01227252|3772926|FG001|Overall Study|Lost to Follow-up|1
2157539|NCT01227252|3772927|FG002|Overall Study|Lost to Follow-up|0
2157540|NCT01227252|3772928|FG003|Overall Study|Lost to Follow-up|0
2157541|NCT01227252|3772925|FG000|Overall Study|Withdrawal by Subject|0
2157542|NCT01227252|3772926|FG001|Overall Study|Withdrawal by Subject|1
2157543|NCT01227252|3772927|FG002|Overall Study|Withdrawal by Subject|0
2157544|NCT01227252|3772928|FG003|Overall Study|Withdrawal by Subject|0
2157545|NCT01227265|3772944|FG000|Overall Study|Did Not Receive Treatment|1
2157546|NCT01227265|3772945|FG001|Overall Study|Did Not Receive Treatment|2
2157547|NCT01227265|3772946|FG002|Overall Study|Did Not Receive Treatment|0
2157548|NCT01227265|3772944|FG000|Overall Study|Administrative|1
2157549|NCT01227265|3772945|FG001|Overall Study|Administrative|0
2157550|NCT01227265|3772946|FG002|Overall Study|Administrative|2
2157551|NCT01227265|3772944|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
2157552|NCT01227265|3772945|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
2157553|NCT01227265|3772946|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
2157554|NCT01227265|3772944|FG000|Overall Study|Protocol Violation|2
2157555|NCT01227265|3772945|FG001|Overall Study|Protocol Violation|1
2157556|NCT01227265|3772946|FG002|Overall Study|Protocol Violation|0
2157557|NCT01227265|3772944|FG000|Overall Study|Withdrawal by Subject|7
2157558|NCT01227265|3772945|FG001|Overall Study|Withdrawal by Subject|7
2157559|NCT01227265|3772946|FG002|Overall Study|Withdrawal by Subject|3
2157560|NCT01227265|3772944|FG000|Overall Study|Lost to Follow-up|2
2157561|NCT01227265|3772945|FG001|Overall Study|Lost to Follow-up|0
2157562|NCT01227265|3772946|FG002|Overall Study|Lost to Follow-up|3
2157563|NCT01227265|3772944|FG000|Overall Study|Adverse Event|6
2157564|NCT01227265|3772945|FG001|Overall Study|Adverse Event|10
2157565|NCT01227265|3772946|FG002|Overall Study|Adverse Event|5
2157566|NCT01227278|3772956|FG000|Overall Study|Withdrawal by Subject|4
2157567|NCT01227278|3772957|FG001|Overall Study|Withdrawal by Subject|4
2157568|NCT01227278|3772956|FG000|Overall Study|Death|0
2157569|NCT01227278|3772957|FG001|Overall Study|Death|2
2157570|NCT01227278|3772956|FG000|Overall Study|Other|1
2157571|NCT01227278|3772957|FG001|Overall Study|Other|2
2157572|NCT01227395|3772971|FG000|Overall Study|Protocol Violation|0
2157573|NCT01227395|3772972|FG001|Overall Study|Protocol Violation|1
2157574|NCT01227421|3773000|FG000|Overall Study|Lost to Follow-up|6
2157575|NCT01227421|3773001|FG001|Overall Study|Lost to Follow-up|7
2157576|NCT01227421|3773002|FG002|Overall Study|Lost to Follow-up|5
2157577|NCT01227421|3773000|FG000|Overall Study|Adverse Event|2
2157578|NCT01227421|3773001|FG001|Overall Study|Adverse Event|7
2157579|NCT01227421|3773002|FG002|Overall Study|Adverse Event|2
2157580|NCT01227421|3773000|FG000|Overall Study|Withdrawal by Subject|1
2157581|NCT01227421|3773001|FG001|Overall Study|Withdrawal by Subject|2
2157582|NCT01227421|3773002|FG002|Overall Study|Withdrawal by Subject|1
2157583|NCT01227421|3773000|FG000|Overall Study|Protocol Violation|1
2157584|NCT01227421|3773001|FG001|Overall Study|Protocol Violation|1
2157585|NCT01227421|3773002|FG002|Overall Study|Protocol Violation|2
2157586|NCT01227421|3773000|FG000|Overall Study|Randomized in error|1
2157587|NCT01227421|3773001|FG001|Overall Study|Randomized in error|1
2157588|NCT01227421|3773002|FG002|Overall Study|Randomized in error|0
2157589|NCT01227512|3773022|FG000|Overall Study|Physician Decision|6
2157590|NCT01227512|3773023|FG001|Overall Study|Physician Decision|6
2157591|NCT01227512|3773022|FG000|Overall Study|Adverse Event|4
2157592|NCT01227512|3773023|FG001|Overall Study|Adverse Event|3
2157593|NCT01227512|3773022|FG000|Overall Study|Withdrawal by Subject|3
2157594|NCT01227512|3773023|FG001|Overall Study|Withdrawal by Subject|0
2157595|NCT01227512|3773022|FG000|Overall Study|Participant met withdrawal criteria|0
2157596|NCT01227512|3773023|FG001|Overall Study|Participant met withdrawal criteria|1
2157597|NCT01227564|3773038|FG000|Overall Study|No Longer Willing to Participate|4
2157598|NCT01227564|3773039|FG001|Overall Study|No Longer Willing to Participate|2
2157599|NCT01227564|3773040|FG002|Overall Study|No Longer Willing to Participate|5
2157600|NCT01227564|3773038|FG000|Overall Study|Participant moved to another town|0
2157601|NCT01227564|3773039|FG001|Overall Study|Participant moved to another town|0
2157602|NCT01227564|3773040|FG002|Overall Study|Participant moved to another town|1
2157603|NCT01227577|3773050|FG000|Overall Study|Protocol deviation|3
2157604|NCT01227577|3773050|FG000|Overall Study|Death|3
2157605|NCT01227577|3773050|FG000|Overall Study|Administrative problems|2
2157606|NCT01227577|3773050|FG000|Overall Study|Lost to Follow-up|1
2157607|NCT01227577|3773050|FG000|Overall Study|Withdrawal by Subject|4
2157608|NCT01227577|3773050|FG000|Overall Study|Lack of Efficacy|5
2157609|NCT01227577|3773050|FG000|Overall Study|Adverse Event|17
2157610|NCT01227629|3773073|FG000|Overall Study|Adverse Event|2
2157611|NCT01227629|3773074|FG001|Overall Study|Adverse Event|2
2157612|NCT01227629|3773075|FG002|Overall Study|Adverse Event|1
2157613|NCT01227629|3773076|FG003|Overall Study|Adverse Event|6
2157614|NCT01227629|3773077|FG004|Overall Study|Adverse Event|1
2157615|NCT01227629|3773078|FG005|Overall Study|Adverse Event|1
2157616|NCT01227629|3773079|FG006|Overall Study|Adverse Event|6
2157617|NCT01227629|3773080|FG007|Overall Study|Adverse Event|6
2157618|NCT01227629|3773081|FG008|Overall Study|Adverse Event|4
2157619|NCT01227629|3773082|FG009|Overall Study|Adverse Event|0
2157620|NCT01227629|3773073|FG000|Overall Study|Protocol Violation|0
2157621|NCT01227629|3773074|FG001|Overall Study|Protocol Violation|0
2157622|NCT01227629|3773075|FG002|Overall Study|Protocol Violation|0
2157623|NCT01227629|3773076|FG003|Overall Study|Protocol Violation|1
2157624|NCT01227629|3773077|FG004|Overall Study|Protocol Violation|0
2157625|NCT01227629|3773078|FG005|Overall Study|Protocol Violation|0
2157626|NCT01227629|3773079|FG006|Overall Study|Protocol Violation|0
2157627|NCT01227629|3773080|FG007|Overall Study|Protocol Violation|0
2157628|NCT01227629|3773081|FG008|Overall Study|Protocol Violation|0
2157629|NCT01227629|3773082|FG009|Overall Study|Protocol Violation|0
2157630|NCT01227629|3773073|FG000|Overall Study|Lost to Follow-up|0
2157631|NCT01227629|3773074|FG001|Overall Study|Lost to Follow-up|0
2157632|NCT01227629|3773075|FG002|Overall Study|Lost to Follow-up|0
2157633|NCT01227629|3773076|FG003|Overall Study|Lost to Follow-up|0
2157634|NCT01227629|3773077|FG004|Overall Study|Lost to Follow-up|1
2157635|NCT01227629|3773078|FG005|Overall Study|Lost to Follow-up|0
2157636|NCT01227629|3773079|FG006|Overall Study|Lost to Follow-up|0
2157637|NCT01227629|3773080|FG007|Overall Study|Lost to Follow-up|0
2157638|NCT01227629|3773081|FG008|Overall Study|Lost to Follow-up|0
2157639|NCT01227629|3773082|FG009|Overall Study|Lost to Follow-up|0
2157640|NCT01227629|3773073|FG000|Overall Study|Withdrawal by Subject|0
2157641|NCT01227629|3773074|FG001|Overall Study|Withdrawal by Subject|0
2157642|NCT01227629|3773075|FG002|Overall Study|Withdrawal by Subject|0
2157643|NCT01227629|3773076|FG003|Overall Study|Withdrawal by Subject|0
2157644|NCT01227629|3773077|FG004|Overall Study|Withdrawal by Subject|0
2157645|NCT01227629|3773078|FG005|Overall Study|Withdrawal by Subject|0
2157646|NCT01227629|3773079|FG006|Overall Study|Withdrawal by Subject|2
2157647|NCT01227629|3773080|FG007|Overall Study|Withdrawal by Subject|0
2157648|NCT01227629|3773081|FG008|Overall Study|Withdrawal by Subject|0
2157649|NCT01227629|3773082|FG009|Overall Study|Withdrawal by Subject|1
2157650|NCT01227629|3773073|FG000|Overall Study|Other|0
2157651|NCT01227629|3773074|FG001|Overall Study|Other|0
2157652|NCT01227629|3773075|FG002|Overall Study|Other|0
2157653|NCT01227629|3773076|FG003|Overall Study|Other|1
2157654|NCT01227629|3773077|FG004|Overall Study|Other|0
2157655|NCT01227629|3773078|FG005|Overall Study|Other|0
2157656|NCT01227629|3773079|FG006|Overall Study|Other|0
2157657|NCT01227629|3773080|FG007|Overall Study|Other|0
2157658|NCT01227629|3773081|FG008|Overall Study|Other|2
2157659|NCT01227629|3773082|FG009|Overall Study|Other|1
2157660|NCT01227668|3773143|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12
2157661|NCT01227668|3773144|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0
2157662|NCT01227668|3773143|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
2157663|NCT01227668|3773144|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
2157664|NCT01227668|3773143|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
2157665|NCT01227668|3773144|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
2157666|NCT01227668|3773143|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
2157667|NCT01227668|3773144|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
2157668|NCT01227668|3773143|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
2157669|NCT01227668|3773144|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
2157670|NCT01227668|3773143|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
2157671|NCT01227668|3773144|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
2157672|NCT01227668|3773143|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
2157673|NCT01227668|3773144|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
2157674|NCT01227668|3773143|FG000|Phase 2 (Randomization Phase)|Adverse Event|0
2157675|NCT01227668|3773144|FG001|Phase 2 (Randomization Phase)|Adverse Event|1
2157676|NCT01227668|3773143|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
2157677|NCT01227668|3773144|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
2157678|NCT01227668|3773143|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1
2157679|NCT01227668|3773144|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0
2157680|NCT01227668|3773143|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13
2157681|NCT01227668|3773144|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23
2157682|NCT01227668|3773143|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
2157683|NCT01227668|3773144|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
2157684|NCT01227707|3773163|FG000|Overall Study|Adverse Event|10
2157685|NCT01227707|3773163|FG000|Overall Study|Progression of disease|3
2157686|NCT01227707|3773163|FG000|Overall Study|Withdrawal by Subject|1
2157687|NCT01227707|3773163|FG000|Overall Study|Patient non-compliance|3
2157688|NCT01227707|3773163|FG000|Overall Study|Medical decision|6
2157689|NCT01227707|3773163|FG000|Overall Study|Death|1
2157690|NCT01227824|3773180|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
2157691|NCT01227824|3773181|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
2157692|NCT01227824|3773182|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
2157693|NCT01227824|3773180|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
2157694|NCT01227824|3773181|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
2157695|NCT01227824|3773182|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
2157696|NCT01227824|3773180|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
2157697|NCT01227824|3773181|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
2157698|NCT01227824|3773182|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
2157699|NCT01227824|3773180|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
2157700|NCT01227824|3773181|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
2157701|NCT01227824|3773182|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
2157702|NCT01227824|3773180|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
2157703|NCT01227824|3773181|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
2157704|NCT01227824|3773182|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
2157705|NCT01227824|3773180|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
2157706|NCT01227824|3773181|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
2157707|NCT01227824|3773182|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
2157708|NCT01227824|3773180|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
2157709|NCT01227824|3773181|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
2157710|NCT01227824|3773182|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
2157711|NCT01227824|3773180|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
2157712|NCT01227824|3773181|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
2157713|NCT01227824|3773182|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
2157714|NCT01227824|3773180|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0
2157715|NCT01227824|3773181|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0
2157716|NCT01227824|3773182|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4
2157717|NCT01227824|3773180|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
2157718|NCT01227824|3773181|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
2157719|NCT01227824|3773182|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
2157720|NCT01227824|3773180|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0
2157721|NCT01227824|3773181|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0
2157722|NCT01227824|3773182|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5
2157723|NCT01227824|3773180|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
2157724|NCT01227824|3773181|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
2157725|NCT01227824|3773182|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
2157726|NCT01227824|3773180|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
2157727|NCT01227824|3773181|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
2157728|NCT01227824|3773182|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
2157729|NCT01227824|3773180|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
2157730|NCT01227824|3773181|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
2157731|NCT01227824|3773182|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
2157732|NCT01227824|3773180|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0
2157733|NCT01227824|3773181|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0
2157734|NCT01227824|3773182|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3
2157735|NCT01227889|3773191|FG000|Randomized Phase (RP)|Adverse Event|13
2157736|NCT01227889|3773192|FG001|Randomized Phase (RP)|Adverse Event|0
2157737|NCT01227889|3773191|FG000|Randomized Phase (RP)|Physician Decision|13
2157738|NCT01227889|3773192|FG001|Randomized Phase (RP)|Physician Decision|5
2157739|NCT01227889|3773191|FG000|Randomized Phase (RP)|Progressive Disease|135
2157740|NCT01227889|3773192|FG001|Randomized Phase (RP)|Progressive Disease|52
2157741|NCT01227889|3773191|FG000|Randomized Phase (RP)|Study terminated by sponsor|10
2157742|NCT01227889|3773192|FG001|Randomized Phase (RP)|Study terminated by sponsor|0
2157743|NCT01227889|3773191|FG000|Randomized Phase (RP)|Missing|1
2157744|NCT01227889|3773192|FG001|Randomized Phase (RP)|Missing|3
2157745|NCT01227889|3773191|FG000|Randomized Phase (RP)|Withdrawal by Subject|15
2157746|NCT01227889|3773192|FG001|Randomized Phase (RP)|Withdrawal by Subject|3
2157747|NCT01227889|3773191|FG000|Crossover Phase|Adverse Event|0
2157748|NCT01227889|3773192|FG001|Crossover Phase|Adverse Event|1
2157749|NCT01227889|3773191|FG000|Crossover Phase|Physician Decision|0
2157750|NCT01227889|3773192|FG001|Crossover Phase|Physician Decision|3
2157751|NCT01227889|3773191|FG000|Crossover Phase|Progressive Disease|0
2157752|NCT01227889|3773192|FG001|Crossover Phase|Progressive Disease|31
2157753|NCT01227889|3773191|FG000|Crossover Phase|Study Terminated By Sponsor|0
2157754|NCT01227889|3773192|FG001|Crossover Phase|Study Terminated By Sponsor|1
2157755|NCT01227889|3773191|FG000|Crossover Phase|Withdrawal by Subject|0
2157756|NCT01227889|3773192|FG001|Crossover Phase|Withdrawal by Subject|1
2157757|NCT01227902|3773210|FG000|Overall Study|Adverse Event|12
2157758|NCT01227902|3773211|FG001|Overall Study|Adverse Event|8
2157759|NCT01227902|3773212|FG002|Overall Study|Adverse Event|11
2157760|NCT01227902|3773213|FG003|Overall Study|Adverse Event|4
2157761|NCT01227902|3773210|FG000|Overall Study|Lack of Efficacy|1
2157762|NCT01227902|3773211|FG001|Overall Study|Lack of Efficacy|2
2157763|NCT01227902|3773212|FG002|Overall Study|Lack of Efficacy|2
2157764|NCT01227902|3773213|FG003|Overall Study|Lack of Efficacy|1
2157765|NCT01227902|3773210|FG000|Overall Study|Protocol Violation|1
2157766|NCT01227902|3773211|FG001|Overall Study|Protocol Violation|0
2157767|NCT01227902|3773212|FG002|Overall Study|Protocol Violation|0
2157768|NCT01227902|3773213|FG003|Overall Study|Protocol Violation|0
2157769|NCT01227902|3773210|FG000|Overall Study|Lost to Follow-up|0
2157770|NCT01227902|3773211|FG001|Overall Study|Lost to Follow-up|0
2157771|NCT01227902|3773212|FG002|Overall Study|Lost to Follow-up|1
2157772|NCT01227902|3773213|FG003|Overall Study|Lost to Follow-up|2
2157773|NCT01227902|3773210|FG000|Overall Study|Physician Decision|0
2157774|NCT01227902|3773211|FG001|Overall Study|Physician Decision|1
2157775|NCT01227902|3773212|FG002|Overall Study|Physician Decision|1
2157776|NCT01227902|3773213|FG003|Overall Study|Physician Decision|0
2157777|NCT01227902|3773210|FG000|Overall Study|Withdrawal by Subject|4
2157778|NCT01227902|3773211|FG001|Overall Study|Withdrawal by Subject|2
2157779|NCT01227902|3773212|FG002|Overall Study|Withdrawal by Subject|4
2157780|NCT01227902|3773213|FG003|Overall Study|Withdrawal by Subject|3
2157781|NCT01227928|3773226|FG000|Overall Study|Lost to Follow-up|4
2157782|NCT01227928|3773227|FG001|Overall Study|Lost to Follow-up|2
2157783|NCT01227928|3773226|FG000|Overall Study|Withdrawal by Subject|4
2157784|NCT01227928|3773227|FG001|Overall Study|Withdrawal by Subject|3
2157785|NCT01227928|3773226|FG000|Overall Study|Death|14
2157786|NCT01227928|3773227|FG001|Overall Study|Death|12
2157787|NCT01227954|3773233|FG000|Overall Study|Protocol Violation|6
2157788|NCT01227954|3773233|FG000|Overall Study|No protocol treatment|7
2157789|NCT01227967|3773239|FG000|Overall Study|Protocol Violation|3
2157790|NCT01227967|3773240|FG001|Overall Study|Protocol Violation|1
2157791|NCT01227967|3773239|FG000|Overall Study|Death|0
2157792|NCT01227967|3773240|FG001|Overall Study|Death|1
2157793|NCT01227967|3773239|FG000|Overall Study|Lost to Follow-up|8
2157794|NCT01227967|3773240|FG001|Overall Study|Lost to Follow-up|3
2157795|NCT01227967|3773239|FG000|Overall Study|Withdrawal by Subject|4
2157796|NCT01227967|3773240|FG001|Overall Study|Withdrawal by Subject|3
2157797|NCT01227967|3773239|FG000|Overall Study|Physician Decision|0
2157798|NCT01227967|3773240|FG001|Overall Study|Physician Decision|1
2157799|NCT01227967|3773239|FG000|Overall Study|Never Started Treatment|0
2157800|NCT01227967|3773240|FG001|Overall Study|Never Started Treatment|4
2157801|NCT01227967|3773239|FG000|Overall Study|Taking Additional Antiviral Drug|1
2157802|NCT01227967|3773240|FG001|Overall Study|Taking Additional Antiviral Drug|0
2157803|NCT01228019|3773259|FG000|Overall Study|Dose Violation|70
2157804|NCT01228019|3773259|FG000|Overall Study|Duplicate enrollment|1
2157805|NCT01228019|3773259|FG000|Overall Study|Missing pre-treatment data|72
2157806|NCT01228019|3773259|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152
2157807|NCT01228019|3773259|FG000|Overall Study|Violation of Entry Criterion|9
2157808|NCT01228071|3773263|FG000|Overall Study|Protocol Violation|1
2157809|NCT01228071|3773263|FG000|Overall Study|Withdrawal by Subject|1
2157810|NCT01228175|3773285|FG000|Overall Study|Lost to Follow-up|64
2157811|NCT01228175|3773286|FG001|Overall Study|Lost to Follow-up|50
2157812|NCT01228175|3773285|FG000|Overall Study|Withdrawal by Subject|1
2157813|NCT01228175|3773286|FG001|Overall Study|Withdrawal by Subject|2
2157814|NCT01228175|3773285|FG000|Overall Study|Physician Decision|1
2157815|NCT01228175|3773286|FG001|Overall Study|Physician Decision|1
2157816|NCT01228318|3773294|FG000|Overall Study|Clinic no show to receive intervention|1
2157817|NCT01228318|3773295|FG001|Overall Study|Clinic no show to receive intervention|0
2157818|NCT01228318|3773294|FG000|Overall Study|Unable to contact|2
2157819|NCT01228318|3773295|FG001|Overall Study|Unable to contact|5
2157820|NCT01228318|3773294|FG000|Overall Study|Moved|0
2157821|NCT01228318|3773295|FG001|Overall Study|Moved|2
2157822|NCT01228318|3773294|FG000|Overall Study|Incarcerated|1
2293696|NCT02528357|3987967|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293697|NCT02528357|3987968|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293698|NCT02528357|3987969|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293699|NCT02528357|3987970|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293700|NCT02528357|3987971|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
2293701|NCT02528357|3987953|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293702|NCT02528357|3987954|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2321237|NCT02957682|4035674|FG000|Overall Study|Poor Compliance to Protocol|30
2157823|NCT01228318|3773295|FG001|Overall Study|Incarcerated|0
2157824|NCT01228591|3773310|FG000|Baseline|Lack of Efficacy|1
2157825|NCT01228591|3773311|FG001|Baseline|Lack of Efficacy|2
2157826|NCT01228734|3773323|FG000|Overall Study|Randomized, but not treated|0
2157827|NCT01228734|3773324|FG001|Overall Study|Randomized, but not treated|4
2157828|NCT01228747|3773332|FG000|Overall Study|Adverse Event|8
2157829|NCT01228747|3773333|FG001|Overall Study|Adverse Event|4
2157830|NCT01228747|3773332|FG000|Overall Study|Lack of Efficacy|40
2157831|NCT01228747|3773333|FG001|Overall Study|Lack of Efficacy|27
2157832|NCT01228747|3773332|FG000|Overall Study|Protocol Violation|6
2157833|NCT01228747|3773333|FG001|Overall Study|Protocol Violation|5
2157834|NCT01228747|3773332|FG000|Overall Study|Lost to Follow-up|4
2157835|NCT01228747|3773333|FG001|Overall Study|Lost to Follow-up|3
2157836|NCT01228747|3773332|FG000|Overall Study|Withdrawal by Subject|5
2157837|NCT01228747|3773333|FG001|Overall Study|Withdrawal by Subject|1
2157838|NCT01228747|3773332|FG000|Overall Study|Other Reason|2
2157839|NCT01228747|3773333|FG001|Overall Study|Other Reason|5
2157840|NCT01229111|3773365|FG000|Overall Study|Death|1
2157841|NCT01229150|3773373|FG000|Overall Study|Toxicity|2
2157842|NCT01229150|3773374|FG001|Overall Study|Toxicity|2
2157843|NCT01229150|3773375|FG002|Overall Study|Toxicity|0
2157844|NCT01229150|3773376|FG003|Overall Study|Toxicity|0
2157845|NCT01229176|3773398|FG000|Overall Study|Withdrawal by Subject|0
2157846|NCT01229176|3773399|FG001|Overall Study|Withdrawal by Subject|0
2157847|NCT01229176|3773400|FG002|Overall Study|Withdrawal by Subject|0
2157848|NCT01229176|3773401|FG003|Overall Study|Withdrawal by Subject|1
2157849|NCT01229176|3773402|FG004|Overall Study|Withdrawal by Subject|1
2157850|NCT01229176|3773403|FG005|Overall Study|Withdrawal by Subject|1
2157851|NCT01229176|3773404|FG006|Overall Study|Withdrawal by Subject|0
2157852|NCT01229176|3773405|FG007|Overall Study|Withdrawal by Subject|1
2157853|NCT01229176|3773398|FG000|Overall Study|Lost to Follow-up|0
2157854|NCT01229176|3773399|FG001|Overall Study|Lost to Follow-up|3
2157855|NCT01229176|3773400|FG002|Overall Study|Lost to Follow-up|0
2157856|NCT01229176|3773401|FG003|Overall Study|Lost to Follow-up|0
2157857|NCT01229176|3773402|FG004|Overall Study|Lost to Follow-up|1
2157858|NCT01229176|3773403|FG005|Overall Study|Lost to Follow-up|1
2157859|NCT01229176|3773404|FG006|Overall Study|Lost to Follow-up|0
2157860|NCT01229176|3773405|FG007|Overall Study|Lost to Follow-up|2
2179328|NCT01393600|3804870|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
2179329|NCT01393600|3804871|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
2179330|NCT01393600|3804868|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
2157861|NCT01229254|3773447|FG000|Overall Study|Not Continuing Into Safety Extension|3
2157862|NCT01229254|3773448|FG001|Overall Study|Not Continuing Into Safety Extension|1
2157863|NCT01229254|3773449|FG002|Overall Study|Not Continuing Into Safety Extension|1
2157864|NCT01229254|3773447|FG000|Overall Study|Adverse Event|4
2157865|NCT01229254|3773448|FG001|Overall Study|Adverse Event|5
2157866|NCT01229254|3773449|FG002|Overall Study|Adverse Event|3
2157867|NCT01229254|3773447|FG000|Overall Study|Lost to Follow-up|3
2157868|NCT01229254|3773448|FG001|Overall Study|Lost to Follow-up|0
2157869|NCT01229254|3773449|FG002|Overall Study|Lost to Follow-up|1
2157870|NCT01229254|3773447|FG000|Overall Study|Physician Decision|0
2157871|NCT01229254|3773448|FG001|Overall Study|Physician Decision|3
2157872|NCT01229254|3773449|FG002|Overall Study|Physician Decision|0
2157873|NCT01229254|3773447|FG000|Overall Study|Protocol Violation|4
2157874|NCT01229254|3773448|FG001|Overall Study|Protocol Violation|6
2157875|NCT01229254|3773449|FG002|Overall Study|Protocol Violation|5
2157876|NCT01229254|3773447|FG000|Overall Study|Withdrawal by Subject|1
2157877|NCT01229254|3773448|FG001|Overall Study|Withdrawal by Subject|0
2157878|NCT01229254|3773449|FG002|Overall Study|Withdrawal by Subject|1
2157879|NCT01229254|3773447|FG000|Overall Study|Non-compliance with Study Drug|0
2157880|NCT01229254|3773448|FG001|Overall Study|Non-compliance with Study Drug|1
2157881|NCT01229254|3773449|FG002|Overall Study|Non-compliance with Study Drug|1
2157882|NCT01229267|3773463|FG000|Overall Study|Adverse Event|4
2157883|NCT01229267|3773464|FG001|Overall Study|Adverse Event|6
2157884|NCT01229267|3773465|FG002|Overall Study|Adverse Event|3
2157885|NCT01229267|3773466|FG003|Overall Study|Adverse Event|2
2157886|NCT01229267|3773467|FG004|Overall Study|Adverse Event|10
2157887|NCT01229267|3773463|FG000|Overall Study|Death|40
2157888|NCT01229267|3773464|FG001|Overall Study|Death|37
2157889|NCT01229267|3773465|FG002|Overall Study|Death|35
2157890|NCT01229267|3773466|FG003|Overall Study|Death|13
2157891|NCT01229267|3773467|FG004|Overall Study|Death|103
2157892|NCT01229267|3773463|FG000|Overall Study|Withdrawal by Subject|23
2157893|NCT01229267|3773464|FG001|Overall Study|Withdrawal by Subject|22
2157894|NCT01229267|3773465|FG002|Overall Study|Withdrawal by Subject|32
2157895|NCT01229267|3773466|FG003|Overall Study|Withdrawal by Subject|14
2157896|NCT01229267|3773467|FG004|Overall Study|Withdrawal by Subject|59
2157897|NCT01229267|3773463|FG000|Overall Study|Protocol Violation|0
2157898|NCT01229267|3773464|FG001|Overall Study|Protocol Violation|1
2157899|NCT01229267|3773465|FG002|Overall Study|Protocol Violation|0
2157900|NCT01229267|3773466|FG003|Overall Study|Protocol Violation|0
2157901|NCT01229267|3773467|FG004|Overall Study|Protocol Violation|0
2157902|NCT01229267|3773463|FG000|Overall Study|Progressive disease|0
2157903|NCT01229267|3773464|FG001|Overall Study|Progressive disease|0
2157904|NCT01229267|3773465|FG002|Overall Study|Progressive disease|0
2157905|NCT01229267|3773466|FG003|Overall Study|Progressive disease|0
2157906|NCT01229267|3773467|FG004|Overall Study|Progressive disease|1
2157907|NCT01229267|3773463|FG000|Overall Study|Physician Decision|8
2157908|NCT01229267|3773464|FG001|Overall Study|Physician Decision|11
2157909|NCT01229267|3773465|FG002|Overall Study|Physician Decision|8
2157910|NCT01229267|3773466|FG003|Overall Study|Physician Decision|3
2157911|NCT01229267|3773467|FG004|Overall Study|Physician Decision|25
2157912|NCT01229267|3773463|FG000|Overall Study|Lost to Follow-up|6
2157913|NCT01229267|3773464|FG001|Overall Study|Lost to Follow-up|5
2157914|NCT01229267|3773465|FG002|Overall Study|Lost to Follow-up|8
2157915|NCT01229267|3773466|FG003|Overall Study|Lost to Follow-up|3
2157916|NCT01229267|3773467|FG004|Overall Study|Lost to Follow-up|22
2157917|NCT01229371|3773478|FG000|Overall Study|Withdrawal by Subject|0
2157918|NCT01229371|3773479|FG001|Overall Study|Withdrawal by Subject|1
2157919|NCT01229371|3773480|FG002|Overall Study|Withdrawal by Subject|0
2157920|NCT01229371|3773481|FG003|Overall Study|Withdrawal by Subject|0
2157921|NCT01229397|3773493|FG000|Overall Study|Withdrawal by Subject|3
2157922|NCT01229397|3773494|FG001|Overall Study|Withdrawal by Subject|3
2157923|NCT01229397|3773493|FG000|Overall Study|Lost to Follow-up|7
2157924|NCT01229397|3773494|FG001|Overall Study|Lost to Follow-up|6
2157925|NCT01229397|3773493|FG000|Overall Study|Migrated/moved from study area|1
2157926|NCT01229397|3773494|FG001|Overall Study|Migrated/moved from study area|0
2157927|NCT01229436|3773517|FG000|Overall Study|Withdrawal by Subject|2
2157928|NCT01229436|3773517|FG000|Overall Study|Lost to Follow-up|3
2157929|NCT01229449|3773526|FG000|Overall Study|Withdrawal by Subject|0
2157930|NCT01229449|3773527|FG001|Overall Study|Withdrawal by Subject|3
2157931|NCT01229449|3773528|FG002|Overall Study|Withdrawal by Subject|0
2157932|NCT01229449|3773529|FG003|Overall Study|Withdrawal by Subject|1
2157933|NCT01229449|3773530|FG004|Overall Study|Withdrawal by Subject|1
2157934|NCT01229449|3773526|FG000|Overall Study|Lost to Follow-up|1
2157935|NCT01229449|3773527|FG001|Overall Study|Lost to Follow-up|1
2157936|NCT01229449|3773528|FG002|Overall Study|Lost to Follow-up|1
2157937|NCT01229449|3773529|FG003|Overall Study|Lost to Follow-up|0
2157938|NCT01229449|3773530|FG004|Overall Study|Lost to Follow-up|0
2157939|NCT01229449|3773526|FG000|Overall Study|Physician Decision|0
2157940|NCT01229449|3773527|FG001|Overall Study|Physician Decision|0
2157941|NCT01229449|3773528|FG002|Overall Study|Physician Decision|1
2157942|NCT01229449|3773529|FG003|Overall Study|Physician Decision|0
2157943|NCT01229449|3773530|FG004|Overall Study|Physician Decision|0
2157944|NCT01229735|3773579|FG000|Overall Study|Lack of Efficacy|8
2157945|NCT01229735|3773580|FG001|Overall Study|Lack of Efficacy|8
2157946|NCT01229735|3773579|FG000|Overall Study|Protocol Violation|13
2157947|NCT01229735|3773580|FG001|Overall Study|Protocol Violation|8
2157948|NCT01229735|3773579|FG000|Overall Study|Lost to Follow-up|0
2157949|NCT01229735|3773580|FG001|Overall Study|Lost to Follow-up|2
2157950|NCT01229735|3773579|FG000|Overall Study|Withdrawal by Subject|18
2157951|NCT01229735|3773580|FG001|Overall Study|Withdrawal by Subject|17
2208142|NCT01636687|3847523|FG000|Extension Period|Withdrawal by Subject|1
2208143|NCT01636687|3847524|FG001|Extension Period|Withdrawal by Subject|0
2157952|NCT01229735|3773579|FG000|Overall Study|Other Reason|13
2157953|NCT01229735|3773580|FG001|Overall Study|Other Reason|10
2157954|NCT01229735|3773579|FG000|Overall Study|SAE, non-fatal|0
2157955|NCT01229735|3773580|FG001|Overall Study|SAE, non-fatal|4
2157956|NCT01229735|3773579|FG000|Overall Study|AE, non-serious non-fatal|13
2157957|NCT01229735|3773580|FG001|Overall Study|AE, non-serious non-fatal|17
2157958|NCT01229735|3773579|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2157959|NCT01229735|3773580|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2157960|NCT01230060|3773616|FG000|Overall Study|Withdrawal by Subject|1
2157961|NCT01230554|3773661|FG000|Overall Study|Lost to Follow-up|2
2157962|NCT01230554|3773661|FG000|Overall Study|Inability to maintain visit schedule|1
2157963|NCT01230710|3773678|FG000|Overall Study|Disease Progression|41
2157964|NCT01230710|3773678|FG000|Overall Study|Lost to Follow-up|3
2157965|NCT01230710|3773678|FG000|Overall Study|Death|4
2157966|NCT01230710|3773678|FG000|Overall Study|Withdrawal of Consent|1
2157967|NCT01230749|3773686|FG000|Overall Study|Adverse Event|0
2157968|NCT01230749|3773687|FG001|Overall Study|Adverse Event|0
2157969|NCT01230749|3773688|FG002|Overall Study|Adverse Event|0
2157970|NCT01230749|3773689|FG003|Overall Study|Adverse Event|1
2157971|NCT01230749|3773686|FG000|Overall Study|Physician Decision|0
2157972|NCT01230749|3773687|FG001|Overall Study|Physician Decision|0
2157973|NCT01230749|3773688|FG002|Overall Study|Physician Decision|1
2157974|NCT01230749|3773689|FG003|Overall Study|Physician Decision|0
2157975|NCT01230749|3773686|FG000|Overall Study|Withdrawal by Subject|0
2157976|NCT01230749|3773687|FG001|Overall Study|Withdrawal by Subject|1
2157977|NCT01230749|3773688|FG002|Overall Study|Withdrawal by Subject|0
2157978|NCT01230749|3773689|FG003|Overall Study|Withdrawal by Subject|0
2157979|NCT01230749|3773686|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0
2157980|NCT01230749|3773687|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1
2157981|NCT01230749|3773688|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1
2157982|NCT01230749|3773689|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1
2157983|NCT01230814|3773720|FG000|Overall Study|Lost to Follow-up|11
2157984|NCT01230814|3773721|FG001|Overall Study|Lost to Follow-up|3
2157985|NCT01230814|3773720|FG000|Overall Study|Discontinued (not due to adverse event)|2
2157986|NCT01230814|3773721|FG001|Overall Study|Discontinued (not due to adverse event)|1
2157987|NCT01230827|3773731|FG000|Overall Study|Lost to Follow-up|0
2157988|NCT01230827|3773732|FG001|Overall Study|Lost to Follow-up|0
2157989|NCT01230827|3773733|FG002|Overall Study|Lost to Follow-up|1
2157990|NCT01230827|3773734|FG003|Overall Study|Lost to Follow-up|3
2157991|NCT01230827|3773731|FG000|Overall Study|Withdrawal by Subject|1
2157992|NCT01230827|3773732|FG001|Overall Study|Withdrawal by Subject|0
2157993|NCT01230827|3773733|FG002|Overall Study|Withdrawal by Subject|3
2157994|NCT01230827|3773734|FG003|Overall Study|Withdrawal by Subject|2
2157995|NCT01230827|3773731|FG000|Overall Study|Lack of Efficacy|14
2157996|NCT01230827|3773732|FG001|Overall Study|Lack of Efficacy|1
2157997|NCT01230827|3773733|FG002|Overall Study|Lack of Efficacy|2
2157998|NCT01230827|3773734|FG003|Overall Study|Lack of Efficacy|3
2157999|NCT01230827|3773731|FG000|Overall Study|Adverse Event|4
2158000|NCT01230827|3773732|FG001|Overall Study|Adverse Event|2
2158001|NCT01230827|3773733|FG002|Overall Study|Adverse Event|3
2158002|NCT01230827|3773734|FG003|Overall Study|Adverse Event|7
2158003|NCT01230827|3773731|FG000|Overall Study|Recovery|0
2158004|NCT01230827|3773732|FG001|Overall Study|Recovery|6
2158005|NCT01230827|3773733|FG002|Overall Study|Recovery|0
2158006|NCT01230827|3773734|FG003|Overall Study|Recovery|0
2158007|NCT01230827|3773731|FG000|Overall Study|Study terminated by Sponsor|0
2158008|NCT01230827|3773732|FG001|Overall Study|Study terminated by Sponsor|2
2158009|NCT01230827|3773733|FG002|Overall Study|Study terminated by Sponsor|56
2158010|NCT01230827|3773734|FG003|Overall Study|Study terminated by Sponsor|63
2158011|NCT01230892|3773744|FG000|Overall Study|Withdrawal by Subject|1
2158012|NCT01230892|3773745|FG001|Overall Study|Withdrawal by Subject|1
2158013|NCT01230892|3773744|FG000|Overall Study|Lost to Follow-up|2
2158014|NCT01230892|3773745|FG001|Overall Study|Lost to Follow-up|0
2158015|NCT01231321|3773771|FG000|Overall Study|Adverse Event|3
2158016|NCT01231321|3773771|FG000|Overall Study|Lack of Efficacy|2
2158017|NCT01231373|3773794|FG000|Overall Study|Withdrew consent prior to randomization|2
2158018|NCT01231373|3773795|FG001|Overall Study|Withdrew consent prior to randomization|1
2158019|NCT01231373|3773796|FG002|Overall Study|Withdrew consent prior to randomization|0
2158020|NCT01231373|3773797|FG003|Overall Study|Withdrew consent prior to randomization|0
2158021|NCT01231373|3773794|FG000|Overall Study|Lost to Follow-up|0
2158022|NCT01231373|3773795|FG001|Overall Study|Lost to Follow-up|0
2158023|NCT01231373|3773796|FG002|Overall Study|Lost to Follow-up|0
2158024|NCT01231373|3773797|FG003|Overall Study|Lost to Follow-up|1
2158025|NCT01231373|3773794|FG000|Overall Study|Withdrew Consent|1
2158026|NCT01231373|3773795|FG001|Overall Study|Withdrew Consent|0
2208144|NCT01636687|3847525|FG002|Extension Period|Withdrawal by Subject|1
2158027|NCT01231373|3773796|FG002|Overall Study|Withdrew Consent|0
2158028|NCT01231373|3773797|FG003|Overall Study|Withdrew Consent|0
2158029|NCT01231464|3773829|FG000|Overall Study|Adverse Event|0
2158030|NCT01231464|3773830|FG001|Overall Study|Adverse Event|1
2158031|NCT01231464|3773829|FG000|Overall Study|Protocol Violation|1
2158032|NCT01231464|3773830|FG001|Overall Study|Protocol Violation|2
2158033|NCT01231464|3773829|FG000|Overall Study|Lost to Follow-up|1
2158034|NCT01231464|3773830|FG001|Overall Study|Lost to Follow-up|2
2158035|NCT01231464|3773829|FG000|Overall Study|Withdrawal by Subject|3
2158036|NCT01231464|3773830|FG001|Overall Study|Withdrawal by Subject|2
2158037|NCT01231503|3773846|FG000|Overall Study|Adverse Event|0
2158038|NCT01231503|3773847|FG001|Overall Study|Adverse Event|0
2158039|NCT01231503|3773848|FG002|Overall Study|Adverse Event|0
2158040|NCT01231503|3773849|FG003|Overall Study|Adverse Event|0
2158041|NCT01231503|3773850|FG004|Overall Study|Adverse Event|0
2158042|NCT01231503|3773851|FG005|Overall Study|Adverse Event|1
2158043|NCT01231503|3773852|FG006|Overall Study|Adverse Event|0
2158044|NCT01231503|3773853|FG007|Overall Study|Adverse Event|0
2158045|NCT01231503|3773846|FG000|Overall Study|Adverse event, serious fatal|0
2158046|NCT01231503|3773847|FG001|Overall Study|Adverse event, serious fatal|0
2158047|NCT01231503|3773848|FG002|Overall Study|Adverse event, serious fatal|1
2158048|NCT01231503|3773849|FG003|Overall Study|Adverse event, serious fatal|1
2158049|NCT01231503|3773850|FG004|Overall Study|Adverse event, serious fatal|0
2158050|NCT01231503|3773851|FG005|Overall Study|Adverse event, serious fatal|1
2158051|NCT01231503|3773852|FG006|Overall Study|Adverse event, serious fatal|0
2158052|NCT01231503|3773853|FG007|Overall Study|Adverse event, serious fatal|0
2158053|NCT01231503|3773846|FG000|Overall Study|Withdrawal by Subject|6
2158054|NCT01231503|3773847|FG001|Overall Study|Withdrawal by Subject|3
2158055|NCT01231503|3773848|FG002|Overall Study|Withdrawal by Subject|3
2158056|NCT01231503|3773849|FG003|Overall Study|Withdrawal by Subject|1
2158057|NCT01231503|3773850|FG004|Overall Study|Withdrawal by Subject|3
2158058|NCT01231503|3773851|FG005|Overall Study|Withdrawal by Subject|5
2158059|NCT01231503|3773852|FG006|Overall Study|Withdrawal by Subject|1
2158060|NCT01231503|3773853|FG007|Overall Study|Withdrawal by Subject|2
2158061|NCT01231503|3773846|FG000|Overall Study|Lost to Follow-up|8
2158062|NCT01231503|3773847|FG001|Overall Study|Lost to Follow-up|10
2158063|NCT01231503|3773848|FG002|Overall Study|Lost to Follow-up|8
2158064|NCT01231503|3773849|FG003|Overall Study|Lost to Follow-up|5
2158065|NCT01231503|3773850|FG004|Overall Study|Lost to Follow-up|7
2158066|NCT01231503|3773851|FG005|Overall Study|Lost to Follow-up|9
2158067|NCT01231503|3773852|FG006|Overall Study|Lost to Follow-up|6
2158068|NCT01231503|3773853|FG007|Overall Study|Lost to Follow-up|6
2158069|NCT01231503|3773846|FG000|Overall Study|Protocol Violation|0
2158070|NCT01231503|3773847|FG001|Overall Study|Protocol Violation|0
2158071|NCT01231503|3773848|FG002|Overall Study|Protocol Violation|0
2158072|NCT01231503|3773849|FG003|Overall Study|Protocol Violation|1
2158073|NCT01231503|3773850|FG004|Overall Study|Protocol Violation|0
2158074|NCT01231503|3773851|FG005|Overall Study|Protocol Violation|0
2158075|NCT01231503|3773852|FG006|Overall Study|Protocol Violation|0
2158076|NCT01231503|3773853|FG007|Overall Study|Protocol Violation|0
2158077|NCT01231516|3773883|FG000|48 Week Double-blind Phase|Adverse Event|4
2158078|NCT01231516|3773884|FG001|48 Week Double-blind Phase|Adverse Event|11
2158079|NCT01231516|3773883|FG000|48 Week Double-blind Phase|Lack of Efficacy|20
2158080|NCT01231516|3773884|FG001|48 Week Double-blind Phase|Lack of Efficacy|42
2158081|NCT01231516|3773883|FG000|48 Week Double-blind Phase|Protocol Violation|9
2158082|NCT01231516|3773884|FG001|48 Week Double-blind Phase|Protocol Violation|6
2158083|NCT01231516|3773883|FG000|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
2158084|NCT01231516|3773884|FG001|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
2158085|NCT01231516|3773883|FG000|48 Week Double-blind Phase|Lost to Follow-up|5
2158086|NCT01231516|3773884|FG001|48 Week Double-blind Phase|Lost to Follow-up|10
2158087|NCT01231516|3773883|FG000|48 Week Double-blind Phase|Physician Decision|1
2158088|NCT01231516|3773884|FG001|48 Week Double-blind Phase|Physician Decision|1
2158089|NCT01231516|3773883|FG000|48 Week Double-blind Phase|Withdrawal by Subject|11
2158090|NCT01231516|3773884|FG001|48 Week Double-blind Phase|Withdrawal by Subject|5
2158091|NCT01231516|3773883|FG000|48 Week Double-blind Phase|Site Closed|3
2158092|NCT01231516|3773884|FG001|48 Week Double-blind Phase|Site Closed|1
2158093|NCT01231516|3773883|FG000|Open-label Phase|Lack of Efficacy|7
2158094|NCT01231516|3773884|FG001|Open-label Phase|Lack of Efficacy|3
2158095|NCT01231516|3773883|FG000|Open-label Phase|Protocol Violation|2
2158096|NCT01231516|3773884|FG001|Open-label Phase|Protocol Violation|0
2158097|NCT01231516|3773883|FG000|Open-label Phase|Lost to Follow-up|3
2158098|NCT01231516|3773884|FG001|Open-label Phase|Lost to Follow-up|0
2158099|NCT01231516|3773883|FG000|Open-label Phase|Withdrawal by Subject|1
2158100|NCT01231516|3773884|FG001|Open-label Phase|Withdrawal by Subject|0
2158101|NCT01231516|3773883|FG000|Open-label Phase|Ongoing at the time of analysis|282
2158102|NCT01231516|3773884|FG001|Open-label Phase|Ongoing at the time of analysis|23
2158103|NCT01231555|3773894|FG000|Overall Study|Study terminated|8
2158104|NCT01231555|3773895|FG001|Overall Study|Study terminated|5
2158105|NCT01231555|3773896|FG002|Overall Study|Study terminated|8
2158106|NCT01231555|3773894|FG000|Overall Study|Withdrawal by Subject|0
2158107|NCT01231555|3773895|FG001|Overall Study|Withdrawal by Subject|2
2158108|NCT01231555|3773896|FG002|Overall Study|Withdrawal by Subject|0
2158109|NCT01231581|3773906|FG000|Overall Study|Lost to Follow-up|2
2158110|NCT01231581|3773907|FG001|Overall Study|Lost to Follow-up|2
2158111|NCT01231581|3773906|FG000|Overall Study|Withdrawal by Subject|6
2158112|NCT01231581|3773907|FG001|Overall Study|Withdrawal by Subject|9
2158113|NCT01231581|3773906|FG000|Overall Study|Study Closed/Terminated|6
2158114|NCT01231581|3773907|FG001|Overall Study|Study Closed/Terminated|5
2158115|NCT01231581|3773906|FG000|Overall Study|Death|65
2158116|NCT01231581|3773907|FG001|Overall Study|Death|64
2158117|NCT01231581|3773906|FG000|Overall Study|Ongoing|1
2158118|NCT01231581|3773907|FG001|Overall Study|Ongoing|0
2158119|NCT01231607|3773918|FG000|Overall Study|Adverse Event|0
2158120|NCT01231607|3773919|FG001|Overall Study|Adverse Event|8
2158121|NCT01231607|3773920|FG002|Overall Study|Adverse Event|4
2158122|NCT01231607|3773921|FG003|Overall Study|Adverse Event|4
2158123|NCT01231607|3773922|FG004|Overall Study|Adverse Event|5
2158124|NCT01231607|3773918|FG000|Overall Study|Lost to Follow-up|13
2158125|NCT01231607|3773919|FG001|Overall Study|Lost to Follow-up|11
2158126|NCT01231607|3773920|FG002|Overall Study|Lost to Follow-up|10
2158127|NCT01231607|3773921|FG003|Overall Study|Lost to Follow-up|10
2158128|NCT01231607|3773922|FG004|Overall Study|Lost to Follow-up|4
2158129|NCT01231607|3773918|FG000|Overall Study|Physician Decision|4
2158130|NCT01231607|3773919|FG001|Overall Study|Physician Decision|4
2158131|NCT01231607|3773920|FG002|Overall Study|Physician Decision|3
2158132|NCT01231607|3773921|FG003|Overall Study|Physician Decision|5
2158133|NCT01231607|3773922|FG004|Overall Study|Physician Decision|4
2158134|NCT01231607|3773918|FG000|Overall Study|Protocol Violation|3
2158135|NCT01231607|3773919|FG001|Overall Study|Protocol Violation|2
2158136|NCT01231607|3773920|FG002|Overall Study|Protocol Violation|0
2158137|NCT01231607|3773921|FG003|Overall Study|Protocol Violation|2
2158138|NCT01231607|3773922|FG004|Overall Study|Protocol Violation|2
2158139|NCT01231607|3773918|FG000|Overall Study|Withdrawal by Subject|9
2158140|NCT01231607|3773919|FG001|Overall Study|Withdrawal by Subject|9
2158141|NCT01231607|3773920|FG002|Overall Study|Withdrawal by Subject|14
2158142|NCT01231607|3773921|FG003|Overall Study|Withdrawal by Subject|17
2158143|NCT01231607|3773922|FG004|Overall Study|Withdrawal by Subject|9
2158144|NCT01231620|3773940|FG000|Overall Study|Physician Decision|3
2158145|NCT01231620|3773941|FG001|Overall Study|Physician Decision|5
2158146|NCT01231620|3773942|FG002|Overall Study|Physician Decision|10
2158147|NCT01231620|3773940|FG000|Overall Study|Death|12
2158148|NCT01231620|3773941|FG001|Overall Study|Death|14
2158149|NCT01231620|3773942|FG002|Overall Study|Death|11
2158150|NCT01231620|3773940|FG000|Overall Study|Adverse Event|2
2158151|NCT01231620|3773941|FG001|Overall Study|Adverse Event|2
2158152|NCT01231620|3773942|FG002|Overall Study|Adverse Event|1
2158153|NCT01231620|3773940|FG000|Overall Study|Withdrawal by Subject|6
2158154|NCT01231620|3773941|FG001|Overall Study|Withdrawal by Subject|6
2158155|NCT01231620|3773942|FG002|Overall Study|Withdrawal by Subject|8
2158156|NCT01231620|3773940|FG000|Overall Study|Lost to Follow-up|3
2158157|NCT01231620|3773941|FG001|Overall Study|Lost to Follow-up|4
2158158|NCT01231620|3773942|FG002|Overall Study|Lost to Follow-up|9
2158159|NCT01231659|3773970|FG000|Overall Study|Adverse Event|9
2158160|NCT01231659|3773970|FG000|Overall Study|Disease Progression|48
2158161|NCT01231659|3773970|FG000|Overall Study|Death|2
2158162|NCT01231659|3773970|FG000|Overall Study|Patient refused to complete study visit|1
2158163|NCT01231659|3773970|FG000|Overall Study|Other protocol defined criteria|12
2158164|NCT01231906|3773980|FG000|Overall Study|Lack of Efficacy|75
2158165|NCT01231906|3773981|FG001|Overall Study|Lack of Efficacy|68
2158166|NCT01231906|3773980|FG000|Overall Study|Lost to Follow-up|1
2158167|NCT01231906|3773981|FG001|Overall Study|Lost to Follow-up|0
2158168|NCT01231906|3773980|FG000|Overall Study|Physician Decision|34
2158169|NCT01231906|3773981|FG001|Overall Study|Physician Decision|24
2158170|NCT01231906|3773980|FG000|Overall Study|Withdrawal by Subject|0
2158171|NCT01231906|3773981|FG001|Overall Study|Withdrawal by Subject|4
2158172|NCT01231906|3773980|FG000|Overall Study|Ineligible|10
2158173|NCT01231906|3773981|FG001|Overall Study|Ineligible|3
2158174|NCT01231906|3773980|FG000|Overall Study|No treatment|1
2158175|NCT01231906|3773981|FG001|Overall Study|No treatment|2
2158176|NCT01231984|3773989|FG000|Study Period 1|Withdrawal by Subject|0
2158177|NCT01231984|3773990|FG001|Study Period 1|Withdrawal by Subject|0
2158178|NCT01231984|3773991|FG002|Study Period 1|Withdrawal by Subject|0
2158179|NCT01231984|3773992|FG003|Study Period 1|Withdrawal by Subject|1
2158180|NCT01231984|3773989|FG000|Study Period 1|Lost to Follow-up|1
2158181|NCT01231984|3773990|FG001|Study Period 1|Lost to Follow-up|1
2158182|NCT01231984|3773991|FG002|Study Period 1|Lost to Follow-up|1
2158183|NCT01231984|3773992|FG003|Study Period 1|Lost to Follow-up|0
2158184|NCT01231984|3773989|FG000|Study Period 1|Did not continue to meet I/E Criteria|2
2158185|NCT01231984|3773990|FG001|Study Period 1|Did not continue to meet I/E Criteria|2
2158186|NCT01231984|3773991|FG002|Study Period 1|Did not continue to meet I/E Criteria|2
2158187|NCT01231984|3773992|FG003|Study Period 1|Did not continue to meet I/E Criteria|2
2041682|NCT00440466|3612399|FG000|Overall Study|Began Dialysis|0
2041683|NCT00440466|3612400|FG001|Overall Study|Began Dialysis|0
2041684|NCT00440466|3612401|FG002|Overall Study|Began Dialysis|1
2158188|NCT01231984|3773989|FG000|Study Period 1|Screen Failure|0
2158189|NCT01231984|3773990|FG001|Study Period 1|Screen Failure|0
2158190|NCT01231984|3773991|FG002|Study Period 1|Screen Failure|0
2158191|NCT01231984|3773992|FG003|Study Period 1|Screen Failure|1
2158192|NCT01231984|3773989|FG000|Study Period 1|Non-compliance with study requirements|5
2158193|NCT01231984|3773990|FG001|Study Period 1|Non-compliance with study requirements|0
2158194|NCT01231984|3773991|FG002|Study Period 1|Non-compliance with study requirements|2
2158195|NCT01231984|3773992|FG003|Study Period 1|Non-compliance with study requirements|1
2158196|NCT01231984|3773989|FG000|Study Period 1|Protocol Violation|3
2158197|NCT01231984|3773990|FG001|Study Period 1|Protocol Violation|4
2158198|NCT01231984|3773991|FG002|Study Period 1|Protocol Violation|2
2158199|NCT01231984|3773992|FG003|Study Period 1|Protocol Violation|3
2158200|NCT01231984|3773989|FG000|Study Period 1|Adverse Event|1
2158201|NCT01231984|3773990|FG001|Study Period 1|Adverse Event|0
2158202|NCT01231984|3773991|FG002|Study Period 1|Adverse Event|0
2158203|NCT01231984|3773992|FG003|Study Period 1|Adverse Event|0
2158204|NCT01231984|3773989|FG000|Study Period 1|Other|0
2158205|NCT01231984|3773990|FG001|Study Period 1|Other|0
2158206|NCT01231984|3773991|FG002|Study Period 1|Other|0
2158207|NCT01231984|3773992|FG003|Study Period 1|Other|1
2158208|NCT01231984|3773989|FG000|Study Period 2|Withdrawal by Subject|1
2158209|NCT01231984|3773990|FG001|Study Period 2|Withdrawal by Subject|1
2158210|NCT01231984|3773991|FG002|Study Period 2|Withdrawal by Subject|0
2158211|NCT01231984|3773992|FG003|Study Period 2|Withdrawal by Subject|0
2158212|NCT01231984|3773989|FG000|Study Period 2|Lost to Follow-up|1
2158213|NCT01231984|3773990|FG001|Study Period 2|Lost to Follow-up|0
2158214|NCT01231984|3773991|FG002|Study Period 2|Lost to Follow-up|0
2158215|NCT01231984|3773992|FG003|Study Period 2|Lost to Follow-up|3
2158216|NCT01231984|3773989|FG000|Study Period 2|Did not continue to meet I/E Criteria|1
2158217|NCT01231984|3773990|FG001|Study Period 2|Did not continue to meet I/E Criteria|1
2158218|NCT01231984|3773991|FG002|Study Period 2|Did not continue to meet I/E Criteria|0
2158219|NCT01231984|3773992|FG003|Study Period 2|Did not continue to meet I/E Criteria|1
2158220|NCT01232127|3774010|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1
2158221|NCT01232127|3774011|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0
2158222|NCT01232127|3774012|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0
2158223|NCT01232283|3774035|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
2158224|NCT01232283|3774036|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
2158225|NCT01232283|3774037|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2158226|NCT01232283|3774038|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2158227|NCT01232283|3774039|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2158228|NCT01232283|3774040|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2158229|NCT01232283|3774041|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2158230|NCT01232283|3774042|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2158231|NCT01232283|3774043|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2158232|NCT01232283|3774044|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2158233|NCT01232283|3774035|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
2158234|NCT01232283|3774036|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
2158235|NCT01232283|3774037|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2158236|NCT01232283|3774038|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2158237|NCT01232283|3774039|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2158238|NCT01232283|3774040|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2158239|NCT01232283|3774041|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2158240|NCT01232283|3774042|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2158241|NCT01232283|3774043|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2158242|NCT01232283|3774044|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2158243|NCT01232283|3774035|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
2158244|NCT01232283|3774036|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2158245|NCT01232283|3774037|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2158246|NCT01232283|3774038|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2158247|NCT01232283|3774039|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2158248|NCT01232283|3774040|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2158249|NCT01232283|3774041|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2158250|NCT01232283|3774042|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2158251|NCT01232283|3774043|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2158252|NCT01232283|3774044|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2158253|NCT01232283|3774035|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
2158254|NCT01232283|3774036|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
2158255|NCT01232283|3774037|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2158256|NCT01232283|3774038|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2158257|NCT01232283|3774039|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2158258|NCT01232283|3774040|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2158259|NCT01232283|3774041|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2158260|NCT01232283|3774042|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2293703|NCT02528357|3987955|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293704|NCT02528357|3987956|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2158261|NCT01232283|3774043|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2158262|NCT01232283|3774044|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2158263|NCT01232283|3774035|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
2158264|NCT01232283|3774036|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
2158265|NCT01232283|3774037|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2158266|NCT01232283|3774038|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2158267|NCT01232283|3774039|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2158268|NCT01232283|3774040|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2158269|NCT01232283|3774041|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2158270|NCT01232283|3774042|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2158271|NCT01232283|3774043|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2158272|NCT01232283|3774044|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2158273|NCT01232283|3774035|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
2158274|NCT01232283|3774036|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
2158275|NCT01232283|3774037|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2158276|NCT01232283|3774038|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2158277|NCT01232283|3774039|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2158278|NCT01232283|3774040|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2158279|NCT01232283|3774041|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2158280|NCT01232283|3774042|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2158281|NCT01232283|3774043|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2158282|NCT01232283|3774044|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2158283|NCT01232283|3774035|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2
2158284|NCT01232283|3774036|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1
2158285|NCT01232283|3774037|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0
2158286|NCT01232283|3774038|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0
2158287|NCT01232283|3774039|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0
2158288|NCT01232283|3774040|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0
2158289|NCT01232283|3774041|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0
2158290|NCT01232283|3774042|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0
2158291|NCT01232283|3774043|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0
2158292|NCT01232283|3774044|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0
2158293|NCT01232283|3774035|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0
2158294|NCT01232283|3774036|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0
2158295|NCT01232283|3774037|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8
2158296|NCT01232283|3774038|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2
2158297|NCT01232283|3774039|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0
2158298|NCT01232283|3774040|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0
2158299|NCT01232283|3774041|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0
2158300|NCT01232283|3774042|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0
2158301|NCT01232283|3774043|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0
2158302|NCT01232283|3774044|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0
2158303|NCT01232283|3774035|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2158304|NCT01232283|3774036|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2158305|NCT01232283|3774037|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
2158306|NCT01232283|3774038|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
2158307|NCT01232283|3774039|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2158308|NCT01232283|3774040|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2158309|NCT01232283|3774041|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2158310|NCT01232283|3774042|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2158311|NCT01232283|3774043|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2158312|NCT01232283|3774044|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2158313|NCT01232283|3774035|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2158314|NCT01232283|3774036|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2158315|NCT01232283|3774037|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
2158316|NCT01232283|3774038|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2158317|NCT01232283|3774039|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2158318|NCT01232283|3774040|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2158319|NCT01232283|3774041|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2158320|NCT01232283|3774042|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2158321|NCT01232283|3774043|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2158322|NCT01232283|3774044|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2158323|NCT01232283|3774035|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2158324|NCT01232283|3774036|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2158325|NCT01232283|3774037|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
2158326|NCT01232283|3774038|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
2158327|NCT01232283|3774039|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2158328|NCT01232283|3774040|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2158329|NCT01232283|3774041|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2158330|NCT01232283|3774042|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2158331|NCT01232283|3774043|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2158332|NCT01232283|3774044|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2158333|NCT01232283|3774035|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2158334|NCT01232283|3774036|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2158335|NCT01232283|3774037|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
2158336|NCT01232283|3774038|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
2158337|NCT01232283|3774039|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2158338|NCT01232283|3774040|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2158339|NCT01232283|3774041|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2158340|NCT01232283|3774042|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2158341|NCT01232283|3774043|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2158342|NCT01232283|3774044|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2158343|NCT01232283|3774035|FG000|Maintenance Phase (Weeks16-32)|Other|0
2158344|NCT01232283|3774036|FG001|Maintenance Phase (Weeks16-32)|Other|0
2158345|NCT01232283|3774037|FG002|Maintenance Phase (Weeks16-32)|Other|2
2158346|NCT01232283|3774038|FG003|Maintenance Phase (Weeks16-32)|Other|0
2158347|NCT01232283|3774039|FG004|Maintenance Phase (Weeks16-32)|Other|0
2158348|NCT01232283|3774040|FG005|Maintenance Phase (Weeks16-32)|Other|0
2158349|NCT01232283|3774041|FG006|Maintenance Phase (Weeks16-32)|Other|0
2158350|NCT01232283|3774042|FG007|Maintenance Phase (Weeks16-32)|Other|0
2158351|NCT01232283|3774043|FG008|Maintenance Phase (Weeks16-32)|Other|0
2158352|NCT01232283|3774044|FG009|Maintenance Phase (Weeks16-32)|Other|0
2158353|NCT01232283|3774035|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2158354|NCT01232283|3774036|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2158355|NCT01232283|3774037|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2158356|NCT01232283|3774038|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2158357|NCT01232283|3774039|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
2158358|NCT01232283|3774040|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
2158359|NCT01232283|3774041|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2158360|NCT01232283|3774042|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
2158361|NCT01232283|3774043|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2158362|NCT01232283|3774044|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2158363|NCT01232283|3774035|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2158364|NCT01232283|3774036|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2158365|NCT01232283|3774037|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2158366|NCT01232283|3774038|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2158367|NCT01232283|3774039|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
2158368|NCT01232283|3774040|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2158369|NCT01232283|3774041|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
2158370|NCT01232283|3774042|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
2158371|NCT01232283|3774043|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2208145|NCT01636687|3847526|FG003|Extension Period|Withdrawal by Subject|1
2208146|NCT01636687|3847527|FG004|Extension Period|Withdrawal by Subject|0
2208147|NCT01636687|3847523|FG000|Follow-up Period|Withdrawal by Subject|1
2208148|NCT01636687|3847524|FG001|Follow-up Period|Withdrawal by Subject|0
2158372|NCT01232283|3774044|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2158373|NCT01232283|3774035|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2158374|NCT01232283|3774036|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2158375|NCT01232283|3774037|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2158376|NCT01232283|3774038|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2158377|NCT01232283|3774039|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
2158378|NCT01232283|3774040|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
2158379|NCT01232283|3774041|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
2158380|NCT01232283|3774042|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
2158381|NCT01232283|3774043|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2158382|NCT01232283|3774044|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2158383|NCT01232283|3774035|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2158384|NCT01232283|3774036|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2158385|NCT01232283|3774037|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2158386|NCT01232283|3774038|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2158387|NCT01232283|3774039|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
2158388|NCT01232283|3774040|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2158389|NCT01232283|3774041|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2158390|NCT01232283|3774042|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2158391|NCT01232283|3774043|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2158392|NCT01232283|3774044|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2158393|NCT01232283|3774035|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2208149|NCT01636687|3847525|FG002|Follow-up Period|Withdrawal by Subject|0
2158394|NCT01232283|3774036|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2158395|NCT01232283|3774037|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2158396|NCT01232283|3774038|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2158397|NCT01232283|3774039|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
2180148|NCT01399125|3806108|FG000|Overall Study|Administrative Problems|7
2158398|NCT01232283|3774040|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2158399|NCT01232283|3774041|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
2158400|NCT01232283|3774042|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
2158401|NCT01232283|3774043|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2158402|NCT01232283|3774044|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2158403|NCT01232283|3774035|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2158404|NCT01232283|3774036|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2158405|NCT01232283|3774037|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2158406|NCT01232283|3774038|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2158407|NCT01232283|3774039|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2158408|NCT01232283|3774040|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2158409|NCT01232283|3774041|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2158410|NCT01232283|3774042|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
2158411|NCT01232283|3774043|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2158412|NCT01232283|3774044|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2158413|NCT01232283|3774035|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2158414|NCT01232283|3774036|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2158415|NCT01232283|3774037|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2158416|NCT01232283|3774038|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2158417|NCT01232283|3774039|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2158418|NCT01232283|3774040|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
2158419|NCT01232283|3774041|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2158420|NCT01232283|3774042|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2158421|NCT01232283|3774043|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2158422|NCT01232283|3774044|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2158423|NCT01232283|3774035|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2158424|NCT01232283|3774036|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2158425|NCT01232283|3774037|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2158426|NCT01232283|3774038|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2158427|NCT01232283|3774039|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2158428|NCT01232283|3774040|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2158429|NCT01232283|3774041|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2158430|NCT01232283|3774042|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2158431|NCT01232283|3774043|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
2158432|NCT01232283|3774044|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
2158433|NCT01232283|3774035|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2158434|NCT01232283|3774036|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2158435|NCT01232283|3774037|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2158436|NCT01232283|3774038|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2158437|NCT01232283|3774039|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2158438|NCT01232283|3774040|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2158439|NCT01232283|3774041|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2158440|NCT01232283|3774042|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2158441|NCT01232283|3774043|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
2158442|NCT01232283|3774044|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
2158443|NCT01232283|3774035|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2158444|NCT01232283|3774036|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2158445|NCT01232283|3774037|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2158446|NCT01232283|3774038|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2158447|NCT01232283|3774039|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2158448|NCT01232283|3774040|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2158449|NCT01232283|3774041|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2158450|NCT01232283|3774042|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2158451|NCT01232283|3774043|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
2158452|NCT01232283|3774044|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
2158453|NCT01232283|3774035|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2158454|NCT01232283|3774036|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2158455|NCT01232283|3774037|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2158456|NCT01232283|3774038|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2158457|NCT01232283|3774039|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2158458|NCT01232283|3774040|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2158459|NCT01232283|3774041|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2158460|NCT01232283|3774042|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2158461|NCT01232283|3774043|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
2158462|NCT01232283|3774044|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
2158463|NCT01232283|3774035|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2158464|NCT01232283|3774036|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2158465|NCT01232283|3774037|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2158466|NCT01232283|3774038|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2158467|NCT01232283|3774039|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2158468|NCT01232283|3774040|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2158469|NCT01232283|3774041|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2158470|NCT01232283|3774042|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2158471|NCT01232283|3774043|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
2158472|NCT01232283|3774044|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
2158473|NCT01232283|3774035|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0
2158474|NCT01232283|3774036|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0
2158475|NCT01232283|3774037|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0
2158476|NCT01232283|3774038|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0
2158477|NCT01232283|3774039|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0
2158478|NCT01232283|3774040|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0
2158479|NCT01232283|3774041|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0
2158480|NCT01232283|3774042|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0
2158481|NCT01232283|3774043|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1
2158482|NCT01232283|3774044|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0
2158483|NCT01232283|3774035|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2158484|NCT01232283|3774036|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2158485|NCT01232283|3774037|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2158486|NCT01232283|3774038|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2158487|NCT01232283|3774039|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2158488|NCT01232283|3774040|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2158489|NCT01232283|3774041|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2158490|NCT01232283|3774042|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2158491|NCT01232283|3774043|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
2158492|NCT01232283|3774044|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2158493|NCT01232283|3774035|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2158494|NCT01232283|3774036|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2158495|NCT01232283|3774037|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2158496|NCT01232283|3774038|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2158497|NCT01232283|3774039|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2158498|NCT01232283|3774040|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2158499|NCT01232283|3774041|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2158500|NCT01232283|3774042|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2158501|NCT01232283|3774043|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
2158502|NCT01232283|3774044|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
2158503|NCT01232296|3774068|FG000|Overall Study|Adverse Event|24
2158504|NCT01232296|3774069|FG001|Overall Study|Adverse Event|12
2158505|NCT01232296|3774068|FG000|Overall Study|Physician Decision|1
2158506|NCT01232296|3774069|FG001|Overall Study|Physician Decision|1
2158507|NCT01232296|3774068|FG000|Overall Study|Progressive disease|43
2158508|NCT01232296|3774069|FG001|Overall Study|Progressive disease|61
2158509|NCT01232296|3774068|FG000|Overall Study|Study terminated by sponsor|0
2158510|NCT01232296|3774069|FG001|Overall Study|Study terminated by sponsor|1
2158511|NCT01232296|3774068|FG000|Overall Study|Technical problems|3
2158512|NCT01232296|3774069|FG001|Overall Study|Technical problems|0
2158513|NCT01232296|3774068|FG000|Overall Study|Subject/guardian decision|10
2158514|NCT01232296|3774069|FG001|Overall Study|Subject/guardian decision|2
2158515|NCT01232296|3774068|FG000|Overall Study|Death|1
2158516|NCT01232296|3774069|FG001|Overall Study|Death|6
2158517|NCT01232452|3774077|FG000|Overall Study|Adverse Event|17
2158518|NCT01232452|3774078|FG001|Overall Study|Adverse Event|15
2158519|NCT01232452|3774077|FG000|Overall Study|Withdrawal by Subject|11
2158520|NCT01232452|3774078|FG001|Overall Study|Withdrawal by Subject|8
2158521|NCT01232452|3774077|FG000|Overall Study|Physician Decision|8
2158522|NCT01232452|3774078|FG001|Overall Study|Physician Decision|12
2158523|NCT01232452|3774077|FG000|Overall Study|Protocol entry criterion not met|0
2158524|NCT01232452|3774078|FG001|Overall Study|Protocol entry criterion not met|2
2158525|NCT01232452|3774077|FG000|Overall Study|Sponsor Decision|3
2158526|NCT01232452|3774078|FG001|Overall Study|Sponsor Decision|1
2158527|NCT01232452|3774077|FG000|Overall Study|Protocol Violation|0
2158528|NCT01232452|3774078|FG001|Overall Study|Protocol Violation|1
2158529|NCT01232491|3774095|FG000|Overall Study|Adverse Event|13
2158530|NCT01232491|3774096|FG001|Overall Study|Adverse Event|8
2158531|NCT01232491|3774095|FG000|Overall Study|Lack of Efficacy|1
2158532|NCT01232491|3774096|FG001|Overall Study|Lack of Efficacy|5
2158533|NCT01232491|3774095|FG000|Overall Study|Protocol Violation|13
2158534|NCT01232491|3774096|FG001|Overall Study|Protocol Violation|11
2158535|NCT01232491|3774095|FG000|Overall Study|Withdrawal Criteria|12
2158536|NCT01232491|3774096|FG001|Overall Study|Withdrawal Criteria|21
2158537|NCT01232491|3774095|FG000|Overall Study|Other|21
2158538|NCT01232491|3774096|FG001|Overall Study|Other|18
2158539|NCT01232556|3774125|FG000|Overall Study|Withdrawal by Subject|21
2158540|NCT01232556|3774126|FG001|Overall Study|Withdrawal by Subject|17
2158541|NCT01232556|3774125|FG000|Overall Study|Death|97
2158542|NCT01232556|3774126|FG001|Overall Study|Death|97
2158543|NCT01232556|3774125|FG000|Overall Study|Lost to Follow-up|0
2158544|NCT01232556|3774126|FG001|Overall Study|Lost to Follow-up|2
2158545|NCT01232556|3774125|FG000|Overall Study|Terminated by Sponsor|35
2158546|NCT01232556|3774126|FG001|Overall Study|Terminated by Sponsor|51
2158547|NCT01232556|3774125|FG000|Overall Study|Other|6
2158548|NCT01232556|3774126|FG001|Overall Study|Other|4
2158549|NCT01232569|3774134|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
2158550|NCT01232569|3774135|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
2158551|NCT01232569|3774136|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
2158552|NCT01232569|3774137|FG003|Double-blind Treatment Period|Withdrawal by Subject|0
2158553|NCT01232569|3774134|FG000|Double-blind Treatment Period|Escape|2
2158554|NCT01232569|3774135|FG001|Double-blind Treatment Period|Escape|2
2158555|NCT01232569|3774136|FG002|Double-blind Treatment Period|Escape|0
2158556|NCT01232569|3774137|FG003|Double-blind Treatment Period|Escape|0
2158557|NCT01232569|3774134|FG000|Double-blind Treatment Period|Lost to Follow-up|4
2158558|NCT01232569|3774135|FG001|Double-blind Treatment Period|Lost to Follow-up|0
2158559|NCT01232569|3774136|FG002|Double-blind Treatment Period|Lost to Follow-up|0
2158560|NCT01232569|3774137|FG003|Double-blind Treatment Period|Lost to Follow-up|0
2158561|NCT01232569|3774134|FG000|Double-blind Treatment Period|Lack of Efficacy|1
2158562|NCT01232569|3774135|FG001|Double-blind Treatment Period|Lack of Efficacy|2
2158563|NCT01232569|3774136|FG002|Double-blind Treatment Period|Lack of Efficacy|0
2158564|NCT01232569|3774137|FG003|Double-blind Treatment Period|Lack of Efficacy|0
2158565|NCT01232569|3774134|FG000|Double-blind Treatment Period|Physician Decision|1
2158566|NCT01232569|3774135|FG001|Double-blind Treatment Period|Physician Decision|0
2158567|NCT01232569|3774136|FG002|Double-blind Treatment Period|Physician Decision|0
2158568|NCT01232569|3774137|FG003|Double-blind Treatment Period|Physician Decision|0
2158569|NCT01232569|3774134|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
2158570|NCT01232569|3774135|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
2158571|NCT01232569|3774136|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
2158572|NCT01232569|3774137|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
2158573|NCT01232569|3774134|FG000|Double-blind Treatment Period|Death|2
2158574|NCT01232569|3774135|FG001|Double-blind Treatment Period|Death|0
2158575|NCT01232569|3774136|FG002|Double-blind Treatment Period|Death|0
2158576|NCT01232569|3774137|FG003|Double-blind Treatment Period|Death|0
2158577|NCT01232738|3774146|FG000|Overall Study|Death|3
2158578|NCT01232738|3774146|FG000|Overall Study|Physician Decision|2
2158579|NCT01232738|3774146|FG000|Overall Study|Lost to Follow-up|1
2158580|NCT01232738|3774146|FG000|Overall Study|Withdrawal by Subject|2
2158581|NCT01232738|3774146|FG000|Overall Study|Adverse Event|5
2158582|NCT01232790|3774154|FG000|Randomization|Withdrawal by Subject|2
2158583|NCT01232790|3774155|FG001|Randomization|Withdrawal by Subject|0
2158584|NCT01232790|3774154|FG000|Randomization|Protocol Violation|0
2158585|NCT01232790|3774155|FG001|Randomization|Protocol Violation|1
2158586|NCT01232790|3774154|FG000|Randomization|Physician Decision|0
2158587|NCT01232790|3774155|FG001|Randomization|Physician Decision|1
2158588|NCT01232790|3774154|FG000|Initial Assessment|Withdrawal by Subject|0
2158589|NCT01232790|3774155|FG001|Initial Assessment|Withdrawal by Subject|1
2158590|NCT01232790|3774154|FG000|First Crossover|Withdrawal by Subject|1
2158591|NCT01232790|3774155|FG001|First Crossover|Withdrawal by Subject|0
2158592|NCT01232790|3774154|FG000|Second Crossover|Withdrawal by Subject|1
2158593|NCT01232790|3774155|FG001|Second Crossover|Withdrawal by Subject|2
2158594|NCT01232868|3774177|FG000|Overall Study|Lost to Follow-up|2
2158595|NCT01232868|3774178|FG001|Overall Study|Lost to Follow-up|4
2158596|NCT01232894|3774186|FG000|Overall Study|Lost to Follow-up|0
2158597|NCT01232894|3774187|FG001|Overall Study|Lost to Follow-up|1
2158598|NCT01232894|3774186|FG000|Overall Study|Death|1
2158599|NCT01232894|3774187|FG001|Overall Study|Death|0
2158600|NCT01232894|3774186|FG000|Overall Study|Protocol Violation|1
2158601|NCT01232894|3774187|FG001|Overall Study|Protocol Violation|1
2158602|NCT01232894|3774186|FG000|Overall Study|Withdrawal by Subject|8
2158603|NCT01232894|3774187|FG001|Overall Study|Withdrawal by Subject|5
2158604|NCT01232894|3774186|FG000|Overall Study|Physician Decision|2
2158605|NCT01232894|3774187|FG001|Overall Study|Physician Decision|1
2158606|NCT01233050|3774217|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8
2158607|NCT01233050|3774218|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6
2158608|NCT01233076|3774224|FG000|Period 2, One Week|Lost to Follow-up|1
2158609|NCT01233076|3774225|FG001|Period 2, One Week|Lost to Follow-up|0
2158610|NCT01233232|3774234|FG000|Overall Study|Voluntary Discontinuation by Subject|1
2158611|NCT01233232|3774235|FG001|Overall Study|Voluntary Discontinuation by Subject|0
2158612|NCT01233232|3774236|FG002|Overall Study|Voluntary Discontinuation by Subject|0
2158613|NCT01233258|3774249|FG000|First Intervention (6 Months)|Withdrawal by Subject|0
2158614|NCT01233258|3774250|FG001|First Intervention (6 Months)|Withdrawal by Subject|0
2158615|NCT01233258|3774251|FG002|First Intervention (6 Months)|Withdrawal by Subject|0
2158616|NCT01233258|3774252|FG003|First Intervention (6 Months)|Withdrawal by Subject|1
2158617|NCT01233258|3774253|FG004|First Intervention (6 Months)|Withdrawal by Subject|0
2158618|NCT01233258|3774254|FG005|First Intervention (6 Months)|Withdrawal by Subject|1
2158619|NCT01233258|3774249|FG000|First Intervention (6 Months)|Protocol Violation|0
2158620|NCT01233258|3774250|FG001|First Intervention (6 Months)|Protocol Violation|0
2158621|NCT01233258|3774251|FG002|First Intervention (6 Months)|Protocol Violation|1
2158622|NCT01233258|3774252|FG003|First Intervention (6 Months)|Protocol Violation|0
2158623|NCT01233258|3774253|FG004|First Intervention (6 Months)|Protocol Violation|0
2158624|NCT01233258|3774254|FG005|First Intervention (6 Months)|Protocol Violation|0
2158625|NCT01233258|3774249|FG000|First Intervention (6 Months)|Non-compliance with study medication|1
2158626|NCT01233258|3774250|FG001|First Intervention (6 Months)|Non-compliance with study medication|0
2158627|NCT01233258|3774251|FG002|First Intervention (6 Months)|Non-compliance with study medication|0
2158628|NCT01233258|3774252|FG003|First Intervention (6 Months)|Non-compliance with study medication|0
2158629|NCT01233258|3774253|FG004|First Intervention (6 Months)|Non-compliance with study medication|0
2158630|NCT01233258|3774254|FG005|First Intervention (6 Months)|Non-compliance with study medication|0
2158631|NCT01233284|3774269|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1
2158632|NCT01233284|3774270|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0
2158633|NCT01233284|3774271|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0
2158634|NCT01233284|3774272|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
2158635|NCT01233284|3774273|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
2158636|NCT01233284|3774269|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0
2158637|NCT01233284|3774270|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1
2158638|NCT01233284|3774271|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
2158639|NCT01233284|3774272|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
2158640|NCT01233284|3774273|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0
2158641|NCT01233284|3774269|FG000|Period 1 (4 Weeks)|Other|0
2158642|NCT01233284|3774270|FG001|Period 1 (4 Weeks)|Other|0
2158643|NCT01233284|3774271|FG002|Period 1 (4 Weeks)|Other|1
2158644|NCT01233284|3774272|FG003|Period 1 (4 Weeks)|Other|0
2158645|NCT01233284|3774273|FG004|Period 1 (4 Weeks)|Other|0
2158646|NCT01233284|3774269|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0
2158647|NCT01233284|3774270|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0
2158648|NCT01233284|3774271|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1
2158649|NCT01233284|3774272|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0
2158650|NCT01233284|3774273|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0
2158651|NCT01233284|3774269|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
2158652|NCT01233284|3774270|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0
2158653|NCT01233284|3774271|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1
2158654|NCT01233284|3774272|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
2158655|NCT01233284|3774273|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0
2158656|NCT01233284|3774269|FG000|Period 3 (4 Weeks)|Other|0
2158657|NCT01233284|3774270|FG001|Period 3 (4 Weeks)|Other|0
2158658|NCT01233284|3774271|FG002|Period 3 (4 Weeks)|Other|0
2158659|NCT01233284|3774272|FG003|Period 3 (4 Weeks)|Other|1
2158660|NCT01233284|3774273|FG004|Period 3 (4 Weeks)|Other|0
2158661|NCT01233284|3774269|FG000|Period 4 (4 Weeks)|Adverse Event|0
2158662|NCT01233284|3774270|FG001|Period 4 (4 Weeks)|Adverse Event|1
2158663|NCT01233284|3774271|FG002|Period 4 (4 Weeks)|Adverse Event|0
2158664|NCT01233284|3774272|FG003|Period 4 (4 Weeks)|Adverse Event|0
2158665|NCT01233284|3774273|FG004|Period 4 (4 Weeks)|Adverse Event|0
2158666|NCT01233284|3774269|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0
2158667|NCT01233284|3774270|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0
2158668|NCT01233284|3774271|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0
2158669|NCT01233284|3774272|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1
2158670|NCT01233284|3774273|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0
2158671|NCT01233609|3774290|FG000|Overall Study|Death|1
2158672|NCT01233609|3774291|FG001|Overall Study|Death|0
2158673|NCT01233609|3774290|FG000|Overall Study|Lost to Follow-up|3
2158674|NCT01233609|3774291|FG001|Overall Study|Lost to Follow-up|1
2158675|NCT01233609|3774290|FG000|Overall Study|Adverse Event|2
2158676|NCT01233609|3774291|FG001|Overall Study|Adverse Event|1
2158677|NCT01233609|3774290|FG000|Overall Study|Withdrawal by Subject|3
2158678|NCT01233609|3774291|FG001|Overall Study|Withdrawal by Subject|0
2158679|NCT01233687|3774305|FG000|Phase II AMG 102 + Erlotinib|Death|1
2158680|NCT01233687|3774305|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2
2158681|NCT01233687|3774305|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
2158682|NCT01233817|3774325|FG000|Overall Study|Lost to Follow-up|1
2158683|NCT01233817|3774325|FG000|Overall Study|Withdrawal by Subject|2
2158684|NCT01233869|3774333|FG000|Initial Treatment Period (24 Months)|Death|1
2158685|NCT01233869|3774334|FG001|Initial Treatment Period (24 Months)|Death|0
2158686|NCT01233869|3774335|FG002|Initial Treatment Period (24 Months)|Death|0
2158687|NCT01233869|3774336|FG003|Initial Treatment Period (24 Months)|Death|0
2158688|NCT01233869|3774333|FG000|Initial Treatment Period (24 Months)|Adverse Event|9
2158689|NCT01233869|3774334|FG001|Initial Treatment Period (24 Months)|Adverse Event|17
2158690|NCT01233869|3774335|FG002|Initial Treatment Period (24 Months)|Adverse Event|0
2158691|NCT01233869|3774336|FG003|Initial Treatment Period (24 Months)|Adverse Event|3
2158692|NCT01233869|3774333|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
2158693|NCT01233869|3774334|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
2158694|NCT01233869|3774335|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
2158695|NCT01233869|3774336|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
2158696|NCT01233869|3774333|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0
2158697|NCT01233869|3774334|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0
2158698|NCT01233869|3774335|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0
2208150|NCT01636687|3847526|FG003|Follow-up Period|Withdrawal by Subject|0
2158699|NCT01233869|3774336|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1
2158700|NCT01233869|3774333|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
2158701|NCT01233869|3774334|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
2158702|NCT01233869|3774335|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
2158703|NCT01233869|3774336|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
2158704|NCT01233869|3774333|FG000|Extended Treatment Period (46 Months)|Other|3
2293705|NCT02528357|3987957|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293706|NCT02528357|3987958|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293707|NCT02528357|3987959|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293708|NCT02528357|3987960|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293709|NCT02528357|3987961|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293710|NCT02528357|3987962|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293711|NCT02528357|3987963|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
2293712|NCT02528357|3987964|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293713|NCT02528357|3987965|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
2293714|NCT02528357|3987966|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
2293715|NCT02528357|3987967|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
2293716|NCT02528357|3987968|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293717|NCT02528357|3987969|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293718|NCT02528357|3987970|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293719|NCT02528357|3987971|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
2293720|NCT02528357|3987953|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293721|NCT02528357|3987954|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293722|NCT02528357|3987955|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293723|NCT02528357|3987956|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293724|NCT02528357|3987957|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293725|NCT02528357|3987958|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293726|NCT02528357|3987959|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293727|NCT02528357|3987960|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293728|NCT02528357|3987961|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
2293729|NCT02528357|3987962|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
2293730|NCT02528357|3987963|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293731|NCT02528357|3987964|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3
2293732|NCT02528357|3987965|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4
2293733|NCT02528357|3987966|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
2293734|NCT02528357|3987967|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
2293735|NCT02528357|3987968|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293736|NCT02528357|3987969|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293737|NCT02528357|3987970|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293738|NCT02528357|3987971|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293739|NCT02528357|3987953|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293740|NCT02528357|3987954|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293741|NCT02528357|3987955|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293742|NCT02528357|3987956|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293743|NCT02528357|3987957|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2158705|NCT01233869|3774334|FG001|Extended Treatment Period (46 Months)|Other|0
2208151|NCT01636687|3847527|FG004|Follow-up Period|Withdrawal by Subject|1
2158706|NCT01233869|3774335|FG002|Extended Treatment Period (46 Months)|Other|0
2158707|NCT01233869|3774336|FG003|Extended Treatment Period (46 Months)|Other|3
2158708|NCT01233869|3774333|FG000|Extended Treatment Period (46 Months)|Adverse Event|1
2158709|NCT01233869|3774334|FG001|Extended Treatment Period (46 Months)|Adverse Event|0
2158710|NCT01233869|3774335|FG002|Extended Treatment Period (46 Months)|Adverse Event|0
2158711|NCT01233869|3774336|FG003|Extended Treatment Period (46 Months)|Adverse Event|1
2158712|NCT01233999|3774355|FG000|Overall Study|Withdrawal by Subject|1
2158713|NCT01233999|3774355|FG000|Overall Study|Lost to Follow-up|1
2158714|NCT01234337|3774370|FG000|Overall Study|Adverse Event|58
2158715|NCT01234337|3774371|FG001|Overall Study|Adverse Event|21
2158716|NCT01234337|3774370|FG000|Overall Study|Disease progression/recurrence/relapse|181
2158717|NCT01234337|3774371|FG001|Overall Study|Disease progression/recurrence/relapse|223
2158718|NCT01234337|3774370|FG000|Overall Study|Investi. decision not protocol driven|5
2158719|NCT01234337|3774371|FG001|Overall Study|Investi. decision not protocol driven|6
2158720|NCT01234337|3774370|FG000|Overall Study|Non-compliant with study medication|3
2158721|NCT01234337|3774371|FG001|Overall Study|Non-compliant with study medication|2
2158722|NCT01234337|3774370|FG000|Overall Study|Randomized but not treated|6
2158723|NCT01234337|3774371|FG001|Overall Study|Randomized but not treated|4
2158724|NCT01234337|3774370|FG000|Overall Study|Lost to Follow-up|0
2158725|NCT01234337|3774371|FG001|Overall Study|Lost to Follow-up|1
2158726|NCT01234337|3774370|FG000|Overall Study|Protocol Violation|2
2158727|NCT01234337|3774371|FG001|Overall Study|Protocol Violation|3
2158728|NCT01234337|3774370|FG000|Overall Study|Withdrawal by Subject|11
2158729|NCT01234337|3774371|FG001|Overall Study|Withdrawal by Subject|9
2158730|NCT01234337|3774370|FG000|Overall Study|Death|0
2158731|NCT01234337|3774371|FG001|Overall Study|Death|1
2158732|NCT01234337|3774370|FG000|Overall Study|Switch to commercial drug|0
2158733|NCT01234337|3774371|FG001|Overall Study|Switch to commercial drug|1
2158734|NCT01234350|3774379|FG000|Overall Study|Adverse Event|277
2158735|NCT01234350|3774380|FG001|Overall Study|Adverse Event|92
2158736|NCT01234350|3774379|FG000|Overall Study|Withdrawal by Subject|61
2158737|NCT01234350|3774380|FG001|Overall Study|Withdrawal by Subject|36
2158738|NCT01234350|3774379|FG000|Overall Study|Lost to Follow-up|115
2158739|NCT01234350|3774380|FG001|Overall Study|Lost to Follow-up|47
2158740|NCT01234350|3774379|FG000|Overall Study|Covers a diverse set of reasons|234
2158741|NCT01234350|3774380|FG001|Overall Study|Covers a diverse set of reasons|92
2158742|NCT01234402|3774391|FG000|Overall Study|Lost to Follow-up|0
2158743|NCT01234402|3774392|FG001|Overall Study|Lost to Follow-up|1
2158744|NCT01234402|3774393|FG002|Overall Study|Lost to Follow-up|3
2158745|NCT01234402|3774391|FG000|Overall Study|Withdrawal by Subject|1
2158746|NCT01234402|3774392|FG001|Overall Study|Withdrawal by Subject|3
2158747|NCT01234402|3774393|FG002|Overall Study|Withdrawal by Subject|4
2158748|NCT01234402|3774391|FG000|Overall Study|Never treated: Death|0
2158749|NCT01234402|3774392|FG001|Overall Study|Never treated: Death|0
2158750|NCT01234402|3774393|FG002|Overall Study|Never treated: Death|1
2158751|NCT01234402|3774391|FG000|Overall Study|Never treated: Withdrawal By Subject|0
2158752|NCT01234402|3774392|FG001|Overall Study|Never treated: Withdrawal By Subject|1
2158753|NCT01234402|3774393|FG002|Overall Study|Never treated: Withdrawal By Subject|0
2158754|NCT01234402|3774391|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0
2158755|NCT01234402|3774392|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1
2158756|NCT01234402|3774393|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0
2158757|NCT01234467|3774403|FG000|Overall Study|Adverse Event|3
2158758|NCT01234467|3774403|FG000|Overall Study|Death|2
2158759|NCT01234467|3774403|FG000|Overall Study|Withdrawal by Subject|2
2158760|NCT01234467|3774403|FG000|Overall Study|Disease Progression|2
2158761|NCT01234467|3774403|FG000|Overall Study|Clinical deterioration|1
2158762|NCT01234467|3774403|FG000|Overall Study|Physician Decision|1
2158763|NCT01234467|3774403|FG000|Overall Study|Other complicating disease (stroke)|1
2158764|NCT01234480|3774407|FG000|Overall Study|Pregnancy|88
2158765|NCT01234480|3774407|FG000|Overall Study|>36/Normal History|50
2158766|NCT01234480|3774407|FG000|Overall Study|Age|3
2158767|NCT01234480|3774407|FG000|Overall Study|HPV Vaccine History|28
2158768|NCT01234480|3774407|FG000|Overall Study|HPV Vaccine after Enrollment|17
2158769|NCT01234480|3774407|FG000|Overall Study|Hysterectomy|2
2158770|NCT01234480|3774407|FG000|Overall Study|Hysterectomy post enrollment|1
2158771|NCT01234480|3774407|FG000|Overall Study|Inclusion/Exclusion Violation|3
2158772|NCT01234480|3774407|FG000|Overall Study|Informed Consent Form Violation|30
2158773|NCT01234480|3774407|FG000|Overall Study|Incorrect Visit|3
2158774|NCT01234480|3774407|FG000|Overall Study|No Florida Lab License|20
2158775|NCT01234480|3774407|FG000|Overall Study|Out of Window|42
2158776|NCT01234480|3774407|FG000|Overall Study|Sample Processing/Storage|92
2158777|NCT01234480|3774407|FG000|Overall Study|Site Amendment prohibited colposcopy|11
2158778|NCT01234480|3774407|FG000|Overall Study|Site/Subject non-compliance|44
2158779|NCT01234480|3774407|FG000|Overall Study|Missing Sample|9
2158780|NCT01234649|3774416|FG000|Overall Study|Withdrawal by Subject|32
2158781|NCT01234649|3774417|FG001|Overall Study|Withdrawal by Subject|26
2158782|NCT01234649|3774416|FG000|Overall Study|Pregnancy|6
2158783|NCT01234649|3774417|FG001|Overall Study|Pregnancy|6
2158784|NCT01234649|3774416|FG000|Overall Study|intolerant to side effects|4
2158785|NCT01234649|3774417|FG001|Overall Study|intolerant to side effects|3
2158786|NCT01234649|3774416|FG000|Overall Study|Allergic reaction|1
2158787|NCT01234649|3774417|FG001|Overall Study|Allergic reaction|0
2158788|NCT01234649|3774416|FG000|Overall Study|Lack of Efficacy|0
2158789|NCT01234649|3774417|FG001|Overall Study|Lack of Efficacy|3
2158790|NCT01234675|3774423|FG000|First Intervention (6 Weeks)|Adverse Event|0
2158791|NCT01234675|3774424|FG001|First Intervention (6 Weeks)|Adverse Event|1
2158792|NCT01234675|3774423|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1
2158793|NCT01234675|3774424|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0
2158794|NCT01234883|3774458|FG000|Overall Study|Early treatment release|8
2158795|NCT01234883|3774459|FG001|Overall Study|Early treatment release|10
2158796|NCT01234883|3774458|FG000|Overall Study|Parent/guardian withdrew consent|1
2158797|NCT01234883|3774459|FG001|Overall Study|Parent/guardian withdrew consent|2
2158798|NCT01234883|3774458|FG000|Overall Study|Technical difficulties with IV infusion|0
2158799|NCT01234883|3774459|FG001|Overall Study|Technical difficulties with IV infusion|1
2158800|NCT01234883|3774458|FG000|Overall Study|Inclusion/exclusion failure|1
2158801|NCT01234883|3774459|FG001|Overall Study|Inclusion/exclusion failure|0
2158802|NCT01235234|3774492|FG000|Overall Study|Adverse Event|2
2158803|NCT01235234|3774493|FG001|Overall Study|Adverse Event|2
2158804|NCT01235234|3774494|FG002|Overall Study|Adverse Event|1
2158805|NCT01235338|3774504|FG000|Overall Study|Adverse Event|3
2158806|NCT01235338|3774505|FG001|Overall Study|Adverse Event|2
2158807|NCT01235338|3774504|FG000|Overall Study|Protocol Violation|1
2158808|NCT01235338|3774505|FG001|Overall Study|Protocol Violation|1
2158809|NCT01235338|3774504|FG000|Overall Study|Withdrawal by Subject|5
2158810|NCT01235338|3774505|FG001|Overall Study|Withdrawal by Subject|0
2158811|NCT01235338|3774504|FG000|Overall Study|Exclusion criteria violations|1
2158812|NCT01235338|3774505|FG001|Overall Study|Exclusion criteria violations|1
2158813|NCT01235338|3774504|FG000|Overall Study|Positive drug screen|0
2158814|NCT01235338|3774505|FG001|Overall Study|Positive drug screen|1
2158815|NCT01235338|3774504|FG000|Overall Study|Prohibited meds|1
2158816|NCT01235338|3774505|FG001|Overall Study|Prohibited meds|0
2158817|NCT01235351|3774515|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
2158818|NCT01235351|3774516|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
2158819|NCT01235403|3774535|FG000|Overall Study|Adverse Event|14
2158820|NCT01235403|3774535|FG000|Overall Study|Lost to Follow-up|2
2158821|NCT01235403|3774535|FG000|Overall Study|Withdrawal by Subject|4
2158822|NCT01235403|3774535|FG000|Overall Study|Lack of Efficacy|2
2158823|NCT01235403|3774535|FG000|Overall Study|Other reasons for premature termination|4
2158824|NCT01235442|3774541|FG000|Overall Study|Lost to Follow-up|12
2158825|NCT01235442|3774542|FG001|Overall Study|Lost to Follow-up|10
2158826|NCT01235442|3774541|FG000|Overall Study|Death|0
2158827|NCT01235442|3774542|FG001|Overall Study|Death|2
2158828|NCT01235442|3774541|FG000|Overall Study|Pregnancy|1
2158829|NCT01235442|3774542|FG001|Overall Study|Pregnancy|1
2158830|NCT01235442|3774541|FG000|Overall Study|Ineligibility determined|5
2158831|NCT01235442|3774542|FG001|Overall Study|Ineligibility determined|4
2158832|NCT01235442|3774541|FG000|Overall Study|Protocol Violation|3
2158833|NCT01235442|3774542|FG001|Overall Study|Protocol Violation|3
2158834|NCT01235442|3774541|FG000|Overall Study|Adverse Event|4
2158835|NCT01235442|3774542|FG001|Overall Study|Adverse Event|6
2158836|NCT01235442|3774541|FG000|Overall Study|Withdrawal by Subject|15
2158837|NCT01235442|3774542|FG001|Overall Study|Withdrawal by Subject|9
2158838|NCT01235442|3774541|FG000|Overall Study|Lack of Efficacy|1
2158839|NCT01235442|3774542|FG001|Overall Study|Lack of Efficacy|3
2158840|NCT01235442|3774541|FG000|Overall Study|Noncompliance|1
2158841|NCT01235442|3774542|FG001|Overall Study|Noncompliance|2
2158842|NCT01235442|3774541|FG000|Overall Study|Administrative decision|1
2158843|NCT01235442|3774542|FG001|Overall Study|Administrative decision|2
2158844|NCT01235442|3774541|FG000|Overall Study|Other unspecified|1
2158845|NCT01235442|3774542|FG001|Overall Study|Other unspecified|2
2158846|NCT01235507|3774548|FG000|Overall Study|Adverse Event|1
2158847|NCT01235507|3774548|FG000|Overall Study|Withdrawal by Subject|1
2179331|NCT01393600|3804869|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
2179332|NCT01393600|3804870|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
2179333|NCT01393600|3804871|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
2179334|NCT01393613|3804887|FG000|Overall Study|Adverse Event|11
2179335|NCT01393613|3804888|FG001|Overall Study|Adverse Event|11
2179336|NCT01393613|3804889|FG002|Overall Study|Adverse Event|13
2179337|NCT01393613|3804890|FG003|Overall Study|Adverse Event|22
2179338|NCT01393613|3804887|FG000|Overall Study|Participant Met Withdrawal Criteria|0
2179339|NCT01393613|3804888|FG001|Overall Study|Participant Met Withdrawal Criteria|0
2179340|NCT01393613|3804889|FG002|Overall Study|Participant Met Withdrawal Criteria|2
2179341|NCT01393613|3804890|FG003|Overall Study|Participant Met Withdrawal Criteria|1
2179342|NCT01393613|3804887|FG000|Overall Study|Physician Decision|2
2179343|NCT01393613|3804888|FG001|Overall Study|Physician Decision|0
2179344|NCT01393613|3804889|FG002|Overall Study|Physician Decision|0
2179345|NCT01393613|3804890|FG003|Overall Study|Physician Decision|1
2179346|NCT01393613|3804887|FG000|Overall Study|Withdrawal by Subject|15
2179347|NCT01393613|3804888|FG001|Overall Study|Withdrawal by Subject|25
2179348|NCT01393613|3804889|FG002|Overall Study|Withdrawal by Subject|23
2179349|NCT01393613|3804890|FG003|Overall Study|Withdrawal by Subject|21
2179350|NCT01393613|3804887|FG000|Overall Study|Protocol Deviation|2
2179351|NCT01393613|3804888|FG001|Overall Study|Protocol Deviation|1
2179352|NCT01393613|3804889|FG002|Overall Study|Protocol Deviation|0
2179353|NCT01393613|3804890|FG003|Overall Study|Protocol Deviation|0
2179354|NCT01393613|3804887|FG000|Overall Study|Lack of Efficacy|9
2179355|NCT01393613|3804888|FG001|Overall Study|Lack of Efficacy|20
2179356|NCT01393613|3804889|FG002|Overall Study|Lack of Efficacy|16
2179357|NCT01393613|3804890|FG003|Overall Study|Lack of Efficacy|21
2179358|NCT01393626|3804906|FG000|Overall Study|Adverse Event|2
2179359|NCT01393626|3804907|FG001|Overall Study|Adverse Event|1
2179360|NCT01393626|3804908|FG002|Overall Study|Adverse Event|5
2179361|NCT01393626|3804909|FG003|Overall Study|Adverse Event|0
2179362|NCT01393626|3804906|FG000|Overall Study|Did not meet entrance criteria|1
2179363|NCT01393626|3804907|FG001|Overall Study|Did not meet entrance criteria|0
2179364|NCT01393626|3804908|FG002|Overall Study|Did not meet entrance criteria|0
2179365|NCT01393626|3804909|FG003|Overall Study|Did not meet entrance criteria|0
2179366|NCT01393626|3804906|FG000|Overall Study|Lack of Efficacy|6
2179367|NCT01393626|3804907|FG001|Overall Study|Lack of Efficacy|6
2179368|NCT01393626|3804908|FG002|Overall Study|Lack of Efficacy|4
2158848|NCT01235546|3774554|FG000|Overall Study|Staff error, medication not administered|1
2158849|NCT01235546|3774555|FG001|Overall Study|Staff error, medication not administered|0
2158850|NCT01235546|3774554|FG000|Overall Study|Protocol Violation|1
2158851|NCT01235546|3774555|FG001|Overall Study|Protocol Violation|1
2158852|NCT01235598|3774572|FG000|Overall Study|Adverse Event|0
2158853|NCT01235598|3774573|FG001|Overall Study|Adverse Event|3
2158854|NCT01235598|3774572|FG000|Overall Study|Lack of Efficacy|0
2158855|NCT01235598|3774573|FG001|Overall Study|Lack of Efficacy|1
2158856|NCT01235598|3774572|FG000|Overall Study|Withdrawal by Subject|1
2158857|NCT01235598|3774573|FG001|Overall Study|Withdrawal by Subject|0
2158858|NCT01235689|3774582|FG000|Overall Study|Adverse Event|12
2158859|NCT01235689|3774583|FG001|Overall Study|Adverse Event|16
2158860|NCT01235689|3774582|FG000|Overall Study|Lack of Efficacy|12
2158861|NCT01235689|3774583|FG001|Overall Study|Lack of Efficacy|5
2158862|NCT01235689|3774582|FG000|Overall Study|Withdrawal by Subject|3
2158863|NCT01235689|3774583|FG001|Overall Study|Withdrawal by Subject|4
2158864|NCT01235689|3774582|FG000|Overall Study|Lost to Follow-up|1
2158865|NCT01235689|3774583|FG001|Overall Study|Lost to Follow-up|2
2158866|NCT01235689|3774582|FG000|Overall Study|Miscellaneous|1
2158867|NCT01235689|3774583|FG001|Overall Study|Miscellaneous|5
2158868|NCT01235715|3774591|FG000|Overall Study|Physician Decision|0
2158869|NCT01235715|3774592|FG001|Overall Study|Physician Decision|2
2158870|NCT01235728|3774599|FG000|Overall Study|Protocol Violation|0
2158871|NCT01235728|3774600|FG001|Overall Study|Protocol Violation|0
2158872|NCT01235728|3774601|FG002|Overall Study|Protocol Violation|0
2158873|NCT01235728|3774602|FG003|Overall Study|Protocol Violation|1
2158874|NCT01235728|3774603|FG004|Overall Study|Protocol Violation|0
2158875|NCT01235728|3774604|FG005|Overall Study|Protocol Violation|0
2158876|NCT01235728|3774605|FG006|Overall Study|Protocol Violation|0
2158877|NCT01235728|3774606|FG007|Overall Study|Protocol Violation|0
2158878|NCT01235741|3774617|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
2158879|NCT01235741|3774618|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
2158880|NCT01235741|3774619|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
2158881|NCT01235741|3774617|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
2158882|NCT01235741|3774618|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
2158883|NCT01235741|3774619|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
2158884|NCT01235741|3774617|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
2158885|NCT01235741|3774618|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
2158886|NCT01235741|3774619|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
2158887|NCT01235741|3774617|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
2158888|NCT01235741|3774618|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
2158889|NCT01235741|3774619|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
2158890|NCT01235741|3774617|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
2158891|NCT01235741|3774618|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
2158892|NCT01235741|3774619|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
2158893|NCT01235741|3774617|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
2158894|NCT01235741|3774618|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
2158895|NCT01235741|3774619|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
2158896|NCT01235741|3774617|FG000|Randomized to Treatment|Withdrawal by Subject|0
2158897|NCT01235741|3774618|FG001|Randomized to Treatment|Withdrawal by Subject|0
2158898|NCT01235741|3774619|FG002|Randomized to Treatment|Withdrawal by Subject|1
2158899|NCT01235741|3774617|FG000|Randomized to Treatment|Adverse Event|0
2158900|NCT01235741|3774618|FG001|Randomized to Treatment|Adverse Event|1
2158901|NCT01235741|3774619|FG002|Randomized to Treatment|Adverse Event|1
2158902|NCT01235741|3774617|FG000|Randomized to Treatment|Sponsor terminated study|0
2158903|NCT01235741|3774618|FG001|Randomized to Treatment|Sponsor terminated study|35
2158904|NCT01235741|3774619|FG002|Randomized to Treatment|Sponsor terminated study|34
2158905|NCT01235741|3774617|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
2158906|NCT01235741|3774618|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
2158907|NCT01235741|3774619|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
2158908|NCT01235741|3774617|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
2158909|NCT01235741|3774618|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
2158910|NCT01235741|3774619|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
2158911|NCT01235741|3774617|FG000|Follow-Up Post Treatment up to Month 6|Other|0
2158912|NCT01235741|3774618|FG001|Follow-Up Post Treatment up to Month 6|Other|1
2158913|NCT01235741|3774619|FG002|Follow-Up Post Treatment up to Month 6|Other|0
2158914|NCT01235793|3774631|FG000|Overall Study|Death|6
2158915|NCT01235949|3774672|FG000|Primary Phase|Migrated/moved from study area|1
2158916|NCT01235949|3774673|FG001|Primary Phase|Migrated/moved from study area|1
2158917|NCT01235949|3774674|FG002|Primary Phase|Migrated/moved from study area|0
2158918|NCT01235949|3774675|FG003|Primary Phase|Migrated/moved from study area|0
2158919|NCT01235949|3774676|FG004|Primary Phase|Migrated/moved from study area|1
2158920|NCT01235949|3774677|FG005|Primary Phase|Migrated/moved from study area|2
2158921|NCT01235949|3774678|FG006|Primary Phase|Migrated/moved from study area|0
2158922|NCT01235949|3774679|FG007|Primary Phase|Migrated/moved from study area|0
2179369|NCT01393626|3804909|FG003|Overall Study|Lack of Efficacy|1
2158923|NCT01235949|3774680|FG008|Primary Phase|Migrated/moved from study area|0
2158924|NCT01235949|3774681|FG009|Primary Phase|Migrated/moved from study area|0
2158925|NCT01235949|3774682|FG010|Primary Phase|Migrated/moved from study area|0
2158926|NCT01235949|3774683|FG011|Primary Phase|Migrated/moved from study area|0
2158927|NCT01235949|3774684|FG012|Primary Phase|Migrated/moved from study area|0
2158928|NCT01235949|3774685|FG013|Primary Phase|Migrated/moved from study area|0
2158929|NCT01235949|3774686|FG014|Primary Phase|Migrated/moved from study area|0
2158930|NCT01235949|3774687|FG015|Primary Phase|Migrated/moved from study area|0
2158931|NCT01235949|3774688|FG016|Primary Phase|Migrated/moved from study area|0
2158932|NCT01235949|3774689|FG017|Primary Phase|Migrated/moved from study area|0
2158933|NCT01235949|3774672|FG000|Primary Phase|Adverse Event|0
2158934|NCT01235949|3774673|FG001|Primary Phase|Adverse Event|0
2158935|NCT01235949|3774674|FG002|Primary Phase|Adverse Event|0
2158936|NCT01235949|3774675|FG003|Primary Phase|Adverse Event|1
2158937|NCT01235949|3774676|FG004|Primary Phase|Adverse Event|0
2158938|NCT01235949|3774677|FG005|Primary Phase|Adverse Event|0
2158939|NCT01235949|3774678|FG006|Primary Phase|Adverse Event|0
2158940|NCT01235949|3774679|FG007|Primary Phase|Adverse Event|0
2158941|NCT01235949|3774680|FG008|Primary Phase|Adverse Event|0
2158942|NCT01235949|3774681|FG009|Primary Phase|Adverse Event|0
2158943|NCT01235949|3774682|FG010|Primary Phase|Adverse Event|0
2158944|NCT01235949|3774683|FG011|Primary Phase|Adverse Event|0
2158945|NCT01235949|3774684|FG012|Primary Phase|Adverse Event|0
2158946|NCT01235949|3774685|FG013|Primary Phase|Adverse Event|0
2158947|NCT01235949|3774686|FG014|Primary Phase|Adverse Event|0
2158948|NCT01235949|3774687|FG015|Primary Phase|Adverse Event|0
2158949|NCT01235949|3774688|FG016|Primary Phase|Adverse Event|0
2158950|NCT01235949|3774689|FG017|Primary Phase|Adverse Event|0
2158951|NCT01235949|3774672|FG000|Primary Phase|Withdrawal by Subject|3
2158952|NCT01235949|3774673|FG001|Primary Phase|Withdrawal by Subject|2
2158953|NCT01235949|3774674|FG002|Primary Phase|Withdrawal by Subject|2
2158954|NCT01235949|3774675|FG003|Primary Phase|Withdrawal by Subject|0
2158955|NCT01235949|3774676|FG004|Primary Phase|Withdrawal by Subject|0
2158956|NCT01235949|3774677|FG005|Primary Phase|Withdrawal by Subject|3
2158957|NCT01235949|3774678|FG006|Primary Phase|Withdrawal by Subject|0
2158958|NCT01235949|3774679|FG007|Primary Phase|Withdrawal by Subject|0
2158959|NCT01235949|3774680|FG008|Primary Phase|Withdrawal by Subject|0
2158960|NCT01235949|3774681|FG009|Primary Phase|Withdrawal by Subject|0
2158961|NCT01235949|3774682|FG010|Primary Phase|Withdrawal by Subject|0
2158962|NCT01235949|3774683|FG011|Primary Phase|Withdrawal by Subject|0
2158963|NCT01235949|3774684|FG012|Primary Phase|Withdrawal by Subject|0
2158964|NCT01235949|3774685|FG013|Primary Phase|Withdrawal by Subject|0
2158965|NCT01235949|3774686|FG014|Primary Phase|Withdrawal by Subject|0
2158966|NCT01235949|3774687|FG015|Primary Phase|Withdrawal by Subject|0
2158967|NCT01235949|3774688|FG016|Primary Phase|Withdrawal by Subject|0
2158968|NCT01235949|3774689|FG017|Primary Phase|Withdrawal by Subject|0
2158969|NCT01235949|3774672|FG000|Primary Phase|Lost to Follow-up|0
2158970|NCT01235949|3774673|FG001|Primary Phase|Lost to Follow-up|0
2158971|NCT01235949|3774674|FG002|Primary Phase|Lost to Follow-up|1
2158972|NCT01235949|3774675|FG003|Primary Phase|Lost to Follow-up|1
2158973|NCT01235949|3774676|FG004|Primary Phase|Lost to Follow-up|0
2158974|NCT01235949|3774677|FG005|Primary Phase|Lost to Follow-up|2
2158975|NCT01235949|3774678|FG006|Primary Phase|Lost to Follow-up|0
2158976|NCT01235949|3774679|FG007|Primary Phase|Lost to Follow-up|0
2158977|NCT01235949|3774680|FG008|Primary Phase|Lost to Follow-up|0
2158978|NCT01235949|3774681|FG009|Primary Phase|Lost to Follow-up|0
2158979|NCT01235949|3774682|FG010|Primary Phase|Lost to Follow-up|0
2158980|NCT01235949|3774683|FG011|Primary Phase|Lost to Follow-up|0
2158981|NCT01235949|3774684|FG012|Primary Phase|Lost to Follow-up|0
2158982|NCT01235949|3774685|FG013|Primary Phase|Lost to Follow-up|0
2158983|NCT01235949|3774686|FG014|Primary Phase|Lost to Follow-up|0
2158984|NCT01235949|3774687|FG015|Primary Phase|Lost to Follow-up|0
2158985|NCT01235949|3774688|FG016|Primary Phase|Lost to Follow-up|0
2158986|NCT01235949|3774689|FG017|Primary Phase|Lost to Follow-up|0
2158987|NCT01235949|3774672|FG000|Booster Phase|Migrated/moved from study area|0
2158988|NCT01235949|3774673|FG001|Booster Phase|Migrated/moved from study area|0
2158989|NCT01235949|3774674|FG002|Booster Phase|Migrated/moved from study area|0
2158990|NCT01235949|3774675|FG003|Booster Phase|Migrated/moved from study area|0
2158991|NCT01235949|3774676|FG004|Booster Phase|Migrated/moved from study area|0
2158992|NCT01235949|3774677|FG005|Booster Phase|Migrated/moved from study area|0
2158993|NCT01235949|3774678|FG006|Booster Phase|Migrated/moved from study area|0
2158994|NCT01235949|3774679|FG007|Booster Phase|Migrated/moved from study area|0
2158995|NCT01235949|3774680|FG008|Booster Phase|Migrated/moved from study area|0
2158996|NCT01235949|3774681|FG009|Booster Phase|Migrated/moved from study area|0
2158997|NCT01235949|3774682|FG010|Booster Phase|Migrated/moved from study area|0
2158998|NCT01235949|3774683|FG011|Booster Phase|Migrated/moved from study area|1
2158999|NCT01235949|3774684|FG012|Booster Phase|Migrated/moved from study area|1
2159000|NCT01235949|3774685|FG013|Booster Phase|Migrated/moved from study area|0
2159001|NCT01235949|3774686|FG014|Booster Phase|Migrated/moved from study area|0
2159002|NCT01235949|3774687|FG015|Booster Phase|Migrated/moved from study area|0
2159003|NCT01235949|3774688|FG016|Booster Phase|Migrated/moved from study area|0
2159004|NCT01235949|3774689|FG017|Booster Phase|Migrated/moved from study area|1
2159005|NCT01235949|3774672|FG000|Booster Phase|Adverse Event|0
2159006|NCT01235949|3774673|FG001|Booster Phase|Adverse Event|0
2159007|NCT01235949|3774674|FG002|Booster Phase|Adverse Event|0
2159008|NCT01235949|3774675|FG003|Booster Phase|Adverse Event|0
2159009|NCT01235949|3774676|FG004|Booster Phase|Adverse Event|0
2159010|NCT01235949|3774677|FG005|Booster Phase|Adverse Event|0
2159011|NCT01235949|3774678|FG006|Booster Phase|Adverse Event|0
2159012|NCT01235949|3774679|FG007|Booster Phase|Adverse Event|0
2159013|NCT01235949|3774680|FG008|Booster Phase|Adverse Event|0
2159014|NCT01235949|3774681|FG009|Booster Phase|Adverse Event|0
2159015|NCT01235949|3774682|FG010|Booster Phase|Adverse Event|0
2159016|NCT01235949|3774683|FG011|Booster Phase|Adverse Event|0
2159017|NCT01235949|3774684|FG012|Booster Phase|Adverse Event|0
2159018|NCT01235949|3774685|FG013|Booster Phase|Adverse Event|0
2159019|NCT01235949|3774686|FG014|Booster Phase|Adverse Event|0
2159020|NCT01235949|3774687|FG015|Booster Phase|Adverse Event|1
2159021|NCT01235949|3774688|FG016|Booster Phase|Adverse Event|0
2159022|NCT01235949|3774689|FG017|Booster Phase|Adverse Event|0
2159023|NCT01235949|3774672|FG000|Booster Phase|Withdrawal by Subject|0
2159024|NCT01235949|3774673|FG001|Booster Phase|Withdrawal by Subject|0
2159025|NCT01235949|3774674|FG002|Booster Phase|Withdrawal by Subject|0
2159026|NCT01235949|3774675|FG003|Booster Phase|Withdrawal by Subject|0
2159027|NCT01235949|3774676|FG004|Booster Phase|Withdrawal by Subject|0
2159028|NCT01235949|3774677|FG005|Booster Phase|Withdrawal by Subject|0
2159029|NCT01235949|3774678|FG006|Booster Phase|Withdrawal by Subject|0
2159030|NCT01235949|3774679|FG007|Booster Phase|Withdrawal by Subject|1
2159031|NCT01235949|3774680|FG008|Booster Phase|Withdrawal by Subject|1
2159032|NCT01235949|3774681|FG009|Booster Phase|Withdrawal by Subject|0
2159033|NCT01235949|3774682|FG010|Booster Phase|Withdrawal by Subject|1
2159034|NCT01235949|3774683|FG011|Booster Phase|Withdrawal by Subject|1
2159035|NCT01235949|3774684|FG012|Booster Phase|Withdrawal by Subject|2
2159036|NCT01235949|3774685|FG013|Booster Phase|Withdrawal by Subject|0
2159037|NCT01235949|3774686|FG014|Booster Phase|Withdrawal by Subject|2
2159038|NCT01235949|3774687|FG015|Booster Phase|Withdrawal by Subject|0
2159039|NCT01235949|3774688|FG016|Booster Phase|Withdrawal by Subject|0
2159040|NCT01235949|3774689|FG017|Booster Phase|Withdrawal by Subject|0
2159041|NCT01235949|3774672|FG000|Booster Phase|Lost to Follow-up|0
2159042|NCT01235949|3774673|FG001|Booster Phase|Lost to Follow-up|0
2159043|NCT01235949|3774674|FG002|Booster Phase|Lost to Follow-up|0
2159044|NCT01235949|3774675|FG003|Booster Phase|Lost to Follow-up|0
2159045|NCT01235949|3774676|FG004|Booster Phase|Lost to Follow-up|0
2159046|NCT01235949|3774677|FG005|Booster Phase|Lost to Follow-up|0
2159047|NCT01235949|3774678|FG006|Booster Phase|Lost to Follow-up|0
2159048|NCT01235949|3774679|FG007|Booster Phase|Lost to Follow-up|0
2159049|NCT01235949|3774680|FG008|Booster Phase|Lost to Follow-up|1
2159050|NCT01235949|3774681|FG009|Booster Phase|Lost to Follow-up|1
2159051|NCT01235949|3774682|FG010|Booster Phase|Lost to Follow-up|1
2159052|NCT01235949|3774683|FG011|Booster Phase|Lost to Follow-up|1
2159053|NCT01235949|3774684|FG012|Booster Phase|Lost to Follow-up|0
2159054|NCT01235949|3774685|FG013|Booster Phase|Lost to Follow-up|0
2159055|NCT01235949|3774686|FG014|Booster Phase|Lost to Follow-up|0
2159056|NCT01235949|3774687|FG015|Booster Phase|Lost to Follow-up|0
2159057|NCT01235949|3774688|FG016|Booster Phase|Lost to Follow-up|0
2159058|NCT01235949|3774689|FG017|Booster Phase|Lost to Follow-up|1
2159059|NCT01235975|3774729|FG000|Overall Study|Serious Adverse Event|0
2159060|NCT01235975|3774730|FG001|Overall Study|Serious Adverse Event|1
2159061|NCT01235975|3774729|FG000|Overall Study|Withdrawal by Subject|8
2159062|NCT01235975|3774730|FG001|Overall Study|Withdrawal by Subject|2
2159063|NCT01235975|3774729|FG000|Overall Study|Migrated/moved from study area|2
2159064|NCT01235975|3774730|FG001|Overall Study|Migrated/moved from study area|1
2159065|NCT01235975|3774729|FG000|Overall Study|Lost to Follow-up|7
2159066|NCT01235975|3774730|FG001|Overall Study|Lost to Follow-up|3
2159067|NCT01236001|3774738|FG000|Overall Study|Adverse Event|5
2159068|NCT01236001|3774739|FG001|Overall Study|Adverse Event|14
2159069|NCT01236001|3774738|FG000|Overall Study|Lack of Efficacy|6
2159070|NCT01236001|3774739|FG001|Overall Study|Lack of Efficacy|6
2159071|NCT01236001|3774738|FG000|Overall Study|Lost to Follow-up|6
2159072|NCT01236001|3774739|FG001|Overall Study|Lost to Follow-up|1
2159073|NCT01236001|3774738|FG000|Overall Study|Incompliance|1
2159074|NCT01236001|3774739|FG001|Overall Study|Incompliance|0
2159075|NCT01236001|3774738|FG000|Overall Study|Planned Visit After End of Study|0
2159076|NCT01236001|3774739|FG001|Overall Study|Planned Visit After End of Study|1
2159077|NCT01236118|3774849|FG000|Overall Study|Adverse Event|2
2159078|NCT01236118|3774850|FG001|Overall Study|Adverse Event|0
2159079|NCT01236118|3774851|FG002|Overall Study|Adverse Event|2
2159080|NCT01236118|3774849|FG000|Overall Study|Physician Decision|0
2159081|NCT01236118|3774850|FG001|Overall Study|Physician Decision|1
2159082|NCT01236118|3774851|FG002|Overall Study|Physician Decision|0
2159083|NCT01236118|3774849|FG000|Overall Study|Withdrawal by Subject|0
2159084|NCT01236118|3774850|FG001|Overall Study|Withdrawal by Subject|0
2159085|NCT01236118|3774851|FG002|Overall Study|Withdrawal by Subject|1
2159086|NCT01236339|3774888|FG000|Overall Study|Termination of study by sponsor|11
2159087|NCT01236339|3774889|FG001|Overall Study|Termination of study by sponsor|13
2159088|NCT01236352|3774907|FG000|Overall Study|Death|0
2159089|NCT01236352|3774908|FG001|Overall Study|Death|0
2159090|NCT01236352|3774909|FG002|Overall Study|Death|0
2159091|NCT01236352|3774910|FG003|Overall Study|Death|0
2159092|NCT01236352|3774911|FG004|Overall Study|Death|0
2159093|NCT01236352|3774912|FG005|Overall Study|Death|0
2159094|NCT01236352|3774913|FG006|Overall Study|Death|0
2159095|NCT01236352|3774914|FG007|Overall Study|Death|1
2159096|NCT01236352|3774915|FG008|Overall Study|Death|0
2159097|NCT01236352|3774916|FG009|Overall Study|Death|0
2159098|NCT01236352|3774917|FG010|Overall Study|Death|0
2159099|NCT01236352|3774907|FG000|Overall Study|Withdrawal by Subject|0
2159100|NCT01236352|3774908|FG001|Overall Study|Withdrawal by Subject|0
2159101|NCT01236352|3774909|FG002|Overall Study|Withdrawal by Subject|0
2159102|NCT01236352|3774910|FG003|Overall Study|Withdrawal by Subject|0
2159103|NCT01236352|3774911|FG004|Overall Study|Withdrawal by Subject|0
2159104|NCT01236352|3774912|FG005|Overall Study|Withdrawal by Subject|0
2159105|NCT01236352|3774913|FG006|Overall Study|Withdrawal by Subject|0
2159106|NCT01236352|3774914|FG007|Overall Study|Withdrawal by Subject|0
2159107|NCT01236352|3774915|FG008|Overall Study|Withdrawal by Subject|0
2159108|NCT01236352|3774916|FG009|Overall Study|Withdrawal by Subject|2
2159109|NCT01236352|3774917|FG010|Overall Study|Withdrawal by Subject|1
2159110|NCT01236352|3774907|FG000|Overall Study|Adverse Event|0
2159111|NCT01236352|3774908|FG001|Overall Study|Adverse Event|0
2159112|NCT01236352|3774909|FG002|Overall Study|Adverse Event|0
2159113|NCT01236352|3774910|FG003|Overall Study|Adverse Event|0
2159114|NCT01236352|3774911|FG004|Overall Study|Adverse Event|0
2159115|NCT01236352|3774912|FG005|Overall Study|Adverse Event|0
2159116|NCT01236352|3774913|FG006|Overall Study|Adverse Event|2
2159117|NCT01236352|3774914|FG007|Overall Study|Adverse Event|0
2159118|NCT01236352|3774915|FG008|Overall Study|Adverse Event|0
2159119|NCT01236352|3774916|FG009|Overall Study|Adverse Event|4
2159120|NCT01236352|3774917|FG010|Overall Study|Adverse Event|1
2159121|NCT01236352|3774907|FG000|Overall Study|Study drug toxicity|0
2159122|NCT01236352|3774908|FG001|Overall Study|Study drug toxicity|0
2159123|NCT01236352|3774909|FG002|Overall Study|Study drug toxicity|0
2159124|NCT01236352|3774910|FG003|Overall Study|Study drug toxicity|0
2159125|NCT01236352|3774911|FG004|Overall Study|Study drug toxicity|0
2159126|NCT01236352|3774912|FG005|Overall Study|Study drug toxicity|1
2159127|NCT01236352|3774913|FG006|Overall Study|Study drug toxicity|1
2159128|NCT01236352|3774914|FG007|Overall Study|Study drug toxicity|0
2159129|NCT01236352|3774915|FG008|Overall Study|Study drug toxicity|0
2159130|NCT01236352|3774916|FG009|Overall Study|Study drug toxicity|2
2159131|NCT01236352|3774917|FG010|Overall Study|Study drug toxicity|2
2159132|NCT01236352|3774907|FG000|Overall Study|Disease progression|1
2159133|NCT01236352|3774908|FG001|Overall Study|Disease progression|2
2159134|NCT01236352|3774909|FG002|Overall Study|Disease progression|1
2159135|NCT01236352|3774910|FG003|Overall Study|Disease progression|2
2159136|NCT01236352|3774911|FG004|Overall Study|Disease progression|2
2159137|NCT01236352|3774912|FG005|Overall Study|Disease progression|2
2159138|NCT01236352|3774913|FG006|Overall Study|Disease progression|1
2159139|NCT01236352|3774914|FG007|Overall Study|Disease progression|3
2159140|NCT01236352|3774915|FG008|Overall Study|Disease progression|2
2159141|NCT01236352|3774916|FG009|Overall Study|Disease progression|2
2159142|NCT01236352|3774917|FG010|Overall Study|Disease progression|2
2159143|NCT01236352|3774907|FG000|Overall Study|Poor/Non-compliance|1
2159144|NCT01236352|3774908|FG001|Overall Study|Poor/Non-compliance|0
2159145|NCT01236352|3774909|FG002|Overall Study|Poor/Non-compliance|0
2159146|NCT01236352|3774910|FG003|Overall Study|Poor/Non-compliance|0
2159147|NCT01236352|3774911|FG004|Overall Study|Poor/Non-compliance|0
2159148|NCT01236352|3774912|FG005|Overall Study|Poor/Non-compliance|0
2159149|NCT01236352|3774913|FG006|Overall Study|Poor/Non-compliance|0
2159150|NCT01236352|3774914|FG007|Overall Study|Poor/Non-compliance|0
2159151|NCT01236352|3774915|FG008|Overall Study|Poor/Non-compliance|0
2159152|NCT01236352|3774916|FG009|Overall Study|Poor/Non-compliance|0
2159153|NCT01236352|3774917|FG010|Overall Study|Poor/Non-compliance|0
2159154|NCT01236352|3774907|FG000|Overall Study|Maximum clinical benefit|1
2159155|NCT01236352|3774908|FG001|Overall Study|Maximum clinical benefit|1
2159156|NCT01236352|3774909|FG002|Overall Study|Maximum clinical benefit|1
2159157|NCT01236352|3774910|FG003|Overall Study|Maximum clinical benefit|0
2159158|NCT01236352|3774911|FG004|Overall Study|Maximum clinical benefit|2
2159159|NCT01236352|3774912|FG005|Overall Study|Maximum clinical benefit|0
2159160|NCT01236352|3774913|FG006|Overall Study|Maximum clinical benefit|3
2159161|NCT01236352|3774914|FG007|Overall Study|Maximum clinical benefit|1
2159162|NCT01236352|3774915|FG008|Overall Study|Maximum clinical benefit|1
2159163|NCT01236352|3774916|FG009|Overall Study|Maximum clinical benefit|4
2159164|NCT01236352|3774917|FG010|Overall Study|Maximum clinical benefit|2
2159165|NCT01236352|3774907|FG000|Overall Study|Subject request to discontinue treatment|0
2159166|NCT01236352|3774908|FG001|Overall Study|Subject request to discontinue treatment|0
2159167|NCT01236352|3774909|FG002|Overall Study|Subject request to discontinue treatment|1
2159168|NCT01236352|3774910|FG003|Overall Study|Subject request to discontinue treatment|1
2159169|NCT01236352|3774911|FG004|Overall Study|Subject request to discontinue treatment|0
2159170|NCT01236352|3774912|FG005|Overall Study|Subject request to discontinue treatment|1
2159171|NCT01236352|3774913|FG006|Overall Study|Subject request to discontinue treatment|0
2159172|NCT01236352|3774914|FG007|Overall Study|Subject request to discontinue treatment|0
2159173|NCT01236352|3774915|FG008|Overall Study|Subject request to discontinue treatment|0
2179370|NCT01393626|3804906|FG000|Overall Study|Lost to Follow-up|1
2159174|NCT01236352|3774916|FG009|Overall Study|Subject request to discontinue treatment|1
2159175|NCT01236352|3774917|FG010|Overall Study|Subject request to discontinue treatment|4
2159176|NCT01236352|3774907|FG000|Overall Study|Subject to receive drug via EAP|1
2159177|NCT01236352|3774908|FG001|Overall Study|Subject to receive drug via EAP|1
2159178|NCT01236352|3774909|FG002|Overall Study|Subject to receive drug via EAP|1
2159179|NCT01236352|3774910|FG003|Overall Study|Subject to receive drug via EAP|0
2159180|NCT01236352|3774911|FG004|Overall Study|Subject to receive drug via EAP|0
2159181|NCT01236352|3774912|FG005|Overall Study|Subject to receive drug via EAP|0
2159182|NCT01236352|3774913|FG006|Overall Study|Subject to receive drug via EAP|0
2159183|NCT01236352|3774914|FG007|Overall Study|Subject to receive drug via EAP|2
2159184|NCT01236352|3774915|FG008|Overall Study|Subject to receive drug via EAP|0
2159185|NCT01236352|3774916|FG009|Overall Study|Subject to receive drug via EAP|4
2159186|NCT01236352|3774917|FG010|Overall Study|Subject to receive drug via EAP|0
2159187|NCT01236352|3774907|FG000|Overall Study|Patient moving to allogeneic transplant|0
2159188|NCT01236352|3774908|FG001|Overall Study|Patient moving to allogeneic transplant|0
2159189|NCT01236352|3774909|FG002|Overall Study|Patient moving to allogeneic transplant|0
2159190|NCT01236352|3774910|FG003|Overall Study|Patient moving to allogeneic transplant|0
2159191|NCT01236352|3774911|FG004|Overall Study|Patient moving to allogeneic transplant|0
2159192|NCT01236352|3774912|FG005|Overall Study|Patient moving to allogeneic transplant|0
2159193|NCT01236352|3774913|FG006|Overall Study|Patient moving to allogeneic transplant|1
2159194|NCT01236352|3774914|FG007|Overall Study|Patient moving to allogeneic transplant|0
2159195|NCT01236352|3774915|FG008|Overall Study|Patient moving to allogeneic transplant|0
2159196|NCT01236352|3774916|FG009|Overall Study|Patient moving to allogeneic transplant|0
2159197|NCT01236352|3774917|FG010|Overall Study|Patient moving to allogeneic transplant|0
2159198|NCT01236352|3774907|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0
2159199|NCT01236352|3774908|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0
2159200|NCT01236352|3774909|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0
2159201|NCT01236352|3774910|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0
2159202|NCT01236352|3774911|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0
2159203|NCT01236352|3774912|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0
2159204|NCT01236352|3774913|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0
2159205|NCT01236352|3774914|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0
2159206|NCT01236352|3774915|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0
2159207|NCT01236352|3774916|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0
2159208|NCT01236352|3774917|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1
2159209|NCT01236352|3774907|FG000|Overall Study|Lack of response to drug|0
2159210|NCT01236352|3774908|FG001|Overall Study|Lack of response to drug|0
2159211|NCT01236352|3774909|FG002|Overall Study|Lack of response to drug|0
2159212|NCT01236352|3774910|FG003|Overall Study|Lack of response to drug|0
2159213|NCT01236352|3774911|FG004|Overall Study|Lack of response to drug|0
2159214|NCT01236352|3774912|FG005|Overall Study|Lack of response to drug|0
2159215|NCT01236352|3774913|FG006|Overall Study|Lack of response to drug|0
2159216|NCT01236352|3774914|FG007|Overall Study|Lack of response to drug|0
2159217|NCT01236352|3774915|FG008|Overall Study|Lack of response to drug|0
2159218|NCT01236352|3774916|FG009|Overall Study|Lack of response to drug|1
2159219|NCT01236352|3774917|FG010|Overall Study|Lack of response to drug|1
2159220|NCT01236352|3774907|FG000|Overall Study|Patient transferred to IST|0
2159221|NCT01236352|3774908|FG001|Overall Study|Patient transferred to IST|0
2159222|NCT01236352|3774909|FG002|Overall Study|Patient transferred to IST|0
2159223|NCT01236352|3774910|FG003|Overall Study|Patient transferred to IST|0
2159224|NCT01236352|3774911|FG004|Overall Study|Patient transferred to IST|0
2159225|NCT01236352|3774912|FG005|Overall Study|Patient transferred to IST|0
2159226|NCT01236352|3774913|FG006|Overall Study|Patient transferred to IST|0
2159227|NCT01236352|3774914|FG007|Overall Study|Patient transferred to IST|0
2159228|NCT01236352|3774915|FG008|Overall Study|Patient transferred to IST|0
2159229|NCT01236352|3774916|FG009|Overall Study|Patient transferred to IST|2
2159230|NCT01236352|3774917|FG010|Overall Study|Patient transferred to IST|6
2159231|NCT01236365|3774943|FG000|Overall Study|Lost to Follow-up|0
2159232|NCT01236365|3774944|FG001|Overall Study|Lost to Follow-up|2
2159233|NCT01236365|3774943|FG000|Overall Study|Moved Out of State|1
2159234|NCT01236365|3774944|FG001|Overall Study|Moved Out of State|0
2159235|NCT01236365|3774943|FG000|Overall Study|Dropped at Randomization due to high LFT|1
2159236|NCT01236365|3774944|FG001|Overall Study|Dropped at Randomization due to high LFT|0
2159237|NCT01236521|3774975|FG000|Overall Study|Withdrawal by Subject|12
2159238|NCT01236521|3774976|FG001|Overall Study|Withdrawal by Subject|17
2159239|NCT01236521|3774975|FG000|Overall Study|Death|2
2159240|NCT01236521|3774976|FG001|Overall Study|Death|1
2159241|NCT01236521|3774975|FG000|Overall Study|Lost to Follow-up|7
2159242|NCT01236521|3774976|FG001|Overall Study|Lost to Follow-up|7
2159243|NCT01236534|3774984|FG000|Overall Study|Adverse Event|3
2159244|NCT01236534|3774985|FG001|Overall Study|Adverse Event|0
2159245|NCT01236547|3774996|FG000|Overall Study|Protocol Violation|0
2159246|NCT01236547|3774997|FG001|Overall Study|Protocol Violation|1
2159247|NCT01236547|3774998|FG002|Overall Study|Protocol Violation|1
2159248|NCT01236547|3774999|FG003|Overall Study|Protocol Violation|6
2159249|NCT01236547|3775000|FG004|Overall Study|Protocol Violation|12
2159250|NCT01236560|3775019|FG000|Overall Study|Adverse Event|0
2159251|NCT01236560|3775020|FG001|Overall Study|Adverse Event|2
2159252|NCT01236560|3775021|FG002|Overall Study|Adverse Event|1
2159253|NCT01236560|3775022|FG003|Overall Study|Adverse Event|3
2159254|NCT01236560|3775023|FG004|Overall Study|Adverse Event|0
2159255|NCT01236560|3775024|FG005|Overall Study|Adverse Event|0
2159256|NCT01236560|3775019|FG000|Overall Study|Death|0
2159257|NCT01236560|3775020|FG001|Overall Study|Death|1
2159258|NCT01236560|3775021|FG002|Overall Study|Death|0
2159259|NCT01236560|3775022|FG003|Overall Study|Death|1
2159260|NCT01236560|3775023|FG004|Overall Study|Death|0
2159261|NCT01236560|3775024|FG005|Overall Study|Death|0
2159262|NCT01236560|3775019|FG000|Overall Study|Lost to Follow-up|0
2159263|NCT01236560|3775020|FG001|Overall Study|Lost to Follow-up|1
2159264|NCT01236560|3775021|FG002|Overall Study|Lost to Follow-up|1
2159265|NCT01236560|3775022|FG003|Overall Study|Lost to Follow-up|0
2159266|NCT01236560|3775023|FG004|Overall Study|Lost to Follow-up|0
2159267|NCT01236560|3775024|FG005|Overall Study|Lost to Follow-up|0
2159268|NCT01236560|3775019|FG000|Overall Study|Physician Decision|0
2159269|NCT01236560|3775020|FG001|Overall Study|Physician Decision|1
2159270|NCT01236560|3775021|FG002|Overall Study|Physician Decision|8
2159271|NCT01236560|3775022|FG003|Overall Study|Physician Decision|0
2159272|NCT01236560|3775023|FG004|Overall Study|Physician Decision|0
2159273|NCT01236560|3775024|FG005|Overall Study|Physician Decision|0
2159274|NCT01236560|3775019|FG000|Overall Study|Withdrawal by Subject|0
2159275|NCT01236560|3775020|FG001|Overall Study|Withdrawal by Subject|0
2159276|NCT01236560|3775021|FG002|Overall Study|Withdrawal by Subject|1
2159277|NCT01236560|3775022|FG003|Overall Study|Withdrawal by Subject|2
2159278|NCT01236560|3775023|FG004|Overall Study|Withdrawal by Subject|0
2159279|NCT01236560|3775024|FG005|Overall Study|Withdrawal by Subject|0
2159280|NCT01236560|3775019|FG000|Overall Study|Progressive disease|5
2159281|NCT01236560|3775020|FG001|Overall Study|Progressive disease|19
2159282|NCT01236560|3775021|FG002|Overall Study|Progressive disease|9
2159283|NCT01236560|3775022|FG003|Overall Study|Progressive disease|16
2159284|NCT01236560|3775023|FG004|Overall Study|Progressive disease|0
2159285|NCT01236560|3775024|FG005|Overall Study|Progressive disease|0
2159286|NCT01236573|3775045|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2159287|NCT01236573|3775046|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2159288|NCT01236573|3775047|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2159289|NCT01236573|3775048|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2159290|NCT01236573|3775049|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2159291|NCT01236573|3775050|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2159292|NCT01236573|3775051|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
2159293|NCT01236573|3775052|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2159294|NCT01236573|3775053|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
2159295|NCT01236573|3775054|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
2159296|NCT01236573|3775055|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2159297|NCT01236573|3775045|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2159298|NCT01236573|3775046|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2159299|NCT01236573|3775047|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2159300|NCT01236573|3775048|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2159301|NCT01236573|3775049|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2159302|NCT01236573|3775050|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2159303|NCT01236573|3775051|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2159304|NCT01236573|3775052|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2159305|NCT01236573|3775053|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
2159306|NCT01236573|3775054|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2159307|NCT01236573|3775055|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2159308|NCT01236573|3775045|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2159309|NCT01236573|3775046|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2159310|NCT01236573|3775047|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2159311|NCT01236573|3775048|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2159312|NCT01236573|3775049|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2159313|NCT01236573|3775050|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2159314|NCT01236573|3775051|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2159315|NCT01236573|3775052|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2159316|NCT01236573|3775053|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2159317|NCT01236573|3775054|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2159318|NCT01236573|3775055|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
2159319|NCT01236755|3775093|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8
2159320|NCT01236755|3775093|FG000|Spectacles Wearing Phase|Lost to Follow-up|9
2159321|NCT01236755|3775093|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5
2159322|NCT01236755|3775093|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
2159323|NCT01237054|3775127|FG000|Overall Study|imaging 10C0096|1
2159324|NCT01237223|3775158|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
2159325|NCT01237223|3775159|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2159326|NCT01237223|3775160|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2159327|NCT01237223|3775161|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2159328|NCT01237223|3775162|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2159329|NCT01237223|3775163|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2159330|NCT01237223|3775158|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
2159331|NCT01237223|3775159|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2159332|NCT01237223|3775160|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2159333|NCT01237223|3775161|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2159334|NCT01237223|3775162|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2159335|NCT01237223|3775163|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2159336|NCT01237223|3775158|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
2159337|NCT01237223|3775159|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2159338|NCT01237223|3775160|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2159339|NCT01237223|3775161|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2159340|NCT01237223|3775162|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2159341|NCT01237223|3775163|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2159342|NCT01237223|3775158|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
2159343|NCT01237223|3775159|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2159344|NCT01237223|3775160|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2159345|NCT01237223|3775161|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2159346|NCT01237223|3775162|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2159347|NCT01237223|3775163|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2159348|NCT01237223|3775158|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
2159349|NCT01237223|3775159|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2159350|NCT01237223|3775160|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2159351|NCT01237223|3775161|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2159352|NCT01237223|3775162|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2159353|NCT01237223|3775163|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2159354|NCT01237223|3775158|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
2159355|NCT01237223|3775159|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
2159356|NCT01237223|3775160|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
2159357|NCT01237223|3775161|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
2159358|NCT01237223|3775162|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
2159359|NCT01237223|3775163|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
2159360|NCT01237223|3775158|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
2159361|NCT01237223|3775159|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
2159362|NCT01237223|3775160|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
2159363|NCT01237223|3775161|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
2159364|NCT01237223|3775162|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
2159365|NCT01237223|3775163|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
2159366|NCT01237223|3775158|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
2159367|NCT01237223|3775159|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
2159368|NCT01237223|3775160|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
2159369|NCT01237223|3775161|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
2159370|NCT01237223|3775162|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
2159371|NCT01237223|3775163|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
2159372|NCT01237223|3775158|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2159373|NCT01237223|3775159|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2159374|NCT01237223|3775160|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2159375|NCT01237223|3775161|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2159376|NCT01237223|3775162|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2159377|NCT01237223|3775163|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
2159378|NCT01237223|3775158|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
2159379|NCT01237223|3775159|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2159380|NCT01237223|3775160|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2159381|NCT01237223|3775161|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
2159382|NCT01237223|3775162|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2159383|NCT01237223|3775163|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2159384|NCT01237327|3775192|FG000|Overall Study|Protocol Violation: Core Study|1
2159385|NCT01237327|3775193|FG001|Overall Study|Protocol Violation: Core Study|0
2159386|NCT01237327|3775192|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3
2159387|NCT01237327|3775193|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2
2159388|NCT01237327|3775192|FG000|Overall Study|Progression of Disease: Core Study|18
2159389|NCT01237327|3775193|FG001|Overall Study|Progression of Disease: Core Study|22
2159390|NCT01237327|3775192|FG000|Overall Study|Progression of Disease: Extension Study|15
2159391|NCT01237327|3775193|FG001|Overall Study|Progression of Disease: Extension Study|13
2159392|NCT01237327|3775192|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1
2159393|NCT01237327|3775193|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0
2293744|NCT02528357|3987958|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293745|NCT02528357|3987959|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293746|NCT02528357|3987960|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293747|NCT02528357|3987961|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293748|NCT02528357|3987962|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293749|NCT02528357|3987963|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293750|NCT02528357|3987964|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2321238|NCT02957682|4035675|FG001|Overall Study|Poor Compliance to Protocol|26
2159394|NCT01237327|3775192|FG000|Overall Study|Withdrawal by Subject|1
2159395|NCT01237327|3775193|FG001|Overall Study|Withdrawal by Subject|3
2159396|NCT01237327|3775192|FG000|Overall Study|Lost to Follow-up|3
2159397|NCT01237327|3775193|FG001|Overall Study|Lost to Follow-up|0
2159398|NCT01237340|3775199|FG000|Overall Study|Adverse Event|3
2159399|NCT01237340|3775199|FG000|Overall Study|Withdrawal by Subject|1
2159400|NCT01237340|3775199|FG000|Overall Study|Early termination of the trial|36
2159401|NCT01237587|3775212|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5
2159402|NCT01237587|3775213|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1
2159403|NCT01237587|3775212|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
2159404|NCT01237587|3775213|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
2159405|NCT01237587|3775212|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
2159406|NCT01237587|3775213|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
2159407|NCT01237587|3775212|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
2159408|NCT01237587|3775213|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
2159409|NCT01237587|3775212|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4
2159410|NCT01237587|3775213|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3
2159411|NCT01237587|3775212|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
2159412|NCT01237587|3775213|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
2159413|NCT01237587|3775212|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
2159414|NCT01237587|3775213|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
2159415|NCT01237587|3775212|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5
2159416|NCT01237587|3775213|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5
2159417|NCT01237587|3775212|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
2159418|NCT01237587|3775213|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
2159419|NCT01237587|3775212|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
2159420|NCT01237587|3775213|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
2159421|NCT01237587|3775212|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
2159422|NCT01237587|3775213|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
2159423|NCT01237587|3775212|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1
2159424|NCT01237587|3775213|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0
2159425|NCT01237587|3775212|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4
2159426|NCT01237587|3775213|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4
2159427|NCT01237587|3775212|FG000|Taper Phase|Adverse Event|0
2159428|NCT01237587|3775213|FG001|Taper Phase|Adverse Event|2
2159429|NCT01237587|3775212|FG000|Taper Phase|Protocol Violation|2
2159430|NCT01237587|3775213|FG001|Taper Phase|Protocol Violation|0
2159431|NCT01237587|3775212|FG000|Taper Phase|Lack of Efficacy|2
2159432|NCT01237587|3775213|FG001|Taper Phase|Lack of Efficacy|5
2159433|NCT01237587|3775212|FG000|Taper Phase|Parent/Guardian Decision|0
2159434|NCT01237587|3775213|FG001|Taper Phase|Parent/Guardian Decision|2
2159435|NCT01237587|3775212|FG000|Taper Phase|Sponsor Decision|1
2159436|NCT01237587|3775213|FG001|Taper Phase|Sponsor Decision|0
2159437|NCT01237587|3775212|FG000|Taper Phase|Withdrawal by Subject|0
2159438|NCT01237587|3775213|FG001|Taper Phase|Withdrawal by Subject|1
2159439|NCT01237678|3775229|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
2159440|NCT01237678|3775230|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
2159441|NCT01237678|3775231|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
2159442|NCT01237678|3775229|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
2159443|NCT01237678|3775230|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
2159444|NCT01237678|3775231|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
2159445|NCT01237678|3775229|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
2159446|NCT01237678|3775230|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
2159447|NCT01237678|3775231|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
2159448|NCT01237678|3775229|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
2159449|NCT01237678|3775230|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
2159450|NCT01237678|3775231|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
2159451|NCT01237678|3775229|FG000|Phase II|Adverse Event|0
2159452|NCT01237678|3775230|FG001|Phase II|Adverse Event|39
2159453|NCT01237678|3775231|FG002|Phase II|Adverse Event|9
2159454|NCT01237678|3775229|FG000|Phase II|Death|0
2159455|NCT01237678|3775230|FG001|Phase II|Death|0
2159456|NCT01237678|3775231|FG002|Phase II|Death|2
2159457|NCT01237678|3775229|FG000|Phase II|Lack of Efficacy|0
2159458|NCT01237678|3775230|FG001|Phase II|Lack of Efficacy|25
2159459|NCT01237678|3775231|FG002|Phase II|Lack of Efficacy|3
2159460|NCT01237678|3775229|FG000|Phase II|Withdrawal by Subject|0
2159461|NCT01237678|3775230|FG001|Phase II|Withdrawal by Subject|1
2159462|NCT01237678|3775231|FG002|Phase II|Withdrawal by Subject|5
2159463|NCT01237678|3775229|FG000|Phase II|Completed Cycles 4-6|0
2159464|NCT01237678|3775230|FG001|Phase II|Completed Cycles 4-6|11
2159465|NCT01237678|3775231|FG002|Phase II|Completed Cycles 4-6|21
2159466|NCT01237678|3775229|FG000|Phase II|Sponsor Decision/Study Closed|0
2159467|NCT01237678|3775230|FG001|Phase II|Sponsor Decision/Study Closed|18
2159468|NCT01237678|3775231|FG002|Phase II|Sponsor Decision/Study Closed|7
2159469|NCT01237678|3775229|FG000|Phase II|Randomized but were not treated|0
2159470|NCT01237678|3775230|FG001|Phase II|Randomized but were not treated|4
2159471|NCT01237678|3775231|FG002|Phase II|Randomized but were not treated|3
2159472|NCT01237899|3775266|FG000|Washout Period of at Least 7 Days|Adverse Event|0
2159473|NCT01237899|3775267|FG001|Washout Period of at Least 7 Days|Adverse Event|0
2159474|NCT01237899|3775268|FG002|Washout Period of at Least 7 Days|Adverse Event|1
2159475|NCT01237899|3775269|FG003|Washout Period of at Least 7 Days|Adverse Event|0
2159476|NCT01237899|3775270|FG004|Washout Period of at Least 7 Days|Adverse Event|0
2159477|NCT01237899|3775271|FG005|Washout Period of at Least 7 Days|Adverse Event|0
2159478|NCT01237899|3775272|FG006|Washout Period of at Least 7 Days|Adverse Event|0
2159479|NCT01237899|3775273|FG007|Washout Period of at Least 7 Days|Adverse Event|0
2159480|NCT01237899|3775274|FG008|Washout Period of at Least 7 Days|Adverse Event|0
2159481|NCT01237899|3775275|FG009|Washout Period of at Least 7 Days|Adverse Event|0
2159482|NCT01237899|3775276|FG010|Washout Period of at Least 7 Days|Adverse Event|0
2159483|NCT01237951|3775294|FG000|Overall Study|Death|1
2159484|NCT01238120|3775302|FG000|Overall Study|Withdrawal by Subject|4
2159485|NCT01238120|3775303|FG001|Overall Study|Withdrawal by Subject|1
2159486|NCT01238120|3775304|FG002|Overall Study|Withdrawal by Subject|2
2159487|NCT01238120|3775305|FG003|Overall Study|Withdrawal by Subject|5
2159488|NCT01238120|3775302|FG000|Overall Study|Lost to Follow-up|2
2159489|NCT01238120|3775303|FG001|Overall Study|Lost to Follow-up|0
2159490|NCT01238120|3775304|FG002|Overall Study|Lost to Follow-up|1
2159491|NCT01238120|3775305|FG003|Overall Study|Lost to Follow-up|1
2159492|NCT01238120|3775302|FG000|Overall Study|Withdrawn due to Medical Problem|2
2159493|NCT01238120|3775303|FG001|Overall Study|Withdrawn due to Medical Problem|0
2159494|NCT01238120|3775304|FG002|Overall Study|Withdrawn due to Medical Problem|1
2159495|NCT01238120|3775305|FG003|Overall Study|Withdrawn due to Medical Problem|0
2159496|NCT01238172|3775317|FG000|Overall Study|Ineligible: based on Eligibility Review|2
2159497|NCT01238172|3775318|FG001|Overall Study|Ineligible: based on Eligibility Review|5
2159498|NCT01238172|3775317|FG000|Overall Study|Ineligible: based on Central Path Review|9
2159499|NCT01238172|3775318|FG001|Overall Study|Ineligible: based on Central Path Review|19
2159500|NCT01238575|3775354|FG000|Overall Study|Lack of Efficacy|2
2159501|NCT01238575|3775355|FG001|Overall Study|Lack of Efficacy|4
2159502|NCT01238575|3775354|FG000|Overall Study|Adverse Event|2
2159503|NCT01238575|3775355|FG001|Overall Study|Adverse Event|0
2159504|NCT01238588|3775361|FG000|Overall Study|Withdrawal by Subject|1
2159505|NCT01238588|3775361|FG000|Overall Study|Physician Decision|2
2159506|NCT01238822|3775373|FG000|Overall Study|COULD NOT SWALLOW PILLS|3
2159507|NCT01238835|3775383|FG000|Overall Study|Death|124
2159508|NCT01238835|3775383|FG000|Overall Study|Withdrawal by Subject|9
2159509|NCT01238835|3775383|FG000|Overall Study|Lost to Follow-up|1
2159510|NCT01238835|3775383|FG000|Overall Study|Site early discontinuation|2
2159511|NCT01238848|3775389|FG000|Overall Study|Physician Decision|13
2159512|NCT01238848|3775390|FG001|Overall Study|Physician Decision|5
2159513|NCT01238861|3775402|FG000|Overall Study|Lost to Follow-up|4
2159514|NCT01238861|3775403|FG001|Overall Study|Lost to Follow-up|2
2159515|NCT01238861|3775404|FG002|Overall Study|Lost to Follow-up|3
2159516|NCT01238861|3775405|FG003|Overall Study|Lost to Follow-up|1
2159517|NCT01238861|3775406|FG004|Overall Study|Lost to Follow-up|1
2159518|NCT01238861|3775407|FG005|Overall Study|Lost to Follow-up|2
2159519|NCT01238861|3775402|FG000|Overall Study|Unplanned surgery|1
2159520|NCT01238861|3775403|FG001|Overall Study|Unplanned surgery|0
2159521|NCT01238861|3775404|FG002|Overall Study|Unplanned surgery|0
2159522|NCT01238861|3775405|FG003|Overall Study|Unplanned surgery|0
2159523|NCT01238861|3775406|FG004|Overall Study|Unplanned surgery|0
2159524|NCT01238861|3775407|FG005|Overall Study|Unplanned surgery|0
2159525|NCT01238861|3775402|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0
2159526|NCT01238861|3775403|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0
2159527|NCT01238861|3775404|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1
2159528|NCT01238861|3775405|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0
2159529|NCT01238861|3775406|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1
2159530|NCT01238861|3775407|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1
2159531|NCT01238861|3775402|FG000|Overall Study|Incorrect enrollment/randomization|0
2159532|NCT01238861|3775403|FG001|Overall Study|Incorrect enrollment/randomization|0
2159533|NCT01238861|3775404|FG002|Overall Study|Incorrect enrollment/randomization|1
2159534|NCT01238861|3775405|FG003|Overall Study|Incorrect enrollment/randomization|0
2159535|NCT01238861|3775406|FG004|Overall Study|Incorrect enrollment/randomization|1
2159536|NCT01238861|3775407|FG005|Overall Study|Incorrect enrollment/randomization|0
2159537|NCT01238861|3775402|FG000|Overall Study|Subject traveled to Argentina by 1 year|0
2159538|NCT01238861|3775403|FG001|Overall Study|Subject traveled to Argentina by 1 year|0
2159539|NCT01238861|3775404|FG002|Overall Study|Subject traveled to Argentina by 1 year|1
2159540|NCT01238861|3775405|FG003|Overall Study|Subject traveled to Argentina by 1 year|0
2159541|NCT01238861|3775406|FG004|Overall Study|Subject traveled to Argentina by 1 year|0
2159542|NCT01238861|3775407|FG005|Overall Study|Subject traveled to Argentina by 1 year|0
2159543|NCT01238861|3775402|FG000|Overall Study|Subject moved out of state/area|0
2159544|NCT01238861|3775403|FG001|Overall Study|Subject moved out of state/area|0
2159545|NCT01238861|3775404|FG002|Overall Study|Subject moved out of state/area|1
2159546|NCT01238861|3775405|FG003|Overall Study|Subject moved out of state/area|1
2159547|NCT01238861|3775406|FG004|Overall Study|Subject moved out of state/area|0
2159548|NCT01238861|3775407|FG005|Overall Study|Subject moved out of state/area|0
2159549|NCT01238861|3775402|FG000|Overall Study|Strongyloides stercoralis antibodies +|0
2159550|NCT01238861|3775403|FG001|Overall Study|Strongyloides stercoralis antibodies +|0
2159551|NCT01238861|3775404|FG002|Overall Study|Strongyloides stercoralis antibodies +|0
2159552|NCT01238861|3775405|FG003|Overall Study|Strongyloides stercoralis antibodies +|1
2159553|NCT01238861|3775406|FG004|Overall Study|Strongyloides stercoralis antibodies +|0
2159554|NCT01238861|3775407|FG005|Overall Study|Strongyloides stercoralis antibodies +|0
2159555|NCT01238861|3775402|FG000|Overall Study|Personal problems|0
2159556|NCT01238861|3775403|FG001|Overall Study|Personal problems|0
2159557|NCT01238861|3775404|FG002|Overall Study|Personal problems|0
2159558|NCT01238861|3775405|FG003|Overall Study|Personal problems|1
2159559|NCT01238861|3775406|FG004|Overall Study|Personal problems|0
2159560|NCT01238861|3775407|FG005|Overall Study|Personal problems|0
2159561|NCT01238861|3775402|FG000|Overall Study|Unable to continue visits|0
2159562|NCT01238861|3775403|FG001|Overall Study|Unable to continue visits|0
2159563|NCT01238861|3775404|FG002|Overall Study|Unable to continue visits|0
2159564|NCT01238861|3775405|FG003|Overall Study|Unable to continue visits|1
2159565|NCT01238861|3775406|FG004|Overall Study|Unable to continue visits|0
2159566|NCT01238861|3775407|FG005|Overall Study|Unable to continue visits|1
2159567|NCT01238861|3775402|FG000|Overall Study|Serious adverse event|0
2159568|NCT01238861|3775403|FG001|Overall Study|Serious adverse event|0
2159569|NCT01238861|3775404|FG002|Overall Study|Serious adverse event|0
2159570|NCT01238861|3775405|FG003|Overall Study|Serious adverse event|0
2159571|NCT01238861|3775406|FG004|Overall Study|Serious adverse event|0
2159572|NCT01238861|3775407|FG005|Overall Study|Serious adverse event|1
2159573|NCT01238861|3775402|FG000|Overall Study|Lack of compliance|0
2159574|NCT01238861|3775403|FG001|Overall Study|Lack of compliance|0
2159575|NCT01238861|3775404|FG002|Overall Study|Lack of compliance|0
2159576|NCT01238861|3775405|FG003|Overall Study|Lack of compliance|0
2159577|NCT01238861|3775406|FG004|Overall Study|Lack of compliance|0
2159578|NCT01238861|3775407|FG005|Overall Study|Lack of compliance|1
2159579|NCT01238861|3775402|FG000|Overall Study|Adverse Event|0
2159580|NCT01238861|3775403|FG001|Overall Study|Adverse Event|1
2159581|NCT01238861|3775404|FG002|Overall Study|Adverse Event|0
2159582|NCT01238861|3775405|FG003|Overall Study|Adverse Event|0
2159583|NCT01238861|3775406|FG004|Overall Study|Adverse Event|0
2159584|NCT01238861|3775407|FG005|Overall Study|Adverse Event|0
2159585|NCT01238861|3775402|FG000|Overall Study|Withdrawal by Subject|6
2159586|NCT01238861|3775403|FG001|Overall Study|Withdrawal by Subject|5
2159587|NCT01238861|3775404|FG002|Overall Study|Withdrawal by Subject|4
2159588|NCT01238861|3775405|FG003|Overall Study|Withdrawal by Subject|8
2159589|NCT01238861|3775406|FG004|Overall Study|Withdrawal by Subject|10
2159590|NCT01238861|3775407|FG005|Overall Study|Withdrawal by Subject|9
2159591|NCT01238900|3775428|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4
2159592|NCT01238900|3775428|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1
2159593|NCT01238991|3775443|FG000|Overall Study|Adverse Event|1
2159594|NCT01238991|3775444|FG001|Overall Study|Adverse Event|0
2159595|NCT01238991|3775445|FG002|Overall Study|Adverse Event|3
2159596|NCT01238991|3775446|FG003|Overall Study|Adverse Event|1
2159597|NCT01238991|3775447|FG004|Overall Study|Adverse Event|1
2159598|NCT01238991|3775448|FG005|Overall Study|Adverse Event|0
2159599|NCT01238991|3775449|FG006|Overall Study|Adverse Event|1
2159600|NCT01238991|3775450|FG007|Overall Study|Adverse Event|1
2159601|NCT01238991|3775451|FG008|Overall Study|Adverse Event|0
2159602|NCT01238991|3775452|FG009|Overall Study|Adverse Event|0
2159603|NCT01238991|3775443|FG000|Overall Study|Death|0
2159604|NCT01238991|3775444|FG001|Overall Study|Death|0
2159605|NCT01238991|3775445|FG002|Overall Study|Death|0
2159606|NCT01238991|3775446|FG003|Overall Study|Death|1
2159607|NCT01238991|3775447|FG004|Overall Study|Death|0
2159608|NCT01238991|3775448|FG005|Overall Study|Death|0
2159609|NCT01238991|3775449|FG006|Overall Study|Death|0
2159610|NCT01238991|3775450|FG007|Overall Study|Death|0
2159611|NCT01238991|3775451|FG008|Overall Study|Death|0
2159612|NCT01238991|3775452|FG009|Overall Study|Death|0
2159613|NCT01238991|3775443|FG000|Overall Study|Lack of Efficacy|0
2159614|NCT01238991|3775444|FG001|Overall Study|Lack of Efficacy|0
2159615|NCT01238991|3775445|FG002|Overall Study|Lack of Efficacy|1
2159616|NCT01238991|3775446|FG003|Overall Study|Lack of Efficacy|0
2159617|NCT01238991|3775447|FG004|Overall Study|Lack of Efficacy|0
2159618|NCT01238991|3775448|FG005|Overall Study|Lack of Efficacy|0
2159619|NCT01238991|3775449|FG006|Overall Study|Lack of Efficacy|0
2159620|NCT01238991|3775450|FG007|Overall Study|Lack of Efficacy|0
2159621|NCT01238991|3775451|FG008|Overall Study|Lack of Efficacy|1
2159622|NCT01238991|3775452|FG009|Overall Study|Lack of Efficacy|0
2159623|NCT01238991|3775443|FG000|Overall Study|Withdrawal by Subject|0
2159624|NCT01238991|3775444|FG001|Overall Study|Withdrawal by Subject|0
2159625|NCT01238991|3775445|FG002|Overall Study|Withdrawal by Subject|1
2159626|NCT01238991|3775446|FG003|Overall Study|Withdrawal by Subject|0
2159627|NCT01238991|3775447|FG004|Overall Study|Withdrawal by Subject|0
2159628|NCT01238991|3775448|FG005|Overall Study|Withdrawal by Subject|0
2159629|NCT01238991|3775449|FG006|Overall Study|Withdrawal by Subject|0
2159630|NCT01238991|3775450|FG007|Overall Study|Withdrawal by Subject|0
2159631|NCT01238991|3775451|FG008|Overall Study|Withdrawal by Subject|0
2159632|NCT01238991|3775452|FG009|Overall Study|Withdrawal by Subject|0
2159633|NCT01238991|3775443|FG000|Overall Study|Study Terminated by Sponsor|0
2159634|NCT01238991|3775444|FG001|Overall Study|Study Terminated by Sponsor|0
2159635|NCT01238991|3775445|FG002|Overall Study|Study Terminated by Sponsor|0
2159636|NCT01238991|3775446|FG003|Overall Study|Study Terminated by Sponsor|0
2159637|NCT01238991|3775447|FG004|Overall Study|Study Terminated by Sponsor|1
2159638|NCT01238991|3775448|FG005|Overall Study|Study Terminated by Sponsor|0
2159639|NCT01238991|3775449|FG006|Overall Study|Study Terminated by Sponsor|7
2159640|NCT01238991|3775450|FG007|Overall Study|Study Terminated by Sponsor|4
2159641|NCT01238991|3775451|FG008|Overall Study|Study Terminated by Sponsor|2
2159642|NCT01238991|3775452|FG009|Overall Study|Study Terminated by Sponsor|2
2159643|NCT01238991|3775443|FG000|Overall Study|Caregiver's request|0
2159644|NCT01238991|3775444|FG001|Overall Study|Caregiver's request|0
2159645|NCT01238991|3775445|FG002|Overall Study|Caregiver's request|0
2159646|NCT01238991|3775446|FG003|Overall Study|Caregiver's request|0
2159647|NCT01238991|3775447|FG004|Overall Study|Caregiver's request|0
2159648|NCT01238991|3775448|FG005|Overall Study|Caregiver's request|0
2159649|NCT01238991|3775449|FG006|Overall Study|Caregiver's request|0
2159650|NCT01238991|3775450|FG007|Overall Study|Caregiver's request|0
2159651|NCT01238991|3775451|FG008|Overall Study|Caregiver's request|1
2159652|NCT01238991|3775452|FG009|Overall Study|Caregiver's request|0
2159653|NCT01238991|3775443|FG000|Overall Study|Admission to a nursing home|1
2159654|NCT01238991|3775444|FG001|Overall Study|Admission to a nursing home|0
2159655|NCT01238991|3775445|FG002|Overall Study|Admission to a nursing home|1
2159656|NCT01238991|3775446|FG003|Overall Study|Admission to a nursing home|0
2159657|NCT01238991|3775447|FG004|Overall Study|Admission to a nursing home|0
2159658|NCT01238991|3775448|FG005|Overall Study|Admission to a nursing home|0
2159659|NCT01238991|3775449|FG006|Overall Study|Admission to a nursing home|0
2159660|NCT01238991|3775450|FG007|Overall Study|Admission to a nursing home|0
2159661|NCT01238991|3775451|FG008|Overall Study|Admission to a nursing home|0
2159662|NCT01238991|3775452|FG009|Overall Study|Admission to a nursing home|0
2159663|NCT01239043|3775479|FG000|Overall Study|Protocol Violation|2
2159664|NCT01239043|3775480|FG001|Overall Study|Protocol Violation|1
2159665|NCT01239121|3775494|FG000|Overall Study|Withdrawal by Subject|2
2159666|NCT01239121|3775495|FG001|Overall Study|Withdrawal by Subject|4
2159667|NCT01239121|3775496|FG002|Overall Study|Withdrawal by Subject|0
2159668|NCT01239160|3775506|FG000|Overall Study|Lost to Follow-up|3
2159669|NCT01239160|3775507|FG001|Overall Study|Lost to Follow-up|5
2159670|NCT01239160|3775508|FG002|Overall Study|Lost to Follow-up|0
2159671|NCT01239160|3775506|FG000|Overall Study|Withdrawal by Subject|17
2159672|NCT01239160|3775507|FG001|Overall Study|Withdrawal by Subject|6
2159673|NCT01239160|3775508|FG002|Overall Study|Withdrawal by Subject|2
2159674|NCT01239160|3775506|FG000|Overall Study|Physician Decision|5
2159675|NCT01239160|3775507|FG001|Overall Study|Physician Decision|7
2159676|NCT01239160|3775508|FG002|Overall Study|Physician Decision|2
2159677|NCT01239160|3775506|FG000|Overall Study|Early Termination Due to Study Closure|0
2159678|NCT01239160|3775507|FG001|Overall Study|Early Termination Due to Study Closure|1
2159679|NCT01239160|3775508|FG002|Overall Study|Early Termination Due to Study Closure|6
2159680|NCT01239316|3775518|FG000|Overall Study|Progression/Relapse|11
2159681|NCT01239316|3775518|FG000|Overall Study|Adverse Event|1
2159682|NCT01239342|3775524|FG000|Overall Study|Adverse Event|1
2159683|NCT01239342|3775525|FG001|Overall Study|Adverse Event|0
2159684|NCT01239342|3775524|FG000|Overall Study|Withdrawal by Subject|1
2159685|NCT01239342|3775525|FG001|Overall Study|Withdrawal by Subject|5
2159686|NCT01239342|3775524|FG000|Overall Study|Reason Unknown|1
2159687|NCT01239342|3775525|FG001|Overall Study|Reason Unknown|1
2159688|NCT01239381|3775535|FG000|Overall Study|Protocol Violation|1
2159689|NCT01239381|3775535|FG000|Overall Study|Withdrawal by Subject|1
2159690|NCT01239394|3775540|FG000|Overall Study|Adverse Event|1
2159691|NCT01239472|3775546|FG000|Overall Study|Withdrawal by Subject|5
2159692|NCT01239472|3775547|FG001|Overall Study|Withdrawal by Subject|1
2159693|NCT01239472|3775546|FG000|Overall Study|Adverse Event|0
2159694|NCT01239472|3775547|FG001|Overall Study|Adverse Event|1
2159695|NCT01239472|3775546|FG000|Overall Study|Lack of Efficacy|0
2159696|NCT01239472|3775547|FG001|Overall Study|Lack of Efficacy|1
2159697|NCT01239732|3775572|FG000|Overall Study|Termination of study per protocol|667
2159698|NCT01239732|3775572|FG000|Overall Study|Death|226
2159699|NCT01239732|3775572|FG000|Overall Study|Withdrawal by Subject|87
2159700|NCT01239732|3775572|FG000|Overall Study|Adverse Event|6
2159701|NCT01239732|3775572|FG000|Overall Study|Protocol Violation|3
2159702|NCT01239732|3775572|FG000|Overall Study|Participant non compliance|5
2159703|NCT01239732|3775572|FG000|Overall Study|Study termination by sponsor|2
2159704|NCT01239732|3775572|FG000|Overall Study|Investigator's decision|4
2159705|NCT01239732|3775572|FG000|Overall Study|Treatment failure|2
2159706|NCT01239732|3775572|FG000|Overall Study|Other|19
2159707|NCT01239745|3775576|FG000|Overall Study|Study terminated by sponsor|45
2159708|NCT01239745|3775576|FG000|Overall Study|Adverse Event|1
2159709|NCT01239797|3775582|FG000|Treated Participants|Disease Progression|153
2159710|NCT01239797|3775583|FG001|Treated Participants|Disease Progression|161
2159711|NCT01239797|3775582|FG000|Treated Participants|Study Drug Toxicity|30
2159712|NCT01239797|3775583|FG001|Treated Participants|Study Drug Toxicity|44
2159713|NCT01239797|3775582|FG000|Treated Participants|Adverse Event Unrelated to Study Drug|22
2159714|NCT01239797|3775583|FG001|Treated Participants|Adverse Event Unrelated to Study Drug|32
2159715|NCT01239797|3775582|FG000|Treated Participants|Withdrawal by Subject|27
2159716|NCT01239797|3775583|FG001|Treated Participants|Withdrawal by Subject|23
2159717|NCT01239797|3775582|FG000|Treated Participants|Non-specified|1
2159718|NCT01239797|3775583|FG001|Treated Participants|Non-specified|11
2159719|NCT01239797|3775582|FG000|Treated Participants|Death|1
2159720|NCT01239797|3775583|FG001|Treated Participants|Death|1
2159721|NCT01239797|3775582|FG000|Treated Participants|Subject No Longer Meets Study Criteria|1
2159722|NCT01239797|3775583|FG001|Treated Participants|Subject No Longer Meets Study Criteria|1
2159723|NCT01239797|3775582|FG000|Treated Participants|Poor/Non-compliance|0
2159724|NCT01239797|3775583|FG001|Treated Participants|Poor/Non-compliance|1
2159725|NCT01239992|3775589|FG000|Overall Study|Withdrawal by Subject|2
2159726|NCT01240135|3775604|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1
2159727|NCT01240135|3775605|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1
2159728|NCT01240135|3775604|FG000|Period Two, 14 Days of Wear|Adverse Event|0
2159729|NCT01240135|3775605|FG001|Period Two, 14 Days of Wear|Adverse Event|1
2159730|NCT01240200|3775613|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
2159731|NCT01240200|3775614|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
2159732|NCT01240356|3775629|FG000|Overall Study|Withdrawal by Subject|2
2159733|NCT01240356|3775630|FG001|Overall Study|Withdrawal by Subject|0
2159734|NCT01240356|3775629|FG000|Overall Study|MRI contraindication|1
2159735|NCT01240356|3775630|FG001|Overall Study|MRI contraindication|0
2159736|NCT01240382|3775641|FG000|Overall Study|Adverse Event|2
2159737|NCT01240382|3775642|FG001|Overall Study|Adverse Event|1
2159738|NCT01240382|3775641|FG000|Overall Study|Lack of Efficacy|0
2159739|NCT01240382|3775642|FG001|Overall Study|Lack of Efficacy|2
2159740|NCT01240382|3775641|FG000|Overall Study|Fear of adverse events|0
2159741|NCT01240382|3775642|FG001|Overall Study|Fear of adverse events|1
2159742|NCT01240551|3775650|FG000|Overall Study|Refused further treatment|3
2159743|NCT01240551|3775651|FG001|Overall Study|Refused further treatment|2
2159744|NCT01240551|3775650|FG000|Overall Study|Lost to Follow-up|1
2159745|NCT01240551|3775651|FG001|Overall Study|Lost to Follow-up|1
2159746|NCT01240590|3775662|FG000|Phase I|Refused further treatment|0
2159747|NCT01240590|3775663|FG001|Phase I|Refused further treatment|0
2159748|NCT01240590|3775664|FG002|Phase I|Refused further treatment|3
2159749|NCT01240590|3775665|FG003|Phase I|Refused further treatment|0
2159750|NCT01240590|3775666|FG004|Phase I|Refused further treatment|0
2159751|NCT01240590|3775662|FG000|Phase II|Refused further treatment|0
2159752|NCT01240590|3775663|FG001|Phase II|Refused further treatment|0
2159753|NCT01240590|3775664|FG002|Phase II|Refused further treatment|0
2159754|NCT01240590|3775665|FG003|Phase II|Refused further treatment|2
2159755|NCT01240590|3775666|FG004|Phase II|Refused further treatment|1
2159756|NCT01240746|3775695|FG000|Overall Study|Adverse Event|2
2159757|NCT01240746|3775696|FG001|Overall Study|Adverse Event|0
2159758|NCT01240746|3775697|FG002|Overall Study|Adverse Event|10
2159759|NCT01240746|3775695|FG000|Overall Study|Lost to Follow-up|23
2159760|NCT01240746|3775696|FG001|Overall Study|Lost to Follow-up|20
2159761|NCT01240746|3775697|FG002|Overall Study|Lost to Follow-up|102
2159762|NCT01240746|3775695|FG000|Overall Study|Protocol Violation|24
2159763|NCT01240746|3775696|FG001|Overall Study|Protocol Violation|15
2159764|NCT01240746|3775697|FG002|Overall Study|Protocol Violation|72
2159765|NCT01240746|3775695|FG000|Overall Study|Withdrawal by Subject|10
2159766|NCT01240746|3775696|FG001|Overall Study|Withdrawal by Subject|13
2159767|NCT01240746|3775697|FG002|Overall Study|Withdrawal by Subject|59
2159768|NCT01240785|3775707|FG000|Overall Study|Lost to Follow-up|1
2159769|NCT01240785|3775708|FG001|Overall Study|Lost to Follow-up|0
2159770|NCT01240785|3775707|FG000|Overall Study|Protocol Violation|0
2159771|NCT01240785|3775708|FG001|Overall Study|Protocol Violation|3
2159772|NCT01240811|3775717|FG000|Overall Study|Physician Decision|0
2159773|NCT01240811|3775718|FG001|Overall Study|Physician Decision|1
2159774|NCT01240811|3775719|FG002|Overall Study|Physician Decision|0
2159775|NCT01240811|3775717|FG000|Overall Study|Withdrawal by Subject|0
2159776|NCT01240811|3775718|FG001|Overall Study|Withdrawal by Subject|0
2159777|NCT01240811|3775719|FG002|Overall Study|Withdrawal by Subject|1
2159778|NCT01240863|3775731|FG000|Open-label Titration Period|Adverse Event|47
2159779|NCT01240863|3775732|FG001|Open-label Titration Period|Adverse Event|0
2159780|NCT01240863|3775733|FG002|Open-label Titration Period|Adverse Event|0
2159781|NCT01240863|3775731|FG000|Open-label Titration Period|Lack of Efficacy|19
2159782|NCT01240863|3775732|FG001|Open-label Titration Period|Lack of Efficacy|0
2159783|NCT01240863|3775733|FG002|Open-label Titration Period|Lack of Efficacy|0
2159784|NCT01240863|3775731|FG000|Open-label Titration Period|Withdrawal by Subject|9
2159785|NCT01240863|3775732|FG001|Open-label Titration Period|Withdrawal by Subject|0
2159786|NCT01240863|3775733|FG002|Open-label Titration Period|Withdrawal by Subject|0
2159787|NCT01240863|3775731|FG000|Open-label Titration Period|Protocol Violation|7
2159788|NCT01240863|3775732|FG001|Open-label Titration Period|Protocol Violation|0
2159789|NCT01240863|3775733|FG002|Open-label Titration Period|Protocol Violation|0
2159790|NCT01240863|3775731|FG000|Open-label Titration Period|Noncompliance to study drug admin|3
2159791|NCT01240863|3775732|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
2159792|NCT01240863|3775733|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
2159793|NCT01240863|3775731|FG000|Open-label Titration Period|Noncompliance to study procedures|3
2159794|NCT01240863|3775732|FG001|Open-label Titration Period|Noncompliance to study procedures|0
2159795|NCT01240863|3775733|FG002|Open-label Titration Period|Noncompliance to study procedures|0
2159796|NCT01240863|3775731|FG000|Open-label Titration Period|Dropped out prior to dosing|2
2159797|NCT01240863|3775732|FG001|Open-label Titration Period|Dropped out prior to dosing|0
2159798|NCT01240863|3775733|FG002|Open-label Titration Period|Dropped out prior to dosing|0
2159799|NCT01240863|3775731|FG000|Open-label Titration Period|Other|7
2159800|NCT01240863|3775732|FG001|Open-label Titration Period|Other|0
2159801|NCT01240863|3775733|FG002|Open-label Titration Period|Other|0
2159802|NCT01240863|3775731|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
2159803|NCT01240863|3775732|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
2159804|NCT01240863|3775733|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
2159805|NCT01240863|3775731|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2159806|NCT01240863|3775732|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
2159807|NCT01240863|3775733|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
2159808|NCT01240863|3775731|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2159809|NCT01240863|3775732|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
2159810|NCT01240863|3775733|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
2159811|NCT01240863|3775731|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
2159812|NCT01240863|3775732|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
2159813|NCT01240863|3775733|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
2159814|NCT01240863|3775731|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
2159815|NCT01240863|3775732|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
2159816|NCT01240863|3775733|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
2159817|NCT01240863|3775731|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
2159818|NCT01240863|3775732|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
2159819|NCT01240863|3775733|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
2159820|NCT01240863|3775731|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
2159821|NCT01240863|3775732|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
2159822|NCT01240863|3775733|FG002|Double-blind Treatment Period (12 Weeks)|Other|5
2159823|NCT01240863|3775731|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
2159824|NCT01240863|3775732|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
2159825|NCT01240863|3775733|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
2159826|NCT01240915|3775770|FG000|Overall Study|Adverse Event|0
2159827|NCT01240915|3775771|FG001|Overall Study|Adverse Event|0
2159828|NCT01240915|3775772|FG002|Overall Study|Adverse Event|0
2159829|NCT01240915|3775773|FG003|Overall Study|Adverse Event|1
2159830|NCT01240915|3775774|FG004|Overall Study|Adverse Event|0
2159831|NCT01240915|3775775|FG005|Overall Study|Adverse Event|2
2159832|NCT01240915|3775776|FG006|Overall Study|Adverse Event|0
2159833|NCT01240915|3775777|FG007|Overall Study|Adverse Event|0
2159834|NCT01240915|3775778|FG008|Overall Study|Adverse Event|1
2159835|NCT01240915|3775770|FG000|Overall Study|Lost to Follow-up|0
2159836|NCT01240915|3775771|FG001|Overall Study|Lost to Follow-up|0
2159837|NCT01240915|3775772|FG002|Overall Study|Lost to Follow-up|0
2159838|NCT01240915|3775773|FG003|Overall Study|Lost to Follow-up|0
2159839|NCT01240915|3775774|FG004|Overall Study|Lost to Follow-up|1
2159840|NCT01240915|3775775|FG005|Overall Study|Lost to Follow-up|1
2159841|NCT01240915|3775776|FG006|Overall Study|Lost to Follow-up|0
2159842|NCT01240915|3775777|FG007|Overall Study|Lost to Follow-up|1
2159843|NCT01240915|3775778|FG008|Overall Study|Lost to Follow-up|1
2159844|NCT01240915|3775770|FG000|Overall Study|Withdrawal by Subject|2
2159845|NCT01240915|3775771|FG001|Overall Study|Withdrawal by Subject|1
2159846|NCT01240915|3775772|FG002|Overall Study|Withdrawal by Subject|0
2159847|NCT01240915|3775773|FG003|Overall Study|Withdrawal by Subject|2
2159848|NCT01240915|3775774|FG004|Overall Study|Withdrawal by Subject|0
2159849|NCT01240915|3775775|FG005|Overall Study|Withdrawal by Subject|4
2159850|NCT01240915|3775776|FG006|Overall Study|Withdrawal by Subject|2
2159851|NCT01240915|3775777|FG007|Overall Study|Withdrawal by Subject|3
2159852|NCT01240915|3775778|FG008|Overall Study|Withdrawal by Subject|3
2159853|NCT01240915|3775770|FG000|Overall Study|Other|0
2159854|NCT01240915|3775771|FG001|Overall Study|Other|0
2159855|NCT01240915|3775772|FG002|Overall Study|Other|0
2159856|NCT01240915|3775773|FG003|Overall Study|Other|0
2159857|NCT01240915|3775774|FG004|Overall Study|Other|2
2159858|NCT01240915|3775775|FG005|Overall Study|Other|0
2159859|NCT01240915|3775776|FG006|Overall Study|Other|0
2159860|NCT01240915|3775777|FG007|Overall Study|Other|0
2159861|NCT01240915|3775778|FG008|Overall Study|Other|0
2159862|NCT01240915|3775770|FG000|Overall Study|Insufficient Clinical Response|0
2159863|NCT01240915|3775771|FG001|Overall Study|Insufficient Clinical Response|0
2159864|NCT01240915|3775772|FG002|Overall Study|Insufficient Clinical Response|0
2159865|NCT01240915|3775773|FG003|Overall Study|Insufficient Clinical Response|0
2159866|NCT01240915|3775774|FG004|Overall Study|Insufficient Clinical Response|1
2159867|NCT01240915|3775775|FG005|Overall Study|Insufficient Clinical Response|3
2159868|NCT01240915|3775776|FG006|Overall Study|Insufficient Clinical Response|6
2159869|NCT01240915|3775777|FG007|Overall Study|Insufficient Clinical Response|0
2159870|NCT01240915|3775778|FG008|Overall Study|Insufficient Clinical Response|3
2159871|NCT01241240|3775802|FG000|Overall Study|Adverse Event|5
2159872|NCT01241240|3775803|FG001|Overall Study|Adverse Event|4
2159873|NCT01241240|3775802|FG000|Overall Study|Lost to Follow-up|2
2159874|NCT01241240|3775803|FG001|Overall Study|Lost to Follow-up|4
2159875|NCT01241240|3775802|FG000|Overall Study|Personal Reasons|1
2159876|NCT01241240|3775803|FG001|Overall Study|Personal Reasons|1
2159877|NCT01241292|3775811|FG000|Overall Study|Administrative Reason by Sponsor|1
2159878|NCT01241292|3775812|FG001|Overall Study|Administrative Reason by Sponsor|0
2159879|NCT01241292|3775811|FG000|Overall Study|Disease Progression|2
2159880|NCT01241292|3775812|FG001|Overall Study|Disease Progression|0
2159881|NCT01241292|3775811|FG000|Overall Study|Study Drug Toxicity|0
2159882|NCT01241292|3775812|FG001|Overall Study|Study Drug Toxicity|1
2159883|NCT01241292|3775811|FG000|Overall Study|Participant Discontinued Treatment|0
2159884|NCT01241292|3775812|FG001|Overall Study|Participant Discontinued Treatment|2
2159885|NCT01241318|3775824|FG000|Overall Study|Woman: false pregnancies|27
2159886|NCT01241318|3775825|FG001|Overall Study|Woman: false pregnancies|15
2159887|NCT01241318|3775824|FG000|Overall Study|Woman: miscarriage/abortion|46
2159888|NCT01241318|3775825|FG001|Overall Study|Woman: miscarriage/abortion|38
2159889|NCT01241318|3775824|FG000|Overall Study|Withdrawal by Subject|175
2159890|NCT01241318|3775825|FG001|Overall Study|Withdrawal by Subject|46
2159891|NCT01241318|3775824|FG000|Overall Study|Lost to Follow-up|740
2159892|NCT01241318|3775825|FG001|Overall Study|Lost to Follow-up|455
2159893|NCT01241318|3775824|FG000|Overall Study|Death|2
2159894|NCT01241318|3775825|FG001|Overall Study|Death|4
2159895|NCT01241318|3775824|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60
2159896|NCT01241318|3775825|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38
2159897|NCT01241318|3775824|FG000|Overall Study|Woman: Stillborn infant|129
2159898|NCT01241318|3775825|FG001|Overall Study|Woman: Stillborn infant|146
2159899|NCT01241448|3775871|FG000|Overall Study|Adverse Event|1
2159900|NCT01241448|3775872|FG001|Overall Study|Adverse Event|0
2159901|NCT01241448|3775873|FG002|Overall Study|Adverse Event|2
2159902|NCT01241448|3775874|FG003|Overall Study|Adverse Event|2
2159903|NCT01241448|3775871|FG000|Overall Study|Lost to Follow-up|2
2159904|NCT01241448|3775872|FG001|Overall Study|Lost to Follow-up|1
2159905|NCT01241448|3775873|FG002|Overall Study|Lost to Follow-up|1
2159906|NCT01241448|3775874|FG003|Overall Study|Lost to Follow-up|1
2159907|NCT01241448|3775871|FG000|Overall Study|Physician Decision|0
2159908|NCT01241448|3775872|FG001|Overall Study|Physician Decision|2
2159909|NCT01241448|3775873|FG002|Overall Study|Physician Decision|0
2159910|NCT01241448|3775874|FG003|Overall Study|Physician Decision|0
2159911|NCT01241448|3775871|FG000|Overall Study|Protocol Violation|10
2159912|NCT01241448|3775872|FG001|Overall Study|Protocol Violation|5
2208152|NCT01636713|3847548|FG000|Overall Study|Adverse Event|16
2159913|NCT01241448|3775873|FG002|Overall Study|Protocol Violation|3
2159914|NCT01241448|3775874|FG003|Overall Study|Protocol Violation|6
2159915|NCT01241448|3775871|FG000|Overall Study|Sponsor Decision|17
2159916|NCT01241448|3775872|FG001|Overall Study|Sponsor Decision|14
2159917|NCT01241448|3775873|FG002|Overall Study|Sponsor Decision|12
2159918|NCT01241448|3775874|FG003|Overall Study|Sponsor Decision|6
2159919|NCT01241448|3775871|FG000|Overall Study|Withdrawal by Subject|4
2159920|NCT01241448|3775872|FG001|Overall Study|Withdrawal by Subject|5
2159921|NCT01241448|3775873|FG002|Overall Study|Withdrawal by Subject|3
2159922|NCT01241448|3775874|FG003|Overall Study|Withdrawal by Subject|6
2159923|NCT01241448|3775871|FG000|Overall Study|Excluded due to data integrity issues|3
2159924|NCT01241448|3775872|FG001|Overall Study|Excluded due to data integrity issues|2
2159925|NCT01241448|3775873|FG002|Overall Study|Excluded due to data integrity issues|2
2159926|NCT01241448|3775874|FG003|Overall Study|Excluded due to data integrity issues|2
2159927|NCT01241461|3775887|FG000|Overall Study|Progressive Disease|3
2159928|NCT01241461|3775888|FG001|Overall Study|Progressive Disease|6
2179371|NCT01393626|3804907|FG001|Overall Study|Lost to Follow-up|1
2179372|NCT01393626|3804908|FG002|Overall Study|Lost to Follow-up|1
2179373|NCT01393626|3804909|FG003|Overall Study|Lost to Follow-up|0
2179374|NCT01393626|3804906|FG000|Overall Study|Withdrawal by Subject|6
2179375|NCT01393626|3804907|FG001|Overall Study|Withdrawal by Subject|4
2179376|NCT01393626|3804908|FG002|Overall Study|Withdrawal by Subject|0
2179377|NCT01393626|3804909|FG003|Overall Study|Withdrawal by Subject|0
2179378|NCT01393626|3804906|FG000|Overall Study|Other|1
2179379|NCT01393626|3804907|FG001|Overall Study|Other|0
2179380|NCT01393626|3804908|FG002|Overall Study|Other|0
2179381|NCT01393626|3804909|FG003|Overall Study|Other|0
2179382|NCT01393626|3804906|FG000|Overall Study|Protocol Violation|1
2179383|NCT01393626|3804907|FG001|Overall Study|Protocol Violation|0
2179384|NCT01393626|3804908|FG002|Overall Study|Protocol Violation|2
2179385|NCT01393626|3804909|FG003|Overall Study|Protocol Violation|0
2179386|NCT01393730|3804946|FG000|Overall Study|Withdrawal by Subject|3
2208153|NCT01636713|3847549|FG001|Overall Study|Adverse Event|16
2293751|NCT02528357|3987965|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293752|NCT02528357|3987966|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293753|NCT02528357|3987967|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293754|NCT02528357|3987968|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293755|NCT02528357|3987969|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2
2293756|NCT02528357|3987970|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293757|NCT02528357|3987971|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
2293758|NCT02528357|3987953|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293759|NCT02528357|3987954|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293760|NCT02528357|3987955|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293761|NCT02528357|3987956|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293762|NCT02528357|3987957|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293763|NCT02528357|3987958|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293764|NCT02528357|3987959|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293765|NCT02528357|3987960|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293766|NCT02528357|3987961|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293767|NCT02528357|3987962|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293768|NCT02528357|3987963|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293769|NCT02528357|3987964|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293770|NCT02528357|3987965|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293771|NCT02528357|3987966|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293772|NCT02528357|3987967|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293773|NCT02528357|3987968|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
2293774|NCT02528357|3987969|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1
2293775|NCT02528357|3987970|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4
2321239|NCT02957682|4035674|FG000|Overall Study|Physician Decision|4
2159929|NCT01241552|3775916|FG000|Overall Study|Lack of Efficacy|1
2159930|NCT01241552|3775917|FG001|Overall Study|Lack of Efficacy|0
2159931|NCT01241552|3775918|FG002|Overall Study|Lack of Efficacy|0
2159932|NCT01241552|3775919|FG003|Overall Study|Lack of Efficacy|0
2159933|NCT01241552|3775916|FG000|Overall Study|Death|26
2159934|NCT01241552|3775917|FG001|Overall Study|Death|30
2159935|NCT01241552|3775918|FG002|Overall Study|Death|20
2159936|NCT01241552|3775919|FG003|Overall Study|Death|25
2159937|NCT01241552|3775916|FG000|Overall Study|Adverse Event|1
2159938|NCT01241552|3775917|FG001|Overall Study|Adverse Event|1
2159939|NCT01241552|3775918|FG002|Overall Study|Adverse Event|0
2159940|NCT01241552|3775919|FG003|Overall Study|Adverse Event|0
2159941|NCT01241552|3775916|FG000|Overall Study|Technical Problems|2
2159942|NCT01241552|3775917|FG001|Overall Study|Technical Problems|0
2159943|NCT01241552|3775918|FG002|Overall Study|Technical Problems|2
2159944|NCT01241552|3775919|FG003|Overall Study|Technical Problems|2
2159945|NCT01241552|3775916|FG000|Overall Study|Progressive Disease|0
2159946|NCT01241552|3775917|FG001|Overall Study|Progressive Disease|0
2159947|NCT01241552|3775918|FG002|Overall Study|Progressive Disease|1
2159948|NCT01241552|3775919|FG003|Overall Study|Progressive Disease|2
2159949|NCT01241552|3775916|FG000|Overall Study|Protocol Violation|0
2159950|NCT01241552|3775917|FG001|Overall Study|Protocol Violation|2
2159951|NCT01241552|3775918|FG002|Overall Study|Protocol Violation|6
2159952|NCT01241552|3775919|FG003|Overall Study|Protocol Violation|1
2159953|NCT01241552|3775916|FG000|Overall Study|Withdrawal by Subject|7
2159954|NCT01241552|3775917|FG001|Overall Study|Withdrawal by Subject|15
2159955|NCT01241552|3775918|FG002|Overall Study|Withdrawal by Subject|14
2159956|NCT01241552|3775919|FG003|Overall Study|Withdrawal by Subject|15
2159957|NCT01241552|3775916|FG000|Overall Study|Physician Decision|2
2159958|NCT01241552|3775917|FG001|Overall Study|Physician Decision|4
2159959|NCT01241552|3775918|FG002|Overall Study|Physician Decision|2
2159960|NCT01241552|3775919|FG003|Overall Study|Physician Decision|3
2159961|NCT01241552|3775916|FG000|Overall Study|Lost to Follow-up|2
2159962|NCT01241552|3775917|FG001|Overall Study|Lost to Follow-up|11
2159963|NCT01241552|3775918|FG002|Overall Study|Lost to Follow-up|15
2159964|NCT01241552|3775919|FG003|Overall Study|Lost to Follow-up|16
2159965|NCT01241591|3775938|FG000|Overall Study|Lack of Efficacy|5
2159966|NCT01241591|3775939|FG001|Overall Study|Lack of Efficacy|2
2159967|NCT01241591|3775940|FG002|Overall Study|Lack of Efficacy|2
2159968|NCT01241591|3775941|FG003|Overall Study|Lack of Efficacy|3
2159969|NCT01241591|3775938|FG000|Overall Study|Protocol Violation|5
2159970|NCT01241591|3775939|FG001|Overall Study|Protocol Violation|2
2159971|NCT01241591|3775940|FG002|Overall Study|Protocol Violation|3
2159972|NCT01241591|3775941|FG003|Overall Study|Protocol Violation|0
2159973|NCT01241591|3775938|FG000|Overall Study|Lost to Follow-up|1
2159974|NCT01241591|3775939|FG001|Overall Study|Lost to Follow-up|2
2159975|NCT01241591|3775940|FG002|Overall Study|Lost to Follow-up|2
2159976|NCT01241591|3775941|FG003|Overall Study|Lost to Follow-up|2
2159977|NCT01241591|3775938|FG000|Overall Study|Screen Failure|3
2159978|NCT01241591|3775939|FG001|Overall Study|Screen Failure|2
2159979|NCT01241591|3775940|FG002|Overall Study|Screen Failure|1
2159980|NCT01241591|3775941|FG003|Overall Study|Screen Failure|0
2159981|NCT01241591|3775938|FG000|Overall Study|Withdrawal by Subject|6
2159982|NCT01241591|3775939|FG001|Overall Study|Withdrawal by Subject|4
2159983|NCT01241591|3775940|FG002|Overall Study|Withdrawal by Subject|2
2159984|NCT01241591|3775941|FG003|Overall Study|Withdrawal by Subject|2
2159985|NCT01241591|3775938|FG000|Overall Study|Other|0
2159986|NCT01241591|3775939|FG001|Overall Study|Other|1
2208154|NCT01636713|3847550|FG002|Overall Study|Adverse Event|7
2208155|NCT01636713|3847548|FG000|Overall Study|Lack of Efficacy|6
2159987|NCT01241591|3775940|FG002|Overall Study|Other|0
2159988|NCT01241591|3775941|FG003|Overall Study|Other|1
2159989|NCT01241591|3775938|FG000|Overall Study|Adverse Event|3
2159990|NCT01241591|3775939|FG001|Overall Study|Adverse Event|11
2159991|NCT01241591|3775940|FG002|Overall Study|Adverse Event|12
2159992|NCT01241591|3775941|FG003|Overall Study|Adverse Event|4
2159993|NCT01241604|3775951|FG000|Screening Period|Screen Failure|3
2159994|NCT01241604|3775952|FG001|Screening Period|Screen Failure|0
2159995|NCT01241604|3775953|FG002|Screening Period|Screen Failure|0
2159996|NCT01241760|3775962|FG000|Overall Study|Adverse Event|1
2159997|NCT01241760|3775963|FG001|Overall Study|Adverse Event|0
2159998|NCT01241760|3775962|FG000|Overall Study|Lost to Follow-up|18
2159999|NCT01241760|3775963|FG001|Overall Study|Lost to Follow-up|22
2160000|NCT01241760|3775962|FG000|Overall Study|Withdrawal by Subject|13
2160001|NCT01241760|3775963|FG001|Overall Study|Withdrawal by Subject|13
2160002|NCT01241760|3775962|FG000|Overall Study|Switch To Commercially Available Medicat|1
2160003|NCT01241760|3775963|FG001|Overall Study|Switch To Commercially Available Medicat|4
2160004|NCT01241760|3775962|FG000|Overall Study|Other|1
2160005|NCT01241760|3775963|FG001|Overall Study|Other|1
2160006|NCT01242085|3775991|FG000|Overall Study|Withdrawal by Subject|4
2160007|NCT01242085|3775992|FG001|Overall Study|Withdrawal by Subject|2
2160008|NCT01242085|3775993|FG002|Overall Study|Withdrawal by Subject|0
2160009|NCT01242085|3775991|FG000|Overall Study|medically unable to have surgery|4
2293776|NCT02528357|3987971|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3
2293777|NCT02528942|3988042|FG000|Overall Study|Did not meet imaging criteria|9
2293778|NCT02528942|3988042|FG000|Overall Study|Lost to Follow-up|25
2293779|NCT02529137|3988055|FG000|Overall Study|Discontinuation for different reasons|8
2293780|NCT02529488|3988060|FG000|Overall Study|Adverse Event|1
2293781|NCT02529488|3988060|FG000|Overall Study|Death|3
2293782|NCT02529553|3988077|FG000|Overall Study|Progressive Disease|1
2293783|NCT02529553|3988078|FG001|Overall Study|Progressive Disease|0
2293784|NCT02529553|3988079|FG002|Overall Study|Progressive Disease|1
2293785|NCT02529553|3988080|FG003|Overall Study|Progressive Disease|3
2293786|NCT02529553|3988081|FG004|Overall Study|Progressive Disease|2
2293787|NCT02529553|3988082|FG005|Overall Study|Progressive Disease|3
2293788|NCT02529553|3988083|FG006|Overall Study|Progressive Disease|3
2293789|NCT02529553|3988084|FG007|Overall Study|Progressive Disease|5
2293790|NCT02529553|3988085|FG008|Overall Study|Progressive Disease|3
2293791|NCT02529553|3988077|FG000|Overall Study|Physician Decision|0
2293792|NCT02529553|3988078|FG001|Overall Study|Physician Decision|1
2293793|NCT02529553|3988079|FG002|Overall Study|Physician Decision|0
2293794|NCT02529553|3988080|FG003|Overall Study|Physician Decision|0
2293795|NCT02529553|3988081|FG004|Overall Study|Physician Decision|1
2293796|NCT02529553|3988082|FG005|Overall Study|Physician Decision|0
2293797|NCT02529553|3988083|FG006|Overall Study|Physician Decision|0
2293798|NCT02529553|3988084|FG007|Overall Study|Physician Decision|0
2293799|NCT02529553|3988085|FG008|Overall Study|Physician Decision|0
2293800|NCT02529553|3988077|FG000|Overall Study|Withdrawal by Subject|0
2293801|NCT02529553|3988078|FG001|Overall Study|Withdrawal by Subject|0
2293802|NCT02529553|3988079|FG002|Overall Study|Withdrawal by Subject|0
2293803|NCT02529553|3988080|FG003|Overall Study|Withdrawal by Subject|0
2293804|NCT02529553|3988081|FG004|Overall Study|Withdrawal by Subject|0
2293805|NCT02529553|3988082|FG005|Overall Study|Withdrawal by Subject|1
2293806|NCT02529553|3988083|FG006|Overall Study|Withdrawal by Subject|0
2293807|NCT02529553|3988084|FG007|Overall Study|Withdrawal by Subject|1
2293808|NCT02529553|3988085|FG008|Overall Study|Withdrawal by Subject|0
2293809|NCT02529995|3988108|FG000|Part A|Ongoing Study at Data Cut-off|14
2293810|NCT02529995|3988109|FG001|Part A|Ongoing Study at Data Cut-off|16
2293811|NCT02529995|3988108|FG000|Part A|Discontinued Study|1
2160010|NCT01242085|3775992|FG001|Overall Study|medically unable to have surgery|5
2160011|NCT01242085|3775993|FG002|Overall Study|medically unable to have surgery|0
2160012|NCT01242111|3775999|FG000|Overall Study|Adverse Event|1
2160013|NCT01242111|3775999|FG000|Overall Study|Withdrawal by Subject|1
2160014|NCT01242111|3775999|FG000|Overall Study|Did not consent to MOR-100 follow-up|1
2208156|NCT01636713|3847549|FG001|Overall Study|Lack of Efficacy|6
2293812|NCT02529995|3988109|FG001|Part A|Discontinued Study|0
2293813|NCT02529995|3988108|FG000|Part B|Ongoing Study at Data Cut-off|0
2293814|NCT02529995|3988109|FG001|Part B|Ongoing Study at Data Cut-off|7
2293815|NCT02529995|3988108|FG000|Part B|Discontinued Study|6
2293816|NCT02529995|3988109|FG001|Part B|Discontinued Study|5
2293817|NCT02530125|3988115|FG000|Completed Treatment|Early termination of study|1
2321240|NCT02957682|4035675|FG001|Overall Study|Physician Decision|4
2160015|NCT01242176|3776003|FG000|Washout Period of 7 Days|Adverse Event|0
2160016|NCT01242176|3776004|FG001|Washout Period of 7 Days|Adverse Event|2
2160017|NCT01242176|3776003|FG000|Washout Period of 7 Days|Non-compliant with protocol|1
2160018|NCT01242176|3776004|FG001|Washout Period of 7 Days|Non-compliant with protocol|0
2160019|NCT01242371|3776021|FG000|Overall Study|Withdrawal by Subject|2
2160020|NCT01242371|3776022|FG001|Overall Study|Withdrawal by Subject|2
2160021|NCT01242371|3776021|FG000|Overall Study|Protocol Violation|0
2160022|NCT01242371|3776022|FG001|Overall Study|Protocol Violation|3
2160023|NCT01242514|3776031|FG000|Overall Study|e.g., project closure|1042
2160024|NCT01242514|3776032|FG001|Overall Study|e.g., project closure|305
2160025|NCT01242514|3776033|FG002|Overall Study|e.g., project closure|171
2160026|NCT01242514|3776031|FG000|Overall Study|Subject decision|33
2160027|NCT01242514|3776032|FG001|Overall Study|Subject decision|8
2160028|NCT01242514|3776033|FG002|Overall Study|Subject decision|2
2160029|NCT01242514|3776031|FG000|Overall Study|Severe non-compliance to protocol|5
2160030|NCT01242514|3776032|FG001|Overall Study|Severe non-compliance to protocol|2
2160031|NCT01242514|3776033|FG002|Overall Study|Severe non-compliance to protocol|1
2160032|NCT01242514|3776031|FG000|Overall Study|Lack of therapeutic response|99
2160033|NCT01242514|3776032|FG001|Overall Study|Lack of therapeutic response|16
2160034|NCT01242514|3776033|FG002|Overall Study|Lack of therapeutic response|10
2160035|NCT01242514|3776031|FG000|Overall Study|Dev. of study specific discont. criteria|21
2160036|NCT01242514|3776032|FG001|Overall Study|Dev. of study specific discont. criteria|3
2160037|NCT01242514|3776033|FG002|Overall Study|Dev. of study specific discont. criteria|5
2160038|NCT01242514|3776031|FG000|Overall Study|Lost to Follow-up|14
2160039|NCT01242514|3776032|FG001|Overall Study|Lost to Follow-up|5
2160040|NCT01242514|3776033|FG002|Overall Study|Lost to Follow-up|4
2160041|NCT01242514|3776031|FG000|Overall Study|Adverse Event|129
2160042|NCT01242514|3776032|FG001|Overall Study|Adverse Event|18
2160043|NCT01242514|3776033|FG002|Overall Study|Adverse Event|19
2160044|NCT01242748|3776073|FG000|Overall Study|Adverse Event|10
2160045|NCT01242748|3776074|FG001|Overall Study|Adverse Event|5
2160046|NCT01242748|3776073|FG000|Overall Study|Lost to Follow-up|6
2160047|NCT01242748|3776074|FG001|Overall Study|Lost to Follow-up|2
2160048|NCT01242748|3776073|FG000|Overall Study|Physician Decision|3
2160049|NCT01242748|3776074|FG001|Overall Study|Physician Decision|2
2160050|NCT01242748|3776073|FG000|Overall Study|Protocol Violation|1
2160051|NCT01242748|3776074|FG001|Overall Study|Protocol Violation|0
2160052|NCT01242748|3776073|FG000|Overall Study|Withdrawal by Subject|10
2160053|NCT01242748|3776074|FG001|Overall Study|Withdrawal by Subject|2
2160054|NCT01242748|3776073|FG000|Overall Study|Miscellaneous reasons|8
2160055|NCT01242748|3776074|FG001|Overall Study|Miscellaneous reasons|3
2160056|NCT01242813|3776080|FG000|Overall Study|Lost to Follow-up|2
2160057|NCT01243151|3776093|FG000|Overall Study|Adverse Event|0
2160058|NCT01243151|3776094|FG001|Overall Study|Adverse Event|1
2160059|NCT01243151|3776095|FG002|Overall Study|Adverse Event|0
2160060|NCT01243151|3776096|FG003|Overall Study|Adverse Event|0
2160061|NCT01243151|3776097|FG004|Overall Study|Adverse Event|0
2160062|NCT01243151|3776093|FG000|Overall Study|Protocol Violation|0
2160063|NCT01243151|3776094|FG001|Overall Study|Protocol Violation|0
2160064|NCT01243151|3776095|FG002|Overall Study|Protocol Violation|1
2160065|NCT01243151|3776096|FG003|Overall Study|Protocol Violation|0
2160066|NCT01243151|3776097|FG004|Overall Study|Protocol Violation|0
2160067|NCT01243151|3776093|FG000|Overall Study|Other|0
2160068|NCT01243151|3776094|FG001|Overall Study|Other|0
2160069|NCT01243151|3776095|FG002|Overall Study|Other|0
2160070|NCT01243151|3776096|FG003|Overall Study|Other|1
2160071|NCT01243151|3776097|FG004|Overall Study|Other|0
2160072|NCT01243151|3776093|FG000|Overall Study|Randomized but not treated|0
2160073|NCT01243151|3776094|FG001|Overall Study|Randomized but not treated|0
2160074|NCT01243151|3776095|FG002|Overall Study|Randomized but not treated|0
2160075|NCT01243151|3776096|FG003|Overall Study|Randomized but not treated|1
2160076|NCT01243151|3776097|FG004|Overall Study|Randomized but not treated|0
2160077|NCT01243177|3776115|FG000|Overall Study|Lack of Efficacy|47
2160078|NCT01243177|3776116|FG001|Overall Study|Lack of Efficacy|31
2160079|NCT01243177|3776115|FG000|Overall Study|Protocol Violation|11
2160080|NCT01243177|3776116|FG001|Overall Study|Protocol Violation|10
2160081|NCT01243177|3776115|FG000|Overall Study|Lost to Follow-up|15
2160082|NCT01243177|3776116|FG001|Overall Study|Lost to Follow-up|18
2160083|NCT01243177|3776115|FG000|Overall Study|Withdrawal by Subject|46
2160084|NCT01243177|3776116|FG001|Overall Study|Withdrawal by Subject|38
2160085|NCT01243177|3776115|FG000|Overall Study|AE, serious fatal|0
2160086|NCT01243177|3776116|FG001|Overall Study|AE, serious fatal|1
2160087|NCT01243177|3776115|FG000|Overall Study|SAE, non-fatal|7
2160088|NCT01243177|3776116|FG001|Overall Study|SAE, non-fatal|9
2160089|NCT01243177|3776115|FG000|Overall Study|AE, non-serious non-fatal|40
2160090|NCT01243177|3776116|FG001|Overall Study|AE, non-serious non-fatal|58
2160091|NCT01243177|3776115|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1
2160092|NCT01243177|3776116|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0
2160093|NCT01243177|3776115|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2160094|NCT01243177|3776116|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
2160095|NCT01243177|3776115|FG000|Overall Study|Other Reason|11
2160096|NCT01243177|3776116|FG001|Overall Study|Other Reason|12
2160097|NCT01243242|3776124|FG000|Overall Study|Adverse Event|1
2160098|NCT01243242|3776125|FG001|Overall Study|Adverse Event|1
2160099|NCT01243242|3776124|FG000|Overall Study|Withdrawal by Subject|1
2160100|NCT01243242|3776125|FG001|Overall Study|Withdrawal by Subject|1
2160101|NCT01243242|3776124|FG000|Overall Study|Physician Decision|0
2160102|NCT01243242|3776125|FG001|Overall Study|Physician Decision|1
2160103|NCT01243242|3776124|FG000|Overall Study|sponsor decision|0
2160104|NCT01243242|3776125|FG001|Overall Study|sponsor decision|1
2160105|NCT01243242|3776124|FG000|Overall Study|non compliance|1
2160106|NCT01243242|3776125|FG001|Overall Study|non compliance|0
2160107|NCT01243268|3776131|FG000|Overall Study|Lost to Follow-up|4
2160108|NCT01243268|3776131|FG000|Overall Study|Protocol Violation|51
2160109|NCT01243268|3776131|FG000|Overall Study|Deviation with contract date|7
2160110|NCT01243268|3776131|FG000|Overall Study|Duplicate subject|2
2160111|NCT01243411|3776152|FG000|Overall Study|Withdrawal by Subject|18
2160112|NCT01243411|3776152|FG000|Overall Study|Lost to Follow-up|10
2160113|NCT01243411|3776152|FG000|Overall Study|Adverse Event|5
2160114|NCT01243411|3776152|FG000|Overall Study|Other|8
2160115|NCT01243424|3776158|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
2160116|NCT01243424|3776159|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
2160117|NCT01243424|3776158|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
2160118|NCT01243424|3776159|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
2160119|NCT01243424|3776158|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
2160120|NCT01243424|3776159|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
2160121|NCT01243424|3776158|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
2160122|NCT01243424|3776159|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
2160123|NCT01243424|3776158|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38
2160124|NCT01243424|3776159|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35
2160125|NCT01243424|3776158|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
2160126|NCT01243424|3776159|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
2160127|NCT01243424|3776158|FG000|Discontinuation From Study (Treated Set)|Not treated|5
2160128|NCT01243424|3776159|FG001|Discontinuation From Study (Treated Set)|Not treated|4
2160129|NCT01243424|3776158|FG000|Discontinuation From Treatment|Not treated|5
2160130|NCT01243424|3776159|FG001|Discontinuation From Treatment|Not treated|4
2160131|NCT01243424|3776158|FG000|Discontinuation From Treatment|Adverse Event|457
2160132|NCT01243424|3776159|FG001|Discontinuation From Treatment|Adverse Event|523
2160133|NCT01243424|3776158|FG000|Discontinuation From Treatment|Lack of Efficacy|61
2160134|NCT01243424|3776159|FG001|Discontinuation From Treatment|Lack of Efficacy|41
2160135|NCT01243424|3776158|FG000|Discontinuation From Treatment|Protocol Violation|46
2160136|NCT01243424|3776159|FG001|Discontinuation From Treatment|Protocol Violation|47
2160137|NCT01243424|3776158|FG000|Discontinuation From Treatment|Lost to Follow-up|24
2160138|NCT01243424|3776159|FG001|Discontinuation From Treatment|Lost to Follow-up|28
2160139|NCT01243424|3776158|FG000|Discontinuation From Treatment|Withdrawal by Subject|309
2160140|NCT01243424|3776159|FG001|Discontinuation From Treatment|Withdrawal by Subject|328
2160141|NCT01243424|3776158|FG000|Discontinuation From Treatment|Other than listed above|230
2160142|NCT01243424|3776159|FG001|Discontinuation From Treatment|Other than listed above|211
2160143|NCT01243671|3776212|FG000|Overall Study|Adverse Event|3
2160144|NCT01243671|3776212|FG000|Overall Study|Anti-adalimumab antibody positive|1
2160145|NCT01243671|3776212|FG000|Overall Study|Other|1
2160146|NCT01243762|3776223|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2160147|NCT01243762|3776224|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2
2160148|NCT01243762|3776225|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2160149|NCT01243762|3776226|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2160150|NCT01243762|3776227|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1
2160151|NCT01243762|3776228|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1
2160152|NCT01243762|3776229|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2160153|NCT01243762|3776223|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2160154|NCT01243762|3776224|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1
2160155|NCT01243762|3776225|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2160156|NCT01243762|3776226|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1
2160157|NCT01243762|3776227|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2160158|NCT01243762|3776228|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2160159|NCT01243762|3776229|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2160160|NCT01243762|3776223|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
2160161|NCT01243762|3776224|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
2160162|NCT01243762|3776225|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
2160163|NCT01243762|3776226|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
2160164|NCT01243762|3776227|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
2160165|NCT01243762|3776228|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
2160166|NCT01243762|3776229|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
2160167|NCT01243762|3776223|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2160168|NCT01243762|3776224|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
2160169|NCT01243762|3776225|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2160170|NCT01243762|3776226|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2160171|NCT01243762|3776227|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2160172|NCT01243762|3776228|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2160173|NCT01243762|3776229|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2160174|NCT01243762|3776223|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2160175|NCT01243762|3776224|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
2160176|NCT01243762|3776225|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2160177|NCT01243762|3776226|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2160178|NCT01243762|3776227|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2160179|NCT01243762|3776228|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2160180|NCT01243762|3776229|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
2160181|NCT01243762|3776223|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
2160182|NCT01243762|3776224|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
2160183|NCT01243762|3776225|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
2160184|NCT01243762|3776226|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
2160185|NCT01243762|3776227|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
2160186|NCT01243762|3776228|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
2160187|NCT01243762|3776229|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
2160188|NCT01243762|3776223|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2160189|NCT01243762|3776224|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
2160190|NCT01243762|3776225|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2160191|NCT01243762|3776226|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2160192|NCT01243762|3776227|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
2160193|NCT01243762|3776228|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2160194|NCT01243762|3776229|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2160195|NCT01243762|3776223|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2160196|NCT01243762|3776224|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2160197|NCT01243762|3776225|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2160198|NCT01243762|3776226|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
2160199|NCT01243762|3776227|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
2160200|NCT01243762|3776228|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2160201|NCT01243762|3776229|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2160202|NCT01243775|3776248|FG000|Overall Study|Withdrawal by Subject|2
2160203|NCT01243944|3776254|FG000|Overall Study|Adverse Event|15
2160204|NCT01243944|3776255|FG001|Overall Study|Adverse Event|13
2160205|NCT01243944|3776254|FG000|Overall Study|Lost to Follow-up|2
2160206|NCT01243944|3776255|FG001|Overall Study|Lost to Follow-up|1
2160207|NCT01243944|3776254|FG000|Overall Study|Physician Decision|2
2160208|NCT01243944|3776255|FG001|Overall Study|Physician Decision|7
2160209|NCT01243944|3776254|FG000|Overall Study|Disease progression|12
2160210|NCT01243944|3776255|FG001|Overall Study|Disease progression|11
2160211|NCT01243944|3776254|FG000|Overall Study|Protocol deviation|1
2160212|NCT01243944|3776255|FG001|Overall Study|Protocol deviation|1
2160213|NCT01243944|3776254|FG000|Overall Study|Participant decision|10
2160214|NCT01243944|3776255|FG001|Overall Study|Participant decision|15
2160215|NCT01243944|3776254|FG000|Overall Study|Death|2
2160216|NCT01243944|3776255|FG001|Overall Study|Death|3
2160217|NCT01243944|3776254|FG000|Overall Study|Non-compliance with study treatment|1
2160218|NCT01243944|3776255|FG001|Overall Study|Non-compliance with study treatment|0
2160219|NCT01244035|3776268|FG000|Part 1: Period 1|Adverse Event|0
2160220|NCT01244035|3776269|FG001|Part 1: Period 1|Adverse Event|0
2160221|NCT01244035|3776270|FG002|Part 1: Period 1|Adverse Event|0
2160222|NCT01244035|3776271|FG003|Part 1: Period 1|Adverse Event|0
2160223|NCT01244035|3776272|FG004|Part 1: Period 1|Adverse Event|0
2160224|NCT01244035|3776273|FG005|Part 1: Period 1|Adverse Event|1
2160225|NCT01244035|3776268|FG000|Part 1: Period 1|Withdrawal by Subject|0
2160226|NCT01244035|3776269|FG001|Part 1: Period 1|Withdrawal by Subject|2
2160227|NCT01244035|3776270|FG002|Part 1: Period 1|Withdrawal by Subject|0
2160228|NCT01244035|3776271|FG003|Part 1: Period 1|Withdrawal by Subject|0
2160229|NCT01244035|3776272|FG004|Part 1: Period 1|Withdrawal by Subject|0
2160230|NCT01244035|3776273|FG005|Part 1: Period 1|Withdrawal by Subject|0
2160231|NCT01244035|3776268|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1
2160232|NCT01244035|3776269|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0
2160233|NCT01244035|3776270|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2
2160234|NCT01244035|3776271|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0
2160235|NCT01244035|3776272|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1
2160236|NCT01244035|3776273|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1
2160237|NCT01244035|3776268|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0
2160238|NCT01244035|3776269|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0
2160239|NCT01244035|3776270|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1
2160240|NCT01244035|3776271|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0
2160241|NCT01244035|3776272|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0
2160242|NCT01244035|3776273|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0
2160243|NCT01244035|3776268|FG000|Part 1: Period 3|Adverse Event|0
2160244|NCT01244035|3776269|FG001|Part 1: Period 3|Adverse Event|0
2160245|NCT01244035|3776270|FG002|Part 1: Period 3|Adverse Event|0
2160246|NCT01244035|3776271|FG003|Part 1: Period 3|Adverse Event|0
2160247|NCT01244035|3776272|FG004|Part 1: Period 3|Adverse Event|0
2160248|NCT01244035|3776273|FG005|Part 1: Period 3|Adverse Event|1
2160249|NCT01244035|3776268|FG000|Part 1: Period 3|Withdrawal by Subject|0
2160250|NCT01244035|3776269|FG001|Part 1: Period 3|Withdrawal by Subject|0
2160251|NCT01244035|3776270|FG002|Part 1: Period 3|Withdrawal by Subject|0
2160252|NCT01244035|3776271|FG003|Part 1: Period 3|Withdrawal by Subject|0
2160253|NCT01244035|3776272|FG004|Part 1: Period 3|Withdrawal by Subject|1
2160254|NCT01244035|3776273|FG005|Part 1: Period 3|Withdrawal by Subject|0
2160255|NCT01244035|3776268|FG000|Part 1: Period 3|Protocol Deviation|0
2160256|NCT01244035|3776269|FG001|Part 1: Period 3|Protocol Deviation|1
2160257|NCT01244035|3776270|FG002|Part 1: Period 3|Protocol Deviation|0
2160258|NCT01244035|3776271|FG003|Part 1: Period 3|Protocol Deviation|0
2160259|NCT01244035|3776272|FG004|Part 1: Period 3|Protocol Deviation|0
2160260|NCT01244035|3776273|FG005|Part 1: Period 3|Protocol Deviation|0
2160261|NCT01244061|3776295|FG000|Overall Study|Death|1
2160262|NCT01244061|3776296|FG001|Overall Study|Death|0
2160263|NCT01244061|3776295|FG000|Overall Study|Did not meet entrance criteria|1
2160264|NCT01244061|3776296|FG001|Overall Study|Did not meet entrance criteria|0
2160265|NCT01244061|3776295|FG000|Overall Study|Lack of Efficacy|1
2160266|NCT01244061|3776296|FG001|Overall Study|Lack of Efficacy|3
2160267|NCT01244061|3776295|FG000|Overall Study|Lost to Follow-up|34
2160268|NCT01244061|3776296|FG001|Overall Study|Lost to Follow-up|30
2160269|NCT01244061|3776295|FG000|Overall Study|Withdrawal by Subject|29
2160270|NCT01244061|3776296|FG001|Overall Study|Withdrawal by Subject|46
2160271|NCT01244061|3776295|FG000|Overall Study|Other|8
2160272|NCT01244061|3776296|FG001|Overall Study|Other|19
2160273|NCT01244061|3776295|FG000|Overall Study|Protocol Violation|1
2160274|NCT01244061|3776296|FG001|Overall Study|Protocol Violation|1
2160275|NCT01244061|3776295|FG000|Overall Study|Adverse Event|5
2160276|NCT01244061|3776296|FG001|Overall Study|Adverse Event|2
2160277|NCT01244061|3776295|FG000|Overall Study|Randomized but not treated|2
2160278|NCT01244061|3776296|FG001|Overall Study|Randomized but not treated|2
2160279|NCT01244126|3776305|FG000|Overall Study|Protocol Violation|3
2160280|NCT01244126|3776306|FG001|Overall Study|Protocol Violation|3
2160281|NCT01244126|3776307|FG002|Overall Study|Protocol Violation|9
2160282|NCT01244191|3776317|FG000|Overall Study|Progressive disease|295
2160283|NCT01244191|3776318|FG001|Overall Study|Progressive disease|350
2160284|NCT01244191|3776317|FG000|Overall Study|Clinical disease progression|54
2160285|NCT01244191|3776318|FG001|Overall Study|Clinical disease progression|36
2160286|NCT01244191|3776317|FG000|Overall Study|Adverse Event|65
2160287|NCT01244191|3776318|FG001|Overall Study|Adverse Event|48
2160288|NCT01244191|3776317|FG000|Overall Study|Death|22
2160289|NCT01244191|3776318|FG001|Overall Study|Death|29
2160290|NCT01244191|3776317|FG000|Overall Study|Lost to Follow-up|0
2160291|NCT01244191|3776318|FG001|Overall Study|Lost to Follow-up|2
2160292|NCT01244191|3776317|FG000|Overall Study|Protocol Violation|1
2160293|NCT01244191|3776318|FG001|Overall Study|Protocol Violation|2
2160294|NCT01244191|3776317|FG000|Overall Study|Withdrawal by Subject|31
2160295|NCT01244191|3776318|FG001|Overall Study|Withdrawal by Subject|23
2160296|NCT01244191|3776317|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12
2160297|NCT01244191|3776318|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8
2160298|NCT01244425|3776334|FG000|Overall Study|Withdrawal by Subject|2
2160299|NCT01244425|3776335|FG001|Overall Study|Withdrawal by Subject|2
2160300|NCT01244425|3776334|FG000|Overall Study|Adverse Event|1
2160301|NCT01244425|3776335|FG001|Overall Study|Adverse Event|1
2160302|NCT01244490|3776368|FG000|Overall Study|Lack of Efficacy|14
2160303|NCT01244490|3776369|FG001|Overall Study|Lack of Efficacy|5
2160304|NCT01244490|3776370|FG002|Overall Study|Lack of Efficacy|5
2160305|NCT01244490|3776368|FG000|Overall Study|Withdrawal by Subject|4
2160306|NCT01244490|3776369|FG001|Overall Study|Withdrawal by Subject|4
2160307|NCT01244490|3776370|FG002|Overall Study|Withdrawal by Subject|9
2160308|NCT01244490|3776368|FG000|Overall Study|Adverse Event|1
2160309|NCT01244490|3776369|FG001|Overall Study|Adverse Event|9
2160310|NCT01244490|3776370|FG002|Overall Study|Adverse Event|5
2160311|NCT01244490|3776368|FG000|Overall Study|Lost to Follow-up|0
2160312|NCT01244490|3776369|FG001|Overall Study|Lost to Follow-up|6
2160313|NCT01244490|3776370|FG002|Overall Study|Lost to Follow-up|3
2160314|NCT01244490|3776368|FG000|Overall Study|Other|0
2160315|NCT01244490|3776369|FG001|Overall Study|Other|0
2160316|NCT01244490|3776370|FG002|Overall Study|Other|1
2160317|NCT01244516|3776385|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
2160318|NCT01244516|3776386|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
2160319|NCT01244516|3776387|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
2160320|NCT01244516|3776385|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
2160321|NCT01244516|3776386|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
2160322|NCT01244516|3776387|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
2160323|NCT01244516|3776385|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
2160324|NCT01244516|3776386|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
2160325|NCT01244516|3776387|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
2160326|NCT01244516|3776385|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2
2160327|NCT01244516|3776386|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0
2160328|NCT01244516|3776387|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0
2160329|NCT01244516|3776385|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
2160330|NCT01244516|3776386|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
2160331|NCT01244516|3776387|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
2179387|NCT01393730|3804946|FG000|Overall Study|Other|2
2160332|NCT01244516|3776385|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
2160333|NCT01244516|3776386|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
2160334|NCT01244516|3776387|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
2160335|NCT01244516|3776385|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
2160336|NCT01244516|3776386|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
2160337|NCT01244516|3776387|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
2160338|NCT01244893|3776424|FG000|Baseline|Protocol Violation|0
2160339|NCT01244893|3776425|FG001|Baseline|Protocol Violation|1
2160340|NCT01244893|3776424|FG000|1-Week Follow Up|Lost to Follow-up|1
2160341|NCT01244893|3776425|FG001|1-Week Follow Up|Lost to Follow-up|0
2160342|NCT01244906|3776436|FG000|Overall Study|Death|2
2160343|NCT01244906|3776436|FG000|Overall Study|Progression of disease post treatment|6
2160344|NCT01244984|3776443|FG000|Overall Study|Adverse Event|2
2160345|NCT01244984|3776444|FG001|Overall Study|Adverse Event|11
2160346|NCT01244984|3776445|FG002|Overall Study|Adverse Event|2
2160347|NCT01244984|3776443|FG000|Overall Study|Protocol Violation|1
2160348|NCT01244984|3776444|FG001|Overall Study|Protocol Violation|0
2160349|NCT01244984|3776445|FG002|Overall Study|Protocol Violation|0
2160350|NCT01244984|3776443|FG000|Overall Study|Protocol Defined Stopping Criteria|1
2160351|NCT01244984|3776444|FG001|Overall Study|Protocol Defined Stopping Criteria|1
2160352|NCT01244984|3776445|FG002|Overall Study|Protocol Defined Stopping Criteria|0
2160353|NCT01244984|3776443|FG000|Overall Study|Withdrawal by Subject|1
2160354|NCT01244984|3776444|FG001|Overall Study|Withdrawal by Subject|2
2160355|NCT01244984|3776445|FG002|Overall Study|Withdrawal by Subject|2
2160356|NCT01245049|3776456|FG000|Overall Study|Migrated/moved from study area|0
2160357|NCT01245049|3776457|FG001|Overall Study|Migrated/moved from study area|1
2160358|NCT01245049|3776456|FG000|Overall Study|Withdrawal by Subject|0
2160359|NCT01245049|3776457|FG001|Overall Study|Withdrawal by Subject|1
2160360|NCT01245049|3776456|FG000|Overall Study|Lost to Follow-up|1
2160361|NCT01245049|3776457|FG001|Overall Study|Lost to Follow-up|2
2160362|NCT01245062|3776465|FG000|Randomization and Crossover Phase|Lost to Follow-up|4
2160363|NCT01245062|3776466|FG001|Randomization and Crossover Phase|Lost to Follow-up|2
2160364|NCT01245062|3776467|FG002|Randomization and Crossover Phase|Lost to Follow-up|0
2160365|NCT01245062|3776465|FG000|Randomization and Crossover Phase|Physician Decision|2
2160366|NCT01245062|3776466|FG001|Randomization and Crossover Phase|Physician Decision|4
2160367|NCT01245062|3776467|FG002|Randomization and Crossover Phase|Physician Decision|0
2160368|NCT01245062|3776465|FG000|Randomization and Crossover Phase|Withdrew Consent|12
2160369|NCT01245062|3776466|FG001|Randomization and Crossover Phase|Withdrew Consent|11
2160370|NCT01245062|3776467|FG002|Randomization and Crossover Phase|Withdrew Consent|0
2160371|NCT01245062|3776465|FG000|Randomization and Crossover Phase|Study closed/ terminated|23
2160372|NCT01245062|3776466|FG001|Randomization and Crossover Phase|Study closed/ terminated|14
2160373|NCT01245062|3776467|FG002|Randomization and Crossover Phase|Study closed/ terminated|0
2160374|NCT01245062|3776465|FG000|Cross-over Phase|Lost to Follow-up|0
2160375|NCT01245062|3776466|FG001|Cross-over Phase|Lost to Follow-up|0
2160376|NCT01245062|3776467|FG002|Cross-over Phase|Lost to Follow-up|1
2160377|NCT01245062|3776465|FG000|Cross-over Phase|Physician Decision|0
2160378|NCT01245062|3776466|FG001|Cross-over Phase|Physician Decision|0
2160379|NCT01245062|3776467|FG002|Cross-over Phase|Physician Decision|1
2160380|NCT01245062|3776465|FG000|Cross-over Phase|Withdrew Consent|0
2160381|NCT01245062|3776466|FG001|Cross-over Phase|Withdrew Consent|0
2160382|NCT01245062|3776467|FG002|Cross-over Phase|Withdrew Consent|4
2160383|NCT01245062|3776465|FG000|Cross-over Phase|Study closed/ terminated|0
2160384|NCT01245062|3776466|FG001|Cross-over Phase|Study closed/ terminated|0
2160385|NCT01245062|3776467|FG002|Cross-over Phase|Study closed/ terminated|11
2160386|NCT01245101|3776477|FG000|Period 1 (Treatment)|Withdrawal by Subject|2
2160387|NCT01245101|3776478|FG001|Period 1 (Treatment)|Withdrawal by Subject|0
2160388|NCT01245101|3776477|FG000|Period 2 (Washout)|Withdrawal by Subject|1
2160389|NCT01245101|3776478|FG001|Period 2 (Washout)|Withdrawal by Subject|0
2160390|NCT01245101|3776477|FG000|Period 3 (Treatment)|Withdrawal by Subject|1
2160391|NCT01245101|3776478|FG001|Period 3 (Treatment)|Withdrawal by Subject|0
2160392|NCT01245140|3776486|FG000|Overall Study|Adverse Event|1
2160393|NCT01245140|3776487|FG001|Overall Study|Adverse Event|3
2160394|NCT01245140|3776486|FG000|Overall Study|Lack of Efficacy|2
2160395|NCT01245140|3776487|FG001|Overall Study|Lack of Efficacy|4
2160396|NCT01245140|3776486|FG000|Overall Study|Protocol Violation|0
2160397|NCT01245140|3776487|FG001|Overall Study|Protocol Violation|1
2160398|NCT01245140|3776486|FG000|Overall Study|Withdrawal by Subject|0
2160399|NCT01245140|3776487|FG001|Overall Study|Withdrawal by Subject|1
2160400|NCT01245140|3776486|FG000|Overall Study|Refused Treatment/Did Not Coopera|0
2160401|NCT01245140|3776487|FG001|Overall Study|Refused Treatment/Did Not Coopera|1
2160402|NCT01245283|3776507|FG000|Overall Study|Lost to Follow-up|14
2160403|NCT01245283|3776508|FG001|Overall Study|Lost to Follow-up|11
2160404|NCT01245283|3776509|FG002|Overall Study|Lost to Follow-up|11
2160405|NCT01245374|3776520|FG000|Overall Study|Protocol Violation|1
2160406|NCT01245374|3776520|FG000|Overall Study|Withdrawal by Subject|3
2160407|NCT01245387|3776525|FG000|Overall Study|Lost to Follow-up|106
2160408|NCT01245387|3776525|FG000|Overall Study|Lack of Efficacy|195
2160409|NCT01245387|3776525|FG000|Overall Study|Adverse Event|9
2160410|NCT01245387|3776525|FG000|Overall Study|Death|3
2160411|NCT01245387|3776525|FG000|Overall Study|Other|131
2160412|NCT01245387|3776525|FG000|Overall Study|Missing discontinuation status|369
2160413|NCT01245673|3776560|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
2160414|NCT01245751|3776582|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2
2160415|NCT01245751|3776583|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1
2160416|NCT01245751|3776584|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0
2160417|NCT01245751|3776585|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0
2160418|NCT01245751|3776582|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
2160419|NCT01245751|3776583|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
2160420|NCT01245751|3776584|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
2160421|NCT01245751|3776585|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
2160422|NCT01245751|3776582|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
2160423|NCT01245751|3776583|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
2160424|NCT01245751|3776584|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
2160425|NCT01245751|3776585|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
2160426|NCT01245764|3776600|FG000|Study Phase A|Other|3
2160427|NCT01245764|3776601|FG001|Study Phase A|Other|2
2160428|NCT01245764|3776602|FG002|Study Phase A|Other|3
2160429|NCT01245764|3776603|FG003|Study Phase A|Other|1
2160430|NCT01245764|3776600|FG000|Study Phase A|Protocol Violation|6
2160431|NCT01245764|3776601|FG001|Study Phase A|Protocol Violation|3
2208157|NCT01636713|3847550|FG002|Overall Study|Lack of Efficacy|2
2160432|NCT01245764|3776602|FG002|Study Phase A|Protocol Violation|2
2160433|NCT01245764|3776603|FG003|Study Phase A|Protocol Violation|2
2160434|NCT01245764|3776600|FG000|Study Phase A|Lost to Follow-up|0
2160435|NCT01245764|3776601|FG001|Study Phase A|Lost to Follow-up|0
2160436|NCT01245764|3776602|FG002|Study Phase A|Lost to Follow-up|5
2160437|NCT01245764|3776603|FG003|Study Phase A|Lost to Follow-up|0
2160438|NCT01246206|3776676|FG000|Overall Study|Patient did not receive study regiments.|1
2160439|NCT01246466|3776705|FG000|Overall Study|Death|1
2160440|NCT01246466|3776705|FG000|Overall Study|Withdrawal by Subject|1
2160441|NCT01246583|3776718|FG000|Overall Study|Lost to Follow-up|0
2160442|NCT01246583|3776719|FG001|Overall Study|Lost to Follow-up|0
2160443|NCT01246583|3776720|FG002|Overall Study|Lost to Follow-up|0
2160444|NCT01246583|3776721|FG003|Overall Study|Lost to Follow-up|1
2160445|NCT01246583|3776718|FG000|Overall Study|Protocol Violation|0
2160446|NCT01246583|3776719|FG001|Overall Study|Protocol Violation|0
2160447|NCT01246583|3776720|FG002|Overall Study|Protocol Violation|1
2160448|NCT01246583|3776721|FG003|Overall Study|Protocol Violation|0
2160449|NCT01246583|3776718|FG000|Overall Study|Withdrawal by Subject|1
2160450|NCT01246583|3776719|FG001|Overall Study|Withdrawal by Subject|0
2160451|NCT01246583|3776720|FG002|Overall Study|Withdrawal by Subject|0
2160452|NCT01246583|3776721|FG003|Overall Study|Withdrawal by Subject|0
2160453|NCT01246960|3776756|FG000|Overall Study|Lost to Follow-up|3
2160454|NCT01246960|3776757|FG001|Overall Study|Lost to Follow-up|1
2160455|NCT01246960|3776756|FG000|Overall Study|Withdrawal (by participant or physician)|3
2160456|NCT01246960|3776757|FG001|Overall Study|Withdrawal (by participant or physician)|3
2160457|NCT01246973|3776765|FG000|Overall Study|Other|38
2160458|NCT01246973|3776766|FG001|Overall Study|Other|25
2160459|NCT01246973|3776765|FG000|Overall Study|Adverse Event|16
2160460|NCT01246973|3776766|FG001|Overall Study|Adverse Event|9
2160461|NCT01246973|3776765|FG000|Overall Study|Withdrawal by Subject|7
2160462|NCT01246973|3776766|FG001|Overall Study|Withdrawal by Subject|13
2160463|NCT01246986|3776779|FG000|Overall Study|Lost to Follow-up|0
2160464|NCT01246986|3776780|FG001|Overall Study|Lost to Follow-up|1
2160465|NCT01246986|3776781|FG002|Overall Study|Lost to Follow-up|3
2160466|NCT01246986|3776782|FG003|Overall Study|Lost to Follow-up|0
2160467|NCT01246986|3776783|FG004|Overall Study|Lost to Follow-up|0
2160468|NCT01246986|3776784|FG005|Overall Study|Lost to Follow-up|1
2160469|NCT01246986|3776785|FG006|Overall Study|Lost to Follow-up|0
2160470|NCT01246986|3776779|FG000|Overall Study|Withdrawal by Subject|3
2160471|NCT01246986|3776780|FG001|Overall Study|Withdrawal by Subject|4
2160472|NCT01246986|3776781|FG002|Overall Study|Withdrawal by Subject|3
2160473|NCT01246986|3776782|FG003|Overall Study|Withdrawal by Subject|0
2160474|NCT01246986|3776783|FG004|Overall Study|Withdrawal by Subject|4
2160475|NCT01246986|3776784|FG005|Overall Study|Withdrawal by Subject|0
2160476|NCT01246986|3776785|FG006|Overall Study|Withdrawal by Subject|0
2160477|NCT01246999|3776820|FG000|Overall Study|Lost to Follow-up|0
2160478|NCT01246999|3776821|FG001|Overall Study|Lost to Follow-up|1
2160479|NCT01246999|3776822|FG002|Overall Study|Lost to Follow-up|0
2160480|NCT01246999|3776823|FG003|Overall Study|Lost to Follow-up|0
2160481|NCT01246999|3776820|FG000|Overall Study|Withdrawal by Subject|0
2160482|NCT01246999|3776821|FG001|Overall Study|Withdrawal by Subject|0
2160483|NCT01246999|3776822|FG002|Overall Study|Withdrawal by Subject|0
2160484|NCT01246999|3776823|FG003|Overall Study|Withdrawal by Subject|2
2160485|NCT01247090|3776848|FG000|Overall Study|Physician Decision|1
2160486|NCT01247090|3776849|FG001|Overall Study|Physician Decision|0
2160487|NCT01247090|3776850|FG002|Overall Study|Physician Decision|0
2160488|NCT01247090|3776848|FG000|Overall Study|Withdrawal by Subject|0
2160489|NCT01247090|3776849|FG001|Overall Study|Withdrawal by Subject|1
2160490|NCT01247090|3776850|FG002|Overall Study|Withdrawal by Subject|0
2160491|NCT01247350|3776895|FG000|Overall Study|Adverse Event|0
2160492|NCT01247350|3776896|FG001|Overall Study|Adverse Event|0
2160493|NCT01247350|3776897|FG002|Overall Study|Adverse Event|1
2293818|NCT02530125|3988115|FG000|Followed for Survival for 2 Years|Early termination of study|3
2293819|NCT02530242|3988130|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0
2293820|NCT02530242|3988131|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1
2293821|NCT02530385|3988159|FG000|Overall Study|Withdrawal by Subject|0
2293822|NCT02530385|3988160|FG001|Overall Study|Withdrawal by Subject|1
2293823|NCT02530619|3988250|FG000|Registered for Study|Withdrawal by Subject|2
2293824|NCT02530619|3988250|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2
2293825|NCT02530619|3988250|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2
2293826|NCT02530619|3988250|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4
2293827|NCT02530619|3988250|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2
2293828|NCT02530619|3988250|FG000|Follow-up Period (6 Months)|Death|4
2160494|NCT01247350|3776898|FG003|Overall Study|Adverse Event|0
2160495|NCT01247350|3776899|FG004|Overall Study|Adverse Event|0
2160496|NCT01247350|3776895|FG000|Overall Study|Withdrawal by Subject|0
2160497|NCT01247350|3776896|FG001|Overall Study|Withdrawal by Subject|0
2208158|NCT01636713|3847548|FG000|Overall Study|Protocol Violation|3
2208159|NCT01636713|3847549|FG001|Overall Study|Protocol Violation|0
2160498|NCT01247350|3776897|FG002|Overall Study|Withdrawal by Subject|0
2160499|NCT01247350|3776898|FG003|Overall Study|Withdrawal by Subject|1
2160500|NCT01247350|3776899|FG004|Overall Study|Withdrawal by Subject|0
2160501|NCT01247350|3776895|FG000|Overall Study|Entry criteria not met|0
2160502|NCT01247350|3776896|FG001|Overall Study|Entry criteria not met|0
2160503|NCT01247350|3776897|FG002|Overall Study|Entry criteria not met|0
2160504|NCT01247350|3776898|FG003|Overall Study|Entry criteria not met|0
2160505|NCT01247350|3776899|FG004|Overall Study|Entry criteria not met|1
2179388|NCT01393730|3804946|FG000|Overall Study|Adverse Event|1
2179389|NCT01393743|3804952|FG000|Core Study|Adverse Event|5
2179390|NCT01393743|3804953|FG001|Core Study|Adverse Event|9
2179391|NCT01393743|3804954|FG002|Core Study|Adverse Event|0
2179392|NCT01393743|3804952|FG000|Core Study|Lost to Follow-up|1
2179393|NCT01393743|3804953|FG001|Core Study|Lost to Follow-up|1
2179394|NCT01393743|3804954|FG002|Core Study|Lost to Follow-up|0
2179395|NCT01393743|3804952|FG000|Core Study|Participant's Choice|2
2179396|NCT01393743|3804953|FG001|Core Study|Participant's Choice|3
2179397|NCT01393743|3804954|FG002|Core Study|Participant's Choice|0
2179398|NCT01393743|3804952|FG000|Core Study|Inadequate therapeutic effect|2
2179399|NCT01393743|3804953|FG001|Core Study|Inadequate therapeutic effect|0
2179400|NCT01393743|3804954|FG002|Core Study|Inadequate therapeutic effect|0
2179401|NCT01393743|3804952|FG000|Extension Phase|Adverse Event|0
2179402|NCT01393743|3804953|FG001|Extension Phase|Adverse Event|0
2179403|NCT01393743|3804954|FG002|Extension Phase|Adverse Event|12
2179404|NCT01393743|3804952|FG000|Extension Phase|Lost to Follow-up|0
2179405|NCT01393743|3804953|FG001|Extension Phase|Lost to Follow-up|0
2179406|NCT01393743|3804954|FG002|Extension Phase|Lost to Follow-up|2
2179407|NCT01393743|3804952|FG000|Extension Phase|Participant choice|0
2179408|NCT01393743|3804953|FG001|Extension Phase|Participant choice|0
2179409|NCT01393743|3804954|FG002|Extension Phase|Participant choice|16
2179410|NCT01393743|3804952|FG000|Extension Phase|Inadequate therapeutic effect|0
2179411|NCT01393743|3804953|FG001|Extension Phase|Inadequate therapeutic effect|0
2179412|NCT01393743|3804954|FG002|Extension Phase|Inadequate therapeutic effect|7
2179413|NCT01393743|3804952|FG000|Extension Phase|Withdrawal by Subject|0
2179414|NCT01393743|3804953|FG001|Extension Phase|Withdrawal by Subject|0
2179415|NCT01393743|3804954|FG002|Extension Phase|Withdrawal by Subject|8
2179416|NCT01393743|3804952|FG000|Extension Phase|Pregnancy|0
2179417|NCT01393743|3804953|FG001|Extension Phase|Pregnancy|0
2179418|NCT01393743|3804954|FG002|Extension Phase|Pregnancy|1
2179419|NCT01393743|3804952|FG000|Extension Phase|Other|0
2179420|NCT01393743|3804953|FG001|Extension Phase|Other|0
2179421|NCT01393743|3804954|FG002|Extension Phase|Other|14
2179422|NCT01393821|3804967|FG000|Overall Study|Cancel|1
2179423|NCT01393821|3804968|FG001|Overall Study|Cancel|1
2179424|NCT01393821|3804967|FG000|Overall Study|not evaluable for primary endpoint|4
2179425|NCT01393821|3804968|FG001|Overall Study|not evaluable for primary endpoint|2
2179426|NCT01393899|3804977|FG000|Overall Study|Study terminated by sponsor|1
2179427|NCT01393899|3804978|FG001|Overall Study|Study terminated by sponsor|0
2179428|NCT01393899|3804979|FG002|Overall Study|Study terminated by sponsor|1
2179429|NCT01393899|3804977|FG000|Overall Study|Other|1
2179430|NCT01393899|3804978|FG001|Overall Study|Other|0
2179431|NCT01393899|3804979|FG002|Overall Study|Other|0
2179432|NCT01393899|3804977|FG000|Overall Study|Withdrawal by Subject|2
2179433|NCT01393899|3804978|FG001|Overall Study|Withdrawal by Subject|2
2179434|NCT01393899|3804979|FG002|Overall Study|Withdrawal by Subject|1
2179435|NCT01393899|3804977|FG000|Overall Study|Lost to Follow-up|0
2179436|NCT01393899|3804978|FG001|Overall Study|Lost to Follow-up|0
2179437|NCT01393899|3804979|FG002|Overall Study|Lost to Follow-up|1
2179438|NCT01393899|3804977|FG000|Overall Study|Does not meet entrance criteria|1
2179439|NCT01393899|3804978|FG001|Overall Study|Does not meet entrance criteria|0
2179440|NCT01393899|3804979|FG002|Overall Study|Does not meet entrance criteria|1
2179441|NCT01393899|3804977|FG000|Overall Study|Lack of Efficacy|26
2179442|NCT01393899|3804978|FG001|Overall Study|Lack of Efficacy|21
2179443|NCT01393899|3804979|FG002|Overall Study|Lack of Efficacy|16
2179444|NCT01393899|3804977|FG000|Overall Study|Adverse Event|1
2179445|NCT01393899|3804978|FG001|Overall Study|Adverse Event|5
2160506|NCT01247922|3776967|FG000|Overall Study|Disease progression|4
2160507|NCT01248013|3776980|FG000|Overall Study|Withdrawal by Subject|14
2160508|NCT01248065|3776986|FG000|Overall Study|Lost to Follow-up|3
2160509|NCT01248065|3776987|FG001|Overall Study|Lost to Follow-up|5
2160510|NCT01248065|3776986|FG000|Overall Study|Withdrawal by Subject|14
2160511|NCT01248065|3776987|FG001|Overall Study|Withdrawal by Subject|11
2160512|NCT01248065|3776986|FG000|Overall Study|Adverse Event|3
2160513|NCT01248065|3776987|FG001|Overall Study|Adverse Event|0
2160514|NCT01248065|3776986|FG000|Overall Study|Third treatment failure event|3
2160515|NCT01248065|3776987|FG001|Overall Study|Third treatment failure event|1
2160516|NCT01248065|3776986|FG000|Overall Study|Other|3
2160517|NCT01248065|3776987|FG001|Overall Study|Other|5
2160518|NCT01248364|3777017|FG000|Overall Study|Adverse Event|0
2160519|NCT01248364|3777018|FG001|Overall Study|Adverse Event|1
2160520|NCT01248364|3777019|FG002|Overall Study|Adverse Event|0
2160521|NCT01248364|3777020|FG003|Overall Study|Adverse Event|0
2160522|NCT01248455|3777045|FG000|Overall Study|switched to alternate treatment|1
2160523|NCT01248468|3777052|FG000|Overall Study|Administrative problem|1
2160524|NCT01248468|3777053|FG001|Overall Study|Administrative problem|0
2160525|NCT01248468|3777054|FG002|Overall Study|Administrative problem|0
2160526|NCT01248468|3777052|FG000|Overall Study|Lost to Follow-up|9
2160527|NCT01248468|3777053|FG001|Overall Study|Lost to Follow-up|12
2160528|NCT01248468|3777054|FG002|Overall Study|Lost to Follow-up|4
2160529|NCT01248468|3777052|FG000|Overall Study|Pregnancy|1
2160530|NCT01248468|3777053|FG001|Overall Study|Pregnancy|0
2160531|NCT01248468|3777054|FG002|Overall Study|Pregnancy|0
2160532|NCT01248468|3777052|FG000|Overall Study|Withdrawal by Subject|4
2160533|NCT01248468|3777053|FG001|Overall Study|Withdrawal by Subject|2
2160534|NCT01248468|3777054|FG002|Overall Study|Withdrawal by Subject|0
2160535|NCT01248715|3777073|FG000|Overall Study|Not influenza positive|501
2160536|NCT01248715|3777074|FG001|Overall Study|Not influenza positive|510
2160537|NCT01248728|3777082|FG000|Overall Study|Adverse Event|1
2160538|NCT01248728|3777083|FG001|Overall Study|Adverse Event|1
2160539|NCT01248728|3777082|FG000|Overall Study|Withdrawal by Subject|2
2160540|NCT01248728|3777083|FG001|Overall Study|Withdrawal by Subject|1
2160541|NCT01248728|3777082|FG000|Overall Study|Lack of Efficacy|1
2160542|NCT01248728|3777083|FG001|Overall Study|Lack of Efficacy|0
2160543|NCT01248780|3777097|FG000|Overall Study|Lack of Efficacy|2
2160544|NCT01248780|3777098|FG001|Overall Study|Lack of Efficacy|0
2160545|NCT01248780|3777097|FG000|Overall Study|Lost to Follow-up|0
2160546|NCT01248780|3777098|FG001|Overall Study|Lost to Follow-up|1
2160547|NCT01248780|3777097|FG000|Overall Study|Death|0
2160548|NCT01248780|3777098|FG001|Overall Study|Death|1
2160549|NCT01248780|3777097|FG000|Overall Study|Adverse Event|2
2160550|NCT01248780|3777098|FG001|Overall Study|Adverse Event|7
2160551|NCT01248780|3777097|FG000|Overall Study|Protocol Violation|1
2160552|NCT01248780|3777098|FG001|Overall Study|Protocol Violation|1
2160553|NCT01248780|3777097|FG000|Overall Study|Withdrawal by Subject|4
2160554|NCT01248780|3777098|FG001|Overall Study|Withdrawal by Subject|4
2160555|NCT01248780|3777097|FG000|Overall Study|Not treated|0
2160556|NCT01248780|3777098|FG001|Overall Study|Not treated|1
2160557|NCT01248793|3777106|FG000|Overall Study|Lost to Follow-up|0
2160558|NCT01248793|3777107|FG001|Overall Study|Lost to Follow-up|1
2160559|NCT01248793|3777106|FG000|Overall Study|Adverse Event|1
2160560|NCT01248793|3777107|FG001|Overall Study|Adverse Event|1
2160561|NCT01248793|3777106|FG000|Overall Study|Protocol Violation|0
2160562|NCT01248793|3777107|FG001|Overall Study|Protocol Violation|1
2160563|NCT01248793|3777106|FG000|Overall Study|Withdrawal by Subject|3
2160564|NCT01248793|3777107|FG001|Overall Study|Withdrawal by Subject|3
2160565|NCT01248884|3777116|FG000|Overall Study|Withdrawal by Subject|1
2160566|NCT01248884|3777117|FG001|Overall Study|Withdrawal by Subject|3
2160567|NCT01248884|3777118|FG002|Overall Study|Withdrawal by Subject|1
2160568|NCT01248884|3777116|FG000|Overall Study|Adverse Event|1
2160569|NCT01248884|3777117|FG001|Overall Study|Adverse Event|0
2160570|NCT01248884|3777118|FG002|Overall Study|Adverse Event|0
2160571|NCT01248936|3777128|FG000|Overall Study|Sponsor Decision|259
2160572|NCT01248936|3777128|FG000|Overall Study|Progression of Disease|50
2160573|NCT01248936|3777128|FG000|Overall Study|Death|26
2160574|NCT01248936|3777128|FG000|Overall Study|Withdrawal of Consent|20
2160575|NCT01248936|3777128|FG000|Overall Study|Adverse Event|8
2160576|NCT01248936|3777128|FG000|Overall Study|Lost to Follow-up|7
2160577|NCT01248936|3777128|FG000|Overall Study|Refused Treatment|1
2160578|NCT01248936|3777128|FG000|Overall Study|Other reason|3
2160579|NCT01248949|3777138|FG000|Overall Study|Lost to Follow-up|2
2160580|NCT01248949|3777139|FG001|Overall Study|Lost to Follow-up|2
2160581|NCT01248949|3777140|FG002|Overall Study|Lost to Follow-up|2
2160582|NCT01248949|3777141|FG003|Overall Study|Lost to Follow-up|1
2160583|NCT01248949|3777142|FG004|Overall Study|Lost to Follow-up|0
2160584|NCT01248949|3777138|FG000|Overall Study|Withdrawal by Subject|5
2160585|NCT01248949|3777139|FG001|Overall Study|Withdrawal by Subject|3
2160586|NCT01248949|3777140|FG002|Overall Study|Withdrawal by Subject|11
2160587|NCT01248949|3777141|FG003|Overall Study|Withdrawal by Subject|3
2160588|NCT01248949|3777142|FG004|Overall Study|Withdrawal by Subject|1
2160589|NCT01248949|3777138|FG000|Overall Study|Death|22
2160590|NCT01248949|3777139|FG001|Overall Study|Death|7
2160591|NCT01248949|3777140|FG002|Overall Study|Death|21
2160592|NCT01248949|3777141|FG003|Overall Study|Death|6
2160593|NCT01248949|3777142|FG004|Overall Study|Death|2
2160594|NCT01248949|3777138|FG000|Overall Study|Alternative Therapy|1
2160595|NCT01248949|3777139|FG001|Overall Study|Alternative Therapy|0
2160596|NCT01248949|3777140|FG002|Overall Study|Alternative Therapy|0
2160597|NCT01248949|3777141|FG003|Overall Study|Alternative Therapy|0
2160598|NCT01248949|3777142|FG004|Overall Study|Alternative Therapy|0
2160599|NCT01248949|3777138|FG000|Overall Study|Alternative Therapy.|1
2160600|NCT01248949|3777139|FG001|Overall Study|Alternative Therapy.|0
2160601|NCT01248949|3777140|FG002|Overall Study|Alternative Therapy.|0
2160602|NCT01248949|3777141|FG003|Overall Study|Alternative Therapy.|0
2160603|NCT01248949|3777142|FG004|Overall Study|Alternative Therapy.|0
2160604|NCT01248949|3777138|FG000|Overall Study|Palliative Radiation To Brain Metastases|1
2160605|NCT01248949|3777139|FG001|Overall Study|Palliative Radiation To Brain Metastases|0
2160606|NCT01248949|3777140|FG002|Overall Study|Palliative Radiation To Brain Metastases|0
2160607|NCT01248949|3777141|FG003|Overall Study|Palliative Radiation To Brain Metastases|0
2160608|NCT01248949|3777142|FG004|Overall Study|Palliative Radiation To Brain Metastases|0
2160609|NCT01248949|3777138|FG000|Overall Study|Entered Hospice And Refused Follow Up|0
2160610|NCT01248949|3777139|FG001|Overall Study|Entered Hospice And Refused Follow Up|0
2160611|NCT01248949|3777140|FG002|Overall Study|Entered Hospice And Refused Follow Up|0
2160612|NCT01248949|3777141|FG003|Overall Study|Entered Hospice And Refused Follow Up|0
2160613|NCT01248949|3777142|FG004|Overall Study|Entered Hospice And Refused Follow Up|1
2160614|NCT01248949|3777138|FG000|Overall Study|Participant Went To Hospice|0
2160615|NCT01248949|3777139|FG001|Overall Study|Participant Went To Hospice|0
2160616|NCT01248949|3777140|FG002|Overall Study|Participant Went To Hospice|1
2160617|NCT01248949|3777141|FG003|Overall Study|Participant Went To Hospice|0
2160618|NCT01248949|3777142|FG004|Overall Study|Participant Went To Hospice|0
2160619|NCT01248949|3777138|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1
2160620|NCT01248949|3777139|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0
2160621|NCT01248949|3777140|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0
2160622|NCT01248949|3777141|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0
2160623|NCT01248949|3777142|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0
2160624|NCT01248949|3777138|FG000|Overall Study|Pi Decision Due To Declining Status|0
2160625|NCT01248949|3777139|FG001|Overall Study|Pi Decision Due To Declining Status|0
2160626|NCT01248949|3777140|FG002|Overall Study|Pi Decision Due To Declining Status|1
2160627|NCT01248949|3777141|FG003|Overall Study|Pi Decision Due To Declining Status|0
2160628|NCT01248949|3777142|FG004|Overall Study|Pi Decision Due To Declining Status|0
2160629|NCT01248949|3777138|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0
2160630|NCT01248949|3777139|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1
2160631|NCT01248949|3777140|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0
2160632|NCT01248949|3777141|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0
2160633|NCT01248949|3777142|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0
2160634|NCT01248949|3777138|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2160635|NCT01248949|3777139|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2160636|NCT01248949|3777140|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
2160637|NCT01248949|3777141|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2160638|NCT01248949|3777142|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2160639|NCT01248962|3777156|FG000|Overall Study|Withdrawal by Subject|1
2160640|NCT01248962|3777157|FG001|Overall Study|Withdrawal by Subject|1
2160641|NCT01248962|3777156|FG000|Overall Study|Adverse Event|2
2160642|NCT01248962|3777157|FG001|Overall Study|Adverse Event|1
2160643|NCT01248962|3777156|FG000|Overall Study|Complete Response after 4 Cycles|1
2160644|NCT01248962|3777157|FG001|Overall Study|Complete Response after 4 Cycles|0
2160645|NCT01248962|3777156|FG000|Overall Study|Complete Response after 3 Cycles|0
2160646|NCT01248962|3777157|FG001|Overall Study|Complete Response after 3 Cycles|1
2160647|NCT01248962|3777156|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12
2160648|NCT01248962|3777157|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13
2160649|NCT01249092|3777168|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1
2160650|NCT01249092|3777168|FG000|Overall Study|Unable to tolerate expected SE -nausea|1
2160651|NCT01249118|3777174|FG000|First Washout Period|Physician Decision|0
2160652|NCT01249118|3777175|FG001|First Washout Period|Physician Decision|1
2160653|NCT01249118|3777176|FG002|First Washout Period|Physician Decision|0
2160654|NCT01249131|3777183|FG000|Washout Period of 10 Days|Adverse Event|0
2160655|NCT01249131|3777184|FG001|Washout Period of 10 Days|Adverse Event|0
2160656|NCT01249131|3777185|FG002|Washout Period of 10 Days|Adverse Event|0
2160657|NCT01249131|3777186|FG003|Washout Period of 10 Days|Adverse Event|0
2160658|NCT01249131|3777187|FG004|Washout Period of 10 Days|Adverse Event|1
2160659|NCT01249131|3777188|FG005|Washout Period of 10 Days|Adverse Event|0
2160660|NCT01249261|3777198|FG000|Overall Study|Withdrawal by Subject|1
2160661|NCT01249261|3777199|FG001|Overall Study|Withdrawal by Subject|0
2160662|NCT01249274|3777207|FG000|Overall Study|Lost to Follow-up|3
2160663|NCT01249274|3777208|FG001|Overall Study|Lost to Follow-up|4
2160664|NCT01249274|3777207|FG000|Overall Study|Received inpatient substance treatment|1
2160665|NCT01249274|3777208|FG001|Overall Study|Received inpatient substance treatment|2
2160666|NCT01249365|3777216|FG000|Overall Study|Lost to Follow-up|1
2160667|NCT01249404|3777223|FG000|Overall Study|Study treatment not received|0
2160668|NCT01249404|3777224|FG001|Overall Study|Study treatment not received|1
2160669|NCT01249404|3777225|FG002|Overall Study|Study treatment not received|2
2160670|NCT01249404|3777223|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2
2160671|NCT01249404|3777224|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0
2160672|NCT01249404|3777225|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2
2160673|NCT01249404|3777223|FG000|Overall Study|Adverse Event|2
2160674|NCT01249404|3777224|FG001|Overall Study|Adverse Event|2
2160675|NCT01249404|3777225|FG002|Overall Study|Adverse Event|2
2160676|NCT01249404|3777223|FG000|Overall Study|Withdrawal by Subject|2
2160677|NCT01249404|3777224|FG001|Overall Study|Withdrawal by Subject|2
2160678|NCT01249404|3777225|FG002|Overall Study|Withdrawal by Subject|0
2160679|NCT01249404|3777223|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1
2160680|NCT01249404|3777224|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2
2160681|NCT01249404|3777225|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1
2160682|NCT01249404|3777223|FG000|Overall Study|Non compliance to visit schedule|0
2160683|NCT01249404|3777224|FG001|Overall Study|Non compliance to visit schedule|1
2160684|NCT01249404|3777225|FG002|Overall Study|Non compliance to visit schedule|0
2160685|NCT01249417|3777236|FG000|Randomised Population|Study treatment not received|0
2160686|NCT01249417|3777237|FG001|Randomised Population|Study treatment not received|0
2160687|NCT01249417|3777238|FG002|Randomised Population|Study treatment not received|2
2160688|NCT01249417|3777236|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1
2160689|NCT01249417|3777237|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1
2160690|NCT01249417|3777238|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2
2160691|NCT01249417|3777236|FG000|Treatment Phase - ITT Population|Other|0
2160692|NCT01249417|3777237|FG001|Treatment Phase - ITT Population|Other|0
2160693|NCT01249417|3777238|FG002|Treatment Phase - ITT Population|Other|1
2160694|NCT01249417|3777236|FG000|Treatment Phase - ITT Population|Adverse Event|0
2160695|NCT01249417|3777237|FG001|Treatment Phase - ITT Population|Adverse Event|0
2160696|NCT01249417|3777238|FG002|Treatment Phase - ITT Population|Adverse Event|1
2160697|NCT01249417|3777236|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1
2160698|NCT01249417|3777237|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3
2160699|NCT01249417|3777238|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1
2160700|NCT01249417|3777236|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0
2160701|NCT01249417|3777237|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1
2160702|NCT01249417|3777238|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1
2160703|NCT01249651|3777255|FG000|Overall Study|Withdrawal by Subject|4
2160704|NCT01249651|3777255|FG000|Overall Study|Adverse Event|1
2160705|NCT01249651|3777255|FG000|Overall Study|Protocol Violation|1
2160706|NCT01249651|3777255|FG000|Overall Study|Sponsor Decision|1
2160707|NCT01249664|3777261|FG000|Overall Study|Withdrawal by Subject|5
2160708|NCT01249664|3777262|FG001|Overall Study|Withdrawal by Subject|0
2160709|NCT01249664|3777261|FG000|Overall Study|Adverse Event|1
2160710|NCT01249664|3777262|FG001|Overall Study|Adverse Event|0
2160711|NCT01249833|3777272|FG000|Overall Study|Lost to Follow-up|0
2160712|NCT01249833|3777273|FG001|Overall Study|Lost to Follow-up|1
2160713|NCT01250002|3777314|FG000|Overall Study|Change to open surgical procedure|4
2160714|NCT01250002|3777315|FG001|Overall Study|Change to open surgical procedure|3
2160715|NCT01250054|3777321|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1
2160716|NCT01250054|3777322|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0
2160717|NCT01250119|3777328|FG000|Diagnostic Phase|Failed to Produce a Test Results|69
2160718|NCT01250119|3777329|FG001|Diagnostic Phase|Failed to Produce a Test Results|0
2160719|NCT01250119|3777328|FG000|Diagnostic Phase|Participants Not Tested|44
2160720|NCT01250119|3777329|FG001|Diagnostic Phase|Participants Not Tested|0
2160721|NCT01250119|3777328|FG000|Treatment Phase|Progressive Disease|0
2160722|NCT01250119|3777329|FG001|Treatment Phase|Progressive Disease|32
2160723|NCT01250119|3777328|FG000|Treatment Phase|Death|0
2160724|NCT01250119|3777329|FG001|Treatment Phase|Death|2
2160725|NCT01250119|3777328|FG000|Treatment Phase|Withdrawal by Subject|0
2160726|NCT01250119|3777329|FG001|Treatment Phase|Withdrawal by Subject|1
2160727|NCT01250119|3777328|FG000|Treatment Phase|Adverse Event|0
2160728|NCT01250119|3777329|FG001|Treatment Phase|Adverse Event|2
2160729|NCT01250119|3777328|FG000|Treatment Phase|Unknown reason|0
2160730|NCT01250119|3777329|FG001|Treatment Phase|Unknown reason|4
2160731|NCT01250145|3777338|FG000|Overall Study|Adverse Event|2
2160732|NCT01250145|3777339|FG001|Overall Study|Adverse Event|1
2160733|NCT01250145|3777338|FG000|Overall Study|Withdrawal by Subject|0
2160734|NCT01250145|3777339|FG001|Overall Study|Withdrawal by Subject|4
2160735|NCT01250171|3777362|FG000|Overall Study|Administrative reasons|1
2160736|NCT01250171|3777363|FG001|Overall Study|Administrative reasons|0
2160737|NCT01250171|3777364|FG002|Overall Study|Administrative reasons|0
2160738|NCT01250379|3777400|FG000|Overall Study|Death|141
2160739|NCT01250379|3777401|FG001|Overall Study|Death|148
2160740|NCT01250379|3777400|FG000|Overall Study|Withdrawal by Subject|32
2160741|NCT01250379|3777401|FG001|Overall Study|Withdrawal by Subject|20
2160742|NCT01250379|3777400|FG000|Overall Study|Physician Decision|11
2160743|NCT01250379|3777401|FG001|Overall Study|Physician Decision|3
2160744|NCT01250379|3777400|FG000|Overall Study|Protocol Violation|2
2160745|NCT01250379|3777401|FG001|Overall Study|Protocol Violation|8
2160746|NCT01250379|3777400|FG000|Overall Study|Lost to Follow-up|9
2160747|NCT01250379|3777401|FG001|Overall Study|Lost to Follow-up|6
2160748|NCT01250379|3777400|FG000|Overall Study|Adverse Event|5
2160749|NCT01250379|3777401|FG001|Overall Study|Adverse Event|4
2160750|NCT01250379|3777400|FG000|Overall Study|Other|0
2160751|NCT01250379|3777401|FG001|Overall Study|Other|4
2160752|NCT01250379|3777400|FG000|Overall Study|Participant noncompliance|2
2160753|NCT01250379|3777401|FG001|Overall Study|Participant noncompliance|0
2160754|NCT01250418|3777409|FG000|Overall Study|monitor data failure|1
2160755|NCT01250418|3777410|FG001|Overall Study|monitor data failure|1
2160756|NCT01250509|3777418|FG000|Overall Study|Lost to Follow-up|5
2160757|NCT01250509|3777419|FG001|Overall Study|Lost to Follow-up|2
2160758|NCT01250756|3777446|FG000|Infant Series|Withdrawal by Subject|4
2160759|NCT01250756|3777447|FG001|Infant Series|Withdrawal by Subject|5
2160760|NCT01250756|3777446|FG000|Infant Series|Randomized, Not Vaccinated|2
2160761|NCT01250756|3777447|FG001|Infant Series|Randomized, Not Vaccinated|2
2160762|NCT01250756|3777446|FG000|Infant Series|Other|22
2160763|NCT01250756|3777447|FG001|Infant Series|Other|0
2160764|NCT01250756|3777446|FG000|After Infant Series|Adverse Event|5
2160765|NCT01250756|3777447|FG001|After Infant Series|Adverse Event|2
2160766|NCT01250756|3777446|FG000|After Infant Series|Withdrawal by Subject|4
2160767|NCT01250756|3777447|FG001|After Infant Series|Withdrawal by Subject|1
2160768|NCT01250756|3777446|FG000|After Infant Series|Other|2
2160769|NCT01250756|3777447|FG001|After Infant Series|Other|1
2160770|NCT01250756|3777446|FG000|Toddler Dose|Adverse Event|0
2160771|NCT01250756|3777447|FG001|Toddler Dose|Adverse Event|1
2160772|NCT01250756|3777446|FG000|After Toddler Dose|Adverse Event|0
2160773|NCT01250756|3777447|FG001|After Toddler Dose|Adverse Event|1
2160774|NCT01250769|3777463|FG000|Overall Study|Withdrawal by Subject|0
2160775|NCT01250769|3777464|FG001|Overall Study|Withdrawal by Subject|1
2160776|NCT01250769|3777465|FG002|Overall Study|Withdrawal by Subject|1
2160777|NCT01250769|3777466|FG003|Overall Study|Withdrawal by Subject|0
2160778|NCT01250769|3777463|FG000|Overall Study|Adverse Event|0
2160779|NCT01250769|3777464|FG001|Overall Study|Adverse Event|0
2160780|NCT01250769|3777465|FG002|Overall Study|Adverse Event|1
2160781|NCT01250769|3777466|FG003|Overall Study|Adverse Event|0
2160782|NCT01250873|3777483|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
2160783|NCT01250873|3777483|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
2160784|NCT01250925|3777499|FG000|Overall Study|Lost to Follow-up|1
2160785|NCT01250925|3777500|FG001|Overall Study|Lost to Follow-up|1
2160786|NCT01250925|3777501|FG002|Overall Study|Lost to Follow-up|0
2160787|NCT01250925|3777499|FG000|Overall Study|Withdrawal by Subject|2
2160788|NCT01250925|3777500|FG001|Overall Study|Withdrawal by Subject|0
2160789|NCT01250925|3777501|FG002|Overall Study|Withdrawal by Subject|0
2160790|NCT01250925|3777499|FG000|Overall Study|Protocol Violation|2
2160791|NCT01250925|3777500|FG001|Overall Study|Protocol Violation|0
2160792|NCT01250925|3777501|FG002|Overall Study|Protocol Violation|0
2160793|NCT01250925|3777499|FG000|Overall Study|Physician Decision|0
2160794|NCT01250925|3777500|FG001|Overall Study|Physician Decision|2
2160795|NCT01250925|3777501|FG002|Overall Study|Physician Decision|1
2160796|NCT01250925|3777499|FG000|Overall Study|Adverse Event|0
2160797|NCT01250925|3777500|FG001|Overall Study|Adverse Event|0
2160798|NCT01250925|3777501|FG002|Overall Study|Adverse Event|1
2160799|NCT01251146|3777538|FG000|Overall Study|Lost to Follow-up|3
2160800|NCT01251146|3777539|FG001|Overall Study|Lost to Follow-up|10
2160801|NCT01251276|3777547|FG000|Overall Study|Protocol Violation|1
2160802|NCT01251276|3777548|FG001|Overall Study|Protocol Violation|0
2160803|NCT01251276|3777547|FG000|Overall Study|Lost to Follow-up|0
2160804|NCT01251276|3777548|FG001|Overall Study|Lost to Follow-up|1
2160805|NCT01251354|3777583|FG000|Overall Study|Adverse Event|1
2160806|NCT01251354|3777583|FG000|Overall Study|Investigator's Decision|1
2160807|NCT01251354|3777583|FG000|Overall Study|Disease Progression|4
2160808|NCT01251367|3777587|FG000|Overall Study|Protocol Violation|1
2160809|NCT01251367|3777587|FG000|Overall Study|Lack of Efficacy|2
2160810|NCT01251367|3777587|FG000|Overall Study|Adverse Event|19
2160811|NCT01251367|3777587|FG000|Overall Study|Withdrawal by Subject|36
2160812|NCT01251367|3777587|FG000|Overall Study|Lost to Follow-up|5
2160813|NCT01251367|3777587|FG000|Overall Study|Subject Required Alternative Treatment|7
2160814|NCT01251367|3777587|FG000|Overall Study|No Study Drug Available|1
2160815|NCT01251367|3777587|FG000|Overall Study|Subject had Personal or Medical Issues|4
2293829|NCT02530619|3988250|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2
2293830|NCT02530619|3988250|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5
2293831|NCT02530671|3988256|FG000|Overall Study|Lost to Follow-up|2
2293832|NCT02530671|3988257|FG001|Overall Study|Lost to Follow-up|0
2293833|NCT02530671|3988256|FG000|Overall Study|Withdrawal by Subject|1
2293834|NCT02530671|3988257|FG001|Overall Study|Withdrawal by Subject|0
2160816|NCT01251367|3777587|FG000|Overall Study|End of Study Visit Performed in Error|1
2160817|NCT01251380|3777591|FG000|Overall Study|Other (Not otherwise specified)|12
2160818|NCT01251380|3777591|FG000|Overall Study|Withdrawal by Subject|6
2160819|NCT01251380|3777591|FG000|Overall Study|Lack of Efficacy|1
2160820|NCT01251380|3777591|FG000|Overall Study|Adverse Event|1
2160821|NCT01251380|3777591|FG000|Overall Study|Lost to Follow-up|2
2160822|NCT01251614|3777644|FG000|Overall Study|Adverse Event|1
2160823|NCT01251614|3777645|FG001|Overall Study|Adverse Event|0
2160824|NCT01251614|3777646|FG002|Overall Study|Adverse Event|1
2160825|NCT01251614|3777644|FG000|Overall Study|Lack of Efficacy|1
2293835|NCT02530905|3988265|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
2160826|NCT01251614|3777645|FG001|Overall Study|Lack of Efficacy|9
2160827|NCT01251614|3777646|FG002|Overall Study|Lack of Efficacy|4
2160828|NCT01251614|3777644|FG000|Overall Study|Clearing of Psoriatic Lesions|1
2160829|NCT01251614|3777645|FG001|Overall Study|Clearing of Psoriatic Lesions|0
2160830|NCT01251614|3777646|FG002|Overall Study|Clearing of Psoriatic Lesions|0
2160831|NCT01251614|3777644|FG000|Overall Study|Pregnancy|0
2160832|NCT01251614|3777645|FG001|Overall Study|Pregnancy|0
2160833|NCT01251614|3777646|FG002|Overall Study|Pregnancy|2
2160834|NCT01251614|3777644|FG000|Overall Study|Loss of Disease Control|0
2160835|NCT01251614|3777645|FG001|Overall Study|Loss of Disease Control|1
2160836|NCT01251614|3777646|FG002|Overall Study|Loss of Disease Control|0
2160837|NCT01251614|3777644|FG000|Overall Study|Withdrawal by Subject|0
2160838|NCT01251614|3777645|FG001|Overall Study|Withdrawal by Subject|2
2160839|NCT01251614|3777646|FG002|Overall Study|Withdrawal by Subject|1
2160840|NCT01251614|3777644|FG000|Overall Study|Lost to Follow-up|0
2160841|NCT01251614|3777645|FG001|Overall Study|Lost to Follow-up|1
2160842|NCT01251614|3777646|FG002|Overall Study|Lost to Follow-up|0
2160843|NCT01251653|3777673|FG000|Overall Study|Progressive Disease|1
2160844|NCT01251653|3777674|FG001|Overall Study|Progressive Disease|7
2160845|NCT01251653|3777675|FG002|Overall Study|Progressive Disease|16
2160846|NCT01251653|3777676|FG003|Overall Study|Progressive Disease|4
2160847|NCT01251653|3777677|FG004|Overall Study|Progressive Disease|0
2160848|NCT01251653|3777678|FG005|Overall Study|Progressive Disease|17
2160849|NCT01251653|3777679|FG006|Overall Study|Progressive Disease|14
2160850|NCT01251653|3777680|FG007|Overall Study|Progressive Disease|7
2160851|NCT01251653|3777681|FG008|Overall Study|Progressive Disease|5
2160852|NCT01251653|3777673|FG000|Overall Study|Dose-limiting toxicity|0
2160853|NCT01251653|3777674|FG001|Overall Study|Dose-limiting toxicity|1
2160854|NCT01251653|3777675|FG002|Overall Study|Dose-limiting toxicity|1
2160855|NCT01251653|3777676|FG003|Overall Study|Dose-limiting toxicity|1
2160856|NCT01251653|3777677|FG004|Overall Study|Dose-limiting toxicity|0
2160857|NCT01251653|3777678|FG005|Overall Study|Dose-limiting toxicity|0
2160858|NCT01251653|3777679|FG006|Overall Study|Dose-limiting toxicity|2
2160859|NCT01251653|3777680|FG007|Overall Study|Dose-limiting toxicity|0
2160860|NCT01251653|3777681|FG008|Overall Study|Dose-limiting toxicity|0
2160861|NCT01251653|3777673|FG000|Overall Study|Adverse Event|1
2160862|NCT01251653|3777674|FG001|Overall Study|Adverse Event|0
2160863|NCT01251653|3777675|FG002|Overall Study|Adverse Event|2
2160864|NCT01251653|3777676|FG003|Overall Study|Adverse Event|1
2160865|NCT01251653|3777677|FG004|Overall Study|Adverse Event|1
2160866|NCT01251653|3777678|FG005|Overall Study|Adverse Event|0
2160867|NCT01251653|3777679|FG006|Overall Study|Adverse Event|2
2160868|NCT01251653|3777680|FG007|Overall Study|Adverse Event|2
2160869|NCT01251653|3777681|FG008|Overall Study|Adverse Event|1
2160870|NCT01251653|3777673|FG000|Overall Study|Withdrawal by Subject|1
2160871|NCT01251653|3777674|FG001|Overall Study|Withdrawal by Subject|0
2160872|NCT01251653|3777675|FG002|Overall Study|Withdrawal by Subject|1
2160873|NCT01251653|3777676|FG003|Overall Study|Withdrawal by Subject|0
2160874|NCT01251653|3777677|FG004|Overall Study|Withdrawal by Subject|1
2160875|NCT01251653|3777678|FG005|Overall Study|Withdrawal by Subject|1
2160876|NCT01251653|3777679|FG006|Overall Study|Withdrawal by Subject|0
2160877|NCT01251653|3777680|FG007|Overall Study|Withdrawal by Subject|1
2160878|NCT01251653|3777681|FG008|Overall Study|Withdrawal by Subject|0
2160879|NCT01251653|3777673|FG000|Overall Study|Other reason not mentioned above|0
2160880|NCT01251653|3777674|FG001|Overall Study|Other reason not mentioned above|0
2160881|NCT01251653|3777675|FG002|Overall Study|Other reason not mentioned above|0
2160882|NCT01251653|3777676|FG003|Overall Study|Other reason not mentioned above|0
2160883|NCT01251653|3777677|FG004|Overall Study|Other reason not mentioned above|0
2160884|NCT01251653|3777678|FG005|Overall Study|Other reason not mentioned above|0
2208160|NCT01636713|3847550|FG002|Overall Study|Protocol Violation|1
2208161|NCT01636713|3847548|FG000|Overall Study|Lost to Follow-up|0
2208162|NCT01636713|3847549|FG001|Overall Study|Lost to Follow-up|0
2208163|NCT01636713|3847550|FG002|Overall Study|Lost to Follow-up|1
2208164|NCT01636713|3847548|FG000|Overall Study|Withdrawal by Subject|5
2293836|NCT02530905|3988266|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
2293837|NCT02530905|3988267|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1
2293838|NCT02530970|3988289|FG000|Overall Study|Adverse Event|8
2293839|NCT02530970|3988289|FG000|Overall Study|Lost to Follow-up|88
2293840|NCT02530970|3988289|FG000|Overall Study|Physician Decision|5
2293841|NCT02530970|3988289|FG000|Overall Study|Withdrawal by Subject|14
2293842|NCT02530970|3988289|FG000|Overall Study|Death|6
2293843|NCT02530970|3988289|FG000|Overall Study|Hospitalization|1
2293844|NCT02530970|3988289|FG000|Overall Study|Insurance|2
2293845|NCT02530970|3988289|FG000|Overall Study|Explant|2
2293846|NCT02530970|3988289|FG000|Overall Study|Change in Provider|5
2293847|NCT02530970|3988289|FG000|Overall Study|Relocation|3
2160885|NCT01251653|3777679|FG006|Overall Study|Other reason not mentioned above|0
2160886|NCT01251653|3777680|FG007|Overall Study|Other reason not mentioned above|2
2160887|NCT01251653|3777681|FG008|Overall Study|Other reason not mentioned above|0
2160888|NCT01251744|3777719|FG000|Overall Study|Lost to Follow-up|1
2208165|NCT01636713|3847549|FG001|Overall Study|Withdrawal by Subject|4
2293848|NCT02531035|3988315|FG000|Overall Study|Death|0
2293849|NCT02531035|3988316|FG001|Overall Study|Death|1
2293850|NCT02531035|3988315|FG000|Overall Study|Protocol Violation|1
2160889|NCT01251744|3777720|FG001|Overall Study|Lost to Follow-up|0
2160890|NCT01251770|3777752|FG000|Overall Study|Protocol Violation|13
2160891|NCT01251770|3777753|FG001|Overall Study|Protocol Violation|7
2160892|NCT01251861|3777761|FG000|Overall Study|Disease progression|6
2160893|NCT01251861|3777762|FG001|Overall Study|Disease progression|6
2160894|NCT01251861|3777761|FG000|Overall Study|Adverse Event|2
2160895|NCT01251861|3777762|FG001|Overall Study|Adverse Event|17
2160896|NCT01251861|3777761|FG000|Overall Study|Withdrawal by Subject|2
2160897|NCT01251861|3777762|FG001|Overall Study|Withdrawal by Subject|2
2160898|NCT01251861|3777761|FG000|Overall Study|Alternative therapy|1
2160899|NCT01251861|3777762|FG001|Overall Study|Alternative therapy|0
2160900|NCT01251861|3777761|FG000|Overall Study|Other complicating disease|0
2160901|NCT01251861|3777762|FG001|Overall Study|Other complicating disease|1
2160902|NCT01251861|3777761|FG000|Overall Study|Physician Decision|1
2160903|NCT01251861|3777762|FG001|Overall Study|Physician Decision|0
2160904|NCT01251861|3777761|FG000|Overall Study|Continued treatment beyond 18 cycles|1
2160905|NCT01251861|3777762|FG001|Overall Study|Continued treatment beyond 18 cycles|0
2160906|NCT01251861|3777761|FG000|Overall Study|Other|1
2160907|NCT01251861|3777762|FG001|Overall Study|Other|0
2160908|NCT01251861|3777761|FG000|Overall Study|Never started therapy|4
2160909|NCT01251861|3777762|FG001|Overall Study|Never started therapy|1
2160910|NCT01251861|3777761|FG000|Overall Study|Potential interaction of drugs|0
2160911|NCT01251861|3777762|FG001|Overall Study|Potential interaction of drugs|1
2160912|NCT01251887|3777771|FG000|Overall Study|Scheduling conflict|1
2160913|NCT01251887|3777772|FG001|Overall Study|Scheduling conflict|2
2160914|NCT01251887|3777773|FG002|Overall Study|Scheduling conflict|2
2160915|NCT01251887|3777771|FG000|Overall Study|Physician Decision|0
2160916|NCT01251887|3777772|FG001|Overall Study|Physician Decision|1
2293851|NCT02531035|3988316|FG001|Overall Study|Protocol Violation|1
2293852|NCT02531035|3988315|FG000|Overall Study|Noncompliance with study drug|8
2293853|NCT02531035|3988316|FG001|Overall Study|Noncompliance with study drug|3
2293854|NCT02531035|3988315|FG000|Overall Study|Physician Decision|1
2293855|NCT02531035|3988316|FG001|Overall Study|Physician Decision|0
2293856|NCT02531035|3988315|FG000|Overall Study|Adverse Event|16
2293857|NCT02531035|3988316|FG001|Overall Study|Adverse Event|45
2293858|NCT02531035|3988315|FG000|Overall Study|Other|3
2293859|NCT02531035|3988316|FG001|Overall Study|Other|2
2293860|NCT02531035|3988315|FG000|Overall Study|Withdrawal by Subject|42
2293861|NCT02531035|3988316|FG001|Overall Study|Withdrawal by Subject|32
2293862|NCT02531035|3988315|FG000|Overall Study|Lost to Follow-up|8
2293863|NCT02531035|3988316|FG001|Overall Study|Lost to Follow-up|10
2293864|NCT02531035|3988315|FG000|Overall Study|Randomized, not treated|2
2293865|NCT02531035|3988316|FG001|Overall Study|Randomized, not treated|1
2321241|NCT02957682|4035674|FG000|Overall Study|Study Terminated by Sponsor|4
2321242|NCT02957682|4035675|FG001|Overall Study|Study Terminated by Sponsor|3
2321243|NCT02957682|4035674|FG000|Overall Study|Subject Moved|10
2321244|NCT02957682|4035675|FG001|Overall Study|Subject Moved|16
2321245|NCT02957682|4035674|FG000|Overall Study|Withdrawal by Subject|64
2321246|NCT02957682|4035675|FG001|Overall Study|Withdrawal by Subject|33
2321247|NCT02957682|4035674|FG000|Overall Study|Related to IMP Administration|3
2321248|NCT02957682|4035675|FG001|Overall Study|Related to IMP Administration|6
2321249|NCT02957682|4035674|FG000|Overall Study|Non-disclosed|16
2321250|NCT02957682|4035675|FG001|Overall Study|Non-disclosed|12
2321251|NCT02957682|4035674|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3
2321252|NCT02957682|4035675|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2
2321253|NCT02957747|4035683|FG000|Overall Study|Withdrawal by Subject|0
2321254|NCT02957747|4035684|FG001|Overall Study|Withdrawal by Subject|3
2321255|NCT02957747|4035683|FG000|Overall Study|Lost to Follow-up|10
2321256|NCT02957747|4035684|FG001|Overall Study|Lost to Follow-up|5
2321257|NCT02957942|4035693|FG000|Overall Study|Withdrawal by Subject|0
2321258|NCT02957942|4035694|FG001|Overall Study|Withdrawal by Subject|1
2321259|NCT02957942|4035693|FG000|Overall Study|Practicing experiment protocol|0
2321260|NCT02957942|4035694|FG001|Overall Study|Practicing experiment protocol|6
2321261|NCT02958267|4035702|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
2321262|NCT02958267|4035703|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
2321263|NCT02958267|4035702|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1
2321264|NCT02958267|4035703|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0
2321265|NCT02958267|4035702|FG000|Follow-up Visits|Additional treatment pursued|2
2321266|NCT02958267|4035703|FG001|Follow-up Visits|Additional treatment pursued|1
2321267|NCT02958527|4035718|FG000|Overall Study|Not collected CRFs|12
2321268|NCT02958553|4035731|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
2321269|NCT02958553|4035731|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
2321270|NCT02959138|4035831|FG000|Overall Study|Enrolled but Never Treated|0
2321271|NCT02959138|4035832|FG001|Overall Study|Enrolled but Never Treated|1
2160917|NCT01251887|3777773|FG002|Overall Study|Physician Decision|0
2321272|NCT02959138|4035833|FG002|Overall Study|Enrolled but Never Treated|0
2321273|NCT02959177|4035848|FG000|Double-Blind Treatment Phase|Adverse Event|5
2321274|NCT02959177|4035849|FG001|Double-Blind Treatment Phase|Adverse Event|2
2321275|NCT02959177|4035850|FG002|Double-Blind Treatment Phase|Adverse Event|0
2321276|NCT02959177|4035848|FG000|Double-Blind Treatment Phase|Physician Decision|1
2321277|NCT02959177|4035849|FG001|Double-Blind Treatment Phase|Physician Decision|0
2160918|NCT01251965|3777784|FG000|Overall Study|Participant/physician decision|1
2160919|NCT01251965|3777785|FG001|Overall Study|Participant/physician decision|2
2160920|NCT01251965|3777786|FG002|Overall Study|Participant/physician decision|0
2160921|NCT01251965|3777784|FG000|Overall Study|Death|0
2160922|NCT01251965|3777785|FG001|Overall Study|Death|0
2160923|NCT01251965|3777786|FG002|Overall Study|Death|11
2160924|NCT01252095|3777806|FG000|Overall Study|Disease progression|1
2160925|NCT01252095|3777807|FG001|Overall Study|Disease progression|0
2160926|NCT01252134|3777813|FG000|Period 1, 8 Hours|Personal Reasons|0
2160927|NCT01252134|3777814|FG001|Period 1, 8 Hours|Personal Reasons|1
2160928|NCT01252134|3777815|FG002|Period 1, 8 Hours|Personal Reasons|1
2160929|NCT01252134|3777816|FG003|Period 1, 8 Hours|Personal Reasons|0
2160930|NCT01252134|3777817|FG004|Period 1, 8 Hours|Personal Reasons|0
2160931|NCT01252134|3777818|FG005|Period 1, 8 Hours|Personal Reasons|0
2160932|NCT01252186|3777833|FG000|Overall Study|Adverse Event|9
2160933|NCT01252186|3777834|FG001|Overall Study|Adverse Event|6
2160934|NCT01252186|3777835|FG002|Overall Study|Adverse Event|8
2160935|NCT01252186|3777833|FG000|Overall Study|Withdrawal by Subject|2
2160936|NCT01252186|3777834|FG001|Overall Study|Withdrawal by Subject|5
2160937|NCT01252186|3777835|FG002|Overall Study|Withdrawal by Subject|2
2160938|NCT01252186|3777833|FG000|Overall Study|Physician Decision|0
2160939|NCT01252186|3777834|FG001|Overall Study|Physician Decision|0
2160940|NCT01252186|3777835|FG002|Overall Study|Physician Decision|1
2160941|NCT01252186|3777833|FG000|Overall Study|Non-compliance|0
2160942|NCT01252186|3777834|FG001|Overall Study|Non-compliance|3
2160943|NCT01252186|3777835|FG002|Overall Study|Non-compliance|4
2160944|NCT01252186|3777833|FG000|Overall Study|Protocol Violation|0
2160945|NCT01252186|3777834|FG001|Overall Study|Protocol Violation|0
2160946|NCT01252186|3777835|FG002|Overall Study|Protocol Violation|1
2160947|NCT01252186|3777833|FG000|Overall Study|Pregnancy|2
2160948|NCT01252186|3777834|FG001|Overall Study|Pregnancy|2
2160949|NCT01252186|3777835|FG002|Overall Study|Pregnancy|0
2160950|NCT01252186|3777833|FG000|Overall Study|Sponsor Request|2
2160951|NCT01252186|3777834|FG001|Overall Study|Sponsor Request|1
2160952|NCT01252186|3777835|FG002|Overall Study|Sponsor Request|0
2160953|NCT01252186|3777833|FG000|Overall Study|Lost to Follow-up|10
2293866|NCT02531113|3988322|FG000|Induction Period: Week 0 to 12|Adverse Event|4
2293867|NCT02531113|3988322|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4
2293868|NCT02531113|3988322|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3
2293869|NCT02531113|3988322|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2
2293870|NCT02531113|3988322|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5
2293871|NCT02531113|3988322|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19
2293872|NCT02531113|3988322|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11
2293873|NCT02531113|3988322|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1
2293874|NCT02531373|3988344|FG000|Overall Study|Lack of Efficacy|0
2293875|NCT02531373|3988345|FG001|Overall Study|Lack of Efficacy|0
2293876|NCT02531373|3988346|FG002|Overall Study|Lack of Efficacy|0
2293877|NCT02531373|3988347|FG003|Overall Study|Lack of Efficacy|0
2293878|NCT02531373|3988348|FG004|Overall Study|Lack of Efficacy|3
2293879|NCT02531373|3988349|FG005|Overall Study|Lack of Efficacy|2
2293880|NCT02531373|3988350|FG006|Overall Study|Lack of Efficacy|4
2293881|NCT02531373|3988351|FG007|Overall Study|Lack of Efficacy|8
2293882|NCT02531373|3988352|FG008|Overall Study|Lack of Efficacy|5
2293883|NCT02531373|3988344|FG000|Overall Study|Lost to Follow-up|0
2293884|NCT02531373|3988345|FG001|Overall Study|Lost to Follow-up|0
2293885|NCT02531373|3988346|FG002|Overall Study|Lost to Follow-up|0
2293886|NCT02531373|3988347|FG003|Overall Study|Lost to Follow-up|0
2293887|NCT02531373|3988348|FG004|Overall Study|Lost to Follow-up|0
2293888|NCT02531373|3988349|FG005|Overall Study|Lost to Follow-up|2
2293889|NCT02531373|3988350|FG006|Overall Study|Lost to Follow-up|2
2293890|NCT02531373|3988351|FG007|Overall Study|Lost to Follow-up|0
2293891|NCT02531373|3988352|FG008|Overall Study|Lost to Follow-up|0
2293892|NCT02531373|3988344|FG000|Overall Study|Physician Decision|0
2293893|NCT02531373|3988345|FG001|Overall Study|Physician Decision|0
2293894|NCT02531373|3988346|FG002|Overall Study|Physician Decision|0
2293895|NCT02531373|3988347|FG003|Overall Study|Physician Decision|0
2293896|NCT02531373|3988348|FG004|Overall Study|Physician Decision|2
2293897|NCT02531373|3988349|FG005|Overall Study|Physician Decision|1
2293898|NCT02531373|3988350|FG006|Overall Study|Physician Decision|0
2293899|NCT02531373|3988351|FG007|Overall Study|Physician Decision|0
2293900|NCT02531373|3988352|FG008|Overall Study|Physician Decision|0
2293901|NCT02531373|3988344|FG000|Overall Study|Protocol Violation|0
2160954|NCT01252186|3777834|FG001|Overall Study|Lost to Follow-up|10
2160955|NCT01252186|3777835|FG002|Overall Study|Lost to Follow-up|11
2160956|NCT01252186|3777833|FG000|Overall Study|Other - Miscellaneous Reasons|5
2160957|NCT01252186|3777834|FG001|Overall Study|Other - Miscellaneous Reasons|5
2293902|NCT02531373|3988345|FG001|Overall Study|Protocol Violation|0
2293903|NCT02531373|3988346|FG002|Overall Study|Protocol Violation|0
2293904|NCT02531373|3988347|FG003|Overall Study|Protocol Violation|0
2293905|NCT02531373|3988348|FG004|Overall Study|Protocol Violation|0
2293906|NCT02531373|3988349|FG005|Overall Study|Protocol Violation|1
2293907|NCT02531373|3988350|FG006|Overall Study|Protocol Violation|1
2293908|NCT02531373|3988351|FG007|Overall Study|Protocol Violation|0
2293909|NCT02531373|3988352|FG008|Overall Study|Protocol Violation|1
2293910|NCT02531373|3988344|FG000|Overall Study|Withdrawal by Parent/Guardian|0
2160958|NCT01252186|3777835|FG002|Overall Study|Other - Miscellaneous Reasons|7
2160959|NCT01252238|3777846|FG000|Overall Study|Sponsor terminated study|4
2160960|NCT01252238|3777847|FG001|Overall Study|Sponsor terminated study|4
2160961|NCT01252238|3777848|FG002|Overall Study|Sponsor terminated study|4
2160962|NCT01252251|3777859|FG000|Overall Study|Withdrawal by Subject|1
2160963|NCT01252290|3777868|FG000|Overall Study|Withdrawal by Subject|1
2160964|NCT01252355|3777875|FG000|Overall Study|Adverse Event|9
2160965|NCT01252355|3777876|FG001|Overall Study|Adverse Event|17
2160966|NCT01252355|3777877|FG002|Overall Study|Adverse Event|22
2160967|NCT01252355|3777875|FG000|Overall Study|Lack of Efficacy|6
2160968|NCT01252355|3777876|FG001|Overall Study|Lack of Efficacy|4
2160969|NCT01252355|3777877|FG002|Overall Study|Lack of Efficacy|2
2160970|NCT01252355|3777875|FG000|Overall Study|Lost to Follow-up|0
2160971|NCT01252355|3777876|FG001|Overall Study|Lost to Follow-up|0
2160972|NCT01252355|3777877|FG002|Overall Study|Lost to Follow-up|1
2160973|NCT01252355|3777875|FG000|Overall Study|Poor Compliance to Protocol|1
2160974|NCT01252355|3777876|FG001|Overall Study|Poor Compliance to Protocol|1
2160975|NCT01252355|3777877|FG002|Overall Study|Poor Compliance to Protocol|1
2160976|NCT01252355|3777875|FG000|Overall Study|Progressive Disease|2
2160977|NCT01252355|3777876|FG001|Overall Study|Progressive Disease|0
2160978|NCT01252355|3777877|FG002|Overall Study|Progressive Disease|0
2160979|NCT01252355|3777875|FG000|Overall Study|Sponsor Early Termination of Study|149
2160980|NCT01252355|3777876|FG001|Overall Study|Sponsor Early Termination of Study|149
2160981|NCT01252355|3777877|FG002|Overall Study|Sponsor Early Termination of Study|146
2160982|NCT01252355|3777875|FG000|Overall Study|Randomized but not Treated|2
2160983|NCT01252355|3777876|FG001|Overall Study|Randomized but not Treated|0
2160984|NCT01252355|3777877|FG002|Overall Study|Randomized but not Treated|0
2160985|NCT01252355|3777875|FG000|Overall Study|Other Than Above|8
2160986|NCT01252355|3777876|FG001|Overall Study|Other Than Above|7
2160987|NCT01252355|3777877|FG002|Overall Study|Other Than Above|7
2160988|NCT01252563|3777885|FG000|Overall Study|Contract Deviation|41
2160989|NCT01252563|3777885|FG000|Overall Study|Centralized Registration Deviation|30
2160990|NCT01252563|3777885|FG000|Overall Study|Lost to Follow-up|161
2160991|NCT01252563|3777885|FG000|Overall Study|No visit after first day of treatment|194
2160992|NCT01252563|3777885|FG000|Overall Study|No drug administration|6
2160993|NCT01252667|3777926|FG000|Overall Study|Transplant aborted post-conditioning|0
2160994|NCT01252667|3777927|FG001|Overall Study|Transplant aborted post-conditioning|0
2160995|NCT01252667|3777928|FG002|Overall Study|Transplant aborted post-conditioning|0
2160996|NCT01252667|3777929|FG003|Overall Study|Transplant aborted post-conditioning|0
2160997|NCT01252667|3777930|FG004|Overall Study|Transplant aborted post-conditioning|0
2160998|NCT01252667|3777931|FG005|Overall Study|Transplant aborted post-conditioning|1
2160999|NCT01252810|3777972|FG000|Overall Study|Withdrawal by Subject|4
2161000|NCT01252810|3777973|FG001|Overall Study|Withdrawal by Subject|1
2161001|NCT01252810|3777972|FG000|Overall Study|Lost to Follow-up|0
2161002|NCT01252810|3777973|FG001|Overall Study|Lost to Follow-up|1
2161003|NCT01252810|3777972|FG000|Overall Study|Physician Decision|2
2161004|NCT01252810|3777973|FG001|Overall Study|Physician Decision|1
2161005|NCT01252810|3777972|FG000|Overall Study|Various reasons|8
2161006|NCT01252810|3777973|FG001|Overall Study|Various reasons|0
2161007|NCT01252940|3777981|FG000|Main Study Phase|Randomized but not treated|4
2161008|NCT01252940|3777982|FG001|Main Study Phase|Randomized but not treated|2
2161009|NCT01252940|3777981|FG000|Main Study Phase|Adverse Event|3
2161010|NCT01252940|3777982|FG001|Main Study Phase|Adverse Event|1
2161011|NCT01252940|3777981|FG000|Main Study Phase|Lack of Efficacy|1
2161012|NCT01252940|3777982|FG001|Main Study Phase|Lack of Efficacy|0
2161013|NCT01252940|3777981|FG000|Main Study Phase|Lost to Follow-up|6
2161014|NCT01252940|3777982|FG001|Main Study Phase|Lost to Follow-up|1
2161015|NCT01252940|3777981|FG000|Main Study Phase|Physician Decision|1
2161016|NCT01252940|3777982|FG001|Main Study Phase|Physician Decision|0
2161017|NCT01252940|3777981|FG000|Main Study Phase|Protocol Violation|4
2161018|NCT01252940|3777982|FG001|Main Study Phase|Protocol Violation|2
2161019|NCT01252940|3777981|FG000|Main Study Phase|Withdrawal by Subject|6
2161020|NCT01252940|3777982|FG001|Main Study Phase|Withdrawal by Subject|5
2161021|NCT01252940|3777981|FG000|Main Study Phase|Subject Non-compliance|1
2161022|NCT01252940|3777982|FG001|Main Study Phase|Subject Non-compliance|1
2161023|NCT01252940|3777981|FG000|Extension Phase|Adverse Event|2
2161024|NCT01252940|3777982|FG001|Extension Phase|Adverse Event|1
2161025|NCT01252940|3777981|FG000|Extension Phase|Lack of Efficacy|1
2161026|NCT01252940|3777982|FG001|Extension Phase|Lack of Efficacy|0
2161027|NCT01252940|3777981|FG000|Extension Phase|Lost to Follow-up|5
2161028|NCT01252940|3777982|FG001|Extension Phase|Lost to Follow-up|0
2161029|NCT01252940|3777981|FG000|Extension Phase|Physician Decision|0
2161030|NCT01252940|3777982|FG001|Extension Phase|Physician Decision|1
2161031|NCT01252940|3777981|FG000|Extension Phase|Subject Non-compliance|1
2161032|NCT01252940|3777982|FG001|Extension Phase|Subject Non-compliance|0
2161033|NCT01252940|3777981|FG000|Extension Phase|Withdrawal by Subject|1
2161034|NCT01252940|3777982|FG001|Extension Phase|Withdrawal by Subject|1
2161035|NCT01252953|3777991|FG000|Overall Study|Withdrawal by Subject|16
2161036|NCT01252953|3777992|FG001|Overall Study|Withdrawal by Subject|17
2161037|NCT01252953|3777991|FG000|Overall Study|Lost to Follow-up|22
2161038|NCT01252953|3777992|FG001|Overall Study|Lost to Follow-up|21
2161039|NCT01252966|3778001|FG000|Overall Study|Lost to Follow-up|16
2161040|NCT01252966|3778002|FG001|Overall Study|Lost to Follow-up|10
2161041|NCT01252966|3778001|FG000|Overall Study|Withdrawal by Subject|7
2161042|NCT01252966|3778002|FG001|Overall Study|Withdrawal by Subject|3
2161043|NCT01253018|3778012|FG000|Overall Study|Lost to Follow-up|1
2161044|NCT01253018|3778013|FG001|Overall Study|Lost to Follow-up|1
2161045|NCT01253018|3778012|FG000|Overall Study|Robot Repair Issues|2
2161046|NCT01253018|3778013|FG001|Overall Study|Robot Repair Issues|0
2161047|NCT01253018|3778012|FG000|Overall Study|Withdrawal by Subject|1
2161048|NCT01253018|3778013|FG001|Overall Study|Withdrawal by Subject|1
2161049|NCT01253044|3778022|FG000|Overall Study|Lost to Follow-up|38
2161050|NCT01253044|3778023|FG001|Overall Study|Lost to Follow-up|29
2161051|NCT01253135|3778034|FG000|Original Protocol|Protocol Amendment|15
2161052|NCT01253135|3778034|FG000|Amended Protocol|Non-compliance|1
2161053|NCT01253174|3778046|FG000|Period 1|Randomized but not treated|0
2161054|NCT01253174|3778047|FG001|Period 1|Randomized but not treated|1
2161055|NCT01253174|3778048|FG002|Period 1|Randomized but not treated|1
2161056|NCT01253174|3778049|FG003|Period 1|Randomized but not treated|0
2161057|NCT01253174|3778050|FG004|Period 1|Randomized but not treated|1
2161058|NCT01253174|3778051|FG005|Period 1|Randomized but not treated|0
2161059|NCT01253174|3778046|FG000|Period 2|Adverse Event|0
2161060|NCT01253174|3778047|FG001|Period 2|Adverse Event|0
2161061|NCT01253174|3778048|FG002|Period 2|Adverse Event|1
2161062|NCT01253174|3778049|FG003|Period 2|Adverse Event|0
2161063|NCT01253174|3778050|FG004|Period 2|Adverse Event|0
2161064|NCT01253174|3778051|FG005|Period 2|Adverse Event|0
2161065|NCT01253174|3778046|FG000|Period 3|Withdrawal by Subject|0
2161066|NCT01253174|3778047|FG001|Period 3|Withdrawal by Subject|1
2161067|NCT01253174|3778048|FG002|Period 3|Withdrawal by Subject|0
2161068|NCT01253174|3778049|FG003|Period 3|Withdrawal by Subject|0
2161069|NCT01253174|3778050|FG004|Period 3|Withdrawal by Subject|1
2161070|NCT01253174|3778051|FG005|Period 3|Withdrawal by Subject|0
2161071|NCT01253174|3778046|FG000|Period 3|Pregnancy|0
2161072|NCT01253174|3778047|FG001|Period 3|Pregnancy|0
2161073|NCT01253174|3778048|FG002|Period 3|Pregnancy|1
2161074|NCT01253174|3778049|FG003|Period 3|Pregnancy|0
2161075|NCT01253174|3778050|FG004|Period 3|Pregnancy|0
2161076|NCT01253174|3778051|FG005|Period 3|Pregnancy|0
2179446|NCT01393899|3804979|FG002|Overall Study|Adverse Event|3
2179447|NCT01393964|3804992|FG000|Overall Study|Disease Progression|4
2179448|NCT01393964|3804993|FG001|Overall Study|Disease Progression|3
2179449|NCT01393964|3804994|FG002|Overall Study|Disease Progression|5
2179450|NCT01393964|3804992|FG000|Overall Study|Study drug toxicity|1
2179451|NCT01393964|3804993|FG001|Overall Study|Study drug toxicity|0
2179452|NCT01393964|3804994|FG002|Overall Study|Study drug toxicity|0
2179453|NCT01393964|3804992|FG000|Overall Study|Withdrawal by Subject|0
2179454|NCT01393964|3804993|FG001|Overall Study|Withdrawal by Subject|0
2179455|NCT01393964|3804994|FG002|Overall Study|Withdrawal by Subject|1
2179456|NCT01393964|3804992|FG000|Overall Study|Adverse event unrelated to study drug|0
2179457|NCT01393964|3804993|FG001|Overall Study|Adverse event unrelated to study drug|3
2179458|NCT01393964|3804994|FG002|Overall Study|Adverse event unrelated to study drug|0
2179459|NCT01393964|3804992|FG000|Overall Study|Subject request stop study treatment|0
2179460|NCT01393964|3804993|FG001|Overall Study|Subject request stop study treatment|1
2179461|NCT01393964|3804994|FG002|Overall Study|Subject request stop study treatment|0
2179462|NCT01393964|3804992|FG000|Overall Study|Subject decided to move to transplant|1
2179463|NCT01393964|3804993|FG001|Overall Study|Subject decided to move to transplant|0
2179464|NCT01393964|3804994|FG002|Overall Study|Subject decided to move to transplant|0
2179465|NCT01393964|3804992|FG000|Overall Study|Subject switched to commercial supply|1
2179466|NCT01393964|3804993|FG001|Overall Study|Subject switched to commercial supply|0
2179467|NCT01393964|3804994|FG002|Overall Study|Subject switched to commercial supply|2
2179468|NCT01393964|3804992|FG000|Overall Study|Subject plateaued in terms of effect|1
2179469|NCT01393964|3804993|FG001|Overall Study|Subject plateaued in terms of effect|0
2179470|NCT01393964|3804994|FG002|Overall Study|Subject plateaued in terms of effect|0
2179471|NCT01393964|3804992|FG000|Overall Study|Investigator removed subject from study|0
2179472|NCT01393964|3804993|FG001|Overall Study|Investigator removed subject from study|1
2179473|NCT01393964|3804994|FG002|Overall Study|Investigator removed subject from study|0
2179474|NCT01393964|3804992|FG000|Overall Study|Subject converted to roll-over study|0
2179475|NCT01393964|3804993|FG001|Overall Study|Subject converted to roll-over study|1
2179476|NCT01393964|3804994|FG002|Overall Study|Subject converted to roll-over study|0
2293911|NCT02531373|3988345|FG001|Overall Study|Withdrawal by Parent/Guardian|0
2293912|NCT02531373|3988346|FG002|Overall Study|Withdrawal by Parent/Guardian|0
2293913|NCT02531373|3988347|FG003|Overall Study|Withdrawal by Parent/Guardian|0
2293914|NCT02531373|3988348|FG004|Overall Study|Withdrawal by Parent/Guardian|0
2293915|NCT02531373|3988349|FG005|Overall Study|Withdrawal by Parent/Guardian|3
2293916|NCT02531373|3988350|FG006|Overall Study|Withdrawal by Parent/Guardian|4
2293917|NCT02531373|3988351|FG007|Overall Study|Withdrawal by Parent/Guardian|1
2293918|NCT02531373|3988352|FG008|Overall Study|Withdrawal by Parent/Guardian|3
2293919|NCT02531373|3988344|FG000|Overall Study|Withdrawal by Subject|0
2293920|NCT02531373|3988345|FG001|Overall Study|Withdrawal by Subject|0
2293921|NCT02531373|3988346|FG002|Overall Study|Withdrawal by Subject|0
2293922|NCT02531373|3988347|FG003|Overall Study|Withdrawal by Subject|0
2293923|NCT02531373|3988348|FG004|Overall Study|Withdrawal by Subject|3
2161077|NCT01253187|3778060|FG000|Period 2|Withdrawal by Subject|0
2161078|NCT01253187|3778061|FG001|Period 2|Withdrawal by Subject|0
2161079|NCT01253187|3778062|FG002|Period 2|Withdrawal by Subject|0
2161080|NCT01253187|3778063|FG003|Period 2|Withdrawal by Subject|0
2161081|NCT01253187|3778064|FG004|Period 2|Withdrawal by Subject|1
2161082|NCT01253187|3778065|FG005|Period 2|Withdrawal by Subject|0
2161083|NCT01253187|3778060|FG000|Period 3|Pregnancy|1
2161084|NCT01253187|3778061|FG001|Period 3|Pregnancy|0
2161085|NCT01253187|3778062|FG002|Period 3|Pregnancy|0
2161086|NCT01253187|3778063|FG003|Period 3|Pregnancy|0
2161087|NCT01253187|3778064|FG004|Period 3|Pregnancy|0
2161088|NCT01253187|3778065|FG005|Period 3|Pregnancy|0
2161089|NCT01253187|3778060|FG000|Period 3|difficulty with blood sampling|0
2161090|NCT01253187|3778061|FG001|Period 3|difficulty with blood sampling|1
2161091|NCT01253187|3778062|FG002|Period 3|difficulty with blood sampling|0
2161092|NCT01253187|3778063|FG003|Period 3|difficulty with blood sampling|0
2161093|NCT01253187|3778064|FG004|Period 3|difficulty with blood sampling|0
2161094|NCT01253187|3778065|FG005|Period 3|difficulty with blood sampling|0
2161095|NCT01253187|3778060|FG000|Period 3|non-compliance|0
2161096|NCT01253187|3778061|FG001|Period 3|non-compliance|0
2161097|NCT01253187|3778062|FG002|Period 3|non-compliance|0
2161098|NCT01253187|3778063|FG003|Period 3|non-compliance|0
2161099|NCT01253187|3778064|FG004|Period 3|non-compliance|1
2161100|NCT01253187|3778065|FG005|Period 3|non-compliance|0
2161101|NCT01253200|3778081|FG000|Overall Study|Death|1
2161102|NCT01253200|3778082|FG001|Overall Study|Death|0
2161103|NCT01253200|3778083|FG002|Overall Study|Death|0
2161104|NCT01253200|3778084|FG003|Overall Study|Death|0
2161105|NCT01253200|3778085|FG004|Overall Study|Death|0
2161106|NCT01253200|3778081|FG000|Overall Study|Lost to Follow-up|1
2161107|NCT01253200|3778082|FG001|Overall Study|Lost to Follow-up|1
2161108|NCT01253200|3778083|FG002|Overall Study|Lost to Follow-up|0
2161109|NCT01253200|3778084|FG003|Overall Study|Lost to Follow-up|0
2161110|NCT01253200|3778085|FG004|Overall Study|Lost to Follow-up|0
2161111|NCT01253200|3778081|FG000|Overall Study|Withdrawal by Subject|2
2161112|NCT01253200|3778082|FG001|Overall Study|Withdrawal by Subject|0
2161113|NCT01253200|3778083|FG002|Overall Study|Withdrawal by Subject|0
2161114|NCT01253200|3778084|FG003|Overall Study|Withdrawal by Subject|0
2161115|NCT01253200|3778085|FG004|Overall Study|Withdrawal by Subject|0
2161116|NCT01253200|3778081|FG000|Overall Study|Protocol Violation|1
2161117|NCT01253200|3778082|FG001|Overall Study|Protocol Violation|4
2161118|NCT01253200|3778083|FG002|Overall Study|Protocol Violation|0
2161119|NCT01253200|3778084|FG003|Overall Study|Protocol Violation|0
2161120|NCT01253200|3778085|FG004|Overall Study|Protocol Violation|5
2161121|NCT01253200|3778081|FG000|Overall Study|intents|10
2161122|NCT01253200|3778082|FG001|Overall Study|intents|10
2161123|NCT01253200|3778083|FG002|Overall Study|intents|1
2161124|NCT01253200|3778084|FG003|Overall Study|intents|3
2161125|NCT01253200|3778085|FG004|Overall Study|intents|0
2161126|NCT01253200|3778081|FG000|Overall Study|Attempts|6
2161127|NCT01253200|3778082|FG001|Overall Study|Attempts|4
2161128|NCT01253200|3778083|FG002|Overall Study|Attempts|1
2161129|NCT01253200|3778084|FG003|Overall Study|Attempts|2
2161130|NCT01253200|3778085|FG004|Overall Study|Attempts|0
2161131|NCT01253226|3778099|FG000|Overall Study|Adverse Event|0
2161132|NCT01253226|3778100|FG001|Overall Study|Adverse Event|0
2161133|NCT01253226|3778101|FG002|Overall Study|Adverse Event|1
2161134|NCT01253226|3778102|FG003|Overall Study|Adverse Event|0
2161135|NCT01253226|3778103|FG004|Overall Study|Adverse Event|0
2161136|NCT01253226|3778099|FG000|Overall Study|Death|0
2161137|NCT01253226|3778100|FG001|Overall Study|Death|1
2161138|NCT01253226|3778101|FG002|Overall Study|Death|0
2161139|NCT01253226|3778102|FG003|Overall Study|Death|0
2161140|NCT01253226|3778103|FG004|Overall Study|Death|0
2161141|NCT01253226|3778099|FG000|Overall Study|Physician Decision|0
2161142|NCT01253226|3778100|FG001|Overall Study|Physician Decision|0
2161143|NCT01253226|3778101|FG002|Overall Study|Physician Decision|0
2161144|NCT01253226|3778102|FG003|Overall Study|Physician Decision|0
2161145|NCT01253226|3778103|FG004|Overall Study|Physician Decision|2
2161146|NCT01253226|3778099|FG000|Overall Study|Withdrawal by Subject|0
2161147|NCT01253226|3778100|FG001|Overall Study|Withdrawal by Subject|0
2161148|NCT01253226|3778101|FG002|Overall Study|Withdrawal by Subject|0
2161149|NCT01253226|3778102|FG003|Overall Study|Withdrawal by Subject|1
2161150|NCT01253226|3778103|FG004|Overall Study|Withdrawal by Subject|0
2161151|NCT01253265|3778120|FG000|Overall Study|Met Predefined Discontinuation Criteria|1
2161152|NCT01253265|3778121|FG001|Overall Study|Met Predefined Discontinuation Criteria|0
2161153|NCT01253265|3778122|FG002|Overall Study|Met Predefined Discontinuation Criteria|0
2161154|NCT01253265|3778123|FG003|Overall Study|Met Predefined Discontinuation Criteria|0
2161155|NCT01253265|3778124|FG004|Overall Study|Met Predefined Discontinuation Criteria|0
2161156|NCT01253265|3778120|FG000|Overall Study|Withdrawal by Subject|0
2161157|NCT01253265|3778121|FG001|Overall Study|Withdrawal by Subject|0
2161158|NCT01253265|3778122|FG002|Overall Study|Withdrawal by Subject|0
2161159|NCT01253265|3778123|FG003|Overall Study|Withdrawal by Subject|0
2161160|NCT01253265|3778124|FG004|Overall Study|Withdrawal by Subject|1
2161161|NCT01253291|3778141|FG000|Overall Study|Withdrawal by Subject|1
2161162|NCT01253291|3778142|FG001|Overall Study|Withdrawal by Subject|1
2161163|NCT01253291|3778143|FG002|Overall Study|Withdrawal by Subject|0
2161164|NCT01253291|3778144|FG003|Overall Study|Withdrawal by Subject|0
2161165|NCT01253291|3778145|FG004|Overall Study|Withdrawal by Subject|0
2161166|NCT01253291|3778141|FG000|Overall Study|Adverse Event|0
2161167|NCT01253291|3778142|FG001|Overall Study|Adverse Event|1
2161168|NCT01253291|3778143|FG002|Overall Study|Adverse Event|0
2161169|NCT01253291|3778144|FG003|Overall Study|Adverse Event|0
2161170|NCT01253291|3778145|FG004|Overall Study|Adverse Event|0
2161171|NCT01253291|3778141|FG000|Overall Study|Lack of Efficacy|1
2161172|NCT01253291|3778142|FG001|Overall Study|Lack of Efficacy|0
2161173|NCT01253291|3778143|FG002|Overall Study|Lack of Efficacy|0
2161174|NCT01253291|3778144|FG003|Overall Study|Lack of Efficacy|0
2161175|NCT01253291|3778145|FG004|Overall Study|Lack of Efficacy|0
2161176|NCT01253291|3778141|FG000|Overall Study|Physician Decision|2
2161177|NCT01253291|3778142|FG001|Overall Study|Physician Decision|0
2161178|NCT01253291|3778143|FG002|Overall Study|Physician Decision|0
2161179|NCT01253291|3778144|FG003|Overall Study|Physician Decision|0
2161180|NCT01253291|3778145|FG004|Overall Study|Physician Decision|2
2161181|NCT01253304|3778162|FG000|Overall Study|Adverse Event|0
2161182|NCT01253304|3778163|FG001|Overall Study|Adverse Event|0
2161183|NCT01253304|3778164|FG002|Overall Study|Adverse Event|0
2161184|NCT01253304|3778165|FG003|Overall Study|Adverse Event|1
2161185|NCT01253317|3778175|FG000|Overall Study|Adverse Event|2
2161186|NCT01253369|3778208|FG000|Overall Study|Adverse Event|4
2161187|NCT01253369|3778208|FG000|Overall Study|Withdrawal by Subject|2
2161188|NCT01253369|3778208|FG000|Overall Study|Death|1
2161189|NCT01253369|3778208|FG000|Overall Study|Progressive disease|23
2161190|NCT01253369|3778208|FG000|Overall Study|Not Evaluable|3
2161191|NCT01253408|3778215|FG000|Overall Study|Adverse Event|0
2161192|NCT01253408|3778216|FG001|Overall Study|Adverse Event|1
2161193|NCT01253408|3778217|FG002|Overall Study|Adverse Event|0
2161194|NCT01253421|3778229|FG000|Assessment and Scheduling|Found to be Ineligible|74
2161195|NCT01253421|3778230|FG001|Assessment and Scheduling|Found to be Ineligible|0
2161196|NCT01253421|3778231|FG002|Assessment and Scheduling|Found to be Ineligible|0
2161197|NCT01253421|3778232|FG003|Assessment and Scheduling|Found to be Ineligible|0
2161198|NCT01253421|3778233|FG004|Assessment and Scheduling|Found to be Ineligible|0
2161199|NCT01253421|3778229|FG000|Assessment and Scheduling|Lost to Follow-up|17
2161200|NCT01253421|3778230|FG001|Assessment and Scheduling|Lost to Follow-up|0
2161201|NCT01253421|3778231|FG002|Assessment and Scheduling|Lost to Follow-up|0
2161202|NCT01253421|3778232|FG003|Assessment and Scheduling|Lost to Follow-up|0
2161203|NCT01253421|3778233|FG004|Assessment and Scheduling|Lost to Follow-up|0
2161204|NCT01253421|3778229|FG000|Assessment and Scheduling|Withdrawal by Subject|7
2161205|NCT01253421|3778230|FG001|Assessment and Scheduling|Withdrawal by Subject|0
2161206|NCT01253421|3778231|FG002|Assessment and Scheduling|Withdrawal by Subject|0
2161207|NCT01253421|3778232|FG003|Assessment and Scheduling|Withdrawal by Subject|0
2161208|NCT01253421|3778233|FG004|Assessment and Scheduling|Withdrawal by Subject|0
2161209|NCT01253421|3778229|FG000|Assessment and Scheduling|Physician Decision|1
2161210|NCT01253421|3778230|FG001|Assessment and Scheduling|Physician Decision|0
2161211|NCT01253421|3778231|FG002|Assessment and Scheduling|Physician Decision|0
2161212|NCT01253421|3778232|FG003|Assessment and Scheduling|Physician Decision|0
2161213|NCT01253421|3778233|FG004|Assessment and Scheduling|Physician Decision|0
2161214|NCT01253421|3778229|FG000|Drug+Scanning Visit|Physician Decision|0
2161215|NCT01253421|3778230|FG001|Drug+Scanning Visit|Physician Decision|0
2161216|NCT01253421|3778231|FG002|Drug+Scanning Visit|Physician Decision|0
2161217|NCT01253421|3778232|FG003|Drug+Scanning Visit|Physician Decision|0
2161218|NCT01253421|3778233|FG004|Drug+Scanning Visit|Physician Decision|1
2161219|NCT01253447|3778243|FG000|Overall Study|Adverse Event|2
2161220|NCT01253564|3778256|FG000|Overall Study|Disease Progression|22
2161221|NCT01253564|3778256|FG000|Overall Study|Withdrawal by Subject|1
2161222|NCT01253564|3778256|FG000|Overall Study|Serious Adverse Event|1
2161223|NCT01253577|3778260|FG000|Overall Study|Lost to Follow-up|3
2161224|NCT01253811|3778271|FG000|Overall Study|Withdrawal criteria|1
2161225|NCT01254019|3778308|FG000|Overall Study|Adverse Event|0
2161226|NCT01254019|3778309|FG001|Overall Study|Adverse Event|2
2161227|NCT01254019|3778308|FG000|Overall Study|Protocol Violation|1
2161228|NCT01254019|3778309|FG001|Overall Study|Protocol Violation|0
2161229|NCT01254019|3778308|FG000|Overall Study|Withdrawal by Subject|0
2161230|NCT01254019|3778309|FG001|Overall Study|Withdrawal by Subject|2
2161231|NCT01254045|3778318|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
2161232|NCT01254045|3778319|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2161233|NCT01254045|3778320|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2161234|NCT01254045|3778321|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2161235|NCT01254045|3778322|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2161236|NCT01254045|3778323|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2161237|NCT01254188|3778333|FG000|Overall Study|Disease Progression|6
2161238|NCT01254188|3778333|FG000|Overall Study|Protocol Violation|6
2161239|NCT01254188|3778333|FG000|Overall Study|Pregnancy|2
2161240|NCT01254188|3778333|FG000|Overall Study|Death|4
2161241|NCT01254188|3778333|FG000|Overall Study|Lost to Follow-up|5
2161242|NCT01254188|3778333|FG000|Overall Study|Withdrawal by Subject|7
2161243|NCT01254188|3778333|FG000|Overall Study|Adverse Event|43
2161244|NCT01254188|3778333|FG000|Overall Study|per investigator discretion|20
2161245|NCT01254227|3778346|FG000|Overall Study|Withdrawal by Subject|6
2161246|NCT01254227|3778346|FG000|Overall Study|Lost to Follow-up|6
2161247|NCT01254227|3778346|FG000|Overall Study|Adverse Event|5
2161248|NCT01254227|3778346|FG000|Overall Study|Abnormal test procedure result|5
2161249|NCT01254227|3778346|FG000|Overall Study|Administrative problems|2
2161250|NCT01254227|3778346|FG000|Overall Study|Death|1
2161251|NCT01254227|3778346|FG000|Overall Study|Protocol deviation|1
2161252|NCT01254292|3778352|FG000|Comparative Phase|Adverse Event|25
2161253|NCT01254292|3778353|FG001|Comparative Phase|Adverse Event|25
2161254|NCT01254292|3778352|FG000|Comparative Phase|Lost to Follow-up|3
2161255|NCT01254292|3778353|FG001|Comparative Phase|Lost to Follow-up|21
2161256|NCT01254292|3778352|FG000|Comparative Phase|Pregnancy|2
2161257|NCT01254292|3778353|FG001|Comparative Phase|Pregnancy|6
2161258|NCT01254292|3778352|FG000|Comparative Phase|Withdrawal by Subject|20
2161259|NCT01254292|3778353|FG001|Comparative Phase|Withdrawal by Subject|21
2161260|NCT01254292|3778352|FG000|Comparative Phase|Protocol Violation|1
2161261|NCT01254292|3778353|FG001|Comparative Phase|Protocol Violation|2
2161262|NCT01254292|3778352|FG000|Comparative Phase|Wish for pregnancy|4
2161263|NCT01254292|3778353|FG001|Comparative Phase|Wish for pregnancy|6
2161264|NCT01254292|3778352|FG000|LCS12 Extension Phase|Wish for pregnancy|14
2161265|NCT01254292|3778353|FG001|LCS12 Extension Phase|Wish for pregnancy|0
2161266|NCT01254292|3778352|FG000|LCS12 Extension Phase|Adverse Event|9
2161267|NCT01254292|3778353|FG001|LCS12 Extension Phase|Adverse Event|0
2161268|NCT01254292|3778352|FG000|LCS12 Extension Phase|Withdrawal by Subject|7
2161269|NCT01254292|3778353|FG001|LCS12 Extension Phase|Withdrawal by Subject|0
2161270|NCT01254292|3778352|FG000|LCS12 Extension Phase|Other unknown|4
2161271|NCT01254292|3778353|FG001|LCS12 Extension Phase|Other unknown|0
2161272|NCT01254292|3778352|FG000|LCS12 Extension Phase|Pregnancy|2
2161273|NCT01254292|3778353|FG001|LCS12 Extension Phase|Pregnancy|0
2293924|NCT02531373|3988349|FG005|Overall Study|Withdrawal by Subject|0
2293925|NCT02531373|3988350|FG006|Overall Study|Withdrawal by Subject|0
2293926|NCT02531373|3988351|FG007|Overall Study|Withdrawal by Subject|0
2293927|NCT02531373|3988352|FG008|Overall Study|Withdrawal by Subject|0
2293928|NCT02531438|3988375|FG000|Overall Study|Adverse Event|7
2293929|NCT02531438|3988376|FG001|Overall Study|Adverse Event|9
2293930|NCT02531438|3988375|FG000|Overall Study|Lost to Follow-up|0
2293931|NCT02531438|3988376|FG001|Overall Study|Lost to Follow-up|3
2293932|NCT02531438|3988375|FG000|Overall Study|Withdrawal by Subject|7
2293933|NCT02531438|3988376|FG001|Overall Study|Withdrawal by Subject|8
2293934|NCT02531438|3988375|FG000|Overall Study|Physician Decision|0
2293935|NCT02531438|3988376|FG001|Overall Study|Physician Decision|1
2293936|NCT02531438|3988375|FG000|Overall Study|Death|6
2293937|NCT02531438|3988376|FG001|Overall Study|Death|3
2293938|NCT02531438|3988375|FG000|Overall Study|Randomized, but Not Treated|4
2293939|NCT02531438|3988376|FG001|Overall Study|Randomized, but Not Treated|0
2293940|NCT02531438|3988375|FG000|Overall Study|Missed EOT/PTE Visit|5
2293941|NCT02531438|3988376|FG001|Overall Study|Missed EOT/PTE Visit|2
2293942|NCT02531438|3988375|FG000|Overall Study|Randomized with Exclusion Criteria|1
2293943|NCT02531438|3988376|FG001|Overall Study|Randomized with Exclusion Criteria|0
2293944|NCT02531633|3988387|FG000|Part A (52 Weeks)|Sponsor request|24
2293945|NCT02531633|3988388|FG001|Part A (52 Weeks)|Sponsor request|24
2293946|NCT02531633|3988389|FG002|Part A (52 Weeks)|Sponsor request|18
2293947|NCT02531633|3988390|FG003|Part A (52 Weeks)|Sponsor request|18
2293948|NCT02531633|3988391|FG004|Part A (52 Weeks)|Sponsor request|19
2293949|NCT02531633|3988392|FG005|Part A (52 Weeks)|Sponsor request|0
2293950|NCT02531633|3988393|FG006|Part A (52 Weeks)|Sponsor request|0
2293951|NCT02531633|3988394|FG007|Part A (52 Weeks)|Sponsor request|0
2293952|NCT02531633|3988395|FG008|Part A (52 Weeks)|Sponsor request|0
2293953|NCT02531633|3988396|FG009|Part A (52 Weeks)|Sponsor request|0
2293954|NCT02531633|3988387|FG000|Part A (52 Weeks)|Protocol Violation|1
2293955|NCT02531633|3988388|FG001|Part A (52 Weeks)|Protocol Violation|0
2293956|NCT02531633|3988389|FG002|Part A (52 Weeks)|Protocol Violation|0
2293957|NCT02531633|3988390|FG003|Part A (52 Weeks)|Protocol Violation|0
2293958|NCT02531633|3988391|FG004|Part A (52 Weeks)|Protocol Violation|0
2293959|NCT02531633|3988392|FG005|Part A (52 Weeks)|Protocol Violation|0
2293960|NCT02531633|3988393|FG006|Part A (52 Weeks)|Protocol Violation|0
2293961|NCT02531633|3988394|FG007|Part A (52 Weeks)|Protocol Violation|0
2293962|NCT02531633|3988395|FG008|Part A (52 Weeks)|Protocol Violation|0
2293963|NCT02531633|3988396|FG009|Part A (52 Weeks)|Protocol Violation|0
2293964|NCT02531633|3988387|FG000|Part A (52 Weeks)|Lost to Follow-up|0
2293965|NCT02531633|3988388|FG001|Part A (52 Weeks)|Lost to Follow-up|0
2293966|NCT02531633|3988389|FG002|Part A (52 Weeks)|Lost to Follow-up|0
2293967|NCT02531633|3988390|FG003|Part A (52 Weeks)|Lost to Follow-up|0
2293968|NCT02531633|3988391|FG004|Part A (52 Weeks)|Lost to Follow-up|1
2293969|NCT02531633|3988392|FG005|Part A (52 Weeks)|Lost to Follow-up|0
2293970|NCT02531633|3988393|FG006|Part A (52 Weeks)|Lost to Follow-up|0
2293971|NCT02531633|3988394|FG007|Part A (52 Weeks)|Lost to Follow-up|0
2293972|NCT02531633|3988395|FG008|Part A (52 Weeks)|Lost to Follow-up|0
2293973|NCT02531633|3988396|FG009|Part A (52 Weeks)|Lost to Follow-up|0
2293974|NCT02531633|3988387|FG000|Part A (52 Weeks)|Physician Decision|1
2293975|NCT02531633|3988388|FG001|Part A (52 Weeks)|Physician Decision|4
2293976|NCT02531633|3988389|FG002|Part A (52 Weeks)|Physician Decision|3
2293977|NCT02531633|3988390|FG003|Part A (52 Weeks)|Physician Decision|1
2293978|NCT02531633|3988391|FG004|Part A (52 Weeks)|Physician Decision|0
2293979|NCT02531633|3988392|FG005|Part A (52 Weeks)|Physician Decision|0
2161274|NCT01254292|3778352|FG000|LCS12 Extension Phase|Lost to Follow-up|1
2161275|NCT01254292|3778353|FG001|LCS12 Extension Phase|Lost to Follow-up|0
2161276|NCT01254305|3778363|FG000|Overall Study|Adverse Event|6
2161277|NCT01254305|3778364|FG001|Overall Study|Adverse Event|3
2161278|NCT01254305|3778365|FG002|Overall Study|Adverse Event|2
2161279|NCT01254305|3778363|FG000|Overall Study|Lack of Efficacy|1
2161280|NCT01254305|3778364|FG001|Overall Study|Lack of Efficacy|0
2161281|NCT01254305|3778365|FG002|Overall Study|Lack of Efficacy|1
2161282|NCT01254305|3778363|FG000|Overall Study|Protocol Violation|1
2161283|NCT01254305|3778364|FG001|Overall Study|Protocol Violation|7
2161284|NCT01254305|3778365|FG002|Overall Study|Protocol Violation|3
2161285|NCT01254305|3778363|FG000|Overall Study|Withdrawal by Subject|4
2161286|NCT01254305|3778364|FG001|Overall Study|Withdrawal by Subject|2
2161287|NCT01254305|3778365|FG002|Overall Study|Withdrawal by Subject|4
2161288|NCT01254305|3778363|FG000|Overall Study|Lost to Follow-up|10
2161289|NCT01254305|3778364|FG001|Overall Study|Lost to Follow-up|6
2161290|NCT01254305|3778365|FG002|Overall Study|Lost to Follow-up|5
2161291|NCT01254305|3778363|FG000|Overall Study|Other Reasons|0
2161292|NCT01254305|3778364|FG001|Overall Study|Other Reasons|0
2161293|NCT01254305|3778365|FG002|Overall Study|Other Reasons|2
2161294|NCT01254318|3778376|FG000|Overall Study|Lost to Follow-up|5
2161295|NCT01254318|3778376|FG000|Overall Study|Death|47
2161296|NCT01254331|3778380|FG000|Initial Phase|Adverse Event|3
2161297|NCT01254331|3778380|FG000|Initial Phase|Withdrawal by Subject|1
2161298|NCT01254331|3778380|FG000|Initial Phase|Pregnancy|1
2161299|NCT01254331|3778380|FG000|Extension Phase|Lack of Efficacy|1
2161300|NCT01254331|3778380|FG000|Extension Phase|Lost to Follow-up|3
2161301|NCT01254344|3778386|FG000|Overall Study|Adverse Event|2
2161302|NCT01254344|3778387|FG001|Overall Study|Adverse Event|5
2161303|NCT01254344|3778386|FG000|Overall Study|Physician Decision|7
2161304|NCT01254344|3778387|FG001|Overall Study|Physician Decision|4
2161305|NCT01254344|3778386|FG000|Overall Study|Protocol Violation|1
2161306|NCT01254344|3778387|FG001|Overall Study|Protocol Violation|4
2161307|NCT01254344|3778386|FG000|Overall Study|Withdrawal by Subject|3
2161308|NCT01254344|3778387|FG001|Overall Study|Withdrawal by Subject|6
2161309|NCT01254409|3778404|FG000|Overall Study|Adverse Event|0
2161310|NCT01254409|3778405|FG001|Overall Study|Adverse Event|1
2161311|NCT01254409|3778406|FG002|Overall Study|Adverse Event|0
2161312|NCT01254409|3778407|FG003|Overall Study|Adverse Event|0
2161313|NCT01254422|3778422|FG000|Overall Study|Protocol Violation|1
2161314|NCT01254422|3778423|FG001|Overall Study|Protocol Violation|0
2161315|NCT01254422|3778422|FG000|Overall Study|Adverse Event|1
2161316|NCT01254422|3778423|FG001|Overall Study|Adverse Event|0
2161317|NCT01254422|3778422|FG000|Overall Study|Serious adverse event|0
2161318|NCT01254422|3778423|FG001|Overall Study|Serious adverse event|1
2161319|NCT01254422|3778422|FG000|Overall Study|Lost to Follow-up|1
2161320|NCT01254422|3778423|FG001|Overall Study|Lost to Follow-up|0
2161321|NCT01254565|3778443|FG000|Overall Study|Non-compliance to Study Procedures|0
2161322|NCT01254565|3778444|FG001|Overall Study|Non-compliance to Study Procedures|0
2161323|NCT01254565|3778445|FG002|Overall Study|Non-compliance to Study Procedures|0
2161324|NCT01254565|3778446|FG003|Overall Study|Non-compliance to Study Procedures|0
2161325|NCT01254565|3778447|FG004|Overall Study|Non-compliance to Study Procedures|1
2161326|NCT01254565|3778448|FG005|Overall Study|Non-compliance to Study Procedures|0
2161327|NCT01254565|3778443|FG000|Overall Study|Did not Receive Treatment|1
2161328|NCT01254565|3778444|FG001|Overall Study|Did not Receive Treatment|1
2161329|NCT01254565|3778445|FG002|Overall Study|Did not Receive Treatment|0
2161330|NCT01254565|3778446|FG003|Overall Study|Did not Receive Treatment|0
2161331|NCT01254565|3778447|FG004|Overall Study|Did not Receive Treatment|3
2161332|NCT01254565|3778448|FG005|Overall Study|Did not Receive Treatment|4
2161333|NCT01254565|3778443|FG000|Overall Study|Other|0
2161334|NCT01254565|3778444|FG001|Overall Study|Other|0
2161335|NCT01254565|3778445|FG002|Overall Study|Other|0
2161336|NCT01254565|3778446|FG003|Overall Study|Other|1
2161337|NCT01254565|3778447|FG004|Overall Study|Other|0
2161338|NCT01254565|3778448|FG005|Overall Study|Other|0
2161339|NCT01254604|3778464|FG000|Overall Study|Lost to Follow-up|1
2161340|NCT01254604|3778465|FG001|Overall Study|Lost to Follow-up|1
2161341|NCT01254604|3778464|FG000|Overall Study|Protocol Violation|2
2161342|NCT01254604|3778465|FG001|Overall Study|Protocol Violation|2
2161343|NCT01254604|3778464|FG000|Overall Study|Withdrawal by Subject|2
2161344|NCT01254604|3778465|FG001|Overall Study|Withdrawal by Subject|4
2161345|NCT01254604|3778464|FG000|Overall Study|Adverse Event|3
2161346|NCT01254604|3778465|FG001|Overall Study|Adverse Event|2
2161347|NCT01254630|3778475|FG000|Overall Study|Adverse Event|36
2293980|NCT02531633|3988393|FG006|Part A (52 Weeks)|Physician Decision|0
2293981|NCT02531633|3988394|FG007|Part A (52 Weeks)|Physician Decision|0
2293982|NCT02531633|3988395|FG008|Part A (52 Weeks)|Physician Decision|0
2293983|NCT02531633|3988396|FG009|Part A (52 Weeks)|Physician Decision|0
2293984|NCT02531633|3988387|FG000|Part A (52 Weeks)|Withdrawal by Subject|6
2161348|NCT01254630|3778476|FG001|Overall Study|Adverse Event|15
2161349|NCT01254630|3778477|FG002|Overall Study|Adverse Event|40
2161350|NCT01254630|3778478|FG003|Overall Study|Adverse Event|8
2161351|NCT01254630|3778475|FG000|Overall Study|Death|461
2161352|NCT01254630|3778476|FG001|Overall Study|Death|151
2161353|NCT01254630|3778477|FG002|Overall Study|Death|478
2293985|NCT02531633|3988388|FG001|Part A (52 Weeks)|Withdrawal by Subject|6
2161354|NCT01254630|3778478|FG003|Overall Study|Death|139
2161355|NCT01254630|3778475|FG000|Overall Study|Lost to Follow-up|80
2208166|NCT01636713|3847550|FG002|Overall Study|Withdrawal by Subject|8
2208167|NCT01636713|3847548|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2
2161356|NCT01254630|3778476|FG001|Overall Study|Lost to Follow-up|26
2161357|NCT01254630|3778477|FG002|Overall Study|Lost to Follow-up|89
2161358|NCT01254630|3778478|FG003|Overall Study|Lost to Follow-up|32
2161359|NCT01254630|3778475|FG000|Overall Study|Physician Decision|24
2161360|NCT01254630|3778476|FG001|Overall Study|Physician Decision|8
2161361|NCT01254630|3778477|FG002|Overall Study|Physician Decision|16
2161362|NCT01254630|3778478|FG003|Overall Study|Physician Decision|7
2161363|NCT01254630|3778475|FG000|Overall Study|Withdrawal by Subject|201
2161364|NCT01254630|3778476|FG001|Overall Study|Withdrawal by Subject|94
2161365|NCT01254630|3778477|FG002|Overall Study|Withdrawal by Subject|188
2161366|NCT01254630|3778478|FG003|Overall Study|Withdrawal by Subject|89
2161367|NCT01254630|3778475|FG000|Overall Study|Study terminated by sponsor|0
2161368|NCT01254630|3778476|FG001|Overall Study|Study terminated by sponsor|994
2161369|NCT01254630|3778477|FG002|Overall Study|Study terminated by sponsor|0
2293986|NCT02531633|3988389|FG002|Part A (52 Weeks)|Withdrawal by Subject|1
2293987|NCT02531633|3988390|FG003|Part A (52 Weeks)|Withdrawal by Subject|3
2293988|NCT02531633|3988391|FG004|Part A (52 Weeks)|Withdrawal by Subject|3
2293989|NCT02531633|3988392|FG005|Part A (52 Weeks)|Withdrawal by Subject|0
2293990|NCT02531633|3988393|FG006|Part A (52 Weeks)|Withdrawal by Subject|0
2293991|NCT02531633|3988394|FG007|Part A (52 Weeks)|Withdrawal by Subject|0
2293992|NCT02531633|3988395|FG008|Part A (52 Weeks)|Withdrawal by Subject|0
2293993|NCT02531633|3988396|FG009|Part A (52 Weeks)|Withdrawal by Subject|0
2293994|NCT02531633|3988387|FG000|Part A (52 Weeks)|Other|2
2293995|NCT02531633|3988388|FG001|Part A (52 Weeks)|Other|0
2293996|NCT02531633|3988389|FG002|Part A (52 Weeks)|Other|0
2293997|NCT02531633|3988390|FG003|Part A (52 Weeks)|Other|0
2293998|NCT02531633|3988391|FG004|Part A (52 Weeks)|Other|0
2293999|NCT02531633|3988392|FG005|Part A (52 Weeks)|Other|0
2294000|NCT02531633|3988393|FG006|Part A (52 Weeks)|Other|0
2294001|NCT02531633|3988394|FG007|Part A (52 Weeks)|Other|0
2294002|NCT02531633|3988395|FG008|Part A (52 Weeks)|Other|0
2294003|NCT02531633|3988396|FG009|Part A (52 Weeks)|Other|0
2294004|NCT02531633|3988387|FG000|Part B (104 Weeks)|Sponsor request|0
2294005|NCT02531633|3988388|FG001|Part B (104 Weeks)|Sponsor request|0
2294006|NCT02531633|3988389|FG002|Part B (104 Weeks)|Sponsor request|0
2294007|NCT02531633|3988390|FG003|Part B (104 Weeks)|Sponsor request|0
2294008|NCT02531633|3988391|FG004|Part B (104 Weeks)|Sponsor request|0
2294009|NCT02531633|3988392|FG005|Part B (104 Weeks)|Sponsor request|8
2294010|NCT02531633|3988393|FG006|Part B (104 Weeks)|Sponsor request|5
2294011|NCT02531633|3988394|FG007|Part B (104 Weeks)|Sponsor request|3
2294012|NCT02531633|3988395|FG008|Part B (104 Weeks)|Sponsor request|5
2294013|NCT02531633|3988396|FG009|Part B (104 Weeks)|Sponsor request|4
2294014|NCT02531633|3988387|FG000|Part B (104 Weeks)|Lost to Follow-up|0
2294015|NCT02531633|3988388|FG001|Part B (104 Weeks)|Lost to Follow-up|0
2294016|NCT02531633|3988389|FG002|Part B (104 Weeks)|Lost to Follow-up|0
2294017|NCT02531633|3988390|FG003|Part B (104 Weeks)|Lost to Follow-up|0
2294018|NCT02531633|3988391|FG004|Part B (104 Weeks)|Lost to Follow-up|0
2294019|NCT02531633|3988392|FG005|Part B (104 Weeks)|Lost to Follow-up|0
2294020|NCT02531633|3988393|FG006|Part B (104 Weeks)|Lost to Follow-up|0
2294021|NCT02531633|3988394|FG007|Part B (104 Weeks)|Lost to Follow-up|1
2294022|NCT02531633|3988395|FG008|Part B (104 Weeks)|Lost to Follow-up|0
2294023|NCT02531633|3988396|FG009|Part B (104 Weeks)|Lost to Follow-up|0
2294024|NCT02531646|3988439|FG000|Overall Study|equip. image processing issue|5
2294025|NCT02531646|3988440|FG001|Overall Study|equip. image processing issue|1
2294026|NCT02531646|3988441|FG002|Overall Study|equip. image processing issue|0
2294027|NCT02531698|3988451|FG000|Overall Study|Adverse Event|2
2294028|NCT02531698|3988452|FG001|Overall Study|Adverse Event|1
2294029|NCT02531698|3988451|FG000|Overall Study|Withdrawal by Subject|6
2294030|NCT02531698|3988452|FG001|Overall Study|Withdrawal by Subject|1
2294031|NCT02531698|3988451|FG000|Overall Study|Protocol Violation|2
2294032|NCT02531698|3988452|FG001|Overall Study|Protocol Violation|0
2294033|NCT02531698|3988451|FG000|Overall Study|Lost to Follow-up|1
2294034|NCT02531698|3988452|FG001|Overall Study|Lost to Follow-up|0
2294035|NCT02531802|3988488|FG000|Received Vaccination 2|Medication interfering with study taken|0
2294036|NCT02531802|3988489|FG001|Received Vaccination 2|Medication interfering with study taken|0
2294037|NCT02531802|3988490|FG002|Received Vaccination 2|Medication interfering with study taken|1
2294038|NCT02531802|3988491|FG003|Received Vaccination 2|Medication interfering with study taken|0
2294039|NCT02531802|3988492|FG004|Received Vaccination 2|Medication interfering with study taken|0
2294040|NCT02531802|3988493|FG005|Received Vaccination 2|Medication interfering with study taken|0
2161370|NCT01254630|3778478|FG003|Overall Study|Study terminated by sponsor|1010
2294041|NCT02531802|3988494|FG006|Received Vaccination 2|Medication interfering with study taken|0
2294042|NCT02531802|3988495|FG007|Received Vaccination 2|Medication interfering with study taken|0
2294043|NCT02531802|3988496|FG008|Received Vaccination 2|Medication interfering with study taken|0
2294044|NCT02531802|3988497|FG009|Received Vaccination 2|Medication interfering with study taken|1
2294045|NCT02531802|3988498|FG010|Received Vaccination 2|Medication interfering with study taken|1
2294046|NCT02531802|3988499|FG011|Received Vaccination 2|Medication interfering with study taken|0
2322395|NCT02971683|4037415|FG001|Overall Study|Lost to Follow-up|0
2161371|NCT01254630|3778475|FG000|Overall Study|Status not recorded|0
2161372|NCT01254630|3778476|FG001|Overall Study|Status not recorded|0
2161373|NCT01254630|3778477|FG002|Overall Study|Status not recorded|1
2161374|NCT01254630|3778478|FG003|Overall Study|Status not recorded|0
2161375|NCT01254643|3778486|FG000|Overall Study|Withdrawal by Subject|1
2161376|NCT01254656|3778493|FG000|Overall Study|Discontinued due to termination of study|40
2161377|NCT01254656|3778494|FG001|Overall Study|Discontinued due to termination of study|39
2161378|NCT01254656|3778495|FG002|Overall Study|Discontinued due to termination of study|13
2161379|NCT01254656|3778493|FG000|Overall Study|Lack of Efficacy|3
2161380|NCT01254656|3778494|FG001|Overall Study|Lack of Efficacy|0
2161381|NCT01254656|3778495|FG002|Overall Study|Lack of Efficacy|0
2161382|NCT01254656|3778493|FG000|Overall Study|Lost to Follow-up|1
2161383|NCT01254656|3778494|FG001|Overall Study|Lost to Follow-up|0
2161384|NCT01254656|3778495|FG002|Overall Study|Lost to Follow-up|2
2161385|NCT01254656|3778493|FG000|Overall Study|Withdrawal by Subject|2
2161386|NCT01254656|3778494|FG001|Overall Study|Withdrawal by Subject|2
2161387|NCT01254656|3778495|FG002|Overall Study|Withdrawal by Subject|1
2161388|NCT01254656|3778493|FG000|Overall Study|Pregnancy|0
2161389|NCT01254656|3778494|FG001|Overall Study|Pregnancy|0
2161390|NCT01254656|3778495|FG002|Overall Study|Pregnancy|2
2161391|NCT01254656|3778493|FG000|Overall Study|Adverse Event|1
2161392|NCT01254656|3778494|FG001|Overall Study|Adverse Event|1
2161393|NCT01254656|3778495|FG002|Overall Study|Adverse Event|0
2161394|NCT01254656|3778493|FG000|Overall Study|Death|0
2161395|NCT01254656|3778494|FG001|Overall Study|Death|1
2208168|NCT01636713|3847549|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2
2208169|NCT01636713|3847550|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4
2161396|NCT01254656|3778495|FG002|Overall Study|Death|0
2161397|NCT01254669|3778505|FG000|Overall Study|Withdrawal by Subject|0
2161398|NCT01254669|3778506|FG001|Overall Study|Withdrawal by Subject|1
2161399|NCT01254669|3778505|FG000|Overall Study|time constraint|2
2161400|NCT01254669|3778506|FG001|Overall Study|time constraint|2
2161401|NCT01254669|3778505|FG000|Overall Study|called to clinic during intervention|1
2161402|NCT01254669|3778506|FG001|Overall Study|called to clinic during intervention|1
2161403|NCT01254721|3778516|FG000|Overall Study|Lost to Follow-up|0
2161404|NCT01254721|3778517|FG001|Overall Study|Lost to Follow-up|4
2161405|NCT01254721|3778516|FG000|Overall Study|Lack of Efficacy|4
2161406|NCT01254721|3778517|FG001|Overall Study|Lack of Efficacy|2
2161407|NCT01254721|3778516|FG000|Overall Study|Death|0
2161408|NCT01254721|3778517|FG001|Overall Study|Death|1
2161409|NCT01254721|3778516|FG000|Overall Study|technical problum|1
2161410|NCT01254721|3778517|FG001|Overall Study|technical problum|0
2161411|NCT01254721|3778516|FG000|Overall Study|Adverse Event|2
2161412|NCT01254721|3778517|FG001|Overall Study|Adverse Event|3
2161413|NCT01254721|3778516|FG000|Overall Study|Withdrawal by Subject|8
2161414|NCT01254721|3778517|FG001|Overall Study|Withdrawal by Subject|11
2161415|NCT01254721|3778516|FG000|Overall Study|Wrongly randomization|0
2161416|NCT01254721|3778517|FG001|Overall Study|Wrongly randomization|1
2161417|NCT01254747|3778527|FG000|Overall Study|Unacceptable subjective vision|0
2161418|NCT01254747|3778528|FG001|Overall Study|Unacceptable subjective vision|0
2161419|NCT01254747|3778529|FG002|Overall Study|Unacceptable subjective vision|0
2161420|NCT01254747|3778530|FG003|Overall Study|Unacceptable subjective vision|2
2161421|NCT01254747|3778527|FG000|Overall Study|Difficult removal handling|0
2161422|NCT01254747|3778528|FG001|Overall Study|Difficult removal handling|0
2161423|NCT01254747|3778529|FG002|Overall Study|Difficult removal handling|1
2161424|NCT01254747|3778530|FG003|Overall Study|Difficult removal handling|0
2161425|NCT01254747|3778527|FG000|Overall Study|Symptoms and problems|0
2161426|NCT01254747|3778528|FG001|Overall Study|Symptoms and problems|2
2161427|NCT01254747|3778529|FG002|Overall Study|Symptoms and problems|1
2161428|NCT01254747|3778530|FG003|Overall Study|Symptoms and problems|0
2161429|NCT01254747|3778527|FG000|Overall Study|Lost to Follow-up|0
2161430|NCT01254747|3778528|FG001|Overall Study|Lost to Follow-up|0
2161431|NCT01254747|3778529|FG002|Overall Study|Lost to Follow-up|1
2161432|NCT01254747|3778530|FG003|Overall Study|Lost to Follow-up|0
2161433|NCT01254747|3778527|FG000|Overall Study|Biomicroscopy|0
2161434|NCT01254747|3778528|FG001|Overall Study|Biomicroscopy|0
2161435|NCT01254747|3778529|FG002|Overall Study|Biomicroscopy|1
2161436|NCT01254747|3778530|FG003|Overall Study|Biomicroscopy|0
2161437|NCT01254747|3778527|FG000|Overall Study|Discomfort|0
2161438|NCT01254747|3778528|FG001|Overall Study|Discomfort|4
2161439|NCT01254747|3778529|FG002|Overall Study|Discomfort|0
2161440|NCT01254747|3778530|FG003|Overall Study|Discomfort|0
2161441|NCT01254890|3778572|FG000|Overall Study|Ineligible|0
2161442|NCT01254890|3778573|FG001|Overall Study|Ineligible|3
2294047|NCT02531802|3988500|FG012|Received Vaccination 2|Medication interfering with study taken|1
2161443|NCT01254890|3778572|FG000|Overall Study|Withdrawal by Subject|1
2161444|NCT01254890|3778573|FG001|Overall Study|Withdrawal by Subject|2
2161445|NCT01254890|3778572|FG000|Overall Study|Disease Progression|0
2161446|NCT01254890|3778573|FG001|Overall Study|Disease Progression|5
2179477|NCT01393964|3804992|FG000|Overall Study|Subject to receive non-protocol therapy|0
2179478|NCT01393964|3804993|FG001|Overall Study|Subject to receive non-protocol therapy|0
2179479|NCT01393964|3804994|FG002|Overall Study|Subject to receive non-protocol therapy|1
2179480|NCT01393990|3805026|FG000|Overall Study|Adverse Event|0
2179481|NCT01393990|3805027|FG001|Overall Study|Adverse Event|0
2161447|NCT01255163|3778584|FG000|Overall Study|Withdrawal by Subject|1
2161448|NCT01255163|3778585|FG001|Overall Study|Withdrawal by Subject|0
2161449|NCT01255163|3778584|FG000|Overall Study|Lost to Follow-up|2
2161450|NCT01255163|3778585|FG001|Overall Study|Lost to Follow-up|0
2161451|NCT01255163|3778584|FG000|Overall Study|Adverse Event|0
2161452|NCT01255163|3778585|FG001|Overall Study|Adverse Event|2
2161453|NCT01255163|3778584|FG000|Overall Study|AstraZeneca stopped support of the study|1
2161454|NCT01255163|3778585|FG001|Overall Study|AstraZeneca stopped support of the study|3
2161455|NCT01255306|3778595|FG000|Overall Study|Physician Decision|1
2161456|NCT01255306|3778596|FG001|Overall Study|Physician Decision|1
2161457|NCT01255423|3778607|FG000|Overall Study|Abnormal Laboratory value|3
2161458|NCT01255423|3778608|FG001|Overall Study|Abnormal Laboratory value|2
2161459|NCT01255423|3778607|FG000|Overall Study|Use of prohibited medications|0
2161460|NCT01255423|3778608|FG001|Overall Study|Use of prohibited medications|1
2161461|NCT01255436|3778616|FG000|Overall Study|Lost to Follow-up|178
2161462|NCT01255436|3778617|FG001|Overall Study|Lost to Follow-up|191
2161463|NCT01255436|3778616|FG000|Overall Study|Death, stroke, or MI|4
2161464|NCT01255436|3778617|FG001|Overall Study|Death, stroke, or MI|3
2161465|NCT01255592|3778630|FG000|Overall Study|Adverse Event|5
2161466|NCT01255592|3778631|FG001|Overall Study|Adverse Event|0
2161467|NCT01255592|3778630|FG000|Overall Study|Withdrawal by Subject|1
2161468|NCT01255592|3778631|FG001|Overall Study|Withdrawal by Subject|0
2161469|NCT01255592|3778630|FG000|Overall Study|Other|0
2161470|NCT01255592|3778631|FG001|Overall Study|Other|1
2161471|NCT01255631|3778640|FG000|Overall Study|poor enrollment, no data analyzed|9
2161472|NCT01255631|3778641|FG001|Overall Study|poor enrollment, no data analyzed|6
2161473|NCT01255670|3778649|FG000|Overall Study|Adverse Event|10
2161474|NCT01255670|3778650|FG001|Overall Study|Adverse Event|10
2161475|NCT01255670|3778649|FG000|Overall Study|Lost to Follow-up|16
2161476|NCT01255670|3778650|FG001|Overall Study|Lost to Follow-up|10
2161477|NCT01255722|3778659|FG000|Overall Study|Adverse Event|0
2161478|NCT01255722|3778660|FG001|Overall Study|Adverse Event|1
2161479|NCT01255722|3778661|FG002|Overall Study|Adverse Event|1
2161480|NCT01255722|3778659|FG000|Overall Study|asymptomatic patient|1
2161481|NCT01255722|3778660|FG001|Overall Study|asymptomatic patient|0
2161482|NCT01255722|3778661|FG002|Overall Study|asymptomatic patient|0
2161483|NCT01255722|3778659|FG000|Overall Study|beta-blocker contraindicated|2
2161484|NCT01255722|3778660|FG001|Overall Study|beta-blocker contraindicated|0
2161485|NCT01255722|3778661|FG002|Overall Study|beta-blocker contraindicated|0
2161486|NCT01255761|3778672|FG000|Overall Study|Adverse Event|29
2161487|NCT01255761|3778673|FG001|Overall Study|Adverse Event|43
2161488|NCT01255761|3778672|FG000|Overall Study|Lack of Efficacy|86
2161489|NCT01255761|3778673|FG001|Overall Study|Lack of Efficacy|74
2161490|NCT01255761|3778672|FG000|Overall Study|Protocol Violation|9
2161491|NCT01255761|3778673|FG001|Overall Study|Protocol Violation|5
2161492|NCT01255761|3778672|FG000|Overall Study|Lost to Follow-up|10
2161493|NCT01255761|3778673|FG001|Overall Study|Lost to Follow-up|8
2161494|NCT01255761|3778672|FG000|Overall Study|Withdrawal by Subject|11
2161495|NCT01255761|3778673|FG001|Overall Study|Withdrawal by Subject|27
2161496|NCT01255761|3778672|FG000|Overall Study|Other Reasons|37
2161497|NCT01255761|3778673|FG001|Overall Study|Other Reasons|18
2161498|NCT01255787|3778683|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6
2161499|NCT01255787|3778684|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2
2161500|NCT01255787|3778685|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9
2161501|NCT01255787|3778686|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9
2161502|NCT01255787|3778683|FG000|Overall Study|Major Protocol Deviation|1
2161503|NCT01255787|3778684|FG001|Overall Study|Major Protocol Deviation|1
2161504|NCT01255787|3778685|FG002|Overall Study|Major Protocol Deviation|0
2161505|NCT01255787|3778686|FG003|Overall Study|Major Protocol Deviation|4
2161506|NCT01255787|3778683|FG000|Overall Study|Lost to Follow-up|1
2161507|NCT01255787|3778684|FG001|Overall Study|Lost to Follow-up|2
2161508|NCT01255787|3778685|FG002|Overall Study|Lost to Follow-up|4
2161509|NCT01255787|3778686|FG003|Overall Study|Lost to Follow-up|2
2161510|NCT01255787|3778683|FG000|Overall Study|Withdrawal of Consent|3
2161511|NCT01255787|3778684|FG001|Overall Study|Withdrawal of Consent|9
2161512|NCT01255787|3778685|FG002|Overall Study|Withdrawal of Consent|3
2161513|NCT01255787|3778686|FG003|Overall Study|Withdrawal of Consent|4
2161514|NCT01255787|3778683|FG000|Overall Study|Pregnancy|0
2161515|NCT01255787|3778684|FG001|Overall Study|Pregnancy|0
2161516|NCT01255787|3778685|FG002|Overall Study|Pregnancy|0
2161517|NCT01255787|3778686|FG003|Overall Study|Pregnancy|1
2161518|NCT01255787|3778683|FG000|Overall Study|Lack of Efficacy|2
2161519|NCT01255787|3778684|FG001|Overall Study|Lack of Efficacy|2
2161520|NCT01255787|3778685|FG002|Overall Study|Lack of Efficacy|2
2161521|NCT01255787|3778686|FG003|Overall Study|Lack of Efficacy|2
2161522|NCT01255787|3778683|FG000|Overall Study|Noncompliance with Study Drug|3
2161523|NCT01255787|3778684|FG001|Overall Study|Noncompliance with Study Drug|1
2161524|NCT01255787|3778685|FG002|Overall Study|Noncompliance with Study Drug|0
2161525|NCT01255787|3778686|FG003|Overall Study|Noncompliance with Study Drug|0
2161526|NCT01255904|3778727|FG000|Overall Study|Physician Decision|1
2161527|NCT01255904|3778728|FG001|Overall Study|Physician Decision|4
2161528|NCT01256008|3778737|FG000|Overall Study|Lost to Follow-up|6
2161529|NCT01256008|3778738|FG001|Overall Study|Lost to Follow-up|4
2161530|NCT01256008|3778739|FG002|Overall Study|Lost to Follow-up|11
2161531|NCT01256008|3778737|FG000|Overall Study|Withdrawal by Subject|2
2161532|NCT01256008|3778738|FG001|Overall Study|Withdrawal by Subject|3
2161533|NCT01256008|3778739|FG002|Overall Study|Withdrawal by Subject|10
2161534|NCT01256060|3778758|FG000|Overall Study|Lost to Follow-up|0
2161535|NCT01256060|3778759|FG001|Overall Study|Lost to Follow-up|1
2161536|NCT01256060|3778760|FG002|Overall Study|Lost to Follow-up|0
2161537|NCT01256060|3778761|FG003|Overall Study|Lost to Follow-up|0
2161538|NCT01256177|3778778|FG000|Overall Study|Withdrawal by Subject|23
2161539|NCT01256177|3778779|FG001|Overall Study|Withdrawal by Subject|22
2161540|NCT01256177|3778778|FG000|Overall Study|Lost to Follow-up|2
2161541|NCT01256177|3778779|FG001|Overall Study|Lost to Follow-up|2
2161542|NCT01256177|3778778|FG000|Overall Study|Adverse Event|8
2161543|NCT01256177|3778779|FG001|Overall Study|Adverse Event|9
2161544|NCT01256177|3778778|FG000|Overall Study|Severe Non-Compliance to Protocol|4
2161545|NCT01256177|3778779|FG001|Overall Study|Severe Non-Compliance to Protocol|2
2161546|NCT01256177|3778778|FG000|Overall Study|Condition under Investigation Worsened|1
2161547|NCT01256177|3778779|FG001|Overall Study|Condition under Investigation Worsened|0
2161548|NCT01256177|3778778|FG000|Overall Study|Lack of Efficacy|11
2161549|NCT01256177|3778779|FG001|Overall Study|Lack of Efficacy|2
2161550|NCT01256177|3778778|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1
2161551|NCT01256177|3778779|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0
2161552|NCT01256190|3778787|FG000|Overall Study|Lost to Follow-up|2
2161553|NCT01256190|3778788|FG001|Overall Study|Lost to Follow-up|0
2161554|NCT01256294|3778794|FG000|Overall Study|Adverse Event|1
2161555|NCT01256294|3778795|FG001|Overall Study|Adverse Event|0
2161556|NCT01256294|3778794|FG000|Overall Study|Withdrawal by Subject|1
2161557|NCT01256294|3778795|FG001|Overall Study|Withdrawal by Subject|1
2161558|NCT01256294|3778794|FG000|Overall Study|Protocol deviation|2
2161559|NCT01256294|3778795|FG001|Overall Study|Protocol deviation|1
2161560|NCT01256385|3778803|FG000|Overall Study|Physician Decision|1
2161561|NCT01256385|3778804|FG001|Overall Study|Physician Decision|1
2161562|NCT01256385|3778803|FG000|Overall Study|Withdrawal by Subject|2
2161563|NCT01256385|3778804|FG001|Overall Study|Withdrawal by Subject|2
2161564|NCT01256398|3778810|FG000|Overall Study|Withdrawal by Subject|1
2161565|NCT01256411|3778818|FG000|Extension by Maximum Treatment|Protocol deviation|0
2161566|NCT01256411|3778819|FG001|Extension by Maximum Treatment|Protocol deviation|0
2161567|NCT01256411|3778820|FG002|Extension by Maximum Treatment|Protocol deviation|1
2161568|NCT01256411|3778821|FG003|Extension by Maximum Treatment|Protocol deviation|0
2161569|NCT01256411|3778822|FG004|Extension by Maximum Treatment|Protocol deviation|0
2161570|NCT01256411|3778823|FG005|Extension by Maximum Treatment|Protocol deviation|0
2161571|NCT01256411|3778818|FG000|Extension by Maximum Treatment|Lost to Follow-up|1
2161572|NCT01256411|3778819|FG001|Extension by Maximum Treatment|Lost to Follow-up|2
2161573|NCT01256411|3778820|FG002|Extension by Maximum Treatment|Lost to Follow-up|0
2161574|NCT01256411|3778821|FG003|Extension by Maximum Treatment|Lost to Follow-up|0
2161575|NCT01256411|3778822|FG004|Extension by Maximum Treatment|Lost to Follow-up|0
2161576|NCT01256411|3778823|FG005|Extension by Maximum Treatment|Lost to Follow-up|0
2161577|NCT01256411|3778818|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1
2161578|NCT01256411|3778819|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6
2161579|NCT01256411|3778820|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1
2161580|NCT01256411|3778821|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0
2161581|NCT01256411|3778822|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0
2161582|NCT01256411|3778823|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0
2161583|NCT01256411|3778818|FG000|Extension by Maximum Treatment|Lack of Efficacy|1
2161584|NCT01256411|3778819|FG001|Extension by Maximum Treatment|Lack of Efficacy|0
2161585|NCT01256411|3778820|FG002|Extension by Maximum Treatment|Lack of Efficacy|1
2161586|NCT01256411|3778821|FG003|Extension by Maximum Treatment|Lack of Efficacy|0
2161587|NCT01256411|3778822|FG004|Extension by Maximum Treatment|Lack of Efficacy|0
2161588|NCT01256411|3778823|FG005|Extension by Maximum Treatment|Lack of Efficacy|0
2161589|NCT01256411|3778818|FG000|Extension by Maximum Treatment|Adverse Event|4
2161590|NCT01256411|3778819|FG001|Extension by Maximum Treatment|Adverse Event|2
2161591|NCT01256411|3778820|FG002|Extension by Maximum Treatment|Adverse Event|1
2161592|NCT01256411|3778821|FG003|Extension by Maximum Treatment|Adverse Event|0
2161593|NCT01256411|3778822|FG004|Extension by Maximum Treatment|Adverse Event|0
2161594|NCT01256411|3778823|FG005|Extension by Maximum Treatment|Adverse Event|0
2161595|NCT01256411|3778818|FG000|Extension by Mono or Combination Therapy|Adverse Event|0
2161596|NCT01256411|3778819|FG001|Extension by Mono or Combination Therapy|Adverse Event|0
2161597|NCT01256411|3778820|FG002|Extension by Mono or Combination Therapy|Adverse Event|0
2161598|NCT01256411|3778821|FG003|Extension by Mono or Combination Therapy|Adverse Event|0
2161599|NCT01256411|3778822|FG004|Extension by Mono or Combination Therapy|Adverse Event|6
2161600|NCT01256411|3778823|FG005|Extension by Mono or Combination Therapy|Adverse Event|1
2161601|NCT01256411|3778818|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0
2161602|NCT01256411|3778819|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0
2161603|NCT01256411|3778820|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0
2161604|NCT01256411|3778821|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0
2161605|NCT01256411|3778822|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0
2161606|NCT01256411|3778823|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1
2161607|NCT01256411|3778818|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2161608|NCT01256411|3778819|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2161609|NCT01256411|3778820|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2161610|NCT01256411|3778821|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2161611|NCT01256411|3778822|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3
2161612|NCT01256411|3778823|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2161613|NCT01256411|3778818|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2161614|NCT01256411|3778819|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2161615|NCT01256411|3778820|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2161616|NCT01256411|3778821|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2161617|NCT01256411|3778822|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
2161618|NCT01256411|3778823|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
2161619|NCT01256411|3778818|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2161620|NCT01256411|3778819|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2161621|NCT01256411|3778820|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2161622|NCT01256411|3778821|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2161623|NCT01256411|3778822|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1
2161624|NCT01256411|3778823|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1
2161625|NCT01256450|3778857|FG000|Open-label Titration|Adverse Event|39
2161626|NCT01256450|3778858|FG001|Open-label Titration|Adverse Event|0
2161627|NCT01256450|3778859|FG002|Open-label Titration|Adverse Event|0
2161628|NCT01256450|3778857|FG000|Open-label Titration|Lost to Follow-up|7
2161629|NCT01256450|3778858|FG001|Open-label Titration|Lost to Follow-up|0
2161630|NCT01256450|3778859|FG002|Open-label Titration|Lost to Follow-up|0
2161631|NCT01256450|3778857|FG000|Open-label Titration|Lack of analgesic effect|30
2161632|NCT01256450|3778858|FG001|Open-label Titration|Lack of analgesic effect|0
2161633|NCT01256450|3778859|FG002|Open-label Titration|Lack of analgesic effect|0
2161634|NCT01256450|3778857|FG000|Open-label Titration|Non-compliance|9
2161635|NCT01256450|3778858|FG001|Open-label Titration|Non-compliance|0
2161636|NCT01256450|3778859|FG002|Open-label Titration|Non-compliance|0
2161637|NCT01256450|3778857|FG000|Open-label Titration|Screen failure|1
2161638|NCT01256450|3778858|FG001|Open-label Titration|Screen failure|0
2161639|NCT01256450|3778859|FG002|Open-label Titration|Screen failure|0
2161640|NCT01256450|3778857|FG000|Open-label Titration|Other|13
2161641|NCT01256450|3778858|FG001|Open-label Titration|Other|0
2161642|NCT01256450|3778859|FG002|Open-label Titration|Other|0
2161643|NCT01256450|3778857|FG000|Double-blind Treatment|Adverse Event|0
2161644|NCT01256450|3778858|FG001|Double-blind Treatment|Adverse Event|8
2161645|NCT01256450|3778859|FG002|Double-blind Treatment|Adverse Event|6
2161646|NCT01256450|3778857|FG000|Double-blind Treatment|Lost to Follow-up|0
2161647|NCT01256450|3778858|FG001|Double-blind Treatment|Lost to Follow-up|1
2161648|NCT01256450|3778859|FG002|Double-blind Treatment|Lost to Follow-up|7
2161649|NCT01256450|3778857|FG000|Double-blind Treatment|Withdrawal by Subject|0
2294048|NCT02531802|3988501|FG013|Received Vaccination 2|Medication interfering with study taken|0
2294049|NCT02531802|3988502|FG014|Received Vaccination 2|Medication interfering with study taken|0
2294050|NCT02531802|3988503|FG015|Received Vaccination 2|Medication interfering with study taken|0
2294051|NCT02531802|3988504|FG016|Received Vaccination 2|Medication interfering with study taken|0
2294052|NCT02531802|3988505|FG017|Received Vaccination 2|Medication interfering with study taken|0
2294053|NCT02531802|3988506|FG018|Received Vaccination 2|Medication interfering with study taken|1
2294054|NCT02531802|3988507|FG019|Received Vaccination 2|Medication interfering with study taken|0
2294055|NCT02531802|3988508|FG020|Received Vaccination 2|Medication interfering with study taken|0
2294056|NCT02531802|3988488|FG000|Received Vaccination 2|Physician Decision|0
2294057|NCT02531802|3988489|FG001|Received Vaccination 2|Physician Decision|0
2294058|NCT02531802|3988490|FG002|Received Vaccination 2|Physician Decision|0
2294059|NCT02531802|3988491|FG003|Received Vaccination 2|Physician Decision|0
2294060|NCT02531802|3988492|FG004|Received Vaccination 2|Physician Decision|0
2294061|NCT02531802|3988493|FG005|Received Vaccination 2|Physician Decision|1
2294062|NCT02531802|3988494|FG006|Received Vaccination 2|Physician Decision|0
2294063|NCT02531802|3988495|FG007|Received Vaccination 2|Physician Decision|0
2294064|NCT02531802|3988496|FG008|Received Vaccination 2|Physician Decision|0
2294065|NCT02531802|3988497|FG009|Received Vaccination 2|Physician Decision|2
2294066|NCT02531802|3988498|FG010|Received Vaccination 2|Physician Decision|0
2294067|NCT02531802|3988499|FG011|Received Vaccination 2|Physician Decision|0
2294068|NCT02531802|3988500|FG012|Received Vaccination 2|Physician Decision|0
2294069|NCT02531802|3988501|FG013|Received Vaccination 2|Physician Decision|1
2161650|NCT01256450|3778858|FG001|Double-blind Treatment|Withdrawal by Subject|0
2161651|NCT01256450|3778859|FG002|Double-blind Treatment|Withdrawal by Subject|1
2161652|NCT01256450|3778857|FG000|Double-blind Treatment|Lack of analgesic effect|0
2161653|NCT01256450|3778858|FG001|Double-blind Treatment|Lack of analgesic effect|5
2161654|NCT01256450|3778859|FG002|Double-blind Treatment|Lack of analgesic effect|6
2161655|NCT01256450|3778857|FG000|Double-blind Treatment|Non-compliance|0
2161656|NCT01256450|3778858|FG001|Double-blind Treatment|Non-compliance|5
2294070|NCT02531802|3988502|FG014|Received Vaccination 2|Physician Decision|0
2161657|NCT01256450|3778859|FG002|Double-blind Treatment|Non-compliance|4
2161658|NCT01256450|3778857|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0
2161659|NCT01256450|3778858|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0
2161660|NCT01256450|3778859|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1
2161661|NCT01256450|3778857|FG000|Double-blind Treatment|Other|0
2161662|NCT01256450|3778858|FG001|Double-blind Treatment|Other|9
2161663|NCT01256450|3778859|FG002|Double-blind Treatment|Other|12
2161664|NCT01256476|3778868|FG000|Overall Study|Adverse Event|2
2161665|NCT01256476|3778869|FG001|Overall Study|Adverse Event|1
2161666|NCT01256476|3778868|FG000|Overall Study|Withdrawal by Subject|2
2161667|NCT01256476|3778869|FG001|Overall Study|Withdrawal by Subject|1
2161668|NCT01256476|3778868|FG000|Overall Study|Lost to Follow-up|1
2161669|NCT01256476|3778869|FG001|Overall Study|Lost to Follow-up|2
2161670|NCT01256476|3778868|FG000|Overall Study|Persistent ALT or AST elevation|1
2161671|NCT01256476|3778869|FG001|Overall Study|Persistent ALT or AST elevation|0
2161672|NCT01256476|3778868|FG000|Overall Study|Physician Decision|0
2161673|NCT01256476|3778869|FG001|Overall Study|Physician Decision|1
2161674|NCT01256476|3778868|FG000|Overall Study|Subject non-compliance|0
2161675|NCT01256476|3778869|FG001|Overall Study|Subject non-compliance|1
2161676|NCT01256476|3778868|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
2161677|NCT01256476|3778869|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
2161678|NCT01256502|3778875|FG000|Overall Study|Had scaffold removed|4
2161679|NCT01256502|3778875|FG000|Overall Study|Personal reasons|5
2161680|NCT01256502|3778875|FG000|Overall Study|Protocol deviation|1
2161681|NCT01256567|3778884|FG000|Overall Study|Withdrawal by Subject|1
2161682|NCT01256593|3778889|FG000|Overall Study|Protocol Violation|26
2161683|NCT01256593|3778889|FG000|Overall Study|No Drug Administration Information|2
2161684|NCT01256593|3778889|FG000|Overall Study|No Visit After Treatment|186
2161685|NCT01256658|3778895|FG000|Period 1|Lost to Follow-up|837
2161686|NCT01256658|3778896|FG001|Period 1|Lost to Follow-up|661
2161687|NCT01256658|3778895|FG000|Period 1|Withdrawal by Subject|35
2161688|NCT01256658|3778896|FG001|Period 1|Withdrawal by Subject|43
2161689|NCT01256658|3778895|FG000|Period 1|Death|48
2161690|NCT01256658|3778896|FG001|Period 1|Death|44
2161691|NCT01256671|3778905|FG000|Overall Study|Adverse Event|29
2161692|NCT01256671|3778905|FG000|Overall Study|Lost to Follow-up|16
2161693|NCT01256671|3778905|FG000|Overall Study|Withdrawal by Subject|31
2161694|NCT01256671|3778905|FG000|Overall Study|Physician Decision|3
2161695|NCT01256671|3778905|FG000|Overall Study|Lack of Efficacy|4
2161696|NCT01256671|3778905|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12
2161697|NCT01256684|3778912|FG000|Overall Study|Adverse Event|1
2161698|NCT01256684|3778913|FG001|Overall Study|Adverse Event|4
2161699|NCT01256684|3778914|FG002|Overall Study|Adverse Event|2
2161700|NCT01256684|3778912|FG000|Overall Study|Withdrawal by Subject|4
2161701|NCT01256684|3778913|FG001|Overall Study|Withdrawal by Subject|0
2161702|NCT01256684|3778914|FG002|Overall Study|Withdrawal by Subject|2
2161703|NCT01256684|3778912|FG000|Overall Study|Physician Decision|0
2161704|NCT01256684|3778913|FG001|Overall Study|Physician Decision|1
2161705|NCT01256684|3778914|FG002|Overall Study|Physician Decision|0
2161706|NCT01256684|3778912|FG000|Overall Study|Lack of Efficacy|0
2161707|NCT01256684|3778913|FG001|Overall Study|Lack of Efficacy|1
2161708|NCT01256684|3778914|FG002|Overall Study|Lack of Efficacy|1
2161709|NCT01256684|3778912|FG000|Overall Study|Entry criteria not met/non-compliance|4
2161710|NCT01256684|3778913|FG001|Overall Study|Entry criteria not met/non-compliance|7
2161711|NCT01256684|3778914|FG002|Overall Study|Entry criteria not met/non-compliance|6
2161712|NCT01256788|3778925|FG000|Overall Study|Lost to Follow-up|5
2161713|NCT01256788|3778926|FG001|Overall Study|Lost to Follow-up|8
2161714|NCT01256788|3778927|FG002|Overall Study|Lost to Follow-up|3
2161715|NCT01256879|3778948|FG000|Overall Study|Withdrawal by Subject|1
2161716|NCT01257204|3779003|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0
2161717|NCT01257204|3779004|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1
2161718|NCT01257204|3779005|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3
2161719|NCT01257204|3779003|FG000|Treatment Period (up to Week 24)|Adverse Event|3
2161720|NCT01257204|3779004|FG001|Treatment Period (up to Week 24)|Adverse Event|1
2161721|NCT01257204|3779005|FG002|Treatment Period (up to Week 24)|Adverse Event|2
2161722|NCT01257204|3779003|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1
2161723|NCT01257204|3779004|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0
2161724|NCT01257204|3779005|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1
2161725|NCT01257204|3779003|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0
2161726|NCT01257204|3779004|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2
2161727|NCT01257204|3779005|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0
2161728|NCT01257204|3779003|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
2161729|NCT01257204|3779004|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
2161730|NCT01257204|3779005|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
2161731|NCT01257204|3779003|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1
2161732|NCT01257204|3779004|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2
2161733|NCT01257204|3779005|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2
2161734|NCT01257204|3779003|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
2161735|NCT01257204|3779004|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
2161736|NCT01257204|3779005|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
2161737|NCT01257204|3779003|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1
2161738|NCT01257204|3779004|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4
2161739|NCT01257204|3779005|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4
2161740|NCT01257204|3779003|FG000|Follow-up Period (up to Week 48)|Other|0
2161741|NCT01257204|3779004|FG001|Follow-up Period (up to Week 48)|Other|0
2161742|NCT01257204|3779005|FG002|Follow-up Period (up to Week 48)|Other|5
2161743|NCT01257230|3779041|FG000|Overall Study|Not Treated|0
2161744|NCT01257230|3779042|FG001|Overall Study|Not Treated|0
2161745|NCT01257230|3779043|FG002|Overall Study|Not Treated|1
2161746|NCT01257230|3779041|FG000|Overall Study|Adverse Event|2
2161747|NCT01257230|3779042|FG001|Overall Study|Adverse Event|0
2161748|NCT01257230|3779043|FG002|Overall Study|Adverse Event|0
2161749|NCT01257230|3779041|FG000|Overall Study|Lack of Efficacy|0
2161750|NCT01257230|3779042|FG001|Overall Study|Lack of Efficacy|1
2161751|NCT01257230|3779043|FG002|Overall Study|Lack of Efficacy|0
2161752|NCT01257230|3779041|FG000|Overall Study|Protocol Violation|3
2161753|NCT01257230|3779042|FG001|Overall Study|Protocol Violation|0
2161754|NCT01257230|3779043|FG002|Overall Study|Protocol Violation|1
2161755|NCT01257230|3779041|FG000|Overall Study|Withdrawal by Subject|0
2161756|NCT01257230|3779042|FG001|Overall Study|Withdrawal by Subject|4
2161757|NCT01257230|3779043|FG002|Overall Study|Withdrawal by Subject|1
2161758|NCT01257230|3779041|FG000|Overall Study|Other reason not defined above|1
2161759|NCT01257230|3779042|FG001|Overall Study|Other reason not defined above|5
2161760|NCT01257230|3779043|FG002|Overall Study|Other reason not defined above|3
2161761|NCT01257425|3779074|FG000|Overall Study|Lack of Efficacy|3
2161762|NCT01257425|3779075|FG001|Overall Study|Lack of Efficacy|3
2161763|NCT01257425|3779074|FG000|Overall Study|Adverse Event|1
2161764|NCT01257425|3779075|FG001|Overall Study|Adverse Event|1
2161765|NCT01257425|3779074|FG000|Overall Study|Protocol Violation|1
2161766|NCT01257425|3779075|FG001|Overall Study|Protocol Violation|1
2161767|NCT01257425|3779074|FG000|Overall Study|Withdrawal by Subject|0
2161768|NCT01257425|3779075|FG001|Overall Study|Withdrawal by Subject|1
2161769|NCT01257425|3779074|FG000|Overall Study|Death|1
2161770|NCT01257425|3779075|FG001|Overall Study|Death|0
2161771|NCT01257503|3779092|FG000|Overall Study|Lost to Follow-up|7
2161772|NCT01257503|3779093|FG001|Overall Study|Lost to Follow-up|10
2161773|NCT01257503|3779092|FG000|Overall Study|Over 5 years old at enrollment|0
2161774|NCT01257503|3779093|FG001|Overall Study|Over 5 years old at enrollment|1
2161775|NCT01257503|3779092|FG000|Overall Study|strep culture positive at enrollment|1
2161776|NCT01257503|3779093|FG001|Overall Study|strep culture positive at enrollment|0
2161777|NCT01257542|3779101|FG000|Overall Study|Protocol Violation|3
2161778|NCT01257542|3779102|FG001|Overall Study|Protocol Violation|5
2161779|NCT01257542|3779101|FG000|Overall Study|Withdrawal by Subject|0
2161780|NCT01257542|3779102|FG001|Overall Study|Withdrawal by Subject|2
2161781|NCT01257581|3779111|FG000|Overall Study|Early Termination|3
2161782|NCT01257581|3779112|FG001|Overall Study|Early Termination|1
2161783|NCT01257581|3779113|FG002|Overall Study|Early Termination|2
2161784|NCT01257581|3779111|FG000|Overall Study|Death|2
2161785|NCT01257581|3779112|FG001|Overall Study|Death|2
2161786|NCT01257581|3779113|FG002|Overall Study|Death|4
2161787|NCT01257698|3779123|FG000|Overall Study|Protocol Violation|4
2161788|NCT01257698|3779124|FG001|Overall Study|Protocol Violation|0
2161789|NCT01257737|3779132|FG000|Overall Study|Lost to Follow-up|1
2208170|NCT01636778|3847562|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
2161790|NCT01257737|3779133|FG001|Overall Study|Lost to Follow-up|2
2161791|NCT01257737|3779132|FG000|Overall Study|Liver transplant|1
2161792|NCT01257737|3779133|FG001|Overall Study|Liver transplant|0
2161793|NCT01257737|3779132|FG000|Overall Study|Relocation out of the country|0
2161794|NCT01257737|3779133|FG001|Overall Study|Relocation out of the country|1
2161795|NCT01257737|3779132|FG000|Overall Study|Withdrew from study|0
2161796|NCT01257737|3779133|FG001|Overall Study|Withdrew from study|1
2179482|NCT01393990|3805028|FG002|Overall Study|Adverse Event|0
2179483|NCT01393990|3805029|FG003|Overall Study|Adverse Event|0
2179484|NCT01393990|3805030|FG004|Overall Study|Adverse Event|0
2179485|NCT01393990|3805031|FG005|Overall Study|Adverse Event|0
2179486|NCT01393990|3805032|FG006|Overall Study|Adverse Event|0
2179487|NCT01393990|3805033|FG007|Overall Study|Adverse Event|0
2179488|NCT01393990|3805034|FG008|Overall Study|Adverse Event|0
2179489|NCT01393990|3805035|FG009|Overall Study|Adverse Event|0
2179490|NCT01393990|3805036|FG010|Overall Study|Adverse Event|0
2179491|NCT01393990|3805037|FG011|Overall Study|Adverse Event|0
2179492|NCT01393990|3805038|FG012|Overall Study|Adverse Event|0
2179493|NCT01393990|3805039|FG013|Overall Study|Adverse Event|0
2179494|NCT01393990|3805040|FG014|Overall Study|Adverse Event|1
2179495|NCT01393990|3805041|FG015|Overall Study|Adverse Event|1
2179496|NCT01393990|3805042|FG016|Overall Study|Adverse Event|0
2179497|NCT01393990|3805043|FG017|Overall Study|Adverse Event|0
2179498|NCT01393990|3805026|FG000|Overall Study|Progressive Disease|1
2179499|NCT01393990|3805027|FG001|Overall Study|Progressive Disease|0
2179500|NCT01393990|3805028|FG002|Overall Study|Progressive Disease|0
2179501|NCT01393990|3805029|FG003|Overall Study|Progressive Disease|1
2179502|NCT01393990|3805030|FG004|Overall Study|Progressive Disease|1
2179503|NCT01393990|3805031|FG005|Overall Study|Progressive Disease|1
2179504|NCT01393990|3805032|FG006|Overall Study|Progressive Disease|1
2161797|NCT01258075|3779175|FG000|Overall Study|Adverse Event|8
2161798|NCT01258075|3779176|FG001|Overall Study|Adverse Event|3
2161799|NCT01258075|3779175|FG000|Overall Study|Lost to Follow-up|11
2161800|NCT01258075|3779176|FG001|Overall Study|Lost to Follow-up|6
2161801|NCT01258075|3779175|FG000|Overall Study|Withdrawal by Subject|10
2161802|NCT01258075|3779176|FG001|Overall Study|Withdrawal by Subject|7
2161803|NCT01258075|3779175|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1
2161804|NCT01258075|3779176|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2
2161805|NCT01258075|3779175|FG000|Overall Study|Other|12
2161806|NCT01258075|3779176|FG001|Overall Study|Other|5
2161807|NCT01258101|3779186|FG000|Overall Study|Adverse Event|5
2161808|NCT01258101|3779187|FG001|Overall Study|Adverse Event|6
2161809|NCT01258101|3779188|FG002|Overall Study|Adverse Event|0
2161810|NCT01258101|3779189|FG003|Overall Study|Adverse Event|0
2161811|NCT01258101|3779186|FG000|Overall Study|Extra exclusion criterion amended|2
2161812|NCT01258101|3779187|FG001|Overall Study|Extra exclusion criterion amended|1
2161813|NCT01258101|3779188|FG002|Overall Study|Extra exclusion criterion amended|1
2161814|NCT01258101|3779189|FG003|Overall Study|Extra exclusion criterion amended|1
2161815|NCT01258101|3779186|FG000|Overall Study|Informed consent has been withdrawn|2
2161816|NCT01258101|3779187|FG001|Overall Study|Informed consent has been withdrawn|2
2161817|NCT01258101|3779188|FG002|Overall Study|Informed consent has been withdrawn|1
2161818|NCT01258101|3779189|FG003|Overall Study|Informed consent has been withdrawn|1
2161819|NCT01258101|3779186|FG000|Overall Study|Patient is not able to attend visits|8
2161820|NCT01258101|3779187|FG001|Overall Study|Patient is not able to attend visits|9
2161821|NCT01258101|3779188|FG002|Overall Study|Patient is not able to attend visits|7
2161822|NCT01258101|3779189|FG003|Overall Study|Patient is not able to attend visits|6
2161823|NCT01258101|3779186|FG000|Overall Study|Patient´s compliance|4
2161824|NCT01258101|3779187|FG001|Overall Study|Patient´s compliance|3
2161825|NCT01258101|3779188|FG002|Overall Study|Patient´s compliance|1
2161826|NCT01258101|3779189|FG003|Overall Study|Patient´s compliance|2
2161827|NCT01258101|3779186|FG000|Overall Study|Lost to Follow-up|5
2161828|NCT01258101|3779187|FG001|Overall Study|Lost to Follow-up|5
2161829|NCT01258101|3779188|FG002|Overall Study|Lost to Follow-up|0
2161830|NCT01258101|3779189|FG003|Overall Study|Lost to Follow-up|6
2161831|NCT01258101|3779186|FG000|Overall Study|PCR positive at week 24|0
2161832|NCT01258101|3779187|FG001|Overall Study|PCR positive at week 24|0
2161833|NCT01258101|3779188|FG002|Overall Study|PCR positive at week 24|0
2161834|NCT01258101|3779189|FG003|Overall Study|PCR positive at week 24|1
2161835|NCT01258101|3779186|FG000|Overall Study|Other reason|7
2161836|NCT01258101|3779187|FG001|Overall Study|Other reason|8
2161837|NCT01258101|3779188|FG002|Overall Study|Other reason|1
2161838|NCT01258101|3779189|FG003|Overall Study|Other reason|8
2161839|NCT01258348|3779214|FG000|Overall Study|Adverse Event|1
2161840|NCT01258348|3779215|FG001|Overall Study|Adverse Event|1
2161841|NCT01258348|3779216|FG002|Overall Study|Adverse Event|3
2161842|NCT01258348|3779217|FG003|Overall Study|Adverse Event|2
2161843|NCT01258348|3779218|FG004|Overall Study|Adverse Event|4
2161844|NCT01258348|3779214|FG000|Overall Study|Progressive Disease|0
2161845|NCT01258348|3779215|FG001|Overall Study|Progressive Disease|3
2161846|NCT01258348|3779216|FG002|Overall Study|Progressive Disease|0
2161847|NCT01258348|3779217|FG003|Overall Study|Progressive Disease|2
2161848|NCT01258348|3779218|FG004|Overall Study|Progressive Disease|2
2161849|NCT01258348|3779214|FG000|Overall Study|Physician Decision|0
2161850|NCT01258348|3779215|FG001|Overall Study|Physician Decision|0
2161851|NCT01258348|3779216|FG002|Overall Study|Physician Decision|0
2161852|NCT01258348|3779217|FG003|Overall Study|Physician Decision|2
2161853|NCT01258348|3779218|FG004|Overall Study|Physician Decision|0
2161854|NCT01258348|3779214|FG000|Overall Study|Withdrawal by Subject|0
2161855|NCT01258348|3779215|FG001|Overall Study|Withdrawal by Subject|1
2161856|NCT01258348|3779216|FG002|Overall Study|Withdrawal by Subject|0
2161857|NCT01258348|3779217|FG003|Overall Study|Withdrawal by Subject|0
2161858|NCT01258348|3779218|FG004|Overall Study|Withdrawal by Subject|0
2161859|NCT01258595|3779289|FG000|Overall Study|Lost to Follow-up|1
2161860|NCT01258595|3779290|FG001|Overall Study|Lost to Follow-up|0
2161861|NCT01258595|3779289|FG000|Overall Study|Withdrawal by Subject|0
2161862|NCT01258595|3779290|FG001|Overall Study|Withdrawal by Subject|1
2161863|NCT01258608|3779298|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1
2161864|NCT01258608|3779299|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0
2161865|NCT01258608|3779298|FG000|Overall Study|Clinical progression|1
2161866|NCT01258608|3779299|FG001|Overall Study|Clinical progression|0
2161867|NCT01258608|3779298|FG000|Overall Study|Sponsor decision|0
2161868|NCT01258608|3779299|FG001|Overall Study|Sponsor decision|1
2161869|NCT01258608|3779298|FG000|Overall Study|Physician Decision|6
2161870|NCT01258608|3779299|FG001|Overall Study|Physician Decision|1
2161871|NCT01258608|3779298|FG000|Overall Study|Lost to Follow-up|0
2161872|NCT01258608|3779299|FG001|Overall Study|Lost to Follow-up|1
2161873|NCT01258608|3779298|FG000|Overall Study|Lack of compliance|1
2161874|NCT01258608|3779299|FG001|Overall Study|Lack of compliance|0
2161875|NCT01258608|3779298|FG000|Overall Study|Lack of Efficacy|0
2161876|NCT01258608|3779299|FG001|Overall Study|Lack of Efficacy|1
2161877|NCT01258608|3779298|FG000|Overall Study|Adverse Event|6
2161878|NCT01258608|3779299|FG001|Overall Study|Adverse Event|10
2161879|NCT01258608|3779298|FG000|Overall Study|Withdrawal by Subject|6
2161880|NCT01258608|3779299|FG001|Overall Study|Withdrawal by Subject|5
2161881|NCT01258660|3779308|FG000|Overall Study|Adverse Event|2
2161882|NCT01258660|3779309|FG001|Overall Study|Adverse Event|4
2161883|NCT01258660|3779308|FG000|Overall Study|Withdrawal by Subject|3
2161884|NCT01258660|3779309|FG001|Overall Study|Withdrawal by Subject|0
2161885|NCT01258660|3779308|FG000|Overall Study|due to relocation|2
2161886|NCT01258660|3779309|FG001|Overall Study|due to relocation|0
2161887|NCT01258660|3779308|FG000|Overall Study|Protocol Violation|0
2161888|NCT01258660|3779309|FG001|Overall Study|Protocol Violation|1
2161889|NCT01258660|3779308|FG000|Overall Study|Invalid for primary analysis data set|4
2161890|NCT01258660|3779309|FG001|Overall Study|Invalid for primary analysis data set|6
2161891|NCT01258738|3779318|FG000|Double-blind Period|Did not meet inclusion criteria|3
2161892|NCT01258738|3779319|FG001|Double-blind Period|Did not meet inclusion criteria|3
2161893|NCT01258738|3779318|FG000|Double-blind Period|Withdrawal by Subject|2
2161894|NCT01258738|3779319|FG001|Double-blind Period|Withdrawal by Subject|2
2161895|NCT01258738|3779318|FG000|Double-blind Period|Protocol Violation|1
2161896|NCT01258738|3779319|FG001|Double-blind Period|Protocol Violation|1
2161897|NCT01258738|3779318|FG000|Double-blind Period|Adverse Event|3
2161898|NCT01258738|3779319|FG001|Double-blind Period|Adverse Event|1
2161899|NCT01258738|3779318|FG000|Open-label Period|Did not meet inclusion criteria|0
2161900|NCT01258738|3779319|FG001|Open-label Period|Did not meet inclusion criteria|1
2161901|NCT01258738|3779318|FG000|Open-label Period|Insufficient clinical response|5
2161902|NCT01258738|3779319|FG001|Open-label Period|Insufficient clinical response|3
2161903|NCT01258738|3779318|FG000|Open-label Period|Lost to Follow-up|0
2161904|NCT01258738|3779319|FG001|Open-label Period|Lost to Follow-up|2
2161905|NCT01258738|3779318|FG000|Open-label Period|Withdrawal by Subject|5
2161906|NCT01258738|3779319|FG001|Open-label Period|Withdrawal by Subject|6
2161907|NCT01258738|3779318|FG000|Open-label Period|Protocol Violation|2
2161908|NCT01258738|3779319|FG001|Open-label Period|Protocol Violation|2
2161909|NCT01258738|3779318|FG000|Open-label Period|Adverse Event|4
2161910|NCT01258738|3779319|FG001|Open-label Period|Adverse Event|5
2161911|NCT01258738|3779318|FG000|Open-label Period|Other Reasons|0
2161912|NCT01258738|3779319|FG001|Open-label Period|Other Reasons|1
2161913|NCT01258738|3779318|FG000|Open-label Period|Withdrawn due to pregnancy|1
2161914|NCT01258738|3779319|FG001|Open-label Period|Withdrawn due to pregnancy|1
2161915|NCT01258998|3779352|FG000|Overall Study|Ineligible|1
2161916|NCT01259089|3779371|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0
2161917|NCT01259089|3779372|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0
2161918|NCT01259089|3779373|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0
2161919|NCT01259089|3779374|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0
2161920|NCT01259089|3779375|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0
2161921|NCT01259089|3779376|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1
2161922|NCT01259089|3779371|FG000|Reached First Response at 4 Weeks|Adverse Event|0
2161923|NCT01259089|3779372|FG001|Reached First Response at 4 Weeks|Adverse Event|0
2161924|NCT01259089|3779373|FG002|Reached First Response at 4 Weeks|Adverse Event|0
2161925|NCT01259089|3779374|FG003|Reached First Response at 4 Weeks|Adverse Event|0
2161926|NCT01259089|3779375|FG004|Reached First Response at 4 Weeks|Adverse Event|0
2161927|NCT01259089|3779376|FG005|Reached First Response at 4 Weeks|Adverse Event|1
2161928|NCT01259089|3779371|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2161929|NCT01259089|3779372|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2161930|NCT01259089|3779373|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2161931|NCT01259089|3779374|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2161932|NCT01259089|3779375|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2161933|NCT01259089|3779376|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
2161934|NCT01259089|3779371|FG000|Confirmed Response at 8 Weeks|Adverse Event|0
2161935|NCT01259089|3779372|FG001|Confirmed Response at 8 Weeks|Adverse Event|0
2161936|NCT01259089|3779373|FG002|Confirmed Response at 8 Weeks|Adverse Event|0
2161937|NCT01259089|3779374|FG003|Confirmed Response at 8 Weeks|Adverse Event|0
2161938|NCT01259089|3779375|FG004|Confirmed Response at 8 Weeks|Adverse Event|1
2161939|NCT01259089|3779376|FG005|Confirmed Response at 8 Weeks|Adverse Event|2
2161940|NCT01259089|3779371|FG000|Confirmed Response at 8 Weeks|Progressive disease|0
2161941|NCT01259089|3779372|FG001|Confirmed Response at 8 Weeks|Progressive disease|0
2161942|NCT01259089|3779373|FG002|Confirmed Response at 8 Weeks|Progressive disease|1
2161943|NCT01259089|3779374|FG003|Confirmed Response at 8 Weeks|Progressive disease|1
2161944|NCT01259089|3779375|FG004|Confirmed Response at 8 Weeks|Progressive disease|3
2161945|NCT01259089|3779376|FG005|Confirmed Response at 8 Weeks|Progressive disease|7
2161946|NCT01259089|3779371|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
2161947|NCT01259089|3779372|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2161948|NCT01259089|3779373|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2161949|NCT01259089|3779374|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2161950|NCT01259089|3779375|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2161951|NCT01259089|3779376|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2161952|NCT01259089|3779371|FG000|Continued Treatment After 8 Weeks|Adverse Event|0
2161953|NCT01259089|3779372|FG001|Continued Treatment After 8 Weeks|Adverse Event|0
2161954|NCT01259089|3779373|FG002|Continued Treatment After 8 Weeks|Adverse Event|0
2161955|NCT01259089|3779374|FG003|Continued Treatment After 8 Weeks|Adverse Event|0
2161956|NCT01259089|3779375|FG004|Continued Treatment After 8 Weeks|Adverse Event|2
2161957|NCT01259089|3779376|FG005|Continued Treatment After 8 Weeks|Adverse Event|1
2161958|NCT01259089|3779371|FG000|Continued Treatment After 8 Weeks|Progressive disease|1
2161959|NCT01259089|3779372|FG001|Continued Treatment After 8 Weeks|Progressive disease|1
2161960|NCT01259089|3779373|FG002|Continued Treatment After 8 Weeks|Progressive disease|1
2161961|NCT01259089|3779374|FG003|Continued Treatment After 8 Weeks|Progressive disease|1
2161962|NCT01259089|3779375|FG004|Continued Treatment After 8 Weeks|Progressive disease|0
2161963|NCT01259089|3779376|FG005|Continued Treatment After 8 Weeks|Progressive disease|0
2161964|NCT01259089|3779371|FG000|Survival Follow up for Two Years|Death|3
2161965|NCT01259089|3779372|FG001|Survival Follow up for Two Years|Death|2
2161966|NCT01259089|3779373|FG002|Survival Follow up for Two Years|Death|2
2161967|NCT01259089|3779374|FG003|Survival Follow up for Two Years|Death|3
2161968|NCT01259089|3779375|FG004|Survival Follow up for Two Years|Death|6
2161969|NCT01259089|3779376|FG005|Survival Follow up for Two Years|Death|13
2161970|NCT01259089|3779371|FG000|Survival Follow up for Two Years|Lost to Follow-up|0
2161971|NCT01259089|3779372|FG001|Survival Follow up for Two Years|Lost to Follow-up|0
2161972|NCT01259089|3779373|FG002|Survival Follow up for Two Years|Lost to Follow-up|0
2161973|NCT01259089|3779374|FG003|Survival Follow up for Two Years|Lost to Follow-up|0
2161974|NCT01259089|3779375|FG004|Survival Follow up for Two Years|Lost to Follow-up|0
2161975|NCT01259089|3779376|FG005|Survival Follow up for Two Years|Lost to Follow-up|2
2161976|NCT01259089|3779371|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0
2161977|NCT01259089|3779372|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0
2161978|NCT01259089|3779373|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0
2161979|NCT01259089|3779374|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0
2161980|NCT01259089|3779375|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0
2161981|NCT01259089|3779376|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4
2161982|NCT01259102|3779395|FG000|Overall Study|Adverse Event|1
2161983|NCT01259102|3779396|FG001|Overall Study|Adverse Event|0
2161984|NCT01259102|3779397|FG002|Overall Study|Adverse Event|1
2161985|NCT01259102|3779398|FG003|Overall Study|Adverse Event|1
2161986|NCT01259102|3779399|FG004|Overall Study|Adverse Event|0
2161987|NCT01259102|3779395|FG000|Overall Study|Other|0
2161988|NCT01259102|3779396|FG001|Overall Study|Other|0
2161989|NCT01259102|3779397|FG002|Overall Study|Other|1
2161990|NCT01259102|3779398|FG003|Overall Study|Other|1
2161991|NCT01259102|3779399|FG004|Overall Study|Other|1
2161992|NCT01259115|3779411|FG000|Period 1|Adverse Event|1
2161993|NCT01259115|3779412|FG001|Period 1|Adverse Event|0
2161994|NCT01259115|3779411|FG000|Period 1|Protocol Violation|2
2161995|NCT01259115|3779412|FG001|Period 1|Protocol Violation|0
2161996|NCT01259115|3779411|FG000|Period 1|Lost to Follow-up|0
2161997|NCT01259115|3779412|FG001|Period 1|Lost to Follow-up|1
2161998|NCT01259115|3779411|FG000|Period 2|Adverse Event|1
2161999|NCT01259115|3779412|FG001|Period 2|Adverse Event|0
2162000|NCT01259245|3779434|FG000|Overall Study|Withdrawal by Subject|27
2162001|NCT01259245|3779435|FG001|Overall Study|Withdrawal by Subject|24
2162002|NCT01259245|3779434|FG000|Overall Study|Death|1
2162003|NCT01259245|3779435|FG001|Overall Study|Death|2
2162004|NCT01259297|3779451|FG000|Double Blind Randomized Period|Death|1
2162005|NCT01259297|3779452|FG001|Double Blind Randomized Period|Death|1
2162006|NCT01259297|3779453|FG002|Double Blind Randomized Period|Death|1
2162007|NCT01259297|3779454|FG003|Double Blind Randomized Period|Death|2
2162008|NCT01259297|3779455|FG004|Double Blind Randomized Period|Death|1
2162009|NCT01259297|3779456|FG005|Double Blind Randomized Period|Death|5
2162010|NCT01259297|3779457|FG006|Double Blind Randomized Period|Death|2
2162011|NCT01259297|3779458|FG007|Double Blind Randomized Period|Death|1
2162012|NCT01259297|3779451|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2162013|NCT01259297|3779452|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2162014|NCT01259297|3779453|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
2162015|NCT01259297|3779454|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
2162016|NCT01259297|3779455|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
2162017|NCT01259297|3779456|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2162018|NCT01259297|3779457|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2162019|NCT01259297|3779458|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2162020|NCT01259297|3779451|FG000|Double Blind Randomized Period|Other reasons|0
2162021|NCT01259297|3779452|FG001|Double Blind Randomized Period|Other reasons|1
2162022|NCT01259297|3779453|FG002|Double Blind Randomized Period|Other reasons|0
2162023|NCT01259297|3779454|FG003|Double Blind Randomized Period|Other reasons|0
2162024|NCT01259297|3779455|FG004|Double Blind Randomized Period|Other reasons|1
2162025|NCT01259297|3779456|FG005|Double Blind Randomized Period|Other reasons|2
2162026|NCT01259297|3779457|FG006|Double Blind Randomized Period|Other reasons|3
2162027|NCT01259297|3779458|FG007|Double Blind Randomized Period|Other reasons|1
2162028|NCT01259375|3779475|FG000|Overall Study|Adverse Event|1
2162029|NCT01259388|3779483|FG000|Overall Study|Adverse Event|3
2162030|NCT01259388|3779484|FG001|Overall Study|Adverse Event|0
2162031|NCT01259388|3779483|FG000|Overall Study|Withdrawal by Subject|1
2162032|NCT01259388|3779484|FG001|Overall Study|Withdrawal by Subject|1
2162033|NCT01259388|3779483|FG000|Overall Study|Physician Decision|1
2162034|NCT01259388|3779484|FG001|Overall Study|Physician Decision|0
2162035|NCT01259401|3779492|FG000|4-month Follow-up|Death|0
2162036|NCT01259401|3779493|FG001|4-month Follow-up|Death|1
2162037|NCT01259401|3779492|FG000|4-month Follow-up|Lost to Follow-up|0
2162038|NCT01259401|3779493|FG001|4-month Follow-up|Lost to Follow-up|1
2162039|NCT01259466|3779520|FG000|Overall Study|Withdrawal by Subject|1
2162040|NCT01259466|3779521|FG001|Overall Study|Withdrawal by Subject|9
2162041|NCT01259492|3779531|FG000|Period 1 (9 Weeks)|Adverse Event|13
2162042|NCT01259492|3779532|FG001|Period 1 (9 Weeks)|Adverse Event|18
2162043|NCT01259492|3779533|FG002|Period 1 (9 Weeks)|Adverse Event|26
2162044|NCT01259492|3779534|FG003|Period 1 (9 Weeks)|Adverse Event|3
2162045|NCT01259492|3779531|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2
2162046|NCT01259492|3779532|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2
2162047|NCT01259492|3779533|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4
2162048|NCT01259492|3779534|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11
2162049|NCT01259492|3779531|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5
2162050|NCT01259492|3779532|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8
2162051|NCT01259492|3779533|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6
2162052|NCT01259492|3779534|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7
2162053|NCT01259492|3779531|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4
2162054|NCT01259492|3779532|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6
2162055|NCT01259492|3779533|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3
2162056|NCT01259492|3779534|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4
2162057|NCT01259492|3779531|FG000|Period 1 (9 Weeks)|Administrative Problems|0
2162058|NCT01259492|3779532|FG001|Period 1 (9 Weeks)|Administrative Problems|1
2162059|NCT01259492|3779533|FG002|Period 1 (9 Weeks)|Administrative Problems|1
2162060|NCT01259492|3779534|FG003|Period 1 (9 Weeks)|Administrative Problems|2
2162061|NCT01259492|3779531|FG000|Period 1 (9 Weeks)|Protocol Violation|5
2162062|NCT01259492|3779532|FG001|Period 1 (9 Weeks)|Protocol Violation|6
2162063|NCT01259492|3779533|FG002|Period 1 (9 Weeks)|Protocol Violation|3
2294071|NCT02531802|3988503|FG015|Received Vaccination 2|Physician Decision|0
2294072|NCT02531802|3988504|FG016|Received Vaccination 2|Physician Decision|0
2294073|NCT02531802|3988505|FG017|Received Vaccination 2|Physician Decision|1
2294074|NCT02531802|3988506|FG018|Received Vaccination 2|Physician Decision|0
2294075|NCT02531802|3988507|FG019|Received Vaccination 2|Physician Decision|0
2294076|NCT02531802|3988508|FG020|Received Vaccination 2|Physician Decision|0
2294077|NCT02531802|3988488|FG000|Received Vaccination 2|Adverse Event|0
2294078|NCT02531802|3988489|FG001|Received Vaccination 2|Adverse Event|0
2294079|NCT02531802|3988490|FG002|Received Vaccination 2|Adverse Event|0
2294080|NCT02531802|3988491|FG003|Received Vaccination 2|Adverse Event|0
2294081|NCT02531802|3988492|FG004|Received Vaccination 2|Adverse Event|0
2294082|NCT02531802|3988493|FG005|Received Vaccination 2|Adverse Event|2
2294083|NCT02531802|3988494|FG006|Received Vaccination 2|Adverse Event|0
2294084|NCT02531802|3988495|FG007|Received Vaccination 2|Adverse Event|0
2294085|NCT02531802|3988496|FG008|Received Vaccination 2|Adverse Event|0
2294086|NCT02531802|3988497|FG009|Received Vaccination 2|Adverse Event|0
2294087|NCT02531802|3988498|FG010|Received Vaccination 2|Adverse Event|0
2294088|NCT02531802|3988499|FG011|Received Vaccination 2|Adverse Event|0
2294089|NCT02531802|3988500|FG012|Received Vaccination 2|Adverse Event|0
2294090|NCT02531802|3988501|FG013|Received Vaccination 2|Adverse Event|0
2294091|NCT02531802|3988502|FG014|Received Vaccination 2|Adverse Event|0
2294092|NCT02531802|3988503|FG015|Received Vaccination 2|Adverse Event|0
2294093|NCT02531802|3988504|FG016|Received Vaccination 2|Adverse Event|0
2294094|NCT02531802|3988505|FG017|Received Vaccination 2|Adverse Event|2
2294095|NCT02531802|3988506|FG018|Received Vaccination 2|Adverse Event|1
2294096|NCT02531802|3988507|FG019|Received Vaccination 2|Adverse Event|0
2294097|NCT02531802|3988508|FG020|Received Vaccination 2|Adverse Event|1
2294098|NCT02531802|3988488|FG000|Received Vaccination 2|Withdrawal by Subject|0
2294099|NCT02531802|3988489|FG001|Received Vaccination 2|Withdrawal by Subject|0
2294100|NCT02531802|3988490|FG002|Received Vaccination 2|Withdrawal by Subject|0
2294101|NCT02531802|3988491|FG003|Received Vaccination 2|Withdrawal by Subject|0
2294102|NCT02531802|3988492|FG004|Received Vaccination 2|Withdrawal by Subject|0
2294103|NCT02531802|3988493|FG005|Received Vaccination 2|Withdrawal by Subject|0
2294104|NCT02531802|3988494|FG006|Received Vaccination 2|Withdrawal by Subject|0
2294105|NCT02531802|3988495|FG007|Received Vaccination 2|Withdrawal by Subject|0
2294106|NCT02531802|3988496|FG008|Received Vaccination 2|Withdrawal by Subject|0
2294107|NCT02531802|3988497|FG009|Received Vaccination 2|Withdrawal by Subject|0
2294108|NCT02531802|3988498|FG010|Received Vaccination 2|Withdrawal by Subject|1
2294109|NCT02531802|3988499|FG011|Received Vaccination 2|Withdrawal by Subject|0
2294110|NCT02531802|3988500|FG012|Received Vaccination 2|Withdrawal by Subject|1
2162064|NCT01259492|3779534|FG003|Period 1 (9 Weeks)|Protocol Violation|1
2162065|NCT01259492|3779531|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3
2162066|NCT01259492|3779532|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4
2294111|NCT02531802|3988501|FG013|Received Vaccination 2|Withdrawal by Subject|1
2294112|NCT02531802|3988502|FG014|Received Vaccination 2|Withdrawal by Subject|1
2294113|NCT02531802|3988503|FG015|Received Vaccination 2|Withdrawal by Subject|0
2294114|NCT02531802|3988504|FG016|Received Vaccination 2|Withdrawal by Subject|0
2294115|NCT02531802|3988505|FG017|Received Vaccination 2|Withdrawal by Subject|1
2162067|NCT01259492|3779533|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7
2162068|NCT01259492|3779534|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8
2162069|NCT01259492|3779531|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
2162070|NCT01259492|3779532|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
2162071|NCT01259492|3779533|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
2162072|NCT01259492|3779534|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
2162073|NCT01259492|3779531|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
2162074|NCT01259492|3779532|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
2162075|NCT01259492|3779533|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
2162076|NCT01259492|3779534|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
2162077|NCT01259492|3779531|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
2162078|NCT01259492|3779532|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
2162079|NCT01259492|3779533|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
2162080|NCT01259492|3779534|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
2162081|NCT01259492|3779531|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0
2162082|NCT01259492|3779532|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2
2162083|NCT01259492|3779533|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1
2162084|NCT01259492|3779534|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0
2162085|NCT01259492|3779531|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
2162086|NCT01259492|3779532|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
2162087|NCT01259492|3779533|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
2162088|NCT01259492|3779534|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
2162089|NCT01259492|3779531|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
2162090|NCT01259492|3779532|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
2162091|NCT01259492|3779533|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
2162092|NCT01259492|3779534|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
2162093|NCT01259492|3779531|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
2162094|NCT01259492|3779532|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
2162095|NCT01259492|3779533|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
2162096|NCT01259492|3779534|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
2162097|NCT01259492|3779531|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
2162098|NCT01259492|3779532|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
2162099|NCT01259492|3779533|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
2162100|NCT01259492|3779534|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
2162101|NCT01259492|3779531|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
2162102|NCT01259492|3779532|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
2162103|NCT01259492|3779533|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
2162104|NCT01259492|3779534|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
2162105|NCT01259492|3779531|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
2162106|NCT01259492|3779532|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
2162107|NCT01259492|3779533|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
2162108|NCT01259492|3779534|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
2162109|NCT01259492|3779531|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
2162110|NCT01259492|3779532|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
2162111|NCT01259492|3779533|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
2162112|NCT01259492|3779534|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
2162113|NCT01259492|3779531|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
2162114|NCT01259492|3779532|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
2162115|NCT01259492|3779533|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
2162116|NCT01259492|3779534|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
2162117|NCT01259492|3779531|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
2162118|NCT01259492|3779532|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
2162119|NCT01259492|3779533|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
2162120|NCT01259492|3779534|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
2162121|NCT01259713|3779556|FG000|Overall Study|Adverse Event|54
2162122|NCT01259713|3779557|FG001|Overall Study|Adverse Event|23
2162123|NCT01259713|3779556|FG000|Overall Study|Death Not Related to IFI|8
2162124|NCT01259713|3779557|FG001|Overall Study|Death Not Related to IFI|1
2162125|NCT01259713|3779556|FG000|Overall Study|Investigators Discretion|14
2162126|NCT01259713|3779557|FG001|Overall Study|Investigators Discretion|6
2162127|NCT01259713|3779556|FG000|Overall Study|Lack of Efficacy|2
2294116|NCT02531802|3988506|FG018|Received Vaccination 2|Withdrawal by Subject|1
2294117|NCT02531802|3988507|FG019|Received Vaccination 2|Withdrawal by Subject|1
2294118|NCT02531802|3988508|FG020|Received Vaccination 2|Withdrawal by Subject|0
2294119|NCT02532179|3988609|FG000|Overall Study|Lost to Follow-up|1
2294120|NCT02532179|3988609|FG000|Overall Study|Pregnancy|1
2294121|NCT02532179|3988609|FG000|Overall Study|Subject received depot steroid injection|1
2162128|NCT01259713|3779557|FG001|Overall Study|Lack of Efficacy|0
2162129|NCT01259713|3779556|FG000|Overall Study|Protocol Violation|5
2162130|NCT01259713|3779557|FG001|Overall Study|Protocol Violation|4
2294122|NCT02532283|3988615|FG000|Overall Study|Adverse Event|0
2162131|NCT01259713|3779556|FG000|Overall Study|Subject Withdrew Consent|12
2162132|NCT01259713|3779557|FG001|Overall Study|Subject Withdrew Consent|7
2162133|NCT01259726|3779567|FG000|Overall Study|Death|1
2162134|NCT01259726|3779568|FG001|Overall Study|Death|0
2162135|NCT01259726|3779569|FG002|Overall Study|Death|0
2162136|NCT01259726|3779570|FG003|Overall Study|Death|0
2162137|NCT01259726|3779567|FG000|Overall Study|Physician Decision|2
2162138|NCT01259726|3779568|FG001|Overall Study|Physician Decision|0
2162139|NCT01259726|3779569|FG002|Overall Study|Physician Decision|1
2162140|NCT01259726|3779570|FG003|Overall Study|Physician Decision|1
2162141|NCT01259726|3779567|FG000|Overall Study|Withdrawal by Subject|1
2162142|NCT01259726|3779568|FG001|Overall Study|Withdrawal by Subject|3
2162143|NCT01259726|3779569|FG002|Overall Study|Withdrawal by Subject|2
2162144|NCT01259726|3779570|FG003|Overall Study|Withdrawal by Subject|1
2162145|NCT01259726|3779567|FG000|Overall Study|Lost to Follow-up|1
2162146|NCT01259726|3779568|FG001|Overall Study|Lost to Follow-up|1
2162147|NCT01259726|3779569|FG002|Overall Study|Lost to Follow-up|1
2162148|NCT01259726|3779570|FG003|Overall Study|Lost to Follow-up|3
2162149|NCT01259856|3779582|FG000|Overall Study|Adverse Event|12
2162150|NCT01259856|3779583|FG001|Overall Study|Adverse Event|9
2162151|NCT01259856|3779582|FG000|Overall Study|Death|0
2162152|NCT01259856|3779583|FG001|Overall Study|Death|1
2162153|NCT01259856|3779582|FG000|Overall Study|Lack of Efficacy|3
2162154|NCT01259856|3779583|FG001|Overall Study|Lack of Efficacy|1
2162155|NCT01259856|3779582|FG000|Overall Study|Lost to Follow-up|1
2162156|NCT01259856|3779583|FG001|Overall Study|Lost to Follow-up|1
2162157|NCT01259856|3779582|FG000|Overall Study|Physician Decision|2
2162158|NCT01259856|3779583|FG001|Overall Study|Physician Decision|1
2162159|NCT01259856|3779582|FG000|Overall Study|Withdrawal by Subject|9
2162160|NCT01259856|3779583|FG001|Overall Study|Withdrawal by Subject|10
2162161|NCT01259856|3779582|FG000|Overall Study|Treatment never started|0
2162162|NCT01259856|3779583|FG001|Overall Study|Treatment never started|6
2162163|NCT01259856|3779582|FG000|Overall Study|Study closure by sponsor|40
2162164|NCT01259856|3779583|FG001|Overall Study|Study closure by sponsor|41
2162165|NCT01259856|3779582|FG000|Overall Study|Patient developed other disease|0
2162166|NCT01259856|3779583|FG001|Overall Study|Patient developed other disease|1
2162167|NCT01259856|3779582|FG000|Overall Study|Transfer to another study|0
2162168|NCT01259856|3779583|FG001|Overall Study|Transfer to another study|1
2162169|NCT01259856|3779582|FG000|Overall Study|Unknown/missing|2
2162170|NCT01259856|3779583|FG001|Overall Study|Unknown/missing|2
2162171|NCT01259869|3779589|FG000|Overall Study|Duplicated registration|1
2162172|NCT01260142|3779599|FG000|Treatment Period 1|Study on hold|1
2162173|NCT01260142|3779600|FG001|Treatment Period 1|Study on hold|1
2162174|NCT01260142|3779601|FG002|Treatment Period 1|Study on hold|0
2162175|NCT01260142|3779602|FG003|Treatment Period 1|Study on hold|0
2162176|NCT01260142|3779603|FG004|Treatment Period 1|Study on hold|1
2162177|NCT01260142|3779604|FG005|Treatment Period 1|Study on hold|2
2162178|NCT01260142|3779599|FG000|Treatment Period 1|Unexplained elevated sys. BP|0
2162179|NCT01260142|3779600|FG001|Treatment Period 1|Unexplained elevated sys. BP|0
2162180|NCT01260142|3779601|FG002|Treatment Period 1|Unexplained elevated sys. BP|0
2294123|NCT02532283|3988616|FG001|Overall Study|Adverse Event|1
2294124|NCT02532283|3988615|FG000|Overall Study|Death|1
2294125|NCT02532283|3988616|FG001|Overall Study|Death|0
2294126|NCT02532283|3988615|FG000|Overall Study|Lost to Follow-up|0
2294127|NCT02532283|3988616|FG001|Overall Study|Lost to Follow-up|1
2294128|NCT02532283|3988615|FG000|Overall Study|Withdrawal by Subject|8
2294129|NCT02532283|3988616|FG001|Overall Study|Withdrawal by Subject|3
2294130|NCT02532374|3988624|FG000|Overall Study|Withdrawal by Subject|1
2294131|NCT02532374|3988624|FG000|Overall Study|Physician Decision|1
2294132|NCT02532465|3988638|FG000|Overall Study|Protocol Violation|1
2294133|NCT02532465|3988639|FG001|Overall Study|Protocol Violation|0
2294134|NCT02532465|3988638|FG000|Overall Study|Lack of Efficacy|0
2294135|NCT02532465|3988639|FG001|Overall Study|Lack of Efficacy|1
2294136|NCT02532517|3988645|FG000|Overall Study|Did not complete 24-Month visit|4
2294137|NCT02532517|3988645|FG000|Overall Study|Failed Angiographic eligibility|1
2294138|NCT02532517|3988645|FG000|Overall Study|Lost to Follow-up|4
2294139|NCT02532517|3988645|FG000|Overall Study|Withdrawal by Subject|4
2294140|NCT02532517|3988645|FG000|Overall Study|Death|4
2294141|NCT02532543|3988653|FG000|Overall Study|Lost to Follow-up|0
2294142|NCT02532543|3988654|FG001|Overall Study|Lost to Follow-up|0
2294143|NCT02532543|3988655|FG002|Overall Study|Lost to Follow-up|1
2162181|NCT01260142|3779602|FG003|Treatment Period 1|Unexplained elevated sys. BP|0
2162182|NCT01260142|3779603|FG004|Treatment Period 1|Unexplained elevated sys. BP|1
2162183|NCT01260142|3779604|FG005|Treatment Period 1|Unexplained elevated sys. BP|0
2162184|NCT01260142|3779599|FG000|Treatment Period 1|Withdrawal by Subject|0
2162185|NCT01260142|3779600|FG001|Treatment Period 1|Withdrawal by Subject|0
2162186|NCT01260142|3779601|FG002|Treatment Period 1|Withdrawal by Subject|0
2294144|NCT02532543|3988656|FG003|Overall Study|Lost to Follow-up|0
2294145|NCT02532647|3988679|FG000|Overall Study|Did not receive trial medication|1
2294146|NCT02532647|3988680|FG001|Overall Study|Did not receive trial medication|0
2294147|NCT02532647|3988681|FG002|Overall Study|Did not receive trial medication|1
2294148|NCT02532764|3988699|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2294149|NCT02532764|3988700|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2294150|NCT02532764|3988701|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2162187|NCT01260142|3779602|FG003|Treatment Period 1|Withdrawal by Subject|0
2162188|NCT01260142|3779603|FG004|Treatment Period 1|Withdrawal by Subject|0
2162189|NCT01260142|3779604|FG005|Treatment Period 1|Withdrawal by Subject|1
2162190|NCT01260181|3779624|FG000|Overall Study|Decision of Investigator|1
2162191|NCT01260194|3779628|FG000|Overall Study|Withdrawal of Consent|1
2162192|NCT01260311|3779643|FG000|Overall Study|Adverse Event|11
2162193|NCT01260311|3779643|FG000|Overall Study|Lack of Efficacy|4
2162194|NCT01260311|3779643|FG000|Overall Study|Lost to Follow-up|25
2162195|NCT01260311|3779643|FG000|Overall Study|Withdrawal by Subject|6
2162196|NCT01260311|3779643|FG000|Overall Study|Financial Constraints|77
2162197|NCT01260311|3779643|FG000|Overall Study|Gone to Province|2
2162198|NCT01260311|3779643|FG000|Overall Study|Medication Stopped|1
2162199|NCT01260311|3779643|FG000|Overall Study|Fesoterodine Started Before Enrollment|1
2162200|NCT01260350|3779676|FG000|Overall Study|Lack of Efficacy|0
2162201|NCT01260350|3779677|FG001|Overall Study|Lack of Efficacy|0
2162202|NCT01260350|3779678|FG002|Overall Study|Lack of Efficacy|0
2162203|NCT01260350|3779679|FG003|Overall Study|Lack of Efficacy|0
2162204|NCT01260350|3779680|FG004|Overall Study|Lack of Efficacy|0
2162205|NCT01260350|3779681|FG005|Overall Study|Lack of Efficacy|0
2162206|NCT01260350|3779682|FG006|Overall Study|Lack of Efficacy|0
2162207|NCT01260350|3779683|FG007|Overall Study|Lack of Efficacy|0
2162208|NCT01260350|3779684|FG008|Overall Study|Lack of Efficacy|0
2162209|NCT01260350|3779685|FG009|Overall Study|Lack of Efficacy|0
2162210|NCT01260350|3779686|FG010|Overall Study|Lack of Efficacy|0
2162211|NCT01260350|3779687|FG011|Overall Study|Lack of Efficacy|0
2162212|NCT01260350|3779688|FG012|Overall Study|Lack of Efficacy|0
2162213|NCT01260350|3779689|FG013|Overall Study|Lack of Efficacy|0
2162214|NCT01260350|3779690|FG014|Overall Study|Lack of Efficacy|0
2162215|NCT01260350|3779691|FG015|Overall Study|Lack of Efficacy|0
2162216|NCT01260350|3779692|FG016|Overall Study|Lack of Efficacy|0
2162217|NCT01260350|3779693|FG017|Overall Study|Lack of Efficacy|1
2162218|NCT01260350|3779694|FG018|Overall Study|Lack of Efficacy|0
2162219|NCT01260350|3779695|FG019|Overall Study|Lack of Efficacy|0
2162220|NCT01260350|3779696|FG020|Overall Study|Lack of Efficacy|3
2162221|NCT01260350|3779697|FG021|Overall Study|Lack of Efficacy|0
2162222|NCT01260350|3779676|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162223|NCT01260350|3779677|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162224|NCT01260350|3779678|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162225|NCT01260350|3779679|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162226|NCT01260350|3779680|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162227|NCT01260350|3779681|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162228|NCT01260350|3779682|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162229|NCT01260350|3779683|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162230|NCT01260350|3779684|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1
2162231|NCT01260350|3779685|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162232|NCT01260350|3779686|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162233|NCT01260350|3779687|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162234|NCT01260350|3779688|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162235|NCT01260350|3779689|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162236|NCT01260350|3779690|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162237|NCT01260350|3779691|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162238|NCT01260350|3779692|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162239|NCT01260350|3779693|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162240|NCT01260350|3779694|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162241|NCT01260350|3779695|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162242|NCT01260350|3779696|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162243|NCT01260350|3779697|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0
2162244|NCT01260467|3779755|FG000|Overall Study|Withdrawal by Subject|2
2162245|NCT01260584|3779774|FG000|Period 1|Protocol Violation|0
2162246|NCT01260584|3779775|FG001|Period 1|Protocol Violation|0
2162247|NCT01260584|3779776|FG002|Period 1|Protocol Violation|1
2162248|NCT01260584|3779777|FG003|Period 1|Protocol Violation|1
2162249|NCT01260584|3779774|FG000|Period 1|Adverse Event|0
2162250|NCT01260584|3779775|FG001|Period 1|Adverse Event|0
2162251|NCT01260584|3779776|FG002|Period 1|Adverse Event|1
2162252|NCT01260584|3779777|FG003|Period 1|Adverse Event|0
2162253|NCT01260584|3779774|FG000|Period 2|Protocol Violation|0
2162254|NCT01260584|3779775|FG001|Period 2|Protocol Violation|2
2162255|NCT01260584|3779776|FG002|Period 2|Protocol Violation|3
2162256|NCT01260584|3779777|FG003|Period 2|Protocol Violation|1
2162257|NCT01260584|3779774|FG000|Period 2|Adverse Event|1
2162258|NCT01260584|3779775|FG001|Period 2|Adverse Event|0
2162259|NCT01260584|3779776|FG002|Period 2|Adverse Event|2
2162260|NCT01260584|3779777|FG003|Period 2|Adverse Event|0
2162261|NCT01260584|3779774|FG000|Period 2|Withdrawal by Subject|0
2162262|NCT01260584|3779775|FG001|Period 2|Withdrawal by Subject|1
2162263|NCT01260584|3779776|FG002|Period 2|Withdrawal by Subject|0
2162264|NCT01260584|3779777|FG003|Period 2|Withdrawal by Subject|0
2162265|NCT01260701|3779821|FG000|Overall Study|Adverse Event|9
2162266|NCT01260701|3779821|FG000|Overall Study|Withdrawal by Subject|2
2162267|NCT01260701|3779821|FG000|Overall Study|Progression|53
2162268|NCT01260701|3779821|FG000|Overall Study|Death|2
2162269|NCT01260701|3779821|FG000|Overall Study|Not protocol specified|3
2162270|NCT01260701|3779821|FG000|Overall Study|Under review|1
2162271|NCT01260701|3779821|FG000|Overall Study|Ineligible|4
2162272|NCT01260701|3779821|FG000|Overall Study|Did not begin protocol therapy|1
2162273|NCT01260896|3779861|FG000|First Intervention|Withdrawn Due to Emesis|2
2162274|NCT01260896|3779862|FG001|First Intervention|Withdrawn Due to Emesis|0
2162275|NCT01260922|3779870|FG000|First Intervention|Withdrawal by Subject|0
2162276|NCT01260922|3779871|FG001|First Intervention|Withdrawal by Subject|1
2162277|NCT01260922|3779870|FG000|Washout of 28 Days|Withdrawal by Subject|4
2162278|NCT01260922|3779871|FG001|Washout of 28 Days|Withdrawal by Subject|2
2162279|NCT01260922|3779870|FG000|Second Intervention|Emesis|0
2162280|NCT01260922|3779871|FG001|Second Intervention|Emesis|2
2162281|NCT01260948|3779879|FG000|Washout of 28 Days|Withdrawal by Subject|1
2162282|NCT01260948|3779880|FG001|Washout of 28 Days|Withdrawal by Subject|3
2162283|NCT01260948|3779879|FG000|Second Intervention|Emesis|0
2162284|NCT01260948|3779880|FG001|Second Intervention|Emesis|1
2162285|NCT01261000|3779886|FG000|Overall Study|Screen failure|1
2162286|NCT01261325|3779898|FG000|Overall Study|Lack of Efficacy|1
2162287|NCT01261325|3779899|FG001|Overall Study|Lack of Efficacy|1
2162288|NCT01261325|3779900|FG002|Overall Study|Lack of Efficacy|0
2162289|NCT01261325|3779898|FG000|Overall Study|Withdrawal by Subject|2
2162290|NCT01261325|3779899|FG001|Overall Study|Withdrawal by Subject|2
2162291|NCT01261325|3779900|FG002|Overall Study|Withdrawal by Subject|4
2162292|NCT01261325|3779898|FG000|Overall Study|SAE, non-fatal|1
2162293|NCT01261325|3779899|FG001|Overall Study|SAE, non-fatal|5
2162294|NCT01261325|3779900|FG002|Overall Study|SAE, non-fatal|1
2162295|NCT01261325|3779898|FG000|Overall Study|AE, non-serious non-fatal|9
2162296|NCT01261325|3779899|FG001|Overall Study|AE, non-serious non-fatal|15
2162297|NCT01261325|3779900|FG002|Overall Study|AE, non-serious non-fatal|13
2162298|NCT01261325|3779898|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2162299|NCT01261325|3779899|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2162300|NCT01261325|3779900|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2162301|NCT01261325|3779898|FG000|Overall Study|Non Compliance|2
2162302|NCT01261325|3779899|FG001|Overall Study|Non Compliance|0
2162303|NCT01261325|3779900|FG002|Overall Study|Non Compliance|0
2162304|NCT01261325|3779898|FG000|Overall Study|Patient Randomized by Mistake|0
2162305|NCT01261325|3779899|FG001|Overall Study|Patient Randomized by Mistake|1
2162306|NCT01261325|3779900|FG002|Overall Study|Patient Randomized by Mistake|0
2162307|NCT01261325|3779898|FG000|Overall Study|Erroneously Randomized|1
2162308|NCT01261325|3779899|FG001|Overall Study|Erroneously Randomized|0
2162309|NCT01261325|3779900|FG002|Overall Study|Erroneously Randomized|0
2162310|NCT01261325|3779898|FG000|Overall Study|Screen Failure|1
2162311|NCT01261325|3779899|FG001|Overall Study|Screen Failure|0
2162312|NCT01261325|3779900|FG002|Overall Study|Screen Failure|0
2162313|NCT01261325|3779898|FG000|Overall Study|Randomized in Error|0
2162314|NCT01261325|3779899|FG001|Overall Study|Randomized in Error|0
2162315|NCT01261325|3779900|FG002|Overall Study|Randomized in Error|1
2162316|NCT01261325|3779898|FG000|Overall Study|Protocol Violation|0
2162317|NCT01261325|3779899|FG001|Overall Study|Protocol Violation|3
2162318|NCT01261325|3779900|FG002|Overall Study|Protocol Violation|1
2162319|NCT01261325|3779898|FG000|Overall Study|Lost to Follow-up|0
2162320|NCT01261325|3779899|FG001|Overall Study|Lost to Follow-up|1
2162321|NCT01261325|3779900|FG002|Overall Study|Lost to Follow-up|3
2162322|NCT01261325|3779898|FG000|Overall Study|AE, serious fatal|0
2162323|NCT01261325|3779899|FG001|Overall Study|AE, serious fatal|0
2162324|NCT01261325|3779900|FG002|Overall Study|AE, serious fatal|2
2162325|NCT01261338|3779913|FG000|Overall Study|Withdrawal by Subject|3
2162326|NCT01261338|3779914|FG001|Overall Study|Withdrawal by Subject|2
2162327|NCT01261390|3779924|FG000|Overall Study|Significant Concurrent Illness|1
2162328|NCT01261390|3779925|FG001|Overall Study|Significant Concurrent Illness|0
2162329|NCT01261390|3779926|FG002|Overall Study|Significant Concurrent Illness|1
2162330|NCT01261390|3779927|FG003|Overall Study|Significant Concurrent Illness|0
2162331|NCT01261390|3779924|FG000|Overall Study|Dissatisfaction with Treatment|2
2162332|NCT01261390|3779925|FG001|Overall Study|Dissatisfaction with Treatment|1
2162333|NCT01261390|3779926|FG002|Overall Study|Dissatisfaction with Treatment|1
2162334|NCT01261390|3779927|FG003|Overall Study|Dissatisfaction with Treatment|2
2162335|NCT01261390|3779924|FG000|Overall Study|Relocation|0
2162336|NCT01261390|3779925|FG001|Overall Study|Relocation|1
2162337|NCT01261390|3779926|FG002|Overall Study|Relocation|0
2162338|NCT01261390|3779927|FG003|Overall Study|Relocation|0
2162339|NCT01261390|3779924|FG000|Overall Study|Loss of Interest in the Study|3
2162340|NCT01261390|3779925|FG001|Overall Study|Loss of Interest in the Study|1
2162341|NCT01261390|3779926|FG002|Overall Study|Loss of Interest in the Study|0
2162342|NCT01261390|3779927|FG003|Overall Study|Loss of Interest in the Study|0
2162343|NCT01261390|3779924|FG000|Overall Study|Lost to Follow-up|1
2162344|NCT01261390|3779925|FG001|Overall Study|Lost to Follow-up|6
2162345|NCT01261390|3779926|FG002|Overall Study|Lost to Follow-up|5
2162346|NCT01261390|3779927|FG003|Overall Study|Lost to Follow-up|6
2162347|NCT01261611|3779962|FG000|Treatment Cycle 1|Withdrawal by Subject|3
2162348|NCT01261611|3779963|FG001|Treatment Cycle 1|Withdrawal by Subject|2
2162349|NCT01261611|3779964|FG002|Treatment Cycle 1|Withdrawal by Subject|0
2162350|NCT01261611|3779962|FG000|Treatment Cycle 1|Lost to Follow-up|1
2162351|NCT01261611|3779963|FG001|Treatment Cycle 1|Lost to Follow-up|0
2162352|NCT01261611|3779964|FG002|Treatment Cycle 1|Lost to Follow-up|0
2162353|NCT01261611|3779962|FG000|Treatment Cycle 1|Adverse Event|0
2162354|NCT01261611|3779963|FG001|Treatment Cycle 1|Adverse Event|1
2162355|NCT01261611|3779964|FG002|Treatment Cycle 1|Adverse Event|0
2162356|NCT01261611|3779962|FG000|Treatment Cycle 1|Protocol Violation|0
2162357|NCT01261611|3779963|FG001|Treatment Cycle 1|Protocol Violation|0
2294151|NCT02532764|3988702|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2294152|NCT02532764|3988703|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2294153|NCT02532764|3988704|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2294154|NCT02532764|3988705|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2294155|NCT02532764|3988706|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
2294156|NCT02532764|3988707|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
2162358|NCT01261611|3779964|FG002|Treatment Cycle 1|Protocol Violation|2
2162359|NCT01261611|3779962|FG000|Treatment Cycle 2|Completed study|4
2162360|NCT01261611|3779963|FG001|Treatment Cycle 2|Completed study|0
2294157|NCT02532764|3988708|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
2294158|NCT02532855|3988737|FG000|Overall Study|Lost to Follow-up|4
2294159|NCT02532855|3988738|FG001|Overall Study|Lost to Follow-up|3
2294160|NCT02532855|3988737|FG000|Overall Study|Withdrawal by Subject|4
2294161|NCT02532855|3988738|FG001|Overall Study|Withdrawal by Subject|8
2294162|NCT02532972|3988753|FG000|Overall Study|Withdrawal by Subject|1
2294163|NCT02533180|3988797|FG000|Overall Study|Death|0
2294164|NCT02533180|3988798|FG001|Overall Study|Death|1
2294165|NCT02533180|3988797|FG000|Overall Study|Lost to Follow-up|0
2294166|NCT02533180|3988798|FG001|Overall Study|Lost to Follow-up|1
2294167|NCT02533180|3988797|FG000|Overall Study|Physician Decision|0
2294168|NCT02533180|3988798|FG001|Overall Study|Physician Decision|1
2294169|NCT02533180|3988797|FG000|Overall Study|Withdrawal by Subject|2
2294170|NCT02533180|3988798|FG001|Overall Study|Withdrawal by Subject|4
2294171|NCT02533180|3988797|FG000|Overall Study|Screen Failure|37
2294172|NCT02533180|3988798|FG001|Overall Study|Screen Failure|0
2294173|NCT02533180|3988797|FG000|Overall Study|Protocol Deviation|0
2294174|NCT02533180|3988798|FG001|Overall Study|Protocol Deviation|1
2294175|NCT02533180|3988797|FG000|Overall Study|On Study|0
2294176|NCT02533180|3988798|FG001|Overall Study|On Study|39
2294177|NCT02533258|3988803|FG000|Overall Study|Adverse Event|1
2294178|NCT02533258|3988803|FG000|Overall Study|Death|2
2294179|NCT02533258|3988803|FG000|Overall Study|Other|1
2294180|NCT02533258|3988803|FG000|Overall Study|Economic factor|1
2294181|NCT02533258|3988803|FG000|Overall Study|Progression of pleural effusion|1
2294182|NCT02533258|3988803|FG000|Overall Study|Lack of Efficacy|2
2294183|NCT02533375|3988807|FG000|Overall Study|Lack of Efficacy|3
2294184|NCT02533375|3988807|FG000|Overall Study|Adverse Event|2
2294185|NCT02533401|3988811|FG000|Overall Study|Adverse Event/Intercurrent Disease|3
2294186|NCT02533401|3988811|FG000|Overall Study|Death|5
2294187|NCT02533401|3988811|FG000|Overall Study|Insufficient Response/Progressed Disease|1
2294188|NCT02533401|3988811|FG000|Overall Study|Lost to Follow-up|1
2294189|NCT02533401|3988811|FG000|Overall Study|Violation of Selection Criteria|1
2294190|NCT02533453|3988822|FG000|Overall Study|Adverse Event|6
2294191|NCT02533453|3988822|FG000|Overall Study|Protocol Violation|1
2294192|NCT02533453|3988822|FG000|Overall Study|Withdrawal by Subject|2
2294193|NCT02533570|3988847|FG000|Overall Study|Adverse Event|0
2294194|NCT02533570|3988848|FG001|Overall Study|Adverse Event|1
2294195|NCT02533570|3988849|FG002|Overall Study|Adverse Event|1
2294196|NCT02533674|3988865|FG000|Dose Level I|Progressive disease|1
2294197|NCT02533674|3988866|FG001|Dose Level I|Progressive disease|0
2294198|NCT02533674|3988867|FG002|Dose Level I|Progressive disease|0
2294199|NCT02533674|3988868|FG003|Dose Level I|Progressive disease|0
2294200|NCT02533674|3988869|FG004|Dose Level I|Progressive disease|0
2294201|NCT02533674|3988870|FG005|Dose Level I|Progressive disease|0
2294202|NCT02533674|3988871|FG006|Dose Level I|Progressive disease|0
2294203|NCT02533674|3988872|FG007|Dose Level I|Progressive disease|0
2294204|NCT02533674|3988865|FG000|Dose Level I|Withdrawal by Subject|1
2294205|NCT02533674|3988866|FG001|Dose Level I|Withdrawal by Subject|0
2294206|NCT02533674|3988867|FG002|Dose Level I|Withdrawal by Subject|0
2294207|NCT02533674|3988868|FG003|Dose Level I|Withdrawal by Subject|0
2294208|NCT02533674|3988869|FG004|Dose Level I|Withdrawal by Subject|0
2294209|NCT02533674|3988870|FG005|Dose Level I|Withdrawal by Subject|0
2294210|NCT02533674|3988871|FG006|Dose Level I|Withdrawal by Subject|0
2294211|NCT02533674|3988872|FG007|Dose Level I|Withdrawal by Subject|0
2294212|NCT02533674|3988865|FG000|Dose Level I|Physician Decision|1
2294213|NCT02533674|3988866|FG001|Dose Level I|Physician Decision|0
2294214|NCT02533674|3988867|FG002|Dose Level I|Physician Decision|0
2162361|NCT01261611|3779964|FG002|Treatment Cycle 2|Completed study|0
2294215|NCT02533674|3988868|FG003|Dose Level I|Physician Decision|0
2294216|NCT02533674|3988869|FG004|Dose Level I|Physician Decision|0
2294217|NCT02533674|3988870|FG005|Dose Level I|Physician Decision|0
2294218|NCT02533674|3988871|FG006|Dose Level I|Physician Decision|0
2294219|NCT02533674|3988872|FG007|Dose Level I|Physician Decision|0
2294220|NCT02533674|3988865|FG000|Dose Level I|Death|1
2294221|NCT02533674|3988866|FG001|Dose Level I|Death|0
2294222|NCT02533674|3988867|FG002|Dose Level I|Death|0
2294223|NCT02533674|3988868|FG003|Dose Level I|Death|0
2294224|NCT02533674|3988869|FG004|Dose Level I|Death|0
2294225|NCT02533674|3988870|FG005|Dose Level I|Death|0
2294226|NCT02533674|3988871|FG006|Dose Level I|Death|0
2294227|NCT02533674|3988872|FG007|Dose Level I|Death|0
2162362|NCT01261611|3779962|FG000|Treatment Cycle 2|Withdrawal by Subject|4
2162363|NCT01261611|3779963|FG001|Treatment Cycle 2|Withdrawal by Subject|0
2162364|NCT01261611|3779964|FG002|Treatment Cycle 2|Withdrawal by Subject|0
2162365|NCT01261611|3779962|FG000|Treatment Cycle 2|Adverse Event|1
2162366|NCT01261611|3779963|FG001|Treatment Cycle 2|Adverse Event|0
2162367|NCT01261611|3779964|FG002|Treatment Cycle 2|Adverse Event|0
2162368|NCT01261611|3779962|FG000|Treatment Cycle 2|Protocol Violation|2
2162369|NCT01261611|3779963|FG001|Treatment Cycle 2|Protocol Violation|0
2162370|NCT01261611|3779964|FG002|Treatment Cycle 2|Protocol Violation|0
2162371|NCT01261611|3779962|FG000|Treatment Cycle 2|Not otherwise specified|2
2162372|NCT01261611|3779963|FG001|Treatment Cycle 2|Not otherwise specified|0
2162373|NCT01261611|3779964|FG002|Treatment Cycle 2|Not otherwise specified|0
2162374|NCT01261611|3779962|FG000|Treatment Cycle 3|Completed study|24
2162375|NCT01261611|3779963|FG001|Treatment Cycle 3|Completed study|0
2162376|NCT01261611|3779964|FG002|Treatment Cycle 3|Completed study|0
2162377|NCT01261611|3779962|FG000|Treatment Cycle 3|Withdrawal by Subject|4
2162378|NCT01261611|3779963|FG001|Treatment Cycle 3|Withdrawal by Subject|0
2162379|NCT01261611|3779964|FG002|Treatment Cycle 3|Withdrawal by Subject|0
2162380|NCT01261611|3779962|FG000|Treatment Cycle 3|Adverse Event|1
2162381|NCT01261611|3779963|FG001|Treatment Cycle 3|Adverse Event|0
2162382|NCT01261611|3779964|FG002|Treatment Cycle 3|Adverse Event|0
2162383|NCT01261611|3779962|FG000|Treatment Cycle 3|Lost to Follow-up|1
2162384|NCT01261611|3779963|FG001|Treatment Cycle 3|Lost to Follow-up|0
2162385|NCT01261611|3779964|FG002|Treatment Cycle 3|Lost to Follow-up|0
2162386|NCT01261611|3779962|FG000|Treatment Cycle 4|Completed study|87
2162387|NCT01261611|3779963|FG001|Treatment Cycle 4|Completed study|0
2162388|NCT01261611|3779964|FG002|Treatment Cycle 4|Completed study|0
2162389|NCT01261611|3779962|FG000|Treatment Cycle 4|Withdrawal by Subject|3
2162390|NCT01261611|3779963|FG001|Treatment Cycle 4|Withdrawal by Subject|0
2162391|NCT01261611|3779964|FG002|Treatment Cycle 4|Withdrawal by Subject|0
2162392|NCT01261611|3779962|FG000|Treatment Cycle 4|Adverse Event|1
2162393|NCT01261611|3779963|FG001|Treatment Cycle 4|Adverse Event|0
2162394|NCT01261611|3779964|FG002|Treatment Cycle 4|Adverse Event|0
2162395|NCT01261611|3779962|FG000|Treatment Cycle 4|Lost to Follow-up|2
2162396|NCT01261611|3779963|FG001|Treatment Cycle 4|Lost to Follow-up|0
2162397|NCT01261611|3779964|FG002|Treatment Cycle 4|Lost to Follow-up|0
2162398|NCT01261611|3779962|FG000|Treatment Cycle 4|Not otherwise specified|3
2162399|NCT01261611|3779963|FG001|Treatment Cycle 4|Not otherwise specified|0
2162400|NCT01261611|3779964|FG002|Treatment Cycle 4|Not otherwise specified|0
2162401|NCT01261611|3779962|FG000|Treatment Cycle 5|Withdrawal by Subject|1
2162402|NCT01261611|3779963|FG001|Treatment Cycle 5|Withdrawal by Subject|0
2162403|NCT01261611|3779964|FG002|Treatment Cycle 5|Withdrawal by Subject|0
2162404|NCT01261611|3779962|FG000|Treatment Cycle 5|Adverse Event|1
2162405|NCT01261611|3779963|FG001|Treatment Cycle 5|Adverse Event|0
2162406|NCT01261611|3779964|FG002|Treatment Cycle 5|Adverse Event|0
2162407|NCT01261611|3779962|FG000|Treatment Cycle 5|Lost to Follow-up|1
2294228|NCT02533674|3988865|FG000|Dose Level I|Never Treated|1
2294229|NCT02533674|3988866|FG001|Dose Level I|Never Treated|0
2294230|NCT02533674|3988867|FG002|Dose Level I|Never Treated|0
2208171|NCT01636778|3847563|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
2208172|NCT01636778|3847564|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
2208173|NCT01636778|3847562|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
2208174|NCT01636778|3847563|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
2208175|NCT01636778|3847564|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
2294231|NCT02533674|3988868|FG003|Dose Level I|Never Treated|0
2294232|NCT02533674|3988869|FG004|Dose Level I|Never Treated|0
2162408|NCT01261611|3779963|FG001|Treatment Cycle 5|Lost to Follow-up|0
2162409|NCT01261611|3779964|FG002|Treatment Cycle 5|Lost to Follow-up|0
2162410|NCT01261624|3779978|FG000|Week 0 to Week 12|Disease Progression|1
2162411|NCT01261624|3779979|FG001|Week 0 to Week 12|Disease Progression|1
2162412|NCT01261624|3779978|FG000|Week 0 to Week 12|Insufficient Response|0
2162413|NCT01261624|3779979|FG001|Week 0 to Week 12|Insufficient Response|2
2162414|NCT01261624|3779978|FG000|Week 13 to Week 24|Insufficient Response|0
2162415|NCT01261624|3779979|FG001|Week 13 to Week 24|Insufficient Response|1
2162416|NCT01261780|3779993|FG000|Overall Study|Withdrawal by Subject|1
2294233|NCT02533674|3988870|FG005|Dose Level I|Never Treated|0
2294234|NCT02533674|3988871|FG006|Dose Level I|Never Treated|0
2294235|NCT02533674|3988872|FG007|Dose Level I|Never Treated|0
2294236|NCT02533674|3988865|FG000|Dose Level II|Progressive disease|0
2294237|NCT02533674|3988866|FG001|Dose Level II|Progressive disease|3
2294238|NCT02533674|3988867|FG002|Dose Level II|Progressive disease|0
2294239|NCT02533674|3988868|FG003|Dose Level II|Progressive disease|0
2294240|NCT02533674|3988869|FG004|Dose Level II|Progressive disease|0
2294241|NCT02533674|3988870|FG005|Dose Level II|Progressive disease|0
2294242|NCT02533674|3988871|FG006|Dose Level II|Progressive disease|0
2294243|NCT02533674|3988872|FG007|Dose Level II|Progressive disease|0
2162417|NCT01261780|3779994|FG001|Overall Study|Withdrawal by Subject|0
2162418|NCT01261780|3779993|FG000|Overall Study|Event not related to subject|1
2162419|NCT01261780|3779994|FG001|Overall Study|Event not related to subject|2
2162420|NCT01261793|3780003|FG000|Overall Study|Lack of Efficacy|44
2162421|NCT01261793|3780004|FG001|Overall Study|Lack of Efficacy|37
2162422|NCT01261793|3780005|FG002|Overall Study|Lack of Efficacy|32
2162423|NCT01261793|3780003|FG000|Overall Study|Protocol Violation|3
2162424|NCT01261793|3780004|FG001|Overall Study|Protocol Violation|5
2162425|NCT01261793|3780005|FG002|Overall Study|Protocol Violation|6
2162426|NCT01261793|3780003|FG000|Overall Study|Lost to Follow-up|10
2162427|NCT01261793|3780004|FG001|Overall Study|Lost to Follow-up|3
2162428|NCT01261793|3780005|FG002|Overall Study|Lost to Follow-up|7
2162429|NCT01261793|3780003|FG000|Overall Study|Withdrawal by Subject|12
2162430|NCT01261793|3780004|FG001|Overall Study|Withdrawal by Subject|14
2162431|NCT01261793|3780005|FG002|Overall Study|Withdrawal by Subject|14
2162432|NCT01261793|3780003|FG000|Overall Study|Death|3
2162433|NCT01261793|3780004|FG001|Overall Study|Death|1
2162434|NCT01261793|3780005|FG002|Overall Study|Death|0
2162435|NCT01261793|3780003|FG000|Overall Study|Adverse Event|9
2162436|NCT01261793|3780004|FG001|Overall Study|Adverse Event|24
2162437|NCT01261793|3780005|FG002|Overall Study|Adverse Event|19
2162438|NCT01261793|3780003|FG000|Overall Study|Patient non-availability|1
2162439|NCT01261793|3780004|FG001|Overall Study|Patient non-availability|1
2162440|NCT01261793|3780005|FG002|Overall Study|Patient non-availability|1
2162441|NCT01261793|3780003|FG000|Overall Study|Suspected pregnancy|1
2162442|NCT01261793|3780004|FG001|Overall Study|Suspected pregnancy|1
2162443|NCT01261793|3780005|FG002|Overall Study|Suspected pregnancy|0
2162444|NCT01261793|3780003|FG000|Overall Study|Patient non-compliance|1
2162445|NCT01261793|3780004|FG001|Overall Study|Patient non-compliance|0
2162446|NCT01261793|3780005|FG002|Overall Study|Patient non-compliance|1
2162447|NCT01261793|3780003|FG000|Overall Study|Patient pregnant|1
2294244|NCT02533674|3988865|FG000|Dose Level II|Withdrawal by Subject|0
2294245|NCT02533674|3988866|FG001|Dose Level II|Withdrawal by Subject|1
2294246|NCT02533674|3988867|FG002|Dose Level II|Withdrawal by Subject|0
2294247|NCT02533674|3988868|FG003|Dose Level II|Withdrawal by Subject|0
2294248|NCT02533674|3988869|FG004|Dose Level II|Withdrawal by Subject|0
2294249|NCT02533674|3988870|FG005|Dose Level II|Withdrawal by Subject|0
2294250|NCT02533674|3988871|FG006|Dose Level II|Withdrawal by Subject|0
2294251|NCT02533674|3988872|FG007|Dose Level II|Withdrawal by Subject|0
2294252|NCT02533674|3988865|FG000|Dose Level II|Treatment-related AE|0
2294253|NCT02533674|3988866|FG001|Dose Level II|Treatment-related AE|1
2294254|NCT02533674|3988867|FG002|Dose Level II|Treatment-related AE|0
2294255|NCT02533674|3988868|FG003|Dose Level II|Treatment-related AE|0
2294256|NCT02533674|3988869|FG004|Dose Level II|Treatment-related AE|0
2294257|NCT02533674|3988870|FG005|Dose Level II|Treatment-related AE|0
2294258|NCT02533674|3988871|FG006|Dose Level II|Treatment-related AE|0
2294259|NCT02533674|3988872|FG007|Dose Level II|Treatment-related AE|0
2294260|NCT02533674|3988865|FG000|Dose Level II|Physician Decision|0
2294261|NCT02533674|3988866|FG001|Dose Level II|Physician Decision|1
2294262|NCT02533674|3988867|FG002|Dose Level II|Physician Decision|0
2294263|NCT02533674|3988868|FG003|Dose Level II|Physician Decision|0
2294264|NCT02533674|3988869|FG004|Dose Level II|Physician Decision|0
2294265|NCT02533674|3988870|FG005|Dose Level II|Physician Decision|0
2294266|NCT02533674|3988871|FG006|Dose Level II|Physician Decision|0
2294267|NCT02533674|3988872|FG007|Dose Level II|Physician Decision|0
2294268|NCT02533674|3988865|FG000|Dose Level II|Non-treatment-related AE|0
2294269|NCT02533674|3988866|FG001|Dose Level II|Non-treatment-related AE|1
2294270|NCT02533674|3988867|FG002|Dose Level II|Non-treatment-related AE|0
2294271|NCT02533674|3988868|FG003|Dose Level II|Non-treatment-related AE|0
2294272|NCT02533674|3988869|FG004|Dose Level II|Non-treatment-related AE|0
2294273|NCT02533674|3988870|FG005|Dose Level II|Non-treatment-related AE|0
2294274|NCT02533674|3988871|FG006|Dose Level II|Non-treatment-related AE|0
2294275|NCT02533674|3988872|FG007|Dose Level II|Non-treatment-related AE|0
2294276|NCT02533674|3988865|FG000|Dose Level III|Progressive disease|0
2294277|NCT02533674|3988866|FG001|Dose Level III|Progressive disease|0
2294278|NCT02533674|3988867|FG002|Dose Level III|Progressive disease|2
2294279|NCT02533674|3988868|FG003|Dose Level III|Progressive disease|0
2294280|NCT02533674|3988869|FG004|Dose Level III|Progressive disease|0
2294281|NCT02533674|3988870|FG005|Dose Level III|Progressive disease|0
2294282|NCT02533674|3988871|FG006|Dose Level III|Progressive disease|0
2294283|NCT02533674|3988872|FG007|Dose Level III|Progressive disease|0
2294284|NCT02533674|3988865|FG000|Dose Level III|Withdrawal by Subject|0
2294285|NCT02533674|3988866|FG001|Dose Level III|Withdrawal by Subject|0
2294286|NCT02533674|3988867|FG002|Dose Level III|Withdrawal by Subject|1
2294287|NCT02533674|3988868|FG003|Dose Level III|Withdrawal by Subject|0
2294288|NCT02533674|3988869|FG004|Dose Level III|Withdrawal by Subject|0
2294289|NCT02533674|3988870|FG005|Dose Level III|Withdrawal by Subject|0
2294290|NCT02533674|3988871|FG006|Dose Level III|Withdrawal by Subject|0
2294291|NCT02533674|3988872|FG007|Dose Level III|Withdrawal by Subject|0
2294292|NCT02533674|3988865|FG000|Dose Level III|Treatment-related AE|0
2294293|NCT02533674|3988866|FG001|Dose Level III|Treatment-related AE|0
2294294|NCT02533674|3988867|FG002|Dose Level III|Treatment-related AE|1
2294295|NCT02533674|3988868|FG003|Dose Level III|Treatment-related AE|0
2294296|NCT02533674|3988869|FG004|Dose Level III|Treatment-related AE|0
2294297|NCT02533674|3988870|FG005|Dose Level III|Treatment-related AE|0
2162448|NCT01261793|3780004|FG001|Overall Study|Patient pregnant|0
2162449|NCT01261793|3780005|FG002|Overall Study|Patient pregnant|0
2162450|NCT01261793|3780003|FG000|Overall Study|Outside the study area|0
2162451|NCT01261793|3780004|FG001|Overall Study|Outside the study area|2
2162452|NCT01261793|3780005|FG002|Overall Study|Outside the study area|1
2162453|NCT01261793|3780003|FG000|Overall Study|Lack of efficacy & patient not available|0
2162454|NCT01261793|3780004|FG001|Overall Study|Lack of efficacy & patient not available|1
2162455|NCT01261793|3780005|FG002|Overall Study|Lack of efficacy & patient not available|0
2162456|NCT01261793|3780003|FG000|Overall Study|Patient withdrew after cardiology visit|0
2162457|NCT01261793|3780004|FG001|Overall Study|Patient withdrew after cardiology visit|1
2162458|NCT01261793|3780005|FG002|Overall Study|Patient withdrew after cardiology visit|0
2162459|NCT01261793|3780003|FG000|Overall Study|Randomization error|0
2162460|NCT01261793|3780004|FG001|Overall Study|Randomization error|1
2162461|NCT01261793|3780005|FG002|Overall Study|Randomization error|0
2162462|NCT01261793|3780003|FG000|Overall Study|Patient unable to start IV line|0
2162463|NCT01261793|3780004|FG001|Overall Study|Patient unable to start IV line|0
2162464|NCT01261793|3780005|FG002|Overall Study|Patient unable to start IV line|1
2162465|NCT01261975|3780022|FG000|Overall Study|Surgical complication|1
2162466|NCT01262027|3780029|FG000|Overall Study|Adverse Event|1
2162467|NCT01262027|3780029|FG000|Overall Study|Withdrawal by Subject|3
2162468|NCT01262027|3780029|FG000|Overall Study|Protocol Violation|1
2162469|NCT01262092|3780035|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
2162470|NCT01262092|3780036|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
2162471|NCT01262092|3780035|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
2162472|NCT01262092|3780036|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
2162473|NCT01262092|3780035|FG000|Buprenorphine Taper|noncompliance - missed medication|1
2162474|NCT01262092|3780036|FG001|Buprenorphine Taper|noncompliance - missed medication|1
2294298|NCT02533674|3988871|FG006|Dose Level III|Treatment-related AE|0
2294299|NCT02533674|3988872|FG007|Dose Level III|Treatment-related AE|0
2294300|NCT02533674|3988865|FG000|Dose Level IV|Progressive disease|0
2294301|NCT02533674|3988866|FG001|Dose Level IV|Progressive disease|0
2294302|NCT02533674|3988867|FG002|Dose Level IV|Progressive disease|0
2294303|NCT02533674|3988868|FG003|Dose Level IV|Progressive disease|3
2294304|NCT02533674|3988869|FG004|Dose Level IV|Progressive disease|0
2294305|NCT02533674|3988870|FG005|Dose Level IV|Progressive disease|0
2294306|NCT02533674|3988871|FG006|Dose Level IV|Progressive disease|0
2294307|NCT02533674|3988872|FG007|Dose Level IV|Progressive disease|0
2294308|NCT02533674|3988865|FG000|Dose Level IV|Withdrawal by Subject|0
2294309|NCT02533674|3988866|FG001|Dose Level IV|Withdrawal by Subject|0
2294310|NCT02533674|3988867|FG002|Dose Level IV|Withdrawal by Subject|0
2294311|NCT02533674|3988868|FG003|Dose Level IV|Withdrawal by Subject|1
2294312|NCT02533674|3988869|FG004|Dose Level IV|Withdrawal by Subject|0
2294313|NCT02533674|3988870|FG005|Dose Level IV|Withdrawal by Subject|0
2294314|NCT02533674|3988871|FG006|Dose Level IV|Withdrawal by Subject|0
2294315|NCT02533674|3988872|FG007|Dose Level IV|Withdrawal by Subject|0
2294316|NCT02533674|3988865|FG000|Dose Level IV|Physician Decision|0
2294317|NCT02533674|3988866|FG001|Dose Level IV|Physician Decision|0
2294318|NCT02533674|3988867|FG002|Dose Level IV|Physician Decision|0
2294319|NCT02533674|3988868|FG003|Dose Level IV|Physician Decision|1
2294320|NCT02533674|3988869|FG004|Dose Level IV|Physician Decision|0
2294321|NCT02533674|3988870|FG005|Dose Level IV|Physician Decision|0
2294322|NCT02533674|3988871|FG006|Dose Level IV|Physician Decision|0
2294323|NCT02533674|3988872|FG007|Dose Level IV|Physician Decision|0
2294324|NCT02533674|3988865|FG000|Dose Level V|Progressive disease|0
2294325|NCT02533674|3988866|FG001|Dose Level V|Progressive disease|0
2294326|NCT02533674|3988867|FG002|Dose Level V|Progressive disease|0
2294327|NCT02533674|3988868|FG003|Dose Level V|Progressive disease|0
2294328|NCT02533674|3988869|FG004|Dose Level V|Progressive disease|3
2294329|NCT02533674|3988870|FG005|Dose Level V|Progressive disease|0
2294330|NCT02533674|3988871|FG006|Dose Level V|Progressive disease|0
2294331|NCT02533674|3988872|FG007|Dose Level V|Progressive disease|0
2294332|NCT02533674|3988865|FG000|Dose Level V|Withdrawal by Subject|0
2294333|NCT02533674|3988866|FG001|Dose Level V|Withdrawal by Subject|0
2294334|NCT02533674|3988867|FG002|Dose Level V|Withdrawal by Subject|0
2294335|NCT02533674|3988868|FG003|Dose Level V|Withdrawal by Subject|0
2294336|NCT02533674|3988869|FG004|Dose Level V|Withdrawal by Subject|1
2294337|NCT02533674|3988870|FG005|Dose Level V|Withdrawal by Subject|0
2294338|NCT02533674|3988871|FG006|Dose Level V|Withdrawal by Subject|0
2294339|NCT02533674|3988872|FG007|Dose Level V|Withdrawal by Subject|0
2294340|NCT02533674|3988865|FG000|Dose Level V|Physician Decision|0
2294341|NCT02533674|3988866|FG001|Dose Level V|Physician Decision|0
2294342|NCT02533674|3988867|FG002|Dose Level V|Physician Decision|0
2294343|NCT02533674|3988868|FG003|Dose Level V|Physician Decision|0
2294344|NCT02533674|3988869|FG004|Dose Level V|Physician Decision|1
2294345|NCT02533674|3988870|FG005|Dose Level V|Physician Decision|0
2294346|NCT02533674|3988871|FG006|Dose Level V|Physician Decision|0
2294347|NCT02533674|3988872|FG007|Dose Level V|Physician Decision|0
2294348|NCT02533674|3988865|FG000|Dose Level VI|Progressive disease|0
2294349|NCT02533674|3988866|FG001|Dose Level VI|Progressive disease|0
2294350|NCT02533674|3988867|FG002|Dose Level VI|Progressive disease|0
2294351|NCT02533674|3988868|FG003|Dose Level VI|Progressive disease|0
2294352|NCT02533674|3988869|FG004|Dose Level VI|Progressive disease|0
2294353|NCT02533674|3988870|FG005|Dose Level VI|Progressive disease|7
2294354|NCT02533674|3988871|FG006|Dose Level VI|Progressive disease|0
2294355|NCT02533674|3988872|FG007|Dose Level VI|Progressive disease|0
2294356|NCT02533674|3988865|FG000|Dose Level VI|Withdrawal by Subject|0
2162475|NCT01262092|3780035|FG000|Gabapentin Taper|noncompliance - missed medications|1
2162476|NCT01262092|3780036|FG001|Gabapentin Taper|noncompliance - missed medications|0
2162477|NCT01262287|3780075|FG000|Overall Study|Lost to Follow-up|2
2162478|NCT01262287|3780076|FG001|Overall Study|Lost to Follow-up|1
2162479|NCT01262352|3780088|FG000|Period 1|Illness after randomization|1
2162480|NCT01262352|3780089|FG001|Period 1|Illness after randomization|0
2162481|NCT01262352|3780088|FG000|Washout|Adverse Event|1
2162482|NCT01262352|3780089|FG001|Washout|Adverse Event|1
2162483|NCT01262352|3780088|FG000|Washout|Extended Washout|0
2162484|NCT01262352|3780089|FG001|Washout|Extended Washout|1
2162485|NCT01262365|3780098|FG000|Overall Study|Lack of Efficacy|35
2294357|NCT02533674|3988866|FG001|Dose Level VI|Withdrawal by Subject|0
2294358|NCT02533674|3988867|FG002|Dose Level VI|Withdrawal by Subject|0
2294359|NCT02533674|3988868|FG003|Dose Level VI|Withdrawal by Subject|0
2294360|NCT02533674|3988869|FG004|Dose Level VI|Withdrawal by Subject|0
2294361|NCT02533674|3988870|FG005|Dose Level VI|Withdrawal by Subject|1
2294362|NCT02533674|3988871|FG006|Dose Level VI|Withdrawal by Subject|0
2294363|NCT02533674|3988872|FG007|Dose Level VI|Withdrawal by Subject|0
2294364|NCT02533674|3988865|FG000|Dose Level VI|Treatment-related AE|0
2294365|NCT02533674|3988866|FG001|Dose Level VI|Treatment-related AE|0
2294366|NCT02533674|3988867|FG002|Dose Level VI|Treatment-related AE|0
2294367|NCT02533674|3988868|FG003|Dose Level VI|Treatment-related AE|0
2294368|NCT02533674|3988869|FG004|Dose Level VI|Treatment-related AE|0
2294369|NCT02533674|3988870|FG005|Dose Level VI|Treatment-related AE|1
2294370|NCT02533674|3988871|FG006|Dose Level VI|Treatment-related AE|0
2294371|NCT02533674|3988872|FG007|Dose Level VI|Treatment-related AE|0
2294372|NCT02533674|3988865|FG000|Dose Level VII|Progressive disease|0
2294373|NCT02533674|3988866|FG001|Dose Level VII|Progressive disease|0
2294374|NCT02533674|3988867|FG002|Dose Level VII|Progressive disease|0
2294375|NCT02533674|3988868|FG003|Dose Level VII|Progressive disease|0
2294376|NCT02533674|3988869|FG004|Dose Level VII|Progressive disease|0
2294377|NCT02533674|3988870|FG005|Dose Level VII|Progressive disease|0
2294378|NCT02533674|3988871|FG006|Dose Level VII|Progressive disease|10
2294379|NCT02533674|3988872|FG007|Dose Level VII|Progressive disease|0
2294380|NCT02533674|3988865|FG000|Dose Level VII|Withdrawal by Subject|0
2294381|NCT02533674|3988866|FG001|Dose Level VII|Withdrawal by Subject|0
2294382|NCT02533674|3988867|FG002|Dose Level VII|Withdrawal by Subject|0
2294383|NCT02533674|3988868|FG003|Dose Level VII|Withdrawal by Subject|0
2294384|NCT02533674|3988869|FG004|Dose Level VII|Withdrawal by Subject|0
2294385|NCT02533674|3988870|FG005|Dose Level VII|Withdrawal by Subject|0
2294386|NCT02533674|3988871|FG006|Dose Level VII|Withdrawal by Subject|3
2294387|NCT02533674|3988872|FG007|Dose Level VII|Withdrawal by Subject|0
2294388|NCT02533674|3988865|FG000|Dose Level VII|Treatment-related AE|0
2294389|NCT02533674|3988866|FG001|Dose Level VII|Treatment-related AE|0
2294390|NCT02533674|3988867|FG002|Dose Level VII|Treatment-related AE|0
2294391|NCT02533674|3988868|FG003|Dose Level VII|Treatment-related AE|0
2294392|NCT02533674|3988869|FG004|Dose Level VII|Treatment-related AE|0
2294393|NCT02533674|3988870|FG005|Dose Level VII|Treatment-related AE|0
2294394|NCT02533674|3988871|FG006|Dose Level VII|Treatment-related AE|1
2294395|NCT02533674|3988872|FG007|Dose Level VII|Treatment-related AE|0
2294396|NCT02533674|3988865|FG000|Dose Level VII|Death|0
2294397|NCT02533674|3988866|FG001|Dose Level VII|Death|0
2294398|NCT02533674|3988867|FG002|Dose Level VII|Death|0
2294399|NCT02533674|3988868|FG003|Dose Level VII|Death|0
2294400|NCT02533674|3988869|FG004|Dose Level VII|Death|0
2294401|NCT02533674|3988870|FG005|Dose Level VII|Death|0
2294402|NCT02533674|3988871|FG006|Dose Level VII|Death|2
2294403|NCT02533674|3988872|FG007|Dose Level VII|Death|0
2294404|NCT02533674|3988865|FG000|Dose Level VIII|Progressive disease|0
2294405|NCT02533674|3988866|FG001|Dose Level VIII|Progressive disease|0
2294406|NCT02533674|3988867|FG002|Dose Level VIII|Progressive disease|0
2294407|NCT02533674|3988868|FG003|Dose Level VIII|Progressive disease|0
2294408|NCT02533674|3988869|FG004|Dose Level VIII|Progressive disease|0
2294409|NCT02533674|3988870|FG005|Dose Level VIII|Progressive disease|0
2294410|NCT02533674|3988871|FG006|Dose Level VIII|Progressive disease|0
2294411|NCT02533674|3988872|FG007|Dose Level VIII|Progressive disease|3
2294412|NCT02533674|3988865|FG000|Dose Level VIII|Withdrawal by Subject|0
2294413|NCT02533674|3988866|FG001|Dose Level VIII|Withdrawal by Subject|0
2294414|NCT02533674|3988867|FG002|Dose Level VIII|Withdrawal by Subject|0
2294415|NCT02533674|3988868|FG003|Dose Level VIII|Withdrawal by Subject|0
2294416|NCT02533674|3988869|FG004|Dose Level VIII|Withdrawal by Subject|0
2294417|NCT02533674|3988870|FG005|Dose Level VIII|Withdrawal by Subject|0
2294418|NCT02533674|3988871|FG006|Dose Level VIII|Withdrawal by Subject|0
2294419|NCT02533674|3988872|FG007|Dose Level VIII|Withdrawal by Subject|1
2162486|NCT01262365|3780099|FG001|Overall Study|Lack of Efficacy|30
2294420|NCT02533674|3988865|FG000|Dose Level VIII|Treatment-related AE|0
2294421|NCT02533674|3988866|FG001|Dose Level VIII|Treatment-related AE|0
2294422|NCT02533674|3988867|FG002|Dose Level VIII|Treatment-related AE|0
2294423|NCT02533674|3988868|FG003|Dose Level VIII|Treatment-related AE|0
2294424|NCT02533674|3988869|FG004|Dose Level VIII|Treatment-related AE|0
2294425|NCT02533674|3988870|FG005|Dose Level VIII|Treatment-related AE|0
2294426|NCT02533674|3988871|FG006|Dose Level VIII|Treatment-related AE|0
2294427|NCT02533674|3988872|FG007|Dose Level VIII|Treatment-related AE|1
2162487|NCT01262365|3780100|FG002|Overall Study|Lack of Efficacy|47
2162488|NCT01262365|3780098|FG000|Overall Study|Protocol Violation|3
2162489|NCT01262365|3780099|FG001|Overall Study|Protocol Violation|1
2162490|NCT01262365|3780100|FG002|Overall Study|Protocol Violation|1
2162491|NCT01262365|3780098|FG000|Overall Study|Lost to Follow-up|3
2162492|NCT01262365|3780099|FG001|Overall Study|Lost to Follow-up|7
2162493|NCT01262365|3780100|FG002|Overall Study|Lost to Follow-up|6
2162494|NCT01262365|3780098|FG000|Overall Study|Withdrawal by Subject|17
2162495|NCT01262365|3780099|FG001|Overall Study|Withdrawal by Subject|22
2162496|NCT01262365|3780100|FG002|Overall Study|Withdrawal by Subject|22
2162497|NCT01262365|3780098|FG000|Overall Study|Death|1
2162498|NCT01262365|3780099|FG001|Overall Study|Death|2
2162499|NCT01262365|3780100|FG002|Overall Study|Death|1
2162500|NCT01262365|3780098|FG000|Overall Study|Adverse Event|26
2162501|NCT01262365|3780099|FG001|Overall Study|Adverse Event|16
2162502|NCT01262365|3780100|FG002|Overall Study|Adverse Event|11
2162503|NCT01262365|3780098|FG000|Overall Study|sponsor decision|1
2162504|NCT01262365|3780099|FG001|Overall Study|sponsor decision|1
2162505|NCT01262365|3780100|FG002|Overall Study|sponsor decision|0
2162506|NCT01262365|3780098|FG000|Overall Study|Randomization error|1
2162507|NCT01262365|3780099|FG001|Overall Study|Randomization error|0
2162508|NCT01262365|3780100|FG002|Overall Study|Randomization error|2
2162509|NCT01262365|3780098|FG000|Overall Study|Non-compliance|1
2162510|NCT01262365|3780099|FG001|Overall Study|Non-compliance|0
2162511|NCT01262365|3780100|FG002|Overall Study|Non-compliance|2
2162512|NCT01262365|3780098|FG000|Overall Study|Suspected pregnancy|1
2162513|NCT01262365|3780099|FG001|Overall Study|Suspected pregnancy|0
2162514|NCT01262365|3780100|FG002|Overall Study|Suspected pregnancy|0
2294428|NCT02533674|3988865|FG000|Dose Level VIII|Never treated|0
2294429|NCT02533674|3988866|FG001|Dose Level VIII|Never treated|0
2294430|NCT02533674|3988867|FG002|Dose Level VIII|Never treated|0
2294431|NCT02533674|3988868|FG003|Dose Level VIII|Never treated|0
2294432|NCT02533674|3988869|FG004|Dose Level VIII|Never treated|0
2294433|NCT02533674|3988870|FG005|Dose Level VIII|Never treated|0
2294434|NCT02533674|3988871|FG006|Dose Level VIII|Never treated|0
2294435|NCT02533674|3988872|FG007|Dose Level VIII|Never treated|1
2294436|NCT02533999|3988919|FG000|Overall Study|Lost to Follow-up|3
2294437|NCT02533999|3988920|FG001|Overall Study|Lost to Follow-up|5
2294438|NCT02533999|3988919|FG000|Overall Study|Protocol Violation|3
2294439|NCT02533999|3988920|FG001|Overall Study|Protocol Violation|0
2294440|NCT02533999|3988919|FG000|Overall Study|Adverse Event|0
2294441|NCT02533999|3988920|FG001|Overall Study|Adverse Event|1
2294442|NCT02533999|3988919|FG000|Overall Study|Randomized but intervention not received|0
2294443|NCT02533999|3988920|FG001|Overall Study|Randomized but intervention not received|1
2294444|NCT02534324|3988944|FG000|Overall Study|Protocol Violation|4
2294445|NCT02534324|3988945|FG001|Overall Study|Protocol Violation|1
2294446|NCT02534324|3988944|FG000|Overall Study|Lost to Follow-up|20
2294447|NCT02534324|3988945|FG001|Overall Study|Lost to Follow-up|7
2294448|NCT02534324|3988944|FG000|Overall Study|Adverse Event|1
2294449|NCT02534324|3988945|FG001|Overall Study|Adverse Event|0
2294450|NCT02534350|3988953|FG000|Overall Study|Randomized But Not Treated|1
2294451|NCT02534350|3988954|FG001|Overall Study|Randomized But Not Treated|0
2294452|NCT02534350|3988953|FG000|Overall Study|Protocol Violation|1
2294453|NCT02534350|3988954|FG001|Overall Study|Protocol Violation|0
2294454|NCT02534350|3988953|FG000|Overall Study|Withdrew Consent|2
2294455|NCT02534350|3988954|FG001|Overall Study|Withdrew Consent|0
2294456|NCT02534493|3988960|FG000|Overall Study|Lost to Follow-up|1
2294457|NCT02534493|3988960|FG000|Overall Study|Withdrawal by Subject|1
2294458|NCT02534883|3988968|FG000|Overall Study|Early Termination|8
2294459|NCT02534883|3988969|FG001|Overall Study|Early Termination|3
2294460|NCT02534896|3988978|FG000|Overall Study|Adverse Event|2
2294461|NCT02534896|3988979|FG001|Overall Study|Adverse Event|1
2294462|NCT02534896|3988980|FG002|Overall Study|Adverse Event|1
2294463|NCT02534896|3988978|FG000|Overall Study|Insufficient therapeutic response|2
2294464|NCT02534896|3988979|FG001|Overall Study|Insufficient therapeutic response|0
2294465|NCT02534896|3988980|FG002|Overall Study|Insufficient therapeutic response|0
2294466|NCT02534935|3988991|FG000|Stage 1: 24 Months|Withdrawal by Subject|0
2162515|NCT01262365|3780098|FG000|Overall Study|Patient pregnant|1
2162516|NCT01262365|3780099|FG001|Overall Study|Patient pregnant|0
2162517|NCT01262365|3780100|FG002|Overall Study|Patient pregnant|1
2162518|NCT01262365|3780098|FG000|Overall Study|Toxicity related to study drug|0
2162519|NCT01262365|3780099|FG001|Overall Study|Toxicity related to study drug|1
2162520|NCT01262365|3780100|FG002|Overall Study|Toxicity related to study drug|0
2162521|NCT01262365|3780098|FG000|Overall Study|Cannot tolerate the protocol|0
2162522|NCT01262365|3780099|FG001|Overall Study|Cannot tolerate the protocol|1
2294467|NCT02534935|3988992|FG001|Stage 1: 24 Months|Withdrawal by Subject|3
2294468|NCT02534935|3988993|FG002|Stage 1: 24 Months|Withdrawal by Subject|3
2294469|NCT02534935|3988991|FG000|Stage 1: 24 Months|No longer willing to participate in study|0
2294470|NCT02534935|3988992|FG001|Stage 1: 24 Months|No longer willing to participate in study|1
2294471|NCT02534935|3988993|FG002|Stage 1: 24 Months|No longer willing to participate in study|1
2294472|NCT02534935|3988991|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0
2294473|NCT02534935|3988992|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3
2294474|NCT02534935|3988993|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0
2294475|NCT02534935|3988991|FG000|Stage 1: 24 Months|Lost to Follow-up|0
2162523|NCT01262365|3780100|FG002|Overall Study|Cannot tolerate the protocol|0
2162524|NCT01262365|3780098|FG000|Overall Study|Patient unavailable|0
2162525|NCT01262365|3780099|FG001|Overall Study|Patient unavailable|0
2162526|NCT01262365|3780100|FG002|Overall Study|Patient unavailable|1
2162527|NCT01262456|3780111|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6
2162528|NCT01262456|3780112|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8
2162529|NCT01262456|3780113|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9
2162530|NCT01262456|3780111|FG000|3-Month Double-Blind Period|Lost to Follow-up|4
2162531|NCT01262456|3780112|FG001|3-Month Double-Blind Period|Lost to Follow-up|5
2162532|NCT01262456|3780113|FG002|3-Month Double-Blind Period|Lost to Follow-up|3
2162533|NCT01262456|3780111|FG000|3-Month Double-Blind Period|Adverse Event|6
2162534|NCT01262456|3780112|FG001|3-Month Double-Blind Period|Adverse Event|4
2162535|NCT01262456|3780113|FG002|3-Month Double-Blind Period|Adverse Event|8
2162536|NCT01262456|3780111|FG000|3-Month Double-Blind Period|Protocol Violation|3
2162537|NCT01262456|3780112|FG001|3-Month Double-Blind Period|Protocol Violation|6
2162538|NCT01262456|3780113|FG002|3-Month Double-Blind Period|Protocol Violation|6
2162539|NCT01262456|3780111|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1
2162540|NCT01262456|3780112|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1
2162541|NCT01262456|3780113|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1
2162542|NCT01262456|3780111|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0
2162543|NCT01262456|3780112|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1
2162544|NCT01262456|3780113|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0
2162545|NCT01262456|3780111|FG000|1-Month Open-Label Extension Period|Adverse Event|2
2162546|NCT01262456|3780112|FG001|1-Month Open-Label Extension Period|Adverse Event|0
2162547|NCT01262456|3780113|FG002|1-Month Open-Label Extension Period|Adverse Event|2
2162548|NCT01262456|3780111|FG000|1-Month Open-Label Extension Period|Protocol Violation|1
2162549|NCT01262456|3780112|FG001|1-Month Open-Label Extension Period|Protocol Violation|0
2162550|NCT01262456|3780113|FG002|1-Month Open-Label Extension Period|Protocol Violation|2
2162551|NCT01262456|3780111|FG000|1-Month Open-Label Extension Period|Other Reason|0
2162552|NCT01262456|3780112|FG001|1-Month Open-Label Extension Period|Other Reason|1
2294476|NCT02534935|3988992|FG001|Stage 1: 24 Months|Lost to Follow-up|1
2294477|NCT02534935|3988993|FG002|Stage 1: 24 Months|Lost to Follow-up|1
2294478|NCT02534935|3988991|FG000|Stage 1: 24 Months|Adverse Event|0
2294479|NCT02534935|3988992|FG001|Stage 1: 24 Months|Adverse Event|2
2294480|NCT02534935|3988993|FG002|Stage 1: 24 Months|Adverse Event|0
2294481|NCT02534935|3988991|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0
2294482|NCT02534935|3988992|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4
2294483|NCT02534935|3988993|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0
2294484|NCT02534935|3988991|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
2294485|NCT02534935|3988992|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1
2294486|NCT02534935|3988993|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
2294487|NCT02535000|3989021|FG000|Overall Study|Cancellation of surgery.|1
2294488|NCT02535000|3989022|FG001|Overall Study|Cancellation of surgery.|2
2294489|NCT02535364|3989046|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
2294490|NCT02535364|3989046|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
2294491|NCT02535364|3989046|FG000|Part A Screening Through Leukapheresis|Disease progression|1
2294492|NCT02535364|3989046|FG000|Part B Screening|Study placed on clinical hold by FDA|7
2294493|NCT02535364|3989046|FG000|Part B Screening|Unable to manufacture JCAR015|3
2294494|NCT02535364|3989046|FG000|Part B Screening|Death|2
2294495|NCT02535364|3989046|FG000|Part B Screening|Physician Decision|1
2294496|NCT02535364|3989046|FG000|Part B Screening|Withdrawal by Subject|1
2294497|NCT02535364|3989046|FG000|Part B Screening|Adverse Event|1
2294498|NCT02535364|3989046|FG000|Part B Screening|Change in diagnosis, no longer eligible|2
2294499|NCT02535364|3989046|FG000|Study Treatment|Death|1
2294500|NCT02535364|3989046|FG000|Study Treatment|Study placed on clinical hold by FDA|1
2294501|NCT02535364|3989046|FG000|12-Month Follow-up Period|Disease progression|22
2294502|NCT02535364|3989046|FG000|12-Month Follow-up Period|Death|5
2294503|NCT02535364|3989046|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5
2294504|NCT02535364|3989046|FG000|12-Month Follow-up Period|Subject received alternative therapy|2
2294505|NCT02535364|3989046|FG000|12-Month Follow-up Period|Subject transferred to hospice|1
2294506|NCT02535416|3989059|FG000|Overall Study|Family bereavement overseas|1
2294507|NCT02535416|3989060|FG001|Overall Study|Family bereavement overseas|0
2294508|NCT02535416|3989061|FG002|Overall Study|Family bereavement overseas|0
2294509|NCT02535416|3989062|FG003|Overall Study|Family bereavement overseas|0
2294510|NCT02535416|3989063|FG004|Overall Study|Family bereavement overseas|0
2294511|NCT02535416|3989064|FG005|Overall Study|Family bereavement overseas|0
2294512|NCT02535416|3989065|FG006|Overall Study|Family bereavement overseas|0
2294513|NCT02535416|3989066|FG007|Overall Study|Family bereavement overseas|0
2294514|NCT02535416|3989067|FG008|Overall Study|Family bereavement overseas|0
2294515|NCT02535715|3989119|FG000|Overall Study|Withdrawal by Subject|0
2294516|NCT02535715|3989120|FG001|Overall Study|Withdrawal by Subject|0
2294517|NCT02535715|3989121|FG002|Overall Study|Withdrawal by Subject|1
2294518|NCT02535741|3989132|FG000|Overall Study|Adverse Event|3
2162553|NCT01262456|3780113|FG002|1-Month Open-Label Extension Period|Other Reason|0
2294519|NCT02535741|3989132|FG000|Overall Study|Withdrawal by Subject|9
2162554|NCT01262560|3780141|FG000|Overall Study|Protocol Violation|0
2162555|NCT01262560|3780142|FG001|Overall Study|Protocol Violation|1
2162556|NCT01262560|3780143|FG002|Overall Study|Protocol Violation|2
2162557|NCT01262573|3780153|FG000|Overall Study|Withdrawal by Subject|0
2162558|NCT01262573|3780154|FG001|Overall Study|Withdrawal by Subject|1
2162559|NCT01262638|3780175|FG000|Overall Study|Adverse Event|3
2162560|NCT01262638|3780176|FG001|Overall Study|Adverse Event|4
2162561|NCT01262638|3780177|FG002|Overall Study|Adverse Event|3
2162562|NCT01262638|3780178|FG003|Overall Study|Adverse Event|4
2294520|NCT02535741|3989132|FG000|Overall Study|Lost to Follow-up|10
2294521|NCT02535741|3989132|FG000|Overall Study|Exclusion criteria: Bilateral implant|4
2294522|NCT02535741|3989132|FG000|Overall Study|Missing data|6
2294523|NCT02536313|3989197|FG000|Overall Study|Lack of Efficacy|0
2294524|NCT02536313|3989198|FG001|Overall Study|Lack of Efficacy|1
2294525|NCT02536378|3989208|FG000|Overall Study|Physician Decision|0
2294526|NCT02536378|3989209|FG001|Overall Study|Physician Decision|2
2294527|NCT02536378|3989208|FG000|Overall Study|Withdrawal by Subject|0
2294528|NCT02536378|3989209|FG001|Overall Study|Withdrawal by Subject|1
2294529|NCT02536378|3989208|FG000|Overall Study|Death|1
2294530|NCT02536378|3989209|FG001|Overall Study|Death|2
2294531|NCT02536378|3989208|FG000|Overall Study|Patient refused further follow up|6
2294532|NCT02536378|3989209|FG001|Overall Study|Patient refused further follow up|2
2294533|NCT02536404|3989219|FG000|Overall Study|Adverse Event|5
2294534|NCT02536404|3989220|FG001|Overall Study|Adverse Event|0
2294535|NCT02536404|3989219|FG000|Overall Study|Withdrawal by Subject|4
2294536|NCT02536404|3989220|FG001|Overall Study|Withdrawal by Subject|1
2294537|NCT02536404|3989219|FG000|Overall Study|Physician Decision|10
2294538|NCT02536404|3989220|FG001|Overall Study|Physician Decision|0
2294539|NCT02536404|3989219|FG000|Overall Study|Sponsor decision|1
2294540|NCT02536404|3989220|FG001|Overall Study|Sponsor decision|0
2294541|NCT02536508|3989229|FG000|Overall Study|Withdrawal by Subject|18
2294542|NCT02536508|3989230|FG001|Overall Study|Withdrawal by Subject|13
2294543|NCT02536508|3989231|FG002|Overall Study|Withdrawal by Subject|7
2294544|NCT02536508|3989229|FG000|Overall Study|Adverse Event|14
2294545|NCT02536508|3989230|FG001|Overall Study|Adverse Event|13
2294546|NCT02536508|3989231|FG002|Overall Study|Adverse Event|6
2294547|NCT02536508|3989229|FG000|Overall Study|Lost to Follow-up|12
2294548|NCT02536508|3989230|FG001|Overall Study|Lost to Follow-up|4
2294549|NCT02536508|3989231|FG002|Overall Study|Lost to Follow-up|0
2294550|NCT02536508|3989229|FG000|Overall Study|Lack of Efficacy|3
2294551|NCT02536508|3989230|FG001|Overall Study|Lack of Efficacy|5
2294552|NCT02536508|3989231|FG002|Overall Study|Lack of Efficacy|4
2294553|NCT02536508|3989229|FG000|Overall Study|Protocol Discontinuation Criteria|3
2294554|NCT02536508|3989230|FG001|Overall Study|Protocol Discontinuation Criteria|2
2294555|NCT02536508|3989231|FG002|Overall Study|Protocol Discontinuation Criteria|2
2294556|NCT02536508|3989229|FG000|Overall Study|Physician Decision|0
2294557|NCT02536508|3989230|FG001|Overall Study|Physician Decision|4
2294558|NCT02536508|3989231|FG002|Overall Study|Physician Decision|2
2294559|NCT02536508|3989229|FG000|Overall Study|Major Protocol Deviation|2
2294560|NCT02536508|3989230|FG001|Overall Study|Major Protocol Deviation|2
2294561|NCT02536508|3989231|FG002|Overall Study|Major Protocol Deviation|2
2294562|NCT02536508|3989229|FG000|Overall Study|Administrative Reasons|0
2294563|NCT02536508|3989230|FG001|Overall Study|Administrative Reasons|1
2294564|NCT02536508|3989231|FG002|Overall Study|Administrative Reasons|0
2294565|NCT02536664|3989241|FG000|Overall Study|Inadequate completion of documentation|2
2294566|NCT02536664|3989242|FG001|Overall Study|Inadequate completion of documentation|4
2294567|NCT02536664|3989241|FG000|Overall Study|Progression|13
2294568|NCT02536664|3989242|FG001|Overall Study|Progression|18
2294569|NCT02536664|3989241|FG000|Overall Study|Death due to lymphoma|2
2294570|NCT02536664|3989242|FG001|Overall Study|Death due to lymphoma|1
2294571|NCT02536664|3989241|FG000|Overall Study|Death due to other reason|3
2294572|NCT02536664|3989242|FG001|Overall Study|Death due to other reason|2
2294573|NCT02536664|3989241|FG000|Overall Study|Intolerability|8
2294574|NCT02536664|3989242|FG001|Overall Study|Intolerability|6
2294575|NCT02536664|3989241|FG000|Overall Study|Withdrawal by Subject|8
2294576|NCT02536664|3989242|FG001|Overall Study|Withdrawal by Subject|5
2294577|NCT02536664|3989241|FG000|Overall Study|Other|18
2294578|NCT02536664|3989242|FG001|Overall Study|Other|24
2294579|NCT02536664|3989241|FG000|Overall Study|Missing|53
2294580|NCT02536664|3989242|FG001|Overall Study|Missing|20
2294581|NCT02536781|3989250|FG000|Overall Study|Lost to Follow-up|2
2294582|NCT02536781|3989251|FG001|Overall Study|Lost to Follow-up|0
2294583|NCT02536794|3989257|FG000|Reached 1st Response Assessment|Adverse Event|2
2294584|NCT02536794|3989257|FG000|Reached 1st Response Assessment|Progressive Disease|2
2294585|NCT02536794|3989257|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1
2294586|NCT02536794|3989257|FG000|Reached 1st Response Assessment|Protocol Violation|1
2162563|NCT01262638|3780175|FG000|Overall Study|Protocol Violation|1
2162564|NCT01262638|3780176|FG001|Overall Study|Protocol Violation|0
2162565|NCT01262638|3780177|FG002|Overall Study|Protocol Violation|0
2294587|NCT02536794|3989257|FG000|Continued Treatment After 1st Response|Progressive disease|7
2294588|NCT02536794|3989257|FG000|Continued Treatment After 1st Response|Adverse Event|1
2294589|NCT02536833|3989265|FG000|Overall Study|Discontinued Before Treatment|0
2294590|NCT02536833|3989266|FG001|Overall Study|Discontinued Before Treatment|0
2162566|NCT01262638|3780178|FG003|Overall Study|Protocol Violation|1
2162567|NCT01262638|3780175|FG000|Overall Study|Withdrawal by Subject|2
2162568|NCT01262638|3780176|FG001|Overall Study|Withdrawal by Subject|1
2162569|NCT01262638|3780177|FG002|Overall Study|Withdrawal by Subject|0
2162570|NCT01262638|3780178|FG003|Overall Study|Withdrawal by Subject|1
2162571|NCT01262638|3780175|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
2162572|NCT01262638|3780176|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
2162573|NCT01262638|3780177|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1
2162574|NCT01262638|3780178|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
2162575|NCT01262638|3780175|FG000|Overall Study|Lost to Follow-up|1
2162576|NCT01262638|3780176|FG001|Overall Study|Lost to Follow-up|1
2162577|NCT01262638|3780177|FG002|Overall Study|Lost to Follow-up|1
2162578|NCT01262638|3780178|FG003|Overall Study|Lost to Follow-up|1
2162579|NCT01262638|3780175|FG000|Overall Study|Participant Went Out of Town|0
2162580|NCT01262638|3780176|FG001|Overall Study|Participant Went Out of Town|0
2162581|NCT01262638|3780177|FG002|Overall Study|Participant Went Out of Town|1
2162582|NCT01262638|3780178|FG003|Overall Study|Participant Went Out of Town|0
2162583|NCT01262651|3780193|FG000|Overall Study|Adverse Event|40
2162584|NCT01262651|3780194|FG001|Overall Study|Adverse Event|35
2162585|NCT01262651|3780193|FG000|Overall Study|Withdrawal by Subject|15
2162586|NCT01262651|3780194|FG001|Overall Study|Withdrawal by Subject|11
2162587|NCT01262651|3780193|FG000|Overall Study|Withdrawal by Investigator|2
2162588|NCT01262651|3780194|FG001|Overall Study|Withdrawal by Investigator|2
2162589|NCT01262651|3780193|FG000|Overall Study|Met Withdrawal Criteria|1
2162590|NCT01262651|3780194|FG001|Overall Study|Met Withdrawal Criteria|0
2162591|NCT01262677|3780203|FG000|Overall Study|Does not meet entrance criteria|0
2162592|NCT01262677|3780204|FG001|Overall Study|Does not meet entrance criteria|2
2294591|NCT02536833|3989267|FG002|Overall Study|Discontinued Before Treatment|1
2294592|NCT02536833|3989268|FG003|Overall Study|Discontinued Before Treatment|2
2294593|NCT02536833|3989265|FG000|Overall Study|Adverse Event|1
2294594|NCT02536833|3989266|FG001|Overall Study|Adverse Event|3
2294595|NCT02536833|3989267|FG002|Overall Study|Adverse Event|4
2294596|NCT02536833|3989268|FG003|Overall Study|Adverse Event|1
2294597|NCT02536833|3989265|FG000|Overall Study|Lost to Follow-up|2
2294598|NCT02536833|3989266|FG001|Overall Study|Lost to Follow-up|1
2294599|NCT02536833|3989267|FG002|Overall Study|Lost to Follow-up|2
2294600|NCT02536833|3989268|FG003|Overall Study|Lost to Follow-up|2
2294601|NCT02536833|3989265|FG000|Overall Study|Physician Decision|0
2294602|NCT02536833|3989266|FG001|Overall Study|Physician Decision|0
2294603|NCT02536833|3989267|FG002|Overall Study|Physician Decision|0
2294604|NCT02536833|3989268|FG003|Overall Study|Physician Decision|1
2294605|NCT02536833|3989265|FG000|Overall Study|Site Terminated by Sponsor|2
2294606|NCT02536833|3989266|FG001|Overall Study|Site Terminated by Sponsor|2
2294607|NCT02536833|3989267|FG002|Overall Study|Site Terminated by Sponsor|2
2294608|NCT02536833|3989268|FG003|Overall Study|Site Terminated by Sponsor|2
2294609|NCT02536833|3989265|FG000|Overall Study|Subject Non-Compliance|0
2294610|NCT02536833|3989266|FG001|Overall Study|Subject Non-Compliance|1
2294611|NCT02536833|3989267|FG002|Overall Study|Subject Non-Compliance|1
2294612|NCT02536833|3989268|FG003|Overall Study|Subject Non-Compliance|0
2294613|NCT02536833|3989265|FG000|Overall Study|Withdrawal by Subject|4
2294614|NCT02536833|3989266|FG001|Overall Study|Withdrawal by Subject|3
2294615|NCT02536833|3989267|FG002|Overall Study|Withdrawal by Subject|5
2294616|NCT02536833|3989268|FG003|Overall Study|Withdrawal by Subject|11
2294617|NCT02536846|3989279|FG000|Overall Study|Withdrawal by Subject|1
2294618|NCT02536963|3989284|FG000|Overall Study|Withdrawal by Subject|18
2294619|NCT02536976|3989290|FG000|Overall Study|Physician Decision|0
2294620|NCT02536976|3989291|FG001|Overall Study|Physician Decision|1
2294621|NCT02537015|3989299|FG000|Overall Study|Adverse Event|3
2294622|NCT02537015|3989299|FG000|Overall Study|Withdrawal by Subject|2
2294623|NCT02537015|3989299|FG000|Overall Study|Other Miscellaneous Reasons|1
2294624|NCT02537431|3989303|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
2294625|NCT02537522|3989316|FG000|Phase I - Contralateral|Subject no longer eligible|15
2294626|NCT02537522|3989317|FG001|Phase I - Contralateral|Subject no longer eligible|7
2294627|NCT02537522|3989318|FG002|Phase I - Contralateral|Subject no longer eligible|0
2294628|NCT02537522|3989319|FG003|Phase I - Contralateral|Subject no longer eligible|0
2294629|NCT02537522|3989316|FG000|Phase I - Contralateral|Withdrawal by Subject|0
2294630|NCT02537522|3989317|FG001|Phase I - Contralateral|Withdrawal by Subject|1
2294631|NCT02537522|3989318|FG002|Phase I - Contralateral|Withdrawal by Subject|0
2294632|NCT02537522|3989319|FG003|Phase I - Contralateral|Withdrawal by Subject|0
2294633|NCT02537522|3989316|FG000|Phase I - Contralateral|incorrect randomization|0
2294634|NCT02537522|3989317|FG001|Phase I - Contralateral|incorrect randomization|1
2294635|NCT02537522|3989318|FG002|Phase I - Contralateral|incorrect randomization|0
2294636|NCT02537522|3989319|FG003|Phase I - Contralateral|incorrect randomization|0
2294637|NCT02537522|3989316|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0
2162593|NCT01262677|3780205|FG002|Overall Study|Does not meet entrance criteria|0
2162594|NCT01262677|3780203|FG000|Overall Study|Insufficient clinical response|0
2162595|NCT01262677|3780204|FG001|Overall Study|Insufficient clinical response|0
2294638|NCT02537522|3989317|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1
2294639|NCT02537522|3989318|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0
2162596|NCT01262677|3780205|FG002|Overall Study|Insufficient clinical response|1
2162597|NCT01262677|3780203|FG000|Overall Study|Lost to Follow-up|1
2162598|NCT01262677|3780204|FG001|Overall Study|Lost to Follow-up|0
2162599|NCT01262677|3780205|FG002|Overall Study|Lost to Follow-up|2
2162600|NCT01262677|3780203|FG000|Overall Study|No longer willing to participate|3
2162601|NCT01262677|3780204|FG001|Overall Study|No longer willing to participate|3
2162602|NCT01262677|3780205|FG002|Overall Study|No longer willing to participate|2
2162603|NCT01262677|3780203|FG000|Overall Study|Reason not provided|2
2162604|NCT01262677|3780204|FG001|Overall Study|Reason not provided|1
2162605|NCT01262677|3780205|FG002|Overall Study|Reason not provided|3
2162606|NCT01262677|3780203|FG000|Overall Study|Protocol Violation|0
2162607|NCT01262677|3780204|FG001|Overall Study|Protocol Violation|1
2162608|NCT01262677|3780205|FG002|Overall Study|Protocol Violation|1
2162609|NCT01262677|3780203|FG000|Overall Study|Adverse Event (AE) related to study drug|3
2162610|NCT01262677|3780204|FG001|Overall Study|Adverse Event (AE) related to study drug|8
2162611|NCT01262677|3780205|FG002|Overall Study|Adverse Event (AE) related to study drug|3
2162612|NCT01262820|3780217|FG000|Overall Study|Adverse Event|5
2162613|NCT01262820|3780217|FG000|Overall Study|Lack of Efficacy|9
2162614|NCT01262820|3780217|FG000|Overall Study|Drug held for 21+ days|1
2162615|NCT01262872|3780238|FG000|Step 2|Death|0
2162616|NCT01262872|3780239|FG001|Step 2|Death|0
2162617|NCT01262872|3780240|FG002|Step 2|Death|0
2162618|NCT01262872|3780241|FG003|Step 2|Death|1
2162619|NCT01262872|3780242|FG004|Step 2|Death|0
2162620|NCT01262872|3780243|FG005|Step 2|Death|2
2162621|NCT01262872|3780244|FG006|Step 2|Death|2
2162622|NCT01262872|3780245|FG007|Step 2|Death|1
2162623|NCT01262872|3780238|FG000|Step 2|Protocol Violation|0
2162624|NCT01262872|3780239|FG001|Step 2|Protocol Violation|0
2162625|NCT01262872|3780240|FG002|Step 2|Protocol Violation|1
2162626|NCT01262872|3780241|FG003|Step 2|Protocol Violation|0
2162627|NCT01262872|3780242|FG004|Step 2|Protocol Violation|0
2162628|NCT01262872|3780243|FG005|Step 2|Protocol Violation|0
2162629|NCT01262872|3780244|FG006|Step 2|Protocol Violation|3
2162630|NCT01262872|3780245|FG007|Step 2|Protocol Violation|1
2162631|NCT01262872|3780238|FG000|Step 2|Withdrawal by Subject|0
2162632|NCT01262872|3780239|FG001|Step 2|Withdrawal by Subject|0
2162633|NCT01262872|3780240|FG002|Step 2|Withdrawal by Subject|4
2162634|NCT01262872|3780241|FG003|Step 2|Withdrawal by Subject|6
2162635|NCT01262872|3780242|FG004|Step 2|Withdrawal by Subject|3
2162636|NCT01262872|3780243|FG005|Step 2|Withdrawal by Subject|1
2162637|NCT01262872|3780244|FG006|Step 2|Withdrawal by Subject|2
2162638|NCT01262872|3780245|FG007|Step 2|Withdrawal by Subject|1
2162639|NCT01262872|3780238|FG000|Step 2|Migrated/moved from study area|0
2162640|NCT01262872|3780239|FG001|Step 2|Migrated/moved from study area|0
2162641|NCT01262872|3780240|FG002|Step 2|Migrated/moved from study area|4
2162642|NCT01262872|3780241|FG003|Step 2|Migrated/moved from study area|3
2162643|NCT01262872|3780242|FG004|Step 2|Migrated/moved from study area|2
2162644|NCT01262872|3780243|FG005|Step 2|Migrated/moved from study area|6
2162645|NCT01262872|3780244|FG006|Step 2|Migrated/moved from study area|2
2162646|NCT01262872|3780245|FG007|Step 2|Migrated/moved from study area|3
2162647|NCT01262898|3780283|FG000|Overall Study|Protocol Violation|1
2162648|NCT01262898|3780284|FG001|Overall Study|Protocol Violation|1
2162649|NCT01262898|3780285|FG002|Overall Study|Protocol Violation|0
2162650|NCT01262898|3780286|FG003|Overall Study|Protocol Violation|0
2162651|NCT01262898|3780283|FG000|Overall Study|Lost to Follow-up|1
2162652|NCT01262898|3780284|FG001|Overall Study|Lost to Follow-up|0
2162653|NCT01262898|3780285|FG002|Overall Study|Lost to Follow-up|0
2162654|NCT01262898|3780286|FG003|Overall Study|Lost to Follow-up|0
2162655|NCT01262898|3780283|FG000|Overall Study|Withdrawal by Subject|1
2162656|NCT01262898|3780284|FG001|Overall Study|Withdrawal by Subject|1
2162657|NCT01262898|3780285|FG002|Overall Study|Withdrawal by Subject|0
2162658|NCT01262898|3780286|FG003|Overall Study|Withdrawal by Subject|0
2162659|NCT01262976|3780305|FG000|Up to Month 2|Serious Adverse Event|0
2162660|NCT01262976|3780306|FG001|Up to Month 2|Serious Adverse Event|0
2162661|NCT01262976|3780307|FG002|Up to Month 2|Serious Adverse Event|1
2162662|NCT01262976|3780308|FG003|Up to Month 2|Serious Adverse Event|0
2162663|NCT01262976|3780309|FG004|Up to Month 2|Serious Adverse Event|0
2162664|NCT01262976|3780310|FG005|Up to Month 2|Serious Adverse Event|0
2162665|NCT01262976|3780305|FG000|Up to Month 2|Withdrawal by Subject|1
2162666|NCT01262976|3780306|FG001|Up to Month 2|Withdrawal by Subject|0
2162667|NCT01262976|3780307|FG002|Up to Month 2|Withdrawal by Subject|0
2294640|NCT02537522|3989319|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0
2162668|NCT01262976|3780308|FG003|Up to Month 2|Withdrawal by Subject|0
2162669|NCT01262976|3780309|FG004|Up to Month 2|Withdrawal by Subject|0
2162670|NCT01262976|3780310|FG005|Up to Month 2|Withdrawal by Subject|0
2162671|NCT01262976|3780305|FG000|Up to Month 2|Migrated/moved from study area|0
2162672|NCT01262976|3780306|FG001|Up to Month 2|Migrated/moved from study area|1
2162673|NCT01262976|3780307|FG002|Up to Month 2|Migrated/moved from study area|0
2162674|NCT01262976|3780308|FG003|Up to Month 2|Migrated/moved from study area|0
2162675|NCT01262976|3780309|FG004|Up to Month 2|Migrated/moved from study area|1
2162676|NCT01262976|3780310|FG005|Up to Month 2|Migrated/moved from study area|1
2162677|NCT01262976|3780305|FG000|Up to Month 2|Lost to Follow-up|1
2162678|NCT01262976|3780306|FG001|Up to Month 2|Lost to Follow-up|0
2162679|NCT01262976|3780307|FG002|Up to Month 2|Lost to Follow-up|0
2162680|NCT01262976|3780308|FG003|Up to Month 2|Lost to Follow-up|1
2162681|NCT01262976|3780309|FG004|Up to Month 2|Lost to Follow-up|1
2162682|NCT01262976|3780310|FG005|Up to Month 2|Lost to Follow-up|1
2162683|NCT01262976|3780305|FG000|Up to Month 2|Other|1
2162684|NCT01262976|3780306|FG001|Up to Month 2|Other|0
2162685|NCT01262976|3780307|FG002|Up to Month 2|Other|0
2162686|NCT01262976|3780308|FG003|Up to Month 2|Other|1
2162687|NCT01262976|3780309|FG004|Up to Month 2|Other|0
2162688|NCT01262976|3780310|FG005|Up to Month 2|Other|2
2162689|NCT01262976|3780305|FG000|Up to Month 7|Serious Adverse Event|0
2162690|NCT01262976|3780306|FG001|Up to Month 7|Serious Adverse Event|0
2162691|NCT01262976|3780307|FG002|Up to Month 7|Serious Adverse Event|2
2162692|NCT01262976|3780308|FG003|Up to Month 7|Serious Adverse Event|0
2162693|NCT01262976|3780309|FG004|Up to Month 7|Serious Adverse Event|0
2162694|NCT01262976|3780310|FG005|Up to Month 7|Serious Adverse Event|0
2162695|NCT01262976|3780305|FG000|Up to Month 7|Withdrawal by Subject|1
2162696|NCT01262976|3780306|FG001|Up to Month 7|Withdrawal by Subject|0
2162697|NCT01262976|3780307|FG002|Up to Month 7|Withdrawal by Subject|0
2162698|NCT01262976|3780308|FG003|Up to Month 7|Withdrawal by Subject|0
2162699|NCT01262976|3780309|FG004|Up to Month 7|Withdrawal by Subject|0
2294641|NCT02537522|3989316|FG000|Phase II - Period 1 Bilateral|Adverse Event|0
2294642|NCT02537522|3989317|FG001|Phase II - Period 1 Bilateral|Adverse Event|0
2294643|NCT02537522|3989318|FG002|Phase II - Period 1 Bilateral|Adverse Event|0
2294644|NCT02537522|3989319|FG003|Phase II - Period 1 Bilateral|Adverse Event|1
2294645|NCT02537574|3989328|FG000|Overall Study|Adverse Event|1
2294646|NCT02537574|3989329|FG001|Overall Study|Adverse Event|3
2294647|NCT02537574|3989330|FG002|Overall Study|Adverse Event|2
2294648|NCT02537574|3989328|FG000|Overall Study|Lost to Follow-up|40
2294649|NCT02537574|3989329|FG001|Overall Study|Lost to Follow-up|51
2294650|NCT02537574|3989330|FG002|Overall Study|Lost to Follow-up|55
2294651|NCT02537574|3989328|FG000|Overall Study|Noncompliance with study drug|0
2294652|NCT02537574|3989329|FG001|Overall Study|Noncompliance with study drug|1
2294653|NCT02537574|3989330|FG002|Overall Study|Noncompliance with study drug|1
2294654|NCT02537574|3989328|FG000|Overall Study|Physician Decision|2
2294655|NCT02537574|3989329|FG001|Overall Study|Physician Decision|0
2294656|NCT02537574|3989330|FG002|Overall Study|Physician Decision|0
2294657|NCT02537574|3989328|FG000|Overall Study|Protocol Violation|4
2294658|NCT02537574|3989329|FG001|Overall Study|Protocol Violation|2
2294659|NCT02537574|3989330|FG002|Overall Study|Protocol Violation|3
2294660|NCT02537574|3989328|FG000|Overall Study|Withdrawal by Subject|37
2162700|NCT01262976|3780310|FG005|Up to Month 7|Withdrawal by Subject|0
2162701|NCT01262976|3780305|FG000|Up to Month 7|Migrated/moved from study area|0
2162702|NCT01262976|3780306|FG001|Up to Month 7|Migrated/moved from study area|0
2162703|NCT01262976|3780307|FG002|Up to Month 7|Migrated/moved from study area|1
2162704|NCT01262976|3780308|FG003|Up to Month 7|Migrated/moved from study area|3
2162705|NCT01262976|3780309|FG004|Up to Month 7|Migrated/moved from study area|1
2162706|NCT01262976|3780310|FG005|Up to Month 7|Migrated/moved from study area|1
2162707|NCT01262976|3780305|FG000|Up to Month 7|Lost to Follow-up|1
2162708|NCT01262976|3780306|FG001|Up to Month 7|Lost to Follow-up|0
2162709|NCT01262976|3780307|FG002|Up to Month 7|Lost to Follow-up|1
2162710|NCT01262976|3780308|FG003|Up to Month 7|Lost to Follow-up|3
2162711|NCT01262976|3780309|FG004|Up to Month 7|Lost to Follow-up|1
2162712|NCT01262976|3780310|FG005|Up to Month 7|Lost to Follow-up|3
2162713|NCT01262976|3780305|FG000|Up to Month 7|Other|3
2294661|NCT02537574|3989329|FG001|Overall Study|Withdrawal by Subject|27
2294662|NCT02537574|3989330|FG002|Overall Study|Withdrawal by Subject|29
2294663|NCT02537574|3989328|FG000|Overall Study|Lack of Efficacy|14
2294664|NCT02537574|3989329|FG001|Overall Study|Lack of Efficacy|16
2294665|NCT02537574|3989330|FG002|Overall Study|Lack of Efficacy|15
2294666|NCT02537574|3989328|FG000|Overall Study|Duplicate Patient|1
2294667|NCT02537574|3989329|FG001|Overall Study|Duplicate Patient|0
2294668|NCT02537574|3989330|FG002|Overall Study|Duplicate Patient|0
2294669|NCT02537574|3989328|FG000|Overall Study|Patient not Stable|0
2294670|NCT02537574|3989329|FG001|Overall Study|Patient not Stable|1
2294671|NCT02537574|3989330|FG002|Overall Study|Patient not Stable|0
2294672|NCT02537574|3989328|FG000|Overall Study|Incarceration|0
2294673|NCT02537574|3989329|FG001|Overall Study|Incarceration|1
2294674|NCT02537574|3989330|FG002|Overall Study|Incarceration|0
2294675|NCT02537574|3989328|FG000|Overall Study|Failed Naloxone Challenge|0
2294676|NCT02537574|3989329|FG001|Overall Study|Failed Naloxone Challenge|1
2294677|NCT02537574|3989330|FG002|Overall Study|Failed Naloxone Challenge|0
2294678|NCT02537574|3989328|FG000|Overall Study|Transportation Issues|0
2294679|NCT02537574|3989329|FG001|Overall Study|Transportation Issues|0
2294680|NCT02537574|3989330|FG002|Overall Study|Transportation Issues|1
2294681|NCT02537574|3989328|FG000|Overall Study|Subject did not want last Vivitrol Injec|0
2294682|NCT02537574|3989329|FG001|Overall Study|Subject did not want last Vivitrol Injec|0
2294683|NCT02537574|3989330|FG002|Overall Study|Subject did not want last Vivitrol Injec|1
2294684|NCT02537574|3989328|FG000|Overall Study|Noncompliance with Protocol|0
2294685|NCT02537574|3989329|FG001|Overall Study|Noncompliance with Protocol|0
2294686|NCT02537574|3989330|FG002|Overall Study|Noncompliance with Protocol|1
2162714|NCT01262976|3780306|FG001|Up to Month 7|Other|0
2162715|NCT01262976|3780307|FG002|Up to Month 7|Other|2
2162716|NCT01262976|3780308|FG003|Up to Month 7|Other|0
2162717|NCT01262976|3780309|FG004|Up to Month 7|Other|0
2162718|NCT01262976|3780310|FG005|Up to Month 7|Other|0
2162719|NCT01262976|3780305|FG000|Up to Year 1|Serious Adverse Event|0
2162720|NCT01262976|3780306|FG001|Up to Year 1|Serious Adverse Event|0
2162721|NCT01262976|3780307|FG002|Up to Year 1|Serious Adverse Event|2
2162722|NCT01262976|3780308|FG003|Up to Year 1|Serious Adverse Event|0
2162723|NCT01262976|3780309|FG004|Up to Year 1|Serious Adverse Event|0
2162724|NCT01262976|3780310|FG005|Up to Year 1|Serious Adverse Event|0
2162725|NCT01262976|3780305|FG000|Up to Year 1|Withdrawal by Subject|1
2162726|NCT01262976|3780306|FG001|Up to Year 1|Withdrawal by Subject|0
2162727|NCT01262976|3780307|FG002|Up to Year 1|Withdrawal by Subject|0
2162728|NCT01262976|3780308|FG003|Up to Year 1|Withdrawal by Subject|0
2162729|NCT01262976|3780309|FG004|Up to Year 1|Withdrawal by Subject|0
2162730|NCT01262976|3780310|FG005|Up to Year 1|Withdrawal by Subject|0
2162731|NCT01262976|3780305|FG000|Up to Year 1|Migrated/moved from study area|1
2162732|NCT01262976|3780306|FG001|Up to Year 1|Migrated/moved from study area|0
2162733|NCT01262976|3780307|FG002|Up to Year 1|Migrated/moved from study area|0
2162734|NCT01262976|3780308|FG003|Up to Year 1|Migrated/moved from study area|3
2162735|NCT01262976|3780309|FG004|Up to Year 1|Migrated/moved from study area|3
2162736|NCT01262976|3780310|FG005|Up to Year 1|Migrated/moved from study area|2
2162737|NCT01262976|3780305|FG000|Up to Year 1|Lost to Follow-up|4
2162738|NCT01262976|3780306|FG001|Up to Year 1|Lost to Follow-up|0
2162739|NCT01262976|3780307|FG002|Up to Year 1|Lost to Follow-up|0
2162740|NCT01262976|3780308|FG003|Up to Year 1|Lost to Follow-up|1
2162741|NCT01262976|3780309|FG004|Up to Year 1|Lost to Follow-up|6
2162742|NCT01262976|3780310|FG005|Up to Year 1|Lost to Follow-up|5
2162743|NCT01262976|3780305|FG000|Up to Year 1|Other|3
2162744|NCT01262976|3780306|FG001|Up to Year 1|Other|1
2162745|NCT01262976|3780307|FG002|Up to Year 1|Other|0
2162746|NCT01262976|3780308|FG003|Up to Year 1|Other|0
2162747|NCT01262976|3780309|FG004|Up to Year 1|Other|2
2162748|NCT01262976|3780310|FG005|Up to Year 1|Other|1
2162749|NCT01262976|3780305|FG000|Up to Year 1|Subjects with unknown completion status|0
2162750|NCT01262976|3780306|FG001|Up to Year 1|Subjects with unknown completion status|0
2162751|NCT01262976|3780307|FG002|Up to Year 1|Subjects with unknown completion status|1
2162752|NCT01262976|3780308|FG003|Up to Year 1|Subjects with unknown completion status|0
2162753|NCT01262976|3780309|FG004|Up to Year 1|Subjects with unknown completion status|0
2162754|NCT01262976|3780310|FG005|Up to Year 1|Subjects with unknown completion status|1
2162755|NCT01262976|3780305|FG000|Up to Year 2|Serious Adverse Event|0
2162756|NCT01262976|3780306|FG001|Up to Year 2|Serious Adverse Event|0
2162757|NCT01262976|3780307|FG002|Up to Year 2|Serious Adverse Event|2
2162758|NCT01262976|3780308|FG003|Up to Year 2|Serious Adverse Event|0
2162759|NCT01262976|3780309|FG004|Up to Year 2|Serious Adverse Event|0
2162760|NCT01262976|3780310|FG005|Up to Year 2|Serious Adverse Event|0
2162761|NCT01262976|3780305|FG000|Up to Year 2|Withdrawal by Subject|1
2162762|NCT01262976|3780306|FG001|Up to Year 2|Withdrawal by Subject|0
2162763|NCT01262976|3780307|FG002|Up to Year 2|Withdrawal by Subject|0
2294687|NCT02538029|3989377|FG000|Overall Study|unable to complete cognitive assessments|1
2294688|NCT02538029|3989378|FG001|Overall Study|unable to complete cognitive assessments|0
2294689|NCT02538029|3989379|FG002|Overall Study|unable to complete cognitive assessments|1
2294690|NCT02538094|3989400|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
2294691|NCT02538094|3989401|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
2294692|NCT02538094|3989400|FG000|Washout (4 Weeks)|Withdrawal by Subject|0
2294693|NCT02538094|3989401|FG001|Washout (4 Weeks)|Withdrawal by Subject|1
2294694|NCT02538107|3989407|FG000|Overall Study|Did not receive any Mircera dose|11
2294695|NCT02538107|3989407|FG000|Overall Study|Missing|5
2294696|NCT02538107|3989407|FG000|Overall Study|Necessity of dialysis|20
2294697|NCT02538107|3989407|FG000|Overall Study|Administration of other ESA|11
2294698|NCT02538107|3989407|FG000|Overall Study|No further treatment necessary|18
2294699|NCT02538107|3989407|FG000|Overall Study|Withdrawal by Subject|17
2294700|NCT02538107|3989407|FG000|Overall Study|Death|4
2294701|NCT02538107|3989407|FG000|Overall Study|Administrative reason|5
2294702|NCT02538107|3989407|FG000|Overall Study|Adverse Event|4
2294703|NCT02538107|3989407|FG000|Overall Study|Surgery|1
2294704|NCT02538107|3989407|FG000|Overall Study|Other|7
2294705|NCT02538107|3989407|FG000|Overall Study|Not recorded|7
2294706|NCT02538341|3989423|FG000|Overall Study|Lost to Follow-up|51
2294707|NCT02538341|3989424|FG001|Overall Study|Lost to Follow-up|46
2294708|NCT02538341|3989423|FG000|Overall Study|Withdrawal by Subject|3
2294709|NCT02538341|3989424|FG001|Overall Study|Withdrawal by Subject|1
2294710|NCT02538341|3989423|FG000|Overall Study|Death|2
2294711|NCT02538341|3989424|FG001|Overall Study|Death|0
2294712|NCT02538471|3989448|FG000|Overall Study|Progression of disease|2
2294713|NCT02538614|3989461|FG000|Overall Study|Progressive Disease|2
2294714|NCT02538900|3989492|FG000|Overall Study|Death|2
2294715|NCT02538900|3989493|FG001|Overall Study|Death|2
2162764|NCT01262976|3780308|FG003|Up to Year 2|Withdrawal by Subject|0
2162765|NCT01262976|3780309|FG004|Up to Year 2|Withdrawal by Subject|0
2294716|NCT02538900|3989494|FG002|Overall Study|Death|2
2294717|NCT02538900|3989492|FG000|Overall Study|Withdrawal by Subject|18
2294718|NCT02538900|3989493|FG001|Overall Study|Withdrawal by Subject|16
2294719|NCT02538900|3989494|FG002|Overall Study|Withdrawal by Subject|15
2321278|NCT02959177|4035850|FG002|Double-Blind Treatment Phase|Physician Decision|0
2162766|NCT01262976|3780310|FG005|Up to Year 2|Withdrawal by Subject|0
2162767|NCT01262976|3780305|FG000|Up to Year 2|Migrated/moved from study area|0
2162768|NCT01262976|3780306|FG001|Up to Year 2|Migrated/moved from study area|0
2162769|NCT01262976|3780307|FG002|Up to Year 2|Migrated/moved from study area|0
2162770|NCT01262976|3780308|FG003|Up to Year 2|Migrated/moved from study area|2
2162771|NCT01262976|3780309|FG004|Up to Year 2|Migrated/moved from study area|1
2162772|NCT01262976|3780310|FG005|Up to Year 2|Migrated/moved from study area|2
2162773|NCT01262976|3780305|FG000|Up to Year 2|Lost to Follow-up|1
2162774|NCT01262976|3780306|FG001|Up to Year 2|Lost to Follow-up|1
2162775|NCT01262976|3780307|FG002|Up to Year 2|Lost to Follow-up|2
2162776|NCT01262976|3780308|FG003|Up to Year 2|Lost to Follow-up|2
2162777|NCT01262976|3780309|FG004|Up to Year 2|Lost to Follow-up|3
2162778|NCT01262976|3780310|FG005|Up to Year 2|Lost to Follow-up|3
2162779|NCT01262976|3780305|FG000|Up to Year 2|Subjects with unknown completion status|0
2162780|NCT01262976|3780306|FG001|Up to Year 2|Subjects with unknown completion status|0
2294720|NCT02538965|3989502|FG000|Treatment Period|Other = Death due to disease progression|1
2294721|NCT02538965|3989502|FG000|Treatment Period|Adverse Event|2
2294722|NCT02538965|3989502|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
2294723|NCT02538965|3989502|FG000|Treatment Period|Treatment Failure|9
2294724|NCT02538965|3989502|FG000|Treatment Period|Disease Progression|1
2294725|NCT02538965|3989502|FG000|Treatment Period|Physician Decision|2
2294726|NCT02538965|3989502|FG000|Follow-Up Period|Other = Death due to disease progression|13
2294727|NCT02538965|3989502|FG000|Follow-Up Period|Withdrawal by Parent|4
2294728|NCT02539134|3989521|FG000|Overall Study|Lost to Follow-up|1
2294729|NCT02539134|3989522|FG001|Overall Study|Lost to Follow-up|0
2294730|NCT02539134|3989523|FG002|Overall Study|Lost to Follow-up|0
2294731|NCT02539134|3989524|FG003|Overall Study|Lost to Follow-up|0
2294732|NCT02539134|3989525|FG004|Overall Study|Lost to Follow-up|0
2294733|NCT02539134|3989526|FG005|Overall Study|Lost to Follow-up|0
2294734|NCT02539225|3989547|FG000|Part A|Adverse Event|13
2294735|NCT02539225|3989548|FG001|Part A|Adverse Event|4
2294736|NCT02539225|3989547|FG000|Part A|Withdrawal by Subject|2
2294737|NCT02539225|3989548|FG001|Part A|Withdrawal by Subject|4
2294738|NCT02539225|3989547|FG000|Part A|Physician Decision|4
2294739|NCT02539225|3989548|FG001|Part A|Physician Decision|7
2294740|NCT02539225|3989547|FG000|Part A|Did Not Receive study Drug|1
2294741|NCT02539225|3989548|FG001|Part A|Did Not Receive study Drug|1
2294742|NCT02539225|3989547|FG000|Pre Treatment for Part B|Progressive disease|1
2294743|NCT02539225|3989548|FG001|Pre Treatment for Part B|Progressive disease|1
2294744|NCT02539225|3989547|FG000|Pre Treatment for Part B|Adverse Event|1
2294745|NCT02539225|3989548|FG001|Pre Treatment for Part B|Adverse Event|1
2294746|NCT02539225|3989547|FG000|Pre Treatment for Part B|Withdrawal by Subject|1
2294747|NCT02539225|3989548|FG001|Pre Treatment for Part B|Withdrawal by Subject|0
2294748|NCT02539225|3989547|FG000|Pre Treatment for Part B|Physician Decision|2
2294749|NCT02539225|3989548|FG001|Pre Treatment for Part B|Physician Decision|0
2294750|NCT02539225|3989547|FG000|Part B|Adverse Event|4
2294751|NCT02539225|3989548|FG001|Part B|Adverse Event|4
2294752|NCT02539225|3989547|FG000|Part B|Withdrawal by Subject|0
2294753|NCT02539225|3989548|FG001|Part B|Withdrawal by Subject|3
2294754|NCT02539225|3989547|FG000|Part B|Physician Decision|0
2294755|NCT02539225|3989548|FG001|Part B|Physician Decision|9
2294756|NCT02539368|3989573|FG000|Overall Study|Death|4
2294757|NCT02539368|3989574|FG001|Overall Study|Death|2
2294758|NCT02539368|3989575|FG002|Overall Study|Death|1
2294759|NCT02539368|3989576|FG003|Overall Study|Death|0
2294760|NCT02539368|3989577|FG004|Overall Study|Death|0
2294761|NCT02539368|3989573|FG000|Overall Study|Withdrawal by Subject|44
2294762|NCT02539368|3989574|FG001|Overall Study|Withdrawal by Subject|35
2294763|NCT02539368|3989575|FG002|Overall Study|Withdrawal by Subject|9
2294764|NCT02539368|3989576|FG003|Overall Study|Withdrawal by Subject|1
2294765|NCT02539368|3989577|FG004|Overall Study|Withdrawal by Subject|3
2294766|NCT02539368|3989573|FG000|Overall Study|Physician Decision|49
2294767|NCT02539368|3989574|FG001|Overall Study|Physician Decision|15
2294768|NCT02539368|3989575|FG002|Overall Study|Physician Decision|7
2294769|NCT02539368|3989576|FG003|Overall Study|Physician Decision|0
2294770|NCT02539368|3989577|FG004|Overall Study|Physician Decision|2
2294771|NCT02539368|3989573|FG000|Overall Study|Lost to Follow-up|96
2294772|NCT02539368|3989574|FG001|Overall Study|Lost to Follow-up|21
2294773|NCT02539368|3989575|FG002|Overall Study|Lost to Follow-up|16
2294774|NCT02539368|3989576|FG003|Overall Study|Lost to Follow-up|4
2294775|NCT02539368|3989577|FG004|Overall Study|Lost to Follow-up|3
2294776|NCT02539368|3989573|FG000|Overall Study|Adverse Event|44
2294777|NCT02539368|3989574|FG001|Overall Study|Adverse Event|5
2294778|NCT02539368|3989575|FG002|Overall Study|Adverse Event|9
2294779|NCT02539368|3989576|FG003|Overall Study|Adverse Event|0
2294780|NCT02539368|3989577|FG004|Overall Study|Adverse Event|3
2294781|NCT02539368|3989573|FG000|Overall Study|Participant Non-compliant|13
2294782|NCT02539368|3989574|FG001|Overall Study|Participant Non-compliant|2
2294783|NCT02539368|3989575|FG002|Overall Study|Participant Non-compliant|1
2294784|NCT02539368|3989576|FG003|Overall Study|Participant Non-compliant|1
2294785|NCT02539368|3989577|FG004|Overall Study|Participant Non-compliant|0
2294786|NCT02539368|3989573|FG000|Overall Study|Other|145
2294787|NCT02539368|3989574|FG001|Overall Study|Other|18
2294788|NCT02539368|3989575|FG002|Overall Study|Other|24
2294789|NCT02539368|3989576|FG003|Overall Study|Other|1
2162781|NCT01262976|3780307|FG002|Up to Year 2|Subjects with unknown completion status|1
2162782|NCT01262976|3780308|FG003|Up to Year 2|Subjects with unknown completion status|0
2162783|NCT01262976|3780309|FG004|Up to Year 2|Subjects with unknown completion status|0
2162784|NCT01262976|3780310|FG005|Up to Year 2|Subjects with unknown completion status|0
2162785|NCT01262976|3780305|FG000|Up to Year 2|Other|3
2162786|NCT01262976|3780306|FG001|Up to Year 2|Other|0
2162787|NCT01262976|3780307|FG002|Up to Year 2|Other|0
2162788|NCT01262976|3780308|FG003|Up to Year 2|Other|0
2162789|NCT01262976|3780309|FG004|Up to Year 2|Other|0
2162790|NCT01262976|3780310|FG005|Up to Year 2|Other|0
2162791|NCT01262976|3780305|FG000|Up to Year 3|Serious Adverse Event|0
2162792|NCT01262976|3780306|FG001|Up to Year 3|Serious Adverse Event|0
2162793|NCT01262976|3780307|FG002|Up to Year 3|Serious Adverse Event|2
2162794|NCT01262976|3780308|FG003|Up to Year 3|Serious Adverse Event|0
2162795|NCT01262976|3780309|FG004|Up to Year 3|Serious Adverse Event|0
2162796|NCT01262976|3780310|FG005|Up to Year 3|Serious Adverse Event|0
2162797|NCT01262976|3780305|FG000|Up to Year 3|Withdrawal by Subject|1
2162798|NCT01262976|3780306|FG001|Up to Year 3|Withdrawal by Subject|0
2162799|NCT01262976|3780307|FG002|Up to Year 3|Withdrawal by Subject|0
2162800|NCT01262976|3780308|FG003|Up to Year 3|Withdrawal by Subject|0
2162801|NCT01262976|3780309|FG004|Up to Year 3|Withdrawal by Subject|0
2162802|NCT01262976|3780310|FG005|Up to Year 3|Withdrawal by Subject|0
2162803|NCT01262976|3780305|FG000|Up to Year 3|Migrated/moved from study area|0
2162804|NCT01262976|3780306|FG001|Up to Year 3|Migrated/moved from study area|0
2162805|NCT01262976|3780307|FG002|Up to Year 3|Migrated/moved from study area|0
2162806|NCT01262976|3780308|FG003|Up to Year 3|Migrated/moved from study area|2
2162807|NCT01262976|3780309|FG004|Up to Year 3|Migrated/moved from study area|1
2162808|NCT01262976|3780310|FG005|Up to Year 3|Migrated/moved from study area|1
2162809|NCT01262976|3780305|FG000|Up to Year 3|Lost to Follow-up|2
2162810|NCT01262976|3780306|FG001|Up to Year 3|Lost to Follow-up|2
2162811|NCT01262976|3780307|FG002|Up to Year 3|Lost to Follow-up|4
2162812|NCT01262976|3780308|FG003|Up to Year 3|Lost to Follow-up|3
2162813|NCT01262976|3780309|FG004|Up to Year 3|Lost to Follow-up|1
2162814|NCT01262976|3780310|FG005|Up to Year 3|Lost to Follow-up|3
2162815|NCT01262976|3780305|FG000|Up to Year 3|Subjects with unknown completion status|0
2162816|NCT01262976|3780306|FG001|Up to Year 3|Subjects with unknown completion status|0
2162817|NCT01262976|3780307|FG002|Up to Year 3|Subjects with unknown completion status|1
2162818|NCT01262976|3780308|FG003|Up to Year 3|Subjects with unknown completion status|0
2162819|NCT01262976|3780309|FG004|Up to Year 3|Subjects with unknown completion status|0
2162820|NCT01262976|3780310|FG005|Up to Year 3|Subjects with unknown completion status|0
2162821|NCT01262976|3780305|FG000|Up to Year 3|Other|3
2162822|NCT01262976|3780306|FG001|Up to Year 3|Other|0
2162823|NCT01262976|3780307|FG002|Up to Year 3|Other|0
2162824|NCT01262976|3780308|FG003|Up to Year 3|Other|0
2162825|NCT01262976|3780309|FG004|Up to Year 3|Other|0
2162826|NCT01262976|3780310|FG005|Up to Year 3|Other|0
2162827|NCT01262989|3780325|FG000|Period 1|Lost to Follow-up|1
2162828|NCT01262989|3780326|FG001|Period 1|Lost to Follow-up|1
2162829|NCT01262989|3780325|FG000|Period 1|Intercurrent disease|0
2162830|NCT01262989|3780326|FG001|Period 1|Intercurrent disease|1
2162831|NCT01262989|3780325|FG000|Period 1|Positive answer for exclusion criteria|0
2294790|NCT02539368|3989577|FG004|Overall Study|Other|3
2294791|NCT02539368|3989573|FG000|Overall Study|Missing|10
2294792|NCT02539368|3989574|FG001|Overall Study|Missing|3
2294793|NCT02539368|3989575|FG002|Overall Study|Missing|0
2294794|NCT02539368|3989576|FG003|Overall Study|Missing|0
2294795|NCT02539368|3989577|FG004|Overall Study|Missing|0
2294796|NCT02539797|3989619|FG000|Overall Study|Lost to Follow-up|0
2294797|NCT02539797|3989620|FG001|Overall Study|Lost to Follow-up|1
2294798|NCT02539797|3989621|FG002|Overall Study|Lost to Follow-up|0
2294799|NCT02540083|3989644|FG000|Overall Study|Withdrawal by Subject|16
2294800|NCT02540213|3989665|FG000|Overall Study|Death/adverse event|18
2294801|NCT02540213|3989665|FG000|Overall Study|Administrative reasons|3
2294802|NCT02540213|3989665|FG000|Overall Study|Kidney transplant|3
2294803|NCT02540213|3989665|FG000|Overall Study|Lack of Efficacy|6
2294804|NCT02540213|3989665|FG000|Overall Study|Consent withdrawn|7
2294805|NCT02540213|3989665|FG000|Overall Study|Enrolled but not treated|2
2294806|NCT02540265|3989681|FG000|Overall Study|Lost to Follow-up|0
2294807|NCT02540265|3989682|FG001|Overall Study|Lost to Follow-up|0
2294808|NCT02540265|3989683|FG002|Overall Study|Lost to Follow-up|1
2294809|NCT02540291|3989695|FG000|Overall Study|Death|7
2162832|NCT01262989|3780326|FG001|Period 1|Positive answer for exclusion criteria|1
2162833|NCT01262989|3780325|FG000|Period 2|Intercurrent disease|0
2162834|NCT01262989|3780326|FG001|Period 2|Intercurrent disease|1
2162835|NCT01263015|3780334|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
2162836|NCT01263015|3780335|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
2162837|NCT01263015|3780334|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
2162838|NCT01263015|3780335|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
2162839|NCT01263015|3780334|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
2294810|NCT02540291|3989696|FG001|Overall Study|Death|7
2294811|NCT02540291|3989697|FG002|Overall Study|Death|5
2294812|NCT02540291|3989698|FG003|Overall Study|Death|7
2294813|NCT02540291|3989695|FG000|Overall Study|Lost to Follow-up|0
2162840|NCT01263015|3780335|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
2162841|NCT01263015|3780334|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
2162842|NCT01263015|3780335|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
2162843|NCT01263015|3780334|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
2162844|NCT01263015|3780335|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
2162845|NCT01263015|3780334|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
2162846|NCT01263015|3780335|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
2162847|NCT01263015|3780334|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3
2162848|NCT01263015|3780335|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10
2162849|NCT01263015|3780334|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
2162850|NCT01263015|3780335|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
2162851|NCT01263015|3780334|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
2162852|NCT01263015|3780335|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
2162853|NCT01263015|3780334|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
2162854|NCT01263015|3780335|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
2162855|NCT01263015|3780334|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0
2162856|NCT01263015|3780335|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2
2162857|NCT01263015|3780334|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
2162858|NCT01263015|3780335|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
2162859|NCT01263054|3780343|FG000|Overall Study|Death|1
2162860|NCT01263054|3780344|FG001|Overall Study|Death|0
2162861|NCT01263054|3780343|FG000|Overall Study|Lost to Follow-up|2
2162862|NCT01263054|3780344|FG001|Overall Study|Lost to Follow-up|2
2162863|NCT01263054|3780343|FG000|Overall Study|Withdrawal by Subject|1
2162864|NCT01263054|3780344|FG001|Overall Study|Withdrawal by Subject|3
2162865|NCT01263054|3780343|FG000|Overall Study|Qualification Violation|1
2162866|NCT01263054|3780344|FG001|Overall Study|Qualification Violation|0
2162867|NCT01263054|3780343|FG000|Overall Study|Other|0
2162868|NCT01263054|3780344|FG001|Overall Study|Other|1
2162869|NCT01263093|3780352|FG000|Washout|Physician Decision|1
2162870|NCT01263093|3780353|FG001|Washout|Physician Decision|0
2162871|NCT01263093|3780352|FG000|Period 2|Adverse Event|1
2162872|NCT01263093|3780353|FG001|Period 2|Adverse Event|0
2162873|NCT01263106|3780360|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1
2162874|NCT01263106|3780361|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1
2162875|NCT01263119|3780370|FG000|Period 1|Protocol Violation|2
2162876|NCT01263119|3780370|FG000|Period 2|Adverse Event|2
2162877|NCT01263197|3780389|FG000|First Intervention (Period 1)|Adverse Event|0
2162878|NCT01263197|3780390|FG001|First Intervention (Period 1)|Adverse Event|0
2162879|NCT01263197|3780391|FG002|First Intervention (Period 1)|Adverse Event|0
2162880|NCT01263197|3780392|FG003|First Intervention (Period 1)|Adverse Event|0
2162881|NCT01263197|3780393|FG004|First Intervention (Period 1)|Adverse Event|0
2162882|NCT01263197|3780394|FG005|First Intervention (Period 1)|Adverse Event|1
2162883|NCT01263197|3780389|FG000|Washout Period 1|Protocol Violation|0
2162884|NCT01263197|3780390|FG001|Washout Period 1|Protocol Violation|0
2162885|NCT01263197|3780391|FG002|Washout Period 1|Protocol Violation|0
2162886|NCT01263197|3780392|FG003|Washout Period 1|Protocol Violation|0
2162887|NCT01263197|3780393|FG004|Washout Period 1|Protocol Violation|1
2162888|NCT01263197|3780394|FG005|Washout Period 1|Protocol Violation|0
2162889|NCT01263197|3780389|FG000|Washout Period 2|Physician Decision|0
2162890|NCT01263197|3780390|FG001|Washout Period 2|Physician Decision|0
2162891|NCT01263197|3780391|FG002|Washout Period 2|Physician Decision|0
2162892|NCT01263197|3780392|FG003|Washout Period 2|Physician Decision|0
2162893|NCT01263197|3780393|FG004|Washout Period 2|Physician Decision|0
2294814|NCT02540291|3989696|FG001|Overall Study|Lost to Follow-up|0
2294815|NCT02540291|3989697|FG002|Overall Study|Lost to Follow-up|1
2294816|NCT02540291|3989698|FG003|Overall Study|Lost to Follow-up|0
2294817|NCT02540291|3989695|FG000|Overall Study|Withdrawal Of Consent|0
2294818|NCT02540291|3989696|FG001|Overall Study|Withdrawal Of Consent|1
2294819|NCT02540291|3989697|FG002|Overall Study|Withdrawal Of Consent|0
2294820|NCT02540291|3989698|FG003|Overall Study|Withdrawal Of Consent|0
2294821|NCT02540291|3989695|FG000|Overall Study|Study Terminated By Sponsor|1
2294822|NCT02540291|3989696|FG001|Overall Study|Study Terminated By Sponsor|0
2294823|NCT02540291|3989697|FG002|Overall Study|Study Terminated By Sponsor|0
2294824|NCT02540291|3989698|FG003|Overall Study|Study Terminated By Sponsor|0
2294825|NCT02540291|3989695|FG000|Overall Study|Other|0
2294826|NCT02540291|3989696|FG001|Overall Study|Other|0
2294827|NCT02540291|3989697|FG002|Overall Study|Other|1
2294828|NCT02540291|3989698|FG003|Overall Study|Other|0
2294829|NCT02540356|3989712|FG000|Overall Study|Terminated due to disease progression|1
2294830|NCT02540356|3989713|FG001|Overall Study|Terminated due to disease progression|0
2294831|NCT02540538|3989730|FG000|Overall Study|Pregnancy|0
2294832|NCT02540538|3989731|FG001|Overall Study|Pregnancy|1
2294833|NCT02540538|3989732|FG002|Overall Study|Pregnancy|0
2294834|NCT02540668|3989750|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0
2294835|NCT02540668|3989751|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1
2294836|NCT02540850|3989770|FG000|Overall Study|Lost to Follow-up|69
2294837|NCT02540850|3989771|FG001|Overall Study|Lost to Follow-up|66
2294838|NCT02540850|3989772|FG002|Overall Study|Lost to Follow-up|34
2294839|NCT02540954|3989782|FG000|Overall Study|Physician Decision|3
2162894|NCT01263197|3780394|FG005|Washout Period 2|Physician Decision|1
2162895|NCT01263197|3780389|FG000|Washout Period 2|Protocol Violation|0
2162896|NCT01263197|3780390|FG001|Washout Period 2|Protocol Violation|0
2162897|NCT01263197|3780391|FG002|Washout Period 2|Protocol Violation|0
2162898|NCT01263197|3780392|FG003|Washout Period 2|Protocol Violation|1
2162899|NCT01263197|3780393|FG004|Washout Period 2|Protocol Violation|0
2162900|NCT01263197|3780394|FG005|Washout Period 2|Protocol Violation|0
2162901|NCT01263197|3780389|FG000|Third Intervention (Period 3)|Adverse Event|0
2162902|NCT01263197|3780390|FG001|Third Intervention (Period 3)|Adverse Event|1
2162903|NCT01263197|3780391|FG002|Third Intervention (Period 3)|Adverse Event|0
2162904|NCT01263197|3780392|FG003|Third Intervention (Period 3)|Adverse Event|0
2162905|NCT01263197|3780393|FG004|Third Intervention (Period 3)|Adverse Event|0
2162906|NCT01263197|3780394|FG005|Third Intervention (Period 3)|Adverse Event|0
2179505|NCT01393990|3805033|FG007|Overall Study|Progressive Disease|1
2179506|NCT01393990|3805034|FG008|Overall Study|Progressive Disease|3
2294840|NCT02540954|3989783|FG001|Overall Study|Physician Decision|1
2294841|NCT02540954|3989782|FG000|Overall Study|Withdrawal by Subject|6
2294842|NCT02540954|3989783|FG001|Overall Study|Withdrawal by Subject|5
2294843|NCT02540954|3989782|FG000|Overall Study|Lost to Follow-up|1
2294844|NCT02540954|3989783|FG001|Overall Study|Lost to Follow-up|1
2294845|NCT02540954|3989782|FG000|Overall Study|Adverse Event|4
2294846|NCT02540954|3989783|FG001|Overall Study|Adverse Event|2
2294847|NCT02540954|3989782|FG000|Overall Study|Death|0
2294848|NCT02540954|3989783|FG001|Overall Study|Death|3
2294849|NCT02540954|3989782|FG000|Overall Study|Treatment failure|1
2294850|NCT02540954|3989783|FG001|Overall Study|Treatment failure|0
2294851|NCT02540954|3989782|FG000|Overall Study|Other reason|4
2294852|NCT02540954|3989783|FG001|Overall Study|Other reason|2
2294853|NCT02540993|3989791|FG000|Overall Study|Lost to Follow-up|5
2294854|NCT02540993|3989792|FG001|Overall Study|Lost to Follow-up|3
2294855|NCT02540993|3989791|FG000|Overall Study|Withdrawal by Subject|4
2294856|NCT02540993|3989792|FG001|Overall Study|Withdrawal by Subject|6
2294857|NCT02540993|3989791|FG000|Overall Study|GCP violations|33
2294858|NCT02540993|3989792|FG001|Overall Study|GCP violations|27
2294859|NCT02541604|3989830|FG000|Overall Study|Death|6
2294860|NCT02541604|3989831|FG001|Overall Study|Death|5
2294861|NCT02541604|3989832|FG002|Overall Study|Death|7
2294862|NCT02541604|3989833|FG003|Overall Study|Death|2
2294863|NCT02541604|3989834|FG004|Overall Study|Death|9
2294864|NCT02541604|3989835|FG005|Overall Study|Death|8
2294865|NCT02541604|3989836|FG006|Overall Study|Death|9
2294866|NCT02541604|3989837|FG007|Overall Study|Death|9
2294867|NCT02541604|3989838|FG008|Overall Study|Death|3
2294868|NCT02541604|3989839|FG009|Overall Study|Death|4
2294869|NCT02541604|3989840|FG010|Overall Study|Death|2
2294870|NCT02541604|3989841|FG011|Overall Study|Death|3
2294871|NCT02541604|3989830|FG000|Overall Study|Lost to Follow-up|2
2294872|NCT02541604|3989831|FG001|Overall Study|Lost to Follow-up|0
2294873|NCT02541604|3989832|FG002|Overall Study|Lost to Follow-up|1
2294874|NCT02541604|3989833|FG003|Overall Study|Lost to Follow-up|0
2294875|NCT02541604|3989834|FG004|Overall Study|Lost to Follow-up|0
2294876|NCT02541604|3989835|FG005|Overall Study|Lost to Follow-up|1
2294877|NCT02541604|3989836|FG006|Overall Study|Lost to Follow-up|1
2294878|NCT02541604|3989837|FG007|Overall Study|Lost to Follow-up|0
2294879|NCT02541604|3989838|FG008|Overall Study|Lost to Follow-up|0
2294880|NCT02541604|3989839|FG009|Overall Study|Lost to Follow-up|0
2294881|NCT02541604|3989840|FG010|Overall Study|Lost to Follow-up|0
2294882|NCT02541604|3989841|FG011|Overall Study|Lost to Follow-up|0
2294883|NCT02541604|3989830|FG000|Overall Study|Withdrawal by Subject|2
2294884|NCT02541604|3989831|FG001|Overall Study|Withdrawal by Subject|0
2294885|NCT02541604|3989832|FG002|Overall Study|Withdrawal by Subject|1
2294886|NCT02541604|3989833|FG003|Overall Study|Withdrawal by Subject|0
2294887|NCT02541604|3989834|FG004|Overall Study|Withdrawal by Subject|1
2294888|NCT02541604|3989835|FG005|Overall Study|Withdrawal by Subject|1
2294889|NCT02541604|3989836|FG006|Overall Study|Withdrawal by Subject|0
2294890|NCT02541604|3989837|FG007|Overall Study|Withdrawal by Subject|0
2294891|NCT02541604|3989838|FG008|Overall Study|Withdrawal by Subject|1
2294892|NCT02541604|3989839|FG009|Overall Study|Withdrawal by Subject|0
2294893|NCT02541604|3989840|FG010|Overall Study|Withdrawal by Subject|0
2294894|NCT02541604|3989841|FG011|Overall Study|Withdrawal by Subject|0
2294895|NCT02541604|3989830|FG000|Overall Study|Study Terminated by Sponsor|1
2294896|NCT02541604|3989831|FG001|Overall Study|Study Terminated by Sponsor|4
2294897|NCT02541604|3989832|FG002|Overall Study|Study Terminated by Sponsor|2
2294898|NCT02541604|3989833|FG003|Overall Study|Study Terminated by Sponsor|1
2294899|NCT02541604|3989834|FG004|Overall Study|Study Terminated by Sponsor|0
2294900|NCT02541604|3989835|FG005|Overall Study|Study Terminated by Sponsor|0
2294901|NCT02541604|3989836|FG006|Overall Study|Study Terminated by Sponsor|0
2294902|NCT02541604|3989837|FG007|Overall Study|Study Terminated by Sponsor|0
2294903|NCT02541604|3989838|FG008|Overall Study|Study Terminated by Sponsor|0
2294904|NCT02541604|3989839|FG009|Overall Study|Study Terminated by Sponsor|0
2294905|NCT02541604|3989840|FG010|Overall Study|Study Terminated by Sponsor|0
2294906|NCT02541604|3989841|FG011|Overall Study|Study Terminated by Sponsor|0
2294907|NCT02541604|3989830|FG000|Overall Study|Medical condition may jeopardize safety|0
2294908|NCT02541604|3989831|FG001|Overall Study|Medical condition may jeopardize safety|0
2294909|NCT02541604|3989832|FG002|Overall Study|Medical condition may jeopardize safety|0
2162907|NCT01263223|3780408|FG000|Period 2|Withdrawal by Subject|0
2162908|NCT01263223|3780409|FG001|Period 2|Withdrawal by Subject|1
2162909|NCT01263223|3780408|FG000|7-day Follow-up|Withdrawal by Subject|0
2162910|NCT01263223|3780409|FG001|7-day Follow-up|Withdrawal by Subject|1
2162911|NCT01263223|3780408|FG000|7-day Follow-up|Lost to Follow-up|1
2162912|NCT01263223|3780409|FG001|7-day Follow-up|Lost to Follow-up|0
2162913|NCT01263444|3780466|FG000|Overall Study|Adverse Event|8
2162914|NCT01263444|3780466|FG000|Overall Study|Withdrawal by Subject|1
2162915|NCT01263444|3780466|FG000|Overall Study|Protocol Violation|1
2162916|NCT01263470|3780476|FG000|Overall Study|Adverse Event|2
2162917|NCT01263470|3780477|FG001|Overall Study|Adverse Event|2
2162918|NCT01263470|3780478|FG002|Overall Study|Adverse Event|1
2162919|NCT01263470|3780479|FG003|Overall Study|Adverse Event|1
2162920|NCT01263470|3780480|FG004|Overall Study|Adverse Event|2
2162921|NCT01263470|3780481|FG005|Overall Study|Adverse Event|2
2162922|NCT01263470|3780476|FG000|Overall Study|Protocol Violation|0
2162923|NCT01263470|3780477|FG001|Overall Study|Protocol Violation|1
2162924|NCT01263470|3780478|FG002|Overall Study|Protocol Violation|0
2162925|NCT01263470|3780479|FG003|Overall Study|Protocol Violation|0
2162926|NCT01263470|3780480|FG004|Overall Study|Protocol Violation|0
2162927|NCT01263470|3780481|FG005|Overall Study|Protocol Violation|1
2162928|NCT01263470|3780476|FG000|Overall Study|Withdrawal by Subject|0
2162929|NCT01263470|3780477|FG001|Overall Study|Withdrawal by Subject|1
2162930|NCT01263470|3780478|FG002|Overall Study|Withdrawal by Subject|1
2162931|NCT01263470|3780479|FG003|Overall Study|Withdrawal by Subject|2
2162932|NCT01263470|3780480|FG004|Overall Study|Withdrawal by Subject|0
2162933|NCT01263470|3780481|FG005|Overall Study|Withdrawal by Subject|2
2162934|NCT01263470|3780476|FG000|Overall Study|Lack of Efficacy|0
2162935|NCT01263470|3780477|FG001|Overall Study|Lack of Efficacy|0
2162936|NCT01263470|3780478|FG002|Overall Study|Lack of Efficacy|2
2162937|NCT01263470|3780479|FG003|Overall Study|Lack of Efficacy|0
2162938|NCT01263470|3780480|FG004|Overall Study|Lack of Efficacy|0
2162939|NCT01263470|3780481|FG005|Overall Study|Lack of Efficacy|0
2162940|NCT01263470|3780476|FG000|Overall Study|Participant Unavailability|0
2162941|NCT01263470|3780477|FG001|Overall Study|Participant Unavailability|1
2162942|NCT01263470|3780478|FG002|Overall Study|Participant Unavailability|0
2162943|NCT01263470|3780479|FG003|Overall Study|Participant Unavailability|0
2162944|NCT01263470|3780480|FG004|Overall Study|Participant Unavailability|0
2162945|NCT01263470|3780481|FG005|Overall Study|Participant Unavailability|0
2162946|NCT01263470|3780476|FG000|Overall Study|Study Drug Non-compliance|0
2162947|NCT01263470|3780477|FG001|Overall Study|Study Drug Non-compliance|0
2162948|NCT01263470|3780478|FG002|Overall Study|Study Drug Non-compliance|0
2162949|NCT01263470|3780479|FG003|Overall Study|Study Drug Non-compliance|0
2162950|NCT01263470|3780480|FG004|Overall Study|Study Drug Non-compliance|1
2162951|NCT01263470|3780481|FG005|Overall Study|Study Drug Non-compliance|0
2162952|NCT01263483|3780498|FG000|Overall Study|Adverse Event|4
2162953|NCT01263483|3780499|FG001|Overall Study|Adverse Event|0
2162954|NCT01263483|3780500|FG002|Overall Study|Adverse Event|3
2162955|NCT01263483|3780498|FG000|Overall Study|Withdrawal by Subject|1
2162956|NCT01263483|3780499|FG001|Overall Study|Withdrawal by Subject|0
2162957|NCT01263483|3780500|FG002|Overall Study|Withdrawal by Subject|0
2162958|NCT01263483|3780498|FG000|Overall Study|Lack of Efficacy|2
2162959|NCT01263483|3780499|FG001|Overall Study|Lack of Efficacy|0
2162960|NCT01263483|3780500|FG002|Overall Study|Lack of Efficacy|0
2162961|NCT01263483|3780498|FG000|Overall Study|Protocol Violation|0
2162962|NCT01263483|3780499|FG001|Overall Study|Protocol Violation|1
2162963|NCT01263483|3780500|FG002|Overall Study|Protocol Violation|1
2162964|NCT01263483|3780498|FG000|Overall Study|Participant Unavailability|0
2162965|NCT01263483|3780499|FG001|Overall Study|Participant Unavailability|1
2162966|NCT01263483|3780500|FG002|Overall Study|Participant Unavailability|1
2162967|NCT01263496|3780513|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1
2162968|NCT01263496|3780514|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0
2162969|NCT01263496|3780515|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0
2162970|NCT01263496|3780516|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0
2162971|NCT01263496|3780517|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0
2162972|NCT01263496|3780518|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0
2162973|NCT01263496|3780519|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0
2162974|NCT01263496|3780520|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0
2162975|NCT01263496|3780521|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0
2162976|NCT01263496|3780513|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
2162977|NCT01263496|3780514|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
2162978|NCT01263496|3780515|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
2162979|NCT01263496|3780516|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
2162980|NCT01263496|3780517|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2
2162981|NCT01263496|3780518|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
2162982|NCT01263496|3780519|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
2162983|NCT01263496|3780520|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
2162984|NCT01263496|3780521|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0
2162985|NCT01263496|3780513|FG000|Entered - Long-Term Extension Study|Adverse Event|0
2162986|NCT01263496|3780514|FG001|Entered - Long-Term Extension Study|Adverse Event|5
2162987|NCT01263496|3780515|FG002|Entered - Long-Term Extension Study|Adverse Event|6
2162988|NCT01263496|3780516|FG003|Entered - Long-Term Extension Study|Adverse Event|3
2162989|NCT01263496|3780517|FG004|Entered - Long-Term Extension Study|Adverse Event|1
2162990|NCT01263496|3780518|FG005|Entered - Long-Term Extension Study|Adverse Event|0
2162991|NCT01263496|3780519|FG006|Entered - Long-Term Extension Study|Adverse Event|0
2162992|NCT01263496|3780520|FG007|Entered - Long-Term Extension Study|Adverse Event|0
2162993|NCT01263496|3780521|FG008|Entered - Long-Term Extension Study|Adverse Event|1
2162994|NCT01263496|3780513|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0
2162995|NCT01263496|3780514|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2
2162996|NCT01263496|3780515|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
2162997|NCT01263496|3780516|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
2162998|NCT01263496|3780517|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0
2162999|NCT01263496|3780518|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0
2163000|NCT01263496|3780519|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0
2163001|NCT01263496|3780520|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0
2163002|NCT01263496|3780521|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0
2163003|NCT01263496|3780513|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2163004|NCT01263496|3780514|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2163005|NCT01263496|3780515|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2163006|NCT01263496|3780516|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2163007|NCT01263496|3780517|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4
2163008|NCT01263496|3780518|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2163009|NCT01263496|3780519|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2163010|NCT01263496|3780520|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2163011|NCT01263496|3780521|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2163012|NCT01263496|3780513|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8
2163013|NCT01263496|3780514|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
2163014|NCT01263496|3780515|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4
2163015|NCT01263496|3780516|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1
2163016|NCT01263496|3780517|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5
2163017|NCT01263496|3780518|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0
2163018|NCT01263496|3780519|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0
2163019|NCT01263496|3780520|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0
2163020|NCT01263496|3780521|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1
2163021|NCT01263496|3780513|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0
2163022|NCT01263496|3780514|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0
2163023|NCT01263496|3780515|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
2163024|NCT01263496|3780516|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
2163025|NCT01263496|3780517|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0
2163026|NCT01263496|3780518|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0
2163027|NCT01263496|3780519|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0
2163028|NCT01263496|3780520|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1
2163029|NCT01263496|3780521|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0
2163030|NCT01263509|3780535|FG000|Entered - Long-Term Extension Study|Adverse Event|5
2163031|NCT01263509|3780536|FG001|Entered - Long-Term Extension Study|Adverse Event|5
2163032|NCT01263509|3780537|FG002|Entered - Long-Term Extension Study|Adverse Event|4
2163033|NCT01263509|3780538|FG003|Entered - Long-Term Extension Study|Adverse Event|1
2163034|NCT01263509|3780535|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1
2163035|NCT01263509|3780536|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
2163036|NCT01263509|3780537|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1
2163037|NCT01263509|3780538|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
2163038|NCT01263509|3780535|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2163039|NCT01263509|3780536|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2163040|NCT01263509|3780537|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2163041|NCT01263509|3780538|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2163042|NCT01263509|3780535|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1
2163043|NCT01263509|3780536|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1
2163044|NCT01263509|3780537|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
2163045|NCT01263509|3780538|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
2163046|NCT01263509|3780535|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
2163047|NCT01263509|3780536|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
2163048|NCT01263509|3780537|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
2163049|NCT01263509|3780538|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
2163050|NCT01263561|3780546|FG000|Overall Study|Death|1
2163051|NCT01263561|3780547|FG001|Overall Study|Death|2
2163052|NCT01263639|3780555|FG000|Overall Study|Lost to Follow-up|66
2163053|NCT01263639|3780556|FG001|Overall Study|Lost to Follow-up|70
2163054|NCT01263639|3780555|FG000|Overall Study|Exclusion =Admission greater than 7 days|7
2163055|NCT01263639|3780556|FG001|Overall Study|Exclusion =Admission greater than 7 days|9
2163056|NCT01263665|3780562|FG000|Overall Study|Withdrew Consent|1
2163057|NCT01263665|3780562|FG000|Overall Study|Lost to Follow-up|3
2163058|NCT01263665|3780562|FG000|Overall Study|Death|2
2163059|NCT01263665|3780562|FG000|Overall Study|Amputation above the ankle|1
2163060|NCT01263665|3780562|FG000|Overall Study|Surgical Bypass|2
2163061|NCT01263691|3780572|FG000|Overall Study|Lost to Follow-up|1
2163062|NCT01263691|3780573|FG001|Overall Study|Lost to Follow-up|0
2163063|NCT01263691|3780574|FG002|Overall Study|Lost to Follow-up|1
2163064|NCT01263691|3780575|FG003|Overall Study|Lost to Follow-up|1
2163065|NCT01263691|3780576|FG004|Overall Study|Lost to Follow-up|0
2163066|NCT01263691|3780577|FG005|Overall Study|Lost to Follow-up|0
2163067|NCT01263691|3780572|FG000|Overall Study|Withdrawal by Subject|1
2163068|NCT01263691|3780573|FG001|Overall Study|Withdrawal by Subject|0
2163069|NCT01263691|3780574|FG002|Overall Study|Withdrawal by Subject|0
2163070|NCT01263691|3780575|FG003|Overall Study|Withdrawal by Subject|0
2163071|NCT01263691|3780576|FG004|Overall Study|Withdrawal by Subject|0
2163072|NCT01263691|3780577|FG005|Overall Study|Withdrawal by Subject|0
2163073|NCT01263691|3780572|FG000|Overall Study|Adverse Event|1
2163074|NCT01263691|3780573|FG001|Overall Study|Adverse Event|0
2163075|NCT01263691|3780574|FG002|Overall Study|Adverse Event|0
2163076|NCT01263691|3780575|FG003|Overall Study|Adverse Event|0
2163077|NCT01263691|3780576|FG004|Overall Study|Adverse Event|0
2163078|NCT01263691|3780577|FG005|Overall Study|Adverse Event|0
2163079|NCT01263704|3780612|FG000|Overall Study|Progressive disease|18
2163080|NCT01263704|3780612|FG000|Overall Study|Adverse Event|3
2163081|NCT01263704|3780612|FG000|Overall Study|Death|2
2163082|NCT01263704|3780612|FG000|Overall Study|Patient withdrew consent|2
2163083|NCT01263704|3780612|FG000|Overall Study|Eligibility criteria not fulfilled|1
2163084|NCT01263704|3780612|FG000|Overall Study|Lost to Follow-up|1
2163085|NCT01263704|3780612|FG000|Overall Study|Colon metastases|1
2163086|NCT01263704|3780612|FG000|Overall Study|Principal Investigator (PI) decision|1
2163087|NCT01263782|3780629|FG000|Overall Study|Death|0
2163088|NCT01263782|3780630|FG001|Overall Study|Death|0
2163089|NCT01263782|3780631|FG002|Overall Study|Death|1
2163090|NCT01263782|3780632|FG003|Overall Study|Death|0
2163091|NCT01263782|3780629|FG000|Overall Study|Progressive disease|0
2163092|NCT01263782|3780630|FG001|Overall Study|Progressive disease|0
2163093|NCT01263782|3780631|FG002|Overall Study|Progressive disease|0
2163094|NCT01263782|3780632|FG003|Overall Study|Progressive disease|1
2163095|NCT01263782|3780629|FG000|Overall Study|Too early|0
2163096|NCT01263782|3780630|FG001|Overall Study|Too early|0
2163097|NCT01263782|3780631|FG002|Overall Study|Too early|1
2163098|NCT01263782|3780632|FG003|Overall Study|Too early|0
2163099|NCT01263782|3780629|FG000|Overall Study|Inevaluable|0
2163100|NCT01263782|3780630|FG001|Overall Study|Inevaluable|0
2163101|NCT01263782|3780631|FG002|Overall Study|Inevaluable|1
2163102|NCT01263782|3780632|FG003|Overall Study|Inevaluable|0
2163103|NCT01263873|3780644|FG000|Overall Study|One provider unable to complete numbers|1
2163104|NCT01263873|3780645|FG001|Overall Study|One provider unable to complete numbers|1
2163105|NCT01263925|3780653|FG000|Overall Study|Protocol Violation|1
2163106|NCT01263925|3780654|FG001|Overall Study|Protocol Violation|0
2163107|NCT01263925|3780653|FG000|Overall Study|Lack of Efficacy|0
2163108|NCT01263925|3780654|FG001|Overall Study|Lack of Efficacy|1
2163109|NCT01263925|3780653|FG000|Overall Study|Adverse Event|23
2163110|NCT01263925|3780654|FG001|Overall Study|Adverse Event|22
2163111|NCT01263925|3780653|FG000|Overall Study|Unsatisfactory Compliance of Subject|8
2163112|NCT01263925|3780654|FG001|Overall Study|Unsatisfactory Compliance of Subject|5
2163113|NCT01263925|3780653|FG000|Overall Study|Withdrawal by Subject|6
2163114|NCT01263925|3780654|FG001|Overall Study|Withdrawal by Subject|8
2163115|NCT01263925|3780653|FG000|Overall Study|Other|4
2163116|NCT01263925|3780654|FG001|Overall Study|Other|4
2163117|NCT01263925|3780653|FG000|Overall Study|Lost to Follow-up|3
2163118|NCT01263925|3780654|FG001|Overall Study|Lost to Follow-up|1
2163119|NCT01263925|3780653|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
2163120|NCT01263925|3780654|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
2163121|NCT01263925|3780653|FG000|Overall Study|AE/ Unsatisfactory Compliance|2
2163122|NCT01263925|3780654|FG001|Overall Study|AE/ Unsatisfactory Compliance|2
2163123|NCT01263925|3780653|FG000|Overall Study|AE/ Withdrawal|1
2163124|NCT01263925|3780654|FG001|Overall Study|AE/ Withdrawal|4
2163125|NCT01263925|3780653|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
2163126|NCT01263925|3780654|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
2163127|NCT01263925|3780653|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
2163128|NCT01263925|3780654|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
2163129|NCT01263925|3780653|FG000|Overall Study|Withdrawal/ Not specified|0
2163130|NCT01263925|3780654|FG001|Overall Study|Withdrawal/ Not specified|1
2163131|NCT01264016|3780665|FG000|Overall Study|Withdrawal by Subject|1
2163132|NCT01264016|3780665|FG000|Overall Study|Felt faint at sight of blood|1
2163133|NCT01264081|3780670|FG000|Participants Screened|Screening failures|30
2163134|NCT01264081|3780670|FG000|Started Treatment|Withdrawal by Subject|1
2163135|NCT01264081|3780670|FG000|Started Treatment|Not complete cycle 1 due to death|1
2163136|NCT01264380|3780674|FG000|Period C|Disease Progression|0
2163137|NCT01264380|3780675|FG001|Period C|Disease Progression|0
2163138|NCT01264380|3780676|FG002|Period C|Disease Progression|4
2163139|NCT01264380|3780674|FG000|Period C|Death|0
2163140|NCT01264380|3780675|FG001|Period C|Death|0
2163141|NCT01264380|3780676|FG002|Period C|Death|2
2163142|NCT01264380|3780674|FG000|Period C|Follow-up for survival status|0
2163143|NCT01264380|3780675|FG001|Period C|Follow-up for survival status|0
2163144|NCT01264380|3780676|FG002|Period C|Follow-up for survival status|6
2163145|NCT01264380|3780674|FG000|Period C|Withdrawal by Subject|0
2163146|NCT01264380|3780675|FG001|Period C|Withdrawal by Subject|0
2163147|NCT01264380|3780676|FG002|Period C|Withdrawal by Subject|1
2163148|NCT01264380|3780674|FG000|Period C|Adverse Event|0
2163149|NCT01264380|3780675|FG001|Period C|Adverse Event|0
2163150|NCT01264380|3780676|FG002|Period C|Adverse Event|1
2163151|NCT01264419|3780684|FG000|Overall Study|Lost to Follow-up|3
2163152|NCT01264718|3780724|FG000|Overall Study|Lost to Follow-up|3
2163153|NCT01264718|3780725|FG001|Overall Study|Lost to Follow-up|2
2163154|NCT01264718|3780724|FG000|Overall Study|Withdrawal by Subject|9
2163155|NCT01264718|3780725|FG001|Overall Study|Withdrawal by Subject|15
2163156|NCT01264718|3780724|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37
2163157|NCT01264718|3780725|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26
2163158|NCT01264770|3780737|FG000|Overall Study|Not reported|0
2163159|NCT01264770|3780738|FG001|Overall Study|Not reported|0
2163160|NCT01264770|3780739|FG002|Overall Study|Not reported|1
2163161|NCT01264770|3780740|FG003|Overall Study|Not reported|0
2163162|NCT01264770|3780741|FG004|Overall Study|Not reported|0
2163163|NCT01264770|3780742|FG005|Overall Study|Not reported|0
2163164|NCT01264770|3780737|FG000|Overall Study|e.g., change in circumstances|8
2163165|NCT01264770|3780738|FG001|Overall Study|e.g., change in circumstances|3
2163166|NCT01264770|3780739|FG002|Overall Study|e.g., change in circumstances|3
2163167|NCT01264770|3780740|FG003|Overall Study|e.g., change in circumstances|3
2163168|NCT01264770|3780741|FG004|Overall Study|e.g., change in circumstances|4
2163169|NCT01264770|3780742|FG005|Overall Study|e.g., change in circumstances|4
2163170|NCT01264770|3780737|FG000|Overall Study|Severe non-compliance to protocol|0
2163171|NCT01264770|3780738|FG001|Overall Study|Severe non-compliance to protocol|0
2163172|NCT01264770|3780739|FG002|Overall Study|Severe non-compliance to protocol|1
2163173|NCT01264770|3780740|FG003|Overall Study|Severe non-compliance to protocol|1
2163174|NCT01264770|3780741|FG004|Overall Study|Severe non-compliance to protocol|0
2163175|NCT01264770|3780742|FG005|Overall Study|Severe non-compliance to protocol|0
2163176|NCT01264770|3780737|FG000|Overall Study|Lack of therapeutic response|1
2163177|NCT01264770|3780738|FG001|Overall Study|Lack of therapeutic response|0
2163178|NCT01264770|3780739|FG002|Overall Study|Lack of therapeutic response|2
2163179|NCT01264770|3780740|FG003|Overall Study|Lack of therapeutic response|1
2163180|NCT01264770|3780741|FG004|Overall Study|Lack of therapeutic response|1
2163181|NCT01264770|3780742|FG005|Overall Study|Lack of therapeutic response|0
2163182|NCT01264770|3780737|FG000|Overall Study|Dev. of study specific discont. criteria|2
2163183|NCT01264770|3780738|FG001|Overall Study|Dev. of study specific discont. criteria|0
2163184|NCT01264770|3780739|FG002|Overall Study|Dev. of study specific discont. criteria|0
2163185|NCT01264770|3780740|FG003|Overall Study|Dev. of study specific discont. criteria|0
2163186|NCT01264770|3780741|FG004|Overall Study|Dev. of study specific discont. criteria|1
2163187|NCT01264770|3780742|FG005|Overall Study|Dev. of study specific discont. criteria|1
2163188|NCT01264770|3780737|FG000|Overall Study|Lost to Follow-up|0
2163189|NCT01264770|3780738|FG001|Overall Study|Lost to Follow-up|0
2163190|NCT01264770|3780739|FG002|Overall Study|Lost to Follow-up|1
2163191|NCT01264770|3780740|FG003|Overall Study|Lost to Follow-up|1
2163192|NCT01264770|3780741|FG004|Overall Study|Lost to Follow-up|0
2163193|NCT01264770|3780742|FG005|Overall Study|Lost to Follow-up|0
2163194|NCT01264770|3780737|FG000|Overall Study|Adverse Event|7
2163195|NCT01264770|3780738|FG001|Overall Study|Adverse Event|7
2163196|NCT01264770|3780739|FG002|Overall Study|Adverse Event|8
2163197|NCT01264770|3780740|FG003|Overall Study|Adverse Event|0
2163198|NCT01264770|3780741|FG004|Overall Study|Adverse Event|2
2163199|NCT01264770|3780742|FG005|Overall Study|Adverse Event|1
2163200|NCT01264887|3780762|FG000|Overall Study|Adverse Event|5
2163201|NCT01264887|3780762|FG000|Overall Study|Death|7
2163202|NCT01264887|3780762|FG000|Overall Study|Lack of Efficacy|5
2163203|NCT01264887|3780762|FG000|Overall Study|Physician Decision|4
2163204|NCT01264887|3780762|FG000|Overall Study|Withdrawal by Subject|6
2163205|NCT01264887|3780762|FG000|Overall Study|Sponsor Decision Administrative Reasons|2
2163206|NCT01264887|3780762|FG000|Overall Study|Other|2
2163207|NCT01264939|3780770|FG000|Overall Study|Adverse Event|1
2163208|NCT01264939|3780771|FG001|Overall Study|Adverse Event|3
2163209|NCT01264939|3780770|FG000|Overall Study|Lost to Follow-up|0
2163210|NCT01264939|3780771|FG001|Overall Study|Lost to Follow-up|3
2163211|NCT01264939|3780770|FG000|Overall Study|Physician Decision|1
2163212|NCT01264939|3780771|FG001|Overall Study|Physician Decision|1
2163213|NCT01264939|3780770|FG000|Overall Study|Patient/Guardian Decision|8
2163214|NCT01264939|3780771|FG001|Overall Study|Patient/Guardian Decision|10
2163215|NCT01264939|3780770|FG000|Overall Study|Disease Progression|8
2163216|NCT01264939|3780771|FG001|Overall Study|Disease Progression|11
2163217|NCT01265056|3780792|FG000|Initial Study Period|Withdrawal by Subject|1
2163218|NCT01265056|3780793|FG001|Initial Study Period|Withdrawal by Subject|1
2163219|NCT01265056|3780792|FG000|Initial Study Period|Withdrawal by Subject|1
2163220|NCT01265056|3780793|FG001|Initial Study Period|Withdrawal by Subject|1
2163221|NCT01265056|3780792|FG000|Follow up|Lost to Follow-up|7
2163222|NCT01265056|3780793|FG001|Follow up|Lost to Follow-up|3
2163223|NCT01265394|3780799|FG000|Overall Study|Subjects withdrawn|37
2163224|NCT01265420|3780804|FG000|Overall Study|Lost to Follow-up|1
2163225|NCT01265498|3780844|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31
2163226|NCT01265498|3780845|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33
2163227|NCT01265511|3780853|FG000|Overall Study|Lack of Efficacy|2
2163228|NCT01265511|3780854|FG001|Overall Study|Lack of Efficacy|1
2163229|NCT01265511|3780853|FG000|Overall Study|Met stopping rules|0
2163230|NCT01265511|3780854|FG001|Overall Study|Met stopping rules|2
2163231|NCT01265537|3780871|FG000|Overall Study|Adverse Event|2
2163232|NCT01265537|3780872|FG001|Overall Study|Adverse Event|1
2163233|NCT01265537|3780871|FG000|Overall Study|Physician Decision|0
2163234|NCT01265537|3780872|FG001|Overall Study|Physician Decision|1
2163235|NCT01265550|3780882|FG000|Pre Randomization|Withdrawal by Subject|0
2163236|NCT01265550|3780883|FG001|Pre Randomization|Withdrawal by Subject|0
2163237|NCT01265550|3780884|FG002|Pre Randomization|Withdrawal by Subject|0
2163238|NCT01265550|3780885|FG003|Pre Randomization|Withdrawal by Subject|70
2163239|NCT01265550|3780882|FG000|Pre Randomization|Technical Exclusions|0
2163240|NCT01265550|3780883|FG001|Pre Randomization|Technical Exclusions|0
2163241|NCT01265550|3780884|FG002|Pre Randomization|Technical Exclusions|0
2163242|NCT01265550|3780885|FG003|Pre Randomization|Technical Exclusions|54
2163243|NCT01265550|3780882|FG000|Pre Randomization|GERD, PPI-Responsive|0
2163244|NCT01265550|3780883|FG001|Pre Randomization|GERD, PPI-Responsive|0
2163245|NCT01265550|3780884|FG002|Pre Randomization|GERD, PPI-Responsive|0
2294910|NCT02541604|3989833|FG003|Overall Study|Medical condition may jeopardize safety|0
2294911|NCT02541604|3989834|FG004|Overall Study|Medical condition may jeopardize safety|0
2294912|NCT02541604|3989835|FG005|Overall Study|Medical condition may jeopardize safety|0
2294913|NCT02541604|3989836|FG006|Overall Study|Medical condition may jeopardize safety|0
2294914|NCT02541604|3989837|FG007|Overall Study|Medical condition may jeopardize safety|1
2294915|NCT02541604|3989838|FG008|Overall Study|Medical condition may jeopardize safety|0
2294916|NCT02541604|3989839|FG009|Overall Study|Medical condition may jeopardize safety|0
2294917|NCT02541604|3989840|FG010|Overall Study|Medical condition may jeopardize safety|0
2294918|NCT02541604|3989841|FG011|Overall Study|Medical condition may jeopardize safety|0
2294919|NCT02541669|3989895|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0
2294920|NCT02541669|3989896|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0
2294921|NCT02541669|3989897|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1
2163246|NCT01265550|3780885|FG003|Pre Randomization|GERD, PPI-Responsive|42
2163247|NCT01265550|3780882|FG000|Pre Randomization|Non-GERD organic disorders|0
2163248|NCT01265550|3780883|FG001|Pre Randomization|Non-GERD organic disorders|0
2163249|NCT01265550|3780884|FG002|Pre Randomization|Non-GERD organic disorders|0
2163250|NCT01265550|3780885|FG003|Pre Randomization|Non-GERD organic disorders|23
2163251|NCT01265550|3780882|FG000|Pre Randomization|Functional heartburn|0
2163252|NCT01265550|3780883|FG001|Pre Randomization|Functional heartburn|0
2163253|NCT01265550|3780884|FG002|Pre Randomization|Functional heartburn|0
2163254|NCT01265550|3780885|FG003|Pre Randomization|Functional heartburn|99
2163255|NCT01265563|3780904|FG000|Overall Study|Withdrawal by Subject|0
2163256|NCT01265563|3780905|FG001|Overall Study|Withdrawal by Subject|1
2163257|NCT01265563|3780906|FG002|Overall Study|Withdrawal by Subject|1
2163258|NCT01265563|3780907|FG003|Overall Study|Withdrawal by Subject|0
2163259|NCT01265563|3780908|FG004|Overall Study|Withdrawal by Subject|2
2163260|NCT01265615|3780929|FG000|Overall Study|Protocol Violation|2
2163261|NCT01265615|3780930|FG001|Overall Study|Protocol Violation|2
2163262|NCT01265615|3780931|FG002|Overall Study|Protocol Violation|4
2163263|NCT01265615|3780932|FG003|Overall Study|Protocol Violation|3
2163264|NCT01265719|3780953|FG000|Overall Study|Does not meet entrance criteria|0
2163265|NCT01265719|3780954|FG001|Overall Study|Does not meet entrance criteria|3
2163266|NCT01265719|3780953|FG000|Overall Study|Other reasons|2
2163267|NCT01265719|3780954|FG001|Overall Study|Other reasons|0
2163268|NCT01265719|3780953|FG000|Overall Study|Withdrawal by Subject|8
2163269|NCT01265719|3780954|FG001|Overall Study|Withdrawal by Subject|3
2163270|NCT01265719|3780953|FG000|Overall Study|Lost to Follow-up|2
2163271|NCT01265719|3780954|FG001|Overall Study|Lost to Follow-up|7
2163272|NCT01265719|3780953|FG000|Overall Study|Adverse Event|2
2163273|NCT01265719|3780954|FG001|Overall Study|Adverse Event|0
2163274|NCT01265797|3780962|FG000|Run-in Month|Withdrawal by Subject|0
2163275|NCT01265797|3780963|FG001|Run-in Month|Withdrawal by Subject|4
2163276|NCT01265797|3780962|FG000|Run-in Month|1st seizure during run-in month|0
2163277|NCT01265797|3780963|FG001|Run-in Month|1st seizure during run-in month|1
2163278|NCT01265797|3780962|FG000|Blinded Month|Lack of Efficacy|5
2163279|NCT01265797|3780963|FG001|Blinded Month|Lack of Efficacy|0
2163280|NCT01265797|3780962|FG000|Blinded Month|Lost to Follow-up|1
2163281|NCT01265797|3780963|FG001|Blinded Month|Lost to Follow-up|0
2163282|NCT01265797|3780962|FG000|Blinded Month|Protocol Violation|2
2163283|NCT01265797|3780963|FG001|Blinded Month|Protocol Violation|1
2163284|NCT01265797|3780962|FG000|Blinded Month|Adverse Event|2
2163285|NCT01265797|3780963|FG001|Blinded Month|Adverse Event|0
2163286|NCT01265797|3780962|FG000|Blinded Month|Diary data incomplete|0
2163287|NCT01265797|3780963|FG001|Blinded Month|Diary data incomplete|1
2163288|NCT01265797|3780962|FG000|Open Label Month|Lost to Follow-up|0
2163289|NCT01265797|3780963|FG001|Open Label Month|Lost to Follow-up|1
2163290|NCT01265823|3780971|FG000|Overall Study|Unsatisfactory Response Efficacy|1
2163291|NCT01265823|3780971|FG000|Overall Study|Failure to Return|4
2163292|NCT01265823|3780971|FG000|Overall Study|Protocol Violation|1
2163293|NCT01265823|3780971|FG000|Overall Study|Participant Request|1
2163294|NCT01265875|3780979|FG000|Overall Study|Uncooperative/unreliable|1
2163295|NCT01265953|3780986|FG000|Overall Study|Non compliance|5
2163296|NCT01265953|3780987|FG001|Overall Study|Non compliance|3
2163297|NCT01265992|3781006|FG000|Overall Study|Lost to Follow-up|1
2163298|NCT01265992|3781006|FG000|Overall Study|Withdrawal by Subject|1
2163299|NCT01265992|3781006|FG000|Overall Study|Adverse Event|1
2163300|NCT01265992|3781006|FG000|Overall Study|Administrative reasons|2
2163301|NCT01265992|3781006|FG000|Overall Study|Stopped treatment|3
2163302|NCT01265992|3781006|FG000|Overall Study|Did not receive treatment|1
2163303|NCT01266018|3781010|FG000|Overall Study|Physician Decision|1
2163304|NCT01266018|3781011|FG001|Overall Study|Physician Decision|0
2163305|NCT01266018|3781010|FG000|Overall Study|Progressive disease|0
2163306|NCT01266018|3781011|FG001|Overall Study|Progressive disease|1
2163307|NCT01266070|3781017|FG000|Overall Study|Adverse Event|3
2163308|NCT01266070|3781017|FG000|Overall Study|Protocol Violation|1
2163309|NCT01266122|3781023|FG000|Overall Study|Lost to Follow-up|6
2163310|NCT01266122|3781024|FG001|Overall Study|Lost to Follow-up|6
2163311|NCT01266148|3781032|FG000|Overall Study|Adverse Event|2
2163312|NCT01266148|3781033|FG001|Overall Study|Adverse Event|0
2163313|NCT01266148|3781032|FG000|Overall Study|Ongoing rejection|1
2163314|NCT01266148|3781033|FG001|Overall Study|Ongoing rejection|0
2163315|NCT01266148|3781032|FG000|Overall Study|2 2R rejections|1
2163316|NCT01266148|3781033|FG001|Overall Study|2 2R rejections|0
2163317|NCT01266148|3781032|FG000|Overall Study|Death|2
2163318|NCT01266148|3781033|FG001|Overall Study|Death|3
2163319|NCT01266148|3781032|FG000|Overall Study|missing mGFR value + AE|1
2163320|NCT01266148|3781033|FG001|Overall Study|missing mGFR value + AE|0
2163321|NCT01266161|3781041|FG000|Overall Study|Ineligible|1
2163322|NCT01266161|3781042|FG001|Overall Study|Ineligible|0
2163323|NCT01266161|3781041|FG000|Overall Study|Lack of Efficacy|0
2163324|NCT01266161|3781042|FG001|Overall Study|Lack of Efficacy|1
2294922|NCT02541669|3989898|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0
2294923|NCT02541669|3989899|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1
2294924|NCT02541903|3989929|FG000|Overall Study|Death|1
2294925|NCT02542072|3989952|FG000|First Intervention (1 Month)|Adverse Event|1
2294926|NCT02542072|3989953|FG001|First Intervention (1 Month)|Adverse Event|1
2294927|NCT02542072|3989952|FG000|First Intervention (1 Month)|Lost to Follow-up|2
2294928|NCT02542072|3989953|FG001|First Intervention (1 Month)|Lost to Follow-up|0
2294929|NCT02542072|3989952|FG000|First Intervention (1 Month)|Lens discomfort|1
2294930|NCT02542072|3989953|FG001|First Intervention (1 Month)|Lens discomfort|2
2294931|NCT02542072|3989952|FG000|First Intervention (1 Month)|Protocol Violation|1
2294932|NCT02542072|3989953|FG001|First Intervention (1 Month)|Protocol Violation|0
2294933|NCT02542072|3989952|FG000|Second Intervention (1 Month)|Lost to Follow-up|1
2294934|NCT02542072|3989953|FG001|Second Intervention (1 Month)|Lost to Follow-up|0
2294935|NCT02542072|3989952|FG000|Second Intervention (1 Month)|Lens discomfort|1
2294936|NCT02542072|3989953|FG001|Second Intervention (1 Month)|Lens discomfort|0
2294937|NCT02542267|3989992|FG000|Overall Study|Ongoing|31
2294938|NCT02542267|3989992|FG000|Overall Study|Withdrawal by Subject|8
2294939|NCT02542267|3989992|FG000|Overall Study|Physician Decision|5
2294940|NCT02542267|3989992|FG000|Overall Study|Lost to Follow-up|4
2294941|NCT02542267|3989992|FG000|Overall Study|Death|12
2294942|NCT02542267|3989992|FG000|Overall Study|Surgical Bypass of All Study Devices|12
2294943|NCT02542267|3989992|FG000|Overall Study|Other|5
2294944|NCT02542397|3990005|FG000|Overall Study|Death|2
2294945|NCT02542397|3990005|FG000|Overall Study|Physician Decision|6
2163325|NCT01266161|3781041|FG000|Overall Study|Vomited within 4 hours of dosing|3
2163326|NCT01266161|3781042|FG001|Overall Study|Vomited within 4 hours of dosing|0
2163327|NCT01266265|3781050|FG000|Overall Study|Death|95
2163328|NCT01266265|3781051|FG001|Overall Study|Death|73
2163329|NCT01266265|3781050|FG000|Overall Study|Lost to Follow-up|23
2163330|NCT01266265|3781051|FG001|Overall Study|Lost to Follow-up|28
2163331|NCT01266265|3781050|FG000|Overall Study|Withdrawal by Subject|13
2163332|NCT01266265|3781051|FG001|Overall Study|Withdrawal by Subject|11
2163333|NCT01266265|3781050|FG000|Overall Study|Respiratory-related adverse event|2
2163334|NCT01266265|3781051|FG001|Overall Study|Respiratory-related adverse event|1
2163335|NCT01266265|3781050|FG000|Overall Study|Transferred care to another provider|22
2163336|NCT01266265|3781051|FG001|Overall Study|Transferred care to another provider|28
2163337|NCT01266265|3781050|FG000|Overall Study|Stopped/changed PAH medication(s)|16
2163338|NCT01266265|3781051|FG001|Overall Study|Stopped/changed PAH medication(s)|9
2163339|NCT01266265|3781050|FG000|Overall Study|Enrolled in another clinical study|15
2163340|NCT01266265|3781051|FG001|Overall Study|Enrolled in another clinical study|26
2163341|NCT01266265|3781050|FG000|Overall Study|Non-compliance|8
2163342|NCT01266265|3781051|FG001|Overall Study|Non-compliance|5
2163343|NCT01266265|3781050|FG000|Overall Study|Lung transplant|6
2163344|NCT01266265|3781051|FG001|Overall Study|Lung transplant|5
2163345|NCT01266265|3781050|FG000|Overall Study|Site closed early|4
2163346|NCT01266265|3781051|FG001|Overall Study|Site closed early|3
2163347|NCT01266265|3781050|FG000|Overall Study|Clinical worsening|1
2163348|NCT01266265|3781051|FG001|Overall Study|Clinical worsening|1
2163349|NCT01266291|3781057|FG000|Overall Study|Adverse Event|1
2294946|NCT02542397|3990005|FG000|Overall Study|Withdrawal by Subject|6
2163350|NCT01266317|3781061|FG000|Overall Study|Withdrawal by Subject|2
2163351|NCT01266460|3781069|FG000|Overall Study|Adverse Event|3
2163352|NCT01266460|3781069|FG000|Overall Study|Withdrawal by Subject|5
2163353|NCT01266460|3781069|FG000|Overall Study|Disease Progression|18
2163354|NCT01266460|3781069|FG000|Overall Study|Not otherwise specified|8
2163355|NCT01266590|3781073|FG000|Overall Study|Adverse Event|3
2163356|NCT01266590|3781073|FG000|Overall Study|Lost to Follow-up|1
2208176|NCT01636778|3847562|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0
2208177|NCT01636778|3847563|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7
2163357|NCT01266590|3781073|FG000|Overall Study|Withdrawal by Subject|1
2163358|NCT01266590|3781073|FG000|Overall Study|Physician Decision|1
2163359|NCT01266603|3781080|FG000|Overall Study|Adverse Event|1
2208178|NCT01636778|3847564|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0
2208179|NCT01636778|3847562|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0
2208180|NCT01636778|3847563|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1
2208181|NCT01636778|3847564|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0
2208182|NCT01636778|3847562|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0
2208183|NCT01636778|3847563|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2
2163360|NCT01266603|3781080|FG000|Overall Study|Lack of Efficacy|14
2163361|NCT01266603|3781080|FG000|Overall Study|Withdrawal by Subject|1
2163362|NCT01266603|3781080|FG000|Overall Study|Failed screening; MAGE-A3 negative|26
2163363|NCT01266642|3781086|FG000|Overall Study|Protocol Violation|0
2163364|NCT01266642|3781087|FG001|Overall Study|Protocol Violation|1
2163365|NCT01266850|3781098|FG000|Overall Study|Lost to Follow-up|19
2163366|NCT01266850|3781099|FG001|Overall Study|Lost to Follow-up|19
2163367|NCT01266850|3781100|FG002|Overall Study|Lost to Follow-up|13
2163368|NCT01266850|3781101|FG003|Overall Study|Lost to Follow-up|13
2163369|NCT01266850|3781102|FG004|Overall Study|Lost to Follow-up|12
2163370|NCT01266850|3781098|FG000|Overall Study|Withdrawal by Subject|8
2163371|NCT01266850|3781099|FG001|Overall Study|Withdrawal by Subject|9
2163372|NCT01266850|3781100|FG002|Overall Study|Withdrawal by Subject|6
2163373|NCT01266850|3781101|FG003|Overall Study|Withdrawal by Subject|9
2163374|NCT01266850|3781102|FG004|Overall Study|Withdrawal by Subject|12
2163375|NCT01266850|3781098|FG000|Overall Study|Physician Decision|3
2163376|NCT01266850|3781099|FG001|Overall Study|Physician Decision|6
2163377|NCT01266850|3781100|FG002|Overall Study|Physician Decision|4
2163378|NCT01266850|3781101|FG003|Overall Study|Physician Decision|4
2163379|NCT01266850|3781102|FG004|Overall Study|Physician Decision|3
2163380|NCT01266850|3781098|FG000|Overall Study|Protocol Violation|0
2163381|NCT01266850|3781099|FG001|Overall Study|Protocol Violation|1
2163382|NCT01266850|3781100|FG002|Overall Study|Protocol Violation|0
2163383|NCT01266850|3781101|FG003|Overall Study|Protocol Violation|1
2163384|NCT01266850|3781102|FG004|Overall Study|Protocol Violation|2
2163385|NCT01266850|3781098|FG000|Overall Study|Adverse Event|0
2163386|NCT01266850|3781099|FG001|Overall Study|Adverse Event|0
2163387|NCT01266850|3781100|FG002|Overall Study|Adverse Event|0
2163388|NCT01266850|3781101|FG003|Overall Study|Adverse Event|0
2163389|NCT01266850|3781102|FG004|Overall Study|Adverse Event|1
2163390|NCT01266850|3781098|FG000|Overall Study|Site Closure|0
2163391|NCT01266850|3781099|FG001|Overall Study|Site Closure|1
2163392|NCT01266850|3781100|FG002|Overall Study|Site Closure|1
2163393|NCT01266850|3781101|FG003|Overall Study|Site Closure|1
2163394|NCT01266850|3781102|FG004|Overall Study|Site Closure|0
2163395|NCT01266876|3781119|FG000|Overall Study|Adverse Event|0
2163396|NCT01266876|3781120|FG001|Overall Study|Adverse Event|0
2163397|NCT01266876|3781121|FG002|Overall Study|Adverse Event|0
2163398|NCT01266876|3781122|FG003|Overall Study|Adverse Event|1
2163399|NCT01266876|3781123|FG004|Overall Study|Adverse Event|0
2163400|NCT01266902|3781137|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2
2163401|NCT01266902|3781138|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3
2163402|NCT01266902|3781139|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0
2163403|NCT01266902|3781137|FG000|Period 1 (Main Study)|Lost to Follow-up|5
2163404|NCT01266902|3781138|FG001|Period 1 (Main Study)|Lost to Follow-up|12
2163405|NCT01266902|3781139|FG002|Period 1 (Main Study)|Lost to Follow-up|0
2163406|NCT01266902|3781137|FG000|Period 1 (Main Study)|Lack of Efficacy|4
2163407|NCT01266902|3781138|FG001|Period 1 (Main Study)|Lack of Efficacy|2
2163408|NCT01266902|3781139|FG002|Period 1 (Main Study)|Lack of Efficacy|0
2163409|NCT01266902|3781137|FG000|Period 1 (Main Study)|Adverse Event|3
2163410|NCT01266902|3781138|FG001|Period 1 (Main Study)|Adverse Event|11
2163411|NCT01266902|3781139|FG002|Period 1 (Main Study)|Adverse Event|0
2163412|NCT01266902|3781137|FG000|Period 1 (Main Study)|Withdrawal by Subject|2
2163413|NCT01266902|3781138|FG001|Period 1 (Main Study)|Withdrawal by Subject|12
2163414|NCT01266902|3781139|FG002|Period 1 (Main Study)|Withdrawal by Subject|0
2163415|NCT01266902|3781137|FG000|Period 1 (Main Study)|Subject non-compliant|3
2163416|NCT01266902|3781138|FG001|Period 1 (Main Study)|Subject non-compliant|7
2163417|NCT01266902|3781139|FG002|Period 1 (Main Study)|Subject non-compliant|0
2163418|NCT01266902|3781137|FG000|Period 1 (Main Study)|Continued RPV treatment|11
2163419|NCT01266902|3781138|FG001|Period 1 (Main Study)|Continued RPV treatment|34
2163420|NCT01266902|3781139|FG002|Period 1 (Main Study)|Continued RPV treatment|0
2163421|NCT01266902|3781137|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
2179507|NCT01393990|3805035|FG009|Overall Study|Progressive Disease|1
2163422|NCT01266902|3781138|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
2163423|NCT01266902|3781139|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1
2163424|NCT01266902|3781137|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0
2163425|NCT01266902|3781138|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0
2163426|NCT01266902|3781139|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1
2163427|NCT01266902|3781137|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
2163428|NCT01266902|3781138|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
2163429|NCT01266902|3781139|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6
2163430|NCT01266967|3781149|FG000|Overall Study|Death|69
2163431|NCT01266967|3781150|FG001|Overall Study|Death|61
2163432|NCT01266967|3781149|FG000|Overall Study|Study Closed/Terminated|15
2163433|NCT01266967|3781150|FG001|Overall Study|Study Closed/Terminated|17
2163434|NCT01266967|3781149|FG000|Overall Study|Lost to Follow-up|2
2163435|NCT01266967|3781150|FG001|Overall Study|Lost to Follow-up|1
2163436|NCT01266967|3781149|FG000|Overall Study|Physician Decision|0
2163437|NCT01266967|3781150|FG001|Overall Study|Physician Decision|1
2163438|NCT01266967|3781149|FG000|Overall Study|Withdrawal by Subject|3
2163439|NCT01266967|3781150|FG001|Overall Study|Withdrawal by Subject|3
2163440|NCT01266993|3781161|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5
2163441|NCT01266993|3781162|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1
2163442|NCT01266993|3781161|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0
2163443|NCT01266993|3781162|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1
2163444|NCT01267175|3781202|FG000|Overall Study|Withdrawal by Subject|1
2163445|NCT01267175|3781202|FG000|Overall Study|Lost to Follow-up|1
2163446|NCT01267201|3781206|FG000|First Intervention Period|Withdrawal by Subject|1
2208184|NCT01636778|3847564|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0
2208185|NCT01636778|3847562|FG000|Follow-up Period After Part 2|Other|0
2208186|NCT01636778|3847563|FG001|Follow-up Period After Part 2|Other|0
2208187|NCT01636778|3847564|FG002|Follow-up Period After Part 2|Other|1
2217477|NCT01708915|3860823|FG002|Overall Study|Lack of Efficacy|35
2163447|NCT01267201|3781207|FG001|First Intervention Period|Withdrawal by Subject|0
2163448|NCT01267201|3781208|FG002|First Intervention Period|Withdrawal by Subject|0
2163449|NCT01267201|3781209|FG003|First Intervention Period|Withdrawal by Subject|0
2163450|NCT01267201|3781210|FG004|First Intervention Period|Withdrawal by Subject|0
2163451|NCT01267201|3781211|FG005|First Intervention Period|Withdrawal by Subject|0
2163452|NCT01267201|3781206|FG000|Second Intervention Period|Withdrawal by Subject|0
2163453|NCT01267201|3781207|FG001|Second Intervention Period|Withdrawal by Subject|1
2163454|NCT01267201|3781208|FG002|Second Intervention Period|Withdrawal by Subject|0
2163455|NCT01267201|3781209|FG003|Second Intervention Period|Withdrawal by Subject|0
2163456|NCT01267201|3781210|FG004|Second Intervention Period|Withdrawal by Subject|0
2163457|NCT01267201|3781211|FG005|Second Intervention Period|Withdrawal by Subject|0
2163458|NCT01267253|3781244|FG000|Overall Study|Ineligible - required test not done|1
2163459|NCT01267253|3781244|FG000|Overall Study|Inevaluable-never received study treatme|2
2163460|NCT01267266|3781248|FG000|Enrollment Phase|Withdrawal by Subject|2
2163461|NCT01267266|3781249|FG001|Enrollment Phase|Withdrawal by Subject|0
2163462|NCT01267266|3781248|FG000|Lead-in Phase|Lack of Efficacy|20
2163463|NCT01267266|3781249|FG001|Lead-in Phase|Lack of Efficacy|0
2163464|NCT01267266|3781248|FG000|Lead-in Phase|Adverse Event|2
2163465|NCT01267266|3781249|FG001|Lead-in Phase|Adverse Event|0
2163466|NCT01267266|3781248|FG000|Lead-in Phase|Withdrawal by Subject|1
2163467|NCT01267266|3781249|FG001|Lead-in Phase|Withdrawal by Subject|0
2163468|NCT01267955|3781324|FG000|Stage 1 (6 Months)|Death|3
2163469|NCT01267955|3781324|FG000|Stage 2 (6 Months)|Death|5
2163470|NCT01267955|3781324|FG000|Stage 2 (6 Months)|Protocol Violation|1
2163471|NCT01267994|3781328|FG000|Overall Study|Adverse Event|2
2163472|NCT01268046|3781337|FG000|Overall Study|Withdrawal by Subject|1
2163473|NCT01268046|3781338|FG001|Overall Study|Withdrawal by Subject|0
2163474|NCT01268046|3781339|FG002|Overall Study|Withdrawal by Subject|0
2163475|NCT01268046|3781340|FG003|Overall Study|Withdrawal by Subject|1
2163476|NCT01268046|3781337|FG000|Overall Study|Lost to Follow-up|0
2163477|NCT01268046|3781338|FG001|Overall Study|Lost to Follow-up|0
2163478|NCT01268046|3781339|FG002|Overall Study|Lost to Follow-up|1
2163479|NCT01268046|3781340|FG003|Overall Study|Lost to Follow-up|0
2163480|NCT01268059|3781354|FG000|Overall Study|Lost to Follow-up|0
2163481|NCT01268059|3781355|FG001|Overall Study|Lost to Follow-up|1
2163482|NCT01268059|3781356|FG002|Overall Study|Lost to Follow-up|0
2163483|NCT01268059|3781357|FG003|Overall Study|Lost to Follow-up|0
2163484|NCT01268059|3781354|FG000|Overall Study|Withdrawal by Subject|7
2163485|NCT01268059|3781355|FG001|Overall Study|Withdrawal by Subject|4
2163486|NCT01268059|3781356|FG002|Overall Study|Withdrawal by Subject|0
2163487|NCT01268059|3781357|FG003|Overall Study|Withdrawal by Subject|0
2163488|NCT01268059|3781354|FG000|Overall Study|Death|20
2163489|NCT01268059|3781355|FG001|Overall Study|Death|30
2163490|NCT01268059|3781356|FG002|Overall Study|Death|3
2163491|NCT01268059|3781357|FG003|Overall Study|Death|5
2163492|NCT01268059|3781354|FG000|Overall Study|Progression of disease|1
2163493|NCT01268059|3781355|FG001|Overall Study|Progression of disease|0
2163494|NCT01268059|3781356|FG002|Overall Study|Progression of disease|0
2163495|NCT01268059|3781357|FG003|Overall Study|Progression of disease|0
2163496|NCT01268098|3781372|FG000|Overall Study|Adverse Event|1
2163497|NCT01268098|3781373|FG001|Overall Study|Adverse Event|0
2163498|NCT01268150|3781388|FG000|Treatment Phase|Progression of disease|18
2163499|NCT01268150|3781388|FG000|Treatment Phase|Adverse Event|3
2163500|NCT01268150|3781388|FG000|Treatment Phase|Withdrawal by Subject|3
2163501|NCT01268150|3781388|FG000|Treatment Phase|Other|4
2163502|NCT01268150|3781388|FG000|Extension Phase|Adverse Event|3
2163503|NCT01268150|3781388|FG000|Extension Phase|Disease progression|18
2163504|NCT01268150|3781388|FG000|Extension Phase|Other|6
2163505|NCT01268267|3781398|FG000|Overall Study|Protocol Violation|1
2163506|NCT01268293|3781403|FG000|Overall Study|Disease progression|7
2163507|NCT01268293|3781403|FG000|Overall Study|Adverse Event|1
2163508|NCT01268293|3781403|FG000|Overall Study|Subject choice|1
2163509|NCT01268306|3781407|FG000|Overall Study|Lost to Follow-up|1
2163510|NCT01268488|3781411|FG000|Overall Study|Adverse Event|3
2163511|NCT01268488|3781411|FG000|Overall Study|Physician Decision|2
2163512|NCT01268501|3781416|FG000|Overall Study|Lost to Follow-up|1
2294947|NCT02542397|3990005|FG000|Overall Study|Lost to Follow-up|2
2294948|NCT02542605|3990037|FG000|Part B: Challenge Phase|Sponsor decision|1
2294949|NCT02542605|3990038|FG001|Part B: Challenge Phase|Sponsor decision|0
2294950|NCT02542605|3990039|FG002|Part B: Challenge Phase|Sponsor decision|0
2294951|NCT02542605|3990037|FG000|Part B: Randomization Phase|Withdrawal by Subject|0
2294952|NCT02542605|3990038|FG001|Part B: Randomization Phase|Withdrawal by Subject|0
2294953|NCT02542605|3990039|FG002|Part B: Randomization Phase|Withdrawal by Subject|1
2294954|NCT02542631|3990050|FG000|Overall Study|Adverse Event|1
2294955|NCT02542631|3990051|FG001|Overall Study|Adverse Event|1
2294956|NCT02542631|3990050|FG000|Overall Study|Sponsor Termination|1
2294957|NCT02542631|3990051|FG001|Overall Study|Sponsor Termination|0
2294958|NCT02542631|3990050|FG000|Overall Study|Withdrawal by Subject|11
2294959|NCT02542631|3990051|FG001|Overall Study|Withdrawal by Subject|16
2294960|NCT02542631|3990050|FG000|Overall Study|Protocol Violation|1
2294961|NCT02542631|3990051|FG001|Overall Study|Protocol Violation|1
2163513|NCT01268501|3781416|FG000|Overall Study|Withdrawal by Subject|3
2163514|NCT01268501|3781416|FG000|Overall Study|Unacceptable Subjective Vision|3
2163515|NCT01268501|3781416|FG000|Overall Study|Handling Difficulties|2
2163516|NCT01268514|3781420|FG000|Overall Study|Adverse Event|20
2163517|NCT01268514|3781420|FG000|Overall Study|Death|8
2163518|NCT01268514|3781420|FG000|Overall Study|Lost to Follow-up|5
2163519|NCT01268514|3781420|FG000|Overall Study|Withdrawal by Subject|3
2163520|NCT01268514|3781420|FG000|Overall Study|Withdrawal by Surgeon|5
2163521|NCT01268566|3781452|FG000|Overall Study|Lost to Follow-up|1
2163522|NCT01268566|3781452|FG000|Overall Study|Withdrawal by Subject|12
2163523|NCT01268566|3781452|FG000|Overall Study|Death|30
2179508|NCT01393990|3805036|FG010|Overall Study|Progressive Disease|0
2179509|NCT01393990|3805037|FG011|Overall Study|Progressive Disease|0
2179510|NCT01393990|3805038|FG012|Overall Study|Progressive Disease|0
2179511|NCT01393990|3805039|FG013|Overall Study|Progressive Disease|1
2179512|NCT01393990|3805040|FG014|Overall Study|Progressive Disease|6
2179513|NCT01393990|3805041|FG015|Overall Study|Progressive Disease|1
2179514|NCT01393990|3805042|FG016|Overall Study|Progressive Disease|0
2179515|NCT01393990|3805043|FG017|Overall Study|Progressive Disease|0
2179516|NCT01393990|3805026|FG000|Overall Study|Death|0
2179517|NCT01393990|3805027|FG001|Overall Study|Death|0
2179518|NCT01393990|3805028|FG002|Overall Study|Death|0
2179519|NCT01393990|3805029|FG003|Overall Study|Death|0
2179520|NCT01393990|3805030|FG004|Overall Study|Death|1
2179521|NCT01393990|3805031|FG005|Overall Study|Death|0
2179522|NCT01393990|3805032|FG006|Overall Study|Death|0
2179523|NCT01393990|3805033|FG007|Overall Study|Death|0
2179524|NCT01393990|3805034|FG008|Overall Study|Death|0
2179525|NCT01393990|3805035|FG009|Overall Study|Death|0
2179526|NCT01393990|3805036|FG010|Overall Study|Death|0
2179527|NCT01393990|3805037|FG011|Overall Study|Death|0
2179528|NCT01393990|3805038|FG012|Overall Study|Death|0
2179529|NCT01393990|3805039|FG013|Overall Study|Death|1
2179530|NCT01393990|3805040|FG014|Overall Study|Death|1
2179531|NCT01393990|3805041|FG015|Overall Study|Death|0
2179532|NCT01393990|3805042|FG016|Overall Study|Death|0
2179533|NCT01393990|3805043|FG017|Overall Study|Death|0
2179534|NCT01393990|3805026|FG000|Overall Study|Withdrawal by Subject|0
2179535|NCT01393990|3805027|FG001|Overall Study|Withdrawal by Subject|0
2179536|NCT01393990|3805028|FG002|Overall Study|Withdrawal by Subject|0
2179537|NCT01393990|3805029|FG003|Overall Study|Withdrawal by Subject|0
2179538|NCT01393990|3805030|FG004|Overall Study|Withdrawal by Subject|0
2179539|NCT01393990|3805031|FG005|Overall Study|Withdrawal by Subject|0
2179540|NCT01393990|3805032|FG006|Overall Study|Withdrawal by Subject|0
2179541|NCT01393990|3805033|FG007|Overall Study|Withdrawal by Subject|0
2179542|NCT01393990|3805034|FG008|Overall Study|Withdrawal by Subject|0
2179543|NCT01393990|3805035|FG009|Overall Study|Withdrawal by Subject|0
2179544|NCT01393990|3805036|FG010|Overall Study|Withdrawal by Subject|0
2179545|NCT01393990|3805037|FG011|Overall Study|Withdrawal by Subject|0
2179546|NCT01393990|3805038|FG012|Overall Study|Withdrawal by Subject|0
2179547|NCT01393990|3805039|FG013|Overall Study|Withdrawal by Subject|0
2179548|NCT01393990|3805040|FG014|Overall Study|Withdrawal by Subject|1
2179549|NCT01393990|3805041|FG015|Overall Study|Withdrawal by Subject|1
2179550|NCT01393990|3805042|FG016|Overall Study|Withdrawal by Subject|0
2179551|NCT01393990|3805043|FG017|Overall Study|Withdrawal by Subject|0
2294962|NCT02542631|3990050|FG000|Overall Study|Physician Decision|6
2294963|NCT02542631|3990051|FG001|Overall Study|Physician Decision|4
2163524|NCT01268683|3781463|FG000|Overall Study|Lost to Follow-up|1
2163525|NCT01268683|3781463|FG000|Overall Study|Death|1
2163526|NCT01268891|3781469|FG000|Overall Study|Adverse Event|3
2163527|NCT01268891|3781470|FG001|Overall Study|Adverse Event|7
2163528|NCT01268891|3781469|FG000|Overall Study|Lack of Efficacy|1
2163529|NCT01268891|3781470|FG001|Overall Study|Lack of Efficacy|0
2163530|NCT01268891|3781469|FG000|Overall Study|Withdrawal of Consent|3
2163531|NCT01268891|3781470|FG001|Overall Study|Withdrawal of Consent|1
2163532|NCT01268891|3781469|FG000|Overall Study|Administrative or other reason(s)|1
2163533|NCT01268891|3781470|FG001|Overall Study|Administrative or other reason(s)|0
2294964|NCT02542631|3990050|FG000|Overall Study|Lost to Follow-up|6
2294965|NCT02542631|3990051|FG001|Overall Study|Lost to Follow-up|5
2294966|NCT02542631|3990050|FG000|Overall Study|Death|1
2294967|NCT02542631|3990051|FG001|Overall Study|Death|2
2163534|NCT01269125|3781511|FG000|Overall Study|Adverse Event|3
2163535|NCT01269125|3781512|FG001|Overall Study|Adverse Event|5
2163536|NCT01269125|3781513|FG002|Overall Study|Adverse Event|0
2163537|NCT01269125|3781511|FG000|Overall Study|Lost to Follow-up|4
2163538|NCT01269125|3781512|FG001|Overall Study|Lost to Follow-up|0
2163539|NCT01269125|3781513|FG002|Overall Study|Lost to Follow-up|0
2163540|NCT01269346|3781521|FG000|Treatment Phase|Disease progression|3
2163541|NCT01269346|3781521|FG000|Treatment Phase|Adverse Event|3
2163542|NCT01269346|3781521|FG000|Treatment Phase|Withdrawal by Subject|1
2163543|NCT01269346|3781521|FG000|Treatment Phase|Other|2
2163544|NCT01269346|3781521|FG000|Extension Phase|Adverse Event|6
2163545|NCT01269346|3781521|FG000|Extension Phase|Withdrawal by Subject|4
2163546|NCT01269346|3781521|FG000|Extension Phase|Disease progression|22
2163547|NCT01269346|3781521|FG000|Extension Phase|Physician decision or participant choice|9
2163548|NCT01269346|3781521|FG000|Extension Phase|Clinical progression|1
2163549|NCT01269346|3781521|FG000|Extension Phase|Started a prohibited con med|1
2163550|NCT01269385|3781535|FG000|Overall Study|Adverse Event|1
2163551|NCT01269385|3781536|FG001|Overall Study|Adverse Event|1
2163552|NCT01269385|3781537|FG002|Overall Study|Adverse Event|0
2163553|NCT01269385|3781538|FG003|Overall Study|Adverse Event|0
2163554|NCT01269918|3781574|FG000|Overall Study|Did not receive study drug|0
2163555|NCT01269918|3781575|FG001|Overall Study|Did not receive study drug|3
2163556|NCT01270139|3781593|FG000|Overall Study|Adverse Event|8
2163557|NCT01270139|3781594|FG001|Overall Study|Adverse Event|17
2163558|NCT01270139|3781595|FG002|Overall Study|Adverse Event|18
2163559|NCT01270139|3781593|FG000|Overall Study|Lost to Follow-up|10
2163560|NCT01270139|3781594|FG001|Overall Study|Lost to Follow-up|9
2163561|NCT01270139|3781595|FG002|Overall Study|Lost to Follow-up|2
2163562|NCT01270256|3781612|FG000|Overall Study|Withdrawal by Subject|1
2163563|NCT01270256|3781613|FG001|Overall Study|Withdrawal by Subject|0
2163564|NCT01270321|3781622|FG000|Overall Study|Death|3
2163565|NCT01270321|3781623|FG001|Overall Study|Death|1
2163566|NCT01270321|3781624|FG002|Overall Study|Death|4
2163567|NCT01270321|3781622|FG000|Overall Study|Adverse Event|7
2163568|NCT01270321|3781623|FG001|Overall Study|Adverse Event|9
2163569|NCT01270321|3781624|FG002|Overall Study|Adverse Event|5
2163570|NCT01270464|3781635|FG000|Overall Study|Protocol Violation|4
2163571|NCT01270464|3781636|FG001|Overall Study|Protocol Violation|3
2163572|NCT01270464|3781637|FG002|Overall Study|Protocol Violation|2
2163573|NCT01270464|3781635|FG000|Overall Study|Lack of Efficacy|2
2163574|NCT01270464|3781636|FG001|Overall Study|Lack of Efficacy|3
2163575|NCT01270464|3781637|FG002|Overall Study|Lack of Efficacy|1
2163576|NCT01270464|3781635|FG000|Overall Study|Adverse Event|9
2163577|NCT01270464|3781636|FG001|Overall Study|Adverse Event|1
2163578|NCT01270464|3781637|FG002|Overall Study|Adverse Event|7
2163579|NCT01270464|3781635|FG000|Overall Study|Withdrawal by Subject|2
2163580|NCT01270464|3781636|FG001|Overall Study|Withdrawal by Subject|1
2163581|NCT01270464|3781637|FG002|Overall Study|Withdrawal by Subject|4
2163582|NCT01270464|3781635|FG000|Overall Study|Lost to Follow-up|2
2163583|NCT01270464|3781636|FG001|Overall Study|Lost to Follow-up|3
2163584|NCT01270464|3781637|FG002|Overall Study|Lost to Follow-up|1
2163585|NCT01270464|3781635|FG000|Overall Study|Other|1
2163586|NCT01270464|3781636|FG001|Overall Study|Other|1
2163587|NCT01270464|3781637|FG002|Overall Study|Other|3
2163588|NCT01270503|3781645|FG000|Overall Study|Lost to Follow-up|1
2163589|NCT01270620|3781695|FG000|Overall Study|Withdrawal by Subject|1
2163590|NCT01270620|3781696|FG001|Overall Study|Withdrawal by Subject|3
2163591|NCT01270802|3781761|FG000|Overall Study|Withdrawal by Subject|1
2163592|NCT01270802|3781762|FG001|Overall Study|Withdrawal by Subject|0
2163593|NCT01270802|3781761|FG000|Overall Study|Adverse Event|1
2163594|NCT01270802|3781762|FG001|Overall Study|Adverse Event|0
2163595|NCT01270802|3781761|FG000|Overall Study|Lost to Follow-up|0
2163596|NCT01270802|3781762|FG001|Overall Study|Lost to Follow-up|1
2163597|NCT01270828|3781771|FG000|Pregabalin CR SB|Reason Unspecified|0
2163598|NCT01270828|3781772|FG001|Pregabalin CR SB|Reason Unspecified|0
2163599|NCT01270828|3781773|FG002|Pregabalin CR SB|Reason Unspecified|8
2163600|NCT01270828|3781771|FG000|Pregabalin CR SB|Enrolled but not treated|0
2163601|NCT01270828|3781772|FG001|Pregabalin CR SB|Enrolled but not treated|0
2163602|NCT01270828|3781773|FG002|Pregabalin CR SB|Enrolled but not treated|5
2163603|NCT01270828|3781771|FG000|Pregabalin CR SB|Related adverse event|0
2163604|NCT01270828|3781772|FG001|Pregabalin CR SB|Related adverse event|0
2294968|NCT02542631|3990050|FG000|Overall Study|Other|2
2294969|NCT02542631|3990051|FG001|Overall Study|Other|1
2294970|NCT02542631|3990050|FG000|Overall Study|Used Prohibited Medication|2
2294971|NCT02542631|3990051|FG001|Overall Study|Used Prohibited Medication|1
2163605|NCT01270828|3781773|FG002|Pregabalin CR SB|Related adverse event|46
2163606|NCT01270828|3781771|FG000|Pregabalin CR SB|Lack of Efficacy|0
2163607|NCT01270828|3781772|FG001|Pregabalin CR SB|Lack of Efficacy|0
2163608|NCT01270828|3781773|FG002|Pregabalin CR SB|Lack of Efficacy|32
2163609|NCT01270828|3781771|FG000|Pregabalin CR SB|Withdrawal by Subject|0
2163610|NCT01270828|3781772|FG001|Pregabalin CR SB|Withdrawal by Subject|0
2163611|NCT01270828|3781773|FG002|Pregabalin CR SB|Withdrawal by Subject|29
2163612|NCT01270828|3781771|FG000|Pregabalin CR SB|Lost to Follow-up|0
2163613|NCT01270828|3781772|FG001|Pregabalin CR SB|Lost to Follow-up|0
2163614|NCT01270828|3781773|FG002|Pregabalin CR SB|Lost to Follow-up|10
2163615|NCT01270828|3781771|FG000|Pregabalin CR SB|Unrelated AE|0
2163616|NCT01270828|3781772|FG001|Pregabalin CR SB|Unrelated AE|0
2163617|NCT01270828|3781773|FG002|Pregabalin CR SB|Unrelated AE|8
2163618|NCT01270828|3781771|FG000|Pregabalin CR SB|Protocol Violation|0
2163619|NCT01270828|3781772|FG001|Pregabalin CR SB|Protocol Violation|0
2163620|NCT01270828|3781773|FG002|Pregabalin CR SB|Protocol Violation|8
2163621|NCT01270828|3781771|FG000|Double Blind Phase|Death|0
2163622|NCT01270828|3781772|FG001|Double Blind Phase|Death|1
2163623|NCT01270828|3781773|FG002|Double Blind Phase|Death|0
2163624|NCT01270828|3781771|FG000|Double Blind Phase|Protocol Violation|0
2163625|NCT01270828|3781772|FG001|Double Blind Phase|Protocol Violation|1
2163626|NCT01270828|3781773|FG002|Double Blind Phase|Protocol Violation|0
2163627|NCT01270828|3781771|FG000|Double Blind Phase|Protocol and GCP non-compliance|4
2163628|NCT01270828|3781772|FG001|Double Blind Phase|Protocol and GCP non-compliance|3
2163629|NCT01270828|3781773|FG002|Double Blind Phase|Protocol and GCP non-compliance|0
2163630|NCT01270828|3781771|FG000|Double Blind Phase|Reason Unspecified|7
2163631|NCT01270828|3781772|FG001|Double Blind Phase|Reason Unspecified|4
2163632|NCT01270828|3781773|FG002|Double Blind Phase|Reason Unspecified|0
2163633|NCT01270828|3781771|FG000|Double Blind Phase|Withdrawal by Subject|6
2163634|NCT01270828|3781772|FG001|Double Blind Phase|Withdrawal by Subject|15
2163635|NCT01270828|3781773|FG002|Double Blind Phase|Withdrawal by Subject|0
2163636|NCT01270828|3781771|FG000|Double Blind Phase|Lost to Follow-up|1
2163637|NCT01270828|3781772|FG001|Double Blind Phase|Lost to Follow-up|2
2163638|NCT01270828|3781773|FG002|Double Blind Phase|Lost to Follow-up|0
2163639|NCT01270828|3781771|FG000|Double Blind Phase|Lack of Efficacy|2
2163640|NCT01270828|3781772|FG001|Double Blind Phase|Lack of Efficacy|11
2163641|NCT01270828|3781773|FG002|Double Blind Phase|Lack of Efficacy|0
2163642|NCT01270828|3781771|FG000|Double Blind Phase|Adverse event not related to study drug|1
2163643|NCT01270828|3781772|FG001|Double Blind Phase|Adverse event not related to study drug|1
2163644|NCT01270828|3781773|FG002|Double Blind Phase|Adverse event not related to study drug|0
2163645|NCT01270828|3781771|FG000|Double Blind Phase|Adverse event related to study drug|5
2163646|NCT01270828|3781772|FG001|Double Blind Phase|Adverse event related to study drug|7
2163647|NCT01270828|3781773|FG002|Double Blind Phase|Adverse event related to study drug|0
2163648|NCT01270841|3781785|FG000|Overall Study|Adverse Event|0
2163649|NCT01270841|3781786|FG001|Overall Study|Adverse Event|1
2163650|NCT01270841|3781787|FG002|Overall Study|Adverse Event|0
2163651|NCT01270841|3781788|FG003|Overall Study|Adverse Event|3
2163652|NCT01270841|3781785|FG000|Overall Study|Withdrawal by Subject|3
2163653|NCT01270841|3781786|FG001|Overall Study|Withdrawal by Subject|2
2163654|NCT01270841|3781787|FG002|Overall Study|Withdrawal by Subject|3
2163655|NCT01270841|3781788|FG003|Overall Study|Withdrawal by Subject|3
2163656|NCT01270841|3781785|FG000|Overall Study|Lost to Follow-up|3
2163657|NCT01270841|3781786|FG001|Overall Study|Lost to Follow-up|1
2163658|NCT01270841|3781787|FG002|Overall Study|Lost to Follow-up|4
2163659|NCT01270841|3781788|FG003|Overall Study|Lost to Follow-up|2
2163660|NCT01270841|3781785|FG000|Overall Study|Physician Decision|0
2163661|NCT01270841|3781786|FG001|Overall Study|Physician Decision|1
2163662|NCT01270841|3781787|FG002|Overall Study|Physician Decision|0
2163663|NCT01270841|3781788|FG003|Overall Study|Physician Decision|0
2163664|NCT01270841|3781785|FG000|Overall Study|Did not qualify|6
2163665|NCT01270841|3781786|FG001|Overall Study|Did not qualify|3
2163666|NCT01270841|3781787|FG002|Overall Study|Did not qualify|4
2163667|NCT01270841|3781788|FG003|Overall Study|Did not qualify|5
2163668|NCT01270841|3781785|FG000|Overall Study|Protocol Violation|1
2163669|NCT01270841|3781786|FG001|Overall Study|Protocol Violation|5
2163670|NCT01270841|3781787|FG002|Overall Study|Protocol Violation|0
2163671|NCT01270841|3781788|FG003|Overall Study|Protocol Violation|0
2163672|NCT01270841|3781785|FG000|Overall Study|Enrolled in error|0
2163673|NCT01270841|3781786|FG001|Overall Study|Enrolled in error|1
2163674|NCT01270841|3781787|FG002|Overall Study|Enrolled in error|0
2163675|NCT01270841|3781788|FG003|Overall Study|Enrolled in error|0
2163676|NCT01270880|3781807|FG000|Overall Study|Never rec'd treatment, but registered.|1
2163677|NCT01270958|3781811|FG000|Overall Study|Lost to Follow-up|2
2163678|NCT01270958|3781811|FG000|Overall Study|Did not meet inclusion criteria for age|2
2163679|NCT01270971|3781817|FG000|Overall Study|Withdrawal by Subject|24
2163680|NCT01270971|3781818|FG001|Overall Study|Withdrawal by Subject|11
2163681|NCT01270971|3781817|FG000|Overall Study|Lost to Follow-up|18
2163682|NCT01270971|3781818|FG001|Overall Study|Lost to Follow-up|5
2163683|NCT01270971|3781817|FG000|Overall Study|Adverse Event|1
2163684|NCT01270971|3781818|FG001|Overall Study|Adverse Event|2
2163685|NCT01270971|3781817|FG000|Overall Study|Non compliance|2
2163686|NCT01270971|3781818|FG001|Overall Study|Non compliance|2
2163687|NCT01270971|3781817|FG000|Overall Study|Non-specific|7
2163688|NCT01270971|3781818|FG001|Overall Study|Non-specific|3
2163689|NCT01271010|3781824|FG000|Overall Study|Reason not specified|11
2163690|NCT01271010|3781824|FG000|Overall Study|Start of new CLL therapy|1
2163691|NCT01271010|3781824|FG000|Overall Study|Protocol Violation|1
2163692|NCT01271010|3781824|FG000|Overall Study|Death|2
2163693|NCT01271010|3781824|FG000|Overall Study|Progression and relapse of disease|1
2163694|NCT01271010|3781824|FG000|Overall Study|Withdrawal by Subject|18
2163695|NCT01271010|3781824|FG000|Overall Study|Disease progression|27
2163696|NCT01271504|3781868|FG000|Overall Study|Death|7
2163697|NCT01271504|3781869|FG001|Overall Study|Death|6
2163698|NCT01271504|3781870|FG002|Overall Study|Death|32
2163699|NCT01271504|3781871|FG003|Overall Study|Death|32
2163700|NCT01271504|3781868|FG000|Overall Study|Lost to Follow-up|0
2163701|NCT01271504|3781869|FG001|Overall Study|Lost to Follow-up|1
2163702|NCT01271504|3781870|FG002|Overall Study|Lost to Follow-up|3
2163703|NCT01271504|3781871|FG003|Overall Study|Lost to Follow-up|1
2163704|NCT01271504|3781868|FG000|Overall Study|Protocol Violation|0
2163705|NCT01271504|3781869|FG001|Overall Study|Protocol Violation|0
2163706|NCT01271504|3781870|FG002|Overall Study|Protocol Violation|0
2163707|NCT01271504|3781871|FG003|Overall Study|Protocol Violation|2
2163708|NCT01271504|3781868|FG000|Overall Study|Administrative Reasons|0
2163709|NCT01271504|3781869|FG001|Overall Study|Administrative Reasons|0
2163710|NCT01271504|3781870|FG002|Overall Study|Administrative Reasons|6
2163711|NCT01271504|3781871|FG003|Overall Study|Administrative Reasons|5
2163712|NCT01271504|3781868|FG000|Overall Study|Withdrawal by Subject|0
2163713|NCT01271504|3781869|FG001|Overall Study|Withdrawal by Subject|0
2163714|NCT01271504|3781870|FG002|Overall Study|Withdrawal by Subject|1
2163715|NCT01271504|3781871|FG003|Overall Study|Withdrawal by Subject|3
2163716|NCT01271504|3781868|FG000|Overall Study|Other|0
2163717|NCT01271504|3781869|FG001|Overall Study|Other|1
2163718|NCT01271504|3781870|FG002|Overall Study|Other|2
2163719|NCT01271504|3781871|FG003|Overall Study|Other|0
2163720|NCT01271712|3781907|FG000|Double Blind Treatment|Death|2
2163721|NCT01271712|3781908|FG001|Double Blind Treatment|Death|0
2163722|NCT01271712|3781907|FG000|Double Blind Treatment|Lack of Efficacy|1
2163723|NCT01271712|3781908|FG001|Double Blind Treatment|Lack of Efficacy|0
2163724|NCT01271712|3781907|FG000|Double Blind Treatment|Adverse Event|9
2163725|NCT01271712|3781908|FG001|Double Blind Treatment|Adverse Event|4
2163726|NCT01271712|3781907|FG000|Double Blind Treatment|Progressive disease|23
2163727|NCT01271712|3781908|FG001|Double Blind Treatment|Progressive disease|3
2163728|NCT01271712|3781907|FG000|Double Blind Treatment|Withdrawal by Subject|4
2163729|NCT01271712|3781908|FG001|Double Blind Treatment|Withdrawal by Subject|1
2163730|NCT01271712|3781907|FG000|Double Blind Treatment|Non compliance with study drug|2
2163731|NCT01271712|3781908|FG001|Double Blind Treatment|Non compliance with study drug|0
2163732|NCT01271712|3781907|FG000|Double Blind Treatment|receive no study drug|1
2163733|NCT01271712|3781908|FG001|Double Blind Treatment|receive no study drug|0
2163734|NCT01271712|3781907|FG000|Open Label Treatment|Death|6
2163735|NCT01271712|3781908|FG001|Open Label Treatment|Death|5
2163736|NCT01271712|3781907|FG000|Open Label Treatment|Withdrawal by Subject|6
2163737|NCT01271712|3781908|FG001|Open Label Treatment|Withdrawal by Subject|11
2163738|NCT01271712|3781907|FG000|Open Label Treatment|Physician Decision|2
2163739|NCT01271712|3781908|FG001|Open Label Treatment|Physician Decision|0
2163740|NCT01271712|3781907|FG000|Open Label Treatment|Adverse Event|14
2163741|NCT01271712|3781908|FG001|Open Label Treatment|Adverse Event|8
2163742|NCT01271712|3781907|FG000|Open Label Treatment|Progressive disease|59
2163743|NCT01271712|3781908|FG001|Open Label Treatment|Progressive disease|32
2163744|NCT01271712|3781907|FG000|Open Label Treatment|transferred to rollover study|1
2163745|NCT01271712|3781908|FG001|Open Label Treatment|transferred to rollover study|0
2163746|NCT01271712|3781907|FG000|Open Label Treatment|Non-compliance with study drug|1
2163747|NCT01271712|3781908|FG001|Open Label Treatment|Non-compliance with study drug|0
2163748|NCT01271712|3781907|FG000|Open Label Treatment|Protocol Violation|0
2163749|NCT01271712|3781908|FG001|Open Label Treatment|Protocol Violation|1
2163750|NCT01271712|3781907|FG000|Open Label Treatment|Switching to other therapy|2
2163751|NCT01271712|3781908|FG001|Open Label Treatment|Switching to other therapy|1
2163752|NCT01271712|3781907|FG000|Safety Follow-up|Death|11
2163753|NCT01271712|3781908|FG001|Safety Follow-up|Death|7
2163754|NCT01271712|3781907|FG000|Safety Follow-up|Withdrawal by Subject|4
2163755|NCT01271712|3781908|FG001|Safety Follow-up|Withdrawal by Subject|2
2163756|NCT01271712|3781907|FG000|Safety Follow-up|Protocol Violation|1
2163757|NCT01271712|3781908|FG001|Safety Follow-up|Protocol Violation|1
2163758|NCT01271712|3781907|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
2163759|NCT01271712|3781908|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
2163760|NCT01271712|3781907|FG000|Safety Follow-up|No follow-up|1
2163761|NCT01271712|3781908|FG001|Safety Follow-up|No follow-up|1
2163762|NCT01271712|3781907|FG000|Safety Follow-up|Progressive disease|1
2163763|NCT01271712|3781908|FG001|Safety Follow-up|Progressive disease|0
2163764|NCT01271712|3781907|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
2163765|NCT01271712|3781908|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
2163766|NCT01271725|3781917|FG000|Part A|Progressive disease according to RECIST|8
2163767|NCT01271725|3781918|FG001|Part A|Progressive disease according to RECIST|0
2163768|NCT01271725|3781917|FG000|Part A|Clinical signs/symptoms of progression|2
2163769|NCT01271725|3781918|FG001|Part A|Clinical signs/symptoms of progression|0
2163770|NCT01271725|3781917|FG000|Part A|Other Adverse Event|8
2163771|NCT01271725|3781918|FG001|Part A|Other Adverse Event|0
2163772|NCT01271725|3781917|FG000|Part A|Lost to Follow-up|1
2163773|NCT01271725|3781918|FG001|Part A|Lost to Follow-up|0
2163774|NCT01271725|3781917|FG000|Part A|Withdrawal by Subject|12
2163775|NCT01271725|3781918|FG001|Part A|Withdrawal by Subject|0
2163776|NCT01271725|3781917|FG000|Part A|Other than specified|3
2163777|NCT01271725|3781918|FG001|Part A|Other than specified|0
2163778|NCT01271725|3781917|FG000|Part A|Protocol Violation|1
2163779|NCT01271725|3781918|FG001|Part A|Protocol Violation|0
2163780|NCT01271725|3781917|FG000|Part B|Other than specified|0
2163781|NCT01271725|3781918|FG001|Part B|Other than specified|2
2163782|NCT01271725|3781917|FG000|Part B|Clinical signs/symptoms of progression|0
2163783|NCT01271725|3781918|FG001|Part B|Clinical signs/symptoms of progression|2
2163784|NCT01271725|3781917|FG000|Part B|Other Adverse Event|0
2163785|NCT01271725|3781918|FG001|Part B|Other Adverse Event|1
2163786|NCT01271725|3781917|FG000|Part B|Protocol Violation|0
2163787|NCT01271725|3781918|FG001|Part B|Protocol Violation|1
2163788|NCT01271725|3781917|FG000|Part B|Withdrawal by Subject|0
2163789|NCT01271725|3781918|FG001|Part B|Withdrawal by Subject|6
2163790|NCT01271803|3781930|FG000|Overall Study|Progressive disease|0
2163791|NCT01271803|3781931|FG001|Overall Study|Progressive disease|0
2163792|NCT01271803|3781932|FG002|Overall Study|Progressive disease|2
2163793|NCT01271803|3781930|FG000|Overall Study|Death|53
2163794|NCT01271803|3781931|FG001|Overall Study|Death|34
2163795|NCT01271803|3781932|FG002|Overall Study|Death|0
2163796|NCT01271803|3781930|FG000|Overall Study|Withdrawal by Subject|1
2163797|NCT01271803|3781931|FG001|Overall Study|Withdrawal by Subject|5
2163798|NCT01271803|3781932|FG002|Overall Study|Withdrawal by Subject|0
2163799|NCT01271803|3781930|FG000|Overall Study|Lost to Follow-up|1
2163800|NCT01271803|3781931|FG001|Overall Study|Lost to Follow-up|0
2163801|NCT01271803|3781932|FG002|Overall Study|Lost to Follow-up|0
2163802|NCT01271933|3782005|FG000|Single-Blind Phase|Lack of Efficacy|37
2163803|NCT01271933|3782006|FG001|Single-Blind Phase|Lack of Efficacy|0
2163804|NCT01271933|3782007|FG002|Single-Blind Phase|Lack of Efficacy|0
2163805|NCT01271933|3782005|FG000|Single-Blind Phase|Lost to Follow-up|10
2163806|NCT01271933|3782006|FG001|Single-Blind Phase|Lost to Follow-up|0
2163807|NCT01271933|3782007|FG002|Single-Blind Phase|Lost to Follow-up|0
2163808|NCT01271933|3782005|FG000|Single-Blind Phase|Withdrawal by Subject|15
2163809|NCT01271933|3782006|FG001|Single-Blind Phase|Withdrawal by Subject|0
2163810|NCT01271933|3782007|FG002|Single-Blind Phase|Withdrawal by Subject|0
2163811|NCT01271933|3782005|FG000|Single-Blind Phase|Protocol Violation|3
2163812|NCT01271933|3782006|FG001|Single-Blind Phase|Protocol Violation|0
2163813|NCT01271933|3782007|FG002|Single-Blind Phase|Protocol Violation|0
2163814|NCT01271933|3782005|FG000|Single-Blind Phase|Adverse Event|52
2163815|NCT01271933|3782006|FG001|Single-Blind Phase|Adverse Event|0
2163816|NCT01271933|3782007|FG002|Single-Blind Phase|Adverse Event|0
2163817|NCT01271933|3782005|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1
2163818|NCT01271933|3782006|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0
2163819|NCT01271933|3782007|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0
2163820|NCT01271933|3782005|FG000|Single-Blind Phase|(Protocol non-compliance)|2
2163821|NCT01271933|3782006|FG001|Single-Blind Phase|(Protocol non-compliance)|0
2163822|NCT01271933|3782007|FG002|Single-Blind Phase|(Protocol non-compliance)|0
2163823|NCT01271933|3782005|FG000|Single-Blind Phase|(Participant request-personal reason)|1
2163824|NCT01271933|3782006|FG001|Single-Blind Phase|(Participant request-personal reason)|0
2163825|NCT01271933|3782007|FG002|Single-Blind Phase|(Participant request-personal reason)|0
2163826|NCT01271933|3782005|FG000|Double-Blind Phase|Randomized but not treated|0
2163827|NCT01271933|3782006|FG001|Double-Blind Phase|Randomized but not treated|0
2163828|NCT01271933|3782007|FG002|Double-Blind Phase|Randomized but not treated|1
2163829|NCT01271933|3782005|FG000|Double-Blind Phase|Lack of Efficacy|0
2208188|NCT01636778|3847562|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
2163830|NCT01271933|3782006|FG001|Double-Blind Phase|Lack of Efficacy|6
2163831|NCT01271933|3782007|FG002|Double-Blind Phase|Lack of Efficacy|9
2163832|NCT01271933|3782005|FG000|Double-Blind Phase|Lost to Follow-up|0
2163833|NCT01271933|3782006|FG001|Double-Blind Phase|Lost to Follow-up|1
2163834|NCT01271933|3782007|FG002|Double-Blind Phase|Lost to Follow-up|1
2163835|NCT01271933|3782005|FG000|Double-Blind Phase|Withdrawal by Subject|0
2163836|NCT01271933|3782006|FG001|Double-Blind Phase|Withdrawal by Subject|6
2163837|NCT01271933|3782007|FG002|Double-Blind Phase|Withdrawal by Subject|1
2163838|NCT01271933|3782005|FG000|Double-Blind Phase|Adverse Event|0
2163839|NCT01271933|3782006|FG001|Double-Blind Phase|Adverse Event|3
2163840|NCT01271933|3782007|FG002|Double-Blind Phase|Adverse Event|0
2163841|NCT01271933|3782005|FG000|Double-Blind Phase|Participant request-personal reason|0
2163842|NCT01271933|3782006|FG001|Double-Blind Phase|Participant request-personal reason|1
2163843|NCT01271933|3782007|FG002|Double-Blind Phase|Participant request-personal reason|0
2163844|NCT01272011|3782043|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0
2163845|NCT01272011|3782044|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2
2179552|NCT01394185|3805151|FG000|Overall Study|Withdrawal by Subject|2
2163846|NCT01272011|3782045|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0
2163847|NCT01272180|3782061|FG000|Overall Study|Adverse Event|0
2163848|NCT01272180|3782062|FG001|Overall Study|Adverse Event|0
2163849|NCT01272180|3782063|FG002|Overall Study|Adverse Event|1
2163850|NCT01272180|3782064|FG003|Overall Study|Adverse Event|0
2163851|NCT01272180|3782061|FG000|Overall Study|Withdrawal by Subject|2
2163852|NCT01272180|3782062|FG001|Overall Study|Withdrawal by Subject|6
2163853|NCT01272180|3782063|FG002|Overall Study|Withdrawal by Subject|3
2163854|NCT01272180|3782064|FG003|Overall Study|Withdrawal by Subject|2
2163855|NCT01272180|3782061|FG000|Overall Study|Lost to Follow-up|15
2163856|NCT01272180|3782062|FG001|Overall Study|Lost to Follow-up|14
2163857|NCT01272180|3782063|FG002|Overall Study|Lost to Follow-up|8
2163858|NCT01272180|3782064|FG003|Overall Study|Lost to Follow-up|10
2163859|NCT01272180|3782061|FG000|Overall Study|Inappropriate enrollment|0
2163860|NCT01272180|3782062|FG001|Overall Study|Inappropriate enrollment|0
2163861|NCT01272180|3782063|FG002|Overall Study|Inappropriate enrollment|1
2163862|NCT01272180|3782064|FG003|Overall Study|Inappropriate enrollment|1
2163863|NCT01272180|3782061|FG000|Overall Study|Protocol Violation|0
2163864|NCT01272180|3782062|FG001|Overall Study|Protocol Violation|1
2163865|NCT01272180|3782063|FG002|Overall Study|Protocol Violation|0
2163866|NCT01272180|3782064|FG003|Overall Study|Protocol Violation|1
2163867|NCT01272193|3782080|FG000|Overall Study|Adverse Event|1
2163868|NCT01272193|3782081|FG001|Overall Study|Adverse Event|1
2163869|NCT01272193|3782080|FG000|Overall Study|Lack of Efficacy|0
2163870|NCT01272193|3782081|FG001|Overall Study|Lack of Efficacy|3
2163871|NCT01272193|3782080|FG000|Overall Study|Withdrawal Criteria|1
2163872|NCT01272193|3782081|FG001|Overall Study|Withdrawal Criteria|1
2163873|NCT01272193|3782080|FG000|Overall Study|Unclassified|8
2163874|NCT01272193|3782081|FG001|Overall Study|Unclassified|7
2163875|NCT01272219|3782091|FG000|Main Period: Week 0 to Week 56|Adverse Event|86
2163876|NCT01272219|3782092|FG001|Main Period: Week 0 to Week 56|Adverse Event|0
2163877|NCT01272219|3782093|FG002|Main Period: Week 0 to Week 56|Adverse Event|0
2163878|NCT01272219|3782094|FG003|Main Period: Week 0 to Week 56|Adverse Event|16
2163879|NCT01272219|3782095|FG004|Main Period: Week 0 to Week 56|Adverse Event|152
2163880|NCT01272219|3782096|FG005|Main Period: Week 0 to Week 56|Adverse Event|29
2163881|NCT01272219|3782091|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11
2163882|NCT01272219|3782092|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0
2163883|NCT01272219|3782093|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0
2163884|NCT01272219|3782094|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14
2163885|NCT01272219|3782095|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12
2163886|NCT01272219|3782096|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22
2163887|NCT01272219|3782091|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25
2163888|NCT01272219|3782092|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0
2163889|NCT01272219|3782093|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0
2163890|NCT01272219|3782094|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18
2163891|NCT01272219|3782095|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40
2208189|NCT01636778|3847563|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
2208190|NCT01636778|3847564|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
2208191|NCT01636778|3847562|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0
2208192|NCT01636778|3847563|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0
2163892|NCT01272219|3782096|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20
2163893|NCT01272219|3782091|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122
2163894|NCT01272219|3782092|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0
2163895|NCT01272219|3782093|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0
2163896|NCT01272219|3782094|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114
2163897|NCT01272219|3782095|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172
2163898|NCT01272219|3782096|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147
2163899|NCT01272219|3782091|FG000|Main Period: Week 0 to Week 56|Unclassified|36
2163900|NCT01272219|3782092|FG001|Main Period: Week 0 to Week 56|Unclassified|0
2163901|NCT01272219|3782093|FG002|Main Period: Week 0 to Week 56|Unclassified|0
2163902|NCT01272219|3782094|FG003|Main Period: Week 0 to Week 56|Unclassified|29
2163903|NCT01272219|3782095|FG004|Main Period: Week 0 to Week 56|Unclassified|42
2163904|NCT01272219|3782096|FG005|Main Period: Week 0 to Week 56|Unclassified|34
2163905|NCT01272219|3782091|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
2163906|NCT01272219|3782092|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
2163907|NCT01272219|3782093|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
2163908|NCT01272219|3782094|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
2163909|NCT01272219|3782095|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
2163910|NCT01272219|3782096|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
2163911|NCT01272219|3782091|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2163912|NCT01272219|3782092|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2163913|NCT01272219|3782093|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2163914|NCT01272219|3782094|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
2163915|NCT01272219|3782095|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2163916|NCT01272219|3782096|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2163917|NCT01272219|3782091|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2163918|NCT01272219|3782092|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
2163919|NCT01272219|3782093|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2163920|NCT01272219|3782094|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
2163921|NCT01272219|3782095|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2163922|NCT01272219|3782096|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2163923|NCT01272219|3782091|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
2163924|NCT01272219|3782092|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
2163925|NCT01272219|3782093|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
2163926|NCT01272219|3782094|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
2163927|NCT01272219|3782095|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
2163928|NCT01272219|3782096|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
2163929|NCT01272219|3782091|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0
2163930|NCT01272219|3782092|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1
2163931|NCT01272219|3782093|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2
2163932|NCT01272219|3782094|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2
2163933|NCT01272219|3782095|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0
2163934|NCT01272219|3782096|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0
2163935|NCT01272219|3782091|FG000|Main + Extension Period: Week 0-172|Adverse Event|0
2163936|NCT01272219|3782092|FG001|Main + Extension Period: Week 0-172|Adverse Event|0
2163937|NCT01272219|3782093|FG002|Main + Extension Period: Week 0-172|Adverse Event|0
2163938|NCT01272219|3782094|FG003|Main + Extension Period: Week 0-172|Adverse Event|0
2163939|NCT01272219|3782095|FG004|Main + Extension Period: Week 0-172|Adverse Event|191
2163940|NCT01272219|3782096|FG005|Main + Extension Period: Week 0-172|Adverse Event|43
2163941|NCT01272219|3782091|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2163942|NCT01272219|3782092|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2163943|NCT01272219|3782093|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2163944|NCT01272219|3782094|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2163945|NCT01272219|3782095|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29
2163946|NCT01272219|3782096|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36
2163947|NCT01272219|3782091|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0
2163948|NCT01272219|3782092|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0
2163949|NCT01272219|3782093|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0
2163950|NCT01272219|3782094|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0
2163951|NCT01272219|3782095|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76
2163952|NCT01272219|3782096|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36
2163953|NCT01272219|3782091|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2163954|NCT01272219|3782092|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2163955|NCT01272219|3782093|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2163956|NCT01272219|3782094|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2163957|NCT01272219|3782095|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364
2163958|NCT01272219|3782096|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256
2163959|NCT01272219|3782091|FG000|Main + Extension Period: Week 0-172|Missing reason|0
2163960|NCT01272219|3782092|FG001|Main + Extension Period: Week 0-172|Missing reason|0
2163961|NCT01272219|3782093|FG002|Main + Extension Period: Week 0-172|Missing reason|0
2163962|NCT01272219|3782094|FG003|Main + Extension Period: Week 0-172|Missing reason|0
2163963|NCT01272219|3782095|FG004|Main + Extension Period: Week 0-172|Missing reason|1
2163964|NCT01272219|3782096|FG005|Main + Extension Period: Week 0-172|Missing reason|0
2163965|NCT01272219|3782091|FG000|Main + Extension Period: Week 0-172|Unclassified|0
2163966|NCT01272219|3782092|FG001|Main + Extension Period: Week 0-172|Unclassified|0
2163967|NCT01272219|3782093|FG002|Main + Extension Period: Week 0-172|Unclassified|0
2163968|NCT01272219|3782094|FG003|Main + Extension Period: Week 0-172|Unclassified|0
2163969|NCT01272219|3782095|FG004|Main + Extension Period: Week 0-172|Unclassified|61
2163970|NCT01272219|3782096|FG005|Main + Extension Period: Week 0-172|Unclassified|51
2163971|NCT01272232|3782112|FG000|Weeks 0-56|Adverse Event|39
2163972|NCT01272232|3782113|FG001|Weeks 0-56|Adverse Event|18
2163973|NCT01272232|3782114|FG002|Weeks 0-56|Adverse Event|7
2163974|NCT01272232|3782112|FG000|Weeks 0-56|Lack of Efficacy|0
2163975|NCT01272232|3782113|FG001|Weeks 0-56|Lack of Efficacy|0
2163976|NCT01272232|3782114|FG002|Weeks 0-56|Lack of Efficacy|3
2163977|NCT01272232|3782112|FG000|Weeks 0-56|Protocol Violation|12
2163978|NCT01272232|3782113|FG001|Weeks 0-56|Protocol Violation|8
2163979|NCT01272232|3782114|FG002|Weeks 0-56|Protocol Violation|13
2163980|NCT01272232|3782112|FG000|Weeks 0-56|Withdrawal criteria|32
2163981|NCT01272232|3782113|FG001|Weeks 0-56|Withdrawal criteria|14
2163982|NCT01272232|3782114|FG002|Weeks 0-56|Withdrawal criteria|37
2163983|NCT01272232|3782112|FG000|Weeks 0-56|Unclassified|16
2163984|NCT01272232|3782113|FG001|Weeks 0-56|Unclassified|7
2163985|NCT01272232|3782114|FG002|Weeks 0-56|Unclassified|12
2163986|NCT01272232|3782112|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
2163987|NCT01272232|3782113|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
2163988|NCT01272232|3782114|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
2163989|NCT01272232|3782112|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
2163990|NCT01272232|3782113|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
2163991|NCT01272232|3782114|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
2163992|NCT01272232|3782112|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
2163993|NCT01272232|3782113|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
2163994|NCT01272232|3782114|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
2163995|NCT01272232|3782112|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
2163996|NCT01272232|3782113|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
2163997|NCT01272232|3782114|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
2163998|NCT01272232|3782112|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
2163999|NCT01272232|3782113|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
2294972|NCT02542865|3990066|FG000|Overall Study|Identified as screen failure|1
2294973|NCT02542865|3990067|FG001|Overall Study|Identified as screen failure|0
2294974|NCT02542865|3990066|FG000|Overall Study|Withdrawal by Subject|16
2294975|NCT02542865|3990067|FG001|Overall Study|Withdrawal by Subject|0
2294976|NCT02542943|3990076|FG000|Overall Study|Lost to Follow-up|1
2294977|NCT02542943|3990077|FG001|Overall Study|Lost to Follow-up|0
2294978|NCT02542943|3990078|FG002|Overall Study|Lost to Follow-up|0
2294979|NCT02542943|3990076|FG000|Overall Study|Withdrawal by Subject|0
2294980|NCT02542943|3990077|FG001|Overall Study|Withdrawal by Subject|1
2294981|NCT02542943|3990078|FG002|Overall Study|Withdrawal by Subject|0
2294982|NCT02543203|3990089|FG000|Overall Study|Unpalatable Fragrance|2
2294983|NCT02543203|3990090|FG001|Overall Study|Unpalatable Fragrance|2
2294984|NCT02543203|3990089|FG000|Overall Study|Lost to Follow-up|1
2294985|NCT02543203|3990090|FG001|Overall Study|Lost to Follow-up|0
2294986|NCT02543203|3990089|FG000|Overall Study|Increased Irritability|1
2294987|NCT02543203|3990090|FG001|Overall Study|Increased Irritability|0
2294988|NCT02543203|3990089|FG000|Overall Study|Family|1
2294989|NCT02543203|3990090|FG001|Overall Study|Family|2
2294990|NCT02543203|3990089|FG000|Overall Study|Negative Behavior|1
2294991|NCT02543203|3990090|FG001|Overall Study|Negative Behavior|0
2164000|NCT01272232|3782114|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
2164001|NCT01272635|3782153|FG000|Overall Study|Lost to Follow-up|31
2164002|NCT01272635|3782154|FG001|Overall Study|Lost to Follow-up|20
2164003|NCT01272635|3782155|FG002|Overall Study|Lost to Follow-up|31
2164004|NCT01272635|3782156|FG003|Overall Study|Lost to Follow-up|23
2164005|NCT01272661|3782167|FG000|Overall Study|lost to followup/case closed/ no birth|126
2164006|NCT01272661|3782168|FG001|Overall Study|lost to followup/case closed/ no birth|209
2164007|NCT01272661|3782169|FG002|Overall Study|lost to followup/case closed/ no birth|72
2294992|NCT02543203|3990089|FG000|Overall Study|Withdrawal by Subject|0
2294993|NCT02543203|3990090|FG001|Overall Study|Withdrawal by Subject|1
2294994|NCT02543294|3990104|FG000|Overall Study|Lost to Follow-up|3
2294995|NCT02543294|3990104|FG000|Overall Study|Physician Decision|2
2294996|NCT02543294|3990104|FG000|Overall Study|Withdrawal by Subject|7
2294997|NCT02543346|3990109|FG000|Second Priming Visit|Withdrawal by Subject|0
2164008|NCT01272804|3782183|FG000|Overall Study|Adverse Event|1
2164009|NCT01272804|3782184|FG001|Overall Study|Adverse Event|0
2164010|NCT01272804|3782185|FG002|Overall Study|Adverse Event|0
2164011|NCT01272804|3782186|FG003|Overall Study|Adverse Event|0
2164012|NCT01272804|3782187|FG004|Overall Study|Adverse Event|2
2164013|NCT01272804|3782188|FG005|Overall Study|Adverse Event|1
2164014|NCT01272869|3782213|FG000|Period 2 (14 Days)|Adverse Event|1
2164015|NCT01272869|3782214|FG001|Period 2 (14 Days)|Adverse Event|0
2164016|NCT01272908|3782224|FG000|Initial Treatment Period|Adverse Event|1
2164017|NCT01272908|3782224|FG000|Initial Treatment Period|Lack of Efficacy|5
2164018|NCT01272908|3782224|FG000|Initial Treatment Period|Protocol Violation|1
2164019|NCT01272908|3782224|FG000|Initial Treatment Period|Withdrawal by Subject|1
2164020|NCT01272908|3782224|FG000|Re-Treatment Period|Adverse Event|2
2164021|NCT01272908|3782224|FG000|Re-Treatment Period|Lack of Efficacy|3
2164022|NCT01272908|3782224|FG000|Re-Treatment Period|Withdrawal by Subject|1
2164023|NCT01272921|3782232|FG000|Overall Study|Protocol Violation|2
2164024|NCT01272921|3782233|FG001|Overall Study|Protocol Violation|1
2164025|NCT01272934|3782243|FG000|Overall Study|Adverse Event|0
2164026|NCT01272934|3782244|FG001|Overall Study|Adverse Event|1
2164027|NCT01272934|3782243|FG000|Overall Study|Abnormal Laboratory Value|0
2164028|NCT01272934|3782244|FG001|Overall Study|Abnormal Laboratory Value|1
2164029|NCT01272947|3782253|FG000|Overall Study|Abnormal Laboratory Value|2
2164030|NCT01272947|3782254|FG001|Overall Study|Abnormal Laboratory Value|2
2164031|NCT01273038|3782283|FG000|Second Intervention (14 Days)|Adverse Event|0
2164032|NCT01273038|3782284|FG001|Second Intervention (14 Days)|Adverse Event|1
2164033|NCT01273038|3782283|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
2164034|NCT01273038|3782284|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
2164035|NCT01273155|3782294|FG000|Overall Study|Off study trmt prior to end of C1/PD|2
2164036|NCT01273155|3782295|FG001|Overall Study|Off study trmt prior to end of C1/PD|3
2164037|NCT01273155|3782296|FG002|Overall Study|Off study trmt prior to end of C1/PD|8
2164038|NCT01273155|3782297|FG003|Overall Study|Off study trmt prior to end of C1/PD|0
2164039|NCT01273155|3782298|FG004|Overall Study|Off study trmt prior to end of C1/PD|0
2164040|NCT01273155|3782299|FG005|Overall Study|Off study trmt prior to end of C1/PD|2
2164041|NCT01273155|3782300|FG006|Overall Study|Off study trmt prior to end of C1/PD|3
2164042|NCT01273155|3782294|FG000|Overall Study|Change in liver function/no longer eval.|0
2164043|NCT01273155|3782295|FG001|Overall Study|Change in liver function/no longer eval.|1
2164044|NCT01273155|3782296|FG002|Overall Study|Change in liver function/no longer eval.|0
2164045|NCT01273155|3782297|FG003|Overall Study|Change in liver function/no longer eval.|0
2164046|NCT01273155|3782298|FG004|Overall Study|Change in liver function/no longer eval.|1
2164047|NCT01273155|3782299|FG005|Overall Study|Change in liver function/no longer eval.|0
2164048|NCT01273155|3782300|FG006|Overall Study|Change in liver function/no longer eval.|0
2164049|NCT01273155|3782294|FG000|Overall Study|Off study prior to C1/due to toxicity|0
2164050|NCT01273155|3782295|FG001|Overall Study|Off study prior to C1/due to toxicity|0
2164051|NCT01273155|3782296|FG002|Overall Study|Off study prior to C1/due to toxicity|2
2164052|NCT01273155|3782297|FG003|Overall Study|Off study prior to C1/due to toxicity|0
2164053|NCT01273155|3782298|FG004|Overall Study|Off study prior to C1/due to toxicity|0
2164054|NCT01273155|3782299|FG005|Overall Study|Off study prior to C1/due to toxicity|0
2164055|NCT01273155|3782300|FG006|Overall Study|Off study prior to C1/due to toxicity|1
2164056|NCT01273155|3782294|FG000|Overall Study|Died during Cycle 1|0
2164057|NCT01273155|3782295|FG001|Overall Study|Died during Cycle 1|0
2164058|NCT01273155|3782296|FG002|Overall Study|Died during Cycle 1|1
2164059|NCT01273155|3782297|FG003|Overall Study|Died during Cycle 1|1
2164060|NCT01273155|3782298|FG004|Overall Study|Died during Cycle 1|0
2164061|NCT01273155|3782299|FG005|Overall Study|Died during Cycle 1|2
2164062|NCT01273155|3782300|FG006|Overall Study|Died during Cycle 1|2
2164063|NCT01273155|3782294|FG000|Overall Study|Withdrew during C1/refused further trmt|0
2164064|NCT01273155|3782295|FG001|Overall Study|Withdrew during C1/refused further trmt|0
2164065|NCT01273155|3782296|FG002|Overall Study|Withdrew during C1/refused further trmt|1
2164066|NCT01273155|3782297|FG003|Overall Study|Withdrew during C1/refused further trmt|0
2164067|NCT01273155|3782298|FG004|Overall Study|Withdrew during C1/refused further trmt|1
2164068|NCT01273155|3782299|FG005|Overall Study|Withdrew during C1/refused further trmt|1
2164069|NCT01273155|3782300|FG006|Overall Study|Withdrew during C1/refused further trmt|0
2164070|NCT01273181|3782327|FG000|Phase I, Dose 1|Study termination|1
2164071|NCT01273181|3782328|FG001|Phase I, Dose 1|Study termination|0
2164072|NCT01273181|3782329|FG002|Phase I, Dose 1|Study termination|0
2164073|NCT01273181|3782330|FG003|Phase I, Dose 1|Study termination|0
2164074|NCT01273181|3782327|FG000|Phase I, Dose 2|Death during treatment|0
2164075|NCT01273181|3782328|FG001|Phase I, Dose 2|Death during treatment|1
2164076|NCT01273181|3782329|FG002|Phase I, Dose 2|Death during treatment|0
2164077|NCT01273181|3782330|FG003|Phase I, Dose 2|Death during treatment|0
2164078|NCT01273181|3782327|FG000|Phase 2, Dose 1|Study termination|0
2164079|NCT01273181|3782328|FG001|Phase 2, Dose 1|Study termination|0
2164080|NCT01273181|3782329|FG002|Phase 2, Dose 1|Study termination|1
2164081|NCT01273181|3782330|FG003|Phase 2, Dose 1|Study termination|0
2164082|NCT01273181|3782327|FG000|Phase 2, Dose 2|Death during treatment|0
2164083|NCT01273181|3782328|FG001|Phase 2, Dose 2|Death during treatment|0
2164084|NCT01273181|3782329|FG002|Phase 2, Dose 2|Death during treatment|0
2164085|NCT01273181|3782330|FG003|Phase 2, Dose 2|Death during treatment|1
2164086|NCT01273519|3782351|FG000|Overall Study|Adverse Event|3
2164087|NCT01273519|3782352|FG001|Overall Study|Adverse Event|0
2164088|NCT01273519|3782353|FG002|Overall Study|Adverse Event|0
2164089|NCT01273519|3782351|FG000|Overall Study|Lost to Follow-up|2
2164090|NCT01273519|3782352|FG001|Overall Study|Lost to Follow-up|1
2164091|NCT01273519|3782353|FG002|Overall Study|Lost to Follow-up|3
2164092|NCT01273519|3782351|FG000|Overall Study|Lack of Efficacy|8
2164093|NCT01273519|3782352|FG001|Overall Study|Lack of Efficacy|3
2164094|NCT01273519|3782353|FG002|Overall Study|Lack of Efficacy|4
2164095|NCT01273519|3782351|FG000|Overall Study|Other|6
2164096|NCT01273519|3782352|FG001|Overall Study|Other|1
2164097|NCT01273519|3782353|FG002|Overall Study|Other|1
2164098|NCT01273597|3782364|FG000|Overall Study|Adverse Event|5
2164099|NCT01273597|3782364|FG000|Overall Study|Underwent Kidney Transplantation|2
2164100|NCT01273597|3782364|FG000|Overall Study|Reason Not Reported|1
2164101|NCT01273623|3782368|FG000|Overall Study|did not meet IVUS criteria|29
2164102|NCT01273805|3782388|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10
2164103|NCT01273805|3782389|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10
2164104|NCT01273818|3782398|FG000|Overall Study|Physician Decision|13
2164105|NCT01273818|3782399|FG001|Overall Study|Physician Decision|2
2164106|NCT01273818|3782400|FG002|Overall Study|Physician Decision|9
2164107|NCT01273883|3782417|FG000|First Intervention|Adverse Event|2
2164108|NCT01273883|3782418|FG001|First Intervention|Adverse Event|1
2164109|NCT01273883|3782417|FG000|Second Intervention|Lost to Follow-up|1
2164110|NCT01273883|3782418|FG001|Second Intervention|Lost to Follow-up|1
2164111|NCT01273883|3782417|FG000|Second Intervention|Lack of Efficacy|1
2164112|NCT01273883|3782418|FG001|Second Intervention|Lack of Efficacy|0
2164113|NCT01274182|3782431|FG000|Overall Study|Unsatisfactory therapeutic effect|6
2164114|NCT01274182|3782432|FG001|Overall Study|Unsatisfactory therapeutic effect|3
2164115|NCT01274182|3782433|FG002|Overall Study|Unsatisfactory therapeutic effect|4
2164116|NCT01274182|3782431|FG000|Overall Study|Adverse Event|4
2164117|NCT01274182|3782432|FG001|Overall Study|Adverse Event|5
2164118|NCT01274182|3782433|FG002|Overall Study|Adverse Event|3
2164119|NCT01274182|3782431|FG000|Overall Study|Withdrawal by Subject|5
2164120|NCT01274182|3782432|FG001|Overall Study|Withdrawal by Subject|5
2164121|NCT01274182|3782433|FG002|Overall Study|Withdrawal by Subject|3
2164122|NCT01274182|3782431|FG000|Overall Study|Lost to Follow-up|2
2164123|NCT01274182|3782432|FG001|Overall Study|Lost to Follow-up|3
2164124|NCT01274182|3782433|FG002|Overall Study|Lost to Follow-up|1
2164125|NCT01274182|3782431|FG000|Overall Study|Protocol Violation|3
2164126|NCT01274182|3782432|FG001|Overall Study|Protocol Violation|2
2164127|NCT01274182|3782433|FG002|Overall Study|Protocol Violation|0
2164128|NCT01274182|3782431|FG000|Overall Study|Death|1
2164129|NCT01274182|3782432|FG001|Overall Study|Death|0
2164130|NCT01274182|3782433|FG002|Overall Study|Death|1
2164131|NCT01274338|3782451|FG000|Overall Study|Lack of Efficacy|72
2164132|NCT01274338|3782452|FG001|Overall Study|Lack of Efficacy|108
2164133|NCT01274338|3782453|FG002|Overall Study|Lack of Efficacy|116
2164134|NCT01274338|3782454|FG003|Overall Study|Lack of Efficacy|0
2164135|NCT01274338|3782455|FG004|Overall Study|Lack of Efficacy|0
2164136|NCT01274338|3782456|FG005|Overall Study|Lack of Efficacy|0
2164137|NCT01274338|3782451|FG000|Overall Study|Adverse Event|272
2164138|NCT01274338|3782452|FG001|Overall Study|Adverse Event|105
2164139|NCT01274338|3782453|FG002|Overall Study|Adverse Event|180
2164140|NCT01274338|3782454|FG003|Overall Study|Adverse Event|1
2164141|NCT01274338|3782455|FG004|Overall Study|Adverse Event|0
2164142|NCT01274338|3782456|FG005|Overall Study|Adverse Event|0
2164143|NCT01274338|3782451|FG000|Overall Study|Death|8
2164144|NCT01274338|3782452|FG001|Overall Study|Death|1
2164145|NCT01274338|3782453|FG002|Overall Study|Death|0
2164146|NCT01274338|3782454|FG003|Overall Study|Death|0
2164147|NCT01274338|3782455|FG004|Overall Study|Death|0
2164148|NCT01274338|3782456|FG005|Overall Study|Death|0
2164149|NCT01274338|3782451|FG000|Overall Study|Withdrawal by Subject|27
2164150|NCT01274338|3782452|FG001|Overall Study|Withdrawal by Subject|99
2164151|NCT01274338|3782453|FG002|Overall Study|Withdrawal by Subject|17
2164152|NCT01274338|3782454|FG003|Overall Study|Withdrawal by Subject|0
2164153|NCT01274338|3782455|FG004|Overall Study|Withdrawal by Subject|0
2164154|NCT01274338|3782456|FG005|Overall Study|Withdrawal by Subject|0
2164155|NCT01274338|3782451|FG000|Overall Study|Did not start treatment|8
2164156|NCT01274338|3782452|FG001|Overall Study|Did not start treatment|116
2164157|NCT01274338|3782453|FG002|Overall Study|Did not start treatment|7
2164158|NCT01274338|3782454|FG003|Overall Study|Did not start treatment|0
2164159|NCT01274338|3782455|FG004|Overall Study|Did not start treatment|0
2164160|NCT01274338|3782456|FG005|Overall Study|Did not start treatment|0
2164161|NCT01274338|3782451|FG000|Overall Study|Alternative therapy|0
2164162|NCT01274338|3782452|FG001|Overall Study|Alternative therapy|1
2164163|NCT01274338|3782453|FG002|Overall Study|Alternative therapy|0
2164164|NCT01274338|3782454|FG003|Overall Study|Alternative therapy|0
2164165|NCT01274338|3782455|FG004|Overall Study|Alternative therapy|0
2164166|NCT01274338|3782456|FG005|Overall Study|Alternative therapy|0
2164167|NCT01274338|3782451|FG000|Overall Study|Other complicating diseases|0
2164168|NCT01274338|3782452|FG001|Overall Study|Other complicating diseases|3
2164169|NCT01274338|3782453|FG002|Overall Study|Other complicating diseases|1
2164170|NCT01274338|3782454|FG003|Overall Study|Other complicating diseases|0
2164171|NCT01274338|3782455|FG004|Overall Study|Other complicating diseases|0
2164172|NCT01274338|3782456|FG005|Overall Study|Other complicating diseases|0
2164173|NCT01274338|3782451|FG000|Overall Study|Treatment arm was suspended due to toxicity|4
2164174|NCT01274338|3782452|FG001|Overall Study|Treatment arm was suspended due to toxicity|0
2164175|NCT01274338|3782453|FG002|Overall Study|Treatment arm was suspended due to toxicity|0
2164176|NCT01274338|3782454|FG003|Overall Study|Treatment arm was suspended due to toxicity|0
2164177|NCT01274338|3782455|FG004|Overall Study|Treatment arm was suspended due to toxicity|0
2164178|NCT01274338|3782456|FG005|Overall Study|Treatment arm was suspended due to toxicity|0
2164179|NCT01274338|3782451|FG000|Overall Study|Pregnancy|0
2164180|NCT01274338|3782452|FG001|Overall Study|Pregnancy|0
2164181|NCT01274338|3782453|FG002|Overall Study|Pregnancy|1
2164182|NCT01274338|3782454|FG003|Overall Study|Pregnancy|0
2164183|NCT01274338|3782455|FG004|Overall Study|Pregnancy|0
2164184|NCT01274338|3782456|FG005|Overall Study|Pregnancy|0
2164185|NCT01274338|3782451|FG000|Overall Study|Reason not reported|12
2164186|NCT01274338|3782452|FG001|Overall Study|Reason not reported|21
2164187|NCT01274338|3782453|FG002|Overall Study|Reason not reported|3
2164188|NCT01274338|3782454|FG003|Overall Study|Reason not reported|0
2164189|NCT01274338|3782455|FG004|Overall Study|Reason not reported|1
2164190|NCT01274338|3782456|FG005|Overall Study|Reason not reported|0
2164191|NCT01274351|3782469|FG000|Overall Study|Lost to Follow-up|1
2164192|NCT01274351|3782469|FG000|Overall Study|patient not compliant with the protocol|1
2164193|NCT01274351|3782469|FG000|Overall Study|Pregnancy|1
2164194|NCT01274351|3782469|FG000|Overall Study|Death|2
2164195|NCT01274351|3782469|FG000|Overall Study|Withdrawal by Subject|3
2164196|NCT01274351|3782469|FG000|Overall Study|Adverse Event|8
2164197|NCT01274351|3782469|FG000|Overall Study|progression of disease|3
2164198|NCT01274351|3782469|FG000|Overall Study|hospitalization|1
2164199|NCT01274637|3782496|FG000|Overall Study|Withdrawal by Subject|0
2164200|NCT01274637|3782497|FG001|Overall Study|Withdrawal by Subject|1
2164201|NCT01274637|3782496|FG000|Overall Study|Lost to Follow-up|0
2164202|NCT01274637|3782497|FG001|Overall Study|Lost to Follow-up|1
2164203|NCT01274715|3782503|FG000|Overall Study|Lost to Follow-up|1
2164204|NCT01274715|3782503|FG000|Overall Study|After consent, met exclusion criteria.|1
2164205|NCT01274715|3782503|FG000|Overall Study|After consent, met exclusion criteria.|1
2164206|NCT01274715|3782503|FG000|Overall Study|After consent, met exclusion criteria.|1
2164207|NCT01275066|3782523|FG000|Overall Study|Withdrawal by Subject|0
2164208|NCT01275066|3782524|FG001|Overall Study|Withdrawal by Subject|0
2164209|NCT01275066|3782525|FG002|Overall Study|Withdrawal by Subject|1
2164210|NCT01275066|3782523|FG000|Overall Study|Not Diagnosed w/ Disease|1
2164211|NCT01275066|3782524|FG001|Overall Study|Not Diagnosed w/ Disease|0
2164212|NCT01275066|3782525|FG002|Overall Study|Not Diagnosed w/ Disease|0
2164213|NCT01275131|3782541|FG000|Period 1|Withdrawal by Subject|1
2164214|NCT01275131|3782542|FG001|Period 1|Withdrawal by Subject|0
2164215|NCT01275131|3782543|FG002|Period 1|Withdrawal by Subject|3
2164216|NCT01275131|3782544|FG003|Period 1|Withdrawal by Subject|2
2164217|NCT01275131|3782541|FG000|Period 1|Physician Decision|1
2164218|NCT01275131|3782542|FG001|Period 1|Physician Decision|0
2164219|NCT01275131|3782543|FG002|Period 1|Physician Decision|0
2164220|NCT01275131|3782544|FG003|Period 1|Physician Decision|0
2164221|NCT01275131|3782541|FG000|Period 2 (Crossover)|Adverse Event|0
2164222|NCT01275131|3782542|FG001|Period 2 (Crossover)|Adverse Event|1
2164223|NCT01275131|3782543|FG002|Period 2 (Crossover)|Adverse Event|0
2164224|NCT01275131|3782544|FG003|Period 2 (Crossover)|Adverse Event|0
2164225|NCT01275131|3782541|FG000|Period 2 (Crossover)|Withdrawal by Subject|1
2164226|NCT01275131|3782542|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
2164227|NCT01275131|3782543|FG002|Period 2 (Crossover)|Withdrawal by Subject|1
2164228|NCT01275131|3782544|FG003|Period 2 (Crossover)|Withdrawal by Subject|2
2164229|NCT01275144|3782562|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1
2164230|NCT01275144|3782563|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0
2164231|NCT01275170|3782579|FG000|Part 1: Period 1|Equipment malfunction before study drug|1
2164232|NCT01275170|3782580|FG001|Part 1: Period 1|Equipment malfunction before study drug|0
2164233|NCT01275170|3782581|FG002|Part 1: Period 1|Equipment malfunction before study drug|0
2164234|NCT01275170|3782582|FG003|Part 1: Period 1|Equipment malfunction before study drug|0
2164235|NCT01275170|3782583|FG004|Part 1: Period 1|Equipment malfunction before study drug|0
2164236|NCT01275170|3782584|FG005|Part 1: Period 1|Equipment malfunction before study drug|0
2164237|NCT01275170|3782585|FG006|Part 1: Period 1|Equipment malfunction before study drug|0
2164238|NCT01275170|3782586|FG007|Part 1: Period 1|Equipment malfunction before study drug|0
2164239|NCT01275196|3782621|FG000|Overall Study|Adverse Event|3
2164240|NCT01275196|3782622|FG001|Overall Study|Adverse Event|5
2164241|NCT01275196|3782621|FG000|Overall Study|Withdrawal by Subject|4
2164242|NCT01275196|3782622|FG001|Overall Study|Withdrawal by Subject|5
2164243|NCT01275196|3782621|FG000|Overall Study|Lost to Follow-up|1
2164244|NCT01275196|3782622|FG001|Overall Study|Lost to Follow-up|0
2164245|NCT01275196|3782621|FG000|Overall Study|Disease Progression|6
2164246|NCT01275196|3782622|FG001|Overall Study|Disease Progression|5
2164247|NCT01275196|3782621|FG000|Overall Study|Protocol Violation|1
2164248|NCT01275196|3782622|FG001|Overall Study|Protocol Violation|0
2164249|NCT01275196|3782621|FG000|Overall Study|Suboptimal response/treatment failure|5
2164250|NCT01275196|3782622|FG001|Overall Study|Suboptimal response/treatment failure|6
2164251|NCT01275222|3782636|FG000|Phase l by Treatment|Adverse Event|1
2164252|NCT01275222|3782637|FG001|Phase l by Treatment|Adverse Event|4
2164253|NCT01275222|3782638|FG002|Phase l by Treatment|Adverse Event|2
2164254|NCT01275222|3782639|FG003|Phase l by Treatment|Adverse Event|3
2164255|NCT01275222|3782640|FG004|Phase l by Treatment|Adverse Event|0
2164256|NCT01275222|3782641|FG005|Phase l by Treatment|Adverse Event|0
2164257|NCT01275222|3782636|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0
2164258|NCT01275222|3782637|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0
2164259|NCT01275222|3782638|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1
2164260|NCT01275222|3782639|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0
2164261|NCT01275222|3782640|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0
2164262|NCT01275222|3782641|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0
2164263|NCT01275222|3782636|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0
2164264|NCT01275222|3782637|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0
2164265|NCT01275222|3782638|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0
2164266|NCT01275222|3782639|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1
2164267|NCT01275222|3782640|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0
2164268|NCT01275222|3782641|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0
2164269|NCT01275222|3782636|FG000|Phase l by Treatment|Disease progression|12
2164270|NCT01275222|3782637|FG001|Phase l by Treatment|Disease progression|8
2164271|NCT01275222|3782638|FG002|Phase l by Treatment|Disease progression|2
2164272|NCT01275222|3782639|FG003|Phase l by Treatment|Disease progression|5
2164273|NCT01275222|3782640|FG004|Phase l by Treatment|Disease progression|0
2164274|NCT01275222|3782641|FG005|Phase l by Treatment|Disease progression|0
2164275|NCT01275222|3782636|FG000|Phase l by Treatment|Withdrawal by Subject|0
2164276|NCT01275222|3782637|FG001|Phase l by Treatment|Withdrawal by Subject|0
2164277|NCT01275222|3782638|FG002|Phase l by Treatment|Withdrawal by Subject|0
2164278|NCT01275222|3782639|FG003|Phase l by Treatment|Withdrawal by Subject|1
2164279|NCT01275222|3782640|FG004|Phase l by Treatment|Withdrawal by Subject|0
2164280|NCT01275222|3782641|FG005|Phase l by Treatment|Withdrawal by Subject|0
2164281|NCT01275222|3782636|FG000|Phase l by Treatment|Death|0
2164282|NCT01275222|3782637|FG001|Phase l by Treatment|Death|1
2164283|NCT01275222|3782638|FG002|Phase l by Treatment|Death|0
2164284|NCT01275222|3782639|FG003|Phase l by Treatment|Death|1
2164285|NCT01275222|3782640|FG004|Phase l by Treatment|Death|0
2164286|NCT01275222|3782641|FG005|Phase l by Treatment|Death|0
2164287|NCT01275222|3782636|FG000|Phase ll by Stratum|Adverse Event|0
2164288|NCT01275222|3782637|FG001|Phase ll by Stratum|Adverse Event|0
2164289|NCT01275222|3782638|FG002|Phase ll by Stratum|Adverse Event|0
2164290|NCT01275222|3782639|FG003|Phase ll by Stratum|Adverse Event|0
2164291|NCT01275222|3782640|FG004|Phase ll by Stratum|Adverse Event|2
2164292|NCT01275222|3782641|FG005|Phase ll by Stratum|Adverse Event|10
2164293|NCT01275222|3782636|FG000|Phase ll by Stratum|Abnormal laboratory values|0
2164294|NCT01275222|3782637|FG001|Phase ll by Stratum|Abnormal laboratory values|0
2164295|NCT01275222|3782638|FG002|Phase ll by Stratum|Abnormal laboratory values|0
2164296|NCT01275222|3782639|FG003|Phase ll by Stratum|Abnormal laboratory values|0
2164297|NCT01275222|3782640|FG004|Phase ll by Stratum|Abnormal laboratory values|0
2164298|NCT01275222|3782641|FG005|Phase ll by Stratum|Abnormal laboratory values|1
2164299|NCT01275222|3782636|FG000|Phase ll by Stratum|Disease progression|0
2164300|NCT01275222|3782637|FG001|Phase ll by Stratum|Disease progression|0
2164301|NCT01275222|3782638|FG002|Phase ll by Stratum|Disease progression|0
2164302|NCT01275222|3782639|FG003|Phase ll by Stratum|Disease progression|0
2164303|NCT01275222|3782640|FG004|Phase ll by Stratum|Disease progression|23
2164304|NCT01275222|3782641|FG005|Phase ll by Stratum|Disease progression|31
2164305|NCT01275222|3782636|FG000|Phase ll by Stratum|Withdrawal by Subject|0
2164306|NCT01275222|3782637|FG001|Phase ll by Stratum|Withdrawal by Subject|0
2164307|NCT01275222|3782638|FG002|Phase ll by Stratum|Withdrawal by Subject|0
2164308|NCT01275222|3782639|FG003|Phase ll by Stratum|Withdrawal by Subject|0
2164309|NCT01275222|3782640|FG004|Phase ll by Stratum|Withdrawal by Subject|2
2164310|NCT01275222|3782641|FG005|Phase ll by Stratum|Withdrawal by Subject|3
2164311|NCT01275222|3782636|FG000|Phase ll by Stratum|Death|0
2164312|NCT01275222|3782637|FG001|Phase ll by Stratum|Death|0
2164313|NCT01275222|3782638|FG002|Phase ll by Stratum|Death|0
2164314|NCT01275222|3782639|FG003|Phase ll by Stratum|Death|0
2164315|NCT01275222|3782640|FG004|Phase ll by Stratum|Death|1
2164316|NCT01275222|3782641|FG005|Phase ll by Stratum|Death|1
2179553|NCT01394185|3805152|FG001|Overall Study|Withdrawal by Subject|0
2179554|NCT01394185|3805153|FG002|Overall Study|Withdrawal by Subject|0
2179555|NCT01394185|3805154|FG003|Overall Study|Withdrawal by Subject|0
2179556|NCT01394185|3805155|FG004|Overall Study|Withdrawal by Subject|1
2179557|NCT01394185|3805156|FG005|Overall Study|Withdrawal by Subject|0
2179558|NCT01394185|3805151|FG000|Overall Study|Change in protocol|3
2179559|NCT01394185|3805152|FG001|Overall Study|Change in protocol|0
2179560|NCT01394185|3805153|FG002|Overall Study|Change in protocol|0
2179561|NCT01394185|3805154|FG003|Overall Study|Change in protocol|0
2179562|NCT01394185|3805155|FG004|Overall Study|Change in protocol|3
2179563|NCT01394185|3805156|FG005|Overall Study|Change in protocol|0
2179564|NCT01394185|3805151|FG000|Overall Study|Protocol Violation|1
2179565|NCT01394185|3805152|FG001|Overall Study|Protocol Violation|0
2179566|NCT01394185|3805153|FG002|Overall Study|Protocol Violation|0
2179567|NCT01394185|3805154|FG003|Overall Study|Protocol Violation|1
2179568|NCT01394185|3805155|FG004|Overall Study|Protocol Violation|0
2179569|NCT01394185|3805156|FG005|Overall Study|Protocol Violation|1
2179570|NCT01394250|3805166|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
2179571|NCT01394250|3805167|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
2179572|NCT01394250|3805166|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
2179573|NCT01394250|3805167|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
2179574|NCT01394276|3805173|FG000|Overall Study|Related Adverse event (AEs)|15
2179575|NCT01394276|3805173|FG000|Overall Study|Not related AEs|9
2179576|NCT01394276|3805173|FG000|Overall Study|Remission of disease|2
2179577|NCT01394276|3805173|FG000|Overall Study|Insufficient therapeutic effect|17
2179578|NCT01394276|3805173|FG000|Overall Study|Insufficient compliance|9
2179579|NCT01394276|3805173|FG000|Overall Study|Lost to Follow-up|5
2179580|NCT01394276|3805173|FG000|Overall Study|Participant moved to another site|1
2179581|NCT01394276|3805173|FG000|Overall Study|Pregnancy|1
2179582|NCT01394276|3805173|FG000|Overall Study|unavailability of drug at the Hospital|2
2179583|NCT01394276|3805173|FG000|Overall Study|Symptoms of concurrent diseases|1
2179584|NCT01394523|3805189|FG000|Overall Study|Unable to place block|1
2179585|NCT01394523|3805190|FG001|Overall Study|Unable to place block|0
2179586|NCT01394523|3805191|FG002|Overall Study|Unable to place block|0
2179587|NCT01394627|3805208|FG000|First Intervention (1 Day)|poor intravenous access|0
2179588|NCT01394627|3805209|FG001|First Intervention (1 Day)|poor intravenous access|1
2179589|NCT01394627|3805208|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1
2179590|NCT01394627|3805209|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0
2179591|NCT01394718|3805236|FG000|Overall Study|Met protocol-specific stopping criteria|2
2179592|NCT01394718|3805237|FG001|Overall Study|Met protocol-specific stopping criteria|1
2179593|NCT01394939|3805247|FG000|Overall Study|Adverse Event|1
2179594|NCT01394939|3805248|FG001|Overall Study|Adverse Event|3
2179595|NCT01394939|3805249|FG002|Overall Study|Adverse Event|0
2179596|NCT01394939|3805250|FG003|Overall Study|Adverse Event|2
2179597|NCT01394939|3805247|FG000|Overall Study|Death|0
2179598|NCT01394939|3805248|FG001|Overall Study|Death|2
2179599|NCT01394939|3805249|FG002|Overall Study|Death|0
2179600|NCT01394939|3805250|FG003|Overall Study|Death|0
2179601|NCT01394939|3805247|FG000|Overall Study|Physician Decision|0
2179602|NCT01394939|3805248|FG001|Overall Study|Physician Decision|1
2179603|NCT01394939|3805249|FG002|Overall Study|Physician Decision|0
2179604|NCT01394939|3805250|FG003|Overall Study|Physician Decision|0
2179605|NCT01394939|3805247|FG000|Overall Study|Withdrawal by Subject|0
2164317|NCT01275339|3782679|FG000|Overall Study|Referred for surgery for AS symptoms|1
2164318|NCT01275339|3782680|FG001|Overall Study|Referred for surgery for AS symptoms|0
2164319|NCT01275339|3782681|FG002|Overall Study|Referred for surgery for AS symptoms|0
2164320|NCT01275339|3782682|FG003|Overall Study|Referred for surgery for AS symptoms|0
2164321|NCT01275339|3782679|FG000|Overall Study|Withdrawal by Subject|0
2164322|NCT01275339|3782680|FG001|Overall Study|Withdrawal by Subject|0
2164323|NCT01275339|3782681|FG002|Overall Study|Withdrawal by Subject|1
2164324|NCT01275339|3782682|FG003|Overall Study|Withdrawal by Subject|0
2164325|NCT01275430|3782709|FG000|Overall Study|Adverse Event|1
2164326|NCT01275430|3782709|FG000|Overall Study|No Contrast Injection|6
2164327|NCT01275430|3782709|FG000|Overall Study|Device Malfunction|1
2164328|NCT01275430|3782709|FG000|Overall Study|Inability to achieve maximum p-wave|1
2164329|NCT01275625|3782718|FG000|Overall Study|Death|1
2164330|NCT01275625|3782718|FG000|Overall Study|Lack of Efficacy|2
2164331|NCT01275625|3782718|FG000|Overall Study|Lost to Follow-up|1
2164332|NCT01275625|3782718|FG000|Overall Study|Withdrawal by Subject|3
2164333|NCT01275625|3782718|FG000|Overall Study|Protocol Violation|1
2164334|NCT01275625|3782718|FG000|Overall Study|Adverse Event|4
2164335|NCT01275625|3782718|FG000|Overall Study|Other|1
2164336|NCT01275755|3782728|FG000|Double-blind Treatment Period|Adverse Event|0
2164337|NCT01275755|3782729|FG001|Double-blind Treatment Period|Adverse Event|2
2164338|NCT01275755|3782728|FG000|Double-blind Treatment Period|Lost to Follow-up|1
2164339|NCT01275755|3782729|FG001|Double-blind Treatment Period|Lost to Follow-up|1
2164340|NCT01275755|3782728|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
2164341|NCT01275755|3782729|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
2164342|NCT01275755|3782728|FG000|Run-out Placebo Period|Lost to Follow-up|1
2164343|NCT01275755|3782729|FG001|Run-out Placebo Period|Lost to Follow-up|0
2164344|NCT01275833|3782737|FG000|Overall Study|Study terminated|1
2164345|NCT01275833|3782738|FG001|Overall Study|Study terminated|1
2164346|NCT01276041|3782744|FG000|Overall Study|Adverse Event|2
2164347|NCT01276041|3782744|FG000|Overall Study|Protocol Violation|1
2164348|NCT01276106|3782752|FG000|Overall Study|Adverse Event|3
2164349|NCT01276106|3782753|FG001|Overall Study|Adverse Event|3
2164350|NCT01276106|3782754|FG002|Overall Study|Adverse Event|11
2164351|NCT01276106|3782755|FG003|Overall Study|Adverse Event|3
2164352|NCT01276106|3782752|FG000|Overall Study|Withdrawal by Subject|6
2164353|NCT01276106|3782753|FG001|Overall Study|Withdrawal by Subject|3
2164354|NCT01276106|3782754|FG002|Overall Study|Withdrawal by Subject|1
2164355|NCT01276106|3782755|FG003|Overall Study|Withdrawal by Subject|6
2164356|NCT01276106|3782752|FG000|Overall Study|Lack of Efficacy|0
2164357|NCT01276106|3782753|FG001|Overall Study|Lack of Efficacy|1
2164358|NCT01276106|3782754|FG002|Overall Study|Lack of Efficacy|0
2164359|NCT01276106|3782755|FG003|Overall Study|Lack of Efficacy|1
2164360|NCT01276106|3782752|FG000|Overall Study|Lost to Follow-up|2
2164361|NCT01276106|3782753|FG001|Overall Study|Lost to Follow-up|1
2164362|NCT01276106|3782754|FG002|Overall Study|Lost to Follow-up|1
2164363|NCT01276106|3782755|FG003|Overall Study|Lost to Follow-up|0
2164364|NCT01276106|3782752|FG000|Overall Study|Physician Decision|0
2164365|NCT01276106|3782753|FG001|Overall Study|Physician Decision|0
2164366|NCT01276106|3782754|FG002|Overall Study|Physician Decision|1
2164367|NCT01276106|3782755|FG003|Overall Study|Physician Decision|1
2164368|NCT01276106|3782752|FG000|Overall Study|Protocol Violation|1
2164369|NCT01276106|3782753|FG001|Overall Study|Protocol Violation|1
2164370|NCT01276106|3782754|FG002|Overall Study|Protocol Violation|0
2164371|NCT01276106|3782755|FG003|Overall Study|Protocol Violation|2
2164372|NCT01276106|3782752|FG000|Overall Study|Insufficient therapeutic effects|0
2164373|NCT01276106|3782753|FG001|Overall Study|Insufficient therapeutic effects|0
2164374|NCT01276106|3782754|FG002|Overall Study|Insufficient therapeutic effects|2
2164375|NCT01276106|3782755|FG003|Overall Study|Insufficient therapeutic effects|0
2164376|NCT01276223|3782799|FG000|Overall Study|Adverse Event|7
2164377|NCT01276223|3782800|FG001|Overall Study|Adverse Event|4
2164378|NCT01276223|3782801|FG002|Overall Study|Adverse Event|1
2164379|NCT01276223|3782799|FG000|Overall Study|Lost to Follow-up|0
2164380|NCT01276223|3782800|FG001|Overall Study|Lost to Follow-up|0
2164381|NCT01276223|3782801|FG002|Overall Study|Lost to Follow-up|1
2164382|NCT01276223|3782799|FG000|Overall Study|Other|0
2164383|NCT01276223|3782800|FG001|Overall Study|Other|0
2164384|NCT01276223|3782801|FG002|Overall Study|Other|1
2164385|NCT01276223|3782799|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3
2164386|NCT01276223|3782800|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0
2164387|NCT01276223|3782801|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0
2164388|NCT01276223|3782799|FG000|Overall Study|Protocol Violation|1
2164389|NCT01276223|3782800|FG001|Overall Study|Protocol Violation|0
2164390|NCT01276223|3782801|FG002|Overall Study|Protocol Violation|0
2164391|NCT01276236|3782808|FG000|Overall Study|Lack of Efficacy|2
2164392|NCT01276236|3782808|FG000|Overall Study|Withdrawal by Subject|4
2164393|NCT01276288|3782812|FG000|Overall Study|Adverse Event|1
2164394|NCT01276288|3782813|FG001|Overall Study|Adverse Event|1
2164395|NCT01276288|3782814|FG002|Overall Study|Adverse Event|0
2164396|NCT01276288|3782815|FG003|Overall Study|Adverse Event|0
2164397|NCT01276288|3782812|FG000|Overall Study|not treated|1
2164398|NCT01276288|3782813|FG001|Overall Study|not treated|0
2164399|NCT01276288|3782814|FG002|Overall Study|not treated|0
2164400|NCT01276288|3782815|FG003|Overall Study|not treated|0
2164401|NCT01276327|3782864|FG000|Overall Study|Adverse Event|1
2164402|NCT01276327|3782865|FG001|Overall Study|Adverse Event|3
2164403|NCT01276327|3782864|FG000|Overall Study|Withdrawal by Subject|1
2164404|NCT01276327|3782865|FG001|Overall Study|Withdrawal by Subject|0
2164405|NCT01276353|3782873|FG000|Double-blind|Adverse Event|2
2164406|NCT01276353|3782874|FG001|Double-blind|Adverse Event|0
2164407|NCT01276353|3782873|FG000|Double-blind|Withdrawal by Subject|1
2164408|NCT01276353|3782874|FG001|Double-blind|Withdrawal by Subject|0
2164409|NCT01276353|3782873|FG000|Extension|Adverse Event|2
2164410|NCT01276353|3782874|FG001|Extension|Adverse Event|5
2164411|NCT01276353|3782873|FG000|Extension|Withdrawal by Subject|1
2164412|NCT01276353|3782874|FG001|Extension|Withdrawal by Subject|2
2164413|NCT01276353|3782873|FG000|Extension|Withdrawal of study drug 4 days in a row|3
2164414|NCT01276353|3782874|FG001|Extension|Withdrawal of study drug 4 days in a row|1
2164415|NCT01276353|3782873|FG000|Extension|Physician Decision|1
2164416|NCT01276353|3782874|FG001|Extension|Physician Decision|0
2164417|NCT01276353|3782873|FG000|Extension|Prohibited concomitant medications|0
2164418|NCT01276353|3782874|FG001|Extension|Prohibited concomitant medications|1
2164419|NCT01276379|3782886|FG000|Overall Study|Screening failure|40
2164420|NCT01276457|3782894|FG000|Core Study|Adverse Event|6
2164421|NCT01276457|3782895|FG001|Core Study|Adverse Event|3
2164422|NCT01276457|3782894|FG000|Core Study|Lost to Follow-up|1
2164423|NCT01276457|3782895|FG001|Core Study|Lost to Follow-up|2
2164424|NCT01276457|3782894|FG000|Core Study|Administrative problems|1
2164425|NCT01276457|3782895|FG001|Core Study|Administrative problems|1
2164426|NCT01276457|3782894|FG000|Core Study|Death|2
2164427|NCT01276457|3782895|FG001|Core Study|Death|2
2164428|NCT01276457|3782894|FG000|Core Study|Lack of Efficacy|3
2164429|NCT01276457|3782895|FG001|Core Study|Lack of Efficacy|12
2164430|NCT01276457|3782894|FG000|Extension Study|Lost to Follow-up|3
2164431|NCT01276457|3782895|FG001|Extension Study|Lost to Follow-up|0
2164432|NCT01276457|3782894|FG000|Extension Study|Death|0
2164433|NCT01276457|3782895|FG001|Extension Study|Death|1
2164434|NCT01276457|3782894|FG000|Extension Study|Lack of Efficacy|3
2164435|NCT01276457|3782895|FG001|Extension Study|Lack of Efficacy|1
2164436|NCT01276509|3782905|FG000|Overall Study|Adverse Event|9
2164437|NCT01276509|3782906|FG001|Overall Study|Adverse Event|8
2164438|NCT01276509|3782907|FG002|Overall Study|Adverse Event|4
2164439|NCT01276509|3782908|FG003|Overall Study|Adverse Event|3
2164440|NCT01276509|3782905|FG000|Overall Study|Lack of Efficacy|2
2164441|NCT01276509|3782906|FG001|Overall Study|Lack of Efficacy|1
2164442|NCT01276509|3782907|FG002|Overall Study|Lack of Efficacy|1
2208193|NCT01636778|3847564|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2
2208194|NCT01636934|3847578|FG000|Overall Study|Withdrawal by Subject|3
2164443|NCT01276509|3782908|FG003|Overall Study|Lack of Efficacy|2
2164444|NCT01276509|3782905|FG000|Overall Study|Pregnancy|1
2164445|NCT01276509|3782906|FG001|Overall Study|Pregnancy|0
2164446|NCT01276509|3782907|FG002|Overall Study|Pregnancy|0
2164447|NCT01276509|3782908|FG003|Overall Study|Pregnancy|0
2164448|NCT01276509|3782905|FG000|Overall Study|Withdrawal by Subject|1
2164449|NCT01276509|3782906|FG001|Overall Study|Withdrawal by Subject|2
2164450|NCT01276509|3782907|FG002|Overall Study|Withdrawal by Subject|0
2164451|NCT01276509|3782908|FG003|Overall Study|Withdrawal by Subject|0
2164452|NCT01276509|3782905|FG000|Overall Study|Other|0
2164453|NCT01276509|3782906|FG001|Overall Study|Other|1
2164454|NCT01276509|3782907|FG002|Overall Study|Other|0
2164455|NCT01276509|3782908|FG003|Overall Study|Other|0
2164456|NCT01276639|3782925|FG000|Week 0 to 16|Death|1
2164457|NCT01276639|3782926|FG001|Week 0 to 16|Death|0
2164458|NCT01276639|3782927|FG002|Week 0 to 16|Death|0
2164459|NCT01276639|3782928|FG003|Week 0 to 16|Death|0
2164460|NCT01276639|3782929|FG004|Week 0 to 16|Death|0
2164461|NCT01276639|3782925|FG000|Week 0 to 16|Adverse Event|11
2164462|NCT01276639|3782926|FG001|Week 0 to 16|Adverse Event|8
2164463|NCT01276639|3782927|FG002|Week 0 to 16|Adverse Event|11
2164464|NCT01276639|3782928|FG003|Week 0 to 16|Adverse Event|0
2164465|NCT01276639|3782929|FG004|Week 0 to 16|Adverse Event|0
2164466|NCT01276639|3782925|FG000|Week 0 to 16|Lack of Efficacy|20
2164467|NCT01276639|3782926|FG001|Week 0 to 16|Lack of Efficacy|15
2164468|NCT01276639|3782927|FG002|Week 0 to 16|Lack of Efficacy|25
2164469|NCT01276639|3782928|FG003|Week 0 to 16|Lack of Efficacy|0
2164470|NCT01276639|3782929|FG004|Week 0 to 16|Lack of Efficacy|0
2164471|NCT01276639|3782925|FG000|Week 0 to 16|Lost to Follow-up|3
2164472|NCT01276639|3782926|FG001|Week 0 to 16|Lost to Follow-up|5
2164473|NCT01276639|3782927|FG002|Week 0 to 16|Lost to Follow-up|3
2164474|NCT01276639|3782928|FG003|Week 0 to 16|Lost to Follow-up|0
2164475|NCT01276639|3782929|FG004|Week 0 to 16|Lost to Follow-up|0
2164476|NCT01276639|3782925|FG000|Week 0 to 16|Withdrawal by Subject|8
2164477|NCT01276639|3782926|FG001|Week 0 to 16|Withdrawal by Subject|5
2164478|NCT01276639|3782927|FG002|Week 0 to 16|Withdrawal by Subject|4
2164479|NCT01276639|3782928|FG003|Week 0 to 16|Withdrawal by Subject|0
2164480|NCT01276639|3782929|FG004|Week 0 to 16|Withdrawal by Subject|0
2164481|NCT01276639|3782925|FG000|Week 0 to 16|Other|7
2164482|NCT01276639|3782926|FG001|Week 0 to 16|Other|7
2164483|NCT01276639|3782927|FG002|Week 0 to 16|Other|2
2164484|NCT01276639|3782928|FG003|Week 0 to 16|Other|0
2164485|NCT01276639|3782929|FG004|Week 0 to 16|Other|0
2164486|NCT01276639|3782925|FG000|Week 0 to 16|Randomized, But Not Treated|0
2164487|NCT01276639|3782926|FG001|Week 0 to 16|Randomized, But Not Treated|1
2164488|NCT01276639|3782927|FG002|Week 0 to 16|Randomized, But Not Treated|0
2164489|NCT01276639|3782928|FG003|Week 0 to 16|Randomized, But Not Treated|0
2164490|NCT01276639|3782929|FG004|Week 0 to 16|Randomized, But Not Treated|0
2164491|NCT01276639|3782925|FG000|Week 16 to 52|Death|1
2164492|NCT01276639|3782926|FG001|Week 16 to 52|Death|0
2164493|NCT01276639|3782927|FG002|Week 16 to 52|Death|0
2164494|NCT01276639|3782928|FG003|Week 16 to 52|Death|0
2164495|NCT01276639|3782929|FG004|Week 16 to 52|Death|0
2164496|NCT01276639|3782925|FG000|Week 16 to 52|Adverse Event|10
2164497|NCT01276639|3782926|FG001|Week 16 to 52|Adverse Event|13
2164498|NCT01276639|3782927|FG002|Week 16 to 52|Adverse Event|0
2164499|NCT01276639|3782928|FG003|Week 16 to 52|Adverse Event|1
2164500|NCT01276639|3782929|FG004|Week 16 to 52|Adverse Event|3
2164501|NCT01276639|3782925|FG000|Week 16 to 52|Lack of Efficacy|99
2164502|NCT01276639|3782926|FG001|Week 16 to 52|Lack of Efficacy|71
2164503|NCT01276639|3782927|FG002|Week 16 to 52|Lack of Efficacy|0
2164504|NCT01276639|3782928|FG003|Week 16 to 52|Lack of Efficacy|14
2164505|NCT01276639|3782929|FG004|Week 16 to 52|Lack of Efficacy|13
2164506|NCT01276639|3782925|FG000|Week 16 to 52|Lost to Follow-up|3
2164507|NCT01276639|3782926|FG001|Week 16 to 52|Lost to Follow-up|1
2164508|NCT01276639|3782927|FG002|Week 16 to 52|Lost to Follow-up|0
2164509|NCT01276639|3782928|FG003|Week 16 to 52|Lost to Follow-up|0
2164510|NCT01276639|3782929|FG004|Week 16 to 52|Lost to Follow-up|1
2164511|NCT01276639|3782925|FG000|Week 16 to 52|Withdrawal by Subject|4
2164512|NCT01276639|3782926|FG001|Week 16 to 52|Withdrawal by Subject|4
2164513|NCT01276639|3782927|FG002|Week 16 to 52|Withdrawal by Subject|0
2164514|NCT01276639|3782928|FG003|Week 16 to 52|Withdrawal by Subject|0
2164515|NCT01276639|3782929|FG004|Week 16 to 52|Withdrawal by Subject|1
2164516|NCT01276639|3782925|FG000|Week 16 to 52|Other|10
2164517|NCT01276639|3782926|FG001|Week 16 to 52|Other|12
2164518|NCT01276639|3782927|FG002|Week 16 to 52|Other|0
2164519|NCT01276639|3782928|FG003|Week 16 to 52|Other|1
2164520|NCT01276639|3782929|FG004|Week 16 to 52|Other|3
2164521|NCT01276756|3782964|FG000|Overall Study|Lost to Follow-up|2
2164522|NCT01276756|3782965|FG001|Overall Study|Lost to Follow-up|0
2164523|NCT01276756|3782964|FG000|Overall Study|Adverse Event|3
2164524|NCT01276756|3782965|FG001|Overall Study|Adverse Event|2
2164525|NCT01276821|3782973|FG000|Overall Study|Protocol Violation|0
2164526|NCT01276821|3782974|FG001|Overall Study|Protocol Violation|1
2164527|NCT01276847|3782983|FG000|Overall Study|Withdrawal by Subject|1
2164528|NCT01276847|3782984|FG001|Overall Study|Withdrawal by Subject|0
2164529|NCT01276847|3782985|FG002|Overall Study|Withdrawal by Subject|0
2164530|NCT01277042|3783003|FG000|Overall Study|Adverse Event|4
2164531|NCT01277042|3783004|FG001|Overall Study|Adverse Event|3
2164532|NCT01277042|3783003|FG000|Overall Study|Lost to Follow-up|2
2164533|NCT01277042|3783004|FG001|Overall Study|Lost to Follow-up|2
2164534|NCT01277042|3783003|FG000|Overall Study|Withdrawal by Subject|2
2164535|NCT01277042|3783004|FG001|Overall Study|Withdrawal by Subject|0
2164536|NCT01277302|3783044|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
2164537|NCT01277302|3783045|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
2164538|NCT01277302|3783046|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
2164539|NCT01277302|3783044|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0
2164540|NCT01277302|3783045|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0
2164541|NCT01277302|3783046|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2
2164542|NCT01277302|3783044|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
2164543|NCT01277302|3783045|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
2164544|NCT01277302|3783046|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
2164545|NCT01277302|3783044|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0
2164546|NCT01277302|3783045|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0
2164547|NCT01277302|3783046|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1
2164548|NCT01277302|3783044|FG000|8-Month Alternate Dose Regimen Period|Death|0
2164549|NCT01277302|3783045|FG001|8-Month Alternate Dose Regimen Period|Death|1
2164550|NCT01277302|3783046|FG002|8-Month Alternate Dose Regimen Period|Death|0
2164551|NCT01277302|3783044|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
2164552|NCT01277302|3783045|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
2164553|NCT01277302|3783046|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
2164554|NCT01277302|3783044|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
2164555|NCT01277302|3783045|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
2164556|NCT01277302|3783046|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
2164557|NCT01277302|3783044|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
2164558|NCT01277302|3783045|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
2164559|NCT01277302|3783046|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
2164560|NCT01277302|3783044|FG000|8-Month Alternate Dose Regimen Period|Relocation|1
2164561|NCT01277302|3783045|FG001|8-Month Alternate Dose Regimen Period|Relocation|0
2164562|NCT01277302|3783046|FG002|8-Month Alternate Dose Regimen Period|Relocation|1
2164563|NCT01277510|3783082|FG000|Double-blind Phase|Non-compliance|0
2164564|NCT01277510|3783083|FG001|Double-blind Phase|Non-compliance|1
2164565|NCT01277510|3783082|FG000|Double-blind Phase|Adverse Event|1
2164566|NCT01277510|3783083|FG001|Double-blind Phase|Adverse Event|0
2164567|NCT01277510|3783082|FG000|Double-blind Phase|Withdrawal by Subject|2
2164568|NCT01277510|3783083|FG001|Double-blind Phase|Withdrawal by Subject|0
2164569|NCT01277510|3783082|FG000|Double-blind Phase|Administrative decision|7
2164570|NCT01277510|3783083|FG001|Double-blind Phase|Administrative decision|9
2164571|NCT01277510|3783082|FG000|Double-blind Phase|Death|0
2164572|NCT01277510|3783083|FG001|Double-blind Phase|Death|1
2164573|NCT01277510|3783082|FG000|Double-blind Phase|Protocol-specified criteria|2
2164574|NCT01277510|3783083|FG001|Double-blind Phase|Protocol-specified criteria|6
2164575|NCT01277510|3783082|FG000|Double-blind Phase|Other|1
2164576|NCT01277510|3783083|FG001|Double-blind Phase|Other|1
2164577|NCT01277510|3783082|FG000|Open-label Phase|Administrative decision|4
2164578|NCT01277510|3783083|FG001|Open-label Phase|Administrative decision|3
2164579|NCT01277510|3783082|FG000|Open-label Phase|Protocol-specified criteria|1
2164580|NCT01277510|3783083|FG001|Open-label Phase|Protocol-specified criteria|0
2164581|NCT01277510|3783082|FG000|Open-label Phase|Never received investigational product|2
2164582|NCT01277510|3783083|FG001|Open-label Phase|Never received investigational product|0
2164583|NCT01277523|3783094|FG000|Overall Study|Adverse Event|1
2164584|NCT01277523|3783095|FG001|Overall Study|Adverse Event|0
2164585|NCT01277523|3783096|FG002|Overall Study|Adverse Event|0
2164586|NCT01277523|3783094|FG000|Overall Study|Protocol Violation|2
2164587|NCT01277523|3783095|FG001|Overall Study|Protocol Violation|0
2164588|NCT01277523|3783096|FG002|Overall Study|Protocol Violation|0
2164589|NCT01277523|3783094|FG000|Overall Study|Other Reason not Defined|0
2164590|NCT01277523|3783095|FG001|Overall Study|Other Reason not Defined|1
2164591|NCT01277523|3783096|FG002|Overall Study|Other Reason not Defined|0
2164592|NCT01277549|3783106|FG000|Overall Study|Failed to meet eligibility criteria|13
2164593|NCT01277549|3783107|FG001|Overall Study|Failed to meet eligibility criteria|9
2164594|NCT01277549|3783106|FG000|Overall Study|Withdrawal by Subject|1
2164595|NCT01277549|3783107|FG001|Overall Study|Withdrawal by Subject|3
2164596|NCT01277549|3783106|FG000|Overall Study|Protocol Violation|10
2164597|NCT01277549|3783107|FG001|Overall Study|Protocol Violation|1
2164598|NCT01277549|3783106|FG000|Overall Study|Physician Decision|2
2164599|NCT01277549|3783107|FG001|Overall Study|Physician Decision|1
2164600|NCT01277601|3783120|FG000|Overall Study|Adverse Event|5
2164601|NCT01277601|3783121|FG001|Overall Study|Adverse Event|3
2164602|NCT01277601|3783122|FG002|Overall Study|Adverse Event|0
2164603|NCT01277601|3783123|FG003|Overall Study|Adverse Event|7
2164604|NCT01277601|3783120|FG000|Overall Study|Withdrawal by Subject|18
2164605|NCT01277601|3783121|FG001|Overall Study|Withdrawal by Subject|21
2164606|NCT01277601|3783122|FG002|Overall Study|Withdrawal by Subject|8
2164607|NCT01277601|3783123|FG003|Overall Study|Withdrawal by Subject|17
2164608|NCT01277601|3783120|FG000|Overall Study|Lost to Follow-up|7
2164609|NCT01277601|3783121|FG001|Overall Study|Lost to Follow-up|9
2164610|NCT01277601|3783122|FG002|Overall Study|Lost to Follow-up|4
2164611|NCT01277601|3783123|FG003|Overall Study|Lost to Follow-up|2
2164612|NCT01277601|3783120|FG000|Overall Study|Physician Decision|3
2164613|NCT01277601|3783121|FG001|Overall Study|Physician Decision|5
2164614|NCT01277601|3783122|FG002|Overall Study|Physician Decision|1
2164615|NCT01277601|3783123|FG003|Overall Study|Physician Decision|6
2164616|NCT01277601|3783120|FG000|Overall Study|Pregnancy|2
2164617|NCT01277601|3783121|FG001|Overall Study|Pregnancy|2
2164618|NCT01277601|3783122|FG002|Overall Study|Pregnancy|4
2164619|NCT01277601|3783123|FG003|Overall Study|Pregnancy|1
2164620|NCT01277601|3783120|FG000|Overall Study|Noncompliance with Study Drug|1
2164621|NCT01277601|3783121|FG001|Overall Study|Noncompliance with Study Drug|3
2164622|NCT01277601|3783122|FG002|Overall Study|Noncompliance with Study Drug|2
2164623|NCT01277601|3783123|FG003|Overall Study|Noncompliance with Study Drug|0
2164624|NCT01277601|3783120|FG000|Overall Study|Subject Never Dosed with Study Drug|1
2164625|NCT01277601|3783121|FG001|Overall Study|Subject Never Dosed with Study Drug|2
2164626|NCT01277601|3783122|FG002|Overall Study|Subject Never Dosed with Study Drug|3
2164627|NCT01277601|3783123|FG003|Overall Study|Subject Never Dosed with Study Drug|1
2164628|NCT01277601|3783120|FG000|Overall Study|Protocol Violation|0
2164629|NCT01277601|3783121|FG001|Overall Study|Protocol Violation|2
2164630|NCT01277601|3783122|FG002|Overall Study|Protocol Violation|5
2164631|NCT01277601|3783123|FG003|Overall Study|Protocol Violation|0
2164632|NCT01277601|3783120|FG000|Overall Study|Subject Terminated from Study by Sponsor|0
2164633|NCT01277601|3783121|FG001|Overall Study|Subject Terminated from Study by Sponsor|1
2164634|NCT01277601|3783122|FG002|Overall Study|Subject Terminated from Study by Sponsor|0
2164635|NCT01277601|3783123|FG003|Overall Study|Subject Terminated from Study by Sponsor|2
2164636|NCT01277666|3783153|FG000|Overall Study|Adverse Event|26
2164637|NCT01277666|3783154|FG001|Overall Study|Adverse Event|25
2164638|NCT01277666|3783155|FG002|Overall Study|Adverse Event|20
2164639|NCT01277666|3783153|FG000|Overall Study|Lack of Efficacy|8
2164640|NCT01277666|3783154|FG001|Overall Study|Lack of Efficacy|20
2164641|NCT01277666|3783155|FG002|Overall Study|Lack of Efficacy|12
2164642|NCT01277666|3783153|FG000|Overall Study|Protocol Violation|2
2164643|NCT01277666|3783154|FG001|Overall Study|Protocol Violation|3
2164644|NCT01277666|3783155|FG002|Overall Study|Protocol Violation|2
2164645|NCT01277666|3783153|FG000|Overall Study|Protocol Defined Stopping criteria|1
2164646|NCT01277666|3783154|FG001|Overall Study|Protocol Defined Stopping criteria|2
2164647|NCT01277666|3783155|FG002|Overall Study|Protocol Defined Stopping criteria|6
2164648|NCT01277666|3783153|FG000|Overall Study|Lost to Follow-up|1
2164649|NCT01277666|3783154|FG001|Overall Study|Lost to Follow-up|1
2164650|NCT01277666|3783155|FG002|Overall Study|Lost to Follow-up|2
2164651|NCT01277666|3783153|FG000|Overall Study|Withdrawal by Subject|7
2164652|NCT01277666|3783154|FG001|Overall Study|Withdrawal by Subject|8
2164653|NCT01277666|3783155|FG002|Overall Study|Withdrawal by Subject|6
2164654|NCT01277666|3783153|FG000|Overall Study|Death|0
2164655|NCT01277666|3783154|FG001|Overall Study|Death|0
2164656|NCT01277666|3783155|FG002|Overall Study|Death|1
2164657|NCT01277718|3783163|FG000|Period 2 - Second Intervention|Protocol Violation|0
2164658|NCT01277718|3783164|FG001|Period 2 - Second Intervention|Protocol Violation|1
2164659|NCT01277718|3783163|FG000|Period 2 - Second Intervention|Physician Decision|0
2164660|NCT01277718|3783164|FG001|Period 2 - Second Intervention|Physician Decision|2
2164661|NCT01277744|3783172|FG000|Overall Study|Physician Decision|2
2164662|NCT01277757|3783176|FG000|Overall Study|Disease Progression|1
2164663|NCT01277757|3783176|FG000|Overall Study|Withdrawal by Subject|1
2164664|NCT01277861|3783187|FG000|Overall Study|Physician Decision|2
2164665|NCT01277861|3783188|FG001|Overall Study|Physician Decision|2
2164666|NCT01277887|3783198|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1
2164667|NCT01277887|3783199|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0
2164668|NCT01277887|3783198|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2
2164669|NCT01277887|3783199|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0
2164670|NCT01277887|3783198|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3
2164671|NCT01277887|3783199|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5
2164672|NCT01278030|3783207|FG000|Overall Study|Withdrawal by Subject|8
2164673|NCT01278030|3783208|FG001|Overall Study|Withdrawal by Subject|4
2164674|NCT01278160|3783216|FG000|Overall Study|Adverse Event|1
2164675|NCT01278160|3783217|FG001|Overall Study|Adverse Event|1
2164676|NCT01278160|3783216|FG000|Overall Study|Lost to Follow-up|0
2164677|NCT01278160|3783217|FG001|Overall Study|Lost to Follow-up|1
2164678|NCT01278160|3783216|FG000|Overall Study|Withdrawal by Subject|3
2164679|NCT01278160|3783217|FG001|Overall Study|Withdrawal by Subject|2
2164680|NCT01278160|3783216|FG000|Overall Study|Unclassified|1
2164681|NCT01278160|3783217|FG001|Overall Study|Unclassified|2
2164682|NCT01278173|3783223|FG000|Overall Study|Lack of Efficacy|13
2164683|NCT01278173|3783223|FG000|Overall Study|Adverse Event|8
2164684|NCT01278173|3783223|FG000|Overall Study|Administrative or other reason|4
2164685|NCT01278173|3783223|FG000|Overall Study|Protocol Violation|1
2164686|NCT01278173|3783223|FG000|Overall Study|Withdrawal by Subject|1
2164687|NCT01278342|3783234|FG000|Overall Study|Physician Decision|0
2164688|NCT01278342|3783235|FG001|Overall Study|Physician Decision|1
2164689|NCT01278342|3783236|FG002|Overall Study|Physician Decision|0
2164690|NCT01278342|3783234|FG000|Overall Study|Lost to Follow-up|1
2164691|NCT01278342|3783235|FG001|Overall Study|Lost to Follow-up|0
2164692|NCT01278342|3783236|FG002|Overall Study|Lost to Follow-up|0
2164693|NCT01278342|3783234|FG000|Overall Study|Administrative problems|2
2164694|NCT01278342|3783235|FG001|Overall Study|Administrative problems|0
2164695|NCT01278342|3783236|FG002|Overall Study|Administrative problems|0
2164696|NCT01278342|3783234|FG000|Overall Study|Other|1
2164697|NCT01278342|3783235|FG001|Overall Study|Other|0
2164698|NCT01278342|3783236|FG002|Overall Study|Other|0
2164699|NCT01278394|3783244|FG000|Overall Study|Lost to Follow-up|1
2164700|NCT01278407|3783251|FG000|Confirmatory Phase|Adverse Event|5
2164701|NCT01278407|3783252|FG001|Confirmatory Phase|Adverse Event|10
2164702|NCT01278407|3783253|FG002|Confirmatory Phase|Adverse Event|1
2164703|NCT01278407|3783254|FG003|Confirmatory Phase|Adverse Event|0
2164704|NCT01278407|3783255|FG004|Confirmatory Phase|Adverse Event|0
2164705|NCT01278407|3783251|FG000|Confirmatory Phase|Participant's Choice|3
2164706|NCT01278407|3783252|FG001|Confirmatory Phase|Participant's Choice|5
2164707|NCT01278407|3783253|FG002|Confirmatory Phase|Participant's Choice|3
2164708|NCT01278407|3783254|FG003|Confirmatory Phase|Participant's Choice|0
2164709|NCT01278407|3783255|FG004|Confirmatory Phase|Participant's Choice|0
2164710|NCT01278407|3783251|FG000|Confirmatory Phase|Other|1
2164711|NCT01278407|3783252|FG001|Confirmatory Phase|Other|1
2164712|NCT01278407|3783253|FG002|Confirmatory Phase|Other|2
2164713|NCT01278407|3783254|FG003|Confirmatory Phase|Other|0
2164714|NCT01278407|3783255|FG004|Confirmatory Phase|Other|0
2164715|NCT01278407|3783251|FG000|Extension Phase|Adverse Event|0
2164716|NCT01278407|3783252|FG001|Extension Phase|Adverse Event|0
2164717|NCT01278407|3783253|FG002|Extension Phase|Adverse Event|0
2164718|NCT01278407|3783254|FG003|Extension Phase|Adverse Event|7
2164719|NCT01278407|3783255|FG004|Extension Phase|Adverse Event|16
2164720|NCT01278407|3783251|FG000|Extension Phase|Participant's Choice|0
2164721|NCT01278407|3783252|FG001|Extension Phase|Participant's Choice|0
2164722|NCT01278407|3783253|FG002|Extension Phase|Participant's Choice|0
2164723|NCT01278407|3783254|FG003|Extension Phase|Participant's Choice|4
2164724|NCT01278407|3783255|FG004|Extension Phase|Participant's Choice|11
2164725|NCT01278407|3783251|FG000|Extension Phase|Other|0
2164726|NCT01278407|3783252|FG001|Extension Phase|Other|0
2164727|NCT01278407|3783253|FG002|Extension Phase|Other|0
2164728|NCT01278407|3783254|FG003|Extension Phase|Other|1
2164729|NCT01278407|3783255|FG004|Extension Phase|Other|3
2164730|NCT01278615|3783269|FG000|Overall Study|Withdrawal by Subject|2
2164731|NCT01278745|3783275|FG000|Overall Study|Death|2
2164732|NCT01278745|3783276|FG001|Overall Study|Death|5
2164733|NCT01278745|3783277|FG002|Overall Study|Death|7
2164734|NCT01278745|3783278|FG003|Overall Study|Death|0
2164735|NCT01278745|3783275|FG000|Overall Study|Physician Decision|1
2164736|NCT01278745|3783276|FG001|Overall Study|Physician Decision|0
2164737|NCT01278745|3783277|FG002|Overall Study|Physician Decision|0
2164738|NCT01278745|3783278|FG003|Overall Study|Physician Decision|9
2164739|NCT01278745|3783275|FG000|Overall Study|Withdrawal by Subject|1
2164740|NCT01278745|3783276|FG001|Overall Study|Withdrawal by Subject|1
2164741|NCT01278745|3783277|FG002|Overall Study|Withdrawal by Subject|5
2164742|NCT01278745|3783278|FG003|Overall Study|Withdrawal by Subject|1
2164743|NCT01278745|3783275|FG000|Overall Study|Sponsor Decision|1
2164744|NCT01278745|3783276|FG001|Overall Study|Sponsor Decision|0
2164745|NCT01278745|3783277|FG002|Overall Study|Sponsor Decision|62
2164746|NCT01278745|3783278|FG003|Overall Study|Sponsor Decision|6
2164747|NCT01278745|3783275|FG000|Overall Study|Ineligible|0
2164748|NCT01278745|3783276|FG001|Overall Study|Ineligible|0
2164749|NCT01278745|3783277|FG002|Overall Study|Ineligible|42
2164750|NCT01278745|3783278|FG003|Overall Study|Ineligible|61
2164751|NCT01278745|3783275|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0
2164752|NCT01278745|3783276|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0
2164753|NCT01278745|3783277|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5
2164754|NCT01278745|3783278|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1
2164755|NCT01278797|3783286|FG000|Period 1|Adverse Event|0
2164756|NCT01278797|3783287|FG001|Period 1|Adverse Event|1
2164757|NCT01278797|3783286|FG000|Period 1|Protocol Violation|1
2164758|NCT01278797|3783287|FG001|Period 1|Protocol Violation|0
2164759|NCT01278862|3783295|FG000|Overall Study|Lost to Follow-up|1
2164760|NCT01278862|3783296|FG001|Overall Study|Lost to Follow-up|1
2164761|NCT01279044|3783332|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
2164762|NCT01279044|3783333|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
2164763|NCT01279044|3783334|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
2164764|NCT01279044|3783332|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
2164765|NCT01279044|3783333|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
2164766|NCT01279044|3783334|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
2164767|NCT01279044|3783332|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0
2164768|NCT01279044|3783333|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0
2164769|NCT01279044|3783334|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1
2164770|NCT01279057|3783343|FG000|Overall Study|Adverse Event|1
2164771|NCT01279057|3783344|FG001|Overall Study|Adverse Event|0
2164772|NCT01279057|3783345|FG002|Overall Study|Adverse Event|1
2164773|NCT01279057|3783343|FG000|Overall Study|Insufficient therapeutic response|0
2164774|NCT01279057|3783344|FG001|Overall Study|Insufficient therapeutic response|0
2164775|NCT01279057|3783345|FG002|Overall Study|Insufficient therapeutic response|1
2164776|NCT01279057|3783343|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
2164777|NCT01279057|3783344|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1
2164778|NCT01279057|3783345|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0
2164779|NCT01279057|3783343|FG000|Overall Study|Withdrew consent|2
2164780|NCT01279057|3783344|FG001|Overall Study|Withdrew consent|0
2164781|NCT01279057|3783345|FG002|Overall Study|Withdrew consent|1
2164782|NCT01279057|3783343|FG000|Overall Study|Pregnancy|0
2164783|NCT01279057|3783344|FG001|Overall Study|Pregnancy|1
2164784|NCT01279057|3783345|FG002|Overall Study|Pregnancy|0
2164785|NCT01279057|3783343|FG000|Overall Study|Other|3
2164786|NCT01279057|3783344|FG001|Overall Study|Other|3
2164787|NCT01279057|3783345|FG002|Overall Study|Other|0
2164788|NCT01279070|3783355|FG000|Overall Study|Withdrawal by Subject|2
2164789|NCT01279070|3783356|FG001|Overall Study|Withdrawal by Subject|3
2164790|NCT01279070|3783355|FG000|Overall Study|Acute exacerbation|3
2164791|NCT01279070|3783356|FG001|Overall Study|Acute exacerbation|1
2164792|NCT01279200|3783386|FG000|Overall Study|Withdrawal by Subject|1
2164793|NCT01279200|3783387|FG001|Overall Study|Withdrawal by Subject|3
2164794|NCT01279200|3783386|FG000|Overall Study|Patient withdrawal due to high cost|0
2164795|NCT01279200|3783387|FG001|Overall Study|Patient withdrawal due to high cost|1
2164796|NCT01279200|3783386|FG000|Overall Study|Inconvenience of ultrasound visit|0
2164797|NCT01279200|3783387|FG001|Overall Study|Inconvenience of ultrasound visit|1
2164798|NCT01279200|3783386|FG000|Overall Study|ultrasound screening failure|0
2164799|NCT01279200|3783387|FG001|Overall Study|ultrasound screening failure|1
2164800|NCT01279200|3783386|FG000|Overall Study|Lost to Follow-up|0
2164801|NCT01279200|3783387|FG001|Overall Study|Lost to Follow-up|1
2164802|NCT01279200|3783386|FG000|Overall Study|Adverse Event|1
2164803|NCT01279200|3783387|FG001|Overall Study|Adverse Event|0
2164804|NCT01279343|3783412|FG000|Overall Study|Did not receive treatment|2
2164805|NCT01279343|3783413|FG001|Overall Study|Did not receive treatment|6
2164806|NCT01279447|3783421|FG000|Overall Study|Lost to Follow-up|3
2164807|NCT01279447|3783422|FG001|Overall Study|Lost to Follow-up|1
2164808|NCT01279486|3783428|FG000|Overall Study|Lost to Follow-up|1
2164809|NCT01279681|3783443|FG000|Overall Study|Disease Progression|9
2164810|NCT01279681|3783444|FG001|Overall Study|Disease Progression|6
2164811|NCT01279681|3783443|FG000|Overall Study|Withdrawal by Subject|3
2164812|NCT01279681|3783444|FG001|Overall Study|Withdrawal by Subject|4
2164813|NCT01279681|3783443|FG000|Overall Study|Adverse Event|2
2164814|NCT01279681|3783444|FG001|Overall Study|Adverse Event|3
2164815|NCT01279681|3783443|FG000|Overall Study|Death|0
2164816|NCT01279681|3783444|FG001|Overall Study|Death|1
2164817|NCT01279681|3783443|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0
2164818|NCT01279681|3783444|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1
2164819|NCT01279681|3783443|FG000|Overall Study|Physician Decision|1
2164820|NCT01279681|3783444|FG001|Overall Study|Physician Decision|0
2164821|NCT01279681|3783443|FG000|Overall Study|Other Reason|0
2164822|NCT01279681|3783444|FG001|Overall Study|Other Reason|2
2164823|NCT01279850|3783450|FG000|Overall Study|Protocol Violation|50
2164824|NCT01279850|3783450|FG000|Overall Study|No Drug Administration Information|7
2164825|NCT01279850|3783450|FG000|Overall Study|No Visit After Treatment|34
2164826|NCT01279954|3783456|FG000|Overall Study|Lack of Efficacy|3
2164827|NCT01279954|3783457|FG001|Overall Study|Lack of Efficacy|4
2164828|NCT01280266|3783507|FG000|First Intervention (Week 1-4)|Adverse Event|1
2164829|NCT01280266|3783508|FG001|First Intervention (Week 1-4)|Adverse Event|0
2164830|NCT01280266|3783507|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0
2164831|NCT01280266|3783508|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2
2164832|NCT01280357|3783518|FG000|Overall Study|Excluded no internal monitoring|14
2164833|NCT01280357|3783518|FG000|Overall Study|IInsufficient data/No data supplied|12
2164834|NCT01280591|3783550|FG000|Overall Study|Withdrawal by Subject|0
2164835|NCT01280591|3783551|FG001|Overall Study|Withdrawal by Subject|0
2164836|NCT01280591|3783552|FG002|Overall Study|Withdrawal by Subject|0
2164837|NCT01280591|3783553|FG003|Overall Study|Withdrawal by Subject|2
2164838|NCT01280591|3783550|FG000|Overall Study|Does not meet exclusion #27 criteria|0
2164839|NCT01280591|3783551|FG001|Overall Study|Does not meet exclusion #27 criteria|0
2164840|NCT01280591|3783552|FG002|Overall Study|Does not meet exclusion #27 criteria|0
2164841|NCT01280591|3783553|FG003|Overall Study|Does not meet exclusion #27 criteria|1
2164842|NCT01280617|3783574|FG000|Overall Study|Adverse Event|0
2164843|NCT01280617|3783575|FG001|Overall Study|Adverse Event|1
2164844|NCT01280656|3783584|FG000|Overall Study|Adverse Event|1
2164845|NCT01280656|3783585|FG001|Overall Study|Adverse Event|14
2164846|NCT01280656|3783586|FG002|Overall Study|Adverse Event|13
2164847|NCT01280656|3783584|FG000|Overall Study|Lack of Efficacy|1
2164848|NCT01280656|3783585|FG001|Overall Study|Lack of Efficacy|22
2294998|NCT02543346|3990110|FG001|Second Priming Visit|Withdrawal by Subject|2
2294999|NCT02543346|3990111|FG002|Second Priming Visit|Withdrawal by Subject|2
2295000|NCT02543346|3990112|FG003|Second Priming Visit|Withdrawal by Subject|2
2295001|NCT02543346|3990109|FG000|Second Priming Visit|Adverse Event|1
2295002|NCT02543346|3990110|FG001|Second Priming Visit|Adverse Event|0
2295003|NCT02543346|3990111|FG002|Second Priming Visit|Adverse Event|0
2295004|NCT02543346|3990112|FG003|Second Priming Visit|Adverse Event|0
2164849|NCT01280656|3783586|FG002|Overall Study|Lack of Efficacy|38
2164850|NCT01280656|3783584|FG000|Overall Study|Treatment shortening (RGT)|0
2164851|NCT01280656|3783585|FG001|Overall Study|Treatment shortening (RGT)|4
2164852|NCT01280656|3783586|FG002|Overall Study|Treatment shortening (RGT)|5
2164853|NCT01280656|3783584|FG000|Overall Study|Other|1
2164854|NCT01280656|3783585|FG001|Overall Study|Other|7
2164855|NCT01280656|3783586|FG002|Overall Study|Other|7
2164856|NCT01280721|3783615|FG000|Overall Study|Adverse Event|4
2164857|NCT01280721|3783615|FG000|Overall Study|Physician Decision|3
2164858|NCT01280721|3783615|FG000|Overall Study|Withdrawal by Subject|6
2164859|NCT01280721|3783615|FG000|Overall Study|eGFR under the withdrawal criteria|7
2164860|NCT01280721|3783615|FG000|Overall Study|No tolerability for the lowest dose|2
2164861|NCT01280812|3783633|FG000|Overall Study|Withdrawal by Subject|2
2164862|NCT01280812|3783634|FG001|Overall Study|Withdrawal by Subject|1
2164863|NCT01280812|3783635|FG002|Overall Study|Withdrawal by Subject|0
2164864|NCT01280812|3783633|FG000|Overall Study|Lost to Follow-up|1
2164865|NCT01280812|3783634|FG001|Overall Study|Lost to Follow-up|1
2164866|NCT01280812|3783635|FG002|Overall Study|Lost to Follow-up|1
2164867|NCT01280903|3783646|FG000|Overall Study|Lost to Follow-up|23
2164868|NCT01280903|3783647|FG001|Overall Study|Lost to Follow-up|16
2164869|NCT01280955|3783662|FG000|Overall Study|Death|2
2164870|NCT01280955|3783662|FG000|Overall Study|Withdrawal by Subject|1
2164871|NCT01280968|3783670|FG000|Overall Study|Lost to Follow-up|8
2164872|NCT01280968|3783671|FG001|Overall Study|Lost to Follow-up|2
2164873|NCT01280968|3783670|FG000|Overall Study|Unable to Follow Experimental Protocol|2
2164874|NCT01280968|3783671|FG001|Overall Study|Unable to Follow Experimental Protocol|0
2164875|NCT01280968|3783670|FG000|Overall Study|Commuting Problems|2
2164876|NCT01280968|3783671|FG001|Overall Study|Commuting Problems|0
2164877|NCT01280968|3783670|FG000|Overall Study|Anxiety|2
2164878|NCT01280968|3783671|FG001|Overall Study|Anxiety|0
2164879|NCT01280968|3783670|FG000|Overall Study|Adverse Event|1
2164880|NCT01280968|3783671|FG001|Overall Study|Adverse Event|0
2164881|NCT01280968|3783670|FG000|Overall Study|Scheduling Conflicts|1
2164882|NCT01280968|3783671|FG001|Overall Study|Scheduling Conflicts|1
2164883|NCT01280968|3783670|FG000|Overall Study|Pre-existing Neurological Condition|1
2164884|NCT01280968|3783671|FG001|Overall Study|Pre-existing Neurological Condition|0
2164885|NCT01280968|3783670|FG000|Overall Study|Unable to Smoke in Supine Position|1
2164886|NCT01280968|3783671|FG001|Overall Study|Unable to Smoke in Supine Position|0
2164887|NCT01280981|3783678|FG000|Overall Study|Withdrawal by Subject|11
2164888|NCT01280981|3783678|FG000|Overall Study|Protocol Violation|2
2164889|NCT01280981|3783678|FG000|Overall Study|Lack of Efficacy|13
2164890|NCT01280981|3783678|FG000|Overall Study|Lost to Follow-up|3
2164891|NCT01280981|3783678|FG000|Overall Study|Adverse Event|6
2164892|NCT01280981|3783678|FG000|Overall Study|Irregular or discontinued menses|3
2164893|NCT01280981|3783678|FG000|Overall Study|Failed to return|45
2164894|NCT01280981|3783678|FG000|Overall Study|Non-compliance with protocol|3
2164895|NCT01280981|3783678|FG000|Overall Study|Withdrawal of consent|3
2164896|NCT01280981|3783678|FG000|Overall Study|Elective surgery|2
2164897|NCT01280981|3783678|FG000|Overall Study|Study site closure|1
2164898|NCT01281137|3783693|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0
2164899|NCT01281137|3783694|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1
2164900|NCT01281137|3783693|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4
2164901|NCT01281137|3783694|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9
2164902|NCT01281137|3783693|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0
2164903|NCT01281137|3783694|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5
2164904|NCT01281137|3783693|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1
2164905|NCT01281137|3783694|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0
2164906|NCT01281137|3783693|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1
2164907|NCT01281137|3783694|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2
2179606|NCT01394939|3805248|FG001|Overall Study|Withdrawal by Subject|2
2179607|NCT01394939|3805249|FG002|Overall Study|Withdrawal by Subject|0
2179608|NCT01394939|3805250|FG003|Overall Study|Withdrawal by Subject|2
2179609|NCT01394939|3805247|FG000|Overall Study|Others|0
2179610|NCT01394939|3805248|FG001|Overall Study|Others|2
2295005|NCT02543528|3990135|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0
2295006|NCT02543528|3990136|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0
2295007|NCT02543528|3990137|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0
2295008|NCT02543528|3990138|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0
2295009|NCT02543528|3990139|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2
2295010|NCT02543528|3990135|FG000|Adaptation Period|Lens Handling Difficultes|0
2295011|NCT02543528|3990136|FG001|Adaptation Period|Lens Handling Difficultes|0
2295012|NCT02543528|3990137|FG002|Adaptation Period|Lens Handling Difficultes|0
2295013|NCT02543528|3990138|FG003|Adaptation Period|Lens Handling Difficultes|0
2295014|NCT02543528|3990139|FG004|Adaptation Period|Lens Handling Difficultes|8
2295015|NCT02543528|3990135|FG000|Adaptation Period|Lost to Follow-up|0
2295016|NCT02543528|3990136|FG001|Adaptation Period|Lost to Follow-up|0
2295017|NCT02543528|3990137|FG002|Adaptation Period|Lost to Follow-up|0
2295018|NCT02543528|3990138|FG003|Adaptation Period|Lost to Follow-up|0
2295019|NCT02543528|3990139|FG004|Adaptation Period|Lost to Follow-up|14
2295020|NCT02543528|3990135|FG000|Adaptation Period|Adverse Event|0
2295021|NCT02543528|3990136|FG001|Adaptation Period|Adverse Event|0
2295022|NCT02543528|3990137|FG002|Adaptation Period|Adverse Event|0
2295023|NCT02543528|3990138|FG003|Adaptation Period|Adverse Event|0
2295024|NCT02543528|3990139|FG004|Adaptation Period|Adverse Event|2
2295025|NCT02543528|3990135|FG000|Extended Wear Period|Adverse Event|17
2295026|NCT02543528|3990136|FG001|Extended Wear Period|Adverse Event|11
2295027|NCT02543528|3990137|FG002|Extended Wear Period|Adverse Event|16
2295028|NCT02543528|3990138|FG003|Extended Wear Period|Adverse Event|3
2295029|NCT02543528|3990139|FG004|Extended Wear Period|Adverse Event|0
2295030|NCT02543528|3990135|FG000|Extended Wear Period|Missed too many scheduled visits|0
2295031|NCT02543528|3990136|FG001|Extended Wear Period|Missed too many scheduled visits|0
2295032|NCT02543528|3990137|FG002|Extended Wear Period|Missed too many scheduled visits|1
2179611|NCT01394939|3805249|FG002|Overall Study|Others|0
2179612|NCT01394939|3805250|FG003|Overall Study|Others|3
2179613|NCT01394952|3805262|FG000|Overall Study|Lost to Follow-up|0
2179614|NCT01394952|3805263|FG001|Overall Study|Lost to Follow-up|5
2179615|NCT01394952|3805262|FG000|Overall Study|Withdrawal by Subject|10
2179616|NCT01394952|3805263|FG001|Overall Study|Withdrawal by Subject|5
2179617|NCT01394952|3805262|FG000|Overall Study|Physician Decision|2
2179618|NCT01394952|3805263|FG001|Overall Study|Physician Decision|0
2179619|NCT01394952|3805262|FG000|Overall Study|Sponsor Decision|5
2179620|NCT01394952|3805263|FG001|Overall Study|Sponsor Decision|7
2179621|NCT01394978|3805272|FG000|Overall Study|Withdrawal by Subject|2
2179622|NCT01394978|3805273|FG001|Overall Study|Withdrawal by Subject|4
2179623|NCT01394978|3805272|FG000|Overall Study|Lost to Follow-up|13
2179624|NCT01394978|3805273|FG001|Overall Study|Lost to Follow-up|20
2179625|NCT01394978|3805272|FG000|Overall Study|Death|6
2179626|NCT01394978|3805273|FG001|Overall Study|Death|7
2179627|NCT01394991|3805282|FG000|Overall Study|Adverse Event|0
2179628|NCT01394991|3805283|FG001|Overall Study|Adverse Event|4
2179629|NCT01394991|3805282|FG000|Overall Study|Lack of Efficacy|5
2179630|NCT01394991|3805283|FG001|Overall Study|Lack of Efficacy|7
2179631|NCT01394991|3805282|FG000|Overall Study|Lost to Follow-up|6
2179632|NCT01394991|3805283|FG001|Overall Study|Lost to Follow-up|8
2179633|NCT01394991|3805282|FG000|Overall Study|Physician Decision|1
2179634|NCT01394991|3805283|FG001|Overall Study|Physician Decision|3
2295033|NCT02543528|3990138|FG003|Extended Wear Period|Missed too many scheduled visits|3
2295034|NCT02543528|3990139|FG004|Extended Wear Period|Missed too many scheduled visits|0
2164908|NCT01281189|3783720|FG000|Overall Study|Adverse Event|7
2164909|NCT01281189|3783721|FG001|Overall Study|Adverse Event|9
2164910|NCT01281189|3783720|FG000|Overall Study|Lost to Follow-up|6
2164911|NCT01281189|3783721|FG001|Overall Study|Lost to Follow-up|4
2164912|NCT01281189|3783720|FG000|Overall Study|Withdrawal by Subject|21
2164913|NCT01281189|3783721|FG001|Overall Study|Withdrawal by Subject|24
2164914|NCT01281189|3783720|FG000|Overall Study|Physician Decision|2
2164915|NCT01281189|3783721|FG001|Overall Study|Physician Decision|3
2164916|NCT01281189|3783720|FG000|Overall Study|Death|103
2164917|NCT01281189|3783721|FG001|Overall Study|Death|91
2164918|NCT01281189|3783720|FG000|Overall Study|Other|8
2164919|NCT01281189|3783721|FG001|Overall Study|Other|12
2164920|NCT01281202|3783729|FG000|Overall Study|Adverse Event|2
2164921|NCT01281202|3783730|FG001|Overall Study|Adverse Event|0
2164922|NCT01281202|3783729|FG000|Overall Study|Withdrawal by Subject|2
2164923|NCT01281202|3783730|FG001|Overall Study|Withdrawal by Subject|2
2164924|NCT01281202|3783729|FG000|Overall Study|Protocol Violation|11
2164925|NCT01281202|3783730|FG001|Overall Study|Protocol Violation|10
2164926|NCT01281202|3783729|FG000|Overall Study|Administrative|2
2164927|NCT01281202|3783730|FG001|Overall Study|Administrative|8
2164928|NCT01281202|3783729|FG000|Overall Study|Lost to Follow-up|11
2164929|NCT01281202|3783730|FG001|Overall Study|Lost to Follow-up|13
2164930|NCT01281202|3783729|FG000|Overall Study|Incarceration|0
2164931|NCT01281202|3783730|FG001|Overall Study|Incarceration|3
2164932|NCT01281306|3783745|FG000|Overall Study|Lack of Efficacy|0
2164933|NCT01281306|3783746|FG001|Overall Study|Lack of Efficacy|1
2164934|NCT01281306|3783747|FG002|Overall Study|Lack of Efficacy|3
2164935|NCT01281306|3783748|FG003|Overall Study|Lack of Efficacy|0
2164936|NCT01281306|3783749|FG004|Overall Study|Lack of Efficacy|2
2164937|NCT01281306|3783750|FG005|Overall Study|Lack of Efficacy|0
2164938|NCT01281306|3783751|FG006|Overall Study|Lack of Efficacy|1
2164939|NCT01281306|3783745|FG000|Overall Study|Withdrawal by Subject|1
2164940|NCT01281306|3783746|FG001|Overall Study|Withdrawal by Subject|0
2164941|NCT01281306|3783747|FG002|Overall Study|Withdrawal by Subject|2
2164942|NCT01281306|3783748|FG003|Overall Study|Withdrawal by Subject|4
2164943|NCT01281306|3783749|FG004|Overall Study|Withdrawal by Subject|1
2164944|NCT01281306|3783750|FG005|Overall Study|Withdrawal by Subject|3
2164945|NCT01281306|3783751|FG006|Overall Study|Withdrawal by Subject|1
2164946|NCT01281306|3783745|FG000|Overall Study|Protocol deviation|0
2164947|NCT01281306|3783746|FG001|Overall Study|Protocol deviation|1
2164948|NCT01281306|3783747|FG002|Overall Study|Protocol deviation|1
2164949|NCT01281306|3783748|FG003|Overall Study|Protocol deviation|1
2164950|NCT01281306|3783749|FG004|Overall Study|Protocol deviation|1
2164951|NCT01281306|3783750|FG005|Overall Study|Protocol deviation|0
2164952|NCT01281306|3783751|FG006|Overall Study|Protocol deviation|0
2164953|NCT01281306|3783745|FG000|Overall Study|Condition no longer requires study drug|1
2164954|NCT01281306|3783746|FG001|Overall Study|Condition no longer requires study drug|0
2164955|NCT01281306|3783747|FG002|Overall Study|Condition no longer requires study drug|0
2164956|NCT01281306|3783748|FG003|Overall Study|Condition no longer requires study drug|0
2164957|NCT01281306|3783749|FG004|Overall Study|Condition no longer requires study drug|0
2164958|NCT01281306|3783750|FG005|Overall Study|Condition no longer requires study drug|1
2164959|NCT01281306|3783751|FG006|Overall Study|Condition no longer requires study drug|1
2164960|NCT01281306|3783745|FG000|Overall Study|Lost to Follow-up|1
2164961|NCT01281306|3783746|FG001|Overall Study|Lost to Follow-up|0
2164962|NCT01281306|3783747|FG002|Overall Study|Lost to Follow-up|0
2164963|NCT01281306|3783748|FG003|Overall Study|Lost to Follow-up|2
2164964|NCT01281306|3783749|FG004|Overall Study|Lost to Follow-up|0
2164965|NCT01281306|3783750|FG005|Overall Study|Lost to Follow-up|0
2164966|NCT01281306|3783751|FG006|Overall Study|Lost to Follow-up|1
2164967|NCT01281306|3783745|FG000|Overall Study|Death|1
2164968|NCT01281306|3783746|FG001|Overall Study|Death|0
2164969|NCT01281306|3783747|FG002|Overall Study|Death|0
2164970|NCT01281306|3783748|FG003|Overall Study|Death|0
2164971|NCT01281306|3783749|FG004|Overall Study|Death|0
2164972|NCT01281306|3783750|FG005|Overall Study|Death|0
2164973|NCT01281306|3783751|FG006|Overall Study|Death|0
2164974|NCT01281306|3783745|FG000|Overall Study|Adverse Event|3
2164975|NCT01281306|3783746|FG001|Overall Study|Adverse Event|2
2164976|NCT01281306|3783747|FG002|Overall Study|Adverse Event|2
2164977|NCT01281306|3783748|FG003|Overall Study|Adverse Event|3
2164978|NCT01281306|3783749|FG004|Overall Study|Adverse Event|5
2295035|NCT02543528|3990135|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1
2295036|NCT02543528|3990136|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0
2295037|NCT02543528|3990137|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0
2295038|NCT02543528|3990138|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0
2295039|NCT02543528|3990139|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0
2295040|NCT02543528|3990135|FG000|Extended Wear Period|Lost to Follow-up|0
2164979|NCT01281306|3783750|FG005|Overall Study|Adverse Event|3
2164980|NCT01281306|3783751|FG006|Overall Study|Adverse Event|3
2164981|NCT01281306|3783745|FG000|Overall Study|Randomized in error|1
2164982|NCT01281306|3783746|FG001|Overall Study|Randomized in error|0
2164983|NCT01281306|3783747|FG002|Overall Study|Randomized in error|0
2164984|NCT01281306|3783748|FG003|Overall Study|Randomized in error|1
2164985|NCT01281306|3783749|FG004|Overall Study|Randomized in error|0
2164986|NCT01281306|3783750|FG005|Overall Study|Randomized in error|0
2164987|NCT01281306|3783751|FG006|Overall Study|Randomized in error|0
2164988|NCT01281839|3783789|FG000|Overall Study|Lost to Follow-up|6
2164989|NCT01281839|3783790|FG001|Overall Study|Lost to Follow-up|3
2164990|NCT01281839|3783789|FG000|Overall Study|Withdrawal by Subject|4
2164991|NCT01281839|3783790|FG001|Overall Study|Withdrawal by Subject|10
2164992|NCT01281839|3783789|FG000|Overall Study|Reason not specified|0
2164993|NCT01281839|3783790|FG001|Overall Study|Reason not specified|1
2164994|NCT01281865|3783798|FG000|Overall Study|Adverse Event|1
2164995|NCT01281865|3783799|FG001|Overall Study|Adverse Event|1
2164996|NCT01281865|3783798|FG000|Overall Study|Withdrawal by Subject|1
2164997|NCT01281865|3783799|FG001|Overall Study|Withdrawal by Subject|0
2164998|NCT01281865|3783798|FG000|Overall Study|Lack of Efficacy|1
2164999|NCT01281865|3783799|FG001|Overall Study|Lack of Efficacy|0
2165000|NCT01281917|3783805|FG000|Overall Study|Withdrawal by Subject|1
2165001|NCT01281956|3783809|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1
2165002|NCT01281956|3783810|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0
2165003|NCT01281969|3783821|FG000|Overall Study|not randomized didn't meet criteria|0
2165004|NCT01281969|3783822|FG001|Overall Study|not randomized didn't meet criteria|0
2165005|NCT01281969|3783823|FG002|Overall Study|not randomized didn't meet criteria|7
2165006|NCT01281969|3783821|FG000|Overall Study|AE during LP prior to IVIG admin|1
2295041|NCT02543528|3990136|FG001|Extended Wear Period|Lost to Follow-up|1
2295042|NCT02543528|3990137|FG002|Extended Wear Period|Lost to Follow-up|2
2295043|NCT02543528|3990138|FG003|Extended Wear Period|Lost to Follow-up|1
2295044|NCT02543528|3990139|FG004|Extended Wear Period|Lost to Follow-up|0
2295045|NCT02543528|3990135|FG000|Extended Wear Period|Withdrawal by Subject|10
2295046|NCT02543528|3990136|FG001|Extended Wear Period|Withdrawal by Subject|9
2295047|NCT02543528|3990137|FG002|Extended Wear Period|Withdrawal by Subject|4
2295048|NCT02543528|3990138|FG003|Extended Wear Period|Withdrawal by Subject|5
2295049|NCT02543528|3990139|FG004|Extended Wear Period|Withdrawal by Subject|0
2295050|NCT02543658|3990164|FG000|Overall Study|Lack of Efficacy|0
2295051|NCT02543658|3990165|FG001|Overall Study|Lack of Efficacy|4
2295052|NCT02543801|3990187|FG000|Overall Study|Protocol Violation|1
2295053|NCT02543801|3990188|FG001|Overall Study|Protocol Violation|2
2295054|NCT02543801|3990189|FG002|Overall Study|Protocol Violation|0
2295055|NCT02543801|3990190|FG003|Overall Study|Protocol Violation|0
2295056|NCT02543892|3990218|FG000|Received Vaccination 2|Withdrawal by Subject|1
2295057|NCT02543892|3990219|FG001|Received Vaccination 2|Withdrawal by Subject|0
2295058|NCT02543892|3990220|FG002|Received Vaccination 2|Withdrawal by Subject|0
2165007|NCT01281969|3783822|FG001|Overall Study|AE during LP prior to IVIG admin|0
2165008|NCT01281969|3783823|FG002|Overall Study|AE during LP prior to IVIG admin|3
2165009|NCT01281969|3783821|FG000|Overall Study|not randomized, child consent not given|0
2165010|NCT01281969|3783822|FG001|Overall Study|not randomized, child consent not given|0
2165011|NCT01281969|3783823|FG002|Overall Study|not randomized, child consent not given|2
2165012|NCT01282164|3783847|FG000|Overall Study|Lack of hypoglycemia during ITT|1
2165013|NCT01282164|3783848|FG001|Overall Study|Lack of hypoglycemia during ITT|0
2165014|NCT01282203|3783862|FG000|Overall Study|Adverse Event|1
2165015|NCT01282229|3783869|FG000|Overall Study|Protocol Violation|2
2165016|NCT01282294|3783896|FG000|Overall Study|Lost to Follow-up|14
2165017|NCT01282294|3783896|FG000|Overall Study|Screening failure|1
2165018|NCT01282294|3783896|FG000|Overall Study|Adverse Event|1
2165019|NCT01282294|3783896|FG000|Overall Study|Patient non-compliance|2
2165020|NCT01282294|3783896|FG000|Overall Study|Physician Decision|1
2165021|NCT01282372|3783900|FG000|Overall Study|Lack of Efficacy / Exacerbation|25
2165022|NCT01282372|3783900|FG000|Overall Study|Lost to Follow-up|23
2165023|NCT01282372|3783900|FG000|Overall Study|Withdrawal by Subject|11
2165024|NCT01282372|3783900|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
2165025|NCT01282372|3783900|FG000|Overall Study|Death|1
2165026|NCT01282372|3783900|FG000|Overall Study|Presence of AE, Lack of Efficacy|1
2165027|NCT01282372|3783900|FG000|Overall Study|Presence of AE, Regression of Symptoms|1
2165028|NCT01282372|3783900|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
2165029|NCT01282372|3783900|FG000|Overall Study|Adverse Event|12
2165030|NCT01282424|3783911|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30
2165031|NCT01282424|3783911|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6
2165032|NCT01282424|3783911|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7
2165033|NCT01282424|3783911|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3
2165034|NCT01282424|3783911|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
2165035|NCT01282424|3783911|FG000|Long-term Follow-up Period (5 Years)|Death|40
2165036|NCT01282424|3783911|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
2165037|NCT01282424|3783911|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
2165038|NCT01282463|3783918|FG000|Overall Study|Lost to Follow-up|1
2165039|NCT01282463|3783919|FG001|Overall Study|Lost to Follow-up|0
2165040|NCT01282463|3783920|FG002|Overall Study|Lost to Follow-up|0
2165041|NCT01282463|3783918|FG000|Overall Study|Withdrawal by Subject|6
2165042|NCT01282463|3783919|FG001|Overall Study|Withdrawal by Subject|2
2165043|NCT01282463|3783920|FG002|Overall Study|Withdrawal by Subject|3
2165044|NCT01282463|3783918|FG000|Overall Study|"Never Treated Death"|0
2165045|NCT01282463|3783919|FG001|Overall Study|"Never Treated Death"|1
2165046|NCT01282463|3783920|FG002|Overall Study|"Never Treated Death"|0
2165047|NCT01282463|3783918|FG000|Overall Study|"Never Treated PD"|0
2165048|NCT01282463|3783919|FG001|Overall Study|"Never Treated PD"|1
2165049|NCT01282463|3783920|FG002|Overall Study|"Never Treated PD"|0
2165050|NCT01282463|3783918|FG000|Overall Study|Protocol Violation|0
2165051|NCT01282463|3783919|FG001|Overall Study|Protocol Violation|0
2165052|NCT01282463|3783920|FG002|Overall Study|Protocol Violation|1
2165053|NCT01282463|3783918|FG000|Overall Study|Physician Decision|1
2165054|NCT01282463|3783919|FG001|Overall Study|Physician Decision|0
2165055|NCT01282463|3783920|FG002|Overall Study|Physician Decision|0
2165056|NCT01282476|3783936|FG000|Overall Study|Death|11
2165057|NCT01282801|3783950|FG000|Second Intervention|Emesis During Critical Breakfast|0
2165058|NCT01282801|3783951|FG001|Second Intervention|Emesis During Critical Breakfast|1
2165059|NCT01282814|3783959|FG000|First Intervention|Emesis During Dosing Interval|0
2165060|NCT01282814|3783960|FG001|First Intervention|Emesis During Dosing Interval|3
2165061|NCT01282814|3783959|FG000|Washout of 7 Days|Withdrawal by Subject|2
2165062|NCT01282814|3783960|FG001|Washout of 7 Days|Withdrawal by Subject|0
2165063|NCT01282866|3783966|FG000|Overall Study|Adverse Event|1
2165064|NCT01283009|3783972|FG000|Overall Study|Death|83
2165065|NCT01283009|3783973|FG001|Overall Study|Death|78
2165066|NCT01283009|3783972|FG000|Overall Study|Study ended early|23
2165067|NCT01283009|3783973|FG001|Overall Study|Study ended early|26
2165068|NCT01283009|3783972|FG000|Overall Study|Withdrawal by Subject|10
2165069|NCT01283009|3783973|FG001|Overall Study|Withdrawal by Subject|8
2165070|NCT01283009|3783972|FG000|Overall Study|Physician Decision|1
2165071|NCT01283009|3783973|FG001|Overall Study|Physician Decision|1
2165072|NCT01283009|3783972|FG000|Overall Study|Lost to Follow-up|1
2165073|NCT01283009|3783973|FG001|Overall Study|Lost to Follow-up|0
2165074|NCT01283009|3783972|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0
2165075|NCT01283009|3783973|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4
2165076|NCT01283035|3783984|FG000|Overall Study|Subject later found ineligible|1
2165077|NCT01283139|3783992|FG000|Overall Study|Lost to Follow-up|5
2165078|NCT01283139|3783993|FG001|Overall Study|Lost to Follow-up|2
2165079|NCT01283139|3783994|FG002|Overall Study|Lost to Follow-up|3
2165080|NCT01283139|3783995|FG003|Overall Study|Lost to Follow-up|1
2165081|NCT01283139|3783992|FG000|Overall Study|Withdrawal by Subject|8
2165082|NCT01283139|3783993|FG001|Overall Study|Withdrawal by Subject|8
2165083|NCT01283139|3783994|FG002|Overall Study|Withdrawal by Subject|6
2165084|NCT01283139|3783995|FG003|Overall Study|Withdrawal by Subject|8
2165085|NCT01283139|3783992|FG000|Overall Study|Death|2
2165086|NCT01283139|3783993|FG001|Overall Study|Death|0
2165087|NCT01283139|3783994|FG002|Overall Study|Death|2
2165088|NCT01283139|3783995|FG003|Overall Study|Death|2
2165089|NCT01283139|3783992|FG000|Overall Study|Lack of Efficacy|1
2165090|NCT01283139|3783993|FG001|Overall Study|Lack of Efficacy|2
2165091|NCT01283139|3783994|FG002|Overall Study|Lack of Efficacy|2
2165092|NCT01283139|3783995|FG003|Overall Study|Lack of Efficacy|1
2165093|NCT01283139|3783992|FG000|Overall Study|Early termination due to AE/SAE|1
2165094|NCT01283139|3783993|FG001|Overall Study|Early termination due to AE/SAE|1
2165095|NCT01283139|3783994|FG002|Overall Study|Early termination due to AE/SAE|0
2165096|NCT01283139|3783995|FG003|Overall Study|Early termination due to AE/SAE|0
2165097|NCT01283139|3783992|FG000|Overall Study|Participant's refusal to continue|0
2165098|NCT01283139|3783993|FG001|Overall Study|Participant's refusal to continue|3
2165099|NCT01283139|3783994|FG002|Overall Study|Participant's refusal to continue|1
2165100|NCT01283139|3783995|FG003|Overall Study|Participant's refusal to continue|1
2165101|NCT01283139|3783992|FG000|Overall Study|Pregnancy|0
2165102|NCT01283139|3783993|FG001|Overall Study|Pregnancy|1
2165103|NCT01283139|3783994|FG002|Overall Study|Pregnancy|1
2165104|NCT01283139|3783995|FG003|Overall Study|Pregnancy|0
2165105|NCT01283139|3783992|FG000|Overall Study|Missed follow-up visit|0
2165106|NCT01283139|3783993|FG001|Overall Study|Missed follow-up visit|1
2165107|NCT01283139|3783994|FG002|Overall Study|Missed follow-up visit|2
2165108|NCT01283139|3783995|FG003|Overall Study|Missed follow-up visit|2
2165109|NCT01283139|3783992|FG000|Overall Study|Participant randomized in error|0
2165110|NCT01283139|3783993|FG001|Overall Study|Participant randomized in error|0
2165111|NCT01283139|3783994|FG002|Overall Study|Participant randomized in error|1
2165112|NCT01283139|3783995|FG003|Overall Study|Participant randomized in error|0
2165113|NCT01283152|3784007|FG000|Overall Study|Discharged prior to 24 hr assessment|1
2165114|NCT01283152|3784008|FG001|Overall Study|Discharged prior to 24 hr assessment|0
2165115|NCT01283152|3784007|FG000|Overall Study|Refused HESA|1
2165116|NCT01283152|3784008|FG001|Overall Study|Refused HESA|0
2165117|NCT01283282|3784014|FG000|First Intervention (6 Weeks)|Physician Decision|0
2165118|NCT01283282|3784015|FG001|First Intervention (6 Weeks)|Physician Decision|1
2165119|NCT01283282|3784014|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2
2165120|NCT01283282|3784015|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3
2165121|NCT01283282|3784014|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1
2165122|NCT01283282|3784015|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0
2165123|NCT01283334|3784033|FG000|Overall Study|Withdrawal by Subject|1
2165124|NCT01283334|3784033|FG000|Overall Study|Inability to Swallow Everolimus Pills|1
2165125|NCT01283334|3784033|FG000|Overall Study|Adverse Event|4
2165126|NCT01283334|3784033|FG000|Overall Study|Physician Decision|1
2165127|NCT01283386|3784041|FG000|Overall Study|Death|2
2165128|NCT01283386|3784042|FG001|Overall Study|Death|0
2165129|NCT01283386|3784041|FG000|Overall Study|Withdrawal by Subject|2
2165130|NCT01283386|3784042|FG001|Overall Study|Withdrawal by Subject|1
2165131|NCT01283386|3784041|FG000|Overall Study|Relapse of underlying disease|1
2165132|NCT01283386|3784042|FG001|Overall Study|Relapse of underlying disease|3
2165133|NCT01283386|3784041|FG000|Overall Study|Progression of underlying disease|2
2165134|NCT01283386|3784042|FG001|Overall Study|Progression of underlying disease|7
2165135|NCT01283386|3784041|FG000|Overall Study|Reason not specified|1
2165136|NCT01283386|3784042|FG001|Overall Study|Reason not specified|0
2165137|NCT01283386|3784041|FG000|Overall Study|Protocol Violation|0
2165138|NCT01283386|3784042|FG001|Overall Study|Protocol Violation|1
2165139|NCT01283464|3784050|FG000|Overall Study|Lost to Follow-up|0
2165140|NCT01283464|3784051|FG001|Overall Study|Lost to Follow-up|1
2165141|NCT01283464|3784050|FG000|Overall Study|Withdrawal by Subject|1
2165142|NCT01283464|3784051|FG001|Overall Study|Withdrawal by Subject|0
2165143|NCT01283464|3784050|FG000|Overall Study|Physician Decision|1
2165144|NCT01283464|3784051|FG001|Overall Study|Physician Decision|0
2165145|NCT01283516|3784066|FG000|Overall Study|Adverse Event|0
2165146|NCT01283516|3784067|FG001|Overall Study|Adverse Event|0
2165147|NCT01283516|3784068|FG002|Overall Study|Adverse Event|0
2165148|NCT01283516|3784069|FG003|Overall Study|Adverse Event|0
2165149|NCT01283516|3784070|FG004|Overall Study|Adverse Event|0
2165150|NCT01283516|3784071|FG005|Overall Study|Adverse Event|0
2165151|NCT01283516|3784072|FG006|Overall Study|Adverse Event|2
2165152|NCT01283516|3784073|FG007|Overall Study|Adverse Event|0
2165153|NCT01283516|3784074|FG008|Overall Study|Adverse Event|28
2165154|NCT01283516|3784066|FG000|Overall Study|Death|0
2165155|NCT01283516|3784067|FG001|Overall Study|Death|0
2165156|NCT01283516|3784068|FG002|Overall Study|Death|0
2165157|NCT01283516|3784069|FG003|Overall Study|Death|0
2165158|NCT01283516|3784070|FG004|Overall Study|Death|0
2165159|NCT01283516|3784071|FG005|Overall Study|Death|1
2165160|NCT01283516|3784072|FG006|Overall Study|Death|0
2165161|NCT01283516|3784073|FG007|Overall Study|Death|1
2165162|NCT01283516|3784074|FG008|Overall Study|Death|12
2165163|NCT01283516|3784066|FG000|Overall Study|Disease Progression|2
2165164|NCT01283516|3784067|FG001|Overall Study|Disease Progression|2
2165165|NCT01283516|3784068|FG002|Overall Study|Disease Progression|3
2165166|NCT01283516|3784069|FG003|Overall Study|Disease Progression|3
2165167|NCT01283516|3784070|FG004|Overall Study|Disease Progression|13
2165168|NCT01283516|3784071|FG005|Overall Study|Disease Progression|8
2165169|NCT01283516|3784072|FG006|Overall Study|Disease Progression|6
2165170|NCT01283516|3784073|FG007|Overall Study|Disease Progression|3
2165171|NCT01283516|3784074|FG008|Overall Study|Disease Progression|139
2165172|NCT01283516|3784066|FG000|Overall Study|Withdrawal by Subject|0
2165173|NCT01283516|3784067|FG001|Overall Study|Withdrawal by Subject|0
2165174|NCT01283516|3784068|FG002|Overall Study|Withdrawal by Subject|0
2165175|NCT01283516|3784069|FG003|Overall Study|Withdrawal by Subject|0
2165176|NCT01283516|3784070|FG004|Overall Study|Withdrawal by Subject|1
2165177|NCT01283516|3784071|FG005|Overall Study|Withdrawal by Subject|0
2165178|NCT01283516|3784072|FG006|Overall Study|Withdrawal by Subject|1
2165179|NCT01283516|3784073|FG007|Overall Study|Withdrawal by Subject|0
2165180|NCT01283516|3784074|FG008|Overall Study|Withdrawal by Subject|36
2165181|NCT01283516|3784066|FG000|Overall Study|Administrative problems|0
2165182|NCT01283516|3784067|FG001|Overall Study|Administrative problems|0
2165183|NCT01283516|3784068|FG002|Overall Study|Administrative problems|0
2165184|NCT01283516|3784069|FG003|Overall Study|Administrative problems|0
2165185|NCT01283516|3784070|FG004|Overall Study|Administrative problems|0
2165186|NCT01283516|3784071|FG005|Overall Study|Administrative problems|1
2165187|NCT01283516|3784072|FG006|Overall Study|Administrative problems|1
2165188|NCT01283516|3784073|FG007|Overall Study|Administrative problems|1
2165189|NCT01283516|3784074|FG008|Overall Study|Administrative problems|39
2165190|NCT01283516|3784066|FG000|Overall Study|Lost to Follow-up|0
2165191|NCT01283516|3784067|FG001|Overall Study|Lost to Follow-up|0
2165192|NCT01283516|3784068|FG002|Overall Study|Lost to Follow-up|0
2208195|NCT01636934|3847579|FG001|Overall Study|Withdrawal by Subject|2
2208196|NCT01636934|3847578|FG000|Overall Study|Chemo cancel|1
2295059|NCT02543892|3990221|FG003|Received Vaccination 2|Withdrawal by Subject|0
2295060|NCT02543892|3990222|FG004|Received Vaccination 2|Withdrawal by Subject|0
2295061|NCT02543892|3990223|FG005|Received Vaccination 2|Withdrawal by Subject|0
2295062|NCT02543892|3990224|FG006|Received Vaccination 2|Withdrawal by Subject|0
2295063|NCT02543892|3990225|FG007|Received Vaccination 2|Withdrawal by Subject|1
2295064|NCT02543892|3990218|FG000|Received Vaccination 2|Physician Decision|0
2295065|NCT02543892|3990219|FG001|Received Vaccination 2|Physician Decision|0
2295066|NCT02543892|3990220|FG002|Received Vaccination 2|Physician Decision|0
2295067|NCT02543892|3990221|FG003|Received Vaccination 2|Physician Decision|0
2295068|NCT02543892|3990222|FG004|Received Vaccination 2|Physician Decision|0
2295069|NCT02543892|3990223|FG005|Received Vaccination 2|Physician Decision|1
2295070|NCT02543892|3990224|FG006|Received Vaccination 2|Physician Decision|0
2295071|NCT02543892|3990225|FG007|Received Vaccination 2|Physician Decision|0
2295072|NCT02543892|3990218|FG000|Received Vaccination 2|Adverse Event|0
2165193|NCT01283516|3784069|FG003|Overall Study|Lost to Follow-up|0
2165194|NCT01283516|3784070|FG004|Overall Study|Lost to Follow-up|0
2165195|NCT01283516|3784071|FG005|Overall Study|Lost to Follow-up|0
2165196|NCT01283516|3784072|FG006|Overall Study|Lost to Follow-up|0
2165197|NCT01283516|3784073|FG007|Overall Study|Lost to Follow-up|0
2165198|NCT01283516|3784074|FG008|Overall Study|Lost to Follow-up|1
2179635|NCT01394991|3805282|FG000|Overall Study|Protocol Violation|1
2165199|NCT01283542|3784102|FG000|Main Phase|Acute or progressive vision loss|1
2165200|NCT01283542|3784102|FG000|Main Phase|Uncontrolled diabetes mellitus|1
2165201|NCT01283542|3784102|FG000|Main Phase|abnormal laboratory values|5
2165202|NCT01283542|3784102|FG000|Extension Phase|Physician Decision|1
2165203|NCT01283542|3784102|FG000|Extension Phase|Adverse Event|1
2165204|NCT01283542|3784102|FG000|Extension Phase|Administrative problems|1
2165205|NCT01283581|3784138|FG000|Overall Study|Lost to Follow-up|8
2165206|NCT01283581|3784139|FG001|Overall Study|Lost to Follow-up|6
2165207|NCT01283581|3784140|FG002|Overall Study|Lost to Follow-up|8
2165208|NCT01283581|3784138|FG000|Overall Study|Withdrawal by Subject|2
2165209|NCT01283581|3784139|FG001|Overall Study|Withdrawal by Subject|5
2165210|NCT01283581|3784140|FG002|Overall Study|Withdrawal by Subject|2
2165211|NCT01283581|3784138|FG000|Overall Study|Adverse Event|1
2165212|NCT01283581|3784139|FG001|Overall Study|Adverse Event|1
2165213|NCT01283581|3784140|FG002|Overall Study|Adverse Event|4
2165214|NCT01283581|3784138|FG000|Overall Study|Physician Decision|0
2165215|NCT01283581|3784139|FG001|Overall Study|Physician Decision|1
2165216|NCT01283581|3784140|FG002|Overall Study|Physician Decision|2
2165217|NCT01283581|3784138|FG000|Overall Study|Protocol Violation|0
2165218|NCT01283581|3784139|FG001|Overall Study|Protocol Violation|1
2165219|NCT01283581|3784140|FG002|Overall Study|Protocol Violation|2
2165220|NCT01283581|3784138|FG000|Overall Study|Noncompliance|1
2165221|NCT01283581|3784139|FG001|Overall Study|Noncompliance|0
2165222|NCT01283581|3784140|FG002|Overall Study|Noncompliance|0
2165223|NCT01283581|3784138|FG000|Overall Study|Investigator unblinded|0
2165224|NCT01283581|3784139|FG001|Overall Study|Investigator unblinded|0
2165225|NCT01283581|3784140|FG002|Overall Study|Investigator unblinded|1
2165226|NCT01283581|3784138|FG000|Overall Study|"Early termination"|0
2165227|NCT01283581|3784139|FG001|Overall Study|"Early termination"|0
2165228|NCT01283581|3784140|FG002|Overall Study|"Early termination"|1
2165229|NCT01283971|3784153|FG000|Overall Study|Adverse Event|3
2165230|NCT01283971|3784154|FG001|Overall Study|Adverse Event|5
2165231|NCT01283971|3784153|FG000|Overall Study|Insufficient therapeutic responses|3
2165232|NCT01283971|3784154|FG001|Overall Study|Insufficient therapeutic responses|3
2165233|NCT01283971|3784153|FG000|Overall Study|Protocol Violation|5
2165234|NCT01283971|3784154|FG001|Overall Study|Protocol Violation|1
2165235|NCT01283971|3784153|FG000|Overall Study|Refused treatment|3
2165236|NCT01283971|3784154|FG001|Overall Study|Refused treatment|1
2165237|NCT01283971|3784153|FG000|Overall Study|Failure to return|0
2165238|NCT01283971|3784154|FG001|Overall Study|Failure to return|1
2165239|NCT01283971|3784153|FG000|Overall Study|Administrative reasons|1
2165240|NCT01283971|3784154|FG001|Overall Study|Administrative reasons|1
2165241|NCT01284062|3784164|FG000|Overall Study|Adverse Event|4
2165242|NCT01284062|3784165|FG001|Overall Study|Adverse Event|5
2165243|NCT01284062|3784166|FG002|Overall Study|Adverse Event|0
2165244|NCT01284062|3784167|FG003|Overall Study|Adverse Event|5
2165245|NCT01284062|3784164|FG000|Overall Study|Lack of Efficacy|3
2165246|NCT01284062|3784165|FG001|Overall Study|Lack of Efficacy|2
2165247|NCT01284062|3784166|FG002|Overall Study|Lack of Efficacy|2
2165248|NCT01284062|3784167|FG003|Overall Study|Lack of Efficacy|1
2165249|NCT01284062|3784164|FG000|Overall Study|Medication error without adverse event|0
2165250|NCT01284062|3784165|FG001|Overall Study|Medication error without adverse event|0
2165251|NCT01284062|3784166|FG002|Overall Study|Medication error without adverse event|1
2165252|NCT01284062|3784167|FG003|Overall Study|Medication error without adverse event|0
2165253|NCT01284062|3784164|FG000|Overall Study|Protocol Violation|1
2165254|NCT01284062|3784165|FG001|Overall Study|Protocol Violation|0
2165255|NCT01284062|3784166|FG002|Overall Study|Protocol Violation|0
2165256|NCT01284062|3784167|FG003|Overall Study|Protocol Violation|2
2165257|NCT01284062|3784164|FG000|Overall Study|Withdrawal by Subject|3
2165258|NCT01284062|3784165|FG001|Overall Study|Withdrawal by Subject|1
2165259|NCT01284062|3784166|FG002|Overall Study|Withdrawal by Subject|2
2165260|NCT01284062|3784167|FG003|Overall Study|Withdrawal by Subject|5
2165261|NCT01284062|3784164|FG000|Overall Study|Other|0
2165262|NCT01284062|3784165|FG001|Overall Study|Other|0
2165263|NCT01284062|3784166|FG002|Overall Study|Other|0
2165264|NCT01284062|3784167|FG003|Overall Study|Other|1
2165265|NCT01284062|3784164|FG000|Overall Study|Site Closed|0
2165266|NCT01284062|3784165|FG001|Overall Study|Site Closed|0
2165267|NCT01284062|3784166|FG002|Overall Study|Site Closed|1
2165268|NCT01284062|3784167|FG003|Overall Study|Site Closed|0
2165269|NCT01284114|3784180|FG000|Overall Study|viral infection|1
2165270|NCT01284114|3784180|FG000|Overall Study|From the results of ALLTITUDE study|1
2165271|NCT01284114|3784180|FG000|Overall Study|Symptomatic hypotension|1
2165272|NCT01284114|3784180|FG000|Overall Study|dizziness|1
2165273|NCT01284127|3784185|FG000|Overall Study|Adverse Event|2
2165274|NCT01284127|3784185|FG000|Overall Study|Withdrawal by Subject|4
2165275|NCT01284127|3784185|FG000|Overall Study|Physician Decision|1
2165276|NCT01284140|3784191|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
2165277|NCT01284140|3784192|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
2165278|NCT01284140|3784191|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
2165279|NCT01284140|3784192|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
2165280|NCT01284361|3784277|FG000|Overall Study|Withdrawal by Subject|1
2165281|NCT01284361|3784277|FG000|Overall Study|Protocol Violation|5
2165282|NCT01284361|3784277|FG000|Overall Study|Adverse Event|1
2295073|NCT02543892|3990219|FG001|Received Vaccination 2|Adverse Event|1
2295074|NCT02543892|3990220|FG002|Received Vaccination 2|Adverse Event|0
2295075|NCT02543892|3990221|FG003|Received Vaccination 2|Adverse Event|0
2295076|NCT02543892|3990222|FG004|Received Vaccination 2|Adverse Event|0
2295077|NCT02543892|3990223|FG005|Received Vaccination 2|Adverse Event|0
2295078|NCT02543892|3990224|FG006|Received Vaccination 2|Adverse Event|0
2165283|NCT01284361|3784277|FG000|Overall Study|Lost to Follow-up|2
2165284|NCT01284621|3784297|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2165285|NCT01284621|3784298|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2165286|NCT01284621|3784299|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2165287|NCT01284621|3784300|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2165288|NCT01284621|3784301|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
2165289|NCT01284621|3784302|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2165290|NCT01284634|3784316|FG000|Overall Study|Adverse Event|1
2165291|NCT01284634|3784317|FG001|Overall Study|Adverse Event|0
2165292|NCT01284634|3784318|FG002|Overall Study|Adverse Event|2
2165293|NCT01284634|3784319|FG003|Overall Study|Adverse Event|1
2165294|NCT01284959|3784332|FG000|Overall Study|Withdrawal by Subject|1
2165295|NCT01284959|3784333|FG001|Overall Study|Withdrawal by Subject|0
2165296|NCT01284959|3784334|FG002|Overall Study|Withdrawal by Subject|0
2165297|NCT01284959|3784332|FG000|Overall Study|Adverse Event|0
2165298|NCT01284959|3784333|FG001|Overall Study|Adverse Event|0
2165299|NCT01284959|3784334|FG002|Overall Study|Adverse Event|1
2165300|NCT01285310|3784363|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
2165301|NCT01285310|3784364|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
2165302|NCT01285310|3784365|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
2165303|NCT01285310|3784366|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
2165304|NCT01285310|3784367|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
2165305|NCT01285310|3784363|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
2165306|NCT01285310|3784364|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
2165307|NCT01285310|3784365|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
2295079|NCT02543892|3990225|FG007|Received Vaccination 2|Adverse Event|0
2295080|NCT02543892|3990218|FG000|Had Immunology Data|Withdrawal by Subject|0
2295081|NCT02543892|3990219|FG001|Had Immunology Data|Withdrawal by Subject|0
2295082|NCT02543892|3990220|FG002|Had Immunology Data|Withdrawal by Subject|0
2295083|NCT02543892|3990221|FG003|Had Immunology Data|Withdrawal by Subject|0
2295084|NCT02543892|3990222|FG004|Had Immunology Data|Withdrawal by Subject|0
2295085|NCT02543892|3990223|FG005|Had Immunology Data|Withdrawal by Subject|0
2295086|NCT02543892|3990224|FG006|Had Immunology Data|Withdrawal by Subject|1
2295087|NCT02543892|3990225|FG007|Had Immunology Data|Withdrawal by Subject|0
2295088|NCT02543918|3990250|FG000|Overall Study|Never treated|0
2295089|NCT02543918|3990251|FG001|Overall Study|Never treated|1
2295090|NCT02543918|3990250|FG000|Overall Study|Lost to Follow-up|1
2295091|NCT02543918|3990251|FG001|Overall Study|Lost to Follow-up|1
2295092|NCT02543918|3990250|FG000|Overall Study|Withdrawal by Subject|1
2295093|NCT02543918|3990251|FG001|Overall Study|Withdrawal by Subject|1
2295094|NCT02543918|3990250|FG000|Overall Study|Adverse Event|1
2295095|NCT02543918|3990251|FG001|Overall Study|Adverse Event|1
2295096|NCT02544074|3990278|FG000|Overall Study|Withdrawal by Subject|0
2295097|NCT02544074|3990279|FG001|Overall Study|Withdrawal by Subject|1
2295098|NCT02544074|3990280|FG002|Overall Study|Withdrawal by Subject|0
2295099|NCT02544074|3990281|FG003|Overall Study|Withdrawal by Subject|0
2295100|NCT02544074|3990282|FG004|Overall Study|Withdrawal by Subject|0
2295101|NCT02544074|3990283|FG005|Overall Study|Withdrawal by Subject|0
2295102|NCT02544074|3990284|FG006|Overall Study|Withdrawal by Subject|0
2295103|NCT02544074|3990285|FG007|Overall Study|Withdrawal by Subject|0
2295104|NCT02544074|3990286|FG008|Overall Study|Withdrawal by Subject|0
2295105|NCT02544074|3990287|FG009|Overall Study|Withdrawal by Subject|0
2295106|NCT02544074|3990288|FG010|Overall Study|Withdrawal by Subject|0
2295107|NCT02544074|3990289|FG011|Overall Study|Withdrawal by Subject|0
2295108|NCT02544074|3990290|FG012|Overall Study|Withdrawal by Subject|0
2295109|NCT02544074|3990291|FG013|Overall Study|Withdrawal by Subject|0
2295110|NCT02544074|3990292|FG014|Overall Study|Withdrawal by Subject|0
2295111|NCT02544074|3990293|FG015|Overall Study|Withdrawal by Subject|0
2295112|NCT02544074|3990294|FG016|Overall Study|Withdrawal by Subject|0
2295113|NCT02544074|3990295|FG017|Overall Study|Withdrawal by Subject|0
2295114|NCT02544074|3990296|FG018|Overall Study|Withdrawal by Subject|0
2295115|NCT02544074|3990297|FG019|Overall Study|Withdrawal by Subject|0
2295116|NCT02544074|3990298|FG020|Overall Study|Withdrawal by Subject|0
2295117|NCT02544074|3990278|FG000|Overall Study|Tablet error|0
2295118|NCT02544074|3990279|FG001|Overall Study|Tablet error|0
2295119|NCT02544074|3990280|FG002|Overall Study|Tablet error|0
2295120|NCT02544074|3990281|FG003|Overall Study|Tablet error|0
2295121|NCT02544074|3990282|FG004|Overall Study|Tablet error|0
2295122|NCT02544074|3990283|FG005|Overall Study|Tablet error|1
2295123|NCT02544074|3990284|FG006|Overall Study|Tablet error|0
2295124|NCT02544074|3990285|FG007|Overall Study|Tablet error|0
2295125|NCT02544074|3990286|FG008|Overall Study|Tablet error|0
2165308|NCT01285310|3784366|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
2165309|NCT01285310|3784367|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
2165310|NCT01285310|3784363|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
2165311|NCT01285310|3784364|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
2165312|NCT01285310|3784365|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
2165313|NCT01285310|3784366|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
2165314|NCT01285310|3784367|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
2165315|NCT01285310|3784363|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
2165316|NCT01285310|3784364|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
2165317|NCT01285310|3784365|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
2165318|NCT01285310|3784366|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
2165319|NCT01285310|3784367|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
2165320|NCT01285310|3784363|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
2165321|NCT01285310|3784364|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
2165322|NCT01285310|3784365|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
2165323|NCT01285310|3784366|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
2165324|NCT01285310|3784367|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
2165325|NCT01285310|3784363|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1
2165326|NCT01285310|3784364|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0
2165327|NCT01285310|3784365|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1
2165328|NCT01285310|3784366|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0
2165329|NCT01285310|3784367|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0
2165330|NCT01285310|3784363|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0
2165331|NCT01285310|3784364|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2
2165332|NCT01285310|3784365|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3
2165333|NCT01285310|3784366|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0
2165334|NCT01285310|3784367|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2
2165335|NCT01285310|3784363|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
2165336|NCT01285310|3784364|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
2165337|NCT01285310|3784365|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
2165338|NCT01285310|3784366|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
2165339|NCT01285310|3784367|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
2165340|NCT01285310|3784363|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
2165341|NCT01285310|3784364|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
2165342|NCT01285310|3784365|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
2165343|NCT01285310|3784366|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
2165344|NCT01285310|3784367|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
2165345|NCT01285310|3784363|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
2165346|NCT01285310|3784364|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
2165347|NCT01285310|3784365|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
2165348|NCT01285310|3784366|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
2165349|NCT01285310|3784367|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
2165350|NCT01285310|3784363|FG000|Active Treatment Phase: Weeks 25-52|Other|0
2165351|NCT01285310|3784364|FG001|Active Treatment Phase: Weeks 25-52|Other|1
2165352|NCT01285310|3784365|FG002|Active Treatment Phase: Weeks 25-52|Other|0
2165353|NCT01285310|3784366|FG003|Active Treatment Phase: Weeks 25-52|Other|0
2165354|NCT01285310|3784367|FG004|Active Treatment Phase: Weeks 25-52|Other|0
2165355|NCT01285310|3784363|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0
2165356|NCT01285310|3784364|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1
2165357|NCT01285310|3784365|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1
2165358|NCT01285310|3784366|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1
2165359|NCT01285310|3784367|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0
2165360|NCT01285323|3784407|FG000|Overall Study|Adverse Event|9
2165361|NCT01285323|3784408|FG001|Overall Study|Adverse Event|8
2165362|NCT01285323|3784407|FG000|Overall Study|Lack of Efficacy|4
2165363|NCT01285323|3784408|FG001|Overall Study|Lack of Efficacy|2
2165364|NCT01285323|3784407|FG000|Overall Study|Withdrawal by Subject|15
2165365|NCT01285323|3784408|FG001|Overall Study|Withdrawal by Subject|11
2165366|NCT01285323|3784407|FG000|Overall Study|Protocol Violation|1
2165367|NCT01285323|3784408|FG001|Overall Study|Protocol Violation|2
2165368|NCT01285323|3784407|FG000|Overall Study|Non-compliance with study procedures|2
2165369|NCT01285323|3784408|FG001|Overall Study|Non-compliance with study procedures|3
2165370|NCT01285323|3784407|FG000|Overall Study|Lost to Follow-up|1
2165371|NCT01285323|3784408|FG001|Overall Study|Lost to Follow-up|1
2165372|NCT01285323|3784407|FG000|Overall Study|Other|1
2165373|NCT01285323|3784408|FG001|Overall Study|Other|3
2165374|NCT01285349|3784417|FG000|Overall Study|Lost to Follow-up|27
2165375|NCT01285349|3784418|FG001|Overall Study|Lost to Follow-up|20
2165376|NCT01285349|3784419|FG002|Overall Study|Lost to Follow-up|27
2165377|NCT01285401|3784430|FG000|Overall Study|Prematurely withdrawn from the study|17
2165378|NCT01285401|3784431|FG001|Overall Study|Prematurely withdrawn from the study|29
2165379|NCT01285492|3784451|FG000|Overall Study|Adverse Event|11
2165380|NCT01285492|3784452|FG001|Overall Study|Adverse Event|0
2165381|NCT01285492|3784451|FG000|Overall Study|Protocol Violation|3
2165382|NCT01285492|3784452|FG001|Overall Study|Protocol Violation|0
2165383|NCT01285492|3784451|FG000|Overall Study|Withdrawal by Subject|2
2165384|NCT01285492|3784452|FG001|Overall Study|Withdrawal by Subject|1
2165385|NCT01285492|3784451|FG000|Overall Study|Death|1
2165386|NCT01285492|3784452|FG001|Overall Study|Death|0
2165387|NCT01285518|3784466|FG000|Overall Study|Lost to Follow-up|0
2165388|NCT01285518|3784467|FG001|Overall Study|Lost to Follow-up|0
2165389|NCT01285518|3784468|FG002|Overall Study|Lost to Follow-up|0
2165390|NCT01285518|3784469|FG003|Overall Study|Lost to Follow-up|0
2165391|NCT01285518|3784470|FG004|Overall Study|Lost to Follow-up|0
2165392|NCT01285518|3784471|FG005|Overall Study|Lost to Follow-up|1
2165393|NCT01285518|3784472|FG006|Overall Study|Lost to Follow-up|0
2165394|NCT01285518|3784473|FG007|Overall Study|Lost to Follow-up|0
2165395|NCT01285609|3784494|FG000|Randomized|Progressive Disease|41
2165396|NCT01285609|3784495|FG001|Randomized|Progressive Disease|61
2165397|NCT01285609|3784494|FG000|Randomized|Adverse Event Unrelated to Study Drug|18
2165398|NCT01285609|3784495|FG001|Randomized|Adverse Event Unrelated to Study Drug|18
2165399|NCT01285609|3784494|FG000|Randomized|Study Drug Toxicity|13
2165400|NCT01285609|3784495|FG001|Randomized|Study Drug Toxicity|14
2165401|NCT01285609|3784494|FG000|Randomized|Death|5
2165402|NCT01285609|3784495|FG001|Randomized|Death|7
2165403|NCT01285609|3784494|FG000|Randomized|Withdrawal by Subject|8
2165404|NCT01285609|3784495|FG001|Randomized|Withdrawal by Subject|11
2165405|NCT01285609|3784494|FG000|Randomized|Subject No Longer Met Study Criteria|1
2165406|NCT01285609|3784495|FG001|Randomized|Subject No Longer Met Study Criteria|1
2165407|NCT01285609|3784494|FG000|Randomized|Undisclosed Reasons|1
2165408|NCT01285609|3784495|FG001|Randomized|Undisclosed Reasons|0
2165409|NCT01285609|3784494|FG000|Randomized|Randomized but not Treated|4
2165410|NCT01285609|3784495|FG001|Randomized|Randomized but not Treated|4
2165411|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Progressive Disease|223
2165412|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Progressive Disease|305
2165413|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87
2165414|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14
2165415|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
2165416|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
2165417|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20
2165418|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7
2165419|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Death|11
2165420|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Death|3
2165421|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2
2165422|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4
2165423|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Not Reported|0
2165424|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Not Reported|2
2165425|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1
2165426|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2
2165427|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
2165428|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
2165429|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
2295126|NCT02544074|3990287|FG009|Overall Study|Tablet error|1
2295127|NCT02544074|3990288|FG010|Overall Study|Tablet error|0
2295128|NCT02544074|3990289|FG011|Overall Study|Tablet error|0
2295129|NCT02544074|3990290|FG012|Overall Study|Tablet error|0
2295130|NCT02544074|3990291|FG013|Overall Study|Tablet error|0
2295131|NCT02544074|3990292|FG014|Overall Study|Tablet error|0
2295132|NCT02544074|3990293|FG015|Overall Study|Tablet error|0
2295133|NCT02544074|3990294|FG016|Overall Study|Tablet error|0
2208197|NCT01636934|3847579|FG001|Overall Study|Chemo cancel|0
2208198|NCT01636934|3847578|FG000|Overall Study|Too ill to continue|1
2208199|NCT01636934|3847579|FG001|Overall Study|Too ill to continue|0
2208200|NCT01636934|3847578|FG000|Overall Study|Never started study medication|1
2208201|NCT01636934|3847579|FG001|Overall Study|Never started study medication|1
2208202|NCT01636947|3847587|FG000|Overall Study|Not Treated|2
2165430|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
2165431|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Physician and Patient decision|1
2165432|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Physician and Patient decision|3
2165433|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Participant refused participation|1
2165434|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Participant refused participation|0
2165435|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1
2165436|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0
2165437|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Participant hospitalized|1
2165438|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Participant hospitalized|0
2165439|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Investigator's assessment|1
2165440|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Investigator's assessment|0
2165441|NCT01285609|3784494|FG000|Treated With Blinded Therapy|PI decision to discontinue|0
2165442|NCT01285609|3784495|FG001|Treated With Blinded Therapy|PI decision to discontinue|1
2165443|NCT01285609|3784494|FG000|Treated With Blinded Therapy|Worsening of general condition|0
2208203|NCT01636947|3847588|FG001|Overall Study|Not Treated|2
2208204|NCT01636947|3847587|FG000|Overall Study|Lost to Follow-up|4
2165444|NCT01285609|3784495|FG001|Treated With Blinded Therapy|Worsening of general condition|1
2295134|NCT02544074|3990295|FG017|Overall Study|Tablet error|0
2165445|NCT01285908|3784550|FG000|Baseline Measurement|unable to insert catheter|1
2165446|NCT01285908|3784551|FG001|Baseline Measurement|unable to insert catheter|0
2165447|NCT01285908|3784552|FG002|Baseline Measurement|unable to insert catheter|0
2165448|NCT01285908|3784550|FG000|Baseline Measurement|History of stroke, exclusion criteria|1
2165449|NCT01285908|3784551|FG001|Baseline Measurement|History of stroke, exclusion criteria|0
2165450|NCT01285908|3784552|FG002|Baseline Measurement|History of stroke, exclusion criteria|0
2165451|NCT01285908|3784550|FG000|Baseline Measurement|unable to tolerate procedure|1
2165452|NCT01285908|3784551|FG001|Baseline Measurement|unable to tolerate procedure|0
2165453|NCT01285908|3784552|FG002|Baseline Measurement|unable to tolerate procedure|0
2165454|NCT01285960|3784582|FG000|Overall Study|Withdrawal by Subject|2
2165455|NCT01285960|3784582|FG000|Overall Study|Lost to Follow-up|2
2165456|NCT01285960|3784582|FG000|Overall Study|2 subjects received less 10 sonications|2
2165457|NCT01286012|3784588|FG000|Overall Study|Adverse Event|3
2165458|NCT01286012|3784589|FG001|Overall Study|Adverse Event|3
2165459|NCT01286012|3784588|FG000|Overall Study|Death|2
2165460|NCT01286012|3784589|FG001|Overall Study|Death|3
2165461|NCT01286012|3784588|FG000|Overall Study|Protocol Violation|1
2165462|NCT01286012|3784589|FG001|Overall Study|Protocol Violation|1
2165463|NCT01286012|3784588|FG000|Overall Study|Withdrawal by Subject|4
2165464|NCT01286012|3784589|FG001|Overall Study|Withdrawal by Subject|4
2165465|NCT01286012|3784588|FG000|Overall Study|Physician Decision|2
2165466|NCT01286012|3784589|FG001|Overall Study|Physician Decision|0
2165467|NCT01286012|3784588|FG000|Overall Study|peritoneal dialysis, randomized in error|1
2165468|NCT01286012|3784589|FG001|Overall Study|peritoneal dialysis, randomized in error|3
2165469|NCT01286077|3784598|FG000|Overall Study|Adverse Event|2
2165470|NCT01286077|3784599|FG001|Overall Study|Adverse Event|0
2165471|NCT01286077|3784598|FG000|Overall Study|Death|1
2165472|NCT01286077|3784599|FG001|Overall Study|Death|0
2165473|NCT01286077|3784598|FG000|Overall Study|Protocol Violation|1
2165474|NCT01286077|3784599|FG001|Overall Study|Protocol Violation|1
2165475|NCT01286077|3784598|FG000|Overall Study|Withdrawal by Subject|0
2165476|NCT01286077|3784599|FG001|Overall Study|Withdrawal by Subject|2
2165477|NCT01286077|3784598|FG000|Overall Study|Intercurrent illness|1
2165478|NCT01286077|3784599|FG001|Overall Study|Intercurrent illness|0
2165479|NCT01286077|3784598|FG000|Overall Study|Non-compliance|1
2165480|NCT01286077|3784599|FG001|Overall Study|Non-compliance|0
2165481|NCT01286077|3784598|FG000|Overall Study|The subject starts with alternative MMY|0
2165482|NCT01286077|3784599|FG001|Overall Study|The subject starts with alternative MMY|3
2165483|NCT01286077|3784598|FG000|Overall Study|Patient's decision to stop treatment|3
2165484|NCT01286077|3784599|FG001|Overall Study|Patient's decision to stop treatment|0
2295135|NCT02544074|3990296|FG018|Overall Study|Tablet error|0
2165485|NCT01286077|3784598|FG000|Overall Study|Progression of disease|0
2165486|NCT01286077|3784599|FG001|Overall Study|Progression of disease|1
2165487|NCT01286077|3784598|FG000|Overall Study|refill medication not received in time|1
2165488|NCT01286077|3784599|FG001|Overall Study|refill medication not received in time|0
2165489|NCT01286129|3784607|FG000|Overall Study|Withdrawal by Subject|4
2165490|NCT01286129|3784608|FG001|Overall Study|Withdrawal by Subject|1
2165491|NCT01286129|3784607|FG000|Overall Study|Could not comply with study requirements|4
2165492|NCT01286129|3784608|FG001|Overall Study|Could not comply with study requirements|4
2165493|NCT01286168|3784616|FG000|Overall Study|Withdrawal by Subject|1
2165494|NCT01286168|3784616|FG000|Overall Study|Surgical Drains Fell Out at Home|2
2165495|NCT01286311|3784627|FG000|Overall Study|Physician did not want outreach sent|14
2165496|NCT01286311|3784628|FG001|Overall Study|Physician did not want outreach sent|0
2165497|NCT01286480|3784695|FG000|Overall Study|Withdrawal by Subject|5
2165498|NCT01286480|3784696|FG001|Overall Study|Withdrawal by Subject|3
2165499|NCT01286558|3784708|FG000|Overall Study|Adverse Event|1
2165500|NCT01286558|3784709|FG001|Overall Study|Adverse Event|1
2165501|NCT01286558|3784708|FG000|Overall Study|Withdrawal by Subject|0
2165502|NCT01286558|3784709|FG001|Overall Study|Withdrawal by Subject|1
2165503|NCT01286740|3784715|FG000|Overall Study|Enrolled but not treated|1
2165504|NCT01286740|3784715|FG000|Overall Study|Protocol Violation|1
2165505|NCT01286753|3784721|FG000|Overall Study|Adverse Event|7
2165506|NCT01286753|3784722|FG001|Overall Study|Adverse Event|6
2165507|NCT01286753|3784721|FG000|Overall Study|Progression|11
2165508|NCT01286753|3784722|FG001|Overall Study|Progression|13
2165509|NCT01286753|3784721|FG000|Overall Study|Refused Treatment|1
2165510|NCT01286753|3784722|FG001|Overall Study|Refused Treatment|0
2165511|NCT01286753|3784721|FG000|Overall Study|Withdrawal of Consent|0
2165512|NCT01286753|3784722|FG001|Overall Study|Withdrawal of Consent|2
2165513|NCT01286753|3784721|FG000|Overall Study|Discontinued to Join Extension Study|6
2165514|NCT01286753|3784722|FG001|Overall Study|Discontinued to Join Extension Study|4
2165515|NCT01286753|3784721|FG000|Overall Study|Participant to Receive Radiotherapy|1
2165516|NCT01286753|3784722|FG001|Overall Study|Participant to Receive Radiotherapy|0
2165517|NCT01286779|3784729|FG000|Overall Study|Withdrawal by Subject|9
2165518|NCT01286779|3784729|FG000|Overall Study|Protocol Violation|5
2165519|NCT01286779|3784729|FG000|Overall Study|Physician Decision|2
2165520|NCT01286779|3784729|FG000|Overall Study|Participant had scheduled surgery|1
2165521|NCT01286779|3784729|FG000|Overall Study|Participant moved to another country|1
2165522|NCT01286779|3784729|FG000|Overall Study|Discontinued by sponsor|1
2165523|NCT01286987|3784775|FG000|Part 1: Dose Escalation|Clinical Progression|1
2165524|NCT01286987|3784776|FG001|Part 1: Dose Escalation|Clinical Progression|1
2165525|NCT01286987|3784777|FG002|Part 1: Dose Escalation|Clinical Progression|0
2165526|NCT01286987|3784778|FG003|Part 1: Dose Escalation|Clinical Progression|1
2165527|NCT01286987|3784779|FG004|Part 1: Dose Escalation|Clinical Progression|1
2165528|NCT01286987|3784780|FG005|Part 1: Dose Escalation|Clinical Progression|1
2165529|NCT01286987|3784781|FG006|Part 1: Dose Escalation|Clinical Progression|0
2165530|NCT01286987|3784782|FG007|Part 1: Dose Escalation|Clinical Progression|2
2165531|NCT01286987|3784783|FG008|Part 1: Dose Escalation|Clinical Progression|1
2165532|NCT01286987|3784784|FG009|Part 1: Dose Escalation|Clinical Progression|0
2165533|NCT01286987|3784785|FG010|Part 1: Dose Escalation|Clinical Progression|0
2165534|NCT01286987|3784786|FG011|Part 1: Dose Escalation|Clinical Progression|0
2165535|NCT01286987|3784787|FG012|Part 1: Dose Escalation|Clinical Progression|0
2165536|NCT01286987|3784788|FG013|Part 1: Dose Escalation|Clinical Progression|0
2165537|NCT01286987|3784789|FG014|Part 1: Dose Escalation|Clinical Progression|0
2165538|NCT01286987|3784775|FG000|Part 1: Dose Escalation|Progressive Disease|2
2165539|NCT01286987|3784776|FG001|Part 1: Dose Escalation|Progressive Disease|2
2165540|NCT01286987|3784777|FG002|Part 1: Dose Escalation|Progressive Disease|3
2165541|NCT01286987|3784778|FG003|Part 1: Dose Escalation|Progressive Disease|2
2165542|NCT01286987|3784779|FG004|Part 1: Dose Escalation|Progressive Disease|1
2165543|NCT01286987|3784780|FG005|Part 1: Dose Escalation|Progressive Disease|5
2165544|NCT01286987|3784781|FG006|Part 1: Dose Escalation|Progressive Disease|5
2165545|NCT01286987|3784782|FG007|Part 1: Dose Escalation|Progressive Disease|3
2165546|NCT01286987|3784783|FG008|Part 1: Dose Escalation|Progressive Disease|5
2165547|NCT01286987|3784784|FG009|Part 1: Dose Escalation|Progressive Disease|0
2165548|NCT01286987|3784785|FG010|Part 1: Dose Escalation|Progressive Disease|0
2165549|NCT01286987|3784786|FG011|Part 1: Dose Escalation|Progressive Disease|0
2165550|NCT01286987|3784787|FG012|Part 1: Dose Escalation|Progressive Disease|0
2165551|NCT01286987|3784788|FG013|Part 1: Dose Escalation|Progressive Disease|0
2165552|NCT01286987|3784789|FG014|Part 1: Dose Escalation|Progressive Disease|0
2165553|NCT01286987|3784775|FG000|Part 1: Dose Escalation|Physician Decision|0
2165554|NCT01286987|3784776|FG001|Part 1: Dose Escalation|Physician Decision|0
2165555|NCT01286987|3784777|FG002|Part 1: Dose Escalation|Physician Decision|0
2165556|NCT01286987|3784778|FG003|Part 1: Dose Escalation|Physician Decision|0
2295136|NCT02544074|3990297|FG019|Overall Study|Tablet error|0
2295137|NCT02544074|3990298|FG020|Overall Study|Tablet error|0
2295138|NCT02544113|3990334|FG000|Overall Study|Death|3
2295139|NCT02544113|3990335|FG001|Overall Study|Death|4
2295140|NCT02544152|3990343|FG000|Overall Study|Adverse Event|0
2295141|NCT02544152|3990344|FG001|Overall Study|Adverse Event|4
2165557|NCT01286987|3784779|FG004|Part 1: Dose Escalation|Physician Decision|1
2165558|NCT01286987|3784780|FG005|Part 1: Dose Escalation|Physician Decision|0
2165559|NCT01286987|3784781|FG006|Part 1: Dose Escalation|Physician Decision|0
2165560|NCT01286987|3784782|FG007|Part 1: Dose Escalation|Physician Decision|0
2165561|NCT01286987|3784783|FG008|Part 1: Dose Escalation|Physician Decision|0
2165562|NCT01286987|3784784|FG009|Part 1: Dose Escalation|Physician Decision|0
2165563|NCT01286987|3784785|FG010|Part 1: Dose Escalation|Physician Decision|0
2165564|NCT01286987|3784786|FG011|Part 1: Dose Escalation|Physician Decision|0
2165565|NCT01286987|3784787|FG012|Part 1: Dose Escalation|Physician Decision|0
2165566|NCT01286987|3784788|FG013|Part 1: Dose Escalation|Physician Decision|0
2165567|NCT01286987|3784789|FG014|Part 1: Dose Escalation|Physician Decision|0
2165568|NCT01286987|3784775|FG000|Part 2: Dose Expansion|Death|0
2165569|NCT01286987|3784776|FG001|Part 2: Dose Expansion|Death|0
2165570|NCT01286987|3784777|FG002|Part 2: Dose Expansion|Death|0
2165571|NCT01286987|3784778|FG003|Part 2: Dose Expansion|Death|0
2165572|NCT01286987|3784779|FG004|Part 2: Dose Expansion|Death|0
2165573|NCT01286987|3784780|FG005|Part 2: Dose Expansion|Death|0
2165574|NCT01286987|3784781|FG006|Part 2: Dose Expansion|Death|0
2165575|NCT01286987|3784782|FG007|Part 2: Dose Expansion|Death|0
2165576|NCT01286987|3784783|FG008|Part 2: Dose Expansion|Death|0
2165577|NCT01286987|3784784|FG009|Part 2: Dose Expansion|Death|0
2165578|NCT01286987|3784785|FG010|Part 2: Dose Expansion|Death|0
2165579|NCT01286987|3784786|FG011|Part 2: Dose Expansion|Death|0
2165580|NCT01286987|3784787|FG012|Part 2: Dose Expansion|Death|1
2165581|NCT01286987|3784788|FG013|Part 2: Dose Expansion|Death|1
2165582|NCT01286987|3784789|FG014|Part 2: Dose Expansion|Death|0
2165583|NCT01286987|3784775|FG000|Part 2: Dose Expansion|Physician Decision|0
2165584|NCT01286987|3784776|FG001|Part 2: Dose Expansion|Physician Decision|0
2165585|NCT01286987|3784777|FG002|Part 2: Dose Expansion|Physician Decision|0
2165586|NCT01286987|3784778|FG003|Part 2: Dose Expansion|Physician Decision|0
2165587|NCT01286987|3784779|FG004|Part 2: Dose Expansion|Physician Decision|0
2165588|NCT01286987|3784780|FG005|Part 2: Dose Expansion|Physician Decision|0
2165589|NCT01286987|3784781|FG006|Part 2: Dose Expansion|Physician Decision|0
2165590|NCT01286987|3784782|FG007|Part 2: Dose Expansion|Physician Decision|0
2165591|NCT01286987|3784783|FG008|Part 2: Dose Expansion|Physician Decision|0
2165592|NCT01286987|3784784|FG009|Part 2: Dose Expansion|Physician Decision|0
2165593|NCT01286987|3784785|FG010|Part 2: Dose Expansion|Physician Decision|1
2295142|NCT02544152|3990343|FG000|Overall Study|Withdrawal by Subject|0
2295143|NCT02544152|3990344|FG001|Overall Study|Withdrawal by Subject|3
2295144|NCT02544152|3990343|FG000|Overall Study|Other|1
2165594|NCT01286987|3784786|FG011|Part 2: Dose Expansion|Physician Decision|1
2165595|NCT01286987|3784787|FG012|Part 2: Dose Expansion|Physician Decision|0
2165596|NCT01286987|3784788|FG013|Part 2: Dose Expansion|Physician Decision|1
2165597|NCT01286987|3784789|FG014|Part 2: Dose Expansion|Physician Decision|0
2165598|NCT01286987|3784775|FG000|Part 2: Dose Expansion|Other|0
2165599|NCT01286987|3784776|FG001|Part 2: Dose Expansion|Other|0
2165600|NCT01286987|3784777|FG002|Part 2: Dose Expansion|Other|0
2165601|NCT01286987|3784778|FG003|Part 2: Dose Expansion|Other|0
2165602|NCT01286987|3784779|FG004|Part 2: Dose Expansion|Other|0
2165603|NCT01286987|3784780|FG005|Part 2: Dose Expansion|Other|0
2165604|NCT01286987|3784781|FG006|Part 2: Dose Expansion|Other|0
2165605|NCT01286987|3784782|FG007|Part 2: Dose Expansion|Other|0
2165606|NCT01286987|3784783|FG008|Part 2: Dose Expansion|Other|0
2165607|NCT01286987|3784784|FG009|Part 2: Dose Expansion|Other|0
2165608|NCT01286987|3784785|FG010|Part 2: Dose Expansion|Other|0
2165609|NCT01286987|3784786|FG011|Part 2: Dose Expansion|Other|0
2165610|NCT01286987|3784787|FG012|Part 2: Dose Expansion|Other|0
2165611|NCT01286987|3784788|FG013|Part 2: Dose Expansion|Other|1
2165612|NCT01286987|3784789|FG014|Part 2: Dose Expansion|Other|0
2165613|NCT01286987|3784775|FG000|Part 2: Dose Expansion|Progressive Disease|0
2165614|NCT01286987|3784776|FG001|Part 2: Dose Expansion|Progressive Disease|0
2165615|NCT01286987|3784777|FG002|Part 2: Dose Expansion|Progressive Disease|0
2165616|NCT01286987|3784778|FG003|Part 2: Dose Expansion|Progressive Disease|0
2165617|NCT01286987|3784779|FG004|Part 2: Dose Expansion|Progressive Disease|0
2165618|NCT01286987|3784780|FG005|Part 2: Dose Expansion|Progressive Disease|0
2165619|NCT01286987|3784781|FG006|Part 2: Dose Expansion|Progressive Disease|0
2165620|NCT01286987|3784782|FG007|Part 2: Dose Expansion|Progressive Disease|0
2165621|NCT01286987|3784783|FG008|Part 2: Dose Expansion|Progressive Disease|0
2165622|NCT01286987|3784784|FG009|Part 2: Dose Expansion|Progressive Disease|11
2165623|NCT01286987|3784785|FG010|Part 2: Dose Expansion|Progressive Disease|6
2165624|NCT01286987|3784786|FG011|Part 2: Dose Expansion|Progressive Disease|7
2165625|NCT01286987|3784787|FG012|Part 2: Dose Expansion|Progressive Disease|11
2165626|NCT01286987|3784788|FG013|Part 2: Dose Expansion|Progressive Disease|19
2165627|NCT01286987|3784789|FG014|Part 2: Dose Expansion|Progressive Disease|2
2165628|NCT01286987|3784775|FG000|Part 2: Dose Expansion|Clinical Progression|0
2165629|NCT01286987|3784776|FG001|Part 2: Dose Expansion|Clinical Progression|0
2165630|NCT01286987|3784777|FG002|Part 2: Dose Expansion|Clinical Progression|0
2165631|NCT01286987|3784778|FG003|Part 2: Dose Expansion|Clinical Progression|0
2165632|NCT01286987|3784779|FG004|Part 2: Dose Expansion|Clinical Progression|0
2165633|NCT01286987|3784780|FG005|Part 2: Dose Expansion|Clinical Progression|0
2165634|NCT01286987|3784781|FG006|Part 2: Dose Expansion|Clinical Progression|0
2165635|NCT01286987|3784782|FG007|Part 2: Dose Expansion|Clinical Progression|0
2165636|NCT01286987|3784783|FG008|Part 2: Dose Expansion|Clinical Progression|0
2165637|NCT01286987|3784784|FG009|Part 2: Dose Expansion|Clinical Progression|0
2165638|NCT01286987|3784785|FG010|Part 2: Dose Expansion|Clinical Progression|2
2165639|NCT01286987|3784786|FG011|Part 2: Dose Expansion|Clinical Progression|2
2165640|NCT01286987|3784787|FG012|Part 2: Dose Expansion|Clinical Progression|0
2208205|NCT01636947|3847588|FG001|Overall Study|Lost to Follow-up|0
2208206|NCT01636947|3847587|FG000|Overall Study|Protocol Violation|1
2165641|NCT01286987|3784788|FG013|Part 2: Dose Expansion|Clinical Progression|2
2165642|NCT01286987|3784789|FG014|Part 2: Dose Expansion|Clinical Progression|0
2165643|NCT01286987|3784775|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0
2165644|NCT01286987|3784776|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0
2165645|NCT01286987|3784777|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0
2165646|NCT01286987|3784778|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0
2165647|NCT01286987|3784779|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0
2165648|NCT01286987|3784780|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0
2165649|NCT01286987|3784781|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0
2165650|NCT01286987|3784782|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0
2165651|NCT01286987|3784783|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0
2165652|NCT01286987|3784784|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0
2165653|NCT01286987|3784785|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1
2165654|NCT01286987|3784786|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0
2165655|NCT01286987|3784787|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0
2165656|NCT01286987|3784788|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0
2165657|NCT01286987|3784789|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0
2165658|NCT01287013|3784833|FG000|Overall Study|Non-evaluable|3
2165659|NCT01287013|3784834|FG001|Overall Study|Non-evaluable|5
2165660|NCT01287013|3784835|FG002|Overall Study|Non-evaluable|21
2165661|NCT01287039|3784845|FG000|Overall Study|Noncompliance with study procedures|0
2165662|NCT01287039|3784846|FG001|Overall Study|Noncompliance with study procedures|1
2165663|NCT01287039|3784845|FG000|Overall Study|Change of location/residence|0
2165664|NCT01287039|3784846|FG001|Overall Study|Change of location/residence|3
2165665|NCT01287039|3784845|FG000|Overall Study|Elective surgery|0
2165666|NCT01287039|3784846|FG001|Overall Study|Elective surgery|1
2165667|NCT01287039|3784845|FG000|Overall Study|Protocol Violation|2
2165668|NCT01287039|3784846|FG001|Overall Study|Protocol Violation|3
2165669|NCT01287039|3784845|FG000|Overall Study|Excluded medication taken|1
2165670|NCT01287039|3784846|FG001|Overall Study|Excluded medication taken|0
2165671|NCT01287039|3784845|FG000|Overall Study|Noncompliance with study medication|0
2165672|NCT01287039|3784846|FG001|Overall Study|Noncompliance with study medication|1
2165673|NCT01287039|3784845|FG000|Overall Study|Problem with travel|0
2165674|NCT01287039|3784846|FG001|Overall Study|Problem with travel|1
2165675|NCT01287039|3784845|FG000|Overall Study|Death|1
2165676|NCT01287039|3784846|FG001|Overall Study|Death|0
2165677|NCT01287039|3784845|FG000|Overall Study|Change of residence|1
2165678|NCT01287039|3784846|FG001|Overall Study|Change of residence|0
2165679|NCT01287039|3784845|FG000|Overall Study|Adverse Event|7
2165680|NCT01287039|3784846|FG001|Overall Study|Adverse Event|4
2165681|NCT01287039|3784845|FG000|Overall Study|Withdrawal by Subject|14
2165682|NCT01287039|3784846|FG001|Overall Study|Withdrawal by Subject|11
2165683|NCT01287039|3784845|FG000|Overall Study|Lost to Follow-up|3
2165684|NCT01287039|3784846|FG001|Overall Study|Lost to Follow-up|2
2165685|NCT01287065|3784852|FG000|Treatment Period 1|Adverse Event|0
2165686|NCT01287065|3784853|FG001|Treatment Period 1|Adverse Event|0
2165687|NCT01287065|3784854|FG002|Treatment Period 1|Adverse Event|0
2165688|NCT01287065|3784855|FG003|Treatment Period 1|Adverse Event|0
2165689|NCT01287065|3784856|FG004|Treatment Period 1|Adverse Event|1
2165690|NCT01287065|3784857|FG005|Treatment Period 1|Adverse Event|0
2165691|NCT01287065|3784852|FG000|Treatment Period 1|Withdrawal by Subject|0
2165692|NCT01287065|3784853|FG001|Treatment Period 1|Withdrawal by Subject|0
2165693|NCT01287065|3784854|FG002|Treatment Period 1|Withdrawal by Subject|0
2165694|NCT01287065|3784855|FG003|Treatment Period 1|Withdrawal by Subject|0
2165695|NCT01287065|3784856|FG004|Treatment Period 1|Withdrawal by Subject|0
2165696|NCT01287065|3784857|FG005|Treatment Period 1|Withdrawal by Subject|1
2165697|NCT01287104|3784878|FG000|Overall Study|Patient developed progressive disease|1
2165698|NCT01287104|3784879|FG001|Overall Study|Patient developed progressive disease|1
2165699|NCT01287104|3784880|FG002|Overall Study|Patient developed progressive disease|3
2165700|NCT01287104|3784881|FG003|Overall Study|Patient developed progressive disease|2
2165701|NCT01287104|3784878|FG000|Overall Study|Donor anaphylaxis|0
2165702|NCT01287104|3784879|FG001|Overall Study|Donor anaphylaxis|1
2165703|NCT01287104|3784880|FG002|Overall Study|Donor anaphylaxis|0
2165704|NCT01287104|3784881|FG003|Overall Study|Donor anaphylaxis|1
2165705|NCT01287104|3784878|FG000|Overall Study|Developed GVHD or complications of BMT|0
2165706|NCT01287104|3784879|FG001|Overall Study|Developed GVHD or complications of BMT|1
2165707|NCT01287104|3784880|FG002|Overall Study|Developed GVHD or complications of BMT|4
2165708|NCT01287104|3784881|FG003|Overall Study|Developed GVHD or complications of BMT|0
2165709|NCT01287104|3784878|FG000|Overall Study|Low donor chimerism|0
2165710|NCT01287104|3784879|FG001|Overall Study|Low donor chimerism|1
2165711|NCT01287104|3784880|FG002|Overall Study|Low donor chimerism|0
2165712|NCT01287104|3784881|FG003|Overall Study|Low donor chimerism|0
2165713|NCT01287104|3784878|FG000|Overall Study|NK cells did not meet release criteria|0
2165714|NCT01287104|3784879|FG001|Overall Study|NK cells did not meet release criteria|1
2165715|NCT01287104|3784880|FG002|Overall Study|NK cells did not meet release criteria|0
2165716|NCT01287104|3784881|FG003|Overall Study|NK cells did not meet release criteria|0
2165717|NCT01287117|3784902|FG000|Overall Study|Adverse Event|2
2165718|NCT01287117|3784903|FG001|Overall Study|Adverse Event|1
2165719|NCT01287117|3784904|FG002|Overall Study|Adverse Event|1
2165720|NCT01287117|3784905|FG003|Overall Study|Adverse Event|1
2165721|NCT01287117|3784902|FG000|Overall Study|Lost to Follow-up|1
2165722|NCT01287117|3784903|FG001|Overall Study|Lost to Follow-up|1
2165723|NCT01287117|3784904|FG002|Overall Study|Lost to Follow-up|0
2165724|NCT01287117|3784905|FG003|Overall Study|Lost to Follow-up|0
2165725|NCT01287117|3784902|FG000|Overall Study|Physician Decision|0
2165726|NCT01287117|3784903|FG001|Overall Study|Physician Decision|1
2165727|NCT01287117|3784904|FG002|Overall Study|Physician Decision|1
2165728|NCT01287117|3784905|FG003|Overall Study|Physician Decision|1
2165729|NCT01287117|3784902|FG000|Overall Study|Patient/Legal Guardian's Decision|2
2165730|NCT01287117|3784903|FG001|Overall Study|Patient/Legal Guardian's Decision|6
2165731|NCT01287117|3784904|FG002|Overall Study|Patient/Legal Guardian's Decision|8
2165732|NCT01287117|3784905|FG003|Overall Study|Patient/Legal Guardian's Decision|5
2165733|NCT01287117|3784902|FG000|Overall Study|Disease Progression|10
2208207|NCT01636947|3847588|FG001|Overall Study|Protocol Violation|1
2208208|NCT01636947|3847587|FG000|Overall Study|Withdrawal by Subject|3
2208209|NCT01636947|3847588|FG001|Overall Study|Withdrawal by Subject|3
2165734|NCT01287117|3784903|FG001|Overall Study|Disease Progression|5
2165735|NCT01287117|3784904|FG002|Overall Study|Disease Progression|6
2165736|NCT01287117|3784905|FG003|Overall Study|Disease Progression|5
2165737|NCT01287195|3784915|FG000|Overall Study|Withdrawal by Subject|2
2165738|NCT01287221|3784932|FG000|Overall Study|Lack of Perceived Benefit|1
2165739|NCT01287221|3784933|FG001|Overall Study|Lack of Perceived Benefit|1
2165740|NCT01287221|3784932|FG000|Overall Study|Adverse Event|3
2165741|NCT01287221|3784933|FG001|Overall Study|Adverse Event|3
2165742|NCT01287221|3784932|FG000|Overall Study|Withdrawal by Subject|0
2165743|NCT01287221|3784933|FG001|Overall Study|Withdrawal by Subject|1
2179636|NCT01394991|3805283|FG001|Overall Study|Protocol Violation|1
2179637|NCT01394991|3805282|FG000|Overall Study|Withdrawal by Subject|20
2179638|NCT01394991|3805283|FG001|Overall Study|Withdrawal by Subject|17
2179639|NCT01394991|3805282|FG000|Overall Study|Chemotherapy Termination|10
2179640|NCT01394991|3805283|FG001|Overall Study|Chemotherapy Termination|15
2179641|NCT01394991|3805282|FG000|Overall Study|Disease Progression|7
2165744|NCT01287364|3784941|FG000|Overall Study|Adverse Event|0
2165745|NCT01287364|3784942|FG001|Overall Study|Adverse Event|3
2165746|NCT01287364|3784941|FG000|Overall Study|Protocol Violation|5
2165747|NCT01287364|3784942|FG001|Overall Study|Protocol Violation|5
2165748|NCT01287364|3784941|FG000|Overall Study|Other Reason|4
2165749|NCT01287364|3784942|FG001|Overall Study|Other Reason|2
2165750|NCT01287403|3784974|FG000|1st Intervention (1 Day)|Adverse Event|1
2165751|NCT01287416|3784990|FG000|Pre-post Training|Withdrawal by Subject|17
2295145|NCT02544152|3990344|FG001|Overall Study|Other|0
2295146|NCT02544217|3990356|FG000|Overall Study|Withdrawal by Subject|1
2295147|NCT02544217|3990357|FG001|Overall Study|Withdrawal by Subject|1
2295148|NCT02544217|3990358|FG002|Overall Study|Withdrawal by Subject|0
2295149|NCT02544217|3990359|FG003|Overall Study|Withdrawal by Subject|0
2295150|NCT02544217|3990360|FG004|Overall Study|Withdrawal by Subject|0
2295151|NCT02544217|3990361|FG005|Overall Study|Withdrawal by Subject|0
2295152|NCT02544321|3990430|FG000|Overall Study|Withdrawal by Subject|1
2165752|NCT01287416|3784991|FG001|Pre-post Training|Withdrawal by Subject|24
2165753|NCT01287416|3784990|FG000|Pre-post Training|Lost to Follow-up|5
2165754|NCT01287416|3784991|FG001|Pre-post Training|Lost to Follow-up|1
2165755|NCT01287416|3784990|FG000|6 Month Follow-up|Lost to Follow-up|3
2165756|NCT01287416|3784991|FG001|6 Month Follow-up|Lost to Follow-up|2
2165757|NCT01287520|3785006|FG000|Overall Study|Adverse Event|2
2165758|NCT01287520|3785007|FG001|Overall Study|Adverse Event|2
2165759|NCT01287520|3785008|FG002|Overall Study|Adverse Event|2
2165760|NCT01287520|3785009|FG003|Overall Study|Adverse Event|1
2165761|NCT01287520|3785010|FG004|Overall Study|Adverse Event|1
2165762|NCT01287520|3785011|FG005|Overall Study|Adverse Event|2
2165763|NCT01287520|3785012|FG006|Overall Study|Adverse Event|0
2165764|NCT01287520|3785013|FG007|Overall Study|Adverse Event|2
2165765|NCT01287520|3785014|FG008|Overall Study|Adverse Event|0
2165766|NCT01287520|3785006|FG000|Overall Study|Physician Decision|1
2165767|NCT01287520|3785007|FG001|Overall Study|Physician Decision|1
2165768|NCT01287520|3785008|FG002|Overall Study|Physician Decision|2
2165769|NCT01287520|3785009|FG003|Overall Study|Physician Decision|0
2165770|NCT01287520|3785010|FG004|Overall Study|Physician Decision|1
2165771|NCT01287520|3785011|FG005|Overall Study|Physician Decision|1
2165772|NCT01287520|3785012|FG006|Overall Study|Physician Decision|0
2165773|NCT01287520|3785013|FG007|Overall Study|Physician Decision|1
2165774|NCT01287520|3785014|FG008|Overall Study|Physician Decision|0
2165775|NCT01287520|3785006|FG000|Overall Study|Progressive disease|0
2165776|NCT01287520|3785007|FG001|Overall Study|Progressive disease|4
2165777|NCT01287520|3785008|FG002|Overall Study|Progressive disease|1
2165778|NCT01287520|3785009|FG003|Overall Study|Progressive disease|6
2165779|NCT01287520|3785010|FG004|Overall Study|Progressive disease|1
2165780|NCT01287520|3785011|FG005|Overall Study|Progressive disease|0
2165781|NCT01287520|3785012|FG006|Overall Study|Progressive disease|2
2165782|NCT01287520|3785013|FG007|Overall Study|Progressive disease|2
2165783|NCT01287520|3785014|FG008|Overall Study|Progressive disease|4
2165784|NCT01287520|3785006|FG000|Overall Study|Withdrawal by Subject|0
2165785|NCT01287520|3785007|FG001|Overall Study|Withdrawal by Subject|0
2165786|NCT01287520|3785008|FG002|Overall Study|Withdrawal by Subject|0
2165787|NCT01287520|3785009|FG003|Overall Study|Withdrawal by Subject|0
2165788|NCT01287520|3785010|FG004|Overall Study|Withdrawal by Subject|0
2165789|NCT01287520|3785011|FG005|Overall Study|Withdrawal by Subject|1
2165790|NCT01287520|3785012|FG006|Overall Study|Withdrawal by Subject|0
2165791|NCT01287520|3785013|FG007|Overall Study|Withdrawal by Subject|0
2165792|NCT01287520|3785014|FG008|Overall Study|Withdrawal by Subject|1
2165793|NCT01287611|3785065|FG000|Overall Study|Lost to Follow-up|29
2165794|NCT01287611|3785066|FG001|Overall Study|Lost to Follow-up|16
2165795|NCT01287611|3785065|FG000|Overall Study|Exclusion due to expanded Kerr incision|4
2165796|NCT01287611|3785066|FG001|Overall Study|Exclusion due to expanded Kerr incision|3
2165797|NCT01287754|3785076|FG000|Overall Study|Death|2
2165798|NCT01287754|3785077|FG001|Overall Study|Death|12
2165799|NCT01287754|3785076|FG000|Overall Study|Lost to Follow-up|1
2165800|NCT01287754|3785077|FG001|Overall Study|Lost to Follow-up|6
2165801|NCT01287754|3785076|FG000|Overall Study|Protocol Violation|0
2165802|NCT01287754|3785077|FG001|Overall Study|Protocol Violation|3
2165803|NCT01287832|3785085|FG000|Overall Study|Adverse Event|1
2165804|NCT01287832|3785086|FG001|Overall Study|Adverse Event|0
2165805|NCT01287832|3785085|FG000|Overall Study|Death|0
2165806|NCT01287832|3785086|FG001|Overall Study|Death|1
2165807|NCT01287897|3785096|FG000|Overall Study|Adverse Event|5
2165808|NCT01287897|3785097|FG001|Overall Study|Adverse Event|3
2165809|NCT01287897|3785098|FG002|Overall Study|Adverse Event|6
2165810|NCT01287897|3785099|FG003|Overall Study|Adverse Event|4
2165811|NCT01287897|3785096|FG000|Overall Study|Lack of Efficacy|2
2295153|NCT02544321|3990431|FG001|Overall Study|Withdrawal by Subject|2
2295154|NCT02544321|3990430|FG000|Overall Study|Adverse Event|1
2165812|NCT01287897|3785097|FG001|Overall Study|Lack of Efficacy|0
2165813|NCT01287897|3785098|FG002|Overall Study|Lack of Efficacy|0
2165814|NCT01287897|3785099|FG003|Overall Study|Lack of Efficacy|0
2165815|NCT01287897|3785096|FG000|Overall Study|Protocol Violation|1
2165816|NCT01287897|3785097|FG001|Overall Study|Protocol Violation|1
2165817|NCT01287897|3785098|FG002|Overall Study|Protocol Violation|0
2165818|NCT01287897|3785099|FG003|Overall Study|Protocol Violation|1
2165819|NCT01287897|3785096|FG000|Overall Study|Lost to Follow-up|0
2165820|NCT01287897|3785097|FG001|Overall Study|Lost to Follow-up|0
2165821|NCT01287897|3785098|FG002|Overall Study|Lost to Follow-up|2
2165822|NCT01287897|3785099|FG003|Overall Study|Lost to Follow-up|0
2165823|NCT01287897|3785096|FG000|Overall Study|Withdrawal by Subject|1
2165824|NCT01287897|3785097|FG001|Overall Study|Withdrawal by Subject|5
2165825|NCT01287897|3785098|FG002|Overall Study|Withdrawal by Subject|3
2165826|NCT01287897|3785099|FG003|Overall Study|Withdrawal by Subject|2
2165827|NCT01287897|3785096|FG000|Overall Study|Not consented properly|0
2165828|NCT01287897|3785097|FG001|Overall Study|Not consented properly|1
2165829|NCT01287897|3785098|FG002|Overall Study|Not consented properly|0
2165830|NCT01287897|3785099|FG003|Overall Study|Not consented properly|0
2165831|NCT01287897|3785096|FG000|Overall Study|Not meeting entrance criteria|1
2165832|NCT01287897|3785097|FG001|Overall Study|Not meeting entrance criteria|1
2165833|NCT01287897|3785098|FG002|Overall Study|Not meeting entrance criteria|0
2165834|NCT01287897|3785099|FG003|Overall Study|Not meeting entrance criteria|0
2165835|NCT01287897|3785096|FG000|Overall Study|Other|1
2165836|NCT01287897|3785097|FG001|Overall Study|Other|0
2165837|NCT01287897|3785098|FG002|Overall Study|Other|1
2165838|NCT01287897|3785099|FG003|Overall Study|Other|0
2165839|NCT01288053|3785117|FG000|Overall Study|Death|1
2165840|NCT01288079|3785125|FG000|Overall Study|Withdrawal by Subject|2
2165841|NCT01288079|3785126|FG001|Overall Study|Withdrawal by Subject|4
2165842|NCT01288079|3785127|FG002|Overall Study|Withdrawal by Subject|1
2165843|NCT01288079|3785128|FG003|Overall Study|Withdrawal by Subject|0
2165844|NCT01288079|3785125|FG000|Overall Study|Adverse Event|2
2165845|NCT01288079|3785126|FG001|Overall Study|Adverse Event|1
2165846|NCT01288079|3785127|FG002|Overall Study|Adverse Event|2
2165847|NCT01288079|3785128|FG003|Overall Study|Adverse Event|3
2165848|NCT01288079|3785125|FG000|Overall Study|Severe Non-Compliance to Protocol|1
2165849|NCT01288079|3785126|FG001|Overall Study|Severe Non-Compliance to Protocol|3
2165850|NCT01288079|3785127|FG002|Overall Study|Severe Non-Compliance to Protocol|1
2165851|NCT01288079|3785128|FG003|Overall Study|Severe Non-Compliance to Protocol|3
2165852|NCT01288079|3785125|FG000|Overall Study|Condition under Investigation Worsened|0
2165853|NCT01288079|3785126|FG001|Overall Study|Condition under Investigation Worsened|0
2165854|NCT01288079|3785127|FG002|Overall Study|Condition under Investigation Worsened|0
2165855|NCT01288079|3785128|FG003|Overall Study|Condition under Investigation Worsened|1
2165856|NCT01288079|3785125|FG000|Overall Study|Lack of Efficacy|2
2165857|NCT01288079|3785126|FG001|Overall Study|Lack of Efficacy|2
2165858|NCT01288079|3785127|FG002|Overall Study|Lack of Efficacy|0
2165859|NCT01288079|3785128|FG003|Overall Study|Lack of Efficacy|2
2165860|NCT01288079|3785125|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
2165861|NCT01288079|3785126|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
2165862|NCT01288079|3785127|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
2165863|NCT01288079|3785128|FG003|Overall Study|Study-Specific Withdrawal Criteria|0
2165864|NCT01288079|3785125|FG000|Overall Study|Lost to Follow-up|1
2165865|NCT01288079|3785126|FG001|Overall Study|Lost to Follow-up|1
2165866|NCT01288079|3785127|FG002|Overall Study|Lost to Follow-up|1
2165867|NCT01288079|3785128|FG003|Overall Study|Lost to Follow-up|0
2165868|NCT01288079|3785125|FG000|Overall Study|Other or Study Termination|11
2165869|NCT01288079|3785126|FG001|Overall Study|Other or Study Termination|15
2165870|NCT01288079|3785127|FG002|Overall Study|Other or Study Termination|14
2165871|NCT01288079|3785128|FG003|Overall Study|Other or Study Termination|8
2165872|NCT01288209|3785140|FG000|Overall Study|Withdrawal by Subject|1
2165873|NCT01288209|3785141|FG001|Overall Study|Withdrawal by Subject|3
2165874|NCT01288209|3785140|FG000|Overall Study|Other|1
2165875|NCT01288209|3785141|FG001|Overall Study|Other|0
2165876|NCT01288287|3785147|FG000|Overall Study|Lost to Follow-up|8
2165877|NCT01288287|3785147|FG000|Overall Study|Withdrawal by Subject|4
2165878|NCT01288287|3785147|FG000|Overall Study|Lack of Efficacy|13
2165879|NCT01288287|3785147|FG000|Overall Study|Other Reason|13
2165880|NCT01288287|3785147|FG000|Overall Study|Unknown Reason|1
2165881|NCT01288287|3785147|FG000|Overall Study|Unknown Status|7
2165882|NCT01288430|3785162|FG000|Part 1|Progressive disease|2
2165883|NCT01288430|3785163|FG001|Part 1|Progressive disease|1
2165884|NCT01288430|3785164|FG002|Part 1|Progressive disease|1
2165885|NCT01288430|3785165|FG003|Part 1|Progressive disease|6
2165886|NCT01288430|3785166|FG004|Part 1|Progressive disease|2
2165887|NCT01288430|3785167|FG005|Part 1|Progressive disease|4
2165888|NCT01288430|3785168|FG006|Part 1|Progressive disease|2
2165889|NCT01288430|3785169|FG007|Part 1|Progressive disease|0
2165890|NCT01288430|3785170|FG008|Part 1|Progressive disease|0
2165891|NCT01288430|3785171|FG009|Part 1|Progressive disease|0
2165892|NCT01288430|3785162|FG000|Part 1|Clinical disease progression|0
2165893|NCT01288430|3785163|FG001|Part 1|Clinical disease progression|0
2165894|NCT01288430|3785164|FG002|Part 1|Clinical disease progression|1
2165895|NCT01288430|3785165|FG003|Part 1|Clinical disease progression|0
2165896|NCT01288430|3785166|FG004|Part 1|Clinical disease progression|0
2165897|NCT01288430|3785167|FG005|Part 1|Clinical disease progression|2
2165898|NCT01288430|3785168|FG006|Part 1|Clinical disease progression|2
2165899|NCT01288430|3785169|FG007|Part 1|Clinical disease progression|0
2165900|NCT01288430|3785170|FG008|Part 1|Clinical disease progression|0
2165901|NCT01288430|3785171|FG009|Part 1|Clinical disease progression|0
2165902|NCT01288430|3785162|FG000|Part 1|Death due to disease progression|0
2165903|NCT01288430|3785163|FG001|Part 1|Death due to disease progression|0
2165904|NCT01288430|3785164|FG002|Part 1|Death due to disease progression|0
2165905|NCT01288430|3785165|FG003|Part 1|Death due to disease progression|0
2165906|NCT01288430|3785166|FG004|Part 1|Death due to disease progression|1
2165907|NCT01288430|3785167|FG005|Part 1|Death due to disease progression|0
2165908|NCT01288430|3785168|FG006|Part 1|Death due to disease progression|0
2165909|NCT01288430|3785169|FG007|Part 1|Death due to disease progression|0
2165910|NCT01288430|3785170|FG008|Part 1|Death due to disease progression|0
2165911|NCT01288430|3785171|FG009|Part 1|Death due to disease progression|0
2165912|NCT01288430|3785162|FG000|Part 1|Adverse Event|0
2165913|NCT01288430|3785163|FG001|Part 1|Adverse Event|0
2165914|NCT01288430|3785164|FG002|Part 1|Adverse Event|3
2165915|NCT01288430|3785165|FG003|Part 1|Adverse Event|1
2165916|NCT01288430|3785166|FG004|Part 1|Adverse Event|0
2165917|NCT01288430|3785167|FG005|Part 1|Adverse Event|0
2165918|NCT01288430|3785168|FG006|Part 1|Adverse Event|2
2165919|NCT01288430|3785169|FG007|Part 1|Adverse Event|0
2165920|NCT01288430|3785170|FG008|Part 1|Adverse Event|0
2165921|NCT01288430|3785171|FG009|Part 1|Adverse Event|0
2165922|NCT01288430|3785162|FG000|Part 1|Other|0
2165923|NCT01288430|3785163|FG001|Part 1|Other|2
2165924|NCT01288430|3785164|FG002|Part 1|Other|0
2165925|NCT01288430|3785165|FG003|Part 1|Other|0
2165926|NCT01288430|3785166|FG004|Part 1|Other|0
2165927|NCT01288430|3785167|FG005|Part 1|Other|0
2165928|NCT01288430|3785168|FG006|Part 1|Other|1
2165929|NCT01288430|3785169|FG007|Part 1|Other|0
2165930|NCT01288430|3785170|FG008|Part 1|Other|0
2165931|NCT01288430|3785171|FG009|Part 1|Other|0
2165932|NCT01288430|3785162|FG000|Part 2|Progressive disease|0
2165933|NCT01288430|3785163|FG001|Part 2|Progressive disease|0
2165934|NCT01288430|3785164|FG002|Part 2|Progressive disease|0
2165935|NCT01288430|3785165|FG003|Part 2|Progressive disease|0
2165936|NCT01288430|3785166|FG004|Part 2|Progressive disease|0
2165937|NCT01288430|3785167|FG005|Part 2|Progressive disease|0
2165938|NCT01288430|3785168|FG006|Part 2|Progressive disease|0
2165939|NCT01288430|3785169|FG007|Part 2|Progressive disease|8
2165940|NCT01288430|3785170|FG008|Part 2|Progressive disease|7
2165941|NCT01288430|3785171|FG009|Part 2|Progressive disease|2
2165942|NCT01288430|3785162|FG000|Part 2|Clinical disease progression|0
2165943|NCT01288430|3785163|FG001|Part 2|Clinical disease progression|0
2165944|NCT01288430|3785164|FG002|Part 2|Clinical disease progression|0
2165945|NCT01288430|3785165|FG003|Part 2|Clinical disease progression|0
2165946|NCT01288430|3785166|FG004|Part 2|Clinical disease progression|0
2165947|NCT01288430|3785167|FG005|Part 2|Clinical disease progression|0
2165948|NCT01288430|3785168|FG006|Part 2|Clinical disease progression|0
2165949|NCT01288430|3785169|FG007|Part 2|Clinical disease progression|2
2165950|NCT01288430|3785170|FG008|Part 2|Clinical disease progression|0
2165951|NCT01288430|3785171|FG009|Part 2|Clinical disease progression|0
2165952|NCT01288430|3785162|FG000|Part 2|Withdrawal by Subject|0
2165953|NCT01288430|3785163|FG001|Part 2|Withdrawal by Subject|0
2165954|NCT01288430|3785164|FG002|Part 2|Withdrawal by Subject|0
2165955|NCT01288430|3785165|FG003|Part 2|Withdrawal by Subject|0
2165956|NCT01288430|3785166|FG004|Part 2|Withdrawal by Subject|0
2165957|NCT01288430|3785167|FG005|Part 2|Withdrawal by Subject|0
2165958|NCT01288430|3785168|FG006|Part 2|Withdrawal by Subject|0
2165959|NCT01288430|3785169|FG007|Part 2|Withdrawal by Subject|1
2165960|NCT01288430|3785170|FG008|Part 2|Withdrawal by Subject|4
2165961|NCT01288430|3785171|FG009|Part 2|Withdrawal by Subject|0
2165962|NCT01288430|3785162|FG000|Part 2|Adverse Event|0
2165963|NCT01288430|3785163|FG001|Part 2|Adverse Event|0
2165964|NCT01288430|3785164|FG002|Part 2|Adverse Event|0
2165965|NCT01288430|3785165|FG003|Part 2|Adverse Event|0
2165966|NCT01288430|3785166|FG004|Part 2|Adverse Event|0
2165967|NCT01288430|3785167|FG005|Part 2|Adverse Event|0
2165968|NCT01288430|3785168|FG006|Part 2|Adverse Event|0
2165969|NCT01288430|3785169|FG007|Part 2|Adverse Event|1
2165970|NCT01288430|3785170|FG008|Part 2|Adverse Event|1
2165971|NCT01288430|3785171|FG009|Part 2|Adverse Event|0
2165972|NCT01288430|3785162|FG000|Part 2|Other|0
2165973|NCT01288430|3785163|FG001|Part 2|Other|0
2165974|NCT01288430|3785164|FG002|Part 2|Other|0
2165975|NCT01288430|3785165|FG003|Part 2|Other|0
2165976|NCT01288430|3785166|FG004|Part 2|Other|0
2165977|NCT01288430|3785167|FG005|Part 2|Other|0
2165978|NCT01288430|3785168|FG006|Part 2|Other|0
2165979|NCT01288430|3785169|FG007|Part 2|Other|0
2165980|NCT01288430|3785170|FG008|Part 2|Other|0
2165981|NCT01288430|3785171|FG009|Part 2|Other|1
2165982|NCT01288443|3785204|FG000|Overall Study|Adverse Event|0
2165983|NCT01288443|3785205|FG001|Overall Study|Adverse Event|0
2165984|NCT01288443|3785206|FG002|Overall Study|Adverse Event|1
2165985|NCT01288443|3785207|FG003|Overall Study|Adverse Event|1
2165986|NCT01288443|3785208|FG004|Overall Study|Adverse Event|3
2165987|NCT01288443|3785209|FG005|Overall Study|Adverse Event|1
2165988|NCT01288443|3785204|FG000|Overall Study|Poor compliance to protocol|0
2165989|NCT01288443|3785205|FG001|Overall Study|Poor compliance to protocol|0
2165990|NCT01288443|3785206|FG002|Overall Study|Poor compliance to protocol|0
2165991|NCT01288443|3785207|FG003|Overall Study|Poor compliance to protocol|0
2165992|NCT01288443|3785208|FG004|Overall Study|Poor compliance to protocol|0
2165993|NCT01288443|3785209|FG005|Overall Study|Poor compliance to protocol|1
2165994|NCT01288443|3785204|FG000|Overall Study|Participant Moved|0
2165995|NCT01288443|3785205|FG001|Overall Study|Participant Moved|0
2165996|NCT01288443|3785206|FG002|Overall Study|Participant Moved|0
2165997|NCT01288443|3785207|FG003|Overall Study|Participant Moved|1
2165998|NCT01288443|3785208|FG004|Overall Study|Participant Moved|2
2165999|NCT01288443|3785209|FG005|Overall Study|Participant Moved|1
2166000|NCT01288443|3785204|FG000|Overall Study|Consent withdrawn by Participant|0
2166001|NCT01288443|3785205|FG001|Overall Study|Consent withdrawn by Participant|0
2166002|NCT01288443|3785206|FG002|Overall Study|Consent withdrawn by Participant|0
2166003|NCT01288443|3785207|FG003|Overall Study|Consent withdrawn by Participant|0
2166004|NCT01288443|3785208|FG004|Overall Study|Consent withdrawn by Participant|0
2166005|NCT01288443|3785209|FG005|Overall Study|Consent withdrawn by Participant|1
2166006|NCT01288443|3785204|FG000|Overall Study|Lost to Follow-up|0
2166007|NCT01288443|3785205|FG001|Overall Study|Lost to Follow-up|1
2166008|NCT01288443|3785206|FG002|Overall Study|Lost to Follow-up|0
2166009|NCT01288443|3785207|FG003|Overall Study|Lost to Follow-up|0
2166010|NCT01288443|3785208|FG004|Overall Study|Lost to Follow-up|0
2166011|NCT01288443|3785209|FG005|Overall Study|Lost to Follow-up|0
2166012|NCT01288443|3785204|FG000|Overall Study|Study drug auto-injector administration|0
2166013|NCT01288443|3785205|FG001|Overall Study|Study drug auto-injector administration|0
2166014|NCT01288443|3785206|FG002|Overall Study|Study drug auto-injector administration|0
2166015|NCT01288443|3785207|FG003|Overall Study|Study drug auto-injector administration|0
2166016|NCT01288443|3785208|FG004|Overall Study|Study drug auto-injector administration|1
2166017|NCT01288443|3785209|FG005|Overall Study|Study drug auto-injector administration|1
2166018|NCT01288443|3785204|FG000|Overall Study|Other than above|0
2166019|NCT01288443|3785205|FG001|Overall Study|Other than above|0
2166020|NCT01288443|3785206|FG002|Overall Study|Other than above|0
2166021|NCT01288443|3785207|FG003|Overall Study|Other than above|2
2166022|NCT01288443|3785208|FG004|Overall Study|Other than above|1
2166023|NCT01288443|3785209|FG005|Overall Study|Other than above|0
2166024|NCT01288469|3785226|FG000|Overall Study|Adverse Event|4
2166025|NCT01288469|3785227|FG001|Overall Study|Adverse Event|1
2166026|NCT01288469|3785228|FG002|Overall Study|Adverse Event|1
2166027|NCT01288469|3785226|FG000|Overall Study|Poor compliance to protocol|0
2166028|NCT01288469|3785227|FG001|Overall Study|Poor compliance to protocol|1
2166029|NCT01288469|3785228|FG002|Overall Study|Poor compliance to protocol|0
2166030|NCT01288469|3785226|FG000|Overall Study|Participant Moved|1
2166031|NCT01288469|3785227|FG001|Overall Study|Participant Moved|0
2166032|NCT01288469|3785228|FG002|Overall Study|Participant Moved|0
2166033|NCT01288469|3785226|FG000|Overall Study|Consent withdrawn by subject|1
2166034|NCT01288469|3785227|FG001|Overall Study|Consent withdrawn by subject|1
2166035|NCT01288469|3785228|FG002|Overall Study|Consent withdrawn by subject|1
2166036|NCT01288469|3785226|FG000|Overall Study|Exclusion criteria finally met|1
2166037|NCT01288469|3785227|FG001|Overall Study|Exclusion criteria finally met|0
2166038|NCT01288469|3785228|FG002|Overall Study|Exclusion criteria finally met|0
2166039|NCT01288612|3785252|FG000|Overall Study|Unable to contact|11
2166040|NCT01288612|3785253|FG001|Overall Study|Unable to contact|16
2166041|NCT01288612|3785254|FG002|Overall Study|Unable to contact|20
2166042|NCT01288612|3785252|FG000|Overall Study|Declined|78
2166043|NCT01288612|3785253|FG001|Overall Study|Declined|63
2166044|NCT01288612|3785254|FG002|Overall Study|Declined|62
2166045|NCT01288612|3785252|FG000|Overall Study|Unable to intubate|0
2166046|NCT01288612|3785253|FG001|Overall Study|Unable to intubate|3
2166047|NCT01288612|3785254|FG002|Overall Study|Unable to intubate|0
2166048|NCT01288729|3785264|FG000|Overall Study|Withdrawal by Subject|1
2166049|NCT01288729|3785265|FG001|Overall Study|Withdrawal by Subject|0
2166050|NCT01288911|3785320|FG000|Double-blind Period|Death|11
2166051|NCT01288911|3785321|FG001|Double-blind Period|Death|7
2166052|NCT01288911|3785320|FG000|Double-blind Period|Lost to Follow-up|0
2166053|NCT01288911|3785321|FG001|Double-blind Period|Lost to Follow-up|2
2166054|NCT01288911|3785320|FG000|Double-blind Period|Progressive Disease|75
2166055|NCT01288911|3785321|FG001|Double-blind Period|Progressive Disease|103
2166056|NCT01288911|3785320|FG000|Double-blind Period|Protocol Violation|1
2166057|NCT01288911|3785321|FG001|Double-blind Period|Protocol Violation|0
2166058|NCT01288911|3785320|FG000|Double-blind Period|Withdrawal by Subject|25
2166059|NCT01288911|3785321|FG001|Double-blind Period|Withdrawal by Subject|26
2166060|NCT01288911|3785320|FG000|Double-blind Period|Miscellaneous Reason|29
2166061|NCT01288911|3785321|FG001|Double-blind Period|Miscellaneous Reason|42
2166062|NCT01288911|3785320|FG000|Double-blind Period|Randomized but never received study drug|1
2166063|NCT01288911|3785321|FG001|Double-blind Period|Randomized but never received study drug|2
2166064|NCT01288911|3785320|FG000|Open-label Period (All Enzalutamide)|Death|0
2166065|NCT01288911|3785321|FG001|Open-label Period (All Enzalutamide)|Death|1
2166066|NCT01288911|3785320|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
2166067|NCT01288911|3785321|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
2166068|NCT01288911|3785320|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18
2166069|NCT01288911|3785321|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3
2166070|NCT01288911|3785320|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
2166071|NCT01288911|3785321|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
2166072|NCT01288911|3785320|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
2166073|NCT01288911|3785321|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
2166074|NCT01288911|3785320|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
2166075|NCT01288911|3785321|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
2166076|NCT01288937|3785332|FG000|Overall Study|Adverse Event|1
2166077|NCT01288937|3785333|FG001|Overall Study|Adverse Event|0
2166078|NCT01288976|3785342|FG000|Overall Study|Withdrawal by Subject|58
2166079|NCT01288976|3785343|FG001|Overall Study|Withdrawal by Subject|12
2166080|NCT01288976|3785344|FG002|Overall Study|Withdrawal by Subject|9
2166081|NCT01288976|3785342|FG000|Overall Study|Death|98
2166082|NCT01288976|3785343|FG001|Overall Study|Death|6
2166083|NCT01288976|3785344|FG002|Overall Study|Death|4
2166084|NCT01288976|3785342|FG000|Overall Study|Data unavailable|22
2166085|NCT01288976|3785343|FG001|Overall Study|Data unavailable|9
2166086|NCT01288976|3785344|FG002|Overall Study|Data unavailable|7
2166087|NCT01288989|3785355|FG000|Overall Study|Death|0
2166088|NCT01288989|3785356|FG001|Overall Study|Death|0
2166089|NCT01288989|3785357|FG002|Overall Study|Death|0
2166090|NCT01288989|3785358|FG003|Overall Study|Death|1
2166091|NCT01288989|3785359|FG004|Overall Study|Death|0
2166092|NCT01288989|3785355|FG000|Overall Study|Dose limiting toxicity|1
2166093|NCT01288989|3785356|FG001|Overall Study|Dose limiting toxicity|0
2166094|NCT01288989|3785357|FG002|Overall Study|Dose limiting toxicity|0
2166095|NCT01288989|3785358|FG003|Overall Study|Dose limiting toxicity|0
2166096|NCT01288989|3785359|FG004|Overall Study|Dose limiting toxicity|0
2166097|NCT01288989|3785355|FG000|Overall Study|Adverse Event|0
2166098|NCT01288989|3785356|FG001|Overall Study|Adverse Event|0
2166099|NCT01288989|3785357|FG002|Overall Study|Adverse Event|0
2166100|NCT01288989|3785358|FG003|Overall Study|Adverse Event|0
2166101|NCT01288989|3785359|FG004|Overall Study|Adverse Event|2
2166102|NCT01288989|3785355|FG000|Overall Study|Physician Decision|0
2166103|NCT01288989|3785356|FG001|Overall Study|Physician Decision|0
2166104|NCT01288989|3785357|FG002|Overall Study|Physician Decision|0
2166105|NCT01288989|3785358|FG003|Overall Study|Physician Decision|0
2166106|NCT01288989|3785359|FG004|Overall Study|Physician Decision|1
2166107|NCT01288989|3785355|FG000|Overall Study|Withdrawal by Subject|0
2166108|NCT01288989|3785356|FG001|Overall Study|Withdrawal by Subject|0
2166109|NCT01288989|3785357|FG002|Overall Study|Withdrawal by Subject|0
2166110|NCT01288989|3785358|FG003|Overall Study|Withdrawal by Subject|0
2166111|NCT01288989|3785359|FG004|Overall Study|Withdrawal by Subject|3
2166112|NCT01289015|3785379|FG000|Overall Study|Protocol Violation|12
2166113|NCT01289015|3785380|FG001|Overall Study|Protocol Violation|9
2166114|NCT01289015|3785379|FG000|Overall Study|Adverse Event|3
2166115|NCT01289015|3785380|FG001|Overall Study|Adverse Event|0
2166116|NCT01289015|3785379|FG000|Overall Study|Lost to Follow-up|33
2166117|NCT01289015|3785380|FG001|Overall Study|Lost to Follow-up|17
2166118|NCT01289015|3785379|FG000|Overall Study|Withdrawal by Subject|17
2166119|NCT01289015|3785380|FG001|Overall Study|Withdrawal by Subject|8
2166120|NCT01289015|3785379|FG000|Overall Study|Disease progression|1
2166121|NCT01289015|3785380|FG001|Overall Study|Disease progression|0
2166122|NCT01289015|3785379|FG000|Overall Study|Negative baseline culture and others|33
2166123|NCT01289015|3785380|FG001|Overall Study|Negative baseline culture and others|20
2166124|NCT01289028|3785386|FG000|Overall Study|Progressive Disease|49
2166125|NCT01289028|3785386|FG000|Overall Study|Adverse Event|14
2166126|NCT01289028|3785386|FG000|Overall Study|Withdrawal by Subject|6
2166127|NCT01289028|3785386|FG000|Overall Study|Death|4
2166128|NCT01289028|3785386|FG000|Overall Study|Lack of Efficacy|2
2166129|NCT01289028|3785386|FG000|Overall Study|No longer required|2
2166130|NCT01289028|3785386|FG000|Overall Study|Lost to Follow-up|2
2166131|NCT01289028|3785386|FG000|Overall Study|New Cancer Therapy|2
2166132|NCT01289028|3785386|FG000|Overall Study|Abnormal Lab Value|1
2166133|NCT01289028|3785386|FG000|Overall Study|Missing reason for discon|1
2166134|NCT01289041|3785392|FG000|Overall Study|Adverse Event|24
2166135|NCT01289041|3785392|FG000|Overall Study|Physician Decision|1
2166136|NCT01289041|3785392|FG000|Overall Study|Progressive Disease|41
2166137|NCT01289041|3785392|FG000|Overall Study|Withdrawal by Subject|3
2166138|NCT01289041|3785392|FG000|Overall Study|Death|1
2166139|NCT01289119|3785418|FG000|Overall Study|Adverse Event|2
2166140|NCT01289119|3785419|FG001|Overall Study|Adverse Event|1
2166141|NCT01289119|3785420|FG002|Overall Study|Adverse Event|0
2166142|NCT01289119|3785421|FG003|Overall Study|Adverse Event|2
2166143|NCT01289119|3785422|FG004|Overall Study|Adverse Event|1
2166144|NCT01289119|3785423|FG005|Overall Study|Adverse Event|0
2166145|NCT01289119|3785418|FG000|Overall Study|Major Protocol Deviation|2
2166146|NCT01289119|3785419|FG001|Overall Study|Major Protocol Deviation|1
2166147|NCT01289119|3785420|FG002|Overall Study|Major Protocol Deviation|3
2166148|NCT01289119|3785421|FG003|Overall Study|Major Protocol Deviation|0
2166149|NCT01289119|3785422|FG004|Overall Study|Major Protocol Deviation|2
2166150|NCT01289119|3785423|FG005|Overall Study|Major Protocol Deviation|1
2166151|NCT01289119|3785418|FG000|Overall Study|Lost to Follow-up|0
2166152|NCT01289119|3785419|FG001|Overall Study|Lost to Follow-up|3
2166153|NCT01289119|3785420|FG002|Overall Study|Lost to Follow-up|0
2166154|NCT01289119|3785421|FG003|Overall Study|Lost to Follow-up|0
2166155|NCT01289119|3785422|FG004|Overall Study|Lost to Follow-up|0
2166156|NCT01289119|3785423|FG005|Overall Study|Lost to Follow-up|1
2166157|NCT01289119|3785418|FG000|Overall Study|Withdrawal by Subject|4
2166158|NCT01289119|3785419|FG001|Overall Study|Withdrawal by Subject|2
2166159|NCT01289119|3785420|FG002|Overall Study|Withdrawal by Subject|4
2166160|NCT01289119|3785421|FG003|Overall Study|Withdrawal by Subject|3
2166161|NCT01289119|3785422|FG004|Overall Study|Withdrawal by Subject|1
2166162|NCT01289119|3785423|FG005|Overall Study|Withdrawal by Subject|1
2166163|NCT01289119|3785418|FG000|Overall Study|Pregnancy|0
2166164|NCT01289119|3785419|FG001|Overall Study|Pregnancy|1
2166165|NCT01289119|3785420|FG002|Overall Study|Pregnancy|0
2166166|NCT01289119|3785421|FG003|Overall Study|Pregnancy|0
2166167|NCT01289119|3785422|FG004|Overall Study|Pregnancy|0
2166168|NCT01289119|3785423|FG005|Overall Study|Pregnancy|0
2166169|NCT01289119|3785418|FG000|Overall Study|Lack of Efficacy|0
2166170|NCT01289119|3785419|FG001|Overall Study|Lack of Efficacy|1
2166171|NCT01289119|3785420|FG002|Overall Study|Lack of Efficacy|1
2166172|NCT01289119|3785421|FG003|Overall Study|Lack of Efficacy|1
2166173|NCT01289119|3785422|FG004|Overall Study|Lack of Efficacy|1
2166174|NCT01289119|3785423|FG005|Overall Study|Lack of Efficacy|1
2166175|NCT01289119|3785418|FG000|Overall Study|Other|1
2166176|NCT01289119|3785419|FG001|Overall Study|Other|0
2166177|NCT01289119|3785420|FG002|Overall Study|Other|1
2166178|NCT01289119|3785421|FG003|Overall Study|Other|0
2166179|NCT01289119|3785422|FG004|Overall Study|Other|0
2166180|NCT01289119|3785423|FG005|Overall Study|Other|0
2166181|NCT01289210|3785437|FG000|Overall Study|Adverse Event|1
2166182|NCT01289353|3785462|FG000|Overall Study|Lost to Follow-up|2
2166183|NCT01289418|3785482|FG000|Day 8 Survey|email address invalid|283
2166184|NCT01289418|3785482|FG000|Day 8 Survey|participants did not complete the survey|1935
2166185|NCT01289418|3785482|FG000|Day 29 Survey|email address invalid|283
2166186|NCT01289418|3785482|FG000|Day 29 Survey|participants did not complete the survey|2185
2166187|NCT01289574|3785550|FG000|Overall Study|Lack of Efficacy|4
2166188|NCT01289574|3785551|FG001|Overall Study|Lack of Efficacy|0
2166189|NCT01289574|3785552|FG002|Overall Study|Lack of Efficacy|1
2166190|NCT01289574|3785550|FG000|Overall Study|Lost to Follow-up|2
2166191|NCT01289574|3785551|FG001|Overall Study|Lost to Follow-up|0
2166192|NCT01289574|3785552|FG002|Overall Study|Lost to Follow-up|1
2166193|NCT01289574|3785550|FG000|Overall Study|Withdrawal by Subject|1
2166194|NCT01289574|3785551|FG001|Overall Study|Withdrawal by Subject|1
2166195|NCT01289574|3785552|FG002|Overall Study|Withdrawal by Subject|1
2166196|NCT01289574|3785550|FG000|Overall Study|Adverse Event|0
2166197|NCT01289574|3785551|FG001|Overall Study|Adverse Event|1
2166198|NCT01289574|3785552|FG002|Overall Study|Adverse Event|0
2166199|NCT01289574|3785550|FG000|Overall Study|Subject wanted alternate treatment|0
2166200|NCT01289574|3785551|FG001|Overall Study|Subject wanted alternate treatment|1
2166201|NCT01289574|3785552|FG002|Overall Study|Subject wanted alternate treatment|0
2166202|NCT01289639|3785564|FG000|Overall Study|Lost to Follow-up|1
2166203|NCT01289639|3785565|FG001|Overall Study|Lost to Follow-up|0
2166204|NCT01289639|3785566|FG002|Overall Study|Lost to Follow-up|0
2166205|NCT01289678|3785583|FG000|Overall Study|Physician Decision|6
2166206|NCT01289782|3785589|FG000|Overall Study|Lost to Follow-up|14
2166207|NCT01289782|3785590|FG001|Overall Study|Lost to Follow-up|7
2166208|NCT01289782|3785589|FG000|Overall Study|Protocol Violation|1
2166209|NCT01289782|3785590|FG001|Overall Study|Protocol Violation|1
2166210|NCT01289782|3785589|FG000|Overall Study|Withdrawal by Subject|8
2166211|NCT01289782|3785590|FG001|Overall Study|Withdrawal by Subject|2
2166212|NCT01289782|3785589|FG000|Overall Study|Sponsor's Decision|1
2166213|NCT01289782|3785590|FG001|Overall Study|Sponsor's Decision|0
2166214|NCT01289782|3785589|FG000|Overall Study|Reason not specified|1
2166215|NCT01289782|3785590|FG001|Overall Study|Reason not specified|2
2166216|NCT01289821|3785596|FG000|Treatment Period|Withdrawal by Subject|1
2166217|NCT01289821|3785596|FG000|Treatment Period|Physician Decision|3
2166218|NCT01289821|3785596|FG000|Treatment Period|Adverse Event|4
2166219|NCT01289821|3785596|FG000|Treatment Period|Radiological Progression|43
2166220|NCT01289821|3785596|FG000|Treatment Period|Clinical Progression|2
2166221|NCT01289821|3785596|FG000|Treatment Period|Therapeutic procedure required|1
2166222|NCT01289821|3785596|FG000|Safety Follow-up Period|Withdrawal by Subject|1
2166223|NCT01289821|3785596|FG000|Safety Follow-up Period|Protocol Violation|3
2166224|NCT01289821|3785596|FG000|Safety Follow-up Period|Unspecified reason|1
2166225|NCT01289821|3785596|FG000|Survival Follow-up Period|Protocol Violation|1
2166226|NCT01289821|3785596|FG000|Survival Follow-up Period|Lost to Follow-up|1
2166227|NCT01289821|3785596|FG000|Survival Follow-up Period|Clinical endpoint reached|16
2166228|NCT01289847|3785600|FG000|Overall Study|Patient could not comply with visits|1
2166229|NCT01289990|3785636|FG000|Overall Study|Death|0
2166230|NCT01289990|3785637|FG001|Overall Study|Death|0
2166231|NCT01289990|3785638|FG002|Overall Study|Death|0
2166232|NCT01289990|3785639|FG003|Overall Study|Death|1
2166233|NCT01289990|3785640|FG004|Overall Study|Death|2
2166234|NCT01289990|3785641|FG005|Overall Study|Death|1
2166235|NCT01289990|3785642|FG006|Overall Study|Death|0
2166236|NCT01289990|3785643|FG007|Overall Study|Death|0
2166237|NCT01289990|3785644|FG008|Overall Study|Death|0
2166238|NCT01289990|3785645|FG009|Overall Study|Death|0
2166239|NCT01289990|3785646|FG010|Overall Study|Death|0
2166240|NCT01289990|3785647|FG011|Overall Study|Death|1
2166241|NCT01289990|3785648|FG012|Overall Study|Death|0
2166242|NCT01289990|3785636|FG000|Overall Study|Lost to Follow-up|3
2166243|NCT01289990|3785637|FG001|Overall Study|Lost to Follow-up|2
2166244|NCT01289990|3785638|FG002|Overall Study|Lost to Follow-up|5
2166245|NCT01289990|3785639|FG003|Overall Study|Lost to Follow-up|5
2166246|NCT01289990|3785640|FG004|Overall Study|Lost to Follow-up|3
2166247|NCT01289990|3785641|FG005|Overall Study|Lost to Follow-up|4
2166248|NCT01289990|3785642|FG006|Overall Study|Lost to Follow-up|2
2166249|NCT01289990|3785643|FG007|Overall Study|Lost to Follow-up|2
2166250|NCT01289990|3785644|FG008|Overall Study|Lost to Follow-up|1
2166251|NCT01289990|3785645|FG009|Overall Study|Lost to Follow-up|4
2166252|NCT01289990|3785646|FG010|Overall Study|Lost to Follow-up|2
2166253|NCT01289990|3785647|FG011|Overall Study|Lost to Follow-up|1
2166254|NCT01289990|3785648|FG012|Overall Study|Lost to Follow-up|2
2166255|NCT01289990|3785636|FG000|Overall Study|Withdrawal by Subject|15
2166256|NCT01289990|3785637|FG001|Overall Study|Withdrawal by Subject|14
2166257|NCT01289990|3785638|FG002|Overall Study|Withdrawal by Subject|12
2166258|NCT01289990|3785639|FG003|Overall Study|Withdrawal by Subject|13
2166259|NCT01289990|3785640|FG004|Overall Study|Withdrawal by Subject|8
2166260|NCT01289990|3785641|FG005|Overall Study|Withdrawal by Subject|7
2166261|NCT01289990|3785642|FG006|Overall Study|Withdrawal by Subject|13
2166262|NCT01289990|3785643|FG007|Overall Study|Withdrawal by Subject|9
2166263|NCT01289990|3785644|FG008|Overall Study|Withdrawal by Subject|12
2166264|NCT01289990|3785645|FG009|Overall Study|Withdrawal by Subject|13
2166265|NCT01289990|3785646|FG010|Overall Study|Withdrawal by Subject|11
2166266|NCT01289990|3785647|FG011|Overall Study|Withdrawal by Subject|13
2166267|NCT01289990|3785648|FG012|Overall Study|Withdrawal by Subject|16
2166268|NCT01289990|3785636|FG000|Overall Study|discontinued in preceding trial|18
2166269|NCT01289990|3785637|FG001|Overall Study|discontinued in preceding trial|20
2166270|NCT01289990|3785638|FG002|Overall Study|discontinued in preceding trial|41
2166271|NCT01289990|3785639|FG003|Overall Study|discontinued in preceding trial|17
2166272|NCT01289990|3785640|FG004|Overall Study|discontinued in preceding trial|11
2166273|NCT01289990|3785641|FG005|Overall Study|discontinued in preceding trial|12
2166274|NCT01289990|3785642|FG006|Overall Study|discontinued in preceding trial|18
2166275|NCT01289990|3785643|FG007|Overall Study|discontinued in preceding trial|8
2166276|NCT01289990|3785644|FG008|Overall Study|discontinued in preceding trial|17
2166277|NCT01289990|3785645|FG009|Overall Study|discontinued in preceding trial|21
2166278|NCT01289990|3785646|FG010|Overall Study|discontinued in preceding trial|17
2166279|NCT01289990|3785647|FG011|Overall Study|discontinued in preceding trial|17
2166280|NCT01289990|3785648|FG012|Overall Study|discontinued in preceding trial|24
2166281|NCT01289990|3785636|FG000|Overall Study|did not continue in extension|41
2166282|NCT01289990|3785637|FG001|Overall Study|did not continue in extension|45
2166283|NCT01289990|3785638|FG002|Overall Study|did not continue in extension|51
2166284|NCT01289990|3785639|FG003|Overall Study|did not continue in extension|51
2166285|NCT01289990|3785640|FG004|Overall Study|did not continue in extension|48
2166286|NCT01289990|3785641|FG005|Overall Study|did not continue in extension|50
2166287|NCT01289990|3785642|FG006|Overall Study|did not continue in extension|54
2166288|NCT01289990|3785643|FG007|Overall Study|did not continue in extension|36
2166289|NCT01289990|3785644|FG008|Overall Study|did not continue in extension|44
2166290|NCT01289990|3785645|FG009|Overall Study|did not continue in extension|48
2166291|NCT01289990|3785646|FG010|Overall Study|did not continue in extension|45
2166292|NCT01289990|3785647|FG011|Overall Study|did not continue in extension|34
2166293|NCT01289990|3785648|FG012|Overall Study|did not continue in extension|56
2166294|NCT01289990|3785636|FG000|Overall Study|Not treated|0
2166295|NCT01289990|3785637|FG001|Overall Study|Not treated|0
2166296|NCT01289990|3785638|FG002|Overall Study|Not treated|0
2166297|NCT01289990|3785639|FG003|Overall Study|Not treated|0
2166298|NCT01289990|3785640|FG004|Overall Study|Not treated|0
2166299|NCT01289990|3785641|FG005|Overall Study|Not treated|0
2166300|NCT01289990|3785642|FG006|Overall Study|Not treated|1
2166301|NCT01289990|3785643|FG007|Overall Study|Not treated|0
2166302|NCT01289990|3785644|FG008|Overall Study|Not treated|1
2166303|NCT01289990|3785645|FG009|Overall Study|Not treated|0
2166304|NCT01289990|3785646|FG010|Overall Study|Not treated|1
2166305|NCT01289990|3785647|FG011|Overall Study|Not treated|2
2166306|NCT01289990|3785648|FG012|Overall Study|Not treated|0
2166307|NCT01290029|3785676|FG000|Overall Study|Other|2
2166308|NCT01290068|3785682|FG000|Overall Study|Adverse Event|1
2166309|NCT01290068|3785683|FG001|Overall Study|Adverse Event|3
2166310|NCT01290068|3785682|FG000|Overall Study|Lost to Follow-up|3
2166311|NCT01290068|3785683|FG001|Overall Study|Lost to Follow-up|0
2166312|NCT01290068|3785682|FG000|Overall Study|Withdrawal by subject prior to implant|0
2166313|NCT01290068|3785683|FG001|Overall Study|Withdrawal by subject prior to implant|2
2166314|NCT01290068|3785682|FG000|Overall Study|Other|3
2166315|NCT01290068|3785683|FG001|Overall Study|Other|1
2166316|NCT01290094|3785689|FG000|Overall Study|Withdrawal by Subject|1
2166317|NCT01290094|3785689|FG000|Overall Study|Lost to Follow-up|5
2166318|NCT01290224|3785693|FG000|Overall Study|Adverse Event|1
2166319|NCT01290224|3785693|FG000|Overall Study|Refused Further Treatment|4
2166320|NCT01290263|3785712|FG000|Overall Study|Adverse Event|0
2166321|NCT01290263|3785713|FG001|Overall Study|Adverse Event|0
2166322|NCT01290263|3785714|FG002|Overall Study|Adverse Event|0
2166323|NCT01290263|3785715|FG003|Overall Study|Adverse Event|1
2166324|NCT01290263|3785716|FG004|Overall Study|Adverse Event|1
2166325|NCT01290263|3785712|FG000|Overall Study|Lack of Efficacy|8
2166326|NCT01290263|3785713|FG001|Overall Study|Lack of Efficacy|2
2166327|NCT01290263|3785714|FG002|Overall Study|Lack of Efficacy|7
2166328|NCT01290263|3785715|FG003|Overall Study|Lack of Efficacy|24
2166329|NCT01290263|3785716|FG004|Overall Study|Lack of Efficacy|33
2208210|NCT01636947|3847587|FG000|Overall Study|Adverse Event|1
2208211|NCT01636947|3847588|FG001|Overall Study|Adverse Event|1
2166330|NCT01290263|3785712|FG000|Overall Study|Withdrawal by Subject|3
2166331|NCT01290263|3785713|FG001|Overall Study|Withdrawal by Subject|1
2166332|NCT01290263|3785714|FG002|Overall Study|Withdrawal by Subject|0
2166333|NCT01290263|3785715|FG003|Overall Study|Withdrawal by Subject|1
2166334|NCT01290263|3785716|FG004|Overall Study|Withdrawal by Subject|2
2166335|NCT01290263|3785712|FG000|Overall Study|Participant Non-Compliance|0
2166336|NCT01290263|3785713|FG001|Overall Study|Participant Non-Compliance|0
2166337|NCT01290263|3785714|FG002|Overall Study|Participant Non-Compliance|0
2166338|NCT01290263|3785715|FG003|Overall Study|Participant Non-Compliance|1
2166339|NCT01290263|3785716|FG004|Overall Study|Participant Non-Compliance|1
2166340|NCT01290315|3785728|FG000|Overall Study|Adverse Event|0
2166341|NCT01290315|3785729|FG001|Overall Study|Adverse Event|0
2166342|NCT01290315|3785730|FG002|Overall Study|Adverse Event|0
2166343|NCT01290315|3785731|FG003|Overall Study|Adverse Event|3
2166344|NCT01290315|3785728|FG000|Overall Study|Selection criteria/compliance|2
2166345|NCT01290315|3785729|FG001|Overall Study|Selection criteria/compliance|1
2166346|NCT01290315|3785730|FG002|Overall Study|Selection criteria/compliance|0
2166347|NCT01290315|3785731|FG003|Overall Study|Selection criteria/compliance|2
2166348|NCT01290315|3785728|FG000|Overall Study|Lost to Follow-up|0
2166349|NCT01290315|3785729|FG001|Overall Study|Lost to Follow-up|1
2166350|NCT01290315|3785730|FG002|Overall Study|Lost to Follow-up|0
2166351|NCT01290315|3785731|FG003|Overall Study|Lost to Follow-up|0
2166352|NCT01290315|3785728|FG000|Overall Study|Withdrawal by Subject|1
2166353|NCT01290315|3785729|FG001|Overall Study|Withdrawal by Subject|1
2166354|NCT01290315|3785730|FG002|Overall Study|Withdrawal by Subject|0
2166355|NCT01290315|3785731|FG003|Overall Study|Withdrawal by Subject|0
2166356|NCT01290341|3785742|FG000|Overall Study|Protocol Violation|7
2166357|NCT01290341|3785743|FG001|Overall Study|Protocol Violation|3
2166358|NCT01290341|3785742|FG000|Overall Study|Adverse Event|1
2166359|NCT01290341|3785743|FG001|Overall Study|Adverse Event|0
2166360|NCT01290341|3785742|FG000|Overall Study|Lost to Follow-up|21
2166361|NCT01290341|3785743|FG001|Overall Study|Lost to Follow-up|10
2166362|NCT01290341|3785742|FG000|Overall Study|Withdrawal by Subject|19
2166363|NCT01290341|3785743|FG001|Overall Study|Withdrawal by Subject|5
2166364|NCT01290341|3785742|FG000|Overall Study|Negative baseline culture and others|44
2166365|NCT01290341|3785743|FG001|Overall Study|Negative baseline culture and others|11
2166366|NCT01290523|3785766|FG000|Overall Study|Death|3
2166367|NCT01290601|3785779|FG000|Overall Study|Adverse Event|0
2166368|NCT01290601|3785780|FG001|Overall Study|Adverse Event|2
2166369|NCT01290601|3785781|FG002|Overall Study|Adverse Event|0
2166370|NCT01290601|3785782|FG003|Overall Study|Adverse Event|0
2166371|NCT01290601|3785779|FG000|Overall Study|Lack of Efficacy|2
2166372|NCT01290601|3785780|FG001|Overall Study|Lack of Efficacy|1
2166373|NCT01290601|3785781|FG002|Overall Study|Lack of Efficacy|0
2166374|NCT01290601|3785782|FG003|Overall Study|Lack of Efficacy|0
2166375|NCT01290601|3785779|FG000|Overall Study|Lost to Follow-up|7
2166376|NCT01290601|3785780|FG001|Overall Study|Lost to Follow-up|2
2166377|NCT01290601|3785781|FG002|Overall Study|Lost to Follow-up|0
2166378|NCT01290601|3785782|FG003|Overall Study|Lost to Follow-up|0
2166379|NCT01290601|3785779|FG000|Overall Study|Other|1
2166380|NCT01290601|3785780|FG001|Overall Study|Other|0
2166381|NCT01290601|3785781|FG002|Overall Study|Other|0
2166382|NCT01290601|3785782|FG003|Overall Study|Other|0
2166383|NCT01290601|3785779|FG000|Overall Study|Protocol Violation|1
2166384|NCT01290601|3785780|FG001|Overall Study|Protocol Violation|0
2166385|NCT01290601|3785781|FG002|Overall Study|Protocol Violation|0
2166386|NCT01290601|3785782|FG003|Overall Study|Protocol Violation|0
2166387|NCT01290666|3785819|FG000|Overall Study|Lost to Follow-up|11
2166388|NCT01290666|3785819|FG000|Overall Study|Withdrawal by Subject|23
2166389|NCT01290666|3785819|FG000|Overall Study|Early Termination of Study|4
2166390|NCT01290679|3785825|FG000|Overall Study|Adverse Event|2
2166391|NCT01290679|3785826|FG001|Overall Study|Adverse Event|0
2166392|NCT01290679|3785825|FG000|Overall Study|Lost to Follow-up|8
2166393|NCT01290679|3785826|FG001|Overall Study|Lost to Follow-up|10
2166394|NCT01290679|3785825|FG000|Overall Study|Protocol Violation|0
2166395|NCT01290679|3785826|FG001|Overall Study|Protocol Violation|1
2166396|NCT01290679|3785825|FG000|Overall Study|Withdrawal by Subject|6
2166397|NCT01290679|3785826|FG001|Overall Study|Withdrawal by Subject|5
2166398|NCT01290679|3785825|FG000|Overall Study|Subject Entered Another Trial|0
2166399|NCT01290679|3785826|FG001|Overall Study|Subject Entered Another Trial|5
2166400|NCT01290731|3785832|FG000|Overall Study|Withdrawal by Subject|1
2166401|NCT01290757|3785838|FG000|Overall Study|Adverse Event|1
2166402|NCT01290757|3785839|FG001|Overall Study|Adverse Event|0
2166403|NCT01290757|3785838|FG000|Overall Study|Protocol Violation|1
2166404|NCT01290757|3785839|FG001|Overall Study|Protocol Violation|1
2166405|NCT01290757|3785838|FG000|Overall Study|Other|0
2166406|NCT01290757|3785839|FG001|Overall Study|Other|1
2166407|NCT01290796|3785845|FG000|Overall Study|Lost to Follow-up|21
2166408|NCT01290796|3785845|FG000|Overall Study|Withdrawal by Subject|4
2166409|NCT01290796|3785845|FG000|Overall Study|Physician Decision|2
2166410|NCT01290796|3785845|FG000|Overall Study|Secondary Surgical Intervention|2
2166411|NCT01290796|3785845|FG000|Overall Study|Withdrawal by Sponsor|1
2166412|NCT01290887|3785861|FG000|Overall Study|Adverse Event|6
2166413|NCT01290887|3785862|FG001|Overall Study|Adverse Event|11
2166414|NCT01290887|3785861|FG000|Overall Study|Lack of Efficacy|4
2166415|NCT01290887|3785862|FG001|Overall Study|Lack of Efficacy|5
2166416|NCT01290887|3785861|FG000|Overall Study|Withdrawal by Subject|26
2166417|NCT01290887|3785862|FG001|Overall Study|Withdrawal by Subject|32
2166418|NCT01290887|3785861|FG000|Overall Study|Protocol Violation|2
2166419|NCT01290887|3785862|FG001|Overall Study|Protocol Violation|1
2166420|NCT01290887|3785861|FG000|Overall Study|Lost to Follow-up|4
2166421|NCT01290887|3785862|FG001|Overall Study|Lost to Follow-up|4
2166422|NCT01290887|3785861|FG000|Overall Study|Non-compliance to study procedures|0
2166423|NCT01290887|3785862|FG001|Overall Study|Non-compliance to study procedures|1
2166424|NCT01290887|3785861|FG000|Overall Study|Non-compliance to study medications|1
2166425|NCT01290887|3785862|FG001|Overall Study|Non-compliance to study medications|0
2166426|NCT01290887|3785861|FG000|Overall Study|Sponsor closure of study|420
2166427|NCT01290887|3785862|FG001|Overall Study|Sponsor closure of study|476
2166428|NCT01290887|3785861|FG000|Overall Study|Other|3
2166429|NCT01290887|3785862|FG001|Overall Study|Other|6
2166430|NCT01291017|3785888|FG000|Overall Study|Lost to Follow-up|2
2166431|NCT01291017|3785888|FG000|Overall Study|Withdrawal by Subject|3
2166432|NCT01291173|3785934|FG000|Overall Study|Adverse Event|0
2166433|NCT01291173|3785935|FG001|Overall Study|Adverse Event|3
2166434|NCT01291173|3785936|FG002|Overall Study|Adverse Event|1
2166435|NCT01291173|3785937|FG003|Overall Study|Adverse Event|3
2166436|NCT01291173|3785934|FG000|Overall Study|Protocol Violation|7
2166437|NCT01291173|3785935|FG001|Overall Study|Protocol Violation|2
2166438|NCT01291173|3785936|FG002|Overall Study|Protocol Violation|2
2166439|NCT01291173|3785937|FG003|Overall Study|Protocol Violation|5
2166440|NCT01291173|3785934|FG000|Overall Study|Withdrawal by Subject|6
2166441|NCT01291173|3785935|FG001|Overall Study|Withdrawal by Subject|4
2166442|NCT01291173|3785936|FG002|Overall Study|Withdrawal by Subject|4
2166443|NCT01291173|3785937|FG003|Overall Study|Withdrawal by Subject|2
2166444|NCT01291173|3785934|FG000|Overall Study|Lost to Follow-up|4
2166445|NCT01291173|3785935|FG001|Overall Study|Lost to Follow-up|6
2166446|NCT01291173|3785936|FG002|Overall Study|Lost to Follow-up|3
2166447|NCT01291173|3785937|FG003|Overall Study|Lost to Follow-up|2
2166448|NCT01291173|3785934|FG000|Overall Study|Unable to meet visit schedule|0
2166449|NCT01291173|3785935|FG001|Overall Study|Unable to meet visit schedule|0
2166450|NCT01291173|3785936|FG002|Overall Study|Unable to meet visit schedule|1
2166451|NCT01291173|3785937|FG003|Overall Study|Unable to meet visit schedule|0
2166452|NCT01291173|3785934|FG000|Overall Study|Lack of compliance|0
2166453|NCT01291173|3785935|FG001|Overall Study|Lack of compliance|0
2166454|NCT01291173|3785936|FG002|Overall Study|Lack of compliance|0
2166455|NCT01291173|3785937|FG003|Overall Study|Lack of compliance|1
2166456|NCT01291173|3785934|FG000|Overall Study|Subject was unblinded|0
2166457|NCT01291173|3785935|FG001|Overall Study|Subject was unblinded|0
2166458|NCT01291173|3785936|FG002|Overall Study|Subject was unblinded|1
2166459|NCT01291173|3785937|FG003|Overall Study|Subject was unblinded|0
2166460|NCT01291173|3785934|FG000|Overall Study|Excluded therapy|0
2166461|NCT01291173|3785935|FG001|Overall Study|Excluded therapy|0
2166462|NCT01291173|3785936|FG002|Overall Study|Excluded therapy|1
2166463|NCT01291173|3785937|FG003|Overall Study|Excluded therapy|0
2166464|NCT01291225|3785949|FG000|Overall Study|Lost to Follow-up|85
2166465|NCT01291225|3785950|FG001|Overall Study|Lost to Follow-up|39
2166466|NCT01291277|3785966|FG000|Overall Study|Death|2
2166467|NCT01291277|3785967|FG001|Overall Study|Death|2
2166468|NCT01291277|3785966|FG000|Overall Study|Lost to Follow-up|3
2166469|NCT01291277|3785967|FG001|Overall Study|Lost to Follow-up|1
2166470|NCT01292057|3786007|FG000|Overall Study|Protocol Violation|1
2166471|NCT01292057|3786008|FG001|Overall Study|Protocol Violation|1
2166472|NCT01292057|3786007|FG000|Overall Study|Lost to Follow-up|1
2166473|NCT01292057|3786008|FG001|Overall Study|Lost to Follow-up|1
2166474|NCT01292187|3786027|FG000|Overall Study|Adverse Event|10
2208212|NCT01636947|3847587|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
2217478|NCT01708915|3860824|FG003|Overall Study|Lack of Efficacy|15
2166475|NCT01292187|3786028|FG001|Overall Study|Adverse Event|5
2166476|NCT01292187|3786027|FG000|Overall Study|Withdrawal by Subject|6
2166477|NCT01292187|3786028|FG001|Overall Study|Withdrawal by Subject|5
2166478|NCT01292187|3786027|FG000|Overall Study|All other reasons|1
2166479|NCT01292187|3786028|FG001|Overall Study|All other reasons|3
2166480|NCT01292226|3786035|FG000|Overall Study|Adverse Event|5
2166481|NCT01292226|3786035|FG000|Overall Study|Death|1
2166482|NCT01292226|3786035|FG000|Overall Study|Graft loss|1
2166483|NCT01292226|3786035|FG000|Overall Study|Protocol Violation|3
2166484|NCT01292226|3786035|FG000|Overall Study|Withdrawal by Subject|1
2166485|NCT01292226|3786035|FG000|Overall Study|Other|2
2166486|NCT01292239|3786041|FG000|Overall Study|Other|1
2166487|NCT01292239|3786042|FG001|Overall Study|Other|1
2166488|NCT01292239|3786041|FG000|Overall Study|Withdrawal by Subject|3
2166489|NCT01292239|3786042|FG001|Overall Study|Withdrawal by Subject|6
2166490|NCT01292473|3786074|FG000|Overall Study|Adverse Event|1
2166491|NCT01292473|3786075|FG001|Overall Study|Adverse Event|0
2166492|NCT01292473|3786076|FG002|Overall Study|Adverse Event|1
2166493|NCT01292473|3786077|FG003|Overall Study|Adverse Event|1
2166494|NCT01292473|3786074|FG000|Overall Study|Lost to Follow-up|1
2166495|NCT01292473|3786075|FG001|Overall Study|Lost to Follow-up|1
2166496|NCT01292473|3786076|FG002|Overall Study|Lost to Follow-up|2
2166497|NCT01292473|3786077|FG003|Overall Study|Lost to Follow-up|2
2166498|NCT01292473|3786074|FG000|Overall Study|Withdrawal by Subject|3
2166499|NCT01292473|3786075|FG001|Overall Study|Withdrawal by Subject|4
2166500|NCT01292473|3786076|FG002|Overall Study|Withdrawal by Subject|3
2166501|NCT01292473|3786077|FG003|Overall Study|Withdrawal by Subject|3
2166502|NCT01292473|3786074|FG000|Overall Study|Physician Decision|0
2166503|NCT01292473|3786075|FG001|Overall Study|Physician Decision|1
2166504|NCT01292473|3786076|FG002|Overall Study|Physician Decision|0
2166505|NCT01292473|3786077|FG003|Overall Study|Physician Decision|0
2166506|NCT01292473|3786074|FG000|Overall Study|Disease Progression|0
2166507|NCT01292473|3786075|FG001|Overall Study|Disease Progression|1
2166508|NCT01292473|3786076|FG002|Overall Study|Disease Progression|3
2166509|NCT01292473|3786077|FG003|Overall Study|Disease Progression|6
2179642|NCT01394991|3805283|FG001|Overall Study|Disease Progression|7
2179643|NCT01394991|3805282|FG000|Overall Study|Prematurely Termination of Trial|9
2179644|NCT01394991|3805283|FG001|Overall Study|Prematurely Termination of Trial|10
2179645|NCT01395017|3805291|FG000|Overall Study|Lost to Follow-up|1
2179646|NCT01395017|3805292|FG001|Overall Study|Lost to Follow-up|0
2179647|NCT01395017|3805291|FG000|Overall Study|Adverse Event|26
2179648|NCT01395017|3805292|FG001|Overall Study|Adverse Event|12
2179649|NCT01395017|3805291|FG000|Overall Study|Physician Decision|11
2179650|NCT01395017|3805292|FG001|Overall Study|Physician Decision|15
2179651|NCT01395017|3805291|FG000|Overall Study|Withdrawal by Subject|14
2179652|NCT01395017|3805292|FG001|Overall Study|Withdrawal by Subject|8
2179653|NCT01395017|3805291|FG000|Overall Study|Protocol deviation|1
2179654|NCT01395017|3805292|FG001|Overall Study|Protocol deviation|2
2179655|NCT01395017|3805291|FG000|Overall Study|Death|4
2179656|NCT01395017|3805292|FG001|Overall Study|Death|3
2179657|NCT01395017|3805291|FG000|Overall Study|Disease progression|42
2179658|NCT01395017|3805292|FG001|Overall Study|Disease progression|58
2179659|NCT01395017|3805291|FG000|Overall Study|Sponsor discontinued study|1
2179660|NCT01395017|3805292|FG001|Overall Study|Sponsor discontinued study|4
2179661|NCT01395030|3805299|FG000|Overall Study|Did not complete FCH PET/CT|7
2179662|NCT01395316|3805321|FG000|Overall Study|Lost to Follow-up|2
2179663|NCT01395316|3805321|FG000|Overall Study|poor MRI quality|1
2179664|NCT01395368|3805341|FG000|Overall Study|Physician Decision|14
2179665|NCT01395368|3805341|FG000|Overall Study|Withdrawal by Subject|2
2179666|NCT01395394|3805348|FG000|Baseline Study Visit|Protocol Violation|1
2179667|NCT01395394|3805349|FG001|Baseline Study Visit|Protocol Violation|0
2179668|NCT01395394|3805350|FG002|Baseline Study Visit|Protocol Violation|0
2179669|NCT01395524|3805361|FG000|Overall Study|Non-compliance with study schedule|1
2179670|NCT01395524|3805362|FG001|Overall Study|Non-compliance with study schedule|0
2179671|NCT01395524|3805363|FG002|Overall Study|Non-compliance with study schedule|1
2179672|NCT01395524|3805361|FG000|Overall Study|Lost to Follow-up|3
2179673|NCT01395524|3805362|FG001|Overall Study|Lost to Follow-up|1
2179674|NCT01395524|3805363|FG002|Overall Study|Lost to Follow-up|1
2179675|NCT01395524|3805361|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
2179676|NCT01395524|3805362|FG001|Overall Study|Study-Specific Withdrawal Criteria|2
2179677|NCT01395524|3805363|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
2179678|NCT01395524|3805361|FG000|Overall Study|Severe noncompliance with protocol|1
2179679|NCT01395524|3805362|FG001|Overall Study|Severe noncompliance with protocol|0
2179680|NCT01395524|3805363|FG002|Overall Study|Severe noncompliance with protocol|0
2179681|NCT01395524|3805361|FG000|Overall Study|Adverse Event|4
2179682|NCT01395524|3805362|FG001|Overall Study|Adverse Event|4
2179683|NCT01395524|3805363|FG002|Overall Study|Adverse Event|3
2179684|NCT01395524|3805361|FG000|Overall Study|Death|1
2179685|NCT01395524|3805362|FG001|Overall Study|Death|0
2179686|NCT01395524|3805363|FG002|Overall Study|Death|0
2179687|NCT01395524|3805361|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
2179688|NCT01395524|3805362|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
2179689|NCT01395524|3805363|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0
2179690|NCT01395524|3805361|FG000|Overall Study|Withdrawal by Subject|4
2179691|NCT01395524|3805362|FG001|Overall Study|Withdrawal by Subject|8
2179692|NCT01395524|3805363|FG002|Overall Study|Withdrawal by Subject|8
2179693|NCT01395524|3805361|FG000|Overall Study|Did not receive treatment|1
2179694|NCT01395524|3805362|FG001|Overall Study|Did not receive treatment|1
2179695|NCT01395524|3805363|FG002|Overall Study|Did not receive treatment|3
2179696|NCT01395524|3805361|FG000|Overall Study|Subject had spinal surgery|0
2179697|NCT01395524|3805362|FG001|Overall Study|Subject had spinal surgery|0
2179698|NCT01395524|3805363|FG002|Overall Study|Subject had spinal surgery|1
2179699|NCT01395758|3805377|FG000|Open-label Treatment Period|Withdrawal by Subject|4
2179700|NCT01395758|3805378|FG001|Open-label Treatment Period|Withdrawal by Subject|0
2179701|NCT01395758|3805379|FG002|Open-label Treatment Period|Withdrawal by Subject|0
2179702|NCT01395784|3805386|FG000|Overall Study|Lost to Follow-up|7
2179703|NCT01395784|3805386|FG000|Overall Study|Withdrawal by Subject|3
2179704|NCT01395784|3805386|FG000|Overall Study|Physician Decision|5
2180149|NCT01399125|3806109|FG001|Overall Study|Administrative Problems|11
2180150|NCT01399125|3806108|FG000|Overall Study|Death|0
2180151|NCT01399125|3806109|FG001|Overall Study|Death|1
2180152|NCT01399125|3806108|FG000|Overall Study|Protocol Deviation|5
2180153|NCT01399125|3806109|FG001|Overall Study|Protocol Deviation|2
2180154|NCT01399190|3806115|FG000|Overall Study|Not Eligible for Final Analysis|5
2166510|NCT01292486|3786091|FG000|Overall Study|Protocol Violation|2
2166511|NCT01292486|3786091|FG000|Overall Study|Did not meet screening criteria|2
2166512|NCT01292486|3786091|FG000|Overall Study|Adverse Event|1
2166513|NCT01292486|3786091|FG000|Overall Study|Physician Decision|1
2166514|NCT01292603|3786110|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0
2166515|NCT01292603|3786111|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0
2208213|NCT01636947|3847588|FG001|Overall Study|Did Not Meet Eligibility Criteria|4
2208214|NCT01636960|3847594|FG000|Induction Phase|Adverse Event|2
2208215|NCT01636960|3847594|FG000|Maintenance Phase|Continued drug after regulatory approval|3
2208216|NCT01636960|3847594|FG000|Maintenance Phase|Adverse Event|3
2295155|NCT02544321|3990431|FG001|Overall Study|Adverse Event|1
2295156|NCT02544321|3990430|FG000|Overall Study|Protocol Violation|0
2166516|NCT01292603|3786112|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0
2166517|NCT01292603|3786113|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4
2166518|NCT01292603|3786114|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0
2166519|NCT01292603|3786115|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0
2166520|NCT01292603|3786110|FG000|Part 1: Pilot Dose Selection Period|Death|0
2166521|NCT01292603|3786111|FG001|Part 1: Pilot Dose Selection Period|Death|0
2166522|NCT01292603|3786112|FG002|Part 1: Pilot Dose Selection Period|Death|0
2166523|NCT01292603|3786113|FG003|Part 1: Pilot Dose Selection Period|Death|1
2166524|NCT01292603|3786114|FG004|Part 1: Pilot Dose Selection Period|Death|0
2166525|NCT01292603|3786115|FG005|Part 1: Pilot Dose Selection Period|Death|0
2166526|NCT01292603|3786110|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2166527|NCT01292603|3786111|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2166528|NCT01292603|3786112|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2166529|NCT01292603|3786113|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2
2166530|NCT01292603|3786114|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2166531|NCT01292603|3786115|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2166532|NCT01292603|3786110|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2166533|NCT01292603|3786111|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2166534|NCT01292603|3786112|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2166535|NCT01292603|3786113|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
2166536|NCT01292603|3786114|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2166537|NCT01292603|3786115|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2166538|NCT01292603|3786110|FG000|Part 1: Regular Follow-Up Period|Death|3
2166539|NCT01292603|3786111|FG001|Part 1: Regular Follow-Up Period|Death|1
2166540|NCT01292603|3786112|FG002|Part 1: Regular Follow-Up Period|Death|3
2166541|NCT01292603|3786113|FG003|Part 1: Regular Follow-Up Period|Death|1
2166542|NCT01292603|3786114|FG004|Part 1: Regular Follow-Up Period|Death|0
2166543|NCT01292603|3786115|FG005|Part 1: Regular Follow-Up Period|Death|0
2166544|NCT01292603|3786110|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3
2166545|NCT01292603|3786111|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6
2166546|NCT01292603|3786112|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3
2166547|NCT01292603|3786113|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0
2166548|NCT01292603|3786114|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0
2166549|NCT01292603|3786115|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0
2166550|NCT01292603|3786110|FG000|Part 2: Dose Confirmation Period|Death|0
2166551|NCT01292603|3786111|FG001|Part 2: Dose Confirmation Period|Death|0
2166552|NCT01292603|3786112|FG002|Part 2: Dose Confirmation Period|Death|0
2166553|NCT01292603|3786113|FG003|Part 2: Dose Confirmation Period|Death|0
2166554|NCT01292603|3786114|FG004|Part 2: Dose Confirmation Period|Death|1
2166555|NCT01292603|3786115|FG005|Part 2: Dose Confirmation Period|Death|0
2166556|NCT01292603|3786110|FG000|Part 2: Dose Confirmation Period|Physician Decision|0
2166557|NCT01292603|3786111|FG001|Part 2: Dose Confirmation Period|Physician Decision|0
2166558|NCT01292603|3786112|FG002|Part 2: Dose Confirmation Period|Physician Decision|0
2166559|NCT01292603|3786113|FG003|Part 2: Dose Confirmation Period|Physician Decision|0
2166560|NCT01292603|3786114|FG004|Part 2: Dose Confirmation Period|Physician Decision|2
2166561|NCT01292603|3786115|FG005|Part 2: Dose Confirmation Period|Physician Decision|0
2166562|NCT01292603|3786110|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2166563|NCT01292603|3786111|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2166564|NCT01292603|3786112|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2166565|NCT01292603|3786113|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2166566|NCT01292603|3786114|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
2166567|NCT01292603|3786115|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
2166568|NCT01292603|3786110|FG000|Part 2: Dose Confirmation Period|Adverse Event|0
2179705|NCT01395810|3805425|FG000|Overall Study|Adverse Event|0
2295157|NCT02544321|3990431|FG001|Overall Study|Protocol Violation|1
2295158|NCT02544451|3990449|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1
2295159|NCT02544451|3990450|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6
2295160|NCT02544451|3990451|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0
2295161|NCT02544451|3990452|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0
2295162|NCT02544451|3990449|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3
2295163|NCT02544451|3990450|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2
2295164|NCT02544451|3990451|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1
2166569|NCT01292603|3786111|FG001|Part 2: Dose Confirmation Period|Adverse Event|0
2166570|NCT01292603|3786112|FG002|Part 2: Dose Confirmation Period|Adverse Event|0
2166571|NCT01292603|3786113|FG003|Part 2: Dose Confirmation Period|Adverse Event|0
2166572|NCT01292603|3786114|FG004|Part 2: Dose Confirmation Period|Adverse Event|7
2166573|NCT01292603|3786115|FG005|Part 2: Dose Confirmation Period|Adverse Event|9
2166574|NCT01292603|3786110|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0
2166575|NCT01292603|3786111|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0
2166576|NCT01292603|3786112|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0
2166577|NCT01292603|3786113|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0
2166578|NCT01292603|3786114|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5
2166579|NCT01292603|3786115|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3
2166580|NCT01292603|3786110|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2166581|NCT01292603|3786111|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2166582|NCT01292603|3786112|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2166583|NCT01292603|3786113|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2166584|NCT01292603|3786114|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2166585|NCT01292603|3786115|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
2166586|NCT01292603|3786110|FG000|Part 2: Regular Follow-Up|Death|0
2166587|NCT01292603|3786111|FG001|Part 2: Regular Follow-Up|Death|0
2166588|NCT01292603|3786112|FG002|Part 2: Regular Follow-Up|Death|0
2166589|NCT01292603|3786113|FG003|Part 2: Regular Follow-Up|Death|0
2166590|NCT01292603|3786114|FG004|Part 2: Regular Follow-Up|Death|6
2166591|NCT01292603|3786115|FG005|Part 2: Regular Follow-Up|Death|3
2166592|NCT01292603|3786110|FG000|Part 2: Regular Follow-Up|Disease Progression|0
2166593|NCT01292603|3786111|FG001|Part 2: Regular Follow-Up|Disease Progression|0
2166594|NCT01292603|3786112|FG002|Part 2: Regular Follow-Up|Disease Progression|0
2166595|NCT01292603|3786113|FG003|Part 2: Regular Follow-Up|Disease Progression|0
2166596|NCT01292603|3786114|FG004|Part 2: Regular Follow-Up|Disease Progression|5
2166597|NCT01292603|3786115|FG005|Part 2: Regular Follow-Up|Disease Progression|5
2166598|NCT01292603|3786110|FG000|Part 2: Regular Follow-Up|Noncompliance|0
2166599|NCT01292603|3786111|FG001|Part 2: Regular Follow-Up|Noncompliance|0
2166600|NCT01292603|3786112|FG002|Part 2: Regular Follow-Up|Noncompliance|0
2166601|NCT01292603|3786113|FG003|Part 2: Regular Follow-Up|Noncompliance|0
2166602|NCT01292603|3786114|FG004|Part 2: Regular Follow-Up|Noncompliance|1
2166603|NCT01292603|3786115|FG005|Part 2: Regular Follow-Up|Noncompliance|0
2166604|NCT01292603|3786110|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2166605|NCT01292603|3786111|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2166606|NCT01292603|3786112|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2166607|NCT01292603|3786113|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2166608|NCT01292603|3786114|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2166609|NCT01292603|3786115|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1
2166610|NCT01292603|3786110|FG000|Part 2: Regular Follow-Up|Protocol Violation|0
2166611|NCT01292603|3786111|FG001|Part 2: Regular Follow-Up|Protocol Violation|0
2208217|NCT01636960|3847594|FG000|Maintenance Phase|Progressive disease|1
2166612|NCT01292603|3786112|FG002|Part 2: Regular Follow-Up|Protocol Violation|0
2166613|NCT01292603|3786113|FG003|Part 2: Regular Follow-Up|Protocol Violation|0
2166614|NCT01292603|3786114|FG004|Part 2: Regular Follow-Up|Protocol Violation|2
2166615|NCT01292603|3786115|FG005|Part 2: Regular Follow-Up|Protocol Violation|0
2166616|NCT01292603|3786110|FG000|Part 2: Regular Follow-Up|Physician Decision|0
2166617|NCT01292603|3786111|FG001|Part 2: Regular Follow-Up|Physician Decision|0
2208218|NCT01636986|3847600|FG000|Overall Study|Withdrawal by Subject|0
2295165|NCT02544451|3990452|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0
2295166|NCT02544451|3990449|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2
2295167|NCT02544451|3990450|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
2295168|NCT02544451|3990451|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
2295169|NCT02544451|3990452|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
2295170|NCT02544451|3990449|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4
2295171|NCT02544451|3990450|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0
2295172|NCT02544451|3990451|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0
2295173|NCT02544451|3990452|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0
2295174|NCT02544451|3990449|FG000|Treatment Period 1 (96 Weeks)|Other|4
2295175|NCT02544451|3990450|FG001|Treatment Period 1 (96 Weeks)|Other|4
2295176|NCT02544451|3990451|FG002|Treatment Period 1 (96 Weeks)|Other|0
2295177|NCT02544451|3990452|FG003|Treatment Period 1 (96 Weeks)|Other|0
2295178|NCT02544451|3990449|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
2295179|NCT02544451|3990450|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
2295180|NCT02544451|3990451|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
2295181|NCT02544451|3990452|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10
2295182|NCT02544633|3990479|FG000|Treatment Period|Patient Still on Treatment/Study|0
2295183|NCT02544633|3990480|FG001|Treatment Period|Patient Still on Treatment/Study|1
2295184|NCT02544633|3990481|FG002|Treatment Period|Patient Still on Treatment/Study|1
2295185|NCT02544633|3990482|FG003|Treatment Period|Patient Still on Treatment/Study|0
2295186|NCT02544633|3990479|FG000|Treatment Period|Adverse Event|7
2295187|NCT02544633|3990480|FG001|Treatment Period|Adverse Event|4
2295188|NCT02544633|3990481|FG002|Treatment Period|Adverse Event|0
2166618|NCT01292603|3786112|FG002|Part 2: Regular Follow-Up|Physician Decision|0
2166619|NCT01292603|3786113|FG003|Part 2: Regular Follow-Up|Physician Decision|0
2166620|NCT01292603|3786114|FG004|Part 2: Regular Follow-Up|Physician Decision|2
2166621|NCT01292603|3786115|FG005|Part 2: Regular Follow-Up|Physician Decision|0
2166622|NCT01292603|3786110|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0
2166623|NCT01292603|3786111|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0
2166624|NCT01292603|3786112|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0
2166625|NCT01292603|3786113|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0
2166626|NCT01292603|3786114|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1
2166627|NCT01292603|3786115|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1
2166628|NCT01292603|3786110|FG000|Part 2: Regular Follow-Up|Adverse Event|0
2166629|NCT01292603|3786111|FG001|Part 2: Regular Follow-Up|Adverse Event|0
2166630|NCT01292603|3786112|FG002|Part 2: Regular Follow-Up|Adverse Event|0
2166631|NCT01292603|3786113|FG003|Part 2: Regular Follow-Up|Adverse Event|0
2166632|NCT01292603|3786114|FG004|Part 2: Regular Follow-Up|Adverse Event|2
2166633|NCT01292603|3786115|FG005|Part 2: Regular Follow-Up|Adverse Event|2
2166634|NCT01292603|3786110|FG000|Overall Survival Status|Death|3
2166635|NCT01292603|3786111|FG001|Overall Survival Status|Death|1
2166636|NCT01292603|3786112|FG002|Overall Survival Status|Death|3
2166637|NCT01292603|3786113|FG003|Overall Survival Status|Death|1
2166638|NCT01292603|3786114|FG004|Overall Survival Status|Death|16
2166639|NCT01292603|3786115|FG005|Overall Survival Status|Death|10
2166640|NCT01292837|3786157|FG000|Overall Study|Adverse Event|1
2166641|NCT01292837|3786157|FG000|Overall Study|Further treatment determined|1
2166642|NCT01292876|3786161|FG000|Overall Study|Physician Decision|4
2166643|NCT01292928|3786167|FG000|Overall Study|Death|8
2166644|NCT01292928|3786167|FG000|Overall Study|Withdrawal by Subject|8
2166645|NCT01292928|3786167|FG000|Overall Study|Lost to Follow-up|6
2166646|NCT01292928|3786167|FG000|Overall Study|Physician Decision|2
2166647|NCT01293006|3786177|FG000|Period 2|Lost to Follow-up|1
2166648|NCT01293006|3786178|FG001|Period 2|Lost to Follow-up|0
2166649|NCT01293006|3786179|FG002|Period 2|Lost to Follow-up|0
2166650|NCT01293006|3786180|FG003|Period 2|Lost to Follow-up|0
2166651|NCT01293032|3786199|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
2166652|NCT01293032|3786200|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
2166653|NCT01293032|3786201|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
2166654|NCT01293032|3786202|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
2166655|NCT01293032|3786199|FG000|Treatment|Adverse Event|0
2166656|NCT01293032|3786200|FG001|Treatment|Adverse Event|0
2166657|NCT01293032|3786201|FG002|Treatment|Adverse Event|1
2166658|NCT01293032|3786202|FG003|Treatment|Adverse Event|1
2166659|NCT01293032|3786199|FG000|Treatment|Withdrawal by Subject|2
2166660|NCT01293032|3786200|FG001|Treatment|Withdrawal by Subject|4
2166661|NCT01293032|3786201|FG002|Treatment|Withdrawal by Subject|0
2166662|NCT01293032|3786202|FG003|Treatment|Withdrawal by Subject|0
2166663|NCT01293032|3786199|FG000|Treatment|Disease Progression, relapse|0
2166664|NCT01293032|3786200|FG001|Treatment|Disease Progression, relapse|1
2166665|NCT01293032|3786201|FG002|Treatment|Disease Progression, relapse|0
2166666|NCT01293032|3786202|FG003|Treatment|Disease Progression, relapse|0
2166667|NCT01293084|3786209|FG000|Overall Study|Physician Decision|3
2166668|NCT01293084|3786209|FG000|Overall Study|Withdrawal by Subject|2
2166669|NCT01293240|3786215|FG000|Overall Study|Noncompliance|2
2166670|NCT01293539|3786229|FG000|Overall Study|Physician Decision|1
2166671|NCT01293695|3786239|FG000|Overall Study|Withdrawal by Subject|7
2166672|NCT01293695|3786240|FG001|Overall Study|Withdrawal by Subject|1
2166673|NCT01293695|3786239|FG000|Overall Study|Lost to Follow-up|8
2166674|NCT01293695|3786240|FG001|Overall Study|Lost to Follow-up|6
2166675|NCT01293968|3786255|FG000|Overall Study|non-cooperation|3
2166676|NCT01293968|3786256|FG001|Overall Study|non-cooperation|3
2166677|NCT01294150|3786277|FG000|Overall Study|Physician Decision|2
2166678|NCT01294150|3786278|FG001|Overall Study|Physician Decision|2
2166679|NCT01294358|3786343|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2166680|NCT01294358|3786344|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2
2166681|NCT01294358|3786345|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2166682|NCT01294358|3786346|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2166683|NCT01294358|3786347|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2166684|NCT01294358|3786343|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2166685|NCT01294358|3786344|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2166686|NCT01294358|3786345|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2
2166687|NCT01294358|3786346|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2166688|NCT01294358|3786347|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2166689|NCT01294358|3786343|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2166690|NCT01294358|3786344|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2166691|NCT01294358|3786345|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2166692|NCT01294358|3786346|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
2166693|NCT01294358|3786347|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2166694|NCT01294358|3786343|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2166695|NCT01294358|3786344|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2166696|NCT01294358|3786345|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2166697|NCT01294358|3786346|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2166698|NCT01294358|3786347|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
2166699|NCT01294371|3786364|FG000|Overall Study|Adverse Event|1
2166700|NCT01294371|3786364|FG000|Overall Study|Withdrawal by Subject|12
2166701|NCT01294371|3786364|FG000|Overall Study|Lost to Follow-up|6
2166702|NCT01294371|3786364|FG000|Overall Study|Administrative Reason|1
2166703|NCT01294371|3786364|FG000|Overall Study|Other|14
2166704|NCT01294397|3786384|FG000|Overall Study|Withdrawal by Subject|1
2166705|NCT01294397|3786384|FG000|Overall Study|Administrative Decision|1
2166706|NCT01294423|3786393|FG000|Overall Study|Adverse Event|1
2166707|NCT01294423|3786394|FG001|Overall Study|Adverse Event|2
2166708|NCT01294423|3786395|FG002|Overall Study|Adverse Event|3
2166709|NCT01294423|3786393|FG000|Overall Study|Withdrawal by Subject|1
2166710|NCT01294423|3786394|FG001|Overall Study|Withdrawal by Subject|2
2166711|NCT01294423|3786395|FG002|Overall Study|Withdrawal by Subject|2
2166712|NCT01294423|3786393|FG000|Overall Study|subject no longer meets study criteria|2
2166713|NCT01294423|3786394|FG001|Overall Study|subject no longer meets study criteria|5
2166714|NCT01294423|3786395|FG002|Overall Study|subject no longer meets study criteria|2
2166715|NCT01294423|3786393|FG000|Overall Study|poor/non-compliance|1
2166716|NCT01294423|3786394|FG001|Overall Study|poor/non-compliance|0
2166717|NCT01294423|3786395|FG002|Overall Study|poor/non-compliance|1
2166718|NCT01294436|3786405|FG000|Overall Study|Adverse Event|10
2166719|NCT01294436|3786406|FG001|Overall Study|Adverse Event|17
2166720|NCT01294436|3786405|FG000|Overall Study|Withdrawal by Subject|11
2166721|NCT01294436|3786406|FG001|Overall Study|Withdrawal by Subject|28
2166722|NCT01294436|3786405|FG000|Overall Study|subject no longer meets study criteria|5
2166723|NCT01294436|3786406|FG001|Overall Study|subject no longer meets study criteria|20
2166724|NCT01294436|3786405|FG000|Overall Study|poor/non-compliance|2
2166725|NCT01294436|3786406|FG001|Overall Study|poor/non-compliance|5
2166726|NCT01294449|3786414|FG000|Overall Study|Death|11
2166727|NCT01294449|3786415|FG001|Overall Study|Death|12
2166728|NCT01294449|3786414|FG000|Overall Study|Withdrawal by Subject|1
2166729|NCT01294449|3786415|FG001|Overall Study|Withdrawal by Subject|3
2166730|NCT01294462|3786423|FG000|Overall Study|Lost to Follow-up|1
2166731|NCT01294462|3786424|FG001|Overall Study|Lost to Follow-up|0
2166732|NCT01294462|3786423|FG000|Overall Study|Withdrawal by Subject|65
2166733|NCT01294462|3786424|FG001|Overall Study|Withdrawal by Subject|63
2166734|NCT01294514|3786430|FG000|Overall Study|Excluded due to Arrhythmia|1
2166735|NCT01294553|3786438|FG000|Overall Study|Duplicated Participants|1
2166736|NCT01294553|3786438|FG000|Overall Study|Protocol Violation|268
2166737|NCT01294579|3786443|FG000|Overall Study|Disease progression|12
2166738|NCT01294579|3786443|FG000|Overall Study|Adverse Event|11
2166739|NCT01294579|3786443|FG000|Overall Study|Study closed/terminated|3
2166740|NCT01294579|3786443|FG000|Overall Study|Lost to Follow-up|1
2166741|NCT01294579|3786443|FG000|Overall Study|Physician Decision|3
2166742|NCT01294579|3786443|FG000|Overall Study|Withdrawal by Subject|5
2166743|NCT01294592|3786449|FG000|Overall Study|Adverse Event|28
2166744|NCT01294592|3786450|FG001|Overall Study|Adverse Event|13
2166745|NCT01294592|3786449|FG000|Overall Study|Lack of Efficacy|7
2166746|NCT01294592|3786450|FG001|Overall Study|Lack of Efficacy|5
2166747|NCT01294592|3786449|FG000|Overall Study|Protocol Violation|1
2166748|NCT01294592|3786450|FG001|Overall Study|Protocol Violation|7
2166749|NCT01294592|3786449|FG000|Overall Study|Lost to Follow-up|7
2166750|NCT01294592|3786450|FG001|Overall Study|Lost to Follow-up|9
2166751|NCT01294592|3786449|FG000|Overall Study|Physician Decision|6
2208219|NCT01636986|3847601|FG001|Overall Study|Withdrawal by Subject|1
2208220|NCT01636986|3847600|FG000|Overall Study|Corneal Staining|0
2208221|NCT01636986|3847601|FG001|Overall Study|Corneal Staining|1
2166752|NCT01294592|3786450|FG001|Overall Study|Physician Decision|11
2166753|NCT01294592|3786449|FG000|Overall Study|Withdrawal by Subject|28
2166754|NCT01294592|3786450|FG001|Overall Study|Withdrawal by Subject|28
2166755|NCT01294644|3786462|FG000|Overall Study|Adverse Event|2
2166756|NCT01294644|3786463|FG001|Overall Study|Adverse Event|0
2166757|NCT01294644|3786464|FG002|Overall Study|Adverse Event|1
2166758|NCT01294644|3786462|FG000|Overall Study|Withdrawal by Subject|3
2166759|NCT01294644|3786463|FG001|Overall Study|Withdrawal by Subject|7
2166760|NCT01294644|3786464|FG002|Overall Study|Withdrawal by Subject|4
2166761|NCT01294644|3786462|FG000|Overall Study|Lost to Follow-up|3
2166762|NCT01294644|3786463|FG001|Overall Study|Lost to Follow-up|2
2166763|NCT01294644|3786464|FG002|Overall Study|Lost to Follow-up|5
2166764|NCT01294644|3786462|FG000|Overall Study|Miscellaneous Reason|2
2166765|NCT01294644|3786463|FG001|Overall Study|Miscellaneous Reason|1
2166766|NCT01294644|3786464|FG002|Overall Study|Miscellaneous Reason|4
2166767|NCT01294683|3786474|FG000|Precrossover (Periods I/II)|Adverse Event|49
2166768|NCT01294683|3786475|FG001|Precrossover (Periods I/II)|Adverse Event|52
2166769|NCT01294683|3786474|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3
2166770|NCT01294683|3786475|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6
2166771|NCT01294683|3786474|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
2166772|NCT01294683|3786475|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
2166773|NCT01294683|3786474|FG000|Precrossover (Periods I/II)|Physician Decision|1
2166774|NCT01294683|3786475|FG001|Precrossover (Periods I/II)|Physician Decision|0
2166775|NCT01294683|3786474|FG000|Precrossover (Periods I/II)|Protocol Violation|5
2179706|NCT01395810|3805426|FG001|Overall Study|Adverse Event|1
2166776|NCT01294683|3786475|FG001|Precrossover (Periods I/II)|Protocol Violation|5
2166777|NCT01294683|3786474|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
2166778|NCT01294683|3786475|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
2166779|NCT01294683|3786474|FG000|Precrossover (Periods I/II)|Technical Problems|0
2166780|NCT01294683|3786475|FG001|Precrossover (Periods I/II)|Technical Problems|1
2166781|NCT01294683|3786474|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11
2166782|NCT01294683|3786475|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9
2166783|NCT01294683|3786474|FG000|Post Crossover (Period III)|Adverse Event|6
2166784|NCT01294683|3786475|FG001|Post Crossover (Period III)|Adverse Event|6
2166785|NCT01294683|3786474|FG000|Post Crossover (Period III)|Lost to Follow-up|1
2166786|NCT01294683|3786475|FG001|Post Crossover (Period III)|Lost to Follow-up|3
2166787|NCT01294683|3786474|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23
2166788|NCT01294683|3786475|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21
2166789|NCT01294683|3786474|FG000|Post Crossover (Period III)|Withdrawal by Subject|3
2166790|NCT01294683|3786475|FG001|Post Crossover (Period III)|Withdrawal by Subject|2
2166791|NCT01294787|3786508|FG000|Period 1|Adverse Event|0
2166792|NCT01294787|3786509|FG001|Period 1|Adverse Event|0
2166793|NCT01294787|3786510|FG002|Period 1|Adverse Event|0
2166794|NCT01294787|3786511|FG003|Period 1|Adverse Event|0
2166795|NCT01294787|3786512|FG004|Period 1|Adverse Event|1
2166796|NCT01294787|3786513|FG005|Period 1|Adverse Event|0
2166797|NCT01294787|3786508|FG000|Period 1|Withdrawal by Subject|0
2166798|NCT01294787|3786509|FG001|Period 1|Withdrawal by Subject|0
2166799|NCT01294787|3786510|FG002|Period 1|Withdrawal by Subject|0
2166800|NCT01294787|3786511|FG003|Period 1|Withdrawal by Subject|1
2166801|NCT01294787|3786512|FG004|Period 1|Withdrawal by Subject|1
2166802|NCT01294787|3786513|FG005|Period 1|Withdrawal by Subject|1
2166803|NCT01294787|3786508|FG000|Period 1|Administrative problem|0
2166804|NCT01294787|3786509|FG001|Period 1|Administrative problem|0
2166805|NCT01294787|3786510|FG002|Period 1|Administrative problem|1
2166806|NCT01294787|3786511|FG003|Period 1|Administrative problem|0
2166807|NCT01294787|3786512|FG004|Period 1|Administrative problem|0
2166808|NCT01294787|3786513|FG005|Period 1|Administrative problem|1
2166809|NCT01294787|3786508|FG000|Period 2|Adverse Event|0
2166810|NCT01294787|3786509|FG001|Period 2|Adverse Event|3
2166811|NCT01294787|3786510|FG002|Period 2|Adverse Event|0
2166812|NCT01294787|3786511|FG003|Period 2|Adverse Event|1
2166813|NCT01294787|3786512|FG004|Period 2|Adverse Event|0
2166814|NCT01294787|3786513|FG005|Period 2|Adverse Event|0
2166815|NCT01294787|3786508|FG000|Period 2|No longer needs study drug|0
2166816|NCT01294787|3786509|FG001|Period 2|No longer needs study drug|0
2166817|NCT01294787|3786510|FG002|Period 2|No longer needs study drug|0
2166818|NCT01294787|3786511|FG003|Period 2|No longer needs study drug|1
2166819|NCT01294787|3786512|FG004|Period 2|No longer needs study drug|0
2166820|NCT01294787|3786513|FG005|Period 2|No longer needs study drug|0
2166821|NCT01294787|3786508|FG000|Period 3|Adverse Event|0
2166822|NCT01294787|3786509|FG001|Period 3|Adverse Event|0
2166823|NCT01294787|3786510|FG002|Period 3|Adverse Event|0
2166824|NCT01294787|3786511|FG003|Period 3|Adverse Event|0
2166825|NCT01294787|3786512|FG004|Period 3|Adverse Event|1
2166826|NCT01294787|3786513|FG005|Period 3|Adverse Event|0
2166827|NCT01294800|3786528|FG000|Overall Study|Adverse Event|7
2166828|NCT01294800|3786529|FG001|Overall Study|Adverse Event|6
2166829|NCT01294800|3786530|FG002|Overall Study|Adverse Event|12
2166830|NCT01294800|3786531|FG003|Overall Study|Adverse Event|5
2166831|NCT01294800|3786528|FG000|Overall Study|Subject Withdrew Consent|2
2166832|NCT01294800|3786529|FG001|Overall Study|Subject Withdrew Consent|2
2166833|NCT01294800|3786530|FG002|Overall Study|Subject Withdrew Consent|2
2166834|NCT01294800|3786531|FG003|Overall Study|Subject Withdrew Consent|11
2166835|NCT01294800|3786528|FG000|Overall Study|Lost to Follow-up|0
2166836|NCT01294800|3786529|FG001|Overall Study|Lost to Follow-up|0
2166837|NCT01294800|3786530|FG002|Overall Study|Lost to Follow-up|1
2166838|NCT01294800|3786531|FG003|Overall Study|Lost to Follow-up|0
2166839|NCT01294800|3786528|FG000|Overall Study|Non-compliance With Protocol|0
2166840|NCT01294800|3786529|FG001|Overall Study|Non-compliance With Protocol|1
2166841|NCT01294800|3786530|FG002|Overall Study|Non-compliance With Protocol|1
2166842|NCT01294800|3786531|FG003|Overall Study|Non-compliance With Protocol|0
2166843|NCT01294800|3786528|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
2166844|NCT01294800|3786529|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
2166845|NCT01294800|3786530|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
2166846|NCT01294800|3786531|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
2166847|NCT01294917|3786541|FG000|Overall Study|Relocation|5
2166848|NCT01294917|3786541|FG000|Overall Study|Inconvenience|1
2166849|NCT01295034|3786549|FG000|Overall Study|Lost to Follow-up|5
2166850|NCT01295034|3786550|FG001|Overall Study|Lost to Follow-up|5
2166851|NCT01295281|3786577|FG000|First Intervention (7 Days)|Death|0
2166852|NCT01295281|3786578|FG001|First Intervention (7 Days)|Death|1
2166853|NCT01295320|3786584|FG000|Overall Study|Adverse Event|2
2166854|NCT01295320|3786584|FG000|Overall Study|Lost to Follow-up|4
2166855|NCT01295320|3786584|FG000|Overall Study|Withdrawal by Subject|2
2166856|NCT01295320|3786584|FG000|Overall Study|Subject was bedridden|1
2166857|NCT01295320|3786584|FG000|Overall Study|Unable to travel|1
2166858|NCT01295580|3786594|FG000|Overall Study|Protocol Violation|4
2166859|NCT01295580|3786595|FG001|Overall Study|Protocol Violation|2
2166860|NCT01295580|3786594|FG000|Overall Study|Withdrawal by Subject|1
2166861|NCT01295580|3786595|FG001|Overall Study|Withdrawal by Subject|4
2166862|NCT01295580|3786594|FG000|Overall Study|Adverse Event|2
2166863|NCT01295580|3786595|FG001|Overall Study|Adverse Event|1
2166864|NCT01295580|3786594|FG000|Overall Study|Lost to Follow-up|1
2166865|NCT01295580|3786595|FG001|Overall Study|Lost to Follow-up|0
2166866|NCT01295580|3786594|FG000|Overall Study|Lack of Efficacy|1
2166867|NCT01295580|3786595|FG001|Overall Study|Lack of Efficacy|0
2166868|NCT01295580|3786594|FG000|Overall Study|Other: inconvenience|1
2166869|NCT01295580|3786595|FG001|Overall Study|Other: inconvenience|0
2166870|NCT01295580|3786594|FG000|Overall Study|Other: family objection|0
2166871|NCT01295580|3786595|FG001|Overall Study|Other: family objection|1
2166872|NCT01295671|3786604|FG000|Overall Study|Lost to Follow-up|4
2166873|NCT01295671|3786605|FG001|Overall Study|Lost to Follow-up|6
2166874|NCT01295671|3786606|FG002|Overall Study|Lost to Follow-up|3
2166875|NCT01295671|3786604|FG000|Overall Study|Withdrawal by Subject|3
2208222|NCT01637077|3847609|FG000|Overall Study|Cancel|1
2208223|NCT01637077|3847610|FG001|Overall Study|Cancel|1
2166876|NCT01295671|3786605|FG001|Overall Study|Withdrawal by Subject|1
2166877|NCT01295671|3786606|FG002|Overall Study|Withdrawal by Subject|0
2166878|NCT01295814|3786625|FG000|Overall Study|Lack of Efficacy|0
2166879|NCT01295814|3786626|FG001|Overall Study|Lack of Efficacy|2
2166880|NCT01295814|3786625|FG000|Overall Study|Withdrawal by Subject|2
2166881|NCT01295814|3786626|FG001|Overall Study|Withdrawal by Subject|0
2166882|NCT01295827|3786644|FG000|Overall Study|Adverse Event|1
2166883|NCT01295827|3786645|FG001|Overall Study|Adverse Event|2
2166884|NCT01295827|3786646|FG002|Overall Study|Adverse Event|2
2166885|NCT01295827|3786647|FG003|Overall Study|Adverse Event|1
2166886|NCT01295827|3786648|FG004|Overall Study|Adverse Event|1
2166887|NCT01295827|3786649|FG005|Overall Study|Adverse Event|4
2166888|NCT01295827|3786650|FG006|Overall Study|Adverse Event|15
2166889|NCT01295827|3786651|FG007|Overall Study|Adverse Event|49
2166890|NCT01295827|3786652|FG008|Overall Study|Adverse Event|22
2166891|NCT01295827|3786653|FG009|Overall Study|Adverse Event|7
2166892|NCT01295827|3786654|FG010|Overall Study|Adverse Event|50
2166893|NCT01295827|3786655|FG011|Overall Study|Adverse Event|21
2166894|NCT01295827|3786656|FG012|Overall Study|Adverse Event|0
2166895|NCT01295827|3786657|FG013|Overall Study|Adverse Event|0
2166896|NCT01295827|3786658|FG014|Overall Study|Adverse Event|0
2166897|NCT01295827|3786644|FG000|Overall Study|Lost to Follow-up|0
2166898|NCT01295827|3786645|FG001|Overall Study|Lost to Follow-up|0
2166899|NCT01295827|3786646|FG002|Overall Study|Lost to Follow-up|3
2166900|NCT01295827|3786647|FG003|Overall Study|Lost to Follow-up|0
2295189|NCT02544633|3990482|FG003|Treatment Period|Adverse Event|5
2295190|NCT02544633|3990479|FG000|Treatment Period|Lack of Efficacy|17
2295191|NCT02544633|3990480|FG001|Treatment Period|Lack of Efficacy|11
2295192|NCT02544633|3990481|FG002|Treatment Period|Lack of Efficacy|5
2295193|NCT02544633|3990482|FG003|Treatment Period|Lack of Efficacy|5
2295194|NCT02544633|3990479|FG000|Treatment Period|Global Deterioration of Health|3
2295195|NCT02544633|3990480|FG001|Treatment Period|Global Deterioration of Health|3
2295196|NCT02544633|3990481|FG002|Treatment Period|Global Deterioration of Health|0
2295197|NCT02544633|3990482|FG003|Treatment Period|Global Deterioration of Health|1
2166901|NCT01295827|3786648|FG004|Overall Study|Lost to Follow-up|1
2166902|NCT01295827|3786649|FG005|Overall Study|Lost to Follow-up|0
2166903|NCT01295827|3786650|FG006|Overall Study|Lost to Follow-up|4
2166904|NCT01295827|3786651|FG007|Overall Study|Lost to Follow-up|8
2166905|NCT01295827|3786652|FG008|Overall Study|Lost to Follow-up|7
2166906|NCT01295827|3786653|FG009|Overall Study|Lost to Follow-up|4
2166907|NCT01295827|3786654|FG010|Overall Study|Lost to Follow-up|7
2166908|NCT01295827|3786655|FG011|Overall Study|Lost to Follow-up|3
2166909|NCT01295827|3786656|FG012|Overall Study|Lost to Follow-up|0
2166910|NCT01295827|3786657|FG013|Overall Study|Lost to Follow-up|0
2166911|NCT01295827|3786658|FG014|Overall Study|Lost to Follow-up|0
2166912|NCT01295827|3786644|FG000|Overall Study|Not Reported|0
2166913|NCT01295827|3786645|FG001|Overall Study|Not Reported|0
2166914|NCT01295827|3786646|FG002|Overall Study|Not Reported|0
2166915|NCT01295827|3786647|FG003|Overall Study|Not Reported|1
2166916|NCT01295827|3786648|FG004|Overall Study|Not Reported|0
2166917|NCT01295827|3786649|FG005|Overall Study|Not Reported|0
2166918|NCT01295827|3786650|FG006|Overall Study|Not Reported|24
2166919|NCT01295827|3786651|FG007|Overall Study|Not Reported|58
2166920|NCT01295827|3786652|FG008|Overall Study|Not Reported|41
2166921|NCT01295827|3786653|FG009|Overall Study|Not Reported|2
2166922|NCT01295827|3786654|FG010|Overall Study|Not Reported|23
2166923|NCT01295827|3786655|FG011|Overall Study|Not Reported|13
2166924|NCT01295827|3786656|FG012|Overall Study|Not Reported|0
2166925|NCT01295827|3786657|FG013|Overall Study|Not Reported|0
2166926|NCT01295827|3786658|FG014|Overall Study|Not Reported|0
2166927|NCT01295827|3786644|FG000|Overall Study|Progressive Disease|2
2166928|NCT01295827|3786645|FG001|Overall Study|Progressive Disease|1
2166929|NCT01295827|3786646|FG002|Overall Study|Progressive Disease|5
2166930|NCT01295827|3786647|FG003|Overall Study|Progressive Disease|2
2166931|NCT01295827|3786648|FG004|Overall Study|Progressive Disease|0
2166932|NCT01295827|3786649|FG005|Overall Study|Progressive Disease|1
2166933|NCT01295827|3786650|FG006|Overall Study|Progressive Disease|87
2166934|NCT01295827|3786651|FG007|Overall Study|Progressive Disease|144
2295198|NCT02544633|3990479|FG000|Treatment Period|Withdrawal by Subject|1
2166935|NCT01295827|3786652|FG008|Overall Study|Progressive Disease|85
2166936|NCT01295827|3786653|FG009|Overall Study|Progressive Disease|40
2166937|NCT01295827|3786654|FG010|Overall Study|Progressive Disease|175
2166938|NCT01295827|3786655|FG011|Overall Study|Progressive Disease|136
2166939|NCT01295827|3786656|FG012|Overall Study|Progressive Disease|0
2166940|NCT01295827|3786657|FG013|Overall Study|Progressive Disease|0
2166941|NCT01295827|3786658|FG014|Overall Study|Progressive Disease|0
2166942|NCT01295827|3786644|FG000|Overall Study|Screen Failure|0
2166943|NCT01295827|3786645|FG001|Overall Study|Screen Failure|0
2166944|NCT01295827|3786646|FG002|Overall Study|Screen Failure|0
2166945|NCT01295827|3786647|FG003|Overall Study|Screen Failure|0
2166946|NCT01295827|3786648|FG004|Overall Study|Screen Failure|0
2166947|NCT01295827|3786649|FG005|Overall Study|Screen Failure|0
2166948|NCT01295827|3786650|FG006|Overall Study|Screen Failure|2
2166949|NCT01295827|3786651|FG007|Overall Study|Screen Failure|2
2166950|NCT01295827|3786652|FG008|Overall Study|Screen Failure|2
2166951|NCT01295827|3786653|FG009|Overall Study|Screen Failure|0
2166952|NCT01295827|3786654|FG010|Overall Study|Screen Failure|1
2166953|NCT01295827|3786655|FG011|Overall Study|Screen Failure|0
2166954|NCT01295827|3786656|FG012|Overall Study|Screen Failure|0
2166955|NCT01295827|3786657|FG013|Overall Study|Screen Failure|0
2166956|NCT01295827|3786658|FG014|Overall Study|Screen Failure|0
2166957|NCT01295827|3786644|FG000|Overall Study|Withdrawal by Subject|1
2166958|NCT01295827|3786645|FG001|Overall Study|Withdrawal by Subject|0
2166959|NCT01295827|3786646|FG002|Overall Study|Withdrawal by Subject|2
2166960|NCT01295827|3786647|FG003|Overall Study|Withdrawal by Subject|0
2166961|NCT01295827|3786648|FG004|Overall Study|Withdrawal by Subject|0
2166962|NCT01295827|3786649|FG005|Overall Study|Withdrawal by Subject|1
2166963|NCT01295827|3786650|FG006|Overall Study|Withdrawal by Subject|13
2166964|NCT01295827|3786651|FG007|Overall Study|Withdrawal by Subject|35
2166965|NCT01295827|3786652|FG008|Overall Study|Withdrawal by Subject|11
2166966|NCT01295827|3786653|FG009|Overall Study|Withdrawal by Subject|2
2166967|NCT01295827|3786654|FG010|Overall Study|Withdrawal by Subject|18
2166968|NCT01295827|3786655|FG011|Overall Study|Withdrawal by Subject|13
2166969|NCT01295827|3786656|FG012|Overall Study|Withdrawal by Subject|0
2166970|NCT01295827|3786657|FG013|Overall Study|Withdrawal by Subject|0
2166971|NCT01295827|3786658|FG014|Overall Study|Withdrawal by Subject|0
2166972|NCT01295827|3786644|FG000|Overall Study|Other|0
2166973|NCT01295827|3786645|FG001|Overall Study|Other|0
2166974|NCT01295827|3786646|FG002|Overall Study|Other|0
2166975|NCT01295827|3786647|FG003|Overall Study|Other|0
2166976|NCT01295827|3786648|FG004|Overall Study|Other|0
2166977|NCT01295827|3786649|FG005|Overall Study|Other|0
2166978|NCT01295827|3786650|FG006|Overall Study|Other|1
2166979|NCT01295827|3786651|FG007|Overall Study|Other|1
2166980|NCT01295827|3786652|FG008|Overall Study|Other|1
2166981|NCT01295827|3786653|FG009|Overall Study|Other|0
2166982|NCT01295827|3786654|FG010|Overall Study|Other|2
2295199|NCT02544633|3990480|FG001|Treatment Period|Withdrawal by Subject|0
2295200|NCT02544633|3990481|FG002|Treatment Period|Withdrawal by Subject|0
2295201|NCT02544633|3990482|FG003|Treatment Period|Withdrawal by Subject|0
2295202|NCT02544633|3990479|FG000|Treatment Period|Lost to Follow-up|0
2295203|NCT02544633|3990480|FG001|Treatment Period|Lost to Follow-up|1
2295204|NCT02544633|3990481|FG002|Treatment Period|Lost to Follow-up|0
2295205|NCT02544633|3990482|FG003|Treatment Period|Lost to Follow-up|0
2295206|NCT02544633|3990479|FG000|Treatment Period|Death|0
2295207|NCT02544633|3990480|FG001|Treatment Period|Death|0
2295208|NCT02544633|3990481|FG002|Treatment Period|Death|1
2295209|NCT02544633|3990482|FG003|Treatment Period|Death|0
2295210|NCT02544633|3990479|FG000|Treatment Period|Non-compliance|0
2295211|NCT02544633|3990480|FG001|Treatment Period|Non-compliance|0
2295212|NCT02544633|3990481|FG002|Treatment Period|Non-compliance|1
2295213|NCT02544633|3990482|FG003|Treatment Period|Non-compliance|0
2295214|NCT02544633|3990479|FG000|Treatment Period|Clinical Disease Progression|0
2295215|NCT02544633|3990480|FG001|Treatment Period|Clinical Disease Progression|0
2295216|NCT02544633|3990481|FG002|Treatment Period|Clinical Disease Progression|0
2295217|NCT02544633|3990482|FG003|Treatment Period|Clinical Disease Progression|1
2295218|NCT02544633|3990479|FG000|Survival Follow-up Period|Death|12
2295219|NCT02544633|3990480|FG001|Survival Follow-up Period|Death|14
2295220|NCT02544633|3990481|FG002|Survival Follow-up Period|Death|3
2295221|NCT02544633|3990482|FG003|Survival Follow-up Period|Death|9
2295222|NCT02544633|3990479|FG000|Survival Follow-up Period|Lost to Follow-up|0
2295223|NCT02544633|3990480|FG001|Survival Follow-up Period|Lost to Follow-up|1
2295224|NCT02544633|3990481|FG002|Survival Follow-up Period|Lost to Follow-up|1
2295225|NCT02544633|3990482|FG003|Survival Follow-up Period|Lost to Follow-up|0
2166983|NCT01295827|3786655|FG011|Overall Study|Other|0
2166984|NCT01295827|3786656|FG012|Overall Study|Other|0
2166985|NCT01295827|3786657|FG013|Overall Study|Other|0
2166986|NCT01295827|3786658|FG014|Overall Study|Other|0
2166987|NCT01295905|3786723|FG000|Overall Study|Did not meet inclusion criteria|1
2166988|NCT01295905|3786724|FG001|Overall Study|Did not meet inclusion criteria|0
2166989|NCT01295905|3786723|FG000|Overall Study|Met exclusion criteria|1
2166990|NCT01295905|3786724|FG001|Overall Study|Met exclusion criteria|0
2166991|NCT01296035|3786730|FG000|Overall Study|Withdrawal by Subject|1
2166992|NCT01296152|3786734|FG000|Overall Study|Unwilling to adhere to study requirement|1
2295226|NCT02544633|3990479|FG000|Survival Follow-up Period|Withdrawal by Subject|4
2166993|NCT01296347|3786749|FG000|Allocation|Withdrawal by Subject|1
2166994|NCT01296347|3786750|FG001|Allocation|Withdrawal by Subject|2
2166995|NCT01296347|3786749|FG000|Allocation|Lack of Efficacy|1
2166996|NCT01296347|3786750|FG001|Allocation|Lack of Efficacy|2
2166997|NCT01296347|3786749|FG000|Allocation|not received infusion|1
2166998|NCT01296347|3786750|FG001|Allocation|not received infusion|0
2166999|NCT01296347|3786749|FG000|6 Week Follow up|Death|0
2167000|NCT01296347|3786750|FG001|6 Week Follow up|Death|1
2167001|NCT01296347|3786749|FG000|3 Month Follow up|Death|1
2167002|NCT01296347|3786750|FG001|3 Month Follow up|Death|0
2167003|NCT01296347|3786749|FG000|3 Month Follow up|Lost to Follow-up|0
2167004|NCT01296347|3786750|FG001|3 Month Follow up|Lost to Follow-up|1
2167005|NCT01296347|3786749|FG000|6 Month Follow up|Death|2
2167006|NCT01296347|3786750|FG001|6 Month Follow up|Death|1
2167007|NCT01296347|3786749|FG000|6 Month Follow up|Lost to Follow-up|0
2167008|NCT01296347|3786750|FG001|6 Month Follow up|Lost to Follow-up|1
2167009|NCT01296347|3786749|FG000|12 Month Follow up|Lost to Follow-up|3
2167010|NCT01296347|3786750|FG001|12 Month Follow up|Lost to Follow-up|1
2167011|NCT01296347|3786749|FG000|12 Month Follow up|Death|1
2167012|NCT01296347|3786750|FG001|12 Month Follow up|Death|1
2167013|NCT01296347|3786749|FG000|12 Month Follow up|Withdrawal by Subject|0
2167014|NCT01296347|3786750|FG001|12 Month Follow up|Withdrawal by Subject|1
2167015|NCT01296412|3786770|FG000|Overall Study|Adverse Event|8
2167016|NCT01296412|3786771|FG001|Overall Study|Adverse Event|29
2167017|NCT01296412|3786770|FG000|Overall Study|Lack of Efficacy|1
2167018|NCT01296412|3786771|FG001|Overall Study|Lack of Efficacy|0
2167019|NCT01296412|3786770|FG000|Overall Study|Lost to Follow-up|10
2167020|NCT01296412|3786771|FG001|Overall Study|Lost to Follow-up|7
2167021|NCT01296412|3786770|FG000|Overall Study|Non-compliance with study drug|1
2167022|NCT01296412|3786771|FG001|Overall Study|Non-compliance with study drug|2
2167023|NCT01296412|3786770|FG000|Overall Study|Other reason not specified|20
2167024|NCT01296412|3786771|FG001|Overall Study|Other reason not specified|15
2167025|NCT01296412|3786770|FG000|Overall Study|Physician Decision|1
2167026|NCT01296412|3786771|FG001|Overall Study|Physician Decision|3
2167027|NCT01296412|3786770|FG000|Overall Study|Pregnancy|0
2167028|NCT01296412|3786771|FG001|Overall Study|Pregnancy|1
2167029|NCT01296412|3786770|FG000|Overall Study|Withdrawal by Subject|10
2167030|NCT01296412|3786771|FG001|Overall Study|Withdrawal by Subject|13
2167031|NCT01296568|3786786|FG000|Continued Access Phase|Lost to Follow-up|1
2167032|NCT01296568|3786786|FG000|Continued Access Phase|Withdrawal by Subject|1
2167033|NCT01296568|3786786|FG000|Continued Access Phase|Disease Progression|1
2167034|NCT01296672|3786803|FG000|Overall Study|Lost to Follow-up|73
2167035|NCT01296672|3786804|FG001|Overall Study|Lost to Follow-up|18
2167036|NCT01296698|3786814|FG000|Overall Study|Adverse Event|1
2167037|NCT01296698|3786815|FG001|Overall Study|Adverse Event|0
2167038|NCT01296698|3786814|FG000|Overall Study|Death|1
2167039|NCT01296698|3786815|FG001|Overall Study|Death|0
2167040|NCT01296698|3786814|FG000|Overall Study|Lost to Follow-up|19
2167041|NCT01296698|3786815|FG001|Overall Study|Lost to Follow-up|1
2167042|NCT01296698|3786814|FG000|Overall Study|Withdrawal by Subject|12
2167043|NCT01296698|3786815|FG001|Overall Study|Withdrawal by Subject|0
2167044|NCT01296698|3786814|FG000|Overall Study|Difficulty Contacting Subject|2
2167045|NCT01296698|3786815|FG001|Overall Study|Difficulty Contacting Subject|0
2167046|NCT01296698|3786814|FG000|Overall Study|Study Terminated by Sponsor|209
2167047|NCT01296698|3786815|FG001|Overall Study|Study Terminated by Sponsor|12
2167048|NCT01296932|3786863|FG000|Overall Study|Dose limiting toxicity|0
2167049|NCT01296932|3786864|FG001|Overall Study|Dose limiting toxicity|0
2167050|NCT01296932|3786865|FG002|Overall Study|Dose limiting toxicity|0
2167051|NCT01296932|3786866|FG003|Overall Study|Dose limiting toxicity|0
2167052|NCT01296932|3786867|FG004|Overall Study|Dose limiting toxicity|0
2167053|NCT01296932|3786868|FG005|Overall Study|Dose limiting toxicity|0
2167054|NCT01296932|3786869|FG006|Overall Study|Dose limiting toxicity|1
2167055|NCT01296932|3786870|FG007|Overall Study|Dose limiting toxicity|0
2167056|NCT01296932|3786871|FG008|Overall Study|Dose limiting toxicity|1
2167057|NCT01296932|3786863|FG000|Overall Study|Progressive disease|2
2167058|NCT01296932|3786864|FG001|Overall Study|Progressive disease|0
2167059|NCT01296932|3786865|FG002|Overall Study|Progressive disease|1
2167060|NCT01296932|3786866|FG003|Overall Study|Progressive disease|1
2167061|NCT01296932|3786867|FG004|Overall Study|Progressive disease|2
2167062|NCT01296932|3786868|FG005|Overall Study|Progressive disease|3
2167063|NCT01296932|3786869|FG006|Overall Study|Progressive disease|1
2167064|NCT01296932|3786870|FG007|Overall Study|Progressive disease|0
2167065|NCT01296932|3786871|FG008|Overall Study|Progressive disease|0
2167066|NCT01296932|3786863|FG000|Overall Study|Withdrawal by Subject|0
2167067|NCT01296932|3786864|FG001|Overall Study|Withdrawal by Subject|0
2167068|NCT01296932|3786865|FG002|Overall Study|Withdrawal by Subject|1
2167069|NCT01296932|3786866|FG003|Overall Study|Withdrawal by Subject|1
2167070|NCT01296932|3786867|FG004|Overall Study|Withdrawal by Subject|0
2167071|NCT01296932|3786868|FG005|Overall Study|Withdrawal by Subject|0
2167072|NCT01296932|3786869|FG006|Overall Study|Withdrawal by Subject|3
2167073|NCT01296932|3786870|FG007|Overall Study|Withdrawal by Subject|0
2167074|NCT01296932|3786871|FG008|Overall Study|Withdrawal by Subject|0
2167075|NCT01296932|3786863|FG000|Overall Study|Adverse Event|1
2167076|NCT01296932|3786864|FG001|Overall Study|Adverse Event|1
2167077|NCT01296932|3786865|FG002|Overall Study|Adverse Event|1
2167078|NCT01296932|3786866|FG003|Overall Study|Adverse Event|2
2167079|NCT01296932|3786867|FG004|Overall Study|Adverse Event|1
2167080|NCT01296932|3786868|FG005|Overall Study|Adverse Event|0
2167081|NCT01296932|3786869|FG006|Overall Study|Adverse Event|0
2167082|NCT01296932|3786870|FG007|Overall Study|Adverse Event|0
2167083|NCT01296932|3786871|FG008|Overall Study|Adverse Event|1
2167084|NCT01296932|3786863|FG000|Overall Study|Investigator decision|0
2167085|NCT01296932|3786864|FG001|Overall Study|Investigator decision|1
2167086|NCT01296932|3786865|FG002|Overall Study|Investigator decision|0
2167087|NCT01296932|3786866|FG003|Overall Study|Investigator decision|1
2167088|NCT01296932|3786867|FG004|Overall Study|Investigator decision|0
2167089|NCT01296932|3786868|FG005|Overall Study|Investigator decision|0
2167090|NCT01296932|3786869|FG006|Overall Study|Investigator decision|1
2167091|NCT01296932|3786870|FG007|Overall Study|Investigator decision|0
2167092|NCT01296932|3786871|FG008|Overall Study|Investigator decision|1
2167093|NCT01296932|3786863|FG000|Overall Study|No clinical benefit anymore|0
2167094|NCT01296932|3786864|FG001|Overall Study|No clinical benefit anymore|1
2167095|NCT01296932|3786865|FG002|Overall Study|No clinical benefit anymore|0
2167096|NCT01296932|3786866|FG003|Overall Study|No clinical benefit anymore|0
2167097|NCT01296932|3786867|FG004|Overall Study|No clinical benefit anymore|0
2167098|NCT01296932|3786868|FG005|Overall Study|No clinical benefit anymore|0
2167099|NCT01296932|3786869|FG006|Overall Study|No clinical benefit anymore|0
2167100|NCT01296932|3786870|FG007|Overall Study|No clinical benefit anymore|0
2167101|NCT01296932|3786871|FG008|Overall Study|No clinical benefit anymore|0
2167102|NCT01296932|3786863|FG000|Overall Study|Physician Decision|0
2167103|NCT01296932|3786864|FG001|Overall Study|Physician Decision|0
2167104|NCT01296932|3786865|FG002|Overall Study|Physician Decision|1
2167105|NCT01296932|3786866|FG003|Overall Study|Physician Decision|0
2167106|NCT01296932|3786867|FG004|Overall Study|Physician Decision|0
2167107|NCT01296932|3786868|FG005|Overall Study|Physician Decision|0
2167108|NCT01296932|3786869|FG006|Overall Study|Physician Decision|0
2167109|NCT01296932|3786870|FG007|Overall Study|Physician Decision|0
2167110|NCT01296932|3786871|FG008|Overall Study|Physician Decision|0
2167111|NCT01296932|3786863|FG000|Overall Study|IV problems, administration not possible|0
2167112|NCT01296932|3786864|FG001|Overall Study|IV problems, administration not possible|0
2167113|NCT01296932|3786865|FG002|Overall Study|IV problems, administration not possible|1
2167114|NCT01296932|3786866|FG003|Overall Study|IV problems, administration not possible|0
2167115|NCT01296932|3786867|FG004|Overall Study|IV problems, administration not possible|0
2167116|NCT01296932|3786868|FG005|Overall Study|IV problems, administration not possible|0
2167117|NCT01296932|3786869|FG006|Overall Study|IV problems, administration not possible|0
2167118|NCT01296932|3786870|FG007|Overall Study|IV problems, administration not possible|0
2167119|NCT01296932|3786871|FG008|Overall Study|IV problems, administration not possible|0
2167120|NCT01296932|3786863|FG000|Overall Study|per protocol|0
2167121|NCT01296932|3786864|FG001|Overall Study|per protocol|0
2167122|NCT01296932|3786865|FG002|Overall Study|per protocol|1
2167123|NCT01296932|3786866|FG003|Overall Study|per protocol|1
2167124|NCT01296932|3786867|FG004|Overall Study|per protocol|0
2167125|NCT01296932|3786868|FG005|Overall Study|per protocol|0
2167126|NCT01296932|3786869|FG006|Overall Study|per protocol|0
2167127|NCT01296932|3786870|FG007|Overall Study|per protocol|0
2167128|NCT01296932|3786871|FG008|Overall Study|per protocol|0
2167129|NCT01296932|3786863|FG000|Overall Study|Low benefit and too many side effects|0
2167130|NCT01296932|3786864|FG001|Overall Study|Low benefit and too many side effects|0
2167131|NCT01296932|3786865|FG002|Overall Study|Low benefit and too many side effects|0
2167132|NCT01296932|3786866|FG003|Overall Study|Low benefit and too many side effects|0
2167133|NCT01296932|3786867|FG004|Overall Study|Low benefit and too many side effects|0
2167134|NCT01296932|3786868|FG005|Overall Study|Low benefit and too many side effects|0
2167135|NCT01296932|3786869|FG006|Overall Study|Low benefit and too many side effects|0
2167136|NCT01296932|3786870|FG007|Overall Study|Low benefit and too many side effects|1
2167137|NCT01296932|3786871|FG008|Overall Study|Low benefit and too many side effects|0
2167138|NCT01296932|3786863|FG000|Overall Study|No adequate treatment response|0
2167139|NCT01296932|3786864|FG001|Overall Study|No adequate treatment response|0
2167140|NCT01296932|3786865|FG002|Overall Study|No adequate treatment response|0
2167141|NCT01296932|3786866|FG003|Overall Study|No adequate treatment response|0
2167142|NCT01296932|3786867|FG004|Overall Study|No adequate treatment response|0
2167143|NCT01296932|3786868|FG005|Overall Study|No adequate treatment response|0
2167144|NCT01296932|3786869|FG006|Overall Study|No adequate treatment response|0
2167145|NCT01296932|3786870|FG007|Overall Study|No adequate treatment response|1
2167146|NCT01296932|3786871|FG008|Overall Study|No adequate treatment response|0
2167147|NCT01296932|3786863|FG000|Overall Study|Dosage already reduced, AE still present|0
2167148|NCT01296932|3786864|FG001|Overall Study|Dosage already reduced, AE still present|0
2167149|NCT01296932|3786865|FG002|Overall Study|Dosage already reduced, AE still present|0
2167150|NCT01296932|3786866|FG003|Overall Study|Dosage already reduced, AE still present|0
2167151|NCT01296932|3786867|FG004|Overall Study|Dosage already reduced, AE still present|0
2167152|NCT01296932|3786868|FG005|Overall Study|Dosage already reduced, AE still present|0
2167153|NCT01296932|3786869|FG006|Overall Study|Dosage already reduced, AE still present|0
2167154|NCT01296932|3786870|FG007|Overall Study|Dosage already reduced, AE still present|0
2167155|NCT01296932|3786871|FG008|Overall Study|Dosage already reduced, AE still present|1
2295227|NCT02544633|3990480|FG001|Survival Follow-up Period|Withdrawal by Subject|0
2295228|NCT02544633|3990481|FG002|Survival Follow-up Period|Withdrawal by Subject|1
2295229|NCT02544633|3990482|FG003|Survival Follow-up Period|Withdrawal by Subject|0
2295230|NCT02544633|3990479|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12
2295231|NCT02544633|3990480|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4
2295232|NCT02544633|3990481|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2
2295233|NCT02544633|3990482|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3
2295234|NCT02544763|3990507|FG000|Overall Study|Adverse Event|8
2295235|NCT02544763|3990508|FG001|Overall Study|Adverse Event|8
2295236|NCT02544763|3990509|FG002|Overall Study|Adverse Event|0
2295237|NCT02544763|3990507|FG000|Overall Study|Withdrawn by parent/guardian|1
2295238|NCT02544763|3990508|FG001|Overall Study|Withdrawn by parent/guardian|1
2295239|NCT02544763|3990509|FG002|Overall Study|Withdrawn by parent/guardian|1
2295240|NCT02544763|3990507|FG000|Overall Study|Met withdrawal criteria|0
2295241|NCT02544763|3990508|FG001|Overall Study|Met withdrawal criteria|2
2295242|NCT02544763|3990509|FG002|Overall Study|Met withdrawal criteria|0
2295243|NCT02544763|3990507|FG000|Overall Study|Physician Decision|0
2295244|NCT02544763|3990508|FG001|Overall Study|Physician Decision|1
2295245|NCT02544763|3990509|FG002|Overall Study|Physician Decision|0
2295246|NCT02544763|3990507|FG000|Overall Study|Difficulties taking IMP|1
2295247|NCT02544763|3990508|FG001|Overall Study|Difficulties taking IMP|0
2295248|NCT02544763|3990509|FG002|Overall Study|Difficulties taking IMP|0
2295249|NCT02545075|3990528|FG000|Randomization|Lost to Follow-up|0
2295250|NCT02545075|3990529|FG001|Randomization|Lost to Follow-up|1
2295251|NCT02545075|3990528|FG000|Randomization|Withdrawal by Subject|0
2295252|NCT02545075|3990529|FG001|Randomization|Withdrawal by Subject|6
2295253|NCT02545075|3990528|FG000|Treatment|Disease progression|71
2295254|NCT02545075|3990529|FG001|Treatment|Disease progression|32
2295255|NCT02545075|3990528|FG000|Treatment|Participant dicontinued study treatment|7
2295256|NCT02545075|3990529|FG001|Treatment|Participant dicontinued study treatment|9
2295257|NCT02545075|3990528|FG000|Treatment|Withdrawal by Subject|1
2295258|NCT02545075|3990529|FG001|Treatment|Withdrawal by Subject|0
2295259|NCT02545075|3990528|FG000|Treatment|Adverse event not related to study drug|1
2167156|NCT01297062|3786898|FG000|Overall Study|Adverse Event|2
2167157|NCT01297062|3786899|FG001|Overall Study|Adverse Event|0
2167158|NCT01297062|3786900|FG002|Overall Study|Adverse Event|1
2167159|NCT01297062|3786901|FG003|Overall Study|Adverse Event|0
2167160|NCT01297062|3786902|FG004|Overall Study|Adverse Event|0
2167161|NCT01297062|3786903|FG005|Overall Study|Adverse Event|0
2167162|NCT01297062|3786904|FG006|Overall Study|Adverse Event|0
2167163|NCT01297062|3786898|FG000|Overall Study|Physician Decision|1
2167164|NCT01297062|3786899|FG001|Overall Study|Physician Decision|0
2167165|NCT01297062|3786900|FG002|Overall Study|Physician Decision|1
2167166|NCT01297062|3786901|FG003|Overall Study|Physician Decision|0
2167167|NCT01297062|3786902|FG004|Overall Study|Physician Decision|0
2167168|NCT01297062|3786903|FG005|Overall Study|Physician Decision|0
2167169|NCT01297062|3786904|FG006|Overall Study|Physician Decision|6
2167170|NCT01297062|3786898|FG000|Overall Study|Protocol Violation|0
2167171|NCT01297062|3786899|FG001|Overall Study|Protocol Violation|0
2167172|NCT01297062|3786900|FG002|Overall Study|Protocol Violation|0
2167173|NCT01297062|3786901|FG003|Overall Study|Protocol Violation|0
2167174|NCT01297062|3786902|FG004|Overall Study|Protocol Violation|1
2167175|NCT01297062|3786903|FG005|Overall Study|Protocol Violation|0
2167176|NCT01297062|3786904|FG006|Overall Study|Protocol Violation|0
2167177|NCT01297062|3786898|FG000|Overall Study|Subject Decision|1
2167178|NCT01297062|3786899|FG001|Overall Study|Subject Decision|1
2167179|NCT01297062|3786900|FG002|Overall Study|Subject Decision|0
2167180|NCT01297062|3786901|FG003|Overall Study|Subject Decision|1
2167181|NCT01297062|3786902|FG004|Overall Study|Subject Decision|1
2167182|NCT01297062|3786903|FG005|Overall Study|Subject Decision|1
2167183|NCT01297062|3786904|FG006|Overall Study|Subject Decision|2
2167184|NCT01297244|3786914|FG000|Overall Study|Progressive disease|22
2167185|NCT01297244|3786915|FG001|Overall Study|Progressive disease|3
2167186|NCT01297244|3786914|FG000|Overall Study|Adverse Event|9
2167187|NCT01297244|3786915|FG001|Overall Study|Adverse Event|1
2167188|NCT01297244|3786914|FG000|Overall Study|Death|1
2167189|NCT01297244|3786915|FG001|Overall Study|Death|1
2167190|NCT01297244|3786914|FG000|Overall Study|Clinical progression|1
2167191|NCT01297244|3786915|FG001|Overall Study|Clinical progression|1
2167192|NCT01297244|3786914|FG000|Overall Study|Withdrawal by Subject|2
2167193|NCT01297244|3786915|FG001|Overall Study|Withdrawal by Subject|0
2167194|NCT01297270|3786930|FG000|Overall Study|Adverse Event|19
2167195|NCT01297270|3786931|FG001|Overall Study|Adverse Event|32
2167196|NCT01297270|3786932|FG002|Overall Study|Adverse Event|5
2167197|NCT01297270|3786930|FG000|Overall Study|Lack of Efficacy|15
2167198|NCT01297270|3786931|FG001|Overall Study|Lack of Efficacy|17
2167199|NCT01297270|3786932|FG002|Overall Study|Lack of Efficacy|15
2167200|NCT01297270|3786930|FG000|Overall Study|Lost to Follow-up|1
2167201|NCT01297270|3786931|FG001|Overall Study|Lost to Follow-up|2
2167202|NCT01297270|3786932|FG002|Overall Study|Lost to Follow-up|1
2167203|NCT01297270|3786930|FG000|Overall Study|Protocol Violation|0
2295260|NCT02545075|3990529|FG001|Treatment|Adverse event not related to study drug|0
2295261|NCT02545075|3990528|FG000|Treatment|Death|1
2295262|NCT02545075|3990529|FG001|Treatment|Death|0
2167204|NCT01297270|3786931|FG001|Overall Study|Protocol Violation|2
2167205|NCT01297270|3786932|FG002|Overall Study|Protocol Violation|0
2167206|NCT01297270|3786930|FG000|Overall Study|Withdrawal by Subject|7
2167207|NCT01297270|3786931|FG001|Overall Study|Withdrawal by Subject|15
2167208|NCT01297270|3786932|FG002|Overall Study|Withdrawal by Subject|7
2167209|NCT01297270|3786930|FG000|Overall Study|Other reason not defined above|3
2167210|NCT01297270|3786931|FG001|Overall Study|Other reason not defined above|3
2167211|NCT01297270|3786932|FG002|Overall Study|Other reason not defined above|1
2167212|NCT01297270|3786930|FG000|Overall Study|Not treated|0
2167213|NCT01297270|3786931|FG001|Overall Study|Not treated|1
2167214|NCT01297270|3786932|FG002|Overall Study|Not treated|0
2167215|NCT01297309|3786944|FG000|Overall Study|Eligibility failure|2
2167216|NCT01297309|3786944|FG000|Overall Study|Screen failure|2
2167217|NCT01297309|3786944|FG000|Overall Study|Withdrawal by Subject|5
2167218|NCT01297309|3786944|FG000|Overall Study|Adverse Event|1
2167219|NCT01297309|3786944|FG000|Overall Study|Investigator Decision|2
2167220|NCT01297309|3786944|FG000|Overall Study|Death|1
2167221|NCT01297309|3786944|FG000|Overall Study|Participant not entering extensionperiod|1
2167222|NCT01297322|3786950|FG000|Overall Study|Lost to Follow-up|1
2167223|NCT01297322|3786951|FG001|Overall Study|Lost to Follow-up|0
2167224|NCT01297322|3786950|FG000|Overall Study|Withdrawal by Subject|0
2167225|NCT01297322|3786951|FG001|Overall Study|Withdrawal by Subject|1
2167226|NCT01297322|3786950|FG000|Overall Study|Protocol Violation|0
2167227|NCT01297322|3786951|FG001|Overall Study|Protocol Violation|3
2167228|NCT01297465|3786976|FG000|Overall Study|Lack of Ovarian Response|1
2167229|NCT01297465|3786977|FG001|Overall Study|Lack of Ovarian Response|1
2167230|NCT01297465|3786976|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0
2167231|NCT01297465|3786977|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
2167232|NCT01297465|3786976|FG000|Overall Study|No Oocytes Retrieved|1
2167233|NCT01297465|3786977|FG001|Overall Study|No Oocytes Retrieved|1
2167234|NCT01297465|3786976|FG000|Overall Study|Poor oocyte quality|0
2167235|NCT01297465|3786977|FG001|Overall Study|Poor oocyte quality|1
2167236|NCT01297465|3786976|FG000|Overall Study|No Fertilization|6
2167237|NCT01297465|3786977|FG001|Overall Study|No Fertilization|4
2167238|NCT01297465|3786976|FG000|Overall Study|All Embryos Discarded|0
2167239|NCT01297465|3786977|FG001|Overall Study|All Embryos Discarded|1
2167240|NCT01297465|3786976|FG000|Overall Study|Intention to Freeze all Embryos|0
2167241|NCT01297465|3786977|FG001|Overall Study|Intention to Freeze all Embryos|1
2167242|NCT01297491|3786985|FG000|Overall Study|Adverse Event|11
2167243|NCT01297491|3786986|FG001|Overall Study|Adverse Event|6
2167244|NCT01297491|3786985|FG000|Overall Study|Physician Decision|3
2167245|NCT01297491|3786986|FG001|Overall Study|Physician Decision|2
2167246|NCT01297491|3786985|FG000|Overall Study|Progressive disease|11
2167247|NCT01297491|3786986|FG001|Overall Study|Progressive disease|20
2167248|NCT01297491|3786985|FG000|Overall Study|Patient/Guardian decision|3
2167249|NCT01297491|3786986|FG001|Overall Study|Patient/Guardian decision|4
2167250|NCT01297491|3786985|FG000|Overall Study|Death|2
2167251|NCT01297491|3786986|FG001|Overall Study|Death|1
2167252|NCT01297504|3786992|FG000|Overall Study|Invalid Consent|1
2167253|NCT01297504|3786992|FG000|Overall Study|Received Palivizumab in Previous Season|1
2167254|NCT01297504|3786992|FG000|Overall Study|No Study Visits|4
2167255|NCT01297504|3786992|FG000|Overall Study|Death|3
2167256|NCT01297504|3786992|FG000|Overall Study|Lost to Follow-up|43
2167257|NCT01297504|3786992|FG000|Overall Study|Withdrawal by Subject|9
2167258|NCT01297504|3786992|FG000|Overall Study|Site Closure|3
2167259|NCT01297504|3786992|FG000|Overall Study|Protocol Violation|3
2167260|NCT01297517|3787003|FG000|Overall Study|Adverse Event|21
2167261|NCT01297517|3787004|FG001|Overall Study|Adverse Event|7
2167262|NCT01297517|3787005|FG002|Overall Study|Adverse Event|16
2167263|NCT01297517|3787003|FG000|Overall Study|Lost to Follow-up|1
2167264|NCT01297517|3787004|FG001|Overall Study|Lost to Follow-up|0
2167265|NCT01297517|3787005|FG002|Overall Study|Lost to Follow-up|1
2167266|NCT01297517|3787003|FG000|Overall Study|Patient Decision Unrelated to AE|2
2167267|NCT01297517|3787004|FG001|Overall Study|Patient Decision Unrelated to AE|3
2167268|NCT01297517|3787005|FG002|Overall Study|Patient Decision Unrelated to AE|7
2167269|NCT01297517|3787003|FG000|Overall Study|Noncompliance|1
2167270|NCT01297517|3787004|FG001|Overall Study|Noncompliance|0
2167271|NCT01297517|3787005|FG002|Overall Study|Noncompliance|0
2167272|NCT01297517|3787003|FG000|Overall Study|Protocol Violation|1
2167273|NCT01297517|3787004|FG001|Overall Study|Protocol Violation|1
2167274|NCT01297517|3787005|FG002|Overall Study|Protocol Violation|1
2167275|NCT01297517|3787003|FG000|Overall Study|Inadequate Control of IOP|1
2167276|NCT01297517|3787004|FG001|Overall Study|Inadequate Control of IOP|1
2167277|NCT01297517|3787005|FG002|Overall Study|Inadequate Control of IOP|2
2167278|NCT01297920|3787023|FG000|Overall Study|Adverse Event|42
2167279|NCT01297920|3787024|FG001|Overall Study|Adverse Event|10
2167280|NCT01297920|3787025|FG002|Overall Study|Adverse Event|38
2167281|NCT01297920|3787023|FG000|Overall Study|Patient Decision Unrelated to AE|6
2167282|NCT01297920|3787024|FG001|Overall Study|Patient Decision Unrelated to AE|5
2167283|NCT01297920|3787025|FG002|Overall Study|Patient Decision Unrelated to AE|2
2167284|NCT01297920|3787023|FG000|Overall Study|Noncompliance|1
2167285|NCT01297920|3787024|FG001|Overall Study|Noncompliance|0
2167286|NCT01297920|3787025|FG002|Overall Study|Noncompliance|0
2167287|NCT01297920|3787023|FG000|Overall Study|Protocol Violation|1
2167288|NCT01297920|3787024|FG001|Overall Study|Protocol Violation|3
2167289|NCT01297920|3787025|FG002|Overall Study|Protocol Violation|0
2167290|NCT01297920|3787023|FG000|Overall Study|Inadequate Control of IOP|7
2167291|NCT01297920|3787024|FG001|Overall Study|Inadequate Control of IOP|9
2167292|NCT01297920|3787025|FG002|Overall Study|Inadequate Control of IOP|17
2167293|NCT01297920|3787023|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1
2167294|NCT01297920|3787024|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0
2167295|NCT01297920|3787025|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0
2167296|NCT01297959|3787035|FG000|Overall Study|Adverse Event|0
2167297|NCT01297959|3787036|FG001|Overall Study|Adverse Event|1
2167298|NCT01297959|3787035|FG000|Overall Study|Protocol Violation|2
2167299|NCT01297959|3787036|FG001|Overall Study|Protocol Violation|1
2167300|NCT01297959|3787035|FG000|Overall Study|Withdrawal by Subject|5
2167301|NCT01297959|3787036|FG001|Overall Study|Withdrawal by Subject|4
2167302|NCT01297959|3787035|FG000|Overall Study|Physician Decision|0
2167303|NCT01297959|3787036|FG001|Overall Study|Physician Decision|1
2167304|NCT01297959|3787035|FG000|Overall Study|Unrelated medical illness / complication|0
2167305|NCT01297959|3787036|FG001|Overall Study|Unrelated medical illness / complication|2
2167306|NCT01297959|3787035|FG000|Overall Study|Other|13
2167307|NCT01297959|3787036|FG001|Overall Study|Other|7
2167308|NCT01298141|3787082|FG000|Overall Study|Adverse Event|3
2167309|NCT01298141|3787082|FG000|Overall Study|Refusal of Required Study Procedures|1
2167310|NCT01298141|3787082|FG000|Overall Study|Withdrawal by Subject|6
2167311|NCT01298141|3787082|FG000|Overall Study|Termination of Study by the Investigator|5
2167312|NCT01298141|3787082|FG000|Overall Study|Other|5
2167313|NCT01298141|3787082|FG000|Overall Study|Lost to Follow-up|1
2167314|NCT01298141|3787082|FG000|Overall Study|Death|6
2167315|NCT01298141|3787082|FG000|Overall Study|Not treated|4
2167316|NCT01298193|3787095|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2
2167317|NCT01298193|3787095|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16
2167318|NCT01298193|3787095|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
2167319|NCT01298193|3787095|FG000|Efficacy Phase (Second Cycle)|Death|1
2167320|NCT01298323|3787113|FG000|Overall Study|Adverse Event|2
2167321|NCT01298323|3787114|FG001|Overall Study|Adverse Event|4
2167322|NCT01298323|3787113|FG000|Overall Study|Death|11
2167323|NCT01298323|3787114|FG001|Overall Study|Death|16
2167324|NCT01298323|3787113|FG000|Overall Study|Lost to Follow-up|1
2167325|NCT01298323|3787114|FG001|Overall Study|Lost to Follow-up|0
2167326|NCT01298323|3787113|FG000|Overall Study|Withdrawal by Subject|6
2167327|NCT01298323|3787114|FG001|Overall Study|Withdrawal by Subject|3
2167328|NCT01298323|3787113|FG000|Overall Study|Protocol Violation|1
2167329|NCT01298323|3787114|FG001|Overall Study|Protocol Violation|0
2167330|NCT01298323|3787113|FG000|Overall Study|Other|10
2167331|NCT01298323|3787114|FG001|Overall Study|Other|9
2167332|NCT01298323|3787113|FG000|Overall Study|Ongoing|55
2167333|NCT01298323|3787114|FG001|Overall Study|Ongoing|55
2167334|NCT01298323|3787113|FG000|Overall Study|Eligibility criteria not fulfilled|0
2167335|NCT01298323|3787114|FG001|Overall Study|Eligibility criteria not fulfilled|1
2179707|NCT01395810|3805427|FG002|Overall Study|Adverse Event|0
2179708|NCT01395810|3805428|FG003|Overall Study|Adverse Event|0
2179709|NCT01395810|3805425|FG000|Overall Study|Lack of Efficacy|0
2179710|NCT01395810|3805426|FG001|Overall Study|Lack of Efficacy|1
2179711|NCT01395810|3805427|FG002|Overall Study|Lack of Efficacy|0
2179712|NCT01395810|3805428|FG003|Overall Study|Lack of Efficacy|0
2179713|NCT01395810|3805425|FG000|Overall Study|Withdrawal criteria|0
2179714|NCT01395810|3805426|FG001|Overall Study|Withdrawal criteria|2
2179715|NCT01395810|3805427|FG002|Overall Study|Withdrawal criteria|0
2179716|NCT01395810|3805428|FG003|Overall Study|Withdrawal criteria|0
2179717|NCT01395810|3805425|FG000|Overall Study|Unclassified|2
2179718|NCT01395810|3805426|FG001|Overall Study|Unclassified|0
2179719|NCT01395810|3805427|FG002|Overall Study|Unclassified|0
2179720|NCT01395810|3805428|FG003|Overall Study|Unclassified|0
2179721|NCT01395823|3805441|FG000|Overall Study|Death|4
2179722|NCT01395823|3805442|FG001|Overall Study|Death|4
2179723|NCT01395823|3805441|FG000|Overall Study|Physician Decision|3
2179724|NCT01395823|3805442|FG001|Overall Study|Physician Decision|1
2179725|NCT01395823|3805441|FG000|Overall Study|Lost to Follow-up|1
2179726|NCT01395823|3805442|FG001|Overall Study|Lost to Follow-up|0
2179727|NCT01395823|3805441|FG000|Overall Study|Transplant|1
2179728|NCT01395823|3805442|FG001|Overall Study|Transplant|0
2179729|NCT01395823|3805441|FG000|Overall Study|GI symptoms|1
2179730|NCT01395823|3805442|FG001|Overall Study|GI symptoms|0
2179731|NCT01395823|3805441|FG000|Overall Study|Withdrawal by Subject|5
2179732|NCT01395823|3805442|FG001|Overall Study|Withdrawal by Subject|4
2179733|NCT01395888|3805450|FG000|2-week Run-in Period|Adverse Event|2
2179734|NCT01395888|3805451|FG001|2-week Run-in Period|Adverse Event|0
2179735|NCT01395888|3805452|FG002|2-week Run-in Period|Adverse Event|0
2179736|NCT01395888|3805450|FG000|2-week Run-in Period|Continuation Criteria Not Met|13
2179737|NCT01395888|3805451|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
2179738|NCT01395888|3805452|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
2179739|NCT01395888|3805450|FG000|2-week Run-in Period|Lost to Follow-up|1
2179740|NCT01395888|3805451|FG001|2-week Run-in Period|Lost to Follow-up|0
2179741|NCT01395888|3805452|FG002|2-week Run-in Period|Lost to Follow-up|0
2179742|NCT01395888|3805450|FG000|2-week Run-in Period|Protocol Violation|2
2179743|NCT01395888|3805451|FG001|2-week Run-in Period|Protocol Violation|0
2167336|NCT01298362|3787122|FG000|Overall Study|Did not provide 12month BMD measurements|38
2167337|NCT01298362|3787123|FG001|Overall Study|Did not provide 12month BMD measurements|43
2167338|NCT01298492|3787131|FG000|Overall Study|Death|2
2167339|NCT01298492|3787131|FG000|Overall Study|Insufficient Clinical Response|22
2167340|NCT01298492|3787131|FG000|Overall Study|Lost to Follow-up|12
2167341|NCT01298492|3787131|FG000|Overall Study|Withdrawal by Subject|47
2167342|NCT01298492|3787131|FG000|Overall Study|Other (Unspecified)|7
2167343|NCT01298492|3787131|FG000|Overall Study|Withdrawn Due to Pregnancy|1
2167344|NCT01298492|3787131|FG000|Overall Study|Protocol Violation|2
2167345|NCT01298492|3787131|FG000|Overall Study|Adverse Event(Related to Study Drug)|8
2167346|NCT01298492|3787131|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18
2167347|NCT01298518|3787138|FG000|Overall Study|Withdrawal by Subject|0
2167348|NCT01298518|3787139|FG001|Overall Study|Withdrawal by Subject|0
2167349|NCT01298518|3787140|FG002|Overall Study|Withdrawal by Subject|1
2167350|NCT01298531|3787150|FG000|Overall Study|Lack of Efficacy|0
2167351|NCT01298531|3787151|FG001|Overall Study|Lack of Efficacy|1
2167352|NCT01298531|3787150|FG000|Overall Study|Lost to Follow-up|2
2167353|NCT01298531|3787151|FG001|Overall Study|Lost to Follow-up|0
2167354|NCT01298531|3787150|FG000|Overall Study|Protocol Violation|1
2167355|NCT01298531|3787151|FG001|Overall Study|Protocol Violation|1
2167356|NCT01298531|3787150|FG000|Overall Study|Adverse Event|4
2167357|NCT01298531|3787151|FG001|Overall Study|Adverse Event|3
2167358|NCT01298531|3787150|FG000|Overall Study|Does not meet entrance criteria|0
2167359|NCT01298531|3787151|FG001|Overall Study|Does not meet entrance criteria|1
2167360|NCT01298531|3787150|FG000|Overall Study|Other|2
2167361|NCT01298531|3787151|FG001|Overall Study|Other|1
2167362|NCT01298570|3787166|FG000|Overall Study|Disease progression, relapse during acti|64
2167363|NCT01298570|3787167|FG001|Overall Study|Disease progression, relapse during acti|40
2167364|NCT01298570|3787166|FG000|Overall Study|Adverse Event|20
2167365|NCT01298570|3787167|FG001|Overall Study|Adverse Event|2
2167366|NCT01298570|3787166|FG000|Overall Study|Withdrawal by Subject|21
2167367|NCT01298570|3787167|FG001|Overall Study|Withdrawal by Subject|6
2167368|NCT01298570|3787166|FG000|Overall Study|Treatment delay > 4 weeks|4
2167369|NCT01298570|3787167|FG001|Overall Study|Treatment delay > 4 weeks|5
2167370|NCT01298570|3787166|FG000|Overall Study|Physician Decision|4
2167371|NCT01298570|3787167|FG001|Overall Study|Physician Decision|2
2167372|NCT01298570|3787166|FG000|Overall Study|Other complicating disease|2
2167373|NCT01298570|3787167|FG001|Overall Study|Other complicating disease|1
2167374|NCT01298570|3787166|FG000|Overall Study|Surgery|2
2167375|NCT01298570|3787167|FG001|Overall Study|Surgery|1
2167376|NCT01298570|3787166|FG000|Overall Study|Symptomatic progression/deterioration|3
2167377|NCT01298570|3787167|FG001|Overall Study|Symptomatic progression/deterioration|2
2167378|NCT01298570|3787166|FG000|Overall Study|Death|0
2167379|NCT01298570|3787167|FG001|Overall Study|Death|1
2167380|NCT01298570|3787166|FG000|Overall Study|Ineligibility|0
2167381|NCT01298570|3787167|FG001|Overall Study|Ineligibility|1
2167382|NCT01298596|3787175|FG000|Overall Study|Withdrawal by Subject|1
2167383|NCT01298596|3787176|FG001|Overall Study|Withdrawal by Subject|1
2167384|NCT01298596|3787175|FG000|Overall Study|Death|5
2167385|NCT01298596|3787176|FG001|Overall Study|Death|3
2167386|NCT01298596|3787175|FG000|Overall Study|Lost to Follow-up|6
2167387|NCT01298596|3787176|FG001|Overall Study|Lost to Follow-up|14
2167388|NCT01298596|3787175|FG000|Overall Study|Referred for further management|16
2167389|NCT01298596|3787176|FG001|Overall Study|Referred for further management|15
2167390|NCT01298648|3787182|FG000|Overall Study|Withdrawal by Subject|2
2167391|NCT01298648|3787182|FG000|Overall Study|Lost to Follow-up|21
2167392|NCT01298661|3787189|FG000|Overall Study|Withdrawal by Subject|2
2167393|NCT01298661|3787190|FG001|Overall Study|Withdrawal by Subject|0
2167394|NCT01298661|3787191|FG002|Overall Study|Withdrawal by Subject|2
2167395|NCT01298700|3787202|FG000|Overall Study|Adverse Event|50
2167396|NCT01298700|3787203|FG001|Overall Study|Adverse Event|51
2167397|NCT01298700|3787202|FG000|Overall Study|Lack of Efficacy|9
2167398|NCT01298700|3787203|FG001|Overall Study|Lack of Efficacy|14
2167399|NCT01298700|3787202|FG000|Overall Study|Lost to Follow-up|5
2167400|NCT01298700|3787203|FG001|Overall Study|Lost to Follow-up|2
2167401|NCT01298700|3787202|FG000|Overall Study|Withdrawal by Subject|12
2167402|NCT01298700|3787203|FG001|Overall Study|Withdrawal by Subject|9
2167403|NCT01298700|3787202|FG000|Overall Study|Protocol Violation|6
2167404|NCT01298700|3787203|FG001|Overall Study|Protocol Violation|4
2167405|NCT01298700|3787202|FG000|Overall Study|Other Miscellaneous Reasons|16
2167406|NCT01298700|3787203|FG001|Overall Study|Other Miscellaneous Reasons|15
2167407|NCT01298700|3787202|FG000|Overall Study|Did not Receive Study Drug|3
2167408|NCT01298700|3787203|FG001|Overall Study|Did not Receive Study Drug|5
2167409|NCT01298765|3787218|FG000|Titration Period|Adverse Event|26
2167410|NCT01298765|3787218|FG000|Titration Period|Death|1
2167411|NCT01298765|3787218|FG000|Titration Period|Lack of Efficacy|21
2167412|NCT01298765|3787218|FG000|Titration Period|Lost to Follow-up|9
2167413|NCT01298765|3787218|FG000|Titration Period|Physician Decision|1
2167414|NCT01298765|3787218|FG000|Titration Period|Withdrawal by Subject|10
2167415|NCT01298765|3787218|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8
2167416|NCT01298765|3787218|FG000|Long-Term Treatment Period|Adverse Event|19
2167417|NCT01298765|3787218|FG000|Long-Term Treatment Period|Lack of Efficacy|6
2167418|NCT01298765|3787218|FG000|Long-Term Treatment Period|Lost to Follow-up|8
2167419|NCT01298765|3787218|FG000|Long-Term Treatment Period|Withdrawal by Subject|19
2167420|NCT01298765|3787218|FG000|Long-Term Treatment Period|Physician Decision|1
2167421|NCT01298765|3787218|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
2167422|NCT01298778|3787224|FG000|Overall Study|Lost to Follow-up|2
2167423|NCT01298778|3787225|FG001|Overall Study|Lost to Follow-up|3
2167424|NCT01298778|3787224|FG000|Overall Study|Incorrect use of VAS|1
2167425|NCT01298778|3787225|FG001|Overall Study|Incorrect use of VAS|0
2167426|NCT01298778|3787224|FG000|Overall Study|Withdrawal by Subject|0
2167427|NCT01298778|3787225|FG001|Overall Study|Withdrawal by Subject|1
2167428|NCT01298778|3787224|FG000|Overall Study|Protocol Violation|0
2167429|NCT01298778|3787225|FG001|Overall Study|Protocol Violation|1
2167430|NCT01298778|3787224|FG000|Overall Study|not meet inclusion/exclusion criteria|0
2167431|NCT01298778|3787225|FG001|Overall Study|not meet inclusion/exclusion criteria|1
2167432|NCT01298999|3787235|FG000|Overall Study|Physician Decision|0
2167433|NCT01298999|3787236|FG001|Overall Study|Physician Decision|1
2167434|NCT01298999|3787235|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3
2167435|NCT01298999|3787236|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0
2167436|NCT01299025|3787244|FG000|Overall Study|Withdrawal by Subject|2
2167437|NCT01299025|3787245|FG001|Overall Study|Withdrawal by Subject|1
2167438|NCT01299025|3787244|FG000|Overall Study|Lost to Follow-up|1
2167439|NCT01299025|3787245|FG001|Overall Study|Lost to Follow-up|0
2167440|NCT01299038|3787253|FG000|Overall Study|Withdrawal by Subject|1
2167441|NCT01299038|3787254|FG001|Overall Study|Withdrawal by Subject|0
2167442|NCT01299116|3787284|FG000|Overall Study|Lost to Follow-up|65
2167443|NCT01299116|3787285|FG001|Overall Study|Lost to Follow-up|9
2167444|NCT01299116|3787286|FG002|Overall Study|Lost to Follow-up|11
2167445|NCT01299272|3787297|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140
2167446|NCT01299272|3787298|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0
2167447|NCT01299272|3787299|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0
2167448|NCT01299272|3787300|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0
2167449|NCT01299272|3787297|FG000|Acute Open-label (OL) Period|Adverse Event|140
2167450|NCT01299272|3787298|FG001|Acute Open-label (OL) Period|Adverse Event|0
2167451|NCT01299272|3787299|FG002|Acute Open-label (OL) Period|Adverse Event|0
2167452|NCT01299272|3787300|FG003|Acute Open-label (OL) Period|Adverse Event|0
2167453|NCT01299272|3787297|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56
2167454|NCT01299272|3787298|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0
2167455|NCT01299272|3787299|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0
2167456|NCT01299272|3787300|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0
2167457|NCT01299272|3787297|FG000|Acute Open-label (OL) Period|Protocol Violation|36
2167458|NCT01299272|3787298|FG001|Acute Open-label (OL) Period|Protocol Violation|0
2167459|NCT01299272|3787299|FG002|Acute Open-label (OL) Period|Protocol Violation|0
2167460|NCT01299272|3787300|FG003|Acute Open-label (OL) Period|Protocol Violation|0
2167461|NCT01299272|3787297|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14
2167462|NCT01299272|3787298|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0
2167463|NCT01299272|3787299|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0
2167464|NCT01299272|3787300|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0
2167465|NCT01299272|3787297|FG000|Acute Open-label (OL) Period|Sponsor Decision|13
2167466|NCT01299272|3787298|FG001|Acute Open-label (OL) Period|Sponsor Decision|0
2167467|NCT01299272|3787299|FG002|Acute Open-label (OL) Period|Sponsor Decision|0
2167468|NCT01299272|3787300|FG003|Acute Open-label (OL) Period|Sponsor Decision|0
2167469|NCT01299272|3787297|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10
2167470|NCT01299272|3787298|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0
2167471|NCT01299272|3787299|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0
2167472|NCT01299272|3787300|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0
2167473|NCT01299272|3787297|FG000|Acute Open-label (OL) Period|Physician Decision|5
2167474|NCT01299272|3787298|FG001|Acute Open-label (OL) Period|Physician Decision|0
2167475|NCT01299272|3787299|FG002|Acute Open-label (OL) Period|Physician Decision|0
2167476|NCT01299272|3787300|FG003|Acute Open-label (OL) Period|Physician Decision|0
2167477|NCT01299272|3787297|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
2167478|NCT01299272|3787298|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
2167479|NCT01299272|3787299|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
2167480|NCT01299272|3787300|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
2167481|NCT01299272|3787297|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0
2167482|NCT01299272|3787298|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44
2167483|NCT01299272|3787299|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0
2167484|NCT01299272|3787300|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0
2167485|NCT01299272|3787297|FG000|Stabilization Open-label (OL) Period|Adverse Event|0
2167486|NCT01299272|3787298|FG001|Stabilization Open-label (OL) Period|Adverse Event|42
2167487|NCT01299272|3787299|FG002|Stabilization Open-label (OL) Period|Adverse Event|0
2167488|NCT01299272|3787300|FG003|Stabilization Open-label (OL) Period|Adverse Event|0
2167489|NCT01299272|3787297|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
2167490|NCT01299272|3787298|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
2167491|NCT01299272|3787299|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
2167492|NCT01299272|3787300|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
2167493|NCT01299272|3787297|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0
2167494|NCT01299272|3787298|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12
2167495|NCT01299272|3787299|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0
2167496|NCT01299272|3787300|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0
2167497|NCT01299272|3787297|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0
2167498|NCT01299272|3787298|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11
2167499|NCT01299272|3787299|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0
2167500|NCT01299272|3787300|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0
2167501|NCT01299272|3787297|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0
2167502|NCT01299272|3787298|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9
2167503|NCT01299272|3787299|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0
2167504|NCT01299272|3787300|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0
2295263|NCT02545075|3990528|FG000|Treatment|Participant drug toxicity|1
2295264|NCT02545075|3990529|FG001|Treatment|Participant drug toxicity|0
2295265|NCT02545075|3990528|FG000|Treatment|Completed treatment|40
2295266|NCT02545075|3990529|FG001|Treatment|Completed treatment|12
2295267|NCT02545270|3990542|FG000|Overall Study|technical difficulties|0
2295268|NCT02545270|3990543|FG001|Overall Study|technical difficulties|1
2295269|NCT02545270|3990544|FG002|Overall Study|technical difficulties|0
2295270|NCT02545270|3990542|FG000|Overall Study|Videos being too similar to other|0
2295271|NCT02545270|3990543|FG001|Overall Study|Videos being too similar to other|0
2295272|NCT02545270|3990544|FG002|Overall Study|Videos being too similar to other|2
2295273|NCT02545322|3990553|FG000|Overall Study|Withdrawal by Subject|3
2295274|NCT02545504|3990559|FG000|Overall Study|Death|174
2295275|NCT02545504|3990560|FG001|Overall Study|Death|168
2295276|NCT02545504|3990559|FG000|Overall Study|Unknown reason|30
2295277|NCT02545504|3990560|FG001|Overall Study|Unknown reason|32
2295278|NCT02545504|3990559|FG000|Overall Study|Withdrew consent|9
2295279|NCT02545504|3990560|FG001|Overall Study|Withdrew consent|11
2295280|NCT02545504|3990559|FG000|Overall Study|Investigator's discretion|3
2295281|NCT02545504|3990560|FG001|Overall Study|Investigator's discretion|1
2295282|NCT02545504|3990559|FG000|Overall Study|Lost to Follow-up|2
2295283|NCT02545504|3990560|FG001|Overall Study|Lost to Follow-up|2
2295284|NCT02545543|3990572|FG000|Overall Study|Lost to Follow-up|67
2295285|NCT02545543|3990573|FG001|Overall Study|Lost to Follow-up|25
2295286|NCT02545543|3990572|FG000|Overall Study|Physician Decision|3
2295287|NCT02545543|3990573|FG001|Overall Study|Physician Decision|0
2295288|NCT02545543|3990572|FG000|Overall Study|Withdrawal by Subject|9
2295289|NCT02545543|3990573|FG001|Overall Study|Withdrawal by Subject|8
2295290|NCT02545543|3990572|FG000|Overall Study|Noncomplaince|1
2295291|NCT02545543|3990573|FG001|Overall Study|Noncomplaince|0
2295292|NCT02545543|3990572|FG000|Overall Study|Enrolment of subject at >1 study site|1
2295293|NCT02545543|3990573|FG001|Overall Study|Enrolment of subject at >1 study site|1
2295294|NCT02545933|3990607|FG000|Overall Study|Adverse Event|3
2295295|NCT02545933|3990608|FG001|Overall Study|Adverse Event|0
2295296|NCT02545933|3990609|FG002|Overall Study|Adverse Event|0
2295297|NCT02545933|3990607|FG000|Overall Study|Withdrawal by Subject|2
2295298|NCT02545933|3990608|FG001|Overall Study|Withdrawal by Subject|3
2295299|NCT02545933|3990609|FG002|Overall Study|Withdrawal by Subject|3
2295300|NCT02545933|3990607|FG000|Overall Study|Protocol Violation|1
2295301|NCT02545933|3990608|FG001|Overall Study|Protocol Violation|0
2295302|NCT02545933|3990609|FG002|Overall Study|Protocol Violation|1
2295303|NCT02546193|3990619|FG000|Overall Study|Withdrawal by Subject|2
2295304|NCT02546193|3990620|FG001|Overall Study|Withdrawal by Subject|0
2295305|NCT02546193|3990621|FG002|Overall Study|Withdrawal by Subject|1
2295306|NCT02546193|3990622|FG003|Overall Study|Withdrawal by Subject|0
2295307|NCT02546193|3990619|FG000|Overall Study|Not eligible at time of induction|4
2295308|NCT02546193|3990620|FG001|Overall Study|Not eligible at time of induction|6
2295309|NCT02546193|3990621|FG002|Overall Study|Not eligible at time of induction|1
2295310|NCT02546193|3990622|FG003|Overall Study|Not eligible at time of induction|0
2295311|NCT02546323|3990630|FG000|Overall Study|Withdrawal by Subject|36
2295312|NCT02546323|3990631|FG001|Overall Study|Withdrawal by Subject|33
2295313|NCT02546323|3990630|FG000|Overall Study|Eligibility Criteria not Fulfilled|0
2295314|NCT02546323|3990631|FG001|Overall Study|Eligibility Criteria not Fulfilled|1
2295315|NCT02546323|3990630|FG000|Overall Study|Adverse Event|17
2295316|NCT02546323|3990631|FG001|Overall Study|Adverse Event|11
2295317|NCT02546323|3990630|FG000|Overall Study|Patient Specific Reasons|1
2295318|NCT02546323|3990631|FG001|Overall Study|Patient Specific Reasons|2
2295319|NCT02546323|3990630|FG000|Overall Study|Lost to Follow-up|2
2295320|NCT02546323|3990631|FG001|Overall Study|Lost to Follow-up|3
2295321|NCT02546323|3990630|FG000|Overall Study|Non-compliance with Study Drug|2
2295322|NCT02546323|3990631|FG001|Overall Study|Non-compliance with Study Drug|2
2295323|NCT02546323|3990630|FG000|Overall Study|Met Withdrawal Criteria|2
2295324|NCT02546323|3990631|FG001|Overall Study|Met Withdrawal Criteria|14
2295325|NCT02546362|3990637|FG000|4-week Treatment Period|Lost to Follow-up|1
2295326|NCT02546362|3990637|FG000|4-week Treatment Period|Change in medication|2
2295327|NCT02546362|3990637|FG000|12-week Treatment Period|Withdrawal by Subject|6
2295328|NCT02546362|3990637|FG000|12-week Treatment Period|Lost to Follow-up|2
2353770|NCT02038153|4107092|FG000|Overall Study|Withdrawal by Subject|1
2167505|NCT01299272|3787297|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
2167506|NCT01299272|3787298|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
2167507|NCT01299272|3787299|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
2167508|NCT01299272|3787300|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
2167509|NCT01299272|3787297|FG000|Stabilization Open-label (OL) Period|Physician Decision|0
2167510|NCT01299272|3787298|FG001|Stabilization Open-label (OL) Period|Physician Decision|3
2167511|NCT01299272|3787299|FG002|Stabilization Open-label (OL) Period|Physician Decision|0
2167512|NCT01299272|3787300|FG003|Stabilization Open-label (OL) Period|Physician Decision|0
2167513|NCT01299272|3787297|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
2167514|NCT01299272|3787298|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
2167515|NCT01299272|3787299|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
2167516|NCT01299272|3787300|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
2167517|NCT01299272|3787297|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0
2167518|NCT01299272|3787298|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0
2167519|NCT01299272|3787299|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20
2167520|NCT01299272|3787300|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10
2167521|NCT01299272|3787297|FG000|Double-blind (DB) Randomized Period|Adverse Event|0
2167522|NCT01299272|3787298|FG001|Double-blind (DB) Randomized Period|Adverse Event|0
2167523|NCT01299272|3787299|FG002|Double-blind (DB) Randomized Period|Adverse Event|8
2167524|NCT01299272|3787300|FG003|Double-blind (DB) Randomized Period|Adverse Event|9
2167525|NCT01299272|3787297|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0
2167526|NCT01299272|3787298|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0
2167527|NCT01299272|3787299|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8
2167528|NCT01299272|3787300|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7
2167529|NCT01299272|3787297|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0
2167530|NCT01299272|3787298|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0
2167531|NCT01299272|3787299|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5
2167532|NCT01299272|3787300|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5
2167533|NCT01299272|3787297|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
2208224|NCT01637077|3847609|FG000|Overall Study|Withdrawal by Subject|1
2208225|NCT01637077|3847610|FG001|Overall Study|Withdrawal by Subject|0
2208226|NCT01637077|3847609|FG000|Overall Study|No cycle 1 questionnaire data|2
2208227|NCT01637077|3847610|FG001|Overall Study|No cycle 1 questionnaire data|0
2208228|NCT01637142|3847620|FG000|Washout Period (at Least 3 Days)|Physician Decision|1
2295329|NCT02546362|3990637|FG000|12-week Treatment Period|Change in medication|1
2167534|NCT01299272|3787298|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
2167535|NCT01299272|3787299|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
2167536|NCT01299272|3787300|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
2167537|NCT01299272|3787297|FG000|Double-blind (DB) Randomized Period|Physician Decision|0
2167538|NCT01299272|3787298|FG001|Double-blind (DB) Randomized Period|Physician Decision|0
2167539|NCT01299272|3787299|FG002|Double-blind (DB) Randomized Period|Physician Decision|2
2167540|NCT01299272|3787300|FG003|Double-blind (DB) Randomized Period|Physician Decision|1
2167541|NCT01299272|3787297|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0
2167542|NCT01299272|3787298|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0
2167543|NCT01299272|3787299|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1
2167544|NCT01299272|3787300|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1
2167545|NCT01299376|3787322|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
2167546|NCT01299376|3787323|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
2167547|NCT01299376|3787322|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
2167548|NCT01299376|3787323|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
2167549|NCT01299376|3787322|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
2167550|NCT01299376|3787323|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
2167551|NCT01299376|3787322|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
2167552|NCT01299376|3787323|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
2167553|NCT01299376|3787322|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
2167554|NCT01299376|3787323|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
2167555|NCT01299376|3787322|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
2167556|NCT01299376|3787323|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
2167557|NCT01299376|3787322|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
2167558|NCT01299376|3787323|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
2167559|NCT01299376|3787322|FG000|Extension (Weeks 9 to 52)|Adverse Event|2
2167560|NCT01299376|3787323|FG001|Extension (Weeks 9 to 52)|Adverse Event|3
2167561|NCT01299376|3787322|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1
2167562|NCT01299376|3787323|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2
2167563|NCT01299376|3787322|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
2167564|NCT01299376|3787323|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
2208229|NCT01637272|3847630|FG000|Overall Study|Adverse Event|6
2295330|NCT02546544|3990655|FG000|Overall Study|Disease Progression|14
2295331|NCT02546544|3990655|FG000|Overall Study|Adverse Event|1
2167565|NCT01299376|3787322|FG000|Extension (Weeks 9 to 52)|Physician Decision|1
2167566|NCT01299376|3787323|FG001|Extension (Weeks 9 to 52)|Physician Decision|0
2167567|NCT01299389|3787335|FG000|Double-blind|Adverse Event|45
2167568|NCT01299389|3787336|FG001|Double-blind|Adverse Event|27
2167569|NCT01299389|3787337|FG002|Double-blind|Adverse Event|0
2167570|NCT01299389|3787338|FG003|Double-blind|Adverse Event|0
2167571|NCT01299389|3787335|FG000|Double-blind|Lack of Efficacy|45
2167572|NCT01299389|3787336|FG001|Double-blind|Lack of Efficacy|21
2167573|NCT01299389|3787337|FG002|Double-blind|Lack of Efficacy|0
2167574|NCT01299389|3787338|FG003|Double-blind|Lack of Efficacy|0
2167575|NCT01299389|3787335|FG000|Double-blind|Lost to Follow-up|2
2167576|NCT01299389|3787336|FG001|Double-blind|Lost to Follow-up|1
2167577|NCT01299389|3787337|FG002|Double-blind|Lost to Follow-up|0
2167578|NCT01299389|3787338|FG003|Double-blind|Lost to Follow-up|0
2167579|NCT01299389|3787335|FG000|Double-blind|Withdrawal by Subject|16
2167580|NCT01299389|3787336|FG001|Double-blind|Withdrawal by Subject|13
2167581|NCT01299389|3787337|FG002|Double-blind|Withdrawal by Subject|0
2167582|NCT01299389|3787338|FG003|Double-blind|Withdrawal by Subject|0
2167583|NCT01299389|3787335|FG000|Double-blind|Other|1
2167584|NCT01299389|3787336|FG001|Double-blind|Other|1
2167585|NCT01299389|3787337|FG002|Double-blind|Other|0
2167586|NCT01299389|3787338|FG003|Double-blind|Other|0
2167587|NCT01299389|3787335|FG000|Double-blind|"fail to meet study population criteria"|0
2167588|NCT01299389|3787336|FG001|Double-blind|"fail to meet study population criteria"|1
2167589|NCT01299389|3787337|FG002|Double-blind|"fail to meet study population criteria"|0
2167590|NCT01299389|3787338|FG003|Double-blind|"fail to meet study population criteria"|0
2167591|NCT01299389|3787335|FG000|Post-observational|Other|0
2167592|NCT01299389|3787336|FG001|Post-observational|Other|0
2167593|NCT01299389|3787337|FG002|Post-observational|Other|12
2167594|NCT01299389|3787338|FG003|Post-observational|Other|6
2167595|NCT01299480|3787395|FG000|Overall Study|No longer willing to participate|19
2167596|NCT01299480|3787396|FG001|Overall Study|No longer willing to participate|17
2167597|NCT01299480|3787397|FG002|Overall Study|No longer willing to participate|14
2167598|NCT01299480|3787398|FG003|Overall Study|No longer willing to participate|13
2167599|NCT01299480|3787399|FG004|Overall Study|No longer willing to participate|10
2167600|NCT01299480|3787395|FG000|Overall Study|Protocol Violation|7
2167601|NCT01299480|3787396|FG001|Overall Study|Protocol Violation|5
2167602|NCT01299480|3787397|FG002|Overall Study|Protocol Violation|8
2167603|NCT01299480|3787398|FG003|Overall Study|Protocol Violation|1
2167604|NCT01299480|3787399|FG004|Overall Study|Protocol Violation|1
2167605|NCT01299480|3787395|FG000|Overall Study|Withdrawal by Subject|3
2167606|NCT01299480|3787396|FG001|Overall Study|Withdrawal by Subject|4
2167607|NCT01299480|3787397|FG002|Overall Study|Withdrawal by Subject|7
2167608|NCT01299480|3787398|FG003|Overall Study|Withdrawal by Subject|3
2167609|NCT01299480|3787399|FG004|Overall Study|Withdrawal by Subject|4
2167610|NCT01299480|3787395|FG000|Overall Study|Adverse Event|6
2167611|NCT01299480|3787396|FG001|Overall Study|Adverse Event|4
2167612|NCT01299480|3787397|FG002|Overall Study|Adverse Event|5
2167613|NCT01299480|3787398|FG003|Overall Study|Adverse Event|4
2167614|NCT01299480|3787399|FG004|Overall Study|Adverse Event|0
2167615|NCT01299480|3787395|FG000|Overall Study|Withdrawal due to pregnancy|0
2167616|NCT01299480|3787396|FG001|Overall Study|Withdrawal due to pregnancy|1
2167617|NCT01299480|3787397|FG002|Overall Study|Withdrawal due to pregnancy|1
2167618|NCT01299480|3787398|FG003|Overall Study|Withdrawal due to pregnancy|0
2167619|NCT01299480|3787399|FG004|Overall Study|Withdrawal due to pregnancy|0
2167620|NCT01299480|3787395|FG000|Overall Study|Physician Decision|1
2167621|NCT01299480|3787396|FG001|Overall Study|Physician Decision|1
2167622|NCT01299480|3787397|FG002|Overall Study|Physician Decision|0
2167623|NCT01299480|3787398|FG003|Overall Study|Physician Decision|2
2167624|NCT01299480|3787399|FG004|Overall Study|Physician Decision|0
2167625|NCT01299480|3787395|FG000|Overall Study|Lost to Follow-up|3
2167626|NCT01299480|3787396|FG001|Overall Study|Lost to Follow-up|1
2167627|NCT01299480|3787397|FG002|Overall Study|Lost to Follow-up|2
2167628|NCT01299480|3787398|FG003|Overall Study|Lost to Follow-up|1
2167629|NCT01299480|3787399|FG004|Overall Study|Lost to Follow-up|2
2167630|NCT01299480|3787395|FG000|Overall Study|Other|3
2167631|NCT01299480|3787396|FG001|Overall Study|Other|2
2167632|NCT01299480|3787397|FG002|Overall Study|Other|3
2167633|NCT01299480|3787398|FG003|Overall Study|Other|0
2167634|NCT01299480|3787399|FG004|Overall Study|Other|3
2167635|NCT01299480|3787395|FG000|Overall Study|Started, but not vaccinated|0
2167636|NCT01299480|3787396|FG001|Overall Study|Started, but not vaccinated|0
2167637|NCT01299480|3787397|FG002|Overall Study|Started, but not vaccinated|1
2167638|NCT01299480|3787398|FG003|Overall Study|Started, but not vaccinated|1
2167639|NCT01299480|3787399|FG004|Overall Study|Started, but not vaccinated|0
2167640|NCT01299571|3787412|FG000|Overall Study|Protocol Violation|107
2167641|NCT01299584|3787417|FG000|Overall Study|Protocol Violation|9
2167642|NCT01299727|3787441|FG000|Overall Study|Withdrawal by Subject|1
2167643|NCT01299727|3787442|FG001|Overall Study|Withdrawal by Subject|0
2167644|NCT01299727|3787443|FG002|Overall Study|Withdrawal by Subject|0
2167645|NCT01299727|3787441|FG000|Overall Study|Adverse Event|0
2167646|NCT01299727|3787442|FG001|Overall Study|Adverse Event|0
2167647|NCT01299727|3787443|FG002|Overall Study|Adverse Event|1
2167648|NCT01299727|3787441|FG000|Overall Study|Completed the Treatment Period|3
2167649|NCT01299727|3787442|FG001|Overall Study|Completed the Treatment Period|4
2167650|NCT01299727|3787443|FG002|Overall Study|Completed the Treatment Period|3
2167651|NCT01299766|3787453|FG000|Overall Study|Death|5
2167652|NCT01299766|3787454|FG001|Overall Study|Death|4
2167653|NCT01299766|3787453|FG000|Overall Study|Withdrawal by Subject|29
2167654|NCT01299766|3787454|FG001|Overall Study|Withdrawal by Subject|19
2167655|NCT01299805|3787462|FG000|Overall Study|Adverse Event|2
2167656|NCT01299805|3787463|FG001|Overall Study|Adverse Event|0
2167657|NCT01299896|3787471|FG000|Overall Study|Withdrawal by Subject|1
2167658|NCT01299896|3787472|FG001|Overall Study|Withdrawal by Subject|7
2167659|NCT01299896|3787471|FG000|Overall Study|Lost to Follow-up|0
2167660|NCT01299896|3787472|FG001|Overall Study|Lost to Follow-up|11
2167661|NCT01299909|3787481|FG000|Overall Study|Lost to Follow-up|22
2167662|NCT01299909|3787482|FG001|Overall Study|Lost to Follow-up|18
2167663|NCT01299909|3787483|FG002|Overall Study|Lost to Follow-up|17
2167664|NCT01299961|3787490|FG000|Overall Study|Adverse Event|3
2167665|NCT01299961|3787490|FG000|Overall Study|Lack of Efficacy|2
2167666|NCT01299961|3787490|FG000|Overall Study|Lost to Follow-up|1
2167667|NCT01300052|3787496|FG000|Overall Study|Adverse Event|3
2167668|NCT01300052|3787497|FG001|Overall Study|Adverse Event|0
2167669|NCT01300052|3787496|FG000|Overall Study|Withdrawal by Subject|2
2167670|NCT01300052|3787497|FG001|Overall Study|Withdrawal by Subject|2
2167671|NCT01300052|3787496|FG000|Overall Study|Protocol Violation|1
2167672|NCT01300052|3787497|FG001|Overall Study|Protocol Violation|1
2167673|NCT01300234|3787514|FG000|Overall Study|Adverse Event|1
2167674|NCT01300234|3787515|FG001|Overall Study|Adverse Event|1
2167675|NCT01300234|3787514|FG000|Overall Study|Protocol Violation|2
2167676|NCT01300234|3787515|FG001|Overall Study|Protocol Violation|3
2167677|NCT01300234|3787514|FG000|Overall Study|Withdrawal by Subject|5
2167678|NCT01300234|3787515|FG001|Overall Study|Withdrawal by Subject|9
2167679|NCT01300234|3787514|FG000|Overall Study|Lost to Follow-up|14
2167680|NCT01300234|3787515|FG001|Overall Study|Lost to Follow-up|12
2167681|NCT01300234|3787514|FG000|Overall Study|Pregnancy|2
2167682|NCT01300234|3787515|FG001|Overall Study|Pregnancy|1
2167683|NCT01300234|3787514|FG000|Overall Study|Participant reached stopping critera|2
2167684|NCT01300234|3787515|FG001|Overall Study|Participant reached stopping critera|0
2167685|NCT01300234|3787514|FG000|Overall Study|Participant stopped medication|1
2167686|NCT01300234|3787515|FG001|Overall Study|Participant stopped medication|1
2167687|NCT01300234|3787514|FG000|Overall Study|Participant refused return to hospital|1
2167688|NCT01300234|3787515|FG001|Overall Study|Participant refused return to hospital|0
2167689|NCT01300247|3787534|FG000|Overall Study|Death|1
2167690|NCT01300247|3787535|FG001|Overall Study|Death|1
2167691|NCT01300247|3787534|FG000|Overall Study|Lost to Follow-up|2
2167692|NCT01300247|3787535|FG001|Overall Study|Lost to Follow-up|0
2167693|NCT01300247|3787534|FG000|Overall Study|Withdrawal by Subject|1
2167694|NCT01300247|3787535|FG001|Overall Study|Withdrawal by Subject|0
2167695|NCT01300247|3787534|FG000|Overall Study|Non-Compliance|0
2167696|NCT01300247|3787535|FG001|Overall Study|Non-Compliance|1
2167697|NCT01300260|3787543|FG000|Period 1 of Study: First Intervention|Adverse Event|0
2167698|NCT01300260|3787544|FG001|Period 1 of Study: First Intervention|Adverse Event|1
2167699|NCT01300260|3787543|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1
2167700|NCT01300260|3787544|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0
2167701|NCT01300260|3787543|FG000|Period 2 of Study: Second Intervention|Adverse Event|0
2167702|NCT01300260|3787544|FG001|Period 2 of Study: Second Intervention|Adverse Event|1
2167703|NCT01300286|3787561|FG000|Overall Study|did not get dosed|1
2167704|NCT01300338|3787568|FG000|Overall Study|Lost to Follow-up|5
2167705|NCT01300338|3787569|FG001|Overall Study|Lost to Follow-up|0
2167706|NCT01300351|3787577|FG000|Overall Study|Did not receive treatment|2
2167707|NCT01300351|3787578|FG001|Overall Study|Did not receive treatment|0
2167708|NCT01300351|3787577|FG000|Overall Study|Ongoing treatment at data cut-off|27
2167709|NCT01300351|3787578|FG001|Overall Study|Ongoing treatment at data cut-off|23
2167710|NCT01300351|3787577|FG000|Overall Study|Lost to Follow-up|0
2167711|NCT01300351|3787578|FG001|Overall Study|Lost to Follow-up|1
2167712|NCT01300351|3787577|FG000|Overall Study|Adverse Event|0
2167713|NCT01300351|3787578|FG001|Overall Study|Adverse Event|4
2167714|NCT01300351|3787577|FG000|Overall Study|Withdrawal by Subject|7
2167715|NCT01300351|3787578|FG001|Overall Study|Withdrawal by Subject|10
2167716|NCT01300455|3787586|FG000|Washout|Withdrawal by Subject|1
2167717|NCT01300455|3787587|FG001|Washout|Withdrawal by Subject|0
2167718|NCT01300546|3787595|FG000|Overall Study|Withdrawal by Subject|1
2167719|NCT01300546|3787596|FG001|Overall Study|Withdrawal by Subject|0
2295332|NCT02546544|3990655|FG000|Overall Study|Withdrawal by Subject|1
2295333|NCT02546609|3990675|FG000|Overall Study|Withdrawal by Subject|0
2295334|NCT02546609|3990676|FG001|Overall Study|Withdrawal by Subject|1
2295335|NCT02546609|3990677|FG002|Overall Study|Withdrawal by Subject|2
2295336|NCT02546609|3990675|FG000|Overall Study|Adverse Event|0
2295337|NCT02546609|3990676|FG001|Overall Study|Adverse Event|6
2295338|NCT02546609|3990677|FG002|Overall Study|Adverse Event|1
2295339|NCT02546609|3990675|FG000|Overall Study|Protocol Violation|0
2167720|NCT01300546|3787595|FG000|Overall Study|Lost to Follow-up|0
2167721|NCT01300546|3787596|FG001|Overall Study|Lost to Follow-up|2
2167722|NCT01300546|3787595|FG000|Overall Study|Lack of Efficacy|0
2167723|NCT01300546|3787596|FG001|Overall Study|Lack of Efficacy|3
2295340|NCT02546609|3990676|FG001|Overall Study|Protocol Violation|1
2167724|NCT01300546|3787595|FG000|Overall Study|Adverse Event|0
2167725|NCT01300546|3787596|FG001|Overall Study|Adverse Event|1
2167726|NCT01300572|3787611|FG000|Overall Study|HAMA + post dosimetry|1
2167727|NCT01300650|3787621|FG000|Overall Study|Adverse Event|1
2167728|NCT01300728|3787628|FG000|Overall Study|Withdrawal by Subject|1
2167729|NCT01300728|3787629|FG001|Overall Study|Withdrawal by Subject|1
2167730|NCT01300728|3787628|FG000|Overall Study|Physician Decision|1
2167731|NCT01300728|3787629|FG001|Overall Study|Physician Decision|0
2167732|NCT01300741|3787635|FG000|Overall Study|Lens deposits|1
2167733|NCT01300741|3787635|FG000|Overall Study|Lost to Follow-up|1
2167734|NCT01300741|3787635|FG000|Overall Study|Discomfort|1
2167735|NCT01300767|3787641|FG000|Overall Study|Discomfort|2
2167736|NCT01300767|3787641|FG000|Overall Study|Biomicroscopy|1
2167737|NCT01300767|3787641|FG000|Overall Study|Unacceptable fit|1
2167738|NCT01300819|3787649|FG000|Overall Study|Adverse Event|9
2167739|NCT01300819|3787650|FG001|Overall Study|Adverse Event|27
2167740|NCT01300819|3787649|FG000|Overall Study|Lack of Efficacy|2
2167741|NCT01300819|3787650|FG001|Overall Study|Lack of Efficacy|1
2167742|NCT01300819|3787649|FG000|Overall Study|Withdrawal by Subject|10
2167743|NCT01300819|3787650|FG001|Overall Study|Withdrawal by Subject|12
2167744|NCT01300819|3787649|FG000|Overall Study|Patient was 1 month late for Visit 10|0
2167745|NCT01300819|3787650|FG001|Overall Study|Patient was 1 month late for Visit 10|1
2167746|NCT01300819|3787649|FG000|Overall Study|Refusal to down titrate study drug|0
2167747|NCT01300819|3787650|FG001|Overall Study|Refusal to down titrate study drug|1
2167748|NCT01300819|3787649|FG000|Overall Study|Administrative reason|0
2167749|NCT01300819|3787650|FG001|Overall Study|Administrative reason|1
2167750|NCT01300819|3787649|FG000|Overall Study|Safety follow up not done by mistake|0
2167751|NCT01300819|3787650|FG001|Overall Study|Safety follow up not done by mistake|1
2167752|NCT01300819|3787649|FG000|Overall Study|Follow up call was not done|1
2167753|NCT01300819|3787650|FG001|Overall Study|Follow up call was not done|0
2167754|NCT01300923|3787656|FG000|Overall Study|Physician Decision|0
2167755|NCT01300923|3787657|FG001|Overall Study|Physician Decision|2
2167756|NCT01301001|3787675|FG000|First Intervention|Lost to Follow-up|4
2167757|NCT01301001|3787676|FG001|First Intervention|Lost to Follow-up|4
2167758|NCT01301001|3787675|FG000|First Intervention|Withdrawal by Subject|1
2167759|NCT01301001|3787676|FG001|First Intervention|Withdrawal by Subject|4
2167760|NCT01301001|3787675|FG000|First Intervention|Adverse Event|5
2167761|NCT01301001|3787676|FG001|First Intervention|Adverse Event|0
2167762|NCT01301001|3787675|FG000|First Intervention|Protocol Violation|0
2167763|NCT01301001|3787676|FG001|First Intervention|Protocol Violation|1
2167764|NCT01301001|3787675|FG000|Second Intervention|Adverse Event|2
2167765|NCT01301001|3787676|FG001|Second Intervention|Adverse Event|0
2167766|NCT01301001|3787675|FG000|Second Intervention|Withdrawal by Subject|2
2167767|NCT01301001|3787676|FG001|Second Intervention|Withdrawal by Subject|0
2167768|NCT01301027|3787685|FG000|Overall Study|Physician Decision|2
2167769|NCT01301027|3787686|FG001|Overall Study|Physician Decision|0
2167770|NCT01301027|3787685|FG000|Overall Study|Withdrawal by Subject|2
2167771|NCT01301027|3787686|FG001|Overall Study|Withdrawal by Subject|3
2167772|NCT01301027|3787685|FG000|Overall Study|Adverse Event|0
2167773|NCT01301027|3787686|FG001|Overall Study|Adverse Event|2
2167774|NCT01301027|3787685|FG000|Overall Study|Fracture|1
2167775|NCT01301027|3787686|FG001|Overall Study|Fracture|3
2167776|NCT01301027|3787685|FG000|Overall Study|Transplant|0
2167777|NCT01301027|3787686|FG001|Overall Study|Transplant|2
2167778|NCT01301027|3787685|FG000|Overall Study|Volume Overload|3
2167779|NCT01301027|3787686|FG001|Overall Study|Volume Overload|0
2167780|NCT01301066|3787694|FG000|Overall Study|Lost to Follow-up|5
2167781|NCT01301066|3787695|FG001|Overall Study|Lost to Follow-up|11
2167782|NCT01301066|3787694|FG000|Overall Study|Protocol Violation|8
2167783|NCT01301066|3787695|FG001|Overall Study|Protocol Violation|7
2167784|NCT01301066|3787694|FG000|Overall Study|Withdrawal by Subject|4
2167785|NCT01301066|3787695|FG001|Overall Study|Withdrawal by Subject|9
2167786|NCT01301066|3787694|FG000|Overall Study|Adverse Event|6
2167787|NCT01301066|3787695|FG001|Overall Study|Adverse Event|6
2167788|NCT01301066|3787694|FG000|Overall Study|Sponsor Decision|2
2167789|NCT01301066|3787695|FG001|Overall Study|Sponsor Decision|1
2167790|NCT01301066|3787694|FG000|Overall Study|Physician Decision|0
2167791|NCT01301066|3787695|FG001|Overall Study|Physician Decision|1
2167792|NCT01301066|3787694|FG000|Overall Study|Other|2
2167793|NCT01301066|3787695|FG001|Overall Study|Other|0
2167794|NCT01301079|3787703|FG000|Overall Study|Lost to Follow-up|2
2167795|NCT01301079|3787704|FG001|Overall Study|Lost to Follow-up|2
2167796|NCT01301092|3787717|FG000|Overall Study|Lost to Follow-up|0
2167797|NCT01301092|3787718|FG001|Overall Study|Lost to Follow-up|0
2167798|NCT01301092|3787719|FG002|Overall Study|Lost to Follow-up|1
2167799|NCT01301274|3787743|FG000|Overall Study|Physician Decision|2
2167800|NCT01301274|3787744|FG001|Overall Study|Physician Decision|1
2167801|NCT01301391|3787755|FG000|Overall Study|Death|13
2167802|NCT01301391|3787755|FG000|Overall Study|Lost to Follow-up|3
2167803|NCT01301391|3787755|FG000|Overall Study|Physician Decision|2
2167804|NCT01301391|3787755|FG000|Overall Study|Sponsor's decision|8
2167805|NCT01301456|3787771|FG000|Stage 1|Withdrawal by Subject|0
2167806|NCT01301456|3787772|FG001|Stage 1|Withdrawal by Subject|0
2167807|NCT01301456|3787773|FG002|Stage 1|Withdrawal by Subject|1
2167808|NCT01301456|3787774|FG003|Stage 1|Withdrawal by Subject|0
2167809|NCT01301456|3787775|FG004|Stage 1|Withdrawal by Subject|1
2167810|NCT01301456|3787776|FG005|Stage 1|Withdrawal by Subject|0
2167811|NCT01301456|3787777|FG006|Stage 1|Withdrawal by Subject|0
2167812|NCT01301456|3787778|FG007|Stage 1|Withdrawal by Subject|0
2167813|NCT01301456|3787779|FG008|Stage 1|Withdrawal by Subject|0
2167814|NCT01301456|3787780|FG009|Stage 1|Withdrawal by Subject|0
2167815|NCT01301456|3787781|FG010|Stage 1|Withdrawal by Subject|0
2167816|NCT01301456|3787782|FG011|Stage 1|Withdrawal by Subject|0
2167817|NCT01301456|3787771|FG000|Stage 1|Randomized but not treated|0
2167818|NCT01301456|3787772|FG001|Stage 1|Randomized but not treated|0
2167819|NCT01301456|3787773|FG002|Stage 1|Randomized but not treated|0
2167820|NCT01301456|3787774|FG003|Stage 1|Randomized but not treated|0
2167821|NCT01301456|3787775|FG004|Stage 1|Randomized but not treated|0
2167822|NCT01301456|3787776|FG005|Stage 1|Randomized but not treated|0
2167823|NCT01301456|3787777|FG006|Stage 1|Randomized but not treated|1
2167824|NCT01301456|3787778|FG007|Stage 1|Randomized but not treated|0
2167825|NCT01301456|3787779|FG008|Stage 1|Randomized but not treated|0
2167826|NCT01301456|3787780|FG009|Stage 1|Randomized but not treated|0
2167827|NCT01301456|3787781|FG010|Stage 1|Randomized but not treated|0
2167828|NCT01301456|3787782|FG011|Stage 1|Randomized but not treated|0
2167829|NCT01301456|3787771|FG000|Stage 2|Adverse Event|0
2167830|NCT01301456|3787772|FG001|Stage 2|Adverse Event|0
2167831|NCT01301456|3787773|FG002|Stage 2|Adverse Event|0
2167832|NCT01301456|3787774|FG003|Stage 2|Adverse Event|0
2167833|NCT01301456|3787775|FG004|Stage 2|Adverse Event|0
2167834|NCT01301456|3787776|FG005|Stage 2|Adverse Event|0
2167835|NCT01301456|3787777|FG006|Stage 2|Adverse Event|0
2167836|NCT01301456|3787778|FG007|Stage 2|Adverse Event|0
2167837|NCT01301456|3787779|FG008|Stage 2|Adverse Event|0
2167838|NCT01301456|3787780|FG009|Stage 2|Adverse Event|0
2167839|NCT01301456|3787781|FG010|Stage 2|Adverse Event|1
2167840|NCT01301456|3787782|FG011|Stage 2|Adverse Event|0
2167841|NCT01301508|3787828|FG000|Overall Study|Withdrawal by Subject|1
2167842|NCT01301508|3787829|FG001|Overall Study|Withdrawal by Subject|2
2167843|NCT01301508|3787828|FG000|Overall Study|Lost to Follow-up|0
2167844|NCT01301508|3787829|FG001|Overall Study|Lost to Follow-up|1
2167845|NCT01301625|3787835|FG000|Overall Study|Death|5
2167846|NCT01301625|3787835|FG000|Overall Study|Not Due|21
2167847|NCT01301625|3787835|FG000|Overall Study|Expected|8
2167848|NCT01301625|3787835|FG000|Overall Study|Lost to Follow-up|1
2167849|NCT01301729|3787839|FG000|Overall Study|Withdrawal by Subject|2
2167850|NCT01301729|3787839|FG000|Overall Study|Participant did not Return for Treatment|1
2167851|NCT01301729|3787839|FG000|Overall Study|Violated Selection Criteria|1
2167852|NCT01301833|3787856|FG000|Overall Study|Adverse Event|7
2167853|NCT01301833|3787857|FG001|Overall Study|Adverse Event|5
2167854|NCT01301833|3787858|FG002|Overall Study|Adverse Event|5
2167855|NCT01301833|3787859|FG003|Overall Study|Adverse Event|5
2167856|NCT01301833|3787856|FG000|Overall Study|Lack of Efficacy|1
2167857|NCT01301833|3787857|FG001|Overall Study|Lack of Efficacy|1
2167858|NCT01301833|3787858|FG002|Overall Study|Lack of Efficacy|0
2167859|NCT01301833|3787859|FG003|Overall Study|Lack of Efficacy|0
2167860|NCT01301833|3787856|FG000|Overall Study|Physician Decision|3
2167861|NCT01301833|3787857|FG001|Overall Study|Physician Decision|1
2167862|NCT01301833|3787858|FG002|Overall Study|Physician Decision|1
2167863|NCT01301833|3787859|FG003|Overall Study|Physician Decision|0
2167864|NCT01301833|3787856|FG000|Overall Study|Withdrawal by Subject|3
2167865|NCT01301833|3787857|FG001|Overall Study|Withdrawal by Subject|1
2167866|NCT01301833|3787858|FG002|Overall Study|Withdrawal by Subject|1
2167867|NCT01301833|3787859|FG003|Overall Study|Withdrawal by Subject|2
2167868|NCT01301833|3787856|FG000|Overall Study|Personal matter|1
2167869|NCT01301833|3787857|FG001|Overall Study|Personal matter|0
2167870|NCT01301833|3787858|FG002|Overall Study|Personal matter|0
2167871|NCT01301833|3787859|FG003|Overall Study|Personal matter|0
2167872|NCT01301950|3787871|FG000|Overall Study|Surgery was cancelled by patient|0
2167873|NCT01301950|3787872|FG001|Overall Study|Surgery was cancelled by patient|1
2167874|NCT01302041|3787878|FG000|Overall Study|Death|5
2167875|NCT01302041|3787878|FG000|Overall Study|Withdrawal by Subject|4
2167876|NCT01302041|3787878|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29
2167877|NCT01302041|3787878|FG000|Overall Study|Other-Miscellaneous Reason|2
2167878|NCT01302054|3787883|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
2167879|NCT01302054|3787884|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
2167880|NCT01302054|3787885|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
2167881|NCT01302054|3787883|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
2167882|NCT01302054|3787884|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
2167883|NCT01302054|3787885|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
2167884|NCT01302054|3787883|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
2167885|NCT01302054|3787884|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
2167886|NCT01302054|3787885|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
2167887|NCT01302054|3787883|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
2167888|NCT01302054|3787884|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
2167889|NCT01302054|3787885|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
2167890|NCT01302054|3787883|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13
2167891|NCT01302054|3787884|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0
2167892|NCT01302054|3787885|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0
2167893|NCT01302054|3787883|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
2167894|NCT01302054|3787884|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
2167895|NCT01302054|3787885|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
2167896|NCT01302054|3787883|FG000|Tolterodine Open-Label Run-In Phase|Other|7
2167897|NCT01302054|3787884|FG001|Tolterodine Open-Label Run-In Phase|Other|0
2167898|NCT01302054|3787885|FG002|Tolterodine Open-Label Run-In Phase|Other|0
2167899|NCT01302054|3787883|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
2167900|NCT01302054|3787884|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
2167901|NCT01302054|3787885|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
2167902|NCT01302054|3787883|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0
2167903|NCT01302054|3787884|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2
2167904|NCT01302054|3787885|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4
2167905|NCT01302054|3787883|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
2167906|NCT01302054|3787884|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
2167907|NCT01302054|3787885|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
2167908|NCT01302054|3787883|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
2167909|NCT01302054|3787884|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6
2167910|NCT01302054|3787885|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14
2167911|NCT01302054|3787883|FG000|Double-Blind Treatment Phase|Protocol Violation|0
2167912|NCT01302054|3787884|FG001|Double-Blind Treatment Phase|Protocol Violation|3
2167913|NCT01302054|3787885|FG002|Double-Blind Treatment Phase|Protocol Violation|6
2167914|NCT01302054|3787883|FG000|Double-Blind Treatment Phase|Adverse Event|0
2167915|NCT01302054|3787884|FG001|Double-Blind Treatment Phase|Adverse Event|10
2167916|NCT01302054|3787885|FG002|Double-Blind Treatment Phase|Adverse Event|10
2167917|NCT01302054|3787883|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
2167918|NCT01302054|3787884|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
2167919|NCT01302054|3787885|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
2167920|NCT01302054|3787883|FG000|Double-Blind Treatment Phase|Other|0
2167921|NCT01302054|3787884|FG001|Double-Blind Treatment Phase|Other|4
2167922|NCT01302054|3787885|FG002|Double-Blind Treatment Phase|Other|9
2167923|NCT01302067|3787897|FG000|Overall Study|Death|0
2167924|NCT01302067|3787898|FG001|Overall Study|Death|0
2167925|NCT01302067|3787899|FG002|Overall Study|Death|1
2167926|NCT01302067|3787897|FG000|Overall Study|Physician Decision|9
2167927|NCT01302067|3787898|FG001|Overall Study|Physician Decision|5
2167928|NCT01302067|3787899|FG002|Overall Study|Physician Decision|14
2167929|NCT01302067|3787897|FG000|Overall Study|Lack of Efficacy|8
2167930|NCT01302067|3787898|FG001|Overall Study|Lack of Efficacy|4
2167931|NCT01302067|3787899|FG002|Overall Study|Lack of Efficacy|2
2167932|NCT01302067|3787897|FG000|Overall Study|Lost to Follow-up|9
2167933|NCT01302067|3787898|FG001|Overall Study|Lost to Follow-up|4
2167934|NCT01302067|3787899|FG002|Overall Study|Lost to Follow-up|15
2167935|NCT01302067|3787897|FG000|Overall Study|Withdrawal by Subject|13
2167936|NCT01302067|3787898|FG001|Overall Study|Withdrawal by Subject|6
2167937|NCT01302067|3787899|FG002|Overall Study|Withdrawal by Subject|10
2167938|NCT01302067|3787897|FG000|Overall Study|Other|1
2167939|NCT01302067|3787898|FG001|Overall Study|Other|1
2167940|NCT01302067|3787899|FG002|Overall Study|Other|3
2167941|NCT01302067|3787897|FG000|Overall Study|Protocol Violation|11
2167942|NCT01302067|3787898|FG001|Overall Study|Protocol Violation|0
2167943|NCT01302067|3787899|FG002|Overall Study|Protocol Violation|8
2167944|NCT01302067|3787897|FG000|Overall Study|Adverse Event|27
2167945|NCT01302067|3787898|FG001|Overall Study|Adverse Event|14
2167946|NCT01302067|3787899|FG002|Overall Study|Adverse Event|45
2167947|NCT01302080|3787910|FG000|Overall Study|Withdrew Consent|92
2167948|NCT01302080|3787911|FG001|Overall Study|Withdrew Consent|39
2167949|NCT01302080|3787910|FG000|Overall Study|Patient/Family Moved|28
2167950|NCT01302080|3787911|FG001|Overall Study|Patient/Family Moved|3
2167951|NCT01302080|3787910|FG000|Overall Study|Lost to Follow-up|192
2167952|NCT01302080|3787911|FG001|Overall Study|Lost to Follow-up|93
2167953|NCT01302080|3787910|FG000|Overall Study|Death|1
2167954|NCT01302080|3787911|FG001|Overall Study|Death|0
2167955|NCT01302080|3787910|FG000|Overall Study|Other|52
2167956|NCT01302080|3787911|FG001|Overall Study|Other|8
2167957|NCT01302080|3787910|FG000|Overall Study|Reason Missing For Discontinuation|1
2167958|NCT01302080|3787911|FG001|Overall Study|Reason Missing For Discontinuation|0
2167959|NCT01302119|3787943|FG000|Overall Study|Withdrawal by Subject|30
2167960|NCT01302119|3787944|FG001|Overall Study|Withdrawal by Subject|20
2167961|NCT01302119|3787943|FG000|Overall Study|Lost to Follow-up|10
2167962|NCT01302119|3787944|FG001|Overall Study|Lost to Follow-up|4
2167963|NCT01302119|3787943|FG000|Overall Study|Adverse Event|2
2167964|NCT01302119|3787944|FG001|Overall Study|Adverse Event|1
2167965|NCT01302119|3787943|FG000|Overall Study|Non-compliance|4
2167966|NCT01302119|3787944|FG001|Overall Study|Non-compliance|2
2167967|NCT01302119|3787943|FG000|Overall Study|Non-specific|4
2167968|NCT01302119|3787944|FG001|Overall Study|Non-specific|1
2167969|NCT01302366|3787950|FG000|Overall Study|patient choice or noncompliance|5
2167970|NCT01302392|3787971|FG000|Overall Study|Lost to Follow-up|1
2167971|NCT01302392|3787972|FG001|Overall Study|Lost to Follow-up|0
2167972|NCT01302392|3787971|FG000|Overall Study|Withdrawal by Subject|6
2167973|NCT01302392|3787972|FG001|Overall Study|Withdrawal by Subject|1
2167974|NCT01302418|3787978|FG000|Overall Study|Protocol Violation|9
2208230|NCT01637272|3847630|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2208231|NCT01637272|3847630|FG000|Overall Study|Withdrawal by Subject|3
2167975|NCT01302418|3787978|FG000|Overall Study|Non-evaluable|9
2167976|NCT01302548|3787999|FG000|Overall Study|Lost to Follow-up|2
2167977|NCT01302548|3788000|FG001|Overall Study|Lost to Follow-up|1
2167978|NCT01302691|3788008|FG000|Overall Study|Adverse Event|2
2167979|NCT01302691|3788009|FG001|Overall Study|Adverse Event|0
2167980|NCT01302691|3788008|FG000|Overall Study|Death|0
2167981|NCT01302691|3788009|FG001|Overall Study|Death|1
2167982|NCT01302691|3788008|FG000|Overall Study|Lost to Follow-up|1
2167983|NCT01302691|3788009|FG001|Overall Study|Lost to Follow-up|0
2167984|NCT01302691|3788008|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6
2167985|NCT01302691|3788009|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4
2167986|NCT01302691|3788008|FG000|Overall Study|Physician Decision|0
2167987|NCT01302691|3788009|FG001|Overall Study|Physician Decision|1
2167988|NCT01302691|3788008|FG000|Overall Study|Protocol Violation|1
2167989|NCT01302691|3788009|FG001|Overall Study|Protocol Violation|0
2167990|NCT01302834|3788049|FG000|Overall Study|Protocol Violation|17
2167991|NCT01302834|3788050|FG001|Overall Study|Protocol Violation|23
2167992|NCT01302834|3788049|FG000|Overall Study|HIV positive|1
2167993|NCT01302834|3788050|FG001|Overall Study|HIV positive|3
2167994|NCT01302899|3788062|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
2167995|NCT01302899|3788063|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
2167996|NCT01302899|3788062|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
2167997|NCT01302899|3788063|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
2167998|NCT01302938|3788075|FG000|Overall Study|Withdrawal by Subject|1
2167999|NCT01302938|3788076|FG001|Overall Study|Withdrawal by Subject|0
2168000|NCT01302938|3788075|FG000|Overall Study|Adverse Event|1
2168001|NCT01302938|3788076|FG001|Overall Study|Adverse Event|0
2168002|NCT01302964|3788085|FG000|Overall Study|Adverse Event|1
2168003|NCT01302964|3788086|FG001|Overall Study|Adverse Event|0
2168004|NCT01303159|3788101|FG000|Overall Study|Death|16
2168005|NCT01303159|3788101|FG000|Overall Study|Study Termination|7
2168006|NCT01303172|3788107|FG000|Overall Study|Physician Decision|9
2168007|NCT01303172|3788108|FG001|Overall Study|Physician Decision|6
2168008|NCT01303172|3788107|FG000|Overall Study|Adverse Event|5
2168009|NCT01303172|3788108|FG001|Overall Study|Adverse Event|2
2168010|NCT01303172|3788107|FG000|Overall Study|Withdrawal by Subject|4
2208232|NCT01637272|3847630|FG000|Overall Study|Lost to Follow-up|2
2295341|NCT02546609|3990677|FG002|Overall Study|Protocol Violation|1
2168011|NCT01303172|3788108|FG001|Overall Study|Withdrawal by Subject|2
2168012|NCT01303172|3788107|FG000|Overall Study|Death|20
2168013|NCT01303172|3788108|FG001|Overall Study|Death|7
2168014|NCT01303172|3788107|FG000|Overall Study|Lack of Efficacy|25
2168015|NCT01303172|3788108|FG001|Overall Study|Lack of Efficacy|17
2168016|NCT01303380|3788132|FG000|Overall Study|Lack of compliance to study procedures|1
2168017|NCT01303419|3788145|FG000|Overall Study|Discontinuation of study|60
2168018|NCT01303419|3788145|FG000|Overall Study|Did not complete both imaging methods|5
2168019|NCT01303419|3788145|FG000|Overall Study|Did not meet all I/E after screening|31
2168020|NCT01303445|3788149|FG000|First Intervention (7 Days)|Withdrawal by Subject|1
2168021|NCT01303445|3788150|FG001|First Intervention (7 Days)|Withdrawal by Subject|0
2168022|NCT01303445|3788149|FG000|Second Intervention (7 Days)|Adverse Event|0
2168023|NCT01303445|3788150|FG001|Second Intervention (7 Days)|Adverse Event|2
2168024|NCT01303445|3788149|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
2168025|NCT01303445|3788150|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
2168026|NCT01303445|3788149|FG000|Washout (14 Days)|Protocol Violation|1
2168027|NCT01303445|3788150|FG001|Washout (14 Days)|Protocol Violation|0
2168028|NCT01303445|3788149|FG000|Washout (14 Days)|Lost to Follow-up|0
2168029|NCT01303445|3788150|FG001|Washout (14 Days)|Lost to Follow-up|2
2168030|NCT01303445|3788149|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1
2295342|NCT02546609|3990675|FG000|Overall Study|Lost to Follow-up|2
2295343|NCT02546609|3990676|FG001|Overall Study|Lost to Follow-up|3
2295344|NCT02546609|3990677|FG002|Overall Study|Lost to Follow-up|1
2295345|NCT02546609|3990675|FG000|Overall Study|travel or work schedule restriction|0
2295346|NCT02546609|3990676|FG001|Overall Study|travel or work schedule restriction|0
2295347|NCT02546609|3990677|FG002|Overall Study|travel or work schedule restriction|2
2295348|NCT02546765|3990689|FG000|Overall Study|Withdrawal by Subject|0
2295349|NCT02546765|3990690|FG001|Overall Study|Withdrawal by Subject|1
2295350|NCT02546765|3990691|FG002|Overall Study|Withdrawal by Subject|0
2295351|NCT02546765|3990692|FG003|Overall Study|Withdrawal by Subject|0
2295352|NCT02546856|3990715|FG000|4 Months Evaluation|Death|2
2295353|NCT02546856|3990716|FG001|4 Months Evaluation|Death|3
2295354|NCT02546856|3990715|FG000|4 Months Evaluation|Withdrawal by Subject|2
2295355|NCT02546856|3990716|FG001|4 Months Evaluation|Withdrawal by Subject|3
2295356|NCT02546856|3990715|FG000|4 Months Evaluation|Lost to Follow-up|3
2295357|NCT02546856|3990716|FG001|4 Months Evaluation|Lost to Follow-up|3
2295358|NCT02546856|3990715|FG000|4 Months Evaluation|Physician Decision|3
2295359|NCT02546856|3990716|FG001|4 Months Evaluation|Physician Decision|0
2295360|NCT02546856|3990715|FG000|4 Months Evaluation|Working or living abroad|5
2295361|NCT02546856|3990716|FG001|4 Months Evaluation|Working or living abroad|1
2168031|NCT01303445|3788150|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0
2168032|NCT01303445|3788149|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0
2168033|NCT01303445|3788150|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1
2168034|NCT01303510|3788162|FG000|Overall Study|Lost to Follow-up|1
2168035|NCT01303510|3788163|FG001|Overall Study|Lost to Follow-up|0
2168036|NCT01303627|3788171|FG000|Overall Study|the failure while performing URS|0
2168037|NCT01303627|3788172|FG001|Overall Study|the failure while performing URS|1
2179744|NCT01395888|3805452|FG002|2-week Run-in Period|Protocol Violation|0
2179745|NCT01395888|3805450|FG000|2-week Run-in Period|Withdrawal by Subject|4
2179746|NCT01395888|3805451|FG001|2-week Run-in Period|Withdrawal by Subject|0
2179747|NCT01395888|3805452|FG002|2-week Run-in Period|Withdrawal by Subject|0
2179748|NCT01395888|3805450|FG000|Treatment Period (TP)|Adverse Event|0
2179749|NCT01395888|3805451|FG001|Treatment Period (TP)|Adverse Event|7
2179750|NCT01395888|3805452|FG002|Treatment Period (TP)|Adverse Event|6
2179751|NCT01395888|3805450|FG000|Treatment Period (TP)|Lack of Efficacy|0
2179752|NCT01395888|3805451|FG001|Treatment Period (TP)|Lack of Efficacy|4
2179753|NCT01395888|3805452|FG002|Treatment Period (TP)|Lack of Efficacy|3
2179754|NCT01395888|3805450|FG000|Treatment Period (TP)|Protocol Violation|0
2179755|NCT01395888|3805451|FG001|Treatment Period (TP)|Protocol Violation|1
2179756|NCT01395888|3805452|FG002|Treatment Period (TP)|Protocol Violation|5
2179757|NCT01395888|3805450|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
2179758|NCT01395888|3805451|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
2179759|NCT01395888|3805452|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
2179760|NCT01395888|3805450|FG000|Treatment Period (TP)|Withdrawal by Subject|0
2179761|NCT01395888|3805451|FG001|Treatment Period (TP)|Withdrawal by Subject|2
2179762|NCT01395888|3805452|FG002|Treatment Period (TP)|Withdrawal by Subject|3
2179763|NCT01395901|3805460|FG000|Overall Study|Lost to Follow-up|4
2179764|NCT01395901|3805461|FG001|Overall Study|Lost to Follow-up|0
2179765|NCT01395901|3805460|FG000|Overall Study|Randomized but not received study drug|5
2179766|NCT01395901|3805461|FG001|Overall Study|Randomized but not received study drug|4
2179767|NCT01395901|3805460|FG000|Overall Study|Adverse Event|0
2179768|NCT01395901|3805461|FG001|Overall Study|Adverse Event|1
2295362|NCT02546856|3990715|FG000|4 Months Evaluation|reasons not due to titration|4
2295363|NCT02546856|3990716|FG001|4 Months Evaluation|reasons not due to titration|1
2295364|NCT02546856|3990715|FG000|4 Months Evaluation|HF Unit not active in summer|1
2295365|NCT02546856|3990716|FG001|4 Months Evaluation|HF Unit not active in summer|0
2295366|NCT02546856|3990715|FG000|6 Months Evaluation|Death|1
2295367|NCT02546856|3990716|FG001|6 Months Evaluation|Death|1
2295368|NCT02546856|3990715|FG000|6 Months Evaluation|Lost to Follow-up|1
2295369|NCT02546856|3990716|FG001|6 Months Evaluation|Lost to Follow-up|1
2295370|NCT02546856|3990715|FG000|6 Months Evaluation|Working or living abroad|6
2295371|NCT02546856|3990716|FG001|6 Months Evaluation|Working or living abroad|4
2295372|NCT02546856|3990715|FG000|6 Months Evaluation|reasons not due to titration|0
2295373|NCT02546856|3990716|FG001|6 Months Evaluation|reasons not due to titration|1
2295374|NCT02547038|3990745|FG000|Overall Study|Lost to Follow-up|3
2295375|NCT02547038|3990746|FG001|Overall Study|Lost to Follow-up|2
2295376|NCT02547220|3990763|FG000|Overall Study|Withdrawal by Subject|1
2295377|NCT02547220|3990764|FG001|Overall Study|Withdrawal by Subject|0
2295378|NCT02547220|3990763|FG000|Overall Study|Study terminated by sponsor|18
2295379|NCT02547220|3990764|FG001|Overall Study|Study terminated by sponsor|20
2295380|NCT02547233|3990772|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1
2295381|NCT02547233|3990773|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0
2295382|NCT02547233|3990772|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
2295383|NCT02547233|3990773|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
2295384|NCT02547233|3990772|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
2295385|NCT02547233|3990773|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
2295386|NCT02547233|3990772|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
2295387|NCT02547233|3990773|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
2295388|NCT02547233|3990772|FG000|12-month Follow-up|Withdrawal by Subject|10
2295389|NCT02547233|3990773|FG001|12-month Follow-up|Withdrawal by Subject|10
2295390|NCT02547233|3990772|FG000|12-month Follow-up|Lost to Follow-up|3
2295391|NCT02547233|3990773|FG001|12-month Follow-up|Lost to Follow-up|3
2295392|NCT02547233|3990772|FG000|12-month Follow-up|Lack of Efficacy|1
2295393|NCT02547233|3990773|FG001|12-month Follow-up|Lack of Efficacy|2
2295394|NCT02547233|3990772|FG000|12-month Follow-up|Protocol Violation|0
2295395|NCT02547233|3990773|FG001|12-month Follow-up|Protocol Violation|1
2295396|NCT02547233|3990772|FG000|12-month Follow-up|Other|0
2295397|NCT02547233|3990773|FG001|12-month Follow-up|Other|1
2295398|NCT02547363|3990783|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
2295399|NCT02547363|3990784|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
2295400|NCT02547363|3990783|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
2295401|NCT02547363|3990784|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
2295402|NCT02547363|3990783|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
2295403|NCT02547363|3990784|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
2295404|NCT02547363|3990783|FG000|3-day Treatment and 8-week Follow-up|Other|1
2295405|NCT02547363|3990784|FG001|3-day Treatment and 8-week Follow-up|Other|1
2168038|NCT01303861|3788209|FG000|Overall Study|Lost to Follow-up|34
2168039|NCT01303861|3788210|FG001|Overall Study|Lost to Follow-up|14
2168040|NCT01303861|3788211|FG002|Overall Study|Lost to Follow-up|27
2168041|NCT01303861|3788212|FG003|Overall Study|Lost to Follow-up|31
2168042|NCT01303861|3788209|FG000|Overall Study|Lack of Efficacy|3
2168043|NCT01303861|3788210|FG001|Overall Study|Lack of Efficacy|2
2168044|NCT01303861|3788211|FG002|Overall Study|Lack of Efficacy|1
2168045|NCT01303861|3788212|FG003|Overall Study|Lack of Efficacy|0
2168046|NCT01303861|3788209|FG000|Overall Study|Withdrawal by Subject|16
2168047|NCT01303861|3788210|FG001|Overall Study|Withdrawal by Subject|8
2168048|NCT01303861|3788211|FG002|Overall Study|Withdrawal by Subject|8
2168049|NCT01303861|3788212|FG003|Overall Study|Withdrawal by Subject|23
2168050|NCT01303861|3788209|FG000|Overall Study|Adverse Event|4
2168051|NCT01303861|3788210|FG001|Overall Study|Adverse Event|1
2168052|NCT01303861|3788211|FG002|Overall Study|Adverse Event|0
2168053|NCT01303861|3788212|FG003|Overall Study|Adverse Event|5
2168054|NCT01303861|3788209|FG000|Overall Study|Pregnancy|1
2168055|NCT01303861|3788210|FG001|Overall Study|Pregnancy|0
2168056|NCT01303861|3788211|FG002|Overall Study|Pregnancy|0
2168057|NCT01303861|3788212|FG003|Overall Study|Pregnancy|0
2168058|NCT01303965|3788236|FG000|Overall Study|Adverse Event|1
2168059|NCT01303965|3788237|FG001|Overall Study|Adverse Event|1
2168060|NCT01303965|3788236|FG000|Overall Study|Death|0
2168061|NCT01303965|3788237|FG001|Overall Study|Death|3
2168062|NCT01303965|3788236|FG000|Overall Study|Withdrawal by Subject|1
2168063|NCT01303965|3788237|FG001|Overall Study|Withdrawal by Subject|0
2168064|NCT01303965|3788236|FG000|Overall Study|Disease Progression|1
2168065|NCT01303965|3788237|FG001|Overall Study|Disease Progression|6
2168066|NCT01304147|3788255|FG000|Second Intervention (7days)|Withdrawal by Subject|1
2168067|NCT01304147|3788256|FG001|Second Intervention (7days)|Withdrawal by Subject|1
2168068|NCT01304329|3788310|FG000|Third Intervention (3 Days)|Adverse Event|0
2168069|NCT01304329|3788311|FG001|Third Intervention (3 Days)|Adverse Event|1
2168070|NCT01304329|3788312|FG002|Third Intervention (3 Days)|Adverse Event|0
2168071|NCT01304329|3788313|FG003|Third Intervention (3 Days)|Adverse Event|0
2168072|NCT01304329|3788314|FG004|Third Intervention (3 Days)|Adverse Event|0
2168073|NCT01304329|3788315|FG005|Third Intervention (3 Days)|Adverse Event|0
2168074|NCT01304498|3788329|FG000|Overall Study|Adverse Event|1
2168075|NCT01304498|3788330|FG001|Overall Study|Adverse Event|1
2168076|NCT01304498|3788329|FG000|Overall Study|Withdrawal by Subject|2
2168077|NCT01304498|3788330|FG001|Overall Study|Withdrawal by Subject|3
2168078|NCT01304498|3788329|FG000|Overall Study|Protocol Violation|1
2168079|NCT01304498|3788330|FG001|Overall Study|Protocol Violation|0
2168080|NCT01304498|3788329|FG000|Overall Study|Lost to Follow-up|2
2168081|NCT01304498|3788330|FG001|Overall Study|Lost to Follow-up|1
2168082|NCT01304693|3788355|FG000|Overall Study|Adverse Event|0
2168083|NCT01304693|3788356|FG001|Overall Study|Adverse Event|0
2168084|NCT01304693|3788357|FG002|Overall Study|Adverse Event|0
2168085|NCT01304693|3788358|FG003|Overall Study|Adverse Event|0
2168086|NCT01304693|3788359|FG004|Overall Study|Adverse Event|1
2168087|NCT01304693|3788355|FG000|Overall Study|Decision Unrelated to an Adverse Event|0
2168088|NCT01304693|3788356|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
2168089|NCT01304693|3788357|FG002|Overall Study|Decision Unrelated to an Adverse Event|1
2168090|NCT01304693|3788358|FG003|Overall Study|Decision Unrelated to an Adverse Event|1
2168091|NCT01304693|3788359|FG004|Overall Study|Decision Unrelated to an Adverse Event|0
2168092|NCT01304706|3788371|FG000|Overall Study|Adverse Event|2
2168093|NCT01304706|3788371|FG000|Overall Study|Lack of Efficacy|1
2168094|NCT01304706|3788371|FG000|Overall Study|Death|3
2168095|NCT01304706|3788371|FG000|Overall Study|Withdrawal by Subject|3
2168096|NCT01304706|3788371|FG000|Overall Study|Lost to Follow-up|7
2168097|NCT01304706|3788371|FG000|Overall Study|Discontinued due to failed drug admin.|1
2168098|NCT01304940|3788377|FG000|Overall Study|not meet symptom severity requirement|3
2168099|NCT01304940|3788378|FG001|Overall Study|not meet symptom severity requirement|0
2168100|NCT01305044|3788392|FG000|Overall Study|Withdrawal by Subject|3
2168101|NCT01305044|3788393|FG001|Overall Study|Withdrawal by Subject|6
2168102|NCT01305200|3788402|FG000|Overall Study|Physician Decision|4
2168103|NCT01305200|3788403|FG001|Overall Study|Physician Decision|6
2168104|NCT01305200|3788404|FG002|Overall Study|Physician Decision|1
2168105|NCT01305200|3788402|FG000|Overall Study|Withdrawal by Subject|24
2168106|NCT01305200|3788403|FG001|Overall Study|Withdrawal by Subject|21
2168107|NCT01305200|3788404|FG002|Overall Study|Withdrawal by Subject|1
2168108|NCT01305200|3788402|FG000|Overall Study|Ineligible|1
2168109|NCT01305200|3788403|FG001|Overall Study|Ineligible|2
2168110|NCT01305200|3788404|FG002|Overall Study|Ineligible|1
2168111|NCT01305200|3788402|FG000|Overall Study|Death|0
2168112|NCT01305200|3788403|FG001|Overall Study|Death|2
2168113|NCT01305200|3788404|FG002|Overall Study|Death|0
2168114|NCT01305239|3788422|FG000|Overall Study|Adverse Event|22
2168115|NCT01305239|3788422|FG000|Overall Study|Exemestane taken prior to inclusion only|1
2168116|NCT01305408|3788459|FG000|Overall Study|Adverse Event|10
2168117|NCT01305408|3788460|FG001|Overall Study|Adverse Event|7
2168118|NCT01305408|3788459|FG000|Overall Study|Lack of Efficacy|3
2168119|NCT01305408|3788460|FG001|Overall Study|Lack of Efficacy|4
2168120|NCT01305408|3788459|FG000|Overall Study|Withdrawal by Subject|9
2168121|NCT01305408|3788460|FG001|Overall Study|Withdrawal by Subject|9
2168122|NCT01305408|3788459|FG000|Overall Study|Protocol Violation|4
2168123|NCT01305408|3788460|FG001|Overall Study|Protocol Violation|6
2168124|NCT01305408|3788459|FG000|Overall Study|Lost to Follow-up|5
2168125|NCT01305408|3788460|FG001|Overall Study|Lost to Follow-up|3
2168126|NCT01305408|3788459|FG000|Overall Study|Noncompliance with study medication|0
2168127|NCT01305408|3788460|FG001|Overall Study|Noncompliance with study medication|1
2168128|NCT01305408|3788459|FG000|Overall Study|Noncompliance with study procedures|0
2168129|NCT01305408|3788460|FG001|Overall Study|Noncompliance with study procedures|1
2168130|NCT01305408|3788459|FG000|Overall Study|Other|1
2168131|NCT01305408|3788460|FG001|Overall Study|Other|0
2168132|NCT01305564|3788470|FG000|Overall Study|Death|21
2168133|NCT01305564|3788470|FG000|Overall Study|Lost to Follow-up|12
2168134|NCT01305564|3788470|FG000|Overall Study|Withdrawal by Subject|1
2168135|NCT01305564|3788470|FG000|Overall Study|Physician Decision|3
2168136|NCT01305577|3788488|FG000|Overall Study|Adverse Event|2
2168137|NCT01305577|3788489|FG001|Overall Study|Adverse Event|2
2168138|NCT01305577|3788490|FG002|Overall Study|Adverse Event|1
2168139|NCT01305577|3788488|FG000|Overall Study|Withdrawal by Subject|7
2168140|NCT01305577|3788489|FG001|Overall Study|Withdrawal by Subject|5
2168141|NCT01305577|3788490|FG002|Overall Study|Withdrawal by Subject|6
2168142|NCT01305577|3788488|FG000|Overall Study|Lost to Follow-up|4
2168143|NCT01305577|3788489|FG001|Overall Study|Lost to Follow-up|3
2168144|NCT01305577|3788490|FG002|Overall Study|Lost to Follow-up|2
2168145|NCT01305577|3788488|FG000|Overall Study|Protocol Deviation|0
2168146|NCT01305577|3788489|FG001|Overall Study|Protocol Deviation|1
2168147|NCT01305577|3788490|FG002|Overall Study|Protocol Deviation|1
2168148|NCT01305941|3788521|FG000|Overall Study|Adverse Event|6
2168149|NCT01305941|3788521|FG000|Overall Study|Clinical decline|2
2168150|NCT01305941|3788521|FG000|Overall Study|Withdrawal by Subject|1
2168151|NCT01305941|3788521|FG000|Overall Study|Death|1
2168152|NCT01306032|3788531|FG000|First Intervention|Adverse Event|1
2168153|NCT01306032|3788532|FG001|First Intervention|Adverse Event|0
2168154|NCT01306032|3788533|FG002|First Intervention|Adverse Event|1
2168155|NCT01306032|3788534|FG003|First Intervention|Adverse Event|0
2168156|NCT01306032|3788535|FG004|First Intervention|Adverse Event|0
2168157|NCT01306032|3788536|FG005|First Intervention|Adverse Event|1
2168158|NCT01306032|3788531|FG000|First Intervention|Withdrawal by Subject|0
2295406|NCT02547363|3990783|FG000|12-month Follow-up|Withdrawal by Subject|4
2295407|NCT02547363|3990784|FG001|12-month Follow-up|Withdrawal by Subject|3
2295408|NCT02547363|3990783|FG000|12-month Follow-up|Lost to Follow-up|4
2295409|NCT02547363|3990784|FG001|12-month Follow-up|Lost to Follow-up|1
2295410|NCT02547363|3990783|FG000|12-month Follow-up|Lack of Efficacy|1
2295411|NCT02547363|3990784|FG001|12-month Follow-up|Lack of Efficacy|1
2295412|NCT02547363|3990783|FG000|12-month Follow-up|Other|1
2295413|NCT02547363|3990784|FG001|12-month Follow-up|Other|0
2295414|NCT02547428|3990794|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8
2295415|NCT02547428|3990795|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1
2295416|NCT02547428|3990794|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
2295417|NCT02547428|3990795|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
2295418|NCT02547428|3990794|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
2295419|NCT02547428|3990795|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
2295420|NCT02547428|3990794|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1
2295421|NCT02547428|3990795|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3
2295422|NCT02547428|3990794|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0
2295423|NCT02547428|3990795|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3
2295424|NCT02547428|3990794|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0
2295425|NCT02547428|3990795|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3
2295426|NCT02547428|3990794|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0
2295427|NCT02547428|3990795|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1
2295428|NCT02547428|3990794|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1
2295429|NCT02547428|3990795|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0
2295430|NCT02547454|3990808|FG000|Overall Study|Due to hemodialysis|53
2295431|NCT02547454|3990808|FG000|Overall Study|Due to transplantation|1
2295432|NCT02547454|3990808|FG000|Overall Study|Due to no further need to treat|4
2295433|NCT02547454|3990808|FG000|Overall Study|Death|38
2295434|NCT02547454|3990808|FG000|Overall Study|Lost to Follow-up|26
2295435|NCT02547454|3990808|FG000|Overall Study|Other|39
2295436|NCT02547454|3990808|FG000|Overall Study|No data|11
2321279|NCT02959177|4035848|FG000|Double-Blind Treatment Phase|Protocol Violation|0
2321280|NCT02959177|4035849|FG001|Double-Blind Treatment Phase|Protocol Violation|1
2321281|NCT02959177|4035850|FG002|Double-Blind Treatment Phase|Protocol Violation|0
2321282|NCT02959177|4035848|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5
2321283|NCT02959177|4035849|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0
2321284|NCT02959177|4035850|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5
2321285|NCT02959177|4035848|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1
2321286|NCT02959177|4035849|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0
2321287|NCT02959177|4035850|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0
2321288|NCT02959177|4035848|FG000|Follow-up Post Treatment Phase|Adverse Event|0
2321289|NCT02959177|4035849|FG001|Follow-up Post Treatment Phase|Adverse Event|1
2168159|NCT01306032|3788532|FG001|First Intervention|Withdrawal by Subject|2
2168160|NCT01306032|3788533|FG002|First Intervention|Withdrawal by Subject|0
2168161|NCT01306032|3788534|FG003|First Intervention|Withdrawal by Subject|1
2168162|NCT01306032|3788535|FG004|First Intervention|Withdrawal by Subject|0
2168163|NCT01306032|3788536|FG005|First Intervention|Withdrawal by Subject|0
2168164|NCT01306032|3788531|FG000|First Intervention|Death|0
2168165|NCT01306032|3788532|FG001|First Intervention|Death|0
2168166|NCT01306032|3788533|FG002|First Intervention|Death|1
2168167|NCT01306032|3788534|FG003|First Intervention|Death|0
2168168|NCT01306032|3788535|FG004|First Intervention|Death|0
2168169|NCT01306032|3788536|FG005|First Intervention|Death|0
2168170|NCT01306032|3788531|FG000|First Intervention|Ineligible|0
2168171|NCT01306032|3788532|FG001|First Intervention|Ineligible|0
2168172|NCT01306032|3788533|FG002|First Intervention|Ineligible|0
2168173|NCT01306032|3788534|FG003|First Intervention|Ineligible|0
2168174|NCT01306032|3788535|FG004|First Intervention|Ineligible|0
2168175|NCT01306032|3788536|FG005|First Intervention|Ineligible|1
2168176|NCT01306032|3788531|FG000|First Intervention|Progressive disease|0
2168177|NCT01306032|3788532|FG001|First Intervention|Progressive disease|0
2168178|NCT01306032|3788533|FG002|First Intervention|Progressive disease|0
2168179|NCT01306032|3788534|FG003|First Intervention|Progressive disease|0
2168180|NCT01306032|3788535|FG004|First Intervention|Progressive disease|2
2168181|NCT01306032|3788536|FG005|First Intervention|Progressive disease|0
2168182|NCT01306032|3788531|FG000|Disease Progression/Crossover|Withdrawal by Subject|0
2168183|NCT01306032|3788532|FG001|Disease Progression/Crossover|Withdrawal by Subject|0
2168184|NCT01306032|3788533|FG002|Disease Progression/Crossover|Withdrawal by Subject|0
2168185|NCT01306032|3788534|FG003|Disease Progression/Crossover|Withdrawal by Subject|1
2168186|NCT01306032|3788535|FG004|Disease Progression/Crossover|Withdrawal by Subject|0
2168187|NCT01306032|3788536|FG005|Disease Progression/Crossover|Withdrawal by Subject|0
2168188|NCT01306032|3788531|FG000|Disease Progression/Crossover|other/symptomatic progression|0
2168189|NCT01306032|3788532|FG001|Disease Progression/Crossover|other/symptomatic progression|2
2168190|NCT01306032|3788533|FG002|Disease Progression/Crossover|other/symptomatic progression|0
2168191|NCT01306032|3788534|FG003|Disease Progression/Crossover|other/symptomatic progression|2
2168192|NCT01306032|3788535|FG004|Disease Progression/Crossover|other/symptomatic progression|0
2168193|NCT01306032|3788536|FG005|Disease Progression/Crossover|other/symptomatic progression|0
2168194|NCT01306058|3788562|FG000|Overall Study|Death|1
2168195|NCT01306058|3788562|FG000|Overall Study|Enrolled but did not get treatment|1
2168196|NCT01306162|3788570|FG000|Period 1|Adverse Event|0
2168197|NCT01306162|3788571|FG001|Period 1|Adverse Event|0
2168198|NCT01306162|3788572|FG002|Period 1|Adverse Event|0
2168199|NCT01306162|3788573|FG003|Period 1|Adverse Event|1
2168200|NCT01306162|3788570|FG000|Washout 1|Non-compliance to protocol|0
2168201|NCT01306162|3788571|FG001|Washout 1|Non-compliance to protocol|1
2168202|NCT01306162|3788572|FG002|Washout 1|Non-compliance to protocol|0
2168203|NCT01306162|3788573|FG003|Washout 1|Non-compliance to protocol|0
2168204|NCT01306201|3788592|FG000|Overall Study|Arrhythmia|4
2168205|NCT01306201|3788592|FG000|Overall Study|Files could not be processed|3
2168206|NCT01306201|3788592|FG000|Overall Study|Files unreadable|3
2168207|NCT01306214|3788603|FG000|Overall Study|Death|0
2168208|NCT01306214|3788604|FG001|Overall Study|Death|0
2168209|NCT01306214|3788605|FG002|Overall Study|Death|1
2168210|NCT01306214|3788603|FG000|Overall Study|Lost to Follow-up|3
2168211|NCT01306214|3788604|FG001|Overall Study|Lost to Follow-up|5
2168212|NCT01306214|3788605|FG002|Overall Study|Lost to Follow-up|4
2168213|NCT01306214|3788603|FG000|Overall Study|Withdrawal by Subject|24
2168214|NCT01306214|3788604|FG001|Overall Study|Withdrawal by Subject|22
2168215|NCT01306214|3788605|FG002|Overall Study|Withdrawal by Subject|16
2168216|NCT01306214|3788603|FG000|Overall Study|Not treated|1
2168217|NCT01306214|3788604|FG001|Overall Study|Not treated|1
2168218|NCT01306214|3788605|FG002|Overall Study|Not treated|1
2168219|NCT01306253|3788615|FG000|Overall Study|Lost to Follow-up|1
2168220|NCT01306253|3788616|FG001|Overall Study|Lost to Follow-up|1
2168221|NCT01306305|3788637|FG000|Overall Study|Lost to Follow-up|1
2295437|NCT02547649|3990824|FG000|Overall Study|Lost to Follow-up|3
2295438|NCT02547649|3990825|FG001|Overall Study|Lost to Follow-up|1
2295439|NCT02547649|3990826|FG002|Overall Study|Lost to Follow-up|1
2295440|NCT02547649|3990824|FG000|Overall Study|Not vaccinated|0
2295441|NCT02547649|3990825|FG001|Overall Study|Not vaccinated|0
2295442|NCT02547649|3990826|FG002|Overall Study|Not vaccinated|1
2295443|NCT02547649|3990824|FG000|Overall Study|Withdrawal by Subject|0
2295444|NCT02547649|3990825|FG001|Overall Study|Withdrawal by Subject|4
2295445|NCT02547649|3990826|FG002|Overall Study|Withdrawal by Subject|2
2295446|NCT02547766|3990839|FG000|Overall Study|Withdrawal by Subject|1
2295447|NCT02547922|3990855|FG000|Overall Study|Withdrawal by Subject|9
2295448|NCT02547922|3990856|FG001|Overall Study|Withdrawal by Subject|6
2295449|NCT02547922|3990857|FG002|Overall Study|Withdrawal by Subject|10
2295450|NCT02547922|3990855|FG000|Overall Study|Adverse Event|3
2295451|NCT02547922|3990856|FG001|Overall Study|Adverse Event|1
2295452|NCT02547922|3990857|FG002|Overall Study|Adverse Event|2
2295453|NCT02547922|3990855|FG000|Overall Study|Lost to Follow-up|1
2295454|NCT02547922|3990856|FG001|Overall Study|Lost to Follow-up|0
2168222|NCT01306305|3788638|FG001|Overall Study|Lost to Follow-up|0
2168223|NCT01306305|3788637|FG000|Overall Study|Withdrew consent|1
2295455|NCT02547922|3990857|FG002|Overall Study|Lost to Follow-up|0
2168224|NCT01306305|3788638|FG001|Overall Study|Withdrew consent|0
2168225|NCT01306331|3788646|FG000|Overall Study|Adverse Event|28
2168226|NCT01306331|3788647|FG001|Overall Study|Adverse Event|25
2168227|NCT01306331|3788646|FG000|Overall Study|Lost to Follow-up|321
2168228|NCT01306331|3788647|FG001|Overall Study|Lost to Follow-up|323
2168229|NCT01306331|3788646|FG000|Overall Study|Physician Decision|26
2168230|NCT01306331|3788647|FG001|Overall Study|Physician Decision|22
2168231|NCT01306331|3788646|FG000|Overall Study|Pregnancy|136
2168232|NCT01306331|3788647|FG001|Overall Study|Pregnancy|151
2168233|NCT01306331|3788646|FG000|Overall Study|Protocol Violation|154
2168234|NCT01306331|3788647|FG001|Overall Study|Protocol Violation|124
2168235|NCT01306331|3788646|FG000|Overall Study|Withdrawal by Subject|163
2168236|NCT01306331|3788647|FG001|Overall Study|Withdrawal by Subject|152
2168237|NCT01306331|3788646|FG000|Overall Study|Not sexually active|29
2168238|NCT01306331|3788647|FG001|Overall Study|Not sexually active|28
2168239|NCT01306331|3788646|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10
2168240|NCT01306331|3788647|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20
2168241|NCT01306331|3788646|FG000|Overall Study|Other|34
2168242|NCT01306331|3788647|FG001|Overall Study|Other|32
2168243|NCT01306617|3788656|FG000|Overall Study|Adverse Event|1
2168244|NCT01306617|3788657|FG001|Overall Study|Adverse Event|0
2168245|NCT01306617|3788658|FG002|Overall Study|Adverse Event|0
2168246|NCT01306617|3788656|FG000|Overall Study|Virologic Failure|0
2168247|NCT01306617|3788657|FG001|Overall Study|Virologic Failure|0
2168248|NCT01306617|3788658|FG002|Overall Study|Virologic Failure|5
2168249|NCT01306617|3788656|FG000|Overall Study|Non-compliance|0
2168250|NCT01306617|3788657|FG001|Overall Study|Non-compliance|1
2168251|NCT01306617|3788658|FG002|Overall Study|Non-compliance|0
2168252|NCT01306643|3788666|FG000|Overall Study|Adverse Event|5
2168253|NCT01306643|3788666|FG000|Overall Study|Disease Progression|7
2168254|NCT01306643|3788666|FG000|Overall Study|Other: Change in Eligibility Status|1
2295456|NCT02547922|3990855|FG000|Overall Study|Lack of Efficacy|5
2295457|NCT02547922|3990856|FG001|Overall Study|Lack of Efficacy|7
2295458|NCT02547922|3990857|FG002|Overall Study|Lack of Efficacy|4
2295459|NCT02547922|3990855|FG000|Overall Study|Death|1
2295460|NCT02547922|3990856|FG001|Overall Study|Death|0
2295461|NCT02547922|3990857|FG002|Overall Study|Death|0
2295462|NCT02547922|3990855|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4
2295463|NCT02547922|3990856|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8
2295464|NCT02547922|3990857|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9
2295465|NCT02547922|3990855|FG000|Overall Study|TECHNICAL PROBLEMS|1
2295466|NCT02547922|3990856|FG001|Overall Study|TECHNICAL PROBLEMS|0
2295467|NCT02547922|3990857|FG002|Overall Study|TECHNICAL PROBLEMS|0
2295468|NCT02547922|3990855|FG000|Overall Study|PROGRESSIVE DISEASE|1
2295469|NCT02547922|3990856|FG001|Overall Study|PROGRESSIVE DISEASE|0
2295470|NCT02547922|3990857|FG002|Overall Study|PROGRESSIVE DISEASE|2
2295471|NCT02547922|3990855|FG000|Overall Study|Physician Decision|2
2295472|NCT02547922|3990856|FG001|Overall Study|Physician Decision|1
2295473|NCT02547922|3990857|FG002|Overall Study|Physician Decision|2
2295474|NCT02547922|3990855|FG000|Overall Study|Patients did not receive IP|1
2295475|NCT02547922|3990856|FG001|Overall Study|Patients did not receive IP|1
2295476|NCT02547922|3990857|FG002|Overall Study|Patients did not receive IP|0
2295477|NCT02547935|3990874|FG000|Overall Study|Other|0
2295478|NCT02547935|3990875|FG001|Overall Study|Other|1
2295479|NCT02547935|3990876|FG002|Overall Study|Other|0
2295480|NCT02547935|3990874|FG000|Overall Study|Withdrawal by Subject|2
2295481|NCT02547935|3990875|FG001|Overall Study|Withdrawal by Subject|3
2295482|NCT02547935|3990876|FG002|Overall Study|Withdrawal by Subject|4
2295483|NCT02547935|3990874|FG000|Overall Study|Screen Failure|2
2295484|NCT02547935|3990875|FG001|Overall Study|Screen Failure|0
2295485|NCT02547935|3990876|FG002|Overall Study|Screen Failure|0
2295486|NCT02547935|3990874|FG000|Overall Study|Physician Decision|0
2295487|NCT02547935|3990875|FG001|Overall Study|Physician Decision|1
2295488|NCT02547935|3990876|FG002|Overall Study|Physician Decision|0
2295489|NCT02547935|3990874|FG000|Overall Study|Lost to Follow-up|0
2295490|NCT02547935|3990875|FG001|Overall Study|Lost to Follow-up|2
2295491|NCT02547935|3990876|FG002|Overall Study|Lost to Follow-up|1
2295492|NCT02547935|3990874|FG000|Overall Study|Death|1
2295493|NCT02547935|3990875|FG001|Overall Study|Death|1
2295494|NCT02547935|3990876|FG002|Overall Study|Death|0
2295495|NCT02547974|3990890|FG000|Overall Study|Withdrawal by Subject|1
2295496|NCT02547974|3990891|FG001|Overall Study|Withdrawal by Subject|0
2295497|NCT02547974|3990892|FG002|Overall Study|Withdrawal by Subject|0
2295498|NCT02547974|3990893|FG003|Overall Study|Withdrawal by Subject|0
2295499|NCT02547987|3990906|FG000|Overall Study|Withdrawal by Subject|1
2295500|NCT02547987|3990906|FG000|Overall Study|Adverse Event|2
2295501|NCT02548078|3990912|FG000|Overall Study|Serious adverse event/Adverse event|1
2295502|NCT02548078|3990913|FG001|Overall Study|Serious adverse event/Adverse event|0
2168255|NCT01306656|3788672|FG000|Overall Study|Lost to Follow-up|1
2295503|NCT02548078|3990912|FG000|Overall Study|Moved from study area|3
2295504|NCT02548078|3990913|FG001|Overall Study|Moved from study area|3
2295505|NCT02548078|3990912|FG000|Overall Study|Lost to Follow-up|1
2295506|NCT02548078|3990913|FG001|Overall Study|Lost to Follow-up|3
2295507|NCT02548156|3990926|FG000|Washout Period 1|Lost to Follow-up|0
2168256|NCT01306656|3788673|FG001|Overall Study|Lost to Follow-up|0
2168257|NCT01306877|3788683|FG000|Overall Study|Lost to Follow-up|3
2168258|NCT01306877|3788684|FG001|Overall Study|Lost to Follow-up|3
2168259|NCT01306877|3788683|FG000|Overall Study|Physician Decision|0
2168260|NCT01306877|3788684|FG001|Overall Study|Physician Decision|1
2168261|NCT01306890|3788690|FG000|Overall Study|Adverse Event|2
2168262|NCT01306890|3788690|FG000|Overall Study|Death|1223
2168263|NCT01306890|3788690|FG000|Overall Study|Lost to Follow-up|58
2168264|NCT01306890|3788690|FG000|Overall Study|Withdrawal by Subject|88
2168265|NCT01306890|3788690|FG000|Overall Study|Unspecified reasons|104
2168266|NCT01306890|3788690|FG000|Overall Study|Study Termination|3
2168267|NCT01306890|3788690|FG000|Overall Study|No discontinuation documentation|41
2168268|NCT01306942|3788697|FG000|Phase I|Adverse Event|2
2168269|NCT01306942|3788698|FG001|Phase I|Adverse Event|2
2168270|NCT01306942|3788699|FG002|Phase I|Adverse Event|0
2168271|NCT01306942|3788700|FG003|Phase I|Adverse Event|0
2168272|NCT01306942|3788697|FG000|Phase I|Physician Decision|3
2168273|NCT01306942|3788698|FG001|Phase I|Physician Decision|1
2168274|NCT01306942|3788699|FG002|Phase I|Physician Decision|0
2168275|NCT01306942|3788700|FG003|Phase I|Physician Decision|0
2168276|NCT01306942|3788697|FG000|Phase II|Adverse Event|0
2168277|NCT01306942|3788698|FG001|Phase II|Adverse Event|0
2168278|NCT01306942|3788699|FG002|Phase II|Adverse Event|0
2168279|NCT01306942|3788700|FG003|Phase II|Adverse Event|6
2168280|NCT01306942|3788697|FG000|Phase II|Physician Decision|2
2168281|NCT01306942|3788698|FG001|Phase II|Physician Decision|0
2168282|NCT01306942|3788699|FG002|Phase II|Physician Decision|0
2168283|NCT01306942|3788700|FG003|Phase II|Physician Decision|5
2168284|NCT01306942|3788697|FG000|Phase II|Withdrawal by Subject|0
2168285|NCT01306942|3788698|FG001|Phase II|Withdrawal by Subject|0
2168286|NCT01306942|3788699|FG002|Phase II|Withdrawal by Subject|0
2168287|NCT01306942|3788700|FG003|Phase II|Withdrawal by Subject|2
2168288|NCT01306942|3788697|FG000|Phase II|Death|0
2168289|NCT01306942|3788698|FG001|Phase II|Death|0
2168290|NCT01306942|3788699|FG002|Phase II|Death|0
2168291|NCT01306942|3788700|FG003|Phase II|Death|1
2168292|NCT01306942|3788697|FG000|Phase II|Not finished treatment|0
2168293|NCT01306942|3788698|FG001|Phase II|Not finished treatment|0
2168294|NCT01306942|3788699|FG002|Phase II|Not finished treatment|0
2168295|NCT01306942|3788700|FG003|Phase II|Not finished treatment|1
2168296|NCT01306942|3788697|FG000|Phase II|Protocol Violation|0
2168297|NCT01306942|3788698|FG001|Phase II|Protocol Violation|0
2168298|NCT01306942|3788699|FG002|Phase II|Protocol Violation|0
2168299|NCT01306942|3788700|FG003|Phase II|Protocol Violation|1
2168300|NCT01306968|3788716|FG000|Overall Study|Lost to Follow-up|1
2168301|NCT01306968|3788717|FG001|Overall Study|Lost to Follow-up|1
2168302|NCT01306968|3788718|FG002|Overall Study|Lost to Follow-up|0
2168303|NCT01306968|3788719|FG003|Overall Study|Lost to Follow-up|0
2168304|NCT01306968|3788716|FG000|Overall Study|Physician Decision|0
2168305|NCT01306968|3788717|FG001|Overall Study|Physician Decision|1
2168306|NCT01306968|3788718|FG002|Overall Study|Physician Decision|0
2208233|NCT01637272|3847630|FG000|Overall Study|completed core, did not enter ext. phase|4
2208234|NCT01637272|3847630|FG000|Overall Study|Administrative problems|1
2295508|NCT02548156|3990927|FG001|Washout Period 1|Lost to Follow-up|0
2295509|NCT02548156|3990928|FG002|Washout Period 1|Lost to Follow-up|0
2295510|NCT02548156|3990929|FG003|Washout Period 1|Lost to Follow-up|0
2295511|NCT02548156|3990930|FG004|Washout Period 1|Lost to Follow-up|1
2295512|NCT02548156|3990931|FG005|Washout Period 1|Lost to Follow-up|0
2295513|NCT02548455|3990972|FG000|Overall Study|Withdrawal by Subject|27
2295514|NCT02548455|3990972|FG000|Overall Study|Death|26
2295515|NCT02548455|3990972|FG000|Overall Study|Lost to Follow-up|14
2295516|NCT02548455|3990972|FG000|Overall Study|Visit not completed|173
2295517|NCT02548585|3990983|FG000|Overall Study|Withdrawal by Subject|0
2295518|NCT02548585|3990984|FG001|Overall Study|Withdrawal by Subject|0
2295519|NCT02548585|3990985|FG002|Overall Study|Withdrawal by Subject|0
2295520|NCT02548585|3990986|FG003|Overall Study|Withdrawal by Subject|0
2295521|NCT02548585|3990987|FG004|Overall Study|Withdrawal by Subject|0
2295522|NCT02548585|3990988|FG005|Overall Study|Withdrawal by Subject|1
2295523|NCT02548585|3990989|FG006|Overall Study|Withdrawal by Subject|0
2295524|NCT02548585|3990983|FG000|Overall Study|Lost to Follow-up|1
2295525|NCT02548585|3990984|FG001|Overall Study|Lost to Follow-up|0
2295526|NCT02548585|3990985|FG002|Overall Study|Lost to Follow-up|0
2295527|NCT02548585|3990986|FG003|Overall Study|Lost to Follow-up|0
2295528|NCT02548585|3990987|FG004|Overall Study|Lost to Follow-up|0
2295529|NCT02548585|3990988|FG005|Overall Study|Lost to Follow-up|0
2295530|NCT02548585|3990989|FG006|Overall Study|Lost to Follow-up|0
2295531|NCT02548585|3990983|FG000|Overall Study|Other|1
2295532|NCT02548585|3990984|FG001|Overall Study|Other|0
2295533|NCT02548585|3990985|FG002|Overall Study|Other|0
2295534|NCT02548585|3990986|FG003|Overall Study|Other|2
2295535|NCT02548585|3990987|FG004|Overall Study|Other|3
2168307|NCT01306968|3788719|FG003|Overall Study|Physician Decision|0
2168308|NCT01306968|3788716|FG000|Overall Study|Relocated and left active duty|0
2295536|NCT02548585|3990988|FG005|Overall Study|Other|0
2295537|NCT02548585|3990989|FG006|Overall Study|Other|1
2295538|NCT02548585|3990983|FG000|Overall Study|Randomized but not treated|0
2295539|NCT02548585|3990984|FG001|Overall Study|Randomized but not treated|0
2295540|NCT02548585|3990985|FG002|Overall Study|Randomized but not treated|0
2295541|NCT02548585|3990986|FG003|Overall Study|Randomized but not treated|0
2168309|NCT01306968|3788717|FG001|Overall Study|Relocated and left active duty|1
2168310|NCT01306968|3788718|FG002|Overall Study|Relocated and left active duty|1
2168311|NCT01306968|3788719|FG003|Overall Study|Relocated and left active duty|1
2168312|NCT01306968|3788716|FG000|Overall Study|Withdrew - time commitment|0
2168313|NCT01306968|3788717|FG001|Overall Study|Withdrew - time commitment|0
2168314|NCT01306968|3788718|FG002|Overall Study|Withdrew - time commitment|0
2168315|NCT01306968|3788719|FG003|Overall Study|Withdrew - time commitment|2
2208235|NCT01637272|3847630|FG000|Overall Study|Protocol Violation|2
2208236|NCT01637402|3847649|FG000|Standard Dose Regimen|Lack of Efficacy|2
2208237|NCT01637402|3847650|FG001|Standard Dose Regimen|Lack of Efficacy|0
2168316|NCT01306968|3788716|FG000|Overall Study|Withdrew over privacy concerns|0
2168317|NCT01306968|3788717|FG001|Overall Study|Withdrew over privacy concerns|0
2295542|NCT02548585|3990987|FG004|Overall Study|Randomized but not treated|0
2295543|NCT02548585|3990988|FG005|Overall Study|Randomized but not treated|1
2295544|NCT02548585|3990989|FG006|Overall Study|Randomized but not treated|0
2295545|NCT02548650|3991032|FG000|Triple Therapy|Adverse Event|1
2295546|NCT02548650|3991033|FG001|Triple Therapy|Adverse Event|0
2295547|NCT02548650|3991032|FG000|Triple Therapy|Withdrawal by Subject|0
2295548|NCT02548650|3991033|FG001|Triple Therapy|Withdrawal by Subject|4
2295549|NCT02548650|3991032|FG000|Double Therapy|Adverse Event|1
2295550|NCT02548650|3991033|FG001|Double Therapy|Adverse Event|1
2295551|NCT02548650|3991032|FG000|Double Therapy|Withdrawal by Subject|0
2295552|NCT02548650|3991033|FG001|Double Therapy|Withdrawal by Subject|1
2295553|NCT02548962|3991072|FG000|Overall Study|Withdrawal by Subject|1
2295554|NCT02548962|3991073|FG001|Overall Study|Withdrawal by Subject|0
2295555|NCT02549027|3991108|FG000|Washout After Period 4|Withdrawal by Subject|0
2295556|NCT02549027|3991109|FG001|Washout After Period 4|Withdrawal by Subject|1
2295557|NCT02549027|3991110|FG002|Washout After Period 4|Withdrawal by Subject|1
2295558|NCT02549027|3991111|FG003|Washout After Period 4|Withdrawal by Subject|1
2295559|NCT02549027|3991112|FG004|Washout After Period 4|Withdrawal by Subject|0
2295560|NCT02549027|3991113|FG005|Washout After Period 4|Withdrawal by Subject|0
2295561|NCT02549027|3991108|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2295562|NCT02549027|3991109|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2295563|NCT02549027|3991110|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2295564|NCT02549027|3991111|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2295565|NCT02549027|3991112|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2
2295566|NCT02549027|3991113|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2295567|NCT02549196|3991144|FG000|Overall Study|Protocol Violation|0
2295568|NCT02549196|3991145|FG001|Overall Study|Protocol Violation|0
2295569|NCT02549196|3991146|FG002|Overall Study|Protocol Violation|0
2295570|NCT02549196|3991147|FG003|Overall Study|Protocol Violation|1
2295571|NCT02549196|3991144|FG000|Overall Study|Withdrawal by Subject|1
2295572|NCT02549196|3991145|FG001|Overall Study|Withdrawal by Subject|0
2295573|NCT02549196|3991146|FG002|Overall Study|Withdrawal by Subject|1
2295574|NCT02549196|3991147|FG003|Overall Study|Withdrawal by Subject|0
2295575|NCT02549287|3991163|FG000|Overall Study|Lost to Follow-up|65
2295576|NCT02549287|3991164|FG001|Overall Study|Lost to Follow-up|26
2295577|NCT02549287|3991163|FG000|Overall Study|Withdrawal by Subject|15
2295578|NCT02549287|3991164|FG001|Overall Study|Withdrawal by Subject|6
2295579|NCT02549339|3991172|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2
2295580|NCT02549339|3991173|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0
2295581|NCT02549339|3991172|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
2295582|NCT02549339|3991173|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
2295583|NCT02549339|3991172|FG000|3-day Treatment and 8-week Follow-up|Other|1
2295584|NCT02549339|3991173|FG001|3-day Treatment and 8-week Follow-up|Other|0
2295585|NCT02549339|3991172|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
2295586|NCT02549339|3991173|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
2295587|NCT02549339|3991172|FG000|12-month Follow-up|Lack of Efficacy|0
2295588|NCT02549339|3991173|FG001|12-month Follow-up|Lack of Efficacy|2
2295589|NCT02549339|3991172|FG000|12-month Follow-up|Withdrawal by Subject|8
2295590|NCT02549339|3991173|FG001|12-month Follow-up|Withdrawal by Subject|3
2295591|NCT02549339|3991172|FG000|12-month Follow-up|Lost to Follow-up|1
2295592|NCT02549339|3991173|FG001|12-month Follow-up|Lost to Follow-up|3
2295593|NCT02549339|3991172|FG000|12-month Follow-up|Other|0
2295594|NCT02549339|3991173|FG001|12-month Follow-up|Other|3
2295595|NCT02549352|3991183|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
2295596|NCT02549352|3991184|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
2295597|NCT02549352|3991183|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
2295598|NCT02549352|3991184|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
2295599|NCT02549352|3991183|FG000|3-day Treatment and 8-week Follow-up|Other|0
2295600|NCT02549352|3991184|FG001|3-day Treatment and 8-week Follow-up|Other|2
2295601|NCT02549352|3991183|FG000|12-month Follow-up|Withdrawal by Subject|4
2295602|NCT02549352|3991184|FG001|12-month Follow-up|Withdrawal by Subject|5
2295603|NCT02549352|3991183|FG000|12-month Follow-up|Lost to Follow-up|3
2295604|NCT02549352|3991184|FG001|12-month Follow-up|Lost to Follow-up|2
2295605|NCT02549352|3991183|FG000|12-month Follow-up|Death|0
2295606|NCT02549352|3991184|FG001|12-month Follow-up|Death|1
2295607|NCT02549352|3991183|FG000|12-month Follow-up|Protocol Violation|0
2168318|NCT01306968|3788718|FG002|Overall Study|Withdrew over privacy concerns|0
2168319|NCT01306968|3788719|FG003|Overall Study|Withdrew over privacy concerns|1
2168320|NCT01307020|3788750|FG000|Overall Study|Lost to Follow-up|0
2168321|NCT01307020|3788751|FG001|Overall Study|Lost to Follow-up|0
2168322|NCT01307020|3788752|FG002|Overall Study|Lost to Follow-up|1
2168323|NCT01307020|3788753|FG003|Overall Study|Lost to Follow-up|1
2168324|NCT01307020|3788754|FG004|Overall Study|Lost to Follow-up|0
2168325|NCT01307020|3788755|FG005|Overall Study|Lost to Follow-up|0
2168326|NCT01307020|3788756|FG006|Overall Study|Lost to Follow-up|1
2168327|NCT01307020|3788757|FG007|Overall Study|Lost to Follow-up|0
2168328|NCT01307020|3788758|FG008|Overall Study|Lost to Follow-up|0
2168329|NCT01307020|3788759|FG009|Overall Study|Lost to Follow-up|0
2168330|NCT01307020|3788750|FG000|Overall Study|Electronic data capture failure|0
2168331|NCT01307020|3788751|FG001|Overall Study|Electronic data capture failure|1
2168332|NCT01307020|3788752|FG002|Overall Study|Electronic data capture failure|0
2168333|NCT01307020|3788753|FG003|Overall Study|Electronic data capture failure|0
2168334|NCT01307020|3788754|FG004|Overall Study|Electronic data capture failure|0
2168335|NCT01307020|3788755|FG005|Overall Study|Electronic data capture failure|0
2168336|NCT01307020|3788756|FG006|Overall Study|Electronic data capture failure|0
2168337|NCT01307020|3788757|FG007|Overall Study|Electronic data capture failure|0
2168338|NCT01307020|3788758|FG008|Overall Study|Electronic data capture failure|0
2168339|NCT01307020|3788759|FG009|Overall Study|Electronic data capture failure|0
2168340|NCT01307111|3788797|FG000|IUD Insertion|Lost to Follow-up|2
2168341|NCT01307111|3788798|FG001|IUD Insertion|Lost to Follow-up|0
2168342|NCT01307111|3788797|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2
2168343|NCT01307111|3788798|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2
2168344|NCT01307267|3788827|FG000|Overall Study|Death|4
2168345|NCT01307267|3788828|FG001|Overall Study|Death|3
2168346|NCT01307267|3788829|FG002|Overall Study|Death|5
2168347|NCT01307267|3788830|FG003|Overall Study|Death|3
2168348|NCT01307267|3788831|FG004|Overall Study|Death|1
2168349|NCT01307267|3788832|FG005|Overall Study|Death|26
2168350|NCT01307267|3788833|FG006|Overall Study|Death|2
2168351|NCT01307267|3788834|FG007|Overall Study|Death|2
2168352|NCT01307267|3788835|FG008|Overall Study|Death|21
2168353|NCT01307267|3788836|FG009|Overall Study|Death|2
2295608|NCT02549352|3991184|FG001|12-month Follow-up|Protocol Violation|1
2295609|NCT02549352|3991183|FG000|12-month Follow-up|Other|1
2295610|NCT02549352|3991184|FG001|12-month Follow-up|Other|3
2295611|NCT02549573|3991214|FG000|Overall Study|Withdrawal by Subject|0
2295612|NCT02549573|3991215|FG001|Overall Study|Withdrawal by Subject|2
2295613|NCT02549573|3991214|FG000|Overall Study|Protocol Violation|0
2295614|NCT02549573|3991215|FG001|Overall Study|Protocol Violation|1
2295615|NCT02549859|3991221|FG000|Long-term 60 Hz DBS|Study Closed|1
2295616|NCT02550106|3991229|FG000|Overall Study|Adverse Event|1
2295617|NCT02550106|3991229|FG000|Overall Study|Lack of Efficacy|3
2295618|NCT02550106|3991229|FG000|Overall Study|Protocol Violation|6
2295619|NCT02550106|3991229|FG000|Overall Study|Withdrawal by Subject|2
2295620|NCT02550795|3991273|FG000|Overall Study|Physician Decision|0
2295621|NCT02550795|3991274|FG001|Overall Study|Physician Decision|1
2295622|NCT02550795|3991275|FG002|Overall Study|Physician Decision|0
2295623|NCT02550873|3991285|FG000|Randomized Double Blind|Adverse Event|3
2295624|NCT02550873|3991286|FG001|Randomized Double Blind|Adverse Event|1
2295625|NCT02550873|3991287|FG002|Randomized Double Blind|Adverse Event|0
2295626|NCT02550873|3991285|FG000|Randomized Double Blind|Disease progression|1
2295627|NCT02550873|3991286|FG001|Randomized Double Blind|Disease progression|1
2295628|NCT02550873|3991287|FG002|Randomized Double Blind|Disease progression|0
2295629|NCT02550873|3991285|FG000|Open Label Extension|Study ongoing|0
2295630|NCT02550873|3991286|FG001|Open Label Extension|Study ongoing|0
2295631|NCT02550873|3991287|FG002|Open Label Extension|Study ongoing|111
2295632|NCT02550938|3991313|FG000|Overall Study|Lost to Follow-up|8
2295633|NCT02550938|3991314|FG001|Overall Study|Lost to Follow-up|7
2295634|NCT02550938|3991315|FG002|Overall Study|Lost to Follow-up|12
2295635|NCT02550938|3991316|FG003|Overall Study|Lost to Follow-up|11
2295636|NCT02551055|3991333|FG000|Overall Study|Death|2
2295637|NCT02551055|3991334|FG001|Overall Study|Death|4
2295638|NCT02551055|3991335|FG002|Overall Study|Death|2
2295639|NCT02551055|3991336|FG003|Overall Study|Death|2
2295640|NCT02551055|3991337|FG004|Overall Study|Death|2
2295641|NCT02551055|3991338|FG005|Overall Study|Death|1
2295642|NCT02551055|3991339|FG006|Overall Study|Death|2
2295643|NCT02551055|3991340|FG007|Overall Study|Death|0
2295644|NCT02551055|3991333|FG000|Overall Study|Study Terminated by Sponsor|1
2168354|NCT01307267|3788837|FG010|Overall Study|Death|3
2168355|NCT01307267|3788838|FG011|Overall Study|Death|9
2168356|NCT01307267|3788839|FG012|Overall Study|Death|0
2168357|NCT01307267|3788840|FG013|Overall Study|Death|0
2168358|NCT01307267|3788841|FG014|Overall Study|Death|0
2168359|NCT01307267|3788842|FG015|Overall Study|Death|0
2295645|NCT02551055|3991334|FG001|Overall Study|Study Terminated by Sponsor|1
2295646|NCT02551055|3991335|FG002|Overall Study|Study Terminated by Sponsor|0
2295647|NCT02551055|3991336|FG003|Overall Study|Study Terminated by Sponsor|2
2295648|NCT02551055|3991337|FG004|Overall Study|Study Terminated by Sponsor|2
2295649|NCT02551055|3991338|FG005|Overall Study|Study Terminated by Sponsor|0
2295650|NCT02551055|3991339|FG006|Overall Study|Study Terminated by Sponsor|0
2295651|NCT02551055|3991340|FG007|Overall Study|Study Terminated by Sponsor|0
2295652|NCT02551055|3991333|FG000|Overall Study|Withdrawal by Subject|1
2168360|NCT01307267|3788843|FG016|Overall Study|Death|1
2168361|NCT01307267|3788844|FG017|Overall Study|Death|1
2168362|NCT01307267|3788845|FG018|Overall Study|Death|2
2168363|NCT01307267|3788846|FG019|Overall Study|Death|8
2168364|NCT01307267|3788847|FG020|Overall Study|Death|1
2168365|NCT01307267|3788848|FG021|Overall Study|Death|2
2168366|NCT01307267|3788849|FG022|Overall Study|Death|2
2168367|NCT01307267|3788827|FG000|Overall Study|Lost to Follow-up|0
2168368|NCT01307267|3788828|FG001|Overall Study|Lost to Follow-up|0
2168369|NCT01307267|3788829|FG002|Overall Study|Lost to Follow-up|0
2168370|NCT01307267|3788830|FG003|Overall Study|Lost to Follow-up|0
2168371|NCT01307267|3788831|FG004|Overall Study|Lost to Follow-up|0
2168372|NCT01307267|3788832|FG005|Overall Study|Lost to Follow-up|7
2168373|NCT01307267|3788833|FG006|Overall Study|Lost to Follow-up|0
2168374|NCT01307267|3788834|FG007|Overall Study|Lost to Follow-up|0
2168375|NCT01307267|3788835|FG008|Overall Study|Lost to Follow-up|1
2168376|NCT01307267|3788836|FG009|Overall Study|Lost to Follow-up|2
2168377|NCT01307267|3788837|FG010|Overall Study|Lost to Follow-up|1
2168378|NCT01307267|3788838|FG011|Overall Study|Lost to Follow-up|0
2295653|NCT02551055|3991334|FG001|Overall Study|Withdrawal by Subject|1
2295654|NCT02551055|3991335|FG002|Overall Study|Withdrawal by Subject|0
2295655|NCT02551055|3991336|FG003|Overall Study|Withdrawal by Subject|1
2295656|NCT02551055|3991337|FG004|Overall Study|Withdrawal by Subject|2
2168379|NCT01307267|3788839|FG012|Overall Study|Lost to Follow-up|0
2168380|NCT01307267|3788840|FG013|Overall Study|Lost to Follow-up|0
2168381|NCT01307267|3788841|FG014|Overall Study|Lost to Follow-up|0
2168382|NCT01307267|3788842|FG015|Overall Study|Lost to Follow-up|0
2168383|NCT01307267|3788843|FG016|Overall Study|Lost to Follow-up|0
2168384|NCT01307267|3788844|FG017|Overall Study|Lost to Follow-up|0
2168385|NCT01307267|3788845|FG018|Overall Study|Lost to Follow-up|0
2168386|NCT01307267|3788846|FG019|Overall Study|Lost to Follow-up|2
2295657|NCT02551055|3991338|FG005|Overall Study|Withdrawal by Subject|0
2295658|NCT02551055|3991339|FG006|Overall Study|Withdrawal by Subject|0
2295659|NCT02551055|3991340|FG007|Overall Study|Withdrawal by Subject|0
2295660|NCT02551055|3991333|FG000|Overall Study|Reason not specified|0
2295661|NCT02551055|3991334|FG001|Overall Study|Reason not specified|0
2295662|NCT02551055|3991335|FG002|Overall Study|Reason not specified|0
2295663|NCT02551055|3991336|FG003|Overall Study|Reason not specified|0
2295664|NCT02551055|3991337|FG004|Overall Study|Reason not specified|1
2295665|NCT02551055|3991338|FG005|Overall Study|Reason not specified|0
2295666|NCT02551055|3991339|FG006|Overall Study|Reason not specified|1
2295667|NCT02551055|3991340|FG007|Overall Study|Reason not specified|0
2295668|NCT02551159|3991370|FG000|Overall Study|Death|352
2295669|NCT02551159|3991371|FG001|Overall Study|Death|174
2295670|NCT02551159|3991372|FG002|Overall Study|Death|161
2295671|NCT02551159|3991370|FG000|Overall Study|Withdrawal by Subject|8
2295672|NCT02551159|3991371|FG001|Overall Study|Withdrawal by Subject|5
2295673|NCT02551159|3991372|FG002|Overall Study|Withdrawal by Subject|16
2295674|NCT02551159|3991370|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53
2295675|NCT02551159|3991371|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25
2295676|NCT02551159|3991372|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29
2295677|NCT02551666|3991402|FG000|Overall Study|Withdrawal by Subject|1
2295678|NCT02551666|3991403|FG001|Overall Study|Withdrawal by Subject|3
2295679|NCT02551692|3991412|FG000|Overall Study|Lost to Follow-up|0
2295680|NCT02551692|3991413|FG001|Overall Study|Lost to Follow-up|1
2295681|NCT02551692|3991414|FG002|Overall Study|Lost to Follow-up|4
2295682|NCT02551692|3991412|FG000|Overall Study|Withdrawal by Subject|1
2295683|NCT02551692|3991413|FG001|Overall Study|Withdrawal by Subject|0
2295684|NCT02551692|3991414|FG002|Overall Study|Withdrawal by Subject|1
2295685|NCT02551731|3991422|FG000|Overall Study|Withdrawal by Subject|2
2295686|NCT02551874|3991478|FG000|Overall Study|Lost to Follow-up|0
2295687|NCT02551874|3991479|FG001|Overall Study|Lost to Follow-up|2
2295688|NCT02551874|3991478|FG000|Overall Study|Pregnancy|0
2295689|NCT02551874|3991479|FG001|Overall Study|Pregnancy|1
2295690|NCT02551874|3991478|FG000|Overall Study|Reason not reported|10
2295691|NCT02551874|3991479|FG001|Overall Study|Reason not reported|4
2295692|NCT02551874|3991478|FG000|Overall Study|Did not receive randomized treatment|0
2295693|NCT02551874|3991479|FG001|Overall Study|Did not receive randomized treatment|7
2295694|NCT02551874|3991478|FG000|Overall Study|Did not enter long-term study|18
2295695|NCT02551874|3991479|FG001|Overall Study|Did not enter long-term study|25
2168387|NCT01307267|3788847|FG020|Overall Study|Lost to Follow-up|0
2168388|NCT01307267|3788848|FG021|Overall Study|Lost to Follow-up|0
2168389|NCT01307267|3788849|FG022|Overall Study|Lost to Follow-up|0
2168390|NCT01307267|3788827|FG000|Overall Study|Withdrawal by Subject|0
2168391|NCT01307267|3788828|FG001|Overall Study|Withdrawal by Subject|0
2168392|NCT01307267|3788829|FG002|Overall Study|Withdrawal by Subject|0
2168393|NCT01307267|3788830|FG003|Overall Study|Withdrawal by Subject|0
2295696|NCT02552121|3991506|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
2295697|NCT02552121|3991507|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2295698|NCT02552121|3991508|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2295699|NCT02552121|3991509|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2295700|NCT02552121|3991510|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2295701|NCT02552121|3991511|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2168394|NCT01307267|3788831|FG004|Overall Study|Withdrawal by Subject|0
2168395|NCT01307267|3788832|FG005|Overall Study|Withdrawal by Subject|1
2168396|NCT01307267|3788833|FG006|Overall Study|Withdrawal by Subject|0
2168397|NCT01307267|3788834|FG007|Overall Study|Withdrawal by Subject|1
2168398|NCT01307267|3788835|FG008|Overall Study|Withdrawal by Subject|5
2168399|NCT01307267|3788836|FG009|Overall Study|Withdrawal by Subject|1
2168400|NCT01307267|3788837|FG010|Overall Study|Withdrawal by Subject|1
2168401|NCT01307267|3788838|FG011|Overall Study|Withdrawal by Subject|1
2168402|NCT01307267|3788839|FG012|Overall Study|Withdrawal by Subject|0
2168403|NCT01307267|3788840|FG013|Overall Study|Withdrawal by Subject|0
2168404|NCT01307267|3788841|FG014|Overall Study|Withdrawal by Subject|0
2168405|NCT01307267|3788842|FG015|Overall Study|Withdrawal by Subject|0
2295702|NCT02552121|3991512|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2295703|NCT02552121|3991513|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2295704|NCT02552121|3991506|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
2295705|NCT02552121|3991507|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2295706|NCT02552121|3991508|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2295707|NCT02552121|3991509|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2295708|NCT02552121|3991510|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2295709|NCT02552121|3991511|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2295710|NCT02552121|3991512|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2295711|NCT02552121|3991513|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2295712|NCT02552121|3991506|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2295713|NCT02552121|3991507|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
2295714|NCT02552121|3991508|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2295715|NCT02552121|3991509|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2295716|NCT02552121|3991510|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2295717|NCT02552121|3991511|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2295718|NCT02552121|3991512|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2295719|NCT02552121|3991513|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2295720|NCT02552121|3991506|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2295721|NCT02552121|3991507|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
2295722|NCT02552121|3991508|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2295723|NCT02552121|3991509|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2295724|NCT02552121|3991510|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2295725|NCT02552121|3991511|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2295726|NCT02552121|3991512|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2295727|NCT02552121|3991513|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2295728|NCT02552121|3991506|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2295729|NCT02552121|3991507|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
2295730|NCT02552121|3991508|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2295731|NCT02552121|3991509|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2295732|NCT02552121|3991510|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2295733|NCT02552121|3991511|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2295734|NCT02552121|3991512|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2295735|NCT02552121|3991513|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2295736|NCT02552121|3991506|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2295737|NCT02552121|3991507|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
2295738|NCT02552121|3991508|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2295739|NCT02552121|3991509|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2295740|NCT02552121|3991510|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2295741|NCT02552121|3991511|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2295742|NCT02552121|3991512|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2295743|NCT02552121|3991513|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2295744|NCT02552121|3991506|FG000|Part 2: Cohort Expansion|Patient Choice|0
2295745|NCT02552121|3991507|FG001|Part 2: Cohort Expansion|Patient Choice|0
2295746|NCT02552121|3991508|FG002|Part 2: Cohort Expansion|Patient Choice|1
2295747|NCT02552121|3991509|FG003|Part 2: Cohort Expansion|Patient Choice|0
2295748|NCT02552121|3991510|FG004|Part 2: Cohort Expansion|Patient Choice|0
2295749|NCT02552121|3991511|FG005|Part 2: Cohort Expansion|Patient Choice|0
2295750|NCT02552121|3991512|FG006|Part 2: Cohort Expansion|Patient Choice|1
2295751|NCT02552121|3991513|FG007|Part 2: Cohort Expansion|Patient Choice|0
2295752|NCT02552121|3991506|FG000|Part 2: Cohort Expansion|Disease Progression|0
2295753|NCT02552121|3991507|FG001|Part 2: Cohort Expansion|Disease Progression|0
2295754|NCT02552121|3991508|FG002|Part 2: Cohort Expansion|Disease Progression|3
2295755|NCT02552121|3991509|FG003|Part 2: Cohort Expansion|Disease Progression|2
2295756|NCT02552121|3991510|FG004|Part 2: Cohort Expansion|Disease Progression|1
2295757|NCT02552121|3991511|FG005|Part 2: Cohort Expansion|Disease Progression|4
2295758|NCT02552121|3991512|FG006|Part 2: Cohort Expansion|Disease Progression|0
2295759|NCT02552121|3991513|FG007|Part 2: Cohort Expansion|Disease Progression|3
2295760|NCT02552121|3991506|FG000|Part 2: Cohort Expansion|Adverse Event|0
2295761|NCT02552121|3991507|FG001|Part 2: Cohort Expansion|Adverse Event|0
2295762|NCT02552121|3991508|FG002|Part 2: Cohort Expansion|Adverse Event|6
2168406|NCT01307267|3788843|FG016|Overall Study|Withdrawal by Subject|0
2168407|NCT01307267|3788844|FG017|Overall Study|Withdrawal by Subject|0
2168408|NCT01307267|3788845|FG018|Overall Study|Withdrawal by Subject|0
2168409|NCT01307267|3788846|FG019|Overall Study|Withdrawal by Subject|3
2168410|NCT01307267|3788847|FG020|Overall Study|Withdrawal by Subject|0
2168411|NCT01307267|3788848|FG021|Overall Study|Withdrawal by Subject|0
2168412|NCT01307267|3788849|FG022|Overall Study|Withdrawal by Subject|0
2168413|NCT01307267|3788827|FG000|Overall Study|Other|0
2168414|NCT01307267|3788828|FG001|Overall Study|Other|0
2168415|NCT01307267|3788829|FG002|Overall Study|Other|0
2168416|NCT01307267|3788830|FG003|Overall Study|Other|0
2168417|NCT01307267|3788831|FG004|Overall Study|Other|0
2168418|NCT01307267|3788832|FG005|Overall Study|Other|7
2168419|NCT01307267|3788833|FG006|Overall Study|Other|0
2168420|NCT01307267|3788834|FG007|Overall Study|Other|1
2168421|NCT01307267|3788835|FG008|Overall Study|Other|3
2168422|NCT01307267|3788836|FG009|Overall Study|Other|0
2168423|NCT01307267|3788837|FG010|Overall Study|Other|1
2168424|NCT01307267|3788838|FG011|Overall Study|Other|1
2168425|NCT01307267|3788839|FG012|Overall Study|Other|1
2168426|NCT01307267|3788840|FG013|Overall Study|Other|0
2168427|NCT01307267|3788841|FG014|Overall Study|Other|2
2168428|NCT01307267|3788842|FG015|Overall Study|Other|1
2168429|NCT01307267|3788843|FG016|Overall Study|Other|0
2168430|NCT01307267|3788844|FG017|Overall Study|Other|0
2168431|NCT01307267|3788845|FG018|Overall Study|Other|0
2168432|NCT01307267|3788846|FG019|Overall Study|Other|19
2168433|NCT01307267|3788847|FG020|Overall Study|Other|2
2168434|NCT01307267|3788848|FG021|Overall Study|Other|3
2168435|NCT01307267|3788849|FG022|Overall Study|Other|2
2168436|NCT01307319|3788911|FG000|Overall Study|Adverse Event|2
2168437|NCT01307319|3788912|FG001|Overall Study|Adverse Event|2
2168438|NCT01307319|3788913|FG002|Overall Study|Adverse Event|1
2295763|NCT02552121|3991509|FG003|Part 2: Cohort Expansion|Adverse Event|1
2295764|NCT02552121|3991510|FG004|Part 2: Cohort Expansion|Adverse Event|0
2295765|NCT02552121|3991511|FG005|Part 2: Cohort Expansion|Adverse Event|0
2295766|NCT02552121|3991512|FG006|Part 2: Cohort Expansion|Adverse Event|0
2295767|NCT02552121|3991513|FG007|Part 2: Cohort Expansion|Adverse Event|0
2295768|NCT02552121|3991506|FG000|Part 2: Cohort Expansion|Death|0
2295769|NCT02552121|3991507|FG001|Part 2: Cohort Expansion|Death|0
2295770|NCT02552121|3991508|FG002|Part 2: Cohort Expansion|Death|1
2295771|NCT02552121|3991509|FG003|Part 2: Cohort Expansion|Death|0
2295772|NCT02552121|3991510|FG004|Part 2: Cohort Expansion|Death|0
2295773|NCT02552121|3991511|FG005|Part 2: Cohort Expansion|Death|0
2295774|NCT02552121|3991512|FG006|Part 2: Cohort Expansion|Death|0
2295775|NCT02552121|3991513|FG007|Part 2: Cohort Expansion|Death|0
2295776|NCT02552147|3991545|FG000|First Intervention (7 Days)|Protocol Violation|1
2295777|NCT02552147|3991546|FG001|First Intervention (7 Days)|Protocol Violation|0
2295778|NCT02552147|3991545|FG000|Second Intervention (7 Days)|Protocol Violation|2
2295779|NCT02552147|3991546|FG001|Second Intervention (7 Days)|Protocol Violation|0
2295780|NCT02552212|3991554|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6
2295781|NCT02552212|3991555|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3
2295782|NCT02552212|3991556|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0
2295783|NCT02552212|3991554|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
2295784|NCT02552212|3991555|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
2295785|NCT02552212|3991556|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0
2295786|NCT02552212|3991554|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
2295787|NCT02552212|3991555|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
2295788|NCT02552212|3991556|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0
2295789|NCT02552212|3991554|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1
2295790|NCT02552212|3991555|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
2295791|NCT02552212|3991556|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
2295792|NCT02552212|3991554|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3
2295793|NCT02552212|3991555|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7
2295794|NCT02552212|3991556|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0
2295795|NCT02552212|3991554|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
2295796|NCT02552212|3991555|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
2295797|NCT02552212|3991556|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0
2295798|NCT02552212|3991554|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0
2295799|NCT02552212|3991555|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1
2295800|NCT02552212|3991556|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0
2295801|NCT02552212|3991554|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0
2295802|NCT02552212|3991555|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1
2295803|NCT02552212|3991556|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0
2295804|NCT02552212|3991554|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0
2168439|NCT01307319|3788911|FG000|Overall Study|Lost to Follow-up|1
2168440|NCT01307319|3788912|FG001|Overall Study|Lost to Follow-up|0
2168441|NCT01307319|3788913|FG002|Overall Study|Lost to Follow-up|1
2168442|NCT01307319|3788911|FG000|Overall Study|Protocol Violation|1
2168443|NCT01307319|3788912|FG001|Overall Study|Protocol Violation|1
2168444|NCT01307319|3788913|FG002|Overall Study|Protocol Violation|0
2168445|NCT01307319|3788911|FG000|Overall Study|Withdrawal by Subject|0
2168446|NCT01307319|3788912|FG001|Overall Study|Withdrawal by Subject|1
2168447|NCT01307319|3788913|FG002|Overall Study|Withdrawal by Subject|2
2168448|NCT01307319|3788911|FG000|Overall Study|Other|0
2168449|NCT01307319|3788912|FG001|Overall Study|Other|4
2168450|NCT01307319|3788913|FG002|Overall Study|Other|3
2168451|NCT01307423|3788928|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
2168452|NCT01307423|3788929|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
2168453|NCT01307423|3788930|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
2168454|NCT01307423|3788931|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2168455|NCT01307423|3788932|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2168456|NCT01307423|3788933|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2168457|NCT01307423|3788934|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2168458|NCT01307423|3788935|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2168459|NCT01307423|3788936|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2168460|NCT01307423|3788928|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
2168461|NCT01307423|3788929|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
2168462|NCT01307423|3788930|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
2168463|NCT01307423|3788931|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2168464|NCT01307423|3788932|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2295805|NCT02552212|3991555|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1
2295806|NCT02552212|3991556|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0
2295807|NCT02552212|3991554|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1
2295808|NCT02552212|3991555|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
2295809|NCT02552212|3991556|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
2295810|NCT02552212|3991554|FG000|SFE Period (Week 52 - 156)|Adverse Event|0
2295811|NCT02552212|3991555|FG001|SFE Period (Week 52 - 156)|Adverse Event|0
2295812|NCT02552212|3991556|FG002|SFE Period (Week 52 - 156)|Adverse Event|5
2295813|NCT02552212|3991554|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0
2295814|NCT02552212|3991555|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0
2295815|NCT02552212|3991556|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4
2295816|NCT02552212|3991554|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0
2295817|NCT02552212|3991555|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0
2295818|NCT02552212|3991556|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2
2295819|NCT02552212|3991554|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
2295820|NCT02552212|3991555|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
2295821|NCT02552212|3991556|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18
2295822|NCT02552212|3991554|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
2295823|NCT02552212|3991555|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
2295824|NCT02552212|3991556|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1
2295825|NCT02552212|3991554|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0
2295826|NCT02552212|3991555|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0
2295827|NCT02552212|3991556|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1
2295828|NCT02552212|3991554|FG000|SFE Period (Week 52 - 156)|Investigator decision|0
2295829|NCT02552212|3991555|FG001|SFE Period (Week 52 - 156)|Investigator decision|0
2295830|NCT02552212|3991556|FG002|SFE Period (Week 52 - 156)|Investigator decision|1
2295831|NCT02552212|3991554|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
2295832|NCT02552212|3991555|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
2295833|NCT02552212|3991556|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1
2295834|NCT02552212|3991554|FG000|SFE Period (Week 52 - 156)|Compassionate access|0
2295835|NCT02552212|3991555|FG001|SFE Period (Week 52 - 156)|Compassionate access|0
2295836|NCT02552212|3991556|FG002|SFE Period (Week 52 - 156)|Compassionate access|2
2295837|NCT02552212|3991554|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
2295838|NCT02552212|3991555|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
2295839|NCT02552212|3991556|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1
2295840|NCT02552212|3991554|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0
2295841|NCT02552212|3991555|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0
2295842|NCT02552212|3991556|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1
2295843|NCT02552225|3991574|FG000|Overall Study|Withdrawal by Subject|1
2295844|NCT02552225|3991575|FG001|Overall Study|Withdrawal by Subject|0
2295845|NCT02552238|3991581|FG000|Overall Study|Withdrawal by Subject|2
2295846|NCT02552238|3991581|FG000|Overall Study|Adverse Event|2
2295847|NCT02552303|3991596|FG000|Allocation|Withdrawal by Subject|2
2295848|NCT02552303|3991597|FG001|Allocation|Withdrawal by Subject|1
2295849|NCT02552303|3991598|FG002|Allocation|Withdrawal by Subject|1
2295850|NCT02552303|3991599|FG003|Allocation|Withdrawal by Subject|1
2295851|NCT02552303|3991596|FG000|Allocation|ineligible|1
2295852|NCT02552303|3991597|FG001|Allocation|ineligible|1
2295853|NCT02552303|3991598|FG002|Allocation|ineligible|0
2295854|NCT02552303|3991599|FG003|Allocation|ineligible|0
2295855|NCT02552303|3991596|FG000|Follow-Up|Lost to Follow-up|0
2295856|NCT02552303|3991597|FG001|Follow-Up|Lost to Follow-up|0
2295857|NCT02552303|3991598|FG002|Follow-Up|Lost to Follow-up|1
2295858|NCT02552303|3991599|FG003|Follow-Up|Lost to Follow-up|0
2295859|NCT02552303|3991596|FG000|Follow-Up|ineligible|0
2295860|NCT02552303|3991597|FG001|Follow-Up|ineligible|2
2168465|NCT01307423|3788933|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2168466|NCT01307423|3788934|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2168467|NCT01307423|3788935|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2168468|NCT01307423|3788936|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2168469|NCT01307423|3788928|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
2168470|NCT01307423|3788929|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
2168471|NCT01307423|3788930|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
2168472|NCT01307423|3788931|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2168473|NCT01307423|3788932|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2168474|NCT01307423|3788933|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2168475|NCT01307423|3788934|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2168476|NCT01307423|3788935|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2168477|NCT01307423|3788936|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2295861|NCT02552303|3991598|FG002|Follow-Up|ineligible|0
2295862|NCT02552303|3991599|FG003|Follow-Up|ineligible|0
2295863|NCT02552316|3991609|FG000|Overall Study|Withdrawal by Subject|1
2295864|NCT02552316|3991609|FG000|Overall Study|Withdrawal due to non-compliance|1
2295865|NCT02552355|3991661|FG000|Overall Study|Adverse Event|0
2295866|NCT02552355|3991662|FG001|Overall Study|Adverse Event|2
2295867|NCT02552355|3991663|FG002|Overall Study|Adverse Event|2
2295868|NCT02552355|3991664|FG003|Overall Study|Adverse Event|0
2295869|NCT02552355|3991661|FG000|Overall Study|Withdrawal by Subject|0
2295870|NCT02552355|3991662|FG001|Overall Study|Withdrawal by Subject|0
2295871|NCT02552355|3991663|FG002|Overall Study|Withdrawal by Subject|0
2295872|NCT02552355|3991664|FG003|Overall Study|Withdrawal by Subject|1
2295873|NCT02552732|3991679|FG000|Overall Study|Lost to Follow-up|2
2295874|NCT02552732|3991679|FG000|Overall Study|Physician Decision|1
2295875|NCT02552732|3991679|FG000|Overall Study|Day 1 SpO2 > 96%|1
2295876|NCT02552732|3991679|FG000|Overall Study|Withdrawal by Subject|6
2295877|NCT02552888|3991695|FG000|Overall Study|Lost to Follow-up|1
2295878|NCT02552888|3991696|FG001|Overall Study|Lost to Follow-up|1
2295879|NCT02552966|3991706|FG000|Overall Study|Lost to Follow-up|2
2295880|NCT02552966|3991706|FG000|Overall Study|Withdrawal by Subject|3
2295881|NCT02553317|3991716|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
2295882|NCT02553317|3991717|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
2295883|NCT02553317|3991716|FG000|Overall Treatment Period + Follow-up|Physician Decision|2
2295884|NCT02553317|3991717|FG001|Overall Treatment Period + Follow-up|Physician Decision|4
2295885|NCT02553317|3991716|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
2295886|NCT02553317|3991717|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
2295887|NCT02553317|3991716|FG000|Overall Treatment Period + Follow-up|Death|1
2295888|NCT02553317|3991717|FG001|Overall Treatment Period + Follow-up|Death|3
2295889|NCT02553317|3991716|FG000|Overall Treatment Period + Follow-up|Adverse Event|6
2295890|NCT02553317|3991717|FG001|Overall Treatment Period + Follow-up|Adverse Event|5
2295891|NCT02553317|3991716|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
2295892|NCT02553317|3991717|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
2295893|NCT02553317|3991716|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0
2295894|NCT02553317|3991717|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1
2295895|NCT02553317|3991716|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
2295896|NCT02553317|3991717|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
2295897|NCT02553317|3991716|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0
2295898|NCT02553317|3991717|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1
2295899|NCT02553317|3991716|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
2295900|NCT02553317|3991717|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
2295901|NCT02553330|3991727|FG000|Overall Study|Study Terminated by Sponsor|2
2295902|NCT02553330|3991728|FG001|Overall Study|Study Terminated by Sponsor|13
2295903|NCT02553330|3991729|FG002|Overall Study|Study Terminated by Sponsor|12
2295904|NCT02553330|3991727|FG000|Overall Study|Withdrawal by Subject|3
2295905|NCT02553330|3991728|FG001|Overall Study|Withdrawal by Subject|19
2295906|NCT02553330|3991729|FG002|Overall Study|Withdrawal by Subject|21
2295907|NCT02553330|3991727|FG000|Overall Study|Other|0
2295908|NCT02553330|3991728|FG001|Overall Study|Other|1
2295909|NCT02553330|3991729|FG002|Overall Study|Other|0
2295910|NCT02553330|3991727|FG000|Overall Study|Non compliance to study treatment|0
2295911|NCT02553330|3991728|FG001|Overall Study|Non compliance to study treatment|1
2295912|NCT02553330|3991729|FG002|Overall Study|Non compliance to study treatment|0
2295913|NCT02553330|3991727|FG000|Overall Study|Adverse Event|0
2295914|NCT02553330|3991728|FG001|Overall Study|Adverse Event|1
2295915|NCT02553330|3991729|FG002|Overall Study|Adverse Event|0
2295916|NCT02553330|3991727|FG000|Overall Study|Lost to Follow-up|0
2295917|NCT02553330|3991728|FG001|Overall Study|Lost to Follow-up|4
2295918|NCT02553330|3991729|FG002|Overall Study|Lost to Follow-up|4
2295919|NCT02553421|3991750|FG000|Overall Study|Lost to Follow-up|21
2295920|NCT02553421|3991751|FG001|Overall Study|Lost to Follow-up|1
2295921|NCT02553421|3991750|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5
2295922|NCT02553421|3991751|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0
2168478|NCT01307423|3788928|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2168479|NCT01307423|3788929|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2168480|NCT01307423|3788930|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
2168481|NCT01307423|3788931|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2168482|NCT01307423|3788932|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2168483|NCT01307423|3788933|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2168484|NCT01307423|3788934|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2168485|NCT01307423|3788935|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2168486|NCT01307423|3788936|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2168487|NCT01307423|3788928|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
2168488|NCT01307423|3788929|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2168489|NCT01307423|3788930|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
2168490|NCT01307423|3788931|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2168491|NCT01307423|3788932|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2168492|NCT01307423|3788933|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2168493|NCT01307423|3788934|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2168494|NCT01307423|3788935|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2168495|NCT01307423|3788936|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2168496|NCT01307423|3788928|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2168497|NCT01307423|3788929|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2168498|NCT01307423|3788930|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2168499|NCT01307423|3788931|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2168500|NCT01307423|3788932|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2168501|NCT01307423|3788933|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2168502|NCT01307423|3788934|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2168503|NCT01307423|3788935|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2168504|NCT01307423|3788936|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2168505|NCT01307423|3788928|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
2168506|NCT01307423|3788929|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
2168507|NCT01307423|3788930|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
2168508|NCT01307423|3788931|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
2168509|NCT01307423|3788932|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
2168510|NCT01307423|3788933|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
2168511|NCT01307423|3788934|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
2168512|NCT01307423|3788935|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
2168513|NCT01307423|3788936|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
2168514|NCT01307423|3788928|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2168515|NCT01307423|3788929|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
2168516|NCT01307423|3788930|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
2168517|NCT01307423|3788931|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2168518|NCT01307423|3788932|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2168519|NCT01307423|3788933|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2168520|NCT01307423|3788934|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2168521|NCT01307423|3788935|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2168522|NCT01307423|3788936|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2168523|NCT01307423|3788928|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0
2168524|NCT01307423|3788929|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3
2168525|NCT01307423|3788930|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2
2168526|NCT01307423|3788931|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2
2168527|NCT01307423|3788932|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2
2168528|NCT01307423|3788933|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0
2168529|NCT01307423|3788934|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0
2168530|NCT01307423|3788935|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0
2168531|NCT01307423|3788936|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0
2168532|NCT01307423|3788928|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2168533|NCT01307423|3788929|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
2168534|NCT01307423|3788930|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
2168535|NCT01307423|3788931|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
2168536|NCT01307423|3788932|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
2168537|NCT01307423|3788933|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2168538|NCT01307423|3788934|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2168539|NCT01307423|3788935|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2168540|NCT01307423|3788936|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2168541|NCT01307423|3788928|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2168542|NCT01307423|3788929|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2168543|NCT01307423|3788930|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2168544|NCT01307423|3788931|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2168545|NCT01307423|3788932|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2168546|NCT01307423|3788933|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
2168547|NCT01307423|3788934|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2168548|NCT01307423|3788935|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2168549|NCT01307423|3788936|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2168550|NCT01307423|3788928|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2168551|NCT01307423|3788929|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
2168552|NCT01307423|3788930|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
2168553|NCT01307423|3788931|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2168554|NCT01307423|3788932|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2168555|NCT01307423|3788933|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
2168556|NCT01307423|3788934|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
2168557|NCT01307423|3788935|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2168558|NCT01307423|3788936|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2168559|NCT01307423|3788928|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2168560|NCT01307423|3788929|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2168561|NCT01307423|3788930|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2168562|NCT01307423|3788931|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
2168563|NCT01307423|3788932|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2168564|NCT01307423|3788933|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2168565|NCT01307423|3788934|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2168566|NCT01307423|3788935|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2168567|NCT01307423|3788936|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2168568|NCT01307423|3788928|FG000|Active Treatment Phase (Week 25-52)|Other|0
2168569|NCT01307423|3788929|FG001|Active Treatment Phase (Week 25-52)|Other|0
2168570|NCT01307423|3788930|FG002|Active Treatment Phase (Week 25-52)|Other|0
2168571|NCT01307423|3788931|FG003|Active Treatment Phase (Week 25-52)|Other|1
2168572|NCT01307423|3788932|FG004|Active Treatment Phase (Week 25-52)|Other|0
2168573|NCT01307423|3788933|FG005|Active Treatment Phase (Week 25-52)|Other|0
2168574|NCT01307423|3788934|FG006|Active Treatment Phase (Week 25-52)|Other|0
2168575|NCT01307423|3788935|FG007|Active Treatment Phase (Week 25-52)|Other|0
2168576|NCT01307423|3788936|FG008|Active Treatment Phase (Week 25-52)|Other|0
2168577|NCT01307423|3788928|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2168578|NCT01307423|3788929|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2168579|NCT01307423|3788930|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2168580|NCT01307423|3788931|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2168581|NCT01307423|3788932|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2168582|NCT01307423|3788933|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1
2168583|NCT01307423|3788934|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2168584|NCT01307423|3788935|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2168585|NCT01307423|3788936|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2168586|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
2168587|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2
2168588|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7
2168589|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
2168590|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
2168591|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
2168592|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
2168593|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1
2168594|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1
2168595|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2168596|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
2168597|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
2168598|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2168599|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2168600|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2168601|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2168602|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
2168603|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
2168604|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2168605|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2168606|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
2168607|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2168608|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2168609|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2168610|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2168611|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2168612|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2168613|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2168614|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
2168615|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
2168616|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2168617|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2168618|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2168619|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2168620|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
2168621|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
2168622|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
2168623|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1
2168624|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0
2168625|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
2168626|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
2295923|NCT02553421|3991750|FG000|Overall Study|Improper Device Placement|3
2295924|NCT02553421|3991751|FG001|Overall Study|Improper Device Placement|0
2295925|NCT02553499|3991772|FG000|Overall Study|Adverse Event|0
2295926|NCT02553499|3991773|FG001|Overall Study|Adverse Event|0
2295927|NCT02553499|3991774|FG002|Overall Study|Adverse Event|0
2295928|NCT02553499|3991775|FG003|Overall Study|Adverse Event|0
2295929|NCT02553499|3991776|FG004|Overall Study|Adverse Event|0
2295930|NCT02553499|3991777|FG005|Overall Study|Adverse Event|0
2295931|NCT02553499|3991778|FG006|Overall Study|Adverse Event|1
2295932|NCT02553499|3991779|FG007|Overall Study|Adverse Event|1
2295933|NCT02553499|3991780|FG008|Overall Study|Adverse Event|0
2295934|NCT02553499|3991781|FG009|Overall Study|Adverse Event|0
2168627|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
2168628|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
2295935|NCT02553499|3991782|FG010|Overall Study|Adverse Event|0
2295936|NCT02553499|3991783|FG011|Overall Study|Adverse Event|0
2295937|NCT02553499|3991784|FG012|Overall Study|Adverse Event|0
2295938|NCT02553499|3991785|FG013|Overall Study|Adverse Event|1
2295939|NCT02553499|3991772|FG000|Overall Study|Death|0
2295940|NCT02553499|3991773|FG001|Overall Study|Death|1
2295941|NCT02553499|3991774|FG002|Overall Study|Death|1
2295942|NCT02553499|3991775|FG003|Overall Study|Death|0
2295943|NCT02553499|3991776|FG004|Overall Study|Death|1
2295944|NCT02553499|3991777|FG005|Overall Study|Death|2
2295945|NCT02553499|3991778|FG006|Overall Study|Death|0
2295946|NCT02553499|3991779|FG007|Overall Study|Death|0
2295947|NCT02553499|3991780|FG008|Overall Study|Death|0
2295948|NCT02553499|3991781|FG009|Overall Study|Death|0
2295949|NCT02553499|3991782|FG010|Overall Study|Death|1
2295950|NCT02553499|3991783|FG011|Overall Study|Death|0
2295951|NCT02553499|3991784|FG012|Overall Study|Death|0
2295952|NCT02553499|3991785|FG013|Overall Study|Death|0
2295953|NCT02553499|3991772|FG000|Overall Study|Lost to Follow-up|0
2295954|NCT02553499|3991773|FG001|Overall Study|Lost to Follow-up|0
2295955|NCT02553499|3991774|FG002|Overall Study|Lost to Follow-up|0
2295956|NCT02553499|3991775|FG003|Overall Study|Lost to Follow-up|0
2295957|NCT02553499|3991776|FG004|Overall Study|Lost to Follow-up|0
2295958|NCT02553499|3991777|FG005|Overall Study|Lost to Follow-up|0
2295959|NCT02553499|3991778|FG006|Overall Study|Lost to Follow-up|1
2295960|NCT02553499|3991779|FG007|Overall Study|Lost to Follow-up|0
2295961|NCT02553499|3991780|FG008|Overall Study|Lost to Follow-up|0
2295962|NCT02553499|3991781|FG009|Overall Study|Lost to Follow-up|0
2295963|NCT02553499|3991782|FG010|Overall Study|Lost to Follow-up|0
2295964|NCT02553499|3991783|FG011|Overall Study|Lost to Follow-up|0
2295965|NCT02553499|3991784|FG012|Overall Study|Lost to Follow-up|0
2295966|NCT02553499|3991785|FG013|Overall Study|Lost to Follow-up|0
2295967|NCT02553499|3991772|FG000|Overall Study|Physician Decision|0
2295968|NCT02553499|3991773|FG001|Overall Study|Physician Decision|1
2295969|NCT02553499|3991774|FG002|Overall Study|Physician Decision|1
2295970|NCT02553499|3991775|FG003|Overall Study|Physician Decision|0
2295971|NCT02553499|3991776|FG004|Overall Study|Physician Decision|1
2295972|NCT02553499|3991777|FG005|Overall Study|Physician Decision|0
2295973|NCT02553499|3991778|FG006|Overall Study|Physician Decision|0
2295974|NCT02553499|3991779|FG007|Overall Study|Physician Decision|1
2295975|NCT02553499|3991780|FG008|Overall Study|Physician Decision|1
2295976|NCT02553499|3991781|FG009|Overall Study|Physician Decision|2
2295977|NCT02553499|3991782|FG010|Overall Study|Physician Decision|1
2295978|NCT02553499|3991783|FG011|Overall Study|Physician Decision|3
2295979|NCT02553499|3991784|FG012|Overall Study|Physician Decision|1
2295980|NCT02553499|3991785|FG013|Overall Study|Physician Decision|0
2295981|NCT02553499|3991772|FG000|Overall Study|Progressive Disease|0
2295982|NCT02553499|3991773|FG001|Overall Study|Progressive Disease|0
2295983|NCT02553499|3991774|FG002|Overall Study|Progressive Disease|0
2295984|NCT02553499|3991775|FG003|Overall Study|Progressive Disease|2
2295985|NCT02553499|3991776|FG004|Overall Study|Progressive Disease|1
2295986|NCT02553499|3991777|FG005|Overall Study|Progressive Disease|1
2295987|NCT02553499|3991778|FG006|Overall Study|Progressive Disease|1
2295988|NCT02553499|3991779|FG007|Overall Study|Progressive Disease|0
2295989|NCT02553499|3991780|FG008|Overall Study|Progressive Disease|0
2295990|NCT02553499|3991781|FG009|Overall Study|Progressive Disease|1
2295991|NCT02553499|3991782|FG010|Overall Study|Progressive Disease|0
2295992|NCT02553499|3991783|FG011|Overall Study|Progressive Disease|0
2295993|NCT02553499|3991784|FG012|Overall Study|Progressive Disease|2
2295994|NCT02553499|3991785|FG013|Overall Study|Progressive Disease|1
2295995|NCT02553499|3991772|FG000|Overall Study|Study Terminated by Sponsor|0
2295996|NCT02553499|3991773|FG001|Overall Study|Study Terminated by Sponsor|0
2295997|NCT02553499|3991774|FG002|Overall Study|Study Terminated by Sponsor|0
2295998|NCT02553499|3991775|FG003|Overall Study|Study Terminated by Sponsor|0
2295999|NCT02553499|3991776|FG004|Overall Study|Study Terminated by Sponsor|0
2168629|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1
2168630|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
2168631|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
2168632|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1
2168633|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
2168634|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
2168635|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
2168636|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
2168637|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
2168638|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3
2168639|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4
2168640|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2168641|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2168642|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
2168643|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2168644|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2168645|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2168646|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2168647|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
2168648|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2168649|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2168650|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
2168651|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
2168652|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2168653|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2168654|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2168655|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2168656|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2168657|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2168658|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2168659|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
2168660|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
2296000|NCT02553499|3991777|FG005|Overall Study|Study Terminated by Sponsor|0
2296001|NCT02553499|3991778|FG006|Overall Study|Study Terminated by Sponsor|0
2296002|NCT02553499|3991779|FG007|Overall Study|Study Terminated by Sponsor|0
2296003|NCT02553499|3991780|FG008|Overall Study|Study Terminated by Sponsor|1
2296004|NCT02553499|3991781|FG009|Overall Study|Study Terminated by Sponsor|0
2296005|NCT02553499|3991782|FG010|Overall Study|Study Terminated by Sponsor|0
2296006|NCT02553499|3991783|FG011|Overall Study|Study Terminated by Sponsor|0
2296007|NCT02553499|3991784|FG012|Overall Study|Study Terminated by Sponsor|0
2296008|NCT02553499|3991785|FG013|Overall Study|Study Terminated by Sponsor|0
2296009|NCT02553499|3991772|FG000|Overall Study|Withdrawal by Subject|2
2296010|NCT02553499|3991773|FG001|Overall Study|Withdrawal by Subject|0
2296011|NCT02553499|3991774|FG002|Overall Study|Withdrawal by Subject|0
2296012|NCT02553499|3991775|FG003|Overall Study|Withdrawal by Subject|0
2296013|NCT02553499|3991776|FG004|Overall Study|Withdrawal by Subject|0
2296014|NCT02553499|3991777|FG005|Overall Study|Withdrawal by Subject|0
2296015|NCT02553499|3991778|FG006|Overall Study|Withdrawal by Subject|0
2296016|NCT02553499|3991779|FG007|Overall Study|Withdrawal by Subject|1
2296017|NCT02553499|3991780|FG008|Overall Study|Withdrawal by Subject|1
2296018|NCT02553499|3991781|FG009|Overall Study|Withdrawal by Subject|0
2296019|NCT02553499|3991782|FG010|Overall Study|Withdrawal by Subject|1
2296020|NCT02553499|3991783|FG011|Overall Study|Withdrawal by Subject|0
2296021|NCT02553499|3991784|FG012|Overall Study|Withdrawal by Subject|0
2296022|NCT02553499|3991785|FG013|Overall Study|Withdrawal by Subject|0
2296023|NCT02553538|3991822|FG000|Overall Study|Could Not Reach by Telephone|133
2296024|NCT02553538|3991823|FG001|Overall Study|Could Not Reach by Telephone|0
2296025|NCT02553538|3991822|FG000|Overall Study|Died or Left Network|54
2296026|NCT02553538|3991823|FG001|Overall Study|Died or Left Network|56
2296027|NCT02553629|3991831|FG000|Overall Study|Logistic reasons|3
2296028|NCT02553629|3991832|FG001|Overall Study|Logistic reasons|6
2296029|NCT02553772|3991849|FG000|Overall Study|Adverse Event|2
2296030|NCT02553772|3991850|FG001|Overall Study|Adverse Event|3
2296031|NCT02553772|3991849|FG000|Overall Study|Lost to Follow-up|2
2296032|NCT02553772|3991850|FG001|Overall Study|Lost to Follow-up|1
2296033|NCT02553772|3991849|FG000|Overall Study|Withdrawal of Consent|1
2296034|NCT02553772|3991850|FG001|Overall Study|Withdrawal of Consent|1
2296035|NCT02553772|3991849|FG000|Overall Study|Lack of Efficacy|1
2296036|NCT02553772|3991850|FG001|Overall Study|Lack of Efficacy|0
2296037|NCT02553772|3991849|FG000|Overall Study|Other Miscellaneous Reasons|0
2296038|NCT02553772|3991850|FG001|Overall Study|Other Miscellaneous Reasons|1
2296039|NCT02553928|3991879|FG000|Overall Study|Adverse Event|2
2296040|NCT02553928|3991880|FG001|Overall Study|Adverse Event|1
2296041|NCT02553928|3991879|FG000|Overall Study|Lost to Follow-up|0
2296042|NCT02553928|3991880|FG001|Overall Study|Lost to Follow-up|1
2296043|NCT02553928|3991879|FG000|Overall Study|Administrative reason(s)|0
2296044|NCT02553928|3991880|FG001|Overall Study|Administrative reason(s)|1
2168661|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2168662|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2168663|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2168664|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2168665|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
2168666|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
2168667|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2168668|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
2168669|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
2208238|NCT01637402|3847649|FG000|Standard Dose Regimen|Adverse Event|1
2296045|NCT02554019|3991890|FG000|Overall Study|Withdrawal by Subject|1
2168670|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2168671|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2168672|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2168673|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2168674|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
2168675|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
2168676|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
2168677|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1
2168678|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0
2168679|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
2168680|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
2168681|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
2168682|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
2168683|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
2168684|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0
2168685|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
2168686|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2
2168687|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0
2168688|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
2168689|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
2168690|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
2179769|NCT01395901|3805460|FG000|Overall Study|Withdrawal of consent|1
2296046|NCT02554019|3991891|FG001|Overall Study|Withdrawal by Subject|0
2296047|NCT02554019|3991892|FG002|Overall Study|Withdrawal by Subject|2
2296048|NCT02554019|3991890|FG000|Overall Study|Adverse Event|1
2296049|NCT02554019|3991891|FG001|Overall Study|Adverse Event|0
2296050|NCT02554019|3991892|FG002|Overall Study|Adverse Event|0
2296051|NCT02554279|3991902|FG000|Overall Study|Adverse Event|2
2296052|NCT02554279|3991903|FG001|Overall Study|Adverse Event|5
2296053|NCT02554279|3991902|FG000|Overall Study|Lost to Follow-up|3
2296054|NCT02554279|3991903|FG001|Overall Study|Lost to Follow-up|2
2296055|NCT02554279|3991902|FG000|Overall Study|Withdrawal by Subject|6
2296056|NCT02554279|3991903|FG001|Overall Study|Withdrawal by Subject|4
2296057|NCT02554279|3991902|FG000|Overall Study|Protocol Violation|2
2296058|NCT02554279|3991903|FG001|Overall Study|Protocol Violation|1
2296059|NCT02554279|3991902|FG000|Overall Study|Other reason|19
2296060|NCT02554279|3991903|FG001|Overall Study|Other reason|6
2296061|NCT02554474|3991928|FG000|Overall Study|Protocol Violation|1
2296062|NCT02554474|3991929|FG001|Overall Study|Protocol Violation|1
2296063|NCT02554474|3991928|FG000|Overall Study|Health issue not related to the study|1
2296064|NCT02554474|3991929|FG001|Overall Study|Health issue not related to the study|0
2296065|NCT02554474|3991928|FG000|Overall Study|Withdrawal by Subject|1
2296066|NCT02554474|3991929|FG001|Overall Study|Withdrawal by Subject|1
2296067|NCT02554513|3991935|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0
2296068|NCT02554513|3991936|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1
2296069|NCT02554656|3991948|FG000|Overall Study|Protocol Violation|3
2296070|NCT02554682|3991962|FG000|Overall Study|Lost to Follow-up|11
2296071|NCT02554682|3991963|FG001|Overall Study|Lost to Follow-up|9
2296072|NCT02554682|3991964|FG002|Overall Study|Lost to Follow-up|4
2296073|NCT02554682|3991965|FG003|Overall Study|Lost to Follow-up|3
2296074|NCT02554682|3991966|FG004|Overall Study|Lost to Follow-up|2
2296075|NCT02554682|3991967|FG005|Overall Study|Lost to Follow-up|1
2296076|NCT02554682|3991968|FG006|Overall Study|Lost to Follow-up|6
2296077|NCT02554682|3991969|FG007|Overall Study|Lost to Follow-up|6
2296078|NCT02554682|3991970|FG008|Overall Study|Lost to Follow-up|2
2296079|NCT02554682|3991971|FG009|Overall Study|Lost to Follow-up|2
2296080|NCT02554682|3991962|FG000|Overall Study|Withdrawal by Subject|2
2296081|NCT02554682|3991963|FG001|Overall Study|Withdrawal by Subject|1
2296082|NCT02554682|3991964|FG002|Overall Study|Withdrawal by Subject|0
2296083|NCT02554682|3991965|FG003|Overall Study|Withdrawal by Subject|0
2296084|NCT02554682|3991966|FG004|Overall Study|Withdrawal by Subject|0
2296085|NCT02554682|3991967|FG005|Overall Study|Withdrawal by Subject|0
2296086|NCT02554682|3991968|FG006|Overall Study|Withdrawal by Subject|0
2296087|NCT02554682|3991969|FG007|Overall Study|Withdrawal by Subject|0
2296088|NCT02554682|3991970|FG008|Overall Study|Withdrawal by Subject|0
2296089|NCT02554682|3991971|FG009|Overall Study|Withdrawal by Subject|0
2296090|NCT02554682|3991962|FG000|Overall Study|Physician Decision|2
2296091|NCT02554682|3991963|FG001|Overall Study|Physician Decision|2
2168691|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
2168692|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
2168693|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0
2168694|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2168695|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
2168696|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2168697|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2168698|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2168699|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2168700|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2168701|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2168702|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
2168703|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2168704|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
2168705|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
2168706|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2168707|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2168708|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2168709|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2168710|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
2168711|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
2168712|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2296092|NCT02554682|3991964|FG002|Overall Study|Physician Decision|0
2296093|NCT02554682|3991965|FG003|Overall Study|Physician Decision|0
2296094|NCT02554682|3991966|FG004|Overall Study|Physician Decision|0
2296095|NCT02554682|3991967|FG005|Overall Study|Physician Decision|0
2296096|NCT02554682|3991968|FG006|Overall Study|Physician Decision|0
2296097|NCT02554682|3991969|FG007|Overall Study|Physician Decision|0
2296098|NCT02554682|3991970|FG008|Overall Study|Physician Decision|0
2296099|NCT02554682|3991971|FG009|Overall Study|Physician Decision|0
2296100|NCT02554721|3992001|FG000|Overall Study|Adverse Event|1
2296101|NCT02554721|3992002|FG001|Overall Study|Adverse Event|0
2296102|NCT02554721|3992003|FG002|Overall Study|Adverse Event|0
2296103|NCT02554721|3992004|FG003|Overall Study|Adverse Event|0
2296104|NCT02554721|3992005|FG004|Overall Study|Adverse Event|1
2296105|NCT02554721|3992001|FG000|Overall Study|Noncompliance|0
2296106|NCT02554721|3992002|FG001|Overall Study|Noncompliance|0
2296107|NCT02554721|3992003|FG002|Overall Study|Noncompliance|0
2296108|NCT02554721|3992004|FG003|Overall Study|Noncompliance|0
2296109|NCT02554721|3992005|FG004|Overall Study|Noncompliance|1
2296110|NCT02554786|3992029|FG000|Overall Study|Subject/guardian decision|29
2296111|NCT02554786|3992030|FG001|Overall Study|Subject/guardian decision|17
2296112|NCT02554786|3992031|FG002|Overall Study|Subject/guardian decision|18
2296113|NCT02554786|3992032|FG003|Overall Study|Subject/guardian decision|30
2296114|NCT02554786|3992033|FG004|Overall Study|Subject/guardian decision|20
2296115|NCT02554786|3992029|FG000|Overall Study|Lost to Follow-up|4
2296116|NCT02554786|3992030|FG001|Overall Study|Lost to Follow-up|3
2296117|NCT02554786|3992031|FG002|Overall Study|Lost to Follow-up|4
2296118|NCT02554786|3992032|FG003|Overall Study|Lost to Follow-up|2
2296119|NCT02554786|3992033|FG004|Overall Study|Lost to Follow-up|2
2296120|NCT02554786|3992029|FG000|Overall Study|Protocol deviation|1
2296121|NCT02554786|3992030|FG001|Overall Study|Protocol deviation|3
2296122|NCT02554786|3992031|FG002|Overall Study|Protocol deviation|3
2296123|NCT02554786|3992032|FG003|Overall Study|Protocol deviation|4
2296124|NCT02554786|3992033|FG004|Overall Study|Protocol deviation|2
2296125|NCT02554786|3992029|FG000|Overall Study|Technical problems|1
2296126|NCT02554786|3992030|FG001|Overall Study|Technical problems|1
2296127|NCT02554786|3992031|FG002|Overall Study|Technical problems|0
2296128|NCT02554786|3992032|FG003|Overall Study|Technical problems|2
2296129|NCT02554786|3992033|FG004|Overall Study|Technical problems|1
2296130|NCT02554786|3992029|FG000|Overall Study|Adverse Event|0
2296131|NCT02554786|3992030|FG001|Overall Study|Adverse Event|0
2296132|NCT02554786|3992031|FG002|Overall Study|Adverse Event|0
2296133|NCT02554786|3992032|FG003|Overall Study|Adverse Event|0
2296134|NCT02554786|3992033|FG004|Overall Study|Adverse Event|2
2296135|NCT02554786|3992029|FG000|Overall Study|Death|0
2296136|NCT02554786|3992030|FG001|Overall Study|Death|0
2296137|NCT02554786|3992031|FG002|Overall Study|Death|0
2296138|NCT02554786|3992032|FG003|Overall Study|Death|1
2296139|NCT02554786|3992033|FG004|Overall Study|Death|0
2296140|NCT02554786|3992029|FG000|Overall Study|Non-compliance with study treatment|0
2296141|NCT02554786|3992030|FG001|Overall Study|Non-compliance with study treatment|1
2296142|NCT02554786|3992031|FG002|Overall Study|Non-compliance with study treatment|1
2296143|NCT02554786|3992032|FG003|Overall Study|Non-compliance with study treatment|0
2296144|NCT02554786|3992033|FG004|Overall Study|Non-compliance with study treatment|1
2296145|NCT02554786|3992029|FG000|Overall Study|Physician Decision|0
2296146|NCT02554786|3992030|FG001|Overall Study|Physician Decision|1
2296147|NCT02554786|3992031|FG002|Overall Study|Physician Decision|4
2296148|NCT02554786|3992032|FG003|Overall Study|Physician Decision|1
2296149|NCT02554786|3992033|FG004|Overall Study|Physician Decision|1
2296150|NCT02554786|3992029|FG000|Overall Study|Pregnancy|0
2296151|NCT02554786|3992030|FG001|Overall Study|Pregnancy|0
2296152|NCT02554786|3992031|FG002|Overall Study|Pregnancy|0
2168713|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2168714|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
2168715|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2168716|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2168717|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2168718|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2168719|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2168720|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2168721|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
2168722|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0
2168723|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
2168724|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
2168725|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
2168726|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
2168727|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
2168728|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1
2168729|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0
2168730|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
2168731|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1
2168732|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1
2168733|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
2168734|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
2168735|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
2168736|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
2168737|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
2168738|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
2168739|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2296153|NCT02554786|3992032|FG003|Overall Study|Pregnancy|1
2296154|NCT02554786|3992033|FG004|Overall Study|Pregnancy|1
2296155|NCT02554877|3992062|FG000|Overall Study|Adverse Event|2
2296156|NCT02554877|3992063|FG001|Overall Study|Adverse Event|0
2296157|NCT02554877|3992064|FG002|Overall Study|Adverse Event|0
2296158|NCT02554877|3992065|FG003|Overall Study|Adverse Event|1
2296159|NCT02554877|3992062|FG000|Overall Study|Lost to Follow-up|1
2296160|NCT02554877|3992063|FG001|Overall Study|Lost to Follow-up|1
2296161|NCT02554877|3992064|FG002|Overall Study|Lost to Follow-up|1
2296162|NCT02554877|3992065|FG003|Overall Study|Lost to Follow-up|2
2296163|NCT02554877|3992062|FG000|Overall Study|Did not meet entrance criteria|0
2296164|NCT02554877|3992063|FG001|Overall Study|Did not meet entrance criteria|0
2296165|NCT02554877|3992064|FG002|Overall Study|Did not meet entrance criteria|1
2296166|NCT02554877|3992065|FG003|Overall Study|Did not meet entrance criteria|0
2296167|NCT02554877|3992062|FG000|Overall Study|No longer met eligibility criteria|1
2296168|NCT02554877|3992063|FG001|Overall Study|No longer met eligibility criteria|0
2296169|NCT02554877|3992064|FG002|Overall Study|No longer met eligibility criteria|1
2296170|NCT02554877|3992065|FG003|Overall Study|No longer met eligibility criteria|1
2296171|NCT02554877|3992062|FG000|Overall Study|Protocol Violation|3
2296172|NCT02554877|3992063|FG001|Overall Study|Protocol Violation|1
2296173|NCT02554877|3992064|FG002|Overall Study|Protocol Violation|1
2296174|NCT02554877|3992065|FG003|Overall Study|Protocol Violation|0
2296175|NCT02554877|3992062|FG000|Overall Study|Other|1
2296176|NCT02554877|3992063|FG001|Overall Study|Other|3
2296177|NCT02554877|3992064|FG002|Overall Study|Other|0
2296178|NCT02554877|3992065|FG003|Overall Study|Other|3
2296179|NCT02554877|3992062|FG000|Overall Study|Insufficient clinical response|4
2296180|NCT02554877|3992063|FG001|Overall Study|Insufficient clinical response|0
2296181|NCT02554877|3992064|FG002|Overall Study|Insufficient clinical response|0
2296182|NCT02554877|3992065|FG003|Overall Study|Insufficient clinical response|0
2296183|NCT02554877|3992062|FG000|Overall Study|No longer willing to participate|0
2296184|NCT02554877|3992063|FG001|Overall Study|No longer willing to participate|2
2296185|NCT02554877|3992064|FG002|Overall Study|No longer willing to participate|2
2296186|NCT02554877|3992065|FG003|Overall Study|No longer willing to participate|0
2296187|NCT02554890|3992077|FG000|Double-blind|Adverse Event|45
2296188|NCT02554890|3992078|FG001|Double-blind|Adverse Event|51
2296189|NCT02554890|3992077|FG000|Double-blind|Death|6
2296190|NCT02554890|3992078|FG001|Double-blind|Death|4
2296191|NCT02554890|3992077|FG000|Double-blind|Protocol Violation|1
2296192|NCT02554890|3992078|FG001|Double-blind|Protocol Violation|1
2296193|NCT02554890|3992077|FG000|Double-blind|Physician Decision|4
2296194|NCT02554890|3992078|FG001|Double-blind|Physician Decision|3
2296195|NCT02554890|3992077|FG000|Double-blind|Subject/Guardian decision|21
2296196|NCT02554890|3992078|FG001|Double-blind|Subject/Guardian decision|16
2296197|NCT02554890|3992077|FG000|Double-blind|Lost to Follow-up|7
2296198|NCT02554890|3992078|FG001|Double-blind|Lost to Follow-up|5
2296199|NCT02554890|3992077|FG000|Double-blind|Technical problems|1
2296200|NCT02554890|3992078|FG001|Double-blind|Technical problems|0
2296201|NCT02554890|3992077|FG000|Double-blind|Withdrawal by Subject|5
2296202|NCT02554890|3992078|FG001|Double-blind|Withdrawal by Subject|6
2296203|NCT02554890|3992077|FG000|Double-blind|Noncompliance with study treatment|6
2296204|NCT02554890|3992078|FG001|Double-blind|Noncompliance with study treatment|5
2296205|NCT02554890|3992077|FG000|Open-label|Adverse Event|0
2296206|NCT02554890|3992078|FG001|Open-label|Adverse Event|30
2168740|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
2168741|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
2168742|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2168743|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2168744|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2168745|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2168746|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2168747|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2168748|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2168749|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
2168750|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
2168751|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2168752|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2168753|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2168754|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2168755|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2168756|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
2168757|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2168758|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
2168759|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2168760|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2168761|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2168762|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2168763|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2168764|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2168765|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2168766|NCT01307423|3788928|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
2168767|NCT01307423|3788929|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
2168768|NCT01307423|3788930|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2
2168769|NCT01307423|3788931|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
2168770|NCT01307423|3788932|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
2168771|NCT01307423|3788933|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
2168772|NCT01307423|3788934|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
2168773|NCT01307423|3788935|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1
2168774|NCT01307423|3788936|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1
2168775|NCT01307449|3788972|FG000|Overall Study|Adverse Event|1
2168776|NCT01307449|3788973|FG001|Overall Study|Adverse Event|0
2168777|NCT01307449|3788974|FG002|Overall Study|Adverse Event|0
2168778|NCT01307449|3788975|FG003|Overall Study|Adverse Event|0
2168779|NCT01307501|3788989|FG000|Overall Study|Treatment Failure|1
2168780|NCT01307501|3788989|FG000|Overall Study|Death|20
2168781|NCT01307501|3788989|FG000|Overall Study|Lost to Follow-up|1
2168782|NCT01307501|3788989|FG000|Overall Study|Starting Hospice|1
2168783|NCT01307579|3788995|FG000|Overall Study|Death|3
2168784|NCT01307579|3788996|FG001|Overall Study|Death|6
2168785|NCT01307579|3788995|FG000|Overall Study|Physician Decision|26
2168786|NCT01307579|3788996|FG001|Overall Study|Physician Decision|29
2168787|NCT01307579|3788995|FG000|Overall Study|Withdrawal by Subject|7
2168788|NCT01307579|3788996|FG001|Overall Study|Withdrawal by Subject|3
2168789|NCT01307579|3788995|FG000|Overall Study|Institutional diagnosis of IFD|21
2168790|NCT01307579|3788996|FG001|Overall Study|Institutional diagnosis of IFD|36
2168791|NCT01307579|3788995|FG000|Overall Study|Begin conditioning for HSCT|42
2168792|NCT01307579|3788996|FG001|Overall Study|Begin conditioning for HSCT|44
2168793|NCT01307579|3788995|FG000|Overall Study|Refractory or relapsed AML|38
2168794|NCT01307579|3788996|FG001|Overall Study|Refractory or relapsed AML|23
2168795|NCT01307579|3788995|FG000|Overall Study|Ineligible|3
2168796|NCT01307579|3788996|FG001|Overall Study|Ineligible|4
2168797|NCT01307891|3789032|FG000|Overall Study|Progressive Disease|3
2168798|NCT01307891|3789033|FG001|Overall Study|Progressive Disease|1
2168799|NCT01308008|3789049|FG000|4 Weeks|Illness, disinterest, time|9
2168800|NCT01308008|3789050|FG001|4 Weeks|Illness, disinterest, time|2
2168801|NCT01308424|3789084|FG000|Baseline Eligibility|Screen Failures|71
2168802|NCT01308424|3789085|FG001|Baseline Eligibility|Screen Failures|0
2168803|NCT01308424|3789086|FG002|Baseline Eligibility|Screen Failures|0
2168804|NCT01308424|3789084|FG000|Randomization|Adverse Event|0
2168805|NCT01308424|3789085|FG001|Randomization|Adverse Event|1
2168806|NCT01308424|3789086|FG002|Randomization|Adverse Event|1
2168807|NCT01308424|3789084|FG000|Randomization|Lost to Follow-up|0
2168808|NCT01308424|3789085|FG001|Randomization|Lost to Follow-up|1
2168809|NCT01308424|3789086|FG002|Randomization|Lost to Follow-up|0
2168810|NCT01308424|3789084|FG000|Randomization|Physician Decision|0
2168811|NCT01308424|3789085|FG001|Randomization|Physician Decision|1
2168812|NCT01308424|3789086|FG002|Randomization|Physician Decision|1
2168813|NCT01308463|3789097|FG000|Overall Study|Study Discontinued|23
2168814|NCT01308463|3789097|FG000|Overall Study|Death|4
2296207|NCT02554890|3992077|FG000|Open-label|Death|0
2296208|NCT02554890|3992078|FG001|Open-label|Death|1
2168815|NCT01308463|3789097|FG000|Overall Study|Revision|2
2168816|NCT01308476|3789103|FG000|Overall Study|Lost to Follow-up|2
2168817|NCT01308476|3789104|FG001|Overall Study|Lost to Follow-up|2
2296209|NCT02554890|3992077|FG000|Open-label|Physician Decision|0
2168818|NCT01308476|3789103|FG000|Overall Study|Other|1
2168819|NCT01308476|3789104|FG001|Overall Study|Other|0
2168820|NCT01308567|3789113|FG000|Overall Study|Lost to Follow-up|2
2168821|NCT01308567|3789114|FG001|Overall Study|Lost to Follow-up|4
2168822|NCT01308567|3789115|FG002|Overall Study|Lost to Follow-up|4
2168823|NCT01308580|3789125|FG000|Overall Study|Lost to Follow-up|12
2168824|NCT01308580|3789126|FG001|Overall Study|Lost to Follow-up|7
2168825|NCT01308736|3789146|FG000|Overall Study|Did not attend a single session|6
2168826|NCT01308736|3789147|FG001|Overall Study|Did not attend a single session|5
2168827|NCT01308749|3789155|FG000|Period 1: Double Blind Treatment|Adverse Event|1
2168828|NCT01308749|3789156|FG001|Period 1: Double Blind Treatment|Adverse Event|0
2168829|NCT01308749|3789155|FG000|Period 2: Open Label Treatment|Adverse Event|0
2168830|NCT01308749|3789156|FG001|Period 2: Open Label Treatment|Adverse Event|1
2168831|NCT01308749|3789155|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0
2168832|NCT01308749|3789156|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1
2168833|NCT01308762|3789179|FG000|Overall Study|Protocol Violation|0
2168834|NCT01308762|3789180|FG001|Overall Study|Protocol Violation|1
2168835|NCT01308762|3789181|FG002|Overall Study|Protocol Violation|0
2168836|NCT01308788|3789194|FG000|2-year Treatment|medication change by treating physician|4
2168837|NCT01308788|3789195|FG001|2-year Treatment|medication change by treating physician|11
2168838|NCT01308853|3789214|FG000|Overall Study|Adverse Event|1
2168839|NCT01308853|3789214|FG000|Overall Study|Lost to Follow-up|2
2168840|NCT01308853|3789214|FG000|Overall Study|Insertion of permanent implants|1
2168841|NCT01309100|3789222|FG000|Overall Study|Protocol Violation|1
2168842|NCT01309100|3789222|FG000|Overall Study|Positive Slit lamp finding|1
2168843|NCT01309165|3789231|FG000|Overall Study|Lost to Follow-up|4
2168844|NCT01309165|3789232|FG001|Overall Study|Lost to Follow-up|3
2168845|NCT01309165|3789231|FG000|Overall Study|Return to work|1
2168846|NCT01309165|3789232|FG001|Overall Study|Return to work|2
2168847|NCT01309165|3789231|FG000|Overall Study|Left country|0
2168848|NCT01309165|3789232|FG001|Overall Study|Left country|1
2168849|NCT01309165|3789231|FG000|Overall Study|No transportation|0
2168850|NCT01309165|3789232|FG001|Overall Study|No transportation|1
2168851|NCT01309165|3789231|FG000|Overall Study|Admitted to hospital for second stroke|1
2168852|NCT01309165|3789232|FG001|Overall Study|Admitted to hospital for second stroke|0
2168853|NCT01309204|3789241|FG000|Overall Study|Adverse Event|48
2168854|NCT01309204|3789242|FG001|Overall Study|Adverse Event|58
2168855|NCT01309204|3789241|FG000|Overall Study|Lost to Follow-up|2
2168856|NCT01309204|3789242|FG001|Overall Study|Lost to Follow-up|2
2168857|NCT01309204|3789241|FG000|Overall Study|Subject's decision unrelated to an AE|9
2168858|NCT01309204|3789242|FG001|Overall Study|Subject's decision unrelated to an AE|10
2168859|NCT01309204|3789241|FG000|Overall Study|Inadequate control of IOP|4
2168860|NCT01309204|3789242|FG001|Overall Study|Inadequate control of IOP|4
2168861|NCT01309204|3789241|FG000|Overall Study|Other|4
2168862|NCT01309204|3789242|FG001|Overall Study|Other|1
2168863|NCT01309243|3789250|FG000|Randomized Phase Through Week 96|Randomized but not treated|6
2168864|NCT01309243|3789251|FG001|Randomized Phase Through Week 96|Randomized but not treated|7
2168865|NCT01309243|3789250|FG000|Randomized Phase Through Week 96|Adverse Event|12
2168866|NCT01309243|3789251|FG001|Randomized Phase Through Week 96|Adverse Event|43
2168867|NCT01309243|3789250|FG000|Randomized Phase Through Week 96|Death|0
2168868|NCT01309243|3789251|FG001|Randomized Phase Through Week 96|Death|1
2168869|NCT01309243|3789250|FG000|Randomized Phase Through Week 96|Pregnancy|2
2168870|NCT01309243|3789251|FG001|Randomized Phase Through Week 96|Pregnancy|0
2168871|NCT01309243|3789250|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16
2168872|NCT01309243|3789251|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4
2168873|NCT01309243|3789250|FG000|Randomized Phase Through Week 96|Investigators Discretion|3
2168874|NCT01309243|3789251|FG001|Randomized Phase Through Week 96|Investigators Discretion|6
2168875|NCT01309243|3789250|FG000|Randomized Phase Through Week 96|Withdrew Consent|12
2168876|NCT01309243|3789251|FG001|Randomized Phase Through Week 96|Withdrew Consent|18
2168877|NCT01309243|3789250|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23
2296210|NCT02554890|3992078|FG001|Open-label|Physician Decision|1
2296211|NCT02554890|3992077|FG000|Open-label|Subject/Guardian decision|0
2296212|NCT02554890|3992078|FG001|Open-label|Subject/Guardian decision|11
2296213|NCT02554890|3992077|FG000|Open-label|Lost to Follow-up|0
2296214|NCT02554890|3992078|FG001|Open-label|Lost to Follow-up|7
2296215|NCT02554890|3992077|FG000|Open-label|Technical problems|0
2296216|NCT02554890|3992078|FG001|Open-label|Technical problems|1
2296217|NCT02554890|3992077|FG000|Open-label|Withdrawal by Subject|0
2296218|NCT02554890|3992078|FG001|Open-label|Withdrawal by Subject|1
2296219|NCT02554903|3992088|FG000|Overall Study|Death|1
2296220|NCT02554903|3992089|FG001|Overall Study|Death|1
2296221|NCT02554903|3992088|FG000|Overall Study|Physician Decision|2
2296222|NCT02554903|3992089|FG001|Overall Study|Physician Decision|2
2168878|NCT01309243|3789251|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22
2168879|NCT01309243|3789250|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9
2168880|NCT01309243|3789251|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7
2168881|NCT01309243|3789250|FG000|Randomized Phase Through Week 96|Protocol Violation|1
2296223|NCT02554903|3992088|FG000|Overall Study|Heart Transplant|1
2296224|NCT02554903|3992089|FG001|Overall Study|Heart Transplant|2
2296225|NCT02554929|3992098|FG000|Overall Study|Lost to Follow-up|4
2296226|NCT02554929|3992099|FG001|Overall Study|Lost to Follow-up|4
2168882|NCT01309243|3789251|FG001|Randomized Phase Through Week 96|Protocol Violation|1
2168883|NCT01309243|3789250|FG000|Extension Phase|Lost to Follow-up|6
2168884|NCT01309243|3789251|FG001|Extension Phase|Lost to Follow-up|0
2168885|NCT01309269|3789257|FG000|Overall Study|Adverse Event|56
2168886|NCT01309269|3789257|FG000|Overall Study|Withdrawal by Subject|25
2168887|NCT01309269|3789257|FG000|Overall Study|Lack of Acceptance|15
2168888|NCT01309269|3789257|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119
2168889|NCT01309269|3789257|FG000|Overall Study|Kidney Transplant|25
2168890|NCT01309269|3789257|FG000|Overall Study|Administrative Problems|141
2168891|NCT01309269|3789257|FG000|Overall Study|Other|256
2168892|NCT01309269|3789257|FG000|Overall Study|Other|1
2168893|NCT01309269|3789257|FG000|Overall Study|Study Completion Data Not Recorded|95
2168894|NCT01309269|3789257|FG000|Overall Study|Enrolled but not Treated|107
2168895|NCT01309282|3789261|FG000|Overall Study|Lost to Follow-up|1
2168896|NCT01309308|3789267|FG000|Overall Study|Lost to Follow-up|6
2168897|NCT01309308|3789268|FG001|Overall Study|Lost to Follow-up|4
2168898|NCT01309386|3789289|FG000|Overall Study|Other|2
2168899|NCT01309386|3789290|FG001|Overall Study|Other|0
2168900|NCT01309386|3789289|FG000|Overall Study|Withdrawal by Subject|2
2168901|NCT01309386|3789290|FG001|Overall Study|Withdrawal by Subject|0
2168902|NCT01309386|3789289|FG000|Overall Study|Progressive disease|9
2168903|NCT01309386|3789290|FG001|Overall Study|Progressive disease|11
2168904|NCT01309386|3789289|FG000|Overall Study|Physician Decision|1
2168905|NCT01309386|3789290|FG001|Overall Study|Physician Decision|1
2168906|NCT01309386|3789289|FG000|Overall Study|Lack of Efficacy|3
2168907|NCT01309386|3789290|FG001|Overall Study|Lack of Efficacy|1
2168908|NCT01309386|3789289|FG000|Overall Study|Adverse Event|5
2168909|NCT01309386|3789290|FG001|Overall Study|Adverse Event|8
2168910|NCT01309659|3789318|FG000|Overall Study|Protocol Violation|0
2168911|NCT01309659|3789319|FG001|Overall Study|Protocol Violation|1
2168912|NCT01309737|3789328|FG000|Week 0 to 16|Death|1
2168913|NCT01309737|3789329|FG001|Week 0 to 16|Death|0
2168914|NCT01309737|3789330|FG002|Week 0 to 16|Death|1
2168915|NCT01309737|3789331|FG003|Week 0 to 16|Death|0
2168916|NCT01309737|3789332|FG004|Week 0 to 16|Death|0
2168917|NCT01309737|3789328|FG000|Week 0 to 16|Adverse Event|11
2168918|NCT01309737|3789329|FG001|Week 0 to 16|Adverse Event|10
2168919|NCT01309737|3789330|FG002|Week 0 to 16|Adverse Event|5
2168920|NCT01309737|3789331|FG003|Week 0 to 16|Adverse Event|0
2168921|NCT01309737|3789332|FG004|Week 0 to 16|Adverse Event|0
2168922|NCT01309737|3789328|FG000|Week 0 to 16|Lack of Efficacy|15
2168923|NCT01309737|3789329|FG001|Week 0 to 16|Lack of Efficacy|2
2168924|NCT01309737|3789330|FG002|Week 0 to 16|Lack of Efficacy|24
2168925|NCT01309737|3789331|FG003|Week 0 to 16|Lack of Efficacy|0
2168926|NCT01309737|3789332|FG004|Week 0 to 16|Lack of Efficacy|0
2168927|NCT01309737|3789328|FG000|Week 0 to 16|Lost to Follow-up|7
2168928|NCT01309737|3789329|FG001|Week 0 to 16|Lost to Follow-up|8
2168929|NCT01309737|3789330|FG002|Week 0 to 16|Lost to Follow-up|3
2168930|NCT01309737|3789331|FG003|Week 0 to 16|Lost to Follow-up|0
2168931|NCT01309737|3789332|FG004|Week 0 to 16|Lost to Follow-up|0
2168932|NCT01309737|3789328|FG000|Week 0 to 16|Withdrawal by Subject|7
2168933|NCT01309737|3789329|FG001|Week 0 to 16|Withdrawal by Subject|6
2168934|NCT01309737|3789330|FG002|Week 0 to 16|Withdrawal by Subject|7
2168935|NCT01309737|3789331|FG003|Week 0 to 16|Withdrawal by Subject|0
2168936|NCT01309737|3789332|FG004|Week 0 to 16|Withdrawal by Subject|0
2168937|NCT01309737|3789328|FG000|Week 0 to 16|Other|10
2168938|NCT01309737|3789329|FG001|Week 0 to 16|Other|14
2168939|NCT01309737|3789330|FG002|Week 0 to 16|Other|4
2168940|NCT01309737|3789331|FG003|Week 0 to 16|Other|0
2168941|NCT01309737|3789332|FG004|Week 0 to 16|Other|0
2168942|NCT01309737|3789328|FG000|Week 0 to 16|Randomized, but not treated|1
2168943|NCT01309737|3789329|FG001|Week 0 to 16|Randomized, but not treated|0
2168944|NCT01309737|3789330|FG002|Week 0 to 16|Randomized, but not treated|0
2168945|NCT01309737|3789331|FG003|Week 0 to 16|Randomized, but not treated|0
2168946|NCT01309737|3789332|FG004|Week 0 to 16|Randomized, but not treated|0
2296227|NCT02554929|3992098|FG000|Overall Study|Withdrawal by Subject|2
2296228|NCT02554929|3992099|FG001|Overall Study|Withdrawal by Subject|8
2296229|NCT02554981|3992105|FG000|Overall Study|Adverse Event|1
2296230|NCT02554981|3992105|FG000|Overall Study|Administrative Reasons|1
2296231|NCT02554981|3992105|FG000|Overall Study|Other Miscellaneous Reasons|3
2296232|NCT02555215|3992120|FG000|Overall Study|Other|1
2296233|NCT02555215|3992120|FG000|Overall Study|Investigator Decision|2
2321290|NCT02959177|4035850|FG002|Follow-up Post Treatment Phase|Adverse Event|0
2321291|NCT02959177|4035848|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0
2321292|NCT02959177|4035849|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0
2168947|NCT01309737|3789328|FG000|Week 16 to 52|Death|0
2168948|NCT01309737|3789329|FG001|Week 16 to 52|Death|0
2168949|NCT01309737|3789330|FG002|Week 16 to 52|Death|0
2168950|NCT01309737|3789331|FG003|Week 16 to 52|Death|0
2168951|NCT01309737|3789332|FG004|Week 16 to 52|Death|1
2168952|NCT01309737|3789328|FG000|Week 16 to 52|Adverse Event|7
2168953|NCT01309737|3789329|FG001|Week 16 to 52|Adverse Event|7
2168954|NCT01309737|3789330|FG002|Week 16 to 52|Adverse Event|0
2168955|NCT01309737|3789331|FG003|Week 16 to 52|Adverse Event|6
2168956|NCT01309737|3789332|FG004|Week 16 to 52|Adverse Event|5
2321293|NCT02959177|4035850|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2
2321294|NCT02959190|4035868|FG000|Open Label|Adverse Event|5
2168957|NCT01309737|3789328|FG000|Week 16 to 52|Lack of Efficacy|107
2168958|NCT01309737|3789329|FG001|Week 16 to 52|Lack of Efficacy|76
2168959|NCT01309737|3789330|FG002|Week 16 to 52|Lack of Efficacy|0
2168960|NCT01309737|3789331|FG003|Week 16 to 52|Lack of Efficacy|25
2168961|NCT01309737|3789332|FG004|Week 16 to 52|Lack of Efficacy|21
2168962|NCT01309737|3789328|FG000|Week 16 to 52|Lost to Follow-up|4
2168963|NCT01309737|3789329|FG001|Week 16 to 52|Lost to Follow-up|2
2168964|NCT01309737|3789330|FG002|Week 16 to 52|Lost to Follow-up|0
2168965|NCT01309737|3789331|FG003|Week 16 to 52|Lost to Follow-up|1
2168966|NCT01309737|3789332|FG004|Week 16 to 52|Lost to Follow-up|4
2168967|NCT01309737|3789328|FG000|Week 16 to 52|Withdrawal by Subject|5
2168968|NCT01309737|3789329|FG001|Week 16 to 52|Withdrawal by Subject|6
2168969|NCT01309737|3789330|FG002|Week 16 to 52|Withdrawal by Subject|0
2168970|NCT01309737|3789331|FG003|Week 16 to 52|Withdrawal by Subject|0
2168971|NCT01309737|3789332|FG004|Week 16 to 52|Withdrawal by Subject|2
2168972|NCT01309737|3789328|FG000|Week 16 to 52|Other|10
2296234|NCT02555371|3992150|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
2296235|NCT02555371|3992151|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2296236|NCT02555371|3992152|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2296237|NCT02555371|3992153|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2296238|NCT02555371|3992154|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2296239|NCT02555371|3992150|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
2296240|NCT02555371|3992151|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2296241|NCT02555371|3992152|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2296242|NCT02555371|3992153|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2296243|NCT02555371|3992154|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2296244|NCT02555371|3992150|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
2296245|NCT02555371|3992151|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2296246|NCT02555371|3992152|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2296247|NCT02555371|3992153|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2296248|NCT02555371|3992154|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2296249|NCT02555371|3992150|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
2296250|NCT02555371|3992151|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2296251|NCT02555371|3992152|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2296252|NCT02555371|3992153|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2296253|NCT02555371|3992154|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2296254|NCT02555371|3992150|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
2296255|NCT02555371|3992151|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2296256|NCT02555371|3992152|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2296257|NCT02555371|3992153|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2296258|NCT02555371|3992154|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2296259|NCT02555371|3992150|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
2296260|NCT02555371|3992151|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
2296261|NCT02555371|3992152|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
2296262|NCT02555371|3992153|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
2296263|NCT02555371|3992154|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
2296264|NCT02555371|3992150|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
2296265|NCT02555371|3992151|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
2296266|NCT02555371|3992152|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
2296267|NCT02555371|3992153|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
2296268|NCT02555371|3992154|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
2296269|NCT02555371|3992150|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2296270|NCT02555371|3992151|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
2296271|NCT02555371|3992152|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2296272|NCT02555371|3992153|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2296273|NCT02555371|3992154|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2296274|NCT02555371|3992150|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0
2296275|NCT02555371|3992151|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2
2296276|NCT02555371|3992152|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1
2296277|NCT02555371|3992153|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0
2296278|NCT02555371|3992154|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0
2296279|NCT02555371|3992150|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2296280|NCT02555371|3992151|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2296281|NCT02555371|3992152|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2296282|NCT02555371|3992153|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
2296283|NCT02555371|3992154|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2296284|NCT02555371|3992150|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2296285|NCT02555371|3992151|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2296286|NCT02555371|3992152|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2296287|NCT02555371|3992153|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
2296288|NCT02555371|3992154|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2168973|NCT01309737|3789329|FG001|Week 16 to 52|Other|12
2168974|NCT01309737|3789330|FG002|Week 16 to 52|Other|0
2168975|NCT01309737|3789331|FG003|Week 16 to 52|Other|2
2168976|NCT01309737|3789332|FG004|Week 16 to 52|Other|0
2168977|NCT01309828|3789366|FG000|Overall Study|Adverse Event|10
2168978|NCT01309828|3789367|FG001|Overall Study|Adverse Event|11
2168979|NCT01309828|3789366|FG000|Overall Study|Voluntary Withdrawal|5
2168980|NCT01309828|3789367|FG001|Overall Study|Voluntary Withdrawal|4
2168981|NCT01309828|3789366|FG000|Overall Study|Major Protocol Deviation|0
2168982|NCT01309828|3789367|FG001|Overall Study|Major Protocol Deviation|1
2168983|NCT01309828|3789366|FG000|Overall Study|Other|1
2168984|NCT01309828|3789367|FG001|Overall Study|Other|0
2168985|NCT01309841|3789376|FG000|Overall Study|Other|0
2168986|NCT01309841|3789377|FG001|Overall Study|Other|1
2168987|NCT01309841|3789378|FG002|Overall Study|Other|1
2168988|NCT01309841|3789376|FG000|Overall Study|Lost to Follow-up|7
2168989|NCT01309841|3789377|FG001|Overall Study|Lost to Follow-up|6
2168990|NCT01309841|3789378|FG002|Overall Study|Lost to Follow-up|4
2168991|NCT01309841|3789376|FG000|Overall Study|Study-Specific Withdrawal Criteria|3
2168992|NCT01309841|3789377|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
2168993|NCT01309841|3789378|FG002|Overall Study|Study-Specific Withdrawal Criteria|2
2168994|NCT01309841|3789376|FG000|Overall Study|Lack of Efficacy|0
2168995|NCT01309841|3789377|FG001|Overall Study|Lack of Efficacy|0
2168996|NCT01309841|3789378|FG002|Overall Study|Lack of Efficacy|2
2168997|NCT01309841|3789376|FG000|Overall Study|Adverse Event|9
2168998|NCT01309841|3789377|FG001|Overall Study|Adverse Event|22
2168999|NCT01309841|3789378|FG002|Overall Study|Adverse Event|11
2296289|NCT02555371|3992150|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2296290|NCT02555371|3992151|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2296291|NCT02555371|3992152|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2296292|NCT02555371|3992153|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2296293|NCT02555371|3992154|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
2296294|NCT02555371|3992150|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2296295|NCT02555371|3992151|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2296296|NCT02555371|3992152|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2296297|NCT02555371|3992153|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2296298|NCT02555371|3992154|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
2296299|NCT02555371|3992150|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2296300|NCT02555371|3992151|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2296301|NCT02555371|3992152|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2296302|NCT02555371|3992153|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
2296303|NCT02555371|3992154|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2296304|NCT02555618|3992169|FG000|Overall Study|Sponsor's Circumstances|1
2296305|NCT02555618|3992170|FG001|Overall Study|Sponsor's Circumstances|0
2296306|NCT02555683|3992183|FG000|Overall Study|Physician Decision|1
2296307|NCT02555683|3992184|FG001|Overall Study|Physician Decision|0
2296308|NCT02555683|3992185|FG002|Overall Study|Physician Decision|2
2296309|NCT02555683|3992183|FG000|Overall Study|Lost to Follow-up|2
2296310|NCT02555683|3992184|FG001|Overall Study|Lost to Follow-up|1
2296311|NCT02555683|3992185|FG002|Overall Study|Lost to Follow-up|2
2296312|NCT02555683|3992183|FG000|Overall Study|Technical Problems|1
2296313|NCT02555683|3992184|FG001|Overall Study|Technical Problems|1
2296314|NCT02555683|3992185|FG002|Overall Study|Technical Problems|0
2296315|NCT02555683|3992183|FG000|Overall Study|Protocol deviation|0
2296316|NCT02555683|3992184|FG001|Overall Study|Protocol deviation|1
2296317|NCT02555683|3992185|FG002|Overall Study|Protocol deviation|0
2296318|NCT02555683|3992183|FG000|Overall Study|Lack of Efficacy|2
2296319|NCT02555683|3992184|FG001|Overall Study|Lack of Efficacy|0
2296320|NCT02555683|3992185|FG002|Overall Study|Lack of Efficacy|0
2296321|NCT02555683|3992183|FG000|Overall Study|Death|0
2296322|NCT02555683|3992184|FG001|Overall Study|Death|1
2296323|NCT02555683|3992185|FG002|Overall Study|Death|2
2296324|NCT02555683|3992183|FG000|Overall Study|Adverse Event|1
2296325|NCT02555683|3992184|FG001|Overall Study|Adverse Event|0
2296326|NCT02555683|3992185|FG002|Overall Study|Adverse Event|1
2296327|NCT02555683|3992183|FG000|Overall Study|Subject/guardian decision|12
2296328|NCT02555683|3992184|FG001|Overall Study|Subject/guardian decision|12
2296329|NCT02555683|3992185|FG002|Overall Study|Subject/guardian decision|22
2296330|NCT02555683|3992183|FG000|Overall Study|Death post Treatment/safety period|0
2296331|NCT02555683|3992184|FG001|Overall Study|Death post Treatment/safety period|1
2296332|NCT02555683|3992185|FG002|Overall Study|Death post Treatment/safety period|0
2296333|NCT02555722|3992195|FG000|Week 2|Adverse Event|0
2296334|NCT02555722|3992196|FG001|Week 2|Adverse Event|1
2296335|NCT02555722|3992195|FG000|Week 2|Withdrawal by Subject|1
2296336|NCT02555722|3992196|FG001|Week 2|Withdrawal by Subject|0
2296337|NCT02555722|3992195|FG000|Month 1|Lens Discomfort|1
2296338|NCT02555722|3992196|FG001|Month 1|Lens Discomfort|0
2296339|NCT02555722|3992195|FG000|Month 2|Withdrawal by Subject|3
2169000|NCT01309841|3789376|FG000|Overall Study|Death|1
2296340|NCT02555722|3992196|FG001|Month 2|Withdrawal by Subject|0
2296341|NCT02555722|3992195|FG000|Month 2|Lost to Follow-up|1
2296342|NCT02555722|3992196|FG001|Month 2|Lost to Follow-up|0
2169001|NCT01309841|3789377|FG001|Overall Study|Death|0
2169002|NCT01309841|3789378|FG002|Overall Study|Death|0
2169003|NCT01309841|3789376|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
2169004|NCT01309841|3789377|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
2169005|NCT01309841|3789378|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
2169006|NCT01309841|3789376|FG000|Overall Study|Withdrawal by Subject|17
2169007|NCT01309841|3789377|FG001|Overall Study|Withdrawal by Subject|6
2169008|NCT01309841|3789378|FG002|Overall Study|Withdrawal by Subject|13
2169009|NCT01309841|3789376|FG000|Overall Study|Did Not Receive Treatment|2
2169010|NCT01309841|3789377|FG001|Overall Study|Did Not Receive Treatment|0
2169011|NCT01309841|3789378|FG002|Overall Study|Did Not Receive Treatment|1
2169012|NCT01309841|3789376|FG000|Overall Study|Severe non-compliance with protocol|0
2169013|NCT01309841|3789377|FG001|Overall Study|Severe non-compliance with protocol|5
2169014|NCT01309841|3789378|FG002|Overall Study|Severe non-compliance with protocol|2
2179770|NCT01395901|3805461|FG001|Overall Study|Withdrawal of consent|0
2179771|NCT01395914|3805469|FG000|Overall Study|Unrelated to study drug AE|6
2179772|NCT01395914|3805470|FG001|Overall Study|Unrelated to study drug AE|1
2179773|NCT01395914|3805469|FG000|Overall Study|Death|23
2179774|NCT01395914|3805470|FG001|Overall Study|Death|17
2179775|NCT01395914|3805469|FG000|Overall Study|Other|9
2179776|NCT01395914|3805470|FG001|Overall Study|Other|3
2179777|NCT01395914|3805469|FG000|Overall Study|Withdrawal by patient|27
2179778|NCT01395914|3805470|FG001|Overall Study|Withdrawal by patient|14
2179779|NCT01395914|3805469|FG000|Overall Study|Study drug-related AE|1
2179780|NCT01395914|3805470|FG001|Overall Study|Study drug-related AE|0
2179781|NCT01395914|3805469|FG000|Overall Study|Lost to Follow-up|6
2179782|NCT01395914|3805470|FG001|Overall Study|Lost to Follow-up|2
2179783|NCT01396005|3805491|FG000|Overall Study|Withdrawal by Subject|0
2296343|NCT02555878|3992227|FG000|Overall Study|Lost to Follow-up|2
2296344|NCT02555878|3992228|FG001|Overall Study|Lost to Follow-up|3
2296345|NCT02555878|3992227|FG000|Overall Study|Withdrawal by Subject|48
2296346|NCT02555878|3992228|FG001|Overall Study|Withdrawal by Subject|48
2296347|NCT02555878|3992227|FG000|Overall Study|Adverse Event|12
2296348|NCT02555878|3992228|FG001|Overall Study|Adverse Event|8
2296349|NCT02555878|3992227|FG000|Overall Study|Death|74
2296350|NCT02555878|3992228|FG001|Overall Study|Death|59
2296351|NCT02555878|3992227|FG000|Overall Study|Protocol Violation|1
2296352|NCT02555878|3992228|FG001|Overall Study|Protocol Violation|2
2296353|NCT02555878|3992227|FG000|Overall Study|Physician Decision|12
2296354|NCT02555878|3992228|FG001|Overall Study|Physician Decision|13
2296355|NCT02555878|3992227|FG000|Overall Study|Other|17
2296356|NCT02555878|3992228|FG001|Overall Study|Other|17
2296357|NCT02556138|3992253|FG000|Overall Study|Withdrawal by Subject|1
2296358|NCT02556177|3992259|FG000|Overall Study|Subjects did not complete all 4 visits|283
2296359|NCT02556177|3992260|FG001|Overall Study|Subjects did not complete all 4 visits|61
2296360|NCT02556203|3992268|FG000|Overall Study|Withdrawal by Subject|21
2296361|NCT02556203|3992269|FG001|Overall Study|Withdrawal by Subject|21
2296362|NCT02556203|3992268|FG000|Overall Study|Lost to Follow-up|5
2296363|NCT02556203|3992269|FG001|Overall Study|Lost to Follow-up|5
2296364|NCT02556203|3992268|FG000|Overall Study|Adverse Event|1
2296365|NCT02556203|3992269|FG001|Overall Study|Adverse Event|0
2296366|NCT02556255|3992275|FG000|Overall Study|Lost to Follow-up|4
2296367|NCT02556307|3992279|FG000|Overall Study|Premature treatment interruption|11
2296368|NCT02556307|3992279|FG000|Overall Study|Lost to Follow-up|36
2296369|NCT02556307|3992279|FG000|Overall Study|Change to triple therapy|4
2296370|NCT02556307|3992279|FG000|Overall Study|Enrolled but not treated|2
2296371|NCT02556632|3992308|FG000|Overall Study|Lost to Follow-up|1
2296372|NCT02556632|3992309|FG001|Overall Study|Lost to Follow-up|0
2296373|NCT02556632|3992310|FG002|Overall Study|Lost to Follow-up|0
2296374|NCT02556632|3992308|FG000|Overall Study|Disliked Intervention|1
2296375|NCT02556632|3992309|FG001|Overall Study|Disliked Intervention|1
2296376|NCT02556632|3992310|FG002|Overall Study|Disliked Intervention|1
2296377|NCT02556632|3992308|FG000|Overall Study|No Reason|1
2296378|NCT02556632|3992309|FG001|Overall Study|No Reason|0
2296379|NCT02556632|3992310|FG002|Overall Study|No Reason|1
2296380|NCT02556632|3992308|FG000|Overall Study|Personal Issues|0
2296381|NCT02556632|3992309|FG001|Overall Study|Personal Issues|1
2296382|NCT02556632|3992310|FG002|Overall Study|Personal Issues|1
2296383|NCT02556632|3992308|FG000|Overall Study|Changed Mind|0
2296384|NCT02556632|3992309|FG001|Overall Study|Changed Mind|1
2296385|NCT02556632|3992310|FG002|Overall Study|Changed Mind|0
2296386|NCT02556632|3992308|FG000|Overall Study|Withdrew (Unrelated Medical)|1
2296387|NCT02556632|3992309|FG001|Overall Study|Withdrew (Unrelated Medical)|0
2296388|NCT02556632|3992310|FG002|Overall Study|Withdrew (Unrelated Medical)|0
2296389|NCT02556632|3992308|FG000|Overall Study|Unrelated Adverse Event|1
2296390|NCT02556632|3992309|FG001|Overall Study|Unrelated Adverse Event|0
2296391|NCT02556632|3992310|FG002|Overall Study|Unrelated Adverse Event|3
2296392|NCT02556632|3992308|FG000|Overall Study|Related Adverse Event|0
2296393|NCT02556632|3992309|FG001|Overall Study|Related Adverse Event|1
2296394|NCT02556632|3992310|FG002|Overall Study|Related Adverse Event|0
2296395|NCT02556632|3992308|FG000|Overall Study|Possibly Related Adverse Event|0
2296396|NCT02556632|3992309|FG001|Overall Study|Possibly Related Adverse Event|0
2296397|NCT02556632|3992310|FG002|Overall Study|Possibly Related Adverse Event|1
2296398|NCT02556632|3992308|FG000|Overall Study|Did Not Start RT|0
2296399|NCT02556632|3992309|FG001|Overall Study|Did Not Start RT|1
2296400|NCT02556632|3992310|FG002|Overall Study|Did Not Start RT|0
2179784|NCT01396005|3805492|FG001|Overall Study|Withdrawal by Subject|1
2179785|NCT01396005|3805491|FG000|Overall Study|Non-compliance with protocol|0
2169015|NCT01309893|3789400|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1
2169016|NCT01309893|3789401|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0
2169017|NCT01309893|3789400|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0
2169018|NCT01309893|3789401|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1
2169019|NCT01309919|3789416|FG000|Overall Study|Did not receive a postpartum IUD|17
2169020|NCT01309919|3789417|FG001|Overall Study|Did not receive a postpartum IUD|48
2169021|NCT01309997|3789425|FG000|Overall Study|Adverse Event|1
2169022|NCT01309997|3789426|FG001|Overall Study|Adverse Event|0
2169023|NCT01309997|3789425|FG000|Overall Study|Death|1
2169024|NCT01309997|3789426|FG001|Overall Study|Death|3
2169025|NCT01309997|3789425|FG000|Overall Study|Lack of Efficacy|2
2169026|NCT01309997|3789426|FG001|Overall Study|Lack of Efficacy|2
2169027|NCT01309997|3789425|FG000|Overall Study|Withdrawal by Subject|1
2169028|NCT01309997|3789426|FG001|Overall Study|Withdrawal by Subject|1
2169029|NCT01310036|3789443|FG000|Overall Study|Administrative/other|10
2169030|NCT01310036|3789443|FG000|Overall Study|Withdrew Consent|11
2169031|NCT01310036|3789443|FG000|Overall Study|Refused Treatment/Did not Cooperate|4
2169032|NCT01310036|3789443|FG000|Overall Study|Progression of Disease|164
2169033|NCT01310036|3789443|FG000|Overall Study|Death|1
2296401|NCT02556632|3992308|FG000|Overall Study|Ineligible|0
2296402|NCT02556632|3992309|FG001|Overall Study|Ineligible|1
2296403|NCT02556632|3992310|FG002|Overall Study|Ineligible|0
2296404|NCT02556632|3992308|FG000|Overall Study|Disliked Study Procedures|0
2296405|NCT02556632|3992309|FG001|Overall Study|Disliked Study Procedures|0
2296406|NCT02556632|3992310|FG002|Overall Study|Disliked Study Procedures|1
2296407|NCT02556632|3992308|FG000|Overall Study|Treatment or Change Delay|0
2296408|NCT02556632|3992309|FG001|Overall Study|Treatment or Change Delay|0
2296409|NCT02556632|3992310|FG002|Overall Study|Treatment or Change Delay|1
2296410|NCT02556775|3992326|FG000|Overall Study|Withdrawal by Subject|1
2296411|NCT02556775|3992327|FG001|Overall Study|Withdrawal by Subject|0
2296412|NCT02556775|3992328|FG002|Overall Study|Withdrawal by Subject|1
2296413|NCT02556775|3992329|FG003|Overall Study|Withdrawal by Subject|0
2296414|NCT02556775|3992326|FG000|Overall Study|Lost to Follow-up|1
2296415|NCT02556775|3992327|FG001|Overall Study|Lost to Follow-up|0
2296416|NCT02556775|3992328|FG002|Overall Study|Lost to Follow-up|0
2296417|NCT02556775|3992329|FG003|Overall Study|Lost to Follow-up|0
2296418|NCT02556801|3992354|FG000|Overall Study|Lost to Follow-up|1
2296419|NCT02556801|3992355|FG001|Overall Study|Lost to Follow-up|0
2296420|NCT02556801|3992356|FG002|Overall Study|Lost to Follow-up|2
2296421|NCT02556801|3992357|FG003|Overall Study|Lost to Follow-up|0
2296422|NCT02556801|3992354|FG000|Overall Study|Withdrawal by Subject|1
2296423|NCT02556801|3992355|FG001|Overall Study|Withdrawal by Subject|1
2296424|NCT02556801|3992356|FG002|Overall Study|Withdrawal by Subject|1
2296425|NCT02556801|3992357|FG003|Overall Study|Withdrawal by Subject|0
2296426|NCT02556801|3992354|FG000|Overall Study|Protocol Violation|0
2296427|NCT02556801|3992355|FG001|Overall Study|Protocol Violation|3
2296428|NCT02556801|3992356|FG002|Overall Study|Protocol Violation|1
2296429|NCT02556801|3992357|FG003|Overall Study|Protocol Violation|1
2296430|NCT02556801|3992354|FG000|Overall Study|Adverse Event|0
2296431|NCT02556801|3992355|FG001|Overall Study|Adverse Event|2
2296432|NCT02556801|3992356|FG002|Overall Study|Adverse Event|0
2296433|NCT02556801|3992357|FG003|Overall Study|Adverse Event|3
2296434|NCT02556801|3992354|FG000|Overall Study|Pregnancy|0
2296435|NCT02556801|3992355|FG001|Overall Study|Pregnancy|1
2296436|NCT02556801|3992356|FG002|Overall Study|Pregnancy|0
2296437|NCT02556801|3992357|FG003|Overall Study|Pregnancy|0
2296438|NCT02556801|3992354|FG000|Overall Study|Personal reasons patient|0
2296439|NCT02556801|3992355|FG001|Overall Study|Personal reasons patient|0
2296440|NCT02556801|3992356|FG002|Overall Study|Personal reasons patient|0
2296441|NCT02556801|3992357|FG003|Overall Study|Personal reasons patient|1
2296442|NCT02556918|3992369|FG000|Overall Study|Protocol Violation|5
2296443|NCT02556918|3992370|FG001|Overall Study|Protocol Violation|6
2296444|NCT02556918|3992369|FG000|Overall Study|Withdrawal by Subject|4
2296445|NCT02556918|3992370|FG001|Overall Study|Withdrawal by Subject|4
2296446|NCT02557100|3992389|FG000|Single Blind Treatment Period|Lost to Follow-up|0
2296447|NCT02557100|3992390|FG001|Single Blind Treatment Period|Lost to Follow-up|1
2296448|NCT02557100|3992391|FG002|Single Blind Treatment Period|Lost to Follow-up|0
2296449|NCT02557100|3992389|FG000|Single Blind Treatment Period|Death|0
2296450|NCT02557100|3992390|FG001|Single Blind Treatment Period|Death|1
2296451|NCT02557100|3992391|FG002|Single Blind Treatment Period|Death|0
2296452|NCT02557100|3992389|FG000|Single Blind Treatment Period|Request to Discontinue|0
2296453|NCT02557100|3992390|FG001|Single Blind Treatment Period|Request to Discontinue|1
2296454|NCT02557100|3992391|FG002|Single Blind Treatment Period|Request to Discontinue|0
2296455|NCT02557100|3992389|FG000|Single Blind Treatment Period|Adverse Event|0
2296456|NCT02557100|3992390|FG001|Single Blind Treatment Period|Adverse Event|1
2296457|NCT02557100|3992391|FG002|Single Blind Treatment Period|Adverse Event|0
2296458|NCT02557100|3992389|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40
2296459|NCT02557100|3992390|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36
2296460|NCT02557100|3992391|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0
2296461|NCT02557100|3992389|FG000|Cumulative Abatacept Period|Other Reasons|0
2296462|NCT02557100|3992390|FG001|Cumulative Abatacept Period|Other Reasons|0
2296463|NCT02557100|3992391|FG002|Cumulative Abatacept Period|Other Reasons|1
2169034|NCT01310036|3789443|FG000|Overall Study|Adverse event or intercurrent illness|12
2169035|NCT01310075|3789449|FG000|Overall Study|Lost to Follow-up|1
2169036|NCT01310075|3789450|FG001|Overall Study|Lost to Follow-up|0
2169037|NCT01310075|3789449|FG000|Overall Study|Physician Decision|10
2169038|NCT01310075|3789450|FG001|Overall Study|Physician Decision|7
2169039|NCT01310075|3789449|FG000|Overall Study|Protocol Violation|2
2169040|NCT01310075|3789450|FG001|Overall Study|Protocol Violation|2
2169041|NCT01310075|3789449|FG000|Overall Study|Withdrawal by Subject|1
2169042|NCT01310075|3789450|FG001|Overall Study|Withdrawal by Subject|1
2169043|NCT01310127|3789458|FG000|Overall Study|Protocol Violation|1
2169044|NCT01310127|3789459|FG001|Overall Study|Protocol Violation|1
2169045|NCT01310127|3789458|FG000|Overall Study|advanced psc cataract outlier|1
2169046|NCT01310127|3789459|FG001|Overall Study|advanced psc cataract outlier|0
2169047|NCT01310413|3789500|FG000|Day 0 to Day 385|Withdrawal by Subject|5
2169048|NCT01310413|3789501|FG001|Day 0 to Day 385|Withdrawal by Subject|2
2169049|NCT01310413|3789502|FG002|Day 0 to Day 385|Withdrawal by Subject|0
2169050|NCT01310413|3789503|FG003|Day 0 to Day 385|Withdrawal by Subject|2
2169051|NCT01310413|3789504|FG004|Day 0 to Day 385|Withdrawal by Subject|1
2169052|NCT01310413|3789505|FG005|Day 0 to Day 385|Withdrawal by Subject|1
2169053|NCT01310413|3789506|FG006|Day 0 to Day 385|Withdrawal by Subject|0
2169054|NCT01310413|3789500|FG000|Day 0 to Day 385|Lost to Follow-up|18
2169055|NCT01310413|3789501|FG001|Day 0 to Day 385|Lost to Follow-up|3
2169056|NCT01310413|3789502|FG002|Day 0 to Day 385|Lost to Follow-up|3
2169057|NCT01310413|3789503|FG003|Day 0 to Day 385|Lost to Follow-up|5
2169058|NCT01310413|3789504|FG004|Day 0 to Day 385|Lost to Follow-up|1
2169059|NCT01310413|3789505|FG005|Day 0 to Day 385|Lost to Follow-up|2
2169060|NCT01310413|3789506|FG006|Day 0 to Day 385|Lost to Follow-up|0
2169061|NCT01310413|3789500|FG000|Day 0 to Day 385|Migrated/moved from study area|3
2169062|NCT01310413|3789501|FG001|Day 0 to Day 385|Migrated/moved from study area|3
2169063|NCT01310413|3789502|FG002|Day 0 to Day 385|Migrated/moved from study area|1
2169064|NCT01310413|3789503|FG003|Day 0 to Day 385|Migrated/moved from study area|1
2169065|NCT01310413|3789504|FG004|Day 0 to Day 385|Migrated/moved from study area|1
2169066|NCT01310413|3789505|FG005|Day 0 to Day 385|Migrated/moved from study area|0
2169067|NCT01310413|3789506|FG006|Day 0 to Day 385|Migrated/moved from study area|0
2169068|NCT01310413|3789500|FG000|Day 0 to Day 385|Other|1
2169069|NCT01310413|3789501|FG001|Day 0 to Day 385|Other|0
2169070|NCT01310413|3789502|FG002|Day 0 to Day 385|Other|3
2169071|NCT01310413|3789503|FG003|Day 0 to Day 385|Other|0
2169072|NCT01310413|3789504|FG004|Day 0 to Day 385|Other|0
2169073|NCT01310413|3789505|FG005|Day 0 to Day 385|Other|0
2169074|NCT01310413|3789506|FG006|Day 0 to Day 385|Other|0
2169075|NCT01310413|3789500|FG000|From Day U0 to Day U385|Withdrawal by Subject|0
2169076|NCT01310413|3789501|FG001|From Day U0 to Day U385|Withdrawal by Subject|0
2169077|NCT01310413|3789502|FG002|From Day U0 to Day U385|Withdrawal by Subject|0
2169078|NCT01310413|3789503|FG003|From Day U0 to Day U385|Withdrawal by Subject|0
2169079|NCT01310413|3789504|FG004|From Day U0 to Day U385|Withdrawal by Subject|0
2169080|NCT01310413|3789505|FG005|From Day U0 to Day U385|Withdrawal by Subject|0
2169081|NCT01310413|3789506|FG006|From Day U0 to Day U385|Withdrawal by Subject|1
2169082|NCT01310413|3789500|FG000|From Day U0 to Day U385|Lost to Follow-up|0
2169083|NCT01310413|3789501|FG001|From Day U0 to Day U385|Lost to Follow-up|0
2169084|NCT01310413|3789502|FG002|From Day U0 to Day U385|Lost to Follow-up|0
2169085|NCT01310413|3789503|FG003|From Day U0 to Day U385|Lost to Follow-up|0
2169086|NCT01310413|3789504|FG004|From Day U0 to Day U385|Lost to Follow-up|0
2169087|NCT01310413|3789505|FG005|From Day U0 to Day U385|Lost to Follow-up|0
2169088|NCT01310413|3789506|FG006|From Day U0 to Day U385|Lost to Follow-up|2
2169089|NCT01310699|3789546|FG000|Overall Study|Patients did not complete tandem.|4
2169090|NCT01310699|3789547|FG001|Overall Study|Patients did not complete tandem.|6
2169091|NCT01310777|3789558|FG000|Overall Study|Adverse Event|23
2169092|NCT01310777|3789559|FG001|Overall Study|Adverse Event|1
2169093|NCT01310777|3789560|FG002|Overall Study|Adverse Event|15
2169094|NCT01310777|3789558|FG000|Overall Study|Lost to Follow-up|0
2169095|NCT01310777|3789559|FG001|Overall Study|Lost to Follow-up|4
2169096|NCT01310777|3789560|FG002|Overall Study|Lost to Follow-up|1
2169097|NCT01310777|3789558|FG000|Overall Study|Patient's Decision Unrelated to AE|1
2169098|NCT01310777|3789559|FG001|Overall Study|Patient's Decision Unrelated to AE|1
2169099|NCT01310777|3789560|FG002|Overall Study|Patient's Decision Unrelated to AE|2
2169100|NCT01310777|3789558|FG000|Overall Study|Inadequate Control of IOP|5
2169101|NCT01310777|3789559|FG001|Overall Study|Inadequate Control of IOP|7
2169102|NCT01310777|3789560|FG002|Overall Study|Inadequate Control of IOP|10
2169103|NCT01310777|3789558|FG000|Overall Study|Other|4
2169104|NCT01310777|3789559|FG001|Overall Study|Other|1
2169105|NCT01310777|3789560|FG002|Overall Study|Other|2
2169106|NCT01310868|3789577|FG000|Overall Study|Do not have histologically confirmed GBM|13
2169107|NCT01311024|3789583|FG000|Overall Study|Protocol Violation|35
2169108|NCT01311024|3789584|FG001|Overall Study|Protocol Violation|22
2169109|NCT01311505|3789610|FG000|First Intervention Period|Protocol Violation|0
2169110|NCT01311505|3789611|FG001|First Intervention Period|Protocol Violation|1
2169111|NCT01311557|3789622|FG000|Overall Study|Serious adverse event|0
2169112|NCT01311557|3789623|FG001|Overall Study|Serious adverse event|1
2169113|NCT01311557|3789622|FG000|Overall Study|Protocol Violation|4
2169114|NCT01311557|3789623|FG001|Overall Study|Protocol Violation|2
2169115|NCT01311557|3789622|FG000|Overall Study|Lost to Follow-up|0
2169116|NCT01311557|3789623|FG001|Overall Study|Lost to Follow-up|1
2169117|NCT01311557|3789622|FG000|Overall Study|Withdrawal by Subject|1
2169118|NCT01311557|3789623|FG001|Overall Study|Withdrawal by Subject|2
2169119|NCT01311648|3789632|FG000|Main Study|Protocol Violation|0
2169120|NCT01311648|3789633|FG001|Main Study|Protocol Violation|1
2169121|NCT01311648|3789632|FG000|Main Study|Adverse Event|0
2169122|NCT01311648|3789633|FG001|Main Study|Adverse Event|1
2169123|NCT01311648|3789632|FG000|Main Study|Inhibitor management|0
2169124|NCT01311648|3789633|FG001|Main Study|Inhibitor management|17
2169125|NCT01311648|3789632|FG000|Main Study|Withdrawal by Subject|0
2169126|NCT01311648|3789633|FG001|Main Study|Withdrawal by Subject|2
2169127|NCT01311648|3789632|FG000|Extension Study|Physician Decision|0
2169128|NCT01311648|3789633|FG001|Extension Study|Physician Decision|1
2169129|NCT01311648|3789632|FG000|Extension Study|ITI therapy with marketed product|0
2169130|NCT01311648|3789633|FG001|Extension Study|ITI therapy with marketed product|1
2169131|NCT01311648|3789632|FG000|Extension Study|Incorrect visit planning|0
2169132|NCT01311648|3789633|FG001|Extension Study|Incorrect visit planning|1
2169133|NCT01311648|3789632|FG000|Extension Study|Family's decision|0
2169134|NCT01311648|3789633|FG001|Extension Study|Family's decision|1
2169135|NCT01311648|3789632|FG000|Extension Study|Failure of ITI therapy|0
2169136|NCT01311648|3789633|FG001|Extension Study|Failure of ITI therapy|3
2169137|NCT01311648|3789632|FG000|Extension Study|Long travel|0
2169138|NCT01311648|3789633|FG001|Extension Study|Long travel|1
2169139|NCT01311648|3789632|FG000|Extension Study|Diagnosed with von Willebrand disease|1
2169140|NCT01311648|3789633|FG001|Extension Study|Diagnosed with von Willebrand disease|0
2169141|NCT01311648|3789632|FG000|Extension Study|Withdrawal by Subject|0
2169142|NCT01311648|3789633|FG001|Extension Study|Withdrawal by Subject|1
2169143|NCT01311648|3789632|FG000|Extension Study|Inhibitor management|0
2169144|NCT01311648|3789633|FG001|Extension Study|Inhibitor management|2
2169145|NCT01311661|3789646|FG000|Overall Study|Adverse Event|2
2169146|NCT01311661|3789646|FG000|Overall Study|Protocol Violation|3
2169147|NCT01311661|3789646|FG000|Overall Study|Withdrawal by Subject|2
2169148|NCT01312129|3789700|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0
2169149|NCT01312129|3789701|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1
2169150|NCT01312467|3789755|FG000|Overall Study|Adverse Event|4
2169151|NCT01312467|3789755|FG000|Overall Study|Lost to Follow-up|1
2169152|NCT01312467|3789755|FG000|Overall Study|Withdrawal by Subject|2
2169153|NCT01312467|3789755|FG000|Overall Study|Deported to country of origin|1
2169154|NCT01312467|3789755|FG000|Overall Study|Another medical condition|1
2169155|NCT01312467|3789755|FG000|Overall Study|Ineligible|4
2169156|NCT01312779|3789787|FG000|Overall Study|Withdrawal by Subject|2
2169157|NCT01312779|3789787|FG000|Overall Study|Death|3
2169158|NCT01312779|3789787|FG000|Overall Study|Not Implanted with Device|27
2169159|NCT01312909|3789827|FG000|Overall Study|Randomized but not treated|1
2169160|NCT01312909|3789828|FG001|Overall Study|Randomized but not treated|3
2169161|NCT01312909|3789829|FG002|Overall Study|Randomized but not treated|1
2296464|NCT02557100|3992389|FG000|Cumulative Abatacept Period|Lost to Follow-up|0
2296465|NCT02557100|3992390|FG001|Cumulative Abatacept Period|Lost to Follow-up|0
2296466|NCT02557100|3992391|FG002|Cumulative Abatacept Period|Lost to Follow-up|2
2296467|NCT02557100|3992389|FG000|Cumulative Abatacept Period|Request to Discontinue|0
2296468|NCT02557100|3992390|FG001|Cumulative Abatacept Period|Request to Discontinue|0
2296469|NCT02557100|3992391|FG002|Cumulative Abatacept Period|Request to Discontinue|1
2296470|NCT02557399|3992410|FG000|Overall Study|Adverse Event|6
2296471|NCT02557399|3992411|FG001|Overall Study|Adverse Event|5
2296472|NCT02557399|3992410|FG000|Overall Study|Protocol Violation|0
2296473|NCT02557399|3992411|FG001|Overall Study|Protocol Violation|1
2296474|NCT02557399|3992410|FG000|Overall Study|Protocol-defined stopping criteria|0
2296475|NCT02557399|3992411|FG001|Overall Study|Protocol-defined stopping criteria|1
2296476|NCT02557399|3992410|FG000|Overall Study|Withdrawal by Subject|1
2296477|NCT02557399|3992411|FG001|Overall Study|Withdrawal by Subject|1
2296478|NCT02557516|3992424|FG000|Overall Study|Adverse Event|1
2296479|NCT02557516|3992425|FG001|Overall Study|Adverse Event|0
2296480|NCT02557516|3992426|FG002|Overall Study|Adverse Event|2
2296481|NCT02557516|3992427|FG003|Overall Study|Adverse Event|1
2296482|NCT02557516|3992424|FG000|Overall Study|Disease progression|0
2296483|NCT02557516|3992425|FG001|Overall Study|Disease progression|2
2296484|NCT02557516|3992426|FG002|Overall Study|Disease progression|0
2296485|NCT02557516|3992427|FG003|Overall Study|Disease progression|0
2296486|NCT02557516|3992424|FG000|Overall Study|Physician Decision|0
2296487|NCT02557516|3992425|FG001|Overall Study|Physician Decision|2
2296488|NCT02557516|3992426|FG002|Overall Study|Physician Decision|0
2296489|NCT02557516|3992427|FG003|Overall Study|Physician Decision|0
2169162|NCT01312909|3789827|FG000|Overall Study|Adverse Event|1
2169163|NCT01312909|3789828|FG001|Overall Study|Adverse Event|0
2169164|NCT01312909|3789829|FG002|Overall Study|Adverse Event|3
2169165|NCT01312909|3789827|FG000|Overall Study|Protocol Violation|2
2169166|NCT01312909|3789828|FG001|Overall Study|Protocol Violation|0
2169167|NCT01312909|3789829|FG002|Overall Study|Protocol Violation|2
2169168|NCT01312909|3789827|FG000|Overall Study|Other|9
2169169|NCT01312909|3789828|FG001|Overall Study|Other|6
2169170|NCT01312909|3789829|FG002|Overall Study|Other|11
2169171|NCT01312909|3789827|FG000|Overall Study|Withdrawal by Subject|8
2169172|NCT01312909|3789828|FG001|Overall Study|Withdrawal by Subject|10
2296490|NCT02557516|3992424|FG000|Overall Study|Sponsor decision|0
2169173|NCT01312909|3789829|FG002|Overall Study|Withdrawal by Subject|7
2169174|NCT01312909|3789827|FG000|Overall Study|Lost to Follow-up|21
2169175|NCT01312909|3789828|FG001|Overall Study|Lost to Follow-up|17
2169176|NCT01312909|3789829|FG002|Overall Study|Lost to Follow-up|20
2169177|NCT01312909|3789827|FG000|Overall Study|Insufficient clinical response|0
2169178|NCT01312909|3789828|FG001|Overall Study|Insufficient clinical response|0
2169179|NCT01312909|3789829|FG002|Overall Study|Insufficient clinical response|1
2169180|NCT01312909|3789827|FG000|Overall Study|Entrance criteria not met|0
2169181|NCT01312909|3789828|FG001|Overall Study|Entrance criteria not met|0
2169182|NCT01312909|3789829|FG002|Overall Study|Entrance criteria not met|2
2169183|NCT01312961|3789846|FG000|Overall Study|Adverse Event|3
2169184|NCT01312961|3789847|FG001|Overall Study|Adverse Event|3
2169185|NCT01312961|3789846|FG000|Overall Study|Lack of Efficacy|11
2169186|NCT01312961|3789847|FG001|Overall Study|Lack of Efficacy|1
2169187|NCT01312961|3789846|FG000|Overall Study|Poor compliance to protocol|1
2169188|NCT01312961|3789847|FG001|Overall Study|Poor compliance to protocol|0
2169189|NCT01312961|3789846|FG000|Overall Study|Other than specified above|2
2169190|NCT01312961|3789847|FG001|Overall Study|Other than specified above|3
2169191|NCT01313039|3789854|FG000|Overall Study|Physician Decision|1
2169192|NCT01313039|3789854|FG000|Overall Study|Adverse Event|1
2169193|NCT01313078|3789858|FG000|Overall Study|Death|1
2169194|NCT01313078|3789858|FG000|Overall Study|Discontinued study drug|1
2169195|NCT01313078|3789858|FG000|Overall Study|Withdrawal by Subject|1
2169196|NCT01313117|3789862|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
2169197|NCT01313117|3789862|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
2169198|NCT01313182|3789869|FG000|Overall Study|Protocol Violation|66
2169199|NCT01313182|3789870|FG001|Overall Study|Protocol Violation|92
2169200|NCT01313208|3789878|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
2169201|NCT01313208|3789879|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
2169202|NCT01313208|3789878|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
2169203|NCT01313208|3789879|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
2169204|NCT01313208|3789878|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
2169205|NCT01313208|3789879|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
2169206|NCT01313208|3789878|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
2169207|NCT01313208|3789879|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
2169208|NCT01313208|3789878|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
2169209|NCT01313208|3789879|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
2169210|NCT01313208|3789878|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
2169211|NCT01313208|3789879|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
2169212|NCT01313208|3789878|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
2169213|NCT01313208|3789879|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
2169214|NCT01313208|3789878|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
2169215|NCT01313208|3789879|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
2169216|NCT01313208|3789878|FG000|Open-label Phase (Weeks 13 - 24)|Other|2
2169217|NCT01313208|3789879|FG001|Open-label Phase (Weeks 13 - 24)|Other|0
2169218|NCT01313221|3789890|FG000|Overall Study|Protocol Violation|0
2169219|NCT01313221|3789891|FG001|Overall Study|Protocol Violation|1
2169220|NCT01313221|3789892|FG002|Overall Study|Protocol Violation|1
2169221|NCT01313221|3789890|FG000|Overall Study|Non-compliance|3
2169222|NCT01313221|3789891|FG001|Overall Study|Non-compliance|0
2169223|NCT01313221|3789892|FG002|Overall Study|Non-compliance|2
2169224|NCT01313221|3789890|FG000|Overall Study|Withdrawal by Subject|2
2169225|NCT01313221|3789891|FG001|Overall Study|Withdrawal by Subject|3
2169226|NCT01313221|3789892|FG002|Overall Study|Withdrawal by Subject|5
2169227|NCT01313221|3789890|FG000|Overall Study|Requirement for alternative therapy|0
2169228|NCT01313221|3789891|FG001|Overall Study|Requirement for alternative therapy|1
2169229|NCT01313221|3789892|FG002|Overall Study|Requirement for alternative therapy|1
2169230|NCT01313221|3789890|FG000|Overall Study|Lost to Follow-up|6
2169231|NCT01313221|3789891|FG001|Overall Study|Lost to Follow-up|3
2169232|NCT01313221|3789892|FG002|Overall Study|Lost to Follow-up|1
2169233|NCT01313221|3789890|FG000|Overall Study|Other|1
2169234|NCT01313221|3789891|FG001|Overall Study|Other|0
2169235|NCT01313221|3789892|FG002|Overall Study|Other|0
2169236|NCT01313221|3789890|FG000|Overall Study|Adverse Event|0
2169237|NCT01313221|3789891|FG001|Overall Study|Adverse Event|0
2169238|NCT01313221|3789892|FG002|Overall Study|Adverse Event|7
2169239|NCT01313221|3789890|FG000|Overall Study|Disease progression|0
2169240|NCT01313221|3789891|FG001|Overall Study|Disease progression|0
2169241|NCT01313221|3789892|FG002|Overall Study|Disease progression|2
2169242|NCT01313221|3789890|FG000|Overall Study|Physician Decision|0
2169243|NCT01313221|3789891|FG001|Overall Study|Physician Decision|0
2169244|NCT01313221|3789892|FG002|Overall Study|Physician Decision|2
2169245|NCT01313221|3789890|FG000|Overall Study|Pregnancy|0
2169246|NCT01313221|3789891|FG001|Overall Study|Pregnancy|0
2169247|NCT01313221|3789892|FG002|Overall Study|Pregnancy|2
2169248|NCT01313286|3789900|FG000|Period 1|Withdrawal by Subject|2
2169249|NCT01313286|3789901|FG001|Period 1|Withdrawal by Subject|0
2169250|NCT01313299|3789910|FG000|Overall Study|Adverse Event|3
2169251|NCT01313299|3789911|FG001|Overall Study|Adverse Event|1
2169252|NCT01313299|3789912|FG002|Overall Study|Adverse Event|1
2169253|NCT01313299|3789910|FG000|Overall Study|Lost to Follow-up|1
2169254|NCT01313299|3789911|FG001|Overall Study|Lost to Follow-up|0
2169255|NCT01313299|3789912|FG002|Overall Study|Lost to Follow-up|0
2169256|NCT01313299|3789910|FG000|Overall Study|Protocol Violation|2
2169257|NCT01313299|3789911|FG001|Overall Study|Protocol Violation|0
2169258|NCT01313299|3789912|FG002|Overall Study|Protocol Violation|0
2169259|NCT01313299|3789910|FG000|Overall Study|Withdrawal by Subject|1
2169260|NCT01313299|3789911|FG001|Overall Study|Withdrawal by Subject|0
2169261|NCT01313299|3789912|FG002|Overall Study|Withdrawal by Subject|2
2169262|NCT01313299|3789910|FG000|Overall Study|Family reason and moved out of state|0
2169263|NCT01313299|3789911|FG001|Overall Study|Family reason and moved out of state|2
2169264|NCT01313299|3789912|FG002|Overall Study|Family reason and moved out of state|0
2169265|NCT01313299|3789910|FG000|Overall Study|Lack of subject compliance|0
2169266|NCT01313299|3789911|FG001|Overall Study|Lack of subject compliance|0
2169267|NCT01313299|3789912|FG002|Overall Study|Lack of subject compliance|1
2169268|NCT01313312|3789920|FG000|Overall Study|Adverse Event|5
2169269|NCT01313312|3789920|FG000|Overall Study|Withdrawal by Subject|18
2169270|NCT01313312|3789920|FG000|Overall Study|Lack of Efficacy|3
2169271|NCT01313312|3789920|FG000|Overall Study|Investigator Decision|1
2169272|NCT01313312|3789920|FG000|Overall Study|Observational Phase|1
2169273|NCT01313312|3789920|FG000|Overall Study|Subject Withdrawn Early in Error|4
2169274|NCT01313312|3789920|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4
2169275|NCT01313559|3789950|FG000|Overall Study|Withdrawal by Subject|1
2169276|NCT01313559|3789951|FG001|Overall Study|Withdrawal by Subject|2
2169277|NCT01313559|3789950|FG000|Overall Study|Disease progression|1
2169278|NCT01313559|3789951|FG001|Overall Study|Disease progression|0
2169279|NCT01313559|3789950|FG000|Overall Study|Rising PSA|2
2169280|NCT01313559|3789951|FG001|Overall Study|Rising PSA|0
2169281|NCT01313624|3789959|FG000|Double-Blind Phase|Adverse Event|27
2169282|NCT01313624|3789960|FG001|Double-Blind Phase|Adverse Event|4
2169283|NCT01313624|3789959|FG000|Double-Blind Phase|Withdrawal by Subject|9
2169284|NCT01313624|3789960|FG001|Double-Blind Phase|Withdrawal by Subject|4
2169285|NCT01313624|3789959|FG000|Double-Blind Phase|Lost to Follow-up|0
2169286|NCT01313624|3789960|FG001|Double-Blind Phase|Lost to Follow-up|2
2169287|NCT01313624|3789959|FG000|Double-Blind Phase|Physician Decision|1
2169288|NCT01313624|3789960|FG001|Double-Blind Phase|Physician Decision|0
2169289|NCT01313624|3789959|FG000|Double-Blind Phase|Lack of Efficacy|1
2169290|NCT01313624|3789960|FG001|Double-Blind Phase|Lack of Efficacy|0
2169291|NCT01313624|3789959|FG000|Open-Label Phase|Adverse Event|1
2169292|NCT01313624|3789960|FG001|Open-Label Phase|Adverse Event|10
2169293|NCT01313624|3789959|FG000|Open-Label Phase|Withdrawal by Subject|2
2169294|NCT01313624|3789960|FG001|Open-Label Phase|Withdrawal by Subject|2
2169295|NCT01313624|3789959|FG000|Open-Label Phase|Lost to Follow-up|1
2169296|NCT01313624|3789960|FG001|Open-Label Phase|Lost to Follow-up|1
2169297|NCT01313637|3789972|FG000|Overall Study|Adverse Event|17
2169298|NCT01313637|3789973|FG001|Overall Study|Adverse Event|24
2169299|NCT01313637|3789974|FG002|Overall Study|Adverse Event|25
2169300|NCT01313637|3789975|FG003|Overall Study|Adverse Event|18
2169301|NCT01313637|3789972|FG000|Overall Study|Lack of Efficacy|44
2169302|NCT01313637|3789973|FG001|Overall Study|Lack of Efficacy|38
2169303|NCT01313637|3789974|FG002|Overall Study|Lack of Efficacy|37
2169304|NCT01313637|3789975|FG003|Overall Study|Lack of Efficacy|24
2169305|NCT01313637|3789972|FG000|Overall Study|Protocol Violation|4
2169306|NCT01313637|3789973|FG001|Overall Study|Protocol Violation|3
2169307|NCT01313637|3789974|FG002|Overall Study|Protocol Violation|11
2169308|NCT01313637|3789975|FG003|Overall Study|Protocol Violation|5
2169309|NCT01313637|3789972|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16
2169310|NCT01313637|3789973|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15
2169311|NCT01313637|3789974|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14
2169312|NCT01313637|3789975|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13
2169313|NCT01313637|3789972|FG000|Overall Study|Lost to Follow-up|0
2169314|NCT01313637|3789973|FG001|Overall Study|Lost to Follow-up|2
2169315|NCT01313637|3789974|FG002|Overall Study|Lost to Follow-up|1
2169316|NCT01313637|3789975|FG003|Overall Study|Lost to Follow-up|3
2169317|NCT01313637|3789972|FG000|Overall Study|Withdrawal by Subject|11
2169318|NCT01313637|3789973|FG001|Overall Study|Withdrawal by Subject|13
2169319|NCT01313637|3789974|FG002|Overall Study|Withdrawal by Subject|18
2169320|NCT01313637|3789975|FG003|Overall Study|Withdrawal by Subject|15
2169321|NCT01313650|3789989|FG000|Overall Study|Adverse Event|9
2169322|NCT01313650|3789990|FG001|Overall Study|Adverse Event|34
2169323|NCT01313650|3789991|FG002|Overall Study|Adverse Event|24
2169324|NCT01313650|3789992|FG003|Overall Study|Adverse Event|23
2169325|NCT01313650|3789989|FG000|Overall Study|Lack of Efficacy|37
2169326|NCT01313650|3789990|FG001|Overall Study|Lack of Efficacy|20
2169327|NCT01313650|3789991|FG002|Overall Study|Lack of Efficacy|32
2169328|NCT01313650|3789992|FG003|Overall Study|Lack of Efficacy|20
2169329|NCT01313650|3789989|FG000|Overall Study|Lost to Follow-up|1
2169330|NCT01313650|3789990|FG001|Overall Study|Lost to Follow-up|0
2169331|NCT01313650|3789991|FG002|Overall Study|Lost to Follow-up|3
2169332|NCT01313650|3789992|FG003|Overall Study|Lost to Follow-up|2
2169333|NCT01313650|3789989|FG000|Overall Study|Withdrawal by Subject|16
2169334|NCT01313650|3789990|FG001|Overall Study|Withdrawal by Subject|20
2169335|NCT01313650|3789991|FG002|Overall Study|Withdrawal by Subject|15
2169336|NCT01313650|3789992|FG003|Overall Study|Withdrawal by Subject|15
2169337|NCT01313650|3789989|FG000|Overall Study|Protocol Violation|4
2169338|NCT01313650|3789990|FG001|Overall Study|Protocol Violation|7
2169339|NCT01313650|3789991|FG002|Overall Study|Protocol Violation|5
2169340|NCT01313650|3789992|FG003|Overall Study|Protocol Violation|6
2169341|NCT01313650|3789989|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9
2169342|NCT01313650|3789990|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13
2169343|NCT01313650|3789991|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24
2169344|NCT01313650|3789992|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15
2169345|NCT01313663|3790004|FG000|Overall Study|Study Closed/Terminated|2
2169346|NCT01313663|3790005|FG001|Overall Study|Study Closed/Terminated|4
2169347|NCT01313663|3790004|FG000|Overall Study|Lost to Follow-up|0
2169348|NCT01313663|3790005|FG001|Overall Study|Lost to Follow-up|1
2169349|NCT01313663|3790004|FG000|Overall Study|Physician Decision|0
2169350|NCT01313663|3790005|FG001|Overall Study|Physician Decision|2
2169351|NCT01313663|3790004|FG000|Overall Study|Withdrawal by Subject|2
2169352|NCT01313663|3790005|FG001|Overall Study|Withdrawal by Subject|1
2169353|NCT01313676|3790015|FG000|Overall Study|Adverse Event|395
2169354|NCT01313676|3790016|FG001|Overall Study|Adverse Event|365
2169355|NCT01313676|3790017|FG002|Overall Study|Adverse Event|372
2169356|NCT01313676|3790018|FG003|Overall Study|Adverse Event|333
2169357|NCT01313676|3790015|FG000|Overall Study|Lack of Efficacy|98
2169358|NCT01313676|3790016|FG001|Overall Study|Lack of Efficacy|90
2169359|NCT01313676|3790017|FG002|Overall Study|Lack of Efficacy|65
2169360|NCT01313676|3790018|FG003|Overall Study|Lack of Efficacy|46
2169361|NCT01313676|3790015|FG000|Overall Study|Protocol Violation|37
2169362|NCT01313676|3790016|FG001|Overall Study|Protocol Violation|44
2169363|NCT01313676|3790017|FG002|Overall Study|Protocol Violation|46
2169364|NCT01313676|3790018|FG003|Overall Study|Protocol Violation|44
2169365|NCT01313676|3790015|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3
2169366|NCT01313676|3790016|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4
2169367|NCT01313676|3790017|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2
2169368|NCT01313676|3790018|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11
2169369|NCT01313676|3790015|FG000|Overall Study|Study Closed/terminated|7
2169370|NCT01313676|3790016|FG001|Overall Study|Study Closed/terminated|6
2169371|NCT01313676|3790017|FG002|Overall Study|Study Closed/terminated|9
2169372|NCT01313676|3790018|FG003|Overall Study|Study Closed/terminated|9
2169373|NCT01313676|3790015|FG000|Overall Study|Lost to Follow-up|0
2169374|NCT01313676|3790016|FG001|Overall Study|Lost to Follow-up|0
2169375|NCT01313676|3790017|FG002|Overall Study|Lost to Follow-up|1
2169376|NCT01313676|3790018|FG003|Overall Study|Lost to Follow-up|0
2169377|NCT01313676|3790015|FG000|Overall Study|Physician Decision|53
2169378|NCT01313676|3790016|FG001|Overall Study|Physician Decision|64
2169379|NCT01313676|3790017|FG002|Overall Study|Physician Decision|62
2169380|NCT01313676|3790018|FG003|Overall Study|Physician Decision|48
2169381|NCT01313676|3790015|FG000|Overall Study|Decision by Participant or Proxy|643
2169382|NCT01313676|3790016|FG001|Overall Study|Decision by Participant or Proxy|527
2169383|NCT01313676|3790017|FG002|Overall Study|Decision by Participant or Proxy|515
2169384|NCT01313676|3790018|FG003|Overall Study|Decision by Participant or Proxy|492
2169385|NCT01313676|3790015|FG000|Overall Study|Sponsor Terminated Study Treatment|1
2169386|NCT01313676|3790016|FG001|Overall Study|Sponsor Terminated Study Treatment|1
2169387|NCT01313676|3790017|FG002|Overall Study|Sponsor Terminated Study Treatment|0
2169388|NCT01313676|3790018|FG003|Overall Study|Sponsor Terminated Study Treatment|1
2169389|NCT01313676|3790015|FG000|Overall Study|Investigator Site Closed|12
2169390|NCT01313676|3790016|FG001|Overall Study|Investigator Site Closed|11
2169391|NCT01313676|3790017|FG002|Overall Study|Investigator Site Closed|15
2169392|NCT01313676|3790018|FG003|Overall Study|Investigator Site Closed|10
2169393|NCT01313676|3790015|FG000|Overall Study|Missing|1
2169394|NCT01313676|3790016|FG001|Overall Study|Missing|1
2169395|NCT01313676|3790017|FG002|Overall Study|Missing|1
2169396|NCT01313676|3790018|FG003|Overall Study|Missing|0
2169397|NCT01313728|3790029|FG000|Informed Consent to Baseline|Withdrawal by Subject|1
2169398|NCT01313767|3790036|FG000|Overall Study|Adverse Event|1
2169399|NCT01313767|3790037|FG001|Overall Study|Adverse Event|0
2169400|NCT01313767|3790036|FG000|Overall Study|Lost to Follow-up|1
2169401|NCT01313767|3790037|FG001|Overall Study|Lost to Follow-up|0
2169402|NCT01313767|3790036|FG000|Overall Study|Withdrawal by Subject|2
2169403|NCT01313767|3790037|FG001|Overall Study|Withdrawal by Subject|1
2169404|NCT01313767|3790036|FG000|Overall Study|Protocol Violation|3
2169405|NCT01313767|3790037|FG001|Overall Study|Protocol Violation|1
2169406|NCT01313780|3790045|FG000|Overall Study|Lack of Efficacy|4
2169407|NCT01313780|3790046|FG001|Overall Study|Lack of Efficacy|2
2169408|NCT01313780|3790045|FG000|Overall Study|Adverse Event|6
2169409|NCT01313780|3790046|FG001|Overall Study|Adverse Event|11
2169410|NCT01313780|3790045|FG000|Overall Study|Withdrawal by Subject|2
2169411|NCT01313780|3790046|FG001|Overall Study|Withdrawal by Subject|8
2169412|NCT01313780|3790045|FG000|Overall Study|Protocol Violation|10
2169413|NCT01313780|3790046|FG001|Overall Study|Protocol Violation|4
2169414|NCT01313780|3790045|FG000|Overall Study|missing data|3
2169415|NCT01313780|3790046|FG001|Overall Study|missing data|3
2169416|NCT01313858|3790055|FG000|Overall Study|Premature Treatment Termination|251
2169417|NCT01313858|3790056|FG001|Overall Study|Premature Treatment Termination|219
2169418|NCT01313858|3790057|FG002|Overall Study|Premature Treatment Termination|191
2169419|NCT01313858|3790055|FG000|Overall Study|Lost to Follow-up|35
2169420|NCT01313858|3790056|FG001|Overall Study|Lost to Follow-up|51
2169421|NCT01313858|3790057|FG002|Overall Study|Lost to Follow-up|47
2169422|NCT01313884|3790063|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
2169423|NCT01314105|3790118|FG000|Overall Study|Progressive Disease|6
2169424|NCT01314105|3790119|FG001|Overall Study|Progressive Disease|10
2169425|NCT01314105|3790118|FG000|Overall Study|Refused to continue taking medication|0
2169426|NCT01314105|3790119|FG001|Overall Study|Refused to continue taking medication|1
2169427|NCT01314105|3790118|FG000|Overall Study|Other Adverse Event|1
2169428|NCT01314105|3790119|FG001|Overall Study|Other Adverse Event|1
2169429|NCT01314261|3790131|FG000|Overall Study|Adverse Event|1
2169430|NCT01314261|3790132|FG001|Overall Study|Adverse Event|0
2169431|NCT01314261|3790133|FG002|Overall Study|Adverse Event|0
2169432|NCT01314261|3790134|FG003|Overall Study|Adverse Event|0
2169433|NCT01314261|3790131|FG000|Overall Study|Withdrawal by Subject|0
2169434|NCT01314261|3790132|FG001|Overall Study|Withdrawal by Subject|3
2169435|NCT01314261|3790133|FG002|Overall Study|Withdrawal by Subject|1
2169436|NCT01314261|3790134|FG003|Overall Study|Withdrawal by Subject|0
2169437|NCT01314261|3790131|FG000|Overall Study|Lost to Follow-up|1
2169438|NCT01314261|3790132|FG001|Overall Study|Lost to Follow-up|0
2169439|NCT01314261|3790133|FG002|Overall Study|Lost to Follow-up|2
2169440|NCT01314261|3790134|FG003|Overall Study|Lost to Follow-up|2
2169441|NCT01314261|3790131|FG000|Overall Study|Virologic Failure|0
2169442|NCT01314261|3790132|FG001|Overall Study|Virologic Failure|1
2169443|NCT01314261|3790133|FG002|Overall Study|Virologic Failure|0
2169444|NCT01314261|3790134|FG003|Overall Study|Virologic Failure|1
2169445|NCT01314443|3790163|FG000|Overall Study|Withdrawal by Subject|2
2169446|NCT01314443|3790164|FG001|Overall Study|Withdrawal by Subject|1
2169447|NCT01314443|3790165|FG002|Overall Study|Withdrawal by Subject|1
2169448|NCT01314443|3790166|FG003|Overall Study|Withdrawal by Subject|1
2169449|NCT01314443|3790163|FG000|Overall Study|Protocol Violation|2
2169450|NCT01314443|3790164|FG001|Overall Study|Protocol Violation|2
2169451|NCT01314443|3790165|FG002|Overall Study|Protocol Violation|1
2169452|NCT01314443|3790166|FG003|Overall Study|Protocol Violation|1
2169453|NCT01314703|3790176|FG000|Overall Study|screen failure and closed enrollment|8
2169454|NCT01314716|3790183|FG000|Double-Blind Phase|Randomized but not treated|1
2169455|NCT01314716|3790184|FG001|Double-Blind Phase|Randomized but not treated|1
2169456|NCT01314716|3790183|FG000|Double-Blind Phase|Adverse Event|10
2169457|NCT01314716|3790184|FG001|Double-Blind Phase|Adverse Event|4
2169458|NCT01314716|3790183|FG000|Double-Blind Phase|Withdrawal by Subject|5
2169459|NCT01314716|3790184|FG001|Double-Blind Phase|Withdrawal by Subject|6
2169460|NCT01314716|3790183|FG000|Double-Blind Phase|Lost to Follow-up|0
2169461|NCT01314716|3790184|FG001|Double-Blind Phase|Lost to Follow-up|1
2169462|NCT01314716|3790183|FG000|Double-Blind Phase|Sponsor request|1
2169463|NCT01314716|3790184|FG001|Double-Blind Phase|Sponsor request|2
2169464|NCT01314716|3790183|FG000|Double-Blind Phase|Physician Decision|0
2169465|NCT01314716|3790184|FG001|Double-Blind Phase|Physician Decision|1
2169466|NCT01314716|3790183|FG000|Open-Label Phase|Adverse Event|4
2169467|NCT01314716|3790184|FG001|Open-Label Phase|Adverse Event|6
2169468|NCT01314716|3790183|FG000|Open-Label Phase|Withdrawal by Subject|1
2169469|NCT01314716|3790184|FG001|Open-Label Phase|Withdrawal by Subject|2
2169470|NCT01314716|3790183|FG000|Open-Label Phase|Physician Decision|5
2169471|NCT01314716|3790184|FG001|Open-Label Phase|Physician Decision|4
2169472|NCT01314872|3790214|FG000|Treatment Period 1|Protocol Violation|2
2169473|NCT01314872|3790215|FG001|Treatment Period 1|Protocol Violation|1
2169474|NCT01314872|3790216|FG002|Treatment Period 1|Protocol Violation|1
2169475|NCT01314872|3790217|FG003|Treatment Period 1|Protocol Violation|0
2169476|NCT01314872|3790218|FG004|Treatment Period 1|Protocol Violation|1
2169477|NCT01314872|3790219|FG005|Treatment Period 1|Protocol Violation|0
2169478|NCT01314872|3790220|FG006|Treatment Period 1|Protocol Violation|0
2169479|NCT01314872|3790221|FG007|Treatment Period 1|Protocol Violation|0
2169480|NCT01314872|3790222|FG008|Treatment Period 1|Protocol Violation|0
2169481|NCT01314872|3790223|FG009|Treatment Period 1|Protocol Violation|1
2169482|NCT01314872|3790224|FG010|Treatment Period 1|Protocol Violation|1
2169483|NCT01314872|3790225|FG011|Treatment Period 1|Protocol Violation|0
2169484|NCT01314872|3790226|FG012|Treatment Period 1|Protocol Violation|0
2169485|NCT01314872|3790227|FG013|Treatment Period 1|Protocol Violation|0
2169486|NCT01314872|3790228|FG014|Treatment Period 1|Protocol Violation|0
2169487|NCT01314872|3790214|FG000|Treatment Period 1|Physician Decision|0
2169488|NCT01314872|3790215|FG001|Treatment Period 1|Physician Decision|1
2169489|NCT01314872|3790216|FG002|Treatment Period 1|Physician Decision|0
2169490|NCT01314872|3790217|FG003|Treatment Period 1|Physician Decision|1
2169491|NCT01314872|3790218|FG004|Treatment Period 1|Physician Decision|0
2169492|NCT01314872|3790219|FG005|Treatment Period 1|Physician Decision|0
2169493|NCT01314872|3790220|FG006|Treatment Period 1|Physician Decision|0
2169494|NCT01314872|3790221|FG007|Treatment Period 1|Physician Decision|0
2169495|NCT01314872|3790222|FG008|Treatment Period 1|Physician Decision|0
2169496|NCT01314872|3790223|FG009|Treatment Period 1|Physician Decision|1
2169497|NCT01314872|3790224|FG010|Treatment Period 1|Physician Decision|0
2169498|NCT01314872|3790225|FG011|Treatment Period 1|Physician Decision|0
2169499|NCT01314872|3790226|FG012|Treatment Period 1|Physician Decision|0
2169500|NCT01314872|3790227|FG013|Treatment Period 1|Physician Decision|0
2169501|NCT01314872|3790228|FG014|Treatment Period 1|Physician Decision|0
2169502|NCT01314872|3790214|FG000|Treatment Period 1|Lack of Efficacy|1
2169503|NCT01314872|3790215|FG001|Treatment Period 1|Lack of Efficacy|0
2169504|NCT01314872|3790216|FG002|Treatment Period 1|Lack of Efficacy|0
2169505|NCT01314872|3790217|FG003|Treatment Period 1|Lack of Efficacy|0
2169506|NCT01314872|3790218|FG004|Treatment Period 1|Lack of Efficacy|0
2169507|NCT01314872|3790219|FG005|Treatment Period 1|Lack of Efficacy|1
2169508|NCT01314872|3790220|FG006|Treatment Period 1|Lack of Efficacy|0
2169509|NCT01314872|3790221|FG007|Treatment Period 1|Lack of Efficacy|2
2169510|NCT01314872|3790222|FG008|Treatment Period 1|Lack of Efficacy|0
2169511|NCT01314872|3790223|FG009|Treatment Period 1|Lack of Efficacy|0
2169512|NCT01314872|3790224|FG010|Treatment Period 1|Lack of Efficacy|0
2169513|NCT01314872|3790225|FG011|Treatment Period 1|Lack of Efficacy|0
2169514|NCT01314872|3790226|FG012|Treatment Period 1|Lack of Efficacy|0
2169515|NCT01314872|3790227|FG013|Treatment Period 1|Lack of Efficacy|0
2169516|NCT01314872|3790228|FG014|Treatment Period 1|Lack of Efficacy|0
2169517|NCT01314872|3790214|FG000|Treatment Period 1|Adverse event, non-fatal|4
2169518|NCT01314872|3790215|FG001|Treatment Period 1|Adverse event, non-fatal|2
2169519|NCT01314872|3790216|FG002|Treatment Period 1|Adverse event, non-fatal|3
2169520|NCT01314872|3790217|FG003|Treatment Period 1|Adverse event, non-fatal|2
2169521|NCT01314872|3790218|FG004|Treatment Period 1|Adverse event, non-fatal|2
2169522|NCT01314872|3790219|FG005|Treatment Period 1|Adverse event, non-fatal|4
2169523|NCT01314872|3790220|FG006|Treatment Period 1|Adverse event, non-fatal|4
2169524|NCT01314872|3790221|FG007|Treatment Period 1|Adverse event, non-fatal|2
2169525|NCT01314872|3790222|FG008|Treatment Period 1|Adverse event, non-fatal|3
2169526|NCT01314872|3790223|FG009|Treatment Period 1|Adverse event, non-fatal|0
2169527|NCT01314872|3790224|FG010|Treatment Period 1|Adverse event, non-fatal|1
2169528|NCT01314872|3790225|FG011|Treatment Period 1|Adverse event, non-fatal|0
2169529|NCT01314872|3790226|FG012|Treatment Period 1|Adverse event, non-fatal|0
2169530|NCT01314872|3790227|FG013|Treatment Period 1|Adverse event, non-fatal|0
2169531|NCT01314872|3790228|FG014|Treatment Period 1|Adverse event, non-fatal|0
2169532|NCT01314872|3790214|FG000|Treatment Period 1|Withdrawal by Subject|3
2169533|NCT01314872|3790215|FG001|Treatment Period 1|Withdrawal by Subject|1
2169534|NCT01314872|3790216|FG002|Treatment Period 1|Withdrawal by Subject|0
2169535|NCT01314872|3790217|FG003|Treatment Period 1|Withdrawal by Subject|2
2169536|NCT01314872|3790218|FG004|Treatment Period 1|Withdrawal by Subject|3
2169537|NCT01314872|3790219|FG005|Treatment Period 1|Withdrawal by Subject|1
2169538|NCT01314872|3790220|FG006|Treatment Period 1|Withdrawal by Subject|3
2169539|NCT01314872|3790221|FG007|Treatment Period 1|Withdrawal by Subject|2
2169540|NCT01314872|3790222|FG008|Treatment Period 1|Withdrawal by Subject|2
2169541|NCT01314872|3790223|FG009|Treatment Period 1|Withdrawal by Subject|2
2169542|NCT01314872|3790224|FG010|Treatment Period 1|Withdrawal by Subject|1
2169543|NCT01314872|3790225|FG011|Treatment Period 1|Withdrawal by Subject|0
2169544|NCT01314872|3790226|FG012|Treatment Period 1|Withdrawal by Subject|0
2169545|NCT01314872|3790227|FG013|Treatment Period 1|Withdrawal by Subject|0
2169546|NCT01314872|3790228|FG014|Treatment Period 1|Withdrawal by Subject|0
2169547|NCT01314872|3790214|FG000|Treatment Period 1|Lost to Follow-up|0
2169548|NCT01314872|3790215|FG001|Treatment Period 1|Lost to Follow-up|1
2169549|NCT01314872|3790216|FG002|Treatment Period 1|Lost to Follow-up|2
2169550|NCT01314872|3790217|FG003|Treatment Period 1|Lost to Follow-up|2
2169551|NCT01314872|3790218|FG004|Treatment Period 1|Lost to Follow-up|1
2169552|NCT01314872|3790219|FG005|Treatment Period 1|Lost to Follow-up|1
2169553|NCT01314872|3790220|FG006|Treatment Period 1|Lost to Follow-up|1
2169554|NCT01314872|3790221|FG007|Treatment Period 1|Lost to Follow-up|1
2169555|NCT01314872|3790222|FG008|Treatment Period 1|Lost to Follow-up|1
2169556|NCT01314872|3790223|FG009|Treatment Period 1|Lost to Follow-up|0
2169557|NCT01314872|3790224|FG010|Treatment Period 1|Lost to Follow-up|0
2169558|NCT01314872|3790225|FG011|Treatment Period 1|Lost to Follow-up|0
2169559|NCT01314872|3790226|FG012|Treatment Period 1|Lost to Follow-up|0
2169560|NCT01314872|3790227|FG013|Treatment Period 1|Lost to Follow-up|0
2169561|NCT01314872|3790228|FG014|Treatment Period 1|Lost to Follow-up|0
2169562|NCT01314872|3790214|FG000|Period 2|Protocol Violation|0
2169563|NCT01314872|3790215|FG001|Period 2|Protocol Violation|0
2169564|NCT01314872|3790216|FG002|Period 2|Protocol Violation|0
2169565|NCT01314872|3790217|FG003|Period 2|Protocol Violation|0
2169566|NCT01314872|3790218|FG004|Period 2|Protocol Violation|0
2169567|NCT01314872|3790219|FG005|Period 2|Protocol Violation|0
2169568|NCT01314872|3790220|FG006|Period 2|Protocol Violation|0
2169569|NCT01314872|3790221|FG007|Period 2|Protocol Violation|0
2169570|NCT01314872|3790222|FG008|Period 2|Protocol Violation|0
2169571|NCT01314872|3790223|FG009|Period 2|Protocol Violation|0
2169572|NCT01314872|3790224|FG010|Period 2|Protocol Violation|0
2169573|NCT01314872|3790225|FG011|Period 2|Protocol Violation|3
2169574|NCT01314872|3790226|FG012|Period 2|Protocol Violation|3
2169575|NCT01314872|3790227|FG013|Period 2|Protocol Violation|2
2169576|NCT01314872|3790228|FG014|Period 2|Protocol Violation|0
2169577|NCT01314872|3790214|FG000|Period 2|Non-compliance with study drug|0
2169578|NCT01314872|3790215|FG001|Period 2|Non-compliance with study drug|0
2169579|NCT01314872|3790216|FG002|Period 2|Non-compliance with study drug|0
2169580|NCT01314872|3790217|FG003|Period 2|Non-compliance with study drug|0
2169581|NCT01314872|3790218|FG004|Period 2|Non-compliance with study drug|0
2169582|NCT01314872|3790219|FG005|Period 2|Non-compliance with study drug|0
2169583|NCT01314872|3790220|FG006|Period 2|Non-compliance with study drug|0
2169584|NCT01314872|3790221|FG007|Period 2|Non-compliance with study drug|0
2169585|NCT01314872|3790222|FG008|Period 2|Non-compliance with study drug|0
2169586|NCT01314872|3790223|FG009|Period 2|Non-compliance with study drug|0
2169587|NCT01314872|3790224|FG010|Period 2|Non-compliance with study drug|0
2169588|NCT01314872|3790225|FG011|Period 2|Non-compliance with study drug|3
2169589|NCT01314872|3790226|FG012|Period 2|Non-compliance with study drug|3
2169590|NCT01314872|3790227|FG013|Period 2|Non-compliance with study drug|1
2169591|NCT01314872|3790228|FG014|Period 2|Non-compliance with study drug|2
2169592|NCT01314872|3790214|FG000|Period 2|Lack of Efficacy|0
2169593|NCT01314872|3790215|FG001|Period 2|Lack of Efficacy|0
2169594|NCT01314872|3790216|FG002|Period 2|Lack of Efficacy|0
2169595|NCT01314872|3790217|FG003|Period 2|Lack of Efficacy|0
2169596|NCT01314872|3790218|FG004|Period 2|Lack of Efficacy|0
2169597|NCT01314872|3790219|FG005|Period 2|Lack of Efficacy|0
2169598|NCT01314872|3790220|FG006|Period 2|Lack of Efficacy|0
2169599|NCT01314872|3790221|FG007|Period 2|Lack of Efficacy|0
2169600|NCT01314872|3790222|FG008|Period 2|Lack of Efficacy|0
2169601|NCT01314872|3790223|FG009|Period 2|Lack of Efficacy|0
2169602|NCT01314872|3790224|FG010|Period 2|Lack of Efficacy|0
2169603|NCT01314872|3790225|FG011|Period 2|Lack of Efficacy|7
2169604|NCT01314872|3790226|FG012|Period 2|Lack of Efficacy|12
2169605|NCT01314872|3790227|FG013|Period 2|Lack of Efficacy|9
2169606|NCT01314872|3790228|FG014|Period 2|Lack of Efficacy|2
2169607|NCT01314872|3790214|FG000|Period 2|Pregnancy|0
2169608|NCT01314872|3790215|FG001|Period 2|Pregnancy|0
2169609|NCT01314872|3790216|FG002|Period 2|Pregnancy|0
2169610|NCT01314872|3790217|FG003|Period 2|Pregnancy|0
2169611|NCT01314872|3790218|FG004|Period 2|Pregnancy|0
2169612|NCT01314872|3790219|FG005|Period 2|Pregnancy|0
2169613|NCT01314872|3790220|FG006|Period 2|Pregnancy|0
2169614|NCT01314872|3790221|FG007|Period 2|Pregnancy|0
2169615|NCT01314872|3790222|FG008|Period 2|Pregnancy|0
2169616|NCT01314872|3790223|FG009|Period 2|Pregnancy|0
2169617|NCT01314872|3790224|FG010|Period 2|Pregnancy|0
2169618|NCT01314872|3790225|FG011|Period 2|Pregnancy|0
2169619|NCT01314872|3790226|FG012|Period 2|Pregnancy|0
2169620|NCT01314872|3790227|FG013|Period 2|Pregnancy|0
2169621|NCT01314872|3790228|FG014|Period 2|Pregnancy|1
2169622|NCT01314872|3790214|FG000|Period 2|Study terminated by Sponsor|0
2169623|NCT01314872|3790215|FG001|Period 2|Study terminated by Sponsor|0
2169624|NCT01314872|3790216|FG002|Period 2|Study terminated by Sponsor|0
2169625|NCT01314872|3790217|FG003|Period 2|Study terminated by Sponsor|0
2169626|NCT01314872|3790218|FG004|Period 2|Study terminated by Sponsor|0
2169627|NCT01314872|3790219|FG005|Period 2|Study terminated by Sponsor|0
2169628|NCT01314872|3790220|FG006|Period 2|Study terminated by Sponsor|0
2169629|NCT01314872|3790221|FG007|Period 2|Study terminated by Sponsor|0
2169630|NCT01314872|3790222|FG008|Period 2|Study terminated by Sponsor|0
2169631|NCT01314872|3790223|FG009|Period 2|Study terminated by Sponsor|0
2169632|NCT01314872|3790224|FG010|Period 2|Study terminated by Sponsor|0
2169633|NCT01314872|3790225|FG011|Period 2|Study terminated by Sponsor|2
2169634|NCT01314872|3790226|FG012|Period 2|Study terminated by Sponsor|2
2169635|NCT01314872|3790227|FG013|Period 2|Study terminated by Sponsor|3
2169636|NCT01314872|3790228|FG014|Period 2|Study terminated by Sponsor|0
2169637|NCT01314872|3790214|FG000|Period 2|Adverse event, non-fatal|0
2169638|NCT01314872|3790215|FG001|Period 2|Adverse event, non-fatal|0
2169639|NCT01314872|3790216|FG002|Period 2|Adverse event, non-fatal|0
2169640|NCT01314872|3790217|FG003|Period 2|Adverse event, non-fatal|0
2169641|NCT01314872|3790218|FG004|Period 2|Adverse event, non-fatal|0
2169642|NCT01314872|3790219|FG005|Period 2|Adverse event, non-fatal|0
2169643|NCT01314872|3790220|FG006|Period 2|Adverse event, non-fatal|0
2169644|NCT01314872|3790221|FG007|Period 2|Adverse event, non-fatal|0
2169645|NCT01314872|3790222|FG008|Period 2|Adverse event, non-fatal|0
2169646|NCT01314872|3790223|FG009|Period 2|Adverse event, non-fatal|0
2169647|NCT01314872|3790224|FG010|Period 2|Adverse event, non-fatal|0
2169648|NCT01314872|3790225|FG011|Period 2|Adverse event, non-fatal|13
2169649|NCT01314872|3790226|FG012|Period 2|Adverse event, non-fatal|16
2169650|NCT01314872|3790227|FG013|Period 2|Adverse event, non-fatal|24
2169651|NCT01314872|3790228|FG014|Period 2|Adverse event, non-fatal|9
2169652|NCT01314872|3790214|FG000|Period 2|Withdrawal by Subject|0
2169653|NCT01314872|3790215|FG001|Period 2|Withdrawal by Subject|0
2169654|NCT01314872|3790216|FG002|Period 2|Withdrawal by Subject|0
2169655|NCT01314872|3790217|FG003|Period 2|Withdrawal by Subject|0
2169656|NCT01314872|3790218|FG004|Period 2|Withdrawal by Subject|0
2169657|NCT01314872|3790219|FG005|Period 2|Withdrawal by Subject|0
2169658|NCT01314872|3790220|FG006|Period 2|Withdrawal by Subject|0
2169659|NCT01314872|3790221|FG007|Period 2|Withdrawal by Subject|0
2169660|NCT01314872|3790222|FG008|Period 2|Withdrawal by Subject|0
2169661|NCT01314872|3790223|FG009|Period 2|Withdrawal by Subject|0
2169662|NCT01314872|3790224|FG010|Period 2|Withdrawal by Subject|0
2169663|NCT01314872|3790225|FG011|Period 2|Withdrawal by Subject|14
2169664|NCT01314872|3790226|FG012|Period 2|Withdrawal by Subject|17
2169665|NCT01314872|3790227|FG013|Period 2|Withdrawal by Subject|12
2169666|NCT01314872|3790228|FG014|Period 2|Withdrawal by Subject|4
2169667|NCT01314872|3790214|FG000|Period 2|Lost to Follow-up|0
2169668|NCT01314872|3790215|FG001|Period 2|Lost to Follow-up|0
2169669|NCT01314872|3790216|FG002|Period 2|Lost to Follow-up|0
2169670|NCT01314872|3790217|FG003|Period 2|Lost to Follow-up|0
2169671|NCT01314872|3790218|FG004|Period 2|Lost to Follow-up|0
2169672|NCT01314872|3790219|FG005|Period 2|Lost to Follow-up|0
2169673|NCT01314872|3790220|FG006|Period 2|Lost to Follow-up|0
2169674|NCT01314872|3790221|FG007|Period 2|Lost to Follow-up|0
2169675|NCT01314872|3790222|FG008|Period 2|Lost to Follow-up|0
2169676|NCT01314872|3790223|FG009|Period 2|Lost to Follow-up|0
2169677|NCT01314872|3790224|FG010|Period 2|Lost to Follow-up|0
2169678|NCT01314872|3790225|FG011|Period 2|Lost to Follow-up|6
2169679|NCT01314872|3790226|FG012|Period 2|Lost to Follow-up|7
2169680|NCT01314872|3790227|FG013|Period 2|Lost to Follow-up|2
2169681|NCT01314872|3790228|FG014|Period 2|Lost to Follow-up|6
2169682|NCT01314911|3790262|FG000|Overall Study|Lost to Follow-up|3
2169683|NCT01314911|3790263|FG001|Overall Study|Lost to Follow-up|2
2169684|NCT01314911|3790262|FG000|Overall Study|Withdrawal by Subject|1
2169685|NCT01314911|3790263|FG001|Overall Study|Withdrawal by Subject|3
2169686|NCT01314911|3790262|FG000|Overall Study|Received Non-randomized Study Drug|0
2169687|NCT01314911|3790263|FG001|Overall Study|Received Non-randomized Study Drug|1
2169688|NCT01314911|3790262|FG000|Overall Study|Never Started Treatment|1
2169689|NCT01314911|3790263|FG001|Overall Study|Never Started Treatment|0
2169690|NCT01315028|3790284|FG000|Overall Study|Lost to Follow-up|1
2169691|NCT01315028|3790285|FG001|Overall Study|Lost to Follow-up|0
2169692|NCT01315028|3790284|FG000|Overall Study|Death|0
2169693|NCT01315028|3790285|FG001|Overall Study|Death|1
2169694|NCT01315132|3790291|FG000|Overall Study|not treated due to disease progression|1
2169695|NCT01315236|3790315|FG000|Double-blind Phase|Death|1
2169696|NCT01315236|3790316|FG001|Double-blind Phase|Death|0
2169697|NCT01315236|3790315|FG000|Double-blind Phase|Adverse Event|1
2169698|NCT01315236|3790316|FG001|Double-blind Phase|Adverse Event|0
2208239|NCT01637402|3847650|FG001|Standard Dose Regimen|Adverse Event|0
2208240|NCT01637402|3847649|FG000|Week 12 Evaluation|Lack of Efficacy|6
2208241|NCT01637402|3847650|FG001|Week 12 Evaluation|Lack of Efficacy|0
2169699|NCT01315236|3790315|FG000|Double-blind Phase|Withdrawal of Consent|1
2169700|NCT01315236|3790316|FG001|Double-blind Phase|Withdrawal of Consent|0
2169701|NCT01315236|3790315|FG000|Double-blind Phase|Lost to Follow-up|1
2169702|NCT01315236|3790316|FG001|Double-blind Phase|Lost to Follow-up|0
2169703|NCT01315236|3790315|FG000|Open-label Phase|Death|1
2169704|NCT01315236|3790316|FG001|Open-label Phase|Death|0
2169705|NCT01315236|3790315|FG000|Open-label Phase|Adverse Event|0
2169706|NCT01315236|3790316|FG001|Open-label Phase|Adverse Event|1
2169707|NCT01315236|3790315|FG000|Open-label Phase|Other|0
2169708|NCT01315236|3790316|FG001|Open-label Phase|Other|1
2169709|NCT01315236|3790315|FG000|12-Month Follow-up Period|Death|0
2169710|NCT01315236|3790316|FG001|12-Month Follow-up Period|Death|1
2169711|NCT01315236|3790315|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1
2169712|NCT01315236|3790316|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0
2169713|NCT01315249|3790326|FG000|Overall Study|Adverse Event|22
2169714|NCT01315249|3790327|FG001|Overall Study|Adverse Event|26
2169715|NCT01315249|3790326|FG000|Overall Study|Withdrawal by Subject|11
2169716|NCT01315249|3790327|FG001|Overall Study|Withdrawal by Subject|10
2169717|NCT01315249|3790326|FG000|Overall Study|Protocol Violation|8
2169718|NCT01315249|3790327|FG001|Overall Study|Protocol Violation|5
2169719|NCT01315249|3790326|FG000|Overall Study|Abnormal test results|1
2169720|NCT01315249|3790327|FG001|Overall Study|Abnormal test results|2
2169721|NCT01315249|3790326|FG000|Overall Study|Administrative problems|1
2169722|NCT01315249|3790327|FG001|Overall Study|Administrative problems|0
2169723|NCT01315249|3790326|FG000|Overall Study|inability to use device|1
2169724|NCT01315249|3790327|FG001|Overall Study|inability to use device|0
2169725|NCT01315249|3790326|FG000|Overall Study|Lack of Efficacy|0
2169726|NCT01315249|3790327|FG001|Overall Study|Lack of Efficacy|1
2169727|NCT01315249|3790326|FG000|Overall Study|Lost to Follow-up|0
2169728|NCT01315249|3790327|FG001|Overall Study|Lost to Follow-up|2
2169729|NCT01315249|3790326|FG000|Overall Study|Death|0
2169730|NCT01315249|3790327|FG001|Overall Study|Death|1
2169731|NCT01315678|3790355|FG000|Overall Study|Withdrawal by Subject|7
2169732|NCT01315678|3790356|FG001|Overall Study|Withdrawal by Subject|3
2169733|NCT01315678|3790355|FG000|Overall Study|Adverse Event|3
2169734|NCT01315678|3790356|FG001|Overall Study|Adverse Event|1
2169735|NCT01315678|3790355|FG000|Overall Study|Lost to Follow-up|1
2169736|NCT01315678|3790356|FG001|Overall Study|Lost to Follow-up|0
2169737|NCT01315678|3790355|FG000|Overall Study|similar reason to those listed above|3
2169738|NCT01315678|3790356|FG001|Overall Study|similar reason to those listed above|2
2169739|NCT01315847|3790366|FG000|Part I, Period 1|Reached maximum number of arterial lines|3
2169740|NCT01315847|3790367|FG001|Part I, Period 1|Reached maximum number of arterial lines|0
2169741|NCT01315847|3790366|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0
2169742|NCT01315847|3790367|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1
2169743|NCT01316055|3790385|FG000|Overall Study|Lost to Follow-up|1
2169744|NCT01316055|3790386|FG001|Overall Study|Lost to Follow-up|0
2169745|NCT01316055|3790387|FG002|Overall Study|Lost to Follow-up|0
2169746|NCT01316224|3790407|FG000|Overall Study|Protocol Violation|3
2169747|NCT01316224|3790407|FG000|Overall Study|Adverse Event|3
2169748|NCT01316224|3790407|FG000|Overall Study|Lack of Efficacy|1
2169749|NCT01316224|3790407|FG000|Overall Study|Withdrawal by Subject|1
2169750|NCT01316224|3790407|FG000|Overall Study|Adverse Event With Treatment Failure|1
2169751|NCT01316224|3790407|FG000|Overall Study|Other|1
2179786|NCT01396005|3805492|FG001|Overall Study|Non-compliance with protocol|1
2179787|NCT01396057|3805511|FG000|Overall Study|Adverse Event|2
2179788|NCT01396057|3805512|FG001|Overall Study|Adverse Event|6
2169752|NCT01316276|3790422|FG000|Overall Study|Death|1
2169753|NCT01316276|3790422|FG000|Overall Study|Adverse Event|19
2169754|NCT01316276|3790422|FG000|Overall Study|Withdrawal of consent|24
2169755|NCT01316276|3790422|FG000|Overall Study|Lost to Follow-up|1
2169756|NCT01316276|3790422|FG000|Overall Study|Other|22
2169757|NCT01316380|3790474|FG000|Overall Study|Adverse Event|0
2169758|NCT01316380|3790475|FG001|Overall Study|Adverse Event|2
2169759|NCT01316380|3790476|FG002|Overall Study|Adverse Event|1
2169760|NCT01316380|3790474|FG000|Overall Study|Protocol Violation|0
2169761|NCT01316380|3790475|FG001|Overall Study|Protocol Violation|0
2169762|NCT01316380|3790476|FG002|Overall Study|Protocol Violation|1
2169763|NCT01316380|3790474|FG000|Overall Study|Withdrawal by Subject|1
2169764|NCT01316380|3790475|FG001|Overall Study|Withdrawal by Subject|2
2169765|NCT01316380|3790476|FG002|Overall Study|Withdrawal by Subject|0
2169766|NCT01316380|3790474|FG000|Overall Study|Other|0
2169767|NCT01316380|3790475|FG001|Overall Study|Other|1
2169768|NCT01316380|3790476|FG002|Overall Study|Other|1
2169769|NCT01316380|3790474|FG000|Overall Study|Not treated|1
2169770|NCT01316380|3790475|FG001|Overall Study|Not treated|0
2169771|NCT01316380|3790476|FG002|Overall Study|Not treated|0
2169772|NCT01316419|3790484|FG000|Overall Study|Not treated|103
2169773|NCT01316419|3790484|FG000|Overall Study|Violated inclusion/exclusion criterion|143
2169774|NCT01316419|3790484|FG000|Overall Study|Lost to Follow-up|19
2169775|NCT01316575|3790499|FG000|Overall Study|Withdrawal by Subject|2
2169776|NCT01316575|3790500|FG001|Overall Study|Withdrawal by Subject|0
2169777|NCT01316575|3790499|FG000|Overall Study|Required alternate treatment|0
2169778|NCT01316575|3790500|FG001|Overall Study|Required alternate treatment|1
2169779|NCT01316614|3790506|FG000|Overall Study|No solid lesion and FNA not indicated|25
2169780|NCT01316614|3790506|FG000|Overall Study|Cytology slides not available for review|4
2169781|NCT01316614|3790506|FG000|Overall Study|Cystic lesion|5
2169782|NCT01316614|3790506|FG000|Overall Study|Inadequate number of passes|2
2169783|NCT01316614|3790506|FG000|Overall Study|Medically unstable|1
2169784|NCT01316692|3790511|FG000|Overall Study|Adverse Event|5
2169785|NCT01316692|3790511|FG000|Overall Study|Disease Progression|7
2169786|NCT01316887|3790529|FG000|Overall Study|Adverse Event|13
2169787|NCT01316887|3790530|FG001|Overall Study|Adverse Event|21
2169788|NCT01316887|3790531|FG002|Overall Study|Adverse Event|17
2169789|NCT01316887|3790529|FG000|Overall Study|Lack of Efficacy|9
2169790|NCT01316887|3790530|FG001|Overall Study|Lack of Efficacy|3
2169791|NCT01316887|3790531|FG002|Overall Study|Lack of Efficacy|1
2169792|NCT01316887|3790529|FG000|Overall Study|Protocol Violation|2
2169793|NCT01316887|3790530|FG001|Overall Study|Protocol Violation|6
2169794|NCT01316887|3790531|FG002|Overall Study|Protocol Violation|6
2169795|NCT01316887|3790529|FG000|Overall Study|Protocol-defined Stopping Criteria|8
2169796|NCT01316887|3790530|FG001|Overall Study|Protocol-defined Stopping Criteria|37
2169797|NCT01316887|3790531|FG002|Overall Study|Protocol-defined Stopping Criteria|36
2169798|NCT01316887|3790529|FG000|Overall Study|Study Closed/Terminated|2
2169799|NCT01316887|3790530|FG001|Overall Study|Study Closed/Terminated|4
2169800|NCT01316887|3790531|FG002|Overall Study|Study Closed/Terminated|3
2169801|NCT01316887|3790529|FG000|Overall Study|Lost to Follow-up|1
2169802|NCT01316887|3790530|FG001|Overall Study|Lost to Follow-up|7
2169803|NCT01316887|3790531|FG002|Overall Study|Lost to Follow-up|5
2169804|NCT01316887|3790529|FG000|Overall Study|Withdrawal by Subject|8
2169805|NCT01316887|3790530|FG001|Overall Study|Withdrawal by Subject|16
2169806|NCT01316887|3790531|FG002|Overall Study|Withdrawal by Subject|15
2169807|NCT01316900|3790544|FG000|Overall Study|Adverse Event|10
2169808|NCT01316900|3790545|FG001|Overall Study|Adverse Event|10
2169809|NCT01316900|3790546|FG002|Overall Study|Adverse Event|15
2169810|NCT01316900|3790547|FG003|Overall Study|Adverse Event|9
2169811|NCT01316900|3790544|FG000|Overall Study|Lack of Efficacy|17
2169812|NCT01316900|3790545|FG001|Overall Study|Lack of Efficacy|9
2169813|NCT01316900|3790546|FG002|Overall Study|Lack of Efficacy|5
2169814|NCT01316900|3790547|FG003|Overall Study|Lack of Efficacy|7
2169815|NCT01316900|3790544|FG000|Overall Study|Protocol Violation|7
2169816|NCT01316900|3790545|FG001|Overall Study|Protocol Violation|1
2169817|NCT01316900|3790546|FG002|Overall Study|Protocol Violation|4
2169818|NCT01316900|3790547|FG003|Overall Study|Protocol Violation|0
2169819|NCT01316900|3790544|FG000|Overall Study|Protocol-defined Stopping Criteria|2
2169820|NCT01316900|3790545|FG001|Overall Study|Protocol-defined Stopping Criteria|3
2169821|NCT01316900|3790546|FG002|Overall Study|Protocol-defined Stopping Criteria|10
2169822|NCT01316900|3790547|FG003|Overall Study|Protocol-defined Stopping Criteria|5
2169823|NCT01316900|3790544|FG000|Overall Study|Lost to Follow-up|1
2169824|NCT01316900|3790545|FG001|Overall Study|Lost to Follow-up|0
2169825|NCT01316900|3790546|FG002|Overall Study|Lost to Follow-up|1
2169826|NCT01316900|3790547|FG003|Overall Study|Lost to Follow-up|1
2169827|NCT01316900|3790544|FG000|Overall Study|Withdrawal by Subject|7
2169828|NCT01316900|3790545|FG001|Overall Study|Withdrawal by Subject|8
2169829|NCT01316900|3790546|FG002|Overall Study|Withdrawal by Subject|6
2169830|NCT01316900|3790547|FG003|Overall Study|Withdrawal by Subject|9
2169831|NCT01316913|3790561|FG000|Overall Study|Adverse Event|17
2169832|NCT01316913|3790562|FG001|Overall Study|Adverse Event|20
2169833|NCT01316913|3790563|FG002|Overall Study|Adverse Event|15
2169834|NCT01316913|3790564|FG003|Overall Study|Adverse Event|11
2169835|NCT01316913|3790561|FG000|Overall Study|Lack of Efficacy|22
2169836|NCT01316913|3790562|FG001|Overall Study|Lack of Efficacy|12
2169837|NCT01316913|3790563|FG002|Overall Study|Lack of Efficacy|9
2169838|NCT01316913|3790564|FG003|Overall Study|Lack of Efficacy|13
2169839|NCT01316913|3790561|FG000|Overall Study|Protocol Violation|1
2169840|NCT01316913|3790562|FG001|Overall Study|Protocol Violation|4
2169841|NCT01316913|3790563|FG002|Overall Study|Protocol Violation|4
2169842|NCT01316913|3790564|FG003|Overall Study|Protocol Violation|1
2169843|NCT01316913|3790561|FG000|Overall Study|Protocol-defined Stopping Criteria|7
2169844|NCT01316913|3790562|FG001|Overall Study|Protocol-defined Stopping Criteria|8
2169845|NCT01316913|3790563|FG002|Overall Study|Protocol-defined Stopping Criteria|11
2169846|NCT01316913|3790564|FG003|Overall Study|Protocol-defined Stopping Criteria|6
2169847|NCT01316913|3790561|FG000|Overall Study|Lost to Follow-up|0
2169848|NCT01316913|3790562|FG001|Overall Study|Lost to Follow-up|1
2169849|NCT01316913|3790563|FG002|Overall Study|Lost to Follow-up|0
2169850|NCT01316913|3790564|FG003|Overall Study|Lost to Follow-up|2
2169851|NCT01316913|3790561|FG000|Overall Study|Withdrawal by Subject|10
2169852|NCT01316913|3790562|FG001|Overall Study|Withdrawal by Subject|9
2169853|NCT01316913|3790563|FG002|Overall Study|Withdrawal by Subject|10
2169854|NCT01316913|3790564|FG003|Overall Study|Withdrawal by Subject|6
2169855|NCT01316939|3790586|FG000|Overall Study|Study closed/terminated|26
2169856|NCT01316939|3790587|FG001|Overall Study|Study closed/terminated|25
2169857|NCT01316939|3790588|FG002|Overall Study|Study closed/terminated|23
2169858|NCT01316939|3790586|FG000|Overall Study|Lack of Efficacy|24
2169859|NCT01316939|3790587|FG001|Overall Study|Lack of Efficacy|25
2169860|NCT01316939|3790588|FG002|Overall Study|Lack of Efficacy|25
2169861|NCT01316939|3790586|FG000|Overall Study|Adverse Event|9
2169862|NCT01316939|3790587|FG001|Overall Study|Adverse Event|12
2169863|NCT01316939|3790588|FG002|Overall Study|Adverse Event|11
2169864|NCT01316939|3790586|FG000|Overall Study|Withdrawal by Subject|1
2169865|NCT01316939|3790587|FG001|Overall Study|Withdrawal by Subject|3
2169866|NCT01316939|3790588|FG002|Overall Study|Withdrawal by Subject|6
2169867|NCT01316939|3790586|FG000|Overall Study|Physician Decision|2
2169868|NCT01316939|3790587|FG001|Overall Study|Physician Decision|2
2169869|NCT01316939|3790588|FG002|Overall Study|Physician Decision|1
2169870|NCT01316939|3790586|FG000|Overall Study|Lost to Follow-up|0
2169871|NCT01316939|3790587|FG001|Overall Study|Lost to Follow-up|0
2169872|NCT01316939|3790588|FG002|Overall Study|Lost to Follow-up|2
2169873|NCT01316939|3790586|FG000|Overall Study|Met Liver chemistry stopping criteria|1
2169874|NCT01316939|3790587|FG001|Overall Study|Met Liver chemistry stopping criteria|0
2169875|NCT01316939|3790588|FG002|Overall Study|Met Liver chemistry stopping criteria|1
2169876|NCT01316939|3790586|FG000|Overall Study|Protocol Violation|0
2169877|NCT01316939|3790587|FG001|Overall Study|Protocol Violation|1
2169878|NCT01316939|3790588|FG002|Overall Study|Protocol Violation|0
2169879|NCT01317004|3790598|FG000|Overall Study|Withdrawal by Subject|1
2169880|NCT01317004|3790599|FG001|Overall Study|Withdrawal by Subject|4
2169881|NCT01317004|3790598|FG000|Overall Study|Protocol Violation|0
2169882|NCT01317004|3790599|FG001|Overall Study|Protocol Violation|2
2169883|NCT01317004|3790598|FG000|Overall Study|Adverse Event|3
2169884|NCT01317004|3790599|FG001|Overall Study|Adverse Event|3
2169885|NCT01317160|3790625|FG000|Overall Study|Incorrect inclusion|1
2169886|NCT01317160|3790626|FG001|Overall Study|Incorrect inclusion|1
2169887|NCT01317160|3790625|FG000|Overall Study|Lost to Follow-up|3
2169888|NCT01317160|3790626|FG001|Overall Study|Lost to Follow-up|3
2169889|NCT01317160|3790625|FG000|Overall Study|Withdrawal by Subject|0
2169890|NCT01317160|3790626|FG001|Overall Study|Withdrawal by Subject|2
2169891|NCT01317199|3790636|FG000|Dose-escalation Phase 1|Physician Decision|5
2169892|NCT01317199|3790637|FG001|Dose-escalation Phase 1|Physician Decision|0
2169893|NCT01317199|3790638|FG002|Dose-escalation Phase 1|Physician Decision|0
2169894|NCT01317199|3790639|FG003|Dose-escalation Phase 1|Physician Decision|0
2169895|NCT01317199|3790636|FG000|Dose-escalation Phase 1|Disease progression|1
2169896|NCT01317199|3790637|FG001|Dose-escalation Phase 1|Disease progression|0
2169897|NCT01317199|3790638|FG002|Dose-escalation Phase 1|Disease progression|0
2169898|NCT01317199|3790639|FG003|Dose-escalation Phase 1|Disease progression|0
2169899|NCT01317199|3790636|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
2169900|NCT01317199|3790637|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
2169901|NCT01317199|3790638|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
2169902|NCT01317199|3790639|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
2169903|NCT01317199|3790636|FG000|Randomized Phase 2|Disease progression|0
2169904|NCT01317199|3790637|FG001|Randomized Phase 2|Disease progression|3
2169905|NCT01317199|3790638|FG002|Randomized Phase 2|Disease progression|7
2169906|NCT01317199|3790639|FG003|Randomized Phase 2|Disease progression|5
2169907|NCT01317199|3790636|FG000|Randomized Phase 2|Withdrawal by Subject|0
2169908|NCT01317199|3790637|FG001|Randomized Phase 2|Withdrawal by Subject|3
2169909|NCT01317199|3790638|FG002|Randomized Phase 2|Withdrawal by Subject|5
2169910|NCT01317199|3790639|FG003|Randomized Phase 2|Withdrawal by Subject|4
2169911|NCT01317199|3790636|FG000|Randomized Phase 2|Adverse Event|0
2169912|NCT01317199|3790637|FG001|Randomized Phase 2|Adverse Event|0
2169913|NCT01317199|3790638|FG002|Randomized Phase 2|Adverse Event|0
2169914|NCT01317199|3790639|FG003|Randomized Phase 2|Adverse Event|1
2169915|NCT01317199|3790636|FG000|Randomized Phase 2|Comorbidities|0
2169916|NCT01317199|3790637|FG001|Randomized Phase 2|Comorbidities|2
2169917|NCT01317199|3790638|FG002|Randomized Phase 2|Comorbidities|2
2169918|NCT01317199|3790639|FG003|Randomized Phase 2|Comorbidities|2
2169919|NCT01317199|3790636|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0
2169920|NCT01317199|3790637|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2
2169921|NCT01317199|3790638|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5
2169922|NCT01317199|3790639|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2
2169923|NCT01317199|3790636|FG000|Randomized Phase 2|Disenrolled before treatment|0
2169924|NCT01317199|3790637|FG001|Randomized Phase 2|Disenrolled before treatment|1
2169925|NCT01317199|3790638|FG002|Randomized Phase 2|Disenrolled before treatment|1
2169926|NCT01317199|3790639|FG003|Randomized Phase 2|Disenrolled before treatment|2
2169927|NCT01317199|3790636|FG000|Randomized Phase 2|Patient stopped taking study drug|0
2169928|NCT01317199|3790637|FG001|Randomized Phase 2|Patient stopped taking study drug|0
2169929|NCT01317199|3790638|FG002|Randomized Phase 2|Patient stopped taking study drug|0
2169930|NCT01317199|3790639|FG003|Randomized Phase 2|Patient stopped taking study drug|1
2169931|NCT01317199|3790636|FG000|Randomized Phase 2|Patient transferred to other facility|0
2169932|NCT01317199|3790637|FG001|Randomized Phase 2|Patient transferred to other facility|0
2169933|NCT01317199|3790638|FG002|Randomized Phase 2|Patient transferred to other facility|1
2169934|NCT01317199|3790639|FG003|Randomized Phase 2|Patient transferred to other facility|0
2169935|NCT01317277|3790658|FG000|Overall Study|Lost to Follow-up|3
2169936|NCT01317277|3790659|FG001|Overall Study|Lost to Follow-up|1
2169937|NCT01317277|3790658|FG000|Overall Study|Lost MEMS|1
2169938|NCT01317277|3790659|FG001|Overall Study|Lost MEMS|1
2169939|NCT01317277|3790658|FG000|Overall Study|Unable to comply with intervention|1
2169940|NCT01317277|3790659|FG001|Overall Study|Unable to comply with intervention|0
2169941|NCT01317277|3790658|FG000|Overall Study|Withdrawal by Subject|1
2169942|NCT01317277|3790659|FG001|Overall Study|Withdrawal by Subject|0
2169943|NCT01317277|3790658|FG000|Overall Study|Adverse Event|1
2169944|NCT01317277|3790659|FG001|Overall Study|Adverse Event|0
2169945|NCT01317472|3790667|FG000|Overall Study|Withdrawal by Subject|1
2169946|NCT01317472|3790668|FG001|Overall Study|Withdrawal by Subject|0
2169947|NCT01317472|3790667|FG000|Overall Study|Unrelated hospitalization|1
2169948|NCT01317472|3790668|FG001|Overall Study|Unrelated hospitalization|0
2169949|NCT01317550|3790678|FG000|Overall Study|Withdrawal by Subject|1
2169950|NCT01317550|3790679|FG001|Overall Study|Withdrawal by Subject|0
2169951|NCT01317550|3790680|FG002|Overall Study|Withdrawal by Subject|0
2169952|NCT01317550|3790681|FG003|Overall Study|Withdrawal by Subject|0
2169953|NCT01317550|3790678|FG000|Overall Study|Lack of compliance study med|1
2169954|NCT01317550|3790679|FG001|Overall Study|Lack of compliance study med|0
2169955|NCT01317550|3790680|FG002|Overall Study|Lack of compliance study med|0
2169956|NCT01317550|3790681|FG003|Overall Study|Lack of compliance study med|0
2169957|NCT01317615|3790691|FG000|Overall Study|Disease progression|25
2169958|NCT01317615|3790691|FG000|Overall Study|New cancer therapy|5
2169959|NCT01317615|3790691|FG000|Overall Study|Death|6
2169960|NCT01317615|3790691|FG000|Overall Study|Withdrawal by Subject|5
2169961|NCT01317615|3790691|FG000|Overall Study|Abnormal laboratory value(s)|1
2169962|NCT01317615|3790691|FG000|Overall Study|Adverse Event|7
2169963|NCT01317641|3790704|FG000|Overall Study|Not treated|0
2169964|NCT01317641|3790705|FG001|Overall Study|Not treated|0
2169965|NCT01317641|3790706|FG002|Overall Study|Not treated|0
2169966|NCT01317641|3790707|FG003|Overall Study|Not treated|0
2169967|NCT01317641|3790708|FG004|Overall Study|Not treated|0
2169968|NCT01317641|3790709|FG005|Overall Study|Not treated|0
2169969|NCT01317641|3790710|FG006|Overall Study|Not treated|0
2169970|NCT01317641|3790711|FG007|Overall Study|Not treated|1
2169971|NCT01317641|3790712|FG008|Overall Study|Not treated|1
2169972|NCT01317641|3790704|FG000|Overall Study|Adverse Event|0
2169973|NCT01317641|3790705|FG001|Overall Study|Adverse Event|1
2169974|NCT01317641|3790706|FG002|Overall Study|Adverse Event|0
2169975|NCT01317641|3790707|FG003|Overall Study|Adverse Event|1
2169976|NCT01317641|3790708|FG004|Overall Study|Adverse Event|0
2169977|NCT01317641|3790709|FG005|Overall Study|Adverse Event|0
2169978|NCT01317641|3790710|FG006|Overall Study|Adverse Event|2
2169979|NCT01317641|3790711|FG007|Overall Study|Adverse Event|1
2169980|NCT01317641|3790712|FG008|Overall Study|Adverse Event|0
2169981|NCT01317641|3790704|FG000|Overall Study|Protocol Violation|1
2169982|NCT01317641|3790705|FG001|Overall Study|Protocol Violation|0
2169983|NCT01317641|3790706|FG002|Overall Study|Protocol Violation|0
2169984|NCT01317641|3790707|FG003|Overall Study|Protocol Violation|0
2169985|NCT01317641|3790708|FG004|Overall Study|Protocol Violation|0
2169986|NCT01317641|3790709|FG005|Overall Study|Protocol Violation|0
2169987|NCT01317641|3790710|FG006|Overall Study|Protocol Violation|0
2169988|NCT01317641|3790711|FG007|Overall Study|Protocol Violation|0
2169989|NCT01317641|3790712|FG008|Overall Study|Protocol Violation|0
2169990|NCT01317641|3790704|FG000|Overall Study|Disease progression|0
2169991|NCT01317641|3790705|FG001|Overall Study|Disease progression|0
2169992|NCT01317641|3790706|FG002|Overall Study|Disease progression|0
2169993|NCT01317641|3790707|FG003|Overall Study|Disease progression|0
2169994|NCT01317641|3790708|FG004|Overall Study|Disease progression|0
2169995|NCT01317641|3790709|FG005|Overall Study|Disease progression|0
2169996|NCT01317641|3790710|FG006|Overall Study|Disease progression|0
2169997|NCT01317641|3790711|FG007|Overall Study|Disease progression|3
2169998|NCT01317641|3790712|FG008|Overall Study|Disease progression|4
2169999|NCT01317641|3790704|FG000|Overall Study|Withdrawal by Subject|0
2170000|NCT01317641|3790705|FG001|Overall Study|Withdrawal by Subject|0
2170001|NCT01317641|3790706|FG002|Overall Study|Withdrawal by Subject|0
2170002|NCT01317641|3790707|FG003|Overall Study|Withdrawal by Subject|0
2170003|NCT01317641|3790708|FG004|Overall Study|Withdrawal by Subject|0
2170004|NCT01317641|3790709|FG005|Overall Study|Withdrawal by Subject|0
2170005|NCT01317641|3790710|FG006|Overall Study|Withdrawal by Subject|1
2170006|NCT01317641|3790711|FG007|Overall Study|Withdrawal by Subject|0
2170007|NCT01317641|3790712|FG008|Overall Study|Withdrawal by Subject|0
2170008|NCT01317797|3790764|FG000|Overall Study|Other|0
2170009|NCT01317797|3790765|FG001|Overall Study|Other|1
2170010|NCT01317797|3790766|FG002|Overall Study|Other|0
2170011|NCT01317797|3790764|FG000|Overall Study|Withdrawal of Patient|0
2170012|NCT01317797|3790765|FG001|Overall Study|Withdrawal of Patient|0
2170013|NCT01317797|3790766|FG002|Overall Study|Withdrawal of Patient|1
2170014|NCT01317940|3790789|FG000|Overall Study|Death|1
2170015|NCT01317940|3790790|FG001|Overall Study|Death|0
2170016|NCT01317940|3790791|FG002|Overall Study|Death|1
2170017|NCT01317940|3790792|FG003|Overall Study|Death|0
2170018|NCT01317940|3790793|FG004|Overall Study|Death|0
2170019|NCT01317940|3790794|FG005|Overall Study|Death|0
2170020|NCT01317940|3790789|FG000|Overall Study|Lost to Follow-up|0
2170021|NCT01317940|3790790|FG001|Overall Study|Lost to Follow-up|0
2170022|NCT01317940|3790791|FG002|Overall Study|Lost to Follow-up|1
2170023|NCT01317940|3790792|FG003|Overall Study|Lost to Follow-up|1
2170024|NCT01317940|3790793|FG004|Overall Study|Lost to Follow-up|1
2170025|NCT01317940|3790794|FG005|Overall Study|Lost to Follow-up|0
2170026|NCT01317940|3790789|FG000|Overall Study|Change in therapy plan|0
2170027|NCT01317940|3790790|FG001|Overall Study|Change in therapy plan|0
2170028|NCT01317940|3790791|FG002|Overall Study|Change in therapy plan|3
2170029|NCT01317940|3790792|FG003|Overall Study|Change in therapy plan|0
2170030|NCT01317940|3790793|FG004|Overall Study|Change in therapy plan|0
2170031|NCT01317940|3790794|FG005|Overall Study|Change in therapy plan|0
2170032|NCT01318070|3790821|FG000|Overall Study|Adverse Event|1
2170033|NCT01318070|3790822|FG001|Overall Study|Adverse Event|1
2170034|NCT01318070|3790823|FG002|Overall Study|Adverse Event|5
2170035|NCT01318070|3790821|FG000|Overall Study|Withdrawal by Subject|0
2170036|NCT01318070|3790822|FG001|Overall Study|Withdrawal by Subject|1
2170037|NCT01318070|3790823|FG002|Overall Study|Withdrawal by Subject|1
2170038|NCT01318070|3790821|FG000|Overall Study|Lack of Efficacy|0
2170039|NCT01318070|3790822|FG001|Overall Study|Lack of Efficacy|0
2170040|NCT01318070|3790823|FG002|Overall Study|Lack of Efficacy|1
2170041|NCT01318070|3790821|FG000|Overall Study|Principal Investigator Discretion|1
2170042|NCT01318070|3790822|FG001|Overall Study|Principal Investigator Discretion|0
2170043|NCT01318070|3790823|FG002|Overall Study|Principal Investigator Discretion|0
2170044|NCT01318083|3790834|FG000|Overall Study|Adverse Event|4
2170045|NCT01318083|3790835|FG001|Overall Study|Adverse Event|1
2170046|NCT01318083|3790836|FG002|Overall Study|Adverse Event|2
2170047|NCT01318083|3790834|FG000|Overall Study|Withdrawal by Subject|1
2170048|NCT01318083|3790835|FG001|Overall Study|Withdrawal by Subject|0
2170049|NCT01318083|3790836|FG002|Overall Study|Withdrawal by Subject|2
2170050|NCT01318083|3790834|FG000|Overall Study|Lack of Efficacy|0
2170051|NCT01318083|3790835|FG001|Overall Study|Lack of Efficacy|0
2170052|NCT01318083|3790836|FG002|Overall Study|Lack of Efficacy|1
2170053|NCT01318083|3790834|FG000|Overall Study|Treatment Complications|1
2170054|NCT01318083|3790835|FG001|Overall Study|Treatment Complications|0
2170055|NCT01318083|3790836|FG002|Overall Study|Treatment Complications|0
2170056|NCT01318083|3790834|FG000|Overall Study|Lack of Study Medication Compliance|0
2170057|NCT01318083|3790835|FG001|Overall Study|Lack of Study Medication Compliance|1
2170058|NCT01318083|3790836|FG002|Overall Study|Lack of Study Medication Compliance|0
2170059|NCT01318109|3790847|FG000|Overall Study|Adverse Event|0
2170060|NCT01318109|3790848|FG001|Overall Study|Adverse Event|2
2170061|NCT01318109|3790849|FG002|Overall Study|Adverse Event|0
2170062|NCT01318109|3790847|FG000|Overall Study|Withdrawal by Subject|1
2170063|NCT01318109|3790848|FG001|Overall Study|Withdrawal by Subject|0
2170064|NCT01318109|3790849|FG002|Overall Study|Withdrawal by Subject|0
2170065|NCT01318109|3790847|FG000|Overall Study|Schedule Conflict|0
2170066|NCT01318109|3790848|FG001|Overall Study|Schedule Conflict|1
2170067|NCT01318109|3790849|FG002|Overall Study|Schedule Conflict|0
2170068|NCT01318122|3790859|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
2170069|NCT01318122|3790860|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
2170070|NCT01318122|3790861|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2
2170071|NCT01318122|3790862|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
2170072|NCT01318122|3790859|FG000|Enrolled - Long-Term Extension Study|Other|1
2170073|NCT01318122|3790860|FG001|Enrolled - Long-Term Extension Study|Other|0
2170074|NCT01318122|3790861|FG002|Enrolled - Long-Term Extension Study|Other|0
2170075|NCT01318122|3790862|FG003|Enrolled - Long-Term Extension Study|Other|0
2170076|NCT01318122|3790859|FG000|Entered - Long-Term Extension Study|Adverse Event|6
2170077|NCT01318122|3790860|FG001|Entered - Long-Term Extension Study|Adverse Event|6
2170078|NCT01318122|3790861|FG002|Entered - Long-Term Extension Study|Adverse Event|2
2170079|NCT01318122|3790862|FG003|Entered - Long-Term Extension Study|Adverse Event|4
2170080|NCT01318122|3790859|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1
2170081|NCT01318122|3790860|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0
2170082|NCT01318122|3790861|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
2170083|NCT01318122|3790862|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
2170084|NCT01318122|3790859|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2170085|NCT01318122|3790860|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3
2170086|NCT01318122|3790861|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2170087|NCT01318122|3790862|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2170088|NCT01318122|3790859|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0
2170089|NCT01318122|3790860|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2
2170090|NCT01318122|3790861|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3
2170091|NCT01318122|3790862|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
2170092|NCT01318135|3790872|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1
2170093|NCT01318135|3790873|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
2170094|NCT01318135|3790874|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
2170095|NCT01318135|3790875|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0
2208242|NCT01637402|3847649|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0
2208243|NCT01637402|3847650|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4
2170096|NCT01318135|3790876|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0
2170097|NCT01318135|3790877|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
2170098|NCT01318135|3790878|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
2170099|NCT01318135|3790879|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
2170100|NCT01318135|3790872|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1
2170101|NCT01318135|3790873|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0
2170102|NCT01318135|3790874|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0
2170103|NCT01318135|3790875|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0
2170104|NCT01318135|3790876|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0
2170105|NCT01318135|3790877|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0
2170106|NCT01318135|3790878|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0
2170107|NCT01318135|3790879|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0
2170108|NCT01318135|3790872|FG000|Entered - Long-Term Extension Study|Adverse Event|9
2170109|NCT01318135|3790873|FG001|Entered - Long-Term Extension Study|Adverse Event|3
2170110|NCT01318135|3790874|FG002|Entered - Long-Term Extension Study|Adverse Event|4
2170111|NCT01318135|3790875|FG003|Entered - Long-Term Extension Study|Adverse Event|3
2170112|NCT01318135|3790876|FG004|Entered - Long-Term Extension Study|Adverse Event|4
2170113|NCT01318135|3790877|FG005|Entered - Long-Term Extension Study|Adverse Event|2
2170114|NCT01318135|3790878|FG006|Entered - Long-Term Extension Study|Adverse Event|0
2170115|NCT01318135|3790879|FG007|Entered - Long-Term Extension Study|Adverse Event|0
2170116|NCT01318135|3790872|FG000|Entered - Long-Term Extension Study|Protocol Violation|1
2170117|NCT01318135|3790873|FG001|Entered - Long-Term Extension Study|Protocol Violation|1
2170118|NCT01318135|3790874|FG002|Entered - Long-Term Extension Study|Protocol Violation|0
2170119|NCT01318135|3790875|FG003|Entered - Long-Term Extension Study|Protocol Violation|0
2170120|NCT01318135|3790876|FG004|Entered - Long-Term Extension Study|Protocol Violation|1
2170121|NCT01318135|3790877|FG005|Entered - Long-Term Extension Study|Protocol Violation|0
2170122|NCT01318135|3790878|FG006|Entered - Long-Term Extension Study|Protocol Violation|0
2170123|NCT01318135|3790879|FG007|Entered - Long-Term Extension Study|Protocol Violation|0
2170124|NCT01318135|3790872|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2170125|NCT01318135|3790873|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2170126|NCT01318135|3790874|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2170127|NCT01318135|3790875|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2170128|NCT01318135|3790876|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2170129|NCT01318135|3790877|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2170130|NCT01318135|3790878|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2170131|NCT01318135|3790879|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2170132|NCT01318135|3790872|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5
2170133|NCT01318135|3790873|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7
2170134|NCT01318135|3790874|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2
2170135|NCT01318135|3790875|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3
2170136|NCT01318135|3790876|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2
2170137|NCT01318135|3790877|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2
2170138|NCT01318135|3790878|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1
2170139|NCT01318135|3790879|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1
2170140|NCT01318135|3790872|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2170141|NCT01318135|3790873|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2170142|NCT01318135|3790874|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2170143|NCT01318135|3790875|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2170144|NCT01318135|3790876|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2170145|NCT01318135|3790877|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2170146|NCT01318135|3790878|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2170147|NCT01318135|3790879|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1
2170148|NCT01318382|3790916|FG000|Overall Study|Physician Decision|2
2170149|NCT01318382|3790916|FG000|Overall Study|Device Malfunction|10
2170150|NCT01318382|3790916|FG000|Overall Study|Protocol Violation|1
2170151|NCT01318499|3790928|FG000|Overall Study|Adverse Event|16
2170152|NCT01318499|3790929|FG001|Overall Study|Adverse Event|11
2170153|NCT01318499|3790930|FG002|Overall Study|Adverse Event|6
2170154|NCT01318499|3790928|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1
2170155|NCT01318499|3790929|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1
2170156|NCT01318499|3790930|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2
2170157|NCT01318499|3790928|FG000|Overall Study|Noncompliance|2
2170158|NCT01318499|3790929|FG001|Overall Study|Noncompliance|3
2170159|NCT01318499|3790930|FG002|Overall Study|Noncompliance|0
2170160|NCT01318499|3790928|FG000|Overall Study|Treatment Failure|19
2170161|NCT01318499|3790929|FG001|Overall Study|Treatment Failure|19
2170162|NCT01318499|3790930|FG002|Overall Study|Treatment Failure|101
2170163|NCT01318499|3790928|FG000|Overall Study|Protocol Violation|2
2170164|NCT01318499|3790929|FG001|Overall Study|Protocol Violation|4
2170165|NCT01318499|3790930|FG002|Overall Study|Protocol Violation|2
2170166|NCT01318499|3790928|FG000|Overall Study|Patient Did Not Use Study Medication|18
2170167|NCT01318499|3790929|FG001|Overall Study|Patient Did Not Use Study Medication|28
2170168|NCT01318499|3790930|FG002|Overall Study|Patient Did Not Use Study Medication|14
2170169|NCT01318499|3790928|FG000|Overall Study|Other|7
2170170|NCT01318499|3790929|FG001|Overall Study|Other|10
2170171|NCT01318499|3790930|FG002|Overall Study|Other|22
2170172|NCT01318512|3790940|FG000|Maintenance Period (6 Months)|Death|2
2170173|NCT01318512|3790940|FG000|Maintenance Period (6 Months)|Protocol Violation|9
2170174|NCT01318811|3790990|FG000|Overall Study|Physician Decision|1
2170175|NCT01318811|3790991|FG001|Overall Study|Physician Decision|1
2170176|NCT01318811|3790990|FG000|Overall Study|CRRT stopped for head CT|0
2170177|NCT01318811|3790991|FG001|Overall Study|CRRT stopped for head CT|1
2170178|NCT01318811|3790990|FG000|Overall Study|Death|0
2170179|NCT01318811|3790991|FG001|Overall Study|Death|1
2170180|NCT01318811|3790990|FG000|Overall Study|CRRT stopped for head MRI|0
2170181|NCT01318811|3790991|FG001|Overall Study|CRRT stopped for head MRI|1
2170182|NCT01318876|3790997|FG000|Day 8 Survey|email address invalid|96
2170183|NCT01318876|3790997|FG000|Day 8 Survey|survey not completed-don't know why|1724
2170184|NCT01318876|3790997|FG000|Day 29 Survey|survey not completed-don't know why|1825
2170185|NCT01318902|3791005|FG000|Overall Study|Symptomatic Deterioration|0
2170186|NCT01318902|3791006|FG001|Overall Study|Symptomatic Deterioration|1
2170187|NCT01318902|3791007|FG002|Overall Study|Symptomatic Deterioration|1
2170188|NCT01318902|3791008|FG003|Overall Study|Symptomatic Deterioration|2
2170189|NCT01318902|3791005|FG000|Overall Study|Withdrawal by Patient|0
2170190|NCT01318902|3791006|FG001|Overall Study|Withdrawal by Patient|1
2170191|NCT01318902|3791007|FG002|Overall Study|Withdrawal by Patient|0
2170192|NCT01318902|3791008|FG003|Overall Study|Withdrawal by Patient|3
2170193|NCT01318902|3791005|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
2170194|NCT01318902|3791006|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
2170195|NCT01318902|3791007|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
2170196|NCT01318902|3791008|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
2170197|NCT01318902|3791005|FG000|Overall Study|Adverse Event|0
2170198|NCT01318902|3791006|FG001|Overall Study|Adverse Event|1
2170199|NCT01318902|3791007|FG002|Overall Study|Adverse Event|0
2170200|NCT01318902|3791008|FG003|Overall Study|Adverse Event|0
2170201|NCT01318902|3791005|FG000|Overall Study|Terminated by Sponsor|0
2170202|NCT01318902|3791006|FG001|Overall Study|Terminated by Sponsor|0
2170203|NCT01318902|3791007|FG002|Overall Study|Terminated by Sponsor|1
2170204|NCT01318902|3791008|FG003|Overall Study|Terminated by Sponsor|0
2170205|NCT01318915|3791020|FG000|Overall Study|Lost to Follow-up|1
2170206|NCT01319383|3791048|FG000|Overall Study|No ex vivo or in vivo response|4
2170207|NCT01319383|3791049|FG001|Overall Study|No ex vivo or in vivo response|0
2170208|NCT01319383|3791048|FG000|Overall Study|Physician Decision|3
2170209|NCT01319383|3791049|FG001|Overall Study|Physician Decision|0
2170210|NCT01319383|3791048|FG000|Overall Study|Lack of Efficacy|5
2170211|NCT01319383|3791049|FG001|Overall Study|Lack of Efficacy|9
2170212|NCT01319383|3791048|FG000|Overall Study|No in vivo response to interval doses|0
2170213|NCT01319383|3791049|FG001|Overall Study|No in vivo response to interval doses|1
2170214|NCT01319422|3791072|FG000|Overall Study|Withdrawal by Subject|1
2170215|NCT01319422|3791073|FG001|Overall Study|Withdrawal by Subject|0
2170216|NCT01319721|3791110|FG000|Overall Study|Lost to Follow-up|1
2170217|NCT01319721|3791111|FG001|Overall Study|Lost to Follow-up|6
2170218|NCT01319877|3791162|FG000|Overall Study|Lost to Follow-up|100
2170219|NCT01319877|3791163|FG001|Overall Study|Lost to Follow-up|37
2170220|NCT01319877|3791162|FG000|Overall Study|Physician Decision|2
2170221|NCT01319877|3791163|FG001|Overall Study|Physician Decision|0
2170222|NCT01319877|3791162|FG000|Overall Study|Disease Progression|2
2170223|NCT01319877|3791163|FG001|Overall Study|Disease Progression|2
2170224|NCT01319877|3791162|FG000|Overall Study|Withdrawal by Subject|0
2170225|NCT01319877|3791163|FG001|Overall Study|Withdrawal by Subject|1
2170226|NCT01319877|3791162|FG000|Overall Study|Reason Not Specified|4
2170227|NCT01319877|3791163|FG001|Overall Study|Reason Not Specified|5
2170228|NCT01319929|3791170|FG000|First Treatment Period (4 Weeks)|Adverse Event|2
2170229|NCT01319929|3791171|FG001|First Treatment Period (4 Weeks)|Adverse Event|0
2170230|NCT01319929|3791170|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
2170231|NCT01319929|3791171|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
2170232|NCT01319929|3791170|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0
2170233|NCT01319929|3791171|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1
2170234|NCT01319929|3791170|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1
2170235|NCT01319929|3791171|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0
2170236|NCT01319929|3791170|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0
2170237|NCT01319929|3791171|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1
2170238|NCT01319994|3791180|FG000|Overall Study|Protocol Violation|7
2170239|NCT01319994|3791181|FG001|Overall Study|Protocol Violation|6
2170240|NCT01320033|3791190|FG000|Overall Study|Lack of Efficacy|0
2170241|NCT01320033|3791191|FG001|Overall Study|Lack of Efficacy|0
2170242|NCT01320033|3791192|FG002|Overall Study|Lack of Efficacy|1
2170243|NCT01320033|3791190|FG000|Overall Study|Adverse Event|9
2170244|NCT01320033|3791191|FG001|Overall Study|Adverse Event|7
2170245|NCT01320033|3791192|FG002|Overall Study|Adverse Event|8
2170246|NCT01320033|3791190|FG000|Overall Study|Withdrawal by Subject|22
2170247|NCT01320033|3791191|FG001|Overall Study|Withdrawal by Subject|23
2170248|NCT01320033|3791192|FG002|Overall Study|Withdrawal by Subject|23
2170249|NCT01320033|3791190|FG000|Overall Study|Protocol Violation|3
2170250|NCT01320033|3791191|FG001|Overall Study|Protocol Violation|5
2170251|NCT01320033|3791192|FG002|Overall Study|Protocol Violation|3
2170252|NCT01320033|3791190|FG000|Overall Study|Lost to Follow-up|22
2170253|NCT01320033|3791191|FG001|Overall Study|Lost to Follow-up|26
2170254|NCT01320033|3791192|FG002|Overall Study|Lost to Follow-up|17
2170255|NCT01320033|3791190|FG000|Overall Study|Other|2
2170256|NCT01320033|3791191|FG001|Overall Study|Other|3
2170257|NCT01320033|3791192|FG002|Overall Study|Other|1
2170258|NCT01320085|3791203|FG000|Overall Study|Treatment Ongoing|0
2170259|NCT01320085|3791204|FG001|Overall Study|Treatment Ongoing|13
2170260|NCT01320085|3791205|FG002|Overall Study|Treatment Ongoing|2
2170261|NCT01320085|3791203|FG000|Overall Study|Disease Progression|26
2170262|NCT01320085|3791204|FG001|Overall Study|Disease Progression|86
2170263|NCT01320085|3791205|FG002|Overall Study|Disease Progression|16
2170264|NCT01320085|3791203|FG000|Overall Study|Adverse Event|12
2170265|NCT01320085|3791204|FG001|Overall Study|Adverse Event|14
2170266|NCT01320085|3791205|FG002|Overall Study|Adverse Event|5
2170267|NCT01320085|3791203|FG000|Overall Study|Withdrawal by Subject|2
2170268|NCT01320085|3791204|FG001|Overall Study|Withdrawal by Subject|4
2170269|NCT01320085|3791205|FG002|Overall Study|Withdrawal by Subject|1
2170270|NCT01320085|3791203|FG000|Overall Study|Protocol Deviation|1
2170271|NCT01320085|3791204|FG001|Overall Study|Protocol Deviation|0
2170272|NCT01320085|3791205|FG002|Overall Study|Protocol Deviation|1
2170273|NCT01320150|3791224|FG000|Overall Study|Protocol Violation|15
2170274|NCT01320150|3791224|FG000|Overall Study|Withdrawal by Subject|5
2170275|NCT01320150|3791224|FG000|Overall Study|Death|2
2170276|NCT01320150|3791224|FG000|Overall Study|Lost to Follow-up|44
2170277|NCT01320202|3791230|FG000|Overall Study|Adverse Event|5
2170278|NCT01320202|3791231|FG001|Overall Study|Adverse Event|5
2170279|NCT01320202|3791230|FG000|Overall Study|Death|5
2170280|NCT01320202|3791231|FG001|Overall Study|Death|3
2170281|NCT01320202|3791230|FG000|Overall Study|Lost to Follow-up|1
2170282|NCT01320202|3791231|FG001|Overall Study|Lost to Follow-up|0
2170283|NCT01320202|3791230|FG000|Overall Study|Physician Decision|3
2170284|NCT01320202|3791231|FG001|Overall Study|Physician Decision|1
2170285|NCT01320202|3791230|FG000|Overall Study|Protocol Violation|2
2170286|NCT01320202|3791231|FG001|Overall Study|Protocol Violation|1
2170287|NCT01320202|3791230|FG000|Overall Study|Withdrawal by Subject|10
2170288|NCT01320202|3791231|FG001|Overall Study|Withdrawal by Subject|3
2170289|NCT01320202|3791230|FG000|Overall Study|non-protocol change to ESA or IV iron|17
2170290|NCT01320202|3791231|FG001|Overall Study|non-protocol change to ESA or IV iron|20
2170291|NCT01320202|3791230|FG000|Overall Study|kidney transplant|1
2170292|NCT01320202|3791231|FG001|Overall Study|kidney transplant|2
2170293|NCT01320202|3791230|FG000|Overall Study|blood transfusion|1
2170294|NCT01320202|3791231|FG001|Overall Study|blood transfusion|7
2170295|NCT01320202|3791230|FG000|Overall Study|moved/changed dialysis|5
2170296|NCT01320202|3791231|FG001|Overall Study|moved/changed dialysis|2
2170297|NCT01320202|3791230|FG000|Overall Study|sponsor request|2
2170298|NCT01320202|3791231|FG001|Overall Study|sponsor request|0
2170299|NCT01320202|3791230|FG000|Overall Study|ineligible|3
2170300|NCT01320202|3791231|FG001|Overall Study|ineligible|0
2296491|NCT02557516|3992425|FG001|Overall Study|Sponsor decision|1
2296492|NCT02557516|3992426|FG002|Overall Study|Sponsor decision|2
2296493|NCT02557516|3992427|FG003|Overall Study|Sponsor decision|8
2296494|NCT02557646|3992451|FG000|Overall Study|Adverse Event|40
2296495|NCT02557646|3992451|FG000|Overall Study|Death|1
2296496|NCT02557646|3992451|FG000|Overall Study|Lack of Efficacy|186
2296497|NCT02557646|3992451|FG000|Overall Study|Withdrawal by Subject|18
2296498|NCT02557646|3992451|FG000|Overall Study|Lost to Follow-up|17
2296499|NCT02557646|3992451|FG000|Overall Study|Other|14
2296500|NCT02558231|3992466|FG000|Overall Study|Death|4
2296501|NCT02558231|3992467|FG001|Overall Study|Death|12
2296502|NCT02558231|3992466|FG000|Overall Study|Lost to Follow-up|7
2296503|NCT02558231|3992467|FG001|Overall Study|Lost to Follow-up|4
2170301|NCT01320202|3791230|FG000|Overall Study|regained renal function|1
2170302|NCT01320202|3791231|FG001|Overall Study|regained renal function|0
2170303|NCT01320293|3791240|FG000|Overall Study|Lack of Efficacy|1
2170304|NCT01320293|3791240|FG000|Overall Study|Adverse Event|1
2296504|NCT02558231|3992466|FG000|Overall Study|Withdrawal by Subject|7
2170305|NCT01320722|3791266|FG000|Overall Study|Did not Receive Intervention|3
2170306|NCT01320722|3791267|FG001|Overall Study|Did not Receive Intervention|2
2170307|NCT01320722|3791268|FG002|Overall Study|Did not Receive Intervention|1
2170308|NCT01320722|3791269|FG003|Overall Study|Did not Receive Intervention|1
2170309|NCT01320722|3791270|FG004|Overall Study|Did not Receive Intervention|2
2170310|NCT01320722|3791266|FG000|Overall Study|Lost to Follow-up|0
2170311|NCT01320722|3791267|FG001|Overall Study|Lost to Follow-up|1
2170312|NCT01320722|3791268|FG002|Overall Study|Lost to Follow-up|0
2170313|NCT01320722|3791269|FG003|Overall Study|Lost to Follow-up|1
2170314|NCT01320722|3791270|FG004|Overall Study|Lost to Follow-up|3
2208244|NCT01637402|3847649|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4
2208245|NCT01637402|3847650|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
2208246|NCT01637402|3847649|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5
2208247|NCT01637402|3847650|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0
2208248|NCT01637584|3847677|FG000|Overall Study|Withdrawal by Subject|1
2208249|NCT01637584|3847678|FG001|Overall Study|Withdrawal by Subject|3
2296505|NCT02558231|3992467|FG001|Overall Study|Withdrawal by Subject|4
2296506|NCT02558231|3992466|FG000|Overall Study|Physician Decision|7
2170315|NCT01320722|3791266|FG000|Overall Study|Not Available for the 8 Week Visit|0
2170316|NCT01320722|3791267|FG001|Overall Study|Not Available for the 8 Week Visit|3
2170317|NCT01320722|3791268|FG002|Overall Study|Not Available for the 8 Week Visit|0
2170318|NCT01320722|3791269|FG003|Overall Study|Not Available for the 8 Week Visit|0
2170319|NCT01320722|3791270|FG004|Overall Study|Not Available for the 8 Week Visit|0
2170320|NCT01320722|3791266|FG000|Overall Study|Participant Developed a Rash|0
2170321|NCT01320722|3791267|FG001|Overall Study|Participant Developed a Rash|0
2170322|NCT01320722|3791268|FG002|Overall Study|Participant Developed a Rash|2
2170323|NCT01320722|3791269|FG003|Overall Study|Participant Developed a Rash|1
2170324|NCT01320722|3791270|FG004|Overall Study|Participant Developed a Rash|1
2170325|NCT01320722|3791266|FG000|Overall Study|Non-compliant with Medication|0
2170326|NCT01320722|3791267|FG001|Overall Study|Non-compliant with Medication|0
2170327|NCT01320722|3791268|FG002|Overall Study|Non-compliant with Medication|1
2170328|NCT01320722|3791269|FG003|Overall Study|Non-compliant with Medication|0
2170329|NCT01320722|3791270|FG004|Overall Study|Non-compliant with Medication|0
2170330|NCT01320722|3791266|FG000|Overall Study|Adverse Event|0
2170331|NCT01320722|3791267|FG001|Overall Study|Adverse Event|0
2170332|NCT01320722|3791268|FG002|Overall Study|Adverse Event|3
2170333|NCT01320722|3791269|FG003|Overall Study|Adverse Event|6
2170334|NCT01320722|3791270|FG004|Overall Study|Adverse Event|0
2170335|NCT01320722|3791266|FG000|Overall Study|Not Compliant with Study Procedures|0
2170336|NCT01320722|3791267|FG001|Overall Study|Not Compliant with Study Procedures|0
2170337|NCT01320722|3791268|FG002|Overall Study|Not Compliant with Study Procedures|0
2170338|NCT01320722|3791269|FG003|Overall Study|Not Compliant with Study Procedures|4
2170339|NCT01320722|3791270|FG004|Overall Study|Not Compliant with Study Procedures|0
2170340|NCT01320722|3791266|FG000|Overall Study|Pregnancy|0
2170341|NCT01320722|3791267|FG001|Overall Study|Pregnancy|0
2296507|NCT02558231|3992467|FG001|Overall Study|Physician Decision|5
2296508|NCT02558231|3992466|FG000|Overall Study|Sponsor Decision|0
2170342|NCT01320722|3791268|FG002|Overall Study|Pregnancy|0
2170343|NCT01320722|3791269|FG003|Overall Study|Pregnancy|1
2170344|NCT01320722|3791270|FG004|Overall Study|Pregnancy|0
2170345|NCT01320722|3791266|FG000|Overall Study|Started an Exclusionary Medication|0
2170346|NCT01320722|3791267|FG001|Overall Study|Started an Exclusionary Medication|0
2170347|NCT01320722|3791268|FG002|Overall Study|Started an Exclusionary Medication|0
2170348|NCT01320722|3791269|FG003|Overall Study|Started an Exclusionary Medication|0
2170349|NCT01320722|3791270|FG004|Overall Study|Started an Exclusionary Medication|1
2170350|NCT01320722|3791266|FG000|Overall Study|Withdrew due to Health Condition|0
2170351|NCT01320722|3791267|FG001|Overall Study|Withdrew due to Health Condition|0
2170352|NCT01320722|3791268|FG002|Overall Study|Withdrew due to Health Condition|0
2170353|NCT01320722|3791269|FG003|Overall Study|Withdrew due to Health Condition|0
2170354|NCT01320722|3791270|FG004|Overall Study|Withdrew due to Health Condition|1
2170355|NCT01320735|3791285|FG000|Overall Study|Adverse Event|3
2170356|NCT01320735|3791285|FG000|Overall Study|Withdrawal by Subject|3
2170357|NCT01320735|3791285|FG000|Overall Study|Lost to Follow-up|13
2170358|NCT01320735|3791285|FG000|Overall Study|Administrative Reason|6
2170359|NCT01320735|3791285|FG000|Overall Study|Progression/Hormone-Refractory Pca|55
2296509|NCT02558231|3992467|FG001|Overall Study|Sponsor Decision|1
2296510|NCT02558296|3992475|FG000|Completed the Study Through Week 24|Adverse Event|9
2296511|NCT02558296|3992476|FG001|Completed the Study Through Week 24|Adverse Event|3
2296512|NCT02558296|3992475|FG000|Completed the Study Through Week 24|Death|7
2296513|NCT02558296|3992476|FG001|Completed the Study Through Week 24|Death|7
2296514|NCT02558296|3992475|FG000|Completed the Study Through Week 24|Lost to Follow-up|8
2296515|NCT02558296|3992476|FG001|Completed the Study Through Week 24|Lost to Follow-up|1
2296516|NCT02558296|3992475|FG000|Completed the Study Through Week 24|Physician Decision|1
2170360|NCT01320735|3791285|FG000|Overall Study|Protocol Violation|1
2170361|NCT01320735|3791285|FG000|Overall Study|Other|1
2170362|NCT01320735|3791285|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7
2170363|NCT01320735|3791285|FG000|Overall Study|Investigator Unable to be Contacted|17
2170364|NCT01320943|3791306|FG000|Overall Study|Lost to Follow-up|1
2170365|NCT01320943|3791307|FG001|Overall Study|Lost to Follow-up|0
2170366|NCT01320943|3791306|FG000|Overall Study|Physician Decision|0
2170367|NCT01320943|3791307|FG001|Overall Study|Physician Decision|1
2170368|NCT01320943|3791306|FG000|Overall Study|Randomized but not Treated|0
2170369|NCT01320943|3791307|FG001|Overall Study|Randomized but not Treated|1
2170370|NCT01321073|3791320|FG000|Overall Study|Did not attempt implant|4
2170371|NCT01321073|3791320|FG000|Overall Study|Death|3
2170372|NCT01321606|3791370|FG000|Overall Study|Lost to Follow-up|0
2170373|NCT01321606|3791371|FG001|Overall Study|Lost to Follow-up|0
2170374|NCT01321606|3791372|FG002|Overall Study|Lost to Follow-up|0
2170375|NCT01321606|3791373|FG003|Overall Study|Lost to Follow-up|1
2170376|NCT01321710|3791386|FG000|Overall Study|Lost to Follow-up|4
2170377|NCT01321710|3791387|FG001|Overall Study|Lost to Follow-up|5
2170378|NCT01321710|3791388|FG002|Overall Study|Lost to Follow-up|0
2170379|NCT01321723|3791401|FG000|Overall Study|Adverse Event|3
2170380|NCT01321723|3791402|FG001|Overall Study|Adverse Event|5
2170381|NCT01321723|3791403|FG002|Overall Study|Adverse Event|2
2170382|NCT01321723|3791401|FG000|Overall Study|Withdrawal by Subject|2
2170383|NCT01321723|3791402|FG001|Overall Study|Withdrawal by Subject|0
2170384|NCT01321723|3791403|FG002|Overall Study|Withdrawal by Subject|2
2170385|NCT01321749|3791413|FG000|Overall Study|Lost to Follow-up|4
2170386|NCT01321749|3791414|FG001|Overall Study|Lost to Follow-up|11
2170387|NCT01321749|3791413|FG000|Overall Study|Protocol Violation|4
2170388|NCT01321749|3791414|FG001|Overall Study|Protocol Violation|7
2170389|NCT01321749|3791413|FG000|Overall Study|Withdrawal by Subject|5
2170390|NCT01321749|3791414|FG001|Overall Study|Withdrawal by Subject|4
2170391|NCT01321879|3791420|FG000|Overall Study|Lack of Efficacy|5
2170392|NCT01321879|3791420|FG000|Overall Study|Adverse Event|5
2170393|NCT01321879|3791420|FG000|Overall Study|Death|3
2170394|NCT01321879|3791420|FG000|Overall Study|Withdrawal by Subject|1
2170395|NCT01322009|3791426|FG000|Overall Study|Death|0
2170396|NCT01322009|3791427|FG001|Overall Study|Death|1
2170397|NCT01322009|3791426|FG000|Overall Study|Adverse Event|0
2170398|NCT01322009|3791427|FG001|Overall Study|Adverse Event|1
2170399|NCT01322009|3791426|FG000|Overall Study|ng tube discontinued|0
2170400|NCT01322009|3791427|FG001|Overall Study|ng tube discontinued|1
2170401|NCT01322347|3791453|FG000|Overall Study|Adverse Event|7
2170402|NCT01322347|3791454|FG001|Overall Study|Adverse Event|2
2170403|NCT01322347|3791453|FG000|Overall Study|Death|5
2170404|NCT01322347|3791454|FG001|Overall Study|Death|3
2170405|NCT01322347|3791453|FG000|Overall Study|Physician Decision|2
2170406|NCT01322347|3791454|FG001|Overall Study|Physician Decision|1
2170407|NCT01322347|3791453|FG000|Overall Study|Protocol Violation|5
2170408|NCT01322347|3791454|FG001|Overall Study|Protocol Violation|2
2170409|NCT01322347|3791453|FG000|Overall Study|Withdrawal by Subject|1
2170410|NCT01322347|3791454|FG001|Overall Study|Withdrawal by Subject|4
2170411|NCT01322347|3791453|FG000|Overall Study|non-protocol change to ESA or IV iron|14
2170412|NCT01322347|3791454|FG001|Overall Study|non-protocol change to ESA or IV iron|6
2170413|NCT01322347|3791453|FG000|Overall Study|blood transfusion|5
2170414|NCT01322347|3791454|FG001|Overall Study|blood transfusion|5
2170415|NCT01322347|3791453|FG000|Overall Study|sponsor decision|1
2170416|NCT01322347|3791454|FG001|Overall Study|sponsor decision|3
2170417|NCT01322347|3791453|FG000|Overall Study|ineligible|6
2170418|NCT01322347|3791454|FG001|Overall Study|ineligible|3
2170419|NCT01322347|3791453|FG000|Overall Study|kidney transplant|3
2170420|NCT01322347|3791454|FG001|Overall Study|kidney transplant|1
2170421|NCT01322347|3791453|FG000|Overall Study|study drug withheld > 12 wks|0
2170422|NCT01322347|3791454|FG001|Overall Study|study drug withheld > 12 wks|1
2170423|NCT01322347|3791453|FG000|Overall Study|moved/changed dialysis|2
2170424|NCT01322347|3791454|FG001|Overall Study|moved/changed dialysis|4
2170425|NCT01322386|3791468|FG000|Overall Study|Protocol Violation|0
2170426|NCT01322386|3791469|FG001|Overall Study|Protocol Violation|1
2170427|NCT01322386|3791468|FG000|Overall Study|Physician Decision|0
2170428|NCT01322386|3791469|FG001|Overall Study|Physician Decision|1
2170429|NCT01322490|3791480|FG000|Treatment Period|Adverse Event|12
2170430|NCT01322490|3791481|FG001|Treatment Period|Adverse Event|18
2170431|NCT01322490|3791482|FG002|Treatment Period|Adverse Event|15
2170432|NCT01322490|3791480|FG000|Treatment Period|Death|5
2170433|NCT01322490|3791481|FG001|Treatment Period|Death|7
2170434|NCT01322490|3791482|FG002|Treatment Period|Death|3
2170435|NCT01322490|3791480|FG000|Treatment Period|Lack of Efficacy|89
2170436|NCT01322490|3791481|FG001|Treatment Period|Lack of Efficacy|100
2170437|NCT01322490|3791482|FG002|Treatment Period|Lack of Efficacy|112
2170438|NCT01322490|3791480|FG000|Treatment Period|Physician Decision|0
2170439|NCT01322490|3791481|FG001|Treatment Period|Physician Decision|2
2170440|NCT01322490|3791482|FG002|Treatment Period|Physician Decision|1
2170441|NCT01322490|3791480|FG000|Treatment Period|Protocol Violation|7
2170442|NCT01322490|3791481|FG001|Treatment Period|Protocol Violation|5
2170443|NCT01322490|3791482|FG002|Treatment Period|Protocol Violation|4
2170444|NCT01322490|3791480|FG000|Treatment Period|Withdrawal by Subject|14
2170445|NCT01322490|3791481|FG001|Treatment Period|Withdrawal by Subject|16
2170446|NCT01322490|3791482|FG002|Treatment Period|Withdrawal by Subject|11
2170447|NCT01322490|3791480|FG000|Treatment Period|Non-compliance with study drug|0
2170448|NCT01322490|3791481|FG001|Treatment Period|Non-compliance with study drug|0
2170449|NCT01322490|3791482|FG002|Treatment Period|Non-compliance with study drug|1
2170450|NCT01322490|3791480|FG000|Treatment Period|Other per report|2
2170451|NCT01322490|3791481|FG001|Treatment Period|Other per report|2
2170452|NCT01322490|3791482|FG002|Treatment Period|Other per report|1
2170453|NCT01322490|3791480|FG000|Treatment Period|Randomized but Not Treated|3
2170454|NCT01322490|3791481|FG001|Treatment Period|Randomized but Not Treated|3
2170455|NCT01322490|3791482|FG002|Treatment Period|Randomized but Not Treated|5
2170456|NCT01322490|3791480|FG000|Long Term Follow-up Period|Death|235
2170457|NCT01322490|3791481|FG001|Long Term Follow-up Period|Death|239
2170458|NCT01322490|3791482|FG002|Long Term Follow-up Period|Death|236
2170459|NCT01322490|3791480|FG000|Long Term Follow-up Period|Lost to Follow-up|2
2170460|NCT01322490|3791481|FG001|Long Term Follow-up Period|Lost to Follow-up|2
2170461|NCT01322490|3791482|FG002|Long Term Follow-up Period|Lost to Follow-up|3
2170462|NCT01322490|3791480|FG000|Long Term Follow-up Period|Withdrawal by Subject|9
2170463|NCT01322490|3791481|FG001|Long Term Follow-up Period|Withdrawal by Subject|6
2170464|NCT01322490|3791482|FG002|Long Term Follow-up Period|Withdrawal by Subject|6
2170465|NCT01322490|3791480|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160
2170466|NCT01322490|3791481|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158
2170467|NCT01322490|3791482|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165
2170468|NCT01322490|3791480|FG000|Long Term Follow-up Period|Other per report|3
2170469|NCT01322490|3791481|FG001|Long Term Follow-up Period|Other per report|2
2170470|NCT01322490|3791482|FG002|Long Term Follow-up Period|Other per report|2
2170471|NCT01322490|3791480|FG000|Long Term Follow-up Period|Unknown/Missing|0
2170472|NCT01322490|3791481|FG001|Long Term Follow-up Period|Unknown/Missing|1
2170473|NCT01322490|3791482|FG002|Long Term Follow-up Period|Unknown/Missing|1
2179789|NCT01396057|3805511|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2179790|NCT01396057|3805512|FG001|Overall Study|Unsatisfactory therapeutic effect|6
2179791|NCT01396057|3805511|FG000|Overall Study|Protocol deviation|4
2179792|NCT01396057|3805512|FG001|Overall Study|Protocol deviation|4
2179793|NCT01396057|3805511|FG000|Overall Study|Consent withdrawn|3
2179794|NCT01396057|3805512|FG001|Overall Study|Consent withdrawn|2
2179795|NCT01396070|3805518|FG000|Overall Study|Withdrawal by Subject|2
2179796|NCT01396070|3805518|FG000|Overall Study|Death|2
2179797|NCT01396070|3805518|FG000|Overall Study|Adverse Event|8
2179798|NCT01396070|3805518|FG000|Overall Study|Physician Decision|3
2179799|NCT01396070|3805518|FG000|Overall Study|Lack of Efficacy|4
2179800|NCT01396083|3805525|FG000|Overall Study|Adverse Event|2
2179801|NCT01396083|3805526|FG001|Overall Study|Adverse Event|28
2179802|NCT01396083|3805525|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2179803|NCT01396083|3805526|FG001|Overall Study|Unsatisfactory therapeutic effect|13
2179804|NCT01396083|3805525|FG000|Overall Study|Consent withdrawn|4
2179805|NCT01396083|3805526|FG001|Overall Study|Consent withdrawn|5
2179806|NCT01396083|3805525|FG000|Overall Study|Protocol deviation(s)|0
2179807|NCT01396083|3805526|FG001|Overall Study|Protocol deviation(s)|1
2179808|NCT01396083|3805525|FG000|Overall Study|Abnormal laboratory value(s)|1
2179809|NCT01396083|3805526|FG001|Overall Study|Abnormal laboratory value(s)|0
2179810|NCT01396083|3805525|FG000|Overall Study|Administrative problems|1
2179811|NCT01396083|3805526|FG001|Overall Study|Administrative problems|0
2179812|NCT01396083|3805525|FG000|Overall Study|Lost to Follow-up|1
2179813|NCT01396083|3805526|FG001|Overall Study|Lost to Follow-up|0
2179814|NCT01396148|3805532|FG000|Overall Study|Patient Decision|1
2179815|NCT01396161|3805545|FG000|Overall Study|Withdrawal by Subject|0
2179816|NCT01396161|3805546|FG001|Overall Study|Withdrawal by Subject|0
2179817|NCT01396161|3805547|FG002|Overall Study|Withdrawal by Subject|0
2179818|NCT01396161|3805548|FG003|Overall Study|Withdrawal by Subject|0
2179819|NCT01396161|3805549|FG004|Overall Study|Withdrawal by Subject|1
2179820|NCT01396161|3805550|FG005|Overall Study|Withdrawal by Subject|0
2179821|NCT01396161|3805551|FG006|Overall Study|Withdrawal by Subject|0
2179822|NCT01396161|3805545|FG000|Overall Study|Other|0
2179823|NCT01396161|3805546|FG001|Overall Study|Other|0
2179824|NCT01396161|3805547|FG002|Overall Study|Other|0
2179825|NCT01396161|3805548|FG003|Overall Study|Other|0
2179826|NCT01396161|3805549|FG004|Overall Study|Other|0
2179827|NCT01396161|3805550|FG005|Overall Study|Other|0
2179828|NCT01396161|3805551|FG006|Overall Study|Other|1
2179829|NCT01396187|3805577|FG000|Overall Study|Adverse Event|0
2179830|NCT01396187|3805578|FG001|Overall Study|Adverse Event|1
2179831|NCT01396187|3805579|FG002|Overall Study|Adverse Event|0
2179832|NCT01396187|3805580|FG003|Overall Study|Adverse Event|0
2179833|NCT01396187|3805581|FG004|Overall Study|Adverse Event|0
2179834|NCT01396187|3805577|FG000|Overall Study|Withdrawal by Subject|0
2179835|NCT01396187|3805578|FG001|Overall Study|Withdrawal by Subject|1
2179836|NCT01396187|3805579|FG002|Overall Study|Withdrawal by Subject|1
2179837|NCT01396187|3805580|FG003|Overall Study|Withdrawal by Subject|0
2179838|NCT01396187|3805581|FG004|Overall Study|Withdrawal by Subject|0
2179839|NCT01396187|3805577|FG000|Overall Study|Other|1
2179840|NCT01396187|3805578|FG001|Overall Study|Other|1
2179841|NCT01396187|3805579|FG002|Overall Study|Other|0
2179842|NCT01396187|3805580|FG003|Overall Study|Other|0
2179843|NCT01396187|3805581|FG004|Overall Study|Other|1
2179844|NCT01396265|3805629|FG000|Rifa+Afatinib|Withdrawal by Subject|1
2179845|NCT01396317|3805637|FG000|Overall Study|Adverse Event|1
2179846|NCT01396317|3805638|FG001|Overall Study|Adverse Event|0
2179847|NCT01396395|3805653|FG000|Overall Study|Withdrawal by Subject|10
2179848|NCT01396395|3805654|FG001|Overall Study|Withdrawal by Subject|12
2170474|NCT01323192|3791598|FG000|Overall Study|Adverse Event|6
2170475|NCT01323192|3791599|FG001|Overall Study|Adverse Event|1
2170476|NCT01323192|3791598|FG000|Overall Study|Withdrawal by Subject|3
2170477|NCT01323192|3791599|FG001|Overall Study|Withdrawal by Subject|1
2170478|NCT01323192|3791598|FG000|Overall Study|Noncompliance with study medication|0
2170479|NCT01323192|3791599|FG001|Overall Study|Noncompliance with study medication|3
2170480|NCT01323192|3791598|FG000|Overall Study|Nonmedical reasons|0
2170481|NCT01323192|3791599|FG001|Overall Study|Nonmedical reasons|1
2170482|NCT01323270|3791607|FG000|Overall Study|Withdrawal by Subject|19
2170483|NCT01323270|3791608|FG001|Overall Study|Withdrawal by Subject|10
2170484|NCT01323270|3791607|FG000|Overall Study|Protocol Violation|9
2170485|NCT01323270|3791608|FG001|Overall Study|Protocol Violation|7
2170486|NCT01323270|3791607|FG000|Overall Study|Lost to Follow-up|4
2170487|NCT01323270|3791608|FG001|Overall Study|Lost to Follow-up|6
2170488|NCT01323270|3791607|FG000|Overall Study|Adverse Event|8
2170489|NCT01323270|3791608|FG001|Overall Study|Adverse Event|0
2170490|NCT01323270|3791607|FG000|Overall Study|Other|0
2170491|NCT01323270|3791608|FG001|Overall Study|Other|3
2170492|NCT01323270|3791607|FG000|Overall Study|Physician Decision|0
2170493|NCT01323270|3791608|FG001|Overall Study|Physician Decision|2
2170494|NCT01323270|3791607|FG000|Overall Study|Not eligible|1
2170495|NCT01323270|3791608|FG001|Overall Study|Not eligible|1
2170496|NCT01323270|3791607|FG000|Overall Study|Death|1
2170497|NCT01323270|3791608|FG001|Overall Study|Death|0
2170498|NCT01323270|3791607|FG000|Overall Study|Randomized, but not vaccinated|1
2170499|NCT01323270|3791608|FG001|Overall Study|Randomized, but not vaccinated|0
2170500|NCT01323387|3791615|FG000|Overall Study|Withdrawal by Subject|41
2170501|NCT01323387|3791615|FG000|Overall Study|Radiographic Data Unavailable|1
2170502|NCT01323387|3791615|FG000|Overall Study|Revision|14
2170503|NCT01323387|3791615|FG000|Overall Study|Protocol Violation|12
2170504|NCT01323387|3791615|FG000|Overall Study|Randomized but Never Treated|16
2170505|NCT01323478|3791621|FG000|Overall Study|Adverse Event|7
2170506|NCT01323478|3791621|FG000|Overall Study|Lack of Efficacy|4
2170507|NCT01323478|3791621|FG000|Overall Study|Non-compliance With Study Product|3
2170508|NCT01323478|3791621|FG000|Overall Study|Protocol Violation|1
2170509|NCT01323478|3791621|FG000|Overall Study|Withdrawal of Consent|1
2170510|NCT01323478|3791621|FG000|Overall Study|Administrative or Other Reasons|8
2170511|NCT01323530|3791636|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2
2170512|NCT01323530|3791637|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0
2170513|NCT01323530|3791638|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0
2170514|NCT01323530|3791639|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0
2170515|NCT01323530|3791640|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0
2170516|NCT01323530|3791641|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2
2170517|NCT01323530|3791642|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0
2170518|NCT01323530|3791636|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
2170519|NCT01323530|3791637|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
2170520|NCT01323530|3791638|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
2170521|NCT01323530|3791639|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
2170522|NCT01323530|3791640|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2
2170523|NCT01323530|3791641|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
2170524|NCT01323530|3791642|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
2170525|NCT01323530|3791636|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
2170526|NCT01323530|3791637|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
2170527|NCT01323530|3791638|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
2170528|NCT01323530|3791639|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
2170529|NCT01323530|3791640|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
2170530|NCT01323530|3791641|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
2170531|NCT01323530|3791642|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
2170532|NCT01323530|3791636|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
2170533|NCT01323530|3791637|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
2170534|NCT01323530|3791638|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
2170535|NCT01323530|3791639|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
2170536|NCT01323530|3791640|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
2170537|NCT01323530|3791641|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
2170538|NCT01323530|3791642|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2
2170539|NCT01323530|3791636|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
2170540|NCT01323530|3791637|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
2170541|NCT01323530|3791638|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
2170542|NCT01323530|3791639|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
2170543|NCT01323530|3791640|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
2170544|NCT01323530|3791641|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
2170545|NCT01323530|3791642|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3
2170546|NCT01323530|3791636|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
2170547|NCT01323530|3791637|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
2170548|NCT01323530|3791638|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
2170549|NCT01323530|3791639|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
2170550|NCT01323530|3791640|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
2170551|NCT01323530|3791641|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
2170552|NCT01323530|3791642|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8
2170553|NCT01323530|3791636|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
2170554|NCT01323530|3791637|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
2170555|NCT01323530|3791638|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
2170556|NCT01323530|3791639|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
2170557|NCT01323530|3791640|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
2170558|NCT01323530|3791641|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
2170559|NCT01323530|3791642|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3
2170560|NCT01323530|3791636|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
2170561|NCT01323530|3791637|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
2170562|NCT01323530|3791638|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
2170563|NCT01323530|3791639|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
2170564|NCT01323530|3791640|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
2170565|NCT01323530|3791641|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
2170566|NCT01323530|3791642|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1
2170567|NCT01323582|3791661|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2
2170568|NCT01323582|3791662|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2
2170569|NCT01323582|3791661|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0
2170570|NCT01323582|3791662|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1
2170571|NCT01323582|3791661|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
2170572|NCT01323582|3791662|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
2170573|NCT01323621|3791683|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
2170574|NCT01323621|3791684|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
2170575|NCT01323621|3791685|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
2170576|NCT01323621|3791683|FG000|2-week, Single-blind Run In Period|Physician Decision|7
2170577|NCT01323621|3791684|FG001|2-week, Single-blind Run In Period|Physician Decision|0
2170578|NCT01323621|3791685|FG002|2-week, Single-blind Run In Period|Physician Decision|0
2170579|NCT01323621|3791683|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12
2170580|NCT01323621|3791684|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0
2170581|NCT01323621|3791685|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0
2170582|NCT01323621|3791683|FG000|2-week, Single-blind Run In Period|Protocol Violation|1
2170583|NCT01323621|3791684|FG001|2-week, Single-blind Run In Period|Protocol Violation|0
2170584|NCT01323621|3791685|FG002|2-week, Single-blind Run In Period|Protocol Violation|0
2170585|NCT01323621|3791683|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1
2170586|NCT01323621|3791684|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0
2170587|NCT01323621|3791685|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0
2170588|NCT01323621|3791683|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
2170589|NCT01323621|3791684|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
2170590|NCT01323621|3791685|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
2170591|NCT01323621|3791683|FG000|12-week, Double-blind Treatment Period|Adverse Event|0
2170592|NCT01323621|3791684|FG001|12-week, Double-blind Treatment Period|Adverse Event|1
2170593|NCT01323621|3791685|FG002|12-week, Double-blind Treatment Period|Adverse Event|5
2170594|NCT01323621|3791683|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0
2170595|NCT01323621|3791684|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2
2170596|NCT01323621|3791685|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6
2170597|NCT01323621|3791683|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0
2170598|NCT01323621|3791684|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4
2170599|NCT01323621|3791685|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4
2170600|NCT01323621|3791683|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0
2170601|NCT01323621|3791684|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1
2170602|NCT01323621|3791685|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0
2170603|NCT01323621|3791683|FG000|12-week, Double-blind Treatment Period|Physician Decision|0
2170604|NCT01323621|3791684|FG001|12-week, Double-blind Treatment Period|Physician Decision|2
2170605|NCT01323621|3791685|FG002|12-week, Double-blind Treatment Period|Physician Decision|1
2170606|NCT01323621|3791683|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
2170607|NCT01323621|3791684|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
2170608|NCT01323621|3791685|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
2170609|NCT01323634|3791693|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
2170610|NCT01323634|3791694|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
2170611|NCT01323634|3791695|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
2170612|NCT01323634|3791693|FG000|2-week Run-in Period|Continuation Criteria not Met|73
2170613|NCT01323634|3791694|FG001|2-week Run-in Period|Continuation Criteria not Met|0
2170614|NCT01323634|3791695|FG002|2-week Run-in Period|Continuation Criteria not Met|0
2170615|NCT01323634|3791693|FG000|2-week Run-in Period|Withdrawal by Subject|7
2170616|NCT01323634|3791694|FG001|2-week Run-in Period|Withdrawal by Subject|0
2170617|NCT01323634|3791695|FG002|2-week Run-in Period|Withdrawal by Subject|0
2170618|NCT01323634|3791693|FG000|2-week Run-in Period|Physician Decision|5
2170619|NCT01323634|3791694|FG001|2-week Run-in Period|Physician Decision|0
2170620|NCT01323634|3791695|FG002|2-week Run-in Period|Physician Decision|0
2170621|NCT01323634|3791693|FG000|2-week Run-in Period|Protocol Violation|1
2170622|NCT01323634|3791694|FG001|2-week Run-in Period|Protocol Violation|0
2170623|NCT01323634|3791695|FG002|2-week Run-in Period|Protocol Violation|0
2170624|NCT01323634|3791693|FG000|2-week Run-in Period|Adverse Event|1
2170625|NCT01323634|3791694|FG001|2-week Run-in Period|Adverse Event|0
2170626|NCT01323634|3791695|FG002|2-week Run-in Period|Adverse Event|0
2170627|NCT01323634|3791693|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0
2170628|NCT01323634|3791694|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8
2170629|NCT01323634|3791695|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4
2170630|NCT01323634|3791693|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2170631|NCT01323634|3791694|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2170632|NCT01323634|3791695|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
2170633|NCT01323634|3791693|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0
2170634|NCT01323634|3791694|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6
2170635|NCT01323634|3791695|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7
2170636|NCT01323634|3791693|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2170637|NCT01323634|3791694|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2170638|NCT01323634|3791695|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2170639|NCT01323634|3791693|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0
2170640|NCT01323634|3791694|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2
2170641|NCT01323634|3791695|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3
2170642|NCT01323634|3791693|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2170643|NCT01323634|3791694|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
2170644|NCT01323634|3791695|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
2170645|NCT01323634|3791693|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
2170646|NCT01323634|3791694|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
2170647|NCT01323634|3791695|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
2170648|NCT01323647|3791703|FG000|Overall Study|Migrated/moved from study area|2
2170649|NCT01323647|3791704|FG001|Overall Study|Migrated/moved from study area|0
2170650|NCT01323647|3791703|FG000|Overall Study|Withdrawal by Subject|5
2170651|NCT01323647|3791704|FG001|Overall Study|Withdrawal by Subject|0
2170652|NCT01323647|3791703|FG000|Overall Study|Lost to Follow-up|2
2170653|NCT01323647|3791704|FG001|Overall Study|Lost to Follow-up|0
2170654|NCT01323660|3791710|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6
2170655|NCT01323660|3791711|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
2170656|NCT01323660|3791712|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
2170657|NCT01323660|3791713|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
2170658|NCT01323660|3791714|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3
2170659|NCT01323660|3791715|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4
2170660|NCT01323660|3791710|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
2170661|NCT01323660|3791711|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
2170662|NCT01323660|3791712|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
2170663|NCT01323660|3791713|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
2170664|NCT01323660|3791714|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2170665|NCT01323660|3791715|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
2170666|NCT01323660|3791710|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2170667|NCT01323660|3791711|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2170668|NCT01323660|3791712|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2170669|NCT01323660|3791713|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2170670|NCT01323660|3791714|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2170671|NCT01323660|3791715|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2170672|NCT01323660|3791710|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2170673|NCT01323660|3791711|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2170674|NCT01323660|3791712|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2170675|NCT01323660|3791713|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2170676|NCT01323660|3791714|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
2170677|NCT01323660|3791715|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2170678|NCT01323660|3791710|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2170679|NCT01323660|3791711|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2170680|NCT01323660|3791712|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2170681|NCT01323660|3791713|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2170682|NCT01323660|3791714|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2170683|NCT01323660|3791715|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2170684|NCT01323660|3791710|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
2170685|NCT01323660|3791711|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2170686|NCT01323660|3791712|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2170687|NCT01323660|3791713|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2170688|NCT01323660|3791714|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
2170689|NCT01323660|3791715|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2170690|NCT01323660|3791710|FG000|Washout Period (14 Days)|Adverse Event|0
2170691|NCT01323660|3791711|FG001|Washout Period (14 Days)|Adverse Event|0
2170692|NCT01323660|3791712|FG002|Washout Period (14 Days)|Adverse Event|0
2170693|NCT01323660|3791713|FG003|Washout Period (14 Days)|Adverse Event|0
2170694|NCT01323660|3791714|FG004|Washout Period (14 Days)|Adverse Event|1
2170695|NCT01323660|3791715|FG005|Washout Period (14 Days)|Adverse Event|0
2170696|NCT01323660|3791710|FG000|Washout Period (14 Days)|Lack of Efficacy|0
2170697|NCT01323660|3791711|FG001|Washout Period (14 Days)|Lack of Efficacy|0
2170698|NCT01323660|3791712|FG002|Washout Period (14 Days)|Lack of Efficacy|1
2170699|NCT01323660|3791713|FG003|Washout Period (14 Days)|Lack of Efficacy|3
2170700|NCT01323660|3791714|FG004|Washout Period (14 Days)|Lack of Efficacy|2
2170701|NCT01323660|3791715|FG005|Washout Period (14 Days)|Lack of Efficacy|2
2170702|NCT01323660|3791710|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1
2170703|NCT01323660|3791711|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
2170704|NCT01323660|3791712|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0
2170705|NCT01323660|3791713|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
2170706|NCT01323660|3791714|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
2170707|NCT01323660|3791715|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2
2170708|NCT01323660|3791710|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
2170709|NCT01323660|3791711|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
2170710|NCT01323660|3791712|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
2170711|NCT01323660|3791713|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
2170712|NCT01323660|3791714|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2170713|NCT01323660|3791715|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
2170714|NCT01323660|3791710|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2170715|NCT01323660|3791711|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2170716|NCT01323660|3791712|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2170717|NCT01323660|3791713|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2170718|NCT01323660|3791714|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2170719|NCT01323660|3791715|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
2170720|NCT01323660|3791710|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2170721|NCT01323660|3791711|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2170722|NCT01323660|3791712|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2170723|NCT01323660|3791713|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2170724|NCT01323660|3791714|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2170725|NCT01323660|3791715|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2170726|NCT01323660|3791710|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2170727|NCT01323660|3791711|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2170728|NCT01323660|3791712|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2170729|NCT01323660|3791713|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2170730|NCT01323660|3791714|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
2170731|NCT01323660|3791715|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2170732|NCT01323673|3791731|FG000|Overall Study|Adverse Event|0
2170733|NCT01323673|3791732|FG001|Overall Study|Adverse Event|1
2170734|NCT01323673|3791731|FG000|Overall Study|Lost to Follow-up|0
2170735|NCT01323673|3791732|FG001|Overall Study|Lost to Follow-up|1
2170736|NCT01323673|3791731|FG000|Overall Study|Protocol Violation|1
2170737|NCT01323673|3791732|FG001|Overall Study|Protocol Violation|0
2170738|NCT01323673|3791731|FG000|Overall Study|Withdrawal by Subject|2
2170739|NCT01323673|3791732|FG001|Overall Study|Withdrawal by Subject|3
2170740|NCT01323790|3791752|FG000|Overall Study|Other|3
2170741|NCT01323790|3791753|FG001|Overall Study|Other|2
2170742|NCT01323790|3791754|FG002|Overall Study|Other|1
2170743|NCT01323790|3791752|FG000|Overall Study|Lost to Follow-up|11
2170744|NCT01323790|3791753|FG001|Overall Study|Lost to Follow-up|9
2170745|NCT01323790|3791754|FG002|Overall Study|Lost to Follow-up|9
2170746|NCT01323790|3791752|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
2170747|NCT01323790|3791753|FG001|Overall Study|Study-Specific Withdrawal Criteria|3
2170748|NCT01323790|3791754|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
2170749|NCT01323790|3791752|FG000|Overall Study|Lack of Efficacy|3
2170750|NCT01323790|3791753|FG001|Overall Study|Lack of Efficacy|0
2170751|NCT01323790|3791754|FG002|Overall Study|Lack of Efficacy|3
2170752|NCT01323790|3791752|FG000|Overall Study|Adverse Event|11
2170753|NCT01323790|3791753|FG001|Overall Study|Adverse Event|24
2170754|NCT01323790|3791754|FG002|Overall Study|Adverse Event|12
2170755|NCT01323790|3791752|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
2170756|NCT01323790|3791753|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
2170757|NCT01323790|3791754|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
2170758|NCT01323790|3791752|FG000|Overall Study|Withdrawal by Subject|23
2170759|NCT01323790|3791753|FG001|Overall Study|Withdrawal by Subject|20
2170760|NCT01323790|3791754|FG002|Overall Study|Withdrawal by Subject|13
2170761|NCT01323790|3791752|FG000|Overall Study|Did Not Receive Treatment|2
2170762|NCT01323790|3791753|FG001|Overall Study|Did Not Receive Treatment|0
2170763|NCT01323790|3791754|FG002|Overall Study|Did Not Receive Treatment|1
2170764|NCT01323790|3791752|FG000|Overall Study|Severe non-compliance with protocol|2
2170765|NCT01323790|3791753|FG001|Overall Study|Severe non-compliance with protocol|2
2170766|NCT01323790|3791754|FG002|Overall Study|Severe non-compliance with protocol|2
2170767|NCT01323920|3791783|FG000|Overall Study|Death|5
2170768|NCT01323920|3791783|FG000|Overall Study|Withdrawal by Subject|1
2170769|NCT01323946|3791790|FG000|Overall Study|Lost to Follow-up|0
2170770|NCT01323946|3791791|FG001|Overall Study|Lost to Follow-up|1
2170771|NCT01323946|3791792|FG002|Overall Study|Lost to Follow-up|0
2170772|NCT01323946|3791790|FG000|Overall Study|Parents refused the last blood draw|1
2170773|NCT01323946|3791791|FG001|Overall Study|Parents refused the last blood draw|0
2170774|NCT01323946|3791792|FG002|Overall Study|Parents refused the last blood draw|0
2170775|NCT01323946|3791790|FG000|Overall Study|Withdrawal by Subject|2
2170776|NCT01323946|3791791|FG001|Overall Study|Withdrawal by Subject|2
2170777|NCT01323946|3791792|FG002|Overall Study|Withdrawal by Subject|0
2170778|NCT01323972|3791819|FG000|Overall Study|Withdrawal by Subject|1
2170779|NCT01323972|3791820|FG001|Overall Study|Withdrawal by Subject|0
2170780|NCT01323972|3791821|FG002|Overall Study|Withdrawal by Subject|1
2170781|NCT01323972|3791822|FG003|Overall Study|Withdrawal by Subject|0
2170782|NCT01323972|3791819|FG000|Overall Study|Migrated/moved from study area|1
2170783|NCT01323972|3791820|FG001|Overall Study|Migrated/moved from study area|2
2170784|NCT01323972|3791821|FG002|Overall Study|Migrated/moved from study area|0
2170785|NCT01323972|3791822|FG003|Overall Study|Migrated/moved from study area|0
2170786|NCT01323972|3791819|FG000|Overall Study|Lost to Follow-up|0
2170787|NCT01323972|3791820|FG001|Overall Study|Lost to Follow-up|1
2170788|NCT01323972|3791821|FG002|Overall Study|Lost to Follow-up|1
2170789|NCT01323972|3791822|FG003|Overall Study|Lost to Follow-up|1
2170790|NCT01324024|3791855|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2
2170791|NCT01324024|3791856|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2170792|NCT01324102|3791868|FG000|Overall Study|illness|1
2170793|NCT01324102|3791869|FG001|Overall Study|illness|6
2170794|NCT01324141|3791891|FG000|Overall Study|Declined to participate before treatment started|1
2170795|NCT01324141|3791891|FG000|Overall Study|Disease progression on study|1
2170796|NCT01324232|3791909|FG000|Overall Study|Protocol Violation|0
2170797|NCT01324232|3791910|FG001|Overall Study|Protocol Violation|0
2170798|NCT01324232|3791911|FG002|Overall Study|Protocol Violation|0
2170799|NCT01324232|3791912|FG003|Overall Study|Protocol Violation|2
2170800|NCT01324232|3791909|FG000|Overall Study|Missing|0
2170801|NCT01324232|3791910|FG001|Overall Study|Missing|0
2170802|NCT01324232|3791911|FG002|Overall Study|Missing|1
2170803|NCT01324232|3791912|FG003|Overall Study|Missing|0
2170804|NCT01324232|3791909|FG000|Overall Study|Participant's Personal Reason/Decision|0
2170805|NCT01324232|3791910|FG001|Overall Study|Participant's Personal Reason/Decision|1
2170806|NCT01324232|3791911|FG002|Overall Study|Participant's Personal Reason/Decision|0
2170807|NCT01324232|3791912|FG003|Overall Study|Participant's Personal Reason/Decision|0
2170808|NCT01324232|3791909|FG000|Overall Study|Lack of Efficacy|2
2170809|NCT01324232|3791910|FG001|Overall Study|Lack of Efficacy|1
2170810|NCT01324232|3791911|FG002|Overall Study|Lack of Efficacy|2
2170811|NCT01324232|3791912|FG003|Overall Study|Lack of Efficacy|2
2170812|NCT01324232|3791909|FG000|Overall Study|Participant Refused Medication|0
2170813|NCT01324232|3791910|FG001|Overall Study|Participant Refused Medication|1
2170814|NCT01324232|3791911|FG002|Overall Study|Participant Refused Medication|0
2170815|NCT01324232|3791912|FG003|Overall Study|Participant Refused Medication|0
2170816|NCT01324232|3791909|FG000|Overall Study|Intercurrent illness|0
2170817|NCT01324232|3791910|FG001|Overall Study|Intercurrent illness|0
2170818|NCT01324232|3791911|FG002|Overall Study|Intercurrent illness|0
2170819|NCT01324232|3791912|FG003|Overall Study|Intercurrent illness|1
2170820|NCT01324232|3791909|FG000|Overall Study|Adverse Event|2
2170821|NCT01324232|3791910|FG001|Overall Study|Adverse Event|5
2170822|NCT01324232|3791911|FG002|Overall Study|Adverse Event|6
2170823|NCT01324232|3791912|FG003|Overall Study|Adverse Event|6
2170824|NCT01324232|3791909|FG000|Overall Study|Withdrawal by Subject|0
2170825|NCT01324232|3791910|FG001|Overall Study|Withdrawal by Subject|3
2170826|NCT01324232|3791911|FG002|Overall Study|Withdrawal by Subject|4
2170827|NCT01324232|3791912|FG003|Overall Study|Withdrawal by Subject|0
2170828|NCT01324232|3791909|FG000|Overall Study|Lost to Follow-up|1
2170829|NCT01324232|3791910|FG001|Overall Study|Lost to Follow-up|0
2170830|NCT01324232|3791911|FG002|Overall Study|Lost to Follow-up|0
2170831|NCT01324232|3791912|FG003|Overall Study|Lost to Follow-up|0
2170832|NCT01324271|3791927|FG000|Overall Study|Lost to Follow-up|3
2170833|NCT01324271|3791928|FG001|Overall Study|Lost to Follow-up|0
2170834|NCT01324271|3791927|FG000|Overall Study|Physician Decision|1
2170835|NCT01324271|3791928|FG001|Overall Study|Physician Decision|0
2170836|NCT01324310|3791934|FG000|Overall Study|Adverse Event|1
2170837|NCT01324310|3791934|FG000|Overall Study|Disease Progression|1
2170838|NCT01324323|3791940|FG000|Overall Study|Withdrawal by Subject|1
2170839|NCT01324349|3791954|FG000|Overall Study|Death|1
2170840|NCT01324349|3791955|FG001|Overall Study|Death|1
2170841|NCT01324349|3791954|FG000|Overall Study|Withdrawal by Subject|0
2170842|NCT01324349|3791955|FG001|Overall Study|Withdrawal by Subject|1
2170843|NCT01324388|3791964|FG000|Part 1 of Study|Adverse Event|2
2170844|NCT01324388|3791965|FG001|Part 1 of Study|Adverse Event|0
2170845|NCT01324388|3791966|FG002|Part 1 of Study|Adverse Event|0
2170846|NCT01324388|3791967|FG003|Part 1 of Study|Adverse Event|0
2170847|NCT01324388|3791964|FG000|Part 1 of Study|Protocol Violation|1
2170848|NCT01324388|3791965|FG001|Part 1 of Study|Protocol Violation|2
2170849|NCT01324388|3791966|FG002|Part 1 of Study|Protocol Violation|0
2170850|NCT01324388|3791967|FG003|Part 1 of Study|Protocol Violation|0
2170851|NCT01324388|3791964|FG000|Part 1 of Study|Physician Decision|1
2170852|NCT01324388|3791965|FG001|Part 1 of Study|Physician Decision|0
2170853|NCT01324388|3791966|FG002|Part 1 of Study|Physician Decision|0
2170854|NCT01324388|3791967|FG003|Part 1 of Study|Physician Decision|0
2170855|NCT01324388|3791964|FG000|Part 2 of Study: First Intervention|Protocol Violation|0
2170856|NCT01324388|3791965|FG001|Part 2 of Study: First Intervention|Protocol Violation|0
2170857|NCT01324388|3791966|FG002|Part 2 of Study: First Intervention|Protocol Violation|0
2170858|NCT01324388|3791967|FG003|Part 2 of Study: First Intervention|Protocol Violation|1
2170859|NCT01324388|3791964|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
2170860|NCT01324388|3791965|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
2170861|NCT01324388|3791966|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
2170862|NCT01324388|3791967|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
2170863|NCT01324401|3791981|FG000|Overall Study|Withdrawn before any treatment|0
2170864|NCT01324401|3791982|FG001|Overall Study|Withdrawn before any treatment|3
2170865|NCT01324401|3791981|FG000|Overall Study|Adverse Event|1
2170866|NCT01324401|3791982|FG001|Overall Study|Adverse Event|3
2170867|NCT01324440|3791990|FG000|Overall Study|Subject moved|0
2170868|NCT01324440|3791991|FG001|Overall Study|Subject moved|1
2170869|NCT01324570|3792021|FG000|Overall Study|Adverse Event|4
2170870|NCT01324570|3792022|FG001|Overall Study|Adverse Event|7
2170871|NCT01324570|3792021|FG000|Overall Study|Withdrawal by Subject|0
2170872|NCT01324570|3792022|FG001|Overall Study|Withdrawal by Subject|3
2170873|NCT01324570|3792021|FG000|Overall Study|Lack of Efficacy|0
2170874|NCT01324570|3792022|FG001|Overall Study|Lack of Efficacy|1
2170875|NCT01324570|3792021|FG000|Overall Study|Confirmed or suspected diversion|0
2170876|NCT01324570|3792022|FG001|Overall Study|Confirmed or suspected diversion|1
2170877|NCT01324570|3792021|FG000|Overall Study|Administrative|0
2170878|NCT01324570|3792022|FG001|Overall Study|Administrative|2
2170879|NCT01324622|3792032|FG000|Overall Study|Lost to Follow-up|7
2170880|NCT01324622|3792033|FG001|Overall Study|Lost to Follow-up|7
2170881|NCT01324622|3792032|FG000|Overall Study|Death|1
2170882|NCT01324622|3792033|FG001|Overall Study|Death|0
2170883|NCT01324622|3792032|FG000|Overall Study|Lack of Efficacy|1
2170884|NCT01324622|3792033|FG001|Overall Study|Lack of Efficacy|0
2170885|NCT01324830|3792085|FG000|Overall Study|Progressive Disease|3
2170886|NCT01324830|3792086|FG001|Overall Study|Progressive Disease|2
2170887|NCT01324830|3792087|FG002|Overall Study|Progressive Disease|3
2170888|NCT01324830|3792088|FG003|Overall Study|Progressive Disease|3
2170889|NCT01324830|3792089|FG004|Overall Study|Progressive Disease|6
2170890|NCT01324830|3792090|FG005|Overall Study|Progressive Disease|6
2170891|NCT01324830|3792091|FG006|Overall Study|Progressive Disease|3
2170892|NCT01324830|3792092|FG007|Overall Study|Progressive Disease|3
2170893|NCT01324830|3792093|FG008|Overall Study|Progressive Disease|3
2170894|NCT01324830|3792094|FG009|Overall Study|Progressive Disease|6
2170895|NCT01324830|3792095|FG010|Overall Study|Progressive Disease|2
2170896|NCT01324830|3792096|FG011|Overall Study|Progressive Disease|1
2170897|NCT01324830|3792097|FG012|Overall Study|Progressive Disease|1
2170898|NCT01324830|3792098|FG013|Overall Study|Progressive Disease|1
2170899|NCT01324830|3792099|FG014|Overall Study|Progressive Disease|1
2170900|NCT01324830|3792100|FG015|Overall Study|Progressive Disease|3
2170901|NCT01324830|3792101|FG016|Overall Study|Progressive Disease|2
2170902|NCT01324830|3792102|FG017|Overall Study|Progressive Disease|3
2170903|NCT01324830|3792103|FG018|Overall Study|Progressive Disease|4
2170904|NCT01324830|3792085|FG000|Overall Study|Dose limiting toxicity|0
2170905|NCT01324830|3792086|FG001|Overall Study|Dose limiting toxicity|0
2170906|NCT01324830|3792087|FG002|Overall Study|Dose limiting toxicity|0
2170907|NCT01324830|3792088|FG003|Overall Study|Dose limiting toxicity|0
2170908|NCT01324830|3792089|FG004|Overall Study|Dose limiting toxicity|1
2170909|NCT01324830|3792090|FG005|Overall Study|Dose limiting toxicity|0
2170910|NCT01324830|3792091|FG006|Overall Study|Dose limiting toxicity|0
2170911|NCT01324830|3792092|FG007|Overall Study|Dose limiting toxicity|0
2170912|NCT01324830|3792093|FG008|Overall Study|Dose limiting toxicity|0
2170913|NCT01324830|3792094|FG009|Overall Study|Dose limiting toxicity|0
2170914|NCT01324830|3792095|FG010|Overall Study|Dose limiting toxicity|0
2170915|NCT01324830|3792096|FG011|Overall Study|Dose limiting toxicity|0
2170916|NCT01324830|3792097|FG012|Overall Study|Dose limiting toxicity|0
2170917|NCT01324830|3792098|FG013|Overall Study|Dose limiting toxicity|0
2170918|NCT01324830|3792099|FG014|Overall Study|Dose limiting toxicity|0
2170919|NCT01324830|3792100|FG015|Overall Study|Dose limiting toxicity|0
2170920|NCT01324830|3792101|FG016|Overall Study|Dose limiting toxicity|1
2170921|NCT01324830|3792102|FG017|Overall Study|Dose limiting toxicity|1
2170922|NCT01324830|3792103|FG018|Overall Study|Dose limiting toxicity|1
2170923|NCT01324830|3792085|FG000|Overall Study|Reason not mentioned above|0
2170924|NCT01324830|3792086|FG001|Overall Study|Reason not mentioned above|0
2170925|NCT01324830|3792087|FG002|Overall Study|Reason not mentioned above|0
2170926|NCT01324830|3792088|FG003|Overall Study|Reason not mentioned above|0
2170927|NCT01324830|3792089|FG004|Overall Study|Reason not mentioned above|0
2170928|NCT01324830|3792090|FG005|Overall Study|Reason not mentioned above|0
2170929|NCT01324830|3792091|FG006|Overall Study|Reason not mentioned above|0
2170930|NCT01324830|3792092|FG007|Overall Study|Reason not mentioned above|0
2170931|NCT01324830|3792093|FG008|Overall Study|Reason not mentioned above|0
2170932|NCT01324830|3792094|FG009|Overall Study|Reason not mentioned above|0
2170933|NCT01324830|3792095|FG010|Overall Study|Reason not mentioned above|0
2170934|NCT01324830|3792096|FG011|Overall Study|Reason not mentioned above|0
2170935|NCT01324830|3792097|FG012|Overall Study|Reason not mentioned above|0
2170936|NCT01324830|3792098|FG013|Overall Study|Reason not mentioned above|0
2170937|NCT01324830|3792099|FG014|Overall Study|Reason not mentioned above|0
2170938|NCT01324830|3792100|FG015|Overall Study|Reason not mentioned above|0
2170939|NCT01324830|3792101|FG016|Overall Study|Reason not mentioned above|0
2170940|NCT01324830|3792102|FG017|Overall Study|Reason not mentioned above|1
2170941|NCT01324830|3792103|FG018|Overall Study|Reason not mentioned above|0
2170942|NCT01324830|3792085|FG000|Overall Study|Adverse Event, serious fatal|0
2170943|NCT01324830|3792086|FG001|Overall Study|Adverse Event, serious fatal|1
2170944|NCT01324830|3792087|FG002|Overall Study|Adverse Event, serious fatal|0
2170945|NCT01324830|3792088|FG003|Overall Study|Adverse Event, serious fatal|0
2170946|NCT01324830|3792089|FG004|Overall Study|Adverse Event, serious fatal|0
2170947|NCT01324830|3792090|FG005|Overall Study|Adverse Event, serious fatal|0
2170948|NCT01324830|3792091|FG006|Overall Study|Adverse Event, serious fatal|0
2170949|NCT01324830|3792092|FG007|Overall Study|Adverse Event, serious fatal|0
2170950|NCT01324830|3792093|FG008|Overall Study|Adverse Event, serious fatal|0
2170951|NCT01324830|3792094|FG009|Overall Study|Adverse Event, serious fatal|0
2170952|NCT01324830|3792095|FG010|Overall Study|Adverse Event, serious fatal|0
2170953|NCT01324830|3792096|FG011|Overall Study|Adverse Event, serious fatal|0
2170954|NCT01324830|3792097|FG012|Overall Study|Adverse Event, serious fatal|0
2170955|NCT01324830|3792098|FG013|Overall Study|Adverse Event, serious fatal|0
2170956|NCT01324830|3792099|FG014|Overall Study|Adverse Event, serious fatal|0
2170957|NCT01324830|3792100|FG015|Overall Study|Adverse Event, serious fatal|0
2170958|NCT01324830|3792101|FG016|Overall Study|Adverse Event, serious fatal|0
2170959|NCT01324830|3792102|FG017|Overall Study|Adverse Event, serious fatal|0
2170960|NCT01324830|3792103|FG018|Overall Study|Adverse Event, serious fatal|0
2170961|NCT01324830|3792085|FG000|Overall Study|Adverse Event, non-fatal|0
2170962|NCT01324830|3792086|FG001|Overall Study|Adverse Event, non-fatal|0
2170963|NCT01324830|3792087|FG002|Overall Study|Adverse Event, non-fatal|0
2170964|NCT01324830|3792088|FG003|Overall Study|Adverse Event, non-fatal|0
2170965|NCT01324830|3792089|FG004|Overall Study|Adverse Event, non-fatal|0
2170966|NCT01324830|3792090|FG005|Overall Study|Adverse Event, non-fatal|0
2170967|NCT01324830|3792091|FG006|Overall Study|Adverse Event, non-fatal|0
2170968|NCT01324830|3792092|FG007|Overall Study|Adverse Event, non-fatal|0
2170969|NCT01324830|3792093|FG008|Overall Study|Adverse Event, non-fatal|2
2170970|NCT01324830|3792094|FG009|Overall Study|Adverse Event, non-fatal|0
2170971|NCT01324830|3792095|FG010|Overall Study|Adverse Event, non-fatal|1
2170972|NCT01324830|3792096|FG011|Overall Study|Adverse Event, non-fatal|0
2170973|NCT01324830|3792097|FG012|Overall Study|Adverse Event, non-fatal|0
2170974|NCT01324830|3792098|FG013|Overall Study|Adverse Event, non-fatal|0
2170975|NCT01324830|3792099|FG014|Overall Study|Adverse Event, non-fatal|0
2170976|NCT01324830|3792100|FG015|Overall Study|Adverse Event, non-fatal|0
2170977|NCT01324830|3792101|FG016|Overall Study|Adverse Event, non-fatal|0
2170978|NCT01324830|3792102|FG017|Overall Study|Adverse Event, non-fatal|1
2170979|NCT01324830|3792103|FG018|Overall Study|Adverse Event, non-fatal|0
2170980|NCT01324830|3792085|FG000|Overall Study|Withdrawal by Subject|0
2170981|NCT01324830|3792086|FG001|Overall Study|Withdrawal by Subject|0
2170982|NCT01324830|3792087|FG002|Overall Study|Withdrawal by Subject|0
2170983|NCT01324830|3792088|FG003|Overall Study|Withdrawal by Subject|0
2170984|NCT01324830|3792089|FG004|Overall Study|Withdrawal by Subject|0
2170985|NCT01324830|3792090|FG005|Overall Study|Withdrawal by Subject|1
2170986|NCT01324830|3792091|FG006|Overall Study|Withdrawal by Subject|0
2170987|NCT01324830|3792092|FG007|Overall Study|Withdrawal by Subject|0
2170988|NCT01324830|3792093|FG008|Overall Study|Withdrawal by Subject|0
2170989|NCT01324830|3792094|FG009|Overall Study|Withdrawal by Subject|0
2170990|NCT01324830|3792095|FG010|Overall Study|Withdrawal by Subject|1
2170991|NCT01324830|3792096|FG011|Overall Study|Withdrawal by Subject|0
2170992|NCT01324830|3792097|FG012|Overall Study|Withdrawal by Subject|0
2170993|NCT01324830|3792098|FG013|Overall Study|Withdrawal by Subject|0
2170994|NCT01324830|3792099|FG014|Overall Study|Withdrawal by Subject|0
2170995|NCT01324830|3792100|FG015|Overall Study|Withdrawal by Subject|0
2170996|NCT01324830|3792101|FG016|Overall Study|Withdrawal by Subject|0
2170997|NCT01324830|3792102|FG017|Overall Study|Withdrawal by Subject|0
2170998|NCT01324830|3792103|FG018|Overall Study|Withdrawal by Subject|1
2170999|NCT01324947|3792160|FG000|Overall Study|Adverse Event|7
2171000|NCT01324947|3792160|FG000|Overall Study|Death|10
2171001|NCT01324947|3792160|FG000|Overall Study|Other|3
2171002|NCT01324947|3792160|FG000|Overall Study|Progressive Disease|50
2171003|NCT01324947|3792160|FG000|Overall Study|Withdrawal by Subject|3
2171004|NCT01324947|3792160|FG000|Overall Study|1 discontinued before starting drug|1
2171005|NCT01324999|3792166|FG000|Overall Study|Adverse Event|3
2171006|NCT01324999|3792166|FG000|Overall Study|Withdrawal by Subject|2
2171007|NCT01325207|3792185|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2171008|NCT01325207|3792186|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2171009|NCT01325207|3792187|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2171010|NCT01325207|3792188|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2171011|NCT01325207|3792189|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
2171012|NCT01325207|3792190|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2171013|NCT01325207|3792185|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
2179849|NCT01396395|3805653|FG000|Overall Study|Protocol Violation|3
2171014|NCT01325207|3792186|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
2171015|NCT01325207|3792187|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
2171016|NCT01325207|3792188|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
2171017|NCT01325207|3792189|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
2171018|NCT01325207|3792190|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
2171019|NCT01325207|3792185|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2171020|NCT01325207|3792186|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2171021|NCT01325207|3792187|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2171022|NCT01325207|3792188|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2171023|NCT01325207|3792189|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
2171024|NCT01325207|3792190|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
2171025|NCT01325207|3792185|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2171026|NCT01325207|3792186|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
2171027|NCT01325207|3792187|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2171028|NCT01325207|3792188|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2171029|NCT01325207|3792189|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2171030|NCT01325207|3792190|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2171031|NCT01325207|3792185|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2171032|NCT01325207|3792186|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2171033|NCT01325207|3792187|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2171034|NCT01325207|3792188|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2171035|NCT01325207|3792189|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2171036|NCT01325207|3792190|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
2171037|NCT01325207|3792185|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2171038|NCT01325207|3792186|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2171039|NCT01325207|3792187|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2171040|NCT01325207|3792188|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2171041|NCT01325207|3792189|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2171042|NCT01325207|3792190|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
2171043|NCT01325207|3792185|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2171044|NCT01325207|3792186|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2171045|NCT01325207|3792187|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2171046|NCT01325207|3792188|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2171047|NCT01325207|3792189|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
2171048|NCT01325207|3792190|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2171049|NCT01325337|3792219|FG000|Overall Study|Adverse Event|0
2171050|NCT01325337|3792220|FG001|Overall Study|Adverse Event|2
2171051|NCT01325337|3792221|FG002|Overall Study|Adverse Event|2
2171052|NCT01325337|3792222|FG003|Overall Study|Adverse Event|1
2171053|NCT01325337|3792223|FG004|Overall Study|Adverse Event|2
2171054|NCT01325337|3792219|FG000|Overall Study|Lost to Follow-up|2
2171055|NCT01325337|3792220|FG001|Overall Study|Lost to Follow-up|2
2171056|NCT01325337|3792221|FG002|Overall Study|Lost to Follow-up|2
2171057|NCT01325337|3792222|FG003|Overall Study|Lost to Follow-up|1
2171058|NCT01325337|3792223|FG004|Overall Study|Lost to Follow-up|2
2171059|NCT01325337|3792219|FG000|Overall Study|Personal Reasons|2
2171060|NCT01325337|3792220|FG001|Overall Study|Personal Reasons|5
2171061|NCT01325337|3792221|FG002|Overall Study|Personal Reasons|4
2171062|NCT01325337|3792222|FG003|Overall Study|Personal Reasons|8
2171063|NCT01325337|3792223|FG004|Overall Study|Personal Reasons|3
2171064|NCT01325337|3792219|FG000|Overall Study|Withdrawal by Subject|1
2171065|NCT01325337|3792220|FG001|Overall Study|Withdrawal by Subject|0
2171066|NCT01325337|3792221|FG002|Overall Study|Withdrawal by Subject|1
2171067|NCT01325337|3792222|FG003|Overall Study|Withdrawal by Subject|0
2171068|NCT01325337|3792223|FG004|Overall Study|Withdrawal by Subject|1
2171069|NCT01325350|3792240|FG000|Overall Study|Adverse Event|3
2171070|NCT01325350|3792241|FG001|Overall Study|Adverse Event|3
2171071|NCT01325350|3792242|FG002|Overall Study|Adverse Event|3
2171072|NCT01325350|3792243|FG003|Overall Study|Adverse Event|1
2171073|NCT01325350|3792244|FG004|Overall Study|Adverse Event|2
2171074|NCT01325350|3792240|FG000|Overall Study|Pregnancy|0
2171075|NCT01325350|3792241|FG001|Overall Study|Pregnancy|0
2171076|NCT01325350|3792242|FG002|Overall Study|Pregnancy|1
2171077|NCT01325350|3792243|FG003|Overall Study|Pregnancy|0
2171078|NCT01325350|3792244|FG004|Overall Study|Pregnancy|1
2171079|NCT01325350|3792240|FG000|Overall Study|Lost to Follow-up|1
2171080|NCT01325350|3792241|FG001|Overall Study|Lost to Follow-up|0
2171081|NCT01325350|3792242|FG002|Overall Study|Lost to Follow-up|5
2171082|NCT01325350|3792243|FG003|Overall Study|Lost to Follow-up|1
2171083|NCT01325350|3792244|FG004|Overall Study|Lost to Follow-up|5
2171084|NCT01325350|3792240|FG000|Overall Study|Personal Reasons|2
2171085|NCT01325350|3792241|FG001|Overall Study|Personal Reasons|1
2171086|NCT01325350|3792242|FG002|Overall Study|Personal Reasons|6
2171087|NCT01325350|3792243|FG003|Overall Study|Personal Reasons|5
2171088|NCT01325350|3792244|FG004|Overall Study|Personal Reasons|3
2171089|NCT01325350|3792240|FG000|Overall Study|Protocol Violation|0
2171090|NCT01325350|3792241|FG001|Overall Study|Protocol Violation|0
2171091|NCT01325350|3792242|FG002|Overall Study|Protocol Violation|0
2171092|NCT01325350|3792243|FG003|Overall Study|Protocol Violation|1
2171093|NCT01325350|3792244|FG004|Overall Study|Protocol Violation|0
2171094|NCT01325350|3792240|FG000|Overall Study|Withdrawal by Subject|0
2171095|NCT01325350|3792241|FG001|Overall Study|Withdrawal by Subject|0
2171096|NCT01325350|3792242|FG002|Overall Study|Withdrawal by Subject|1
2171097|NCT01325350|3792243|FG003|Overall Study|Withdrawal by Subject|1
2171098|NCT01325350|3792244|FG004|Overall Study|Withdrawal by Subject|0
2171099|NCT01325350|3792240|FG000|Overall Study|Did Not Receive Treatment|0
2171100|NCT01325350|3792241|FG001|Overall Study|Did Not Receive Treatment|1
2171101|NCT01325350|3792242|FG002|Overall Study|Did Not Receive Treatment|1
2171102|NCT01325350|3792243|FG003|Overall Study|Did Not Receive Treatment|0
2171103|NCT01325350|3792244|FG004|Overall Study|Did Not Receive Treatment|1
2171104|NCT01325428|3792256|FG000|Part A|Progressive disease according to RECIST|9
2171105|NCT01325428|3792256|FG000|Part A|Clinical signs, symptoms of progression|2
2171106|NCT01325428|3792256|FG000|Part A|Other adverse event|1
2171107|NCT01325428|3792256|FG000|Part A|Refused continue taking trial medication|2
2171108|NCT01325428|3792256|FG000|Part A|Other reason not defined above|2
2171109|NCT01325428|3792256|FG000|Part B|Refused continue taking trial medication|2
2171110|NCT01325428|3792256|FG000|Part B|Other reason not defined above|1
2171111|NCT01325493|3792267|FG000|Overall Study|Protocol Violation|0
2171112|NCT01325493|3792268|FG001|Overall Study|Protocol Violation|1
2171113|NCT01325493|3792267|FG000|Overall Study|loss of neuromonitoring signals|0
2171114|NCT01325493|3792268|FG001|Overall Study|loss of neuromonitoring signals|2
2171115|NCT01325493|3792267|FG000|Overall Study|Allergy|1
2171116|NCT01325493|3792268|FG001|Overall Study|Allergy|0
2171117|NCT01325532|3792276|FG000|Overall Study|Withdrawal by Subject|2
2171118|NCT01325532|3792277|FG001|Overall Study|Withdrawal by Subject|0
2171119|NCT01325584|3792283|FG000|Overall Study|Death|1
2171120|NCT01325623|3792287|FG000|Overall Study|Withdrawal by Subject|3
2171121|NCT01325701|3792326|FG000|Overall Study|Adverse Event|12
2171122|NCT01325701|3792327|FG001|Overall Study|Adverse Event|0
2171123|NCT01325701|3792326|FG000|Overall Study|Protocol Violation|1
2171124|NCT01325701|3792327|FG001|Overall Study|Protocol Violation|0
2171125|NCT01325701|3792326|FG000|Overall Study|Physician Decision|2
2171126|NCT01325701|3792327|FG001|Overall Study|Physician Decision|2
2171127|NCT01325701|3792326|FG000|Overall Study|Withdrawal by Subject|2
2171128|NCT01325701|3792327|FG001|Overall Study|Withdrawal by Subject|1
2171129|NCT01325701|3792326|FG000|Overall Study|Rollerover Extension Study|4
2171130|NCT01325701|3792327|FG001|Overall Study|Rollerover Extension Study|0
2171131|NCT01326026|3792364|FG000|Overall Study|Adverse Event|4
2171132|NCT01326026|3792365|FG001|Overall Study|Adverse Event|3
2171133|NCT01326026|3792364|FG000|Overall Study|Withdrawal Criteria|5
2171134|NCT01326026|3792365|FG001|Overall Study|Withdrawal Criteria|7
2171135|NCT01326026|3792364|FG000|Overall Study|Other|3
2171136|NCT01326026|3792365|FG001|Overall Study|Other|3
2171137|NCT01326481|3792371|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
2171138|NCT01326533|3792379|FG000|Overall Study|Lost to Follow-up|2
2171139|NCT01326533|3792380|FG001|Overall Study|Lost to Follow-up|0
2171140|NCT01326533|3792379|FG000|Overall Study|Withdrawal by Subject|1
2171141|NCT01326533|3792380|FG001|Overall Study|Withdrawal by Subject|0
2171142|NCT01326533|3792379|FG000|Overall Study|Adverse Event|1
2171143|NCT01326533|3792380|FG001|Overall Study|Adverse Event|0
2171144|NCT01326546|3792388|FG000|Overall Study|Lost to Follow-up|8
2171145|NCT01326546|3792389|FG001|Overall Study|Lost to Follow-up|7
2171146|NCT01326546|3792388|FG000|Overall Study|Protocol Violation|3
2171147|NCT01326546|3792389|FG001|Overall Study|Protocol Violation|4
2171148|NCT01326546|3792388|FG000|Overall Study|Pregnancy|0
2171149|NCT01326546|3792389|FG001|Overall Study|Pregnancy|1
2171150|NCT01326546|3792388|FG000|Overall Study|Adverse Event|1
2171151|NCT01326546|3792389|FG001|Overall Study|Adverse Event|0
2171152|NCT01326546|3792388|FG000|Overall Study|Withdrawal by Subject|5
2171153|NCT01326546|3792389|FG001|Overall Study|Withdrawal by Subject|1
2171154|NCT01326702|3792402|FG000|Overall Study|Other|1
2171155|NCT01326702|3792403|FG001|Overall Study|Other|0
2171156|NCT01326702|3792404|FG002|Overall Study|Other|0
2171157|NCT01326702|3792405|FG003|Overall Study|Other|0
2171158|NCT01326702|3792406|FG004|Overall Study|Other|0
2171159|NCT01326702|3792407|FG005|Overall Study|Other|1
2171160|NCT01326702|3792408|FG006|Overall Study|Other|0
2171161|NCT01326702|3792402|FG000|Overall Study|progressive disease|1
2171162|NCT01326702|3792403|FG001|Overall Study|progressive disease|1
2171163|NCT01326702|3792404|FG002|Overall Study|progressive disease|3
2171164|NCT01326702|3792405|FG003|Overall Study|progressive disease|1
2171165|NCT01326702|3792406|FG004|Overall Study|progressive disease|3
2171166|NCT01326702|3792407|FG005|Overall Study|progressive disease|2
2171167|NCT01326702|3792408|FG006|Overall Study|progressive disease|3
2171168|NCT01326702|3792402|FG000|Overall Study|Death|0
2171169|NCT01326702|3792403|FG001|Overall Study|Death|1
2171170|NCT01326702|3792404|FG002|Overall Study|Death|0
2171171|NCT01326702|3792405|FG003|Overall Study|Death|0
2171172|NCT01326702|3792406|FG004|Overall Study|Death|0
2171173|NCT01326702|3792407|FG005|Overall Study|Death|0
2171174|NCT01326702|3792408|FG006|Overall Study|Death|0
2171175|NCT01326702|3792402|FG000|Overall Study|Adverse Event|0
2171176|NCT01326702|3792403|FG001|Overall Study|Adverse Event|0
2171177|NCT01326702|3792404|FG002|Overall Study|Adverse Event|1
2171178|NCT01326702|3792405|FG003|Overall Study|Adverse Event|1
2171179|NCT01326702|3792406|FG004|Overall Study|Adverse Event|0
2171180|NCT01326702|3792407|FG005|Overall Study|Adverse Event|3
2171181|NCT01326702|3792408|FG006|Overall Study|Adverse Event|1
2171182|NCT01326702|3792402|FG000|Overall Study|Withdrawal by Subject|0
2171183|NCT01326702|3792403|FG001|Overall Study|Withdrawal by Subject|0
2171184|NCT01326702|3792404|FG002|Overall Study|Withdrawal by Subject|1
2171185|NCT01326702|3792405|FG003|Overall Study|Withdrawal by Subject|0
2171186|NCT01326702|3792406|FG004|Overall Study|Withdrawal by Subject|1
2171187|NCT01326702|3792407|FG005|Overall Study|Withdrawal by Subject|1
2171188|NCT01326702|3792408|FG006|Overall Study|Withdrawal by Subject|3
2171189|NCT01326702|3792402|FG000|Overall Study|Not Treated|0
2171190|NCT01326702|3792403|FG001|Overall Study|Not Treated|0
2171191|NCT01326702|3792404|FG002|Overall Study|Not Treated|0
2171192|NCT01326702|3792405|FG003|Overall Study|Not Treated|1
2171193|NCT01326702|3792406|FG004|Overall Study|Not Treated|0
2171194|NCT01326702|3792407|FG005|Overall Study|Not Treated|1
2171195|NCT01326702|3792408|FG006|Overall Study|Not Treated|0
2171196|NCT01326728|3792429|FG000|Overall Study|Death|13
2171197|NCT01326728|3792430|FG001|Overall Study|Death|0
2171198|NCT01326728|3792429|FG000|Overall Study|Early closure of study|34
2171199|NCT01326728|3792430|FG001|Overall Study|Early closure of study|9
2171200|NCT01326910|3792454|FG000|Overall Study|Withdrawal by Subject|3
2171201|NCT01326910|3792455|FG001|Overall Study|Withdrawal by Subject|2
2171202|NCT01326910|3792454|FG000|Overall Study|Protocol Violation|1
2171203|NCT01326910|3792455|FG001|Overall Study|Protocol Violation|1
2171204|NCT01326962|3792461|FG000|Overall Study|Adverse Event|1
2171205|NCT01326962|3792461|FG000|Overall Study|Withdrawal by Subject|1
2171206|NCT01326962|3792461|FG000|Overall Study|Lost to Follow-up|3
2171207|NCT01326962|3792461|FG000|Overall Study|Other|2
2171208|NCT01327053|3792467|FG000|Overall Study|Adverse Event|23
2171209|NCT01327053|3792468|FG001|Overall Study|Adverse Event|57
2171210|NCT01327053|3792467|FG000|Overall Study|Patient/guardian decision|11
2171211|NCT01327053|3792468|FG001|Overall Study|Patient/guardian decision|35
2171212|NCT01327053|3792467|FG000|Overall Study|Physician Decision|10
2171213|NCT01327053|3792468|FG001|Overall Study|Physician Decision|14
2171214|NCT01327053|3792467|FG000|Overall Study|Death|1
2171215|NCT01327053|3792468|FG001|Overall Study|Death|5
2171216|NCT01327053|3792467|FG000|Overall Study|Lost to Follow-up|2
2171217|NCT01327053|3792468|FG001|Overall Study|Lost to Follow-up|4
2171218|NCT01327053|3792467|FG000|Overall Study|Non-compliance with study treatment|0
2171219|NCT01327053|3792468|FG001|Overall Study|Non-compliance with study treatment|5
2171220|NCT01327053|3792467|FG000|Overall Study|Study terminated by Sponsor|1
2171221|NCT01327053|3792468|FG001|Overall Study|Study terminated by Sponsor|3
2171222|NCT01327053|3792467|FG000|Overall Study|Progressive disease|31
2171223|NCT01327053|3792468|FG001|Overall Study|Progressive disease|26
2171224|NCT01327053|3792467|FG000|Overall Study|Protocol Violation|0
2171225|NCT01327053|3792468|FG001|Overall Study|Protocol Violation|1
2171226|NCT01327053|3792467|FG000|Overall Study|Untreated|0
2171227|NCT01327053|3792468|FG001|Overall Study|Untreated|1
2171228|NCT01327300|3792497|FG000|Washout (3 Weeks)|Withdrawal by Subject|1
2171229|NCT01327300|3792498|FG001|Washout (3 Weeks)|Withdrawal by Subject|0
2171230|NCT01327339|3792531|FG000|Overall Study|Protocol Violation|8
2171231|NCT01327482|3792535|FG000|Overall Study|Adverse Event|1
2171232|NCT01327495|3792545|FG000|Overall Study|Adverse Event|2
2171233|NCT01327495|3792546|FG001|Overall Study|Adverse Event|1
2171234|NCT01327495|3792547|FG002|Overall Study|Adverse Event|1
2171235|NCT01327495|3792548|FG003|Overall Study|Adverse Event|0
2171236|NCT01327495|3792549|FG004|Overall Study|Adverse Event|0
2171237|NCT01327495|3792550|FG005|Overall Study|Adverse Event|2
2171238|NCT01327495|3792545|FG000|Overall Study|Withdrawal by Subject|0
2171239|NCT01327495|3792546|FG001|Overall Study|Withdrawal by Subject|1
2171240|NCT01327495|3792547|FG002|Overall Study|Withdrawal by Subject|1
2171241|NCT01327495|3792548|FG003|Overall Study|Withdrawal by Subject|0
2171242|NCT01327495|3792549|FG004|Overall Study|Withdrawal by Subject|1
2171243|NCT01327495|3792550|FG005|Overall Study|Withdrawal by Subject|0
2171244|NCT01327495|3792545|FG000|Overall Study|Physician Decision|0
2171245|NCT01327495|3792546|FG001|Overall Study|Physician Decision|0
2171246|NCT01327495|3792547|FG002|Overall Study|Physician Decision|0
2171247|NCT01327495|3792548|FG003|Overall Study|Physician Decision|0
2171248|NCT01327495|3792549|FG004|Overall Study|Physician Decision|2
2171249|NCT01327495|3792550|FG005|Overall Study|Physician Decision|0
2171250|NCT01327547|3792581|FG000|Overall Study|Adverse Event|4
2171251|NCT01327547|3792582|FG001|Overall Study|Adverse Event|1
2171252|NCT01327547|3792581|FG000|Overall Study|Death|1
2171253|NCT01327547|3792582|FG001|Overall Study|Death|2
2171254|NCT01327547|3792581|FG000|Overall Study|Lost to Follow-up|6
2171255|NCT01327547|3792582|FG001|Overall Study|Lost to Follow-up|6
2171256|NCT01327547|3792581|FG000|Overall Study|Non-Compliance With Study Treatment|0
2171257|NCT01327547|3792582|FG001|Overall Study|Non-Compliance With Study Treatment|2
2171258|NCT01327547|3792581|FG000|Overall Study|Withdrawal by Subject|3
2171259|NCT01327547|3792582|FG001|Overall Study|Withdrawal by Subject|7
2171260|NCT01327547|3792581|FG000|Overall Study|Does Not Meet Entrance Criteria|2
2171261|NCT01327547|3792582|FG001|Overall Study|Does Not Meet Entrance Criteria|2
2171262|NCT01327547|3792581|FG000|Overall Study|Protocol Violation|1
2171263|NCT01327547|3792582|FG001|Overall Study|Protocol Violation|0
2171264|NCT01327547|3792581|FG000|Overall Study|Non-compliance due to alcohol intake|0
2171265|NCT01327547|3792582|FG001|Overall Study|Non-compliance due to alcohol intake|1
2171266|NCT01327547|3792581|FG000|Overall Study|Required prohibited medication|2
2171267|NCT01327547|3792582|FG001|Overall Study|Required prohibited medication|0
2171268|NCT01327547|3792581|FG000|Overall Study|Non-compliance with study procedures|1
2171269|NCT01327547|3792582|FG001|Overall Study|Non-compliance with study procedures|0
2171270|NCT01327547|3792581|FG000|Overall Study|By investigator in subject's interest|0
2296517|NCT02558296|3992476|FG001|Completed the Study Through Week 24|Physician Decision|0
2296518|NCT02558296|3992475|FG000|Completed the Study Through Week 24|Protocol Violation|1
2171271|NCT01327547|3792582|FG001|Overall Study|By investigator in subject's interest|1
2171272|NCT01327573|3792599|FG000|Overall Study|Physician Decision|3
2171273|NCT01327573|3792600|FG001|Overall Study|Physician Decision|1
2171274|NCT01327599|3792607|FG000|Overall Study|Adverse Event|1
2171275|NCT01327599|3792607|FG000|Overall Study|Could Not Attend Visit|1
2171276|NCT01327599|3792607|FG000|Overall Study|Withdrawal of Consent|1
2171277|NCT01327612|3792618|FG000|Overall Study|Withdrawal by Subject|0
2171278|NCT01327612|3792619|FG001|Overall Study|Withdrawal by Subject|0
2171279|NCT01327612|3792620|FG002|Overall Study|Withdrawal by Subject|0
2171280|NCT01327612|3792621|FG003|Overall Study|Withdrawal by Subject|0
2171281|NCT01327612|3792622|FG004|Overall Study|Withdrawal by Subject|0
2171282|NCT01327612|3792623|FG005|Overall Study|Withdrawal by Subject|1
2171283|NCT01327612|3792624|FG006|Overall Study|Withdrawal by Subject|0
2171284|NCT01327612|3792618|FG000|Overall Study|Disease Progression|1
2171285|NCT01327612|3792619|FG001|Overall Study|Disease Progression|1
2171286|NCT01327612|3792620|FG002|Overall Study|Disease Progression|1
2171287|NCT01327612|3792621|FG003|Overall Study|Disease Progression|0
2171288|NCT01327612|3792622|FG004|Overall Study|Disease Progression|1
2171289|NCT01327612|3792623|FG005|Overall Study|Disease Progression|2
2171290|NCT01327612|3792624|FG006|Overall Study|Disease Progression|2
2171291|NCT01327612|3792618|FG000|Overall Study|Administrative Decision|0
2171292|NCT01327612|3792619|FG001|Overall Study|Administrative Decision|0
2171293|NCT01327612|3792620|FG002|Overall Study|Administrative Decision|0
2171294|NCT01327612|3792621|FG003|Overall Study|Administrative Decision|1
2171295|NCT01327612|3792622|FG004|Overall Study|Administrative Decision|0
2171296|NCT01327612|3792623|FG005|Overall Study|Administrative Decision|0
2171297|NCT01327612|3792624|FG006|Overall Study|Administrative Decision|0
2171298|NCT01327612|3792618|FG000|Overall Study|Death|0
2171299|NCT01327612|3792619|FG001|Overall Study|Death|0
2171300|NCT01327612|3792620|FG002|Overall Study|Death|0
2171301|NCT01327612|3792621|FG003|Overall Study|Death|0
2171302|NCT01327612|3792622|FG004|Overall Study|Death|1
2171303|NCT01327612|3792623|FG005|Overall Study|Death|0
2171304|NCT01327612|3792624|FG006|Overall Study|Death|0
2171305|NCT01327651|3792650|FG000|Self-administered Dosing Period|Lost to Follow-up|3
2171306|NCT01327651|3792651|FG001|Self-administered Dosing Period|Lost to Follow-up|2
2171307|NCT01327651|3792652|FG002|Self-administered Dosing Period|Lost to Follow-up|4
2171308|NCT01327651|3792653|FG003|Self-administered Dosing Period|Lost to Follow-up|2
2171309|NCT01327651|3792654|FG004|Self-administered Dosing Period|Lost to Follow-up|3
2171310|NCT01327651|3792655|FG005|Self-administered Dosing Period|Lost to Follow-up|0
2171311|NCT01327651|3792656|FG006|Self-administered Dosing Period|Lost to Follow-up|8
2171312|NCT01327651|3792657|FG007|Self-administered Dosing Period|Lost to Follow-up|9
2171313|NCT01327651|3792658|FG008|Self-administered Dosing Period|Lost to Follow-up|10
2296519|NCT02558296|3992476|FG001|Completed the Study Through Week 24|Protocol Violation|1
2296520|NCT02558296|3992475|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17
2296521|NCT02558296|3992476|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13
2296522|NCT02558296|3992475|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1
2296523|NCT02558296|3992476|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0
2296524|NCT02558296|3992475|FG000|Completed the Study|Adverse Event|14
2296525|NCT02558296|3992476|FG001|Completed the Study|Adverse Event|5
2296526|NCT02558296|3992475|FG000|Completed the Study|Death|39
2296527|NCT02558296|3992476|FG001|Completed the Study|Death|25
2296528|NCT02558296|3992475|FG000|Completed the Study|Lost to Follow-up|31
2296529|NCT02558296|3992476|FG001|Completed the Study|Lost to Follow-up|23
2296530|NCT02558296|3992475|FG000|Completed the Study|Physician Decision|6
2296531|NCT02558296|3992476|FG001|Completed the Study|Physician Decision|0
2296532|NCT02558296|3992475|FG000|Completed the Study|Protocol Violation|2
2296533|NCT02558296|3992476|FG001|Completed the Study|Protocol Violation|1
2296534|NCT02558296|3992475|FG000|Completed the Study|Withdrawal by Subject|53
2296535|NCT02558296|3992476|FG001|Completed the Study|Withdrawal by Subject|31
2296536|NCT02558296|3992475|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1
2296537|NCT02558296|3992476|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0
2296538|NCT02558400|3992498|FG000|Overall Study|Adverse Event|47
2296539|NCT02558400|3992499|FG001|Overall Study|Adverse Event|53
2296540|NCT02558400|3992500|FG002|Overall Study|Adverse Event|4
2296541|NCT02558400|3992498|FG000|Overall Study|Withdrawal by Subject|13
2296542|NCT02558400|3992499|FG001|Overall Study|Withdrawal by Subject|9
2296543|NCT02558400|3992500|FG002|Overall Study|Withdrawal by Subject|8
2296544|NCT02558400|3992498|FG000|Overall Study|Non-Compliant|0
2208250|NCT01637623|3847688|FG000|Overall Study|Lost to Follow-up|0
2208251|NCT01637623|3847689|FG001|Overall Study|Lost to Follow-up|0
2208252|NCT01637623|3847690|FG002|Overall Study|Lost to Follow-up|2
2208253|NCT01637623|3847688|FG000|Overall Study|Physician Decision|1
2208254|NCT01637623|3847689|FG001|Overall Study|Physician Decision|0
2208255|NCT01637623|3847690|FG002|Overall Study|Physician Decision|1
2208256|NCT01637922|3847704|FG000|Overall Study|Adverse Event|0
2208257|NCT01637922|3847705|FG001|Overall Study|Adverse Event|1
2208258|NCT01637922|3847704|FG000|Overall Study|Protocol Violation|0
2208259|NCT01637922|3847705|FG001|Overall Study|Protocol Violation|1
2208260|NCT01637922|3847704|FG000|Overall Study|Withdrawal by Subject|0
2208261|NCT01637922|3847705|FG001|Overall Study|Withdrawal by Subject|3
2208262|NCT01637922|3847704|FG000|Overall Study|Lost to Follow-up|2
2208263|NCT01637922|3847705|FG001|Overall Study|Lost to Follow-up|0
2208264|NCT01637961|3847721|FG000|Overall Study|Ineligible: wrong primary|1
2208265|NCT01637961|3847721|FG000|Overall Study|Ineligible: inadequate pathology|1
2208266|NCT01638000|3847733|FG000|Overall Study|Randomized but Never Received Drug|7
2208267|NCT01638000|3847734|FG001|Overall Study|Randomized but Never Received Drug|10
2171314|NCT01327651|3792650|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1
2171315|NCT01327651|3792651|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0
2171316|NCT01327651|3792652|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0
2171317|NCT01327651|3792653|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0
2171318|NCT01327651|3792654|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0
2171319|NCT01327651|3792655|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0
2171320|NCT01327651|3792656|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0
2171321|NCT01327651|3792657|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0
2171322|NCT01327651|3792658|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0
2171323|NCT01327651|3792650|FG000|Self-administered Dosing Period|Withdrawal by Subject|0
2171324|NCT01327651|3792651|FG001|Self-administered Dosing Period|Withdrawal by Subject|1
2171325|NCT01327651|3792652|FG002|Self-administered Dosing Period|Withdrawal by Subject|0
2171326|NCT01327651|3792653|FG003|Self-administered Dosing Period|Withdrawal by Subject|1
2171327|NCT01327651|3792654|FG004|Self-administered Dosing Period|Withdrawal by Subject|0
2171328|NCT01327651|3792655|FG005|Self-administered Dosing Period|Withdrawal by Subject|0
2171329|NCT01327651|3792656|FG006|Self-administered Dosing Period|Withdrawal by Subject|2
2171330|NCT01327651|3792657|FG007|Self-administered Dosing Period|Withdrawal by Subject|1
2171331|NCT01327651|3792658|FG008|Self-administered Dosing Period|Withdrawal by Subject|1
2171332|NCT01327651|3792650|FG000|Post Study Follow-up|Lost to Follow-up|0
2171333|NCT01327651|3792651|FG001|Post Study Follow-up|Lost to Follow-up|1
2171334|NCT01327651|3792652|FG002|Post Study Follow-up|Lost to Follow-up|1
2171335|NCT01327651|3792653|FG003|Post Study Follow-up|Lost to Follow-up|0
2171336|NCT01327651|3792654|FG004|Post Study Follow-up|Lost to Follow-up|0
2171337|NCT01327651|3792655|FG005|Post Study Follow-up|Lost to Follow-up|0
2171338|NCT01327651|3792656|FG006|Post Study Follow-up|Lost to Follow-up|4
2171339|NCT01327651|3792657|FG007|Post Study Follow-up|Lost to Follow-up|1
2171340|NCT01327651|3792658|FG008|Post Study Follow-up|Lost to Follow-up|2
2171341|NCT01327703|3792708|FG000|Second Treatment Period|Adverse Event|1
2171342|NCT01327703|3792709|FG001|Second Treatment Period|Adverse Event|1
2171343|NCT01327703|3792708|FG000|Second Treatment Period|Protocol Violation|0
2171344|NCT01327703|3792709|FG001|Second Treatment Period|Protocol Violation|1
2171345|NCT01327846|3792722|FG000|Core Phase|Subject decision (vital status: missing)|1
2171346|NCT01327846|3792723|FG001|Core Phase|Subject decision (vital status: missing)|2
2171347|NCT01327846|3792724|FG002|Core Phase|Subject decision (vital status: missing)|2
2171348|NCT01327846|3792725|FG003|Core Phase|Subject decision (vital status: missing)|1
2171349|NCT01327846|3792722|FG000|Core Phase|Subject decision (vital stat: unkn)|0
2171350|NCT01327846|3792723|FG001|Core Phase|Subject decision (vital stat: unkn)|0
2171351|NCT01327846|3792724|FG002|Core Phase|Subject decision (vital stat: unkn)|3
2171352|NCT01327846|3792725|FG003|Core Phase|Subject decision (vital stat: unkn)|3
2171353|NCT01327846|3792722|FG000|Core Phase|Subject decision (vital stat: dead)|1
2171354|NCT01327846|3792723|FG001|Core Phase|Subject decision (vital stat: dead)|3
2171355|NCT01327846|3792724|FG002|Core Phase|Subject decision (vital stat: dead)|4
2171356|NCT01327846|3792725|FG003|Core Phase|Subject decision (vital stat: dead)|4
2171357|NCT01327846|3792722|FG000|Core Phase|Subject decision (vital stat: alive)|23
2171358|NCT01327846|3792723|FG001|Core Phase|Subject decision (vital stat: alive)|24
2171359|NCT01327846|3792724|FG002|Core Phase|Subject decision (vital stat: alive)|13
2171360|NCT01327846|3792725|FG003|Core Phase|Subject decision (vital stat: alive)|20
2171361|NCT01327846|3792722|FG000|Core Phase|Lost to Follow-up|3
2171362|NCT01327846|3792723|FG001|Core Phase|Lost to Follow-up|3
2171363|NCT01327846|3792724|FG002|Core Phase|Lost to Follow-up|4
2171364|NCT01327846|3792725|FG003|Core Phase|Lost to Follow-up|5
2171365|NCT01327846|3792722|FG000|Extension Phase|Study terminated by sponsor|1073
2171366|NCT01327846|3792723|FG001|Extension Phase|Study terminated by sponsor|1124
2171367|NCT01327846|3792724|FG002|Extension Phase|Study terminated by sponsor|1067
2171368|NCT01327846|3792725|FG003|Extension Phase|Study terminated by sponsor|1660
2208268|NCT01638000|3847733|FG000|Overall Study|Adverse Event|14
2208269|NCT01638000|3847734|FG001|Overall Study|Adverse Event|16
2208270|NCT01638000|3847733|FG000|Overall Study|Lack of Efficacy|5
2171369|NCT01327846|3792722|FG000|Extension Phase|Withdrawal by Subject|20
2171370|NCT01327846|3792723|FG001|Extension Phase|Withdrawal by Subject|13
2171371|NCT01327846|3792724|FG002|Extension Phase|Withdrawal by Subject|19
2171372|NCT01327846|3792725|FG003|Extension Phase|Withdrawal by Subject|37
2171373|NCT01327846|3792722|FG000|Extension Phase|Lost to Follow-up|4
2171374|NCT01327846|3792723|FG001|Extension Phase|Lost to Follow-up|3
2171375|NCT01327846|3792724|FG002|Extension Phase|Lost to Follow-up|4
2171376|NCT01327846|3792725|FG003|Extension Phase|Lost to Follow-up|7
2171377|NCT01327846|3792722|FG000|Extension Phase|Technical Problems|2
2171378|NCT01327846|3792723|FG001|Extension Phase|Technical Problems|4
2171379|NCT01327846|3792724|FG002|Extension Phase|Technical Problems|2
2171380|NCT01327846|3792725|FG003|Extension Phase|Technical Problems|2
2171381|NCT01327885|3792738|FG000|Overall Study|Disease progression-according to RECIST|173
2171382|NCT01327885|3792739|FG001|Overall Study|Disease progression-according to RECIST|165
2171383|NCT01327885|3792738|FG000|Overall Study|Clinical progression|24
2171384|NCT01327885|3792739|FG001|Overall Study|Clinical progression|27
2171385|NCT01327885|3792738|FG000|Overall Study|Adverse Event|14
2171386|NCT01327885|3792739|FG001|Overall Study|Adverse Event|10
2171387|NCT01327885|3792738|FG000|Overall Study|Subject choice|5
2171388|NCT01327885|3792739|FG001|Overall Study|Subject choice|10
2171389|NCT01327885|3792738|FG000|Overall Study|Other|8
2171390|NCT01327885|3792739|FG001|Overall Study|Other|6
2171391|NCT01327885|3792738|FG000|Overall Study|Withdrawal of consent from study|3
2171392|NCT01327885|3792739|FG001|Overall Study|Withdrawal of consent from study|4
2171393|NCT01327885|3792738|FG000|Overall Study|Not treated|1
2171394|NCT01327885|3792739|FG001|Overall Study|Not treated|1
2171395|NCT01327885|3792738|FG000|Overall Study|Administrative decision|0
2171396|NCT01327885|3792739|FG001|Overall Study|Administrative decision|1
2171397|NCT01328002|3792767|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66
2171398|NCT01328002|3792768|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0
2171399|NCT01328002|3792767|FG000|Open-Label Period|Adverse Event|8
2171400|NCT01328002|3792768|FG001|Open-Label Period|Adverse Event|0
2171401|NCT01328002|3792767|FG000|Open-Label Period|Lack of Efficacy|3
2171402|NCT01328002|3792768|FG001|Open-Label Period|Lack of Efficacy|0
2171403|NCT01328002|3792767|FG000|Open-Label Period|Protocol Violation|2
2171404|NCT01328002|3792768|FG001|Open-Label Period|Protocol Violation|0
2171405|NCT01328002|3792767|FG000|Open-Label Period|Withdrawal by Subject|9
2171406|NCT01328002|3792768|FG001|Open-Label Period|Withdrawal by Subject|0
2171407|NCT01328002|3792767|FG000|Open-Label Period|Lost to Follow-up|6
2171408|NCT01328002|3792768|FG001|Open-Label Period|Lost to Follow-up|0
2171409|NCT01328002|3792767|FG000|Open-Label Period|Other Reason|2
2171410|NCT01328002|3792768|FG001|Open-Label Period|Other Reason|0
2171411|NCT01328002|3792767|FG000|Double-Blind Period|Adverse Event|1
2171412|NCT01328002|3792768|FG001|Double-Blind Period|Adverse Event|0
2171413|NCT01328002|3792767|FG000|Double-Blind Period|Lack of Efficacy|1
2171414|NCT01328002|3792768|FG001|Double-Blind Period|Lack of Efficacy|0
2171415|NCT01328041|3792775|FG000|Overall Study|Adverse Event|7
2171416|NCT01328041|3792775|FG000|Overall Study|Lack of Efficacy|27
2171417|NCT01328041|3792775|FG000|Overall Study|Protocol Violation|7
2171418|NCT01328041|3792775|FG000|Overall Study|Lost to Follow-up|7
2171419|NCT01328041|3792775|FG000|Overall Study|Physician Decision|2
2171420|NCT01328041|3792775|FG000|Overall Study|Withdrawal by Subject|7
2171421|NCT01328054|3792779|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
2171422|NCT01328054|3792780|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
2171423|NCT01328054|3792779|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
2171424|NCT01328054|3792780|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
2171425|NCT01328054|3792779|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
2171426|NCT01328054|3792780|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
2171427|NCT01328080|3792792|FG000|Overall Study|Lost to Follow-up|5
2179850|NCT01396395|3805654|FG001|Overall Study|Protocol Violation|1
2179851|NCT01396395|3805653|FG000|Overall Study|Adverse Event|10
2179852|NCT01396395|3805654|FG001|Overall Study|Adverse Event|2
2179853|NCT01396395|3805653|FG000|Overall Study|Lost to Follow-up|17
2179854|NCT01396395|3805654|FG001|Overall Study|Lost to Follow-up|11
2179855|NCT01396395|3805653|FG000|Overall Study|Other|0
2179856|NCT01396395|3805654|FG001|Overall Study|Other|1
2179857|NCT01396421|3805666|FG000|Overall Study|Lost to Follow-up|0
2041685|NCT00440466|3612399|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0
2041686|NCT00440466|3612400|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4
2041687|NCT00440466|3612401|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4
2041688|NCT00440518|3612425|FG000|Randomized /Titration Period|Lack of Efficacy|1
2041689|NCT00440518|3612426|FG001|Randomized /Titration Period|Lack of Efficacy|0
2041690|NCT00440518|3612427|FG002|Randomized /Titration Period|Lack of Efficacy|1
2041691|NCT00440518|3612425|FG000|Randomized /Titration Period|Subject Withdrew Consent|4
2041692|NCT00440518|3612426|FG001|Randomized /Titration Period|Subject Withdrew Consent|1
2041693|NCT00440518|3612427|FG002|Randomized /Titration Period|Subject Withdrew Consent|0
2041694|NCT00440518|3612425|FG000|Randomized /Titration Period|Protocol Deviation|1
2041695|NCT00440518|3612426|FG001|Randomized /Titration Period|Protocol Deviation|0
2041696|NCT00440518|3612427|FG002|Randomized /Titration Period|Protocol Deviation|0
2041697|NCT00440518|3612425|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2
2041698|NCT00440518|3612426|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3
2041699|NCT00440518|3612427|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2
2041700|NCT00440518|3612425|FG000|Randomized /Titration Period|Other|1
2041701|NCT00440518|3612426|FG001|Randomized /Titration Period|Other|0
2041702|NCT00440518|3612427|FG002|Randomized /Titration Period|Other|0
2041703|NCT00440518|3612425|FG000|Randomized /Titration Period|Lost to Follow-up|2
2041704|NCT00440518|3612426|FG001|Randomized /Titration Period|Lost to Follow-up|2
2041705|NCT00440518|3612427|FG002|Randomized /Titration Period|Lost to Follow-up|1
2041706|NCT00440518|3612425|FG000|Randomized /Titration Period|Adverse Event|2
2041707|NCT00440518|3612426|FG001|Randomized /Titration Period|Adverse Event|3
2041708|NCT00440518|3612427|FG002|Randomized /Titration Period|Adverse Event|0
2041709|NCT00440518|3612425|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3
2041710|NCT00440518|3612426|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4
2041711|NCT00440518|3612427|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2
2041712|NCT00440518|3612425|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
2041713|NCT00440518|3612426|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
2041714|NCT00440518|3612427|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
2171428|NCT01328249|3792811|FG000|Overall Study|Adverse Event|3
2171429|NCT01328249|3792812|FG001|Overall Study|Adverse Event|0
2171430|NCT01328249|3792811|FG000|Overall Study|Disease progression|1
2171431|NCT01328249|3792812|FG001|Overall Study|Disease progression|0
2171432|NCT01328249|3792811|FG000|Overall Study|Withdrawal by Subject|1
2171433|NCT01328249|3792812|FG001|Overall Study|Withdrawal by Subject|1
2171434|NCT01328249|3792811|FG000|Overall Study|Moved before end of treatment visit|1
2171435|NCT01328249|3792812|FG001|Overall Study|Moved before end of treatment visit|0
2171436|NCT01328249|3792811|FG000|Overall Study|Subject choice|1
2171437|NCT01328249|3792812|FG001|Overall Study|Subject choice|1
2171438|NCT01328249|3792811|FG000|Overall Study|Protocol Violation|0
2171439|NCT01328249|3792812|FG001|Overall Study|Protocol Violation|1
2171440|NCT01328366|3792820|FG000|Overall Study|Death|1
2171441|NCT01328366|3792820|FG000|Overall Study|Withdrawal by Subject|2
2171442|NCT01328366|3792820|FG000|Overall Study|Lost to Follow-up|7
2171443|NCT01328431|3792848|FG000|Baseline|Protocol Violation|0
2171444|NCT01328431|3792849|FG001|Baseline|Protocol Violation|2
2171445|NCT01328431|3792848|FG000|1 Month (1M)|Lost to Follow-up|55
2171446|NCT01328431|3792849|FG001|1 Month (1M)|Lost to Follow-up|58
2171447|NCT01328431|3792848|FG000|3 Month (3M)|Death|2
2171448|NCT01328431|3792849|FG001|3 Month (3M)|Death|2
2171449|NCT01328431|3792848|FG000|3 Month (3M)|Lost to Follow-up|75
2171450|NCT01328431|3792849|FG001|3 Month (3M)|Lost to Follow-up|70
2171451|NCT01328431|3792848|FG000|12 Month (12M)|Death|2
2171452|NCT01328431|3792849|FG001|12 Month (12M)|Death|6
2171453|NCT01328431|3792848|FG000|12 Month (12M)|Lost to Follow-up|82
2171454|NCT01328431|3792849|FG001|12 Month (12M)|Lost to Follow-up|91
2171455|NCT01328444|3792855|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3
2171456|NCT01328444|3792856|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
2171457|NCT01328444|3792857|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
2171458|NCT01328444|3792858|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
2171459|NCT01328444|3792859|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5
2171460|NCT01328444|3792860|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2
2171461|NCT01328444|3792855|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
2171462|NCT01328444|3792856|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2171463|NCT01328444|3792857|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2171464|NCT01328444|3792858|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2171465|NCT01328444|3792859|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
2171466|NCT01328444|3792860|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
2171467|NCT01328444|3792855|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2171468|NCT01328444|3792856|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2171469|NCT01328444|3792857|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2171470|NCT01328444|3792858|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2171471|NCT01328444|3792859|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2171472|NCT01328444|3792860|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2171473|NCT01328444|3792855|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2171474|NCT01328444|3792856|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
2171475|NCT01328444|3792857|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2171476|NCT01328444|3792858|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2171477|NCT01328444|3792859|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
2171478|NCT01328444|3792860|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2171479|NCT01328444|3792855|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
2171480|NCT01328444|3792856|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2171481|NCT01328444|3792857|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2171482|NCT01328444|3792858|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2171483|NCT01328444|3792859|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2171484|NCT01328444|3792860|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2171485|NCT01328444|3792855|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2171486|NCT01328444|3792856|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
2171487|NCT01328444|3792857|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2171488|NCT01328444|3792858|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
2171489|NCT01328444|3792859|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2171490|NCT01328444|3792860|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2171491|NCT01328444|3792855|FG000|Washout Period (14 Days)|Adverse Event|1
2171492|NCT01328444|3792856|FG001|Washout Period (14 Days)|Adverse Event|1
2171493|NCT01328444|3792857|FG002|Washout Period (14 Days)|Adverse Event|0
2171494|NCT01328444|3792858|FG003|Washout Period (14 Days)|Adverse Event|1
2171495|NCT01328444|3792859|FG004|Washout Period (14 Days)|Adverse Event|1
2171496|NCT01328444|3792860|FG005|Washout Period (14 Days)|Adverse Event|2
2171497|NCT01328444|3792855|FG000|Washout Period (14 Days)|Lack of Efficacy|0
2171498|NCT01328444|3792856|FG001|Washout Period (14 Days)|Lack of Efficacy|0
2171499|NCT01328444|3792857|FG002|Washout Period (14 Days)|Lack of Efficacy|0
2171500|NCT01328444|3792858|FG003|Washout Period (14 Days)|Lack of Efficacy|0
2171501|NCT01328444|3792859|FG004|Washout Period (14 Days)|Lack of Efficacy|0
2171502|NCT01328444|3792860|FG005|Washout Period (14 Days)|Lack of Efficacy|1
2171503|NCT01328444|3792855|FG000|Washout Period (14 Days)|Withdrawal by Subject|0
2171504|NCT01328444|3792856|FG001|Washout Period (14 Days)|Withdrawal by Subject|0
2171505|NCT01328444|3792857|FG002|Washout Period (14 Days)|Withdrawal by Subject|0
2171506|NCT01328444|3792858|FG003|Washout Period (14 Days)|Withdrawal by Subject|0
2171507|NCT01328444|3792859|FG004|Washout Period (14 Days)|Withdrawal by Subject|0
2171508|NCT01328444|3792860|FG005|Washout Period (14 Days)|Withdrawal by Subject|1
2171509|NCT01328444|3792855|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5
2171510|NCT01328444|3792856|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
2171511|NCT01328444|3792857|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1
2171512|NCT01328444|3792858|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
2171513|NCT01328444|3792859|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
2171514|NCT01328444|3792860|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0
2171515|NCT01328444|3792855|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
2171516|NCT01328444|3792856|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2171517|NCT01328444|3792857|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2171518|NCT01328444|3792858|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
2171519|NCT01328444|3792859|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
2171520|NCT01328444|3792860|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
2171521|NCT01328444|3792855|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1
2171522|NCT01328444|3792856|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2171523|NCT01328444|3792857|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2171524|NCT01328444|3792858|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2171525|NCT01328444|3792859|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1
2171526|NCT01328444|3792860|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2171527|NCT01328444|3792855|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2171528|NCT01328444|3792856|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2171529|NCT01328444|3792857|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2171530|NCT01328444|3792858|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
2171531|NCT01328444|3792859|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
2171532|NCT01328444|3792860|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2171533|NCT01328444|3792855|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2171534|NCT01328444|3792856|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2171535|NCT01328444|3792857|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2171536|NCT01328444|3792858|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2171537|NCT01328444|3792859|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2171538|NCT01328444|3792860|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
2171539|NCT01328444|3792855|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2171540|NCT01328444|3792856|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2171541|NCT01328444|3792857|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2171542|NCT01328444|3792858|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2171543|NCT01328444|3792859|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2171544|NCT01328444|3792860|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2171545|NCT01328496|3792876|FG000|Overall Study|Significant Change in Health Status|1
2171546|NCT01328496|3792877|FG001|Overall Study|Significant Change in Health Status|0
2171547|NCT01328535|3792886|FG000|Overall Study|Ineligible|1
2171548|NCT01328548|3792894|FG000|Overall Study|Death|3
2171549|NCT01328548|3792895|FG001|Overall Study|Death|0
2171550|NCT01328548|3792894|FG000|Overall Study|Protocol Violation|1
2171551|NCT01328548|3792895|FG001|Overall Study|Protocol Violation|0
2171552|NCT01328574|3792901|FG000|Overall Study|Refused further treatment|1
2171553|NCT01328717|3792910|FG000|Overall Study|Adverse Event|1
2171554|NCT01328756|3792923|FG000|Overall Study|Protocol Violation|4
2171555|NCT01328756|3792923|FG000|Overall Study|Adverse Event|39
2171556|NCT01328756|3792923|FG000|Overall Study|Lack of Efficacy|5
2171557|NCT01328756|3792923|FG000|Overall Study|Withdrawal by Subject|41
2171558|NCT01328756|3792923|FG000|Overall Study|Lost to Follow-up|5
2171559|NCT01328756|3792923|FG000|Overall Study|Other|29
2171560|NCT01328951|3792957|FG000|Overall Study|Disease Progression|17
2171561|NCT01328951|3792958|FG001|Overall Study|Disease Progression|14
2171562|NCT01328951|3792957|FG000|Overall Study|Adverse Event|2
2171563|NCT01328951|3792958|FG001|Overall Study|Adverse Event|0
2171564|NCT01328951|3792957|FG000|Overall Study|Death|243
2171565|NCT01328951|3792958|FG001|Overall Study|Death|258
2171566|NCT01328951|3792957|FG000|Overall Study|Lost to Follow-up|6
2171567|NCT01328951|3792958|FG001|Overall Study|Lost to Follow-up|7
2171568|NCT01328951|3792957|FG000|Overall Study|Withdrawal by Subject|6
2171569|NCT01328951|3792958|FG001|Overall Study|Withdrawal by Subject|6
2171570|NCT01328951|3792957|FG000|Overall Study|Study Closed by the Sponsor|36
2171571|NCT01328951|3792958|FG001|Overall Study|Study Closed by the Sponsor|31
2171572|NCT01328951|3792957|FG000|Overall Study|Other|11
2171573|NCT01328951|3792958|FG001|Overall Study|Other|6
2171574|NCT01329029|3792983|FG000|Overall Study|Withdrawal by Subject|117
2171575|NCT01329029|3792984|FG001|Overall Study|Withdrawal by Subject|87
2171576|NCT01329029|3792983|FG000|Overall Study|Adverse Event|82
2171577|NCT01329029|3792984|FG001|Overall Study|Adverse Event|29
2208271|NCT01638000|3847734|FG001|Overall Study|Lack of Efficacy|6
2208272|NCT01638000|3847733|FG000|Overall Study|Protocol Violation|11
2208273|NCT01638000|3847734|FG001|Overall Study|Protocol Violation|13
2208274|NCT01638000|3847733|FG000|Overall Study|Withdrawal by Subject|21
2171578|NCT01329029|3792983|FG000|Overall Study|Death|16
2171579|NCT01329029|3792984|FG001|Overall Study|Death|19
2171580|NCT01329029|3792983|FG000|Overall Study|Other|14
2171581|NCT01329029|3792984|FG001|Overall Study|Other|20
2171582|NCT01329029|3792983|FG000|Overall Study|COPD Exacerbation|11
2171583|NCT01329029|3792984|FG001|Overall Study|COPD Exacerbation|18
2171584|NCT01329029|3792983|FG000|Overall Study|Physician Decision|16
2171585|NCT01329029|3792984|FG001|Overall Study|Physician Decision|13
2171586|NCT01329029|3792983|FG000|Overall Study|Lost to Follow-up|8
2171587|NCT01329029|3792984|FG001|Overall Study|Lost to Follow-up|5
2171588|NCT01329029|3792983|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5
2171589|NCT01329029|3792984|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1
2171590|NCT01329263|3793015|FG000|Overall Study|Lost to Follow-up|4
2171591|NCT01329263|3793016|FG001|Overall Study|Lost to Follow-up|21
2171592|NCT01329263|3793015|FG000|Overall Study|Withdrawal by Subject|1
2171593|NCT01329263|3793016|FG001|Overall Study|Withdrawal by Subject|2
2171594|NCT01329328|3793027|FG000|Overall Study|Withdrawal by Subject|2
2171595|NCT01329328|3793028|FG001|Overall Study|Withdrawal by Subject|4
2171596|NCT01329328|3793029|FG002|Overall Study|Withdrawal by Subject|3
2171597|NCT01329419|3793041|FG000|Overall Study|Protocol Violation|235
2171598|NCT01329562|3793048|FG000|Overall Study|Protocol Violation|5
2171599|NCT01329562|3793049|FG001|Overall Study|Protocol Violation|3
2171600|NCT01329562|3793048|FG000|Overall Study|Lost to Follow-up|1
2171601|NCT01329562|3793049|FG001|Overall Study|Lost to Follow-up|1
2171602|NCT01329562|3793048|FG000|Overall Study|Subject withdrew due to personal issues.|3
2171603|NCT01329562|3793049|FG001|Overall Study|Subject withdrew due to personal issues.|2
2171604|NCT01329562|3793048|FG000|Overall Study|Physician Decision|0
2171605|NCT01329562|3793049|FG001|Overall Study|Physician Decision|1
2171606|NCT01329900|3793070|FG000|Overall Study|Elevated creatinine/renal function|1
2171607|NCT01329939|3793078|FG000|Overall Study|Lost to Follow-up|3
2171608|NCT01329939|3793079|FG001|Overall Study|Lost to Follow-up|0
2171609|NCT01329939|3793080|FG002|Overall Study|Lost to Follow-up|1
2171610|NCT01329939|3793081|FG003|Overall Study|Lost to Follow-up|2
2171611|NCT01329939|3793078|FG000|Overall Study|Withdrawal by Subject|0
2171612|NCT01329939|3793079|FG001|Overall Study|Withdrawal by Subject|1
2171613|NCT01329939|3793080|FG002|Overall Study|Withdrawal by Subject|0
2171614|NCT01329939|3793081|FG003|Overall Study|Withdrawal by Subject|0
2171615|NCT01329939|3793078|FG000|Overall Study|Adverse Event|0
2171616|NCT01329939|3793079|FG001|Overall Study|Adverse Event|0
2171617|NCT01329939|3793080|FG002|Overall Study|Adverse Event|0
2171618|NCT01329939|3793081|FG003|Overall Study|Adverse Event|3
2171619|NCT01329978|3793094|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
2171620|NCT01329978|3793095|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
2171621|NCT01329978|3793096|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
2171622|NCT01329978|3793097|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
2171623|NCT01329978|3793098|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
2171624|NCT01329978|3793094|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
2171625|NCT01329978|3793095|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
2171626|NCT01329978|3793096|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
2171627|NCT01329978|3793097|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
2171628|NCT01329978|3793098|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
2171629|NCT01329978|3793094|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
2171630|NCT01329978|3793095|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
2171631|NCT01329978|3793096|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
2171632|NCT01329978|3793097|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
2171633|NCT01329978|3793098|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
2171634|NCT01329978|3793094|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2171635|NCT01329978|3793095|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
2171636|NCT01329978|3793096|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2171637|NCT01329978|3793097|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2171638|NCT01329978|3793098|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2171639|NCT01329978|3793094|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2171640|NCT01329978|3793095|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
2171641|NCT01329978|3793096|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2171642|NCT01329978|3793097|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2171643|NCT01329978|3793098|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2171644|NCT01329978|3793094|FG000|Rerandomization Treatment Period|Lost to Follow-up|0
2171645|NCT01329978|3793095|FG001|Rerandomization Treatment Period|Lost to Follow-up|0
2171646|NCT01329978|3793096|FG002|Rerandomization Treatment Period|Lost to Follow-up|0
2171647|NCT01329978|3793097|FG003|Rerandomization Treatment Period|Lost to Follow-up|5
2171648|NCT01329978|3793098|FG004|Rerandomization Treatment Period|Lost to Follow-up|3
2171649|NCT01329978|3793094|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0
2171650|NCT01329978|3793095|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0
2171651|NCT01329978|3793096|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0
2171652|NCT01329978|3793097|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0
2171653|NCT01329978|3793098|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1
2171654|NCT01330017|3793115|FG000|Overall Study|Adverse Event|0
2171655|NCT01330017|3793116|FG001|Overall Study|Adverse Event|1
2171656|NCT01330017|3793117|FG002|Overall Study|Adverse Event|1
2171657|NCT01330017|3793118|FG003|Overall Study|Adverse Event|4
2171658|NCT01330017|3793119|FG004|Overall Study|Adverse Event|0
2171659|NCT01330017|3793115|FG000|Overall Study|Withdrawal by Subject|0
2171660|NCT01330017|3793116|FG001|Overall Study|Withdrawal by Subject|0
2171661|NCT01330017|3793117|FG002|Overall Study|Withdrawal by Subject|1
2171662|NCT01330017|3793118|FG003|Overall Study|Withdrawal by Subject|0
2171663|NCT01330017|3793119|FG004|Overall Study|Withdrawal by Subject|1
2171664|NCT01330017|3793115|FG000|Overall Study|Lost to Follow-up|0
2171665|NCT01330017|3793116|FG001|Overall Study|Lost to Follow-up|0
2171666|NCT01330017|3793117|FG002|Overall Study|Lost to Follow-up|1
2171667|NCT01330017|3793118|FG003|Overall Study|Lost to Follow-up|0
2171668|NCT01330017|3793119|FG004|Overall Study|Lost to Follow-up|0
2171669|NCT01330017|3793115|FG000|Overall Study|Protocol Violation|0
2171670|NCT01330017|3793116|FG001|Overall Study|Protocol Violation|0
2171671|NCT01330017|3793117|FG002|Overall Study|Protocol Violation|0
2171672|NCT01330017|3793118|FG003|Overall Study|Protocol Violation|1
2171673|NCT01330017|3793119|FG004|Overall Study|Protocol Violation|0
2171674|NCT01330017|3793115|FG000|Overall Study|Unknown Reason|5
2171675|NCT01330017|3793116|FG001|Overall Study|Unknown Reason|3
2171676|NCT01330017|3793117|FG002|Overall Study|Unknown Reason|5
2171677|NCT01330017|3793118|FG003|Overall Study|Unknown Reason|7
2171678|NCT01330017|3793119|FG004|Overall Study|Unknown Reason|2
2171679|NCT01330030|3793133|FG000|Overall Study|Lost to Follow-up|16
2171680|NCT01330030|3793134|FG001|Overall Study|Lost to Follow-up|17
2171681|NCT01330108|3793149|FG000|Overall Study|Withdrawal by Subject|4
2171682|NCT01330303|3793166|FG000|Period 1|Adverse Event|1
2171683|NCT01330303|3793167|FG001|Period 1|Adverse Event|0
2171684|NCT01330303|3793166|FG000|Period 1|Protocol Violation|0
2171685|NCT01330303|3793167|FG001|Period 1|Protocol Violation|1
2171686|NCT01330303|3793166|FG000|Period 1|Withdrawal by Subject|0
2171687|NCT01330303|3793167|FG001|Period 1|Withdrawal by Subject|1
2171688|NCT01330316|3793176|FG000|Overall Study|Adverse Event|2
2171689|NCT01330316|3793177|FG001|Overall Study|Adverse Event|2
2171690|NCT01330316|3793176|FG000|Overall Study|Lack of Efficacy|0
2171691|NCT01330316|3793177|FG001|Overall Study|Lack of Efficacy|10
2171692|NCT01330316|3793176|FG000|Overall Study|Lost to Follow-up|0
2171693|NCT01330316|3793177|FG001|Overall Study|Lost to Follow-up|1
2171694|NCT01330316|3793176|FG000|Overall Study|Withdrawal by Subject|0
2171695|NCT01330316|3793177|FG001|Overall Study|Withdrawal by Subject|1
2171696|NCT01330316|3793176|FG000|Overall Study|other than above|0
2171697|NCT01330316|3793177|FG001|Overall Study|other than above|1
2171698|NCT01330381|3793194|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
2171699|NCT01330381|3793195|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
2171700|NCT01330381|3793196|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
2171701|NCT01330381|3793194|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
2171702|NCT01330381|3793195|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
2171703|NCT01330381|3793196|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
2171704|NCT01330381|3793194|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
2171705|NCT01330381|3793195|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
2171706|NCT01330381|3793196|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
2171707|NCT01330381|3793194|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
2171708|NCT01330381|3793195|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
2171709|NCT01330381|3793196|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
2171710|NCT01330381|3793194|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
2171711|NCT01330381|3793195|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
2171712|NCT01330381|3793196|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
2171713|NCT01330381|3793194|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
2171714|NCT01330381|3793195|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
2171715|NCT01330381|3793196|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
2171716|NCT01330381|3793194|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
2171717|NCT01330381|3793195|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
2171718|NCT01330381|3793196|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
2171719|NCT01330381|3793194|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2
2171720|NCT01330381|3793195|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0
2171721|NCT01330381|3793196|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0
2171722|NCT01330381|3793194|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
2171723|NCT01330381|3793195|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
2171724|NCT01330381|3793196|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
2171725|NCT01330381|3793194|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0
2171726|NCT01330381|3793195|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0
2171727|NCT01330381|3793196|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1
2171728|NCT01330433|3793220|FG000|Overall Study|Death|1
2171729|NCT01330433|3793221|FG001|Overall Study|Death|3
2171730|NCT01330433|3793220|FG000|Overall Study|Lost to Follow-up|1
2171731|NCT01330433|3793221|FG001|Overall Study|Lost to Follow-up|0
2171732|NCT01330459|3793229|FG000|Overall Study|Physician Decision|0
2171733|NCT01330459|3793230|FG001|Overall Study|Physician Decision|2
2171734|NCT01330628|3793240|FG000|Overall Study|Death|2
2171735|NCT01330628|3793241|FG001|Overall Study|Death|3
2171736|NCT01330628|3793240|FG000|Overall Study|Lost to Follow-up|5
2171737|NCT01330628|3793241|FG001|Overall Study|Lost to Follow-up|6
2171738|NCT01330628|3793240|FG000|Overall Study|Adverse Event|44
2171739|NCT01330628|3793241|FG001|Overall Study|Adverse Event|25
2171740|NCT01330628|3793240|FG000|Overall Study|Withdrawn|18
2171741|NCT01330628|3793241|FG001|Overall Study|Withdrawn|6
2171742|NCT01330628|3793240|FG000|Overall Study|Didn't receive study treatment|1
2171743|NCT01330628|3793241|FG001|Overall Study|Didn't receive study treatment|0
2171744|NCT01330914|3793247|FG000|Overall Study|Withdrawal by Subject|4
2171745|NCT01330914|3793247|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3
2171746|NCT01331005|3793283|FG000|Overall Study|Lost to Follow-up|2
2171747|NCT01331005|3793284|FG001|Overall Study|Lost to Follow-up|1
2171748|NCT01331005|3793283|FG000|Overall Study|Withdrawal by Subject|2
2171749|NCT01331005|3793284|FG001|Overall Study|Withdrawal by Subject|3
2171750|NCT01331109|3793299|FG000|Overall Study|Adverse Event|6
2171751|NCT01331109|3793299|FG000|Overall Study|Lack of Efficacy|2
2171752|NCT01331109|3793299|FG000|Overall Study|Protocol Violation|3
2171753|NCT01331109|3793299|FG000|Overall Study|Withdrawal by Subject|7
2171754|NCT01331109|3793299|FG000|Overall Study|Lost to Follow-up|1
2171755|NCT01331109|3793299|FG000|Overall Study|Study Terminated by Sponsor|38
2171756|NCT01331161|3793305|FG000|Overall Study|Physician Decision|1
2171757|NCT01331161|3793306|FG001|Overall Study|Physician Decision|0
2171758|NCT01331161|3793305|FG000|Overall Study|Lost to Follow-up|0
2171759|NCT01331161|3793306|FG001|Overall Study|Lost to Follow-up|1
2171760|NCT01331161|3793305|FG000|Overall Study|Pregnancy|0
2171761|NCT01331161|3793306|FG001|Overall Study|Pregnancy|1
2171762|NCT01331239|3793325|FG000|Part II: Core Study|Adverse Event|0
2171763|NCT01331239|3793326|FG001|Part II: Core Study|Adverse Event|3
2171764|NCT01331239|3793327|FG002|Part II: Core Study|Adverse Event|0
2171765|NCT01331239|3793325|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0
2171766|NCT01331239|3793326|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2
2171767|NCT01331239|3793327|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1
2171768|NCT01331239|3793325|FG000|Part II: Core Study|Withdrawal by Subject|0
2171769|NCT01331239|3793326|FG001|Part II: Core Study|Withdrawal by Subject|2
2171770|NCT01331239|3793327|FG002|Part II: Core Study|Withdrawal by Subject|0
2171771|NCT01331239|3793325|FG000|Part II: Core Study|Administrative problems|0
2171772|NCT01331239|3793326|FG001|Part II: Core Study|Administrative problems|1
2171773|NCT01331239|3793327|FG002|Part II: Core Study|Administrative problems|0
2171774|NCT01331291|3793345|FG000|Overall Study|Lack of Efficacy|2
2171775|NCT01331291|3793346|FG001|Overall Study|Lack of Efficacy|8
2171776|NCT01331291|3793345|FG000|Overall Study|Death|0
2171777|NCT01331291|3793346|FG001|Overall Study|Death|1
2171778|NCT01331681|3793368|FG000|Overall Study|Adverse Event|10
2171779|NCT01331681|3793369|FG001|Overall Study|Adverse Event|13
2171780|NCT01331681|3793370|FG002|Overall Study|Adverse Event|10
2171781|NCT01331681|3793368|FG000|Overall Study|Death|6
2171782|NCT01331681|3793369|FG001|Overall Study|Death|6
2171783|NCT01331681|3793370|FG002|Overall Study|Death|2
2171784|NCT01331681|3793368|FG000|Overall Study|Lack of Efficacy|0
2171785|NCT01331681|3793369|FG001|Overall Study|Lack of Efficacy|1
2171786|NCT01331681|3793370|FG002|Overall Study|Lack of Efficacy|0
2171787|NCT01331681|3793368|FG000|Overall Study|Withdrawal by Subject|12
2171788|NCT01331681|3793369|FG001|Overall Study|Withdrawal by Subject|8
2171789|NCT01331681|3793370|FG002|Overall Study|Withdrawal by Subject|15
2171790|NCT01331681|3793368|FG000|Overall Study|Protocol Violation|1
2171791|NCT01331681|3793369|FG001|Overall Study|Protocol Violation|1
2296545|NCT02558400|3992499|FG001|Overall Study|Non-Compliant|1
2296546|NCT02558400|3992500|FG002|Overall Study|Non-Compliant|3
2296547|NCT02558400|3992498|FG000|Overall Study|Lost to Follow-up|5
2296548|NCT02558400|3992499|FG001|Overall Study|Lost to Follow-up|5
2296549|NCT02558400|3992500|FG002|Overall Study|Lost to Follow-up|4
2296550|NCT02558400|3992498|FG000|Overall Study|Lack of Efficacy|0
2296551|NCT02558400|3992499|FG001|Overall Study|Lack of Efficacy|13
2296552|NCT02558400|3992500|FG002|Overall Study|Lack of Efficacy|1
2171792|NCT01331681|3793370|FG002|Overall Study|Protocol Violation|0
2171793|NCT01331681|3793368|FG000|Overall Study|Lost to Follow-up|2
2171794|NCT01331681|3793369|FG001|Overall Study|Lost to Follow-up|4
2171795|NCT01331681|3793370|FG002|Overall Study|Lost to Follow-up|1
2171796|NCT01331681|3793368|FG000|Overall Study|Physician Decision|2
2171797|NCT01331681|3793369|FG001|Overall Study|Physician Decision|0
2171798|NCT01331681|3793370|FG002|Overall Study|Physician Decision|4
2171799|NCT01331681|3793368|FG000|Overall Study|Therapeutic procedure required|1
2171800|NCT01331681|3793369|FG001|Overall Study|Therapeutic procedure required|0
2171801|NCT01331681|3793370|FG002|Overall Study|Therapeutic procedure required|0
2171802|NCT01331681|3793368|FG000|Overall Study|Sponsor decision|1
2171803|NCT01331681|3793369|FG001|Overall Study|Sponsor decision|1
2171804|NCT01331681|3793370|FG002|Overall Study|Sponsor decision|0
2171805|NCT01331681|3793368|FG000|Overall Study|Switching to other therapy|0
2171806|NCT01331681|3793369|FG001|Overall Study|Switching to other therapy|0
2171807|NCT01331681|3793370|FG002|Overall Study|Switching to other therapy|1
2296553|NCT02558400|3992498|FG000|Overall Study|Disallowed Concurrent Medication|6
2296554|NCT02558400|3992499|FG001|Overall Study|Disallowed Concurrent Medication|7
2296555|NCT02558400|3992500|FG002|Overall Study|Disallowed Concurrent Medication|5
2296556|NCT02558400|3992498|FG000|Overall Study|Physician Decision|2
2296557|NCT02558400|3992499|FG001|Overall Study|Physician Decision|2
2296558|NCT02558400|3992500|FG002|Overall Study|Physician Decision|0
2296559|NCT02558400|3992498|FG000|Overall Study|Protocol Violation|6
2296560|NCT02558400|3992499|FG001|Overall Study|Protocol Violation|3
2171808|NCT01331681|3793368|FG000|Overall Study|Not Received Study Treatment|0
2171809|NCT01331681|3793369|FG001|Overall Study|Not Received Study Treatment|0
2171810|NCT01331681|3793370|FG002|Overall Study|Not Received Study Treatment|2
2171811|NCT01331824|3793403|FG000|Overall Study|Adverse Event|2
2171812|NCT01331824|3793403|FG000|Overall Study|Death|1
2171813|NCT01331824|3793403|FG000|Overall Study|Disease Progression|9
2171814|NCT01331824|3793403|FG000|Overall Study|Withdrawal by Subject|1
2171815|NCT01331837|3793409|FG000|Overall Study|Death|30
2171816|NCT01331837|3793410|FG001|Overall Study|Death|34
2171817|NCT01331837|3793409|FG000|Overall Study|Lost to Follow-up|3
2171818|NCT01331837|3793410|FG001|Overall Study|Lost to Follow-up|1
2171819|NCT01331837|3793409|FG000|Overall Study|Info not recorded|10
2171820|NCT01331837|3793410|FG001|Overall Study|Info not recorded|16
2171821|NCT01331837|3793409|FG000|Overall Study|Withdrawal by Subject|13
2171822|NCT01331837|3793410|FG001|Overall Study|Withdrawal by Subject|16
2171823|NCT01332019|3793418|FG000|Overall Study|Was Not Dosed|1
2171824|NCT01332019|3793419|FG001|Overall Study|Was Not Dosed|0
2171825|NCT01332019|3793418|FG000|Overall Study|Other|16
2171826|NCT01332019|3793419|FG001|Overall Study|Other|18
2171827|NCT01332019|3793418|FG000|Overall Study|Death|2
2171828|NCT01332019|3793419|FG001|Overall Study|Death|1
2171829|NCT01332019|3793418|FG000|Overall Study|Physician Decision|4
2171830|NCT01332019|3793419|FG001|Overall Study|Physician Decision|3
2171831|NCT01332019|3793418|FG000|Overall Study|Withdrawal by Subject|73
2171832|NCT01332019|3793419|FG001|Overall Study|Withdrawal by Subject|71
2171833|NCT01332019|3793418|FG000|Overall Study|Lost to Follow-up|4
2171834|NCT01332019|3793419|FG001|Overall Study|Lost to Follow-up|7
2171835|NCT01332019|3793418|FG000|Overall Study|Adverse Event|13
2171836|NCT01332019|3793419|FG001|Overall Study|Adverse Event|22
2171837|NCT01332149|3793441|FG000|Overall Study|Adverse Event|11
2171838|NCT01332149|3793442|FG001|Overall Study|Adverse Event|9
2171839|NCT01332149|3793441|FG000|Overall Study|Other unspecified|5
2171840|NCT01332149|3793442|FG001|Overall Study|Other unspecified|7
2171841|NCT01332149|3793441|FG000|Overall Study|Protocol Violation|1
2171842|NCT01332149|3793442|FG001|Overall Study|Protocol Violation|3
2171843|NCT01332149|3793441|FG000|Overall Study|Withdrawal by Subject|4
2171844|NCT01332149|3793442|FG001|Overall Study|Withdrawal by Subject|5
2171845|NCT01332149|3793441|FG000|Overall Study|Lost to Follow-up|1
2171846|NCT01332149|3793442|FG001|Overall Study|Lost to Follow-up|1
2171847|NCT01332149|3793441|FG000|Overall Study|Insufficient clinical response|4
2171848|NCT01332149|3793442|FG001|Overall Study|Insufficient clinical response|7
2171849|NCT01332149|3793441|FG000|Overall Study|Did not meet entrance criteria|3
2171850|NCT01332149|3793442|FG001|Overall Study|Did not meet entrance criteria|4
2171851|NCT01332149|3793441|FG000|Overall Study|Randomized but not treated|1
2171852|NCT01332149|3793442|FG001|Overall Study|Randomized but not treated|2
2171853|NCT01332227|3793467|FG000|Overall Study|Adverse Event|4
2171854|NCT01332227|3793468|FG001|Overall Study|Adverse Event|1
2171855|NCT01332227|3793467|FG000|Overall Study|Withdrawal by Subject|5
2171856|NCT01332227|3793468|FG001|Overall Study|Withdrawal by Subject|1
2171857|NCT01332227|3793467|FG000|Overall Study|Lost to Follow-up|2
2171858|NCT01332227|3793468|FG001|Overall Study|Lost to Follow-up|0
2171859|NCT01332227|3793467|FG000|Overall Study|Lack of Efficacy|3
2171860|NCT01332227|3793468|FG001|Overall Study|Lack of Efficacy|1
2171861|NCT01332227|3793467|FG000|Overall Study|Poor compliance/noncompliance|1
2171862|NCT01332227|3793468|FG001|Overall Study|Poor compliance/noncompliance|1
2171863|NCT01332227|3793467|FG000|Overall Study|Patient moved from area|1
2171864|NCT01332227|3793468|FG001|Overall Study|Patient moved from area|0
2171865|NCT01332227|3793467|FG000|Overall Study|Patient began prohibited medication|0
2171866|NCT01332227|3793468|FG001|Overall Study|Patient began prohibited medication|1
2171867|NCT01332292|3793483|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
2171868|NCT01332292|3793484|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
2296561|NCT02558400|3992500|FG002|Overall Study|Protocol Violation|8
2296562|NCT02558400|3992498|FG000|Overall Study|Death|0
2171869|NCT01332292|3793483|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
2171870|NCT01332292|3793484|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1
2171871|NCT01332292|3793483|FG000|Treatment Period 2 (14 Days)|Physician Decision|1
2171872|NCT01332292|3793484|FG001|Treatment Period 2 (14 Days)|Physician Decision|1
2171873|NCT01332305|3793497|FG000|Overall Study|Adverse Event|1
2171874|NCT01332305|3793498|FG001|Overall Study|Adverse Event|4
2171875|NCT01332305|3793499|FG002|Overall Study|Adverse Event|6
2171876|NCT01332305|3793500|FG003|Overall Study|Adverse Event|3
2171877|NCT01332305|3793501|FG004|Overall Study|Adverse Event|5
2171878|NCT01332305|3793497|FG000|Overall Study|Withdrawal by Subject|6
2171879|NCT01332305|3793498|FG001|Overall Study|Withdrawal by Subject|5
2171880|NCT01332305|3793499|FG002|Overall Study|Withdrawal by Subject|4
2171881|NCT01332305|3793500|FG003|Overall Study|Withdrawal by Subject|1
2171882|NCT01332305|3793501|FG004|Overall Study|Withdrawal by Subject|0
2171883|NCT01332305|3793497|FG000|Overall Study|Lost to Follow-up|0
2171884|NCT01332305|3793498|FG001|Overall Study|Lost to Follow-up|2
2171885|NCT01332305|3793499|FG002|Overall Study|Lost to Follow-up|3
2171886|NCT01332305|3793500|FG003|Overall Study|Lost to Follow-up|2
2171887|NCT01332305|3793501|FG004|Overall Study|Lost to Follow-up|3
2171888|NCT01332305|3793497|FG000|Overall Study|Protocol Violation|1
2171889|NCT01332305|3793498|FG001|Overall Study|Protocol Violation|2
2171890|NCT01332305|3793499|FG002|Overall Study|Protocol Violation|1
2171891|NCT01332305|3793500|FG003|Overall Study|Protocol Violation|0
2171892|NCT01332305|3793501|FG004|Overall Study|Protocol Violation|3
2171893|NCT01332305|3793497|FG000|Overall Study|Withdrawal by Sponsor|1
2171894|NCT01332305|3793498|FG001|Overall Study|Withdrawal by Sponsor|0
2171895|NCT01332305|3793499|FG002|Overall Study|Withdrawal by Sponsor|0
2171896|NCT01332305|3793500|FG003|Overall Study|Withdrawal by Sponsor|1
2171897|NCT01332305|3793501|FG004|Overall Study|Withdrawal by Sponsor|1
2171898|NCT01332305|3793497|FG000|Overall Study|Treatment Failure|1
2171899|NCT01332305|3793498|FG001|Overall Study|Treatment Failure|1
2171900|NCT01332305|3793499|FG002|Overall Study|Treatment Failure|0
2171901|NCT01332305|3793500|FG003|Overall Study|Treatment Failure|0
2171902|NCT01332305|3793501|FG004|Overall Study|Treatment Failure|0
2171903|NCT01332305|3793497|FG000|Overall Study|Physician Decision|0
2171904|NCT01332305|3793498|FG001|Overall Study|Physician Decision|0
2171905|NCT01332305|3793499|FG002|Overall Study|Physician Decision|0
2171906|NCT01332305|3793500|FG003|Overall Study|Physician Decision|1
2171907|NCT01332305|3793501|FG004|Overall Study|Physician Decision|0
2171908|NCT01332318|3793517|FG000|Overall Study|Adverse Event|0
2171909|NCT01332318|3793518|FG001|Overall Study|Adverse Event|3
2171910|NCT01332318|3793519|FG002|Overall Study|Adverse Event|0
2171911|NCT01332318|3793520|FG003|Overall Study|Adverse Event|0
2171912|NCT01332318|3793517|FG000|Overall Study|Withdrawal by Subject|1
2171913|NCT01332318|3793518|FG001|Overall Study|Withdrawal by Subject|1
2171914|NCT01332318|3793519|FG002|Overall Study|Withdrawal by Subject|0
2171915|NCT01332318|3793520|FG003|Overall Study|Withdrawal by Subject|1
2171916|NCT01332318|3793517|FG000|Overall Study|Protocol Violation|1
2171917|NCT01332318|3793518|FG001|Overall Study|Protocol Violation|0
2171918|NCT01332318|3793519|FG002|Overall Study|Protocol Violation|1
2171919|NCT01332318|3793520|FG003|Overall Study|Protocol Violation|1
2171920|NCT01332331|3793533|FG000|Overall Study|Lost to Follow-up|0
2171921|NCT01332331|3793534|FG001|Overall Study|Lost to Follow-up|1
2171922|NCT01332331|3793533|FG000|Overall Study|Adverse Event|1
2171923|NCT01332331|3793534|FG001|Overall Study|Adverse Event|1
2171924|NCT01332331|3793533|FG000|Overall Study|Physician Decision|1
2171925|NCT01332331|3793534|FG001|Overall Study|Physician Decision|0
2171926|NCT01332630|3793606|FG000|Overall Study|Withdrawal by Subject|3
2171927|NCT01332851|3793616|FG000|Overall Study|Withdrawal by Subject|4
2171928|NCT01332851|3793617|FG001|Overall Study|Withdrawal by Subject|2
2171929|NCT01332851|3793616|FG000|Overall Study|Lost to Follow-up|7
2171930|NCT01332851|3793617|FG001|Overall Study|Lost to Follow-up|11
2171931|NCT01332994|3793634|FG000|Overall Study|Adverse Event|34
2171932|NCT01332994|3793634|FG000|Overall Study|Death|1
2171933|NCT01332994|3793634|FG000|Overall Study|Lack of Efficacy|1
2171934|NCT01332994|3793634|FG000|Overall Study|Lost to Follow-up|4
2171935|NCT01332994|3793634|FG000|Overall Study|Protocol Violation|6
2171936|NCT01332994|3793634|FG000|Overall Study|Withdrawal by Subject|15
2171937|NCT01332994|3793634|FG000|Overall Study|Administrative Problem|2
2171938|NCT01332994|3793634|FG000|Overall Study|Other|8
2171939|NCT01333033|3793640|FG000|Overall Study|Ineligible|0
2171940|NCT01333033|3793641|FG001|Overall Study|Ineligible|0
2171941|NCT01333033|3793642|FG002|Overall Study|Ineligible|0
2171942|NCT01333033|3793643|FG003|Overall Study|Ineligible|0
2171943|NCT01333033|3793644|FG004|Overall Study|Ineligible|6
2171944|NCT01333033|3793645|FG005|Overall Study|Ineligible|8
2171945|NCT01333033|3793640|FG000|Overall Study|Withdrawal by Subject|0
2171946|NCT01333033|3793641|FG001|Overall Study|Withdrawal by Subject|0
2171947|NCT01333033|3793642|FG002|Overall Study|Withdrawal by Subject|0
2171948|NCT01333033|3793643|FG003|Overall Study|Withdrawal by Subject|0
2171949|NCT01333033|3793644|FG004|Overall Study|Withdrawal by Subject|4
2171950|NCT01333033|3793645|FG005|Overall Study|Withdrawal by Subject|2
2171951|NCT01333033|3793640|FG000|Overall Study|PET inevaluable|0
2171952|NCT01333033|3793641|FG001|Overall Study|PET inevaluable|0
2171953|NCT01333033|3793642|FG002|Overall Study|PET inevaluable|0
2171954|NCT01333033|3793643|FG003|Overall Study|PET inevaluable|0
2171955|NCT01333033|3793644|FG004|Overall Study|PET inevaluable|2
2171956|NCT01333033|3793645|FG005|Overall Study|PET inevaluable|4
2171957|NCT01333033|3793640|FG000|Overall Study|Adverse Event|0
2171958|NCT01333033|3793641|FG001|Overall Study|Adverse Event|0
2171959|NCT01333033|3793642|FG002|Overall Study|Adverse Event|0
2171960|NCT01333033|3793643|FG003|Overall Study|Adverse Event|0
2171961|NCT01333033|3793644|FG004|Overall Study|Adverse Event|2
2171962|NCT01333033|3793645|FG005|Overall Study|Adverse Event|1
2171963|NCT01333033|3793640|FG000|Overall Study|Progression|0
2171964|NCT01333033|3793641|FG001|Overall Study|Progression|0
2171965|NCT01333033|3793642|FG002|Overall Study|Progression|0
2171966|NCT01333033|3793643|FG003|Overall Study|Progression|0
2171967|NCT01333033|3793644|FG004|Overall Study|Progression|0
2171968|NCT01333033|3793645|FG005|Overall Study|Progression|1
2171969|NCT01333033|3793640|FG000|Overall Study|MD Decision|0
2171970|NCT01333033|3793641|FG001|Overall Study|MD Decision|0
2171971|NCT01333033|3793642|FG002|Overall Study|MD Decision|0
2171972|NCT01333033|3793643|FG003|Overall Study|MD Decision|0
2171973|NCT01333033|3793644|FG004|Overall Study|MD Decision|0
2171974|NCT01333033|3793645|FG005|Overall Study|MD Decision|2
2171975|NCT01333059|3793665|FG000|Overall Study|Physician Decision|3
2171976|NCT01333059|3793666|FG001|Overall Study|Physician Decision|3
2171977|NCT01333059|3793665|FG000|Overall Study|Protocol Violation|3
2171978|NCT01333059|3793666|FG001|Overall Study|Protocol Violation|0
2171979|NCT01333072|3793676|FG000|Overall Study|Lost to Follow-up|3
2171980|NCT01333072|3793677|FG001|Overall Study|Lost to Follow-up|0
2171981|NCT01333072|3793676|FG000|Overall Study|Adverse Event|2
2171982|NCT01333072|3793677|FG001|Overall Study|Adverse Event|4
2171983|NCT01333072|3793676|FG000|Overall Study|Physician Decision|1
2171984|NCT01333072|3793677|FG001|Overall Study|Physician Decision|0
2171985|NCT01333111|3793692|FG000|Overall Study|patient undergoing major surgery|0
2171986|NCT01333111|3793693|FG001|Overall Study|patient undergoing major surgery|2
2171987|NCT01333111|3793694|FG002|Overall Study|patient undergoing major surgery|0
2171988|NCT01333111|3793692|FG000|Overall Study|personal reasons|0
2171989|NCT01333111|3793693|FG001|Overall Study|personal reasons|0
2171990|NCT01333111|3793694|FG002|Overall Study|personal reasons|1
2171991|NCT01333111|3793692|FG000|Overall Study|unclassified|1
2171992|NCT01333111|3793693|FG001|Overall Study|unclassified|0
2171993|NCT01333111|3793694|FG002|Overall Study|unclassified|0
2171994|NCT01333111|3793692|FG000|Overall Study|withdrawal criteria|0
2171995|NCT01333111|3793693|FG001|Overall Study|withdrawal criteria|1
2171996|NCT01333111|3793694|FG002|Overall Study|withdrawal criteria|0
2171997|NCT01333111|3793692|FG000|Overall Study|Non-compliance|1
2171998|NCT01333111|3793693|FG001|Overall Study|Non-compliance|0
2171999|NCT01333111|3793694|FG002|Overall Study|Non-compliance|0
2172000|NCT01333111|3793692|FG000|Overall Study|Ineffective therapy|0
2172001|NCT01333111|3793693|FG001|Overall Study|Ineffective therapy|0
2172002|NCT01333111|3793694|FG002|Overall Study|Ineffective therapy|1
2172003|NCT01333189|3793704|FG000|Overall Study|Time constraints|1
2172004|NCT01333189|3793705|FG001|Overall Study|Time constraints|0
2172005|NCT01333189|3793704|FG000|Overall Study|Adverse Event|1
2172006|NCT01333189|3793705|FG001|Overall Study|Adverse Event|0
2172007|NCT01333189|3793704|FG000|Overall Study|Transportation difficulties|0
2172008|NCT01333189|3793705|FG001|Overall Study|Transportation difficulties|1
2172009|NCT01333189|3793704|FG000|Overall Study|Moved from region|0
2172010|NCT01333189|3793705|FG001|Overall Study|Moved from region|1
2172011|NCT01333397|3793716|FG000|Overall Study|Lost to Follow-up|1
2172012|NCT01333397|3793717|FG001|Overall Study|Lost to Follow-up|0
2172013|NCT01333397|3793718|FG002|Overall Study|Lost to Follow-up|0
2172014|NCT01333397|3793719|FG003|Overall Study|Lost to Follow-up|1
2172015|NCT01333397|3793720|FG004|Overall Study|Lost to Follow-up|0
2172016|NCT01333475|3793743|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1
2172017|NCT01333475|3793744|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0
2172018|NCT01333475|3793743|FG000|Overall Study|Toxicity|1
2172019|NCT01333475|3793744|FG001|Overall Study|Toxicity|3
2172020|NCT01333501|3793767|FG000|Overall Study|Adverse Event|3
2172021|NCT01333501|3793768|FG001|Overall Study|Adverse Event|1
2172022|NCT01333501|3793767|FG000|Overall Study|Abnormal laboratory value|2
2172023|NCT01333501|3793768|FG001|Overall Study|Abnormal laboratory value|1
2172024|NCT01333501|3793767|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2172025|NCT01333501|3793768|FG001|Overall Study|Unsatisfactory therapeutic effect|7
2172026|NCT01333501|3793767|FG000|Overall Study|Withdrawn consent|3
2172027|NCT01333501|3793768|FG001|Overall Study|Withdrawn consent|12
2172028|NCT01333722|3793794|FG000|Overall Study|Lack of Efficacy|0
2172029|NCT01333722|3793795|FG001|Overall Study|Lack of Efficacy|2
2172030|NCT01333722|3793794|FG000|Overall Study|Withdrawal by Subject|0
2172031|NCT01333722|3793795|FG001|Overall Study|Withdrawal by Subject|1
2172032|NCT01333865|3793807|FG000|Overall Study|Adverse Event|2
2172033|NCT01333943|3793813|FG000|Overall Study|Known neuropathy|1
2172034|NCT01333943|3793814|FG001|Overall Study|Known neuropathy|0
2179858|NCT01396421|3805667|FG001|Overall Study|Lost to Follow-up|0
2179859|NCT01396421|3805668|FG002|Overall Study|Lost to Follow-up|0
2179860|NCT01396421|3805669|FG003|Overall Study|Lost to Follow-up|1
2179861|NCT01396421|3805666|FG000|Overall Study|Adverse Event|17
2179862|NCT01396421|3805667|FG001|Overall Study|Adverse Event|15
2179863|NCT01396421|3805668|FG002|Overall Study|Adverse Event|12
2179864|NCT01396421|3805669|FG003|Overall Study|Adverse Event|32
2180155|NCT01399190|3806115|FG000|Overall Study|Adverse Event|8
2172035|NCT01333956|3793824|FG000|Overall Study|Lost to Follow-up|1
2172036|NCT01333956|3793825|FG001|Overall Study|Lost to Follow-up|2
2172037|NCT01333956|3793826|FG002|Overall Study|Lost to Follow-up|0
2172038|NCT01333956|3793827|FG003|Overall Study|Lost to Follow-up|1
2172039|NCT01333956|3793824|FG000|Overall Study|Unable to complete study procedure|1
2172040|NCT01333956|3793825|FG001|Overall Study|Unable to complete study procedure|0
2172041|NCT01333956|3793826|FG002|Overall Study|Unable to complete study procedure|0
2172042|NCT01333956|3793827|FG003|Overall Study|Unable to complete study procedure|1
2172043|NCT01333956|3793824|FG000|Overall Study|Withdrawal by Subject|0
2172044|NCT01333956|3793825|FG001|Overall Study|Withdrawal by Subject|2
2172045|NCT01333956|3793826|FG002|Overall Study|Withdrawal by Subject|1
2172046|NCT01333956|3793827|FG003|Overall Study|Withdrawal by Subject|0
2172047|NCT01334125|3793844|FG000|Overall Study|Lost to Follow-up|3
2172048|NCT01334125|3793845|FG001|Overall Study|Lost to Follow-up|3
2172049|NCT01334515|3793872|FG000|Overall Study|Adverse Event|1
2172050|NCT01334515|3793873|FG001|Overall Study|Adverse Event|6
2172051|NCT01334515|3793872|FG000|Overall Study|Death|1
2172052|NCT01334515|3793873|FG001|Overall Study|Death|0
2172053|NCT01334515|3793872|FG000|Overall Study|Lack of Efficacy|8
2172054|NCT01334515|3793873|FG001|Overall Study|Lack of Efficacy|21
2172055|NCT01334515|3793872|FG000|Overall Study|Physician Decision|1
2172056|NCT01334515|3793873|FG001|Overall Study|Physician Decision|1
2172057|NCT01334515|3793872|FG000|Overall Study|Withdrawal by Subject|1
2172058|NCT01334515|3793873|FG001|Overall Study|Withdrawal by Subject|1
2172059|NCT01334554|3793881|FG000|Overall Study|Adverse Event|4
2172060|NCT01334554|3793882|FG001|Overall Study|Adverse Event|2
2172061|NCT01334710|3793890|FG000|Overall Study|Trial was terminated|3
2172062|NCT01334866|3793924|FG000|Overall Study|Withdrawal by Subject|10
2172063|NCT01334866|3793924|FG000|Overall Study|Lost to Follow-up|3
2172064|NCT01334866|3793924|FG000|Overall Study|Physician Decision|3
2172065|NCT01334866|3793924|FG000|Overall Study|medically necessary prior to procedure|2
2172066|NCT01334866|3793924|FG000|Overall Study|medically necessary post-procedure|1
2172067|NCT01334918|3793932|FG000|Overall Study|Did not receive study drug|6
2172068|NCT01334918|3793933|FG001|Overall Study|Did not receive study drug|0
2172069|NCT01334918|3793932|FG000|Overall Study|Adverse Event|2
2172070|NCT01334918|3793933|FG001|Overall Study|Adverse Event|0
2172071|NCT01334918|3793932|FG000|Overall Study|Withdrawal by Subject|0
2172072|NCT01334918|3793933|FG001|Overall Study|Withdrawal by Subject|1
2172073|NCT01335009|3793966|FG000|Overall Study|Too ill to travel to study sites|1
2172074|NCT01335009|3793967|FG001|Overall Study|Too ill to travel to study sites|0
2172075|NCT01335009|3793966|FG000|Overall Study|Death|28
2172076|NCT01335009|3793967|FG001|Overall Study|Death|32
2172077|NCT01335009|3793966|FG000|Overall Study|Withdrawal by Subject|1
2172078|NCT01335009|3793967|FG001|Overall Study|Withdrawal by Subject|1
2172079|NCT01335009|3793966|FG000|Overall Study|Lost to Follow-up|1
2172080|NCT01335009|3793967|FG001|Overall Study|Lost to Follow-up|0
2172081|NCT01335464|3794029|FG000|Overall Study|Adverse Event|15
2172082|NCT01335464|3794030|FG001|Overall Study|Adverse Event|25
2172083|NCT01335464|3794029|FG000|Overall Study|Non compliant with protocol|2
2172084|NCT01335464|3794030|FG001|Overall Study|Non compliant with protocol|0
2172085|NCT01335464|3794029|FG000|Overall Study|Consent withdrawn, not due to AE|12
2172086|NCT01335464|3794030|FG001|Overall Study|Consent withdrawn, not due to AE|23
2172087|NCT01335464|3794029|FG000|Overall Study|Not treated|2
2172088|NCT01335464|3794030|FG001|Overall Study|Not treated|0
2172089|NCT01335464|3794029|FG000|Overall Study|Reason other than those stated above|1
2172090|NCT01335464|3794030|FG001|Overall Study|Reason other than those stated above|1
2172091|NCT01335477|3794038|FG000|Overall Study|Adverse Event|30
2172092|NCT01335477|3794039|FG001|Overall Study|Adverse Event|42
2172093|NCT01335477|3794038|FG000|Overall Study|Non compliant with protocol|0
2172094|NCT01335477|3794039|FG001|Overall Study|Non compliant with protocol|2
2172095|NCT01335477|3794038|FG000|Overall Study|Lost to Follow-up|1
2172096|NCT01335477|3794039|FG001|Overall Study|Lost to Follow-up|2
2172097|NCT01335477|3794038|FG000|Overall Study|Consent withdrawn, not due to AE|7
2172098|NCT01335477|3794039|FG001|Overall Study|Consent withdrawn, not due to AE|9
2172099|NCT01335477|3794038|FG000|Overall Study|Not treated|1
2172100|NCT01335477|3794039|FG001|Overall Study|Not treated|2
2172101|NCT01335477|3794038|FG000|Overall Study|Reason other than those stated above|2
2172102|NCT01335477|3794039|FG001|Overall Study|Reason other than those stated above|2
2172103|NCT01335698|3794063|FG000|Treatment Stage 1|Lack of Efficacy|3
2172104|NCT01335698|3794064|FG001|Treatment Stage 1|Lack of Efficacy|1
2172105|NCT01335698|3794065|FG002|Treatment Stage 1|Lack of Efficacy|3
2172106|NCT01335698|3794066|FG003|Treatment Stage 1|Lack of Efficacy|3
2172107|NCT01335698|3794067|FG004|Treatment Stage 1|Lack of Efficacy|1
2172108|NCT01335698|3794063|FG000|Treatment Stage 1|Adverse Event|1
2172109|NCT01335698|3794064|FG001|Treatment Stage 1|Adverse Event|2
2172110|NCT01335698|3794065|FG002|Treatment Stage 1|Adverse Event|2
2172111|NCT01335698|3794066|FG003|Treatment Stage 1|Adverse Event|1
2172112|NCT01335698|3794067|FG004|Treatment Stage 1|Adverse Event|1
2172113|NCT01335698|3794063|FG000|Treatment Stage 1|Withdrawal by Subject|1
2172114|NCT01335698|3794064|FG001|Treatment Stage 1|Withdrawal by Subject|2
2172115|NCT01335698|3794065|FG002|Treatment Stage 1|Withdrawal by Subject|0
2172116|NCT01335698|3794066|FG003|Treatment Stage 1|Withdrawal by Subject|1
2172117|NCT01335698|3794067|FG004|Treatment Stage 1|Withdrawal by Subject|0
2172118|NCT01335698|3794063|FG000|Treatment Stage 1|Lost to Follow-up|1
2172119|NCT01335698|3794064|FG001|Treatment Stage 1|Lost to Follow-up|1
2172120|NCT01335698|3794065|FG002|Treatment Stage 1|Lost to Follow-up|0
2172121|NCT01335698|3794066|FG003|Treatment Stage 1|Lost to Follow-up|0
2172122|NCT01335698|3794067|FG004|Treatment Stage 1|Lost to Follow-up|0
2172123|NCT01335698|3794063|FG000|Treatment Stage 1|Poor compliance/noncompliance|0
2172124|NCT01335698|3794064|FG001|Treatment Stage 1|Poor compliance/noncompliance|1
2172125|NCT01335698|3794065|FG002|Treatment Stage 1|Poor compliance/noncompliance|0
2172126|NCT01335698|3794066|FG003|Treatment Stage 1|Poor compliance/noncompliance|2
2172127|NCT01335698|3794067|FG004|Treatment Stage 1|Poor compliance/noncompliance|0
2172128|NCT01335698|3794063|FG000|Treatment Stage 1|No longer meets study criteria|1
2172129|NCT01335698|3794064|FG001|Treatment Stage 1|No longer meets study criteria|1
2172130|NCT01335698|3794065|FG002|Treatment Stage 1|No longer meets study criteria|0
2172131|NCT01335698|3794066|FG003|Treatment Stage 1|No longer meets study criteria|1
2172132|NCT01335698|3794067|FG004|Treatment Stage 1|No longer meets study criteria|0
2172133|NCT01335698|3794063|FG000|Treatment Stage 1|Other|1
2172134|NCT01335698|3794064|FG001|Treatment Stage 1|Other|0
2172135|NCT01335698|3794065|FG002|Treatment Stage 1|Other|0
2172136|NCT01335698|3794066|FG003|Treatment Stage 1|Other|1
2172137|NCT01335698|3794067|FG004|Treatment Stage 1|Other|0
2172138|NCT01335698|3794063|FG000|Treatment Stage 2|Lack of Efficacy|2
2172139|NCT01335698|3794064|FG001|Treatment Stage 2|Lack of Efficacy|1
2172140|NCT01335698|3794065|FG002|Treatment Stage 2|Lack of Efficacy|3
2172141|NCT01335698|3794066|FG003|Treatment Stage 2|Lack of Efficacy|1
2172142|NCT01335698|3794067|FG004|Treatment Stage 2|Lack of Efficacy|0
2172143|NCT01335698|3794063|FG000|Treatment Stage 2|Adverse Event|2
2172144|NCT01335698|3794064|FG001|Treatment Stage 2|Adverse Event|0
2172145|NCT01335698|3794065|FG002|Treatment Stage 2|Adverse Event|0
2172146|NCT01335698|3794066|FG003|Treatment Stage 2|Adverse Event|3
2172147|NCT01335698|3794067|FG004|Treatment Stage 2|Adverse Event|0
2172148|NCT01335698|3794063|FG000|Treatment Stage 2|Withdrawal by Subject|3
2172149|NCT01335698|3794064|FG001|Treatment Stage 2|Withdrawal by Subject|1
2172150|NCT01335698|3794065|FG002|Treatment Stage 2|Withdrawal by Subject|1
2172151|NCT01335698|3794066|FG003|Treatment Stage 2|Withdrawal by Subject|0
2172152|NCT01335698|3794067|FG004|Treatment Stage 2|Withdrawal by Subject|0
2172153|NCT01335698|3794063|FG000|Treatment Stage 2|Poor compliance/noncompliance|1
2172154|NCT01335698|3794064|FG001|Treatment Stage 2|Poor compliance/noncompliance|0
2172155|NCT01335698|3794065|FG002|Treatment Stage 2|Poor compliance/noncompliance|1
2172156|NCT01335698|3794066|FG003|Treatment Stage 2|Poor compliance/noncompliance|3
2172157|NCT01335698|3794067|FG004|Treatment Stage 2|Poor compliance/noncompliance|1
2172158|NCT01335698|3794063|FG000|Treatment Stage 2|Lost to Follow-up|1
2172159|NCT01335698|3794064|FG001|Treatment Stage 2|Lost to Follow-up|0
2172160|NCT01335698|3794065|FG002|Treatment Stage 2|Lost to Follow-up|0
2172161|NCT01335698|3794066|FG003|Treatment Stage 2|Lost to Follow-up|0
2172162|NCT01335698|3794067|FG004|Treatment Stage 2|Lost to Follow-up|0
2172163|NCT01335698|3794063|FG000|Treatment Stage 2|Capsules received at state hospital|1
2172164|NCT01335698|3794064|FG001|Treatment Stage 2|Capsules received at state hospital|0
2172165|NCT01335698|3794065|FG002|Treatment Stage 2|Capsules received at state hospital|0
2172166|NCT01335698|3794066|FG003|Treatment Stage 2|Capsules received at state hospital|0
2172167|NCT01335698|3794067|FG004|Treatment Stage 2|Capsules received at state hospital|0
2172168|NCT01335698|3794063|FG000|Treatment Stage 2|Subject no longer meets study criteria|0
2172169|NCT01335698|3794064|FG001|Treatment Stage 2|Subject no longer meets study criteria|0
2172170|NCT01335698|3794065|FG002|Treatment Stage 2|Subject no longer meets study criteria|0
2172171|NCT01335698|3794066|FG003|Treatment Stage 2|Subject no longer meets study criteria|1
2172172|NCT01335698|3794067|FG004|Treatment Stage 2|Subject no longer meets study criteria|0
2172173|NCT01335698|3794063|FG000|Treatment Stage 2|Switched to another formulation|1
2172174|NCT01335698|3794064|FG001|Treatment Stage 2|Switched to another formulation|1
2172175|NCT01335698|3794065|FG002|Treatment Stage 2|Switched to another formulation|0
2172176|NCT01335698|3794066|FG003|Treatment Stage 2|Switched to another formulation|0
2172177|NCT01335698|3794067|FG004|Treatment Stage 2|Switched to another formulation|0
2172178|NCT01335971|3794139|FG000|Overall Study|Withdrawal by Subject|1
2172179|NCT01335971|3794140|FG001|Overall Study|Withdrawal by Subject|0
2172180|NCT01335971|3794141|FG002|Overall Study|Withdrawal by Subject|0
2172181|NCT01335971|3794139|FG000|Overall Study|Did not complete bronchoscopy|1
2172182|NCT01335971|3794140|FG001|Overall Study|Did not complete bronchoscopy|1
2172183|NCT01335971|3794141|FG002|Overall Study|Did not complete bronchoscopy|1
2172184|NCT01336023|3794152|FG000|Week 0 to Week 26|Adverse Event|8
2172185|NCT01336023|3794153|FG001|Week 0 to Week 26|Adverse Event|10
2172186|NCT01336023|3794154|FG002|Week 0 to Week 26|Adverse Event|24
2172187|NCT01336023|3794152|FG000|Week 0 to Week 26|Lack of Efficacy|0
2172188|NCT01336023|3794153|FG001|Week 0 to Week 26|Lack of Efficacy|1
2172189|NCT01336023|3794154|FG002|Week 0 to Week 26|Lack of Efficacy|0
2172190|NCT01336023|3794152|FG000|Week 0 to Week 26|Protocol Violation|1
2172191|NCT01336023|3794153|FG001|Week 0 to Week 26|Protocol Violation|2
2172192|NCT01336023|3794154|FG002|Week 0 to Week 26|Protocol Violation|0
2172193|NCT01336023|3794152|FG000|Week 0 to Week 26|Withdrawal Criteria|34
2172194|NCT01336023|3794153|FG001|Week 0 to Week 26|Withdrawal Criteria|69
2172195|NCT01336023|3794154|FG002|Week 0 to Week 26|Withdrawal Criteria|40
2172196|NCT01336023|3794152|FG000|Week 0 to Week 26|Unclassified|5
2172197|NCT01336023|3794153|FG001|Week 0 to Week 26|Unclassified|16
2172198|NCT01336023|3794154|FG002|Week 0 to Week 26|Unclassified|9
2172199|NCT01336023|3794152|FG000|Week 27 to 52|Adverse Event|1
2172200|NCT01336023|3794153|FG001|Week 27 to 52|Adverse Event|5
2172201|NCT01336023|3794154|FG002|Week 27 to 52|Adverse Event|2
2172202|NCT01336023|3794152|FG000|Week 27 to 52|Protocol Violation|0
2172203|NCT01336023|3794153|FG001|Week 27 to 52|Protocol Violation|2
2172204|NCT01336023|3794154|FG002|Week 27 to 52|Protocol Violation|1
2172205|NCT01336023|3794152|FG000|Week 27 to 52|Withdrawal Criteria|14
2172206|NCT01336023|3794153|FG001|Week 27 to 52|Withdrawal Criteria|19
2172207|NCT01336023|3794154|FG002|Week 27 to 52|Withdrawal Criteria|16
2172208|NCT01336023|3794152|FG000|Week 27 to 52|Unclassified|13
2172209|NCT01336023|3794153|FG001|Week 27 to 52|Unclassified|18
2172210|NCT01336023|3794154|FG002|Week 27 to 52|Unclassified|9
2172211|NCT01336205|3794173|FG000|Overall Study|Other|22
2172212|NCT01336205|3794174|FG001|Overall Study|Other|9
2172213|NCT01336205|3794173|FG000|Overall Study|Lost to Follow-up|40
2172214|NCT01336205|3794174|FG001|Overall Study|Lost to Follow-up|20
2172215|NCT01336205|3794173|FG000|Overall Study|Study-Specific Withdrawal Criteria|16
2172216|NCT01336205|3794174|FG001|Overall Study|Study-Specific Withdrawal Criteria|7
2172217|NCT01336205|3794173|FG000|Overall Study|Lack of Efficacy|4
2172218|NCT01336205|3794174|FG001|Overall Study|Lack of Efficacy|0
2172219|NCT01336205|3794173|FG000|Overall Study|Severe noncompliance with protocol|9
2172220|NCT01336205|3794174|FG001|Overall Study|Severe noncompliance with protocol|2
2172221|NCT01336205|3794173|FG000|Overall Study|Adverse Event|56
2172222|NCT01336205|3794174|FG001|Overall Study|Adverse Event|6
2172223|NCT01336205|3794173|FG000|Overall Study|Death|1
2172224|NCT01336205|3794174|FG001|Overall Study|Death|1
2172225|NCT01336205|3794173|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9
2172226|NCT01336205|3794174|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
2172227|NCT01336205|3794173|FG000|Overall Study|Withdrawal by Subject|72
2172228|NCT01336205|3794174|FG001|Overall Study|Withdrawal by Subject|38
2172229|NCT01336205|3794173|FG000|Overall Study|Did not receive treatment|4
2172230|NCT01336205|3794174|FG001|Overall Study|Did not receive treatment|0
2172231|NCT01336569|3794200|FG000|Overall Study|Lost to Follow-up|4
2172232|NCT01336608|3794207|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
2172233|NCT01336608|3794208|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2172234|NCT01336608|3794209|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2172235|NCT01336608|3794210|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2172236|NCT01336608|3794207|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
2172237|NCT01336608|3794208|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2172238|NCT01336608|3794209|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2172239|NCT01336608|3794210|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2172240|NCT01336608|3794207|FG000|2-week, Single-blind Run-In Period|Adverse Event|1
2172241|NCT01336608|3794208|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
2172242|NCT01336608|3794209|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
2172243|NCT01336608|3794210|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
2172244|NCT01336608|3794207|FG000|2-week, Single-blind Run-In Period|Physician Decision|1
2172245|NCT01336608|3794208|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
2172246|NCT01336608|3794209|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
2172247|NCT01336608|3794210|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
2172248|NCT01336608|3794207|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2
2172249|NCT01336608|3794208|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2172250|NCT01336608|3794209|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2172251|NCT01336608|3794210|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2172252|NCT01336608|3794207|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
2172253|NCT01336608|3794208|FG001|24-week, Double-blind Treatment Period|Adverse Event|8
2172254|NCT01336608|3794209|FG002|24-week, Double-blind Treatment Period|Adverse Event|6
2172255|NCT01336608|3794210|FG003|24-week, Double-blind Treatment Period|Adverse Event|7
2172256|NCT01336608|3794207|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2172257|NCT01336608|3794208|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
2172258|NCT01336608|3794209|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2172259|NCT01336608|3794210|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2172260|NCT01336608|3794207|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
2172261|NCT01336608|3794208|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
2172262|NCT01336608|3794209|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
2172263|NCT01336608|3794210|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
2172264|NCT01336608|3794207|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
2172265|NCT01336608|3794208|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4
2172266|NCT01336608|3794209|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3
2172267|NCT01336608|3794210|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3
2172268|NCT01336608|3794207|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
2172269|NCT01336608|3794208|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
2172270|NCT01336608|3794209|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
2172271|NCT01336608|3794210|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
2172272|NCT01336608|3794207|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2172273|NCT01336608|3794208|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
2172274|NCT01336608|3794209|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2172275|NCT01336608|3794210|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2172276|NCT01336608|3794207|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
2172277|NCT01336608|3794208|FG001|24-week, Double-blind Treatment Period|Physician Decision|3
2172278|NCT01336608|3794209|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
2172279|NCT01336608|3794210|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
2172280|NCT01336608|3794207|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2172281|NCT01336608|3794208|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
2172282|NCT01336608|3794209|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
2172283|NCT01336608|3794210|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
2172284|NCT01336634|3794221|FG000|Overall Study|Death|60
2172285|NCT01336634|3794222|FG001|Overall Study|Death|33
2172286|NCT01336634|3794223|FG002|Overall Study|Death|10
2172287|NCT01336634|3794221|FG000|Overall Study|Lost to Follow-up|2
2172288|NCT01336634|3794222|FG001|Overall Study|Lost to Follow-up|1
2172289|NCT01336634|3794223|FG002|Overall Study|Lost to Follow-up|1
2172290|NCT01336634|3794221|FG000|Overall Study|Withdrawal by Subject|6
2172291|NCT01336634|3794222|FG001|Overall Study|Withdrawal by Subject|0
2172292|NCT01336634|3794223|FG002|Overall Study|Withdrawal by Subject|1
2172293|NCT01336634|3794221|FG000|Overall Study|Physician Decision|1
2172294|NCT01336634|3794222|FG001|Overall Study|Physician Decision|1
2172295|NCT01336634|3794223|FG002|Overall Study|Physician Decision|0
2172296|NCT01336634|3794221|FG000|Overall Study|Ongoing|15
2172297|NCT01336634|3794222|FG001|Overall Study|Ongoing|22
2172298|NCT01336634|3794223|FG002|Overall Study|Ongoing|24
2172299|NCT01336647|3794237|FG000|Overall Study|Lost to Follow-up|4
2172300|NCT01336647|3794238|FG001|Overall Study|Lost to Follow-up|1
2172301|NCT01336647|3794239|FG002|Overall Study|Lost to Follow-up|3
2172302|NCT01336712|3794249|FG000|Overall Study|Death|2
2172303|NCT01336712|3794249|FG000|Overall Study|Lack of Efficacy|1
2172304|NCT01336738|3794258|FG000|Overall Study|Adverse Event|0
2172305|NCT01336738|3794259|FG001|Overall Study|Adverse Event|3
2172306|NCT01336738|3794260|FG002|Overall Study|Adverse Event|2
2172307|NCT01336738|3794261|FG003|Overall Study|Adverse Event|1
2172308|NCT01336738|3794262|FG004|Overall Study|Adverse Event|3
2172309|NCT01336738|3794258|FG000|Overall Study|Lost to Follow-up|2
2172310|NCT01336738|3794259|FG001|Overall Study|Lost to Follow-up|1
2172311|NCT01336738|3794260|FG002|Overall Study|Lost to Follow-up|2
2172312|NCT01336738|3794261|FG003|Overall Study|Lost to Follow-up|2
2172313|NCT01336738|3794262|FG004|Overall Study|Lost to Follow-up|2
2172314|NCT01336738|3794258|FG000|Overall Study|Did not meet entrance criteria|0
2172315|NCT01336738|3794259|FG001|Overall Study|Did not meet entrance criteria|1
2172316|NCT01336738|3794260|FG002|Overall Study|Did not meet entrance criteria|0
2172317|NCT01336738|3794261|FG003|Overall Study|Did not meet entrance criteria|0
2172318|NCT01336738|3794262|FG004|Overall Study|Did not meet entrance criteria|0
2296563|NCT02558400|3992499|FG001|Overall Study|Death|1
2296564|NCT02558400|3992500|FG002|Overall Study|Death|0
2172319|NCT01336738|3794258|FG000|Overall Study|Protocol Violation|0
2172320|NCT01336738|3794259|FG001|Overall Study|Protocol Violation|1
2172321|NCT01336738|3794260|FG002|Overall Study|Protocol Violation|0
2172322|NCT01336738|3794261|FG003|Overall Study|Protocol Violation|0
2172323|NCT01336738|3794262|FG004|Overall Study|Protocol Violation|0
2172324|NCT01336738|3794258|FG000|Overall Study|Withdrawal by Subject|2
2172325|NCT01336738|3794259|FG001|Overall Study|Withdrawal by Subject|0
2172326|NCT01336738|3794260|FG002|Overall Study|Withdrawal by Subject|2
2172327|NCT01336738|3794261|FG003|Overall Study|Withdrawal by Subject|1
2172328|NCT01336738|3794262|FG004|Overall Study|Withdrawal by Subject|1
2172329|NCT01336738|3794258|FG000|Overall Study|Other|3
2172330|NCT01336738|3794259|FG001|Overall Study|Other|3
2172331|NCT01336738|3794260|FG002|Overall Study|Other|2
2172332|NCT01336738|3794261|FG003|Overall Study|Other|3
2172333|NCT01336738|3794262|FG004|Overall Study|Other|4
2172334|NCT01336764|3794276|FG000|Overall Study|Withdrawal by Subject|5
2172335|NCT01336764|3794277|FG001|Overall Study|Withdrawal by Subject|5
2172336|NCT01336894|3794297|FG000|Follow-up|Study terminated prematurely|2
2172337|NCT01336894|3794298|FG001|Follow-up|Study terminated prematurely|7
2172338|NCT01336972|3794328|FG000|Overall Study|Adverse Event|1
2172339|NCT01336972|3794329|FG001|Overall Study|Adverse Event|1
2172340|NCT01336972|3794330|FG002|Overall Study|Adverse Event|0
2172341|NCT01337050|3794342|FG000|Overall Study|Death|0
2172342|NCT01337050|3794343|FG001|Overall Study|Death|0
2172343|NCT01337050|3794344|FG002|Overall Study|Death|4
2172344|NCT01337050|3794342|FG000|Overall Study|Other|4
2172345|NCT01337050|3794343|FG001|Overall Study|Other|6
2172346|NCT01337050|3794344|FG002|Overall Study|Other|8
2172347|NCT01337050|3794342|FG000|Overall Study|Participants refused further follow-up|0
2172348|NCT01337050|3794343|FG001|Overall Study|Participants refused further follow-up|7
2172349|NCT01337050|3794344|FG002|Overall Study|Participants refused further follow-up|7
2172350|NCT01337089|3794357|FG000|Overall Study|Adverse Event|237
2296565|NCT02558400|3992498|FG000|Overall Study|Ineligible for the study|0
2172351|NCT01337089|3794357|FG000|Overall Study|Withdrawal by Subject|129
2172352|NCT01337089|3794357|FG000|Overall Study|Withdrawal by Investigator|33
2172353|NCT01337089|3794357|FG000|Overall Study|Met Withdrawal Criteria|3
2172354|NCT01337089|3794357|FG000|Overall Study|Lost to Follow-up|2
2172355|NCT01337115|3794363|FG000|Overall Study|Protocol Violation|2
2172356|NCT01337115|3794364|FG001|Overall Study|Protocol Violation|0
2172357|NCT01337167|3794374|FG000|Infant Series|Adverse Event|1
2172358|NCT01337167|3794375|FG001|Infant Series|Adverse Event|1
2172359|NCT01337167|3794374|FG000|Infant Series|Death|1
2172360|NCT01337167|3794375|FG001|Infant Series|Death|1
2172361|NCT01337167|3794374|FG000|Infant Series|Lost to Follow-up|13
2172362|NCT01337167|3794375|FG001|Infant Series|Lost to Follow-up|7
2172363|NCT01337167|3794374|FG000|Infant Series|Non-compliance with study drug|2
2172364|NCT01337167|3794375|FG001|Infant Series|Non-compliance with study drug|1
2172365|NCT01337167|3794374|FG000|Infant Series|Physician Decision|3
2172366|NCT01337167|3794375|FG001|Infant Series|Physician Decision|1
2172367|NCT01337167|3794374|FG000|Infant Series|Protocol Violation|22
2172368|NCT01337167|3794375|FG001|Infant Series|Protocol Violation|9
2172369|NCT01337167|3794374|FG000|Infant Series|Withdrawal by Subject|15
2172370|NCT01337167|3794375|FG001|Infant Series|Withdrawal by Subject|4
2172371|NCT01337167|3794374|FG000|Infant Series|Randomized but not vaccinated|5
2172372|NCT01337167|3794375|FG001|Infant Series|Randomized but not vaccinated|3
2172373|NCT01337167|3794374|FG000|Interim Period|Lost to Follow-up|51
2172374|NCT01337167|3794375|FG001|Interim Period|Lost to Follow-up|23
2172375|NCT01337167|3794374|FG000|Interim Period|Non-compliance with study drug|1
2172376|NCT01337167|3794375|FG001|Interim Period|Non-compliance with study drug|0
2172377|NCT01337167|3794374|FG000|Interim Period|Physician Decision|6
2172378|NCT01337167|3794375|FG001|Interim Period|Physician Decision|3
2172379|NCT01337167|3794374|FG000|Interim Period|Protocol Violation|5
2172380|NCT01337167|3794375|FG001|Interim Period|Protocol Violation|3
2172381|NCT01337167|3794374|FG000|Interim Period|Withdrawal by Subject|18
2172382|NCT01337167|3794375|FG001|Interim Period|Withdrawal by Subject|10
2172383|NCT01337167|3794374|FG000|Interim Period|Other protocol criterion not met|0
2172384|NCT01337167|3794375|FG001|Interim Period|Other protocol criterion not met|1
2172385|NCT01337167|3794374|FG000|Toddler Vaccinations|Lost to Follow-up|11
2172386|NCT01337167|3794375|FG001|Toddler Vaccinations|Lost to Follow-up|12
2172387|NCT01337167|3794374|FG000|Toddler Vaccinations|Protocol Violation|0
2172388|NCT01337167|3794375|FG001|Toddler Vaccinations|Protocol Violation|1
2172389|NCT01337167|3794374|FG000|Toddler Vaccinations|Withdrawal by Subject|3
2172390|NCT01337167|3794375|FG001|Toddler Vaccinations|Withdrawal by Subject|0
2296566|NCT02558400|3992499|FG001|Overall Study|Ineligible for the study|2
2296567|NCT02558400|3992500|FG002|Overall Study|Ineligible for the study|0
2296568|NCT02558790|3992511|FG000|Overall Study|Lost to Follow-up|2
2296569|NCT02558790|3992511|FG000|Overall Study|Physician Decision|1
2296570|NCT02558790|3992511|FG000|Overall Study|Withdrawal by Subject|1
2296571|NCT02558790|3992511|FG000|Overall Study|Screen Fail|3
2296572|NCT02558894|3992550|FG000|Overall Study|Death; any cause, entire study duration|28
2296573|NCT02558894|3992551|FG001|Overall Study|Death; any cause, entire study duration|31
2296574|NCT02558894|3992550|FG000|Overall Study|Withdrawal by Subject|2
2296575|NCT02558894|3992551|FG001|Overall Study|Withdrawal by Subject|1
2296576|NCT02558894|3992550|FG000|Overall Study|Closure of Part A|2
2296577|NCT02558894|3992551|FG001|Overall Study|Closure of Part A|1
2296578|NCT02559115|3992557|FG000|Overall Study|Withdrawal by Subject|3
2296579|NCT02559206|3992569|FG000|Overall Study|Adverse Event|0
2296580|NCT02559206|3992570|FG001|Overall Study|Adverse Event|4
2296581|NCT02559206|3992571|FG002|Overall Study|Adverse Event|1
2296582|NCT02559206|3992572|FG003|Overall Study|Adverse Event|5
2296583|NCT02559206|3992573|FG004|Overall Study|Adverse Event|3
2296584|NCT02559206|3992574|FG005|Overall Study|Adverse Event|0
2296585|NCT02559206|3992575|FG006|Overall Study|Adverse Event|1
2296586|NCT02559206|3992576|FG007|Overall Study|Adverse Event|0
2296587|NCT02559206|3992569|FG000|Overall Study|Protocol Violation|1
2296588|NCT02559206|3992570|FG001|Overall Study|Protocol Violation|0
2296589|NCT02559206|3992571|FG002|Overall Study|Protocol Violation|1
2296590|NCT02559206|3992572|FG003|Overall Study|Protocol Violation|0
2296591|NCT02559206|3992573|FG004|Overall Study|Protocol Violation|0
2296592|NCT02559206|3992574|FG005|Overall Study|Protocol Violation|2
2296593|NCT02559206|3992575|FG006|Overall Study|Protocol Violation|0
2296594|NCT02559206|3992576|FG007|Overall Study|Protocol Violation|0
2296595|NCT02559206|3992569|FG000|Overall Study|Withdrawal by Subject|3
2296596|NCT02559206|3992570|FG001|Overall Study|Withdrawal by Subject|3
2296597|NCT02559206|3992571|FG002|Overall Study|Withdrawal by Subject|1
2296598|NCT02559206|3992572|FG003|Overall Study|Withdrawal by Subject|3
2296599|NCT02559206|3992573|FG004|Overall Study|Withdrawal by Subject|5
2296600|NCT02559206|3992574|FG005|Overall Study|Withdrawal by Subject|4
2296601|NCT02559206|3992575|FG006|Overall Study|Withdrawal by Subject|1
2296602|NCT02559206|3992576|FG007|Overall Study|Withdrawal by Subject|2
2296603|NCT02559206|3992569|FG000|Overall Study|Lost to Follow-up|3
2172391|NCT01337297|3794383|FG000|Overall Study|They entered to single anodal tDCS|4
2172392|NCT01337297|3794384|FG001|Overall Study|They entered to single anodal tDCS|3
2172393|NCT01337297|3794383|FG000|Overall Study|Lost to Follow-up|1
2296604|NCT02559206|3992570|FG001|Overall Study|Lost to Follow-up|5
2296605|NCT02559206|3992571|FG002|Overall Study|Lost to Follow-up|3
2172394|NCT01337297|3794384|FG001|Overall Study|Lost to Follow-up|3
2172395|NCT01337596|3794408|FG000|Overall Study|Withdrawal by Subject|0
2172396|NCT01337596|3794409|FG001|Overall Study|Withdrawal by Subject|0
2172397|NCT01337596|3794410|FG002|Overall Study|Withdrawal by Subject|0
2172398|NCT01337596|3794411|FG003|Overall Study|Withdrawal by Subject|0
2172399|NCT01337596|3794412|FG004|Overall Study|Withdrawal by Subject|2
2172400|NCT01337596|3794413|FG005|Overall Study|Withdrawal by Subject|0
2172401|NCT01337596|3794414|FG006|Overall Study|Withdrawal by Subject|0
2172402|NCT01337596|3794415|FG007|Overall Study|Withdrawal by Subject|0
2172403|NCT01337596|3794416|FG008|Overall Study|Withdrawal by Subject|0
2172404|NCT01337635|3794441|FG000|Overall Study|Lost to Follow-up|0
2172405|NCT01337635|3794442|FG001|Overall Study|Lost to Follow-up|1
2172406|NCT01337674|3794450|FG000|Treatment Period 1|Adverse Event|0
2172407|NCT01337674|3794451|FG001|Treatment Period 1|Adverse Event|1
2172408|NCT01337674|3794452|FG002|Treatment Period 1|Adverse Event|0
2172409|NCT01337674|3794453|FG003|Treatment Period 1|Adverse Event|0
2172410|NCT01337674|3794450|FG000|Treatment Period 1|Discontinued due to blood draws|0
2172411|NCT01337674|3794451|FG001|Treatment Period 1|Discontinued due to blood draws|0
2172412|NCT01337674|3794452|FG002|Treatment Period 1|Discontinued due to blood draws|0
2172413|NCT01337674|3794453|FG003|Treatment Period 1|Discontinued due to blood draws|1
2172414|NCT01337674|3794450|FG000|Treatment Period 2|Withdrawal by Subject|0
2172415|NCT01337674|3794451|FG001|Treatment Period 2|Withdrawal by Subject|0
2172416|NCT01337674|3794452|FG002|Treatment Period 2|Withdrawal by Subject|1
2172417|NCT01337674|3794453|FG003|Treatment Period 2|Withdrawal by Subject|0
2172418|NCT01337960|3794496|FG000|Overall Study|Lost to Follow-up|1
2172419|NCT01337960|3794497|FG001|Overall Study|Lost to Follow-up|0
2172420|NCT01337960|3794498|FG002|Overall Study|Lost to Follow-up|0
2172421|NCT01337960|3794496|FG000|Overall Study|Withdrawal by Subject|1
2172422|NCT01337960|3794497|FG001|Overall Study|Withdrawal by Subject|0
2172423|NCT01337960|3794498|FG002|Overall Study|Withdrawal by Subject|0
2296606|NCT02559206|3992572|FG003|Overall Study|Lost to Follow-up|3
2296607|NCT02559206|3992573|FG004|Overall Study|Lost to Follow-up|2
2296608|NCT02559206|3992574|FG005|Overall Study|Lost to Follow-up|5
2296609|NCT02559206|3992575|FG006|Overall Study|Lost to Follow-up|1
2296610|NCT02559206|3992576|FG007|Overall Study|Lost to Follow-up|4
2296611|NCT02559206|3992569|FG000|Overall Study|Lack of Efficacy|1
2296612|NCT02559206|3992570|FG001|Overall Study|Lack of Efficacy|0
2296613|NCT02559206|3992571|FG002|Overall Study|Lack of Efficacy|3
2296614|NCT02559206|3992572|FG003|Overall Study|Lack of Efficacy|2
2296615|NCT02559206|3992573|FG004|Overall Study|Lack of Efficacy|2
2296616|NCT02559206|3992574|FG005|Overall Study|Lack of Efficacy|3
2296617|NCT02559206|3992575|FG006|Overall Study|Lack of Efficacy|3
2296618|NCT02559206|3992576|FG007|Overall Study|Lack of Efficacy|3
2296619|NCT02559206|3992569|FG000|Overall Study|Other Not Specified|0
2296620|NCT02559206|3992570|FG001|Overall Study|Other Not Specified|0
2296621|NCT02559206|3992571|FG002|Overall Study|Other Not Specified|0
2296622|NCT02559206|3992572|FG003|Overall Study|Other Not Specified|1
2296623|NCT02559206|3992573|FG004|Overall Study|Other Not Specified|0
2296624|NCT02559206|3992574|FG005|Overall Study|Other Not Specified|0
2296625|NCT02559206|3992575|FG006|Overall Study|Other Not Specified|0
2296626|NCT02559206|3992576|FG007|Overall Study|Other Not Specified|0
2296627|NCT02559310|3992596|FG000|Overall Study|Death|4
2296628|NCT02559310|3992597|FG001|Overall Study|Death|3
2296629|NCT02559310|3992596|FG000|Overall Study|Lost to Follow-up|5
2296630|NCT02559310|3992597|FG001|Overall Study|Lost to Follow-up|3
2296631|NCT02559310|3992596|FG000|Overall Study|Physician Decision|2
2296632|NCT02559310|3992597|FG001|Overall Study|Physician Decision|1
2296633|NCT02559310|3992596|FG000|Overall Study|Withdrawal by Subject|13
2296634|NCT02559310|3992597|FG001|Overall Study|Withdrawal by Subject|9
2296635|NCT02559310|3992596|FG000|Overall Study|Sponsor Decision|0
2296636|NCT02559310|3992597|FG001|Overall Study|Sponsor Decision|1
2296637|NCT02559310|3992596|FG000|Overall Study|Randomized but not treated|3
2296638|NCT02559310|3992597|FG001|Overall Study|Randomized but not treated|2
2296639|NCT02559414|3992606|FG000|Overall Study|Lost to Follow-up|0
2296640|NCT02559414|3992607|FG001|Overall Study|Lost to Follow-up|1
2296641|NCT02559414|3992608|FG002|Overall Study|Lost to Follow-up|0
2296642|NCT02559414|3992606|FG000|Overall Study|Withdrawal by Subject|1
2296643|NCT02559414|3992607|FG001|Overall Study|Withdrawal by Subject|0
2296644|NCT02559414|3992608|FG002|Overall Study|Withdrawal by Subject|1
2296645|NCT02559414|3992606|FG000|Overall Study|Other|0
2296646|NCT02559414|3992607|FG001|Overall Study|Other|1
2296647|NCT02559414|3992608|FG002|Overall Study|Other|1
2296648|NCT02559505|3992633|FG000|Overall Study|Lost to Follow-up|23
2296649|NCT02559505|3992634|FG001|Overall Study|Lost to Follow-up|20
2296650|NCT02559505|3992633|FG000|Overall Study|Withdrawal by Subject|4
2296651|NCT02559505|3992634|FG001|Overall Study|Withdrawal by Subject|2
2296652|NCT02559570|3992657|FG000|Overall Study|Adverse Event|0
2296653|NCT02559570|3992658|FG001|Overall Study|Adverse Event|2
2296654|NCT02559570|3992659|FG002|Overall Study|Adverse Event|0
2172424|NCT01337973|3794509|FG000|Overall Study|Lost to Follow-up|2
2296655|NCT02559570|3992660|FG003|Overall Study|Adverse Event|1
2296656|NCT02559570|3992661|FG004|Overall Study|Adverse Event|0
2296657|NCT02559570|3992657|FG000|Overall Study|Withdrawal of Consent|0
2296658|NCT02559570|3992658|FG001|Overall Study|Withdrawal of Consent|0
2296659|NCT02559570|3992659|FG002|Overall Study|Withdrawal of Consent|1
2172425|NCT01337973|3794510|FG001|Overall Study|Lost to Follow-up|4
2172426|NCT01337973|3794511|FG002|Overall Study|Lost to Follow-up|3
2172427|NCT01337973|3794509|FG000|Overall Study|Death|1
2172428|NCT01337973|3794510|FG001|Overall Study|Death|2
2172429|NCT01337973|3794511|FG002|Overall Study|Death|1
2172430|NCT01337973|3794509|FG000|Overall Study|Withdrawal by Subject|10
2172431|NCT01337973|3794510|FG001|Overall Study|Withdrawal by Subject|8
2172432|NCT01337973|3794511|FG002|Overall Study|Withdrawal by Subject|4
2172433|NCT01337973|3794509|FG000|Overall Study|missing data on primary outcome|3
2172434|NCT01337973|3794510|FG001|Overall Study|missing data on primary outcome|1
2172435|NCT01337973|3794511|FG002|Overall Study|missing data on primary outcome|3
2172436|NCT01337986|3794521|FG000|Overall Study|Adverse Event|2
2172437|NCT01337986|3794522|FG001|Overall Study|Adverse Event|2
2172438|NCT01337986|3794521|FG000|Overall Study|Lost to Follow-up|1
2172439|NCT01337986|3794522|FG001|Overall Study|Lost to Follow-up|0
2172440|NCT01337986|3794521|FG000|Overall Study|Protocol Violation|0
2172441|NCT01337986|3794522|FG001|Overall Study|Protocol Violation|3
2172442|NCT01338012|3794544|FG000|Overall Study|Death|4
2172443|NCT01338012|3794544|FG000|Overall Study|Study terminated|4
2172444|NCT01338025|3794550|FG000|Overall Study|Unexpected closure of study|10
2172445|NCT01338025|3794551|FG001|Overall Study|Unexpected closure of study|9
2172446|NCT01338025|3794550|FG000|Overall Study|Withdrawal by Subject|0
2172447|NCT01338025|3794551|FG001|Overall Study|Withdrawal by Subject|2
2172448|NCT01338025|3794550|FG000|Overall Study|Found ineligible after starting|1
2172449|NCT01338025|3794551|FG001|Overall Study|Found ineligible after starting|0
2172450|NCT01338298|3794559|FG000|Overall Study|Withdrawal by Subject|1
2172451|NCT01338298|3794560|FG001|Overall Study|Withdrawal by Subject|1
2172452|NCT01338298|3794559|FG000|Overall Study|Abdominal Pain and scheduled surgery|0
2172453|NCT01338298|3794560|FG001|Overall Study|Abdominal Pain and scheduled surgery|1
2172454|NCT01338298|3794559|FG000|Overall Study|Administrative error|0
2172455|NCT01338298|3794560|FG001|Overall Study|Administrative error|1
2172456|NCT01338298|3794559|FG000|Overall Study|Positive symptom worsening|1
2172457|NCT01338298|3794560|FG001|Overall Study|Positive symptom worsening|0
2172458|NCT01338298|3794559|FG000|Overall Study|Depressive symptoms and nausea|1
2172459|NCT01338298|3794560|FG001|Overall Study|Depressive symptoms and nausea|0
2172460|NCT01338298|3794559|FG000|Overall Study|Non-adherence|1
2172461|NCT01338298|3794560|FG001|Overall Study|Non-adherence|0
2172462|NCT01338415|3794568|FG000|Core + Extension|Adverse Event|8
2172463|NCT01338415|3794569|FG001|Core + Extension|Adverse Event|6
2172464|NCT01338415|3794570|FG002|Core + Extension|Adverse Event|0
2172465|NCT01338415|3794568|FG000|Core + Extension|Withdrawal by Subject|1
2172466|NCT01338415|3794569|FG001|Core + Extension|Withdrawal by Subject|1
2172467|NCT01338415|3794570|FG002|Core + Extension|Withdrawal by Subject|0
2172468|NCT01338415|3794568|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0
2172469|NCT01338415|3794569|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2
2172470|NCT01338415|3794570|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0
2172471|NCT01338415|3794568|FG000|Core + Extension|Other (administrative reason)|1
2172472|NCT01338415|3794569|FG001|Core + Extension|Other (administrative reason)|0
2172473|NCT01338415|3794570|FG002|Core + Extension|Other (administrative reason)|0
2172474|NCT01338415|3794568|FG000|Exceptional Use Treatment Period|Administrative decision|0
2172475|NCT01338415|3794569|FG001|Exceptional Use Treatment Period|Administrative decision|0
2172476|NCT01338415|3794570|FG002|Exceptional Use Treatment Period|Administrative decision|1
2172477|NCT01338415|3794568|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
2172478|NCT01338415|3794569|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
2172479|NCT01338415|3794570|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3
2172480|NCT01338415|3794568|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0
2172481|NCT01338415|3794569|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0
2172482|NCT01338415|3794570|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1
2172483|NCT01338415|3794568|FG000|Exceptional Use Treatment Period|Death|0
2172484|NCT01338415|3794569|FG001|Exceptional Use Treatment Period|Death|0
2172485|NCT01338415|3794570|FG002|Exceptional Use Treatment Period|Death|1
2172486|NCT01338493|3794578|FG000|Enrolled|Withdrawal by Subject|1
2172487|NCT01338493|3794578|FG000|Enrolled|Patient not implanted|4
2172488|NCT01338493|3794578|FG000|Discharge|Death|1
2172489|NCT01338493|3794578|FG000|Discharge|Missed visit|1
2172490|NCT01338493|3794578|FG000|6 Months Follow up|Lost to Follow-up|11
2172491|NCT01338493|3794578|FG000|6 Months Follow up|Missed visit|8
2172492|NCT01338493|3794578|FG000|12 Months Follow up|Lost to Follow-up|9
2172493|NCT01338610|3794598|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1
2172494|NCT01338610|3794599|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1
2172495|NCT01338610|3794600|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0
2172496|NCT01338610|3794598|FG000|Overall Study|Protocol Violation|1
2172497|NCT01338610|3794599|FG001|Overall Study|Protocol Violation|0
2172498|NCT01338610|3794600|FG002|Overall Study|Protocol Violation|1
2172499|NCT01338610|3794598|FG000|Overall Study|Adverse Event|3
2172500|NCT01338610|3794599|FG001|Overall Study|Adverse Event|0
2172501|NCT01338610|3794600|FG002|Overall Study|Adverse Event|0
2172502|NCT01338792|3794616|FG000|Overall Study|Adverse Event|2
2172503|NCT01338792|3794616|FG000|Overall Study|Death|1
2172504|NCT01338792|3794616|FG000|Overall Study|Withdrawal by Subject|1
2172505|NCT01338818|3794620|FG000|Overall Study|Adverse Event|8
2172506|NCT01338818|3794620|FG000|Overall Study|Lack of Efficacy|5
2172507|NCT01338818|3794620|FG000|Overall Study|no longer require study drug|1
2172508|NCT01338818|3794620|FG000|Overall Study|Withdrawal by Subject|11
2172509|NCT01338818|3794620|FG000|Overall Study|Lost to Follow-up|4
2172510|NCT01338818|3794620|FG000|Overall Study|Administrative problems|3
2172511|NCT01338818|3794620|FG000|Overall Study|Protocol Deviation|4
2172512|NCT01338870|3794634|FG000|Overall Study|Lost to Follow-up|0
2172513|NCT01338870|3794635|FG001|Overall Study|Lost to Follow-up|0
2172514|NCT01338870|3794636|FG002|Overall Study|Lost to Follow-up|1
2172515|NCT01338870|3794637|FG003|Overall Study|Lost to Follow-up|0
2172516|NCT01338870|3794638|FG004|Overall Study|Lost to Follow-up|1
2172517|NCT01338870|3794639|FG005|Overall Study|Lost to Follow-up|0
2172518|NCT01338870|3794634|FG000|Overall Study|Withdrawal by Subject|2
2172519|NCT01338870|3794635|FG001|Overall Study|Withdrawal by Subject|3
2172520|NCT01338870|3794636|FG002|Overall Study|Withdrawal by Subject|4
2172521|NCT01338870|3794637|FG003|Overall Study|Withdrawal by Subject|0
2172522|NCT01338870|3794638|FG004|Overall Study|Withdrawal by Subject|0
2172523|NCT01338870|3794639|FG005|Overall Study|Withdrawal by Subject|2
2172524|NCT01338870|3794634|FG000|Overall Study|Other|3
2172525|NCT01338870|3794635|FG001|Overall Study|Other|3
2172526|NCT01338870|3794636|FG002|Overall Study|Other|3
2172527|NCT01338870|3794637|FG003|Overall Study|Other|2
2172528|NCT01338870|3794638|FG004|Overall Study|Other|0
2172529|NCT01338870|3794639|FG005|Overall Study|Other|2
2172530|NCT01338870|3794634|FG000|Overall Study|Protocol Violation|0
2172531|NCT01338870|3794635|FG001|Overall Study|Protocol Violation|2
2172532|NCT01338870|3794636|FG002|Overall Study|Protocol Violation|2
2172533|NCT01338870|3794637|FG003|Overall Study|Protocol Violation|2
2172534|NCT01338870|3794638|FG004|Overall Study|Protocol Violation|1
2172535|NCT01338870|3794639|FG005|Overall Study|Protocol Violation|1
2172536|NCT01338870|3794634|FG000|Overall Study|Adverse Event|4
2172537|NCT01338870|3794635|FG001|Overall Study|Adverse Event|4
2172538|NCT01338870|3794636|FG002|Overall Study|Adverse Event|1
2172539|NCT01338870|3794637|FG003|Overall Study|Adverse Event|5
2172540|NCT01338870|3794638|FG004|Overall Study|Adverse Event|4
2172541|NCT01338870|3794639|FG005|Overall Study|Adverse Event|1
2172542|NCT01338987|3794658|FG000|Overall Study|enrolled on new protocol|0
2172543|NCT01338987|3794659|FG001|Overall Study|enrolled on new protocol|0
2172544|NCT01338987|3794660|FG002|Overall Study|enrolled on new protocol|1
2172545|NCT01338987|3794661|FG003|Overall Study|enrolled on new protocol|0
2172546|NCT01338987|3794662|FG004|Overall Study|enrolled on new protocol|0
2172547|NCT01338987|3794658|FG000|Overall Study|Disease progression on study|2
2172548|NCT01338987|3794659|FG001|Overall Study|Disease progression on study|1
2172549|NCT01338987|3794660|FG002|Overall Study|Disease progression on study|1
2172550|NCT01338987|3794661|FG003|Overall Study|Disease progression on study|0
2172551|NCT01338987|3794662|FG004|Overall Study|Disease progression on study|0
2172552|NCT01339000|3794678|FG000|Overall Study|study closed due to lack of drug supply|1
2172553|NCT01339000|3794679|FG001|Overall Study|study closed due to lack of drug supply|0
2172554|NCT01339052|3794694|FG000|Overall Study|Disease progression|13
2172555|NCT01339052|3794695|FG001|Overall Study|Disease progression|46
2172556|NCT01339052|3794694|FG000|Overall Study|Adverse Event|1
2172557|NCT01339052|3794695|FG001|Overall Study|Adverse Event|1
2172558|NCT01339052|3794694|FG000|Overall Study|Withdrawal by Subject|0
2172559|NCT01339052|3794695|FG001|Overall Study|Withdrawal by Subject|3
2172560|NCT01339052|3794694|FG000|Overall Study|Physician Decision|1
2172561|NCT01339052|3794695|FG001|Overall Study|Physician Decision|0
2172562|NCT01339273|3794733|FG000|Overall Study|Lost to Follow-up|8
2172563|NCT01339273|3794734|FG001|Overall Study|Lost to Follow-up|8
2172564|NCT01339390|3794751|FG000|Overall Study|Death|32
2172565|NCT01339390|3794752|FG001|Overall Study|Death|29
2172566|NCT01339390|3794751|FG000|Overall Study|Lost to Follow-up|125
2172567|NCT01339390|3794752|FG001|Overall Study|Lost to Follow-up|127
2172568|NCT01339429|3794771|FG000|Overall Study|Withdrawal by Subject|1
2172569|NCT01339429|3794771|FG000|Overall Study|Physician Decision|3
2172570|NCT01339559|3794775|FG000|Overall Study|Adverse Event|92
2172571|NCT01339559|3794775|FG000|Overall Study|Death|5
2172572|NCT01339559|3794775|FG000|Overall Study|Lack of Efficacy|164
2172573|NCT01339559|3794775|FG000|Overall Study|Lost to Follow-up|22
2172574|NCT01339559|3794775|FG000|Overall Study|Subject choice|89
2172575|NCT01339559|3794775|FG000|Overall Study|Protocol Violation|15
2296660|NCT02559570|3992660|FG003|Overall Study|Withdrawal of Consent|2
2172576|NCT01339559|3794775|FG000|Overall Study|Study closure at site|1
2172577|NCT01339559|3794775|FG000|Overall Study|Incarcerated|2
2172578|NCT01339559|3794775|FG000|Overall Study|Epilepsy surgery|1
2172579|NCT01339559|3794775|FG000|Overall Study|Pregnancy planned|2
2172580|NCT01339559|3794775|FG000|Overall Study|Left the country|1
2172581|NCT01339559|3794775|FG000|Overall Study|Investigator decision|2
2172582|NCT01339559|3794775|FG000|Overall Study|Patient didn't wish to continue|1
2172583|NCT01339559|3794775|FG000|Overall Study|PI decision|1
2172584|NCT01339832|3794780|FG000|Overall Study|Lost to Follow-up|3
2172585|NCT01339832|3794780|FG000|Overall Study|Death|11
2172586|NCT01339897|3794799|FG000|Overall Study|Adverse Event|1
2172587|NCT01339897|3794800|FG001|Overall Study|Adverse Event|0
2172588|NCT01339897|3794801|FG002|Overall Study|Adverse Event|0
2172589|NCT01339897|3794802|FG003|Overall Study|Adverse Event|1
2172590|NCT01339910|3794816|FG000|Overall Study|Withdrawal by Subject|1
2172591|NCT01339910|3794817|FG001|Overall Study|Withdrawal by Subject|0
2172592|NCT01339910|3794816|FG000|Overall Study|Physician Decision|1
2172593|NCT01339910|3794817|FG001|Overall Study|Physician Decision|0
2172594|NCT01339910|3794816|FG000|Overall Study|Disease relapse|1
2172595|NCT01339910|3794817|FG001|Overall Study|Disease relapse|4
2172596|NCT01339923|3794830|FG000|Overall Study|Adverse Event|1
2172597|NCT01339923|3794831|FG001|Overall Study|Adverse Event|1
2172598|NCT01339923|3794832|FG002|Overall Study|Adverse Event|1
2172599|NCT01339923|3794833|FG003|Overall Study|Adverse Event|0
2172600|NCT01339923|3794834|FG004|Overall Study|Adverse Event|0
2172601|NCT01339923|3794835|FG005|Overall Study|Adverse Event|0
2172602|NCT01339923|3794836|FG006|Overall Study|Adverse Event|1
2172603|NCT01339923|3794830|FG000|Overall Study|Inappropriate Enrollment|1
2172604|NCT01339923|3794831|FG001|Overall Study|Inappropriate Enrollment|0
2172605|NCT01339923|3794832|FG002|Overall Study|Inappropriate Enrollment|0
2172606|NCT01339923|3794833|FG003|Overall Study|Inappropriate Enrollment|0
2172607|NCT01339923|3794834|FG004|Overall Study|Inappropriate Enrollment|0
2172608|NCT01339923|3794835|FG005|Overall Study|Inappropriate Enrollment|1
2172609|NCT01339923|3794836|FG006|Overall Study|Inappropriate Enrollment|0
2172610|NCT01339923|3794830|FG000|Overall Study|Lost to Follow-up|4
2172611|NCT01339923|3794831|FG001|Overall Study|Lost to Follow-up|4
2172612|NCT01339923|3794832|FG002|Overall Study|Lost to Follow-up|0
2172613|NCT01339923|3794833|FG003|Overall Study|Lost to Follow-up|3
2172614|NCT01339923|3794834|FG004|Overall Study|Lost to Follow-up|1
2172615|NCT01339923|3794835|FG005|Overall Study|Lost to Follow-up|1
2172616|NCT01339923|3794836|FG006|Overall Study|Lost to Follow-up|5
2172617|NCT01339923|3794830|FG000|Overall Study|Protocol Violation|0
2172618|NCT01339923|3794831|FG001|Overall Study|Protocol Violation|0
2172619|NCT01339923|3794832|FG002|Overall Study|Protocol Violation|0
2172620|NCT01339923|3794833|FG003|Overall Study|Protocol Violation|0
2172621|NCT01339923|3794834|FG004|Overall Study|Protocol Violation|0
2172622|NCT01339923|3794835|FG005|Overall Study|Protocol Violation|3
2172623|NCT01339923|3794836|FG006|Overall Study|Protocol Violation|1
2172624|NCT01339923|3794830|FG000|Overall Study|Unable to Classify|1
2172625|NCT01339923|3794831|FG001|Overall Study|Unable to Classify|0
2172626|NCT01339923|3794832|FG002|Overall Study|Unable to Classify|1
2172627|NCT01339923|3794833|FG003|Overall Study|Unable to Classify|0
2172628|NCT01339923|3794834|FG004|Overall Study|Unable to Classify|0
2172629|NCT01339923|3794835|FG005|Overall Study|Unable to Classify|1
2172630|NCT01339923|3794836|FG006|Overall Study|Unable to Classify|5
2172631|NCT01339923|3794830|FG000|Overall Study|Withdrawal by Subject|7
2172632|NCT01339923|3794831|FG001|Overall Study|Withdrawal by Subject|11
2172633|NCT01339923|3794832|FG002|Overall Study|Withdrawal by Subject|6
2172634|NCT01339923|3794833|FG003|Overall Study|Withdrawal by Subject|1
2172635|NCT01339923|3794834|FG004|Overall Study|Withdrawal by Subject|4
2172636|NCT01339923|3794835|FG005|Overall Study|Withdrawal by Subject|3
2172637|NCT01339923|3794836|FG006|Overall Study|Withdrawal by Subject|2
2172638|NCT01340014|3794871|FG000|Period 1, First 7 Days|Adverse Event|1
2172639|NCT01340014|3794872|FG001|Period 1, First 7 Days|Adverse Event|0
2172640|NCT01340014|3794871|FG000|Period 1, First 7 Days|Personal Reasons|1
2172641|NCT01340014|3794872|FG001|Period 1, First 7 Days|Personal Reasons|0
2172642|NCT01340014|3794871|FG000|Period 2, Second 7 Days|Adverse Event|0
2172643|NCT01340014|3794872|FG001|Period 2, Second 7 Days|Adverse Event|1
2172644|NCT01340027|3794890|FG000|Overall Study|Randomized but Never Received Study Drug|0
2172645|NCT01340027|3794891|FG001|Overall Study|Randomized but Never Received Study Drug|0
2172646|NCT01340027|3794892|FG002|Overall Study|Randomized but Never Received Study Drug|1
2172647|NCT01340027|3794893|FG003|Overall Study|Randomized but Never Received Study Drug|0
2172648|NCT01340027|3794894|FG004|Overall Study|Randomized but Never Received Study Drug|0
2172649|NCT01340027|3794895|FG005|Overall Study|Randomized but Never Received Study Drug|0
2172650|NCT01340027|3794896|FG006|Overall Study|Randomized but Never Received Study Drug|0
2172651|NCT01340027|3794897|FG007|Overall Study|Randomized but Never Received Study Drug|0
2172652|NCT01340027|3794898|FG008|Overall Study|Randomized but Never Received Study Drug|0
2172653|NCT01340027|3794899|FG009|Overall Study|Randomized but Never Received Study Drug|0
2172654|NCT01340027|3794900|FG010|Overall Study|Randomized but Never Received Study Drug|0
2172655|NCT01340027|3794901|FG011|Overall Study|Randomized but Never Received Study Drug|0
2172656|NCT01340027|3794890|FG000|Overall Study|Adverse Event|0
2172657|NCT01340027|3794891|FG001|Overall Study|Adverse Event|1
2172658|NCT01340027|3794892|FG002|Overall Study|Adverse Event|2
2172659|NCT01340027|3794893|FG003|Overall Study|Adverse Event|0
2172660|NCT01340027|3794894|FG004|Overall Study|Adverse Event|1
2172661|NCT01340027|3794895|FG005|Overall Study|Adverse Event|2
2172662|NCT01340027|3794896|FG006|Overall Study|Adverse Event|2
2172663|NCT01340027|3794897|FG007|Overall Study|Adverse Event|1
2172664|NCT01340027|3794898|FG008|Overall Study|Adverse Event|4
2172665|NCT01340027|3794899|FG009|Overall Study|Adverse Event|1
2172666|NCT01340027|3794900|FG010|Overall Study|Adverse Event|1
2172667|NCT01340027|3794901|FG011|Overall Study|Adverse Event|3
2172668|NCT01340027|3794890|FG000|Overall Study|Lack of Efficacy|0
2172669|NCT01340027|3794891|FG001|Overall Study|Lack of Efficacy|0
2172670|NCT01340027|3794892|FG002|Overall Study|Lack of Efficacy|0
2172671|NCT01340027|3794893|FG003|Overall Study|Lack of Efficacy|0
2172672|NCT01340027|3794894|FG004|Overall Study|Lack of Efficacy|0
2172673|NCT01340027|3794895|FG005|Overall Study|Lack of Efficacy|0
2172674|NCT01340027|3794896|FG006|Overall Study|Lack of Efficacy|1
2172675|NCT01340027|3794897|FG007|Overall Study|Lack of Efficacy|1
2172676|NCT01340027|3794898|FG008|Overall Study|Lack of Efficacy|1
2172677|NCT01340027|3794899|FG009|Overall Study|Lack of Efficacy|0
2172678|NCT01340027|3794900|FG010|Overall Study|Lack of Efficacy|0
2172679|NCT01340027|3794901|FG011|Overall Study|Lack of Efficacy|0
2172680|NCT01340027|3794890|FG000|Overall Study|Lost to Follow-up|0
2172681|NCT01340027|3794891|FG001|Overall Study|Lost to Follow-up|1
2172682|NCT01340027|3794892|FG002|Overall Study|Lost to Follow-up|0
2172683|NCT01340027|3794893|FG003|Overall Study|Lost to Follow-up|0
2172684|NCT01340027|3794894|FG004|Overall Study|Lost to Follow-up|0
2172685|NCT01340027|3794895|FG005|Overall Study|Lost to Follow-up|0
2172686|NCT01340027|3794896|FG006|Overall Study|Lost to Follow-up|1
2172687|NCT01340027|3794897|FG007|Overall Study|Lost to Follow-up|0
2172688|NCT01340027|3794898|FG008|Overall Study|Lost to Follow-up|0
2172689|NCT01340027|3794899|FG009|Overall Study|Lost to Follow-up|1
2172690|NCT01340027|3794900|FG010|Overall Study|Lost to Follow-up|0
2172691|NCT01340027|3794901|FG011|Overall Study|Lost to Follow-up|0
2172692|NCT01340027|3794890|FG000|Overall Study|Protocol Violation|1
2172693|NCT01340027|3794891|FG001|Overall Study|Protocol Violation|2
2172694|NCT01340027|3794892|FG002|Overall Study|Protocol Violation|0
2172695|NCT01340027|3794893|FG003|Overall Study|Protocol Violation|0
2172696|NCT01340027|3794894|FG004|Overall Study|Protocol Violation|6
2172697|NCT01340027|3794895|FG005|Overall Study|Protocol Violation|0
2172698|NCT01340027|3794896|FG006|Overall Study|Protocol Violation|0
2172699|NCT01340027|3794897|FG007|Overall Study|Protocol Violation|1
2172700|NCT01340027|3794898|FG008|Overall Study|Protocol Violation|2
2172701|NCT01340027|3794899|FG009|Overall Study|Protocol Violation|2
2172702|NCT01340027|3794900|FG010|Overall Study|Protocol Violation|0
2172703|NCT01340027|3794901|FG011|Overall Study|Protocol Violation|0
2172704|NCT01340027|3794890|FG000|Overall Study|Withdrawal by Subject|4
2172705|NCT01340027|3794891|FG001|Overall Study|Withdrawal by Subject|3
2172706|NCT01340027|3794892|FG002|Overall Study|Withdrawal by Subject|1
2172707|NCT01340027|3794893|FG003|Overall Study|Withdrawal by Subject|3
2172708|NCT01340027|3794894|FG004|Overall Study|Withdrawal by Subject|3
2172709|NCT01340027|3794895|FG005|Overall Study|Withdrawal by Subject|2
2172710|NCT01340027|3794896|FG006|Overall Study|Withdrawal by Subject|3
2172711|NCT01340027|3794897|FG007|Overall Study|Withdrawal by Subject|4
2172712|NCT01340027|3794898|FG008|Overall Study|Withdrawal by Subject|1
2172713|NCT01340027|3794899|FG009|Overall Study|Withdrawal by Subject|2
2172714|NCT01340027|3794900|FG010|Overall Study|Withdrawal by Subject|0
2172715|NCT01340027|3794901|FG011|Overall Study|Withdrawal by Subject|1
2172716|NCT01340027|3794890|FG000|Overall Study|Miscellaneous|0
2172717|NCT01340027|3794891|FG001|Overall Study|Miscellaneous|0
2172718|NCT01340027|3794892|FG002|Overall Study|Miscellaneous|0
2172719|NCT01340027|3794893|FG003|Overall Study|Miscellaneous|1
2172720|NCT01340027|3794894|FG004|Overall Study|Miscellaneous|0
2172721|NCT01340027|3794895|FG005|Overall Study|Miscellaneous|0
2172722|NCT01340027|3794896|FG006|Overall Study|Miscellaneous|0
2172723|NCT01340027|3794897|FG007|Overall Study|Miscellaneous|0
2172724|NCT01340027|3794898|FG008|Overall Study|Miscellaneous|0
2172725|NCT01340027|3794899|FG009|Overall Study|Miscellaneous|0
2172726|NCT01340027|3794900|FG010|Overall Study|Miscellaneous|1
2172727|NCT01340027|3794901|FG011|Overall Study|Miscellaneous|0
2172728|NCT01340066|3794946|FG000|Placebo Run in Period|Screen Failures|27
2172729|NCT01340066|3794947|FG001|Placebo Run in Period|Screen Failures|0
2172730|NCT01340066|3794948|FG002|Placebo Run in Period|Screen Failures|0
2172731|NCT01340066|3794946|FG000|5 Week Double Blind Randomization Period|Adverse Event|0
2172732|NCT01340066|3794947|FG001|5 Week Double Blind Randomization Period|Adverse Event|2
2172733|NCT01340066|3794948|FG002|5 Week Double Blind Randomization Period|Adverse Event|2
2172734|NCT01340066|3794946|FG000|5 Week Double Blind Randomization Period|Physician Decision|0
2172735|NCT01340066|3794947|FG001|5 Week Double Blind Randomization Period|Physician Decision|1
2172736|NCT01340066|3794948|FG002|5 Week Double Blind Randomization Period|Physician Decision|0
2172737|NCT01340066|3794946|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
2172738|NCT01340066|3794947|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
2172739|NCT01340066|3794948|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
2179865|NCT01396421|3805666|FG000|Overall Study|Participant Met Withdrawal Criteria|1
2179866|NCT01396421|3805667|FG001|Overall Study|Participant Met Withdrawal Criteria|0
2179867|NCT01396421|3805668|FG002|Overall Study|Participant Met Withdrawal Criteria|1
2179868|NCT01396421|3805669|FG003|Overall Study|Participant Met Withdrawal Criteria|0
2179869|NCT01396421|3805666|FG000|Overall Study|Physician Decision|1
2179870|NCT01396421|3805667|FG001|Overall Study|Physician Decision|1
2179871|NCT01396421|3805668|FG002|Overall Study|Physician Decision|0
2179872|NCT01396421|3805669|FG003|Overall Study|Physician Decision|3
2179873|NCT01396421|3805666|FG000|Overall Study|Withdrawal by Subject|31
2179874|NCT01396421|3805667|FG001|Overall Study|Withdrawal by Subject|24
2179875|NCT01396421|3805668|FG002|Overall Study|Withdrawal by Subject|13
2179876|NCT01396421|3805669|FG003|Overall Study|Withdrawal by Subject|21
2179877|NCT01396421|3805666|FG000|Overall Study|Protocol Deviation|2
2179878|NCT01396421|3805667|FG001|Overall Study|Protocol Deviation|1
2179879|NCT01396421|3805668|FG002|Overall Study|Protocol Deviation|1
2179880|NCT01396421|3805669|FG003|Overall Study|Protocol Deviation|0
2172740|NCT01340196|3794964|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2
2172741|NCT01340209|3794976|FG000|Overall Study|Adverse Event|1
2172742|NCT01340209|3794977|FG001|Overall Study|Adverse Event|1
2172743|NCT01340209|3794978|FG002|Overall Study|Adverse Event|2
2172744|NCT01340209|3794976|FG000|Overall Study|Protocol Violation|1
2172745|NCT01340209|3794977|FG001|Overall Study|Protocol Violation|2
2172746|NCT01340209|3794978|FG002|Overall Study|Protocol Violation|1
2172747|NCT01340209|3794976|FG000|Overall Study|Withdrawal by Subject|0
2172748|NCT01340209|3794977|FG001|Overall Study|Withdrawal by Subject|0
2172749|NCT01340209|3794978|FG002|Overall Study|Withdrawal by Subject|1
2172750|NCT01340209|3794976|FG000|Overall Study|Other reason not defined above|3
2172751|NCT01340209|3794977|FG001|Overall Study|Other reason not defined above|5
2172752|NCT01340209|3794978|FG002|Overall Study|Other reason not defined above|4
2172753|NCT01340300|3794990|FG000|Overall Study|Lost to Follow-up|3
2172754|NCT01340300|3794991|FG001|Overall Study|Lost to Follow-up|0
2172755|NCT01340300|3794992|FG002|Overall Study|Lost to Follow-up|5
2172756|NCT01340300|3794993|FG003|Overall Study|Lost to Follow-up|10
2172757|NCT01340300|3794990|FG000|Overall Study|Withdrawal by Subject|5
2172758|NCT01340300|3794991|FG001|Overall Study|Withdrawal by Subject|6
2172759|NCT01340300|3794992|FG002|Overall Study|Withdrawal by Subject|6
2172760|NCT01340300|3794993|FG003|Overall Study|Withdrawal by Subject|3
2172761|NCT01340300|3794990|FG000|Overall Study|Adverse Event|1
2172762|NCT01340300|3794991|FG001|Overall Study|Adverse Event|0
2172763|NCT01340300|3794992|FG002|Overall Study|Adverse Event|4
2172764|NCT01340300|3794993|FG003|Overall Study|Adverse Event|0
2172765|NCT01340300|3794990|FG000|Overall Study|Physician Decision|0
2172766|NCT01340300|3794991|FG001|Overall Study|Physician Decision|1
2172767|NCT01340300|3794992|FG002|Overall Study|Physician Decision|0
2172768|NCT01340300|3794993|FG003|Overall Study|Physician Decision|0
2172769|NCT01340300|3794990|FG000|Overall Study|Unrelated sickness|0
2172770|NCT01340300|3794991|FG001|Overall Study|Unrelated sickness|2
2172771|NCT01340300|3794992|FG002|Overall Study|Unrelated sickness|0
2172772|NCT01340300|3794993|FG003|Overall Study|Unrelated sickness|1
2172773|NCT01340482|3795006|FG000|Overall Study|Adverse Event|2
2172774|NCT01340482|3795007|FG001|Overall Study|Adverse Event|0
2172775|NCT01340482|3795008|FG002|Overall Study|Adverse Event|0
2172776|NCT01340495|3795018|FG000|Overall Study|Withdrawal by Subject|1
2172777|NCT01340625|3795038|FG000|First Intervention|Adverse Event|1
2172778|NCT01340625|3795039|FG001|First Intervention|Adverse Event|0
2172779|NCT01340625|3795038|FG000|Washout Period of 28 Days|Withdrawal by Subject|1
2172780|NCT01340625|3795039|FG001|Washout Period of 28 Days|Withdrawal by Subject|0
2172781|NCT01340651|3795045|FG000|Overall Study|Adverse Event|3
2172782|NCT01340651|3795045|FG000|Overall Study|Consent Withdrawn|2
2172783|NCT01340651|3795045|FG000|Overall Study|Commercial Supply per Sponsor|12
2172784|NCT01340664|3795054|FG000|Overall Study|Adverse Event|0
2172785|NCT01340664|3795055|FG001|Overall Study|Adverse Event|1
2172786|NCT01340664|3795056|FG002|Overall Study|Adverse Event|7
2172787|NCT01340664|3795054|FG000|Overall Study|Lost to Follow-up|2
2172788|NCT01340664|3795055|FG001|Overall Study|Lost to Follow-up|0
2172789|NCT01340664|3795056|FG002|Overall Study|Lost to Follow-up|2
2172790|NCT01340664|3795054|FG000|Overall Study|Withdrawal by Subject|2
2172791|NCT01340664|3795055|FG001|Overall Study|Withdrawal by Subject|4
2172792|NCT01340664|3795056|FG002|Overall Study|Withdrawal by Subject|0
2172793|NCT01340664|3795054|FG000|Overall Study|Glycemic withdrawal criteria|2
2172794|NCT01340664|3795055|FG001|Overall Study|Glycemic withdrawal criteria|0
2172795|NCT01340664|3795056|FG002|Overall Study|Glycemic withdrawal criteria|0
2172796|NCT01340664|3795054|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0
2172797|NCT01340664|3795055|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1
2172798|NCT01340664|3795056|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2
2172799|NCT01340664|3795054|FG000|Overall Study|Other|1
2172800|NCT01340664|3795055|FG001|Overall Study|Other|2
2172801|NCT01340664|3795056|FG002|Overall Study|Other|2
2172802|NCT01340768|3795066|FG000|Overall Study|Lost to Follow-up|10
2172803|NCT01340768|3795067|FG001|Overall Study|Lost to Follow-up|4
2172804|NCT01340768|3795066|FG000|Overall Study|Withdrawal by Subject|5
2172805|NCT01340768|3795067|FG001|Overall Study|Withdrawal by Subject|1
2172806|NCT01340768|3795066|FG000|Overall Study|Other|2
2172807|NCT01340768|3795067|FG001|Overall Study|Other|0
2172808|NCT01340794|3795075|FG000|Overall Study|Withdrawal by Subject|0
2172809|NCT01340794|3795076|FG001|Overall Study|Withdrawal by Subject|1
2172810|NCT01340872|3795086|FG000|Double-blind Phase|Adverse Event|6
2172811|NCT01340872|3795087|FG001|Double-blind Phase|Adverse Event|4
2172812|NCT01340872|3795088|FG002|Double-blind Phase|Adverse Event|0
2172813|NCT01340872|3795089|FG003|Double-blind Phase|Adverse Event|0
2172814|NCT01340872|3795086|FG000|Double-blind Phase|Withdrawal by Subject|3
2172815|NCT01340872|3795087|FG001|Double-blind Phase|Withdrawal by Subject|5
2172816|NCT01340872|3795088|FG002|Double-blind Phase|Withdrawal by Subject|0
2172817|NCT01340872|3795089|FG003|Double-blind Phase|Withdrawal by Subject|0
2172818|NCT01340872|3795086|FG000|Double-blind Phase|Lost to Follow-up|0
2172819|NCT01340872|3795087|FG001|Double-blind Phase|Lost to Follow-up|1
2172820|NCT01340872|3795088|FG002|Double-blind Phase|Lost to Follow-up|0
2172821|NCT01340872|3795089|FG003|Double-blind Phase|Lost to Follow-up|0
2172822|NCT01340872|3795086|FG000|Double-blind Phase|Protocol Violation|0
2172823|NCT01340872|3795087|FG001|Double-blind Phase|Protocol Violation|1
2172824|NCT01340872|3795088|FG002|Double-blind Phase|Protocol Violation|0
2172825|NCT01340872|3795089|FG003|Double-blind Phase|Protocol Violation|0
2172826|NCT01340872|3795086|FG000|Open-label Phase|Physician Decision|0
2172827|NCT01340872|3795087|FG001|Open-label Phase|Physician Decision|0
2172828|NCT01340872|3795088|FG002|Open-label Phase|Physician Decision|2
2172829|NCT01340872|3795089|FG003|Open-label Phase|Physician Decision|1
2172830|NCT01340872|3795086|FG000|Open-label Phase|Pregnancy|0
2172831|NCT01340872|3795087|FG001|Open-label Phase|Pregnancy|0
2172832|NCT01340872|3795088|FG002|Open-label Phase|Pregnancy|1
2172833|NCT01340872|3795089|FG003|Open-label Phase|Pregnancy|0
2172834|NCT01340872|3795086|FG000|Open-label Phase|Adverse Event|0
2172835|NCT01340872|3795087|FG001|Open-label Phase|Adverse Event|0
2172836|NCT01340872|3795088|FG002|Open-label Phase|Adverse Event|8
2172837|NCT01340872|3795089|FG003|Open-label Phase|Adverse Event|4
2172838|NCT01340872|3795086|FG000|Open-label Phase|Withdrawal by Subject|0
2172839|NCT01340872|3795087|FG001|Open-label Phase|Withdrawal by Subject|0
2172840|NCT01340872|3795088|FG002|Open-label Phase|Withdrawal by Subject|1
2172841|NCT01340872|3795089|FG003|Open-label Phase|Withdrawal by Subject|6
2172842|NCT01340872|3795086|FG000|Open-label Phase|Worsening of IBD|0
2172843|NCT01340872|3795087|FG001|Open-label Phase|Worsening of IBD|0
2172844|NCT01340872|3795088|FG002|Open-label Phase|Worsening of IBD|1
2172845|NCT01340872|3795089|FG003|Open-label Phase|Worsening of IBD|0
2172846|NCT01340898|3795104|FG000|Primary Phase|Serious Adverse Events|0
2172847|NCT01340898|3795105|FG001|Primary Phase|Serious Adverse Events|0
2172848|NCT01340898|3795106|FG002|Primary Phase|Serious Adverse Events|1
2172849|NCT01340898|3795104|FG000|Primary Phase|Withdrawal by Subject|8
2172850|NCT01340898|3795105|FG001|Primary Phase|Withdrawal by Subject|7
2172851|NCT01340898|3795106|FG002|Primary Phase|Withdrawal by Subject|5
2172852|NCT01340898|3795104|FG000|Primary Phase|Migrated/moved from study area|4
2172853|NCT01340898|3795105|FG001|Primary Phase|Migrated/moved from study area|1
2172854|NCT01340898|3795106|FG002|Primary Phase|Migrated/moved from study area|0
2172855|NCT01340898|3795104|FG000|Primary Phase|Lost to Follow-up|4
2172856|NCT01340898|3795105|FG001|Primary Phase|Lost to Follow-up|1
2172857|NCT01340898|3795106|FG002|Primary Phase|Lost to Follow-up|0
2172858|NCT01340898|3795104|FG000|Booster Phase|Withdrawal by Subject|3
2172859|NCT01340898|3795105|FG001|Booster Phase|Withdrawal by Subject|0
2172860|NCT01340898|3795106|FG002|Booster Phase|Withdrawal by Subject|4
2172861|NCT01340898|3795104|FG000|Booster Phase|Migrated/moved from study area|3
2172862|NCT01340898|3795105|FG001|Booster Phase|Migrated/moved from study area|0
2172863|NCT01340898|3795106|FG002|Booster Phase|Migrated/moved from study area|0
2172864|NCT01340898|3795104|FG000|Booster Phase|Lost to Follow-up|4
2172865|NCT01340898|3795105|FG001|Booster Phase|Lost to Follow-up|2
2172866|NCT01340898|3795106|FG002|Booster Phase|Lost to Follow-up|3
2172867|NCT01340937|3795120|FG000|Period 1: Infant Series|Other protocol criterion not met|0
2172868|NCT01340937|3795121|FG001|Period 1: Infant Series|Other protocol criterion not met|1
2172869|NCT01340937|3795122|FG002|Period 1: Infant Series|Other protocol criterion not met|1
2172870|NCT01340937|3795123|FG003|Period 1: Infant Series|Other protocol criterion not met|0
2172871|NCT01340937|3795120|FG000|Period 1: Infant Series|Adverse Event|0
2172872|NCT01340937|3795121|FG001|Period 1: Infant Series|Adverse Event|1
2172873|NCT01340937|3795122|FG002|Period 1: Infant Series|Adverse Event|4
2172874|NCT01340937|3795123|FG003|Period 1: Infant Series|Adverse Event|0
2172875|NCT01340937|3795120|FG000|Period 1: Infant Series|Death|2
2172876|NCT01340937|3795121|FG001|Period 1: Infant Series|Death|0
2172877|NCT01340937|3795122|FG002|Period 1: Infant Series|Death|2
2172878|NCT01340937|3795123|FG003|Period 1: Infant Series|Death|0
2172879|NCT01340937|3795120|FG000|Period 1: Infant Series|Lost to Follow-up|20
2172880|NCT01340937|3795121|FG001|Period 1: Infant Series|Lost to Follow-up|14
2172881|NCT01340937|3795122|FG002|Period 1: Infant Series|Lost to Follow-up|12
2172882|NCT01340937|3795123|FG003|Period 1: Infant Series|Lost to Follow-up|13
2172883|NCT01340937|3795120|FG000|Period 1: Infant Series|Physician Decision|2
2172884|NCT01340937|3795121|FG001|Period 1: Infant Series|Physician Decision|3
2172885|NCT01340937|3795122|FG002|Period 1: Infant Series|Physician Decision|1
2172886|NCT01340937|3795123|FG003|Period 1: Infant Series|Physician Decision|0
2172887|NCT01340937|3795120|FG000|Period 1: Infant Series|Protocol Violation|1
2172888|NCT01340937|3795121|FG001|Period 1: Infant Series|Protocol Violation|4
2172889|NCT01340937|3795122|FG002|Period 1: Infant Series|Protocol Violation|4
2172890|NCT01340937|3795123|FG003|Period 1: Infant Series|Protocol Violation|3
2172891|NCT01340937|3795120|FG000|Period 1: Infant Series|Withdrawal by Subject|33
2172892|NCT01340937|3795121|FG001|Period 1: Infant Series|Withdrawal by Subject|32
2172893|NCT01340937|3795122|FG002|Period 1: Infant Series|Withdrawal by Subject|30
2172894|NCT01340937|3795123|FG003|Period 1: Infant Series|Withdrawal by Subject|15
2172895|NCT01340937|3795120|FG000|Period 1: Infant Series|Randomized but not vaccinated|0
2172896|NCT01340937|3795121|FG001|Period 1: Infant Series|Randomized but not vaccinated|5
2172897|NCT01340937|3795122|FG002|Period 1: Infant Series|Randomized but not vaccinated|2
2172898|NCT01340937|3795123|FG003|Period 1: Infant Series|Randomized but not vaccinated|1
2172899|NCT01340937|3795120|FG000|Period 2: Interim Period|Withdrawal by Subject|28
2172900|NCT01340937|3795121|FG001|Period 2: Interim Period|Withdrawal by Subject|23
2172901|NCT01340937|3795122|FG002|Period 2: Interim Period|Withdrawal by Subject|17
2172902|NCT01340937|3795123|FG003|Period 2: Interim Period|Withdrawal by Subject|12
2172903|NCT01340937|3795120|FG000|Period 2: Interim Period|Adverse Event|1
2172904|NCT01340937|3795121|FG001|Period 2: Interim Period|Adverse Event|0
2172905|NCT01340937|3795122|FG002|Period 2: Interim Period|Adverse Event|1
2172906|NCT01340937|3795123|FG003|Period 2: Interim Period|Adverse Event|0
2172907|NCT01340937|3795120|FG000|Period 2: Interim Period|Lost to Follow-up|29
2172908|NCT01340937|3795121|FG001|Period 2: Interim Period|Lost to Follow-up|48
2172909|NCT01340937|3795122|FG002|Period 2: Interim Period|Lost to Follow-up|53
2172910|NCT01340937|3795123|FG003|Period 2: Interim Period|Lost to Follow-up|23
2172911|NCT01340937|3795120|FG000|Period 2: Interim Period|Physician Decision|0
2172912|NCT01340937|3795121|FG001|Period 2: Interim Period|Physician Decision|1
2172913|NCT01340937|3795122|FG002|Period 2: Interim Period|Physician Decision|1
2172914|NCT01340937|3795123|FG003|Period 2: Interim Period|Physician Decision|0
2172915|NCT01340937|3795120|FG000|Period 2: Interim Period|Protocol Violation|5
2172916|NCT01340937|3795121|FG001|Period 2: Interim Period|Protocol Violation|3
2172917|NCT01340937|3795122|FG002|Period 2: Interim Period|Protocol Violation|6
2172918|NCT01340937|3795123|FG003|Period 2: Interim Period|Protocol Violation|3
2172919|NCT01340937|3795120|FG000|Period 2: Interim Period|Technical problems|4
2172920|NCT01340937|3795121|FG001|Period 2: Interim Period|Technical problems|4
2172921|NCT01340937|3795122|FG002|Period 2: Interim Period|Technical problems|6
2172922|NCT01340937|3795123|FG003|Period 2: Interim Period|Technical problems|3
2172923|NCT01340937|3795120|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
2172924|NCT01340937|3795121|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
2172925|NCT01340937|3795122|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
2172926|NCT01340937|3795123|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
2172927|NCT01340937|3795120|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6
2172928|NCT01340937|3795121|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14
2172929|NCT01340937|3795122|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7
2172930|NCT01340937|3795123|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8
2172931|NCT01340937|3795120|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0
2172932|NCT01340937|3795121|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0
2172933|NCT01340937|3795122|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0
2172934|NCT01340937|3795123|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1
2172935|NCT01340937|3795120|FG000|Period 3: Toddler Vaccinations|Technical problem|1
2172936|NCT01340937|3795121|FG001|Period 3: Toddler Vaccinations|Technical problem|1
2172937|NCT01340937|3795122|FG002|Period 3: Toddler Vaccinations|Technical problem|1
2172938|NCT01340937|3795123|FG003|Period 3: Toddler Vaccinations|Technical problem|0
2172939|NCT01340976|3795145|FG000|Overall Study|Physician Decision|2
2172940|NCT01340976|3795146|FG001|Overall Study|Physician Decision|0
2172941|NCT01340976|3795147|FG002|Overall Study|Physician Decision|1
2172942|NCT01340976|3795148|FG003|Overall Study|Physician Decision|1
2172943|NCT01340976|3795149|FG004|Overall Study|Physician Decision|1
2172944|NCT01340976|3795150|FG005|Overall Study|Physician Decision|0
2172945|NCT01340976|3795145|FG000|Overall Study|Death|0
2172946|NCT01340976|3795146|FG001|Overall Study|Death|1
2172947|NCT01340976|3795147|FG002|Overall Study|Death|0
2172948|NCT01340976|3795148|FG003|Overall Study|Death|0
2172949|NCT01340976|3795149|FG004|Overall Study|Death|0
2172950|NCT01340976|3795150|FG005|Overall Study|Death|0
2172951|NCT01340976|3795145|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1
2172952|NCT01340976|3795146|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2172953|NCT01340976|3795147|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2172954|NCT01340976|3795148|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2172955|NCT01340976|3795149|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2172956|NCT01340976|3795150|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2172957|NCT01340976|3795145|FG000|Overall Study|Withdrawal by Subject|0
2172958|NCT01340976|3795146|FG001|Overall Study|Withdrawal by Subject|0
2172959|NCT01340976|3795147|FG002|Overall Study|Withdrawal by Subject|0
2172960|NCT01340976|3795148|FG003|Overall Study|Withdrawal by Subject|1
2172961|NCT01340976|3795149|FG004|Overall Study|Withdrawal by Subject|1
2172962|NCT01340976|3795150|FG005|Overall Study|Withdrawal by Subject|0
2172963|NCT01340976|3795145|FG000|Overall Study|Other anemia treatment|1
2172964|NCT01340976|3795146|FG001|Overall Study|Other anemia treatment|0
2172965|NCT01340976|3795147|FG002|Overall Study|Other anemia treatment|2
2172966|NCT01340976|3795148|FG003|Overall Study|Other anemia treatment|1
2172967|NCT01340976|3795149|FG004|Overall Study|Other anemia treatment|0
2172968|NCT01340976|3795150|FG005|Overall Study|Other anemia treatment|1
2172969|NCT01340976|3795145|FG000|Overall Study|Adverse Event|0
2172970|NCT01340976|3795146|FG001|Overall Study|Adverse Event|1
2172971|NCT01340976|3795147|FG002|Overall Study|Adverse Event|0
2172972|NCT01340976|3795148|FG003|Overall Study|Adverse Event|0
2172973|NCT01340976|3795149|FG004|Overall Study|Adverse Event|0
2172974|NCT01340976|3795150|FG005|Overall Study|Adverse Event|0
2172975|NCT01341457|3795191|FG000|Overall Study|Adverse Event|2
2172976|NCT01341457|3795192|FG001|Overall Study|Adverse Event|0
2172977|NCT01341470|3795205|FG000|Overall Study|Sponsor decision|0
2172978|NCT01341470|3795206|FG001|Overall Study|Sponsor decision|0
2172979|NCT01341470|3795207|FG002|Overall Study|Sponsor decision|1
2172980|NCT01341470|3795208|FG003|Overall Study|Sponsor decision|1
2172981|NCT01341470|3795209|FG004|Overall Study|Sponsor decision|0
2172982|NCT01341470|3795210|FG005|Overall Study|Sponsor decision|1
2172983|NCT01341639|3795228|FG000|Infant Series|Protocol Violation|1
2172984|NCT01341639|3795229|FG001|Infant Series|Protocol Violation|0
2172985|NCT01341639|3795228|FG000|Infant Series|Not Vaccinated|0
2172986|NCT01341639|3795229|FG001|Infant Series|Not Vaccinated|1
2172987|NCT01341639|3795228|FG000|Infant Series|Adverse Event|0
2172988|NCT01341639|3795229|FG001|Infant Series|Adverse Event|5
2172989|NCT01341639|3795228|FG000|Infant Series|Withdrawal by Subject|11
2172990|NCT01341639|3795229|FG001|Infant Series|Withdrawal by Subject|8
2172991|NCT01341639|3795228|FG000|Infant Series|Lost to Follow-up|0
2172992|NCT01341639|3795229|FG001|Infant Series|Lost to Follow-up|2
2172993|NCT01341639|3795228|FG000|Infant Series|Site 0048 Participants|17
2172994|NCT01341639|3795229|FG001|Infant Series|Site 0048 Participants|16
2172995|NCT01341639|3795228|FG000|Interim Period|Withdrawal by Subject|6
2172996|NCT01341639|3795229|FG001|Interim Period|Withdrawal by Subject|7
2172997|NCT01341639|3795228|FG000|Interim Period|Lost to Follow-up|2
2172998|NCT01341639|3795229|FG001|Interim Period|Lost to Follow-up|0
2172999|NCT01341639|3795228|FG000|Interim Period|Physician Decision|0
2173000|NCT01341639|3795229|FG001|Interim Period|Physician Decision|1
2173001|NCT01341639|3795228|FG000|Interim Period|Protocol Violation|0
2173002|NCT01341639|3795229|FG001|Interim Period|Protocol Violation|1
2173003|NCT01341639|3795228|FG000|Post-Treatment|Withdrawal by Subject|0
2173004|NCT01341639|3795229|FG001|Post-Treatment|Withdrawal by Subject|1
2173005|NCT01341639|3795228|FG000|Post-Treatment|Adverse Event|0
2173006|NCT01341639|3795229|FG001|Post-Treatment|Adverse Event|2
2173007|NCT01341652|3795237|FG000|Overall Study|Incorrect Random Assignment|0
2173008|NCT01341652|3795238|FG001|Overall Study|Incorrect Random Assignment|1
2173009|NCT01341652|3795237|FG000|Overall Study|ineligible; presence metastatic disease|0
2173010|NCT01341652|3795238|FG001|Overall Study|ineligible; presence metastatic disease|1
2173011|NCT01341782|3795257|FG000|Overall Study|Adverse Event|1
2173012|NCT01341782|3795258|FG001|Overall Study|Adverse Event|1
2173013|NCT01341782|3795257|FG000|Overall Study|Withdrawal by Subject|6
2173014|NCT01341782|3795258|FG001|Overall Study|Withdrawal by Subject|5
2173015|NCT01341782|3795257|FG000|Overall Study|Missed 3 consecutive doses|0
2173016|NCT01341782|3795258|FG001|Overall Study|Missed 3 consecutive doses|4
2173017|NCT01341782|3795257|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
2173018|NCT01341782|3795258|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
2173019|NCT01341782|3795257|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
2173020|NCT01341782|3795258|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
2173021|NCT01341782|3795257|FG000|Overall Study|Other|5
2173022|NCT01341782|3795258|FG001|Overall Study|Other|0
2173023|NCT01341990|3795279|FG000|Overall Study|Adverse Event|0
2173024|NCT01341990|3795280|FG001|Overall Study|Adverse Event|1
2173025|NCT01341990|3795279|FG000|Overall Study|Torn Study Lens|1
2173026|NCT01341990|3795280|FG001|Overall Study|Torn Study Lens|0
2173027|NCT01341990|3795279|FG000|Overall Study|Withdrawal by Subject|2
2173028|NCT01341990|3795280|FG001|Overall Study|Withdrawal by Subject|0
2173029|NCT01342081|3795298|FG000|Overall Study|Did not receive allocated intervention|0
2173030|NCT01342081|3795299|FG001|Overall Study|Did not receive allocated intervention|0
2173031|NCT01342081|3795300|FG002|Overall Study|Did not receive allocated intervention|1
2173032|NCT01342081|3795298|FG000|Overall Study|Adverse Event|1
2173033|NCT01342081|3795299|FG001|Overall Study|Adverse Event|0
2173034|NCT01342081|3795300|FG002|Overall Study|Adverse Event|0
2173035|NCT01342081|3795298|FG000|Overall Study|Physician Decision|0
2173036|NCT01342081|3795299|FG001|Overall Study|Physician Decision|1
2173037|NCT01342081|3795300|FG002|Overall Study|Physician Decision|0
2173038|NCT01342081|3795298|FG000|Overall Study|Withdrawal by Subject|1
2173039|NCT01342081|3795299|FG001|Overall Study|Withdrawal by Subject|1
2173040|NCT01342081|3795300|FG002|Overall Study|Withdrawal by Subject|0
2173041|NCT01342094|3795310|FG000|Overall Study|Adverse Event|5
2173042|NCT01342094|3795311|FG001|Overall Study|Adverse Event|0
2173043|NCT01342094|3795310|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
2173044|NCT01342094|3795311|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
2173045|NCT01342094|3795310|FG000|Overall Study|Withdrawal by Subject|0
2173046|NCT01342094|3795311|FG001|Overall Study|Withdrawal by Subject|2
2173047|NCT01342211|3795336|FG000|Overall Study|Lost to Follow-up|0
2173048|NCT01342211|3795337|FG001|Overall Study|Lost to Follow-up|0
2173049|NCT01342211|3795338|FG002|Overall Study|Lost to Follow-up|0
2173050|NCT01342211|3795339|FG003|Overall Study|Lost to Follow-up|1
2173051|NCT01342211|3795340|FG004|Overall Study|Lost to Follow-up|0
2173052|NCT01342211|3795336|FG000|Overall Study|Adverse Event|0
2173053|NCT01342211|3795337|FG001|Overall Study|Adverse Event|0
2173054|NCT01342211|3795338|FG002|Overall Study|Adverse Event|0
2173055|NCT01342211|3795339|FG003|Overall Study|Adverse Event|0
2173056|NCT01342211|3795340|FG004|Overall Study|Adverse Event|1
2173057|NCT01342211|3795336|FG000|Overall Study|Withdrawal by Subject|0
2173058|NCT01342211|3795337|FG001|Overall Study|Withdrawal by Subject|0
2173059|NCT01342211|3795338|FG002|Overall Study|Withdrawal by Subject|0
2173060|NCT01342211|3795339|FG003|Overall Study|Withdrawal by Subject|1
2173061|NCT01342211|3795340|FG004|Overall Study|Withdrawal by Subject|0
2173062|NCT01342211|3795336|FG000|Overall Study|Randomized, but not Treated|0
2173063|NCT01342211|3795337|FG001|Overall Study|Randomized, but not Treated|2
2173064|NCT01342211|3795338|FG002|Overall Study|Randomized, but not Treated|0
2173065|NCT01342211|3795339|FG003|Overall Study|Randomized, but not Treated|0
2173066|NCT01342211|3795340|FG004|Overall Study|Randomized, but not Treated|1
2173067|NCT01342341|3795358|FG000|Overall Study|Lost to Follow-up|4
2173068|NCT01342341|3795359|FG001|Overall Study|Lost to Follow-up|4
2173069|NCT01342367|3795367|FG000|Overall Study|Death|1
2173070|NCT01342367|3795368|FG001|Overall Study|Death|0
2173071|NCT01342367|3795367|FG000|Overall Study|Withdrawal by Subject|1
2173072|NCT01342367|3795368|FG001|Overall Study|Withdrawal by Subject|2
2173073|NCT01342445|3795376|FG000|Overall Study|Experienced side effects|0
2173074|NCT01342445|3795377|FG001|Overall Study|Experienced side effects|2
2173075|NCT01342484|3795422|FG000|Overall Study|Other Reasons|1
2173076|NCT01342484|3795423|FG001|Overall Study|Other Reasons|0
2173077|NCT01342484|3795424|FG002|Overall Study|Other Reasons|0
2173078|NCT01342484|3795422|FG000|Overall Study|Protocol Violation|0
2173079|NCT01342484|3795423|FG001|Overall Study|Protocol Violation|0
2173080|NCT01342484|3795424|FG002|Overall Study|Protocol Violation|1
2173081|NCT01342484|3795422|FG000|Overall Study|Withdrawal by Subject|1
2173082|NCT01342484|3795423|FG001|Overall Study|Withdrawal by Subject|0
2173083|NCT01342484|3795424|FG002|Overall Study|Withdrawal by Subject|0
2173084|NCT01342510|3795436|FG000|Overall Study|Protocol Violation|12
2173085|NCT01342510|3795437|FG001|Overall Study|Protocol Violation|6
2173086|NCT01342510|3795438|FG002|Overall Study|Protocol Violation|13
2173087|NCT01342510|3795439|FG003|Overall Study|Protocol Violation|11
2173088|NCT01342640|3795538|FG000|Overall Study|Adverse Event|3
2173089|NCT01342640|3795538|FG000|Overall Study|Protocol Violation|16
2173090|NCT01342640|3795538|FG000|Overall Study|Lost to Follow-up|21
2173091|NCT01342640|3795538|FG000|Overall Study|Other|1
2173092|NCT01342796|3795561|FG000|Overall Study|Withdrawal by Subject|2
2173093|NCT01342796|3795562|FG001|Overall Study|Withdrawal by Subject|0
2173094|NCT01342796|3795561|FG000|Overall Study|Lost to Follow-up|0
2173095|NCT01342796|3795562|FG001|Overall Study|Lost to Follow-up|3
2173096|NCT01342796|3795561|FG000|Overall Study|Inappropriate enrollment|1
2173097|NCT01342796|3795562|FG001|Overall Study|Inappropriate enrollment|0
2173098|NCT01342887|3795568|FG000|Overall Study|Death|2
2173099|NCT01342913|3795574|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
2173100|NCT01342913|3795575|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2173101|NCT01342913|3795576|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2173102|NCT01342913|3795574|FG000|2-week Run-in Period|Physician Decision|6
2173103|NCT01342913|3795575|FG001|2-week Run-in Period|Physician Decision|0
2173104|NCT01342913|3795576|FG002|2-week Run-in Period|Physician Decision|0
2173105|NCT01342913|3795574|FG000|2-week Run-in Period|Withdrawal by Subject|7
2173106|NCT01342913|3795575|FG001|2-week Run-in Period|Withdrawal by Subject|0
2173107|NCT01342913|3795576|FG002|2-week Run-in Period|Withdrawal by Subject|0
2173108|NCT01342913|3795574|FG000|2-week Run-in Period|Adverse Event|2
2173109|NCT01342913|3795575|FG001|2-week Run-in Period|Adverse Event|0
2173110|NCT01342913|3795576|FG002|2-week Run-in Period|Adverse Event|0
2173111|NCT01342913|3795574|FG000|2-week Run-in Period|Protocol Violation|5
2173112|NCT01342913|3795575|FG001|2-week Run-in Period|Protocol Violation|0
2173113|NCT01342913|3795576|FG002|2-week Run-in Period|Protocol Violation|0
2173114|NCT01342913|3795574|FG000|2-week Run-in Period|Continuation Criteria Not Met|88
2173115|NCT01342913|3795575|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
2173116|NCT01342913|3795576|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
2173117|NCT01342913|3795574|FG000|Double-Blind Treatment Period|Adverse Event|0
2173118|NCT01342913|3795575|FG001|Double-Blind Treatment Period|Adverse Event|3
2173119|NCT01342913|3795576|FG002|Double-Blind Treatment Period|Adverse Event|6
2173120|NCT01342913|3795574|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
2173121|NCT01342913|3795575|FG001|Double-Blind Treatment Period|Lack of Efficacy|2
2173122|NCT01342913|3795576|FG002|Double-Blind Treatment Period|Lack of Efficacy|3
2173123|NCT01342913|3795574|FG000|Double-Blind Treatment Period|Protocol Violation|0
2173124|NCT01342913|3795575|FG001|Double-Blind Treatment Period|Protocol Violation|6
2173125|NCT01342913|3795576|FG002|Double-Blind Treatment Period|Protocol Violation|9
2173126|NCT01342913|3795574|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
2173127|NCT01342913|3795575|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
2173128|NCT01342913|3795576|FG002|Double-Blind Treatment Period|Lost to Follow-up|3
2173129|NCT01342913|3795574|FG000|Double-Blind Treatment Period|Physician Decision|0
2173130|NCT01342913|3795575|FG001|Double-Blind Treatment Period|Physician Decision|2
2173131|NCT01342913|3795576|FG002|Double-Blind Treatment Period|Physician Decision|0
2173132|NCT01342913|3795574|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
2173133|NCT01342913|3795575|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2
2173134|NCT01342913|3795576|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2
2173135|NCT01342926|3795586|FG000|Overall Study|Adverse Event|5
2173136|NCT01342926|3795587|FG001|Overall Study|Adverse Event|8
2173137|NCT01342926|3795588|FG002|Overall Study|Adverse Event|10
2173138|NCT01342926|3795589|FG003|Overall Study|Adverse Event|7
2173139|NCT01342926|3795586|FG000|Overall Study|Lost to Follow-up|0
2173140|NCT01342926|3795587|FG001|Overall Study|Lost to Follow-up|1
2173141|NCT01342926|3795588|FG002|Overall Study|Lost to Follow-up|1
2173142|NCT01342926|3795589|FG003|Overall Study|Lost to Follow-up|0
2173143|NCT01342926|3795586|FG000|Overall Study|Investigator Discretion|2
2173144|NCT01342926|3795587|FG001|Overall Study|Investigator Discretion|2
2173145|NCT01342926|3795588|FG002|Overall Study|Investigator Discretion|0
2173146|NCT01342926|3795589|FG003|Overall Study|Investigator Discretion|0
2173147|NCT01342926|3795586|FG000|Overall Study|Withdrawal by Subject|2
2173148|NCT01342926|3795587|FG001|Overall Study|Withdrawal by Subject|4
2173149|NCT01342926|3795588|FG002|Overall Study|Withdrawal by Subject|3
2173150|NCT01342926|3795589|FG003|Overall Study|Withdrawal by Subject|5
2173151|NCT01342965|3795601|FG000|Overall Study|Death|58
2173152|NCT01342965|3795602|FG001|Overall Study|Death|57
2173153|NCT01342965|3795601|FG000|Overall Study|Lost to Follow-up|5
2173154|NCT01342965|3795602|FG001|Overall Study|Lost to Follow-up|3
2173155|NCT01342965|3795601|FG000|Overall Study|Other Reasons- Unspecified|44
2173156|NCT01342965|3795602|FG001|Overall Study|Other Reasons- Unspecified|38
2173157|NCT01342965|3795601|FG000|Overall Study|Withdrawal by Subject|2
2173158|NCT01342965|3795602|FG001|Overall Study|Withdrawal by Subject|9
2173159|NCT01343043|3795625|FG000|Overall Study|Disease progression before treatment|1
2173160|NCT01343043|3795626|FG001|Overall Study|Disease progression before treatment|0
2173161|NCT01343043|3795627|FG002|Overall Study|Disease progression before treatment|0
2173162|NCT01343043|3795628|FG003|Overall Study|Disease progression before treatment|0
2173163|NCT01343043|3795625|FG000|Overall Study|Withdrawal by Subject|1
2173164|NCT01343043|3795626|FG001|Overall Study|Withdrawal by Subject|0
2173165|NCT01343043|3795627|FG002|Overall Study|Withdrawal by Subject|0
2173166|NCT01343043|3795628|FG003|Overall Study|Withdrawal by Subject|0
2173167|NCT01343043|3795625|FG000|Overall Study|Death|1
2173168|NCT01343043|3795626|FG001|Overall Study|Death|1
2173169|NCT01343043|3795627|FG002|Overall Study|Death|0
2173170|NCT01343043|3795628|FG003|Overall Study|Death|1
2173171|NCT01343056|3795645|FG000|Overall Study|Lost to Follow-up|7
2173172|NCT01343056|3795646|FG001|Overall Study|Lost to Follow-up|5
2173173|NCT01343056|3795647|FG002|Overall Study|Lost to Follow-up|3
2173174|NCT01343056|3795648|FG003|Overall Study|Lost to Follow-up|9
2173175|NCT01343082|3795662|FG000|The run-in Period|Not meeting criteria|3
2173176|NCT01343082|3795663|FG001|The run-in Period|Not meeting criteria|4
2173177|NCT01343082|3795664|FG002|The run-in Period|Not meeting criteria|5
2173178|NCT01343082|3795662|FG000|Treatment Period , Switched to DE-111|Adverse Event|1
2173179|NCT01343082|3795663|FG001|Treatment Period , Switched to DE-111|Adverse Event|4
2173180|NCT01343082|3795664|FG002|Treatment Period , Switched to DE-111|Adverse Event|3
2173181|NCT01343082|3795662|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0
2173182|NCT01343082|3795663|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1
2173183|NCT01343082|3795664|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2
2173184|NCT01343082|3795662|FG000|Treatment Period , Switched to DE-111|Physician Decision|0
2173185|NCT01343082|3795663|FG001|Treatment Period , Switched to DE-111|Physician Decision|2
2173186|NCT01343082|3795664|FG002|Treatment Period , Switched to DE-111|Physician Decision|2
2173187|NCT01343082|3795662|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
2173188|NCT01343082|3795663|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
2173189|NCT01343082|3795664|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
2173190|NCT01343277|3795702|FG000|Overall Study|Other|3
2173191|NCT01343277|3795703|FG001|Overall Study|Other|3
2173192|NCT01343277|3795702|FG000|Overall Study|Withdrawal by Subject|18
2173193|NCT01343277|3795703|FG001|Overall Study|Withdrawal by Subject|13
2173194|NCT01343277|3795702|FG000|Overall Study|Physician Decision|1
2173195|NCT01343277|3795703|FG001|Overall Study|Physician Decision|2
2173196|NCT01343277|3795702|FG000|Overall Study|Death|10
2173197|NCT01343277|3795703|FG001|Overall Study|Death|1
2173198|NCT01343277|3795702|FG000|Overall Study|Adverse Event|67
2173199|NCT01343277|3795703|FG001|Overall Study|Adverse Event|13
2173200|NCT01343277|3795702|FG000|Overall Study|Disease progression|270
2173201|NCT01343277|3795703|FG001|Overall Study|Disease progression|138
2173202|NCT01343277|3795702|FG000|Overall Study|Randomized not treated|6
2173203|NCT01343277|3795703|FG001|Overall Study|Randomized not treated|21
2173204|NCT01343277|3795702|FG000|Overall Study|Treatment ongoing|8
2173205|NCT01343277|3795703|FG001|Overall Study|Treatment ongoing|2
2173206|NCT01343277|3795702|FG000|Overall Study|Subsequent anticancer therapy|1
2173207|NCT01343277|3795703|FG001|Overall Study|Subsequent anticancer therapy|0
2173208|NCT01343368|3795711|FG000|Overall Study|Death|1
2173209|NCT01343368|3795712|FG001|Overall Study|Death|0
2173210|NCT01343368|3795711|FG000|Overall Study|Lost to Follow-up|1
2173211|NCT01343368|3795712|FG001|Overall Study|Lost to Follow-up|0
2173212|NCT01343407|3795718|FG000|Second Treatment Period (Part 2)|Adverse Event|0
2173213|NCT01343407|3795719|FG001|Second Treatment Period (Part 2)|Adverse Event|0
2173214|NCT01343407|3795720|FG002|Second Treatment Period (Part 2)|Adverse Event|1
2173215|NCT01343407|3795721|FG003|Second Treatment Period (Part 2)|Adverse Event|0
2173216|NCT01343407|3795722|FG004|Second Treatment Period (Part 2)|Adverse Event|0
2173217|NCT01343407|3795723|FG005|Second Treatment Period (Part 2)|Adverse Event|0
2173218|NCT01343407|3795718|FG000|Second Washout (Part 2)|Withdrawal by Subject|0
2173219|NCT01343407|3795719|FG001|Second Washout (Part 2)|Withdrawal by Subject|0
2173220|NCT01343407|3795720|FG002|Second Washout (Part 2)|Withdrawal by Subject|1
2173221|NCT01343407|3795721|FG003|Second Washout (Part 2)|Withdrawal by Subject|0
2173222|NCT01343407|3795722|FG004|Second Washout (Part 2)|Withdrawal by Subject|0
2173223|NCT01343407|3795723|FG005|Second Washout (Part 2)|Withdrawal by Subject|0
2173224|NCT01343693|3795749|FG000|Overall Study|Lost to Follow-up|9
2173225|NCT01343823|3795757|FG000|Overall Study|Study Terminated|1
2173226|NCT01343823|3795758|FG001|Overall Study|Study Terminated|0
2173227|NCT01343823|3795759|FG002|Overall Study|Study Terminated|0
2173228|NCT01343823|3795760|FG003|Overall Study|Study Terminated|1
2173229|NCT01343823|3795757|FG000|Overall Study|Withdrawal by Subject|1
2173230|NCT01343823|3795758|FG001|Overall Study|Withdrawal by Subject|0
2173231|NCT01343823|3795759|FG002|Overall Study|Withdrawal by Subject|0
2173232|NCT01343823|3795760|FG003|Overall Study|Withdrawal by Subject|0
2173233|NCT01343888|3795773|FG000|Overall Study|Adverse Event|12
2173234|NCT01343888|3795774|FG001|Overall Study|Adverse Event|22
2173235|NCT01343888|3795775|FG002|Overall Study|Adverse Event|5
2173236|NCT01343888|3795773|FG000|Overall Study|Lack of Efficacy|9
2173237|NCT01343888|3795774|FG001|Overall Study|Lack of Efficacy|9
2173238|NCT01343888|3795775|FG002|Overall Study|Lack of Efficacy|13
2173239|NCT01343888|3795773|FG000|Overall Study|Lost to Follow-up|0
2173240|NCT01343888|3795774|FG001|Overall Study|Lost to Follow-up|2
2173241|NCT01343888|3795775|FG002|Overall Study|Lost to Follow-up|1
2173242|NCT01343888|3795773|FG000|Overall Study|Protocol Violation|0
2173243|NCT01343888|3795774|FG001|Overall Study|Protocol Violation|2
2173244|NCT01343888|3795775|FG002|Overall Study|Protocol Violation|0
2173245|NCT01343888|3795773|FG000|Overall Study|Withdrawal by Subject|4
2173246|NCT01343888|3795774|FG001|Overall Study|Withdrawal by Subject|4
2173247|NCT01343888|3795775|FG002|Overall Study|Withdrawal by Subject|2
2173248|NCT01343888|3795773|FG000|Overall Study|other than stated above|0
2173249|NCT01343888|3795774|FG001|Overall Study|other than stated above|0
2173250|NCT01343888|3795775|FG002|Overall Study|other than stated above|1
2173251|NCT01343901|3795783|FG000|Overall Study|Death|85
2173252|NCT01343901|3795783|FG000|Overall Study|Physician Decision|4
2173253|NCT01343901|3795783|FG000|Overall Study|Lost to Follow-up|12
2173254|NCT01343901|3795783|FG000|Overall Study|Management by another medical team|11
2173255|NCT01343901|3795783|FG000|Overall Study|Participant decision|1
2173256|NCT01344057|3795787|FG000|Overall Study|Premature Withdrawal|1
2173257|NCT01344161|3795793|FG000|Overall Study|Lost to Follow-up|4
2173258|NCT01344161|3795794|FG001|Overall Study|Lost to Follow-up|1
2173259|NCT01344161|3795793|FG000|Overall Study|Pregnancy|0
2173260|NCT01344161|3795794|FG001|Overall Study|Pregnancy|1
2173261|NCT01344161|3795793|FG000|Overall Study|Protocol Violation|1
2173262|NCT01344161|3795794|FG001|Overall Study|Protocol Violation|1
2173263|NCT01344226|3795800|FG000|Overall Study|Protocol Violation|2
2173264|NCT01344226|3795800|FG000|Overall Study|Withdrawal by Subject|3
2173265|NCT01344226|3795800|FG000|Overall Study|Lack of Efficacy|3
2173266|NCT01344356|3795806|FG000|Overall Study|Physician Decision|0
2173267|NCT01344356|3795807|FG001|Overall Study|Physician Decision|3
2173268|NCT01344356|3795806|FG000|Overall Study|Lost to Follow-up|0
2173269|NCT01344356|3795807|FG001|Overall Study|Lost to Follow-up|6
2173270|NCT01344369|3795817|FG000|Washout of 28 Days|Withdrawal by Subject|1
2173271|NCT01344369|3795818|FG001|Washout of 28 Days|Withdrawal by Subject|0
2173272|NCT01344369|3795817|FG000|Washout of 28 Days|Physician Decision|0
2173273|NCT01344369|3795818|FG001|Washout of 28 Days|Physician Decision|1
2173274|NCT01344369|3795817|FG000|Second Intervention|Emesis within 2 x Tmax|0
2173275|NCT01344369|3795818|FG001|Second Intervention|Emesis within 2 x Tmax|1
2173276|NCT01344447|3795824|FG000|Overall Study|Adverse Event|1
2173277|NCT01344447|3795824|FG000|Overall Study|Protocol Violation|1
2173278|NCT01344447|3795824|FG000|Overall Study|Withdrawal by Subject|1
2173279|NCT01344447|3795824|FG000|Overall Study|The contrast was not seen|1
2173280|NCT01344447|3795824|FG000|Overall Study|Physician Decision|1
2173281|NCT01344447|3795824|FG000|Overall Study|MRA unsuccessful|1
2173282|NCT01344447|3795824|FG000|Overall Study|Bolus tracking failed|1
2173283|NCT01344447|3795824|FG000|Overall Study|Error of power injector|1
2173284|NCT01344460|3795832|FG000|Overall Study|Withdrawal by Subject|1
2173285|NCT01344460|3795832|FG000|Overall Study|Lost to Follow-up|2
2173286|NCT01344538|3795842|FG000|Overall Study|Adverse Event|1
2173287|NCT01344538|3795843|FG001|Overall Study|Adverse Event|1
2173288|NCT01344538|3795842|FG000|Overall Study|Lost to Follow-up|1
2173289|NCT01344538|3795843|FG001|Overall Study|Lost to Follow-up|0
2173290|NCT01344629|3795860|FG000|Crossover Period 2|Withdrawal by Subject|0
2173291|NCT01344629|3795861|FG001|Crossover Period 2|Withdrawal by Subject|1
2173292|NCT01344759|3795869|FG000|Overall Study|Patients failed to reach sedation level|0
2173293|NCT01344759|3795870|FG001|Overall Study|Patients failed to reach sedation level|2
2173294|NCT01344824|3795882|FG000|Overall Study|Adverse Event|15
2173295|NCT01344824|3795882|FG000|Overall Study|Withdrawal by Subject|6
2173296|NCT01344824|3795882|FG000|Overall Study|Other complicating disease|1
2173297|NCT01344824|3795882|FG000|Overall Study|Progression|15
2173298|NCT01344876|3795887|FG000|Overall Study|Adverse Event|0
2173299|NCT01344876|3795888|FG001|Overall Study|Adverse Event|0
2173300|NCT01344876|3795889|FG002|Overall Study|Adverse Event|0
2173301|NCT01344876|3795890|FG003|Overall Study|Adverse Event|0
2173302|NCT01344876|3795891|FG004|Overall Study|Adverse Event|1
2173303|NCT01344876|3795887|FG000|Overall Study|Withdrawal by Subject|0
2173304|NCT01344876|3795888|FG001|Overall Study|Withdrawal by Subject|0
2173305|NCT01344876|3795889|FG002|Overall Study|Withdrawal by Subject|1
2173306|NCT01344876|3795890|FG003|Overall Study|Withdrawal by Subject|0
2173307|NCT01344876|3795891|FG004|Overall Study|Withdrawal by Subject|0
2173308|NCT01344876|3795887|FG000|Overall Study|Definite progression of primary disease|1
2173309|NCT01344876|3795888|FG001|Overall Study|Definite progression of primary disease|0
2173310|NCT01344876|3795889|FG002|Overall Study|Definite progression of primary disease|0
2173311|NCT01344876|3795890|FG003|Overall Study|Definite progression of primary disease|3
2173312|NCT01344876|3795891|FG004|Overall Study|Definite progression of primary disease|0
2173313|NCT01345019|3795906|FG000|Blinded Treatment Phase|Death|147
2173314|NCT01345019|3795907|FG001|Blinded Treatment Phase|Death|137
2173315|NCT01345019|3795906|FG000|Blinded Treatment Phase|Withdrawal by Subject|103
2173316|NCT01345019|3795907|FG001|Blinded Treatment Phase|Withdrawal by Subject|112
2173317|NCT01345019|3795906|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21
2173318|NCT01345019|3795907|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9
2173319|NCT01345019|3795906|FG000|Blinded Treatment Phase|Disease Progression|12
2173320|NCT01345019|3795907|FG001|Blinded Treatment Phase|Disease Progression|10
2173321|NCT01345019|3795906|FG000|Blinded Treatment Phase|Adverse Event|6
2173322|NCT01345019|3795907|FG001|Blinded Treatment Phase|Adverse Event|13
2173323|NCT01345019|3795906|FG000|Blinded Treatment Phase|Administrative Decision|10
2173324|NCT01345019|3795907|FG001|Blinded Treatment Phase|Administrative Decision|8
2173325|NCT01345019|3795906|FG000|Blinded Treatment Phase|Noncompliance|5
2173326|NCT01345019|3795907|FG001|Blinded Treatment Phase|Noncompliance|3
2173327|NCT01345019|3795906|FG000|Blinded Treatment Phase|Ineligibility Determined|1
2173328|NCT01345019|3795907|FG001|Blinded Treatment Phase|Ineligibility Determined|6
2173329|NCT01345019|3795906|FG000|Blinded Treatment Phase|Protocol Deviation|5
2173330|NCT01345019|3795907|FG001|Blinded Treatment Phase|Protocol Deviation|0
2173331|NCT01345019|3795906|FG000|Blinded Treatment Phase|Other, Not Specified|2
2173332|NCT01345019|3795907|FG001|Blinded Treatment Phase|Other, Not Specified|3
2173333|NCT01345019|3795906|FG000|Blinded Treatment Phase|Lost to Follow-up|6
2173334|NCT01345019|3795907|FG001|Blinded Treatment Phase|Lost to Follow-up|3
2173335|NCT01345019|3795906|FG000|Open Label Treatment Phase|Death|49
2173336|NCT01345019|3795907|FG001|Open Label Treatment Phase|Death|48
2173337|NCT01345019|3795906|FG000|Open Label Treatment Phase|Withdrawal by Subject|49
2173338|NCT01345019|3795907|FG001|Open Label Treatment Phase|Withdrawal by Subject|47
2173339|NCT01345019|3795906|FG000|Open Label Treatment Phase|Adverse Event|30
2173340|NCT01345019|3795907|FG001|Open Label Treatment Phase|Adverse Event|51
2173341|NCT01345019|3795906|FG000|Open Label Treatment Phase|Administrative Decision|30
2173342|NCT01345019|3795907|FG001|Open Label Treatment Phase|Administrative Decision|15
2173343|NCT01345019|3795906|FG000|Open Label Treatment Phase|Disease Progression|17
2173344|NCT01345019|3795907|FG001|Open Label Treatment Phase|Disease Progression|18
2173345|NCT01345019|3795906|FG000|Open Label Treatment Phase|Noncompliance|5
2173346|NCT01345019|3795907|FG001|Open Label Treatment Phase|Noncompliance|4
2173347|NCT01345019|3795906|FG000|Open Label Treatment Phase|Lost to Follow-up|1
2173348|NCT01345019|3795907|FG001|Open Label Treatment Phase|Lost to Follow-up|2
2173349|NCT01345019|3795906|FG000|Open Label Treatment Phase|Pregnancy|1
2173350|NCT01345019|3795907|FG001|Open Label Treatment Phase|Pregnancy|0
2173351|NCT01345019|3795906|FG000|Open Label Treatment Phase|Other, Not Specified|9
2173352|NCT01345019|3795907|FG001|Open Label Treatment Phase|Other, Not Specified|7
2173353|NCT01345019|3795906|FG000|Open Label Treatment Phase|Protocol Violation|0
2173354|NCT01345019|3795907|FG001|Open Label Treatment Phase|Protocol Violation|1
2173355|NCT01345058|3795917|FG000|Overall Study|Withdrawal by Subject|1
2173356|NCT01345058|3795918|FG001|Overall Study|Withdrawal by Subject|0
2173357|NCT01345058|3795917|FG000|Overall Study|Participant Reported Increase in Events|1
2173358|NCT01345058|3795918|FG001|Overall Study|Participant Reported Increase in Events|0
2173359|NCT01345058|3795917|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1
2173360|NCT01345058|3795918|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0
2173361|NCT01345058|3795917|FG000|Overall Study|Participant Stopped Taking Study Drug|1
2173362|NCT01345058|3795918|FG001|Overall Study|Participant Stopped Taking Study Drug|0
2173363|NCT01345058|3795917|FG000|Overall Study|Participant No-Show at Multiple Visits|1
2173364|NCT01345058|3795918|FG001|Overall Study|Participant No-Show at Multiple Visits|0
2173365|NCT01345123|3795927|FG000|Overall Study|participants no longer with health plan|79
2173366|NCT01345123|3795928|FG001|Overall Study|participants no longer with health plan|85
2173367|NCT01345123|3795929|FG002|Overall Study|participants no longer with health plan|88
2173368|NCT01345162|3795940|FG000|Overall Study|Protocol Violation|2
2173369|NCT01345162|3795941|FG001|Overall Study|Protocol Violation|4
2173370|NCT01345188|3795947|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
2173371|NCT01345188|3795947|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
2173372|NCT01345253|3795956|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
2173373|NCT01345253|3795957|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
2173374|NCT01345253|3795956|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
2173375|NCT01345253|3795957|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
2173376|NCT01345253|3795956|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
2173377|NCT01345253|3795957|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
2173378|NCT01345253|3795956|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
2173379|NCT01345253|3795957|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
2173380|NCT01345253|3795956|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
2173381|NCT01345253|3795957|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
2173382|NCT01345253|3795956|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
2173383|NCT01345253|3795957|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
2173384|NCT01345253|3795956|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
2173385|NCT01345253|3795957|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
2173386|NCT01345253|3795956|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
2173387|NCT01345253|3795957|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
2173388|NCT01345253|3795956|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0
2173389|NCT01345253|3795957|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1
2173390|NCT01345253|3795956|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
2173391|NCT01345253|3795957|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
2173392|NCT01345253|3795956|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
2173393|NCT01345253|3795957|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
2173394|NCT01345253|3795956|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
2173395|NCT01345253|3795957|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
2173396|NCT01345253|3795956|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
2173397|NCT01345253|3795957|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
2173398|NCT01345253|3795956|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
2173399|NCT01345253|3795957|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
2173400|NCT01345253|3795956|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
2173401|NCT01345253|3795957|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
2173402|NCT01345292|3795968|FG000|Overall Study|Withdrawal by Subject|2
2173403|NCT01345292|3795969|FG001|Overall Study|Withdrawal by Subject|0
2173404|NCT01345292|3795970|FG002|Overall Study|Withdrawal by Subject|1
2173405|NCT01345318|3795978|FG000|Overall Study|Adverse Event|16
2173406|NCT01345318|3795978|FG000|Overall Study|Lack of Efficacy|17
2173407|NCT01345318|3795978|FG000|Overall Study|Lost to Follow-up|2
2173408|NCT01345318|3795978|FG000|Overall Study|Protocol Violation|1
2173409|NCT01345318|3795978|FG000|Overall Study|Withdrawal by Subject|41
2173410|NCT01345318|3795978|FG000|Overall Study|Other|3
2173411|NCT01345591|3795987|FG000|Overall Study|Lost to Follow-up|1
2173412|NCT01345630|3795998|FG000|Overall Study|Adverse Event|22
2173413|NCT01345630|3795999|FG001|Overall Study|Adverse Event|23
2173414|NCT01345630|3795998|FG000|Overall Study|Lost to Follow-up|17
2173415|NCT01345630|3795999|FG001|Overall Study|Lost to Follow-up|16
2173416|NCT01345630|3795998|FG000|Overall Study|Protocol Violation|4
2173417|NCT01345630|3795999|FG001|Overall Study|Protocol Violation|1
2173418|NCT01345630|3795998|FG000|Overall Study|Medication error without associated AE|0
2173419|NCT01345630|3795999|FG001|Overall Study|Medication error without associated AE|1
2173420|NCT01345630|3795998|FG000|Overall Study|Study terminated by sponsor|254
2173421|NCT01345630|3795999|FG001|Overall Study|Study terminated by sponsor|285
2173422|NCT01345630|3795998|FG000|Overall Study|Other reasons|6
2173423|NCT01345630|3795999|FG001|Overall Study|Other reasons|8
2173424|NCT01345630|3795998|FG000|Overall Study|Withdrawn due to pregnancy|1
2173425|NCT01345630|3795999|FG001|Overall Study|Withdrawn due to pregnancy|2
2173426|NCT01345630|3795998|FG000|Overall Study|No longer willing to participate|9
2173427|NCT01345630|3795999|FG001|Overall Study|No longer willing to participate|12
2173428|NCT01345630|3795998|FG000|Overall Study|Insufficient clinical response|48
2173429|NCT01345630|3795999|FG001|Overall Study|Insufficient clinical response|11
2173430|NCT01345669|3796011|FG000|Overall Study|Primary tumour recurrence|53
2173431|NCT01345669|3796012|FG001|Overall Study|Primary tumour recurrence|32
2173432|NCT01345669|3796011|FG000|Overall Study|Second primary tumour|4
2173433|NCT01345669|3796012|FG001|Overall Study|Second primary tumour|3
2173434|NCT01345669|3796011|FG000|Overall Study|Adverse Event|63
2173435|NCT01345669|3796012|FG001|Overall Study|Adverse Event|9
2173436|NCT01345669|3796011|FG000|Overall Study|Protocol Violation|3
2173437|NCT01345669|3796012|FG001|Overall Study|Protocol Violation|1
2173438|NCT01345669|3796011|FG000|Overall Study|Lost to Follow-up|1
2173439|NCT01345669|3796012|FG001|Overall Study|Lost to Follow-up|1
2173440|NCT01345669|3796011|FG000|Overall Study|Withdrawal by Subject|52
2173441|NCT01345669|3796012|FG001|Overall Study|Withdrawal by Subject|13
2173442|NCT01345669|3796011|FG000|Overall Study|Other Reasons|111
2173443|NCT01345669|3796012|FG001|Overall Study|Other Reasons|60
2173444|NCT01345682|3796020|FG000|Overall Study|Progressive disease per RECIST|226
2173445|NCT01345682|3796021|FG001|Overall Study|Progressive disease per RECIST|93
2173446|NCT01345682|3796020|FG000|Overall Study|Worsening of underlying cancer disease|23
2173447|NCT01345682|3796021|FG001|Overall Study|Worsening of underlying cancer disease|12
2173448|NCT01345682|3796020|FG000|Overall Study|Adverse Event|51
2173449|NCT01345682|3796021|FG001|Overall Study|Adverse Event|41
2173450|NCT01345682|3796020|FG000|Overall Study|Non-compliance with protocol|0
2173451|NCT01345682|3796021|FG001|Overall Study|Non-compliance with protocol|1
2173452|NCT01345682|3796020|FG000|Overall Study|Lost to Follow-up|0
2173453|NCT01345682|3796021|FG001|Overall Study|Lost to Follow-up|1
2173454|NCT01345682|3796020|FG000|Overall Study|Refused to continue trial medication|16
2173455|NCT01345682|3796021|FG001|Overall Study|Refused to continue trial medication|9
2173456|NCT01345682|3796020|FG000|Overall Study|Not treated|2
2173457|NCT01345682|3796021|FG001|Overall Study|Not treated|1
2173458|NCT01345682|3796020|FG000|Overall Study|Reason other than those specified above|4
2173459|NCT01345682|3796021|FG001|Overall Study|Reason other than those specified above|3
2173460|NCT01345929|3796046|FG000|Overall Study|Withdrawal by Subject|9
2173461|NCT01345929|3796047|FG001|Overall Study|Withdrawal by Subject|8
2173462|NCT01345929|3796046|FG000|Overall Study|Lost to Follow-up|9
2173463|NCT01345929|3796047|FG001|Overall Study|Lost to Follow-up|9
2173464|NCT01345929|3796046|FG000|Overall Study|Adverse Event|0
2173465|NCT01345929|3796047|FG001|Overall Study|Adverse Event|1
2173466|NCT01345929|3796046|FG000|Overall Study|Didn't meet eligibility criteria|2
2173467|NCT01345929|3796047|FG001|Overall Study|Didn't meet eligibility criteria|0
2173468|NCT01345929|3796046|FG000|Overall Study|40,000 CFU/ML|1
2173469|NCT01345929|3796047|FG001|Overall Study|40,000 CFU/ML|0
2173470|NCT01345929|3796046|FG000|Overall Study|Patient withdrawal|0
2173471|NCT01345929|3796047|FG001|Overall Study|Patient withdrawal|1
2173472|NCT01346059|3796055|FG000|Overall Study|Withdrawal by Subject|1
2173473|NCT01346059|3796056|FG001|Overall Study|Withdrawal by Subject|0
2173474|NCT01346176|3796078|FG000|Recruited|Protocol Violation|1
2173475|NCT01346176|3796079|FG001|Recruited|Protocol Violation|0
2173476|NCT01346176|3796080|FG002|Recruited|Protocol Violation|0
2173477|NCT01346176|3796078|FG000|Completed Advance Directive|Death|3
2173478|NCT01346176|3796079|FG001|Completed Advance Directive|Death|2
2173479|NCT01346176|3796080|FG002|Completed Advance Directive|Death|2
2173480|NCT01346176|3796078|FG000|Completed Advance Directive|Became Ineligible|3
2173481|NCT01346176|3796079|FG001|Completed Advance Directive|Became Ineligible|0
2173482|NCT01346176|3796080|FG002|Completed Advance Directive|Became Ineligible|1
2173483|NCT01346176|3796078|FG000|Completed Advance Directive|Other reason did not complete AD|7
2173484|NCT01346176|3796079|FG001|Completed Advance Directive|Other reason did not complete AD|12
2173485|NCT01346176|3796080|FG002|Completed Advance Directive|Other reason did not complete AD|7
2173486|NCT01346176|3796078|FG000|Completed Satisfaction Survey|Death|3
2173487|NCT01346176|3796079|FG001|Completed Satisfaction Survey|Death|0
2173488|NCT01346176|3796080|FG002|Completed Satisfaction Survey|Death|2
2173489|NCT01346176|3796078|FG000|Completed Satisfaction Survey|Lost to Follow-up|3
2173490|NCT01346176|3796079|FG001|Completed Satisfaction Survey|Lost to Follow-up|4
2173491|NCT01346176|3796080|FG002|Completed Satisfaction Survey|Lost to Follow-up|4
2179881|NCT01396421|3805666|FG000|Overall Study|Lack of Efficacy|7
2179882|NCT01396421|3805667|FG001|Overall Study|Lack of Efficacy|17
2179883|NCT01396421|3805668|FG002|Overall Study|Lack of Efficacy|7
2179884|NCT01396421|3805669|FG003|Overall Study|Lack of Efficacy|18
2179885|NCT01396434|3805696|FG000|Overall Study|Lost to Follow-up|1
2179886|NCT01396434|3805697|FG001|Overall Study|Lost to Follow-up|0
2179887|NCT01396434|3805698|FG002|Overall Study|Lost to Follow-up|0
2179888|NCT01396434|3805696|FG000|Overall Study|Other|10
2179889|NCT01396434|3805697|FG001|Overall Study|Other|0
2179890|NCT01396434|3805698|FG002|Overall Study|Other|0
2179891|NCT01396447|3805710|FG000|Overall Study|Did Not Receive Treatment|3
2179892|NCT01396447|3805711|FG001|Overall Study|Did Not Receive Treatment|2
2179893|NCT01396447|3805712|FG002|Overall Study|Did Not Receive Treatment|1
2179894|NCT01396447|3805713|FG003|Overall Study|Did Not Receive Treatment|0
2179895|NCT01396447|3805710|FG000|Overall Study|Adverse Event|15
2179896|NCT01396447|3805711|FG001|Overall Study|Adverse Event|12
2179897|NCT01396447|3805712|FG002|Overall Study|Adverse Event|12
2179898|NCT01396447|3805713|FG003|Overall Study|Adverse Event|17
2179899|NCT01396447|3805710|FG000|Overall Study|Insufficient Therapeutic Response|5
2179900|NCT01396447|3805711|FG001|Overall Study|Insufficient Therapeutic Response|5
2179901|NCT01396447|3805712|FG002|Overall Study|Insufficient Therapeutic Response|2
2179902|NCT01396447|3805713|FG003|Overall Study|Insufficient Therapeutic Response|4
2179903|NCT01396447|3805710|FG000|Overall Study|Protocol Violation|5
2179904|NCT01396447|3805711|FG001|Overall Study|Protocol Violation|2
2179905|NCT01396447|3805712|FG002|Overall Study|Protocol Violation|3
2179906|NCT01396447|3805713|FG003|Overall Study|Protocol Violation|7
2179907|NCT01396447|3805710|FG000|Overall Study|Withdrawal of Consent|11
2179908|NCT01396447|3805711|FG001|Overall Study|Withdrawal of Consent|9
2179909|NCT01396447|3805712|FG002|Overall Study|Withdrawal of Consent|4
2179910|NCT01396447|3805713|FG003|Overall Study|Withdrawal of Consent|15
2179911|NCT01396447|3805710|FG000|Overall Study|Lost to Follow-up|4
2179912|NCT01396447|3805711|FG001|Overall Study|Lost to Follow-up|8
2179913|NCT01396447|3805712|FG002|Overall Study|Lost to Follow-up|7
2179914|NCT01396447|3805713|FG003|Overall Study|Lost to Follow-up|9
2179915|NCT01396447|3805710|FG000|Overall Study|Other Miscellaneous Reasons|0
2179916|NCT01396447|3805711|FG001|Overall Study|Other Miscellaneous Reasons|2
2179917|NCT01396447|3805712|FG002|Overall Study|Other Miscellaneous Reasons|1
2179918|NCT01396447|3805713|FG003|Overall Study|Other Miscellaneous Reasons|0
2179919|NCT01396512|3805738|FG000|Overall Study|Withdrawal by Subject|0
2179920|NCT01396512|3805739|FG001|Overall Study|Withdrawal by Subject|1
2179921|NCT01396525|3805745|FG000|Overall Study|Withdrawal by Subject|8
2179922|NCT01396525|3805745|FG000|Overall Study|Death|14
2179923|NCT01396525|3805745|FG000|Overall Study|Lost to Follow-up|4
2179924|NCT01397084|3805769|FG000|Overall Study|Severe Non-Compliance to Protocol|1
2179925|NCT01397084|3805769|FG000|Overall Study|Protocol Violation|2
2179926|NCT01397084|3805769|FG000|Overall Study|Adverse Event|2
2179927|NCT01397084|3805769|FG000|Overall Study|Withdrawal by Subject|1
2179928|NCT01397084|3805769|FG000|Overall Study|Lost to Follow-up|1
2179929|NCT01397084|3805769|FG000|Overall Study|Used other proton pump inhibitor|1
2179930|NCT01397253|3805775|FG000|Overall Study|Reviewed by only 1 pharmacist|126
2179931|NCT01397253|3805776|FG001|Overall Study|Reviewed by only 1 pharmacist|149
2179932|NCT01397409|3805792|FG000|Stage 2|Adverse Event|0
2179933|NCT01397409|3805793|FG001|Stage 2|Adverse Event|0
2179934|NCT01397409|3805794|FG002|Stage 2|Adverse Event|0
2179935|NCT01397409|3805795|FG003|Stage 2|Adverse Event|0
2173492|NCT01346189|3796092|FG000|Overall Study|Withdrawal by Subject|7
2173493|NCT01346189|3796093|FG001|Overall Study|Withdrawal by Subject|5
2173494|NCT01346189|3796094|FG002|Overall Study|Withdrawal by Subject|3
2173495|NCT01346189|3796095|FG003|Overall Study|Withdrawal by Subject|5
2173496|NCT01346189|3796092|FG000|Overall Study|Physician Decision|4
2173497|NCT01346189|3796093|FG001|Overall Study|Physician Decision|0
2173498|NCT01346189|3796094|FG002|Overall Study|Physician Decision|0
2173499|NCT01346189|3796095|FG003|Overall Study|Physician Decision|0
2173500|NCT01346189|3796092|FG000|Overall Study|Moved|3
2173501|NCT01346189|3796093|FG001|Overall Study|Moved|0
2173502|NCT01346189|3796094|FG002|Overall Study|Moved|4
2173503|NCT01346189|3796095|FG003|Overall Study|Moved|0
2173504|NCT01346189|3796092|FG000|Overall Study|Other|2
2173505|NCT01346189|3796093|FG001|Overall Study|Other|4
2173506|NCT01346189|3796094|FG002|Overall Study|Other|7
2173507|NCT01346189|3796095|FG003|Overall Study|Other|3
2173508|NCT01346189|3796092|FG000|Overall Study|Death|0
2173509|NCT01346189|3796093|FG001|Overall Study|Death|3
2173510|NCT01346189|3796094|FG002|Overall Study|Death|0
2173511|NCT01346189|3796095|FG003|Overall Study|Death|0
2173512|NCT01346189|3796092|FG000|Overall Study|Non-health system primary care physician|0
2173513|NCT01346189|3796093|FG001|Overall Study|Non-health system primary care physician|5
2173514|NCT01346189|3796094|FG002|Overall Study|Non-health system primary care physician|0
2173515|NCT01346189|3796095|FG003|Overall Study|Non-health system primary care physician|0
2173516|NCT01346189|3796092|FG000|Overall Study|Travel|0
2173517|NCT01346189|3796093|FG001|Overall Study|Travel|0
2173518|NCT01346189|3796094|FG002|Overall Study|Travel|0
2173519|NCT01346189|3796095|FG003|Overall Study|Travel|3
2173520|NCT01346293|3796116|FG000|Overall Study|Protocol Violation|30
2173521|NCT01346293|3796117|FG001|Overall Study|Protocol Violation|9
2173522|NCT01346293|3796116|FG000|Overall Study|Lost to Follow-up|21
2173523|NCT01346293|3796117|FG001|Overall Study|Lost to Follow-up|8
2173524|NCT01346293|3796116|FG000|Overall Study|Withdrawal by Subject|15
2173525|NCT01346293|3796117|FG001|Overall Study|Withdrawal by Subject|4
2173526|NCT01346293|3796116|FG000|Overall Study|Other|1
2173527|NCT01346293|3796117|FG001|Overall Study|Other|0
2173528|NCT01346371|3796127|FG000|Overall Study|Lost to Follow-up|2
2173529|NCT01346371|3796128|FG001|Overall Study|Lost to Follow-up|0
2173530|NCT01346410|3796143|FG000|Overall Study|Death|1
2173531|NCT01346475|3796149|FG000|First Intervention|Lost to Follow-up|4
2173532|NCT01346475|3796150|FG001|First Intervention|Lost to Follow-up|3
2173533|NCT01346501|3796162|FG000|Overall Study|Initiated Other Biological Agents|3
2173534|NCT01346501|3796163|FG001|Overall Study|Initiated Other Biological Agents|1
2173535|NCT01346501|3796162|FG000|Overall Study|Other|8
2173536|NCT01346501|3796163|FG001|Overall Study|Other|12
2173537|NCT01346514|3796173|FG000|Overall Study|Lost to Follow-up|19
2173538|NCT01346514|3796174|FG001|Overall Study|Lost to Follow-up|30
2173539|NCT01346514|3796173|FG000|Overall Study|Withdrawal by Subject|7
2173540|NCT01346514|3796174|FG001|Overall Study|Withdrawal by Subject|3
2173541|NCT01346514|3796173|FG000|Overall Study|Death|3
2173542|NCT01346514|3796174|FG001|Overall Study|Death|4
2173543|NCT01346540|3796184|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3
2173544|NCT01346540|3796185|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8
2173545|NCT01346540|3796184|FG000|Overall Study|Adverse Event|0
2173546|NCT01346540|3796185|FG001|Overall Study|Adverse Event|4
2173547|NCT01346592|3796195|FG000|Overall Study|Lost to Follow-up|62
2173548|NCT01346592|3796196|FG001|Overall Study|Lost to Follow-up|29
2173549|NCT01346592|3796197|FG002|Overall Study|Lost to Follow-up|29
2173550|NCT01346592|3796195|FG000|Overall Study|Protocol Violation|2
2173551|NCT01346592|3796196|FG001|Overall Study|Protocol Violation|1
2173552|NCT01346592|3796197|FG002|Overall Study|Protocol Violation|0
2173553|NCT01346592|3796195|FG000|Overall Study|Death|1
2173554|NCT01346592|3796196|FG001|Overall Study|Death|3
2173555|NCT01346592|3796197|FG002|Overall Study|Death|4
2173556|NCT01346592|3796195|FG000|Overall Study|Adverse Event|0
2173557|NCT01346592|3796196|FG001|Overall Study|Adverse Event|1
2173558|NCT01346592|3796197|FG002|Overall Study|Adverse Event|0
2173559|NCT01346592|3796195|FG000|Overall Study|Withdrawal by Subject|77
2173560|NCT01346592|3796196|FG001|Overall Study|Withdrawal by Subject|51
2173561|NCT01346592|3796197|FG002|Overall Study|Withdrawal by Subject|38
2173562|NCT01346592|3796195|FG000|Overall Study|Inappropriate enrollment|3
2173563|NCT01346592|3796196|FG001|Overall Study|Inappropriate enrollment|1
2173564|NCT01346592|3796197|FG002|Overall Study|Inappropriate enrollment|1
2173565|NCT01346592|3796195|FG000|Overall Study|Administrative reason|1
2173566|NCT01346592|3796196|FG001|Overall Study|Administrative reason|0
2173567|NCT01346592|3796197|FG002|Overall Study|Administrative reason|0
2173568|NCT01346592|3796195|FG000|Overall Study|Unable to Classify|7
2173569|NCT01346592|3796196|FG001|Overall Study|Unable to Classify|3
2173570|NCT01346592|3796197|FG002|Overall Study|Unable to Classify|6
2173571|NCT01346696|3796226|FG000|Overall Study|Death|1
2173572|NCT01346774|3796232|FG000|Overall Study|Did not take a single dose|6
2173573|NCT01346774|3796233|FG001|Overall Study|Did not take a single dose|4
2173574|NCT01346774|3796232|FG000|Overall Study|Lost to Follow-up|3
2173575|NCT01346774|3796233|FG001|Overall Study|Lost to Follow-up|4
2173576|NCT01346774|3796232|FG000|Overall Study|Withdrawal by Subject|1
2173577|NCT01346774|3796233|FG001|Overall Study|Withdrawal by Subject|4
2173578|NCT01346774|3796232|FG000|Overall Study|Protocol Violation|2
2173579|NCT01346774|3796233|FG001|Overall Study|Protocol Violation|3
2173580|NCT01346774|3796232|FG000|Overall Study|Adverse Event|1
2173581|NCT01346774|3796233|FG001|Overall Study|Adverse Event|2
2173582|NCT01346969|3796261|FG000|Overall Study|Withdrawal by Subject|0
2173583|NCT01346969|3796262|FG001|Overall Study|Withdrawal by Subject|0
2173584|NCT01346969|3796263|FG002|Overall Study|Withdrawal by Subject|1
2173585|NCT01346969|3796264|FG003|Overall Study|Withdrawal by Subject|0
2173586|NCT01346969|3796261|FG000|Overall Study|Lost to Follow-up|1
2173587|NCT01346969|3796262|FG001|Overall Study|Lost to Follow-up|0
2173588|NCT01346969|3796263|FG002|Overall Study|Lost to Follow-up|2
2173589|NCT01346969|3796264|FG003|Overall Study|Lost to Follow-up|0
2173590|NCT01346969|3796261|FG000|Overall Study|Physician Decision|0
2173591|NCT01346969|3796262|FG001|Overall Study|Physician Decision|0
2173592|NCT01346969|3796263|FG002|Overall Study|Physician Decision|0
2173593|NCT01346969|3796264|FG003|Overall Study|Physician Decision|1
2173594|NCT01346969|3796261|FG000|Overall Study|Randomized but not treated|1
2173595|NCT01346969|3796262|FG001|Overall Study|Randomized but not treated|0
2173596|NCT01346969|3796263|FG002|Overall Study|Randomized but not treated|0
2173597|NCT01346969|3796264|FG003|Overall Study|Randomized but not treated|0
2173598|NCT01347073|3796301|FG000|Overall Study|Adverse Event|1
2173599|NCT01347073|3796301|FG000|Overall Study|Liver Transplant|1
2173600|NCT01347086|3796321|FG000|Overall Study|failed screening visit|0
2173601|NCT01347086|3796322|FG001|Overall Study|failed screening visit|0
2173602|NCT01347086|3796323|FG002|Overall Study|failed screening visit|1
2173603|NCT01347086|3796324|FG003|Overall Study|failed screening visit|0
2173604|NCT01347086|3796325|FG004|Overall Study|failed screening visit|0
2173605|NCT01347086|3796326|FG005|Overall Study|failed screening visit|0
2173606|NCT01347086|3796327|FG006|Overall Study|failed screening visit|1
2173607|NCT01347086|3796328|FG007|Overall Study|failed screening visit|1
2173608|NCT01347086|3796329|FG008|Overall Study|failed screening visit|0
2173609|NCT01347086|3796330|FG009|Overall Study|failed screening visit|1
2173610|NCT01347112|3796364|FG000|Overall Study|Withdrawal by Subject|1
2173611|NCT01347112|3796365|FG001|Overall Study|Withdrawal by Subject|7
2173612|NCT01347112|3796364|FG000|Overall Study|Lost to Follow-up|3
2173613|NCT01347112|3796365|FG001|Overall Study|Lost to Follow-up|5
2173614|NCT01347307|3796381|FG000|Overall Study|Death|0
2173615|NCT01347307|3796382|FG001|Overall Study|Death|4
2173616|NCT01347307|3796381|FG000|Overall Study|Physician Decision|0
2173617|NCT01347307|3796382|FG001|Overall Study|Physician Decision|1
2173618|NCT01347554|3796408|FG000|Overall Study|Lack of Efficacy|7
2173619|NCT01347554|3796409|FG001|Overall Study|Lack of Efficacy|11
2173620|NCT01347580|3796417|FG000|Overall Study|Withdrawal by Subject|13
2173621|NCT01347580|3796418|FG001|Overall Study|Withdrawal by Subject|23
2173622|NCT01347580|3796417|FG000|Overall Study|Death|30
2173623|NCT01347580|3796418|FG001|Overall Study|Death|19
2173624|NCT01347580|3796417|FG000|Overall Study|Protocol Violation|10
2173625|NCT01347580|3796418|FG001|Overall Study|Protocol Violation|7
2173626|NCT01347580|3796417|FG000|Overall Study|Lost to Follow-up|3
2173627|NCT01347580|3796418|FG001|Overall Study|Lost to Follow-up|1
2173628|NCT01347580|3796417|FG000|Overall Study|Had other reason|9
2173629|NCT01347580|3796418|FG001|Overall Study|Had other reason|6
2173630|NCT01347710|3796424|FG000|Overall Study|Withdrawal by Subject|2
2173631|NCT01347710|3796424|FG000|Overall Study|Adverse Event|4
2173632|NCT01347710|3796424|FG000|Overall Study|Angio or SPECT not completed|18
2173633|NCT01347710|3796424|FG000|Overall Study|issue with vitals prior to dosing|1
2173634|NCT01347710|3796424|FG000|Overall Study|Lost to Follow-up|1
2173635|NCT01347710|3796424|FG000|Overall Study|Physician Decision|2
2173636|NCT01347710|3796424|FG000|Overall Study|Other|3
2173637|NCT01347762|3796436|FG000|Overall Study|Lost to Follow-up|0
2173638|NCT01347762|3796437|FG001|Overall Study|Lost to Follow-up|1
2173639|NCT01347762|3796438|FG002|Overall Study|Lost to Follow-up|6
2173640|NCT01347762|3796439|FG003|Overall Study|Lost to Follow-up|5
2173641|NCT01347762|3796436|FG000|Overall Study|Withdrawal by Subject|4
2173642|NCT01347762|3796437|FG001|Overall Study|Withdrawal by Subject|1
2173643|NCT01347762|3796438|FG002|Overall Study|Withdrawal by Subject|3
2173644|NCT01347762|3796439|FG003|Overall Study|Withdrawal by Subject|3
2173645|NCT01347866|3796476|FG000|Overall Study|Death|0
2173646|NCT01347866|3796477|FG001|Overall Study|Death|0
2173647|NCT01347866|3796478|FG002|Overall Study|Death|0
2173648|NCT01347866|3796479|FG003|Overall Study|Death|1
2173649|NCT01347866|3796480|FG004|Overall Study|Death|2
2173650|NCT01347866|3796481|FG005|Overall Study|Death|2
2173651|NCT01347866|3796482|FG006|Overall Study|Death|1
2173652|NCT01347866|3796483|FG007|Overall Study|Death|0
2173653|NCT01347866|3796484|FG008|Overall Study|Death|4
2173654|NCT01347866|3796485|FG009|Overall Study|Death|1
2173655|NCT01347866|3796486|FG010|Overall Study|Death|3
2173656|NCT01347866|3796487|FG011|Overall Study|Death|1
2173657|NCT01347866|3796488|FG012|Overall Study|Death|2
2296661|NCT02559570|3992661|FG004|Overall Study|Withdrawal of Consent|1
2296662|NCT02559570|3992657|FG000|Overall Study|Lost to Follow-up|1
2296663|NCT02559570|3992658|FG001|Overall Study|Lost to Follow-up|0
2296664|NCT02559570|3992659|FG002|Overall Study|Lost to Follow-up|0
2296665|NCT02559570|3992660|FG003|Overall Study|Lost to Follow-up|0
2296666|NCT02559570|3992661|FG004|Overall Study|Lost to Follow-up|0
2173658|NCT01347866|3796489|FG013|Overall Study|Death|0
2173659|NCT01347866|3796490|FG014|Overall Study|Death|0
2173660|NCT01347866|3796491|FG015|Overall Study|Death|1
2173661|NCT01347866|3796492|FG016|Overall Study|Death|0
2173662|NCT01347866|3796476|FG000|Overall Study|Lost to Follow-up|0
2173663|NCT01347866|3796477|FG001|Overall Study|Lost to Follow-up|0
2173664|NCT01347866|3796478|FG002|Overall Study|Lost to Follow-up|0
2173665|NCT01347866|3796479|FG003|Overall Study|Lost to Follow-up|0
2173666|NCT01347866|3796480|FG004|Overall Study|Lost to Follow-up|0
2173667|NCT01347866|3796481|FG005|Overall Study|Lost to Follow-up|0
2173668|NCT01347866|3796482|FG006|Overall Study|Lost to Follow-up|0
2173669|NCT01347866|3796483|FG007|Overall Study|Lost to Follow-up|1
2173670|NCT01347866|3796484|FG008|Overall Study|Lost to Follow-up|1
2173671|NCT01347866|3796485|FG009|Overall Study|Lost to Follow-up|0
2173672|NCT01347866|3796486|FG010|Overall Study|Lost to Follow-up|0
2173673|NCT01347866|3796487|FG011|Overall Study|Lost to Follow-up|0
2173674|NCT01347866|3796488|FG012|Overall Study|Lost to Follow-up|0
2173675|NCT01347866|3796489|FG013|Overall Study|Lost to Follow-up|0
2173676|NCT01347866|3796490|FG014|Overall Study|Lost to Follow-up|0
2173677|NCT01347866|3796491|FG015|Overall Study|Lost to Follow-up|0
2173678|NCT01347866|3796492|FG016|Overall Study|Lost to Follow-up|0
2173679|NCT01347866|3796476|FG000|Overall Study|Other|3
2173680|NCT01347866|3796477|FG001|Overall Study|Other|1
2173681|NCT01347866|3796478|FG002|Overall Study|Other|1
2173682|NCT01347866|3796479|FG003|Overall Study|Other|4
2173683|NCT01347866|3796480|FG004|Overall Study|Other|5
2173684|NCT01347866|3796481|FG005|Overall Study|Other|0
2173685|NCT01347866|3796482|FG006|Overall Study|Other|5
2173686|NCT01347866|3796483|FG007|Overall Study|Other|3
2173687|NCT01347866|3796484|FG008|Overall Study|Other|22
2173688|NCT01347866|3796485|FG009|Overall Study|Other|5
2173689|NCT01347866|3796486|FG010|Overall Study|Other|0
2173690|NCT01347866|3796487|FG011|Overall Study|Other|3
2173691|NCT01347866|3796488|FG012|Overall Study|Other|4
2173692|NCT01347866|3796489|FG013|Overall Study|Other|4
2173693|NCT01347866|3796490|FG014|Overall Study|Other|2
2173694|NCT01347866|3796491|FG015|Overall Study|Other|3
2173695|NCT01347866|3796492|FG016|Overall Study|Other|0
2173696|NCT01347866|3796476|FG000|Overall Study|Subject refused further follow-up|2
2173697|NCT01347866|3796477|FG001|Overall Study|Subject refused further follow-up|0
2173698|NCT01347866|3796478|FG002|Overall Study|Subject refused further follow-up|0
2173699|NCT01347866|3796479|FG003|Overall Study|Subject refused further follow-up|2
2173700|NCT01347866|3796480|FG004|Overall Study|Subject refused further follow-up|0
2173701|NCT01347866|3796481|FG005|Overall Study|Subject refused further follow-up|1
2173702|NCT01347866|3796482|FG006|Overall Study|Subject refused further follow-up|0
2173703|NCT01347866|3796483|FG007|Overall Study|Subject refused further follow-up|0
2173704|NCT01347866|3796484|FG008|Overall Study|Subject refused further follow-up|4
2173705|NCT01347866|3796485|FG009|Overall Study|Subject refused further follow-up|1
2173706|NCT01347866|3796486|FG010|Overall Study|Subject refused further follow-up|0
2173707|NCT01347866|3796487|FG011|Overall Study|Subject refused further follow-up|0
2173708|NCT01347866|3796488|FG012|Overall Study|Subject refused further follow-up|1
2173709|NCT01347866|3796489|FG013|Overall Study|Subject refused further follow-up|3
2173710|NCT01347866|3796490|FG014|Overall Study|Subject refused further follow-up|1
2173711|NCT01347866|3796491|FG015|Overall Study|Subject refused further follow-up|0
2173712|NCT01347866|3796492|FG016|Overall Study|Subject refused further follow-up|2
2173713|NCT01347879|3796565|FG000|Overall Study|Adverse Event|0
2173714|NCT01347879|3796566|FG001|Overall Study|Adverse Event|12
2173715|NCT01347879|3796565|FG000|Overall Study|Lost to Follow-up|2
2173716|NCT01347879|3796566|FG001|Overall Study|Lost to Follow-up|0
2173717|NCT01347879|3796565|FG000|Overall Study|Withdrawal by Subject|3
2173718|NCT01347879|3796566|FG001|Overall Study|Withdrawal by Subject|2
2173719|NCT01347879|3796565|FG000|Overall Study|Other|2
2173720|NCT01347879|3796566|FG001|Overall Study|Other|3
2173721|NCT01347931|3796572|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1
2173722|NCT01348087|3796578|FG000|Overall Study|Unsatisfactory therapeutic effect|35
2173723|NCT01348087|3796578|FG000|Overall Study|Administrative problems|79
2173724|NCT01348087|3796578|FG000|Overall Study|protocol deviation|1
2173725|NCT01348087|3796578|FG000|Overall Study|Lost to Follow-up|1
2173726|NCT01348087|3796578|FG000|Overall Study|Subject withdrew consent|7
2173727|NCT01348087|3796578|FG000|Overall Study|Adverse Event|25
2173728|NCT01348100|3796599|FG000|Overall Study|Subject Withdrew Consent|0
2173729|NCT01348100|3796600|FG001|Overall Study|Subject Withdrew Consent|0
2173730|NCT01348100|3796601|FG002|Overall Study|Subject Withdrew Consent|2
2173731|NCT01348100|3796602|FG003|Overall Study|Subject Withdrew Consent|0
2173732|NCT01348100|3796603|FG004|Overall Study|Subject Withdrew Consent|1
2173733|NCT01348100|3796604|FG005|Overall Study|Subject Withdrew Consent|0
2173734|NCT01348100|3796605|FG006|Overall Study|Subject Withdrew Consent|1
2173735|NCT01348100|3796599|FG000|Overall Study|Protocol Deviation|0
2173736|NCT01348100|3796600|FG001|Overall Study|Protocol Deviation|0
2173737|NCT01348100|3796601|FG002|Overall Study|Protocol Deviation|0
2173738|NCT01348100|3796602|FG003|Overall Study|Protocol Deviation|1
2173739|NCT01348100|3796603|FG004|Overall Study|Protocol Deviation|0
2173740|NCT01348100|3796604|FG005|Overall Study|Protocol Deviation|0
2173741|NCT01348100|3796605|FG006|Overall Study|Protocol Deviation|0
2173742|NCT01348100|3796599|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
2173743|NCT01348100|3796600|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
2173744|NCT01348100|3796601|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0
2173745|NCT01348100|3796602|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
2173746|NCT01348100|3796603|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0
2173747|NCT01348100|3796604|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1
2173748|NCT01348100|3796605|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0
2173749|NCT01348100|3796599|FG000|Overall Study|Lost to Follow-up|0
2173750|NCT01348100|3796600|FG001|Overall Study|Lost to Follow-up|0
2173751|NCT01348100|3796601|FG002|Overall Study|Lost to Follow-up|0
2173752|NCT01348100|3796602|FG003|Overall Study|Lost to Follow-up|0
2173753|NCT01348100|3796603|FG004|Overall Study|Lost to Follow-up|0
2173754|NCT01348100|3796604|FG005|Overall Study|Lost to Follow-up|0
2173755|NCT01348100|3796605|FG006|Overall Study|Lost to Follow-up|1
2173756|NCT01348100|3796599|FG000|Overall Study|Administrative Problems|0
2173757|NCT01348100|3796600|FG001|Overall Study|Administrative Problems|0
2173758|NCT01348100|3796601|FG002|Overall Study|Administrative Problems|0
2173759|NCT01348100|3796602|FG003|Overall Study|Administrative Problems|0
2173760|NCT01348100|3796603|FG004|Overall Study|Administrative Problems|0
2173761|NCT01348100|3796604|FG005|Overall Study|Administrative Problems|1
2173762|NCT01348100|3796605|FG006|Overall Study|Administrative Problems|1
2173763|NCT01348139|3796626|FG000|Period 1|Adverse Event|1
2173764|NCT01348139|3796627|FG001|Period 1|Adverse Event|0
2173765|NCT01348139|3796628|FG002|Period 1|Adverse Event|0
2173766|NCT01348139|3796629|FG003|Period 1|Adverse Event|0
2173767|NCT01348139|3796630|FG004|Period 1|Adverse Event|0
2173768|NCT01348139|3796631|FG005|Period 1|Adverse Event|0
2173769|NCT01348165|3796652|FG000|Overall Study|Adverse Event|0
2173770|NCT01348165|3796653|FG001|Overall Study|Adverse Event|0
2173771|NCT01348165|3796654|FG002|Overall Study|Adverse Event|0
2173772|NCT01348165|3796655|FG003|Overall Study|Adverse Event|0
2173773|NCT01348165|3796656|FG004|Overall Study|Adverse Event|0
2173774|NCT01348165|3796657|FG005|Overall Study|Adverse Event|0
2173775|NCT01348165|3796658|FG006|Overall Study|Adverse Event|1
2173776|NCT01348347|3796681|FG000|Overall Study|Withdrawal by Subject|1
2173777|NCT01348347|3796682|FG001|Overall Study|Withdrawal by Subject|1
2173778|NCT01348347|3796683|FG002|Overall Study|Withdrawal by Subject|1
2173779|NCT01348347|3796681|FG000|Overall Study|Progressive disease|2
2173780|NCT01348347|3796682|FG001|Overall Study|Progressive disease|5
2173781|NCT01348347|3796683|FG002|Overall Study|Progressive disease|5
2173782|NCT01348425|3796694|FG000|Overall Study|Imaging was not taken.|1
2173783|NCT01348425|3796695|FG001|Overall Study|Imaging was not taken.|1
2173784|NCT01348490|3796700|FG000|Overall Study|Death|1
2173785|NCT01348490|3796700|FG000|Overall Study|Adverse Event|3
2173786|NCT01348490|3796700|FG000|Overall Study|Consent withdrawn|7
2173787|NCT01348490|3796700|FG000|Overall Study|Disease progression|3
2173788|NCT01348490|3796700|FG000|Overall Study|Lost to Follow-up|1
2173789|NCT01348490|3796700|FG000|Overall Study|Termination of clinical trial by sponsor|1
2173790|NCT01348490|3796700|FG000|Overall Study|Other Unspecified|8
2173791|NCT01348542|3796723|FG000|Overall Study|Withdrawal by Subject|3
2173792|NCT01348542|3796724|FG001|Overall Study|Withdrawal by Subject|0
2173793|NCT01348698|3796743|FG000|Overall Study|Does not meet lesion size criteria|1
2173794|NCT01348698|3796743|FG000|Overall Study|Death|3
2173795|NCT01348698|3796743|FG000|Overall Study|PI decision to close study|68
2173796|NCT01348763|3796747|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
2173797|NCT01348763|3796747|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
2173798|NCT01348776|3796751|FG000|Overall Study|Lost to Follow-up|3
2173799|NCT01348789|3796764|FG000|Overall Study|Protocol Violation|2
2173800|NCT01348789|3796764|FG000|Overall Study|Withdrawal by Subject|2
2173801|NCT01348828|3796775|FG000|Overall Study|Death|20
2173802|NCT01348828|3796775|FG000|Overall Study|Withdrawals/Lost to Follow-up|10
2173803|NCT01348828|3796775|FG000|Overall Study|Conversion|2
2173804|NCT01348828|3796775|FG000|Overall Study|missed visit|1
2173805|NCT01348854|3796781|FG000|Overall Study|Lost to Follow-up|2
2173806|NCT01348854|3796782|FG001|Overall Study|Lost to Follow-up|1
2173807|NCT01348854|3796781|FG000|Overall Study|Withdrawal by Subject|1
2173808|NCT01348854|3796782|FG001|Overall Study|Withdrawal by Subject|0
2173809|NCT01349036|3796790|FG000|Overall Study|Disease progression|13
2173810|NCT01349036|3796791|FG001|Overall Study|Disease progression|22
2173811|NCT01349036|3796790|FG000|Overall Study|Other|1
2173812|NCT01349036|3796791|FG001|Overall Study|Other|0
2173813|NCT01349036|3796790|FG000|Overall Study|Withdrawal by Subject|0
2173814|NCT01349036|3796791|FG001|Overall Study|Withdrawal by Subject|2
2173815|NCT01349049|3796810|FG000|Overall Study|Disease progression|3
2173816|NCT01349049|3796811|FG001|Overall Study|Disease progression|5
2173817|NCT01349049|3796812|FG002|Overall Study|Disease progression|3
2173818|NCT01349049|3796813|FG003|Overall Study|Disease progression|2
2173819|NCT01349049|3796814|FG004|Overall Study|Disease progression|2
2173820|NCT01349049|3796815|FG005|Overall Study|Disease progression|2
2173821|NCT01349049|3796816|FG006|Overall Study|Disease progression|3
2173822|NCT01349049|3796817|FG007|Overall Study|Disease progression|2
2173823|NCT01349049|3796818|FG008|Overall Study|Disease progression|33
2173824|NCT01349049|3796810|FG000|Overall Study|Adverse Event|0
2173825|NCT01349049|3796811|FG001|Overall Study|Adverse Event|1
2173826|NCT01349049|3796812|FG002|Overall Study|Adverse Event|0
2173827|NCT01349049|3796813|FG003|Overall Study|Adverse Event|0
2173828|NCT01349049|3796814|FG004|Overall Study|Adverse Event|0
2173829|NCT01349049|3796815|FG005|Overall Study|Adverse Event|3
2173830|NCT01349049|3796816|FG006|Overall Study|Adverse Event|1
2173831|NCT01349049|3796817|FG007|Overall Study|Adverse Event|0
2173832|NCT01349049|3796818|FG008|Overall Study|Adverse Event|4
2173833|NCT01349049|3796810|FG000|Overall Study|Physician Decision|0
2173834|NCT01349049|3796811|FG001|Overall Study|Physician Decision|1
2173835|NCT01349049|3796812|FG002|Overall Study|Physician Decision|0
2173836|NCT01349049|3796813|FG003|Overall Study|Physician Decision|0
2173837|NCT01349049|3796814|FG004|Overall Study|Physician Decision|0
2173838|NCT01349049|3796815|FG005|Overall Study|Physician Decision|0
2173839|NCT01349049|3796816|FG006|Overall Study|Physician Decision|0
2173840|NCT01349049|3796817|FG007|Overall Study|Physician Decision|0
2173841|NCT01349049|3796818|FG008|Overall Study|Physician Decision|2
2173842|NCT01349049|3796810|FG000|Overall Study|Protocol Violation|0
2173843|NCT01349049|3796811|FG001|Overall Study|Protocol Violation|0
2173844|NCT01349049|3796812|FG002|Overall Study|Protocol Violation|0
2173845|NCT01349049|3796813|FG003|Overall Study|Protocol Violation|0
2173846|NCT01349049|3796814|FG004|Overall Study|Protocol Violation|0
2173847|NCT01349049|3796815|FG005|Overall Study|Protocol Violation|0
2173848|NCT01349049|3796816|FG006|Overall Study|Protocol Violation|0
2173849|NCT01349049|3796817|FG007|Overall Study|Protocol Violation|0
2173850|NCT01349049|3796818|FG008|Overall Study|Protocol Violation|1
2173851|NCT01349049|3796810|FG000|Overall Study|Hematopoietic stem cell transplant|0
2173852|NCT01349049|3796811|FG001|Overall Study|Hematopoietic stem cell transplant|0
2173853|NCT01349049|3796812|FG002|Overall Study|Hematopoietic stem cell transplant|0
2173854|NCT01349049|3796813|FG003|Overall Study|Hematopoietic stem cell transplant|0
2173855|NCT01349049|3796814|FG004|Overall Study|Hematopoietic stem cell transplant|1
2173856|NCT01349049|3796815|FG005|Overall Study|Hematopoietic stem cell transplant|0
2173857|NCT01349049|3796816|FG006|Overall Study|Hematopoietic stem cell transplant|1
2173858|NCT01349049|3796817|FG007|Overall Study|Hematopoietic stem cell transplant|1
2173859|NCT01349049|3796818|FG008|Overall Study|Hematopoietic stem cell transplant|0
2173860|NCT01349049|3796810|FG000|Overall Study|Other|0
2173861|NCT01349049|3796811|FG001|Overall Study|Other|0
2173862|NCT01349049|3796812|FG002|Overall Study|Other|0
2173863|NCT01349049|3796813|FG003|Overall Study|Other|0
2173864|NCT01349049|3796814|FG004|Overall Study|Other|0
2173865|NCT01349049|3796815|FG005|Overall Study|Other|1
2173866|NCT01349049|3796816|FG006|Overall Study|Other|0
2173867|NCT01349049|3796817|FG007|Overall Study|Other|0
2173868|NCT01349049|3796818|FG008|Overall Study|Other|4
2173869|NCT01349049|3796810|FG000|Overall Study|Death|0
2173870|NCT01349049|3796811|FG001|Overall Study|Death|0
2173871|NCT01349049|3796812|FG002|Overall Study|Death|0
2173872|NCT01349049|3796813|FG003|Overall Study|Death|0
2173873|NCT01349049|3796814|FG004|Overall Study|Death|0
2173874|NCT01349049|3796815|FG005|Overall Study|Death|0
2173875|NCT01349049|3796816|FG006|Overall Study|Death|0
2173876|NCT01349049|3796817|FG007|Overall Study|Death|1
2173877|NCT01349049|3796818|FG008|Overall Study|Death|5
2173878|NCT01349049|3796810|FG000|Overall Study|Non-compliance|0
2173879|NCT01349049|3796811|FG001|Overall Study|Non-compliance|0
2296667|NCT02559570|3992657|FG000|Overall Study|Protocol Violation|1
2296668|NCT02559570|3992658|FG001|Overall Study|Protocol Violation|0
2296669|NCT02559570|3992659|FG002|Overall Study|Protocol Violation|0
2296670|NCT02559570|3992660|FG003|Overall Study|Protocol Violation|0
2296671|NCT02559570|3992661|FG004|Overall Study|Protocol Violation|1
2296672|NCT02559570|3992657|FG000|Overall Study|Other Miscellaneous Reasons|0
2296673|NCT02559570|3992658|FG001|Overall Study|Other Miscellaneous Reasons|0
2296674|NCT02559570|3992659|FG002|Overall Study|Other Miscellaneous Reasons|1
2296675|NCT02559570|3992660|FG003|Overall Study|Other Miscellaneous Reasons|0
2296676|NCT02559570|3992661|FG004|Overall Study|Other Miscellaneous Reasons|0
2296677|NCT02559622|3992676|FG000|Overall Study|Progressive disease|0
2296678|NCT02559622|3992677|FG001|Overall Study|Progressive disease|1
2296679|NCT02559622|3992678|FG002|Overall Study|Progressive disease|0
2296680|NCT02559622|3992679|FG003|Overall Study|Progressive disease|0
2296681|NCT02559622|3992676|FG000|Overall Study|Adverse Event|0
2296682|NCT02559622|3992677|FG001|Overall Study|Adverse Event|2
2296683|NCT02559622|3992678|FG002|Overall Study|Adverse Event|2
2296684|NCT02559622|3992679|FG003|Overall Study|Adverse Event|2
2296685|NCT02559622|3992676|FG000|Overall Study|Patient/guardian decision|1
2296686|NCT02559622|3992677|FG001|Overall Study|Patient/guardian decision|2
2296687|NCT02559622|3992678|FG002|Overall Study|Patient/guardian decision|0
2296688|NCT02559622|3992679|FG003|Overall Study|Patient/guardian decision|1
2296689|NCT02559687|3992693|FG000|Overall Study|Death|103
2296690|NCT02559687|3992693|FG000|Overall Study|Withdrawal by Subject|4
2296691|NCT02559687|3992693|FG000|Overall Study|Ongoing Follow-Up|14
2296692|NCT02559713|3992697|FG000|Overall Study|Pretreatment Event/ Adverse Event|1
2296693|NCT02559817|3992706|FG000|Treatment Period|Adverse Event|1
2296694|NCT02559817|3992707|FG001|Treatment Period|Adverse Event|0
2296695|NCT02559817|3992708|FG002|Treatment Period|Adverse Event|1
2296696|NCT02559817|3992709|FG003|Treatment Period|Adverse Event|0
2296697|NCT02559817|3992710|FG004|Treatment Period|Adverse Event|0
2296698|NCT02559817|3992706|FG000|Treatment Period|Lack of Efficacy|0
2296699|NCT02559817|3992707|FG001|Treatment Period|Lack of Efficacy|1
2173880|NCT01349049|3796812|FG002|Overall Study|Non-compliance|0
2173881|NCT01349049|3796813|FG003|Overall Study|Non-compliance|1
2173882|NCT01349049|3796814|FG004|Overall Study|Non-compliance|0
2173883|NCT01349049|3796815|FG005|Overall Study|Non-compliance|0
2296700|NCT02559817|3992708|FG002|Treatment Period|Lack of Efficacy|0
2173884|NCT01349049|3796816|FG006|Overall Study|Non-compliance|0
2173885|NCT01349049|3796817|FG007|Overall Study|Non-compliance|0
2173886|NCT01349049|3796818|FG008|Overall Study|Non-compliance|0
2173887|NCT01349049|3796810|FG000|Overall Study|Withdrawal by Subject|0
2173888|NCT01349049|3796811|FG001|Overall Study|Withdrawal by Subject|0
2173889|NCT01349049|3796812|FG002|Overall Study|Withdrawal by Subject|0
2173890|NCT01349049|3796813|FG003|Overall Study|Withdrawal by Subject|0
2173891|NCT01349049|3796814|FG004|Overall Study|Withdrawal by Subject|0
2173892|NCT01349049|3796815|FG005|Overall Study|Withdrawal by Subject|0
2173893|NCT01349049|3796816|FG006|Overall Study|Withdrawal by Subject|0
2173894|NCT01349049|3796817|FG007|Overall Study|Withdrawal by Subject|0
2173895|NCT01349049|3796818|FG008|Overall Study|Withdrawal by Subject|6
2173896|NCT01349192|3796867|FG000|Overall Study|Protocol Violation|0
2173897|NCT01349192|3796868|FG001|Overall Study|Protocol Violation|1
2173898|NCT01349192|3796867|FG000|Overall Study|Withdrawal by Subject|0
2173899|NCT01349192|3796868|FG001|Overall Study|Withdrawal by Subject|2
2173900|NCT01349192|3796867|FG000|Overall Study|Lost to Follow-up|1
2173901|NCT01349192|3796868|FG001|Overall Study|Lost to Follow-up|3
2173902|NCT01349192|3796867|FG000|Overall Study|Failure to adhere to Protocol|2
2173903|NCT01349192|3796868|FG001|Overall Study|Failure to adhere to Protocol|0
2173904|NCT01349465|3796882|FG000|Overall Study|Adverse Event|1
2173905|NCT01349465|3796883|FG001|Overall Study|Adverse Event|0
2173906|NCT01349465|3796882|FG000|Overall Study|Death|3
2173907|NCT01349465|3796883|FG001|Overall Study|Death|0
2173908|NCT01349465|3796882|FG000|Overall Study|Lost to Follow-up|10
2173909|NCT01349465|3796883|FG001|Overall Study|Lost to Follow-up|1
2173910|NCT01349465|3796882|FG000|Overall Study|Withdrawal by Subject|4
2173911|NCT01349465|3796883|FG001|Overall Study|Withdrawal by Subject|2
2173912|NCT01349465|3796882|FG000|Overall Study|Subject Ineligible To Continue The Trial|0
2173913|NCT01349465|3796883|FG001|Overall Study|Subject Ineligible To Continue The Trial|19
2173914|NCT01349569|3796900|FG000|Overall Study|Lack of Efficacy|4
2173915|NCT01349660|3796910|FG000|Overall Study|Still Receiving Study Treatment|0
2173916|NCT01349660|3796911|FG001|Overall Study|Still Receiving Study Treatment|0
2173917|NCT01349660|3796912|FG002|Overall Study|Still Receiving Study Treatment|1
2173918|NCT01349660|3796910|FG000|Overall Study|Disease Progression|2
2173919|NCT01349660|3796911|FG001|Overall Study|Disease Progression|4
2173920|NCT01349660|3796912|FG002|Overall Study|Disease Progression|50
2173921|NCT01349660|3796910|FG000|Overall Study|Adverse Event|1
2173922|NCT01349660|3796911|FG001|Overall Study|Adverse Event|1
2173923|NCT01349660|3796912|FG002|Overall Study|Adverse Event|12
2173924|NCT01349660|3796910|FG000|Overall Study|Withdrawal by Subject|2
2173925|NCT01349660|3796911|FG001|Overall Study|Withdrawal by Subject|0
2173926|NCT01349660|3796912|FG002|Overall Study|Withdrawal by Subject|9
2173927|NCT01349660|3796910|FG000|Overall Study|Death|1
2173928|NCT01349660|3796911|FG001|Overall Study|Death|1
2173929|NCT01349660|3796912|FG002|Overall Study|Death|0
2173930|NCT01349660|3796910|FG000|Overall Study|Non-Permitted Interventions|0
2173931|NCT01349660|3796911|FG001|Overall Study|Non-Permitted Interventions|0
2173932|NCT01349660|3796912|FG002|Overall Study|Non-Permitted Interventions|2
2173933|NCT01349660|3796910|FG000|Overall Study|Study Compliance|0
2173934|NCT01349660|3796911|FG001|Overall Study|Study Compliance|0
2173935|NCT01349660|3796912|FG002|Overall Study|Study Compliance|1
2173936|NCT01349660|3796910|FG000|Overall Study|Declining Performance Status|0
2173937|NCT01349660|3796911|FG001|Overall Study|Declining Performance Status|0
2173938|NCT01349660|3796912|FG002|Overall Study|Declining Performance Status|1
2173939|NCT01349673|3796927|FG000|Overall Study|Progression Of Disease Past 40 cm|1
2173940|NCT01349673|3796927|FG000|Overall Study|No Longer Qualified For Study|1
2173941|NCT01349673|3796927|FG000|Overall Study|Site Closure|10
2173942|NCT01349673|3796927|FG000|Overall Study|Withdrawal by Subject|21
2173943|NCT01349673|3796927|FG000|Overall Study|Lost to Follow-up|6
2296701|NCT02559817|3992709|FG003|Treatment Period|Lack of Efficacy|0
2296702|NCT02559817|3992710|FG004|Treatment Period|Lack of Efficacy|0
2173944|NCT01349673|3796927|FG000|Overall Study|Adverse Event|17
2173945|NCT01349673|3796927|FG000|Overall Study|Study Terminated By Sponsor|50
2173946|NCT01349673|3796927|FG000|Overall Study|Lack of Efficacy|8
2173947|NCT01349790|3796931|FG000|Overall Study|Investigator Judgement|3
2173948|NCT01349790|3796931|FG000|Overall Study|Death|2
2173949|NCT01349790|3796931|FG000|Overall Study|Withdrawal by Patient|2
2173950|NCT01349790|3796931|FG000|Overall Study|Adverse Event|1
2173951|NCT01349790|3796931|FG000|Overall Study|Lost to Follow-up|1
2173952|NCT01349803|3796939|FG000|Overall Study|Adverse Event|0
2173953|NCT01349803|3796940|FG001|Overall Study|Adverse Event|0
2173954|NCT01349803|3796941|FG002|Overall Study|Adverse Event|0
2173955|NCT01349803|3796942|FG003|Overall Study|Adverse Event|2
2173956|NCT01349803|3796939|FG000|Overall Study|Withdrawal by Subject|1
2173957|NCT01349803|3796940|FG001|Overall Study|Withdrawal by Subject|0
2173958|NCT01349803|3796941|FG002|Overall Study|Withdrawal by Subject|0
2173959|NCT01349803|3796942|FG003|Overall Study|Withdrawal by Subject|0
2173960|NCT01349803|3796939|FG000|Overall Study|Protocol-specified criteria|0
2173961|NCT01349803|3796940|FG001|Overall Study|Protocol-specified criteria|1
2173962|NCT01349803|3796941|FG002|Overall Study|Protocol-specified criteria|3
2173963|NCT01349803|3796942|FG003|Overall Study|Protocol-specified criteria|0
2173964|NCT01349816|3796960|FG000|Overall Study|Withdrawal by Subject|4
2296703|NCT02559817|3992706|FG000|Treatment Period|Lost to Follow-up|0
2173965|NCT01349816|3796960|FG000|Overall Study|Physician Decision|1
2173966|NCT01349816|3796960|FG000|Overall Study|Adverse Event|14
2173967|NCT01349816|3796960|FG000|Overall Study|Lost to Follow-up|2
2173968|NCT01349816|3796960|FG000|Overall Study|Protocol Violation|1
2173969|NCT01349816|3796960|FG000|Overall Study|Protocol-specified criteria|8
2173970|NCT01349829|3796976|FG000|Overall Study|Lost to Follow-up|4
2173971|NCT01349829|3796977|FG001|Overall Study|Lost to Follow-up|8
2173972|NCT01349829|3796976|FG000|Overall Study|Consent withdrawal|3
2173973|NCT01349829|3796977|FG001|Overall Study|Consent withdrawal|8
2173974|NCT01349829|3796976|FG000|Overall Study|Migrated/moved|2
2173975|NCT01349829|3796977|FG001|Overall Study|Migrated/moved|7
2173976|NCT01350102|3797008|FG000|Overall Study|Adverse Event|0
2173977|NCT01350102|3797009|FG001|Overall Study|Adverse Event|0
2173978|NCT01350102|3797010|FG002|Overall Study|Adverse Event|1
2173979|NCT01350102|3797011|FG003|Overall Study|Adverse Event|0
2173980|NCT01350115|3797023|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
2173981|NCT01350115|3797024|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
2173982|NCT01350115|3797023|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0
2173983|NCT01350115|3797024|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1
2173984|NCT01350115|3797023|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
2173985|NCT01350115|3797024|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
2173986|NCT01350128|3797032|FG000|Overall Study|Withdrawal by Subject|3
2173987|NCT01350128|3797032|FG000|Overall Study|Protocol discontinuation criteria|8
2173988|NCT01350128|3797032|FG000|Overall Study|Physician Decision|1
2173989|NCT01350128|3797032|FG000|Overall Study|Lost to Follow-up|2
2173990|NCT01350141|3797049|FG000|Overall Study|Lost to Follow-up|1
2173991|NCT01350141|3797050|FG001|Overall Study|Lost to Follow-up|0
2173992|NCT01350141|3797051|FG002|Overall Study|Lost to Follow-up|1
2173993|NCT01350141|3797049|FG000|Overall Study|Withdrawal by Subject|1
2173994|NCT01350141|3797050|FG001|Overall Study|Withdrawal by Subject|0
2173995|NCT01350141|3797051|FG002|Overall Study|Withdrawal by Subject|0
2173996|NCT01350141|3797049|FG000|Overall Study|Randomized but not treated|1
2173997|NCT01350141|3797050|FG001|Overall Study|Randomized but not treated|0
2173998|NCT01350141|3797051|FG002|Overall Study|Randomized but not treated|0
2173999|NCT01350271|3797068|FG000|Overall Study|Lost to Follow-up|21
2174000|NCT01350271|3797069|FG001|Overall Study|Lost to Follow-up|17
2174001|NCT01350271|3797070|FG002|Overall Study|Lost to Follow-up|26
2174002|NCT01350336|3797081|FG000|Overall Study|Lost to Follow-up|31
2174003|NCT01350336|3797081|FG000|Overall Study|Withdrawal by Subject|14
2174004|NCT01350336|3797081|FG000|Overall Study|Physician Decision|8
2174005|NCT01350336|3797081|FG000|Overall Study|Death|4
2174006|NCT01350414|3797147|FG000|Overall Study|Lost to Follow-up|13
2174007|NCT01350414|3797147|FG000|Overall Study|Withdrawal by Subject|4
2174008|NCT01350414|3797147|FG000|Overall Study|Physician Decision|2
2174009|NCT01350492|3797179|FG000|Intervention|Lost to Follow-up|2
2174010|NCT01350492|3797180|FG001|Intervention|Lost to Follow-up|5
2174011|NCT01350492|3797179|FG000|Intervention|Withdrawal by Subject|3
2174012|NCT01350492|3797180|FG001|Intervention|Withdrawal by Subject|1
2174013|NCT01350492|3797179|FG000|Post Intervention Follow-Up|Lost to Follow-up|6
2174014|NCT01350492|3797180|FG001|Post Intervention Follow-Up|Lost to Follow-up|1
2174015|NCT01350492|3797179|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0
2174016|NCT01350492|3797180|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1
2174017|NCT01350505|3797186|FG000|Overall Study|Lost to Follow-up|4
2174018|NCT01350544|3797192|FG000|Overall Study|Administrative Withdrawal|0
2174019|NCT01350544|3797193|FG001|Overall Study|Administrative Withdrawal|1
2174020|NCT01350544|3797192|FG000|Overall Study|Death|1
2174021|NCT01350544|3797193|FG001|Overall Study|Death|2
2174022|NCT01350544|3797192|FG000|Overall Study|Moved out of LA County|2
2174023|NCT01350544|3797193|FG001|Overall Study|Moved out of LA County|2
2174024|NCT01350544|3797192|FG000|Overall Study|Medical Issues|1
2174025|NCT01350544|3797193|FG001|Overall Study|Medical Issues|1
2174026|NCT01350544|3797192|FG000|Overall Study|Withdrawal by Subject|0
2174027|NCT01350544|3797193|FG001|Overall Study|Withdrawal by Subject|1
2174028|NCT01350544|3797192|FG000|Overall Study|Incarceration|1
2174029|NCT01350544|3797193|FG001|Overall Study|Incarceration|0
2174030|NCT01350544|3797192|FG000|Overall Study|Lost to Follow-up|18
2174031|NCT01350544|3797193|FG001|Overall Study|Lost to Follow-up|15
2174032|NCT01350804|3797203|FG000|Core Study|Withdrawal by Subject|11
2174033|NCT01350804|3797204|FG001|Core Study|Withdrawal by Subject|17
2174034|NCT01350804|3797205|FG002|Core Study|Withdrawal by Subject|16
2174035|NCT01350804|3797206|FG003|Core Study|Withdrawal by Subject|7
2174036|NCT01350804|3797203|FG000|Core Study|Study terminated by Sponsor|0
2174037|NCT01350804|3797204|FG001|Core Study|Study terminated by Sponsor|0
2174038|NCT01350804|3797205|FG002|Core Study|Study terminated by Sponsor|0
2174039|NCT01350804|3797206|FG003|Core Study|Study terminated by Sponsor|2
2174040|NCT01350804|3797203|FG000|Core Study|Protocol deviation|1
2174041|NCT01350804|3797204|FG001|Core Study|Protocol deviation|0
2174042|NCT01350804|3797205|FG002|Core Study|Protocol deviation|1
2174043|NCT01350804|3797206|FG003|Core Study|Protocol deviation|0
2174044|NCT01350804|3797203|FG000|Core Study|Physician Decision|1
2174045|NCT01350804|3797204|FG001|Core Study|Physician Decision|0
2174046|NCT01350804|3797205|FG002|Core Study|Physician Decision|1
2174047|NCT01350804|3797206|FG003|Core Study|Physician Decision|3
2174048|NCT01350804|3797203|FG000|Core Study|Lost to Follow-up|3
2174049|NCT01350804|3797204|FG001|Core Study|Lost to Follow-up|0
2174050|NCT01350804|3797205|FG002|Core Study|Lost to Follow-up|2
2174051|NCT01350804|3797206|FG003|Core Study|Lost to Follow-up|1
2174052|NCT01350804|3797203|FG000|Core Study|Lack of Efficacy|16
2174053|NCT01350804|3797204|FG001|Core Study|Lack of Efficacy|19
2174054|NCT01350804|3797205|FG002|Core Study|Lack of Efficacy|18
2174055|NCT01350804|3797206|FG003|Core Study|Lack of Efficacy|5
2174056|NCT01350804|3797203|FG000|Core Study|Death|1
2174057|NCT01350804|3797204|FG001|Core Study|Death|1
2174058|NCT01350804|3797205|FG002|Core Study|Death|1
2174059|NCT01350804|3797206|FG003|Core Study|Death|0
2174060|NCT01350804|3797203|FG000|Core Study|Adverse Event|8
2174061|NCT01350804|3797204|FG001|Core Study|Adverse Event|10
2174062|NCT01350804|3797205|FG002|Core Study|Adverse Event|8
2174063|NCT01350804|3797206|FG003|Core Study|Adverse Event|8
2174064|NCT01350804|3797203|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
2174065|NCT01350804|3797204|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
2174066|NCT01350804|3797205|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
2174067|NCT01350804|3797206|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
2174068|NCT01350804|3797203|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
2174069|NCT01350804|3797204|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
2174070|NCT01350804|3797205|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
2174071|NCT01350804|3797206|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
2174072|NCT01350804|3797203|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1
2174073|NCT01350804|3797204|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0
2174074|NCT01350804|3797205|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2
2174075|NCT01350804|3797206|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0
2174076|NCT01350804|3797203|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
2174077|NCT01350804|3797204|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
2174078|NCT01350804|3797205|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
2174079|NCT01350804|3797206|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
2174080|NCT01350804|3797203|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
2174081|NCT01350804|3797204|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
2174082|NCT01350804|3797205|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
2174083|NCT01350804|3797206|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
2174084|NCT01350804|3797203|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3
2174085|NCT01350804|3797204|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1
2174086|NCT01350804|3797205|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2
2174087|NCT01350804|3797206|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3
2174088|NCT01350973|3797233|FG000|Overall Study|Adverse Event|4
2174089|NCT01350973|3797234|FG001|Overall Study|Adverse Event|7
2174090|NCT01350973|3797235|FG002|Overall Study|Adverse Event|7
2174091|NCT01350973|3797233|FG000|Overall Study|Voluntary Withdrawal|2
2174092|NCT01350973|3797234|FG001|Overall Study|Voluntary Withdrawal|1
2174093|NCT01350973|3797235|FG002|Overall Study|Voluntary Withdrawal|1
2174094|NCT01350999|3797246|FG000|Overall Study|Adverse Event|4
2174095|NCT01350999|3797247|FG001|Overall Study|Adverse Event|9
2174096|NCT01350999|3797248|FG002|Overall Study|Adverse Event|10
2174097|NCT01350999|3797246|FG000|Overall Study|Voluntary withdrawal|3
2174098|NCT01350999|3797247|FG001|Overall Study|Voluntary withdrawal|4
2174099|NCT01350999|3797248|FG002|Overall Study|Voluntary withdrawal|6
2174100|NCT01350999|3797246|FG000|Overall Study|Difficulty Making it to Study Visit|1
2174101|NCT01350999|3797247|FG001|Overall Study|Difficulty Making it to Study Visit|1
2174102|NCT01350999|3797248|FG002|Overall Study|Difficulty Making it to Study Visit|5
2174103|NCT01351025|3797258|FG000|Week 0 - 20|Lost to Follow-up|2
2174104|NCT01351025|3797259|FG001|Week 0 - 20|Lost to Follow-up|1
2174105|NCT01351025|3797258|FG000|Week 0 - 20|Withdrawal by Subject|1
2174106|NCT01351025|3797259|FG001|Week 0 - 20|Withdrawal by Subject|0
2174107|NCT01351025|3797258|FG000|Week 24 - 44|Lost to Follow-up|0
2174108|NCT01351025|3797259|FG001|Week 24 - 44|Lost to Follow-up|2
2174109|NCT01351025|3797258|FG000|Week 24 - 44|Site closed|0
2174110|NCT01351025|3797259|FG001|Week 24 - 44|Site closed|1
2174111|NCT01351025|3797258|FG000|Week 24 - 44|unable to get to clinic|1
2174112|NCT01351025|3797259|FG001|Week 24 - 44|unable to get to clinic|1
2174113|NCT01351350|3797312|FG000|Overall Study|Disease Progression|5
2174114|NCT01351350|3797313|FG001|Overall Study|Disease Progression|13
2174115|NCT01351350|3797314|FG002|Overall Study|Disease Progression|6
2174116|NCT01351350|3797315|FG003|Overall Study|Disease Progression|8
2174117|NCT01351350|3797316|FG004|Overall Study|Disease Progression|5
2174118|NCT01351350|3797312|FG000|Overall Study|Adverse Event|1
2174119|NCT01351350|3797313|FG001|Overall Study|Adverse Event|10
2174120|NCT01351350|3797314|FG002|Overall Study|Adverse Event|1
2174121|NCT01351350|3797315|FG003|Overall Study|Adverse Event|2
2174122|NCT01351350|3797316|FG004|Overall Study|Adverse Event|0
2174123|NCT01351350|3797312|FG000|Overall Study|Participant Decision|2
2174124|NCT01351350|3797313|FG001|Overall Study|Participant Decision|6
2174125|NCT01351350|3797314|FG002|Overall Study|Participant Decision|3
2174126|NCT01351350|3797315|FG003|Overall Study|Participant Decision|3
2174127|NCT01351350|3797316|FG004|Overall Study|Participant Decision|2
2174128|NCT01351350|3797312|FG000|Overall Study|Enrolled but not Treated|0
2174129|NCT01351350|3797313|FG001|Overall Study|Enrolled but not Treated|0
2174130|NCT01351350|3797314|FG002|Overall Study|Enrolled but not Treated|1
2174131|NCT01351350|3797315|FG003|Overall Study|Enrolled but not Treated|0
2174132|NCT01351350|3797316|FG004|Overall Study|Enrolled but not Treated|0
2174133|NCT01351415|3797352|FG000|Overall Study|Withdrawal by Subject|15
2174134|NCT01351415|3797353|FG001|Overall Study|Withdrawal by Subject|17
2174135|NCT01351415|3797352|FG000|Overall Study|Trial termination by the Sponsor|28
2174136|NCT01351415|3797353|FG001|Overall Study|Trial termination by the Sponsor|19
2174137|NCT01351415|3797352|FG000|Overall Study|Lost to Follow-up|5
2174138|NCT01351415|3797353|FG001|Overall Study|Lost to Follow-up|7
2174139|NCT01351415|3797352|FG000|Overall Study|Death|190
2174140|NCT01351415|3797353|FG001|Overall Study|Death|187
2174141|NCT01351415|3797352|FG000|Overall Study|Physician Decision|2
2174142|NCT01351415|3797353|FG001|Overall Study|Physician Decision|3
2174143|NCT01351415|3797352|FG000|Overall Study|Reason unknown|0
2174144|NCT01351415|3797353|FG001|Overall Study|Reason unknown|2
2174145|NCT01351415|3797352|FG000|Overall Study|Never Started|5
2174146|NCT01351415|3797353|FG001|Overall Study|Never Started|5
2174147|NCT01351623|3797371|FG000|Overall Study|Protocol Violation|2
2174148|NCT01351623|3797371|FG000|Overall Study|Adverse Event|4
2174149|NCT01351623|3797371|FG000|Overall Study|Withdrawal by Subject|1
2174150|NCT01351623|3797371|FG000|Overall Study|Death|2
2179936|NCT01397409|3805796|FG004|Stage 2|Adverse Event|6
2179937|NCT01397409|3805797|FG005|Stage 2|Adverse Event|3
2179938|NCT01397409|3805798|FG006|Stage 2|Adverse Event|0
2179939|NCT01397409|3805799|FG007|Stage 2|Adverse Event|0
2179940|NCT01397409|3805800|FG008|Stage 2|Adverse Event|0
2179941|NCT01397409|3805801|FG009|Stage 2|Adverse Event|0
2179942|NCT01397409|3805792|FG000|Stage 2|Personal Reasons|0
2179943|NCT01397409|3805793|FG001|Stage 2|Personal Reasons|0
2179944|NCT01397409|3805794|FG002|Stage 2|Personal Reasons|0
2179945|NCT01397409|3805795|FG003|Stage 2|Personal Reasons|0
2179946|NCT01397409|3805796|FG004|Stage 2|Personal Reasons|1
2179947|NCT01397409|3805797|FG005|Stage 2|Personal Reasons|0
2179948|NCT01397409|3805798|FG006|Stage 2|Personal Reasons|0
2179949|NCT01397409|3805799|FG007|Stage 2|Personal Reasons|0
2179950|NCT01397409|3805800|FG008|Stage 2|Personal Reasons|0
2208275|NCT01638000|3847734|FG001|Overall Study|Withdrawal by Subject|24
2208276|NCT01638000|3847733|FG000|Overall Study|Miscellaneous|2
2208277|NCT01638000|3847734|FG001|Overall Study|Miscellaneous|2
2296704|NCT02559817|3992707|FG001|Treatment Period|Lost to Follow-up|1
2296705|NCT02559817|3992708|FG002|Treatment Period|Lost to Follow-up|0
2296706|NCT02559817|3992709|FG003|Treatment Period|Lost to Follow-up|1
2296707|NCT02559817|3992710|FG004|Treatment Period|Lost to Follow-up|0
2296708|NCT02559817|3992706|FG000|Treatment Period|Non-Compliance With Study Drug|0
2296709|NCT02559817|3992707|FG001|Treatment Period|Non-Compliance With Study Drug|0
2296710|NCT02559817|3992708|FG002|Treatment Period|Non-Compliance With Study Drug|1
2296711|NCT02559817|3992709|FG003|Treatment Period|Non-Compliance With Study Drug|0
2296712|NCT02559817|3992710|FG004|Treatment Period|Non-Compliance With Study Drug|0
2296713|NCT02559817|3992706|FG000|Treatment Period|Protocol Violation|0
2296714|NCT02559817|3992707|FG001|Treatment Period|Protocol Violation|0
2296715|NCT02559817|3992708|FG002|Treatment Period|Protocol Violation|0
2296716|NCT02559817|3992709|FG003|Treatment Period|Protocol Violation|1
2296717|NCT02559817|3992710|FG004|Treatment Period|Protocol Violation|0
2296718|NCT02559895|3992726|FG000|Overall Study|Adverse Event|3
2296719|NCT02559895|3992727|FG001|Overall Study|Adverse Event|3
2296720|NCT02559895|3992728|FG002|Overall Study|Adverse Event|2
2296721|NCT02559895|3992729|FG003|Overall Study|Adverse Event|1
2296722|NCT02559895|3992726|FG000|Overall Study|Lack of Efficacy|2
2296723|NCT02559895|3992727|FG001|Overall Study|Lack of Efficacy|3
2296724|NCT02559895|3992728|FG002|Overall Study|Lack of Efficacy|2
2296725|NCT02559895|3992729|FG003|Overall Study|Lack of Efficacy|8
2296726|NCT02559895|3992726|FG000|Overall Study|Lost to Follow-up|22
2296727|NCT02559895|3992727|FG001|Overall Study|Lost to Follow-up|16
2296728|NCT02559895|3992728|FG002|Overall Study|Lost to Follow-up|12
2296729|NCT02559895|3992729|FG003|Overall Study|Lost to Follow-up|17
2296730|NCT02559895|3992726|FG000|Overall Study|Physician Decision|1
2296731|NCT02559895|3992727|FG001|Overall Study|Physician Decision|1
2296732|NCT02559895|3992728|FG002|Overall Study|Physician Decision|3
2296733|NCT02559895|3992729|FG003|Overall Study|Physician Decision|0
2296734|NCT02559895|3992726|FG000|Overall Study|Withdrawal by Subject|16
2296735|NCT02559895|3992727|FG001|Overall Study|Withdrawal by Subject|9
2296736|NCT02559895|3992728|FG002|Overall Study|Withdrawal by Subject|20
2296737|NCT02559895|3992729|FG003|Overall Study|Withdrawal by Subject|9
2296738|NCT02559895|3992726|FG000|Overall Study|Study Burden|10
2296739|NCT02559895|3992727|FG001|Overall Study|Study Burden|16
2296740|NCT02559895|3992728|FG002|Overall Study|Study Burden|12
2179951|NCT01397409|3805801|FG009|Stage 2|Personal Reasons|0
2179952|NCT01397409|3805792|FG000|Stage 2|Other Miscellaneous Reasons|0
2179953|NCT01397409|3805793|FG001|Stage 2|Other Miscellaneous Reasons|0
2179954|NCT01397409|3805794|FG002|Stage 2|Other Miscellaneous Reasons|0
2296741|NCT02559895|3992729|FG003|Overall Study|Study Burden|22
2296742|NCT02559895|3992726|FG000|Overall Study|Other|1
2296743|NCT02559895|3992727|FG001|Overall Study|Other|5
2296744|NCT02559895|3992728|FG002|Overall Study|Other|3
2296745|NCT02559895|3992729|FG003|Overall Study|Other|3
2296746|NCT02560012|3992739|FG000|Overall Study|Study Terminated|2
2296747|NCT02560025|3992743|FG000|Overall Study|Ineligible after consent/ registration|3
2296748|NCT02560389|3992780|FG000|Overall Study|Lost to Follow-up|1
2296749|NCT02560389|3992781|FG001|Overall Study|Lost to Follow-up|2
2296750|NCT02560389|3992782|FG002|Overall Study|Lost to Follow-up|2
2296751|NCT02560389|3992780|FG000|Overall Study|Tested positive for illicit substance|0
2296752|NCT02560389|3992781|FG001|Overall Study|Tested positive for illicit substance|1
2296753|NCT02560389|3992782|FG002|Overall Study|Tested positive for illicit substance|0
2296754|NCT02560558|3992801|FG000|Overall Study|Adverse Event|1
2296755|NCT02560558|3992802|FG001|Overall Study|Adverse Event|0
2296756|NCT02560558|3992801|FG000|Overall Study|Death|0
2296757|NCT02560558|3992802|FG001|Overall Study|Death|2
2296758|NCT02560558|3992801|FG000|Overall Study|Lost to Follow-up|0
2296759|NCT02560558|3992802|FG001|Overall Study|Lost to Follow-up|4
2296760|NCT02560558|3992801|FG000|Overall Study|Protocol Violation|3
2296761|NCT02560558|3992802|FG001|Overall Study|Protocol Violation|0
2296762|NCT02560558|3992801|FG000|Overall Study|Withdrawal by Subject|3
2296763|NCT02560558|3992802|FG001|Overall Study|Withdrawal by Subject|0
2296764|NCT02561000|3992861|FG000|Overall Study|Withdrawal by Subject|2
2296765|NCT02561000|3992862|FG001|Overall Study|Withdrawal by Subject|3
2296766|NCT02561000|3992863|FG002|Overall Study|Withdrawal by Subject|0
2296767|NCT02561000|3992861|FG000|Overall Study|Adverse Event|0
2296768|NCT02561000|3992862|FG001|Overall Study|Adverse Event|1
2296769|NCT02561000|3992863|FG002|Overall Study|Adverse Event|0
2296770|NCT02561078|3992873|FG000|Overall Study|Adverse Event|5
2296771|NCT02561078|3992874|FG001|Overall Study|Adverse Event|2
2296772|NCT02561078|3992873|FG000|Overall Study|Death|2
2296773|NCT02561078|3992874|FG001|Overall Study|Death|1
2296774|NCT02561078|3992873|FG000|Overall Study|Lost to Follow-up|2
2296775|NCT02561078|3992874|FG001|Overall Study|Lost to Follow-up|6
2174151|NCT01352117|3797439|FG000|Overall Study|Death|15
2174152|NCT01352117|3797440|FG001|Overall Study|Death|16
2174153|NCT01352117|3797439|FG000|Overall Study|Withdrawal by Subject|1
2174154|NCT01352117|3797440|FG001|Overall Study|Withdrawal by Subject|0
2174155|NCT01352117|3797439|FG000|Overall Study|Lost to Follow-up|2
2174156|NCT01352117|3797440|FG001|Overall Study|Lost to Follow-up|7
2174157|NCT01352117|3797439|FG000|Overall Study|Non-adherent to study requirements|1
2174158|NCT01352117|3797440|FG001|Overall Study|Non-adherent to study requirements|1
2174159|NCT01352117|3797439|FG000|Overall Study|Did not initiate study treatment|1
2174160|NCT01352117|3797440|FG001|Overall Study|Did not initiate study treatment|0
2174161|NCT01352117|3797439|FG000|Overall Study|Ineligible (no KS diagnosis)|1
2174162|NCT01352117|3797440|FG001|Overall Study|Ineligible (no KS diagnosis)|0
2174163|NCT01352221|3797462|FG000|Double-blind Phase|Adverse Event|6
2174164|NCT01352221|3797463|FG001|Double-blind Phase|Adverse Event|4
2174165|NCT01352221|3797464|FG002|Double-blind Phase|Adverse Event|0
2174166|NCT01352221|3797465|FG003|Double-blind Phase|Adverse Event|0
2174167|NCT01352221|3797462|FG000|Double-blind Phase|Withdrawal by Subject|3
2174168|NCT01352221|3797463|FG001|Double-blind Phase|Withdrawal by Subject|5
2174169|NCT01352221|3797464|FG002|Double-blind Phase|Withdrawal by Subject|0
2174170|NCT01352221|3797465|FG003|Double-blind Phase|Withdrawal by Subject|0
2174171|NCT01352221|3797462|FG000|Double-blind Phase|Lost to Follow-up|0
2174172|NCT01352221|3797463|FG001|Double-blind Phase|Lost to Follow-up|1
2174173|NCT01352221|3797464|FG002|Double-blind Phase|Lost to Follow-up|0
2174174|NCT01352221|3797465|FG003|Double-blind Phase|Lost to Follow-up|0
2174175|NCT01352221|3797462|FG000|Double-blind Phase|Protocol Violation|0
2174176|NCT01352221|3797463|FG001|Double-blind Phase|Protocol Violation|1
2174177|NCT01352221|3797464|FG002|Double-blind Phase|Protocol Violation|0
2174178|NCT01352221|3797465|FG003|Double-blind Phase|Protocol Violation|0
2174179|NCT01352221|3797462|FG000|Open-label Phase|Physician Decision|0
2174180|NCT01352221|3797463|FG001|Open-label Phase|Physician Decision|0
2174181|NCT01352221|3797464|FG002|Open-label Phase|Physician Decision|2
2174182|NCT01352221|3797465|FG003|Open-label Phase|Physician Decision|1
2174183|NCT01352221|3797462|FG000|Open-label Phase|Pregnancy|0
2174184|NCT01352221|3797463|FG001|Open-label Phase|Pregnancy|0
2174185|NCT01352221|3797464|FG002|Open-label Phase|Pregnancy|1
2174186|NCT01352221|3797465|FG003|Open-label Phase|Pregnancy|0
2174187|NCT01352221|3797462|FG000|Open-label Phase|Adverse Event|0
2174188|NCT01352221|3797463|FG001|Open-label Phase|Adverse Event|0
2174189|NCT01352221|3797464|FG002|Open-label Phase|Adverse Event|8
2174190|NCT01352221|3797465|FG003|Open-label Phase|Adverse Event|4
2174191|NCT01352221|3797462|FG000|Open-label Phase|Withdrawal by Subject|0
2174192|NCT01352221|3797463|FG001|Open-label Phase|Withdrawal by Subject|0
2174193|NCT01352221|3797464|FG002|Open-label Phase|Withdrawal by Subject|1
2174194|NCT01352221|3797465|FG003|Open-label Phase|Withdrawal by Subject|6
2174195|NCT01352221|3797462|FG000|Open-label Phase|Worsening of IBD|0
2174196|NCT01352221|3797463|FG001|Open-label Phase|Worsening of IBD|0
2174197|NCT01352221|3797464|FG002|Open-label Phase|Worsening of IBD|1
2174198|NCT01352221|3797465|FG003|Open-label Phase|Worsening of IBD|0
2174199|NCT01352507|3797497|FG000|Treatment Period 1|Adverse Event|3
2174200|NCT01352507|3797498|FG001|Treatment Period 1|Adverse Event|0
2174201|NCT01352507|3797497|FG000|Treatment Period 1|Lost to Follow-up|3
2174202|NCT01352507|3797498|FG001|Treatment Period 1|Lost to Follow-up|4
2174203|NCT01352507|3797497|FG000|Treatment Period 1|Withdrawal by Subject|7
2174204|NCT01352507|3797498|FG001|Treatment Period 1|Withdrawal by Subject|5
2174205|NCT01352507|3797497|FG000|Treatment Period 1|Physician Decision|1
2174206|NCT01352507|3797498|FG001|Treatment Period 1|Physician Decision|0
2296776|NCT02561078|3992873|FG000|Overall Study|Non-Compliance with Study Drug|6
2174207|NCT01352507|3797497|FG000|Washout Period|Withdrawal by Subject|0
2174208|NCT01352507|3797498|FG001|Washout Period|Withdrawal by Subject|1
2174209|NCT01352507|3797497|FG000|Treatment Period 2|Entry Criteria Not Met|1
2174210|NCT01352507|3797498|FG001|Treatment Period 2|Entry Criteria Not Met|0
2174211|NCT01352507|3797497|FG000|Treatment Period 2|Withdrawal by Subject|4
2174212|NCT01352507|3797498|FG001|Treatment Period 2|Withdrawal by Subject|3
2174213|NCT01352507|3797497|FG000|Treatment Period 2|Lack of Efficacy|1
2174214|NCT01352507|3797498|FG001|Treatment Period 2|Lack of Efficacy|0
2174215|NCT01352585|3797516|FG000|Overall Study|Adverse Event|2
2174216|NCT01352585|3797517|FG001|Overall Study|Adverse Event|1
2174217|NCT01352585|3797516|FG000|Overall Study|Lost to Follow-up|1
2174218|NCT01352585|3797517|FG001|Overall Study|Lost to Follow-up|0
2174219|NCT01352585|3797516|FG000|Overall Study|Other|5
2174220|NCT01352585|3797517|FG001|Overall Study|Other|2
2174221|NCT01352715|3797547|FG000|Overall Study|Death|3
2174222|NCT01352715|3797548|FG001|Overall Study|Death|3
2174223|NCT01352715|3797547|FG000|Overall Study|Lost to Follow-up|5
2174224|NCT01352715|3797548|FG001|Overall Study|Lost to Follow-up|7
2174225|NCT01352715|3797547|FG000|Overall Study|Withdrawal by Subject|4
2174226|NCT01352715|3797548|FG001|Overall Study|Withdrawal by Subject|8
2174227|NCT01352715|3797547|FG000|Overall Study|site closure|16
2174228|NCT01352715|3797548|FG001|Overall Study|site closure|15
2174229|NCT01352715|3797547|FG000|Overall Study|no final visit in closeout period|15
2174230|NCT01352715|3797548|FG001|Overall Study|no final visit in closeout period|12
2174231|NCT01352715|3797547|FG000|Overall Study|major ineligibility|2
2174232|NCT01352715|3797548|FG001|Overall Study|major ineligibility|1
2174233|NCT01352741|3797554|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4
2174234|NCT01352741|3797555|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0
2174235|NCT01352741|3797554|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19
2174236|NCT01352741|3797555|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0
2174237|NCT01352741|3797554|FG000|Open-label Tapentadol Titration Period|Adverse Event|34
2174238|NCT01352741|3797555|FG001|Open-label Tapentadol Titration Period|Adverse Event|0
2174239|NCT01352741|3797554|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7
2174240|NCT01352741|3797555|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0
2174241|NCT01352741|3797554|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
2174242|NCT01352741|3797555|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
2174243|NCT01352741|3797554|FG000|Open-label Tapentadol Titration Period|Other|4
2174244|NCT01352741|3797555|FG001|Open-label Tapentadol Titration Period|Other|0
2174245|NCT01352741|3797554|FG000|Double-blind Comparative Period|Protocol Violation|2
2174246|NCT01352741|3797555|FG001|Double-blind Comparative Period|Protocol Violation|0
2174247|NCT01352741|3797554|FG000|Double-blind Comparative Period|Lack of Efficacy|0
2174248|NCT01352741|3797555|FG001|Double-blind Comparative Period|Lack of Efficacy|3
2174249|NCT01352741|3797554|FG000|Double-blind Comparative Period|Adverse Event|16
2174250|NCT01352741|3797555|FG001|Double-blind Comparative Period|Adverse Event|17
2174251|NCT01352741|3797554|FG000|Double-blind Comparative Period|Lost to Follow-up|1
2174252|NCT01352741|3797555|FG001|Double-blind Comparative Period|Lost to Follow-up|0
2174253|NCT01352741|3797554|FG000|Double-blind Comparative Period|Death|0
2174254|NCT01352741|3797555|FG001|Double-blind Comparative Period|Death|1
2174255|NCT01352741|3797554|FG000|Double-blind Comparative Period|Withdrawal of consent|8
2174256|NCT01352741|3797555|FG001|Double-blind Comparative Period|Withdrawal of consent|3
2174257|NCT01352741|3797554|FG000|Double-blind Comparative Period|Other|1
2174258|NCT01352741|3797555|FG001|Double-blind Comparative Period|Other|2
2174259|NCT01352741|3797554|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4
2174260|NCT01352741|3797555|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0
2174261|NCT01352741|3797554|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
2174262|NCT01352741|3797555|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
2174263|NCT01352741|3797554|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
2296777|NCT02561078|3992874|FG001|Overall Study|Non-Compliance with Study Drug|3
2296778|NCT02561078|3992873|FG000|Overall Study|Physician Decision|2
2296779|NCT02561078|3992874|FG001|Overall Study|Physician Decision|3
2296780|NCT02561078|3992873|FG000|Overall Study|Withdrawal by Subject|13
2296781|NCT02561078|3992874|FG001|Overall Study|Withdrawal by Subject|10
2296782|NCT02561156|3992902|FG000|Part 2|Adverse Event|0
2296783|NCT02561156|3992903|FG001|Part 2|Adverse Event|0
2296784|NCT02561156|3992904|FG002|Part 2|Adverse Event|0
2296785|NCT02561156|3992905|FG003|Part 2|Adverse Event|0
2296786|NCT02561156|3992906|FG004|Part 2|Adverse Event|0
2296787|NCT02561156|3992907|FG005|Part 2|Adverse Event|0
2296788|NCT02561156|3992908|FG006|Part 2|Adverse Event|0
2296789|NCT02561156|3992909|FG007|Part 2|Adverse Event|0
2296790|NCT02561156|3992910|FG008|Part 2|Adverse Event|0
2296791|NCT02561156|3992911|FG009|Part 2|Adverse Event|0
2296792|NCT02561156|3992912|FG010|Part 2|Adverse Event|0
2296793|NCT02561156|3992913|FG011|Part 2|Adverse Event|1
2296794|NCT02561156|3992914|FG012|Part 2|Adverse Event|0
2296795|NCT02561195|3992964|FG000|Vaccination 1 to 3|Adverse Event|4
2296796|NCT02561195|3992965|FG001|Vaccination 1 to 3|Adverse Event|5
2296797|NCT02561195|3992966|FG002|Vaccination 1 to 3|Adverse Event|0
2296798|NCT02561195|3992967|FG003|Vaccination 1 to 3|Adverse Event|3
2296799|NCT02561195|3992968|FG004|Vaccination 1 to 3|Adverse Event|4
2174264|NCT01352741|3797555|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
2174265|NCT01352741|3797554|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
2174266|NCT01352741|3797555|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
2174267|NCT01352793|3797577|FG000|Overall Study|Lost to Follow-up|289
2174268|NCT01352793|3797578|FG001|Overall Study|Lost to Follow-up|125
2174269|NCT01352793|3797577|FG000|Overall Study|Withdrawal by Subject|120
2174270|NCT01352793|3797578|FG001|Overall Study|Withdrawal by Subject|55
2174271|NCT01352793|3797577|FG000|Overall Study|Protocol Violation|44
2174272|NCT01352793|3797578|FG001|Overall Study|Protocol Violation|23
2174273|NCT01352793|3797577|FG000|Overall Study|Adverse Event|44
2174274|NCT01352793|3797578|FG001|Overall Study|Adverse Event|10
2174275|NCT01352793|3797577|FG000|Overall Study|Physician Decision|1
2174276|NCT01352793|3797578|FG001|Overall Study|Physician Decision|0
2174277|NCT01352793|3797577|FG000|Overall Study|Pregnancy|26
2174278|NCT01352793|3797578|FG001|Overall Study|Pregnancy|8
2174279|NCT01352793|3797577|FG000|Overall Study|Other|25
2174280|NCT01352793|3797578|FG001|Overall Study|Other|7
2174281|NCT01352793|3797577|FG000|Overall Study|Medication error|2
2174282|NCT01352793|3797578|FG001|Overall Study|Medication error|2
2174283|NCT01352793|3797577|FG000|Overall Study|Death|1
2174284|NCT01352793|3797578|FG001|Overall Study|Death|0
2174285|NCT01352793|3797577|FG000|Overall Study|Randomized but not vaccinated|8
2174286|NCT01352793|3797578|FG001|Overall Study|Randomized but not vaccinated|0
2174287|NCT01352793|3797577|FG000|Overall Study|No longer meets eligibility criteria|25
2174288|NCT01352793|3797578|FG001|Overall Study|No longer meets eligibility criteria|15
2174289|NCT01352845|3797586|FG000|Overall Study|Lost to Follow-up|313
2174290|NCT01352845|3797587|FG001|Overall Study|Lost to Follow-up|92
2174291|NCT01352845|3797586|FG000|Overall Study|No Longer Willing to Participate|205
2174292|NCT01352845|3797587|FG001|Overall Study|No Longer Willing to Participate|58
2174293|NCT01352845|3797586|FG000|Overall Study|Withdrawal by Subject|48
2174294|NCT01352845|3797587|FG001|Overall Study|Withdrawal by Subject|16
2174295|NCT01352845|3797586|FG000|Overall Study|No Longer Meets Eligibility Criteria|24
2174296|NCT01352845|3797587|FG001|Overall Study|No Longer Meets Eligibility Criteria|11
2174297|NCT01352845|3797586|FG000|Overall Study|Pregnancy|27
2174298|NCT01352845|3797587|FG001|Overall Study|Pregnancy|7
2174299|NCT01352845|3797586|FG000|Overall Study|Adverse Event|22
2174300|NCT01352845|3797587|FG001|Overall Study|Adverse Event|6
2174301|NCT01352845|3797586|FG000|Overall Study|Other|17
2174302|NCT01352845|3797587|FG001|Overall Study|Other|7
2174303|NCT01352845|3797586|FG000|Overall Study|Protocol Violation|12
2174304|NCT01352845|3797587|FG001|Overall Study|Protocol Violation|6
2174305|NCT01352845|3797586|FG000|Overall Study|Death|3
2174306|NCT01352845|3797587|FG001|Overall Study|Death|0
2174307|NCT01353222|3797626|FG000|Overall Study|Death|30
2174308|NCT01353222|3797627|FG001|Overall Study|Death|30
2174309|NCT01353222|3797626|FG000|Overall Study|Withdrawal by Subject|8
2174310|NCT01353222|3797627|FG001|Overall Study|Withdrawal by Subject|5
2174311|NCT01353222|3797626|FG000|Overall Study|Study Terminated|31
2174312|NCT01353222|3797627|FG001|Overall Study|Study Terminated|37
2174313|NCT01353222|3797626|FG000|Overall Study|Site closed research department|1
2174314|NCT01353222|3797627|FG001|Overall Study|Site closed research department|0
2174315|NCT01353274|3797633|FG000|Overall Study|No case report form (CRF) collected|28
2174316|NCT01353508|3797650|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0
2174317|NCT01353508|3797651|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0
2174318|NCT01353508|3797652|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0
2174319|NCT01353508|3797653|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1
2174320|NCT01353508|3797650|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
2174321|NCT01353508|3797651|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
2174322|NCT01353508|3797652|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
2174323|NCT01353508|3797653|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
2174324|NCT01353586|3797665|FG000|Overall Study|Procedure terminated prior to ablation|3
2174325|NCT01353586|3797666|FG001|Overall Study|Procedure terminated prior to ablation|0
2174326|NCT01353586|3797665|FG000|Overall Study|Never had insertion of study catheter|4
2174327|NCT01353586|3797666|FG001|Overall Study|Never had insertion of study catheter|1
2174328|NCT01353586|3797665|FG000|Overall Study|Neurological exam not done|0
2174329|NCT01353586|3797666|FG001|Overall Study|Neurological exam not done|1
2174330|NCT01353664|3797675|FG000|Overall Study|Other|3
2174331|NCT01353664|3797675|FG000|Overall Study|Disease Progression|16
2174332|NCT01353703|3797681|FG000|Overall Study|Migrated/moved from study area|1
2174333|NCT01353703|3797682|FG001|Overall Study|Migrated/moved from study area|0
2174334|NCT01353859|3797690|FG000|Overall Study|Adverse Event|3
2174335|NCT01353859|3797690|FG000|Overall Study|Lack of Efficacy|1
2174336|NCT01353898|3797700|FG000|Overall Study|Study site terminated|0
2174337|NCT01353898|3797701|FG001|Overall Study|Study site terminated|0
2174338|NCT01353898|3797702|FG002|Overall Study|Study site terminated|0
2174339|NCT01353898|3797703|FG003|Overall Study|Study site terminated|0
2174340|NCT01353898|3797704|FG004|Overall Study|Study site terminated|0
2174341|NCT01353898|3797705|FG005|Overall Study|Study site terminated|1
2174342|NCT01353911|3797727|FG000|Overall Study|Lost to Follow-up|2
2174343|NCT01353911|3797728|FG001|Overall Study|Lost to Follow-up|6
2174344|NCT01353911|3797729|FG002|Overall Study|Lost to Follow-up|4
2174345|NCT01353911|3797730|FG003|Overall Study|Lost to Follow-up|0
2174346|NCT01353911|3797731|FG004|Overall Study|Lost to Follow-up|4
2174347|NCT01353911|3797732|FG005|Overall Study|Lost to Follow-up|4
2174348|NCT01353911|3797733|FG006|Overall Study|Lost to Follow-up|3
2174349|NCT01353911|3797734|FG007|Overall Study|Lost to Follow-up|6
2174350|NCT01353911|3797727|FG000|Overall Study|Withdrawal by Subject|2
2174351|NCT01353911|3797728|FG001|Overall Study|Withdrawal by Subject|3
2174352|NCT01353911|3797729|FG002|Overall Study|Withdrawal by Subject|4
2174353|NCT01353911|3797730|FG003|Overall Study|Withdrawal by Subject|2
2174354|NCT01353911|3797731|FG004|Overall Study|Withdrawal by Subject|2
2174355|NCT01353911|3797732|FG005|Overall Study|Withdrawal by Subject|3
2174356|NCT01353911|3797733|FG006|Overall Study|Withdrawal by Subject|3
2174357|NCT01353911|3797734|FG007|Overall Study|Withdrawal by Subject|9
2174358|NCT01353911|3797727|FG000|Overall Study|Status Not Recorded|4
2174359|NCT01353911|3797728|FG001|Overall Study|Status Not Recorded|0
2174360|NCT01353911|3797729|FG002|Overall Study|Status Not Recorded|1
2174361|NCT01353911|3797730|FG003|Overall Study|Status Not Recorded|0
2174362|NCT01353911|3797731|FG004|Overall Study|Status Not Recorded|0
2174363|NCT01353911|3797732|FG005|Overall Study|Status Not Recorded|0
2174364|NCT01353911|3797733|FG006|Overall Study|Status Not Recorded|0
2174365|NCT01353911|3797734|FG007|Overall Study|Status Not Recorded|0
2174366|NCT01353963|3797752|FG000|Overall Study|Adverse Event|2
2174367|NCT01354028|3797774|FG000|Overall Study|Physician Decision|0
2174368|NCT01354028|3797775|FG001|Overall Study|Physician Decision|2
2174369|NCT01354028|3797774|FG000|Overall Study|Discharged before study start|2
2174370|NCT01354028|3797775|FG001|Overall Study|Discharged before study start|2
2174371|NCT01354028|3797774|FG000|Overall Study|No quiet alert state|0
2174372|NCT01354028|3797775|FG001|Overall Study|No quiet alert state|1
2174373|NCT01354106|3797787|FG000|Overall Study|Withdrawal by Subject|2
2174374|NCT01354132|3797795|FG000|Randomization|Physician Decision|1
2174375|NCT01354132|3797796|FG001|Randomization|Physician Decision|0
2174376|NCT01354132|3797795|FG000|Randomization|Withdrawal by Subject|0
2174377|NCT01354132|3797796|FG001|Randomization|Withdrawal by Subject|1
2174378|NCT01354132|3797795|FG000|Double Blind (Visits 1-7)|Adverse Event|1
2174379|NCT01354132|3797796|FG001|Double Blind (Visits 1-7)|Adverse Event|0
2174380|NCT01354132|3797795|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8
2174381|NCT01354132|3797796|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11
2174382|NCT01354132|3797795|FG000|1 Month Post Study Medication|Withdrawal by Subject|1
2174383|NCT01354132|3797796|FG001|1 Month Post Study Medication|Withdrawal by Subject|3
2174384|NCT01354223|3797823|FG000|Overall Study|Withdrawal by Subject|3
2174385|NCT01354223|3797824|FG001|Overall Study|Withdrawal by Subject|1
2174386|NCT01354314|3797834|FG000|Overall Study|Lost to Follow-up|1
2174387|NCT01354314|3797835|FG001|Overall Study|Lost to Follow-up|0
2174388|NCT01354314|3797836|FG002|Overall Study|Lost to Follow-up|1
2174389|NCT01354314|3797837|FG003|Overall Study|Lost to Follow-up|1
2174390|NCT01354314|3797834|FG000|Overall Study|Withdrawal by Subject|0
2174391|NCT01354314|3797835|FG001|Overall Study|Withdrawal by Subject|0
2174392|NCT01354314|3797836|FG002|Overall Study|Withdrawal by Subject|1
2174393|NCT01354314|3797837|FG003|Overall Study|Withdrawal by Subject|0
2174394|NCT01354314|3797834|FG000|Overall Study|Adverse Event|0
2174395|NCT01354314|3797835|FG001|Overall Study|Adverse Event|0
2174396|NCT01354314|3797836|FG002|Overall Study|Adverse Event|0
2174397|NCT01354314|3797837|FG003|Overall Study|Adverse Event|1
2174398|NCT01354314|3797834|FG000|Overall Study|Protocol Violation|1
2174399|NCT01354314|3797835|FG001|Overall Study|Protocol Violation|1
2174400|NCT01354314|3797836|FG002|Overall Study|Protocol Violation|0
2174401|NCT01354314|3797837|FG003|Overall Study|Protocol Violation|0
2174402|NCT01354314|3797834|FG000|Overall Study|Less than 90% Adherence|4
2174403|NCT01354314|3797835|FG001|Overall Study|Less than 90% Adherence|2
2174404|NCT01354314|3797836|FG002|Overall Study|Less than 90% Adherence|6
2174405|NCT01354314|3797837|FG003|Overall Study|Less than 90% Adherence|4
2174406|NCT01354353|3797855|FG000|Overall Study|Adverse Event|1
2174407|NCT01354353|3797856|FG001|Overall Study|Adverse Event|0
2174408|NCT01354353|3797857|FG002|Overall Study|Adverse Event|0
2174409|NCT01354353|3797858|FG003|Overall Study|Adverse Event|4
2174410|NCT01354353|3797859|FG004|Overall Study|Adverse Event|0
2174411|NCT01354353|3797860|FG005|Overall Study|Adverse Event|5
2174412|NCT01354353|3797855|FG000|Overall Study|Entry Criteria Not Met|0
2174413|NCT01354353|3797856|FG001|Overall Study|Entry Criteria Not Met|0
2174414|NCT01354353|3797857|FG002|Overall Study|Entry Criteria Not Met|0
2174415|NCT01354353|3797858|FG003|Overall Study|Entry Criteria Not Met|1
2174416|NCT01354353|3797859|FG004|Overall Study|Entry Criteria Not Met|1
2174417|NCT01354353|3797860|FG005|Overall Study|Entry Criteria Not Met|0
2174418|NCT01354353|3797855|FG000|Overall Study|Physician Decision|0
2174419|NCT01354353|3797856|FG001|Overall Study|Physician Decision|1
2174420|NCT01354353|3797857|FG002|Overall Study|Physician Decision|1
2174421|NCT01354353|3797858|FG003|Overall Study|Physician Decision|0
2174422|NCT01354353|3797859|FG004|Overall Study|Physician Decision|0
2174423|NCT01354353|3797860|FG005|Overall Study|Physician Decision|0
2174424|NCT01354353|3797855|FG000|Overall Study|Withdrawal by Subject|2
2174425|NCT01354353|3797856|FG001|Overall Study|Withdrawal by Subject|0
2174426|NCT01354353|3797857|FG002|Overall Study|Withdrawal by Subject|1
2174427|NCT01354353|3797858|FG003|Overall Study|Withdrawal by Subject|0
2174428|NCT01354353|3797859|FG004|Overall Study|Withdrawal by Subject|0
2174429|NCT01354353|3797860|FG005|Overall Study|Withdrawal by Subject|1
2174430|NCT01354431|3797884|FG000|Randomized to Enter Treatment Period|No longer met criteria|1
2174431|NCT01354431|3797885|FG001|Randomized to Enter Treatment Period|No longer met criteria|0
2174432|NCT01354431|3797886|FG002|Randomized to Enter Treatment Period|No longer met criteria|0
2174433|NCT01354431|3797884|FG000|Participants Treated|Continuing Treatment|6
2174434|NCT01354431|3797885|FG001|Participants Treated|Continuing Treatment|2
2174435|NCT01354431|3797886|FG002|Participants Treated|Continuing Treatment|4
2174436|NCT01354431|3797884|FG000|Participants Treated|Disease Progression|49
2174437|NCT01354431|3797885|FG001|Participants Treated|Disease Progression|40
2174438|NCT01354431|3797886|FG002|Participants Treated|Disease Progression|41
2174439|NCT01354431|3797884|FG000|Participants Treated|Study Drug Toxicity|2
2174440|NCT01354431|3797885|FG001|Participants Treated|Study Drug Toxicity|7
2174441|NCT01354431|3797886|FG002|Participants Treated|Study Drug Toxicity|4
2174442|NCT01354431|3797884|FG000|Participants Treated|Death|0
2174443|NCT01354431|3797885|FG001|Participants Treated|Death|1
2174444|NCT01354431|3797886|FG002|Participants Treated|Death|0
2174445|NCT01354431|3797884|FG000|Participants Treated|Adverse Event|1
2174446|NCT01354431|3797885|FG001|Participants Treated|Adverse Event|2
2174447|NCT01354431|3797886|FG002|Participants Treated|Adverse Event|4
2174448|NCT01354431|3797884|FG000|Participants Treated|Withdrawal by Subject|1
2174449|NCT01354431|3797885|FG001|Participants Treated|Withdrawal by Subject|2
2174450|NCT01354431|3797886|FG002|Participants Treated|Withdrawal by Subject|1
2174451|NCT01354496|3797911|FG000|Period 1|Adverse Event|0
2174452|NCT01354496|3797912|FG001|Period 1|Adverse Event|0
2174453|NCT01354496|3797913|FG002|Period 1|Adverse Event|1
2174454|NCT01354496|3797914|FG003|Period 1|Adverse Event|0
2174455|NCT01354496|3797915|FG004|Period 1|Adverse Event|0
2174456|NCT01354496|3797916|FG005|Period 1|Adverse Event|0
2174457|NCT01354496|3797911|FG000|Period 1|Physician Decision|0
2174458|NCT01354496|3797912|FG001|Period 1|Physician Decision|0
2174459|NCT01354496|3797913|FG002|Period 1|Physician Decision|1
2174460|NCT01354496|3797914|FG003|Period 1|Physician Decision|0
2174461|NCT01354496|3797915|FG004|Period 1|Physician Decision|0
2174462|NCT01354496|3797916|FG005|Period 1|Physician Decision|0
2174463|NCT01354496|3797911|FG000|Period 2|Adverse Event|0
2174464|NCT01354496|3797912|FG001|Period 2|Adverse Event|0
2174465|NCT01354496|3797913|FG002|Period 2|Adverse Event|0
2174466|NCT01354496|3797914|FG003|Period 2|Adverse Event|1
2174467|NCT01354496|3797915|FG004|Period 2|Adverse Event|0
2174468|NCT01354496|3797916|FG005|Period 2|Adverse Event|0
2174469|NCT01354496|3797911|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0
2174470|NCT01354496|3797912|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1
2174471|NCT01354496|3797913|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0
2174472|NCT01354496|3797914|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1
2174473|NCT01354496|3797915|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0
2174474|NCT01354496|3797916|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0
2174475|NCT01354899|3797960|FG000|Overall Study|discharge from the hospital|2
2174476|NCT01354899|3797960|FG000|Overall Study|Protocol Violation|1
2174477|NCT01354938|3797964|FG000|Overall Study|Lost to Follow-up|1
2174478|NCT01354964|3797970|FG000|Overall Study|Lost to Follow-up|2
2174479|NCT01354964|3797971|FG001|Overall Study|Lost to Follow-up|0
2174480|NCT01354964|3797970|FG000|Overall Study|IV access issues|1
2174481|NCT01354964|3797971|FG001|Overall Study|IV access issues|1
2174482|NCT01354964|3797970|FG000|Overall Study|Physician Decision|1
2174483|NCT01354964|3797971|FG001|Overall Study|Physician Decision|0
2174484|NCT01355068|3797983|FG000|First Intervention Period|Adverse Event|0
2174485|NCT01355068|3797984|FG001|First Intervention Period|Adverse Event|1
2174486|NCT01355068|3797983|FG000|First Intervention Period|Withdrawal by Subject|0
2174487|NCT01355068|3797984|FG001|First Intervention Period|Withdrawal by Subject|1
2174488|NCT01355081|3797993|FG000|Overall Study|Pretreatment Event or Adverse Event|3
2174489|NCT01355081|3797994|FG001|Overall Study|Pretreatment Event or Adverse Event|4
2174490|NCT01355081|3797995|FG002|Overall Study|Pretreatment Event or Adverse Event|6
2174491|NCT01355081|3797993|FG000|Overall Study|Major Protocol Deviation|0
2174492|NCT01355081|3797994|FG001|Overall Study|Major Protocol Deviation|1
2174493|NCT01355081|3797995|FG002|Overall Study|Major Protocol Deviation|0
2174494|NCT01355081|3797993|FG000|Overall Study|Lost to Follow-up|0
2174495|NCT01355081|3797994|FG001|Overall Study|Lost to Follow-up|0
2174496|NCT01355081|3797995|FG002|Overall Study|Lost to Follow-up|1
2174497|NCT01355081|3797993|FG000|Overall Study|Withdrawal of Consent|2
2174498|NCT01355081|3797994|FG001|Overall Study|Withdrawal of Consent|3
2174499|NCT01355081|3797995|FG002|Overall Study|Withdrawal of Consent|3
2174500|NCT01355081|3797993|FG000|Overall Study|Lack of Efficacy|2
2174501|NCT01355081|3797994|FG001|Overall Study|Lack of Efficacy|1
2174502|NCT01355081|3797995|FG002|Overall Study|Lack of Efficacy|1
2174503|NCT01355081|3797993|FG000|Overall Study|Non Compliance with Study Medication|0
2174504|NCT01355081|3797994|FG001|Overall Study|Non Compliance with Study Medication|1
2174505|NCT01355081|3797995|FG002|Overall Study|Non Compliance with Study Medication|0
2174506|NCT01355159|3798005|FG000|Overall Study|Withdrew consent|39
2174507|NCT01355159|3798006|FG001|Overall Study|Withdrew consent|47
2174508|NCT01355159|3798005|FG000|Overall Study|No primary outcome data|17
2174509|NCT01355159|3798006|FG001|Overall Study|No primary outcome data|11
2174510|NCT01355159|3798005|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22
2174511|NCT01355159|3798006|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15
2174512|NCT01355159|3798005|FG000|Overall Study|Early intrauterine fetal death|6
2174513|NCT01355159|3798006|FG001|Overall Study|Early intrauterine fetal death|6
2174514|NCT01355289|3798041|FG000|Core Study|Adverse Event, Non-Fatal|1
2174515|NCT01355289|3798042|FG001|Core Study|Adverse Event, Non-Fatal|0
2174516|NCT01355289|3798043|FG002|Core Study|Adverse Event, Non-Fatal|0
2174517|NCT01355289|3798044|FG003|Core Study|Adverse Event, Non-Fatal|0
2174518|NCT01355289|3798045|FG004|Core Study|Adverse Event, Non-Fatal|0
2174519|NCT01355289|3798041|FG000|Core Study|Inadequate Therapeutic Effect|0
2174520|NCT01355289|3798042|FG001|Core Study|Inadequate Therapeutic Effect|0
2174521|NCT01355289|3798043|FG002|Core Study|Inadequate Therapeutic Effect|0
2174522|NCT01355289|3798044|FG003|Core Study|Inadequate Therapeutic Effect|1
2174523|NCT01355289|3798045|FG004|Core Study|Inadequate Therapeutic Effect|0
2174524|NCT01355289|3798041|FG000|Core Study|Other|0
2174525|NCT01355289|3798042|FG001|Core Study|Other|0
2174526|NCT01355289|3798043|FG002|Core Study|Other|0
2174527|NCT01355289|3798044|FG003|Core Study|Other|1
2174528|NCT01355289|3798045|FG004|Core Study|Other|0
2174529|NCT01355289|3798041|FG000|Open Label Extension|Adverse Event, Non-Fatal|0
2174530|NCT01355289|3798042|FG001|Open Label Extension|Adverse Event, Non-Fatal|0
2174531|NCT01355289|3798043|FG002|Open Label Extension|Adverse Event, Non-Fatal|0
2174532|NCT01355289|3798044|FG003|Open Label Extension|Adverse Event, Non-Fatal|0
2174533|NCT01355289|3798045|FG004|Open Label Extension|Adverse Event, Non-Fatal|1
2174534|NCT01355289|3798041|FG000|Open Label Extension|Lost to Follow-up|0
2174535|NCT01355289|3798042|FG001|Open Label Extension|Lost to Follow-up|0
2174536|NCT01355289|3798043|FG002|Open Label Extension|Lost to Follow-up|0
2174537|NCT01355289|3798044|FG003|Open Label Extension|Lost to Follow-up|0
2174538|NCT01355289|3798045|FG004|Open Label Extension|Lost to Follow-up|1
2174539|NCT01355289|3798041|FG000|Open Label Extension|Inadequate Therapeutic Effect|0
2174540|NCT01355289|3798042|FG001|Open Label Extension|Inadequate Therapeutic Effect|0
2174541|NCT01355289|3798043|FG002|Open Label Extension|Inadequate Therapeutic Effect|0
2174542|NCT01355289|3798044|FG003|Open Label Extension|Inadequate Therapeutic Effect|0
2174543|NCT01355289|3798045|FG004|Open Label Extension|Inadequate Therapeutic Effect|29
2174544|NCT01355289|3798041|FG000|Open Label Extension|Other|0
2174545|NCT01355289|3798042|FG001|Open Label Extension|Other|0
2174546|NCT01355289|3798043|FG002|Open Label Extension|Other|0
2174547|NCT01355289|3798044|FG003|Open Label Extension|Other|0
2174548|NCT01355289|3798045|FG004|Open Label Extension|Other|3
2174549|NCT01355302|3798058|FG000|Phase 1b|Death|4
2174550|NCT01355302|3798059|FG001|Phase 1b|Death|0
2174551|NCT01355302|3798060|FG002|Phase 1b|Death|0
2174552|NCT01355302|3798058|FG000|Phase 1b|Study terminated by sponsor|2
2174553|NCT01355302|3798059|FG001|Phase 1b|Study terminated by sponsor|0
2174554|NCT01355302|3798060|FG002|Phase 1b|Study terminated by sponsor|0
2174555|NCT01355497|3798101|FG000|Overall Study|Death|19
2174556|NCT01355497|3798102|FG001|Overall Study|Death|18
2174557|NCT01355497|3798101|FG000|Overall Study|Lost to Follow-up|3
2174558|NCT01355497|3798102|FG001|Overall Study|Lost to Follow-up|0
2174559|NCT01355497|3798101|FG000|Overall Study|Protocol Violation|0
2174560|NCT01355497|3798102|FG001|Overall Study|Protocol Violation|1
2174561|NCT01355497|3798101|FG000|Overall Study|other-not provided|9
2174562|NCT01355497|3798102|FG001|Overall Study|other-not provided|4
2174563|NCT01355497|3798101|FG000|Overall Study|Withdrawal by Subject|12
2174564|NCT01355497|3798102|FG001|Overall Study|Withdrawal by Subject|20
2174565|NCT01355497|3798101|FG000|Overall Study|noncompliance|1
2174566|NCT01355497|3798102|FG001|Overall Study|noncompliance|2
2174567|NCT01355497|3798101|FG000|Overall Study|progressive disease|11
2174568|NCT01355497|3798102|FG001|Overall Study|progressive disease|8
2174569|NCT01355497|3798101|FG000|Overall Study|Adverse Event|11
2174570|NCT01355497|3798102|FG001|Overall Study|Adverse Event|10
2174571|NCT01355523|3798110|FG000|Overall Study|Withdrawal by Subject|1
2174572|NCT01355523|3798111|FG001|Overall Study|Withdrawal by Subject|4
2174573|NCT01355523|3798110|FG000|Overall Study|Lost to Follow-up|0
2174574|NCT01355523|3798111|FG001|Overall Study|Lost to Follow-up|2
2174575|NCT01355523|3798110|FG000|Overall Study|Protocol Violation|0
2174576|NCT01355523|3798111|FG001|Overall Study|Protocol Violation|2
2174577|NCT01355523|3798110|FG000|Overall Study|Adverse Event|0
2174578|NCT01355523|3798111|FG001|Overall Study|Adverse Event|2
2174579|NCT01355575|3798117|FG000|Overall Study|Withdrawal by Subject|2
2174580|NCT01355627|3798144|FG000|Overall Study|Request By the Patient to Discontinue|5
2174581|NCT01355627|3798145|FG001|Overall Study|Request By the Patient to Discontinue|7
2174582|NCT01355627|3798144|FG000|Overall Study|Lost to Follow-up|8
2174583|NCT01355627|3798145|FG001|Overall Study|Lost to Follow-up|7
2174584|NCT01355627|3798144|FG000|Overall Study|Fatal Adverse Event|19
2174585|NCT01355627|3798145|FG001|Overall Study|Fatal Adverse Event|23
2174586|NCT01355627|3798144|FG000|Overall Study|Other|1
2174587|NCT01355627|3798145|FG001|Overall Study|Other|1
2174588|NCT01355679|3798151|FG000|Overall Study|benign tumor types found at biopsy|2
2174589|NCT01356407|3798194|FG000|Overall Study|Lost to Follow-up|2
2174590|NCT01356407|3798195|FG001|Overall Study|Lost to Follow-up|0
2174591|NCT01356407|3798194|FG000|Overall Study|Patient Withdrew Consent|2
2174592|NCT01356407|3798195|FG001|Overall Study|Patient Withdrew Consent|1
2174593|NCT01356407|3798194|FG000|Overall Study|Could not afford IMP administration|0
2174594|NCT01356407|3798195|FG001|Overall Study|Could not afford IMP administration|1
2174595|NCT01356407|3798194|FG000|Overall Study|Not complete Endoscopy|2
2174596|NCT01356407|3798195|FG001|Overall Study|Not complete Endoscopy|2
2174597|NCT01356589|3798232|FG000|Overall Study|Enrolled, but not treated|3
2174598|NCT01356589|3798232|FG000|Overall Study|Dose data not recorded|2
2174599|NCT01356602|3798239|FG000|Overall Study|Protocol Deviation|0
2174600|NCT01356602|3798240|FG001|Overall Study|Protocol Deviation|1
2174601|NCT01356602|3798241|FG002|Overall Study|Protocol Deviation|1
2174602|NCT01356602|3798239|FG000|Overall Study|Administrative Problems|1
2174603|NCT01356602|3798240|FG001|Overall Study|Administrative Problems|4
2174604|NCT01356602|3798241|FG002|Overall Study|Administrative Problems|5
2174605|NCT01356602|3798239|FG000|Overall Study|Lost to Follow-up|4
2174606|NCT01356602|3798240|FG001|Overall Study|Lost to Follow-up|5
2174607|NCT01356602|3798241|FG002|Overall Study|Lost to Follow-up|6
2174608|NCT01356602|3798239|FG000|Overall Study|Withdrawal by Subject|4
2174609|NCT01356602|3798240|FG001|Overall Study|Withdrawal by Subject|3
2174610|NCT01356602|3798241|FG002|Overall Study|Withdrawal by Subject|7
2174611|NCT01356602|3798239|FG000|Overall Study|Lack of Efficacy|0
2174612|NCT01356602|3798240|FG001|Overall Study|Lack of Efficacy|1
2174613|NCT01356602|3798241|FG002|Overall Study|Lack of Efficacy|4
2174614|NCT01356602|3798239|FG000|Overall Study|Adverse Event|0
2174615|NCT01356602|3798240|FG001|Overall Study|Adverse Event|1
2174616|NCT01356602|3798241|FG002|Overall Study|Adverse Event|1
2174617|NCT01356940|3798255|FG000|First Intervention (28 Days)|Adverse Event|1
2174618|NCT01356940|3798256|FG001|First Intervention (28 Days)|Adverse Event|0
2174619|NCT01356940|3798255|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1
2174620|NCT01356940|3798256|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0
2174621|NCT01356966|3798266|FG000|Overall Study|Withdrawal by Subject|1
2174622|NCT01356966|3798267|FG001|Overall Study|Withdrawal by Subject|2
2174623|NCT01356966|3798266|FG000|Overall Study|Physician Decision|1
2174624|NCT01356966|3798267|FG001|Overall Study|Physician Decision|0
2174625|NCT01357161|3798293|FG000|Part 1 (Open Label Run-in)|Death|5
2174626|NCT01357161|3798294|FG001|Part 1 (Open Label Run-in)|Death|0
2174627|NCT01357161|3798295|FG002|Part 1 (Open Label Run-in)|Death|0
2174628|NCT01357161|3798293|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3
2174629|NCT01357161|3798294|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0
2174630|NCT01357161|3798295|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0
2174631|NCT01357161|3798293|FG000|Part 1 (Open Label Run-in)|Physician Decision|1
2174632|NCT01357161|3798294|FG001|Part 1 (Open Label Run-in)|Physician Decision|0
2174633|NCT01357161|3798295|FG002|Part 1 (Open Label Run-in)|Physician Decision|0
2174634|NCT01357161|3798293|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
2174635|NCT01357161|3798294|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
2174636|NCT01357161|3798295|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
2174637|NCT01357161|3798293|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
2174638|NCT01357161|3798294|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
2174639|NCT01357161|3798295|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
2174640|NCT01357161|3798293|FG000|Part 2 (Double-Blind Comparison)|Death|0
2174641|NCT01357161|3798294|FG001|Part 2 (Double-Blind Comparison)|Death|22
2174642|NCT01357161|3798295|FG002|Part 2 (Double-Blind Comparison)|Death|19
2174643|NCT01357161|3798293|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
2174644|NCT01357161|3798294|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
2174645|NCT01357161|3798295|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
2174646|NCT01357161|3798293|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0
2174647|NCT01357161|3798294|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1
2174648|NCT01357161|3798295|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4
2174649|NCT01357161|3798293|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0
2174650|NCT01357161|3798294|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1
2174651|NCT01357161|3798295|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3
2174652|NCT01357161|3798293|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
2174653|NCT01357161|3798294|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
2174654|NCT01357161|3798295|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
2174655|NCT01357161|3798293|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
2174656|NCT01357161|3798294|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
2174657|NCT01357161|3798295|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
2174658|NCT01357239|3798307|FG000|Stratum: All Patients|Adverse Event|0
2174659|NCT01357239|3798308|FG001|Stratum: All Patients|Adverse Event|0
2174660|NCT01357239|3798309|FG002|Stratum: All Patients|Adverse Event|1
2174661|NCT01357239|3798310|FG003|Stratum: All Patients|Adverse Event|1
2174662|NCT01357239|3798307|FG000|Stratum: All Patients|Subject withdrew consent|0
2174663|NCT01357239|3798308|FG001|Stratum: All Patients|Subject withdrew consent|0
2174664|NCT01357239|3798309|FG002|Stratum: All Patients|Subject withdrew consent|1
2174665|NCT01357239|3798310|FG003|Stratum: All Patients|Subject withdrew consent|1
2174666|NCT01357239|3798307|FG000|Stratum I: Fully-Methylated|Adverse Event|0
2174667|NCT01357239|3798308|FG001|Stratum I: Fully-Methylated|Adverse Event|0
2174668|NCT01357239|3798309|FG002|Stratum I: Fully-Methylated|Adverse Event|1
2174669|NCT01357239|3798310|FG003|Stratum I: Fully-Methylated|Adverse Event|0
2174670|NCT01357239|3798307|FG000|Stratum II: Partially-Methylated|Adverse Event|0
2174671|NCT01357239|3798308|FG001|Stratum II: Partially-Methylated|Adverse Event|0
2174672|NCT01357239|3798309|FG002|Stratum II: Partially-Methylated|Adverse Event|0
2174673|NCT01357239|3798310|FG003|Stratum II: Partially-Methylated|Adverse Event|1
2174674|NCT01357239|3798307|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0
2174675|NCT01357239|3798308|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0
2174676|NCT01357239|3798309|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1
2174677|NCT01357239|3798310|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1
2174678|NCT01357551|3798357|FG000|Overall Study|Withdrawal by Subject|6
2174679|NCT01357551|3798358|FG001|Overall Study|Withdrawal by Subject|4
2174680|NCT01357551|3798357|FG000|Overall Study|Death|0
2174681|NCT01357551|3798358|FG001|Overall Study|Death|1
2174682|NCT01357551|3798357|FG000|Overall Study|Lost to Follow-up|16
2174683|NCT01357551|3798358|FG001|Overall Study|Lost to Follow-up|6
2174684|NCT01357577|3798380|FG000|Overall Study|Lost to Follow-up|20
2174685|NCT01357577|3798381|FG001|Overall Study|Lost to Follow-up|16
2174686|NCT01357577|3798380|FG000|Overall Study|Withdrawal by Subject|16
2174687|NCT01357577|3798381|FG001|Overall Study|Withdrawal by Subject|8
2174688|NCT01357577|3798380|FG000|Overall Study|look at data in database?|1
2174689|NCT01357577|3798381|FG001|Overall Study|look at data in database?|2
2174690|NCT01357616|3798390|FG000|Overall Study|Adverse Event|1
2174691|NCT01357616|3798391|FG001|Overall Study|Adverse Event|1
2174692|NCT01357616|3798390|FG000|Overall Study|Lost to Follow-up|4
2174693|NCT01357616|3798391|FG001|Overall Study|Lost to Follow-up|3
2174694|NCT01357616|3798390|FG000|Overall Study|Protocol Violation|0
2174695|NCT01357616|3798391|FG001|Overall Study|Protocol Violation|2
2174696|NCT01357616|3798390|FG000|Overall Study|Inadequate Control of IOP|1
2174697|NCT01357616|3798391|FG001|Overall Study|Inadequate Control of IOP|2
2174698|NCT01357616|3798390|FG000|Overall Study|Decision Unrelated to Adverse Event|3
2174699|NCT01357616|3798391|FG001|Overall Study|Decision Unrelated to Adverse Event|1
2174700|NCT01357616|3798390|FG000|Overall Study|Withdrawal by Subject|1
2174701|NCT01357616|3798391|FG001|Overall Study|Withdrawal by Subject|0
2174702|NCT01357655|3798399|FG000|Overall Study|Administrative Reason by Sponsor|45
2174703|NCT01357655|3798400|FG001|Overall Study|Administrative Reason by Sponsor|0
2174704|NCT01357655|3798399|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3
2174705|NCT01357655|3798400|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0
2174706|NCT01357655|3798399|FG000|Overall Study|Disease Progression|1
2174707|NCT01357655|3798400|FG001|Overall Study|Disease Progression|0
2174708|NCT01357655|3798399|FG000|Overall Study|Lost to Follow-up|2
2174709|NCT01357655|3798400|FG001|Overall Study|Lost to Follow-up|0
2174710|NCT01357655|3798399|FG000|Overall Study|Maximum Clinical Benefit|2
2174711|NCT01357655|3798400|FG001|Overall Study|Maximum Clinical Benefit|0
2296800|NCT02561195|3992969|FG005|Vaccination 1 to 3|Adverse Event|0
2296801|NCT02561195|3992970|FG006|Vaccination 1 to 3|Adverse Event|0
2296802|NCT02561195|3992971|FG007|Vaccination 1 to 3|Adverse Event|0
2296803|NCT02561195|3992972|FG008|Vaccination 1 to 3|Adverse Event|0
2296804|NCT02561195|3992973|FG009|Vaccination 1 to 3|Adverse Event|0
2296805|NCT02561195|3992974|FG010|Vaccination 1 to 3|Adverse Event|0
2296806|NCT02561195|3992975|FG011|Vaccination 1 to 3|Adverse Event|0
2296807|NCT02561195|3992976|FG012|Vaccination 1 to 3|Adverse Event|0
2296808|NCT02561195|3992977|FG013|Vaccination 1 to 3|Adverse Event|0
2296809|NCT02561195|3992964|FG000|Vaccination 1 to 3|Lost to Follow-up|3
2296810|NCT02561195|3992965|FG001|Vaccination 1 to 3|Lost to Follow-up|4
2296811|NCT02561195|3992966|FG002|Vaccination 1 to 3|Lost to Follow-up|0
2296812|NCT02561195|3992967|FG003|Vaccination 1 to 3|Lost to Follow-up|2
2296813|NCT02561195|3992968|FG004|Vaccination 1 to 3|Lost to Follow-up|3
2296814|NCT02561195|3992969|FG005|Vaccination 1 to 3|Lost to Follow-up|3
2296815|NCT02561195|3992970|FG006|Vaccination 1 to 3|Lost to Follow-up|0
2296816|NCT02561195|3992971|FG007|Vaccination 1 to 3|Lost to Follow-up|0
2296817|NCT02561195|3992972|FG008|Vaccination 1 to 3|Lost to Follow-up|0
2296818|NCT02561195|3992973|FG009|Vaccination 1 to 3|Lost to Follow-up|0
2296819|NCT02561195|3992974|FG010|Vaccination 1 to 3|Lost to Follow-up|0
2174712|NCT01357655|3798399|FG000|Overall Study|Reason Unspecified|1
2174713|NCT01357655|3798400|FG001|Overall Study|Reason Unspecified|0
2174714|NCT01357655|3798399|FG000|Overall Study|Study Drug Toxicity|11
2174715|NCT01357655|3798400|FG001|Overall Study|Study Drug Toxicity|0
2174716|NCT01357655|3798399|FG000|Overall Study|Subject Withdrew Consent|1
2174717|NCT01357655|3798400|FG001|Overall Study|Subject Withdrew Consent|0
2174718|NCT01357850|3798418|FG000|Overall Study|Lost to Follow-up|1
2174719|NCT01357850|3798419|FG001|Overall Study|Lost to Follow-up|0
2174720|NCT01357850|3798420|FG002|Overall Study|Lost to Follow-up|0
2174721|NCT01357850|3798421|FG003|Overall Study|Lost to Follow-up|0
2174722|NCT01357889|3798434|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
2174723|NCT01357889|3798435|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
2174724|NCT01357889|3798434|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
2174725|NCT01357889|3798435|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
2174726|NCT01357889|3798434|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
2174727|NCT01357889|3798435|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
2174728|NCT01357889|3798434|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
2296820|NCT02561195|3992975|FG011|Vaccination 1 to 3|Lost to Follow-up|0
2296821|NCT02561195|3992976|FG012|Vaccination 1 to 3|Lost to Follow-up|0
2296822|NCT02561195|3992977|FG013|Vaccination 1 to 3|Lost to Follow-up|0
2296823|NCT02561195|3992964|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0
2296824|NCT02561195|3992965|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1
2174729|NCT01357889|3798435|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
2174730|NCT01357889|3798434|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
2174731|NCT01357889|3798435|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
2174732|NCT01357889|3798434|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
2174733|NCT01357889|3798435|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
2174734|NCT01357889|3798434|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
2174735|NCT01357889|3798435|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
2174736|NCT01357889|3798434|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
2174737|NCT01357889|3798435|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
2174738|NCT01357889|3798434|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
2174739|NCT01357889|3798435|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
2174740|NCT01357889|3798434|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
2174741|NCT01357889|3798435|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
2174742|NCT01357889|3798434|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
2174743|NCT01357889|3798435|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
2174744|NCT01357889|3798434|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
2174745|NCT01357889|3798435|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
2174746|NCT01357889|3798434|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
2174747|NCT01357889|3798435|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
2174748|NCT01357915|3798445|FG000|Overall Study|Lost to Follow-up|3
2174749|NCT01357915|3798446|FG001|Overall Study|Lost to Follow-up|0
2174750|NCT01357980|3798456|FG000|Overall Study|Lack of Efficacy|0
2174751|NCT01357980|3798457|FG001|Overall Study|Lack of Efficacy|1
2174752|NCT01357980|3798458|FG002|Overall Study|Lack of Efficacy|0
2174753|NCT01357980|3798459|FG003|Overall Study|Lack of Efficacy|0
2174754|NCT01357980|3798456|FG000|Overall Study|Consent withdrawn|0
2174755|NCT01357980|3798457|FG001|Overall Study|Consent withdrawn|0
2174756|NCT01357980|3798458|FG002|Overall Study|Consent withdrawn|1
2174757|NCT01357980|3798459|FG003|Overall Study|Consent withdrawn|0
2174758|NCT01358175|3798472|FG000|Overall Study|Death|1
2174759|NCT01358175|3798473|FG001|Overall Study|Death|0
2174760|NCT01358175|3798474|FG002|Overall Study|Death|1
2174761|NCT01358175|3798472|FG000|Overall Study|Withdrawal by Subject|9
2174762|NCT01358175|3798473|FG001|Overall Study|Withdrawal by Subject|5
2174763|NCT01358175|3798474|FG002|Overall Study|Withdrawal by Subject|10
2174764|NCT01358175|3798472|FG000|Overall Study|Technical issues|0
2174765|NCT01358175|3798473|FG001|Overall Study|Technical issues|1
2174766|NCT01358175|3798474|FG002|Overall Study|Technical issues|0
2174767|NCT01358175|3798472|FG000|Overall Study|Pregnancy|0
2174768|NCT01358175|3798473|FG001|Overall Study|Pregnancy|1
2174769|NCT01358175|3798474|FG002|Overall Study|Pregnancy|0
2174770|NCT01358175|3798472|FG000|Overall Study|Physician Decision|1
2174771|NCT01358175|3798473|FG001|Overall Study|Physician Decision|0
2174772|NCT01358175|3798474|FG002|Overall Study|Physician Decision|0
2174773|NCT01358175|3798472|FG000|Overall Study|Non Compliance with Study Treatment|0
2208278|NCT01638013|3847743|FG000|Overall Study|Adverse Event|36
2208279|NCT01638013|3847744|FG001|Overall Study|Adverse Event|29
2208280|NCT01638013|3847745|FG002|Overall Study|Adverse Event|48
2208281|NCT01638013|3847743|FG000|Overall Study|Lack of Efficacy|39
2174774|NCT01358175|3798473|FG001|Overall Study|Non Compliance with Study Treatment|1
2174775|NCT01358175|3798474|FG002|Overall Study|Non Compliance with Study Treatment|1
2174776|NCT01358175|3798472|FG000|Overall Study|Lost to Follow-up|1
2174777|NCT01358175|3798473|FG001|Overall Study|Lost to Follow-up|1
2174778|NCT01358175|3798474|FG002|Overall Study|Lost to Follow-up|3
2174779|NCT01358175|3798472|FG000|Overall Study|Lack of Efficacy|3
2174780|NCT01358175|3798473|FG001|Overall Study|Lack of Efficacy|8
2174781|NCT01358175|3798474|FG002|Overall Study|Lack of Efficacy|6
2174782|NCT01358175|3798472|FG000|Overall Study|Adverse Event|6
2174783|NCT01358175|3798473|FG001|Overall Study|Adverse Event|11
2174784|NCT01358175|3798474|FG002|Overall Study|Adverse Event|11
2174785|NCT01358331|3798506|FG000|Overall Study|Lost to Follow-up|0
2174786|NCT01358331|3798507|FG001|Overall Study|Lost to Follow-up|0
2174787|NCT01358331|3798508|FG002|Overall Study|Lost to Follow-up|0
2174788|NCT01358331|3798509|FG003|Overall Study|Lost to Follow-up|1
2174789|NCT01358331|3798510|FG004|Overall Study|Lost to Follow-up|0
2174790|NCT01358331|3798511|FG005|Overall Study|Lost to Follow-up|0
2174791|NCT01358331|3798506|FG000|Overall Study|Withdrawal by Subject|0
2174792|NCT01358331|3798507|FG001|Overall Study|Withdrawal by Subject|0
2174793|NCT01358331|3798508|FG002|Overall Study|Withdrawal by Subject|0
2174794|NCT01358331|3798509|FG003|Overall Study|Withdrawal by Subject|1
2174795|NCT01358331|3798510|FG004|Overall Study|Withdrawal by Subject|1
2174796|NCT01358331|3798511|FG005|Overall Study|Withdrawal by Subject|1
2174797|NCT01358331|3798506|FG000|Overall Study|Adverse Events|1
2174798|NCT01358331|3798507|FG001|Overall Study|Adverse Events|1
2174799|NCT01358331|3798508|FG002|Overall Study|Adverse Events|1
2174800|NCT01358331|3798509|FG003|Overall Study|Adverse Events|0
2174801|NCT01358331|3798510|FG004|Overall Study|Adverse Events|1
2174802|NCT01358331|3798511|FG005|Overall Study|Adverse Events|5
2174803|NCT01358331|3798506|FG000|Overall Study|Symptomatic Deterioration|0
2174804|NCT01358331|3798507|FG001|Overall Study|Symptomatic Deterioration|0
2174805|NCT01358331|3798508|FG002|Overall Study|Symptomatic Deterioration|0
2174806|NCT01358331|3798509|FG003|Overall Study|Symptomatic Deterioration|0
2174807|NCT01358331|3798510|FG004|Overall Study|Symptomatic Deterioration|1
2174808|NCT01358331|3798511|FG005|Overall Study|Symptomatic Deterioration|0
2174809|NCT01358331|3798506|FG000|Overall Study|Participants did not wish to continue|0
2174810|NCT01358331|3798507|FG001|Overall Study|Participants did not wish to continue|0
2174811|NCT01358331|3798508|FG002|Overall Study|Participants did not wish to continue|0
2174812|NCT01358331|3798509|FG003|Overall Study|Participants did not wish to continue|0
2174813|NCT01358331|3798510|FG004|Overall Study|Participants did not wish to continue|1
2174814|NCT01358331|3798511|FG005|Overall Study|Participants did not wish to continue|0
2174815|NCT01358331|3798506|FG000|Overall Study|Progress of disease under investigation|1
2174816|NCT01358331|3798507|FG001|Overall Study|Progress of disease under investigation|2
2174817|NCT01358331|3798508|FG002|Overall Study|Progress of disease under investigation|3
2174818|NCT01358331|3798509|FG003|Overall Study|Progress of disease under investigation|1
2174819|NCT01358331|3798510|FG004|Overall Study|Progress of disease under investigation|3
2174820|NCT01358331|3798511|FG005|Overall Study|Progress of disease under investigation|0
2174821|NCT01358357|3798527|FG000|Open Label Phase|Adverse Event|0
2174822|NCT01358357|3798528|FG001|Open Label Phase|Adverse Event|0
2174823|NCT01358357|3798529|FG002|Open Label Phase|Adverse Event|59
2174824|NCT01358357|3798527|FG000|Open Label Phase|Lack of Efficacy|0
2174825|NCT01358357|3798528|FG001|Open Label Phase|Lack of Efficacy|0
2174826|NCT01358357|3798529|FG002|Open Label Phase|Lack of Efficacy|107
2174827|NCT01358357|3798527|FG000|Open Label Phase|Lost to Follow-up|0
2174828|NCT01358357|3798528|FG001|Open Label Phase|Lost to Follow-up|0
2174829|NCT01358357|3798529|FG002|Open Label Phase|Lost to Follow-up|76
2296825|NCT02561195|3992966|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0
2296826|NCT02561195|3992967|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4
2296827|NCT02561195|3992968|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4
2296828|NCT02561195|3992969|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1
2296829|NCT02561195|3992970|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0
2296830|NCT02561195|3992971|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0
2296831|NCT02561195|3992972|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0
2296832|NCT02561195|3992973|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0
2296833|NCT02561195|3992974|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0
2296834|NCT02561195|3992975|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0
2296835|NCT02561195|3992976|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0
2296836|NCT02561195|3992977|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0
2296837|NCT02561195|3992964|FG000|Vaccination 1 to 3|No longer willing to participate|2
2296838|NCT02561195|3992965|FG001|Vaccination 1 to 3|No longer willing to participate|4
2296839|NCT02561195|3992966|FG002|Vaccination 1 to 3|No longer willing to participate|0
2296840|NCT02561195|3992967|FG003|Vaccination 1 to 3|No longer willing to participate|4
2296841|NCT02561195|3992968|FG004|Vaccination 1 to 3|No longer willing to participate|1
2296842|NCT02561195|3992969|FG005|Vaccination 1 to 3|No longer willing to participate|3
2296843|NCT02561195|3992970|FG006|Vaccination 1 to 3|No longer willing to participate|0
2296844|NCT02561195|3992971|FG007|Vaccination 1 to 3|No longer willing to participate|0
2296845|NCT02561195|3992972|FG008|Vaccination 1 to 3|No longer willing to participate|0
2296846|NCT02561195|3992973|FG009|Vaccination 1 to 3|No longer willing to participate|0
2296847|NCT02561195|3992974|FG010|Vaccination 1 to 3|No longer willing to participate|0
2296848|NCT02561195|3992975|FG011|Vaccination 1 to 3|No longer willing to participate|0
2296849|NCT02561195|3992976|FG012|Vaccination 1 to 3|No longer willing to participate|0
2296850|NCT02561195|3992977|FG013|Vaccination 1 to 3|No longer willing to participate|0
2296851|NCT02561195|3992964|FG000|Vaccination 1 to 3|Other|7
2296852|NCT02561195|3992965|FG001|Vaccination 1 to 3|Other|3
2296853|NCT02561195|3992966|FG002|Vaccination 1 to 3|Other|1
2296854|NCT02561195|3992967|FG003|Vaccination 1 to 3|Other|7
2296855|NCT02561195|3992968|FG004|Vaccination 1 to 3|Other|5
2296856|NCT02561195|3992969|FG005|Vaccination 1 to 3|Other|1
2296857|NCT02561195|3992970|FG006|Vaccination 1 to 3|Other|0
2296858|NCT02561195|3992971|FG007|Vaccination 1 to 3|Other|0
2296859|NCT02561195|3992972|FG008|Vaccination 1 to 3|Other|0
2296860|NCT02561195|3992973|FG009|Vaccination 1 to 3|Other|0
2296861|NCT02561195|3992974|FG010|Vaccination 1 to 3|Other|0
2296862|NCT02561195|3992975|FG011|Vaccination 1 to 3|Other|0
2296863|NCT02561195|3992976|FG012|Vaccination 1 to 3|Other|0
2296864|NCT02561195|3992977|FG013|Vaccination 1 to 3|Other|0
2296865|NCT02561195|3992964|FG000|Vaccination 1 to 3|Protocol Violation|1
2296866|NCT02561195|3992965|FG001|Vaccination 1 to 3|Protocol Violation|0
2296867|NCT02561195|3992966|FG002|Vaccination 1 to 3|Protocol Violation|1
2296868|NCT02561195|3992967|FG003|Vaccination 1 to 3|Protocol Violation|2
2296869|NCT02561195|3992968|FG004|Vaccination 1 to 3|Protocol Violation|5
2296870|NCT02561195|3992969|FG005|Vaccination 1 to 3|Protocol Violation|2
2296871|NCT02561195|3992970|FG006|Vaccination 1 to 3|Protocol Violation|0
2296872|NCT02561195|3992971|FG007|Vaccination 1 to 3|Protocol Violation|0
2296873|NCT02561195|3992972|FG008|Vaccination 1 to 3|Protocol Violation|0
2296874|NCT02561195|3992973|FG009|Vaccination 1 to 3|Protocol Violation|0
2296875|NCT02561195|3992974|FG010|Vaccination 1 to 3|Protocol Violation|0
2296876|NCT02561195|3992975|FG011|Vaccination 1 to 3|Protocol Violation|0
2296877|NCT02561195|3992976|FG012|Vaccination 1 to 3|Protocol Violation|0
2296878|NCT02561195|3992977|FG013|Vaccination 1 to 3|Protocol Violation|0
2296879|NCT02561195|3992964|FG000|Vaccination 1 to 3|Death|2
2296880|NCT02561195|3992965|FG001|Vaccination 1 to 3|Death|1
2296881|NCT02561195|3992966|FG002|Vaccination 1 to 3|Death|0
2174830|NCT01358357|3798527|FG000|Open Label Phase|Protocol Violation|0
2174831|NCT01358357|3798528|FG001|Open Label Phase|Protocol Violation|0
2174832|NCT01358357|3798529|FG002|Open Label Phase|Protocol Violation|45
2174833|NCT01358357|3798527|FG000|Open Label Phase|Withdrawal by Subject|0
2174834|NCT01358357|3798528|FG001|Open Label Phase|Withdrawal by Subject|0
2174835|NCT01358357|3798529|FG002|Open Label Phase|Withdrawal by Subject|112
2174836|NCT01358357|3798527|FG000|Open Label Phase|Did not meet criteria for DB phase|0
2174837|NCT01358357|3798528|FG001|Open Label Phase|Did not meet criteria for DB phase|0
2174838|NCT01358357|3798529|FG002|Open Label Phase|Did not meet criteria for DB phase|16
2174839|NCT01358357|3798527|FG000|Open Label Phase|Terminated at study completion|0
2174840|NCT01358357|3798528|FG001|Open Label Phase|Terminated at study completion|0
2174841|NCT01358357|3798529|FG002|Open Label Phase|Terminated at study completion|5
2174842|NCT01358357|3798527|FG000|Open Label Phase|Mood episode|0
2174843|NCT01358357|3798528|FG001|Open Label Phase|Mood episode|0
2174844|NCT01358357|3798529|FG002|Open Label Phase|Mood episode|42
2174845|NCT01358357|3798527|FG000|Double-Blind Phase|Adverse Event|8
2174846|NCT01358357|3798528|FG001|Double-Blind Phase|Adverse Event|5
2174847|NCT01358357|3798529|FG002|Double-Blind Phase|Adverse Event|0
2174848|NCT01358357|3798527|FG000|Double-Blind Phase|Lost to Follow-up|5
2174849|NCT01358357|3798528|FG001|Double-Blind Phase|Lost to Follow-up|7
2174850|NCT01358357|3798529|FG002|Double-Blind Phase|Lost to Follow-up|0
2174851|NCT01358357|3798527|FG000|Double-Blind Phase|Protocol Violation|1
2174852|NCT01358357|3798528|FG001|Double-Blind Phase|Protocol Violation|11
2174853|NCT01358357|3798529|FG002|Double-Blind Phase|Protocol Violation|0
2174854|NCT01358357|3798527|FG000|Double-Blind Phase|Protocol Violation|16
2174855|NCT01358357|3798528|FG001|Double-Blind Phase|Protocol Violation|12
2174856|NCT01358357|3798529|FG002|Double-Blind Phase|Protocol Violation|0
2174857|NCT01358357|3798527|FG000|Double-Blind Phase|Terminated at study completion|2
2174858|NCT01358357|3798528|FG001|Double-Blind Phase|Terminated at study completion|0
2174859|NCT01358357|3798529|FG002|Double-Blind Phase|Terminated at study completion|0
2174860|NCT01358357|3798527|FG000|Double-Blind Phase|Recurrence of mood event|48
2174861|NCT01358357|3798528|FG001|Double-Blind Phase|Recurrence of mood event|64
2174862|NCT01358357|3798529|FG002|Double-Blind Phase|Recurrence of mood event|0
2174863|NCT01358357|3798527|FG000|Double-Blind Phase|Administrative|0
2174864|NCT01358357|3798528|FG001|Double-Blind Phase|Administrative|1
2174865|NCT01358357|3798529|FG002|Double-Blind Phase|Administrative|0
2179955|NCT01397409|3805795|FG003|Stage 2|Other Miscellaneous Reasons|0
2179956|NCT01397409|3805796|FG004|Stage 2|Other Miscellaneous Reasons|1
2179957|NCT01397409|3805797|FG005|Stage 2|Other Miscellaneous Reasons|1
2179958|NCT01397409|3805798|FG006|Stage 2|Other Miscellaneous Reasons|0
2179959|NCT01397409|3805799|FG007|Stage 2|Other Miscellaneous Reasons|0
2179960|NCT01397409|3805800|FG008|Stage 2|Other Miscellaneous Reasons|0
2179961|NCT01397409|3805801|FG009|Stage 2|Other Miscellaneous Reasons|0
2179962|NCT01397409|3805792|FG000|Stage 3|Adverse Event|0
2179963|NCT01397409|3805793|FG001|Stage 3|Adverse Event|0
2179964|NCT01397409|3805794|FG002|Stage 3|Adverse Event|0
2179965|NCT01397409|3805795|FG003|Stage 3|Adverse Event|0
2179966|NCT01397409|3805796|FG004|Stage 3|Adverse Event|0
2179967|NCT01397409|3805797|FG005|Stage 3|Adverse Event|0
2179968|NCT01397409|3805798|FG006|Stage 3|Adverse Event|0
2179969|NCT01397409|3805799|FG007|Stage 3|Adverse Event|1
2179970|NCT01397409|3805800|FG008|Stage 3|Adverse Event|0
2179971|NCT01397409|3805801|FG009|Stage 3|Adverse Event|0
2179972|NCT01397409|3805792|FG000|Stage 3|Other Miscellaneous Reasons|0
2179973|NCT01397409|3805793|FG001|Stage 3|Other Miscellaneous Reasons|0
2179974|NCT01397409|3805794|FG002|Stage 3|Other Miscellaneous Reasons|0
2179975|NCT01397409|3805795|FG003|Stage 3|Other Miscellaneous Reasons|0
2179976|NCT01397409|3805796|FG004|Stage 3|Other Miscellaneous Reasons|0
2179977|NCT01397409|3805797|FG005|Stage 3|Other Miscellaneous Reasons|0
2179978|NCT01397409|3805798|FG006|Stage 3|Other Miscellaneous Reasons|0
2179979|NCT01397409|3805799|FG007|Stage 3|Other Miscellaneous Reasons|1
2179980|NCT01397409|3805800|FG008|Stage 3|Other Miscellaneous Reasons|0
2179981|NCT01397409|3805801|FG009|Stage 3|Other Miscellaneous Reasons|0
2179982|NCT01397422|3805828|FG000|Overall Study|Adverse Event|0
2179983|NCT01397422|3805829|FG001|Overall Study|Adverse Event|3
2179984|NCT01397422|3805830|FG002|Overall Study|Adverse Event|3
2179985|NCT01397422|3805831|FG003|Overall Study|Adverse Event|8
2179986|NCT01397422|3805828|FG000|Overall Study|Withdrawal by Subject|1
2179987|NCT01397422|3805829|FG001|Overall Study|Withdrawal by Subject|0
2179988|NCT01397422|3805830|FG002|Overall Study|Withdrawal by Subject|0
2179989|NCT01397422|3805831|FG003|Overall Study|Withdrawal by Subject|0
2179990|NCT01397422|3805828|FG000|Overall Study|Increased bradykinesia related to PD|1
2179991|NCT01397422|3805829|FG001|Overall Study|Increased bradykinesia related to PD|0
2179992|NCT01397422|3805830|FG002|Overall Study|Increased bradykinesia related to PD|0
2179993|NCT01397422|3805831|FG003|Overall Study|Increased bradykinesia related to PD|0
2179994|NCT01397448|3805846|FG000|Overall Study|Adverse Event|4
2179995|NCT01397448|3805847|FG001|Overall Study|Adverse Event|4
2179996|NCT01397448|3805848|FG002|Overall Study|Adverse Event|6
2179997|NCT01397448|3805846|FG000|Overall Study|Withdrawal by Subject|4
2179998|NCT01397448|3805847|FG001|Overall Study|Withdrawal by Subject|4
2296882|NCT02561195|3992967|FG003|Vaccination 1 to 3|Death|2
2174866|NCT01358526|3798538|FG000|Open-label Titration Period|Adverse Event|95
2174867|NCT01358526|3798539|FG001|Open-label Titration Period|Adverse Event|0
2174868|NCT01358526|3798540|FG002|Open-label Titration Period|Adverse Event|0
2174869|NCT01358526|3798538|FG000|Open-label Titration Period|Withdrawal by Subject|65
2174870|NCT01358526|3798539|FG001|Open-label Titration Period|Withdrawal by Subject|0
2174871|NCT01358526|3798540|FG002|Open-label Titration Period|Withdrawal by Subject|0
2174872|NCT01358526|3798538|FG000|Open-label Titration Period|Lost to Follow-up|25
2174873|NCT01358526|3798539|FG001|Open-label Titration Period|Lost to Follow-up|0
2174874|NCT01358526|3798540|FG002|Open-label Titration Period|Lost to Follow-up|0
2174875|NCT01358526|3798538|FG000|Open-label Titration Period|Lack of Efficacy|107
2174876|NCT01358526|3798539|FG001|Open-label Titration Period|Lack of Efficacy|0
2174877|NCT01358526|3798540|FG002|Open-label Titration Period|Lack of Efficacy|0
2174878|NCT01358526|3798538|FG000|Open-label Titration Period|Confirmed or suspected diversion|16
2174879|NCT01358526|3798539|FG001|Open-label Titration Period|Confirmed or suspected diversion|0
2174880|NCT01358526|3798540|FG002|Open-label Titration Period|Confirmed or suspected diversion|0
2174881|NCT01358526|3798538|FG000|Open-label Titration Period|Administrative|8
2174882|NCT01358526|3798539|FG001|Open-label Titration Period|Administrative|0
2174883|NCT01358526|3798540|FG002|Open-label Titration Period|Administrative|0
2174884|NCT01358526|3798538|FG000|Open-label Titration Period|Did not qualify|178
2174885|NCT01358526|3798539|FG001|Open-label Titration Period|Did not qualify|0
2174886|NCT01358526|3798540|FG002|Open-label Titration Period|Did not qualify|0
2174887|NCT01358526|3798538|FG000|Double-blind Phase|Adverse Event|0
2174888|NCT01358526|3798539|FG001|Double-blind Phase|Adverse Event|24
2174889|NCT01358526|3798540|FG002|Double-blind Phase|Adverse Event|23
2174890|NCT01358526|3798538|FG000|Double-blind Phase|Withdrawal by Subject|0
2174891|NCT01358526|3798539|FG001|Double-blind Phase|Withdrawal by Subject|10
2174892|NCT01358526|3798540|FG002|Double-blind Phase|Withdrawal by Subject|8
2174893|NCT01358526|3798538|FG000|Double-blind Phase|Lost to Follow-up|0
2174894|NCT01358526|3798539|FG001|Double-blind Phase|Lost to Follow-up|4
2174895|NCT01358526|3798540|FG002|Double-blind Phase|Lost to Follow-up|1
2174896|NCT01358526|3798538|FG000|Double-blind Phase|Lack of Efficacy|0
2174897|NCT01358526|3798539|FG001|Double-blind Phase|Lack of Efficacy|31
2174898|NCT01358526|3798540|FG002|Double-blind Phase|Lack of Efficacy|73
2174899|NCT01358526|3798538|FG000|Double-blind Phase|Confirmed or suspected diversion|0
2174900|NCT01358526|3798539|FG001|Double-blind Phase|Confirmed or suspected diversion|5
2174901|NCT01358526|3798540|FG002|Double-blind Phase|Confirmed or suspected diversion|6
2174902|NCT01358526|3798538|FG000|Double-blind Phase|Administrative|0
2174903|NCT01358526|3798539|FG001|Double-blind Phase|Administrative|6
2174904|NCT01358526|3798540|FG002|Double-blind Phase|Administrative|10
2174905|NCT01358578|3798551|FG000|Induction Period|Adverse Event|2
2174906|NCT01358578|3798552|FG001|Induction Period|Adverse Event|4
2174907|NCT01358578|3798553|FG002|Induction Period|Adverse Event|2
2174908|NCT01358578|3798554|FG003|Induction Period|Adverse Event|6
2174909|NCT01358578|3798555|FG004|Induction Period|Adverse Event|0
2174910|NCT01358578|3798556|FG005|Induction Period|Adverse Event|0
2174911|NCT01358578|3798551|FG000|Induction Period|Lack of Efficacy|0
2174912|NCT01358578|3798552|FG001|Induction Period|Lack of Efficacy|0
2174913|NCT01358578|3798553|FG002|Induction Period|Lack of Efficacy|9
2174914|NCT01358578|3798554|FG003|Induction Period|Lack of Efficacy|1
2174915|NCT01358578|3798555|FG004|Induction Period|Lack of Efficacy|0
2174916|NCT01358578|3798556|FG005|Induction Period|Lack of Efficacy|0
2174917|NCT01358578|3798551|FG000|Induction Period|Lost to Follow-up|0
2174918|NCT01358578|3798552|FG001|Induction Period|Lost to Follow-up|0
2174919|NCT01358578|3798553|FG002|Induction Period|Lost to Follow-up|1
2174920|NCT01358578|3798554|FG003|Induction Period|Lost to Follow-up|4
2174921|NCT01358578|3798555|FG004|Induction Period|Lost to Follow-up|0
2174922|NCT01358578|3798556|FG005|Induction Period|Lost to Follow-up|0
2174923|NCT01358578|3798551|FG000|Induction Period|Physician Decision|2
2174924|NCT01358578|3798552|FG001|Induction Period|Physician Decision|1
2174925|NCT01358578|3798553|FG002|Induction Period|Physician Decision|2
2174926|NCT01358578|3798554|FG003|Induction Period|Physician Decision|0
2174927|NCT01358578|3798555|FG004|Induction Period|Physician Decision|0
2174928|NCT01358578|3798556|FG005|Induction Period|Physician Decision|0
2174929|NCT01358578|3798551|FG000|Induction Period|Protocol Deviation|3
2174930|NCT01358578|3798552|FG001|Induction Period|Protocol Deviation|5
2174931|NCT01358578|3798553|FG002|Induction Period|Protocol Deviation|0
2174932|NCT01358578|3798554|FG003|Induction Period|Protocol Deviation|3
2174933|NCT01358578|3798555|FG004|Induction Period|Protocol Deviation|0
2174934|NCT01358578|3798556|FG005|Induction Period|Protocol Deviation|0
2174935|NCT01358578|3798551|FG000|Induction Period|technical problems|0
2174936|NCT01358578|3798552|FG001|Induction Period|technical problems|0
2174937|NCT01358578|3798553|FG002|Induction Period|technical problems|1
2174938|NCT01358578|3798554|FG003|Induction Period|technical problems|1
2174939|NCT01358578|3798555|FG004|Induction Period|technical problems|0
2174940|NCT01358578|3798556|FG005|Induction Period|technical problems|0
2174941|NCT01358578|3798551|FG000|Induction Period|Withdrawal by Subject|5
2174942|NCT01358578|3798552|FG001|Induction Period|Withdrawal by Subject|5
2174943|NCT01358578|3798553|FG002|Induction Period|Withdrawal by Subject|10
2174944|NCT01358578|3798554|FG003|Induction Period|Withdrawal by Subject|6
2174945|NCT01358578|3798555|FG004|Induction Period|Withdrawal by Subject|0
2174946|NCT01358578|3798556|FG005|Induction Period|Withdrawal by Subject|0
2174947|NCT01358578|3798551|FG000|Maintenance Period|Adverse Event|2
2174948|NCT01358578|3798552|FG001|Maintenance Period|Adverse Event|7
2174949|NCT01358578|3798553|FG002|Maintenance Period|Adverse Event|0
2174950|NCT01358578|3798554|FG003|Maintenance Period|Adverse Event|6
2174951|NCT01358578|3798555|FG004|Maintenance Period|Adverse Event|4
2174952|NCT01358578|3798556|FG005|Maintenance Period|Adverse Event|3
2174953|NCT01358578|3798551|FG000|Maintenance Period|Lack of Efficacy|10
2208282|NCT01638013|3847744|FG001|Overall Study|Lack of Efficacy|11
2208283|NCT01638013|3847745|FG002|Overall Study|Lack of Efficacy|14
2208284|NCT01638013|3847743|FG000|Overall Study|Protocol Violation|10
2208285|NCT01638013|3847744|FG001|Overall Study|Protocol Violation|7
2174954|NCT01358578|3798552|FG001|Maintenance Period|Lack of Efficacy|2
2174955|NCT01358578|3798553|FG002|Maintenance Period|Lack of Efficacy|0
2174956|NCT01358578|3798554|FG003|Maintenance Period|Lack of Efficacy|11
2174957|NCT01358578|3798555|FG004|Maintenance Period|Lack of Efficacy|3
2174958|NCT01358578|3798556|FG005|Maintenance Period|Lack of Efficacy|0
2208286|NCT01638013|3847745|FG002|Overall Study|Protocol Violation|11
2174959|NCT01358578|3798551|FG000|Maintenance Period|Lost to Follow-up|4
2174960|NCT01358578|3798552|FG001|Maintenance Period|Lost to Follow-up|0
2174961|NCT01358578|3798553|FG002|Maintenance Period|Lost to Follow-up|0
2174962|NCT01358578|3798554|FG003|Maintenance Period|Lost to Follow-up|5
2174963|NCT01358578|3798555|FG004|Maintenance Period|Lost to Follow-up|1
2174964|NCT01358578|3798556|FG005|Maintenance Period|Lost to Follow-up|1
2174965|NCT01358578|3798551|FG000|Maintenance Period|Non-compliance with study treatment|3
2174966|NCT01358578|3798552|FG001|Maintenance Period|Non-compliance with study treatment|1
2174967|NCT01358578|3798553|FG002|Maintenance Period|Non-compliance with study treatment|0
2174968|NCT01358578|3798554|FG003|Maintenance Period|Non-compliance with study treatment|2
2174969|NCT01358578|3798555|FG004|Maintenance Period|Non-compliance with study treatment|1
2174970|NCT01358578|3798556|FG005|Maintenance Period|Non-compliance with study treatment|2
2174971|NCT01358578|3798551|FG000|Maintenance Period|Physician Decision|0
2174972|NCT01358578|3798552|FG001|Maintenance Period|Physician Decision|1
2174973|NCT01358578|3798553|FG002|Maintenance Period|Physician Decision|0
2174974|NCT01358578|3798554|FG003|Maintenance Period|Physician Decision|1
2174975|NCT01358578|3798555|FG004|Maintenance Period|Physician Decision|0
2174976|NCT01358578|3798556|FG005|Maintenance Period|Physician Decision|0
2174977|NCT01358578|3798551|FG000|Maintenance Period|Pregnancy|1
2174978|NCT01358578|3798552|FG001|Maintenance Period|Pregnancy|0
2174979|NCT01358578|3798553|FG002|Maintenance Period|Pregnancy|0
2174980|NCT01358578|3798554|FG003|Maintenance Period|Pregnancy|0
2174981|NCT01358578|3798555|FG004|Maintenance Period|Pregnancy|0
2174982|NCT01358578|3798556|FG005|Maintenance Period|Pregnancy|0
2174983|NCT01358578|3798551|FG000|Maintenance Period|Protocol deviation|7
2174984|NCT01358578|3798552|FG001|Maintenance Period|Protocol deviation|4
2174985|NCT01358578|3798553|FG002|Maintenance Period|Protocol deviation|0
2174986|NCT01358578|3798554|FG003|Maintenance Period|Protocol deviation|2
2174987|NCT01358578|3798555|FG004|Maintenance Period|Protocol deviation|2
2174988|NCT01358578|3798556|FG005|Maintenance Period|Protocol deviation|2
2174989|NCT01358578|3798551|FG000|Maintenance Period|Withdrawal by Subject|12
2174990|NCT01358578|3798552|FG001|Maintenance Period|Withdrawal by Subject|7
2174991|NCT01358578|3798553|FG002|Maintenance Period|Withdrawal by Subject|2
2174992|NCT01358578|3798554|FG003|Maintenance Period|Withdrawal by Subject|15
2174993|NCT01358578|3798555|FG004|Maintenance Period|Withdrawal by Subject|6
2174994|NCT01358578|3798556|FG005|Maintenance Period|Withdrawal by Subject|3
2174995|NCT01358578|3798551|FG000|Follow-up Period|Adverse Event|1
2174996|NCT01358578|3798552|FG001|Follow-up Period|Adverse Event|1
2174997|NCT01358578|3798553|FG002|Follow-up Period|Adverse Event|0
2174998|NCT01358578|3798554|FG003|Follow-up Period|Adverse Event|0
2174999|NCT01358578|3798555|FG004|Follow-up Period|Adverse Event|0
2175000|NCT01358578|3798556|FG005|Follow-up Period|Adverse Event|0
2175001|NCT01358578|3798551|FG000|Follow-up Period|Lack of Efficacy|3
2175002|NCT01358578|3798552|FG001|Follow-up Period|Lack of Efficacy|0
2175003|NCT01358578|3798553|FG002|Follow-up Period|Lack of Efficacy|4
2175004|NCT01358578|3798554|FG003|Follow-up Period|Lack of Efficacy|1
2175005|NCT01358578|3798555|FG004|Follow-up Period|Lack of Efficacy|0
2175006|NCT01358578|3798556|FG005|Follow-up Period|Lack of Efficacy|0
2175007|NCT01358578|3798551|FG000|Follow-up Period|Lost to Follow-up|0
2175008|NCT01358578|3798552|FG001|Follow-up Period|Lost to Follow-up|1
2175009|NCT01358578|3798553|FG002|Follow-up Period|Lost to Follow-up|0
2175010|NCT01358578|3798554|FG003|Follow-up Period|Lost to Follow-up|4
2175011|NCT01358578|3798555|FG004|Follow-up Period|Lost to Follow-up|0
2175012|NCT01358578|3798556|FG005|Follow-up Period|Lost to Follow-up|0
2175013|NCT01358578|3798551|FG000|Follow-up Period|non- compliance with study treatment|1
2175014|NCT01358578|3798552|FG001|Follow-up Period|non- compliance with study treatment|0
2175015|NCT01358578|3798553|FG002|Follow-up Period|non- compliance with study treatment|0
2175016|NCT01358578|3798554|FG003|Follow-up Period|non- compliance with study treatment|0
2175017|NCT01358578|3798555|FG004|Follow-up Period|non- compliance with study treatment|0
2175018|NCT01358578|3798556|FG005|Follow-up Period|non- compliance with study treatment|0
2175019|NCT01358578|3798551|FG000|Follow-up Period|Pregnancy|1
2175020|NCT01358578|3798552|FG001|Follow-up Period|Pregnancy|0
2208287|NCT01638013|3847743|FG000|Overall Study|Met discontinuation criteria|4
2175021|NCT01358578|3798553|FG002|Follow-up Period|Pregnancy|0
2175022|NCT01358578|3798554|FG003|Follow-up Period|Pregnancy|0
2175023|NCT01358578|3798555|FG004|Follow-up Period|Pregnancy|0
2175024|NCT01358578|3798556|FG005|Follow-up Period|Pregnancy|0
2175025|NCT01358578|3798551|FG000|Follow-up Period|Withdrawal by Subject|3
2175026|NCT01358578|3798552|FG001|Follow-up Period|Withdrawal by Subject|3
2175027|NCT01358578|3798553|FG002|Follow-up Period|Withdrawal by Subject|1
2175028|NCT01358578|3798554|FG003|Follow-up Period|Withdrawal by Subject|12
2175029|NCT01358578|3798555|FG004|Follow-up Period|Withdrawal by Subject|0
2175030|NCT01358578|3798556|FG005|Follow-up Period|Withdrawal by Subject|0
2175031|NCT01358578|3798551|FG000|Follow-up Period|Physician Decision|1
2175032|NCT01358578|3798552|FG001|Follow-up Period|Physician Decision|1
2175033|NCT01358578|3798553|FG002|Follow-up Period|Physician Decision|0
2175034|NCT01358578|3798554|FG003|Follow-up Period|Physician Decision|2
2175035|NCT01358578|3798555|FG004|Follow-up Period|Physician Decision|0
2175036|NCT01358578|3798556|FG005|Follow-up Period|Physician Decision|0
2175037|NCT01358708|3798586|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2
2175038|NCT01358708|3798587|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
2175039|NCT01358708|3798586|FG000|Double-Blind Treatment Phase|Protocol Violation|1
2175040|NCT01358708|3798587|FG001|Double-Blind Treatment Phase|Protocol Violation|0
2175041|NCT01358721|3798601|FG000|Overall Study|Withdrawal by Subject|0
2175042|NCT01358721|3798602|FG001|Overall Study|Withdrawal by Subject|0
2175043|NCT01358721|3798603|FG002|Overall Study|Withdrawal by Subject|0
2175044|NCT01358721|3798604|FG003|Overall Study|Withdrawal by Subject|1
2175045|NCT01358721|3798601|FG000|Overall Study|Death|0
2175046|NCT01358721|3798602|FG001|Overall Study|Death|2
2175047|NCT01358721|3798603|FG002|Overall Study|Death|0
2175048|NCT01358721|3798604|FG003|Overall Study|Death|0
2175049|NCT01358721|3798601|FG000|Overall Study|Study Drug Toxicity|1
2175050|NCT01358721|3798602|FG001|Overall Study|Study Drug Toxicity|3
2175051|NCT01358721|3798603|FG002|Overall Study|Study Drug Toxicity|4
2175052|NCT01358721|3798604|FG003|Overall Study|Study Drug Toxicity|5
2175053|NCT01358721|3798601|FG000|Overall Study|SUBJ request to discontinue study TRT|0
2175054|NCT01358721|3798602|FG001|Overall Study|SUBJ request to discontinue study TRT|0
2175055|NCT01358721|3798603|FG002|Overall Study|SUBJ request to discontinue study TRT|0
2175056|NCT01358721|3798604|FG003|Overall Study|SUBJ request to discontinue study TRT|1
2175057|NCT01358721|3798601|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
2175058|NCT01358721|3798602|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
2175059|NCT01358721|3798603|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
2175060|NCT01358721|3798604|FG003|Overall Study|Subject No Longer Meets Study Criteria|1
2175061|NCT01358721|3798601|FG000|Overall Study|Adverse Event related to study drug|1
2175062|NCT01358721|3798602|FG001|Overall Study|Adverse Event related to study drug|0
2175063|NCT01358721|3798603|FG002|Overall Study|Adverse Event related to study drug|0
2175064|NCT01358721|3798604|FG003|Overall Study|Adverse Event related to study drug|1
2175065|NCT01358721|3798601|FG000|Overall Study|Disease Progression|19
2175066|NCT01358721|3798602|FG001|Overall Study|Disease Progression|15
2175067|NCT01358721|3798603|FG002|Overall Study|Disease Progression|17
2175068|NCT01358721|3798604|FG003|Overall Study|Disease Progression|15
2175069|NCT01358721|3798601|FG000|Overall Study|Out of State/Unmet Criteria|0
2175070|NCT01358721|3798602|FG001|Overall Study|Out of State/Unmet Criteria|0
2175071|NCT01358721|3798603|FG002|Overall Study|Out of State/Unmet Criteria|1
2175072|NCT01358721|3798604|FG003|Overall Study|Out of State/Unmet Criteria|0
2175073|NCT01358734|3798617|FG000|Overall Study|Adverse Event|4
2175074|NCT01358734|3798618|FG001|Overall Study|Adverse Event|7
2175075|NCT01358734|3798619|FG002|Overall Study|Adverse Event|3
2175076|NCT01358734|3798617|FG000|Overall Study|Lack of Efficacy|0
2175077|NCT01358734|3798618|FG001|Overall Study|Lack of Efficacy|1
2175078|NCT01358734|3798619|FG002|Overall Study|Lack of Efficacy|3
2175079|NCT01358734|3798617|FG000|Overall Study|Withdrawal by Subject|1
2175080|NCT01358734|3798618|FG001|Overall Study|Withdrawal by Subject|6
2175081|NCT01358734|3798619|FG002|Overall Study|Withdrawal by Subject|3
2175082|NCT01358734|3798617|FG000|Overall Study|Death|3
2175083|NCT01358734|3798618|FG001|Overall Study|Death|7
2175084|NCT01358734|3798619|FG002|Overall Study|Death|2
2175085|NCT01358734|3798617|FG000|Overall Study|Progressive Disease|5
2175086|NCT01358734|3798618|FG001|Overall Study|Progressive Disease|13
2175087|NCT01358734|3798619|FG002|Overall Study|Progressive Disease|16
2175088|NCT01358734|3798617|FG000|Overall Study|Non-compliance with study drug|0
2175089|NCT01358734|3798618|FG001|Overall Study|Non-compliance with study drug|0
2175090|NCT01358734|3798619|FG002|Overall Study|Non-compliance with study drug|1
2175091|NCT01358734|3798617|FG000|Overall Study|Other|2
2175092|NCT01358734|3798618|FG001|Overall Study|Other|5
2175093|NCT01358734|3798619|FG002|Overall Study|Other|4
2175094|NCT01358734|3798617|FG000|Overall Study|Protocol Violation|0
2175095|NCT01358734|3798618|FG001|Overall Study|Protocol Violation|0
2175096|NCT01358734|3798619|FG002|Overall Study|Protocol Violation|2
2175097|NCT01358760|3798630|FG000|Overall Study|Adverse Event|3
2175098|NCT01358760|3798631|FG001|Overall Study|Adverse Event|4
2175099|NCT01358760|3798632|FG002|Overall Study|Adverse Event|3
2175100|NCT01358760|3798630|FG000|Overall Study|Lost to Follow-up|1
2175101|NCT01358760|3798631|FG001|Overall Study|Lost to Follow-up|1
2175102|NCT01358760|3798632|FG002|Overall Study|Lost to Follow-up|3
2175103|NCT01358760|3798630|FG000|Overall Study|Withdrawal by Subject|5
2175104|NCT01358760|3798631|FG001|Overall Study|Withdrawal by Subject|3
2175105|NCT01358760|3798632|FG002|Overall Study|Withdrawal by Subject|2
2175106|NCT01358760|3798630|FG000|Overall Study|Physician Decision|1
2175107|NCT01358760|3798631|FG001|Overall Study|Physician Decision|0
2175108|NCT01358760|3798632|FG002|Overall Study|Physician Decision|1
2175109|NCT01358760|3798630|FG000|Overall Study|Entry criteria not met/Non-compliance|12
2175110|NCT01358760|3798631|FG001|Overall Study|Entry criteria not met/Non-compliance|12
2175111|NCT01358760|3798632|FG002|Overall Study|Entry criteria not met/Non-compliance|16
2175112|NCT01358825|3798642|FG000|Overall Study|Blood sample not drawn|0
2175113|NCT01358825|3798643|FG001|Overall Study|Blood sample not drawn|1
2175114|NCT01358864|3798657|FG000|Overall Study|Adverse Event|0
2175115|NCT01358864|3798658|FG001|Overall Study|Adverse Event|6
2175116|NCT01358864|3798659|FG002|Overall Study|Adverse Event|9
2175117|NCT01358864|3798660|FG003|Overall Study|Adverse Event|0
2175118|NCT01358864|3798661|FG004|Overall Study|Adverse Event|4
2175119|NCT01358864|3798662|FG005|Overall Study|Adverse Event|8
2175120|NCT01358864|3798663|FG006|Overall Study|Adverse Event|12
2175121|NCT01358864|3798664|FG007|Overall Study|Adverse Event|7
2175122|NCT01358864|3798657|FG000|Overall Study|Lack of Efficacy|26
2175123|NCT01358864|3798658|FG001|Overall Study|Lack of Efficacy|3
2175124|NCT01358864|3798659|FG002|Overall Study|Lack of Efficacy|4
2175125|NCT01358864|3798660|FG003|Overall Study|Lack of Efficacy|19
2175126|NCT01358864|3798661|FG004|Overall Study|Lack of Efficacy|7
2175127|NCT01358864|3798662|FG005|Overall Study|Lack of Efficacy|4
2175128|NCT01358864|3798663|FG006|Overall Study|Lack of Efficacy|49
2175129|NCT01358864|3798664|FG007|Overall Study|Lack of Efficacy|44
2175130|NCT01358864|3798657|FG000|Overall Study|Lost to Follow-up|0
2175131|NCT01358864|3798658|FG001|Overall Study|Lost to Follow-up|0
2175132|NCT01358864|3798659|FG002|Overall Study|Lost to Follow-up|1
2175133|NCT01358864|3798660|FG003|Overall Study|Lost to Follow-up|0
2175134|NCT01358864|3798661|FG004|Overall Study|Lost to Follow-up|0
2175135|NCT01358864|3798662|FG005|Overall Study|Lost to Follow-up|0
2175136|NCT01358864|3798663|FG006|Overall Study|Lost to Follow-up|0
2175137|NCT01358864|3798664|FG007|Overall Study|Lost to Follow-up|1
2175138|NCT01358864|3798657|FG000|Overall Study|Withdrawal by Subject|3
2296883|NCT02561195|3992968|FG004|Vaccination 1 to 3|Death|0
2296884|NCT02561195|3992969|FG005|Vaccination 1 to 3|Death|0
2296885|NCT02561195|3992970|FG006|Vaccination 1 to 3|Death|0
2296886|NCT02561195|3992971|FG007|Vaccination 1 to 3|Death|0
2296887|NCT02561195|3992972|FG008|Vaccination 1 to 3|Death|0
2296888|NCT02561195|3992973|FG009|Vaccination 1 to 3|Death|0
2296889|NCT02561195|3992974|FG010|Vaccination 1 to 3|Death|0
2296890|NCT02561195|3992975|FG011|Vaccination 1 to 3|Death|0
2296891|NCT02561195|3992976|FG012|Vaccination 1 to 3|Death|0
2296892|NCT02561195|3992977|FG013|Vaccination 1 to 3|Death|0
2296893|NCT02561195|3992964|FG000|Vaccination 1 to 3|Withdrawal by Subject|3
2296894|NCT02561195|3992965|FG001|Vaccination 1 to 3|Withdrawal by Subject|4
2296895|NCT02561195|3992966|FG002|Vaccination 1 to 3|Withdrawal by Subject|4
2296896|NCT02561195|3992967|FG003|Vaccination 1 to 3|Withdrawal by Subject|2
2296897|NCT02561195|3992968|FG004|Vaccination 1 to 3|Withdrawal by Subject|6
2296898|NCT02561195|3992969|FG005|Vaccination 1 to 3|Withdrawal by Subject|0
2296899|NCT02561195|3992970|FG006|Vaccination 1 to 3|Withdrawal by Subject|0
2296900|NCT02561195|3992971|FG007|Vaccination 1 to 3|Withdrawal by Subject|0
2296901|NCT02561195|3992972|FG008|Vaccination 1 to 3|Withdrawal by Subject|0
2296902|NCT02561195|3992973|FG009|Vaccination 1 to 3|Withdrawal by Subject|0
2296903|NCT02561195|3992974|FG010|Vaccination 1 to 3|Withdrawal by Subject|0
2296904|NCT02561195|3992975|FG011|Vaccination 1 to 3|Withdrawal by Subject|0
2296905|NCT02561195|3992976|FG012|Vaccination 1 to 3|Withdrawal by Subject|0
2296906|NCT02561195|3992977|FG013|Vaccination 1 to 3|Withdrawal by Subject|0
2296907|NCT02561195|3992964|FG000|Vaccination 1 to 3|Randomized but not treated|1
2296908|NCT02561195|3992965|FG001|Vaccination 1 to 3|Randomized but not treated|0
2296909|NCT02561195|3992966|FG002|Vaccination 1 to 3|Randomized but not treated|0
2296910|NCT02561195|3992967|FG003|Vaccination 1 to 3|Randomized but not treated|0
2296911|NCT02561195|3992968|FG004|Vaccination 1 to 3|Randomized but not treated|0
2296912|NCT02561195|3992969|FG005|Vaccination 1 to 3|Randomized but not treated|0
2296913|NCT02561195|3992970|FG006|Vaccination 1 to 3|Randomized but not treated|0
2296914|NCT02561195|3992971|FG007|Vaccination 1 to 3|Randomized but not treated|0
2296915|NCT02561195|3992972|FG008|Vaccination 1 to 3|Randomized but not treated|0
2296916|NCT02561195|3992973|FG009|Vaccination 1 to 3|Randomized but not treated|0
2296917|NCT02561195|3992974|FG010|Vaccination 1 to 3|Randomized but not treated|0
2296918|NCT02561195|3992975|FG011|Vaccination 1 to 3|Randomized but not treated|0
2296919|NCT02561195|3992976|FG012|Vaccination 1 to 3|Randomized but not treated|0
2296920|NCT02561195|3992977|FG013|Vaccination 1 to 3|Randomized but not treated|0
2296921|NCT02561195|3992964|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0
2175139|NCT01358864|3798658|FG001|Overall Study|Withdrawal by Subject|4
2175140|NCT01358864|3798659|FG002|Overall Study|Withdrawal by Subject|2
2175141|NCT01358864|3798660|FG003|Overall Study|Withdrawal by Subject|0
2296922|NCT02561195|3992965|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0
2296923|NCT02561195|3992966|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0
2296924|NCT02561195|3992967|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0
2296925|NCT02561195|3992968|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0
2296926|NCT02561195|3992969|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0
2296927|NCT02561195|3992970|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0
2175142|NCT01358864|3798661|FG004|Overall Study|Withdrawal by Subject|0
2175143|NCT01358864|3798662|FG005|Overall Study|Withdrawal by Subject|1
2175144|NCT01358864|3798663|FG006|Overall Study|Withdrawal by Subject|1
2175145|NCT01358864|3798664|FG007|Overall Study|Withdrawal by Subject|3
2175146|NCT01358864|3798657|FG000|Overall Study|Other reason not defined above|2
2175147|NCT01358864|3798658|FG001|Overall Study|Other reason not defined above|0
2175148|NCT01358864|3798659|FG002|Overall Study|Other reason not defined above|0
2175149|NCT01358864|3798660|FG003|Overall Study|Other reason not defined above|0
2175150|NCT01358864|3798661|FG004|Overall Study|Other reason not defined above|0
2175151|NCT01358864|3798662|FG005|Overall Study|Other reason not defined above|0
2175152|NCT01358864|3798663|FG006|Overall Study|Other reason not defined above|2
2175153|NCT01358864|3798664|FG007|Overall Study|Other reason not defined above|0
2175154|NCT01358864|3798657|FG000|Overall Study|Not treated|0
2175155|NCT01358864|3798658|FG001|Overall Study|Not treated|0
2175156|NCT01358864|3798659|FG002|Overall Study|Not treated|0
2175157|NCT01358864|3798660|FG003|Overall Study|Not treated|0
2175158|NCT01358864|3798661|FG004|Overall Study|Not treated|0
2175159|NCT01358864|3798662|FG005|Overall Study|Not treated|0
2175160|NCT01358864|3798663|FG006|Overall Study|Not treated|1
2175161|NCT01358864|3798664|FG007|Overall Study|Not treated|0
2175162|NCT01358877|3798686|FG000|Overall Study|Death|80
2175163|NCT01358877|3798687|FG001|Overall Study|Death|89
2175164|NCT01358877|3798686|FG000|Overall Study|Ongoing follow-up for post-recurrence|87
2175165|NCT01358877|3798687|FG001|Overall Study|Ongoing follow-up for post-recurrence|108
2175166|NCT01358877|3798686|FG000|Overall Study|Ongoing follow-up for IDFS event|2084
2175167|NCT01358877|3798687|FG001|Overall Study|Ongoing follow-up for IDFS event|2073
2175168|NCT01358877|3798686|FG000|Overall Study|Ongoing follow-up for overall survival|7
2175169|NCT01358877|3798687|FG001|Overall Study|Ongoing follow-up for overall survival|5
2175170|NCT01358877|3798686|FG000|Overall Study|Other|142
2175171|NCT01358877|3798687|FG001|Overall Study|Other|129
2175172|NCT01358968|3798693|FG000|Period 2|Adverse Event|0
2041715|NCT00440518|3612425|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
2041716|NCT00440518|3612426|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
2041717|NCT00440518|3612427|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
2041718|NCT00440518|3612425|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
2175173|NCT01358968|3798694|FG001|Period 2|Adverse Event|1
2175174|NCT01358968|3798695|FG002|Period 2|Adverse Event|0
2175175|NCT01358968|3798696|FG003|Period 2|Adverse Event|0
2175176|NCT01358968|3798693|FG000|Continued Access Phase|Progression of Disease|0
2175177|NCT01358968|3798694|FG001|Continued Access Phase|Progression of Disease|0
2175178|NCT01358968|3798695|FG002|Continued Access Phase|Progression of Disease|8
2175179|NCT01358968|3798696|FG003|Continued Access Phase|Progression of Disease|4
2175180|NCT01358968|3798693|FG000|Continued Access Phase|Protocol Violation|0
2175181|NCT01358968|3798694|FG001|Continued Access Phase|Protocol Violation|0
2175182|NCT01358968|3798695|FG002|Continued Access Phase|Protocol Violation|0
2175183|NCT01358968|3798696|FG003|Continued Access Phase|Protocol Violation|2
2175184|NCT01358968|3798693|FG000|Continued Access Phase|Withdrawal by Subject|0
2175185|NCT01358968|3798694|FG001|Continued Access Phase|Withdrawal by Subject|0
2175186|NCT01358968|3798695|FG002|Continued Access Phase|Withdrawal by Subject|3
2175187|NCT01358968|3798696|FG003|Continued Access Phase|Withdrawal by Subject|0
2175188|NCT01358968|3798693|FG000|Continued Access Phase|Death|0
2175189|NCT01358968|3798694|FG001|Continued Access Phase|Death|0
2175190|NCT01358968|3798695|FG002|Continued Access Phase|Death|1
2175191|NCT01358968|3798696|FG003|Continued Access Phase|Death|1
2175192|NCT01358981|3798713|FG000|Period 1|Withdrawal by Subject|0
2175193|NCT01358981|3798714|FG001|Period 1|Withdrawal by Subject|0
2175194|NCT01358981|3798715|FG002|Period 1|Withdrawal by Subject|0
2175195|NCT01358981|3798716|FG003|Period 1|Withdrawal by Subject|1
2175196|NCT01358981|3798717|FG004|Period 1|Withdrawal by Subject|0
2175197|NCT01358981|3798718|FG005|Period 1|Withdrawal by Subject|0
2175198|NCT01358981|3798719|FG006|Period 1|Withdrawal by Subject|0
2175199|NCT01359046|3798751|FG000|Overall Study|Did not receive allocated intervention|6
2175200|NCT01359046|3798752|FG001|Overall Study|Did not receive allocated intervention|6
2175201|NCT01359046|3798751|FG000|Overall Study|Physician Decision|1
2175202|NCT01359046|3798752|FG001|Overall Study|Physician Decision|11
2175203|NCT01359150|3798766|FG000|Overall Study|Lack of Efficacy|1
2175204|NCT01359150|3798767|FG001|Overall Study|Lack of Efficacy|1
2175205|NCT01359150|3798766|FG000|Overall Study|Withdrawal by Subject|1
2175206|NCT01359150|3798767|FG001|Overall Study|Withdrawal by Subject|1
2175207|NCT01359150|3798766|FG000|Overall Study|Adverse Event|4
2175208|NCT01359150|3798767|FG001|Overall Study|Adverse Event|3
2175209|NCT01359150|3798766|FG000|Overall Study|Other|1
2175210|NCT01359150|3798767|FG001|Overall Study|Other|0
2175211|NCT01359449|3798793|FG000|Overall Study|Lost to Follow-up|1
2175212|NCT01359449|3798794|FG001|Overall Study|Lost to Follow-up|0
2175213|NCT01359449|3798793|FG000|Overall Study|Protocol Violation|0
2175214|NCT01359449|3798794|FG001|Overall Study|Protocol Violation|2
2175215|NCT01359449|3798793|FG000|Overall Study|Withdrawal by Subject|3
2175216|NCT01359449|3798794|FG001|Overall Study|Withdrawal by Subject|2
2175217|NCT01359592|3798800|FG000|Initial Registration|Adverse Event|1
2175218|NCT01359592|3798801|FG001|Initial Registration|Adverse Event|0
2175219|NCT01359592|3798802|FG002|Initial Registration|Adverse Event|0
2175220|NCT01359592|3798803|FG003|Initial Registration|Adverse Event|0
2175221|NCT01359592|3798800|FG000|Initial Registration|Death|1
2175222|NCT01359592|3798801|FG001|Initial Registration|Death|0
2175223|NCT01359592|3798802|FG002|Initial Registration|Death|0
2175224|NCT01359592|3798803|FG003|Initial Registration|Death|0
2175225|NCT01359592|3798800|FG000|Initial Registration|Other reason not protocol specified|1
2175226|NCT01359592|3798801|FG001|Initial Registration|Other reason not protocol specified|0
2175227|NCT01359592|3798802|FG002|Initial Registration|Other reason not protocol specified|0
2175228|NCT01359592|3798803|FG003|Initial Registration|Other reason not protocol specified|0
2175229|NCT01359592|3798800|FG000|Initial Registration|Ineligible|26
2175230|NCT01359592|3798801|FG001|Initial Registration|Ineligible|0
2175231|NCT01359592|3798802|FG002|Initial Registration|Ineligible|0
2175232|NCT01359592|3798803|FG003|Initial Registration|Ineligible|0
2175233|NCT01359592|3798800|FG000|PET-Directed Therapy|Adverse Event|0
2175234|NCT01359592|3798801|FG001|PET-Directed Therapy|Adverse Event|0
2175235|NCT01359592|3798802|FG002|PET-Directed Therapy|Adverse Event|1
2175236|NCT01359592|3798803|FG003|PET-Directed Therapy|Adverse Event|0
2175237|NCT01359592|3798800|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0
2175238|NCT01359592|3798801|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0
2175239|NCT01359592|3798802|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1
2175240|NCT01359592|3798803|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0
2175241|NCT01359592|3798800|FG000|PET-Directed Therapy|Ineligible|0
2175242|NCT01359592|3798801|FG001|PET-Directed Therapy|Ineligible|0
2175243|NCT01359592|3798802|FG002|PET-Directed Therapy|Ineligible|24
2175244|NCT01359592|3798803|FG003|PET-Directed Therapy|Ineligible|0
2175245|NCT01359644|3798828|FG000|Treatment Period|Lack of Efficacy|0
2175246|NCT01359644|3798829|FG001|Treatment Period|Lack of Efficacy|1
2175247|NCT01359644|3798830|FG002|Treatment Period|Lack of Efficacy|0
2175248|NCT01359644|3798831|FG003|Treatment Period|Lack of Efficacy|0
2175249|NCT01359644|3798832|FG004|Treatment Period|Lack of Efficacy|0
2175250|NCT01359644|3798833|FG005|Treatment Period|Lack of Efficacy|0
2175251|NCT01359644|3798834|FG006|Treatment Period|Lack of Efficacy|0
2175252|NCT01359644|3798835|FG007|Treatment Period|Lack of Efficacy|0
2175253|NCT01359644|3798836|FG008|Treatment Period|Lack of Efficacy|0
2175254|NCT01359644|3798837|FG009|Treatment Period|Lack of Efficacy|0
2175255|NCT01359644|3798828|FG000|Treatment Period|Adverse Event|0
2175256|NCT01359644|3798829|FG001|Treatment Period|Adverse Event|0
2175257|NCT01359644|3798830|FG002|Treatment Period|Adverse Event|1
2175258|NCT01359644|3798831|FG003|Treatment Period|Adverse Event|0
2175259|NCT01359644|3798832|FG004|Treatment Period|Adverse Event|0
2175260|NCT01359644|3798833|FG005|Treatment Period|Adverse Event|1
2175261|NCT01359644|3798834|FG006|Treatment Period|Adverse Event|0
2175262|NCT01359644|3798835|FG007|Treatment Period|Adverse Event|0
2175263|NCT01359644|3798836|FG008|Treatment Period|Adverse Event|0
2175264|NCT01359644|3798837|FG009|Treatment Period|Adverse Event|0
2175265|NCT01359644|3798828|FG000|Treatment Period|Lost to Follow-up|0
2175266|NCT01359644|3798829|FG001|Treatment Period|Lost to Follow-up|0
2175267|NCT01359644|3798830|FG002|Treatment Period|Lost to Follow-up|0
2175268|NCT01359644|3798831|FG003|Treatment Period|Lost to Follow-up|0
2175269|NCT01359644|3798832|FG004|Treatment Period|Lost to Follow-up|0
2175270|NCT01359644|3798833|FG005|Treatment Period|Lost to Follow-up|1
2175271|NCT01359644|3798834|FG006|Treatment Period|Lost to Follow-up|0
2175272|NCT01359644|3798835|FG007|Treatment Period|Lost to Follow-up|0
2175273|NCT01359644|3798836|FG008|Treatment Period|Lost to Follow-up|0
2175274|NCT01359644|3798837|FG009|Treatment Period|Lost to Follow-up|0
2175275|NCT01359644|3798828|FG000|Follow-up Period|Withdrawal by Subject|0
2175276|NCT01359644|3798829|FG001|Follow-up Period|Withdrawal by Subject|0
2175277|NCT01359644|3798830|FG002|Follow-up Period|Withdrawal by Subject|0
2175278|NCT01359644|3798831|FG003|Follow-up Period|Withdrawal by Subject|0
2175279|NCT01359644|3798832|FG004|Follow-up Period|Withdrawal by Subject|0
2175280|NCT01359644|3798833|FG005|Follow-up Period|Withdrawal by Subject|1
2175281|NCT01359644|3798834|FG006|Follow-up Period|Withdrawal by Subject|0
2175282|NCT01359644|3798835|FG007|Follow-up Period|Withdrawal by Subject|0
2175283|NCT01359644|3798836|FG008|Follow-up Period|Withdrawal by Subject|0
2175284|NCT01359644|3798837|FG009|Follow-up Period|Withdrawal by Subject|0
2175285|NCT01359644|3798828|FG000|Follow-up Period|Lost to Follow-up|0
2175286|NCT01359644|3798829|FG001|Follow-up Period|Lost to Follow-up|0
2175287|NCT01359644|3798830|FG002|Follow-up Period|Lost to Follow-up|0
2175288|NCT01359644|3798831|FG003|Follow-up Period|Lost to Follow-up|0
2175289|NCT01359644|3798832|FG004|Follow-up Period|Lost to Follow-up|0
2175290|NCT01359644|3798833|FG005|Follow-up Period|Lost to Follow-up|0
2175291|NCT01359644|3798834|FG006|Follow-up Period|Lost to Follow-up|1
2175292|NCT01359644|3798835|FG007|Follow-up Period|Lost to Follow-up|2
2175293|NCT01359644|3798836|FG008|Follow-up Period|Lost to Follow-up|0
2175294|NCT01359644|3798837|FG009|Follow-up Period|Lost to Follow-up|0
2175295|NCT01359904|3798896|FG000|Overall Study|Withdrawal by Subject|1
2175296|NCT01359904|3798897|FG001|Overall Study|Withdrawal by Subject|0
2175297|NCT01359943|3798906|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
2175298|NCT01359943|3798907|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
2175299|NCT01359943|3798908|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
2175300|NCT01359943|3798906|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1
2175301|NCT01359943|3798907|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2
2296928|NCT02561195|3992971|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0
2296929|NCT02561195|3992972|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3
2296930|NCT02561195|3992973|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1
2296931|NCT02561195|3992974|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2
2296932|NCT02561195|3992975|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2
2175302|NCT01359943|3798908|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0
2175303|NCT01359943|3798906|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
2175304|NCT01359943|3798907|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
2175305|NCT01359943|3798908|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
2175306|NCT01359943|3798906|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
2175307|NCT01359943|3798907|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
2175308|NCT01359943|3798908|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
2175309|NCT01359943|3798906|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
2175310|NCT01359943|3798907|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
2175311|NCT01359943|3798908|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
2175312|NCT01359943|3798906|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
2175313|NCT01359943|3798907|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
2175314|NCT01359943|3798908|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
2296933|NCT02561195|3992976|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3
2296934|NCT02561195|3992977|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0
2296935|NCT02561195|3992964|FG000|Extension Stage (Vaccination 4)|Adverse Event|0
2296936|NCT02561195|3992965|FG001|Extension Stage (Vaccination 4)|Adverse Event|0
2296937|NCT02561195|3992966|FG002|Extension Stage (Vaccination 4)|Adverse Event|0
2296938|NCT02561195|3992967|FG003|Extension Stage (Vaccination 4)|Adverse Event|0
2296939|NCT02561195|3992968|FG004|Extension Stage (Vaccination 4)|Adverse Event|0
2296940|NCT02561195|3992969|FG005|Extension Stage (Vaccination 4)|Adverse Event|0
2296941|NCT02561195|3992970|FG006|Extension Stage (Vaccination 4)|Adverse Event|0
2296942|NCT02561195|3992971|FG007|Extension Stage (Vaccination 4)|Adverse Event|0
2296943|NCT02561195|3992972|FG008|Extension Stage (Vaccination 4)|Adverse Event|0
2296944|NCT02561195|3992973|FG009|Extension Stage (Vaccination 4)|Adverse Event|0
2175315|NCT01359943|3798906|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
2175316|NCT01359943|3798907|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
2175317|NCT01359943|3798908|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
2175318|NCT01359943|3798906|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
2175319|NCT01359943|3798907|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
2179999|NCT01397448|3805848|FG002|Overall Study|Withdrawal by Subject|3
2296945|NCT02561195|3992974|FG010|Extension Stage (Vaccination 4)|Adverse Event|0
2296946|NCT02561195|3992975|FG011|Extension Stage (Vaccination 4)|Adverse Event|0
2296947|NCT02561195|3992976|FG012|Extension Stage (Vaccination 4)|Adverse Event|0
2296948|NCT02561195|3992977|FG013|Extension Stage (Vaccination 4)|Adverse Event|2
2296949|NCT02561195|3992964|FG000|Extension Stage (Vaccination 4)|Death|0
2296950|NCT02561195|3992965|FG001|Extension Stage (Vaccination 4)|Death|0
2296951|NCT02561195|3992966|FG002|Extension Stage (Vaccination 4)|Death|0
2296952|NCT02561195|3992967|FG003|Extension Stage (Vaccination 4)|Death|0
2296953|NCT02561195|3992968|FG004|Extension Stage (Vaccination 4)|Death|0
2296954|NCT02561195|3992969|FG005|Extension Stage (Vaccination 4)|Death|0
2296955|NCT02561195|3992970|FG006|Extension Stage (Vaccination 4)|Death|0
2296956|NCT02561195|3992971|FG007|Extension Stage (Vaccination 4)|Death|0
2296957|NCT02561195|3992972|FG008|Extension Stage (Vaccination 4)|Death|0
2296958|NCT02561195|3992973|FG009|Extension Stage (Vaccination 4)|Death|1
2296959|NCT02561195|3992974|FG010|Extension Stage (Vaccination 4)|Death|0
2296960|NCT02561195|3992975|FG011|Extension Stage (Vaccination 4)|Death|0
2296961|NCT02561195|3992976|FG012|Extension Stage (Vaccination 4)|Death|0
2296962|NCT02561195|3992977|FG013|Extension Stage (Vaccination 4)|Death|0
2296963|NCT02561195|3992964|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0
2296964|NCT02561195|3992965|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0
2296965|NCT02561195|3992966|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0
2296966|NCT02561195|3992967|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0
2296967|NCT02561195|3992968|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0
2296968|NCT02561195|3992969|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0
2296969|NCT02561195|3992970|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1
2296970|NCT02561195|3992971|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1
2296971|NCT02561195|3992972|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0
2296972|NCT02561195|3992973|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0
2296973|NCT02561195|3992974|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2
2296974|NCT02561195|3992975|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1
2296975|NCT02561195|3992976|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2
2296976|NCT02561195|3992977|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1
2296977|NCT02561195|3992964|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
2296978|NCT02561195|3992965|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
2296979|NCT02561195|3992966|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
2296980|NCT02561195|3992967|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
2296981|NCT02561195|3992968|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
2175320|NCT01359943|3798908|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
2175321|NCT01359943|3798906|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
2175322|NCT01359943|3798907|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
2175323|NCT01359943|3798908|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
2175324|NCT01359943|3798906|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
2175325|NCT01359943|3798907|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
2175326|NCT01359943|3798908|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
2175327|NCT01359943|3798906|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1
2175328|NCT01359943|3798907|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0
2175329|NCT01359943|3798908|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0
2175330|NCT01359943|3798906|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0
2175331|NCT01359943|3798907|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1
2175332|NCT01359943|3798908|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0
2175333|NCT01359943|3798906|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
2175334|NCT01359943|3798907|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
2175335|NCT01359943|3798908|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
2175336|NCT01359943|3798906|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
2175337|NCT01359943|3798907|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
2175338|NCT01359943|3798908|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
2175339|NCT01359943|3798906|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3
2175340|NCT01359943|3798907|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5
2175341|NCT01359943|3798908|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1
2175342|NCT01359956|3798922|FG000|Overall Study|Death|61
2175343|NCT01359956|3798923|FG001|Overall Study|Death|64
2175344|NCT01359956|3798924|FG002|Overall Study|Death|67
2175345|NCT01359956|3798925|FG003|Overall Study|Death|58
2175346|NCT01360021|3798938|FG000|Overall Study|Eligibility criteria + other|2
2175347|NCT01360021|3798939|FG001|Overall Study|Eligibility criteria + other|1
2175348|NCT01360021|3798940|FG002|Overall Study|Eligibility criteria + other|1
2175349|NCT01360021|3798938|FG000|Overall Study|Protocol Violation|0
2175350|NCT01360021|3798939|FG001|Overall Study|Protocol Violation|0
2175351|NCT01360021|3798940|FG002|Overall Study|Protocol Violation|1
2175352|NCT01360021|3798938|FG000|Overall Study|Withdrawal by Subject|4
2175353|NCT01360021|3798939|FG001|Overall Study|Withdrawal by Subject|0
2175354|NCT01360021|3798940|FG002|Overall Study|Withdrawal by Subject|2
2175355|NCT01360021|3798938|FG000|Overall Study|Adverse Event|2
2175356|NCT01360021|3798939|FG001|Overall Study|Adverse Event|3
2175357|NCT01360021|3798940|FG002|Overall Study|Adverse Event|3
2175358|NCT01360398|3798957|FG000|Overall Study|Withdrawal by Subject|14
2175359|NCT01360398|3798957|FG000|Overall Study|Other|7
2175360|NCT01360398|3798957|FG000|Overall Study|Migrated/moved from study area|1
2175361|NCT01360554|3798973|FG000|Overall Study|Death|359
2175362|NCT01360554|3798974|FG001|Overall Study|Death|371
2175363|NCT01360554|3798973|FG000|Overall Study|Lost to Follow-up|4
2175364|NCT01360554|3798974|FG001|Overall Study|Lost to Follow-up|4
2175365|NCT01360554|3798973|FG000|Overall Study|Withdrawal by Subject|23
2175366|NCT01360554|3798974|FG001|Overall Study|Withdrawal by Subject|24
2175367|NCT01360554|3798973|FG000|Overall Study|Study terminated by sponsor|49
2175368|NCT01360554|3798974|FG001|Overall Study|Study terminated by sponsor|37
2175369|NCT01360554|3798973|FG000|Overall Study|Other, not specified|1
2175370|NCT01360554|3798974|FG001|Overall Study|Other, not specified|0
2175371|NCT01360554|3798973|FG000|Overall Study|Randomized but not treated.|3
2175372|NCT01360554|3798974|FG001|Overall Study|Randomized but not treated.|3
2175373|NCT01360632|3798983|FG000|Phase A (8 Weeks)|Lost to Follow-up|27
2175374|NCT01360632|3798984|FG001|Phase A (8 Weeks)|Lost to Follow-up|0
2175375|NCT01360632|3798985|FG002|Phase A (8 Weeks)|Lost to Follow-up|0
2175376|NCT01360632|3798986|FG003|Phase A (8 Weeks)|Lost to Follow-up|0
2175377|NCT01360632|3798987|FG004|Phase A (8 Weeks)|Lost to Follow-up|0
2175378|NCT01360632|3798983|FG000|Phase A (8 Weeks)|Adverse Event|60
2175379|NCT01360632|3798984|FG001|Phase A (8 Weeks)|Adverse Event|0
2175380|NCT01360632|3798985|FG002|Phase A (8 Weeks)|Adverse Event|0
2175381|NCT01360632|3798986|FG003|Phase A (8 Weeks)|Adverse Event|0
2175382|NCT01360632|3798987|FG004|Phase A (8 Weeks)|Adverse Event|0
2175383|NCT01360632|3798983|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45
2175384|NCT01360632|3798984|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2175385|NCT01360632|3798985|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2175386|NCT01360632|3798986|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2175387|NCT01360632|3798987|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2175388|NCT01360632|3798983|FG000|Phase A (8 Weeks)|Physician Decision|10
2175389|NCT01360632|3798984|FG001|Phase A (8 Weeks)|Physician Decision|0
2175390|NCT01360632|3798985|FG002|Phase A (8 Weeks)|Physician Decision|0
2175391|NCT01360632|3798986|FG003|Phase A (8 Weeks)|Physician Decision|0
2175392|NCT01360632|3798987|FG004|Phase A (8 Weeks)|Physician Decision|0
2175393|NCT01360632|3798983|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74
2175394|NCT01360632|3798984|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0
2175395|NCT01360632|3798985|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0
2175396|NCT01360632|3798986|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0
2175397|NCT01360632|3798987|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0
2175398|NCT01360632|3798983|FG000|Phase A (8 Weeks)|Protocol Deviation|39
2175399|NCT01360632|3798984|FG001|Phase A (8 Weeks)|Protocol Deviation|0
2175400|NCT01360632|3798985|FG002|Phase A (8 Weeks)|Protocol Deviation|0
2175401|NCT01360632|3798986|FG003|Phase A (8 Weeks)|Protocol Deviation|0
2175402|NCT01360632|3798987|FG004|Phase A (8 Weeks)|Protocol Deviation|0
2175403|NCT01360632|3798983|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
2175404|NCT01360632|3798984|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
2175405|NCT01360632|3798985|FG002|Phase B (6 Weeks)|Lost to Follow-up|1
2175406|NCT01360632|3798986|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
2175407|NCT01360632|3798987|FG004|Phase B (6 Weeks)|Lost to Follow-up|0
2175408|NCT01360632|3798983|FG000|Phase B (6 Weeks)|Adverse Event|0
2175409|NCT01360632|3798984|FG001|Phase B (6 Weeks)|Adverse Event|3
2175410|NCT01360632|3798985|FG002|Phase B (6 Weeks)|Adverse Event|9
2175411|NCT01360632|3798986|FG003|Phase B (6 Weeks)|Adverse Event|3
2175412|NCT01360632|3798987|FG004|Phase B (6 Weeks)|Adverse Event|0
2175413|NCT01360632|3798983|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2175414|NCT01360632|3798984|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2175415|NCT01360632|3798985|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
2175416|NCT01360632|3798986|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1
2175417|NCT01360632|3798987|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2175418|NCT01360632|3798983|FG000|Phase B (6 Weeks)|Physician Decision|0
2175419|NCT01360632|3798984|FG001|Phase B (6 Weeks)|Physician Decision|0
2175420|NCT01360632|3798985|FG002|Phase B (6 Weeks)|Physician Decision|0
2175421|NCT01360632|3798986|FG003|Phase B (6 Weeks)|Physician Decision|1
2175422|NCT01360632|3798987|FG004|Phase B (6 Weeks)|Physician Decision|0
2175423|NCT01360632|3798983|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
2175424|NCT01360632|3798984|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4
2175425|NCT01360632|3798985|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4
2175426|NCT01360632|3798986|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7
2175427|NCT01360632|3798987|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0
2175428|NCT01360632|3798983|FG000|Phase B (6 Weeks)|Protocol Deviation|0
2175429|NCT01360632|3798984|FG001|Phase B (6 Weeks)|Protocol Deviation|1
2175430|NCT01360632|3798985|FG002|Phase B (6 Weeks)|Protocol Deviation|4
2175431|NCT01360632|3798986|FG003|Phase B (6 Weeks)|Protocol Deviation|1
2175432|NCT01360632|3798987|FG004|Phase B (6 Weeks)|Protocol Deviation|0
2175433|NCT01360632|3798983|FG000|Phase B (6 Weeks)|Lack of Efficacy|0
2175434|NCT01360632|3798984|FG001|Phase B (6 Weeks)|Lack of Efficacy|1
2175435|NCT01360632|3798985|FG002|Phase B (6 Weeks)|Lack of Efficacy|0
2175436|NCT01360632|3798986|FG003|Phase B (6 Weeks)|Lack of Efficacy|0
2175437|NCT01360632|3798987|FG004|Phase B (6 Weeks)|Lack of Efficacy|0
2175438|NCT01360632|3798983|FG000|Phase A+|Lost to Follow-up|0
2175439|NCT01360632|3798984|FG001|Phase A+|Lost to Follow-up|0
2175440|NCT01360632|3798985|FG002|Phase A+|Lost to Follow-up|0
2175441|NCT01360632|3798986|FG003|Phase A+|Lost to Follow-up|0
2175442|NCT01360632|3798987|FG004|Phase A+|Lost to Follow-up|2
2175443|NCT01360632|3798983|FG000|Phase A+|Adverse Event|0
2175444|NCT01360632|3798984|FG001|Phase A+|Adverse Event|0
2175445|NCT01360632|3798985|FG002|Phase A+|Adverse Event|0
2296982|NCT02561195|3992969|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
2296983|NCT02561195|3992970|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
2296984|NCT02561195|3992971|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
2296985|NCT02561195|3992972|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
2296986|NCT02561195|3992973|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
2296987|NCT02561195|3992974|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
2296988|NCT02561195|3992975|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
2296989|NCT02561195|3992976|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
2296990|NCT02561195|3992977|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
2296991|NCT02561195|3992964|FG000|Extension Stage (Vaccination 4)|Other|0
2296992|NCT02561195|3992965|FG001|Extension Stage (Vaccination 4)|Other|0
2296993|NCT02561195|3992966|FG002|Extension Stage (Vaccination 4)|Other|0
2296994|NCT02561195|3992967|FG003|Extension Stage (Vaccination 4)|Other|0
2296995|NCT02561195|3992968|FG004|Extension Stage (Vaccination 4)|Other|0
2296996|NCT02561195|3992969|FG005|Extension Stage (Vaccination 4)|Other|0
2296997|NCT02561195|3992970|FG006|Extension Stage (Vaccination 4)|Other|0
2296998|NCT02561195|3992971|FG007|Extension Stage (Vaccination 4)|Other|0
2296999|NCT02561195|3992972|FG008|Extension Stage (Vaccination 4)|Other|0
2297000|NCT02561195|3992973|FG009|Extension Stage (Vaccination 4)|Other|0
2297001|NCT02561195|3992974|FG010|Extension Stage (Vaccination 4)|Other|2
2297002|NCT02561195|3992975|FG011|Extension Stage (Vaccination 4)|Other|2
2297003|NCT02561195|3992976|FG012|Extension Stage (Vaccination 4)|Other|1
2297004|NCT02561195|3992977|FG013|Extension Stage (Vaccination 4)|Other|0
2297005|NCT02561195|3992964|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0
2297006|NCT02561195|3992965|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0
2297007|NCT02561195|3992966|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0
2297008|NCT02561195|3992967|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0
2321295|NCT02959190|4035869|FG001|Open Label|Adverse Event|7
2175446|NCT01360632|3798986|FG003|Phase A+|Adverse Event|0
2175447|NCT01360632|3798987|FG004|Phase A+|Adverse Event|2
2175448|NCT01360632|3798983|FG000|Phase A+|Met Withdrawal Criteria|0
2175449|NCT01360632|3798984|FG001|Phase A+|Met Withdrawal Criteria|0
2175450|NCT01360632|3798985|FG002|Phase A+|Met Withdrawal Criteria|0
2175451|NCT01360632|3798986|FG003|Phase A+|Met Withdrawal Criteria|0
2175452|NCT01360632|3798987|FG004|Phase A+|Met Withdrawal Criteria|7
2175453|NCT01360632|3798983|FG000|Phase A+|Physician Decision|0
2175454|NCT01360632|3798984|FG001|Phase A+|Physician Decision|0
2175455|NCT01360632|3798985|FG002|Phase A+|Physician Decision|0
2175456|NCT01360632|3798986|FG003|Phase A+|Physician Decision|0
2175457|NCT01360632|3798987|FG004|Phase A+|Physician Decision|3
2175458|NCT01360632|3798983|FG000|Phase A+|Withdrawal by Subject|0
2175459|NCT01360632|3798984|FG001|Phase A+|Withdrawal by Subject|0
2175460|NCT01360632|3798985|FG002|Phase A+|Withdrawal by Subject|0
2175461|NCT01360632|3798986|FG003|Phase A+|Withdrawal by Subject|0
2175462|NCT01360632|3798987|FG004|Phase A+|Withdrawal by Subject|8
2175463|NCT01360632|3798983|FG000|Phase A+|Protocol Deviation|0
2175464|NCT01360632|3798984|FG001|Phase A+|Protocol Deviation|0
2175465|NCT01360632|3798985|FG002|Phase A+|Protocol Deviation|0
2175466|NCT01360632|3798986|FG003|Phase A+|Protocol Deviation|0
2175467|NCT01360632|3798987|FG004|Phase A+|Protocol Deviation|3
2175468|NCT01360645|3798997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
2175469|NCT01360645|3798998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
2175470|NCT01360645|3798999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
2175471|NCT01360645|3799000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
2175472|NCT01360645|3798997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
2175473|NCT01360645|3798998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
2175474|NCT01360645|3798999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
2175475|NCT01360645|3799000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
2175476|NCT01360645|3798997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
2175477|NCT01360645|3798998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
2175478|NCT01360645|3798999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
2175479|NCT01360645|3799000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
2175480|NCT01360645|3798997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
2175481|NCT01360645|3798998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
2175482|NCT01360645|3798999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
2175483|NCT01360645|3799000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
2175484|NCT01360645|3798997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
2175485|NCT01360645|3798998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
2175486|NCT01360645|3798999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
2175487|NCT01360645|3799000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
2175488|NCT01360645|3798997|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
2297009|NCT02561195|3992968|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0
2297010|NCT02561195|3992969|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0
2297011|NCT02561195|3992970|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1
2297012|NCT02561195|3992971|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0
2297013|NCT02561195|3992972|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0
2297014|NCT02561195|3992973|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0
2297015|NCT02561195|3992974|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2
2297016|NCT02561195|3992975|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1
2297017|NCT02561195|3992976|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0
2297018|NCT02561195|3992977|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1
2297019|NCT02561247|3993018|FG000|Overall Study|Protocol Violation|1
2297020|NCT02561247|3993018|FG000|Overall Study|Withdrawal by Subject|1
2297021|NCT02561247|3993018|FG000|Overall Study|Two filter changes required within the first 24 hours.|4
2297022|NCT02561273|3993024|FG000|Overall Study|Protocol Violation|1
2297023|NCT02561273|3993025|FG001|Overall Study|Protocol Violation|0
2297024|NCT02561455|3993060|FG000|Overall Study|Participant Transitioned to Commercial Drug|1
2297025|NCT02561455|3993061|FG001|Overall Study|Participant Transitioned to Commercial Drug|1
2297026|NCT02561455|3993062|FG002|Overall Study|Participant Transitioned to Commercial Drug|2
2297027|NCT02561455|3993063|FG003|Overall Study|Participant Transitioned to Commercial Drug|1
2297028|NCT02561455|3993060|FG000|Overall Study|Withdrawal by Subject|1
2297029|NCT02561455|3993061|FG001|Overall Study|Withdrawal by Subject|0
2297030|NCT02561455|3993062|FG002|Overall Study|Withdrawal by Subject|1
2297031|NCT02561455|3993063|FG003|Overall Study|Withdrawal by Subject|0
2297032|NCT02561455|3993060|FG000|Overall Study|Disease Progression|0
2297033|NCT02561455|3993061|FG001|Overall Study|Disease Progression|1
2297034|NCT02561455|3993062|FG002|Overall Study|Disease Progression|0
2297035|NCT02561455|3993063|FG003|Overall Study|Disease Progression|0
2297036|NCT02561572|3993087|FG000|Overall Study|Inadequate time before surgery|2
2297037|NCT02561572|3993088|FG001|Overall Study|Inadequate time before surgery|1
2297038|NCT02561572|3993087|FG000|Overall Study|Protocol Violation|0
2297039|NCT02561572|3993088|FG001|Overall Study|Protocol Violation|1
2297040|NCT02561806|3993116|FG000|Induction Period|Adverse Event|0
2297041|NCT02561806|3993117|FG001|Induction Period|Adverse Event|2
2297042|NCT02561806|3993116|FG000|Induction Period|Lack of Efficacy|1
2297043|NCT02561806|3993117|FG001|Induction Period|Lack of Efficacy|0
2297044|NCT02561806|3993116|FG000|Induction Period|Withdrawal by Subject|0
2297045|NCT02561806|3993117|FG001|Induction Period|Withdrawal by Subject|2
2297046|NCT02561806|3993116|FG000|Induction Period|Site staff became unblinded|1
2297047|NCT02561806|3993117|FG001|Induction Period|Site staff became unblinded|0
2175489|NCT01360645|3798998|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
2175490|NCT01360645|3798999|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
2175491|NCT01360645|3799000|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
2175492|NCT01360645|3798997|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
2175493|NCT01360645|3798998|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
2175494|NCT01360645|3798999|FG002|Phase B (6 Weeks)|Lost to Follow-up|0
2175495|NCT01360645|3799000|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
2175496|NCT01360645|3798997|FG000|Phase B (6 Weeks)|Adverse Event|0
2175497|NCT01360645|3798998|FG001|Phase B (6 Weeks)|Adverse Event|6
2175498|NCT01360645|3798999|FG002|Phase B (6 Weeks)|Adverse Event|0
2175499|NCT01360645|3799000|FG003|Phase B (6 Weeks)|Adverse Event|0
2175500|NCT01360645|3798997|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2175501|NCT01360645|3798998|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3
2175502|NCT01360645|3798999|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
2175503|NCT01360645|3799000|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2175504|NCT01360645|3798997|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
2175505|NCT01360645|3798998|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3
2175506|NCT01360645|3798999|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8
2297048|NCT02561806|3993116|FG000|Induction Period|Randomized but not treated|0
2297049|NCT02561806|3993117|FG001|Induction Period|Randomized but not treated|1
2297050|NCT02561806|3993116|FG000|Maintenance Period|Adverse Event|2
2297051|NCT02561806|3993117|FG001|Maintenance Period|Adverse Event|1
2297052|NCT02561806|3993116|FG000|Maintenance Period|Lack of Efficacy|3
2297053|NCT02561806|3993117|FG001|Maintenance Period|Lack of Efficacy|1
2297054|NCT02561806|3993116|FG000|Maintenance Period|Lost to Follow-up|2
2297055|NCT02561806|3993117|FG001|Maintenance Period|Lost to Follow-up|2
2297056|NCT02561806|3993116|FG000|Maintenance Period|Protocol Violation|1
2297057|NCT02561806|3993117|FG001|Maintenance Period|Protocol Violation|0
2297058|NCT02561806|3993116|FG000|Maintenance Period|Withdrawal by Subject|5
2297059|NCT02561806|3993117|FG001|Maintenance Period|Withdrawal by Subject|3
2297060|NCT02561806|3993116|FG000|Maintenance Period|Site staff became unblinded|0
2297061|NCT02561806|3993117|FG001|Maintenance Period|Site staff became unblinded|1
2297062|NCT02561806|3993116|FG000|Post-Treatment Follow-up|Lost to Follow-up|1
2297063|NCT02561806|3993117|FG001|Post-Treatment Follow-up|Lost to Follow-up|1
2297064|NCT02561806|3993116|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1
2297065|NCT02561806|3993117|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0
2297066|NCT02561832|3993140|FG000|Overall Study|Withdrawal by Subject|1
2297067|NCT02561832|3993141|FG001|Overall Study|Withdrawal by Subject|1
2297068|NCT02561832|3993140|FG000|Overall Study|Adverse Event|3
2297069|NCT02561832|3993141|FG001|Overall Study|Adverse Event|0
2297070|NCT02561832|3993140|FG000|Overall Study|Disease progression|3
2297071|NCT02561832|3993141|FG001|Overall Study|Disease progression|3
2297072|NCT02562482|3993170|FG000|Overall Study|Enrolled, but did not receive product|4
2297073|NCT02562482|3993171|FG001|Overall Study|Enrolled, but did not receive product|0
2297074|NCT02562482|3993170|FG000|Overall Study|Lost to Follow-up|9
2297075|NCT02562482|3993171|FG001|Overall Study|Lost to Follow-up|6
2175507|NCT01360645|3799000|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0
2297076|NCT02562482|3993170|FG000|Overall Study|Moved from area|2
2297077|NCT02562482|3993171|FG001|Overall Study|Moved from area|3
2297078|NCT02562482|3993170|FG000|Overall Study|Withdrawal by Subject|5
2297079|NCT02562482|3993171|FG001|Overall Study|Withdrawal by Subject|3
2297080|NCT02562482|3993170|FG000|Overall Study|Physician Decision|1
2297081|NCT02562482|3993171|FG001|Overall Study|Physician Decision|3
2297082|NCT02562482|3993170|FG000|Overall Study|Illness/Injury unrelated to product|0
2297083|NCT02562482|3993171|FG001|Overall Study|Illness/Injury unrelated to product|1
2297084|NCT02563028|3993233|FG000|Overall Study|Lack of equipment|1
2297085|NCT02563028|3993233|FG000|Overall Study|Unable to elicit VEP post induction|1
2297086|NCT02563067|3993240|FG000|Overall Study|Subject/guardian decision|14
2297087|NCT02563067|3993241|FG001|Overall Study|Subject/guardian decision|20
2297088|NCT02563067|3993242|FG002|Overall Study|Subject/guardian decision|16
2297089|NCT02563067|3993240|FG000|Overall Study|Physician Decision|0
2297090|NCT02563067|3993241|FG001|Overall Study|Physician Decision|1
2297091|NCT02563067|3993242|FG002|Overall Study|Physician Decision|3
2297092|NCT02563067|3993240|FG000|Overall Study|Lost to Follow-up|1
2297093|NCT02563067|3993241|FG001|Overall Study|Lost to Follow-up|2
2297094|NCT02563067|3993242|FG002|Overall Study|Lost to Follow-up|0
2297095|NCT02563067|3993240|FG000|Overall Study|Technical problems|0
2297096|NCT02563067|3993241|FG001|Overall Study|Technical problems|1
2297097|NCT02563067|3993242|FG002|Overall Study|Technical problems|0
2297098|NCT02563067|3993240|FG000|Overall Study|Lack of Efficacy|1
2297099|NCT02563067|3993241|FG001|Overall Study|Lack of Efficacy|0
2297100|NCT02563067|3993242|FG002|Overall Study|Lack of Efficacy|0
2297101|NCT02563067|3993240|FG000|Overall Study|Death|0
2297102|NCT02563067|3993241|FG001|Overall Study|Death|1
2297103|NCT02563067|3993242|FG002|Overall Study|Death|1
2297104|NCT02563067|3993240|FG000|Overall Study|Adverse Event|2
2297105|NCT02563067|3993241|FG001|Overall Study|Adverse Event|1
2297106|NCT02563067|3993242|FG002|Overall Study|Adverse Event|0
2297107|NCT02563067|3993240|FG000|Overall Study|Death post Treatment/safety period|1
2297108|NCT02563067|3993241|FG001|Overall Study|Death post Treatment/safety period|0
2297109|NCT02563067|3993242|FG002|Overall Study|Death post Treatment/safety period|0
2297110|NCT02563106|3993270|FG000|Overall Study|Withdrawal by Subject|7
2175508|NCT01360645|3798997|FG000|Phase B (6 Weeks)|Protocol Deviation|0
2175509|NCT01360645|3798998|FG001|Phase B (6 Weeks)|Protocol Deviation|1
2175510|NCT01360645|3798999|FG002|Phase B (6 Weeks)|Protocol Deviation|3
2175511|NCT01360645|3799000|FG003|Phase B (6 Weeks)|Protocol Deviation|0
2175512|NCT01360645|3798997|FG000|Phase A+|Lost to Follow-up|0
2175513|NCT01360645|3798998|FG001|Phase A+|Lost to Follow-up|0
2175514|NCT01360645|3798999|FG002|Phase A+|Lost to Follow-up|0
2175515|NCT01360645|3799000|FG003|Phase A+|Lost to Follow-up|7
2208288|NCT01638013|3847744|FG001|Overall Study|Met discontinuation criteria|0
2175516|NCT01360645|3798997|FG000|Phase A+|Adverse Event|0
2175517|NCT01360645|3798998|FG001|Phase A+|Adverse Event|0
2175518|NCT01360645|3798999|FG002|Phase A+|Adverse Event|0
2175519|NCT01360645|3799000|FG003|Phase A+|Adverse Event|2
2175520|NCT01360645|3798997|FG000|Phase A+|Met Withdrawal Criteria|0
2175521|NCT01360645|3798998|FG001|Phase A+|Met Withdrawal Criteria|0
2175522|NCT01360645|3798999|FG002|Phase A+|Met Withdrawal Criteria|0
2175523|NCT01360645|3799000|FG003|Phase A+|Met Withdrawal Criteria|4
2175524|NCT01360645|3798997|FG000|Phase A+|Physician Decision|0
2175525|NCT01360645|3798998|FG001|Phase A+|Physician Decision|0
2175526|NCT01360645|3798999|FG002|Phase A+|Physician Decision|0
2175527|NCT01360645|3799000|FG003|Phase A+|Physician Decision|2
2175528|NCT01360645|3798997|FG000|Phase A+|Withdrawal by Subject|0
2175529|NCT01360645|3798998|FG001|Phase A+|Withdrawal by Subject|0
2175530|NCT01360645|3798999|FG002|Phase A+|Withdrawal by Subject|0
2175531|NCT01360645|3799000|FG003|Phase A+|Withdrawal by Subject|5
2175532|NCT01360645|3798997|FG000|Phase A+|Protocol Deviation|0
2297111|NCT02563106|3993271|FG001|Overall Study|Withdrawal by Subject|8
2297112|NCT02563106|3993270|FG000|Overall Study|Adverse Event|17
2297113|NCT02563106|3993271|FG001|Overall Study|Adverse Event|15
2297114|NCT02563106|3993270|FG000|Overall Study|Protocol Violation|1
2297115|NCT02563106|3993271|FG001|Overall Study|Protocol Violation|0
2297116|NCT02563106|3993270|FG000|Overall Study|Use of non-permitted concurrent therapy|1
2297117|NCT02563106|3993271|FG001|Overall Study|Use of non-permitted concurrent therapy|2
2297118|NCT02563106|3993270|FG000|Overall Study|Lost to Follow-up|3
2297119|NCT02563106|3993271|FG001|Overall Study|Lost to Follow-up|2
2297120|NCT02563106|3993270|FG000|Overall Study|Physician Decision|3
2297121|NCT02563106|3993271|FG001|Overall Study|Physician Decision|1
2297122|NCT02563106|3993270|FG000|Overall Study|Other reason - not specified|2
2297123|NCT02563106|3993271|FG001|Overall Study|Other reason - not specified|1
2297124|NCT02563548|3993300|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
2297125|NCT02563548|3993301|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2297126|NCT02563548|3993302|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2297127|NCT02563548|3993303|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
2297128|NCT02563548|3993304|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2297129|NCT02563548|3993305|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2297130|NCT02563548|3993300|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
2297131|NCT02563548|3993301|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
2297132|NCT02563548|3993302|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
2297133|NCT02563548|3993303|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
2297134|NCT02563548|3993304|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
2297135|NCT02563548|3993305|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
2297136|NCT02563548|3993300|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2297137|NCT02563548|3993301|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2297138|NCT02563548|3993302|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
2297139|NCT02563548|3993303|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2297140|NCT02563548|3993304|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2297141|NCT02563548|3993305|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2297142|NCT02563548|3993300|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2297143|NCT02563548|3993301|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2297144|NCT02563548|3993302|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
2297145|NCT02563548|3993303|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
2297146|NCT02563548|3993304|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2297147|NCT02563548|3993305|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2297148|NCT02563548|3993300|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2297149|NCT02563548|3993301|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2297150|NCT02563548|3993302|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2297151|NCT02563548|3993303|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2297152|NCT02563548|3993304|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
2297153|NCT02563548|3993305|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
2297154|NCT02563548|3993300|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2297155|NCT02563548|3993301|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2297156|NCT02563548|3993302|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2297157|NCT02563548|3993303|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2297158|NCT02563548|3993304|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
2175533|NCT01360645|3798998|FG001|Phase A+|Protocol Deviation|0
2175534|NCT01360645|3798999|FG002|Phase A+|Protocol Deviation|0
2175535|NCT01360645|3799000|FG003|Phase A+|Protocol Deviation|4
2175536|NCT01360762|3799006|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7
2175537|NCT01360762|3799006|FG000|Main Study Period (12-month Treatment)|Death|5
2175538|NCT01360762|3799006|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
2175539|NCT01360762|3799006|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15
2175540|NCT01360762|3799006|FG000|Main Study Period (12-month Treatment)|Discontinuation|1
2175541|NCT01360762|3799006|FG000|Whole Study Period|Lost to Follow-up|10
2175542|NCT01360762|3799006|FG000|Whole Study Period|Death|7
2175543|NCT01360762|3799006|FG000|Whole Study Period|Patient relapsed|18
2175544|NCT01360762|3799006|FG000|Whole Study Period|Discontinuation of study drug for safety|1
2175545|NCT01360840|3799013|FG000|Overall Study|Ongoing at data cut-off|10
2175546|NCT01360840|3799014|FG001|Overall Study|Ongoing at data cut-off|10
2175547|NCT01360840|3799015|FG002|Overall Study|Ongoing at data cut-off|9
2175548|NCT01360866|3799029|FG000|Overall Study|Lost to Follow-up|11
2175549|NCT01360866|3799030|FG001|Overall Study|Lost to Follow-up|28
2175550|NCT01360866|3799031|FG002|Overall Study|Lost to Follow-up|41
2175551|NCT01360866|3799032|FG003|Overall Study|Lost to Follow-up|0
2175552|NCT01360866|3799029|FG000|Overall Study|Adverse Event|56
2175553|NCT01360866|3799030|FG001|Overall Study|Adverse Event|61
2175554|NCT01360866|3799031|FG002|Overall Study|Adverse Event|134
2175555|NCT01360866|3799032|FG003|Overall Study|Adverse Event|6
2175556|NCT01360866|3799029|FG000|Overall Study|Paticipant met withdrawal criteria|11
2175557|NCT01360866|3799030|FG001|Overall Study|Paticipant met withdrawal criteria|28
2175558|NCT01360866|3799031|FG002|Overall Study|Paticipant met withdrawal criteria|54
2175559|NCT01360866|3799032|FG003|Overall Study|Paticipant met withdrawal criteria|0
2175560|NCT01360866|3799029|FG000|Overall Study|Withdrawn by Investigator|9
2175561|NCT01360866|3799030|FG001|Overall Study|Withdrawn by Investigator|8
2175562|NCT01360866|3799031|FG002|Overall Study|Withdrawn by Investigator|31
2175563|NCT01360866|3799032|FG003|Overall Study|Withdrawn by Investigator|2
2175564|NCT01360866|3799029|FG000|Overall Study|Withdrawal by participant|79
2175565|NCT01360866|3799030|FG001|Overall Study|Withdrawal by participant|89
2175566|NCT01360866|3799031|FG002|Overall Study|Withdrawal by participant|168
2175567|NCT01360866|3799032|FG003|Overall Study|Withdrawal by participant|8
2175568|NCT01360866|3799029|FG000|Overall Study|Protocol Deviation|25
2175569|NCT01360866|3799030|FG001|Overall Study|Protocol Deviation|33
2175570|NCT01360866|3799031|FG002|Overall Study|Protocol Deviation|61
2175571|NCT01360866|3799032|FG003|Overall Study|Protocol Deviation|2
2175572|NCT01360866|3799029|FG000|Overall Study|Lack of Efficacy|30
2175573|NCT01360866|3799030|FG001|Overall Study|Lack of Efficacy|40
2175574|NCT01360866|3799031|FG002|Overall Study|Lack of Efficacy|30
2175575|NCT01360866|3799032|FG003|Overall Study|Lack of Efficacy|4
2175576|NCT01360996|3799045|FG000|Overall Study|Withdrawal by Subject|4
2175577|NCT01360996|3799046|FG001|Overall Study|Withdrawal by Subject|3
2297159|NCT02563548|3993305|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
2297160|NCT02563548|3993300|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2297161|NCT02563548|3993301|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2297162|NCT02563548|3993302|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2297163|NCT02563548|3993303|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2297164|NCT02563548|3993304|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
2297165|NCT02563548|3993305|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2297166|NCT02563548|3993300|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2297167|NCT02563548|3993301|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2297168|NCT02563548|3993302|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2297169|NCT02563548|3993303|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2297170|NCT02563548|3993304|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
2297171|NCT02563548|3993305|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
2297172|NCT02563548|3993300|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2297173|NCT02563548|3993301|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2297174|NCT02563548|3993302|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2297175|NCT02563548|3993303|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2297176|NCT02563548|3993304|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2297177|NCT02563548|3993305|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
2297178|NCT02563548|3993300|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2297179|NCT02563548|3993301|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2297180|NCT02563548|3993302|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2297181|NCT02563548|3993303|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2297182|NCT02563548|3993304|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2297183|NCT02563548|3993305|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
2297184|NCT02563548|3993300|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2297185|NCT02563548|3993301|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2297186|NCT02563548|3993302|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2297187|NCT02563548|3993303|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2297188|NCT02563548|3993304|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2297189|NCT02563548|3993305|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
2297190|NCT02563548|3993300|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2297191|NCT02563548|3993301|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2297192|NCT02563548|3993302|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2175578|NCT01360996|3799047|FG002|Overall Study|Withdrawal by Subject|2
2175579|NCT01360996|3799045|FG000|Overall Study|Noncompliant|2
2175580|NCT01360996|3799046|FG001|Overall Study|Noncompliant|0
2175581|NCT01360996|3799047|FG002|Overall Study|Noncompliant|0
2175582|NCT01361009|3799054|FG000|Overall Study|Protocol Violation|116
2175583|NCT01361126|3799082|FG000|Overall Study|Sponsor decision|0
2175584|NCT01361126|3799083|FG001|Overall Study|Sponsor decision|2
2175585|NCT01361178|3799092|FG000|Overall Study|Death|13
2175586|NCT01361178|3799093|FG001|Overall Study|Death|0
2175587|NCT01361308|3799107|FG000|Overall Study|Withdrawal by Subject|9
2175588|NCT01361308|3799108|FG001|Overall Study|Withdrawal by Subject|13
2175589|NCT01361308|3799107|FG000|Overall Study|Physician Decision|3
2175590|NCT01361308|3799108|FG001|Overall Study|Physician Decision|3
2175591|NCT01361308|3799107|FG000|Overall Study|Lack of Efficacy|2
2175592|NCT01361308|3799108|FG001|Overall Study|Lack of Efficacy|0
2175593|NCT01361308|3799107|FG000|Overall Study|Protocol Violation|1
2175594|NCT01361308|3799108|FG001|Overall Study|Protocol Violation|0
2297193|NCT02563548|3993303|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2297194|NCT02563548|3993304|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
2297195|NCT02563548|3993305|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2297196|NCT02563561|3993328|FG000|Overall Study|Histology Other than Ta, G1-G2|3
2297197|NCT02563561|3993329|FG001|Overall Study|Histology Other than Ta, G1-G2|6
2297198|NCT02563561|3993330|FG002|Overall Study|Histology Other than Ta, G1-G2|6
2297199|NCT02563561|3993328|FG000|Overall Study|Withdrew of Consent|1
2297200|NCT02563561|3993329|FG001|Overall Study|Withdrew of Consent|1
2297201|NCT02563561|3993330|FG002|Overall Study|Withdrew of Consent|2
2297202|NCT02563561|3993328|FG000|Overall Study|Lost to Follow-up|1
2297203|NCT02563561|3993329|FG001|Overall Study|Lost to Follow-up|1
2297204|NCT02563561|3993330|FG002|Overall Study|Lost to Follow-up|0
2297205|NCT02563561|3993328|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4
2297206|NCT02563561|3993329|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2
2297207|NCT02563561|3993330|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1
2297208|NCT02563561|3993328|FG000|Overall Study|Investigator Decision|3
2297209|NCT02563561|3993329|FG001|Overall Study|Investigator Decision|4
2297210|NCT02563561|3993330|FG002|Overall Study|Investigator Decision|2
2297211|NCT02563561|3993328|FG000|Overall Study|Sponsor Decision|5
2297212|NCT02563561|3993329|FG001|Overall Study|Sponsor Decision|2
2297213|NCT02563561|3993330|FG002|Overall Study|Sponsor Decision|4
2297214|NCT02563561|3993328|FG000|Overall Study|Other|1
2297215|NCT02563561|3993329|FG001|Overall Study|Other|5
2297216|NCT02563561|3993330|FG002|Overall Study|Other|2
2297217|NCT02563899|3993366|FG000|Overall Study|Protocol Violation|1
2297218|NCT02563899|3993367|FG001|Overall Study|Protocol Violation|0
2297219|NCT02563899|3993368|FG002|Overall Study|Protocol Violation|0
2297220|NCT02563899|3993369|FG003|Overall Study|Protocol Violation|0
2297221|NCT02563899|3993366|FG000|Overall Study|Withdrawal by Subject|0
2297222|NCT02563899|3993367|FG001|Overall Study|Withdrawal by Subject|0
2297223|NCT02563899|3993368|FG002|Overall Study|Withdrawal by Subject|1
2297224|NCT02563899|3993369|FG003|Overall Study|Withdrawal by Subject|0
2321296|NCT02959190|4035870|FG002|Open Label|Adverse Event|3
2321297|NCT02959190|4035871|FG003|Open Label|Adverse Event|4
2321298|NCT02959190|4035868|FG000|Open Label|Pregnancy|0
2321299|NCT02959190|4035869|FG001|Open Label|Pregnancy|1
2321300|NCT02959190|4035870|FG002|Open Label|Pregnancy|0
2321301|NCT02959190|4035871|FG003|Open Label|Pregnancy|0
2321302|NCT02959190|4035868|FG000|Open Label|Withdrawal by Subject|2
2321303|NCT02959190|4035869|FG001|Open Label|Withdrawal by Subject|8
2321304|NCT02959190|4035870|FG002|Open Label|Withdrawal by Subject|0
2321305|NCT02959190|4035871|FG003|Open Label|Withdrawal by Subject|0
2321306|NCT02959190|4035868|FG000|Open Label|Physician Decision|0
2321307|NCT02959190|4035869|FG001|Open Label|Physician Decision|0
2321308|NCT02959190|4035870|FG002|Open Label|Physician Decision|1
2321309|NCT02959190|4035871|FG003|Open Label|Physician Decision|0
2321310|NCT02959190|4035868|FG000|Open Label|Protocol Violation|0
2321311|NCT02959190|4035869|FG001|Open Label|Protocol Violation|0
2321312|NCT02959190|4035870|FG002|Open Label|Protocol Violation|0
2321313|NCT02959190|4035871|FG003|Open Label|Protocol Violation|2
2321314|NCT02959190|4035868|FG000|Post Treatment Follow Up|Adverse Event|1
2321315|NCT02959190|4035869|FG001|Post Treatment Follow Up|Adverse Event|1
2321316|NCT02959190|4035870|FG002|Post Treatment Follow Up|Adverse Event|0
2321317|NCT02959190|4035871|FG003|Post Treatment Follow Up|Adverse Event|0
2321318|NCT02959190|4035868|FG000|Post Treatment Follow Up|Withdrawal by Subject|2
2321319|NCT02959190|4035869|FG001|Post Treatment Follow Up|Withdrawal by Subject|0
2321320|NCT02959190|4035870|FG002|Post Treatment Follow Up|Withdrawal by Subject|1
2321321|NCT02959190|4035871|FG003|Post Treatment Follow Up|Withdrawal by Subject|0
2321322|NCT02959437|4035903|FG000|Overall Study|Death|33
2321323|NCT02959437|4035904|FG001|Overall Study|Death|3
2321324|NCT02959437|4035905|FG002|Overall Study|Death|0
2321325|NCT02959437|4035906|FG003|Overall Study|Death|0
2321326|NCT02959437|4035903|FG000|Overall Study|Lost to Follow-up|3
2321327|NCT02959437|4035904|FG001|Overall Study|Lost to Follow-up|1
2321328|NCT02959437|4035905|FG002|Overall Study|Lost to Follow-up|0
2321329|NCT02959437|4035906|FG003|Overall Study|Lost to Follow-up|0
2175595|NCT01361308|3799107|FG000|Overall Study|Lost to Follow-up|5
2175596|NCT01361308|3799108|FG001|Overall Study|Lost to Follow-up|4
2175597|NCT01361308|3799107|FG000|Overall Study|Adverse Event|8
2175598|NCT01361308|3799108|FG001|Overall Study|Adverse Event|4
2175599|NCT01361308|3799107|FG000|Overall Study|Eligibility Criteria Not Met|2
2175600|NCT01361308|3799108|FG001|Overall Study|Eligibility Criteria Not Met|3
2175601|NCT01361308|3799107|FG000|Overall Study|Failed C-SSRS|5
2175602|NCT01361308|3799108|FG001|Overall Study|Failed C-SSRS|2
2175603|NCT01361308|3799107|FG000|Overall Study|Other|0
2175604|NCT01361308|3799108|FG001|Overall Study|Other|1
2175605|NCT01361464|3799114|FG000|Overall Study|Death|1
2175606|NCT01361464|3799114|FG000|Overall Study|Withdrawal by Subject|2
2175607|NCT01361568|3799124|FG000|Overall Study|Adverse Event|0
2175608|NCT01361568|3799125|FG001|Overall Study|Adverse Event|0
2175609|NCT01361568|3799126|FG002|Overall Study|Adverse Event|0
2175610|NCT01361568|3799127|FG003|Overall Study|Adverse Event|0
2175611|NCT01361568|3799128|FG004|Overall Study|Adverse Event|1
2175612|NCT01361568|3799129|FG005|Overall Study|Adverse Event|0
2175613|NCT01361568|3799124|FG000|Overall Study|Physician Decision|0
2175614|NCT01361568|3799125|FG001|Overall Study|Physician Decision|0
2175615|NCT01361568|3799126|FG002|Overall Study|Physician Decision|0
2175616|NCT01361568|3799127|FG003|Overall Study|Physician Decision|0
2175617|NCT01361568|3799128|FG004|Overall Study|Physician Decision|0
2175618|NCT01361568|3799129|FG005|Overall Study|Physician Decision|1
2175619|NCT01361568|3799124|FG000|Overall Study|Withdrawal by Subject|2
2175620|NCT01361568|3799125|FG001|Overall Study|Withdrawal by Subject|1
2175621|NCT01361568|3799126|FG002|Overall Study|Withdrawal by Subject|0
2175622|NCT01361568|3799127|FG003|Overall Study|Withdrawal by Subject|0
2175623|NCT01361568|3799128|FG004|Overall Study|Withdrawal by Subject|0
2175624|NCT01361568|3799129|FG005|Overall Study|Withdrawal by Subject|1
2175625|NCT01361594|3799146|FG000|Overall Study|Withdrawal by Subject|1
2175626|NCT01361594|3799147|FG001|Overall Study|Withdrawal by Subject|2
2175627|NCT01361607|3799155|FG000|Overall Study|Adverse Event|38
2175628|NCT01361607|3799156|FG001|Overall Study|Adverse Event|29
2175629|NCT01361607|3799155|FG000|Overall Study|Withdrawal by Subject|19
2175630|NCT01361607|3799156|FG001|Overall Study|Withdrawal by Subject|8
2175631|NCT01361607|3799155|FG000|Overall Study|Withdrawal by Investigator|5
2175632|NCT01361607|3799156|FG001|Overall Study|Withdrawal by Investigator|3
2175633|NCT01361607|3799155|FG000|Overall Study|Lost to Follow-up|1
2175634|NCT01361607|3799156|FG001|Overall Study|Lost to Follow-up|0
2175635|NCT01361607|3799155|FG000|Overall Study|Met Withdrawal Criteria|1
2175636|NCT01361607|3799156|FG001|Overall Study|Met Withdrawal Criteria|1
2175637|NCT01361711|3799178|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1
2175638|NCT01361711|3799178|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1
2175639|NCT01361711|3799178|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7
2175640|NCT01361711|3799178|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2
2175641|NCT01361711|3799178|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1
2175642|NCT01361711|3799178|FG000|Completed Week 18 of Treatment|Complete Remission|2
2175643|NCT01361711|3799178|FG000|Completed Week 18 of Treatment|Other|9
2175644|NCT01361711|3799178|FG000|10 Year Follow-up|Still in follow-up|22
2175645|NCT01361711|3799178|FG000|10 Year Follow-up|Death|7
2175646|NCT01361711|3799178|FG000|10 Year Follow-up|Developed new cancer|1
2175647|NCT01361711|3799178|FG000|10 Year Follow-up|Lost to Follow-up|2
2175648|NCT01361711|3799178|FG000|10 Year Follow-up|New treatment started|6
2175649|NCT01361711|3799178|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11
2175650|NCT01361711|3799178|FG000|10 Year Follow-up|Progressive Disease|1
2175651|NCT01361919|3799196|FG000|Overall Study|technical issues|10
2175652|NCT01361919|3799197|FG001|Overall Study|technical issues|12
2175653|NCT01361919|3799198|FG002|Overall Study|technical issues|10
2175654|NCT01362049|3799210|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3
2175655|NCT01362049|3799211|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3
2175656|NCT01362049|3799212|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2
2175657|NCT01362049|3799213|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1
2175658|NCT01362049|3799210|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
2175659|NCT01362049|3799211|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
2175660|NCT01362049|3799212|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
2175661|NCT01362049|3799213|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
2175662|NCT01362062|3799229|FG000|Overall Study|Adverse Event|1
2175663|NCT01362062|3799230|FG001|Overall Study|Adverse Event|0
2175664|NCT01362062|3799229|FG000|Overall Study|Lost to Follow-up|11
2175665|NCT01362062|3799230|FG001|Overall Study|Lost to Follow-up|0
2175666|NCT01362062|3799229|FG000|Overall Study|Withdrawal by Subject|2
2175667|NCT01362062|3799230|FG001|Overall Study|Withdrawal by Subject|0
2175668|NCT01362062|3799229|FG000|Overall Study|Non-compliant participant|2
2175669|NCT01362062|3799230|FG001|Overall Study|Non-compliant participant|0
2175670|NCT01362062|3799229|FG000|Overall Study|Detected with Spondylo-arthritis|1
2175671|NCT01362062|3799230|FG001|Overall Study|Detected with Spondylo-arthritis|0
2175672|NCT01362062|3799229|FG000|Overall Study|Had significant improvement|9
2175673|NCT01362062|3799230|FG001|Overall Study|Had significant improvement|0
2175674|NCT01362140|3799246|FG000|Overall Study|Noncompliance|1
2175675|NCT01362140|3799247|FG001|Overall Study|Noncompliance|0
2175676|NCT01362140|3799246|FG000|Overall Study|Adverse Event|2
2175677|NCT01362140|3799247|FG001|Overall Study|Adverse Event|2
2175678|NCT01362140|3799246|FG000|Overall Study|Withdrawal by Subject|3
2175679|NCT01362140|3799247|FG001|Overall Study|Withdrawal by Subject|3
2297225|NCT02564042|3993417|FG000|Overall Study|Adverse Event|4
2297226|NCT02564042|3993418|FG001|Overall Study|Adverse Event|4
2297227|NCT02564042|3993419|FG002|Overall Study|Adverse Event|3
2297228|NCT02564042|3993420|FG003|Overall Study|Adverse Event|0
2297229|NCT02564042|3993421|FG004|Overall Study|Adverse Event|0
2297230|NCT02564042|3993422|FG005|Overall Study|Adverse Event|1
2297231|NCT02564042|3993417|FG000|Overall Study|Lost to Follow-up|1
2297232|NCT02564042|3993418|FG001|Overall Study|Lost to Follow-up|1
2297233|NCT02564042|3993419|FG002|Overall Study|Lost to Follow-up|1
2297234|NCT02564042|3993420|FG003|Overall Study|Lost to Follow-up|0
2297235|NCT02564042|3993421|FG004|Overall Study|Lost to Follow-up|1
2297236|NCT02564042|3993422|FG005|Overall Study|Lost to Follow-up|1
2297237|NCT02564042|3993417|FG000|Overall Study|Physician Decision|1
2297238|NCT02564042|3993418|FG001|Overall Study|Physician Decision|0
2297239|NCT02564042|3993419|FG002|Overall Study|Physician Decision|0
2297240|NCT02564042|3993420|FG003|Overall Study|Physician Decision|1
2297241|NCT02564042|3993421|FG004|Overall Study|Physician Decision|0
2297242|NCT02564042|3993422|FG005|Overall Study|Physician Decision|0
2297243|NCT02564042|3993417|FG000|Overall Study|Withdrawal by Subject|5
2297244|NCT02564042|3993418|FG001|Overall Study|Withdrawal by Subject|3
2297245|NCT02564042|3993419|FG002|Overall Study|Withdrawal by Subject|2
2297246|NCT02564042|3993420|FG003|Overall Study|Withdrawal by Subject|2
2297247|NCT02564042|3993421|FG004|Overall Study|Withdrawal by Subject|10
2297248|NCT02564042|3993422|FG005|Overall Study|Withdrawal by Subject|12
2297249|NCT02564055|3993442|FG000|Overall Study|Adverse Event|1
2297250|NCT02564055|3993443|FG001|Overall Study|Adverse Event|0
2297251|NCT02564055|3993444|FG002|Overall Study|Adverse Event|4
2297252|NCT02564055|3993445|FG003|Overall Study|Adverse Event|1
2297253|NCT02564055|3993446|FG004|Overall Study|Adverse Event|4
2297254|NCT02564055|3993447|FG005|Overall Study|Adverse Event|1
2297255|NCT02564055|3993442|FG000|Overall Study|Protocol Violation|1
2297256|NCT02564055|3993443|FG001|Overall Study|Protocol Violation|0
2297257|NCT02564055|3993444|FG002|Overall Study|Protocol Violation|0
2297258|NCT02564055|3993445|FG003|Overall Study|Protocol Violation|0
2297259|NCT02564055|3993446|FG004|Overall Study|Protocol Violation|0
2297260|NCT02564055|3993447|FG005|Overall Study|Protocol Violation|0
2297261|NCT02564055|3993442|FG000|Overall Study|Reached stopping criteria|0
2297262|NCT02564055|3993443|FG001|Overall Study|Reached stopping criteria|0
2297263|NCT02564055|3993444|FG002|Overall Study|Reached stopping criteria|0
2297264|NCT02564055|3993445|FG003|Overall Study|Reached stopping criteria|0
2297265|NCT02564055|3993446|FG004|Overall Study|Reached stopping criteria|0
2297266|NCT02564055|3993447|FG005|Overall Study|Reached stopping criteria|1
2297267|NCT02564055|3993442|FG000|Overall Study|Lost to Follow-up|0
2297268|NCT02564055|3993443|FG001|Overall Study|Lost to Follow-up|1
2297269|NCT02564055|3993444|FG002|Overall Study|Lost to Follow-up|4
2297270|NCT02564055|3993445|FG003|Overall Study|Lost to Follow-up|2
2297271|NCT02564055|3993446|FG004|Overall Study|Lost to Follow-up|1
2297272|NCT02564055|3993447|FG005|Overall Study|Lost to Follow-up|0
2297273|NCT02564055|3993442|FG000|Overall Study|Physician Decision|0
2297274|NCT02564055|3993443|FG001|Overall Study|Physician Decision|0
2297275|NCT02564055|3993444|FG002|Overall Study|Physician Decision|1
2297276|NCT02564055|3993445|FG003|Overall Study|Physician Decision|0
2297277|NCT02564055|3993446|FG004|Overall Study|Physician Decision|0
2297278|NCT02564055|3993447|FG005|Overall Study|Physician Decision|0
2297279|NCT02564055|3993442|FG000|Overall Study|Withdrawal by Subject|4
2297280|NCT02564055|3993443|FG001|Overall Study|Withdrawal by Subject|4
2297281|NCT02564055|3993444|FG002|Overall Study|Withdrawal by Subject|3
2297282|NCT02564055|3993445|FG003|Overall Study|Withdrawal by Subject|3
2297283|NCT02564055|3993446|FG004|Overall Study|Withdrawal by Subject|10
2297284|NCT02564055|3993447|FG005|Overall Study|Withdrawal by Subject|10
2297285|NCT02564120|3993466|FG000|Overall Study|Did not return release forms|160
2297286|NCT02564120|3993466|FG000|Overall Study|Death|58
2297287|NCT02564120|3993466|FG000|Overall Study|Withdrawal by Subject|204
2297288|NCT02564120|3993466|FG000|Overall Study|Other medical condition|24
2297289|NCT02564198|3993483|FG000|Overall Study|Withdrawal by Subject|2
2297290|NCT02564198|3993484|FG001|Overall Study|Withdrawal by Subject|4
2297291|NCT02564198|3993485|FG002|Overall Study|Withdrawal by Subject|0
2297292|NCT02564198|3993483|FG000|Overall Study|Adverse Event|0
2297293|NCT02564198|3993484|FG001|Overall Study|Adverse Event|1
2297294|NCT02564198|3993485|FG002|Overall Study|Adverse Event|0
2297295|NCT02564211|3993495|FG000|Overall Study|Adverse Event|4
2297296|NCT02564471|3993518|FG000|Overall Study|Adverse Event|1
2297297|NCT02564471|3993519|FG001|Overall Study|Adverse Event|0
2297298|NCT02564471|3993520|FG002|Overall Study|Adverse Event|0
2297299|NCT02564471|3993521|FG003|Overall Study|Adverse Event|0
2297300|NCT02564471|3993518|FG000|Overall Study|Withdrawal by Subject|2
2297301|NCT02564471|3993519|FG001|Overall Study|Withdrawal by Subject|1
2297302|NCT02564471|3993520|FG002|Overall Study|Withdrawal by Subject|3
2297303|NCT02564471|3993521|FG003|Overall Study|Withdrawal by Subject|0
2297304|NCT02564471|3993518|FG000|Overall Study|Lost to Follow-up|0
2297305|NCT02564471|3993519|FG001|Overall Study|Lost to Follow-up|2
2175680|NCT01362140|3799246|FG000|Overall Study|Administrative Decision|0
2297306|NCT02564471|3993520|FG002|Overall Study|Lost to Follow-up|0
2297307|NCT02564471|3993521|FG003|Overall Study|Lost to Follow-up|0
2175681|NCT01362140|3799247|FG001|Overall Study|Administrative Decision|1
2175682|NCT01362140|3799246|FG000|Overall Study|Death|2
2175683|NCT01362140|3799247|FG001|Overall Study|Death|1
2175684|NCT01362140|3799246|FG000|Overall Study|Other|1
2175685|NCT01362140|3799247|FG001|Overall Study|Other|1
2175686|NCT01362140|3799246|FG000|Overall Study|Protocol-specified Criteria|1
2175687|NCT01362140|3799247|FG001|Overall Study|Protocol-specified Criteria|2
2175688|NCT01362140|3799246|FG000|Overall Study|Discontinued Without Receiving Treatment|0
2175689|NCT01362140|3799247|FG001|Overall Study|Discontinued Without Receiving Treatment|1
2175690|NCT01362244|3799268|FG000|Overall Study|Adverse Event|3
2175691|NCT01362244|3799269|FG001|Overall Study|Adverse Event|5
2175692|NCT01362244|3799268|FG000|Overall Study|Lack of Efficacy|5
2175693|NCT01362244|3799269|FG001|Overall Study|Lack of Efficacy|11
2175694|NCT01362244|3799268|FG000|Overall Study|Lost to Follow-up|0
2175695|NCT01362244|3799269|FG001|Overall Study|Lost to Follow-up|2
2175696|NCT01362244|3799268|FG000|Overall Study|Protocol Violation|5
2175697|NCT01362244|3799269|FG001|Overall Study|Protocol Violation|1
2175698|NCT01362244|3799268|FG000|Overall Study|Withdrawal by Subject|2
2175699|NCT01362244|3799269|FG001|Overall Study|Withdrawal by Subject|1
2175700|NCT01362244|3799268|FG000|Overall Study|Did not Meet Continuation Criteria|17
2175701|NCT01362244|3799269|FG001|Overall Study|Did not Meet Continuation Criteria|11
2175702|NCT01362244|3799268|FG000|Overall Study|Protocol Defined Stopping Criteria|0
2175703|NCT01362244|3799269|FG001|Overall Study|Protocol Defined Stopping Criteria|1
2175704|NCT01362270|3799277|FG000|Overall Study|Withdrawal by Subject|1
2175705|NCT01362270|3799278|FG001|Overall Study|Withdrawal by Subject|0
2175706|NCT01362270|3799277|FG000|Overall Study|Met exclusion criteria after 1st session|0
2175707|NCT01362270|3799278|FG001|Overall Study|Met exclusion criteria after 1st session|1
2175708|NCT01362270|3799277|FG000|Overall Study|Met excl. criteria before 1st session|1
2175709|NCT01362270|3799278|FG001|Overall Study|Met excl. criteria before 1st session|1
2175710|NCT01362296|3799286|FG000|Randomized Phase (RP)|PD including Death due to PD|56
2175711|NCT01362296|3799287|FG001|Randomized Phase (RP)|PD including Death due to PD|28
2175712|NCT01362296|3799288|FG002|Randomized Phase (RP)|PD including Death due to PD|0
2175713|NCT01362296|3799289|FG003|Randomized Phase (RP)|PD including Death due to PD|0
2175714|NCT01362296|3799286|FG000|Randomized Phase (RP)|Physician Decision|1
2175715|NCT01362296|3799287|FG001|Randomized Phase (RP)|Physician Decision|9
2175716|NCT01362296|3799288|FG002|Randomized Phase (RP)|Physician Decision|0
2175717|NCT01362296|3799289|FG003|Randomized Phase (RP)|Physician Decision|0
2175718|NCT01362296|3799286|FG000|Randomized Phase (RP)|Withdrawal by Subject|2
2175719|NCT01362296|3799287|FG001|Randomized Phase (RP)|Withdrawal by Subject|1
2175720|NCT01362296|3799288|FG002|Randomized Phase (RP)|Withdrawal by Subject|0
2175721|NCT01362296|3799289|FG003|Randomized Phase (RP)|Withdrawal by Subject|0
2175722|NCT01362296|3799286|FG000|Randomized Phase (RP)|Adverse Event|20
2175723|NCT01362296|3799287|FG001|Randomized Phase (RP)|Adverse Event|4
2175724|NCT01362296|3799288|FG002|Randomized Phase (RP)|Adverse Event|0
2175725|NCT01362296|3799289|FG003|Randomized Phase (RP)|Adverse Event|0
2175726|NCT01362296|3799286|FG000|Randomized Phase (RP)|Study Closed/Terminated|8
2175727|NCT01362296|3799287|FG001|Randomized Phase (RP)|Study Closed/Terminated|1
2175728|NCT01362296|3799288|FG002|Randomized Phase (RP)|Study Closed/Terminated|0
2175729|NCT01362296|3799289|FG003|Randomized Phase (RP)|Study Closed/Terminated|0
2041719|NCT00440518|3612426|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
2041720|NCT00440518|3612427|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
2041721|NCT00440518|3612425|FG000|Maintenance and Safety Follow-up Periods|Other|0
2041722|NCT00440518|3612426|FG001|Maintenance and Safety Follow-up Periods|Other|0
2041723|NCT00440518|3612427|FG002|Maintenance and Safety Follow-up Periods|Other|2
2041724|NCT00440518|3612425|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
2041725|NCT00440518|3612426|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
2175730|NCT01362296|3799286|FG000|Crossover Phase|PD including Death due to PD|0
2175731|NCT01362296|3799287|FG001|Crossover Phase|PD including Death due to PD|0
2175732|NCT01362296|3799288|FG002|Crossover Phase|PD including Death due to PD|16
2175733|NCT01362296|3799289|FG003|Crossover Phase|PD including Death due to PD|1
2175734|NCT01362296|3799286|FG000|Crossover Phase|Withdrawal by Subject|0
2175735|NCT01362296|3799287|FG001|Crossover Phase|Withdrawal by Subject|0
2175736|NCT01362296|3799288|FG002|Crossover Phase|Withdrawal by Subject|2
2175737|NCT01362296|3799289|FG003|Crossover Phase|Withdrawal by Subject|1
2175738|NCT01362296|3799286|FG000|Crossover Phase|Adverse Event|0
2175739|NCT01362296|3799287|FG001|Crossover Phase|Adverse Event|0
2175740|NCT01362296|3799288|FG002|Crossover Phase|Adverse Event|4
2175741|NCT01362296|3799289|FG003|Crossover Phase|Adverse Event|0
2175742|NCT01362296|3799286|FG000|Crossover Phase|Study Closed/Terminated|0
2175743|NCT01362296|3799287|FG001|Crossover Phase|Study Closed/Terminated|0
2175744|NCT01362296|3799288|FG002|Crossover Phase|Study Closed/Terminated|1
2175745|NCT01362296|3799289|FG003|Crossover Phase|Study Closed/Terminated|0
2175746|NCT01362322|3799301|FG000|Overall Study|Withdrawal by Subject|3
2175747|NCT01362322|3799302|FG001|Overall Study|Withdrawal by Subject|1
2175748|NCT01362322|3799301|FG000|Overall Study|Lost to Follow-up|2
2175749|NCT01362322|3799302|FG001|Overall Study|Lost to Follow-up|6
2175750|NCT01362348|3799308|FG000|Overall Study|Protocol-defined stopping criteria|9
2175751|NCT01362348|3799308|FG000|Overall Study|Study closed/terminated|5
2175752|NCT01362439|3799312|FG000|Overall Study|Adverse Event|1
2175753|NCT01362439|3799312|FG000|Overall Study|Lack of Efficacy|3
2175754|NCT01362439|3799312|FG000|Overall Study|Lost to Follow-up|2
2175755|NCT01362439|3799312|FG000|Overall Study|Study medication non-compliant|1
2175756|NCT01362439|3799312|FG000|Overall Study|Participant who withdrew consent|8
2175757|NCT01362491|3799320|FG000|Overall Study|Ineligible|1
2175758|NCT01362491|3799321|FG001|Overall Study|Ineligible|0
2175759|NCT01362491|3799322|FG002|Overall Study|Ineligible|0
2175760|NCT01362517|3799331|FG000|Overall Study|Protocol Violation|1
2175761|NCT01362517|3799331|FG000|Overall Study|Lost to Follow-up|1
2175762|NCT01362530|3799340|FG000|Base Study (Cycle 1)|Adverse Event|2
2175763|NCT01362530|3799341|FG001|Base Study (Cycle 1)|Adverse Event|0
2175764|NCT01362530|3799340|FG000|Base Study (Cycle 1)|Physician Decision|0
2175765|NCT01362530|3799341|FG001|Base Study (Cycle 1)|Physician Decision|1
2297308|NCT02564718|3993542|FG000|Overall Study|Withdrew from treatment|0
2297309|NCT02564718|3993543|FG001|Overall Study|Withdrew from treatment|1
2297310|NCT02564887|3993551|FG000|Overall Study|Lost to Follow-up|6
2297311|NCT02564887|3993552|FG001|Overall Study|Lost to Follow-up|0
2297312|NCT02564952|3993569|FG000|Overall Study|Adverse Event|6
2297313|NCT02564952|3993569|FG000|Overall Study|Lost to Follow-up|1
2297314|NCT02564952|3993569|FG000|Overall Study|Participant Withdrawn by Investigator|1
2297315|NCT02564952|3993569|FG000|Overall Study|Withdrawal by Subject|1
2297316|NCT02564952|3993569|FG000|Overall Study|Low Efficacy|1
2297317|NCT02564952|3993569|FG000|Overall Study|Participant Met Withdrawal Criteria|1
2297318|NCT02565108|3993575|FG000|Overall Study|Adverse Event|1
2297319|NCT02565108|3993576|FG001|Overall Study|Adverse Event|0
2297320|NCT02565108|3993575|FG000|Overall Study|Withdrew Consent|1
2297321|NCT02565108|3993576|FG001|Overall Study|Withdrew Consent|0
2297322|NCT02565147|3993584|FG000|Overall Study|Withdrawal by Subject|5
2297323|NCT02565147|3993585|FG001|Overall Study|Withdrawal by Subject|1
2297324|NCT02565147|3993584|FG000|Overall Study|Lost to Follow-up|0
2297325|NCT02565147|3993585|FG001|Overall Study|Lost to Follow-up|1
2297326|NCT02565147|3993584|FG000|Overall Study|Death|1
2297327|NCT02565147|3993585|FG001|Overall Study|Death|1
2297328|NCT02565186|3993593|FG000|Overall Study|Adverse Event|113
2297329|NCT02565186|3993594|FG001|Overall Study|Adverse Event|148
2297330|NCT02565186|3993593|FG000|Overall Study|Lost to Follow-up|102
2297331|NCT02565186|3993594|FG001|Overall Study|Lost to Follow-up|93
2297332|NCT02565186|3993593|FG000|Overall Study|Non-Compliance|57
2297333|NCT02565186|3993594|FG001|Overall Study|Non-Compliance|55
2297334|NCT02565186|3993593|FG000|Overall Study|Withdrawal by Subject|229
2297335|NCT02565186|3993594|FG001|Overall Study|Withdrawal by Subject|214
2297336|NCT02565186|3993593|FG000|Overall Study|Physician Decision|18
2297337|NCT02565186|3993594|FG001|Overall Study|Physician Decision|16
2297338|NCT02565186|3993593|FG000|Overall Study|Sponsor Request|5
2297339|NCT02565186|3993594|FG001|Overall Study|Sponsor Request|9
2297340|NCT02565186|3993593|FG000|Overall Study|Missing|1
2297341|NCT02565186|3993594|FG001|Overall Study|Missing|0
2297342|NCT02565186|3993593|FG000|Overall Study|Did Not Receive Study Drug|55
2297343|NCT02565186|3993594|FG001|Overall Study|Did Not Receive Study Drug|86
2297344|NCT02565381|3993603|FG000|Overall Study|Lost to Follow-up|1
2297345|NCT02565381|3993604|FG001|Overall Study|Lost to Follow-up|0
2297346|NCT02565381|3993605|FG002|Overall Study|Lost to Follow-up|1
2297347|NCT02565511|3993626|FG000|Overall Study|Study terminated by Sponsor|35
2297348|NCT02565511|3993627|FG001|Overall Study|Study terminated by Sponsor|22
2297349|NCT02565511|3993628|FG002|Overall Study|Study terminated by Sponsor|235
2297350|NCT02565511|3993629|FG003|Overall Study|Study terminated by Sponsor|156
2297351|NCT02565511|3993626|FG000|Overall Study|Withdrawal by Subject|3
2297352|NCT02565511|3993627|FG001|Overall Study|Withdrawal by Subject|0
2297353|NCT02565511|3993628|FG002|Overall Study|Withdrawal by Subject|12
2297354|NCT02565511|3993629|FG003|Overall Study|Withdrawal by Subject|5
2297355|NCT02565511|3993626|FG000|Overall Study|Adverse Event|0
2297356|NCT02565511|3993627|FG001|Overall Study|Adverse Event|0
2297357|NCT02565511|3993628|FG002|Overall Study|Adverse Event|1
2297358|NCT02565511|3993629|FG003|Overall Study|Adverse Event|1
2297359|NCT02565511|3993626|FG000|Overall Study|Lost to Follow-up|4
2297360|NCT02565511|3993627|FG001|Overall Study|Lost to Follow-up|1
2297361|NCT02565511|3993628|FG002|Overall Study|Lost to Follow-up|0
2297362|NCT02565511|3993629|FG003|Overall Study|Lost to Follow-up|1
2297363|NCT02565511|3993626|FG000|Overall Study|Physician Decision|0
2297364|NCT02565511|3993627|FG001|Overall Study|Physician Decision|0
2297365|NCT02565511|3993628|FG002|Overall Study|Physician Decision|0
2297366|NCT02565511|3993629|FG003|Overall Study|Physician Decision|1
2297367|NCT02565511|3993626|FG000|Overall Study|Protocol deviation|0
2297368|NCT02565511|3993627|FG001|Overall Study|Protocol deviation|0
2297369|NCT02565511|3993628|FG002|Overall Study|Protocol deviation|3
2297370|NCT02565511|3993629|FG003|Overall Study|Protocol deviation|0
2297371|NCT02565576|3993641|FG000|Overall Study|abnormal lab value|2
2297372|NCT02565576|3993642|FG001|Overall Study|abnormal lab value|0
2297373|NCT02565576|3993641|FG000|Overall Study|subject / guardian decision|1
2297374|NCT02565576|3993642|FG001|Overall Study|subject / guardian decision|3
2297375|NCT02565576|3993641|FG000|Overall Study|Lost to Follow-up|1
2297376|NCT02565576|3993642|FG001|Overall Study|Lost to Follow-up|0
2297377|NCT02565576|3993641|FG000|Overall Study|Death|0
2297378|NCT02565576|3993642|FG001|Overall Study|Death|2
2297379|NCT02565576|3993641|FG000|Overall Study|Adverse Event|1
2175766|NCT01362530|3799340|FG000|Base Study (Cycle 1)|Protocol Violation|2
2175767|NCT01362530|3799341|FG001|Base Study (Cycle 1)|Protocol Violation|0
2175768|NCT01362530|3799340|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1
2175769|NCT01362530|3799341|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2
2175770|NCT01362530|3799340|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2
2175771|NCT01362530|3799341|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0
2175772|NCT01362530|3799340|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
2175773|NCT01362530|3799341|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
2175774|NCT01362530|3799340|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
2175775|NCT01362530|3799341|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
2175776|NCT01362530|3799340|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
2175777|NCT01362530|3799341|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
2175778|NCT01362530|3799340|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
2175779|NCT01362530|3799341|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
2175780|NCT01362530|3799340|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
2175781|NCT01362530|3799341|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
2175782|NCT01362530|3799340|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19
2175783|NCT01362530|3799341|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0
2175784|NCT01362530|3799340|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4
2175785|NCT01362530|3799341|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0
2175786|NCT01362530|3799340|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
2175787|NCT01362530|3799341|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
2175788|NCT01362608|3799350|FG000|Overall Study|Protocol Violation|0
2175789|NCT01362608|3799351|FG001|Overall Study|Protocol Violation|1
2175790|NCT01362608|3799350|FG000|Overall Study|Lost to Follow-up|3
2175791|NCT01362608|3799351|FG001|Overall Study|Lost to Follow-up|1
2175792|NCT01362608|3799350|FG000|Overall Study|Withdrawal by Subject|1
2175793|NCT01362608|3799351|FG001|Overall Study|Withdrawal by Subject|2
2175794|NCT01362608|3799350|FG000|Overall Study|Lack of Efficacy|0
2175795|NCT01362608|3799351|FG001|Overall Study|Lack of Efficacy|2
2175796|NCT01362608|3799350|FG000|Overall Study|Adverse Event|0
2175797|NCT01362608|3799351|FG001|Overall Study|Adverse Event|2
2175798|NCT01362790|3799376|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
2175799|NCT01362790|3799377|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2175800|NCT01362790|3799378|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2175801|NCT01362790|3799379|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2175802|NCT01362790|3799380|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2175803|NCT01362790|3799381|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2175804|NCT01362790|3799382|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2175805|NCT01362790|3799376|FG000|Pilot Phase & Phase 2|Adverse Event|0
2175806|NCT01362790|3799377|FG001|Pilot Phase & Phase 2|Adverse Event|1
2175807|NCT01362790|3799378|FG002|Pilot Phase & Phase 2|Adverse Event|0
2175808|NCT01362790|3799379|FG003|Pilot Phase & Phase 2|Adverse Event|1
2175809|NCT01362790|3799380|FG004|Pilot Phase & Phase 2|Adverse Event|0
2175810|NCT01362790|3799381|FG005|Pilot Phase & Phase 2|Adverse Event|2
2175811|NCT01362790|3799382|FG006|Pilot Phase & Phase 2|Adverse Event|0
2175812|NCT01362790|3799376|FG000|Pilot Phase & Phase 2|Physician Decision|0
2175813|NCT01362790|3799377|FG001|Pilot Phase & Phase 2|Physician Decision|0
2175814|NCT01362790|3799378|FG002|Pilot Phase & Phase 2|Physician Decision|0
2175815|NCT01362790|3799379|FG003|Pilot Phase & Phase 2|Physician Decision|1
2175816|NCT01362790|3799380|FG004|Pilot Phase & Phase 2|Physician Decision|0
2175817|NCT01362790|3799381|FG005|Pilot Phase & Phase 2|Physician Decision|0
2175818|NCT01362790|3799382|FG006|Pilot Phase & Phase 2|Physician Decision|0
2175819|NCT01362790|3799376|FG000|Pilot Phase & Phase 2|Developed antibodies|7
2175820|NCT01362790|3799377|FG001|Pilot Phase & Phase 2|Developed antibodies|2
2175821|NCT01362790|3799378|FG002|Pilot Phase & Phase 2|Developed antibodies|3
2297380|NCT02565576|3993642|FG001|Overall Study|Adverse Event|0
2297381|NCT02565615|3993653|FG000|Overall Study|Death|0
2297382|NCT02565615|3993654|FG001|Overall Study|Death|1
2297383|NCT02565615|3993655|FG002|Overall Study|Death|0
2297384|NCT02565615|3993656|FG003|Overall Study|Death|0
2297385|NCT02565615|3993657|FG004|Overall Study|Death|4
2297386|NCT02565615|3993653|FG000|Overall Study|Not willing to participate in study|2
2297387|NCT02565615|3993654|FG001|Overall Study|Not willing to participate in study|21
2297388|NCT02565615|3993655|FG002|Overall Study|Not willing to participate in study|0
2297389|NCT02565615|3993656|FG003|Overall Study|Not willing to participate in study|1
2297390|NCT02565615|3993657|FG004|Overall Study|Not willing to participate in study|169
2297391|NCT02565615|3993653|FG000|Overall Study|Lost to Follow-up|0
2297392|NCT02565615|3993654|FG001|Overall Study|Lost to Follow-up|4
2297393|NCT02565615|3993655|FG002|Overall Study|Lost to Follow-up|0
2297394|NCT02565615|3993656|FG003|Overall Study|Lost to Follow-up|1
2297395|NCT02565615|3993657|FG004|Overall Study|Lost to Follow-up|765
2297396|NCT02565615|3993653|FG000|Overall Study|Not meeting eligibility criteria|0
2297397|NCT02565615|3993654|FG001|Overall Study|Not meeting eligibility criteria|7
2297398|NCT02565615|3993655|FG002|Overall Study|Not meeting eligibility criteria|0
2297399|NCT02565615|3993656|FG003|Overall Study|Not meeting eligibility criteria|0
2297400|NCT02565615|3993657|FG004|Overall Study|Not meeting eligibility criteria|25
2175822|NCT01362790|3799379|FG003|Pilot Phase & Phase 2|Developed antibodies|8
2175823|NCT01362790|3799380|FG004|Pilot Phase & Phase 2|Developed antibodies|0
2175824|NCT01362790|3799381|FG005|Pilot Phase & Phase 2|Developed antibodies|0
2175825|NCT01362790|3799382|FG006|Pilot Phase & Phase 2|Developed antibodies|0
2175826|NCT01362790|3799376|FG000|Pilot Phase & Phase 2|Refused further treatment|0
2175827|NCT01362790|3799377|FG001|Pilot Phase & Phase 2|Refused further treatment|1
2175828|NCT01362790|3799378|FG002|Pilot Phase & Phase 2|Refused further treatment|0
2175829|NCT01362790|3799379|FG003|Pilot Phase & Phase 2|Refused further treatment|0
2175830|NCT01362790|3799380|FG004|Pilot Phase & Phase 2|Refused further treatment|0
2175831|NCT01362790|3799381|FG005|Pilot Phase & Phase 2|Refused further treatment|0
2175832|NCT01362790|3799382|FG006|Pilot Phase & Phase 2|Refused further treatment|0
2175833|NCT01362790|3799376|FG000|Pilot Phase & Phase 2|Progressive disease|1
2175834|NCT01362790|3799377|FG001|Pilot Phase & Phase 2|Progressive disease|2
2175835|NCT01362790|3799378|FG002|Pilot Phase & Phase 2|Progressive disease|2
2175836|NCT01362790|3799379|FG003|Pilot Phase & Phase 2|Progressive disease|3
2175837|NCT01362790|3799380|FG004|Pilot Phase & Phase 2|Progressive disease|0
2175838|NCT01362790|3799381|FG005|Pilot Phase & Phase 2|Progressive disease|2
2175839|NCT01362790|3799382|FG006|Pilot Phase & Phase 2|Progressive disease|0
2175840|NCT01362790|3799376|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
2175841|NCT01362790|3799377|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2175842|NCT01362790|3799378|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2175843|NCT01362790|3799379|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2175844|NCT01362790|3799380|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2175845|NCT01362790|3799381|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2175846|NCT01362790|3799382|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2175847|NCT01362790|3799376|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2208289|NCT01638013|3847745|FG002|Overall Study|Met discontinuation criteria|7
2208290|NCT01638013|3847743|FG000|Overall Study|Subject Lost to Follow up|1
2208291|NCT01638013|3847744|FG001|Overall Study|Subject Lost to Follow up|0
2208292|NCT01638013|3847745|FG002|Overall Study|Subject Lost to Follow up|1
2208293|NCT01638013|3847743|FG000|Overall Study|Miscellaneous|25
2208294|NCT01638013|3847744|FG001|Overall Study|Miscellaneous|19
2208295|NCT01638013|3847745|FG002|Overall Study|Miscellaneous|23
2297401|NCT02565615|3993653|FG000|Overall Study|Reason not defined|0
2297402|NCT02565615|3993654|FG001|Overall Study|Reason not defined|2
2297403|NCT02565615|3993655|FG002|Overall Study|Reason not defined|0
2297404|NCT02565615|3993656|FG003|Overall Study|Reason not defined|1
2297405|NCT02565615|3993657|FG004|Overall Study|Reason not defined|62
2297406|NCT02565615|3993653|FG000|Overall Study|Adverse Event|1
2297407|NCT02565615|3993654|FG001|Overall Study|Adverse Event|1
2297408|NCT02565615|3993655|FG002|Overall Study|Adverse Event|0
2297409|NCT02565615|3993656|FG003|Overall Study|Adverse Event|0
2297410|NCT02565615|3993657|FG004|Overall Study|Adverse Event|9
2297411|NCT02565615|3993653|FG000|Overall Study|Untreated|0
2297412|NCT02565615|3993654|FG001|Overall Study|Untreated|0
2297413|NCT02565615|3993655|FG002|Overall Study|Untreated|0
2297414|NCT02565615|3993656|FG003|Overall Study|Untreated|0
2297415|NCT02565615|3993657|FG004|Overall Study|Untreated|567
2297416|NCT02565706|3993682|FG000|Overall Study|Withdrawal by Subject|5
2297417|NCT02565706|3993683|FG001|Overall Study|Withdrawal by Subject|7
2297418|NCT02565706|3993684|FG002|Overall Study|Withdrawal by Subject|7
2297419|NCT02565706|3993685|FG003|Overall Study|Withdrawal by Subject|11
2297420|NCT02565706|3993682|FG000|Overall Study|Lost to Follow-up|72
2297421|NCT02565706|3993683|FG001|Overall Study|Lost to Follow-up|75
2297422|NCT02565706|3993684|FG002|Overall Study|Lost to Follow-up|82
2297423|NCT02565706|3993685|FG003|Overall Study|Lost to Follow-up|74
2297424|NCT02565784|3993700|FG000|First Treatment|Adverse Event|1
2297425|NCT02565784|3993700|FG000|First Treatment|Withdrawal by Subject|1
2297426|NCT02565784|3993700|FG000|Second Treatment|Withdrawal by Subject|2
2297427|NCT02565810|3993708|FG000|Overall Study|Withdrawal by Subject|1
2297428|NCT02565914|3993731|FG000|Overall Study|Adverse Event|17
2297429|NCT02565914|3993731|FG000|Overall Study|Withdrawal of consent (not due to AE)|25
2297430|NCT02565914|3993731|FG000|Overall Study|Lost to Follow-up|12
2297431|NCT02565914|3993731|FG000|Overall Study|Death (not treatment emergent)|1
2297432|NCT02565914|3993731|FG000|Overall Study|Other noncompliance|6
2297433|NCT02565914|3993731|FG000|Overall Study|Physician Decision|6
2297434|NCT02565914|3993731|FG000|Overall Study|Parent study termination by sponsor|1
2297435|NCT02565914|3993731|FG000|Overall Study|Commercial drug available|5
2297436|NCT02565914|3993731|FG000|Overall Study|Other|18
2297437|NCT02565914|3993731|FG000|Overall Study|Enrolled, but did not receive study drug|2
2208296|NCT01638013|3847743|FG000|Overall Study|Withdrawal of Consent|16
2208297|NCT01638013|3847744|FG001|Overall Study|Withdrawal of Consent|12
2208298|NCT01638013|3847745|FG002|Overall Study|Withdrawal of Consent|16
2208299|NCT01638013|3847743|FG000|Overall Study|Not met inclusion or exclusion criteria|0
2208300|NCT01638013|3847744|FG001|Overall Study|Not met inclusion or exclusion criteria|0
2208301|NCT01638013|3847745|FG002|Overall Study|Not met inclusion or exclusion criteria|1
2208302|NCT01638390|3847775|FG000|Overall Study|screening failures|21
2208303|NCT01638429|3847796|FG000|Overall Study|Withdrawal by Subject|1
2208304|NCT01638546|3847816|FG000|Overall Study|Adverse Event|1
2208305|NCT01638546|3847817|FG001|Overall Study|Adverse Event|3
2208306|NCT01638559|3847825|FG000|Overall Study|Lost to Follow-up|1
2175848|NCT01362790|3799377|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
2175849|NCT01362790|3799378|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2175850|NCT01362790|3799379|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2175851|NCT01362790|3799380|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2175852|NCT01362790|3799381|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2175853|NCT01362790|3799382|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2175854|NCT01362790|3799376|FG000|Pilot Phase & Phase 2|Death on study|0
2175855|NCT01362790|3799377|FG001|Pilot Phase & Phase 2|Death on study|0
2175856|NCT01362790|3799378|FG002|Pilot Phase & Phase 2|Death on study|0
2175857|NCT01362790|3799379|FG003|Pilot Phase & Phase 2|Death on study|1
2175858|NCT01362790|3799380|FG004|Pilot Phase & Phase 2|Death on study|0
2175859|NCT01362790|3799381|FG005|Pilot Phase & Phase 2|Death on study|0
2175860|NCT01362790|3799382|FG006|Pilot Phase & Phase 2|Death on study|0
2175861|NCT01362790|3799376|FG000|Dose De-escalation of Regimen A|Adverse Event|0
2175862|NCT01362790|3799377|FG001|Dose De-escalation of Regimen A|Adverse Event|0
2175863|NCT01362790|3799378|FG002|Dose De-escalation of Regimen A|Adverse Event|0
2175864|NCT01362790|3799379|FG003|Dose De-escalation of Regimen A|Adverse Event|0
2175865|NCT01362790|3799380|FG004|Dose De-escalation of Regimen A|Adverse Event|1
2175866|NCT01362790|3799381|FG005|Dose De-escalation of Regimen A|Adverse Event|0
2175867|NCT01362790|3799382|FG006|Dose De-escalation of Regimen A|Adverse Event|0
2208307|NCT01638559|3847825|FG000|Overall Study|Withdrawal by Subject|1
2208308|NCT01638559|3847825|FG000|Overall Study|Subject declined to travel for biopsy|1
2208309|NCT01638819|3847842|FG000|Overall Study|Lost to Follow-up|1
2208310|NCT01638819|3847843|FG001|Overall Study|Lost to Follow-up|0
2208311|NCT01639001|3847850|FG000|Overall Study|Refused further follow-up|9
2208312|NCT01639001|3847851|FG001|Overall Study|Refused further follow-up|12
2208313|NCT01639001|3847850|FG000|Overall Study|Lost to Follow-up|3
2297438|NCT02566005|3993745|FG000|Overall Study|vaginal bleeding|0
2297439|NCT02566005|3993746|FG001|Overall Study|vaginal bleeding|1
2297440|NCT02566005|3993745|FG000|Overall Study|received foley|8
2297441|NCT02566005|3993746|FG001|Overall Study|received foley|0
2297442|NCT02566005|3993745|FG000|Overall Study|did not receive foley|0
2297443|NCT02566005|3993746|FG001|Overall Study|did not receive foley|1
2297444|NCT02566005|3993745|FG000|Overall Study|labor after randomization|0
2297445|NCT02566005|3993746|FG001|Overall Study|labor after randomization|4
2297446|NCT02566031|3993754|FG000|Overall Study|Patient/guardian decision|14
2297447|NCT02566031|3993755|FG001|Overall Study|Patient/guardian decision|7
2297448|NCT02566031|3993754|FG000|Overall Study|Protocol deviation|2
2297449|NCT02566031|3993755|FG001|Overall Study|Protocol deviation|3
2297450|NCT02566031|3993754|FG000|Overall Study|Adverse Event|3
2297451|NCT02566031|3993755|FG001|Overall Study|Adverse Event|1
2297452|NCT02566031|3993754|FG000|Overall Study|Lost to Follow-up|1
2297453|NCT02566031|3993755|FG001|Overall Study|Lost to Follow-up|1
2297454|NCT02566109|3993789|FG000|Overall Study|Withdrawal by Subject|1
2297455|NCT02566525|3993840|FG000|Overall Study|Protocol Violation|3
2297456|NCT02566525|3993841|FG001|Overall Study|Protocol Violation|5
2297457|NCT02566577|3993851|FG000|Overall Study|Withdrawal by Subject|1
2297458|NCT02566577|3993852|FG001|Overall Study|Withdrawal by Subject|1
2297459|NCT02566577|3993851|FG000|Overall Study|Equipment failure|1
2297460|NCT02566577|3993852|FG001|Overall Study|Equipment failure|1
2297461|NCT02566577|3993851|FG000|Overall Study|Physical limitation|1
2297462|NCT02566577|3993852|FG001|Overall Study|Physical limitation|0
2297463|NCT02566759|3993886|FG000|All Parts|Withdrawal by Subject|0
2297464|NCT02566759|3993887|FG001|All Parts|Withdrawal by Subject|1
2297465|NCT02566759|3993888|FG002|All Parts|Withdrawal by Subject|0
2297466|NCT02566759|3993889|FG003|All Parts|Withdrawal by Subject|0
2297467|NCT02566759|3993890|FG004|All Parts|Withdrawal by Subject|0
2297468|NCT02566759|3993891|FG005|All Parts|Withdrawal by Subject|0
2297469|NCT02566759|3993892|FG006|All Parts|Withdrawal by Subject|0
2297470|NCT02566759|3993893|FG007|All Parts|Withdrawal by Subject|0
2297471|NCT02566759|3993894|FG008|All Parts|Withdrawal by Subject|0
2297472|NCT02566759|3993895|FG009|All Parts|Withdrawal by Subject|0
2297473|NCT02566759|3993896|FG010|All Parts|Withdrawal by Subject|0
2297474|NCT02566759|3993897|FG011|All Parts|Withdrawal by Subject|0
2297475|NCT02566759|3993898|FG012|All Parts|Withdrawal by Subject|0
2297476|NCT02566759|3993899|FG013|All Parts|Withdrawal by Subject|0
2297477|NCT02566759|3993900|FG014|All Parts|Withdrawal by Subject|0
2297478|NCT02566759|3993901|FG015|All Parts|Withdrawal by Subject|0
2297479|NCT02566759|3993902|FG016|All Parts|Withdrawal by Subject|0
2297480|NCT02566759|3993886|FG000|All Parts|Adverse Event|0
2297481|NCT02566759|3993887|FG001|All Parts|Adverse Event|0
2297482|NCT02566759|3993888|FG002|All Parts|Adverse Event|0
2297483|NCT02566759|3993889|FG003|All Parts|Adverse Event|0
2297484|NCT02566759|3993890|FG004|All Parts|Adverse Event|0
2297485|NCT02566759|3993891|FG005|All Parts|Adverse Event|0
2297486|NCT02566759|3993892|FG006|All Parts|Adverse Event|0
2297487|NCT02566759|3993893|FG007|All Parts|Adverse Event|0
2297488|NCT02566759|3993894|FG008|All Parts|Adverse Event|0
2297489|NCT02566759|3993895|FG009|All Parts|Adverse Event|0
2297490|NCT02566759|3993896|FG010|All Parts|Adverse Event|0
2297491|NCT02566759|3993897|FG011|All Parts|Adverse Event|0
2297492|NCT02566759|3993898|FG012|All Parts|Adverse Event|1
2297493|NCT02566759|3993899|FG013|All Parts|Adverse Event|3
2297494|NCT02566759|3993900|FG014|All Parts|Adverse Event|0
2175868|NCT01362790|3799376|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0
2175869|NCT01362790|3799377|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0
2175870|NCT01362790|3799378|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0
2175871|NCT01362790|3799379|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0
2175872|NCT01362790|3799380|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3
2175873|NCT01362790|3799381|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0
2175874|NCT01362790|3799382|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0
2175875|NCT01362790|3799376|FG000|Dose De-escalation of Regimen A|Progressive disease|0
2175876|NCT01362790|3799377|FG001|Dose De-escalation of Regimen A|Progressive disease|0
2175877|NCT01362790|3799378|FG002|Dose De-escalation of Regimen A|Progressive disease|0
2175878|NCT01362790|3799379|FG003|Dose De-escalation of Regimen A|Progressive disease|0
2175879|NCT01362790|3799380|FG004|Dose De-escalation of Regimen A|Progressive disease|2
2175880|NCT01362790|3799381|FG005|Dose De-escalation of Regimen A|Progressive disease|0
2175881|NCT01362790|3799382|FG006|Dose De-escalation of Regimen A|Progressive disease|0
2175882|NCT01363011|3799434|FG000|Main Study|Adverse Event|2
2175883|NCT01363011|3799435|FG001|Main Study|Adverse Event|3
2175884|NCT01363011|3799434|FG000|Main Study|Investigator's Discretion|1
2175885|NCT01363011|3799435|FG001|Main Study|Investigator's Discretion|1
2175886|NCT01363011|3799434|FG000|Main Study|Withdrew Consent|1
2175887|NCT01363011|3799435|FG001|Main Study|Withdrew Consent|4
2175888|NCT01363011|3799434|FG000|Main Study|Protocol Violation|0
2175889|NCT01363011|3799435|FG001|Main Study|Protocol Violation|1
2175890|NCT01363011|3799434|FG000|Extension Phase|Adverse Event|1
2175891|NCT01363011|3799435|FG001|Extension Phase|Adverse Event|1
2175892|NCT01363011|3799434|FG000|Extension Phase|Lack of Efficacy|0
2175893|NCT01363011|3799435|FG001|Extension Phase|Lack of Efficacy|1
2175894|NCT01363011|3799434|FG000|Extension Phase|Investigator's Discretion|2
2175895|NCT01363011|3799435|FG001|Extension Phase|Investigator's Discretion|2
2175896|NCT01363011|3799434|FG000|Extension Phase|Withdrew Consent|0
2175897|NCT01363011|3799435|FG001|Extension Phase|Withdrew Consent|1
2175898|NCT01363011|3799434|FG000|Extension Phase|Lost to Follow-up|0
2175899|NCT01363011|3799435|FG001|Extension Phase|Lost to Follow-up|2
2175900|NCT01363011|3799434|FG000|Extension Phase|Rolled Over to Another Gilead Study|2
2175901|NCT01363011|3799435|FG001|Extension Phase|Rolled Over to Another Gilead Study|1
2175902|NCT01363076|3799449|FG000|Overall Study|Withdrawal by Subject|0
2175903|NCT01363076|3799450|FG001|Overall Study|Withdrawal by Subject|1
2175904|NCT01363297|3799474|FG000|Overall Study|Other|0
2175905|NCT01363297|3799475|FG001|Overall Study|Other|0
2175906|NCT01363297|3799476|FG002|Overall Study|Other|0
2175907|NCT01363297|3799477|FG003|Overall Study|Other|0
2175908|NCT01363297|3799478|FG004|Overall Study|Other|1
2175909|NCT01363297|3799474|FG000|Overall Study|Death|3
2175910|NCT01363297|3799475|FG001|Overall Study|Death|6
2175911|NCT01363297|3799476|FG002|Overall Study|Death|6
2175912|NCT01363297|3799477|FG003|Overall Study|Death|10
2175913|NCT01363297|3799478|FG004|Overall Study|Death|30
2297495|NCT02566759|3993901|FG015|All Parts|Adverse Event|0
2297496|NCT02566759|3993902|FG016|All Parts|Adverse Event|0
2297497|NCT02566759|3993886|FG000|All Parts|Other|0
2297498|NCT02566759|3993887|FG001|All Parts|Other|0
2297499|NCT02566759|3993888|FG002|All Parts|Other|0
2297500|NCT02566759|3993889|FG003|All Parts|Other|0
2297501|NCT02566759|3993890|FG004|All Parts|Other|0
2297502|NCT02566759|3993891|FG005|All Parts|Other|0
2297503|NCT02566759|3993892|FG006|All Parts|Other|0
2297504|NCT02566759|3993893|FG007|All Parts|Other|0
2297505|NCT02566759|3993894|FG008|All Parts|Other|0
2297506|NCT02566759|3993895|FG009|All Parts|Other|0
2297507|NCT02566759|3993896|FG010|All Parts|Other|0
2297508|NCT02566759|3993897|FG011|All Parts|Other|0
2297509|NCT02566759|3993898|FG012|All Parts|Other|0
2297510|NCT02566759|3993899|FG013|All Parts|Other|2
2297511|NCT02566759|3993900|FG014|All Parts|Other|0
2297512|NCT02566759|3993901|FG015|All Parts|Other|0
2297513|NCT02566759|3993902|FG016|All Parts|Other|0
2297514|NCT02566759|3993886|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297515|NCT02566759|3993887|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297516|NCT02566759|3993888|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297517|NCT02566759|3993889|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297518|NCT02566759|3993890|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297519|NCT02566759|3993891|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297520|NCT02566759|3993892|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297521|NCT02566759|3993893|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297522|NCT02566759|3993894|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297523|NCT02566759|3993895|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297524|NCT02566759|3993896|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297525|NCT02566759|3993897|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297526|NCT02566759|3993898|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297527|NCT02566759|3993899|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297528|NCT02566759|3993900|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297529|NCT02566759|3993901|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2297530|NCT02566759|3993902|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
2297531|NCT02566785|3993963|FG000|Overall Study|Lost to Follow-up|0
2175914|NCT01363349|3799497|FG000|Overall Study|Adverse Event|6
2175915|NCT01363349|3799498|FG001|Overall Study|Adverse Event|7
2175916|NCT01363349|3799497|FG000|Overall Study|Lack of Efficacy|3
2175917|NCT01363349|3799498|FG001|Overall Study|Lack of Efficacy|10
2175918|NCT01363349|3799497|FG000|Overall Study|Non compliance/Protocol deviations|2
2175919|NCT01363349|3799498|FG001|Overall Study|Non compliance/Protocol deviations|2
2175920|NCT01363349|3799497|FG000|Overall Study|Withdrawal by Subject|14
2175921|NCT01363349|3799498|FG001|Overall Study|Withdrawal by Subject|6
2175922|NCT01363349|3799497|FG000|Overall Study|Lost to Follow-up|5
2175923|NCT01363349|3799498|FG001|Overall Study|Lost to Follow-up|6
2297532|NCT02566785|3993964|FG001|Overall Study|Lost to Follow-up|2
2297533|NCT02566785|3993963|FG000|Overall Study|Worsening condition|1
2297534|NCT02566785|3993964|FG001|Overall Study|Worsening condition|1
2297535|NCT02566889|3993972|FG000|Overall Study|Withdrawal by Subject|3
2297536|NCT02566889|3993973|FG001|Overall Study|Withdrawal by Subject|1
2297537|NCT02566889|3993972|FG000|Overall Study|Adverse Event|4
2297538|NCT02566889|3993973|FG001|Overall Study|Adverse Event|2
2297539|NCT02566889|3993972|FG000|Overall Study|Other|6
2297540|NCT02566889|3993973|FG001|Overall Study|Other|2
2297541|NCT02566902|3993980|FG000|Overall Study|Protocol Violation|2
2297542|NCT02566902|3993981|FG001|Overall Study|Protocol Violation|1
2297543|NCT02566993|3993989|FG000|Overall Study|Randomized but not treated|5
2297544|NCT02566993|3993990|FG001|Overall Study|Randomized but not treated|16
2297545|NCT02566993|3993989|FG000|Overall Study|Progressive disease|213
2297546|NCT02566993|3993990|FG001|Overall Study|Progressive disease|152
2297547|NCT02566993|3993989|FG000|Overall Study|Withdrawal by Subject|12
2297548|NCT02566993|3993990|FG001|Overall Study|Withdrawal by Subject|28
2297549|NCT02566993|3993989|FG000|Overall Study|Death|17
2297550|NCT02566993|3993990|FG001|Overall Study|Death|23
2297551|NCT02566993|3993989|FG000|Overall Study|Physician Decision|10
2297552|NCT02566993|3993990|FG001|Overall Study|Physician Decision|17
2297553|NCT02566993|3993989|FG000|Overall Study|Study drug-related adverse event|20
2297554|NCT02566993|3993990|FG001|Overall Study|Study drug-related adverse event|41
2297555|NCT02566993|3993989|FG000|Overall Study|Non study drug-related adverse event|9
2297556|NCT02566993|3993990|FG001|Overall Study|Non study drug-related adverse event|9
2297557|NCT02566993|3993989|FG000|Overall Study|Symptomatic deterioration|9
2297558|NCT02566993|3993990|FG001|Overall Study|Symptomatic deterioration|16
2297559|NCT02566993|3993989|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9
2297560|NCT02566993|3993990|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1
2297561|NCT02566993|3993989|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1
2297562|NCT02566993|3993990|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1
2297563|NCT02566993|3993989|FG000|Overall Study|Screening failure|2
2297564|NCT02566993|3993990|FG001|Overall Study|Screening failure|0
2297565|NCT02566993|3993989|FG000|Overall Study|Lost to Follow-up|0
2297566|NCT02566993|3993990|FG001|Overall Study|Lost to Follow-up|1
2297567|NCT02566993|3993989|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0
2297568|NCT02566993|3993990|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1
2297569|NCT02567188|3993998|FG000|Overall Study|Death|10
2297570|NCT02567188|3993998|FG000|Overall Study|Terminated Mircera Treatment|9
2297571|NCT02567188|3993998|FG000|Overall Study|Lost to Follow-up|5
2297572|NCT02567188|3993998|FG000|Overall Study|Adverse Event|1
2297573|NCT02567188|3993998|FG000|Overall Study|Withdrawal by Subject|1
2297574|NCT02567188|3993998|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1
2297575|NCT02567188|3993998|FG000|Overall Study|Moved and Changed Clinic|1
2297576|NCT02567188|3993998|FG000|Overall Study|Started Hemodialysis|2
2297577|NCT02567188|3993998|FG000|Overall Study|Protocol Violation|5
2297578|NCT02567227|3994005|FG000|9 Weeks|Adverse Event|5
2297579|NCT02567227|3994006|FG001|9 Weeks|Adverse Event|5
2297580|NCT02567227|3994005|FG000|9 Weeks|Withdrawal by Subject|18
2297581|NCT02567227|3994006|FG001|9 Weeks|Withdrawal by Subject|8
2297582|NCT02567227|3994005|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11
2297583|NCT02567227|3994006|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11
2297584|NCT02567227|3994005|FG000|6 Month|Death|2
2297585|NCT02567227|3994006|FG001|6 Month|Death|0
2297586|NCT02567227|3994005|FG000|6 Month|Lost to Follow-up|43
2297587|NCT02567227|3994006|FG001|6 Month|Lost to Follow-up|40
2297588|NCT02567227|3994005|FG000|12 Months|Lost to Follow-up|31
2297589|NCT02567227|3994006|FG001|12 Months|Lost to Follow-up|32
2297590|NCT02567227|3994005|FG000|12 Months|Death|0
2297591|NCT02567227|3994006|FG001|12 Months|Death|2
2297592|NCT02567266|3994015|FG000|Overall Study|Withdrawal by Subject|10
2297593|NCT02567266|3994016|FG001|Overall Study|Withdrawal by Subject|7
2297594|NCT02567266|3994017|FG002|Overall Study|Withdrawal by Subject|6
2297595|NCT02567266|3994015|FG000|Overall Study|Lost to Follow-up|13
2297596|NCT02567266|3994016|FG001|Overall Study|Lost to Follow-up|8
2297597|NCT02567266|3994017|FG002|Overall Study|Lost to Follow-up|10
2175924|NCT01363349|3799497|FG000|Overall Study|Not reported|36
2175925|NCT01363349|3799498|FG001|Overall Study|Not reported|37
2175926|NCT01363349|3799497|FG000|Overall Study|missing|1
2175927|NCT01363349|3799498|FG001|Overall Study|missing|2
2297598|NCT02567552|3994027|FG000|Overall Study|Adverse Event|0
2297599|NCT02567552|3994028|FG001|Overall Study|Adverse Event|1
2175928|NCT01363440|3799529|FG000|Overall Study|Adverse Event|5
2175929|NCT01363440|3799530|FG001|Overall Study|Adverse Event|4
2175930|NCT01363440|3799531|FG002|Overall Study|Adverse Event|4
2175931|NCT01363440|3799529|FG000|Overall Study|Death|3
2175932|NCT01363440|3799530|FG001|Overall Study|Death|7
2175933|NCT01363440|3799531|FG002|Overall Study|Death|5
2175934|NCT01363440|3799529|FG000|Overall Study|Withdrawal by Subject|9
2175935|NCT01363440|3799530|FG001|Overall Study|Withdrawal by Subject|11
2175936|NCT01363440|3799531|FG002|Overall Study|Withdrawal by Subject|11
2175937|NCT01363440|3799529|FG000|Overall Study|Lost to Follow-up|2
2175938|NCT01363440|3799530|FG001|Overall Study|Lost to Follow-up|4
2175939|NCT01363440|3799531|FG002|Overall Study|Lost to Follow-up|5
2175940|NCT01363440|3799529|FG000|Overall Study|Other|4
2175941|NCT01363440|3799530|FG001|Overall Study|Other|5
2175942|NCT01363440|3799531|FG002|Overall Study|Other|2
2175943|NCT01363661|3799559|FG000|Overall Study|Adverse Event|9
2175944|NCT01363661|3799560|FG001|Overall Study|Adverse Event|2
2175945|NCT01363661|3799559|FG000|Overall Study|Withdrawal by Subject|1
2175946|NCT01363661|3799560|FG001|Overall Study|Withdrawal by Subject|1
2297600|NCT02567656|3994040|FG000|Overall Study|Premature discontinuation due to PD|1
2297601|NCT02567656|3994041|FG001|Overall Study|Premature discontinuation due to PD|1
2297602|NCT02567656|3994042|FG002|Overall Study|Premature discontinuation due to PD|2
2297603|NCT02567656|3994043|FG003|Overall Study|Premature discontinuation due to PD|0
2297604|NCT02567656|3994044|FG004|Overall Study|Premature discontinuation due to PD|0
2297605|NCT02567656|3994045|FG005|Overall Study|Premature discontinuation due to PD|0
2297606|NCT02567708|3994059|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
2297607|NCT02567708|3994060|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
2297608|NCT02567708|3994059|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
2297609|NCT02567708|3994060|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
2297610|NCT02567708|3994059|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
2297611|NCT02567708|3994060|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
2297612|NCT02567708|3994059|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
2297613|NCT02567708|3994060|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
2297614|NCT02568046|3994076|FG000|Overall Study|Adverse Event|0
2297615|NCT02568046|3994077|FG001|Overall Study|Adverse Event|1
2297616|NCT02568046|3994076|FG000|Overall Study|Death|2
2297617|NCT02568046|3994077|FG001|Overall Study|Death|0
2297618|NCT02568046|3994076|FG000|Overall Study|Progressive Disease|1
2297619|NCT02568046|3994077|FG001|Overall Study|Progressive Disease|0
2297620|NCT02568046|3994076|FG000|Overall Study|Withdrawal by Subject|2
2297621|NCT02568046|3994077|FG001|Overall Study|Withdrawal by Subject|1
2297622|NCT02568046|3994076|FG000|Overall Study|Other Events|0
2297623|NCT02568046|3994077|FG001|Overall Study|Other Events|1
2297624|NCT02568072|3994083|FG000|Overall Study|Unavailable for appointment|23
2297625|NCT02568072|3994083|FG000|Overall Study|Unable to contact|3
2297626|NCT02568072|3994083|FG000|Overall Study|Diagnosis of Long QT Syndrome|1
2297627|NCT02568072|3994083|FG000|Overall Study|Withdrawal by Subject|1
2297628|NCT02568072|3994083|FG000|Overall Study|Sustained injury, marathon not run|24
2297629|NCT02568254|3994088|FG000|Period 2|Adverse Event|0
2297630|NCT02568254|3994089|FG001|Period 2|Adverse Event|0
2297631|NCT02568254|3994090|FG002|Period 2|Adverse Event|1
2297632|NCT02568254|3994091|FG003|Period 2|Adverse Event|0
2297633|NCT02568254|3994092|FG004|Period 2|Adverse Event|0
2297634|NCT02568254|3994093|FG005|Period 2|Adverse Event|0
2297635|NCT02568254|3994088|FG000|Period 3|Unstatisfactory Lens fitting|0
2297636|NCT02568254|3994089|FG001|Period 3|Unstatisfactory Lens fitting|0
2297637|NCT02568254|3994090|FG002|Period 3|Unstatisfactory Lens fitting|0
2297638|NCT02568254|3994091|FG003|Period 3|Unstatisfactory Lens fitting|0
2297639|NCT02568254|3994092|FG004|Period 3|Unstatisfactory Lens fitting|1
2297640|NCT02568254|3994093|FG005|Period 3|Unstatisfactory Lens fitting|0
2297641|NCT02568384|3994105|FG000|Overall Study|Mobile devices incompatible with App|2
2297642|NCT02568397|3994109|FG000|Period 2|Withdrawal by Subject|0
2297643|NCT02568397|3994110|FG001|Period 2|Withdrawal by Subject|1
2297644|NCT02568397|3994109|FG000|Period 2|Physician Decision|0
2297645|NCT02568397|3994110|FG001|Period 2|Physician Decision|1
2297646|NCT02568475|3994127|FG000|Overall Study|Lost to Follow-up|40
2297647|NCT02568475|3994128|FG001|Overall Study|Lost to Follow-up|39
2297648|NCT02568475|3994127|FG000|Overall Study|Withdrawal by Subject|2
2297649|NCT02568475|3994128|FG001|Overall Study|Withdrawal by Subject|0
2297650|NCT02568475|3994127|FG000|Overall Study|Discharged home|4
2297651|NCT02568475|3994128|FG001|Overall Study|Discharged home|4
2297652|NCT02568475|3994127|FG000|Overall Study|Short-term: Discharge location unknown|4
2297653|NCT02568475|3994128|FG001|Overall Study|Short-term: Discharge location unknown|0
2297654|NCT02568475|3994127|FG000|Overall Study|Transferred to another facility|1
2297655|NCT02568475|3994128|FG001|Overall Study|Transferred to another facility|0
2297656|NCT02568683|3994147|FG000|Overall Study|Death|0
2297657|NCT02568683|3994148|FG001|Overall Study|Death|2
2297658|NCT02568683|3994147|FG000|Overall Study|Withdrew Consent|1
2297659|NCT02568683|3994148|FG001|Overall Study|Withdrew Consent|0
2297660|NCT02568683|3994147|FG000|Overall Study|Study Terminated By Sponsor|5
2297661|NCT02568683|3994148|FG001|Overall Study|Study Terminated By Sponsor|2
2297662|NCT02569398|3994176|FG000|Overall Study|Adverse Event|0
2175947|NCT01363661|3799559|FG000|Overall Study|Protocol Violation|1
2175948|NCT01363661|3799560|FG001|Overall Study|Protocol Violation|0
2175949|NCT01363661|3799559|FG000|Overall Study|Lost to Follow-up|3
2175950|NCT01363661|3799560|FG001|Overall Study|Lost to Follow-up|1
2297663|NCT02569398|3994177|FG001|Overall Study|Adverse Event|1
2297664|NCT02569398|3994178|FG002|Overall Study|Adverse Event|6
2297665|NCT02569398|3994176|FG000|Overall Study|Withdrawal by Subject|43
2297666|NCT02569398|3994177|FG001|Overall Study|Withdrawal by Subject|43
2297667|NCT02569398|3994178|FG002|Overall Study|Withdrawal by Subject|30
2297668|NCT02569398|3994176|FG000|Overall Study|Study terminated by sponsor|130
2297669|NCT02569398|3994177|FG001|Overall Study|Study terminated by sponsor|131
2297670|NCT02569398|3994178|FG002|Overall Study|Study terminated by sponsor|134
2297671|NCT02569398|3994176|FG000|Overall Study|Other|12
2297672|NCT02569398|3994177|FG001|Overall Study|Other|14
2297673|NCT02569398|3994178|FG002|Overall Study|Other|13
2297674|NCT02569437|3994197|FG000|Overall Study|Lost to Follow-up|12
2297675|NCT02569437|3994198|FG001|Overall Study|Lost to Follow-up|14
2297676|NCT02569476|3994204|FG000|Overall Study|Roll over to Long-Term Extension Study|73
2297677|NCT02569476|3994204|FG000|Overall Study|Death|33
2297678|NCT02569476|3994204|FG000|Overall Study|Withdrawal by Subject|9
2297679|NCT02569476|3994204|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1
2297680|NCT02569476|3994204|FG000|Overall Study|Palliative care|1
2297681|NCT02569476|3994204|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1
2297682|NCT02569476|3994204|FG000|Overall Study|Transitioned to Long Term Extension Study|1
2297683|NCT02569710|3994241|FG000|Overall Study|Adverse Event|1
2297684|NCT02569710|3994242|FG001|Overall Study|Adverse Event|0
2297685|NCT02569710|3994243|FG002|Overall Study|Adverse Event|0
2297686|NCT02569710|3994244|FG003|Overall Study|Adverse Event|0
2297687|NCT02569710|3994245|FG004|Overall Study|Adverse Event|0
2297688|NCT02569710|3994246|FG005|Overall Study|Adverse Event|0
2297689|NCT02569710|3994247|FG006|Overall Study|Adverse Event|0
2297690|NCT02569710|3994248|FG007|Overall Study|Adverse Event|0
2297691|NCT02569710|3994249|FG008|Overall Study|Adverse Event|0
2297692|NCT02569710|3994250|FG009|Overall Study|Adverse Event|0
2297693|NCT02569710|3994241|FG000|Overall Study|Lost to Follow-up|0
2297694|NCT02569710|3994242|FG001|Overall Study|Lost to Follow-up|0
2297695|NCT02569710|3994243|FG002|Overall Study|Lost to Follow-up|0
2297696|NCT02569710|3994244|FG003|Overall Study|Lost to Follow-up|0
2297697|NCT02569710|3994245|FG004|Overall Study|Lost to Follow-up|0
2297698|NCT02569710|3994246|FG005|Overall Study|Lost to Follow-up|0
2297699|NCT02569710|3994247|FG006|Overall Study|Lost to Follow-up|1
2297700|NCT02569710|3994248|FG007|Overall Study|Lost to Follow-up|0
2297701|NCT02569710|3994249|FG008|Overall Study|Lost to Follow-up|1
2297702|NCT02569710|3994250|FG009|Overall Study|Lost to Follow-up|0
2297703|NCT02569710|3994241|FG000|Overall Study|Virologic failure|0
2297704|NCT02569710|3994242|FG001|Overall Study|Virologic failure|0
2297705|NCT02569710|3994243|FG002|Overall Study|Virologic failure|0
2297706|NCT02569710|3994244|FG003|Overall Study|Virologic failure|0
2297707|NCT02569710|3994245|FG004|Overall Study|Virologic failure|1
2297708|NCT02569710|3994246|FG005|Overall Study|Virologic failure|0
2297709|NCT02569710|3994247|FG006|Overall Study|Virologic failure|1
2297710|NCT02569710|3994248|FG007|Overall Study|Virologic failure|0
2297711|NCT02569710|3994249|FG008|Overall Study|Virologic failure|0
2297712|NCT02569710|3994250|FG009|Overall Study|Virologic failure|0
2297713|NCT02569710|3994241|FG000|Overall Study|Withdrawal by Subject|0
2297714|NCT02569710|3994242|FG001|Overall Study|Withdrawal by Subject|0
2297715|NCT02569710|3994243|FG002|Overall Study|Withdrawal by Subject|0
2297716|NCT02569710|3994244|FG003|Overall Study|Withdrawal by Subject|0
2297717|NCT02569710|3994245|FG004|Overall Study|Withdrawal by Subject|0
2297718|NCT02569710|3994246|FG005|Overall Study|Withdrawal by Subject|1
2297719|NCT02569710|3994247|FG006|Overall Study|Withdrawal by Subject|0
2297720|NCT02569710|3994248|FG007|Overall Study|Withdrawal by Subject|0
2297721|NCT02569710|3994249|FG008|Overall Study|Withdrawal by Subject|0
2297722|NCT02569710|3994250|FG009|Overall Study|Withdrawal by Subject|0
2297723|NCT02569801|3994289|FG000|Overall Study|Withdrawal by Subject|9
2297724|NCT02569801|3994290|FG001|Overall Study|Withdrawal by Subject|9
2297725|NCT02569801|3994289|FG000|Overall Study|Sponsor Decision|13
2297726|NCT02569801|3994290|FG001|Overall Study|Sponsor Decision|14
2297727|NCT02569801|3994289|FG000|Overall Study|Progressive Disease|2
2297728|NCT02569801|3994290|FG001|Overall Study|Progressive Disease|7
2297729|NCT02569801|3994289|FG000|Overall Study|Lost to Follow-up|0
2297730|NCT02569801|3994290|FG001|Overall Study|Lost to Follow-up|1
2297731|NCT02569801|3994289|FG000|Overall Study|Death|12
2297732|NCT02569801|3994290|FG001|Overall Study|Death|4
2297733|NCT02569853|3994298|FG000|Overall Study|Adverse Event|2
2297734|NCT02569853|3994299|FG001|Overall Study|Adverse Event|0
2297735|NCT02569853|3994298|FG000|Overall Study|Withdrawal by Subject|3
2297736|NCT02569853|3994299|FG001|Overall Study|Withdrawal by Subject|2
2297737|NCT02569853|3994298|FG000|Overall Study|Lost to Follow-up|3
2297738|NCT02569853|3994299|FG001|Overall Study|Lost to Follow-up|3
2297739|NCT02569853|3994298|FG000|Overall Study|Protocol Violation|1
2297740|NCT02569853|3994299|FG001|Overall Study|Protocol Violation|1
2297741|NCT02569853|3994298|FG000|Overall Study|Did not experience migraine attack|10
2297742|NCT02569853|3994299|FG001|Overall Study|Did not experience migraine attack|7
2297743|NCT02569853|3994298|FG000|Overall Study|Physician Decision|1
2297744|NCT02569853|3994299|FG001|Overall Study|Physician Decision|1
2175951|NCT01363700|3799569|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2175952|NCT01363700|3799570|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1
2175953|NCT01363700|3799571|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2175954|NCT01363700|3799572|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2175955|NCT01363700|3799573|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2175956|NCT01363713|3799584|FG000|Overall Study|Adverse Event|1
2175957|NCT01363713|3799584|FG000|Overall Study|Protocol Violation|3
2175958|NCT01363713|3799584|FG000|Overall Study|Withdrawal by Subject|2
2175959|NCT01363765|3799590|FG000|Overall Study|non-diagnostic|2621
2175960|NCT01363765|3799591|FG001|Overall Study|non-diagnostic|1124
2175961|NCT01363765|3799590|FG000|Overall Study|duplicate records|736
2175962|NCT01363765|3799591|FG001|Overall Study|duplicate records|3177
2175963|NCT01363765|3799590|FG000|Overall Study|non-resident|156
2175964|NCT01363765|3799591|FG001|Overall Study|non-resident|76
2175965|NCT01363765|3799590|FG000|Overall Study|age not recorded (used for cross-linkage|117
2175966|NCT01363765|3799591|FG001|Overall Study|age not recorded (used for cross-linkage|354
2175967|NCT01363765|3799590|FG000|Overall Study|smear during intervention|2170
2175968|NCT01363765|3799591|FG001|Overall Study|smear during intervention|0
2175969|NCT01363908|3799606|FG000|Chronic Dosing (CD) Phase|Adverse Event|1
2175970|NCT01363908|3799607|FG001|Chronic Dosing (CD) Phase|Adverse Event|1
2175971|NCT01363908|3799606|FG000|Chronic Dosing (CD) Phase|Patient decision|0
2175972|NCT01363908|3799607|FG001|Chronic Dosing (CD) Phase|Patient decision|1
2175973|NCT01363908|3799606|FG000|Chronic Dosing (CD) Phase|Physician Decision|0
2175974|NCT01363908|3799607|FG001|Chronic Dosing (CD) Phase|Physician Decision|1
2175975|NCT01363908|3799606|FG000|Chronic Dosing (CD) Phase|Early study termination|9
2175976|NCT01363908|3799607|FG001|Chronic Dosing (CD) Phase|Early study termination|3
2175977|NCT01363986|3799613|FG000|Overall Study|Disease progression|1
2175978|NCT01364233|3799644|FG000|Overall Study|Lost to Follow-up|1
2175979|NCT01364298|3799659|FG000|Overall Study|Adverse Event|3
2175980|NCT01364298|3799660|FG001|Overall Study|Adverse Event|4
2175981|NCT01364298|3799659|FG000|Overall Study|Lack of adherence to treatment|1
2175982|NCT01364298|3799660|FG001|Overall Study|Lack of adherence to treatment|3
2175983|NCT01364298|3799659|FG000|Overall Study|Lack of Efficacy|1
2175984|NCT01364298|3799660|FG001|Overall Study|Lack of Efficacy|0
2175985|NCT01364298|3799659|FG000|Overall Study|Lost to Follow-up|5
2175986|NCT01364298|3799660|FG001|Overall Study|Lost to Follow-up|10
2175987|NCT01364298|3799659|FG000|Overall Study|Withdrawal by Subject|3
2175988|NCT01364298|3799660|FG001|Overall Study|Withdrawal by Subject|3
2175989|NCT01364298|3799659|FG000|Overall Study|Other|1
2175990|NCT01364298|3799660|FG001|Overall Study|Other|3
2180000|NCT01397448|3805846|FG000|Overall Study|Lack of Efficacy|2
2180001|NCT01397448|3805847|FG001|Overall Study|Lack of Efficacy|0
2180002|NCT01397448|3805848|FG002|Overall Study|Lack of Efficacy|5
2180003|NCT01397448|3805846|FG000|Overall Study|Other|8
2180004|NCT01397448|3805847|FG001|Overall Study|Other|7
2180005|NCT01397448|3805848|FG002|Overall Study|Other|4
2180006|NCT01397461|3805859|FG000|Overall Study|Withdrawal by Subject|2
2180007|NCT01397461|3805860|FG001|Overall Study|Withdrawal by Subject|1
2180008|NCT01397461|3805861|FG002|Overall Study|Withdrawal by Subject|0
2180009|NCT01397461|3805859|FG000|Overall Study|Lost to Follow-up|0
2180010|NCT01397461|3805860|FG001|Overall Study|Lost to Follow-up|2
2180011|NCT01397461|3805861|FG002|Overall Study|Lost to Follow-up|1
2180012|NCT01397461|3805859|FG000|Overall Study|Lack of Efficacy|0
2180013|NCT01397461|3805860|FG001|Overall Study|Lack of Efficacy|3
2180014|NCT01397461|3805861|FG002|Overall Study|Lack of Efficacy|0
2180015|NCT01397461|3805859|FG000|Overall Study|Not treated|0
2180016|NCT01397461|3805860|FG001|Overall Study|Not treated|0
2180017|NCT01397461|3805861|FG002|Overall Study|Not treated|1
2180018|NCT01397747|3805901|FG000|Overall Study|Multitarget DNA test excluded|689
2180019|NCT01397747|3805901|FG000|Overall Study|Colonoscopy excluded|304
2180020|NCT01397747|3805901|FG000|Overall Study|FIT excluded|34
2180021|NCT01397786|3805909|FG000|Phase A|Lost to Follow-up|0
2180022|NCT01397786|3805910|FG001|Phase A|Lost to Follow-up|0
2180023|NCT01397786|3805911|FG002|Phase A|Lost to Follow-up|6
2180024|NCT01397786|3805909|FG000|Phase A|Adverse Event|0
2180025|NCT01397786|3805910|FG001|Phase A|Adverse Event|0
2180026|NCT01397786|3805911|FG002|Phase A|Adverse Event|8
2180027|NCT01397786|3805909|FG000|Phase A|Subject Met Withdrawal Criteria|0
2180028|NCT01397786|3805910|FG001|Phase A|Subject Met Withdrawal Criteria|0
2180029|NCT01397786|3805911|FG002|Phase A|Subject Met Withdrawal Criteria|7
2180030|NCT01397786|3805909|FG000|Phase A|Physician Decision|0
2180031|NCT01397786|3805910|FG001|Phase A|Physician Decision|0
2180032|NCT01397786|3805911|FG002|Phase A|Physician Decision|1
2180033|NCT01397786|3805909|FG000|Phase A|Withdrawal by Subject|0
2180034|NCT01397786|3805910|FG001|Phase A|Withdrawal by Subject|0
2180035|NCT01397786|3805911|FG002|Phase A|Withdrawal by Subject|5
2180036|NCT01397786|3805909|FG000|Phase A|Lack of Efficacy|0
2180037|NCT01397786|3805910|FG001|Phase A|Lack of Efficacy|0
2180038|NCT01397786|3805911|FG002|Phase A|Lack of Efficacy|1
2180039|NCT01397786|3805909|FG000|Phase B|Lost to Follow-up|22
2180040|NCT01397786|3805910|FG001|Phase B|Lost to Follow-up|12
2180041|NCT01397786|3805911|FG002|Phase B|Lost to Follow-up|22
2180042|NCT01397786|3805909|FG000|Phase B|Adverse Event|109
2180043|NCT01397786|3805910|FG001|Phase B|Adverse Event|23
2180044|NCT01397786|3805911|FG002|Phase B|Adverse Event|27
2180045|NCT01397786|3805909|FG000|Phase B|Subject Met Withdrawal Criteria|38
2175991|NCT01364389|3799669|FG000|Overall Study|Withdrawal by Subject|0
2175992|NCT01364389|3799670|FG001|Overall Study|Withdrawal by Subject|1
2175993|NCT01364389|3799671|FG002|Overall Study|Withdrawal by Subject|0
2175994|NCT01364389|3799669|FG000|Overall Study|Protocol deviation|0
2175995|NCT01364389|3799670|FG001|Overall Study|Protocol deviation|0
2175996|NCT01364389|3799671|FG002|Overall Study|Protocol deviation|1
2175997|NCT01364389|3799669|FG000|Overall Study|Administrative problems|1
2175998|NCT01364389|3799670|FG001|Overall Study|Administrative problems|0
2175999|NCT01364389|3799671|FG002|Overall Study|Administrative problems|0
2176000|NCT01364389|3799669|FG000|Overall Study|Adverse Event|1
2176001|NCT01364389|3799670|FG001|Overall Study|Adverse Event|0
2176002|NCT01364389|3799671|FG002|Overall Study|Adverse Event|0
2176003|NCT01364428|3799681|FG000|Overall Study|Adverse Event|1
2176004|NCT01364428|3799682|FG001|Overall Study|Adverse Event|2
2176005|NCT01364428|3799681|FG000|Overall Study|Protocol Violation|2
2176006|NCT01364428|3799682|FG001|Overall Study|Protocol Violation|0
2176007|NCT01364428|3799681|FG000|Overall Study|Withdrawal Criteria|14
2176008|NCT01364428|3799682|FG001|Overall Study|Withdrawal Criteria|10
2176009|NCT01364428|3799681|FG000|Overall Study|Other|3
2176010|NCT01364428|3799682|FG001|Overall Study|Other|3
2176011|NCT01364467|3799690|FG000|Overall Study|Lost to Follow-up|1
2176012|NCT01364467|3799691|FG001|Overall Study|Lost to Follow-up|2
2176013|NCT01364649|3799741|FG000|Overall Study|Pretreatment Event or Adverse Event|20
2176014|NCT01364649|3799742|FG001|Overall Study|Pretreatment Event or Adverse Event|14
2176015|NCT01364649|3799741|FG000|Overall Study|Lack of Efficacy|6
2176016|NCT01364649|3799742|FG001|Overall Study|Lack of Efficacy|0
2176017|NCT01364649|3799741|FG000|Overall Study|Non-compliance with Investigational Drug|1
2176018|NCT01364649|3799742|FG001|Overall Study|Non-compliance with Investigational Drug|0
2176019|NCT01364649|3799741|FG000|Overall Study|Protocol Deviations|4
2176020|NCT01364649|3799742|FG001|Overall Study|Protocol Deviations|8
2176021|NCT01364649|3799741|FG000|Overall Study|Withdrawal of Consent|9
2176022|NCT01364649|3799742|FG001|Overall Study|Withdrawal of Consent|7
2176023|NCT01364649|3799741|FG000|Overall Study|Lost to Follow-up|12
2176024|NCT01364649|3799742|FG001|Overall Study|Lost to Follow-up|13
2176025|NCT01364649|3799741|FG000|Overall Study|Other|4
2176026|NCT01364649|3799742|FG001|Overall Study|Other|1
2176027|NCT01364727|3799748|FG000|Overall Study|Not Eligible|2
2176028|NCT01364870|3799762|FG000|Overall Study|Withdrawal by Subject|13
2176029|NCT01364870|3799763|FG001|Overall Study|Withdrawal by Subject|24
2176030|NCT01364870|3799764|FG002|Overall Study|Withdrawal by Subject|10
2176031|NCT01364870|3799762|FG000|Overall Study|Adverse Event|8
2176032|NCT01364870|3799763|FG001|Overall Study|Adverse Event|6
2176033|NCT01364870|3799764|FG002|Overall Study|Adverse Event|4
2176034|NCT01364870|3799762|FG000|Overall Study|Protocol Violation|1
2176035|NCT01364870|3799763|FG001|Overall Study|Protocol Violation|0
2176036|NCT01364870|3799764|FG002|Overall Study|Protocol Violation|0
2176037|NCT01364922|3799779|FG000|Open-label (OL) Period|Adverse Event|7
2176038|NCT01364922|3799780|FG001|Open-label (OL) Period|Adverse Event|0
2176039|NCT01364922|3799781|FG002|Open-label (OL) Period|Adverse Event|0
2176040|NCT01364922|3799779|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
2176041|NCT01364922|3799780|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
2176042|NCT01364922|3799781|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
2176043|NCT01364922|3799779|FG000|Open-label (OL) Period|Withdrawal by Subject|4
2176044|NCT01364922|3799780|FG001|Open-label (OL) Period|Withdrawal by Subject|0
2176045|NCT01364922|3799781|FG002|Open-label (OL) Period|Withdrawal by Subject|0
2176046|NCT01364922|3799779|FG000|Open-label (OL) Period|Lack of Efficacy|3
2176047|NCT01364922|3799780|FG001|Open-label (OL) Period|Lack of Efficacy|0
2176048|NCT01364922|3799781|FG002|Open-label (OL) Period|Lack of Efficacy|0
2176049|NCT01364922|3799779|FG000|Open-label (OL) Period|Lost to Follow-up|1
2176050|NCT01364922|3799780|FG001|Open-label (OL) Period|Lost to Follow-up|0
2176051|NCT01364922|3799781|FG002|Open-label (OL) Period|Lost to Follow-up|0
2176052|NCT01364922|3799779|FG000|Open-label (OL) Period|Other, Unspecified|1
2176053|NCT01364922|3799780|FG001|Open-label (OL) Period|Other, Unspecified|0
2176054|NCT01364922|3799781|FG002|Open-label (OL) Period|Other, Unspecified|0
2176055|NCT01364922|3799779|FG000|Double-Blind (DB) Period|Lack of Efficacy|0
2176056|NCT01364922|3799780|FG001|Double-Blind (DB) Period|Lack of Efficacy|3
2176057|NCT01364922|3799781|FG002|Double-Blind (DB) Period|Lack of Efficacy|4
2176058|NCT01364922|3799779|FG000|Double-Blind (DB) Period|Subject Noncompliant|0
2176059|NCT01364922|3799780|FG001|Double-Blind (DB) Period|Subject Noncompliant|1
2176060|NCT01364922|3799781|FG002|Double-Blind (DB) Period|Subject Noncompliant|0
2176061|NCT01364922|3799779|FG000|Double-Blind (DB) Period|Adverse Event|0
2176062|NCT01364922|3799780|FG001|Double-Blind (DB) Period|Adverse Event|0
2176063|NCT01364922|3799781|FG002|Double-Blind (DB) Period|Adverse Event|1
2176064|NCT01364922|3799779|FG000|Double-Blind (DB) Period|Other, Unspecified|0
2176065|NCT01364922|3799780|FG001|Double-Blind (DB) Period|Other, Unspecified|1
2176066|NCT01364922|3799781|FG002|Double-Blind (DB) Period|Other, Unspecified|0
2176067|NCT01365039|3799790|FG000|Overall Study|Study related symptoms and complaints|1
2176068|NCT01365039|3799791|FG001|Overall Study|Study related symptoms and complaints|0
2176069|NCT01365052|3799800|FG000|Overall Study|Adverse Event|4
2176070|NCT01365052|3799801|FG001|Overall Study|Adverse Event|4
2176071|NCT01365091|3799811|FG000|Period 1|Adverse Event|1
2176072|NCT01365091|3799812|FG001|Period 1|Adverse Event|0
2176073|NCT01365091|3799813|FG002|Period 1|Adverse Event|2
2176074|NCT01365091|3799814|FG003|Period 1|Adverse Event|3
2176075|NCT01365091|3799811|FG000|Period 1|Positive test result for drugs of abuse|1
2176076|NCT01365091|3799812|FG001|Period 1|Positive test result for drugs of abuse|0
2176077|NCT01365091|3799813|FG002|Period 1|Positive test result for drugs of abuse|0
2176078|NCT01365091|3799814|FG003|Period 1|Positive test result for drugs of abuse|0
2176079|NCT01365091|3799811|FG000|Period 1|No longer met study criteria|0
2176080|NCT01365091|3799812|FG001|Period 1|No longer met study criteria|1
2176081|NCT01365091|3799813|FG002|Period 1|No longer met study criteria|0
2176082|NCT01365091|3799814|FG003|Period 1|No longer met study criteria|0
2176083|NCT01365091|3799811|FG000|Period 1|Withdrawal by Subject|0
2176084|NCT01365091|3799812|FG001|Period 1|Withdrawal by Subject|1
2176085|NCT01365091|3799813|FG002|Period 1|Withdrawal by Subject|0
2176086|NCT01365091|3799814|FG003|Period 1|Withdrawal by Subject|0
2176087|NCT01365091|3799811|FG000|Period 1|Personal reasons|0
2176088|NCT01365091|3799812|FG001|Period 1|Personal reasons|0
2176089|NCT01365091|3799813|FG002|Period 1|Personal reasons|1
2176090|NCT01365091|3799814|FG003|Period 1|Personal reasons|0
2176091|NCT01365091|3799811|FG000|Period 2|Withdrawal by Subject|1
2176092|NCT01365091|3799812|FG001|Period 2|Withdrawal by Subject|0
2176093|NCT01365091|3799813|FG002|Period 2|Withdrawal by Subject|0
2176094|NCT01365091|3799814|FG003|Period 2|Withdrawal by Subject|0
2176095|NCT01365091|3799811|FG000|Period 2|Adverse Event|0
2176096|NCT01365091|3799812|FG001|Period 2|Adverse Event|0
2297745|NCT02569996|3994314|FG000|Overall Study|Adverse Event|6
2297746|NCT02569996|3994314|FG000|Overall Study|Physician Decision|3
2297747|NCT02569996|3994314|FG000|Overall Study|Progression of the disease|18
2297748|NCT02569996|3994314|FG000|Overall Study|New anti-lymphoma treatment|1
2297749|NCT02569996|3994314|FG000|Overall Study|Non-compliance|9
2297750|NCT02569996|3994314|FG000|Overall Study|Withdrawal by Subject|5
2297751|NCT02569996|3994314|FG000|Overall Study|Lost to Follow-up|5
2297752|NCT02569996|3994314|FG000|Overall Study|Complete remission|7
2297753|NCT02569996|3994314|FG000|Overall Study|Unknown reason|1
2297754|NCT02570074|3994329|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
2297755|NCT02570074|3994330|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
2297756|NCT02570126|3994350|FG000|Overall Study|Lost to Follow-up|2
2297757|NCT02570126|3994351|FG001|Overall Study|Lost to Follow-up|0
2297758|NCT02570126|3994350|FG000|Overall Study|Unable To Arrange Visit 3|1
2297759|NCT02570126|3994351|FG001|Overall Study|Unable To Arrange Visit 3|0
2297760|NCT02570126|3994350|FG000|Overall Study|Violation Of Procedures GSK|0
2297761|NCT02570126|3994351|FG001|Overall Study|Violation Of Procedures GSK|1
2297762|NCT02570126|3994350|FG000|Overall Study|Protocol Violation|0
2297763|NCT02570126|3994351|FG001|Overall Study|Protocol Violation|1
2297764|NCT02570126|3994350|FG000|Overall Study|Withdrawal by Subject|3
2297765|NCT02570126|3994351|FG001|Overall Study|Withdrawal by Subject|7
2297766|NCT02570152|3994366|FG000|Overall Study|Protocol Violation|2
2297767|NCT02570152|3994366|FG000|Overall Study|Migrated/moved from study area|13
2297768|NCT02570165|3994377|FG000|Overall Study|Adverse Event|1
2297769|NCT02570165|3994378|FG001|Overall Study|Adverse Event|0
2297770|NCT02570165|3994379|FG002|Overall Study|Adverse Event|2
2297771|NCT02570165|3994380|FG003|Overall Study|Adverse Event|0
2297772|NCT02570165|3994381|FG004|Overall Study|Adverse Event|0
2297773|NCT02570165|3994382|FG005|Overall Study|Adverse Event|0
2297774|NCT02570165|3994383|FG006|Overall Study|Adverse Event|0
2297775|NCT02570165|3994377|FG000|Overall Study|Lack of Efficacy|0
2297776|NCT02570165|3994378|FG001|Overall Study|Lack of Efficacy|1
2297777|NCT02570165|3994379|FG002|Overall Study|Lack of Efficacy|0
2297778|NCT02570165|3994380|FG003|Overall Study|Lack of Efficacy|0
2297779|NCT02570165|3994381|FG004|Overall Study|Lack of Efficacy|4
2297780|NCT02570165|3994382|FG005|Overall Study|Lack of Efficacy|0
2297781|NCT02570165|3994383|FG006|Overall Study|Lack of Efficacy|0
2297782|NCT02570165|3994377|FG000|Overall Study|Par. Reached Stopping Criteria|1
2297783|NCT02570165|3994378|FG001|Overall Study|Par. Reached Stopping Criteria|1
2297784|NCT02570165|3994379|FG002|Overall Study|Par. Reached Stopping Criteria|0
2297785|NCT02570165|3994380|FG003|Overall Study|Par. Reached Stopping Criteria|2
2297786|NCT02570165|3994381|FG004|Overall Study|Par. Reached Stopping Criteria|1
2297787|NCT02570165|3994382|FG005|Overall Study|Par. Reached Stopping Criteria|1
2297788|NCT02570165|3994383|FG006|Overall Study|Par. Reached Stopping Criteria|0
2297789|NCT02570165|3994377|FG000|Overall Study|Lost to Follow-up|0
2297790|NCT02570165|3994378|FG001|Overall Study|Lost to Follow-up|0
2297791|NCT02570165|3994379|FG002|Overall Study|Lost to Follow-up|1
2297792|NCT02570165|3994380|FG003|Overall Study|Lost to Follow-up|1
2297793|NCT02570165|3994381|FG004|Overall Study|Lost to Follow-up|0
2297794|NCT02570165|3994382|FG005|Overall Study|Lost to Follow-up|0
2297795|NCT02570165|3994383|FG006|Overall Study|Lost to Follow-up|0
2297796|NCT02570165|3994377|FG000|Overall Study|Physician Decision|0
2297797|NCT02570165|3994378|FG001|Overall Study|Physician Decision|1
2297798|NCT02570165|3994379|FG002|Overall Study|Physician Decision|0
2176097|NCT01365091|3799813|FG002|Period 2|Adverse Event|1
2176098|NCT01365091|3799814|FG003|Period 2|Adverse Event|0
2176099|NCT01365130|3799838|FG000|Overall Study|Progression/worsening of Dx prior to txt|2
2297799|NCT02570165|3994380|FG003|Overall Study|Physician Decision|0
2297800|NCT02570165|3994381|FG004|Overall Study|Physician Decision|0
2297801|NCT02570165|3994382|FG005|Overall Study|Physician Decision|0
2297802|NCT02570165|3994383|FG006|Overall Study|Physician Decision|0
2176100|NCT01365273|3799844|FG000|Overall Study|Lost to Follow-up|1
2176101|NCT01365273|3799845|FG001|Overall Study|Lost to Follow-up|0
2176102|NCT01365273|3799844|FG000|Overall Study|Protocol Violation|0
2176103|NCT01365273|3799845|FG001|Overall Study|Protocol Violation|1
2176104|NCT01365273|3799844|FG000|Overall Study|Physician Decision|1
2176105|NCT01365273|3799845|FG001|Overall Study|Physician Decision|0
2176106|NCT01365455|3799854|FG000|Induction Period|Adverse Event|5
2176107|NCT01365455|3799855|FG001|Induction Period|Adverse Event|3
2176108|NCT01365455|3799856|FG002|Induction Period|Adverse Event|4
2176109|NCT01365455|3799857|FG003|Induction Period|Adverse Event|0
2176110|NCT01365455|3799858|FG004|Induction Period|Adverse Event|0
2176111|NCT01365455|3799854|FG000|Induction Period|Lack of Efficacy|1
2176112|NCT01365455|3799855|FG001|Induction Period|Lack of Efficacy|1
2176113|NCT01365455|3799856|FG002|Induction Period|Lack of Efficacy|0
2176114|NCT01365455|3799857|FG003|Induction Period|Lack of Efficacy|0
2176115|NCT01365455|3799858|FG004|Induction Period|Lack of Efficacy|0
2176116|NCT01365455|3799854|FG000|Induction Period|Pregnancy|0
2176117|NCT01365455|3799855|FG001|Induction Period|Pregnancy|1
2297803|NCT02570165|3994377|FG000|Overall Study|Withdrawal by Subject|0
2297804|NCT02570165|3994378|FG001|Overall Study|Withdrawal by Subject|0
2297805|NCT02570165|3994379|FG002|Overall Study|Withdrawal by Subject|0
2297806|NCT02570165|3994380|FG003|Overall Study|Withdrawal by Subject|2
2297807|NCT02570165|3994381|FG004|Overall Study|Withdrawal by Subject|1
2297808|NCT02570165|3994382|FG005|Overall Study|Withdrawal by Subject|0
2297809|NCT02570165|3994383|FG006|Overall Study|Withdrawal by Subject|0
2297810|NCT02570165|3994377|FG000|Overall Study|Par. did not Meet Continuation Criteria|0
2297811|NCT02570165|3994378|FG001|Overall Study|Par. did not Meet Continuation Criteria|0
2297812|NCT02570165|3994379|FG002|Overall Study|Par. did not Meet Continuation Criteria|0
2297813|NCT02570165|3994380|FG003|Overall Study|Par. did not Meet Continuation Criteria|0
2297814|NCT02570165|3994381|FG004|Overall Study|Par. did not Meet Continuation Criteria|0
2297815|NCT02570165|3994382|FG005|Overall Study|Par. did not Meet Continuation Criteria|1
2297816|NCT02570165|3994383|FG006|Overall Study|Par. did not Meet Continuation Criteria|0
2297817|NCT02570165|3994377|FG000|Overall Study|Withdrawal Request by GSK|0
2297818|NCT02570165|3994378|FG001|Overall Study|Withdrawal Request by GSK|0
2297819|NCT02570165|3994379|FG002|Overall Study|Withdrawal Request by GSK|2
2297820|NCT02570165|3994380|FG003|Overall Study|Withdrawal Request by GSK|0
2297821|NCT02570165|3994381|FG004|Overall Study|Withdrawal Request by GSK|0
2297822|NCT02570165|3994382|FG005|Overall Study|Withdrawal Request by GSK|0
2297823|NCT02570165|3994383|FG006|Overall Study|Withdrawal Request by GSK|0
2297824|NCT02570308|3994413|FG000|Overall Study|Death|1
2297825|NCT02570308|3994414|FG001|Overall Study|Death|5
2297826|NCT02570308|3994415|FG002|Overall Study|Death|4
2297827|NCT02570308|3994416|FG003|Overall Study|Death|4
2297828|NCT02570308|3994417|FG004|Overall Study|Death|69
2297829|NCT02570308|3994413|FG000|Overall Study|Lost to Follow-up|0
2297830|NCT02570308|3994414|FG001|Overall Study|Lost to Follow-up|0
2297831|NCT02570308|3994415|FG002|Overall Study|Lost to Follow-up|0
2297832|NCT02570308|3994416|FG003|Overall Study|Lost to Follow-up|0
2297833|NCT02570308|3994417|FG004|Overall Study|Lost to Follow-up|2
2297834|NCT02570308|3994413|FG000|Overall Study|Withdrawal by Subject|0
2297835|NCT02570308|3994414|FG001|Overall Study|Withdrawal by Subject|0
2297836|NCT02570308|3994415|FG002|Overall Study|Withdrawal by Subject|0
2297837|NCT02570308|3994416|FG003|Overall Study|Withdrawal by Subject|0
2297838|NCT02570308|3994417|FG004|Overall Study|Withdrawal by Subject|1
2297839|NCT02570308|3994413|FG000|Overall Study|Other|0
2297840|NCT02570308|3994414|FG001|Overall Study|Other|0
2297841|NCT02570308|3994415|FG002|Overall Study|Other|0
2297842|NCT02570308|3994416|FG003|Overall Study|Other|0
2297843|NCT02570308|3994417|FG004|Overall Study|Other|2
2297844|NCT02570711|3994449|FG000|Overall Study|Death|1
2297845|NCT02570711|3994450|FG001|Overall Study|Death|0
2297846|NCT02570711|3994449|FG000|Overall Study|Early Termination of Study by Sponsor|0
2297847|NCT02570711|3994450|FG001|Overall Study|Early Termination of Study by Sponsor|2
2297848|NCT02570750|3994458|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
2297849|NCT02570750|3994459|FG001|Overall Study|Inclusion/exclusion criteria deviation|0
2297850|NCT02570750|3994458|FG000|Overall Study|Protocol deviation|4
2297851|NCT02570750|3994459|FG001|Overall Study|Protocol deviation|2
2297852|NCT02570750|3994458|FG000|Overall Study|Withdrawal by Subject|5
2297853|NCT02570750|3994459|FG001|Overall Study|Withdrawal by Subject|0
2297854|NCT02570750|3994458|FG000|Overall Study|Lost to Follow-up|2
2297855|NCT02570750|3994459|FG001|Overall Study|Lost to Follow-up|2
2297856|NCT02570750|3994458|FG000|Overall Study|Adverse Event|2
2176118|NCT01365455|3799856|FG002|Induction Period|Pregnancy|0
2176119|NCT01365455|3799857|FG003|Induction Period|Pregnancy|0
2176120|NCT01365455|3799858|FG004|Induction Period|Pregnancy|0
2297857|NCT02570750|3994459|FG001|Overall Study|Adverse Event|1
2297858|NCT02571049|3994465|FG000|Screening|Did not meet entry criteria|2
2297859|NCT02571049|3994466|FG001|Screening|Did not meet entry criteria|2
2297860|NCT02571049|3994465|FG000|Randomization|No migraine attack|0
2297861|NCT02571049|3994466|FG001|Randomization|No migraine attack|1
2297862|NCT02571049|3994465|FG000|Randomization|Adverse Event|0
2297863|NCT02571049|3994466|FG001|Randomization|Adverse Event|1
2297864|NCT02571075|3994474|FG000|Overall Study|Lost to Follow-up|20
2176121|NCT01365455|3799854|FG000|Induction Period|Protocol deviation|0
2176122|NCT01365455|3799855|FG001|Induction Period|Protocol deviation|1
2176123|NCT01365455|3799856|FG002|Induction Period|Protocol deviation|1
2176124|NCT01365455|3799857|FG003|Induction Period|Protocol deviation|0
2176125|NCT01365455|3799858|FG004|Induction Period|Protocol deviation|0
2176126|NCT01365455|3799854|FG000|Induction Period|Subject/guardian decision|9
2176127|NCT01365455|3799855|FG001|Induction Period|Subject/guardian decision|1
2176128|NCT01365455|3799856|FG002|Induction Period|Subject/guardian decision|8
2176129|NCT01365455|3799857|FG003|Induction Period|Subject/guardian decision|0
2176130|NCT01365455|3799858|FG004|Induction Period|Subject/guardian decision|0
2176131|NCT01365455|3799854|FG000|Induction Period|Lost to Follow-up|0
2176132|NCT01365455|3799855|FG001|Induction Period|Lost to Follow-up|0
2176133|NCT01365455|3799856|FG002|Induction Period|Lost to Follow-up|3
2176134|NCT01365455|3799857|FG003|Induction Period|Lost to Follow-up|0
2176135|NCT01365455|3799858|FG004|Induction Period|Lost to Follow-up|0
2176136|NCT01365455|3799854|FG000|Maintenance Period|Adverse Event|12
2176137|NCT01365455|3799855|FG001|Maintenance Period|Adverse Event|5
2176138|NCT01365455|3799856|FG002|Maintenance Period|Adverse Event|1
2176139|NCT01365455|3799857|FG003|Maintenance Period|Adverse Event|2
2176140|NCT01365455|3799858|FG004|Maintenance Period|Adverse Event|4
2176141|NCT01365455|3799854|FG000|Maintenance Period|Lack of Efficacy|10
2176142|NCT01365455|3799855|FG001|Maintenance Period|Lack of Efficacy|2
2176143|NCT01365455|3799856|FG002|Maintenance Period|Lack of Efficacy|0
2176144|NCT01365455|3799857|FG003|Maintenance Period|Lack of Efficacy|2
2176145|NCT01365455|3799858|FG004|Maintenance Period|Lack of Efficacy|2
2176146|NCT01365455|3799854|FG000|Maintenance Period|Lost to Follow-up|2
2176147|NCT01365455|3799855|FG001|Maintenance Period|Lost to Follow-up|4
2176148|NCT01365455|3799856|FG002|Maintenance Period|Lost to Follow-up|0
2176149|NCT01365455|3799857|FG003|Maintenance Period|Lost to Follow-up|0
2176150|NCT01365455|3799858|FG004|Maintenance Period|Lost to Follow-up|3
2176151|NCT01365455|3799854|FG000|Maintenance Period|Non-compliance with study treatment|0
2176152|NCT01365455|3799855|FG001|Maintenance Period|Non-compliance with study treatment|0
2176153|NCT01365455|3799856|FG002|Maintenance Period|Non-compliance with study treatment|0
2176154|NCT01365455|3799857|FG003|Maintenance Period|Non-compliance with study treatment|1
2176155|NCT01365455|3799858|FG004|Maintenance Period|Non-compliance with study treatment|0
2176156|NCT01365455|3799854|FG000|Maintenance Period|Physician Decision|0
2176157|NCT01365455|3799855|FG001|Maintenance Period|Physician Decision|1
2176158|NCT01365455|3799856|FG002|Maintenance Period|Physician Decision|0
2176159|NCT01365455|3799857|FG003|Maintenance Period|Physician Decision|0
2176160|NCT01365455|3799858|FG004|Maintenance Period|Physician Decision|1
2176161|NCT01365455|3799854|FG000|Maintenance Period|Pregnancy|0
2176162|NCT01365455|3799855|FG001|Maintenance Period|Pregnancy|4
2176163|NCT01365455|3799856|FG002|Maintenance Period|Pregnancy|0
2176164|NCT01365455|3799857|FG003|Maintenance Period|Pregnancy|0
2176165|NCT01365455|3799858|FG004|Maintenance Period|Pregnancy|2
2176166|NCT01365455|3799854|FG000|Maintenance Period|Protocol deviation|1
2176167|NCT01365455|3799855|FG001|Maintenance Period|Protocol deviation|1
2176168|NCT01365455|3799856|FG002|Maintenance Period|Protocol deviation|0
2176169|NCT01365455|3799857|FG003|Maintenance Period|Protocol deviation|0
2297865|NCT02571075|3994475|FG001|Overall Study|Lost to Follow-up|24
2297866|NCT02571244|3994505|FG000|Overall Study|Lost to Follow-up|0
2297867|NCT02571244|3994506|FG001|Overall Study|Lost to Follow-up|1
2297868|NCT02571244|3994505|FG000|Overall Study|Unable to reach out post discharge|3
2297869|NCT02571244|3994506|FG001|Overall Study|Unable to reach out post discharge|0
2297870|NCT02571452|3994526|FG000|Overall Study Treatment|Protocol Violation|0
2297871|NCT02571452|3994527|FG001|Overall Study Treatment|Protocol Violation|1
2297872|NCT02571452|3994526|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4
2297873|NCT02571452|3994527|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0
2297874|NCT02571452|3994526|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1
2297875|NCT02571452|3994527|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0
2297876|NCT02571777|3994543|FG000|Overall Study|Subject/guardian decision|34
2297877|NCT02571777|3994544|FG001|Overall Study|Subject/guardian decision|26
2297878|NCT02571777|3994545|FG002|Overall Study|Subject/guardian decision|26
2297879|NCT02571777|3994546|FG003|Overall Study|Subject/guardian decision|25
2297880|NCT02571777|3994547|FG004|Overall Study|Subject/guardian decision|27
2297881|NCT02571777|3994543|FG000|Overall Study|Protocol Deviation|2
2297882|NCT02571777|3994544|FG001|Overall Study|Protocol Deviation|3
2297883|NCT02571777|3994545|FG002|Overall Study|Protocol Deviation|4
2297884|NCT02571777|3994546|FG003|Overall Study|Protocol Deviation|8
2297885|NCT02571777|3994547|FG004|Overall Study|Protocol Deviation|4
2297886|NCT02571777|3994543|FG000|Overall Study|Death|1
2297887|NCT02571777|3994544|FG001|Overall Study|Death|1
2297888|NCT02571777|3994545|FG002|Overall Study|Death|4
2297889|NCT02571777|3994546|FG003|Overall Study|Death|0
2297890|NCT02571777|3994547|FG004|Overall Study|Death|0
2297891|NCT02571777|3994543|FG000|Overall Study|Lost to Follow-up|1
2297892|NCT02571777|3994544|FG001|Overall Study|Lost to Follow-up|1
2297893|NCT02571777|3994545|FG002|Overall Study|Lost to Follow-up|2
2297894|NCT02571777|3994546|FG003|Overall Study|Lost to Follow-up|0
2297895|NCT02571777|3994547|FG004|Overall Study|Lost to Follow-up|1
2297896|NCT02571777|3994543|FG000|Overall Study|Physician Decision|1
2297897|NCT02571777|3994544|FG001|Overall Study|Physician Decision|7
2297898|NCT02571777|3994545|FG002|Overall Study|Physician Decision|5
2176170|NCT01365455|3799858|FG004|Maintenance Period|Protocol deviation|0
2176171|NCT01365455|3799854|FG000|Maintenance Period|Subject/guardian decision|4
2176172|NCT01365455|3799855|FG001|Maintenance Period|Subject/guardian decision|6
2176173|NCT01365455|3799856|FG002|Maintenance Period|Subject/guardian decision|2
2176174|NCT01365455|3799857|FG003|Maintenance Period|Subject/guardian decision|4
2176175|NCT01365455|3799858|FG004|Maintenance Period|Subject/guardian decision|1
2176176|NCT01365468|3799878|FG000|Overall Study|Physician Decision|1
2176177|NCT01365468|3799879|FG001|Overall Study|Physician Decision|0
2176178|NCT01365468|3799878|FG000|Overall Study|Disease progression|1
2176179|NCT01365468|3799879|FG001|Overall Study|Disease progression|0
2176180|NCT01365468|3799878|FG000|Overall Study|Lost to Follow-up|2
2176181|NCT01365468|3799879|FG001|Overall Study|Lost to Follow-up|0
2176182|NCT01365481|3799890|FG000|Overall Study|Adverse Event|6
2176183|NCT01365481|3799891|FG001|Overall Study|Adverse Event|9
2176184|NCT01365481|3799892|FG002|Overall Study|Adverse Event|0
2176185|NCT01365481|3799893|FG003|Overall Study|Adverse Event|2
2176186|NCT01365481|3799890|FG000|Overall Study|Withdrawal by Subject|0
2176187|NCT01365481|3799891|FG001|Overall Study|Withdrawal by Subject|2
2176188|NCT01365481|3799892|FG002|Overall Study|Withdrawal by Subject|1
2176189|NCT01365481|3799893|FG003|Overall Study|Withdrawal by Subject|1
2176190|NCT01365481|3799890|FG000|Overall Study|Lost to Follow-up|1
2176191|NCT01365481|3799891|FG001|Overall Study|Lost to Follow-up|1
2176192|NCT01365481|3799892|FG002|Overall Study|Lost to Follow-up|2
2176193|NCT01365481|3799893|FG003|Overall Study|Lost to Follow-up|3
2176194|NCT01365481|3799890|FG000|Overall Study|Abnormal laboratory value(s)|0
2176195|NCT01365481|3799891|FG001|Overall Study|Abnormal laboratory value(s)|1
2176196|NCT01365481|3799892|FG002|Overall Study|Abnormal laboratory value(s)|0
2176197|NCT01365481|3799893|FG003|Overall Study|Abnormal laboratory value(s)|0
2176198|NCT01365481|3799890|FG000|Overall Study|Administrative problems|0
2176199|NCT01365481|3799891|FG001|Overall Study|Administrative problems|1
2176200|NCT01365481|3799892|FG002|Overall Study|Administrative problems|0
2176201|NCT01365481|3799893|FG003|Overall Study|Administrative problems|0
2176202|NCT01365481|3799890|FG000|Overall Study|Protocol deviation|0
2176203|NCT01365481|3799891|FG001|Overall Study|Protocol deviation|1
2176204|NCT01365481|3799892|FG002|Overall Study|Protocol deviation|0
2176205|NCT01365481|3799893|FG003|Overall Study|Protocol deviation|1
2176206|NCT01365481|3799890|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2176207|NCT01365481|3799891|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2176208|NCT01365481|3799892|FG002|Overall Study|Unsatisfactory therapeutic effect|1
2176209|NCT01365481|3799893|FG003|Overall Study|Unsatisfactory therapeutic effect|0
2176210|NCT01365494|3799905|FG000|Overall Study|Adverse Event|1
2176211|NCT01365494|3799906|FG001|Overall Study|Adverse Event|0
2176212|NCT01365494|3799905|FG000|Overall Study|Withdrawal by Subject|0
2176213|NCT01365494|3799906|FG001|Overall Study|Withdrawal by Subject|1
2176214|NCT01365494|3799905|FG000|Overall Study|Lost to Follow-up|1
2208314|NCT01639001|3847851|FG001|Overall Study|Lost to Follow-up|0
2208315|NCT01639001|3847850|FG000|Overall Study|Death|62
2208316|NCT01639001|3847851|FG001|Overall Study|Death|61
2208317|NCT01639001|3847850|FG000|Overall Study|Randomized but not treated|0
2208318|NCT01639001|3847851|FG001|Overall Study|Randomized but not treated|2
2208319|NCT01639001|3847850|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1
2208320|NCT01639001|3847851|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2
2208321|NCT01639040|3847861|FG000|Overall Study|Adverse Event|1
2297899|NCT02571777|3994546|FG003|Overall Study|Physician Decision|2
2297900|NCT02571777|3994547|FG004|Overall Study|Physician Decision|4
2297901|NCT02571777|3994543|FG000|Overall Study|Pregnancy|0
2297902|NCT02571777|3994544|FG001|Overall Study|Pregnancy|0
2297903|NCT02571777|3994545|FG002|Overall Study|Pregnancy|0
2297904|NCT02571777|3994546|FG003|Overall Study|Pregnancy|2
2297905|NCT02571777|3994547|FG004|Overall Study|Pregnancy|0
2297906|NCT02571972|3994559|FG000|Overall Study|Protocol Violation|2
2297907|NCT02571972|3994559|FG000|Overall Study|Withdrawal by Subject|2
2297908|NCT02572076|3994563|FG000|Overall Study|Protocol Violation|1
2321330|NCT02959437|4035903|FG000|Overall Study|Withdrawal by Subject|11
2321331|NCT02959437|4035904|FG001|Overall Study|Withdrawal by Subject|3
2321332|NCT02959437|4035905|FG002|Overall Study|Withdrawal by Subject|0
2321333|NCT02959437|4035906|FG003|Overall Study|Withdrawal by Subject|0
2321334|NCT02959437|4035903|FG000|Overall Study|Progressive Disease|9
2321335|NCT02959437|4035904|FG001|Overall Study|Progressive Disease|1
2321336|NCT02959437|4035905|FG002|Overall Study|Progressive Disease|0
2321337|NCT02959437|4035906|FG003|Overall Study|Progressive Disease|0
2321338|NCT02959437|4035903|FG000|Overall Study|Study Terminated by Sponsor|4
2321339|NCT02959437|4035904|FG001|Overall Study|Study Terminated by Sponsor|0
2321340|NCT02959437|4035905|FG002|Overall Study|Study Terminated by Sponsor|0
2321341|NCT02959437|4035906|FG003|Overall Study|Study Terminated by Sponsor|0
2321342|NCT02959437|4035903|FG000|Overall Study|Other Unspecified|2
2321343|NCT02959437|4035904|FG001|Overall Study|Other Unspecified|0
2321344|NCT02959437|4035905|FG002|Overall Study|Other Unspecified|0
2321345|NCT02959437|4035906|FG003|Overall Study|Other Unspecified|0
2321346|NCT02959671|4035917|FG000|Overall Study|Adverse Event|2
2321347|NCT02959671|4035917|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3
2176215|NCT01365494|3799906|FG001|Overall Study|Lost to Follow-up|2
2176216|NCT01365507|3799915|FG000|Overall Study|Withdrawal Criteria|8
2176217|NCT01365507|3799916|FG001|Overall Study|Withdrawal Criteria|5
2297909|NCT02572167|3994570|FG000|Overall Study|In follow up|6
2297910|NCT02572167|3994571|FG001|Overall Study|In follow up|48
2297911|NCT02572167|3994572|FG002|Overall Study|In follow up|27
2297912|NCT02572167|3994570|FG000|Overall Study|Withdrawal by Subject|0
2297913|NCT02572167|3994571|FG001|Overall Study|Withdrawal by Subject|3
2297914|NCT02572167|3994572|FG002|Overall Study|Withdrawal by Subject|1
2297915|NCT02572167|3994570|FG000|Overall Study|Lost to Follow-up|0
2297916|NCT02572167|3994571|FG001|Overall Study|Lost to Follow-up|2
2297917|NCT02572167|3994572|FG002|Overall Study|Lost to Follow-up|1
2297918|NCT02572167|3994570|FG000|Overall Study|Death|0
2297919|NCT02572167|3994571|FG001|Overall Study|Death|3
2297920|NCT02572167|3994572|FG002|Overall Study|Death|1
2297921|NCT02572167|3994570|FG000|Overall Study|Did not meet inclusion criteria|0
2297922|NCT02572167|3994571|FG001|Overall Study|Did not meet inclusion criteria|0
2297923|NCT02572167|3994572|FG002|Overall Study|Did not meet inclusion criteria|1
2297924|NCT02572388|3994584|FG000|Overall Study|Withdrawal by Subject|1
2297925|NCT02572388|3994585|FG001|Overall Study|Withdrawal by Subject|1
2297926|NCT02572388|3994586|FG002|Overall Study|Withdrawal by Subject|2
2297927|NCT02572388|3994587|FG003|Overall Study|Withdrawal by Subject|2
2297928|NCT02572401|3994601|FG000|Overall Study|Lost to Follow-up|5
2297929|NCT02572401|3994602|FG001|Overall Study|Lost to Follow-up|8
2297930|NCT02572401|3994603|FG002|Overall Study|Lost to Follow-up|9
2297931|NCT02572401|3994604|FG003|Overall Study|Lost to Follow-up|9
2297932|NCT02572401|3994601|FG000|Overall Study|Death|0
2297933|NCT02572401|3994602|FG001|Overall Study|Death|0
2297934|NCT02572401|3994603|FG002|Overall Study|Death|0
2297935|NCT02572401|3994604|FG003|Overall Study|Death|1
2297936|NCT02572570|3994623|FG000|Overall Study|Study Terminated|27
2297937|NCT02572817|3994653|FG000|Overall Study|Death|6
2297938|NCT02572817|3994654|FG001|Overall Study|Death|3
2297939|NCT02572817|3994653|FG000|Overall Study|Lost to Follow-up|3
2297940|NCT02572817|3994654|FG001|Overall Study|Lost to Follow-up|3
2297941|NCT02573012|3994662|FG000|Overall Study|Adverse Event|5
2297942|NCT02573012|3994663|FG001|Overall Study|Adverse Event|5
2297943|NCT02573012|3994662|FG000|Overall Study|Lack of Efficacy|5
2297944|NCT02573012|3994663|FG001|Overall Study|Lack of Efficacy|4
2297945|NCT02573012|3994662|FG000|Overall Study|Non-compliance|1
2297946|NCT02573012|3994663|FG001|Overall Study|Non-compliance|2
2297947|NCT02573012|3994662|FG000|Overall Study|Withdrawal by Subject|2
2297948|NCT02573012|3994663|FG001|Overall Study|Withdrawal by Subject|2
2297949|NCT02573012|3994662|FG000|Overall Study|Study Ended per Protocol|1
2297950|NCT02573012|3994663|FG001|Overall Study|Study Ended per Protocol|0
2297951|NCT02573012|3994662|FG000|Overall Study|Physician Decision|1
2297952|NCT02573012|3994663|FG001|Overall Study|Physician Decision|2
2297953|NCT02573155|3994671|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0
2297954|NCT02573155|3994672|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1
2297955|NCT02573155|3994671|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
2297956|NCT02573155|3994672|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
2297957|NCT02573155|3994671|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0
2297958|NCT02573155|3994672|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3
2297959|NCT02573155|3994671|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
2297960|NCT02573155|3994672|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
2297961|NCT02573155|3994671|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0
2297962|NCT02573155|3994672|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2
2297963|NCT02573155|3994671|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
2297964|NCT02573155|3994672|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
2297965|NCT02573155|3994671|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0
2297966|NCT02573155|3994672|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1
2297967|NCT02573155|3994671|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0
2297968|NCT02573155|3994672|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1
2297969|NCT02573246|3994722|FG000|Overall Study|Lost to Follow-up|2
2297970|NCT02573246|3994723|FG001|Overall Study|Lost to Follow-up|0
2297971|NCT02573246|3994724|FG002|Overall Study|Lost to Follow-up|0
2297972|NCT02573246|3994725|FG003|Overall Study|Lost to Follow-up|0
2297973|NCT02573246|3994726|FG004|Overall Study|Lost to Follow-up|1
2297974|NCT02573246|3994722|FG000|Overall Study|Withdrawal by Subject|0
2297975|NCT02573246|3994723|FG001|Overall Study|Withdrawal by Subject|0
2297976|NCT02573246|3994724|FG002|Overall Study|Withdrawal by Subject|0
2297977|NCT02573246|3994725|FG003|Overall Study|Withdrawal by Subject|0
2297978|NCT02573246|3994726|FG004|Overall Study|Withdrawal by Subject|1
2297979|NCT02573246|3994722|FG000|Overall Study|Physician Decision|1
2297980|NCT02573246|3994723|FG001|Overall Study|Physician Decision|1
2297981|NCT02573246|3994724|FG002|Overall Study|Physician Decision|3
2297982|NCT02573246|3994725|FG003|Overall Study|Physician Decision|2
2297983|NCT02573246|3994726|FG004|Overall Study|Physician Decision|2
2297984|NCT02573311|3994745|FG000|Disposition for Part 1|Withdrawal by Subject|7
2297985|NCT02573311|3994746|FG001|Disposition for Part 1|Withdrawal by Subject|3
2297986|NCT02573311|3994745|FG000|Disposition for Part 2|Physician Decision|25
2297987|NCT02573311|3994746|FG001|Disposition for Part 2|Physician Decision|7
2176218|NCT01365507|3799915|FG000|Overall Study|Unclassified|1
2176219|NCT01365507|3799916|FG001|Overall Study|Unclassified|4
2176220|NCT01365546|3799922|FG000|Overall Study|Withdrawal by Subject|1
2176221|NCT01365546|3799922|FG000|Overall Study|Screen failure|9
2176222|NCT01365546|3799922|FG000|Overall Study|Study termination|1
2176223|NCT01365910|3799990|FG000|Overall Study|Withdrawal by Subject|7
2176224|NCT01365910|3799990|FG000|Overall Study|disease progression|18
2176225|NCT01365910|3799990|FG000|Overall Study|Adverse Event|3
2176226|NCT01365910|3799990|FG000|Overall Study|other complicating disease|1
2176227|NCT01365910|3799990|FG000|Overall Study|pt did not get tx, nausea/vomiting|1
2176228|NCT01366209|3800005|FG000|Overall Study|Adverse Event|6
2176229|NCT01366209|3800006|FG001|Overall Study|Adverse Event|7
2176230|NCT01366209|3800005|FG000|Overall Study|Withdrawal by Subject|4
2176231|NCT01366209|3800006|FG001|Overall Study|Withdrawal by Subject|4
2208322|NCT01639040|3847862|FG001|Overall Study|Adverse Event|0
2208323|NCT01639144|3847873|FG000|Overall Study|Withdrawal by Subject|4
2208324|NCT01639144|3847874|FG001|Overall Study|Withdrawal by Subject|2
2208325|NCT01639144|3847873|FG000|Overall Study|Physician Decision|2
2208326|NCT01639144|3847874|FG001|Overall Study|Physician Decision|0
2208327|NCT01639144|3847873|FG000|Overall Study|Met postoperative exclusion criteria|4
2208328|NCT01639144|3847874|FG001|Overall Study|Met postoperative exclusion criteria|3
2208329|NCT01639339|3847895|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26
2208330|NCT01639339|3847896|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19
2208331|NCT01639339|3847895|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11
2208332|NCT01639339|3847896|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5
2208333|NCT01639339|3847895|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5
2208334|NCT01639339|3847896|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4
2208335|NCT01639339|3847895|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0
2208336|NCT01639339|3847896|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2
2176232|NCT01366209|3800005|FG000|Overall Study|Death|12
2176233|NCT01366209|3800006|FG001|Overall Study|Death|19
2176234|NCT01366209|3800005|FG000|Overall Study|Lung transplantation|6
2176235|NCT01366209|3800006|FG001|Overall Study|Lung transplantation|1
2176236|NCT01366209|3800005|FG000|Overall Study|Lost to Follow-up|2
2176237|NCT01366209|3800006|FG001|Overall Study|Lost to Follow-up|1
2176238|NCT01366209|3800005|FG000|Overall Study|Physician Decision|1
2176239|NCT01366209|3800006|FG001|Overall Study|Physician Decision|0
2176240|NCT01366209|3800005|FG000|Overall Study|Sponsors decision|0
2176241|NCT01366209|3800006|FG001|Overall Study|Sponsors decision|1
2176242|NCT01366209|3800005|FG000|Overall Study|Withdrew consent|4
2176243|NCT01366209|3800006|FG001|Overall Study|Withdrew consent|3
2176244|NCT01366443|3800017|FG000|Overall Study|Lost to Follow-up|2
2176245|NCT01366443|3800017|FG000|Overall Study|Under 18 yo|1
2176246|NCT01366521|3800043|FG000|Overall Study|Adverse Event|1
2176247|NCT01366521|3800044|FG001|Overall Study|Adverse Event|0
2176248|NCT01366521|3800045|FG002|Overall Study|Adverse Event|0
2176249|NCT01366521|3800046|FG003|Overall Study|Adverse Event|0
2176250|NCT01366521|3800043|FG000|Overall Study|Protocol Violation|0
2176251|NCT01366521|3800044|FG001|Overall Study|Protocol Violation|0
2176252|NCT01366521|3800045|FG002|Overall Study|Protocol Violation|1
2176253|NCT01366521|3800046|FG003|Overall Study|Protocol Violation|0
2176254|NCT01366521|3800043|FG000|Overall Study|Physician Decision|0
2176255|NCT01366521|3800044|FG001|Overall Study|Physician Decision|0
2176256|NCT01366521|3800045|FG002|Overall Study|Physician Decision|1
2176257|NCT01366521|3800046|FG003|Overall Study|Physician Decision|0
2176258|NCT01366521|3800043|FG000|Overall Study|Withdrawal by Subject|0
2176259|NCT01366521|3800044|FG001|Overall Study|Withdrawal by Subject|1
2176260|NCT01366521|3800045|FG002|Overall Study|Withdrawal by Subject|0
2176261|NCT01366521|3800046|FG003|Overall Study|Withdrawal by Subject|0
2176262|NCT01366534|3800061|FG000|Overall Study|Lost to Follow-up|1
2176263|NCT01366534|3800062|FG001|Overall Study|Lost to Follow-up|0
2176264|NCT01366534|3800063|FG002|Overall Study|Lost to Follow-up|0
2176265|NCT01366534|3800061|FG000|Overall Study|Migrated|1
2176266|NCT01366534|3800062|FG001|Overall Study|Migrated|1
2176267|NCT01366534|3800063|FG002|Overall Study|Migrated|0
2208337|NCT01639339|3847895|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2
2208338|NCT01639339|3847896|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1
2208339|NCT01639339|3847895|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10
2208340|NCT01639339|3847896|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7
2208341|NCT01639339|3847895|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0
2297988|NCT02573311|3994745|FG000|Disposition for Part 2|Adverse Event|36
2297989|NCT02573311|3994746|FG001|Disposition for Part 2|Adverse Event|5
2297990|NCT02573311|3994745|FG000|Disposition for Part 2|Lost to Follow-up|76
2297991|NCT02573311|3994746|FG001|Disposition for Part 2|Lost to Follow-up|7
2176268|NCT01366534|3800061|FG000|Overall Study|Declined challenged|0
2176269|NCT01366534|3800062|FG001|Overall Study|Declined challenged|1
2176270|NCT01366534|3800063|FG002|Overall Study|Declined challenged|0
2176271|NCT01366638|3800074|FG000|Overall Study|Withdrawal by Subject|0
2176272|NCT01366638|3800075|FG001|Overall Study|Withdrawal by Subject|0
2176273|NCT01366638|3800076|FG002|Overall Study|Withdrawal by Subject|6
2176274|NCT01366638|3800074|FG000|Overall Study|Other|1
2176275|NCT01366638|3800075|FG001|Overall Study|Other|0
2176276|NCT01366638|3800076|FG002|Overall Study|Other|0
2297992|NCT02573311|3994745|FG000|Disposition for Part 2|Withdrawal by Subject|60
2297993|NCT02573311|3994746|FG001|Disposition for Part 2|Withdrawal by Subject|3
2297994|NCT02573311|3994745|FG000|Disposition for Part 2|Investigator decision|0
2297995|NCT02573311|3994746|FG001|Disposition for Part 2|Investigator decision|1
2297996|NCT02573311|3994745|FG000|Disposition for Part 2|Other than specified above|13
2297997|NCT02573311|3994746|FG001|Disposition for Part 2|Other than specified above|3
2297998|NCT02573350|3994754|FG000|Overall Study|Lost to Follow-up|2
2297999|NCT02573350|3994755|FG001|Overall Study|Lost to Follow-up|1
2298000|NCT02573350|3994754|FG000|Overall Study|Adverse Event|3
2298001|NCT02573350|3994755|FG001|Overall Study|Adverse Event|4
2298002|NCT02573350|3994754|FG000|Overall Study|Subject met Withdrawal Criteria|1
2298003|NCT02573350|3994755|FG001|Overall Study|Subject met Withdrawal Criteria|1
2298004|NCT02573350|3994754|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3
2298005|NCT02573350|3994755|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1
2298006|NCT02573350|3994754|FG000|Overall Study|Subject withdrew consent to participate|6
2298007|NCT02573350|3994755|FG001|Overall Study|Subject withdrew consent to participate|1
2298008|NCT02573350|3994754|FG000|Overall Study|Protocol Deviation|1
2298009|NCT02573350|3994755|FG001|Overall Study|Protocol Deviation|1
2298010|NCT02573467|3994777|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0
2298011|NCT02573467|3994778|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0
2298012|NCT02573467|3994779|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1
2298013|NCT02573467|3994780|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0
2298014|NCT02573467|3994777|FG000|Double-blind Treatment Epoch|Adverse Event|1
2298015|NCT02573467|3994778|FG001|Double-blind Treatment Epoch|Adverse Event|0
2176277|NCT01366846|3800088|FG000|Overall Study|Withdrawal by Subject|2
2176278|NCT01366846|3800089|FG001|Overall Study|Withdrawal by Subject|0
2176279|NCT01366846|3800090|FG002|Overall Study|Withdrawal by Subject|0
2176280|NCT01366846|3800091|FG003|Overall Study|Withdrawal by Subject|0
2176281|NCT01366846|3800088|FG000|Overall Study|Communication Difficulties|1
2176282|NCT01366846|3800089|FG001|Overall Study|Communication Difficulties|4
2176283|NCT01366846|3800090|FG002|Overall Study|Communication Difficulties|0
2176284|NCT01366846|3800091|FG003|Overall Study|Communication Difficulties|1
2176285|NCT01366846|3800088|FG000|Overall Study|Scheduling Conflicts|0
2176286|NCT01366846|3800089|FG001|Overall Study|Scheduling Conflicts|0
2176287|NCT01366846|3800090|FG002|Overall Study|Scheduling Conflicts|1
2176288|NCT01366846|3800091|FG003|Overall Study|Scheduling Conflicts|0
2176289|NCT01367119|3800134|FG000|Overall Study|Adverse Event|1
2176290|NCT01367119|3800135|FG001|Overall Study|Adverse Event|0
2176291|NCT01367119|3800134|FG000|Overall Study|Withdrawal by Subject|1
2176292|NCT01367119|3800135|FG001|Overall Study|Withdrawal by Subject|1
2176293|NCT01367158|3800152|FG000|Overall Study|Withdrew consent|0
2176294|NCT01367158|3800153|FG001|Overall Study|Withdrew consent|2
2176295|NCT01367158|3800154|FG002|Overall Study|Withdrew consent|1
2176296|NCT01367158|3800155|FG003|Overall Study|Withdrew consent|0
2176297|NCT01367158|3800156|FG004|Overall Study|Withdrew consent|2
2176298|NCT01367158|3800157|FG005|Overall Study|Withdrew consent|0
2176299|NCT01367158|3800158|FG006|Overall Study|Withdrew consent|0
2176300|NCT01367158|3800159|FG007|Overall Study|Withdrew consent|1
2176301|NCT01367158|3800160|FG008|Overall Study|Withdrew consent|0
2298016|NCT02573467|3994779|FG002|Double-blind Treatment Epoch|Adverse Event|1
2176302|NCT01367158|3800161|FG009|Overall Study|Withdrew consent|0
2176303|NCT01367158|3800162|FG010|Overall Study|Withdrew consent|0
2176304|NCT01367158|3800152|FG000|Overall Study|Lost to Follow-up|0
2176305|NCT01367158|3800153|FG001|Overall Study|Lost to Follow-up|0
2176306|NCT01367158|3800154|FG002|Overall Study|Lost to Follow-up|0
2176307|NCT01367158|3800155|FG003|Overall Study|Lost to Follow-up|1
2176308|NCT01367158|3800156|FG004|Overall Study|Lost to Follow-up|0
2176309|NCT01367158|3800157|FG005|Overall Study|Lost to Follow-up|2
2176310|NCT01367158|3800158|FG006|Overall Study|Lost to Follow-up|0
2176311|NCT01367158|3800159|FG007|Overall Study|Lost to Follow-up|1
2176312|NCT01367158|3800160|FG008|Overall Study|Lost to Follow-up|0
2176313|NCT01367158|3800161|FG009|Overall Study|Lost to Follow-up|0
2176314|NCT01367158|3800162|FG010|Overall Study|Lost to Follow-up|1
2176315|NCT01367158|3800152|FG000|Overall Study|Protocol Violation|0
2176316|NCT01367158|3800153|FG001|Overall Study|Protocol Violation|1
2176317|NCT01367158|3800154|FG002|Overall Study|Protocol Violation|0
2176318|NCT01367158|3800155|FG003|Overall Study|Protocol Violation|0
2176319|NCT01367158|3800156|FG004|Overall Study|Protocol Violation|0
2176320|NCT01367158|3800157|FG005|Overall Study|Protocol Violation|0
2176321|NCT01367158|3800158|FG006|Overall Study|Protocol Violation|0
2176322|NCT01367158|3800159|FG007|Overall Study|Protocol Violation|0
2176323|NCT01367158|3800160|FG008|Overall Study|Protocol Violation|0
2176324|NCT01367158|3800161|FG009|Overall Study|Protocol Violation|0
2176325|NCT01367158|3800162|FG010|Overall Study|Protocol Violation|0
2208342|NCT01639339|3847896|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2
2208343|NCT01639339|3847895|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0
2176326|NCT01367236|3800199|FG000|Overall Study|Withdrawal by Subject|3
2176327|NCT01367236|3800200|FG001|Overall Study|Withdrawal by Subject|1
2176328|NCT01367249|3800208|FG000|Overall Study|Withdrawal by Subject|6
2176329|NCT01367249|3800209|FG001|Overall Study|Withdrawal by Subject|6
2176330|NCT01367249|3800208|FG000|Overall Study|Other|3
2176331|NCT01367249|3800209|FG001|Overall Study|Other|10
2176332|NCT01367275|3800219|FG000|Overall Study|Ineligible|1
2176333|NCT01367275|3800219|FG000|Overall Study|Disease Progression|2
2176334|NCT01367457|3800255|FG000|Overall Study|Death|2
2176335|NCT01367457|3800256|FG001|Overall Study|Death|0
2176336|NCT01367457|3800257|FG002|Overall Study|Death|0
2176337|NCT01367457|3800255|FG000|Overall Study|Investigator's decision|2
2176338|NCT01367457|3800256|FG001|Overall Study|Investigator's decision|0
2176339|NCT01367457|3800257|FG002|Overall Study|Investigator's decision|0
2176340|NCT01367457|3800255|FG000|Overall Study|Clinical decline (CD)|2
2176341|NCT01367457|3800256|FG001|Overall Study|Clinical decline (CD)|0
2176342|NCT01367457|3800257|FG002|Overall Study|Clinical decline (CD)|0
2176343|NCT01367457|3800255|FG000|Overall Study|Progression and death|8
2176344|NCT01367457|3800256|FG001|Overall Study|Progression and death|0
2176345|NCT01367457|3800257|FG002|Overall Study|Progression and death|0
2176346|NCT01367457|3800255|FG000|Overall Study|Toxicity|16
2176347|NCT01367457|3800256|FG001|Overall Study|Toxicity|0
2176348|NCT01367457|3800257|FG002|Overall Study|Toxicity|0
2176349|NCT01367457|3800255|FG000|Overall Study|Progression|137
2176350|NCT01367457|3800256|FG001|Overall Study|Progression|0
2176351|NCT01367457|3800257|FG002|Overall Study|Progression|0
2176352|NCT01367457|3800255|FG000|Overall Study|Patient asks for rest + slow progression|1
2176353|NCT01367457|3800256|FG001|Overall Study|Patient asks for rest + slow progression|0
2176354|NCT01367457|3800257|FG002|Overall Study|Patient asks for rest + slow progression|0
2176355|NCT01367457|3800255|FG000|Overall Study|Investigator's opinion, stable disease|1
2176356|NCT01367457|3800256|FG001|Overall Study|Investigator's opinion, stable disease|0
2176357|NCT01367457|3800257|FG002|Overall Study|Investigator's opinion, stable disease|0
2176358|NCT01367457|3800255|FG000|Overall Study|Bleeding from cavernous haemangioma|1
2176359|NCT01367457|3800256|FG001|Overall Study|Bleeding from cavernous haemangioma|0
2176360|NCT01367457|3800257|FG002|Overall Study|Bleeding from cavernous haemangioma|0
2176361|NCT01367457|3800255|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1
2176362|NCT01367457|3800256|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0
2176363|NCT01367457|3800257|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0
2176364|NCT01367457|3800255|FG000|Overall Study|low grade toxicities + stable disease|1
2176365|NCT01367457|3800256|FG001|Overall Study|low grade toxicities + stable disease|0
2176366|NCT01367457|3800257|FG002|Overall Study|low grade toxicities + stable disease|0
2176367|NCT01367457|3800255|FG000|Overall Study|Choledocolithiasis and pancreatitis|1
2176368|NCT01367457|3800256|FG001|Overall Study|Choledocolithiasis and pancreatitis|0
2176369|NCT01367457|3800257|FG002|Overall Study|Choledocolithiasis and pancreatitis|0
2176370|NCT01367457|3800255|FG000|Overall Study|Withdrawal by Subject|1
2176371|NCT01367457|3800256|FG001|Overall Study|Withdrawal by Subject|0
2176372|NCT01367457|3800257|FG002|Overall Study|Withdrawal by Subject|0
2176373|NCT01367457|3800255|FG000|Overall Study|CD, associated leukaemia|1
2176374|NCT01367457|3800256|FG001|Overall Study|CD, associated leukaemia|0
2176375|NCT01367457|3800257|FG002|Overall Study|CD, associated leukaemia|0
2176376|NCT01367457|3800255|FG000|Overall Study|Uncontrolled pain|1
2176377|NCT01367457|3800256|FG001|Overall Study|Uncontrolled pain|0
2176378|NCT01367457|3800257|FG002|Overall Study|Uncontrolled pain|0
2176379|NCT01367457|3800255|FG000|Overall Study|Overall status worsens to grade 4|1
2176380|NCT01367457|3800256|FG001|Overall Study|Overall status worsens to grade 4|0
2176381|NCT01367457|3800257|FG002|Overall Study|Overall status worsens to grade 4|0
2041726|NCT00440518|3612427|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
2041727|NCT00440557|3612438|FG000|Overall Study|Withdrawal by Subject|10
2041728|NCT00440557|3612439|FG001|Overall Study|Withdrawal by Subject|5
2041729|NCT00440557|3612440|FG002|Overall Study|Withdrawal by Subject|11
2041730|NCT00440557|3612438|FG000|Overall Study|Lost to Follow-up|1
2041731|NCT00440557|3612439|FG001|Overall Study|Lost to Follow-up|2
2041732|NCT00440557|3612440|FG002|Overall Study|Lost to Follow-up|6
2041733|NCT00440557|3612438|FG000|Overall Study|Adverse Event|3
2041734|NCT00440557|3612439|FG001|Overall Study|Adverse Event|3
2041735|NCT00440557|3612440|FG002|Overall Study|Adverse Event|5
2041736|NCT00440557|3612438|FG000|Overall Study|Death|2
2041737|NCT00440557|3612439|FG001|Overall Study|Death|6
2041738|NCT00440557|3612440|FG002|Overall Study|Death|3
2041739|NCT00440557|3612438|FG000|Overall Study|Began Dialysis|4
2041740|NCT00440557|3612439|FG001|Overall Study|Began Dialysis|1
2041741|NCT00440557|3612440|FG002|Overall Study|Began Dialysis|4
2041742|NCT00440557|3612438|FG000|Overall Study|Principal Investigator decision|0
2041743|NCT00440557|3612439|FG001|Overall Study|Principal Investigator decision|3
2041744|NCT00440557|3612440|FG002|Overall Study|Principal Investigator decision|1
2041745|NCT00440557|3612438|FG000|Overall Study|Patient moved|1
2041746|NCT00440557|3612439|FG001|Overall Study|Patient moved|2
2041747|NCT00440557|3612440|FG002|Overall Study|Patient moved|1
2041748|NCT00440557|3612438|FG000|Overall Study|Principal Investigator's office closed|3
2041749|NCT00440557|3612439|FG001|Overall Study|Principal Investigator's office closed|6
2105005|NCT00854724|3697476|FG001|Second Intervention|Protocol Violation|0
2176382|NCT01367457|3800255|FG000|Overall Study|Stabilisation + frequent infections|1
2176383|NCT01367457|3800256|FG001|Overall Study|Stabilisation + frequent infections|0
2176384|NCT01367457|3800257|FG002|Overall Study|Stabilisation + frequent infections|0
2176385|NCT01367457|3800255|FG000|Overall Study|No clinical benefit|1
2176386|NCT01367457|3800256|FG001|Overall Study|No clinical benefit|0
2176387|NCT01367457|3800257|FG002|Overall Study|No clinical benefit|0
2176388|NCT01367457|3800255|FG000|Overall Study|Intestinal obstruction with necrosis|1
2176389|NCT01367457|3800256|FG001|Overall Study|Intestinal obstruction with necrosis|0
2176390|NCT01367457|3800257|FG002|Overall Study|Intestinal obstruction with necrosis|0
2176391|NCT01367457|3800255|FG000|Overall Study|Overall decline|1
2176392|NCT01367457|3800256|FG001|Overall Study|Overall decline|0
2176393|NCT01367457|3800257|FG002|Overall Study|Overall decline|0
2176394|NCT01367457|3800255|FG000|Overall Study|Rejection of treatment|1
2176395|NCT01367457|3800256|FG001|Overall Study|Rejection of treatment|0
2176396|NCT01367457|3800257|FG002|Overall Study|Rejection of treatment|0
2176397|NCT01367457|3800255|FG000|Overall Study|Lost to Follow-up|1
2176398|NCT01367457|3800256|FG001|Overall Study|Lost to Follow-up|0
2176399|NCT01367457|3800257|FG002|Overall Study|Lost to Follow-up|0
2176400|NCT01367457|3800255|FG000|Overall Study|Death from septic shock|1
2176401|NCT01367457|3800256|FG001|Overall Study|Death from septic shock|0
2176402|NCT01367457|3800257|FG002|Overall Study|Death from septic shock|0
2176403|NCT01367457|3800255|FG000|Overall Study|CD, Suspected disease progression (DP)|1
2176404|NCT01367457|3800256|FG001|Overall Study|CD, Suspected disease progression (DP)|0
2176405|NCT01367457|3800257|FG002|Overall Study|CD, Suspected disease progression (DP)|0
2176406|NCT01367457|3800255|FG000|Overall Study|Patient's Wish|1
2176407|NCT01367457|3800256|FG001|Overall Study|Patient's Wish|0
2176408|NCT01367457|3800257|FG002|Overall Study|Patient's Wish|0
2176409|NCT01367457|3800255|FG000|Overall Study|Palliative. Overall decline|1
2176410|NCT01367457|3800256|FG001|Overall Study|Palliative. Overall decline|0
2176411|NCT01367457|3800257|FG002|Overall Study|Palliative. Overall decline|0
2176412|NCT01367457|3800255|FG000|Overall Study|Suspected DP/suspected active infection|1
2176413|NCT01367457|3800256|FG001|Overall Study|Suspected DP/suspected active infection|0
2176414|NCT01367457|3800257|FG002|Overall Study|Suspected DP/suspected active infection|0
2176415|NCT01367665|3800267|FG000|Overall Study|Death|102
2176416|NCT01367665|3800268|FG001|Overall Study|Death|19
2176417|NCT01367665|3800267|FG000|Overall Study|Lost to Follow-up|222
2176418|NCT01367665|3800268|FG001|Overall Study|Lost to Follow-up|22
2176419|NCT01367665|3800267|FG000|Overall Study|Not Done|118
2176420|NCT01367665|3800268|FG001|Overall Study|Not Done|14
2176421|NCT01367704|3800277|FG000|Overall Study|Lost to Follow-up|47
2176422|NCT01367704|3800278|FG001|Overall Study|Lost to Follow-up|161
2176423|NCT01367834|3800286|FG000|Overall Study|Withdrawal by Subject|2
2176424|NCT01367834|3800287|FG001|Overall Study|Withdrawal by Subject|2
2176425|NCT01367834|3800286|FG000|Overall Study|Study was ended.|0
2176426|NCT01367834|3800287|FG001|Overall Study|Study was ended.|1
2176427|NCT01367847|3800295|FG000|Overall Study|Withdrawal by Subject|2
2176428|NCT01367847|3800296|FG001|Overall Study|Withdrawal by Subject|2
2176429|NCT01367886|3800312|FG000|Overall Study|Lost to Follow-up|4
2176430|NCT01367886|3800312|FG000|Overall Study|Lack of Efficacy|2
2176431|NCT01367886|3800312|FG000|Overall Study|Death|1
2176432|NCT01368042|3800317|FG000|Overall Study|Death|14
2176433|NCT01368042|3800317|FG000|Overall Study|Protocol Violation|11
2176434|NCT01368042|3800317|FG000|Overall Study|Lost to Follow-up|4
2176435|NCT01368042|3800317|FG000|Overall Study|Transplanted|1
2176436|NCT01368081|3800334|FG000|Overall Study|Adverse Event|4
2176437|NCT01368081|3800335|FG001|Overall Study|Adverse Event|4
2176438|NCT01368081|3800336|FG002|Overall Study|Adverse Event|3
2176439|NCT01368081|3800337|FG003|Overall Study|Adverse Event|2
2176440|NCT01368081|3800338|FG004|Overall Study|Adverse Event|2
2176441|NCT01368081|3800339|FG005|Overall Study|Adverse Event|5
2176442|NCT01368081|3800340|FG006|Overall Study|Adverse Event|6
2176443|NCT01368081|3800341|FG007|Overall Study|Adverse Event|2
2176444|NCT01368081|3800342|FG008|Overall Study|Adverse Event|3
2176445|NCT01368081|3800343|FG009|Overall Study|Adverse Event|5
2176446|NCT01368081|3800344|FG010|Overall Study|Adverse Event|6
2176447|NCT01368081|3800345|FG011|Overall Study|Adverse Event|1
2176448|NCT01368081|3800346|FG012|Overall Study|Adverse Event|3
2176449|NCT01368081|3800334|FG000|Overall Study|Lack of Efficacy|0
2176450|NCT01368081|3800335|FG001|Overall Study|Lack of Efficacy|1
2176451|NCT01368081|3800336|FG002|Overall Study|Lack of Efficacy|0
2176452|NCT01368081|3800337|FG003|Overall Study|Lack of Efficacy|1
2176453|NCT01368081|3800338|FG004|Overall Study|Lack of Efficacy|0
2176454|NCT01368081|3800339|FG005|Overall Study|Lack of Efficacy|0
2176455|NCT01368081|3800340|FG006|Overall Study|Lack of Efficacy|0
2176456|NCT01368081|3800341|FG007|Overall Study|Lack of Efficacy|2
2176457|NCT01368081|3800342|FG008|Overall Study|Lack of Efficacy|0
2176458|NCT01368081|3800343|FG009|Overall Study|Lack of Efficacy|0
2176459|NCT01368081|3800344|FG010|Overall Study|Lack of Efficacy|0
2176460|NCT01368081|3800345|FG011|Overall Study|Lack of Efficacy|0
2176461|NCT01368081|3800346|FG012|Overall Study|Lack of Efficacy|0
2176462|NCT01368081|3800334|FG000|Overall Study|Protocol Violation|0
2176463|NCT01368081|3800335|FG001|Overall Study|Protocol Violation|0
2176464|NCT01368081|3800336|FG002|Overall Study|Protocol Violation|0
2176465|NCT01368081|3800337|FG003|Overall Study|Protocol Violation|0
2176466|NCT01368081|3800338|FG004|Overall Study|Protocol Violation|0
2176467|NCT01368081|3800339|FG005|Overall Study|Protocol Violation|1
2176468|NCT01368081|3800340|FG006|Overall Study|Protocol Violation|0
2176469|NCT01368081|3800341|FG007|Overall Study|Protocol Violation|1
2176470|NCT01368081|3800342|FG008|Overall Study|Protocol Violation|0
2176471|NCT01368081|3800343|FG009|Overall Study|Protocol Violation|0
2176472|NCT01368081|3800344|FG010|Overall Study|Protocol Violation|0
2176473|NCT01368081|3800345|FG011|Overall Study|Protocol Violation|0
2176474|NCT01368081|3800346|FG012|Overall Study|Protocol Violation|0
2176475|NCT01368081|3800334|FG000|Overall Study|Lost to Follow-up|0
2176476|NCT01368081|3800335|FG001|Overall Study|Lost to Follow-up|0
2176477|NCT01368081|3800336|FG002|Overall Study|Lost to Follow-up|0
2176478|NCT01368081|3800337|FG003|Overall Study|Lost to Follow-up|0
2176479|NCT01368081|3800338|FG004|Overall Study|Lost to Follow-up|0
2208344|NCT01639339|3847896|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1
2208345|NCT01639339|3847895|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0
2208346|NCT01639339|3847896|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1
2208347|NCT01639339|3847895|FG000|Open-label Period (Up to Week 28)|Adverse Event|1
2208348|NCT01639339|3847896|FG001|Open-label Period (Up to Week 28)|Adverse Event|4
2208349|NCT01639469|3847921|FG000|Overall Study|Death|4
2041750|NCT00440557|3612440|FG002|Overall Study|Principal Investigator's office closed|4
2041751|NCT00440557|3612438|FG000|Overall Study|Patient transferred to nursing home|0
2041752|NCT00440557|3612439|FG001|Overall Study|Patient transferred to nursing home|1
2041753|NCT00440557|3612440|FG002|Overall Study|Patient transferred to nursing home|0
2041754|NCT00440557|3612438|FG000|Overall Study|Patient had surgery|1
2041755|NCT00440557|3612439|FG001|Overall Study|Patient had surgery|0
2041756|NCT00440557|3612440|FG002|Overall Study|Patient had surgery|0
2105006|NCT00854724|3697475|FG000|Second Intervention|Physician Decision|0
2105007|NCT00854724|3697476|FG001|Second Intervention|Physician Decision|1
2105008|NCT00854828|3697486|FG000|Overall Study|Death|1
2105009|NCT00854828|3697487|FG001|Overall Study|Death|0
2105010|NCT00854828|3697488|FG002|Overall Study|Death|0
2105011|NCT00854828|3697489|FG003|Overall Study|Death|0
2105012|NCT00854828|3697486|FG000|Overall Study|Withdrawal by Subject|1
2105013|NCT00854828|3697487|FG001|Overall Study|Withdrawal by Subject|1
2105014|NCT00854828|3697488|FG002|Overall Study|Withdrawal by Subject|0
2105015|NCT00854828|3697489|FG003|Overall Study|Withdrawal by Subject|9
2176480|NCT01368081|3800339|FG005|Overall Study|Lost to Follow-up|0
2176481|NCT01368081|3800340|FG006|Overall Study|Lost to Follow-up|0
2176482|NCT01368081|3800341|FG007|Overall Study|Lost to Follow-up|0
2176483|NCT01368081|3800342|FG008|Overall Study|Lost to Follow-up|0
2176484|NCT01368081|3800343|FG009|Overall Study|Lost to Follow-up|0
2176485|NCT01368081|3800344|FG010|Overall Study|Lost to Follow-up|0
2176486|NCT01368081|3800345|FG011|Overall Study|Lost to Follow-up|0
2176487|NCT01368081|3800346|FG012|Overall Study|Lost to Follow-up|1
2176488|NCT01368081|3800334|FG000|Overall Study|Withdrawal by Subject|4
2176489|NCT01368081|3800335|FG001|Overall Study|Withdrawal by Subject|4
2176490|NCT01368081|3800336|FG002|Overall Study|Withdrawal by Subject|1
2176491|NCT01368081|3800337|FG003|Overall Study|Withdrawal by Subject|1
2176492|NCT01368081|3800338|FG004|Overall Study|Withdrawal by Subject|0
2176493|NCT01368081|3800339|FG005|Overall Study|Withdrawal by Subject|3
2176494|NCT01368081|3800340|FG006|Overall Study|Withdrawal by Subject|4
2176495|NCT01368081|3800341|FG007|Overall Study|Withdrawal by Subject|2
2176496|NCT01368081|3800342|FG008|Overall Study|Withdrawal by Subject|5
2176497|NCT01368081|3800343|FG009|Overall Study|Withdrawal by Subject|4
2176498|NCT01368081|3800344|FG010|Overall Study|Withdrawal by Subject|3
2176499|NCT01368081|3800345|FG011|Overall Study|Withdrawal by Subject|2
2176500|NCT01368081|3800346|FG012|Overall Study|Withdrawal by Subject|0
2176501|NCT01368081|3800334|FG000|Overall Study|Other reason not defined above|2
2176502|NCT01368081|3800335|FG001|Overall Study|Other reason not defined above|0
2176503|NCT01368081|3800336|FG002|Overall Study|Other reason not defined above|0
2176504|NCT01368081|3800337|FG003|Overall Study|Other reason not defined above|1
2176505|NCT01368081|3800338|FG004|Overall Study|Other reason not defined above|0
2176506|NCT01368081|3800339|FG005|Overall Study|Other reason not defined above|1
2041757|NCT00440700|3612462|FG000|Overall Study|Withdrawal by Subject|8
2041758|NCT00440700|3612463|FG001|Overall Study|Withdrawal by Subject|8
2041759|NCT00440700|3612464|FG002|Overall Study|Withdrawal by Subject|4
2041760|NCT00440726|3612475|FG000|Phase 1|Dose-Limiting Toxicity|0
2041761|NCT00440726|3612476|FG001|Phase 1|Dose-Limiting Toxicity|1
2041762|NCT00440726|3612477|FG002|Phase 1|Dose-Limiting Toxicity|0
2041763|NCT00440726|3612475|FG000|Phase 1|Physician Decision|1
2041764|NCT00440726|3612476|FG001|Phase 1|Physician Decision|0
2041765|NCT00440726|3612477|FG002|Phase 1|Physician Decision|0
2041766|NCT00440726|3612475|FG000|Phase 2|Death|0
2041767|NCT00440726|3612476|FG001|Phase 2|Death|0
2041768|NCT00440726|3612477|FG002|Phase 2|Death|1
2041769|NCT00440726|3612475|FG000|Phase 2|Adverse Event|0
2041770|NCT00440726|3612476|FG001|Phase 2|Adverse Event|0
2041771|NCT00440726|3612477|FG002|Phase 2|Adverse Event|1
2041772|NCT00440947|3612509|FG000|36-Week Induction Phase|Adverse Event|16
2041773|NCT00440947|3612510|FG001|36-Week Induction Phase|Adverse Event|0
2041774|NCT00440947|3612511|FG002|36-Week Induction Phase|Adverse Event|0
2041775|NCT00440947|3612512|FG003|36-Week Induction Phase|Adverse Event|0
2041776|NCT00440947|3612513|FG004|36-Week Induction Phase|Adverse Event|0
2041777|NCT00440947|3612509|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11
2041778|NCT00440947|3612510|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0
2041779|NCT00440947|3612511|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0
2041780|NCT00440947|3612512|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0
2041781|NCT00440947|3612513|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0
2176507|NCT01368081|3800340|FG006|Overall Study|Other reason not defined above|2
2176508|NCT01368081|3800341|FG007|Overall Study|Other reason not defined above|0
2176509|NCT01368081|3800342|FG008|Overall Study|Other reason not defined above|0
2176510|NCT01368081|3800343|FG009|Overall Study|Other reason not defined above|1
2176511|NCT01368081|3800344|FG010|Overall Study|Other reason not defined above|0
2176512|NCT01368081|3800345|FG011|Overall Study|Other reason not defined above|0
2176513|NCT01368081|3800346|FG012|Overall Study|Other reason not defined above|3
2176514|NCT01368211|3800376|FG000|Second Platelets Transfusion|No need for additional transfusion|1
2176515|NCT01368211|3800377|FG001|Second Platelets Transfusion|No need for additional transfusion|2
2176516|NCT01368276|3800398|FG000|Overall Study|Death|1
2176517|NCT01368276|3800399|FG001|Overall Study|Death|10
2176518|NCT01368406|3800407|FG000|Overall Study|Lost to Follow-up|8
2176519|NCT01368406|3800408|FG001|Overall Study|Lost to Follow-up|4
2176520|NCT01368406|3800407|FG000|Overall Study|Withdrawal by Subject|8
2176521|NCT01368406|3800408|FG001|Overall Study|Withdrawal by Subject|4
2176522|NCT01368406|3800407|FG000|Overall Study|relapse of the disease|3
2176523|NCT01368406|3800408|FG001|Overall Study|relapse of the disease|2
2176524|NCT01368406|3800407|FG000|Overall Study|started working|2
2176525|NCT01368406|3800408|FG001|Overall Study|started working|3
2176526|NCT01368432|3800416|FG000|Overall Study|Lost to Follow-up|0
2176527|NCT01368432|3800417|FG001|Overall Study|Lost to Follow-up|1
2176528|NCT01368497|3800437|FG000|Overall Study|Lost to Follow-up|2
2176529|NCT01368536|3800444|FG000|Overall Study|Adverse Event|5
2176530|NCT01368536|3800445|FG001|Overall Study|Adverse Event|6
2176531|NCT01368536|3800446|FG002|Overall Study|Adverse Event|8
2176532|NCT01368536|3800444|FG000|Overall Study|Abnormal laboratory value(s)|0
2176533|NCT01368536|3800445|FG001|Overall Study|Abnormal laboratory value(s)|1
2208350|NCT01639469|3847922|FG001|Overall Study|Death|2
2208351|NCT01639469|3847921|FG000|Overall Study|Lost to Follow-up|1
2298017|NCT02573467|3994780|FG003|Double-blind Treatment Epoch|Adverse Event|0
2176534|NCT01368536|3800446|FG002|Overall Study|Abnormal laboratory value(s)|2
2176535|NCT01368536|3800444|FG000|Overall Study|Abnormal test procedure result(s)|0
2176536|NCT01368536|3800445|FG001|Overall Study|Abnormal test procedure result(s)|0
2176537|NCT01368536|3800446|FG002|Overall Study|Abnormal test procedure result(s)|1
2176538|NCT01368536|3800444|FG000|Overall Study|Unsatisfactory therapeutic effect|7
2176539|NCT01368536|3800445|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2176540|NCT01368536|3800446|FG002|Overall Study|Unsatisfactory therapeutic effect|2
2176541|NCT01368536|3800444|FG000|Overall Study|No longer required study medication|0
2176542|NCT01368536|3800445|FG001|Overall Study|No longer required study medication|0
2176543|NCT01368536|3800446|FG002|Overall Study|No longer required study medication|1
2176544|NCT01368536|3800444|FG000|Overall Study|Withdrawal by Subject|2
2176545|NCT01368536|3800445|FG001|Overall Study|Withdrawal by Subject|5
2176546|NCT01368536|3800446|FG002|Overall Study|Withdrawal by Subject|4
2176547|NCT01368536|3800444|FG000|Overall Study|Lost to Follow-up|3
2176548|NCT01368536|3800445|FG001|Overall Study|Lost to Follow-up|3
2176549|NCT01368536|3800446|FG002|Overall Study|Lost to Follow-up|5
2176550|NCT01368536|3800444|FG000|Overall Study|Administrative problems|34
2176551|NCT01368536|3800445|FG001|Overall Study|Administrative problems|39
2176552|NCT01368536|3800446|FG002|Overall Study|Administrative problems|35
2176553|NCT01368536|3800444|FG000|Overall Study|Protocol deviation|0
2176554|NCT01368536|3800445|FG001|Overall Study|Protocol deviation|3
2176555|NCT01368536|3800446|FG002|Overall Study|Protocol deviation|1
2176556|NCT01368562|3800455|FG000|Overall Study|Adverse Event|1
2176557|NCT01368562|3800455|FG000|Overall Study|Disease progression|1
2176558|NCT01368562|3800455|FG000|Overall Study|Lost to Follow-up|1
2176559|NCT01368562|3800455|FG000|Overall Study|Death|6
2176560|NCT01368562|3800455|FG000|Overall Study|Unresponsive to treatment|5
2176561|NCT01368562|3800455|FG000|Overall Study|Other|3
2176562|NCT01368562|3800455|FG000|Overall Study|Other than specified|2
2176563|NCT01368614|3800459|FG000|Screening Period|Screen Failure|58
2176564|NCT01368614|3800460|FG001|Screening Period|Screen Failure|0
2176565|NCT01368614|3800461|FG002|Screening Period|Screen Failure|0
2176566|NCT01368614|3800462|FG003|Screening Period|Screen Failure|0
2176567|NCT01368614|3800459|FG000|Study Period|Withdrawal by Subject|0
2176568|NCT01368614|3800460|FG001|Study Period|Withdrawal by Subject|1
2298018|NCT02573467|3994777|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2
2298019|NCT02573467|3994778|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1
2298020|NCT02573467|3994779|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1
2298021|NCT02573467|3994780|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0
2019149|NCT00296504|3586498|FG007|Interim Analysis|Participant Stopped HIV Medications|0
2019150|NCT00296504|3586499|FG008|Interim Analysis|Participant Stopped HIV Medications|0
2019151|NCT00296504|3586491|FG000|Interim Analysis|Study Ended|0
2019152|NCT00296504|3586492|FG001|Interim Analysis|Study Ended|0
2176569|NCT01368614|3800461|FG002|Study Period|Withdrawal by Subject|1
2176570|NCT01368614|3800462|FG003|Study Period|Withdrawal by Subject|3
2176571|NCT01368614|3800459|FG000|Study Period|Lost to Follow-up|0
2176572|NCT01368614|3800460|FG001|Study Period|Lost to Follow-up|0
2176573|NCT01368614|3800461|FG002|Study Period|Lost to Follow-up|1
2176574|NCT01368614|3800462|FG003|Study Period|Lost to Follow-up|0
2176575|NCT01368835|3800495|FG000|Overall Study|Inclusion criteria/photography quality|22
2176576|NCT01368835|3800495|FG000|Overall Study|Lost to Follow-up|11
2176577|NCT01368900|3800547|FG000|Overall Study|Lost to Follow-up|7
2176578|NCT01368965|3800553|FG000|Overall Study|Lost to Follow-up|12
2298022|NCT02573467|3994777|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50
2298023|NCT02573467|3994778|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51
2298024|NCT02573467|3994779|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48
2298025|NCT02573467|3994780|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55
2298026|NCT02573467|3994777|FG000|Post-treatment Follow up Epoch|Death|1
2298027|NCT02573467|3994778|FG001|Post-treatment Follow up Epoch|Death|1
2298028|NCT02573467|3994779|FG002|Post-treatment Follow up Epoch|Death|0
2298029|NCT02573467|3994780|FG003|Post-treatment Follow up Epoch|Death|1
2298030|NCT02573467|3994777|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5
2298031|NCT02573467|3994778|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4
2298032|NCT02573467|3994779|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9
2176579|NCT01369069|3800565|FG000|Overall Study|Lost to Follow-up|8
2176580|NCT01369069|3800566|FG001|Overall Study|Lost to Follow-up|9
2176581|NCT01369069|3800565|FG000|Overall Study|Withdrawal by Subject|9
2176582|NCT01369069|3800566|FG001|Overall Study|Withdrawal by Subject|7
2176583|NCT01369199|3800577|FG000|Overall Study|Withdrawal by Subject|1
2176584|NCT01369199|3800577|FG000|Overall Study|Lost to Follow-up|2
2176585|NCT01369225|3800587|FG000|Overall Study|Withdrawal by Subject|1
2176586|NCT01369225|3800588|FG001|Overall Study|Withdrawal by Subject|0
2176587|NCT01369225|3800589|FG002|Overall Study|Withdrawal by Subject|2
2176588|NCT01369225|3800590|FG003|Overall Study|Withdrawal by Subject|1
2176589|NCT01369225|3800591|FG004|Overall Study|Withdrawal by Subject|0
2176590|NCT01369225|3800592|FG005|Overall Study|Withdrawal by Subject|0
2176591|NCT01369225|3800587|FG000|Overall Study|Does Not Meet Entrance Criteria|0
2176592|NCT01369225|3800588|FG001|Overall Study|Does Not Meet Entrance Criteria|0
2176593|NCT01369225|3800589|FG002|Overall Study|Does Not Meet Entrance Criteria|1
2176594|NCT01369225|3800590|FG003|Overall Study|Does Not Meet Entrance Criteria|0
2176595|NCT01369225|3800591|FG004|Overall Study|Does Not Meet Entrance Criteria|0
2176596|NCT01369225|3800592|FG005|Overall Study|Does Not Meet Entrance Criteria|0
2176597|NCT01369225|3800587|FG000|Overall Study|Other|1
2176598|NCT01369225|3800588|FG001|Overall Study|Other|0
2176599|NCT01369225|3800589|FG002|Overall Study|Other|0
2176600|NCT01369225|3800590|FG003|Overall Study|Other|0
2176601|NCT01369225|3800591|FG004|Overall Study|Other|1
2176602|NCT01369225|3800592|FG005|Overall Study|Other|0
2176603|NCT01369225|3800587|FG000|Overall Study|Adverse Event|0
2176604|NCT01369225|3800588|FG001|Overall Study|Adverse Event|0
2176605|NCT01369225|3800589|FG002|Overall Study|Adverse Event|0
2176606|NCT01369225|3800590|FG003|Overall Study|Adverse Event|1
2176607|NCT01369225|3800591|FG004|Overall Study|Adverse Event|1
2176608|NCT01369225|3800592|FG005|Overall Study|Adverse Event|0
2176609|NCT01369329|3800609|FG000|Overall Study|Withdrawal by Subject|8
2176610|NCT01369329|3800610|FG001|Overall Study|Withdrawal by Subject|6
2176611|NCT01369329|3800611|FG002|Overall Study|Withdrawal by Subject|10
2176612|NCT01369329|3800609|FG000|Overall Study|Lost to Follow-up|2
2176613|NCT01369329|3800610|FG001|Overall Study|Lost to Follow-up|2
2176614|NCT01369329|3800611|FG002|Overall Study|Lost to Follow-up|2
2176615|NCT01369329|3800609|FG000|Overall Study|Other|2
2176616|NCT01369329|3800610|FG001|Overall Study|Other|3
2176617|NCT01369329|3800611|FG002|Overall Study|Other|2
2176618|NCT01369342|3800622|FG000|Overall Study|Withdrawal by Subject|7
2176619|NCT01369342|3800623|FG001|Overall Study|Withdrawal by Subject|7
2176620|NCT01369342|3800624|FG002|Overall Study|Withdrawal by Subject|2
2176621|NCT01369342|3800622|FG000|Overall Study|Lost to Follow-up|5
2176622|NCT01369342|3800623|FG001|Overall Study|Lost to Follow-up|2
2176623|NCT01369342|3800624|FG002|Overall Study|Lost to Follow-up|1
2176624|NCT01369342|3800622|FG000|Overall Study|Not Treated|1
2176625|NCT01369342|3800623|FG001|Overall Study|Not Treated|0
2176626|NCT01369342|3800624|FG002|Overall Study|Not Treated|0
2176627|NCT01369355|3800638|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9
2176628|NCT01369355|3800639|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12
2176629|NCT01369355|3800640|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6
2176630|NCT01369355|3800641|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7
2176631|NCT01369355|3800642|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14
2176632|NCT01369355|3800643|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25
2176633|NCT01369355|3800644|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0
2176634|NCT01369355|3800645|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0
2176635|NCT01369355|3800646|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0
2176636|NCT01369355|3800638|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
2176637|NCT01369355|3800639|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14
2176638|NCT01369355|3800640|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
2176639|NCT01369355|3800641|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
2176640|NCT01369355|3800642|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126
2176641|NCT01369355|3800643|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217
2176642|NCT01369355|3800644|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
2176643|NCT01369355|3800645|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
2176644|NCT01369355|3800646|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
2176645|NCT01369355|3800638|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
2176646|NCT01369355|3800639|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
2176647|NCT01369355|3800640|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
2176648|NCT01369355|3800641|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
2176649|NCT01369355|3800642|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
2176650|NCT01369355|3800643|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2
2176651|NCT01369355|3800644|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
2176652|NCT01369355|3800645|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
2176653|NCT01369355|3800646|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
2176654|NCT01369355|3800638|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
2176655|NCT01369355|3800639|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
2176656|NCT01369355|3800640|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
2176657|NCT01369355|3800641|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2
2176658|NCT01369355|3800642|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5
2176659|NCT01369355|3800643|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6
2176660|NCT01369355|3800644|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
2176661|NCT01369355|3800645|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
2176662|NCT01369355|3800646|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
2176663|NCT01369355|3800638|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
2176664|NCT01369355|3800639|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2
2208352|NCT01639469|3847922|FG001|Overall Study|Lost to Follow-up|1
2176665|NCT01369355|3800640|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7
2176666|NCT01369355|3800641|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
2041782|NCT00440947|3612509|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5
2041783|NCT00440947|3612510|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0
2041784|NCT00440947|3612511|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0
2041785|NCT00440947|3612512|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0
2041786|NCT00440947|3612513|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0
2041787|NCT00440947|3612509|FG000|36-Week Induction Phase|Non-compliance|10
2041788|NCT00440947|3612510|FG001|36-Week Induction Phase|Non-compliance|0
2041789|NCT00440947|3612511|FG002|36-Week Induction Phase|Non-compliance|0
2041790|NCT00440947|3612512|FG003|36-Week Induction Phase|Non-compliance|0
2041791|NCT00440947|3612513|FG004|36-Week Induction Phase|Non-compliance|0
2041792|NCT00440947|3612509|FG000|36-Week Induction Phase|Lost to Follow-up|16
2041793|NCT00440947|3612510|FG001|36-Week Induction Phase|Lost to Follow-up|0
2041794|NCT00440947|3612511|FG002|36-Week Induction Phase|Lost to Follow-up|0
2041795|NCT00440947|3612512|FG003|36-Week Induction Phase|Lost to Follow-up|0
2041796|NCT00440947|3612513|FG004|36-Week Induction Phase|Lost to Follow-up|0
2041797|NCT00440947|3612509|FG000|36-Week Induction Phase|Withdrawal by Subject|7
2041798|NCT00440947|3612510|FG001|36-Week Induction Phase|Withdrawal by Subject|0
2041799|NCT00440947|3612511|FG002|36-Week Induction Phase|Withdrawal by Subject|0
2041800|NCT00440947|3612512|FG003|36-Week Induction Phase|Withdrawal by Subject|0
2041801|NCT00440947|3612513|FG004|36-Week Induction Phase|Withdrawal by Subject|0
2041802|NCT00440947|3612509|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
2041803|NCT00440947|3612510|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
2041804|NCT00440947|3612511|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
2041805|NCT00440947|3612512|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
2041806|NCT00440947|3612513|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
2041807|NCT00440947|3612509|FG000|36-Week Induction Phase|Took Exclusionary Medications|1
2041808|NCT00440947|3612510|FG001|36-Week Induction Phase|Took Exclusionary Medications|0
2041809|NCT00440947|3612511|FG002|36-Week Induction Phase|Took Exclusionary Medications|0
2041810|NCT00440947|3612512|FG003|36-Week Induction Phase|Took Exclusionary Medications|0
2041811|NCT00440947|3612513|FG004|36-Week Induction Phase|Took Exclusionary Medications|0
2041812|NCT00440947|3612509|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
2041813|NCT00440947|3612510|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
2041814|NCT00440947|3612511|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
2176667|NCT01369355|3800642|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8
2176668|NCT01369355|3800643|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22
2176669|NCT01369355|3800644|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
2176670|NCT01369355|3800645|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
2176671|NCT01369355|3800646|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
2176672|NCT01369355|3800638|FG000|Week 0 - Week 44 (Maintenance)|Other|0
2176673|NCT01369355|3800639|FG001|Week 0 - Week 44 (Maintenance)|Other|0
2176674|NCT01369355|3800640|FG002|Week 0 - Week 44 (Maintenance)|Other|1
2176675|NCT01369355|3800641|FG003|Week 0 - Week 44 (Maintenance)|Other|0
2176676|NCT01369355|3800642|FG004|Week 0 - Week 44 (Maintenance)|Other|1
2176677|NCT01369355|3800643|FG005|Week 0 - Week 44 (Maintenance)|Other|0
2176678|NCT01369355|3800644|FG006|Week 0 - Week 44 (Maintenance)|Other|0
2176679|NCT01369355|3800645|FG007|Week 0 - Week 44 (Maintenance)|Other|0
2176680|NCT01369355|3800646|FG008|Week 0 - Week 44 (Maintenance)|Other|0
2176681|NCT01369355|3800638|FG000|Long-term Extension (Week 44-272)|Adverse Event|0
2176682|NCT01369355|3800639|FG001|Long-term Extension (Week 44-272)|Adverse Event|0
2176683|NCT01369355|3800640|FG002|Long-term Extension (Week 44-272)|Adverse Event|0
2176684|NCT01369355|3800641|FG003|Long-term Extension (Week 44-272)|Adverse Event|0
2176685|NCT01369355|3800642|FG004|Long-term Extension (Week 44-272)|Adverse Event|0
2180046|NCT01397786|3805910|FG001|Phase B|Subject Met Withdrawal Criteria|5
2041815|NCT00440947|3612512|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
2041816|NCT00440947|3612513|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
2041817|NCT00440947|3612509|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
2041818|NCT00440947|3612510|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
2041819|NCT00440947|3612511|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
2041820|NCT00440947|3612512|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
2041821|NCT00440947|3612513|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
2041822|NCT00440947|3612509|FG000|36-Week Induction Phase|Incarceration|3
2041823|NCT00440947|3612510|FG001|36-Week Induction Phase|Incarceration|0
2041824|NCT00440947|3612511|FG002|36-Week Induction Phase|Incarceration|0
2041825|NCT00440947|3612512|FG003|36-Week Induction Phase|Incarceration|0
2041826|NCT00440947|3612513|FG004|36-Week Induction Phase|Incarceration|0
2041827|NCT00440947|3612509|FG000|36-Week Induction Phase|Pregnancy|1
2041828|NCT00440947|3612510|FG001|36-Week Induction Phase|Pregnancy|0
2041829|NCT00440947|3612511|FG002|36-Week Induction Phase|Pregnancy|0
2041830|NCT00440947|3612512|FG003|36-Week Induction Phase|Pregnancy|0
2041831|NCT00440947|3612513|FG004|36-Week Induction Phase|Pregnancy|0
2041832|NCT00440947|3612509|FG000|48-Week Randomization Phase|Adverse Event|0
2041833|NCT00440947|3612510|FG001|48-Week Randomization Phase|Adverse Event|2
2041834|NCT00440947|3612511|FG002|48-Week Randomization Phase|Adverse Event|5
2041835|NCT00440947|3612512|FG003|48-Week Randomization Phase|Adverse Event|0
2041836|NCT00440947|3612513|FG004|48-Week Randomization Phase|Adverse Event|0
2041837|NCT00440947|3612509|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
2041838|NCT00440947|3612510|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
2041839|NCT00440947|3612511|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
2041840|NCT00440947|3612512|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
2041841|NCT00440947|3612513|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
2041842|NCT00440947|3612509|FG000|48-Week Randomization Phase|Non-compliance|0
2041843|NCT00440947|3612510|FG001|48-Week Randomization Phase|Non-compliance|3
2041844|NCT00440947|3612511|FG002|48-Week Randomization Phase|Non-compliance|4
2041845|NCT00440947|3612512|FG003|48-Week Randomization Phase|Non-compliance|0
2041846|NCT00440947|3612513|FG004|48-Week Randomization Phase|Non-compliance|0
2041847|NCT00440947|3612509|FG000|48-Week Randomization Phase|Lost to Follow-up|0
2041848|NCT00440947|3612510|FG001|48-Week Randomization Phase|Lost to Follow-up|2
2041849|NCT00440947|3612511|FG002|48-Week Randomization Phase|Lost to Follow-up|8
2041850|NCT00440947|3612512|FG003|48-Week Randomization Phase|Lost to Follow-up|0
2041851|NCT00440947|3612513|FG004|48-Week Randomization Phase|Lost to Follow-up|0
2041852|NCT00440947|3612509|FG000|48-Week Randomization Phase|Protocol Violation|0
2041853|NCT00440947|3612510|FG001|48-Week Randomization Phase|Protocol Violation|0
2041854|NCT00440947|3612511|FG002|48-Week Randomization Phase|Protocol Violation|1
2041855|NCT00440947|3612512|FG003|48-Week Randomization Phase|Protocol Violation|0
2041856|NCT00440947|3612513|FG004|48-Week Randomization Phase|Protocol Violation|0
2041857|NCT00440947|3612509|FG000|48-Week Randomization Phase|Withdrawal by Subject|0
2041858|NCT00440947|3612510|FG001|48-Week Randomization Phase|Withdrawal by Subject|2
2041859|NCT00440947|3612511|FG002|48-Week Randomization Phase|Withdrawal by Subject|4
2176686|NCT01369355|3800643|FG005|Long-term Extension (Week 44-272)|Adverse Event|0
2176687|NCT01369355|3800644|FG006|Long-term Extension (Week 44-272)|Adverse Event|15
2176688|NCT01369355|3800645|FG007|Long-term Extension (Week 44-272)|Adverse Event|29
2176689|NCT01369355|3800646|FG008|Long-term Extension (Week 44-272)|Adverse Event|53
2176690|NCT01369355|3800638|FG000|Long-term Extension (Week 44-272)|Death|0
2176691|NCT01369355|3800639|FG001|Long-term Extension (Week 44-272)|Death|0
2176692|NCT01369355|3800640|FG002|Long-term Extension (Week 44-272)|Death|0
2176693|NCT01369355|3800641|FG003|Long-term Extension (Week 44-272)|Death|0
2176694|NCT01369355|3800642|FG004|Long-term Extension (Week 44-272)|Death|0
2176695|NCT01369355|3800643|FG005|Long-term Extension (Week 44-272)|Death|0
2176696|NCT01369355|3800644|FG006|Long-term Extension (Week 44-272)|Death|0
2176697|NCT01369355|3800645|FG007|Long-term Extension (Week 44-272)|Death|1
2176698|NCT01369355|3800646|FG008|Long-term Extension (Week 44-272)|Death|3
2176699|NCT01369355|3800638|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0
2176700|NCT01369355|3800639|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0
2176701|NCT01369355|3800640|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0
2176702|NCT01369355|3800641|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0
2176703|NCT01369355|3800642|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0
2176704|NCT01369355|3800643|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0
2176705|NCT01369355|3800644|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12
2176706|NCT01369355|3800645|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26
2176707|NCT01369355|3800646|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29
2176708|NCT01369355|3800638|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0
2176709|NCT01369355|3800639|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0
2176710|NCT01369355|3800640|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0
2176711|NCT01369355|3800641|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0
2176712|NCT01369355|3800642|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0
2176713|NCT01369355|3800643|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0
2176714|NCT01369355|3800644|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0
2176715|NCT01369355|3800645|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1
2176716|NCT01369355|3800646|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2
2176717|NCT01369355|3800638|FG000|Long-term Extension (Week 44-272)|Physician Decision|0
2176718|NCT01369355|3800639|FG001|Long-term Extension (Week 44-272)|Physician Decision|0
2176719|NCT01369355|3800640|FG002|Long-term Extension (Week 44-272)|Physician Decision|0
2176720|NCT01369355|3800641|FG003|Long-term Extension (Week 44-272)|Physician Decision|0
2298033|NCT02573467|3994780|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2
2298034|NCT02573467|3994777|FG000|Post-treatment Follow up Epoch|Technical problems|0
2298035|NCT02573467|3994778|FG001|Post-treatment Follow up Epoch|Technical problems|0
2298036|NCT02573467|3994779|FG002|Post-treatment Follow up Epoch|Technical problems|1
2298037|NCT02573467|3994780|FG003|Post-treatment Follow up Epoch|Technical problems|0
2298038|NCT02573493|3994795|FG000|Overall Study|Determined to not be eligible after enrollment|0
2298039|NCT02573493|3994796|FG001|Overall Study|Determined to not be eligible after enrollment|0
2298040|NCT02573493|3994797|FG002|Overall Study|Determined to not be eligible after enrollment|0
2041860|NCT00440947|3612512|FG003|48-Week Randomization Phase|Withdrawal by Subject|0
2041861|NCT00440947|3612513|FG004|48-Week Randomization Phase|Withdrawal by Subject|0
2041862|NCT00440947|3612509|FG000|48-Week Randomization Phase|Pregnancy|0
2041863|NCT00440947|3612510|FG001|48-Week Randomization Phase|Pregnancy|0
2041864|NCT00440947|3612511|FG002|48-Week Randomization Phase|Pregnancy|1
2041865|NCT00440947|3612512|FG003|48-Week Randomization Phase|Pregnancy|0
2041866|NCT00440947|3612513|FG004|48-Week Randomization Phase|Pregnancy|0
2041867|NCT00440947|3612509|FG000|48-Week Randomization Phase|Incarceration|0
2041868|NCT00440947|3612510|FG001|48-Week Randomization Phase|Incarceration|3
2041869|NCT00440947|3612511|FG002|48-Week Randomization Phase|Incarceration|0
2041870|NCT00440947|3612512|FG003|48-Week Randomization Phase|Incarceration|0
2041871|NCT00440947|3612513|FG004|48-Week Randomization Phase|Incarceration|0
2041872|NCT00440947|3612509|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0
2041873|NCT00440947|3612510|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1
2041874|NCT00440947|3612511|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0
2176721|NCT01369355|3800642|FG004|Long-term Extension (Week 44-272)|Physician Decision|0
2176722|NCT01369355|3800643|FG005|Long-term Extension (Week 44-272)|Physician Decision|0
2176723|NCT01369355|3800644|FG006|Long-term Extension (Week 44-272)|Physician Decision|1
2176724|NCT01369355|3800645|FG007|Long-term Extension (Week 44-272)|Physician Decision|5
2176725|NCT01369355|3800646|FG008|Long-term Extension (Week 44-272)|Physician Decision|11
2176726|NCT01369355|3800638|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0
2176727|NCT01369355|3800639|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0
2176728|NCT01369355|3800640|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0
2176729|NCT01369355|3800641|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0
2176730|NCT01369355|3800642|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0
2176731|NCT01369355|3800643|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0
2176732|NCT01369355|3800644|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1
2176733|NCT01369355|3800645|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5
2176734|NCT01369355|3800646|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9
2176735|NCT01369355|3800638|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
2176736|NCT01369355|3800639|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
2176737|NCT01369355|3800640|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
2176738|NCT01369355|3800641|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
2176739|NCT01369355|3800642|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
2176740|NCT01369355|3800643|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
2176741|NCT01369355|3800644|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12
2176742|NCT01369355|3800645|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30
2176743|NCT01369355|3800646|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47
2176744|NCT01369355|3800638|FG000|Long-term Extension (Week 44-272)|Other|0
2176745|NCT01369355|3800639|FG001|Long-term Extension (Week 44-272)|Other|0
2176746|NCT01369355|3800640|FG002|Long-term Extension (Week 44-272)|Other|0
2176747|NCT01369355|3800641|FG003|Long-term Extension (Week 44-272)|Other|0
2176748|NCT01369355|3800642|FG004|Long-term Extension (Week 44-272)|Other|0
2176749|NCT01369355|3800643|FG005|Long-term Extension (Week 44-272)|Other|0
2176750|NCT01369355|3800644|FG006|Long-term Extension (Week 44-272)|Other|110
2176751|NCT01369355|3800645|FG007|Long-term Extension (Week 44-272)|Other|9
2176752|NCT01369355|3800646|FG008|Long-term Extension (Week 44-272)|Other|17
2176753|NCT01369433|3800665|FG000|Overall Study|Adverse Event|31
2176754|NCT01369433|3800666|FG001|Overall Study|Adverse Event|1
2176755|NCT01369433|3800665|FG000|Overall Study|Required significant surgical procedure|1
2176756|NCT01369433|3800666|FG001|Overall Study|Required significant surgical procedure|0
2176757|NCT01369433|3800665|FG000|Overall Study|Non-compliance|1
2176758|NCT01369433|3800666|FG001|Overall Study|Non-compliance|0
2176759|NCT01369433|3800665|FG000|Overall Study|Withdrawal by Subject|5
2176760|NCT01369433|3800666|FG001|Overall Study|Withdrawal by Subject|2
2176761|NCT01369433|3800665|FG000|Overall Study|Study terminated by Sponsor|67
2176762|NCT01369433|3800666|FG001|Overall Study|Study terminated by Sponsor|0
2176763|NCT01369433|3800665|FG000|Overall Study|Lost to Follow-up|1
2176764|NCT01369433|3800666|FG001|Overall Study|Lost to Follow-up|0
2176765|NCT01369433|3800665|FG000|Overall Study|Death|5
2176766|NCT01369433|3800666|FG001|Overall Study|Death|0
2176767|NCT01369433|3800665|FG000|Overall Study|Investigator discretion|6
2176768|NCT01369433|3800666|FG001|Overall Study|Investigator discretion|1
2176769|NCT01369433|3800665|FG000|Overall Study|Progressive Disease|92
2176770|NCT01369433|3800666|FG001|Overall Study|Progressive Disease|12
2176771|NCT01369485|3800674|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
2176772|NCT01369485|3800675|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
2176773|NCT01369485|3800674|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
2176774|NCT01369485|3800675|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
2176775|NCT01369485|3800674|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
2176776|NCT01369485|3800675|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
2176777|NCT01369485|3800674|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2
2176778|NCT01369485|3800675|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0
2176779|NCT01369485|3800674|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
2176780|NCT01369485|3800675|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
2176781|NCT01369485|3800674|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
2176782|NCT01369485|3800675|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
2176783|NCT01369485|3800674|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
2176784|NCT01369485|3800675|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
2176785|NCT01369485|3800674|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
2176786|NCT01369485|3800675|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
2176787|NCT01369485|3800674|FG000|Open Label Phase (Week 12 to Month 12)|Death|0
2176788|NCT01369485|3800675|FG001|Open Label Phase (Week 12 to Month 12)|Death|1
2176789|NCT01369485|3800674|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
2176790|NCT01369485|3800675|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
2176791|NCT01369498|3800693|FG000|Overall Study|Lack of Efficacy|9
2176792|NCT01369498|3800694|FG001|Overall Study|Lack of Efficacy|9
2176793|NCT01369498|3800695|FG002|Overall Study|Lack of Efficacy|1
2176794|NCT01369498|3800696|FG003|Overall Study|Lack of Efficacy|3
2176795|NCT01369498|3800693|FG000|Overall Study|Adverse Event|1
2176796|NCT01369498|3800694|FG001|Overall Study|Adverse Event|2
2176797|NCT01369498|3800695|FG002|Overall Study|Adverse Event|0
2176798|NCT01369498|3800696|FG003|Overall Study|Adverse Event|1
2176799|NCT01369498|3800693|FG000|Overall Study|Withdrawal of Consent|0
2176800|NCT01369498|3800694|FG001|Overall Study|Withdrawal of Consent|1
2176801|NCT01369498|3800695|FG002|Overall Study|Withdrawal of Consent|1
2176802|NCT01369498|3800696|FG003|Overall Study|Withdrawal of Consent|1
2176803|NCT01369498|3800693|FG000|Overall Study|Death|0
2176804|NCT01369498|3800694|FG001|Overall Study|Death|0
2176805|NCT01369498|3800695|FG002|Overall Study|Death|1
2176806|NCT01369498|3800696|FG003|Overall Study|Death|0
2176807|NCT01369498|3800693|FG000|Overall Study|Investigator's Discretion|1
2176808|NCT01369498|3800694|FG001|Overall Study|Investigator's Discretion|0
2176809|NCT01369498|3800695|FG002|Overall Study|Investigator's Discretion|1
2176810|NCT01369498|3800696|FG003|Overall Study|Investigator's Discretion|3
2176811|NCT01369498|3800693|FG000|Overall Study|Unknown Reason|1
2176812|NCT01369498|3800694|FG001|Overall Study|Unknown Reason|0
2176813|NCT01369498|3800695|FG002|Overall Study|Unknown Reason|11
2176814|NCT01369498|3800696|FG003|Overall Study|Unknown Reason|6
2176815|NCT01369498|3800693|FG000|Overall Study|Disease Progression|0
2176816|NCT01369498|3800694|FG001|Overall Study|Disease Progression|0
2176817|NCT01369498|3800695|FG002|Overall Study|Disease Progression|0
2176818|NCT01369498|3800696|FG003|Overall Study|Disease Progression|1
2176819|NCT01369511|3800711|FG000|Overall Study|Adverse Event|1
2176820|NCT01369511|3800712|FG001|Overall Study|Adverse Event|1
2176821|NCT01369511|3800713|FG002|Overall Study|Adverse Event|5
2176822|NCT01369511|3800714|FG003|Overall Study|Adverse Event|0
2176823|NCT01369511|3800711|FG000|Overall Study|Entry criteria not met|2
2176824|NCT01369511|3800712|FG001|Overall Study|Entry criteria not met|0
2176825|NCT01369511|3800713|FG002|Overall Study|Entry criteria not met|0
2176826|NCT01369511|3800714|FG003|Overall Study|Entry criteria not met|1
2176827|NCT01369511|3800711|FG000|Overall Study|Lost to Follow-up|0
2176828|NCT01369511|3800712|FG001|Overall Study|Lost to Follow-up|1
2176829|NCT01369511|3800713|FG002|Overall Study|Lost to Follow-up|1
2176830|NCT01369511|3800714|FG003|Overall Study|Lost to Follow-up|2
2176831|NCT01369511|3800711|FG000|Overall Study|Protocol Violation|0
2176832|NCT01369511|3800712|FG001|Overall Study|Protocol Violation|1
2176833|NCT01369511|3800713|FG002|Overall Study|Protocol Violation|0
2176834|NCT01369511|3800714|FG003|Overall Study|Protocol Violation|2
2176835|NCT01369511|3800711|FG000|Overall Study|Physician Decision|3
2176836|NCT01369511|3800712|FG001|Overall Study|Physician Decision|4
2176837|NCT01369511|3800713|FG002|Overall Study|Physician Decision|0
2176838|NCT01369511|3800714|FG003|Overall Study|Physician Decision|0
2176839|NCT01369511|3800711|FG000|Overall Study|Sponsor decision|2
2176840|NCT01369511|3800712|FG001|Overall Study|Sponsor decision|0
2176841|NCT01369511|3800713|FG002|Overall Study|Sponsor decision|1
2176842|NCT01369511|3800714|FG003|Overall Study|Sponsor decision|0
2176843|NCT01369511|3800711|FG000|Overall Study|Withdrawal by Subject|5
2176844|NCT01369511|3800712|FG001|Overall Study|Withdrawal by Subject|6
2176845|NCT01369511|3800713|FG002|Overall Study|Withdrawal by Subject|4
2176846|NCT01369511|3800714|FG003|Overall Study|Withdrawal by Subject|6
2176847|NCT01369615|3800726|FG000|Overall Study|Withdrawal by Subject|0
2176848|NCT01369615|3800727|FG001|Overall Study|Withdrawal by Subject|1
2176849|NCT01369615|3800726|FG000|Overall Study|Lost to Follow-up|0
2176850|NCT01369615|3800727|FG001|Overall Study|Lost to Follow-up|1
2176851|NCT01369680|3800737|FG000|Overall Study|Lost to Follow-up|0
2176852|NCT01369680|3800738|FG001|Overall Study|Lost to Follow-up|0
2176853|NCT01369680|3800739|FG002|Overall Study|Lost to Follow-up|1
2176854|NCT01369680|3800740|FG003|Overall Study|Lost to Follow-up|2
2176855|NCT01369784|3800799|FG000|Overall Study|Protocol Violation|12
2176856|NCT01369849|3800806|FG000|Overall Study|Ineligible prior to treatment|0
2176857|NCT01369849|3800807|FG001|Overall Study|Ineligible prior to treatment|0
2176858|NCT01369849|3800808|FG002|Overall Study|Ineligible prior to treatment|1
2176859|NCT01369849|3800806|FG000|Overall Study|Ineligible after receiving treatment|0
2176860|NCT01369849|3800807|FG001|Overall Study|Ineligible after receiving treatment|1
2176861|NCT01369849|3800808|FG002|Overall Study|Ineligible after receiving treatment|0
2176862|NCT01370005|3800843|FG000|Overall Study|Not treated|1
2176863|NCT01370005|3800844|FG001|Overall Study|Not treated|0
2176864|NCT01370005|3800845|FG002|Overall Study|Not treated|0
2176865|NCT01370005|3800843|FG000|Overall Study|Adverse Event|5
2176866|NCT01370005|3800844|FG001|Overall Study|Adverse Event|5
2176867|NCT01370005|3800845|FG002|Overall Study|Adverse Event|6
2176868|NCT01370005|3800843|FG000|Overall Study|Lack of Efficacy|1
2176869|NCT01370005|3800844|FG001|Overall Study|Lack of Efficacy|0
2176870|NCT01370005|3800845|FG002|Overall Study|Lack of Efficacy|0
2176871|NCT01370005|3800843|FG000|Overall Study|Non compliant with protocol|0
2176872|NCT01370005|3800844|FG001|Overall Study|Non compliant with protocol|1
2176873|NCT01370005|3800845|FG002|Overall Study|Non compliant with protocol|2
2176874|NCT01370005|3800843|FG000|Overall Study|Lost to Follow-up|1
2176875|NCT01370005|3800844|FG001|Overall Study|Lost to Follow-up|1
2176876|NCT01370005|3800845|FG002|Overall Study|Lost to Follow-up|1
2176877|NCT01370005|3800843|FG000|Overall Study|Patient refusal to continue,not due toAE|5
2176878|NCT01370005|3800844|FG001|Overall Study|Patient refusal to continue,not due toAE|4
2176879|NCT01370005|3800845|FG002|Overall Study|Patient refusal to continue,not due toAE|0
2176880|NCT01370005|3800843|FG000|Overall Study|Other reason not defined above|3
2176881|NCT01370005|3800844|FG001|Overall Study|Other reason not defined above|0
2176882|NCT01370005|3800845|FG002|Overall Study|Other reason not defined above|2
2176883|NCT01370018|3800853|FG000|Overall Study|Did not meet criteria for analysis|1
2176884|NCT01370083|3800859|FG000|Overall Study|Lost to Follow-up|2
2176885|NCT01370083|3800860|FG001|Overall Study|Lost to Follow-up|0
2176886|NCT01370083|3800859|FG000|Overall Study|Adverse Event|0
2176887|NCT01370083|3800860|FG001|Overall Study|Adverse Event|1
2180047|NCT01397786|3805911|FG002|Phase B|Subject Met Withdrawal Criteria|38
2180048|NCT01397786|3805909|FG000|Phase B|Physician Decision|9
2180049|NCT01397786|3805910|FG001|Phase B|Physician Decision|1
2180050|NCT01397786|3805911|FG002|Phase B|Physician Decision|3
2180051|NCT01397786|3805909|FG000|Phase B|Withdrawal by Subject|102
2180052|NCT01397786|3805910|FG001|Phase B|Withdrawal by Subject|45
2180053|NCT01397786|3805911|FG002|Phase B|Withdrawal by Subject|30
2180054|NCT01397786|3805909|FG000|Phase B|Protocol Deviation|1
2180055|NCT01397786|3805910|FG001|Phase B|Protocol Deviation|2
2180056|NCT01397786|3805911|FG002|Phase B|Protocol Deviation|4
2180057|NCT01397786|3805909|FG000|Phase B|Lack of Efficacy|22
2180058|NCT01397786|3805910|FG001|Phase B|Lack of Efficacy|7
2180059|NCT01397786|3805911|FG002|Phase B|Lack of Efficacy|14
2180060|NCT01397825|3805927|FG000|Overall Study|Progressive Disease|10
2180061|NCT01397825|3805928|FG001|Overall Study|Progressive Disease|3
2041875|NCT00440947|3612512|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0
2041876|NCT00440947|3612513|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0
2041877|NCT00440947|3612509|FG000|48-Week Randomization Phase|Physician Decision|0
2041878|NCT00440947|3612510|FG001|48-Week Randomization Phase|Physician Decision|2
2041879|NCT00440947|3612511|FG002|48-Week Randomization Phase|Physician Decision|0
2041880|NCT00440947|3612512|FG003|48-Week Randomization Phase|Physician Decision|0
2180062|NCT01397825|3805929|FG002|Overall Study|Progressive Disease|11
2180063|NCT01397825|3805930|FG003|Overall Study|Progressive Disease|1
2176888|NCT01370213|3800886|FG000|Overall Study|Early Death|1
2176889|NCT01370213|3800887|FG001|Overall Study|Early Death|0
2176890|NCT01370213|3800888|FG002|Overall Study|Early Death|0
2176891|NCT01370213|3800886|FG000|Overall Study|Not evaluable|0
2176892|NCT01370213|3800887|FG001|Overall Study|Not evaluable|2
2176893|NCT01370213|3800888|FG002|Overall Study|Not evaluable|0
2176894|NCT01370265|3800895|FG000|First Intervention|Adverse Event|1
2176895|NCT01370265|3800896|FG001|First Intervention|Adverse Event|1
2176896|NCT01370317|3800905|FG000|Overall Study|Participant withdrew consent|1
2176897|NCT01370317|3800906|FG001|Overall Study|Participant withdrew consent|0
2176898|NCT01370317|3800905|FG000|Overall Study|Protocol deviation|0
2176899|NCT01370317|3800906|FG001|Overall Study|Protocol deviation|1
2176900|NCT01370356|3800914|FG000|Overall Study|Death|1
2176901|NCT01370356|3800915|FG001|Overall Study|Death|0
2176902|NCT01370356|3800914|FG000|Overall Study|Lack of Efficacy|6
2176903|NCT01370356|3800915|FG001|Overall Study|Lack of Efficacy|28
2176904|NCT01370356|3800914|FG000|Overall Study|Lost to Follow-up|76
2176905|NCT01370356|3800915|FG001|Overall Study|Lost to Follow-up|81
2176906|NCT01370356|3800914|FG000|Overall Study|Withdrawal by Subject|54
2176907|NCT01370356|3800915|FG001|Overall Study|Withdrawal by Subject|59
2208353|NCT01639495|3847928|FG000|Overall Study|Lost to Follow-up|6
2208354|NCT01639495|3847928|FG000|Overall Study|Consented but didn't have study catheter|4
2208355|NCT01639495|3847928|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4
2208356|NCT01639495|3847928|FG000|Overall Study|No radiofrequency energy applied|2
2208357|NCT01639560|3847934|FG000|Overall Study|Withdrawal by Subject|9
2208358|NCT01639560|3847935|FG001|Overall Study|Withdrawal by Subject|14
2208359|NCT01639560|3847934|FG000|Overall Study|Lack of Efficacy|1
2208360|NCT01639560|3847935|FG001|Overall Study|Lack of Efficacy|2
2298041|NCT02573493|3994798|FG003|Overall Study|Determined to not be eligible after enrollment|1
2298042|NCT02573870|3994842|FG000|Overall Study|Adverse Event|0
2176908|NCT01370356|3800914|FG000|Overall Study|Reason not specified|39
2176909|NCT01370356|3800915|FG001|Overall Study|Reason not specified|43
2298043|NCT02573870|3994843|FG001|Overall Study|Adverse Event|2
2298044|NCT02573870|3994842|FG000|Overall Study|Lack of Efficacy|0
2041881|NCT00440947|3612513|FG004|48-Week Randomization Phase|Physician Decision|0
2041882|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Adverse Event|0
2041883|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Adverse Event|0
2041884|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Adverse Event|0
2041885|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Adverse Event|1
2041886|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Adverse Event|3
2176910|NCT01370356|3800914|FG000|Overall Study|Protocol Violation|3
2176911|NCT01370356|3800915|FG001|Overall Study|Protocol Violation|3
2176912|NCT01370356|3800914|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12
2041887|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
2041888|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
2041889|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
2041890|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
2041891|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
2041892|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
2041893|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
2041894|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
2041895|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
2041896|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
2041897|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Non-compliance|0
2041898|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Non-compliance|0
2041899|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Non-compliance|0
2041900|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Non-compliance|1
2041901|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Non-compliance|1
2041902|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0
2041903|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0
2041904|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0
2041905|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9
2041906|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9
2041907|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Protocol Violation|0
2041908|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Protocol Violation|0
2041909|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Protocol Violation|0
2041910|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Protocol Violation|1
2041911|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Protocol Violation|0
2041912|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0
2041913|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0
2041914|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0
2041915|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4
2041916|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3
2041917|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Pregnancy|0
2041918|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Pregnancy|0
2041919|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Pregnancy|0
2041920|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Pregnancy|3
2041921|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Pregnancy|0
2041922|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Participant Moved|0
2041923|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Participant Moved|0
2041924|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Participant Moved|0
2041925|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Participant Moved|1
2041926|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Participant Moved|1
2041927|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Sponsor Request|0
2041928|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Sponsor Request|0
2041929|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Sponsor Request|0
2041930|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Sponsor Request|1
2041931|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Sponsor Request|1
2041932|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
2041933|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
2041934|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
2041935|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
2041936|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
2041937|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Other|0
2041938|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Other|0
2176913|NCT01370356|3800915|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9
2176914|NCT01370356|3800914|FG000|Overall Study|AE Not Related to Study Drug|1
2176915|NCT01370356|3800915|FG001|Overall Study|AE Not Related to Study Drug|4
2176916|NCT01370408|3800934|FG000|Overall Study|treatment failure|9
2176917|NCT01370499|3800950|FG000|Overall Study|Adverse Event|38
2176918|NCT01370499|3800951|FG001|Overall Study|Adverse Event|12
2176919|NCT01370499|3800950|FG000|Overall Study|Lack of Efficacy|4
2176920|NCT01370499|3800951|FG001|Overall Study|Lack of Efficacy|2
2176921|NCT01370499|3800950|FG000|Overall Study|Lost to Follow-up|2
2176922|NCT01370499|3800951|FG001|Overall Study|Lost to Follow-up|1
2176923|NCT01370499|3800950|FG000|Overall Study|Physician Decision|3
2176924|NCT01370499|3800951|FG001|Overall Study|Physician Decision|3
2176925|NCT01370499|3800950|FG000|Overall Study|Protocol Violation|5
2176926|NCT01370499|3800951|FG001|Overall Study|Protocol Violation|4
2176927|NCT01370499|3800950|FG000|Overall Study|Withdrawal by Subject|18
2176928|NCT01370499|3800951|FG001|Overall Study|Withdrawal by Subject|7
2176929|NCT01370499|3800950|FG000|Overall Study|Sponsor Decision|41
2176930|NCT01370499|3800951|FG001|Overall Study|Sponsor Decision|15
2176931|NCT01370525|3800961|FG000|Overall Study|Voluntary Discontinuation by Subject|2
2176932|NCT01370525|3800962|FG001|Overall Study|Voluntary Discontinuation by Subject|3
2176933|NCT01370525|3800961|FG000|Overall Study|Eligibility criteria not fulfilled|2
2176934|NCT01370525|3800962|FG001|Overall Study|Eligibility criteria not fulfilled|0
2176935|NCT01370525|3800961|FG000|Overall Study|Adverse Event|0
2176936|NCT01370525|3800962|FG001|Overall Study|Adverse Event|1
2176937|NCT01370525|3800961|FG000|Overall Study|Protocol Violation|2
2176938|NCT01370525|3800962|FG001|Overall Study|Protocol Violation|1
2176939|NCT01370525|3800961|FG000|Overall Study|Lost to follow up|2
2176940|NCT01370525|3800962|FG001|Overall Study|Lost to follow up|6
2176941|NCT01370538|3800970|FG000|Overall Study|Voluntary Discontinuation by Subject|3
2176942|NCT01370538|3800971|FG001|Overall Study|Voluntary Discontinuation by Subject|2
2176943|NCT01370538|3800970|FG000|Overall Study|Eligibility criteria not fulfilled|0
2176944|NCT01370538|3800971|FG001|Overall Study|Eligibility criteria not fulfilled|1
2176945|NCT01370538|3800970|FG000|Overall Study|Adverse Event|1
2176946|NCT01370538|3800971|FG001|Overall Study|Adverse Event|0
2176947|NCT01370538|3800970|FG000|Overall Study|Protocol Violation|8
2176948|NCT01370538|3800971|FG001|Overall Study|Protocol Violation|5
2176949|NCT01370538|3800970|FG000|Overall Study|Development of study specific withdrawal|1
2176950|NCT01370538|3800971|FG001|Overall Study|Development of study specific withdrawal|1
2176951|NCT01370538|3800970|FG000|Overall Study|Lost to follow up|6
2298045|NCT02573870|3994843|FG001|Overall Study|Lack of Efficacy|1
2298046|NCT02573870|3994842|FG000|Overall Study|Other: Reached defined stopping criteria|0
2298047|NCT02573870|3994843|FG001|Overall Study|Other: Reached defined stopping criteria|1
2298048|NCT02573870|3994842|FG000|Overall Study|Lost to Follow-up|0
2298049|NCT02573870|3994843|FG001|Overall Study|Lost to Follow-up|1
2298050|NCT02573870|3994842|FG000|Overall Study|Other: Fail to Meet Visit|0
2298051|NCT02573870|3994843|FG001|Overall Study|Other: Fail to Meet Visit|2
2298052|NCT02573883|3994851|FG000|Six Month Follow Up|Lost to Follow-up|1
2298053|NCT02573883|3994852|FG001|Six Month Follow Up|Lost to Follow-up|0
2298054|NCT02573883|3994853|FG002|Six Month Follow Up|Lost to Follow-up|0
2298055|NCT02573883|3994854|FG003|Six Month Follow Up|Lost to Follow-up|0
2298056|NCT02573883|3994851|FG000|One Year Follow Up|Lost to Follow-up|2
2298057|NCT02573883|3994852|FG001|One Year Follow Up|Lost to Follow-up|1
2298058|NCT02573883|3994853|FG002|One Year Follow Up|Lost to Follow-up|0
2298059|NCT02573883|3994854|FG003|One Year Follow Up|Lost to Follow-up|0
2298060|NCT02573948|3994869|FG000|Longitudinal Cohort|Death|9
2298061|NCT02573948|3994869|FG000|Longitudinal Cohort|Lost to Follow-up|22
2298062|NCT02573948|3994869|FG000|Longitudinal Cohort|Incarcerated|25
2298063|NCT02574078|3994889|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0
2298064|NCT02574078|3994890|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0
2298065|NCT02574078|3994891|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0
2298066|NCT02574078|3994892|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0
2176952|NCT01370538|3800971|FG001|Overall Study|Lost to follow up|10
2176953|NCT01370616|3800983|FG000|Overall Study|Adverse Event|11
2176954|NCT01370616|3800984|FG001|Overall Study|Adverse Event|16
2176955|NCT01370616|3800983|FG000|Overall Study|Death|1
2176956|NCT01370616|3800984|FG001|Overall Study|Death|0
2176957|NCT01370616|3800983|FG000|Overall Study|Lack of Efficacy|6
2176958|NCT01370616|3800984|FG001|Overall Study|Lack of Efficacy|2
2176959|NCT01370616|3800983|FG000|Overall Study|Lost to Follow-up|0
2176960|NCT01370616|3800984|FG001|Overall Study|Lost to Follow-up|3
2176961|NCT01370616|3800983|FG000|Overall Study|Physician Decision|6
2176962|NCT01370616|3800984|FG001|Overall Study|Physician Decision|6
2176963|NCT01370616|3800983|FG000|Overall Study|Progressive Disease|0
2176964|NCT01370616|3800984|FG001|Overall Study|Progressive Disease|1
2176965|NCT01370616|3800983|FG000|Overall Study|Recovery|1
2176966|NCT01370616|3800984|FG001|Overall Study|Recovery|0
2208361|NCT01639560|3847934|FG000|Overall Study|Lost to Follow-up|9
2019153|NCT00296504|3586493|FG002|Interim Analysis|Study Ended|0
2019154|NCT00296504|3586494|FG003|Interim Analysis|Study Ended|0
2019155|NCT00296504|3586495|FG004|Interim Analysis|Study Ended|0
2019156|NCT00296504|3586496|FG005|Interim Analysis|Study Ended|0
2019157|NCT00296504|3586497|FG006|Interim Analysis|Study Ended|1
2019158|NCT00296504|3586498|FG007|Interim Analysis|Study Ended|0
2019159|NCT00296504|3586499|FG008|Interim Analysis|Study Ended|0
2019160|NCT00296504|3586491|FG000|Interim Analysis|Participant Needed Interferon|0
2019161|NCT00296504|3586492|FG001|Interim Analysis|Participant Needed Interferon|0
2019162|NCT00296504|3586493|FG002|Interim Analysis|Participant Needed Interferon|0
2019163|NCT00296504|3586494|FG003|Interim Analysis|Participant Needed Interferon|0
2019164|NCT00296504|3586495|FG004|Interim Analysis|Participant Needed Interferon|0
2019165|NCT00296504|3586496|FG005|Interim Analysis|Participant Needed Interferon|0
2019166|NCT00296504|3586497|FG006|Interim Analysis|Participant Needed Interferon|0
2019167|NCT00296504|3586498|FG007|Interim Analysis|Participant Needed Interferon|1
2019168|NCT00296504|3586499|FG008|Interim Analysis|Participant Needed Interferon|0
2019169|NCT00296504|3586491|FG000|Interim Analysis|Ongoing|32
2019170|NCT00296504|3586492|FG001|Interim Analysis|Ongoing|12
2019171|NCT00296504|3586493|FG002|Interim Analysis|Ongoing|16
2019172|NCT00296504|3586494|FG003|Interim Analysis|Ongoing|22
2019173|NCT00296504|3586495|FG004|Interim Analysis|Ongoing|0
2019174|NCT00296504|3586496|FG005|Interim Analysis|Ongoing|0
2019175|NCT00296504|3586497|FG006|Interim Analysis|Ongoing|30
2019176|NCT00296504|3586498|FG007|Interim Analysis|Ongoing|1
2019177|NCT00296504|3586499|FG008|Interim Analysis|Ongoing|0
2019178|NCT00296504|3586491|FG000|Final Analysis|Withdrawal by Subject|0
2019179|NCT00296504|3586492|FG001|Final Analysis|Withdrawal by Subject|0
2019180|NCT00296504|3586493|FG002|Final Analysis|Withdrawal by Subject|0
2019181|NCT00296504|3586494|FG003|Final Analysis|Withdrawal by Subject|0
2019182|NCT00296504|3586495|FG004|Final Analysis|Withdrawal by Subject|0
2019183|NCT00296504|3586496|FG005|Final Analysis|Withdrawal by Subject|0
2019184|NCT00296504|3586497|FG006|Final Analysis|Withdrawal by Subject|0
2019185|NCT00296504|3586498|FG007|Final Analysis|Withdrawal by Subject|0
2019186|NCT00296504|3586499|FG008|Final Analysis|Withdrawal by Subject|1
2019187|NCT00296504|3586491|FG000|Final Analysis|Lost to Follow-up|0
2041939|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Other|0
2041940|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Other|1
2041941|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Other|0
2041942|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Physician Decision|0
2041943|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Physician Decision|0
2041944|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Physician Decision|0
2041945|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Physician Decision|0
2041946|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Physician Decision|1
2041947|NCT00440947|3612509|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
2041948|NCT00440947|3612510|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
2041949|NCT00440947|3612511|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
2041950|NCT00440947|3612512|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
2041951|NCT00440947|3612513|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
2041952|NCT00440999|3612527|FG000|Overall Study|Adverse Event|0
2019188|NCT00296504|3586492|FG001|Final Analysis|Lost to Follow-up|0
2041953|NCT00440999|3612528|FG001|Overall Study|Adverse Event|2
2041954|NCT00440999|3612527|FG000|Overall Study|Lack of Efficacy|6
2041955|NCT00440999|3612528|FG001|Overall Study|Lack of Efficacy|7
2041956|NCT00440999|3612527|FG000|Overall Study|Lost to Follow-up|19
2041957|NCT00440999|3612528|FG001|Overall Study|Lost to Follow-up|12
2041958|NCT00440999|3612527|FG000|Overall Study|Protocol Violation|1
2041959|NCT00440999|3612528|FG001|Overall Study|Protocol Violation|0
2041960|NCT00440999|3612527|FG000|Overall Study|Withdrawal by Subject|2
2041961|NCT00440999|3612528|FG001|Overall Study|Withdrawal by Subject|5
2041962|NCT00440999|3612527|FG000|Overall Study|Subjets missed the visit|1
2041963|NCT00440999|3612528|FG001|Overall Study|Subjets missed the visit|0
2041964|NCT00440999|3612527|FG000|Overall Study|Mixed infection at entry|1
2176967|NCT01370616|3800983|FG000|Overall Study|Technical Problems|3
2176968|NCT01370616|3800984|FG001|Overall Study|Technical Problems|5
2176969|NCT01370616|3800983|FG000|Overall Study|Withdrawal by Subject|34
2176970|NCT01370616|3800984|FG001|Overall Study|Withdrawal by Subject|34
2176971|NCT01370642|3800997|FG000|Overall Study|Adverse Event|2
2176972|NCT01370642|3800998|FG001|Overall Study|Adverse Event|1
2176973|NCT01370642|3800999|FG002|Overall Study|Adverse Event|1
2176974|NCT01370642|3800997|FG000|Overall Study|Detectable HCV RNA|0
2176975|NCT01370642|3800998|FG001|Overall Study|Detectable HCV RNA|0
2176976|NCT01370642|3800999|FG002|Overall Study|Detectable HCV RNA|22
2041965|NCT00440999|3612528|FG001|Overall Study|Mixed infection at entry|0
2041966|NCT00440999|3612527|FG000|Overall Study|P. falciparum malaria|5
2041967|NCT00440999|3612528|FG001|Overall Study|P. falciparum malaria|14
2041968|NCT00440999|3612527|FG000|Overall Study|Subj left hosp without inform staff|0
2041969|NCT00440999|3612528|FG001|Overall Study|Subj left hosp without inform staff|1
2041970|NCT00441012|3612538|FG000|Overall Study|Adverse Event|0
2041971|NCT00441012|3612539|FG001|Overall Study|Adverse Event|1
2041972|NCT00441012|3612538|FG000|Overall Study|Lost to Follow-up|3
2041973|NCT00441012|3612539|FG001|Overall Study|Lost to Follow-up|3
2041974|NCT00441012|3612538|FG000|Overall Study|Protocol Violation|10
2041975|NCT00441012|3612539|FG001|Overall Study|Protocol Violation|9
2041976|NCT00441012|3612538|FG000|Overall Study|Withdrawal by Subject|4
2041977|NCT00441012|3612539|FG001|Overall Study|Withdrawal by Subject|0
2041978|NCT00441012|3612538|FG000|Overall Study|Subject Randomized but Not Vaccinated|1
2041979|NCT00441012|3612539|FG001|Overall Study|Subject Randomized but Not Vaccinated|0
2041980|NCT00441064|3612547|FG000|Overall Study|Adverse Event|1
2041981|NCT00441064|3612548|FG001|Overall Study|Adverse Event|0
2041982|NCT00441064|3612547|FG000|Overall Study|Abnormal laboratory values|0
2041983|NCT00441064|3612548|FG001|Overall Study|Abnormal laboratory values|2
2041984|NCT00441064|3612547|FG000|Overall Study|Abnormal test procedure results|0
2041985|NCT00441064|3612548|FG001|Overall Study|Abnormal test procedure results|1
2041986|NCT00441064|3612547|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2041987|NCT00441064|3612548|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2041988|NCT00441064|3612547|FG000|Overall Study|Protocol Deviation|3
2041989|NCT00441064|3612548|FG001|Overall Study|Protocol Deviation|2
2041990|NCT00441064|3612547|FG000|Overall Study|Patient withdrew consent|5
2041991|NCT00441064|3612548|FG001|Overall Study|Patient withdrew consent|2
2041992|NCT00441090|3612559|FG000|Overall Study|Adverse Event|0
2041993|NCT00441090|3612560|FG001|Overall Study|Adverse Event|1
2041994|NCT00441090|3612561|FG002|Overall Study|Adverse Event|1
2176977|NCT01370642|3800997|FG000|Overall Study|Lost to Follow-up|0
2041995|NCT00441090|3612562|FG003|Overall Study|Adverse Event|0
2041996|NCT00441090|3612563|FG004|Overall Study|Adverse Event|0
2041997|NCT00441090|3612559|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0
2041998|NCT00441090|3612560|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0
2041999|NCT00441090|3612561|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0
2042000|NCT00441090|3612562|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2
2176978|NCT01370642|3800998|FG001|Overall Study|Lost to Follow-up|0
2176979|NCT01370642|3800999|FG002|Overall Study|Lost to Follow-up|1
2176980|NCT01370642|3800997|FG000|Overall Study|Physician Decision|4
2176981|NCT01370642|3800998|FG001|Overall Study|Physician Decision|1
2176982|NCT01370642|3800999|FG002|Overall Study|Physician Decision|2
2176983|NCT01370642|3800997|FG000|Overall Study|Withdrawal by Subject|2
2176984|NCT01370642|3800998|FG001|Overall Study|Withdrawal by Subject|4
2176985|NCT01370642|3800999|FG002|Overall Study|Withdrawal by Subject|3
2176986|NCT01370655|3801019|FG000|Period 1|Adverse Event|2
2176987|NCT01370655|3801020|FG001|Period 1|Adverse Event|0
2176988|NCT01370655|3801021|FG002|Period 1|Adverse Event|0
2176989|NCT01370655|3801022|FG003|Period 1|Adverse Event|0
2176990|NCT01370655|3801023|FG004|Period 1|Adverse Event|0
2176991|NCT01370655|3801024|FG005|Period 1|Adverse Event|0
2176992|NCT01370655|3801025|FG006|Period 1|Adverse Event|1
2176993|NCT01370655|3801026|FG007|Period 1|Adverse Event|0
2176994|NCT01370655|3801027|FG008|Period 1|Adverse Event|0
2042001|NCT00441090|3612563|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0
2042002|NCT00441090|3612559|FG000|Overall Study|Withdrawal by Subject|1
2042003|NCT00441090|3612560|FG001|Overall Study|Withdrawal by Subject|0
2042004|NCT00441090|3612561|FG002|Overall Study|Withdrawal by Subject|1
2042005|NCT00441090|3612562|FG003|Overall Study|Withdrawal by Subject|0
2042006|NCT00441090|3612563|FG004|Overall Study|Withdrawal by Subject|0
2042007|NCT00441090|3612559|FG000|Overall Study|Lack of Efficacy|1
2042008|NCT00441090|3612560|FG001|Overall Study|Lack of Efficacy|0
2042009|NCT00441090|3612561|FG002|Overall Study|Lack of Efficacy|0
2042010|NCT00441090|3612562|FG003|Overall Study|Lack of Efficacy|0
2042011|NCT00441090|3612563|FG004|Overall Study|Lack of Efficacy|0
2042012|NCT00441103|3612577|FG000|Overall Study|Adverse Event|2
2042013|NCT00441103|3612578|FG001|Overall Study|Adverse Event|1
2042014|NCT00441103|3612577|FG000|Overall Study|Death|1
2042015|NCT00441103|3612578|FG001|Overall Study|Death|0
2042016|NCT00441103|3612577|FG000|Overall Study|Disease Progression|2
2042017|NCT00441103|3612578|FG001|Overall Study|Disease Progression|0
2042018|NCT00441103|3612577|FG000|Overall Study|Lost to Follow-up|1
2042019|NCT00441103|3612578|FG001|Overall Study|Lost to Follow-up|0
2042020|NCT00441103|3612577|FG000|Overall Study|Protocol Violation|1
2042021|NCT00441103|3612578|FG001|Overall Study|Protocol Violation|0
2042022|NCT00441103|3612577|FG000|Overall Study|Participant unable to use Rebiject II|1
2042023|NCT00441103|3612578|FG001|Overall Study|Participant unable to use Rebiject II|0
2042024|NCT00441103|3612577|FG000|Overall Study|Participant refused MRI|1
2042025|NCT00441103|3612578|FG001|Overall Study|Participant refused MRI|0
2042026|NCT00441103|3612577|FG000|Overall Study|Inclusion criteria absent|1
2042027|NCT00441103|3612578|FG001|Overall Study|Inclusion criteria absent|0
2042028|NCT00441103|3612577|FG000|Overall Study|Non-compliant|0
2042029|NCT00441103|3612578|FG001|Overall Study|Non-compliant|1
2042030|NCT00441103|3612577|FG000|Overall Study|Participant decided to withdraw|1
2042031|NCT00441103|3612578|FG001|Overall Study|Participant decided to withdraw|0
2042032|NCT00441103|3612577|FG000|Overall Study|Participant's reason|0
2042033|NCT00441103|3612578|FG001|Overall Study|Participant's reason|1
2042034|NCT00441103|3612577|FG000|Overall Study|Participant decided to stop|0
2042035|NCT00441103|3612578|FG001|Overall Study|Participant decided to stop|1
2042036|NCT00441116|3612587|FG000|Overall Study|Adverse Event|1
2042037|NCT00441116|3612588|FG001|Overall Study|Adverse Event|1
2042038|NCT00441116|3612587|FG000|Overall Study|Withdrawal by Subject|1
2042039|NCT00441116|3612588|FG001|Overall Study|Withdrawal by Subject|0
2042040|NCT00441116|3612587|FG000|Overall Study|Did not meet Eligibility Criteria|1
2042041|NCT00441116|3612588|FG001|Overall Study|Did not meet Eligibility Criteria|1
2042042|NCT00441129|3612596|FG000|Overall Study|Withdrawal by Subject|6
2042043|NCT00441129|3612597|FG001|Overall Study|Withdrawal by Subject|14
2042044|NCT00441142|3612607|FG000|Overall Study|Adverse Event|2
2042045|NCT00441142|3612608|FG001|Overall Study|Adverse Event|3
2042046|NCT00441142|3612609|FG002|Overall Study|Adverse Event|3
2042047|NCT00441142|3612610|FG003|Overall Study|Adverse Event|22
2042048|NCT00441142|3612607|FG000|Overall Study|Lack of Efficacy|3
2176995|NCT01370655|3801028|FG009|Period 1|Adverse Event|0
2176996|NCT01370655|3801029|FG010|Period 1|Adverse Event|0
2176997|NCT01370655|3801030|FG011|Period 1|Adverse Event|0
2176998|NCT01370655|3801019|FG000|Period 2|Adverse Event|0
2176999|NCT01370655|3801020|FG001|Period 2|Adverse Event|0
2177000|NCT01370655|3801021|FG002|Period 2|Adverse Event|1
2177001|NCT01370655|3801022|FG003|Period 2|Adverse Event|0
2177002|NCT01370655|3801023|FG004|Period 2|Adverse Event|1
2177003|NCT01370655|3801024|FG005|Period 2|Adverse Event|0
2177004|NCT01370655|3801025|FG006|Period 2|Adverse Event|0
2177005|NCT01370655|3801026|FG007|Period 2|Adverse Event|1
2177006|NCT01370655|3801027|FG008|Period 2|Adverse Event|0
2177007|NCT01370655|3801028|FG009|Period 2|Adverse Event|0
2177008|NCT01370655|3801029|FG010|Period 2|Adverse Event|0
2177009|NCT01370655|3801030|FG011|Period 2|Adverse Event|0
2177010|NCT01370655|3801019|FG000|Period 2|met protocol specified stopping criteria|0
2177011|NCT01370655|3801020|FG001|Period 2|met protocol specified stopping criteria|0
2042049|NCT00441142|3612608|FG001|Overall Study|Lack of Efficacy|3
2042050|NCT00441142|3612609|FG002|Overall Study|Lack of Efficacy|17
2042051|NCT00441142|3612610|FG003|Overall Study|Lack of Efficacy|32
2042052|NCT00441142|3612607|FG000|Overall Study|Withdrawal by Subject|0
2042053|NCT00441142|3612608|FG001|Overall Study|Withdrawal by Subject|0
2042054|NCT00441142|3612609|FG002|Overall Study|Withdrawal by Subject|2
2177012|NCT01370655|3801021|FG002|Period 2|met protocol specified stopping criteria|1
2177013|NCT01370655|3801022|FG003|Period 2|met protocol specified stopping criteria|0
2180064|NCT01397825|3805931|FG004|Overall Study|Progressive Disease|0
2177014|NCT01370655|3801023|FG004|Period 2|met protocol specified stopping criteria|0
2177015|NCT01370655|3801024|FG005|Period 2|met protocol specified stopping criteria|0
2177016|NCT01370655|3801025|FG006|Period 2|met protocol specified stopping criteria|1
2177017|NCT01370655|3801026|FG007|Period 2|met protocol specified stopping criteria|0
2177018|NCT01370655|3801027|FG008|Period 2|met protocol specified stopping criteria|1
2177019|NCT01370655|3801028|FG009|Period 2|met protocol specified stopping criteria|0
2177020|NCT01370655|3801029|FG010|Period 2|met protocol specified stopping criteria|1
2177021|NCT01370655|3801030|FG011|Period 2|met protocol specified stopping criteria|0
2177022|NCT01370655|3801019|FG000|Period 2|Withdrawal by Subject|0
2177023|NCT01370655|3801020|FG001|Period 2|Withdrawal by Subject|0
2177024|NCT01370655|3801021|FG002|Period 2|Withdrawal by Subject|0
2177025|NCT01370655|3801022|FG003|Period 2|Withdrawal by Subject|0
2177026|NCT01370655|3801023|FG004|Period 2|Withdrawal by Subject|0
2177027|NCT01370655|3801024|FG005|Period 2|Withdrawal by Subject|0
2177028|NCT01370655|3801025|FG006|Period 2|Withdrawal by Subject|0
2177029|NCT01370655|3801026|FG007|Period 2|Withdrawal by Subject|0
2177030|NCT01370655|3801027|FG008|Period 2|Withdrawal by Subject|1
2177031|NCT01370655|3801028|FG009|Period 2|Withdrawal by Subject|0
2177032|NCT01370655|3801029|FG010|Period 2|Withdrawal by Subject|0
2177033|NCT01370655|3801030|FG011|Period 2|Withdrawal by Subject|0
2177034|NCT01370694|3801040|FG000|Overall Study|Switched to rituximab|4
2177035|NCT01370694|3801040|FG000|Overall Study|Progressive disease|2
2177036|NCT01370733|3801046|FG000|Overall Study|Withdrawal by Subject|8
2177037|NCT01370733|3801047|FG001|Overall Study|Withdrawal by Subject|8
2177038|NCT01370733|3801046|FG000|Overall Study|Lost to Follow-up|3
2177039|NCT01370733|3801047|FG001|Overall Study|Lost to Follow-up|0
2177040|NCT01370733|3801046|FG000|Overall Study|Adverse Event|2
2177041|NCT01370733|3801047|FG001|Overall Study|Adverse Event|4
2019189|NCT00296504|3586493|FG002|Final Analysis|Lost to Follow-up|0
2019190|NCT00296504|3586494|FG003|Final Analysis|Lost to Follow-up|0
2042055|NCT00441142|3612610|FG003|Overall Study|Withdrawal by Subject|10
2042056|NCT00441142|3612607|FG000|Overall Study|Patient still receiving active study tx|1
2042057|NCT00441142|3612608|FG001|Overall Study|Patient still receiving active study tx|0
2177042|NCT01370733|3801046|FG000|Overall Study|Lack of Efficacy|3
2177043|NCT01370733|3801047|FG001|Overall Study|Lack of Efficacy|5
2019191|NCT00296504|3586495|FG004|Final Analysis|Lost to Follow-up|0
2019192|NCT00296504|3586496|FG005|Final Analysis|Lost to Follow-up|0
2019193|NCT00296504|3586497|FG006|Final Analysis|Lost to Follow-up|0
2019194|NCT00296504|3586498|FG007|Final Analysis|Lost to Follow-up|0
2019195|NCT00296504|3586499|FG008|Final Analysis|Lost to Follow-up|5
2019196|NCT00296504|3586491|FG000|Final Analysis|Insufficient Viral Load Response|0
2019197|NCT00296504|3586492|FG001|Final Analysis|Insufficient Viral Load Response|0
2019198|NCT00296504|3586493|FG002|Final Analysis|Insufficient Viral Load Response|0
2019199|NCT00296504|3586494|FG003|Final Analysis|Insufficient Viral Load Response|0
2019200|NCT00296504|3586495|FG004|Final Analysis|Insufficient Viral Load Response|0
2019201|NCT00296504|3586496|FG005|Final Analysis|Insufficient Viral Load Response|0
2019202|NCT00296504|3586497|FG006|Final Analysis|Insufficient Viral Load Response|0
2019203|NCT00296504|3586498|FG007|Final Analysis|Insufficient Viral Load Response|0
2019204|NCT00296504|3586499|FG008|Final Analysis|Insufficient Viral Load Response|6
2019205|NCT00296504|3586491|FG000|Final Analysis|Adverse Event|0
2019206|NCT00296504|3586492|FG001|Final Analysis|Adverse Event|0
2019207|NCT00296504|3586493|FG002|Final Analysis|Adverse Event|0
2019208|NCT00296504|3586494|FG003|Final Analysis|Adverse Event|0
2019209|NCT00296504|3586495|FG004|Final Analysis|Adverse Event|0
2019210|NCT00296504|3586496|FG005|Final Analysis|Adverse Event|0
2019211|NCT00296504|3586497|FG006|Final Analysis|Adverse Event|0
2019212|NCT00296504|3586498|FG007|Final Analysis|Adverse Event|0
2019213|NCT00296504|3586499|FG008|Final Analysis|Adverse Event|2
2019214|NCT00296504|3586491|FG000|Final Analysis|Pregnancy|0
2019215|NCT00296504|3586492|FG001|Final Analysis|Pregnancy|0
2019216|NCT00296504|3586493|FG002|Final Analysis|Pregnancy|0
2019217|NCT00296504|3586494|FG003|Final Analysis|Pregnancy|0
2019218|NCT00296504|3586495|FG004|Final Analysis|Pregnancy|0
2019219|NCT00296504|3586496|FG005|Final Analysis|Pregnancy|0
2019220|NCT00296504|3586497|FG006|Final Analysis|Pregnancy|0
2019221|NCT00296504|3586498|FG007|Final Analysis|Pregnancy|0
2019222|NCT00296504|3586499|FG008|Final Analysis|Pregnancy|4
2019223|NCT00296504|3586491|FG000|Final Analysis|Tuberculosis|0
2019224|NCT00296504|3586492|FG001|Final Analysis|Tuberculosis|0
2019225|NCT00296504|3586493|FG002|Final Analysis|Tuberculosis|0
2019226|NCT00296504|3586494|FG003|Final Analysis|Tuberculosis|0
2019227|NCT00296504|3586495|FG004|Final Analysis|Tuberculosis|0
2019228|NCT00296504|3586496|FG005|Final Analysis|Tuberculosis|0
2019229|NCT00296504|3586497|FG006|Final Analysis|Tuberculosis|0
2019230|NCT00296504|3586498|FG007|Final Analysis|Tuberculosis|0
2019231|NCT00296504|3586499|FG008|Final Analysis|Tuberculosis|1
2019232|NCT00296504|3586491|FG000|Final Analysis|Participant Moved to Another Country|0
2019233|NCT00296504|3586492|FG001|Final Analysis|Participant Moved to Another Country|0
2019234|NCT00296504|3586493|FG002|Final Analysis|Participant Moved to Another Country|0
2019235|NCT00296504|3586494|FG003|Final Analysis|Participant Moved to Another Country|0
2019236|NCT00296504|3586495|FG004|Final Analysis|Participant Moved to Another Country|0
2019237|NCT00296504|3586496|FG005|Final Analysis|Participant Moved to Another Country|0
2019238|NCT00296504|3586497|FG006|Final Analysis|Participant Moved to Another Country|0
2019239|NCT00296504|3586498|FG007|Final Analysis|Participant Moved to Another Country|0
2019240|NCT00296504|3586499|FG008|Final Analysis|Participant Moved to Another Country|1
2019241|NCT00296504|3586491|FG000|Final Analysis|Poor Adherence|0
2019242|NCT00296504|3586492|FG001|Final Analysis|Poor Adherence|0
2019243|NCT00296504|3586493|FG002|Final Analysis|Poor Adherence|0
2019244|NCT00296504|3586494|FG003|Final Analysis|Poor Adherence|0
2019245|NCT00296504|3586495|FG004|Final Analysis|Poor Adherence|0
2019246|NCT00296504|3586496|FG005|Final Analysis|Poor Adherence|0
2019247|NCT00296504|3586497|FG006|Final Analysis|Poor Adherence|0
2019248|NCT00296504|3586498|FG007|Final Analysis|Poor Adherence|0
2019249|NCT00296504|3586499|FG008|Final Analysis|Poor Adherence|1
2019250|NCT00296517|3586526|FG000|Dose Level 2 - Week 2|Adverse Event|1
2019251|NCT00296517|3586527|FG001|Dose Level 2 - Week 2|Adverse Event|5
2019252|NCT00296517|3586526|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1
2019253|NCT00296517|3586527|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0
2019254|NCT00296517|3586526|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30
2019255|NCT00296517|3586527|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34
2019256|NCT00296517|3586526|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
2019257|NCT00296517|3586527|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
2019258|NCT00296517|3586526|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
2019259|NCT00296517|3586527|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
2019260|NCT00296517|3586526|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1
2019261|NCT00296517|3586527|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0
2019262|NCT00296517|3586526|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
2019263|NCT00296517|3586527|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
2019264|NCT00296517|3586526|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1
2019265|NCT00296517|3586527|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0
2019266|NCT00296517|3586526|FG000|Dose Level 3 - Weeks 3-12|Other|0
2019267|NCT00296517|3586527|FG001|Dose Level 3 - Weeks 3-12|Other|2
2019268|NCT00296647|3586538|FG000|Overall Study|Death|4
2019269|NCT00296647|3586539|FG001|Overall Study|Death|1
2019270|NCT00296647|3586540|FG002|Overall Study|Death|2
2019271|NCT00296647|3586541|FG003|Overall Study|Death|1
2019272|NCT00296647|3586542|FG004|Overall Study|Death|1
2019273|NCT00296647|3586538|FG000|Overall Study|Withdrawal by Subject|28
2019274|NCT00296647|3586539|FG001|Overall Study|Withdrawal by Subject|27
2019275|NCT00296647|3586540|FG002|Overall Study|Withdrawal by Subject|32
2019276|NCT00296647|3586541|FG003|Overall Study|Withdrawal by Subject|16
2019277|NCT00296647|3586542|FG004|Overall Study|Withdrawal by Subject|19
2019278|NCT00296725|3586554|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
2019279|NCT00296725|3586554|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
2019280|NCT00296725|3586554|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
2019281|NCT00296816|3586562|FG000|Overall Study|Disease Progression|37
2019282|NCT00296816|3586562|FG000|Overall Study|Adverse Event|18
2019283|NCT00296816|3586562|FG000|Overall Study|Investigator/Participant request|5
2019284|NCT00296816|3586562|FG000|Overall Study|Non-compliance|1
2019285|NCT00296816|3586562|FG000|Overall Study|Missing for end of treatment|4
2019286|NCT00296816|3586562|FG000|Overall Study|Progression based on CA-125 (biomarker)|2
2019287|NCT00296816|3586562|FG000|Overall Study|Poor performance status|1
2019288|NCT00296816|3586562|FG000|Overall Study|Relocation to Florida|1
2019289|NCT00296816|3586562|FG000|Overall Study|Noncompliance/decision to discontinue|1
2019290|NCT00296816|3586562|FG000|Overall Study|Urine protein/creatinine ratio delay|1
2298067|NCT02574078|3994893|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0
2298068|NCT02574078|3994894|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1
2298069|NCT02574078|3994895|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2
2298070|NCT02574078|3994896|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0
2298071|NCT02574078|3994897|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1
2298072|NCT02574078|3994898|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0
2298073|NCT02574078|3994899|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0
2298074|NCT02574078|3994900|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0
2298075|NCT02574078|3994901|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0
2298076|NCT02574078|3994889|FG000|Pre-Treatment Period|Participant withdrew consent|0
2298077|NCT02574078|3994890|FG001|Pre-Treatment Period|Participant withdrew consent|0
2298078|NCT02574078|3994891|FG002|Pre-Treatment Period|Participant withdrew consent|0
2298079|NCT02574078|3994892|FG003|Pre-Treatment Period|Participant withdrew consent|0
2298080|NCT02574078|3994893|FG004|Pre-Treatment Period|Participant withdrew consent|0
2298081|NCT02574078|3994894|FG005|Pre-Treatment Period|Participant withdrew consent|0
2298082|NCT02574078|3994895|FG006|Pre-Treatment Period|Participant withdrew consent|0
2298083|NCT02574078|3994896|FG007|Pre-Treatment Period|Participant withdrew consent|3
2042058|NCT00441142|3612609|FG002|Overall Study|Patient still receiving active study tx|0
2042059|NCT00441142|3612610|FG003|Overall Study|Patient still receiving active study tx|2
2042060|NCT00441142|3612607|FG000|Overall Study|Physician Decision|0
2042061|NCT00441142|3612608|FG001|Overall Study|Physician Decision|1
2042062|NCT00441142|3612609|FG002|Overall Study|Physician Decision|0
2042063|NCT00441142|3612610|FG003|Overall Study|Physician Decision|1
2042064|NCT00441142|3612607|FG000|Overall Study|Death|0
2042065|NCT00441142|3612608|FG001|Overall Study|Death|0
2042066|NCT00441142|3612609|FG002|Overall Study|Death|0
2042067|NCT00441142|3612610|FG003|Overall Study|Death|1
2042068|NCT00441168|3612624|FG000|Treatment Period|Death|3
2042069|NCT00441168|3612625|FG001|Treatment Period|Death|0
2042070|NCT00441168|3612624|FG000|Treatment Period|Adverse Event|1
2042071|NCT00441168|3612625|FG001|Treatment Period|Adverse Event|2
2042072|NCT00441168|3612624|FG000|Treatment Period|Progressive Disease|0
2042073|NCT00441168|3612625|FG001|Treatment Period|Progressive Disease|2
2042074|NCT00441168|3612624|FG000|Treatment Period|Protocol Violation|0
2042075|NCT00441168|3612625|FG001|Treatment Period|Protocol Violation|1
2042076|NCT00441168|3612624|FG000|Treatment Period|Lost to Follow-up|0
2042077|NCT00441168|3612625|FG001|Treatment Period|Lost to Follow-up|1
2042078|NCT00441168|3612624|FG000|Treatment Period|Withdrawal by Subject|3
2042079|NCT00441168|3612625|FG001|Treatment Period|Withdrawal by Subject|0
2042080|NCT00441168|3612624|FG000|Treatment Period|qualified for stem-cell transplantation|3
2042081|NCT00441168|3612625|FG001|Treatment Period|qualified for stem-cell transplantation|0
2042082|NCT00441168|3612624|FG000|Treatment Period|refractory disease|1
2042083|NCT00441168|3612625|FG001|Treatment Period|refractory disease|0
2042084|NCT00441168|3612624|FG000|Follow-up Period|Death|3
2042085|NCT00441168|3612625|FG001|Follow-up Period|Death|0
2042086|NCT00441168|3612624|FG000|Follow-up Period|Lost to Follow-up|5
2042087|NCT00441168|3612625|FG001|Follow-up Period|Lost to Follow-up|6
2042088|NCT00441168|3612624|FG000|Follow-up Period|Withdrawal by Subject|3
2042089|NCT00441168|3612625|FG001|Follow-up Period|Withdrawal by Subject|0
2042090|NCT00441168|3612624|FG000|Follow-up Period|Other|1
2042091|NCT00441168|3612625|FG001|Follow-up Period|Other|3
2042092|NCT00441337|3612665|FG000|Overall Study|Disease Progression|6
2042093|NCT00441337|3612666|FG001|Overall Study|Disease Progression|6
2042094|NCT00441337|3612667|FG002|Overall Study|Disease Progression|4
2042095|NCT00441337|3612668|FG003|Overall Study|Disease Progression|18
2042096|NCT00441337|3612665|FG000|Overall Study|Lost to Follow-up|0
2042097|NCT00441337|3612666|FG001|Overall Study|Lost to Follow-up|0
2042098|NCT00441337|3612667|FG002|Overall Study|Lost to Follow-up|0
2042099|NCT00441337|3612668|FG003|Overall Study|Lost to Follow-up|1
2042100|NCT00441337|3612665|FG000|Overall Study|Sponsor Decision|0
2042101|NCT00441337|3612666|FG001|Overall Study|Sponsor Decision|0
2042102|NCT00441337|3612667|FG002|Overall Study|Sponsor Decision|1
2042103|NCT00441337|3612668|FG003|Overall Study|Sponsor Decision|2
2042104|NCT00441337|3612665|FG000|Overall Study|Did not meet inclusion criteria|0
2042105|NCT00441337|3612666|FG001|Overall Study|Did not meet inclusion criteria|0
2042106|NCT00441337|3612667|FG002|Overall Study|Did not meet inclusion criteria|1
2042107|NCT00441337|3612668|FG003|Overall Study|Did not meet inclusion criteria|0
2042108|NCT00441363|3612709|FG000|Overall Study|Adverse Event|4
2042109|NCT00441363|3612710|FG001|Overall Study|Adverse Event|2
2042110|NCT00441363|3612709|FG000|Overall Study|Withdrawal by Subject|3
2042111|NCT00441363|3612710|FG001|Overall Study|Withdrawal by Subject|4
2042112|NCT00441363|3612709|FG000|Overall Study|Physician Decision|6
2042113|NCT00441363|3612710|FG001|Overall Study|Physician Decision|7
2042114|NCT00441363|3612709|FG000|Overall Study|Lost to Follow-up|2
2042115|NCT00441363|3612710|FG001|Overall Study|Lost to Follow-up|2
2042116|NCT00441363|3612709|FG000|Overall Study|Other|2
2042117|NCT00441363|3612710|FG001|Overall Study|Other|0
2042118|NCT00441441|3612718|FG000|Overall Study|Adverse Event|2
2042119|NCT00441441|3612719|FG001|Overall Study|Adverse Event|1
2042120|NCT00441441|3612718|FG000|Overall Study|Protocol Violation|4
2042121|NCT00441441|3612719|FG001|Overall Study|Protocol Violation|6
2042122|NCT00441441|3612718|FG000|Overall Study|Exacerbation of asthma|1
2042123|NCT00441441|3612719|FG001|Overall Study|Exacerbation of asthma|2
2042124|NCT00441441|3612718|FG000|Overall Study|Withdrawal by Subject|1
2042125|NCT00441441|3612719|FG001|Overall Study|Withdrawal by Subject|2
2042126|NCT00441441|3612718|FG000|Overall Study|Other|3
2042127|NCT00441441|3612719|FG001|Overall Study|Other|3
2042128|NCT00441467|3612739|FG000|Overall Study|Adverse Event|6
2042129|NCT00441467|3612739|FG000|Overall Study|Withdrawal by Subject|3
2019291|NCT00296816|3586562|FG000|Overall Study|Neuropathy/patient preference|1
2019292|NCT00296816|3586562|FG000|Overall Study|Proteinuria|1
2019293|NCT00296816|3586562|FG000|Overall Study|ineligibility due to radiation treatment|1
2019294|NCT00297037|3586568|FG000|Overall Study|Withdrawal by Subject|2
2019295|NCT00297037|3586569|FG001|Overall Study|Withdrawal by Subject|0
2019296|NCT00297167|3586595|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
2019297|NCT00297167|3586596|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
2019298|NCT00297167|3586597|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
2042130|NCT00441467|3612739|FG000|Overall Study|Progressive disease|9
2042131|NCT00441480|3612745|FG000|Overall Study|Protocol Violation|1
2042132|NCT00441480|3612746|FG001|Overall Study|Protocol Violation|1
2042133|NCT00441480|3612745|FG000|Overall Study|Withdrawal by Subject|2
2042134|NCT00441480|3612746|FG001|Overall Study|Withdrawal by Subject|3
2042135|NCT00441545|3612752|FG000|First Intervention|Adverse Event|6
2042136|NCT00441545|3612753|FG001|First Intervention|Adverse Event|5
2042137|NCT00441545|3612752|FG000|First Intervention|Protocol Violation|2
2042138|NCT00441545|3612753|FG001|First Intervention|Protocol Violation|2
2042139|NCT00441545|3612752|FG000|First Intervention|Withdrawal by Subject|3
2042140|NCT00441545|3612753|FG001|First Intervention|Withdrawal by Subject|3
2042141|NCT00441545|3612752|FG000|First Intervention|Kidney transplant|1
2042142|NCT00441545|3612753|FG001|First Intervention|Kidney transplant|1
2042143|NCT00441545|3612752|FG000|First Intervention|Lack of Efficacy|2
2042144|NCT00441545|3612753|FG001|First Intervention|Lack of Efficacy|0
2042145|NCT00441545|3612752|FG000|First Intervention|Subject exceeded safety criteria|0
2042146|NCT00441545|3612753|FG001|First Intervention|Subject exceeded safety criteria|1
2042147|NCT00441545|3612752|FG000|First Intervention|Subject met an exclusionary criteria|1
2042148|NCT00441545|3612753|FG001|First Intervention|Subject met an exclusionary criteria|0
2042149|NCT00441545|3612752|FG000|First Intervention|Extended hospitalization|1
2042150|NCT00441545|3612753|FG001|First Intervention|Extended hospitalization|0
2042151|NCT00441545|3612752|FG000|First Intervention|Site error|1
2042152|NCT00441545|3612753|FG001|First Intervention|Site error|0
2042153|NCT00441545|3612752|FG000|First Intervention|Sponsor's request|1
2042154|NCT00441545|3612753|FG001|First Intervention|Sponsor's request|0
2042155|NCT00441545|3612752|FG000|Second Intervention|Adverse Event|5
2042156|NCT00441545|3612753|FG001|Second Intervention|Adverse Event|2
2042157|NCT00441545|3612752|FG000|Second Intervention|Protocol Violation|4
2042158|NCT00441545|3612753|FG001|Second Intervention|Protocol Violation|1
2042159|NCT00441545|3612752|FG000|Second Intervention|Withdrawal by Subject|1
2042160|NCT00441545|3612753|FG001|Second Intervention|Withdrawal by Subject|1
2042161|NCT00441545|3612752|FG000|Second Intervention|Kidney Transplant|1
2042162|NCT00441545|3612753|FG001|Second Intervention|Kidney Transplant|1
2042163|NCT00441545|3612752|FG000|Second Intervention|Lack of Efficacy|0
2042164|NCT00441545|3612753|FG001|Second Intervention|Lack of Efficacy|1
2042165|NCT00441545|3612752|FG000|Second Intervention|Subject exceeded safety criteria|1
2042166|NCT00441545|3612753|FG001|Second Intervention|Subject exceeded safety criteria|0
2042167|NCT00441545|3612752|FG000|Second Intervention|Subject moved|0
2042168|NCT00441545|3612753|FG001|Second Intervention|Subject moved|1
2042169|NCT00441584|3612763|FG000|Overall Study|Lack of Efficacy|79
2042170|NCT00441584|3612763|FG000|Overall Study|Withdrawal by Subject|8
2042171|NCT00441584|3612763|FG000|Overall Study|Adverse Event|6
2042172|NCT00441584|3612763|FG000|Overall Study|Protocol Violation|5
2042173|NCT00441584|3612763|FG000|Overall Study|Lost to Follow-up|4
2042174|NCT00441584|3612763|FG000|Overall Study|Failure to meet eligibility criteria|3
2208362|NCT01639560|3847935|FG001|Overall Study|Lost to Follow-up|11
2208363|NCT01639560|3847934|FG000|Overall Study|Adverse Event|0
2298084|NCT02574078|3994897|FG008|Pre-Treatment Period|Participant withdrew consent|0
2298085|NCT02574078|3994898|FG009|Pre-Treatment Period|Participant withdrew consent|0
2298086|NCT02574078|3994899|FG010|Pre-Treatment Period|Participant withdrew consent|2
2042175|NCT00441701|3612777|FG000|Overall Study|Adverse Event|3
2042176|NCT00441701|3612778|FG001|Overall Study|Adverse Event|2
2042177|NCT00441701|3612779|FG002|Overall Study|Adverse Event|1
2042178|NCT00441701|3612780|FG003|Overall Study|Adverse Event|0
2042179|NCT00441701|3612781|FG004|Overall Study|Adverse Event|2
2042180|NCT00441701|3612782|FG005|Overall Study|Adverse Event|2
2042181|NCT00441701|3612783|FG006|Overall Study|Adverse Event|0
2042182|NCT00441701|3612784|FG007|Overall Study|Adverse Event|0
2042183|NCT00441701|3612785|FG008|Overall Study|Adverse Event|0
2042184|NCT00441701|3612786|FG009|Overall Study|Adverse Event|0
2042185|NCT00441701|3612777|FG000|Overall Study|Lack of Efficacy|2
2042186|NCT00441701|3612778|FG001|Overall Study|Lack of Efficacy|0
2042187|NCT00441701|3612779|FG002|Overall Study|Lack of Efficacy|2
2042188|NCT00441701|3612780|FG003|Overall Study|Lack of Efficacy|2
2042189|NCT00441701|3612781|FG004|Overall Study|Lack of Efficacy|0
2042190|NCT00441701|3612782|FG005|Overall Study|Lack of Efficacy|1
2042191|NCT00441701|3612783|FG006|Overall Study|Lack of Efficacy|0
2042192|NCT00441701|3612784|FG007|Overall Study|Lack of Efficacy|0
2042193|NCT00441701|3612785|FG008|Overall Study|Lack of Efficacy|0
2042194|NCT00441701|3612786|FG009|Overall Study|Lack of Efficacy|0
2042195|NCT00441701|3612777|FG000|Overall Study|Withdrawal by Subject|0
2042196|NCT00441701|3612778|FG001|Overall Study|Withdrawal by Subject|2
2042197|NCT00441701|3612779|FG002|Overall Study|Withdrawal by Subject|1
2042198|NCT00441701|3612780|FG003|Overall Study|Withdrawal by Subject|1
2042199|NCT00441701|3612781|FG004|Overall Study|Withdrawal by Subject|0
2042200|NCT00441701|3612782|FG005|Overall Study|Withdrawal by Subject|0
2042201|NCT00441701|3612783|FG006|Overall Study|Withdrawal by Subject|0
2042202|NCT00441701|3612784|FG007|Overall Study|Withdrawal by Subject|0
2042203|NCT00441701|3612785|FG008|Overall Study|Withdrawal by Subject|0
2042204|NCT00441701|3612786|FG009|Overall Study|Withdrawal by Subject|0
2042205|NCT00441727|3612807|FG000|Overall Study|Protocol Violation|19
2042206|NCT00441727|3612808|FG001|Overall Study|Protocol Violation|28
2042207|NCT00441727|3612809|FG002|Overall Study|Protocol Violation|32
2042208|NCT00441727|3612807|FG000|Overall Study|Adverse Event|26
2042209|NCT00441727|3612808|FG001|Overall Study|Adverse Event|33
2042210|NCT00441727|3612809|FG002|Overall Study|Adverse Event|28
2042211|NCT00441727|3612807|FG000|Overall Study|Lack of Efficacy|7
2042212|NCT00441727|3612808|FG001|Overall Study|Lack of Efficacy|8
2298087|NCT02574078|3994900|FG011|Pre-Treatment Period|Participant withdrew consent|0
2298088|NCT02574078|3994901|FG012|Pre-Treatment Period|Participant withdrew consent|0
2298089|NCT02574078|3994889|FG000|Pre-Treatment Period|Other reasons|0
2298090|NCT02574078|3994890|FG001|Pre-Treatment Period|Other reasons|0
2298091|NCT02574078|3994891|FG002|Pre-Treatment Period|Other reasons|0
2298092|NCT02574078|3994892|FG003|Pre-Treatment Period|Other reasons|0
2298093|NCT02574078|3994893|FG004|Pre-Treatment Period|Other reasons|0
2298094|NCT02574078|3994894|FG005|Pre-Treatment Period|Other reasons|0
2298095|NCT02574078|3994895|FG006|Pre-Treatment Period|Other reasons|2
2298096|NCT02574078|3994896|FG007|Pre-Treatment Period|Other reasons|0
2298097|NCT02574078|3994897|FG008|Pre-Treatment Period|Other reasons|0
2298098|NCT02574078|3994898|FG009|Pre-Treatment Period|Other reasons|0
2298099|NCT02574078|3994899|FG010|Pre-Treatment Period|Other reasons|2
2298100|NCT02574078|3994900|FG011|Pre-Treatment Period|Other reasons|0
2298101|NCT02574078|3994901|FG012|Pre-Treatment Period|Other reasons|0
2298102|NCT02574078|3994889|FG000|Pre-Treatment Period|Poor/non-compliance|0
2298103|NCT02574078|3994890|FG001|Pre-Treatment Period|Poor/non-compliance|0
2298104|NCT02574078|3994891|FG002|Pre-Treatment Period|Poor/non-compliance|0
2298105|NCT02574078|3994892|FG003|Pre-Treatment Period|Poor/non-compliance|0
2298106|NCT02574078|3994893|FG004|Pre-Treatment Period|Poor/non-compliance|0
2298107|NCT02574078|3994894|FG005|Pre-Treatment Period|Poor/non-compliance|0
2042213|NCT00441727|3612809|FG002|Overall Study|Lack of Efficacy|48
2042214|NCT00441727|3612807|FG000|Overall Study|Withdrawal by Subject|40
2042215|NCT00441727|3612808|FG001|Overall Study|Withdrawal by Subject|34
2042216|NCT00441727|3612809|FG002|Overall Study|Withdrawal by Subject|47
2042217|NCT00441727|3612807|FG000|Overall Study|Lost to Follow-up|5
2042218|NCT00441727|3612808|FG001|Overall Study|Lost to Follow-up|6
2042219|NCT00441727|3612809|FG002|Overall Study|Lost to Follow-up|5
2042220|NCT00441727|3612807|FG000|Overall Study|Safety Reasons|3
2042221|NCT00441727|3612808|FG001|Overall Study|Safety Reasons|1
2042222|NCT00441727|3612809|FG002|Overall Study|Safety Reasons|3
2042223|NCT00441727|3612807|FG000|Overall Study|Various reason specified|6
2042224|NCT00441727|3612808|FG001|Overall Study|Various reason specified|8
2042225|NCT00441727|3612809|FG002|Overall Study|Various reason specified|5
2042226|NCT00441792|3612841|FG000|Overall Study|Lost to Follow-up|0
2042227|NCT00441792|3612842|FG001|Overall Study|Lost to Follow-up|2
2042228|NCT00441974|3612869|FG000|Overall Study|Adverse Event|6
2042229|NCT00441974|3612869|FG000|Overall Study|Consent Withdrawn|35
2042230|NCT00441974|3612869|FG000|Overall Study|Lost to Follow-up|80
2042231|NCT00441974|3612869|FG000|Overall Study|Protocol Violation|7
2042232|NCT00442286|3612914|FG000|Overall Study|Death|2
2042233|NCT00442286|3612915|FG001|Overall Study|Death|2
2042234|NCT00442286|3612914|FG000|Overall Study|Lost to Follow-up|1
2042235|NCT00442286|3612915|FG001|Overall Study|Lost to Follow-up|0
2042236|NCT00442286|3612914|FG000|Overall Study|Withdrawal by Subject|2
2042237|NCT00442286|3612915|FG001|Overall Study|Withdrawal by Subject|0
2042238|NCT00442286|3612914|FG000|Overall Study|System explanted|1
2042239|NCT00442286|3612915|FG001|Overall Study|System explanted|0
2042240|NCT00442286|3612914|FG000|Overall Study|Patient Injury|1
2042241|NCT00442286|3612915|FG001|Overall Study|Patient Injury|0
2042242|NCT00442416|3612929|FG000|Overall Study|Adverse Event|4
2042243|NCT00442416|3612930|FG001|Overall Study|Adverse Event|1
2042244|NCT00442416|3612929|FG000|Overall Study|Death|1
2042245|NCT00442416|3612930|FG001|Overall Study|Death|0
2042246|NCT00442416|3612929|FG000|Overall Study|Lack of Efficacy|2
2042247|NCT00442416|3612930|FG001|Overall Study|Lack of Efficacy|0
2042248|NCT00442416|3612929|FG000|Overall Study|Protocol Violation|2
2042249|NCT00442416|3612930|FG001|Overall Study|Protocol Violation|3
2042250|NCT00442416|3612929|FG000|Overall Study|Withdrew consent|1
2042251|NCT00442416|3612930|FG001|Overall Study|Withdrew consent|2
2042252|NCT00442416|3612929|FG000|Overall Study|Administrative/Other|27
2042253|NCT00442416|3612930|FG001|Overall Study|Administrative/Other|33
2042254|NCT00442468|3612936|FG000|Overall Study|Adverse Event|4
2042255|NCT00442468|3612936|FG000|Overall Study|Withdrawal by Subject|91
2042256|NCT00442468|3612936|FG000|Overall Study|Did not complete all study procedures|88
2042257|NCT00442572|3612946|FG000|Overall Study|Relapse|8
2042258|NCT00442572|3612947|FG001|Overall Study|Relapse|1
2042259|NCT00442572|3612946|FG000|Overall Study|Lost to Follow-up|0
2042260|NCT00442572|3612947|FG001|Overall Study|Lost to Follow-up|1
2042261|NCT00442572|3612946|FG000|Overall Study|Withdrawal by Subject|0
2042262|NCT00442572|3612947|FG001|Overall Study|Withdrawal by Subject|1
2042263|NCT00442598|3612957|FG000|Overall Study|Adverse Event|1
2042264|NCT00442598|3612958|FG001|Overall Study|Adverse Event|0
2042265|NCT00442598|3612959|FG002|Overall Study|Adverse Event|0
2042266|NCT00442598|3612957|FG000|Overall Study|Tumor progression|3
2042267|NCT00442598|3612958|FG001|Overall Study|Tumor progression|4
2042268|NCT00442598|3612959|FG002|Overall Study|Tumor progression|0
2042269|NCT00442598|3612957|FG000|Overall Study|Clinical deterioration|1
2042270|NCT00442598|3612958|FG001|Overall Study|Clinical deterioration|2
2042271|NCT00442598|3612959|FG002|Overall Study|Clinical deterioration|0
2042272|NCT00442598|3612957|FG000|Overall Study|CA125 progression|0
2042273|NCT00442598|3612958|FG001|Overall Study|CA125 progression|1
2042274|NCT00442598|3612959|FG002|Overall Study|CA125 progression|0
2042275|NCT00442598|3612957|FG000|Overall Study|Reduced creatinine clearance|1
2042276|NCT00442598|3612958|FG001|Overall Study|Reduced creatinine clearance|0
2042277|NCT00442598|3612959|FG002|Overall Study|Reduced creatinine clearance|0
2042278|NCT00442598|3612957|FG000|Overall Study|Death|0
2042279|NCT00442598|3612958|FG001|Overall Study|Death|1
2042280|NCT00442598|3612959|FG002|Overall Study|Death|0
2042281|NCT00442702|3612990|FG000|Titration Period|Adverse Event|2
2042282|NCT00442702|3612991|FG001|Titration Period|Adverse Event|0
2042283|NCT00442702|3612990|FG000|Titration Period|Death|3
2042284|NCT00442702|3612991|FG001|Titration Period|Death|2
2042285|NCT00442702|3612990|FG000|Titration Period|Insufficient Therapeutic Response|1
2042286|NCT00442702|3612991|FG001|Titration Period|Insufficient Therapeutic Response|0
2042287|NCT00442702|3612990|FG000|Titration Period|Refused Treatment|4
2042288|NCT00442702|3612991|FG001|Titration Period|Refused Treatment|1
2042289|NCT00442702|3612990|FG000|Titration Period|Failure to return|1
2042290|NCT00442702|3612991|FG001|Titration Period|Failure to return|0
2042291|NCT00442702|3612990|FG000|Titration Period|Hospitalized in another hospital|1
2042292|NCT00442702|3612991|FG001|Titration Period|Hospitalized in another hospital|0
2042293|NCT00442702|3612990|FG000|Evaluation Period|Adverse Event|1
2042294|NCT00442702|3612991|FG001|Evaluation Period|Adverse Event|0
2042295|NCT00442702|3612990|FG000|Evaluation Period|Death|1
2042296|NCT00442702|3612991|FG001|Evaluation Period|Death|1
2042297|NCT00442702|3612990|FG000|Evaluation Period|Insufficient Therapeutic Response|1
2042298|NCT00442702|3612991|FG001|Evaluation Period|Insufficient Therapeutic Response|0
2042299|NCT00442702|3612990|FG000|Evaluation Period|Refused treatment|1
2042300|NCT00442702|3612991|FG001|Evaluation Period|Refused treatment|1
2042301|NCT00442702|3612990|FG000|Evaluation Period|Renal transplant|0
2042302|NCT00442702|3612991|FG001|Evaluation Period|Renal transplant|1
2042303|NCT00442702|3612990|FG000|Evaluation Period|Failure to return|1
2042304|NCT00442702|3612991|FG001|Evaluation Period|Failure to return|0
2042305|NCT00442702|3612990|FG000|Evaluation Period|Site closure|0
2042306|NCT00442702|3612991|FG001|Evaluation Period|Site closure|1
2042307|NCT00442936|3613007|FG000|Overall Study|Protocol Violation|1
2042308|NCT00442936|3613008|FG001|Overall Study|Protocol Violation|0
2042309|NCT00442936|3613009|FG002|Overall Study|Protocol Violation|1
2042310|NCT00442936|3613010|FG003|Overall Study|Protocol Violation|1
2042311|NCT00442962|3613020|FG000|Overall Study|Pregnancy|1
2042312|NCT00442962|3613020|FG000|Overall Study|Lost to Follow-up|7
2042313|NCT00443053|3613026|FG000|Overall Study|Adverse Event|2
2042314|NCT00443053|3613027|FG001|Overall Study|Adverse Event|1
2042315|NCT00443053|3613026|FG000|Overall Study|Withdrawal by Subject|9
2042316|NCT00443053|3613027|FG001|Overall Study|Withdrawal by Subject|18
2042317|NCT00443053|3613026|FG000|Overall Study|Lost to Follow-up|4
2042318|NCT00443053|3613027|FG001|Overall Study|Lost to Follow-up|5
2042319|NCT00443053|3613026|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
2042320|NCT00443053|3613027|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
2042321|NCT00443053|3613026|FG000|Overall Study|Noncompliance|2
2042322|NCT00443053|3613027|FG001|Overall Study|Noncompliance|1
2042323|NCT00443053|3613026|FG000|Overall Study|Other|3
2042324|NCT00443053|3613027|FG001|Overall Study|Other|4
2042325|NCT00443053|3613026|FG000|Overall Study|Physician Decision|0
2042326|NCT00443053|3613027|FG001|Overall Study|Physician Decision|4
2042327|NCT00443079|3613035|FG000|Overall Study|Lost to Follow-up|0
2042328|NCT00443079|3613036|FG001|Overall Study|Lost to Follow-up|1
2042329|NCT00443118|3613047|FG000|Overall Study|unknown primary outcome|3
2042330|NCT00443118|3613048|FG001|Overall Study|unknown primary outcome|1
2042331|NCT00443118|3613049|FG002|Overall Study|unknown primary outcome|0
2042332|NCT00443118|3613047|FG000|Overall Study|Withdrawal by Subject|1
2042333|NCT00443118|3613048|FG001|Overall Study|Withdrawal by Subject|0
2042334|NCT00443118|3613049|FG002|Overall Study|Withdrawal by Subject|0
2042335|NCT00443209|3613077|FG000|Months 1 to 12 Treatment Period|Adverse Event|22
2042336|NCT00443209|3613078|FG001|Months 1 to 12 Treatment Period|Adverse Event|11
2042337|NCT00443209|3613077|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14
2042338|NCT00443209|3613078|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7
2042339|NCT00443209|3613077|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50
2042340|NCT00443209|3613078|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11
2042341|NCT00443209|3613077|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
2042342|NCT00443209|3613078|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
2019299|NCT00297167|3586595|FG000|Second Double-blind Intervention Period|Protocol Violation|1
2019300|NCT00297167|3586596|FG001|Second Double-blind Intervention Period|Protocol Violation|0
2019301|NCT00297167|3586597|FG002|Second Double-blind Intervention Period|Protocol Violation|0
2019302|NCT00297232|3586604|FG000|Overall Study|Lack of Efficacy|7
2019303|NCT00297232|3586604|FG000|Overall Study|Lost to Follow-up|10
2019304|NCT00297232|3586604|FG000|Overall Study|Adverse Event|63
2019305|NCT00297232|3586604|FG000|Overall Study|Voluntary Withdrawal|120
2019306|NCT00297232|3586604|FG000|Overall Study|Subject was Noncompliant|9
2019307|NCT00297232|3586604|FG000|Overall Study|Death|9
2042343|NCT00443209|3613077|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36
2042344|NCT00443209|3613078|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15
2042345|NCT00443209|3613077|FG000|Months 1 to 12 Treatment Period|Physician Decision|8
2042346|NCT00443209|3613078|FG001|Months 1 to 12 Treatment Period|Physician Decision|4
2042347|NCT00443209|3613077|FG000|Months 1 to 12 Treatment Period|Pregnancy|3
2042348|NCT00443209|3613078|FG001|Months 1 to 12 Treatment Period|Pregnancy|4
2042349|NCT00443209|3613077|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43
2042350|NCT00443209|3613078|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23
2042351|NCT00443209|3613077|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
2042352|NCT00443209|3613078|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
2042353|NCT00443209|3613077|FG000|Months 1 to 12 Treatment Period|Missing|2
2042354|NCT00443209|3613078|FG001|Months 1 to 12 Treatment Period|Missing|1
2042355|NCT00443209|3613077|FG000|Months 1 to 12 Treatment Period|Not Treated|71
2042356|NCT00443209|3613078|FG001|Months 1 to 12 Treatment Period|Not Treated|43
2042357|NCT00443209|3613077|FG000|Months 13 to 18 Treatment Period|Adverse Event|1
2042358|NCT00443209|3613078|FG001|Months 13 to 18 Treatment Period|Adverse Event|0
2042359|NCT00443209|3613077|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1
2042360|NCT00443209|3613078|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0
2042361|NCT00443209|3613077|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1
2042362|NCT00443209|3613078|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0
2042363|NCT00443209|3613077|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2
2042364|NCT00443209|3613078|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2
2042365|NCT00443209|3613077|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87
2042366|NCT00443209|3613078|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43
2042367|NCT00443209|3613077|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
2042368|NCT00443209|3613078|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
2042369|NCT00443261|3613084|FG000|Overall Study|Death|1
2042370|NCT00443430|3613094|FG000|Overall Study|Lack of Efficacy|3
2042371|NCT00443430|3613095|FG001|Overall Study|Lack of Efficacy|3
2042372|NCT00443430|3613094|FG000|Overall Study|Adverse Event|1
2042373|NCT00443430|3613095|FG001|Overall Study|Adverse Event|1
2042374|NCT00443456|3613101|FG000|Overall Study|Adverse Event|16
2042375|NCT00443456|3613101|FG000|Overall Study|Move|1
2042376|NCT00443456|3613101|FG000|Overall Study|Withdrawal by Subject|1
2042377|NCT00443534|3613109|FG000|Overall Study|Lack of Efficacy|67
2042378|NCT00443534|3613109|FG000|Overall Study|Adverse Event|16
2042379|NCT00443534|3613109|FG000|Overall Study|Death|9
2042380|NCT00443534|3613109|FG000|Overall Study|Withdrawal by Subject|8
2042381|NCT00443534|3613109|FG000|Overall Study|Study Terminated by Sponsor|12
2042382|NCT00443534|3613109|FG000|Overall Study|Other|10
2042383|NCT00443534|3613109|FG000|Overall Study|Enrolled, Not Treated|1
2042384|NCT00443560|3613132|FG000|Overall Study|No intrathecal dose|58
2042385|NCT00443560|3613133|FG001|Overall Study|No intrathecal dose|26
2042386|NCT00443560|3613132|FG000|Overall Study|Multiple pregnancies or fetal demise|2
2042387|NCT00443560|3613133|FG001|Overall Study|Multiple pregnancies or fetal demise|4
2042388|NCT00443599|3613141|FG000|Overall Study|Physician Decision|2
2042389|NCT00443599|3613142|FG001|Overall Study|Physician Decision|1
2042390|NCT00443599|3613141|FG000|Overall Study|Death|1
2042391|NCT00443599|3613142|FG001|Overall Study|Death|1
2042392|NCT00443599|3613141|FG000|Overall Study|Cardiopulmonary bypass canceled|3
2042393|NCT00443599|3613142|FG001|Overall Study|Cardiopulmonary bypass canceled|1
2208364|NCT01639560|3847935|FG001|Overall Study|Adverse Event|2
2208365|NCT01639703|3847964|FG000|Overall Study|Withdrawal by Subject|5
2208366|NCT01639703|3847964|FG000|Overall Study|Other reason|7
2208367|NCT01639729|3847980|FG000|Overall Study|Withdrawal by Subject|1
2208368|NCT01639729|3847981|FG001|Overall Study|Withdrawal by Subject|0
2208369|NCT01639729|3847982|FG002|Overall Study|Withdrawal by Subject|1
2208370|NCT01639729|3847983|FG003|Overall Study|Withdrawal by Subject|1
2208371|NCT01639729|3847984|FG004|Overall Study|Withdrawal by Subject|0
2208372|NCT01639729|3847985|FG005|Overall Study|Withdrawal by Subject|0
2208373|NCT01639742|3847995|FG000|Overall Study|Study Ongoing|17
2208374|NCT01639742|3847995|FG000|Overall Study|Lost to Follow-up|1
2042394|NCT00443651|3613150|FG000|Overall Study|Death|1
2042395|NCT00443651|3613151|FG001|Overall Study|Death|5
2042396|NCT00443651|3613150|FG000|Overall Study|Adverse Event|5
2042397|NCT00443651|3613151|FG001|Overall Study|Adverse Event|6
2042398|NCT00443651|3613150|FG000|Overall Study|Lost to Follow-up|18
2042399|NCT00443651|3613151|FG001|Overall Study|Lost to Follow-up|12
2042400|NCT00443651|3613150|FG000|Overall Study|Patient's/Guardian's Decision|58
2042401|NCT00443651|3613151|FG001|Overall Study|Patient's/Guardian's Decision|30
2042402|NCT00443651|3613150|FG000|Overall Study|Physician Decision|13
2042403|NCT00443651|3613151|FG001|Overall Study|Physician Decision|4
2042404|NCT00443651|3613150|FG000|Overall Study|Pregnancy|0
2042405|NCT00443651|3613151|FG001|Overall Study|Pregnancy|1
2042406|NCT00443703|3613159|FG000|Overall Study|Never Treated|3
2042407|NCT00443703|3613160|FG001|Overall Study|Never Treated|1
2042408|NCT00443703|3613159|FG000|Overall Study|Adverse Event|7
2208375|NCT01639755|3847999|FG000|Overall Study|Study Ongoing|15
2042409|NCT00443703|3613160|FG001|Overall Study|Adverse Event|3
2042410|NCT00443703|3613159|FG000|Overall Study|Lack of Efficacy|3
2042411|NCT00443703|3613160|FG001|Overall Study|Lack of Efficacy|1
2042412|NCT00443703|3613159|FG000|Overall Study|Lost to Follow-up|0
2042413|NCT00443703|3613160|FG001|Overall Study|Lost to Follow-up|4
2042414|NCT00443703|3613159|FG000|Overall Study|Physician Decision|4
2042415|NCT00443703|3613160|FG001|Overall Study|Physician Decision|2
2042416|NCT00443703|3613159|FG000|Overall Study|Protocol Violation|1
2042417|NCT00443703|3613160|FG001|Overall Study|Protocol Violation|1
2042418|NCT00443703|3613159|FG000|Overall Study|Withdrawal by Subject|9
2042419|NCT00443703|3613160|FG001|Overall Study|Withdrawal by Subject|6
2042420|NCT00443703|3613159|FG000|Overall Study|Progressive Disease|1
2042421|NCT00443703|3613160|FG001|Overall Study|Progressive Disease|0
2042422|NCT00443729|3613168|FG000|Overall Study|Never Treated|0
2042423|NCT00443729|3613169|FG001|Overall Study|Never Treated|1
2042424|NCT00443729|3613168|FG000|Overall Study|Lack of Efficacy|4
2042425|NCT00443729|3613169|FG001|Overall Study|Lack of Efficacy|2
2042426|NCT00443729|3613168|FG000|Overall Study|Lost to Follow-up|0
2042427|NCT00443729|3613169|FG001|Overall Study|Lost to Follow-up|1
2042428|NCT00443729|3613168|FG000|Overall Study|Physician Decision|2
2042429|NCT00443729|3613169|FG001|Overall Study|Physician Decision|1
2042430|NCT00443729|3613168|FG000|Overall Study|Protocol Violation|1
2042431|NCT00443729|3613169|FG001|Overall Study|Protocol Violation|1
2042432|NCT00443729|3613168|FG000|Overall Study|Withdrawal by Subject|3
2042433|NCT00443729|3613169|FG001|Overall Study|Withdrawal by Subject|1
2042434|NCT00443755|3613177|FG000|Overall Study|Withdrawal by Subject|2
2042435|NCT00443755|3613178|FG001|Overall Study|Withdrawal by Subject|1
2042436|NCT00443781|3613184|FG000|Overall Study|Lost to Follow-up|10
2042437|NCT00443781|3613184|FG000|Overall Study|Physician Decision|2
2042438|NCT00443781|3613184|FG000|Overall Study|Protocol Violation|1
2042439|NCT00443781|3613184|FG000|Overall Study|Withdrawal by Subject|6
2042440|NCT00443781|3613184|FG000|Overall Study|Unable to comply with study follow up|2
2042441|NCT00443781|3613184|FG000|Overall Study|Investigator terminated participation|1
2042442|NCT00443781|3613184|FG000|Overall Study|Insurance not covered|2
2042443|NCT00443781|3613184|FG000|Overall Study|PD/FAD not done|1
2042444|NCT00443820|3613192|FG000|Overall Study|Adverse Event|1
2042445|NCT00443820|3613193|FG001|Overall Study|Adverse Event|1
2042446|NCT00443820|3613194|FG002|Overall Study|Adverse Event|0
2042447|NCT00443820|3613195|FG003|Overall Study|Adverse Event|0
2298108|NCT02574078|3994895|FG006|Pre-Treatment Period|Poor/non-compliance|0
2042448|NCT00443820|3613192|FG000|Overall Study|Lack of Efficacy|3
2042449|NCT00443820|3613193|FG001|Overall Study|Lack of Efficacy|2
2042450|NCT00443820|3613194|FG002|Overall Study|Lack of Efficacy|1
2042451|NCT00443820|3613195|FG003|Overall Study|Lack of Efficacy|1
2042452|NCT00443820|3613192|FG000|Overall Study|Protocol Violation|2
2042453|NCT00443820|3613193|FG001|Overall Study|Protocol Violation|1
2042454|NCT00443820|3613194|FG002|Overall Study|Protocol Violation|2
2042455|NCT00443820|3613195|FG003|Overall Study|Protocol Violation|1
2042456|NCT00443820|3613192|FG000|Overall Study|Withdrawal by Subject|6
2042457|NCT00443820|3613193|FG001|Overall Study|Withdrawal by Subject|7
2042458|NCT00443820|3613194|FG002|Overall Study|Withdrawal by Subject|8
2042459|NCT00443820|3613195|FG003|Overall Study|Withdrawal by Subject|9
2042460|NCT00443820|3613192|FG000|Overall Study|Lost to Follow-up|9
2042461|NCT00443820|3613193|FG001|Overall Study|Lost to Follow-up|8
2042462|NCT00443820|3613194|FG002|Overall Study|Lost to Follow-up|6
2042463|NCT00443820|3613195|FG003|Overall Study|Lost to Follow-up|5
2042464|NCT00443820|3613192|FG000|Overall Study|Administrative problems|0
2042465|NCT00443820|3613193|FG001|Overall Study|Administrative problems|0
2042466|NCT00443820|3613194|FG002|Overall Study|Administrative problems|0
2042467|NCT00443820|3613195|FG003|Overall Study|Administrative problems|1
2042468|NCT00443820|3613192|FG000|Overall Study|Death|0
2042469|NCT00443820|3613193|FG001|Overall Study|Death|0
2042470|NCT00443820|3613194|FG002|Overall Study|Death|1
2042471|NCT00443820|3613195|FG003|Overall Study|Death|0
2042472|NCT00443846|3613207|FG000|Overall Study|Withdrawn due to intercurrent disease|1
2042473|NCT00443846|3613208|FG001|Overall Study|Withdrawn due to intercurrent disease|0
2042474|NCT00443846|3613207|FG000|Overall Study|Not vaccinated, no blood sample drawn|1
2042475|NCT00443846|3613208|FG001|Overall Study|Not vaccinated, no blood sample drawn|0
2019308|NCT00297232|3586604|FG000|Overall Study|Anti-natalizumab Positive|8
2019309|NCT00297232|3586604|FG000|Overall Study|Switched to Commercial Tysabri|22
2019310|NCT00297232|3586604|FG000|Overall Study|Disease Progression|8
2019311|NCT00297232|3586604|FG000|Overall Study|Fear of PML|10
2019312|NCT00297232|3586604|FG000|Overall Study|Anti-JCV Antibody Positive|13
2019313|NCT00297232|3586604|FG000|Overall Study|Miscellaneous|5
2019314|NCT00297232|3586604|FG000|Overall Study|Sponsor Decision|34
2019315|NCT00297232|3586604|FG000|Overall Study|Subject Relocated|7
2019316|NCT00297232|3586604|FG000|Overall Study|Subject Withdrew Consent|37
2019317|NCT00297232|3586604|FG000|Overall Study|Persistently Positive Antibodies|11
2019318|NCT00297232|3586604|FG000|Overall Study|Investigator Withdrew From Program|19
2019319|NCT00297232|3586604|FG000|Overall Study|Did Not Enroll to Week 264|34
2019320|NCT00297232|3586604|FG000|Overall Study|Did Not Enroll to Week 480|17
2019321|NCT00297232|3586604|FG000|Overall Study|No data available after Week 264|161
2019322|NCT00297232|3586604|FG000|Overall Study|Other|1
2019323|NCT00297258|3586608|FG000|Overall Study|Disease Progression, Relapse, Death|120
2019324|NCT00297258|3586608|FG000|Overall Study|Toxicity (or Toxic Death)|10
2019325|NCT00297258|3586608|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2
2019326|NCT00297258|3586608|FG000|Overall Study|Intercurrent Illness|3
2019327|NCT00297258|3586608|FG000|Overall Study|Intercurrent Death|2
2019328|NCT00297258|3586608|FG000|Overall Study|Deteriorization of General Condition|1
2019329|NCT00297258|3586608|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1
2019330|NCT00297258|3586608|FG000|Overall Study|Surgery Performed on Target Lesion|1
2019331|NCT00297258|3586608|FG000|Overall Study|Switch to Commercial Treatment|1
2019332|NCT00297258|3586608|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1
2019333|NCT00297427|3586617|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8
2019334|NCT00297427|3586618|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5
2019335|NCT00297427|3586617|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0
2019336|NCT00297427|3586618|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3
2019337|NCT00297427|3586617|FG000|Phase 1: Initial Intervention|Death|0
2019338|NCT00297427|3586618|FG001|Phase 1: Initial Intervention|Death|1
2026049|NCT00348283|3594715|FG001|Double Blind|Pregnancy|1
2042476|NCT00443846|3613207|FG000|Overall Study|Adverse Event|0
2042477|NCT00443846|3613208|FG001|Overall Study|Adverse Event|1
2042478|NCT00443846|3613207|FG000|Overall Study|Personal reason|8
2042479|NCT00443846|3613208|FG001|Overall Study|Personal reason|3
2042480|NCT00443846|3613207|FG000|Overall Study|Lost to Follow-up|1
2042481|NCT00443846|3613208|FG001|Overall Study|Lost to Follow-up|2
2042482|NCT00443872|3613214|FG000|Overall Study|Protocol Violation|7
2042483|NCT00443872|3613214|FG000|Overall Study|Lost to Follow-up|2
2042484|NCT00443872|3613214|FG000|Overall Study|Adverse Event|8
2042485|NCT00443898|3613231|FG000|Overall Study|Adverse Event|0
2042486|NCT00443898|3613232|FG001|Overall Study|Adverse Event|0
2042487|NCT00443898|3613233|FG002|Overall Study|Adverse Event|1
2042488|NCT00443898|3613234|FG003|Overall Study|Adverse Event|1
2042489|NCT00443898|3613231|FG000|Overall Study|Lack of Efficacy|2
2042490|NCT00443898|3613232|FG001|Overall Study|Lack of Efficacy|3
2042491|NCT00443898|3613233|FG002|Overall Study|Lack of Efficacy|3
2042492|NCT00443898|3613234|FG003|Overall Study|Lack of Efficacy|1
2042493|NCT00443898|3613231|FG000|Overall Study|Protocol Violation|1
2042494|NCT00443898|3613232|FG001|Overall Study|Protocol Violation|1
2042495|NCT00443898|3613233|FG002|Overall Study|Protocol Violation|1
2042496|NCT00443898|3613234|FG003|Overall Study|Protocol Violation|0
2042497|NCT00443898|3613231|FG000|Overall Study|Withdrawal by Subject|11
2042498|NCT00443898|3613232|FG001|Overall Study|Withdrawal by Subject|10
2042499|NCT00443898|3613233|FG002|Overall Study|Withdrawal by Subject|10
2042500|NCT00443898|3613234|FG003|Overall Study|Withdrawal by Subject|6
2042501|NCT00443898|3613231|FG000|Overall Study|Lost to Follow-up|10
2042502|NCT00443898|3613232|FG001|Overall Study|Lost to Follow-up|10
2042503|NCT00443898|3613233|FG002|Overall Study|Lost to Follow-up|14
2042504|NCT00443898|3613234|FG003|Overall Study|Lost to Follow-up|10
2042505|NCT00443898|3613231|FG000|Overall Study|Death|0
2042506|NCT00443898|3613232|FG001|Overall Study|Death|1
2042507|NCT00443898|3613233|FG002|Overall Study|Death|0
2042508|NCT00443898|3613234|FG003|Overall Study|Death|0
2042509|NCT00444067|3613270|FG000|Overall Study|Lost to Follow-up|0
2042510|NCT00444067|3613271|FG001|Overall Study|Lost to Follow-up|1
2042511|NCT00444106|3613292|FG000|Overall Study|Lost to Follow-up|2
2042512|NCT00444106|3613293|FG001|Overall Study|Lost to Follow-up|1
2042513|NCT00444106|3613294|FG002|Overall Study|Lost to Follow-up|0
2042514|NCT00444106|3613292|FG000|Overall Study|Abnormal Test Procedure Results|0
2042515|NCT00444106|3613293|FG001|Overall Study|Abnormal Test Procedure Results|0
2042516|NCT00444106|3613294|FG002|Overall Study|Abnormal Test Procedure Results|1
2042517|NCT00444145|3613305|FG000|Overall Study|Withdrawal by Subject|2
2042518|NCT00444145|3613305|FG000|Overall Study|Lost to Follow-up|1
2042519|NCT00444145|3613305|FG000|Overall Study|non-compliant|11
2042520|NCT00444145|3613305|FG000|Overall Study|Screen Failures|5
2042521|NCT00444275|3613312|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0
2042522|NCT00444275|3613313|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0
2042523|NCT00444275|3613314|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22
2042524|NCT00444275|3613315|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17
2042525|NCT00444275|3613316|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29
2042526|NCT00444275|3613312|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
2042527|NCT00444275|3613313|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
2208376|NCT01639755|3847999|FG000|Overall Study|Patient had device explantation|4
2042528|NCT00444275|3613314|FG002|Maintenance Treatment Phase|Lost to Follow-up|8
2042529|NCT00444275|3613315|FG003|Maintenance Treatment Phase|Lost to Follow-up|14
2042530|NCT00444275|3613316|FG004|Maintenance Treatment Phase|Lost to Follow-up|10
2042531|NCT00444275|3613312|FG000|Maintenance Treatment Phase|Adverse Event|0
2042532|NCT00444275|3613313|FG001|Maintenance Treatment Phase|Adverse Event|0
2042533|NCT00444275|3613314|FG002|Maintenance Treatment Phase|Adverse Event|3
2042534|NCT00444275|3613315|FG003|Maintenance Treatment Phase|Adverse Event|2
2042535|NCT00444275|3613316|FG004|Maintenance Treatment Phase|Adverse Event|13
2042536|NCT00444275|3613312|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0
2042537|NCT00444275|3613313|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0
2042538|NCT00444275|3613314|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1
2042539|NCT00444275|3613315|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0
2042540|NCT00444275|3613316|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6
2042541|NCT00444275|3613312|FG000|Maintenance Treatment Phase|Patient's wish|0
2042542|NCT00444275|3613313|FG001|Maintenance Treatment Phase|Patient's wish|0
2042543|NCT00444275|3613314|FG002|Maintenance Treatment Phase|Patient's wish|19
2042544|NCT00444275|3613315|FG003|Maintenance Treatment Phase|Patient's wish|9
2042545|NCT00444275|3613316|FG004|Maintenance Treatment Phase|Patient's wish|20
2042546|NCT00444275|3613312|FG000|Maintenance Treatment Phase|Protocol Violation|0
2042547|NCT00444275|3613313|FG001|Maintenance Treatment Phase|Protocol Violation|0
2042548|NCT00444275|3613314|FG002|Maintenance Treatment Phase|Protocol Violation|103
2042549|NCT00444275|3613315|FG003|Maintenance Treatment Phase|Protocol Violation|88
2042550|NCT00444275|3613316|FG004|Maintenance Treatment Phase|Protocol Violation|87
2042551|NCT00444275|3613312|FG000|Maintenance Treatment Phase|Ineffectiveness|0
2042552|NCT00444275|3613313|FG001|Maintenance Treatment Phase|Ineffectiveness|0
2042553|NCT00444275|3613314|FG002|Maintenance Treatment Phase|Ineffectiveness|5
2042554|NCT00444275|3613315|FG003|Maintenance Treatment Phase|Ineffectiveness|3
2042555|NCT00444275|3613316|FG004|Maintenance Treatment Phase|Ineffectiveness|14
2042556|NCT00444457|3613335|FG000|Infant Series|Other|0
2042557|NCT00444457|3613336|FG001|Infant Series|Other|1
2042558|NCT00444457|3613337|FG002|Infant Series|Other|0
2042559|NCT00444457|3613338|FG003|Infant Series|Other|0
2042560|NCT00444457|3613335|FG000|Infant Series|Parent or legal guardian request|18
2042561|NCT00444457|3613336|FG001|Infant Series|Parent or legal guardian request|29
2042562|NCT00444457|3613337|FG002|Infant Series|Parent or legal guardian request|34
2042563|NCT00444457|3613338|FG003|Infant Series|Parent or legal guardian request|14
2042564|NCT00444457|3613335|FG000|Infant Series|Lost to Follow-up|10
2042565|NCT00444457|3613336|FG001|Infant Series|Lost to Follow-up|11
2042566|NCT00444457|3613337|FG002|Infant Series|Lost to Follow-up|7
2042567|NCT00444457|3613338|FG003|Infant Series|Lost to Follow-up|6
2042568|NCT00444457|3613335|FG000|Infant Series|Protocol Violation|16
2042569|NCT00444457|3613336|FG001|Infant Series|Protocol Violation|8
2042570|NCT00444457|3613337|FG002|Infant Series|Protocol Violation|6
2042571|NCT00444457|3613338|FG003|Infant Series|Protocol Violation|3
2042572|NCT00444457|3613335|FG000|Infant Series|Failed to return|5
2042573|NCT00444457|3613336|FG001|Infant Series|Failed to return|4
2042574|NCT00444457|3613337|FG002|Infant Series|Failed to return|4
2042575|NCT00444457|3613338|FG003|Infant Series|Failed to return|2
2042576|NCT00444457|3613335|FG000|Infant Series|Investigator request|4
2042577|NCT00444457|3613336|FG001|Infant Series|Investigator request|3
2042578|NCT00444457|3613337|FG002|Infant Series|Investigator request|3
2042579|NCT00444457|3613338|FG003|Infant Series|Investigator request|2
2042580|NCT00444457|3613335|FG000|Infant Series|Other|0
2042581|NCT00444457|3613336|FG001|Infant Series|Other|2
2042582|NCT00444457|3613337|FG002|Infant Series|Other|4
2042583|NCT00444457|3613338|FG003|Infant Series|Other|0
2042584|NCT00444457|3613335|FG000|Infant Series|Adverse Event|1
2042585|NCT00444457|3613336|FG001|Infant Series|Adverse Event|2
2042586|NCT00444457|3613337|FG002|Infant Series|Adverse Event|2
2042587|NCT00444457|3613338|FG003|Infant Series|Adverse Event|0
2042588|NCT00444457|3613335|FG000|Infant Series|Death|0
2042589|NCT00444457|3613336|FG001|Infant Series|Death|1
2042590|NCT00444457|3613337|FG002|Infant Series|Death|1
2042591|NCT00444457|3613338|FG003|Infant Series|Death|1
2042592|NCT00444457|3613335|FG000|After Infant Series|Other|0
2042593|NCT00444457|3613336|FG001|After Infant Series|Other|1
2042594|NCT00444457|3613337|FG002|After Infant Series|Other|1
2042595|NCT00444457|3613338|FG003|After Infant Series|Other|1
2042596|NCT00444457|3613335|FG000|After Infant Series|Parent or legal guardian request|4
2042597|NCT00444457|3613336|FG001|After Infant Series|Parent or legal guardian request|11
2042598|NCT00444457|3613337|FG002|After Infant Series|Parent or legal guardian request|6
2042599|NCT00444457|3613338|FG003|After Infant Series|Parent or legal guardian request|3
2042600|NCT00444457|3613335|FG000|After Infant Series|Failed to return|7
2042601|NCT00444457|3613336|FG001|After Infant Series|Failed to return|6
2042602|NCT00444457|3613337|FG002|After Infant Series|Failed to return|5
2042603|NCT00444457|3613338|FG003|After Infant Series|Failed to return|1
2042604|NCT00444457|3613335|FG000|After Infant Series|Lost to Follow-up|5
2042605|NCT00444457|3613336|FG001|After Infant Series|Lost to Follow-up|5
2042606|NCT00444457|3613337|FG002|After Infant Series|Lost to Follow-up|5
2042607|NCT00444457|3613338|FG003|After Infant Series|Lost to Follow-up|2
2042608|NCT00444457|3613335|FG000|After Infant Series|Protocol Violation|2
2042609|NCT00444457|3613336|FG001|After Infant Series|Protocol Violation|4
2042610|NCT00444457|3613337|FG002|After Infant Series|Protocol Violation|2
2042611|NCT00444457|3613338|FG003|After Infant Series|Protocol Violation|2
2042612|NCT00444457|3613335|FG000|After Infant Series|Adverse Event|2
2042613|NCT00444457|3613336|FG001|After Infant Series|Adverse Event|2
2042614|NCT00444457|3613337|FG002|After Infant Series|Adverse Event|0
2042615|NCT00444457|3613338|FG003|After Infant Series|Adverse Event|0
2042616|NCT00444457|3613335|FG000|After Infant Series|Investigator request|0
2042617|NCT00444457|3613336|FG001|After Infant Series|Investigator request|0
2042618|NCT00444457|3613337|FG002|After Infant Series|Investigator request|0
2042619|NCT00444457|3613338|FG003|After Infant Series|Investigator request|1
2042620|NCT00444457|3613335|FG000|After Infant Series|Other|0
2042621|NCT00444457|3613336|FG001|After Infant Series|Other|1
2042622|NCT00444457|3613337|FG002|After Infant Series|Other|0
2042623|NCT00444457|3613338|FG003|After Infant Series|Other|0
2042624|NCT00444457|3613335|FG000|Toddler Dose|Lost to Follow-up|4
2042625|NCT00444457|3613336|FG001|Toddler Dose|Lost to Follow-up|1
2042626|NCT00444457|3613337|FG002|Toddler Dose|Lost to Follow-up|1
2042627|NCT00444457|3613338|FG003|Toddler Dose|Lost to Follow-up|3
2042628|NCT00444457|3613335|FG000|Toddler Dose|Failed to return|2
2042629|NCT00444457|3613336|FG001|Toddler Dose|Failed to return|2
2042630|NCT00444457|3613337|FG002|Toddler Dose|Failed to return|1
2042631|NCT00444457|3613338|FG003|Toddler Dose|Failed to return|3
2042632|NCT00444457|3613335|FG000|Toddler Dose|Parent or legal guardian request|0
2042633|NCT00444457|3613336|FG001|Toddler Dose|Parent or legal guardian request|3
2042634|NCT00444457|3613337|FG002|Toddler Dose|Parent or legal guardian request|2
2042635|NCT00444457|3613338|FG003|Toddler Dose|Parent or legal guardian request|1
2042636|NCT00444457|3613335|FG000|Toddler Dose|Protocol Violation|1
2042637|NCT00444457|3613336|FG001|Toddler Dose|Protocol Violation|0
2042638|NCT00444457|3613337|FG002|Toddler Dose|Protocol Violation|0
2042639|NCT00444457|3613338|FG003|Toddler Dose|Protocol Violation|1
2042640|NCT00444535|3613359|FG000|Overall Study|Withdrawal by Subject|5
2042641|NCT00444535|3613359|FG000|Overall Study|Physician Decision|5
2042642|NCT00444535|3613359|FG000|Overall Study|progressive disease|1
2042643|NCT00444535|3613359|FG000|Overall Study|Adverse Event|2
2042644|NCT00444587|3613365|FG000|Overall Study|Death|2
2042645|NCT00444587|3613366|FG001|Overall Study|Death|1
2042646|NCT00444587|3613365|FG000|Overall Study|Progression of the disease|73
2042647|NCT00444587|3613366|FG001|Overall Study|Progression of the disease|8
2042648|NCT00444587|3613365|FG000|Overall Study|Refused treatment/did not cooperate|4
2042649|NCT00444587|3613366|FG001|Overall Study|Refused treatment/did not cooperate|1
2042650|NCT00444587|3613365|FG000|Overall Study|Investigator decision|3
2042651|NCT00444587|3613366|FG001|Overall Study|Investigator decision|0
2042652|NCT00444587|3613365|FG000|Overall Study|Protocol Violation|1
2042653|NCT00444587|3613366|FG001|Overall Study|Protocol Violation|0
2042654|NCT00444587|3613365|FG000|Overall Study|Missing|0
2042655|NCT00444587|3613366|FG001|Overall Study|Missing|5
2042656|NCT00444600|3613378|FG000|Overall Study|Death|7
2042657|NCT00444600|3613379|FG001|Overall Study|Death|5
2042658|NCT00444600|3613380|FG002|Overall Study|Death|3
2042659|NCT00444600|3613381|FG003|Overall Study|Death|2
2042660|NCT00444600|3613378|FG000|Overall Study|Dropped|11
2042661|NCT00444600|3613379|FG001|Overall Study|Dropped|11
2042662|NCT00444600|3613380|FG002|Overall Study|Dropped|7
2042663|NCT00444600|3613381|FG003|Overall Study|Dropped|7
2042664|NCT00444600|3613378|FG000|Overall Study|Missed visit|1
2042665|NCT00444600|3613379|FG001|Overall Study|Missed visit|0
2042666|NCT00444600|3613380|FG002|Overall Study|Missed visit|0
2042667|NCT00444600|3613381|FG003|Overall Study|Missed visit|1
2042668|NCT00444626|3613397|FG000|Initial Treatment Period|Withdrawal by Subject|2
2042669|NCT00444626|3613397|FG000|Initial Treatment Period|Adverse Event|1
2042670|NCT00444626|3613397|FG000|Initial Treatment Period|Lost to Follow-up|9
2042671|NCT00444678|3613410|FG000|Overall Study|Toxicity|11
2042672|NCT00444678|3613410|FG000|Overall Study|Disease Progression|12
2042673|NCT00444678|3613410|FG000|Overall Study|Death|3
2042674|NCT00444678|3613410|FG000|Overall Study|Physician Decision|3
2042675|NCT00444678|3613410|FG000|Overall Study|Withdrawal by Subject|2
2042676|NCT00444795|3613414|FG000|Overall Study|Not Treated|1
2042677|NCT00444795|3613414|FG000|Overall Study|Treated Prior to the Contract Date|2
2042678|NCT00444912|3613429|FG000|Overall Study|Death|1
2042679|NCT00444912|3613430|FG001|Overall Study|Death|2
2042680|NCT00444912|3613429|FG000|Overall Study|Lost to Follow-up|1
2042681|NCT00444912|3613430|FG001|Overall Study|Lost to Follow-up|0
2042682|NCT00444912|3613429|FG000|Overall Study|Participant Failed Mobilization|1
2042683|NCT00444912|3613430|FG001|Overall Study|Participant Failed Mobilization|0
2042684|NCT00444925|3613439|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3
2042685|NCT00444925|3613440|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6
2042686|NCT00444925|3613441|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6
2042687|NCT00444925|3613439|FG000|Double-blind Treatment Period|Death|2
2042688|NCT00444925|3613440|FG001|Double-blind Treatment Period|Death|0
2042689|NCT00444925|3613441|FG002|Double-blind Treatment Period|Death|0
2042690|NCT00444925|3613439|FG000|Double-blind Treatment Period|Adverse Event|6
2042691|NCT00444925|3613440|FG001|Double-blind Treatment Period|Adverse Event|28
2042692|NCT00444925|3613441|FG002|Double-blind Treatment Period|Adverse Event|44
2042693|NCT00444925|3613439|FG000|Double-blind Treatment Period|Lack of Efficacy|5
2042694|NCT00444925|3613440|FG001|Double-blind Treatment Period|Lack of Efficacy|5
2042695|NCT00444925|3613441|FG002|Double-blind Treatment Period|Lack of Efficacy|13
2042696|NCT00444925|3613439|FG000|Double-blind Treatment Period|Lost to Follow-up|4
2042697|NCT00444925|3613440|FG001|Double-blind Treatment Period|Lost to Follow-up|8
2042698|NCT00444925|3613441|FG002|Double-blind Treatment Period|Lost to Follow-up|5
2042699|NCT00444925|3613439|FG000|Double-blind Treatment Period|Withdrawal by Subject|6
2042700|NCT00444925|3613440|FG001|Double-blind Treatment Period|Withdrawal by Subject|8
2042701|NCT00444925|3613441|FG002|Double-blind Treatment Period|Withdrawal by Subject|7
2042702|NCT00444925|3613439|FG000|Double-blind Treatment Period|Other|7
2042703|NCT00444925|3613440|FG001|Double-blind Treatment Period|Other|7
2042704|NCT00444925|3613441|FG002|Double-blind Treatment Period|Other|12
2042705|NCT00444951|3613452|FG000|Overall Study|Lost to Follow-up|1
2042706|NCT00444951|3613453|FG001|Overall Study|Lost to Follow-up|1
2042707|NCT00444951|3613454|FG002|Overall Study|Lost to Follow-up|0
2042708|NCT00444951|3613452|FG000|Overall Study|Withdrawal by Subject|4
2042709|NCT00444951|3613453|FG001|Overall Study|Withdrawal by Subject|5
2042710|NCT00444951|3613454|FG002|Overall Study|Withdrawal by Subject|3
2042711|NCT00445003|3613469|FG000|Overall Study|Death|1
2042712|NCT00445003|3613470|FG001|Overall Study|Death|2
2042713|NCT00445003|3613471|FG002|Overall Study|Death|1
2042714|NCT00445003|3613469|FG000|Overall Study|Missed Visit|3
2042715|NCT00445003|3613470|FG001|Overall Study|Missed Visit|5
2042716|NCT00445003|3613471|FG002|Overall Study|Missed Visit|1
2042717|NCT00445003|3613469|FG000|Overall Study|Dropped|1
2042718|NCT00445003|3613470|FG001|Overall Study|Dropped|3
2042719|NCT00445003|3613471|FG002|Overall Study|Dropped|2
2042720|NCT00445068|3613479|FG000|Overall Study|Disease progression|26
2042721|NCT00445068|3613479|FG000|Overall Study|Adverse Event|5
2042722|NCT00445068|3613479|FG000|Overall Study|Abnormal laboratory value|2
2042723|NCT00445068|3613479|FG000|Overall Study|Withdrawal by Subject|2
2042724|NCT00445068|3613479|FG000|Overall Study|Death|1
2042725|NCT00445146|3613483|FG000|Overall Study|Withdrew Consent|29
2042726|NCT00445146|3613483|FG000|Overall Study|Lack of Efficacy|28
2042727|NCT00445146|3613483|FG000|Overall Study|Investigator's Discretion|22
2042728|NCT00445146|3613483|FG000|Overall Study|Adverse Event|13
2042729|NCT00445146|3613483|FG000|Overall Study|Lost to Follow-up|13
2042730|NCT00445146|3613483|FG000|Overall Study|Death|9
2042731|NCT00445146|3613483|FG000|Overall Study|Protocol Violation|4
2042732|NCT00445146|3613483|FG000|Overall Study|Pregnancy|1
2042733|NCT00445224|3613498|FG000|Specific Exercises|Withdrawal by Subject|3
2042734|NCT00445224|3613499|FG001|Specific Exercises|Withdrawal by Subject|3
2042735|NCT00445224|3613498|FG000|Specific Exercises|Withdrawal by Subject|1
2042736|NCT00445224|3613499|FG001|Specific Exercises|Withdrawal by Subject|0
2042737|NCT00445328|3613555|FG000|Overall Study|Death|0
2042738|NCT00445328|3613556|FG001|Overall Study|Death|1
2042739|NCT00445328|3613555|FG000|Overall Study|Adverse Event|0
2042740|NCT00445328|3613556|FG001|Overall Study|Adverse Event|3
2042741|NCT00445328|3613555|FG000|Overall Study|Other|0
2042742|NCT00445328|3613556|FG001|Overall Study|Other|2
2042743|NCT00445328|3613555|FG000|Overall Study|Withdrawal by Subject|2
2042744|NCT00445328|3613556|FG001|Overall Study|Withdrawal by Subject|0
2042745|NCT00445328|3613555|FG000|Overall Study|Protocol Violation|1
2042746|NCT00445328|3613556|FG001|Overall Study|Protocol Violation|0
2042747|NCT00445341|3613562|FG000|Overall Study|refused further treatment|1
2042748|NCT00445341|3613562|FG000|Overall Study|taken off treatment too early|1
2042749|NCT00445432|3613569|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
2042750|NCT00445432|3613570|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
2042751|NCT00445432|3613571|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
2042752|NCT00445432|3613572|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
2042753|NCT00445432|3613569|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
2042754|NCT00445432|3613570|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
2042755|NCT00445432|3613571|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
2042756|NCT00445432|3613572|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
2042757|NCT00445432|3613569|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
2042758|NCT00445432|3613570|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
2042759|NCT00445432|3613571|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
2042760|NCT00445432|3613572|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
2042761|NCT00445432|3613569|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0
2042762|NCT00445432|3613570|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1
2042763|NCT00445432|3613571|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2
2042764|NCT00445432|3613572|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0
2042765|NCT00445432|3613569|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0
2042766|NCT00445432|3613570|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0
2042767|NCT00445432|3613571|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0
2042768|NCT00445432|3613572|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32
2042769|NCT00445432|3613569|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
2042770|NCT00445432|3613570|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
2042771|NCT00445432|3613571|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
2042772|NCT00445432|3613572|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
2042773|NCT00445432|3613569|FG000|148 Weeks of Adalimumab Treatment|Other|0
2042774|NCT00445432|3613570|FG001|148 Weeks of Adalimumab Treatment|Other|0
2042775|NCT00445432|3613571|FG002|148 Weeks of Adalimumab Treatment|Other|0
2042776|NCT00445432|3613572|FG003|148 Weeks of Adalimumab Treatment|Other|9
2042777|NCT00445458|3613587|FG000|Overall Study|Disease Progression|3
2042778|NCT00445458|3613588|FG001|Overall Study|Disease Progression|4
2042779|NCT00445458|3613589|FG002|Overall Study|Disease Progression|54
2042780|NCT00445458|3613590|FG003|Overall Study|Disease Progression|27
2042781|NCT00445458|3613587|FG000|Overall Study|Withdrawal by Subject|0
2042782|NCT00445458|3613588|FG001|Overall Study|Withdrawal by Subject|0
2042783|NCT00445458|3613589|FG002|Overall Study|Withdrawal by Subject|7
2042784|NCT00445458|3613590|FG003|Overall Study|Withdrawal by Subject|0
2042785|NCT00445458|3613587|FG000|Overall Study|Adverse Event|0
2042786|NCT00445458|3613588|FG001|Overall Study|Adverse Event|0
2042787|NCT00445458|3613589|FG002|Overall Study|Adverse Event|3
2042788|NCT00445458|3613590|FG003|Overall Study|Adverse Event|0
2042789|NCT00445458|3613587|FG000|Overall Study|Death|0
2042790|NCT00445458|3613588|FG001|Overall Study|Death|1
2042791|NCT00445458|3613589|FG002|Overall Study|Death|2
2042792|NCT00445458|3613590|FG003|Overall Study|Death|0
2042793|NCT00445458|3613587|FG000|Overall Study|Physician Decision|0
2042794|NCT00445458|3613588|FG001|Overall Study|Physician Decision|0
2042795|NCT00445458|3613589|FG002|Overall Study|Physician Decision|1
2042796|NCT00445458|3613590|FG003|Overall Study|Physician Decision|1
2042797|NCT00445458|3613587|FG000|Overall Study|Surgery|0
2042798|NCT00445458|3613588|FG001|Overall Study|Surgery|0
2042799|NCT00445458|3613589|FG002|Overall Study|Surgery|1
2042800|NCT00445458|3613590|FG003|Overall Study|Surgery|0
2042801|NCT00445549|3613612|FG000|Overall Study|progressive disease|12
2105016|NCT00854828|3697486|FG000|Overall Study|Missed 24mo visit|1
2208377|NCT01639833|3848005|FG000|Overall Study|Death|4
2019339|NCT00297427|3586617|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
2019340|NCT00297427|3586618|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
2019341|NCT00297427|3586617|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
2019342|NCT00297427|3586618|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
2019343|NCT00297427|3586617|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
2019344|NCT00297427|3586618|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
2019345|NCT00297427|3586617|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
2019346|NCT00297427|3586618|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
2019347|NCT00297427|3586617|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
2019348|NCT00297427|3586618|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
2019349|NCT00297479|3586635|FG000|Overall Study|Lost to Follow-up|37
2019350|NCT00297479|3586636|FG001|Overall Study|Lost to Follow-up|54
2019351|NCT00297479|3586637|FG002|Overall Study|Lost to Follow-up|51
2019352|NCT00297492|3586648|FG000|Set Quit Date|Lost to Follow-up|7
2019353|NCT00297492|3586649|FG001|Set Quit Date|Lost to Follow-up|13
2019354|NCT00297492|3586650|FG002|Set Quit Date|Lost to Follow-up|5
2019355|NCT00297492|3586648|FG000|6 Month Follow-up|Lost to Follow-up|63
2019356|NCT00297492|3586649|FG001|6 Month Follow-up|Lost to Follow-up|49
2019357|NCT00297492|3586650|FG002|6 Month Follow-up|Lost to Follow-up|27
2019358|NCT00297648|3586662|FG000|Overall Study|Adverse Event|13
2019359|NCT00297648|3586662|FG000|Overall Study|Lack of Efficacy|18
2019360|NCT00297648|3586662|FG000|Overall Study|Lost to Follow-up|1
2208378|NCT01639833|3848006|FG001|Overall Study|Death|2
2208379|NCT01639833|3848005|FG000|Overall Study|Withdrawal by Subject|2
2208380|NCT01639833|3848006|FG001|Overall Study|Withdrawal by Subject|2
2042802|NCT00445601|3613623|FG000|Overall Study|Withdrawal by Subject|11
2042803|NCT00445601|3613624|FG001|Overall Study|Withdrawal by Subject|11
2298109|NCT02574078|3994896|FG007|Pre-Treatment Period|Poor/non-compliance|0
2298110|NCT02574078|3994897|FG008|Pre-Treatment Period|Poor/non-compliance|0
2298111|NCT02574078|3994898|FG009|Pre-Treatment Period|Poor/non-compliance|0
2298112|NCT02574078|3994899|FG010|Pre-Treatment Period|Poor/non-compliance|0
2298113|NCT02574078|3994900|FG011|Pre-Treatment Period|Poor/non-compliance|1
2298114|NCT02574078|3994901|FG012|Pre-Treatment Period|Poor/non-compliance|0
2298115|NCT02574078|3994889|FG000|Treatment Period|Disease progression|6
2298116|NCT02574078|3994890|FG001|Treatment Period|Disease progression|4
2298117|NCT02574078|3994891|FG002|Treatment Period|Disease progression|7
2298118|NCT02574078|3994892|FG003|Treatment Period|Disease progression|18
2298119|NCT02574078|3994893|FG004|Treatment Period|Disease progression|16
2298120|NCT02574078|3994894|FG005|Treatment Period|Disease progression|26
2298121|NCT02574078|3994895|FG006|Treatment Period|Disease progression|5
2298122|NCT02574078|3994896|FG007|Treatment Period|Disease progression|9
2298123|NCT02574078|3994897|FG008|Treatment Period|Disease progression|8
2298124|NCT02574078|3994898|FG009|Treatment Period|Disease progression|5
2298125|NCT02574078|3994899|FG010|Treatment Period|Disease progression|20
2298126|NCT02574078|3994900|FG011|Treatment Period|Disease progression|29
2298127|NCT02574078|3994901|FG012|Treatment Period|Disease progression|2
2298128|NCT02574078|3994889|FG000|Treatment Period|Study drug toxicity|1
2298129|NCT02574078|3994890|FG001|Treatment Period|Study drug toxicity|1
2298130|NCT02574078|3994891|FG002|Treatment Period|Study drug toxicity|0
2298131|NCT02574078|3994892|FG003|Treatment Period|Study drug toxicity|5
2298132|NCT02574078|3994893|FG004|Treatment Period|Study drug toxicity|3
2298133|NCT02574078|3994894|FG005|Treatment Period|Study drug toxicity|1
2298134|NCT02574078|3994895|FG006|Treatment Period|Study drug toxicity|2
2298135|NCT02574078|3994896|FG007|Treatment Period|Study drug toxicity|0
2298136|NCT02574078|3994897|FG008|Treatment Period|Study drug toxicity|2
2298137|NCT02574078|3994898|FG009|Treatment Period|Study drug toxicity|1
2298138|NCT02574078|3994899|FG010|Treatment Period|Study drug toxicity|16
2298139|NCT02574078|3994900|FG011|Treatment Period|Study drug toxicity|2
2298140|NCT02574078|3994901|FG012|Treatment Period|Study drug toxicity|4
2298141|NCT02574078|3994889|FG000|Treatment Period|Death|2
2298142|NCT02574078|3994890|FG001|Treatment Period|Death|0
2042804|NCT00445601|3613623|FG000|Overall Study|TURBT Complication|12
2042805|NCT00445601|3613624|FG001|Overall Study|TURBT Complication|8
2042806|NCT00445601|3613623|FG000|Overall Study|Incorrect Disease Status|6
2042807|NCT00445601|3613624|FG001|Overall Study|Incorrect Disease Status|6
2042808|NCT00445601|3613623|FG000|Overall Study|Drug Delivery Issue|2
2042809|NCT00445601|3613624|FG001|Overall Study|Drug Delivery Issue|2
2042810|NCT00445601|3613623|FG000|Overall Study|Adverse Event|2
2042811|NCT00445601|3613624|FG001|Overall Study|Adverse Event|0
2042812|NCT00445601|3613623|FG000|Overall Study|Death prior to TURBT|0
2042813|NCT00445601|3613624|FG001|Overall Study|Death prior to TURBT|1
2042814|NCT00445679|3613638|FG000|Overall Study|Adverse Event|22
2042815|NCT00445679|3613639|FG001|Overall Study|Adverse Event|12
2042816|NCT00445679|3613640|FG002|Overall Study|Adverse Event|30
2042817|NCT00445679|3613641|FG003|Overall Study|Adverse Event|19
2042818|NCT00445679|3613638|FG000|Overall Study|Failed to return|1
2042819|NCT00445679|3613639|FG001|Overall Study|Failed to return|3
2042820|NCT00445679|3613640|FG002|Overall Study|Failed to return|2
2042821|NCT00445679|3613641|FG003|Overall Study|Failed to return|2
2042822|NCT00445679|3613638|FG000|Overall Study|Physician Decision|0
2042823|NCT00445679|3613639|FG001|Overall Study|Physician Decision|0
2042824|NCT00445679|3613640|FG002|Overall Study|Physician Decision|1
2042825|NCT00445679|3613641|FG003|Overall Study|Physician Decision|0
2042826|NCT00445679|3613638|FG000|Overall Study|Lost to Follow-up|10
2042827|NCT00445679|3613639|FG001|Overall Study|Lost to Follow-up|6
2042828|NCT00445679|3613640|FG002|Overall Study|Lost to Follow-up|6
2042829|NCT00445679|3613641|FG003|Overall Study|Lost to Follow-up|5
2042830|NCT00445679|3613638|FG000|Overall Study|Compliance|3
2042831|NCT00445679|3613639|FG001|Overall Study|Compliance|2
2042832|NCT00445679|3613640|FG002|Overall Study|Compliance|1
2042833|NCT00445679|3613641|FG003|Overall Study|Compliance|2
2042834|NCT00445679|3613638|FG000|Overall Study|Withdrawal of Informed Consent|0
2042835|NCT00445679|3613639|FG001|Overall Study|Withdrawal of Informed Consent|0
2042836|NCT00445679|3613640|FG002|Overall Study|Withdrawal of Informed Consent|1
2042837|NCT00445679|3613641|FG003|Overall Study|Withdrawal of Informed Consent|0
2042838|NCT00445679|3613638|FG000|Overall Study|Protocol Violation|2
2042839|NCT00445679|3613639|FG001|Overall Study|Protocol Violation|3
2042840|NCT00445679|3613640|FG002|Overall Study|Protocol Violation|3
2042841|NCT00445679|3613641|FG003|Overall Study|Protocol Violation|1
2042842|NCT00445679|3613638|FG000|Overall Study|Withdrawal by Subject|8
2042843|NCT00445679|3613639|FG001|Overall Study|Withdrawal by Subject|14
2042844|NCT00445679|3613640|FG002|Overall Study|Withdrawal by Subject|20
2042845|NCT00445679|3613641|FG003|Overall Study|Withdrawal by Subject|18
2042846|NCT00445679|3613638|FG000|Overall Study|Lack of Efficacy|2
2042847|NCT00445679|3613639|FG001|Overall Study|Lack of Efficacy|6
2042848|NCT00445679|3613640|FG002|Overall Study|Lack of Efficacy|2
2298143|NCT02574078|3994891|FG002|Treatment Period|Death|0
2298144|NCT02574078|3994892|FG003|Treatment Period|Death|0
2298145|NCT02574078|3994893|FG004|Treatment Period|Death|1
2298146|NCT02574078|3994894|FG005|Treatment Period|Death|1
2042849|NCT00445679|3613641|FG003|Overall Study|Lack of Efficacy|0
2042850|NCT00445692|3613651|FG000|Overall Study|Adverse Event|11
2042851|NCT00445692|3613651|FG000|Overall Study|Lack of Efficacy|5
2042852|NCT00445770|3613681|FG000|Overall Study|Adverse Event|9
2042853|NCT00445770|3613682|FG001|Overall Study|Adverse Event|15
2042854|NCT00445770|3613683|FG002|Overall Study|Adverse Event|19
2042855|NCT00445770|3613681|FG000|Overall Study|Lack of Efficacy|38
2042856|NCT00445770|3613682|FG001|Overall Study|Lack of Efficacy|13
2042857|NCT00445770|3613683|FG002|Overall Study|Lack of Efficacy|6
2042858|NCT00445770|3613681|FG000|Overall Study|Lost to Follow-up|0
2042859|NCT00445770|3613682|FG001|Overall Study|Lost to Follow-up|2
2042860|NCT00445770|3613683|FG002|Overall Study|Lost to Follow-up|0
2042861|NCT00445770|3613681|FG000|Overall Study|Other|6
2042862|NCT00445770|3613682|FG001|Overall Study|Other|5
2042863|NCT00445770|3613683|FG002|Overall Study|Other|6
2105017|NCT00854828|3697487|FG001|Overall Study|Missed 24mo visit|1
2105018|NCT00854828|3697488|FG002|Overall Study|Missed 24mo visit|8
2105019|NCT00854828|3697489|FG003|Overall Study|Missed 24mo visit|8
2105020|NCT00854906|3697499|FG000|Overall Study|One person had no ocular history|1
2105021|NCT00855062|3697521|FG000|Step1|Early Study Closure|5
2105022|NCT00855062|3697522|FG001|Step1|Early Study Closure|7
2105023|NCT00855062|3697521|FG000|Step1|Adverse Event|1
2105024|NCT00855062|3697522|FG001|Step1|Adverse Event|1
2105025|NCT00855062|3697521|FG000|Step1|Protocol Violation|1
2105026|NCT00855062|3697522|FG001|Step1|Protocol Violation|0
2105027|NCT00855062|3697521|FG000|Step1|Pregnancy|1
2105028|NCT00855062|3697522|FG001|Step1|Pregnancy|0
2105029|NCT00855062|3697521|FG000|Step1|Withdrawal by Subject|2
2105030|NCT00855062|3697522|FG001|Step1|Withdrawal by Subject|3
2105031|NCT00855062|3697521|FG000|Step2|Early Study Closure|6
2105032|NCT00855062|3697522|FG001|Step2|Early Study Closure|2
2105033|NCT00855062|3697521|FG000|Step2|Adverse Event|0
2105034|NCT00855062|3697522|FG001|Step2|Adverse Event|3
2105035|NCT00855062|3697521|FG000|Step2|Initiation of antiretroviral therapy/ART|0
2105036|NCT00855062|3697522|FG001|Step2|Initiation of antiretroviral therapy/ART|1
2105037|NCT00855166|3697530|FG000|Overall Study|Adverse Event|0
2105038|NCT00855166|3697531|FG001|Overall Study|Adverse Event|2
2105039|NCT00855166|3697530|FG000|Overall Study|Death|0
2105040|NCT00855166|3697531|FG001|Overall Study|Death|1
2105041|NCT00855166|3697530|FG000|Overall Study|Withdrawal by Subject|1
2105042|NCT00855166|3697531|FG001|Overall Study|Withdrawal by Subject|4
2105043|NCT00855166|3697530|FG000|Overall Study|Poor/non-compliance|2
2105044|NCT00855166|3697531|FG001|Overall Study|Poor/non-compliance|0
2105045|NCT00855166|3697530|FG000|Overall Study|Administrative reasons by sponsor|1
2105046|NCT00855166|3697531|FG001|Overall Study|Administrative reasons by sponsor|0
2105047|NCT00855166|3697530|FG000|Overall Study|Subject no longer meets study criteria|1
2105048|NCT00855166|3697531|FG001|Overall Study|Subject no longer meets study criteria|1
2105049|NCT00855218|3697541|FG000|Overall Study|Adverse Event|43
2105050|NCT00855218|3697542|FG001|Overall Study|Adverse Event|27
2105051|NCT00855218|3697541|FG000|Overall Study|Withdrawal by Subject|10
2105052|NCT00855218|3697542|FG001|Overall Study|Withdrawal by Subject|6
2208381|NCT01640054|3848021|FG000|Overall Study|Study-specific disc criteria|1
2208382|NCT01640054|3848021|FG000|Overall Study|Lack of Efficacy|3
2105053|NCT00855218|3697541|FG000|Overall Study|Physician Decision|18
2105054|NCT00855218|3697542|FG001|Overall Study|Physician Decision|11
2298147|NCT02574078|3994895|FG006|Treatment Period|Death|1
2019361|NCT00297648|3586662|FG000|Overall Study|Withdrawal by Subject|3
2019362|NCT00297648|3586662|FG000|Overall Study|Other: Incompliance|1
2019363|NCT00297778|3586668|FG000|Overall Study|Adverse Event|16
2019364|NCT00297778|3586669|FG001|Overall Study|Adverse Event|10
2019365|NCT00297778|3586668|FG000|Overall Study|Withdrawal by Subject|1
2019366|NCT00297778|3586669|FG001|Overall Study|Withdrawal by Subject|5
2019367|NCT00297778|3586668|FG000|Overall Study|Lack of Efficacy|2
2019368|NCT00297778|3586669|FG001|Overall Study|Lack of Efficacy|1
2019369|NCT00297778|3586668|FG000|Overall Study|Non-compliant with trial protocol|0
2019370|NCT00297778|3586669|FG001|Overall Study|Non-compliant with trial protocol|3
2019371|NCT00297778|3586668|FG000|Overall Study|Other|0
2019372|NCT00297778|3586669|FG001|Overall Study|Other|1
2019373|NCT00297830|3586678|FG000|6 Month Visit|Death|1
2019374|NCT00297830|3586679|FG001|6 Month Visit|Death|0
2019375|NCT00297830|3586680|FG002|6 Month Visit|Death|2
2019376|NCT00297830|3586678|FG000|6 Month Visit|Withdrawal by Subject|2
2019377|NCT00297830|3586679|FG001|6 Month Visit|Withdrawal by Subject|1
2019378|NCT00297830|3586680|FG002|6 Month Visit|Withdrawal by Subject|1
2019379|NCT00297830|3586678|FG000|6 Month Visit|Adverse Event|0
2019380|NCT00297830|3586679|FG001|6 Month Visit|Adverse Event|1
2019381|NCT00297830|3586680|FG002|6 Month Visit|Adverse Event|0
2019382|NCT00297830|3586678|FG000|12 Month Visit|Lost to Follow-up|1
2019383|NCT00297830|3586679|FG001|12 Month Visit|Lost to Follow-up|0
2019384|NCT00297830|3586680|FG002|12 Month Visit|Lost to Follow-up|0
2019385|NCT00297830|3586678|FG000|12 Month Visit|Adverse Event|0
2019386|NCT00297830|3586679|FG001|12 Month Visit|Adverse Event|3
2019387|NCT00297830|3586680|FG002|12 Month Visit|Adverse Event|0
2019388|NCT00297830|3586678|FG000|12 Month Visit|Withdrawal by Subject|0
2019389|NCT00297830|3586679|FG001|12 Month Visit|Withdrawal by Subject|3
2019390|NCT00297830|3586680|FG002|12 Month Visit|Withdrawal by Subject|0
2019391|NCT00297882|3586690|FG000|Day 14|Lack of Efficacy|12
2019392|NCT00297882|3586691|FG001|Day 14|Lack of Efficacy|49
2019393|NCT00297882|3586690|FG000|Day 28|Lost to Follow-up|13
2019394|NCT00297882|3586691|FG001|Day 28|Lost to Follow-up|23
2019395|NCT00297882|3586690|FG000|Day 28|Lack of Efficacy|3
2019396|NCT00297882|3586691|FG001|Day 28|Lack of Efficacy|0
2019397|NCT00298038|3586701|FG000|Overall Study|Lost to Follow-up|0
2019398|NCT00298038|3586702|FG001|Overall Study|Lost to Follow-up|1
2019399|NCT00298038|3586701|FG000|Overall Study|Liver Transplant|0
2019400|NCT00298038|3586702|FG001|Overall Study|Liver Transplant|1
2019401|NCT00298038|3586701|FG000|Overall Study|Protocol Violation|1
2019402|NCT00298038|3586702|FG001|Overall Study|Protocol Violation|3
2019403|NCT00298038|3586701|FG000|Overall Study|Death|6
2019404|NCT00298038|3586702|FG001|Overall Study|Death|3
2019405|NCT00298038|3586701|FG000|Overall Study|Withdrawal by Subject|6
2019406|NCT00298038|3586702|FG001|Overall Study|Withdrawal by Subject|9
2019407|NCT00298038|3586701|FG000|Overall Study|Adverse Event|8
2298148|NCT02574078|3994896|FG007|Treatment Period|Death|1
2298149|NCT02574078|3994897|FG008|Treatment Period|Death|7
2298150|NCT02574078|3994898|FG009|Treatment Period|Death|1
2298151|NCT02574078|3994899|FG010|Treatment Period|Death|0
2298152|NCT02574078|3994900|FG011|Treatment Period|Death|2
2298153|NCT02574078|3994901|FG012|Treatment Period|Death|1
2298154|NCT02574078|3994889|FG000|Treatment Period|Adverse event unrelated to drug|0
2298155|NCT02574078|3994890|FG001|Treatment Period|Adverse event unrelated to drug|0
2298156|NCT02574078|3994891|FG002|Treatment Period|Adverse event unrelated to drug|1
2298157|NCT02574078|3994892|FG003|Treatment Period|Adverse event unrelated to drug|0
2298158|NCT02574078|3994893|FG004|Treatment Period|Adverse event unrelated to drug|2
2298159|NCT02574078|3994894|FG005|Treatment Period|Adverse event unrelated to drug|3
2019408|NCT00298038|3586702|FG001|Overall Study|Adverse Event|7
2019409|NCT00298038|3586701|FG000|Overall Study|Breakthrough overt HE episode|28
2298160|NCT02574078|3994895|FG006|Treatment Period|Adverse event unrelated to drug|0
2019410|NCT00298038|3586702|FG001|Overall Study|Breakthrough overt HE episode|69
2019411|NCT00298038|3586701|FG000|Overall Study|Noncompliance|1
2019412|NCT00298038|3586702|FG001|Overall Study|Noncompliance|0
2019413|NCT00298038|3586701|FG000|Overall Study|Cocaine Abuse|1
2019414|NCT00298038|3586702|FG001|Overall Study|Cocaine Abuse|0
2019415|NCT00298038|3586701|FG000|Overall Study|Severe Gastrointestinal Bleed|1
2019416|NCT00298038|3586702|FG001|Overall Study|Severe Gastrointestinal Bleed|0
2019417|NCT00298272|3586738|FG000|Double-blind Phase|Adverse Event|2
2019418|NCT00298272|3586739|FG001|Double-blind Phase|Adverse Event|0
2208383|NCT01640054|3848021|FG000|Overall Study|Adverse Event|2
2208384|NCT01640184|3848033|FG000|Overall Study|Death|1
2208385|NCT01640184|3848034|FG001|Overall Study|Death|0
2208386|NCT01640184|3848035|FG002|Overall Study|Death|0
2208387|NCT01640184|3848033|FG000|Overall Study|Lost to Follow-up|4
2208388|NCT01640184|3848034|FG001|Overall Study|Lost to Follow-up|1
2208389|NCT01640184|3848035|FG002|Overall Study|Lost to Follow-up|0
2208390|NCT01640184|3848033|FG000|Overall Study|Physician Decision|3
2208391|NCT01640184|3848034|FG001|Overall Study|Physician Decision|0
2208392|NCT01640184|3848035|FG002|Overall Study|Physician Decision|0
2208393|NCT01640184|3848033|FG000|Overall Study|Withdrawal by Subject|0
2208394|NCT01640184|3848034|FG001|Overall Study|Withdrawal by Subject|1
2208395|NCT01640184|3848035|FG002|Overall Study|Withdrawal by Subject|1
2208396|NCT01640184|3848033|FG000|Overall Study|Protocol Violation|0
2208397|NCT01640184|3848034|FG001|Overall Study|Protocol Violation|0
2208398|NCT01640184|3848035|FG002|Overall Study|Protocol Violation|1
2208399|NCT01640249|3848062|FG000|Period 1|Withdrawal by Subject|1
2208400|NCT01640249|3848063|FG001|Period 1|Withdrawal by Subject|0
2208401|NCT01640249|3848064|FG002|Period 1|Withdrawal by Subject|0
2208402|NCT01640249|3848065|FG003|Period 1|Withdrawal by Subject|0
2208403|NCT01640249|3848066|FG004|Period 1|Withdrawal by Subject|0
2208404|NCT01640249|3848067|FG005|Period 1|Withdrawal by Subject|1
2208405|NCT01640249|3848068|FG006|Period 1|Withdrawal by Subject|0
2208406|NCT01640288|3848089|FG000|Overall Study|Equipment Failure or Poor Image Quality|4
2208407|NCT01640288|3848090|FG001|Overall Study|Equipment Failure or Poor Image Quality|5
2042864|NCT00445848|3613693|FG000|Overall Study|Adverse Event|14
2042865|NCT00445848|3613693|FG000|Overall Study|Withdrawal by Subject|4
2042866|NCT00445848|3613693|FG000|Overall Study|Progression|62
2042867|NCT00445848|3613693|FG000|Overall Study|Other-Not protocol specified|5
2042868|NCT00445939|3613719|FG000|Period A - Week 0 - Week 4|Adverse Event|1
2042869|NCT00445939|3613720|FG001|Period A - Week 0 - Week 4|Adverse Event|2
2042870|NCT00445939|3613721|FG002|Period A - Week 0 - Week 4|Adverse Event|0
2042871|NCT00445939|3613722|FG003|Period A - Week 0 - Week 4|Adverse Event|0
2042872|NCT00445939|3613719|FG000|Period B - Week 4 - Week 8|Adverse Event|2
2042873|NCT00445939|3613720|FG001|Period B - Week 4 - Week 8|Adverse Event|0
2042874|NCT00445939|3613721|FG002|Period B - Week 4 - Week 8|Adverse Event|0
2042875|NCT00445939|3613722|FG003|Period B - Week 4 - Week 8|Adverse Event|1
2042876|NCT00445978|3613742|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1
2042877|NCT00445978|3613742|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1
2042878|NCT00445978|3613742|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1
2042879|NCT00445978|3613742|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1
2042880|NCT00445978|3613742|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1
2042881|NCT00445978|3613742|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1
2042882|NCT00445978|3613742|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1
2042883|NCT00445978|3613742|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1
2042884|NCT00445978|3613742|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1
2042885|NCT00446030|3613755|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29
2042886|NCT00446030|3613756|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8
2042887|NCT00446030|3613755|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9
2042888|NCT00446030|3613756|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1
2042889|NCT00446030|3613755|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1
2042890|NCT00446030|3613756|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0
2042891|NCT00446030|3613755|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
2042892|NCT00446030|3613756|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
2042893|NCT00446030|3613755|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1
2042894|NCT00446030|3613756|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0
2042895|NCT00446030|3613755|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1
2042896|NCT00446030|3613756|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0
2042897|NCT00446030|3613755|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1
2042898|NCT00446030|3613756|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0
2042899|NCT00446030|3613755|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
2042900|NCT00446030|3613756|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
2042901|NCT00446030|3613755|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9
2042902|NCT00446030|3613756|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4
2042903|NCT00446030|3613755|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
2042904|NCT00446030|3613756|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
2042905|NCT00446030|3613755|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
2042906|NCT00446030|3613756|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
2042907|NCT00446030|3613755|FG000|FOLLOW-UP (up to 2-years)|Death|2
2042908|NCT00446030|3613756|FG001|FOLLOW-UP (up to 2-years)|Death|2
2042909|NCT00446030|3613755|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
2042910|NCT00446030|3613756|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
2042911|NCT00446030|3613755|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
2042912|NCT00446030|3613756|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
2042913|NCT00446030|3613755|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2
2042914|NCT00446030|3613756|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0
2042915|NCT00446030|3613755|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1
2042916|NCT00446030|3613756|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0
2042917|NCT00446030|3613755|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1
2208408|NCT01640288|3848089|FG000|Overall Study|Screen Failure|20
2208409|NCT01640288|3848090|FG001|Overall Study|Screen Failure|18
2208410|NCT01640288|3848089|FG000|Overall Study|Withdrawn by PI|5
2208411|NCT01640288|3848090|FG001|Overall Study|Withdrawn by PI|0
2208412|NCT01640288|3848089|FG000|Overall Study|Withdrawal by Subject|1
2208413|NCT01640288|3848090|FG001|Overall Study|Withdrawal by Subject|0
2208414|NCT01640314|3848099|FG000|Overall Study|Protocol Violation|0
2208415|NCT01640314|3848100|FG001|Overall Study|Protocol Violation|1
2208416|NCT01640353|3848124|FG000|Overall Study|Withdrew prior to treatment|10
2208417|NCT01640353|3848124|FG000|Overall Study|Withdrawn from analysis at term site|12
2208418|NCT01640353|3848124|FG000|Overall Study|Withdrawal by Subject|5
2208419|NCT01640353|3848124|FG000|Overall Study|Death|2
2042918|NCT00446030|3613756|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0
2042919|NCT00446030|3613755|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1
2042920|NCT00446030|3613756|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0
2042921|NCT00446030|3613755|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
2042922|NCT00446030|3613756|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
2042923|NCT00446095|3613767|FG000|Phase II (8 Weeks)|Lost to Follow-up|1
2208420|NCT01640353|3848124|FG000|Overall Study|Early site termination|3
2042924|NCT00446095|3613768|FG001|Phase II (8 Weeks)|Lost to Follow-up|0
2042925|NCT00446095|3613769|FG002|Phase II (8 Weeks)|Lost to Follow-up|0
2042926|NCT00446095|3613770|FG003|Phase II (8 Weeks)|Lost to Follow-up|0
2042927|NCT00446095|3613771|FG004|Phase II (8 Weeks)|Lost to Follow-up|0
2042928|NCT00446095|3613767|FG000|Phase II (8 Weeks)|Adverse Event|0
2042929|NCT00446095|3613768|FG001|Phase II (8 Weeks)|Adverse Event|1
2042930|NCT00446095|3613769|FG002|Phase II (8 Weeks)|Adverse Event|1
2042931|NCT00446095|3613770|FG003|Phase II (8 Weeks)|Adverse Event|0
2042932|NCT00446095|3613771|FG004|Phase II (8 Weeks)|Adverse Event|0
2042933|NCT00446095|3613767|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1
2042934|NCT00446095|3613768|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0
2042935|NCT00446095|3613769|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0
2042936|NCT00446095|3613770|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0
2042937|NCT00446095|3613771|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0
2042938|NCT00446095|3613767|FG000|Phase II (8 Weeks)|Physician Decision|1
2042939|NCT00446095|3613768|FG001|Phase II (8 Weeks)|Physician Decision|0
2042940|NCT00446095|3613769|FG002|Phase II (8 Weeks)|Physician Decision|0
2042941|NCT00446095|3613770|FG003|Phase II (8 Weeks)|Physician Decision|0
2042942|NCT00446095|3613771|FG004|Phase II (8 Weeks)|Physician Decision|0
2042943|NCT00446095|3613767|FG000|Phase II (8 Weeks)|Lack of Efficacy|9
2042944|NCT00446095|3613768|FG001|Phase II (8 Weeks)|Lack of Efficacy|2
2042945|NCT00446095|3613769|FG002|Phase II (8 Weeks)|Lack of Efficacy|1
2042946|NCT00446095|3613770|FG003|Phase II (8 Weeks)|Lack of Efficacy|0
2042947|NCT00446095|3613771|FG004|Phase II (8 Weeks)|Lack of Efficacy|0
2042948|NCT00446095|3613767|FG000|Phase II (8 Weeks)|Ongoing|0
2042949|NCT00446095|3613768|FG001|Phase II (8 Weeks)|Ongoing|0
2042950|NCT00446095|3613769|FG002|Phase II (8 Weeks)|Ongoing|1
2042951|NCT00446095|3613770|FG003|Phase II (8 Weeks)|Ongoing|0
2042952|NCT00446095|3613771|FG004|Phase II (8 Weeks)|Ongoing|0
2042953|NCT00446095|3613767|FG000|Phase I (28 Days)|Adverse Event|0
2042954|NCT00446095|3613768|FG001|Phase I (28 Days)|Adverse Event|0
2042955|NCT00446095|3613769|FG002|Phase I (28 Days)|Adverse Event|0
2042956|NCT00446095|3613770|FG003|Phase I (28 Days)|Adverse Event|1
2042957|NCT00446095|3613771|FG004|Phase I (28 Days)|Adverse Event|0
2042958|NCT00446095|3613767|FG000|Phase I (28 Days)|Lack of Efficacy|0
2042959|NCT00446095|3613768|FG001|Phase I (28 Days)|Lack of Efficacy|0
2042960|NCT00446095|3613769|FG002|Phase I (28 Days)|Lack of Efficacy|0
2042961|NCT00446095|3613770|FG003|Phase I (28 Days)|Lack of Efficacy|0
2042962|NCT00446095|3613771|FG004|Phase I (28 Days)|Lack of Efficacy|3
2042963|NCT00446134|3613786|FG000|Overall Study|Adverse Event|7
2042964|NCT00446134|3613787|FG001|Overall Study|Adverse Event|17
2042965|NCT00446134|3613788|FG002|Overall Study|Adverse Event|13
2042966|NCT00446134|3613789|FG003|Overall Study|Adverse Event|18
2042967|NCT00446134|3613786|FG000|Overall Study|Lack of Efficacy|19
2042968|NCT00446134|3613787|FG001|Overall Study|Lack of Efficacy|19
2042969|NCT00446134|3613788|FG002|Overall Study|Lack of Efficacy|24
2042970|NCT00446134|3613789|FG003|Overall Study|Lack of Efficacy|19
2042971|NCT00446134|3613786|FG000|Overall Study|Protocol Violation|0
2042972|NCT00446134|3613787|FG001|Overall Study|Protocol Violation|2
2042973|NCT00446134|3613788|FG002|Overall Study|Protocol Violation|1
2042974|NCT00446134|3613789|FG003|Overall Study|Protocol Violation|0
2042975|NCT00446134|3613786|FG000|Overall Study|Lost to Follow-up|1
2042976|NCT00446134|3613787|FG001|Overall Study|Lost to Follow-up|3
2042977|NCT00446134|3613788|FG002|Overall Study|Lost to Follow-up|1
2042978|NCT00446134|3613789|FG003|Overall Study|Lost to Follow-up|1
2042979|NCT00446134|3613786|FG000|Overall Study|Withdrawal by Subject|3
2042980|NCT00446134|3613787|FG001|Overall Study|Withdrawal by Subject|3
2042981|NCT00446134|3613788|FG002|Overall Study|Withdrawal by Subject|1
2042982|NCT00446134|3613789|FG003|Overall Study|Withdrawal by Subject|3
2208421|NCT01640353|3848124|FG000|Overall Study|Lost to Follow-up|12
2208422|NCT01640353|3848124|FG000|Overall Study|Physician Decision|1
2208423|NCT01640366|3848128|FG000|Overall Study|Withdrawal by Subject|1
2208424|NCT01640366|3848128|FG000|Overall Study|Protocol Violation|16
2042983|NCT00446134|3613786|FG000|Overall Study|Physician Decision|0
2042984|NCT00446134|3613787|FG001|Overall Study|Physician Decision|0
2042985|NCT00446134|3613788|FG002|Overall Study|Physician Decision|0
2042986|NCT00446134|3613789|FG003|Overall Study|Physician Decision|2
2208425|NCT01640366|3848128|FG000|Overall Study|Lost to Follow-up|5
2208426|NCT01640808|3848150|FG000|Overall Study|Unable to continue dynamic CT|14
2208427|NCT01640808|3848151|FG001|Overall Study|Unable to continue dynamic CT|4
2208428|NCT01640808|3848150|FG000|Overall Study|Withdrawal by Subject|12
2208429|NCT01640808|3848151|FG001|Overall Study|Withdrawal by Subject|4
2208430|NCT01640808|3848150|FG000|Overall Study|Lost to Follow-up|4
2208431|NCT01640808|3848151|FG001|Overall Study|Lost to Follow-up|0
2208432|NCT01640808|3848150|FG000|Overall Study|Start an antiviral therapy using IFN|3
2208433|NCT01640808|3848151|FG001|Overall Study|Start an antiviral therapy using IFN|0
2208434|NCT01640808|3848150|FG000|Overall Study|Administration of anticancer drugs|2
2208435|NCT01640808|3848151|FG001|Overall Study|Administration of anticancer drugs|1
2208436|NCT01640808|3848150|FG000|Overall Study|Physician Decision|19
2208437|NCT01640808|3848151|FG001|Overall Study|Physician Decision|5
2208438|NCT01640808|3848150|FG000|Overall Study|Randomized but not treated|4
2208439|NCT01640808|3848151|FG001|Overall Study|Randomized but not treated|2
2208440|NCT01640873|3848174|FG000|Overall Study|Protocol Violation|2
2208441|NCT01640873|3848175|FG001|Overall Study|Protocol Violation|1
2208442|NCT01640925|3848183|FG000|Overall Study|Withdrawal by Subject|1
2208443|NCT01640925|3848184|FG001|Overall Study|Withdrawal by Subject|0
2208444|NCT01640925|3848183|FG000|Overall Study|Previously enrolled in this trial|13
2208445|NCT01640925|3848184|FG001|Overall Study|Previously enrolled in this trial|11
2208446|NCT01640951|3848198|FG000|Overall Study|Adverse Event|8
2208447|NCT01640951|3848199|FG001|Overall Study|Adverse Event|3
2208448|NCT01640951|3848200|FG002|Overall Study|Adverse Event|10
2208449|NCT01640951|3848201|FG003|Overall Study|Adverse Event|6
2208450|NCT01640951|3848202|FG004|Overall Study|Adverse Event|1
2208451|NCT01640951|3848203|FG005|Overall Study|Adverse Event|11
2208452|NCT01640951|3848204|FG006|Overall Study|Adverse Event|1
2208453|NCT01640951|3848205|FG007|Overall Study|Adverse Event|3
2208454|NCT01640951|3848198|FG000|Overall Study|Lack of Efficacy|20
2208455|NCT01640951|3848199|FG001|Overall Study|Lack of Efficacy|1
2208456|NCT01640951|3848200|FG002|Overall Study|Lack of Efficacy|7
2208457|NCT01640951|3848201|FG003|Overall Study|Lack of Efficacy|14
2208458|NCT01640951|3848202|FG004|Overall Study|Lack of Efficacy|0
2208459|NCT01640951|3848203|FG005|Overall Study|Lack of Efficacy|6
2208460|NCT01640951|3848204|FG006|Overall Study|Lack of Efficacy|5
2208461|NCT01640951|3848205|FG007|Overall Study|Lack of Efficacy|6
2208462|NCT01640951|3848198|FG000|Overall Study|Lost to Follow-up|1
2208463|NCT01640951|3848199|FG001|Overall Study|Lost to Follow-up|0
2208464|NCT01640951|3848200|FG002|Overall Study|Lost to Follow-up|6
2208465|NCT01640951|3848201|FG003|Overall Study|Lost to Follow-up|2
2042987|NCT00446134|3613786|FG000|Overall Study|Adverse Event-Diarrhea|1
2042988|NCT00446134|3613787|FG001|Overall Study|Adverse Event-Diarrhea|1
2042989|NCT00446134|3613788|FG002|Overall Study|Adverse Event-Diarrhea|2
2042990|NCT00446134|3613789|FG003|Overall Study|Adverse Event-Diarrhea|0
2042991|NCT00446134|3613786|FG000|Overall Study|Reason Not Completed|3
2042992|NCT00446134|3613787|FG001|Overall Study|Reason Not Completed|0
2042993|NCT00446134|3613788|FG002|Overall Study|Reason Not Completed|1
2042994|NCT00446134|3613789|FG003|Overall Study|Reason Not Completed|2
2042995|NCT00446199|3613812|FG000|Overall Study|Adverse Event|7
2042996|NCT00446199|3613813|FG001|Overall Study|Adverse Event|4
2042997|NCT00446199|3613814|FG002|Overall Study|Adverse Event|6
2042998|NCT00446199|3613815|FG003|Overall Study|Adverse Event|4
2042999|NCT00446199|3613812|FG000|Overall Study|Lost to Follow-up|4
2043000|NCT00446199|3613813|FG001|Overall Study|Lost to Follow-up|5
2043001|NCT00446199|3613814|FG002|Overall Study|Lost to Follow-up|2
2043002|NCT00446199|3613815|FG003|Overall Study|Lost to Follow-up|6
2043003|NCT00446199|3613812|FG000|Overall Study|Protocol Violation|1
2043004|NCT00446199|3613813|FG001|Overall Study|Protocol Violation|2
2043005|NCT00446199|3613814|FG002|Overall Study|Protocol Violation|1
2043006|NCT00446199|3613815|FG003|Overall Study|Protocol Violation|3
2043007|NCT00446199|3613812|FG000|Overall Study|Withdrawal by Subject|2
2043008|NCT00446199|3613813|FG001|Overall Study|Withdrawal by Subject|5
2298161|NCT02574078|3994896|FG007|Treatment Period|Adverse event unrelated to drug|0
2298162|NCT02574078|3994897|FG008|Treatment Period|Adverse event unrelated to drug|1
2298163|NCT02574078|3994898|FG009|Treatment Period|Adverse event unrelated to drug|2
2298164|NCT02574078|3994899|FG010|Treatment Period|Adverse event unrelated to drug|4
2298165|NCT02574078|3994900|FG011|Treatment Period|Adverse event unrelated to drug|1
2298166|NCT02574078|3994901|FG012|Treatment Period|Adverse event unrelated to drug|0
2298167|NCT02574078|3994889|FG000|Treatment Period|Administrative reason by Sponsor|0
2298168|NCT02574078|3994890|FG001|Treatment Period|Administrative reason by Sponsor|1
2298169|NCT02574078|3994891|FG002|Treatment Period|Administrative reason by Sponsor|0
2298170|NCT02574078|3994892|FG003|Treatment Period|Administrative reason by Sponsor|0
2298171|NCT02574078|3994893|FG004|Treatment Period|Administrative reason by Sponsor|0
2298172|NCT02574078|3994894|FG005|Treatment Period|Administrative reason by Sponsor|0
2298173|NCT02574078|3994895|FG006|Treatment Period|Administrative reason by Sponsor|1
2298174|NCT02574078|3994896|FG007|Treatment Period|Administrative reason by Sponsor|0
2298175|NCT02574078|3994897|FG008|Treatment Period|Administrative reason by Sponsor|0
2298176|NCT02574078|3994898|FG009|Treatment Period|Administrative reason by Sponsor|0
2298177|NCT02574078|3994899|FG010|Treatment Period|Administrative reason by Sponsor|0
2298178|NCT02574078|3994900|FG011|Treatment Period|Administrative reason by Sponsor|0
2298179|NCT02574078|3994901|FG012|Treatment Period|Administrative reason by Sponsor|3
2298180|NCT02574078|3994889|FG000|Treatment Period|Other reasons|1
2298181|NCT02574078|3994890|FG001|Treatment Period|Other reasons|0
2208466|NCT01640951|3848202|FG004|Overall Study|Lost to Follow-up|2
2208467|NCT01640951|3848203|FG005|Overall Study|Lost to Follow-up|3
2208468|NCT01640951|3848204|FG006|Overall Study|Lost to Follow-up|1
2208469|NCT01640951|3848205|FG007|Overall Study|Lost to Follow-up|1
2208470|NCT01640951|3848198|FG000|Overall Study|Non-compliance with study treatment|0
2208471|NCT01640951|3848199|FG001|Overall Study|Non-compliance with study treatment|0
2208472|NCT01640951|3848200|FG002|Overall Study|Non-compliance with study treatment|1
2208473|NCT01640951|3848201|FG003|Overall Study|Non-compliance with study treatment|1
2208474|NCT01640951|3848202|FG004|Overall Study|Non-compliance with study treatment|1
2208475|NCT01640951|3848203|FG005|Overall Study|Non-compliance with study treatment|4
2208476|NCT01640951|3848204|FG006|Overall Study|Non-compliance with study treatment|1
2208477|NCT01640951|3848205|FG007|Overall Study|Non-compliance with study treatment|0
2208478|NCT01640951|3848198|FG000|Overall Study|Physician Decision|2
2208479|NCT01640951|3848199|FG001|Overall Study|Physician Decision|5
2208480|NCT01640951|3848200|FG002|Overall Study|Physician Decision|2
2208481|NCT01640951|3848201|FG003|Overall Study|Physician Decision|2
2208482|NCT01640951|3848202|FG004|Overall Study|Physician Decision|2
2208483|NCT01640951|3848203|FG005|Overall Study|Physician Decision|3
2208484|NCT01640951|3848204|FG006|Overall Study|Physician Decision|3
2208485|NCT01640951|3848205|FG007|Overall Study|Physician Decision|0
2208486|NCT01640951|3848198|FG000|Overall Study|Pregnancy|3
2208487|NCT01640951|3848199|FG001|Overall Study|Pregnancy|0
2208488|NCT01640951|3848200|FG002|Overall Study|Pregnancy|0
2208489|NCT01640951|3848201|FG003|Overall Study|Pregnancy|4
2208490|NCT01640951|3848202|FG004|Overall Study|Pregnancy|0
2208491|NCT01640951|3848203|FG005|Overall Study|Pregnancy|0
2208492|NCT01640951|3848204|FG006|Overall Study|Pregnancy|2
2208493|NCT01640951|3848205|FG007|Overall Study|Pregnancy|0
2208494|NCT01640951|3848198|FG000|Overall Study|Protocol Deviation|0
2208495|NCT01640951|3848199|FG001|Overall Study|Protocol Deviation|1
2208496|NCT01640951|3848200|FG002|Overall Study|Protocol Deviation|2
2208497|NCT01640951|3848201|FG003|Overall Study|Protocol Deviation|1
2208498|NCT01640951|3848202|FG004|Overall Study|Protocol Deviation|0
2208499|NCT01640951|3848203|FG005|Overall Study|Protocol Deviation|1
2208500|NCT01640951|3848204|FG006|Overall Study|Protocol Deviation|0
2208501|NCT01640951|3848205|FG007|Overall Study|Protocol Deviation|0
2208502|NCT01640951|3848198|FG000|Overall Study|Subject/Guardian decision|12
2208503|NCT01640951|3848199|FG001|Overall Study|Subject/Guardian decision|4
2208504|NCT01640951|3848200|FG002|Overall Study|Subject/Guardian decision|13
2208505|NCT01640951|3848201|FG003|Overall Study|Subject/Guardian decision|15
2208506|NCT01640951|3848202|FG004|Overall Study|Subject/Guardian decision|7
2208507|NCT01640951|3848203|FG005|Overall Study|Subject/Guardian decision|19
2208508|NCT01640951|3848204|FG006|Overall Study|Subject/Guardian decision|5
2208509|NCT01640951|3848205|FG007|Overall Study|Subject/Guardian decision|4
2208510|NCT01640951|3848198|FG000|Overall Study|Death|0
2208511|NCT01640951|3848199|FG001|Overall Study|Death|1
2208512|NCT01640951|3848200|FG002|Overall Study|Death|1
2208513|NCT01640951|3848201|FG003|Overall Study|Death|0
2208514|NCT01640951|3848202|FG004|Overall Study|Death|0
2208515|NCT01640951|3848203|FG005|Overall Study|Death|0
2208516|NCT01640951|3848204|FG006|Overall Study|Death|0
2043009|NCT00446199|3613814|FG002|Overall Study|Withdrawal by Subject|9
2043010|NCT00446199|3613815|FG003|Overall Study|Withdrawal by Subject|10
2043011|NCT00446199|3613812|FG000|Overall Study|Site termination|2
2043012|NCT00446199|3613813|FG001|Overall Study|Site termination|0
2043013|NCT00446199|3613814|FG002|Overall Study|Site termination|0
2043014|NCT00446199|3613815|FG003|Overall Study|Site termination|1
2043015|NCT00446199|3613812|FG000|Overall Study|Randomization in Error|2
2043016|NCT00446199|3613813|FG001|Overall Study|Randomization in Error|0
2043017|NCT00446199|3613814|FG002|Overall Study|Randomization in Error|1
2043018|NCT00446199|3613815|FG003|Overall Study|Randomization in Error|1
2043019|NCT00446199|3613812|FG000|Overall Study|Lack of Efficacy|1
2043020|NCT00446199|3613813|FG001|Overall Study|Lack of Efficacy|0
2208517|NCT01640951|3848205|FG007|Overall Study|Death|2
2208518|NCT01640964|3848228|FG000|Overall Study|Lost to Follow-up|0
2208519|NCT01640964|3848229|FG001|Overall Study|Lost to Follow-up|0
2208520|NCT01640964|3848230|FG002|Overall Study|Lost to Follow-up|1
2208521|NCT01640964|3848228|FG000|Overall Study|Protocol Deviation|1
2208522|NCT01640964|3848229|FG001|Overall Study|Protocol Deviation|1
2208523|NCT01640964|3848230|FG002|Overall Study|Protocol Deviation|2
2208524|NCT01641081|3848248|FG000|Period 1|Sponsor request (potential unblinding)|0
2208525|NCT01641081|3848249|FG001|Period 1|Sponsor request (potential unblinding)|0
2208526|NCT01641081|3848250|FG002|Period 1|Sponsor request (potential unblinding)|0
2208527|NCT01641081|3848251|FG003|Period 1|Sponsor request (potential unblinding)|0
2208528|NCT01641081|3848252|FG004|Period 1|Sponsor request (potential unblinding)|0
2208529|NCT01641081|3848253|FG005|Period 1|Sponsor request (potential unblinding)|0
2208530|NCT01641081|3848254|FG006|Period 1|Sponsor request (potential unblinding)|1
2208531|NCT01641081|3848255|FG007|Period 1|Sponsor request (potential unblinding)|0
2208532|NCT01641081|3848256|FG008|Period 1|Sponsor request (potential unblinding)|0
2208533|NCT01641081|3848257|FG009|Period 1|Sponsor request (potential unblinding)|0
2208534|NCT01641081|3848248|FG000|Period 1|Protocol Violation|0
2208535|NCT01641081|3848249|FG001|Period 1|Protocol Violation|0
2208536|NCT01641081|3848250|FG002|Period 1|Protocol Violation|0
2208537|NCT01641081|3848251|FG003|Period 1|Protocol Violation|0
2208538|NCT01641081|3848252|FG004|Period 1|Protocol Violation|1
2208539|NCT01641081|3848253|FG005|Period 1|Protocol Violation|0
2208540|NCT01641081|3848254|FG006|Period 1|Protocol Violation|0
2208541|NCT01641081|3848255|FG007|Period 1|Protocol Violation|1
2208542|NCT01641081|3848256|FG008|Period 1|Protocol Violation|0
2208543|NCT01641081|3848257|FG009|Period 1|Protocol Violation|0
2208544|NCT01641081|3848248|FG000|Period 1|Adverse Event|1
2208545|NCT01641081|3848249|FG001|Period 1|Adverse Event|0
2208546|NCT01641081|3848250|FG002|Period 1|Adverse Event|0
2208547|NCT01641081|3848251|FG003|Period 1|Adverse Event|0
2208548|NCT01641081|3848252|FG004|Period 1|Adverse Event|0
2208549|NCT01641081|3848253|FG005|Period 1|Adverse Event|0
2208550|NCT01641081|3848254|FG006|Period 1|Adverse Event|0
2208551|NCT01641081|3848255|FG007|Period 1|Adverse Event|2
2208552|NCT01641081|3848256|FG008|Period 1|Adverse Event|0
2208553|NCT01641081|3848257|FG009|Period 1|Adverse Event|0
2208554|NCT01641081|3848248|FG000|Period 2|Adverse Event|0
2208555|NCT01641081|3848249|FG001|Period 2|Adverse Event|0
2208556|NCT01641081|3848250|FG002|Period 2|Adverse Event|0
2208557|NCT01641081|3848251|FG003|Period 2|Adverse Event|0
2208558|NCT01641081|3848252|FG004|Period 2|Adverse Event|0
2208559|NCT01641081|3848253|FG005|Period 2|Adverse Event|1
2208560|NCT01641081|3848254|FG006|Period 2|Adverse Event|0
2208561|NCT01641081|3848255|FG007|Period 2|Adverse Event|0
2208562|NCT01641081|3848256|FG008|Period 2|Adverse Event|0
2208563|NCT01641081|3848257|FG009|Period 2|Adverse Event|0
2208564|NCT01641081|3848248|FG000|Period 2|Withdrawal by Subject|0
2208565|NCT01641081|3848249|FG001|Period 2|Withdrawal by Subject|0
2208566|NCT01641081|3848250|FG002|Period 2|Withdrawal by Subject|0
2208567|NCT01641081|3848251|FG003|Period 2|Withdrawal by Subject|1
2019419|NCT00298272|3586738|FG000|Double-blind Phase|Failure to Return|2
2019420|NCT00298272|3586739|FG001|Double-blind Phase|Failure to Return|0
2019421|NCT00298272|3586738|FG000|Double-blind Phase|Protocol Violation|2
2019422|NCT00298272|3586739|FG001|Double-blind Phase|Protocol Violation|0
2019423|NCT00298272|3586738|FG000|Double-blind Phase|Withdrawal by Subject|2
2019424|NCT00298272|3586739|FG001|Double-blind Phase|Withdrawal by Subject|0
2019425|NCT00298272|3586738|FG000|Open Label Retreatment Phase|Adverse Event|1
2019426|NCT00298272|3586739|FG001|Open Label Retreatment Phase|Adverse Event|2
2019427|NCT00298272|3586738|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
2043021|NCT00446199|3613814|FG002|Overall Study|Lack of Efficacy|0
2043022|NCT00446199|3613815|FG003|Overall Study|Lack of Efficacy|1
2043023|NCT00446199|3613812|FG000|Overall Study|Non-compliant with study drug|1
2043024|NCT00446199|3613813|FG001|Overall Study|Non-compliant with study drug|0
2043025|NCT00446199|3613814|FG002|Overall Study|Non-compliant with study drug|5
2208568|NCT01641081|3848252|FG004|Period 2|Withdrawal by Subject|0
2208569|NCT01641081|3848253|FG005|Period 2|Withdrawal by Subject|0
2208570|NCT01641081|3848254|FG006|Period 2|Withdrawal by Subject|2
2208571|NCT01641081|3848255|FG007|Period 2|Withdrawal by Subject|0
2208572|NCT01641081|3848256|FG008|Period 2|Withdrawal by Subject|0
2208573|NCT01641081|3848257|FG009|Period 2|Withdrawal by Subject|0
2208574|NCT01641081|3848248|FG000|Period 2|Protocol Violation|1
2019428|NCT00298272|3586739|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
2019429|NCT00298272|3586738|FG000|Open Label Retreatment Phase|Failure to Return|1
2019430|NCT00298272|3586739|FG001|Open Label Retreatment Phase|Failure to Return|0
2043026|NCT00446199|3613815|FG003|Overall Study|Non-compliant with study drug|0
2043027|NCT00446199|3613812|FG000|Overall Study|Non-compliant with visit schedule|1
2043028|NCT00446199|3613813|FG001|Overall Study|Non-compliant with visit schedule|1
2043029|NCT00446199|3613814|FG002|Overall Study|Non-compliant with visit schedule|1
2043030|NCT00446199|3613815|FG003|Overall Study|Non-compliant with visit schedule|2
2043031|NCT00446199|3613812|FG000|Overall Study|Hormone fear|0
2043032|NCT00446199|3613813|FG001|Overall Study|Hormone fear|0
2043033|NCT00446199|3613814|FG002|Overall Study|Hormone fear|0
2043034|NCT00446199|3613815|FG003|Overall Study|Hormone fear|1
2043035|NCT00446199|3613812|FG000|Overall Study|Lost interest in study participation|0
2043036|NCT00446199|3613813|FG001|Overall Study|Lost interest in study participation|1
2043037|NCT00446199|3613814|FG002|Overall Study|Lost interest in study participation|0
2043038|NCT00446199|3613815|FG003|Overall Study|Lost interest in study participation|0
2043039|NCT00446199|3613812|FG000|Overall Study|In-/Exclusion criterion violated|2
2043040|NCT00446199|3613813|FG001|Overall Study|In-/Exclusion criterion violated|1
2043041|NCT00446199|3613814|FG002|Overall Study|In-/Exclusion criterion violated|2
2043042|NCT00446199|3613815|FG003|Overall Study|In-/Exclusion criterion violated|1
2043043|NCT00446199|3613812|FG000|Overall Study|Move|0
2043044|NCT00446199|3613813|FG001|Overall Study|Move|1
2043045|NCT00446199|3613814|FG002|Overall Study|Move|0
2043046|NCT00446199|3613815|FG003|Overall Study|Move|0
2043047|NCT00446251|3613825|FG000|Overall Study|On-study Transplants|2
2043048|NCT00446251|3613825|FG000|Overall Study|Rituximab Infusion Reaction|2
2043049|NCT00446251|3613825|FG000|Overall Study|Lost to Follow-up|1
2043050|NCT00446446|3613837|FG000|Overall Study|Death|10
2043051|NCT00446446|3613837|FG000|Overall Study|Withdrawal by Subject|6
2043052|NCT00446446|3613837|FG000|Overall Study|Other|4
2043053|NCT00446446|3613837|FG000|Overall Study|Disease Progession|2
2043054|NCT00446446|3613837|FG000|Overall Study|Adverse Event|1
2043055|NCT00446446|3613837|FG000|Overall Study|On Treatment at Time of Data Cut-off|1
2043056|NCT00446459|3613841|FG000|8 Months|Protocol Violation|12
2043057|NCT00446459|3613841|FG000|12 Months|Protocol Violation|4
2043058|NCT00446459|3613841|FG000|12 Months|14 subjects to MMF + Rituximab Study|14
2043059|NCT00446511|3613849|FG000|Overall Study|Adverse Event|7
2043060|NCT00446511|3613850|FG001|Overall Study|Adverse Event|2
2043061|NCT00446511|3613851|FG002|Overall Study|Adverse Event|3
2043062|NCT00446511|3613852|FG003|Overall Study|Adverse Event|1
2043063|NCT00446511|3613849|FG000|Overall Study|Protocol Violation|0
2043064|NCT00446511|3613850|FG001|Overall Study|Protocol Violation|0
2043065|NCT00446511|3613851|FG002|Overall Study|Protocol Violation|0
2043066|NCT00446511|3613852|FG003|Overall Study|Protocol Violation|1
2043067|NCT00446511|3613849|FG000|Overall Study|Withdrawal by Subject|0
2043068|NCT00446511|3613850|FG001|Overall Study|Withdrawal by Subject|0
2043069|NCT00446511|3613851|FG002|Overall Study|Withdrawal by Subject|0
2043070|NCT00446511|3613852|FG003|Overall Study|Withdrawal by Subject|3
2043071|NCT00446511|3613849|FG000|Overall Study|Administrative Problems|3
2043072|NCT00446511|3613850|FG001|Overall Study|Administrative Problems|0
2043073|NCT00446511|3613851|FG002|Overall Study|Administrative Problems|4
2043074|NCT00446511|3613852|FG003|Overall Study|Administrative Problems|1
2043075|NCT00446550|3613866|FG000|Overall Study|Adverse Event|1
2043076|NCT00446550|3613867|FG001|Overall Study|Adverse Event|0
2043077|NCT00446563|3613876|FG000|Overall Study|Adverse Event|4
2043078|NCT00446563|3613877|FG001|Overall Study|Adverse Event|3
2043079|NCT00446563|3613876|FG000|Overall Study|Abnormal laboratory value(s)|0
2043080|NCT00446563|3613877|FG001|Overall Study|Abnormal laboratory value(s)|1
2043081|NCT00446563|3613876|FG000|Overall Study|Abnormal test procedure result(s)|1
2043082|NCT00446563|3613877|FG001|Overall Study|Abnormal test procedure result(s)|0
2043083|NCT00446563|3613876|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2043084|NCT00446563|3613877|FG001|Overall Study|Unsatisfactory therapeutic effect|3
2043085|NCT00446563|3613876|FG000|Overall Study|Withdrawal by Subject|2
2043086|NCT00446563|3613877|FG001|Overall Study|Withdrawal by Subject|1
2043087|NCT00446563|3613876|FG000|Overall Study|Administrative problems|0
2043088|NCT00446563|3613877|FG001|Overall Study|Administrative problems|1
2043089|NCT00446641|3613885|FG000|Overall Study|Withdrawal by Subject|8
2043090|NCT00446641|3613886|FG001|Overall Study|Withdrawal by Subject|3
2043091|NCT00446641|3613885|FG000|Overall Study|poor compliance|8
2026050|NCT00348283|3594714|FG000|Open Label|Adverse Event|0
2026051|NCT00348283|3594715|FG001|Open Label|Adverse Event|8
2026052|NCT00348283|3594714|FG000|Open Label|Withdrawal by Subject|0
2043092|NCT00446641|3613886|FG001|Overall Study|poor compliance|6
2043093|NCT00446641|3613885|FG000|Overall Study|Lost to Follow-up|1
2043094|NCT00446641|3613886|FG001|Overall Study|Lost to Follow-up|1
2043095|NCT00446654|3613894|FG000|Overall Study|Withdrawal by Subject|1
2043096|NCT00446654|3613895|FG001|Overall Study|Withdrawal by Subject|0
2043097|NCT00446654|3613894|FG000|Overall Study|Adverse Event|1
2043098|NCT00446654|3613895|FG001|Overall Study|Adverse Event|0
2043099|NCT00446797|3613903|FG000|Overall Study|Lack of Efficacy|0
2043100|NCT00446797|3613904|FG001|Overall Study|Lack of Efficacy|2
2043101|NCT00446797|3613903|FG000|Overall Study|Lost to Follow-up|5
2043102|NCT00446797|3613904|FG001|Overall Study|Lost to Follow-up|3
2043103|NCT00446797|3613903|FG000|Overall Study|Withdrawal by Subject|2
2043104|NCT00446797|3613904|FG001|Overall Study|Withdrawal by Subject|2
2043105|NCT00446797|3613903|FG000|Overall Study|Protocol Violation|1
2043106|NCT00446797|3613904|FG001|Overall Study|Protocol Violation|3
2043107|NCT00446797|3613903|FG000|Overall Study|subject entered at another site|0
2043108|NCT00446797|3613904|FG001|Overall Study|subject entered at another site|1
2043109|NCT00446797|3613903|FG000|Overall Study|did not meet entrance criteria|0
2043110|NCT00446797|3613904|FG001|Overall Study|did not meet entrance criteria|1
2043111|NCT00446849|3613910|FG000|Acute Phase|Lack of Efficacy|64
2043112|NCT00446849|3613910|FG000|Acute Phase|Protocol Violation|10
2043113|NCT00446849|3613910|FG000|Acute Phase|Consent withdrawn|4
2043114|NCT00446849|3613910|FG000|Acute Phase|Lost to Follow-up|2
2043115|NCT00446849|3613910|FG000|Acute Phase|Physician Decision|1
2043116|NCT00446849|3613910|FG000|Acute Phase|noncompliance|1
2043117|NCT00446849|3613910|FG000|Maintenance Phase|Lack of Efficacy|40
2043118|NCT00446849|3613910|FG000|Maintenance Phase|Protocol Violation|7
2043119|NCT00446849|3613910|FG000|Maintenance Phase|Adverse Event|6
2043120|NCT00446849|3613910|FG000|Maintenance Phase|Consent withdrawn|5
2043121|NCT00446849|3613910|FG000|Maintenance Phase|Lost to Follow-up|3
2043122|NCT00446849|3613910|FG000|Maintenance Phase|Pregnancy|1
2043123|NCT00446849|3613910|FG000|Maintenance Phase|noncompliance|2
2043124|NCT00446849|3613910|FG000|Maintenance Phase|prohibited medication use|2
2043125|NCT00446849|3613910|FG000|Maintenance Phase|antibiotic use|1
2043126|NCT00446849|3613910|FG000|Maintenance Phase|study closure|1
2043127|NCT00446849|3613910|FG000|Maintenance Phase|hydrocodone use|1
2043128|NCT00446849|3613910|FG000|Maintenance Phase|concomitant medication use|1
2043129|NCT00446966|3613917|FG000|Overall Study|Lost to Follow-up|10
2043130|NCT00446966|3613918|FG001|Overall Study|Lost to Follow-up|7
2043131|NCT00446992|3613924|FG000|Overall Study|Adverse Event|11
2043132|NCT00446992|3613924|FG000|Overall Study|Lost to Follow-up|5
2043133|NCT00447005|3613928|FG000|Overall Study|Adverse Event|1
2043134|NCT00447005|3613928|FG000|Overall Study|Lack of Efficacy|11
2043135|NCT00447057|3613936|FG000|Overall Study|Adverse Event|4
2043136|NCT00447057|3613937|FG001|Overall Study|Adverse Event|10
2043137|NCT00447057|3613938|FG002|Overall Study|Adverse Event|0
2043138|NCT00447057|3613939|FG003|Overall Study|Adverse Event|3
2043139|NCT00447057|3613936|FG000|Overall Study|Death due to study disease|6
2177044|NCT01370733|3801046|FG000|Overall Study|Physician Decision|0
2177045|NCT01370733|3801047|FG001|Overall Study|Physician Decision|2
2177046|NCT01370733|3801046|FG000|Overall Study|Protocol Violation|1
2177047|NCT01370733|3801047|FG001|Overall Study|Protocol Violation|3
2177048|NCT01370863|3801068|FG000|Overall Study|Adverse Event|1
2177049|NCT01370863|3801069|FG001|Overall Study|Adverse Event|1
2177050|NCT01370863|3801068|FG000|Overall Study|Did not want second pH/MII monitoring|1
2177051|NCT01370863|3801069|FG001|Overall Study|Did not want second pH/MII monitoring|1
2043140|NCT00447057|3613937|FG001|Overall Study|Death due to study disease|4
2043141|NCT00447057|3613938|FG002|Overall Study|Death due to study disease|1
2043142|NCT00447057|3613939|FG003|Overall Study|Death due to study disease|1
2043143|NCT00447057|3613936|FG000|Overall Study|Lost to Follow-up|0
2043144|NCT00447057|3613937|FG001|Overall Study|Lost to Follow-up|1
2043145|NCT00447057|3613938|FG002|Overall Study|Lost to Follow-up|0
2043146|NCT00447057|3613939|FG003|Overall Study|Lost to Follow-up|0
2043147|NCT00447057|3613936|FG000|Overall Study|Entry criteria not met|1
2043148|NCT00447057|3613937|FG001|Overall Study|Entry criteria not met|1
2043149|NCT00447057|3613938|FG002|Overall Study|Entry criteria not met|0
2043150|NCT00447057|3613939|FG003|Overall Study|Entry criteria not met|0
2043151|NCT00447057|3613936|FG000|Overall Study|Protocol Violation|0
2043152|NCT00447057|3613937|FG001|Overall Study|Protocol Violation|1
2043153|NCT00447057|3613938|FG002|Overall Study|Protocol Violation|0
2043154|NCT00447057|3613939|FG003|Overall Study|Protocol Violation|0
2043155|NCT00447057|3613936|FG000|Overall Study|Withdrawal by Subject|4
2043156|NCT00447057|3613937|FG001|Overall Study|Withdrawal by Subject|5
2177052|NCT01370863|3801068|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
2177053|NCT01370863|3801069|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
2298182|NCT02574078|3994891|FG002|Treatment Period|Other reasons|1
2043157|NCT00447057|3613938|FG002|Overall Study|Withdrawal by Subject|1
2043158|NCT00447057|3613939|FG003|Overall Study|Withdrawal by Subject|1
2043159|NCT00447057|3613936|FG000|Overall Study|Physician Decision|9
2043160|NCT00447057|3613937|FG001|Overall Study|Physician Decision|6
2043161|NCT00447057|3613938|FG002|Overall Study|Physician Decision|3
2043162|NCT00447057|3613939|FG003|Overall Study|Physician Decision|1
2043163|NCT00447057|3613936|FG000|Overall Study|Sponsor decision|1
2043164|NCT00447057|3613937|FG001|Overall Study|Sponsor decision|1
2043165|NCT00447057|3613938|FG002|Overall Study|Sponsor decision|0
2043166|NCT00447057|3613939|FG003|Overall Study|Sponsor decision|0
2043167|NCT00447057|3613936|FG000|Overall Study|Progressive disease|58
2043168|NCT00447057|3613937|FG001|Overall Study|Progressive disease|43
2043169|NCT00447057|3613938|FG002|Overall Study|Progressive disease|13
2043170|NCT00447057|3613939|FG003|Overall Study|Progressive disease|18
2043171|NCT00447057|3613936|FG000|Overall Study|Death due to adverse event|0
2043172|NCT00447057|3613937|FG001|Overall Study|Death due to adverse event|0
2043173|NCT00447057|3613938|FG002|Overall Study|Death due to adverse event|1
2043174|NCT00447057|3613939|FG003|Overall Study|Death due to adverse event|2
2043175|NCT00447057|3613936|FG000|Overall Study|Death, study drug related|0
2043176|NCT00447057|3613937|FG001|Overall Study|Death, study drug related|1
2043177|NCT00447057|3613938|FG002|Overall Study|Death, study drug related|0
2043178|NCT00447057|3613939|FG003|Overall Study|Death, study drug related|0
2043179|NCT00447226|3613964|FG000|12-Week Open-label Phase|Adverse Event|0
2043180|NCT00447226|3613965|FG001|12-Week Open-label Phase|Adverse Event|3
2043181|NCT00447226|3613964|FG000|12-Week Open-label Phase|Protocol Violation|0
2043182|NCT00447226|3613965|FG001|12-Week Open-label Phase|Protocol Violation|1
2043183|NCT00447226|3613964|FG000|12-Week Open-label Phase|Disease Progression|0
2043184|NCT00447226|3613965|FG001|12-Week Open-label Phase|Disease Progression|20
2043185|NCT00447226|3613964|FG000|12-Week Open-label Phase|Physician Decision|0
2298183|NCT02574078|3994892|FG003|Treatment Period|Other reasons|3
2298184|NCT02574078|3994893|FG004|Treatment Period|Other reasons|3
2298185|NCT02574078|3994894|FG005|Treatment Period|Other reasons|1
2298186|NCT02574078|3994895|FG006|Treatment Period|Other reasons|2
2298187|NCT02574078|3994896|FG007|Treatment Period|Other reasons|1
2298188|NCT02574078|3994897|FG008|Treatment Period|Other reasons|3
2298189|NCT02574078|3994898|FG009|Treatment Period|Other reasons|1
2298190|NCT02574078|3994899|FG010|Treatment Period|Other reasons|1
2298191|NCT02574078|3994900|FG011|Treatment Period|Other reasons|3
2298192|NCT02574078|3994901|FG012|Treatment Period|Other reasons|1
2298193|NCT02574078|3994889|FG000|Treatment Period|Participant request to stop drug|0
2298194|NCT02574078|3994890|FG001|Treatment Period|Participant request to stop drug|0
2298195|NCT02574078|3994891|FG002|Treatment Period|Participant request to stop drug|0
2298196|NCT02574078|3994892|FG003|Treatment Period|Participant request to stop drug|2
2298197|NCT02574078|3994893|FG004|Treatment Period|Participant request to stop drug|4
2298198|NCT02574078|3994894|FG005|Treatment Period|Participant request to stop drug|0
2298199|NCT02574078|3994895|FG006|Treatment Period|Participant request to stop drug|1
2043186|NCT00447226|3613965|FG001|12-Week Open-label Phase|Physician Decision|1
2043187|NCT00447226|3613964|FG000|Double-blind Phase|Disease Progression|4
2043188|NCT00447226|3613965|FG001|Double-blind Phase|Disease Progression|3
2043189|NCT00447265|3613980|FG000|Overall Study|Physician Decision|1
2043190|NCT00447265|3613981|FG001|Overall Study|Physician Decision|0
2043191|NCT00447278|3613987|FG000|Period II (6 Month Open-Label)|Adverse Event|7
2043192|NCT00447278|3613988|FG001|Period II (6 Month Open-Label)|Adverse Event|3
2043193|NCT00447278|3613987|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0
2043194|NCT00447278|3613988|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4
2043195|NCT00447278|3613987|FG000|Period II (6 Month Open-Label)|Protocol Violation|10
2043196|NCT00447278|3613988|FG001|Period II (6 Month Open-Label)|Protocol Violation|7
2043197|NCT00447278|3613987|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1
2043198|NCT00447278|3613988|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3
2043199|NCT00447278|3613987|FG000|Period II (6 Month Open-Label)|Physician Decision|4
2043200|NCT00447278|3613988|FG001|Period II (6 Month Open-Label)|Physician Decision|1
2043201|NCT00447278|3613987|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11
2043202|NCT00447278|3613988|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1
2043203|NCT00447278|3613987|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
2043204|NCT00447278|3613988|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
2043205|NCT00447278|3613987|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2
2043206|NCT00447278|3613988|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2
2043207|NCT00447278|3613987|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
2043208|NCT00447278|3613988|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
2043209|NCT00447278|3613987|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6
2043210|NCT00447278|3613988|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1
2043211|NCT00447278|3613987|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
2043212|NCT00447278|3613988|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
2043213|NCT00447278|3613987|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1
2043214|NCT00447278|3613988|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1
2043215|NCT00447278|3613987|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
2043216|NCT00447278|3613988|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
2043217|NCT00447278|3613987|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
2043218|NCT00447278|3613988|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
2043219|NCT00447382|3614002|FG000|Overall Study|Adverse Event|1
2043220|NCT00447382|3614003|FG001|Overall Study|Adverse Event|1
2043221|NCT00447382|3614002|FG000|Overall Study|Lack of Efficacy|1
2043222|NCT00447382|3614003|FG001|Overall Study|Lack of Efficacy|0
2043223|NCT00447382|3614002|FG000|Overall Study|Protocol Violation|2
2043224|NCT00447382|3614003|FG001|Overall Study|Protocol Violation|0
2043225|NCT00447382|3614002|FG000|Overall Study|Unclassified|2
2043226|NCT00447382|3614003|FG001|Overall Study|Unclassified|5
2043227|NCT00447499|3614009|FG000|Overall Study|Adverse Event|1
2043228|NCT00447499|3614009|FG000|Overall Study|Patient Decision|4
2043229|NCT00447499|3614009|FG000|Overall Study|Sponsor Decision|1
2043230|NCT00447499|3614009|FG000|Overall Study|Physician Decision|1
2043231|NCT00447590|3614015|FG000|Overall Study|Withdrawal by Subject|26
2043232|NCT00447590|3614015|FG000|Overall Study|Lost to Follow-up|24
2043233|NCT00447590|3614015|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
2043234|NCT00447694|3614019|FG000|Overall Study|Adverse Event|2
2043235|NCT00447694|3614019|FG000|Overall Study|Abnormal laboratory value|1
2043236|NCT00447694|3614019|FG000|Overall Study|Abnormal test procedure result|1
2043237|NCT00447694|3614019|FG000|Overall Study|Withdrawal by Subject|2
2043238|NCT00447772|3614023|FG000|Overall Study|Lack of Efficacy|3
2043239|NCT00447772|3614023|FG000|Overall Study|Insufficient compliance|6
2043240|NCT00447772|3614023|FG000|Overall Study|Discontinuation of drug therapy|1
2043241|NCT00447772|3614023|FG000|Overall Study|Lost to Follow-up|9
2043242|NCT00447772|3614023|FG000|Overall Study|Withdrawal by Subject|1
2043243|NCT00447772|3614023|FG000|Overall Study|Unable to attend all study visits|2
2043244|NCT00447772|3614023|FG000|Overall Study|Adverse Event|1
2043245|NCT00447772|3614023|FG000|Overall Study|Patient relocated|1
2043246|NCT00447772|3614023|FG000|Overall Study|Incomplete documentation at visit 1|1
2043247|NCT00447772|3614023|FG000|Overall Study|Chemotherapy for lung cancer|1
2043248|NCT00447772|3614023|FG000|Overall Study|Premature re-injection required|1
2043249|NCT00447876|3614032|FG000|Overall Study|Withdrawal by Subject|1
2043250|NCT00447876|3614033|FG001|Overall Study|Withdrawal by Subject|4
2043251|NCT00447876|3614032|FG000|Overall Study|Lost to Follow-up|1
2043252|NCT00447876|3614033|FG001|Overall Study|Lost to Follow-up|0
2043253|NCT00447876|3614032|FG000|Overall Study|Deterioration of symptomology|1
2043254|NCT00447876|3614033|FG001|Overall Study|Deterioration of symptomology|0
2043255|NCT00447902|3614041|FG000|Overall Study|Adverse Event|0
2043256|NCT00447902|3614042|FG001|Overall Study|Adverse Event|3
2043257|NCT00447902|3614041|FG000|Overall Study|Protocol Violation|1
2043258|NCT00447902|3614042|FG001|Overall Study|Protocol Violation|0
2043259|NCT00447902|3614041|FG000|Overall Study|Withdrawal by Subject|0
2043260|NCT00447902|3614042|FG001|Overall Study|Withdrawal by Subject|1
2043261|NCT00447902|3614041|FG000|Overall Study|included patients who discontinued|1
2043262|NCT00447902|3614042|FG001|Overall Study|included patients who discontinued|1
2043263|NCT00447902|3614041|FG000|Overall Study|Lack of Efficacy|2
2043264|NCT00447902|3614042|FG001|Overall Study|Lack of Efficacy|1
2043265|NCT00448019|3614048|FG000|Overall Study|Withdrawal by Subject|3
2043266|NCT00448019|3614048|FG000|Overall Study|Disease progression|1
2043267|NCT00448019|3614048|FG000|Overall Study|Death|2
2043268|NCT00448019|3614048|FG000|Overall Study|Insurance Issues|1
2043269|NCT00448123|3614054|FG000|Overall Study|Lost to Follow-up|9
2043270|NCT00448123|3614055|FG001|Overall Study|Lost to Follow-up|6
2043271|NCT00448123|3614054|FG000|Overall Study|Physician Decision|6
2043272|NCT00448123|3614055|FG001|Overall Study|Physician Decision|6
2043273|NCT00448136|3614066|FG000|Overall Study|Death|3
2043274|NCT00448136|3614067|FG001|Overall Study|Death|8
2043275|NCT00448136|3614066|FG000|Overall Study|Investigator's decision (progression)|1
2043276|NCT00448136|3614067|FG001|Overall Study|Investigator's decision (progression)|0
2043277|NCT00448279|3614097|FG000|Overall Study|Lost to Follow-up|2
2043278|NCT00448279|3614098|FG001|Overall Study|Lost to Follow-up|2
2043279|NCT00448279|3614097|FG000|Overall Study|Adverse Event|1
2043280|NCT00448279|3614098|FG001|Overall Study|Adverse Event|1
2043281|NCT00448279|3614097|FG000|Overall Study|Disease progression|16
2043282|NCT00448279|3614098|FG001|Overall Study|Disease progression|18
2043283|NCT00448279|3614097|FG000|Overall Study|Withdrawal by Subject|4
2043284|NCT00448279|3614098|FG001|Overall Study|Withdrawal by Subject|3
2043285|NCT00448279|3614097|FG000|Overall Study|Other|6
2043286|NCT00448279|3614098|FG001|Overall Study|Other|4
2043287|NCT00448279|3614097|FG000|Overall Study|Protocol Violation|0
2043288|NCT00448279|3614098|FG001|Overall Study|Protocol Violation|1
2043289|NCT00448344|3614106|FG000|Overall Study|Lost to Follow-up|20
2043290|NCT00448344|3614107|FG001|Overall Study|Lost to Follow-up|22
2043291|NCT00448344|3614106|FG000|Overall Study|Withdrawal by Subject|6
2043292|NCT00448344|3614107|FG001|Overall Study|Withdrawal by Subject|8
2043293|NCT00448344|3614106|FG000|Overall Study|Death|3
2043294|NCT00448344|3614107|FG001|Overall Study|Death|4
2043295|NCT00448344|3614106|FG000|Overall Study|Physician Decision|1
2043296|NCT00448344|3614107|FG001|Overall Study|Physician Decision|2
2043297|NCT00448435|3614129|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1
2043298|NCT00448435|3614130|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0
2043299|NCT00448448|3614141|FG000|Overall Study|Withdrawal by Subject|13
2043300|NCT00448448|3614142|FG001|Overall Study|Withdrawal by Subject|2
2043301|NCT00448448|3614141|FG000|Overall Study|On protocol when study ended|83
2043302|NCT00448448|3614142|FG001|Overall Study|On protocol when study ended|36
2298200|NCT02574078|3994896|FG007|Treatment Period|Participant request to stop drug|0
2043303|NCT00448448|3614141|FG000|Overall Study|Lost to Follow-up|2
2043304|NCT00448448|3614142|FG001|Overall Study|Lost to Follow-up|1
2043305|NCT00448448|3614141|FG000|Overall Study|Wrong diagnosis (n=3) or other|2
2043306|NCT00448448|3614142|FG001|Overall Study|Wrong diagnosis (n=3) or other|1
2043307|NCT00448448|3614141|FG000|Overall Study|Signed consent lost|0
2043308|NCT00448448|3614142|FG001|Overall Study|Signed consent lost|1
2043309|NCT00448539|3614150|FG000|Overall Study|Medication non-compliance|4
2043310|NCT00448539|3614151|FG001|Overall Study|Medication non-compliance|1
2043311|NCT00448539|3614150|FG000|Overall Study|Protocol Violation|1
2043312|NCT00448539|3614151|FG001|Overall Study|Protocol Violation|0
2043313|NCT00448539|3614150|FG000|Overall Study|Request of the investigator or sponsor|67
2043314|NCT00448539|3614151|FG001|Overall Study|Request of the investigator or sponsor|54
2043315|NCT00448539|3614150|FG000|Overall Study|Withdrawal by Subject|20
2043316|NCT00448539|3614151|FG001|Overall Study|Withdrawal by Subject|24
2043317|NCT00448539|3614150|FG000|Overall Study|Diary non-compliance|1
2043318|NCT00448539|3614151|FG001|Overall Study|Diary non-compliance|0
2043319|NCT00448539|3614150|FG000|Overall Study|Adverse Event|9
2043320|NCT00448539|3614151|FG001|Overall Study|Adverse Event|26
2043321|NCT00448539|3614150|FG000|Overall Study|Lack of Efficacy|27
2043322|NCT00448539|3614151|FG001|Overall Study|Lack of Efficacy|40
2043323|NCT00448539|3614150|FG000|Overall Study|Miscellaneous|2
2043324|NCT00448539|3614151|FG001|Overall Study|Miscellaneous|1
2043325|NCT00448539|3614150|FG000|Overall Study|Change of meds|2
2043326|NCT00448539|3614151|FG001|Overall Study|Change of meds|3
2043327|NCT00448539|3614150|FG000|Overall Study|Lost to Follow-up|1
2043328|NCT00448539|3614151|FG001|Overall Study|Lost to Follow-up|3
2043329|NCT00448591|3614157|FG000|Overall Study|Withdrawal by Subject|178
2043330|NCT00448591|3614157|FG000|Overall Study|Progressive Disease|1382
2043331|NCT00448591|3614157|FG000|Overall Study|Adverse Event|382
2043332|NCT00448591|3614157|FG000|Overall Study|Protocol Violation|41
2043333|NCT00448591|3614157|FG000|Overall Study|Lost to Follow-up|19
2043334|NCT00448591|3614157|FG000|Overall Study|Treatment Regimen Completed|70
2043335|NCT00448591|3614157|FG000|Overall Study|Other|154
2043336|NCT00448591|3614157|FG000|Overall Study|Termination of Study|70
2043337|NCT00448669|3614182|FG000|Overall Study|Lost to Follow-up|52
2043338|NCT00448669|3614183|FG001|Overall Study|Lost to Follow-up|63
2043339|NCT00448669|3614182|FG000|Overall Study|Withdrawal by Subject|90
2043340|NCT00448669|3614183|FG001|Overall Study|Withdrawal by Subject|74
2043341|NCT00448669|3614182|FG000|Overall Study|Relocated|49
2043342|NCT00448669|3614183|FG001|Overall Study|Relocated|36
2043343|NCT00448669|3614182|FG000|Overall Study|Were withdrawn by investigator|10
2043344|NCT00448669|3614183|FG001|Overall Study|Were withdrawn by investigator|6
2043345|NCT00448669|3614182|FG000|Overall Study|Death|2
2043346|NCT00448669|3614183|FG001|Overall Study|Death|4
2043347|NCT00448669|3614182|FG000|Overall Study|Had other reasons|5
2043348|NCT00448669|3614183|FG001|Overall Study|Had other reasons|6
2043349|NCT00448669|3614182|FG000|Overall Study|HIV-infected at enrollment|1
2043350|NCT00448669|3614183|FG001|Overall Study|HIV-infected at enrollment|2
2043351|NCT00448669|3614182|FG000|Overall Study|Never started drug|9
2043352|NCT00448669|3614183|FG001|Overall Study|Never started drug|7
2043353|NCT00448708|3614193|FG000|Overall Study|Death|21
2043354|NCT00448708|3614194|FG001|Overall Study|Death|17
2043355|NCT00448708|3614193|FG000|Overall Study|Withdrawal by Subject|8
2043356|NCT00448708|3614194|FG001|Overall Study|Withdrawal by Subject|4
2043357|NCT00448708|3614193|FG000|Overall Study|Lost to Follow-up|6
2043358|NCT00448708|3614194|FG001|Overall Study|Lost to Follow-up|8
2043359|NCT00448708|3614193|FG000|Overall Study|not listed|0
2043360|NCT00448708|3614194|FG001|Overall Study|not listed|2
2043361|NCT00448747|3614202|FG000|Overall Study|collapsed veins|1
2043362|NCT00448747|3614203|FG001|Overall Study|collapsed veins|0
2043363|NCT00448760|3614219|FG000|Overall Study|Death|3
2043364|NCT00448812|3614225|FG000|Year 2|Missed visit but remained in study|4
2043365|NCT00448812|3614226|FG001|Year 2|Missed visit but remained in study|1
2043366|NCT00448812|3614225|FG000|Year 3|Withdrawal by Subject|1
2043367|NCT00448812|3614226|FG001|Year 3|Withdrawal by Subject|3
2043368|NCT00448812|3614225|FG000|Year 3|Lost to Follow-up|1
2043369|NCT00448812|3614226|FG001|Year 3|Lost to Follow-up|0
2043370|NCT00448812|3614225|FG000|Year 3|Missed visit but remained in study|2
2043371|NCT00448812|3614226|FG001|Year 3|Missed visit but remained in study|0
2043372|NCT00448812|3614225|FG000|Year 5|Missed visit but remained in study|1
2043373|NCT00448812|3614226|FG001|Year 5|Missed visit but remained in study|0
2043374|NCT00448864|3614247|FG000|Overall Study|Death|1
2043375|NCT00448864|3614248|FG001|Overall Study|Death|0
2043376|NCT00448864|3614249|FG002|Overall Study|Death|0
2043377|NCT00448864|3614247|FG000|Overall Study|Lost to Follow-up|3
2043378|NCT00448864|3614248|FG001|Overall Study|Lost to Follow-up|1
2043379|NCT00448864|3614249|FG002|Overall Study|Lost to Follow-up|0
2043380|NCT00448864|3614247|FG000|Overall Study|Physician Decision|1
2043381|NCT00448864|3614248|FG001|Overall Study|Physician Decision|0
2043382|NCT00448864|3614249|FG002|Overall Study|Physician Decision|1
2043383|NCT00448864|3614247|FG000|Overall Study|Withdrawal by Subject|0
2043384|NCT00448864|3614248|FG001|Overall Study|Withdrawal by Subject|2
2043385|NCT00448864|3614249|FG002|Overall Study|Withdrawal by Subject|0
2043386|NCT00448864|3614247|FG000|Overall Study|Protocol Violation|0
2043387|NCT00448864|3614248|FG001|Overall Study|Protocol Violation|2
2043388|NCT00448864|3614249|FG002|Overall Study|Protocol Violation|0
2043389|NCT00448916|3614263|FG000|Overall Study|Adverse Event|2
2043390|NCT00448916|3614264|FG001|Overall Study|Adverse Event|2
2043391|NCT00448916|3614265|FG002|Overall Study|Adverse Event|3
2043392|NCT00448916|3614266|FG003|Overall Study|Adverse Event|2
2043393|NCT00448916|3614263|FG000|Overall Study|Lack of Efficacy|1
2043394|NCT00448916|3614264|FG001|Overall Study|Lack of Efficacy|0
2043395|NCT00448916|3614265|FG002|Overall Study|Lack of Efficacy|2
2043396|NCT00448916|3614266|FG003|Overall Study|Lack of Efficacy|1
2043397|NCT00448916|3614263|FG000|Overall Study|Withdrawal by Subject|3
2043398|NCT00448916|3614264|FG001|Overall Study|Withdrawal by Subject|3
2043399|NCT00448916|3614265|FG002|Overall Study|Withdrawal by Subject|1
2043400|NCT00448916|3614266|FG003|Overall Study|Withdrawal by Subject|1
2043401|NCT00448916|3614263|FG000|Overall Study|Other|1
2043402|NCT00448916|3614264|FG001|Overall Study|Other|0
2043403|NCT00448916|3614265|FG002|Overall Study|Other|0
2043404|NCT00448916|3614266|FG003|Overall Study|Other|0
2043405|NCT00448916|3614263|FG000|Overall Study|Lost to Follow-up|0
2043406|NCT00448916|3614264|FG001|Overall Study|Lost to Follow-up|1
2043407|NCT00448916|3614265|FG002|Overall Study|Lost to Follow-up|0
2043408|NCT00448916|3614266|FG003|Overall Study|Lost to Follow-up|1
2043409|NCT00448916|3614263|FG000|Overall Study|Protocol Violation|0
2043410|NCT00448916|3614264|FG001|Overall Study|Protocol Violation|0
2043411|NCT00448916|3614265|FG002|Overall Study|Protocol Violation|0
2043412|NCT00448916|3614266|FG003|Overall Study|Protocol Violation|1
2043413|NCT00449033|3614291|FG000|Treatment Period|Adverse Event|117
2043414|NCT00449033|3614292|FG001|Treatment Period|Adverse Event|83
2043415|NCT00449033|3614291|FG000|Treatment Period|Death|21
2043416|NCT00449033|3614292|FG001|Treatment Period|Death|12
2043417|NCT00449033|3614291|FG000|Treatment Period|Lost to Follow-up|0
2043418|NCT00449033|3614292|FG001|Treatment Period|Lost to Follow-up|2
2043419|NCT00449033|3614291|FG000|Treatment Period|Physician Decision|4
2043420|NCT00449033|3614292|FG001|Treatment Period|Physician Decision|5
2043421|NCT00449033|3614291|FG000|Treatment Period|Protocol Violation|8
2043422|NCT00449033|3614292|FG001|Treatment Period|Protocol Violation|7
2043423|NCT00449033|3614291|FG000|Treatment Period|Disease Progression|231
2043424|NCT00449033|3614292|FG001|Treatment Period|Disease Progression|288
2043425|NCT00449033|3614291|FG000|Treatment Period|Consent Withdrawn|36
2043426|NCT00449033|3614292|FG001|Treatment Period|Consent Withdrawn|20
2043427|NCT00449033|3614291|FG000|Treatment Period|Amended Protocol Criteria|22
2043428|NCT00449033|3614292|FG001|Treatment Period|Amended Protocol Criteria|18
2043429|NCT00449033|3614291|FG000|Treatment Period|Non-compliance|7
2043430|NCT00449033|3614292|FG001|Treatment Period|Non-compliance|8
2043431|NCT00449033|3614291|FG000|Treatment Period|Second Malignancy|0
2043432|NCT00449033|3614292|FG001|Treatment Period|Second Malignancy|1
2043433|NCT00449033|3614291|FG000|Treatment Period|Reason Missing|0
2043434|NCT00449033|3614292|FG001|Treatment Period|Reason Missing|4
2043435|NCT00449033|3614291|FG000|Treatment Period|Treatment Ongoing|6
2043436|NCT00449033|3614292|FG001|Treatment Period|Treatment Ongoing|4
2043437|NCT00449033|3614291|FG000|Follow-up Period|Death|299
2043438|NCT00449033|3614292|FG001|Follow-up Period|Death|311
2043439|NCT00449033|3614291|FG000|Follow-up Period|Lost to Follow-up|6
2043440|NCT00449033|3614292|FG001|Follow-up Period|Lost to Follow-up|10
2043441|NCT00449033|3614291|FG000|Follow-up Period|Reason Missing|120
2043442|NCT00449033|3614292|FG001|Follow-up Period|Reason Missing|113
2043443|NCT00449072|3614304|FG000|Overall Study|Adverse Event|3
2043444|NCT00449072|3614305|FG001|Overall Study|Adverse Event|1
2043445|NCT00449072|3614304|FG000|Overall Study|Protocol Violation|14
2043446|NCT00449072|3614305|FG001|Overall Study|Protocol Violation|12
2043447|NCT00449072|3614304|FG000|Overall Study|Lost to Follow-up|5
2043448|NCT00449072|3614305|FG001|Overall Study|Lost to Follow-up|7
2043449|NCT00449072|3614304|FG000|Overall Study|Withdrawal by Subject|11
2043450|NCT00449072|3614305|FG001|Overall Study|Withdrawal by Subject|8
2043451|NCT00449072|3614304|FG000|Overall Study|Lack of Efficacy|1
2043452|NCT00449072|3614305|FG001|Overall Study|Lack of Efficacy|1
2043453|NCT00449072|3614304|FG000|Overall Study|Physician Decision|1
2043454|NCT00449072|3614305|FG001|Overall Study|Physician Decision|0
2043455|NCT00449072|3614304|FG000|Overall Study|Not treated|0
2043456|NCT00449072|3614305|FG001|Overall Study|Not treated|1
2043457|NCT00449072|3614304|FG000|Overall Study|Excluded medication|0
2043458|NCT00449072|3614305|FG001|Overall Study|Excluded medication|2
2043459|NCT00449072|3614304|FG000|Overall Study|Non-compliance|2
2043460|NCT00449072|3614305|FG001|Overall Study|Non-compliance|5
2043461|NCT00449072|3614304|FG000|Overall Study|Sponsor decision|1
2043462|NCT00449072|3614305|FG001|Overall Study|Sponsor decision|3
2043463|NCT00449072|3614304|FG000|Overall Study|Relocation|3
2043464|NCT00449072|3614305|FG001|Overall Study|Relocation|2
2043465|NCT00449150|3614314|FG000|Overall Study|Adverse Event|11
2043466|NCT00449150|3614315|FG001|Overall Study|Adverse Event|18
2043467|NCT00449150|3614316|FG002|Overall Study|Adverse Event|9
2043468|NCT00449150|3614314|FG000|Overall Study|Lack of Efficacy|1
2043469|NCT00449150|3614315|FG001|Overall Study|Lack of Efficacy|2
2043470|NCT00449150|3614316|FG002|Overall Study|Lack of Efficacy|2
2043471|NCT00449150|3614314|FG000|Overall Study|Other|16
2043472|NCT00449150|3614315|FG001|Overall Study|Other|13
2043473|NCT00449150|3614316|FG002|Overall Study|Other|14
2043474|NCT00449150|3614314|FG000|Overall Study|Withdrawal by Subject|17
2043475|NCT00449150|3614315|FG001|Overall Study|Withdrawal by Subject|18
2043476|NCT00449150|3614316|FG002|Overall Study|Withdrawal by Subject|21
2043477|NCT00449150|3614314|FG000|Overall Study|Protocol Violation|1
2043478|NCT00449150|3614315|FG001|Overall Study|Protocol Violation|2
2043479|NCT00449150|3614316|FG002|Overall Study|Protocol Violation|1
2043480|NCT00449163|3614327|FG000|Overall Study|Physician Decision|3
2298201|NCT02574078|3994897|FG008|Treatment Period|Participant request to stop drug|3
2298202|NCT02574078|3994898|FG009|Treatment Period|Participant request to stop drug|2
2298203|NCT02574078|3994899|FG010|Treatment Period|Participant request to stop drug|2
2298204|NCT02574078|3994900|FG011|Treatment Period|Participant request to stop drug|4
2298205|NCT02574078|3994901|FG012|Treatment Period|Participant request to stop drug|1
2298206|NCT02574078|3994889|FG000|Treatment Period|Participant withdrew consent|0
2298207|NCT02574078|3994890|FG001|Treatment Period|Participant withdrew consent|0
2043481|NCT00449176|3614334|FG000|Overall Study|Withdrawal by Subject|39
2043482|NCT00449176|3614335|FG001|Overall Study|Withdrawal by Subject|43
2043483|NCT00449176|3614336|FG002|Overall Study|Withdrawal by Subject|59
2043484|NCT00449176|3614334|FG000|Overall Study|Lost to Follow-up|13
2043485|NCT00449176|3614335|FG001|Overall Study|Lost to Follow-up|8
2043486|NCT00449176|3614336|FG002|Overall Study|Lost to Follow-up|12
2043487|NCT00449176|3614334|FG000|Overall Study|Adverse Event|51
2043488|NCT00449176|3614335|FG001|Overall Study|Adverse Event|107
2043489|NCT00449176|3614336|FG002|Overall Study|Adverse Event|15
2043490|NCT00449176|3614334|FG000|Overall Study|Lack of Efficacy|13
2043491|NCT00449176|3614335|FG001|Overall Study|Lack of Efficacy|7
2043492|NCT00449176|3614336|FG002|Overall Study|Lack of Efficacy|50
2043493|NCT00449176|3614334|FG000|Overall Study|Study drug non-compliant|14
2043494|NCT00449176|3614335|FG001|Overall Study|Study drug non-compliant|11
2043495|NCT00449176|3614336|FG002|Overall Study|Study drug non-compliant|11
2043496|NCT00449176|3614334|FG000|Overall Study|all other|22
2043497|NCT00449176|3614335|FG001|Overall Study|all other|19
2043498|NCT00449176|3614336|FG002|Overall Study|all other|20
2043499|NCT00449540|3614346|FG000|Pretreatment Phase|No migraine experienced|66
2043500|NCT00449540|3614347|FG001|Pretreatment Phase|No migraine experienced|0
2043501|NCT00449540|3614348|FG002|Pretreatment Phase|No migraine experienced|0
2043502|NCT00449540|3614346|FG000|Treatment Phase|did not experience or treat migraine|0
2043503|NCT00449540|3614347|FG001|Treatment Phase|did not experience or treat migraine|20
2043504|NCT00449540|3614348|FG002|Treatment Phase|did not experience or treat migraine|17
2043505|NCT00449644|3614360|FG000|Overall Study|Adverse Event|0
2043506|NCT00449644|3614361|FG001|Overall Study|Adverse Event|0
2043507|NCT00449644|3614362|FG002|Overall Study|Adverse Event|3
2043508|NCT00449644|3614363|FG003|Overall Study|Adverse Event|5
2043509|NCT00449644|3614360|FG000|Overall Study|Death|1
2043510|NCT00449644|3614361|FG001|Overall Study|Death|0
2043511|NCT00449644|3614362|FG002|Overall Study|Death|6
2043512|NCT00449644|3614363|FG003|Overall Study|Death|1
2043513|NCT00449644|3614360|FG000|Overall Study|Lost to Follow-up|1
2043514|NCT00449644|3614361|FG001|Overall Study|Lost to Follow-up|1
2043515|NCT00449644|3614362|FG002|Overall Study|Lost to Follow-up|5
2043516|NCT00449644|3614363|FG003|Overall Study|Lost to Follow-up|3
2043517|NCT00449644|3614360|FG000|Overall Study|Pregnancy|0
2043518|NCT00449644|3614361|FG001|Overall Study|Pregnancy|0
2043519|NCT00449644|3614362|FG002|Overall Study|Pregnancy|3
2043520|NCT00449644|3614363|FG003|Overall Study|Pregnancy|2
2043521|NCT00449644|3614360|FG000|Overall Study|Protocol Violation|4
2043522|NCT00449644|3614361|FG001|Overall Study|Protocol Violation|4
2043523|NCT00449644|3614362|FG002|Overall Study|Protocol Violation|3
2043524|NCT00449644|3614363|FG003|Overall Study|Protocol Violation|7
2043525|NCT00449644|3614360|FG000|Overall Study|Withdrawal by Subject|3
2043526|NCT00449644|3614361|FG001|Overall Study|Withdrawal by Subject|4
2043527|NCT00449644|3614362|FG002|Overall Study|Withdrawal by Subject|6
2043528|NCT00449644|3614363|FG003|Overall Study|Withdrawal by Subject|7
2043529|NCT00449644|3614360|FG000|Overall Study|Inclusion/exclusion criteria not met|0
2043530|NCT00449644|3614361|FG001|Overall Study|Inclusion/exclusion criteria not met|0
2043531|NCT00449644|3614362|FG002|Overall Study|Inclusion/exclusion criteria not met|2
2043532|NCT00449644|3614363|FG003|Overall Study|Inclusion/exclusion criteria not met|6
2043533|NCT00449644|3614360|FG000|Overall Study|Other|1
2043534|NCT00449644|3614361|FG001|Overall Study|Other|4
2043535|NCT00449644|3614362|FG002|Overall Study|Other|1
2043536|NCT00449644|3614363|FG003|Overall Study|Other|0
2043537|NCT00449644|3614360|FG000|Overall Study|Rolled-over to treatment with TMC207|0
2043538|NCT00449644|3614361|FG001|Overall Study|Rolled-over to treatment with TMC207|0
2043539|NCT00449644|3614362|FG002|Overall Study|Rolled-over to treatment with TMC207|0
2043540|NCT00449644|3614363|FG003|Overall Study|Rolled-over to treatment with TMC207|1
2043541|NCT00449670|3614378|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1
2043542|NCT00449670|3614379|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0
2043543|NCT00449670|3614378|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4
2043544|NCT00449670|3614379|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0
2043545|NCT00449670|3614378|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4
2043546|NCT00449670|3614379|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1
2043547|NCT00449670|3614378|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5
2043548|NCT00449670|3614379|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1
2043549|NCT00449670|3614378|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0
2043550|NCT00449670|3614379|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1
2043551|NCT00449670|3614378|FG000|Booster Phase (Study no.109873)|Other|0
2043552|NCT00449670|3614379|FG001|Booster Phase (Study no.109873)|Other|2
2043553|NCT00449696|3614394|FG000|Overall Study|Other Treatment Required|6
2043554|NCT00449696|3614395|FG001|Overall Study|Other Treatment Required|1
2019431|NCT00298272|3586738|FG000|Open Label Retreatment Phase|Protocol Violation|2
2019432|NCT00298272|3586739|FG001|Open Label Retreatment Phase|Protocol Violation|1
2019433|NCT00298272|3586738|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1
2019434|NCT00298272|3586739|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0
2019435|NCT00298272|3586738|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2
2019436|NCT00298272|3586739|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0
2019437|NCT00298272|3586738|FG000|Safety Follow-up Phase|Failure to Return|1
2019438|NCT00298272|3586739|FG001|Safety Follow-up Phase|Failure to Return|1
2019439|NCT00298272|3586738|FG000|Safety Follow-up Phase|Withdrawal by Subject|2
2019440|NCT00298272|3586739|FG001|Safety Follow-up Phase|Withdrawal by Subject|2
2019441|NCT00298272|3586738|FG000|Safety Follow-up Phase|Administrative/Other Reason|1
2019442|NCT00298272|3586739|FG001|Safety Follow-up Phase|Administrative/Other Reason|1
2019443|NCT00298363|3586751|FG000|Overall Study|Lost to Follow-up|0
2019444|NCT00298363|3586752|FG001|Overall Study|Lost to Follow-up|0
2019445|NCT00298363|3586753|FG002|Overall Study|Lost to Follow-up|1
2019446|NCT00298363|3586751|FG000|Overall Study|Physician Decision|4
2019447|NCT00298363|3586752|FG001|Overall Study|Physician Decision|1
2019448|NCT00298363|3586753|FG002|Overall Study|Physician Decision|0
2019449|NCT00298363|3586751|FG000|Overall Study|Protocol Violation|1
2019450|NCT00298363|3586752|FG001|Overall Study|Protocol Violation|1
2019451|NCT00298363|3586753|FG002|Overall Study|Protocol Violation|0
2019452|NCT00298363|3586751|FG000|Overall Study|Withdrawal by Subject|5
2019453|NCT00298363|3586752|FG001|Overall Study|Withdrawal by Subject|1
2019454|NCT00298363|3586753|FG002|Overall Study|Withdrawal by Subject|3
2019455|NCT00298363|3586751|FG000|Overall Study|Adverse Event|5
2019456|NCT00298363|3586752|FG001|Overall Study|Adverse Event|2
2019457|NCT00298363|3586753|FG002|Overall Study|Adverse Event|2
2019458|NCT00298363|3586751|FG000|Overall Study|Lack of Efficacy|2
2019459|NCT00298363|3586752|FG001|Overall Study|Lack of Efficacy|3
2019460|NCT00298363|3586753|FG002|Overall Study|Lack of Efficacy|0
2019461|NCT00298766|3586801|FG000|Overall Study|Adverse Event|18
2019462|NCT00298766|3586801|FG000|Overall Study|Death|2
2019463|NCT00298766|3586801|FG000|Overall Study|Withdrawal by Subject|9
2019464|NCT00298766|3586801|FG000|Overall Study|Treatment ongoing|4
2019465|NCT00298766|3586801|FG000|Overall Study|Progression of amyloid markers|4
2019466|NCT00298766|3586801|FG000|Overall Study|Deterioration in KPS and organ function|1
2019467|NCT00298766|3586801|FG000|Overall Study|Subjects overall condition deterioration|4
2019468|NCT00298766|3586801|FG000|Overall Study|Other|4
2043555|NCT00449696|3614394|FG000|Overall Study|Withdrawal by Subject|5
2043556|NCT00449696|3614395|FG001|Overall Study|Withdrawal by Subject|5
2043557|NCT00449696|3614394|FG000|Overall Study|Lost to Follow-up|2
2043558|NCT00449696|3614395|FG001|Overall Study|Lost to Follow-up|3
2043559|NCT00449696|3614394|FG000|Overall Study|Others|7
2043560|NCT00449696|3614395|FG001|Overall Study|Others|0
2043561|NCT00449761|3614405|FG000|Overall Study|Disease progression|12
2043562|NCT00449761|3614405|FG000|Overall Study|Death|5
2043563|NCT00449761|3614405|FG000|Overall Study|New cancer therapy|1
2043564|NCT00449787|3614412|FG000|Overall Study|Lost to Follow-up|10
2043565|NCT00449787|3614413|FG001|Overall Study|Lost to Follow-up|8
2043566|NCT00449787|3614412|FG000|Overall Study|Did not require medication|95
2043567|NCT00449787|3614413|FG001|Overall Study|Did not require medication|92
2043568|NCT00449865|3614423|FG000|Overall Study|Withdrawal by Subject|110
2043569|NCT00449865|3614424|FG001|Overall Study|Withdrawal by Subject|110
2043570|NCT00449865|3614423|FG000|Overall Study|Lost to Follow-up|36
2043571|NCT00449865|3614424|FG001|Overall Study|Lost to Follow-up|37
2043572|NCT00449865|3614423|FG000|Overall Study|Physician Decision|13
2043573|NCT00449865|3614424|FG001|Overall Study|Physician Decision|12
2043574|NCT00449865|3614423|FG000|Overall Study|Death|31
2043575|NCT00449865|3614424|FG001|Overall Study|Death|40
2043576|NCT00449865|3614423|FG000|Overall Study|Protocol Violation|8
2043577|NCT00449865|3614424|FG001|Overall Study|Protocol Violation|7
2043578|NCT00449865|3614423|FG000|Overall Study|Study was stopped|324
2043579|NCT00449865|3614424|FG001|Overall Study|Study was stopped|328
2043580|NCT00449930|3614432|FG000|Overall Study|Adverse Event|9
2043581|NCT00449930|3614433|FG001|Overall Study|Adverse Event|19
2043582|NCT00449930|3614432|FG000|Overall Study|Trial Terminated ( Site Closed)|1
2043583|NCT00449930|3614433|FG001|Overall Study|Trial Terminated ( Site Closed)|0
2043584|NCT00449930|3614432|FG000|Overall Study|Lack of Efficacy|10
2043585|NCT00449930|3614433|FG001|Overall Study|Lack of Efficacy|1
2043586|NCT00449930|3614432|FG000|Overall Study|Lost to Follow-up|9
2043587|NCT00449930|3614433|FG001|Overall Study|Lost to Follow-up|14
2043588|NCT00449930|3614432|FG000|Overall Study|Physician Decision|1
2043589|NCT00449930|3614433|FG001|Overall Study|Physician Decision|2
2043590|NCT00449930|3614432|FG000|Overall Study|Protocol Violation|14
2043591|NCT00449930|3614433|FG001|Overall Study|Protocol Violation|15
2043592|NCT00449930|3614432|FG000|Overall Study|Withdrawal by Subject|16
2043593|NCT00449930|3614433|FG001|Overall Study|Withdrawal by Subject|23
2043594|NCT00449930|3614432|FG000|Overall Study|Glycemic discontinuation criteria|1
2043595|NCT00449930|3614433|FG001|Overall Study|Glycemic discontinuation criteria|1
2043596|NCT00449956|3614442|FG000|Overall Study|Adverse Event|7
2043597|NCT00449956|3614443|FG001|Overall Study|Adverse Event|1
2043598|NCT00449956|3614444|FG002|Overall Study|Adverse Event|6
2043599|NCT00449956|3614442|FG000|Overall Study|Lack of Efficacy|0
2043600|NCT00449956|3614443|FG001|Overall Study|Lack of Efficacy|0
2043601|NCT00449956|3614444|FG002|Overall Study|Lack of Efficacy|1
2043602|NCT00449956|3614442|FG000|Overall Study|Protocol Violation|1
2043603|NCT00449956|3614443|FG001|Overall Study|Protocol Violation|1
2043604|NCT00449956|3614444|FG002|Overall Study|Protocol Violation|1
2043605|NCT00449956|3614442|FG000|Overall Study|Withdrawal by Subject|0
2043606|NCT00449956|3614443|FG001|Overall Study|Withdrawal by Subject|1
2043607|NCT00449956|3614444|FG002|Overall Study|Withdrawal by Subject|0
2043608|NCT00449956|3614442|FG000|Overall Study|Physician Decision|2
2043609|NCT00449956|3614443|FG001|Overall Study|Physician Decision|1
2043610|NCT00449956|3614444|FG002|Overall Study|Physician Decision|1
2043611|NCT00450112|3614467|FG000|Overall Study|Other Treatment Required|5
2043612|NCT00450112|3614468|FG001|Overall Study|Other Treatment Required|1
2043613|NCT00450112|3614467|FG000|Overall Study|Withdrawal by Subject|4
2043614|NCT00450112|3614468|FG001|Overall Study|Withdrawal by Subject|1
2043615|NCT00450112|3614467|FG000|Overall Study|Lost to Follow-up|2
2043616|NCT00450112|3614468|FG001|Overall Study|Lost to Follow-up|1
2043617|NCT00450112|3614467|FG000|Overall Study|Others|2
2043618|NCT00450112|3614468|FG001|Overall Study|Others|3
2043619|NCT00450177|3614476|FG000|Overall Study|Adverse Event|7
2043620|NCT00450177|3614477|FG001|Overall Study|Adverse Event|4
2043621|NCT00450177|3614476|FG000|Overall Study|Withdrawal by Subject|1
2043622|NCT00450177|3614477|FG001|Overall Study|Withdrawal by Subject|6
2043623|NCT00450177|3614476|FG000|Overall Study|Withdrawal by Primary Team|1
2043624|NCT00450177|3614477|FG001|Overall Study|Withdrawal by Primary Team|1
2043625|NCT00450190|3614483|FG000|Overall Study|Withdrawal by Subject|2
2043626|NCT00450216|3614489|FG000|Overall Study|Adverse Event|38
2043627|NCT00450216|3614490|FG001|Overall Study|Adverse Event|23
2043628|NCT00450216|3614489|FG000|Overall Study|Withdrawal by Subject|48
2043629|NCT00450216|3614490|FG001|Overall Study|Withdrawal by Subject|26
2043630|NCT00450216|3614489|FG000|Overall Study|Lost to Follow-up|16
2043631|NCT00450216|3614490|FG001|Overall Study|Lost to Follow-up|9
2043632|NCT00450216|3614489|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51
2043633|NCT00450216|3614490|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51
2043634|NCT00450216|3614489|FG000|Overall Study|misc|21
2043635|NCT00450216|3614490|FG001|Overall Study|misc|20
2043636|NCT00450255|3614507|FG000|Overall Study|Prior RFA ablation of liver|1
2043637|NCT00450372|3614517|FG000|Overall Study|Physician Decision|1
2043638|NCT00450385|3614524|FG000|Overall Study|Death|3
2043639|NCT00450385|3614524|FG000|Overall Study|Protocol Violation|1
2043640|NCT00450385|3614524|FG000|Overall Study|Withdrawal by Subject|2
2043641|NCT00450385|3614524|FG000|Overall Study|Lack of Efficacy|2
2043642|NCT00450385|3614524|FG000|Overall Study|Adverse Event|1
2043643|NCT00450385|3614524|FG000|Overall Study|Physician Decision|1
2043644|NCT00450385|3614524|FG000|Overall Study|Other|3
2043645|NCT00450411|3614529|FG000|Overall Study|Protocol Violation|6
2043646|NCT00450411|3614529|FG000|Overall Study|No protocol treatment|2
2043647|NCT00450437|3614544|FG000|Overall Study|Withdrawal by Subject|10
2043648|NCT00450437|3614545|FG001|Overall Study|Withdrawal by Subject|2
2043649|NCT00450437|3614546|FG002|Overall Study|Withdrawal by Subject|0
2043650|NCT00450437|3614547|FG003|Overall Study|Withdrawal by Subject|1
2043651|NCT00450437|3614544|FG000|Overall Study|Lost to Follow-up|31
2043652|NCT00450437|3614545|FG001|Overall Study|Lost to Follow-up|12
2043653|NCT00450437|3614546|FG002|Overall Study|Lost to Follow-up|19
2043654|NCT00450437|3614547|FG003|Overall Study|Lost to Follow-up|9
2043655|NCT00450437|3614544|FG000|Overall Study|Protocol Violation|0
2043656|NCT00450437|3614545|FG001|Overall Study|Protocol Violation|1
2043657|NCT00450437|3614546|FG002|Overall Study|Protocol Violation|0
2043658|NCT00450437|3614547|FG003|Overall Study|Protocol Violation|1
2043659|NCT00450437|3614544|FG000|Overall Study|Inappropriate enrollment|4
2043660|NCT00450437|3614545|FG001|Overall Study|Inappropriate enrollment|1
2043661|NCT00450437|3614546|FG002|Overall Study|Inappropriate enrollment|3
2043662|NCT00450437|3614547|FG003|Overall Study|Inappropriate enrollment|0
2043663|NCT00450437|3614544|FG000|Overall Study|Administrative reason|0
2043664|NCT00450437|3614545|FG001|Overall Study|Administrative reason|0
2043665|NCT00450437|3614546|FG002|Overall Study|Administrative reason|1
2043666|NCT00450437|3614547|FG003|Overall Study|Administrative reason|0
2043667|NCT00450437|3614544|FG000|Overall Study|Unable to Classify|1
2043668|NCT00450437|3614545|FG001|Overall Study|Unable to Classify|0
2043669|NCT00450437|3614546|FG002|Overall Study|Unable to Classify|1
2043670|NCT00450437|3614547|FG003|Overall Study|Unable to Classify|0
2043671|NCT00450450|3614563|FG000|Overall Study|Death|1
2043672|NCT00450450|3614564|FG001|Overall Study|Death|3
2043673|NCT00450450|3614563|FG000|Overall Study|Relapse|2
2043674|NCT00450450|3614564|FG001|Overall Study|Relapse|0
2043675|NCT00450450|3614563|FG000|Overall Study|Missing Data|2
2043676|NCT00450450|3614564|FG001|Overall Study|Missing Data|0
2043677|NCT00450580|3614584|FG000|Overall Study|Adverse Event|5
2043678|NCT00450580|3614585|FG001|Overall Study|Adverse Event|7
2043679|NCT00450580|3614584|FG000|Overall Study|Lost to Follow-up|4
2043680|NCT00450580|3614585|FG001|Overall Study|Lost to Follow-up|5
2043681|NCT00450580|3614584|FG000|Overall Study|Withdrawal by Subject|2
2043682|NCT00450580|3614585|FG001|Overall Study|Withdrawal by Subject|2
2043683|NCT00450580|3614584|FG000|Overall Study|Protocol Violation|1
2043684|NCT00450580|3614585|FG001|Overall Study|Protocol Violation|1
2043685|NCT00450580|3614584|FG000|Overall Study|Protocol-defined virologic failure|1
2043686|NCT00450580|3614585|FG001|Overall Study|Protocol-defined virologic failure|0
2043687|NCT00450580|3614584|FG000|Overall Study|Could not comply with scheduled visits|1
2043688|NCT00450580|3614585|FG001|Overall Study|Could not comply with scheduled visits|0
2043689|NCT00450580|3614584|FG000|Overall Study|Patient went to Brazil|1
2043690|NCT00450580|3614585|FG001|Overall Study|Patient went to Brazil|0
2043691|NCT00450580|3614584|FG000|Overall Study|Patient could not swallow Norvir|1
2043692|NCT00450580|3614585|FG001|Overall Study|Patient could not swallow Norvir|0
2043693|NCT00450580|3614584|FG000|Overall Study|Withdrawal due to pregnancy|0
2043694|NCT00450580|3614585|FG001|Overall Study|Withdrawal due to pregnancy|1
2043695|NCT00450619|3614593|FG000|Overall Study|refused treatment after randomization|2
2019469|NCT00298831|3586805|FG000|Overall Study|Adverse Event|1
2019470|NCT00298831|3586805|FG000|Overall Study|Lost to Follow-up|3
2019471|NCT00298831|3586805|FG000|Overall Study|Withdrawal by Subject|1
2019472|NCT00298831|3586805|FG000|Overall Study|Participants did not receive treatment|27
2019473|NCT00298896|3586809|FG000|Overall Study|Death|3
2019474|NCT00298896|3586809|FG000|Overall Study|Physician Decision|2
2019475|NCT00298896|3586809|FG000|Overall Study|Intercurrent Illness|1
2019476|NCT00298896|3586809|FG000|Overall Study|Disease Progression|41
2019477|NCT00298896|3586809|FG000|Overall Study|Withdrawal by Subject|2
2019478|NCT00298896|3586809|FG000|Overall Study|Assigned to treatment in error|1
2019479|NCT00299104|3586825|FG000|Treatment Period|Adverse Event|14
2019480|NCT00299104|3586826|FG001|Treatment Period|Adverse Event|9
2019481|NCT00299104|3586827|FG002|Treatment Period|Adverse Event|7
2019482|NCT00299104|3586825|FG000|Treatment Period|Death|1
2019483|NCT00299104|3586826|FG001|Treatment Period|Death|1
2019484|NCT00299104|3586827|FG002|Treatment Period|Death|1
2019485|NCT00299104|3586825|FG000|Treatment Period|Insufficient therapeutic response|34
2019486|NCT00299104|3586826|FG001|Treatment Period|Insufficient therapeutic response|13
2019487|NCT00299104|3586827|FG002|Treatment Period|Insufficient therapeutic response|8
2019488|NCT00299104|3586825|FG000|Treatment Period|Failure to return|9
2019489|NCT00299104|3586826|FG001|Treatment Period|Failure to return|8
2019490|NCT00299104|3586827|FG002|Treatment Period|Failure to return|8
2019491|NCT00299104|3586825|FG000|Treatment Period|Violation of selection criteria|1
2019492|NCT00299104|3586826|FG001|Treatment Period|Violation of selection criteria|2
2019493|NCT00299104|3586827|FG002|Treatment Period|Violation of selection criteria|0
2019494|NCT00299104|3586825|FG000|Treatment Period|Protocol Violation|1
2019495|NCT00299104|3586826|FG001|Treatment Period|Protocol Violation|1
2019496|NCT00299104|3586827|FG002|Treatment Period|Protocol Violation|0
2019497|NCT00299104|3586825|FG000|Treatment Period|Refused treatment|9
2019498|NCT00299104|3586826|FG001|Treatment Period|Refused treatment|2
2019499|NCT00299104|3586827|FG002|Treatment Period|Refused treatment|2
2019500|NCT00299104|3586825|FG000|Treatment Period|Withdrew consent|14
2019501|NCT00299104|3586826|FG001|Treatment Period|Withdrew consent|19
2019502|NCT00299104|3586827|FG002|Treatment Period|Withdrew consent|9
2019503|NCT00299104|3586825|FG000|Treatment Period|Administrative reasons|106
2019504|NCT00299104|3586826|FG001|Treatment Period|Administrative reasons|120
2019505|NCT00299104|3586827|FG002|Treatment Period|Administrative reasons|137
2019506|NCT00299104|3586825|FG000|Safety Follow-Up (SFU) Period|Death|3
2019507|NCT00299104|3586826|FG001|Safety Follow-Up (SFU) Period|Death|2
2019508|NCT00299104|3586827|FG002|Safety Follow-Up (SFU) Period|Death|1
2019509|NCT00299104|3586825|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
2019510|NCT00299104|3586826|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
2019511|NCT00299104|3586827|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
2019512|NCT00299104|3586825|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
2298208|NCT02574078|3994891|FG002|Treatment Period|Participant withdrew consent|0
2298209|NCT02574078|3994892|FG003|Treatment Period|Participant withdrew consent|0
2298210|NCT02574078|3994893|FG004|Treatment Period|Participant withdrew consent|1
2298211|NCT02574078|3994894|FG005|Treatment Period|Participant withdrew consent|1
2298212|NCT02574078|3994895|FG006|Treatment Period|Participant withdrew consent|0
2298213|NCT02574078|3994896|FG007|Treatment Period|Participant withdrew consent|1
2298214|NCT02574078|3994897|FG008|Treatment Period|Participant withdrew consent|0
2298215|NCT02574078|3994898|FG009|Treatment Period|Participant withdrew consent|2
2298216|NCT02574078|3994899|FG010|Treatment Period|Participant withdrew consent|1
2019513|NCT00299104|3586826|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
2019514|NCT00299104|3586827|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
2019515|NCT00299104|3586825|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27
2019516|NCT00299104|3586826|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7
2019517|NCT00299104|3586827|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5
2019518|NCT00299104|3586825|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0
2019519|NCT00299104|3586826|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1
2019520|NCT00299104|3586827|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0
2019521|NCT00299104|3586825|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
2019522|NCT00299104|3586826|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
2019523|NCT00299104|3586827|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
2298217|NCT02574078|3994900|FG011|Treatment Period|Participant withdrew consent|4
2298218|NCT02574078|3994901|FG012|Treatment Period|Participant withdrew consent|1
2298219|NCT02574078|3994889|FG000|Treatment Period|Participant no longer meets criteria|0
2298220|NCT02574078|3994890|FG001|Treatment Period|Participant no longer meets criteria|0
2298221|NCT02574078|3994891|FG002|Treatment Period|Participant no longer meets criteria|0
2298222|NCT02574078|3994892|FG003|Treatment Period|Participant no longer meets criteria|0
2298223|NCT02574078|3994893|FG004|Treatment Period|Participant no longer meets criteria|1
2298224|NCT02574078|3994894|FG005|Treatment Period|Participant no longer meets criteria|0
2298225|NCT02574078|3994895|FG006|Treatment Period|Participant no longer meets criteria|0
2298226|NCT02574078|3994896|FG007|Treatment Period|Participant no longer meets criteria|0
2298227|NCT02574078|3994897|FG008|Treatment Period|Participant no longer meets criteria|0
2298228|NCT02574078|3994898|FG009|Treatment Period|Participant no longer meets criteria|1
2298229|NCT02574078|3994899|FG010|Treatment Period|Participant no longer meets criteria|1
2298230|NCT02574078|3994900|FG011|Treatment Period|Participant no longer meets criteria|1
2298231|NCT02574078|3994901|FG012|Treatment Period|Participant no longer meets criteria|0
2298232|NCT02574078|3994889|FG000|Treatment Period|Lost to Follow-up|0
2298233|NCT02574078|3994890|FG001|Treatment Period|Lost to Follow-up|0
2298234|NCT02574078|3994891|FG002|Treatment Period|Lost to Follow-up|0
2298235|NCT02574078|3994892|FG003|Treatment Period|Lost to Follow-up|0
2298236|NCT02574078|3994893|FG004|Treatment Period|Lost to Follow-up|0
2298237|NCT02574078|3994894|FG005|Treatment Period|Lost to Follow-up|0
2298238|NCT02574078|3994895|FG006|Treatment Period|Lost to Follow-up|0
2298239|NCT02574078|3994896|FG007|Treatment Period|Lost to Follow-up|0
2298240|NCT02574078|3994897|FG008|Treatment Period|Lost to Follow-up|0
2298241|NCT02574078|3994898|FG009|Treatment Period|Lost to Follow-up|1
2298242|NCT02574078|3994899|FG010|Treatment Period|Lost to Follow-up|0
2298243|NCT02574078|3994900|FG011|Treatment Period|Lost to Follow-up|1
2026053|NCT00348283|3594715|FG001|Open Label|Withdrawal by Subject|4
2026054|NCT00348283|3594714|FG000|Open Label|Lost to Follow-up|0
2043696|NCT00450619|3614594|FG001|Overall Study|refused treatment after randomization|0
2043697|NCT00450619|3614593|FG000|Overall Study|did not progress; refused further trmt|1
2043698|NCT00450619|3614594|FG001|Overall Study|did not progress; refused further trmt|1
2043699|NCT00450619|3614593|FG000|Overall Study|Adverse Event|1
2043700|NCT00450619|3614594|FG001|Overall Study|Adverse Event|0
2043701|NCT00450658|3614603|FG000|Overall Study|Adverse Event|24
2043702|NCT00450658|3614604|FG001|Overall Study|Adverse Event|15
2043703|NCT00450658|3614603|FG000|Overall Study|Withdrawal by Subject|43
2043704|NCT00450658|3614604|FG001|Overall Study|Withdrawal by Subject|26
2043705|NCT00450658|3614603|FG000|Overall Study|Lost to Follow-up|22
2043706|NCT00450658|3614604|FG001|Overall Study|Lost to Follow-up|5
2043707|NCT00450658|3614603|FG000|Overall Study|UGI ulcer|33
2043708|NCT00450658|3614604|FG001|Overall Study|UGI ulcer|34
2043709|NCT00450658|3614603|FG000|Overall Study|misc|21
2043710|NCT00450658|3614604|FG001|Overall Study|misc|10
2105055|NCT00855218|3697541|FG000|Overall Study|Lost to Follow-up|0
2105056|NCT00855218|3697542|FG001|Overall Study|Lost to Follow-up|1
2105057|NCT00855218|3697541|FG000|Overall Study|Protocol Violation|5
2105058|NCT00855218|3697542|FG001|Overall Study|Protocol Violation|9
2105059|NCT00855218|3697541|FG000|Overall Study|non-compliant with study drug|3
2105060|NCT00855218|3697542|FG001|Overall Study|non-compliant with study drug|1
2105061|NCT00855218|3697541|FG000|Overall Study|patient convenience|2
2105062|NCT00855218|3697542|FG001|Overall Study|patient convenience|0
2105063|NCT00855218|3697541|FG000|Overall Study|technical problems|2
2105064|NCT00855218|3697542|FG001|Overall Study|technical problems|1
2105065|NCT00855218|3697541|FG000|Overall Study|Still treated with study medication|0
2105066|NCT00855218|3697542|FG001|Overall Study|Still treated with study medication|1
2105067|NCT00855218|3697541|FG000|Overall Study|Untreatable disease progression|54
2105068|NCT00855218|3697542|FG001|Overall Study|Untreatable disease progression|67
2105069|NCT00855218|3697541|FG000|Overall Study|Second malignancy|0
2105070|NCT00855218|3697542|FG001|Overall Study|Second malignancy|1
2105071|NCT00855218|3697541|FG000|Overall Study|Progression measurement proven|7
2105072|NCT00855218|3697542|FG001|Overall Study|Progression measurement proven|15
2105073|NCT00855218|3697541|FG000|Overall Study|Clinical endpoint reached|10
2105074|NCT00855218|3697542|FG001|Overall Study|Clinical endpoint reached|13
2105075|NCT00855309|3697550|FG000|Overall Study|patient never recieved drug|1
2105076|NCT00855309|3697551|FG001|Overall Study|patient never recieved drug|0
2105077|NCT00855335|3697562|FG000|Overall Study|Lost to Follow-up|0
2105078|NCT00855335|3697563|FG001|Overall Study|Lost to Follow-up|0
2105079|NCT00855335|3697564|FG002|Overall Study|Lost to Follow-up|3
2105080|NCT00855335|3697565|FG003|Overall Study|Lost to Follow-up|1
2105081|NCT00855335|3697566|FG004|Overall Study|Lost to Follow-up|0
2105082|NCT00855335|3697562|FG000|Overall Study|Withdrawal by Subject|0
2105083|NCT00855335|3697563|FG001|Overall Study|Withdrawal by Subject|0
2105084|NCT00855335|3697564|FG002|Overall Study|Withdrawal by Subject|0
2105085|NCT00855335|3697565|FG003|Overall Study|Withdrawal by Subject|1
2105086|NCT00855335|3697566|FG004|Overall Study|Withdrawal by Subject|0
2105087|NCT00855335|3697562|FG000|Overall Study|Adverse Event|2
2026055|NCT00348283|3594715|FG001|Open Label|Lost to Follow-up|1
2026056|NCT00348283|3594714|FG000|Open Label|Lack of Efficacy|0
2026057|NCT00348283|3594715|FG001|Open Label|Lack of Efficacy|13
2026058|NCT00348283|3594714|FG000|Open Label|Administrative reasons|0
2026059|NCT00348283|3594715|FG001|Open Label|Administrative reasons|5
2026060|NCT00348283|3594714|FG000|Open Label|Subject moved to the United States|0
2026061|NCT00348283|3594715|FG001|Open Label|Subject moved to the United States|1
2026062|NCT00348283|3594714|FG000|Open Label|Pregnancy|0
2026063|NCT00348283|3594715|FG001|Open Label|Pregnancy|1
2026064|NCT00348283|3594714|FG000|Open Label|Sponsor decision|0
2026065|NCT00348283|3594715|FG001|Open Label|Sponsor decision|1
2026066|NCT00348309|3594724|FG000|Overall Study|Adverse Event|56
2026067|NCT00348309|3594725|FG001|Overall Study|Adverse Event|28
2298244|NCT02574078|3994901|FG012|Treatment Period|Lost to Follow-up|0
2298245|NCT02574078|3994889|FG000|Treatment Period|Maximum clinical benefit|0
2298246|NCT02574078|3994890|FG001|Treatment Period|Maximum clinical benefit|0
2298247|NCT02574078|3994891|FG002|Treatment Period|Maximum clinical benefit|0
2298248|NCT02574078|3994892|FG003|Treatment Period|Maximum clinical benefit|0
2298249|NCT02574078|3994893|FG004|Treatment Period|Maximum clinical benefit|0
2298250|NCT02574078|3994894|FG005|Treatment Period|Maximum clinical benefit|0
2298251|NCT02574078|3994895|FG006|Treatment Period|Maximum clinical benefit|0
2298252|NCT02574078|3994896|FG007|Treatment Period|Maximum clinical benefit|0
2019524|NCT00299104|3586825|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
2019525|NCT00299104|3586826|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
2019526|NCT00299104|3586827|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
2019527|NCT00299104|3586825|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
2019528|NCT00299104|3586826|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
2019529|NCT00299104|3586827|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
2019530|NCT00299130|3586838|FG000|Treatment Period (up to 5 Years)|Adverse Event|13
2019531|NCT00299130|3586839|FG001|Treatment Period (up to 5 Years)|Adverse Event|8
2019532|NCT00299130|3586840|FG002|Treatment Period (up to 5 Years)|Adverse Event|13
2019533|NCT00299130|3586838|FG000|Treatment Period (up to 5 Years)|Death|1
2019534|NCT00299130|3586839|FG001|Treatment Period (up to 5 Years)|Death|3
2019535|NCT00299130|3586840|FG002|Treatment Period (up to 5 Years)|Death|1
2019536|NCT00299130|3586838|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
2019537|NCT00299130|3586839|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
2019538|NCT00299130|3586840|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
2019539|NCT00299130|3586838|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0
2019540|NCT00299130|3586839|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1
2019541|NCT00299130|3586840|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0
2019542|NCT00299130|3586838|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12
2019543|NCT00299130|3586839|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12
2019544|NCT00299130|3586840|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19
2019545|NCT00299130|3586838|FG000|Treatment Period (up to 5 Years)|Failure to Return|4
2043711|NCT00450723|3614610|FG000|Overall Study|Physician Decision|5
2043712|NCT00450749|3614618|FG000|Overall Study|Withdrawal by Subject|0
2043713|NCT00450749|3614619|FG001|Overall Study|Withdrawal by Subject|0
2043714|NCT00450749|3614620|FG002|Overall Study|Withdrawal by Subject|2
2043715|NCT00450749|3614618|FG000|Overall Study|Noncompliant|0
2043716|NCT00450749|3614619|FG001|Overall Study|Noncompliant|1
2043717|NCT00450749|3614620|FG002|Overall Study|Noncompliant|0
2043718|NCT00450801|3614628|FG000|Overall Study|Death|1
2043719|NCT00450814|3614647|FG000|Overall Study|Failed to complete the initial therapy|0
2105088|NCT00855335|3697563|FG001|Overall Study|Adverse Event|0
2298253|NCT02574078|3994897|FG008|Treatment Period|Maximum clinical benefit|0
2298254|NCT02574078|3994898|FG009|Treatment Period|Maximum clinical benefit|1
2298255|NCT02574078|3994899|FG010|Treatment Period|Maximum clinical benefit|0
2298256|NCT02574078|3994900|FG011|Treatment Period|Maximum clinical benefit|0
2298257|NCT02574078|3994901|FG012|Treatment Period|Maximum clinical benefit|0
2298258|NCT02574247|3994935|FG000|Overall Study|Withdrawal by Subject|1
2298259|NCT02574247|3994936|FG001|Overall Study|Withdrawal by Subject|0
2298260|NCT02574247|3994937|FG002|Overall Study|Withdrawal by Subject|0
2043720|NCT00450814|3614648|FG001|Overall Study|Failed to complete the initial therapy|0
2043721|NCT00450814|3614649|FG002|Overall Study|Failed to complete the initial therapy|0
2043722|NCT00450814|3614650|FG003|Overall Study|Failed to complete the initial therapy|1
2043723|NCT00450814|3614651|FG004|Overall Study|Failed to complete the initial therapy|1
2043724|NCT00450814|3614652|FG005|Overall Study|Failed to complete the initial therapy|1
2043725|NCT00450814|3614653|FG006|Overall Study|Failed to complete the initial therapy|0
2043726|NCT00450814|3614654|FG007|Overall Study|Failed to complete the initial therapy|0
2043727|NCT00450814|3614655|FG008|Overall Study|Failed to complete the initial therapy|0
2043728|NCT00450814|3614656|FG009|Overall Study|Failed to complete the initial therapy|0
2043729|NCT00450814|3614657|FG010|Overall Study|Failed to complete the initial therapy|0
2043730|NCT00450814|3614647|FG000|Overall Study|Patient withdrawal prior to treatment|0
2043731|NCT00450814|3614648|FG001|Overall Study|Patient withdrawal prior to treatment|0
2043732|NCT00450814|3614649|FG002|Overall Study|Patient withdrawal prior to treatment|0
2043733|NCT00450814|3614650|FG003|Overall Study|Patient withdrawal prior to treatment|0
2043734|NCT00450814|3614651|FG004|Overall Study|Patient withdrawal prior to treatment|0
2043735|NCT00450814|3614652|FG005|Overall Study|Patient withdrawal prior to treatment|0
2043736|NCT00450814|3614653|FG006|Overall Study|Patient withdrawal prior to treatment|0
2043737|NCT00450814|3614654|FG007|Overall Study|Patient withdrawal prior to treatment|0
2043738|NCT00450814|3614655|FG008|Overall Study|Patient withdrawal prior to treatment|0
2043739|NCT00450814|3614656|FG009|Overall Study|Patient withdrawal prior to treatment|1
2043740|NCT00450814|3614657|FG010|Overall Study|Patient withdrawal prior to treatment|0
2043741|NCT00450866|3614682|FG000|Overall Study|Adverse Event|0
2043742|NCT00450866|3614683|FG001|Overall Study|Adverse Event|1
2043743|NCT00450866|3614682|FG000|Overall Study|Withdrawal by Subject|5
2043744|NCT00450866|3614683|FG001|Overall Study|Withdrawal by Subject|2
2043745|NCT00450866|3614682|FG000|Overall Study|Death|1
2043746|NCT00450866|3614683|FG001|Overall Study|Death|0
2043747|NCT00450866|3614682|FG000|Overall Study|Physician Decision|1
2043748|NCT00450866|3614683|FG001|Overall Study|Physician Decision|0
2019546|NCT00299130|3586839|FG001|Treatment Period (up to 5 Years)|Failure to Return|6
2019547|NCT00299130|3586840|FG002|Treatment Period (up to 5 Years)|Failure to Return|6
2043749|NCT00451035|3614693|FG000|Overall Study|Disease progression|11
2043750|NCT00451035|3614693|FG000|Overall Study|Death|3
2043751|NCT00451035|3614693|FG000|Overall Study|New anti-neoplastic therapy|3
2043752|NCT00451178|3614704|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
2043753|NCT00451178|3614705|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
2043754|NCT00451178|3614704|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4
2043755|NCT00451178|3614705|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3
2043756|NCT00451178|3614704|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2
2043757|NCT00451178|3614705|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1
2043758|NCT00451178|3614704|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1
2043759|NCT00451178|3614705|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2
2043760|NCT00451178|3614704|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4
2043761|NCT00451178|3614705|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3
2043762|NCT00451178|3614704|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1
2043763|NCT00451178|3614705|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2
2043764|NCT00451178|3614704|FG000|Prior to Maintenance Therapy|Physician Decision|2
2043765|NCT00451178|3614705|FG001|Prior to Maintenance Therapy|Physician Decision|0
2043766|NCT00451178|3614704|FG000|Prior to Maintenance Therapy|PD|2
2043767|NCT00451178|3614705|FG001|Prior to Maintenance Therapy|PD|0
2043768|NCT00451178|3614704|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4
2043769|NCT00451178|3614705|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0
2043770|NCT00451178|3614704|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5
2043771|NCT00451178|3614705|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0
2043772|NCT00451178|3614704|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1
2043773|NCT00451178|3614705|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0
2043774|NCT00451178|3614704|FG000|Maintenance Therapy (up to 3 Years)|Death|1
2043775|NCT00451178|3614705|FG001|Maintenance Therapy (up to 3 Years)|Death|0
2043776|NCT00451178|3614704|FG000|Maintenance Therapy (up to 3 Years)|PD|10
2043777|NCT00451178|3614705|FG001|Maintenance Therapy (up to 3 Years)|PD|0
2043778|NCT00451178|3614704|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9
2043779|NCT00451178|3614705|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0
2043780|NCT00451178|3614704|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6
2043781|NCT00451178|3614705|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26
2043782|NCT00451191|3614717|FG000|Overall Study|withdrawal or received alternate tx|15
2043783|NCT00451191|3614718|FG001|Overall Study|withdrawal or received alternate tx|11
2043784|NCT00451204|3614726|FG000|Overall Study|Adverse Event|4
2043785|NCT00451204|3614727|FG001|Overall Study|Adverse Event|6
2043786|NCT00451204|3614726|FG000|Overall Study|Lack of Efficacy|4
2043787|NCT00451204|3614727|FG001|Overall Study|Lack of Efficacy|4
2043788|NCT00451204|3614726|FG000|Overall Study|Lost to Follow-up|4
2043789|NCT00451204|3614727|FG001|Overall Study|Lost to Follow-up|4
2043790|NCT00451204|3614726|FG000|Overall Study|Protocol Violation|1
2043791|NCT00451204|3614727|FG001|Overall Study|Protocol Violation|0
2043792|NCT00451204|3614726|FG000|Overall Study|Patient refusal|8
2043793|NCT00451204|3614727|FG001|Overall Study|Patient refusal|4
2043794|NCT00451204|3614726|FG000|Overall Study|Other|1
2043795|NCT00451204|3614727|FG001|Overall Study|Other|2
2043796|NCT00451217|3614740|FG000|Overall Study|Lost to Follow-up|0
2043797|NCT00451217|3614741|FG001|Overall Study|Lost to Follow-up|1
2043798|NCT00451217|3614742|FG002|Overall Study|Lost to Follow-up|1
2043799|NCT00451217|3614743|FG003|Overall Study|Lost to Follow-up|1
2043800|NCT00451217|3614740|FG000|Overall Study|Withdrawal by Subject|1
2043801|NCT00451217|3614741|FG001|Overall Study|Withdrawal by Subject|0
2043802|NCT00451217|3614742|FG002|Overall Study|Withdrawal by Subject|0
2043803|NCT00451217|3614743|FG003|Overall Study|Withdrawal by Subject|0
2043804|NCT00451217|3614740|FG000|Overall Study|Not Treated|1
2019548|NCT00299130|3586838|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4
2019549|NCT00299130|3586839|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6
2043805|NCT00451217|3614741|FG001|Overall Study|Not Treated|1
2043806|NCT00451217|3614742|FG002|Overall Study|Not Treated|3
2043807|NCT00451217|3614743|FG003|Overall Study|Not Treated|4
2043808|NCT00451282|3614755|FG000|Overall Study|Lost to Follow-up|6
2043809|NCT00451282|3614756|FG001|Overall Study|Lost to Follow-up|5
2043810|NCT00451321|3614770|FG000|Overall Study|Lost to Follow-up|3
2043811|NCT00451321|3614771|FG001|Overall Study|Lost to Follow-up|3
2043812|NCT00451321|3614772|FG002|Overall Study|Lost to Follow-up|1
2043813|NCT00451321|3614773|FG003|Overall Study|Lost to Follow-up|3
2043814|NCT00451321|3614774|FG004|Overall Study|Lost to Follow-up|0
2043815|NCT00451321|3614775|FG005|Overall Study|Lost to Follow-up|1
2043816|NCT00451321|3614776|FG006|Overall Study|Lost to Follow-up|0
2043817|NCT00451321|3614777|FG007|Overall Study|Lost to Follow-up|0
2043818|NCT00451321|3614770|FG000|Overall Study|Withdrawal by Subject|3
2043819|NCT00451321|3614771|FG001|Overall Study|Withdrawal by Subject|1
2043820|NCT00451321|3614772|FG002|Overall Study|Withdrawal by Subject|0
2043821|NCT00451321|3614773|FG003|Overall Study|Withdrawal by Subject|4
2043822|NCT00451321|3614774|FG004|Overall Study|Withdrawal by Subject|0
2043823|NCT00451321|3614775|FG005|Overall Study|Withdrawal by Subject|0
2043824|NCT00451321|3614776|FG006|Overall Study|Withdrawal by Subject|0
2043825|NCT00451321|3614777|FG007|Overall Study|Withdrawal by Subject|0
2043826|NCT00451321|3614770|FG000|Overall Study|Study closed/terminated|1
2043827|NCT00451321|3614771|FG001|Overall Study|Study closed/terminated|1
2043828|NCT00451321|3614772|FG002|Overall Study|Study closed/terminated|17
2043829|NCT00451321|3614773|FG003|Overall Study|Study closed/terminated|5
2043830|NCT00451321|3614774|FG004|Overall Study|Study closed/terminated|7
2043831|NCT00451321|3614775|FG005|Overall Study|Study closed/terminated|7
2043832|NCT00451321|3614776|FG006|Overall Study|Study closed/terminated|5
2043833|NCT00451321|3614777|FG007|Overall Study|Study closed/terminated|3
2043834|NCT00451321|3614770|FG000|Overall Study|Sponsor decision to amend protocol|0
2043835|NCT00451321|3614771|FG001|Overall Study|Sponsor decision to amend protocol|0
2043836|NCT00451321|3614772|FG002|Overall Study|Sponsor decision to amend protocol|0
2043837|NCT00451321|3614773|FG003|Overall Study|Sponsor decision to amend protocol|0
2043838|NCT00451321|3614774|FG004|Overall Study|Sponsor decision to amend protocol|0
2043839|NCT00451321|3614775|FG005|Overall Study|Sponsor decision to amend protocol|1
2043840|NCT00451321|3614776|FG006|Overall Study|Sponsor decision to amend protocol|1
2043841|NCT00451321|3614777|FG007|Overall Study|Sponsor decision to amend protocol|3
2298261|NCT02574247|3994935|FG000|Overall Study|Did not meet inclusion criteria|4
2298262|NCT02574247|3994936|FG001|Overall Study|Did not meet inclusion criteria|3
2298263|NCT02574247|3994937|FG002|Overall Study|Did not meet inclusion criteria|5
2298264|NCT02574260|3994947|FG000|Overall Study|Disease Progression|1
2298265|NCT02574312|3994953|FG000|3 Months Follow-up|Withdrawal by Subject|1
2298266|NCT02574312|3994954|FG001|3 Months Follow-up|Withdrawal by Subject|0
2298267|NCT02574520|3994964|FG000|Overall Study|Not dosed|2
2298268|NCT02574520|3994965|FG001|Overall Study|Not dosed|0
2298269|NCT02574520|3994966|FG002|Overall Study|Not dosed|5
2298270|NCT02574520|3994967|FG003|Overall Study|Not dosed|4
2298271|NCT02574520|3994964|FG000|Overall Study|Adverse Event|0
2298272|NCT02574520|3994965|FG001|Overall Study|Adverse Event|0
2298273|NCT02574520|3994966|FG002|Overall Study|Adverse Event|0
2298274|NCT02574520|3994967|FG003|Overall Study|Adverse Event|1
2298275|NCT02574520|3994964|FG000|Overall Study|Withdrawal by Subject|0
2298276|NCT02574520|3994965|FG001|Overall Study|Withdrawal by Subject|0
2298277|NCT02574520|3994966|FG002|Overall Study|Withdrawal by Subject|0
2298278|NCT02574520|3994967|FG003|Overall Study|Withdrawal by Subject|1
2298279|NCT02574520|3994964|FG000|Overall Study|Other|0
2298280|NCT02574520|3994965|FG001|Overall Study|Other|0
2298281|NCT02574520|3994966|FG002|Overall Study|Other|0
2298282|NCT02574520|3994967|FG003|Overall Study|Other|2
2298283|NCT02574637|3994991|FG000|Double-blind Period|Adverse Event|1
2298284|NCT02574637|3994992|FG001|Double-blind Period|Adverse Event|0
2298285|NCT02574637|3994993|FG002|Double-blind Period|Adverse Event|0
2298286|NCT02574637|3994994|FG003|Double-blind Period|Adverse Event|0
2043842|NCT00451451|3614799|FG000|Overall Study|Adverse Event|11
2043843|NCT00451451|3614800|FG001|Overall Study|Adverse Event|21
2043844|NCT00451451|3614801|FG002|Overall Study|Adverse Event|26
2043845|NCT00451451|3614802|FG003|Overall Study|Adverse Event|10
2043846|NCT00451451|3614799|FG000|Overall Study|Lost to Follow-up|11
2043847|NCT00451451|3614800|FG001|Overall Study|Lost to Follow-up|9
2043848|NCT00451451|3614801|FG002|Overall Study|Lost to Follow-up|8
2043849|NCT00451451|3614802|FG003|Overall Study|Lost to Follow-up|11
2043850|NCT00451451|3614799|FG000|Overall Study|Consent Withdrawn|14
2043851|NCT00451451|3614800|FG001|Overall Study|Consent Withdrawn|9
2043852|NCT00451451|3614801|FG002|Overall Study|Consent Withdrawn|17
2043853|NCT00451451|3614802|FG003|Overall Study|Consent Withdrawn|17
2043854|NCT00451451|3614799|FG000|Overall Study|Investigator Decision|6
2043855|NCT00451451|3614800|FG001|Overall Study|Investigator Decision|2
2043856|NCT00451451|3614801|FG002|Overall Study|Investigator Decision|1
2043857|NCT00451451|3614802|FG003|Overall Study|Investigator Decision|2
2043858|NCT00451451|3614799|FG000|Overall Study|Subject Non-Compliance|8
2043859|NCT00451451|3614800|FG001|Overall Study|Subject Non-Compliance|4
2043860|NCT00451451|3614801|FG002|Overall Study|Subject Non-Compliance|3
2043861|NCT00451451|3614802|FG003|Overall Study|Subject Non-Compliance|3
2043862|NCT00451451|3614799|FG000|Overall Study|Death|1
2043863|NCT00451451|3614800|FG001|Overall Study|Death|0
2043864|NCT00451451|3614801|FG002|Overall Study|Death|0
2043865|NCT00451451|3614802|FG003|Overall Study|Death|1
2043866|NCT00451451|3614799|FG000|Overall Study|Other Reasons for Not Completing Study|34
2043867|NCT00451451|3614800|FG001|Overall Study|Other Reasons for Not Completing Study|30
2043868|NCT00451451|3614801|FG002|Overall Study|Other Reasons for Not Completing Study|17
2043869|NCT00451451|3614802|FG003|Overall Study|Other Reasons for Not Completing Study|14
2043870|NCT00451555|3614817|FG000|Overall Study|Protocol Violation|2
2043871|NCT00451555|3614818|FG001|Overall Study|Protocol Violation|2
2043872|NCT00451555|3614817|FG000|Overall Study|Adverse Event|3
2298287|NCT02574637|3994995|FG004|Double-blind Period|Adverse Event|0
2298288|NCT02574637|3994996|FG005|Double-blind Period|Adverse Event|0
2298289|NCT02574637|3994997|FG006|Double-blind Period|Adverse Event|0
2298290|NCT02574637|3994998|FG007|Double-blind Period|Adverse Event|0
2298291|NCT02574637|3994999|FG008|Double-blind Period|Adverse Event|0
2298292|NCT02574637|3995000|FG009|Double-blind Period|Adverse Event|0
2298293|NCT02574637|3994991|FG000|Double-blind Period|Lack of Efficacy|0
2298294|NCT02574637|3994992|FG001|Double-blind Period|Lack of Efficacy|0
2298295|NCT02574637|3994993|FG002|Double-blind Period|Lack of Efficacy|2
2298296|NCT02574637|3994994|FG003|Double-blind Period|Lack of Efficacy|0
2298297|NCT02574637|3994995|FG004|Double-blind Period|Lack of Efficacy|0
2298298|NCT02574637|3994996|FG005|Double-blind Period|Lack of Efficacy|0
2298299|NCT02574637|3994997|FG006|Double-blind Period|Lack of Efficacy|0
2298300|NCT02574637|3994998|FG007|Double-blind Period|Lack of Efficacy|0
2298301|NCT02574637|3994999|FG008|Double-blind Period|Lack of Efficacy|0
2043873|NCT00451555|3614818|FG001|Overall Study|Adverse Event|1
2043874|NCT00451555|3614817|FG000|Overall Study|Withdrawal by Subject|6
2043875|NCT00451555|3614818|FG001|Overall Study|Withdrawal by Subject|0
2043876|NCT00451555|3614817|FG000|Overall Study|Physician Decision|2
2043877|NCT00451555|3614818|FG001|Overall Study|Physician Decision|1
2043878|NCT00451906|3614844|FG000|Overall Study|Adverse Event|515
2043879|NCT00451906|3614844|FG000|Overall Study|Lost to Follow-up|31
2043880|NCT00451906|3614844|FG000|Overall Study|Withdrawal by Subject|111
2043881|NCT00451906|3614844|FG000|Overall Study|Protocol Violation|21
2298302|NCT02574637|3995000|FG009|Double-blind Period|Lack of Efficacy|0
2298303|NCT02574637|3994991|FG000|Double-blind Period|Protocol Deviation|1
2298304|NCT02574637|3994992|FG001|Double-blind Period|Protocol Deviation|0
2043882|NCT00451906|3614844|FG000|Overall Study|Progressive disease|1328
2043883|NCT00451906|3614844|FG000|Overall Study|Termination of the study|108
2043884|NCT00451906|3614844|FG000|Overall Study|Other Reasons|121
2043885|NCT00451906|3614844|FG000|Overall Study|Did not complete final visit|4
2043886|NCT00451958|3614852|FG000|CS21A (NCT00451958)|Adverse Event|21
2043887|NCT00451958|3614853|FG001|CS21A (NCT00451958)|Adverse Event|34
2043888|NCT00451958|3614854|FG002|CS21A (NCT00451958)|Adverse Event|14
2043889|NCT00451958|3614855|FG003|CS21A (NCT00451958)|Adverse Event|17
2043890|NCT00451958|3614856|FG004|CS21A (NCT00451958)|Adverse Event|0
2043891|NCT00451958|3614852|FG000|CS21A (NCT00451958)|Lost to Follow-up|6
2019550|NCT00299130|3586840|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4
2019551|NCT00299130|3586838|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
2019552|NCT00299130|3586839|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
2019553|NCT00299130|3586840|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
2019554|NCT00299130|3586838|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
2019555|NCT00299130|3586839|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
2019556|NCT00299130|3586840|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
2019557|NCT00299130|3586838|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4
2019558|NCT00299130|3586839|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5
2019559|NCT00299130|3586840|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3
2019560|NCT00299130|3586838|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
2019561|NCT00299130|3586839|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
2019562|NCT00299130|3586840|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
2019563|NCT00299130|3586838|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
2298305|NCT02574637|3994993|FG002|Double-blind Period|Protocol Deviation|0
2298306|NCT02574637|3994994|FG003|Double-blind Period|Protocol Deviation|0
2298307|NCT02574637|3994995|FG004|Double-blind Period|Protocol Deviation|0
2298308|NCT02574637|3994996|FG005|Double-blind Period|Protocol Deviation|0
2298309|NCT02574637|3994997|FG006|Double-blind Period|Protocol Deviation|0
2298310|NCT02574637|3994998|FG007|Double-blind Period|Protocol Deviation|0
2298311|NCT02574637|3994999|FG008|Double-blind Period|Protocol Deviation|0
2298312|NCT02574637|3995000|FG009|Double-blind Period|Protocol Deviation|0
2298313|NCT02574637|3994991|FG000|Double-blind Period|Non-Compliance With Study Drug|0
2298314|NCT02574637|3994992|FG001|Double-blind Period|Non-Compliance With Study Drug|0
2298315|NCT02574637|3994993|FG002|Double-blind Period|Non-Compliance With Study Drug|0
2298316|NCT02574637|3994994|FG003|Double-blind Period|Non-Compliance With Study Drug|1
2298317|NCT02574637|3994995|FG004|Double-blind Period|Non-Compliance With Study Drug|0
2298318|NCT02574637|3994996|FG005|Double-blind Period|Non-Compliance With Study Drug|0
2298319|NCT02574637|3994997|FG006|Double-blind Period|Non-Compliance With Study Drug|0
2298320|NCT02574637|3994998|FG007|Double-blind Period|Non-Compliance With Study Drug|0
2298321|NCT02574637|3994999|FG008|Double-blind Period|Non-Compliance With Study Drug|0
2298322|NCT02574637|3995000|FG009|Double-blind Period|Non-Compliance With Study Drug|0
2298323|NCT02574637|3994991|FG000|Double-blind Period|Study Terminated By Sponsor|1
2298324|NCT02574637|3994992|FG001|Double-blind Period|Study Terminated By Sponsor|1
2298325|NCT02574637|3994993|FG002|Double-blind Period|Study Terminated By Sponsor|5
2298326|NCT02574637|3994994|FG003|Double-blind Period|Study Terminated By Sponsor|2
2298327|NCT02574637|3994995|FG004|Double-blind Period|Study Terminated By Sponsor|2
2298328|NCT02574637|3994996|FG005|Double-blind Period|Study Terminated By Sponsor|0
2298329|NCT02574637|3994997|FG006|Double-blind Period|Study Terminated By Sponsor|0
2298330|NCT02574637|3994998|FG007|Double-blind Period|Study Terminated By Sponsor|0
2298331|NCT02574637|3994999|FG008|Double-blind Period|Study Terminated By Sponsor|0
2298332|NCT02574637|3995000|FG009|Double-blind Period|Study Terminated By Sponsor|0
2298333|NCT02574637|3994991|FG000|Double-blind Period|Reason Not Specified|0
2298334|NCT02574637|3994992|FG001|Double-blind Period|Reason Not Specified|0
2298335|NCT02574637|3994993|FG002|Double-blind Period|Reason Not Specified|0
2298336|NCT02574637|3994994|FG003|Double-blind Period|Reason Not Specified|1
2298337|NCT02574637|3994995|FG004|Double-blind Period|Reason Not Specified|0
2298338|NCT02574637|3994996|FG005|Double-blind Period|Reason Not Specified|0
2298339|NCT02574637|3994997|FG006|Double-blind Period|Reason Not Specified|0
2019564|NCT00299130|3586839|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
2019565|NCT00299130|3586840|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
2019566|NCT00299130|3586838|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
2019567|NCT00299130|3586839|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
2019568|NCT00299130|3586840|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
2019569|NCT00299130|3586838|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
2019570|NCT00299130|3586839|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
2019571|NCT00299130|3586840|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
2019572|NCT00299130|3586838|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
2019573|NCT00299130|3586839|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
2019574|NCT00299130|3586840|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
2019575|NCT00299130|3586838|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
2019576|NCT00299130|3586839|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
2043892|NCT00451958|3614853|FG001|CS21A (NCT00451958)|Lost to Follow-up|5
2043893|NCT00451958|3614854|FG002|CS21A (NCT00451958)|Lost to Follow-up|1
2043894|NCT00451958|3614855|FG003|CS21A (NCT00451958)|Lost to Follow-up|1
2043895|NCT00451958|3614856|FG004|CS21A (NCT00451958)|Lost to Follow-up|0
2043896|NCT00451958|3614852|FG000|CS21A (NCT00451958)|Protocol Violation|1
2043897|NCT00451958|3614853|FG001|CS21A (NCT00451958)|Protocol Violation|3
2043898|NCT00451958|3614854|FG002|CS21A (NCT00451958)|Protocol Violation|2
2043899|NCT00451958|3614855|FG003|CS21A (NCT00451958)|Protocol Violation|0
2043900|NCT00451958|3614856|FG004|CS21A (NCT00451958)|Protocol Violation|0
2043901|NCT00451958|3614852|FG000|CS21A (NCT00451958)|Physician Decision|2
2043902|NCT00451958|3614853|FG001|CS21A (NCT00451958)|Physician Decision|4
2043903|NCT00451958|3614854|FG002|CS21A (NCT00451958)|Physician Decision|4
2043904|NCT00451958|3614855|FG003|CS21A (NCT00451958)|Physician Decision|4
2043905|NCT00451958|3614856|FG004|CS21A (NCT00451958)|Physician Decision|0
2043906|NCT00451958|3614852|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7
2043907|NCT00451958|3614853|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4
2043908|NCT00451958|3614854|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4
2043909|NCT00451958|3614855|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3
2043910|NCT00451958|3614856|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0
2043911|NCT00451958|3614852|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28
2043912|NCT00451958|3614853|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27
2043913|NCT00451958|3614854|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17
2043914|NCT00451958|3614855|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14
2043915|NCT00451958|3614856|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0
2043916|NCT00452114|3614872|FG000|Overall Study|Physician Decision|3
2043917|NCT00452114|3614873|FG001|Overall Study|Physician Decision|3
2043918|NCT00452348|3614897|FG000|Overall Study|Adverse Event|6
2043919|NCT00452348|3614898|FG001|Overall Study|Adverse Event|9
2043920|NCT00452348|3614897|FG000|Overall Study|Lack of Efficacy|10
2043921|NCT00452348|3614898|FG001|Overall Study|Lack of Efficacy|9
2043922|NCT00452348|3614897|FG000|Overall Study|Lost to Follow-up|14
2043923|NCT00452348|3614898|FG001|Overall Study|Lost to Follow-up|8
2043924|NCT00452348|3614897|FG000|Overall Study|Protocol Violation|22
2043925|NCT00452348|3614898|FG001|Overall Study|Protocol Violation|28
2043926|NCT00452348|3614897|FG000|Overall Study|Withdrawal by Subject|18
2043927|NCT00452348|3614898|FG001|Overall Study|Withdrawal by Subject|21
2043928|NCT00452348|3614897|FG000|Overall Study|Other|9
2043929|NCT00452348|3614898|FG001|Overall Study|Other|9
2043930|NCT00452400|3614919|FG000|Overall Study|Adverse Event|1
2043931|NCT00452400|3614920|FG001|Overall Study|Adverse Event|1
2043932|NCT00452400|3614921|FG002|Overall Study|Adverse Event|5
2043933|NCT00452400|3614922|FG003|Overall Study|Adverse Event|0
2043934|NCT00452400|3614923|FG004|Overall Study|Adverse Event|2
2043935|NCT00452400|3614919|FG000|Overall Study|Protocol Violation|0
2043936|NCT00452400|3614920|FG001|Overall Study|Protocol Violation|0
2043937|NCT00452400|3614921|FG002|Overall Study|Protocol Violation|1
2043938|NCT00452400|3614922|FG003|Overall Study|Protocol Violation|0
2043939|NCT00452400|3614923|FG004|Overall Study|Protocol Violation|0
2043940|NCT00452400|3614919|FG000|Overall Study|Lost to Follow-up|1
2019577|NCT00299130|3586840|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
2019578|NCT00299130|3586838|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
2019579|NCT00299130|3586839|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
2019580|NCT00299130|3586840|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
2019581|NCT00299156|3586858|FG000|Period 2 (Randomized)|Screen Failure|0
2019582|NCT00299156|3586859|FG001|Period 2 (Randomized)|Screen Failure|1
2019583|NCT00299156|3586860|FG002|Period 2 (Randomized)|Screen Failure|0
2019584|NCT00299182|3586875|FG000|Overall Study|Withdrawal by Subject|0
2019585|NCT00299182|3586876|FG001|Overall Study|Withdrawal by Subject|0
2019586|NCT00299182|3586877|FG002|Overall Study|Withdrawal by Subject|1
2019587|NCT00299182|3586878|FG003|Overall Study|Withdrawal by Subject|0
2019588|NCT00299182|3586879|FG004|Overall Study|Withdrawal by Subject|1
2019589|NCT00299182|3586880|FG005|Overall Study|Withdrawal by Subject|2
2019590|NCT00299182|3586881|FG006|Overall Study|Withdrawal by Subject|0
2019591|NCT00299182|3586875|FG000|Overall Study|Chemotherapy Changed|0
2019592|NCT00299182|3586876|FG001|Overall Study|Chemotherapy Changed|0
2019593|NCT00299182|3586877|FG002|Overall Study|Chemotherapy Changed|1
2019594|NCT00299182|3586878|FG003|Overall Study|Chemotherapy Changed|0
2019595|NCT00299182|3586879|FG004|Overall Study|Chemotherapy Changed|1
2019596|NCT00299182|3586880|FG005|Overall Study|Chemotherapy Changed|0
2019597|NCT00299182|3586881|FG006|Overall Study|Chemotherapy Changed|1
2019598|NCT00299182|3586875|FG000|Overall Study|Adverse Event|0
2019599|NCT00299182|3586876|FG001|Overall Study|Adverse Event|0
2019600|NCT00299182|3586877|FG002|Overall Study|Adverse Event|0
2019601|NCT00299182|3586878|FG003|Overall Study|Adverse Event|0
2019602|NCT00299182|3586879|FG004|Overall Study|Adverse Event|0
2019603|NCT00299182|3586880|FG005|Overall Study|Adverse Event|1
2019604|NCT00299182|3586881|FG006|Overall Study|Adverse Event|0
2019605|NCT00299182|3586875|FG000|Overall Study|Not Eligible|0
2019606|NCT00299182|3586876|FG001|Overall Study|Not Eligible|0
2019607|NCT00299182|3586877|FG002|Overall Study|Not Eligible|0
2019608|NCT00299182|3586878|FG003|Overall Study|Not Eligible|0
2019609|NCT00299182|3586879|FG004|Overall Study|Not Eligible|1
2019610|NCT00299182|3586880|FG005|Overall Study|Not Eligible|0
2019611|NCT00299182|3586881|FG006|Overall Study|Not Eligible|0
2019612|NCT00299494|3586918|FG000|Overall Study|Withdrawal by Subject|0
2043941|NCT00452400|3614920|FG001|Overall Study|Lost to Follow-up|0
2043942|NCT00452400|3614921|FG002|Overall Study|Lost to Follow-up|0
2043943|NCT00452400|3614922|FG003|Overall Study|Lost to Follow-up|0
2043944|NCT00452400|3614923|FG004|Overall Study|Lost to Follow-up|0
2043945|NCT00452400|3614919|FG000|Overall Study|Withdrawal by Subject|1
2043946|NCT00452400|3614920|FG001|Overall Study|Withdrawal by Subject|0
2043947|NCT00452400|3614921|FG002|Overall Study|Withdrawal by Subject|1
2043948|NCT00452400|3614922|FG003|Overall Study|Withdrawal by Subject|0
2043949|NCT00452400|3614923|FG004|Overall Study|Withdrawal by Subject|0
2043950|NCT00452400|3614919|FG000|Overall Study|Lack of Efficacy|2
2043951|NCT00452400|3614920|FG001|Overall Study|Lack of Efficacy|0
2043952|NCT00452400|3614921|FG002|Overall Study|Lack of Efficacy|0
2043953|NCT00452400|3614922|FG003|Overall Study|Lack of Efficacy|0
2043954|NCT00452400|3614923|FG004|Overall Study|Lack of Efficacy|0
2043955|NCT00452400|3614919|FG000|Overall Study|Other reasons not listed above|0
2043956|NCT00452400|3614920|FG001|Overall Study|Other reasons not listed above|0
2043957|NCT00452400|3614921|FG002|Overall Study|Other reasons not listed above|0
2043958|NCT00452400|3614922|FG003|Overall Study|Other reasons not listed above|1
2043959|NCT00452400|3614923|FG004|Overall Study|Other reasons not listed above|1
2043960|NCT00452413|3614938|FG000|Overall Study|Progressive Disease|4
2043961|NCT00452413|3614939|FG001|Overall Study|Progressive Disease|11
2043962|NCT00452413|3614940|FG002|Overall Study|Progressive Disease|30
2043963|NCT00452413|3614938|FG000|Overall Study|Withdrawal by Subject|0
2043964|NCT00452413|3614939|FG001|Overall Study|Withdrawal by Subject|1
2043965|NCT00452413|3614940|FG002|Overall Study|Withdrawal by Subject|4
2043966|NCT00452413|3614938|FG000|Overall Study|Adverse Event|0
2043967|NCT00452413|3614939|FG001|Overall Study|Adverse Event|0
2043968|NCT00452413|3614940|FG002|Overall Study|Adverse Event|5
2043969|NCT00452413|3614938|FG000|Overall Study|Physician Decision|0
2043970|NCT00452413|3614939|FG001|Overall Study|Physician Decision|0
2043971|NCT00452413|3614940|FG002|Overall Study|Physician Decision|4
2043972|NCT00452413|3614938|FG000|Overall Study|Death due to study disease|0
2043973|NCT00452413|3614939|FG001|Overall Study|Death due to study disease|0
2043974|NCT00452413|3614940|FG002|Overall Study|Death due to study disease|2
2043975|NCT00452413|3614938|FG000|Overall Study|Death due to adverse event (AE)|0
2043976|NCT00452413|3614939|FG001|Overall Study|Death due to adverse event (AE)|0
2043977|NCT00452413|3614940|FG002|Overall Study|Death due to adverse event (AE)|1
2043978|NCT00452413|3614938|FG000|Overall Study|On treatment|0
2043979|NCT00452413|3614939|FG001|Overall Study|On treatment|0
2208575|NCT01641081|3848249|FG001|Period 2|Protocol Violation|0
2208576|NCT01641081|3848250|FG002|Period 2|Protocol Violation|0
2208577|NCT01641081|3848251|FG003|Period 2|Protocol Violation|0
2208578|NCT01641081|3848252|FG004|Period 2|Protocol Violation|0
2208579|NCT01641081|3848253|FG005|Period 2|Protocol Violation|0
2208580|NCT01641081|3848254|FG006|Period 2|Protocol Violation|0
2208581|NCT01641081|3848255|FG007|Period 2|Protocol Violation|0
2208582|NCT01641081|3848256|FG008|Period 2|Protocol Violation|0
2208583|NCT01641081|3848257|FG009|Period 2|Protocol Violation|0
2208584|NCT01641081|3848248|FG000|Period 3|Adverse Event|0
2208585|NCT01641081|3848249|FG001|Period 3|Adverse Event|0
2208586|NCT01641081|3848250|FG002|Period 3|Adverse Event|1
2208587|NCT01641081|3848251|FG003|Period 3|Adverse Event|0
2208588|NCT01641081|3848252|FG004|Period 3|Adverse Event|0
2208589|NCT01641081|3848253|FG005|Period 3|Adverse Event|0
2208590|NCT01641081|3848254|FG006|Period 3|Adverse Event|0
2208591|NCT01641081|3848255|FG007|Period 3|Adverse Event|0
2208592|NCT01641081|3848256|FG008|Period 3|Adverse Event|0
2208593|NCT01641081|3848257|FG009|Period 3|Adverse Event|0
2208594|NCT01641081|3848248|FG000|Period 3|Withdrawal by Subject|0
2208595|NCT01641081|3848249|FG001|Period 3|Withdrawal by Subject|0
2208596|NCT01641081|3848250|FG002|Period 3|Withdrawal by Subject|0
2208597|NCT01641081|3848251|FG003|Period 3|Withdrawal by Subject|0
2208598|NCT01641081|3848252|FG004|Period 3|Withdrawal by Subject|0
2043980|NCT00452413|3614940|FG002|Overall Study|On treatment|3
2043981|NCT00452439|3614960|FG000|Overall Study|Lost to Follow-up|1
2043982|NCT00452439|3614961|FG001|Overall Study|Lost to Follow-up|1
2043983|NCT00452439|3614960|FG000|Overall Study|Refused Treatment|4
2043984|NCT00452439|3614961|FG001|Overall Study|Refused Treatment|3
2043985|NCT00452439|3614960|FG000|Overall Study|Death|3
2043986|NCT00452439|3614961|FG001|Overall Study|Death|1
2043987|NCT00452439|3614960|FG000|Overall Study|Bone Marrow Transplant|0
2043988|NCT00452439|3614961|FG001|Overall Study|Bone Marrow Transplant|1
2043989|NCT00452439|3614960|FG000|Overall Study|Too Ill to Continue|0
2043990|NCT00452439|3614961|FG001|Overall Study|Too Ill to Continue|1
2043991|NCT00452439|3614960|FG000|Overall Study|Failed to achieve complete response|2
2043992|NCT00452439|3614961|FG001|Overall Study|Failed to achieve complete response|0
2043993|NCT00452439|3614960|FG000|Overall Study|Relapse|3
2043994|NCT00452439|3614961|FG001|Overall Study|Relapse|0
2043995|NCT00452439|3614960|FG000|Overall Study|Fracture|1
2043996|NCT00452439|3614961|FG001|Overall Study|Fracture|0
2043997|NCT00452452|3614970|FG000|Overall Study|Protocol Violation|0
2208599|NCT01641081|3848253|FG005|Period 3|Withdrawal by Subject|0
2208600|NCT01641081|3848254|FG006|Period 3|Withdrawal by Subject|0
2208601|NCT01641081|3848255|FG007|Period 3|Withdrawal by Subject|0
2208602|NCT01641081|3848256|FG008|Period 3|Withdrawal by Subject|1
2208603|NCT01641081|3848257|FG009|Period 3|Withdrawal by Subject|0
2043998|NCT00452452|3614971|FG001|Overall Study|Protocol Violation|0
2043999|NCT00452452|3614972|FG002|Overall Study|Protocol Violation|1
2044000|NCT00452452|3614970|FG000|Overall Study|Withdrawal by Subject|1
2044001|NCT00452452|3614971|FG001|Overall Study|Withdrawal by Subject|0
2044002|NCT00452452|3614972|FG002|Overall Study|Withdrawal by Subject|0
2208604|NCT01641081|3848248|FG000|Period 4|Adverse Event|0
2208605|NCT01641081|3848249|FG001|Period 4|Adverse Event|1
2208606|NCT01641081|3848250|FG002|Period 4|Adverse Event|0
2019613|NCT00299494|3586919|FG001|Overall Study|Withdrawal by Subject|0
2019614|NCT00299494|3586920|FG002|Overall Study|Withdrawal by Subject|0
2019615|NCT00299494|3586921|FG003|Overall Study|Withdrawal by Subject|3
2019616|NCT00299494|3586922|FG004|Overall Study|Withdrawal by Subject|1
2019617|NCT00299494|3586923|FG005|Overall Study|Withdrawal by Subject|4
2019618|NCT00299494|3586918|FG000|Overall Study|Physician Decision|0
2019619|NCT00299494|3586919|FG001|Overall Study|Physician Decision|0
2019620|NCT00299494|3586920|FG002|Overall Study|Physician Decision|0
2019621|NCT00299494|3586921|FG003|Overall Study|Physician Decision|0
2019622|NCT00299494|3586922|FG004|Overall Study|Physician Decision|1
2019623|NCT00299494|3586923|FG005|Overall Study|Physician Decision|0
2019624|NCT00299494|3586918|FG000|Overall Study|Death|3
2019625|NCT00299494|3586919|FG001|Overall Study|Death|1
2019626|NCT00299494|3586920|FG002|Overall Study|Death|4
2019627|NCT00299494|3586921|FG003|Overall Study|Death|6
2019628|NCT00299494|3586922|FG004|Overall Study|Death|18
2019629|NCT00299494|3586923|FG005|Overall Study|Death|19
2019630|NCT00299494|3586918|FG000|Overall Study|Lost to Follow-up|0
2019631|NCT00299494|3586919|FG001|Overall Study|Lost to Follow-up|0
2019632|NCT00299494|3586920|FG002|Overall Study|Lost to Follow-up|0
2019633|NCT00299494|3586921|FG003|Overall Study|Lost to Follow-up|0
2019634|NCT00299494|3586922|FG004|Overall Study|Lost to Follow-up|3
2019635|NCT00299494|3586923|FG005|Overall Study|Lost to Follow-up|1
2019636|NCT00299494|3586918|FG000|Overall Study|Other - Unspecified|0
2044003|NCT00452452|3614970|FG000|Overall Study|Lost to Follow-up|1
2044004|NCT00452452|3614971|FG001|Overall Study|Lost to Follow-up|0
2044005|NCT00452452|3614972|FG002|Overall Study|Lost to Follow-up|0
2044006|NCT00452530|3614988|FG000|Overall Study|Death|1
2044007|NCT00452530|3614989|FG001|Overall Study|Death|0
2044008|NCT00452530|3614988|FG000|Overall Study|Adverse Event|40
2044009|NCT00452530|3614989|FG001|Overall Study|Adverse Event|44
2044010|NCT00452530|3614988|FG000|Overall Study|Withdrawal by Subject|68
2044011|NCT00452530|3614989|FG001|Overall Study|Withdrawal by Subject|57
2044012|NCT00452530|3614988|FG000|Overall Study|Lost to Follow-up|1
2044013|NCT00452530|3614989|FG001|Overall Study|Lost to Follow-up|0
2044014|NCT00452530|3614988|FG000|Overall Study|Poor compliance/noncompliance|1
2044015|NCT00452530|3614989|FG001|Overall Study|Poor compliance/noncompliance|2
2044016|NCT00452530|3614988|FG000|Overall Study|No longer met study criteria|18
2044017|NCT00452530|3614989|FG001|Overall Study|No longer met study criteria|22
2044018|NCT00452530|3614988|FG000|Overall Study|Other|7
2044019|NCT00452530|3614989|FG001|Overall Study|Other|11
2044020|NCT00452673|3615012|FG000|Dose Escalation Period|Disease Progression|6
2044021|NCT00452673|3615013|FG001|Dose Escalation Period|Disease Progression|6
2044022|NCT00452673|3615014|FG002|Dose Escalation Period|Disease Progression|2
2044023|NCT00452673|3615015|FG003|Dose Escalation Period|Disease Progression|6
2044024|NCT00452673|3615016|FG004|Dose Escalation Period|Disease Progression|0
2044025|NCT00452673|3615012|FG000|Dose Escalation Period|study drug toxicity|1
2044026|NCT00452673|3615013|FG001|Dose Escalation Period|study drug toxicity|3
2044027|NCT00452673|3615014|FG002|Dose Escalation Period|study drug toxicity|3
2044028|NCT00452673|3615015|FG003|Dose Escalation Period|study drug toxicity|1
2044029|NCT00452673|3615016|FG004|Dose Escalation Period|study drug toxicity|0
2044030|NCT00452673|3615012|FG000|Dose Escalation Period|Other|0
2044031|NCT00452673|3615013|FG001|Dose Escalation Period|Other|0
2044032|NCT00452673|3615014|FG002|Dose Escalation Period|Other|1
2044033|NCT00452673|3615015|FG003|Dose Escalation Period|Other|0
2044034|NCT00452673|3615016|FG004|Dose Escalation Period|Other|0
2044035|NCT00452673|3615012|FG000|Dose Escalation Period|Adverse Event|0
2044036|NCT00452673|3615013|FG001|Dose Escalation Period|Adverse Event|0
2044037|NCT00452673|3615014|FG002|Dose Escalation Period|Adverse Event|0
2044038|NCT00452673|3615015|FG003|Dose Escalation Period|Adverse Event|1
2044039|NCT00452673|3615016|FG004|Dose Escalation Period|Adverse Event|0
2044040|NCT00452673|3615012|FG000|Dose Escalation Period|Withdrawal by Subject|0
2044041|NCT00452673|3615013|FG001|Dose Escalation Period|Withdrawal by Subject|0
2044042|NCT00452673|3615014|FG002|Dose Escalation Period|Withdrawal by Subject|0
2044043|NCT00452673|3615015|FG003|Dose Escalation Period|Withdrawal by Subject|1
2044044|NCT00452673|3615016|FG004|Dose Escalation Period|Withdrawal by Subject|0
2044045|NCT00452673|3615012|FG000|Dose Expansion Period|Disease Progression|0
2044046|NCT00452673|3615013|FG001|Dose Expansion Period|Disease Progression|0
2044047|NCT00452673|3615014|FG002|Dose Expansion Period|Disease Progression|0
2044048|NCT00452673|3615015|FG003|Dose Expansion Period|Disease Progression|0
2044049|NCT00452673|3615016|FG004|Dose Expansion Period|Disease Progression|19
2044050|NCT00452673|3615012|FG000|Dose Expansion Period|Other|0
2044051|NCT00452673|3615013|FG001|Dose Expansion Period|Other|0
2044052|NCT00452673|3615014|FG002|Dose Expansion Period|Other|0
2019637|NCT00299494|3586919|FG001|Overall Study|Other - Unspecified|0
2044053|NCT00452673|3615015|FG003|Dose Expansion Period|Other|0
2044054|NCT00452673|3615016|FG004|Dose Expansion Period|Other|2
2044055|NCT00452699|3615029|FG000|Overall Study|Adverse Event|10
2044056|NCT00452699|3615030|FG001|Overall Study|Adverse Event|3
2044057|NCT00452699|3615029|FG000|Overall Study|Lack of Efficacy|6
2044058|NCT00452699|3615030|FG001|Overall Study|Lack of Efficacy|4
2208607|NCT01641081|3848251|FG003|Period 4|Adverse Event|1
2208608|NCT01641081|3848252|FG004|Period 4|Adverse Event|0
2208609|NCT01641081|3848253|FG005|Period 4|Adverse Event|0
2208610|NCT01641081|3848254|FG006|Period 4|Adverse Event|0
2208611|NCT01641081|3848255|FG007|Period 4|Adverse Event|0
2208612|NCT01641081|3848256|FG008|Period 4|Adverse Event|0
2208613|NCT01641081|3848257|FG009|Period 4|Adverse Event|0
2044059|NCT00452699|3615029|FG000|Overall Study|Lost to Follow-up|6
2044060|NCT00452699|3615030|FG001|Overall Study|Lost to Follow-up|9
2044061|NCT00452699|3615029|FG000|Overall Study|Protocol Violation|21
2044062|NCT00452699|3615030|FG001|Overall Study|Protocol Violation|25
2044063|NCT00452699|3615029|FG000|Overall Study|Withdrawal by Subject|26
2044064|NCT00452699|3615030|FG001|Overall Study|Withdrawal by Subject|25
2044065|NCT00452699|3615029|FG000|Overall Study|Other|12
2044066|NCT00452699|3615030|FG001|Overall Study|Other|7
2044067|NCT00452790|3615038|FG000|Infant Series|Clinical hold - consent withdrawn|118
2044068|NCT00452790|3615039|FG001|Infant Series|Clinical hold - consent withdrawn|123
2044069|NCT00452790|3615038|FG000|Infant Series|Parent/legal guardian request|8
2044070|NCT00452790|3615039|FG001|Infant Series|Parent/legal guardian request|6
2044071|NCT00452790|3615038|FG000|Infant Series|Failed to return|4
2044072|NCT00452790|3615039|FG001|Infant Series|Failed to return|1
2044073|NCT00452790|3615038|FG000|Infant Series|Protocol Violation|1
2044074|NCT00452790|3615039|FG001|Infant Series|Protocol Violation|3
2044075|NCT00452790|3615038|FG000|Infant Series|Lost to Follow-up|2
2044076|NCT00452790|3615039|FG001|Infant Series|Lost to Follow-up|2
2044077|NCT00452790|3615038|FG000|Infant Series|Adverse Event|1
2044078|NCT00452790|3615039|FG001|Infant Series|Adverse Event|2
2044079|NCT00452790|3615038|FG000|Infant Series|Other reasons|1
2044080|NCT00452790|3615039|FG001|Infant Series|Other reasons|2
2044081|NCT00452790|3615038|FG000|Infant Series|Investigator request|0
2044082|NCT00452790|3615039|FG001|Infant Series|Investigator request|1
2044083|NCT00452790|3615038|FG000|Infant Series|Death|0
2044084|NCT00452790|3615039|FG001|Infant Series|Death|1
2044085|NCT00452790|3615038|FG000|After Infant Series|Investigator request|10
2044086|NCT00452790|3615039|FG001|After Infant Series|Investigator request|10
2044087|NCT00452790|3615038|FG000|After Infant Series|Adverse Event|4
2044088|NCT00452790|3615039|FG001|After Infant Series|Adverse Event|1
2044089|NCT00452790|3615038|FG000|After Infant Series|Parent/legal guardian request|1
2044090|NCT00452790|3615039|FG001|After Infant Series|Parent/legal guardian request|3
2044091|NCT00452790|3615038|FG000|After Infant Series|Lost to Follow-up|4
2044092|NCT00452790|3615039|FG001|After Infant Series|Lost to Follow-up|0
2044093|NCT00452790|3615038|FG000|After Infant Series|Failed to return|1
2044094|NCT00452790|3615039|FG001|After Infant Series|Failed to return|0
2044095|NCT00452790|3615038|FG000|After Infant Series|Other reasons|1
2044096|NCT00452790|3615039|FG001|After Infant Series|Other reasons|0
2044097|NCT00452790|3615038|FG000|Toddler Dose|Failed to return|0
2044098|NCT00452790|3615039|FG001|Toddler Dose|Failed to return|1
2044099|NCT00452790|3615038|FG000|Toddler Dose|Parent/legal guardian request|0
2044100|NCT00452790|3615039|FG001|Toddler Dose|Parent/legal guardian request|1
2044101|NCT00453102|3615053|FG000|Overall Study|Withdrawal by Subject|2
2044102|NCT00453154|3615060|FG000|Double BIind Maintenance|Adverse Event|0
2044103|NCT00453154|3615061|FG001|Double BIind Maintenance|Adverse Event|0
2044104|NCT00453154|3615062|FG002|Double BIind Maintenance|Adverse Event|3
2044105|NCT00453154|3615063|FG003|Double BIind Maintenance|Adverse Event|12
2044106|NCT00453154|3615060|FG000|Double BIind Maintenance|Death|0
2044107|NCT00453154|3615061|FG001|Double BIind Maintenance|Death|0
2044108|NCT00453154|3615062|FG002|Double BIind Maintenance|Death|2
2044109|NCT00453154|3615063|FG003|Double BIind Maintenance|Death|1
2044110|NCT00453154|3615060|FG000|Double BIind Maintenance|Withdrawal by Subject|0
2044111|NCT00453154|3615061|FG001|Double BIind Maintenance|Withdrawal by Subject|0
2044112|NCT00453154|3615062|FG002|Double BIind Maintenance|Withdrawal by Subject|4
2044113|NCT00453154|3615063|FG003|Double BIind Maintenance|Withdrawal by Subject|4
2044114|NCT00453154|3615060|FG000|Double BIind Maintenance|Progression|0
2044115|NCT00453154|3615061|FG001|Double BIind Maintenance|Progression|0
2044116|NCT00453154|3615062|FG002|Double BIind Maintenance|Progression|29
2044117|NCT00453154|3615063|FG003|Double BIind Maintenance|Progression|26
2044118|NCT00453154|3615060|FG000|Double BIind Maintenance|Medical Issues|0
2044119|NCT00453154|3615061|FG001|Double BIind Maintenance|Medical Issues|0
2208614|NCT01641081|3848248|FG000|Period 5|Adverse Event|0
2208615|NCT01641081|3848249|FG001|Period 5|Adverse Event|0
2208616|NCT01641081|3848250|FG002|Period 5|Adverse Event|2
2208617|NCT01641081|3848251|FG003|Period 5|Adverse Event|0
2019638|NCT00299494|3586920|FG002|Overall Study|Other - Unspecified|0
2019639|NCT00299494|3586921|FG003|Overall Study|Other - Unspecified|0
2019640|NCT00299494|3586922|FG004|Overall Study|Other - Unspecified|3
2019641|NCT00299494|3586923|FG005|Overall Study|Other - Unspecified|1
2019642|NCT00299494|3586918|FG000|Overall Study|Other - site closure|0
2019643|NCT00299494|3586919|FG001|Overall Study|Other - site closure|0
2019644|NCT00299494|3586920|FG002|Overall Study|Other - site closure|0
2044120|NCT00453154|3615062|FG002|Double BIind Maintenance|Medical Issues|3
2044121|NCT00453154|3615063|FG003|Double BIind Maintenance|Medical Issues|1
2044122|NCT00453154|3615060|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0
2044123|NCT00453154|3615061|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0
2044124|NCT00453154|3615062|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5
2044125|NCT00453154|3615063|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5
2044126|NCT00453180|3615074|FG000|Overall Study|Lost to Follow-up|2
2044127|NCT00453180|3615075|FG001|Overall Study|Lost to Follow-up|1
2044128|NCT00453180|3615074|FG000|Overall Study|Adverse Event|1
2044129|NCT00453180|3615075|FG001|Overall Study|Adverse Event|2
2044130|NCT00453206|3615085|FG000|Overall Study|Death|1
2044131|NCT00453310|3615089|FG000|Overall Study|Progression of Disease|10
2044132|NCT00453349|3615099|FG000|Randomized|Adverse Event|12
2044133|NCT00453349|3615100|FG001|Randomized|Adverse Event|11
2044134|NCT00453349|3615099|FG000|Randomized|Lack of Efficacy|2
2044135|NCT00453349|3615100|FG001|Randomized|Lack of Efficacy|1
2044136|NCT00453349|3615099|FG000|Randomized|Lost to Follow-up|7
2298340|NCT02574637|3994998|FG007|Double-blind Period|Reason Not Specified|0
2298341|NCT02574637|3994999|FG008|Double-blind Period|Reason Not Specified|0
2298342|NCT02574637|3995000|FG009|Double-blind Period|Reason Not Specified|0
2298343|NCT02574637|3994991|FG000|Open-label (OL) Period|Adverse Event|0
2298344|NCT02574637|3994992|FG001|Open-label (OL) Period|Adverse Event|0
2298345|NCT02574637|3994993|FG002|Open-label (OL) Period|Adverse Event|0
2044137|NCT00453349|3615100|FG001|Randomized|Lost to Follow-up|5
2044138|NCT00453349|3615099|FG000|Randomized|Protocol Violation|1
2044139|NCT00453349|3615100|FG001|Randomized|Protocol Violation|1
2044140|NCT00453349|3615099|FG000|Randomized|Withdrawal by Subject|3
2044141|NCT00453349|3615100|FG001|Randomized|Withdrawal by Subject|5
2044142|NCT00453349|3615099|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10
2044143|NCT00453349|3615100|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11
2044144|NCT00453349|3615099|FG000|Completed Study|Adverse Event|12
2044145|NCT00453349|3615100|FG001|Completed Study|Adverse Event|11
2044146|NCT00453349|3615099|FG000|Completed Study|Lack of Efficacy|2
2044147|NCT00453349|3615100|FG001|Completed Study|Lack of Efficacy|1
2044148|NCT00453349|3615099|FG000|Completed Study|Lost to Follow-up|7
2044149|NCT00453349|3615100|FG001|Completed Study|Lost to Follow-up|5
2044150|NCT00453349|3615099|FG000|Completed Study|Protocol Violation|1
2044151|NCT00453349|3615100|FG001|Completed Study|Protocol Violation|1
2044152|NCT00453349|3615099|FG000|Completed Study|Withdrawal by Subject|3
2044153|NCT00453349|3615100|FG001|Completed Study|Withdrawal by Subject|5
2044154|NCT00453349|3615099|FG000|Completed Study|Lost to follow up after study treatment|2
2044155|NCT00453349|3615100|FG001|Completed Study|Lost to follow up after study treatment|11
2044156|NCT00453362|3615106|FG000|Overall Study|Adverse Event|5
2044157|NCT00453362|3615106|FG000|Overall Study|Death|7
2044158|NCT00453362|3615106|FG000|Overall Study|Physician Decision|2
2044159|NCT00453362|3615106|FG000|Overall Study|Withdrawal by Subject|3
2044160|NCT00453362|3615106|FG000|Overall Study|Progression of disease|56
2044161|NCT00453362|3615106|FG000|Overall Study|Screening Failure|14
2044162|NCT00453921|3615162|FG000|Overall Study|Withdrawal by Subject|1
2044163|NCT00453921|3615163|FG001|Overall Study|Withdrawal by Subject|1
2044164|NCT00453921|3615164|FG002|Overall Study|Withdrawal by Subject|1
2044165|NCT00453921|3615165|FG003|Overall Study|Withdrawal by Subject|1
2044166|NCT00453921|3615162|FG000|Overall Study|Lost to Follow-up|0
2044167|NCT00453921|3615163|FG001|Overall Study|Lost to Follow-up|0
2044168|NCT00453921|3615164|FG002|Overall Study|Lost to Follow-up|1
2044169|NCT00453921|3615165|FG003|Overall Study|Lost to Follow-up|0
2298346|NCT02574637|3994994|FG003|Open-label (OL) Period|Adverse Event|0
2298347|NCT02574637|3994995|FG004|Open-label (OL) Period|Adverse Event|0
2298348|NCT02574637|3994996|FG005|Open-label (OL) Period|Adverse Event|0
2298349|NCT02574637|3994997|FG006|Open-label (OL) Period|Adverse Event|0
2298350|NCT02574637|3994998|FG007|Open-label (OL) Period|Adverse Event|0
2298351|NCT02574637|3994999|FG008|Open-label (OL) Period|Adverse Event|1
2298352|NCT02574637|3995000|FG009|Open-label (OL) Period|Adverse Event|0
2298353|NCT02574637|3994991|FG000|Open-label (OL) Period|Withdrawal by Subject|0
2298354|NCT02574637|3994992|FG001|Open-label (OL) Period|Withdrawal by Subject|0
2298355|NCT02574637|3994993|FG002|Open-label (OL) Period|Withdrawal by Subject|0
2298356|NCT02574637|3994994|FG003|Open-label (OL) Period|Withdrawal by Subject|0
2298357|NCT02574637|3994995|FG004|Open-label (OL) Period|Withdrawal by Subject|0
2298358|NCT02574637|3994996|FG005|Open-label (OL) Period|Withdrawal by Subject|1
2298359|NCT02574637|3994997|FG006|Open-label (OL) Period|Withdrawal by Subject|0
2298360|NCT02574637|3994998|FG007|Open-label (OL) Period|Withdrawal by Subject|0
2298361|NCT02574637|3994999|FG008|Open-label (OL) Period|Withdrawal by Subject|0
2019645|NCT00299494|3586921|FG003|Overall Study|Other - site closure|1
2019646|NCT00299494|3586922|FG004|Overall Study|Other - site closure|1
2044170|NCT00453973|3615181|FG000|Overall Study|Adverse Event|4
2044171|NCT00453973|3615182|FG001|Overall Study|Adverse Event|9
2044172|NCT00453973|3615181|FG000|Overall Study|Withdrawal by Subject|7
2044173|NCT00453973|3615182|FG001|Overall Study|Withdrawal by Subject|6
2044174|NCT00453973|3615181|FG000|Overall Study|PI Decision|0
2044175|NCT00453973|3615182|FG001|Overall Study|PI Decision|2
2044176|NCT00453973|3615181|FG000|Overall Study|Relocation|1
2044177|NCT00453973|3615182|FG001|Overall Study|Relocation|0
2044178|NCT00453973|3615181|FG000|Overall Study|Renal transplant|1
2044179|NCT00453973|3615182|FG001|Overall Study|Renal transplant|1
2044180|NCT00453973|3615181|FG000|Overall Study|Site closed by sponsor|3
2044181|NCT00453973|3615182|FG001|Overall Study|Site closed by sponsor|0
2044182|NCT00453973|3615181|FG000|Overall Study|Sponsor Decision to Terminate Study|35
2044183|NCT00453973|3615182|FG001|Overall Study|Sponsor Decision to Terminate Study|30
2044184|NCT00453986|3615193|FG000|Overall Study|Lost to Follow-up|6
2044185|NCT00453986|3615194|FG001|Overall Study|Lost to Follow-up|5
2044186|NCT00453986|3615195|FG002|Overall Study|Lost to Follow-up|6
2044187|NCT00453986|3615196|FG003|Overall Study|Lost to Follow-up|2
2044188|NCT00453986|3615197|FG004|Overall Study|Lost to Follow-up|0
2044189|NCT00453999|3615216|FG000|Overall Study|Adverse Event|1
2044190|NCT00453999|3615217|FG001|Overall Study|Adverse Event|2
2044191|NCT00453999|3615218|FG002|Overall Study|Adverse Event|1
2044192|NCT00453999|3615216|FG000|Overall Study|Lost to Follow-up|0
2044193|NCT00453999|3615217|FG001|Overall Study|Lost to Follow-up|1
2044194|NCT00453999|3615218|FG002|Overall Study|Lost to Follow-up|1
2044195|NCT00453999|3615216|FG000|Overall Study|Withdrawal by Subject|2
2044196|NCT00453999|3615217|FG001|Overall Study|Withdrawal by Subject|1
2044197|NCT00453999|3615218|FG002|Overall Study|Withdrawal by Subject|1
2044198|NCT00453999|3615216|FG000|Overall Study|Subject Request|2
2044199|NCT00453999|3615217|FG001|Overall Study|Subject Request|1
2044200|NCT00453999|3615218|FG002|Overall Study|Subject Request|0
2044201|NCT00454051|3615229|FG000|Overall Study|Adverse Event|1
2044202|NCT00454051|3615230|FG001|Overall Study|Adverse Event|2
2044203|NCT00454051|3615229|FG000|Overall Study|Withdrawal by Subject|1
2044204|NCT00454051|3615230|FG001|Overall Study|Withdrawal by Subject|0
2019647|NCT00299494|3586923|FG005|Overall Study|Other - site closure|1
2019648|NCT00299546|3586951|FG000|Overall Study|Death|3
2019649|NCT00299546|3586952|FG001|Overall Study|Death|2
2019650|NCT00299546|3586953|FG002|Overall Study|Death|0
2019651|NCT00299546|3586951|FG000|Overall Study|Lost to Follow-up|2
2208618|NCT01641081|3848252|FG004|Period 5|Adverse Event|0
2208619|NCT01641081|3848253|FG005|Period 5|Adverse Event|0
2208620|NCT01641081|3848254|FG006|Period 5|Adverse Event|0
2208621|NCT01641081|3848255|FG007|Period 5|Adverse Event|0
2208622|NCT01641081|3848256|FG008|Period 5|Adverse Event|0
2019652|NCT00299546|3586952|FG001|Overall Study|Lost to Follow-up|2
2019653|NCT00299546|3586953|FG002|Overall Study|Lost to Follow-up|5
2019654|NCT00299546|3586951|FG000|Overall Study|Adverse Event|37
2044205|NCT00454051|3615229|FG000|Overall Study|Protocol Violation|1
2044206|NCT00454051|3615230|FG001|Overall Study|Protocol Violation|1
2208623|NCT01641081|3848257|FG009|Period 5|Adverse Event|0
2019655|NCT00299546|3586952|FG001|Overall Study|Adverse Event|22
2019656|NCT00299546|3586953|FG002|Overall Study|Adverse Event|27
2019657|NCT00299546|3586951|FG000|Overall Study|Unsatisfactory therapeutic effect|34
2019658|NCT00299546|3586952|FG001|Overall Study|Unsatisfactory therapeutic effect|39
2019659|NCT00299546|3586953|FG002|Overall Study|Unsatisfactory therapeutic effect|34
2019660|NCT00299546|3586951|FG000|Overall Study|Other|24
2019661|NCT00299546|3586952|FG001|Overall Study|Other|26
2208624|NCT01641133|3848279|FG000|Overall Study|Protocol Violation|0
2044207|NCT00454116|3615239|FG000|Overall Study|Adverse Event|5
2044208|NCT00454116|3615240|FG001|Overall Study|Adverse Event|11
2044209|NCT00454116|3615241|FG002|Overall Study|Adverse Event|9
2044210|NCT00454116|3615239|FG000|Overall Study|Condition under investigation worsened|17
2044211|NCT00454116|3615240|FG001|Overall Study|Condition under investigation worsened|13
2044212|NCT00454116|3615241|FG002|Overall Study|Condition under investigation worsened|18
2044213|NCT00454116|3615239|FG000|Overall Study|Withdrawal by Subject|3
2044214|NCT00454116|3615240|FG001|Overall Study|Withdrawal by Subject|3
2044215|NCT00454116|3615241|FG002|Overall Study|Withdrawal by Subject|1
2044216|NCT00454116|3615239|FG000|Overall Study|Other|2
2044217|NCT00454116|3615240|FG001|Overall Study|Other|2
2044218|NCT00454116|3615241|FG002|Overall Study|Other|0
2044219|NCT00454142|3615249|FG000|Overall Study|Withdrawal by Subject|1
2044220|NCT00454181|3615257|FG000|Overall Study|Adverse Event|1
2044221|NCT00454181|3615258|FG001|Overall Study|Adverse Event|1
2044222|NCT00454181|3615257|FG000|Overall Study|Lost to Follow-up|11
2044223|NCT00454181|3615258|FG001|Overall Study|Lost to Follow-up|1
2044224|NCT00454181|3615257|FG000|Overall Study|Protocol Violation|1
2044225|NCT00454181|3615258|FG001|Overall Study|Protocol Violation|1
2044226|NCT00454181|3615257|FG000|Overall Study|Withdrawal by Subject|2
2044227|NCT00454181|3615258|FG001|Overall Study|Withdrawal by Subject|0
2044228|NCT00454194|3615266|FG000|Overall Study|Adverse Event|7
2044229|NCT00454194|3615267|FG001|Overall Study|Adverse Event|2
2044230|NCT00454194|3615266|FG000|Overall Study|Withdrawal by Subject|12
2044231|NCT00454194|3615267|FG001|Overall Study|Withdrawal by Subject|8
2044232|NCT00454194|3615266|FG000|Overall Study|Other Medical Problems|1
2044233|NCT00454194|3615267|FG001|Overall Study|Other Medical Problems|2
2044234|NCT00454194|3615266|FG000|Overall Study|Other Unspecified Reason|2
2044235|NCT00454194|3615267|FG001|Overall Study|Other Unspecified Reason|2
2044236|NCT00454207|3615275|FG000|Overall Study|Adverse Event|3
2044237|NCT00454207|3615276|FG001|Overall Study|Adverse Event|1
2044238|NCT00454207|3615275|FG000|Overall Study|Lack of Efficacy|1
2044239|NCT00454207|3615276|FG001|Overall Study|Lack of Efficacy|0
2044240|NCT00454207|3615275|FG000|Overall Study|Protocol Violation|0
2044241|NCT00454207|3615276|FG001|Overall Study|Protocol Violation|1
2044242|NCT00454246|3615297|FG000|Overall Study|Adverse Event|2
2044243|NCT00454246|3615298|FG001|Overall Study|Adverse Event|2
2044244|NCT00454246|3615299|FG002|Overall Study|Adverse Event|0
2298362|NCT02574637|3995000|FG009|Open-label (OL) Period|Withdrawal by Subject|1
2298363|NCT02574637|3994991|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0
2298364|NCT02574637|3994992|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0
2298365|NCT02574637|3994993|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0
2298366|NCT02574637|3994994|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0
2298367|NCT02574637|3994995|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0
2298368|NCT02574637|3994996|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1
2298369|NCT02574637|3994997|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2
2298370|NCT02574637|3994998|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1
2298371|NCT02574637|3994999|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1
2298372|NCT02574637|3995000|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0
2298373|NCT02574845|3995031|FG000|Overall Study|Consent withdrawn further participation|0
2298374|NCT02574845|3995032|FG001|Overall Study|Consent withdrawn further participation|0
2298375|NCT02574845|3995033|FG002|Overall Study|Consent withdrawn further participation|0
2298376|NCT02574845|3995034|FG003|Overall Study|Consent withdrawn further participation|0
2298377|NCT02574845|3995035|FG004|Overall Study|Consent withdrawn further participation|1
2298378|NCT02574845|3995036|FG005|Overall Study|Consent withdrawn further participation|0
2298379|NCT02574845|3995031|FG000|Overall Study|Adverse Event|0
2298380|NCT02574845|3995032|FG001|Overall Study|Adverse Event|1
2298381|NCT02574845|3995033|FG002|Overall Study|Adverse Event|0
2298382|NCT02574845|3995034|FG003|Overall Study|Adverse Event|0
2298383|NCT02574845|3995035|FG004|Overall Study|Adverse Event|0
2298384|NCT02574845|3995036|FG005|Overall Study|Adverse Event|1
2298385|NCT02575079|3995056|FG000|Overall Study|Death|3
2298386|NCT02575079|3995057|FG001|Overall Study|Death|0
2298387|NCT02575079|3995056|FG000|Overall Study|Withdrawal by Subject|3
2298388|NCT02575079|3995057|FG001|Overall Study|Withdrawal by Subject|0
2298389|NCT02575807|3995071|FG000|Overall Study|Death|8
2298390|NCT02575807|3995072|FG001|Overall Study|Death|3
2298391|NCT02575807|3995073|FG002|Overall Study|Death|7
2298392|NCT02575807|3995074|FG003|Overall Study|Death|0
2298393|NCT02575807|3995075|FG004|Overall Study|Death|1
2019662|NCT00299546|3586953|FG002|Overall Study|Other|19
2019663|NCT00299546|3586951|FG000|Overall Study|Not treated|0
2019664|NCT00299546|3586952|FG001|Overall Study|Not treated|1
2019665|NCT00299546|3586953|FG002|Overall Study|Not treated|1
2019666|NCT00299702|3586968|FG000|Overall Study|Death|1
2019667|NCT00299702|3586969|FG001|Overall Study|Death|0
2019668|NCT00299702|3586968|FG000|Overall Study|Adverse Event|0
2019669|NCT00299702|3586969|FG001|Overall Study|Adverse Event|4
2019670|NCT00299702|3586968|FG000|Overall Study|Lost to Follow-up|18
2019671|NCT00299702|3586969|FG001|Overall Study|Lost to Follow-up|10
2019672|NCT00299702|3586968|FG000|Overall Study|Withdrawal by Subject|25
2019673|NCT00299702|3586969|FG001|Overall Study|Withdrawal by Subject|23
2019674|NCT00299702|3586968|FG000|Overall Study|Pregnancy|0
2019675|NCT00299702|3586969|FG001|Overall Study|Pregnancy|1
2019676|NCT00299702|3586968|FG000|Overall Study|Insufficient Response|4
2019677|NCT00299702|3586969|FG001|Overall Study|Insufficient Response|3
2019678|NCT00299702|3586968|FG000|Overall Study|Admin issues, sponsor decision, etc.|5
2019679|NCT00299702|3586969|FG001|Overall Study|Admin issues, sponsor decision, etc.|9
2019680|NCT00299975|3586982|FG000|Overall Study|Adverse Event|1
2019681|NCT00299975|3586983|FG001|Overall Study|Adverse Event|0
2044245|NCT00454246|3615297|FG000|Overall Study|Violation of selection criteria at entry|6
2044246|NCT00454246|3615298|FG001|Overall Study|Violation of selection criteria at entry|0
2044247|NCT00454246|3615299|FG002|Overall Study|Violation of selection criteria at entry|0
2044248|NCT00454246|3615297|FG000|Overall Study|Protocol Violation|1
2044249|NCT00454246|3615298|FG001|Overall Study|Protocol Violation|0
2044250|NCT00454246|3615299|FG002|Overall Study|Protocol Violation|0
2044251|NCT00454246|3615297|FG000|Overall Study|Refused Treatment|1
2044252|NCT00454246|3615298|FG001|Overall Study|Refused Treatment|1
2044253|NCT00454246|3615299|FG002|Overall Study|Refused Treatment|0
2044254|NCT00454246|3615297|FG000|Overall Study|Failure to return|1
2044255|NCT00454246|3615298|FG001|Overall Study|Failure to return|0
2044256|NCT00454246|3615299|FG002|Overall Study|Failure to return|0
2044257|NCT00454246|3615297|FG000|Overall Study|Early termination of study|62
2044258|NCT00454246|3615298|FG001|Overall Study|Early termination of study|26
2044259|NCT00454246|3615299|FG002|Overall Study|Early termination of study|9
2044260|NCT00454363|3615318|FG000|Overall Study|Adverse Event|1
2044261|NCT00454363|3615319|FG001|Overall Study|Adverse Event|2
2298394|NCT02575807|3995071|FG000|Overall Study|Study terminated by Sponsor|0
2298395|NCT02575807|3995072|FG001|Overall Study|Study terminated by Sponsor|1
2298396|NCT02575807|3995073|FG002|Overall Study|Study terminated by Sponsor|7
2298397|NCT02575807|3995074|FG003|Overall Study|Study terminated by Sponsor|0
2298398|NCT02575807|3995075|FG004|Overall Study|Study terminated by Sponsor|1
2298399|NCT02575807|3995071|FG000|Overall Study|Terminated due to FDA clinical hold|1
2298400|NCT02575807|3995072|FG001|Overall Study|Terminated due to FDA clinical hold|0
2298401|NCT02575807|3995073|FG002|Overall Study|Terminated due to FDA clinical hold|0
2298402|NCT02575807|3995074|FG003|Overall Study|Terminated due to FDA clinical hold|0
2298403|NCT02575807|3995075|FG004|Overall Study|Terminated due to FDA clinical hold|0
2298404|NCT02575807|3995071|FG000|Overall Study|Terminated due to physician decision|0
2298405|NCT02575807|3995072|FG001|Overall Study|Terminated due to physician decision|0
2298406|NCT02575807|3995073|FG002|Overall Study|Terminated due to physician decision|1
2298407|NCT02575807|3995074|FG003|Overall Study|Terminated due to physician decision|0
2298408|NCT02575807|3995075|FG004|Overall Study|Terminated due to physician decision|0
2298409|NCT02575807|3995071|FG000|Overall Study|Subject ineligible - medical implant|0
2298410|NCT02575807|3995072|FG001|Overall Study|Subject ineligible - medical implant|0
2298411|NCT02575807|3995073|FG002|Overall Study|Subject ineligible - medical implant|0
2298412|NCT02575807|3995074|FG003|Overall Study|Subject ineligible - medical implant|1
2298413|NCT02575807|3995075|FG004|Overall Study|Subject ineligible - medical implant|0
2298414|NCT02575807|3995071|FG000|Overall Study|Withdrawal by Subject|0
2298415|NCT02575807|3995072|FG001|Overall Study|Withdrawal by Subject|0
2298416|NCT02575807|3995073|FG002|Overall Study|Withdrawal by Subject|1
2298417|NCT02575807|3995074|FG003|Overall Study|Withdrawal by Subject|1
2298418|NCT02575807|3995075|FG004|Overall Study|Withdrawal by Subject|2
2298419|NCT02575833|3995091|FG000|Overall Study|Withdrawal by Subject|0
2298420|NCT02575833|3995092|FG001|Overall Study|Withdrawal by Subject|1
2298421|NCT02575833|3995091|FG000|Overall Study|Lost to Follow-up|1
2298422|NCT02575833|3995092|FG001|Overall Study|Lost to Follow-up|0
2298423|NCT02575911|3995098|FG000|Overall Study|Lost to Follow-up|1
2298424|NCT02575950|3995110|FG000|Overall Study|Withdrawal by Subject|0
2298425|NCT02575950|3995111|FG001|Overall Study|Withdrawal by Subject|0
2298426|NCT02575950|3995112|FG002|Overall Study|Withdrawal by Subject|0
2298427|NCT02575950|3995113|FG003|Overall Study|Withdrawal by Subject|2
2298428|NCT02575950|3995110|FG000|Overall Study|Lost to Follow-up|0
2044262|NCT00454363|3615318|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4
2044263|NCT00454363|3615319|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0
2044264|NCT00454584|3615344|FG000|Controlled Period|Adverse Event|5
2044265|NCT00454584|3615345|FG001|Controlled Period|Adverse Event|2
2044266|NCT00454584|3615346|FG002|Controlled Period|Adverse Event|1
2044267|NCT00454584|3615347|FG003|Controlled Period|Adverse Event|0
2044268|NCT00454584|3615348|FG004|Controlled Period|Adverse Event|0
2044269|NCT00454584|3615349|FG005|Controlled Period|Adverse Event|0
2044270|NCT00454584|3615344|FG000|Controlled Period|Lost to Follow-up|1
2044271|NCT00454584|3615345|FG001|Controlled Period|Lost to Follow-up|2
2044272|NCT00454584|3615346|FG002|Controlled Period|Lost to Follow-up|2
2044273|NCT00454584|3615347|FG003|Controlled Period|Lost to Follow-up|0
2044274|NCT00454584|3615348|FG004|Controlled Period|Lost to Follow-up|0
2044275|NCT00454584|3615349|FG005|Controlled Period|Lost to Follow-up|0
2044276|NCT00454584|3615344|FG000|Controlled Period|Other|5
2044277|NCT00454584|3615345|FG001|Controlled Period|Other|4
2044278|NCT00454584|3615346|FG002|Controlled Period|Other|2
2044279|NCT00454584|3615347|FG003|Controlled Period|Other|0
2044280|NCT00454584|3615348|FG004|Controlled Period|Other|0
2044281|NCT00454584|3615349|FG005|Controlled Period|Other|0
2044282|NCT00454584|3615344|FG000|After Controlled Period|Adverse Event|0
2044283|NCT00454584|3615345|FG001|After Controlled Period|Adverse Event|0
2044284|NCT00454584|3615346|FG002|After Controlled Period|Adverse Event|0
2044285|NCT00454584|3615347|FG003|After Controlled Period|Adverse Event|9
2044286|NCT00454584|3615348|FG004|After Controlled Period|Adverse Event|3
2044287|NCT00454584|3615349|FG005|After Controlled Period|Adverse Event|9
2044288|NCT00454584|3615344|FG000|After Controlled Period|Lack of Efficacy|0
2044289|NCT00454584|3615345|FG001|After Controlled Period|Lack of Efficacy|0
2044290|NCT00454584|3615346|FG002|After Controlled Period|Lack of Efficacy|0
2044291|NCT00454584|3615347|FG003|After Controlled Period|Lack of Efficacy|1
2044292|NCT00454584|3615348|FG004|After Controlled Period|Lack of Efficacy|0
2044293|NCT00454584|3615349|FG005|After Controlled Period|Lack of Efficacy|0
2044294|NCT00454584|3615344|FG000|After Controlled Period|Lost to Follow-up|0
2044295|NCT00454584|3615345|FG001|After Controlled Period|Lost to Follow-up|0
2044296|NCT00454584|3615346|FG002|After Controlled Period|Lost to Follow-up|0
2044297|NCT00454584|3615347|FG003|After Controlled Period|Lost to Follow-up|2
2044298|NCT00454584|3615348|FG004|After Controlled Period|Lost to Follow-up|4
2044299|NCT00454584|3615349|FG005|After Controlled Period|Lost to Follow-up|6
2044300|NCT00454584|3615344|FG000|After Controlled Period|Other|0
2044301|NCT00454584|3615345|FG001|After Controlled Period|Other|0
2044302|NCT00454584|3615346|FG002|After Controlled Period|Other|0
2044303|NCT00454584|3615347|FG003|After Controlled Period|Other|1
2044304|NCT00454584|3615348|FG004|After Controlled Period|Other|0
2044305|NCT00454584|3615349|FG005|After Controlled Period|Other|0
2044306|NCT00454584|3615344|FG000|After Controlled Period|Other|0
2044307|NCT00454584|3615345|FG001|After Controlled Period|Other|0
2044308|NCT00454584|3615346|FG002|After Controlled Period|Other|0
2044309|NCT00454584|3615347|FG003|After Controlled Period|Other|13
2044310|NCT00454584|3615348|FG004|After Controlled Period|Other|5
2044311|NCT00454584|3615349|FG005|After Controlled Period|Other|17
2044312|NCT00454636|3615367|FG000|Overall Study|Adverse Event|10
2044313|NCT00454636|3615368|FG001|Overall Study|Adverse Event|6
2044314|NCT00454636|3615369|FG002|Overall Study|Adverse Event|9
2044315|NCT00454636|3615370|FG003|Overall Study|Adverse Event|15
2044316|NCT00454636|3615367|FG000|Overall Study|Disease Progression|11
2044317|NCT00454636|3615368|FG001|Overall Study|Disease Progression|12
2044318|NCT00454636|3615369|FG002|Overall Study|Disease Progression|4
2044319|NCT00454636|3615370|FG003|Overall Study|Disease Progression|11
2044320|NCT00454636|3615367|FG000|Overall Study|Protocol Violation|3
2044321|NCT00454636|3615368|FG001|Overall Study|Protocol Violation|2
2044322|NCT00454636|3615369|FG002|Overall Study|Protocol Violation|3
2044323|NCT00454636|3615370|FG003|Overall Study|Protocol Violation|3
2044324|NCT00454636|3615367|FG000|Overall Study|Death|6
2044325|NCT00454636|3615368|FG001|Overall Study|Death|1
2044326|NCT00454636|3615369|FG002|Overall Study|Death|1
2044327|NCT00454636|3615370|FG003|Overall Study|Death|1
2044328|NCT00454636|3615367|FG000|Overall Study|Patient refusal|1
2044329|NCT00454636|3615368|FG001|Overall Study|Patient refusal|1
2044330|NCT00454636|3615369|FG002|Overall Study|Patient refusal|3
2044331|NCT00454636|3615370|FG003|Overall Study|Patient refusal|2
2044332|NCT00454636|3615367|FG000|Overall Study|Lost to Follow-up|0
2044333|NCT00454636|3615368|FG001|Overall Study|Lost to Follow-up|1
2044334|NCT00454636|3615369|FG002|Overall Study|Lost to Follow-up|0
2044335|NCT00454636|3615370|FG003|Overall Study|Lost to Follow-up|0
2044336|NCT00454649|3615390|FG000|Overall Study|Lack of Efficacy|2
2044337|NCT00454649|3615391|FG001|Overall Study|Lack of Efficacy|2
2044338|NCT00454649|3615392|FG002|Overall Study|Lack of Efficacy|10
2044339|NCT00454649|3615393|FG003|Overall Study|Lack of Efficacy|3
2044340|NCT00454649|3615394|FG004|Overall Study|Lack of Efficacy|0
2044341|NCT00454649|3615395|FG005|Overall Study|Lack of Efficacy|4
2044342|NCT00454649|3615396|FG006|Overall Study|Lack of Efficacy|5
2044343|NCT00454649|3615397|FG007|Overall Study|Lack of Efficacy|13
2044344|NCT00454649|3615398|FG008|Overall Study|Lack of Efficacy|10
2044345|NCT00454649|3615399|FG009|Overall Study|Lack of Efficacy|2
2044346|NCT00454649|3615390|FG000|Overall Study|Adverse Event|0
2044347|NCT00454649|3615391|FG001|Overall Study|Adverse Event|1
2044348|NCT00454649|3615392|FG002|Overall Study|Adverse Event|3
2044349|NCT00454649|3615393|FG003|Overall Study|Adverse Event|0
2019682|NCT00299975|3586984|FG002|Overall Study|Adverse Event|2
2019683|NCT00299975|3586982|FG000|Overall Study|Pregnancy|0
2019684|NCT00299975|3586983|FG001|Overall Study|Pregnancy|0
2019685|NCT00299975|3586984|FG002|Overall Study|Pregnancy|1
2019686|NCT00299975|3586982|FG000|Overall Study|Lack of Efficacy|1
2019687|NCT00299975|3586983|FG001|Overall Study|Lack of Efficacy|0
2019688|NCT00299975|3586984|FG002|Overall Study|Lack of Efficacy|1
2019689|NCT00299975|3586982|FG000|Overall Study|Lost to Follow-up|1
2019690|NCT00299975|3586983|FG001|Overall Study|Lost to Follow-up|0
2019691|NCT00299975|3586984|FG002|Overall Study|Lost to Follow-up|0
2019692|NCT00299975|3586982|FG000|Overall Study|Withdrawal by Subject|0
2019693|NCT00299975|3586983|FG001|Overall Study|Withdrawal by Subject|1
2019694|NCT00299975|3586984|FG002|Overall Study|Withdrawal by Subject|3
2019695|NCT00299975|3586982|FG000|Overall Study|Physician Decision|0
2019696|NCT00299975|3586983|FG001|Overall Study|Physician Decision|0
2019697|NCT00299975|3586984|FG002|Overall Study|Physician Decision|1
2019698|NCT00300053|3587005|FG000|Overall Study|Patient/Caregiver Preference|2
2019699|NCT00300053|3587006|FG001|Overall Study|Patient/Caregiver Preference|2
2019700|NCT00300053|3587007|FG002|Overall Study|Patient/Caregiver Preference|3
2208625|NCT01641133|3848280|FG001|Overall Study|Protocol Violation|1
2208626|NCT01641133|3848281|FG002|Overall Study|Protocol Violation|1
2208627|NCT01641133|3848279|FG000|Overall Study|Migrated/moved from study area|5
2208628|NCT01641133|3848280|FG001|Overall Study|Migrated/moved from study area|3
2208629|NCT01641133|3848281|FG002|Overall Study|Migrated/moved from study area|1
2208630|NCT01641133|3848279|FG000|Overall Study|Adverse Event|0
2208631|NCT01641133|3848280|FG001|Overall Study|Adverse Event|0
2208632|NCT01641133|3848281|FG002|Overall Study|Adverse Event|1
2208633|NCT01641133|3848279|FG000|Overall Study|Withdrawal by Subject|5
2208634|NCT01641133|3848280|FG001|Overall Study|Withdrawal by Subject|3
2019701|NCT00300053|3587005|FG000|Overall Study|Death|0
2019702|NCT00300053|3587006|FG001|Overall Study|Death|0
2044350|NCT00454649|3615394|FG004|Overall Study|Adverse Event|1
2044351|NCT00454649|3615395|FG005|Overall Study|Adverse Event|2
2044352|NCT00454649|3615396|FG006|Overall Study|Adverse Event|3
2044353|NCT00454649|3615397|FG007|Overall Study|Adverse Event|4
2044354|NCT00454649|3615398|FG008|Overall Study|Adverse Event|6
2044355|NCT00454649|3615399|FG009|Overall Study|Adverse Event|2
2044356|NCT00454649|3615390|FG000|Overall Study|Lost to Follow-up|0
2044357|NCT00454649|3615391|FG001|Overall Study|Lost to Follow-up|0
2044358|NCT00454649|3615392|FG002|Overall Study|Lost to Follow-up|1
2044359|NCT00454649|3615393|FG003|Overall Study|Lost to Follow-up|0
2044360|NCT00454649|3615394|FG004|Overall Study|Lost to Follow-up|0
2044361|NCT00454649|3615395|FG005|Overall Study|Lost to Follow-up|0
2044362|NCT00454649|3615396|FG006|Overall Study|Lost to Follow-up|1
2044363|NCT00454649|3615397|FG007|Overall Study|Lost to Follow-up|0
2044364|NCT00454649|3615398|FG008|Overall Study|Lost to Follow-up|0
2044365|NCT00454649|3615399|FG009|Overall Study|Lost to Follow-up|0
2044366|NCT00454649|3615390|FG000|Overall Study|Other|1
2044367|NCT00454649|3615391|FG001|Overall Study|Other|1
2044368|NCT00454649|3615392|FG002|Overall Study|Other|5
2044369|NCT00454649|3615393|FG003|Overall Study|Other|3
2044370|NCT00454649|3615394|FG004|Overall Study|Other|0
2044371|NCT00454649|3615395|FG005|Overall Study|Other|0
2044372|NCT00454649|3615396|FG006|Overall Study|Other|0
2044373|NCT00454649|3615397|FG007|Overall Study|Other|0
2044374|NCT00454649|3615398|FG008|Overall Study|Other|3
2044375|NCT00454649|3615399|FG009|Overall Study|Other|1
2044376|NCT00454649|3615390|FG000|Overall Study|Withdrawal by Subject|0
2044377|NCT00454649|3615391|FG001|Overall Study|Withdrawal by Subject|0
2044378|NCT00454649|3615392|FG002|Overall Study|Withdrawal by Subject|0
2044379|NCT00454649|3615393|FG003|Overall Study|Withdrawal by Subject|0
2044380|NCT00454649|3615394|FG004|Overall Study|Withdrawal by Subject|0
2044381|NCT00454649|3615395|FG005|Overall Study|Withdrawal by Subject|1
2044382|NCT00454649|3615396|FG006|Overall Study|Withdrawal by Subject|0
2044383|NCT00454649|3615397|FG007|Overall Study|Withdrawal by Subject|2
2044384|NCT00454649|3615398|FG008|Overall Study|Withdrawal by Subject|1
2044385|NCT00454649|3615399|FG009|Overall Study|Withdrawal by Subject|0
2044386|NCT00454779|3615442|FG000|First-line Treatment Phase|Lack of Efficacy|0
2044387|NCT00454779|3615443|FG001|First-line Treatment Phase|Lack of Efficacy|2
2044388|NCT00454779|3615442|FG000|First-line Treatment Phase|Withdrawal by Subject|2
2044389|NCT00454779|3615443|FG001|First-line Treatment Phase|Withdrawal by Subject|4
2044390|NCT00454779|3615442|FG000|First-line Treatment Phase|Lost to Follow-up|1
2044391|NCT00454779|3615443|FG001|First-line Treatment Phase|Lost to Follow-up|0
2044392|NCT00454779|3615442|FG000|First-line Treatment Phase|Protocol Violation|0
2044393|NCT00454779|3615443|FG001|First-line Treatment Phase|Protocol Violation|1
2044394|NCT00454779|3615442|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1
2044395|NCT00454779|3615443|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1
2208635|NCT01641133|3848281|FG002|Overall Study|Withdrawal by Subject|3
2208636|NCT01641133|3848279|FG000|Overall Study|Lost to Follow-up|0
2019703|NCT00300053|3587007|FG002|Overall Study|Death|3
2044396|NCT00454779|3615442|FG000|First-line Treatment Phase|Ongoing|1
2044397|NCT00454779|3615443|FG001|First-line Treatment Phase|Ongoing|0
2177054|NCT01371006|3801077|FG000|Overall Study|Adverse Event|1
2044398|NCT00454779|3615442|FG000|Second-line Treatment Phase|Withdrawal by Subject|0
2044399|NCT00454779|3615443|FG001|Second-line Treatment Phase|Withdrawal by Subject|1
2044400|NCT00454779|3615442|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0
2044401|NCT00454779|3615443|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1
2044402|NCT00454779|3615442|FG000|Second-line Treatment Phase|Ongoing|0
2044403|NCT00454779|3615443|FG001|Second-line Treatment Phase|Ongoing|1
2044404|NCT00454805|3615451|FG000|Overall Study|Withdrawal by Subject|9
2044405|NCT00454805|3615452|FG001|Overall Study|Withdrawal by Subject|2
2044406|NCT00454805|3615451|FG000|Overall Study|Death|0
2044407|NCT00454805|3615452|FG001|Overall Study|Death|2
2044408|NCT00454805|3615451|FG000|Overall Study|Disease progression|16
2044409|NCT00454805|3615452|FG001|Overall Study|Disease progression|19
2044410|NCT00454805|3615451|FG000|Overall Study|In order to begin radiotherapy|1
2044411|NCT00454805|3615452|FG001|Overall Study|In order to begin radiotherapy|0
2044412|NCT00454818|3615466|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1
2044413|NCT00454818|3615467|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0
2044414|NCT00454818|3615468|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0
2044415|NCT00454818|3615469|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0
2044416|NCT00454818|3615470|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0
2044417|NCT00454818|3615466|FG000|Phase I: Open-label Dose-escalation|Death|0
2044418|NCT00454818|3615467|FG001|Phase I: Open-label Dose-escalation|Death|1
2044419|NCT00454818|3615468|FG002|Phase I: Open-label Dose-escalation|Death|0
2044420|NCT00454818|3615469|FG003|Phase I: Open-label Dose-escalation|Death|0
2044421|NCT00454818|3615470|FG004|Phase I: Open-label Dose-escalation|Death|0
2044422|NCT00454818|3615466|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
2044423|NCT00454818|3615467|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
2044424|NCT00454818|3615468|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
2044425|NCT00454818|3615469|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
2044426|NCT00454818|3615470|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
2044427|NCT00454818|3615466|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
2044428|NCT00454818|3615467|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
2044429|NCT00454818|3615468|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
2044430|NCT00454818|3615469|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
2044431|NCT00454818|3615470|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
2044432|NCT00454818|3615466|FG000|Phase 2: Randomized Double-blind|Death|0
2044433|NCT00454818|3615467|FG001|Phase 2: Randomized Double-blind|Death|1
2044434|NCT00454818|3615468|FG002|Phase 2: Randomized Double-blind|Death|0
2044435|NCT00454818|3615469|FG003|Phase 2: Randomized Double-blind|Death|0
2044436|NCT00454818|3615470|FG004|Phase 2: Randomized Double-blind|Death|1
2044437|NCT00454818|3615466|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0
2044438|NCT00454818|3615467|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0
2044439|NCT00454818|3615468|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2
2044440|NCT00454818|3615469|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0
2044441|NCT00454818|3615470|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1
2044442|NCT00454818|3615466|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
2044443|NCT00454818|3615467|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
2044444|NCT00454818|3615468|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
2044445|NCT00454818|3615469|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
2044446|NCT00454818|3615470|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
2019704|NCT00300053|3587005|FG000|Overall Study|Lost to Follow-up|0
2019705|NCT00300053|3587006|FG001|Overall Study|Lost to Follow-up|1
2019706|NCT00300053|3587007|FG002|Overall Study|Lost to Follow-up|0
2019707|NCT00300274|3587040|FG000|Overall Study|Withdrawal by Subject|12
2019708|NCT00300274|3587041|FG001|Overall Study|Withdrawal by Subject|3
2019709|NCT00300274|3587042|FG002|Overall Study|Withdrawal by Subject|14
2019710|NCT00300274|3587040|FG000|Overall Study|Lost to Follow-up|3
2019711|NCT00300274|3587041|FG001|Overall Study|Lost to Follow-up|4
2019712|NCT00300274|3587042|FG002|Overall Study|Lost to Follow-up|5
2019713|NCT00300274|3587040|FG000|Overall Study|Death|31
2019714|NCT00300274|3587041|FG001|Overall Study|Death|20
2019715|NCT00300274|3587042|FG002|Overall Study|Death|25
2019716|NCT00300274|3587040|FG000|Overall Study|Re-transplant|0
2019717|NCT00300274|3587041|FG001|Overall Study|Re-transplant|0
2019718|NCT00300274|3587042|FG002|Overall Study|Re-transplant|1
2019719|NCT00300365|3587052|FG000|Overall Study|Lost to Follow-up|1
2019720|NCT00300365|3587053|FG001|Overall Study|Lost to Follow-up|0
2019721|NCT00300365|3587052|FG000|Overall Study|Physician Decision|2
2019722|NCT00300365|3587053|FG001|Overall Study|Physician Decision|0
2208637|NCT01641133|3848280|FG001|Overall Study|Lost to Follow-up|2
2208638|NCT01641133|3848281|FG002|Overall Study|Lost to Follow-up|2
2208639|NCT01641159|3848291|FG000|Overall Study|Lost to Follow-up|2
2208640|NCT01641159|3848292|FG001|Overall Study|Lost to Follow-up|1
2208641|NCT01641159|3848291|FG000|Overall Study|Withdrawal by Subject|0
2208642|NCT01641159|3848292|FG001|Overall Study|Withdrawal by Subject|1
2208643|NCT01641198|3848301|FG000|After 12 Months of Function|Lost to Follow-up|3
2208644|NCT01641198|3848302|FG001|After 12 Months of Function|Lost to Follow-up|2
2019723|NCT00300365|3587052|FG000|Overall Study|Withdrawal by Subject|1
2019724|NCT00300365|3587053|FG001|Overall Study|Withdrawal by Subject|0
2019725|NCT00300365|3587052|FG000|Overall Study|Adverse Event|0
2019726|NCT00300365|3587053|FG001|Overall Study|Adverse Event|2
2019727|NCT00300495|3587159|FG000|Overall Study|Protocol Violation|4
2019728|NCT00300495|3587160|FG001|Overall Study|Protocol Violation|1
2019729|NCT00300755|3587178|FG000|Overall Study|Adverse Event|1
2019730|NCT00300755|3587179|FG001|Overall Study|Adverse Event|2
2019731|NCT00300755|3587180|FG002|Overall Study|Adverse Event|1
2019732|NCT00300755|3587178|FG000|Overall Study|Withdrawal by Subject|0
2019733|NCT00300755|3587179|FG001|Overall Study|Withdrawal by Subject|2
2019734|NCT00300755|3587180|FG002|Overall Study|Withdrawal by Subject|0
2019735|NCT00300755|3587178|FG000|Overall Study|Protocol Violation|0
2019736|NCT00300755|3587179|FG001|Overall Study|Protocol Violation|0
2019737|NCT00300755|3587180|FG002|Overall Study|Protocol Violation|1
2019738|NCT00300781|3587190|FG000|Overall Study|Disease Progression|55
2019739|NCT00300781|3587191|FG001|Overall Study|Disease Progression|52
2019740|NCT00300781|3587190|FG000|Overall Study|Adverse Event|5
2019741|NCT00300781|3587191|FG001|Overall Study|Adverse Event|6
2019742|NCT00300781|3587190|FG000|Overall Study|Withdrawal by Subject|1
2019743|NCT00300781|3587191|FG001|Overall Study|Withdrawal by Subject|2
2019744|NCT00300781|3587190|FG000|Overall Study|Physician Decision|1
2019745|NCT00300781|3587191|FG001|Overall Study|Physician Decision|0
2019746|NCT00300781|3587190|FG000|Overall Study|Not Recorded|0
2019747|NCT00300781|3587191|FG001|Overall Study|Not Recorded|1
2019748|NCT00300781|3587190|FG000|Overall Study|Symptomatic Deterioration|1
2019749|NCT00300781|3587191|FG001|Overall Study|Symptomatic Deterioration|0
2019750|NCT00300781|3587190|FG000|Overall Study|Lost to Follow-up|0
2019751|NCT00300781|3587191|FG001|Overall Study|Lost to Follow-up|1
2019752|NCT00300885|3587199|FG000|Treatment|Adverse Event|134
2019753|NCT00300885|3587200|FG001|Treatment|Adverse Event|82
2019754|NCT00300885|3587199|FG000|Treatment|Death|20
2019755|NCT00300885|3587200|FG001|Treatment|Death|7
2019756|NCT00300885|3587199|FG000|Treatment|Lack of Efficacy|1
2019757|NCT00300885|3587200|FG001|Treatment|Lack of Efficacy|1
2019758|NCT00300885|3587199|FG000|Treatment|Lost to Follow-up|3
2208645|NCT01641198|3848303|FG002|After 12 Months of Function|Lost to Follow-up|2
2208646|NCT01641198|3848301|FG000|After 12 Months of Function|Protocol Violation|1
2019759|NCT00300885|3587200|FG001|Treatment|Lost to Follow-up|2
2019760|NCT00300885|3587199|FG000|Treatment|Physician Decision|4
2019761|NCT00300885|3587200|FG001|Treatment|Physician Decision|5
2044447|NCT00454857|3615487|FG000|Overall Study|Withdrawal by Subject|15
2044448|NCT00454857|3615487|FG000|Overall Study|Lost to Follow-up|16
2044449|NCT00454857|3615487|FG000|Overall Study|Noncompliance|6
2044450|NCT00454857|3615487|FG000|Overall Study|Death|5
2044451|NCT00454857|3615487|FG000|Overall Study|Other|11
2044452|NCT00454857|3615487|FG000|Overall Study|Reason unknown|1
2044453|NCT00454909|3615494|FG000|Overall Study|Withdrawal by Subject|1
2044454|NCT00454909|3615495|FG001|Overall Study|Withdrawal by Subject|0
2044455|NCT00454909|3615496|FG002|Overall Study|Withdrawal by Subject|0
2044456|NCT00454909|3615494|FG000|Overall Study|Migrated/moved from study area|0
2044457|NCT00454909|3615495|FG001|Overall Study|Migrated/moved from study area|0
2044458|NCT00454909|3615496|FG002|Overall Study|Migrated/moved from study area|1
2208647|NCT01641198|3848302|FG001|After 12 Months of Function|Protocol Violation|0
2208648|NCT01641198|3848303|FG002|After 12 Months of Function|Protocol Violation|0
2208649|NCT01641198|3848301|FG000|After 12 Months of Function|Adverse Event|0
2298429|NCT02575950|3995111|FG001|Overall Study|Lost to Follow-up|1
2298430|NCT02575950|3995112|FG002|Overall Study|Lost to Follow-up|0
2298431|NCT02575950|3995113|FG003|Overall Study|Lost to Follow-up|3
2298432|NCT02576054|3995125|FG000|Overall Study|Withdrawal by Subject|1
2298433|NCT02576067|3995133|FG000|Overall Study|Death|0
2298434|NCT02576067|3995134|FG001|Overall Study|Death|1
2298435|NCT02576067|3995133|FG000|Overall Study|Lack of Efficacy|1
2298436|NCT02576067|3995134|FG001|Overall Study|Lack of Efficacy|0
2298437|NCT02576067|3995133|FG000|Overall Study|Lost to Follow-up|11
2298438|NCT02576067|3995134|FG001|Overall Study|Lost to Follow-up|0
2298439|NCT02576067|3995133|FG000|Overall Study|Withdrawal by Subject|11
2298440|NCT02576067|3995134|FG001|Overall Study|Withdrawal by Subject|2
2298441|NCT02576067|3995133|FG000|Overall Study|study closure of main CIRT trial)|0
2298442|NCT02576067|3995134|FG001|Overall Study|study closure of main CIRT trial)|8
2298443|NCT02576067|3995133|FG000|Overall Study|not randomized, failed run-in|7
2298444|NCT02576067|3995134|FG001|Overall Study|not randomized, failed run-in|0
2298445|NCT02576067|3995133|FG000|Overall Study|screen failure/ re-enrolled|0
2298446|NCT02576067|3995134|FG001|Overall Study|screen failure/ re-enrolled|25
2298447|NCT02576067|3995133|FG000|Overall Study|Physician Decision|4
2298448|NCT02576067|3995134|FG001|Overall Study|Physician Decision|0
2298449|NCT02576145|3995142|FG000|Overall Study|Adverse Event|1
2298450|NCT02576145|3995143|FG001|Overall Study|Adverse Event|0
2298451|NCT02576145|3995142|FG000|Overall Study|Withdrawal by Subject|1
2298452|NCT02576145|3995143|FG001|Overall Study|Withdrawal by Subject|0
2298453|NCT02576145|3995142|FG000|Overall Study|Acute rejection|1
2298454|NCT02576145|3995143|FG001|Overall Study|Acute rejection|0
2298455|NCT02576145|3995142|FG000|Overall Study|Tetanus Titers Decreased|0
2298456|NCT02576145|3995143|FG001|Overall Study|Tetanus Titers Decreased|1
2298457|NCT02576509|3995160|FG000|Pre-Treatment Period|Participant request to stop therapy|0
2298458|NCT02576509|3995161|FG001|Pre-Treatment Period|Participant request to stop therapy|2
2298459|NCT02576509|3995160|FG000|Pre-Treatment Period|Participant withdrew consent|1
2298460|NCT02576509|3995161|FG001|Pre-Treatment Period|Participant withdrew consent|5
2298461|NCT02576509|3995160|FG000|Pre-Treatment Period|Participant no longer meets criteria|3
2298462|NCT02576509|3995161|FG001|Pre-Treatment Period|Participant no longer meets criteria|2
2298463|NCT02576509|3995160|FG000|Treatment Period|Disease progression|245
2298464|NCT02576509|3995161|FG001|Treatment Period|Disease progression|240
2298465|NCT02576509|3995160|FG000|Treatment Period|Study drug toxicity|32
2298466|NCT02576509|3995161|FG001|Treatment Period|Study drug toxicity|41
2298467|NCT02576509|3995160|FG000|Treatment Period|Death|1
2298468|NCT02576509|3995161|FG001|Treatment Period|Death|1
2298469|NCT02576509|3995160|FG000|Treatment Period|Adverse event unrelated to study drug|37
2298470|NCT02576509|3995161|FG001|Treatment Period|Adverse event unrelated to study drug|40
2298471|NCT02576509|3995160|FG000|Treatment Period|Participant request to stop treatment|8
2298472|NCT02576509|3995161|FG001|Treatment Period|Participant request to stop treatment|17
2298473|NCT02576509|3995160|FG000|Treatment Period|Participant withdrew consent|2
2298474|NCT02576509|3995161|FG001|Treatment Period|Participant withdrew consent|7
2298475|NCT02576509|3995160|FG000|Treatment Period|Lost to Follow-up|0
2208650|NCT01641198|3848302|FG001|After 12 Months of Function|Adverse Event|1
2208651|NCT01641198|3848303|FG002|After 12 Months of Function|Adverse Event|0
2208652|NCT01641198|3848301|FG000|After 24 Months of Function|Lost to Follow-up|4
2208653|NCT01641198|3848302|FG001|After 24 Months of Function|Lost to Follow-up|9
2208654|NCT01641198|3848303|FG002|After 24 Months of Function|Lost to Follow-up|6
2208655|NCT01641198|3848301|FG000|At 15-20 Years of Function|Lost to Follow-up|5
2208656|NCT01641198|3848302|FG001|At 15-20 Years of Function|Lost to Follow-up|1
2298476|NCT02576509|3995161|FG001|Treatment Period|Lost to Follow-up|1
2298477|NCT02576509|3995160|FG000|Treatment Period|Maximum clinical benefit|1
2298478|NCT02576509|3995161|FG001|Treatment Period|Maximum clinical benefit|0
2298479|NCT02576509|3995160|FG000|Treatment Period|Poor/non-compliance|0
2298480|NCT02576509|3995161|FG001|Treatment Period|Poor/non-compliance|1
2298481|NCT02576509|3995160|FG000|Treatment Period|Participant no longer meets criteria|1
2298482|NCT02576509|3995161|FG001|Treatment Period|Participant no longer meets criteria|0
2298483|NCT02576509|3995160|FG000|Treatment Period|Other reason|2
2298484|NCT02576509|3995161|FG001|Treatment Period|Other reason|7
2298485|NCT02576509|3995160|FG000|Follow-up Period|Death|41
2044459|NCT00454909|3615494|FG000|Overall Study|Lost to follow-up (complete vaccination)|5
2044460|NCT00454909|3615495|FG001|Overall Study|Lost to follow-up (complete vaccination)|3
2044461|NCT00454909|3615496|FG002|Overall Study|Lost to follow-up (complete vaccination)|1
2044462|NCT00454909|3615494|FG000|Overall Study|Others|1
2044463|NCT00454909|3615495|FG001|Overall Study|Others|0
2044464|NCT00454909|3615496|FG002|Overall Study|Others|0
2044465|NCT00454987|3615508|FG000|Booster Period (NCT00258700)|Adverse Event|1
2044466|NCT00454987|3615509|FG001|Booster Period (NCT00258700)|Adverse Event|0
2044467|NCT00454987|3615510|FG002|Booster Period (NCT00258700)|Adverse Event|0
2044468|NCT00454987|3615508|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0
2044469|NCT00454987|3615509|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1
2044470|NCT00454987|3615510|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0
2044471|NCT00454987|3615508|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1
2044472|NCT00454987|3615509|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0
2044473|NCT00454987|3615510|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0
2298486|NCT02576509|3995161|FG001|Follow-up Period|Death|35
2298487|NCT02576509|3995160|FG000|Follow-up Period|Participant withdrew consent|7
2298488|NCT02576509|3995161|FG001|Follow-up Period|Participant withdrew consent|14
2298489|NCT02576509|3995160|FG000|Follow-up Period|Lost to Follow-up|0
2298490|NCT02576509|3995161|FG001|Follow-up Period|Lost to Follow-up|1
2298491|NCT02576509|3995160|FG000|Follow-up Period|Other reason|1
2298492|NCT02576509|3995161|FG001|Follow-up Period|Other reason|2
2298493|NCT02576535|3995167|FG000|Overall Study|Withdrawal by Subject|2
2298494|NCT02576587|3995173|FG000|Baseline|Equipment failure|0
2298495|NCT02576587|3995174|FG001|Baseline|Equipment failure|1
2298496|NCT02576587|3995173|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25
2298497|NCT02576587|3995174|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0
2298498|NCT02576587|3995173|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
2298499|NCT02576587|3995174|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
2298500|NCT02576587|3995173|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0
2298501|NCT02576587|3995174|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155
2298502|NCT02576639|3995187|FG000|Overall Study|Withdrawal by Subject|1
2298503|NCT02576639|3995188|FG001|Overall Study|Withdrawal by Subject|2
2298504|NCT02576639|3995189|FG002|Overall Study|Withdrawal by Subject|1
2298505|NCT02576639|3995190|FG003|Overall Study|Withdrawal by Subject|0
2298506|NCT02576639|3995191|FG004|Overall Study|Withdrawal by Subject|1
2298507|NCT02576639|3995187|FG000|Overall Study|Adverse Event|1
2298508|NCT02576639|3995188|FG001|Overall Study|Adverse Event|0
2298509|NCT02576639|3995189|FG002|Overall Study|Adverse Event|1
2298510|NCT02576639|3995190|FG003|Overall Study|Adverse Event|1
2298511|NCT02576639|3995191|FG004|Overall Study|Adverse Event|2
2298512|NCT02576639|3995187|FG000|Overall Study|Physician Decision|0
2298513|NCT02576639|3995188|FG001|Overall Study|Physician Decision|0
2298514|NCT02576639|3995189|FG002|Overall Study|Physician Decision|0
2298515|NCT02576639|3995190|FG003|Overall Study|Physician Decision|0
2298516|NCT02576639|3995191|FG004|Overall Study|Physician Decision|1
2298517|NCT02576652|3995207|FG000|Overall Study|Withdrawal by Subject|2
2298518|NCT02576678|3995214|FG000|Overall Study|Adverse Event|0
2298519|NCT02576678|3995215|FG001|Overall Study|Adverse Event|0
2298520|NCT02576678|3995216|FG002|Overall Study|Adverse Event|2
2298521|NCT02576678|3995214|FG000|Overall Study|Withdrawal by Subject|3
2298522|NCT02576678|3995215|FG001|Overall Study|Withdrawal by Subject|1
2298523|NCT02576678|3995216|FG002|Overall Study|Withdrawal by Subject|2
2298524|NCT02576678|3995214|FG000|Overall Study|Lost to Follow-up|0
2298525|NCT02576678|3995215|FG001|Overall Study|Lost to Follow-up|0
2298526|NCT02576678|3995216|FG002|Overall Study|Lost to Follow-up|1
2298527|NCT02576678|3995214|FG000|Overall Study|Miscellaneous|2
2298528|NCT02576678|3995215|FG001|Overall Study|Miscellaneous|0
2298529|NCT02576678|3995216|FG002|Overall Study|Miscellaneous|0
2298530|NCT02576938|3995237|FG000|Overall Study|Adverse Event|5
2298531|NCT02576938|3995238|FG001|Overall Study|Adverse Event|3
2298532|NCT02576938|3995239|FG002|Overall Study|Adverse Event|6
2298533|NCT02576938|3995237|FG000|Overall Study|Protocol Violation|1
2298534|NCT02576938|3995238|FG001|Overall Study|Protocol Violation|1
2298535|NCT02576938|3995239|FG002|Overall Study|Protocol Violation|1
2298536|NCT02576938|3995237|FG000|Overall Study|Withdrawal by Subject|3
2298537|NCT02576938|3995238|FG001|Overall Study|Withdrawal by Subject|2
2298538|NCT02576938|3995239|FG002|Overall Study|Withdrawal by Subject|4
2298539|NCT02576938|3995237|FG000|Overall Study|Lack of Efficacy|9
2298540|NCT02576938|3995238|FG001|Overall Study|Lack of Efficacy|4
2044474|NCT00455013|3615522|FG000|Short Term Period|Adverse Event|2
2044475|NCT00455013|3615523|FG001|Short Term Period|Adverse Event|5
2044476|NCT00455013|3615524|FG002|Short Term Period|Adverse Event|0
2044477|NCT00455013|3615522|FG000|Short Term Period|Withdrawal by Subject|0
2044478|NCT00455013|3615523|FG001|Short Term Period|Withdrawal by Subject|0
2044479|NCT00455013|3615524|FG002|Short Term Period|Withdrawal by Subject|1
2044480|NCT00455013|3615522|FG000|Short Term Period|Lack of Efficacy|4
2044481|NCT00455013|3615523|FG001|Short Term Period|Lack of Efficacy|0
2044482|NCT00455013|3615524|FG002|Short Term Period|Lack of Efficacy|0
2044483|NCT00455013|3615522|FG000|Short Term Period|Other|0
2298541|NCT02576938|3995239|FG002|Overall Study|Lack of Efficacy|0
2298542|NCT02576938|3995237|FG000|Overall Study|Lost to Follow-up|2
2298543|NCT02576938|3995238|FG001|Overall Study|Lost to Follow-up|0
2298544|NCT02576938|3995239|FG002|Overall Study|Lost to Follow-up|1
2298545|NCT02576938|3995237|FG000|Overall Study|Physician Decision|0
2298546|NCT02576938|3995238|FG001|Overall Study|Physician Decision|1
2298547|NCT02576938|3995239|FG002|Overall Study|Physician Decision|0
2298548|NCT02576938|3995237|FG000|Overall Study|Met Exclusion Criteria|0
2298549|NCT02576938|3995238|FG001|Overall Study|Met Exclusion Criteria|1
2298550|NCT02576938|3995239|FG002|Overall Study|Met Exclusion Criteria|0
2298551|NCT02576951|3995253|FG000|Overall Study|Lost to Follow-up|0
2298552|NCT02576951|3995254|FG001|Overall Study|Lost to Follow-up|0
2298553|NCT02576951|3995255|FG002|Overall Study|Lost to Follow-up|2
2298554|NCT02576951|3995256|FG003|Overall Study|Lost to Follow-up|2
2298555|NCT02576951|3995253|FG000|Overall Study|Withdrawal by Subject|1
2298556|NCT02576951|3995254|FG001|Overall Study|Withdrawal by Subject|0
2298557|NCT02576951|3995255|FG002|Overall Study|Withdrawal by Subject|0
2298558|NCT02576951|3995256|FG003|Overall Study|Withdrawal by Subject|2
2298559|NCT02576951|3995253|FG000|Overall Study|Protocol Violation|0
2298560|NCT02576951|3995254|FG001|Overall Study|Protocol Violation|0
2298561|NCT02576951|3995255|FG002|Overall Study|Protocol Violation|0
2298562|NCT02576951|3995256|FG003|Overall Study|Protocol Violation|1
2298563|NCT02576977|3995270|FG000|Overall Study|Adverse Event|13
2298564|NCT02576977|3995271|FG001|Overall Study|Adverse Event|2
2298565|NCT02576977|3995270|FG000|Overall Study|Death|73
2298566|NCT02576977|3995271|FG001|Overall Study|Death|60
2298567|NCT02576977|3995270|FG000|Overall Study|Screen failure|1
2298568|NCT02576977|3995271|FG001|Overall Study|Screen failure|0
2298569|NCT02576977|3995270|FG000|Overall Study|Study Terminated at Selected Sites|27
2298570|NCT02576977|3995271|FG001|Overall Study|Study Terminated at Selected Sites|50
2298571|NCT02576977|3995270|FG000|Overall Study|Withdrawal by Subject|11
2298572|NCT02576977|3995271|FG001|Overall Study|Withdrawal by Subject|11
2298573|NCT02576977|3995270|FG000|Overall Study|Final Disposition Unknown|0
2298574|NCT02576977|3995271|FG001|Overall Study|Final Disposition Unknown|1
2298575|NCT02576977|3995270|FG000|Overall Study|Lost to Follow-up|1
2298576|NCT02576977|3995271|FG001|Overall Study|Lost to Follow-up|0
2298577|NCT02576977|3995270|FG000|Overall Study|Progressive Disease|0
2298578|NCT02576977|3995271|FG001|Overall Study|Progressive Disease|1
2298579|NCT02576990|3995279|FG000|Overall Study|Death|29
2298580|NCT02576990|3995280|FG001|Overall Study|Death|18
2298581|NCT02576990|3995279|FG000|Overall Study|Physician Decision|1
2298582|NCT02576990|3995280|FG001|Overall Study|Physician Decision|0
2298583|NCT02576990|3995279|FG000|Overall Study|Screen failure|2
2298584|NCT02576990|3995280|FG001|Overall Study|Screen failure|0
2298585|NCT02576990|3995279|FG000|Overall Study|Sponsor's decision|24
2298586|NCT02576990|3995280|FG001|Overall Study|Sponsor's decision|4
2298587|NCT02576990|3995279|FG000|Overall Study|Withdrawal by Subject|0
2298588|NCT02576990|3995280|FG001|Overall Study|Withdrawal by Subject|2
2298589|NCT02577003|3995288|FG000|Overall Study|Adverse Event|2
2298590|NCT02577003|3995289|FG001|Overall Study|Adverse Event|4
2298591|NCT02577003|3995288|FG000|Overall Study|Withdrawal by Subject|0
2298592|NCT02577003|3995289|FG001|Overall Study|Withdrawal by Subject|1
2298593|NCT02577016|3995297|FG000|Overall Study|Adverse Event|2
2298594|NCT02577016|3995298|FG001|Overall Study|Adverse Event|1
2298595|NCT02577016|3995297|FG000|Overall Study|Physician Decision|0
2298596|NCT02577016|3995298|FG001|Overall Study|Physician Decision|1
2298597|NCT02577029|3995312|FG000|Overall Study|Adverse Event|1
2298598|NCT02577029|3995313|FG001|Overall Study|Adverse Event|0
2298599|NCT02577029|3995314|FG002|Overall Study|Adverse Event|2
2298600|NCT02577029|3995315|FG003|Overall Study|Adverse Event|0
2298601|NCT02577029|3995316|FG004|Overall Study|Adverse Event|1
2298602|NCT02577029|3995317|FG005|Overall Study|Adverse Event|0
2298603|NCT02577029|3995318|FG006|Overall Study|Adverse Event|0
2298604|NCT02577029|3995319|FG007|Overall Study|Adverse Event|0
2298605|NCT02577029|3995312|FG000|Overall Study|Withdrawal by Subject|0
2298606|NCT02577029|3995313|FG001|Overall Study|Withdrawal by Subject|0
2298607|NCT02577029|3995314|FG002|Overall Study|Withdrawal by Subject|0
2298608|NCT02577029|3995315|FG003|Overall Study|Withdrawal by Subject|0
2298609|NCT02577029|3995316|FG004|Overall Study|Withdrawal by Subject|0
2298610|NCT02577029|3995317|FG005|Overall Study|Withdrawal by Subject|1
2298611|NCT02577029|3995318|FG006|Overall Study|Withdrawal by Subject|0
2298612|NCT02577029|3995319|FG007|Overall Study|Withdrawal by Subject|0
2298613|NCT02577029|3995312|FG000|Overall Study|Sponsor Termination of the Study|9
2298614|NCT02577029|3995313|FG001|Overall Study|Sponsor Termination of the Study|2
2298615|NCT02577029|3995314|FG002|Overall Study|Sponsor Termination of the Study|5
2044484|NCT00455013|3615523|FG001|Short Term Period|Other|0
2044485|NCT00455013|3615524|FG002|Short Term Period|Other|1
2044486|NCT00455013|3615522|FG000|Long Term Extension (LTE)|Adverse Event|0
2044487|NCT00455013|3615523|FG001|Long Term Extension (LTE)|Adverse Event|1
2044488|NCT00455013|3615524|FG002|Long Term Extension (LTE)|Adverse Event|1
2044489|NCT00455013|3615522|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1
2044490|NCT00455013|3615523|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0
2044491|NCT00455013|3615524|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1
2044492|NCT00455013|3615522|FG000|Long Term Extension (LTE)|Death|1
2044493|NCT00455013|3615523|FG001|Long Term Extension (LTE)|Death|1
2044494|NCT00455013|3615524|FG002|Long Term Extension (LTE)|Death|0
2044495|NCT00455013|3615522|FG000|Long Term Extension (LTE)|No longer met criteria|0
2044496|NCT00455013|3615523|FG001|Long Term Extension (LTE)|No longer met criteria|0
2044497|NCT00455013|3615524|FG002|Long Term Extension (LTE)|No longer met criteria|1
2044498|NCT00455013|3615522|FG000|Long Term Extension (LTE)|Subject Request or refused|0
2044499|NCT00455013|3615523|FG001|Long Term Extension (LTE)|Subject Request or refused|0
2044500|NCT00455013|3615524|FG002|Long Term Extension (LTE)|Subject Request or refused|3
2044501|NCT00455013|3615522|FG000|Long Term Extension (LTE)|Poor non-compliance|0
2044502|NCT00455013|3615523|FG001|Long Term Extension (LTE)|Poor non-compliance|1
2044503|NCT00455013|3615524|FG002|Long Term Extension (LTE)|Poor non-compliance|0
2044504|NCT00455013|3615522|FG000|Long Term Extension (LTE)|non-specified|0
2044505|NCT00455013|3615523|FG001|Long Term Extension (LTE)|non-specified|0
2044506|NCT00455013|3615524|FG002|Long Term Extension (LTE)|non-specified|1
2044507|NCT00455195|3615534|FG000|Double-blind Study AGLU02704|Adverse Event|2
2044508|NCT00455195|3615535|FG001|Double-blind Study AGLU02704|Adverse Event|1
2044509|NCT00455195|3615534|FG000|Double-blind Study AGLU02704|Death|1
2044510|NCT00455195|3615535|FG001|Double-blind Study AGLU02704|Death|0
2044511|NCT00455195|3615534|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2
2044512|NCT00455195|3615535|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2
2044513|NCT00455195|3615534|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0
2044514|NCT00455195|3615535|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1
2044515|NCT00455312|3615543|FG000|Overall Study|Death|0
2044516|NCT00455312|3615544|FG001|Overall Study|Death|1
2044517|NCT00455429|3615554|FG000|Overall Study|Study Terminated by Sponsor|0
2044518|NCT00455429|3615555|FG001|Overall Study|Study Terminated by Sponsor|0
2044519|NCT00455429|3615556|FG002|Overall Study|Study Terminated by Sponsor|0
2044520|NCT00455429|3615557|FG003|Overall Study|Study Terminated by Sponsor|3
2044521|NCT00455429|3615554|FG000|Overall Study|Lost to Follow-up|1
2044522|NCT00455429|3615555|FG001|Overall Study|Lost to Follow-up|0
2044523|NCT00455429|3615556|FG002|Overall Study|Lost to Follow-up|0
2044524|NCT00455429|3615557|FG003|Overall Study|Lost to Follow-up|3
2044525|NCT00455429|3615554|FG000|Overall Study|Withdrawal by Subject|0
2044526|NCT00455429|3615555|FG001|Overall Study|Withdrawal by Subject|1
2044527|NCT00455429|3615556|FG002|Overall Study|Withdrawal by Subject|1
2044528|NCT00455429|3615557|FG003|Overall Study|Withdrawal by Subject|0
2044529|NCT00455429|3615554|FG000|Overall Study|Lack of Efficacy|0
2044530|NCT00455429|3615555|FG001|Overall Study|Lack of Efficacy|1
2044531|NCT00455429|3615556|FG002|Overall Study|Lack of Efficacy|0
2044532|NCT00455429|3615557|FG003|Overall Study|Lack of Efficacy|1
2044533|NCT00455429|3615554|FG000|Overall Study|Adverse Event|0
2044534|NCT00455429|3615555|FG001|Overall Study|Adverse Event|1
2044535|NCT00455429|3615556|FG002|Overall Study|Adverse Event|0
2044536|NCT00455429|3615557|FG003|Overall Study|Adverse Event|3
2044537|NCT00455429|3615554|FG000|Overall Study|Randomly assigned but not treated|0
2044538|NCT00455429|3615555|FG001|Overall Study|Randomly assigned but not treated|0
2044539|NCT00455429|3615556|FG002|Overall Study|Randomly assigned but not treated|0
2044540|NCT00455429|3615557|FG003|Overall Study|Randomly assigned but not treated|2
2044541|NCT00455429|3615554|FG000|Overall Study|Personal Reason|1
2044542|NCT00455429|3615555|FG001|Overall Study|Personal Reason|0
2044543|NCT00455429|3615556|FG002|Overall Study|Personal Reason|0
2044544|NCT00455429|3615557|FG003|Overall Study|Personal Reason|0
2044545|NCT00455429|3615554|FG000|Overall Study|Non-compliance|0
2044546|NCT00455429|3615555|FG001|Overall Study|Non-compliance|0
2044547|NCT00455429|3615556|FG002|Overall Study|Non-compliance|0
2044548|NCT00455429|3615557|FG003|Overall Study|Non-compliance|1
2044549|NCT00455429|3615554|FG000|Overall Study|Other|0
2044550|NCT00455429|3615555|FG001|Overall Study|Other|2
2044551|NCT00455429|3615556|FG002|Overall Study|Other|0
2044552|NCT00455429|3615557|FG003|Overall Study|Other|1
2044553|NCT00455455|3615570|FG000|Washout|Withdrawal by Subject|0
2044554|NCT00455455|3615571|FG001|Washout|Withdrawal by Subject|1
2044555|NCT00455455|3615570|FG000|Washout|Withdrawal by Subject|1
2044556|NCT00455455|3615571|FG001|Washout|Withdrawal by Subject|0
2044557|NCT00455520|3615582|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
2044558|NCT00455520|3615583|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
2298616|NCT02577029|3995315|FG003|Overall Study|Sponsor Termination of the Study|12
2298617|NCT02577029|3995316|FG004|Overall Study|Sponsor Termination of the Study|10
2298618|NCT02577029|3995317|FG005|Overall Study|Sponsor Termination of the Study|12
2298619|NCT02577029|3995318|FG006|Overall Study|Sponsor Termination of the Study|12
2298620|NCT02577029|3995319|FG007|Overall Study|Sponsor Termination of the Study|12
2105089|NCT00855335|3697564|FG002|Overall Study|Adverse Event|0
2044559|NCT00455520|3615582|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3
2044560|NCT00455520|3615583|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0
2044561|NCT00455520|3615582|FG000|Open Label Tapentadol Extended Release|Adverse Event|100
2044562|NCT00455520|3615583|FG001|Open Label Tapentadol Extended Release|Adverse Event|0
2044563|NCT00455520|3615582|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23
2044564|NCT00455520|3615583|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0
2044565|NCT00455520|3615582|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13
2044566|NCT00455520|3615583|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0
2044567|NCT00455520|3615582|FG000|Open Label Tapentadol Extended Release|All other|33
2044568|NCT00455520|3615583|FG001|Open Label Tapentadol Extended Release|All other|0
2044569|NCT00455520|3615582|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
2044570|NCT00455520|3615583|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
2044571|NCT00455520|3615582|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
2044572|NCT00455520|3615583|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
2044573|NCT00455520|3615582|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
2044574|NCT00455520|3615583|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
2044575|NCT00455520|3615582|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
2208657|NCT01641198|3848303|FG002|At 15-20 Years of Function|Lost to Follow-up|1
2208658|NCT01641198|3848301|FG000|At 15-20 Years of Function|Death|1
2044576|NCT00455520|3615583|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
2044577|NCT00455520|3615582|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
2044578|NCT00455520|3615583|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
2044579|NCT00455520|3615582|FG000|Double Blind Tapentadol ER vs Placebo|All other|4
2044580|NCT00455520|3615583|FG001|Double Blind Tapentadol ER vs Placebo|All other|6
2044581|NCT00455533|3615591|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
2044582|NCT00455533|3615592|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
2044583|NCT00455533|3615593|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
2044584|NCT00455533|3615591|FG000|Period One: Initial Chemotherapy|Disease Progression|5
2044585|NCT00455533|3615592|FG001|Period One: Initial Chemotherapy|Disease Progression|0
2044586|NCT00455533|3615593|FG002|Period One: Initial Chemotherapy|Disease Progression|0
2044587|NCT00455533|3615591|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2
2044588|NCT00455533|3615592|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0
2044589|NCT00455533|3615593|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0
2044590|NCT00455533|3615591|FG000|Period One: Initial Chemotherapy|Not Reported|1
2208659|NCT01641198|3848302|FG001|At 15-20 Years of Function|Death|0
2208660|NCT01641198|3848303|FG002|At 15-20 Years of Function|Death|1
2208661|NCT01641237|3848312|FG000|Period II|Withdrawal by Subject|1
2208662|NCT01641237|3848313|FG001|Period II|Withdrawal by Subject|0
2208663|NCT01641237|3848314|FG002|Period II|Withdrawal by Subject|0
2298621|NCT02577107|3995349|FG000|Overall Study|Protocol deviation|0
2298622|NCT02577107|3995350|FG001|Overall Study|Protocol deviation|1
2298623|NCT02577146|3995356|FG000|Overall Study|Lost to Follow-up|8
2298624|NCT02577146|3995356|FG000|Overall Study|Physician Decision|3
2298625|NCT02577146|3995356|FG000|Overall Study|Screen Failure|17
2298626|NCT02577315|3995362|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2298627|NCT02577315|3995363|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
2298628|NCT02577718|3995415|FG000|Overall Study|Death|6
2298629|NCT02577718|3995415|FG000|Overall Study|Withdrawal by Subject|2
2298630|NCT02577887|3995430|FG000|Overall Study|Death|93
2298631|NCT02577887|3995430|FG000|Overall Study|Protocol Violation|125
2298632|NCT02577887|3995430|FG000|Overall Study|Withdrawal by Subject|80
2298633|NCT02578186|3995469|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
2298634|NCT02578186|3995470|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
2298635|NCT02578186|3995469|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1
2298636|NCT02578186|3995470|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1
2298637|NCT02578316|3995484|FG000|Extension Phase|Progression of disease|6
2298638|NCT02578680|3995494|FG000|Overall Study|Death|124
2298639|NCT02578680|3995495|FG001|Overall Study|Death|104
2298640|NCT02578680|3995494|FG000|Overall Study|Protocol Violation|1
2298641|NCT02578680|3995495|FG001|Overall Study|Protocol Violation|1
2298642|NCT02578680|3995494|FG000|Overall Study|Withdrawal by Parent/Guardian|1
2298643|NCT02578680|3995495|FG001|Overall Study|Withdrawal by Parent/Guardian|0
2298644|NCT02578680|3995494|FG000|Overall Study|Withdrawal by Subject|8
2298645|NCT02578680|3995495|FG001|Overall Study|Withdrawal by Subject|5
2298646|NCT02578680|3995494|FG000|Overall Study|Ongoing in Study|276
2298647|NCT02578680|3995495|FG001|Overall Study|Ongoing in Study|96
2298648|NCT02578706|3995504|FG000|Overall Study|Withdrawal by Subject|1
2298649|NCT02578706|3995505|FG001|Overall Study|Withdrawal by Subject|0
2298650|NCT02578706|3995506|FG002|Overall Study|Withdrawal by Subject|0
2298651|NCT02578706|3995504|FG000|Overall Study|Lost to Follow-up|0
2298652|NCT02578706|3995505|FG001|Overall Study|Lost to Follow-up|4
2298653|NCT02578706|3995506|FG002|Overall Study|Lost to Follow-up|0
2298654|NCT02578706|3995504|FG000|Overall Study|Physician Decision|0
2298655|NCT02578706|3995505|FG001|Overall Study|Physician Decision|1
2298656|NCT02578706|3995506|FG002|Overall Study|Physician Decision|0
2298657|NCT02578862|3995530|FG000|Overall Study|Withdrawal by Subject|0
2044591|NCT00455533|3615592|FG001|Period One: Initial Chemotherapy|Not Reported|0
2044592|NCT00455533|3615593|FG002|Period One: Initial Chemotherapy|Not Reported|0
2044593|NCT00455533|3615591|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2
2044594|NCT00455533|3615592|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0
2044595|NCT00455533|3615593|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0
2044596|NCT00455533|3615591|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2
2044597|NCT00455533|3615592|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0
2044598|NCT00455533|3615593|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0
2044599|NCT00455533|3615591|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
2044600|NCT00455533|3615592|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
2044601|NCT00455533|3615593|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
2044602|NCT00455533|3615591|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
2044603|NCT00455533|3615592|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
2044604|NCT00455533|3615593|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
2044605|NCT00455533|3615591|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
2044606|NCT00455533|3615592|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
2044607|NCT00455533|3615593|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
2044608|NCT00455533|3615591|FG000|Period Two: Randomized Period|Death|0
2044609|NCT00455533|3615592|FG001|Period Two: Randomized Period|Death|0
2044610|NCT00455533|3615593|FG002|Period Two: Randomized Period|Death|3
2044611|NCT00455533|3615591|FG000|Period Two: Randomized Period|Disease Progression|0
2044612|NCT00455533|3615592|FG001|Period Two: Randomized Period|Disease Progression|1
2044613|NCT00455533|3615593|FG002|Period Two: Randomized Period|Disease Progression|1
2044614|NCT00455533|3615591|FG000|Period Two: Randomized Period|Lost to Follow-up|0
2044615|NCT00455533|3615592|FG001|Period Two: Randomized Period|Lost to Follow-up|0
2044616|NCT00455533|3615593|FG002|Period Two: Randomized Period|Lost to Follow-up|1
2044617|NCT00455533|3615591|FG000|Period Two: Randomized Period|Other - need reasons|0
2044618|NCT00455533|3615592|FG001|Period Two: Randomized Period|Other - need reasons|1
2044619|NCT00455533|3615593|FG002|Period Two: Randomized Period|Other - need reasons|0
2044620|NCT00455533|3615591|FG000|Period Two: Randomized Period|Study Drug Toxicity|0
2044621|NCT00455533|3615592|FG001|Period Two: Randomized Period|Study Drug Toxicity|2
2044622|NCT00455533|3615593|FG002|Period Two: Randomized Period|Study Drug Toxicity|0
2044623|NCT00455533|3615591|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0
2044624|NCT00455533|3615592|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2
2044625|NCT00455533|3615593|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1
2044626|NCT00455741|3615656|FG000|Overall Study|Physician Decision|0
2044627|NCT00455741|3615657|FG001|Overall Study|Physician Decision|1
2044628|NCT00455858|3615673|FG000|Overall Study|Lost to Follow-up|2
2044629|NCT00455858|3615673|FG000|Overall Study|Protocol Violation|1
2044630|NCT00455858|3615673|FG000|Overall Study|Lack of Efficacy|1
2044631|NCT00455858|3615673|FG000|Overall Study|Well controlled FPG without insulin|1
2044632|NCT00455858|3615673|FG000|Overall Study|Withdrawal|1
2044633|NCT00455923|3615679|FG000|Overall Study|Pregnancy|0
2044634|NCT00455923|3615680|FG001|Overall Study|Pregnancy|2
2044635|NCT00455923|3615679|FG000|Overall Study|Other|3
2044636|NCT00455923|3615680|FG001|Overall Study|Other|1
2044637|NCT00456092|3615713|FG000|Extension Phase|Grade 2 or Greater AE|2
2044638|NCT00456092|3615714|FG001|Extension Phase|Grade 2 or Greater AE|2
2044639|NCT00456092|3615715|FG002|Extension Phase|Grade 2 or Greater AE|0
2044640|NCT00456092|3615716|FG003|Extension Phase|Grade 2 or Greater AE|0
2044641|NCT00456092|3615717|FG004|Extension Phase|Grade 2 or Greater AE|2
2044642|NCT00456092|3615713|FG000|Extension Phase|Flare of Psoriatic Arthritis|1
2044643|NCT00456092|3615714|FG001|Extension Phase|Flare of Psoriatic Arthritis|0
2044644|NCT00456092|3615715|FG002|Extension Phase|Flare of Psoriatic Arthritis|0
2044645|NCT00456092|3615716|FG003|Extension Phase|Flare of Psoriatic Arthritis|0
2044646|NCT00456092|3615717|FG004|Extension Phase|Flare of Psoriatic Arthritis|1
2044647|NCT00456092|3615713|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3
2044648|NCT00456092|3615714|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1
2298658|NCT02578862|3995531|FG001|Overall Study|Withdrawal by Subject|1
2298659|NCT02578862|3995530|FG000|Overall Study|Unplanned unilateral procedure|0
2298660|NCT02578862|3995531|FG001|Overall Study|Unplanned unilateral procedure|1
2298661|NCT02578940|3995546|FG000|Overall Study|Screening failure|5
2298662|NCT02578940|3995546|FG000|Overall Study|Lost to Follow-up|1
2298663|NCT02578992|3995554|FG000|Overall Study|equipment not available or malfunction|3
2298664|NCT02578992|3995555|FG001|Overall Study|equipment not available or malfunction|3
2298665|NCT02579382|3995598|FG000|Main Study Phase|Lost to Follow-up|0
2298666|NCT02579382|3995599|FG001|Main Study Phase|Lost to Follow-up|0
2298667|NCT02579382|3995600|FG002|Main Study Phase|Lost to Follow-up|2
2298668|NCT02579382|3995601|FG003|Main Study Phase|Lost to Follow-up|0
2298669|NCT02579382|3995598|FG000|Main Study Phase|Withdrew Consent|0
2298670|NCT02579382|3995599|FG001|Main Study Phase|Withdrew Consent|0
2298671|NCT02579382|3995600|FG002|Main Study Phase|Withdrew Consent|0
2298672|NCT02579382|3995601|FG003|Main Study Phase|Withdrew Consent|2
2298673|NCT02579382|3995598|FG000|Main Study Phase|Lack of Efficacy|0
2298674|NCT02579382|3995599|FG001|Main Study Phase|Lack of Efficacy|0
2298675|NCT02579382|3995600|FG002|Main Study Phase|Lack of Efficacy|0
2044649|NCT00456092|3615715|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0
2044650|NCT00456092|3615716|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0
2044651|NCT00456092|3615717|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2
2044652|NCT00456092|3615713|FG000|Extension Phase|Withdrew Consent|2
2044653|NCT00456092|3615714|FG001|Extension Phase|Withdrew Consent|0
2044654|NCT00456092|3615715|FG002|Extension Phase|Withdrew Consent|0
2044655|NCT00456092|3615716|FG003|Extension Phase|Withdrew Consent|0
2044656|NCT00456092|3615717|FG004|Extension Phase|Withdrew Consent|0
2044657|NCT00456092|3615713|FG000|Extension Phase|Lost to Follow-up|1
2044658|NCT00456092|3615714|FG001|Extension Phase|Lost to Follow-up|1
2044659|NCT00456092|3615715|FG002|Extension Phase|Lost to Follow-up|0
2044660|NCT00456092|3615716|FG003|Extension Phase|Lost to Follow-up|0
2044661|NCT00456092|3615717|FG004|Extension Phase|Lost to Follow-up|1
2044662|NCT00456092|3615713|FG000|Extension Phase|Other|2
2044663|NCT00456092|3615714|FG001|Extension Phase|Other|0
2044664|NCT00456092|3615715|FG002|Extension Phase|Other|0
2044665|NCT00456092|3615716|FG003|Extension Phase|Other|1
2044666|NCT00456092|3615717|FG004|Extension Phase|Other|1
2044667|NCT00456092|3615713|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
2044668|NCT00456092|3615714|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
2105090|NCT00855335|3697565|FG003|Overall Study|Adverse Event|0
2298676|NCT02579382|3995601|FG003|Main Study Phase|Lack of Efficacy|1
2298677|NCT02579382|3995598|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
2298678|NCT02579382|3995599|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
2298679|NCT02579382|3995600|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
2298680|NCT02579382|3995601|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
2298681|NCT02579382|3995598|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1
2298682|NCT02579382|3995599|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
2298683|NCT02579382|3995600|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2
2298684|NCT02579382|3995601|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
2298685|NCT02579382|3995598|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
2298686|NCT02579382|3995599|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
2298687|NCT02579382|3995600|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
2298688|NCT02579382|3995601|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
2298689|NCT02579382|3995598|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
2298690|NCT02579382|3995599|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
2298691|NCT02579382|3995600|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
2298692|NCT02579382|3995601|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
2298693|NCT02579382|3995598|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
2298694|NCT02579382|3995599|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
2298695|NCT02579382|3995600|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
2298696|NCT02579382|3995601|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
2298697|NCT02579382|3995598|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
2298698|NCT02579382|3995599|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
2298699|NCT02579382|3995600|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
2298700|NCT02579382|3995601|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
2298701|NCT02579603|3995638|FG000|Overall Study|Not treated|1
2298702|NCT02579603|3995639|FG001|Overall Study|Not treated|0
2298703|NCT02579603|3995638|FG000|Overall Study|Adverse Event|2
2298704|NCT02579603|3995639|FG001|Overall Study|Adverse Event|2
2298705|NCT02579603|3995638|FG000|Overall Study|Other than stated|1
2298706|NCT02579603|3995639|FG001|Overall Study|Other than stated|0
2298707|NCT02579616|3995646|FG000|Overall Study|Participants did not receive treatment|3
2298708|NCT02579629|3995653|FG000|Overall Study|Withdrawal by Subject|0
2298709|NCT02579629|3995654|FG001|Overall Study|Withdrawal by Subject|1
2298710|NCT02579629|3995655|FG002|Overall Study|Withdrawal by Subject|0
2298711|NCT02579629|3995653|FG000|Overall Study|Screen Failure|2
2298712|NCT02579629|3995654|FG001|Overall Study|Screen Failure|0
2298713|NCT02579629|3995655|FG002|Overall Study|Screen Failure|2
2298714|NCT02579759|3995666|FG000|Overall Study|Protocol Violation|2
2298715|NCT02579759|3995667|FG001|Overall Study|Protocol Violation|0
2298716|NCT02579759|3995668|FG002|Overall Study|Protocol Violation|0
2298717|NCT02579759|3995666|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0
2298718|NCT02579759|3995667|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1
2298719|NCT02579759|3995668|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0
2298720|NCT02579759|3995666|FG000|Overall Study|BfArM hold|13
2298721|NCT02579759|3995667|FG001|Overall Study|BfArM hold|12
2298722|NCT02579759|3995668|FG002|Overall Study|BfArM hold|12
2298723|NCT02579759|3995666|FG000|Overall Study|Sponsor stopped Dose 2|0
2298724|NCT02579759|3995667|FG001|Overall Study|Sponsor stopped Dose 2|41
2298725|NCT02579759|3995668|FG002|Overall Study|Sponsor stopped Dose 2|0
2298726|NCT02579759|3995666|FG000|Overall Study|Non compliance|0
2298727|NCT02579759|3995667|FG001|Overall Study|Non compliance|1
2298728|NCT02579759|3995668|FG002|Overall Study|Non compliance|0
2298729|NCT02579759|3995666|FG000|Overall Study|Pregnancy|0
2298730|NCT02579759|3995667|FG001|Overall Study|Pregnancy|1
2298731|NCT02579759|3995668|FG002|Overall Study|Pregnancy|0
2298732|NCT02579759|3995666|FG000|Overall Study|Inclusion/exclusion criteria|0
2044669|NCT00456092|3615715|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
2044670|NCT00456092|3615716|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
2044671|NCT00456092|3615717|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
2044672|NCT00456092|3615713|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
2044673|NCT00456092|3615714|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
2044674|NCT00456092|3615715|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
2044675|NCT00456092|3615716|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
2044676|NCT00456092|3615717|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
2044677|NCT00456092|3615713|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
2044678|NCT00456092|3615714|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
2044679|NCT00456092|3615715|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
2044680|NCT00456092|3615716|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
2044681|NCT00456092|3615717|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
2044682|NCT00456092|3615713|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
2044683|NCT00456092|3615714|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
2044684|NCT00456092|3615715|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
2044685|NCT00456092|3615716|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
2044686|NCT00456092|3615717|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
2044687|NCT00456092|3615713|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
2044688|NCT00456092|3615714|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
2044689|NCT00456092|3615715|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
2044690|NCT00456092|3615716|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
2044691|NCT00456092|3615717|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
2044692|NCT00456092|3615713|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
2044693|NCT00456092|3615714|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
2044694|NCT00456092|3615715|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
2044695|NCT00456092|3615716|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
2044696|NCT00456092|3615717|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
2044697|NCT00456092|3615713|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0
2044698|NCT00456092|3615714|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1
2044699|NCT00456092|3615715|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2
2044700|NCT00456092|3615716|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0
2044701|NCT00456092|3615717|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0
2044702|NCT00456092|3615713|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0
2044703|NCT00456092|3615714|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1
2044704|NCT00456092|3615715|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1
2044705|NCT00456092|3615716|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0
2044706|NCT00456092|3615717|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0
2044707|NCT00456092|3615713|FG000|Treatment Phase (12 Weeks)|Other|1
2044708|NCT00456092|3615714|FG001|Treatment Phase (12 Weeks)|Other|0
2044709|NCT00456092|3615715|FG002|Treatment Phase (12 Weeks)|Other|1
2044710|NCT00456092|3615716|FG003|Treatment Phase (12 Weeks)|Other|0
2044711|NCT00456092|3615717|FG004|Treatment Phase (12 Weeks)|Other|0
2044712|NCT00456300|3615740|FG000|Overall Study|Adverse Event|1
2044713|NCT00456300|3615741|FG001|Overall Study|Adverse Event|0
2044714|NCT00456365|3615751|FG000|Overall Study|Lost to Follow-up|1
2044715|NCT00456365|3615752|FG001|Overall Study|Lost to Follow-up|3
2044716|NCT00456365|3615751|FG000|Overall Study|Withdrawal by Subject|4
2044717|NCT00456365|3615752|FG001|Overall Study|Withdrawal by Subject|7
2298733|NCT02579759|3995667|FG001|Overall Study|Inclusion/exclusion criteria|0
2298734|NCT02579759|3995668|FG002|Overall Study|Inclusion/exclusion criteria|1
2298735|NCT02579759|3995666|FG000|Overall Study|Adverse Event|4
2298736|NCT02579759|3995667|FG001|Overall Study|Adverse Event|3
2298737|NCT02579759|3995668|FG002|Overall Study|Adverse Event|1
2298738|NCT02579759|3995666|FG000|Overall Study|Withdrawal by Subject|3
2298739|NCT02579759|3995667|FG001|Overall Study|Withdrawal by Subject|3
2298740|NCT02579759|3995668|FG002|Overall Study|Withdrawal by Subject|5
2298741|NCT02579759|3995666|FG000|Overall Study|Lost to Follow-up|2
2298742|NCT02579759|3995667|FG001|Overall Study|Lost to Follow-up|2
2298743|NCT02579759|3995668|FG002|Overall Study|Lost to Follow-up|2
2298744|NCT02579772|3995678|FG000|Overall Study|Withdrawal by Subject|0
2298745|NCT02579772|3995679|FG001|Overall Study|Withdrawal by Subject|1
2298746|NCT02579772|3995678|FG000|Overall Study|Usage of additional antioxidants|1
2298747|NCT02579772|3995679|FG001|Overall Study|Usage of additional antioxidants|0
2298748|NCT02579772|3995678|FG000|Overall Study|flu-like illness, orthopedic trauma|1
2298749|NCT02579772|3995679|FG001|Overall Study|flu-like illness, orthopedic trauma|1
2298750|NCT02579863|3995691|FG000|Overall Study|Final Disposition Unknown|2
2298751|NCT02579863|3995692|FG001|Overall Study|Final Disposition Unknown|1
2298752|NCT02579863|3995691|FG000|Overall Study|Adverse Event|18
2298753|NCT02579863|3995692|FG001|Overall Study|Adverse Event|11
2298754|NCT02579863|3995691|FG000|Overall Study|Death|31
2298755|NCT02579863|3995692|FG001|Overall Study|Death|29
2298756|NCT02579863|3995691|FG000|Overall Study|Lost to Follow-up|2
2298757|NCT02579863|3995692|FG001|Overall Study|Lost to Follow-up|1
2298758|NCT02579863|3995691|FG000|Overall Study|Physician Decision|1
2044718|NCT00456365|3615751|FG000|Overall Study|Pregnancy|1
2044719|NCT00456365|3615752|FG001|Overall Study|Pregnancy|1
2044720|NCT00456365|3615751|FG000|Overall Study|oncologic diagnosis|1
2044721|NCT00456365|3615752|FG001|Overall Study|oncologic diagnosis|1
2044722|NCT00456495|3615760|FG000|Overall Study|Physician Decision|2
2044723|NCT00456521|3615771|FG000|Overall Study|Adverse Event|150
2044724|NCT00456521|3615772|FG001|Overall Study|Adverse Event|25
2044725|NCT00456521|3615771|FG000|Overall Study|Withdrawal by Subject|43
2044726|NCT00456521|3615772|FG001|Overall Study|Withdrawal by Subject|24
2044727|NCT00456521|3615771|FG000|Overall Study|Lost to Follow-up|22
2044728|NCT00456521|3615772|FG001|Overall Study|Lost to Follow-up|17
2044729|NCT00456521|3615771|FG000|Overall Study|Lack of Efficacy|3
2044730|NCT00456521|3615772|FG001|Overall Study|Lack of Efficacy|6
2044731|NCT00456521|3615771|FG000|Overall Study|Protocol Violation|4
2044732|NCT00456521|3615772|FG001|Overall Study|Protocol Violation|0
2044733|NCT00456521|3615771|FG000|Overall Study|Pregnancy|1
2044734|NCT00456521|3615772|FG001|Overall Study|Pregnancy|1
2044735|NCT00456521|3615771|FG000|Overall Study|Drug non-compliance, moved, other|26
2044736|NCT00456521|3615772|FG001|Overall Study|Drug non-compliance, moved, other|11
2044737|NCT00456599|3615788|FG000|Overall Study|Non-compliance|1
2044738|NCT00456599|3615788|FG000|Overall Study|Withdrawal by Subject|2
2044739|NCT00456755|3615798|FG000|Overall Study|Lost to Follow-up|2
2044740|NCT00456755|3615799|FG001|Overall Study|Lost to Follow-up|1
2044741|NCT00456846|3615816|FG000|Overall Study|Adverse Event|2
2044742|NCT00456846|3615817|FG001|Overall Study|Adverse Event|15
2044743|NCT00456846|3615816|FG000|Overall Study|Physician Decision|11
2044744|NCT00456846|3615817|FG001|Overall Study|Physician Decision|6
2044745|NCT00456846|3615816|FG000|Overall Study|Protocol Deviation|2
2044746|NCT00456846|3615817|FG001|Overall Study|Protocol Deviation|0
2044747|NCT00456846|3615816|FG000|Overall Study|Participant Discretion|1
2044748|NCT00456846|3615817|FG001|Overall Study|Participant Discretion|5
2044749|NCT00456846|3615816|FG000|Overall Study|Other|0
2044750|NCT00456846|3615817|FG001|Overall Study|Other|2
2105091|NCT00855335|3697566|FG004|Overall Study|Adverse Event|0
2105092|NCT00855335|3697562|FG000|Overall Study|Physician Decision|1
2298759|NCT02579863|3995692|FG001|Overall Study|Physician Decision|2
2298760|NCT02579863|3995691|FG000|Overall Study|Screen Failure|0
2298761|NCT02579863|3995692|FG001|Overall Study|Screen Failure|2
2298762|NCT02579863|3995691|FG000|Overall Study|Study Terminated at Selected Sites|82
2298763|NCT02579863|3995692|FG001|Overall Study|Study Terminated at Selected Sites|88
2298764|NCT02579863|3995691|FG000|Overall Study|Withdrawal by Subject|20
2298765|NCT02579863|3995692|FG001|Overall Study|Withdrawal by Subject|20
2298766|NCT02579928|3995718|FG000|Overall Study|Withdrawal by Subject|1
2298767|NCT02579928|3995719|FG001|Overall Study|Withdrawal by Subject|0
2298768|NCT02580058|3995728|FG000|Overall Study|Lost to Follow-up|4
2298769|NCT02580058|3995729|FG001|Overall Study|Lost to Follow-up|5
2298770|NCT02580058|3995730|FG002|Overall Study|Lost to Follow-up|4
2298771|NCT02580058|3995728|FG000|Overall Study|Ongoing|51
2298772|NCT02580058|3995729|FG001|Overall Study|Ongoing|55
2298773|NCT02580058|3995730|FG002|Overall Study|Ongoing|46
2298774|NCT02580058|3995728|FG000|Overall Study|Withdrawal by Subject|24
2298775|NCT02580058|3995729|FG001|Overall Study|Withdrawal by Subject|26
2298776|NCT02580058|3995730|FG002|Overall Study|Withdrawal by Subject|36
2321348|NCT02959814|4035921|FG000|Overall Study|Excluded based on diagnostic angiography|16
2321349|NCT02959814|4035921|FG000|Overall Study|Excluded based on anatomical criteria|2
2321350|NCT02959814|4035921|FG000|Overall Study|Protocol Violation|7
2321351|NCT02959814|4035921|FG000|Overall Study|FFR not measured|2
2321352|NCT02959814|4035921|FG000|Overall Study|In-procedure QFR not computed|6
2321353|NCT02959814|4035921|FG000|Overall Study|Excluded by FFR core-lab|24
2321354|NCT02959866|4035957|FG000|Overall Study|Withdrawal by Subject|1
2321355|NCT02959892|4035964|FG000|Overall Study|PET tracer synthesis failure|1
2321356|NCT02959892|4035965|FG001|Overall Study|PET tracer synthesis failure|0
2321357|NCT02959892|4035964|FG000|Overall Study|Study termination|0
2321358|NCT02959892|4035965|FG001|Overall Study|Study termination|1
2321359|NCT02959970|4035973|FG000|Overall Study|Adverse Event|1
2321360|NCT02959970|4035974|FG001|Overall Study|Adverse Event|0
2321361|NCT02959970|4035973|FG000|Overall Study|Withdrawal by Subject|0
2321362|NCT02959970|4035974|FG001|Overall Study|Withdrawal by Subject|2
2321363|NCT02959970|4035973|FG000|Overall Study|Lost to Follow-up|1
2321364|NCT02959970|4035974|FG001|Overall Study|Lost to Follow-up|5
2321365|NCT02959983|4035984|FG000|Overall Study|Protocol Violation|0
2321366|NCT02959983|4035985|FG001|Overall Study|Protocol Violation|1
2321367|NCT02959983|4035984|FG000|Overall Study|Lack of Efficacy|0
2321368|NCT02959983|4035985|FG001|Overall Study|Lack of Efficacy|1
2321369|NCT02959983|4035984|FG000|Overall Study|Lost to Follow-up|12
2321370|NCT02959983|4035985|FG001|Overall Study|Lost to Follow-up|9
2321371|NCT02959983|4035984|FG000|Overall Study|Other|1
2321372|NCT02959983|4035985|FG001|Overall Study|Other|1
2321373|NCT02959983|4035984|FG000|Overall Study|Physician Decision|1
2321374|NCT02959983|4035985|FG001|Overall Study|Physician Decision|0
2321375|NCT02959983|4035984|FG000|Overall Study|Adverse Event|5
2321376|NCT02959983|4035985|FG001|Overall Study|Adverse Event|1
2321377|NCT02959983|4035984|FG000|Overall Study|Withdrawal by Subject|7
2321378|NCT02959983|4035985|FG001|Overall Study|Withdrawal by Subject|12
2105093|NCT00855335|3697563|FG001|Overall Study|Physician Decision|1
2321379|NCT02960217|4036002|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1
2044751|NCT00457002|3615831|FG000|Overall Study|Death|40
2044752|NCT00457002|3615832|FG001|Overall Study|Death|47
2044753|NCT00457002|3615831|FG000|Overall Study|Adverse Event|284
2044754|NCT00457002|3615832|FG001|Overall Study|Adverse Event|260
2044755|NCT00457002|3615831|FG000|Overall Study|Withdrawal by Subject|299
2044756|NCT00457002|3615832|FG001|Overall Study|Withdrawal by Subject|271
2044757|NCT00457002|3615831|FG000|Overall Study|Lost to Follow-up|72
2044758|NCT00457002|3615832|FG001|Overall Study|Lost to Follow-up|71
2044759|NCT00457002|3615831|FG000|Overall Study|Poor/Non-compliance|46
2044760|NCT00457002|3615832|FG001|Overall Study|Poor/Non-compliance|33
2044761|NCT00457002|3615831|FG000|Overall Study|No longer met criteria|41
2044762|NCT00457002|3615832|FG001|Overall Study|No longer met criteria|37
2044763|NCT00457002|3615831|FG000|Overall Study|Administrative reason by Sponsor|1
2044764|NCT00457002|3615832|FG001|Overall Study|Administrative reason by Sponsor|0
2044765|NCT00457002|3615831|FG000|Overall Study|non-specified|29
2044766|NCT00457002|3615832|FG001|Overall Study|non-specified|38
2044767|NCT00457002|3615831|FG000|Overall Study|treated for 1 day; missing status/reason|1
2044768|NCT00457002|3615832|FG001|Overall Study|treated for 1 day; missing status/reason|0
2044769|NCT00457015|3615840|FG000|Overall Study|Left study site against medical advice|0
2044770|NCT00457015|3615841|FG001|Overall Study|Left study site against medical advice|1
2044771|NCT00457249|3615858|FG000|Overall Study|Lost to Follow-up|3
2044772|NCT00457249|3615859|FG001|Overall Study|Lost to Follow-up|0
2044773|NCT00457249|3615858|FG000|Overall Study|Protocol Violation|4
2044774|NCT00457249|3615859|FG001|Overall Study|Protocol Violation|1
2044775|NCT00457249|3615858|FG000|Overall Study|Withdrawal by Subject|3
2044776|NCT00457249|3615859|FG001|Overall Study|Withdrawal by Subject|1
2044777|NCT00457249|3615858|FG000|Overall Study|Serious Adverse Events|2
2044778|NCT00457249|3615859|FG001|Overall Study|Serious Adverse Events|0
2044779|NCT00457301|3615869|FG000|Overall Study|Withdrawal by Subject|3
2044780|NCT00457301|3615870|FG001|Overall Study|Withdrawal by Subject|3
2044781|NCT00457301|3615869|FG000|Overall Study|Censored out of the study|15
2044782|NCT00457301|3615870|FG001|Overall Study|Censored out of the study|14
2044783|NCT00457301|3615869|FG000|Overall Study|Death|5
2044784|NCT00457301|3615870|FG001|Overall Study|Death|7
2044785|NCT00457392|3615887|FG000|Overall Study|Objective Progression or Relapse|229
2044786|NCT00457392|3615888|FG001|Overall Study|Objective Progression or Relapse|296
2044787|NCT00457392|3615887|FG000|Overall Study|Death|106
2044788|NCT00457392|3615888|FG001|Overall Study|Death|106
2044789|NCT00457392|3615887|FG000|Overall Study|Adverse Event|84
2044790|NCT00457392|3615888|FG001|Overall Study|Adverse Event|41
2044791|NCT00457392|3615887|FG000|Overall Study|Global Deterioration of Health Status|22
2044792|NCT00457392|3615888|FG001|Overall Study|Global Deterioration of Health Status|8
2208664|NCT01641237|3848315|FG003|Period II|Withdrawal by Subject|0
2208665|NCT01641237|3848312|FG000|Period III|Lost to Follow-up|1
2208666|NCT01641237|3848313|FG001|Period III|Lost to Follow-up|0
2208667|NCT01641237|3848314|FG002|Period III|Lost to Follow-up|0
2208668|NCT01641237|3848315|FG003|Period III|Lost to Follow-up|0
2298777|NCT02580240|3995760|FG000|Overall Study|Physician Decision|2
2298778|NCT02580240|3995761|FG001|Overall Study|Physician Decision|0
2298779|NCT02580357|3995774|FG000|Overall Study|Lost to Follow-up|2
2298780|NCT02580357|3995775|FG001|Overall Study|Lost to Follow-up|0
2298781|NCT02580357|3995776|FG002|Overall Study|Lost to Follow-up|0
2298782|NCT02580357|3995774|FG000|Overall Study|Protocol Violation|1
2298783|NCT02580357|3995775|FG001|Overall Study|Protocol Violation|0
2298784|NCT02580357|3995776|FG002|Overall Study|Protocol Violation|0
2298785|NCT02580591|3995788|FG000|Overall Study|Adverse Event|0
2298786|NCT02580591|3995789|FG001|Overall Study|Adverse Event|1
2298787|NCT02580591|3995790|FG002|Overall Study|Adverse Event|2
2298788|NCT02580591|3995791|FG003|Overall Study|Adverse Event|5
2298789|NCT02580591|3995788|FG000|Overall Study|Protocol Violation|3
2298790|NCT02580591|3995789|FG001|Overall Study|Protocol Violation|2
2298791|NCT02580591|3995790|FG002|Overall Study|Protocol Violation|1
2298792|NCT02580591|3995791|FG003|Overall Study|Protocol Violation|1
2298793|NCT02580591|3995788|FG000|Overall Study|Lost to Follow-up|5
2298794|NCT02580591|3995789|FG001|Overall Study|Lost to Follow-up|3
2298795|NCT02580591|3995790|FG002|Overall Study|Lost to Follow-up|3
2298796|NCT02580591|3995791|FG003|Overall Study|Lost to Follow-up|1
2298797|NCT02580591|3995788|FG000|Overall Study|Withdrawal by Subject|6
2298798|NCT02580591|3995789|FG001|Overall Study|Withdrawal by Subject|1
2298799|NCT02580591|3995790|FG002|Overall Study|Withdrawal by Subject|2
2298800|NCT02580591|3995791|FG003|Overall Study|Withdrawal by Subject|3
2217479|NCT01708915|3860821|FG000|Overall Study|Protocol Violation|0
2217480|NCT01708915|3860822|FG001|Overall Study|Protocol Violation|0
2217481|NCT01708915|3860823|FG002|Overall Study|Protocol Violation|0
2217482|NCT01708915|3860824|FG003|Overall Study|Protocol Violation|1
2217483|NCT01708915|3860821|FG000|Overall Study|Withdrawal by Subject|0
2217484|NCT01708915|3860822|FG001|Overall Study|Withdrawal by Subject|1
2217485|NCT01708915|3860823|FG002|Overall Study|Withdrawal by Subject|2
2217486|NCT01708915|3860824|FG003|Overall Study|Withdrawal by Subject|2
2217487|NCT01708915|3860821|FG000|Overall Study|Other reasons than stated above|1
2217488|NCT01708915|3860822|FG001|Overall Study|Other reasons than stated above|1
2217489|NCT01708915|3860823|FG002|Overall Study|Other reasons than stated above|0
2298801|NCT02580591|3995788|FG000|Overall Study|Not treated|1
2298802|NCT02580591|3995789|FG001|Overall Study|Not treated|1
2044793|NCT00457392|3615887|FG000|Overall Study|Withdrawal by Subject|14
2044794|NCT00457392|3615888|FG001|Overall Study|Withdrawal by Subject|8
2044795|NCT00457392|3615887|FG000|Overall Study|Lost to Follow-up|6
2044796|NCT00457392|3615888|FG001|Overall Study|Lost to Follow-up|7
2044797|NCT00457392|3615887|FG000|Overall Study|Protocol Violation|4
2044798|NCT00457392|3615888|FG001|Overall Study|Protocol Violation|3
2044799|NCT00457392|3615887|FG000|Overall Study|Other|7
2044800|NCT00457392|3615888|FG001|Overall Study|Other|4
2044801|NCT00457392|3615887|FG000|Overall Study|Study Terminated by Sponsor|1
2044802|NCT00457392|3615888|FG001|Overall Study|Study Terminated by Sponsor|4
2044803|NCT00457392|3615887|FG000|Overall Study|Randomized, Not Treated|7
2044804|NCT00457392|3615888|FG001|Overall Study|Randomized, Not Treated|3
2044805|NCT00457418|3615894|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
2044806|NCT00457418|3615894|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
2044807|NCT00457418|3615894|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
2044808|NCT00457418|3615894|FG000|Post PK Maintenance|Adverse Event|10
2044809|NCT00457418|3615894|FG000|Post PK Maintenance|Progression of Disease|6
2044810|NCT00457418|3615894|FG000|Post PK Maintenance|Withdrawal by Subject|11
2044811|NCT00457418|3615894|FG000|Post PK Maintenance|Lost to Follow-up|1
2044812|NCT00457626|3615898|FG000|Overall Study|Adverse Event|3
2298803|NCT02580591|3995790|FG002|Overall Study|Not treated|0
2298804|NCT02580591|3995791|FG003|Overall Study|Not treated|0
2298805|NCT02580591|3995788|FG000|Overall Study|Other than specified|3
2298806|NCT02580591|3995789|FG001|Overall Study|Other than specified|2
2298807|NCT02580591|3995790|FG002|Overall Study|Other than specified|5
2298808|NCT02580591|3995791|FG003|Overall Study|Other than specified|2
2298809|NCT02580877|3995807|FG000|Overall Study|Withdrawal by Subject|1
2298810|NCT02580877|3995808|FG001|Overall Study|Withdrawal by Subject|3
2298811|NCT02580877|3995807|FG000|Overall Study|Adverse Event|0
2298812|NCT02580877|3995808|FG001|Overall Study|Adverse Event|1
2044813|NCT00457626|3615898|FG000|Overall Study|Administrative Problems|2
2044814|NCT00457626|3615898|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1
2044815|NCT00457639|3615902|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3
2298813|NCT02581163|3995824|FG000|Overall Study|Failure to return|15
2298814|NCT02581163|3995824|FG000|Overall Study|Insufficient virological response|3
2298815|NCT02581163|3995824|FG000|Overall Study|Withdrew consent|1
2298816|NCT02581163|3995824|FG000|Overall Study|Death|1
2298817|NCT02581163|3995824|FG000|Overall Study|Other, not specified|9
2298818|NCT02581189|3995831|FG000|Overall Study|Failure to return|36
2298819|NCT02581189|3995831|FG000|Overall Study|Withdrew consent|5
2298820|NCT02581189|3995831|FG000|Overall Study|Death|3
2298821|NCT02581189|3995831|FG000|Overall Study|Insufficient virological response|2
2298822|NCT02581189|3995831|FG000|Overall Study|Other, not specified|7
2298823|NCT02581202|3995838|FG000|Overall Study|Lack of Efficacy|2
2298824|NCT02581202|3995838|FG000|Overall Study|Withdrawal by Subject|4
2298825|NCT02581202|3995838|FG000|Overall Study|Lost to Follow-up|5
2298826|NCT02581202|3995838|FG000|Overall Study|Pregnancy|3
2298827|NCT02581345|3995845|FG000|Part 1: up to Week 16|Adverse Event|3
2298828|NCT02581345|3995846|FG001|Part 1: up to Week 16|Adverse Event|8
2298829|NCT02581345|3995847|FG002|Part 1: up to Week 16|Adverse Event|0
2298830|NCT02581345|3995848|FG003|Part 1: up to Week 16|Adverse Event|0
2298831|NCT02581345|3995845|FG000|Part 1: up to Week 16|Physician Decision|2
2298832|NCT02581345|3995846|FG001|Part 1: up to Week 16|Physician Decision|4
2298833|NCT02581345|3995847|FG002|Part 1: up to Week 16|Physician Decision|0
2298834|NCT02581345|3995848|FG003|Part 1: up to Week 16|Physician Decision|0
2298835|NCT02581345|3995845|FG000|Part 1: up to Week 16|Withdrawal by Subject|4
2298836|NCT02581345|3995846|FG001|Part 1: up to Week 16|Withdrawal by Subject|7
2298837|NCT02581345|3995847|FG002|Part 1: up to Week 16|Withdrawal by Subject|0
2298838|NCT02581345|3995848|FG003|Part 1: up to Week 16|Withdrawal by Subject|0
2298839|NCT02581345|3995845|FG000|Part 1: up to Week 16|Lost to Follow-up|2
2298840|NCT02581345|3995846|FG001|Part 1: up to Week 16|Lost to Follow-up|0
2298841|NCT02581345|3995847|FG002|Part 1: up to Week 16|Lost to Follow-up|0
2298842|NCT02581345|3995848|FG003|Part 1: up to Week 16|Lost to Follow-up|0
2298843|NCT02581345|3995845|FG000|Part 1: up to Week 16|Unspecified Reason|3
2298844|NCT02581345|3995846|FG001|Part 1: up to Week 16|Unspecified Reason|3
2298845|NCT02581345|3995847|FG002|Part 1: up to Week 16|Unspecified Reason|0
2298846|NCT02581345|3995848|FG003|Part 1: up to Week 16|Unspecified Reason|0
2298847|NCT02581345|3995845|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1
2298848|NCT02581345|3995846|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1
2298849|NCT02581345|3995847|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0
2298850|NCT02581345|3995848|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0
2298851|NCT02581345|3995845|FG000|Part 2: Week 17 to Week 47|Adverse Event|5
2298852|NCT02581345|3995846|FG001|Part 2: Week 17 to Week 47|Adverse Event|0
2298853|NCT02581345|3995847|FG002|Part 2: Week 17 to Week 47|Adverse Event|2
2298854|NCT02581345|3995848|FG003|Part 2: Week 17 to Week 47|Adverse Event|2
2298855|NCT02581345|3995845|FG000|Part 2: Week 17 to Week 47|Physician Decision|3
2298856|NCT02581345|3995846|FG001|Part 2: Week 17 to Week 47|Physician Decision|0
2298857|NCT02581345|3995847|FG002|Part 2: Week 17 to Week 47|Physician Decision|2
2298858|NCT02581345|3995848|FG003|Part 2: Week 17 to Week 47|Physician Decision|1
2298859|NCT02581345|3995845|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
2298860|NCT02581345|3995846|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
2044816|NCT00457639|3615903|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0
2044817|NCT00457639|3615902|FG000|Intervention 1 (6 Months)|unrelated illness|0
2044818|NCT00457639|3615903|FG001|Intervention 1 (6 Months)|unrelated illness|2
2044819|NCT00457639|3615902|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
2044820|NCT00457639|3615903|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
2044821|NCT00457665|3615911|FG000|12 Months|Drug allergy|1
2044822|NCT00457665|3615912|FG001|12 Months|Drug allergy|1
2044823|NCT00457665|3615911|FG000|12 Months|High HIV viral load|5
2044824|NCT00457665|3615912|FG001|12 Months|High HIV viral load|1
2044825|NCT00457665|3615911|FG000|12 Months|Lipodystrophy|2
2044826|NCT00457665|3615912|FG001|12 Months|Lipodystrophy|0
2044827|NCT00457665|3615911|FG000|12 Months|Withdrawal by Subject|0
2044828|NCT00457665|3615912|FG001|12 Months|Withdrawal by Subject|2
2044829|NCT00457665|3615911|FG000|12 Months|Abnormal Liver function tests|0
2044830|NCT00457665|3615912|FG001|12 Months|Abnormal Liver function tests|5
2044831|NCT00457665|3615911|FG000|24 Months|Withdrawal by Subject|3
2044832|NCT00457665|3615912|FG001|24 Months|Withdrawal by Subject|2
2044833|NCT00457665|3615911|FG000|24 Months|Lipodystrophy|1
2044834|NCT00457665|3615912|FG001|24 Months|Lipodystrophy|1
2044835|NCT00457665|3615911|FG000|24 Months|Abnormal liver function tests|1
2044836|NCT00457665|3615912|FG001|24 Months|Abnormal liver function tests|5
2044837|NCT00457691|3615920|FG000|Overall Study|Adverse Event|4
2044838|NCT00457691|3615921|FG001|Overall Study|Adverse Event|1
2044839|NCT00457691|3615920|FG000|Overall Study|Death|163
2044840|NCT00457691|3615921|FG001|Overall Study|Death|148
2044841|NCT00457691|3615920|FG000|Overall Study|Protocol Violation|1
2044842|NCT00457691|3615921|FG001|Overall Study|Protocol Violation|3
2044843|NCT00457691|3615920|FG000|Overall Study|Lost to Follow-up|23
2044844|NCT00457691|3615921|FG001|Overall Study|Lost to Follow-up|14
2044845|NCT00457691|3615920|FG000|Overall Study|Study terminated by Sponsor|1
2044846|NCT00457691|3615921|FG001|Overall Study|Study terminated by Sponsor|1
2044847|NCT00457691|3615920|FG000|Overall Study|Subject refused (reason other than AE)|14
2044848|NCT00457691|3615921|FG001|Overall Study|Subject refused (reason other than AE)|19
2298861|NCT02581345|3995847|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
2298862|NCT02581345|3995848|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
2298863|NCT02581345|3995845|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
2298864|NCT02581345|3995846|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
2298865|NCT02581345|3995847|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
2298866|NCT02581345|3995848|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
2298867|NCT02581345|3995845|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2
2298868|NCT02581345|3995846|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0
2298869|NCT02581345|3995847|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0
2298870|NCT02581345|3995848|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1
2298871|NCT02581345|3995845|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2
2298872|NCT02581345|3995846|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0
2298873|NCT02581345|3995847|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1
2298874|NCT02581345|3995848|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1
2298875|NCT02581410|3995876|FG000|Vaccination Phase|Adverse Event|2
2298876|NCT02581410|3995877|FG001|Vaccination Phase|Adverse Event|1
2298877|NCT02581410|3995876|FG000|Vaccination Phase|Withdrawal by Subject|0
2298878|NCT02581410|3995877|FG001|Vaccination Phase|Withdrawal by Subject|1
2298879|NCT02581410|3995876|FG000|Vaccination Phase|Migrated/moved from study area|0
2298880|NCT02581410|3995877|FG001|Vaccination Phase|Migrated/moved from study area|1
2298881|NCT02581410|3995876|FG000|End of Study Phase|Adverse Event|4
2298882|NCT02581410|3995877|FG001|End of Study Phase|Adverse Event|3
2298883|NCT02581410|3995876|FG000|End of Study Phase|Withdrawal by Subject|1
2298884|NCT02581410|3995877|FG001|End of Study Phase|Withdrawal by Subject|2
2298885|NCT02581410|3995876|FG000|End of Study Phase|Migrated/moved from study area|0
2298886|NCT02581410|3995877|FG001|End of Study Phase|Migrated/moved from study area|3
2298887|NCT02581410|3995876|FG000|End of Study Phase|Lost to Follow-up|0
2298888|NCT02581410|3995877|FG001|End of Study Phase|Lost to Follow-up|2
2298889|NCT02581410|3995876|FG000|End of Study Phase|Other-transfer of subject not completed|0
2298890|NCT02581410|3995877|FG001|End of Study Phase|Other-transfer of subject not completed|1
2298891|NCT02581488|3995895|FG000|Overall Study|Adverse Event|6
2298892|NCT02581488|3995896|FG001|Overall Study|Adverse Event|7
2298893|NCT02581488|3995895|FG000|Overall Study|Lost to Follow-up|1
2298894|NCT02581488|3995896|FG001|Overall Study|Lost to Follow-up|0
2298895|NCT02581488|3995895|FG000|Overall Study|Withdrawal by Subject|1
2298896|NCT02581488|3995896|FG001|Overall Study|Withdrawal by Subject|0
2298897|NCT02581488|3995895|FG000|Overall Study|Non-Compliance|1
2298898|NCT02581488|3995896|FG001|Overall Study|Non-Compliance|0
2298899|NCT02581488|3995895|FG000|Overall Study|Protocol Violation|0
2298900|NCT02581488|3995896|FG001|Overall Study|Protocol Violation|4
2298901|NCT02581891|3995924|FG000|Overall Study|Adverse Event|4
2298902|NCT02581891|3995925|FG001|Overall Study|Adverse Event|6
2298903|NCT02581891|3995924|FG000|Overall Study|Death|3
2298904|NCT02581891|3995925|FG001|Overall Study|Death|4
2298905|NCT02581891|3995924|FG000|Overall Study|Lost to Follow-up|1
2298906|NCT02581891|3995925|FG001|Overall Study|Lost to Follow-up|2
2298907|NCT02581891|3995924|FG000|Overall Study|Physician Decision|0
2044849|NCT00457691|3615920|FG000|Overall Study|Disease progression, study terminated|180
2044850|NCT00457691|3615921|FG001|Overall Study|Disease progression, study terminated|196
2044851|NCT00457743|3615943|FG000|Overall Study|Adverse Event|0
2044852|NCT00457743|3615944|FG001|Overall Study|Adverse Event|4
2044853|NCT00457743|3615945|FG002|Overall Study|Adverse Event|0
2044854|NCT00457743|3615943|FG000|Overall Study|Lack of Efficacy|3
2044855|NCT00457743|3615944|FG001|Overall Study|Lack of Efficacy|23
2044856|NCT00457743|3615945|FG002|Overall Study|Lack of Efficacy|3
2044857|NCT00457821|3615966|FG000|Part 2|Withdrawal by Subject|0
2044858|NCT00457821|3615967|FG001|Part 2|Withdrawal by Subject|0
2044859|NCT00457821|3615968|FG002|Part 2|Withdrawal by Subject|0
2044860|NCT00457821|3615969|FG003|Part 2|Withdrawal by Subject|0
2044861|NCT00457821|3615970|FG004|Part 2|Withdrawal by Subject|0
2044862|NCT00457821|3615971|FG005|Part 2|Withdrawal by Subject|0
2044863|NCT00457821|3615972|FG006|Part 2|Withdrawal by Subject|0
2044864|NCT00457821|3615973|FG007|Part 2|Withdrawal by Subject|1
2044865|NCT00458211|3615999|FG000|Overall Study|Lack of Efficacy|12
2044866|NCT00458211|3615999|FG000|Overall Study|Withdrawal by Subject|2
2044867|NCT00458211|3615999|FG000|Overall Study|Protocol Violation|2
2044868|NCT00458302|3616023|FG000|Overall Study|Adverse Event|4
2044869|NCT00458302|3616024|FG001|Overall Study|Adverse Event|14
2044870|NCT00458302|3616023|FG000|Overall Study|Pregnancy|2
2044871|NCT00458302|3616024|FG001|Overall Study|Pregnancy|1
2044872|NCT00458302|3616023|FG000|Overall Study|Protocol Violation|0
2044873|NCT00458302|3616024|FG001|Overall Study|Protocol Violation|2
2044874|NCT00458302|3616023|FG000|Overall Study|Withdrawal by Subject|6
2298908|NCT02581891|3995925|FG001|Overall Study|Physician Decision|1
2298909|NCT02581891|3995924|FG000|Overall Study|Withdrawal by Subject|4
2298910|NCT02581891|3995925|FG001|Overall Study|Withdrawal by Subject|5
2298911|NCT02581891|3995924|FG000|Overall Study|Other Reasons|3
2298912|NCT02581891|3995925|FG001|Overall Study|Other Reasons|1
2298913|NCT02581891|3995924|FG000|Overall Study|Discontinued during followup|1
2298914|NCT02581891|3995925|FG001|Overall Study|Discontinued during followup|0
2298915|NCT02581995|3995932|FG000|Overall Study|Unspecified other|3
2044875|NCT00458302|3616024|FG001|Overall Study|Withdrawal by Subject|4
2044876|NCT00458302|3616023|FG000|Overall Study|Inc/Exc Criteria Not Met|1
2044877|NCT00458302|3616024|FG001|Overall Study|Inc/Exc Criteria Not Met|1
2044878|NCT00458302|3616023|FG000|Overall Study|Study Termination By Sponsor|1
2044879|NCT00458302|3616024|FG001|Overall Study|Study Termination By Sponsor|0
2044880|NCT00458302|3616023|FG000|Overall Study|Lost to Follow-up|2
2044881|NCT00458302|3616024|FG001|Overall Study|Lost to Follow-up|0
2044882|NCT00458302|3616023|FG000|Overall Study|Other|4
2044883|NCT00458302|3616024|FG001|Overall Study|Other|2
2044884|NCT00458341|3616033|FG000|Cycle 1|Adverse Event|1
2044885|NCT00458341|3616034|FG001|Cycle 1|Adverse Event|0
2044886|NCT00458393|3616042|FG000|Overall Study|Withdrawal by Subject|67
2044887|NCT00458393|3616043|FG001|Overall Study|Withdrawal by Subject|80
2044888|NCT00458393|3616042|FG000|Overall Study|Physician Decision|31
2044889|NCT00458393|3616043|FG001|Overall Study|Physician Decision|22
2044890|NCT00458393|3616042|FG000|Overall Study|Relocated|77
2044891|NCT00458393|3616043|FG001|Overall Study|Relocated|81
2044892|NCT00458393|3616042|FG000|Overall Study|Lost to Follow-up|115
2044893|NCT00458393|3616043|FG001|Overall Study|Lost to Follow-up|92
2044894|NCT00458393|3616042|FG000|Overall Study|Sites marked other on the form.|19
2044895|NCT00458393|3616043|FG001|Overall Study|Sites marked other on the form.|20
2044896|NCT00458484|3616074|FG000|Overall Study|Not eligible b/c prior radiation history|0
2044897|NCT00458484|3616075|FG001|Overall Study|Not eligible b/c prior radiation history|0
2298916|NCT02581995|3995932|FG000|Overall Study|Adverse Event|6
2298917|NCT02581995|3995932|FG000|Overall Study|Lost to Follow-up|5
2298918|NCT02581995|3995932|FG000|Overall Study|Withdrawal by participant|12
2298919|NCT02581995|3995932|FG000|Overall Study|Physician Decision|1
2298920|NCT02581995|3995932|FG000|Overall Study|Death|4
2298921|NCT02582242|3995952|FG000|Overall Study|Adverse Event|4
2298922|NCT02582242|3995953|FG001|Overall Study|Adverse Event|3
2298923|NCT02582242|3995952|FG000|Overall Study|Protocol Violation|3
2298924|NCT02582242|3995953|FG001|Overall Study|Protocol Violation|1
2298925|NCT02582242|3995952|FG000|Overall Study|Lost to Follow-up|0
2298926|NCT02582242|3995953|FG001|Overall Study|Lost to Follow-up|1
2298927|NCT02582242|3995952|FG000|Overall Study|Withdrawal by Subject|11
2298928|NCT02582242|3995953|FG001|Overall Study|Withdrawal by Subject|11
2298929|NCT02582242|3995952|FG000|Overall Study|Unclassified|2
2298930|NCT02582242|3995953|FG001|Overall Study|Unclassified|1
2044898|NCT00458484|3616076|FG002|Overall Study|Not eligible b/c prior radiation history|0
2044899|NCT00458484|3616077|FG003|Overall Study|Not eligible b/c prior radiation history|0
2044900|NCT00458484|3616078|FG004|Overall Study|Not eligible b/c prior radiation history|0
2044901|NCT00458484|3616079|FG005|Overall Study|Not eligible b/c prior radiation history|1
2044902|NCT00458484|3616080|FG006|Overall Study|Not eligible b/c prior radiation history|0
2044903|NCT00458705|3616105|FG000|Overall Study|Adverse Event|4
2044904|NCT00458705|3616105|FG000|Overall Study|Not Treated|1
2044905|NCT00458783|3616111|FG000|Overall Study|Protocol Violation|1228
2044906|NCT00458783|3616112|FG001|Overall Study|Protocol Violation|1220
2298931|NCT02582255|3995961|FG000|Overall Study|Protocol Violation|0
2298932|NCT02582255|3995962|FG001|Overall Study|Protocol Violation|3
2298933|NCT02582515|3995971|FG000|Overall Study|Withdrawal by Subject|0
2044907|NCT00459043|3616135|FG000|Overall Study|Withdrawal by Subject|1
2044908|NCT00459043|3616136|FG001|Overall Study|Withdrawal by Subject|0
2298934|NCT02582515|3995972|FG001|Overall Study|Withdrawal by Subject|1
2298935|NCT02582632|3995978|FG000|Overall Study|Other|1
2298936|NCT02582658|3995982|FG000|Overall Study|Failure to Return|10
2298937|NCT02582658|3995982|FG000|Overall Study|Insufficient Virological Response|2
2298938|NCT02582658|3995982|FG000|Overall Study|Withdrawn Consent|1
2044909|NCT00459056|3616144|FG000|First Intervention (First Three Months)|Lost to Follow-up|1
2044910|NCT00459056|3616145|FG001|First Intervention (First Three Months)|Lost to Follow-up|1
2044911|NCT00459108|3616151|FG000|Overall Study|Withdrawal by Subject|5
2044912|NCT00459108|3616151|FG000|Overall Study|Adverse Event|3
2044913|NCT00459108|3616151|FG000|Overall Study|Death|2
2298939|NCT02582658|3995982|FG000|Overall Study|Death|1
2298940|NCT02582658|3995982|FG000|Overall Study|Not further specified|11
2298941|NCT02582671|3995986|FG000|Overall Study|Failure to return|1
2298942|NCT02582671|3995986|FG000|Overall Study|Other, not specified|1
2298943|NCT02582684|3995991|FG000|Overall Study|Unable to contact subject/parent|4
2298944|NCT02582684|3995991|FG000|Overall Study|Subject not able to get to clinic|10
2298945|NCT02582684|3995991|FG000|Overall Study|Subject withdrew consent|1
2298946|NCT02582684|3995991|FG000|Overall Study|Found to be ineligible after enrollment|2
2298947|NCT02582814|3995997|FG000|Overall Study|Study-specific withdrawal criteria|1
2298948|NCT02582814|3995998|FG001|Overall Study|Study-specific withdrawal criteria|0
2298949|NCT02582814|3995997|FG000|Overall Study|Withdrawal by Subject|4
2298950|NCT02582814|3995998|FG001|Overall Study|Withdrawal by Subject|3
2298951|NCT02582814|3995997|FG000|Overall Study|Adverse Event|4
2298952|NCT02582814|3995998|FG001|Overall Study|Adverse Event|4
2298953|NCT02582866|3996019|FG000|Overall Study|Death|1
2298954|NCT02582866|3996019|FG000|Overall Study|Lack of Efficacy|2
2298955|NCT02582866|3996019|FG000|Overall Study|Lost to Follow-up|2
2298956|NCT02582866|3996019|FG000|Overall Study|Withdrawal by Subject|7
2298957|NCT02582866|3996019|FG000|Overall Study|Investigator decision|5
2298958|NCT02582866|3996019|FG000|Overall Study|Participant wants to get pregnant|1
2298959|NCT02582866|3996019|FG000|Overall Study|Pregnancy|2
2298960|NCT02582866|3996019|FG000|Overall Study|Sponsor decision|1
2298961|NCT02582866|3996019|FG000|Overall Study|Withdrawal due to personal reasons|1
2298962|NCT02582983|3996027|FG000|Overall Study|Death|3
2298963|NCT02582983|3996027|FG000|Overall Study|Withdrawal by Subject|2
2298964|NCT02582983|3996027|FG000|Overall Study|Adverse Event|1
2298965|NCT02583256|3996039|FG000|Overall Study|Withdrawal by Subject|0
2298966|NCT02583256|3996040|FG001|Overall Study|Withdrawal by Subject|1
2298967|NCT02583256|3996041|FG002|Overall Study|Withdrawal by Subject|1
2298968|NCT02583256|3996042|FG003|Overall Study|Withdrawal by Subject|0
2298969|NCT02583256|3996039|FG000|Overall Study|Lost to Follow-up|1
2298970|NCT02583256|3996040|FG001|Overall Study|Lost to Follow-up|1
2298971|NCT02583256|3996041|FG002|Overall Study|Lost to Follow-up|0
2298972|NCT02583256|3996042|FG003|Overall Study|Lost to Follow-up|1
2298973|NCT02583256|3996039|FG000|Overall Study|Administrative/Other|2
2298974|NCT02583256|3996040|FG001|Overall Study|Administrative/Other|0
2298975|NCT02583256|3996041|FG002|Overall Study|Administrative/Other|1
2298976|NCT02583256|3996042|FG003|Overall Study|Administrative/Other|2
2298977|NCT02583399|3996063|FG000|Overall Study|Able to be discharged|3
2298978|NCT02583399|3996063|FG000|Overall Study|Wanted to use a restricted medication|3
2298979|NCT02583425|3996067|FG000|Screening|Did not meet entry criteria|12
2298980|NCT02583425|3996067|FG000|Baseline|Did not meet continued criteria|5
2298981|NCT02583425|3996067|FG000|Treatment Period|Adverse Event|1
2298982|NCT02583477|3996074|FG000|Overall Study|Adverse Event|0
2298983|NCT02583477|3996075|FG001|Overall Study|Adverse Event|2
2298984|NCT02583477|3996074|FG000|Overall Study|Death|1
2298985|NCT02583477|3996075|FG001|Overall Study|Death|16
2298986|NCT02583477|3996074|FG000|Overall Study|Study terminated|2
2298987|NCT02583477|3996075|FG001|Overall Study|Study terminated|2
2298988|NCT02583711|3996085|FG000|Overall Study|Withdrawal by Subject|0
2298989|NCT02583711|3996086|FG001|Overall Study|Withdrawal by Subject|10
2298990|NCT02583711|3996087|FG002|Overall Study|Withdrawal by Subject|0
2298991|NCT02584257|3996101|FG000|Period 1|Withdrawal by Subject|0
2298992|NCT02584257|3996102|FG001|Period 1|Withdrawal by Subject|0
2298993|NCT02584257|3996103|FG002|Period 1|Withdrawal by Subject|0
2298994|NCT02584257|3996104|FG003|Period 1|Withdrawal by Subject|0
2298995|NCT02584257|3996105|FG004|Period 1|Withdrawal by Subject|0
2298996|NCT02584257|3996106|FG005|Period 1|Withdrawal by Subject|0
2298997|NCT02584257|3996107|FG006|Period 1|Withdrawal by Subject|1
2298998|NCT02584257|3996108|FG007|Period 1|Withdrawal by Subject|0
2298999|NCT02584257|3996109|FG008|Period 1|Withdrawal by Subject|0
2299000|NCT02584257|3996101|FG000|Period 2|Physician Decision|1
2299001|NCT02584257|3996102|FG001|Period 2|Physician Decision|0
2299002|NCT02584257|3996103|FG002|Period 2|Physician Decision|0
2299003|NCT02584257|3996104|FG003|Period 2|Physician Decision|0
2299004|NCT02584257|3996105|FG004|Period 2|Physician Decision|0
2299005|NCT02584257|3996106|FG005|Period 2|Physician Decision|0
2299006|NCT02584257|3996107|FG006|Period 2|Physician Decision|0
2044914|NCT00459108|3616151|FG000|Overall Study|Progression|1
2299007|NCT02584257|3996108|FG007|Period 2|Physician Decision|0
2299008|NCT02584257|3996109|FG008|Period 2|Physician Decision|0
2299009|NCT02584257|3996101|FG000|Period 2|Adverse Event|0
2299010|NCT02584257|3996102|FG001|Period 2|Adverse Event|1
2299011|NCT02584257|3996103|FG002|Period 2|Adverse Event|0
2299012|NCT02584257|3996104|FG003|Period 2|Adverse Event|0
2044915|NCT00459134|3616158|FG000|Overall Study|Physician Decision|1
2044916|NCT00459134|3616159|FG001|Overall Study|Physician Decision|1
2044917|NCT00459134|3616158|FG000|Overall Study|Withdrawal by Subject|8
2044918|NCT00459134|3616159|FG001|Overall Study|Withdrawal by Subject|7
2044919|NCT00459134|3616158|FG000|Overall Study|Lost to Follow-up|6
2044920|NCT00459134|3616159|FG001|Overall Study|Lost to Follow-up|7
2044921|NCT00459134|3616158|FG000|Overall Study|Surgery|1
2044922|NCT00459134|3616159|FG001|Overall Study|Surgery|2
2044923|NCT00459134|3616158|FG000|Overall Study|Toxicity|4
2044924|NCT00459134|3616159|FG001|Overall Study|Toxicity|5
2044925|NCT00459134|3616158|FG000|Overall Study|Progression|1
2044926|NCT00459134|3616159|FG001|Overall Study|Progression|0
2044927|NCT00459134|3616158|FG000|Overall Study|Multiple Reasons|2
2044928|NCT00459134|3616159|FG001|Overall Study|Multiple Reasons|3
2044929|NCT00459186|3616165|FG000|Single Agent RAD001|Withdrawal by Subject|1
2044930|NCT00459186|3616165|FG000|PET Imaging and Assessment|Adverse Event|3
2044931|NCT00459290|3616169|FG000|Overall Study|Adverse Event|3
2044932|NCT00459290|3616169|FG000|Overall Study|Ineligible|2
2044933|NCT00459316|3616192|FG000|Steps 1 & 2|Other eligibility failure|1
2044934|NCT00459316|3616193|FG001|Steps 1 & 2|Other eligibility failure|1
2044935|NCT00459316|3616194|FG002|Steps 1 & 2|Other eligibility failure|0
2044936|NCT00459316|3616192|FG000|Steps 1 & 2|Death|1
2044937|NCT00459316|3616193|FG001|Steps 1 & 2|Death|1
2044938|NCT00459316|3616194|FG002|Steps 1 & 2|Death|0
2044939|NCT00459316|3616192|FG000|Steps 1 & 2|Not able to get to clinic|7
2044940|NCT00459316|3616193|FG001|Steps 1 & 2|Not able to get to clinic|4
2044941|NCT00459316|3616194|FG002|Steps 1 & 2|Not able to get to clinic|0
2044942|NCT00459316|3616192|FG000|Steps 1 & 2|Withdrawal by Subject|6
2044943|NCT00459316|3616193|FG001|Steps 1 & 2|Withdrawal by Subject|1
2044944|NCT00459316|3616194|FG002|Steps 1 & 2|Withdrawal by Subject|0
2044945|NCT00459316|3616192|FG000|Steps 1 & 2|Not willing to adhere to regulations|1
2044946|NCT00459316|3616193|FG001|Steps 1 & 2|Not willing to adhere to regulations|0
2299013|NCT02584257|3996105|FG004|Period 2|Adverse Event|0
2299014|NCT02584257|3996106|FG005|Period 2|Adverse Event|0
2299015|NCT02584257|3996107|FG006|Period 2|Adverse Event|0
2299016|NCT02584257|3996108|FG007|Period 2|Adverse Event|0
2299017|NCT02584257|3996109|FG008|Period 2|Adverse Event|0
2299018|NCT02584452|3996123|FG000|Overall Study|Physician Decision|1
2299019|NCT02584452|3996124|FG001|Overall Study|Physician Decision|1
2299020|NCT02584452|3996123|FG000|Overall Study|Lost to Follow-up|1
2299021|NCT02584452|3996124|FG001|Overall Study|Lost to Follow-up|1
2299022|NCT02584504|3996134|FG000|Double-blind Treatment|Participant withdrew consent|0
2299023|NCT02584504|3996135|FG001|Double-blind Treatment|Participant withdrew consent|0
2299024|NCT02584504|3996136|FG002|Double-blind Treatment|Participant withdrew consent|1
2299025|NCT02584504|3996134|FG000|Double-blind Treatment|Adverse Event|0
2299026|NCT02584504|3996135|FG001|Double-blind Treatment|Adverse Event|1
2299027|NCT02584504|3996136|FG002|Double-blind Treatment|Adverse Event|0
2299028|NCT02584504|3996134|FG000|Double-blind Treatment|Family Matter|0
2299029|NCT02584504|3996135|FG001|Double-blind Treatment|Family Matter|1
2299030|NCT02584504|3996136|FG002|Double-blind Treatment|Family Matter|0
2299031|NCT02584504|3996134|FG000|Open-label Treatment|Participant withdrew consent|0
2299032|NCT02584504|3996135|FG001|Open-label Treatment|Participant withdrew consent|0
2299033|NCT02584504|3996136|FG002|Open-label Treatment|Participant withdrew consent|4
2299034|NCT02584504|3996134|FG000|Open-label Treatment|Adverse Event|2
2299035|NCT02584504|3996135|FG001|Open-label Treatment|Adverse Event|2
2299036|NCT02584504|3996136|FG002|Open-label Treatment|Adverse Event|3
2299037|NCT02584504|3996134|FG000|Open-label Treatment|Physician Decision|0
2299038|NCT02584504|3996135|FG001|Open-label Treatment|Physician Decision|1
2299039|NCT02584504|3996136|FG002|Open-label Treatment|Physician Decision|0
2299040|NCT02584504|3996134|FG000|Open-label Treatment|Entered but not treated|0
2299041|NCT02584504|3996135|FG001|Open-label Treatment|Entered but not treated|1
2299042|NCT02584504|3996136|FG002|Open-label Treatment|Entered but not treated|1
2299043|NCT02584660|3996154|FG000|Overall Study|Adverse Event|4
2299044|NCT02584660|3996155|FG001|Overall Study|Adverse Event|0
2299045|NCT02584660|3996154|FG000|Overall Study|Lost to Follow-up|3
2299046|NCT02584660|3996155|FG001|Overall Study|Lost to Follow-up|4
2299047|NCT02584660|3996154|FG000|Overall Study|Protocol Violation|0
2299048|NCT02584660|3996155|FG001|Overall Study|Protocol Violation|1
2299049|NCT02584660|3996154|FG000|Overall Study|Withdrawal by Subject|0
2299050|NCT02584660|3996155|FG001|Overall Study|Withdrawal by Subject|2
2299051|NCT02584660|3996154|FG000|Overall Study|Other|0
2299052|NCT02584660|3996155|FG001|Overall Study|Other|1
2299053|NCT02584855|3996197|FG000|Open-Label Treatment Period|Lack of Efficacy|61
2299054|NCT02584855|3996198|FG001|Open-Label Treatment Period|Lack of Efficacy|0
2299055|NCT02584855|3996199|FG002|Open-Label Treatment Period|Lack of Efficacy|0
2299056|NCT02584855|3996200|FG003|Open-Label Treatment Period|Lack of Efficacy|0
2299057|NCT02584855|3996201|FG004|Open-Label Treatment Period|Lack of Efficacy|0
2044947|NCT00459316|3616194|FG002|Steps 1 & 2|Not willing to adhere to regulations|0
2044948|NCT00459316|3616192|FG000|Steps 1 & 2|Lost to Follow-up|5
2044949|NCT00459316|3616193|FG001|Steps 1 & 2|Lost to Follow-up|0
2044950|NCT00459316|3616194|FG002|Steps 1 & 2|Lost to Follow-up|2
2044951|NCT00459316|3616192|FG000|Step 3|Withdrawal by Subject|3
2044952|NCT00459316|3616193|FG001|Step 3|Withdrawal by Subject|0
2044953|NCT00459316|3616194|FG002|Step 3|Withdrawal by Subject|1
2044954|NCT00459342|3616217|FG000|Overall Study|Not eligible|1
2299058|NCT02584855|3996202|FG005|Open-Label Treatment Period|Lack of Efficacy|0
2299059|NCT02584855|3996197|FG000|Open-Label Treatment Period|Withdrawal by Subject|21
2299060|NCT02584855|3996198|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
2299061|NCT02584855|3996199|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
2299062|NCT02584855|3996200|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
2299063|NCT02584855|3996201|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
2299064|NCT02584855|3996202|FG005|Open-Label Treatment Period|Withdrawal by Subject|0
2299065|NCT02584855|3996197|FG000|Open-Label Treatment Period|Adverse Event|14
2299066|NCT02584855|3996198|FG001|Open-Label Treatment Period|Adverse Event|0
2299067|NCT02584855|3996199|FG002|Open-Label Treatment Period|Adverse Event|0
2044955|NCT00459355|3616223|FG000|Overall Study|Subject no longer met inc criteria|20
2044956|NCT00459355|3616224|FG001|Overall Study|Subject no longer met inc criteria|18
2044957|NCT00459537|3616249|FG000|Overall Study|Adverse Event|1
2044958|NCT00459537|3616250|FG001|Overall Study|Adverse Event|6
2044959|NCT00459537|3616249|FG000|Overall Study|Lack of Efficacy|10
2044960|NCT00459537|3616250|FG001|Overall Study|Lack of Efficacy|11
2044961|NCT00459537|3616249|FG000|Overall Study|Withdrawal by Subject|20
2044962|NCT00459537|3616250|FG001|Overall Study|Withdrawal by Subject|26
2044963|NCT00459537|3616249|FG000|Overall Study|Lost to Follow-up|27
2044964|NCT00459537|3616250|FG001|Overall Study|Lost to Follow-up|30
2044965|NCT00459537|3616249|FG000|Overall Study|Administrative problems|3
2044966|NCT00459537|3616250|FG001|Overall Study|Administrative problems|0
2044967|NCT00459537|3616249|FG000|Overall Study|Protocol Violation|4
2044968|NCT00459537|3616250|FG001|Overall Study|Protocol Violation|3
2044969|NCT00459537|3616249|FG000|Overall Study|Missing|1
2044970|NCT00459537|3616250|FG001|Overall Study|Missing|0
2044971|NCT00459667|3616259|FG000|Overall Study|Adverse Event|9
2044972|NCT00459667|3616260|FG001|Overall Study|Adverse Event|12
2299068|NCT02584855|3996200|FG003|Open-Label Treatment Period|Adverse Event|0
2299069|NCT02584855|3996201|FG004|Open-Label Treatment Period|Adverse Event|0
2299070|NCT02584855|3996202|FG005|Open-Label Treatment Period|Adverse Event|0
2299071|NCT02584855|3996197|FG000|Open-Label Treatment Period|Death|2
2299072|NCT02584855|3996198|FG001|Open-Label Treatment Period|Death|0
2299073|NCT02584855|3996199|FG002|Open-Label Treatment Period|Death|0
2299074|NCT02584855|3996200|FG003|Open-Label Treatment Period|Death|0
2299075|NCT02584855|3996201|FG004|Open-Label Treatment Period|Death|0
2299076|NCT02584855|3996202|FG005|Open-Label Treatment Period|Death|0
2299077|NCT02584855|3996197|FG000|Open-Label Treatment Period|Lost to Follow-up|1
2299078|NCT02584855|3996198|FG001|Open-Label Treatment Period|Lost to Follow-up|0
2299079|NCT02584855|3996199|FG002|Open-Label Treatment Period|Lost to Follow-up|0
2299080|NCT02584855|3996200|FG003|Open-Label Treatment Period|Lost to Follow-up|0
2299081|NCT02584855|3996201|FG004|Open-Label Treatment Period|Lost to Follow-up|0
2299082|NCT02584855|3996202|FG005|Open-Label Treatment Period|Lost to Follow-up|0
2299083|NCT02584855|3996197|FG000|Open-Label Treatment Period|Protocol Violation|1
2299084|NCT02584855|3996198|FG001|Open-Label Treatment Period|Protocol Violation|0
2299085|NCT02584855|3996199|FG002|Open-Label Treatment Period|Protocol Violation|0
2299086|NCT02584855|3996200|FG003|Open-Label Treatment Period|Protocol Violation|0
2299087|NCT02584855|3996201|FG004|Open-Label Treatment Period|Protocol Violation|0
2299088|NCT02584855|3996202|FG005|Open-Label Treatment Period|Protocol Violation|0
2299089|NCT02584855|3996197|FG000|Open-Label Treatment Period|No PI Available|2
2299090|NCT02584855|3996198|FG001|Open-Label Treatment Period|No PI Available|0
2299091|NCT02584855|3996199|FG002|Open-Label Treatment Period|No PI Available|0
2299092|NCT02584855|3996200|FG003|Open-Label Treatment Period|No PI Available|0
2299093|NCT02584855|3996201|FG004|Open-Label Treatment Period|No PI Available|0
2299094|NCT02584855|3996202|FG005|Open-Label Treatment Period|No PI Available|0
2299095|NCT02584855|3996197|FG000|Open-Label Treatment Period|Sponsor Decision|1
2299096|NCT02584855|3996198|FG001|Open-Label Treatment Period|Sponsor Decision|0
2299097|NCT02584855|3996199|FG002|Open-Label Treatment Period|Sponsor Decision|0
2299098|NCT02584855|3996200|FG003|Open-Label Treatment Period|Sponsor Decision|0
2299099|NCT02584855|3996201|FG004|Open-Label Treatment Period|Sponsor Decision|0
2299100|NCT02584855|3996202|FG005|Open-Label Treatment Period|Sponsor Decision|0
2299101|NCT02584855|3996197|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2299102|NCT02584855|3996198|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2299103|NCT02584855|3996199|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2
2299104|NCT02584855|3996200|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2299105|NCT02584855|3996201|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2299106|NCT02584855|3996202|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2299107|NCT02584855|3996197|FG000|Double-Blind Withdrawal Period|Adverse Event|0
2299108|NCT02584855|3996198|FG001|Double-Blind Withdrawal Period|Adverse Event|4
2299109|NCT02584855|3996199|FG002|Double-Blind Withdrawal Period|Adverse Event|0
2299110|NCT02584855|3996200|FG003|Double-Blind Withdrawal Period|Adverse Event|1
2299111|NCT02584855|3996201|FG004|Double-Blind Withdrawal Period|Adverse Event|0
2299112|NCT02584855|3996202|FG005|Double-Blind Withdrawal Period|Adverse Event|0
2299113|NCT02584855|3996197|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0
2044973|NCT00459667|3616261|FG002|Overall Study|Adverse Event|8
2044974|NCT00459667|3616259|FG000|Overall Study|Lost to Follow-up|5
2044975|NCT00459667|3616260|FG001|Overall Study|Lost to Follow-up|9
2044976|NCT00459667|3616261|FG002|Overall Study|Lost to Follow-up|3
2044977|NCT00459667|3616259|FG000|Overall Study|Pregnancy|1
2044978|NCT00459667|3616260|FG001|Overall Study|Pregnancy|1
2044979|NCT00459667|3616261|FG002|Overall Study|Pregnancy|1
2044980|NCT00459667|3616259|FG000|Overall Study|Protocol Violation|1
2044981|NCT00459667|3616260|FG001|Overall Study|Protocol Violation|0
2044982|NCT00459667|3616261|FG002|Overall Study|Protocol Violation|0
2044983|NCT00459667|3616259|FG000|Overall Study|Withdrawal by Subject|3
2044984|NCT00459667|3616260|FG001|Overall Study|Withdrawal by Subject|5
2044985|NCT00459667|3616261|FG002|Overall Study|Withdrawal by Subject|5
2044986|NCT00459667|3616259|FG000|Overall Study|Other disease modifying treatment|1
2044987|NCT00459667|3616260|FG001|Overall Study|Other disease modifying treatment|2
2044988|NCT00459667|3616261|FG002|Overall Study|Other disease modifying treatment|1
2044989|NCT00459667|3616259|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12
2044990|NCT00459667|3616260|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15
2044991|NCT00459667|3616261|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1
2044992|NCT00459667|3616259|FG000|Overall Study|No treatment administered|6
2044993|NCT00459667|3616260|FG001|Overall Study|No treatment administered|3
2044994|NCT00459667|3616261|FG002|Overall Study|No treatment administered|1
2299114|NCT02584855|3996198|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10
2299115|NCT02584855|3996199|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0
2299116|NCT02584855|3996200|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0
2299117|NCT02584855|3996201|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0
2299118|NCT02584855|3996202|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0
2299119|NCT02584855|3996197|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2299120|NCT02584855|3996198|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
2299121|NCT02584855|3996199|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2299122|NCT02584855|3996200|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2299123|NCT02584855|3996201|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2299124|NCT02584855|3996202|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2299125|NCT02584855|3996197|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0
2299126|NCT02584855|3996198|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0
2299127|NCT02584855|3996199|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0
2299128|NCT02584855|3996200|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0
2299129|NCT02584855|3996201|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7
2299130|NCT02584855|3996202|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0
2299131|NCT02584855|3996197|FG000|Post Treatment Follow-up Period|Protocol Violation|0
2299132|NCT02584855|3996198|FG001|Post Treatment Follow-up Period|Protocol Violation|0
2299133|NCT02584855|3996199|FG002|Post Treatment Follow-up Period|Protocol Violation|0
2299134|NCT02584855|3996200|FG003|Post Treatment Follow-up Period|Protocol Violation|0
2299135|NCT02584855|3996201|FG004|Post Treatment Follow-up Period|Protocol Violation|1
2299136|NCT02584855|3996202|FG005|Post Treatment Follow-up Period|Protocol Violation|0
2299137|NCT02584959|3996227|FG000|Period 1|Withdrawn from study|3
2299138|NCT02584959|3996228|FG001|Period 1|Withdrawn from study|4
2299139|NCT02584959|3996229|FG002|Period 1|Withdrawn from study|0
2299140|NCT02584959|3996227|FG000|Period 2|Withdrawn from study|6
2299141|NCT02584959|3996228|FG001|Period 2|Withdrawn from study|1
2299142|NCT02584959|3996229|FG002|Period 2|Withdrawn from study|2
2299143|NCT02585713|3996275|FG000|Overall Study|Withdrew prior to treatment|2
2299144|NCT02585713|3996276|FG001|Overall Study|Withdrew prior to treatment|7
2299145|NCT02585713|3996275|FG000|Overall Study|Other|3
2299146|NCT02585713|3996276|FG001|Overall Study|Other|1
2299147|NCT02585778|3996286|FG000|Overall Study|Adverse Event|17
2299148|NCT02585778|3996287|FG001|Overall Study|Adverse Event|4
2299149|NCT02585778|3996286|FG000|Overall Study|Participant did not wish to continue|9
2299150|NCT02585778|3996287|FG001|Overall Study|Participant did not wish to continue|4
2299151|NCT02585778|3996286|FG000|Overall Study|Poor compliance to study protocol|0
2299152|NCT02585778|3996287|FG001|Overall Study|Poor compliance to study protocol|2
2299153|NCT02585778|3996286|FG000|Overall Study|Death|0
2299154|NCT02585778|3996287|FG001|Overall Study|Death|1
2299155|NCT02585778|3996286|FG000|Overall Study|Randomized but not treated|1
2299156|NCT02585778|3996287|FG001|Overall Study|Randomized but not treated|2
2299157|NCT02585778|3996286|FG000|Overall Study|Other than specified above|6
2299158|NCT02585778|3996287|FG001|Overall Study|Other than specified above|2
2299159|NCT02585830|3996297|FG000|Overall Study|Withdrawal by Subject|3
2299160|NCT02585934|3996324|FG000|Overall Study|Lost to Follow-up|2
2299161|NCT02585934|3996325|FG001|Overall Study|Lost to Follow-up|2
2299162|NCT02585934|3996324|FG000|Overall Study|Protocol Violation|14
2299163|NCT02585934|3996325|FG001|Overall Study|Protocol Violation|11
2299164|NCT02585934|3996324|FG000|Overall Study|Adverse Event|21
2299165|NCT02585934|3996325|FG001|Overall Study|Adverse Event|22
2299166|NCT02585934|3996324|FG000|Overall Study|Physician Decision|3
2299167|NCT02585934|3996325|FG001|Overall Study|Physician Decision|2
2299168|NCT02585934|3996324|FG000|Overall Study|Withdrawal by Subject|7
2299169|NCT02585934|3996325|FG001|Overall Study|Withdrawal by Subject|21
2299170|NCT02585934|3996324|FG000|Overall Study|Lack of Efficacy|2
2044995|NCT00459706|3616271|FG000|Overall Study|Adverse Event|19
2044996|NCT00459706|3616272|FG001|Overall Study|Adverse Event|13
2044997|NCT00459706|3616271|FG000|Overall Study|Withdrawal by Subject|1
2044998|NCT00459706|3616272|FG001|Overall Study|Withdrawal by Subject|6
2044999|NCT00459706|3616271|FG000|Overall Study|Physician Decision|2
2045000|NCT00459706|3616272|FG001|Overall Study|Physician Decision|0
2045001|NCT00459706|3616271|FG000|Overall Study|Discontinuation of Study by Sponsor|1
2045002|NCT00459706|3616272|FG001|Overall Study|Discontinuation of Study by Sponsor|0
2045003|NCT00459706|3616271|FG000|Overall Study|Protocol Violation|2
2045004|NCT00459706|3616272|FG001|Overall Study|Protocol Violation|1
2045005|NCT00459706|3616271|FG000|Overall Study|Failed to Return|1
2045006|NCT00459706|3616272|FG001|Overall Study|Failed to Return|0
2045007|NCT00459706|3616271|FG000|Overall Study|Other|0
2045008|NCT00459706|3616272|FG001|Overall Study|Other|1
2045009|NCT00459875|3616295|FG000|Overall Study|Ineligible participant|1
2045010|NCT00459875|3616295|FG000|Overall Study|Adverse Event|2
2045011|NCT00459953|3616301|FG000|Overall Study|not analyzed-household member in study|1
2045012|NCT00459953|3616302|FG001|Overall Study|not analyzed-household member in study|1
2045013|NCT00459979|3616308|FG000|Overall Study|Withdrawal by Subject|1
2045014|NCT00459979|3616308|FG000|Overall Study|Protocol Violation|1
2045015|NCT00460031|3616312|FG000|Overall Study|Adverse Event|5
2045016|NCT00460031|3616312|FG000|Overall Study|Withdrawal by Subject|5
2045017|NCT00460031|3616312|FG000|Overall Study|Death|1
2045018|NCT00460109|3616316|FG000|Overall Study|Death|1
2299171|NCT02585934|3996325|FG001|Overall Study|Lack of Efficacy|1
2299172|NCT02585934|3996324|FG000|Overall Study|Death|2
2299173|NCT02585934|3996325|FG001|Overall Study|Death|0
2299174|NCT02585934|3996324|FG000|Overall Study|Caregiver Withdrew Consent|7
2299175|NCT02585934|3996325|FG001|Overall Study|Caregiver Withdrew Consent|7
2299176|NCT02585934|3996324|FG000|Overall Study|Sponsor Termination|1
2299177|NCT02585934|3996325|FG001|Overall Study|Sponsor Termination|2
2299178|NCT02585934|3996324|FG000|Overall Study|Another Reason|10
2299179|NCT02585934|3996325|FG001|Overall Study|Another Reason|5
2299180|NCT02585960|3996339|FG000|PK/Safety Assessment Period|Physician Decision|0
2299181|NCT02585960|3996340|FG001|PK/Safety Assessment Period|Physician Decision|1
2299182|NCT02585960|3996341|FG002|PK/Safety Assessment Period|Physician Decision|0
2299183|NCT02585960|3996339|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1
2299184|NCT02585960|3996340|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2
2299185|NCT02585960|3996341|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5
2299186|NCT02585960|3996339|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0
2299187|NCT02585960|3996340|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2
2299188|NCT02585960|3996341|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0
2299189|NCT02585960|3996339|FG000|PK/Safety Assessment Period|Other|4
2299190|NCT02585960|3996340|FG001|PK/Safety Assessment Period|Other|4
2299191|NCT02585960|3996341|FG002|PK/Safety Assessment Period|Other|0
2299192|NCT02585960|3996339|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0
2299193|NCT02585960|3996340|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1
2299194|NCT02585960|3996341|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0
2299195|NCT02585960|3996339|FG000|PK/Safety Assessment Period|Screen Failure|0
2299196|NCT02585960|3996340|FG001|PK/Safety Assessment Period|Screen Failure|0
2299197|NCT02585960|3996341|FG002|PK/Safety Assessment Period|Screen Failure|1
2299198|NCT02585960|3996339|FG000|Prophylactic Treatment Period|Major protocol deviation|0
2299199|NCT02585960|3996340|FG001|Prophylactic Treatment Period|Major protocol deviation|4
2299200|NCT02585960|3996341|FG002|Prophylactic Treatment Period|Major protocol deviation|0
2299201|NCT02585960|3996339|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
2299202|NCT02585960|3996340|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
2299203|NCT02585960|3996341|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
2299204|NCT02585999|3996352|FG000|Overall Study|Lost to Follow-up|1
2299205|NCT02585999|3996352|FG000|Overall Study|Protocol Violation|1
2299206|NCT02586012|3996357|FG000|Overall Study|Withdrawal by Subject|1
2299207|NCT02586012|3996358|FG001|Overall Study|Withdrawal by Subject|1
2299208|NCT02586012|3996359|FG002|Overall Study|Withdrawal by Subject|0
2299209|NCT02586012|3996360|FG003|Overall Study|Withdrawal by Subject|1
2299210|NCT02586012|3996361|FG004|Overall Study|Withdrawal by Subject|0
2299211|NCT02586012|3996362|FG005|Overall Study|Withdrawal by Subject|2
2299212|NCT02586012|3996357|FG000|Overall Study|Protocol Violation|0
2299213|NCT02586012|3996358|FG001|Overall Study|Protocol Violation|0
2299214|NCT02586012|3996359|FG002|Overall Study|Protocol Violation|0
2299215|NCT02586012|3996360|FG003|Overall Study|Protocol Violation|0
2299216|NCT02586012|3996361|FG004|Overall Study|Protocol Violation|0
2299217|NCT02586012|3996362|FG005|Overall Study|Protocol Violation|1
2299218|NCT02586012|3996357|FG000|Overall Study|study terminated|0
2299219|NCT02586012|3996358|FG001|Overall Study|study terminated|2
2299220|NCT02586012|3996359|FG002|Overall Study|study terminated|1
2299221|NCT02586012|3996360|FG003|Overall Study|study terminated|1
2299222|NCT02586012|3996361|FG004|Overall Study|study terminated|1
2299223|NCT02586012|3996362|FG005|Overall Study|study terminated|0
2299224|NCT02586064|3996373|FG000|Overall Study|Other Obligations|6
2299225|NCT02586064|3996374|FG001|Overall Study|Other Obligations|6
2299226|NCT02586064|3996373|FG000|Overall Study|Other|3
2045019|NCT00460239|3616320|FG000|Overall Study|Physician Decision|0
2045020|NCT00460239|3616321|FG001|Overall Study|Physician Decision|1
2045021|NCT00460239|3616322|FG002|Overall Study|Physician Decision|0
2045022|NCT00460239|3616323|FG003|Overall Study|Physician Decision|0
2299227|NCT02586064|3996374|FG001|Overall Study|Other|7
2045023|NCT00460239|3616324|FG004|Overall Study|Physician Decision|0
2045024|NCT00460239|3616325|FG005|Overall Study|Physician Decision|2
2045025|NCT00460239|3616326|FG006|Overall Study|Physician Decision|0
2045026|NCT00460239|3616327|FG007|Overall Study|Physician Decision|0
2045027|NCT00460239|3616328|FG008|Overall Study|Physician Decision|0
2045028|NCT00460239|3616320|FG000|Overall Study|Withdrawal by Subject|0
2045029|NCT00460239|3616321|FG001|Overall Study|Withdrawal by Subject|0
2045030|NCT00460239|3616322|FG002|Overall Study|Withdrawal by Subject|0
2045031|NCT00460239|3616323|FG003|Overall Study|Withdrawal by Subject|0
2045032|NCT00460239|3616324|FG004|Overall Study|Withdrawal by Subject|0
2045033|NCT00460239|3616325|FG005|Overall Study|Withdrawal by Subject|1
2045034|NCT00460239|3616326|FG006|Overall Study|Withdrawal by Subject|0
2045035|NCT00460239|3616327|FG007|Overall Study|Withdrawal by Subject|0
2045036|NCT00460239|3616328|FG008|Overall Study|Withdrawal by Subject|0
2045037|NCT00460265|3616343|FG000|Overall Study|Lost to Follow-up|14
2045038|NCT00460265|3616344|FG001|Overall Study|Lost to Follow-up|15
2045039|NCT00460265|3616343|FG000|Overall Study|Physician Decision|1
2045040|NCT00460265|3616344|FG001|Overall Study|Physician Decision|2
2045041|NCT00460265|3616343|FG000|Overall Study|Withdrawal by Subject|10
2045042|NCT00460265|3616344|FG001|Overall Study|Withdrawal by Subject|25
2045043|NCT00460265|3616343|FG000|Overall Study|Ongoing|60
2299228|NCT02586064|3996373|FG000|Overall Study|Never Started|3
2299229|NCT02586064|3996374|FG001|Overall Study|Never Started|3
2299230|NCT02586064|3996373|FG000|Overall Study|Lost Interest|1
2299231|NCT02586064|3996374|FG001|Overall Study|Lost Interest|4
2299232|NCT02586064|3996373|FG000|Overall Study|Miscellaneous Life Issues|0
2299233|NCT02586064|3996374|FG001|Overall Study|Miscellaneous Life Issues|5
2299234|NCT02586064|3996373|FG000|Overall Study|Infrequent Attendance|2
2299235|NCT02586064|3996374|FG001|Overall Study|Infrequent Attendance|1
2299236|NCT02586064|3996373|FG000|Overall Study|Timed Out|2
2299237|NCT02586064|3996374|FG001|Overall Study|Timed Out|0
2299238|NCT02586064|3996373|FG000|Overall Study|AUD relapse|0
2299239|NCT02586064|3996374|FG001|Overall Study|AUD relapse|2
2299240|NCT02586064|3996373|FG000|Overall Study|Legal Issue|1
2299241|NCT02586064|3996374|FG001|Overall Study|Legal Issue|0
2299242|NCT02586077|3996383|FG000|Overall Study|Withdrawal by Subject|1
2299243|NCT02586077|3996383|FG000|Overall Study|Physician Decision|4
2299244|NCT02586077|3996383|FG000|Overall Study|Lost to Follow-up|3
2299245|NCT02586155|3996390|FG000|Overall Study|Adverse Event|2
2299246|NCT02586155|3996391|FG001|Overall Study|Adverse Event|3
2299247|NCT02586155|3996390|FG000|Overall Study|Withdrawal by Subject|31
2299248|NCT02586155|3996391|FG001|Overall Study|Withdrawal by Subject|24
2299249|NCT02586155|3996390|FG000|Overall Study|Lost to Follow-up|7
2299250|NCT02586155|3996391|FG001|Overall Study|Lost to Follow-up|13
2299251|NCT02586155|3996390|FG000|Overall Study|Death|61
2299252|NCT02586155|3996391|FG001|Overall Study|Death|72
2299253|NCT02586155|3996390|FG000|Overall Study|Other reasons|26
2299254|NCT02586155|3996391|FG001|Overall Study|Other reasons|15
2299255|NCT02586207|3996397|FG000|Overall Study|Physician Decision|1
2299256|NCT02586207|3996397|FG000|Overall Study|Withdrawal by Subject|1
2299257|NCT02586233|3996408|FG000|Overall Study|Randomized but did not receive treatment|0
2299258|NCT02586233|3996409|FG001|Overall Study|Randomized but did not receive treatment|1
2299259|NCT02586233|3996410|FG002|Overall Study|Randomized but did not receive treatment|0
2299260|NCT02586233|3996411|FG003|Overall Study|Randomized but did not receive treatment|0
2299261|NCT02586233|3996412|FG004|Overall Study|Randomized but did not receive treatment|0
2299262|NCT02586233|3996413|FG005|Overall Study|Randomized but did not receive treatment|2
2299263|NCT02586233|3996414|FG006|Overall Study|Randomized but did not receive treatment|2
2299264|NCT02586233|3996408|FG000|Overall Study|Death|0
2299265|NCT02586233|3996409|FG001|Overall Study|Death|1
2299266|NCT02586233|3996410|FG002|Overall Study|Death|0
2299267|NCT02586233|3996411|FG003|Overall Study|Death|0
2299268|NCT02586233|3996412|FG004|Overall Study|Death|2
2299269|NCT02586233|3996413|FG005|Overall Study|Death|0
2299270|NCT02586233|3996414|FG006|Overall Study|Death|0
2299271|NCT02586415|3996436|FG000|Overall Study|Death|13
2299272|NCT02586415|3996437|FG001|Overall Study|Death|23
2299273|NCT02586415|3996436|FG000|Overall Study|Lost to Follow-up|1
2299274|NCT02586415|3996437|FG001|Overall Study|Lost to Follow-up|2
2299275|NCT02586493|3996444|FG000|Overall Study|Adverse Event|4
2299276|NCT02586493|3996444|FG000|Overall Study|Protocol Violation|6
2299277|NCT02586493|3996444|FG000|Overall Study|Lost to Follow-up|1
2299278|NCT02586493|3996444|FG000|Overall Study|Withdrawal by Subject|1
2299279|NCT02586506|3996448|FG000|Overall Study|Protocol Violation|6
2299280|NCT02586506|3996448|FG000|Overall Study|Lost to Follow-up|1
2299281|NCT02586506|3996448|FG000|Overall Study|Other Reason|2
2299282|NCT02586727|3996454|FG000|Overall Study|Lost to Follow-up|1
2299283|NCT02586727|3996455|FG001|Overall Study|Lost to Follow-up|0
2299284|NCT02586805|3996465|FG000|Overall Study|Withdrawal by Subject|3
2299285|NCT02586805|3996466|FG001|Overall Study|Withdrawal by Subject|1
2299286|NCT02586805|3996467|FG002|Overall Study|Withdrawal by Subject|1
2045044|NCT00460265|3616344|FG001|Overall Study|Ongoing|47
2045045|NCT00460408|3616354|FG000|Overall Study|Adverse Event|1
2045046|NCT00460408|3616355|FG001|Overall Study|Adverse Event|0
2045047|NCT00460408|3616356|FG002|Overall Study|Adverse Event|0
2045048|NCT00460408|3616357|FG003|Overall Study|Adverse Event|0
2045049|NCT00460408|3616354|FG000|Overall Study|Death|7
2299287|NCT02586805|3996468|FG003|Overall Study|Withdrawal by Subject|2
2045050|NCT00460408|3616355|FG001|Overall Study|Death|0
2045051|NCT00460408|3616356|FG002|Overall Study|Death|0
2045052|NCT00460408|3616357|FG003|Overall Study|Death|0
2045053|NCT00460408|3616354|FG000|Overall Study|Lost to Follow-up|11
2045054|NCT00460408|3616355|FG001|Overall Study|Lost to Follow-up|0
2045055|NCT00460408|3616356|FG002|Overall Study|Lost to Follow-up|1
2045056|NCT00460408|3616357|FG003|Overall Study|Lost to Follow-up|0
2045057|NCT00460408|3616354|FG000|Overall Study|Withdrawal by Subject|31
2045058|NCT00460408|3616355|FG001|Overall Study|Withdrawal by Subject|0
2045059|NCT00460408|3616356|FG002|Overall Study|Withdrawal by Subject|0
2045060|NCT00460408|3616357|FG003|Overall Study|Withdrawal by Subject|0
2045061|NCT00460408|3616354|FG000|Overall Study|Insufficient clinical response|5
2045062|NCT00460408|3616355|FG001|Overall Study|Insufficient clinical response|1
2045063|NCT00460408|3616356|FG002|Overall Study|Insufficient clinical response|5
2045064|NCT00460408|3616357|FG003|Overall Study|Insufficient clinical response|0
2045065|NCT00460408|3616354|FG000|Overall Study|Other|12
2045066|NCT00460408|3616355|FG001|Overall Study|Other|2
2045067|NCT00460408|3616356|FG002|Overall Study|Other|0
2045068|NCT00460408|3616357|FG003|Overall Study|Other|0
2045069|NCT00460434|3616381|FG000|Overall Study|Lost to Follow-up|3
2045070|NCT00460434|3616382|FG001|Overall Study|Lost to Follow-up|7
2045071|NCT00460564|3616405|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
2045072|NCT00460564|3616406|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1
2045073|NCT00460564|3616407|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
2045074|NCT00460564|3616408|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
2045075|NCT00460564|3616409|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0
2045076|NCT00460564|3616410|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0
2045077|NCT00460564|3616411|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0
2045078|NCT00460564|3616412|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0
2045079|NCT00460564|3616405|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
2045080|NCT00460564|3616406|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2045081|NCT00460564|3616407|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2045082|NCT00460564|3616408|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2045083|NCT00460564|3616409|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2045084|NCT00460564|3616410|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2045085|NCT00460564|3616411|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2045086|NCT00460564|3616412|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2045087|NCT00460564|3616405|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
2045088|NCT00460564|3616406|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
2045089|NCT00460564|3616407|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0
2045090|NCT00460564|3616408|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0
2045091|NCT00460564|3616409|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3
2045092|NCT00460564|3616410|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5
2045093|NCT00460564|3616411|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2
2045094|NCT00460564|3616412|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0
2045095|NCT00460564|3616405|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2045096|NCT00460564|3616406|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2299288|NCT02586805|3996465|FG000|Overall Study|Adverse Event|2
2299289|NCT02586805|3996466|FG001|Overall Study|Adverse Event|0
2299290|NCT02586805|3996467|FG002|Overall Study|Adverse Event|1
2299291|NCT02586805|3996468|FG003|Overall Study|Adverse Event|0
2299292|NCT02586805|3996465|FG000|Overall Study|Lost to Follow-up|0
2299293|NCT02586805|3996466|FG001|Overall Study|Lost to Follow-up|0
2299294|NCT02586805|3996467|FG002|Overall Study|Lost to Follow-up|1
2299295|NCT02586805|3996468|FG003|Overall Study|Lost to Follow-up|0
2299296|NCT02586805|3996465|FG000|Overall Study|Physician Decision|1
2299297|NCT02586805|3996466|FG001|Overall Study|Physician Decision|0
2299298|NCT02586805|3996467|FG002|Overall Study|Physician Decision|0
2299299|NCT02586805|3996468|FG003|Overall Study|Physician Decision|0
2299300|NCT02587065|3996502|FG000|Overall Study|Adverse Event|14
2299301|NCT02587065|3996502|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5
2299302|NCT02587065|3996502|FG000|Overall Study|Non-adherence to the Protocol|3
2299303|NCT02587065|3996502|FG000|Overall Study|Discontinuation of Study Medication|2
2299304|NCT02587065|3996502|FG000|Overall Study|Reason not Specified|3
2299305|NCT02587143|3996517|FG000|Overall Study|Adverse Event|1
2299306|NCT02587143|3996518|FG001|Overall Study|Adverse Event|0
2299307|NCT02587221|3996526|FG000|Overall Study|Adverse Event|3
2299308|NCT02587221|3996527|FG001|Overall Study|Adverse Event|3
2299309|NCT02587221|3996526|FG000|Overall Study|Death|33
2299310|NCT02587221|3996527|FG001|Overall Study|Death|34
2299311|NCT02587221|3996526|FG000|Overall Study|Withdrawal by Subject|66
2299312|NCT02587221|3996527|FG001|Overall Study|Withdrawal by Subject|61
2045097|NCT00460564|3616407|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2045098|NCT00460564|3616408|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2045099|NCT00460564|3616409|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
2045100|NCT00460564|3616410|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
2045101|NCT00460564|3616411|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2045102|NCT00460564|3616412|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2045103|NCT00460564|3616405|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2299313|NCT02587221|3996526|FG000|Overall Study|Lost to Follow-up|21
2299314|NCT02587221|3996527|FG001|Overall Study|Lost to Follow-up|19
2045104|NCT00460564|3616406|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2045105|NCT00460564|3616407|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2045106|NCT00460564|3616408|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2299315|NCT02587221|3996526|FG000|Overall Study|Protocol Violation|6
2299316|NCT02587221|3996527|FG001|Overall Study|Protocol Violation|5
2299317|NCT02587221|3996526|FG000|Overall Study|Other Reason or Unspecified|2
2299318|NCT02587221|3996527|FG001|Overall Study|Other Reason or Unspecified|1
2299319|NCT02587234|3996535|FG000|Overall Study|Withdrawal by Subject|1
2299320|NCT02587234|3996536|FG001|Overall Study|Withdrawal by Subject|1
2299321|NCT02587234|3996535|FG000|Overall Study|Lost to Follow-up|0
2299322|NCT02587234|3996536|FG001|Overall Study|Lost to Follow-up|2
2299323|NCT02587520|3996569|FG000|Overall Study|Protocol Violation|2
2299324|NCT02587520|3996570|FG001|Overall Study|Protocol Violation|0
2299325|NCT02587520|3996571|FG002|Overall Study|Protocol Violation|0
2299326|NCT02587520|3996572|FG003|Overall Study|Protocol Violation|2
2299327|NCT02587520|3996573|FG004|Overall Study|Protocol Violation|0
2299328|NCT02587520|3996574|FG005|Overall Study|Protocol Violation|1
2299329|NCT02587520|3996575|FG006|Overall Study|Protocol Violation|1
2299330|NCT02587520|3996576|FG007|Overall Study|Protocol Violation|1
2299331|NCT02587520|3996577|FG008|Overall Study|Protocol Violation|3
2299332|NCT02587520|3996578|FG009|Overall Study|Protocol Violation|3
2299333|NCT02587520|3996579|FG010|Overall Study|Protocol Violation|1
2299334|NCT02587520|3996580|FG011|Overall Study|Protocol Violation|2
2299335|NCT02587520|3996581|FG012|Overall Study|Protocol Violation|0
2299336|NCT02587520|3996582|FG013|Overall Study|Protocol Violation|0
2299337|NCT02587520|3996583|FG014|Overall Study|Protocol Violation|0
2299338|NCT02587520|3996584|FG015|Overall Study|Protocol Violation|0
2299339|NCT02587520|3996585|FG016|Overall Study|Protocol Violation|0
2299340|NCT02587520|3996586|FG017|Overall Study|Protocol Violation|0
2299341|NCT02587520|3996569|FG000|Overall Study|Adverse Event|0
2299342|NCT02587520|3996570|FG001|Overall Study|Adverse Event|0
2299343|NCT02587520|3996571|FG002|Overall Study|Adverse Event|0
2299344|NCT02587520|3996572|FG003|Overall Study|Adverse Event|0
2299345|NCT02587520|3996573|FG004|Overall Study|Adverse Event|0
2299346|NCT02587520|3996574|FG005|Overall Study|Adverse Event|0
2299347|NCT02587520|3996575|FG006|Overall Study|Adverse Event|0
2299348|NCT02587520|3996576|FG007|Overall Study|Adverse Event|0
2299349|NCT02587520|3996577|FG008|Overall Study|Adverse Event|0
2299350|NCT02587520|3996578|FG009|Overall Study|Adverse Event|0
2299351|NCT02587520|3996579|FG010|Overall Study|Adverse Event|0
2299352|NCT02587520|3996580|FG011|Overall Study|Adverse Event|1
2299353|NCT02587520|3996581|FG012|Overall Study|Adverse Event|0
2299354|NCT02587520|3996582|FG013|Overall Study|Adverse Event|0
2299355|NCT02587520|3996583|FG014|Overall Study|Adverse Event|0
2299356|NCT02587520|3996584|FG015|Overall Study|Adverse Event|0
2299357|NCT02587520|3996585|FG016|Overall Study|Adverse Event|0
2299358|NCT02587520|3996586|FG017|Overall Study|Adverse Event|0
2299359|NCT02587520|3996569|FG000|Overall Study|Withdrawal by Subject|0
2299360|NCT02587520|3996570|FG001|Overall Study|Withdrawal by Subject|0
2299361|NCT02587520|3996571|FG002|Overall Study|Withdrawal by Subject|1
2299362|NCT02587520|3996572|FG003|Overall Study|Withdrawal by Subject|1
2299363|NCT02587520|3996573|FG004|Overall Study|Withdrawal by Subject|0
2299364|NCT02587520|3996574|FG005|Overall Study|Withdrawal by Subject|1
2299365|NCT02587520|3996575|FG006|Overall Study|Withdrawal by Subject|1
2299366|NCT02587520|3996576|FG007|Overall Study|Withdrawal by Subject|0
2299367|NCT02587520|3996577|FG008|Overall Study|Withdrawal by Subject|0
2299368|NCT02587520|3996578|FG009|Overall Study|Withdrawal by Subject|0
2299369|NCT02587520|3996579|FG010|Overall Study|Withdrawal by Subject|0
2299370|NCT02587520|3996580|FG011|Overall Study|Withdrawal by Subject|0
2299371|NCT02587520|3996581|FG012|Overall Study|Withdrawal by Subject|0
2299372|NCT02587520|3996582|FG013|Overall Study|Withdrawal by Subject|1
2299373|NCT02587520|3996583|FG014|Overall Study|Withdrawal by Subject|0
2299374|NCT02587520|3996584|FG015|Overall Study|Withdrawal by Subject|0
2299375|NCT02587520|3996585|FG016|Overall Study|Withdrawal by Subject|0
2299376|NCT02587520|3996586|FG017|Overall Study|Withdrawal by Subject|0
2299377|NCT02587520|3996569|FG000|Overall Study|Lost to Follow-up|0
2299378|NCT02587520|3996570|FG001|Overall Study|Lost to Follow-up|2
2299379|NCT02587520|3996571|FG002|Overall Study|Lost to Follow-up|0
2299380|NCT02587520|3996572|FG003|Overall Study|Lost to Follow-up|2
2299381|NCT02587520|3996573|FG004|Overall Study|Lost to Follow-up|0
2299382|NCT02587520|3996574|FG005|Overall Study|Lost to Follow-up|1
2299383|NCT02587520|3996575|FG006|Overall Study|Lost to Follow-up|1
2299384|NCT02587520|3996576|FG007|Overall Study|Lost to Follow-up|1
2299385|NCT02587520|3996577|FG008|Overall Study|Lost to Follow-up|0
2299386|NCT02587520|3996578|FG009|Overall Study|Lost to Follow-up|2
2299387|NCT02587520|3996579|FG010|Overall Study|Lost to Follow-up|2
2299388|NCT02587520|3996580|FG011|Overall Study|Lost to Follow-up|1
2299389|NCT02587520|3996581|FG012|Overall Study|Lost to Follow-up|0
2299390|NCT02587520|3996582|FG013|Overall Study|Lost to Follow-up|0
2299391|NCT02587520|3996583|FG014|Overall Study|Lost to Follow-up|0
2299392|NCT02587520|3996584|FG015|Overall Study|Lost to Follow-up|0
2299393|NCT02587520|3996585|FG016|Overall Study|Lost to Follow-up|0
2299394|NCT02587520|3996586|FG017|Overall Study|Lost to Follow-up|0
2299395|NCT02587819|3996624|FG000|Overall Study|Adverse Event|1
2299396|NCT02587819|3996624|FG000|Overall Study|Lost to Follow-up|1
2045107|NCT00460564|3616409|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
2045108|NCT00460564|3616410|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2045109|NCT00460564|3616411|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2045110|NCT00460564|3616412|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2045111|NCT00460577|3616434|FG000|Overall Study|Protocol Violation|2
2045112|NCT00460577|3616435|FG001|Overall Study|Protocol Violation|6
2045113|NCT00460603|3616453|FG000|Phase 1|Death|1
2045114|NCT00460603|3616454|FG001|Phase 1|Death|0
2045115|NCT00460603|3616455|FG002|Phase 1|Death|0
2045116|NCT00460603|3616456|FG003|Phase 1|Death|2
2045117|NCT00460603|3616457|FG004|Phase 1|Death|0
2045118|NCT00460603|3616458|FG005|Phase 1|Death|0
2045119|NCT00460603|3616459|FG006|Phase 1|Death|0
2045120|NCT00460603|3616460|FG007|Phase 1|Death|0
2045121|NCT00460603|3616461|FG008|Phase 1|Death|1
2045122|NCT00460603|3616462|FG009|Phase 1|Death|0
2045123|NCT00460603|3616463|FG010|Phase 1|Death|0
2045124|NCT00460603|3616464|FG011|Phase 1|Death|0
2045125|NCT00460603|3616453|FG000|Phase 1|Adverse Event|3
2045126|NCT00460603|3616454|FG001|Phase 1|Adverse Event|1
2045127|NCT00460603|3616455|FG002|Phase 1|Adverse Event|1
2045128|NCT00460603|3616456|FG003|Phase 1|Adverse Event|2
2045129|NCT00460603|3616457|FG004|Phase 1|Adverse Event|0
2045130|NCT00460603|3616458|FG005|Phase 1|Adverse Event|0
2045131|NCT00460603|3616459|FG006|Phase 1|Adverse Event|3
2045132|NCT00460603|3616460|FG007|Phase 1|Adverse Event|0
2045133|NCT00460603|3616461|FG008|Phase 1|Adverse Event|4
2208669|NCT01641367|3848331|FG000|Cohorts|Death|18
2208670|NCT01641367|3848332|FG001|Cohorts|Death|1
2299397|NCT02587962|3996634|FG000|Overall Study|Adverse Event|0
2299398|NCT02587962|3996635|FG001|Overall Study|Adverse Event|0
2299399|NCT02587962|3996636|FG002|Overall Study|Adverse Event|1
2299400|NCT02587962|3996637|FG003|Overall Study|Adverse Event|0
2299401|NCT02587962|3996638|FG004|Overall Study|Adverse Event|0
2299402|NCT02587962|3996634|FG000|Overall Study|Withdrawal by Subject|0
2299403|NCT02587962|3996635|FG001|Overall Study|Withdrawal by Subject|0
2299404|NCT02587962|3996636|FG002|Overall Study|Withdrawal by Subject|1
2299405|NCT02587962|3996637|FG003|Overall Study|Withdrawal by Subject|1
2299406|NCT02587962|3996638|FG004|Overall Study|Withdrawal by Subject|4
2299407|NCT02587962|3996634|FG000|Overall Study|Radiological progression|2
2299408|NCT02587962|3996635|FG001|Overall Study|Radiological progression|2
2208671|NCT01641367|3848333|FG002|Cohorts|Death|2
2208672|NCT01641367|3848334|FG003|Cohorts|Death|0
2208673|NCT01641367|3848335|FG004|Cohorts|Death|1
2208674|NCT01641367|3848336|FG005|Cohorts|Death|1
2208675|NCT01641367|3848337|FG006|Cohorts|Death|0
2208676|NCT01641367|3848338|FG007|Cohorts|Death|0
2208677|NCT01641367|3848331|FG000|Cohorts|Lost to Follow-up|16
2208678|NCT01641367|3848332|FG001|Cohorts|Lost to Follow-up|0
2299409|NCT02587962|3996636|FG002|Overall Study|Radiological progression|2
2299410|NCT02587962|3996637|FG003|Overall Study|Radiological progression|5
2299411|NCT02587962|3996638|FG004|Overall Study|Radiological progression|10
2299412|NCT02587962|3996634|FG000|Overall Study|Clinical progression|0
2299413|NCT02587962|3996635|FG001|Overall Study|Clinical progression|1
2299414|NCT02587962|3996636|FG002|Overall Study|Clinical progression|2
2299415|NCT02587962|3996637|FG003|Overall Study|Clinical progression|0
2299416|NCT02587962|3996638|FG004|Overall Study|Clinical progression|1
2299417|NCT02588092|3996663|FG000|Overall Study|Death|4
2299418|NCT02588092|3996664|FG001|Overall Study|Death|3
2299419|NCT02588092|3996665|FG002|Overall Study|Death|3
2299420|NCT02588092|3996666|FG003|Overall Study|Death|3
2299421|NCT02588092|3996667|FG004|Overall Study|Death|2
2299422|NCT02588092|3996668|FG005|Overall Study|Death|2
2299423|NCT02588092|3996669|FG006|Overall Study|Death|2
2299424|NCT02588092|3996670|FG007|Overall Study|Death|1
2299425|NCT02588092|3996671|FG008|Overall Study|Death|5
2299426|NCT02588092|3996672|FG009|Overall Study|Death|2
2299427|NCT02588092|3996663|FG000|Overall Study|Withdrawal by Subject|0
2299428|NCT02588092|3996664|FG001|Overall Study|Withdrawal by Subject|0
2299429|NCT02588092|3996665|FG002|Overall Study|Withdrawal by Subject|0
2045134|NCT00460603|3616462|FG009|Phase 1|Adverse Event|0
2045135|NCT00460603|3616463|FG010|Phase 1|Adverse Event|0
2045136|NCT00460603|3616464|FG011|Phase 1|Adverse Event|0
2045137|NCT00460603|3616453|FG000|Phase 1|Lack of Efficacy|1
2045138|NCT00460603|3616454|FG001|Phase 1|Lack of Efficacy|0
2208679|NCT01641367|3848333|FG002|Cohorts|Lost to Follow-up|2
2208680|NCT01641367|3848334|FG003|Cohorts|Lost to Follow-up|0
2299430|NCT02588092|3996666|FG003|Overall Study|Withdrawal by Subject|0
2299431|NCT02588092|3996667|FG004|Overall Study|Withdrawal by Subject|0
2299432|NCT02588092|3996668|FG005|Overall Study|Withdrawal by Subject|1
2299433|NCT02588092|3996669|FG006|Overall Study|Withdrawal by Subject|1
2299434|NCT02588092|3996670|FG007|Overall Study|Withdrawal by Subject|2
2299435|NCT02588092|3996671|FG008|Overall Study|Withdrawal by Subject|0
2299436|NCT02588092|3996672|FG009|Overall Study|Withdrawal by Subject|0
2299437|NCT02588092|3996663|FG000|Overall Study|Started Another Treatment|0
2299438|NCT02588092|3996664|FG001|Overall Study|Started Another Treatment|0
2045139|NCT00460603|3616455|FG002|Phase 1|Lack of Efficacy|1
2045140|NCT00460603|3616456|FG003|Phase 1|Lack of Efficacy|2
2045141|NCT00460603|3616457|FG004|Phase 1|Lack of Efficacy|2
2045142|NCT00460603|3616458|FG005|Phase 1|Lack of Efficacy|2
2208681|NCT01641367|3848335|FG004|Cohorts|Lost to Follow-up|2
2045143|NCT00460603|3616459|FG006|Phase 1|Lack of Efficacy|2
2045144|NCT00460603|3616460|FG007|Phase 1|Lack of Efficacy|2
2045145|NCT00460603|3616461|FG008|Phase 1|Lack of Efficacy|11
2045146|NCT00460603|3616462|FG009|Phase 1|Lack of Efficacy|0
2045147|NCT00460603|3616463|FG010|Phase 1|Lack of Efficacy|0
2045148|NCT00460603|3616464|FG011|Phase 1|Lack of Efficacy|0
2045149|NCT00460603|3616453|FG000|Phase 1|Withdrawal by Subject|1
2045150|NCT00460603|3616454|FG001|Phase 1|Withdrawal by Subject|2
2208682|NCT01641367|3848336|FG005|Cohorts|Lost to Follow-up|0
2208683|NCT01641367|3848337|FG006|Cohorts|Lost to Follow-up|0
2208684|NCT01641367|3848338|FG007|Cohorts|Lost to Follow-up|0
2299439|NCT02588092|3996665|FG002|Overall Study|Started Another Treatment|0
2299440|NCT02588092|3996666|FG003|Overall Study|Started Another Treatment|0
2299441|NCT02588092|3996667|FG004|Overall Study|Started Another Treatment|1
2299442|NCT02588092|3996668|FG005|Overall Study|Started Another Treatment|0
2299443|NCT02588092|3996669|FG006|Overall Study|Started Another Treatment|0
2299444|NCT02588092|3996670|FG007|Overall Study|Started Another Treatment|1
2299445|NCT02588092|3996671|FG008|Overall Study|Started Another Treatment|0
2299446|NCT02588092|3996672|FG009|Overall Study|Started Another Treatment|0
2299447|NCT02588092|3996663|FG000|Overall Study|Sponsor Decision|0
2299448|NCT02588092|3996664|FG001|Overall Study|Sponsor Decision|0
2299449|NCT02588092|3996665|FG002|Overall Study|Sponsor Decision|0
2299450|NCT02588092|3996666|FG003|Overall Study|Sponsor Decision|0
2299451|NCT02588092|3996667|FG004|Overall Study|Sponsor Decision|0
2299452|NCT02588092|3996668|FG005|Overall Study|Sponsor Decision|0
2299453|NCT02588092|3996669|FG006|Overall Study|Sponsor Decision|0
2299454|NCT02588092|3996670|FG007|Overall Study|Sponsor Decision|0
2299455|NCT02588092|3996671|FG008|Overall Study|Sponsor Decision|1
2299456|NCT02588092|3996672|FG009|Overall Study|Sponsor Decision|1
2321380|NCT02960217|4036003|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0
2321381|NCT02960217|4036002|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0
2321382|NCT02960217|4036003|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1
2321383|NCT02960217|4036002|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
2321384|NCT02960217|4036003|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
2321385|NCT02960217|4036002|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
2321386|NCT02960217|4036003|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
2321387|NCT02960217|4036002|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
2321388|NCT02960217|4036003|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
2321389|NCT02960217|4036002|FG000|Open-Label Extension Phase|Adverse Event|1
2321390|NCT02960217|4036003|FG001|Open-Label Extension Phase|Adverse Event|0
2321391|NCT02960217|4036002|FG000|Open-Label Extension Phase|Sponsor Decision|18
2321392|NCT02960217|4036003|FG001|Open-Label Extension Phase|Sponsor Decision|11
2321393|NCT02960217|4036002|FG000|Open-Label Extension Phase|Lack of Efficacy|1
2321394|NCT02960217|4036003|FG001|Open-Label Extension Phase|Lack of Efficacy|1
2321395|NCT02960217|4036002|FG000|Open-Label Extension Phase|Other, Not Specified|0
2321396|NCT02960217|4036003|FG001|Open-Label Extension Phase|Other, Not Specified|1
2321397|NCT02960438|4036022|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
2321398|NCT02960438|4036023|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1
2321399|NCT02960438|4036024|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
2321400|NCT02960438|4036025|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5
2321401|NCT02960438|4036022|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2
2321402|NCT02960438|4036023|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1
2321403|NCT02960438|4036024|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0
2321404|NCT02960438|4036025|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3
2045151|NCT00460603|3616455|FG002|Phase 1|Withdrawal by Subject|1
2045152|NCT00460603|3616456|FG003|Phase 1|Withdrawal by Subject|1
2208685|NCT01641367|3848331|FG000|Randomized Adherence Intervention|Death|0
2208686|NCT01641367|3848332|FG001|Randomized Adherence Intervention|Death|0
2208687|NCT01641367|3848333|FG002|Randomized Adherence Intervention|Death|0
2208688|NCT01641367|3848334|FG003|Randomized Adherence Intervention|Death|0
2208689|NCT01641367|3848335|FG004|Randomized Adherence Intervention|Death|0
2208690|NCT01641367|3848336|FG005|Randomized Adherence Intervention|Death|0
2208691|NCT01641367|3848337|FG006|Randomized Adherence Intervention|Death|11
2208692|NCT01641367|3848338|FG007|Randomized Adherence Intervention|Death|12
2208693|NCT01641367|3848331|FG000|Randomized Adherence Intervention|Lost to Follow-up|0
2208694|NCT01641367|3848332|FG001|Randomized Adherence Intervention|Lost to Follow-up|0
2208695|NCT01641367|3848333|FG002|Randomized Adherence Intervention|Lost to Follow-up|0
2208696|NCT01641367|3848334|FG003|Randomized Adherence Intervention|Lost to Follow-up|0
2208697|NCT01641367|3848335|FG004|Randomized Adherence Intervention|Lost to Follow-up|0
2208698|NCT01641367|3848336|FG005|Randomized Adherence Intervention|Lost to Follow-up|0
2208699|NCT01641367|3848337|FG006|Randomized Adherence Intervention|Lost to Follow-up|8
2208700|NCT01641367|3848338|FG007|Randomized Adherence Intervention|Lost to Follow-up|12
2208701|NCT01641471|3848382|FG000|Overall Study|Withdrawal by Subject|19
2208702|NCT01641471|3848383|FG001|Overall Study|Withdrawal by Subject|19
2208703|NCT01641471|3848382|FG000|Overall Study|Lost to Follow-up|2
2208704|NCT01641471|3848383|FG001|Overall Study|Lost to Follow-up|4
2321405|NCT02960438|4036022|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2
2045153|NCT00460603|3616457|FG004|Phase 1|Withdrawal by Subject|3
2045154|NCT00460603|3616458|FG005|Phase 1|Withdrawal by Subject|0
2045155|NCT00460603|3616459|FG006|Phase 1|Withdrawal by Subject|1
2045156|NCT00460603|3616460|FG007|Phase 1|Withdrawal by Subject|0
2045157|NCT00460603|3616461|FG008|Phase 1|Withdrawal by Subject|2
2045158|NCT00460603|3616462|FG009|Phase 1|Withdrawal by Subject|0
2045159|NCT00460603|3616463|FG010|Phase 1|Withdrawal by Subject|0
2045160|NCT00460603|3616464|FG011|Phase 1|Withdrawal by Subject|0
2045161|NCT00460603|3616453|FG000|Phase 1|Other|0
2045162|NCT00460603|3616454|FG001|Phase 1|Other|3
2045163|NCT00460603|3616455|FG002|Phase 1|Other|1
2045164|NCT00460603|3616456|FG003|Phase 1|Other|1
2045165|NCT00460603|3616457|FG004|Phase 1|Other|1
2045166|NCT00460603|3616458|FG005|Phase 1|Other|2
2045167|NCT00460603|3616459|FG006|Phase 1|Other|0
2045168|NCT00460603|3616460|FG007|Phase 1|Other|1
2045169|NCT00460603|3616461|FG008|Phase 1|Other|0
2045170|NCT00460603|3616462|FG009|Phase 1|Other|0
2045171|NCT00460603|3616463|FG010|Phase 1|Other|0
2045172|NCT00460603|3616464|FG011|Phase 1|Other|0
2045173|NCT00460603|3616453|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2045174|NCT00460603|3616454|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2045175|NCT00460603|3616455|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2045176|NCT00460603|3616456|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2045177|NCT00460603|3616457|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2045178|NCT00460603|3616458|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2045179|NCT00460603|3616459|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2045180|NCT00460603|3616460|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2045181|NCT00460603|3616461|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2045182|NCT00460603|3616462|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
2045183|NCT00460603|3616463|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2045184|NCT00460603|3616464|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2045185|NCT00460603|3616453|FG000|Phase 2|Adverse Event|0
2045186|NCT00460603|3616454|FG001|Phase 2|Adverse Event|0
2045187|NCT00460603|3616455|FG002|Phase 2|Adverse Event|0
2045188|NCT00460603|3616456|FG003|Phase 2|Adverse Event|0
2045189|NCT00460603|3616457|FG004|Phase 2|Adverse Event|0
2045190|NCT00460603|3616458|FG005|Phase 2|Adverse Event|0
2045191|NCT00460603|3616459|FG006|Phase 2|Adverse Event|0
2045192|NCT00460603|3616460|FG007|Phase 2|Adverse Event|0
2045193|NCT00460603|3616461|FG008|Phase 2|Adverse Event|0
2045194|NCT00460603|3616462|FG009|Phase 2|Adverse Event|12
2045195|NCT00460603|3616463|FG010|Phase 2|Adverse Event|9
2045196|NCT00460603|3616464|FG011|Phase 2|Adverse Event|10
2045197|NCT00460603|3616453|FG000|Phase 2|Death|0
2045198|NCT00460603|3616454|FG001|Phase 2|Death|0
2045199|NCT00460603|3616455|FG002|Phase 2|Death|0
2045200|NCT00460603|3616456|FG003|Phase 2|Death|0
2045201|NCT00460603|3616457|FG004|Phase 2|Death|0
2045202|NCT00460603|3616458|FG005|Phase 2|Death|0
2045203|NCT00460603|3616459|FG006|Phase 2|Death|0
2045204|NCT00460603|3616460|FG007|Phase 2|Death|0
2045205|NCT00460603|3616461|FG008|Phase 2|Death|0
2045206|NCT00460603|3616462|FG009|Phase 2|Death|4
2299457|NCT04960228|3996700|FG000|Overall Study|Withdrawal by Subject|216
2299458|NCT04960228|3996701|FG001|Overall Study|Withdrawal by Subject|35
2299459|NCT04960228|3996700|FG000|Overall Study|Failed attention check|69
2299460|NCT04960228|3996701|FG001|Overall Study|Failed attention check|148
2299461|NCT04960228|3996700|FG000|Overall Study|Flagged for response quality by Dynata|3
2299462|NCT04960228|3996701|FG001|Overall Study|Flagged for response quality by Dynata|3
2299463|NCT03922477|3996707|FG000|Overall Study|Death|9
2299464|NCT03922477|3996707|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1
2299465|NCT03922477|3996707|FG000|Overall Study|Physician Decision|1
2299466|NCT03922477|3996707|FG000|Overall Study|Withdrawal by Subject|2
2299467|NCT03688074|3996713|FG000|Overall Study|Adverse Event|0
2299468|NCT03688074|3996714|FG001|Overall Study|Adverse Event|1
2299469|NCT03688074|3996713|FG000|Overall Study|Other|1
2045207|NCT00460603|3616463|FG010|Phase 2|Death|2
2045208|NCT00460603|3616464|FG011|Phase 2|Death|2
2045209|NCT00460603|3616453|FG000|Phase 2|Protocol Violation|0
2045210|NCT00460603|3616454|FG001|Phase 2|Protocol Violation|0
2045211|NCT00460603|3616455|FG002|Phase 2|Protocol Violation|0
2045212|NCT00460603|3616456|FG003|Phase 2|Protocol Violation|0
2045213|NCT00460603|3616457|FG004|Phase 2|Protocol Violation|0
2045214|NCT00460603|3616458|FG005|Phase 2|Protocol Violation|0
2045215|NCT00460603|3616459|FG006|Phase 2|Protocol Violation|0
2045216|NCT00460603|3616460|FG007|Phase 2|Protocol Violation|0
2045217|NCT00460603|3616461|FG008|Phase 2|Protocol Violation|0
2045218|NCT00460603|3616462|FG009|Phase 2|Protocol Violation|1
2045219|NCT00460603|3616463|FG010|Phase 2|Protocol Violation|1
2045220|NCT00460603|3616464|FG011|Phase 2|Protocol Violation|0
2045221|NCT00460603|3616453|FG000|Phase 2|Lost to Follow-up|0
2045222|NCT00460603|3616454|FG001|Phase 2|Lost to Follow-up|0
2045223|NCT00460603|3616455|FG002|Phase 2|Lost to Follow-up|0
2045224|NCT00460603|3616456|FG003|Phase 2|Lost to Follow-up|0
2045225|NCT00460603|3616457|FG004|Phase 2|Lost to Follow-up|0
2045226|NCT00460603|3616458|FG005|Phase 2|Lost to Follow-up|0
2045227|NCT00460603|3616459|FG006|Phase 2|Lost to Follow-up|0
2045228|NCT00460603|3616460|FG007|Phase 2|Lost to Follow-up|0
2045229|NCT00460603|3616461|FG008|Phase 2|Lost to Follow-up|0
2045230|NCT00460603|3616462|FG009|Phase 2|Lost to Follow-up|1
2299470|NCT03688074|3996714|FG001|Overall Study|Other|0
2045231|NCT00460603|3616463|FG010|Phase 2|Lost to Follow-up|0
2045232|NCT00460603|3616464|FG011|Phase 2|Lost to Follow-up|0
2045233|NCT00460603|3616453|FG000|Phase 2|Other|0
2045234|NCT00460603|3616454|FG001|Phase 2|Other|0
2045235|NCT00460603|3616455|FG002|Phase 2|Other|0
2045236|NCT00460603|3616456|FG003|Phase 2|Other|0
2045237|NCT00460603|3616457|FG004|Phase 2|Other|0
2045238|NCT00460603|3616458|FG005|Phase 2|Other|0
2045239|NCT00460603|3616459|FG006|Phase 2|Other|0
2045240|NCT00460603|3616460|FG007|Phase 2|Other|0
2045241|NCT00460603|3616461|FG008|Phase 2|Other|0
2045242|NCT00460603|3616462|FG009|Phase 2|Other|6
2045243|NCT00460603|3616463|FG010|Phase 2|Other|16
2045244|NCT00460603|3616464|FG011|Phase 2|Other|7
2045245|NCT00460603|3616453|FG000|Phase 2|Objective Progression or Relapse|0
2045246|NCT00460603|3616454|FG001|Phase 2|Objective Progression or Relapse|0
2045247|NCT00460603|3616455|FG002|Phase 2|Objective Progression or Relapse|0
2045248|NCT00460603|3616456|FG003|Phase 2|Objective Progression or Relapse|0
2045249|NCT00460603|3616457|FG004|Phase 2|Objective Progression or Relapse|0
2045250|NCT00460603|3616458|FG005|Phase 2|Objective Progression or Relapse|0
2045251|NCT00460603|3616459|FG006|Phase 2|Objective Progression or Relapse|0
2045252|NCT00460603|3616460|FG007|Phase 2|Objective Progression or Relapse|0
2045253|NCT00460603|3616461|FG008|Phase 2|Objective Progression or Relapse|0
2045254|NCT00460603|3616462|FG009|Phase 2|Objective Progression or Relapse|9
2045255|NCT00460603|3616463|FG010|Phase 2|Objective Progression or Relapse|10
2045256|NCT00460603|3616464|FG011|Phase 2|Objective Progression or Relapse|17
2045257|NCT00460603|3616453|FG000|Phase 2|Global Deterioration of Health Status|0
2045258|NCT00460603|3616454|FG001|Phase 2|Global Deterioration of Health Status|0
2045259|NCT00460603|3616455|FG002|Phase 2|Global Deterioration of Health Status|0
2045260|NCT00460603|3616456|FG003|Phase 2|Global Deterioration of Health Status|0
2045261|NCT00460603|3616457|FG004|Phase 2|Global Deterioration of Health Status|0
2045262|NCT00460603|3616458|FG005|Phase 2|Global Deterioration of Health Status|0
2045263|NCT00460603|3616459|FG006|Phase 2|Global Deterioration of Health Status|0
2045264|NCT00460603|3616460|FG007|Phase 2|Global Deterioration of Health Status|0
2045265|NCT00460603|3616461|FG008|Phase 2|Global Deterioration of Health Status|0
2045266|NCT00460603|3616462|FG009|Phase 2|Global Deterioration of Health Status|0
2045267|NCT00460603|3616463|FG010|Phase 2|Global Deterioration of Health Status|1
2045268|NCT00460603|3616464|FG011|Phase 2|Global Deterioration of Health Status|0
2045269|NCT00460603|3616453|FG000|Phase 2|Withdrawal by Subject|0
2045270|NCT00460603|3616454|FG001|Phase 2|Withdrawal by Subject|0
2045271|NCT00460603|3616455|FG002|Phase 2|Withdrawal by Subject|0
2045272|NCT00460603|3616456|FG003|Phase 2|Withdrawal by Subject|0
2045273|NCT00460603|3616457|FG004|Phase 2|Withdrawal by Subject|0
2045274|NCT00460603|3616458|FG005|Phase 2|Withdrawal by Subject|0
2045275|NCT00460603|3616459|FG006|Phase 2|Withdrawal by Subject|0
2045276|NCT00460603|3616460|FG007|Phase 2|Withdrawal by Subject|0
2045277|NCT00460603|3616461|FG008|Phase 2|Withdrawal by Subject|0
2045278|NCT00460603|3616462|FG009|Phase 2|Withdrawal by Subject|5
2045279|NCT00460603|3616463|FG010|Phase 2|Withdrawal by Subject|4
2045280|NCT00460603|3616464|FG011|Phase 2|Withdrawal by Subject|5
2045281|NCT00460603|3616453|FG000|Phase 2|Randomized, but not treated|0
2045282|NCT00460603|3616454|FG001|Phase 2|Randomized, but not treated|0
2045283|NCT00460603|3616455|FG002|Phase 2|Randomized, but not treated|0
2045284|NCT00460603|3616456|FG003|Phase 2|Randomized, but not treated|0
2045285|NCT00460603|3616457|FG004|Phase 2|Randomized, but not treated|0
2045286|NCT00460603|3616458|FG005|Phase 2|Randomized, but not treated|0
2045287|NCT00460603|3616459|FG006|Phase 2|Randomized, but not treated|0
2045288|NCT00460603|3616460|FG007|Phase 2|Randomized, but not treated|0
2299471|NCT03342001|3996720|FG000|Overall Study|Adverse Event|1
2045289|NCT00460603|3616461|FG008|Phase 2|Randomized, but not treated|0
2045290|NCT00460603|3616462|FG009|Phase 2|Randomized, but not treated|3
2045291|NCT00460603|3616463|FG010|Phase 2|Randomized, but not treated|0
2045292|NCT00460603|3616464|FG011|Phase 2|Randomized, but not treated|0
2045293|NCT00460655|3616492|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
2045294|NCT00460655|3616493|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0
2045295|NCT00460655|3616494|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
2045296|NCT00460655|3616495|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
2045297|NCT00460655|3616492|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
2045298|NCT00460655|3616493|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2045299|NCT00460655|3616494|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2045300|NCT00460655|3616495|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2045301|NCT00460655|3616492|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0
2045302|NCT00460655|3616493|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1
2045303|NCT00460655|3616494|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0
2045304|NCT00460655|3616495|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0
2045305|NCT00460655|3616492|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
2045306|NCT00460655|3616493|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
2045307|NCT00460655|3616494|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1
2045308|NCT00460655|3616495|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6
2045309|NCT00460655|3616492|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2045310|NCT00460655|3616493|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2045311|NCT00460655|3616494|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
2299472|NCT03342001|3996720|FG000|Overall Study|Lost to Follow-up|1
2045312|NCT00460655|3616495|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
2045313|NCT00460655|3616492|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
2045314|NCT00460655|3616493|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
2045315|NCT00460655|3616494|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
2045316|NCT00460655|3616495|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
2045317|NCT00460746|3616505|FG000|Overall Study|Adverse Event|1
2045318|NCT00460746|3616505|FG000|Overall Study|Lost to Follow-up|1
2045319|NCT00460798|3616509|FG000|Overall Study|Death|59
2045320|NCT00460798|3616509|FG000|Overall Study|Adverse Event|27
2045321|NCT00460798|3616509|FG000|Overall Study|Lost to Follow-up|19
2045322|NCT00460798|3616509|FG000|Overall Study|Progressive Disease|99
2045323|NCT00460798|3616509|FG000|Overall Study|Other|27
2045324|NCT00460798|3616509|FG000|Overall Study|Ongoing at Date of Cut-Off|82
2045325|NCT00460798|3616509|FG000|Overall Study|Missing/Incomplete Dosing Information|27
2045326|NCT00460811|3616518|FG000|Overall Study|Adverse Event|4
2045327|NCT00460811|3616519|FG001|Overall Study|Adverse Event|6
2045328|NCT00460811|3616520|FG002|Overall Study|Adverse Event|3
2045329|NCT00460811|3616521|FG003|Overall Study|Adverse Event|10
2045330|NCT00460811|3616522|FG004|Overall Study|Adverse Event|2
2045331|NCT00460811|3616518|FG000|Overall Study|Noncompliance|1
2045332|NCT00460811|3616519|FG001|Overall Study|Noncompliance|0
2045333|NCT00460811|3616520|FG002|Overall Study|Noncompliance|0
2045334|NCT00460811|3616521|FG003|Overall Study|Noncompliance|2
2045335|NCT00460811|3616522|FG004|Overall Study|Noncompliance|1
2045336|NCT00460811|3616518|FG000|Overall Study|Withdrawal by Subject|7
2045337|NCT00460811|3616519|FG001|Overall Study|Withdrawal by Subject|7
2045338|NCT00460811|3616520|FG002|Overall Study|Withdrawal by Subject|6
2045339|NCT00460811|3616521|FG003|Overall Study|Withdrawal by Subject|3
2045340|NCT00460811|3616522|FG004|Overall Study|Withdrawal by Subject|11
2045341|NCT00460811|3616518|FG000|Overall Study|Physician Decision|1
2045342|NCT00460811|3616519|FG001|Overall Study|Physician Decision|0
2045343|NCT00460811|3616520|FG002|Overall Study|Physician Decision|0
2045344|NCT00460811|3616521|FG003|Overall Study|Physician Decision|0
2045345|NCT00460811|3616522|FG004|Overall Study|Physician Decision|0
2045346|NCT00460811|3616518|FG000|Overall Study|Lost to Follow-up|3
2045347|NCT00460811|3616519|FG001|Overall Study|Lost to Follow-up|2
2045348|NCT00460811|3616520|FG002|Overall Study|Lost to Follow-up|5
2045349|NCT00460811|3616521|FG003|Overall Study|Lost to Follow-up|3
2045350|NCT00460811|3616522|FG004|Overall Study|Lost to Follow-up|6
2045351|NCT00461123|3616564|FG000|Overall Study|Adverse Event|1
2045352|NCT00461123|3616565|FG001|Overall Study|Adverse Event|0
2045353|NCT00461123|3616564|FG000|Overall Study|Lost to Follow-up|1
2045354|NCT00461123|3616565|FG001|Overall Study|Lost to Follow-up|1
2045355|NCT00461123|3616564|FG000|Overall Study|Protocol Violation|3
2045356|NCT00461123|3616565|FG001|Overall Study|Protocol Violation|2
2045357|NCT00461123|3616564|FG000|Overall Study|Withdrawal by Subject|1
2045358|NCT00461123|3616565|FG001|Overall Study|Withdrawal by Subject|3
2045359|NCT00461175|3616573|FG000|Overall Study|Protocol Violation|522
2045360|NCT00461175|3616574|FG001|Overall Study|Protocol Violation|365
2045361|NCT00461253|3616582|FG000|Overall Study|Death|985
2045362|NCT00461253|3616583|FG001|Overall Study|Death|0
2045363|NCT00461253|3616582|FG000|Overall Study|Protocol Violation|613
2045364|NCT00461253|3616583|FG001|Overall Study|Protocol Violation|236
2045365|NCT00461253|3616582|FG000|Overall Study|no response|2609
2045366|NCT00461253|3616583|FG001|Overall Study|no response|11789
2045367|NCT00461253|3616582|FG000|Overall Study|administrative|773
2045368|NCT00461253|3616583|FG001|Overall Study|administrative|7773
2045369|NCT00461305|3616604|FG000|Treatment|Adverse Event|26
2045370|NCT00461305|3616605|FG001|Treatment|Adverse Event|3
2045371|NCT00461305|3616604|FG000|Treatment|Lost to Follow-up|4
2045372|NCT00461305|3616605|FG001|Treatment|Lost to Follow-up|2
2045373|NCT00461305|3616604|FG000|Treatment|Protocol Violation|13
2045374|NCT00461305|3616605|FG001|Treatment|Protocol Violation|2
2045375|NCT00461305|3616604|FG000|Treatment|Withdrawal by Subject|48
2045376|NCT00461305|3616605|FG001|Treatment|Withdrawal by Subject|2
2045377|NCT00461305|3616604|FG000|Treatment|Never dispensed|5
2045378|NCT00461305|3616605|FG001|Treatment|Never dispensed|0
2045379|NCT00461305|3616604|FG000|Treatment|Study drug not taken|1
2045380|NCT00461305|3616605|FG001|Treatment|Study drug not taken|0
2045381|NCT00461305|3616604|FG000|Treatment|Partially missing diary|2
2045382|NCT00461305|3616605|FG001|Treatment|Partially missing diary|0
2045383|NCT00461305|3616604|FG000|Treatment|Other (missing drug etc)|2
2045384|NCT00461305|3616605|FG001|Treatment|Other (missing drug etc)|0
2045385|NCT00461305|3616604|FG000|Continued Treatment|Adverse Event|26
2045386|NCT00461305|3616605|FG001|Continued Treatment|Adverse Event|0
2045387|NCT00461305|3616604|FG000|Continued Treatment|Lost to Follow-up|4
2045388|NCT00461305|3616605|FG001|Continued Treatment|Lost to Follow-up|0
2045389|NCT00461305|3616604|FG000|Continued Treatment|Protocol Violation|13
2045390|NCT00461305|3616605|FG001|Continued Treatment|Protocol Violation|0
2045391|NCT00461305|3616604|FG000|Continued Treatment|Withdrawal by Subject|48
2045392|NCT00461305|3616605|FG001|Continued Treatment|Withdrawal by Subject|0
2045393|NCT00461305|3616604|FG000|Continued Treatment|Partially missing diary|2
2045394|NCT00461305|3616605|FG001|Continued Treatment|Partially missing diary|0
2045395|NCT00461305|3616604|FG000|Continued Treatment|Other (missing drug etc)|2
2045396|NCT00461305|3616605|FG001|Continued Treatment|Other (missing drug etc)|0
2045397|NCT00461500|3616622|FG000|Overall Study|Adverse Event|1
2045398|NCT00461500|3616623|FG001|Overall Study|Adverse Event|0
2045399|NCT00461500|3616622|FG000|Overall Study|Lack of Efficacy|0
2045400|NCT00461500|3616623|FG001|Overall Study|Lack of Efficacy|1
2045401|NCT00461500|3616622|FG000|Overall Study|Expired Drug Treatment|1
2045402|NCT00461500|3616623|FG001|Overall Study|Expired Drug Treatment|1
2045403|NCT00461500|3616622|FG000|Overall Study|Study Stopped|1
2045404|NCT00461500|3616623|FG001|Overall Study|Study Stopped|2
2045405|NCT00461500|3616622|FG000|Overall Study|Drug Treatment Misuse|1
2045406|NCT00461500|3616623|FG001|Overall Study|Drug Treatment Misuse|0
2045407|NCT00461500|3616622|FG000|Overall Study|No Longer Willing to Take Part in Study|1
2045408|NCT00461500|3616623|FG001|Overall Study|No Longer Willing to Take Part in Study|0
2045409|NCT00461500|3616622|FG000|Overall Study|Lost to Follow-up|2
2045410|NCT00461500|3616623|FG001|Overall Study|Lost to Follow-up|2
2045411|NCT00461552|3616644|FG000|Overall Study|Drug Dispensing error|0
2045412|NCT00461552|3616645|FG001|Overall Study|Drug Dispensing error|2
2045413|NCT00461630|3616662|FG000|Overall Study|Death|798
2045414|NCT00461630|3616663|FG001|Overall Study|Death|732
2045415|NCT00461630|3616662|FG000|Overall Study|Lost to Follow-up|108
2045416|NCT00461630|3616663|FG001|Overall Study|Lost to Follow-up|95
2045417|NCT00461708|3616671|FG000|Overall Study|Adverse Event|17
2045418|NCT00461708|3616672|FG001|Overall Study|Adverse Event|7
2045419|NCT00461708|3616671|FG000|Overall Study|Lack of Efficacy|68
2045420|NCT00461708|3616672|FG001|Overall Study|Lack of Efficacy|20
2045421|NCT00461708|3616671|FG000|Overall Study|Physician Decision|10
2045422|NCT00461708|3616672|FG001|Overall Study|Physician Decision|4
2045423|NCT00461708|3616671|FG000|Overall Study|Withdrawal by Subject|8
2045424|NCT00461708|3616672|FG001|Overall Study|Withdrawal by Subject|2
2045425|NCT00461708|3616671|FG000|Overall Study|Other|4
2045426|NCT00461708|3616672|FG001|Overall Study|Other|4
2045427|NCT00461708|3616671|FG000|Overall Study|Death|8
2045428|NCT00461708|3616672|FG001|Overall Study|Death|1
2045429|NCT00461786|3616704|FG000|Overall Study|Entry Criteria Not Met|2
2045430|NCT00461786|3616704|FG000|Overall Study|Inevaluable (Never Treated)|1
2045431|NCT00461981|3616714|FG000|Overall Study|Lost to Follow-up|9
2045432|NCT00461981|3616715|FG001|Overall Study|Lost to Follow-up|6
2045433|NCT00461981|3616714|FG000|Overall Study|Withdrawal by Subject|2
2045434|NCT00461981|3616715|FG001|Overall Study|Withdrawal by Subject|3
2045435|NCT00462306|3616780|FG000|Overall Study|insufficient data|0
2045436|NCT00462306|3616781|FG001|Overall Study|insufficient data|13
2045437|NCT00462345|3616800|FG000|Overall Study|Withdrawal by Subject|2
2045438|NCT00462345|3616800|FG000|Overall Study|Did not complete second course|1
2045439|NCT00462384|3616804|FG000|Overall Study|Adverse Event|2
2045440|NCT00462384|3616804|FG000|Overall Study|Death|2
2045441|NCT00462384|3616804|FG000|Overall Study|Withdrawal by Subject|1
2045442|NCT00462384|3616804|FG000|Overall Study|Other|4
2045443|NCT00462462|3616824|FG000|Overall Study|Physician Decision|0
2045444|NCT00462462|3616825|FG001|Overall Study|Physician Decision|1
2045445|NCT00462488|3616835|FG000|Overall Study|Protocol Violation|1
2045446|NCT00462488|3616836|FG001|Overall Study|Protocol Violation|0
2045447|NCT00462488|3616835|FG000|Overall Study|Lack of Efficacy|19
2045448|NCT00462488|3616836|FG001|Overall Study|Lack of Efficacy|17
2105094|NCT00855335|3697564|FG002|Overall Study|Physician Decision|0
2105095|NCT00855335|3697565|FG003|Overall Study|Physician Decision|0
2105096|NCT00855335|3697566|FG004|Overall Study|Physician Decision|0
2105097|NCT00855335|3697562|FG000|Overall Study|Other|2
2105098|NCT00855335|3697563|FG001|Overall Study|Other|1
2105099|NCT00855335|3697564|FG002|Overall Study|Other|2
2105100|NCT00855335|3697565|FG003|Overall Study|Other|5
2105101|NCT00855335|3697566|FG004|Overall Study|Other|1
2105102|NCT00855439|3697597|FG000|Overall Study|Withdrawal by Subject|2
2105103|NCT00855439|3697598|FG001|Overall Study|Withdrawal by Subject|0
2105104|NCT00855439|3697597|FG000|Overall Study|Pregnancy|1
2105105|NCT00855439|3697598|FG001|Overall Study|Pregnancy|0
2105106|NCT00855465|3697606|FG000|Treatment Period|Adverse Event|4
2105107|NCT00855465|3697607|FG001|Treatment Period|Adverse Event|2
2105108|NCT00855465|3697606|FG000|Treatment Period|Death|2
2105109|NCT00855465|3697607|FG001|Treatment Period|Death|2
2105110|NCT00855465|3697606|FG000|Treatment Period|Lack of Efficacy|2
2105111|NCT00855465|3697607|FG001|Treatment Period|Lack of Efficacy|1
2105112|NCT00855465|3697606|FG000|Treatment Period|Non-compliance|1
2105113|NCT00855465|3697607|FG001|Treatment Period|Non-compliance|0
2105114|NCT00855465|3697606|FG000|Treatment Period|Protocol Violation|2
2105115|NCT00855465|3697607|FG001|Treatment Period|Protocol Violation|0
2105116|NCT00855465|3697606|FG000|Treatment Period|Withdrawal by Subject|2
2105117|NCT00855465|3697607|FG001|Treatment Period|Withdrawal by Subject|0
2105118|NCT00855465|3697606|FG000|Treatment Period|Not treated|1
2105119|NCT00855465|3697607|FG001|Treatment Period|Not treated|0
2105120|NCT00855465|3697606|FG000|Follow-up Period (FUP)|Adverse Event|0
2105121|NCT00855465|3697607|FG001|Follow-up Period (FUP)|Adverse Event|1
2105122|NCT00855465|3697606|FG000|Follow-up Period (FUP)|Death|0
2105123|NCT00855465|3697607|FG001|Follow-up Period (FUP)|Death|1
2105124|NCT00855465|3697606|FG000|Follow-up Period (FUP)|Lost to Follow-up|3
2105125|NCT00855465|3697607|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
2105126|NCT00855465|3697606|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4
2105127|NCT00855465|3697607|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0
2105128|NCT00855465|3697606|FG000|Follow-up Period (FUP)|Missing|1
2045449|NCT00462501|3616842|FG000|Overall Study|Not treated|3
2045450|NCT00462501|3616842|FG000|Overall Study|Adverse Event|2
2045451|NCT00462670|3616861|FG000|Overall Study|Adverse Event|3
2045452|NCT00462670|3616862|FG001|Overall Study|Adverse Event|5
2045453|NCT00462670|3616861|FG000|Overall Study|Lack of Efficacy|1
2045454|NCT00462670|3616862|FG001|Overall Study|Lack of Efficacy|0
2045455|NCT00462670|3616861|FG000|Overall Study|Protocol Violation|1
2045456|NCT00462670|3616862|FG001|Overall Study|Protocol Violation|0
2045457|NCT00462670|3616861|FG000|Overall Study|Resolution of signs and symptoms|0
2045458|NCT00462670|3616862|FG001|Overall Study|Resolution of signs and symptoms|2
2045459|NCT00462709|3616868|FG000|Overall Study|Transitioned to commercial C1INH-nf|40
2045460|NCT00462709|3616868|FG000|Overall Study|Lost to Follow-up|10
2045461|NCT00462709|3616868|FG000|Overall Study|Withdrawal by Subject|8
2045462|NCT00462709|3616868|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
2045463|NCT00462709|3616868|FG000|Overall Study|Death|2
2045464|NCT00462709|3616868|FG000|Overall Study|Logistical reasons|2
2045465|NCT00462709|3616868|FG000|Overall Study|Physician Decision|1
2045466|NCT00462709|3616868|FG000|Overall Study|Withdrew to start treatment with Cetor|1
2045467|NCT00462761|3616890|FG000|Overall Study|Adverse Event|6
2045468|NCT00462761|3616890|FG000|Overall Study|Withdrawal by Subject|9
2299473|NCT03227029|3996727|FG000|Overall Study|Child Wheezed (no treatment)|0
2299474|NCT03227029|3996728|FG001|Overall Study|Child Wheezed (no treatment)|1
2299475|NCT03227029|3996729|FG002|Overall Study|Child Wheezed (no treatment)|0
2299476|NCT03227029|3996727|FG000|Overall Study|No post RSV season visit due to COVID|3
2299477|NCT03227029|3996728|FG001|Overall Study|No post RSV season visit due to COVID|3
2299478|NCT03227029|3996729|FG002|Overall Study|No post RSV season visit due to COVID|2
2299479|NCT03227029|3996727|FG000|Overall Study|Not able to get to clinic|0
2299480|NCT03227029|3996728|FG001|Overall Study|Not able to get to clinic|0
2299481|NCT03227029|3996729|FG002|Overall Study|Not able to get to clinic|1
2299482|NCT03227029|3996727|FG000|Overall Study|Withdrawal by Subject|1
2299483|NCT03227029|3996728|FG001|Overall Study|Withdrawal by Subject|0
2299484|NCT03227029|3996729|FG002|Overall Study|Withdrawal by Subject|0
2299485|NCT03227029|3996727|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0
2299486|NCT03227029|3996728|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0
2299487|NCT03227029|3996729|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1
2299488|NCT03091192|3996739|FG000|Overall Study|Study terminated by sponsor|21
2299489|NCT03091192|3996740|FG001|Overall Study|Study terminated by sponsor|14
2299490|NCT03091192|3996739|FG000|Overall Study|Death|9
2299491|NCT03091192|3996740|FG001|Overall Study|Death|13
2299492|NCT03091192|3996739|FG000|Overall Study|Withdrawal by Subject|2
2299493|NCT03091192|3996740|FG001|Overall Study|Withdrawal by Subject|0
2299494|NCT03091192|3996739|FG000|Overall Study|Lost to Follow-up|1
2299495|NCT03091192|3996740|FG001|Overall Study|Lost to Follow-up|0
2299496|NCT02859558|3996760|FG000|Step 1|Not Eligible|0
2299497|NCT02859558|3996761|FG001|Step 1|Not Eligible|0
2299498|NCT02859558|3996762|FG002|Step 1|Not Eligible|0
2299499|NCT02859558|3996763|FG003|Step 1|Not Eligible|0
2299500|NCT02859558|3996764|FG004|Step 1|Not Eligible|3
2299501|NCT02859558|3996760|FG000|Step 1|Lost to Follow-up|1
2299502|NCT02859558|3996761|FG001|Step 1|Lost to Follow-up|3
2299503|NCT02859558|3996762|FG002|Step 1|Lost to Follow-up|3
2299504|NCT02859558|3996763|FG003|Step 1|Lost to Follow-up|0
2299505|NCT02859558|3996764|FG004|Step 1|Lost to Follow-up|0
2299506|NCT02859558|3996760|FG000|Step 1|Did Not Return to Clinic|2
2299507|NCT02859558|3996761|FG001|Step 1|Did Not Return to Clinic|3
2299508|NCT02859558|3996762|FG002|Step 1|Did Not Return to Clinic|4
2299509|NCT02859558|3996763|FG003|Step 1|Did Not Return to Clinic|0
2299510|NCT02859558|3996764|FG004|Step 1|Did Not Return to Clinic|0
2299511|NCT02859558|3996760|FG000|Step 1|Moved|0
2299512|NCT02859558|3996761|FG001|Step 1|Moved|1
2299513|NCT02859558|3996762|FG002|Step 1|Moved|1
2299514|NCT02859558|3996763|FG003|Step 1|Moved|0
2299515|NCT02859558|3996764|FG004|Step 1|Moved|0
2299516|NCT02859558|3996760|FG000|Step 1|Withdrawal By Participant|1
2299517|NCT02859558|3996761|FG001|Step 1|Withdrawal By Participant|2
2299518|NCT02859558|3996762|FG002|Step 1|Withdrawal By Participant|1
2299519|NCT02859558|3996763|FG003|Step 1|Withdrawal By Participant|0
2299520|NCT02859558|3996764|FG004|Step 1|Withdrawal By Participant|0
2299521|NCT02859558|3996760|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1
2299522|NCT02859558|3996761|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0
2299523|NCT02859558|3996762|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0
2299524|NCT02859558|3996763|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0
2299525|NCT02859558|3996764|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0
2045469|NCT00462761|3616890|FG000|Overall Study|Physician Decision|5
2045470|NCT00462761|3616890|FG000|Overall Study|Disease progression|43
2045471|NCT00462761|3616890|FG000|Overall Study|Death|12
2299526|NCT02859558|3996760|FG000|Step 1|Incarceration|0
2299527|NCT02859558|3996761|FG001|Step 1|Incarceration|1
2299528|NCT02859558|3996762|FG002|Step 1|Incarceration|0
2299529|NCT02859558|3996763|FG003|Step 1|Incarceration|0
2299530|NCT02859558|3996764|FG004|Step 1|Incarceration|0
2299531|NCT02859558|3996760|FG000|Step 1|Non-Adherence to Study Drug|2
2299532|NCT02859558|3996761|FG001|Step 1|Non-Adherence to Study Drug|0
2299533|NCT02859558|3996762|FG002|Step 1|Non-Adherence to Study Drug|1
2299534|NCT02859558|3996763|FG003|Step 1|Non-Adherence to Study Drug|0
2045472|NCT00462761|3616890|FG000|Overall Study|Other|1
2045473|NCT00462826|3616922|FG000|Overall Study|Ineligible - second primary|1
2045474|NCT00462826|3616922|FG000|Overall Study|Ineligible - wrong cell type|1
2045475|NCT00462826|3616922|FG000|Overall Study|Ineligible - wrong primary|2
2045476|NCT00462826|3616922|FG000|Overall Study|Never treated|1
2045477|NCT00462865|3616941|FG000|Overall Study|Adverse Event|1
2045478|NCT00462982|3616962|FG000|Overall Study|Adverse Event|1
2045479|NCT00462982|3616962|FG000|Overall Study|Patient Not Treated|2
2045480|NCT00463047|3616966|FG000|Titration Period 1|Adverse Event|10
2045481|NCT00463047|3616967|FG001|Titration Period 1|Adverse Event|8
2045482|NCT00463047|3616966|FG000|Titration Period 1|Lack of Efficacy|10
2045483|NCT00463047|3616967|FG001|Titration Period 1|Lack of Efficacy|4
2045484|NCT00463047|3616966|FG000|Titration Period 1|Lost to Follow-up|2
2045485|NCT00463047|3616967|FG001|Titration Period 1|Lost to Follow-up|0
2045486|NCT00463047|3616966|FG000|Titration Period 1|Non-compliance with study medication|3
2045487|NCT00463047|3616967|FG001|Titration Period 1|Non-compliance with study medication|5
2045488|NCT00463047|3616966|FG000|Titration Period 1|Protocol Violation|5
2045489|NCT00463047|3616967|FG001|Titration Period 1|Protocol Violation|5
2045490|NCT00463047|3616966|FG000|Titration Period 1|Withdrawal by Subject|3
2045491|NCT00463047|3616967|FG001|Titration Period 1|Withdrawal by Subject|5
2045492|NCT00463047|3616966|FG000|Titration Period 1|Non-compliance procedures|4
2045493|NCT00463047|3616967|FG001|Titration Period 1|Non-compliance procedures|10
2045494|NCT00463047|3616966|FG000|Titration Period 1|Other|0
2045495|NCT00463047|3616967|FG001|Titration Period 1|Other|2
2045496|NCT00463047|3616966|FG000|Titration Period 2|Adverse Event|9
2045497|NCT00463047|3616967|FG001|Titration Period 2|Adverse Event|9
2045498|NCT00463047|3616966|FG000|Titration Period 2|Lack of Efficacy|6
2045499|NCT00463047|3616967|FG001|Titration Period 2|Lack of Efficacy|4
2045500|NCT00463047|3616966|FG000|Titration Period 2|Withdrawal by Subject|1
2045501|NCT00463047|3616967|FG001|Titration Period 2|Withdrawal by Subject|0
2045502|NCT00463047|3616966|FG000|Titration Period 2|Protocol Violation|2
2045503|NCT00463047|3616967|FG001|Titration Period 2|Protocol Violation|3
2045504|NCT00463047|3616966|FG000|Titration Period 2|Lost to Follow-up|1
2045505|NCT00463047|3616967|FG001|Titration Period 2|Lost to Follow-up|2
2045506|NCT00463047|3616966|FG000|Titration Period 2|Non-compliance study medication|4
2045507|NCT00463047|3616967|FG001|Titration Period 2|Non-compliance study medication|2
2045508|NCT00463047|3616966|FG000|Titration Period 2|Non-compliance procedures|4
2045509|NCT00463047|3616967|FG001|Titration Period 2|Non-compliance procedures|1
2045510|NCT00463047|3616966|FG000|Titration Period 2|Other|3
2045511|NCT00463047|3616967|FG001|Titration Period 2|Other|2
2045512|NCT00463047|3616966|FG000|Double-Blind Treatment Period 1|Adverse Event|0
2045513|NCT00463047|3616967|FG001|Double-Blind Treatment Period 1|Adverse Event|2
2045514|NCT00463047|3616966|FG000|Double-Blind Treatment Period 1|Protocol Violation|1
2045515|NCT00463047|3616967|FG001|Double-Blind Treatment Period 1|Protocol Violation|2
2045516|NCT00463047|3616966|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1
2045517|NCT00463047|3616967|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0
2045518|NCT00463047|3616966|FG000|Double-Blind Treatment Period 1|Other|1
2045519|NCT00463047|3616967|FG001|Double-Blind Treatment Period 1|Other|0
2045520|NCT00463047|3616966|FG000|Double-Blind Treatment Period 2|Adverse Event|0
2045521|NCT00463047|3616967|FG001|Double-Blind Treatment Period 2|Adverse Event|1
2045522|NCT00463047|3616966|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
2045523|NCT00463047|3616967|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1
2045524|NCT00463047|3616966|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1
2045525|NCT00463047|3616967|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0
2045526|NCT00463060|3616976|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
2045527|NCT00463060|3616976|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
2045528|NCT00463151|3616989|FG000|Overall Study|Adverse Event|0
2045529|NCT00463151|3616990|FG001|Overall Study|Adverse Event|0
2045530|NCT00463151|3616991|FG002|Overall Study|Adverse Event|1
2045531|NCT00463151|3616992|FG003|Overall Study|Adverse Event|0
2045532|NCT00463151|3616989|FG000|Overall Study|Lack of Efficacy|2
2045533|NCT00463151|3616990|FG001|Overall Study|Lack of Efficacy|5
2045534|NCT00463151|3616991|FG002|Overall Study|Lack of Efficacy|2
2045535|NCT00463151|3616992|FG003|Overall Study|Lack of Efficacy|5
2045536|NCT00463151|3616989|FG000|Overall Study|Protocol Violation|0
2045537|NCT00463151|3616990|FG001|Overall Study|Protocol Violation|0
2045538|NCT00463151|3616991|FG002|Overall Study|Protocol Violation|0
2045539|NCT00463151|3616992|FG003|Overall Study|Protocol Violation|1
2045540|NCT00463151|3616989|FG000|Overall Study|Withdrawal by Subject|0
2045541|NCT00463151|3616990|FG001|Overall Study|Withdrawal by Subject|0
2045542|NCT00463151|3616991|FG002|Overall Study|Withdrawal by Subject|0
2045543|NCT00463151|3616992|FG003|Overall Study|Withdrawal by Subject|1
2045544|NCT00463229|3617004|FG000|Overall Study|Lost to Follow-up|5
2045545|NCT00463229|3617005|FG001|Overall Study|Lost to Follow-up|7
2045546|NCT00463229|3617004|FG000|Overall Study|Death|4
2045547|NCT00463229|3617005|FG001|Overall Study|Death|3
2045548|NCT00463346|3617014|FG000|Overall Study|Withdrawal by Subject|3
2045549|NCT00463346|3617015|FG001|Overall Study|Withdrawal by Subject|3
2045550|NCT00463385|3617027|FG000|Overall Study|Other|4
2045551|NCT00463385|3617028|FG001|Overall Study|Other|3
2045552|NCT00463385|3617029|FG002|Overall Study|Other|6
2045553|NCT00463385|3617030|FG003|Overall Study|Other|4
2045554|NCT00463385|3617027|FG000|Overall Study|Adverse Event|5
2045555|NCT00463385|3617028|FG001|Overall Study|Adverse Event|8
2045556|NCT00463385|3617029|FG002|Overall Study|Adverse Event|4
2045557|NCT00463385|3617030|FG003|Overall Study|Adverse Event|2
2045558|NCT00463385|3617027|FG000|Overall Study|Lack of Efficacy|6
2045559|NCT00463385|3617028|FG001|Overall Study|Lack of Efficacy|6
2045560|NCT00463385|3617029|FG002|Overall Study|Lack of Efficacy|7
2045561|NCT00463385|3617030|FG003|Overall Study|Lack of Efficacy|9
2045562|NCT00463385|3617027|FG000|Overall Study|Withdrawal by Subject|3
2045563|NCT00463385|3617028|FG001|Overall Study|Withdrawal by Subject|3
2045564|NCT00463385|3617029|FG002|Overall Study|Withdrawal by Subject|3
2045565|NCT00463385|3617030|FG003|Overall Study|Withdrawal by Subject|4
2045566|NCT00463385|3617027|FG000|Overall Study|Lost to Follow-up|0
2045567|NCT00463385|3617028|FG001|Overall Study|Lost to Follow-up|0
2045568|NCT00463385|3617029|FG002|Overall Study|Lost to Follow-up|0
2045569|NCT00463385|3617030|FG003|Overall Study|Lost to Follow-up|1
2045570|NCT00463385|3617027|FG000|Overall Study|Death|2
2045571|NCT00463385|3617028|FG001|Overall Study|Death|1
2045572|NCT00463385|3617029|FG002|Overall Study|Death|2
2045573|NCT00463385|3617030|FG003|Overall Study|Death|0
2045574|NCT00463385|3617027|FG000|Overall Study|Missing|2
2045575|NCT00463385|3617028|FG001|Overall Study|Missing|0
2045576|NCT00463385|3617029|FG002|Overall Study|Missing|0
2045577|NCT00463385|3617030|FG003|Overall Study|Missing|2
2045578|NCT00463385|3617027|FG000|Overall Study|1 participant received commercial drug|0
2045579|NCT00463385|3617028|FG001|Overall Study|1 participant received commercial drug|1
2045580|NCT00463385|3617029|FG002|Overall Study|1 participant received commercial drug|0
2045581|NCT00463385|3617030|FG003|Overall Study|1 participant received commercial drug|0
2045582|NCT00463476|3617067|FG000|Overall Study|Withdrawal by Subject|1
2045583|NCT00463476|3617068|FG001|Overall Study|Withdrawal by Subject|2
2045584|NCT00463476|3617067|FG000|Overall Study|Lost to Follow-up|1
2045585|NCT00463476|3617068|FG001|Overall Study|Lost to Follow-up|1
2045586|NCT00463567|3617081|FG000|Overall Study|Adverse Event|29
2045587|NCT00463567|3617082|FG001|Overall Study|Adverse Event|26
2045588|NCT00463567|3617083|FG002|Overall Study|Adverse Event|17
2045589|NCT00463567|3617084|FG003|Overall Study|Adverse Event|46
2045590|NCT00463567|3617085|FG004|Overall Study|Adverse Event|10
2045591|NCT00463567|3617086|FG005|Overall Study|Adverse Event|10
2045592|NCT00463567|3617087|FG006|Overall Study|Adverse Event|4
2045593|NCT00463567|3617081|FG000|Overall Study|Withdrawal by Subject|29
2045594|NCT00463567|3617082|FG001|Overall Study|Withdrawal by Subject|22
2045595|NCT00463567|3617083|FG002|Overall Study|Withdrawal by Subject|20
2045596|NCT00463567|3617084|FG003|Overall Study|Withdrawal by Subject|37
2045597|NCT00463567|3617085|FG004|Overall Study|Withdrawal by Subject|6
2045598|NCT00463567|3617086|FG005|Overall Study|Withdrawal by Subject|5
2045599|NCT00463567|3617087|FG006|Overall Study|Withdrawal by Subject|1
2045600|NCT00463567|3617081|FG000|Overall Study|Protocol Deviation|13
2045601|NCT00463567|3617082|FG001|Overall Study|Protocol Deviation|9
2045602|NCT00463567|3617083|FG002|Overall Study|Protocol Deviation|14
2045603|NCT00463567|3617084|FG003|Overall Study|Protocol Deviation|11
2045604|NCT00463567|3617085|FG004|Overall Study|Protocol Deviation|1
2045605|NCT00463567|3617086|FG005|Overall Study|Protocol Deviation|1
2045606|NCT00463567|3617087|FG006|Overall Study|Protocol Deviation|2
2045607|NCT00463567|3617081|FG000|Overall Study|Lost to Follow-up|12
2045608|NCT00463567|3617082|FG001|Overall Study|Lost to Follow-up|6
2045609|NCT00463567|3617083|FG002|Overall Study|Lost to Follow-up|13
2045610|NCT00463567|3617084|FG003|Overall Study|Lost to Follow-up|8
2045611|NCT00463567|3617085|FG004|Overall Study|Lost to Follow-up|1
2045612|NCT00463567|3617086|FG005|Overall Study|Lost to Follow-up|1
2045613|NCT00463567|3617087|FG006|Overall Study|Lost to Follow-up|1
2045614|NCT00463567|3617081|FG000|Overall Study|Administrative problems|5
2208705|NCT01641471|3848382|FG000|Overall Study|Protocol Violation|2
2208706|NCT01641471|3848383|FG001|Overall Study|Protocol Violation|4
2208707|NCT01641640|3848389|FG000|Overall Study|Enrolled but not treated|1
2045615|NCT00463567|3617082|FG001|Overall Study|Administrative problems|3
2045616|NCT00463567|3617083|FG002|Overall Study|Administrative problems|6
2045617|NCT00463567|3617084|FG003|Overall Study|Administrative problems|9
2045618|NCT00463567|3617085|FG004|Overall Study|Administrative problems|3
2045619|NCT00463567|3617086|FG005|Overall Study|Administrative problems|2
2045620|NCT00463567|3617087|FG006|Overall Study|Administrative problems|2
2045621|NCT00463567|3617081|FG000|Overall Study|Lack of Efficacy|4
2045622|NCT00463567|3617082|FG001|Overall Study|Lack of Efficacy|9
2045623|NCT00463567|3617083|FG002|Overall Study|Lack of Efficacy|9
2045624|NCT00463567|3617084|FG003|Overall Study|Lack of Efficacy|17
2045625|NCT00463567|3617085|FG004|Overall Study|Lack of Efficacy|1
2045626|NCT00463567|3617086|FG005|Overall Study|Lack of Efficacy|0
2045627|NCT00463567|3617087|FG006|Overall Study|Lack of Efficacy|1
2045628|NCT00463567|3617081|FG000|Overall Study|Abnormal lab value(s)|1
2045629|NCT00463567|3617082|FG001|Overall Study|Abnormal lab value(s)|1
2045630|NCT00463567|3617083|FG002|Overall Study|Abnormal lab value(s)|2
2045631|NCT00463567|3617084|FG003|Overall Study|Abnormal lab value(s)|1
2045632|NCT00463567|3617085|FG004|Overall Study|Abnormal lab value(s)|1
2045633|NCT00463567|3617086|FG005|Overall Study|Abnormal lab value(s)|0
2045634|NCT00463567|3617087|FG006|Overall Study|Abnormal lab value(s)|0
2045635|NCT00463567|3617081|FG000|Overall Study|Abnormal test procedure result(s)|1
2045636|NCT00463567|3617082|FG001|Overall Study|Abnormal test procedure result(s)|1
2045637|NCT00463567|3617083|FG002|Overall Study|Abnormal test procedure result(s)|6
2045638|NCT00463567|3617084|FG003|Overall Study|Abnormal test procedure result(s)|2
2045639|NCT00463567|3617085|FG004|Overall Study|Abnormal test procedure result(s)|0
2045640|NCT00463567|3617086|FG005|Overall Study|Abnormal test procedure result(s)|2
2045641|NCT00463567|3617087|FG006|Overall Study|Abnormal test procedure result(s)|0
2045642|NCT00463567|3617081|FG000|Overall Study|Death|1
2045643|NCT00463567|3617082|FG001|Overall Study|Death|0
2045644|NCT00463567|3617083|FG002|Overall Study|Death|2
2045645|NCT00463567|3617084|FG003|Overall Study|Death|0
2045646|NCT00463567|3617085|FG004|Overall Study|Death|0
2045647|NCT00463567|3617086|FG005|Overall Study|Death|0
2045648|NCT00463567|3617087|FG006|Overall Study|Death|0
2045649|NCT00463580|3617111|FG000|Overall Study|Lost to Follow-up|1
2045650|NCT00463580|3617112|FG001|Overall Study|Lost to Follow-up|0
2045651|NCT00463580|3617111|FG000|Overall Study|Schedule conflict|2
2045652|NCT00463580|3617112|FG001|Overall Study|Schedule conflict|0
2045653|NCT00463580|3617111|FG000|Overall Study|Medical/psychiatric complications|0
2045654|NCT00463580|3617112|FG001|Overall Study|Medical/psychiatric complications|2
2045655|NCT00463606|3617127|FG000|Overall Study|Adverse Event|21
2045656|NCT00463606|3617128|FG001|Overall Study|Adverse Event|18
2045657|NCT00463606|3617129|FG002|Overall Study|Adverse Event|11
2045658|NCT00463606|3617127|FG000|Overall Study|Withdrawal by Subject|11
2045659|NCT00463606|3617128|FG001|Overall Study|Withdrawal by Subject|11
2045660|NCT00463606|3617129|FG002|Overall Study|Withdrawal by Subject|5
2045661|NCT00463606|3617127|FG000|Overall Study|Lost to Follow-up|2
2045662|NCT00463606|3617128|FG001|Overall Study|Lost to Follow-up|2
2045663|NCT00463606|3617129|FG002|Overall Study|Lost to Follow-up|3
2045664|NCT00463606|3617127|FG000|Overall Study|Subject noncompliance|1
2045665|NCT00463606|3617128|FG001|Overall Study|Subject noncompliance|1
2045666|NCT00463606|3617129|FG002|Overall Study|Subject noncompliance|0
2045667|NCT00463606|3617127|FG000|Overall Study|Subject moved out of town|1
2045668|NCT00463606|3617128|FG001|Overall Study|Subject moved out of town|0
2045669|NCT00463606|3617129|FG002|Overall Study|Subject moved out of town|0
2045670|NCT00463606|3617127|FG000|Overall Study|Physician Decision|0
2045671|NCT00463606|3617128|FG001|Overall Study|Physician Decision|1
2045672|NCT00463606|3617129|FG002|Overall Study|Physician Decision|0
2045673|NCT00463606|3617127|FG000|Overall Study|Sponsor request|0
2045674|NCT00463606|3617128|FG001|Overall Study|Sponsor request|1
2045675|NCT00463606|3617129|FG002|Overall Study|Sponsor request|0
2045676|NCT00463606|3617127|FG000|Overall Study|Exclusion criteria violation|2
2045677|NCT00463606|3617128|FG001|Overall Study|Exclusion criteria violation|0
2045678|NCT00463606|3617129|FG002|Overall Study|Exclusion criteria violation|0
2045679|NCT00463606|3617127|FG000|Overall Study|Coordinator error|1
2045680|NCT00463606|3617128|FG001|Overall Study|Coordinator error|0
2045681|NCT00463606|3617129|FG002|Overall Study|Coordinator error|0
2045682|NCT00463606|3617127|FG000|Overall Study|Patient randomized in error|1
2045683|NCT00463606|3617128|FG001|Overall Study|Patient randomized in error|0
2045684|NCT00463606|3617129|FG002|Overall Study|Patient randomized in error|0
2045685|NCT00463606|3617127|FG000|Overall Study|Participation in another ABT-335 trial|1
2045686|NCT00463606|3617128|FG001|Overall Study|Participation in another ABT-335 trial|0
2045687|NCT00463606|3617129|FG002|Overall Study|Participation in another ABT-335 trial|0
2045688|NCT00463606|3617127|FG000|Overall Study|Protocol Violation|0
2045689|NCT00463606|3617128|FG001|Overall Study|Protocol Violation|0
2045690|NCT00463606|3617129|FG002|Overall Study|Protocol Violation|1
2045691|NCT00463684|3617137|FG000|Overall Study|Withdrawal by Subject|1
2045692|NCT00463684|3617137|FG000|Overall Study|Lost to Follow-up|3
2045693|NCT00463788|3617143|FG000|Overall Study|Progressive Disease|86
2045694|NCT00463788|3617144|FG001|Overall Study|Progressive Disease|42
2045695|NCT00463788|3617143|FG000|Overall Study|Adverse Event|6
2045696|NCT00463788|3617144|FG001|Overall Study|Adverse Event|2
2045697|NCT00463788|3617143|FG000|Overall Study|Withdrawal by Subject|6
2045698|NCT00463788|3617144|FG001|Overall Study|Withdrawal by Subject|2
2045699|NCT00463788|3617143|FG000|Overall Study|Death|4
2045700|NCT00463788|3617144|FG001|Overall Study|Death|3
2045701|NCT00463788|3617143|FG000|Overall Study|Symptomatic Deterioration|2
2045702|NCT00463788|3617144|FG001|Overall Study|Symptomatic Deterioration|3
2045703|NCT00463788|3617143|FG000|Overall Study|Lost to Follow-up|1
2045704|NCT00463788|3617144|FG001|Overall Study|Lost to Follow-up|0
2045705|NCT00463788|3617143|FG000|Overall Study|Protocol Violation|0
2045706|NCT00463788|3617144|FG001|Overall Study|Protocol Violation|1
2045707|NCT00463788|3617143|FG000|Overall Study|Other|3
2045708|NCT00463788|3617144|FG001|Overall Study|Other|0
2045709|NCT00463788|3617143|FG000|Overall Study|Randomized but not treated|1
2045710|NCT00463788|3617144|FG001|Overall Study|Randomized but not treated|1
2045711|NCT00463801|3617151|FG000|Overall Study|Protocol Violation|1
2045712|NCT00463801|3617151|FG000|Overall Study|Lack of Efficacy|2
2045713|NCT00463801|3617151|FG000|Overall Study|Adverse Event|4
2045714|NCT00463801|3617151|FG000|Overall Study|Lost to Follow-up|5
2045715|NCT00463801|3617151|FG000|Overall Study|No longer require therapy|1
2045716|NCT00463840|3617155|FG000|Overall Study|Disease progression|7
2045717|NCT00463840|3617155|FG000|Overall Study|Withdrawal by Subject|2
2045718|NCT00463840|3617155|FG000|Overall Study|Adverse Event|3
2177055|NCT01371006|3801078|FG001|Overall Study|Adverse Event|0
2177056|NCT01371539|3801124|FG000|Period One: One Week|Lost to Follow-up|0
2045719|NCT00463866|3617161|FG000|Overall Study|Adverse Event|70
2045720|NCT00463866|3617162|FG001|Overall Study|Adverse Event|93
2045721|NCT00463866|3617161|FG000|Overall Study|Withdrawal by Subject|81
2045722|NCT00463866|3617162|FG001|Overall Study|Withdrawal by Subject|79
2045723|NCT00463866|3617161|FG000|Overall Study|Lost to Follow-up|46
2045724|NCT00463866|3617162|FG001|Overall Study|Lost to Follow-up|55
2045725|NCT00463866|3617161|FG000|Overall Study|Incorrect Enrolment|64
2045726|NCT00463866|3617162|FG001|Overall Study|Incorrect Enrolment|66
2045727|NCT00463866|3617161|FG000|Overall Study|Severe Non-Compliance to Protocol|25
2045728|NCT00463866|3617162|FG001|Overall Study|Severe Non-Compliance to Protocol|21
2045729|NCT00463866|3617161|FG000|Overall Study|Safety Reason|1
2045730|NCT00463866|3617162|FG001|Overall Study|Safety Reason|3
2045731|NCT00463866|3617161|FG000|Overall Study|Mis-Randomization of subject|0
2045732|NCT00463866|3617162|FG001|Overall Study|Mis-Randomization of subject|1
2045733|NCT00463866|3617161|FG000|Overall Study|Other|22
2045734|NCT00463866|3617162|FG001|Overall Study|Other|22
2045735|NCT00464087|3617171|FG000|Overall Study|No PCI per inclusion criteria|0
2045736|NCT00464087|3617172|FG001|Overall Study|No PCI per inclusion criteria|0
2045737|NCT00464087|3617173|FG002|Overall Study|No PCI per inclusion criteria|29
2045738|NCT00464269|3617196|FG000|Overall Study|Lack of Efficacy|1
2045739|NCT00464269|3617197|FG001|Overall Study|Lack of Efficacy|0
2045740|NCT00464269|3617198|FG002|Overall Study|Lack of Efficacy|0
2045741|NCT00464269|3617199|FG003|Overall Study|Lack of Efficacy|0
2045742|NCT00464269|3617196|FG000|Overall Study|Lost to Follow-up|0
2045743|NCT00464269|3617197|FG001|Overall Study|Lost to Follow-up|4
2045744|NCT00464269|3617198|FG002|Overall Study|Lost to Follow-up|0
2045745|NCT00464269|3617199|FG003|Overall Study|Lost to Follow-up|1
2045746|NCT00464269|3617196|FG000|Overall Study|Withdrawal by Subject|0
2045747|NCT00464269|3617197|FG001|Overall Study|Withdrawal by Subject|2
2045748|NCT00464269|3617198|FG002|Overall Study|Withdrawal by Subject|1
2045749|NCT00464269|3617199|FG003|Overall Study|Withdrawal by Subject|1
2045750|NCT00464269|3617196|FG000|Overall Study|Other reason|3
2045751|NCT00464269|3617197|FG001|Overall Study|Other reason|3
2045752|NCT00464269|3617198|FG002|Overall Study|Other reason|1
2045753|NCT00464269|3617199|FG003|Overall Study|Other reason|1
2045754|NCT00464269|3617196|FG000|Overall Study|AE, serious fatal|0
2045755|NCT00464269|3617197|FG001|Overall Study|AE, serious fatal|0
2045756|NCT00464269|3617198|FG002|Overall Study|AE, serious fatal|1
2045757|NCT00464269|3617199|FG003|Overall Study|AE, serious fatal|1
2045758|NCT00464269|3617196|FG000|Overall Study|SAE, non-fatal|0
2045759|NCT00464269|3617197|FG001|Overall Study|SAE, non-fatal|0
2045760|NCT00464269|3617198|FG002|Overall Study|SAE, non-fatal|0
2045761|NCT00464269|3617199|FG003|Overall Study|SAE, non-fatal|1
2045762|NCT00464269|3617196|FG000|Overall Study|AE, non-serious non-fatal|2
2045763|NCT00464269|3617197|FG001|Overall Study|AE, non-serious non-fatal|8
2045764|NCT00464269|3617198|FG002|Overall Study|AE, non-serious non-fatal|3
2045765|NCT00464269|3617199|FG003|Overall Study|AE, non-serious non-fatal|4
2045766|NCT00464269|3617196|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2045767|NCT00464269|3617197|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2045768|NCT00464269|3617198|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
2045769|NCT00464269|3617199|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2045770|NCT00464308|3617214|FG000|Overall Study|Adverse Event|22
2045771|NCT00464308|3617215|FG001|Overall Study|Adverse Event|27
2045772|NCT00464308|3617216|FG002|Overall Study|Adverse Event|16
2045773|NCT00464308|3617214|FG000|Overall Study|Lost to Follow-up|29
2045774|NCT00464308|3617215|FG001|Overall Study|Lost to Follow-up|19
2045775|NCT00464308|3617216|FG002|Overall Study|Lost to Follow-up|20
2045776|NCT00464308|3617214|FG000|Overall Study|Patient discontinued and other reasons|17
2045777|NCT00464308|3617215|FG001|Overall Study|Patient discontinued and other reasons|17
2045778|NCT00464308|3617216|FG002|Overall Study|Patient discontinued and other reasons|23
2045779|NCT00464308|3617214|FG000|Overall Study|Physician Decision|1
2045780|NCT00464308|3617215|FG001|Overall Study|Physician Decision|0
2045781|NCT00464308|3617216|FG002|Overall Study|Physician Decision|0
2045782|NCT00464334|3617235|FG000|Overall Study|Adverse Event|0
2299535|NCT02859558|3996764|FG004|Step 1|Non-Adherence to Study Drug|0
2299536|NCT02859558|3996760|FG000|Step 1|Non-Adherence to Study Requirements|3
2299537|NCT02859558|3996761|FG001|Step 1|Non-Adherence to Study Requirements|1
2299538|NCT02859558|3996762|FG002|Step 1|Non-Adherence to Study Requirements|0
2299539|NCT02859558|3996763|FG003|Step 1|Non-Adherence to Study Requirements|0
2299540|NCT02859558|3996764|FG004|Step 1|Non-Adherence to Study Requirements|0
2299541|NCT02859558|3996760|FG000|Step 1|Virologic Failure|2
2299542|NCT02859558|3996761|FG001|Step 1|Virologic Failure|1
2299543|NCT02859558|3996762|FG002|Step 1|Virologic Failure|1
2299544|NCT02859558|3996763|FG003|Step 1|Virologic Failure|0
2299545|NCT02859558|3996764|FG004|Step 1|Virologic Failure|0
2299546|NCT02859558|3996760|FG000|Step 2|Active On Study|23
2299547|NCT02859558|3996761|FG001|Step 2|Active On Study|38
2299548|NCT02859558|3996762|FG002|Step 2|Active On Study|20
2299549|NCT02859558|3996763|FG003|Step 2|Active On Study|0
2299550|NCT02859558|3996764|FG004|Step 2|Active On Study|0
2045783|NCT00464334|3617236|FG001|Overall Study|Adverse Event|0
2045784|NCT00464334|3617237|FG002|Overall Study|Adverse Event|0
2045785|NCT00464334|3617238|FG003|Overall Study|Adverse Event|1
2045786|NCT00464334|3617239|FG004|Overall Study|Adverse Event|1
2045787|NCT00464334|3617240|FG005|Overall Study|Adverse Event|1
2045788|NCT00464334|3617241|FG006|Overall Study|Adverse Event|0
2045789|NCT00464334|3617242|FG007|Overall Study|Adverse Event|0
2045790|NCT00464334|3617243|FG008|Overall Study|Adverse Event|2
2045791|NCT00464334|3617244|FG009|Overall Study|Adverse Event|1
2045792|NCT00464334|3617245|FG010|Overall Study|Adverse Event|2
2045793|NCT00464334|3617235|FG000|Overall Study|Lack of Efficacy|0
2045794|NCT00464334|3617236|FG001|Overall Study|Lack of Efficacy|1
2045795|NCT00464334|3617237|FG002|Overall Study|Lack of Efficacy|0
2045796|NCT00464334|3617238|FG003|Overall Study|Lack of Efficacy|0
2045797|NCT00464334|3617239|FG004|Overall Study|Lack of Efficacy|0
2045798|NCT00464334|3617240|FG005|Overall Study|Lack of Efficacy|0
2045799|NCT00464334|3617241|FG006|Overall Study|Lack of Efficacy|0
2045800|NCT00464334|3617242|FG007|Overall Study|Lack of Efficacy|0
2045801|NCT00464334|3617243|FG008|Overall Study|Lack of Efficacy|0
2045802|NCT00464334|3617244|FG009|Overall Study|Lack of Efficacy|0
2045803|NCT00464334|3617245|FG010|Overall Study|Lack of Efficacy|0
2045804|NCT00464334|3617235|FG000|Overall Study|Lost to Follow-up|0
2045805|NCT00464334|3617236|FG001|Overall Study|Lost to Follow-up|0
2045806|NCT00464334|3617237|FG002|Overall Study|Lost to Follow-up|1
2045807|NCT00464334|3617238|FG003|Overall Study|Lost to Follow-up|0
2045808|NCT00464334|3617239|FG004|Overall Study|Lost to Follow-up|1
2045809|NCT00464334|3617240|FG005|Overall Study|Lost to Follow-up|0
2045810|NCT00464334|3617241|FG006|Overall Study|Lost to Follow-up|1
2045811|NCT00464334|3617242|FG007|Overall Study|Lost to Follow-up|0
2045812|NCT00464334|3617243|FG008|Overall Study|Lost to Follow-up|0
2045813|NCT00464334|3617244|FG009|Overall Study|Lost to Follow-up|0
2045814|NCT00464334|3617245|FG010|Overall Study|Lost to Follow-up|2
2045815|NCT00464334|3617235|FG000|Overall Study|Progressive Disease|0
2045816|NCT00464334|3617236|FG001|Overall Study|Progressive Disease|0
2045817|NCT00464334|3617237|FG002|Overall Study|Progressive Disease|0
2045818|NCT00464334|3617238|FG003|Overall Study|Progressive Disease|0
2045819|NCT00464334|3617239|FG004|Overall Study|Progressive Disease|0
2045820|NCT00464334|3617240|FG005|Overall Study|Progressive Disease|1
2045821|NCT00464334|3617241|FG006|Overall Study|Progressive Disease|0
2045822|NCT00464334|3617242|FG007|Overall Study|Progressive Disease|0
2045823|NCT00464334|3617243|FG008|Overall Study|Progressive Disease|1
2045824|NCT00464334|3617244|FG009|Overall Study|Progressive Disease|0
2045825|NCT00464334|3617245|FG010|Overall Study|Progressive Disease|0
2045826|NCT00464334|3617235|FG000|Overall Study|Study Terminated by Sponsor|0
2045827|NCT00464334|3617236|FG001|Overall Study|Study Terminated by Sponsor|0
2045828|NCT00464334|3617237|FG002|Overall Study|Study Terminated by Sponsor|0
2045829|NCT00464334|3617238|FG003|Overall Study|Study Terminated by Sponsor|1
2045830|NCT00464334|3617239|FG004|Overall Study|Study Terminated by Sponsor|0
2045831|NCT00464334|3617240|FG005|Overall Study|Study Terminated by Sponsor|0
2045832|NCT00464334|3617241|FG006|Overall Study|Study Terminated by Sponsor|0
2045833|NCT00464334|3617242|FG007|Overall Study|Study Terminated by Sponsor|0
2045834|NCT00464334|3617243|FG008|Overall Study|Study Terminated by Sponsor|0
2045835|NCT00464334|3617244|FG009|Overall Study|Study Terminated by Sponsor|0
2045836|NCT00464334|3617245|FG010|Overall Study|Study Terminated by Sponsor|0
2045837|NCT00464334|3617235|FG000|Overall Study|Withdrawal by Subject|1
2045838|NCT00464334|3617236|FG001|Overall Study|Withdrawal by Subject|7
2045839|NCT00464334|3617237|FG002|Overall Study|Withdrawal by Subject|4
2045840|NCT00464334|3617238|FG003|Overall Study|Withdrawal by Subject|2
2045841|NCT00464334|3617239|FG004|Overall Study|Withdrawal by Subject|2
2045842|NCT00464334|3617240|FG005|Overall Study|Withdrawal by Subject|2
2045843|NCT00464334|3617241|FG006|Overall Study|Withdrawal by Subject|2
2045844|NCT00464334|3617242|FG007|Overall Study|Withdrawal by Subject|1
2045845|NCT00464334|3617243|FG008|Overall Study|Withdrawal by Subject|3
2045846|NCT00464334|3617244|FG009|Overall Study|Withdrawal by Subject|0
2045847|NCT00464334|3617245|FG010|Overall Study|Withdrawal by Subject|0
2045848|NCT00464490|3617300|FG000|Overall Study|Physician Decision|11
2045849|NCT00464490|3617301|FG001|Overall Study|Physician Decision|11
2045850|NCT00464542|3617307|FG000|Pre-treatment|Withdrawal by Subject|2
2045851|NCT00464568|3617311|FG000|Overall Study|Adverse Event|2
2045852|NCT00464620|3617328|FG000|Overall Study|Physician Decision|1
2045853|NCT00464620|3617329|FG001|Overall Study|Physician Decision|0
2045854|NCT00464620|3617330|FG002|Overall Study|Physician Decision|0
2045855|NCT00464620|3617328|FG000|Overall Study|Withdrawal by Subject|1
2045856|NCT00464620|3617329|FG001|Overall Study|Withdrawal by Subject|0
2045857|NCT00464620|3617330|FG002|Overall Study|Withdrawal by Subject|3
2045858|NCT00464620|3617328|FG000|Overall Study|Ineligible sarcoma subtype|0
2045859|NCT00464620|3617329|FG001|Overall Study|Ineligible sarcoma subtype|2
2045860|NCT00464620|3617330|FG002|Overall Study|Ineligible sarcoma subtype|2
2045861|NCT00464620|3617328|FG000|Overall Study|Use of prohibited concomitant medication|0
2045862|NCT00464620|3617329|FG001|Overall Study|Use of prohibited concomitant medication|0
2045863|NCT00464620|3617330|FG002|Overall Study|Use of prohibited concomitant medication|2
2045864|NCT00464672|3617355|FG000|Overall Study|withdrawal of consent|0
2045865|NCT00464672|3617356|FG001|Overall Study|withdrawal of consent|0
2045866|NCT00464672|3617357|FG002|Overall Study|withdrawal of consent|0
2045867|NCT00464672|3617358|FG003|Overall Study|withdrawal of consent|1
2045868|NCT00464672|3617359|FG004|Overall Study|withdrawal of consent|9
2045869|NCT00464672|3617360|FG005|Overall Study|withdrawal of consent|4
2045870|NCT00464672|3617355|FG000|Overall Study|Lost to Follow-up|25
2045871|NCT00464672|3617356|FG001|Overall Study|Lost to Follow-up|10
2045872|NCT00464672|3617357|FG002|Overall Study|Lost to Follow-up|0
2045873|NCT00464672|3617358|FG003|Overall Study|Lost to Follow-up|0
2045874|NCT00464672|3617359|FG004|Overall Study|Lost to Follow-up|1
2045875|NCT00464672|3617360|FG005|Overall Study|Lost to Follow-up|0
2045876|NCT00464737|3617410|FG000|Overall Study|Adverse Event|12
2045877|NCT00464737|3617411|FG001|Overall Study|Adverse Event|17
2045878|NCT00464737|3617412|FG002|Overall Study|Adverse Event|33
2045879|NCT00464737|3617410|FG000|Overall Study|Lack of Efficacy|7
2045880|NCT00464737|3617411|FG001|Overall Study|Lack of Efficacy|7
2045881|NCT00464737|3617412|FG002|Overall Study|Lack of Efficacy|4
2045882|NCT00464737|3617410|FG000|Overall Study|Withdrawal by Subject|5
2045883|NCT00464737|3617411|FG001|Overall Study|Withdrawal by Subject|3
2045884|NCT00464737|3617412|FG002|Overall Study|Withdrawal by Subject|5
2045885|NCT00464737|3617410|FG000|Overall Study|Protocol Violation|1
2045886|NCT00464737|3617411|FG001|Overall Study|Protocol Violation|1
2045887|NCT00464737|3617412|FG002|Overall Study|Protocol Violation|5
2045888|NCT00464737|3617410|FG000|Overall Study|Non-compliance|0
2045889|NCT00464737|3617411|FG001|Overall Study|Non-compliance|1
2045890|NCT00464737|3617412|FG002|Overall Study|Non-compliance|1
2045891|NCT00464737|3617410|FG000|Overall Study|Lost to Follow-up|5
2045892|NCT00464737|3617411|FG001|Overall Study|Lost to Follow-up|2
2045893|NCT00464737|3617412|FG002|Overall Study|Lost to Follow-up|5
2045894|NCT00464737|3617410|FG000|Overall Study|Other: Subject's schedule doesn't permit|1
2045895|NCT00464737|3617411|FG001|Overall Study|Other: Subject's schedule doesn't permit|0
2045896|NCT00464737|3617412|FG002|Overall Study|Other: Subject's schedule doesn't permit|0
2045897|NCT00464737|3617410|FG000|Overall Study|Other: Subject left town; family illness|1
2045898|NCT00464737|3617411|FG001|Overall Study|Other: Subject left town; family illness|0
2045899|NCT00464737|3617412|FG002|Overall Study|Other: Subject left town; family illness|0
2045900|NCT00464737|3617410|FG000|Overall Study|Other: Study demands too great|0
2045901|NCT00464737|3617411|FG001|Overall Study|Other: Study demands too great|1
2045902|NCT00464737|3617412|FG002|Overall Study|Other: Study demands too great|0
2045903|NCT00464737|3617410|FG000|Overall Study|Other: Personal family reasons|0
2045904|NCT00464737|3617411|FG001|Overall Study|Other: Personal family reasons|0
2045905|NCT00464737|3617412|FG002|Overall Study|Other: Personal family reasons|1
2045906|NCT00464737|3617410|FG000|Overall Study|Other: Subject's disability per sponsor|0
2045907|NCT00464737|3617411|FG001|Overall Study|Other: Subject's disability per sponsor|0
2299551|NCT02859558|3996760|FG000|Step 2|Did Not Return to Clinic|2
2299552|NCT02859558|3996761|FG001|Step 2|Did Not Return to Clinic|0
2299553|NCT02859558|3996762|FG002|Step 2|Did Not Return to Clinic|0
2299554|NCT02859558|3996763|FG003|Step 2|Did Not Return to Clinic|0
2299555|NCT02859558|3996764|FG004|Step 2|Did Not Return to Clinic|0
2299556|NCT02859558|3996760|FG000|Step 2|Unexpected Closure of Site|0
2299557|NCT02859558|3996761|FG001|Step 2|Unexpected Closure of Site|1
2299558|NCT02859558|3996762|FG002|Step 2|Unexpected Closure of Site|1
2299559|NCT02859558|3996763|FG003|Step 2|Unexpected Closure of Site|0
2299560|NCT02859558|3996764|FG004|Step 2|Unexpected Closure of Site|0
2299561|NCT02818920|3996774|FG000|Overall Study|Unresectable|4
2299562|NCT02818920|3996774|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1
2299563|NCT02818920|3996774|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
2299564|NCT02818920|3996774|FG000|Overall Study|Adverse Event|3
2299565|NCT02818920|3996774|FG000|Overall Study|Developed Other Disease|1
2299566|NCT02818920|3996774|FG000|Overall Study|Refused Further Treatment|1
2299567|NCT02481310|3996781|FG000|Follow up|Still in follow up|0
2299568|NCT02481310|3996782|FG001|Follow up|Still in follow up|3
2299569|NCT02481310|3996783|FG002|Follow up|Still in follow up|0
2299570|NCT02343952|3996787|FG000|Study Treatment|Disease Progression|23
2299571|NCT02343952|3996787|FG000|Study Treatment|Death|3
2299572|NCT02343952|3996787|FG000|Study Treatment|Adverse Event|19
2299573|NCT02343952|3996787|FG000|Study Treatment|Withdrawal by Subject|7
2299574|NCT02343952|3996787|FG000|Study Treatment|other complicating Diseases|1
2299575|NCT02343952|3996787|FG000|Follow up|Withdrawal by Subject|3
2299576|NCT02343952|3996787|FG000|Follow up|Death|33
2299577|NCT02343952|3996787|FG000|Follow up|Patient does not meet eligibility for study.|1
2299578|NCT02343952|3996787|FG000|Follow up|Research department closed by the practice.|5
2299579|NCT02343952|3996787|FG000|Follow up|Patient went home to Russia|1
2299580|NCT02343952|3996787|FG000|Follow up|Disease Progression|1
2299581|NCT02343952|3996787|FG000|Follow up|study terminated|1
2299582|NCT02326155|3996793|FG000|Overall Study|Adverse Event|21
2299583|NCT02326155|3996794|FG001|Overall Study|Adverse Event|5
2299584|NCT02326155|3996793|FG000|Overall Study|Death|3
2299585|NCT02326155|3996794|FG001|Overall Study|Death|0
2299586|NCT02326155|3996793|FG000|Overall Study|Lack of Efficacy|49
2299587|NCT02326155|3996794|FG001|Overall Study|Lack of Efficacy|5
2299588|NCT02326155|3996793|FG000|Overall Study|Lost to Follow-up|14
2299589|NCT02326155|3996794|FG001|Overall Study|Lost to Follow-up|3
2299590|NCT02326155|3996793|FG000|Overall Study|Protocol Violation|2
2299591|NCT02326155|3996794|FG001|Overall Study|Protocol Violation|0
2299592|NCT02326155|3996793|FG000|Overall Study|Withdrawal by Subject|34
2299593|NCT02326155|3996794|FG001|Overall Study|Withdrawal by Subject|11
2299594|NCT02326155|3996793|FG000|Overall Study|Disease progression|37
2045908|NCT00464737|3617412|FG002|Overall Study|Other: Subject's disability per sponsor|1
2045909|NCT00464815|3617422|FG000|Overall Study|Withdrawal by Subject|6
2045910|NCT00464815|3617423|FG001|Overall Study|Withdrawal by Subject|3
2045911|NCT00464945|3617431|FG000|Infant Series|Withdrawal by parent/guardian request|2
2045912|NCT00464945|3617432|FG001|Infant Series|Withdrawal by parent/guardian request|1
2045913|NCT00464945|3617431|FG000|Infant Series|Protocol Violation|1
2045914|NCT00464945|3617432|FG001|Infant Series|Protocol Violation|0
2045915|NCT00464945|3617431|FG000|Infant Series|Lost to Follow-up|1
2045916|NCT00464945|3617432|FG001|Infant Series|Lost to Follow-up|0
2045917|NCT00464945|3617431|FG000|After Infant Series|Withdrawal by Subject|0
2045918|NCT00464945|3617432|FG001|After Infant Series|Withdrawal by Subject|2
2045919|NCT00464945|3617431|FG000|Toddler Dose|Lost to Follow-up|0
2045920|NCT00464945|3617432|FG001|Toddler Dose|Lost to Follow-up|1
2045921|NCT00465101|3617463|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3
2045922|NCT00465101|3617463|FG000|Overall Study|Change in health precluded follow up|4
2045923|NCT00465101|3617463|FG000|Overall Study|Did not meet study criteria|4
2045924|NCT00465101|3617463|FG000|Overall Study|Lost to Follow-up|5
2045925|NCT00465101|3617463|FG000|Overall Study|Other|6
2045926|NCT00465101|3617463|FG000|Overall Study|Pt. Insurance not accepted at center|2
2045927|NCT00465101|3617463|FG000|Overall Study|Patient postponed procedure|1
2045928|NCT00465101|3617463|FG000|Overall Study|Site closed due to IRB expiration|1
2045929|NCT00465101|3617463|FG000|Overall Study|Unable to obtain IRB approval|1
2045930|NCT00465101|3617463|FG000|Overall Study|Death|3
2045931|NCT00465101|3617463|FG000|Overall Study|Withdrawal by Subject|25
2045932|NCT00465101|3617463|FG000|Overall Study|Physician Decision|1
2045933|NCT00465101|3617463|FG000|Overall Study|Withdrew consent prior to procedure|3
2045934|NCT00465179|3617489|FG000|Overall Study|Adverse Event|4
2045935|NCT00465179|3617489|FG000|Overall Study|Withdrawal by Subject|2
2045936|NCT00465179|3617489|FG000|Overall Study|Progression of Disease|47
2045937|NCT00465270|3617495|FG000|Overall Study|Death|7
2045938|NCT00465270|3617496|FG001|Overall Study|Death|11
2045939|NCT00465270|3617495|FG000|Overall Study|Withdrawal by Subject|34
2045940|NCT00465270|3617496|FG001|Overall Study|Withdrawal by Subject|78
2045941|NCT00465270|3617495|FG000|Overall Study|Lost to Follow-up|60
2045942|NCT00465270|3617496|FG001|Overall Study|Lost to Follow-up|67
2045943|NCT00465270|3617495|FG000|Overall Study|Investigator request|3
2045944|NCT00465270|3617496|FG001|Overall Study|Investigator request|4
2045945|NCT00465361|3617502|FG000|Baseline Assessment|Personal Issues/Scheduling|4
2045946|NCT00465569|3617517|FG000|Overall Study|persistent eczema during dose escalation|1
2045947|NCT00465569|3617518|FG001|Overall Study|persistent eczema during dose escalation|0
2045948|NCT00465647|3617543|FG000|Overall Study|Administrative|2
2045949|NCT00465647|3617544|FG001|Overall Study|Administrative|2
2045950|NCT00465647|3617545|FG002|Overall Study|Administrative|3
2045951|NCT00465647|3617546|FG003|Overall Study|Administrative|2
2045952|NCT00465647|3617543|FG000|Overall Study|Adverse Event|2
2045953|NCT00465647|3617544|FG001|Overall Study|Adverse Event|0
2045954|NCT00465647|3617545|FG002|Overall Study|Adverse Event|3
2045955|NCT00465647|3617546|FG003|Overall Study|Adverse Event|2
2045956|NCT00465647|3617543|FG000|Overall Study|Withdrawal by Subject|1
2045957|NCT00465647|3617544|FG001|Overall Study|Withdrawal by Subject|2
2045958|NCT00465647|3617545|FG002|Overall Study|Withdrawal by Subject|2
2045959|NCT00465647|3617546|FG003|Overall Study|Withdrawal by Subject|7
2045960|NCT00465647|3617543|FG000|Overall Study|"The other reasons included loss of IV"|8
2045961|NCT00465647|3617544|FG001|Overall Study|"The other reasons included loss of IV"|4
2045962|NCT00465647|3617545|FG002|Overall Study|"The other reasons included loss of IV"|3
2045963|NCT00465647|3617546|FG003|Overall Study|"The other reasons included loss of IV"|2
2045964|NCT00465738|3617568|FG000|Overall Study|Lost to Follow-up|2
2045965|NCT00465738|3617569|FG001|Overall Study|Lost to Follow-up|0
2045966|NCT00465738|3617568|FG000|Overall Study|Adverse Event|0
2045967|NCT00465738|3617569|FG001|Overall Study|Adverse Event|1
2045968|NCT00465738|3617568|FG000|Overall Study|Withdrawal by Subject|2
2045969|NCT00465738|3617569|FG001|Overall Study|Withdrawal by Subject|0
2045970|NCT00465738|3617568|FG000|Overall Study|Other|2
2045971|NCT00465738|3617569|FG001|Overall Study|Other|5
2045972|NCT00465816|3617578|FG000|Overall Study|Lost to Follow-up|0
2045973|NCT00465816|3617579|FG001|Overall Study|Lost to Follow-up|0
2045974|NCT00465816|3617580|FG002|Overall Study|Lost to Follow-up|2
2045975|NCT00465894|3617591|FG000|Treatment For 12 Weeks|Lost to Follow-up|4
2045976|NCT00465894|3617592|FG001|Treatment For 12 Weeks|Lost to Follow-up|1
2045977|NCT00465894|3617591|FG000|Treatment For 12 Weeks|Family Issues|1
2299595|NCT02326155|3996794|FG001|Overall Study|Disease progression|4
2299596|NCT02326155|3996793|FG000|Overall Study|Study close|188
2299597|NCT02326155|3996794|FG001|Overall Study|Study close|21
2299598|NCT02326155|3996793|FG000|Overall Study|except for study close|46
2299599|NCT02326155|3996794|FG001|Overall Study|except for study close|13
2299600|NCT02304367|3996800|FG000|Overall Study|Lack of Response to Bruosumab|1
2299601|NCT02304367|3996800|FG000|Overall Study|Sponsor Decision|3
2045978|NCT00465894|3617592|FG001|Treatment For 12 Weeks|Family Issues|1
2045979|NCT00465894|3617591|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0
2045980|NCT00465894|3617592|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1
2045981|NCT00465972|3617616|FG000|Overall Study|Withdrawal by Subject|2
2045982|NCT00465972|3617617|FG001|Overall Study|Withdrawal by Subject|1
2045983|NCT00465985|3617625|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
2045984|NCT00465985|3617626|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
2045985|NCT00465985|3617625|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
2045986|NCT00465985|3617626|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
2045987|NCT00465985|3617625|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
2045988|NCT00465985|3617626|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
2045989|NCT00465985|3617625|FG000|Part III - Open-label Treatment Period|Adverse Event|1
2045990|NCT00465985|3617626|FG001|Part III - Open-label Treatment Period|Adverse Event|0
2045991|NCT00466167|3617643|FG000|Overall Study|Adverse Event|8
2045992|NCT00466167|3617644|FG001|Overall Study|Adverse Event|8
2045993|NCT00466167|3617645|FG002|Overall Study|Adverse Event|7
2045994|NCT00466167|3617643|FG000|Overall Study|Lack of Efficacy|2
2045995|NCT00466167|3617644|FG001|Overall Study|Lack of Efficacy|0
2045996|NCT00466167|3617645|FG002|Overall Study|Lack of Efficacy|3
2045997|NCT00466167|3617643|FG000|Overall Study|Protocol Violation|1
2045998|NCT00466167|3617644|FG001|Overall Study|Protocol Violation|1
2045999|NCT00466167|3617645|FG002|Overall Study|Protocol Violation|2
2208708|NCT01641640|3848389|FG000|Overall Study|Efficacy failure|29
2208709|NCT01641640|3848389|FG000|Overall Study|Lost to Follow-up|3
2208710|NCT01641640|3848389|FG000|Overall Study|Withdrawal by Subject|2
2208711|NCT01641640|3848389|FG000|Overall Study|Adverse Event|1
2208712|NCT01641692|3848405|FG000|Treatment Period 1|Adverse Event|1
2208713|NCT01641692|3848406|FG001|Treatment Period 1|Adverse Event|0
2208714|NCT01641692|3848407|FG002|Treatment Period 1|Adverse Event|0
2208715|NCT01641692|3848408|FG003|Treatment Period 1|Adverse Event|0
2208716|NCT01641692|3848409|FG004|Treatment Period 1|Adverse Event|0
2208717|NCT01641692|3848410|FG005|Treatment Period 1|Adverse Event|0
2208718|NCT01641692|3848411|FG006|Treatment Period 1|Adverse Event|0
2208719|NCT01641692|3848412|FG007|Treatment Period 1|Adverse Event|0
2208720|NCT01641692|3848405|FG000|Treatment Period 1|Lack of Efficacy|0
2208721|NCT01641692|3848406|FG001|Treatment Period 1|Lack of Efficacy|0
2208722|NCT01641692|3848407|FG002|Treatment Period 1|Lack of Efficacy|0
2046000|NCT00466167|3617643|FG000|Overall Study|Lost to Follow-up|3
2046001|NCT00466167|3617644|FG001|Overall Study|Lost to Follow-up|2
2046002|NCT00466167|3617645|FG002|Overall Study|Lost to Follow-up|2
2046003|NCT00466167|3617643|FG000|Overall Study|Withdrawal by Subject|4
2046004|NCT00466167|3617644|FG001|Overall Study|Withdrawal by Subject|1
2046005|NCT00466167|3617645|FG002|Overall Study|Withdrawal by Subject|6
2046006|NCT00466167|3617643|FG000|Overall Study|patient did not meet inclusion criteria|1
2046007|NCT00466167|3617644|FG001|Overall Study|patient did not meet inclusion criteria|0
2046008|NCT00466167|3617645|FG002|Overall Study|patient did not meet inclusion criteria|1
2046009|NCT00466167|3617643|FG000|Overall Study|Not treated|1
2046010|NCT00466167|3617644|FG001|Overall Study|Not treated|0
2046011|NCT00466167|3617645|FG002|Overall Study|Not treated|0
2046012|NCT00466193|3617655|FG000|Overall Study|Adverse Event|0
2046013|NCT00466193|3617656|FG001|Overall Study|Adverse Event|1
2046014|NCT00466193|3617655|FG000|Overall Study|Lost to Follow-up|2
2046015|NCT00466193|3617656|FG001|Overall Study|Lost to Follow-up|4
2046016|NCT00466193|3617655|FG000|Overall Study|Physician Decision|1
2046017|NCT00466193|3617656|FG001|Overall Study|Physician Decision|0
2046018|NCT00466193|3617655|FG000|Overall Study|Protocol Violation|1
2046019|NCT00466193|3617656|FG001|Overall Study|Protocol Violation|1
2046020|NCT00466193|3617655|FG000|Overall Study|Withdrawal by Subject|7
2046021|NCT00466193|3617656|FG001|Overall Study|Withdrawal by Subject|2
2046022|NCT00466193|3617655|FG000|Overall Study|Patient refused Visit 4 procedures|1
2046023|NCT00466193|3617656|FG001|Overall Study|Patient refused Visit 4 procedures|0
2046024|NCT00466440|3617694|FG000|Overall Study|Adverse Event|0
2046025|NCT00466440|3617695|FG001|Overall Study|Adverse Event|3
2046026|NCT00466440|3617696|FG002|Overall Study|Adverse Event|1
2046027|NCT00466440|3617694|FG000|Overall Study|Death|1
2046028|NCT00466440|3617695|FG001|Overall Study|Death|1
2046029|NCT00466440|3617696|FG002|Overall Study|Death|0
2046030|NCT00466440|3617694|FG000|Overall Study|Progressive disease|13
2208723|NCT01641692|3848408|FG003|Treatment Period 1|Lack of Efficacy|0
2299602|NCT02304367|3996800|FG000|Overall Study|Death|2
2299603|NCT02304367|3996800|FG000|Overall Study|Physician Decision|1
2299604|NCT02304367|3996800|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1
2321406|NCT02960438|4036023|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
2321407|NCT02960438|4036024|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
2321408|NCT02960438|4036025|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
2321409|NCT02960438|4036022|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
2321410|NCT02960438|4036023|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
2046031|NCT00466440|3617695|FG001|Overall Study|Progressive disease|5
2046032|NCT00466440|3617696|FG002|Overall Study|Progressive disease|4
2046033|NCT00466440|3617694|FG000|Overall Study|Lost to Follow-up|0
2046034|NCT00466440|3617695|FG001|Overall Study|Lost to Follow-up|1
2046035|NCT00466440|3617696|FG002|Overall Study|Lost to Follow-up|0
2046036|NCT00466440|3617694|FG000|Overall Study|Physician Decision|0
2046037|NCT00466440|3617695|FG001|Overall Study|Physician Decision|1
2046038|NCT00466440|3617696|FG002|Overall Study|Physician Decision|2
2208724|NCT01641692|3848409|FG004|Treatment Period 1|Lack of Efficacy|0
2046039|NCT00466440|3617694|FG000|Overall Study|Protocol entry criteria not met|0
2046040|NCT00466440|3617695|FG001|Overall Study|Protocol entry criteria not met|0
2046041|NCT00466440|3617696|FG002|Overall Study|Protocol entry criteria not met|4
2046042|NCT00466440|3617694|FG000|Overall Study|Withdrawal by Subject|0
2046043|NCT00466440|3617695|FG001|Overall Study|Withdrawal by Subject|1
2046044|NCT00466440|3617696|FG002|Overall Study|Withdrawal by Subject|0
2046045|NCT00466440|3617694|FG000|Overall Study|Sponsor decision|0
2046046|NCT00466440|3617695|FG001|Overall Study|Sponsor decision|0
2046047|NCT00466440|3617696|FG002|Overall Study|Sponsor decision|1
2046048|NCT00466505|3617713|FG000|Overall Study|disease progression|13
2046049|NCT00466505|3617713|FG000|Overall Study|Adverse Event|4
2046050|NCT00466687|3617726|FG000|Overall Study|Adverse Event|1
2046051|NCT00466687|3617726|FG000|Overall Study|Other complicating illness|3
2046052|NCT00466687|3617726|FG000|Overall Study|Withdrawal by Subject|1
2046053|NCT00466687|3617726|FG000|Overall Study|Disease progression|29
2046054|NCT00466726|3617732|FG000|Overall Study|Not evaluable for response|14
2046055|NCT00466921|3617763|FG000|First 3 Cycles of Treatment|Adverse Event|2
2046056|NCT00466921|3617763|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5
2046057|NCT00466921|3617763|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2
2046058|NCT00466921|3617763|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2
2046059|NCT00466921|3617763|FG000|Completed 4 Cycles/Reached 1st Response|Other|1
2046060|NCT00466921|3617763|FG000|Follow up for a Minimum of 1 Year|Death|6
2046061|NCT00466947|3617769|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875
2046062|NCT00466947|3617770|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863
2046063|NCT00466947|3617769|FG000|Study End Analysis Period|Adverse Event|35
2046064|NCT00466947|3617770|FG001|Study End Analysis Period|Adverse Event|43
2046065|NCT00466947|3617769|FG000|Study End Analysis Period|Lost to Follow-up|1137
2046066|NCT00466947|3617770|FG001|Study End Analysis Period|Lost to Follow-up|1167
2046067|NCT00466947|3617769|FG000|Study End Analysis Period|Physician Decision|29
2046068|NCT00466947|3617770|FG001|Study End Analysis Period|Physician Decision|29
2046069|NCT00466947|3617769|FG000|Study End Analysis Period|Protocol Violation|9
2046070|NCT00466947|3617770|FG001|Study End Analysis Period|Protocol Violation|17
2046071|NCT00466947|3617769|FG000|Study End Analysis Period|Withdrawal by Subject|1264
2046072|NCT00466947|3617770|FG001|Study End Analysis Period|Withdrawal by Subject|1267
2046073|NCT00466947|3617769|FG000|Study End Analysis Period|Other - Forbidden vaccination|21
2046074|NCT00466947|3617770|FG001|Study End Analysis Period|Other - Forbidden vaccination|10
2046075|NCT00466947|3617769|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1
2046076|NCT00466947|3617770|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0
2046077|NCT00466947|3617769|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0
2046078|NCT00466947|3617770|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1
2046079|NCT00467051|3617791|FG000|Overall Study|Adverse Event|2
2046080|NCT00467259|3617802|FG000|Overall Study|Adverse Event|24
2046081|NCT00467259|3617803|FG001|Overall Study|Adverse Event|90
2046082|NCT00467259|3617802|FG000|Overall Study|Protocol Violation|1
2046083|NCT00467259|3617803|FG001|Overall Study|Protocol Violation|7
2046084|NCT00467259|3617802|FG000|Overall Study|Withdrawal by Subject|34
2046085|NCT00467259|3617803|FG001|Overall Study|Withdrawal by Subject|108
2046086|NCT00467259|3617802|FG000|Overall Study|Physician Decision|0
2046087|NCT00467259|3617803|FG001|Overall Study|Physician Decision|2
2046088|NCT00467259|3617802|FG000|Overall Study|Lost to Follow-up|14
2046089|NCT00467259|3617803|FG001|Overall Study|Lost to Follow-up|34
2046090|NCT00467259|3617802|FG000|Overall Study|Site Closed|2
2046091|NCT00467259|3617803|FG001|Overall Study|Site Closed|1
2046092|NCT00467272|3617809|FG000|Overall Study|Pneumonia|2
2046093|NCT00467272|3617809|FG000|Overall Study|Thrombophlebitis|1
2046094|NCT00467285|3617815|FG000|Overall Study|Lost to Follow-up|4
2046095|NCT00467285|3617816|FG001|Overall Study|Lost to Follow-up|4
2046096|NCT00467363|3617844|FG000|Overall Study|Lost to Follow-up|80
2046097|NCT00467363|3617845|FG001|Overall Study|Lost to Follow-up|70
2046098|NCT00467519|3617860|FG000|Overall Study|Protocol Violation|8
2046099|NCT00467519|3617861|FG001|Overall Study|Protocol Violation|4
2046100|NCT00467519|3617860|FG000|Overall Study|Lost to Follow-up|2
2046101|NCT00467519|3617861|FG001|Overall Study|Lost to Follow-up|9
2046102|NCT00467519|3617860|FG000|Overall Study|Withdrawal by Subject|4
2046103|NCT00467519|3617861|FG001|Overall Study|Withdrawal by Subject|10
2046104|NCT00467558|3617869|FG000|Overall Study|Lost to Follow-up|2
2046105|NCT00467558|3617870|FG001|Overall Study|Lost to Follow-up|0
2046106|NCT00467584|3617879|FG000|Overall Study|Withdrawal by Subject|4
2046107|NCT00467584|3617880|FG001|Overall Study|Withdrawal by Subject|5
2046108|NCT00467584|3617881|FG002|Overall Study|Withdrawal by Subject|1
2046109|NCT00467597|3617893|FG000|Overall Study|Withdrawal by Subject|2
2046110|NCT00467597|3617894|FG001|Overall Study|Withdrawal by Subject|0
2046111|NCT00467610|3617904|FG000|Overall Study|Withdrawal by Subject|1
2046112|NCT00467649|3617910|FG000|Phase 1 (Randomized Population)|Adverse Event|2
2046113|NCT00467649|3617911|FG001|Phase 1 (Randomized Population)|Adverse Event|0
2046114|NCT00467649|3617912|FG002|Phase 1 (Randomized Population)|Adverse Event|0
2046115|NCT00467649|3617913|FG003|Phase 1 (Randomized Population)|Adverse Event|0
2046116|NCT00467649|3617914|FG004|Phase 1 (Randomized Population)|Adverse Event|0
2046117|NCT00467649|3617915|FG005|Phase 1 (Randomized Population)|Adverse Event|0
2046118|NCT00467649|3617910|FG000|Phase 1 (Randomized Population)|Investigator Decision|1
2046119|NCT00467649|3617911|FG001|Phase 1 (Randomized Population)|Investigator Decision|0
2046120|NCT00467649|3617912|FG002|Phase 1 (Randomized Population)|Investigator Decision|0
2046121|NCT00467649|3617913|FG003|Phase 1 (Randomized Population)|Investigator Decision|0
2046122|NCT00467649|3617914|FG004|Phase 1 (Randomized Population)|Investigator Decision|0
2046123|NCT00467649|3617915|FG005|Phase 1 (Randomized Population)|Investigator Decision|0
2046124|NCT00467649|3617910|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2
2046125|NCT00467649|3617911|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4
2046126|NCT00467649|3617912|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0
2046127|NCT00467649|3617913|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0
2046128|NCT00467649|3617914|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0
2046129|NCT00467649|3617915|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0
2046130|NCT00467649|3617910|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4
2046131|NCT00467649|3617911|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2
2046132|NCT00467649|3617912|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0
2046133|NCT00467649|3617913|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0
2046134|NCT00467649|3617914|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0
2046135|NCT00467649|3617915|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0
2046136|NCT00467649|3617910|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
2046137|NCT00467649|3617911|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
2046138|NCT00467649|3617912|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
2046139|NCT00467649|3617913|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
2046140|NCT00467649|3617914|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
2046141|NCT00467649|3617915|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
2046142|NCT00467649|3617910|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
2046143|NCT00467649|3617911|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
2046144|NCT00467649|3617912|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
2046145|NCT00467649|3617913|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
2046146|NCT00467649|3617914|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
2046147|NCT00467649|3617915|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
2046148|NCT00467649|3617910|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
2046149|NCT00467649|3617911|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
2046150|NCT00467649|3617912|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
2046151|NCT00467649|3617913|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
2046152|NCT00467649|3617914|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
2046153|NCT00467649|3617915|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
2046154|NCT00467740|3617938|FG000|Overall Study|Adverse Event|0
2046155|NCT00467740|3617939|FG001|Overall Study|Adverse Event|0
2046156|NCT00467740|3617940|FG002|Overall Study|Adverse Event|1
2046157|NCT00467740|3617941|FG003|Overall Study|Adverse Event|0
2046158|NCT00467740|3617942|FG004|Overall Study|Adverse Event|0
2046159|NCT00467740|3617938|FG000|Overall Study|Protocol Violation|0
2046160|NCT00467740|3617939|FG001|Overall Study|Protocol Violation|0
2046161|NCT00467740|3617940|FG002|Overall Study|Protocol Violation|1
2046162|NCT00467740|3617941|FG003|Overall Study|Protocol Violation|0
2046163|NCT00467740|3617942|FG004|Overall Study|Protocol Violation|0
2046164|NCT00467740|3617938|FG000|Overall Study|Lost to Follow-up|0
2046165|NCT00467740|3617939|FG001|Overall Study|Lost to Follow-up|1
2046166|NCT00467740|3617940|FG002|Overall Study|Lost to Follow-up|0
2046167|NCT00467740|3617941|FG003|Overall Study|Lost to Follow-up|0
2046168|NCT00467740|3617942|FG004|Overall Study|Lost to Follow-up|0
2046169|NCT00467740|3617938|FG000|Overall Study|Withdrawal by Subject|1
2046170|NCT00467740|3617939|FG001|Overall Study|Withdrawal by Subject|1
2046171|NCT00467740|3617940|FG002|Overall Study|Withdrawal by Subject|0
2046172|NCT00467740|3617941|FG003|Overall Study|Withdrawal by Subject|1
2046173|NCT00467740|3617942|FG004|Overall Study|Withdrawal by Subject|0
2046174|NCT00467740|3617938|FG000|Overall Study|Lack of Efficacy|0
2046175|NCT00467740|3617939|FG001|Overall Study|Lack of Efficacy|1
2046176|NCT00467740|3617940|FG002|Overall Study|Lack of Efficacy|0
2046177|NCT00467740|3617941|FG003|Overall Study|Lack of Efficacy|0
2046178|NCT00467740|3617942|FG004|Overall Study|Lack of Efficacy|0
2046179|NCT00467779|3617969|FG000|Stage 1|Adverse Event|1
2046180|NCT00467779|3617970|FG001|Stage 1|Adverse Event|0
2046181|NCT00467779|3617971|FG002|Stage 1|Adverse Event|0
2046182|NCT00467779|3617972|FG003|Stage 1|Adverse Event|0
2046183|NCT00467779|3617973|FG004|Stage 1|Adverse Event|0
2046184|NCT00467779|3617974|FG005|Stage 1|Adverse Event|1
2046185|NCT00467779|3617975|FG006|Stage 1|Adverse Event|2
2046186|NCT00467779|3617976|FG007|Stage 1|Adverse Event|1
2046187|NCT00467779|3617977|FG008|Stage 1|Adverse Event|0
2046188|NCT00467779|3617978|FG009|Stage 1|Adverse Event|0
2046189|NCT00467779|3617979|FG010|Stage 1|Adverse Event|0
2046190|NCT00467779|3617980|FG011|Stage 1|Adverse Event|0
2046191|NCT00467779|3617981|FG012|Stage 1|Adverse Event|0
2046192|NCT00467779|3617982|FG013|Stage 1|Adverse Event|0
2046193|NCT00467779|3617983|FG014|Stage 1|Adverse Event|0
2046194|NCT00467779|3617969|FG000|Stage 1|Disease Progression|2
2046195|NCT00467779|3617970|FG001|Stage 1|Disease Progression|2
2046196|NCT00467779|3617971|FG002|Stage 1|Disease Progression|2
2046197|NCT00467779|3617972|FG003|Stage 1|Disease Progression|3
2046198|NCT00467779|3617973|FG004|Stage 1|Disease Progression|2
2046199|NCT00467779|3617974|FG005|Stage 1|Disease Progression|2
2046200|NCT00467779|3617975|FG006|Stage 1|Disease Progression|4
2046201|NCT00467779|3617976|FG007|Stage 1|Disease Progression|5
2046202|NCT00467779|3617977|FG008|Stage 1|Disease Progression|0
2046203|NCT00467779|3617978|FG009|Stage 1|Disease Progression|0
2046204|NCT00467779|3617979|FG010|Stage 1|Disease Progression|0
2046205|NCT00467779|3617980|FG011|Stage 1|Disease Progression|0
2046206|NCT00467779|3617981|FG012|Stage 1|Disease Progression|0
2046207|NCT00467779|3617982|FG013|Stage 1|Disease Progression|0
2046208|NCT00467779|3617983|FG014|Stage 1|Disease Progression|0
2046209|NCT00467779|3617969|FG000|Stage 1|Unspecified Reason|1
2046210|NCT00467779|3617970|FG001|Stage 1|Unspecified Reason|0
2046211|NCT00467779|3617971|FG002|Stage 1|Unspecified Reason|1
2046212|NCT00467779|3617972|FG003|Stage 1|Unspecified Reason|0
2046213|NCT00467779|3617973|FG004|Stage 1|Unspecified Reason|1
2046214|NCT00467779|3617974|FG005|Stage 1|Unspecified Reason|2
2046215|NCT00467779|3617975|FG006|Stage 1|Unspecified Reason|0
2046216|NCT00467779|3617976|FG007|Stage 1|Unspecified Reason|0
2046217|NCT00467779|3617977|FG008|Stage 1|Unspecified Reason|0
2046218|NCT00467779|3617978|FG009|Stage 1|Unspecified Reason|0
2046219|NCT00467779|3617979|FG010|Stage 1|Unspecified Reason|0
2046220|NCT00467779|3617980|FG011|Stage 1|Unspecified Reason|0
2046221|NCT00467779|3617981|FG012|Stage 1|Unspecified Reason|0
2046222|NCT00467779|3617982|FG013|Stage 1|Unspecified Reason|0
2046223|NCT00467779|3617983|FG014|Stage 1|Unspecified Reason|0
2046224|NCT00467779|3617969|FG000|Stage 1|Physician Decision|0
2046225|NCT00467779|3617970|FG001|Stage 1|Physician Decision|1
2046226|NCT00467779|3617971|FG002|Stage 1|Physician Decision|0
2046227|NCT00467779|3617972|FG003|Stage 1|Physician Decision|0
2046228|NCT00467779|3617973|FG004|Stage 1|Physician Decision|0
2046229|NCT00467779|3617974|FG005|Stage 1|Physician Decision|0
2046230|NCT00467779|3617975|FG006|Stage 1|Physician Decision|0
2046231|NCT00467779|3617976|FG007|Stage 1|Physician Decision|0
2046232|NCT00467779|3617977|FG008|Stage 1|Physician Decision|0
2046233|NCT00467779|3617978|FG009|Stage 1|Physician Decision|0
2046234|NCT00467779|3617979|FG010|Stage 1|Physician Decision|0
2046235|NCT00467779|3617980|FG011|Stage 1|Physician Decision|0
2046236|NCT00467779|3617981|FG012|Stage 1|Physician Decision|0
2046237|NCT00467779|3617982|FG013|Stage 1|Physician Decision|0
2046238|NCT00467779|3617983|FG014|Stage 1|Physician Decision|0
2046239|NCT00467779|3617969|FG000|Stage 1|Withdrawal by Subject|0
2046240|NCT00467779|3617970|FG001|Stage 1|Withdrawal by Subject|0
2046241|NCT00467779|3617971|FG002|Stage 1|Withdrawal by Subject|0
2046242|NCT00467779|3617972|FG003|Stage 1|Withdrawal by Subject|0
2046243|NCT00467779|3617973|FG004|Stage 1|Withdrawal by Subject|0
2046244|NCT00467779|3617974|FG005|Stage 1|Withdrawal by Subject|0
2046245|NCT00467779|3617975|FG006|Stage 1|Withdrawal by Subject|1
2046246|NCT00467779|3617976|FG007|Stage 1|Withdrawal by Subject|1
2046247|NCT00467779|3617977|FG008|Stage 1|Withdrawal by Subject|0
2046248|NCT00467779|3617978|FG009|Stage 1|Withdrawal by Subject|0
2046249|NCT00467779|3617979|FG010|Stage 1|Withdrawal by Subject|0
2046250|NCT00467779|3617980|FG011|Stage 1|Withdrawal by Subject|0
2046251|NCT00467779|3617981|FG012|Stage 1|Withdrawal by Subject|0
2046252|NCT00467779|3617982|FG013|Stage 1|Withdrawal by Subject|0
2046253|NCT00467779|3617983|FG014|Stage 1|Withdrawal by Subject|0
2046254|NCT00467779|3617969|FG000|Stage 1A|Adverse Event|0
2046255|NCT00467779|3617970|FG001|Stage 1A|Adverse Event|0
2046256|NCT00467779|3617971|FG002|Stage 1A|Adverse Event|0
2046257|NCT00467779|3617972|FG003|Stage 1A|Adverse Event|0
2046258|NCT00467779|3617973|FG004|Stage 1A|Adverse Event|0
2046259|NCT00467779|3617974|FG005|Stage 1A|Adverse Event|0
2046260|NCT00467779|3617975|FG006|Stage 1A|Adverse Event|0
2046261|NCT00467779|3617976|FG007|Stage 1A|Adverse Event|0
2046262|NCT00467779|3617977|FG008|Stage 1A|Adverse Event|0
2046263|NCT00467779|3617978|FG009|Stage 1A|Adverse Event|0
2208725|NCT01641692|3848410|FG005|Treatment Period 1|Lack of Efficacy|0
2046264|NCT00467779|3617979|FG010|Stage 1A|Adverse Event|0
2046265|NCT00467779|3617980|FG011|Stage 1A|Adverse Event|0
2046266|NCT00467779|3617981|FG012|Stage 1A|Adverse Event|1
2046267|NCT00467779|3617982|FG013|Stage 1A|Adverse Event|0
2046268|NCT00467779|3617983|FG014|Stage 1A|Adverse Event|0
2046269|NCT00467779|3617969|FG000|Stage 1A|Death|0
2046270|NCT00467779|3617970|FG001|Stage 1A|Death|0
2046271|NCT00467779|3617971|FG002|Stage 1A|Death|0
2046272|NCT00467779|3617972|FG003|Stage 1A|Death|0
2046273|NCT00467779|3617973|FG004|Stage 1A|Death|0
2046274|NCT00467779|3617974|FG005|Stage 1A|Death|0
2046275|NCT00467779|3617975|FG006|Stage 1A|Death|0
2046276|NCT00467779|3617976|FG007|Stage 1A|Death|0
2046277|NCT00467779|3617977|FG008|Stage 1A|Death|0
2046278|NCT00467779|3617978|FG009|Stage 1A|Death|0
2046279|NCT00467779|3617979|FG010|Stage 1A|Death|0
2046280|NCT00467779|3617980|FG011|Stage 1A|Death|1
2046281|NCT00467779|3617981|FG012|Stage 1A|Death|1
2046282|NCT00467779|3617982|FG013|Stage 1A|Death|0
2046283|NCT00467779|3617983|FG014|Stage 1A|Death|0
2046284|NCT00467779|3617969|FG000|Stage 1A|Disease Progression|0
2046285|NCT00467779|3617970|FG001|Stage 1A|Disease Progression|0
2046286|NCT00467779|3617971|FG002|Stage 1A|Disease Progression|0
2046287|NCT00467779|3617972|FG003|Stage 1A|Disease Progression|0
2046288|NCT00467779|3617973|FG004|Stage 1A|Disease Progression|0
2046289|NCT00467779|3617974|FG005|Stage 1A|Disease Progression|0
2046290|NCT00467779|3617975|FG006|Stage 1A|Disease Progression|0
2046291|NCT00467779|3617976|FG007|Stage 1A|Disease Progression|0
2046292|NCT00467779|3617977|FG008|Stage 1A|Disease Progression|0
2046293|NCT00467779|3617978|FG009|Stage 1A|Disease Progression|2
2046294|NCT00467779|3617979|FG010|Stage 1A|Disease Progression|2
2046295|NCT00467779|3617980|FG011|Stage 1A|Disease Progression|5
2046296|NCT00467779|3617981|FG012|Stage 1A|Disease Progression|2
2046297|NCT00467779|3617982|FG013|Stage 1A|Disease Progression|0
2046298|NCT00467779|3617983|FG014|Stage 1A|Disease Progression|0
2046299|NCT00467779|3617969|FG000|Stage 1A|Physician Decision|0
2046300|NCT00467779|3617970|FG001|Stage 1A|Physician Decision|0
2046301|NCT00467779|3617971|FG002|Stage 1A|Physician Decision|0
2046302|NCT00467779|3617972|FG003|Stage 1A|Physician Decision|0
2046303|NCT00467779|3617973|FG004|Stage 1A|Physician Decision|0
2046304|NCT00467779|3617974|FG005|Stage 1A|Physician Decision|0
2046305|NCT00467779|3617975|FG006|Stage 1A|Physician Decision|0
2046306|NCT00467779|3617976|FG007|Stage 1A|Physician Decision|0
2046307|NCT00467779|3617977|FG008|Stage 1A|Physician Decision|0
2046308|NCT00467779|3617978|FG009|Stage 1A|Physician Decision|1
2046309|NCT00467779|3617979|FG010|Stage 1A|Physician Decision|0
2046310|NCT00467779|3617980|FG011|Stage 1A|Physician Decision|0
2046311|NCT00467779|3617981|FG012|Stage 1A|Physician Decision|0
2046312|NCT00467779|3617982|FG013|Stage 1A|Physician Decision|0
2046313|NCT00467779|3617983|FG014|Stage 1A|Physician Decision|0
2046314|NCT00467779|3617969|FG000|Stage 1A|Withdrawal by Subject|0
2046315|NCT00467779|3617970|FG001|Stage 1A|Withdrawal by Subject|0
2046316|NCT00467779|3617971|FG002|Stage 1A|Withdrawal by Subject|0
2046317|NCT00467779|3617972|FG003|Stage 1A|Withdrawal by Subject|0
2046318|NCT00467779|3617973|FG004|Stage 1A|Withdrawal by Subject|0
2046319|NCT00467779|3617974|FG005|Stage 1A|Withdrawal by Subject|0
2046320|NCT00467779|3617975|FG006|Stage 1A|Withdrawal by Subject|0
2046321|NCT00467779|3617976|FG007|Stage 1A|Withdrawal by Subject|0
2046322|NCT00467779|3617977|FG008|Stage 1A|Withdrawal by Subject|0
2046323|NCT00467779|3617978|FG009|Stage 1A|Withdrawal by Subject|0
2046324|NCT00467779|3617979|FG010|Stage 1A|Withdrawal by Subject|1
2046325|NCT00467779|3617980|FG011|Stage 1A|Withdrawal by Subject|1
2046326|NCT00467779|3617981|FG012|Stage 1A|Withdrawal by Subject|1
2046327|NCT00467779|3617982|FG013|Stage 1A|Withdrawal by Subject|0
2046328|NCT00467779|3617983|FG014|Stage 1A|Withdrawal by Subject|0
2046329|NCT00467779|3617969|FG000|Stage 1A|Unspecified Reason|0
2046330|NCT00467779|3617970|FG001|Stage 1A|Unspecified Reason|0
2046331|NCT00467779|3617971|FG002|Stage 1A|Unspecified Reason|0
2046332|NCT00467779|3617972|FG003|Stage 1A|Unspecified Reason|0
2046333|NCT00467779|3617973|FG004|Stage 1A|Unspecified Reason|0
2046334|NCT00467779|3617974|FG005|Stage 1A|Unspecified Reason|0
2046335|NCT00467779|3617975|FG006|Stage 1A|Unspecified Reason|0
2046336|NCT00467779|3617976|FG007|Stage 1A|Unspecified Reason|0
2046337|NCT00467779|3617977|FG008|Stage 1A|Unspecified Reason|0
2046338|NCT00467779|3617978|FG009|Stage 1A|Unspecified Reason|0
2046339|NCT00467779|3617979|FG010|Stage 1A|Unspecified Reason|0
2046340|NCT00467779|3617980|FG011|Stage 1A|Unspecified Reason|1
2046341|NCT00467779|3617981|FG012|Stage 1A|Unspecified Reason|1
2046342|NCT00467779|3617982|FG013|Stage 1A|Unspecified Reason|0
2046343|NCT00467779|3617983|FG014|Stage 1A|Unspecified Reason|0
2046344|NCT00467779|3617969|FG000|Stage 2|Adverse Event|0
2046345|NCT00467779|3617970|FG001|Stage 2|Adverse Event|0
2046346|NCT00467779|3617971|FG002|Stage 2|Adverse Event|0
2046347|NCT00467779|3617972|FG003|Stage 2|Adverse Event|0
2046348|NCT00467779|3617973|FG004|Stage 2|Adverse Event|0
2046349|NCT00467779|3617974|FG005|Stage 2|Adverse Event|0
2046350|NCT00467779|3617975|FG006|Stage 2|Adverse Event|0
2046351|NCT00467779|3617976|FG007|Stage 2|Adverse Event|0
2046352|NCT00467779|3617977|FG008|Stage 2|Adverse Event|1
2046353|NCT00467779|3617978|FG009|Stage 2|Adverse Event|0
2046354|NCT00467779|3617979|FG010|Stage 2|Adverse Event|0
2046355|NCT00467779|3617980|FG011|Stage 2|Adverse Event|0
2046356|NCT00467779|3617981|FG012|Stage 2|Adverse Event|0
2046357|NCT00467779|3617982|FG013|Stage 2|Adverse Event|0
2046358|NCT00467779|3617983|FG014|Stage 2|Adverse Event|0
2046359|NCT00467779|3617969|FG000|Stage 2|Death|0
2046360|NCT00467779|3617970|FG001|Stage 2|Death|0
2046361|NCT00467779|3617971|FG002|Stage 2|Death|0
2046362|NCT00467779|3617972|FG003|Stage 2|Death|0
2046363|NCT00467779|3617973|FG004|Stage 2|Death|0
2046364|NCT00467779|3617974|FG005|Stage 2|Death|0
2046365|NCT00467779|3617975|FG006|Stage 2|Death|0
2046366|NCT00467779|3617976|FG007|Stage 2|Death|0
2046367|NCT00467779|3617977|FG008|Stage 2|Death|1
2046368|NCT00467779|3617978|FG009|Stage 2|Death|0
2046369|NCT00467779|3617979|FG010|Stage 2|Death|0
2046370|NCT00467779|3617980|FG011|Stage 2|Death|0
2046371|NCT00467779|3617981|FG012|Stage 2|Death|0
2046372|NCT00467779|3617982|FG013|Stage 2|Death|0
2046373|NCT00467779|3617983|FG014|Stage 2|Death|0
2046374|NCT00467779|3617969|FG000|Stage 2|Disease Progression|0
2046375|NCT00467779|3617970|FG001|Stage 2|Disease Progression|0
2046376|NCT00467779|3617971|FG002|Stage 2|Disease Progression|0
2046377|NCT00467779|3617972|FG003|Stage 2|Disease Progression|0
2046378|NCT00467779|3617973|FG004|Stage 2|Disease Progression|0
2046379|NCT00467779|3617974|FG005|Stage 2|Disease Progression|0
2046380|NCT00467779|3617975|FG006|Stage 2|Disease Progression|0
2046381|NCT00467779|3617976|FG007|Stage 2|Disease Progression|0
2046382|NCT00467779|3617977|FG008|Stage 2|Disease Progression|16
2046383|NCT00467779|3617978|FG009|Stage 2|Disease Progression|0
2046384|NCT00467779|3617979|FG010|Stage 2|Disease Progression|0
2046385|NCT00467779|3617980|FG011|Stage 2|Disease Progression|0
2046386|NCT00467779|3617981|FG012|Stage 2|Disease Progression|0
2046387|NCT00467779|3617982|FG013|Stage 2|Disease Progression|0
2046388|NCT00467779|3617983|FG014|Stage 2|Disease Progression|0
2046389|NCT00467779|3617969|FG000|Stage 2|Unspecified Reason|0
2046390|NCT00467779|3617970|FG001|Stage 2|Unspecified Reason|0
2046391|NCT00467779|3617971|FG002|Stage 2|Unspecified Reason|0
2046392|NCT00467779|3617972|FG003|Stage 2|Unspecified Reason|0
2046393|NCT00467779|3617973|FG004|Stage 2|Unspecified Reason|0
2046394|NCT00467779|3617974|FG005|Stage 2|Unspecified Reason|0
2046395|NCT00467779|3617975|FG006|Stage 2|Unspecified Reason|0
2046396|NCT00467779|3617976|FG007|Stage 2|Unspecified Reason|0
2046397|NCT00467779|3617977|FG008|Stage 2|Unspecified Reason|3
2046398|NCT00467779|3617978|FG009|Stage 2|Unspecified Reason|0
2046399|NCT00467779|3617979|FG010|Stage 2|Unspecified Reason|0
2046400|NCT00467779|3617980|FG011|Stage 2|Unspecified Reason|0
2046401|NCT00467779|3617981|FG012|Stage 2|Unspecified Reason|0
2046402|NCT00467779|3617982|FG013|Stage 2|Unspecified Reason|0
2046403|NCT00467779|3617983|FG014|Stage 2|Unspecified Reason|0
2046404|NCT00467779|3617969|FG000|Stage 2A|Adverse Event|0
2046405|NCT00467779|3617970|FG001|Stage 2A|Adverse Event|0
2046406|NCT00467779|3617971|FG002|Stage 2A|Adverse Event|0
2046407|NCT00467779|3617972|FG003|Stage 2A|Adverse Event|0
2046408|NCT00467779|3617973|FG004|Stage 2A|Adverse Event|0
2046409|NCT00467779|3617974|FG005|Stage 2A|Adverse Event|0
2046410|NCT00467779|3617975|FG006|Stage 2A|Adverse Event|0
2046411|NCT00467779|3617976|FG007|Stage 2A|Adverse Event|0
2046412|NCT00467779|3617977|FG008|Stage 2A|Adverse Event|0
2046413|NCT00467779|3617978|FG009|Stage 2A|Adverse Event|0
2046414|NCT00467779|3617979|FG010|Stage 2A|Adverse Event|0
2046415|NCT00467779|3617980|FG011|Stage 2A|Adverse Event|0
2046416|NCT00467779|3617981|FG012|Stage 2A|Adverse Event|0
2046417|NCT00467779|3617982|FG013|Stage 2A|Adverse Event|2
2046418|NCT00467779|3617983|FG014|Stage 2A|Adverse Event|0
2046419|NCT00467779|3617969|FG000|Stage 2A|Death|0
2046420|NCT00467779|3617970|FG001|Stage 2A|Death|0
2046421|NCT00467779|3617971|FG002|Stage 2A|Death|0
2046422|NCT00467779|3617972|FG003|Stage 2A|Death|0
2046423|NCT00467779|3617973|FG004|Stage 2A|Death|0
2046424|NCT00467779|3617974|FG005|Stage 2A|Death|0
2046425|NCT00467779|3617975|FG006|Stage 2A|Death|0
2046426|NCT00467779|3617976|FG007|Stage 2A|Death|0
2046427|NCT00467779|3617977|FG008|Stage 2A|Death|0
2046428|NCT00467779|3617978|FG009|Stage 2A|Death|0
2046429|NCT00467779|3617979|FG010|Stage 2A|Death|0
2046430|NCT00467779|3617980|FG011|Stage 2A|Death|0
2046431|NCT00467779|3617981|FG012|Stage 2A|Death|0
2046432|NCT00467779|3617982|FG013|Stage 2A|Death|1
2046433|NCT00467779|3617983|FG014|Stage 2A|Death|0
2046434|NCT00467779|3617969|FG000|Stage 2A|Disease Progression|0
2046435|NCT00467779|3617970|FG001|Stage 2A|Disease Progression|0
2046436|NCT00467779|3617971|FG002|Stage 2A|Disease Progression|0
2046437|NCT00467779|3617972|FG003|Stage 2A|Disease Progression|0
2046438|NCT00467779|3617973|FG004|Stage 2A|Disease Progression|0
2046439|NCT00467779|3617974|FG005|Stage 2A|Disease Progression|0
2046440|NCT00467779|3617975|FG006|Stage 2A|Disease Progression|0
2046441|NCT00467779|3617976|FG007|Stage 2A|Disease Progression|0
2046442|NCT00467779|3617977|FG008|Stage 2A|Disease Progression|0
2046443|NCT00467779|3617978|FG009|Stage 2A|Disease Progression|0
2046444|NCT00467779|3617979|FG010|Stage 2A|Disease Progression|0
2046445|NCT00467779|3617980|FG011|Stage 2A|Disease Progression|0
2046446|NCT00467779|3617981|FG012|Stage 2A|Disease Progression|0
2046447|NCT00467779|3617982|FG013|Stage 2A|Disease Progression|10
2046448|NCT00467779|3617983|FG014|Stage 2A|Disease Progression|0
2046449|NCT00467779|3617969|FG000|Stage 2A|Unspecified Reason|0
2046450|NCT00467779|3617970|FG001|Stage 2A|Unspecified Reason|0
2046451|NCT00467779|3617971|FG002|Stage 2A|Unspecified Reason|0
2046452|NCT00467779|3617972|FG003|Stage 2A|Unspecified Reason|0
2046453|NCT00467779|3617973|FG004|Stage 2A|Unspecified Reason|0
2046454|NCT00467779|3617974|FG005|Stage 2A|Unspecified Reason|0
2046455|NCT00467779|3617975|FG006|Stage 2A|Unspecified Reason|0
2046456|NCT00467779|3617976|FG007|Stage 2A|Unspecified Reason|0
2046457|NCT00467779|3617977|FG008|Stage 2A|Unspecified Reason|0
2046458|NCT00467779|3617978|FG009|Stage 2A|Unspecified Reason|0
2046459|NCT00467779|3617979|FG010|Stage 2A|Unspecified Reason|0
2046460|NCT00467779|3617980|FG011|Stage 2A|Unspecified Reason|0
2046461|NCT00467779|3617981|FG012|Stage 2A|Unspecified Reason|0
2046462|NCT00467779|3617982|FG013|Stage 2A|Unspecified Reason|7
2046463|NCT00467779|3617983|FG014|Stage 2A|Unspecified Reason|0
2046464|NCT00467779|3617969|FG000|Stage 2A|Withdrawal by Subject|0
2046465|NCT00467779|3617970|FG001|Stage 2A|Withdrawal by Subject|0
2046466|NCT00467779|3617971|FG002|Stage 2A|Withdrawal by Subject|0
2046467|NCT00467779|3617972|FG003|Stage 2A|Withdrawal by Subject|0
2046468|NCT00467779|3617973|FG004|Stage 2A|Withdrawal by Subject|0
2046469|NCT00467779|3617974|FG005|Stage 2A|Withdrawal by Subject|0
2046470|NCT00467779|3617975|FG006|Stage 2A|Withdrawal by Subject|0
2046471|NCT00467779|3617976|FG007|Stage 2A|Withdrawal by Subject|0
2299605|NCT02588261|3996822|FG000|Overall Study|Study Terminated by Sponsor|157
2299606|NCT02588261|3996823|FG001|Overall Study|Study Terminated by Sponsor|142
2299607|NCT02588261|3996822|FG000|Overall Study|Protocol Deviation|1
2299608|NCT02588261|3996823|FG001|Overall Study|Protocol Deviation|0
2299609|NCT02588261|3996822|FG000|Overall Study|Death|1
2299610|NCT02588261|3996823|FG001|Overall Study|Death|2
2299611|NCT02588261|3996822|FG000|Overall Study|Withdrawal by Subject|12
2299612|NCT02588261|3996823|FG001|Overall Study|Withdrawal by Subject|8
2299613|NCT02588261|3996822|FG000|Overall Study|Noncompliance with Study Drug|0
2299614|NCT02588261|3996823|FG001|Overall Study|Noncompliance with Study Drug|1
2299615|NCT02588261|3996822|FG000|Overall Study|Miscellaneous|5
2299616|NCT02588261|3996823|FG001|Overall Study|Miscellaneous|4
2299617|NCT02588261|3996822|FG000|Overall Study|Progressive Disease|61
2299618|NCT02588261|3996823|FG001|Overall Study|Progressive Disease|82
2299619|NCT02588261|3996822|FG000|Overall Study|Adverse Event|29
2299620|NCT02588261|3996823|FG001|Overall Study|Adverse Event|24
2299621|NCT02588261|3996822|FG000|Overall Study|Lost to Follow-up|1
2299622|NCT02588261|3996823|FG001|Overall Study|Lost to Follow-up|0
2299623|NCT02588339|3996829|FG000|Overall Study|Withdrawal by Subject|1
2299624|NCT02588339|3996829|FG000|Overall Study|GVHD Progression prior to treatment|2
2321411|NCT02960438|4036024|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
2321412|NCT02960438|4036025|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
2321413|NCT02960438|4036022|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0
2321414|NCT02960438|4036023|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0
2321415|NCT02960438|4036024|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1
2321416|NCT02960438|4036025|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0
2321417|NCT02960438|4036022|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2
2321418|NCT02960438|4036023|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
2321419|NCT02960438|4036024|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0
2321420|NCT02960438|4036025|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
2321421|NCT02960438|4036022|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
2321422|NCT02960438|4036023|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2
2321423|NCT02960438|4036024|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4
2321424|NCT02960438|4036025|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
2321425|NCT02960438|4036022|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
2321426|NCT02960438|4036023|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
2321427|NCT02960438|4036024|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1
2321428|NCT02960438|4036025|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
2321429|NCT02960438|4036022|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
2321430|NCT02960438|4036023|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
2321431|NCT02960438|4036024|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0
2321432|NCT02960438|4036025|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
2321433|NCT02960438|4036022|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
2321434|NCT02960438|4036023|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5
2321435|NCT02960438|4036024|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
2321436|NCT02960438|4036025|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6
2321437|NCT02960438|4036022|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
2321438|NCT02960438|4036023|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
2321439|NCT02960438|4036024|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
2321440|NCT02960438|4036025|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
2321441|NCT02960438|4036022|FG000|Extension Phase (Open-label): 80 Weeks|Other|0
2321442|NCT02960438|4036023|FG001|Extension Phase (Open-label): 80 Weeks|Other|0
2321443|NCT02960438|4036024|FG002|Extension Phase (Open-label): 80 Weeks|Other|1
2321444|NCT02960438|4036025|FG003|Extension Phase (Open-label): 80 Weeks|Other|1
2321445|NCT02960490|4036045|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3
2321446|NCT02960490|4036046|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2
2321447|NCT02960490|4036047|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
2321448|NCT02960490|4036048|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
2321449|NCT02960490|4036049|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
2321450|NCT02960490|4036050|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
2321451|NCT02960490|4036051|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
2321452|NCT02960490|4036052|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
2321453|NCT02960490|4036053|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
2321454|NCT02960490|4036054|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
2321455|NCT02960490|4036045|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
2321456|NCT02960490|4036046|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1
2046472|NCT00467779|3617977|FG008|Stage 2A|Withdrawal by Subject|0
2046473|NCT00467779|3617978|FG009|Stage 2A|Withdrawal by Subject|0
2046474|NCT00467779|3617979|FG010|Stage 2A|Withdrawal by Subject|0
2046475|NCT00467779|3617980|FG011|Stage 2A|Withdrawal by Subject|0
2208726|NCT01641692|3848411|FG006|Treatment Period 1|Lack of Efficacy|0
2208727|NCT01641692|3848412|FG007|Treatment Period 1|Lack of Efficacy|1
2208728|NCT01641692|3848405|FG000|Treatment Period 1|Protocol Violation|1
2208729|NCT01641692|3848406|FG001|Treatment Period 1|Protocol Violation|0
2208730|NCT01641692|3848407|FG002|Treatment Period 1|Protocol Violation|0
2208731|NCT01641692|3848408|FG003|Treatment Period 1|Protocol Violation|0
2208732|NCT01641692|3848409|FG004|Treatment Period 1|Protocol Violation|2
2208733|NCT01641692|3848410|FG005|Treatment Period 1|Protocol Violation|0
2208734|NCT01641692|3848411|FG006|Treatment Period 1|Protocol Violation|0
2208735|NCT01641692|3848412|FG007|Treatment Period 1|Protocol Violation|0
2208736|NCT01641692|3848405|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0
2208737|NCT01641692|3848406|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0
2208738|NCT01641692|3848407|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0
2208739|NCT01641692|3848408|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0
2208740|NCT01641692|3848409|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1
2208741|NCT01641692|3848410|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0
2208742|NCT01641692|3848411|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0
2208743|NCT01641692|3848412|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1
2208744|NCT01641692|3848405|FG000|Treatment Period 1|Lost to Follow-up|0
2208745|NCT01641692|3848406|FG001|Treatment Period 1|Lost to Follow-up|0
2208746|NCT01641692|3848407|FG002|Treatment Period 1|Lost to Follow-up|1
2208747|NCT01641692|3848408|FG003|Treatment Period 1|Lost to Follow-up|0
2208748|NCT01641692|3848409|FG004|Treatment Period 1|Lost to Follow-up|0
2208749|NCT01641692|3848410|FG005|Treatment Period 1|Lost to Follow-up|0
2208750|NCT01641692|3848411|FG006|Treatment Period 1|Lost to Follow-up|0
2208751|NCT01641692|3848412|FG007|Treatment Period 1|Lost to Follow-up|0
2208752|NCT01641692|3848405|FG000|Treatment Period 1|Physician Decision|0
2208753|NCT01641692|3848406|FG001|Treatment Period 1|Physician Decision|0
2208754|NCT01641692|3848407|FG002|Treatment Period 1|Physician Decision|0
2208755|NCT01641692|3848408|FG003|Treatment Period 1|Physician Decision|0
2208756|NCT01641692|3848409|FG004|Treatment Period 1|Physician Decision|1
2046476|NCT00467779|3617981|FG012|Stage 2A|Withdrawal by Subject|0
2046477|NCT00467779|3617982|FG013|Stage 2A|Withdrawal by Subject|1
2046478|NCT00467779|3617983|FG014|Stage 2A|Withdrawal by Subject|0
2046479|NCT00467779|3617969|FG000|Stage 3|Adverse Event|0
2046480|NCT00467779|3617970|FG001|Stage 3|Adverse Event|0
2046481|NCT00467779|3617971|FG002|Stage 3|Adverse Event|0
2046482|NCT00467779|3617972|FG003|Stage 3|Adverse Event|0
2046483|NCT00467779|3617973|FG004|Stage 3|Adverse Event|0
2046484|NCT00467779|3617974|FG005|Stage 3|Adverse Event|0
2046485|NCT00467779|3617975|FG006|Stage 3|Adverse Event|0
2046486|NCT00467779|3617976|FG007|Stage 3|Adverse Event|0
2046487|NCT00467779|3617977|FG008|Stage 3|Adverse Event|0
2046488|NCT00467779|3617978|FG009|Stage 3|Adverse Event|0
2046489|NCT00467779|3617979|FG010|Stage 3|Adverse Event|0
2046490|NCT00467779|3617980|FG011|Stage 3|Adverse Event|0
2046491|NCT00467779|3617981|FG012|Stage 3|Adverse Event|0
2046492|NCT00467779|3617982|FG013|Stage 3|Adverse Event|0
2046493|NCT00467779|3617983|FG014|Stage 3|Adverse Event|2
2046494|NCT00467779|3617969|FG000|Stage 3|Death|0
2046495|NCT00467779|3617970|FG001|Stage 3|Death|0
2046496|NCT00467779|3617971|FG002|Stage 3|Death|0
2046497|NCT00467779|3617972|FG003|Stage 3|Death|0
2046498|NCT00467779|3617973|FG004|Stage 3|Death|0
2046499|NCT00467779|3617974|FG005|Stage 3|Death|0
2046500|NCT00467779|3617975|FG006|Stage 3|Death|0
2046501|NCT00467779|3617976|FG007|Stage 3|Death|0
2046502|NCT00467779|3617977|FG008|Stage 3|Death|0
2046503|NCT00467779|3617978|FG009|Stage 3|Death|0
2046504|NCT00467779|3617979|FG010|Stage 3|Death|0
2046505|NCT00467779|3617980|FG011|Stage 3|Death|0
2046506|NCT00467779|3617981|FG012|Stage 3|Death|0
2046507|NCT00467779|3617982|FG013|Stage 3|Death|0
2046508|NCT00467779|3617983|FG014|Stage 3|Death|1
2046509|NCT00467779|3617969|FG000|Stage 3|Disease Progression|0
2046510|NCT00467779|3617970|FG001|Stage 3|Disease Progression|0
2046511|NCT00467779|3617971|FG002|Stage 3|Disease Progression|0
2046512|NCT00467779|3617972|FG003|Stage 3|Disease Progression|0
2046513|NCT00467779|3617973|FG004|Stage 3|Disease Progression|0
2046514|NCT00467779|3617974|FG005|Stage 3|Disease Progression|0
2046515|NCT00467779|3617975|FG006|Stage 3|Disease Progression|0
2046516|NCT00467779|3617976|FG007|Stage 3|Disease Progression|0
2046517|NCT00467779|3617977|FG008|Stage 3|Disease Progression|0
2046518|NCT00467779|3617978|FG009|Stage 3|Disease Progression|0
2046519|NCT00467779|3617979|FG010|Stage 3|Disease Progression|0
2046520|NCT00467779|3617980|FG011|Stage 3|Disease Progression|0
2046521|NCT00467779|3617981|FG012|Stage 3|Disease Progression|0
2046522|NCT00467779|3617982|FG013|Stage 3|Disease Progression|0
2046523|NCT00467779|3617983|FG014|Stage 3|Disease Progression|9
2046524|NCT00467779|3617969|FG000|Stage 3|Unspecified Reason|0
2046525|NCT00467779|3617970|FG001|Stage 3|Unspecified Reason|0
2046526|NCT00467779|3617971|FG002|Stage 3|Unspecified Reason|0
2046527|NCT00467779|3617972|FG003|Stage 3|Unspecified Reason|0
2046528|NCT00467779|3617973|FG004|Stage 3|Unspecified Reason|0
2046529|NCT00467779|3617974|FG005|Stage 3|Unspecified Reason|0
2046530|NCT00467779|3617975|FG006|Stage 3|Unspecified Reason|0
2046531|NCT00467779|3617976|FG007|Stage 3|Unspecified Reason|0
2046532|NCT00467779|3617977|FG008|Stage 3|Unspecified Reason|0
2046533|NCT00467779|3617978|FG009|Stage 3|Unspecified Reason|0
2046534|NCT00467779|3617979|FG010|Stage 3|Unspecified Reason|0
2046535|NCT00467779|3617980|FG011|Stage 3|Unspecified Reason|0
2046536|NCT00467779|3617981|FG012|Stage 3|Unspecified Reason|0
2046537|NCT00467779|3617982|FG013|Stage 3|Unspecified Reason|0
2046538|NCT00467779|3617983|FG014|Stage 3|Unspecified Reason|5
2046539|NCT00467818|3618023|FG000|Overall Study|Adverse Event|1
2046540|NCT00467818|3618024|FG001|Overall Study|Adverse Event|0
2046541|NCT00467818|3618023|FG000|Overall Study|Lost to Follow-up|2
2046542|NCT00467818|3618024|FG001|Overall Study|Lost to Follow-up|2
2046543|NCT00467831|3618032|FG000|Overall Study|Death|2
2046544|NCT00467831|3618032|FG000|Overall Study|Withdrawal by Subject|1
2046545|NCT00467857|3618054|FG000|Overall Study|Adverse Event|1
2046546|NCT00467857|3618055|FG001|Overall Study|Adverse Event|0
2046547|NCT00467857|3618054|FG000|Overall Study|Withdrew consent|2
2046548|NCT00467857|3618055|FG001|Overall Study|Withdrew consent|0
2046549|NCT00467857|3618054|FG000|Overall Study|Death|0
2046550|NCT00467857|3618055|FG001|Overall Study|Death|1
2046551|NCT00467857|3618054|FG000|Overall Study|Discharged from court service|0
2046552|NCT00467857|3618055|FG001|Overall Study|Discharged from court service|1
2046553|NCT00467857|3618054|FG000|Overall Study|Emergency care required|0
2046554|NCT00467857|3618055|FG001|Overall Study|Emergency care required|1
2046555|NCT00467857|3618054|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0
2046556|NCT00467857|3618055|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2
2046557|NCT00467857|3618054|FG000|Overall Study|Discontinuation reason missing|0
2046558|NCT00467857|3618055|FG001|Overall Study|Discontinuation reason missing|3
2105129|NCT00855465|3697607|FG001|Follow-up Period (FUP)|Missing|0
2105130|NCT00855582|3697616|FG000|Overall Study|Adverse Event|2
2105131|NCT00855582|3697617|FG001|Overall Study|Adverse Event|6
2105132|NCT00855582|3697618|FG002|Overall Study|Adverse Event|3
2105133|NCT00855582|3697616|FG000|Overall Study|Death|1
2105134|NCT00855582|3697617|FG001|Overall Study|Death|0
2105135|NCT00855582|3697618|FG002|Overall Study|Death|0
2105136|NCT00855582|3697616|FG000|Overall Study|Lack of Efficacy|1
2105137|NCT00855582|3697617|FG001|Overall Study|Lack of Efficacy|3
2105138|NCT00855582|3697618|FG002|Overall Study|Lack of Efficacy|8
2105139|NCT00855582|3697616|FG000|Overall Study|Lost to Follow-up|1
2105140|NCT00855582|3697617|FG001|Overall Study|Lost to Follow-up|3
2105141|NCT00855582|3697618|FG002|Overall Study|Lost to Follow-up|1
2105142|NCT00855582|3697616|FG000|Overall Study|Physician Decision|0
2105143|NCT00855582|3697617|FG001|Overall Study|Physician Decision|0
2105144|NCT00855582|3697618|FG002|Overall Study|Physician Decision|1
2105145|NCT00855582|3697616|FG000|Overall Study|Protocol Violation|6
2105146|NCT00855582|3697617|FG001|Overall Study|Protocol Violation|2
2105147|NCT00855582|3697618|FG002|Overall Study|Protocol Violation|6
2105148|NCT00855582|3697616|FG000|Overall Study|Entry Criteria Not Met|8
2105149|NCT00855582|3697617|FG001|Overall Study|Entry Criteria Not Met|6
2105150|NCT00855582|3697618|FG002|Overall Study|Entry Criteria Not Met|3
2105151|NCT00855582|3697616|FG000|Overall Study|Withdrawal by Subject|7
2105152|NCT00855582|3697617|FG001|Overall Study|Withdrawal by Subject|4
2105153|NCT00855582|3697618|FG002|Overall Study|Withdrawal by Subject|8
2105154|NCT00855595|3697631|FG000|Overall Study|Withdrawal by Subject|1
2105155|NCT00855595|3697632|FG001|Overall Study|Withdrawal by Subject|2
2105156|NCT00855595|3697631|FG000|Overall Study|Lost to Follow-up|3
2105157|NCT00855595|3697632|FG001|Overall Study|Lost to Follow-up|3
2105158|NCT00855595|3697631|FG000|Overall Study|Adverse Event|1
2105159|NCT00855595|3697632|FG001|Overall Study|Adverse Event|1
2105160|NCT00855595|3697631|FG000|Overall Study|patient moved out of state|1
2105161|NCT00855595|3697632|FG001|Overall Study|patient moved out of state|0
2105162|NCT00855595|3697631|FG000|Overall Study|patient left country|0
2105163|NCT00855595|3697632|FG001|Overall Study|patient left country|1
2105164|NCT00855738|3697638|FG000|Overall Study|Lost to Follow-up|2
2105165|NCT00855738|3697638|FG000|Overall Study|Adverse Event|1
2105166|NCT00855738|3697638|FG000|Overall Study|Subject Defaulted|1
2105167|NCT00855738|3697638|FG000|Overall Study|Death|1
2105168|NCT00855816|3697646|FG000|Overall Study|Withdrawal by Subject|22
2105169|NCT00855816|3697647|FG001|Overall Study|Withdrawal by Subject|15
2105170|NCT00855816|3697646|FG000|Overall Study|Lost to Follow-up|3
2105171|NCT00855816|3697647|FG001|Overall Study|Lost to Follow-up|5
2105172|NCT00855816|3697646|FG000|Overall Study|Death|1
2105173|NCT00855816|3697647|FG001|Overall Study|Death|0
2105174|NCT00855816|3697646|FG000|Overall Study|Became ineligible|0
2105175|NCT00855816|3697647|FG001|Overall Study|Became ineligible|1
2105176|NCT00855894|3697666|FG000|Overall Study|Death|31
2105177|NCT00855894|3697666|FG000|Overall Study|Patient's decision|1
2105178|NCT00855894|3697666|FG000|Overall Study|Disease progression|1
2105179|NCT00855920|3697673|FG000|Overall Study|Protocol Violation|0
2105180|NCT00855920|3697674|FG001|Overall Study|Protocol Violation|0
2105181|NCT00855920|3697675|FG002|Overall Study|Protocol Violation|2
2105182|NCT00855920|3697673|FG000|Overall Study|Adverse Event|2
2105183|NCT00855920|3697674|FG001|Overall Study|Adverse Event|1
2105184|NCT00855920|3697675|FG002|Overall Study|Adverse Event|1
2105185|NCT00855920|3697673|FG000|Overall Study|Lack of Efficacy|2
2105186|NCT00855920|3697674|FG001|Overall Study|Lack of Efficacy|2
2105187|NCT00855920|3697675|FG002|Overall Study|Lack of Efficacy|2
2105188|NCT00855920|3697673|FG000|Overall Study|Withdrawal by Subject|2
2105189|NCT00855920|3697674|FG001|Overall Study|Withdrawal by Subject|3
2105190|NCT00855920|3697675|FG002|Overall Study|Withdrawal by Subject|2
2105191|NCT00855920|3697673|FG000|Overall Study|Lost to Follow-up|1
2105192|NCT00855920|3697674|FG001|Overall Study|Lost to Follow-up|0
2046559|NCT00467870|3618067|FG000|Overall Study|Adverse Event|13
2046560|NCT00467870|3618068|FG001|Overall Study|Adverse Event|9
2046561|NCT00467870|3618069|FG002|Overall Study|Adverse Event|1
2046562|NCT00467870|3618070|FG003|Overall Study|Adverse Event|15
2046563|NCT00467870|3618071|FG004|Overall Study|Adverse Event|15
2046564|NCT00467870|3618072|FG005|Overall Study|Adverse Event|1
2046565|NCT00467870|3618067|FG000|Overall Study|Protocol Violation|2
2046566|NCT00467870|3618068|FG001|Overall Study|Protocol Violation|1
2046567|NCT00467870|3618069|FG002|Overall Study|Protocol Violation|1
2046568|NCT00467870|3618070|FG003|Overall Study|Protocol Violation|2
2046569|NCT00467870|3618071|FG004|Overall Study|Protocol Violation|0
2046570|NCT00467870|3618072|FG005|Overall Study|Protocol Violation|0
2046571|NCT00467870|3618067|FG000|Overall Study|Withdrawal by Subject|14
2046572|NCT00467870|3618068|FG001|Overall Study|Withdrawal by Subject|21
2046573|NCT00467870|3618069|FG002|Overall Study|Withdrawal by Subject|0
2046574|NCT00467870|3618070|FG003|Overall Study|Withdrawal by Subject|9
2046575|NCT00467870|3618071|FG004|Overall Study|Withdrawal by Subject|10
2208757|NCT01641692|3848410|FG005|Treatment Period 1|Physician Decision|0
2208758|NCT01641692|3848411|FG006|Treatment Period 1|Physician Decision|0
2208759|NCT01641692|3848412|FG007|Treatment Period 1|Physician Decision|0
2208760|NCT01641692|3848405|FG000|Treatment Period 1|Withdrawal by Subject|0
2046576|NCT00467870|3618072|FG005|Overall Study|Withdrawal by Subject|1
2046577|NCT00467870|3618067|FG000|Overall Study|Lost to Follow-up|5
2208761|NCT01641692|3848406|FG001|Treatment Period 1|Withdrawal by Subject|0
2046578|NCT00467870|3618068|FG001|Overall Study|Lost to Follow-up|3
2046579|NCT00467870|3618069|FG002|Overall Study|Lost to Follow-up|1
2046580|NCT00467870|3618070|FG003|Overall Study|Lost to Follow-up|1
2046581|NCT00467870|3618071|FG004|Overall Study|Lost to Follow-up|3
2046582|NCT00467870|3618072|FG005|Overall Study|Lost to Follow-up|0
2046583|NCT00467870|3618067|FG000|Overall Study|Subject Non-compliance|3
2046584|NCT00467870|3618068|FG001|Overall Study|Subject Non-compliance|4
2046585|NCT00467870|3618069|FG002|Overall Study|Subject Non-compliance|0
2046586|NCT00467870|3618070|FG003|Overall Study|Subject Non-compliance|1
2046587|NCT00467870|3618071|FG004|Overall Study|Subject Non-compliance|5
2046588|NCT00467870|3618072|FG005|Overall Study|Subject Non-compliance|0
2046589|NCT00467870|3618067|FG000|Overall Study|Other/Unknown|8
2046590|NCT00467870|3618068|FG001|Overall Study|Other/Unknown|5
2046591|NCT00467870|3618069|FG002|Overall Study|Other/Unknown|1
2046592|NCT00467870|3618070|FG003|Overall Study|Other/Unknown|5
2046593|NCT00467870|3618071|FG004|Overall Study|Other/Unknown|4
2046594|NCT00467870|3618072|FG005|Overall Study|Other/Unknown|0
2046595|NCT00467896|3618082|FG000|Overall Study|Consent Withdrawal|18
2046596|NCT00467896|3618082|FG000|Overall Study|Adverse Event|7
2046597|NCT00467896|3618082|FG000|Overall Study|Serious Adverse Event|13
2046598|NCT00467896|3618082|FG000|Overall Study|Non-compliance|3
2046599|NCT00467896|3618082|FG000|Overall Study|Changed therapy|2
2046600|NCT00467896|3618082|FG000|Overall Study|Patient received transplant|2
2046601|NCT00467896|3618082|FG000|Overall Study|Patient had atrial septostomy|1
2046602|NCT00467896|3618082|FG000|Overall Study|Patient weaned off iloprost|1
2046603|NCT00467896|3618082|FG000|Overall Study|Mainly used Prodose not I-neb® device|1
2046604|NCT00467896|3618082|FG000|Overall Study|Started intravenous prostacyclin|1
2046605|NCT00467896|3618082|FG000|Overall Study|Started inhaled Remodulin|1
2046606|NCT00467896|3618082|FG000|Overall Study|Patient had no improvement|1
2046607|NCT00467961|3618088|FG000|Overall Study|Technical Failures|5
2046608|NCT00467961|3618088|FG000|Overall Study|Disease Progression|2
2046609|NCT00468052|3618094|FG000|Overall Study|Protocol Violation|7
2046610|NCT00468052|3618095|FG001|Overall Study|Protocol Violation|8
2046611|NCT00468104|3618103|FG000|First Intervention|Protocol Violation|2
2046612|NCT00468104|3618104|FG001|First Intervention|Protocol Violation|1
2046613|NCT00468104|3618103|FG000|First Intervention|bleeding at chest tube site--first dose|1
2046614|NCT00468104|3618104|FG001|First Intervention|bleeding at chest tube site--first dose|0
2046615|NCT00468104|3618103|FG000|First Intervention|died within 3 weeks|1
2046616|NCT00468104|3618104|FG001|First Intervention|died within 3 weeks|0
2046617|NCT00468104|3618103|FG000|First Intervention|malposition/blocked chest tube tube|2
2046618|NCT00468104|3618104|FG001|First Intervention|malposition/blocked chest tube tube|0
2046619|NCT00468104|3618103|FG000|First Intervention|large lung mass with minimal effusion|1
2046620|NCT00468104|3618104|FG001|First Intervention|large lung mass with minimal effusion|0
2046621|NCT00468104|3618103|FG000|First Intervention|associated prolonged pneumothorax|1
2046622|NCT00468104|3618104|FG001|First Intervention|associated prolonged pneumothorax|0
2046623|NCT00468104|3618103|FG000|First Intervention|trapped lung|1
2046624|NCT00468104|3618104|FG001|First Intervention|trapped lung|0
2046625|NCT00468104|3618103|FG000|Second Intervention|Withdrawal by Subject|5
2046626|NCT00468104|3618104|FG001|Second Intervention|Withdrawal by Subject|2
2046627|NCT00468104|3618103|FG000|Second Intervention|discarded for malposition of chest tube|0
2046628|NCT00468104|3618104|FG001|Second Intervention|discarded for malposition of chest tube|2
2046629|NCT00468143|3618113|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3
2046630|NCT00468143|3618114|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4
2046631|NCT00468143|3618113|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3
2046632|NCT00468143|3618114|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3
2046633|NCT00468169|3618122|FG000|Overall Study|Withdrawal by Subject|1
2046634|NCT00468169|3618123|FG001|Overall Study|Withdrawal by Subject|0
2046635|NCT00468286|3618137|FG000|Overall Study|Adverse Event|1
2046636|NCT00468286|3618138|FG001|Overall Study|Adverse Event|6
2046637|NCT00468286|3618137|FG000|Overall Study|Protocol Violation|2
2046638|NCT00468286|3618138|FG001|Overall Study|Protocol Violation|2
2046639|NCT00468286|3618137|FG000|Overall Study|Withdrawal by Subject|4
2046640|NCT00468286|3618138|FG001|Overall Study|Withdrawal by Subject|3
2046641|NCT00468286|3618137|FG000|Overall Study|Physician Decision|0
2046642|NCT00468286|3618138|FG001|Overall Study|Physician Decision|1
2046643|NCT00468299|3618146|FG000|Overall Study|Withdrawal by Subject|0
2046644|NCT00468299|3618147|FG001|Overall Study|Withdrawal by Subject|1
2046645|NCT00468481|3618157|FG000|Overall Study|Adverse Event|13
2046646|NCT00468481|3618158|FG001|Overall Study|Adverse Event|3
2046647|NCT00468481|3618157|FG000|Overall Study|Lost to Follow-up|25
2046648|NCT00468481|3618158|FG001|Overall Study|Lost to Follow-up|8
2046649|NCT00468481|3618157|FG000|Overall Study|Pregnancy|2
2046650|NCT00468481|3618158|FG001|Overall Study|Pregnancy|0
2046651|NCT00468481|3618157|FG000|Overall Study|Protocol Violation|18
2046652|NCT00468481|3618158|FG001|Overall Study|Protocol Violation|8
2046653|NCT00468481|3618157|FG000|Overall Study|Withdrawal by Subject|12
2046654|NCT00468481|3618158|FG001|Overall Study|Withdrawal by Subject|3
2046655|NCT00468481|3618157|FG000|Overall Study|susp/diag malignant/premalignant disease|1
2046656|NCT00468481|3618158|FG001|Overall Study|susp/diag malignant/premalignant disease|0
2046657|NCT00468481|3618157|FG000|Overall Study|Prohibited Medication|1
2046658|NCT00468481|3618158|FG001|Overall Study|Prohibited Medication|1
2046659|NCT00468481|3618157|FG000|Overall Study|Egg Donor|1
2046660|NCT00468481|3618158|FG001|Overall Study|Egg Donor|0
2046661|NCT00468481|3618157|FG000|Overall Study|Moved out of area|4
2046662|NCT00468481|3618158|FG001|Overall Study|Moved out of area|1
2046663|NCT00468481|3618157|FG000|Overall Study|Non-Compliance|5
2046664|NCT00468481|3618158|FG001|Overall Study|Non-Compliance|0
2046665|NCT00468481|3618157|FG000|Overall Study|Other|6
2046666|NCT00468481|3618158|FG001|Overall Study|Other|0
2046667|NCT00468546|3618166|FG000|Week 24 Analysis|Lack of Efficacy|83
2046668|NCT00468546|3618167|FG001|Week 24 Analysis|Lack of Efficacy|37
2046669|NCT00468546|3618166|FG000|Week 24 Analysis|Refused treatment|5
2046670|NCT00468546|3618167|FG001|Week 24 Analysis|Refused treatment|5
2046671|NCT00468546|3618166|FG000|Week 24 Analysis|Adverse Event|1
2046672|NCT00468546|3618167|FG001|Week 24 Analysis|Adverse Event|8
2046673|NCT00468546|3618166|FG000|Week 24 Analysis|Failure to return|3
2046674|NCT00468546|3618167|FG001|Week 24 Analysis|Failure to return|4
2046675|NCT00468546|3618166|FG000|Week 24 Analysis|Rescue therapy|2
2046676|NCT00468546|3618167|FG001|Week 24 Analysis|Rescue therapy|0
2046677|NCT00468546|3618166|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0
2046678|NCT00468546|3618167|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1
2046679|NCT00468546|3618166|FG000|Week 24 Analysis|Due to clinical hold|1
2046680|NCT00468546|3618167|FG001|Week 24 Analysis|Due to clinical hold|0
2046681|NCT00468546|3618166|FG000|Week 24 Analysis|Went onto rescue therapy|1
2046682|NCT00468546|3618167|FG001|Week 24 Analysis|Went onto rescue therapy|0
2046683|NCT00468546|3618166|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1
2046684|NCT00468546|3618167|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0
2046685|NCT00468546|3618166|FG000|Week 24 to Week 104 Analysis|Adverse Event|2
2046686|NCT00468546|3618167|FG001|Week 24 to Week 104 Analysis|Adverse Event|5
2046687|NCT00468546|3618166|FG000|Week 24 to Week 104 Analysis|Death|1
2046688|NCT00468546|3618167|FG001|Week 24 to Week 104 Analysis|Death|0
2046689|NCT00468546|3618166|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3
2046690|NCT00468546|3618167|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12
2046691|NCT00468546|3618166|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0
2046692|NCT00468546|3618167|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2
2046693|NCT00468546|3618166|FG000|Week 24 to Week 104 Analysis|Refused treatment|4
2046694|NCT00468546|3618167|FG001|Week 24 to Week 104 Analysis|Refused treatment|7
2046695|NCT00468546|3618166|FG000|Week 24 to Week 104 Analysis|Failure to return|1
2046696|NCT00468546|3618167|FG001|Week 24 to Week 104 Analysis|Failure to return|2
2046697|NCT00468546|3618166|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
2046698|NCT00468546|3618167|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
2046699|NCT00468546|3618166|FG000|Week 24 to Week 104 Analysis|Other|17
2046700|NCT00468546|3618167|FG001|Week 24 to Week 104 Analysis|Other|14
2046701|NCT00468559|3618175|FG000|Open-label Treatment Phase|Adverse Event|5
2046702|NCT00468559|3618176|FG001|Open-label Treatment Phase|Adverse Event|0
2046703|NCT00468559|3618177|FG002|Open-label Treatment Phase|Adverse Event|0
2046704|NCT00468559|3618175|FG000|Open-label Treatment Phase|Lack of Efficacy|9
2046705|NCT00468559|3618176|FG001|Open-label Treatment Phase|Lack of Efficacy|0
2046706|NCT00468559|3618177|FG002|Open-label Treatment Phase|Lack of Efficacy|0
2046707|NCT00468559|3618175|FG000|Open-label Treatment Phase|Withdrawal by Subject|4
2046708|NCT00468559|3618176|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
2046709|NCT00468559|3618177|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
2046710|NCT00468559|3618175|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
2046711|NCT00468559|3618176|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
2046712|NCT00468559|3618177|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
2046713|NCT00468559|3618175|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
2046714|NCT00468559|3618176|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
2046715|NCT00468559|3618177|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
2046716|NCT00468585|3618189|FG000|Overall Study|Patient not treated|1
2046717|NCT00468585|3618190|FG001|Overall Study|Patient not treated|0
2046718|NCT00468585|3618191|FG002|Overall Study|Patient not treated|1
2046719|NCT00468585|3618192|FG003|Overall Study|Patient not treated|0
2046720|NCT00468585|3618189|FG000|Overall Study|Patient found to be ineligible|0
2046721|NCT00468585|3618190|FG001|Overall Study|Patient found to be ineligible|0
2046722|NCT00468585|3618191|FG002|Overall Study|Patient found to be ineligible|1
2046723|NCT00468585|3618192|FG003|Overall Study|Patient found to be ineligible|0
2046724|NCT00468585|3618189|FG000|Overall Study|Adverse Event|0
2046725|NCT00468585|3618190|FG001|Overall Study|Adverse Event|0
2046726|NCT00468585|3618191|FG002|Overall Study|Adverse Event|1
2046727|NCT00468585|3618192|FG003|Overall Study|Adverse Event|0
2046728|NCT00468585|3618189|FG000|Overall Study|Withdrawal by Subject|0
2046729|NCT00468585|3618190|FG001|Overall Study|Withdrawal by Subject|0
2046730|NCT00468585|3618191|FG002|Overall Study|Withdrawal by Subject|2
2046731|NCT00468585|3618192|FG003|Overall Study|Withdrawal by Subject|1
2046732|NCT00468650|3618202|FG000|Overall Study|Lost to Follow-up|4
2046733|NCT00468650|3618202|FG000|Overall Study|Withdrawal by Subject|2
2046734|NCT00468650|3618202|FG000|Overall Study|Protocol Violation|1
2046735|NCT00468676|3618209|FG000|Overall Study|Lost to Follow-up|14
2046736|NCT00468676|3618210|FG001|Overall Study|Lost to Follow-up|11
2046737|NCT00468676|3618209|FG000|Overall Study|Death|2
2046738|NCT00468676|3618210|FG001|Overall Study|Death|1
2046739|NCT00468728|3618220|FG000|Treatment|criteria for mITT population|4
2046740|NCT00468728|3618221|FG001|Treatment|criteria for mITT population|11
2046741|NCT00468728|3618220|FG000|Follow-up|mITT failure|34
2046742|NCT00468728|3618221|FG001|Follow-up|mITT failure|31
2046743|NCT00468819|3618232|FG000|Overall Study|Withdrawal by Subject|4
2046744|NCT00468819|3618233|FG001|Overall Study|Withdrawal by Subject|0
2046745|NCT00468819|3618234|FG002|Overall Study|Withdrawal by Subject|1
2046746|NCT00468819|3618232|FG000|Overall Study|Lost to Follow-up|0
2046747|NCT00468819|3618233|FG001|Overall Study|Lost to Follow-up|0
2046748|NCT00468819|3618234|FG002|Overall Study|Lost to Follow-up|1
2046749|NCT00468819|3618232|FG000|Overall Study|Drop-outs (Treatment never received)|2
2046750|NCT00468819|3618233|FG001|Overall Study|Drop-outs (Treatment never received)|0
2046751|NCT00468819|3618234|FG002|Overall Study|Drop-outs (Treatment never received)|0
2046752|NCT00468845|3618247|FG000|Overall Study|Adverse Event|9
2046753|NCT00468845|3618248|FG001|Overall Study|Adverse Event|14
2046754|NCT00468845|3618249|FG002|Overall Study|Adverse Event|11
2046755|NCT00468845|3618247|FG000|Overall Study|Lost to Follow-up|2
2046756|NCT00468845|3618248|FG001|Overall Study|Lost to Follow-up|1
2046757|NCT00468845|3618249|FG002|Overall Study|Lost to Follow-up|2
2046758|NCT00468845|3618247|FG000|Overall Study|Other|4
2046759|NCT00468845|3618248|FG001|Overall Study|Other|9
2046760|NCT00468845|3618249|FG002|Overall Study|Other|5
2046761|NCT00468845|3618247|FG000|Overall Study|No longer willing to participate|5
2046762|NCT00468845|3618248|FG001|Overall Study|No longer willing to participate|6
2046763|NCT00468845|3618249|FG002|Overall Study|No longer willing to participate|10
2046764|NCT00468845|3618247|FG000|Overall Study|Randomized, not treated|1
2046765|NCT00468845|3618248|FG001|Overall Study|Randomized, not treated|4
2046766|NCT00468845|3618249|FG002|Overall Study|Randomized, not treated|2
2046767|NCT00468858|3618260|FG000|Overall Study|Adverse Event|0
2046768|NCT00468858|3618261|FG001|Overall Study|Adverse Event|1
2046769|NCT00468858|3618262|FG002|Overall Study|Adverse Event|0
2046770|NCT00468858|3618260|FG000|Overall Study|Withdrawal by Subject|7
2046771|NCT00468858|3618261|FG001|Overall Study|Withdrawal by Subject|4
2046772|NCT00468858|3618262|FG002|Overall Study|Withdrawal by Subject|5
2046773|NCT00468858|3618260|FG000|Overall Study|Relocation|1
2046774|NCT00468858|3618261|FG001|Overall Study|Relocation|3
2046775|NCT00468858|3618262|FG002|Overall Study|Relocation|3
2046776|NCT00468858|3618260|FG000|Overall Study|Lost to Follow-up|1
2046777|NCT00468858|3618261|FG001|Overall Study|Lost to Follow-up|2
2046778|NCT00468858|3618262|FG002|Overall Study|Lost to Follow-up|5
2046779|NCT00468858|3618260|FG000|Overall Study|Other|0
2046780|NCT00468858|3618261|FG001|Overall Study|Other|0
2046781|NCT00468858|3618262|FG002|Overall Study|Other|1
2046782|NCT00468910|3618326|FG000|Overall Study|Lost to Follow-up|2
2046783|NCT00468910|3618327|FG001|Overall Study|Lost to Follow-up|1
2046784|NCT00468910|3618326|FG000|Overall Study|Withdrawal by Subject|2
2046785|NCT00468910|3618327|FG001|Overall Study|Withdrawal by Subject|1
2046786|NCT00468910|3618326|FG000|Overall Study|Medical Contraindication|0
2046787|NCT00468910|3618327|FG001|Overall Study|Medical Contraindication|1
2046788|NCT00469014|3618338|FG000|Initial Phase Randomization|Disease Progression|0
2046789|NCT00469014|3618339|FG001|Initial Phase Randomization|Disease Progression|1
2046790|NCT00469014|3618340|FG002|Initial Phase Randomization|Disease Progression|1
2046791|NCT00469014|3618341|FG003|Initial Phase Randomization|Disease Progression|0
2046792|NCT00469014|3618338|FG000|Initial Phase Randomization|No Response|1
2046793|NCT00469014|3618339|FG001|Initial Phase Randomization|No Response|0
2046794|NCT00469014|3618340|FG002|Initial Phase Randomization|No Response|0
2046795|NCT00469014|3618341|FG003|Initial Phase Randomization|No Response|1
2046796|NCT00469014|3618338|FG000|Adaptive Randomization|Not Evaluable|1
2046797|NCT00469014|3618339|FG001|Adaptive Randomization|Not Evaluable|0
2046798|NCT00469014|3618340|FG002|Adaptive Randomization|Not Evaluable|0
2046799|NCT00469014|3618341|FG003|Adaptive Randomization|Not Evaluable|1
2046800|NCT00469014|3618338|FG000|Adaptive Randomization|No Response|0
2046801|NCT00469014|3618339|FG001|Adaptive Randomization|No Response|1
2046802|NCT00469014|3618340|FG002|Adaptive Randomization|No Response|0
2046803|NCT00469014|3618341|FG003|Adaptive Randomization|No Response|0
2046804|NCT00469014|3618338|FG000|Adaptive Randomization|Death|0
2046805|NCT00469014|3618339|FG001|Adaptive Randomization|Death|0
2046806|NCT00469014|3618340|FG002|Adaptive Randomization|Death|1
2046807|NCT00469014|3618341|FG003|Adaptive Randomization|Death|0
2046808|NCT00469079|3618354|FG000|Overall Study|Lack of Efficacy|3
2046809|NCT00469079|3618355|FG001|Overall Study|Lack of Efficacy|8
2046810|NCT00469079|3618356|FG002|Overall Study|Lack of Efficacy|5
2046811|NCT00469079|3618354|FG000|Overall Study|Adverse Event|1
2046812|NCT00469079|3618355|FG001|Overall Study|Adverse Event|3
2046813|NCT00469079|3618356|FG002|Overall Study|Adverse Event|2
2046814|NCT00469079|3618354|FG000|Overall Study|Lost to Follow-up|4
2046815|NCT00469079|3618355|FG001|Overall Study|Lost to Follow-up|8
2046816|NCT00469079|3618356|FG002|Overall Study|Lost to Follow-up|10
2046817|NCT00469079|3618354|FG000|Overall Study|Withdrawal by Subject|1
2046818|NCT00469079|3618355|FG001|Overall Study|Withdrawal by Subject|2
2046819|NCT00469079|3618356|FG002|Overall Study|Withdrawal by Subject|2
2046820|NCT00469079|3618354|FG000|Overall Study|Ineligible|0
2046821|NCT00469079|3618355|FG001|Overall Study|Ineligible|1
2046822|NCT00469079|3618356|FG002|Overall Study|Ineligible|0
2046823|NCT00469092|3618372|FG000|Overall Study|Adverse Event|5
2046824|NCT00469092|3618373|FG001|Overall Study|Adverse Event|4
2046825|NCT00469092|3618372|FG000|Overall Study|Lack of Efficacy|1
2046826|NCT00469092|3618373|FG001|Overall Study|Lack of Efficacy|0
2046827|NCT00469092|3618372|FG000|Overall Study|Lost to Follow-up|1
2046828|NCT00469092|3618373|FG001|Overall Study|Lost to Follow-up|2
2046829|NCT00469092|3618372|FG000|Overall Study|Protocol Violation|3
2046830|NCT00469092|3618373|FG001|Overall Study|Protocol Violation|3
2046831|NCT00469092|3618372|FG000|Overall Study|Withdrawal by Subject|4
2046832|NCT00469092|3618373|FG001|Overall Study|Withdrawal by Subject|4
2046833|NCT00469092|3618372|FG000|Overall Study|Withdrawal Criteria|3
2046834|NCT00469092|3618373|FG001|Overall Study|Withdrawal Criteria|4
2046835|NCT00469092|3618372|FG000|Overall Study|Incorrectly Randomised|4
2046836|NCT00469092|3618373|FG001|Overall Study|Incorrectly Randomised|3
2046837|NCT00469092|3618372|FG000|Overall Study|Contraindication metformin/glimepiride|1
2046838|NCT00469092|3618373|FG001|Overall Study|Contraindication metformin/glimepiride|0
2046839|NCT00469092|3618372|FG000|Overall Study|Use of lipid lowering drug|1
2046840|NCT00469092|3618373|FG001|Overall Study|Use of lipid lowering drug|0
2046841|NCT00469092|3618372|FG000|Overall Study|Hypoglycaemic Episodes|1
2046842|NCT00469092|3618373|FG001|Overall Study|Hypoglycaemic Episodes|1
2046843|NCT00469092|3618372|FG000|Overall Study|Abnormal lab value|1
2046844|NCT00469092|3618373|FG001|Overall Study|Abnormal lab value|0
2046845|NCT00469092|3618372|FG000|Overall Study|Use of Corticosteroid|1
2046846|NCT00469092|3618373|FG001|Overall Study|Use of Corticosteroid|0
2046847|NCT00469144|3618381|FG000|Overall Study|Death|0
2046848|NCT00469144|3618382|FG001|Overall Study|Death|1
2046849|NCT00469144|3618381|FG000|Overall Study|No Response|5
2046850|NCT00469144|3618382|FG001|Overall Study|No Response|5
2046851|NCT00469144|3618381|FG000|Overall Study|Progressive Disease|1
2046852|NCT00469144|3618382|FG001|Overall Study|Progressive Disease|0
2046853|NCT00469209|3618395|FG000|Overall Study|Adverse Event|1
2046854|NCT00469209|3618396|FG001|Overall Study|Adverse Event|0
2046855|NCT00469209|3618397|FG002|Overall Study|Adverse Event|1
2046856|NCT00469456|3618425|FG000|Overall Study|Adverse Event|4
2046857|NCT00469456|3618426|FG001|Overall Study|Adverse Event|3
2046858|NCT00469456|3618425|FG000|Overall Study|Protocol Violation|1
2046859|NCT00469456|3618426|FG001|Overall Study|Protocol Violation|0
2046860|NCT00469456|3618425|FG000|Overall Study|Withdrawal by Subject|4
2046861|NCT00469456|3618426|FG001|Overall Study|Withdrawal by Subject|1
2046862|NCT00469833|3618441|FG000|Overall Study|No IV access|2
2046863|NCT00469859|3618453|FG000|Overall Study|Inevaluable|0
2046864|NCT00469859|3618454|FG001|Overall Study|Inevaluable|2
2046865|NCT00469898|3618460|FG000|Overall Study|Adverse Event|7
2046866|NCT00469898|3618460|FG000|Overall Study|Withdrawal by Subject|4
2046867|NCT00469898|3618460|FG000|Overall Study|Death|4
2046868|NCT00469898|3618460|FG000|Overall Study|Disease progression|9
2046869|NCT00469898|3618460|FG000|Overall Study|Decreased performance status|1
2046870|NCT00470054|3618472|FG000|Overall Study|Ineligible|1
2046871|NCT00470093|3618476|FG000|Overall Study|Adverse Event|2
2046872|NCT00470158|3618506|FG000|Overall Study|Death|0
2046873|NCT00470158|3618507|FG001|Overall Study|Death|0
2046874|NCT00470158|3618508|FG002|Overall Study|Death|0
2046875|NCT00470158|3618509|FG003|Overall Study|Death|0
2046876|NCT00470158|3618510|FG004|Overall Study|Death|2
2046877|NCT00470158|3618506|FG000|Overall Study|Lost to Follow-up|7
2046878|NCT00470158|3618507|FG001|Overall Study|Lost to Follow-up|8
2046879|NCT00470158|3618508|FG002|Overall Study|Lost to Follow-up|8
2046880|NCT00470158|3618509|FG003|Overall Study|Lost to Follow-up|5
2046881|NCT00470158|3618510|FG004|Overall Study|Lost to Follow-up|4
2046882|NCT00470158|3618506|FG000|Overall Study|Protocol Violation|1
2046883|NCT00470158|3618507|FG001|Overall Study|Protocol Violation|0
2046884|NCT00470158|3618508|FG002|Overall Study|Protocol Violation|0
2046885|NCT00470158|3618509|FG003|Overall Study|Protocol Violation|0
2046886|NCT00470158|3618510|FG004|Overall Study|Protocol Violation|0
2046887|NCT00470184|3618522|FG000|Overall Study|Not Treated(became ineligible)|4
2046888|NCT00470184|3618522|FG000|Overall Study|Not treated (other)|1
2046889|NCT00470184|3618522|FG000|Overall Study|disease Progression|4
2046890|NCT00470184|3618522|FG000|Overall Study|Adverse Event|3
2046891|NCT00470184|3618522|FG000|Overall Study|Withdrawal by Subject|4
2046892|NCT00470184|3618522|FG000|Overall Study|other|5
2046893|NCT00470184|3618522|FG000|Overall Study|recurrence|1
2046894|NCT00470262|3618529|FG000|Overall Study|Withdrawal by Subject|2
2046895|NCT00470262|3618530|FG001|Overall Study|Withdrawal by Subject|0
2046896|NCT00470275|3618537|FG000|Overall Study|Death|1
2046897|NCT00470275|3618537|FG000|Overall Study|Lack of Efficacy|7
2046898|NCT00470275|3618537|FG000|Overall Study|Withdrawal by Subject|2
2046899|NCT00470366|3618546|FG000|Overall Study|Adverse Event|3
2046900|NCT00470366|3618546|FG000|Overall Study|Poor compliance|1
2046901|NCT00470418|3618562|FG000|Overall Study|Withdrawal by Subject|1
2046902|NCT00470418|3618563|FG001|Overall Study|Withdrawal by Subject|0
2046903|NCT00470470|3618569|FG000|Overall Study|Adverse Event|2
2046904|NCT00470470|3618569|FG000|Overall Study|Death|2
2046905|NCT00470470|3618569|FG000|Overall Study|Not treated|1
2046906|NCT00470535|3618573|FG000|Overall Study|Disease Progression|13
2046907|NCT00470535|3618573|FG000|Overall Study|Withdrawal by Subject|1
2046908|NCT00470535|3618573|FG000|Overall Study|Adverse Event|1
2046909|NCT00470535|3618573|FG000|Overall Study|Death|1
2046910|NCT00470535|3618573|FG000|Overall Study|Other|2
2046911|NCT00470626|3618601|FG000|Overall Study|Lost to Follow-up|10
2046912|NCT00470626|3618601|FG000|Overall Study|Withdrawal by Subject|7
2046913|NCT00470834|3618611|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
2046914|NCT00470834|3618612|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
2046915|NCT00470834|3618611|FG000|Treatment Period (18 Months)|Adverse Event|7
2046916|NCT00470834|3618612|FG001|Treatment Period (18 Months)|Adverse Event|6
2046917|NCT00470834|3618611|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4
2046918|NCT00470834|3618612|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5
2046919|NCT00470834|3618611|FG000|Treatment Period (18 Months)|Physician Decision|4
2046920|NCT00470834|3618612|FG001|Treatment Period (18 Months)|Physician Decision|4
2046921|NCT00470834|3618611|FG000|Treatment Period (18 Months)|Protocol Violation|3
2046922|NCT00470834|3618612|FG001|Treatment Period (18 Months)|Protocol Violation|1
2046923|NCT00470834|3618611|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1
2046924|NCT00470834|3618612|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1
2046925|NCT00470834|3618611|FG000|Treatment Period (18 Months)|Lost to Follow-up|1
2046926|NCT00470834|3618612|FG001|Treatment Period (18 Months)|Lost to Follow-up|0
2046927|NCT00470834|3618611|FG000|Treatment Period (18 Months)|Non-compliance|1
2046928|NCT00470834|3618612|FG001|Treatment Period (18 Months)|Non-compliance|0
2046929|NCT00470834|3618611|FG000|Treatment Period (18 Months)|Lack of Efficacy|1
2046930|NCT00470834|3618612|FG001|Treatment Period (18 Months)|Lack of Efficacy|0
2046931|NCT00470834|3618611|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
2046932|NCT00470834|3618612|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
2046933|NCT00470834|3618611|FG000|Extension Period (24 Months)|Adverse Event|3
2046934|NCT00470834|3618612|FG001|Extension Period (24 Months)|Adverse Event|4
2046935|NCT00470834|3618611|FG000|Extension Period (24 Months)|Withdrawal by Subject|2
2046936|NCT00470834|3618612|FG001|Extension Period (24 Months)|Withdrawal by Subject|5
2046937|NCT00470834|3618611|FG000|Extension Period (24 Months)|Physician Decision|4
2046938|NCT00470834|3618612|FG001|Extension Period (24 Months)|Physician Decision|3
2046939|NCT00470834|3618611|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0
2046940|NCT00470834|3618612|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1
2046941|NCT00470834|3618611|FG000|Extension Period (24 Months)|Lost to Follow-up|0
2046942|NCT00470834|3618612|FG001|Extension Period (24 Months)|Lost to Follow-up|1
2046943|NCT00470834|3618611|FG000|Extension Period (24 Months)|Non-compliance|0
2046944|NCT00470834|3618612|FG001|Extension Period (24 Months)|Non-compliance|1
2046945|NCT00470834|3618611|FG000|Extension Period (24 Months)|Disease Progression|0
2046946|NCT00470834|3618612|FG001|Extension Period (24 Months)|Disease Progression|1
2046947|NCT00470847|3618618|FG000|Overall Study|Pt still receiving treatment|1
2046948|NCT00471081|3618635|FG000|Active Phase|Protocol Violation|1
2046949|NCT00471081|3618636|FG001|Active Phase|Protocol Violation|1
2046950|NCT00471081|3618635|FG000|Active Phase|Withdrawal by Subject|0
2046951|NCT00471081|3618636|FG001|Active Phase|Withdrawal by Subject|3
2046952|NCT00471081|3618635|FG000|Active Phase|Lost to Follow-up|0
2046953|NCT00471081|3618636|FG001|Active Phase|Lost to Follow-up|1
2046954|NCT00471081|3618635|FG000|Active Phase|Lost health plan/insurance|1
2046955|NCT00471081|3618636|FG001|Active Phase|Lost health plan/insurance|8
2046956|NCT00471081|3618635|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1
2046957|NCT00471081|3618636|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4
2046958|NCT00471081|3618635|FG000|Extended Safety Follow-Up|Lost to Follow-up|1
2046959|NCT00471081|3618636|FG001|Extended Safety Follow-Up|Lost to Follow-up|8
2046960|NCT00471081|3618635|FG000|Extended Safety Follow-Up|Missing confirmed|0
2046961|NCT00471081|3618636|FG001|Extended Safety Follow-Up|Missing confirmed|1
2046962|NCT00471107|3618646|FG000|Overall Study|Technical problems/data loss|3
2046963|NCT00471107|3618647|FG001|Overall Study|Technical problems/data loss|1
2046964|NCT00471107|3618648|FG002|Overall Study|Technical problems/data loss|3
2046965|NCT00471146|3618658|FG000|Overall Study|Adverse Event|32
2046966|NCT00471146|3618659|FG001|Overall Study|Adverse Event|33
2046967|NCT00471146|3618658|FG000|Overall Study|Withdrawal by Subject|14
2046968|NCT00471146|3618659|FG001|Overall Study|Withdrawal by Subject|11
2046969|NCT00471146|3618658|FG000|Overall Study|Death|11
2046970|NCT00471146|3618659|FG001|Overall Study|Death|12
2046971|NCT00471146|3618658|FG000|Overall Study|Lost to Follow-up|4
2046972|NCT00471146|3618659|FG001|Overall Study|Lost to Follow-up|2
2046973|NCT00471146|3618658|FG000|Overall Study|Protocol Violation|2
2046974|NCT00471146|3618659|FG001|Overall Study|Protocol Violation|2
2046975|NCT00471146|3618658|FG000|Overall Study|Objective progression or relapse|84
2046976|NCT00471146|3618659|FG001|Overall Study|Objective progression or relapse|87
2046977|NCT00471146|3618658|FG000|Overall Study|Global deterioration of health status|12
2046978|NCT00471146|3618659|FG001|Overall Study|Global deterioration of health status|14
2046979|NCT00471146|3618658|FG000|Overall Study|Randomized but not treated|9
2046980|NCT00471146|3618659|FG001|Overall Study|Randomized but not treated|8
2046981|NCT00471146|3618658|FG000|Overall Study|Other|4
2046982|NCT00471146|3618659|FG001|Overall Study|Other|5
2046983|NCT00471237|3618672|FG000|Overall Study|Adverse Event|6
2046984|NCT00471237|3618673|FG001|Overall Study|Adverse Event|5
2046985|NCT00471237|3618674|FG002|Overall Study|Adverse Event|4
2046986|NCT00471237|3618675|FG003|Overall Study|Adverse Event|8
2046987|NCT00471237|3618676|FG004|Overall Study|Adverse Event|7
2046988|NCT00471237|3618677|FG005|Overall Study|Adverse Event|5
2046989|NCT00471237|3618678|FG006|Overall Study|Adverse Event|0
2046990|NCT00471237|3618672|FG000|Overall Study|Lost to Follow-up|1
2046991|NCT00471237|3618673|FG001|Overall Study|Lost to Follow-up|1
2046992|NCT00471237|3618674|FG002|Overall Study|Lost to Follow-up|0
2046993|NCT00471237|3618675|FG003|Overall Study|Lost to Follow-up|2
2046994|NCT00471237|3618676|FG004|Overall Study|Lost to Follow-up|3
2046995|NCT00471237|3618677|FG005|Overall Study|Lost to Follow-up|0
2046996|NCT00471237|3618678|FG006|Overall Study|Lost to Follow-up|0
2046997|NCT00471237|3618672|FG000|Overall Study|Protocol Violation|3
2046998|NCT00471237|3618673|FG001|Overall Study|Protocol Violation|6
2046999|NCT00471237|3618674|FG002|Overall Study|Protocol Violation|3
2047000|NCT00471237|3618675|FG003|Overall Study|Protocol Violation|2
2047001|NCT00471237|3618676|FG004|Overall Study|Protocol Violation|2
2047002|NCT00471237|3618677|FG005|Overall Study|Protocol Violation|4
2047003|NCT00471237|3618678|FG006|Overall Study|Protocol Violation|1
2047004|NCT00471237|3618672|FG000|Overall Study|Withdrawal by Subject|8
2047005|NCT00471237|3618673|FG001|Overall Study|Withdrawal by Subject|6
2047006|NCT00471237|3618674|FG002|Overall Study|Withdrawal by Subject|5
2047007|NCT00471237|3618675|FG003|Overall Study|Withdrawal by Subject|8
2047008|NCT00471237|3618676|FG004|Overall Study|Withdrawal by Subject|7
2047009|NCT00471237|3618677|FG005|Overall Study|Withdrawal by Subject|4
2047010|NCT00471237|3618678|FG006|Overall Study|Withdrawal by Subject|2
2047011|NCT00471237|3618672|FG000|Overall Study|Sponsor terminated study|20
2047012|NCT00471237|3618673|FG001|Overall Study|Sponsor terminated study|23
2047013|NCT00471237|3618674|FG002|Overall Study|Sponsor terminated study|19
2047014|NCT00471237|3618675|FG003|Overall Study|Sponsor terminated study|22
2047015|NCT00471237|3618676|FG004|Overall Study|Sponsor terminated study|18
2047016|NCT00471237|3618677|FG005|Overall Study|Sponsor terminated study|24
2047017|NCT00471237|3618678|FG006|Overall Study|Sponsor terminated study|0
2047018|NCT00471237|3618672|FG000|Overall Study|Non-compliance|0
2047019|NCT00471237|3618673|FG001|Overall Study|Non-compliance|1
2047020|NCT00471237|3618674|FG002|Overall Study|Non-compliance|0
2047021|NCT00471237|3618675|FG003|Overall Study|Non-compliance|1
2047022|NCT00471237|3618676|FG004|Overall Study|Non-compliance|0
2047023|NCT00471237|3618677|FG005|Overall Study|Non-compliance|0
2047024|NCT00471237|3618678|FG006|Overall Study|Non-compliance|0
2047025|NCT00471237|3618672|FG000|Overall Study|Met serum creatinine withdrawal criteria|1
2047026|NCT00471237|3618673|FG001|Overall Study|Met serum creatinine withdrawal criteria|0
2047027|NCT00471237|3618674|FG002|Overall Study|Met serum creatinine withdrawal criteria|2
2047028|NCT00471237|3618675|FG003|Overall Study|Met serum creatinine withdrawal criteria|2
2047029|NCT00471237|3618676|FG004|Overall Study|Met serum creatinine withdrawal criteria|0
2047030|NCT00471237|3618677|FG005|Overall Study|Met serum creatinine withdrawal criteria|0
2047031|NCT00471237|3618678|FG006|Overall Study|Met serum creatinine withdrawal criteria|0
2047032|NCT00471237|3618672|FG000|Overall Study|Early stopping due to non-efficacy|1
2047033|NCT00471237|3618673|FG001|Overall Study|Early stopping due to non-efficacy|0
2047034|NCT00471237|3618674|FG002|Overall Study|Early stopping due to non-efficacy|0
2047035|NCT00471237|3618675|FG003|Overall Study|Early stopping due to non-efficacy|0
2299625|NCT02588612|3996862|FG000|Overall Study|Physician Decision|1
2299626|NCT02588612|3996862|FG000|Overall Study|Leukapheresis did not yield enough cells|1
2047036|NCT00471237|3618676|FG004|Overall Study|Early stopping due to non-efficacy|1
2047037|NCT00471237|3618677|FG005|Overall Study|Early stopping due to non-efficacy|0
2047038|NCT00471237|3618678|FG006|Overall Study|Early stopping due to non-efficacy|0
2047039|NCT00471237|3618672|FG000|Overall Study|Participant planned to travel to abraod|1
2047040|NCT00471237|3618673|FG001|Overall Study|Participant planned to travel to abraod|0
2047041|NCT00471237|3618674|FG002|Overall Study|Participant planned to travel to abraod|0
2047042|NCT00471237|3618675|FG003|Overall Study|Participant planned to travel to abraod|0
2047043|NCT00471237|3618676|FG004|Overall Study|Participant planned to travel to abraod|0
2047044|NCT00471237|3618677|FG005|Overall Study|Participant planned to travel to abraod|1
2208762|NCT01641692|3848407|FG002|Treatment Period 1|Withdrawal by Subject|0
2047045|NCT00471237|3618678|FG006|Overall Study|Participant planned to travel to abraod|0
2047046|NCT00471237|3618672|FG000|Overall Study|High parathyroid hormone|0
2047047|NCT00471237|3618673|FG001|Overall Study|High parathyroid hormone|0
2047048|NCT00471237|3618674|FG002|Overall Study|High parathyroid hormone|1
2047049|NCT00471237|3618675|FG003|Overall Study|High parathyroid hormone|0
2047050|NCT00471237|3618676|FG004|Overall Study|High parathyroid hormone|0
2047051|NCT00471237|3618677|FG005|Overall Study|High parathyroid hormone|0
2047052|NCT00471237|3618678|FG006|Overall Study|High parathyroid hormone|0
2047053|NCT00471237|3618672|FG000|Overall Study|Participant lost medication|0
2047054|NCT00471237|3618673|FG001|Overall Study|Participant lost medication|0
2047055|NCT00471237|3618674|FG002|Overall Study|Participant lost medication|0
2047056|NCT00471237|3618675|FG003|Overall Study|Participant lost medication|0
2047057|NCT00471237|3618676|FG004|Overall Study|Participant lost medication|1
2047058|NCT00471237|3618677|FG005|Overall Study|Participant lost medication|0
2047059|NCT00471237|3618678|FG006|Overall Study|Participant lost medication|0
2047060|NCT00471237|3618672|FG000|Overall Study|Administration of prohibited medicine|0
2047061|NCT00471237|3618673|FG001|Overall Study|Administration of prohibited medicine|0
2047062|NCT00471237|3618674|FG002|Overall Study|Administration of prohibited medicine|0
2047063|NCT00471237|3618675|FG003|Overall Study|Administration of prohibited medicine|0
2047064|NCT00471237|3618676|FG004|Overall Study|Administration of prohibited medicine|1
2047065|NCT00471237|3618677|FG005|Overall Study|Administration of prohibited medicine|0
2047066|NCT00471237|3618678|FG006|Overall Study|Administration of prohibited medicine|0
2047067|NCT00471237|3618672|FG000|Overall Study|Participant shifted residence|0
2047068|NCT00471237|3618673|FG001|Overall Study|Participant shifted residence|0
2047069|NCT00471237|3618674|FG002|Overall Study|Participant shifted residence|0
2047070|NCT00471237|3618675|FG003|Overall Study|Participant shifted residence|0
2047071|NCT00471237|3618676|FG004|Overall Study|Participant shifted residence|1
2047072|NCT00471237|3618677|FG005|Overall Study|Participant shifted residence|0
2047073|NCT00471237|3618678|FG006|Overall Study|Participant shifted residence|0
2047074|NCT00471237|3618672|FG000|Overall Study|Participant's decision|0
2047075|NCT00471237|3618673|FG001|Overall Study|Participant's decision|0
2047076|NCT00471237|3618674|FG002|Overall Study|Participant's decision|0
2047077|NCT00471237|3618675|FG003|Overall Study|Participant's decision|0
2047078|NCT00471237|3618676|FG004|Overall Study|Participant's decision|0
2047079|NCT00471237|3618677|FG005|Overall Study|Participant's decision|1
2047080|NCT00471237|3618678|FG006|Overall Study|Participant's decision|0
2047081|NCT00471276|3618698|FG000|Overall Study|Death|2
2047082|NCT00471276|3618698|FG000|Overall Study|Adverse Event|16
2047083|NCT00471276|3618698|FG000|Overall Study|Protocol Violation|1
2047084|NCT00471276|3618698|FG000|Overall Study|Objective progression or relapse|54
2047085|NCT00471276|3618698|FG000|Overall Study|Global deterioration of health status|1
2047086|NCT00471276|3618698|FG000|Overall Study|Other|3
2047087|NCT00471276|3618698|FG000|Overall Study|Refused treatment|6
2047088|NCT00471315|3618702|FG000|Overall Study|Adverse Event|7
2047089|NCT00471315|3618702|FG000|Overall Study|Withdrawal by Subject|1
2047090|NCT00471328|3618708|FG000|Core Phase|Adverse Event|18
2047091|NCT00471328|3618709|FG001|Core Phase|Adverse Event|6
2047092|NCT00471328|3618708|FG000|Core Phase|Death|8
2047093|NCT00471328|3618709|FG001|Core Phase|Death|4
2047094|NCT00471328|3618708|FG000|Core Phase|Withdrawal by Subject|2
2047095|NCT00471328|3618709|FG001|Core Phase|Withdrawal by Subject|2
2047096|NCT00471328|3618708|FG000|Core Phase|Abnormal laboratory value|1
2047097|NCT00471328|3618709|FG001|Core Phase|Abnormal laboratory value|0
2047098|NCT00471328|3618708|FG000|Core Phase|Disease Progression|78
2047099|NCT00471328|3618709|FG001|Core Phase|Disease Progression|53
2047100|NCT00471328|3618708|FG000|Core Phase|Administrative Problem|0
2047101|NCT00471328|3618709|FG001|Core Phase|Administrative Problem|1
2047102|NCT00471328|3618708|FG000|Core Phase|Protocol Deviation|0
2047103|NCT00471328|3618709|FG001|Core Phase|Protocol Deviation|1
2047104|NCT00471328|3618708|FG000|Extension Phase|Adverse Event|3
2047105|NCT00471328|3618709|FG001|Extension Phase|Adverse Event|12
2047106|NCT00471328|3618708|FG000|Extension Phase|Withdrawal by Subject|0
2047107|NCT00471328|3618709|FG001|Extension Phase|Withdrawal by Subject|2
2047108|NCT00471328|3618708|FG000|Extension Phase|Death|1
2047109|NCT00471328|3618709|FG001|Extension Phase|Death|7
2047110|NCT00471328|3618708|FG000|Extension Phase|Protocol Deviation|3
2047111|NCT00471328|3618709|FG001|Extension Phase|Protocol Deviation|1
2047112|NCT00471328|3618708|FG000|Extension Phase|Treatment duration as per protocol|0
2047113|NCT00471328|3618709|FG001|Extension Phase|Treatment duration as per protocol|1
2047114|NCT00471328|3618708|FG000|Extension Phase|Disease Progression|32
2047115|NCT00471328|3618709|FG001|Extension Phase|Disease Progression|44
2047116|NCT00471328|3618708|FG000|Extension Phase|New cancer Therapy|1
2047117|NCT00471328|3618709|FG001|Extension Phase|New cancer Therapy|0
2047118|NCT00471328|3618708|FG000|Extension Phase|Administrative Problem|1
2047119|NCT00471328|3618709|FG001|Extension Phase|Administrative Problem|0
2047120|NCT00471354|3618717|FG000|Overall Study|Protocol Entry Criteria Not Met|1
2047121|NCT00471354|3618717|FG000|Overall Study|Adverse Event|13
2047122|NCT00471354|3618717|FG000|Overall Study|Protocol Violation|12
2047123|NCT00471354|3618717|FG000|Overall Study|Withdrawal by Subject|1
2047124|NCT00471354|3618717|FG000|Overall Study|Physician Decision|4
2047125|NCT00471354|3618717|FG000|Overall Study|Sponsor Decision|1
2047126|NCT00471354|3618717|FG000|Overall Study|Lost to Follow-up|3
2047127|NCT00471354|3618717|FG000|Overall Study|Lack of Efficacy|5
2047128|NCT00471354|3618717|FG000|Overall Study|Patient/Caregiver Decision|12
2047129|NCT00471445|3618730|FG000|Overall Study|Withdrawal by Subject|1
2047130|NCT00471445|3618731|FG001|Overall Study|Withdrawal by Subject|1
2047131|NCT00471445|3618730|FG000|Overall Study|Ineligible|1
2047132|NCT00471445|3618731|FG001|Overall Study|Ineligible|0
2047133|NCT00471445|3618730|FG000|Overall Study|Protocol Violation|0
2047134|NCT00471445|3618731|FG001|Overall Study|Protocol Violation|1
2047135|NCT00471497|3618740|FG000|Core Treatment Phase|Abnormal Laboratory Values|3
2047136|NCT00471497|3618741|FG001|Core Treatment Phase|Abnormal Laboratory Values|9
2047137|NCT00471497|3618742|FG002|Core Treatment Phase|Abnormal Laboratory Values|9
2047138|NCT00471497|3618740|FG000|Core Treatment Phase|Abnormal Test Procedures|1
2047139|NCT00471497|3618741|FG001|Core Treatment Phase|Abnormal Test Procedures|0
2047140|NCT00471497|3618742|FG002|Core Treatment Phase|Abnormal Test Procedures|1
2047141|NCT00471497|3618740|FG000|Core Treatment Phase|Condition no longer requires study drug|0
2047142|NCT00471497|3618741|FG001|Core Treatment Phase|Condition no longer requires study drug|1
2047143|NCT00471497|3618742|FG002|Core Treatment Phase|Condition no longer requires study drug|0
2047144|NCT00471497|3618740|FG000|Core Treatment Phase|Withdrawal by Subject|31
2047145|NCT00471497|3618741|FG001|Core Treatment Phase|Withdrawal by Subject|29
2047146|NCT00471497|3618742|FG002|Core Treatment Phase|Withdrawal by Subject|34
2047147|NCT00471497|3618740|FG000|Core Treatment Phase|Lost to Follow-up|6
2047148|NCT00471497|3618741|FG001|Core Treatment Phase|Lost to Follow-up|6
2047149|NCT00471497|3618742|FG002|Core Treatment Phase|Lost to Follow-up|3
2047150|NCT00471497|3618740|FG000|Core Treatment Phase|Death|3
2047151|NCT00471497|3618741|FG001|Core Treatment Phase|Death|9
2047152|NCT00471497|3618742|FG002|Core Treatment Phase|Death|3
2047153|NCT00471497|3618740|FG000|Core Treatment Phase|Disease Progression|10
2047154|NCT00471497|3618741|FG001|Core Treatment Phase|Disease Progression|2
2047155|NCT00471497|3618742|FG002|Core Treatment Phase|Disease Progression|4
2047156|NCT00471497|3618740|FG000|Core Treatment Phase|Protocol Violation|6
2047157|NCT00471497|3618741|FG001|Core Treatment Phase|Protocol Violation|15
2047158|NCT00471497|3618742|FG002|Core Treatment Phase|Protocol Violation|11
2047159|NCT00471497|3618740|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19
2047160|NCT00471497|3618741|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11
2047161|NCT00471497|3618742|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13
2047162|NCT00471497|3618740|FG000|Core Treatment Phase|Administrative problems|14
2047163|NCT00471497|3618741|FG001|Core Treatment Phase|Administrative problems|14
2047164|NCT00471497|3618742|FG002|Core Treatment Phase|Administrative problems|12
2047165|NCT00471497|3618740|FG000|Core Treatment Phase|Adverse Event|43
2047166|NCT00471497|3618741|FG001|Core Treatment Phase|Adverse Event|53
2047167|NCT00471497|3618742|FG002|Core Treatment Phase|Adverse Event|89
2047168|NCT00471497|3618740|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2
2047169|NCT00471497|3618741|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
2047170|NCT00471497|3618742|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
2047171|NCT00471497|3618740|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46
2047172|NCT00471497|3618741|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26
2047173|NCT00471497|3618742|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3
2047174|NCT00471497|3618740|FG000|Extension Phase|Adverse Event|9
2047175|NCT00471497|3618741|FG001|Extension Phase|Adverse Event|5
2047176|NCT00471497|3618742|FG002|Extension Phase|Adverse Event|1
2047177|NCT00471497|3618740|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
2047178|NCT00471497|3618741|FG001|Extension Phase|Unsatisfactory therapeutic effect|6
2047179|NCT00471497|3618742|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
2047180|NCT00471497|3618740|FG000|Extension Phase|Withdrawal by Subject|3
2047181|NCT00471497|3618741|FG001|Extension Phase|Withdrawal by Subject|1
2047182|NCT00471497|3618742|FG002|Extension Phase|Withdrawal by Subject|0
2047183|NCT00471497|3618740|FG000|Extension Phase|Lost to Follow-up|2
2047184|NCT00471497|3618741|FG001|Extension Phase|Lost to Follow-up|0
2047185|NCT00471497|3618742|FG002|Extension Phase|Lost to Follow-up|0
2047186|NCT00471497|3618740|FG000|Extension Phase|Death|1
2047187|NCT00471497|3618741|FG001|Extension Phase|Death|0
2047188|NCT00471497|3618742|FG002|Extension Phase|Death|0
2047189|NCT00471497|3618740|FG000|Extension Phase|Disease progression|2
2047190|NCT00471497|3618741|FG001|Extension Phase|Disease progression|0
2047191|NCT00471497|3618742|FG002|Extension Phase|Disease progression|0
2047192|NCT00471497|3618740|FG000|Extension Phase|Protocol Violation|2
2047193|NCT00471497|3618741|FG001|Extension Phase|Protocol Violation|2
2047194|NCT00471497|3618742|FG002|Extension Phase|Protocol Violation|0
2047195|NCT00471536|3618753|FG000|Overall Study|Withdrawal by Subject|1
2047196|NCT00471718|3618770|FG000|Overall Study|Adverse Event|3
2047197|NCT00471718|3618770|FG000|Overall Study|other complicating disease|1
2047198|NCT00471718|3618770|FG000|Overall Study|disease progression|22
2047199|NCT00471718|3618770|FG000|Overall Study|Withdrawal by Subject|1
2047200|NCT00471822|3618778|FG000|Overall Study|Protocol Violation|2
2047201|NCT00471887|3618786|FG000|Overall Study|Adverse Event|9
2047202|NCT00472030|3618792|FG000|Overall Study|Physician Decision|1
2047203|NCT00472030|3618793|FG001|Overall Study|Physician Decision|0
2047204|NCT00472199|3618820|FG000|Overall Study|Adverse Event|19
2047205|NCT00472199|3618821|FG001|Overall Study|Adverse Event|23
2047206|NCT00472199|3618820|FG000|Overall Study|Lack of Efficacy|4
2047207|NCT00472199|3618821|FG001|Overall Study|Lack of Efficacy|25
2047208|NCT00472199|3618820|FG000|Overall Study|Lost to Follow-up|2
2047209|NCT00472199|3618821|FG001|Overall Study|Lost to Follow-up|4
2299627|NCT02588612|3996862|FG000|Overall Study|Failed eligibility prior to chemotherapy|2
2299628|NCT02588612|3996862|FG000|Overall Study|Death prior to T-cell infusion|1
2299629|NCT02588664|3996868|FG000|Overall Study|Death|56
2299630|NCT02588664|3996869|FG001|Overall Study|Death|55
2299631|NCT02588664|3996868|FG000|Overall Study|Lost to Follow-up|1305
2299632|NCT02588664|3996869|FG001|Overall Study|Lost to Follow-up|990
2299633|NCT02588833|3996877|FG000|Part 1|Withdrawal by Subject|1
2299634|NCT02588833|3996878|FG001|Part 1|Withdrawal by Subject|0
2299635|NCT02588833|3996877|FG000|Part 2A|Physician Decision|0
2047210|NCT00472199|3618820|FG000|Overall Study|Protocol Violation|3
2047211|NCT00472199|3618821|FG001|Overall Study|Protocol Violation|2
2047212|NCT00472199|3618820|FG000|Overall Study|Withdrawal by Subject|6
2047213|NCT00472199|3618821|FG001|Overall Study|Withdrawal by Subject|5
2047214|NCT00472199|3618820|FG000|Overall Study|personal reason|0
2047215|NCT00472199|3618821|FG001|Overall Study|personal reason|1
2047216|NCT00472199|3618820|FG000|Overall Study|patient was asymptomatic|1
2047217|NCT00472199|3618821|FG001|Overall Study|patient was asymptomatic|0
2047218|NCT00472290|3618827|FG000|Overall Study|Progression of Therapy-Related MDS|1
2047219|NCT00472290|3618827|FG000|Overall Study|Protocol Specified Criteria|7
2047220|NCT00472290|3618827|FG000|Overall Study|Administrative Decision|37
2047221|NCT00472290|3618827|FG000|Overall Study|Death|3
2047222|NCT00472290|3618827|FG000|Overall Study|Lost to Follow-up|1
2047223|NCT00472290|3618827|FG000|Overall Study|Lack of Efficacy|1
2047224|NCT00472290|3618827|FG000|Overall Study|Disease Progression|4
2047225|NCT00472290|3618827|FG000|Overall Study|Withdrawal by Subject|5
2047226|NCT00472290|3618827|FG000|Overall Study|Adverse Event|6
2208763|NCT01641692|3848408|FG003|Treatment Period 1|Withdrawal by Subject|0
2208764|NCT01641692|3848409|FG004|Treatment Period 1|Withdrawal by Subject|0
2208765|NCT01641692|3848410|FG005|Treatment Period 1|Withdrawal by Subject|2
2047227|NCT00472290|3618827|FG000|Overall Study|Requirement for alternative therapy|7
2047228|NCT00472303|3618833|FG000|Titration Phase|Adverse Event|22
2047229|NCT00472303|3618834|FG001|Titration Phase|Adverse Event|12
2047230|NCT00472303|3618835|FG002|Titration Phase|Adverse Event|0
2047231|NCT00472303|3618833|FG000|Titration Phase|Death|4
2047232|NCT00472303|3618834|FG001|Titration Phase|Death|2
2047233|NCT00472303|3618835|FG002|Titration Phase|Death|0
2047234|NCT00472303|3618833|FG000|Titration Phase|Lack of Efficacy|10
2047235|NCT00472303|3618834|FG001|Titration Phase|Lack of Efficacy|0
2047236|NCT00472303|3618835|FG002|Titration Phase|Lack of Efficacy|0
2047237|NCT00472303|3618833|FG000|Titration Phase|Withdrawal by Subject|16
2047238|NCT00472303|3618834|FG001|Titration Phase|Withdrawal by Subject|13
2047239|NCT00472303|3618835|FG002|Titration Phase|Withdrawal by Subject|0
2047240|NCT00472303|3618833|FG000|Titration Phase|Trial Medication non-compliant|4
2047241|NCT00472303|3618834|FG001|Titration Phase|Trial Medication non-compliant|1
2047242|NCT00472303|3618835|FG002|Titration Phase|Trial Medication non-compliant|0
2047243|NCT00472303|3618833|FG000|Titration Phase|Other|3
2047244|NCT00472303|3618834|FG001|Titration Phase|Other|1
2047245|NCT00472303|3618835|FG002|Titration Phase|Other|0
2047246|NCT00472303|3618833|FG000|Discontinuations After Titration Phase|Adverse Event|6
2047247|NCT00472303|3618834|FG001|Discontinuations After Titration Phase|Adverse Event|0
2047248|NCT00472303|3618835|FG002|Discontinuations After Titration Phase|Adverse Event|0
2047249|NCT00472303|3618833|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48
2047250|NCT00472303|3618834|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17
2047251|NCT00472303|3618835|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0
2047252|NCT00472303|3618833|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2
2047253|NCT00472303|3618834|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2
2047254|NCT00472303|3618835|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0
2047255|NCT00472303|3618833|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0
2047256|NCT00472303|3618834|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1
2047257|NCT00472303|3618835|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0
2047258|NCT00472303|3618833|FG000|Discontinuations After Titration Phase|Other|5
2047259|NCT00472303|3618834|FG001|Discontinuations After Titration Phase|Other|0
2047260|NCT00472303|3618835|FG002|Discontinuations After Titration Phase|Other|0
2047261|NCT00472303|3618833|FG000|Maintenance Phase|Adverse Event|5
2047262|NCT00472303|3618834|FG001|Maintenance Phase|Adverse Event|6
2047263|NCT00472303|3618835|FG002|Maintenance Phase|Adverse Event|6
2047264|NCT00472303|3618833|FG000|Maintenance Phase|Death|3
2047265|NCT00472303|3618834|FG001|Maintenance Phase|Death|0
2047266|NCT00472303|3618835|FG002|Maintenance Phase|Death|2
2047267|NCT00472303|3618833|FG000|Maintenance Phase|Lack of Efficacy|2
2047268|NCT00472303|3618834|FG001|Maintenance Phase|Lack of Efficacy|2
2047269|NCT00472303|3618835|FG002|Maintenance Phase|Lack of Efficacy|4
2047270|NCT00472303|3618833|FG000|Maintenance Phase|Withdrawal by Subject|6
2047271|NCT00472303|3618834|FG001|Maintenance Phase|Withdrawal by Subject|7
2299636|NCT02588833|3996878|FG001|Part 2A|Physician Decision|1
2047272|NCT00472303|3618835|FG002|Maintenance Phase|Withdrawal by Subject|3
2047273|NCT00472303|3618833|FG000|Maintenance Phase|Trial medication non-compliant|0
2047274|NCT00472303|3618834|FG001|Maintenance Phase|Trial medication non-compliant|0
2047275|NCT00472303|3618835|FG002|Maintenance Phase|Trial medication non-compliant|1
2047276|NCT00472303|3618833|FG000|Maintenance Phase|Resolution of pain|0
2047277|NCT00472303|3618834|FG001|Maintenance Phase|Resolution of pain|0
2047278|NCT00472303|3618835|FG002|Maintenance Phase|Resolution of pain|1
2047279|NCT00472303|3618833|FG000|Maintenance Phase|Other|1
2047280|NCT00472303|3618834|FG001|Maintenance Phase|Other|1
2047281|NCT00472303|3618835|FG002|Maintenance Phase|Other|0
2047282|NCT00472420|3618863|FG000|Induction Treatment Period|Physician Decision|9
2047283|NCT00472420|3618863|FG000|Induction Treatment Period|Adverse Event|3
2047284|NCT00472420|3618863|FG000|Induction Treatment Period|Non-compliance|1
2047285|NCT00472420|3618863|FG000|Induction Treatment Period|Death|3
2047286|NCT00472420|3618863|FG000|Follow-up Period|Death|5
2047287|NCT00472420|3618863|FG000|Follow-up Period|Physician Decision|9
2208766|NCT01641692|3848411|FG006|Treatment Period 1|Withdrawal by Subject|0
2208767|NCT01641692|3848412|FG007|Treatment Period 1|Withdrawal by Subject|1
2208768|NCT01641692|3848405|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2
2208769|NCT01641692|3848406|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0
2208770|NCT01641692|3848407|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0
2208771|NCT01641692|3848408|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0
2208772|NCT01641692|3848409|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0
2208773|NCT01641692|3848410|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0
2208774|NCT01641692|3848411|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0
2208775|NCT01641692|3848412|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0
2047288|NCT00472420|3618863|FG000|Follow-up Period|Lost to Follow-up|2
2047289|NCT00472420|3618863|FG000|Follow-up Period|Protocol Violation|1
2047290|NCT00472446|3618871|FG000|Overall Study|Protocol Violation|0
2047291|NCT00472446|3618872|FG001|Overall Study|Protocol Violation|0
2047292|NCT00472446|3618873|FG002|Overall Study|Protocol Violation|0
2047293|NCT00472446|3618874|FG003|Overall Study|Protocol Violation|1
2047294|NCT00472446|3618871|FG000|Overall Study|Reintervention|0
2047295|NCT00472446|3618872|FG001|Overall Study|Reintervention|0
2047296|NCT00472446|3618873|FG002|Overall Study|Reintervention|1
2047297|NCT00472446|3618874|FG003|Overall Study|Reintervention|1
2047298|NCT00472446|3618871|FG000|Overall Study|Questionnaires not returned|5
2047299|NCT00472446|3618872|FG001|Overall Study|Questionnaires not returned|6
2047300|NCT00472446|3618873|FG002|Overall Study|Questionnaires not returned|6
2047301|NCT00472446|3618874|FG003|Overall Study|Questionnaires not returned|4
2047302|NCT00472641|3618893|FG000|Overall Study|Lack of Efficacy|3
2047303|NCT00472641|3618893|FG000|Overall Study|Adverse Event|3
2047304|NCT00472641|3618893|FG000|Overall Study|Lost to Follow-up|1
2047305|NCT00473083|3618930|FG000|Overall Study|Adverse Event|1
2047306|NCT00473083|3618931|FG001|Overall Study|Adverse Event|0
2047307|NCT00473083|3618932|FG002|Overall Study|Adverse Event|0
2047308|NCT00473265|3618943|FG000|Overall Study|Unrelated adverse event|5
2047309|NCT00473265|3618943|FG000|Overall Study|Off treatment early|15
2047310|NCT00473330|3618950|FG000|Core Study|Adverse Event|4
2047311|NCT00473330|3618951|FG001|Core Study|Adverse Event|4
2047312|NCT00473330|3618952|FG002|Core Study|Adverse Event|1
2047313|NCT00473330|3618950|FG000|Core Study|Death|6
2047314|NCT00473330|3618951|FG001|Core Study|Death|4
2047315|NCT00473330|3618952|FG002|Core Study|Death|4
2047316|NCT00473330|3618950|FG000|Core Study|Lost to Follow-up|5
2047317|NCT00473330|3618951|FG001|Core Study|Lost to Follow-up|5
2047318|NCT00473330|3618952|FG002|Core Study|Lost to Follow-up|10
2047319|NCT00473330|3618950|FG000|Core Study|Physician Decision|2
2047320|NCT00473330|3618951|FG001|Core Study|Physician Decision|1
2047321|NCT00473330|3618952|FG002|Core Study|Physician Decision|3
2047322|NCT00473330|3618950|FG000|Core Study|Subject Non-compliance|1
2047323|NCT00473330|3618951|FG001|Core Study|Subject Non-compliance|2
2047324|NCT00473330|3618952|FG002|Core Study|Subject Non-compliance|1
2047325|NCT00473330|3618950|FG000|Core Study|Subject Required Other Therapy|0
2047326|NCT00473330|3618951|FG001|Core Study|Subject Required Other Therapy|1
2047327|NCT00473330|3618952|FG002|Core Study|Subject Required Other Therapy|3
2047328|NCT00473330|3618950|FG000|Core Study|Subject's Decision|9
2047329|NCT00473330|3618951|FG001|Core Study|Subject's Decision|8
2047330|NCT00473330|3618952|FG002|Core Study|Subject's Decision|19
2047331|NCT00473330|3618950|FG000|Open-label Extension Through Month 48|Adverse Event|0
2047332|NCT00473330|3618951|FG001|Open-label Extension Through Month 48|Adverse Event|0
2047333|NCT00473330|3618952|FG002|Open-label Extension Through Month 48|Adverse Event|2
2047334|NCT00473330|3618950|FG000|Open-label Extension Through Month 48|Death|2
2047335|NCT00473330|3618951|FG001|Open-label Extension Through Month 48|Death|0
2047336|NCT00473330|3618952|FG002|Open-label Extension Through Month 48|Death|0
2047337|NCT00473330|3618950|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
2047338|NCT00473330|3618951|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0
2047339|NCT00473330|3618952|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2
2047340|NCT00473330|3618950|FG000|Open-label Extension Through Month 48|Physician's Decision|2
2047341|NCT00473330|3618951|FG001|Open-label Extension Through Month 48|Physician's Decision|1
2047342|NCT00473330|3618952|FG002|Open-label Extension Through Month 48|Physician's Decision|3
2047343|NCT00473330|3618950|FG000|Open-label Extension Through Month 48|Subject's Decision|1
2047344|NCT00473330|3618951|FG001|Open-label Extension Through Month 48|Subject's Decision|3
2047345|NCT00473330|3618952|FG002|Open-label Extension Through Month 48|Subject's Decision|3
2047346|NCT00473330|3618950|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18
2047347|NCT00473330|3618951|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15
2047348|NCT00473330|3618952|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16
2047349|NCT00473330|3618950|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2
2047350|NCT00473330|3618951|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1
2047351|NCT00473330|3618952|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0
2047352|NCT00473330|3618950|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0
2047353|NCT00473330|3618951|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0
2047354|NCT00473330|3618952|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1
2047355|NCT00473330|3618950|FG000|Open-label Extension Through Month 60|Adverse Event|0
2047356|NCT00473330|3618951|FG001|Open-label Extension Through Month 60|Adverse Event|0
2047357|NCT00473330|3618952|FG002|Open-label Extension Through Month 60|Adverse Event|2
2047358|NCT00473330|3618950|FG000|Open-label Extension Through Month 60|Death|2
2047359|NCT00473330|3618951|FG001|Open-label Extension Through Month 60|Death|2
2047360|NCT00473330|3618952|FG002|Open-label Extension Through Month 60|Death|1
2047361|NCT00473330|3618950|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3
2047362|NCT00473330|3618951|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0
2047363|NCT00473330|3618952|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4
2047364|NCT00473330|3618950|FG000|Open-label Extension Through Month 60|Physician's Decision|2
2047365|NCT00473330|3618951|FG001|Open-label Extension Through Month 60|Physician's Decision|1
2047366|NCT00473330|3618952|FG002|Open-label Extension Through Month 60|Physician's Decision|3
2047367|NCT00473330|3618950|FG000|Open-label Extension Through Month 60|Subject's Decision|1
2047368|NCT00473330|3618951|FG001|Open-label Extension Through Month 60|Subject's Decision|3
2047369|NCT00473330|3618952|FG002|Open-label Extension Through Month 60|Subject's Decision|4
2047370|NCT00473330|3618950|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77
2047371|NCT00473330|3618951|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71
2047372|NCT00473330|3618952|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62
2047373|NCT00473330|3618950|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2
2047374|NCT00473330|3618951|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1
2047375|NCT00473330|3618952|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0
2047376|NCT00473330|3618950|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1
2047377|NCT00473330|3618951|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0
2047378|NCT00473330|3618952|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1
2047379|NCT00473382|3618983|FG000|Core Study|Adverse Event|3
2047380|NCT00473382|3618984|FG001|Core Study|Adverse Event|1
2047381|NCT00473382|3618985|FG002|Core Study|Adverse Event|1
2047382|NCT00473382|3618983|FG000|Core Study|Death|3
2047383|NCT00473382|3618984|FG001|Core Study|Death|5
2047384|NCT00473382|3618985|FG002|Core Study|Death|10
2047385|NCT00473382|3618983|FG000|Core Study|Lost to Follow-up|3
2047386|NCT00473382|3618984|FG001|Core Study|Lost to Follow-up|3
2047387|NCT00473382|3618985|FG002|Core Study|Lost to Follow-up|3
2208776|NCT01641692|3848405|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0
2208777|NCT01641692|3848406|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0
2208778|NCT01641692|3848407|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0
2208779|NCT01641692|3848408|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0
2208780|NCT01641692|3848409|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0
2208781|NCT01641692|3848410|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0
2047388|NCT00473382|3618983|FG000|Core Study|Physician Decision|1
2047389|NCT00473382|3618984|FG001|Core Study|Physician Decision|2
2047390|NCT00473382|3618985|FG002|Core Study|Physician Decision|2
2047391|NCT00473382|3618983|FG000|Core Study|Subject non-compliance|5
2047392|NCT00473382|3618984|FG001|Core Study|Subject non-compliance|2
2047393|NCT00473382|3618985|FG002|Core Study|Subject non-compliance|1
2047394|NCT00473382|3618983|FG000|Core Study|Subject needed other treatment|1
2047395|NCT00473382|3618984|FG001|Core Study|Subject needed other treatment|3
2047396|NCT00473382|3618985|FG002|Core Study|Subject needed other treatment|2
2047397|NCT00473382|3618983|FG000|Core Study|Subject's decision|12
2047398|NCT00473382|3618984|FG001|Core Study|Subject's decision|11
2047399|NCT00473382|3618985|FG002|Core Study|Subject's decision|10
2047400|NCT00473382|3618983|FG000|Open-label Extension Through Month 48|Adverse Event|0
2047401|NCT00473382|3618984|FG001|Open-label Extension Through Month 48|Adverse Event|0
2047402|NCT00473382|3618985|FG002|Open-label Extension Through Month 48|Adverse Event|1
2047403|NCT00473382|3618983|FG000|Open-label Extension Through Month 48|Death|1
2047404|NCT00473382|3618984|FG001|Open-label Extension Through Month 48|Death|3
2047405|NCT00473382|3618985|FG002|Open-label Extension Through Month 48|Death|3
2047406|NCT00473382|3618983|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
2047407|NCT00473382|3618984|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2
2047408|NCT00473382|3618985|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1
2047409|NCT00473382|3618983|FG000|Open-label Extension Through Month 48|Subject's Decision|5
2047410|NCT00473382|3618984|FG001|Open-label Extension Through Month 48|Subject's Decision|1
2047411|NCT00473382|3618985|FG002|Open-label Extension Through Month 48|Subject's Decision|6
2047412|NCT00473382|3618983|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41
2047413|NCT00473382|3618984|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34
2047414|NCT00473382|3618985|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36
2047415|NCT00473382|3618983|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2
2047416|NCT00473382|3618984|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1
2047417|NCT00473382|3618985|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0
2047418|NCT00473382|3618983|FG000|Open-label Extension Through Month 60|Adverse Event|0
2047419|NCT00473382|3618984|FG001|Open-label Extension Through Month 60|Adverse Event|0
2047420|NCT00473382|3618985|FG002|Open-label Extension Through Month 60|Adverse Event|2
2047421|NCT00473382|3618983|FG000|Open-label Extension Through Month 60|Death|1
2047422|NCT00473382|3618984|FG001|Open-label Extension Through Month 60|Death|7
2047423|NCT00473382|3618985|FG002|Open-label Extension Through Month 60|Death|4
2047424|NCT00473382|3618983|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1
2047425|NCT00473382|3618984|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3
2047426|NCT00473382|3618985|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1
2047427|NCT00473382|3618983|FG000|Open-label Extension Through Month 60|Subject's Decision|7
2047428|NCT00473382|3618984|FG001|Open-label Extension Through Month 60|Subject's Decision|1
2047429|NCT00473382|3618985|FG002|Open-label Extension Through Month 60|Subject's Decision|6
2047430|NCT00473382|3618983|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75
2047431|NCT00473382|3618984|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70
2047432|NCT00473382|3618985|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69
2047433|NCT00473382|3618983|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2
2047434|NCT00473382|3618984|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1
2047435|NCT00473382|3618985|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0
2047436|NCT00473434|3619011|FG000|Overall Study|Physician Decision|3
2047437|NCT00473434|3619011|FG000|Overall Study|Withdrawal by Subject|9
2047438|NCT00473434|3619011|FG000|Overall Study|Compliance|3
2047439|NCT00473434|3619011|FG000|Overall Study|Lack of Efficacy|3
2047440|NCT00473434|3619011|FG000|Overall Study|Adverse Event|3
2047441|NCT00473434|3619011|FG000|Overall Study|Patient was selling medication to others|1
2047442|NCT00473434|3619011|FG000|Overall Study|Safety evaluation|1
2047443|NCT00473434|3619011|FG000|Overall Study|Reason not specified|6
2047444|NCT00473434|3619011|FG000|Overall Study|Ceased in favor of Paliperidone|1
2047445|NCT00473434|3619011|FG000|Overall Study|Switching to trial medication|1
2047446|NCT00473434|3619011|FG000|Overall Study|No longer required|1
2047447|NCT00473512|3619033|FG000|Period 1 (Phase 1)|Adverse Event|0
2047448|NCT00473512|3619034|FG001|Period 1 (Phase 1)|Adverse Event|0
2047449|NCT00473512|3619035|FG002|Period 1 (Phase 1)|Adverse Event|0
2047450|NCT00473512|3619036|FG003|Period 1 (Phase 1)|Adverse Event|5
2047451|NCT00473512|3619037|FG004|Period 1 (Phase 1)|Adverse Event|0
2047452|NCT00473512|3619033|FG000|Period 1 (Phase 1)|Death|0
2047453|NCT00473512|3619034|FG001|Period 1 (Phase 1)|Death|0
2047454|NCT00473512|3619035|FG002|Period 1 (Phase 1)|Death|0
2047455|NCT00473512|3619036|FG003|Period 1 (Phase 1)|Death|1
2047456|NCT00473512|3619037|FG004|Period 1 (Phase 1)|Death|0
2047457|NCT00473512|3619033|FG000|Period 1 (Phase 1)|Disease Progression|1
2047458|NCT00473512|3619034|FG001|Period 1 (Phase 1)|Disease Progression|1
2047459|NCT00473512|3619035|FG002|Period 1 (Phase 1)|Disease Progression|0
2047460|NCT00473512|3619036|FG003|Period 1 (Phase 1)|Disease Progression|10
2047461|NCT00473512|3619037|FG004|Period 1 (Phase 1)|Disease Progression|1
2047462|NCT00473512|3619033|FG000|Period 1 (Phase 1)|Other|0
2047463|NCT00473512|3619034|FG001|Period 1 (Phase 1)|Other|0
2047464|NCT00473512|3619035|FG002|Period 1 (Phase 1)|Other|0
2047465|NCT00473512|3619036|FG003|Period 1 (Phase 1)|Other|1
2047466|NCT00473512|3619037|FG004|Period 1 (Phase 1)|Other|0
2047467|NCT00473512|3619033|FG000|Period 2 (Phase 2)|Adverse Event|0
2047468|NCT00473512|3619034|FG001|Period 2 (Phase 2)|Adverse Event|0
2047469|NCT00473512|3619035|FG002|Period 2 (Phase 2)|Adverse Event|0
2047470|NCT00473512|3619036|FG003|Period 2 (Phase 2)|Adverse Event|1
2047471|NCT00473512|3619037|FG004|Period 2 (Phase 2)|Adverse Event|0
2047472|NCT00473512|3619033|FG000|Period 2 (Phase 2)|Death|0
2047473|NCT00473512|3619034|FG001|Period 2 (Phase 2)|Death|0
2047474|NCT00473512|3619035|FG002|Period 2 (Phase 2)|Death|0
2047475|NCT00473512|3619036|FG003|Period 2 (Phase 2)|Death|1
2047476|NCT00473512|3619037|FG004|Period 2 (Phase 2)|Death|1
2047477|NCT00473512|3619033|FG000|Period 2 (Phase 2)|Disease Progression|0
2047478|NCT00473512|3619034|FG001|Period 2 (Phase 2)|Disease Progression|2
2047479|NCT00473512|3619035|FG002|Period 2 (Phase 2)|Disease Progression|2
2047480|NCT00473512|3619036|FG003|Period 2 (Phase 2)|Disease Progression|17
2047481|NCT00473512|3619037|FG004|Period 2 (Phase 2)|Disease Progression|1
2047482|NCT00473512|3619033|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0
2047483|NCT00473512|3619034|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0
2047484|NCT00473512|3619035|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0
2047485|NCT00473512|3619036|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1
2047486|NCT00473512|3619037|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0
2047487|NCT00473512|3619033|FG000|Period 2 (Phase 2)|Other|1
2047488|NCT00473512|3619034|FG001|Period 2 (Phase 2)|Other|0
2047489|NCT00473512|3619035|FG002|Period 2 (Phase 2)|Other|0
2047490|NCT00473512|3619036|FG003|Period 2 (Phase 2)|Other|3
2047491|NCT00473512|3619037|FG004|Period 2 (Phase 2)|Other|0
2047492|NCT00473564|3619057|FG000|Overall Study|robot surgery aborted in OR|23
2047493|NCT00473590|3619063|FG000|Overall Study|Adverse Event|3
2047494|NCT00473590|3619064|FG001|Overall Study|Adverse Event|3
2047495|NCT00473590|3619063|FG000|Overall Study|Death|4
2047496|NCT00473590|3619064|FG001|Overall Study|Death|2
2047497|NCT00473590|3619063|FG000|Overall Study|Progression not resulting in death|24
2047498|NCT00473590|3619064|FG001|Overall Study|Progression not resulting in death|20
2047499|NCT00473590|3619063|FG000|Overall Study|Non-protocol-specified therapy|7
2047500|NCT00473590|3619064|FG001|Overall Study|Non-protocol-specified therapy|5
2047501|NCT00473590|3619063|FG000|Overall Study|Physician Decision|2
2047502|NCT00473590|3619064|FG001|Overall Study|Physician Decision|4
2047503|NCT00473590|3619063|FG000|Overall Study|Withdrawal by Subject|5
2047504|NCT00473590|3619064|FG001|Overall Study|Withdrawal by Subject|3
2047505|NCT00473590|3619063|FG000|Overall Study|Other|0
2047506|NCT00473590|3619064|FG001|Overall Study|Other|1
2047507|NCT00473655|3619089|FG000|Overall Study|Lost to Follow-up|9
2047508|NCT00473655|3619090|FG001|Overall Study|Lost to Follow-up|5
2047509|NCT00473655|3619091|FG002|Overall Study|Lost to Follow-up|8
2047510|NCT00473668|3619102|FG000|Overall Study|Withdrawal by Subject|0
2047511|NCT00473668|3619103|FG001|Overall Study|Withdrawal by Subject|2
2047512|NCT00473668|3619104|FG002|Overall Study|Withdrawal by Subject|0
2047513|NCT00473668|3619102|FG000|Overall Study|Migrated/moved from study area|3
2047514|NCT00473668|3619103|FG001|Overall Study|Migrated/moved from study area|2
2047515|NCT00473668|3619104|FG002|Overall Study|Migrated/moved from study area|0
2047516|NCT00473668|3619102|FG000|Overall Study|Lost to Follow-up|0
2047517|NCT00473668|3619103|FG001|Overall Study|Lost to Follow-up|4
2047518|NCT00473668|3619104|FG002|Overall Study|Lost to Follow-up|6
2047519|NCT00473668|3619102|FG000|Overall Study|Other|2
2047520|NCT00473668|3619103|FG001|Overall Study|Other|3
2047521|NCT00473668|3619104|FG002|Overall Study|Other|4
2047522|NCT00473694|3619116|FG000|Overall Study|Adverse Event|0
2047523|NCT00473694|3619117|FG001|Overall Study|Adverse Event|1
2047524|NCT00473694|3619118|FG002|Overall Study|Adverse Event|0
2047525|NCT00473694|3619119|FG003|Overall Study|Adverse Event|0
2047526|NCT00473694|3619116|FG000|Overall Study|Participants did not receive treatment|11
2047527|NCT00473694|3619117|FG001|Overall Study|Participants did not receive treatment|3
2047528|NCT00473694|3619118|FG002|Overall Study|Participants did not receive treatment|5
2047529|NCT00473694|3619119|FG003|Overall Study|Participants did not receive treatment|6
2047530|NCT00473694|3619116|FG000|Overall Study|Lost to Follow-up|0
2047531|NCT00473694|3619117|FG001|Overall Study|Lost to Follow-up|0
2047532|NCT00473694|3619118|FG002|Overall Study|Lost to Follow-up|0
2047533|NCT00473694|3619119|FG003|Overall Study|Lost to Follow-up|1
2047534|NCT00473746|3619137|FG000|Period 1 (Phase 1)|Adverse Event|1
2047535|NCT00473746|3619138|FG001|Period 1 (Phase 1)|Adverse Event|0
2047536|NCT00473746|3619139|FG002|Period 1 (Phase 1)|Adverse Event|0
2047537|NCT00473746|3619140|FG003|Period 1 (Phase 1)|Adverse Event|0
2047538|NCT00473746|3619141|FG004|Period 1 (Phase 1)|Adverse Event|0
2047539|NCT00473746|3619137|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0
2047540|NCT00473746|3619138|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1
2047541|NCT00473746|3619139|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0
2047542|NCT00473746|3619140|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0
2047543|NCT00473746|3619141|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0
2047544|NCT00473746|3619137|FG000|Period 1 (Phase 1)|Progressive Disease|5
2047545|NCT00473746|3619138|FG001|Period 1 (Phase 1)|Progressive Disease|6
2208782|NCT01641692|3848411|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1
2208783|NCT01641692|3848412|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0
2208784|NCT01641692|3848405|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
2208785|NCT01641692|3848406|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
2208786|NCT01641692|3848407|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
2208787|NCT01641692|3848408|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
2208788|NCT01641692|3848409|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
2047546|NCT00473746|3619139|FG002|Period 1 (Phase 1)|Progressive Disease|6
2047547|NCT00473746|3619140|FG003|Period 1 (Phase 1)|Progressive Disease|10
2047548|NCT00473746|3619141|FG004|Period 1 (Phase 1)|Progressive Disease|0
2047549|NCT00473746|3619137|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0
2047550|NCT00473746|3619138|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1
2047551|NCT00473746|3619139|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0
2047552|NCT00473746|3619140|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0
2047553|NCT00473746|3619141|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0
2047554|NCT00473746|3619137|FG000|Period 1 (Phase 1)|Reason not specified|0
2047555|NCT00473746|3619138|FG001|Period 1 (Phase 1)|Reason not specified|1
2047556|NCT00473746|3619139|FG002|Period 1 (Phase 1)|Reason not specified|0
2047557|NCT00473746|3619140|FG003|Period 1 (Phase 1)|Reason not specified|0
2047558|NCT00473746|3619141|FG004|Period 1 (Phase 1)|Reason not specified|0
2047559|NCT00473746|3619137|FG000|Period 2 (Phase 2)|Adverse Event|0
2047560|NCT00473746|3619138|FG001|Period 2 (Phase 2)|Adverse Event|0
2047561|NCT00473746|3619139|FG002|Period 2 (Phase 2)|Adverse Event|0
2047562|NCT00473746|3619140|FG003|Period 2 (Phase 2)|Adverse Event|0
2047563|NCT00473746|3619141|FG004|Period 2 (Phase 2)|Adverse Event|3
2047564|NCT00473746|3619137|FG000|Period 2 (Phase 2)|Death|0
2047565|NCT00473746|3619138|FG001|Period 2 (Phase 2)|Death|0
2047566|NCT00473746|3619139|FG002|Period 2 (Phase 2)|Death|0
2047567|NCT00473746|3619140|FG003|Period 2 (Phase 2)|Death|0
2047568|NCT00473746|3619141|FG004|Period 2 (Phase 2)|Death|1
2047569|NCT00473746|3619137|FG000|Period 2 (Phase 2)|Progressive Disease|0
2047570|NCT00473746|3619138|FG001|Period 2 (Phase 2)|Progressive Disease|0
2047571|NCT00473746|3619139|FG002|Period 2 (Phase 2)|Progressive Disease|0
2047572|NCT00473746|3619140|FG003|Period 2 (Phase 2)|Progressive Disease|0
2047573|NCT00473746|3619141|FG004|Period 2 (Phase 2)|Progressive Disease|20
2047574|NCT00473746|3619137|FG000|Period 2 (Phase 2)|Reason not specified|0
2047575|NCT00473746|3619138|FG001|Period 2 (Phase 2)|Reason not specified|0
2047576|NCT00473746|3619139|FG002|Period 2 (Phase 2)|Reason not specified|0
2047577|NCT00473746|3619140|FG003|Period 2 (Phase 2)|Reason not specified|0
2047578|NCT00473746|3619141|FG004|Period 2 (Phase 2)|Reason not specified|3
2047579|NCT00473824|3619157|FG000|Overall Study|Virologic Breakthrough|1
2047580|NCT00473824|3619158|FG001|Overall Study|Virologic Breakthrough|0
2047581|NCT00473824|3619157|FG000|Overall Study|Adverse Event|1
2047582|NCT00473824|3619158|FG001|Overall Study|Adverse Event|0
2047583|NCT00473824|3619157|FG000|Overall Study|Death|1
2047584|NCT00473824|3619158|FG001|Overall Study|Death|0
2047585|NCT00473824|3619157|FG000|Overall Study|Lost to Follow-up|1
2047586|NCT00473824|3619158|FG001|Overall Study|Lost to Follow-up|0
2047587|NCT00473824|3619157|FG000|Overall Study|Withdrawal by physician|1
2047588|NCT00473824|3619158|FG001|Overall Study|Withdrawal by physician|0
2047589|NCT00473876|3619175|FG000|Overall Study|Lost to Follow-up|3
2047590|NCT00473876|3619176|FG001|Overall Study|Lost to Follow-up|1
2047591|NCT00473889|3619186|FG000|Overall Study|Did not receive study medication|1
2047592|NCT00473889|3619187|FG001|Overall Study|Did not receive study medication|4
2047593|NCT00473889|3619186|FG000|Overall Study|Adverse Event|30
2047594|NCT00473889|3619187|FG001|Overall Study|Adverse Event|17
2047595|NCT00473889|3619186|FG000|Overall Study|Protocol Violation|4
2047596|NCT00473889|3619187|FG001|Overall Study|Protocol Violation|2
2047597|NCT00473889|3619186|FG000|Overall Study|Lack of Efficacy|28
2047598|NCT00473889|3619187|FG001|Overall Study|Lack of Efficacy|29
2047599|NCT00473889|3619186|FG000|Overall Study|Lost to Follow-up|2
2047600|NCT00473889|3619187|FG001|Overall Study|Lost to Follow-up|1
2047601|NCT00473889|3619186|FG000|Overall Study|Physician Decision|10
2047602|NCT00473889|3619187|FG001|Overall Study|Physician Decision|5
2047603|NCT00473889|3619186|FG000|Overall Study|Trial Terminated|3
2047604|NCT00473889|3619187|FG001|Overall Study|Trial Terminated|6
2047605|NCT00473889|3619186|FG000|Overall Study|Withdrawal by Subject|5
2047606|NCT00473889|3619187|FG001|Overall Study|Withdrawal by Subject|0
2105193|NCT00855920|3697675|FG002|Overall Study|Lost to Follow-up|2
2105194|NCT00855920|3697673|FG000|Overall Study|Death|0
2105195|NCT00855920|3697674|FG001|Overall Study|Death|1
2105196|NCT00855920|3697675|FG002|Overall Study|Death|0
2105197|NCT00855920|3697673|FG000|Overall Study|Decision by the sponsor|0
2105198|NCT00855920|3697674|FG001|Overall Study|Decision by the sponsor|1
2105199|NCT00855920|3697675|FG002|Overall Study|Decision by the sponsor|1
2105200|NCT00855920|3697673|FG000|Overall Study|Other than specified above|1
2105201|NCT00855920|3697674|FG001|Overall Study|Other than specified above|1
2105202|NCT00855920|3697675|FG002|Overall Study|Other than specified above|1
2105203|NCT00855933|3697685|FG000|Overall Study|Withdrawal by Subject|0
2105204|NCT00855933|3697686|FG001|Overall Study|Withdrawal by Subject|1
2105205|NCT00855959|3697692|FG000|Overall Study|Adverse Event|2
2105206|NCT00855959|3697692|FG000|Overall Study|Lost to Follow-up|2
2105207|NCT00855959|3697692|FG000|Overall Study|Withdrawal by Subject|3
2105208|NCT00855959|3697692|FG000|Overall Study|Pregnancy|1
2105209|NCT00855959|3697692|FG000|Overall Study|Incorrect enrolment|1
2105210|NCT00856180|3697706|FG000|Overall Study|Adverse Event|4
2105211|NCT00856180|3697706|FG000|Overall Study|Progressive Disease|16
2108134|NCT00878501|3701987|FG000|Overall Study|Protocol Violation|0
2108135|NCT00878501|3701988|FG001|Overall Study|Protocol Violation|0
2108136|NCT00878501|3701989|FG002|Overall Study|Protocol Violation|1
2108137|NCT00878501|3701987|FG000|Overall Study|Incorrect enrolment|1
2108138|NCT00878501|3701988|FG001|Overall Study|Incorrect enrolment|2
2108139|NCT00878501|3701989|FG002|Overall Study|Incorrect enrolment|0
2108140|NCT00878501|3701987|FG000|Overall Study|Intake of prohibited concom. medication|0
2108141|NCT00878501|3701988|FG001|Overall Study|Intake of prohibited concom. medication|0
2108142|NCT00878501|3701989|FG002|Overall Study|Intake of prohibited concom. medication|1
2108143|NCT00878501|3701987|FG000|Overall Study|Mis-randomisation of patient|1
2108144|NCT00878501|3701988|FG001|Overall Study|Mis-randomisation of patient|0
2108145|NCT00878501|3701989|FG002|Overall Study|Mis-randomisation of patient|0
2108146|NCT00878501|3701987|FG000|Overall Study|Administrative|0
2108147|NCT00878501|3701988|FG001|Overall Study|Administrative|0
2108148|NCT00878501|3701989|FG002|Overall Study|Administrative|1
2108149|NCT00878553|3702001|FG000|Sleep Study|Withdrawal by Subject|2
2108150|NCT00878553|3702002|FG001|Sleep Study|Withdrawal by Subject|0
2108151|NCT00878553|3702003|FG002|Sleep Study|Withdrawal by Subject|0
2108152|NCT00878553|3702004|FG003|Sleep Study|Withdrawal by Subject|0
2108153|NCT00878553|3702005|FG004|Sleep Study|Withdrawal by Subject|0
2108154|NCT00878553|3702001|FG000|Sleep Study|Lost to Follow-up|1
2108155|NCT00878553|3702002|FG001|Sleep Study|Lost to Follow-up|0
2047607|NCT00474045|3619195|FG000|Overall Study|Adverse Event|18
2047608|NCT00474045|3619196|FG001|Overall Study|Adverse Event|8
2047609|NCT00474045|3619195|FG000|Overall Study|Unclassified|1
2047610|NCT00474045|3619196|FG001|Overall Study|Unclassified|3
2047611|NCT00474045|3619195|FG000|Overall Study|Lack of Efficacy|0
2047612|NCT00474045|3619196|FG001|Overall Study|Lack of Efficacy|9
2047613|NCT00474045|3619195|FG000|Overall Study|Lost to Follow-up|1
2047614|NCT00474045|3619196|FG001|Overall Study|Lost to Follow-up|1
2047615|NCT00474045|3619195|FG000|Overall Study|Protocol Violation|10
2047616|NCT00474045|3619196|FG001|Overall Study|Protocol Violation|12
2047617|NCT00474045|3619195|FG000|Overall Study|Withdrawal by Subject|16
2047618|NCT00474045|3619196|FG001|Overall Study|Withdrawal by Subject|18
2047619|NCT00474045|3619195|FG000|Overall Study|Withdrawal criteria|60
2047620|NCT00474045|3619196|FG001|Overall Study|Withdrawal criteria|50
2047621|NCT00474058|3619204|FG000|Overall Study|Adverse Event|11
2047622|NCT00474058|3619205|FG001|Overall Study|Adverse Event|6
2047623|NCT00474058|3619204|FG000|Overall Study|Lack of Efficacy|0
2047624|NCT00474058|3619205|FG001|Overall Study|Lack of Efficacy|4
2047625|NCT00474058|3619204|FG000|Overall Study|Withdrawal by Subject|11
2047626|NCT00474058|3619205|FG001|Overall Study|Withdrawal by Subject|7
2047627|NCT00474058|3619204|FG000|Overall Study|Other|2
2047628|NCT00474058|3619205|FG001|Overall Study|Other|0
2047629|NCT00474175|3619223|FG000|Overall Study|Lack of Efficacy|0
2047630|NCT00474175|3619224|FG001|Overall Study|Lack of Efficacy|0
2047631|NCT00474175|3619225|FG002|Overall Study|Lack of Efficacy|1
2047632|NCT00474175|3619223|FG000|Overall Study|Withdrawal by Subject|0
2047633|NCT00474175|3619224|FG001|Overall Study|Withdrawal by Subject|1
2047634|NCT00474175|3619225|FG002|Overall Study|Withdrawal by Subject|1
2047635|NCT00474175|3619223|FG000|Overall Study|Ineligible|1
2047636|NCT00474175|3619224|FG001|Overall Study|Ineligible|3
2047637|NCT00474175|3619225|FG002|Overall Study|Ineligible|1
2047638|NCT00474175|3619223|FG000|Overall Study|Protocol Violation|0
2047639|NCT00474175|3619224|FG001|Overall Study|Protocol Violation|2
2047640|NCT00474175|3619225|FG002|Overall Study|Protocol Violation|1
2047641|NCT00474175|3619223|FG000|Overall Study|Administrative|0
2047642|NCT00474175|3619224|FG001|Overall Study|Administrative|1
2047643|NCT00474175|3619225|FG002|Overall Study|Administrative|0
2047644|NCT00474240|3619244|FG000|Overall Study|Withdrawal by Subject|1
2047645|NCT00474240|3619245|FG001|Overall Study|Withdrawal by Subject|1
2047646|NCT00474240|3619246|FG002|Overall Study|Withdrawal by Subject|0
2047647|NCT00474240|3619247|FG003|Overall Study|Withdrawal by Subject|2
2047648|NCT00474240|3619248|FG004|Overall Study|Withdrawal by Subject|3
2047649|NCT00474240|3619249|FG005|Overall Study|Withdrawal by Subject|1
2047650|NCT00474240|3619244|FG000|Overall Study|Adverse Event|0
2047651|NCT00474240|3619245|FG001|Overall Study|Adverse Event|0
2047652|NCT00474240|3619246|FG002|Overall Study|Adverse Event|9
2047653|NCT00474240|3619247|FG003|Overall Study|Adverse Event|14
2047654|NCT00474240|3619248|FG004|Overall Study|Adverse Event|5
2047655|NCT00474240|3619249|FG005|Overall Study|Adverse Event|16
2047656|NCT00474240|3619244|FG000|Overall Study|Removed due to lab value|0
2047657|NCT00474240|3619245|FG001|Overall Study|Removed due to lab value|0
2047658|NCT00474240|3619246|FG002|Overall Study|Removed due to lab value|0
2047659|NCT00474240|3619247|FG003|Overall Study|Removed due to lab value|0
2047660|NCT00474240|3619248|FG004|Overall Study|Removed due to lab value|0
2047661|NCT00474240|3619249|FG005|Overall Study|Removed due to lab value|1
2047662|NCT00474253|3619265|FG000|Overall Study|Withdrew consent|2
2047663|NCT00474253|3619266|FG001|Overall Study|Withdrew consent|0
2047664|NCT00474253|3619265|FG000|Overall Study|Withdrew due to surgery-related issues|0
2047665|NCT00474253|3619266|FG001|Overall Study|Withdrew due to surgery-related issues|3
2047666|NCT00474253|3619265|FG000|Overall Study|Lost to Follow-up|1
2047667|NCT00474253|3619266|FG001|Overall Study|Lost to Follow-up|0
2047668|NCT00474253|3619265|FG000|Overall Study|Discharged prior to study completion|0
2047669|NCT00474253|3619266|FG001|Overall Study|Discharged prior to study completion|1
2047670|NCT00474266|3619276|FG000|Overall Study|Withdrawal by Subject|7
2047671|NCT00474266|3619277|FG001|Overall Study|Withdrawal by Subject|20
2047672|NCT00474266|3619278|FG002|Overall Study|Withdrawal by Subject|4
2047673|NCT00474266|3619279|FG003|Overall Study|Withdrawal by Subject|7
2047674|NCT00474383|3619292|FG000|Main Study|Adverse Event|11
2047675|NCT00474383|3619293|FG001|Main Study|Adverse Event|0
2047676|NCT00474383|3619292|FG000|Main Study|Symptomatic Deterioration|1
2047677|NCT00474383|3619293|FG001|Main Study|Symptomatic Deterioration|0
2047678|NCT00474383|3619292|FG000|Main Study|Progressive Disease|23
2047679|NCT00474383|3619293|FG001|Main Study|Progressive Disease|0
2047680|NCT00474383|3619292|FG000|Main Study|Other|1
2047681|NCT00474383|3619293|FG001|Main Study|Other|0
2047682|NCT00474383|3619292|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6
2047683|NCT00474383|3619293|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0
2047684|NCT00474383|3619292|FG000|Extension|Progressive Disease|0
2047685|NCT00474383|3619293|FG001|Extension|Progressive Disease|5
2047686|NCT00474487|3619301|FG000|Overall Study|Withdrawal by Subject|6
2047687|NCT00474487|3619302|FG001|Overall Study|Withdrawal by Subject|0
2047688|NCT00474487|3619303|FG002|Overall Study|Withdrawal by Subject|0
2047689|NCT00474487|3619304|FG003|Overall Study|Withdrawal by Subject|0
2047690|NCT00474487|3619301|FG000|Overall Study|Lost to Follow-up|20
2047691|NCT00474487|3619302|FG001|Overall Study|Lost to Follow-up|1
2047692|NCT00474487|3619303|FG002|Overall Study|Lost to Follow-up|7
2047693|NCT00474487|3619304|FG003|Overall Study|Lost to Follow-up|0
2047694|NCT00474487|3619301|FG000|Overall Study|Inappropriate enrollment|4
2047695|NCT00474487|3619302|FG001|Overall Study|Inappropriate enrollment|0
2047696|NCT00474487|3619303|FG002|Overall Study|Inappropriate enrollment|7
2047697|NCT00474487|3619304|FG003|Overall Study|Inappropriate enrollment|0
2047698|NCT00474487|3619301|FG000|Overall Study|Death|0
2047699|NCT00474487|3619302|FG001|Overall Study|Death|1
2047700|NCT00474487|3619303|FG002|Overall Study|Death|0
2047701|NCT00474487|3619304|FG003|Overall Study|Death|0
2047702|NCT00474526|3619331|FG000|Overall Study|ADMINISTRATIVE REASON|11
2047703|NCT00474526|3619332|FG001|Overall Study|ADMINISTRATIVE REASON|9
2047704|NCT00474526|3619333|FG002|Overall Study|ADMINISTRATIVE REASON|9
2047705|NCT00474526|3619334|FG003|Overall Study|ADMINISTRATIVE REASON|20
2047706|NCT00474526|3619335|FG004|Overall Study|ADMINISTRATIVE REASON|9
2047707|NCT00474526|3619336|FG005|Overall Study|ADMINISTRATIVE REASON|1
2047708|NCT00474526|3619337|FG006|Overall Study|ADMINISTRATIVE REASON|1
2047709|NCT00474526|3619338|FG007|Overall Study|ADMINISTRATIVE REASON|0
2047710|NCT00474526|3619339|FG008|Overall Study|ADMINISTRATIVE REASON|2
2047711|NCT00474526|3619340|FG009|Overall Study|ADMINISTRATIVE REASON|1
2047712|NCT00474526|3619341|FG010|Overall Study|ADMINISTRATIVE REASON|1
2047713|NCT00474526|3619342|FG011|Overall Study|ADMINISTRATIVE REASON|1
2047714|NCT00474526|3619343|FG012|Overall Study|ADMINISTRATIVE REASON|1
2047715|NCT00474526|3619344|FG013|Overall Study|ADMINISTRATIVE REASON|1
2047716|NCT00474526|3619345|FG014|Overall Study|ADMINISTRATIVE REASON|2
2047717|NCT00474526|3619346|FG015|Overall Study|ADMINISTRATIVE REASON|0
2047718|NCT00474526|3619347|FG016|Overall Study|ADMINISTRATIVE REASON|0
2047719|NCT00474526|3619331|FG000|Overall Study|Adverse Event|2
2047720|NCT00474526|3619332|FG001|Overall Study|Adverse Event|0
2047721|NCT00474526|3619333|FG002|Overall Study|Adverse Event|2
2047722|NCT00474526|3619334|FG003|Overall Study|Adverse Event|4
2047723|NCT00474526|3619335|FG004|Overall Study|Adverse Event|2
2047724|NCT00474526|3619336|FG005|Overall Study|Adverse Event|1
2047725|NCT00474526|3619337|FG006|Overall Study|Adverse Event|1
2047726|NCT00474526|3619338|FG007|Overall Study|Adverse Event|0
2047727|NCT00474526|3619339|FG008|Overall Study|Adverse Event|0
2047728|NCT00474526|3619340|FG009|Overall Study|Adverse Event|0
2047729|NCT00474526|3619341|FG010|Overall Study|Adverse Event|0
2047730|NCT00474526|3619342|FG011|Overall Study|Adverse Event|0
2047731|NCT00474526|3619343|FG012|Overall Study|Adverse Event|0
2047732|NCT00474526|3619344|FG013|Overall Study|Adverse Event|0
2047733|NCT00474526|3619345|FG014|Overall Study|Adverse Event|1
2047734|NCT00474526|3619346|FG015|Overall Study|Adverse Event|1
2047735|NCT00474526|3619347|FG016|Overall Study|Adverse Event|0
2047736|NCT00474526|3619331|FG000|Overall Study|Death|0
2047737|NCT00474526|3619332|FG001|Overall Study|Death|0
2047738|NCT00474526|3619333|FG002|Overall Study|Death|0
2047739|NCT00474526|3619334|FG003|Overall Study|Death|0
2047740|NCT00474526|3619335|FG004|Overall Study|Death|0
2047741|NCT00474526|3619336|FG005|Overall Study|Death|0
2047742|NCT00474526|3619337|FG006|Overall Study|Death|0
2047743|NCT00474526|3619338|FG007|Overall Study|Death|0
2047744|NCT00474526|3619339|FG008|Overall Study|Death|0
2047745|NCT00474526|3619340|FG009|Overall Study|Death|0
2047746|NCT00474526|3619341|FG010|Overall Study|Death|0
2047747|NCT00474526|3619342|FG011|Overall Study|Death|0
2047748|NCT00474526|3619343|FG012|Overall Study|Death|0
2047749|NCT00474526|3619344|FG013|Overall Study|Death|3
2047750|NCT00474526|3619345|FG014|Overall Study|Death|0
2047751|NCT00474526|3619346|FG015|Overall Study|Death|0
2047752|NCT00474526|3619347|FG016|Overall Study|Death|0
2047753|NCT00474526|3619331|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047754|NCT00474526|3619332|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1
2047755|NCT00474526|3619333|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047756|NCT00474526|3619334|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1
2047757|NCT00474526|3619335|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2
2047758|NCT00474526|3619336|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047759|NCT00474526|3619337|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047760|NCT00474526|3619338|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047761|NCT00474526|3619339|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047762|NCT00474526|3619340|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047763|NCT00474526|3619341|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047764|NCT00474526|3619342|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047765|NCT00474526|3619343|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047766|NCT00474526|3619344|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2
2047767|NCT00474526|3619345|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2
2047768|NCT00474526|3619346|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047769|NCT00474526|3619347|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0
2047770|NCT00474526|3619331|FG000|Overall Study|Lost to Follow-up|8
2047771|NCT00474526|3619332|FG001|Overall Study|Lost to Follow-up|6
2047772|NCT00474526|3619333|FG002|Overall Study|Lost to Follow-up|13
2047773|NCT00474526|3619334|FG003|Overall Study|Lost to Follow-up|29
2047774|NCT00474526|3619335|FG004|Overall Study|Lost to Follow-up|11
2047775|NCT00474526|3619336|FG005|Overall Study|Lost to Follow-up|5
2047776|NCT00474526|3619337|FG006|Overall Study|Lost to Follow-up|8
2047777|NCT00474526|3619338|FG007|Overall Study|Lost to Follow-up|1
2047778|NCT00474526|3619339|FG008|Overall Study|Lost to Follow-up|0
2047779|NCT00474526|3619340|FG009|Overall Study|Lost to Follow-up|6
2047780|NCT00474526|3619341|FG010|Overall Study|Lost to Follow-up|2
2047781|NCT00474526|3619342|FG011|Overall Study|Lost to Follow-up|4
2047782|NCT00474526|3619343|FG012|Overall Study|Lost to Follow-up|6
2047783|NCT00474526|3619344|FG013|Overall Study|Lost to Follow-up|74
2047784|NCT00474526|3619345|FG014|Overall Study|Lost to Follow-up|29
2047785|NCT00474526|3619346|FG015|Overall Study|Lost to Follow-up|4
2047786|NCT00474526|3619347|FG016|Overall Study|Lost to Follow-up|5
2047787|NCT00474526|3619331|FG000|Overall Study|Protocol Violation|2
2047788|NCT00474526|3619332|FG001|Overall Study|Protocol Violation|6
2047789|NCT00474526|3619333|FG002|Overall Study|Protocol Violation|4
2047790|NCT00474526|3619334|FG003|Overall Study|Protocol Violation|12
2047791|NCT00474526|3619335|FG004|Overall Study|Protocol Violation|3
2047792|NCT00474526|3619336|FG005|Overall Study|Protocol Violation|1
2047793|NCT00474526|3619337|FG006|Overall Study|Protocol Violation|3
2047794|NCT00474526|3619338|FG007|Overall Study|Protocol Violation|0
2047795|NCT00474526|3619339|FG008|Overall Study|Protocol Violation|0
2047796|NCT00474526|3619340|FG009|Overall Study|Protocol Violation|4
2047797|NCT00474526|3619341|FG010|Overall Study|Protocol Violation|2
2047798|NCT00474526|3619342|FG011|Overall Study|Protocol Violation|2
2047799|NCT00474526|3619343|FG012|Overall Study|Protocol Violation|4
2047800|NCT00474526|3619344|FG013|Overall Study|Protocol Violation|19
2047801|NCT00474526|3619345|FG014|Overall Study|Protocol Violation|9
2047802|NCT00474526|3619346|FG015|Overall Study|Protocol Violation|6
2047803|NCT00474526|3619347|FG016|Overall Study|Protocol Violation|2
2047804|NCT00474526|3619331|FG000|Overall Study|UNABLE TO CLASSIFY|1
2047805|NCT00474526|3619332|FG001|Overall Study|UNABLE TO CLASSIFY|0
2047806|NCT00474526|3619333|FG002|Overall Study|UNABLE TO CLASSIFY|0
2047807|NCT00474526|3619334|FG003|Overall Study|UNABLE TO CLASSIFY|1
2047808|NCT00474526|3619335|FG004|Overall Study|UNABLE TO CLASSIFY|3
2047809|NCT00474526|3619336|FG005|Overall Study|UNABLE TO CLASSIFY|2
2047810|NCT00474526|3619337|FG006|Overall Study|UNABLE TO CLASSIFY|0
2047811|NCT00474526|3619338|FG007|Overall Study|UNABLE TO CLASSIFY|1
2047812|NCT00474526|3619339|FG008|Overall Study|UNABLE TO CLASSIFY|0
2047813|NCT00474526|3619340|FG009|Overall Study|UNABLE TO CLASSIFY|3
2047814|NCT00474526|3619341|FG010|Overall Study|UNABLE TO CLASSIFY|0
2047815|NCT00474526|3619342|FG011|Overall Study|UNABLE TO CLASSIFY|0
2047816|NCT00474526|3619343|FG012|Overall Study|UNABLE TO CLASSIFY|0
2047817|NCT00474526|3619344|FG013|Overall Study|UNABLE TO CLASSIFY|20
2047818|NCT00474526|3619345|FG014|Overall Study|UNABLE TO CLASSIFY|12
2047819|NCT00474526|3619346|FG015|Overall Study|UNABLE TO CLASSIFY|6
2047820|NCT00474526|3619347|FG016|Overall Study|UNABLE TO CLASSIFY|1
2047821|NCT00474526|3619331|FG000|Overall Study|Withdrawal by Subject|9
2047822|NCT00474526|3619332|FG001|Overall Study|Withdrawal by Subject|24
2047823|NCT00474526|3619333|FG002|Overall Study|Withdrawal by Subject|21
2047824|NCT00474526|3619334|FG003|Overall Study|Withdrawal by Subject|52
2047825|NCT00474526|3619335|FG004|Overall Study|Withdrawal by Subject|38
2047826|NCT00474526|3619336|FG005|Overall Study|Withdrawal by Subject|6
2047827|NCT00474526|3619337|FG006|Overall Study|Withdrawal by Subject|12
2047828|NCT00474526|3619338|FG007|Overall Study|Withdrawal by Subject|4
2047829|NCT00474526|3619339|FG008|Overall Study|Withdrawal by Subject|4
2047830|NCT00474526|3619340|FG009|Overall Study|Withdrawal by Subject|13
2047831|NCT00474526|3619341|FG010|Overall Study|Withdrawal by Subject|5
2047832|NCT00474526|3619342|FG011|Overall Study|Withdrawal by Subject|4
2047833|NCT00474526|3619343|FG012|Overall Study|Withdrawal by Subject|4
2047834|NCT00474526|3619344|FG013|Overall Study|Withdrawal by Subject|37
2047835|NCT00474526|3619345|FG014|Overall Study|Withdrawal by Subject|22
2047836|NCT00474526|3619346|FG015|Overall Study|Withdrawal by Subject|1
2047837|NCT00474526|3619347|FG016|Overall Study|Withdrawal by Subject|1
2047838|NCT00474539|3619435|FG000|Infant Series|Withdrawal by Subject|3
2047839|NCT00474539|3619436|FG001|Infant Series|Withdrawal by Subject|4
2047840|NCT00474539|3619435|FG000|Infant Series|Randomization error|5
2047841|NCT00474539|3619436|FG001|Infant Series|Randomization error|0
2047842|NCT00474539|3619435|FG000|Infant Series|Lost to Follow-up|2
2047843|NCT00474539|3619436|FG001|Infant Series|Lost to Follow-up|1
2047844|NCT00474539|3619435|FG000|Infant Series|Protocol Violation|0
2047845|NCT00474539|3619436|FG001|Infant Series|Protocol Violation|1
2047846|NCT00474539|3619435|FG000|After Infant Series|Lost to Follow-up|3
2047847|NCT00474539|3619436|FG001|After Infant Series|Lost to Follow-up|0
2047848|NCT00474539|3619435|FG000|After Infant Series|Withdrawal by Subject|1
2047849|NCT00474539|3619436|FG001|After Infant Series|Withdrawal by Subject|0
2047850|NCT00474539|3619435|FG000|Toddler Dose|Protocol Violation|1
2047851|NCT00474539|3619436|FG001|Toddler Dose|Protocol Violation|0
2047852|NCT00474630|3619482|FG000|Overall Study|Adverse Event|98
2047853|NCT00474630|3619483|FG001|Overall Study|Adverse Event|26
2047854|NCT00474630|3619482|FG000|Overall Study|Lost to Follow-up|22
2047855|NCT00474630|3619483|FG001|Overall Study|Lost to Follow-up|15
2047856|NCT00474630|3619482|FG000|Overall Study|Withdrawal by Subject|21
2047857|NCT00474630|3619483|FG001|Overall Study|Withdrawal by Subject|15
2047858|NCT00474630|3619482|FG000|Overall Study|Protocol Violation|3
2047859|NCT00474630|3619483|FG001|Overall Study|Protocol Violation|4
2047860|NCT00474630|3619482|FG000|Overall Study|Lack of Efficacy|5
2047861|NCT00474630|3619483|FG001|Overall Study|Lack of Efficacy|6
2047862|NCT00474630|3619482|FG000|Overall Study|Drug noncompliance, other|11
2047863|NCT00474630|3619483|FG001|Overall Study|Drug noncompliance, other|4
2047864|NCT00474708|3619492|FG000|Overall Study|Lack of Efficacy|11
2047865|NCT00474708|3619493|FG001|Overall Study|Lack of Efficacy|5
2047866|NCT00474708|3619492|FG000|Overall Study|Suicide ideation/behavior|0
2047867|NCT00474708|3619493|FG001|Overall Study|Suicide ideation/behavior|1
2047868|NCT00474708|3619492|FG000|Overall Study|Withdrawal by Subject|7
2047869|NCT00474708|3619493|FG001|Overall Study|Withdrawal by Subject|0
2047870|NCT00474708|3619492|FG000|Overall Study|Lack of compliance|12
2047871|NCT00474708|3619493|FG001|Overall Study|Lack of compliance|4
2047872|NCT00474708|3619492|FG000|Overall Study|Lost to Follow-up|18
2047873|NCT00474708|3619493|FG001|Overall Study|Lost to Follow-up|9
2047874|NCT00474708|3619492|FG000|Overall Study|Physician Decision|9
2047875|NCT00474708|3619493|FG001|Overall Study|Physician Decision|6
2047876|NCT00474760|3619506|FG000|Overall Study|Death|0
2047877|NCT00474760|3619507|FG001|Overall Study|Death|0
2047878|NCT00474760|3619508|FG002|Overall Study|Death|0
2047879|NCT00474760|3619509|FG003|Overall Study|Death|0
2047880|NCT00474760|3619510|FG004|Overall Study|Death|2
2047881|NCT00474760|3619511|FG005|Overall Study|Death|0
2047882|NCT00474760|3619512|FG006|Overall Study|Death|0
2047883|NCT00474760|3619506|FG000|Overall Study|Adverse Event|0
2047884|NCT00474760|3619507|FG001|Overall Study|Adverse Event|0
2047885|NCT00474760|3619508|FG002|Overall Study|Adverse Event|0
2047886|NCT00474760|3619509|FG003|Overall Study|Adverse Event|0
2047887|NCT00474760|3619510|FG004|Overall Study|Adverse Event|1
2047888|NCT00474760|3619511|FG005|Overall Study|Adverse Event|7
2047889|NCT00474760|3619512|FG006|Overall Study|Adverse Event|0
2047890|NCT00474760|3619506|FG000|Overall Study|Laboratory abnormality|0
2047891|NCT00474760|3619507|FG001|Overall Study|Laboratory abnormality|0
2047892|NCT00474760|3619508|FG002|Overall Study|Laboratory abnormality|0
2047893|NCT00474760|3619509|FG003|Overall Study|Laboratory abnormality|0
2047894|NCT00474760|3619510|FG004|Overall Study|Laboratory abnormality|0
2047895|NCT00474760|3619511|FG005|Overall Study|Laboratory abnormality|1
2047896|NCT00474760|3619512|FG006|Overall Study|Laboratory abnormality|0
2047897|NCT00474760|3619506|FG000|Overall Study|Withdrawal by Subject|0
2047898|NCT00474760|3619507|FG001|Overall Study|Withdrawal by Subject|0
2047899|NCT00474760|3619508|FG002|Overall Study|Withdrawal by Subject|0
2047900|NCT00474760|3619509|FG003|Overall Study|Withdrawal by Subject|1
2047901|NCT00474760|3619510|FG004|Overall Study|Withdrawal by Subject|0
2047902|NCT00474760|3619511|FG005|Overall Study|Withdrawal by Subject|1
2047903|NCT00474760|3619512|FG006|Overall Study|Withdrawal by Subject|1
2047904|NCT00474760|3619506|FG000|Overall Study|Other|0
2047905|NCT00474760|3619507|FG001|Overall Study|Other|1
2047906|NCT00474760|3619508|FG002|Overall Study|Other|0
2047907|NCT00474760|3619509|FG003|Overall Study|Other|0
2047908|NCT00474760|3619510|FG004|Overall Study|Other|1
2047909|NCT00474760|3619511|FG005|Overall Study|Other|0
2047910|NCT00474760|3619512|FG006|Overall Study|Other|0
2047911|NCT00474760|3619506|FG000|Overall Study|Progressive disease|3
2047912|NCT00474760|3619507|FG001|Overall Study|Progressive disease|2
2047913|NCT00474760|3619508|FG002|Overall Study|Progressive disease|3
2047914|NCT00474760|3619509|FG003|Overall Study|Progressive disease|2
2047915|NCT00474760|3619510|FG004|Overall Study|Progressive disease|8
2047916|NCT00474760|3619511|FG005|Overall Study|Progressive disease|20
2047917|NCT00474760|3619512|FG006|Overall Study|Progressive disease|7
2047918|NCT00474760|3619506|FG000|Overall Study|Terminated by sponsor|0
2047919|NCT00474760|3619507|FG001|Overall Study|Terminated by sponsor|0
2047920|NCT00474760|3619508|FG002|Overall Study|Terminated by sponsor|0
2047921|NCT00474760|3619509|FG003|Overall Study|Terminated by sponsor|0
2047922|NCT00474760|3619510|FG004|Overall Study|Terminated by sponsor|0
2047923|NCT00474760|3619511|FG005|Overall Study|Terminated by sponsor|0
2047924|NCT00474760|3619512|FG006|Overall Study|Terminated by sponsor|2
2047925|NCT00474786|3619537|FG000|Overall Study|Not Meeting Study Criteria|0
2047926|NCT00474786|3619538|FG001|Overall Study|Not Meeting Study Criteria|1
2047927|NCT00474786|3619537|FG000|Overall Study|Investigator Request|2
2047928|NCT00474786|3619538|FG001|Overall Study|Investigator Request|1
2047929|NCT00474786|3619537|FG000|Overall Study|Death|189
2047930|NCT00474786|3619538|FG001|Overall Study|Death|170
2047931|NCT00474786|3619537|FG000|Overall Study|Discontinuation of Study by Sponsor|42
2047932|NCT00474786|3619538|FG001|Overall Study|Discontinuation of Study by Sponsor|59
2047933|NCT00474786|3619537|FG000|Overall Study|Lost to Follow-up|4
2047934|NCT00474786|3619538|FG001|Overall Study|Lost to Follow-up|7
2047935|NCT00474786|3619537|FG000|Overall Study|Protocol Violation|2
2047936|NCT00474786|3619538|FG001|Overall Study|Protocol Violation|0
2047937|NCT00474786|3619537|FG000|Overall Study|Withdrawal by Subject|15
2047938|NCT00474786|3619538|FG001|Overall Study|Withdrawal by Subject|15
2047939|NCT00474786|3619537|FG000|Overall Study|Other|5
2047940|NCT00474786|3619538|FG001|Overall Study|Other|0
2047941|NCT00474812|3619544|FG000|Overall Study|Withdrawal by Subject|5
2047942|NCT00474812|3619544|FG000|Overall Study|No Initiation of treatment|2
2047943|NCT00474903|3619561|FG000|Overall Study|Protocol Violation|1
2047944|NCT00474903|3619562|FG001|Overall Study|Protocol Violation|5
2047945|NCT00474903|3619563|FG002|Overall Study|Protocol Violation|2
2047946|NCT00474929|3619576|FG000|Overall Study|Withdrawal by Subject|0
2047947|NCT00474929|3619577|FG001|Overall Study|Withdrawal by Subject|1
2047948|NCT00474929|3619578|FG002|Overall Study|Withdrawal by Subject|0
2047949|NCT00474929|3619579|FG003|Overall Study|Withdrawal by Subject|0
2047950|NCT00474929|3619580|FG004|Overall Study|Withdrawal by Subject|0
2047951|NCT00474929|3619576|FG000|Overall Study|Unrelated medical condition|0
2047952|NCT00474929|3619577|FG001|Overall Study|Unrelated medical condition|0
2047953|NCT00474929|3619578|FG002|Overall Study|Unrelated medical condition|1
2047954|NCT00474929|3619579|FG003|Overall Study|Unrelated medical condition|0
2047955|NCT00474929|3619580|FG004|Overall Study|Unrelated medical condition|0
2047956|NCT00474929|3619576|FG000|Overall Study|Physician Decision|0
2047957|NCT00474929|3619577|FG001|Overall Study|Physician Decision|0
2047958|NCT00474929|3619578|FG002|Overall Study|Physician Decision|1
2047959|NCT00474929|3619579|FG003|Overall Study|Physician Decision|2
2217672|NCT01709305|3860932|FG004|Phase 1|Protocol Violation|0
2047960|NCT00474929|3619580|FG004|Overall Study|Physician Decision|0
2047961|NCT00474955|3619593|FG000|Overall Study|Adverse Event|2
2047962|NCT00474955|3619593|FG000|Overall Study|Drug unavailability|1
2047963|NCT00474955|3619593|FG000|Overall Study|Personal reasons|5
2047964|NCT00474968|3619599|FG000|Overall Study|Withdrawal by Subject|8
2047965|NCT00474968|3619600|FG001|Overall Study|Withdrawal by Subject|7
2047966|NCT00474968|3619599|FG000|Overall Study|Protocol Violation|9
2047967|NCT00474968|3619600|FG001|Overall Study|Protocol Violation|8
2047968|NCT00474968|3619599|FG000|Overall Study|Sample not collected|1
2047969|NCT00474968|3619600|FG001|Overall Study|Sample not collected|1
2047970|NCT00474994|3619606|FG000|Overall Study|Patient Not treated|1
2047971|NCT00474994|3619606|FG000|Overall Study|Patient evaluable for toxicity only|3
2047972|NCT00474994|3619606|FG000|Overall Study|Patient found to be ineligible|1
2047973|NCT00475020|3619610|FG000|Overall Study|Physician Decision|3
2047974|NCT00475020|3619610|FG000|Overall Study|Insurance Denial|1
2047975|NCT00475020|3619610|FG000|Overall Study|Donor not able to donate the last minute|1
2047976|NCT00475033|3619616|FG000|Infant Series|Failed to return|3
2047977|NCT00475033|3619617|FG001|Infant Series|Failed to return|4
2047978|NCT00475033|3619616|FG000|Infant Series|Parent or legal guardian request|1
2047979|NCT00475033|3619617|FG001|Infant Series|Parent or legal guardian request|5
2047980|NCT00475033|3619616|FG000|Infant Series|Protocol Violation|1
2047981|NCT00475033|3619617|FG001|Infant Series|Protocol Violation|2
2047982|NCT00475033|3619616|FG000|Infant Series|Lost to Follow-up|2
2047983|NCT00475033|3619617|FG001|Infant Series|Lost to Follow-up|0
2047984|NCT00475033|3619616|FG000|Infant Series|Adverse Event|0
2047985|NCT00475033|3619617|FG001|Infant Series|Adverse Event|2
2047986|NCT00475033|3619616|FG000|After the Infant Series|Adverse Event|0
2047987|NCT00475033|3619617|FG001|After the Infant Series|Adverse Event|4
2047988|NCT00475033|3619616|FG000|After the Infant Series|Parent or legal guardian request|2
2047989|NCT00475033|3619617|FG001|After the Infant Series|Parent or legal guardian request|2
2047990|NCT00475033|3619616|FG000|After the Infant Series|Failed to return|2
2047991|NCT00475033|3619617|FG001|After the Infant Series|Failed to return|1
2047992|NCT00475033|3619616|FG000|After the Infant Series|Protocol Violation|1
2047993|NCT00475033|3619617|FG001|After the Infant Series|Protocol Violation|0
2047994|NCT00475033|3619616|FG000|After the Infant Series|Lost to Follow-up|1
2047995|NCT00475033|3619617|FG001|After the Infant Series|Lost to Follow-up|0
2047996|NCT00475033|3619616|FG000|After the Infant Series|Other|0
2047997|NCT00475033|3619617|FG001|After the Infant Series|Other|1
2047998|NCT00475033|3619616|FG000|Toddler Dose|Parent or legal guardian request|2
2047999|NCT00475033|3619617|FG001|Toddler Dose|Parent or legal guardian request|0
2048000|NCT00475033|3619616|FG000|Toddler Dose|Failed to return|1
2048001|NCT00475033|3619617|FG001|Toddler Dose|Failed to return|0
2048002|NCT00475033|3619616|FG000|Toddler Dose|Lost to Follow-up|1
2048003|NCT00475033|3619617|FG001|Toddler Dose|Lost to Follow-up|0
2048004|NCT00475176|3619655|FG000|Overall Study|Adverse Event|2
2048005|NCT00475176|3619655|FG000|Overall Study|Withdrawal by Subject|1
2048006|NCT00475176|3619655|FG000|Overall Study|Protocol Violation|1
2048007|NCT00475228|3619670|FG000|Overall Study|Lost to Follow-up|17
2048008|NCT00475228|3619671|FG001|Overall Study|Lost to Follow-up|17
2048009|NCT00475306|3619695|FG000|Overall Study|Protocol Violation|1
2048010|NCT00475306|3619696|FG001|Overall Study|Protocol Violation|1
2048011|NCT00475306|3619697|FG002|Overall Study|Protocol Violation|0
2048012|NCT00475306|3619698|FG003|Overall Study|Protocol Violation|1
2048013|NCT00475423|3619724|FG000|Overall Study|Protocol Violation|5
2048014|NCT00475423|3619724|FG000|Overall Study|Adverse Event|4
2048015|NCT00475423|3619724|FG000|Overall Study|Withdrawal by Subject|6
2048016|NCT00475423|3619724|FG000|Overall Study|Lack of Efficacy|8
2048017|NCT00475423|3619724|FG000|Overall Study|Death|1
2048018|NCT00475423|3619724|FG000|Overall Study|Reason not specified|1
2048019|NCT00475423|3619724|FG000|Overall Study|Lost to Follow-up|7
2048020|NCT00475644|3619777|FG000|Overall Study|Protocol Violation|13
2048021|NCT00475670|3619783|FG000|Overall Study|Death|0
2048022|NCT00475670|3619784|FG001|Overall Study|Death|1
2048023|NCT00475670|3619783|FG000|Overall Study|Lack of Efficacy|3
2048024|NCT00475670|3619784|FG001|Overall Study|Lack of Efficacy|34
2048025|NCT00475670|3619783|FG000|Overall Study|Refused treatment|0
2048026|NCT00475670|3619784|FG001|Overall Study|Refused treatment|2
2048027|NCT00475670|3619783|FG000|Overall Study|Failure to Return|0
2048028|NCT00475670|3619784|FG001|Overall Study|Failure to Return|1
2048029|NCT00475670|3619783|FG000|Overall Study|Other|0
2048030|NCT00475670|3619784|FG001|Overall Study|Other|3
2048031|NCT00475709|3619790|FG000|Overall Study|Did not meet eligibility criteria|8
2048032|NCT00475709|3619790|FG000|Overall Study|Death|41
2048033|NCT00475709|3619790|FG000|Overall Study|Device Explant|6
2048034|NCT00475709|3619790|FG000|Overall Study|Lost to Follow-up|21
2048035|NCT00475722|3619796|FG000|Overall Study|Withdrawal by Subject|12
2048036|NCT00475722|3619797|FG001|Overall Study|Withdrawal by Subject|12
2048037|NCT00475722|3619796|FG000|Overall Study|Protocol Violation|3
2208789|NCT01641692|3848410|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
2217673|NCT01709305|3860928|FG000|Phase 1|Withdrawal by Subject|218
2048038|NCT00475722|3619797|FG001|Overall Study|Protocol Violation|0
2048039|NCT00475735|3619809|FG000|Treatment Period 1|Adverse Event|2
2048040|NCT00475735|3619810|FG001|Treatment Period 1|Adverse Event|0
2048041|NCT00475735|3619811|FG002|Treatment Period 1|Adverse Event|0
2048042|NCT00475735|3619812|FG003|Treatment Period 1|Adverse Event|0
2048043|NCT00475735|3619813|FG004|Treatment Period 1|Adverse Event|0
2048044|NCT00475735|3619814|FG005|Treatment Period 1|Adverse Event|0
2048045|NCT00475735|3619809|FG000|Treatment Period 1|Lack of Efficacy|1
2048046|NCT00475735|3619810|FG001|Treatment Period 1|Lack of Efficacy|0
2048047|NCT00475735|3619811|FG002|Treatment Period 1|Lack of Efficacy|0
2048048|NCT00475735|3619812|FG003|Treatment Period 1|Lack of Efficacy|0
2048049|NCT00475735|3619813|FG004|Treatment Period 1|Lack of Efficacy|0
2048050|NCT00475735|3619814|FG005|Treatment Period 1|Lack of Efficacy|0
2048051|NCT00475735|3619809|FG000|Treatment Period 1|Lost to Follow-up|0
2048052|NCT00475735|3619810|FG001|Treatment Period 1|Lost to Follow-up|0
2048053|NCT00475735|3619811|FG002|Treatment Period 1|Lost to Follow-up|0
2048054|NCT00475735|3619812|FG003|Treatment Period 1|Lost to Follow-up|0
2048055|NCT00475735|3619813|FG004|Treatment Period 1|Lost to Follow-up|0
2048056|NCT00475735|3619814|FG005|Treatment Period 1|Lost to Follow-up|1
2048057|NCT00475735|3619809|FG000|Treatment Period 1|Protocol Violation|0
2048058|NCT00475735|3619810|FG001|Treatment Period 1|Protocol Violation|0
2048059|NCT00475735|3619811|FG002|Treatment Period 1|Protocol Violation|0
2048060|NCT00475735|3619812|FG003|Treatment Period 1|Protocol Violation|1
2048061|NCT00475735|3619813|FG004|Treatment Period 1|Protocol Violation|0
2048062|NCT00475735|3619814|FG005|Treatment Period 1|Protocol Violation|0
2048063|NCT00475735|3619809|FG000|Treatment Period 1|Withdrawal by Subject|1
2048064|NCT00475735|3619810|FG001|Treatment Period 1|Withdrawal by Subject|1
2048065|NCT00475735|3619811|FG002|Treatment Period 1|Withdrawal by Subject|0
2048066|NCT00475735|3619812|FG003|Treatment Period 1|Withdrawal by Subject|0
2048067|NCT00475735|3619813|FG004|Treatment Period 1|Withdrawal by Subject|0
2048068|NCT00475735|3619814|FG005|Treatment Period 1|Withdrawal by Subject|0
2048069|NCT00475735|3619809|FG000|Treatment Period 1|DC due to AE but continuing|0
2048070|NCT00475735|3619810|FG001|Treatment Period 1|DC due to AE but continuing|0
2048071|NCT00475735|3619811|FG002|Treatment Period 1|DC due to AE but continuing|0
2048072|NCT00475735|3619812|FG003|Treatment Period 1|DC due to AE but continuing|1
2048073|NCT00475735|3619813|FG004|Treatment Period 1|DC due to AE but continuing|2
2048074|NCT00475735|3619814|FG005|Treatment Period 1|DC due to AE but continuing|2
2048075|NCT00475735|3619809|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0
2048076|NCT00475735|3619810|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1
2048077|NCT00475735|3619811|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0
2048078|NCT00475735|3619812|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0
2048079|NCT00475735|3619813|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0
2048080|NCT00475735|3619814|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0
2048081|NCT00475735|3619809|FG000|Treatment Washout|Lost to Follow-up|0
2048082|NCT00475735|3619810|FG001|Treatment Washout|Lost to Follow-up|1
2048083|NCT00475735|3619811|FG002|Treatment Washout|Lost to Follow-up|0
2048084|NCT00475735|3619812|FG003|Treatment Washout|Lost to Follow-up|0
2048085|NCT00475735|3619813|FG004|Treatment Washout|Lost to Follow-up|0
2048086|NCT00475735|3619814|FG005|Treatment Washout|Lost to Follow-up|0
2048087|NCT00475735|3619809|FG000|Treatment Washout|Protocol Violation|0
2048088|NCT00475735|3619810|FG001|Treatment Washout|Protocol Violation|1
2048089|NCT00475735|3619811|FG002|Treatment Washout|Protocol Violation|0
2048090|NCT00475735|3619812|FG003|Treatment Washout|Protocol Violation|0
2048091|NCT00475735|3619813|FG004|Treatment Washout|Protocol Violation|0
2048092|NCT00475735|3619814|FG005|Treatment Washout|Protocol Violation|0
2048093|NCT00475735|3619809|FG000|Treatment Period 2|Adverse Event|0
2048094|NCT00475735|3619810|FG001|Treatment Period 2|Adverse Event|1
2048095|NCT00475735|3619811|FG002|Treatment Period 2|Adverse Event|0
2048096|NCT00475735|3619812|FG003|Treatment Period 2|Adverse Event|2
2048097|NCT00475735|3619813|FG004|Treatment Period 2|Adverse Event|0
2048098|NCT00475735|3619814|FG005|Treatment Period 2|Adverse Event|0
2048099|NCT00475735|3619809|FG000|Treatment Period 2|Lack of Efficacy|0
2048100|NCT00475735|3619810|FG001|Treatment Period 2|Lack of Efficacy|0
2048101|NCT00475735|3619811|FG002|Treatment Period 2|Lack of Efficacy|0
2048102|NCT00475735|3619812|FG003|Treatment Period 2|Lack of Efficacy|0
2048103|NCT00475735|3619813|FG004|Treatment Period 2|Lack of Efficacy|0
2048104|NCT00475735|3619814|FG005|Treatment Period 2|Lack of Efficacy|1
2048105|NCT00475735|3619809|FG000|Treatment Period 2|Withdrawal by Subject|0
2048106|NCT00475735|3619810|FG001|Treatment Period 2|Withdrawal by Subject|0
2048107|NCT00475735|3619811|FG002|Treatment Period 2|Withdrawal by Subject|0
2048108|NCT00475735|3619812|FG003|Treatment Period 2|Withdrawal by Subject|0
2048109|NCT00475735|3619813|FG004|Treatment Period 2|Withdrawal by Subject|1
2048110|NCT00475735|3619814|FG005|Treatment Period 2|Withdrawal by Subject|0
2048111|NCT00475852|3619835|FG000|Overall Study|Death|444
2048112|NCT00475852|3619836|FG001|Overall Study|Death|456
2048113|NCT00475852|3619835|FG000|Overall Study|Withdrawal by Subject|19
2048114|NCT00475852|3619836|FG001|Overall Study|Withdrawal by Subject|24
2048115|NCT00475852|3619835|FG000|Overall Study|Lost to Follow-up|54
2048116|NCT00475852|3619836|FG001|Overall Study|Lost to Follow-up|68
2048117|NCT00475865|3619845|FG000|Overall Study|Adverse Event|0
2048118|NCT00475865|3619846|FG001|Overall Study|Adverse Event|3
2048119|NCT00475865|3619847|FG002|Overall Study|Adverse Event|4
2048120|NCT00475865|3619845|FG000|Overall Study|Lack of Efficacy|1
2048121|NCT00475865|3619846|FG001|Overall Study|Lack of Efficacy|0
2048122|NCT00475865|3619847|FG002|Overall Study|Lack of Efficacy|0
2048123|NCT00475865|3619845|FG000|Overall Study|Progressive disease|0
2048124|NCT00475865|3619846|FG001|Overall Study|Progressive disease|1
2048125|NCT00475865|3619847|FG002|Overall Study|Progressive disease|2
2048126|NCT00475865|3619845|FG000|Overall Study|Participant did not wish to continue|1
2048127|NCT00475865|3619846|FG001|Overall Study|Participant did not wish to continue|0
2048128|NCT00475865|3619847|FG002|Overall Study|Participant did not wish to continue|0
2048129|NCT00475865|3619845|FG000|Overall Study|Other than above|0
2048130|NCT00475865|3619846|FG001|Overall Study|Other than above|1
2048131|NCT00475865|3619847|FG002|Overall Study|Other than above|0
2048132|NCT00475982|3619883|FG000|Overall Study|surgery rescheduled|7
2048133|NCT00475982|3619884|FG001|Overall Study|surgery rescheduled|3
2048134|NCT00476008|3619892|FG000|Overall Study|Adverse Event|4
2048135|NCT00476008|3619893|FG001|Overall Study|Adverse Event|4
2048136|NCT00476008|3619892|FG000|Overall Study|Placebo concerns|2
2048137|NCT00476008|3619893|FG001|Overall Study|Placebo concerns|2
2048138|NCT00476008|3619892|FG000|Overall Study|Physician Decision: Medication Noncompli|2
2048139|NCT00476008|3619893|FG001|Overall Study|Physician Decision: Medication Noncompli|1
2048140|NCT00476008|3619892|FG000|Overall Study|Withdrawal by Subject|0
2048141|NCT00476008|3619893|FG001|Overall Study|Withdrawal by Subject|1
2048142|NCT00476008|3619892|FG000|Overall Study|Death|1
2048143|NCT00476008|3619893|FG001|Overall Study|Death|0
2048144|NCT00476047|3619918|FG000|Overall Study|Lost to Follow-up|1
2048145|NCT00476086|3619924|FG000|Overall Study|Alternative therapy|1
2048146|NCT00476086|3619924|FG000|Overall Study|Progressive Disease|4
2048147|NCT00476151|3619932|FG000|Overall Study|Adverse Event|0
2048148|NCT00476151|3619933|FG001|Overall Study|Adverse Event|2
2048149|NCT00476151|3619932|FG000|Overall Study|Protocol Violation|1
2048150|NCT00476151|3619933|FG001|Overall Study|Protocol Violation|3
2048151|NCT00476151|3619932|FG000|Overall Study|Withdrawal by Subject|2
2048152|NCT00476151|3619933|FG001|Overall Study|Withdrawal by Subject|0
2048153|NCT00476151|3619932|FG000|Overall Study|Physician Decision|0
2048154|NCT00476151|3619933|FG001|Overall Study|Physician Decision|2
2048155|NCT00476229|3619939|FG000|Overall Study|Progressive shortness of breath|1
2048156|NCT00476476|3619956|FG000|Overall Study|Adverse Event|2
2048157|NCT00476476|3619957|FG001|Overall Study|Adverse Event|7
2048158|NCT00476476|3619956|FG000|Overall Study|Progressive Disease|0
2048159|NCT00476476|3619957|FG001|Overall Study|Progressive Disease|17
2048160|NCT00476593|3619966|FG000|Overall Study|Lost to Follow-up|10
2048161|NCT00476593|3619967|FG001|Overall Study|Lost to Follow-up|2
2048162|NCT00476593|3619968|FG002|Overall Study|Lost to Follow-up|8
2048163|NCT00476593|3619969|FG003|Overall Study|Lost to Follow-up|22
2048164|NCT00476957|3619989|FG000|Overall Study|Lost to Follow-up|176
2048165|NCT00476957|3619990|FG001|Overall Study|Lost to Follow-up|193
2048166|NCT00476996|3619999|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
2048167|NCT00476996|3620000|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
2048168|NCT00476996|3620001|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
2048169|NCT00476996|3620002|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
2048170|NCT00476996|3619999|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
2048171|NCT00476996|3620000|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
2048172|NCT00476996|3620001|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
2048173|NCT00476996|3620002|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
2048174|NCT00476996|3619999|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
2048175|NCT00476996|3620000|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
2048176|NCT00476996|3620001|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
2048177|NCT00476996|3620002|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
2048178|NCT00476996|3619999|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
2048179|NCT00476996|3620000|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
2048180|NCT00476996|3620001|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
2048181|NCT00476996|3620002|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
2048182|NCT00476996|3619999|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
2048183|NCT00476996|3620000|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
2048184|NCT00476996|3620001|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
2048185|NCT00476996|3620002|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
2048186|NCT00476996|3619999|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
2048187|NCT00476996|3620000|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
2048188|NCT00476996|3620001|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
2048189|NCT00476996|3620002|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
2048190|NCT00476996|3619999|FG000|Blinded Treatment Phase (up to Week 48)|Death|2
2048191|NCT00476996|3620000|FG001|Blinded Treatment Phase (up to Week 48)|Death|1
2048192|NCT00476996|3620001|FG002|Blinded Treatment Phase (up to Week 48)|Death|1
2048193|NCT00476996|3620002|FG003|Blinded Treatment Phase (up to Week 48)|Death|0
2048194|NCT00476996|3619999|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
2048195|NCT00476996|3620000|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
2048196|NCT00476996|3620001|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
2048197|NCT00476996|3620002|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
2048198|NCT00476996|3619999|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0
2048199|NCT00476996|3620000|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0
2048200|NCT00476996|3620001|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0
2048201|NCT00476996|3620002|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50
2048202|NCT00476996|3619999|FG000|OLE Phase (From Week 48)|Adverse Event|0
2048203|NCT00476996|3620000|FG001|OLE Phase (From Week 48)|Adverse Event|0
2048204|NCT00476996|3620001|FG002|OLE Phase (From Week 48)|Adverse Event|0
2048205|NCT00476996|3620002|FG003|OLE Phase (From Week 48)|Adverse Event|8
2048206|NCT00476996|3619999|FG000|OLE Phase (From Week 48)|Death|0
2048207|NCT00476996|3620000|FG001|OLE Phase (From Week 48)|Death|0
2048208|NCT00476996|3620001|FG002|OLE Phase (From Week 48)|Death|0
2048209|NCT00476996|3620002|FG003|OLE Phase (From Week 48)|Death|7
2048210|NCT00476996|3619999|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0
2048211|NCT00476996|3620000|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0
2048212|NCT00476996|3620001|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0
2048213|NCT00476996|3620002|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13
2048214|NCT00476996|3619999|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0
2048215|NCT00476996|3620000|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0
2048216|NCT00476996|3620001|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0
2048217|NCT00476996|3620002|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4
2048218|NCT00476996|3619999|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
2048219|NCT00476996|3620000|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
2048220|NCT00476996|3620001|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
2048221|NCT00476996|3620002|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
2048222|NCT00476996|3619999|FG000|OLE Phase (From Week 48)|Early termination of the study|0
2048223|NCT00476996|3620000|FG001|OLE Phase (From Week 48)|Early termination of the study|0
2048224|NCT00476996|3620001|FG002|OLE Phase (From Week 48)|Early termination of the study|0
2048225|NCT00476996|3620002|FG003|OLE Phase (From Week 48)|Early termination of the study|578
2048226|NCT00477152|3620015|FG000|Overall Study|Parent withdrew consent|2
2048227|NCT00477152|3620015|FG000|Overall Study|Adverse Event|1
2048228|NCT00477165|3620021|FG000|Overall Study|Adverse Event|7
2048229|NCT00477165|3620022|FG001|Overall Study|Adverse Event|2
2048230|NCT00477269|3620043|FG000|Core Study|Adverse Event|6
2048231|NCT00477269|3620044|FG001|Core Study|Adverse Event|4
2048232|NCT00477269|3620045|FG002|Core Study|Adverse Event|0
2048233|NCT00477269|3620043|FG000|Core Study|Death|3
2048234|NCT00477269|3620044|FG001|Core Study|Death|3
2048235|NCT00477269|3620045|FG002|Core Study|Death|0
2048236|NCT00477269|3620043|FG000|Core Study|Withdrawn Consent|0
2048237|NCT00477269|3620044|FG001|Core Study|Withdrawn Consent|1
2048238|NCT00477269|3620045|FG002|Core Study|Withdrawn Consent|0
2048239|NCT00477269|3620043|FG000|Open Label Extension|Adverse Event|0
2048240|NCT00477269|3620044|FG001|Open Label Extension|Adverse Event|0
2048241|NCT00477269|3620045|FG002|Open Label Extension|Adverse Event|4
2048242|NCT00477269|3620043|FG000|Open Label Extension|Abnormal laboratory values|0
2048243|NCT00477269|3620044|FG001|Open Label Extension|Abnormal laboratory values|0
2048244|NCT00477269|3620045|FG002|Open Label Extension|Abnormal laboratory values|1
2048245|NCT00477269|3620043|FG000|Open Label Extension|unsatisfactory therapeutic effects|0
2048246|NCT00477269|3620044|FG001|Open Label Extension|unsatisfactory therapeutic effects|0
2048247|NCT00477269|3620045|FG002|Open Label Extension|unsatisfactory therapeutic effects|2
2048248|NCT00477269|3620043|FG000|Open Label Extension|Adminiatrative problems|0
2048249|NCT00477269|3620044|FG001|Open Label Extension|Adminiatrative problems|0
2048250|NCT00477269|3620045|FG002|Open Label Extension|Adminiatrative problems|2
2048251|NCT00477269|3620043|FG000|Open Label Extension|Death|0
2048252|NCT00477269|3620044|FG001|Open Label Extension|Death|0
2048253|NCT00477269|3620045|FG002|Open Label Extension|Death|4
2048254|NCT00477295|3620055|FG000|Overall Study|Adverse Event|31
2048255|NCT00477295|3620056|FG001|Overall Study|Adverse Event|35
2048256|NCT00477295|3620055|FG000|Overall Study|Withdrawal by Subject|35
2048257|NCT00477295|3620056|FG001|Overall Study|Withdrawal by Subject|24
2048258|NCT00477295|3620055|FG000|Overall Study|Lack of Efficacy|23
2048259|NCT00477295|3620056|FG001|Overall Study|Lack of Efficacy|23
2048260|NCT00477295|3620055|FG000|Overall Study|Protocol Violation|3
2048261|NCT00477295|3620056|FG001|Overall Study|Protocol Violation|8
2048262|NCT00477295|3620055|FG000|Overall Study|Physician Decision|4
2048263|NCT00477295|3620056|FG001|Overall Study|Physician Decision|5
2048264|NCT00477295|3620055|FG000|Overall Study|Lost to Follow-up|21
2048265|NCT00477295|3620056|FG001|Overall Study|Lost to Follow-up|11
2048266|NCT00477295|3620055|FG000|Overall Study|Other|4
2048267|NCT00477295|3620056|FG001|Overall Study|Other|3
2048268|NCT00477334|3620066|FG000|Overall Study|Discontinued prior to taking study drug|106
2048269|NCT00477334|3620067|FG001|Overall Study|Discontinued prior to taking study drug|53
2048270|NCT00477334|3620066|FG000|Overall Study|Adverse Event|1
2048271|NCT00477334|3620067|FG001|Overall Study|Adverse Event|2
2048272|NCT00477334|3620066|FG000|Overall Study|Withdrawal by Subject|2
2048273|NCT00477334|3620067|FG001|Overall Study|Withdrawal by Subject|1
2048274|NCT00477334|3620066|FG000|Overall Study|Lost to Follow-up|15
2048275|NCT00477334|3620067|FG001|Overall Study|Lost to Follow-up|4
2048276|NCT00477334|3620066|FG000|Overall Study|Administrative Problems|39
2048277|NCT00477334|3620067|FG001|Overall Study|Administrative Problems|15
2048278|NCT00477334|3620066|FG000|Overall Study|Protocol Violation|7
2048279|NCT00477334|3620067|FG001|Overall Study|Protocol Violation|1
2048280|NCT00477386|3620079|FG000|Overall Study|Adverse Event|4
2048281|NCT00477386|3620080|FG001|Overall Study|Adverse Event|8
2048282|NCT00477386|3620079|FG000|Overall Study|Disease progression, relapse|3
2048283|NCT00477386|3620080|FG001|Overall Study|Disease progression, relapse|4
2048284|NCT00477386|3620079|FG000|Overall Study|Disease progression, refractory|1
2048285|NCT00477386|3620080|FG001|Overall Study|Disease progression, refractory|3
2048286|NCT00477386|3620079|FG000|Overall Study|Other|1
2048287|NCT00477386|3620080|FG001|Overall Study|Other|2
2048288|NCT00477386|3620079|FG000|Overall Study|Physician Decision|1
2048289|NCT00477386|3620080|FG001|Overall Study|Physician Decision|0
2048290|NCT00477386|3620079|FG000|Overall Study|Withdrawal by Subject|1
2048291|NCT00477386|3620080|FG001|Overall Study|Withdrawal by Subject|0
2048292|NCT00477464|3620101|FG000|Overall Study|Lost to Follow-up|1
2048293|NCT00477464|3620101|FG000|Overall Study|Death|36
2048294|NCT00477464|3620101|FG000|Overall Study|Completion of protocol-defined follow-up|14
2048295|NCT00477490|3620112|FG000|Part I: 4 Week Efficacy|Adverse Event|1
2048296|NCT00477490|3620113|FG001|Part I: 4 Week Efficacy|Adverse Event|4
2048297|NCT00477490|3620114|FG002|Part I: 4 Week Efficacy|Adverse Event|0
2048298|NCT00477490|3620115|FG003|Part I: 4 Week Efficacy|Adverse Event|5
2048299|NCT00477490|3620116|FG004|Part I: 4 Week Efficacy|Adverse Event|6
2048300|NCT00477490|3620117|FG005|Part I: 4 Week Efficacy|Adverse Event|0
2048301|NCT00477490|3620118|FG006|Part I: 4 Week Efficacy|Adverse Event|0
2048302|NCT00477490|3620119|FG007|Part I: 4 Week Efficacy|Adverse Event|0
2048303|NCT00477490|3620120|FG008|Part I: 4 Week Efficacy|Adverse Event|0
2048304|NCT00477490|3620112|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
2048305|NCT00477490|3620113|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2048306|NCT00477490|3620114|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2048307|NCT00477490|3620115|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
2048308|NCT00477490|3620116|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
2048309|NCT00477490|3620117|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2048310|NCT00477490|3620118|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2048311|NCT00477490|3620119|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2048312|NCT00477490|3620120|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2048313|NCT00477490|3620112|FG000|Part I: 4 Week Efficacy|Protocol Violation|2
2048314|NCT00477490|3620113|FG001|Part I: 4 Week Efficacy|Protocol Violation|0
2048315|NCT00477490|3620114|FG002|Part I: 4 Week Efficacy|Protocol Violation|0
2208790|NCT01641692|3848411|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
2217674|NCT01709305|3860929|FG001|Phase 1|Withdrawal by Subject|0
2048316|NCT00477490|3620115|FG003|Part I: 4 Week Efficacy|Protocol Violation|0
2048317|NCT00477490|3620116|FG004|Part I: 4 Week Efficacy|Protocol Violation|1
2048318|NCT00477490|3620117|FG005|Part I: 4 Week Efficacy|Protocol Violation|0
2048319|NCT00477490|3620118|FG006|Part I: 4 Week Efficacy|Protocol Violation|0
2048320|NCT00477490|3620119|FG007|Part I: 4 Week Efficacy|Protocol Violation|0
2048321|NCT00477490|3620120|FG008|Part I: 4 Week Efficacy|Protocol Violation|0
2048322|NCT00477490|3620112|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6
2048323|NCT00477490|3620113|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5
2048324|NCT00477490|3620114|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6
2048325|NCT00477490|3620115|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4
2048326|NCT00477490|3620116|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9
2048327|NCT00477490|3620117|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0
2048328|NCT00477490|3620118|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0
2048329|NCT00477490|3620119|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0
2048330|NCT00477490|3620120|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0
2048331|NCT00477490|3620112|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2
2048332|NCT00477490|3620113|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4
2048333|NCT00477490|3620114|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1
2048334|NCT00477490|3620115|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5
2048335|NCT00477490|3620116|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3
2048336|NCT00477490|3620117|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0
2048337|NCT00477490|3620118|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0
2048338|NCT00477490|3620119|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0
2048339|NCT00477490|3620120|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0
2048340|NCT00477490|3620112|FG000|Part I: 4 Week Efficacy|Other, not specified|2
2048341|NCT00477490|3620113|FG001|Part I: 4 Week Efficacy|Other, not specified|4
2048342|NCT00477490|3620114|FG002|Part I: 4 Week Efficacy|Other, not specified|0
2048343|NCT00477490|3620115|FG003|Part I: 4 Week Efficacy|Other, not specified|1
2048344|NCT00477490|3620116|FG004|Part I: 4 Week Efficacy|Other, not specified|1
2048345|NCT00477490|3620117|FG005|Part I: 4 Week Efficacy|Other, not specified|0
2048346|NCT00477490|3620118|FG006|Part I: 4 Week Efficacy|Other, not specified|0
2048347|NCT00477490|3620119|FG007|Part I: 4 Week Efficacy|Other, not specified|0
2048348|NCT00477490|3620120|FG008|Part I: 4 Week Efficacy|Other, not specified|0
2048349|NCT00477490|3620112|FG000|Part I: 4 Week Efficacy|Not Reported|1
2048350|NCT00477490|3620113|FG001|Part I: 4 Week Efficacy|Not Reported|2
2048351|NCT00477490|3620114|FG002|Part I: 4 Week Efficacy|Not Reported|3
2048352|NCT00477490|3620115|FG003|Part I: 4 Week Efficacy|Not Reported|0
2048353|NCT00477490|3620116|FG004|Part I: 4 Week Efficacy|Not Reported|1
2208791|NCT01641692|3848412|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
2208792|NCT01641692|3848405|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2048354|NCT00477490|3620117|FG005|Part I: 4 Week Efficacy|Not Reported|0
2048355|NCT00477490|3620118|FG006|Part I: 4 Week Efficacy|Not Reported|0
2048356|NCT00477490|3620119|FG007|Part I: 4 Week Efficacy|Not Reported|0
2048357|NCT00477490|3620120|FG008|Part I: 4 Week Efficacy|Not Reported|0
2048358|NCT00477490|3620112|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
2048359|NCT00477490|3620113|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
2048360|NCT00477490|3620114|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
2048361|NCT00477490|3620115|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
2048362|NCT00477490|3620116|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
2048363|NCT00477490|3620117|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
2048364|NCT00477490|3620118|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
2048365|NCT00477490|3620119|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
2048366|NCT00477490|3620120|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
2048367|NCT00477490|3620112|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0
2048368|NCT00477490|3620113|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2
2048369|NCT00477490|3620114|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3
2048370|NCT00477490|3620115|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1
2048371|NCT00477490|3620116|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1
2048372|NCT00477490|3620117|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1
2048373|NCT00477490|3620118|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1
2048374|NCT00477490|3620119|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1
2048375|NCT00477490|3620120|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4
2048376|NCT00477490|3620112|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
2048377|NCT00477490|3620113|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
2048378|NCT00477490|3620114|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
2048379|NCT00477490|3620115|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
2048380|NCT00477490|3620116|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
2048381|NCT00477490|3620117|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
2048382|NCT00477490|3620118|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
2048383|NCT00477490|3620119|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
2048384|NCT00477490|3620120|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
2048385|NCT00477490|3620112|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2048386|NCT00477490|3620113|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2048387|NCT00477490|3620114|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2048388|NCT00477490|3620115|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2048389|NCT00477490|3620116|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
2048390|NCT00477490|3620117|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2048391|NCT00477490|3620118|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2048392|NCT00477490|3620119|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
2048393|NCT00477490|3620120|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
2048394|NCT00477490|3620112|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2048395|NCT00477490|3620113|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1
2048396|NCT00477490|3620114|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2048397|NCT00477490|3620115|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2048398|NCT00477490|3620116|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2048399|NCT00477490|3620117|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2048400|NCT00477490|3620118|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2048401|NCT00477490|3620119|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2048402|NCT00477490|3620120|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2048403|NCT00477490|3620112|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0
2048404|NCT00477490|3620113|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4
2048405|NCT00477490|3620114|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2
2048406|NCT00477490|3620115|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4
2048407|NCT00477490|3620116|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2
2048408|NCT00477490|3620117|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1
2048409|NCT00477490|3620118|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1
2048410|NCT00477490|3620119|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0
2048411|NCT00477490|3620120|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1
2048412|NCT00477490|3620112|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0
2048413|NCT00477490|3620113|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3
2048414|NCT00477490|3620114|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1
2048415|NCT00477490|3620115|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0
2048416|NCT00477490|3620116|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1
2048417|NCT00477490|3620117|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0
2048418|NCT00477490|3620118|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0
2048419|NCT00477490|3620119|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0
2048420|NCT00477490|3620120|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0
2048421|NCT00477594|3620150|FG000|Year 1 and Year 2|Adverse Event|4
2048422|NCT00477594|3620151|FG001|Year 1 and Year 2|Adverse Event|2
2048423|NCT00477594|3620150|FG000|Year 1 and Year 2|Physician Decision|2
2048424|NCT00477594|3620151|FG001|Year 1 and Year 2|Physician Decision|1
2048425|NCT00477594|3620150|FG000|Year 1 and Year 2|Withdrawal by Subject|2
2048426|NCT00477594|3620151|FG001|Year 1 and Year 2|Withdrawal by Subject|1
2048427|NCT00477594|3620150|FG000|Year 1 and Year 2|Other|1
2048428|NCT00477594|3620151|FG001|Year 1 and Year 2|Other|0
2048429|NCT00477594|3620150|FG000|Year 3|Adverse Event|1
2048430|NCT00477594|3620151|FG001|Year 3|Adverse Event|0
2048431|NCT00477594|3620150|FG000|Year 3|Withdrawal by Subject|1
2048432|NCT00477594|3620151|FG001|Year 3|Withdrawal by Subject|0
2048433|NCT00477594|3620150|FG000|Follow-up Period|Withdrawal by Subject|2
2048434|NCT00477594|3620151|FG001|Follow-up Period|Withdrawal by Subject|1
2048435|NCT00477594|3620150|FG000|Follow-up Period|Other|1
2048436|NCT00477594|3620151|FG001|Follow-up Period|Other|0
2048437|NCT00477607|3620159|FG000|Overall Study|Lost to Follow-up|7
2048438|NCT00477607|3620160|FG001|Overall Study|Lost to Follow-up|7
2048439|NCT00477633|3620166|FG000|Overall Study|Did not receive treatment|23
2048440|NCT00477633|3620166|FG000|Overall Study|Adverse Event|143
2048441|NCT00477633|3620166|FG000|Overall Study|Pregnancy|23
2299637|NCT02588833|3996877|FG000|Part 2A|Withdrawal by Subject|0
2299638|NCT02588833|3996878|FG001|Part 2A|Withdrawal by Subject|1
2299639|NCT02588833|3996877|FG000|Part 2B|Adverse Event|0
2299640|NCT02588833|3996878|FG001|Part 2B|Adverse Event|1
2299641|NCT02588833|3996877|FG000|Part 2C|Adverse Event|0
2299642|NCT02588833|3996878|FG001|Part 2C|Adverse Event|1
2299643|NCT02588833|3996877|FG000|Part 2C|Withdrawal by Subject|0
2299644|NCT02588833|3996878|FG001|Part 2C|Withdrawal by Subject|1
2299645|NCT02588833|3996877|FG000|Part 3 (Safety Follow-up)|Other|0
2299646|NCT02588833|3996878|FG001|Part 3 (Safety Follow-up)|Other|2
2299647|NCT02589405|3996918|FG000|Overall Study|Adverse Event|3
2299648|NCT02589405|3996918|FG000|Overall Study|Withdrawal by Subject|1
2299649|NCT02589626|3996924|FG000|Overall Study|Other than the reason specified|1
2299650|NCT02589626|3996925|FG001|Overall Study|Other than the reason specified|0
2299651|NCT02589626|3996924|FG000|Overall Study|Withdrawal by Subject|1
2299652|NCT02589626|3996925|FG001|Overall Study|Withdrawal by Subject|1
2299653|NCT02589626|3996924|FG000|Overall Study|Adverse Event|1
2299654|NCT02589626|3996925|FG001|Overall Study|Adverse Event|1
2299655|NCT02589639|3996934|FG000|Overall Study|Lost to Follow-up|1
2299656|NCT02589639|3996935|FG001|Overall Study|Lost to Follow-up|0
2299657|NCT02589639|3996936|FG002|Overall Study|Lost to Follow-up|0
2299658|NCT02589639|3996934|FG000|Overall Study|Protocol Violation|1
2299659|NCT02589639|3996935|FG001|Overall Study|Protocol Violation|0
2299660|NCT02589639|3996936|FG002|Overall Study|Protocol Violation|0
2299661|NCT02589639|3996934|FG000|Overall Study|Patient withdrawal, not due to AE|3
2299662|NCT02589639|3996935|FG001|Overall Study|Patient withdrawal, not due to AE|0
2299663|NCT02589639|3996936|FG002|Overall Study|Patient withdrawal, not due to AE|0
2299664|NCT02589639|3996934|FG000|Overall Study|Adverse Event|4
2299665|NCT02589639|3996935|FG001|Overall Study|Adverse Event|5
2299666|NCT02589639|3996936|FG002|Overall Study|Adverse Event|3
2299667|NCT02589639|3996934|FG000|Overall Study|Other reason than specified above|1
2299668|NCT02589639|3996935|FG001|Overall Study|Other reason than specified above|2
2299669|NCT02589639|3996936|FG002|Overall Study|Other reason than specified above|1
2299670|NCT02589639|3996934|FG000|Overall Study|Not Treated|0
2299671|NCT02589639|3996935|FG001|Overall Study|Not Treated|3
2299672|NCT02589639|3996936|FG002|Overall Study|Not Treated|0
2299673|NCT02589665|3996948|FG000|Induction Period|Did not receive drug|0
2299674|NCT02589665|3996949|FG001|Induction Period|Did not receive drug|0
2299675|NCT02589665|3996950|FG002|Induction Period|Did not receive drug|0
2299676|NCT02589665|3996951|FG003|Induction Period|Did not receive drug|1
2299677|NCT02589665|3996952|FG004|Induction Period|Did not receive drug|0
2299678|NCT02589665|3996953|FG005|Induction Period|Did not receive drug|0
2299679|NCT02589665|3996954|FG006|Induction Period|Did not receive drug|0
2299680|NCT02589665|3996955|FG007|Induction Period|Did not receive drug|0
2299681|NCT02589665|3996956|FG008|Induction Period|Did not receive drug|0
2299682|NCT02589665|3996957|FG009|Induction Period|Did not receive drug|0
2299683|NCT02589665|3996948|FG000|Induction Period|Adverse Event|3
2299684|NCT02589665|3996949|FG001|Induction Period|Adverse Event|0
2299685|NCT02589665|3996950|FG002|Induction Period|Adverse Event|2
2299686|NCT02589665|3996951|FG003|Induction Period|Adverse Event|2
2299687|NCT02589665|3996952|FG004|Induction Period|Adverse Event|0
2299688|NCT02589665|3996953|FG005|Induction Period|Adverse Event|0
2299689|NCT02589665|3996954|FG006|Induction Period|Adverse Event|0
2048442|NCT00477633|3620166|FG000|Overall Study|Lost to Follow-up|271
2299690|NCT02589665|3996955|FG007|Induction Period|Adverse Event|0
2299691|NCT02589665|3996956|FG008|Induction Period|Adverse Event|0
2299692|NCT02589665|3996957|FG009|Induction Period|Adverse Event|0
2299693|NCT02589665|3996948|FG000|Induction Period|Withdrawal by Subject|0
2048443|NCT00477633|3620166|FG000|Overall Study|Withdrawal by Subject|149
2048444|NCT00477633|3620166|FG000|Overall Study|Protocol Violation|25
2048445|NCT00477633|3620166|FG000|Overall Study|Various (Moving, Enrollment closed)|75
2048446|NCT00477672|3620177|FG000|Overall Study|Adverse Event|3
2048447|NCT00477672|3620178|FG001|Overall Study|Adverse Event|5
2048448|NCT00477672|3620179|FG002|Overall Study|Adverse Event|6
2048449|NCT00477672|3620177|FG000|Overall Study|Death|0
2048450|NCT00477672|3620178|FG001|Overall Study|Death|1
2048451|NCT00477672|3620179|FG002|Overall Study|Death|0
2048452|NCT00477672|3620177|FG000|Overall Study|Disease progression|0
2048453|NCT00477672|3620178|FG001|Overall Study|Disease progression|1
2048454|NCT00477672|3620179|FG002|Overall Study|Disease progression|0
2048455|NCT00477672|3620177|FG000|Overall Study|Physician Decision|1
2048456|NCT00477672|3620178|FG001|Overall Study|Physician Decision|0
2048457|NCT00477672|3620179|FG002|Overall Study|Physician Decision|0
2048458|NCT00477672|3620177|FG000|Overall Study|Protocol noncompliance|0
2048459|NCT00477672|3620178|FG001|Overall Study|Protocol noncompliance|2
2048460|NCT00477672|3620179|FG002|Overall Study|Protocol noncompliance|0
2048461|NCT00477672|3620177|FG000|Overall Study|Consent withdrawn|2
2048462|NCT00477672|3620178|FG001|Overall Study|Consent withdrawn|5
2048463|NCT00477672|3620179|FG002|Overall Study|Consent withdrawn|10
2048464|NCT00477672|3620177|FG000|Overall Study|Discretion of Sponsor|1
2048465|NCT00477672|3620178|FG001|Overall Study|Discretion of Sponsor|2
2048466|NCT00477672|3620179|FG002|Overall Study|Discretion of Sponsor|0
2048467|NCT00477750|3620191|FG000|Overall Study|Currently Receiving Treatment|11
2048468|NCT00477971|3620199|FG000|Overall Study|Disease progression|6
2048469|NCT00477971|3620200|FG001|Overall Study|Disease progression|0
2048470|NCT00477971|3620199|FG000|Overall Study|Withdrawal by Subject|3
2048471|NCT00477971|3620200|FG001|Overall Study|Withdrawal by Subject|1
2048472|NCT00477971|3620199|FG000|Overall Study|Adverse Event|3
2048473|NCT00477971|3620200|FG001|Overall Study|Adverse Event|0
2048474|NCT00477971|3620199|FG000|Overall Study|Death|2
2048475|NCT00477971|3620200|FG001|Overall Study|Death|4
2048476|NCT00477971|3620199|FG000|Overall Study|Alternative treatment|3
2048477|NCT00477971|3620200|FG001|Overall Study|Alternative treatment|1
2048478|NCT00478023|3620211|FG000|Overall Study|Adverse Event|11
2048479|NCT00478023|3620212|FG001|Overall Study|Adverse Event|7
2048480|NCT00478023|3620213|FG002|Overall Study|Adverse Event|8
2048481|NCT00478023|3620214|FG003|Overall Study|Adverse Event|14
2048482|NCT00478023|3620215|FG004|Overall Study|Adverse Event|6
2048483|NCT00478023|3620211|FG000|Overall Study|Death|1
2048484|NCT00478023|3620212|FG001|Overall Study|Death|0
2048485|NCT00478023|3620213|FG002|Overall Study|Death|0
2048486|NCT00478023|3620214|FG003|Overall Study|Death|0
2048487|NCT00478023|3620215|FG004|Overall Study|Death|0
2048488|NCT00478023|3620211|FG000|Overall Study|Lack of Efficacy|11
2048489|NCT00478023|3620212|FG001|Overall Study|Lack of Efficacy|10
2048490|NCT00478023|3620213|FG002|Overall Study|Lack of Efficacy|4
2048491|NCT00478023|3620214|FG003|Overall Study|Lack of Efficacy|5
2048492|NCT00478023|3620215|FG004|Overall Study|Lack of Efficacy|41
2048493|NCT00478023|3620211|FG000|Overall Study|Lost to Follow-up|3
2048494|NCT00478023|3620212|FG001|Overall Study|Lost to Follow-up|1
2048495|NCT00478023|3620213|FG002|Overall Study|Lost to Follow-up|1
2048496|NCT00478023|3620214|FG003|Overall Study|Lost to Follow-up|1
2048497|NCT00478023|3620215|FG004|Overall Study|Lost to Follow-up|0
2048498|NCT00478023|3620211|FG000|Overall Study|Withdrawal by Subject|2
2048499|NCT00478023|3620212|FG001|Overall Study|Withdrawal by Subject|3
2048500|NCT00478023|3620213|FG002|Overall Study|Withdrawal by Subject|2
2048501|NCT00478023|3620214|FG003|Overall Study|Withdrawal by Subject|4
2048502|NCT00478023|3620215|FG004|Overall Study|Withdrawal by Subject|5
2048503|NCT00478023|3620211|FG000|Overall Study|Lack of pain, Technical difficulties|7
2048504|NCT00478023|3620212|FG001|Overall Study|Lack of pain, Technical difficulties|3
2048505|NCT00478023|3620213|FG002|Overall Study|Lack of pain, Technical difficulties|5
2048506|NCT00478023|3620214|FG003|Overall Study|Lack of pain, Technical difficulties|6
2048507|NCT00478023|3620215|FG004|Overall Study|Lack of pain, Technical difficulties|3
2048508|NCT00478140|3620240|FG000|Overall Study|Clinical Disease Progression|1
2048509|NCT00478205|3620260|FG000|Overall Study|Adverse Event|182
2048510|NCT00478205|3620261|FG001|Overall Study|Adverse Event|39
2048511|NCT00478205|3620260|FG000|Overall Study|Medication Non-compliance|9
2048512|NCT00478205|3620261|FG001|Overall Study|Medication Non-compliance|4
2048513|NCT00478205|3620260|FG000|Overall Study|Protocol Violation|15
2048514|NCT00478205|3620261|FG001|Overall Study|Protocol Violation|5
2048515|NCT00478205|3620260|FG000|Overall Study|Request of Investigator or Sponsor|4
2048516|NCT00478205|3620261|FG001|Overall Study|Request of Investigator or Sponsor|5
2048517|NCT00478205|3620260|FG000|Overall Study|Withdrawal by Subject|61
2048518|NCT00478205|3620261|FG001|Overall Study|Withdrawal by Subject|22
2048519|NCT00478205|3620260|FG000|Overall Study|Lack of Efficacy|1
2048520|NCT00478205|3620261|FG001|Overall Study|Lack of Efficacy|0
2048521|NCT00478205|3620260|FG000|Overall Study|Other|24
2048522|NCT00478205|3620261|FG001|Overall Study|Other|12
2048523|NCT00478231|3620276|FG000|Overall Study|Death|7
2048524|NCT00478231|3620276|FG000|Overall Study|Lack of Efficacy|47
2048525|NCT00478231|3620276|FG000|Overall Study|Lost to Follow-up|7
2048526|NCT00478231|3620276|FG000|Overall Study|Withdrawal by Subject|6
2048527|NCT00478231|3620276|FG000|Overall Study|Other|9
2048528|NCT00478231|3620276|FG000|Overall Study|Adverse Event|5
2048529|NCT00478231|3620276|FG000|Overall Study|Randomized, not treated|3
2048530|NCT00478244|3620280|FG000|Overall Study|Did not receive transplant|1
2048531|NCT00478257|3620286|FG000|Overall Study|Withdrawal by Subject|8
2048532|NCT00478257|3620287|FG001|Overall Study|Withdrawal by Subject|3
2048533|NCT00478426|3620306|FG000|Overall Study|Withdrawal by Subject|1
2048534|NCT00478608|3620331|FG000|Overall Study|Adverse Event|1
2048535|NCT00478608|3620331|FG000|Overall Study|Serious Adverse Event|14
2048536|NCT00478608|3620331|FG000|Overall Study|Withdrawal by Subject|2
2048537|NCT00478608|3620331|FG000|Overall Study|Protocol Violation|3
2048538|NCT00478647|3620335|FG000|Overall Study|Adverse Event|1
2048539|NCT00478647|3620335|FG000|Overall Study|Withdrawal by Subject|1
2048540|NCT00478673|3620339|FG000|30-Days Post-Procedure|Death|2
2048541|NCT00478673|3620339|FG000|30-Days Post-Procedure|Withdrawal by Subject|1
2048542|NCT00478673|3620339|FG000|30-Days Post-Procedure|Missed Visit|7
2048543|NCT00478673|3620339|FG000|12-Months Post-Procedure|Death|23
2048544|NCT00478673|3620339|FG000|12-Months Post-Procedure|Lost to Follow-up|4
2048545|NCT00478673|3620339|FG000|12-Months Post-Procedure|Withdrawal by Subject|6
2048546|NCT00478673|3620339|FG000|12-Months Post-Procedure|Missed Visit|25
2048547|NCT00478673|3620339|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6
2048548|NCT00478777|3620343|FG000|Overall Study|Adverse Event|29
2048549|NCT00478777|3620343|FG000|Overall Study|Lack of Efficacy|23
2048550|NCT00478777|3620343|FG000|Overall Study|Withdrawal by Subject|4
2048551|NCT00478777|3620343|FG000|Overall Study|Death|3
2048552|NCT00478777|3620343|FG000|Overall Study|Protocol Violation|3
2048553|NCT00478777|3620343|FG000|Overall Study|Lost to Follow-up|3
2048554|NCT00478777|3620343|FG000|Overall Study|Physician Decision|1
2048555|NCT00478777|3620343|FG000|Overall Study|Intolerance of therapy|1
2048556|NCT00478777|3620343|FG000|Overall Study|Lack of compliance|1
2048557|NCT00478777|3620343|FG000|Overall Study|Lymphocytes infusion|1
2048558|NCT00478777|3620343|FG000|Overall Study|End of therapy|2
2048559|NCT00478777|3620343|FG000|Overall Study|Not treated with lenalidomide|6
2048560|NCT00478881|3620349|FG000|Overall Study|Adverse Event|31
2048561|NCT00478881|3620350|FG001|Overall Study|Adverse Event|12
2048562|NCT00478881|3620349|FG000|Overall Study|Lack of Efficacy|0
2048563|NCT00478881|3620350|FG001|Overall Study|Lack of Efficacy|3
2048564|NCT00478881|3620349|FG000|Overall Study|Lost to Follow-up|0
2048565|NCT00478881|3620350|FG001|Overall Study|Lost to Follow-up|1
2048566|NCT00478881|3620349|FG000|Overall Study|Protocol Violation|2
2048567|NCT00478881|3620350|FG001|Overall Study|Protocol Violation|2
2048568|NCT00478881|3620349|FG000|Overall Study|Withdrawal by Subject|6
2048569|NCT00478881|3620350|FG001|Overall Study|Withdrawal by Subject|2
2048570|NCT00478881|3620349|FG000|Overall Study|Non-Compliance with Study Medication|0
2048571|NCT00478881|3620350|FG001|Overall Study|Non-Compliance with Study Medication|2
2048572|NCT00478933|3620356|FG000|Overall Study|Protocol Violation|22
2048573|NCT00478933|3620356|FG000|Overall Study|Informed consent not verified|3
2048574|NCT00478933|3620356|FG000|Overall Study|Inadequate data available|53
2105212|NCT00856193|3697712|FG000|Period 2|Abnormal test procedure results|0
2105213|NCT00856193|3697713|FG001|Period 2|Abnormal test procedure results|1
2105214|NCT00856193|3697712|FG000|Period 2|Lost to Follow-up|0
2105215|NCT00856193|3697713|FG001|Period 2|Lost to Follow-up|1
2105216|NCT00856206|3697721|FG000|Overall Study|Protocol Violation|6
2105217|NCT00856206|3697722|FG001|Overall Study|Protocol Violation|18
2105218|NCT00856206|3697721|FG000|Overall Study|Adverse Event|10
2105219|NCT00856206|3697722|FG001|Overall Study|Adverse Event|46
2105220|NCT00856206|3697721|FG000|Overall Study|Lack of Efficacy|1
2105221|NCT00856206|3697722|FG001|Overall Study|Lack of Efficacy|2
2105222|NCT00856206|3697721|FG000|Overall Study|Withdrawal by Subject|15
2105223|NCT00856206|3697722|FG001|Overall Study|Withdrawal by Subject|36
2105224|NCT00856206|3697721|FG000|Overall Study|Lost to Follow-up|13
2105225|NCT00856206|3697722|FG001|Overall Study|Lost to Follow-up|39
2105226|NCT00856206|3697721|FG000|Overall Study|Death|2
2105227|NCT00856206|3697722|FG001|Overall Study|Death|2
2105228|NCT00856206|3697721|FG000|Overall Study|Decision by the Sponsor|4
2105229|NCT00856206|3697722|FG001|Overall Study|Decision by the Sponsor|8
2105230|NCT00856206|3697721|FG000|Overall Study|Other than specified above|3
2105231|NCT00856206|3697722|FG001|Overall Study|Other than specified above|10
2105232|NCT00856245|3697743|FG000|Overall Study|Was not transplanted|5
2105233|NCT00856284|3697750|FG000|Overall Study|Hyperglycemic rescue|231
2105234|NCT00856284|3697751|FG001|Overall Study|Hyperglycemic rescue|201
2105235|NCT00856284|3697752|FG002|Overall Study|Hyperglycemic rescue|235
2105236|NCT00856284|3697750|FG000|Overall Study|Adverse Event|60
2105237|NCT00856284|3697751|FG001|Overall Study|Adverse Event|74
2105238|NCT00856284|3697752|FG002|Overall Study|Adverse Event|82
2105239|NCT00856284|3697750|FG000|Overall Study|Major protocol deviation|24
2105240|NCT00856284|3697751|FG001|Overall Study|Major protocol deviation|16
2105241|NCT00856284|3697752|FG002|Overall Study|Major protocol deviation|15
2105242|NCT00856284|3697750|FG000|Overall Study|Lost to Follow-up|20
2105243|NCT00856284|3697751|FG001|Overall Study|Lost to Follow-up|22
2105244|NCT00856284|3697752|FG002|Overall Study|Lost to Follow-up|28
2105245|NCT00856284|3697750|FG000|Overall Study|Voluntary withdrawal|48
2105246|NCT00856284|3697751|FG001|Overall Study|Voluntary withdrawal|52
2105247|NCT00856284|3697752|FG002|Overall Study|Voluntary withdrawal|62
2105248|NCT00856284|3697750|FG000|Overall Study|Pregnancy|1
2105249|NCT00856284|3697751|FG001|Overall Study|Pregnancy|2
2048575|NCT00479232|3620413|FG000|Overall Study|Adverse Event|0
2048576|NCT00479232|3620414|FG001|Overall Study|Adverse Event|0
2048577|NCT00479232|3620415|FG002|Overall Study|Adverse Event|5
2048578|NCT00479232|3620416|FG003|Overall Study|Adverse Event|0
2048579|NCT00479232|3620417|FG004|Overall Study|Adverse Event|0
2048580|NCT00479232|3620418|FG005|Overall Study|Adverse Event|10
2048581|NCT00479232|3620413|FG000|Overall Study|Deviation from Protocol|0
2048582|NCT00479232|3620414|FG001|Overall Study|Deviation from Protocol|0
2048583|NCT00479232|3620415|FG002|Overall Study|Deviation from Protocol|1
2048584|NCT00479232|3620416|FG003|Overall Study|Deviation from Protocol|0
2048585|NCT00479232|3620417|FG004|Overall Study|Deviation from Protocol|0
2048586|NCT00479232|3620418|FG005|Overall Study|Deviation from Protocol|0
2048587|NCT00479232|3620413|FG000|Overall Study|Lack of Efficacy|0
2048588|NCT00479232|3620414|FG001|Overall Study|Lack of Efficacy|0
2048589|NCT00479232|3620415|FG002|Overall Study|Lack of Efficacy|2
2048590|NCT00479232|3620416|FG003|Overall Study|Lack of Efficacy|0
2048591|NCT00479232|3620417|FG004|Overall Study|Lack of Efficacy|0
2048592|NCT00479232|3620418|FG005|Overall Study|Lack of Efficacy|4
2048593|NCT00479232|3620413|FG000|Overall Study|Physician Decision|0
2048594|NCT00479232|3620414|FG001|Overall Study|Physician Decision|0
2048595|NCT00479232|3620415|FG002|Overall Study|Physician Decision|2
2048596|NCT00479232|3620416|FG003|Overall Study|Physician Decision|0
2048597|NCT00479232|3620417|FG004|Overall Study|Physician Decision|0
2048598|NCT00479232|3620418|FG005|Overall Study|Physician Decision|1
2048599|NCT00479232|3620413|FG000|Overall Study|Progressive Disease|3
2048600|NCT00479232|3620414|FG001|Overall Study|Progressive Disease|1
2048601|NCT00479232|3620415|FG002|Overall Study|Progressive Disease|12
2048602|NCT00479232|3620416|FG003|Overall Study|Progressive Disease|3
2048603|NCT00479232|3620417|FG004|Overall Study|Progressive Disease|3
2048604|NCT00479232|3620418|FG005|Overall Study|Progressive Disease|12
2048605|NCT00479232|3620413|FG000|Overall Study|Withdrew Consent|0
2048606|NCT00479232|3620414|FG001|Overall Study|Withdrew Consent|2
2048607|NCT00479232|3620415|FG002|Overall Study|Withdrew Consent|6
2048608|NCT00479232|3620416|FG003|Overall Study|Withdrew Consent|0
2048609|NCT00479232|3620417|FG004|Overall Study|Withdrew Consent|1
2048610|NCT00479232|3620418|FG005|Overall Study|Withdrew Consent|3
2048611|NCT00479336|3620440|FG000|Overall Study|Adverse Event|1
2048612|NCT00479336|3620441|FG001|Overall Study|Adverse Event|1
2048613|NCT00479336|3620442|FG002|Overall Study|Adverse Event|1
2048614|NCT00479336|3620443|FG003|Overall Study|Adverse Event|3
2048615|NCT00479336|3620440|FG000|Overall Study|Lack of Efficacy|1
2048616|NCT00479336|3620441|FG001|Overall Study|Lack of Efficacy|0
2048617|NCT00479336|3620442|FG002|Overall Study|Lack of Efficacy|0
2048618|NCT00479336|3620443|FG003|Overall Study|Lack of Efficacy|0
2048619|NCT00479336|3620440|FG000|Overall Study|Protocol Violation|0
2048620|NCT00479336|3620441|FG001|Overall Study|Protocol Violation|1
2048621|NCT00479336|3620442|FG002|Overall Study|Protocol Violation|0
2048622|NCT00479336|3620443|FG003|Overall Study|Protocol Violation|0
2048623|NCT00479336|3620440|FG000|Overall Study|Withdrawal by Subject|1
2048624|NCT00479336|3620441|FG001|Overall Study|Withdrawal by Subject|2
2048625|NCT00479336|3620442|FG002|Overall Study|Withdrawal by Subject|0
2048626|NCT00479336|3620443|FG003|Overall Study|Withdrawal by Subject|0
2048627|NCT00479336|3620440|FG000|Overall Study|Physician Decision|0
2048628|NCT00479336|3620441|FG001|Overall Study|Physician Decision|1
2048629|NCT00479336|3620442|FG002|Overall Study|Physician Decision|0
2048630|NCT00479336|3620443|FG003|Overall Study|Physician Decision|2
2048631|NCT00479336|3620440|FG000|Overall Study|Resolution of all hepatic edema findings|1
2048632|NCT00479336|3620441|FG001|Overall Study|Resolution of all hepatic edema findings|1
2048633|NCT00479336|3620442|FG002|Overall Study|Resolution of all hepatic edema findings|0
2048634|NCT00479336|3620443|FG003|Overall Study|Resolution of all hepatic edema findings|0
2048635|NCT00479388|3620455|FG000|Overall Study|Adverse Event|90
2048636|NCT00479388|3620456|FG001|Overall Study|Adverse Event|45
2048637|NCT00479388|3620455|FG000|Overall Study|Lost to Follow-up|0
2048638|NCT00479388|3620456|FG001|Overall Study|Lost to Follow-up|2
2048639|NCT00479388|3620455|FG000|Overall Study|Protocol Violation|10
2048640|NCT00479388|3620456|FG001|Overall Study|Protocol Violation|9
2048641|NCT00479388|3620455|FG000|Overall Study|Withdrawal by Subject|32
2048642|NCT00479388|3620456|FG001|Overall Study|Withdrawal by Subject|17
2048643|NCT00479401|3620465|FG000|Overall Study|Adverse Event|24
2048644|NCT00479401|3620466|FG001|Overall Study|Adverse Event|20
2048645|NCT00479401|3620467|FG002|Overall Study|Adverse Event|4
2048646|NCT00479401|3620465|FG000|Overall Study|Lack of Efficacy|2
2048647|NCT00479401|3620466|FG001|Overall Study|Lack of Efficacy|2
2048648|NCT00479401|3620467|FG002|Overall Study|Lack of Efficacy|4
2048649|NCT00479401|3620465|FG000|Overall Study|Protocol Violation|2
2048650|NCT00479401|3620466|FG001|Overall Study|Protocol Violation|1
2048651|NCT00479401|3620467|FG002|Overall Study|Protocol Violation|1
2048652|NCT00479401|3620465|FG000|Overall Study|Lost to Follow-up|1
2048653|NCT00479401|3620466|FG001|Overall Study|Lost to Follow-up|1
2048654|NCT00479401|3620467|FG002|Overall Study|Lost to Follow-up|1
2048655|NCT00479401|3620465|FG000|Overall Study|Withdrawal by Subject|16
2048656|NCT00479401|3620466|FG001|Overall Study|Withdrawal by Subject|10
2048657|NCT00479401|3620467|FG002|Overall Study|Withdrawal by Subject|2
2048658|NCT00479401|3620465|FG000|Overall Study|Exclusion criteria, relocation|4
2048659|NCT00479401|3620466|FG001|Overall Study|Exclusion criteria, relocation|3
2105250|NCT00856284|3697752|FG002|Overall Study|Pregnancy|0
2048660|NCT00479401|3620467|FG002|Overall Study|Exclusion criteria, relocation|0
2048661|NCT00479466|3620481|FG000|Overall Study|Adverse Event|5
2048662|NCT00479466|3620482|FG001|Overall Study|Adverse Event|1
2048663|NCT00479466|3620483|FG002|Overall Study|Adverse Event|0
2048664|NCT00479466|3620484|FG003|Overall Study|Adverse Event|1
2048665|NCT00479466|3620485|FG004|Overall Study|Adverse Event|2
2048666|NCT00479466|3620486|FG005|Overall Study|Adverse Event|0
2048667|NCT00479466|3620481|FG000|Overall Study|Hyperglycemia|0
2048668|NCT00479466|3620482|FG001|Overall Study|Hyperglycemia|0
2048669|NCT00479466|3620483|FG002|Overall Study|Hyperglycemia|0
2048670|NCT00479466|3620484|FG003|Overall Study|Hyperglycemia|0
2048671|NCT00479466|3620485|FG004|Overall Study|Hyperglycemia|0
2048672|NCT00479466|3620486|FG005|Overall Study|Hyperglycemia|1
2208793|NCT01641692|3848406|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2048673|NCT00479466|3620481|FG000|Overall Study|Lack of Efficacy|2
2048674|NCT00479466|3620482|FG001|Overall Study|Lack of Efficacy|0
2048675|NCT00479466|3620483|FG002|Overall Study|Lack of Efficacy|1
2048676|NCT00479466|3620484|FG003|Overall Study|Lack of Efficacy|0
2048677|NCT00479466|3620485|FG004|Overall Study|Lack of Efficacy|0
2048678|NCT00479466|3620486|FG005|Overall Study|Lack of Efficacy|0
2048679|NCT00479466|3620481|FG000|Overall Study|Lost to Follow-up|0
2048680|NCT00479466|3620482|FG001|Overall Study|Lost to Follow-up|1
2048681|NCT00479466|3620483|FG002|Overall Study|Lost to Follow-up|1
2048682|NCT00479466|3620484|FG003|Overall Study|Lost to Follow-up|0
2048683|NCT00479466|3620485|FG004|Overall Study|Lost to Follow-up|2
2048684|NCT00479466|3620486|FG005|Overall Study|Lost to Follow-up|2
2048685|NCT00479466|3620481|FG000|Overall Study|Physician Decision|2
2048686|NCT00479466|3620482|FG001|Overall Study|Physician Decision|1
2048687|NCT00479466|3620483|FG002|Overall Study|Physician Decision|1
2048688|NCT00479466|3620484|FG003|Overall Study|Physician Decision|0
2048689|NCT00479466|3620485|FG004|Overall Study|Physician Decision|0
2048690|NCT00479466|3620486|FG005|Overall Study|Physician Decision|0
2048691|NCT00479466|3620481|FG000|Overall Study|Pregnancy|0
2048692|NCT00479466|3620482|FG001|Overall Study|Pregnancy|0
2048693|NCT00479466|3620483|FG002|Overall Study|Pregnancy|0
2048694|NCT00479466|3620484|FG003|Overall Study|Pregnancy|0
2048695|NCT00479466|3620485|FG004|Overall Study|Pregnancy|1
2048696|NCT00479466|3620486|FG005|Overall Study|Pregnancy|0
2048697|NCT00479466|3620481|FG000|Overall Study|Protocol Violation|1
2048698|NCT00479466|3620482|FG001|Overall Study|Protocol Violation|0
2048699|NCT00479466|3620483|FG002|Overall Study|Protocol Violation|0
2048700|NCT00479466|3620484|FG003|Overall Study|Protocol Violation|0
2048701|NCT00479466|3620485|FG004|Overall Study|Protocol Violation|0
2048702|NCT00479466|3620486|FG005|Overall Study|Protocol Violation|0
2048703|NCT00479466|3620481|FG000|Overall Study|Withdrawal by Subject|3
2048704|NCT00479466|3620482|FG001|Overall Study|Withdrawal by Subject|5
2048705|NCT00479466|3620483|FG002|Overall Study|Withdrawal by Subject|0
2048706|NCT00479466|3620484|FG003|Overall Study|Withdrawal by Subject|2
2048707|NCT00479466|3620485|FG004|Overall Study|Withdrawal by Subject|3
2048708|NCT00479466|3620486|FG005|Overall Study|Withdrawal by Subject|1
2048709|NCT00479557|3620507|FG000|Overall Study|Death|0
2048710|NCT00479557|3620508|FG001|Overall Study|Death|0
2048711|NCT00479557|3620509|FG002|Overall Study|Death|0
2048712|NCT00479557|3620510|FG003|Overall Study|Death|0
2048713|NCT00479557|3620511|FG004|Overall Study|Death|0
2048714|NCT00479557|3620512|FG005|Overall Study|Death|1
2048715|NCT00479557|3620513|FG006|Overall Study|Death|0
2048716|NCT00479557|3620507|FG000|Overall Study|Lack of Efficacy|1
2048717|NCT00479557|3620508|FG001|Overall Study|Lack of Efficacy|0
2048718|NCT00479557|3620509|FG002|Overall Study|Lack of Efficacy|0
2048719|NCT00479557|3620510|FG003|Overall Study|Lack of Efficacy|0
2048720|NCT00479557|3620511|FG004|Overall Study|Lack of Efficacy|0
2048721|NCT00479557|3620512|FG005|Overall Study|Lack of Efficacy|0
2048722|NCT00479557|3620513|FG006|Overall Study|Lack of Efficacy|0
2048723|NCT00479557|3620507|FG000|Overall Study|Lost to Follow-up|0
2048724|NCT00479557|3620508|FG001|Overall Study|Lost to Follow-up|2
2048725|NCT00479557|3620509|FG002|Overall Study|Lost to Follow-up|0
2048726|NCT00479557|3620510|FG003|Overall Study|Lost to Follow-up|2
2048727|NCT00479557|3620511|FG004|Overall Study|Lost to Follow-up|0
2048728|NCT00479557|3620512|FG005|Overall Study|Lost to Follow-up|0
2048729|NCT00479557|3620513|FG006|Overall Study|Lost to Follow-up|0
2048730|NCT00479557|3620507|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
2048731|NCT00479557|3620508|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
2048732|NCT00479557|3620509|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
2048733|NCT00479557|3620510|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
2048734|NCT00479557|3620511|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
2048735|NCT00479557|3620512|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
2048736|NCT00479557|3620513|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
2048737|NCT00479557|3620507|FG000|Overall Study|AE not related to Study Drug|1
2048738|NCT00479557|3620508|FG001|Overall Study|AE not related to Study Drug|3
2048739|NCT00479557|3620509|FG002|Overall Study|AE not related to Study Drug|0
2048740|NCT00479557|3620510|FG003|Overall Study|AE not related to Study Drug|0
2048741|NCT00479557|3620511|FG004|Overall Study|AE not related to Study Drug|2
2048742|NCT00479557|3620512|FG005|Overall Study|AE not related to Study Drug|2
2048743|NCT00479557|3620513|FG006|Overall Study|AE not related to Study Drug|1
2048744|NCT00479557|3620507|FG000|Overall Study|Caregiver Request|2
2048745|NCT00479557|3620508|FG001|Overall Study|Caregiver Request|2
2048746|NCT00479557|3620509|FG002|Overall Study|Caregiver Request|2
2048747|NCT00479557|3620510|FG003|Overall Study|Caregiver Request|0
2048748|NCT00479557|3620511|FG004|Overall Study|Caregiver Request|1
2048749|NCT00479557|3620512|FG005|Overall Study|Caregiver Request|2
2048750|NCT00479557|3620513|FG006|Overall Study|Caregiver Request|0
2048751|NCT00479557|3620507|FG000|Overall Study|Investigator Request|0
2048752|NCT00479557|3620508|FG001|Overall Study|Investigator Request|0
2048753|NCT00479557|3620509|FG002|Overall Study|Investigator Request|1
2048754|NCT00479557|3620510|FG003|Overall Study|Investigator Request|0
2048755|NCT00479557|3620511|FG004|Overall Study|Investigator Request|0
2048756|NCT00479557|3620512|FG005|Overall Study|Investigator Request|0
2048757|NCT00479557|3620513|FG006|Overall Study|Investigator Request|0
2048758|NCT00479557|3620507|FG000|Overall Study|Subject Request|3
2048759|NCT00479557|3620508|FG001|Overall Study|Subject Request|0
2048760|NCT00479557|3620509|FG002|Overall Study|Subject Request|1
2048761|NCT00479557|3620510|FG003|Overall Study|Subject Request|1
2048762|NCT00479557|3620511|FG004|Overall Study|Subject Request|1
2048763|NCT00479557|3620512|FG005|Overall Study|Subject Request|4
2048764|NCT00479557|3620513|FG006|Overall Study|Subject Request|1
2048765|NCT00479557|3620507|FG000|Overall Study|Other|2
2048766|NCT00479557|3620508|FG001|Overall Study|Other|3
2048767|NCT00479557|3620509|FG002|Overall Study|Other|1
2048768|NCT00479557|3620510|FG003|Overall Study|Other|0
2048769|NCT00479557|3620511|FG004|Overall Study|Other|0
2048770|NCT00479557|3620512|FG005|Overall Study|Other|3
2048771|NCT00479557|3620513|FG006|Overall Study|Other|0
2048772|NCT00479674|3620535|FG000|Overall Study|Adverse Event|18
2048773|NCT00479674|3620535|FG000|Overall Study|Withdrawal by Subject|6
2048774|NCT00479674|3620535|FG000|Overall Study|Physician Decision|14
2048775|NCT00479674|3620535|FG000|Overall Study|none provided|3
2048776|NCT00479687|3620541|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
2048777|NCT00479687|3620542|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2
2048778|NCT00479687|3620543|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
2048779|NCT00479687|3620541|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0
2048780|NCT00479687|3620542|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1
2048781|NCT00479687|3620543|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0
2048782|NCT00479687|3620541|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4
2048783|NCT00479687|3620542|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5
2048784|NCT00479687|3620543|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0
2048785|NCT00479687|3620541|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2
2048786|NCT00479687|3620542|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
2048787|NCT00479687|3620543|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
2048788|NCT00479687|3620541|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19
2048789|NCT00479687|3620542|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11
2048790|NCT00479687|3620543|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0
2048791|NCT00479687|3620541|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
2048792|NCT00479687|3620542|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
2048793|NCT00479687|3620543|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4
2048794|NCT00479687|3620541|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
2048795|NCT00479687|3620542|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
2048796|NCT00479687|3620543|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3
2048797|NCT00479687|3620541|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
2048798|NCT00479687|3620542|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
2048799|NCT00479687|3620543|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1
2048800|NCT00479687|3620541|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0
2048801|NCT00479687|3620542|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0
2048802|NCT00479687|3620543|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1
2048803|NCT00479765|3620550|FG000|Overall Study|study terminated|4
2048804|NCT00479856|3620554|FG000|Overall Study|Adverse Event|1
2048805|NCT00479856|3620554|FG000|Overall Study|Withdrawal by Subject|1
2048806|NCT00479856|3620554|FG000|Overall Study|Physician Decision|1
2048807|NCT00479882|3620562|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
2048808|NCT00479882|3620563|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
2048809|NCT00479882|3620564|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
2048810|NCT00479882|3620565|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
2048811|NCT00479882|3620562|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
2048812|NCT00479882|3620563|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
2048813|NCT00479882|3620564|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
2048814|NCT00479882|3620565|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
2048815|NCT00479882|3620562|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
2048816|NCT00479882|3620563|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
2048817|NCT00479882|3620564|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
2048818|NCT00479882|3620565|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
2048819|NCT00479882|3620562|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4
2048820|NCT00479882|3620563|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6
2048821|NCT00479882|3620564|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9
2048822|NCT00479882|3620565|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5
2048823|NCT00479882|3620562|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
2048824|NCT00479882|3620563|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
2048825|NCT00479882|3620564|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
2048826|NCT00479882|3620565|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
2048827|NCT00479882|3620562|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
2048828|NCT00479882|3620563|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
2048829|NCT00479882|3620564|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
2048830|NCT00479882|3620565|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
2048831|NCT00479882|3620562|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
2048832|NCT00479882|3620563|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
2048833|NCT00479882|3620564|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
2048834|NCT00479882|3620565|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
2048835|NCT00479882|3620562|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
2048836|NCT00479882|3620563|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
2048837|NCT00479882|3620564|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
2048838|NCT00479882|3620565|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
2048839|NCT00479882|3620562|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
2048840|NCT00479882|3620563|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
2048841|NCT00479882|3620564|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
2048842|NCT00479882|3620565|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
2048843|NCT00479882|3620562|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
2048844|NCT00479882|3620563|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
2048845|NCT00479882|3620564|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
2048846|NCT00479882|3620565|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
2048847|NCT00479882|3620562|FG000|Crossover: Period III (Weeks 13-20)|Other|5
2048848|NCT00479882|3620563|FG001|Crossover: Period III (Weeks 13-20)|Other|0
2048849|NCT00479882|3620564|FG002|Crossover: Period III (Weeks 13-20)|Other|2
2048850|NCT00479882|3620565|FG003|Crossover: Period III (Weeks 13-20)|Other|2
2048851|NCT00479882|3620562|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1
2048852|NCT00479882|3620563|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2
2048853|NCT00479882|3620564|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1
2048854|NCT00479882|3620565|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0
2048855|NCT00479882|3620562|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
2048856|NCT00479882|3620563|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
2048857|NCT00479882|3620564|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
2048858|NCT00479882|3620565|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
2048859|NCT00479882|3620562|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
2048860|NCT00479882|3620563|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
2048861|NCT00479882|3620564|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
2048862|NCT00479882|3620565|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
2048863|NCT00480025|3620593|FG000|Overall Study|Protocol Violation|12
2048864|NCT00480025|3620594|FG001|Overall Study|Protocol Violation|7
2048865|NCT00480025|3620593|FG000|Overall Study|Patients remaining ongoing at Data Lock|101
2048866|NCT00480025|3620594|FG001|Overall Study|Patients remaining ongoing at Data Lock|55
2048867|NCT00480025|3620593|FG000|Overall Study|Disease Progression / Recurrence|449
2048868|NCT00480025|3620594|FG001|Overall Study|Disease Progression / Recurrence|224
2048869|NCT00480025|3620593|FG000|Overall Study|Adverse Event|44
2048870|NCT00480025|3620594|FG001|Overall Study|Adverse Event|12
2048871|NCT00480025|3620593|FG000|Overall Study|Other|70
2048872|NCT00480025|3620594|FG001|Overall Study|Other|29
2048873|NCT00480025|3620593|FG000|Overall Study|SAE including intercurrent illness|76
2048874|NCT00480025|3620594|FG001|Overall Study|SAE including intercurrent illness|42
2048875|NCT00480077|3620608|FG000|Overall Study|Death|19
2048876|NCT00480077|3620609|FG001|Overall Study|Death|15
2048877|NCT00480077|3620608|FG000|Overall Study|early exit|12
2048878|NCT00480077|3620609|FG001|Overall Study|early exit|11
2048879|NCT00480324|3620617|FG000|Overall Study|Adverse Event|1
2048880|NCT00480324|3620618|FG001|Overall Study|Adverse Event|1
2048881|NCT00480324|3620617|FG000|Overall Study|Protocol Violation|0
2048882|NCT00480324|3620618|FG001|Overall Study|Protocol Violation|1
2048883|NCT00480324|3620617|FG000|Overall Study|Withdrawal by Subject|14
2048884|NCT00480324|3620618|FG001|Overall Study|Withdrawal by Subject|5
2048885|NCT00480324|3620617|FG000|Overall Study|Lost to Follow-up|17
2048886|NCT00480324|3620618|FG001|Overall Study|Lost to Follow-up|8
2048887|NCT00480324|3620617|FG000|Overall Study|Subject's mother pregnant|0
2048888|NCT00480324|3620618|FG001|Overall Study|Subject's mother pregnant|1
2048889|NCT00480441|3620626|FG000|Screening|Not Eligible|37
2048890|NCT00480441|3620627|FG001|Screening|Not Eligible|0
2048891|NCT00480441|3620628|FG002|Screening|Not Eligible|0
2048892|NCT00480441|3620626|FG000|Baseline Functional MRI|Functional MRI data not usable|4
2048893|NCT00480441|3620627|FG001|Baseline Functional MRI|Functional MRI data not usable|0
2105251|NCT00856284|3697750|FG000|Overall Study|Investigator discretion|9
2048894|NCT00480441|3620628|FG002|Baseline Functional MRI|Functional MRI data not usable|0
2048895|NCT00480441|3620626|FG000|Baseline Functional MRI|Lost to Follow-up|4
2048896|NCT00480441|3620627|FG001|Baseline Functional MRI|Lost to Follow-up|0
2048897|NCT00480441|3620628|FG002|Baseline Functional MRI|Lost to Follow-up|0
2048898|NCT00480441|3620626|FG000|Baseline Functional MRI|physical contraindication|4
2048899|NCT00480441|3620627|FG001|Baseline Functional MRI|physical contraindication|0
2048900|NCT00480441|3620628|FG002|Baseline Functional MRI|physical contraindication|0
2048901|NCT00480441|3620626|FG000|Randomization|Lost to Follow-up|0
2048902|NCT00480441|3620627|FG001|Randomization|Lost to Follow-up|7
2048903|NCT00480441|3620628|FG002|Randomization|Lost to Follow-up|2
2048904|NCT00480493|3620637|FG000|Overall Study|moved|2
2048905|NCT00480493|3620638|FG001|Overall Study|moved|7
2048906|NCT00480532|3620650|FG000|Overall Study|Withdrawal by Subject|2
2048907|NCT00480532|3620651|FG001|Overall Study|Withdrawal by Subject|4
2048908|NCT00480532|3620652|FG002|Overall Study|Withdrawal by Subject|3
2048909|NCT00480532|3620653|FG003|Overall Study|Withdrawal by Subject|1
2048910|NCT00480532|3620650|FG000|Overall Study|Protocol Violation|0
2048911|NCT00480532|3620651|FG001|Overall Study|Protocol Violation|0
2048912|NCT00480532|3620652|FG002|Overall Study|Protocol Violation|1
2048913|NCT00480532|3620653|FG003|Overall Study|Protocol Violation|0
2299694|NCT02589665|3996949|FG001|Induction Period|Withdrawal by Subject|1
2299695|NCT02589665|3996950|FG002|Induction Period|Withdrawal by Subject|0
2299696|NCT02589665|3996951|FG003|Induction Period|Withdrawal by Subject|1
2048914|NCT00480636|3620663|FG000|Overall Study|Death|12
2048915|NCT00480636|3620663|FG000|Overall Study|Lost to Follow-up|4
2048916|NCT00480636|3620663|FG000|Overall Study|Other|2
2048917|NCT00480636|3620663|FG000|Overall Study|Lost to follow-up; subsequently died|1
2048918|NCT00480779|3620682|FG000|Overall Study|Other|2
2048919|NCT00480779|3620683|FG001|Overall Study|Other|0
2048920|NCT00480779|3620682|FG000|Overall Study|Job and Health-related|0
2048921|NCT00480779|3620683|FG001|Overall Study|Job and Health-related|3
2048922|NCT00480857|3620689|FG000|Overall Study|Lack of Efficacy|2
2048923|NCT00481065|3620705|FG000|Overall Study|Adverse event or death|1
2048924|NCT00481065|3620706|FG001|Overall Study|Adverse event or death|1
2048925|NCT00481065|3620707|FG002|Overall Study|Adverse event or death|3
2048926|NCT00481065|3620708|FG003|Overall Study|Adverse event or death|0
2048927|NCT00481065|3620709|FG004|Overall Study|Adverse event or death|2
2048928|NCT00481065|3620710|FG005|Overall Study|Adverse event or death|0
2048929|NCT00481065|3620711|FG006|Overall Study|Adverse event or death|1
2048930|NCT00481065|3620712|FG007|Overall Study|Adverse event or death|1
2048931|NCT00481065|3620705|FG000|Overall Study|Withdrawal by Subject|11
2048932|NCT00481065|3620706|FG001|Overall Study|Withdrawal by Subject|12
2048933|NCT00481065|3620707|FG002|Overall Study|Withdrawal by Subject|7
2048934|NCT00481065|3620708|FG003|Overall Study|Withdrawal by Subject|11
2048935|NCT00481065|3620709|FG004|Overall Study|Withdrawal by Subject|13
2048936|NCT00481065|3620710|FG005|Overall Study|Withdrawal by Subject|12
2048937|NCT00481065|3620711|FG006|Overall Study|Withdrawal by Subject|9
2048938|NCT00481065|3620712|FG007|Overall Study|Withdrawal by Subject|10
2048939|NCT00481065|3620705|FG000|Overall Study|Lost to Follow-up|4
2048940|NCT00481065|3620706|FG001|Overall Study|Lost to Follow-up|2
2048941|NCT00481065|3620707|FG002|Overall Study|Lost to Follow-up|4
2048942|NCT00481065|3620708|FG003|Overall Study|Lost to Follow-up|3
2048943|NCT00481065|3620709|FG004|Overall Study|Lost to Follow-up|3
2048944|NCT00481065|3620710|FG005|Overall Study|Lost to Follow-up|3
2048945|NCT00481065|3620711|FG006|Overall Study|Lost to Follow-up|2
2048946|NCT00481065|3620712|FG007|Overall Study|Lost to Follow-up|5
2048947|NCT00481065|3620705|FG000|Overall Study|Inappropriate enrollment|4
2048948|NCT00481065|3620706|FG001|Overall Study|Inappropriate enrollment|0
2048949|NCT00481065|3620707|FG002|Overall Study|Inappropriate enrollment|2
2048950|NCT00481065|3620708|FG003|Overall Study|Inappropriate enrollment|0
2048951|NCT00481065|3620709|FG004|Overall Study|Inappropriate enrollment|2
2048952|NCT00481065|3620710|FG005|Overall Study|Inappropriate enrollment|1
2048953|NCT00481065|3620711|FG006|Overall Study|Inappropriate enrollment|0
2048954|NCT00481065|3620712|FG007|Overall Study|Inappropriate enrollment|1
2208794|NCT01641692|3848407|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2208795|NCT01641692|3848408|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2208796|NCT01641692|3848409|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2208797|NCT01641692|3848410|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2208798|NCT01641692|3848411|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2048955|NCT00481065|3620705|FG000|Overall Study|Administrative reason|0
2048956|NCT00481065|3620706|FG001|Overall Study|Administrative reason|0
2048957|NCT00481065|3620707|FG002|Overall Study|Administrative reason|0
2048958|NCT00481065|3620708|FG003|Overall Study|Administrative reason|0
2048959|NCT00481065|3620709|FG004|Overall Study|Administrative reason|0
2048960|NCT00481065|3620710|FG005|Overall Study|Administrative reason|2
2048961|NCT00481065|3620711|FG006|Overall Study|Administrative reason|1
2048962|NCT00481065|3620712|FG007|Overall Study|Administrative reason|0
2048963|NCT00481065|3620705|FG000|Overall Study|Protocol Violation|2
2048964|NCT00481065|3620706|FG001|Overall Study|Protocol Violation|1
2048965|NCT00481065|3620707|FG002|Overall Study|Protocol Violation|1
2048966|NCT00481065|3620708|FG003|Overall Study|Protocol Violation|1
2048967|NCT00481065|3620709|FG004|Overall Study|Protocol Violation|2
2048968|NCT00481065|3620710|FG005|Overall Study|Protocol Violation|6
2048969|NCT00481065|3620711|FG006|Overall Study|Protocol Violation|3
2048970|NCT00481065|3620712|FG007|Overall Study|Protocol Violation|2
2048971|NCT00481065|3620705|FG000|Overall Study|Unable to classify|0
2048972|NCT00481065|3620706|FG001|Overall Study|Unable to classify|1
2048973|NCT00481065|3620707|FG002|Overall Study|Unable to classify|2
2048974|NCT00481065|3620708|FG003|Overall Study|Unable to classify|0
2048975|NCT00481065|3620709|FG004|Overall Study|Unable to classify|1
2048976|NCT00481065|3620710|FG005|Overall Study|Unable to classify|0
2048977|NCT00481065|3620711|FG006|Overall Study|Unable to classify|0
2048978|NCT00481065|3620712|FG007|Overall Study|Unable to classify|0
2048979|NCT00481078|3620734|FG000|Overall Study|Progression of disease|11
2048980|NCT00481078|3620735|FG001|Overall Study|Progression of disease|11
2048981|NCT00481078|3620734|FG000|Overall Study|Adverse Event|15
2048982|NCT00481078|3620735|FG001|Overall Study|Adverse Event|3
2048983|NCT00481078|3620734|FG000|Overall Study|Death|5
2048984|NCT00481078|3620735|FG001|Overall Study|Death|3
2048985|NCT00481078|3620734|FG000|Overall Study|Intercurrent illness|1
2048986|NCT00481078|3620735|FG001|Overall Study|Intercurrent illness|0
2048987|NCT00481078|3620734|FG000|Overall Study|Withdrawal by Subject|7
2048988|NCT00481078|3620735|FG001|Overall Study|Withdrawal by Subject|1
2048989|NCT00481078|3620734|FG000|Overall Study|Information not available|1
2048990|NCT00481078|3620735|FG001|Overall Study|Information not available|0
2048991|NCT00481078|3620734|FG000|Overall Study|Received other treatment|2
2048992|NCT00481078|3620735|FG001|Overall Study|Received other treatment|1
2048993|NCT00481078|3620734|FG000|Overall Study|Brain metastasis|0
2048994|NCT00481078|3620735|FG001|Overall Study|Brain metastasis|1
2048995|NCT00481195|3620743|FG000|Overall Study|Adverse Event|16
2048996|NCT00481195|3620744|FG001|Overall Study|Adverse Event|11
2048997|NCT00481195|3620743|FG000|Overall Study|Lack of Efficacy|1
2048998|NCT00481195|3620744|FG001|Overall Study|Lack of Efficacy|3
2048999|NCT00481195|3620743|FG000|Overall Study|Lost to Follow-up|4
2049000|NCT00481195|3620744|FG001|Overall Study|Lost to Follow-up|6
2049001|NCT00481195|3620743|FG000|Overall Study|Physician Decision|3
2049002|NCT00481195|3620744|FG001|Overall Study|Physician Decision|1
2049003|NCT00481195|3620743|FG000|Overall Study|Protocol Violation|10
2049004|NCT00481195|3620744|FG001|Overall Study|Protocol Violation|7
2049005|NCT00481195|3620743|FG000|Overall Study|Withdrawal by Subject|3
2049006|NCT00481195|3620744|FG001|Overall Study|Withdrawal by Subject|9
2049007|NCT00481195|3620743|FG000|Overall Study|Miscellaneous|2
2049008|NCT00481195|3620744|FG001|Overall Study|Miscellaneous|2
2049009|NCT00481247|3620752|FG000|Overall Study|Death|0
2049010|NCT00481247|3620753|FG001|Overall Study|Death|1
2049011|NCT00481247|3620752|FG000|Overall Study|Disease progression|18
2049012|NCT00481247|3620753|FG001|Overall Study|Disease progression|22
2049013|NCT00481247|3620752|FG000|Overall Study|Intolerance|42
2049014|NCT00481247|3620753|FG001|Overall Study|Intolerance|17
2049015|NCT00481247|3620752|FG000|Overall Study|Treatment failure|10
2049016|NCT00481247|3620753|FG001|Overall Study|Treatment failure|14
2049017|NCT00481247|3620752|FG000|Overall Study|AE unrelated to study drug|13
2049018|NCT00481247|3620753|FG001|Overall Study|AE unrelated to study drug|4
2049019|NCT00481247|3620752|FG000|Overall Study|Withdrawal by Subject|8
2049020|NCT00481247|3620753|FG001|Overall Study|Withdrawal by Subject|13
2049021|NCT00481247|3620752|FG000|Overall Study|Pregnancy|2
2049022|NCT00481247|3620753|FG001|Overall Study|Pregnancy|1
2049023|NCT00481247|3620752|FG000|Overall Study|Lost to Follow-up|1
2049024|NCT00481247|3620753|FG001|Overall Study|Lost to Follow-up|2
2049025|NCT00481247|3620752|FG000|Overall Study|Poor compliance/noncompliance|1
2049026|NCT00481247|3620753|FG001|Overall Study|Poor compliance/noncompliance|7
2049027|NCT00481247|3620752|FG000|Overall Study|Administrative reason by sponsor|157
2049028|NCT00481247|3620753|FG001|Overall Study|Administrative reason by sponsor|162
2049029|NCT00481247|3620752|FG000|Overall Study|Varied|6
2049030|NCT00481247|3620753|FG001|Overall Study|Varied|15
2049031|NCT00481247|3620752|FG000|Overall Study|Did not receive treatment|1
2049032|NCT00481247|3620753|FG001|Overall Study|Did not receive treatment|2
2049033|NCT00481676|3620779|FG000|Overall Study|Adverse Event|0
2049034|NCT00481676|3620780|FG001|Overall Study|Adverse Event|1
2049035|NCT00481676|3620779|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2049036|NCT00481676|3620780|FG001|Overall Study|Unsatisfactory therapeutic effect|4
2049037|NCT00481676|3620779|FG000|Overall Study|Administrative problem|1
2049038|NCT00481676|3620780|FG001|Overall Study|Administrative problem|0
2049039|NCT00481767|3620788|FG000|Overall Study|Withdrawal by Subject|16
2049040|NCT00481767|3620789|FG001|Overall Study|Withdrawal by Subject|11
2049041|NCT00481767|3620788|FG000|Overall Study|Lost to Follow-up|16
2049042|NCT00481767|3620789|FG001|Overall Study|Lost to Follow-up|10
2049043|NCT00481832|3620795|FG000|Enrollment|Physician Decision|8
2049044|NCT00481832|3620795|FG000|Enrollment|Unable to collect enough stem cells|2
2049045|NCT00481832|3620795|FG000|Inter-transplant Period|Adverse Event|4
2049046|NCT00481832|3620795|FG000|Inter-transplant Period|Death|3
2049047|NCT00481832|3620795|FG000|Inter-transplant Period|Physician Decision|4
2049048|NCT00481832|3620795|FG000|Inter-transplant Period|Disease relapse|11
2049049|NCT00481832|3620795|FG000|Inter-transplant Period|Lack of allogeneic donor|5
2049050|NCT00481871|3620813|FG000|Overall Study|Progressive Disease - pt withdrew|0
2049051|NCT00481871|3620814|FG001|Overall Study|Progressive Disease - pt withdrew|0
2049052|NCT00481871|3620815|FG002|Overall Study|Progressive Disease - pt withdrew|1
2049053|NCT00481871|3620816|FG003|Overall Study|Progressive Disease - pt withdrew|0
2049054|NCT00481871|3620817|FG004|Overall Study|Progressive Disease - pt withdrew|0
2049055|NCT00481988|3620827|FG000|Overall Study|Withdrawal by Subject|1
2049056|NCT00481988|3620828|FG001|Overall Study|Withdrawal by Subject|1
2049057|NCT00482001|3620836|FG000|Overall Study|Protocol Violation|1
2049058|NCT00482001|3620837|FG001|Overall Study|Protocol Violation|1
2049059|NCT00482014|3620849|FG000|Overall Study|Withdrawal by Subject|1
2049060|NCT00482014|3620850|FG001|Overall Study|Withdrawal by Subject|2
2049061|NCT00482014|3620851|FG002|Overall Study|Withdrawal by Subject|3
2049062|NCT00482014|3620852|FG003|Overall Study|Withdrawal by Subject|4
2049063|NCT00482014|3620849|FG000|Overall Study|Adverse Event|3
2049064|NCT00482014|3620850|FG001|Overall Study|Adverse Event|0
2049065|NCT00482014|3620851|FG002|Overall Study|Adverse Event|2
2049066|NCT00482014|3620852|FG003|Overall Study|Adverse Event|8
2049067|NCT00482014|3620849|FG000|Overall Study|Death|1
2049068|NCT00482014|3620850|FG001|Overall Study|Death|2
2049069|NCT00482014|3620851|FG002|Overall Study|Death|1
2049070|NCT00482014|3620852|FG003|Overall Study|Death|4
2049071|NCT00482014|3620849|FG000|Overall Study|Lack of Efficacy|1
2049072|NCT00482014|3620850|FG001|Overall Study|Lack of Efficacy|0
2049073|NCT00482014|3620851|FG002|Overall Study|Lack of Efficacy|4
2049074|NCT00482014|3620852|FG003|Overall Study|Lack of Efficacy|6
2049075|NCT00482014|3620849|FG000|Overall Study|Sponsor Decision|1
2049076|NCT00482014|3620850|FG001|Overall Study|Sponsor Decision|2
2049077|NCT00482014|3620851|FG002|Overall Study|Sponsor Decision|1
2049078|NCT00482014|3620852|FG003|Overall Study|Sponsor Decision|1
2049079|NCT00482053|3620864|FG000|Inter-treatment Period|Disease progression|1
2049080|NCT00482170|3620870|FG000|Overall Study|Adverse Event|5
2049081|NCT00482170|3620871|FG001|Overall Study|Adverse Event|14
2049082|NCT00482170|3620870|FG000|Overall Study|Withdrawal by Subject|6
2049083|NCT00482170|3620871|FG001|Overall Study|Withdrawal by Subject|1
2049084|NCT00482170|3620870|FG000|Overall Study|Protocol Violation|2
2049085|NCT00482170|3620871|FG001|Overall Study|Protocol Violation|3
2049086|NCT00482170|3620870|FG000|Overall Study|Lost to Follow-up|2
2049087|NCT00482170|3620871|FG001|Overall Study|Lost to Follow-up|0
2049088|NCT00482170|3620870|FG000|Overall Study|Unspecified reason|0
2049089|NCT00482170|3620871|FG001|Overall Study|Unspecified reason|2
2049090|NCT00482274|3620877|FG000|Overall Study|Adverse Event|1
2049091|NCT00482391|3620881|FG000|Overall Study|Withdrawal by Subject|1
2049092|NCT00482391|3620881|FG000|Overall Study|Adverse Event|1
2049093|NCT00482391|3620881|FG000|Overall Study|Death|1
2049094|NCT00482612|3620899|FG000|In-treatment Period|No study medication administered|0
2049095|NCT00482612|3620900|FG001|In-treatment Period|No study medication administered|0
2049096|NCT00482612|3620901|FG002|In-treatment Period|No study medication administered|1
2049097|NCT00482612|3620902|FG003|In-treatment Period|No study medication administered|0
2049098|NCT00482612|3620899|FG000|Follow-up Period|Other|4
2049099|NCT00482612|3620900|FG001|Follow-up Period|Other|2
2049100|NCT00482612|3620901|FG002|Follow-up Period|Other|1
2049101|NCT00482612|3620902|FG003|Follow-up Period|Other|2
2049102|NCT00482612|3620899|FG000|Follow-up Period|Lack of compliance|0
2049103|NCT00482612|3620900|FG001|Follow-up Period|Lack of compliance|0
2049104|NCT00482612|3620901|FG002|Follow-up Period|Lack of compliance|1
2049105|NCT00482612|3620902|FG003|Follow-up Period|Lack of compliance|0
2049106|NCT00482612|3620899|FG000|Follow-up Period|Lost to Follow-up|0
2049107|NCT00482612|3620900|FG001|Follow-up Period|Lost to Follow-up|4
2049108|NCT00482612|3620901|FG002|Follow-up Period|Lost to Follow-up|2
2049109|NCT00482612|3620902|FG003|Follow-up Period|Lost to Follow-up|1
2049110|NCT00482612|3620899|FG000|Follow-up Period|Adverse Event|4
2049111|NCT00482612|3620900|FG001|Follow-up Period|Adverse Event|7
2049112|NCT00482612|3620901|FG002|Follow-up Period|Adverse Event|9
2049113|NCT00482612|3620902|FG003|Follow-up Period|Adverse Event|0
2049114|NCT00482612|3620899|FG000|Follow-up Period|Lack of Efficacy|2
2049115|NCT00482612|3620900|FG001|Follow-up Period|Lack of Efficacy|0
2049116|NCT00482612|3620901|FG002|Follow-up Period|Lack of Efficacy|1
2049117|NCT00482612|3620902|FG003|Follow-up Period|Lack of Efficacy|0
2049118|NCT00482612|3620899|FG000|Follow-up Period|Withdrawal by Subject|3
2049119|NCT00482612|3620900|FG001|Follow-up Period|Withdrawal by Subject|5
2049120|NCT00482612|3620901|FG002|Follow-up Period|Withdrawal by Subject|7
2049121|NCT00482612|3620902|FG003|Follow-up Period|Withdrawal by Subject|2
2049122|NCT00482612|3620899|FG000|Follow-up Period|Reasons not related to trial|1
2049123|NCT00482612|3620900|FG001|Follow-up Period|Reasons not related to trial|0
2049124|NCT00482612|3620901|FG002|Follow-up Period|Reasons not related to trial|1
2049125|NCT00482612|3620902|FG003|Follow-up Period|Reasons not related to trial|3
2049126|NCT00482703|3620931|FG000|Overall Study|Poor compliance|1
2049127|NCT00482703|3620932|FG001|Overall Study|Poor compliance|0
2049128|NCT00482729|3620947|FG000|Overall Study|Adverse Event|29
2049129|NCT00482729|3620948|FG001|Overall Study|Adverse Event|33
2049130|NCT00482729|3620947|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0
2049131|NCT00482729|3620948|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2
2049132|NCT00482729|3620947|FG000|Overall Study|Hyperglycemia Criteria|7
2049133|NCT00482729|3620948|FG001|Overall Study|Hyperglycemia Criteria|5
2049134|NCT00482729|3620947|FG000|Overall Study|Lack of Efficacy|4
2049135|NCT00482729|3620948|FG001|Overall Study|Lack of Efficacy|16
2049136|NCT00482729|3620947|FG000|Overall Study|Lost to Follow-up|86
2049137|NCT00482729|3620948|FG001|Overall Study|Lost to Follow-up|66
2049138|NCT00482729|3620947|FG000|Overall Study|Physician Decision|10
2049139|NCT00482729|3620948|FG001|Overall Study|Physician Decision|7
2049140|NCT00482729|3620947|FG000|Overall Study|Pregnancy|4
2049141|NCT00482729|3620948|FG001|Overall Study|Pregnancy|2
2049142|NCT00482729|3620947|FG000|Overall Study|Protocol Violation|10
2049143|NCT00482729|3620948|FG001|Overall Study|Protocol Violation|18
2049144|NCT00482729|3620947|FG000|Overall Study|Withdrawal by Subject|67
2049145|NCT00482729|3620948|FG001|Overall Study|Withdrawal by Subject|69
2049146|NCT00483002|3620963|FG000|Overall Study|Adverse Event|68
2049147|NCT00483002|3620963|FG000|Overall Study|Lack of Efficacy|555
2049148|NCT00483002|3620963|FG000|Overall Study|Lost to Follow-up|962
2049149|NCT00483002|3620963|FG000|Overall Study|Other|2
2049150|NCT00483002|3620963|FG000|Overall Study|Other|967
2049151|NCT00483041|3620969|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
2049152|NCT00483041|3620970|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
2049153|NCT00483184|3620979|FG000|Overall Study|Withdrawal by Subject|2
2049154|NCT00483184|3620980|FG001|Overall Study|Withdrawal by Subject|2
2049155|NCT00483184|3620981|FG002|Overall Study|Withdrawal by Subject|0
2049156|NCT00483184|3620979|FG000|Overall Study|Lost to Follow-up|1
2049157|NCT00483184|3620980|FG001|Overall Study|Lost to Follow-up|0
2049158|NCT00483184|3620981|FG002|Overall Study|Lost to Follow-up|0
2049159|NCT00483184|3620979|FG000|Overall Study|Adverse Event|1
2049160|NCT00483184|3620980|FG001|Overall Study|Adverse Event|2
2049161|NCT00483184|3620981|FG002|Overall Study|Adverse Event|2
2049162|NCT00483184|3620979|FG000|Overall Study|Protocol Violation|1
2049163|NCT00483184|3620980|FG001|Overall Study|Protocol Violation|0
2049164|NCT00483184|3620981|FG002|Overall Study|Protocol Violation|1
2049165|NCT00483327|3621006|FG000|Overall Study|Adverse Event|1
2049166|NCT00483327|3621006|FG000|Overall Study|Withdrawal by Subject|3
2049167|NCT00483327|3621006|FG000|Overall Study|Lost to Follow-up|4
2049168|NCT00483327|3621006|FG000|Overall Study|Patient Non Compliance|2
2049169|NCT00483379|3621014|FG000|Treatment Period|Adverse Event|1
2049170|NCT00483379|3621015|FG001|Treatment Period|Adverse Event|0
2049171|NCT00483379|3621014|FG000|Treatment Period|Withdrawal by Subject|1
2049172|NCT00483379|3621015|FG001|Treatment Period|Withdrawal by Subject|0
2049173|NCT00483405|3621023|FG000|Overall Study|Adverse Event|8
2049174|NCT00483405|3621023|FG000|Overall Study|Lack of Efficacy|14
2049175|NCT00483405|3621023|FG000|Overall Study|Death|3
2049176|NCT00483405|3621023|FG000|Overall Study|Withdrawal by Subject|2
2049177|NCT00483405|3621023|FG000|Overall Study|Other complicating disease|1
2049178|NCT00483548|3621045|FG000|Overall Study|Randomized; not treated with study drug|1
2049179|NCT00483548|3621046|FG001|Overall Study|Randomized; not treated with study drug|3
2049180|NCT00483548|3621045|FG000|Overall Study|Adverse Event|25
2049181|NCT00483548|3621046|FG001|Overall Study|Adverse Event|14
2049182|NCT00483548|3621045|FG000|Overall Study|Laboratory abnormality|1
2049183|NCT00483548|3621046|FG001|Overall Study|Laboratory abnormality|2
2049184|NCT00483548|3621045|FG000|Overall Study|Lack of Efficacy|4
2049185|NCT00483548|3621046|FG001|Overall Study|Lack of Efficacy|8
2049186|NCT00483548|3621045|FG000|Overall Study|Protocol Violation|11
2049187|NCT00483548|3621046|FG001|Overall Study|Protocol Violation|7
2049188|NCT00483548|3621045|FG000|Overall Study|Pregnancy|1
2049189|NCT00483548|3621046|FG001|Overall Study|Pregnancy|0
2049190|NCT00483548|3621045|FG000|Overall Study|Protocol required discontinuation|6
2049191|NCT00483548|3621046|FG001|Overall Study|Protocol required discontinuation|6
2049192|NCT00483548|3621045|FG000|Overall Study|Unable to comply with protocol schedule|1
2049193|NCT00483548|3621046|FG001|Overall Study|Unable to comply with protocol schedule|0
2049194|NCT00483548|3621045|FG000|Overall Study|Non-compliance with medication|2
2049195|NCT00483548|3621046|FG001|Overall Study|Non-compliance with medication|0
2049196|NCT00483548|3621045|FG000|Overall Study|Lost to Follow-up|3
2049197|NCT00483548|3621046|FG001|Overall Study|Lost to Follow-up|4
2049198|NCT00483548|3621045|FG000|Overall Study|Withdrawal by Subject|5
2049199|NCT00483548|3621046|FG001|Overall Study|Withdrawal by Subject|2
2049200|NCT00483574|3621058|FG000|Overall Study|Adverse Event|6
2049201|NCT00483574|3621059|FG001|Overall Study|Adverse Event|0
2049202|NCT00483574|3621058|FG000|Overall Study|Protocol Violation|28
2049203|NCT00483574|3621059|FG001|Overall Study|Protocol Violation|9
2049204|NCT00483574|3621058|FG000|Overall Study|Lost to Follow-up|16
2049205|NCT00483574|3621059|FG001|Overall Study|Lost to Follow-up|4
2049206|NCT00483574|3621058|FG000|Overall Study|Withdrawal by Subject|52
2049207|NCT00483574|3621059|FG001|Overall Study|Withdrawal by Subject|0
2049208|NCT00483652|3621069|FG000|Double-blind Treatment Period|Protocol Violation|2
2049209|NCT00483652|3621070|FG001|Double-blind Treatment Period|Protocol Violation|1
2049210|NCT00483652|3621069|FG000|Double-blind Treatment Period|Adverse Event|3
2049211|NCT00483652|3621070|FG001|Double-blind Treatment Period|Adverse Event|4
2049212|NCT00483652|3621069|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1
2049213|NCT00483652|3621070|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0
2049214|NCT00483652|3621069|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1
2049215|NCT00483652|3621070|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0
2049216|NCT00483704|3621079|FG000|Randomization|Withdrawal by Subject|19
2049217|NCT00483704|3621080|FG001|Randomization|Withdrawal by Subject|28
2049218|NCT00483704|3621081|FG002|Randomization|Withdrawal by Subject|18
2049219|NCT00483704|3621079|FG000|Randomization|Protocol Violation|14
2049220|NCT00483704|3621080|FG001|Randomization|Protocol Violation|25
2049221|NCT00483704|3621081|FG002|Randomization|Protocol Violation|22
2049222|NCT00483704|3621079|FG000|Randomization|Lost to Follow-up|14
2049223|NCT00483704|3621080|FG001|Randomization|Lost to Follow-up|14
2049224|NCT00483704|3621081|FG002|Randomization|Lost to Follow-up|19
2049225|NCT00483704|3621079|FG000|Randomization|Pregnancy|1
2049226|NCT00483704|3621080|FG001|Randomization|Pregnancy|0
2049227|NCT00483704|3621081|FG002|Randomization|Pregnancy|0
2049228|NCT00483704|3621079|FG000|Randomization|Physician Decision|2
2299697|NCT02589665|3996952|FG004|Induction Period|Withdrawal by Subject|0
2299698|NCT02589665|3996953|FG005|Induction Period|Withdrawal by Subject|0
2299699|NCT02589665|3996954|FG006|Induction Period|Withdrawal by Subject|0
2299700|NCT02589665|3996955|FG007|Induction Period|Withdrawal by Subject|0
2299701|NCT02589665|3996956|FG008|Induction Period|Withdrawal by Subject|0
2299702|NCT02589665|3996957|FG009|Induction Period|Withdrawal by Subject|0
2049229|NCT00483704|3621080|FG001|Randomization|Physician Decision|4
2049230|NCT00483704|3621081|FG002|Randomization|Physician Decision|0
2049231|NCT00483704|3621079|FG000|Randomization|Progressive disease|0
2049232|NCT00483704|3621080|FG001|Randomization|Progressive disease|0
2049233|NCT00483704|3621081|FG002|Randomization|Progressive disease|1
2049234|NCT00483704|3621079|FG000|Randomization|Lack of qualifying migraines|21
2049235|NCT00483704|3621080|FG001|Randomization|Lack of qualifying migraines|25
2049236|NCT00483704|3621081|FG002|Randomization|Lack of qualifying migraines|31
2049237|NCT00483704|3621079|FG000|Treatment|Lack of qualifying migraines|101
2049238|NCT00483704|3621080|FG001|Treatment|Lack of qualifying migraines|99
2049239|NCT00483704|3621081|FG002|Treatment|Lack of qualifying migraines|116
2049240|NCT00483704|3621079|FG000|Treatment|Adverse Event|3
2049241|NCT00483704|3621080|FG001|Treatment|Adverse Event|5
2049242|NCT00483704|3621081|FG002|Treatment|Adverse Event|4
2049243|NCT00483704|3621079|FG000|Treatment|Withdrawal by Subject|16
2049244|NCT00483704|3621080|FG001|Treatment|Withdrawal by Subject|12
2049245|NCT00483704|3621081|FG002|Treatment|Withdrawal by Subject|21
2049246|NCT00483704|3621079|FG000|Treatment|Protocol Violation|6
2049247|NCT00483704|3621080|FG001|Treatment|Protocol Violation|3
2049248|NCT00483704|3621081|FG002|Treatment|Protocol Violation|5
2049249|NCT00483704|3621079|FG000|Treatment|Lost to Follow-up|2
2049250|NCT00483704|3621080|FG001|Treatment|Lost to Follow-up|7
2049251|NCT00483704|3621081|FG002|Treatment|Lost to Follow-up|5
2049252|NCT00483704|3621079|FG000|Treatment|Lack of Efficacy|1
2049253|NCT00483704|3621080|FG001|Treatment|Lack of Efficacy|1
2049254|NCT00483704|3621081|FG002|Treatment|Lack of Efficacy|1
2049255|NCT00483704|3621079|FG000|Treatment|Pregnancy|0
2049256|NCT00483704|3621080|FG001|Treatment|Pregnancy|1
2049257|NCT00483704|3621081|FG002|Treatment|Pregnancy|0
2049258|NCT00483704|3621079|FG000|Treatment|Physician Decision|0
2049259|NCT00483704|3621080|FG001|Treatment|Physician Decision|1
2049260|NCT00483704|3621081|FG002|Treatment|Physician Decision|4
2049261|NCT00483717|3621094|FG000|Overall Study|Protocol Violation|5
2049262|NCT00483717|3621095|FG001|Overall Study|Protocol Violation|7
2049263|NCT00483717|3621094|FG000|Overall Study|Time of dosing missing|1
2049264|NCT00483717|3621095|FG001|Overall Study|Time of dosing missing|1
2049265|NCT00483717|3621094|FG000|Overall Study|No treatment for migraine|16
2049266|NCT00483717|3621095|FG001|Overall Study|No treatment for migraine|13
2049267|NCT00483717|3621094|FG000|Overall Study|Lost to Follow-up|1
2049268|NCT00483717|3621095|FG001|Overall Study|Lost to Follow-up|0
2049269|NCT00483717|3621094|FG000|Overall Study|Withdrawal by Subject|1
2049270|NCT00483717|3621095|FG001|Overall Study|Withdrawal by Subject|0
2049271|NCT00483756|3621104|FG000|Overall Study|Death|2
2049272|NCT00483756|3621105|FG001|Overall Study|Death|0
2049273|NCT00483756|3621106|FG002|Overall Study|Death|1
2049274|NCT00483756|3621104|FG000|Overall Study|Adverse Event|19
2049275|NCT00483756|3621105|FG001|Overall Study|Adverse Event|38
2049276|NCT00483756|3621106|FG002|Overall Study|Adverse Event|40
2049277|NCT00483756|3621104|FG000|Overall Study|Lack of Efficacy|1
2049278|NCT00483756|3621105|FG001|Overall Study|Lack of Efficacy|0
2049279|NCT00483756|3621106|FG002|Overall Study|Lack of Efficacy|0
2049280|NCT00483756|3621104|FG000|Overall Study|Lost to Follow-up|3
2049281|NCT00483756|3621105|FG001|Overall Study|Lost to Follow-up|1
2049282|NCT00483756|3621106|FG002|Overall Study|Lost to Follow-up|0
2049283|NCT00483756|3621104|FG000|Overall Study|Withdrawal by Subject|5
2049284|NCT00483756|3621105|FG001|Overall Study|Withdrawal by Subject|3
2049285|NCT00483756|3621106|FG002|Overall Study|Withdrawal by Subject|4
2049286|NCT00483756|3621104|FG000|Overall Study|Other|2
2049287|NCT00483756|3621105|FG001|Overall Study|Other|4
2049288|NCT00483756|3621106|FG002|Overall Study|Other|3
2049289|NCT00483756|3621104|FG000|Overall Study|Randomized, Not Treated|1
2049290|NCT00483756|3621105|FG001|Overall Study|Randomized, Not Treated|4
2049291|NCT00483756|3621106|FG002|Overall Study|Randomized, Not Treated|4
2049292|NCT00483938|3621121|FG000|Overall Study|Protocol Violation|0
2049293|NCT00483938|3621122|FG001|Overall Study|Protocol Violation|0
2049294|NCT00483938|3621123|FG002|Overall Study|Protocol Violation|0
2049295|NCT00483938|3621124|FG003|Overall Study|Protocol Violation|0
2049296|NCT00483938|3621125|FG004|Overall Study|Protocol Violation|0
2049297|NCT00483938|3621126|FG005|Overall Study|Protocol Violation|0
2049298|NCT00483938|3621127|FG006|Overall Study|Protocol Violation|3
2299703|NCT02589665|3996948|FG000|Induction Period|Protocol Violation|0
2049299|NCT00483938|3621121|FG000|Overall Study|Withdrawal by Subject|1
2049300|NCT00483938|3621122|FG001|Overall Study|Withdrawal by Subject|6
2049301|NCT00483938|3621123|FG002|Overall Study|Withdrawal by Subject|0
2049302|NCT00483938|3621124|FG003|Overall Study|Withdrawal by Subject|0
2049303|NCT00483938|3621125|FG004|Overall Study|Withdrawal by Subject|1
2049304|NCT00483938|3621126|FG005|Overall Study|Withdrawal by Subject|3
2049305|NCT00483938|3621127|FG006|Overall Study|Withdrawal by Subject|2
2049306|NCT00483938|3621121|FG000|Overall Study|Lost to Follow-up|1
2049307|NCT00483938|3621122|FG001|Overall Study|Lost to Follow-up|2
2049308|NCT00483938|3621123|FG002|Overall Study|Lost to Follow-up|0
2049309|NCT00483938|3621124|FG003|Overall Study|Lost to Follow-up|2
2049310|NCT00483938|3621125|FG004|Overall Study|Lost to Follow-up|1
2049311|NCT00483938|3621126|FG005|Overall Study|Lost to Follow-up|1
2049312|NCT00483938|3621127|FG006|Overall Study|Lost to Follow-up|3
2049313|NCT00483938|3621121|FG000|Overall Study|Death|0
2049314|NCT00483938|3621122|FG001|Overall Study|Death|2
2049315|NCT00483938|3621123|FG002|Overall Study|Death|0
2049316|NCT00483938|3621124|FG003|Overall Study|Death|0
2049317|NCT00483938|3621125|FG004|Overall Study|Death|0
2049318|NCT00483938|3621126|FG005|Overall Study|Death|0
2049319|NCT00483938|3621127|FG006|Overall Study|Death|0
2049320|NCT00483938|3621121|FG000|Overall Study|Other|3
2049321|NCT00483938|3621122|FG001|Overall Study|Other|9
2049322|NCT00483938|3621123|FG002|Overall Study|Other|0
2049323|NCT00483938|3621124|FG003|Overall Study|Other|4
2049324|NCT00483938|3621125|FG004|Overall Study|Other|0
2049325|NCT00483938|3621126|FG005|Overall Study|Other|4
2049326|NCT00483938|3621127|FG006|Overall Study|Other|32
2049327|NCT00484094|3621146|FG000|Overall Study|Discontinued|39
2049328|NCT00484094|3621146|FG000|Overall Study|Other|3
2049329|NCT00484159|3621153|FG000|Overall Study|Lost to Follow-up|1
2049330|NCT00484159|3621154|FG001|Overall Study|Lost to Follow-up|1
2049331|NCT00484159|3621155|FG002|Overall Study|Lost to Follow-up|0
2049332|NCT00484185|3621163|FG000|Overall Study|Lost to Follow-up|44
2049333|NCT00484185|3621163|FG000|Overall Study|Other|20
2049334|NCT00484185|3621163|FG000|Overall Study|Randomized but not treated|5
2049335|NCT00484185|3621163|FG000|Overall Study|Death|2
2049336|NCT00484198|3621171|FG000|Overall Study|Participant Withdrew Consent|12
2049337|NCT00484198|3621172|FG001|Overall Study|Participant Withdrew Consent|21
2049338|NCT00484198|3621173|FG002|Overall Study|Participant Withdrew Consent|47
2049339|NCT00484198|3621174|FG003|Overall Study|Participant Withdrew Consent|59
2049340|NCT00484198|3621171|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16
2049341|NCT00484198|3621172|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17
2049342|NCT00484198|3621173|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29
2049343|NCT00484198|3621174|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38
2049344|NCT00484198|3621171|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3
2049345|NCT00484198|3621172|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2
2049346|NCT00484198|3621173|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6
2049347|NCT00484198|3621174|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8
2049348|NCT00484198|3621171|FG000|Overall Study|Adverse Event|3
2049349|NCT00484198|3621172|FG001|Overall Study|Adverse Event|11
2049350|NCT00484198|3621173|FG002|Overall Study|Adverse Event|32
2049351|NCT00484198|3621174|FG003|Overall Study|Adverse Event|31
2049352|NCT00484198|3621171|FG000|Overall Study|Protocol Violation|0
2049353|NCT00484198|3621172|FG001|Overall Study|Protocol Violation|5
2049354|NCT00484198|3621173|FG002|Overall Study|Protocol Violation|6
2049355|NCT00484198|3621174|FG003|Overall Study|Protocol Violation|8
2049356|NCT00484198|3621171|FG000|Overall Study|Other|7
2049357|NCT00484198|3621172|FG001|Overall Study|Other|10
2049358|NCT00484198|3621173|FG002|Overall Study|Other|31
2049359|NCT00484198|3621174|FG003|Overall Study|Other|28
2049360|NCT00484289|3621192|FG000|Long Term Phase|Adverse Event|1
2049361|NCT00484289|3621193|FG001|Long Term Phase|Adverse Event|17
2049362|NCT00484289|3621194|FG002|Long Term Phase|Adverse Event|5
2049363|NCT00484289|3621192|FG000|Long Term Phase|Withdrawal by Subject|0
2049364|NCT00484289|3621193|FG001|Long Term Phase|Withdrawal by Subject|7
2049365|NCT00484289|3621194|FG002|Long Term Phase|Withdrawal by Subject|6
2049366|NCT00484289|3621192|FG000|Long Term Phase|Inadequate response|2
2049367|NCT00484289|3621193|FG001|Long Term Phase|Inadequate response|7
2049368|NCT00484289|3621194|FG002|Long Term Phase|Inadequate response|4
2049369|NCT00484289|3621192|FG000|Long Term Phase|Other Reason|0
2049370|NCT00484289|3621193|FG001|Long Term Phase|Other Reason|5
2049371|NCT00484289|3621194|FG002|Long Term Phase|Other Reason|1
2049372|NCT00484289|3621192|FG000|Post Marketing Phase|Adverse Event|0
2049373|NCT00484289|3621193|FG001|Post Marketing Phase|Adverse Event|1
2049374|NCT00484289|3621194|FG002|Post Marketing Phase|Adverse Event|0
2049375|NCT00484315|3621205|FG000|12-Month Clinical Follow-up|Death|6
2049376|NCT00484315|3621206|FG001|12-Month Clinical Follow-up|Death|2
2049377|NCT00484315|3621205|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4
2049378|NCT00484315|3621206|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0
2049379|NCT00484315|3621205|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
2049380|NCT00484315|3621206|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1
2049381|NCT00484315|3621205|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13
2049382|NCT00484315|3621206|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4
2049383|NCT00484315|3621205|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
2049384|NCT00484315|3621206|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
2049385|NCT00484315|3621205|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
2049386|NCT00484315|3621206|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
2049387|NCT00484315|3621205|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
2049388|NCT00484315|3621206|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
2049389|NCT00484679|3621230|FG000|Overall Study|Withdrawal by Subject|3
2049390|NCT00484939|3621243|FG000|Overall Study|Death|9
2049391|NCT00484939|3621244|FG001|Overall Study|Death|13
2049392|NCT00484939|3621243|FG000|Overall Study|Adverse Event|22
2049393|NCT00484939|3621244|FG001|Overall Study|Adverse Event|12
2049394|NCT00484939|3621243|FG000|Overall Study|Patient Withdrew Consent|19
2049395|NCT00484939|3621244|FG001|Overall Study|Patient Withdrew Consent|10
2049396|NCT00484939|3621243|FG000|Overall Study|Protocol Violation|3
2049397|NCT00484939|3621244|FG001|Overall Study|Protocol Violation|3
2049398|NCT00484939|3621243|FG000|Overall Study|Lost to Follow-up|0
2049399|NCT00484939|3621244|FG001|Overall Study|Lost to Follow-up|3
2049400|NCT00484939|3621243|FG000|Overall Study|Discretion of Investigator or Sponsor|7
2049401|NCT00484939|3621244|FG001|Overall Study|Discretion of Investigator or Sponsor|3
2049402|NCT00484939|3621243|FG000|Overall Study|Disease progression|67
2049403|NCT00484939|3621244|FG001|Overall Study|Disease progression|88
2049404|NCT00484939|3621243|FG000|Overall Study|Screen Failure|2
2049405|NCT00484939|3621244|FG001|Overall Study|Screen Failure|2
2049406|NCT00484939|3621243|FG000|Overall Study|Reason Not Specified|11
2049407|NCT00484939|3621244|FG001|Overall Study|Reason Not Specified|6
2049408|NCT00485069|3621252|FG000|Overall Study|Adverse Event|10
2049409|NCT00485069|3621253|FG001|Overall Study|Adverse Event|4
2049410|NCT00485069|3621252|FG000|Overall Study|Lack of Efficacy|2
2049411|NCT00485069|3621253|FG001|Overall Study|Lack of Efficacy|1
2049412|NCT00485069|3621252|FG000|Overall Study|Protocol Violation|0
2049413|NCT00485069|3621253|FG001|Overall Study|Protocol Violation|1
2049414|NCT00485069|3621252|FG000|Overall Study|Withdrawal by Subject|6
2049415|NCT00485069|3621253|FG001|Overall Study|Withdrawal by Subject|6
2049416|NCT00485134|3621274|FG000|Overall Study|Lost to Follow-up|1
2049417|NCT00485134|3621275|FG001|Overall Study|Lost to Follow-up|0
2049418|NCT00485134|3621276|FG002|Overall Study|Lost to Follow-up|0
2049419|NCT00485134|3621277|FG003|Overall Study|Lost to Follow-up|0
2049420|NCT00485134|3621278|FG004|Overall Study|Lost to Follow-up|0
2049421|NCT00485134|3621279|FG005|Overall Study|Lost to Follow-up|0
2049422|NCT00485134|3621280|FG006|Overall Study|Lost to Follow-up|0
2049423|NCT00485134|3621281|FG007|Overall Study|Lost to Follow-up|0
2049424|NCT00485134|3621274|FG000|Overall Study|Withdrawal by Subject|0
2049425|NCT00485134|3621275|FG001|Overall Study|Withdrawal by Subject|1
2049426|NCT00485134|3621276|FG002|Overall Study|Withdrawal by Subject|0
2049427|NCT00485134|3621277|FG003|Overall Study|Withdrawal by Subject|0
2049428|NCT00485134|3621278|FG004|Overall Study|Withdrawal by Subject|0
2049429|NCT00485134|3621279|FG005|Overall Study|Withdrawal by Subject|0
2049430|NCT00485134|3621280|FG006|Overall Study|Withdrawal by Subject|0
2049431|NCT00485134|3621281|FG007|Overall Study|Withdrawal by Subject|0
2049432|NCT00485134|3621274|FG000|Overall Study|Change in health status|0
2049433|NCT00485134|3621275|FG001|Overall Study|Change in health status|1
2049434|NCT00485134|3621276|FG002|Overall Study|Change in health status|2
2049435|NCT00485134|3621277|FG003|Overall Study|Change in health status|1
2049436|NCT00485134|3621278|FG004|Overall Study|Change in health status|0
2049437|NCT00485134|3621279|FG005|Overall Study|Change in health status|1
2049438|NCT00485134|3621280|FG006|Overall Study|Change in health status|0
2049439|NCT00485134|3621281|FG007|Overall Study|Change in health status|0
2049440|NCT00485134|3621274|FG000|Overall Study|Withdrew for adverse event|0
2049441|NCT00485134|3621275|FG001|Overall Study|Withdrew for adverse event|0
2049442|NCT00485134|3621276|FG002|Overall Study|Withdrew for adverse event|1
2049443|NCT00485134|3621277|FG003|Overall Study|Withdrew for adverse event|0
2049444|NCT00485134|3621278|FG004|Overall Study|Withdrew for adverse event|0
2049445|NCT00485134|3621279|FG005|Overall Study|Withdrew for adverse event|0
2049446|NCT00485134|3621280|FG006|Overall Study|Withdrew for adverse event|0
2049447|NCT00485134|3621281|FG007|Overall Study|Withdrew for adverse event|0
2049448|NCT00485134|3621274|FG000|Overall Study|Positive drug test|0
2049449|NCT00485134|3621275|FG001|Overall Study|Positive drug test|0
2049450|NCT00485134|3621276|FG002|Overall Study|Positive drug test|0
2049451|NCT00485134|3621277|FG003|Overall Study|Positive drug test|0
2049452|NCT00485134|3621278|FG004|Overall Study|Positive drug test|2
2049453|NCT00485134|3621279|FG005|Overall Study|Positive drug test|1
2049454|NCT00485134|3621280|FG006|Overall Study|Positive drug test|0
2049455|NCT00485134|3621281|FG007|Overall Study|Positive drug test|0
2049456|NCT00485134|3621274|FG000|Overall Study|Non-compliance|0
2049457|NCT00485134|3621275|FG001|Overall Study|Non-compliance|0
2049458|NCT00485134|3621276|FG002|Overall Study|Non-compliance|0
2049459|NCT00485134|3621277|FG003|Overall Study|Non-compliance|0
2049460|NCT00485134|3621278|FG004|Overall Study|Non-compliance|1
2049461|NCT00485134|3621279|FG005|Overall Study|Non-compliance|2
2049462|NCT00485134|3621280|FG006|Overall Study|Non-compliance|2
2049463|NCT00485134|3621281|FG007|Overall Study|Non-compliance|0
2049464|NCT00485134|3621274|FG000|Overall Study|Unable to comply with study schedule|0
2049465|NCT00485134|3621275|FG001|Overall Study|Unable to comply with study schedule|0
2049466|NCT00485134|3621276|FG002|Overall Study|Unable to comply with study schedule|0
2049467|NCT00485134|3621277|FG003|Overall Study|Unable to comply with study schedule|0
2049468|NCT00485134|3621278|FG004|Overall Study|Unable to comply with study schedule|0
2049469|NCT00485134|3621279|FG005|Overall Study|Unable to comply with study schedule|0
2049470|NCT00485134|3621280|FG006|Overall Study|Unable to comply with study schedule|0
2049471|NCT00485134|3621281|FG007|Overall Study|Unable to comply with study schedule|1
2049472|NCT00485134|3621274|FG000|Overall Study|Pregnancy|0
2049473|NCT00485134|3621275|FG001|Overall Study|Pregnancy|0
2049474|NCT00485134|3621276|FG002|Overall Study|Pregnancy|0
2049475|NCT00485134|3621277|FG003|Overall Study|Pregnancy|0
2049476|NCT00485134|3621278|FG004|Overall Study|Pregnancy|0
2049477|NCT00485134|3621279|FG005|Overall Study|Pregnancy|0
2049478|NCT00485134|3621280|FG006|Overall Study|Pregnancy|1
2049479|NCT00485134|3621281|FG007|Overall Study|Pregnancy|0
2049480|NCT00485173|3621295|FG000|Overall Study|Death|4
2049481|NCT00485173|3621296|FG001|Overall Study|Death|3
2049482|NCT00485173|3621295|FG000|Overall Study|Lost to Follow-up|32
2049483|NCT00485173|3621296|FG001|Overall Study|Lost to Follow-up|61
2049484|NCT00485264|3621308|FG000|Overall Study|Enrolled But Not Given Treatment|0
2049485|NCT00485264|3621309|FG001|Overall Study|Enrolled But Not Given Treatment|0
2049486|NCT00485264|3621310|FG002|Overall Study|Enrolled But Not Given Treatment|0
2049487|NCT00485264|3621311|FG003|Overall Study|Enrolled But Not Given Treatment|0
2049488|NCT00485264|3621312|FG004|Overall Study|Enrolled But Not Given Treatment|1
2049489|NCT00485264|3621313|FG005|Overall Study|Enrolled But Not Given Treatment|0
2049490|NCT00485264|3621308|FG000|Overall Study|Death|1
2049491|NCT00485264|3621309|FG001|Overall Study|Death|0
2049492|NCT00485264|3621310|FG002|Overall Study|Death|0
2049493|NCT00485264|3621311|FG003|Overall Study|Death|0
2049494|NCT00485264|3621312|FG004|Overall Study|Death|1
2049495|NCT00485264|3621313|FG005|Overall Study|Death|0
2049496|NCT00485264|3621308|FG000|Overall Study|Adverse Event|1
2049497|NCT00485264|3621309|FG001|Overall Study|Adverse Event|0
2049498|NCT00485264|3621310|FG002|Overall Study|Adverse Event|2
2049499|NCT00485264|3621311|FG003|Overall Study|Adverse Event|3
2049500|NCT00485264|3621312|FG004|Overall Study|Adverse Event|1
2049501|NCT00485264|3621313|FG005|Overall Study|Adverse Event|3
2049502|NCT00485264|3621308|FG000|Overall Study|Pregnancy|4
2049503|NCT00485264|3621309|FG001|Overall Study|Pregnancy|0
2049504|NCT00485264|3621310|FG002|Overall Study|Pregnancy|0
2049505|NCT00485264|3621311|FG003|Overall Study|Pregnancy|0
2049506|NCT00485264|3621312|FG004|Overall Study|Pregnancy|0
2049507|NCT00485264|3621313|FG005|Overall Study|Pregnancy|0
2049508|NCT00485264|3621308|FG000|Overall Study|Disallowed Medication|0
2049509|NCT00485264|3621309|FG001|Overall Study|Disallowed Medication|0
2049510|NCT00485264|3621310|FG002|Overall Study|Disallowed Medication|0
2049511|NCT00485264|3621311|FG003|Overall Study|Disallowed Medication|0
2049512|NCT00485264|3621312|FG004|Overall Study|Disallowed Medication|0
2049513|NCT00485264|3621313|FG005|Overall Study|Disallowed Medication|1
2049514|NCT00485264|3621308|FG000|Overall Study|Number/Volume/Timing of Study Meds|2
2049515|NCT00485264|3621309|FG001|Overall Study|Number/Volume/Timing of Study Meds|1
2049516|NCT00485264|3621310|FG002|Overall Study|Number/Volume/Timing of Study Meds|1
2049517|NCT00485264|3621311|FG003|Overall Study|Number/Volume/Timing of Study Meds|0
2049518|NCT00485264|3621312|FG004|Overall Study|Number/Volume/Timing of Study Meds|0
2049519|NCT00485264|3621313|FG005|Overall Study|Number/Volume/Timing of Study Meds|0
2049520|NCT00485264|3621308|FG000|Overall Study|Lack of Efficacy|0
2049521|NCT00485264|3621309|FG001|Overall Study|Lack of Efficacy|1
2049522|NCT00485264|3621310|FG002|Overall Study|Lack of Efficacy|0
2049523|NCT00485264|3621311|FG003|Overall Study|Lack of Efficacy|0
2049524|NCT00485264|3621312|FG004|Overall Study|Lack of Efficacy|0
2049525|NCT00485264|3621313|FG005|Overall Study|Lack of Efficacy|0
2049526|NCT00485264|3621308|FG000|Overall Study|Guardian Consent Withdrawn|1
2049527|NCT00485264|3621309|FG001|Overall Study|Guardian Consent Withdrawn|0
2299704|NCT02589665|3996949|FG001|Induction Period|Protocol Violation|1
2299705|NCT02589665|3996950|FG002|Induction Period|Protocol Violation|0
2299706|NCT02589665|3996951|FG003|Induction Period|Protocol Violation|0
2299707|NCT02589665|3996952|FG004|Induction Period|Protocol Violation|0
2299708|NCT02589665|3996953|FG005|Induction Period|Protocol Violation|0
2049528|NCT00485264|3621310|FG002|Overall Study|Guardian Consent Withdrawn|0
2049529|NCT00485264|3621311|FG003|Overall Study|Guardian Consent Withdrawn|0
2049530|NCT00485264|3621312|FG004|Overall Study|Guardian Consent Withdrawn|1
2049531|NCT00485264|3621313|FG005|Overall Study|Guardian Consent Withdrawn|0
2049532|NCT00485264|3621308|FG000|Overall Study|Physician Decision|0
2049533|NCT00485264|3621309|FG001|Overall Study|Physician Decision|2
2049534|NCT00485264|3621310|FG002|Overall Study|Physician Decision|0
2049535|NCT00485264|3621311|FG003|Overall Study|Physician Decision|0
2049536|NCT00485264|3621312|FG004|Overall Study|Physician Decision|0
2049537|NCT00485264|3621313|FG005|Overall Study|Physician Decision|0
2049538|NCT00485264|3621308|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0
2049539|NCT00485264|3621309|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0
2049540|NCT00485264|3621310|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1
2049541|NCT00485264|3621311|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0
2049542|NCT00485264|3621312|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0
2299709|NCT02589665|3996954|FG006|Induction Period|Protocol Violation|0
2299710|NCT02589665|3996955|FG007|Induction Period|Protocol Violation|0
2299711|NCT02589665|3996956|FG008|Induction Period|Protocol Violation|0
2299712|NCT02589665|3996957|FG009|Induction Period|Protocol Violation|0
2299713|NCT02589665|3996948|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2299714|NCT02589665|3996949|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2299715|NCT02589665|3996950|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2299716|NCT02589665|3996951|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2299717|NCT02589665|3996952|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
2299718|NCT02589665|3996953|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
2299719|NCT02589665|3996954|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
2299720|NCT02589665|3996955|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2299721|NCT02589665|3996956|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2299722|NCT02589665|3996957|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2299723|NCT02589665|3996948|FG000|Maintenance Period|Withdrawal by Subject|0
2299724|NCT02589665|3996949|FG001|Maintenance Period|Withdrawal by Subject|0
2299725|NCT02589665|3996950|FG002|Maintenance Period|Withdrawal by Subject|0
2299726|NCT02589665|3996951|FG003|Maintenance Period|Withdrawal by Subject|0
2299727|NCT02589665|3996952|FG004|Maintenance Period|Withdrawal by Subject|4
2299728|NCT02589665|3996953|FG005|Maintenance Period|Withdrawal by Subject|2
2299729|NCT02589665|3996954|FG006|Maintenance Period|Withdrawal by Subject|4
2299730|NCT02589665|3996955|FG007|Maintenance Period|Withdrawal by Subject|0
2299731|NCT02589665|3996956|FG008|Maintenance Period|Withdrawal by Subject|0
2299732|NCT02589665|3996957|FG009|Maintenance Period|Withdrawal by Subject|0
2299733|NCT02589665|3996948|FG000|Maintenance Period|Lack of Efficacy|0
2299734|NCT02589665|3996949|FG001|Maintenance Period|Lack of Efficacy|0
2299735|NCT02589665|3996950|FG002|Maintenance Period|Lack of Efficacy|0
2299736|NCT02589665|3996951|FG003|Maintenance Period|Lack of Efficacy|0
2299737|NCT02589665|3996952|FG004|Maintenance Period|Lack of Efficacy|2
2299738|NCT02589665|3996953|FG005|Maintenance Period|Lack of Efficacy|1
2299739|NCT02589665|3996954|FG006|Maintenance Period|Lack of Efficacy|0
2299740|NCT02589665|3996955|FG007|Maintenance Period|Lack of Efficacy|0
2299741|NCT02589665|3996956|FG008|Maintenance Period|Lack of Efficacy|0
2299742|NCT02589665|3996957|FG009|Maintenance Period|Lack of Efficacy|0
2299743|NCT02589665|3996948|FG000|Maintenance Period|Adverse Event|0
2049543|NCT00485264|3621313|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0
2049544|NCT00485264|3621308|FG000|Overall Study|Not Able to Attend Clinic|5
2049545|NCT00485264|3621309|FG001|Overall Study|Not Able to Attend Clinic|0
2049546|NCT00485264|3621310|FG002|Overall Study|Not Able to Attend Clinic|0
2049547|NCT00485264|3621311|FG003|Overall Study|Not Able to Attend Clinic|1
2049548|NCT00485264|3621312|FG004|Overall Study|Not Able to Attend Clinic|1
2049549|NCT00485264|3621313|FG005|Overall Study|Not Able to Attend Clinic|2
2049550|NCT00485264|3621308|FG000|Overall Study|Non-Compliant|17
2049551|NCT00485264|3621309|FG001|Overall Study|Non-Compliant|2
2049552|NCT00485264|3621310|FG002|Overall Study|Non-Compliant|1
2049553|NCT00485264|3621311|FG003|Overall Study|Non-Compliant|0
2049554|NCT00485264|3621312|FG004|Overall Study|Non-Compliant|1
2049555|NCT00485264|3621313|FG005|Overall Study|Non-Compliant|0
2049556|NCT00485264|3621308|FG000|Overall Study|Lost to Follow-up|2
2049557|NCT00485264|3621309|FG001|Overall Study|Lost to Follow-up|1
2049558|NCT00485264|3621310|FG002|Overall Study|Lost to Follow-up|1
2049559|NCT00485264|3621311|FG003|Overall Study|Lost to Follow-up|0
2049560|NCT00485264|3621312|FG004|Overall Study|Lost to Follow-up|0
2049561|NCT00485264|3621313|FG005|Overall Study|Lost to Follow-up|1
2049562|NCT00485264|3621308|FG000|Overall Study|Other Reason|3
2049563|NCT00485264|3621309|FG001|Overall Study|Other Reason|0
2049564|NCT00485264|3621310|FG002|Overall Study|Other Reason|0
2049565|NCT00485264|3621311|FG003|Overall Study|Other Reason|0
2049566|NCT00485264|3621312|FG004|Overall Study|Other Reason|0
2049567|NCT00485264|3621313|FG005|Overall Study|Other Reason|0
2049568|NCT00485303|3621332|FG000|Overall Study|Adverse Event|5
2049569|NCT00485303|3621332|FG000|Overall Study|Progressive Disease|44
2049570|NCT00485303|3621332|FG000|Overall Study|Other|3
2049571|NCT00485303|3621332|FG000|Overall Study|Initiation of new anti-cancer treatment|2
2049572|NCT00485303|3621332|FG000|Overall Study|Treatment ongoing at cutoff date|2
2049573|NCT00485472|3621353|FG000|Overall Study|Adverse Event|8
2049574|NCT00485472|3621354|FG001|Overall Study|Adverse Event|5
2049575|NCT00485472|3621353|FG000|Overall Study|Lack of Efficacy|5
2049576|NCT00485472|3621354|FG001|Overall Study|Lack of Efficacy|4
2049577|NCT00485472|3621353|FG000|Overall Study|Withdrawal by Subject|1
2049578|NCT00485472|3621354|FG001|Overall Study|Withdrawal by Subject|0
2049579|NCT00485472|3621353|FG000|Overall Study|Protocol Violation|0
2049580|NCT00485472|3621354|FG001|Overall Study|Protocol Violation|1
2049581|NCT00485472|3621353|FG000|Overall Study|Other|2
2049582|NCT00485472|3621354|FG001|Overall Study|Other|1
2049583|NCT00485472|3621353|FG000|Overall Study|Lost to Follow-up|0
2049584|NCT00485472|3621354|FG001|Overall Study|Lost to Follow-up|1
2049585|NCT00485589|3621367|FG000|Overall Study|Death|2
2049586|NCT00485589|3621368|FG001|Overall Study|Death|2
2299744|NCT02589665|3996949|FG001|Maintenance Period|Adverse Event|0
2299745|NCT02589665|3996950|FG002|Maintenance Period|Adverse Event|0
2299746|NCT02589665|3996951|FG003|Maintenance Period|Adverse Event|0
2299747|NCT02589665|3996952|FG004|Maintenance Period|Adverse Event|0
2049587|NCT00485589|3621369|FG002|Overall Study|Death|0
2049588|NCT00485589|3621367|FG000|Overall Study|Failure to return|6
2049589|NCT00485589|3621368|FG001|Overall Study|Failure to return|5
2049590|NCT00485589|3621369|FG002|Overall Study|Failure to return|1
2049591|NCT00485589|3621367|FG000|Overall Study|Protocol Violation|1
2049592|NCT00485589|3621368|FG001|Overall Study|Protocol Violation|0
2049593|NCT00485589|3621369|FG002|Overall Study|Protocol Violation|0
2049594|NCT00485589|3621367|FG000|Overall Study|Violation of selection criteria at entry|0
2049595|NCT00485589|3621368|FG001|Overall Study|Violation of selection criteria at entry|3
2049596|NCT00485589|3621369|FG002|Overall Study|Violation of selection criteria at entry|1
2049597|NCT00485589|3621367|FG000|Overall Study|Administrative/Other|1
2049598|NCT00485589|3621368|FG001|Overall Study|Administrative/Other|2
2049599|NCT00485589|3621369|FG002|Overall Study|Administrative/Other|1
2049600|NCT00485589|3621367|FG000|Overall Study|Insufficient therapeutic response|10
2049601|NCT00485589|3621368|FG001|Overall Study|Insufficient therapeutic response|3
2049602|NCT00485589|3621369|FG002|Overall Study|Insufficient therapeutic response|1
2049603|NCT00485589|3621367|FG000|Overall Study|Refused treatment/did not cooperate|1
2049604|NCT00485589|3621368|FG001|Overall Study|Refused treatment/did not cooperate|0
2049605|NCT00485589|3621369|FG002|Overall Study|Refused treatment/did not cooperate|2
2049606|NCT00485589|3621367|FG000|Overall Study|Withdrawal by Subject|3
2049607|NCT00485589|3621368|FG001|Overall Study|Withdrawal by Subject|2
2049608|NCT00485589|3621369|FG002|Overall Study|Withdrawal by Subject|2
2049609|NCT00485589|3621367|FG000|Overall Study|Adverse Event|3
2049610|NCT00485589|3621368|FG001|Overall Study|Adverse Event|3
2049611|NCT00485589|3621369|FG002|Overall Study|Adverse Event|10
2049612|NCT00485732|3621400|FG000|Overall Study|Protocol Violation|1
2049613|NCT00485732|3621401|FG001|Overall Study|Protocol Violation|3
2049614|NCT00485732|3621400|FG000|Overall Study|Withdrawal by Subject|5
2049615|NCT00485732|3621401|FG001|Overall Study|Withdrawal by Subject|4
2049616|NCT00485732|3621400|FG000|Overall Study|Lost to Follow-up|2
2049617|NCT00485732|3621401|FG001|Overall Study|Lost to Follow-up|2
2049618|NCT00485758|3621409|FG000|Overall Study|Adverse Event|102
2049619|NCT00485758|3621410|FG001|Overall Study|Adverse Event|31
2049620|NCT00485758|3621409|FG000|Overall Study|Death|0
2049621|NCT00485758|3621410|FG001|Overall Study|Death|1
2049622|NCT00485758|3621409|FG000|Overall Study|Lost to Follow-up|5
2049623|NCT00485758|3621410|FG001|Overall Study|Lost to Follow-up|1
2049624|NCT00485758|3621409|FG000|Overall Study|Physician Decision|3
2049625|NCT00485758|3621410|FG001|Overall Study|Physician Decision|3
2049626|NCT00485758|3621409|FG000|Overall Study|Protocol Violation|11
2049627|NCT00485758|3621410|FG001|Overall Study|Protocol Violation|2
2049628|NCT00485758|3621409|FG000|Overall Study|Withdrawal by Subject|32
2049629|NCT00485758|3621410|FG001|Overall Study|Withdrawal by Subject|27
2049630|NCT00485758|3621409|FG000|Overall Study|Study Terminated by Sponsor|3
2049631|NCT00485758|3621410|FG001|Overall Study|Study Terminated by Sponsor|0
2049632|NCT00486044|3621460|FG000|Overall Study|Withdrawal by Subject|2
2049633|NCT00486044|3621461|FG001|Overall Study|Withdrawal by Subject|1
2049634|NCT00486044|3621460|FG000|Overall Study|Adverse Event|0
2049635|NCT00486044|3621461|FG001|Overall Study|Adverse Event|1
2049636|NCT00486044|3621460|FG000|Overall Study|Lost to Follow-up|0
2049637|NCT00486044|3621461|FG001|Overall Study|Lost to Follow-up|1
2049638|NCT00486226|3621467|FG000|Overall Study|Death|3
2049639|NCT00486226|3621467|FG000|Overall Study|Adverse Event|1
2049640|NCT00486226|3621467|FG000|Overall Study|Withdrawal by Subject|1
2049641|NCT00486226|3621467|FG000|Overall Study|Lost to Follow-up|8
2049642|NCT00486252|3621474|FG000|Overall Study|Adverse Event|7
2049643|NCT00486252|3621474|FG000|Overall Study|Lack of Efficacy|9
2049644|NCT00486252|3621474|FG000|Overall Study|Lost to Follow-up|24
2049645|NCT00486252|3621474|FG000|Overall Study|Other|18
2049646|NCT00486265|3621480|FG000|Overall Study|Adverse Event|1
2049647|NCT00486265|3621480|FG000|Overall Study|Lack of Efficacy|8
2105252|NCT00856284|3697751|FG001|Overall Study|Investigator discretion|8
2105253|NCT00856284|3697752|FG002|Overall Study|Investigator discretion|10
2105254|NCT00856284|3697750|FG000|Overall Study|Other|15
2105255|NCT00856284|3697751|FG001|Overall Study|Other|17
2105256|NCT00856284|3697752|FG002|Overall Study|Other|14
2105257|NCT00856284|3697750|FG000|Overall Study|Randomized in error|0
2105258|NCT00856284|3697751|FG001|Overall Study|Randomized in error|0
2105259|NCT00856284|3697752|FG002|Overall Study|Randomized in error|1
2105260|NCT00856297|3697765|FG000|Overall Study|Unable to classify|2
2105261|NCT00856297|3697766|FG001|Overall Study|Unable to classify|0
2105262|NCT00856297|3697767|FG002|Overall Study|Unable to classify|0
2105263|NCT00856297|3697768|FG003|Overall Study|Unable to classify|0
2105264|NCT00856297|3697769|FG004|Overall Study|Unable to classify|0
2105265|NCT00856323|3697786|FG000|Overall Study|Withdrawal by Subject|2
2105266|NCT00856349|3697790|FG000|Overall Study|Death|418
2105267|NCT00856349|3697790|FG000|Overall Study|Withdrawal by Subject|116
2105268|NCT00856349|3697790|FG000|Overall Study|Lost to Follow-up|91
2105269|NCT00856349|3697790|FG000|Overall Study|Protocol Violation|38
2105270|NCT00856349|3697790|FG000|Overall Study|Physician Decision|13
2105271|NCT00856349|3697790|FG000|Overall Study|Subject relocation|104
2105272|NCT00856349|3697790|FG000|Overall Study|Device explant|33
2105273|NCT00856349|3697790|FG000|Overall Study|Site closure|78
2105274|NCT00856349|3697790|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130
2105275|NCT00856375|3697798|FG000|Overall Study|Other|0
2049648|NCT00486278|3621484|FG000|Overall Study|Adverse Event|5
2049649|NCT00486278|3621484|FG000|Overall Study|Withdrawal by Subject|2
2049650|NCT00486278|3621484|FG000|Overall Study|Physician Decision|2
2049651|NCT00486291|3621500|FG000|Overall Study|Adverse Event|3
2049652|NCT00486291|3621501|FG001|Overall Study|Adverse Event|4
2049653|NCT00486291|3621500|FG000|Overall Study|Lost to Follow-up|3
2049654|NCT00486291|3621501|FG001|Overall Study|Lost to Follow-up|7
2049655|NCT00486291|3621500|FG000|Overall Study|protocol non-compliance|10
2049656|NCT00486291|3621501|FG001|Overall Study|protocol non-compliance|15
2049657|NCT00486291|3621500|FG000|Overall Study|requirement for restricted medication|0
2049658|NCT00486291|3621501|FG001|Overall Study|requirement for restricted medication|3
2049659|NCT00486330|3621507|FG000|Overall Study|Adverse Event|2
2049660|NCT00486434|3621513|FG000|Overall Study|Withdrawal by Subject|34
2049661|NCT00486434|3621514|FG001|Overall Study|Withdrawal by Subject|39
2049662|NCT00486434|3621513|FG000|Overall Study|Adverse Event|118
2049663|NCT00486434|3621514|FG001|Overall Study|Adverse Event|44
2049664|NCT00486434|3621513|FG000|Overall Study|Protocol Violation|22
2049665|NCT00486434|3621514|FG001|Overall Study|Protocol Violation|21
2049666|NCT00486434|3621513|FG000|Overall Study|Lack of Efficacy|12
2049667|NCT00486434|3621514|FG001|Overall Study|Lack of Efficacy|19
2049668|NCT00486434|3621513|FG000|Overall Study|Lost to Follow-up|2
2049669|NCT00486434|3621514|FG001|Overall Study|Lost to Follow-up|3
2049670|NCT00486434|3621513|FG000|Overall Study|Death|1
2049671|NCT00486434|3621514|FG001|Overall Study|Death|2
2049672|NCT00486434|3621513|FG000|Overall Study|Personal reasons|5
2049673|NCT00486434|3621514|FG001|Overall Study|Personal reasons|6
2049674|NCT00486603|3621537|FG000|Overall Study|Withdrawal by Subject|1
2049675|NCT00486603|3621538|FG001|Overall Study|Withdrawal by Subject|0
2049676|NCT00486603|3621539|FG002|Overall Study|Withdrawal by Subject|0
2049677|NCT00486603|3621540|FG003|Overall Study|Withdrawal by Subject|0
2049678|NCT00486603|3621541|FG004|Overall Study|Withdrawal by Subject|0
2049679|NCT00486603|3621537|FG000|Overall Study|Physician Decision|0
2049680|NCT00486603|3621538|FG001|Overall Study|Physician Decision|1
2049681|NCT00486603|3621539|FG002|Overall Study|Physician Decision|0
2049682|NCT00486603|3621540|FG003|Overall Study|Physician Decision|0
2049683|NCT00486603|3621541|FG004|Overall Study|Physician Decision|0
2049684|NCT00486720|3621569|FG000|Overall Study|Adverse Event|1
2049685|NCT00486720|3621570|FG001|Overall Study|Adverse Event|2
2049686|NCT00486720|3621569|FG000|Overall Study|Lack of Efficacy|4
2049687|NCT00486720|3621570|FG001|Overall Study|Lack of Efficacy|6
2049688|NCT00486720|3621569|FG000|Overall Study|Physician Decision|1
2049689|NCT00486720|3621570|FG001|Overall Study|Physician Decision|2
2049690|NCT00486720|3621569|FG000|Overall Study|Protocol Violation|1
2049691|NCT00486720|3621570|FG001|Overall Study|Protocol Violation|0
2049692|NCT00486720|3621569|FG000|Overall Study|Withdrawal by Subject|3
2049693|NCT00486720|3621570|FG001|Overall Study|Withdrawal by Subject|1
2049694|NCT00486720|3621569|FG000|Overall Study|Progressive Disease|0
2049695|NCT00486720|3621570|FG001|Overall Study|Progressive Disease|1
2049696|NCT00486759|3621578|FG000|Treatment|Adverse event/intercurrent illness|86
2049697|NCT00486759|3621579|FG001|Treatment|Adverse event/intercurrent illness|39
2049698|NCT00486759|3621578|FG000|Treatment|Insufficient therapeutic response|37
2049699|NCT00486759|3621579|FG001|Treatment|Insufficient therapeutic response|39
2049700|NCT00486759|3621578|FG000|Treatment|Death|17
2049701|NCT00486759|3621579|FG001|Treatment|Death|10
2049702|NCT00486759|3621578|FG000|Treatment|Withdrew consent|15
2049703|NCT00486759|3621579|FG001|Treatment|Withdrew consent|12
2049704|NCT00486759|3621578|FG000|Treatment|Administrative/reason not specified|17
2049705|NCT00486759|3621579|FG001|Treatment|Administrative/reason not specified|21
2049706|NCT00486759|3621578|FG000|Treatment|Refused treatment|10
2049707|NCT00486759|3621579|FG001|Treatment|Refused treatment|7
2049708|NCT00486759|3621578|FG000|Treatment|Violation of selection criteria at entry|3
2049709|NCT00486759|3621579|FG001|Treatment|Violation of selection criteria at entry|3
2049710|NCT00486759|3621578|FG000|Treatment|Other protocol violation|1
2049711|NCT00486759|3621579|FG001|Treatment|Other protocol violation|5
2049712|NCT00486759|3621578|FG000|Treatment|Failure to return|1
2049713|NCT00486759|3621579|FG001|Treatment|Failure to return|1
2049714|NCT00486759|3621578|FG000|Safety Follow-up|Insufficient therapeutic response|40
2049715|NCT00486759|3621579|FG001|Safety Follow-up|Insufficient therapeutic response|50
2049716|NCT00486759|3621578|FG000|Safety Follow-up|Death|40
2049717|NCT00486759|3621579|FG001|Safety Follow-up|Death|29
2049718|NCT00486759|3621578|FG000|Safety Follow-up|Withdrew consent|32
2049719|NCT00486759|3621579|FG001|Safety Follow-up|Withdrew consent|23
2049720|NCT00486759|3621578|FG000|Safety Follow-up|Failure to return|9
2049721|NCT00486759|3621579|FG001|Safety Follow-up|Failure to return|6
2049722|NCT00486759|3621578|FG000|Safety Follow-up|Administrative/not specified|8
2049723|NCT00486759|3621579|FG001|Safety Follow-up|Administrative/not specified|6
2049724|NCT00486759|3621578|FG000|Safety Follow-up|Refused treatment/did not cooperate|6
2049725|NCT00486759|3621579|FG001|Safety Follow-up|Refused treatment/did not cooperate|4
2049726|NCT00486759|3621578|FG000|Safety Follow-up|Adverse event/intercurrent illness|4
2049727|NCT00486759|3621579|FG001|Safety Follow-up|Adverse event/intercurrent illness|0
2049728|NCT00486811|3621588|FG000|Overall Study|Adverse Event|28
2049729|NCT00486811|3621589|FG001|Overall Study|Adverse Event|60
2049730|NCT00486811|3621590|FG002|Overall Study|Adverse Event|135
2299748|NCT02589665|3996953|FG005|Maintenance Period|Adverse Event|0
2299749|NCT02589665|3996954|FG006|Maintenance Period|Adverse Event|2
2299750|NCT02589665|3996955|FG007|Maintenance Period|Adverse Event|0
2299751|NCT02589665|3996956|FG008|Maintenance Period|Adverse Event|0
2299752|NCT02589665|3996957|FG009|Maintenance Period|Adverse Event|0
2299753|NCT02589665|3996948|FG000|Maintenance Period|Lost to Follow-up|0
2299754|NCT02589665|3996949|FG001|Maintenance Period|Lost to Follow-up|0
2299755|NCT02589665|3996950|FG002|Maintenance Period|Lost to Follow-up|0
2299756|NCT02589665|3996951|FG003|Maintenance Period|Lost to Follow-up|0
2299757|NCT02589665|3996952|FG004|Maintenance Period|Lost to Follow-up|0
2299758|NCT02589665|3996953|FG005|Maintenance Period|Lost to Follow-up|1
2299759|NCT02589665|3996954|FG006|Maintenance Period|Lost to Follow-up|0
2299760|NCT02589665|3996955|FG007|Maintenance Period|Lost to Follow-up|0
2299761|NCT02589665|3996956|FG008|Maintenance Period|Lost to Follow-up|0
2299762|NCT02589665|3996957|FG009|Maintenance Period|Lost to Follow-up|0
2299763|NCT02589665|3996948|FG000|Maintenance Period|Physician Decision|0
2299764|NCT02589665|3996949|FG001|Maintenance Period|Physician Decision|0
2299765|NCT02589665|3996950|FG002|Maintenance Period|Physician Decision|0
2299766|NCT02589665|3996951|FG003|Maintenance Period|Physician Decision|0
2299767|NCT02589665|3996952|FG004|Maintenance Period|Physician Decision|0
2299768|NCT02589665|3996953|FG005|Maintenance Period|Physician Decision|1
2299769|NCT02589665|3996954|FG006|Maintenance Period|Physician Decision|0
2299770|NCT02589665|3996955|FG007|Maintenance Period|Physician Decision|0
2299771|NCT02589665|3996956|FG008|Maintenance Period|Physician Decision|0
2299772|NCT02589665|3996957|FG009|Maintenance Period|Physician Decision|0
2299773|NCT02589665|3996948|FG000|Maintenance Period|Reason Not Collected|0
2299774|NCT02589665|3996949|FG001|Maintenance Period|Reason Not Collected|0
2299775|NCT02589665|3996950|FG002|Maintenance Period|Reason Not Collected|0
2299776|NCT02589665|3996951|FG003|Maintenance Period|Reason Not Collected|0
2299777|NCT02589665|3996952|FG004|Maintenance Period|Reason Not Collected|0
2299778|NCT02589665|3996953|FG005|Maintenance Period|Reason Not Collected|1
2299779|NCT02589665|3996954|FG006|Maintenance Period|Reason Not Collected|1
2299780|NCT02589665|3996955|FG007|Maintenance Period|Reason Not Collected|0
2299781|NCT02589665|3996956|FG008|Maintenance Period|Reason Not Collected|0
2299782|NCT02589665|3996957|FG009|Maintenance Period|Reason Not Collected|0
2299783|NCT02589665|3996948|FG000|Induction Extension Period|Adverse Event|0
2299784|NCT02589665|3996949|FG001|Induction Extension Period|Adverse Event|0
2299785|NCT02589665|3996950|FG002|Induction Extension Period|Adverse Event|0
2299786|NCT02589665|3996951|FG003|Induction Extension Period|Adverse Event|0
2299787|NCT02589665|3996952|FG004|Induction Extension Period|Adverse Event|0
2299788|NCT02589665|3996953|FG005|Induction Extension Period|Adverse Event|0
2299789|NCT02589665|3996954|FG006|Induction Extension Period|Adverse Event|0
2299790|NCT02589665|3996955|FG007|Induction Extension Period|Adverse Event|0
2299791|NCT02589665|3996956|FG008|Induction Extension Period|Adverse Event|4
2299792|NCT02589665|3996957|FG009|Induction Extension Period|Adverse Event|0
2299793|NCT02589665|3996948|FG000|Induction Extension Period|Lack of Efficacy|0
2299794|NCT02589665|3996949|FG001|Induction Extension Period|Lack of Efficacy|0
2299795|NCT02589665|3996950|FG002|Induction Extension Period|Lack of Efficacy|0
2299796|NCT02589665|3996951|FG003|Induction Extension Period|Lack of Efficacy|0
2299797|NCT02589665|3996952|FG004|Induction Extension Period|Lack of Efficacy|0
2299798|NCT02589665|3996953|FG005|Induction Extension Period|Lack of Efficacy|0
2299799|NCT02589665|3996954|FG006|Induction Extension Period|Lack of Efficacy|0
2049731|NCT00486811|3621588|FG000|Overall Study|Lack of Efficacy|34
2049732|NCT00486811|3621589|FG001|Overall Study|Lack of Efficacy|14
2049733|NCT00486811|3621590|FG002|Overall Study|Lack of Efficacy|7
2049734|NCT00486811|3621588|FG000|Overall Study|Lost to Follow-up|4
2208799|NCT01641692|3848412|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2208800|NCT01641692|3848405|FG000|Treatment Period 2|Lack of Efficacy|1
2208801|NCT01641692|3848406|FG001|Treatment Period 2|Lack of Efficacy|0
2208802|NCT01641692|3848407|FG002|Treatment Period 2|Lack of Efficacy|0
2208803|NCT01641692|3848408|FG003|Treatment Period 2|Lack of Efficacy|0
2208804|NCT01641692|3848409|FG004|Treatment Period 2|Lack of Efficacy|0
2208805|NCT01641692|3848410|FG005|Treatment Period 2|Lack of Efficacy|0
2208806|NCT01641692|3848411|FG006|Treatment Period 2|Lack of Efficacy|0
2208807|NCT01641692|3848412|FG007|Treatment Period 2|Lack of Efficacy|0
2208808|NCT01641692|3848405|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
2049735|NCT00486811|3621589|FG001|Overall Study|Lost to Follow-up|6
2049736|NCT00486811|3621590|FG002|Overall Study|Lost to Follow-up|4
2049737|NCT00486811|3621588|FG000|Overall Study|Withdrawal by Subject|33
2049738|NCT00486811|3621589|FG001|Overall Study|Withdrawal by Subject|44
2049739|NCT00486811|3621590|FG002|Overall Study|Withdrawal by Subject|58
2049740|NCT00486811|3621588|FG000|Overall Study|Study drug non-compliant|5
2049741|NCT00486811|3621589|FG001|Overall Study|Study drug non-compliant|6
2049742|NCT00486811|3621590|FG002|Overall Study|Study drug non-compliant|3
2049743|NCT00486811|3621588|FG000|Overall Study|All other|18
2208809|NCT01641692|3848406|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
2208810|NCT01641692|3848407|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
2208811|NCT01641692|3848408|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
2299800|NCT02589665|3996955|FG007|Induction Extension Period|Lack of Efficacy|0
2299801|NCT02589665|3996956|FG008|Induction Extension Period|Lack of Efficacy|3
2208812|NCT01641692|3848409|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
2208813|NCT01641692|3848410|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
2208814|NCT01641692|3848411|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
2208815|NCT01641692|3848412|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
2208816|NCT01641692|3848405|FG000|Treatment Period 2|Lost to Follow-up|0
2208817|NCT01641692|3848406|FG001|Treatment Period 2|Lost to Follow-up|0
2208818|NCT01641692|3848407|FG002|Treatment Period 2|Lost to Follow-up|0
2208819|NCT01641692|3848408|FG003|Treatment Period 2|Lost to Follow-up|0
2208820|NCT01641692|3848409|FG004|Treatment Period 2|Lost to Follow-up|0
2208821|NCT01641692|3848410|FG005|Treatment Period 2|Lost to Follow-up|1
2208822|NCT01641692|3848411|FG006|Treatment Period 2|Lost to Follow-up|0
2208823|NCT01641692|3848412|FG007|Treatment Period 2|Lost to Follow-up|0
2208824|NCT01641692|3848405|FG000|Treatment Period 2|Withdrawal by Subject|1
2208825|NCT01641692|3848406|FG001|Treatment Period 2|Withdrawal by Subject|0
2208826|NCT01641692|3848407|FG002|Treatment Period 2|Withdrawal by Subject|0
2208827|NCT01641692|3848408|FG003|Treatment Period 2|Withdrawal by Subject|0
2208828|NCT01641692|3848409|FG004|Treatment Period 2|Withdrawal by Subject|0
2208829|NCT01641692|3848410|FG005|Treatment Period 2|Withdrawal by Subject|1
2208830|NCT01641692|3848411|FG006|Treatment Period 2|Withdrawal by Subject|0
2208831|NCT01641692|3848412|FG007|Treatment Period 2|Withdrawal by Subject|1
2208832|NCT01641692|3848405|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2208833|NCT01641692|3848406|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2208834|NCT01641692|3848407|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2208835|NCT01641692|3848408|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2208836|NCT01641692|3848409|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
2208837|NCT01641692|3848410|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2208838|NCT01641692|3848411|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
2208839|NCT01641692|3848412|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2208840|NCT01641692|3848405|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2208841|NCT01641692|3848406|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2208842|NCT01641692|3848407|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2208843|NCT01641692|3848408|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2208844|NCT01641692|3848409|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2208845|NCT01641692|3848410|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2208846|NCT01641692|3848411|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2208847|NCT01641692|3848412|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2208848|NCT01641692|3848405|FG000|Treatment Period 3|Adverse Event|0
2208849|NCT01641692|3848406|FG001|Treatment Period 3|Adverse Event|0
2208850|NCT01641692|3848407|FG002|Treatment Period 3|Adverse Event|0
2208851|NCT01641692|3848408|FG003|Treatment Period 3|Adverse Event|0
2208852|NCT01641692|3848409|FG004|Treatment Period 3|Adverse Event|0
2208853|NCT01641692|3848410|FG005|Treatment Period 3|Adverse Event|0
2208854|NCT01641692|3848411|FG006|Treatment Period 3|Adverse Event|1
2208855|NCT01641692|3848412|FG007|Treatment Period 3|Adverse Event|0
2208856|NCT01641692|3848405|FG000|Treatment Period 3|Protocol Violation|0
2208857|NCT01641692|3848406|FG001|Treatment Period 3|Protocol Violation|0
2208858|NCT01641692|3848407|FG002|Treatment Period 3|Protocol Violation|1
2208859|NCT01641692|3848408|FG003|Treatment Period 3|Protocol Violation|0
2208860|NCT01641692|3848409|FG004|Treatment Period 3|Protocol Violation|0
2208861|NCT01641692|3848410|FG005|Treatment Period 3|Protocol Violation|0
2208862|NCT01641692|3848411|FG006|Treatment Period 3|Protocol Violation|0
2208863|NCT01641692|3848412|FG007|Treatment Period 3|Protocol Violation|0
2208864|NCT01641692|3848405|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0
2208865|NCT01641692|3848406|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
2208866|NCT01641692|3848407|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
2208867|NCT01641692|3848408|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
2208868|NCT01641692|3848409|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
2208869|NCT01641692|3848410|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
2208870|NCT01641692|3848411|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1
2208871|NCT01641692|3848412|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0
2208872|NCT01641692|3848405|FG000|Treatment Period 3|Lost to Follow-up|0
2208873|NCT01641692|3848406|FG001|Treatment Period 3|Lost to Follow-up|1
2208874|NCT01641692|3848407|FG002|Treatment Period 3|Lost to Follow-up|0
2208875|NCT01641692|3848408|FG003|Treatment Period 3|Lost to Follow-up|0
2208876|NCT01641692|3848409|FG004|Treatment Period 3|Lost to Follow-up|0
2208877|NCT01641692|3848410|FG005|Treatment Period 3|Lost to Follow-up|0
2208878|NCT01641692|3848411|FG006|Treatment Period 3|Lost to Follow-up|0
2208879|NCT01641692|3848412|FG007|Treatment Period 3|Lost to Follow-up|0
2208880|NCT01641692|3848405|FG000|Washout Period 3 or Follow-up|Protocol Violation|0
2208881|NCT01641692|3848406|FG001|Washout Period 3 or Follow-up|Protocol Violation|0
2208882|NCT01641692|3848407|FG002|Washout Period 3 or Follow-up|Protocol Violation|0
2208883|NCT01641692|3848408|FG003|Washout Period 3 or Follow-up|Protocol Violation|0
2299802|NCT02589665|3996957|FG009|Induction Extension Period|Lack of Efficacy|0
2299803|NCT02589665|3996948|FG000|Induction Extension Period|Withdrawal by Subject|0
2299804|NCT02589665|3996949|FG001|Induction Extension Period|Withdrawal by Subject|0
2299805|NCT02589665|3996950|FG002|Induction Extension Period|Withdrawal by Subject|0
2208884|NCT01641692|3848409|FG004|Washout Period 3 or Follow-up|Protocol Violation|0
2208885|NCT01641692|3848410|FG005|Washout Period 3 or Follow-up|Protocol Violation|1
2208886|NCT01641692|3848411|FG006|Washout Period 3 or Follow-up|Protocol Violation|0
2208887|NCT01641692|3848412|FG007|Washout Period 3 or Follow-up|Protocol Violation|0
2208888|NCT01641692|3848405|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2208889|NCT01641692|3848406|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
2208890|NCT01641692|3848407|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2208891|NCT01641692|3848408|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2208892|NCT01641692|3848409|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
2049744|NCT00486811|3621589|FG001|Overall Study|All other|11
2049745|NCT00486811|3621590|FG002|Overall Study|All other|7
2049746|NCT00486837|3621609|FG000|Overall Study|Withdrawal by Subject|1
2049747|NCT00486837|3621610|FG001|Overall Study|Withdrawal by Subject|0
2049748|NCT00486837|3621609|FG000|Overall Study|Adverse Event|1
2049749|NCT00486837|3621610|FG001|Overall Study|Adverse Event|1
2049750|NCT00486837|3621609|FG000|Overall Study|Protocol Violation|4
2049751|NCT00486837|3621610|FG001|Overall Study|Protocol Violation|2
2049752|NCT00486837|3621609|FG000|Overall Study|No sputum, devise issues, exacerbation|3
2049753|NCT00486837|3621610|FG001|Overall Study|No sputum, devise issues, exacerbation|4
2049754|NCT00486902|3621630|FG000|Overall Study|Withdrawal by Subject|1
2049755|NCT00486902|3621631|FG001|Overall Study|Withdrawal by Subject|2
2049756|NCT00486902|3621630|FG000|Overall Study|decision for postpartum tubal ligation|3
2049757|NCT00486902|3621631|FG001|Overall Study|decision for postpartum tubal ligation|1
2049758|NCT00486902|3621630|FG000|Overall Study|spinal anesthetic protocal violation|1
2049759|NCT00486902|3621631|FG001|Overall Study|spinal anesthetic protocal violation|1
2049760|NCT00486902|3621630|FG000|Overall Study|Did not meet inclusion criteria|1
2049761|NCT00486902|3621631|FG001|Overall Study|Did not meet inclusion criteria|0
2049762|NCT00486902|3621630|FG000|Overall Study|No toradol due to hemmorhage or allergy|3
2049763|NCT00486902|3621631|FG001|Overall Study|No toradol due to hemmorhage or allergy|1
2049764|NCT00486954|3621641|FG000|Pilot Part|Adverse Event|4
2049765|NCT00486954|3621642|FG001|Pilot Part|Adverse Event|0
2049766|NCT00486954|3621643|FG002|Pilot Part|Adverse Event|5
2049767|NCT00486954|3621644|FG003|Pilot Part|Adverse Event|0
2049768|NCT00486954|3621645|FG004|Pilot Part|Adverse Event|0
2049769|NCT00486954|3621641|FG000|Pilot Part|Disease Progression|2
2049770|NCT00486954|3621642|FG001|Pilot Part|Disease Progression|0
2049771|NCT00486954|3621643|FG002|Pilot Part|Disease Progression|1
2049772|NCT00486954|3621644|FG003|Pilot Part|Disease Progression|0
2049773|NCT00486954|3621645|FG004|Pilot Part|Disease Progression|0
2049774|NCT00486954|3621641|FG000|Randomized Part|Lost to Follow-up|0
2049775|NCT00486954|3621642|FG001|Randomized Part|Lost to Follow-up|0
2049776|NCT00486954|3621643|FG002|Randomized Part|Lost to Follow-up|0
2049777|NCT00486954|3621644|FG003|Randomized Part|Lost to Follow-up|0
2049778|NCT00486954|3621645|FG004|Randomized Part|Lost to Follow-up|1
2049779|NCT00486954|3621641|FG000|Randomized Part|Withdrawal by Subject|0
2049780|NCT00486954|3621642|FG001|Randomized Part|Withdrawal by Subject|0
2049781|NCT00486954|3621643|FG002|Randomized Part|Withdrawal by Subject|0
2049782|NCT00486954|3621644|FG003|Randomized Part|Withdrawal by Subject|1
2049783|NCT00486954|3621645|FG004|Randomized Part|Withdrawal by Subject|0
2208893|NCT01641692|3848410|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2208894|NCT01641692|3848411|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2208895|NCT01641692|3848412|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
2208896|NCT01641809|3848435|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
2299806|NCT02589665|3996951|FG003|Induction Extension Period|Withdrawal by Subject|0
2299807|NCT02589665|3996952|FG004|Induction Extension Period|Withdrawal by Subject|0
2299808|NCT02589665|3996953|FG005|Induction Extension Period|Withdrawal by Subject|0
2299809|NCT02589665|3996954|FG006|Induction Extension Period|Withdrawal by Subject|0
2299810|NCT02589665|3996955|FG007|Induction Extension Period|Withdrawal by Subject|2
2299811|NCT02589665|3996956|FG008|Induction Extension Period|Withdrawal by Subject|3
2299812|NCT02589665|3996957|FG009|Induction Extension Period|Withdrawal by Subject|0
2299813|NCT02589665|3996948|FG000|Induction Extension Period|Physician Decision|0
2299814|NCT02589665|3996949|FG001|Induction Extension Period|Physician Decision|0
2299815|NCT02589665|3996950|FG002|Induction Extension Period|Physician Decision|0
2299816|NCT02589665|3996951|FG003|Induction Extension Period|Physician Decision|0
2299817|NCT02589665|3996952|FG004|Induction Extension Period|Physician Decision|0
2299818|NCT02589665|3996953|FG005|Induction Extension Period|Physician Decision|0
2299819|NCT02589665|3996954|FG006|Induction Extension Period|Physician Decision|0
2208897|NCT01641809|3848436|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
2208898|NCT01641809|3848437|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
2208899|NCT01641809|3848438|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
2208900|NCT01641809|3848435|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0
2208901|NCT01641809|3848436|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1
2208902|NCT01641809|3848437|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0
2217675|NCT01709305|3860930|FG002|Phase 1|Withdrawal by Subject|0
2299820|NCT02589665|3996955|FG007|Induction Extension Period|Physician Decision|0
2299821|NCT02589665|3996956|FG008|Induction Extension Period|Physician Decision|1
2049784|NCT00486954|3621641|FG000|Randomized Part|Sponsor Terminated Study|0
2049785|NCT00486954|3621642|FG001|Randomized Part|Sponsor Terminated Study|0
2049786|NCT00486954|3621643|FG002|Randomized Part|Sponsor Terminated Study|0
2049787|NCT00486954|3621644|FG003|Randomized Part|Sponsor Terminated Study|19
2049788|NCT00486954|3621645|FG004|Randomized Part|Sponsor Terminated Study|13
2049789|NCT00487084|3621658|FG000|Overall Study|Did not receive intervention|4
2049790|NCT00487084|3621659|FG001|Overall Study|Did not receive intervention|3
2049791|NCT00487084|3621660|FG002|Overall Study|Did not receive intervention|5
2049792|NCT00487188|3621670|FG000|Induction Phase|Abnormality of Laboratory Test|0
2049793|NCT00487188|3621671|FG001|Induction Phase|Abnormality of Laboratory Test|1
2049794|NCT00487188|3621672|FG002|Induction Phase|Abnormality of Laboratory Test|0
2049795|NCT00487188|3621670|FG000|Induction Phase|Adverse Event|5
2049796|NCT00487188|3621671|FG001|Induction Phase|Adverse Event|0
2049797|NCT00487188|3621672|FG002|Induction Phase|Adverse Event|0
2049798|NCT00487188|3621670|FG000|Induction Phase|Lack of Efficacy|0
2049799|NCT00487188|3621671|FG001|Induction Phase|Lack of Efficacy|1
2049800|NCT00487188|3621672|FG002|Induction Phase|Lack of Efficacy|0
2049801|NCT00487188|3621670|FG000|Induction Phase|Protocol Violation|1
2049802|NCT00487188|3621671|FG001|Induction Phase|Protocol Violation|0
2049803|NCT00487188|3621672|FG002|Induction Phase|Protocol Violation|0
2049804|NCT00487188|3621670|FG000|Induction Phase|Refused Treatment|1
2049805|NCT00487188|3621671|FG001|Induction Phase|Refused Treatment|2
2049806|NCT00487188|3621672|FG002|Induction Phase|Refused Treatment|0
2049807|NCT00487188|3621670|FG000|Induction Phase|Lost to Follow-up|2
2049808|NCT00487188|3621671|FG001|Induction Phase|Lost to Follow-up|2
2049809|NCT00487188|3621672|FG002|Induction Phase|Lost to Follow-up|0
2049810|NCT00487188|3621670|FG000|Induction Phase|Administrative|0
2049811|NCT00487188|3621671|FG001|Induction Phase|Administrative|1
2049812|NCT00487188|3621672|FG002|Induction Phase|Administrative|0
2049813|NCT00487188|3621670|FG000|Maintenance Phase|Adverse Event|1
2049814|NCT00487188|3621671|FG001|Maintenance Phase|Adverse Event|0
2049815|NCT00487188|3621672|FG002|Maintenance Phase|Adverse Event|0
2049816|NCT00487188|3621670|FG000|Maintenance Phase|Death|1
2049817|NCT00487188|3621671|FG001|Maintenance Phase|Death|0
2049818|NCT00487188|3621672|FG002|Maintenance Phase|Death|0
2049819|NCT00487188|3621670|FG000|Maintenance Phase|Lost to Follow-up|1
2049820|NCT00487188|3621671|FG001|Maintenance Phase|Lost to Follow-up|0
2049821|NCT00487188|3621672|FG002|Maintenance Phase|Lost to Follow-up|0
2049822|NCT00487188|3621670|FG000|Maintenance Phase|Administrative|0
2049823|NCT00487188|3621671|FG001|Maintenance Phase|Administrative|0
2049824|NCT00487188|3621672|FG002|Maintenance Phase|Administrative|1
2049825|NCT00487240|3621690|FG000|Overall Study|Withdrawal by Subject|12
2049826|NCT00487240|3621691|FG001|Overall Study|Withdrawal by Subject|6
2049827|NCT00487240|3621690|FG000|Overall Study|Lost to Follow-up|7
2049828|NCT00487240|3621691|FG001|Overall Study|Lost to Follow-up|6
2049829|NCT00487240|3621690|FG000|Overall Study|Adverse Event|0
2049830|NCT00487240|3621691|FG001|Overall Study|Adverse Event|4
2049831|NCT00487240|3621690|FG000|Overall Study|Protocol Violation|5
2049832|NCT00487240|3621691|FG001|Overall Study|Protocol Violation|5
2049833|NCT00487240|3621690|FG000|Overall Study|Entry Criteria Not Met|3
2049834|NCT00487240|3621691|FG001|Overall Study|Entry Criteria Not Met|4
2049835|NCT00487240|3621690|FG000|Overall Study|Sponsor Decision|2
2049836|NCT00487240|3621691|FG001|Overall Study|Sponsor Decision|1
2049837|NCT00487240|3621690|FG000|Overall Study|Physician Decision|2
2049838|NCT00487240|3621691|FG001|Overall Study|Physician Decision|0
2049839|NCT00487279|3621699|FG000|Overall Study|Death|1
2049840|NCT00487279|3621700|FG001|Overall Study|Death|0
2049841|NCT00487279|3621699|FG000|Overall Study|Withdrawal by Subject|0
2049842|NCT00487279|3621700|FG001|Overall Study|Withdrawal by Subject|2
2049843|NCT00487435|3621715|FG000|Overall Study|Adverse Event|146
2049844|NCT00487435|3621715|FG000|Overall Study|Death|2
2049845|NCT00487435|3621715|FG000|Overall Study|Lack of Efficacy|33
2049846|NCT00487435|3621715|FG000|Overall Study|Lost to Follow-up|54
2049847|NCT00487435|3621715|FG000|Overall Study|Pregnancy|2
2049848|NCT00487435|3621715|FG000|Overall Study|Withdrawal by Subject|132
2049849|NCT00487435|3621715|FG000|Overall Study|Resolution Of Pain|1
2049850|NCT00487435|3621715|FG000|Overall Study|Study Medication Non-Compliant|32
2049851|NCT00487435|3621715|FG000|Overall Study|Other|83
2049852|NCT00487539|3621723|FG000|Overall Study|Adverse Event|3
2049853|NCT00487539|3621724|FG001|Overall Study|Adverse Event|2
2049854|NCT00487539|3621725|FG002|Overall Study|Adverse Event|1
2049855|NCT00487539|3621726|FG003|Overall Study|Adverse Event|1
2049856|NCT00487539|3621723|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2049857|NCT00487539|3621724|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2049858|NCT00487539|3621725|FG002|Overall Study|Unsatisfactory therapeutic effect|0
2049859|NCT00487539|3621726|FG003|Overall Study|Unsatisfactory therapeutic effect|1
2049860|NCT00487539|3621723|FG000|Overall Study|Other|3
2049861|NCT00487539|3621724|FG001|Overall Study|Other|1
2049862|NCT00487539|3621725|FG002|Overall Study|Other|2
2049863|NCT00487539|3621726|FG003|Overall Study|Other|2
2049864|NCT00487552|3621735|FG000|Overall Study|Unsuccessful magnet placements|3
2049865|NCT00487552|3621735|FG000|Overall Study|Death due to progressive malignancy|2
2049866|NCT00487552|3621735|FG000|Overall Study|Stent not placed|1
2049867|NCT00487695|3621750|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1
2049868|NCT00487695|3621751|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0
2049869|NCT00487695|3621750|FG000|First Procedure|active wheezing (did not have procedure)|1
2049870|NCT00487695|3621751|FG001|First Procedure|active wheezing (did not have procedure)|0
2049871|NCT00487695|3621750|FG000|First Procedure|esophageal stricture found (excl crit)|1
2049872|NCT00487695|3621751|FG001|First Procedure|esophageal stricture found (excl crit)|0
2049873|NCT00487695|3621750|FG000|Second Procedure|active wheezing|0
2049874|NCT00487695|3621751|FG001|Second Procedure|active wheezing|1
2049875|NCT00487695|3621750|FG000|Second Procedure|Withdrawal by Subject|1
2049876|NCT00487695|3621751|FG001|Second Procedure|Withdrawal by Subject|2
2049877|NCT00487747|3621765|FG000|Overall Study|Adverse Event|1
2049878|NCT00487747|3621765|FG000|Overall Study|Lost to Follow-up|9
2049879|NCT00487747|3621765|FG000|Overall Study|Lack of Efficacy|1
2049880|NCT00487825|3621771|FG000|Overall Study|Adverse Event|2
2049881|NCT00487825|3621772|FG001|Overall Study|Adverse Event|2
2049882|NCT00487825|3621771|FG000|Overall Study|Lack of Efficacy|1
2049883|NCT00487825|3621772|FG001|Overall Study|Lack of Efficacy|1
2049884|NCT00487825|3621771|FG000|Overall Study|Other|3
2049885|NCT00487825|3621772|FG001|Overall Study|Other|2
2049886|NCT00487942|3621782|FG000|Overall Study|Adverse Event|1
2049887|NCT00487942|3621783|FG001|Overall Study|Adverse Event|1
2049888|NCT00487942|3621784|FG002|Overall Study|Adverse Event|1
2049889|NCT00487942|3621785|FG003|Overall Study|Adverse Event|1
2049890|NCT00487942|3621782|FG000|Overall Study|Lost to Follow-up|1
2049891|NCT00487942|3621783|FG001|Overall Study|Lost to Follow-up|0
2049892|NCT00487942|3621784|FG002|Overall Study|Lost to Follow-up|0
2049893|NCT00487942|3621785|FG003|Overall Study|Lost to Follow-up|1
2049894|NCT00487942|3621782|FG000|Overall Study|Protocol Violation|1
2049895|NCT00487942|3621783|FG001|Overall Study|Protocol Violation|1
2049896|NCT00487942|3621784|FG002|Overall Study|Protocol Violation|0
2049897|NCT00487942|3621785|FG003|Overall Study|Protocol Violation|0
2049898|NCT00487942|3621782|FG000|Overall Study|Withdrawal by Subject|0
2049899|NCT00487942|3621783|FG001|Overall Study|Withdrawal by Subject|1
2049900|NCT00487942|3621784|FG002|Overall Study|Withdrawal by Subject|2
2049901|NCT00487942|3621785|FG003|Overall Study|Withdrawal by Subject|0
2049902|NCT00488033|3621797|FG000|Overall Study|Withdrawal by Subject|1
2049903|NCT00488033|3621798|FG001|Overall Study|Withdrawal by Subject|0
2049904|NCT00488293|3621821|FG000|Overall Study|Lost to Follow-up|28
2049905|NCT00488293|3621822|FG001|Overall Study|Lost to Follow-up|25
2208903|NCT01641809|3848438|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1
2208904|NCT01641809|3848435|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
2208905|NCT01641809|3848436|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
2208906|NCT01641809|3848437|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
2208907|NCT01641809|3848438|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
2208908|NCT01641809|3848435|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
2208909|NCT01641809|3848436|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
2208910|NCT01641809|3848437|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
2208911|NCT01641809|3848438|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
2208912|NCT01641809|3848435|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
2208913|NCT01641809|3848436|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
2208914|NCT01641809|3848437|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
2208915|NCT01641809|3848438|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
2208916|NCT01641809|3848435|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0
2208917|NCT01641809|3848436|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1
2208918|NCT01641809|3848437|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3
2208919|NCT01641809|3848438|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7
2208920|NCT01641809|3848435|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
2208921|NCT01641809|3848436|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
2208922|NCT01641809|3848437|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
2208923|NCT01641809|3848438|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
2208924|NCT01641809|3848435|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
2208925|NCT01641809|3848436|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
2208926|NCT01641809|3848437|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
2208927|NCT01641809|3848438|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
2208928|NCT01641809|3848435|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
2208929|NCT01641809|3848436|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
2208930|NCT01641809|3848437|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
2208931|NCT01641809|3848438|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
2208932|NCT01641809|3848435|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
2208933|NCT01641809|3848436|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
2208934|NCT01641809|3848437|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
2208935|NCT01641809|3848438|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
2208936|NCT01641809|3848435|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
2208937|NCT01641809|3848436|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
2208938|NCT01641809|3848437|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
2049906|NCT00488293|3621821|FG000|Overall Study|Withdrawal by Subject|5
2049907|NCT00488293|3621822|FG001|Overall Study|Withdrawal by Subject|3
2049908|NCT00488293|3621821|FG000|Overall Study|Death|2
2049909|NCT00488293|3621822|FG001|Overall Study|Death|1
2049910|NCT00488293|3621821|FG000|Overall Study|Misrandomization/Other Unspecified|1
2049911|NCT00488293|3621822|FG001|Overall Study|Misrandomization/Other Unspecified|1
2049912|NCT00488319|3621831|FG000|Overall Study|Adverse Event|1
2049913|NCT00488319|3621832|FG001|Overall Study|Adverse Event|2
2049914|NCT00488319|3621833|FG002|Overall Study|Adverse Event|23
2049915|NCT00488319|3621831|FG000|Overall Study|Lack of Efficacy|6
2049916|NCT00488319|3621832|FG001|Overall Study|Lack of Efficacy|12
2049917|NCT00488319|3621833|FG002|Overall Study|Lack of Efficacy|27
2049918|NCT00488319|3621831|FG000|Overall Study|Lost to Follow-up|3
2049919|NCT00488319|3621832|FG001|Overall Study|Lost to Follow-up|5
2049920|NCT00488319|3621833|FG002|Overall Study|Lost to Follow-up|16
2049921|NCT00488319|3621831|FG000|Overall Study|Withdrawal by Subject|5
2049922|NCT00488319|3621832|FG001|Overall Study|Withdrawal by Subject|20
2049923|NCT00488319|3621833|FG002|Overall Study|Withdrawal by Subject|44
2049924|NCT00488319|3621831|FG000|Overall Study|Other reasons for withdrawal|0
2049925|NCT00488319|3621832|FG001|Overall Study|Other reasons for withdrawal|4
2049926|NCT00488319|3621833|FG002|Overall Study|Other reasons for withdrawal|12
2049927|NCT00488345|3621845|FG000|Overall Study|Adverse Event|0
2049928|NCT00488345|3621846|FG001|Overall Study|Adverse Event|1
2049929|NCT00488345|3621847|FG002|Overall Study|Adverse Event|1
2049930|NCT00488345|3621845|FG000|Overall Study|Unable to administer antibiotics at home|0
2049931|NCT00488345|3621846|FG001|Overall Study|Unable to administer antibiotics at home|1
2049932|NCT00488345|3621847|FG002|Overall Study|Unable to administer antibiotics at home|0
2049933|NCT00488345|3621845|FG000|Overall Study|Institutional Review Board review|0
2049934|NCT00488345|3621846|FG001|Overall Study|Institutional Review Board review|0
2049935|NCT00488345|3621847|FG002|Overall Study|Institutional Review Board review|1
2049936|NCT00488345|3621845|FG000|Overall Study|Surgical team recommendation|0
2049937|NCT00488345|3621846|FG001|Overall Study|Surgical team recommendation|1
2049938|NCT00488345|3621847|FG002|Overall Study|Surgical team recommendation|0
2049939|NCT00488345|3621845|FG000|Overall Study|Parent/legal guardian request|0
2049940|NCT00488345|3621846|FG001|Overall Study|Parent/legal guardian request|1
2049941|NCT00488345|3621847|FG002|Overall Study|Parent/legal guardian request|1
2049942|NCT00488475|3621856|FG000|Overall Study|Other|1754
2049943|NCT00488514|3621864|FG000|Overall Study|Adverse Event|41
2049944|NCT00488514|3621864|FG000|Overall Study|Lost to Follow-up|44
2049945|NCT00488514|3621864|FG000|Overall Study|Protocol Violation|32
2049946|NCT00488514|3621864|FG000|Overall Study|Withdrawal by Subject|106
2049947|NCT00488514|3621864|FG000|Overall Study|Lack of Efficacy|28
2049948|NCT00488514|3621864|FG000|Overall Study|Did not meet criteria for treatment|30
2049949|NCT00488514|3621864|FG000|Overall Study|Postive drug screen|1
2049950|NCT00488514|3621864|FG000|Overall Study|Withdrawn per medical monitor decision|2
2049951|NCT00488514|3621864|FG000|Overall Study|Investigator decision|1
2049952|NCT00488514|3621864|FG000|Overall Study|Participant had too few migraines|5
2049953|NCT00488514|3621864|FG000|Overall Study|Increase in number of migraines|2
2049954|NCT00488514|3621864|FG000|Overall Study|Increased use of concomitant medication|1
2049955|NCT00488592|3621885|FG000|Overall Study|Withdrawal by Subject|1
2049956|NCT00488592|3621885|FG000|Overall Study|Disease progression|1
2049957|NCT00488592|3621885|FG000|Overall Study|Enrolled but not treated|1
2049958|NCT00488618|3621891|FG000|Overall Study|Adverse Event|13
2049959|NCT00488618|3621892|FG001|Overall Study|Adverse Event|17
2049960|NCT00488618|3621891|FG000|Overall Study|Insufficient Therapeutic Response|18
2049961|NCT00488618|3621892|FG001|Overall Study|Insufficient Therapeutic Response|11
2049962|NCT00488618|3621891|FG000|Overall Study|Protocol Violation|0
2049963|NCT00488618|3621892|FG001|Overall Study|Protocol Violation|2
2049964|NCT00488618|3621891|FG000|Overall Study|Withdrawal of Consent|15
2049965|NCT00488618|3621892|FG001|Overall Study|Withdrawal of Consent|13
2049966|NCT00488618|3621891|FG000|Overall Study|Lost to Follow-up|1
2049967|NCT00488618|3621892|FG001|Overall Study|Lost to Follow-up|0
2049968|NCT00488631|3621904|FG000|Double Blind Period (Week 0-54)|Adverse Event|17
2049969|NCT00488631|3621905|FG001|Double Blind Period (Week 0-54)|Adverse Event|12
2049970|NCT00488631|3621906|FG002|Double Blind Period (Week 0-54)|Adverse Event|12
2049971|NCT00488631|3621907|FG003|Double Blind Period (Week 0-54)|Adverse Event|12
2049972|NCT00488631|3621908|FG004|Double Blind Period (Week 0-54)|Adverse Event|30
2049973|NCT00488631|3621909|FG005|Double Blind Period (Week 0-54)|Adverse Event|50
2049974|NCT00488631|3621910|FG006|Double Blind Period (Week 0-54)|Adverse Event|0
2049975|NCT00488631|3621911|FG007|Double Blind Period (Week 0-54)|Adverse Event|0
2049976|NCT00488631|3621912|FG008|Double Blind Period (Week 0-54)|Adverse Event|0
2049977|NCT00488631|3621913|FG009|Double Blind Period (Week 0-54)|Adverse Event|0
2049978|NCT00488631|3621904|FG000|Double Blind Period (Week 0-54)|Death|0
2049979|NCT00488631|3621905|FG001|Double Blind Period (Week 0-54)|Death|0
2049980|NCT00488631|3621906|FG002|Double Blind Period (Week 0-54)|Death|0
2049981|NCT00488631|3621907|FG003|Double Blind Period (Week 0-54)|Death|0
2049982|NCT00488631|3621908|FG004|Double Blind Period (Week 0-54)|Death|0
2049983|NCT00488631|3621909|FG005|Double Blind Period (Week 0-54)|Death|1
2049984|NCT00488631|3621910|FG006|Double Blind Period (Week 0-54)|Death|0
2049985|NCT00488631|3621911|FG007|Double Blind Period (Week 0-54)|Death|0
2049986|NCT00488631|3621912|FG008|Double Blind Period (Week 0-54)|Death|0
2049987|NCT00488631|3621913|FG009|Double Blind Period (Week 0-54)|Death|0
2049988|NCT00488631|3621904|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
2049989|NCT00488631|3621905|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
2049990|NCT00488631|3621906|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
2049991|NCT00488631|3621907|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
2049992|NCT00488631|3621908|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
2049993|NCT00488631|3621909|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
2049994|NCT00488631|3621910|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
2049995|NCT00488631|3621911|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
2049996|NCT00488631|3621912|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
2049997|NCT00488631|3621913|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
2049998|NCT00488631|3621904|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1
2049999|NCT00488631|3621905|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2
2050000|NCT00488631|3621906|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1
2050001|NCT00488631|3621907|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0
2050002|NCT00488631|3621908|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3
2050003|NCT00488631|3621909|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7
2050004|NCT00488631|3621910|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0
2050005|NCT00488631|3621911|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0
2050006|NCT00488631|3621912|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0
2050007|NCT00488631|3621913|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0
2050008|NCT00488631|3621904|FG000|Double Blind Period (Week 0-54)|Other|6
2050009|NCT00488631|3621905|FG001|Double Blind Period (Week 0-54)|Other|12
2050010|NCT00488631|3621906|FG002|Double Blind Period (Week 0-54)|Other|10
2050011|NCT00488631|3621907|FG003|Double Blind Period (Week 0-54)|Other|11
2050012|NCT00488631|3621908|FG004|Double Blind Period (Week 0-54)|Other|14
2050013|NCT00488631|3621909|FG005|Double Blind Period (Week 0-54)|Other|34
2050014|NCT00488631|3621910|FG006|Double Blind Period (Week 0-54)|Other|0
2050015|NCT00488631|3621911|FG007|Double Blind Period (Week 0-54)|Other|0
2050016|NCT00488631|3621912|FG008|Double Blind Period (Week 0-54)|Other|0
2050017|NCT00488631|3621913|FG009|Double Blind Period (Week 0-54)|Other|0
2050018|NCT00488631|3621904|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0
2050019|NCT00488631|3621905|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0
2050020|NCT00488631|3621906|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0
2050021|NCT00488631|3621907|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0
2050022|NCT00488631|3621908|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0
2050023|NCT00488631|3621909|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0
2050024|NCT00488631|3621910|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10
2050025|NCT00488631|3621911|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8
2050026|NCT00488631|3621912|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54
2050027|NCT00488631|3621913|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0
2050028|NCT00488631|3621904|FG000|Open Label Study Extension (Week 54-228)|Death|0
2050029|NCT00488631|3621905|FG001|Open Label Study Extension (Week 54-228)|Death|0
2050030|NCT00488631|3621906|FG002|Open Label Study Extension (Week 54-228)|Death|0
2050031|NCT00488631|3621907|FG003|Open Label Study Extension (Week 54-228)|Death|0
2050032|NCT00488631|3621908|FG004|Open Label Study Extension (Week 54-228)|Death|0
2050033|NCT00488631|3621909|FG005|Open Label Study Extension (Week 54-228)|Death|0
2050034|NCT00488631|3621910|FG006|Open Label Study Extension (Week 54-228)|Death|0
2050035|NCT00488631|3621911|FG007|Open Label Study Extension (Week 54-228)|Death|0
2050036|NCT00488631|3621912|FG008|Open Label Study Extension (Week 54-228)|Death|1
2050037|NCT00488631|3621913|FG009|Open Label Study Extension (Week 54-228)|Death|0
2050038|NCT00488631|3621904|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2050039|NCT00488631|3621905|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2208939|NCT01641809|3848438|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
2208940|NCT01641809|3848435|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
2208941|NCT01641809|3848436|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
2208942|NCT01641809|3848437|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
2208943|NCT01641809|3848438|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
2208944|NCT01641809|3848435|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0
2208945|NCT01641809|3848436|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1
2208946|NCT01641809|3848437|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1
2050040|NCT00488631|3621906|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2050041|NCT00488631|3621907|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2050042|NCT00488631|3621908|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2050043|NCT00488631|3621909|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2050044|NCT00488631|3621910|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
2050045|NCT00488631|3621911|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
2050046|NCT00488631|3621912|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
2050047|NCT00488631|3621913|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
2050048|NCT00488631|3621904|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2050049|NCT00488631|3621905|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2050050|NCT00488631|3621906|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2050051|NCT00488631|3621907|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2050052|NCT00488631|3621908|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2050053|NCT00488631|3621909|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2050054|NCT00488631|3621910|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
2050055|NCT00488631|3621911|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2050056|NCT00488631|3621912|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
2050057|NCT00488631|3621913|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2050058|NCT00488631|3621904|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2050059|NCT00488631|3621905|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2050060|NCT00488631|3621906|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2050061|NCT00488631|3621907|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2050062|NCT00488631|3621908|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2050063|NCT00488631|3621909|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2050064|NCT00488631|3621910|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
2050065|NCT00488631|3621911|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
2050066|NCT00488631|3621912|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
2050067|NCT00488631|3621913|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2050068|NCT00488644|3621936|FG000|Overall Study|Not Eligible|1
2050069|NCT00488644|3621936|FG000|Overall Study|Not Evaluable|1
2050070|NCT00488683|3621943|FG000|Overall Study|Withdrawal by Subject|1
2050071|NCT00488683|3621944|FG001|Overall Study|Withdrawal by Subject|2
2050072|NCT00488683|3621945|FG002|Overall Study|Withdrawal by Subject|2
2050073|NCT00488683|3621943|FG000|Overall Study|Lost to Follow-up|5
2050074|NCT00488683|3621944|FG001|Overall Study|Lost to Follow-up|3
2050075|NCT00488683|3621945|FG002|Overall Study|Lost to Follow-up|0
2050076|NCT00488683|3621943|FG000|Overall Study|Protocol Violation|5
2050077|NCT00488683|3621944|FG001|Overall Study|Protocol Violation|1
2050078|NCT00488683|3621945|FG002|Overall Study|Protocol Violation|0
2050079|NCT00488683|3621943|FG000|Overall Study|Unable to Classify|1
2050080|NCT00488683|3621944|FG001|Overall Study|Unable to Classify|0
2050081|NCT00488683|3621945|FG002|Overall Study|Unable to Classify|0
2050082|NCT00488774|3621961|FG000|Overall Study|Withdrawal of consent|2
2050083|NCT00488774|3621962|FG001|Overall Study|Withdrawal of consent|2
2050084|NCT00488774|3621963|FG002|Overall Study|Withdrawal of consent|2
2050085|NCT00488774|3621964|FG003|Overall Study|Withdrawal of consent|0
2050086|NCT00488774|3621961|FG000|Overall Study|Other|6
2050087|NCT00488774|3621962|FG001|Overall Study|Other|3
2050088|NCT00488774|3621963|FG002|Overall Study|Other|2
2050089|NCT00488774|3621964|FG003|Overall Study|Other|2
2050090|NCT00488774|3621961|FG000|Overall Study|Lost to Follow-up|0
2050091|NCT00488774|3621962|FG001|Overall Study|Lost to Follow-up|0
2050092|NCT00488774|3621963|FG002|Overall Study|Lost to Follow-up|1
2050093|NCT00488774|3621964|FG003|Overall Study|Lost to Follow-up|1
2050094|NCT00488826|3621978|FG000|Overall Study|Withdrawal by Subject|40
2050095|NCT00488826|3621979|FG001|Overall Study|Withdrawal by Subject|35
2050096|NCT00488826|3621980|FG002|Overall Study|Withdrawal by Subject|19
2050097|NCT00488826|3621978|FG000|Overall Study|Protocol Violation|0
2050098|NCT00488826|3621979|FG001|Overall Study|Protocol Violation|0
2050099|NCT00488826|3621980|FG002|Overall Study|Protocol Violation|2
2050100|NCT00488826|3621978|FG000|Overall Study|Adverse Event|9
2050101|NCT00488826|3621979|FG001|Overall Study|Adverse Event|15
2050102|NCT00488826|3621980|FG002|Overall Study|Adverse Event|4
2050103|NCT00488826|3621978|FG000|Overall Study|Lost to Follow-up|5
2050104|NCT00488826|3621979|FG001|Overall Study|Lost to Follow-up|1
2050105|NCT00488826|3621980|FG002|Overall Study|Lost to Follow-up|0
2050106|NCT00488826|3621978|FG000|Overall Study|Protocol Deviations|2
2050107|NCT00488826|3621979|FG001|Overall Study|Protocol Deviations|1
2050108|NCT00488826|3621980|FG002|Overall Study|Protocol Deviations|1
2050109|NCT00488982|3621992|FG000|Course 1|Physician Decision|0
2050110|NCT00488982|3621993|FG001|Course 1|Physician Decision|2
2050111|NCT00488982|3621994|FG002|Course 1|Physician Decision|4
2050112|NCT00488982|3621992|FG000|Course 1|Withdrawal by Subject|0
2050113|NCT00488982|3621993|FG001|Course 1|Withdrawal by Subject|8
2050114|NCT00488982|3621994|FG002|Course 1|Withdrawal by Subject|2
2050115|NCT00488982|3621992|FG000|Course 1|nonprotocol therapy|0
2050116|NCT00488982|3621993|FG001|Course 1|nonprotocol therapy|2
2050117|NCT00488982|3621994|FG002|Course 1|nonprotocol therapy|2
2050118|NCT00488982|3621992|FG000|Course 1|Adverse Event|0
2050119|NCT00488982|3621993|FG001|Course 1|Adverse Event|0
2050120|NCT00488982|3621994|FG002|Course 1|Adverse Event|6
2050121|NCT00489216|3622012|FG000|Overall Study|Adverse Event|1
2050122|NCT00489255|3622018|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9
2050123|NCT00489255|3622019|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3
2050124|NCT00489255|3622018|FG000|Period 1: Days 1 to 28|Adverse Event|21
2050125|NCT00489255|3622019|FG001|Period 1: Days 1 to 28|Adverse Event|8
2050126|NCT00489255|3622018|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5
2050127|NCT00489255|3622019|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0
2050128|NCT00489255|3622018|FG000|Period 1: Days 1 to 28|Physician Decision|1
2050129|NCT00489255|3622019|FG001|Period 1: Days 1 to 28|Physician Decision|4
2050130|NCT00489255|3622018|FG000|Period 1: Days 1 to 28|Noncompliance|2
2050131|NCT00489255|3622019|FG001|Period 1: Days 1 to 28|Noncompliance|0
2050132|NCT00489255|3622018|FG000|Period 2: Days 29 to 56|Adverse Event|3
2050133|NCT00489255|3622019|FG001|Period 2: Days 29 to 56|Adverse Event|1
2050134|NCT00489255|3622018|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0
2050135|NCT00489255|3622019|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3
2050136|NCT00489255|3622018|FG000|Period 3: Days 57 to 84|Adverse Event|3
2050137|NCT00489255|3622019|FG001|Period 3: Days 57 to 84|Adverse Event|3
2050138|NCT00489255|3622018|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1
2050139|NCT00489255|3622019|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0
2050140|NCT00489255|3622018|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0
2050141|NCT00489255|3622019|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1
2050142|NCT00489359|3622057|FG000|Overall Study|Death|0
2050143|NCT00489359|3622058|FG001|Overall Study|Death|2
2050144|NCT00489359|3622057|FG000|Overall Study|Progressive Disease|5
2050145|NCT00489359|3622058|FG001|Overall Study|Progressive Disease|6
2050146|NCT00489359|3622057|FG000|Overall Study|Lost to Follow-up|1
2050147|NCT00489359|3622058|FG001|Overall Study|Lost to Follow-up|0
2050148|NCT00489359|3622057|FG000|Overall Study|Withdrawal by Subject|1
2050149|NCT00489359|3622058|FG001|Overall Study|Withdrawal by Subject|5
2050150|NCT00489359|3622057|FG000|Overall Study|Adverse Event|0
2050151|NCT00489359|3622058|FG001|Overall Study|Adverse Event|16
2050152|NCT00489411|3622071|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
2050153|NCT00489411|3622072|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
2050154|NCT00489411|3622071|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
2050155|NCT00489411|3622072|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
2050156|NCT00489411|3622071|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
2050157|NCT00489411|3622072|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
2050158|NCT00489411|3622071|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
2050159|NCT00489411|3622072|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
2050160|NCT00489411|3622071|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
2050161|NCT00489411|3622072|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
2050162|NCT00489424|3622081|FG000|Overall Study|Adverse Event|3
2050163|NCT00489424|3622082|FG001|Overall Study|Adverse Event|3
2050164|NCT00489424|3622083|FG002|Overall Study|Adverse Event|4
2050165|NCT00489424|3622081|FG000|Overall Study|Lack of Efficacy|1
2050166|NCT00489424|3622082|FG001|Overall Study|Lack of Efficacy|0
2050167|NCT00489424|3622083|FG002|Overall Study|Lack of Efficacy|0
2050168|NCT00489424|3622081|FG000|Overall Study|Administrative problems|0
2050169|NCT00489424|3622082|FG001|Overall Study|Administrative problems|2
2050170|NCT00489424|3622083|FG002|Overall Study|Administrative problems|1
2050171|NCT00489476|3622095|FG000|Overall Study|Lost to Follow-up|0
2050172|NCT00489476|3622096|FG001|Overall Study|Lost to Follow-up|1
2050173|NCT00489476|3622097|FG002|Overall Study|Lost to Follow-up|0
2050174|NCT00489476|3622098|FG003|Overall Study|Lost to Follow-up|0
2050175|NCT00489489|3622111|FG000|Overall Study|Not treated due to protocol violation|0
2050176|NCT00489489|3622112|FG001|Overall Study|Not treated due to protocol violation|1
2050177|NCT00489489|3622113|FG002|Overall Study|Not treated due to protocol violation|1
2050178|NCT00489489|3622111|FG000|Overall Study|Adverse Event|1
2050179|NCT00489489|3622112|FG001|Overall Study|Adverse Event|1
2050180|NCT00489489|3622113|FG002|Overall Study|Adverse Event|1
2050181|NCT00489489|3622111|FG000|Overall Study|Protocol Violation|1
2050182|NCT00489489|3622112|FG001|Overall Study|Protocol Violation|0
2050183|NCT00489489|3622113|FG002|Overall Study|Protocol Violation|1
2050184|NCT00489489|3622111|FG000|Overall Study|Progressive disease|0
2050185|NCT00489489|3622112|FG001|Overall Study|Progressive disease|1
2050186|NCT00489489|3622113|FG002|Overall Study|Progressive disease|0
2050187|NCT00489489|3622111|FG000|Overall Study|Participant did not wish to continue|1
2050188|NCT00489489|3622112|FG001|Overall Study|Participant did not wish to continue|1
2050189|NCT00489489|3622113|FG002|Overall Study|Participant did not wish to continue|0
2050190|NCT00489489|3622111|FG000|Overall Study|Other than above|0
2050191|NCT00489489|3622112|FG001|Overall Study|Other than above|1
2050192|NCT00489489|3622113|FG002|Overall Study|Other than above|0
2050193|NCT00489541|3622125|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2
2050194|NCT00489541|3622126|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3
2050195|NCT00489541|3622125|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
2050196|NCT00489541|3622126|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0
2050197|NCT00489541|3622125|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2
2050198|NCT00489541|3622126|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0
2050199|NCT00489541|3622125|FG000|12-Month Clinical Follow-up|Death|3
2050200|NCT00489541|3622126|FG001|12-Month Clinical Follow-up|Death|2
2050201|NCT00489541|3622125|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
2050202|NCT00489541|3622126|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
2050203|NCT00489541|3622125|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
2050204|NCT00489541|3622126|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
2050205|NCT00489554|3622132|FG000|Overall Study|Adverse Event|2
2050206|NCT00489554|3622132|FG000|Overall Study|Withdrawal by Subject|1
2050207|NCT00489554|3622132|FG000|Overall Study|Lost to Follow-up|1
2050208|NCT00489736|3622138|FG000|Overall Study|Lack of Efficacy|53
2050209|NCT00489736|3622139|FG001|Overall Study|Lack of Efficacy|14
2208947|NCT01641809|3848438|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0
2208948|NCT01641809|3848435|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
2208949|NCT01641809|3848436|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
2208950|NCT01641809|3848437|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
2208951|NCT01641809|3848438|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
2208952|NCT01641809|3848435|FG000|Open-label (Week 96 to Week 324)|Site closed|1
2217676|NCT01709305|3860931|FG003|Phase 1|Withdrawal by Subject|0
2050210|NCT00489736|3622138|FG000|Overall Study|Adverse Event|32
2050211|NCT00489736|3622139|FG001|Overall Study|Adverse Event|45
2050212|NCT00489736|3622138|FG000|Overall Study|Poor compliance|6
2050213|NCT00489736|3622139|FG001|Overall Study|Poor compliance|2
2050214|NCT00489736|3622138|FG000|Overall Study|Not coded/ Not pre-specified|5
2050215|NCT00489736|3622139|FG001|Overall Study|Not coded/ Not pre-specified|8
2050216|NCT00489827|3622147|FG000|Overall Study|Intraoperative exclusion criteria|1
2050217|NCT00489827|3622148|FG001|Overall Study|Intraoperative exclusion criteria|1
2050218|NCT00489827|3622147|FG000|Overall Study|Intraoperative exclusion criteria|1
2050219|NCT00489827|3622148|FG001|Overall Study|Intraoperative exclusion criteria|1
2050220|NCT00489853|3622154|FG000|Wash-out Period 1|Withdrawal by Subject|1
2050221|NCT00489853|3622155|FG001|Wash-out Period 1|Withdrawal by Subject|0
2050222|NCT00489853|3622156|FG002|Wash-out Period 1|Withdrawal by Subject|0
2050223|NCT00489853|3622154|FG000|Wash-out Period 1|Adverse Event|0
2050224|NCT00489853|3622155|FG001|Wash-out Period 1|Adverse Event|1
2050225|NCT00489853|3622156|FG002|Wash-out Period 1|Adverse Event|1
2050226|NCT00489853|3622154|FG000|Wash-out Period 1|Protocol Violation|0
2050227|NCT00489853|3622155|FG001|Wash-out Period 1|Protocol Violation|1
2050228|NCT00489853|3622156|FG002|Wash-out Period 1|Protocol Violation|1
2050229|NCT00489853|3622154|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0
2050230|NCT00489853|3622155|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1
2050231|NCT00489853|3622156|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4
2050232|NCT00489853|3622154|FG000|Wash-out Period 2|Adverse Event|1
2050233|NCT00489853|3622155|FG001|Wash-out Period 2|Adverse Event|1
2050234|NCT00489853|3622156|FG002|Wash-out Period 2|Adverse Event|0
2050235|NCT00489853|3622154|FG000|Wash-out Period 2|Study specific discontinuation criteria|3
2050236|NCT00489853|3622155|FG001|Wash-out Period 2|Study specific discontinuation criteria|2
2050237|NCT00489853|3622156|FG002|Wash-out Period 2|Study specific discontinuation criteria|2
2050238|NCT00489853|3622154|FG000|Treatment Period 3|Study specific discontinuation criteria|0
2050239|NCT00489853|3622155|FG001|Treatment Period 3|Study specific discontinuation criteria|1
2050240|NCT00489853|3622156|FG002|Treatment Period 3|Study specific discontinuation criteria|0
2050241|NCT00489918|3622186|FG000|Overall Study|Withdrawal by Subject|2
2050242|NCT00489918|3622187|FG001|Overall Study|Withdrawal by Subject|1
2050243|NCT00489918|3622188|FG002|Overall Study|Withdrawal by Subject|1
2050244|NCT00489918|3622189|FG003|Overall Study|Withdrawal by Subject|0
2050245|NCT00489918|3622190|FG004|Overall Study|Withdrawal by Subject|1
2050246|NCT00489918|3622186|FG000|Overall Study|Adverse Event|0
2050247|NCT00489918|3622187|FG001|Overall Study|Adverse Event|1
2050248|NCT00489918|3622188|FG002|Overall Study|Adverse Event|1
2050249|NCT00489918|3622189|FG003|Overall Study|Adverse Event|0
2050250|NCT00489918|3622190|FG004|Overall Study|Adverse Event|0
2050251|NCT00489918|3622186|FG000|Overall Study|Lost to Follow-up|0
2050252|NCT00489918|3622187|FG001|Overall Study|Lost to Follow-up|0
2050253|NCT00489918|3622188|FG002|Overall Study|Lost to Follow-up|1
2050254|NCT00489918|3622189|FG003|Overall Study|Lost to Follow-up|1
2050255|NCT00489918|3622190|FG004|Overall Study|Lost to Follow-up|0
2050256|NCT00489918|3622186|FG000|Overall Study|Physician Decision|0
2050257|NCT00489918|3622187|FG001|Overall Study|Physician Decision|0
2050258|NCT00489918|3622188|FG002|Overall Study|Physician Decision|1
2050259|NCT00489918|3622189|FG003|Overall Study|Physician Decision|0
2050260|NCT00489918|3622190|FG004|Overall Study|Physician Decision|0
2050261|NCT00489970|3622205|FG000|Persistence Year 9|Lost to Follow-up|2
2050262|NCT00489970|3622206|FG001|Persistence Year 9|Lost to Follow-up|2
2050263|NCT00489970|3622207|FG002|Persistence Year 9|Lost to Follow-up|3
2050264|NCT00489970|3622205|FG000|Persistence Year 9|Other|1
2050265|NCT00489970|3622206|FG001|Persistence Year 9|Other|0
2050266|NCT00489970|3622207|FG002|Persistence Year 9|Other|2
2050267|NCT00490022|3622225|FG000|Overall Study|Adverse Event|0
2050268|NCT00490022|3622226|FG001|Overall Study|Adverse Event|2
2050269|NCT00490022|3622225|FG000|Overall Study|Withdrawal by Subject|1
2050270|NCT00490022|3622226|FG001|Overall Study|Withdrawal by Subject|0
2050271|NCT00490022|3622225|FG000|Overall Study|Subject failed to disclose concommitant|0
2050272|NCT00490022|3622226|FG001|Overall Study|Subject failed to disclose concommitant|1
2050273|NCT00490035|3622236|FG000|Overall Study|AE, non-serious non-fatal|3
2050274|NCT00490035|3622237|FG001|Overall Study|AE, non-serious non-fatal|4
2050275|NCT00490035|3622238|FG002|Overall Study|AE, non-serious non-fatal|4
2050276|NCT00490035|3622239|FG003|Overall Study|AE, non-serious non-fatal|5
2050277|NCT00490035|3622236|FG000|Overall Study|Lost to Follow-up|2
2050278|NCT00490035|3622237|FG001|Overall Study|Lost to Follow-up|0
2050279|NCT00490035|3622238|FG002|Overall Study|Lost to Follow-up|1
2050280|NCT00490035|3622239|FG003|Overall Study|Lost to Follow-up|0
2050281|NCT00490035|3622236|FG000|Overall Study|Withdrawal by Subject|2
2050282|NCT00490035|3622237|FG001|Overall Study|Withdrawal by Subject|1
2050283|NCT00490035|3622238|FG002|Overall Study|Withdrawal by Subject|1
2050284|NCT00490035|3622239|FG003|Overall Study|Withdrawal by Subject|0
2050285|NCT00490035|3622236|FG000|Overall Study|Other reason|0
2050286|NCT00490035|3622237|FG001|Overall Study|Other reason|1
2050287|NCT00490035|3622238|FG002|Overall Study|Other reason|3
2050288|NCT00490035|3622239|FG003|Overall Study|Other reason|1
2050289|NCT00490035|3622236|FG000|Overall Study|AE, serious fatal|1
2050290|NCT00490035|3622237|FG001|Overall Study|AE, serious fatal|0
2050291|NCT00490035|3622238|FG002|Overall Study|AE, serious fatal|0
2050292|NCT00490035|3622239|FG003|Overall Study|AE, serious fatal|0
2050293|NCT00490035|3622236|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0
2050294|NCT00490035|3622237|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0
2050295|NCT00490035|3622238|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1
2050296|NCT00490035|3622239|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0
2050297|NCT00490035|3622236|FG000|Overall Study|AE of unknown type|0
2050298|NCT00490035|3622237|FG001|Overall Study|AE of unknown type|0
2050299|NCT00490035|3622238|FG002|Overall Study|AE of unknown type|2
2050300|NCT00490035|3622239|FG003|Overall Study|AE of unknown type|0
2050301|NCT00490061|3622249|FG000|Overall Study|Physician Decision|1
2050302|NCT00490139|3622262|FG000|Overall Study|Death|106
2050303|NCT00490139|3622263|FG001|Overall Study|Death|119
2050304|NCT00490139|3622264|FG002|Overall Study|Death|168
2050305|NCT00490139|3622265|FG003|Overall Study|Death|135
2050306|NCT00490139|3622262|FG000|Overall Study|Lost to Follow-up|56
2050307|NCT00490139|3622263|FG001|Overall Study|Lost to Follow-up|46
2050308|NCT00490139|3622264|FG002|Overall Study|Lost to Follow-up|58
2050309|NCT00490139|3622265|FG003|Overall Study|Lost to Follow-up|56
2050310|NCT00490139|3622262|FG000|Overall Study|Participant Withdrew Consent|146
2050311|NCT00490139|3622263|FG001|Overall Study|Participant Withdrew Consent|110
2050312|NCT00490139|3622264|FG002|Overall Study|Participant Withdrew Consent|208
2050313|NCT00490139|3622265|FG003|Overall Study|Participant Withdrew Consent|116
2050314|NCT00490282|3622295|FG000|Overall Study|Withdrawal by Subject|3
2050315|NCT00490451|3622302|FG000|Overall Study|Adverse Event|3
2050316|NCT00490451|3622303|FG001|Overall Study|Adverse Event|3
2050317|NCT00490451|3622302|FG000|Overall Study|Death|3
2050318|NCT00490451|3622303|FG001|Overall Study|Death|1
2050319|NCT00490451|3622302|FG000|Overall Study|Withdrawal by Subject|2
2050320|NCT00490451|3622303|FG001|Overall Study|Withdrawal by Subject|0
2050321|NCT00490451|3622302|FG000|Overall Study|Investigator Decision|1
2050322|NCT00490451|3622303|FG001|Overall Study|Investigator Decision|0
2050323|NCT00490451|3622302|FG000|Overall Study|Protocol Violation|1
2050324|NCT00490451|3622303|FG001|Overall Study|Protocol Violation|0
2050325|NCT00490451|3622302|FG000|Overall Study|Progressive Disease|53
2050326|NCT00490451|3622303|FG001|Overall Study|Progressive Disease|34
2050327|NCT00490490|3622318|FG000|Completed Assessment for TTP|Withdrawal by Subject|1
2050328|NCT00490490|3622318|FG000|Completed Assessment for TTP|Lost to Follow-up|2
2050329|NCT00490529|3622322|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
2050330|NCT00490529|3622322|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
2050331|NCT00490529|3622322|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
2050332|NCT00490529|3622322|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
2050333|NCT00490529|3622322|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
2050334|NCT00490529|3622322|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
2050335|NCT00490542|3622328|FG000|Overall Study|Lost to Follow-up|3
2050336|NCT00490542|3622329|FG001|Overall Study|Lost to Follow-up|0
2050337|NCT00490542|3622328|FG000|Overall Study|Adverse Event|3
2050338|NCT00490542|3622329|FG001|Overall Study|Adverse Event|3
2050339|NCT00490542|3622328|FG000|Overall Study|Lack of Efficacy|1
2050340|NCT00490542|3622329|FG001|Overall Study|Lack of Efficacy|1
2050341|NCT00490555|3622339|FG000|Overall Study|noncompliant with drug administration|0
2050342|NCT00490555|3622340|FG001|Overall Study|noncompliant with drug administration|0
2050343|NCT00490555|3622341|FG002|Overall Study|noncompliant with drug administration|2
2050344|NCT00490555|3622342|FG003|Overall Study|noncompliant with drug administration|0
2050345|NCT00490568|3622352|FG000|Overall Study|Adverse Event|116
2050346|NCT00490568|3622352|FG000|Overall Study|Lost to Follow-up|13
2050347|NCT00490568|3622352|FG000|Overall Study|Protocol Violation|45
2050348|NCT00490568|3622352|FG000|Overall Study|Withdrawal by Subject|135
2050349|NCT00490568|3622352|FG000|Overall Study|Still in the study at termination|974
2050350|NCT00490568|3622352|FG000|Overall Study|Other|1
2050351|NCT00490568|3622352|FG000|Overall Study|Exclusion criteria met|1
2050352|NCT00490568|3622352|FG000|Overall Study|Caregiver related|20
2050353|NCT00490568|3622352|FG000|Overall Study|Abnormal ECG|25
2050354|NCT00490568|3622352|FG000|Overall Study|Participant refused follow-up|9
2050355|NCT00490568|3622352|FG000|Overall Study|Legal representative withdrew consent|1
2050356|NCT00490568|3622352|FG000|Overall Study|Disease progression|4
2050357|NCT00490568|3622352|FG000|Overall Study|Unmet inclusion-exclusion criteria|5
2050358|NCT00490568|3622352|FG000|Overall Study|Investigator decision|3
2050359|NCT00490568|3622352|FG000|Overall Study|Non-Compliance|7
2050360|NCT00490568|3622352|FG000|Overall Study|Efficacy related|3
2050361|NCT00490568|3622352|FG000|Overall Study|Participant died|1
2050362|NCT00490568|3622352|FG000|Overall Study|Participant withdrawal due to surgery|1
2050363|NCT00490646|3622359|FG000|Overall Study|Still on trastuzumab monotherapy|1
2050364|NCT00490646|3622360|FG001|Overall Study|Still on trastuzumab monotherapy|1
2050365|NCT00490646|3622359|FG000|Overall Study|Never Treated (had an adverse event)|1
2050366|NCT00490646|3622360|FG001|Overall Study|Never Treated (had an adverse event)|0
2050367|NCT00490646|3622359|FG000|Overall Study|Never Treated (withdrew consent)|0
2050368|NCT00490646|3622360|FG001|Overall Study|Never Treated (withdrew consent)|1
2050369|NCT00490698|3622366|FG000|Overall Study|Withdrawal by Subject|1
2050370|NCT00490698|3622366|FG000|Overall Study|Disease Progression|7
2050371|NCT00490698|3622366|FG000|Overall Study|Physician Decision|2
2050372|NCT00490724|3622373|FG000|Period I|Physician Decision|0
2050373|NCT00490724|3622374|FG001|Period I|Physician Decision|0
2050374|NCT00490724|3622375|FG002|Period I|Physician Decision|1
2050375|NCT00490724|3622373|FG000|Period II|Treatment Discontinuation|3
2050376|NCT00490724|3622374|FG001|Period II|Treatment Discontinuation|1
2050377|NCT00490724|3622375|FG002|Period II|Treatment Discontinuation|3
2050378|NCT00490815|3622395|FG000|Overall Study|Adverse Event|2
2050379|NCT00490815|3622396|FG001|Overall Study|Adverse Event|3
2050380|NCT00490815|3622395|FG000|Overall Study|Withdrawal by Subject|4
2050381|NCT00490815|3622396|FG001|Overall Study|Withdrawal by Subject|0
2050382|NCT00490815|3622395|FG000|Overall Study|Lost to Follow-up|1
2050383|NCT00490815|3622396|FG001|Overall Study|Lost to Follow-up|3
2050384|NCT00490815|3622395|FG000|Overall Study|Death|1
2050385|NCT00490815|3622396|FG001|Overall Study|Death|3
2050386|NCT00490841|3622402|FG000|Overall Study|Death|5
2050387|NCT00490841|3622402|FG000|Overall Study|Withdrawal by Subject|4
2050388|NCT00490841|3622402|FG000|Overall Study|Lost to Follow-up|1
2050389|NCT00490841|3622402|FG000|Overall Study|30 day f/u, only non-study stent used|3
2050390|NCT00490919|3622409|FG000|Open-label Run-in Period|Adverse Event|239
2050391|NCT00490919|3622410|FG001|Open-label Run-in Period|Adverse Event|0
2050392|NCT00490919|3622411|FG002|Open-label Run-in Period|Adverse Event|0
2050393|NCT00490919|3622409|FG000|Open-label Run-in Period|Withdrawal by Subject|37
2050394|NCT00490919|3622410|FG001|Open-label Run-in Period|Withdrawal by Subject|0
2208953|NCT01641809|3848436|FG001|Open-label (Week 96 to Week 324)|Site closed|0
2208954|NCT01641809|3848437|FG002|Open-label (Week 96 to Week 324)|Site closed|0
2208955|NCT01641809|3848438|FG003|Open-label (Week 96 to Week 324)|Site closed|0
2208956|NCT01641809|3848435|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1
2050395|NCT00490919|3622411|FG002|Open-label Run-in Period|Withdrawal by Subject|0
2050396|NCT00490919|3622409|FG000|Open-label Run-in Period|Lost to Follow-up|21
2050397|NCT00490919|3622410|FG001|Open-label Run-in Period|Lost to Follow-up|0
2050398|NCT00490919|3622411|FG002|Open-label Run-in Period|Lost to Follow-up|0
2050399|NCT00490919|3622409|FG000|Open-label Run-in Period|Lack of Efficacy|143
2050400|NCT00490919|3622410|FG001|Open-label Run-in Period|Lack of Efficacy|0
2050401|NCT00490919|3622411|FG002|Open-label Run-in Period|Lack of Efficacy|0
2050402|NCT00490919|3622409|FG000|Open-label Run-in Period|Administrative|40
2050403|NCT00490919|3622410|FG001|Open-label Run-in Period|Administrative|0
2050404|NCT00490919|3622411|FG002|Open-label Run-in Period|Administrative|0
2050405|NCT00490919|3622409|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3
2050406|NCT00490919|3622410|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0
2050407|NCT00490919|3622411|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0
2050408|NCT00490919|3622409|FG000|Double-blind Phase|Adverse Event|0
2050409|NCT00490919|3622410|FG001|Double-blind Phase|Adverse Event|40
2050410|NCT00490919|3622411|FG002|Double-blind Phase|Adverse Event|20
2050411|NCT00490919|3622409|FG000|Double-blind Phase|Withdrawal by Subject|0
2050412|NCT00490919|3622410|FG001|Double-blind Phase|Withdrawal by Subject|10
2050413|NCT00490919|3622411|FG002|Double-blind Phase|Withdrawal by Subject|11
2050414|NCT00490919|3622409|FG000|Double-blind Phase|Lost to Follow-up|0
2050415|NCT00490919|3622410|FG001|Double-blind Phase|Lost to Follow-up|8
2050416|NCT00490919|3622411|FG002|Double-blind Phase|Lost to Follow-up|11
2050417|NCT00490919|3622409|FG000|Double-blind Phase|Lack of Efficacy|0
2050418|NCT00490919|3622410|FG001|Double-blind Phase|Lack of Efficacy|22
2050419|NCT00490919|3622411|FG002|Double-blind Phase|Lack of Efficacy|36
2050420|NCT00490919|3622409|FG000|Double-blind Phase|Administrative|0
2050421|NCT00490919|3622410|FG001|Double-blind Phase|Administrative|6
2050422|NCT00490919|3622411|FG002|Double-blind Phase|Administrative|6
2050423|NCT00490945|3622423|FG000|Overall Study|Adverse Event|0
2050424|NCT00490945|3622424|FG001|Overall Study|Adverse Event|1
2050425|NCT00490945|3622425|FG002|Overall Study|Adverse Event|0
2050426|NCT00490945|3622426|FG003|Overall Study|Adverse Event|0
2050427|NCT00490945|3622427|FG004|Overall Study|Adverse Event|0
2050428|NCT00490971|3622447|FG000|Acute/Continuation|Adverse Event|62
2050429|NCT00490971|3622448|FG001|Acute/Continuation|Adverse Event|13
2050430|NCT00490971|3622449|FG002|Acute/Continuation|Adverse Event|0
2050431|NCT00490971|3622450|FG003|Acute/Continuation|Adverse Event|0
2050432|NCT00490971|3622451|FG004|Acute/Continuation|Adverse Event|0
2050433|NCT00490971|3622447|FG000|Acute/Continuation|Death|2
2050434|NCT00490971|3622448|FG001|Acute/Continuation|Death|0
2050435|NCT00490971|3622449|FG002|Acute/Continuation|Death|0
2050436|NCT00490971|3622450|FG003|Acute/Continuation|Death|0
2050437|NCT00490971|3622451|FG004|Acute/Continuation|Death|0
2050438|NCT00490971|3622447|FG000|Acute/Continuation|Lack of Efficacy|106
2050439|NCT00490971|3622448|FG001|Acute/Continuation|Lack of Efficacy|12
2050440|NCT00490971|3622449|FG002|Acute/Continuation|Lack of Efficacy|0
2050441|NCT00490971|3622450|FG003|Acute/Continuation|Lack of Efficacy|0
2050442|NCT00490971|3622451|FG004|Acute/Continuation|Lack of Efficacy|0
2050443|NCT00490971|3622447|FG000|Acute/Continuation|Lost to Follow-up|23
2050444|NCT00490971|3622448|FG001|Acute/Continuation|Lost to Follow-up|7
2050445|NCT00490971|3622449|FG002|Acute/Continuation|Lost to Follow-up|0
2050446|NCT00490971|3622450|FG003|Acute/Continuation|Lost to Follow-up|0
2050447|NCT00490971|3622451|FG004|Acute/Continuation|Lost to Follow-up|0
2050448|NCT00490971|3622447|FG000|Acute/Continuation|Protocol Violation|10
2050449|NCT00490971|3622448|FG001|Acute/Continuation|Protocol Violation|2
2050450|NCT00490971|3622449|FG002|Acute/Continuation|Protocol Violation|0
2050451|NCT00490971|3622450|FG003|Acute/Continuation|Protocol Violation|0
2050452|NCT00490971|3622451|FG004|Acute/Continuation|Protocol Violation|0
2050453|NCT00490971|3622447|FG000|Acute/Continuation|Withdrawal by Subject|92
2050454|NCT00490971|3622448|FG001|Acute/Continuation|Withdrawal by Subject|24
2050455|NCT00490971|3622449|FG002|Acute/Continuation|Withdrawal by Subject|0
2050456|NCT00490971|3622450|FG003|Acute/Continuation|Withdrawal by Subject|0
2050457|NCT00490971|3622451|FG004|Acute/Continuation|Withdrawal by Subject|0
2050458|NCT00490971|3622447|FG000|Acute/Continuation|Other|11
2050459|NCT00490971|3622448|FG001|Acute/Continuation|Other|4
2050460|NCT00490971|3622449|FG002|Acute/Continuation|Other|0
2050461|NCT00490971|3622450|FG003|Acute/Continuation|Other|0
2050462|NCT00490971|3622451|FG004|Acute/Continuation|Other|0
2050463|NCT00490971|3622447|FG000|Maintenance|Adverse Event|0
2050464|NCT00490971|3622448|FG001|Maintenance|Adverse Event|0
2050465|NCT00490971|3622449|FG002|Maintenance|Adverse Event|4
2050466|NCT00490971|3622450|FG003|Maintenance|Adverse Event|5
2050467|NCT00490971|3622451|FG004|Maintenance|Adverse Event|7
2050468|NCT00490971|3622447|FG000|Maintenance|Death|0
2050469|NCT00490971|3622448|FG001|Maintenance|Death|0
2050470|NCT00490971|3622449|FG002|Maintenance|Death|0
2050471|NCT00490971|3622450|FG003|Maintenance|Death|2
2050472|NCT00490971|3622451|FG004|Maintenance|Death|0
2050473|NCT00490971|3622447|FG000|Maintenance|Lost to Follow-up|0
2050474|NCT00490971|3622448|FG001|Maintenance|Lost to Follow-up|0
2050475|NCT00490971|3622449|FG002|Maintenance|Lost to Follow-up|5
2050476|NCT00490971|3622450|FG003|Maintenance|Lost to Follow-up|8
2050477|NCT00490971|3622451|FG004|Maintenance|Lost to Follow-up|10
2050478|NCT00490971|3622447|FG000|Maintenance|Pregnancy|0
2050479|NCT00490971|3622448|FG001|Maintenance|Pregnancy|0
2050480|NCT00490971|3622449|FG002|Maintenance|Pregnancy|1
2050481|NCT00490971|3622450|FG003|Maintenance|Pregnancy|0
2050482|NCT00490971|3622451|FG004|Maintenance|Pregnancy|0
2050483|NCT00490971|3622447|FG000|Maintenance|Protocol Violation|0
2050484|NCT00490971|3622448|FG001|Maintenance|Protocol Violation|0
2050485|NCT00490971|3622449|FG002|Maintenance|Protocol Violation|4
2050486|NCT00490971|3622450|FG003|Maintenance|Protocol Violation|1
2050487|NCT00490971|3622451|FG004|Maintenance|Protocol Violation|1
2050488|NCT00490971|3622447|FG000|Maintenance|Withdrawal by Subject|0
2050489|NCT00490971|3622448|FG001|Maintenance|Withdrawal by Subject|0
2050490|NCT00490971|3622449|FG002|Maintenance|Withdrawal by Subject|26
2050491|NCT00490971|3622450|FG003|Maintenance|Withdrawal by Subject|28
2050492|NCT00490971|3622451|FG004|Maintenance|Withdrawal by Subject|18
2050493|NCT00490971|3622447|FG000|Maintenance|Other|0
2050494|NCT00490971|3622448|FG001|Maintenance|Other|0
2050495|NCT00490971|3622449|FG002|Maintenance|Other|11
2050496|NCT00490971|3622450|FG003|Maintenance|Other|9
2050497|NCT00490971|3622451|FG004|Maintenance|Other|3
2050498|NCT00491075|3622463|FG000|Overall Study|Withdrawal by Subject|1
2050499|NCT00491075|3622463|FG000|Overall Study|Physician Decision|1
2050500|NCT00491179|3622469|FG000|Overall Study|Adverse Event|5
2050501|NCT00491179|3622470|FG001|Overall Study|Adverse Event|1
2050502|NCT00491179|3622469|FG000|Overall Study|Withdrawal by Subject|2
2050503|NCT00491179|3622470|FG001|Overall Study|Withdrawal by Subject|1
2050504|NCT00491322|3622487|FG000|Overall Study|Protocol Violation|1
2050505|NCT00491322|3622488|FG001|Overall Study|Protocol Violation|0
2050506|NCT00491322|3622487|FG000|Overall Study|Pregnancy|0
2050507|NCT00491322|3622488|FG001|Overall Study|Pregnancy|1
2050508|NCT00491530|3622515|FG000|Overall Study|Adverse Event|6
2050509|NCT00491530|3622516|FG001|Overall Study|Adverse Event|1
2050510|NCT00491530|3622517|FG002|Overall Study|Adverse Event|2
2050511|NCT00491530|3622515|FG000|Overall Study|Withdrawal by Subject|3
2050512|NCT00491530|3622516|FG001|Overall Study|Withdrawal by Subject|0
2050513|NCT00491530|3622517|FG002|Overall Study|Withdrawal by Subject|0
2050514|NCT00491530|3622515|FG000|Overall Study|Lost to Follow-up|3
2050515|NCT00491530|3622516|FG001|Overall Study|Lost to Follow-up|2
2050516|NCT00491530|3622517|FG002|Overall Study|Lost to Follow-up|2
2050517|NCT00491530|3622515|FG000|Overall Study|Lack of Efficacy|0
2050518|NCT00491530|3622516|FG001|Overall Study|Lack of Efficacy|1
2050519|NCT00491530|3622517|FG002|Overall Study|Lack of Efficacy|0
2050520|NCT00491530|3622515|FG000|Overall Study|Investigator Discretion|0
2050521|NCT00491530|3622516|FG001|Overall Study|Investigator Discretion|1
2050522|NCT00491530|3622517|FG002|Overall Study|Investigator Discretion|0
2050523|NCT00491530|3622515|FG000|Overall Study|Patient Request|0
2050524|NCT00491530|3622516|FG001|Overall Study|Patient Request|1
2050525|NCT00491530|3622517|FG002|Overall Study|Patient Request|0
2050526|NCT00491530|3622515|FG000|Overall Study|Use of Prohibited Medication|0
2050527|NCT00491530|3622516|FG001|Overall Study|Use of Prohibited Medication|0
2050528|NCT00491530|3622517|FG002|Overall Study|Use of Prohibited Medication|1
2050529|NCT00491556|3622527|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
2208957|NCT01641809|3848436|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1
2208958|NCT01641809|3848437|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0
2208959|NCT01641809|3848438|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0
2208960|NCT01641809|3848435|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
2208961|NCT01641809|3848436|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
2050530|NCT00491556|3622528|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
2050531|NCT00491556|3622527|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
2050532|NCT00491556|3622528|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
2050533|NCT00491556|3622527|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
2050534|NCT00491556|3622528|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
2050535|NCT00491556|3622527|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
2050536|NCT00491556|3622528|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
2050537|NCT00491556|3622527|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
2050538|NCT00491556|3622528|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
2050539|NCT00491556|3622527|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
2050540|NCT00491556|3622528|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
2050541|NCT00491556|3622527|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
2050542|NCT00491556|3622528|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
2050543|NCT00491556|3622527|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
2050544|NCT00491556|3622528|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
2050545|NCT00491556|3622527|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3
2050546|NCT00491556|3622528|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0
2050547|NCT00491556|3622527|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
2050548|NCT00491556|3622528|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
2050549|NCT00491556|3622527|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
2050550|NCT00491556|3622528|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
2050551|NCT00491556|3622527|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
2050552|NCT00491556|3622528|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
2050553|NCT00491556|3622527|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
2050554|NCT00491556|3622528|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
2050555|NCT00491556|3622527|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
2050556|NCT00491556|3622528|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
2050557|NCT00491556|3622527|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
2050558|NCT00491556|3622528|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
2050559|NCT00491556|3622527|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
2050560|NCT00491556|3622528|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
2050561|NCT00491556|3622527|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
2050562|NCT00491556|3622528|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
2050563|NCT00491556|3622527|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
2050564|NCT00491556|3622528|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
2050565|NCT00491556|3622527|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
2050566|NCT00491556|3622528|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
2050567|NCT00491556|3622527|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
2050568|NCT00491556|3622528|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
2050569|NCT00491608|3622534|FG000|Overall Study|Death|2
2050570|NCT00491608|3622534|FG000|Overall Study|Withdrawal by Subject|1
2105276|NCT00856375|3697799|FG001|Overall Study|Other|1
2105277|NCT00856375|3697798|FG000|Overall Study|Death|32
2105278|NCT00856375|3697799|FG001|Overall Study|Death|30
2105279|NCT00856375|3697798|FG000|Overall Study|Sponsor Terminated Study|7
2105280|NCT00856375|3697799|FG001|Overall Study|Sponsor Terminated Study|7
2105281|NCT00856375|3697798|FG000|Overall Study|Withdrawal by Subject|2
2105282|NCT00856375|3697799|FG001|Overall Study|Withdrawal by Subject|1
2105283|NCT00856375|3697798|FG000|Overall Study|Lost to Follow-up|1
2105284|NCT00856375|3697799|FG001|Overall Study|Lost to Follow-up|2
2105285|NCT00856388|3697805|FG000|Overall Study|Other|1
2105286|NCT00856492|3697817|FG000|Overall Study|Ineligible or withdrew consent|1
2105287|NCT00856492|3697818|FG001|Overall Study|Ineligible or withdrew consent|1
2105288|NCT00856492|3697819|FG002|Overall Study|Ineligible or withdrew consent|2
2105289|NCT00856518|3697832|FG000|Overall Study|Lost to Follow-up|4
2105290|NCT00856518|3697833|FG001|Overall Study|Lost to Follow-up|2
2105291|NCT00856544|3697845|FG000|Overall Study|Randomized but not treated|3
2105292|NCT00856544|3697846|FG001|Overall Study|Randomized but not treated|0
2105293|NCT00856544|3697847|FG002|Overall Study|Randomized but not treated|0
2105294|NCT00856544|3697848|FG003|Overall Study|Randomized but not treated|0
2105295|NCT00856544|3697845|FG000|Overall Study|Death|0
2105296|NCT00856544|3697846|FG001|Overall Study|Death|2
2105297|NCT00856544|3697847|FG002|Overall Study|Death|0
2105298|NCT00856544|3697848|FG003|Overall Study|Death|0
2105299|NCT00856544|3697845|FG000|Overall Study|Adverse Event|20
2105300|NCT00856544|3697846|FG001|Overall Study|Adverse Event|29
2105301|NCT00856544|3697847|FG002|Overall Study|Adverse Event|2
2105302|NCT00856544|3697848|FG003|Overall Study|Adverse Event|3
2105303|NCT00856544|3697845|FG000|Overall Study|Lack of Efficacy|16
2105304|NCT00856544|3697846|FG001|Overall Study|Lack of Efficacy|12
2050571|NCT00491764|3622559|FG000|Overall Study|Adverse Event|1
2050572|NCT00491764|3622560|FG001|Overall Study|Adverse Event|2
2050573|NCT00491764|3622561|FG002|Overall Study|Adverse Event|4
2050574|NCT00491764|3622562|FG003|Overall Study|Adverse Event|4
2050575|NCT00491764|3622563|FG004|Overall Study|Adverse Event|0
2050576|NCT00491764|3622564|FG005|Overall Study|Adverse Event|1
2050577|NCT00491764|3622559|FG000|Overall Study|Lost to Follow-up|0
2050578|NCT00491764|3622560|FG001|Overall Study|Lost to Follow-up|1
2050579|NCT00491764|3622561|FG002|Overall Study|Lost to Follow-up|0
2050580|NCT00491764|3622562|FG003|Overall Study|Lost to Follow-up|1
2050581|NCT00491764|3622563|FG004|Overall Study|Lost to Follow-up|0
2050582|NCT00491764|3622564|FG005|Overall Study|Lost to Follow-up|3
2050583|NCT00491764|3622559|FG000|Overall Study|Withdrawal by Subject|2
2050584|NCT00491764|3622560|FG001|Overall Study|Withdrawal by Subject|3
2050585|NCT00491764|3622561|FG002|Overall Study|Withdrawal by Subject|1
2050586|NCT00491764|3622562|FG003|Overall Study|Withdrawal by Subject|2
2050587|NCT00491764|3622563|FG004|Overall Study|Withdrawal by Subject|2
2050588|NCT00491764|3622564|FG005|Overall Study|Withdrawal by Subject|4
2050589|NCT00491764|3622559|FG000|Overall Study|Non Compliance with the Protocol|1
2050590|NCT00491764|3622560|FG001|Overall Study|Non Compliance with the Protocol|0
2050591|NCT00491764|3622561|FG002|Overall Study|Non Compliance with the Protocol|0
2050592|NCT00491764|3622562|FG003|Overall Study|Non Compliance with the Protocol|0
2050593|NCT00491764|3622563|FG004|Overall Study|Non Compliance with the Protocol|0
2050594|NCT00491764|3622564|FG005|Overall Study|Non Compliance with the Protocol|0
2050595|NCT00491764|3622559|FG000|Overall Study|Did not Meet Protocol Eligibility|0
2050596|NCT00491764|3622560|FG001|Overall Study|Did not Meet Protocol Eligibility|1
2050597|NCT00491764|3622561|FG002|Overall Study|Did not Meet Protocol Eligibility|1
2050598|NCT00491764|3622562|FG003|Overall Study|Did not Meet Protocol Eligibility|0
2050599|NCT00491764|3622563|FG004|Overall Study|Did not Meet Protocol Eligibility|1
2050600|NCT00491764|3622564|FG005|Overall Study|Did not Meet Protocol Eligibility|1
2050601|NCT00491764|3622559|FG000|Overall Study|Administrative|1
2050602|NCT00491764|3622560|FG001|Overall Study|Administrative|0
2050603|NCT00491764|3622561|FG002|Overall Study|Administrative|2
2050604|NCT00491764|3622562|FG003|Overall Study|Administrative|1
2050605|NCT00491764|3622563|FG004|Overall Study|Administrative|0
2050606|NCT00491764|3622564|FG005|Overall Study|Administrative|0
2050607|NCT00491894|3622591|FG000|Overall Study|Adverse Event|14
2050608|NCT00491894|3622591|FG000|Overall Study|Withdrawal by Subject|5
2050609|NCT00491894|3622591|FG000|Overall Study|Death|3
2050610|NCT00491894|3622591|FG000|Overall Study|Lost to Follow-up|3
2050611|NCT00491894|3622591|FG000|Overall Study|Lack of Efficacy|2
2050612|NCT00491894|3622591|FG000|Overall Study|Other-Failed to meet any criteria|2
2050613|NCT00491894|3622591|FG000|Overall Study|Physician Decision|2
2050614|NCT00491894|3622591|FG000|Overall Study|Protocol Violation|2
2050615|NCT00491894|3622591|FG000|Overall Study|Other-Intake of prohibited medication|1
2050616|NCT00492024|3622597|FG000|Treatment|Adverse Event|3
2050617|NCT00492024|3622598|FG001|Treatment|Adverse Event|1
2050618|NCT00492024|3622597|FG000|Treatment|Lack of Efficacy|21
2050619|NCT00492024|3622598|FG001|Treatment|Lack of Efficacy|20
2050620|NCT00492024|3622597|FG000|Treatment|Lost to Follow-up|3
2050621|NCT00492024|3622598|FG001|Treatment|Lost to Follow-up|1
2050622|NCT00492024|3622597|FG000|Treatment|Withdrawal by Subject|2
2050623|NCT00492024|3622598|FG001|Treatment|Withdrawal by Subject|0
2050624|NCT00492024|3622597|FG000|Follow up|Lack of Efficacy|0
2050625|NCT00492024|3622598|FG001|Follow up|Lack of Efficacy|1
2050626|NCT00492024|3622597|FG000|Follow up|Lost to Follow-up|1
2050627|NCT00492024|3622598|FG001|Follow up|Lost to Follow-up|1
2050628|NCT00492063|3622608|FG000|Overall Study|Death|0
2050629|NCT00492063|3622609|FG001|Overall Study|Death|0
2050630|NCT00492063|3622610|FG002|Overall Study|Death|1
2050631|NCT00492063|3622611|FG003|Overall Study|Death|2
2050632|NCT00492063|3622608|FG000|Overall Study|Withdrawal by Subject|4
2050633|NCT00492063|3622609|FG001|Overall Study|Withdrawal by Subject|3
2050634|NCT00492063|3622610|FG002|Overall Study|Withdrawal by Subject|5
2050635|NCT00492063|3622611|FG003|Overall Study|Withdrawal by Subject|4
2050636|NCT00492063|3622608|FG000|Overall Study|Lost to Follow-up|6
2050637|NCT00492063|3622609|FG001|Overall Study|Lost to Follow-up|11
2050638|NCT00492063|3622610|FG002|Overall Study|Lost to Follow-up|5
2050639|NCT00492063|3622611|FG003|Overall Study|Lost to Follow-up|3
2050640|NCT00492063|3622608|FG000|Overall Study|Protocol Violation|0
2050641|NCT00492063|3622609|FG001|Overall Study|Protocol Violation|0
2050642|NCT00492063|3622610|FG002|Overall Study|Protocol Violation|0
2050643|NCT00492063|3622611|FG003|Overall Study|Protocol Violation|1
2050644|NCT00492115|3622632|FG000|Overall Study|Withdrawal by Subject|3
2050645|NCT00492115|3622633|FG001|Overall Study|Withdrawal by Subject|4
2050646|NCT00492232|3622647|FG000|Placebo Run-in|Adverse Event|0
2050647|NCT00492232|3622648|FG001|Placebo Run-in|Adverse Event|2
2050648|NCT00492232|3622647|FG000|Placebo Run-in|Protocol Violation|0
2050649|NCT00492232|3622648|FG001|Placebo Run-in|Protocol Violation|3
2050650|NCT00492232|3622647|FG000|Placebo Run-in|Lost to Follow-up|0
2050651|NCT00492232|3622648|FG001|Placebo Run-in|Lost to Follow-up|3
2050652|NCT00492232|3622647|FG000|Placebo Run-in|Withdrawal by Subject|0
2050653|NCT00492232|3622648|FG001|Placebo Run-in|Withdrawal by Subject|8
2050654|NCT00492232|3622647|FG000|Placebo Run-in|Pregnancy|0
2050655|NCT00492232|3622648|FG001|Placebo Run-in|Pregnancy|1
2050656|NCT00492232|3622647|FG000|Placebo Run-in|Entrance criteria not met|0
2050657|NCT00492232|3622648|FG001|Placebo Run-in|Entrance criteria not met|45
2050658|NCT00492232|3622647|FG000|Placebo Run-in|Other|0
2050659|NCT00492232|3622648|FG001|Placebo Run-in|Other|6
2050660|NCT00492232|3622647|FG000|Placebo Run-in|Missing|0
2050661|NCT00492232|3622648|FG001|Placebo Run-in|Missing|2
2050662|NCT00492232|3622647|FG000|Double-Blind Treatment|Adverse Event|1
2050663|NCT00492232|3622648|FG001|Double-Blind Treatment|Adverse Event|2
2050664|NCT00492232|3622647|FG000|Double-Blind Treatment|Protocol Violation|3
2050665|NCT00492232|3622648|FG001|Double-Blind Treatment|Protocol Violation|7
2050666|NCT00492232|3622647|FG000|Double-Blind Treatment|Lost to Follow-up|2
2050667|NCT00492232|3622648|FG001|Double-Blind Treatment|Lost to Follow-up|3
2050668|NCT00492232|3622647|FG000|Double-Blind Treatment|Withdrawal by Subject|4
2050669|NCT00492232|3622648|FG001|Double-Blind Treatment|Withdrawal by Subject|8
2050670|NCT00492232|3622647|FG000|Double-Blind Treatment|Lack of Efficacy|1
2050671|NCT00492232|3622648|FG001|Double-Blind Treatment|Lack of Efficacy|0
2050672|NCT00492232|3622647|FG000|Double-Blind Treatment|Other|6
2050673|NCT00492232|3622648|FG001|Double-Blind Treatment|Other|5
2050674|NCT00492232|3622647|FG000|Double-Blind Treatment|Randomized not treated|1
2050675|NCT00492232|3622648|FG001|Double-Blind Treatment|Randomized not treated|0
2050676|NCT00492232|3622647|FG000|Open-Label Treatment|Withdrawal by Subject|1
2050677|NCT00492232|3622648|FG001|Open-Label Treatment|Withdrawal by Subject|0
2050678|NCT00492284|3622658|FG000|Overall Study|Adverse Event|0
2050679|NCT00492284|3622659|FG001|Overall Study|Adverse Event|1
2050680|NCT00492284|3622660|FG002|Overall Study|Adverse Event|1
2050681|NCT00492284|3622661|FG003|Overall Study|Adverse Event|2
2050682|NCT00492284|3622658|FG000|Overall Study|Lost to Follow-up|0
2050683|NCT00492284|3622659|FG001|Overall Study|Lost to Follow-up|0
2050684|NCT00492284|3622660|FG002|Overall Study|Lost to Follow-up|3
2050685|NCT00492284|3622661|FG003|Overall Study|Lost to Follow-up|1
2050686|NCT00492284|3622658|FG000|Overall Study|Death|0
2050687|NCT00492284|3622659|FG001|Overall Study|Death|3
2050688|NCT00492284|3622660|FG002|Overall Study|Death|2
2050689|NCT00492284|3622661|FG003|Overall Study|Death|5
2050690|NCT00492284|3622658|FG000|Overall Study|Withdrawal by Subject|1
2050691|NCT00492284|3622659|FG001|Overall Study|Withdrawal by Subject|0
2050692|NCT00492284|3622660|FG002|Overall Study|Withdrawal by Subject|0
2050693|NCT00492284|3622661|FG003|Overall Study|Withdrawal by Subject|2
2050694|NCT00492297|3622671|FG000|Treatment|Death|2
2050695|NCT00492297|3622671|FG000|Treatment|Study terminated by sponsor|3
2050696|NCT00492297|3622671|FG000|Active Follow-up 30(+4) Days Duration|Death|17
2050697|NCT00492297|3622671|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
2050698|NCT00492297|3622671|FG000|Survival Only Follow-up|Death|46
2050699|NCT00492297|3622671|FG000|Survival Only Follow-up|Lack of Efficacy|1
2050700|NCT00492297|3622671|FG000|Survival Only Follow-up|Study terminated by sponsor|12
2050701|NCT00492531|3622692|FG000|Overall Study|Withdrawn(More than one reason selected)|22
2050702|NCT00492531|3622693|FG001|Overall Study|Withdrawn(More than one reason selected)|23
2050703|NCT00492557|3622705|FG000|Overall Study|Subject request|12
2050704|NCT00492557|3622706|FG001|Overall Study|Subject request|11
2050705|NCT00492557|3622705|FG000|Overall Study|Protocol Violation|7
2050706|NCT00492557|3622706|FG001|Overall Study|Protocol Violation|8
2050707|NCT00492557|3622705|FG000|Overall Study|Other|2
2050708|NCT00492557|3622706|FG001|Overall Study|Other|2
2050709|NCT00492557|3622705|FG000|Overall Study|Death|1
2050710|NCT00492557|3622706|FG001|Overall Study|Death|1
2050711|NCT00492557|3622705|FG000|Overall Study|Adverse Event|1
2050712|NCT00492557|3622706|FG001|Overall Study|Adverse Event|0
2050713|NCT00492557|3622705|FG000|Overall Study|Failed to return|1
2050714|NCT00492557|3622706|FG001|Overall Study|Failed to return|0
2050715|NCT00492557|3622705|FG000|Overall Study|Lost to Follow-up|0
2050716|NCT00492557|3622706|FG001|Overall Study|Lost to Follow-up|1
2050717|NCT00492648|3622734|FG000|Month 30 (109671 Study)|Protocol Violation|0
2050718|NCT00492648|3622735|FG001|Month 30 (109671 Study)|Protocol Violation|1
2050719|NCT00492726|3622743|FG000|Overall Study|Adverse Event|10
2050720|NCT00492726|3622744|FG001|Overall Study|Adverse Event|6
2050721|NCT00492726|3622743|FG000|Overall Study|Death|7
2050722|NCT00492726|3622744|FG001|Overall Study|Death|2
2050723|NCT00492726|3622743|FG000|Overall Study|Lack of Efficacy|0
2050724|NCT00492726|3622744|FG001|Overall Study|Lack of Efficacy|2
2050725|NCT00492726|3622743|FG000|Overall Study|Lost to Follow-up|27
2050726|NCT00492726|3622744|FG001|Overall Study|Lost to Follow-up|19
2050727|NCT00492726|3622743|FG000|Overall Study|Physician Decision|0
2050728|NCT00492726|3622744|FG001|Overall Study|Physician Decision|1
2050729|NCT00492726|3622743|FG000|Overall Study|Withdrawal by Subject|6
2050730|NCT00492726|3622744|FG001|Overall Study|Withdrawal by Subject|3
2050731|NCT00492726|3622743|FG000|Overall Study|Non compliant with study medication|0
2050732|NCT00492726|3622744|FG001|Overall Study|Non compliant with study medication|3
2050733|NCT00492752|3622752|FG000|Double Blind Treatment|Death|13
2050734|NCT00492752|3622753|FG001|Double Blind Treatment|Death|0
2050735|NCT00492752|3622754|FG002|Double Blind Treatment|Death|2
2050736|NCT00492752|3622755|FG003|Double Blind Treatment|Death|0
2050737|NCT00492752|3622752|FG000|Double Blind Treatment|Adverse Event|1
2050738|NCT00492752|3622753|FG001|Double Blind Treatment|Adverse Event|0
2050739|NCT00492752|3622754|FG002|Double Blind Treatment|Adverse Event|0
2050740|NCT00492752|3622755|FG003|Double Blind Treatment|Adverse Event|0
2050741|NCT00492752|3622752|FG000|Double Blind Treatment|Protocol Violation|0
2050742|NCT00492752|3622753|FG001|Double Blind Treatment|Protocol Violation|0
2050743|NCT00492752|3622754|FG002|Double Blind Treatment|Protocol Violation|1
2050744|NCT00492752|3622755|FG003|Double Blind Treatment|Protocol Violation|0
2050745|NCT00492752|3622752|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0
2050746|NCT00492752|3622753|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2
2050747|NCT00492752|3622754|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0
2050748|NCT00492752|3622755|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2
2050749|NCT00492752|3622752|FG000|Follow-up and/or Open Label Sorafenib|Death|75
2050750|NCT00492752|3622753|FG001|Follow-up and/or Open Label Sorafenib|Death|5
2050751|NCT00492752|3622754|FG002|Follow-up and/or Open Label Sorafenib|Death|45
2050752|NCT00492752|3622755|FG003|Follow-up and/or Open Label Sorafenib|Death|1
2050753|NCT00492752|3622752|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
2050754|NCT00492752|3622753|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
2050755|NCT00492752|3622754|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
2050756|NCT00492752|3622755|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
2050757|NCT00492752|3622752|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
2050758|NCT00492752|3622753|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
2050759|NCT00492752|3622754|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
2050760|NCT00492752|3622755|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
2050761|NCT00492752|3622752|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
2050762|NCT00492752|3622753|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
2050763|NCT00492752|3622754|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
2050764|NCT00492752|3622755|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
2050765|NCT00492752|3622752|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
2050766|NCT00492752|3622753|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
2050767|NCT00492752|3622754|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
2050768|NCT00492752|3622755|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
2050769|NCT00492752|3622752|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
2050770|NCT00492752|3622753|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
2050771|NCT00492752|3622754|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
2050772|NCT00492752|3622755|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
2050773|NCT00492752|3622752|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
2050774|NCT00492752|3622753|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
2050775|NCT00492752|3622754|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
2050776|NCT00492752|3622755|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
2050777|NCT00492856|3622762|FG000|Induction|Adverse Event|2
2050778|NCT00492856|3622763|FG001|Induction|Adverse Event|0
2050779|NCT00492856|3622764|FG002|Induction|Adverse Event|0
2050780|NCT00492856|3622765|FG003|Induction|Adverse Event|0
2050781|NCT00492856|3622762|FG000|Induction|Withdrawal by Subject|1
2050782|NCT00492856|3622763|FG001|Induction|Withdrawal by Subject|0
2050783|NCT00492856|3622764|FG002|Induction|Withdrawal by Subject|0
2050784|NCT00492856|3622765|FG003|Induction|Withdrawal by Subject|0
2050785|NCT00492856|3622762|FG000|Induction|Death|3
2050786|NCT00492856|3622763|FG001|Induction|Death|0
2050787|NCT00492856|3622764|FG002|Induction|Death|0
2050788|NCT00492856|3622765|FG003|Induction|Death|0
2050789|NCT00492856|3622762|FG000|Consolidation|Adverse Event|6
2050790|NCT00492856|3622763|FG001|Consolidation|Adverse Event|0
2050791|NCT00492856|3622764|FG002|Consolidation|Adverse Event|0
2050792|NCT00492856|3622765|FG003|Consolidation|Adverse Event|0
2050793|NCT00492856|3622762|FG000|Consolidation|Not protocol specified|2
2050794|NCT00492856|3622763|FG001|Consolidation|Not protocol specified|0
2050795|NCT00492856|3622764|FG002|Consolidation|Not protocol specified|0
2050796|NCT00492856|3622765|FG003|Consolidation|Not protocol specified|0
2050797|NCT00492856|3622762|FG000|Consolidation|Lost to Follow-up|1
2050798|NCT00492856|3622763|FG001|Consolidation|Lost to Follow-up|0
2050799|NCT00492856|3622764|FG002|Consolidation|Lost to Follow-up|0
2050800|NCT00492856|3622765|FG003|Consolidation|Lost to Follow-up|0
2050801|NCT00492856|3622762|FG000|Post-consolidation|Adverse Event|0
2050802|NCT00492856|3622763|FG001|Post-consolidation|Adverse Event|4
2050803|NCT00492856|3622764|FG002|Post-consolidation|Adverse Event|0
2050804|NCT00492856|3622765|FG003|Post-consolidation|Adverse Event|1
2050805|NCT00492856|3622762|FG000|Post-consolidation|Withdrawal by Subject|0
2050806|NCT00492856|3622763|FG001|Post-consolidation|Withdrawal by Subject|4
2050807|NCT00492856|3622764|FG002|Post-consolidation|Withdrawal by Subject|0
2050808|NCT00492856|3622765|FG003|Post-consolidation|Withdrawal by Subject|0
2050809|NCT00492856|3622762|FG000|Post-consolidation|Death|0
2050810|NCT00492856|3622763|FG001|Post-consolidation|Death|1
2050811|NCT00492856|3622764|FG002|Post-consolidation|Death|0
2050812|NCT00492856|3622765|FG003|Post-consolidation|Death|0
2050813|NCT00492856|3622762|FG000|Post-consolidation|Not protocol specified|0
2050814|NCT00492856|3622763|FG001|Post-consolidation|Not protocol specified|1
2050815|NCT00492856|3622764|FG002|Post-consolidation|Not protocol specified|0
2050816|NCT00492856|3622765|FG003|Post-consolidation|Not protocol specified|0
2050817|NCT00492856|3622762|FG000|Post-consolidation|Lost to Follow-up|0
2050818|NCT00492856|3622763|FG001|Post-consolidation|Lost to Follow-up|2
2050819|NCT00492856|3622764|FG002|Post-consolidation|Lost to Follow-up|0
2050820|NCT00492856|3622765|FG003|Post-consolidation|Lost to Follow-up|0
2050821|NCT00492856|3622762|FG000|Post-consolidation|Observation Arm|0
2050822|NCT00492856|3622763|FG001|Post-consolidation|Observation Arm|0
2050823|NCT00492856|3622764|FG002|Post-consolidation|Observation Arm|27
2050824|NCT00492856|3622765|FG003|Post-consolidation|Observation Arm|0
2050825|NCT00492921|3622777|FG000|Overall Study|Death|1
2050826|NCT00492921|3622778|FG001|Overall Study|Death|0
2050827|NCT00492921|3622779|FG002|Overall Study|Death|1
2050828|NCT00493012|3622798|FG000|Overall Study|Lost to Follow-up|18
2050829|NCT00493012|3622799|FG001|Overall Study|Lost to Follow-up|17
2050830|NCT00493038|3622807|FG000|Treatment|Adverse Event|8
2050831|NCT00493038|3622808|FG001|Treatment|Adverse Event|4
2050832|NCT00493038|3622807|FG000|Treatment|Lost to Follow-up|5
2050833|NCT00493038|3622808|FG001|Treatment|Lost to Follow-up|3
2050834|NCT00493038|3622807|FG000|Treatment|Withdrawal by Subject|11
2050835|NCT00493038|3622808|FG001|Treatment|Withdrawal by Subject|12
2050836|NCT00493038|3622807|FG000|Treatment|Other|0
2050837|NCT00493038|3622808|FG001|Treatment|Other|1
2050838|NCT00493038|3622807|FG000|Follow-up|Lost to Follow-up|1
2050839|NCT00493038|3622808|FG001|Follow-up|Lost to Follow-up|0
2050840|NCT00493220|3622828|FG000|Third Intervention|Withdrawal by Subject|1
2050841|NCT00493220|3622829|FG001|Third Intervention|Withdrawal by Subject|0
2050842|NCT00493220|3622830|FG002|Third Intervention|Withdrawal by Subject|0
2050843|NCT00493220|3622831|FG003|Third Intervention|Withdrawal by Subject|0
2050844|NCT00493220|3622832|FG004|Third Intervention|Withdrawal by Subject|0
2050845|NCT00493220|3622833|FG005|Third Intervention|Withdrawal by Subject|0
2050846|NCT00493246|3622851|FG000|Overall Study|Withdrawal by Subject|0
2050847|NCT00493246|3622852|FG001|Overall Study|Withdrawal by Subject|0
2050848|NCT00493246|3622853|FG002|Overall Study|Withdrawal by Subject|0
2050849|NCT00493246|3622854|FG003|Overall Study|Withdrawal by Subject|0
2050850|NCT00493246|3622855|FG004|Overall Study|Withdrawal by Subject|1
2050851|NCT00493246|3622856|FG005|Overall Study|Withdrawal by Subject|0
2050852|NCT00493246|3622857|FG006|Overall Study|Withdrawal by Subject|0
2050853|NCT00493246|3622858|FG007|Overall Study|Withdrawal by Subject|0
2050854|NCT00493246|3622851|FG000|Overall Study|No access to draw blood|0
2050855|NCT00493246|3622852|FG001|Overall Study|No access to draw blood|0
2050856|NCT00493246|3622853|FG002|Overall Study|No access to draw blood|0
2050857|NCT00493246|3622854|FG003|Overall Study|No access to draw blood|0
2050858|NCT00493246|3622855|FG004|Overall Study|No access to draw blood|0
2050859|NCT00493246|3622856|FG005|Overall Study|No access to draw blood|1
2050860|NCT00493246|3622857|FG006|Overall Study|No access to draw blood|0
2050861|NCT00493246|3622858|FG007|Overall Study|No access to draw blood|0
2050862|NCT00493246|3622851|FG000|Overall Study|Lost to Follow-up|0
2050863|NCT00493246|3622852|FG001|Overall Study|Lost to Follow-up|0
2050864|NCT00493246|3622853|FG002|Overall Study|Lost to Follow-up|0
2050865|NCT00493246|3622854|FG003|Overall Study|Lost to Follow-up|0
2050866|NCT00493246|3622855|FG004|Overall Study|Lost to Follow-up|0
2050867|NCT00493246|3622856|FG005|Overall Study|Lost to Follow-up|0
2050868|NCT00493246|3622857|FG006|Overall Study|Lost to Follow-up|1
2050869|NCT00493246|3622858|FG007|Overall Study|Lost to Follow-up|0
2050870|NCT00493285|3622882|FG000|Overall Study|Lost to Follow-up|0
2050871|NCT00493285|3622883|FG001|Overall Study|Lost to Follow-up|0
2050872|NCT00493285|3622884|FG002|Overall Study|Lost to Follow-up|0
2050873|NCT00493285|3622885|FG003|Overall Study|Lost to Follow-up|0
2050874|NCT00493285|3622886|FG004|Overall Study|Lost to Follow-up|1
2050875|NCT00493285|3622887|FG005|Overall Study|Lost to Follow-up|0
2050876|NCT00493311|3622903|FG000|Overall Study|Need for rescue medication|2
2050877|NCT00493311|3622904|FG001|Overall Study|Need for rescue medication|2
2050878|NCT00493454|3622910|FG000|Overall Study|Withdrawal by Subject|1
2050879|NCT00493467|3622914|FG000|Overall Study|Death|1
2050880|NCT00493636|3622920|FG000|Overall Study|Withdrawal by Subject|1
2050881|NCT00493636|3622921|FG001|Overall Study|Withdrawal by Subject|0
2050882|NCT00493636|3622920|FG000|Overall Study|Disease progression/recurrence/relapse|0
2050883|NCT00493636|3622921|FG001|Overall Study|Disease progression/recurrence/relapse|1
2050884|NCT00493636|3622920|FG000|Overall Study|Mis-randomization|1
2050885|NCT00493636|3622921|FG001|Overall Study|Mis-randomization|1
2050886|NCT00493649|3622927|FG000|Overall Study|Adverse Event|44
2050887|NCT00493649|3622927|FG000|Overall Study|Patient Request|21
2050888|NCT00493649|3622927|FG000|Overall Study|Investigator Request|2
2050889|NCT00493649|3622927|FG000|Overall Study|Disease Progression|1
2050890|NCT00493649|3622927|FG000|Overall Study|Lost to Follow-up|1
2050891|NCT00493649|3622927|FG000|Overall Study|Other|13
2050892|NCT00493779|3622934|FG000|Overall Study|Logistical issue at site|1
2050893|NCT00493974|3622948|FG000|Overall Study|Death|1
2050894|NCT00493974|3622949|FG001|Overall Study|Death|2
2050895|NCT00493974|3622948|FG000|Overall Study|Withdrawal by Subject|8
2050896|NCT00493974|3622949|FG001|Overall Study|Withdrawal by Subject|6
2050897|NCT00493974|3622948|FG000|Overall Study|Lost to Follow-up|4
2050898|NCT00493974|3622949|FG001|Overall Study|Lost to Follow-up|6
2050899|NCT00494013|3622957|FG000|Overall Study|Adverse Event|0
2050900|NCT00494013|3622958|FG001|Overall Study|Adverse Event|1
2050901|NCT00494013|3622957|FG000|Overall Study|Entry Criteria Not Met|1
2050902|NCT00494013|3622958|FG001|Overall Study|Entry Criteria Not Met|4
2050903|NCT00494013|3622957|FG000|Overall Study|Lost to Follow-up|5
2050904|NCT00494013|3622958|FG001|Overall Study|Lost to Follow-up|6
2050905|NCT00494013|3622957|FG000|Overall Study|Physician Decision|3
2050906|NCT00494013|3622958|FG001|Overall Study|Physician Decision|5
2050907|NCT00494013|3622957|FG000|Overall Study|Protocol Violation|8
2050908|NCT00494013|3622958|FG001|Overall Study|Protocol Violation|5
2050909|NCT00494013|3622957|FG000|Overall Study|Withdrawal by Subject|13
2050910|NCT00494013|3622958|FG001|Overall Study|Withdrawal by Subject|14
2050911|NCT00494013|3622957|FG000|Overall Study|Sponsor Decision|0
2050912|NCT00494013|3622958|FG001|Overall Study|Sponsor Decision|1
2050913|NCT00494026|3622964|FG000|Overall Study|Sponsor Decision|4
2050914|NCT00494091|3622970|FG000|Overall Study|Death|5
2050915|NCT00494091|3622971|FG001|Overall Study|Death|54
2050916|NCT00494091|3622970|FG000|Overall Study|Lost to Follow-up|0
2050917|NCT00494091|3622971|FG001|Overall Study|Lost to Follow-up|4
2050918|NCT00494091|3622970|FG000|Overall Study|Other|1
2050919|NCT00494091|3622971|FG001|Overall Study|Other|11
2050920|NCT00494091|3622970|FG000|Overall Study|Withdrawal by Subject|0
2050921|NCT00494091|3622971|FG001|Overall Study|Withdrawal by Subject|7
2050922|NCT00494221|3622998|FG000|Overall Study|Death|15
2050923|NCT00494221|3622999|FG001|Overall Study|Death|9
2050924|NCT00494221|3623000|FG002|Overall Study|Death|14
2050925|NCT00494221|3622998|FG000|Overall Study|Withdrawal by Subject|1
2050926|NCT00494221|3622999|FG001|Overall Study|Withdrawal by Subject|2
2050927|NCT00494221|3623000|FG002|Overall Study|Withdrawal by Subject|0
2050928|NCT00494234|3623010|FG000|Overall Study|Lack of Efficacy|12
2050929|NCT00494234|3623011|FG001|Overall Study|Lack of Efficacy|9
2050930|NCT00494234|3623010|FG000|Overall Study|Withdrawal by Subject|1
2050931|NCT00494234|3623011|FG001|Overall Study|Withdrawal by Subject|0
2050932|NCT00494234|3623010|FG000|Overall Study|Death|2
2050933|NCT00494234|3623011|FG001|Overall Study|Death|1
2050934|NCT00494299|3623023|FG000|Overall Study|Adverse Event|93
2050935|NCT00494299|3623024|FG001|Overall Study|Adverse Event|13
2050936|NCT00494299|3623023|FG000|Overall Study|Lost to Follow-up|1
2050937|NCT00494299|3623024|FG001|Overall Study|Lost to Follow-up|0
2050938|NCT00494299|3623023|FG000|Overall Study|Physician Decision|0
2050939|NCT00494299|3623024|FG001|Overall Study|Physician Decision|2
2050940|NCT00494299|3623023|FG000|Overall Study|Protocol Violation|1
2050941|NCT00494299|3623024|FG001|Overall Study|Protocol Violation|2
2050942|NCT00494299|3623023|FG000|Overall Study|Withdrawal by Subject|8
2050943|NCT00494299|3623024|FG001|Overall Study|Withdrawal by Subject|3
2050944|NCT00494299|3623023|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109
2050945|NCT00494299|3623024|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185
2050946|NCT00494299|3623023|FG000|Overall Study|Participant Did Not Take Study Drug|0
2050947|NCT00494299|3623024|FG001|Overall Study|Participant Did Not Take Study Drug|2
2050948|NCT00494299|3623023|FG000|Overall Study|Site Closed by Sponsor|6
2208962|NCT01641809|3848437|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
2208963|NCT01641809|3848438|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
2208964|NCT01641809|3848435|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3
2208965|NCT01641809|3848436|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2
2208966|NCT01641809|3848437|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1
2208967|NCT01641809|3848438|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0
2208968|NCT01641822|3848458|FG000|Run-in Phase|Noncompliance with study drug|1
2208969|NCT01641822|3848459|FG001|Run-in Phase|Noncompliance with study drug|0
2217677|NCT01709305|3860932|FG004|Phase 1|Withdrawal by Subject|0
2050949|NCT00494299|3623024|FG001|Overall Study|Site Closed by Sponsor|0
2050950|NCT00494299|3623023|FG000|Overall Study|Protocol Driven Decision Point|11
2050951|NCT00494299|3623024|FG001|Overall Study|Protocol Driven Decision Point|22
2050952|NCT00494442|3623032|FG000|Overall Study|Death|1
2050953|NCT00494442|3623033|FG001|Overall Study|Death|1
2050954|NCT00494442|3623032|FG000|Overall Study|Lack of Efficacy|16
2050955|NCT00494442|3623033|FG001|Overall Study|Lack of Efficacy|10
2050956|NCT00494442|3623032|FG000|Overall Study|Adverse Event|0
2050957|NCT00494442|3623033|FG001|Overall Study|Adverse Event|2
2050958|NCT00494442|3623032|FG000|Overall Study|Physician Decision|0
2050959|NCT00494442|3623033|FG001|Overall Study|Physician Decision|1
2050960|NCT00494442|3623032|FG000|Overall Study|Non-compliance|0
2050961|NCT00494442|3623033|FG001|Overall Study|Non-compliance|1
2050962|NCT00494442|3623032|FG000|Overall Study|Intercurrent illness|0
2050963|NCT00494442|3623033|FG001|Overall Study|Intercurrent illness|1
2050964|NCT00494481|3623041|FG000|Overall Study|Condition under investigation worsened|11
2050965|NCT00494481|3623042|FG001|Overall Study|Condition under investigation worsened|13
2050966|NCT00494481|3623041|FG000|Overall Study|Adverse Event|15
2050967|NCT00494481|3623042|FG001|Overall Study|Adverse Event|11
2050968|NCT00494481|3623041|FG000|Overall Study|Other|1
2050969|NCT00494481|3623042|FG001|Overall Study|Other|0
2050970|NCT00494481|3623041|FG000|Overall Study|Never received IP|2
2050971|NCT00494481|3623042|FG001|Overall Study|Never received IP|0
2050972|NCT00494507|3623061|FG000|Double-Blind Phase|Adverse Event|2
2050973|NCT00494507|3623062|FG001|Double-Blind Phase|Adverse Event|0
2050974|NCT00494507|3623063|FG002|Double-Blind Phase|Adverse Event|1
2050975|NCT00494507|3623064|FG003|Double-Blind Phase|Adverse Event|0
2050976|NCT00494507|3623061|FG000|Double-Blind Phase|Withdrawal by Subject|1
2050977|NCT00494507|3623062|FG001|Double-Blind Phase|Withdrawal by Subject|0
2050978|NCT00494507|3623063|FG002|Double-Blind Phase|Withdrawal by Subject|0
2050979|NCT00494507|3623064|FG003|Double-Blind Phase|Withdrawal by Subject|0
2050980|NCT00494507|3623061|FG000|Double-Blind Phase|Subject Non-compliance|0
2050981|NCT00494507|3623062|FG001|Double-Blind Phase|Subject Non-compliance|0
2050982|NCT00494507|3623063|FG002|Double-Blind Phase|Subject Non-compliance|1
2050983|NCT00494507|3623064|FG003|Double-Blind Phase|Subject Non-compliance|0
2050984|NCT00494507|3623061|FG000|Double-Blind Phase|Negative DNA test|0
2050985|NCT00494507|3623062|FG001|Double-Blind Phase|Negative DNA test|0
2050986|NCT00494507|3623063|FG002|Double-Blind Phase|Negative DNA test|0
2050987|NCT00494507|3623064|FG003|Double-Blind Phase|Negative DNA test|1
2050988|NCT00494507|3623061|FG000|Open-Label Phase|Adverse Event|0
2050989|NCT00494507|3623062|FG001|Open-Label Phase|Adverse Event|1
2050990|NCT00494507|3623063|FG002|Open-Label Phase|Adverse Event|5
2050991|NCT00494507|3623064|FG003|Open-Label Phase|Adverse Event|3
2050992|NCT00494507|3623061|FG000|Open-Label Phase|Worsening Disease|0
2050993|NCT00494507|3623062|FG001|Open-Label Phase|Worsening Disease|0
2050994|NCT00494507|3623063|FG002|Open-Label Phase|Worsening Disease|0
2050995|NCT00494507|3623064|FG003|Open-Label Phase|Worsening Disease|2
2050996|NCT00494676|3623088|FG000|Allocation|Withdrawal by Subject|2
2050997|NCT00494676|3623089|FG001|Allocation|Withdrawal by Subject|4
2050998|NCT00494676|3623088|FG000|First Intervention|Withdrawal by Subject|1
2050999|NCT00494676|3623089|FG001|First Intervention|Withdrawal by Subject|3
2051000|NCT00494676|3623088|FG000|Second Intervention|Withdrawal by Subject|1
2051001|NCT00494676|3623089|FG001|Second Intervention|Withdrawal by Subject|1
2051002|NCT00494780|3623097|FG000|Overall Study|Adverse Event|1
2051003|NCT00494780|3623098|FG001|Overall Study|Adverse Event|0
2051004|NCT00494780|3623097|FG000|Overall Study|Withdrew before Dosed|0
2051005|NCT00494780|3623098|FG001|Overall Study|Withdrew before Dosed|1
2051006|NCT00494780|3623097|FG000|Overall Study|Progression of Study Disease|7
2051007|NCT00494780|3623098|FG001|Overall Study|Progression of Study Disease|8
2051008|NCT00494780|3623097|FG000|Overall Study|New Treatment|2
2051009|NCT00494780|3623098|FG001|Overall Study|New Treatment|2
2051010|NCT00494780|3623097|FG000|Overall Study|Non-compliance|1
2051011|NCT00494780|3623098|FG001|Overall Study|Non-compliance|0
2051012|NCT00494780|3623097|FG000|Overall Study|Residual Tumour Mass|0
2051013|NCT00494780|3623098|FG001|Overall Study|Residual Tumour Mass|1
2051014|NCT00494780|3623097|FG000|Overall Study|Insurance Issues|0
2051015|NCT00494780|3623098|FG001|Overall Study|Insurance Issues|1
2051016|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Adverse Event|73
2051017|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Adverse Event|70
2051018|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
2051019|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
2051020|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Death|8
2051021|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Death|3
2051022|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Physician Decision|4
2051023|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Physician Decision|13
2051024|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4
2051025|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1
2051026|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9
2051027|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9
2051028|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
2051029|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
2051030|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
2051031|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
2051032|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
2051033|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
2051034|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
2051035|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
2051036|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
2051037|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
2051038|NCT00494871|3623117|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
2051039|NCT00494871|3623118|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
2208970|NCT01641822|3848460|FG002|Run-in Phase|Noncompliance with study drug|0
2208971|NCT01641822|3848458|FG000|Run-in Phase|Adverse Event|3
2208972|NCT01641822|3848459|FG001|Run-in Phase|Adverse Event|0
2208973|NCT01641822|3848460|FG002|Run-in Phase|Adverse Event|0
2208974|NCT01641822|3848458|FG000|Run-in Phase|Withdrew consent|1
2208975|NCT01641822|3848459|FG001|Run-in Phase|Withdrew consent|0
2208976|NCT01641822|3848460|FG002|Run-in Phase|Withdrew consent|0
2208977|NCT01641822|3848458|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9
2208978|NCT01641822|3848459|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0
2208979|NCT01641822|3848460|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0
2208980|NCT01641822|3848458|FG000|Comparative Phase|Noncompliance with study drug|0
2208981|NCT01641822|3848459|FG001|Comparative Phase|Noncompliance with study drug|1
2208982|NCT01641822|3848460|FG002|Comparative Phase|Noncompliance with study drug|0
2208983|NCT01641822|3848458|FG000|Comparative Phase|Investigator's discretion|0
2208984|NCT01641822|3848459|FG001|Comparative Phase|Investigator's discretion|0
2208985|NCT01641822|3848460|FG002|Comparative Phase|Investigator's discretion|1
2208986|NCT01641822|3848458|FG000|Comparative Phase|Pregnancy|0
2208987|NCT01641822|3848459|FG001|Comparative Phase|Pregnancy|0
2208988|NCT01641822|3848460|FG002|Comparative Phase|Pregnancy|1
2208989|NCT01641822|3848458|FG000|Comparative Phase|Adverse event, serious fatal|0
2051040|NCT00494871|3623117|FG000|Follow-up (FU) Period|Adverse Event|1
2051041|NCT00494871|3623118|FG001|Follow-up (FU) Period|Adverse Event|1
2051042|NCT00494871|3623117|FG000|Follow-up (FU) Period|Death|13
2051043|NCT00494871|3623118|FG001|Follow-up (FU) Period|Death|12
2051044|NCT00494871|3623117|FG000|Follow-up (FU) Period|Lost to Follow-up|6
2051045|NCT00494871|3623118|FG001|Follow-up (FU) Period|Lost to Follow-up|2
2051046|NCT00494871|3623117|FG000|Follow-up (FU) Period|Physician Decision|0
2051047|NCT00494871|3623118|FG001|Follow-up (FU) Period|Physician Decision|1
2051048|NCT00494871|3623117|FG000|Follow-up (FU) Period|Protocol Violation|1
2051049|NCT00494871|3623118|FG001|Follow-up (FU) Period|Protocol Violation|0
2051050|NCT00494871|3623117|FG000|Follow-up (FU) Period|Withdrawal by Subject|5
2051051|NCT00494871|3623118|FG001|Follow-up (FU) Period|Withdrawal by Subject|5
2051052|NCT00494871|3623117|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3
2051053|NCT00494871|3623118|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2
2051054|NCT00495040|3623135|FG000|Overall Study|Withdrawal by Subject|3
2051055|NCT00495170|3623159|FG000|Overall Study|Lost to Follow-up|9
2051056|NCT00495170|3623159|FG000|Overall Study|Withdrawal by Subject|3
2051057|NCT00495170|3623159|FG000|Overall Study|Inappropriate staging|8
2051058|NCT00495391|3623165|FG000|Overall Study|Lack of Efficacy|34
2051059|NCT00495391|3623166|FG001|Overall Study|Lack of Efficacy|18
2051060|NCT00495391|3623165|FG000|Overall Study|Withdrawal by Subject|2
2051061|NCT00495391|3623166|FG001|Overall Study|Withdrawal by Subject|3
2051062|NCT00495469|3623179|FG000|Overall Study|Adverse Event|0
2051063|NCT00495469|3623180|FG001|Overall Study|Adverse Event|1
2051064|NCT00495469|3623181|FG002|Overall Study|Adverse Event|3
2051065|NCT00495469|3623182|FG003|Overall Study|Adverse Event|0
2051066|NCT00495469|3623183|FG004|Overall Study|Adverse Event|1
2051067|NCT00495469|3623184|FG005|Overall Study|Adverse Event|1
2208990|NCT01641822|3848459|FG001|Comparative Phase|Adverse event, serious fatal|1
2208991|NCT01641822|3848460|FG002|Comparative Phase|Adverse event, serious fatal|0
2208992|NCT01641822|3848458|FG000|Comparative Phase|Withdrew consent|0
2208993|NCT01641822|3848459|FG001|Comparative Phase|Withdrew consent|3
2208994|NCT01641822|3848460|FG002|Comparative Phase|Withdrew consent|7
2208995|NCT01641822|3848458|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0
2208996|NCT01641822|3848459|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1
2208997|NCT01641822|3848460|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1
2208998|NCT01641861|3848473|FG000|Overall Study|Lost to Follow-up|21
2208999|NCT01641861|3848474|FG001|Overall Study|Lost to Follow-up|16
2209000|NCT01641861|3848473|FG000|Overall Study|Lost the tooth due to normal exfoliation|14
2209001|NCT01641861|3848474|FG001|Overall Study|Lost the tooth due to normal exfoliation|8
2209002|NCT01641861|3848473|FG000|Overall Study|Died due to drowning|0
2209003|NCT01641861|3848474|FG001|Overall Study|Died due to drowning|1
2209004|NCT01641900|3848482|FG000|Overall Study|Withdrawal by Subject|2
2209005|NCT01641900|3848483|FG001|Overall Study|Withdrawal by Subject|2
2209006|NCT01641926|3848495|FG000|Overall Study|Adverse Event|5
2209007|NCT01641926|3848496|FG001|Overall Study|Adverse Event|2
2209008|NCT01641926|3848497|FG002|Overall Study|Adverse Event|3
2209009|NCT01641926|3848498|FG003|Overall Study|Adverse Event|1
2209010|NCT01641926|3848495|FG000|Overall Study|Lost to Follow-up|2
2209011|NCT01641926|3848496|FG001|Overall Study|Lost to Follow-up|2
2209012|NCT01641926|3848497|FG002|Overall Study|Lost to Follow-up|1
2209013|NCT01641926|3848498|FG003|Overall Study|Lost to Follow-up|0
2299822|NCT02589665|3996957|FG009|Induction Extension Period|Physician Decision|0
2299823|NCT02589665|3996948|FG000|Induction Extension Period|Reason Not Collected|0
2299824|NCT02589665|3996949|FG001|Induction Extension Period|Reason Not Collected|0
2299825|NCT02589665|3996950|FG002|Induction Extension Period|Reason Not Collected|0
2299826|NCT02589665|3996951|FG003|Induction Extension Period|Reason Not Collected|0
2299827|NCT02589665|3996952|FG004|Induction Extension Period|Reason Not Collected|0
2299828|NCT02589665|3996953|FG005|Induction Extension Period|Reason Not Collected|0
2299829|NCT02589665|3996954|FG006|Induction Extension Period|Reason Not Collected|0
2299830|NCT02589665|3996955|FG007|Induction Extension Period|Reason Not Collected|0
2299831|NCT02589665|3996956|FG008|Induction Extension Period|Reason Not Collected|1
2299832|NCT02589665|3996957|FG009|Induction Extension Period|Reason Not Collected|0
2299833|NCT02589665|3996948|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2299834|NCT02589665|3996949|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2299835|NCT02589665|3996950|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2299836|NCT02589665|3996951|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2299837|NCT02589665|3996952|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2299838|NCT02589665|3996953|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2051068|NCT00495469|3623185|FG006|Overall Study|Adverse Event|1
2209014|NCT01641926|3848495|FG000|Overall Study|Physician Decision|6
2209015|NCT01641926|3848496|FG001|Overall Study|Physician Decision|5
2299839|NCT02589665|3996954|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2051069|NCT00495469|3623179|FG000|Overall Study|Lost to Follow-up|1
2209016|NCT01641926|3848497|FG002|Overall Study|Physician Decision|0
2209017|NCT01641926|3848498|FG003|Overall Study|Physician Decision|1
2209018|NCT01641926|3848495|FG000|Overall Study|Protocol Violation|1
2209019|NCT01641926|3848496|FG001|Overall Study|Protocol Violation|0
2209020|NCT01641926|3848497|FG002|Overall Study|Protocol Violation|0
2209021|NCT01641926|3848498|FG003|Overall Study|Protocol Violation|1
2209022|NCT01641926|3848495|FG000|Overall Study|Withdrawal by Subject|13
2209023|NCT01641926|3848496|FG001|Overall Study|Withdrawal by Subject|5
2209024|NCT01641926|3848497|FG002|Overall Study|Withdrawal by Subject|6
2209025|NCT01641926|3848498|FG003|Overall Study|Withdrawal by Subject|1
2209026|NCT01641926|3848495|FG000|Overall Study|Not Treated|1
2209027|NCT01641926|3848496|FG001|Overall Study|Not Treated|1
2209028|NCT01641926|3848497|FG002|Overall Study|Not Treated|1
2209029|NCT01641926|3848498|FG003|Overall Study|Not Treated|0
2209030|NCT01641939|3848511|FG000|Overall Study|Death|90
2209031|NCT01641939|3848512|FG001|Overall Study|Death|187
2209032|NCT01641939|3848513|FG002|Overall Study|Death|61
2209033|NCT01641939|3848511|FG000|Overall Study|Lost to Follow-up|3
2209034|NCT01641939|3848512|FG001|Overall Study|Lost to Follow-up|2
2209035|NCT01641939|3848513|FG002|Overall Study|Lost to Follow-up|1
2209036|NCT01641939|3848511|FG000|Overall Study|Withdrawal by Subject|14
2209037|NCT01641939|3848512|FG001|Overall Study|Withdrawal by Subject|11
2209038|NCT01641939|3848513|FG002|Overall Study|Withdrawal by Subject|5
2209039|NCT01641939|3848511|FG000|Overall Study|Study Terminated by Sponsor|10
2209040|NCT01641939|3848512|FG001|Overall Study|Study Terminated by Sponsor|28
2209041|NCT01641939|3848513|FG002|Overall Study|Study Terminated by Sponsor|3
2209042|NCT01641952|3848523|FG000|Overall Study|Lost to Follow-up|28
2209043|NCT01641952|3848523|FG000|Overall Study|Adverse Event|6
2209044|NCT01641991|3848539|FG000|Overall Study|Physician Decision|0
2209045|NCT01641991|3848540|FG001|Overall Study|Physician Decision|1
2209046|NCT01641991|3848541|FG002|Overall Study|Physician Decision|7
2209047|NCT01641991|3848542|FG003|Overall Study|Physician Decision|5
2209048|NCT01641991|3848539|FG000|Overall Study|Withdrawal by Subject|4
2209049|NCT01641991|3848540|FG001|Overall Study|Withdrawal by Subject|2
2051070|NCT00495469|3623180|FG001|Overall Study|Lost to Follow-up|1
2051071|NCT00495469|3623181|FG002|Overall Study|Lost to Follow-up|3
2051072|NCT00495469|3623182|FG003|Overall Study|Lost to Follow-up|1
2051073|NCT00495469|3623183|FG004|Overall Study|Lost to Follow-up|0
2051074|NCT00495469|3623184|FG005|Overall Study|Lost to Follow-up|0
2051075|NCT00495469|3623185|FG006|Overall Study|Lost to Follow-up|0
2051076|NCT00495469|3623179|FG000|Overall Study|Protocol Violation|0
2051077|NCT00495469|3623180|FG001|Overall Study|Protocol Violation|0
2051078|NCT00495469|3623181|FG002|Overall Study|Protocol Violation|0
2051079|NCT00495469|3623182|FG003|Overall Study|Protocol Violation|0
2051080|NCT00495469|3623183|FG004|Overall Study|Protocol Violation|1
2051081|NCT00495469|3623184|FG005|Overall Study|Protocol Violation|2
2051082|NCT00495469|3623185|FG006|Overall Study|Protocol Violation|0
2051083|NCT00495469|3623179|FG000|Overall Study|Withdrawal by Subject|5
2051084|NCT00495469|3623180|FG001|Overall Study|Withdrawal by Subject|3
2051085|NCT00495469|3623181|FG002|Overall Study|Withdrawal by Subject|1
2051086|NCT00495469|3623182|FG003|Overall Study|Withdrawal by Subject|3
2051087|NCT00495469|3623183|FG004|Overall Study|Withdrawal by Subject|3
2051088|NCT00495469|3623184|FG005|Overall Study|Withdrawal by Subject|2
2051089|NCT00495469|3623185|FG006|Overall Study|Withdrawal by Subject|3
2051090|NCT00495469|3623179|FG000|Overall Study|Lack of Efficacy|0
2051091|NCT00495469|3623180|FG001|Overall Study|Lack of Efficacy|0
2051092|NCT00495469|3623181|FG002|Overall Study|Lack of Efficacy|0
2051093|NCT00495469|3623182|FG003|Overall Study|Lack of Efficacy|0
2051094|NCT00495469|3623183|FG004|Overall Study|Lack of Efficacy|0
2051095|NCT00495469|3623184|FG005|Overall Study|Lack of Efficacy|0
2051096|NCT00495469|3623185|FG006|Overall Study|Lack of Efficacy|1
2051097|NCT00495469|3623179|FG000|Overall Study|Liver function test abnormality|0
2051098|NCT00495469|3623180|FG001|Overall Study|Liver function test abnormality|1
2051099|NCT00495469|3623181|FG002|Overall Study|Liver function test abnormality|0
2051100|NCT00495469|3623182|FG003|Overall Study|Liver function test abnormality|0
2051101|NCT00495469|3623183|FG004|Overall Study|Liver function test abnormality|0
2051102|NCT00495469|3623184|FG005|Overall Study|Liver function test abnormality|0
2051103|NCT00495469|3623185|FG006|Overall Study|Liver function test abnormality|0
2051104|NCT00495469|3623179|FG000|Overall Study|ST depression at randomisation in ECG|0
2051105|NCT00495469|3623180|FG001|Overall Study|ST depression at randomisation in ECG|1
2051106|NCT00495469|3623181|FG002|Overall Study|ST depression at randomisation in ECG|0
2051107|NCT00495469|3623182|FG003|Overall Study|ST depression at randomisation in ECG|0
2051108|NCT00495469|3623183|FG004|Overall Study|ST depression at randomisation in ECG|0
2051109|NCT00495469|3623184|FG005|Overall Study|ST depression at randomisation in ECG|0
2051110|NCT00495469|3623185|FG006|Overall Study|ST depression at randomisation in ECG|0
2051111|NCT00495495|3623208|FG000|Overall Study|Protocol Violation|99
2209050|NCT01641991|3848541|FG002|Overall Study|Withdrawal by Subject|1
2209051|NCT01641991|3848542|FG003|Overall Study|Withdrawal by Subject|5
2209052|NCT01641991|3848539|FG000|Overall Study|Adverse Event|2
2209053|NCT01641991|3848540|FG001|Overall Study|Adverse Event|1
2209054|NCT01641991|3848541|FG002|Overall Study|Adverse Event|2
2209055|NCT01641991|3848542|FG003|Overall Study|Adverse Event|1
2209056|NCT01641991|3848539|FG000|Overall Study|Lost to Follow-up|0
2209057|NCT01641991|3848540|FG001|Overall Study|Lost to Follow-up|2
2051112|NCT00495521|3623215|FG000|Overall Study|Physician Decision|0
2051113|NCT00495521|3623216|FG001|Overall Study|Physician Decision|1
2051114|NCT00495586|3623224|FG000|Overall Study|Withdrawal by Subject|4
2051115|NCT00495586|3623225|FG001|Overall Study|Withdrawal by Subject|4
2051116|NCT00495612|3623235|FG000|Overall Study|Lost to Follow-up|1
2051117|NCT00495612|3623236|FG001|Overall Study|Lost to Follow-up|0
2051118|NCT00495612|3623235|FG000|Overall Study|Subject's Decision to Withdraw|3
2051119|NCT00495612|3623236|FG001|Overall Study|Subject's Decision to Withdraw|0
2051120|NCT00495625|3623242|FG000|Overall Study|Did not complete at least 1 42 day cycle|10
2051121|NCT00495677|3623253|FG000|Stage 1 (25 Days)|Adverse Event|0
2051122|NCT00495677|3623254|FG001|Stage 1 (25 Days)|Adverse Event|0
2051123|NCT00495677|3623255|FG002|Stage 1 (25 Days)|Adverse Event|1
2051124|NCT00495677|3623256|FG003|Stage 1 (25 Days)|Adverse Event|0
2051125|NCT00495677|3623257|FG004|Stage 1 (25 Days)|Adverse Event|0
2051126|NCT00495677|3623258|FG005|Stage 1 (25 Days)|Adverse Event|0
2051127|NCT00495677|3623259|FG006|Stage 1 (25 Days)|Adverse Event|0
2051128|NCT00495755|3623275|FG000|Overall Study|Adverse Event|3
2051129|NCT00495794|3623282|FG000|Overall Study|Pharmacist did not activate patient|522
2051130|NCT00495794|3623283|FG001|Overall Study|Pharmacist did not activate patient|0
2051131|NCT00495820|3623291|FG000|Overall Study|Adverse Event|1
2051132|NCT00495820|3623292|FG001|Overall Study|Adverse Event|1
2051133|NCT00496015|3623303|FG000|Overall Study|Other|1
2051134|NCT00496015|3623304|FG001|Overall Study|Other|0
2051135|NCT00496015|3623305|FG002|Overall Study|Other|0
2051136|NCT00496015|3623306|FG003|Overall Study|Other|1
2051137|NCT00496015|3623307|FG004|Overall Study|Other|0
2051138|NCT00496054|3623327|FG000|Overall Study|Adverse Event|1
2051139|NCT00496054|3623327|FG000|Overall Study|Lost to Follow-up|7
2051140|NCT00496080|3623331|FG000|Overall Study|Lost to Follow-up|9
2051141|NCT00496080|3623331|FG000|Overall Study|Surgical re-intervention|7
2051142|NCT00496080|3623331|FG000|Overall Study|Withdrawal by Subject|5
2051143|NCT00496080|3623331|FG000|Overall Study|Physician Decision|6
2051144|NCT00496197|3623336|FG000|Overall Study|Discontinued study due to death|43
2051145|NCT00496197|3623336|FG000|Overall Study|Adverse Event|13
2051146|NCT00496197|3623336|FG000|Overall Study|Does not meet entrance criteria|5
2051147|NCT00496197|3623336|FG000|Overall Study|Insufficient clinical response|3
2051148|NCT00496197|3623336|FG000|Overall Study|Insufficient bacteriological response|10
2051149|NCT00496197|3623336|FG000|Overall Study|Lost to Follow-up|11
2051150|NCT00496197|3623336|FG000|Overall Study|Withdrawal by Subject|11
2051151|NCT00496197|3623336|FG000|Overall Study|Pathogen not isolated baseline specimen|4
2051152|NCT00496197|3623336|FG000|Overall Study|Other|14
2051153|NCT00496197|3623336|FG000|Overall Study|Protocol Violation|8
2051154|NCT00496366|3623350|FG000|Overall Study|Death|1
2051155|NCT00496470|3623360|FG000|Overall Study|Adverse Event|8
2051156|NCT00496470|3623361|FG001|Overall Study|Adverse Event|10
2051157|NCT00496470|3623360|FG000|Overall Study|Withdrawal by Subject|5
2051158|NCT00496470|3623361|FG001|Overall Study|Withdrawal by Subject|12
2209058|NCT01641991|3848541|FG002|Overall Study|Lost to Follow-up|3
2209059|NCT01641991|3848542|FG003|Overall Study|Lost to Follow-up|1
2209060|NCT01641991|3848539|FG000|Overall Study|Protocol Violation|1
2299840|NCT02589665|3996955|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2299841|NCT02589665|3996956|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2299842|NCT02589665|3996957|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
2299843|NCT02589665|3996948|FG000|Maintenance Extension Period|Withdrawal by Subject|0
2299844|NCT02589665|3996949|FG001|Maintenance Extension Period|Withdrawal by Subject|0
2299845|NCT02589665|3996950|FG002|Maintenance Extension Period|Withdrawal by Subject|0
2299846|NCT02589665|3996951|FG003|Maintenance Extension Period|Withdrawal by Subject|0
2299847|NCT02589665|3996952|FG004|Maintenance Extension Period|Withdrawal by Subject|0
2299848|NCT02589665|3996953|FG005|Maintenance Extension Period|Withdrawal by Subject|0
2299849|NCT02589665|3996954|FG006|Maintenance Extension Period|Withdrawal by Subject|0
2299850|NCT02589665|3996955|FG007|Maintenance Extension Period|Withdrawal by Subject|0
2299851|NCT02589665|3996956|FG008|Maintenance Extension Period|Withdrawal by Subject|0
2299852|NCT02589665|3996957|FG009|Maintenance Extension Period|Withdrawal by Subject|4
2299853|NCT02589665|3996948|FG000|Maintenance Extension Period|Lack of Efficacy|0
2299854|NCT02589665|3996949|FG001|Maintenance Extension Period|Lack of Efficacy|0
2299855|NCT02589665|3996950|FG002|Maintenance Extension Period|Lack of Efficacy|0
2299856|NCT02589665|3996951|FG003|Maintenance Extension Period|Lack of Efficacy|0
2299857|NCT02589665|3996952|FG004|Maintenance Extension Period|Lack of Efficacy|0
2299858|NCT02589665|3996953|FG005|Maintenance Extension Period|Lack of Efficacy|0
2299859|NCT02589665|3996954|FG006|Maintenance Extension Period|Lack of Efficacy|0
2299860|NCT02589665|3996955|FG007|Maintenance Extension Period|Lack of Efficacy|0
2299861|NCT02589665|3996956|FG008|Maintenance Extension Period|Lack of Efficacy|0
2299862|NCT02589665|3996957|FG009|Maintenance Extension Period|Lack of Efficacy|4
2299863|NCT02589665|3996948|FG000|Maintenance Extension Period|Adverse Event|0
2299864|NCT02589665|3996949|FG001|Maintenance Extension Period|Adverse Event|0
2051159|NCT00496470|3623360|FG000|Overall Study|Incorrectly enrolled|13
2051160|NCT00496470|3623361|FG001|Overall Study|Incorrectly enrolled|5
2299865|NCT02589665|3996950|FG002|Maintenance Extension Period|Adverse Event|0
2299866|NCT02589665|3996951|FG003|Maintenance Extension Period|Adverse Event|0
2353771|NCT02054910|4107098|FG000|Overall Study|Lost to Follow-up|4
2209061|NCT01641991|3848540|FG001|Overall Study|Protocol Violation|1
2209062|NCT01641991|3848541|FG002|Overall Study|Protocol Violation|3
2209063|NCT01641991|3848542|FG003|Overall Study|Protocol Violation|0
2209064|NCT01641991|3848539|FG000|Overall Study|Pregnancy|0
2209065|NCT01641991|3848540|FG001|Overall Study|Pregnancy|0
2209066|NCT01641991|3848541|FG002|Overall Study|Pregnancy|1
2209067|NCT01641991|3848542|FG003|Overall Study|Pregnancy|0
2209068|NCT01641991|3848539|FG000|Overall Study|no longer eligible|2
2209069|NCT01641991|3848540|FG001|Overall Study|no longer eligible|1
2299867|NCT02589665|3996952|FG004|Maintenance Extension Period|Adverse Event|0
2051161|NCT00496470|3623360|FG000|Overall Study|Other reason|0
2051162|NCT00496470|3623361|FG001|Overall Study|Other reason|2
2051163|NCT00496483|3623367|FG000|Overall Study|Not dosed|9
2051164|NCT00496483|3623367|FG000|Overall Study|Adverse Event|2
2051165|NCT00496483|3623367|FG000|Overall Study|Lack of Efficacy|1
2051166|NCT00496587|3623374|FG000|Overall Study|Adverse Event|2
2051167|NCT00496587|3623374|FG000|Overall Study|Progressive Disease|24
2051168|NCT00496587|3623374|FG000|Overall Study|Withdrawal by Subject|2
2051169|NCT00496587|3623374|FG000|Overall Study|Death|1
2051170|NCT00496587|3623374|FG000|Overall Study|Complications unrelated|2
2051171|NCT00496626|3623380|FG000|Overall Study|Lost to Follow-up|0
2051172|NCT00496626|3623381|FG001|Overall Study|Lost to Follow-up|1
2051173|NCT00496626|3623380|FG000|Overall Study|Protocol Violation|1
2051174|NCT00496626|3623381|FG001|Overall Study|Protocol Violation|0
2051175|NCT00496626|3623380|FG000|Overall Study|Withdrawal by Subject|5
2051176|NCT00496626|3623381|FG001|Overall Study|Withdrawal by Subject|4
2051177|NCT00496626|3623380|FG000|Overall Study|Relocated|0
2051178|NCT00496626|3623381|FG001|Overall Study|Relocated|1
2051179|NCT00496769|3623393|FG000|Double Blind|>=1 reason assigned per patient|558
2051180|NCT00496769|3623394|FG001|Double Blind|>=1 reason assigned per patient|649
2051181|NCT00496769|3623395|FG002|Double Blind|>=1 reason assigned per patient|0
2051182|NCT00496769|3623393|FG000|Open Label|>=1 reason assigned per patient|0
2051183|NCT00496769|3623394|FG001|Open Label|>=1 reason assigned per patient|0
2051184|NCT00496769|3623395|FG002|Open Label|>=1 reason assigned per patient|1011
2051185|NCT00496873|3623421|FG000|Overall Study|Ineligible|2
2051186|NCT00496873|3623421|FG000|Overall Study|Death|2
2051187|NCT00496873|3623421|FG000|Overall Study|Withdrawal by Subject|3
2051188|NCT00496964|3623427|FG000|Overall Study|Withdrawal by Subject|0
2051189|NCT00496964|3623428|FG001|Overall Study|Withdrawal by Subject|1
2051190|NCT00497146|3623456|FG000|Treatment Period|Adverse Event|6
2051191|NCT00497146|3623457|FG001|Treatment Period|Adverse Event|2
2051192|NCT00497146|3623456|FG000|Treatment Period|Withdrawal by Subject|5
2051193|NCT00497146|3623457|FG001|Treatment Period|Withdrawal by Subject|9
2051194|NCT00497146|3623456|FG000|Treatment Period|Lost to Follow-up|1
2051195|NCT00497146|3623457|FG001|Treatment Period|Lost to Follow-up|3
2051196|NCT00497146|3623456|FG000|Treatment Period|Required dialysis|4
2051197|NCT00497146|3623457|FG001|Treatment Period|Required dialysis|1
2051198|NCT00497146|3623456|FG000|Treatment Period|Change in RAAS inhibitor therapy|5
2051199|NCT00497146|3623457|FG001|Treatment Period|Change in RAAS inhibitor therapy|2
2051200|NCT00497146|3623456|FG000|Treatment Period|Unable to dose reduce per protocol|4
2051201|NCT00497146|3623457|FG001|Treatment Period|Unable to dose reduce per protocol|1
2051202|NCT00497146|3623456|FG000|Treatment Period|Other Reason|2
2051203|NCT00497146|3623457|FG001|Treatment Period|Other Reason|3
2051204|NCT00497146|3623456|FG000|Long-term Follow-up Period|Adverse Event|2
2051205|NCT00497146|3623457|FG001|Long-term Follow-up Period|Adverse Event|2
2051206|NCT00497146|3623456|FG000|Long-term Follow-up Period|Withdrawal by Subject|8
2051207|NCT00497146|3623457|FG001|Long-term Follow-up Period|Withdrawal by Subject|2
2051208|NCT00497146|3623456|FG000|Long-term Follow-up Period|Lost to Follow-up|5
2051209|NCT00497146|3623457|FG001|Long-term Follow-up Period|Lost to Follow-up|1
2051210|NCT00497146|3623456|FG000|Long-term Follow-up Period|Other|0
2051211|NCT00497146|3623457|FG001|Long-term Follow-up Period|Other|1
2299868|NCT02589665|3996953|FG005|Maintenance Extension Period|Adverse Event|0
2299869|NCT02589665|3996954|FG006|Maintenance Extension Period|Adverse Event|0
2299870|NCT02589665|3996955|FG007|Maintenance Extension Period|Adverse Event|0
2299871|NCT02589665|3996956|FG008|Maintenance Extension Period|Adverse Event|0
2299872|NCT02589665|3996957|FG009|Maintenance Extension Period|Adverse Event|2
2299873|NCT02589665|3996948|FG000|Maintenance Extension Period|Non-responder|0
2299874|NCT02589665|3996949|FG001|Maintenance Extension Period|Non-responder|0
2299875|NCT02589665|3996950|FG002|Maintenance Extension Period|Non-responder|0
2299876|NCT02589665|3996951|FG003|Maintenance Extension Period|Non-responder|0
2299877|NCT02589665|3996952|FG004|Maintenance Extension Period|Non-responder|0
2299878|NCT02589665|3996953|FG005|Maintenance Extension Period|Non-responder|0
2299879|NCT02589665|3996954|FG006|Maintenance Extension Period|Non-responder|0
2299880|NCT02589665|3996955|FG007|Maintenance Extension Period|Non-responder|0
2299881|NCT02589665|3996956|FG008|Maintenance Extension Period|Non-responder|0
2299882|NCT02589665|3996957|FG009|Maintenance Extension Period|Non-responder|1
2051212|NCT00497198|3623467|FG000|Overall Study|Adverse Event|4
2051213|NCT00497198|3623468|FG001|Overall Study|Adverse Event|2
2051214|NCT00497198|3623467|FG000|Overall Study|Physician Decision|1
2051215|NCT00497198|3623468|FG001|Overall Study|Physician Decision|2
2051216|NCT00497198|3623467|FG000|Overall Study|Withdrawal by Subject|0
2209070|NCT01641991|3848541|FG002|Overall Study|no longer eligible|0
2051217|NCT00497198|3623468|FG001|Overall Study|Withdrawal by Subject|1
2051218|NCT00497796|3623505|FG000|Overall Study|Adverse event (not related)|9
2051219|NCT00497796|3623506|FG001|Overall Study|Adverse event (not related)|9
2051220|NCT00497796|3623505|FG000|Overall Study|Adverse event (related)|5
2051221|NCT00497796|3623506|FG001|Overall Study|Adverse event (related)|4
2051222|NCT00497796|3623505|FG000|Overall Study|CMV infection or disease treatment|30
2051223|NCT00497796|3623506|FG001|Overall Study|CMV infection or disease treatment|4
2209071|NCT01641991|3848542|FG003|Overall Study|no longer eligible|4
2209072|NCT01642212|3848586|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
2209073|NCT01642212|3848587|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2209074|NCT01642212|3848588|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2209075|NCT01642212|3848589|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2051224|NCT00497796|3623505|FG000|Overall Study|Consent withdrawn|10
2051225|NCT00497796|3623506|FG001|Overall Study|Consent withdrawn|3
2051226|NCT00497796|3623505|FG000|Overall Study|Investigator/sponsor discretion|31
2051227|NCT00497796|3623506|FG001|Overall Study|Investigator/sponsor discretion|34
2051228|NCT00497796|3623505|FG000|Overall Study|Lost to Follow-up|0
2051229|NCT00497796|3623506|FG001|Overall Study|Lost to Follow-up|1
2051230|NCT00497796|3623505|FG000|Overall Study|Not applicable (randomized not treated)|0
2051231|NCT00497796|3623506|FG001|Overall Study|Not applicable (randomized not treated)|4
2051232|NCT00497874|3623514|FG000|Overall Study|Withdrawal by Subject|48
2051233|NCT00497874|3623515|FG001|Overall Study|Withdrawal by Subject|17
2051234|NCT00497874|3623514|FG000|Overall Study|Illness|8
2051235|NCT00497874|3623515|FG001|Overall Study|Illness|4
2051236|NCT00497874|3623514|FG000|Overall Study|Death|2
2051237|NCT00497874|3623515|FG001|Overall Study|Death|4
2051238|NCT00497874|3623514|FG000|Overall Study|Unable to contact|52
2051239|NCT00497874|3623515|FG001|Overall Study|Unable to contact|67
2051240|NCT00497874|3623514|FG000|Overall Study|Unable to schedule|37
2051241|NCT00497874|3623515|FG001|Overall Study|Unable to schedule|24
2051242|NCT00498173|3623525|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
2051243|NCT00498173|3623526|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
2051244|NCT00498173|3623527|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
2051245|NCT00498186|3623535|FG000|Overall Study|Protocol Violation|10
2051246|NCT00498186|3623535|FG000|Overall Study|Lack of Efficacy|31
2051247|NCT00498186|3623535|FG000|Overall Study|Adverse Event|89
2051248|NCT00498186|3623535|FG000|Overall Study|Unsatisfactory compliance of subject|12
2051249|NCT00498186|3623535|FG000|Overall Study|Withdrawal by Subject|18
2051250|NCT00498186|3623535|FG000|Overall Study|Lost to Follow-up|3
2051251|NCT00498186|3623535|FG000|Overall Study|Other|10
2051252|NCT00498355|3623539|FG000|Overall Study|Lost to Follow-up|1
2105305|NCT00856544|3697847|FG002|Overall Study|Lack of Efficacy|3
2105306|NCT00856544|3697848|FG003|Overall Study|Lack of Efficacy|3
2105307|NCT00856544|3697845|FG000|Overall Study|Other|9
2105308|NCT00856544|3697846|FG001|Overall Study|Other|16
2105309|NCT00856544|3697847|FG002|Overall Study|Other|1
2105310|NCT00856544|3697848|FG003|Overall Study|Other|6
2105311|NCT00856544|3697845|FG000|Overall Study|Lost to Follow-up|1
2105312|NCT00856544|3697846|FG001|Overall Study|Lost to Follow-up|2
2105313|NCT00856544|3697847|FG002|Overall Study|Lost to Follow-up|2
2105314|NCT00856544|3697848|FG003|Overall Study|Lost to Follow-up|0
2105315|NCT00856544|3697845|FG000|Overall Study|Withdrawal by Subject|8
2105316|NCT00856544|3697846|FG001|Overall Study|Withdrawal by Subject|5
2105317|NCT00856544|3697847|FG002|Overall Study|Withdrawal by Subject|0
2105318|NCT00856544|3697848|FG003|Overall Study|Withdrawal by Subject|1
2105319|NCT00856557|3697872|FG000|Overall Study|No patients with contextual flags|12
2105320|NCT00856557|3697873|FG001|Overall Study|No patients with contextual flags|16
2105321|NCT00856583|3697881|FG000|Overall Study|Lack of Efficacy|389
2105322|NCT00856583|3697882|FG001|Overall Study|Lack of Efficacy|377
2105323|NCT00856583|3697881|FG000|Overall Study|Serious Adverse Event (SAE)|99
2105324|NCT00856583|3697882|FG001|Overall Study|Serious Adverse Event (SAE)|65
2105325|NCT00856583|3697881|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
2105326|NCT00856583|3697882|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
2105327|NCT00856583|3697881|FG000|Overall Study|Non-compliance|305
2105328|NCT00856583|3697882|FG001|Overall Study|Non-compliance|262
2105329|NCT00856583|3697881|FG000|Overall Study|Withdrawal by Subject|1092
2105330|NCT00856583|3697882|FG001|Overall Study|Withdrawal by Subject|919
2105331|NCT00856583|3697881|FG000|Overall Study|Physician Decision|59
2105332|NCT00856583|3697882|FG001|Overall Study|Physician Decision|82
2105333|NCT00856583|3697881|FG000|Overall Study|Pregnancy|14
2105334|NCT00856583|3697882|FG001|Overall Study|Pregnancy|5
2105335|NCT00856583|3697881|FG000|Overall Study|Other|92
2105336|NCT00856583|3697882|FG001|Overall Study|Other|104
2105337|NCT00856583|3697881|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694
2105338|NCT00856583|3697882|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604
2105339|NCT00856609|3697890|FG000|Overall Study|Adverse Event|1
2105340|NCT00856609|3697891|FG001|Overall Study|Adverse Event|0
2105341|NCT00856635|3697899|FG000|Overall Study|Lost to Follow-up|2
2105342|NCT00856635|3697900|FG001|Overall Study|Lost to Follow-up|5
2105343|NCT00856635|3697899|FG000|Overall Study|Pregnancy|1
2105344|NCT00856635|3697900|FG001|Overall Study|Pregnancy|0
2105345|NCT00856635|3697899|FG000|Overall Study|Withdrawal by Subject|3
2105346|NCT00856635|3697900|FG001|Overall Study|Withdrawal by Subject|1
2051253|NCT00498368|3623546|FG000|Overall Study|Withdrawal by Subject|3
2051254|NCT00498368|3623547|FG001|Overall Study|Withdrawal by Subject|2
2051255|NCT00498433|3623556|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
2051256|NCT00498433|3623557|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
2051257|NCT00498433|3623558|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
2051258|NCT00498433|3623556|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
2051259|NCT00498433|3623557|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
2051260|NCT00498433|3623558|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
2051261|NCT00498433|3623556|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
2051262|NCT00498433|3623557|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
2051263|NCT00498433|3623558|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
2051264|NCT00498433|3623556|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
2051265|NCT00498433|3623557|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
2051266|NCT00498433|3623558|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
2051267|NCT00498485|3623577|FG000|Overall Study|Adverse Event|1
2051268|NCT00498485|3623578|FG001|Overall Study|Adverse Event|5
2051269|NCT00498602|3623602|FG000|Overall Study|Death|0
2051270|NCT00498602|3623603|FG001|Overall Study|Death|0
2051271|NCT00498602|3623604|FG002|Overall Study|Death|0
2051272|NCT00498602|3623605|FG003|Overall Study|Death|0
2051273|NCT00498602|3623606|FG004|Overall Study|Death|0
2051274|NCT00498602|3623607|FG005|Overall Study|Death|1
2051275|NCT00498602|3623608|FG006|Overall Study|Death|0
2051276|NCT00498602|3623602|FG000|Overall Study|Lack of Efficacy|1
2051277|NCT00498602|3623603|FG001|Overall Study|Lack of Efficacy|0
2051278|NCT00498602|3623604|FG002|Overall Study|Lack of Efficacy|0
2051279|NCT00498602|3623605|FG003|Overall Study|Lack of Efficacy|0
2051280|NCT00498602|3623606|FG004|Overall Study|Lack of Efficacy|0
2051281|NCT00498602|3623607|FG005|Overall Study|Lack of Efficacy|0
2051282|NCT00498602|3623608|FG006|Overall Study|Lack of Efficacy|0
2051283|NCT00498602|3623602|FG000|Overall Study|Lost to Follow-up|0
2051284|NCT00498602|3623603|FG001|Overall Study|Lost to Follow-up|2
2051285|NCT00498602|3623604|FG002|Overall Study|Lost to Follow-up|0
2051286|NCT00498602|3623605|FG003|Overall Study|Lost to Follow-up|2
2051287|NCT00498602|3623606|FG004|Overall Study|Lost to Follow-up|0
2051288|NCT00498602|3623607|FG005|Overall Study|Lost to Follow-up|0
2051289|NCT00498602|3623608|FG006|Overall Study|Lost to Follow-up|0
2051290|NCT00498602|3623602|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
2051291|NCT00498602|3623603|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
2051292|NCT00498602|3623604|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
2051293|NCT00498602|3623605|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
2051294|NCT00498602|3623606|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
2051295|NCT00498602|3623607|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
2051296|NCT00498602|3623608|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
2051297|NCT00498602|3623602|FG000|Overall Study|AE not related to Study Drug|1
2051298|NCT00498602|3623603|FG001|Overall Study|AE not related to Study Drug|3
2209076|NCT01642212|3848590|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2209077|NCT01642212|3848586|FG000|Double-blind Treatment|Other|0
2209078|NCT01642212|3848587|FG001|Double-blind Treatment|Other|2
2209079|NCT01642212|3848588|FG002|Double-blind Treatment|Other|1
2209080|NCT01642212|3848589|FG003|Double-blind Treatment|Other|0
2209081|NCT01642212|3848590|FG004|Double-blind Treatment|Other|0
2209082|NCT01642212|3848586|FG000|Double-blind Treatment|Non-compliance|0
2209083|NCT01642212|3848587|FG001|Double-blind Treatment|Non-compliance|1
2209084|NCT01642212|3848588|FG002|Double-blind Treatment|Non-compliance|0
2209085|NCT01642212|3848589|FG003|Double-blind Treatment|Non-compliance|0
2209086|NCT01642212|3848590|FG004|Double-blind Treatment|Non-compliance|0
2209087|NCT01642212|3848586|FG000|Double-blind Treatment|Adverse Event|0
2209088|NCT01642212|3848587|FG001|Double-blind Treatment|Adverse Event|0
2209089|NCT01642212|3848588|FG002|Double-blind Treatment|Adverse Event|1
2209090|NCT01642212|3848589|FG003|Double-blind Treatment|Adverse Event|0
2209091|NCT01642212|3848590|FG004|Double-blind Treatment|Adverse Event|0
2209092|NCT01642212|3848586|FG000|Open-label Extension|Adverse Event|0
2209093|NCT01642212|3848587|FG001|Open-label Extension|Adverse Event|0
2209094|NCT01642212|3848588|FG002|Open-label Extension|Adverse Event|0
2209095|NCT01642212|3848589|FG003|Open-label Extension|Adverse Event|3
2209096|NCT01642212|3848590|FG004|Open-label Extension|Adverse Event|0
2209097|NCT01642212|3848586|FG000|Open-label Extension|Sponsor Decision|0
2209098|NCT01642212|3848587|FG001|Open-label Extension|Sponsor Decision|0
2209099|NCT01642212|3848588|FG002|Open-label Extension|Sponsor Decision|0
2051299|NCT00498602|3623604|FG002|Overall Study|AE not related to Study Drug|0
2051300|NCT00498602|3623605|FG003|Overall Study|AE not related to Study Drug|0
2051301|NCT00498602|3623606|FG004|Overall Study|AE not related to Study Drug|2
2051302|NCT00498602|3623607|FG005|Overall Study|AE not related to Study Drug|2
2051303|NCT00498602|3623608|FG006|Overall Study|AE not related to Study Drug|1
2209100|NCT01642212|3848589|FG003|Open-label Extension|Sponsor Decision|7
2209101|NCT01642212|3848590|FG004|Open-label Extension|Sponsor Decision|4
2209102|NCT01642212|3848586|FG000|Open-label Extension|Consent Withdrawn|0
2209103|NCT01642212|3848587|FG001|Open-label Extension|Consent Withdrawn|0
2209104|NCT01642212|3848588|FG002|Open-label Extension|Consent Withdrawn|0
2051304|NCT00498602|3623602|FG000|Overall Study|Caregiver Request|2
2051305|NCT00498602|3623603|FG001|Overall Study|Caregiver Request|2
2051306|NCT00498602|3623604|FG002|Overall Study|Caregiver Request|2
2051307|NCT00498602|3623605|FG003|Overall Study|Caregiver Request|0
2051308|NCT00498602|3623606|FG004|Overall Study|Caregiver Request|1
2051309|NCT00498602|3623607|FG005|Overall Study|Caregiver Request|2
2051310|NCT00498602|3623608|FG006|Overall Study|Caregiver Request|0
2051311|NCT00498602|3623602|FG000|Overall Study|Investigator Request|0
2051312|NCT00498602|3623603|FG001|Overall Study|Investigator Request|0
2051313|NCT00498602|3623604|FG002|Overall Study|Investigator Request|1
2051314|NCT00498602|3623605|FG003|Overall Study|Investigator Request|0
2051315|NCT00498602|3623606|FG004|Overall Study|Investigator Request|0
2051316|NCT00498602|3623607|FG005|Overall Study|Investigator Request|0
2051317|NCT00498602|3623608|FG006|Overall Study|Investigator Request|0
2051318|NCT00498602|3623602|FG000|Overall Study|Subject Request|3
2051319|NCT00498602|3623603|FG001|Overall Study|Subject Request|0
2051320|NCT00498602|3623604|FG002|Overall Study|Subject Request|1
2051321|NCT00498602|3623605|FG003|Overall Study|Subject Request|1
2051322|NCT00498602|3623606|FG004|Overall Study|Subject Request|1
2051323|NCT00498602|3623607|FG005|Overall Study|Subject Request|4
2051324|NCT00498602|3623608|FG006|Overall Study|Subject Request|1
2051325|NCT00498602|3623602|FG000|Overall Study|Other|2
2051326|NCT00498602|3623603|FG001|Overall Study|Other|3
2051327|NCT00498602|3623604|FG002|Overall Study|Other|1
2051328|NCT00498602|3623605|FG003|Overall Study|Other|0
2051329|NCT00498602|3623606|FG004|Overall Study|Other|0
2051330|NCT00498602|3623607|FG005|Overall Study|Other|3
2051331|NCT00498602|3623608|FG006|Overall Study|Other|0
2051332|NCT00498797|3623667|FG000|Overall Study|Withdrawal by Subject|4
2051333|NCT00498797|3623668|FG001|Overall Study|Withdrawal by Subject|2
2051334|NCT00498797|3623667|FG000|Overall Study|Adverse Event|12
2051335|NCT00498797|3623668|FG001|Overall Study|Adverse Event|5
2051336|NCT00498797|3623667|FG000|Overall Study|Condition under investigation worsened|19
2051337|NCT00498797|3623668|FG001|Overall Study|Condition under investigation worsened|21
2051338|NCT00498797|3623667|FG000|Overall Study|Other|3
2209105|NCT01642212|3848589|FG003|Open-label Extension|Consent Withdrawn|0
2209106|NCT01642212|3848590|FG004|Open-label Extension|Consent Withdrawn|2
2209107|NCT01642212|3848586|FG000|Open-label Extension|Lost to Follow-up|0
2209108|NCT01642212|3848587|FG001|Open-label Extension|Lost to Follow-up|0
2209109|NCT01642212|3848588|FG002|Open-label Extension|Lost to Follow-up|0
2209110|NCT01642212|3848589|FG003|Open-label Extension|Lost to Follow-up|0
2209111|NCT01642212|3848590|FG004|Open-label Extension|Lost to Follow-up|1
2209112|NCT01642212|3848586|FG000|Open-label Extension|Other|0
2209113|NCT01642212|3848587|FG001|Open-label Extension|Other|0
2209114|NCT01642212|3848588|FG002|Open-label Extension|Other|0
2209115|NCT01642212|3848589|FG003|Open-label Extension|Other|0
2209116|NCT01642212|3848590|FG004|Open-label Extension|Other|1
2209117|NCT01642251|3848608|FG000|Overall Study|Progressive disease|0
2051339|NCT00498797|3623668|FG001|Overall Study|Other|1
2051340|NCT00499031|3623687|FG000|Overall Study|Improper pre-protocol treatment|1
2051341|NCT00499031|3623687|FG000|Overall Study|Required test not done|1
2051342|NCT00499031|3623687|FG000|Overall Study|Never treated|1
2051343|NCT00499083|3623691|FG000|Overall Study|Not evaluable|3
2051344|NCT00499122|3623718|FG000|Overall Study|Withdrawal by Subject|2
2051345|NCT00499174|3623725|FG000|Overall Study|Physician Decision|78
2051346|NCT00499174|3623726|FG001|Overall Study|Physician Decision|9
2051347|NCT00499252|3623734|FG000|Overall Study|Adverse Event|3
2051348|NCT00499252|3623734|FG000|Overall Study|Refused further treatment|2
2051349|NCT00499252|3623734|FG000|Overall Study|Ineligible|4
2051350|NCT00499252|3623734|FG000|Overall Study|<no further label>|3
2051351|NCT00499369|3623756|FG000|Overall Study|Adverse Event|2
2051352|NCT00499369|3623757|FG001|Overall Study|Adverse Event|2
2051353|NCT00499369|3623758|FG002|Overall Study|Adverse Event|3
2051354|NCT00499369|3623759|FG003|Overall Study|Adverse Event|1
2051355|NCT00499369|3623760|FG004|Overall Study|Adverse Event|2
2051356|NCT00499369|3623756|FG000|Overall Study|Withdrawal by Subject|0
2051357|NCT00499369|3623757|FG001|Overall Study|Withdrawal by Subject|1
2051358|NCT00499369|3623758|FG002|Overall Study|Withdrawal by Subject|1
2051359|NCT00499369|3623759|FG003|Overall Study|Withdrawal by Subject|0
2051360|NCT00499369|3623760|FG004|Overall Study|Withdrawal by Subject|0
2051361|NCT00499369|3623756|FG000|Overall Study|Progression|10
2051362|NCT00499369|3623757|FG001|Overall Study|Progression|12
2051363|NCT00499369|3623758|FG002|Overall Study|Progression|9
2051364|NCT00499369|3623759|FG003|Overall Study|Progression|6
2051365|NCT00499369|3623760|FG004|Overall Study|Progression|10
2051366|NCT00499369|3623756|FG000|Overall Study|Death|0
2051367|NCT00499369|3623757|FG001|Overall Study|Death|1
2051368|NCT00499369|3623758|FG002|Overall Study|Death|0
2051369|NCT00499369|3623759|FG003|Overall Study|Death|0
2051370|NCT00499369|3623760|FG004|Overall Study|Death|0
2051371|NCT00499369|3623756|FG000|Overall Study|Not protocol specified|2
2051372|NCT00499369|3623757|FG001|Overall Study|Not protocol specified|0
2051373|NCT00499369|3623758|FG002|Overall Study|Not protocol specified|3
2051374|NCT00499369|3623759|FG003|Overall Study|Not protocol specified|1
2051375|NCT00499369|3623760|FG004|Overall Study|Not protocol specified|0
2051376|NCT00499369|3623756|FG000|Overall Study|Ineligible|2
2051377|NCT00499369|3623757|FG001|Overall Study|Ineligible|2
2051378|NCT00499369|3623758|FG002|Overall Study|Ineligible|1
2051379|NCT00499369|3623759|FG003|Overall Study|Ineligible|1
2051380|NCT00499369|3623760|FG004|Overall Study|Ineligible|0
2051381|NCT00499460|3623782|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1
2051382|NCT00499460|3623783|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0
2051383|NCT00499460|3623782|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
2051384|NCT00499460|3623783|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
2051385|NCT00499460|3623782|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0
2051386|NCT00499460|3623783|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1
2051387|NCT00499486|3623808|FG000|Overall Study|Withdrawal by Subject|16
2051388|NCT00499603|3623814|FG000|Overall Study|Adverse Event|0
2051389|NCT00499603|3623815|FG001|Overall Study|Adverse Event|1
2051390|NCT00499616|3623827|FG000|Overall Study|Death|1
2051391|NCT00499616|3623828|FG001|Overall Study|Death|5
2051392|NCT00499616|3623829|FG002|Overall Study|Death|3
2051393|NCT00499616|3623830|FG003|Overall Study|Death|1
2051394|NCT00499616|3623827|FG000|Overall Study|Lack of Efficacy|5
2051395|NCT00499616|3623828|FG001|Overall Study|Lack of Efficacy|0
2051396|NCT00499616|3623829|FG002|Overall Study|Lack of Efficacy|19
2051397|NCT00499616|3623830|FG003|Overall Study|Lack of Efficacy|0
2051398|NCT00499616|3623827|FG000|Overall Study|Lost to Follow-up|0
2051399|NCT00499616|3623828|FG001|Overall Study|Lost to Follow-up|0
2051400|NCT00499616|3623829|FG002|Overall Study|Lost to Follow-up|1
2051401|NCT00499616|3623830|FG003|Overall Study|Lost to Follow-up|0
2051402|NCT00499616|3623827|FG000|Overall Study|Physician Decision|6
2051403|NCT00499616|3623828|FG001|Overall Study|Physician Decision|16
2051404|NCT00499616|3623829|FG002|Overall Study|Physician Decision|9
2051405|NCT00499616|3623830|FG003|Overall Study|Physician Decision|0
2051406|NCT00499616|3623827|FG000|Overall Study|Withdrawal by Subject|1
2051407|NCT00499616|3623828|FG001|Overall Study|Withdrawal by Subject|0
2051408|NCT00499616|3623829|FG002|Overall Study|Withdrawal by Subject|1
2051409|NCT00499616|3623830|FG003|Overall Study|Withdrawal by Subject|0
2051410|NCT00499616|3623827|FG000|Overall Study|Ineligible|1
2051411|NCT00499616|3623828|FG001|Overall Study|Ineligible|2
2051412|NCT00499616|3623829|FG002|Overall Study|Ineligible|0
2051413|NCT00499616|3623830|FG003|Overall Study|Ineligible|15
2051414|NCT00499616|3623827|FG000|Overall Study|Not evaluable|0
2051415|NCT00499616|3623828|FG001|Overall Study|Not evaluable|0
2051416|NCT00499616|3623829|FG002|Overall Study|Not evaluable|0
2051417|NCT00499616|3623830|FG003|Overall Study|Not evaluable|41
2051418|NCT00499616|3623827|FG000|Overall Study|Patient/Parent Refusal|1
2051419|NCT00499616|3623828|FG001|Overall Study|Patient/Parent Refusal|5
2051420|NCT00499616|3623829|FG002|Overall Study|Patient/Parent Refusal|3
2051421|NCT00499616|3623830|FG003|Overall Study|Patient/Parent Refusal|0
2051422|NCT00499681|3623855|FG000|Overall Study|toxicity|0
2051423|NCT00499681|3623856|FG001|Overall Study|toxicity|1
2051424|NCT00499681|3623855|FG000|Overall Study|disease progression|0
2051425|NCT00499681|3623856|FG001|Overall Study|disease progression|1
2051426|NCT00499694|3623862|FG000|Overall Study|Patient never received treatment.|1
2051427|NCT00499746|3623867|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
2051428|NCT00499746|3623867|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
2051429|NCT00499746|3623867|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1
2051430|NCT00499746|3623867|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1
2051431|NCT00499863|3623883|FG000|Overall Study|Lack of Efficacy|21
2051432|NCT00499863|3623884|FG001|Overall Study|Lack of Efficacy|27
2051433|NCT00499863|3623883|FG000|Overall Study|Protocol Violation|12
2051434|NCT00499863|3623884|FG001|Overall Study|Protocol Violation|7
2051435|NCT00499863|3623883|FG000|Overall Study|Withdrawal by Subject|6
2051436|NCT00499863|3623884|FG001|Overall Study|Withdrawal by Subject|4
2051437|NCT00499863|3623883|FG000|Overall Study|Adverse Event|8
2051438|NCT00499863|3623884|FG001|Overall Study|Adverse Event|2
2051439|NCT00499863|3623883|FG000|Overall Study|Sponsor decision|2
2051440|NCT00499863|3623884|FG001|Overall Study|Sponsor decision|2
2051441|NCT00499863|3623883|FG000|Overall Study|Lost to Follow-up|1
2051442|NCT00499863|3623884|FG001|Overall Study|Lost to Follow-up|1
2051443|NCT00499889|3623890|FG000|Overall Study|Infection prior to treatment|1
2051444|NCT00500071|3623903|FG000|Screening and Washout Phase|Protocol Violation|1
2051445|NCT00500071|3623903|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13
2051446|NCT00500071|3623903|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2
2051447|NCT00500071|3623903|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
2051448|NCT00500071|3623903|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
2051449|NCT00500071|3623903|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
2051450|NCT00500071|3623903|FG000|30-day Safety Follow-up|Lost to Follow-up|17
2051451|NCT00500110|3623907|FG000|Overall Study|Withdrawal by Subject|3
2051452|NCT00500149|3623911|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
2051453|NCT00500149|3623912|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
2051454|NCT00500149|3623911|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8
2051455|NCT00500149|3623912|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0
2051456|NCT00500149|3623911|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1
2051457|NCT00500149|3623912|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0
2051458|NCT00500149|3623911|FG000|First Intervention (Cross-over Phase)|Adverse Event|0
2051459|NCT00500149|3623912|FG001|First Intervention (Cross-over Phase)|Adverse Event|1
2051460|NCT00500149|3623911|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
2209118|NCT01642251|3848609|FG001|Overall Study|Progressive disease|0
2209119|NCT01642251|3848610|FG002|Overall Study|Progressive disease|3
2209120|NCT01642251|3848611|FG003|Overall Study|Progressive disease|3
2209121|NCT01642251|3848608|FG000|Overall Study|Adverse Event|0
2209122|NCT01642251|3848609|FG001|Overall Study|Adverse Event|0
2209123|NCT01642251|3848610|FG002|Overall Study|Adverse Event|5
2209124|NCT01642251|3848611|FG003|Overall Study|Adverse Event|4
2209125|NCT01642251|3848608|FG000|Overall Study|Death|0
2209126|NCT01642251|3848609|FG001|Overall Study|Death|0
2209127|NCT01642251|3848610|FG002|Overall Study|Death|1
2209128|NCT01642251|3848611|FG003|Overall Study|Death|3
2209129|NCT01642251|3848608|FG000|Overall Study|Withdrawal by Subject|0
2209130|NCT01642251|3848609|FG001|Overall Study|Withdrawal by Subject|0
2209131|NCT01642251|3848610|FG002|Overall Study|Withdrawal by Subject|1
2209132|NCT01642251|3848611|FG003|Overall Study|Withdrawal by Subject|3
2209133|NCT01642251|3848608|FG000|Overall Study|Alternative therapy|0
2209134|NCT01642251|3848609|FG001|Overall Study|Alternative therapy|0
2209135|NCT01642251|3848610|FG002|Overall Study|Alternative therapy|0
2209136|NCT01642251|3848611|FG003|Overall Study|Alternative therapy|2
2209137|NCT01642251|3848608|FG000|Overall Study|Other complicating disease|0
2209138|NCT01642251|3848609|FG001|Overall Study|Other complicating disease|0
2209139|NCT01642251|3848610|FG002|Overall Study|Other complicating disease|1
2209140|NCT01642251|3848611|FG003|Overall Study|Other complicating disease|0
2209141|NCT01642251|3848608|FG000|Overall Study|Ineligible/never start protocol therapy|0
2209142|NCT01642251|3848609|FG001|Overall Study|Ineligible/never start protocol therapy|0
2209143|NCT01642251|3848610|FG002|Overall Study|Ineligible/never start protocol therapy|11
2209144|NCT01642251|3848611|FG003|Overall Study|Ineligible/never start protocol therapy|8
2209145|NCT01642277|3848622|FG000|Overall Study|Adverse Event|10
2209146|NCT01642277|3848623|FG001|Overall Study|Adverse Event|0
2209147|NCT01642277|3848622|FG000|Overall Study|Physician Decision|2
2209148|NCT01642277|3848623|FG001|Overall Study|Physician Decision|0
2209149|NCT01642277|3848622|FG000|Overall Study|Protocol Violation|1
2209150|NCT01642277|3848623|FG001|Overall Study|Protocol Violation|0
2209151|NCT01642277|3848622|FG000|Overall Study|Withdrawal by Subject|11
2209152|NCT01642277|3848623|FG001|Overall Study|Withdrawal by Subject|0
2209153|NCT01642407|3848630|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
2209154|NCT01642407|3848630|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
2209155|NCT01642407|3848630|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
2209156|NCT01642589|3848661|FG000|Overall Study|Withdrawal by Subject|1
2209157|NCT01642589|3848662|FG001|Overall Study|Withdrawal by Subject|1
2209158|NCT01642602|3848668|FG000|Overall Study|Adverse Event|2
2209159|NCT01642615|3848672|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
2209160|NCT01642615|3848673|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
2209161|NCT01642615|3848674|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
2209162|NCT01642615|3848672|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1
2209163|NCT01642615|3848673|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0
2209164|NCT01642615|3848674|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0
2209165|NCT01642615|3848672|FG000|Open Label Maintenance Phase|Lost to Follow-up|1
2209166|NCT01642615|3848673|FG001|Open Label Maintenance Phase|Lost to Follow-up|0
2209167|NCT01642615|3848674|FG002|Open Label Maintenance Phase|Lost to Follow-up|0
2209168|NCT01642615|3848672|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1
2209169|NCT01642615|3848673|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0
2209170|NCT01642615|3848674|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0
2209171|NCT01642615|3848672|FG000|Open Label Maintenance Phase|Did not receive treatment|1
2209172|NCT01642615|3848673|FG001|Open Label Maintenance Phase|Did not receive treatment|0
2209173|NCT01642615|3848674|FG002|Open Label Maintenance Phase|Did not receive treatment|0
2209174|NCT01642615|3848672|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0
2209175|NCT01642615|3848673|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1
2209176|NCT01642615|3848674|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3
2209177|NCT01642615|3848672|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0
2209178|NCT01642615|3848673|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5
2209179|NCT01642615|3848674|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2
2209180|NCT01642615|3848672|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
2209181|NCT01642615|3848673|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
2209182|NCT01642615|3848674|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
2299883|NCT02590003|3997010|FG000|Overall Study|Death|1
2299884|NCT02590003|3997011|FG001|Overall Study|Death|2
2299885|NCT02590354|3997017|FG000|Phase 1|Active hepatitis B or C infection|1
2299886|NCT02590354|3997017|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1
2299887|NCT02590354|3997017|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75
2299888|NCT02590354|3997017|FG000|Phase 1|Subject does not want to participate|20
2299889|NCT02590354|3997017|FG000|Phase 1|Lost to Follow-up|1
2299890|NCT02590354|3997017|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2
2299891|NCT02590406|3997024|FG000|Overall Study|Adverse Event|1
2299892|NCT02590406|3997025|FG001|Overall Study|Adverse Event|0
2299893|NCT02590406|3997024|FG000|Overall Study|Saturometer malfunction|0
2299894|NCT02590406|3997025|FG001|Overall Study|Saturometer malfunction|1
2209183|NCT01642615|3848672|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
2209184|NCT01642615|3848673|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
2209185|NCT01642615|3848674|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
2209186|NCT01642914|3848685|FG000|Overall Study|Adverse Event|11
2209187|NCT01642914|3848686|FG001|Overall Study|Adverse Event|7
2209188|NCT01642914|3848687|FG002|Overall Study|Adverse Event|15
2209189|NCT01642914|3848685|FG000|Overall Study|Lack of Efficacy|9
2209190|NCT01642914|3848686|FG001|Overall Study|Lack of Efficacy|4
2209191|NCT01642914|3848687|FG002|Overall Study|Lack of Efficacy|2
2209192|NCT01642914|3848685|FG000|Overall Study|Protocol Violation|15
2209193|NCT01642914|3848686|FG001|Overall Study|Protocol Violation|13
2209194|NCT01642914|3848687|FG002|Overall Study|Protocol Violation|6
2209195|NCT01642914|3848685|FG000|Overall Study|Withdrawal by Subject|5
2209196|NCT01642914|3848686|FG001|Overall Study|Withdrawal by Subject|5
2209197|NCT01642914|3848687|FG002|Overall Study|Withdrawal by Subject|10
2209198|NCT01642914|3848685|FG000|Overall Study|Lost to Follow-up|5
2209199|NCT01642914|3848686|FG001|Overall Study|Lost to Follow-up|3
2209200|NCT01642914|3848687|FG002|Overall Study|Lost to Follow-up|7
2209201|NCT01642914|3848685|FG000|Overall Study|Other Reason|1
2209202|NCT01642914|3848686|FG001|Overall Study|Other Reason|0
2209203|NCT01642914|3848687|FG002|Overall Study|Other Reason|0
2209204|NCT01643044|3848699|FG000|Overall Study|Lost to Follow-up|1
2209205|NCT01643044|3848700|FG001|Overall Study|Lost to Follow-up|1
2209206|NCT01643044|3848699|FG000|Overall Study|Miscarried baby|2
2209207|NCT01643044|3848700|FG001|Overall Study|Miscarried baby|2
2209208|NCT01643044|3848699|FG000|Overall Study|Delivered outside of hospital|1
2209209|NCT01643044|3848700|FG001|Overall Study|Delivered outside of hospital|2
2209210|NCT01643408|3848724|FG000|Overall Study|Adverse Event|12
2209211|NCT01643408|3848724|FG000|Overall Study|Other|2
2209212|NCT01643473|3848730|FG000|Overall Study|Lost to Follow-up|1
2209213|NCT01643473|3848731|FG001|Overall Study|Lost to Follow-up|0
2209214|NCT01643668|3848746|FG000|Overall Study|Death|1
2209215|NCT01643772|3848766|FG000|Overall Study|Protocol Violation|0
2209216|NCT01643772|3848767|FG001|Overall Study|Protocol Violation|0
2209217|NCT01643772|3848768|FG002|Overall Study|Protocol Violation|0
2209218|NCT01643772|3848769|FG003|Overall Study|Protocol Violation|1
2209219|NCT01643772|3848766|FG000|Overall Study|Adverse Event|0
2209220|NCT01643772|3848767|FG001|Overall Study|Adverse Event|0
2209221|NCT01643772|3848768|FG002|Overall Study|Adverse Event|0
2209222|NCT01643772|3848769|FG003|Overall Study|Adverse Event|1
2209223|NCT01643798|3848781|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
2209224|NCT01643798|3848782|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
2209225|NCT01643850|3848802|FG000|Overall Study|Withdrawal by Subject|0
2209226|NCT01643850|3848803|FG001|Overall Study|Withdrawal by Subject|0
2209227|NCT01643850|3848804|FG002|Overall Study|Withdrawal by Subject|0
2209228|NCT01643850|3848805|FG003|Overall Study|Withdrawal by Subject|0
2209229|NCT01643850|3848806|FG004|Overall Study|Withdrawal by Subject|1
2051461|NCT00500149|3623912|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
2051462|NCT00500149|3623911|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1
2051463|NCT00500149|3623912|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0
2051464|NCT00500149|3623911|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
2051465|NCT00500149|3623912|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
2051466|NCT00500266|3623929|FG000|Overall Study|Death|3
2051467|NCT00500266|3623929|FG000|Overall Study|Lost to Follow-up|3
2051468|NCT00500266|3623929|FG000|Overall Study|Withdrawal by Subject|3
2051469|NCT00500266|3623929|FG000|Overall Study|Assigned, not treated|4
2051470|NCT00500292|3623937|FG000|Overall Study|Adverse Event|3
2051471|NCT00500292|3623938|FG001|Overall Study|Adverse Event|6
2051472|NCT00500292|3623939|FG002|Overall Study|Adverse Event|4
2051473|NCT00500292|3623937|FG000|Overall Study|Condition under investigation worsened|21
2051474|NCT00500292|3623938|FG001|Overall Study|Condition under investigation worsened|23
2051475|NCT00500292|3623939|FG002|Overall Study|Condition under investigation worsened|19
2051476|NCT00500292|3623937|FG000|Overall Study|Withdrawal by Subject|0
2051477|NCT00500292|3623938|FG001|Overall Study|Withdrawal by Subject|1
2051478|NCT00500292|3623939|FG002|Overall Study|Withdrawal by Subject|0
2051479|NCT00500292|3623937|FG000|Overall Study|Other|1
2051480|NCT00500292|3623938|FG001|Overall Study|Other|1
2051481|NCT00500292|3623939|FG002|Overall Study|Other|4
2051482|NCT00500318|3623949|FG000|Overall Study|Adverse Event|3
2051483|NCT00500318|3623950|FG001|Overall Study|Adverse Event|8
2209230|NCT01643850|3848807|FG005|Overall Study|Withdrawal by Subject|0
2209231|NCT01643850|3848808|FG006|Overall Study|Withdrawal by Subject|0
2209232|NCT01643850|3848809|FG007|Overall Study|Withdrawal by Subject|0
2209233|NCT01643850|3848810|FG008|Overall Study|Withdrawal by Subject|0
2209234|NCT01643850|3848802|FG000|Overall Study|Lost to Follow-up|0
2209235|NCT01643850|3848803|FG001|Overall Study|Lost to Follow-up|0
2209236|NCT01643850|3848804|FG002|Overall Study|Lost to Follow-up|0
2209237|NCT01643850|3848805|FG003|Overall Study|Lost to Follow-up|0
2051484|NCT00500318|3623949|FG000|Overall Study|Protocol Violation|1
2051485|NCT00500318|3623950|FG001|Overall Study|Protocol Violation|3
2209238|NCT01643850|3848806|FG004|Overall Study|Lost to Follow-up|0
2209239|NCT01643850|3848807|FG005|Overall Study|Lost to Follow-up|0
2209240|NCT01643850|3848808|FG006|Overall Study|Lost to Follow-up|1
2051486|NCT00500318|3623949|FG000|Overall Study|Withdrawal by Subject|1
2051487|NCT00500318|3623950|FG001|Overall Study|Withdrawal by Subject|2
2051488|NCT00500318|3623949|FG000|Overall Study|Lack of Efficacy|0
2051489|NCT00500318|3623950|FG001|Overall Study|Lack of Efficacy|3
2051490|NCT00500318|3623949|FG000|Overall Study|Other Reason|0
2051491|NCT00500318|3623950|FG001|Overall Study|Other Reason|1
2051492|NCT00500331|3623963|FG000|Overall Study|Adverse Event|0
2051493|NCT00500331|3623964|FG001|Overall Study|Adverse Event|2
2051494|NCT00500331|3623965|FG002|Overall Study|Adverse Event|0
2051495|NCT00500331|3623966|FG003|Overall Study|Adverse Event|1
2051496|NCT00500331|3623967|FG004|Overall Study|Adverse Event|2
2051497|NCT00500331|3623968|FG005|Overall Study|Adverse Event|2
2051498|NCT00500331|3623969|FG006|Overall Study|Adverse Event|0
2051499|NCT00500331|3623963|FG000|Overall Study|Lost to Follow-up|1
2051500|NCT00500331|3623964|FG001|Overall Study|Lost to Follow-up|1
2051501|NCT00500331|3623965|FG002|Overall Study|Lost to Follow-up|1
2051502|NCT00500331|3623966|FG003|Overall Study|Lost to Follow-up|2
2051503|NCT00500331|3623967|FG004|Overall Study|Lost to Follow-up|1
2051504|NCT00500331|3623968|FG005|Overall Study|Lost to Follow-up|0
2051505|NCT00500331|3623969|FG006|Overall Study|Lost to Follow-up|0
2051506|NCT00500331|3623963|FG000|Overall Study|Protocol Violation|3
2051507|NCT00500331|3623964|FG001|Overall Study|Protocol Violation|1
2051508|NCT00500331|3623965|FG002|Overall Study|Protocol Violation|1
2051509|NCT00500331|3623966|FG003|Overall Study|Protocol Violation|0
2051510|NCT00500331|3623967|FG004|Overall Study|Protocol Violation|1
2051511|NCT00500331|3623968|FG005|Overall Study|Protocol Violation|1
2051512|NCT00500331|3623969|FG006|Overall Study|Protocol Violation|1
2051513|NCT00500331|3623963|FG000|Overall Study|Withdrawal by Subject|4
2051514|NCT00500331|3623964|FG001|Overall Study|Withdrawal by Subject|0
2051515|NCT00500331|3623965|FG002|Overall Study|Withdrawal by Subject|1
2051516|NCT00500331|3623966|FG003|Overall Study|Withdrawal by Subject|5
2051517|NCT00500331|3623967|FG004|Overall Study|Withdrawal by Subject|0
2051518|NCT00500331|3623968|FG005|Overall Study|Withdrawal by Subject|1
2209241|NCT01643850|3848809|FG007|Overall Study|Lost to Follow-up|0
2209242|NCT01643850|3848810|FG008|Overall Study|Lost to Follow-up|1
2209243|NCT01643850|3848802|FG000|Overall Study|Adverse Event|0
2299895|NCT02590432|3997033|FG000|Open-label Treatment Period|Adverse Event|97
2051519|NCT00500331|3623969|FG006|Overall Study|Withdrawal by Subject|1
2051520|NCT00500331|3623963|FG000|Overall Study|Lack of Efficacy|3
2051521|NCT00500331|3623964|FG001|Overall Study|Lack of Efficacy|1
2051522|NCT00500331|3623965|FG002|Overall Study|Lack of Efficacy|0
2051523|NCT00500331|3623966|FG003|Overall Study|Lack of Efficacy|0
2051524|NCT00500331|3623967|FG004|Overall Study|Lack of Efficacy|0
2051525|NCT00500331|3623968|FG005|Overall Study|Lack of Efficacy|0
2051526|NCT00500331|3623969|FG006|Overall Study|Lack of Efficacy|0
2051527|NCT00500331|3623963|FG000|Overall Study|Liver function test abnormality|0
2051528|NCT00500331|3623964|FG001|Overall Study|Liver function test abnormality|0
2051529|NCT00500331|3623965|FG002|Overall Study|Liver function test abnormality|1
2051530|NCT00500331|3623966|FG003|Overall Study|Liver function test abnormality|0
2051531|NCT00500331|3623967|FG004|Overall Study|Liver function test abnormality|0
2051532|NCT00500331|3623968|FG005|Overall Study|Liver function test abnormality|0
2051533|NCT00500331|3623969|FG006|Overall Study|Liver function test abnormality|0
2051534|NCT00500331|3623963|FG000|Overall Study|Increased serum creatinine from Baseline|0
2051535|NCT00500331|3623964|FG001|Overall Study|Increased serum creatinine from Baseline|0
2051536|NCT00500331|3623965|FG002|Overall Study|Increased serum creatinine from Baseline|0
2051537|NCT00500331|3623966|FG003|Overall Study|Increased serum creatinine from Baseline|0
2051538|NCT00500331|3623967|FG004|Overall Study|Increased serum creatinine from Baseline|0
2051539|NCT00500331|3623968|FG005|Overall Study|Increased serum creatinine from Baseline|1
2051540|NCT00500331|3623969|FG006|Overall Study|Increased serum creatinine from Baseline|0
2051541|NCT00500331|3623963|FG000|Overall Study|Didn't return for continuation of study|1
2051542|NCT00500331|3623964|FG001|Overall Study|Didn't return for continuation of study|0
2051543|NCT00500331|3623965|FG002|Overall Study|Didn't return for continuation of study|0
2051544|NCT00500331|3623966|FG003|Overall Study|Didn't return for continuation of study|0
2051545|NCT00500331|3623967|FG004|Overall Study|Didn't return for continuation of study|0
2051546|NCT00500331|3623968|FG005|Overall Study|Didn't return for continuation of study|0
2051547|NCT00500331|3623969|FG006|Overall Study|Didn't return for continuation of study|0
2299896|NCT02590432|3997034|FG001|Open-label Treatment Period|Adverse Event|79
2299897|NCT02590432|3997035|FG002|Open-label Treatment Period|Adverse Event|0
2299898|NCT02590432|3997036|FG003|Open-label Treatment Period|Adverse Event|0
2299899|NCT02590432|3997037|FG004|Open-label Treatment Period|Adverse Event|0
2299900|NCT02590432|3997038|FG005|Open-label Treatment Period|Adverse Event|0
2299901|NCT02590432|3997039|FG006|Open-label Treatment Period|Adverse Event|0
2299902|NCT02590432|3997040|FG007|Open-label Treatment Period|Adverse Event|0
2299903|NCT02590432|3997041|FG008|Open-label Treatment Period|Adverse Event|0
2299904|NCT02590432|3997033|FG000|Open-label Treatment Period|Lack of Efficacy|14
2299905|NCT02590432|3997034|FG001|Open-label Treatment Period|Lack of Efficacy|5
2299906|NCT02590432|3997035|FG002|Open-label Treatment Period|Lack of Efficacy|0
2299907|NCT02590432|3997036|FG003|Open-label Treatment Period|Lack of Efficacy|0
2299908|NCT02590432|3997037|FG004|Open-label Treatment Period|Lack of Efficacy|0
2299909|NCT02590432|3997038|FG005|Open-label Treatment Period|Lack of Efficacy|0
2051548|NCT00500331|3623963|FG000|Overall Study|Exclusion citeria not met on Visit 4|1
2051549|NCT00500331|3623964|FG001|Overall Study|Exclusion citeria not met on Visit 4|0
2051550|NCT00500331|3623965|FG002|Overall Study|Exclusion citeria not met on Visit 4|0
2051551|NCT00500331|3623966|FG003|Overall Study|Exclusion citeria not met on Visit 4|0
2051552|NCT00500331|3623967|FG004|Overall Study|Exclusion citeria not met on Visit 4|0
2051553|NCT00500331|3623968|FG005|Overall Study|Exclusion citeria not met on Visit 4|0
2051554|NCT00500331|3623969|FG006|Overall Study|Exclusion citeria not met on Visit 4|0
2051555|NCT00500331|3623963|FG000|Overall Study|Sponsor decided to withdraw participant|1
2051556|NCT00500331|3623964|FG001|Overall Study|Sponsor decided to withdraw participant|0
2051557|NCT00500331|3623965|FG002|Overall Study|Sponsor decided to withdraw participant|0
2051558|NCT00500331|3623966|FG003|Overall Study|Sponsor decided to withdraw participant|0
2051559|NCT00500331|3623967|FG004|Overall Study|Sponsor decided to withdraw participant|0
2051560|NCT00500331|3623968|FG005|Overall Study|Sponsor decided to withdraw participant|0
2051561|NCT00500331|3623969|FG006|Overall Study|Sponsor decided to withdraw participant|0
2051562|NCT00500331|3623963|FG000|Overall Study|Participant was randomized by mistake|1
2051563|NCT00500331|3623964|FG001|Overall Study|Participant was randomized by mistake|0
2051564|NCT00500331|3623965|FG002|Overall Study|Participant was randomized by mistake|0
2051565|NCT00500331|3623966|FG003|Overall Study|Participant was randomized by mistake|0
2051566|NCT00500331|3623967|FG004|Overall Study|Participant was randomized by mistake|0
2051567|NCT00500331|3623968|FG005|Overall Study|Participant was randomized by mistake|0
2051568|NCT00500331|3623969|FG006|Overall Study|Participant was randomized by mistake|0
2051569|NCT00500331|3623963|FG000|Overall Study|Diabetologist nurse in the study|0
2051570|NCT00500331|3623964|FG001|Overall Study|Diabetologist nurse in the study|0
2051571|NCT00500331|3623965|FG002|Overall Study|Diabetologist nurse in the study|1
2051572|NCT00500331|3623966|FG003|Overall Study|Diabetologist nurse in the study|0
2051573|NCT00500331|3623967|FG004|Overall Study|Diabetologist nurse in the study|0
2051574|NCT00500331|3623968|FG005|Overall Study|Diabetologist nurse in the study|0
2051575|NCT00500331|3623969|FG006|Overall Study|Diabetologist nurse in the study|0
2051576|NCT00500331|3623963|FG000|Overall Study|State ban of biological samples export|0
2051577|NCT00500331|3623964|FG001|Overall Study|State ban of biological samples export|0
2051578|NCT00500331|3623965|FG002|Overall Study|State ban of biological samples export|0
2051579|NCT00500331|3623966|FG003|Overall Study|State ban of biological samples export|1
2051580|NCT00500331|3623967|FG004|Overall Study|State ban of biological samples export|0
2051581|NCT00500331|3623968|FG005|Overall Study|State ban of biological samples export|0
2051582|NCT00500331|3623969|FG006|Overall Study|State ban of biological samples export|0
2051583|NCT00500331|3623963|FG000|Overall Study|Protocol violated|0
2051584|NCT00500331|3623964|FG001|Overall Study|Protocol violated|0
2051585|NCT00500331|3623965|FG002|Overall Study|Protocol violated|0
2051586|NCT00500331|3623966|FG003|Overall Study|Protocol violated|1
2051587|NCT00500331|3623967|FG004|Overall Study|Protocol violated|0
2051588|NCT00500331|3623968|FG005|Overall Study|Protocol violated|0
2051589|NCT00500331|3623969|FG006|Overall Study|Protocol violated|0
2051590|NCT00500357|3623986|FG000|Overall Study|Death|1
2051591|NCT00500370|3624003|FG000|Overall Study|Adverse Event|9
2051592|NCT00500370|3624004|FG001|Overall Study|Adverse Event|3
2051593|NCT00500370|3624003|FG000|Overall Study|Lost to Follow-up|10
2051594|NCT00500370|3624004|FG001|Overall Study|Lost to Follow-up|10
2051595|NCT00500370|3624003|FG000|Overall Study|Protocol Violation|2
2051596|NCT00500370|3624004|FG001|Overall Study|Protocol Violation|4
2051597|NCT00500370|3624003|FG000|Overall Study|Sponsor Decision|2
2051598|NCT00500370|3624004|FG001|Overall Study|Sponsor Decision|0
2051599|NCT00500370|3624003|FG000|Overall Study|Subject Decision|10
2051600|NCT00500370|3624004|FG001|Overall Study|Subject Decision|17
2051601|NCT00500539|3624019|FG000|Treatment Period (24 Weeks)|Adverse Event|4
2051602|NCT00500539|3624019|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
2051603|NCT00500539|3624019|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1
2051604|NCT00500539|3624019|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2
2051605|NCT00500539|3624019|FG000|Treatment Period (24 Weeks)|Administrative problems|2
2051606|NCT00500539|3624019|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5
2051607|NCT00500539|3624019|FG000|Follow-up Period (16 Weeks)|Adverse Event|1
2051608|NCT00500539|3624019|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2
2051609|NCT00500539|3624019|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3
2051610|NCT00500539|3624019|FG000|Follow-up Period (16 Weeks)|Administrative problems|1
2051611|NCT00500539|3624019|FG000|Follow-up Period (16 Weeks)|Death|1
2051612|NCT00500539|3624019|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1
2051613|NCT00500539|3624019|FG000|Follow-up Period (16 Weeks)|Missing|3
2051614|NCT00500682|3624054|FG000|Overall Study|Adverse Event|37
2051615|NCT00500682|3624055|FG001|Overall Study|Adverse Event|29
2051616|NCT00500682|3624054|FG000|Overall Study|Death|25
2051617|NCT00500682|3624055|FG001|Overall Study|Death|16
2051618|NCT00500682|3624054|FG000|Overall Study|Lost to Follow-up|11
2051619|NCT00500682|3624055|FG001|Overall Study|Lost to Follow-up|11
2051620|NCT00500682|3624054|FG000|Overall Study|Physician Decision|6
2051621|NCT00500682|3624055|FG001|Overall Study|Physician Decision|10
2299910|NCT02590432|3997039|FG006|Open-label Treatment Period|Lack of Efficacy|0
2299911|NCT02590432|3997040|FG007|Open-label Treatment Period|Lack of Efficacy|0
2299912|NCT02590432|3997041|FG008|Open-label Treatment Period|Lack of Efficacy|0
2051622|NCT00500682|3624054|FG000|Overall Study|Pregnancy|2
2051623|NCT00500682|3624055|FG001|Overall Study|Pregnancy|0
2051624|NCT00500682|3624054|FG000|Overall Study|Protocol Violation|1
2209244|NCT01643850|3848803|FG001|Overall Study|Adverse Event|0
2209245|NCT01643850|3848804|FG002|Overall Study|Adverse Event|0
2051625|NCT00500682|3624055|FG001|Overall Study|Protocol Violation|3
2051626|NCT00500682|3624054|FG000|Overall Study|Withdrawal by Subject|80
2051627|NCT00500682|3624055|FG001|Overall Study|Withdrawal by Subject|74
2051628|NCT00500682|3624054|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144
2051629|NCT00500682|3624055|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144
2051630|NCT00500760|3624063|FG000|Overall Study|Death|32
2051631|NCT00500760|3624064|FG001|Overall Study|Death|15
2051632|NCT00500760|3624063|FG000|Overall Study|Withdrawal by Subject|5
2051633|NCT00500760|3624064|FG001|Overall Study|Withdrawal by Subject|7
2051634|NCT00500760|3624063|FG000|Overall Study|Administrative decision|2
2051635|NCT00500760|3624064|FG001|Overall Study|Administrative decision|0
2209246|NCT01643850|3848805|FG003|Overall Study|Adverse Event|0
2051636|NCT00500760|3624063|FG000|Overall Study|Lost to Follow-up|3
2051637|NCT00500760|3624064|FG001|Overall Study|Lost to Follow-up|0
2051638|NCT00500760|3624063|FG000|Overall Study|Other|1
2051639|NCT00500760|3624064|FG001|Overall Study|Other|2
2051640|NCT00500903|3624073|FG000|Overall Study|Occurrence of Adverse Event(s)|10
2051641|NCT00500903|3624074|FG001|Overall Study|Occurrence of Adverse Event(s)|0
2051642|NCT00500903|3624075|FG002|Overall Study|Occurrence of Adverse Event(s)|0
2051643|NCT00500903|3624073|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
2051644|NCT00500903|3624074|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
2051645|NCT00500903|3624075|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
2051646|NCT00500903|3624073|FG000|Overall Study|Progressive Disease|41
2051647|NCT00500903|3624074|FG001|Overall Study|Progressive Disease|2
2051648|NCT00500903|3624075|FG002|Overall Study|Progressive Disease|15
2051649|NCT00500903|3624073|FG000|Overall Study|Patient Declined Further Treatment|0
2051650|NCT00500903|3624074|FG001|Overall Study|Patient Declined Further Treatment|0
2051651|NCT00500903|3624075|FG002|Overall Study|Patient Declined Further Treatment|3
2051652|NCT00500903|3624073|FG000|Overall Study|Symptomatic Deterioration|2
2051653|NCT00500903|3624074|FG001|Overall Study|Symptomatic Deterioration|0
2051654|NCT00500903|3624075|FG002|Overall Study|Symptomatic Deterioration|0
2051655|NCT00500903|3624073|FG000|Overall Study|Reason Not Specified|10
2051656|NCT00500903|3624074|FG001|Overall Study|Reason Not Specified|0
2051657|NCT00500903|3624075|FG002|Overall Study|Reason Not Specified|2
2051658|NCT00501007|3624113|FG000|Overall Study|Inclusion criteria not met.|29
2051659|NCT00501007|3624114|FG001|Overall Study|Inclusion criteria not met.|25
2051660|NCT00501046|3624122|FG000|Overall Study|Adverse Event|21
2051661|NCT00501046|3624123|FG001|Overall Study|Adverse Event|25
2051662|NCT00501046|3624122|FG000|Overall Study|Death|23
2051663|NCT00501046|3624123|FG001|Overall Study|Death|30
2051664|NCT00501046|3624122|FG000|Overall Study|Lost to Follow-up|14
2051665|NCT00501046|3624123|FG001|Overall Study|Lost to Follow-up|13
2051666|NCT00501046|3624122|FG000|Overall Study|Physician Decision|7
2051667|NCT00501046|3624123|FG001|Overall Study|Physician Decision|2
2051668|NCT00501046|3624122|FG000|Overall Study|Pregnancy|0
2051669|NCT00501046|3624123|FG001|Overall Study|Pregnancy|3
2051670|NCT00501046|3624122|FG000|Overall Study|Protocol Violation|2
2209247|NCT01643850|3848806|FG004|Overall Study|Adverse Event|1
2209248|NCT01643850|3848807|FG005|Overall Study|Adverse Event|0
2209249|NCT01643850|3848808|FG006|Overall Study|Adverse Event|0
2209250|NCT01643850|3848809|FG007|Overall Study|Adverse Event|0
2209251|NCT01643850|3848810|FG008|Overall Study|Adverse Event|0
2209252|NCT01643850|3848802|FG000|Overall Study|Administrative Problems|0
2209253|NCT01643850|3848803|FG001|Overall Study|Administrative Problems|0
2209254|NCT01643850|3848804|FG002|Overall Study|Administrative Problems|1
2299913|NCT02590432|3997033|FG000|Open-label Treatment Period|Withdrawal of Consent|43
2299914|NCT02590432|3997034|FG001|Open-label Treatment Period|Withdrawal of Consent|28
2299915|NCT02590432|3997035|FG002|Open-label Treatment Period|Withdrawal of Consent|0
2299916|NCT02590432|3997036|FG003|Open-label Treatment Period|Withdrawal of Consent|0
2299917|NCT02590432|3997037|FG004|Open-label Treatment Period|Withdrawal of Consent|0
2299918|NCT02590432|3997038|FG005|Open-label Treatment Period|Withdrawal of Consent|0
2299919|NCT02590432|3997039|FG006|Open-label Treatment Period|Withdrawal of Consent|0
2299920|NCT02590432|3997040|FG007|Open-label Treatment Period|Withdrawal of Consent|0
2299921|NCT02590432|3997041|FG008|Open-label Treatment Period|Withdrawal of Consent|0
2299922|NCT02590432|3997033|FG000|Open-label Treatment Period|Lost to Follow-up|51
2299923|NCT02590432|3997034|FG001|Open-label Treatment Period|Lost to Follow-up|29
2299924|NCT02590432|3997035|FG002|Open-label Treatment Period|Lost to Follow-up|0
2299925|NCT02590432|3997036|FG003|Open-label Treatment Period|Lost to Follow-up|0
2209255|NCT01643850|3848805|FG003|Overall Study|Administrative Problems|0
2209256|NCT01643850|3848806|FG004|Overall Study|Administrative Problems|1
2299926|NCT02590432|3997037|FG004|Open-label Treatment Period|Lost to Follow-up|0
2051671|NCT00501046|3624123|FG001|Overall Study|Protocol Violation|1
2051672|NCT00501046|3624122|FG000|Overall Study|Withdrawal by Subject|84
2051673|NCT00501046|3624123|FG001|Overall Study|Withdrawal by Subject|83
2051674|NCT00501046|3624122|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119
2209257|NCT01643850|3848807|FG005|Overall Study|Administrative Problems|0
2209258|NCT01643850|3848808|FG006|Overall Study|Administrative Problems|0
2051675|NCT00501046|3624123|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137
2051676|NCT00501059|3624131|FG000|Overall Study|Protocol Violation|80
2051677|NCT00501059|3624132|FG001|Overall Study|Protocol Violation|69
2051678|NCT00501059|3624131|FG000|Overall Study|Death|140
2051679|NCT00501059|3624132|FG001|Overall Study|Death|137
2051680|NCT00501059|3624131|FG000|Overall Study|Other|236
2051681|NCT00501059|3624132|FG001|Overall Study|Other|239
2051682|NCT00501059|3624131|FG000|Overall Study|Missing end-of-study page|91
2051683|NCT00501059|3624132|FG001|Overall Study|Missing end-of-study page|92
2051684|NCT00501059|3624131|FG000|Overall Study|Clinical endpoint reached|110
2051685|NCT00501059|3624132|FG001|Overall Study|Clinical endpoint reached|123
2051686|NCT00501059|3624131|FG000|Overall Study|Insufficient therapeutic effect|4
2051687|NCT00501059|3624132|FG001|Overall Study|Insufficient therapeutic effect|5
2209259|NCT01643850|3848809|FG007|Overall Study|Administrative Problems|0
2209260|NCT01643850|3848810|FG008|Overall Study|Administrative Problems|0
2209261|NCT01643928|3848890|FG000|Overall Study|Lost to Follow-up|1
2209262|NCT01643928|3848891|FG001|Overall Study|Lost to Follow-up|0
2209263|NCT01643928|3848892|FG002|Overall Study|Lost to Follow-up|2
2209264|NCT01643928|3848893|FG003|Overall Study|Lost to Follow-up|0
2209265|NCT01643928|3848894|FG004|Overall Study|Lost to Follow-up|0
2209266|NCT01643928|3848890|FG000|Overall Study|Withdrawal by Subject|2
2209267|NCT01643928|3848891|FG001|Overall Study|Withdrawal by Subject|0
2209268|NCT01643928|3848892|FG002|Overall Study|Withdrawal by Subject|0
2209269|NCT01643928|3848893|FG003|Overall Study|Withdrawal by Subject|1
2209270|NCT01643928|3848894|FG004|Overall Study|Withdrawal by Subject|0
2209271|NCT01643928|3848890|FG000|Overall Study|Pregnancy|0
2299927|NCT02590432|3997038|FG005|Open-label Treatment Period|Lost to Follow-up|0
2299928|NCT02590432|3997039|FG006|Open-label Treatment Period|Lost to Follow-up|0
2051688|NCT00501059|3624131|FG000|Overall Study|Consent withdrawn by subject|817
2051689|NCT00501059|3624132|FG001|Overall Study|Consent withdrawn by subject|873
2051690|NCT00501059|3624131|FG000|Overall Study|Non-compliant with study treatment|23
2051691|NCT00501059|3624132|FG001|Overall Study|Non-compliant with study treatment|16
2051692|NCT00501059|3624131|FG000|Overall Study|Reason not given|3
2051693|NCT00501059|3624132|FG001|Overall Study|Reason not given|1
2051694|NCT00501059|3624131|FG000|Overall Study|Adverse Event|129
2209272|NCT01643928|3848891|FG001|Overall Study|Pregnancy|0
2299929|NCT02590432|3997040|FG007|Open-label Treatment Period|Lost to Follow-up|0
2299930|NCT02590432|3997041|FG008|Open-label Treatment Period|Lost to Follow-up|0
2299931|NCT02590432|3997033|FG000|Open-label Treatment Period|Protocol Violation|10
2299932|NCT02590432|3997034|FG001|Open-label Treatment Period|Protocol Violation|4
2299933|NCT02590432|3997035|FG002|Open-label Treatment Period|Protocol Violation|0
2299934|NCT02590432|3997036|FG003|Open-label Treatment Period|Protocol Violation|0
2299935|NCT02590432|3997037|FG004|Open-label Treatment Period|Protocol Violation|0
2299936|NCT02590432|3997038|FG005|Open-label Treatment Period|Protocol Violation|0
2299937|NCT02590432|3997039|FG006|Open-label Treatment Period|Protocol Violation|0
2299938|NCT02590432|3997040|FG007|Open-label Treatment Period|Protocol Violation|0
2299939|NCT02590432|3997041|FG008|Open-label Treatment Period|Protocol Violation|0
2299940|NCT02590432|3997033|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7
2299941|NCT02590432|3997034|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1
2299942|NCT02590432|3997035|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0
2299943|NCT02590432|3997036|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0
2299944|NCT02590432|3997037|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0
2299945|NCT02590432|3997038|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0
2299946|NCT02590432|3997039|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0
2299947|NCT02590432|3997040|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0
2299948|NCT02590432|3997041|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0
2299949|NCT02590432|3997033|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10
2299950|NCT02590432|3997034|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6
2299951|NCT02590432|3997035|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0
2299952|NCT02590432|3997036|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0
2299953|NCT02590432|3997037|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0
2299954|NCT02590432|3997038|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0
2299955|NCT02590432|3997039|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0
2299956|NCT02590432|3997040|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0
2299957|NCT02590432|3997041|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0
2299958|NCT02590432|3997033|FG000|Double-blind Treatment Period|Adverse Event|0
2299959|NCT02590432|3997034|FG001|Double-blind Treatment Period|Adverse Event|0
2299960|NCT02590432|3997035|FG002|Double-blind Treatment Period|Adverse Event|14
2299961|NCT02590432|3997036|FG003|Double-blind Treatment Period|Adverse Event|12
2299962|NCT02590432|3997037|FG004|Double-blind Treatment Period|Adverse Event|6
2299963|NCT02590432|3997038|FG005|Double-blind Treatment Period|Adverse Event|22
2299964|NCT02590432|3997039|FG006|Double-blind Treatment Period|Adverse Event|20
2299965|NCT02590432|3997040|FG007|Double-blind Treatment Period|Adverse Event|0
2299966|NCT02590432|3997041|FG008|Double-blind Treatment Period|Adverse Event|0
2299967|NCT02590432|3997033|FG000|Double-blind Treatment Period|Lack of Efficacy|0
2353772|NCT02054910|4107099|FG001|Overall Study|Lost to Follow-up|1
2209273|NCT01643928|3848892|FG002|Overall Study|Pregnancy|0
2051695|NCT00501059|3624132|FG001|Overall Study|Adverse Event|122
2051696|NCT00501059|3624131|FG000|Overall Study|Lost to Follow-up|210
2051697|NCT00501059|3624132|FG001|Overall Study|Lost to Follow-up|198
2051698|NCT00501059|3624131|FG000|Overall Study|Not treated|25
2051699|NCT00501059|3624132|FG001|Overall Study|Not treated|17
2051700|NCT00501085|3624140|FG000|Overall Study|Lost to Follow-up|195
2051701|NCT00501085|3624140|FG000|Overall Study|Withdrawal by Subject|34
2051702|NCT00501085|3624140|FG000|Overall Study|Subject Decision|1
2051703|NCT00501085|3624140|FG000|Overall Study|Revision Surgery|7
2051704|NCT00501085|3624140|FG000|Overall Study|Explantation Surgery|26
2051705|NCT00501085|3624140|FG000|Overall Study|Adverse Event|4
2051706|NCT00501085|3624140|FG000|Overall Study|Non-Compliance|24
2051707|NCT00501085|3624140|FG000|Overall Study|Study closed by sponsor|109
2051708|NCT00501085|3624140|FG000|Overall Study|Other loss to follow-up|32
2051709|NCT00501293|3624146|FG000|Optimization Period|Enrolled in error|1
2051710|NCT00501293|3624147|FG001|Optimization Period|Enrolled in error|0
2051711|NCT00501293|3624146|FG000|Maintenance Period|Withdrawal by Subject|14
2051712|NCT00501293|3624147|FG001|Maintenance Period|Withdrawal by Subject|13
2051713|NCT00501293|3624146|FG000|Maintenance Period|Lost to Follow-up|12
2051714|NCT00501293|3624147|FG001|Maintenance Period|Lost to Follow-up|7
2051715|NCT00501293|3624146|FG000|Maintenance Period|Adverse Event|6
2051716|NCT00501293|3624147|FG001|Maintenance Period|Adverse Event|6
2051717|NCT00501293|3624146|FG000|Maintenance Period|Protocol Violation|2
2051718|NCT00501293|3624147|FG001|Maintenance Period|Protocol Violation|1
2051719|NCT00501293|3624146|FG000|Maintenance Period|Lack of Efficacy|4
2051720|NCT00501293|3624147|FG001|Maintenance Period|Lack of Efficacy|1
2051721|NCT00501293|3624146|FG000|Maintenance Period|Noncompliant with study medication|5
2051722|NCT00501293|3624147|FG001|Maintenance Period|Noncompliant with study medication|0
2051723|NCT00501293|3624146|FG000|Maintenance Period|Went into rehabilitation|1
2051724|NCT00501293|3624147|FG001|Maintenance Period|Went into rehabilitation|0
2051725|NCT00501293|3624146|FG000|Maintenance Period|Would not wear patch|1
2051726|NCT00501293|3624147|FG001|Maintenance Period|Would not wear patch|0
2051727|NCT00501293|3624146|FG000|Maintenance Period|Application site reaction|1
2051728|NCT00501293|3624147|FG001|Maintenance Period|Application site reaction|0
2051729|NCT00501540|3624154|FG000|Overall Study|Death|5
2051730|NCT00501644|3624180|FG000|Overall Study|Adverse Event|4
2051731|NCT00501644|3624180|FG000|Overall Study|Withdrawal by Subject|1
2051732|NCT00501852|3624184|FG000|Overall Study|Adverse Event|3
2051733|NCT00501852|3624184|FG000|Overall Study|Withdrawal by Subject|2
2051734|NCT00501969|3624214|FG000|Overall Study|Major Protocol Violation|4
2051735|NCT00501969|3624214|FG000|Overall Study|Lack of Efficacy|29
2051736|NCT00501969|3624214|FG000|Overall Study|Adverse Event|76
2051737|NCT00501969|3624214|FG000|Overall Study|Unsatisfactory compliance of subject|7
2051738|NCT00501969|3624214|FG000|Overall Study|Subject withdrew consent|51
2051739|NCT00501969|3624214|FG000|Overall Study|Lost to Follow-up|4
2051740|NCT00501969|3624214|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1
2051741|NCT00501969|3624214|FG000|Overall Study|Other: Sponsors Request|10
2051742|NCT00501969|3624214|FG000|Overall Study|Other: Sponsor Termination at Site|1
2051743|NCT00501969|3624214|FG000|Overall Study|Other: Sponsor Stopped Study|12
2051744|NCT00501969|3624214|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1
2051745|NCT00501969|3624214|FG000|Overall Study|Other: Patients + Investigator Agreement|1
2051746|NCT00501969|3624214|FG000|Overall Study|Other: Patient is Going to Have DBS|1
2051747|NCT00501969|3624214|FG000|Overall Study|Other: Pat Pending Surgery for PD|1
2051748|NCT00501969|3624214|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
2051749|NCT00501969|3624214|FG000|Overall Study|Other: As Required by Local EC|2
2051750|NCT00501969|3624214|FG000|Overall Study|Other: Admin Request from the Sponsor|3
2051751|NCT00501969|3624214|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1
2051752|NCT00502203|3624222|FG000|Overall Study|Inevaluable|1
2051753|NCT00502242|3624237|FG000|Overall Study|Lack of Efficacy|1
2051754|NCT00502242|3624238|FG001|Overall Study|Lack of Efficacy|11
2051755|NCT00502242|3624237|FG000|Overall Study|Adverse Event|31
2051756|NCT00502242|3624238|FG001|Overall Study|Adverse Event|20
2051757|NCT00502242|3624237|FG000|Overall Study|Physician Decision|2
2051758|NCT00502242|3624238|FG001|Overall Study|Physician Decision|3
2051759|NCT00502242|3624237|FG000|Overall Study|Other - Unspecified|8
2051760|NCT00502242|3624238|FG001|Overall Study|Other - Unspecified|14
2051761|NCT00502242|3624237|FG000|Overall Study|Protocol Violation|3
2051762|NCT00502242|3624238|FG001|Overall Study|Protocol Violation|1
2051763|NCT00502242|3624237|FG000|Overall Study|Withdrawal by Subject|6
2051764|NCT00502242|3624238|FG001|Overall Study|Withdrawal by Subject|7
2051765|NCT00502307|3624244|FG000|Open Label Period (16 Weeks)|Progressive disease|50
2051766|NCT00502307|3624245|FG001|Open Label Period (16 Weeks)|Progressive disease|0
2051767|NCT00502307|3624246|FG002|Open Label Period (16 Weeks)|Progressive disease|0
2051768|NCT00502307|3624244|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26
2051769|NCT00502307|3624245|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
2051770|NCT00502307|3624246|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
2051771|NCT00502307|3624244|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0
2051772|NCT00502307|3624245|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23
2051773|NCT00502307|3624246|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2
2051774|NCT00502307|3624244|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0
2051775|NCT00502307|3624245|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3
2051776|NCT00502307|3624246|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7
2051777|NCT00502307|3624244|FG000|Maintenance Period|Progressive disease|80
2051778|NCT00502307|3624245|FG001|Maintenance Period|Progressive disease|0
2051779|NCT00502307|3624246|FG002|Maintenance Period|Progressive disease|0
2051780|NCT00502307|3624244|FG000|Maintenance Period|Discontinued due to other reasons|68
2051781|NCT00502307|3624245|FG001|Maintenance Period|Discontinued due to other reasons|0
2051782|NCT00502307|3624246|FG002|Maintenance Period|Discontinued due to other reasons|0
2051783|NCT00502320|3624265|FG000|Overall Study|Lost to Follow-up|1
2051784|NCT00502320|3624266|FG001|Overall Study|Lost to Follow-up|1
2051785|NCT00502320|3624265|FG000|Overall Study|Withdrew Consent|1
2051786|NCT00502320|3624266|FG001|Overall Study|Withdrew Consent|0
2051787|NCT00502320|3624265|FG000|Overall Study|No longer met criteria|1
2051788|NCT00502320|3624266|FG001|Overall Study|No longer met criteria|0
2051789|NCT00502320|3624265|FG000|Overall Study|Screen Failure|0
2051790|NCT00502320|3624266|FG001|Overall Study|Screen Failure|1
2051791|NCT00502320|3624265|FG000|Overall Study|Adverse Event|3
2051792|NCT00502320|3624266|FG001|Overall Study|Adverse Event|5
2051793|NCT00502593|3624284|FG000|Overall Study|Withdrawn unspecified reason|1
2051794|NCT00502593|3624285|FG001|Overall Study|Withdrawn unspecified reason|1
2051795|NCT00502593|3624286|FG002|Overall Study|Withdrawn unspecified reason|3
2051796|NCT00502593|3624287|FG003|Overall Study|Withdrawn unspecified reason|1
2051797|NCT00502593|3624288|FG004|Overall Study|Withdrawn unspecified reason|2
2051798|NCT00502593|3624289|FG005|Overall Study|Withdrawn unspecified reason|0
2051799|NCT00502593|3624290|FG006|Overall Study|Withdrawn unspecified reason|2
2051800|NCT00502593|3624291|FG007|Overall Study|Withdrawn unspecified reason|0
2051801|NCT00502593|3624292|FG008|Overall Study|Withdrawn unspecified reason|0
2051802|NCT00502593|3624293|FG009|Overall Study|Withdrawn unspecified reason|0
2051803|NCT00502593|3624294|FG010|Overall Study|Withdrawn unspecified reason|0
2051804|NCT00502593|3624295|FG011|Overall Study|Withdrawn unspecified reason|0
2051805|NCT00502593|3624284|FG000|Overall Study|Withdrawal by Subject|0
2051806|NCT00502593|3624285|FG001|Overall Study|Withdrawal by Subject|0
2051807|NCT00502593|3624286|FG002|Overall Study|Withdrawal by Subject|6
2051808|NCT00502593|3624287|FG003|Overall Study|Withdrawal by Subject|2
2051809|NCT00502593|3624288|FG004|Overall Study|Withdrawal by Subject|2
2051810|NCT00502593|3624289|FG005|Overall Study|Withdrawal by Subject|0
2051811|NCT00502593|3624290|FG006|Overall Study|Withdrawal by Subject|3
2051812|NCT00502593|3624291|FG007|Overall Study|Withdrawal by Subject|0
2051813|NCT00502593|3624292|FG008|Overall Study|Withdrawal by Subject|3
2051814|NCT00502593|3624293|FG009|Overall Study|Withdrawal by Subject|0
2051815|NCT00502593|3624294|FG010|Overall Study|Withdrawal by Subject|1
2051816|NCT00502593|3624295|FG011|Overall Study|Withdrawal by Subject|0
2299968|NCT02590432|3997034|FG001|Double-blind Treatment Period|Lack of Efficacy|0
2299969|NCT02590432|3997035|FG002|Double-blind Treatment Period|Lack of Efficacy|1
2299970|NCT02590432|3997036|FG003|Double-blind Treatment Period|Lack of Efficacy|0
2299971|NCT02590432|3997037|FG004|Double-blind Treatment Period|Lack of Efficacy|0
2299972|NCT02590432|3997038|FG005|Double-blind Treatment Period|Lack of Efficacy|0
2299973|NCT02590432|3997039|FG006|Double-blind Treatment Period|Lack of Efficacy|0
2299974|NCT02590432|3997040|FG007|Double-blind Treatment Period|Lack of Efficacy|0
2299975|NCT02590432|3997041|FG008|Double-blind Treatment Period|Lack of Efficacy|0
2299976|NCT02590432|3997033|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
2299977|NCT02590432|3997034|FG001|Double-blind Treatment Period|Withdrawal of Consent|0
2299978|NCT02590432|3997035|FG002|Double-blind Treatment Period|Withdrawal of Consent|1
2299979|NCT02590432|3997036|FG003|Double-blind Treatment Period|Withdrawal of Consent|3
2299980|NCT02590432|3997037|FG004|Double-blind Treatment Period|Withdrawal of Consent|3
2299981|NCT02590432|3997038|FG005|Double-blind Treatment Period|Withdrawal of Consent|1
2299982|NCT02590432|3997039|FG006|Double-blind Treatment Period|Withdrawal of Consent|1
2299983|NCT02590432|3997040|FG007|Double-blind Treatment Period|Withdrawal of Consent|0
2299984|NCT02590432|3997041|FG008|Double-blind Treatment Period|Withdrawal of Consent|0
2299985|NCT02590432|3997033|FG000|Double-blind Treatment Period|Lost to Follow-up|0
2299986|NCT02590432|3997034|FG001|Double-blind Treatment Period|Lost to Follow-up|0
2299987|NCT02590432|3997035|FG002|Double-blind Treatment Period|Lost to Follow-up|1
2299988|NCT02590432|3997036|FG003|Double-blind Treatment Period|Lost to Follow-up|0
2299989|NCT02590432|3997037|FG004|Double-blind Treatment Period|Lost to Follow-up|0
2299990|NCT02590432|3997038|FG005|Double-blind Treatment Period|Lost to Follow-up|2
2299991|NCT02590432|3997039|FG006|Double-blind Treatment Period|Lost to Follow-up|0
2299992|NCT02590432|3997040|FG007|Double-blind Treatment Period|Lost to Follow-up|0
2299993|NCT02590432|3997041|FG008|Double-blind Treatment Period|Lost to Follow-up|0
2299994|NCT02590432|3997033|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0
2299995|NCT02590432|3997034|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0
2299996|NCT02590432|3997035|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0
2299997|NCT02590432|3997036|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0
2299998|NCT02590432|3997037|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0
2299999|NCT02590432|3997038|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1
2300000|NCT02590432|3997039|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0
2051817|NCT00502593|3624284|FG000|Overall Study|Lost to Follow-up|2
2051818|NCT00502593|3624285|FG001|Overall Study|Lost to Follow-up|1
2051819|NCT00502593|3624286|FG002|Overall Study|Lost to Follow-up|1
2051820|NCT00502593|3624287|FG003|Overall Study|Lost to Follow-up|1
2051821|NCT00502593|3624288|FG004|Overall Study|Lost to Follow-up|0
2051822|NCT00502593|3624289|FG005|Overall Study|Lost to Follow-up|0
2051823|NCT00502593|3624290|FG006|Overall Study|Lost to Follow-up|0
2051824|NCT00502593|3624291|FG007|Overall Study|Lost to Follow-up|0
2051825|NCT00502593|3624292|FG008|Overall Study|Lost to Follow-up|3
2051826|NCT00502593|3624293|FG009|Overall Study|Lost to Follow-up|0
2051827|NCT00502593|3624294|FG010|Overall Study|Lost to Follow-up|1
2051828|NCT00502593|3624295|FG011|Overall Study|Lost to Follow-up|0
2051829|NCT00502671|3624344|FG000|Overall Study|Disease Progression|13
2051830|NCT00502671|3624344|FG000|Overall Study|Personal Reasons|22
2051831|NCT00502671|3624344|FG000|Overall Study|Lost to Follow-up|7
2051832|NCT00502671|3624344|FG000|Overall Study|Protocol Violation|16
2051833|NCT00502671|3624344|FG000|Overall Study|Adverse Event|19
2051834|NCT00502697|3624350|FG000|Overall Study|Withdrawal by Subject|3
2051835|NCT00502697|3624351|FG001|Overall Study|Withdrawal by Subject|1
2051836|NCT00502697|3624350|FG000|Overall Study|disenrolled due to pregnancy loss|3
2051837|NCT00502697|3624351|FG001|Overall Study|disenrolled due to pregnancy loss|5
2051838|NCT00502697|3624350|FG000|Overall Study|found not to meet eligibility criteria|3
2051839|NCT00502697|3624351|FG001|Overall Study|found not to meet eligibility criteria|4
2051840|NCT00502697|3624350|FG000|Overall Study|did not meet assignment criteria|4
2051841|NCT00502697|3624351|FG001|Overall Study|did not meet assignment criteria|2
2051842|NCT00502775|3624360|FG000|Overall Study|Adverse Event|1
2051843|NCT00502775|3624361|FG001|Overall Study|Adverse Event|2
2051844|NCT00502775|3624362|FG002|Overall Study|Adverse Event|1
2051845|NCT00502775|3624360|FG000|Overall Study|Protocol Violation|1
2051846|NCT00502775|3624361|FG001|Overall Study|Protocol Violation|5
2051847|NCT00502775|3624362|FG002|Overall Study|Protocol Violation|2
2051848|NCT00502775|3624360|FG000|Overall Study|Withdrawal by Subject|1
2051849|NCT00502775|3624361|FG001|Overall Study|Withdrawal by Subject|1
2051850|NCT00502775|3624362|FG002|Overall Study|Withdrawal by Subject|2
2051851|NCT00502775|3624360|FG000|Overall Study|Sponsor Terminated Study|1
2051852|NCT00502775|3624361|FG001|Overall Study|Sponsor Terminated Study|0
2051853|NCT00502775|3624362|FG002|Overall Study|Sponsor Terminated Study|1
2051854|NCT00502775|3624360|FG000|Overall Study|Non-compliance with eDiary|4
2051855|NCT00502775|3624361|FG001|Overall Study|Non-compliance with eDiary|1
2051856|NCT00502775|3624362|FG002|Overall Study|Non-compliance with eDiary|1
2051857|NCT00502775|3624360|FG000|Overall Study|Subject unable to swallow capsule|1
2051858|NCT00502775|3624361|FG001|Overall Study|Subject unable to swallow capsule|0
2051859|NCT00502775|3624362|FG002|Overall Study|Subject unable to swallow capsule|1
2051860|NCT00502775|3624360|FG000|Overall Study|Logpad compliance <80%|1
2051861|NCT00502775|3624361|FG001|Overall Study|Logpad compliance <80%|0
2051862|NCT00502775|3624362|FG002|Overall Study|Logpad compliance <80%|0
2051863|NCT00502775|3624360|FG000|Overall Study|Randomized in error|0
2051864|NCT00502775|3624361|FG001|Overall Study|Randomized in error|1
2051865|NCT00502775|3624362|FG002|Overall Study|Randomized in error|1
2051866|NCT00502775|3624360|FG000|Overall Study|Non-compliance|0
2051867|NCT00502775|3624361|FG001|Overall Study|Non-compliance|2
2051868|NCT00502775|3624362|FG002|Overall Study|Non-compliance|2
2051869|NCT00502775|3624360|FG000|Overall Study|Outside pollen area more than 48 hours|0
2051870|NCT00502775|3624361|FG001|Overall Study|Outside pollen area more than 48 hours|1
2051871|NCT00502775|3624362|FG002|Overall Study|Outside pollen area more than 48 hours|0
2051872|NCT00502775|3624360|FG000|Overall Study|Declining pollen counts|0
2051873|NCT00502775|3624361|FG001|Overall Study|Declining pollen counts|1
2051874|NCT00502775|3624362|FG002|Overall Study|Declining pollen counts|1
2051875|NCT00502775|3624360|FG000|Overall Study|Subject in jail|0
2051876|NCT00502775|3624361|FG001|Overall Study|Subject in jail|1
2051877|NCT00502775|3624362|FG002|Overall Study|Subject in jail|0
2051878|NCT00502775|3624360|FG000|Overall Study|Subject took disallowed drug|0
2051879|NCT00502775|3624361|FG001|Overall Study|Subject took disallowed drug|0
2051880|NCT00502775|3624362|FG002|Overall Study|Subject took disallowed drug|1
2051881|NCT00502801|3624370|FG000|Treatment Period|Withdrawal by Subject|3
2051882|NCT00502801|3624370|FG000|Treatment Period|Adverse Event|7
2051883|NCT00502801|3624370|FG000|Treatment Period|Death|14
2051884|NCT00502801|3624370|FG000|Treatment Period|OTHER|30
2051885|NCT00502801|3624370|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1
2051886|NCT00502801|3624370|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2
2051887|NCT00502801|3624370|FG000|End of Therapy to Test of Cure|Death|3
2051888|NCT00502801|3624370|FG000|End of Therapy to Test of Cure|OTHER|2
2051889|NCT00502840|3624374|FG000|Overall Study|Adverse Event|5
2051890|NCT00502840|3624374|FG000|Overall Study|Additional or changed therapy|48
2051891|NCT00502840|3624374|FG000|Overall Study|Lack of Efficacy|11
2051892|NCT00502840|3624374|FG000|Overall Study|Protocol Violation|4
2051893|NCT00502840|3624374|FG000|Overall Study|Withdrawal by Subject|5
2051894|NCT00502840|3624374|FG000|Overall Study|Lost to Follow-up|6
2051895|NCT00502840|3624374|FG000|Overall Study|Administrative problems|1
2051896|NCT00502840|3624374|FG000|Overall Study|Other|20
2051897|NCT00502996|3624397|FG000|Overall Study|Lost to Follow-up|9
2051898|NCT00502996|3624397|FG000|Overall Study|Protocol Violation|2
2051899|NCT00502996|3624397|FG000|Overall Study|Treatment failure|25
2051900|NCT00502996|3624397|FG000|Overall Study|Withdrawal Informed Consent|6
2051901|NCT00502996|3624397|FG000|Overall Study|Adverse Event|2
2051902|NCT00503139|3624414|FG000|Overall Study|Case Report Forms were not collected|4
2051903|NCT00503139|3624414|FG000|Overall Study|Protocol Violation|4
2051904|NCT00503308|3624420|FG000|Overall Study|Protocol Violation|2
2051905|NCT00503308|3624421|FG001|Overall Study|Protocol Violation|1
2051906|NCT00503399|3624429|FG000|Overall Study|Death|2
2051907|NCT00503399|3624430|FG001|Overall Study|Death|1
2051908|NCT00503399|3624429|FG000|Overall Study|Protocol Violation|1
2051909|NCT00503399|3624430|FG001|Overall Study|Protocol Violation|0
2051910|NCT00503399|3624429|FG000|Overall Study|Withdrawal by Subject|4
2051911|NCT00503399|3624430|FG001|Overall Study|Withdrawal by Subject|2
2051912|NCT00503399|3624429|FG000|Overall Study|Adverse Event|0
2051913|NCT00503399|3624430|FG001|Overall Study|Adverse Event|3
2051914|NCT00503399|3624429|FG000|Overall Study|Lost to Follow-up|0
2051915|NCT00503399|3624430|FG001|Overall Study|Lost to Follow-up|2
2051916|NCT00503425|3624436|FG000|Overall Study|Participant files lost|6
2051917|NCT00503425|3624436|FG000|Overall Study|Adverse Event|5
2051918|NCT00503425|3624436|FG000|Overall Study|Lack of Efficacy|25
2051919|NCT00503425|3624436|FG000|Overall Study|Withdrawal by Subject|8
2051920|NCT00503425|3624436|FG000|Overall Study|Lost to Follow-up|3
2051921|NCT00503425|3624436|FG000|Overall Study|Death|3
2051922|NCT00503425|3624436|FG000|Overall Study|Missing Data/Unknown|4
2051923|NCT00503685|3624444|FG000|Overall Study|Adverse Event|0
2209274|NCT01643928|3848893|FG003|Overall Study|Pregnancy|1
2209275|NCT01643928|3848894|FG004|Overall Study|Pregnancy|0
2209276|NCT01643928|3848890|FG000|Overall Study|Other|5
2209277|NCT01643928|3848891|FG001|Overall Study|Other|1
2209278|NCT01643928|3848892|FG002|Overall Study|Other|1
2209279|NCT01643928|3848893|FG003|Overall Study|Other|0
2209280|NCT01643928|3848894|FG004|Overall Study|Other|0
2209281|NCT01643928|3848890|FG000|Overall Study|Adverse Event|2
2209282|NCT01643928|3848891|FG001|Overall Study|Adverse Event|1
2209283|NCT01643928|3848892|FG002|Overall Study|Adverse Event|0
2209284|NCT01643928|3848893|FG003|Overall Study|Adverse Event|1
2209285|NCT01643928|3848894|FG004|Overall Study|Adverse Event|2
2209286|NCT01644149|3848942|FG000|Overall Study|Withdrawal by Subject|1
2300001|NCT02590432|3997040|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0
2300002|NCT02590432|3997041|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0
2300003|NCT02590432|3997033|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0
2300004|NCT02590432|3997034|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0
2300005|NCT02590432|3997035|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0
2300006|NCT02590432|3997036|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0
2300007|NCT02590432|3997037|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0
2300008|NCT02590432|3997038|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0
2300009|NCT02590432|3997039|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0
2300010|NCT02590432|3997040|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12
2300011|NCT02590432|3997041|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15
2300012|NCT02590432|3997033|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2300013|NCT02590432|3997034|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2300014|NCT02590432|3997035|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2300015|NCT02590432|3997036|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2300016|NCT02590432|3997037|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2300017|NCT02590432|3997038|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2300018|NCT02590432|3997039|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2300019|NCT02590432|3997040|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
2300020|NCT02590432|3997041|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2300021|NCT02590432|3997033|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2300022|NCT02590432|3997034|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2300023|NCT02590432|3997035|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2300024|NCT02590432|3997036|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2300025|NCT02590432|3997037|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2300026|NCT02590432|3997038|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2300027|NCT02590432|3997039|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2300028|NCT02590432|3997040|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
2300029|NCT02590432|3997041|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
2300030|NCT02590432|3997033|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2300031|NCT02590432|3997034|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2300032|NCT02590432|3997035|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2300033|NCT02590432|3997036|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2300034|NCT02590432|3997037|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2300035|NCT02590432|3997038|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2300036|NCT02590432|3997039|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2300037|NCT02590432|3997040|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2051924|NCT00503685|3624445|FG001|Overall Study|Adverse Event|0
2209287|NCT01644149|3848943|FG001|Overall Study|Withdrawal by Subject|0
2051925|NCT00503685|3624446|FG002|Overall Study|Adverse Event|2
2051926|NCT00503685|3624444|FG000|Overall Study|Withdrawal by Subject|0
2051927|NCT00503685|3624445|FG001|Overall Study|Withdrawal by Subject|1
2051928|NCT00503685|3624446|FG002|Overall Study|Withdrawal by Subject|0
2051929|NCT00503685|3624444|FG000|Overall Study|Protocol Violation|0
2051930|NCT00503685|3624445|FG001|Overall Study|Protocol Violation|1
2051931|NCT00503685|3624446|FG002|Overall Study|Protocol Violation|0
2051932|NCT00503685|3624444|FG000|Overall Study|Eligibility Criteria Not Met|0
2051933|NCT00503685|3624445|FG001|Overall Study|Eligibility Criteria Not Met|1
2051934|NCT00503685|3624446|FG002|Overall Study|Eligibility Criteria Not Met|0
2051935|NCT00503698|3624457|FG000|Overall Study|Protocol Violation|5
2051936|NCT00503698|3624458|FG001|Overall Study|Protocol Violation|6
2051937|NCT00503698|3624457|FG000|Overall Study|Adverse Event|52
2051938|NCT00503698|3624458|FG001|Overall Study|Adverse Event|41
2051939|NCT00503698|3624457|FG000|Overall Study|Death|1
2051940|NCT00503698|3624458|FG001|Overall Study|Death|0
2051941|NCT00503698|3624457|FG000|Overall Study|Lack of Efficacy|3
2051942|NCT00503698|3624458|FG001|Overall Study|Lack of Efficacy|4
2051943|NCT00503698|3624457|FG000|Overall Study|Trial terminated|216
2051944|NCT00503698|3624458|FG001|Overall Study|Trial terminated|253
2051945|NCT00503698|3624457|FG000|Overall Study|End hemodialysis due to renal transplant|10
2051946|NCT00503698|3624458|FG001|Overall Study|End hemodialysis due to renal transplant|4
2051947|NCT00503698|3624457|FG000|Overall Study|Pregnancy/intention to become pregnant|1
2051948|NCT00503698|3624458|FG001|Overall Study|Pregnancy/intention to become pregnant|0
2051949|NCT00503698|3624457|FG000|Overall Study|Any condition in exclusion criteria|4
2051950|NCT00503698|3624458|FG001|Overall Study|Any condition in exclusion criteria|6
2051951|NCT00503698|3624457|FG000|Overall Study|Switch to peritoneal or home dialysis|2
2051952|NCT00503698|3624458|FG001|Overall Study|Switch to peritoneal or home dialysis|2
2051953|NCT00503698|3624457|FG000|Overall Study|Move to nonparticipating dialysis center|2
2051954|NCT00503698|3624458|FG001|Overall Study|Move to nonparticipating dialysis center|1
2051955|NCT00503698|3624457|FG000|Overall Study|Critically ill|2
2209288|NCT01644149|3848942|FG000|Overall Study|Lost to Follow-up|3
2209289|NCT01644149|3848943|FG001|Overall Study|Lost to Follow-up|1
2300038|NCT02590432|3997041|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
2300039|NCT02590432|3997033|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2300040|NCT02590432|3997034|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2300041|NCT02590432|3997035|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2300042|NCT02590432|3997036|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2300043|NCT02590432|3997037|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2300044|NCT02590432|3997038|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2300045|NCT02590432|3997039|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2300046|NCT02590432|3997040|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2300047|NCT02590432|3997041|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1
2300048|NCT02590432|3997033|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2300049|NCT02590432|3997034|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2300050|NCT02590432|3997035|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2300051|NCT02590432|3997036|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2300052|NCT02590432|3997037|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2300053|NCT02590432|3997038|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2300054|NCT02590432|3997039|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2300055|NCT02590432|3997040|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
2300056|NCT02590432|3997041|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2300057|NCT02590432|3997033|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2300058|NCT02590432|3997034|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2300059|NCT02590432|3997035|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2300060|NCT02590432|3997036|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2300061|NCT02590432|3997037|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2300062|NCT02590432|3997038|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2300063|NCT02590432|3997039|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2300064|NCT02590432|3997040|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
2300065|NCT02590432|3997041|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2300066|NCT02590562|3997053|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6
2300067|NCT02590588|3997063|FG000|Overall Study|Adverse Event|1
2300068|NCT02590939|3997069|FG000|Overall Study|Withdrawal by Subject|3
2300069|NCT02590939|3997070|FG001|Overall Study|Withdrawal by Subject|1
2300070|NCT02590939|3997069|FG000|Overall Study|Failed the nociceptive test|2
2300071|NCT02590939|3997070|FG001|Overall Study|Failed the nociceptive test|1
2300072|NCT02591238|3997084|FG000|Overall Study|Pregnancy|1
2300073|NCT02591238|3997085|FG001|Overall Study|Pregnancy|0
2300074|NCT02591238|3997086|FG002|Overall Study|Pregnancy|0
2300075|NCT02591238|3997087|FG003|Overall Study|Pregnancy|0
2300076|NCT02591238|3997084|FG000|Overall Study|Withdrawal by Subject|0
2300077|NCT02591238|3997085|FG001|Overall Study|Withdrawal by Subject|0
2051956|NCT00503698|3624458|FG001|Overall Study|Critically ill|0
2051957|NCT00503698|3624457|FG000|Overall Study|Unclassified|48
2051958|NCT00503698|3624458|FG001|Overall Study|Unclassified|32
2051959|NCT00503698|3624457|FG000|Overall Study|Not exposed to trial drug|11
2051960|NCT00503698|3624458|FG001|Overall Study|Not exposed to trial drug|6
2051961|NCT00503776|3624472|FG000|Overall Study|Withdrawal by Subject|1
2051962|NCT00503776|3624473|FG001|Overall Study|Withdrawal by Subject|0
2051963|NCT00503776|3624474|FG002|Overall Study|Withdrawal by Subject|1
2051964|NCT00503776|3624475|FG003|Overall Study|Withdrawal by Subject|1
2051965|NCT00503776|3624472|FG000|Overall Study|Physician Decision|0
2051966|NCT00503776|3624473|FG001|Overall Study|Physician Decision|0
2051967|NCT00503776|3624474|FG002|Overall Study|Physician Decision|1
2051968|NCT00503776|3624475|FG003|Overall Study|Physician Decision|1
2051969|NCT00503867|3624490|FG000|Overall Study|Lost to Follow-up|1
2051970|NCT00503867|3624490|FG000|Overall Study|Adverse Event|1
2051971|NCT00503906|3624494|FG000|Overall Study|Withdrawal by Subject|1
2051972|NCT00503984|3624501|FG000|Overall Study|Protocol Violation|0
2051973|NCT00503984|3624502|FG001|Overall Study|Protocol Violation|1
2051974|NCT00503984|3624503|FG002|Overall Study|Protocol Violation|0
2051975|NCT00503984|3624504|FG003|Overall Study|Protocol Violation|0
2051976|NCT00503984|3624505|FG004|Overall Study|Protocol Violation|0
2051977|NCT00503984|3624506|FG005|Overall Study|Protocol Violation|0
2051978|NCT00503984|3624501|FG000|Overall Study|Adverse Event|0
2051979|NCT00503984|3624502|FG001|Overall Study|Adverse Event|1
2051980|NCT00503984|3624503|FG002|Overall Study|Adverse Event|0
2051981|NCT00503984|3624504|FG003|Overall Study|Adverse Event|0
2051982|NCT00503984|3624505|FG004|Overall Study|Adverse Event|0
2051983|NCT00503984|3624506|FG005|Overall Study|Adverse Event|0
2051984|NCT00503984|3624501|FG000|Overall Study|Death|0
2051985|NCT00503984|3624502|FG001|Overall Study|Death|0
2051986|NCT00503984|3624503|FG002|Overall Study|Death|0
2051987|NCT00503984|3624504|FG003|Overall Study|Death|0
2051988|NCT00503984|3624505|FG004|Overall Study|Death|1
2051989|NCT00503984|3624506|FG005|Overall Study|Death|0
2051990|NCT00503997|3624530|FG000|Overall Study|disease progression|1
2051991|NCT00503997|3624530|FG000|Overall Study|Adverse Event|5
2051992|NCT00503997|3624530|FG000|Overall Study|Death|1
2051993|NCT00503997|3624530|FG000|Overall Study|Withdrawal by Subject|1
2051994|NCT00504075|3624538|FG000|Overall Study|Adverse Event|1
2051995|NCT00504075|3624538|FG000|Overall Study|Lost to Follow-up|5
2051996|NCT00504075|3624538|FG000|Overall Study|Withdrawal by Subject|1
2300078|NCT02591238|3997086|FG002|Overall Study|Withdrawal by Subject|0
2300079|NCT02591238|3997087|FG003|Overall Study|Withdrawal by Subject|1
2300080|NCT02591238|3997084|FG000|Overall Study|influenza|0
2300081|NCT02591238|3997085|FG001|Overall Study|influenza|0
2300082|NCT02591238|3997086|FG002|Overall Study|influenza|0
2300083|NCT02591238|3997087|FG003|Overall Study|influenza|1
2300084|NCT02591238|3997084|FG000|Overall Study|personal circumstances|0
2300085|NCT02591238|3997085|FG001|Overall Study|personal circumstances|0
2300086|NCT02591238|3997086|FG002|Overall Study|personal circumstances|0
2300087|NCT02591238|3997087|FG003|Overall Study|personal circumstances|1
2300088|NCT02591238|3997084|FG000|Overall Study|personal circumstances|0
2300089|NCT02591238|3997085|FG001|Overall Study|personal circumstances|1
2300090|NCT02591238|3997086|FG002|Overall Study|personal circumstances|0
2300091|NCT02591238|3997087|FG003|Overall Study|personal circumstances|0
2300092|NCT02591290|3997097|FG000|Overall Study|Withdrawal by Subject|2
2300093|NCT02592018|3997120|FG000|Overall Study|Adverse Event|1
2300094|NCT02592018|3997120|FG000|Overall Study|Lost to Follow-up|1
2300095|NCT02592434|3997133|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12
2300096|NCT02592434|3997134|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0
2300097|NCT02592434|3997135|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0
2300098|NCT02592434|3997133|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
2300099|NCT02592434|3997134|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
2300100|NCT02592434|3997135|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
2300101|NCT02592434|3997133|FG000|Open-Label Phase (18 Weeks)|Other|3
2300102|NCT02592434|3997134|FG001|Open-Label Phase (18 Weeks)|Other|0
2300103|NCT02592434|3997135|FG002|Open-Label Phase (18 Weeks)|Other|0
2300104|NCT02592434|3997133|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4
2300105|NCT02592434|3997134|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0
2300106|NCT02592434|3997135|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0
2300107|NCT02592434|3997133|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0
2300108|NCT02592434|3997134|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2
2300109|NCT02592434|3997135|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2
2300110|NCT02592434|3997133|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
2300111|NCT02592434|3997134|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
2300112|NCT02592434|3997135|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
2300113|NCT02592434|3997133|FG000|Double Blind Phase (26 Weeks)|Other|0
2300114|NCT02592434|3997134|FG001|Double Blind Phase (26 Weeks)|Other|1
2300115|NCT02592434|3997135|FG002|Double Blind Phase (26 Weeks)|Other|0
2051997|NCT00504075|3624538|FG000|Overall Study|Required other therapeutic intervention|1
2051998|NCT00504153|3624543|FG000|Overall Study|Withdrawal by Subject|1
2051999|NCT00504153|3624543|FG000|Overall Study|Adverse Event|4
2052000|NCT00504153|3624543|FG000|Overall Study|Death|1
2052001|NCT00504166|3624549|FG000|Overall Study|Adverse Event|1
2052002|NCT00504166|3624550|FG001|Overall Study|Adverse Event|4
2052003|NCT00504166|3624549|FG000|Overall Study|Withdrawal by Subject|3
2052004|NCT00504166|3624550|FG001|Overall Study|Withdrawal by Subject|6
2052005|NCT00504166|3624549|FG000|Overall Study|Physician Decision|1
2052006|NCT00504166|3624550|FG001|Overall Study|Physician Decision|1
2052007|NCT00504166|3624549|FG000|Overall Study|Lost to Follow-up|1
2052008|NCT00504166|3624550|FG001|Overall Study|Lost to Follow-up|3
2052009|NCT00504231|3624560|FG000|Overall Study|Discrepant chart documentation re route|0
2052010|NCT00504231|3624561|FG001|Overall Study|Discrepant chart documentation re route|0
2052011|NCT00504231|3624562|FG002|Overall Study|Discrepant chart documentation re route|1
2052012|NCT00504231|3624563|FG003|Overall Study|Discrepant chart documentation re route|0
2052013|NCT00504257|3624577|FG000|Overall Study|Withdrawal by Subject|2
2052014|NCT00504257|3624577|FG000|Overall Study|ineligible histology|2
2052015|NCT00504309|3624587|FG000|Overall Study|Death|0
2052016|NCT00504309|3624588|FG001|Overall Study|Death|0
2052017|NCT00504309|3624589|FG002|Overall Study|Death|0
2052018|NCT00504309|3624590|FG003|Overall Study|Death|0
2052019|NCT00504309|3624591|FG004|Overall Study|Death|1
2052020|NCT00504309|3624592|FG005|Overall Study|Death|0
2052021|NCT00504309|3624587|FG000|Overall Study|Withdrawal by Subject|0
2052022|NCT00504309|3624588|FG001|Overall Study|Withdrawal by Subject|0
2052023|NCT00504309|3624589|FG002|Overall Study|Withdrawal by Subject|1
2052024|NCT00504309|3624590|FG003|Overall Study|Withdrawal by Subject|0
2052025|NCT00504309|3624591|FG004|Overall Study|Withdrawal by Subject|0
2052026|NCT00504309|3624592|FG005|Overall Study|Withdrawal by Subject|0
2105347|NCT00856635|3697899|FG000|Overall Study|Serious Adverse Event|1
2105348|NCT00856635|3697900|FG001|Overall Study|Serious Adverse Event|0
2300116|NCT02592434|3997133|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0
2300117|NCT02592434|3997134|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0
2300118|NCT02592434|3997135|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1
2300119|NCT02592434|3997133|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
2300120|NCT02592434|3997134|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
2300121|NCT02592434|3997135|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
2300122|NCT02592434|3997133|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
2300123|NCT02592434|3997134|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
2300124|NCT02592434|3997135|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
2300125|NCT02592447|3997145|FG000|Overall Study|Lost to Follow-up|1
2300126|NCT02592447|3997146|FG001|Overall Study|Lost to Follow-up|0
2300127|NCT02592447|3997145|FG000|Overall Study|Ineligible after randomization|1
2300128|NCT02592447|3997146|FG001|Overall Study|Ineligible after randomization|0
2300129|NCT02592447|3997145|FG000|Overall Study|Withdrawal by Subject|0
2300130|NCT02592447|3997146|FG001|Overall Study|Withdrawal by Subject|1
2300131|NCT02592798|3997193|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1
2300132|NCT02592798|3997194|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0
2300133|NCT02592798|3997193|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0
2300134|NCT02592798|3997194|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1
2300135|NCT02592798|3997193|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1
2300136|NCT02592798|3997194|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3
2300137|NCT02592798|3997193|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1
2300138|NCT02592798|3997194|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2
2300139|NCT02592798|3997193|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3
2300140|NCT02592798|3997194|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2
2300141|NCT02592798|3997193|FG000|Double-Blind Period 2 (DB2)|Other reasons|1
2300142|NCT02592798|3997194|FG001|Double-Blind Period 2 (DB2)|Other reasons|0
2300143|NCT02592798|3997193|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1
2300144|NCT02592798|3997194|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0
2300145|NCT02592798|3997193|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1
2300146|NCT02592798|3997194|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0
2300147|NCT02592798|3997193|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1
2300148|NCT02592798|3997194|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2
2300149|NCT02592798|3997193|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1
2300150|NCT02592798|3997194|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0
2300151|NCT02592798|3997193|FG000|Transition From DB2 to OLE|Other reasons|1
2300152|NCT02592798|3997194|FG001|Transition From DB2 to OLE|Other reasons|0
2300153|NCT02592798|3997193|FG000|Open Label Period (OLE)|Other reasons|0
2300154|NCT02592798|3997194|FG001|Open Label Period (OLE)|Other reasons|2
2300155|NCT02592798|3997193|FG000|Open Label Period (OLE)|Participant request to discontinue|1
2300156|NCT02592798|3997194|FG001|Open Label Period (OLE)|Participant request to discontinue|0
2300157|NCT02592798|3997193|FG000|Open Label Period (OLE)|Lost to Follow-up|0
2300158|NCT02592798|3997194|FG001|Open Label Period (OLE)|Lost to Follow-up|1
2300159|NCT02592798|3997193|FG000|Open Label Period (OLE)|Lack of Efficacy|3
2300160|NCT02592798|3997194|FG001|Open Label Period (OLE)|Lack of Efficacy|5
2300161|NCT02592798|3997193|FG000|Open Label Period (OLE)|Adverse Event|0
2300162|NCT02592798|3997194|FG001|Open Label Period (OLE)|Adverse Event|1
2300163|NCT02592876|3997209|FG000|Overall Study|Withdrawal by Subject|3
2105349|NCT00856635|3697899|FG000|Overall Study|Other|1
2052027|NCT00504348|3624604|FG000|Overall Study|Adverse Event|3
2052028|NCT00504348|3624604|FG000|Overall Study|Lack of Efficacy|4
2052029|NCT00504348|3624604|FG000|Overall Study|Physician Decision|1
2052030|NCT00504426|3624612|FG000|Overall Study|Adverse Event|0
2052031|NCT00504426|3624613|FG001|Overall Study|Adverse Event|0
2052032|NCT00504426|3624614|FG002|Overall Study|Adverse Event|2
2052033|NCT00504426|3624615|FG003|Overall Study|Adverse Event|0
2052034|NCT00504426|3624612|FG000|Overall Study|Protocol Violation|1
2052035|NCT00504426|3624613|FG001|Overall Study|Protocol Violation|1
2052036|NCT00504426|3624614|FG002|Overall Study|Protocol Violation|2
2052037|NCT00504426|3624615|FG003|Overall Study|Protocol Violation|0
2052038|NCT00504426|3624612|FG000|Overall Study|Withdrawal by Subject|2
2052039|NCT00504426|3624613|FG001|Overall Study|Withdrawal by Subject|0
2052040|NCT00504426|3624614|FG002|Overall Study|Withdrawal by Subject|0
2052041|NCT00504426|3624615|FG003|Overall Study|Withdrawal by Subject|0
2052042|NCT00504556|3624637|FG000|Overall Study|Adverse Event|11
2052043|NCT00504556|3624638|FG001|Overall Study|Adverse Event|11
2052044|NCT00504556|3624639|FG002|Overall Study|Adverse Event|14
2052045|NCT00504556|3624640|FG003|Overall Study|Adverse Event|13
2052046|NCT00504556|3624641|FG004|Overall Study|Adverse Event|5
2052047|NCT00504556|3624637|FG000|Overall Study|Death|3
2052048|NCT00504556|3624638|FG001|Overall Study|Death|3
2052049|NCT00504556|3624639|FG002|Overall Study|Death|1
2052050|NCT00504556|3624640|FG003|Overall Study|Death|0
2052051|NCT00504556|3624641|FG004|Overall Study|Death|2
2052052|NCT00504556|3624637|FG000|Overall Study|Protocol Violation|1
2052053|NCT00504556|3624638|FG001|Overall Study|Protocol Violation|3
2052054|NCT00504556|3624639|FG002|Overall Study|Protocol Violation|2
2052055|NCT00504556|3624640|FG003|Overall Study|Protocol Violation|1
2052056|NCT00504556|3624641|FG004|Overall Study|Protocol Violation|2
2052057|NCT00504556|3624637|FG000|Overall Study|Lost to Follow-up|0
2052058|NCT00504556|3624638|FG001|Overall Study|Lost to Follow-up|0
2052059|NCT00504556|3624639|FG002|Overall Study|Lost to Follow-up|1
2052060|NCT00504556|3624640|FG003|Overall Study|Lost to Follow-up|1
2052061|NCT00504556|3624641|FG004|Overall Study|Lost to Follow-up|1
2052062|NCT00504556|3624637|FG000|Overall Study|Withdrawal by Subject|16
2052063|NCT00504556|3624638|FG001|Overall Study|Withdrawal by Subject|16
2052064|NCT00504556|3624639|FG002|Overall Study|Withdrawal by Subject|7
2052065|NCT00504556|3624640|FG003|Overall Study|Withdrawal by Subject|8
2052066|NCT00504556|3624641|FG004|Overall Study|Withdrawal by Subject|12
2052067|NCT00504556|3624637|FG000|Overall Study|administrative reasons|0
2300164|NCT02592876|3997210|FG001|Overall Study|Withdrawal by Subject|3
2300165|NCT02592876|3997209|FG000|Overall Study|Study Termination by Sponsor|32
2300166|NCT02592876|3997210|FG001|Overall Study|Study Termination by Sponsor|27
2300167|NCT02592876|3997209|FG000|Overall Study|Lost to Follow-up|0
2300168|NCT02592876|3997210|FG001|Overall Study|Lost to Follow-up|1
2300169|NCT02592876|3997209|FG000|Overall Study|Death|6
2300170|NCT02592876|3997210|FG001|Overall Study|Death|9
2300171|NCT02593097|3997241|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
2300172|NCT02593097|3997242|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2
2300173|NCT02593097|3997241|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
2300174|NCT02593097|3997242|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2
2300175|NCT02593097|3997241|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1
2300176|NCT02593097|3997242|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1
2300177|NCT02593097|3997241|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1
2300178|NCT02593097|3997242|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0
2300179|NCT02593097|3997241|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
2300180|NCT02593097|3997242|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
2300181|NCT02593149|3997250|FG000|Run-In|Didn't use CVC for at least 21 days|36
2300182|NCT02593149|3997251|FG001|Run-In|Didn't use CVC for at least 21 days|38
2300183|NCT02593149|3997250|FG000|Intervention|Didn't use CVC for at least 21 day|116
2300184|NCT02593149|3997251|FG001|Intervention|Didn't use CVC for at least 21 day|115
2300185|NCT02593305|3997260|FG000|Post 1|Comparison only group. No intervention.|0
2300186|NCT02593305|3997261|FG001|Post 1|Comparison only group. No intervention.|0
2300187|NCT02593305|3997262|FG002|Post 1|Comparison only group. No intervention.|10
2300188|NCT02593318|3997273|FG000|Overall Study|Withdrawal by Subject|1
2300189|NCT02593318|3997274|FG001|Overall Study|Withdrawal by Subject|1
2300190|NCT02593539|3997295|FG000|Overall Study|Adverse Event|1
2300191|NCT02593773|3997307|FG000|Overall Study|Voluntary Withdrawal|3
2300192|NCT02593773|3997307|FG000|Overall Study|Study Terminated by Sponsor|31
2300193|NCT02593773|3997307|FG000|Overall Study|Death|1
2300194|NCT02593825|3997313|FG000|Intervention|Lost to Follow-up|10
2300195|NCT02593825|3997314|FG001|Intervention|Lost to Follow-up|12
2300196|NCT02593864|3997322|FG000|Overall Study|Withdrawal by Subject|3
2300197|NCT02593864|3997322|FG000|Overall Study|Lost to Follow-up|3
2300198|NCT02594098|3997337|FG000|Overall Study|Lack of Efficacy|17
2052068|NCT00504556|3624638|FG001|Overall Study|administrative reasons|2
2052069|NCT00504556|3624639|FG002|Overall Study|administrative reasons|2
2052070|NCT00504556|3624640|FG003|Overall Study|administrative reasons|1
2052071|NCT00504556|3624641|FG004|Overall Study|administrative reasons|2
2052072|NCT00504556|3624637|FG000|Overall Study|did not meet entry criteria|2
2052073|NCT00504556|3624638|FG001|Overall Study|did not meet entry criteria|0
2052074|NCT00504556|3624639|FG002|Overall Study|did not meet entry criteria|1
2209290|NCT01644175|3848952|FG000|Overall Study|Randomized But Not Treated|0
2209291|NCT01644175|3848953|FG001|Overall Study|Randomized But Not Treated|2
2052075|NCT00504556|3624640|FG003|Overall Study|did not meet entry criteria|1
2052076|NCT00504556|3624641|FG004|Overall Study|did not meet entry criteria|0
2052077|NCT00504556|3624637|FG000|Overall Study|data monitor committee decision|0
2052078|NCT00504556|3624638|FG001|Overall Study|data monitor committee decision|0
2052079|NCT00504556|3624639|FG002|Overall Study|data monitor committee decision|0
2052080|NCT00504556|3624640|FG003|Overall Study|data monitor committee decision|100
2052081|NCT00504556|3624641|FG004|Overall Study|data monitor committee decision|0
2052082|NCT00504556|3624637|FG000|Overall Study|Other|2
2052083|NCT00504556|3624638|FG001|Overall Study|Other|2
2052084|NCT00504556|3624639|FG002|Overall Study|Other|2
2052085|NCT00504556|3624640|FG003|Overall Study|Other|3
2052086|NCT00504556|3624641|FG004|Overall Study|Other|0
2052087|NCT00504556|3624637|FG000|Overall Study|not in safety analysis set|0
2052088|NCT00504556|3624638|FG001|Overall Study|not in safety analysis set|1
2052089|NCT00504556|3624639|FG002|Overall Study|not in safety analysis set|1
2052090|NCT00504556|3624640|FG003|Overall Study|not in safety analysis set|0
2052091|NCT00504556|3624641|FG004|Overall Study|not in safety analysis set|1
2052092|NCT00504582|3624656|FG000|Overall Study|Lost to Follow-up|1
2052093|NCT00504582|3624657|FG001|Overall Study|Lost to Follow-up|0
2052094|NCT00504582|3624658|FG002|Overall Study|Lost to Follow-up|0
2052095|NCT00504595|3624670|FG000|Overall Study|Lack of Efficacy|1
2052096|NCT00504595|3624671|FG001|Overall Study|Lack of Efficacy|0
2052097|NCT00504595|3624672|FG002|Overall Study|Lack of Efficacy|0
2052098|NCT00504595|3624673|FG003|Overall Study|Lack of Efficacy|0
2052099|NCT00504595|3624670|FG000|Overall Study|Other|0
2052100|NCT00504595|3624671|FG001|Overall Study|Other|0
2052101|NCT00504595|3624672|FG002|Overall Study|Other|2
2052102|NCT00504595|3624673|FG003|Overall Study|Other|0
2052103|NCT00504725|3624694|FG000|Overall Study|Protocol Violation|1
2052104|NCT00504725|3624695|FG001|Overall Study|Protocol Violation|0
2052105|NCT00504777|3624705|FG000|Overall Study|Adverse Event|1
2052106|NCT00504829|3624712|FG000|Overall Study|Protocol Violation|6
2052107|NCT00504829|3624713|FG001|Overall Study|Protocol Violation|4
2052108|NCT00504829|3624714|FG002|Overall Study|Protocol Violation|10
2052109|NCT00504881|3624724|FG000|Overall Study|Lack of Efficacy|1
2052110|NCT00504881|3624725|FG001|Overall Study|Lack of Efficacy|5
2052111|NCT00504881|3624724|FG000|Overall Study|Lost to Follow-up|0
2052112|NCT00504881|3624725|FG001|Overall Study|Lost to Follow-up|2
2052113|NCT00504881|3624724|FG000|Overall Study|Withdrawal by Subject|1
2052114|NCT00504881|3624725|FG001|Overall Study|Withdrawal by Subject|4
2052115|NCT00504881|3624724|FG000|Overall Study|Non-Compliance|1
2052116|NCT00504881|3624725|FG001|Overall Study|Non-Compliance|0
2052117|NCT00504881|3624724|FG000|Overall Study|No Birth Control|0
2052118|NCT00504881|3624725|FG001|Overall Study|No Birth Control|1
2052119|NCT00504881|3624724|FG000|Overall Study|Safety Visit not performed|0
2052120|NCT00504881|3624725|FG001|Overall Study|Safety Visit not performed|1
2052121|NCT00504881|3624724|FG000|Overall Study|AE, serious fatal|0
2052122|NCT00504881|3624725|FG001|Overall Study|AE, serious fatal|1
2052123|NCT00504881|3624724|FG000|Overall Study|SAE, non-fatal|2
2052124|NCT00504881|3624725|FG001|Overall Study|SAE, non-fatal|6
2052125|NCT00504881|3624724|FG000|Overall Study|AE, non-serious non-fatal|4
2052126|NCT00504881|3624725|FG001|Overall Study|AE, non-serious non-fatal|14
2052127|NCT00504881|3624724|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2052128|NCT00504881|3624725|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
2052129|NCT00504881|3624724|FG000|Overall Study|AE of unknown type|1
2052130|NCT00504881|3624725|FG001|Overall Study|AE of unknown type|0
2052131|NCT00504894|3624736|FG000|Overall Study|fMRI technical problems|1
2052132|NCT00504894|3624737|FG001|Overall Study|fMRI technical problems|1
2052133|NCT00504894|3624738|FG002|Overall Study|fMRI technical problems|0
2052134|NCT00504894|3624736|FG000|Overall Study|Withdrawal by Subject|0
2052135|NCT00504894|3624737|FG001|Overall Study|Withdrawal by Subject|1
2052136|NCT00504894|3624738|FG002|Overall Study|Withdrawal by Subject|0
2052137|NCT00504894|3624736|FG000|Overall Study|Infusion technical problems|0
2052138|NCT00504894|3624737|FG001|Overall Study|Infusion technical problems|1
2052139|NCT00504894|3624738|FG002|Overall Study|Infusion technical problems|0
2052140|NCT00504894|3624736|FG000|Overall Study|poor subject data|2
2052141|NCT00504894|3624737|FG001|Overall Study|poor subject data|0
2052142|NCT00504894|3624738|FG002|Overall Study|poor subject data|0
2052143|NCT00505076|3624749|FG000|Overall Study|Adverse Event|1
2052144|NCT00505076|3624750|FG001|Overall Study|Adverse Event|0
2052145|NCT00505076|3624751|FG002|Overall Study|Adverse Event|1
2052146|NCT00505076|3624749|FG000|Overall Study|Protocol Violation|2
2052147|NCT00505076|3624750|FG001|Overall Study|Protocol Violation|1
2052148|NCT00505076|3624751|FG002|Overall Study|Protocol Violation|2
2052149|NCT00505076|3624749|FG000|Overall Study|Withdrawal by Subject|0
2052150|NCT00505076|3624750|FG001|Overall Study|Withdrawal by Subject|1
2052151|NCT00505076|3624751|FG002|Overall Study|Withdrawal by Subject|2
2052152|NCT00505284|3624764|FG000|Overall Study|Adverse Event|3
2052153|NCT00505284|3624765|FG001|Overall Study|Adverse Event|7
2052154|NCT00505284|3624766|FG002|Overall Study|Adverse Event|9
2052155|NCT00505284|3624767|FG003|Overall Study|Adverse Event|14
2052156|NCT00505284|3624768|FG004|Overall Study|Adverse Event|22
2052157|NCT00505284|3624764|FG000|Overall Study|Protocol Violation|0
2052158|NCT00505284|3624765|FG001|Overall Study|Protocol Violation|1
2052159|NCT00505284|3624766|FG002|Overall Study|Protocol Violation|1
2052160|NCT00505284|3624767|FG003|Overall Study|Protocol Violation|0
2052161|NCT00505284|3624768|FG004|Overall Study|Protocol Violation|0
2052162|NCT00505284|3624764|FG000|Overall Study|Withdrawal by Subject|2
2052163|NCT00505284|3624765|FG001|Overall Study|Withdrawal by Subject|6
2052164|NCT00505284|3624766|FG002|Overall Study|Withdrawal by Subject|1
2052165|NCT00505284|3624767|FG003|Overall Study|Withdrawal by Subject|0
2052166|NCT00505284|3624768|FG004|Overall Study|Withdrawal by Subject|6
2052167|NCT00505284|3624764|FG000|Overall Study|Lack of Efficacy|0
2052168|NCT00505284|3624765|FG001|Overall Study|Lack of Efficacy|1
2052169|NCT00505284|3624766|FG002|Overall Study|Lack of Efficacy|1
2052170|NCT00505284|3624767|FG003|Overall Study|Lack of Efficacy|1
2052171|NCT00505284|3624768|FG004|Overall Study|Lack of Efficacy|1
2052172|NCT00505284|3624764|FG000|Overall Study|Physician Decision|0
2052173|NCT00505284|3624765|FG001|Overall Study|Physician Decision|1
2052174|NCT00505284|3624766|FG002|Overall Study|Physician Decision|0
2052175|NCT00505284|3624767|FG003|Overall Study|Physician Decision|0
2052176|NCT00505284|3624768|FG004|Overall Study|Physician Decision|0
2052177|NCT00505284|3624764|FG000|Overall Study|Other|5
2052178|NCT00505284|3624765|FG001|Overall Study|Other|0
2052179|NCT00505284|3624766|FG002|Overall Study|Other|0
2052180|NCT00505284|3624767|FG003|Overall Study|Other|4
2052181|NCT00505284|3624768|FG004|Overall Study|Other|4
2052182|NCT00505375|3624791|FG000|Overall Study|Death|1
2052183|NCT00505375|3624792|FG001|Overall Study|Death|0
2052184|NCT00505375|3624791|FG000|Overall Study|Withdrawal by Subject|2
2052185|NCT00505375|3624792|FG001|Overall Study|Withdrawal by Subject|2
2052186|NCT00505375|3624791|FG000|Overall Study|Lost to Follow-up|0
2052187|NCT00505375|3624792|FG001|Overall Study|Lost to Follow-up|2
2052188|NCT00505375|3624791|FG000|Overall Study|Pregnancy|1
2052189|NCT00505375|3624792|FG001|Overall Study|Pregnancy|0
2052190|NCT00505375|3624791|FG000|Overall Study|Travel issues|0
2052191|NCT00505375|3624792|FG001|Overall Study|Travel issues|1
2052192|NCT00505414|3624800|FG000|Titration Phase|Adverse Event|0
2052193|NCT00505414|3624801|FG001|Titration Phase|Adverse Event|0
2052194|NCT00505414|3624802|FG002|Titration Phase|Adverse Event|0
2052195|NCT00505414|3624803|FG003|Titration Phase|Adverse Event|8
2052196|NCT00505414|3624804|FG004|Titration Phase|Adverse Event|3
2052197|NCT00505414|3624800|FG000|Titration Phase|Death|0
2052198|NCT00505414|3624801|FG001|Titration Phase|Death|0
2052199|NCT00505414|3624802|FG002|Titration Phase|Death|0
2052200|NCT00505414|3624803|FG003|Titration Phase|Death|2
2052201|NCT00505414|3624804|FG004|Titration Phase|Death|0
2052202|NCT00505414|3624800|FG000|Titration Phase|Lack of Efficacy|0
2052203|NCT00505414|3624801|FG001|Titration Phase|Lack of Efficacy|0
2052204|NCT00505414|3624802|FG002|Titration Phase|Lack of Efficacy|0
2052205|NCT00505414|3624803|FG003|Titration Phase|Lack of Efficacy|10
2052206|NCT00505414|3624804|FG004|Titration Phase|Lack of Efficacy|1
2052207|NCT00505414|3624800|FG000|Titration Phase|Protocol Violation|0
2052208|NCT00505414|3624801|FG001|Titration Phase|Protocol Violation|0
2052209|NCT00505414|3624802|FG002|Titration Phase|Protocol Violation|0
2052210|NCT00505414|3624803|FG003|Titration Phase|Protocol Violation|0
2052211|NCT00505414|3624804|FG004|Titration Phase|Protocol Violation|1
2052212|NCT00505414|3624800|FG000|Titration Phase|Withdrawal by Subject|0
2052213|NCT00505414|3624801|FG001|Titration Phase|Withdrawal by Subject|0
2052214|NCT00505414|3624802|FG002|Titration Phase|Withdrawal by Subject|0
2052215|NCT00505414|3624803|FG003|Titration Phase|Withdrawal by Subject|3
2052216|NCT00505414|3624804|FG004|Titration Phase|Withdrawal by Subject|4
2052217|NCT00505414|3624800|FG000|Titration Phase|Underlying disease and therapy required|0
2052218|NCT00505414|3624801|FG001|Titration Phase|Underlying disease and therapy required|0
2052219|NCT00505414|3624802|FG002|Titration Phase|Underlying disease and therapy required|0
2052220|NCT00505414|3624803|FG003|Titration Phase|Underlying disease and therapy required|7
2052221|NCT00505414|3624804|FG004|Titration Phase|Underlying disease and therapy required|3
2052222|NCT00505414|3624800|FG000|Maintenance Phase|Adverse Event|2
2052223|NCT00505414|3624801|FG001|Maintenance Phase|Adverse Event|2
2052224|NCT00505414|3624802|FG002|Maintenance Phase|Adverse Event|3
2052225|NCT00505414|3624803|FG003|Maintenance Phase|Adverse Event|0
2052226|NCT00505414|3624804|FG004|Maintenance Phase|Adverse Event|0
2052227|NCT00505414|3624800|FG000|Maintenance Phase|Death|2
2052228|NCT00505414|3624801|FG001|Maintenance Phase|Death|0
2052229|NCT00505414|3624802|FG002|Maintenance Phase|Death|1
2052230|NCT00505414|3624803|FG003|Maintenance Phase|Death|0
2052231|NCT00505414|3624804|FG004|Maintenance Phase|Death|0
2052232|NCT00505414|3624800|FG000|Maintenance Phase|Lack of Efficacy|2
2052233|NCT00505414|3624801|FG001|Maintenance Phase|Lack of Efficacy|1
2052234|NCT00505414|3624802|FG002|Maintenance Phase|Lack of Efficacy|1
2052235|NCT00505414|3624803|FG003|Maintenance Phase|Lack of Efficacy|0
2052236|NCT00505414|3624804|FG004|Maintenance Phase|Lack of Efficacy|0
2052237|NCT00505414|3624800|FG000|Maintenance Phase|Withdrawal by Subject|0
2052238|NCT00505414|3624801|FG001|Maintenance Phase|Withdrawal by Subject|0
2052239|NCT00505414|3624802|FG002|Maintenance Phase|Withdrawal by Subject|1
2052240|NCT00505414|3624803|FG003|Maintenance Phase|Withdrawal by Subject|0
2052241|NCT00505414|3624804|FG004|Maintenance Phase|Withdrawal by Subject|0
2052242|NCT00505414|3624800|FG000|Maintenance Phase|underlying disease and therapy required|0
2052243|NCT00505414|3624801|FG001|Maintenance Phase|underlying disease and therapy required|2
2052244|NCT00505414|3624802|FG002|Maintenance Phase|underlying disease and therapy required|2
2052245|NCT00505414|3624803|FG003|Maintenance Phase|underlying disease and therapy required|0
2052246|NCT00505414|3624804|FG004|Maintenance Phase|underlying disease and therapy required|0
2052247|NCT00505622|3624823|FG000|Overall Study|Adverse Event|5
2052248|NCT00505622|3624824|FG001|Overall Study|Adverse Event|6
2052249|NCT00505622|3624825|FG002|Overall Study|Adverse Event|4
2052250|NCT00505622|3624823|FG000|Overall Study|Protocol Violation|1
2052251|NCT00505622|3624824|FG001|Overall Study|Protocol Violation|1
2052252|NCT00505622|3624825|FG002|Overall Study|Protocol Violation|0
2052253|NCT00505622|3624823|FG000|Overall Study|Withdrawal by Subject|0
2052254|NCT00505622|3624824|FG001|Overall Study|Withdrawal by Subject|3
2052255|NCT00505622|3624825|FG002|Overall Study|Withdrawal by Subject|2
2052256|NCT00505622|3624823|FG000|Overall Study|Study termination by sponsor|115
2052257|NCT00505622|3624824|FG001|Overall Study|Study termination by sponsor|98
2052258|NCT00505622|3624825|FG002|Overall Study|Study termination by sponsor|90
2052259|NCT00505661|3624837|FG000|Overall Study|Not Eligible|4
2300199|NCT02594098|3997338|FG001|Overall Study|Lack of Efficacy|6
2300200|NCT02594098|3997337|FG000|Overall Study|Withdrawal by Subject|1
2300201|NCT02594098|3997338|FG001|Overall Study|Withdrawal by Subject|3
2300202|NCT02594098|3997337|FG000|Overall Study|Terminated participation|6
2052260|NCT00505687|3624841|FG000|Overall Study|Important protocol violation|2
2052261|NCT00505687|3624841|FG000|Overall Study|Lack of Efficacy|15
2300203|NCT02594098|3997338|FG001|Overall Study|Terminated participation|2
2300204|NCT02594098|3997337|FG000|Overall Study|Seek alternative treatment|2
2300205|NCT02594098|3997338|FG001|Overall Study|Seek alternative treatment|1
2300206|NCT02594098|3997337|FG000|Overall Study|Other|0
2300207|NCT02594098|3997338|FG001|Overall Study|Other|1
2300208|NCT02594163|3997357|FG000|Treatment Period|Progressive disease|2
2300209|NCT02594163|3997358|FG001|Treatment Period|Progressive disease|3
2300210|NCT02594163|3997357|FG000|Treatment Period|Adverse Event|1
2300211|NCT02594163|3997358|FG001|Treatment Period|Adverse Event|5
2300212|NCT02594163|3997357|FG000|Treatment Period|Physician Decision|1
2300213|NCT02594163|3997358|FG001|Treatment Period|Physician Decision|3
2300214|NCT02594163|3997357|FG000|Treatment Period|Study termination by sponsor|2
2300215|NCT02594163|3997358|FG001|Treatment Period|Study termination by sponsor|1
2300216|NCT02594163|3997357|FG000|Treatment Period|Other, Non-AE|1
2300217|NCT02594163|3997358|FG001|Treatment Period|Other, Non-AE|0
2300218|NCT02594163|3997357|FG000|Follow-up Period|Withdrawal by Subject|0
2300219|NCT02594163|3997358|FG001|Follow-up Period|Withdrawal by Subject|1
2300220|NCT02594163|3997357|FG000|Follow-up Period|Study Termination by Sponsor|6
2300221|NCT02594163|3997358|FG001|Follow-up Period|Study Termination by Sponsor|4
2300222|NCT02594163|3997357|FG000|Follow-up Period|Lost to Follow-up|1
2300223|NCT02594163|3997358|FG001|Follow-up Period|Lost to Follow-up|0
2300224|NCT02594163|3997357|FG000|Follow-up Period|Death|2
2300225|NCT02594163|3997358|FG001|Follow-up Period|Death|5
2300226|NCT02594163|3997357|FG000|Follow-up Period|Adverse Event|0
2300227|NCT02594163|3997358|FG001|Follow-up Period|Adverse Event|1
2300228|NCT02594163|3997357|FG000|Follow-up Period|Progressive Disease|2
2300229|NCT02594163|3997358|FG001|Follow-up Period|Progressive Disease|0
2300230|NCT02594163|3997357|FG000|Follow-up Period|Physician Decision|0
2300231|NCT02594163|3997358|FG001|Follow-up Period|Physician Decision|1
2300232|NCT02595008|3997394|FG000|Overall Study|Enrolled In Error|1
2300233|NCT02595008|3997395|FG001|Overall Study|Enrolled In Error|0
2300234|NCT02595073|3997403|FG000|Overall Study|Progressive Disease|0
2300235|NCT02595073|3997404|FG001|Overall Study|Progressive Disease|1
2300236|NCT02595073|3997403|FG000|Overall Study|Protocol Violation|2
2300237|NCT02595073|3997404|FG001|Overall Study|Protocol Violation|0
2300238|NCT02595398|3997412|FG000|Overall Study|Non-compliance|1
2300239|NCT02595398|3997413|FG001|Overall Study|Non-compliance|0
2300240|NCT02595398|3997412|FG000|Overall Study|Withdrawal by Subject|2
2300241|NCT02595398|3997413|FG001|Overall Study|Withdrawal by Subject|1
2300242|NCT02595398|3997412|FG000|Overall Study|Lost to Follow-up|1
2300243|NCT02595398|3997413|FG001|Overall Study|Lost to Follow-up|0
2300244|NCT02595437|3997419|FG000|Triferic Via IV|Withdrawal by Subject|1
2300245|NCT02595450|3997431|FG000|Overall Study|Unspecified (only completed 1 cycle)|73
2300246|NCT02595450|3997431|FG000|Overall Study|Enrolled, but not treated|8
2300247|NCT02595502|3997435|FG000|Period 1|Adverse Event|0
2300248|NCT02595502|3997436|FG001|Period 1|Adverse Event|1
2300249|NCT02595502|3997435|FG000|Period 1|Withdrawal by Subject|1
2052262|NCT00505687|3624841|FG000|Overall Study|Adverse Event|48
2300250|NCT02595502|3997436|FG001|Period 1|Withdrawal by Subject|0
2300251|NCT02595502|3997435|FG000|Period 1|Lost to Follow-up|0
2300252|NCT02595502|3997436|FG001|Period 1|Lost to Follow-up|1
2300253|NCT02595502|3997435|FG000|Period 2|Adverse Event|1
2300254|NCT02595502|3997436|FG001|Period 2|Adverse Event|1
2300255|NCT02595502|3997435|FG000|Period 2|Received incorrect lens at Period 1|0
2300256|NCT02595502|3997436|FG001|Period 2|Received incorrect lens at Period 1|1
2300257|NCT02595502|3997435|FG000|Period 3|Protocol Violation|0
2300258|NCT02595502|3997436|FG001|Period 3|Protocol Violation|1
2300259|NCT02595502|3997435|FG000|Period 3|Lost to Follow-up|1
2300260|NCT02595502|3997436|FG001|Period 3|Lost to Follow-up|0
2300261|NCT02595502|3997435|FG000|Period 3|Received Incorrect Treatment at period 3|0
2300262|NCT02595502|3997436|FG001|Period 3|Received Incorrect Treatment at period 3|1
2300263|NCT02595528|3997446|FG000|Overall Study|Withdrawal by Subject|1
2052263|NCT00505687|3624841|FG000|Overall Study|Subject withdrew consent|15
2052264|NCT00505687|3624841|FG000|Overall Study|Lost to Follow-up|1
2052265|NCT00505687|3624841|FG000|Overall Study|Other: Underwent Implantation Of DBS|1
2052266|NCT00505687|3624841|FG000|Overall Study|Other: Scheduled DBS Surgery|1
2052267|NCT00505687|3624841|FG000|Overall Study|Other: Prolonged Hospitalization|1
2052268|NCT00505687|3624841|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
2052269|NCT00505687|3624841|FG000|Overall Study|Other: Neupro Given In Hospital|1
2052270|NCT00505687|3624841|FG000|Overall Study|Other: Disease Progression|1
2052271|NCT00505687|3624841|FG000|Overall Study|Other: As Per Sponsor|8
2052272|NCT00505752|3624849|FG000|Overall Study|Adverse Event|1
2052273|NCT00505752|3624850|FG001|Overall Study|Adverse Event|0
2052274|NCT00505752|3624851|FG002|Overall Study|Adverse Event|1
2052275|NCT00505752|3624852|FG003|Overall Study|Adverse Event|0
2052276|NCT00505752|3624849|FG000|Overall Study|Lost to Follow-up|1
2052277|NCT00505752|3624850|FG001|Overall Study|Lost to Follow-up|0
2052278|NCT00505752|3624851|FG002|Overall Study|Lost to Follow-up|0
2052279|NCT00505752|3624852|FG003|Overall Study|Lost to Follow-up|0
2052280|NCT00505752|3624849|FG000|Overall Study|Lack of ovarian response|1
2052281|NCT00505752|3624850|FG001|Overall Study|Lack of ovarian response|3
2052282|NCT00505752|3624851|FG002|Overall Study|Lack of ovarian response|0
2052283|NCT00505752|3624852|FG003|Overall Study|Lack of ovarian response|0
2052284|NCT00505752|3624849|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1
2052285|NCT00505752|3624850|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
2052286|NCT00505752|3624851|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3
2052287|NCT00505752|3624852|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1
2052288|NCT00505752|3624849|FG000|Overall Study|No oocytes retrieved|0
2052289|NCT00505752|3624850|FG001|Overall Study|No oocytes retrieved|2
2052290|NCT00505752|3624851|FG002|Overall Study|No oocytes retrieved|0
2052291|NCT00505752|3624852|FG003|Overall Study|No oocytes retrieved|1
2052292|NCT00505752|3624849|FG000|Overall Study|No Fertilization|1
2052293|NCT00505752|3624850|FG001|Overall Study|No Fertilization|1
2052294|NCT00505752|3624851|FG002|Overall Study|No Fertilization|2
2052295|NCT00505752|3624852|FG003|Overall Study|No Fertilization|1
2052296|NCT00505752|3624849|FG000|Overall Study|All embryos/blastocysts discarded|0
2052297|NCT00505752|3624850|FG001|Overall Study|All embryos/blastocysts discarded|0
2052298|NCT00505752|3624851|FG002|Overall Study|All embryos/blastocysts discarded|1
2052299|NCT00505752|3624852|FG003|Overall Study|All embryos/blastocysts discarded|1
2052300|NCT00505752|3624849|FG000|Overall Study|Other|1
2052301|NCT00505752|3624850|FG001|Overall Study|Other|2
2052302|NCT00505752|3624851|FG002|Overall Study|Other|1
2052303|NCT00505752|3624852|FG003|Overall Study|Other|2
2052304|NCT00505765|3624865|FG000|Overall Study|Withdrawal by Subject|1
2052305|NCT00505765|3624866|FG001|Overall Study|Withdrawal by Subject|0
2052306|NCT00505765|3624867|FG002|Overall Study|Withdrawal by Subject|0
2052307|NCT00505765|3624865|FG000|Overall Study|Adverse Event|1
2052308|NCT00505765|3624866|FG001|Overall Study|Adverse Event|2
2052309|NCT00505765|3624867|FG002|Overall Study|Adverse Event|0
2052310|NCT00505765|3624865|FG000|Overall Study|Noncompliance|0
2052311|NCT00505765|3624866|FG001|Overall Study|Noncompliance|1
2052312|NCT00505765|3624867|FG002|Overall Study|Noncompliance|3
2052313|NCT00505778|3624877|FG000|Overall Study|Adverse Event|2
2052314|NCT00505778|3624878|FG001|Overall Study|Adverse Event|7
2052315|NCT00505778|3624877|FG000|Overall Study|Physician Decision|8
2300264|NCT02595528|3997447|FG001|Overall Study|Withdrawal by Subject|2
2300265|NCT02595528|3997448|FG002|Overall Study|Withdrawal by Subject|1
2300266|NCT02595528|3997449|FG003|Overall Study|Withdrawal by Subject|3
2300267|NCT02595528|3997446|FG000|Overall Study|Lost to Follow-up|1
2300268|NCT02595528|3997447|FG001|Overall Study|Lost to Follow-up|1
2300269|NCT02595528|3997448|FG002|Overall Study|Lost to Follow-up|0
2300270|NCT02595528|3997449|FG003|Overall Study|Lost to Follow-up|1
2300271|NCT02595723|3997475|FG000|First Washout (21 Days)|Withdrawal by Subject|1
2300272|NCT02595723|3997476|FG001|First Washout (21 Days)|Withdrawal by Subject|0
2300273|NCT02595723|3997477|FG002|First Washout (21 Days)|Withdrawal by Subject|0
2300274|NCT02595723|3997475|FG000|First Washout (21 Days)|Lost to Follow-up|1
2300275|NCT02595723|3997476|FG001|First Washout (21 Days)|Lost to Follow-up|0
2300276|NCT02595723|3997477|FG002|First Washout (21 Days)|Lost to Follow-up|0
2300277|NCT02595749|3997487|FG000|Overall Study|Withdrawal by Subject|12
2300278|NCT02595749|3997488|FG001|Overall Study|Withdrawal by Subject|7
2300279|NCT02595970|3997494|FG000|Overall Study|Withdrawal by Subject|2
2300280|NCT02595970|3997494|FG000|Overall Study|Physician Decision|2
2300281|NCT02595970|3997494|FG000|Overall Study|Protocol Violation|4
2300282|NCT02595970|3997494|FG000|Overall Study|Adverse Event|5
2300283|NCT02595970|3997494|FG000|Overall Study|Lack of Efficacy|7
2300284|NCT02596009|3997503|FG000|Overall Study|Administrative problems|0
2300285|NCT02596009|3997504|FG001|Overall Study|Administrative problems|1
2300286|NCT02596009|3997505|FG002|Overall Study|Administrative problems|0
2300287|NCT02596009|3997506|FG003|Overall Study|Administrative problems|0
2300288|NCT02596009|3997507|FG004|Overall Study|Administrative problems|0
2300289|NCT02596009|3997508|FG005|Overall Study|Administrative problems|0
2300290|NCT02596035|3997526|FG000|Overall Study|Disease Progression|62
2300291|NCT02596035|3997527|FG001|Overall Study|Disease Progression|32
2052316|NCT00505778|3624878|FG001|Overall Study|Physician Decision|14
2052317|NCT00505778|3624877|FG000|Overall Study|Lost to Follow-up|17
2052318|NCT00505778|3624878|FG001|Overall Study|Lost to Follow-up|23
2052319|NCT00505778|3624877|FG000|Overall Study|Unable to Meet Protocol Criteria|4
2052320|NCT00505778|3624878|FG001|Overall Study|Unable to Meet Protocol Criteria|1
2052321|NCT00505778|3624877|FG000|Overall Study|Protocol Violation|7
2052322|NCT00505778|3624878|FG001|Overall Study|Protocol Violation|9
2052323|NCT00505778|3624877|FG000|Overall Study|Withdrawal by Subject|29
2052324|NCT00505778|3624878|FG001|Overall Study|Withdrawal by Subject|14
2052325|NCT00505778|3624877|FG000|Overall Study|Relapse|65
2052326|NCT00505778|3624878|FG001|Overall Study|Relapse|65
2052327|NCT00505778|3624877|FG000|Overall Study|Took No Study Drug|2
2052328|NCT00505778|3624878|FG001|Overall Study|Took No Study Drug|2
2052329|NCT00505921|3624893|FG000|Overall Study|Ineligible|1
2052330|NCT00505921|3624893|FG000|Overall Study|Failed to Mobilize|8
2052331|NCT00505934|3624897|FG000|Overall Study|Adverse Event|1
2052332|NCT00505934|3624897|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1
2052333|NCT00505934|3624897|FG000|Overall Study|Other: IV dose needed to be changed|1
2300292|NCT02596035|3997528|FG002|Overall Study|Disease Progression|1
2300293|NCT02596035|3997526|FG000|Overall Study|Study Drug Toxicity|11
2300294|NCT02596035|3997527|FG001|Overall Study|Study Drug Toxicity|3
2300295|NCT02596035|3997528|FG002|Overall Study|Study Drug Toxicity|0
2300296|NCT02596035|3997526|FG000|Overall Study|Adverse Event|6
2300297|NCT02596035|3997527|FG001|Overall Study|Adverse Event|2
2300298|NCT02596035|3997528|FG002|Overall Study|Adverse Event|0
2300299|NCT02596035|3997526|FG000|Overall Study|Withdrawal by Subject|4
2300300|NCT02596035|3997527|FG001|Overall Study|Withdrawal by Subject|2
2300301|NCT02596035|3997528|FG002|Overall Study|Withdrawal by Subject|0
2300302|NCT02596035|3997526|FG000|Overall Study|Poor/Non-Compliance|0
2300303|NCT02596035|3997527|FG001|Overall Study|Poor/Non-Compliance|1
2300304|NCT02596035|3997528|FG002|Overall Study|Poor/Non-Compliance|0
2300305|NCT02596035|3997526|FG000|Overall Study|Other Reasons|3
2300306|NCT02596035|3997527|FG001|Overall Study|Other Reasons|4
2300307|NCT02596035|3997528|FG002|Overall Study|Other Reasons|0
2300308|NCT02596230|3997540|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714
2300309|NCT02596230|3997541|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228
2300310|NCT02596230|3997542|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0
2300311|NCT02596230|3997543|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846
2300312|NCT02596230|3997544|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0
2300313|NCT02596230|3997540|FG000|Objective 2, One Year|Lost to Follow-up|0
2300314|NCT02596230|3997541|FG001|Objective 2, One Year|Lost to Follow-up|41
2300315|NCT02596230|3997542|FG002|Objective 2, One Year|Lost to Follow-up|41
2300316|NCT02596230|3997543|FG003|Objective 2, One Year|Lost to Follow-up|32
2300317|NCT02596230|3997544|FG004|Objective 2, One Year|Lost to Follow-up|46
2300318|NCT02596230|3997540|FG000|Objective 2, One Year|Withdrawal by Subject|0
2300319|NCT02596230|3997541|FG001|Objective 2, One Year|Withdrawal by Subject|11
2300320|NCT02596230|3997542|FG002|Objective 2, One Year|Withdrawal by Subject|14
2300321|NCT02596230|3997543|FG003|Objective 2, One Year|Withdrawal by Subject|5
2300322|NCT02596230|3997544|FG004|Objective 2, One Year|Withdrawal by Subject|2
2300323|NCT02596230|3997540|FG000|Objective 2, One Year|Adverse drug reaction|0
2300324|NCT02596230|3997541|FG001|Objective 2, One Year|Adverse drug reaction|1
2300325|NCT02596230|3997542|FG002|Objective 2, One Year|Adverse drug reaction|0
2300326|NCT02596230|3997543|FG003|Objective 2, One Year|Adverse drug reaction|0
2300327|NCT02596230|3997544|FG004|Objective 2, One Year|Adverse drug reaction|0
2300328|NCT02596230|3997540|FG000|Objective 2, One Year|Death|0
2300329|NCT02596230|3997541|FG001|Objective 2, One Year|Death|12
2300330|NCT02596230|3997542|FG002|Objective 2, One Year|Death|41
2300331|NCT02596230|3997543|FG003|Objective 2, One Year|Death|21
2300332|NCT02596230|3997544|FG004|Objective 2, One Year|Death|30
2300333|NCT02596230|3997540|FG000|Objective 2, One Year|Other|0
2300334|NCT02596230|3997541|FG001|Objective 2, One Year|Other|3
2300335|NCT02596230|3997542|FG002|Objective 2, One Year|Other|2
2300336|NCT02596230|3997543|FG003|Objective 2, One Year|Other|0
2300337|NCT02596230|3997544|FG004|Objective 2, One Year|Other|0
2300338|NCT02596620|3997577|FG000|Overall Study|Lost to Follow-up|1
2300339|NCT02596620|3997578|FG001|Overall Study|Lost to Follow-up|1
2300340|NCT02596711|3997587|FG000|Overall Study|Lost to Follow-up|1
2300341|NCT02596711|3997588|FG001|Overall Study|Lost to Follow-up|2
2300342|NCT02596711|3997589|FG002|Overall Study|Lost to Follow-up|3
2300343|NCT02596854|3997607|FG000|Overall Study|Withdrawn|8
2300344|NCT02596893|3997620|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
2300345|NCT02596893|3997621|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
2300346|NCT02596893|3997622|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
2300347|NCT02596893|3997623|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
2300348|NCT02596893|3997620|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
2300349|NCT02596893|3997621|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
2300350|NCT02596893|3997622|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
2300351|NCT02596893|3997623|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
2300352|NCT02596893|3997620|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
2300353|NCT02596893|3997621|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
2052334|NCT00506077|3624916|FG000|Treatment Period 1|Adverse Event|2
2052335|NCT00506077|3624917|FG001|Treatment Period 1|Adverse Event|1
2052336|NCT00506077|3624916|FG000|Treatment Period 1|Lost to Follow-up|0
2052337|NCT00506077|3624917|FG001|Treatment Period 1|Lost to Follow-up|2
2052338|NCT00506077|3624916|FG000|Treatment Period 1|Withdrawal by Subject|2
2052339|NCT00506077|3624917|FG001|Treatment Period 1|Withdrawal by Subject|0
2052340|NCT00506077|3624916|FG000|Treatment Period 2|Adverse Event|0
2052341|NCT00506077|3624917|FG001|Treatment Period 2|Adverse Event|1
2052342|NCT00506077|3624916|FG000|Treatment Period 2|Withdrawal by Subject|1
2052343|NCT00506077|3624917|FG001|Treatment Period 2|Withdrawal by Subject|0
2052344|NCT00506129|3624923|FG000|Overall Study|Disease Progression/Relapse|15
2052345|NCT00506129|3624923|FG000|Overall Study|Death|7
2052346|NCT00506142|3624929|FG000|Overall Study|Adverse Event|8
2052347|NCT00506142|3624930|FG001|Overall Study|Adverse Event|7
2052348|NCT00506142|3624929|FG000|Overall Study|Lack of Efficacy|21
2052349|NCT00506142|3624930|FG001|Overall Study|Lack of Efficacy|7
2052350|NCT00506142|3624929|FG000|Overall Study|Withdrawal by Subject|4
2052351|NCT00506142|3624930|FG001|Overall Study|Withdrawal by Subject|5
2052352|NCT00506142|3624929|FG000|Overall Study|Physician Decision|1
2052353|NCT00506142|3624930|FG001|Overall Study|Physician Decision|0
2052354|NCT00506142|3624929|FG000|Overall Study|New health condition|1
2052355|NCT00506142|3624930|FG001|Overall Study|New health condition|0
2052356|NCT00506285|3624942|FG000|3 Week Screening Phase|Withdrawal by Subject|17
2052357|NCT00506285|3624943|FG001|3 Week Screening Phase|Withdrawal by Subject|10
2052358|NCT00506285|3624942|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4
2052359|NCT00506285|3624943|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3
2052360|NCT00506285|3624942|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5
2052361|NCT00506285|3624943|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2
2052362|NCT00506285|3624942|FG000|6-month Open Label Phase|Lost to Follow-up|1
2052363|NCT00506285|3624943|FG001|6-month Open Label Phase|Lost to Follow-up|7
2052364|NCT00506285|3624942|FG000|6-month Open Label Phase|Withdrawal by Subject|9
2052365|NCT00506285|3624943|FG001|6-month Open Label Phase|Withdrawal by Subject|5
2052366|NCT00506350|3624960|FG000|Overall Study|Serious Adverse Event|1
2052367|NCT00506350|3624961|FG001|Overall Study|Serious Adverse Event|0
2052368|NCT00506350|3624962|FG002|Overall Study|Serious Adverse Event|0
2052369|NCT00506350|3624963|FG003|Overall Study|Serious Adverse Event|0
2052370|NCT00506350|3624964|FG004|Overall Study|Serious Adverse Event|0
2052371|NCT00506350|3624965|FG005|Overall Study|Serious Adverse Event|0
2052372|NCT00506350|3624966|FG006|Overall Study|Serious Adverse Event|0
2052373|NCT00506350|3624967|FG007|Overall Study|Serious Adverse Event|0
2052374|NCT00506350|3624968|FG008|Overall Study|Serious Adverse Event|0
2052375|NCT00506350|3624960|FG000|Overall Study|Adverse Event|0
2052376|NCT00506350|3624961|FG001|Overall Study|Adverse Event|0
2052377|NCT00506350|3624962|FG002|Overall Study|Adverse Event|0
2052378|NCT00506350|3624963|FG003|Overall Study|Adverse Event|0
2052379|NCT00506350|3624964|FG004|Overall Study|Adverse Event|0
2052380|NCT00506350|3624965|FG005|Overall Study|Adverse Event|0
2052381|NCT00506350|3624966|FG006|Overall Study|Adverse Event|0
2052382|NCT00506350|3624967|FG007|Overall Study|Adverse Event|1
2300354|NCT02596893|3997622|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
2300355|NCT02596893|3997623|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
2300356|NCT02596893|3997620|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
2300357|NCT02596893|3997621|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
2300358|NCT02596893|3997622|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
2300359|NCT02596893|3997623|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
2300360|NCT02596893|3997620|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
2300361|NCT02596893|3997621|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
2300362|NCT02596893|3997622|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
2300363|NCT02596893|3997623|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
2300364|NCT02596893|3997620|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
2300365|NCT02596893|3997621|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
2300366|NCT02596893|3997622|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
2300367|NCT02596893|3997623|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
2300368|NCT02596893|3997620|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
2300369|NCT02596893|3997621|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
2300370|NCT02596893|3997622|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
2300371|NCT02596893|3997623|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
2300372|NCT02596893|3997620|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
2300373|NCT02596893|3997621|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
2300374|NCT02596893|3997622|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
2300375|NCT02596893|3997623|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
2300376|NCT02596893|3997620|FG000|Overall Double-Blind Period Weeks 0-52|Death|0
2300377|NCT02596893|3997621|FG001|Overall Double-Blind Period Weeks 0-52|Death|0
2300378|NCT02596893|3997622|FG002|Overall Double-Blind Period Weeks 0-52|Death|1
2300379|NCT02596893|3997623|FG003|Overall Double-Blind Period Weeks 0-52|Death|0
2052383|NCT00506350|3624968|FG008|Overall Study|Adverse Event|1
2052384|NCT00506350|3624960|FG000|Overall Study|Protocol Violation|0
2052385|NCT00506350|3624961|FG001|Overall Study|Protocol Violation|0
2052386|NCT00506350|3624962|FG002|Overall Study|Protocol Violation|1
2052387|NCT00506350|3624963|FG003|Overall Study|Protocol Violation|0
2052388|NCT00506350|3624964|FG004|Overall Study|Protocol Violation|0
2052389|NCT00506350|3624965|FG005|Overall Study|Protocol Violation|0
2052390|NCT00506350|3624966|FG006|Overall Study|Protocol Violation|1
2052391|NCT00506350|3624967|FG007|Overall Study|Protocol Violation|0
2052392|NCT00506350|3624968|FG008|Overall Study|Protocol Violation|0
2052393|NCT00506350|3624960|FG000|Overall Study|Withdrawal by Subject|0
2052394|NCT00506350|3624961|FG001|Overall Study|Withdrawal by Subject|1
2052395|NCT00506350|3624962|FG002|Overall Study|Withdrawal by Subject|1
2052396|NCT00506350|3624963|FG003|Overall Study|Withdrawal by Subject|1
2052397|NCT00506350|3624964|FG004|Overall Study|Withdrawal by Subject|4
2052398|NCT00506350|3624965|FG005|Overall Study|Withdrawal by Subject|1
2052399|NCT00506350|3624966|FG006|Overall Study|Withdrawal by Subject|1
2052400|NCT00506350|3624967|FG007|Overall Study|Withdrawal by Subject|2
2052401|NCT00506350|3624968|FG008|Overall Study|Withdrawal by Subject|0
2052402|NCT00506350|3624960|FG000|Overall Study|Lost to Follow-up|1
2052403|NCT00506350|3624961|FG001|Overall Study|Lost to Follow-up|1
2052404|NCT00506350|3624962|FG002|Overall Study|Lost to Follow-up|1
2052405|NCT00506350|3624963|FG003|Overall Study|Lost to Follow-up|1
2052406|NCT00506350|3624964|FG004|Overall Study|Lost to Follow-up|2
2052407|NCT00506350|3624965|FG005|Overall Study|Lost to Follow-up|1
2052408|NCT00506350|3624966|FG006|Overall Study|Lost to Follow-up|0
2052409|NCT00506350|3624967|FG007|Overall Study|Lost to Follow-up|0
2052410|NCT00506350|3624968|FG008|Overall Study|Lost to Follow-up|2
2052411|NCT00506350|3624960|FG000|Overall Study|Medical Reason|0
2052412|NCT00506350|3624961|FG001|Overall Study|Medical Reason|0
2052413|NCT00506350|3624962|FG002|Overall Study|Medical Reason|0
2052414|NCT00506350|3624963|FG003|Overall Study|Medical Reason|0
2052415|NCT00506350|3624964|FG004|Overall Study|Medical Reason|1
2052416|NCT00506350|3624965|FG005|Overall Study|Medical Reason|0
2052417|NCT00506350|3624966|FG006|Overall Study|Medical Reason|0
2052418|NCT00506350|3624967|FG007|Overall Study|Medical Reason|0
2052419|NCT00506350|3624968|FG008|Overall Study|Medical Reason|0
2052420|NCT00506350|3624960|FG000|Overall Study|Other|1
2052421|NCT00506350|3624961|FG001|Overall Study|Other|1
2052422|NCT00506350|3624962|FG002|Overall Study|Other|3
2052423|NCT00506350|3624963|FG003|Overall Study|Other|0
2052424|NCT00506350|3624964|FG004|Overall Study|Other|3
2052425|NCT00506350|3624965|FG005|Overall Study|Other|0
2052426|NCT00506350|3624966|FG006|Overall Study|Other|0
2052427|NCT00506350|3624967|FG007|Overall Study|Other|2
2052428|NCT00506350|3624968|FG008|Overall Study|Other|2
2052429|NCT00506389|3624998|FG000|In-treatment Period|Other|3
2052430|NCT00506389|3624999|FG001|In-treatment Period|Other|3
2052431|NCT00506389|3625000|FG002|In-treatment Period|Other|4
2052432|NCT00506389|3624998|FG000|In-treatment Period|Lost to Follow-up|0
2052433|NCT00506389|3624999|FG001|In-treatment Period|Lost to Follow-up|0
2052434|NCT00506389|3625000|FG002|In-treatment Period|Lost to Follow-up|1
2052435|NCT00506389|3624998|FG000|In-treatment Period|Lack of compliance|1
2052436|NCT00506389|3624999|FG001|In-treatment Period|Lack of compliance|0
2052437|NCT00506389|3625000|FG002|In-treatment Period|Lack of compliance|0
2052438|NCT00506389|3624998|FG000|In-treatment Period|Reasons not related to trial|4
2052439|NCT00506389|3624999|FG001|In-treatment Period|Reasons not related to trial|1
2052440|NCT00506389|3625000|FG002|In-treatment Period|Reasons not related to trial|0
2052441|NCT00506389|3624998|FG000|In-treatment Period|Withdrawal by Subject|3
2052442|NCT00506389|3624999|FG001|In-treatment Period|Withdrawal by Subject|3
2052443|NCT00506389|3625000|FG002|In-treatment Period|Withdrawal by Subject|4
2052444|NCT00506389|3624998|FG000|In-treatment Period|Lack of Efficacy|0
2052445|NCT00506389|3624999|FG001|In-treatment Period|Lack of Efficacy|2
2052446|NCT00506389|3625000|FG002|In-treatment Period|Lack of Efficacy|0
2052447|NCT00506389|3624998|FG000|In-treatment Period|Adverse Event|11
2052448|NCT00506389|3624999|FG001|In-treatment Period|Adverse Event|5
2052449|NCT00506389|3625000|FG002|In-treatment Period|Adverse Event|2
2052450|NCT00506389|3624998|FG000|In-treatment Period|Randomized but not treated|4
2052451|NCT00506389|3624999|FG001|In-treatment Period|Randomized but not treated|1
2052452|NCT00506389|3625000|FG002|In-treatment Period|Randomized but not treated|1
2052453|NCT00506415|3625011|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
2052454|NCT00506415|3625012|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
2052455|NCT00506415|3625013|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
2052456|NCT00506415|3625014|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
2052457|NCT00506415|3625011|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
2052458|NCT00506415|3625012|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
2052459|NCT00506415|3625013|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
2052460|NCT00506415|3625014|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
2052461|NCT00506415|3625011|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
2052462|NCT00506415|3625012|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
2052463|NCT00506415|3625013|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
2052464|NCT00506415|3625014|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
2052465|NCT00506415|3625011|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
2052466|NCT00506415|3625012|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2105350|NCT00856635|3697900|FG001|Overall Study|Other|0
2052467|NCT00506415|3625013|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2052468|NCT00506415|3625014|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2052469|NCT00506415|3625011|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
2052470|NCT00506415|3625012|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2052471|NCT00506415|3625013|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2052472|NCT00506415|3625014|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2052473|NCT00506415|3625011|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
2052474|NCT00506415|3625012|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2052475|NCT00506415|3625013|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2052476|NCT00506415|3625014|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2052477|NCT00506415|3625011|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
2052478|NCT00506415|3625012|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
2052479|NCT00506415|3625013|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
2052480|NCT00506415|3625014|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
2052481|NCT00506415|3625011|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22
2052482|NCT00506415|3625012|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0
2052483|NCT00506415|3625013|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0
2052484|NCT00506415|3625014|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0
2052485|NCT00506415|3625011|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
2052486|NCT00506415|3625012|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
2052487|NCT00506415|3625013|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
2052488|NCT00506415|3625014|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
2052489|NCT00506415|3625011|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0
2052490|NCT00506415|3625012|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33
2052491|NCT00506415|3625013|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28
2052492|NCT00506415|3625014|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0
2052493|NCT00506415|3625011|FG000|Double Blind (Maximum 48 Weeks )|Death|0
2052494|NCT00506415|3625012|FG001|Double Blind (Maximum 48 Weeks )|Death|5
2052495|NCT00506415|3625013|FG002|Double Blind (Maximum 48 Weeks )|Death|3
2052496|NCT00506415|3625014|FG003|Double Blind (Maximum 48 Weeks )|Death|0
2052497|NCT00506415|3625011|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
2052498|NCT00506415|3625012|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
2052499|NCT00506415|3625013|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
2052500|NCT00506415|3625014|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
2052501|NCT00506415|3625011|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
2052502|NCT00506415|3625012|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
2052503|NCT00506415|3625013|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
2052504|NCT00506415|3625014|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
2052505|NCT00506415|3625011|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
2052506|NCT00506415|3625012|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
2052507|NCT00506415|3625013|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
2052508|NCT00506415|3625014|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
2052509|NCT00506415|3625011|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
2052510|NCT00506415|3625012|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
2052511|NCT00506415|3625013|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
2052512|NCT00506415|3625014|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
2052513|NCT00506415|3625011|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0
2052514|NCT00506415|3625012|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3
2052515|NCT00506415|3625013|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2
2052516|NCT00506415|3625014|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0
2052517|NCT00506415|3625011|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
2300380|NCT02596893|3997620|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
2300381|NCT02596893|3997621|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
2300382|NCT02596893|3997622|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
2300383|NCT02596893|3997623|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
2300384|NCT02596893|3997620|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66
2300385|NCT02596893|3997621|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76
2300386|NCT02596893|3997622|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69
2300387|NCT02596893|3997623|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70
2300388|NCT02596945|3997642|FG000|Overall Study|No documentation of study drug dosing|3
2300389|NCT02596945|3997642|FG000|Overall Study|Other|32
2300390|NCT02596945|3997642|FG000|Overall Study|Change to hemodialysis|15
2300391|NCT02596945|3997642|FG000|Overall Study|Other Erythropoietin stimulating agent|4
2300392|NCT02596945|3997642|FG000|Overall Study|Withdrawal by Subject|1
2300393|NCT02596945|3997642|FG000|Overall Study|Missing|1
2300394|NCT02596958|3997646|FG000|Overall Study|Serious Adverse Drug Reactions|44
2300395|NCT02596958|3997646|FG000|Overall Study|Cancer Progression|441
2300396|NCT02596958|3997646|FG000|Overall Study|Death From Cancer|112
2300397|NCT02596958|3997646|FG000|Overall Study|Death From Other Cause|33
2300398|NCT02596958|3997646|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61
2353773|NCT02044302|4107109|FG000|Overall Study|study terminated|2
2052518|NCT00506415|3625012|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
2052519|NCT00506415|3625013|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
2052520|NCT00506415|3625014|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
2300399|NCT02596958|3997646|FG000|Overall Study|Administrative Reasons/Other|231
2300400|NCT02596958|3997646|FG000|Overall Study|Lost to Follow-up|33
2300401|NCT02596958|3997646|FG000|Overall Study|Missing|32
2300402|NCT02596958|3997646|FG000|Overall Study|Excluded Due to Second Line Treatment|9
2300403|NCT02596971|3997653|FG000|Overall Study|Death|5
2300404|NCT02596971|3997654|FG001|Overall Study|Death|1
2300405|NCT02596971|3997655|FG002|Overall Study|Death|5
2300406|NCT02596971|3997653|FG000|Overall Study|Withdrawal by Subject|5
2300407|NCT02596971|3997654|FG001|Overall Study|Withdrawal by Subject|1
2300408|NCT02596971|3997655|FG002|Overall Study|Withdrawal by Subject|4
2300409|NCT02597049|3997669|FG000|Overall Study|Lost to Follow-up|0
2300410|NCT02597049|3997670|FG001|Overall Study|Lost to Follow-up|3
2300411|NCT02597049|3997671|FG002|Overall Study|Lost to Follow-up|2
2300412|NCT02597049|3997669|FG000|Overall Study|Withdrawal by Subject|2
2300413|NCT02597049|3997670|FG001|Overall Study|Withdrawal by Subject|2
2300414|NCT02597049|3997671|FG002|Overall Study|Withdrawal by Subject|1
2300415|NCT02597049|3997669|FG000|Overall Study|Adverse Event|2
2300416|NCT02597049|3997670|FG001|Overall Study|Adverse Event|0
2300417|NCT02597049|3997671|FG002|Overall Study|Adverse Event|0
2300418|NCT02597049|3997669|FG000|Overall Study|Death|2
2300419|NCT02597049|3997670|FG001|Overall Study|Death|0
2300420|NCT02597049|3997671|FG002|Overall Study|Death|0
2300421|NCT02597049|3997669|FG000|Overall Study|Noncompliant with Study Visits|1
2300422|NCT02597049|3997670|FG001|Overall Study|Noncompliant with Study Visits|0
2300423|NCT02597049|3997671|FG002|Overall Study|Noncompliant with Study Visits|0
2300424|NCT02597452|3997742|FG000|Overall Study|testing incomplete|30
2300425|NCT02597478|3997748|FG000|Overall Study|Withdrawal by Subject|2
2300426|NCT02597478|3997749|FG001|Overall Study|Withdrawal by Subject|0
2300427|NCT02597478|3997748|FG000|Overall Study|Change of opioid dose|1
2300428|NCT02597478|3997749|FG001|Overall Study|Change of opioid dose|0
2300429|NCT02597478|3997748|FG000|Overall Study|Insufficient exertional dyspnea|0
2300430|NCT02597478|3997749|FG001|Overall Study|Insufficient exertional dyspnea|1
2321457|NCT02960490|4036047|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
2321458|NCT02960490|4036048|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
2321459|NCT02960490|4036049|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
2321460|NCT02960490|4036050|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
2321461|NCT02960490|4036051|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
2321462|NCT02960490|4036052|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
2321463|NCT02960490|4036053|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
2321464|NCT02960490|4036054|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
2321465|NCT02960490|4036045|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1
2321466|NCT02960490|4036046|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2
2321467|NCT02960490|4036047|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
2321468|NCT02960490|4036048|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
2321469|NCT02960490|4036049|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
2321470|NCT02960490|4036050|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
2321471|NCT02960490|4036051|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
2321472|NCT02960490|4036052|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
2321473|NCT02960490|4036053|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
2321474|NCT02960490|4036054|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
2321475|NCT02960490|4036045|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
2321476|NCT02960490|4036046|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
2321477|NCT02960490|4036047|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
2321478|NCT02960490|4036048|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
2321479|NCT02960490|4036049|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
2321480|NCT02960490|4036050|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
2321481|NCT02960490|4036051|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
2321482|NCT02960490|4036052|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
2321483|NCT02960490|4036053|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
2321484|NCT02960490|4036054|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
2321485|NCT02960490|4036045|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
2321486|NCT02960490|4036046|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
2321487|NCT02960490|4036047|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
2321488|NCT02960490|4036048|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
2321489|NCT02960490|4036049|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
2321490|NCT02960490|4036050|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2
2321491|NCT02960490|4036051|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
2321492|NCT02960490|4036052|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
2321493|NCT02960490|4036053|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
2321494|NCT02960490|4036054|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
2108156|NCT00878553|3702003|FG002|Sleep Study|Lost to Follow-up|0
2052521|NCT00506415|3625011|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
2052522|NCT00506415|3625012|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
2052523|NCT00506415|3625013|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
2052524|NCT00506415|3625014|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
2052525|NCT00506415|3625011|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
2052526|NCT00506415|3625012|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
2052527|NCT00506415|3625013|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
2052528|NCT00506415|3625014|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
2052529|NCT00506415|3625011|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2052530|NCT00506415|3625012|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2052531|NCT00506415|3625013|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2052532|NCT00506415|3625014|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
2052533|NCT00506415|3625011|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2052534|NCT00506415|3625012|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2052535|NCT00506415|3625013|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2052536|NCT00506415|3625014|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
2052537|NCT00506415|3625011|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
2052538|NCT00506415|3625012|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
2052539|NCT00506415|3625013|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
2052540|NCT00506415|3625014|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
2052541|NCT00506415|3625011|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2052542|NCT00506415|3625012|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2300431|NCT02597712|3997795|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2
2300432|NCT02597712|3997796|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0
2300433|NCT02597712|3997795|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1
2300434|NCT02597712|3997796|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0
2300435|NCT02597712|3997795|FG000|Overall Study|Recurrent metastatic prostate cancer|0
2300436|NCT02597712|3997796|FG001|Overall Study|Recurrent metastatic prostate cancer|1
2300437|NCT02597855|3997804|FG000|Overall Study|Lost to Follow-up|2
2300438|NCT02597855|3997805|FG001|Overall Study|Lost to Follow-up|1
2300439|NCT02597920|3997823|FG000|Overall Study|Worsening of other pre-existing disease|0
2300440|NCT02597920|3997824|FG001|Overall Study|Worsening of other pre-existing disease|1
2300441|NCT02597920|3997825|FG002|Overall Study|Worsening of other pre-existing disease|0
2300442|NCT02597920|3997823|FG000|Overall Study|Other adverse event|20
2300443|NCT02597920|3997824|FG001|Overall Study|Other adverse event|30
2300444|NCT02597920|3997825|FG002|Overall Study|Other adverse event|0
2300445|NCT02597920|3997823|FG000|Overall Study|Lost to Follow-up|7
2300446|NCT02597920|3997824|FG001|Overall Study|Lost to Follow-up|9
2300447|NCT02597920|3997825|FG002|Overall Study|Lost to Follow-up|0
2300448|NCT02597920|3997823|FG000|Overall Study|Refuse to continue in the study|3
2300449|NCT02597920|3997824|FG001|Overall Study|Refuse to continue in the study|13
2300450|NCT02597920|3997825|FG002|Overall Study|Refuse to continue in the study|1
2300451|NCT02597920|3997823|FG000|Overall Study|Other than specified|10
2300452|NCT02597920|3997824|FG001|Overall Study|Other than specified|31
2300453|NCT02597920|3997825|FG002|Overall Study|Other than specified|5
2300454|NCT02597920|3997823|FG000|Overall Study|Other|1
2300455|NCT02597920|3997824|FG001|Overall Study|Other|0
2300456|NCT02597920|3997825|FG002|Overall Study|Other|0
2300457|NCT02597933|3997837|FG000|Overall Study|Withdrawal by Subject|7
2300458|NCT02597933|3997838|FG001|Overall Study|Withdrawal by Subject|5
2300459|NCT02597933|3997837|FG000|Overall Study|Protocol Violation|2
2300460|NCT02597933|3997838|FG001|Overall Study|Protocol Violation|2
2300461|NCT02597933|3997837|FG000|Overall Study|Adverse Event|20
2300462|NCT02597933|3997838|FG001|Overall Study|Adverse Event|28
2300463|NCT02597933|3997837|FG000|Overall Study|Not treated|2
2300464|NCT02597933|3997838|FG001|Overall Study|Not treated|2
2300465|NCT02597933|3997837|FG000|Overall Study|Other than stated above|7
2300466|NCT02597933|3997838|FG001|Overall Study|Other than stated above|14
2300467|NCT02597946|3997844|FG000|Overall Study|Withdrawal by Subject|1
2300468|NCT02597946|3997844|FG000|Overall Study|Progressive disease|16
2300469|NCT02597946|3997844|FG000|Overall Study|Other than above|1
2300470|NCT02598076|3997850|FG000|Overall Study|Lost to Follow-up|2
2300471|NCT02598076|3997851|FG001|Overall Study|Lost to Follow-up|3
2321495|NCT02960490|4036045|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0
2321496|NCT02960490|4036046|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0
2321497|NCT02960490|4036047|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1
2321498|NCT02960490|4036048|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0
2321499|NCT02960490|4036049|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1
2321500|NCT02960490|4036050|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0
2321501|NCT02960490|4036051|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0
2321502|NCT02960490|4036052|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0
2321503|NCT02960490|4036053|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0
2321504|NCT02960490|4036054|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0
2321505|NCT02960490|4036045|FG000|Re-randomized Participants: 12 Weeks|Other|0
2321506|NCT02960490|4036046|FG001|Re-randomized Participants: 12 Weeks|Other|0
2052543|NCT00506415|3625013|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2052544|NCT00506415|3625014|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
2052545|NCT00506415|3625011|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0
2052546|NCT00506415|3625012|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0
2052547|NCT00506415|3625013|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0
2052548|NCT00506415|3625014|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7
2052549|NCT00506441|3625027|FG000|Period 1; Open-label Period|Adverse Event|21
2052550|NCT00506441|3625028|FG001|Period 1; Open-label Period|Adverse Event|0
2052551|NCT00506441|3625027|FG000|Period 1; Open-label Period|Lack of Efficacy|13
2052552|NCT00506441|3625028|FG001|Period 1; Open-label Period|Lack of Efficacy|0
2052553|NCT00506441|3625027|FG000|Period 1; Open-label Period|Lost to Follow-up|2
2052554|NCT00506441|3625028|FG001|Period 1; Open-label Period|Lost to Follow-up|0
2052555|NCT00506441|3625027|FG000|Period 1; Open-label Period|Physician Decision|5
2052556|NCT00506441|3625028|FG001|Period 1; Open-label Period|Physician Decision|0
2052557|NCT00506441|3625027|FG000|Period 1; Open-label Period|Protocol Violation|9
2052558|NCT00506441|3625028|FG001|Period 1; Open-label Period|Protocol Violation|0
2052559|NCT00506441|3625027|FG000|Period 1; Open-label Period|Withdrawal by Subject|13
2052560|NCT00506441|3625028|FG001|Period 1; Open-label Period|Withdrawal by Subject|0
2052561|NCT00506441|3625027|FG000|Period 1; Open-label Period|Other Reasons|13
2052562|NCT00506441|3625028|FG001|Period 1; Open-label Period|Other Reasons|0
2052563|NCT00506441|3625027|FG000|Period 2; Double-blind Period|Adverse Event|0
2052564|NCT00506441|3625028|FG001|Period 2; Double-blind Period|Adverse Event|1
2052565|NCT00506441|3625027|FG000|Period 2; Double-blind Period|Lack of Efficacy|0
2052566|NCT00506441|3625028|FG001|Period 2; Double-blind Period|Lack of Efficacy|2
2052567|NCT00506441|3625027|FG000|Period 2; Double-blind Period|Physician Decision|1
2052568|NCT00506441|3625028|FG001|Period 2; Double-blind Period|Physician Decision|1
2052569|NCT00506441|3625027|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1
2052570|NCT00506441|3625028|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0
2052571|NCT00506441|3625027|FG000|Period 2; Double-blind Period|Other Reason|1
2052572|NCT00506441|3625028|FG001|Period 2; Double-blind Period|Other Reason|1
2052573|NCT00506454|3625038|FG000|Overall Study|Withdrawal by Subject|1
2052574|NCT00506454|3625039|FG001|Overall Study|Withdrawal by Subject|1
2052575|NCT00506493|3625045|FG000|Overall Study|Death|6
2052576|NCT00506493|3625045|FG000|Overall Study|Withdrawal by Subject|5
2052577|NCT00506519|3625054|FG000|Overall Study|Death|4
2052578|NCT00506519|3625055|FG001|Overall Study|Death|6
2052579|NCT00506519|3625056|FG002|Overall Study|Death|0
2052580|NCT00506519|3625054|FG000|Overall Study|Adverse Event|1
2052581|NCT00506519|3625055|FG001|Overall Study|Adverse Event|0
2052582|NCT00506519|3625056|FG002|Overall Study|Adverse Event|0
2052583|NCT00506662|3625073|FG000|Overall Study|Adverse Event|0
2052584|NCT00506662|3625074|FG001|Overall Study|Adverse Event|2
2052585|NCT00506662|3625073|FG000|Overall Study|Lack of Efficacy|1
2052586|NCT00506662|3625074|FG001|Overall Study|Lack of Efficacy|0
2052587|NCT00506662|3625073|FG000|Overall Study|Protocol Violation|2
2052588|NCT00506662|3625074|FG001|Overall Study|Protocol Violation|4
2052589|NCT00506662|3625073|FG000|Overall Study|Trial terminated|10
2052590|NCT00506662|3625074|FG001|Overall Study|Trial terminated|16
2052591|NCT00506662|3625073|FG000|Overall Study|Not recorded|4
2052592|NCT00506662|3625074|FG001|Overall Study|Not recorded|6
2052593|NCT00506753|3625102|FG000|Overall Study|Lost to Follow-up|21
2052594|NCT00506753|3625103|FG001|Overall Study|Lost to Follow-up|15
2052595|NCT00506779|3625111|FG000|Overall Study|Withdrawal by Subject|1
2052596|NCT00506779|3625112|FG001|Overall Study|Withdrawal by Subject|0
2052597|NCT00506779|3625113|FG002|Overall Study|Withdrawal by Subject|1
2052598|NCT00506779|3625114|FG003|Overall Study|Withdrawal by Subject|0
2052599|NCT00506779|3625111|FG000|Overall Study|Adverse Event|0
2052600|NCT00506779|3625112|FG001|Overall Study|Adverse Event|1
2052601|NCT00506779|3625113|FG002|Overall Study|Adverse Event|1
2300472|NCT02598128|3997873|FG000|Period A: Days -7 to -1|Adverse Event|1
2300473|NCT02598128|3997874|FG001|Period A: Days -7 to -1|Adverse Event|0
2300474|NCT02598128|3997875|FG002|Period A: Days -7 to -1|Adverse Event|0
2300475|NCT02598128|3997876|FG003|Period A: Days -7 to -1|Adverse Event|0
2300476|NCT02598193|3997888|FG000|Overall Study|Adverse Event|13
2300477|NCT02598193|3997888|FG000|Overall Study|Withdrawal by Subject|1
2300478|NCT02598193|3997888|FG000|Overall Study|Listed in active lung transplant list|1
2300479|NCT02598193|3997888|FG000|Overall Study|Does not want to take Nintedanib|1
2300480|NCT02598297|3997894|FG000|Overall Study|Study terminated by Sponsor|21
2300481|NCT02598297|3997895|FG001|Overall Study|Study terminated by Sponsor|23
2300482|NCT02598297|3997894|FG000|Overall Study|Adverse Event|1
2300483|NCT02598297|3997895|FG001|Overall Study|Adverse Event|1
2300484|NCT02598297|3997894|FG000|Overall Study|Physician Decision|1
2300485|NCT02598297|3997895|FG001|Overall Study|Physician Decision|0
2052602|NCT00506779|3625114|FG003|Overall Study|Adverse Event|1
2052603|NCT00506831|3625125|FG000|Overall Study|Death|1
2052604|NCT00506831|3625125|FG000|Overall Study|Withdrawal by Subject|1
2052605|NCT00506883|3625137|FG000|Overall Study|Lost to Follow-up|1
2052606|NCT00506883|3625138|FG001|Overall Study|Lost to Follow-up|1
2052607|NCT00506883|3625139|FG002|Overall Study|Lost to Follow-up|1
2052608|NCT00506883|3625137|FG000|Overall Study|Withdrawal by Subject|1
2052609|NCT00506883|3625138|FG001|Overall Study|Withdrawal by Subject|0
2052610|NCT00506883|3625139|FG002|Overall Study|Withdrawal by Subject|1
2052611|NCT00506883|3625137|FG000|Overall Study|Lack of Efficacy|0
2052612|NCT00506883|3625138|FG001|Overall Study|Lack of Efficacy|1
2052613|NCT00506883|3625139|FG002|Overall Study|Lack of Efficacy|1
2052614|NCT00506883|3625137|FG000|Overall Study|Other|5
2052615|NCT00506883|3625138|FG001|Overall Study|Other|1
2052616|NCT00506883|3625139|FG002|Overall Study|Other|1
2300486|NCT02598297|3997894|FG000|Overall Study|Subject/guardian decision|1
2300487|NCT02598297|3997895|FG001|Overall Study|Subject/guardian decision|0
2300488|NCT02598297|3997894|FG000|Overall Study|Followed for survival|1
2300489|NCT02598297|3997895|FG001|Overall Study|Followed for survival|0
2300490|NCT02598934|3997912|FG000|Overall Study|Adverse Event|11
2300491|NCT02598934|3997913|FG001|Overall Study|Adverse Event|13
2300492|NCT02598934|3997912|FG000|Overall Study|Failure to Return|3
2300493|NCT02598934|3997913|FG001|Overall Study|Failure to Return|3
2300494|NCT02598934|3997912|FG000|Overall Study|Withdrawal by Subject|2
2300495|NCT02598934|3997913|FG001|Overall Study|Withdrawal by Subject|3
2300496|NCT02598934|3997912|FG000|Overall Study|Administrative|2
2300497|NCT02598934|3997913|FG001|Overall Study|Administrative|1
2300498|NCT02598934|3997912|FG000|Overall Study|Protocol Violation|1
2300499|NCT02598934|3997913|FG001|Overall Study|Protocol Violation|2
2300500|NCT02599129|3997921|FG000|Overall Study|Lack of Efficacy|2
2300501|NCT02599129|3997922|FG001|Overall Study|Lack of Efficacy|2
2300502|NCT02599129|3997921|FG000|Overall Study|Lost to Follow-up|1
2300503|NCT02599129|3997922|FG001|Overall Study|Lost to Follow-up|0
2300504|NCT02599129|3997921|FG000|Overall Study|Withdrawal by Subject|2
2300505|NCT02599129|3997922|FG001|Overall Study|Withdrawal by Subject|1
2300506|NCT02599402|3997934|FG000|Overall Study|Disease progression|153
2300507|NCT02599402|3997934|FG000|Overall Study|Study drug toxicity|201
2300508|NCT02599402|3997934|FG000|Overall Study|Death|26
2300509|NCT02599402|3997934|FG000|Overall Study|Adverse Event unrelated to study drug|23
2300510|NCT02599402|3997934|FG000|Overall Study|Participant request to discontinue study treatment|13
2300511|NCT02599402|3997934|FG000|Overall Study|Participant withdrew consent|5
2300512|NCT02599402|3997934|FG000|Overall Study|Lost to Follow-up|1
2300513|NCT02599402|3997934|FG000|Overall Study|Maximum Clinical Benefit|7
2300514|NCT02599402|3997934|FG000|Overall Study|Poor/non-compliance|1
2300515|NCT02599402|3997934|FG000|Overall Study|Pregnancy|1
2300516|NCT02599402|3997934|FG000|Overall Study|Participant no longer met study criteria|7
2300517|NCT02599402|3997934|FG000|Overall Study|Other Reasons|95
2300518|NCT02599688|3997985|FG000|Overall Study|Lack of Efficacy|1
2300519|NCT02599688|3997985|FG000|Overall Study|Withdrawal by Subject|1
2300520|NCT02599688|3997985|FG000|Overall Study|Termination by Sponsor|2
2300521|NCT02599961|3997997|FG000|Overall Study|Withdrawal by Subject|1
2300522|NCT02599961|3997997|FG000|Overall Study|Subject Non-Compliance|2
2300523|NCT02599961|3997997|FG000|Overall Study|Discontinuation of Study by Sponsor|9
2300524|NCT02599961|3997997|FG000|Overall Study|Other, Not Specified|3
2300525|NCT02600351|3998009|FG000|Overall Study|Lack of Efficacy|3
2300526|NCT02600351|3998010|FG001|Overall Study|Lack of Efficacy|0
2300527|NCT02600351|3998011|FG002|Overall Study|Lack of Efficacy|5
2300528|NCT02600351|3998012|FG003|Overall Study|Lack of Efficacy|2
2300529|NCT02600351|3998009|FG000|Overall Study|Lost to Follow-up|1
2300530|NCT02600351|3998010|FG001|Overall Study|Lost to Follow-up|0
2300531|NCT02600351|3998011|FG002|Overall Study|Lost to Follow-up|0
2300532|NCT02600351|3998012|FG003|Overall Study|Lost to Follow-up|0
2300533|NCT02600351|3998009|FG000|Overall Study|Randomized but Not Treated|1
2300534|NCT02600351|3998010|FG001|Overall Study|Randomized but Not Treated|0
2300535|NCT02600351|3998011|FG002|Overall Study|Randomized but Not Treated|1
2300536|NCT02600351|3998012|FG003|Overall Study|Randomized but Not Treated|3
2300537|NCT02600559|3998040|FG000|Overall Study|Withdrawal by Subject|3
2300538|NCT02600559|3998040|FG000|Overall Study|Lost to Follow-up|20
2300539|NCT02600819|3998078|FG000|GEN Phase|Adverse Event|2
2300540|NCT02600819|3998079|FG001|GEN Phase|Adverse Event|0
2300541|NCT02600819|3998078|FG000|GEN Phase|Death|2
2300542|NCT02600819|3998079|FG001|GEN Phase|Death|0
2300543|NCT02600819|3998078|FG000|GEN Phase|Investigator's Discretion|4
2300544|NCT02600819|3998079|FG001|GEN Phase|Investigator's Discretion|0
2300545|NCT02600819|3998078|FG000|GEN Phase|Non-Compliance with Study Drug|1
2300546|NCT02600819|3998079|FG001|GEN Phase|Non-Compliance with Study Drug|0
2300547|NCT02600819|3998078|FG000|GEN Phase|Withdrew Consent|5
2300548|NCT02600819|3998079|FG001|GEN Phase|Withdrew Consent|0
2300549|NCT02600819|3998078|FG000|GEN Phase|Lost to Follow-up|2
2300550|NCT02600819|3998079|FG001|GEN Phase|Lost to Follow-up|0
2052617|NCT00506922|3625152|FG000|Overall Study|Physician Decision|0
2052618|NCT00506922|3625153|FG001|Overall Study|Physician Decision|0
2300551|NCT02600845|3998085|FG000|Overall Study|Reason Not Specified|3
2300552|NCT02600845|3998085|FG000|Overall Study|Non-compliance with Study Procedures|10
2300553|NCT02600845|3998085|FG000|Overall Study|Consent Withdrawal|5
2300554|NCT02600871|3998091|FG000|Overall Study|Lost to Follow-up|13
2300555|NCT02600871|3998092|FG001|Overall Study|Lost to Follow-up|10
2300556|NCT02601001|3998102|FG000|Dosing Period 2|Adverse Event|0
2300557|NCT02601001|3998103|FG001|Dosing Period 2|Adverse Event|0
2300558|NCT02601001|3998104|FG002|Dosing Period 2|Adverse Event|0
2300559|NCT02601001|3998105|FG003|Dosing Period 2|Adverse Event|0
2300560|NCT02601001|3998106|FG004|Dosing Period 2|Adverse Event|0
2300561|NCT02601001|3998107|FG005|Dosing Period 2|Adverse Event|0
2300562|NCT02601001|3998108|FG006|Dosing Period 2|Adverse Event|1
2052619|NCT00506922|3625154|FG002|Overall Study|Physician Decision|0
2052620|NCT00506922|3625155|FG003|Overall Study|Physician Decision|2
2052621|NCT00506922|3625156|FG004|Overall Study|Physician Decision|0
2052622|NCT00506922|3625152|FG000|Overall Study|Withdrawal by Subject|0
2300563|NCT02601027|3998131|FG000|Registration to Surgery|Withdrawal by Subject|20
2300564|NCT02601027|3998132|FG001|Registration to Surgery|Withdrawal by Subject|10
2300565|NCT02601300|3998153|FG000|Induction Phase|Lack of Efficacy|2
2300566|NCT02601300|3998153|FG000|Induction Phase|Protocol Violation|1
2300567|NCT02601300|3998153|FG000|Extension Phase|Withdrawal by Subject|3
2300568|NCT02601300|3998153|FG000|Extension Phase|Adverse Event|4
2300569|NCT02601300|3998153|FG000|Extension Phase|Lack of Efficacy|10
2300570|NCT02601313|3998162|FG000|Overall Study|Death|2
2300571|NCT02601313|3998163|FG001|Overall Study|Death|16
2300572|NCT02601313|3998164|FG002|Overall Study|Death|4
2300573|NCT02601313|3998162|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0
2300574|NCT02601313|3998163|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5
2300575|NCT02601313|3998164|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2
2300576|NCT02601313|3998162|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0
2300577|NCT02601313|3998163|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1
2300578|NCT02601313|3998164|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1
2300579|NCT02601313|3998162|FG000|Overall Study|Still on study|0
2300580|NCT02601313|3998163|FG001|Overall Study|Still on study|52
2300581|NCT02601313|3998164|FG002|Overall Study|Still on study|10
2300582|NCT02601313|3998162|FG000|Overall Study|Enrolled, did not initiate AC|4
2300583|NCT02601313|3998163|FG001|Overall Study|Enrolled, did not initiate AC|0
2300584|NCT02601313|3998164|FG002|Overall Study|Enrolled, did not initiate AC|0
2300585|NCT02601469|3998174|FG000|Overall Study|Enrolled in Error|1
2300586|NCT02601469|3998175|FG001|Overall Study|Enrolled in Error|0
2300587|NCT02601560|3998189|FG000|Overall Study|Other|0
2300588|NCT02601560|3998190|FG001|Overall Study|Other|0
2300589|NCT02601560|3998191|FG002|Overall Study|Other|0
2300590|NCT02601560|3998192|FG003|Overall Study|Other|0
2300591|NCT02601560|3998193|FG004|Overall Study|Other|0
2300592|NCT02601560|3998194|FG005|Overall Study|Other|0
2300593|NCT02601560|3998195|FG006|Overall Study|Other|1
2300594|NCT02601560|3998196|FG007|Overall Study|Other|0
2300595|NCT02601573|3998226|FG000|Overall Study|Lost to Follow-up|0
2300596|NCT02601573|3998227|FG001|Overall Study|Lost to Follow-up|3
2300597|NCT02601573|3998228|FG002|Overall Study|Lost to Follow-up|1
2300598|NCT02601573|3998229|FG003|Overall Study|Lost to Follow-up|0
2300599|NCT02601573|3998230|FG004|Overall Study|Lost to Follow-up|2
2300600|NCT02601573|3998226|FG000|Overall Study|Withdrawal by Subject|0
2300601|NCT02601573|3998227|FG001|Overall Study|Withdrawal by Subject|1
2300602|NCT02601573|3998228|FG002|Overall Study|Withdrawal by Subject|0
2300603|NCT02601573|3998229|FG003|Overall Study|Withdrawal by Subject|1
2300604|NCT02601573|3998230|FG004|Overall Study|Withdrawal by Subject|0
2300605|NCT02601625|3998246|FG000|Overall Study|Lost to Follow-up|0
2300606|NCT02601625|3998247|FG001|Overall Study|Lost to Follow-up|0
2300607|NCT02601625|3998248|FG002|Overall Study|Lost to Follow-up|1
2300608|NCT02601625|3998249|FG003|Overall Study|Lost to Follow-up|1
2300609|NCT02601820|3998273|FG000|Early On-Treatment (T2)|Missing T2 Record|51
2300610|NCT02601820|3998273|FG000|Late On-Treatment (T3)|missing T3 Record|49
2300611|NCT02601820|3998273|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3
2300612|NCT02601820|3998273|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88
2300613|NCT02602080|3998309|FG000|Overall Study|Protocol Violation|6
2300614|NCT02602080|3998310|FG001|Overall Study|Protocol Violation|1
2300615|NCT02602080|3998311|FG002|Overall Study|Protocol Violation|3
2300616|NCT02603107|3998340|FG000|Randomized Phase|Withdrew consent|8
2300617|NCT02603107|3998341|FG001|Randomized Phase|Withdrew consent|15
2300618|NCT02603107|3998340|FG000|Randomized Phase|Lost to Follow-up|1
2300619|NCT02603107|3998341|FG001|Randomized Phase|Lost to Follow-up|3
2300620|NCT02603107|3998340|FG000|Randomized Phase|Adverse Event|2
2300621|NCT02603107|3998341|FG001|Randomized Phase|Adverse Event|0
2300622|NCT02603107|3998340|FG000|Randomized Phase|Death|1
2300623|NCT02603107|3998341|FG001|Randomized Phase|Death|1
2300624|NCT02603107|3998340|FG000|Randomized Phase|Non-compliance with study drug|1
2300625|NCT02603107|3998341|FG001|Randomized Phase|Non-compliance with study drug|1
2300626|NCT02603107|3998340|FG000|Randomized Phase|Investigator's discretion|0
2300627|NCT02603107|3998341|FG001|Randomized Phase|Investigator's discretion|1
2052623|NCT00506922|3625153|FG001|Overall Study|Withdrawal by Subject|0
2300628|NCT02603107|3998340|FG000|Randomized Phase|Lack of Efficacy|1
2300629|NCT02603107|3998341|FG001|Randomized Phase|Lack of Efficacy|0
2300630|NCT02603107|3998340|FG000|Randomized Phase|Protocol Violation|1
2300631|NCT02603107|3998341|FG001|Randomized Phase|Protocol Violation|0
2300632|NCT02603107|3998340|FG000|Optional Extension Phase|Lost to Follow-up|3
2300633|NCT02603107|3998341|FG001|Optional Extension Phase|Lost to Follow-up|3
2300634|NCT02603107|3998340|FG000|Optional Extension Phase|Withdrew consent|3
2300635|NCT02603107|3998341|FG001|Optional Extension Phase|Withdrew consent|2
2300636|NCT02603107|3998340|FG000|Optional Extension Phase|Investigator's discretion|2
2300637|NCT02603107|3998341|FG001|Optional Extension Phase|Investigator's discretion|2
2300638|NCT02603107|3998340|FG000|Optional Extension Phase|Pregnancy|0
2300639|NCT02603107|3998341|FG001|Optional Extension Phase|Pregnancy|3
2300640|NCT02603107|3998340|FG000|Optional Extension Phase|Adverse Event|0
2300641|NCT02603107|3998341|FG001|Optional Extension Phase|Adverse Event|2
2052624|NCT00506922|3625154|FG002|Overall Study|Withdrawal by Subject|0
2052625|NCT00506922|3625155|FG003|Overall Study|Withdrawal by Subject|0
2052626|NCT00506922|3625156|FG004|Overall Study|Withdrawal by Subject|1
2052627|NCT00506948|3625164|FG000|Overall Study|Death|4
2052628|NCT00506948|3625164|FG000|Overall Study|Adverse Event|5
2052629|NCT00506948|3625164|FG000|Overall Study|Physician Decision|1
2209292|NCT01644175|3848952|FG000|Overall Study|Adverse Event|8
2300642|NCT02603107|3998340|FG000|Optional Extension Phase|Not treated in extension phase|0
2300643|NCT02603107|3998341|FG001|Optional Extension Phase|Not treated in extension phase|1
2300644|NCT02603107|3998340|FG000|Optional Extension Phase|Protocol Violation|1
2300645|NCT02603107|3998341|FG001|Optional Extension Phase|Protocol Violation|0
2300646|NCT02603120|3998351|FG000|Double-Blind Treatment Phase|Withdrew consent|4
2300647|NCT02603120|3998352|FG001|Double-Blind Treatment Phase|Withdrew consent|8
2300648|NCT02603120|3998351|FG000|Double-Blind Treatment Phase|Adverse Event|3
2300649|NCT02603120|3998352|FG001|Double-Blind Treatment Phase|Adverse Event|3
2300650|NCT02603120|3998351|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
2300651|NCT02603120|3998352|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
2300652|NCT02603120|3998351|FG000|Double-Blind Treatment Phase|Death|2
2300653|NCT02603120|3998352|FG001|Double-Blind Treatment Phase|Death|0
2300654|NCT02603120|3998351|FG000|Double-Blind Treatment Phase|Investigator's discretion|2
2300655|NCT02603120|3998352|FG001|Double-Blind Treatment Phase|Investigator's discretion|0
2300656|NCT02603120|3998351|FG000|Double-Blind Treatment Phase|Pregnancy|1
2300657|NCT02603120|3998352|FG001|Double-Blind Treatment Phase|Pregnancy|1
2300658|NCT02603120|3998351|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1
2300659|NCT02603120|3998352|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0
2300660|NCT02603120|3998351|FG000|Double-Blind Treatment Phase|Did not receive study drug|2
2300661|NCT02603120|3998352|FG001|Double-Blind Treatment Phase|Did not receive study drug|2
2300662|NCT02603120|3998351|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3
2300663|NCT02603120|3998352|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4
2300664|NCT02603120|3998351|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1
2300665|NCT02603120|3998352|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2
2300666|NCT02603120|3998351|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1
2300667|NCT02603120|3998352|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2
2300668|NCT02603120|3998351|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0
2300669|NCT02603120|3998352|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1
2209293|NCT01644175|3848953|FG001|Overall Study|Adverse Event|13
2209294|NCT01644175|3848952|FG000|Overall Study|Death|1
2209295|NCT01644175|3848953|FG001|Overall Study|Death|2
2209296|NCT01644175|3848952|FG000|Overall Study|Poor compliance to protocol|9
2209297|NCT01644175|3848953|FG001|Overall Study|Poor compliance to protocol|10
2209298|NCT01644175|3848952|FG000|Overall Study|Physician Decision|1
2209299|NCT01644175|3848953|FG001|Overall Study|Physician Decision|2
2209300|NCT01644175|3848952|FG000|Overall Study|Participant Moved|1
2209301|NCT01644175|3848953|FG001|Overall Study|Participant Moved|2
2209302|NCT01644175|3848952|FG000|Overall Study|Consent withdrawn by participant|3
2209303|NCT01644175|3848953|FG001|Overall Study|Consent withdrawn by participant|4
2209304|NCT01644175|3848952|FG000|Overall Study|Related to Autoinjector Administration|2
2300670|NCT02603120|3998351|FG000|OL Extension B/F/TAF Treatment Phase|Death|0
2300671|NCT02603120|3998352|FG001|OL Extension B/F/TAF Treatment Phase|Death|1
2300672|NCT02603120|3998351|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0
2300673|NCT02603120|3998352|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1
2300674|NCT02603172|3998368|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0
2300675|NCT02603172|3998369|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0
2300676|NCT02603172|3998370|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1
2300677|NCT02603172|3998371|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0
2300678|NCT02603172|3998372|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0
2300679|NCT02603172|3998373|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0
2300680|NCT02603172|3998374|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0
2209305|NCT01644175|3848953|FG001|Overall Study|Related to Autoinjector Administration|1
2209306|NCT01644175|3848952|FG000|Overall Study|Last visit outside protocol visit window|4
2209307|NCT01644175|3848953|FG001|Overall Study|Last visit outside protocol visit window|11
2209308|NCT01644175|3848952|FG000|Overall Study|Selection criteria finally not met|0
2209309|NCT01644175|3848953|FG001|Overall Study|Selection criteria finally not met|1
2209310|NCT01644175|3848952|FG000|Overall Study|Site closure|2
2209311|NCT01644175|3848953|FG001|Overall Study|Site closure|2
2209312|NCT01644175|3848952|FG000|Overall Study|Lost to Follow-up|1
2209313|NCT01644175|3848953|FG001|Overall Study|Lost to Follow-up|0
2209314|NCT01644175|3848952|FG000|Overall Study|Other than specified above|0
2209315|NCT01644175|3848953|FG001|Overall Study|Other than specified above|3
2209316|NCT01644188|3848961|FG000|Overall Study|Adverse Event|44
2209317|NCT01644188|3848962|FG001|Overall Study|Adverse Event|20
2209318|NCT01644188|3848961|FG000|Overall Study|Poor compliance to protocol|26
2209319|NCT01644188|3848962|FG001|Overall Study|Poor compliance to protocol|14
2209320|NCT01644188|3848961|FG000|Overall Study|Physician Decision|1
2209321|NCT01644188|3848962|FG001|Overall Study|Physician Decision|3
2209322|NCT01644188|3848961|FG000|Overall Study|Participant moved|7
2209323|NCT01644188|3848962|FG001|Overall Study|Participant moved|2
2052630|NCT00507026|3625171|FG000|Overall Study|Lack of Efficacy|6
2052631|NCT00507026|3625172|FG001|Overall Study|Lack of Efficacy|4
2052632|NCT00507026|3625173|FG002|Overall Study|Lack of Efficacy|21
2052633|NCT00507026|3625171|FG000|Overall Study|Withdrawal by Subject|2
2052634|NCT00507026|3625172|FG001|Overall Study|Withdrawal by Subject|0
2052635|NCT00507026|3625173|FG002|Overall Study|Withdrawal by Subject|0
2052636|NCT00507026|3625171|FG000|Overall Study|Investigator Decision|1
2052637|NCT00507026|3625172|FG001|Overall Study|Investigator Decision|0
2052638|NCT00507026|3625173|FG002|Overall Study|Investigator Decision|0
2052639|NCT00507026|3625171|FG000|Overall Study|Adverse Event|2
2052640|NCT00507026|3625172|FG001|Overall Study|Adverse Event|0
2052641|NCT00507026|3625173|FG002|Overall Study|Adverse Event|0
2209324|NCT01644188|3848961|FG000|Overall Study|Related to auto-injector administration|2
2209325|NCT01644188|3848962|FG001|Overall Study|Related to auto-injector administration|2
2209326|NCT01644188|3848961|FG000|Overall Study|Consent withdrawn by participant|14
2300681|NCT02603172|3998375|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0
2300682|NCT02603393|3998398|FG000|Overall Study|Patient/guardian decision|32
2300683|NCT02603393|3998399|FG001|Overall Study|Patient/guardian decision|18
2300684|NCT02603393|3998398|FG000|Overall Study|Adverse Event|17
2300685|NCT02603393|3998399|FG001|Overall Study|Adverse Event|15
2300686|NCT02603393|3998398|FG000|Overall Study|Technical problems|4
2300687|NCT02603393|3998399|FG001|Overall Study|Technical problems|7
2300688|NCT02603393|3998398|FG000|Overall Study|Lack of Efficacy|7
2300689|NCT02603393|3998399|FG001|Overall Study|Lack of Efficacy|2
2300690|NCT02603393|3998398|FG000|Overall Study|Death|3
2209327|NCT01644188|3848962|FG001|Overall Study|Consent withdrawn by participant|7
2209328|NCT01644188|3848961|FG000|Overall Study|Selection criteria finally not met|2
2209329|NCT01644188|3848962|FG001|Overall Study|Selection criteria finally not met|0
2209330|NCT01644188|3848961|FG000|Overall Study|Lost to Follow-up|1
2209331|NCT01644188|3848962|FG001|Overall Study|Lost to Follow-up|0
2209332|NCT01644188|3848961|FG000|Overall Study|Death|4
2209333|NCT01644188|3848962|FG001|Overall Study|Death|3
2209334|NCT01644188|3848961|FG000|Overall Study|Last visit outside protocol visit window|14
2300691|NCT02603393|3998399|FG001|Overall Study|Death|4
2300692|NCT02603393|3998398|FG000|Overall Study|Physician Decision|3
2300693|NCT02603393|3998399|FG001|Overall Study|Physician Decision|3
2300694|NCT02603393|3998398|FG000|Overall Study|Protocol deviation|2
2300695|NCT02603393|3998399|FG001|Overall Study|Protocol deviation|3
2300696|NCT02603393|3998398|FG000|Overall Study|Lost to Follow-up|1
2300697|NCT02603393|3998399|FG001|Overall Study|Lost to Follow-up|2
2300698|NCT02603393|3998398|FG000|Overall Study|Non-compliance with study treatment|1
2300699|NCT02603393|3998399|FG001|Overall Study|Non-compliance with study treatment|0
2300700|NCT02603393|3998398|FG000|Overall Study|Sponsor decision|1
2300701|NCT02603393|3998399|FG001|Overall Study|Sponsor decision|0
2300702|NCT02603419|3998411|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2300703|NCT02603419|3998412|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
2300704|NCT02603419|3998413|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2300705|NCT02603419|3998414|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2300706|NCT02603419|3998415|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2300707|NCT02603419|3998416|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2300708|NCT02603419|3998411|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
2300709|NCT02603419|3998412|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
2209335|NCT01644188|3848962|FG001|Overall Study|Last visit outside protocol visit window|16
2209336|NCT01644188|3848961|FG000|Overall Study|Site closure|1
2209337|NCT01644188|3848962|FG001|Overall Study|Site closure|1
2209338|NCT01644188|3848961|FG000|Overall Study|Other than specified above|6
2209339|NCT01644188|3848962|FG001|Overall Study|Other than specified above|7
2209340|NCT01644474|3849001|FG000|Overall Study|Poor compliance to protocol|1
2300710|NCT02603419|3998413|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
2300711|NCT02603419|3998414|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
2300712|NCT02603419|3998415|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
2300713|NCT02603419|3998416|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
2300714|NCT02603419|3998411|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
2300715|NCT02603419|3998412|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
2300716|NCT02603419|3998413|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
2300717|NCT02603419|3998414|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
2300718|NCT02603419|3998415|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
2300719|NCT02603419|3998416|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
2300720|NCT02603419|3998411|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2300721|NCT02603419|3998412|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2300722|NCT02603419|3998413|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2300723|NCT02603419|3998414|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2300724|NCT02603419|3998415|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
2300725|NCT02603419|3998416|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2300726|NCT02603419|3998411|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2300727|NCT02603419|3998412|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
2052642|NCT00507026|3625171|FG000|Overall Study|Protocol Violation|1
2052643|NCT00507026|3625172|FG001|Overall Study|Protocol Violation|0
2052644|NCT00507026|3625173|FG002|Overall Study|Protocol Violation|0
2052645|NCT00507026|3625171|FG000|Overall Study|Other|1
2052646|NCT00507026|3625172|FG001|Overall Study|Other|0
2052647|NCT00507026|3625173|FG002|Overall Study|Other|0
2052648|NCT00507130|3625185|FG000|Overall Study|Lost to Follow-up|0
2052649|NCT00507130|3625186|FG001|Overall Study|Lost to Follow-up|0
2052650|NCT00507130|3625187|FG002|Overall Study|Lost to Follow-up|1
2052651|NCT00507130|3625188|FG003|Overall Study|Lost to Follow-up|1
2052652|NCT00507130|3625185|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
2052653|NCT00507130|3625186|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
2052654|NCT00507130|3625187|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
2052655|NCT00507130|3625188|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
2052656|NCT00507416|3625210|FG000|Overall Study|Adverse Event|58
2052657|NCT00507416|3625211|FG001|Overall Study|Adverse Event|67
2052658|NCT00507416|3625212|FG002|Overall Study|Adverse Event|65
2052659|NCT00507416|3625210|FG000|Overall Study|Protocol Violation|1
2052660|NCT00507416|3625211|FG001|Overall Study|Protocol Violation|2
2052661|NCT00507416|3625212|FG002|Overall Study|Protocol Violation|0
2052662|NCT00507416|3625210|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7
2052663|NCT00507416|3625211|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7
2052664|NCT00507416|3625212|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8
2052665|NCT00507416|3625210|FG000|Overall Study|Progressive Disease|20
2052666|NCT00507416|3625211|FG001|Overall Study|Progressive Disease|10
2052667|NCT00507416|3625212|FG002|Overall Study|Progressive Disease|13
2052668|NCT00507416|3625210|FG000|Overall Study|Patient declined further treatment|18
2052669|NCT00507416|3625211|FG001|Overall Study|Patient declined further treatment|14
2052670|NCT00507416|3625212|FG002|Overall Study|Patient declined further treatment|11
2052671|NCT00507416|3625210|FG000|Overall Study|Other|11
2052672|NCT00507416|3625211|FG001|Overall Study|Other|16
2052673|NCT00507416|3625212|FG002|Overall Study|Other|13
2052674|NCT00507416|3625210|FG000|Overall Study|Did not Receive Study Treatment|3
2052675|NCT00507416|3625211|FG001|Overall Study|Did not Receive Study Treatment|9
2052676|NCT00507416|3625212|FG002|Overall Study|Did not Receive Study Treatment|4
2300728|NCT02603419|3998413|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2300729|NCT02603419|3998414|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2300730|NCT02603419|3998415|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2300731|NCT02603419|3998416|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2300732|NCT02603419|3998411|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
2300733|NCT02603419|3998412|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
2300734|NCT02603419|3998413|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
2300735|NCT02603419|3998414|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
2300736|NCT02603419|3998415|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
2300737|NCT02603419|3998416|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
2300738|NCT02603419|3998411|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2300739|NCT02603419|3998412|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2300740|NCT02603419|3998413|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2300741|NCT02603419|3998414|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
2300742|NCT02603419|3998415|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2300743|NCT02603419|3998416|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2300744|NCT02603419|3998411|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2300745|NCT02603419|3998412|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2300746|NCT02603419|3998413|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2300747|NCT02603419|3998414|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2300748|NCT02603419|3998415|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2300749|NCT02603419|3998416|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
2300750|NCT02603419|3998411|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2300751|NCT02603419|3998412|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2300752|NCT02603419|3998413|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2300753|NCT02603419|3998414|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2300754|NCT02603419|3998415|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2300755|NCT02603419|3998416|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1
2300756|NCT02603419|3998411|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2300757|NCT02603419|3998412|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2300758|NCT02603419|3998413|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2300759|NCT02603419|3998414|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2300760|NCT02603419|3998415|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2300761|NCT02603419|3998416|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
2300762|NCT02603809|3998441|FG000|Overall Study|Withdrawal by Subject|4
2300763|NCT02603809|3998442|FG001|Overall Study|Withdrawal by Subject|1
2300764|NCT02603809|3998443|FG002|Overall Study|Withdrawal by Subject|2
2052677|NCT00507429|3625222|FG000|Treatment Phase|Disease Progression|12
2052678|NCT00507429|3625223|FG001|Treatment Phase|Disease Progression|5
2052679|NCT00507429|3625222|FG000|Treatment Phase|Adverse Event|12
2052680|NCT00507429|3625223|FG001|Treatment Phase|Adverse Event|5
2052681|NCT00507429|3625222|FG000|Treatment Phase|Withdrawal by Subject|3
2300765|NCT02603809|3998444|FG003|Overall Study|Withdrawal by Subject|3
2300766|NCT02603809|3998445|FG004|Overall Study|Withdrawal by Subject|3
2300767|NCT02603809|3998446|FG005|Overall Study|Withdrawal by Subject|4
2300768|NCT02603809|3998441|FG000|Overall Study|Lost to Follow-up|2
2300769|NCT02603809|3998442|FG001|Overall Study|Lost to Follow-up|3
2300770|NCT02603809|3998443|FG002|Overall Study|Lost to Follow-up|1
2300771|NCT02603809|3998444|FG003|Overall Study|Lost to Follow-up|4
2300772|NCT02603809|3998445|FG004|Overall Study|Lost to Follow-up|2
2300773|NCT02603809|3998446|FG005|Overall Study|Lost to Follow-up|2
2300774|NCT02603809|3998441|FG000|Overall Study|Pre-specified discontinuation criteria|3
2300775|NCT02603809|3998442|FG001|Overall Study|Pre-specified discontinuation criteria|3
2300776|NCT02603809|3998443|FG002|Overall Study|Pre-specified discontinuation criteria|2
2300777|NCT02603809|3998444|FG003|Overall Study|Pre-specified discontinuation criteria|2
2300778|NCT02603809|3998445|FG004|Overall Study|Pre-specified discontinuation criteria|3
2300779|NCT02603809|3998446|FG005|Overall Study|Pre-specified discontinuation criteria|1
2300780|NCT02603809|3998441|FG000|Overall Study|Physician Decision|0
2300781|NCT02603809|3998442|FG001|Overall Study|Physician Decision|0
2300782|NCT02603809|3998443|FG002|Overall Study|Physician Decision|0
2300783|NCT02603809|3998444|FG003|Overall Study|Physician Decision|1
2300784|NCT02603809|3998445|FG004|Overall Study|Physician Decision|2
2300785|NCT02603809|3998446|FG005|Overall Study|Physician Decision|1
2300786|NCT02603809|3998441|FG000|Overall Study|Adverse Event|3
2300787|NCT02603809|3998442|FG001|Overall Study|Adverse Event|0
2300788|NCT02603809|3998443|FG002|Overall Study|Adverse Event|2
2300789|NCT02603809|3998444|FG003|Overall Study|Adverse Event|2
2300790|NCT02603809|3998445|FG004|Overall Study|Adverse Event|1
2300791|NCT02603809|3998446|FG005|Overall Study|Adverse Event|1
2300792|NCT02603809|3998441|FG000|Overall Study|Lack of Efficacy|0
2300793|NCT02603809|3998442|FG001|Overall Study|Lack of Efficacy|1
2300794|NCT02603809|3998443|FG002|Overall Study|Lack of Efficacy|0
2300795|NCT02603809|3998444|FG003|Overall Study|Lack of Efficacy|0
2300796|NCT02603809|3998445|FG004|Overall Study|Lack of Efficacy|0
2300797|NCT02603809|3998446|FG005|Overall Study|Lack of Efficacy|1
2300798|NCT02603887|3998462|FG000|Overall Study|FDA Guidance|1
2300799|NCT02603887|3998462|FG000|Overall Study|Adverse Event|4
2300800|NCT02603887|3998462|FG000|Overall Study|Disease progression|1
2300801|NCT02603952|3998475|FG000|Overall Study|Withdrawal by Subject|1
2300802|NCT02603952|3998476|FG001|Overall Study|Withdrawal by Subject|0
2300803|NCT02603952|3998477|FG002|Overall Study|Withdrawal by Subject|0
2300804|NCT02603952|3998478|FG003|Overall Study|Withdrawal by Subject|0
2300805|NCT02603952|3998475|FG000|Overall Study|Received oseltamivir by error|0
2300806|NCT02603952|3998476|FG001|Overall Study|Received oseltamivir by error|0
2300807|NCT02603952|3998477|FG002|Overall Study|Received oseltamivir by error|0
2300808|NCT02603952|3998478|FG003|Overall Study|Received oseltamivir by error|1
2300809|NCT02604017|3998493|FG000|Overall Study|Withdrew Consent|0
2300810|NCT02604017|3998494|FG001|Overall Study|Withdrew Consent|2
2300811|NCT02604017|3998493|FG000|Overall Study|Lost to Follow-up|5
2300812|NCT02604017|3998494|FG001|Overall Study|Lost to Follow-up|6
2177057|NCT01371539|3801125|FG001|Period One: One Week|Lost to Follow-up|1
2177058|NCT01371539|3801124|FG000|Period Two: One Week|Lost to Follow-up|0
2209341|NCT01644474|3849002|FG001|Overall Study|Poor compliance to protocol|0
2209342|NCT01644474|3849001|FG000|Overall Study|Consent withdrawn by participant|0
2209343|NCT01644474|3849002|FG001|Overall Study|Consent withdrawn by participant|1
2209344|NCT01644474|3849001|FG000|Overall Study|Participant moved|0
2209345|NCT01644474|3849002|FG001|Overall Study|Participant moved|1
2177059|NCT01371539|3801125|FG001|Period Two: One Week|Lost to Follow-up|1
2177060|NCT01371539|3801124|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0
2177061|NCT01371539|3801125|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1
2177062|NCT01371539|3801124|FG000|Period Two: One Week|Time/job conflict|0
2177063|NCT01371539|3801125|FG001|Period Two: One Week|Time/job conflict|1
2177064|NCT01371552|3801131|FG000|Part 1, First 3 Days|Inconvenience|0
2177065|NCT01371552|3801132|FG001|Part 1, First 3 Days|Inconvenience|0
2177066|NCT01371552|3801133|FG002|Part 1, First 3 Days|Inconvenience|1
2177067|NCT01371552|3801134|FG003|Part 1, First 3 Days|Inconvenience|0
2177068|NCT01371552|3801135|FG004|Part 1, First 3 Days|Inconvenience|0
2177069|NCT01371552|3801136|FG005|Part 1, First 3 Days|Inconvenience|0
2177070|NCT01371565|3801145|FG000|Overall Study|Withdrawal by Subject|1
2177071|NCT01371565|3801145|FG000|Overall Study|Death|1
2177072|NCT01371565|3801145|FG000|Overall Study|Resection of neuroendocrine tumor|1
2177073|NCT01371643|3801151|FG000|Overall Study|Withdrawal by Subject|3
2177074|NCT01371643|3801152|FG001|Overall Study|Withdrawal by Subject|0
2300813|NCT02604017|3998493|FG000|Overall Study|Other|1
2300814|NCT02604017|3998494|FG001|Overall Study|Other|0
2300815|NCT02604160|3998502|FG000|Overall Study|Protocol Violation|0
2300816|NCT02604160|3998503|FG001|Overall Study|Protocol Violation|1
2052682|NCT00507429|3625223|FG001|Treatment Phase|Withdrawal by Subject|3
2209346|NCT01644474|3849001|FG000|Overall Study|Adverse Event|4
2300817|NCT02604160|3998502|FG000|Overall Study|Physician Decision|0
2300818|NCT02604160|3998503|FG001|Overall Study|Physician Decision|1
2300819|NCT02604199|3998528|FG000|Overall Study|Pregnancy|0
2300820|NCT02604199|3998529|FG001|Overall Study|Pregnancy|0
2300821|NCT02604199|3998530|FG002|Overall Study|Pregnancy|0
2300822|NCT02604199|3998531|FG003|Overall Study|Pregnancy|1
2052683|NCT00507429|3625222|FG000|Treatment Phase|Physician Decision|4
2052684|NCT00507429|3625223|FG001|Treatment Phase|Physician Decision|2
2052685|NCT00507429|3625222|FG000|Treatment Phase|Other|6
2052686|NCT00507429|3625223|FG001|Treatment Phase|Other|3
2052687|NCT00507429|3625222|FG000|Maintenance Phase|Progressive Disease|14
2052688|NCT00507429|3625223|FG001|Maintenance Phase|Progressive Disease|0
2052689|NCT00507442|3625235|FG000|Overall Study|Adverse Event|8
2052690|NCT00507442|3625236|FG001|Overall Study|Adverse Event|11
2052691|NCT00507442|3625237|FG002|Overall Study|Adverse Event|4
2052692|NCT00507442|3625238|FG003|Overall Study|Adverse Event|1
2052693|NCT00507442|3625235|FG000|Overall Study|Protocol Violation|0
2052694|NCT00507442|3625236|FG001|Overall Study|Protocol Violation|1
2052695|NCT00507442|3625237|FG002|Overall Study|Protocol Violation|0
2052696|NCT00507442|3625238|FG003|Overall Study|Protocol Violation|0
2052697|NCT00507442|3625235|FG000|Overall Study|Lost to Follow-up|0
2052698|NCT00507442|3625236|FG001|Overall Study|Lost to Follow-up|0
2052699|NCT00507442|3625237|FG002|Overall Study|Lost to Follow-up|1
2052700|NCT00507442|3625238|FG003|Overall Study|Lost to Follow-up|0
2052701|NCT00507442|3625235|FG000|Overall Study|Physician Decision|0
2052702|NCT00507442|3625236|FG001|Overall Study|Physician Decision|2
2052703|NCT00507442|3625237|FG002|Overall Study|Physician Decision|4
2052704|NCT00507442|3625238|FG003|Overall Study|Physician Decision|1
2052705|NCT00507442|3625235|FG000|Overall Study|Progressive Disease|2
2052706|NCT00507442|3625236|FG001|Overall Study|Progressive Disease|4
2052707|NCT00507442|3625237|FG002|Overall Study|Progressive Disease|2
2052708|NCT00507442|3625238|FG003|Overall Study|Progressive Disease|0
2052709|NCT00507442|3625235|FG000|Overall Study|Withdrawal by Subject|4
2052710|NCT00507442|3625236|FG001|Overall Study|Withdrawal by Subject|4
2052711|NCT00507442|3625237|FG002|Overall Study|Withdrawal by Subject|2
2052712|NCT00507442|3625238|FG003|Overall Study|Withdrawal by Subject|1
2052713|NCT00507442|3625235|FG000|Overall Study|Other|2
2052714|NCT00507442|3625236|FG001|Overall Study|Other|5
2052715|NCT00507442|3625237|FG002|Overall Study|Other|2
2052716|NCT00507442|3625238|FG003|Overall Study|Other|2
2052717|NCT00507455|3625255|FG000|Overall Study|Adverse Event|3
2052718|NCT00507455|3625256|FG001|Overall Study|Adverse Event|3
2052719|NCT00507455|3625257|FG002|Overall Study|Adverse Event|6
2052720|NCT00507455|3625255|FG000|Overall Study|Withdrawal by Subject|2
2052721|NCT00507455|3625256|FG001|Overall Study|Withdrawal by Subject|1
2052722|NCT00507455|3625257|FG002|Overall Study|Withdrawal by Subject|2
2052723|NCT00507455|3625255|FG000|Overall Study|Protocol Violation|4
2052724|NCT00507455|3625256|FG001|Overall Study|Protocol Violation|1
2052725|NCT00507455|3625257|FG002|Overall Study|Protocol Violation|1
2052726|NCT00507455|3625255|FG000|Overall Study|Lost to Follow-up|2
2052727|NCT00507455|3625256|FG001|Overall Study|Lost to Follow-up|0
2052728|NCT00507455|3625257|FG002|Overall Study|Lost to Follow-up|2
2052729|NCT00507455|3625255|FG000|Overall Study|Lack of Efficacy|0
2052730|NCT00507455|3625256|FG001|Overall Study|Lack of Efficacy|1
2052731|NCT00507455|3625257|FG002|Overall Study|Lack of Efficacy|0
2052732|NCT00507455|3625255|FG000|Overall Study|Other - miscellaneous reason|1
2052733|NCT00507455|3625256|FG001|Overall Study|Other - miscellaneous reason|0
2052734|NCT00507455|3625257|FG002|Overall Study|Other - miscellaneous reason|1
2052735|NCT00507507|3625267|FG000|Treatment Period|Lost to Follow-up|0
2052736|NCT00507507|3625268|FG001|Treatment Period|Lost to Follow-up|2
2052737|NCT00507507|3625267|FG000|Treatment Period|Physician Decision|4
2052738|NCT00507507|3625268|FG001|Treatment Period|Physician Decision|1
2052739|NCT00507507|3625267|FG000|Treatment Period|Protocol Violation|1
2052740|NCT00507507|3625268|FG001|Treatment Period|Protocol Violation|2
2052741|NCT00507507|3625267|FG000|Treatment Period|Adverse Event|1
2052742|NCT00507507|3625268|FG001|Treatment Period|Adverse Event|1
2052743|NCT00507507|3625267|FG000|Treatment Period|Withdrawal by Subject|46
2052744|NCT00507507|3625268|FG001|Treatment Period|Withdrawal by Subject|47
2052745|NCT00507507|3625267|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1
2300823|NCT02604199|3998528|FG000|Overall Study|Study terminated by sponsor|0
2300824|NCT02604199|3998529|FG001|Overall Study|Study terminated by sponsor|2
2300825|NCT02604199|3998530|FG002|Overall Study|Study terminated by sponsor|0
2300826|NCT02604199|3998531|FG003|Overall Study|Study terminated by sponsor|2
2300827|NCT02604199|3998528|FG000|Overall Study|Withdrawal by Subject|0
2300828|NCT02604199|3998529|FG001|Overall Study|Withdrawal by Subject|1
2300829|NCT02604199|3998530|FG002|Overall Study|Withdrawal by Subject|0
2300830|NCT02604199|3998531|FG003|Overall Study|Withdrawal by Subject|0
2300831|NCT02604212|3998548|FG000|Overall Study|Study Terminated by Sponsor|2
2300832|NCT02604212|3998549|FG001|Overall Study|Study Terminated by Sponsor|1
2300833|NCT02604212|3998550|FG002|Overall Study|Study Terminated by Sponsor|3
2052746|NCT00507507|3625268|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0
2052747|NCT00507507|3625267|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0
2052748|NCT00507507|3625268|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1
2052749|NCT00507507|3625267|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
2052750|NCT00507507|3625268|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
2052751|NCT00507546|3625278|FG000|Overall Study|Withdrawal by Subject|1
2052752|NCT00507546|3625279|FG001|Overall Study|Withdrawal by Subject|0
2052753|NCT00507546|3625278|FG000|Overall Study|Protocol Violation|1
2052754|NCT00507546|3625279|FG001|Overall Study|Protocol Violation|0
2052755|NCT00507546|3625278|FG000|Overall Study|Physician Decision|0
2052756|NCT00507546|3625279|FG001|Overall Study|Physician Decision|1
2052757|NCT00507689|3625294|FG000|Pre-Randomization Period|Adverse Event|1
2052758|NCT00507689|3625295|FG001|Pre-Randomization Period|Adverse Event|0
2052759|NCT00507689|3625294|FG000|Pre-Randomization Period|Physician Decision|1
2052760|NCT00507689|3625295|FG001|Pre-Randomization Period|Physician Decision|0
2052761|NCT00507689|3625294|FG000|Pre-Randomization Period|Withdrawal by Subject|1
2052762|NCT00507689|3625295|FG001|Pre-Randomization Period|Withdrawal by Subject|0
2052763|NCT00507689|3625294|FG000|Randomized Period|Adverse Event|1
2052764|NCT00507689|3625295|FG001|Randomized Period|Adverse Event|1
2052765|NCT00507689|3625294|FG000|Randomized Period|Withdrawal by Subject|0
2052766|NCT00507689|3625295|FG001|Randomized Period|Withdrawal by Subject|1
2052767|NCT00507728|3625305|FG000|Randomization to Month 3|Lost to Follow-up|15
2052768|NCT00507728|3625306|FG001|Randomization to Month 3|Lost to Follow-up|14
2052769|NCT00507728|3625307|FG002|Randomization to Month 3|Lost to Follow-up|20
2052770|NCT00507728|3625305|FG000|From 3 Months to 6 Months|Lost to Follow-up|6
2052771|NCT00507728|3625306|FG001|From 3 Months to 6 Months|Lost to Follow-up|10
2052772|NCT00507728|3625307|FG002|From 3 Months to 6 Months|Lost to Follow-up|9
2052773|NCT00507819|3625325|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
2052774|NCT00507819|3625326|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
2052775|NCT00508001|3625335|FG000|Overall Study|Adverse Event|2
2052776|NCT00508001|3625336|FG001|Overall Study|Adverse Event|0
2052777|NCT00508001|3625337|FG002|Overall Study|Adverse Event|4
2052778|NCT00508001|3625335|FG000|Overall Study|condition under investigation worsened|13
2052779|NCT00508001|3625336|FG001|Overall Study|condition under investigation worsened|7
2052780|NCT00508001|3625337|FG002|Overall Study|condition under investigation worsened|1
2052781|NCT00508001|3625335|FG000|Overall Study|Death|0
2052782|NCT00508001|3625336|FG001|Overall Study|Death|1
2209347|NCT01644474|3849002|FG001|Overall Study|Adverse Event|5
2209348|NCT01644474|3849001|FG000|Overall Study|Site scheduling error|1
2209349|NCT01644474|3849002|FG001|Overall Study|Site scheduling error|1
2209350|NCT01644474|3849001|FG000|Overall Study|Protocol Violation|1
2209351|NCT01644474|3849002|FG001|Overall Study|Protocol Violation|0
2209352|NCT01644500|3849011|FG000|Overall Study|Adverse Event|6
2209353|NCT01644500|3849012|FG001|Overall Study|Adverse Event|1
2209354|NCT01644500|3849013|FG002|Overall Study|Adverse Event|2
2209355|NCT01644500|3849011|FG000|Overall Study|Death|0
2209356|NCT01644500|3849012|FG001|Overall Study|Death|1
2052783|NCT00508001|3625337|FG002|Overall Study|Death|1
2052784|NCT00508001|3625335|FG000|Overall Study|Withdrawal by Subject|4
2052785|NCT00508001|3625336|FG001|Overall Study|Withdrawal by Subject|4
2052786|NCT00508001|3625337|FG002|Overall Study|Withdrawal by Subject|1
2052787|NCT00508027|3625345|FG000|Dose Level 1|Lost to Follow-up|4
2052788|NCT00508027|3625345|FG000|Dose Level 1|Withdrawal by Subject|2
2052789|NCT00508027|3625345|FG000|Dose Level 1|Physician Decision|2
2300834|NCT02604212|3998551|FG003|Overall Study|Study Terminated by Sponsor|3
2300835|NCT02604212|3998548|FG000|Overall Study|Withdrawal by Subject|0
2300836|NCT02604212|3998549|FG001|Overall Study|Withdrawal by Subject|0
2300837|NCT02604212|3998550|FG002|Overall Study|Withdrawal by Subject|1
2300838|NCT02604212|3998551|FG003|Overall Study|Withdrawal by Subject|0
2300839|NCT02604264|3998568|FG000|Intervention|Didn't use CVC for at least 21 days|200
2300840|NCT02604264|3998569|FG001|Intervention|Didn't use CVC for at least 21 days|242
2300841|NCT02604342|3998577|FG000|Overall Study|Death|32
2052790|NCT00508027|3625345|FG000|Dose Level 2|Lost to Follow-up|2
2052791|NCT00508027|3625345|FG000|Dose Level 2|Withdrawal by Subject|2
2052792|NCT00508144|3625378|FG000|Overall Study|Not eligible|6
2052793|NCT00508144|3625378|FG000|Overall Study|Death|5
2052794|NCT00508157|3625384|FG000|Overall Study|Adverse Event|0
2052795|NCT00508157|3625385|FG001|Overall Study|Adverse Event|1
2052796|NCT00508157|3625384|FG000|Overall Study|Subject Withdrew Consent|1
2052797|NCT00508157|3625385|FG001|Overall Study|Subject Withdrew Consent|0
2052798|NCT00508157|3625384|FG000|Overall Study|Lost to Follow-up|1
2052799|NCT00508157|3625385|FG001|Overall Study|Lost to Follow-up|0
2052800|NCT00508157|3625384|FG000|Overall Study|Subject no longer met study criteria|0
2052801|NCT00508157|3625385|FG001|Overall Study|Subject no longer met study criteria|1
2052802|NCT00508157|3625384|FG000|Overall Study|Other known cause|0
2052803|NCT00508157|3625385|FG001|Overall Study|Other known cause|1
2052804|NCT00508261|3625411|FG000|Overall Study|Other|0
2052805|NCT00508261|3625412|FG001|Overall Study|Other|1
2052806|NCT00508261|3625413|FG002|Overall Study|Other|1
2052807|NCT00508261|3625414|FG003|Overall Study|Other|0
2052808|NCT00508261|3625411|FG000|Overall Study|Serious Adverse Event|0
2052809|NCT00508261|3625412|FG001|Overall Study|Serious Adverse Event|1
2052810|NCT00508261|3625413|FG002|Overall Study|Serious Adverse Event|0
2052811|NCT00508261|3625414|FG003|Overall Study|Serious Adverse Event|0
2052812|NCT00508261|3625411|FG000|Overall Study|Withdrawal by Subject|3
2052813|NCT00508261|3625412|FG001|Overall Study|Withdrawal by Subject|4
2052814|NCT00508261|3625413|FG002|Overall Study|Withdrawal by Subject|4
2052815|NCT00508261|3625414|FG003|Overall Study|Withdrawal by Subject|0
2052816|NCT00508261|3625411|FG000|Overall Study|Migrated/ moved from study area|0
2209357|NCT01644500|3849013|FG002|Overall Study|Death|0
2300842|NCT02604342|3998578|FG001|Overall Study|Death|16
2108157|NCT00878553|3702004|FG003|Sleep Study|Lost to Follow-up|0
2052817|NCT00508261|3625412|FG001|Overall Study|Migrated/ moved from study area|1
2052818|NCT00508261|3625413|FG002|Overall Study|Migrated/ moved from study area|0
2052819|NCT00508261|3625414|FG003|Overall Study|Migrated/ moved from study area|0
2052820|NCT00508261|3625411|FG000|Overall Study|Lost to Follow-up|0
2052821|NCT00508261|3625412|FG001|Overall Study|Lost to Follow-up|1
2052822|NCT00508261|3625413|FG002|Overall Study|Lost to Follow-up|1
2052823|NCT00508261|3625414|FG003|Overall Study|Lost to Follow-up|1
2052824|NCT00508274|3625428|FG000|Overall Study|Adverse Event|5
2052825|NCT00508274|3625428|FG000|Overall Study|Death|7
2052826|NCT00508274|3625428|FG000|Overall Study|Disease progression|32
2052827|NCT00508274|3625428|FG000|Overall Study|Withdrawal by Subject|1
2052828|NCT00508274|3625428|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2
2052829|NCT00508274|3625428|FG000|Overall Study|Missing|3
2052830|NCT00508391|3625443|FG000|First Treatment|Withdrawal by Subject|6
2052831|NCT00508391|3625444|FG001|First Treatment|Withdrawal by Subject|3
2052832|NCT00508391|3625443|FG000|Second Treatment|Withdrawal by Subject|2
2052833|NCT00508391|3625444|FG001|Second Treatment|Withdrawal by Subject|0
2052834|NCT00508404|3625452|FG000|Overall Study|Ongoing at Data Cut-off|12
2052835|NCT00508404|3625452|FG000|Overall Study|Adverse Event|2
2052836|NCT00508404|3625452|FG000|Overall Study|Death|16
2052837|NCT00508404|3625452|FG000|Overall Study|Physician Decision|2
2052838|NCT00508404|3625452|FG000|Overall Study|Withdrawal by Subject|3
2052839|NCT00508404|3625452|FG000|Overall Study|Protocol-specified Criteria|2
2052840|NCT00508404|3625452|FG000|Overall Study|Lost to Follow-up|2
2052841|NCT00508404|3625452|FG000|Overall Study|Other - Not Specified|3
2052842|NCT00508482|3625469|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9
2052843|NCT00508482|3625470|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7
2052844|NCT00508482|3625471|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4
2052845|NCT00508482|3625469|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12
2052846|NCT00508482|3625470|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10
2052847|NCT00508482|3625471|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16
2052848|NCT00508482|3625469|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20
2052849|NCT00508482|3625470|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6
2052850|NCT00508482|3625471|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1
2052851|NCT00508651|3625486|FG000|Overall Study|Lost to Follow-up|3
2052852|NCT00508651|3625487|FG001|Overall Study|Lost to Follow-up|1
2052853|NCT00508651|3625486|FG000|Overall Study|Withdrawal by Subject|1
2052854|NCT00508651|3625487|FG001|Overall Study|Withdrawal by Subject|1
2052855|NCT00508742|3625504|FG000|Period 1: Infant Series|Adverse Event|5
2052856|NCT00508742|3625505|FG001|Period 1: Infant Series|Adverse Event|4
2052857|NCT00508742|3625504|FG000|Period 1: Infant Series|Protocol Violation|1
2052858|NCT00508742|3625505|FG001|Period 1: Infant Series|Protocol Violation|0
2052859|NCT00508742|3625504|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31
2052860|NCT00508742|3625505|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40
2052861|NCT00508742|3625504|FG000|Period 1: Infant Series|Physician Decision|1
2052862|NCT00508742|3625505|FG001|Period 1: Infant Series|Physician Decision|0
2052863|NCT00508742|3625504|FG000|Period 1: Infant Series|Other|4
2052864|NCT00508742|3625505|FG001|Period 1: Infant Series|Other|1
2052865|NCT00508742|3625504|FG000|Period 2: After Infant Series|Adverse Event|2
2052866|NCT00508742|3625505|FG001|Period 2: After Infant Series|Adverse Event|6
2052867|NCT00508742|3625504|FG000|Period 2: After Infant Series|Lost to Follow-up|1
2052868|NCT00508742|3625505|FG001|Period 2: After Infant Series|Lost to Follow-up|1
2052869|NCT00508742|3625504|FG000|Period 2: After Infant Series|Protocol Violation|1
2052870|NCT00508742|3625505|FG001|Period 2: After Infant Series|Protocol Violation|0
2052871|NCT00508742|3625504|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0
2052872|NCT00508742|3625505|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3
2052873|NCT00508742|3625504|FG000|Period 2: After Infant Series|Failed to Return|1
2052874|NCT00508742|3625505|FG001|Period 2: After Infant Series|Failed to Return|0
2052875|NCT00508742|3625504|FG000|Period 2: After Infant Series|Other|2
2052876|NCT00508742|3625505|FG001|Period 2: After Infant Series|Other|1
2052877|NCT00508742|3625504|FG000|Period 3: Toddler Dose|Adverse Event|1
2052878|NCT00508742|3625505|FG001|Period 3: Toddler Dose|Adverse Event|0
2052879|NCT00508742|3625504|FG000|Period 3: Toddler Dose|Lost to Follow-up|2
2052880|NCT00508742|3625505|FG001|Period 3: Toddler Dose|Lost to Follow-up|3
2052881|NCT00508742|3625504|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
2052882|NCT00508742|3625505|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
2052883|NCT00508742|3625504|FG000|Period 3: Toddler Dose|Other|5
2052884|NCT00508742|3625505|FG001|Period 3: Toddler Dose|Other|4
2052885|NCT00508755|3625517|FG000|Overall Study|Withdrawal by Subject|1
2052886|NCT00508820|3625525|FG000|Overall Study|Adverse Event|6
2052887|NCT00508820|3625526|FG001|Overall Study|Adverse Event|10
2052888|NCT00508820|3625525|FG000|Overall Study|Death|6
2052889|NCT00508820|3625526|FG001|Overall Study|Death|8
2052890|NCT00508820|3625525|FG000|Overall Study|Lost to Follow-up|1
2052891|NCT00508820|3625526|FG001|Overall Study|Lost to Follow-up|1
2052892|NCT00508820|3625525|FG000|Overall Study|Physician Decision|8
2052893|NCT00508820|3625526|FG001|Overall Study|Physician Decision|2
2052894|NCT00508820|3625525|FG000|Overall Study|Pregnancy|0
2052895|NCT00508820|3625526|FG001|Overall Study|Pregnancy|2
2052896|NCT00508820|3625525|FG000|Overall Study|Protocol Violation|2
2052897|NCT00508820|3625526|FG001|Overall Study|Protocol Violation|0
2052898|NCT00508820|3625525|FG000|Overall Study|Withdrawal by Subject|10
2052899|NCT00508820|3625526|FG001|Overall Study|Withdrawal by Subject|12
2052900|NCT00508820|3625525|FG000|Overall Study|Other|11
2052901|NCT00508820|3625526|FG001|Overall Study|Other|2
2052902|NCT00508820|3625525|FG000|Overall Study|Noncompliance|1
2052903|NCT00508820|3625526|FG001|Overall Study|Noncompliance|0
2052904|NCT00508820|3625525|FG000|Overall Study|Requirement for alternative therapy|7
2052905|NCT00508820|3625526|FG001|Overall Study|Requirement for alternative therapy|15
2052906|NCT00508820|3625525|FG000|Overall Study|Protocol-specified Criteria|3
2052907|NCT00508820|3625526|FG001|Overall Study|Protocol-specified Criteria|12
2052908|NCT00508924|3625536|FG000|Overall Study|Protocol Violation|0
2052909|NCT00508924|3625537|FG001|Overall Study|Protocol Violation|0
2052910|NCT00508924|3625538|FG002|Overall Study|Protocol Violation|1
2052911|NCT00508924|3625539|FG003|Overall Study|Protocol Violation|1
2052912|NCT00509028|3625555|FG000|Overall Study|Adverse Event|2
2052913|NCT00509028|3625556|FG001|Overall Study|Adverse Event|0
2052914|NCT00509028|3625555|FG000|Overall Study|Withdrawal by Subject|4
2052915|NCT00509028|3625556|FG001|Overall Study|Withdrawal by Subject|3
2052916|NCT00509028|3625555|FG000|Overall Study|Lost to Follow-up|0
2052917|NCT00509028|3625556|FG001|Overall Study|Lost to Follow-up|1
2052918|NCT00509028|3625555|FG000|Overall Study|Protocol Violation|4
2052919|NCT00509028|3625556|FG001|Overall Study|Protocol Violation|2
2052920|NCT00509028|3625555|FG000|Overall Study|Non-compliance|2
2052921|NCT00509028|3625556|FG001|Overall Study|Non-compliance|1
2052922|NCT00509067|3625568|FG000|Overall Study|Lost to Follow-up|1
2052923|NCT00509067|3625569|FG001|Overall Study|Lost to Follow-up|1
2052924|NCT00509067|3625568|FG000|Overall Study|Adverse Event|3
2052925|NCT00509067|3625569|FG001|Overall Study|Adverse Event|1
2052926|NCT00509067|3625568|FG000|Overall Study|Protocol Violation|0
2052927|NCT00509067|3625569|FG001|Overall Study|Protocol Violation|3
2052928|NCT00509093|3625579|FG000|Overall Study|Adverse Event|10
2052929|NCT00509093|3625579|FG000|Overall Study|Disease Progression|9
2052930|NCT00509093|3625579|FG000|Overall Study|Transformed into MDS|1
2052931|NCT00509093|3625579|FG000|Overall Study|Withdrawal by Subject|3
2052932|NCT00509093|3625579|FG000|Overall Study|Physician Decision|1
2052933|NCT00509106|3625585|FG000|Overall Study|Adverse Event|3
2052934|NCT00509106|3625586|FG001|Overall Study|Adverse Event|2
2052935|NCT00509106|3625585|FG000|Overall Study|Noncompliance|0
2052936|NCT00509106|3625586|FG001|Overall Study|Noncompliance|1
2052937|NCT00509106|3625585|FG000|Overall Study|At the request of sponsor/investigator|1
2052938|NCT00509106|3625586|FG001|Overall Study|At the request of sponsor/investigator|2
2052939|NCT00509106|3625585|FG000|Overall Study|Withdrew consent|4
2052940|NCT00509106|3625586|FG001|Overall Study|Withdrew consent|8
2052941|NCT00509106|3625585|FG000|Overall Study|Lost to Follow-up|16
2052942|NCT00509106|3625586|FG001|Overall Study|Lost to Follow-up|10
2052943|NCT00509106|3625585|FG000|Overall Study|Other|1
2052944|NCT00509106|3625586|FG001|Overall Study|Other|0
2052945|NCT00509106|3625585|FG000|Overall Study|Death|6
2052946|NCT00509106|3625586|FG001|Overall Study|Death|6
2052947|NCT00509145|3625594|FG000|Overall Study|Death|0
2052948|NCT00509145|3625595|FG001|Overall Study|Death|2
2052949|NCT00509145|3625594|FG000|Overall Study|Adverse Event|42
2052950|NCT00509145|3625595|FG001|Overall Study|Adverse Event|28
2052951|NCT00509145|3625594|FG000|Overall Study|Withdrawal by Subject|32
2052952|NCT00509145|3625595|FG001|Overall Study|Withdrawal by Subject|38
2052953|NCT00509145|3625594|FG000|Overall Study|Physician Decision|11
2052954|NCT00509145|3625595|FG001|Overall Study|Physician Decision|14
2052955|NCT00509145|3625594|FG000|Overall Study|Protocol Violation|1
2052956|NCT00509145|3625595|FG001|Overall Study|Protocol Violation|6
2052957|NCT00509145|3625594|FG000|Overall Study|Pregnancy|3
2052958|NCT00509145|3625595|FG001|Overall Study|Pregnancy|8
2052959|NCT00509145|3625594|FG000|Overall Study|Lost to Follow-up|6
2052960|NCT00509145|3625595|FG001|Overall Study|Lost to Follow-up|5
2052961|NCT00509145|3625594|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12
2052962|NCT00509145|3625595|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22
2052963|NCT00509145|3625594|FG000|Overall Study|Other|6
2052964|NCT00509145|3625595|FG001|Overall Study|Other|6
2052965|NCT00509223|3625623|FG000|Overall Study|Lost to Follow-up|1
2052966|NCT00509223|3625624|FG001|Overall Study|Lost to Follow-up|1
2052967|NCT00509223|3625623|FG000|Overall Study|Adverse Event|1
2052968|NCT00509223|3625624|FG001|Overall Study|Adverse Event|1
2052969|NCT00509223|3625623|FG000|Overall Study|Withdrawal by Subject|25
2052970|NCT00509223|3625624|FG001|Overall Study|Withdrawal by Subject|6
2052971|NCT00509223|3625623|FG000|Overall Study|Including: subject change of address|5
2052972|NCT00509223|3625624|FG001|Overall Study|Including: subject change of address|2
2052973|NCT00509223|3625623|FG000|Overall Study|Did not meet revised inclusion criteria|56
2052974|NCT00509223|3625624|FG001|Overall Study|Did not meet revised inclusion criteria|62
2052975|NCT00509236|3625632|FG000|Overall Study|Adverse Event|7
2052976|NCT00509236|3625633|FG001|Overall Study|Adverse Event|9
2052977|NCT00509236|3625632|FG000|Overall Study|Withdrawal by Subject|5
2052978|NCT00509236|3625633|FG001|Overall Study|Withdrawal by Subject|10
2052979|NCT00509236|3625632|FG000|Overall Study|Protocol Violation|3
2052980|NCT00509236|3625633|FG001|Overall Study|Protocol Violation|0
2052981|NCT00509236|3625632|FG000|Overall Study|Excluded Medication|1
2052982|NCT00509236|3625633|FG001|Overall Study|Excluded Medication|1
2052983|NCT00509236|3625632|FG000|Overall Study|Scheduled Kidney Transplant|1
2052984|NCT00509236|3625633|FG001|Overall Study|Scheduled Kidney Transplant|0
2105351|NCT00856635|3697899|FG000|Overall Study|Discontinued at Randomization|2
2105352|NCT00856635|3697900|FG001|Overall Study|Discontinued at Randomization|2
2105353|NCT00856661|3697910|FG000|Overall Study|Death|15
2105354|NCT00856661|3697911|FG001|Overall Study|Death|18
2105355|NCT00856661|3697910|FG000|Overall Study|Protocol Violation|2
2105356|NCT00856661|3697911|FG001|Overall Study|Protocol Violation|1
2105357|NCT00856661|3697910|FG000|Overall Study|Withdrawal by Subject|1
2105358|NCT00856661|3697911|FG001|Overall Study|Withdrawal by Subject|2
2105359|NCT00856661|3697910|FG000|Overall Study|Lost to Follow-up|1
2105360|NCT00856661|3697911|FG001|Overall Study|Lost to Follow-up|3
2105361|NCT00856661|3697910|FG000|Overall Study|Physician Judgement|8
2105362|NCT00856661|3697911|FG001|Overall Study|Physician Judgement|5
2105363|NCT00856778|3697937|FG000|Overall Study|Adverse Event|7
2105364|NCT00856778|3697937|FG000|Overall Study|Withdrawal by Subject|10
2105365|NCT00856778|3697937|FG000|Overall Study|Study deviation|2
2105366|NCT00856778|3697937|FG000|Overall Study|Lost to Follow-up|5
2105367|NCT00856830|3697949|FG000|Irinotecan & Bendamustine|Death|0
2105368|NCT00856830|3697950|FG001|Irinotecan & Bendamustine|Death|0
2105369|NCT00856830|3697951|FG002|Irinotecan & Bendamustine|Death|0
2105370|NCT00856830|3697952|FG003|Irinotecan & Bendamustine|Death|2
2105371|NCT00856830|3697949|FG000|Irinotecan & Bendamustine|Physician Decision|0
2105372|NCT00856830|3697950|FG001|Irinotecan & Bendamustine|Physician Decision|0
2105373|NCT00856830|3697951|FG002|Irinotecan & Bendamustine|Physician Decision|0
2105374|NCT00856830|3697952|FG003|Irinotecan & Bendamustine|Physician Decision|1
2105375|NCT00856843|3697959|FG000|Overall Study|Withdrawal by Subject|1
2105376|NCT00856843|3697960|FG001|Overall Study|Withdrawal by Subject|5
2105377|NCT00856843|3697959|FG000|Overall Study|Lack of Efficacy|1
2105378|NCT00856843|3697960|FG001|Overall Study|Lack of Efficacy|0
2105379|NCT00856856|3697966|FG000|2-year Clinical Follow-up|Lost to Follow-up|1
2105380|NCT00856856|3697966|FG000|4-year Clinical Follow-up|Missed visit|1
2105381|NCT00856908|3697977|FG000|Overall Study|Lost to Follow-up|1
2105382|NCT00856908|3697978|FG001|Overall Study|Lost to Follow-up|0
2105383|NCT00856973|3697987|FG000|Overall Study|Adverse Event|5
2105384|NCT00856973|3697988|FG001|Overall Study|Adverse Event|5
2105385|NCT00856973|3697989|FG002|Overall Study|Adverse Event|3
2105386|NCT00856973|3697987|FG000|Overall Study|Lost to Follow-up|6
2105387|NCT00856973|3697988|FG001|Overall Study|Lost to Follow-up|3
2105388|NCT00856973|3697989|FG002|Overall Study|Lost to Follow-up|5
2105389|NCT00856973|3697987|FG000|Overall Study|Physician Decision|0
2105390|NCT00856973|3697988|FG001|Overall Study|Physician Decision|3
2105391|NCT00856973|3697989|FG002|Overall Study|Physician Decision|1
2105392|NCT00856973|3697987|FG000|Overall Study|Protocol Violation|1
2105393|NCT00856973|3697988|FG001|Overall Study|Protocol Violation|2
2105394|NCT00856973|3697989|FG002|Overall Study|Protocol Violation|1
2105395|NCT00856973|3697987|FG000|Overall Study|Withdrawal by Subject|13
2105396|NCT00856973|3697988|FG001|Overall Study|Withdrawal by Subject|16
2105397|NCT00856973|3697989|FG002|Overall Study|Withdrawal by Subject|15
2105398|NCT00856973|3697987|FG000|Overall Study|Other|11
2105399|NCT00856973|3697988|FG001|Overall Study|Other|12
2105400|NCT00856973|3697989|FG002|Overall Study|Other|13
2105401|NCT00856986|3698006|FG000|Run-in Period, Weeks -12-0|Adverse Event|0
2105402|NCT00856986|3698007|FG001|Run-in Period, Weeks -12-0|Adverse Event|0
2105403|NCT00856986|3698008|FG002|Run-in Period, Weeks -12-0|Adverse Event|0
2105404|NCT00856986|3698009|FG003|Run-in Period, Weeks -12-0|Adverse Event|92
2105405|NCT00856986|3698010|FG004|Run-in Period, Weeks -12-0|Adverse Event|0
2105406|NCT00856986|3698006|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0
2105407|NCT00856986|3698007|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0
2105408|NCT00856986|3698008|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0
2209358|NCT01644500|3849011|FG000|Overall Study|Lost to Follow-up|3
2209359|NCT01644500|3849012|FG001|Overall Study|Lost to Follow-up|8
2209360|NCT01644500|3849013|FG002|Overall Study|Lost to Follow-up|0
2209361|NCT01644500|3849011|FG000|Overall Study|Protocol Violation|1
2209362|NCT01644500|3849012|FG001|Overall Study|Protocol Violation|1
2209363|NCT01644500|3849013|FG002|Overall Study|Protocol Violation|0
2209364|NCT01644500|3849011|FG000|Overall Study|Withdrawal by Subject|11
2209365|NCT01644500|3849012|FG001|Overall Study|Withdrawal by Subject|12
2209366|NCT01644500|3849013|FG002|Overall Study|Withdrawal by Subject|12
2209367|NCT01644500|3849011|FG000|Overall Study|Physician Decision|1
2209368|NCT01644500|3849012|FG001|Overall Study|Physician Decision|1
2209369|NCT01644500|3849013|FG002|Overall Study|Physician Decision|1
2209370|NCT01644565|3849021|FG000|Overall Study|Undisclosed Medical History|1
2105409|NCT00856986|3698009|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24
2105410|NCT00856986|3698010|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0
2105411|NCT00856986|3698006|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
2105412|NCT00856986|3698007|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
2105413|NCT00856986|3698008|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
2105414|NCT00856986|3698009|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
2105415|NCT00856986|3698010|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
2108158|NCT00878553|3702005|FG004|Sleep Study|Lost to Follow-up|0
2209371|NCT01644565|3849022|FG001|Overall Study|Undisclosed Medical History|0
2209372|NCT01644565|3849023|FG002|Overall Study|Undisclosed Medical History|0
2209373|NCT01644565|3849024|FG003|Overall Study|Undisclosed Medical History|0
2209374|NCT01644565|3849025|FG004|Overall Study|Undisclosed Medical History|0
2209375|NCT01644565|3849026|FG005|Overall Study|Undisclosed Medical History|0
2209376|NCT01644565|3849027|FG006|Overall Study|Undisclosed Medical History|0
2209377|NCT01644565|3849028|FG007|Overall Study|Undisclosed Medical History|0
2209378|NCT01644565|3849029|FG008|Overall Study|Undisclosed Medical History|0
2209379|NCT01644565|3849021|FG000|Overall Study|Lost to Follow-up|0
2209380|NCT01644565|3849022|FG001|Overall Study|Lost to Follow-up|0
2209381|NCT01644565|3849023|FG002|Overall Study|Lost to Follow-up|0
2209382|NCT01644565|3849024|FG003|Overall Study|Lost to Follow-up|1
2209383|NCT01644565|3849025|FG004|Overall Study|Lost to Follow-up|0
2209384|NCT01644565|3849026|FG005|Overall Study|Lost to Follow-up|0
2209385|NCT01644565|3849027|FG006|Overall Study|Lost to Follow-up|0
2209386|NCT01644565|3849028|FG007|Overall Study|Lost to Follow-up|2
2209387|NCT01644565|3849029|FG008|Overall Study|Lost to Follow-up|0
2209388|NCT01644565|3849021|FG000|Overall Study|Family emergency|0
2209389|NCT01644565|3849022|FG001|Overall Study|Family emergency|0
2209390|NCT01644565|3849023|FG002|Overall Study|Family emergency|0
2300843|NCT02604342|3998577|FG000|Overall Study|Progression of disease|1
2300844|NCT02604342|3998578|FG001|Overall Study|Progression of disease|0
2052985|NCT00509262|3625645|FG000|Overall Study|Adverse Event|16
2052986|NCT00509262|3625646|FG001|Overall Study|Adverse Event|18
2052987|NCT00509262|3625645|FG000|Overall Study|Other|2
2052988|NCT00509262|3625646|FG001|Overall Study|Other|2
2052989|NCT00509262|3625645|FG000|Overall Study|Lack of Efficacy|1
2052990|NCT00509262|3625646|FG001|Overall Study|Lack of Efficacy|0
2052991|NCT00509262|3625645|FG000|Overall Study|Lost to Follow-up|1
2052992|NCT00509262|3625646|FG001|Overall Study|Lost to Follow-up|6
2052993|NCT00509262|3625645|FG000|Overall Study|Physician Decision|1
2052994|NCT00509262|3625646|FG001|Overall Study|Physician Decision|3
2052995|NCT00509262|3625645|FG000|Overall Study|Protocol Violation|2
2052996|NCT00509262|3625646|FG001|Overall Study|Protocol Violation|2
2052997|NCT00509262|3625645|FG000|Overall Study|Withdrawal by Subject|24
2052998|NCT00509262|3625646|FG001|Overall Study|Withdrawal by Subject|11
2052999|NCT00509366|3625666|FG000|Overall Study|Not Treated (Screen Failure)|1
2053000|NCT00509366|3625667|FG001|Overall Study|Not Treated (Screen Failure)|1
2053001|NCT00509366|3625668|FG002|Overall Study|Not Treated (Screen Failure)|1
2053002|NCT00509366|3625669|FG003|Overall Study|Not Treated (Screen Failure)|0
2053003|NCT00509366|3625670|FG004|Overall Study|Not Treated (Screen Failure)|0
2053004|NCT00509769|3625707|FG000|Overall Study|Progressive disease|77
2053005|NCT00509769|3625707|FG000|Overall Study|Adverse Event|4
2053006|NCT00509769|3625707|FG000|Overall Study|Patient's decision|1
2053007|NCT00509769|3625707|FG000|Overall Study|Physician Decision|8
2053008|NCT00509769|3625707|FG000|Overall Study|Use of prohibited therapies during study|1
2053009|NCT00509795|3625715|FG000|Overall Study|Adverse Event|4
2053010|NCT00509795|3625716|FG001|Overall Study|Adverse Event|3
2053011|NCT00509795|3625717|FG002|Overall Study|Adverse Event|5
2053012|NCT00509795|3625718|FG003|Overall Study|Adverse Event|4
2053013|NCT00509795|3625715|FG000|Overall Study|Death|3
2053014|NCT00509795|3625716|FG001|Overall Study|Death|1
2053015|NCT00509795|3625717|FG002|Overall Study|Death|2
2053016|NCT00509795|3625718|FG003|Overall Study|Death|7
2053017|NCT00509795|3625715|FG000|Overall Study|Lack of Efficacy|0
2053018|NCT00509795|3625716|FG001|Overall Study|Lack of Efficacy|0
2053019|NCT00509795|3625717|FG002|Overall Study|Lack of Efficacy|2
2053020|NCT00509795|3625718|FG003|Overall Study|Lack of Efficacy|2
2053021|NCT00509795|3625715|FG000|Overall Study|Lost to Follow-up|1
2300845|NCT02604342|3998577|FG000|Overall Study|Withdrawal by Subject|5
2300846|NCT02604342|3998578|FG001|Overall Study|Withdrawal by Subject|6
2300847|NCT02604342|3998577|FG000|Overall Study|Other|1
2300848|NCT02604342|3998578|FG001|Overall Study|Other|0
2300849|NCT02604342|3998577|FG000|Overall Study|Study Termination by Sponsor|1
2300850|NCT02604342|3998578|FG001|Overall Study|Study Termination by Sponsor|0
2300851|NCT02604342|3998577|FG000|Overall Study|Lost to Follow-up|1
2053022|NCT00509795|3625716|FG001|Overall Study|Lost to Follow-up|2
2053023|NCT00509795|3625717|FG002|Overall Study|Lost to Follow-up|4
2053024|NCT00509795|3625718|FG003|Overall Study|Lost to Follow-up|4
2053025|NCT00509795|3625715|FG000|Overall Study|OTHER|1
2053026|NCT00509795|3625716|FG001|Overall Study|OTHER|0
2053027|NCT00509795|3625717|FG002|Overall Study|OTHER|4
2053028|NCT00509795|3625718|FG003|Overall Study|OTHER|1
2053029|NCT00509795|3625715|FG000|Overall Study|Protocol Violation|3
2053030|NCT00509795|3625716|FG001|Overall Study|Protocol Violation|0
2053031|NCT00509795|3625717|FG002|Overall Study|Protocol Violation|3
2053032|NCT00509795|3625718|FG003|Overall Study|Protocol Violation|1
2053033|NCT00509795|3625715|FG000|Overall Study|Withdrawal by Subject|10
2053034|NCT00509795|3625716|FG001|Overall Study|Withdrawal by Subject|5
2053035|NCT00509795|3625717|FG002|Overall Study|Withdrawal by Subject|7
2209391|NCT01644565|3849024|FG003|Overall Study|Family emergency|0
2209392|NCT01644565|3849025|FG004|Overall Study|Family emergency|1
2053036|NCT00509795|3625718|FG003|Overall Study|Withdrawal by Subject|8
2053037|NCT00509821|3625731|FG000|Study Period 1 (Induction)|Death|0
2053038|NCT00509821|3625732|FG001|Study Period 1 (Induction)|Death|1
2053039|NCT00509821|3625731|FG000|Study Period 1 (Induction)|Adverse Event|0
2053040|NCT00509821|3625732|FG001|Study Period 1 (Induction)|Adverse Event|2
2053041|NCT00509821|3625731|FG000|Study Period 1 (Induction)|Progressive Disease|0
2053042|NCT00509821|3625732|FG001|Study Period 1 (Induction)|Progressive Disease|1
2053043|NCT00509899|3625760|FG000|Overall Study|Progressive disease|1
2053044|NCT00509899|3625761|FG001|Overall Study|Progressive disease|3
2053045|NCT00509899|3625762|FG002|Overall Study|Progressive disease|5
2053046|NCT00509899|3625763|FG003|Overall Study|Progressive disease|1
2053047|NCT00509899|3625764|FG004|Overall Study|Progressive disease|0
2053048|NCT00509899|3625765|FG005|Overall Study|Progressive disease|1
2053049|NCT00509899|3625766|FG006|Overall Study|Progressive disease|0
2053050|NCT00509899|3625767|FG007|Overall Study|Progressive disease|0
2053051|NCT00509899|3625760|FG000|Overall Study|Unacceptable Toxicity|1
2053052|NCT00509899|3625761|FG001|Overall Study|Unacceptable Toxicity|0
2053053|NCT00509899|3625762|FG002|Overall Study|Unacceptable Toxicity|0
2053054|NCT00509899|3625763|FG003|Overall Study|Unacceptable Toxicity|2
2053055|NCT00509899|3625764|FG004|Overall Study|Unacceptable Toxicity|0
2053056|NCT00509899|3625765|FG005|Overall Study|Unacceptable Toxicity|0
2053057|NCT00509899|3625766|FG006|Overall Study|Unacceptable Toxicity|0
2053058|NCT00509899|3625767|FG007|Overall Study|Unacceptable Toxicity|0
2053059|NCT00509899|3625760|FG000|Overall Study|Withdrawal by Subject|6
2053060|NCT00509899|3625761|FG001|Overall Study|Withdrawal by Subject|2
2053061|NCT00509899|3625762|FG002|Overall Study|Withdrawal by Subject|3
2053062|NCT00509899|3625763|FG003|Overall Study|Withdrawal by Subject|0
2053063|NCT00509899|3625764|FG004|Overall Study|Withdrawal by Subject|3
2053064|NCT00509899|3625765|FG005|Overall Study|Withdrawal by Subject|2
2053065|NCT00509899|3625766|FG006|Overall Study|Withdrawal by Subject|0
2053066|NCT00509899|3625767|FG007|Overall Study|Withdrawal by Subject|0
2053067|NCT00509899|3625760|FG000|Overall Study|Physician Decision|4
2053068|NCT00509899|3625761|FG001|Overall Study|Physician Decision|2
2053069|NCT00509899|3625762|FG002|Overall Study|Physician Decision|7
2053070|NCT00509899|3625763|FG003|Overall Study|Physician Decision|0
2053071|NCT00509899|3625764|FG004|Overall Study|Physician Decision|1
2053072|NCT00509899|3625765|FG005|Overall Study|Physician Decision|4
2053073|NCT00509899|3625766|FG006|Overall Study|Physician Decision|0
2053074|NCT00509899|3625767|FG007|Overall Study|Physician Decision|0
2053075|NCT00509899|3625760|FG000|Overall Study|Intercurrent Illness|1
2053076|NCT00509899|3625761|FG001|Overall Study|Intercurrent Illness|0
2053077|NCT00509899|3625762|FG002|Overall Study|Intercurrent Illness|0
2053078|NCT00509899|3625763|FG003|Overall Study|Intercurrent Illness|1
2053079|NCT00509899|3625764|FG004|Overall Study|Intercurrent Illness|0
2053080|NCT00509899|3625765|FG005|Overall Study|Intercurrent Illness|1
2053081|NCT00509899|3625766|FG006|Overall Study|Intercurrent Illness|0
2053082|NCT00509899|3625767|FG007|Overall Study|Intercurrent Illness|0
2053083|NCT00509899|3625760|FG000|Overall Study|Death|2
2053084|NCT00509899|3625761|FG001|Overall Study|Death|2
2053085|NCT00509899|3625762|FG002|Overall Study|Death|3
2053086|NCT00509899|3625763|FG003|Overall Study|Death|0
2053087|NCT00509899|3625764|FG004|Overall Study|Death|1
2053088|NCT00509899|3625765|FG005|Overall Study|Death|1
2053089|NCT00509899|3625766|FG006|Overall Study|Death|1
2053090|NCT00509899|3625767|FG007|Overall Study|Death|1
2053091|NCT00509899|3625760|FG000|Overall Study|Lack of Efficacy|1
2053092|NCT00509899|3625761|FG001|Overall Study|Lack of Efficacy|0
2053093|NCT00509899|3625762|FG002|Overall Study|Lack of Efficacy|2
2053094|NCT00509899|3625763|FG003|Overall Study|Lack of Efficacy|0
2053095|NCT00509899|3625764|FG004|Overall Study|Lack of Efficacy|0
2053096|NCT00509899|3625765|FG005|Overall Study|Lack of Efficacy|1
2053097|NCT00509899|3625766|FG006|Overall Study|Lack of Efficacy|0
2053098|NCT00509899|3625767|FG007|Overall Study|Lack of Efficacy|0
2053099|NCT00509925|3625781|FG000|Overall Study|Personal reasons|0
2053100|NCT00509925|3625782|FG001|Overall Study|Personal reasons|1
2053101|NCT00510068|3625792|FG000|Double-blind Period|Disease progression|98
2053102|NCT00510068|3625793|FG001|Double-blind Period|Disease progression|169
2053103|NCT00510068|3625792|FG000|Double-blind Period|Final primary analysis|52
2053104|NCT00510068|3625793|FG001|Double-blind Period|Final primary analysis|18
2053105|NCT00510068|3625792|FG000|Double-blind Period|Adverse Event|37
2053106|NCT00510068|3625793|FG001|Double-blind Period|Adverse Event|7
2053107|NCT00510068|3625792|FG000|Double-blind Period|Withdrawal by Subject|8
2053108|NCT00510068|3625793|FG001|Double-blind Period|Withdrawal by Subject|6
2053109|NCT00510068|3625792|FG000|Double-blind Period|Death|4
2053110|NCT00510068|3625793|FG001|Double-blind Period|Death|3
2053111|NCT00510068|3625792|FG000|Double-blind Period|Abnormal test result (s)|1
2053112|NCT00510068|3625793|FG001|Double-blind Period|Abnormal test result (s)|0
2053113|NCT00510068|3625792|FG000|Double-blind Period|Lost to Follow-up|1
2053114|NCT00510068|3625793|FG001|Double-blind Period|Lost to Follow-up|0
2053115|NCT00510068|3625792|FG000|Double-blind Period|Protocol Violation|6
2053116|NCT00510068|3625793|FG001|Double-blind Period|Protocol Violation|0
2053117|NCT00510068|3625792|FG000|Open-label Period|Disease Progression|124
2053118|NCT00510068|3625793|FG001|Open-label Period|Disease Progression|0
2053119|NCT00510068|3625792|FG000|Open-label Period|Adverse Event|46
2053120|NCT00510068|3625793|FG001|Open-label Period|Adverse Event|0
2300852|NCT02604342|3998578|FG001|Overall Study|Lost to Follow-up|1
2300853|NCT02604342|3998577|FG000|Overall Study|Physician Decision|2
2053121|NCT00510068|3625792|FG000|Open-label Period|Withdrawal by Subject|21
2053122|NCT00510068|3625793|FG001|Open-label Period|Withdrawal by Subject|0
2053123|NCT00510068|3625792|FG000|Open-label Period|Administrative problems|17
2053124|NCT00510068|3625793|FG001|Open-label Period|Administrative problems|0
2053125|NCT00510068|3625792|FG000|Open-label Period|Death|7
2053126|NCT00510068|3625793|FG001|Open-label Period|Death|0
2053127|NCT00510068|3625792|FG000|Open-label Period|New cancer therapy|7
2053128|NCT00510068|3625793|FG001|Open-label Period|New cancer therapy|0
2053129|NCT00510068|3625792|FG000|Open-label Period|Protocol Violation|2
2053130|NCT00510068|3625793|FG001|Open-label Period|Protocol Violation|0
2053131|NCT00510068|3625792|FG000|Open-label Period|Abnormal laboratory value (s)|1
2053132|NCT00510068|3625793|FG001|Open-label Period|Abnormal laboratory value (s)|0
2053133|NCT00510146|3625803|FG000|Double-Blind Treatment|Adverse Event|30
2053134|NCT00510146|3625804|FG001|Double-Blind Treatment|Adverse Event|13
2053135|NCT00510146|3625803|FG000|Double-Blind Treatment|Lack of Efficacy|6
2053136|NCT00510146|3625804|FG001|Double-Blind Treatment|Lack of Efficacy|13
2053137|NCT00510146|3625803|FG000|Double-Blind Treatment|Lost to Follow-up|3
2053138|NCT00510146|3625804|FG001|Double-Blind Treatment|Lost to Follow-up|7
2053139|NCT00510146|3625803|FG000|Double-Blind Treatment|Physician Decision|6
2053140|NCT00510146|3625804|FG001|Double-Blind Treatment|Physician Decision|0
2053141|NCT00510146|3625803|FG000|Double-Blind Treatment|Protocol Violation|1
2053142|NCT00510146|3625804|FG001|Double-Blind Treatment|Protocol Violation|2
2053143|NCT00510146|3625803|FG000|Double-Blind Treatment|Withdrawal by Subject|27
2053144|NCT00510146|3625804|FG001|Double-Blind Treatment|Withdrawal by Subject|13
2053145|NCT00510146|3625803|FG000|Double-Blind Treatment|Clinical Relapse|0
2053146|NCT00510146|3625804|FG001|Double-Blind Treatment|Clinical Relapse|1
2053147|NCT00510146|3625803|FG000|Double-Blind Treatment|Entry Criteria Not Met|3
2053148|NCT00510146|3625804|FG001|Double-Blind Treatment|Entry Criteria Not Met|0
2053149|NCT00510146|3625803|FG000|Open-Label Treatment|Adverse Event|22
2053150|NCT00510146|3625804|FG001|Open-Label Treatment|Adverse Event|8
2053151|NCT00510146|3625803|FG000|Open-Label Treatment|Death|1
2053152|NCT00510146|3625804|FG001|Open-Label Treatment|Death|1
2053153|NCT00510146|3625803|FG000|Open-Label Treatment|Lack of Efficacy|4
2053154|NCT00510146|3625804|FG001|Open-Label Treatment|Lack of Efficacy|0
2053155|NCT00510146|3625803|FG000|Open-Label Treatment|Lost to Follow-up|10
2053156|NCT00510146|3625804|FG001|Open-Label Treatment|Lost to Follow-up|1
2053157|NCT00510146|3625803|FG000|Open-Label Treatment|Physician Decision|3
2053158|NCT00510146|3625804|FG001|Open-Label Treatment|Physician Decision|1
2053159|NCT00510146|3625803|FG000|Open-Label Treatment|Protocol Violation|4
2053160|NCT00510146|3625804|FG001|Open-Label Treatment|Protocol Violation|2
2053161|NCT00510146|3625803|FG000|Open-Label Treatment|Withdrawal by Subject|24
2053162|NCT00510146|3625804|FG001|Open-Label Treatment|Withdrawal by Subject|12
2053163|NCT00510146|3625803|FG000|Open-Label Treatment|Clinical Relapse|1
2053164|NCT00510146|3625804|FG001|Open-Label Treatment|Clinical Relapse|1
2053165|NCT00510146|3625803|FG000|Open-Label Treatment|Sponsor Decision|2
2053166|NCT00510146|3625804|FG001|Open-Label Treatment|Sponsor Decision|0
2053167|NCT00510198|3625814|FG000|Overall Study|Withdrawal by Subject|5
2053168|NCT00510198|3625815|FG001|Overall Study|Withdrawal by Subject|4
2053169|NCT00510276|3625829|FG000|Acute Double-Blind Phase|Adverse Event|21
2053170|NCT00510276|3625830|FG001|Acute Double-Blind Phase|Adverse Event|6
2053171|NCT00510276|3625829|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1
2053172|NCT00510276|3625830|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1
2053173|NCT00510276|3625829|FG000|Acute Double-Blind Phase|Lack of Efficacy|3
2053174|NCT00510276|3625830|FG001|Acute Double-Blind Phase|Lack of Efficacy|4
2053175|NCT00510276|3625829|FG000|Acute Double-Blind Phase|Lost to Follow-up|48
2053176|NCT00510276|3625830|FG001|Acute Double-Blind Phase|Lost to Follow-up|49
2053177|NCT00510276|3625829|FG000|Acute Double-Blind Phase|Physician Decision|0
2053178|NCT00510276|3625830|FG001|Acute Double-Blind Phase|Physician Decision|3
2053179|NCT00510276|3625829|FG000|Acute Double-Blind Phase|Protocol Violation|4
2053180|NCT00510276|3625830|FG001|Acute Double-Blind Phase|Protocol Violation|3
2053181|NCT00510276|3625829|FG000|Acute Double-Blind Phase|Sponsor Decision|2
2053182|NCT00510276|3625830|FG001|Acute Double-Blind Phase|Sponsor Decision|1
2053183|NCT00510276|3625829|FG000|Acute Double-Blind Phase|Subject Decision|26
2053184|NCT00510276|3625830|FG001|Acute Double-Blind Phase|Subject Decision|28
2053185|NCT00510276|3625829|FG000|Extension Open-Label Phase|Adverse Event|9
2053186|NCT00510276|3625830|FG001|Extension Open-Label Phase|Adverse Event|18
2053187|NCT00510276|3625829|FG000|Extension Open-Label Phase|Lack of Efficacy|2
2053188|NCT00510276|3625830|FG001|Extension Open-Label Phase|Lack of Efficacy|7
2053189|NCT00510276|3625829|FG000|Extension Open-Label Phase|Lost to Follow-up|12
2053190|NCT00510276|3625830|FG001|Extension Open-Label Phase|Lost to Follow-up|10
2053191|NCT00510276|3625829|FG000|Extension Open-Label Phase|Physician Decision|2
2053192|NCT00510276|3625830|FG001|Extension Open-Label Phase|Physician Decision|3
2053193|NCT00510276|3625829|FG000|Extension Open-Label Phase|Protocol Violation|0
2053194|NCT00510276|3625830|FG001|Extension Open-Label Phase|Protocol Violation|1
2053195|NCT00510276|3625829|FG000|Extension Open-Label Phase|Sponsor Decision|1
2053196|NCT00510276|3625830|FG001|Extension Open-Label Phase|Sponsor Decision|0
2053197|NCT00510276|3625829|FG000|Extension Open-Label Phase|Subject Decision|7
2053198|NCT00510276|3625830|FG001|Extension Open-Label Phase|Subject Decision|9
2053199|NCT00510289|3625843|FG000|Overall Study|Withdrawal by Subject|7
2053200|NCT00510289|3625843|FG000|Overall Study|Refused bone marrow biopsy|2
2053201|NCT00510289|3625843|FG000|Overall Study|Lost to Follow-up|1
2053202|NCT00510289|3625843|FG000|Overall Study|Progressed prior to starting drug|2
2053203|NCT00510458|3625848|FG000|Overall Study|5 year not evaluable/missed|21
2053204|NCT00510458|3625848|FG000|Overall Study|Death|1
2053205|NCT00510458|3625848|FG000|Overall Study|Terminated|14
2053206|NCT00510458|3625848|FG000|Overall Study|Lost to Follow-up|6
2053207|NCT00510458|3625848|FG000|Overall Study|Withdrawal by Subject|3
2053208|NCT00510458|3625848|FG000|Overall Study|Revision|2
2053209|NCT00510484|3625855|FG000|Wash-out Period|Adverse Event|0
2053210|NCT00510484|3625856|FG001|Wash-out Period|Adverse Event|1
2053211|NCT00510510|3625869|FG000|Overall Study|Adverse Event|4
2053212|NCT00510510|3625870|FG001|Overall Study|Adverse Event|3
2053213|NCT00510510|3625871|FG002|Overall Study|Adverse Event|6
2053214|NCT00510510|3625869|FG000|Overall Study|Lack of Efficacy|0
2053215|NCT00510510|3625870|FG001|Overall Study|Lack of Efficacy|1
2053216|NCT00510510|3625871|FG002|Overall Study|Lack of Efficacy|1
2053217|NCT00510510|3625869|FG000|Overall Study|Subjects no longer requires study drug|0
2053218|NCT00510510|3625870|FG001|Overall Study|Subjects no longer requires study drug|0
2053219|NCT00510510|3625871|FG002|Overall Study|Subjects no longer requires study drug|2
2053220|NCT00510510|3625869|FG000|Overall Study|Withdrawal by Subject|1
2053221|NCT00510510|3625870|FG001|Overall Study|Withdrawal by Subject|2
2053222|NCT00510510|3625871|FG002|Overall Study|Withdrawal by Subject|3
2053223|NCT00510510|3625869|FG000|Overall Study|Lost to Follow-up|0
2053224|NCT00510510|3625870|FG001|Overall Study|Lost to Follow-up|0
2053225|NCT00510510|3625871|FG002|Overall Study|Lost to Follow-up|1
2053226|NCT00510510|3625869|FG000|Overall Study|Protocol Violation|0
2053227|NCT00510510|3625870|FG001|Overall Study|Protocol Violation|3
2053228|NCT00510510|3625871|FG002|Overall Study|Protocol Violation|4
2053229|NCT00510653|3625879|FG000|Overall Study|Withdrawal by Subject|8
2053230|NCT00510653|3625879|FG000|Overall Study|Monetary|3
2053231|NCT00510692|3625885|FG000|Overall Study|Adverse Event|1
2053232|NCT00510692|3625886|FG001|Overall Study|Adverse Event|3
2053233|NCT00510692|3625885|FG000|Overall Study|Withdrawal by Subject|1
2053234|NCT00510692|3625886|FG001|Overall Study|Withdrawal by Subject|0
2053235|NCT00510718|3625901|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1
2053236|NCT00510718|3625902|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8
2053237|NCT00510718|3625901|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
2053238|NCT00510718|3625902|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
2053239|NCT00510718|3625901|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
2053240|NCT00510718|3625902|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
2053241|NCT00510718|3625901|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
2053242|NCT00510718|3625902|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
2053243|NCT00510718|3625901|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
2053244|NCT00510718|3625902|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
2053245|NCT00510718|3625901|FG000|Multiple Dose Period: 12 Weeks|Other|1
2053246|NCT00510718|3625902|FG001|Multiple Dose Period: 12 Weeks|Other|1
2053247|NCT00510783|3625927|FG000|Overall Study|Lost to Follow-up|29
2053248|NCT00510783|3625928|FG001|Overall Study|Lost to Follow-up|25
2053249|NCT00510783|3625927|FG000|Overall Study|Withdrawal by Subject|2
2053250|NCT00510783|3625928|FG001|Overall Study|Withdrawal by Subject|3
2053251|NCT00510783|3625927|FG000|Overall Study|Protocol Violation|0
2053252|NCT00510783|3625928|FG001|Overall Study|Protocol Violation|1
2053253|NCT00510835|3625950|FG000|Overall Study|Withdrawal by Subject|6
2053254|NCT00510835|3625951|FG001|Overall Study|Withdrawal by Subject|2
2053255|NCT00510835|3625952|FG002|Overall Study|Withdrawal by Subject|2
2053256|NCT00510874|3625967|FG000|Overall Study|Withdrawal by Subject|1
2053257|NCT00510874|3625968|FG001|Overall Study|Withdrawal by Subject|1
2053258|NCT00510874|3625969|FG002|Overall Study|Withdrawal by Subject|0
2053259|NCT00510874|3625970|FG003|Overall Study|Withdrawal by Subject|0
2053260|NCT00510874|3625971|FG004|Overall Study|Withdrawal by Subject|3
2053261|NCT00510874|3625972|FG005|Overall Study|Withdrawal by Subject|0
2053262|NCT00510874|3625973|FG006|Overall Study|Withdrawal by Subject|0
2053263|NCT00510874|3625967|FG000|Overall Study|Lost to Follow-up|2
2053264|NCT00510874|3625968|FG001|Overall Study|Lost to Follow-up|3
2053265|NCT00510874|3625969|FG002|Overall Study|Lost to Follow-up|1
2053266|NCT00510874|3625970|FG003|Overall Study|Lost to Follow-up|3
2053267|NCT00510874|3625971|FG004|Overall Study|Lost to Follow-up|4
2053268|NCT00510874|3625972|FG005|Overall Study|Lost to Follow-up|0
2053269|NCT00510874|3625973|FG006|Overall Study|Lost to Follow-up|1
2053270|NCT00510887|3625990|FG000|Overall Study|Lost to Follow-up|1
2053271|NCT00510952|3625996|FG000|Overall Study|Adverse Event|1
2053272|NCT00510952|3625997|FG001|Overall Study|Adverse Event|0
2053273|NCT00510952|3625996|FG000|Overall Study|Entry Criteria Not Met|3
2053274|NCT00510952|3625997|FG001|Overall Study|Entry Criteria Not Met|1
2053275|NCT00510952|3625996|FG000|Overall Study|Lost to Follow-up|5
2053276|NCT00510952|3625997|FG001|Overall Study|Lost to Follow-up|3
2053277|NCT00510952|3625996|FG000|Overall Study|Physician Decision|1
2053278|NCT00510952|3625997|FG001|Overall Study|Physician Decision|1
2053279|NCT00510952|3625996|FG000|Overall Study|Protocol Violation|7
2053280|NCT00510952|3625997|FG001|Overall Study|Protocol Violation|4
2053281|NCT00510952|3625996|FG000|Overall Study|Sponsor Decision|1
2053282|NCT00510952|3625997|FG001|Overall Study|Sponsor Decision|0
2053283|NCT00510952|3625996|FG000|Overall Study|Withdrawal by Subject|6
2053284|NCT00510952|3625997|FG001|Overall Study|Withdrawal by Subject|7
2053285|NCT00510952|3625996|FG000|Overall Study|Did Not Receive Study Drug|2
2053286|NCT00510952|3625997|FG001|Overall Study|Did Not Receive Study Drug|0
2053287|NCT00511004|3626006|FG000|Overall Study|Lost to Follow-up|0
2053288|NCT00511004|3626007|FG001|Overall Study|Lost to Follow-up|0
2053289|NCT00511004|3626008|FG002|Overall Study|Lost to Follow-up|4
2053290|NCT00511108|3626033|FG000|Overall Study|Adverse Event|2
2053291|NCT00511108|3626034|FG001|Overall Study|Adverse Event|0
2053292|NCT00511108|3626035|FG002|Overall Study|Adverse Event|1
2053293|NCT00511108|3626036|FG003|Overall Study|Adverse Event|2
2053294|NCT00511108|3626033|FG000|Overall Study|Lost to Follow-up|0
2053295|NCT00511108|3626034|FG001|Overall Study|Lost to Follow-up|2
2053296|NCT00511108|3626035|FG002|Overall Study|Lost to Follow-up|1
2053297|NCT00511108|3626036|FG003|Overall Study|Lost to Follow-up|0
2053298|NCT00511108|3626033|FG000|Overall Study|Physician Decision|0
2053299|NCT00511108|3626034|FG001|Overall Study|Physician Decision|0
2053300|NCT00511108|3626035|FG002|Overall Study|Physician Decision|0
2053301|NCT00511108|3626036|FG003|Overall Study|Physician Decision|1
2053302|NCT00511108|3626033|FG000|Overall Study|Withdrawal by Subject|4
2053303|NCT00511108|3626034|FG001|Overall Study|Withdrawal by Subject|0
2053304|NCT00511108|3626035|FG002|Overall Study|Withdrawal by Subject|3
2053305|NCT00511108|3626036|FG003|Overall Study|Withdrawal by Subject|2
2053306|NCT00511134|3626048|FG000|Overall Study|Withdrawal by Subject|0
2053307|NCT00511134|3626049|FG001|Overall Study|Withdrawal by Subject|2
2053308|NCT00511147|3626055|FG000|Overall Study|Withdrawal by Subject|1
2053309|NCT00511147|3626055|FG000|Overall Study|Disease progression|5
2053310|NCT00511147|3626055|FG000|Overall Study|Required platelet transfusion|1
2053311|NCT00511238|3626066|FG000|Overall Study|Adverse Event|13
2053312|NCT00511238|3626067|FG001|Overall Study|Adverse Event|33
2053313|NCT00511238|3626066|FG000|Overall Study|Withdrawal by Subject|2
2053314|NCT00511238|3626067|FG001|Overall Study|Withdrawal by Subject|22
2300854|NCT02604342|3998578|FG001|Overall Study|Physician Decision|0
2300855|NCT02604407|3998587|FG000|Overall Study|Adverse Event|0
2300856|NCT02604407|3998588|FG001|Overall Study|Adverse Event|7
2300857|NCT02604407|3998589|FG002|Overall Study|Adverse Event|5
2300858|NCT02604407|3998587|FG000|Overall Study|Protocol Violation|2
2300859|NCT02604407|3998588|FG001|Overall Study|Protocol Violation|0
2300860|NCT02604407|3998589|FG002|Overall Study|Protocol Violation|0
2300861|NCT02604407|3998587|FG000|Overall Study|Withdrawal by Subject|3
2300862|NCT02604407|3998588|FG001|Overall Study|Withdrawal by Subject|3
2300863|NCT02604407|3998589|FG002|Overall Study|Withdrawal by Subject|5
2300864|NCT02604407|3998587|FG000|Overall Study|Lost to Follow-up|2
2053315|NCT00511238|3626066|FG000|Overall Study|Progressive Disease|23
2053316|NCT00511238|3626067|FG001|Overall Study|Progressive Disease|157
2053317|NCT00511238|3626066|FG000|Overall Study|various reasons|4
2053318|NCT00511238|3626067|FG001|Overall Study|various reasons|14
2053319|NCT00511472|3626085|FG000|Overall Study|Clinical Adverse Event|1
2053320|NCT00511472|3626086|FG001|Overall Study|Clinical Adverse Event|2
2053321|NCT00511472|3626085|FG000|Overall Study|Laboratory Adverse Event|0
2053322|NCT00511472|3626086|FG001|Overall Study|Laboratory Adverse Event|2
2053323|NCT00511472|3626085|FG000|Overall Study|Not reported|2
2053324|NCT00511472|3626086|FG001|Overall Study|Not reported|2
2053325|NCT00511667|3626103|FG000|Overall Study|Adverse Event|1
2053326|NCT00511667|3626104|FG001|Overall Study|Adverse Event|0
2053327|NCT00511667|3626103|FG000|Overall Study|Protocol Violation|1
2053328|NCT00511667|3626104|FG001|Overall Study|Protocol Violation|1
2053329|NCT00511667|3626103|FG000|Overall Study|Withdrawal by Subject|2
2053330|NCT00511667|3626104|FG001|Overall Study|Withdrawal by Subject|0
2053331|NCT00511667|3626103|FG000|Overall Study|Site terminated|6
2053332|NCT00511667|3626104|FG001|Overall Study|Site terminated|1
2053333|NCT00511667|3626103|FG000|Overall Study|Other|2
2053334|NCT00511667|3626104|FG001|Overall Study|Other|1
2053335|NCT00511797|3626129|FG000|Overall Study|Adverse Event|1
2053336|NCT00511797|3626130|FG001|Overall Study|Adverse Event|2
2053337|NCT00511797|3626131|FG002|Overall Study|Adverse Event|2
2053338|NCT00511797|3626132|FG003|Overall Study|Adverse Event|2
2053339|NCT00511797|3626129|FG000|Overall Study|Lost to Follow-up|1
2053340|NCT00511797|3626130|FG001|Overall Study|Lost to Follow-up|0
2053341|NCT00511797|3626131|FG002|Overall Study|Lost to Follow-up|0
2053342|NCT00511797|3626132|FG003|Overall Study|Lost to Follow-up|1
2053343|NCT00511797|3626129|FG000|Overall Study|Pregnancy|0
2053344|NCT00511797|3626130|FG001|Overall Study|Pregnancy|0
2053345|NCT00511797|3626131|FG002|Overall Study|Pregnancy|0
2053346|NCT00511797|3626132|FG003|Overall Study|Pregnancy|1
2053347|NCT00511797|3626129|FG000|Overall Study|Protocol Violation|0
2053348|NCT00511797|3626130|FG001|Overall Study|Protocol Violation|2
2053349|NCT00511797|3626131|FG002|Overall Study|Protocol Violation|2
2053350|NCT00511797|3626132|FG003|Overall Study|Protocol Violation|3
2053351|NCT00511797|3626129|FG000|Overall Study|Withdrawal by Subject|3
2053352|NCT00511797|3626130|FG001|Overall Study|Withdrawal by Subject|3
2053353|NCT00511797|3626131|FG002|Overall Study|Withdrawal by Subject|4
2053354|NCT00511797|3626132|FG003|Overall Study|Withdrawal by Subject|2
2053355|NCT00511797|3626129|FG000|Overall Study|Never dispensed|1
2053356|NCT00511797|3626130|FG001|Overall Study|Never dispensed|0
2053357|NCT00511797|3626131|FG002|Overall Study|Never dispensed|1
2053358|NCT00511797|3626132|FG003|Overall Study|Never dispensed|3
2053359|NCT00511797|3626129|FG000|Overall Study|Study drug not taken|0
2053360|NCT00511797|3626130|FG001|Overall Study|Study drug not taken|1
2053361|NCT00511797|3626131|FG002|Overall Study|Study drug not taken|0
2053362|NCT00511797|3626132|FG003|Overall Study|Study drug not taken|1
2053363|NCT00511797|3626129|FG000|Overall Study|Partially missing diary|0
2053364|NCT00511797|3626130|FG001|Overall Study|Partially missing diary|0
2053365|NCT00511797|3626131|FG002|Overall Study|Partially missing diary|1
2053366|NCT00511797|3626132|FG003|Overall Study|Partially missing diary|0
2053367|NCT00511797|3626129|FG000|Overall Study|Other (moving etc)|1
2053368|NCT00511797|3626130|FG001|Overall Study|Other (moving etc)|0
2053369|NCT00511797|3626131|FG002|Overall Study|Other (moving etc)|1
2053370|NCT00511797|3626132|FG003|Overall Study|Other (moving etc)|2
2053371|NCT00511810|3626144|FG000|Overall Study|Lost to Follow-up|1
2053372|NCT00511810|3626145|FG001|Overall Study|Lost to Follow-up|2
2053373|NCT00511810|3626144|FG000|Overall Study|Lack of Efficacy|0
2053374|NCT00511810|3626145|FG001|Overall Study|Lack of Efficacy|2
2053375|NCT00511810|3626144|FG000|Overall Study|Refused second scn|0
2053376|NCT00511810|3626145|FG001|Overall Study|Refused second scn|1
2053377|NCT00511836|3626153|FG000|Double-blind Period|Lost to Follow-up|1
2053378|NCT00511836|3626154|FG001|Double-blind Period|Lost to Follow-up|0
2053379|NCT00511875|3626178|FG000|Overall Study|Lost to Follow-up|4
2053380|NCT00511875|3626179|FG001|Overall Study|Lost to Follow-up|0
2053381|NCT00511875|3626178|FG000|Overall Study|Missing variables|1
2053382|NCT00511875|3626179|FG001|Overall Study|Missing variables|0
2053383|NCT00511901|3626187|FG000|Overall Study|Withdrawal by Subject|1
2053384|NCT00511901|3626188|FG001|Overall Study|Withdrawal by Subject|3
2053385|NCT00512096|3626207|FG000|Overall Study|Adverse Event|2
2053386|NCT00512096|3626207|FG000|Overall Study|Withdrawal by Subject|2
2053387|NCT00512096|3626207|FG000|Overall Study|Lack of Efficacy|3
2053388|NCT00512135|3626211|FG000|Overall Study|Not Treated|5
2053389|NCT00512135|3626211|FG000|Overall Study|Lack of Efficacy|2
2053390|NCT00512135|3626211|FG000|Overall Study|Adverse Event|6
2053391|NCT00512135|3626211|FG000|Overall Study|Withdrawal by Subject|22
2053392|NCT00512135|3626211|FG000|Overall Study|Lost to Follow-up|27
2053393|NCT00512135|3626211|FG000|Overall Study|Other|22
2053394|NCT00512148|3626216|FG000|Primay Study Period|Withdrawal by Subject|1
2053395|NCT00512252|3626225|FG000|Overall Study|Lost to Follow-up|0
2053396|NCT00512252|3626226|FG001|Overall Study|Lost to Follow-up|0
2053397|NCT00512252|3626227|FG002|Overall Study|Lost to Follow-up|1
2053398|NCT00512252|3626225|FG000|Overall Study|Protocol Violation|0
2053399|NCT00512252|3626226|FG001|Overall Study|Protocol Violation|0
2053400|NCT00512252|3626227|FG002|Overall Study|Protocol Violation|1
2053401|NCT00512252|3626225|FG000|Overall Study|Death|0
2053402|NCT00512252|3626226|FG001|Overall Study|Death|0
2053403|NCT00512252|3626227|FG002|Overall Study|Death|1
2053404|NCT00512707|3626255|FG000|Overall Study|Lost to Follow-up|5
2053405|NCT00512707|3626256|FG001|Overall Study|Lost to Follow-up|11
2053406|NCT00512707|3626255|FG000|Overall Study|Developed skin irritation|2
2053407|NCT00512707|3626256|FG001|Overall Study|Developed skin irritation|1
2053408|NCT00512707|3626255|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2
2053409|NCT00512707|3626256|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0
2053410|NCT00512707|3626255|FG000|Overall Study|Unable to tolerate the smell of the gel|1
2053411|NCT00512707|3626256|FG001|Overall Study|Unable to tolerate the smell of the gel|0
2053412|NCT00512798|3626264|FG000|Overall Study|Death|0
2053413|NCT00512798|3626265|FG001|Overall Study|Death|3
2053414|NCT00512798|3626264|FG000|Overall Study|Adverse Event|2
2053415|NCT00512798|3626265|FG001|Overall Study|Adverse Event|4
2053416|NCT00512798|3626264|FG000|Overall Study|Progression of disease|14
2053417|NCT00512798|3626265|FG001|Overall Study|Progression of disease|20
2053418|NCT00512798|3626264|FG000|Overall Study|Withdrawal by Subject|3
2053419|NCT00512798|3626265|FG001|Overall Study|Withdrawal by Subject|0
2053420|NCT00512902|3626276|FG000|Overall Study|Adverse Event|7
2053421|NCT00512902|3626276|FG000|Overall Study|Lost to Follow-up|1
2053422|NCT00513019|3626282|FG000|Overall Study|Adverse Event|1
2053423|NCT00513019|3626283|FG001|Overall Study|Adverse Event|0
2053424|NCT00513019|3626282|FG000|Overall Study|Withdrawal by Subject|4
2053425|NCT00513019|3626283|FG001|Overall Study|Withdrawal by Subject|5
2053426|NCT00513071|3626289|FG000|Overall Study|Adverse Event|1
2053427|NCT00513071|3626289|FG000|Overall Study|Withdrawal by Subject|1
2053428|NCT00513071|3626289|FG000|Overall Study|Physician Decision|3
2053429|NCT00513240|3626295|FG000|Overall Study|Did not have intended surgery|3
2053430|NCT00513240|3626296|FG001|Overall Study|Did not have intended surgery|0
2053431|NCT00513240|3626295|FG000|Overall Study|Death|3
2053432|NCT00513240|3626296|FG001|Overall Study|Death|3
2053433|NCT00513240|3626295|FG000|Overall Study|Withdrawal by Subject|7
2053434|NCT00513240|3626296|FG001|Overall Study|Withdrawal by Subject|4
2053435|NCT00513305|3626316|FG000|Overall Study|Adverse Event|6
2053436|NCT00513305|3626317|FG001|Overall Study|Adverse Event|2
2053437|NCT00513305|3626316|FG000|Overall Study|Death (through Consolidation Treatment)|2
2053438|NCT00513305|3626317|FG001|Overall Study|Death (through Consolidation Treatment)|2
2053439|NCT00513305|3626316|FG000|Overall Study|Lack of Efficacy|8
2053440|NCT00513305|3626317|FG001|Overall Study|Lack of Efficacy|13
2053441|NCT00513305|3626316|FG000|Overall Study|Withdrawal by Subject|1
2053442|NCT00513305|3626317|FG001|Overall Study|Withdrawal by Subject|2
2053443|NCT00513305|3626316|FG000|Overall Study|Disease progression|8
2053444|NCT00513305|3626317|FG001|Overall Study|Disease progression|5
2053445|NCT00513305|3626316|FG000|Overall Study|Eligible for stem cell transplant|1
2053446|NCT00513305|3626317|FG001|Overall Study|Eligible for stem cell transplant|0
2053447|NCT00513305|3626316|FG000|Overall Study|Hematologic counts did not recover|1
2053448|NCT00513305|3626317|FG001|Overall Study|Hematologic counts did not recover|0
2053449|NCT00513305|3626316|FG000|Overall Study|Physician Decision|1
2053450|NCT00513305|3626317|FG001|Overall Study|Physician Decision|0
2053451|NCT00513305|3626316|FG000|Overall Study|Persistent hypocellularity|0
2053452|NCT00513305|3626317|FG001|Overall Study|Persistent hypocellularity|1
2053453|NCT00513305|3626316|FG000|Overall Study|Sponsor Decision|0
2053454|NCT00513305|3626317|FG001|Overall Study|Sponsor Decision|2
2053455|NCT00513357|3626333|FG000|Overall Study|did not receive allocated placebo|2
2053456|NCT00513357|3626334|FG001|Overall Study|did not receive allocated placebo|3
2053457|NCT00513357|3626333|FG000|Overall Study|Adverse Event|4
2053458|NCT00513357|3626334|FG001|Overall Study|Adverse Event|2
2053459|NCT00513357|3626333|FG000|Overall Study|Death|2
2053460|NCT00513357|3626334|FG001|Overall Study|Death|0
2053461|NCT00513357|3626333|FG000|Overall Study|Withdrawal by Subject|5
2053462|NCT00513357|3626334|FG001|Overall Study|Withdrawal by Subject|4
2053463|NCT00513357|3626333|FG000|Overall Study|Disease Progression|2
2053464|NCT00513357|3626334|FG001|Overall Study|Disease Progression|1
2053465|NCT00513409|3626348|FG000|Overall Study|Adverse Event|0
2053466|NCT00513409|3626349|FG001|Overall Study|Adverse Event|1
2053467|NCT00513409|3626348|FG000|Overall Study|Withdrawal by Subject|0
2053468|NCT00513409|3626349|FG001|Overall Study|Withdrawal by Subject|2
2053469|NCT00513409|3626348|FG000|Overall Study|Lost to Follow-up|0
2053470|NCT00513409|3626349|FG001|Overall Study|Lost to Follow-up|1
2053471|NCT00513409|3626348|FG000|Overall Study|Physician Decision|1
2053472|NCT00513409|3626349|FG001|Overall Study|Physician Decision|0
2053473|NCT00513409|3626348|FG000|Overall Study|Visit 3 not done|1
2053474|NCT00513409|3626349|FG001|Overall Study|Visit 3 not done|2
2053475|NCT00513474|3626370|FG000|Overall Study|Death|6
2053476|NCT00513474|3626371|FG001|Overall Study|Death|9
2053477|NCT00513474|3626370|FG000|Overall Study|Participant Withdrew Consent|1
2053478|NCT00513474|3626371|FG001|Overall Study|Participant Withdrew Consent|0
2053479|NCT00513500|3626379|FG000|Overall Study|Lost to Follow-up|35
2053480|NCT00513500|3626380|FG001|Overall Study|Lost to Follow-up|39
2053481|NCT00513500|3626379|FG000|Overall Study|Death|2
2053482|NCT00513500|3626380|FG001|Overall Study|Death|1
2053483|NCT00513500|3626379|FG000|Overall Study|Hospitalized|4
2053484|NCT00513500|3626380|FG001|Overall Study|Hospitalized|14
2053485|NCT00513604|3626397|FG000|Overall Study|Not treated|2
2053486|NCT00513604|3626398|FG001|Overall Study|Not treated|0
2053487|NCT00513604|3626399|FG002|Overall Study|Not treated|1
2053488|NCT00513604|3626400|FG003|Overall Study|Not treated|0
2053489|NCT00513604|3626401|FG004|Overall Study|Not treated|0
2053490|NCT00513604|3626397|FG000|Overall Study|Death during treatment|0
2053491|NCT00513604|3626398|FG001|Overall Study|Death during treatment|3
2053492|NCT00513604|3626399|FG002|Overall Study|Death during treatment|2
2053493|NCT00513604|3626400|FG003|Overall Study|Death during treatment|0
2053494|NCT00513604|3626401|FG004|Overall Study|Death during treatment|0
2053495|NCT00513682|3626413|FG000|Washout Phase|Adverse Event|2
2053496|NCT00513695|3626420|FG000|Overall Study|Discontinued therapy|2
2053497|NCT00513695|3626420|FG000|Overall Study|Progression prior to surgery|3
2053498|NCT00513708|3626427|FG000|Overall Study|Lost to Follow-up|4
2053499|NCT00513708|3626428|FG001|Overall Study|Lost to Follow-up|4
2053500|NCT00513708|3626429|FG002|Overall Study|Lost to Follow-up|4
2053501|NCT00514020|3626473|FG000|Overall Study|Adverse Event|6
2053502|NCT00514020|3626473|FG000|Overall Study|Withdrawal by Subject|3
2053503|NCT00514020|3626473|FG000|Overall Study|Physician Decision|1
2053504|NCT00514020|3626473|FG000|Overall Study|disease progression|9
2053505|NCT00514020|3626473|FG000|Overall Study|other complicating disease|2
2053506|NCT00514020|3626473|FG000|Overall Study|patient went to radiation treatment|1
2053507|NCT00514020|3626473|FG000|Overall Study|"patients moved to the no tx group"|6
2053508|NCT00514046|3626486|FG000|Overall Study|transferred to another protocol|2
2053509|NCT00514046|3626487|FG001|Overall Study|transferred to another protocol|1
2053510|NCT00514046|3626488|FG002|Overall Study|transferred to another protocol|3
2053511|NCT00514046|3626489|FG003|Overall Study|transferred to another protocol|0
2053512|NCT00514046|3626490|FG004|Overall Study|transferred to another protocol|1
2053513|NCT00514046|3626491|FG005|Overall Study|transferred to another protocol|0
2053514|NCT00514046|3626492|FG006|Overall Study|transferred to another protocol|0
2053515|NCT00514046|3626493|FG007|Overall Study|transferred to another protocol|0
2053516|NCT00514046|3626494|FG008|Overall Study|transferred to another protocol|0
2053517|NCT00514046|3626486|FG000|Overall Study|Getting vandetanib via the REMS program|1
2053518|NCT00514046|3626487|FG001|Overall Study|Getting vandetanib via the REMS program|0
2053519|NCT00514046|3626488|FG002|Overall Study|Getting vandetanib via the REMS program|0
2053520|NCT00514046|3626489|FG003|Overall Study|Getting vandetanib via the REMS program|0
2053521|NCT00514046|3626490|FG004|Overall Study|Getting vandetanib via the REMS program|0
2053522|NCT00514046|3626491|FG005|Overall Study|Getting vandetanib via the REMS program|0
2053523|NCT00514046|3626492|FG006|Overall Study|Getting vandetanib via the REMS program|0
2053524|NCT00514046|3626493|FG007|Overall Study|Getting vandetanib via the REMS program|1
2053525|NCT00514046|3626494|FG008|Overall Study|Getting vandetanib via the REMS program|1
2053526|NCT00514046|3626486|FG000|Overall Study|Disease progression on study|0
2053527|NCT00514046|3626487|FG001|Overall Study|Disease progression on study|0
2053528|NCT00514046|3626488|FG002|Overall Study|Disease progression on study|2
2053529|NCT00514046|3626489|FG003|Overall Study|Disease progression on study|0
2053530|NCT00514046|3626490|FG004|Overall Study|Disease progression on study|0
2053531|NCT00514046|3626491|FG005|Overall Study|Disease progression on study|1
2053532|NCT00514046|3626492|FG006|Overall Study|Disease progression on study|0
2053533|NCT00514046|3626493|FG007|Overall Study|Disease progression on study|0
2053534|NCT00514046|3626494|FG008|Overall Study|Disease progression on study|0
2053535|NCT00514449|3626526|FG000|Overall Study|Withdrawal by Subject|1
2053536|NCT00514449|3626527|FG001|Overall Study|Withdrawal by Subject|2
2053537|NCT00514449|3626526|FG000|Overall Study|Protocol Violation|1
2053538|NCT00514449|3626527|FG001|Overall Study|Protocol Violation|2
2053539|NCT00514449|3626526|FG000|Overall Study|Lost to Follow-up|1
2053540|NCT00514449|3626527|FG001|Overall Study|Lost to Follow-up|0
2053541|NCT00514514|3626543|FG000|Pre-phase|Death|10
2053542|NCT00514514|3626544|FG001|Pre-phase|Death|0
2053543|NCT00514514|3626545|FG002|Pre-phase|Death|0
2053544|NCT00514514|3626543|FG000|Pre-phase|administrative problems|2
2053545|NCT00514514|3626544|FG001|Pre-phase|administrative problems|0
2053546|NCT00514514|3626545|FG002|Pre-phase|administrative problems|0
2053547|NCT00514514|3626543|FG000|Pre-phase|Protocol Violation|6
2053548|NCT00514514|3626544|FG001|Pre-phase|Protocol Violation|0
2053549|NCT00514514|3626545|FG002|Pre-phase|Protocol Violation|0
2053550|NCT00514514|3626543|FG000|Pre-phase|condition no longer requires study drug|7
2053551|NCT00514514|3626544|FG001|Pre-phase|condition no longer requires study drug|0
2053552|NCT00514514|3626545|FG002|Pre-phase|condition no longer requires study drug|0
2053553|NCT00514514|3626543|FG000|Pre-phase|abnormal test procedure results|15
2053554|NCT00514514|3626544|FG001|Pre-phase|abnormal test procedure results|0
2053555|NCT00514514|3626545|FG002|Pre-phase|abnormal test procedure results|0
2053556|NCT00514514|3626543|FG000|Pre-phase|Lost to Follow-up|2
2053557|NCT00514514|3626544|FG001|Pre-phase|Lost to Follow-up|0
2209393|NCT01644565|3849026|FG005|Overall Study|Family emergency|0
2209394|NCT01644565|3849027|FG006|Overall Study|Family emergency|0
2209395|NCT01644565|3849028|FG007|Overall Study|Family emergency|0
2209396|NCT01644565|3849029|FG008|Overall Study|Family emergency|0
2209397|NCT01644565|3849021|FG000|Overall Study|Relocation|0
2209398|NCT01644565|3849022|FG001|Overall Study|Relocation|0
2209399|NCT01644565|3849023|FG002|Overall Study|Relocation|0
2209400|NCT01644565|3849024|FG003|Overall Study|Relocation|0
2209401|NCT01644565|3849025|FG004|Overall Study|Relocation|0
2209402|NCT01644565|3849026|FG005|Overall Study|Relocation|0
2209403|NCT01644565|3849027|FG006|Overall Study|Relocation|0
2209404|NCT01644565|3849028|FG007|Overall Study|Relocation|0
2209405|NCT01644565|3849029|FG008|Overall Study|Relocation|1
2209406|NCT01644617|3849052|FG000|Overall Study|Withdrawal by Subject|3
2209407|NCT01644617|3849053|FG001|Overall Study|Withdrawal by Subject|4
2209408|NCT01644617|3849054|FG002|Overall Study|Withdrawal by Subject|1
2209409|NCT01644617|3849052|FG000|Overall Study|Lost to Follow-up|0
2209410|NCT01644617|3849053|FG001|Overall Study|Lost to Follow-up|1
2209411|NCT01644617|3849054|FG002|Overall Study|Lost to Follow-up|0
2209412|NCT01644617|3849052|FG000|Overall Study|Adverse Event|3
2209413|NCT01644617|3849053|FG001|Overall Study|Adverse Event|0
2209414|NCT01644617|3849054|FG002|Overall Study|Adverse Event|6
2209415|NCT01644643|3849066|FG000|Overall Study|Death|1
2209416|NCT01644643|3849067|FG001|Overall Study|Death|0
2209417|NCT01644643|3849068|FG002|Overall Study|Death|3
2209418|NCT01644643|3849069|FG003|Overall Study|Death|3
2209419|NCT01644643|3849066|FG000|Overall Study|Lost to Follow-up|0
2209420|NCT01644643|3849067|FG001|Overall Study|Lost to Follow-up|0
2209421|NCT01644643|3849068|FG002|Overall Study|Lost to Follow-up|0
2053558|NCT00514514|3626545|FG002|Pre-phase|Lost to Follow-up|0
2053559|NCT00514514|3626543|FG000|Pre-phase|abnormal lab values|23
2053560|NCT00514514|3626544|FG001|Pre-phase|abnormal lab values|0
2053561|NCT00514514|3626545|FG002|Pre-phase|abnormal lab values|0
2053562|NCT00514514|3626543|FG000|Pre-phase|Lack of Efficacy|35
2053563|NCT00514514|3626544|FG001|Pre-phase|Lack of Efficacy|0
2053564|NCT00514514|3626545|FG002|Pre-phase|Lack of Efficacy|0
2053565|NCT00514514|3626543|FG000|Pre-phase|Adverse Event|137
2053566|NCT00514514|3626544|FG001|Pre-phase|Adverse Event|0
2053567|NCT00514514|3626545|FG002|Pre-phase|Adverse Event|0
2053568|NCT00514514|3626543|FG000|Pre-phase|Withdrawal by Subject|66
2053569|NCT00514514|3626544|FG001|Pre-phase|Withdrawal by Subject|0
2053570|NCT00514514|3626545|FG002|Pre-phase|Withdrawal by Subject|0
2053571|NCT00514514|3626543|FG000|Randomized - 9 Month|Death|3
2053572|NCT00514514|3626544|FG001|Randomized - 9 Month|Death|2
2053573|NCT00514514|3626545|FG002|Randomized - 9 Month|Death|2
2053574|NCT00514514|3626543|FG000|Randomized - 9 Month|Administrative problems|1
2053575|NCT00514514|3626544|FG001|Randomized - 9 Month|Administrative problems|1
2053576|NCT00514514|3626545|FG002|Randomized - 9 Month|Administrative problems|2
2053577|NCT00514514|3626543|FG000|Randomized - 9 Month|Withdrawal by Subject|7
2053578|NCT00514514|3626544|FG001|Randomized - 9 Month|Withdrawal by Subject|7
2053579|NCT00514514|3626545|FG002|Randomized - 9 Month|Withdrawal by Subject|5
2053580|NCT00514514|3626543|FG000|Randomized - 9 Month|Protocol Violation|1
2053581|NCT00514514|3626544|FG001|Randomized - 9 Month|Protocol Violation|1
2053582|NCT00514514|3626545|FG002|Randomized - 9 Month|Protocol Violation|0
2209422|NCT01644643|3849069|FG003|Overall Study|Lost to Follow-up|4
2053583|NCT00514514|3626543|FG000|Randomized - 9 Month|Lack of Efficacy|2
2053584|NCT00514514|3626544|FG001|Randomized - 9 Month|Lack of Efficacy|3
2053585|NCT00514514|3626545|FG002|Randomized - 9 Month|Lack of Efficacy|1
2053586|NCT00514514|3626543|FG000|Randomized - 9 Month|Abnormal laboratory values|0
2053587|NCT00514514|3626544|FG001|Randomized - 9 Month|Abnormal laboratory values|3
2053588|NCT00514514|3626545|FG002|Randomized - 9 Month|Abnormal laboratory values|1
2053589|NCT00514514|3626543|FG000|Randomized - 9 Month|Adverse Event|25
2053590|NCT00514514|3626544|FG001|Randomized - 9 Month|Adverse Event|44
2053591|NCT00514514|3626545|FG002|Randomized - 9 Month|Adverse Event|27
2053592|NCT00514514|3626543|FG000|Extension - 4 Years|Withdrawal by Subject|5
2053593|NCT00514514|3626544|FG001|Extension - 4 Years|Withdrawal by Subject|2
2053594|NCT00514514|3626545|FG002|Extension - 4 Years|Withdrawal by Subject|2
2053595|NCT00514514|3626543|FG000|Extension - 4 Years|Lost to Follow-up|12
2053596|NCT00514514|3626544|FG001|Extension - 4 Years|Lost to Follow-up|10
2053597|NCT00514514|3626545|FG002|Extension - 4 Years|Lost to Follow-up|9
2053598|NCT00514514|3626543|FG000|Extension - 4 Years|Administrative problems|3
2053599|NCT00514514|3626544|FG001|Extension - 4 Years|Administrative problems|1
2053600|NCT00514514|3626545|FG002|Extension - 4 Years|Administrative problems|1
2053601|NCT00514514|3626543|FG000|Extension - 4 Years|Death|8
2053602|NCT00514514|3626544|FG001|Extension - 4 Years|Death|3
2053603|NCT00514514|3626545|FG002|Extension - 4 Years|Death|6
2053604|NCT00514514|3626543|FG000|Extension - 4 Years|Adverse Event|9
2053605|NCT00514514|3626544|FG001|Extension - 4 Years|Adverse Event|6
2053606|NCT00514514|3626545|FG002|Extension - 4 Years|Adverse Event|3
2053607|NCT00514540|3626553|FG000|First-Line Chemo|Withdrawal by Subject|1
2053608|NCT00514540|3626553|FG000|First-Line Chemo|Protocol Violation|7
2053609|NCT00514540|3626553|FG000|Second-Line|Physician/Patient Decision|31
2053610|NCT00514683|3626570|FG000|Overall Study|Not treated|2
2053611|NCT00514683|3626571|FG001|Overall Study|Not treated|1
2053612|NCT00514683|3626572|FG002|Overall Study|Not treated|0
2053613|NCT00514683|3626573|FG003|Overall Study|Not treated|0
2053614|NCT00514683|3626574|FG004|Overall Study|Not treated|1
2053615|NCT00514683|3626570|FG000|Overall Study|Adverse Event|21
2053616|NCT00514683|3626571|FG001|Overall Study|Adverse Event|20
2053617|NCT00514683|3626572|FG002|Overall Study|Adverse Event|15
2053618|NCT00514683|3626573|FG003|Overall Study|Adverse Event|13
2053619|NCT00514683|3626574|FG004|Overall Study|Adverse Event|27
2053620|NCT00514683|3626570|FG000|Overall Study|Protocol Violation|1
2053621|NCT00514683|3626571|FG001|Overall Study|Protocol Violation|1
2053622|NCT00514683|3626572|FG002|Overall Study|Protocol Violation|0
2053623|NCT00514683|3626573|FG003|Overall Study|Protocol Violation|1
2053624|NCT00514683|3626574|FG004|Overall Study|Protocol Violation|0
2053625|NCT00514683|3626570|FG000|Overall Study|Withdrawal by Subject|2
2053626|NCT00514683|3626571|FG001|Overall Study|Withdrawal by Subject|2
2053627|NCT00514683|3626572|FG002|Overall Study|Withdrawal by Subject|1
2053628|NCT00514683|3626573|FG003|Overall Study|Withdrawal by Subject|0
2053629|NCT00514683|3626574|FG004|Overall Study|Withdrawal by Subject|4
2053630|NCT00514683|3626570|FG000|Overall Study|Reason other than listed above|0
2053631|NCT00514683|3626571|FG001|Overall Study|Reason other than listed above|1
2053632|NCT00514683|3626572|FG002|Overall Study|Reason other than listed above|2
2053633|NCT00514683|3626573|FG003|Overall Study|Reason other than listed above|0
2053634|NCT00514683|3626574|FG004|Overall Study|Reason other than listed above|1
2053635|NCT00514735|3626603|FG000|Overall Study|Withdrawal by Subject|13
2053636|NCT00514735|3626604|FG001|Overall Study|Withdrawal by Subject|5
2053637|NCT00514735|3626603|FG000|Overall Study|Death|1
2053638|NCT00514735|3626604|FG001|Overall Study|Death|0
2053639|NCT00514735|3626603|FG000|Overall Study|Lost to Follow-up|0
2053640|NCT00514735|3626604|FG001|Overall Study|Lost to Follow-up|1
2053641|NCT00514904|3626623|FG000|Overall Study|Withdrawal by Subject|3
2053642|NCT00514904|3626624|FG001|Overall Study|Withdrawal by Subject|2
2053643|NCT00514904|3626623|FG000|Overall Study|Lost to Follow-up|21
2053644|NCT00514904|3626624|FG001|Overall Study|Lost to Follow-up|3
2053645|NCT00514917|3626632|FG000|Overall Study|Death|4
2053646|NCT00514917|3626633|FG001|Overall Study|Death|10
2053647|NCT00514917|3626632|FG000|Overall Study|Protocol Violation|1
2053648|NCT00514917|3626633|FG001|Overall Study|Protocol Violation|0
2053649|NCT00514917|3626632|FG000|Overall Study|Lost to Follow-up|4
2053650|NCT00514917|3626633|FG001|Overall Study|Lost to Follow-up|3
2053651|NCT00514917|3626632|FG000|Overall Study|Withdrawal by Subject|18
2053652|NCT00514917|3626633|FG001|Overall Study|Withdrawal by Subject|16
2053653|NCT00514917|3626632|FG000|Overall Study|Discontinued due to study closure|88
2053654|NCT00514917|3626633|FG001|Overall Study|Discontinued due to study closure|81
2053655|NCT00514917|3626632|FG000|Overall Study|Undefined|11
2053656|NCT00514917|3626633|FG001|Overall Study|Undefined|5
2053657|NCT00514943|3626643|FG000|Stage 1|Progressive disease|4
2053658|NCT00514943|3626644|FG001|Stage 1|Progressive disease|8
2053659|NCT00514943|3626643|FG000|Stage 1|Other Adverse Event|16
2053660|NCT00514943|3626644|FG001|Stage 1|Other Adverse Event|6
2053661|NCT00514943|3626643|FG000|Stage 1|Not treated|1
2053662|NCT00514943|3626644|FG001|Stage 1|Not treated|2
2053663|NCT00514943|3626643|FG000|Stage 1|Patient refused to continue study meds|8
2053664|NCT00514943|3626644|FG001|Stage 1|Patient refused to continue study meds|3
2053665|NCT00514943|3626643|FG000|Stage 1|Other than stated above|1
2053666|NCT00514943|3626644|FG001|Stage 1|Other than stated above|7
2053667|NCT00514943|3626643|FG000|Stage 2|Progressive disease|27
2053668|NCT00514943|3626644|FG001|Stage 2|Progressive disease|24
2053669|NCT00514943|3626643|FG000|Stage 2|Other Adverse Event|3
2053670|NCT00514943|3626644|FG001|Stage 2|Other Adverse Event|10
2053671|NCT00514943|3626643|FG000|Stage 2|Patient refused to continue study meds|2
2053672|NCT00514943|3626644|FG001|Stage 2|Patient refused to continue study meds|0
2053673|NCT00514943|3626643|FG000|Stage 2|Other than stated above|0
2053674|NCT00514943|3626644|FG001|Stage 2|Other than stated above|2
2053675|NCT00515008|3626667|FG000|Overall Study|Lost to Follow-up|1
2053676|NCT00515008|3626668|FG001|Overall Study|Lost to Follow-up|0
2053677|NCT00515008|3626667|FG000|Overall Study|Declined|0
2053678|NCT00515008|3626668|FG001|Overall Study|Declined|3
2053679|NCT00515008|3626667|FG000|Overall Study|Left the Boston Area|1
2053680|NCT00515008|3626668|FG001|Overall Study|Left the Boston Area|1
2053681|NCT00515008|3626667|FG000|Overall Study|Scheduling conflict|1
2053682|NCT00515008|3626668|FG001|Overall Study|Scheduling conflict|0
2053683|NCT00515034|3626692|FG000|Overall Study|Adverse Event|2
2053684|NCT00515034|3626693|FG001|Overall Study|Adverse Event|0
2053685|NCT00515034|3626694|FG002|Overall Study|Adverse Event|1
2053686|NCT00515034|3626695|FG003|Overall Study|Adverse Event|0
2053687|NCT00515034|3626692|FG000|Overall Study|Death|4
2053688|NCT00515034|3626693|FG001|Overall Study|Death|2
2053689|NCT00515034|3626694|FG002|Overall Study|Death|1
2053690|NCT00515034|3626695|FG003|Overall Study|Death|3
2053691|NCT00515034|3626692|FG000|Overall Study|Withdrawal by Subject|1
2209423|NCT01644643|3849066|FG000|Overall Study|Withdrawal by Subject|1
2209424|NCT01644643|3849067|FG001|Overall Study|Withdrawal by Subject|0
2209425|NCT01644643|3849068|FG002|Overall Study|Withdrawal by Subject|2
2053692|NCT00515034|3626693|FG001|Overall Study|Withdrawal by Subject|0
2053693|NCT00515034|3626694|FG002|Overall Study|Withdrawal by Subject|3
2053694|NCT00515034|3626695|FG003|Overall Study|Withdrawal by Subject|0
2053695|NCT00515034|3626692|FG000|Overall Study|Physician Decision|0
2053696|NCT00515034|3626693|FG001|Overall Study|Physician Decision|0
2053697|NCT00515034|3626694|FG002|Overall Study|Physician Decision|1
2053698|NCT00515034|3626695|FG003|Overall Study|Physician Decision|1
2053699|NCT00515034|3626692|FG000|Overall Study|Other|1
2053700|NCT00515034|3626693|FG001|Overall Study|Other|0
2053701|NCT00515034|3626694|FG002|Overall Study|Other|2
2053702|NCT00515034|3626695|FG003|Overall Study|Other|1
2105416|NCT00856986|3698006|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0
2105417|NCT00856986|3698007|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0
2105418|NCT00856986|3698008|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0
2105419|NCT00856986|3698009|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11
2105420|NCT00856986|3698010|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0
2105421|NCT00856986|3698006|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0
2105422|NCT00856986|3698007|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0
2105423|NCT00856986|3698008|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0
2105424|NCT00856986|3698009|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6
2105425|NCT00856986|3698010|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0
2105426|NCT00856986|3698006|FG000|Run-in Period, Weeks -12-0|Unclassified|0
2105427|NCT00856986|3698007|FG001|Run-in Period, Weeks -12-0|Unclassified|0
2105428|NCT00856986|3698008|FG002|Run-in Period, Weeks -12-0|Unclassified|0
2105429|NCT00856986|3698009|FG003|Run-in Period, Weeks -12-0|Unclassified|24
2105430|NCT00856986|3698010|FG004|Run-in Period, Weeks -12-0|Unclassified|0
2105431|NCT00856986|3698006|FG000|Main Period, Weeks 0-26|Adverse Event|6
2105432|NCT00856986|3698007|FG001|Main Period, Weeks 0-26|Adverse Event|4
2105433|NCT00856986|3698008|FG002|Main Period, Weeks 0-26|Adverse Event|9
2105434|NCT00856986|3698009|FG003|Main Period, Weeks 0-26|Adverse Event|0
2105435|NCT00856986|3698010|FG004|Main Period, Weeks 0-26|Adverse Event|0
2105436|NCT00856986|3698006|FG000|Main Period, Weeks 0-26|Protocol Violation|4
2105437|NCT00856986|3698007|FG001|Main Period, Weeks 0-26|Protocol Violation|5
2105438|NCT00856986|3698008|FG002|Main Period, Weeks 0-26|Protocol Violation|7
2105439|NCT00856986|3698009|FG003|Main Period, Weeks 0-26|Protocol Violation|0
2105440|NCT00856986|3698010|FG004|Main Period, Weeks 0-26|Protocol Violation|0
2105441|NCT00856986|3698006|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11
2105442|NCT00856986|3698007|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0
2105443|NCT00856986|3698008|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3
2105444|NCT00856986|3698009|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0
2105445|NCT00856986|3698010|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0
2105446|NCT00856986|3698006|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1
2105447|NCT00856986|3698007|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1
2105448|NCT00856986|3698008|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2
2105449|NCT00856986|3698009|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0
2105450|NCT00856986|3698010|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0
2105451|NCT00856986|3698006|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5
2105452|NCT00856986|3698007|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2
2105453|NCT00856986|3698008|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0
2105454|NCT00856986|3698009|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0
2105455|NCT00856986|3698010|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0
2105456|NCT00856986|3698006|FG000|Main Period, Weeks 0-26|Unclassified|7
2105457|NCT00856986|3698007|FG001|Main Period, Weeks 0-26|Unclassified|6
2105458|NCT00856986|3698008|FG002|Main Period, Weeks 0-26|Unclassified|7
2105459|NCT00856986|3698009|FG003|Main Period, Weeks 0-26|Unclassified|0
2209426|NCT01644643|3849069|FG003|Overall Study|Withdrawal by Subject|1
2209427|NCT01644643|3849066|FG000|Overall Study|Other Eligibility criteria|0
2209428|NCT01644643|3849067|FG001|Overall Study|Other Eligibility criteria|0
2209429|NCT01644643|3849068|FG002|Overall Study|Other Eligibility criteria|0
2053703|NCT00515073|3626705|FG000|Overall Study|Withdrawal by Subject|1
2053704|NCT00515073|3626705|FG000|Overall Study|Physician Decision|1
2053705|NCT00515086|3626713|FG000|Overall Study|Adverse Event|1
2053706|NCT00515086|3626714|FG001|Overall Study|Adverse Event|1
2053707|NCT00515086|3626715|FG002|Overall Study|Adverse Event|2
2053708|NCT00515086|3626716|FG003|Overall Study|Adverse Event|3
2053709|NCT00515086|3626713|FG000|Overall Study|Administrative|1
2053710|NCT00515086|3626714|FG001|Overall Study|Administrative|1
2053711|NCT00515086|3626715|FG002|Overall Study|Administrative|0
2053712|NCT00515086|3626716|FG003|Overall Study|Administrative|0
2053713|NCT00515086|3626713|FG000|Overall Study|Withdrawal by Subject|1
2053714|NCT00515086|3626714|FG001|Overall Study|Withdrawal by Subject|0
2053715|NCT00515086|3626715|FG002|Overall Study|Withdrawal by Subject|0
2053716|NCT00515086|3626716|FG003|Overall Study|Withdrawal by Subject|1
2053717|NCT00515086|3626713|FG000|Overall Study|Unsatisfactory therapeutic effect|18
2053718|NCT00515086|3626714|FG001|Overall Study|Unsatisfactory therapeutic effect|3
2053719|NCT00515086|3626715|FG002|Overall Study|Unsatisfactory therapeutic effect|3
2053720|NCT00515086|3626716|FG003|Overall Study|Unsatisfactory therapeutic effect|2
2053721|NCT00515086|3626713|FG000|Overall Study|Lost to Follow-up|1
2053722|NCT00515086|3626714|FG001|Overall Study|Lost to Follow-up|0
2053723|NCT00515086|3626715|FG002|Overall Study|Lost to Follow-up|0
2053724|NCT00515086|3626716|FG003|Overall Study|Lost to Follow-up|0
2053725|NCT00515086|3626713|FG000|Overall Study|Study drug no longer required|0
2053726|NCT00515086|3626714|FG001|Overall Study|Study drug no longer required|1
2053727|NCT00515086|3626715|FG002|Overall Study|Study drug no longer required|0
2053728|NCT00515086|3626716|FG003|Overall Study|Study drug no longer required|0
2053729|NCT00515086|3626713|FG000|Overall Study|Death|2
2053730|NCT00515086|3626714|FG001|Overall Study|Death|0
2053731|NCT00515086|3626715|FG002|Overall Study|Death|0
2053732|NCT00515086|3626716|FG003|Overall Study|Death|0
2053733|NCT00515099|3626734|FG000|Overall Study|Lost to Follow-up|0
2053734|NCT00515099|3626735|FG001|Overall Study|Lost to Follow-up|4
2053735|NCT00515099|3626734|FG000|Overall Study|Withdrawal by Subject|2
2053736|NCT00515099|3626735|FG001|Overall Study|Withdrawal by Subject|0
2053737|NCT00515099|3626734|FG000|Overall Study|IRB Recommendation|1
2053738|NCT00515099|3626735|FG001|Overall Study|IRB Recommendation|0
2053739|NCT00515216|3626760|FG000|Overall Study|Withdrawal by Subject|1
2053740|NCT00515294|3626769|FG000|Overall Study|Lost to Follow-up|3
2053741|NCT00515294|3626770|FG001|Overall Study|Lost to Follow-up|2
2053742|NCT00515294|3626771|FG002|Overall Study|Lost to Follow-up|3
2053743|NCT00515294|3626772|FG003|Overall Study|Lost to Follow-up|1
2053744|NCT00515294|3626769|FG000|Overall Study|Driver simulator problems|1
2053745|NCT00515294|3626770|FG001|Overall Study|Driver simulator problems|1
2053746|NCT00515294|3626771|FG002|Overall Study|Driver simulator problems|1
2053747|NCT00515294|3626772|FG003|Overall Study|Driver simulator problems|3
2053748|NCT00515294|3626769|FG000|Overall Study|Caffeine amount inaccurate|5
2053749|NCT00515294|3626770|FG001|Overall Study|Caffeine amount inaccurate|0
2053750|NCT00515294|3626771|FG002|Overall Study|Caffeine amount inaccurate|7
2053751|NCT00515294|3626772|FG003|Overall Study|Caffeine amount inaccurate|0
2053752|NCT00515463|3626814|FG000|Overall Study|Physician Decision|4
2053753|NCT00515463|3626815|FG001|Overall Study|Physician Decision|2
2053754|NCT00515463|3626814|FG000|Overall Study|Adverse Event|1
2053755|NCT00515463|3626815|FG001|Overall Study|Adverse Event|2
2053756|NCT00515463|3626814|FG000|Overall Study|Withdrawal by Subject|3
2053757|NCT00515463|3626815|FG001|Overall Study|Withdrawal by Subject|4
2053758|NCT00515463|3626814|FG000|Overall Study|Lost to Follow-up|6
2053759|NCT00515463|3626815|FG001|Overall Study|Lost to Follow-up|5
2053760|NCT00515463|3626814|FG000|Overall Study|Other|0
2053761|NCT00515463|3626815|FG001|Overall Study|Other|1
2053762|NCT00515502|3626822|FG000|Treatment Period 1|Adverse Event|0
2053763|NCT00515502|3626823|FG001|Treatment Period 1|Adverse Event|0
2053764|NCT00515502|3626824|FG002|Treatment Period 1|Adverse Event|0
2053765|NCT00515502|3626825|FG003|Treatment Period 1|Adverse Event|0
2053766|NCT00515502|3626826|FG004|Treatment Period 1|Adverse Event|0
2053767|NCT00515502|3626827|FG005|Treatment Period 1|Adverse Event|0
2053768|NCT00515502|3626828|FG006|Treatment Period 1|Adverse Event|1
2053769|NCT00515502|3626829|FG007|Treatment Period 1|Adverse Event|0
2053770|NCT00515502|3626830|FG008|Treatment Period 1|Adverse Event|1
2053771|NCT00515502|3626831|FG009|Treatment Period 1|Adverse Event|0
2053772|NCT00515502|3626832|FG010|Treatment Period 1|Adverse Event|0
2053773|NCT00515502|3626833|FG011|Treatment Period 1|Adverse Event|1
2053774|NCT00515502|3626822|FG000|Treatment Period 2|Adverse Event|0
2053775|NCT00515502|3626823|FG001|Treatment Period 2|Adverse Event|1
2053776|NCT00515502|3626824|FG002|Treatment Period 2|Adverse Event|0
2053777|NCT00515502|3626825|FG003|Treatment Period 2|Adverse Event|0
2053778|NCT00515502|3626826|FG004|Treatment Period 2|Adverse Event|0
2053779|NCT00515502|3626827|FG005|Treatment Period 2|Adverse Event|0
2053780|NCT00515502|3626828|FG006|Treatment Period 2|Adverse Event|0
2053781|NCT00515502|3626829|FG007|Treatment Period 2|Adverse Event|0
2053782|NCT00515502|3626830|FG008|Treatment Period 2|Adverse Event|0
2053783|NCT00515502|3626831|FG009|Treatment Period 2|Adverse Event|0
2053784|NCT00515502|3626832|FG010|Treatment Period 2|Adverse Event|0
2053785|NCT00515502|3626833|FG011|Treatment Period 2|Adverse Event|0
2053786|NCT00515541|3626863|FG000|Overall Study|Physician Decision|0
2053787|NCT00515541|3626864|FG001|Overall Study|Physician Decision|2
2053788|NCT00515541|3626865|FG002|Overall Study|Physician Decision|0
2053789|NCT00515541|3626866|FG003|Overall Study|Physician Decision|1
2053790|NCT00515541|3626863|FG000|Overall Study|No show for appointments|0
2053791|NCT00515541|3626864|FG001|Overall Study|No show for appointments|1
2053792|NCT00515541|3626865|FG002|Overall Study|No show for appointments|0
2053793|NCT00515541|3626866|FG003|Overall Study|No show for appointments|2
2053794|NCT00515541|3626863|FG000|Overall Study|Withdrawal by Subject|0
2053795|NCT00515541|3626864|FG001|Overall Study|Withdrawal by Subject|2
2053796|NCT00515541|3626865|FG002|Overall Study|Withdrawal by Subject|0
2053797|NCT00515541|3626866|FG003|Overall Study|Withdrawal by Subject|2
2053798|NCT00515619|3626876|FG000|Overall Study|Adverse Event|34
2053799|NCT00515619|3626876|FG000|Overall Study|Lack of Efficacy|92
2053800|NCT00515619|3626876|FG000|Overall Study|Withdrawal by Subject|66
2053801|NCT00515619|3626876|FG000|Overall Study|Protocol Violation|3
2053802|NCT00515619|3626876|FG000|Overall Study|Lost to Follow-up|4
2053803|NCT00515619|3626876|FG000|Overall Study|Unsatisfactory compliance|6
2053804|NCT00515619|3626876|FG000|Overall Study|Other: Site discontinuing trials|2
2053805|NCT00515619|3626876|FG000|Overall Study|Other: Subject cannot attend visits|2
2053806|NCT00515619|3626876|FG000|Overall Study|Other: Subject required surgery|1
2053807|NCT00515619|3626876|FG000|Overall Study|Other: Subject moved to another country|1
2053808|NCT00515619|3626876|FG000|Overall Study|Other: Investigator decision|1
2053809|NCT00515619|3626876|FG000|Overall Study|Other: Subject became pregnant|1
2053810|NCT00515619|3626876|FG000|Overall Study|Other: Request from sponsor|1
2053811|NCT00515619|3626876|FG000|Overall Study|Other: Drug available on license|1
2053812|NCT00515619|3626876|FG000|Overall Study|Other: Subject interested in other AED|1
2053813|NCT00515827|3626904|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
2053814|NCT00515827|3626905|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
2053815|NCT00515827|3626904|FG000|Second Intervention (12 Weeks)|Consent withdraw|1
2053816|NCT00515827|3626905|FG001|Second Intervention (12 Weeks)|Consent withdraw|0
2053817|NCT00516048|3626926|FG000|Overall Study|Death|0
2053818|NCT00516048|3626927|FG001|Overall Study|Death|0
2053819|NCT00516048|3626928|FG002|Overall Study|Death|1
2053820|NCT00516048|3626926|FG000|Overall Study|Subject Decision|0
2053821|NCT00516048|3626927|FG001|Overall Study|Subject Decision|2
2053822|NCT00516048|3626928|FG002|Overall Study|Subject Decision|0
2053823|NCT00516074|3626938|FG000|Overall Study|Adverse Event|0
2053824|NCT00516074|3626939|FG001|Overall Study|Adverse Event|1
2053825|NCT00516074|3626938|FG000|Overall Study|Subject Decision|4
2053826|NCT00516074|3626939|FG001|Overall Study|Subject Decision|2
2053827|NCT00516074|3626938|FG000|Overall Study|Loss of Glucose Control|2
2053828|NCT00516074|3626939|FG001|Overall Study|Loss of Glucose Control|0
2053829|NCT00516139|3626945|FG000|Overall Study|Adverse Event|27
2053830|NCT00516139|3626945|FG000|Overall Study|Lost to Follow-up|1
2053831|NCT00516139|3626945|FG000|Overall Study|Protocol Violation|1
2053832|NCT00516139|3626945|FG000|Overall Study|Withdrawal by Subject|8
2053833|NCT00516139|3626945|FG000|Overall Study|Lack of Efficacy|1
2053834|NCT00516269|3626963|FG000|Overall Study|Adverse Event|2
2053835|NCT00516269|3626964|FG001|Overall Study|Adverse Event|1
2053836|NCT00516269|3626963|FG000|Overall Study|Lost to Follow-up|0
2053837|NCT00516269|3626964|FG001|Overall Study|Lost to Follow-up|1
2053838|NCT00516269|3626963|FG000|Overall Study|Protocol Violation|0
2053839|NCT00516269|3626964|FG001|Overall Study|Protocol Violation|1
2053840|NCT00516295|3626973|FG000|Overall Study|Lack of Efficacy|2
2053841|NCT00516295|3626974|FG001|Overall Study|Lack of Efficacy|0
2053842|NCT00516295|3626975|FG002|Overall Study|Lack of Efficacy|0
2053843|NCT00516295|3626973|FG000|Overall Study|Ineligible|1
2053844|NCT00516295|3626974|FG001|Overall Study|Ineligible|0
2053845|NCT00516295|3626975|FG002|Overall Study|Ineligible|0
2053846|NCT00516321|3626985|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
2053847|NCT00516321|3626986|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
2053848|NCT00516321|3626987|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
2053849|NCT00516321|3626985|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
2053850|NCT00516321|3626986|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
2053851|NCT00516321|3626987|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
2053852|NCT00516321|3626985|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
2053853|NCT00516321|3626986|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
2053854|NCT00516321|3626987|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
2053855|NCT00516321|3626985|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
2053856|NCT00516321|3626986|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
2053857|NCT00516321|3626987|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
2053858|NCT00516321|3626985|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
2053859|NCT00516321|3626986|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
2053860|NCT00516321|3626987|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
2053861|NCT00516321|3626985|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
2053862|NCT00516321|3626986|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
2053863|NCT00516321|3626987|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
2053864|NCT00516321|3626985|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
2053865|NCT00516321|3626986|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
2053866|NCT00516321|3626987|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
2053867|NCT00516321|3626985|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
2053868|NCT00516321|3626986|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
2053869|NCT00516321|3626987|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
2053870|NCT00516321|3626985|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0
2053871|NCT00516321|3626986|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8
2053872|NCT00516321|3626987|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13
2053873|NCT00516321|3626985|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
2053874|NCT00516321|3626986|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
2053875|NCT00516321|3626987|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
2053876|NCT00516321|3626985|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0
2053877|NCT00516321|3626986|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2
2053878|NCT00516321|3626987|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0
2053879|NCT00516386|3626995|FG000|Overall Study|not interested in the study|4
2053880|NCT00516386|3626995|FG000|Overall Study|Lost to Follow-up|2
2053881|NCT00516893|3627008|FG000|Overall Study|Lost to Follow-up|4
2053882|NCT00516893|3627008|FG000|Overall Study|Adverse Event|3
2053883|NCT00516893|3627008|FG000|Overall Study|Withdrawal by Subject|2
2053884|NCT00516893|3627008|FG000|Overall Study|Noncompliance|2
2053885|NCT00516893|3627008|FG000|Overall Study|Death|1
2053886|NCT00516893|3627008|FG000|Overall Study|Persistent Antibodies per Protocol|6
2053887|NCT00516893|3627008|FG000|Overall Study|Relocated|1
2053888|NCT00516893|3627008|FG000|Overall Study|Pregnancy|1
2053889|NCT00516893|3627008|FG000|Overall Study|Received Medication From Another Study|1
2053890|NCT00516906|3627014|FG000|Overall Study|Final Dressing Removal Data not captured|6
2053891|NCT00516906|3627015|FG001|Overall Study|Final Dressing Removal Data not captured|2
2053892|NCT00517296|3627034|FG000|Overall Study|Withdrawal by Subject|1
2053893|NCT00517296|3627035|FG001|Overall Study|Withdrawal by Subject|0
2053894|NCT00517413|3627041|FG000|Overall Study|Adverse Event|7
2053895|NCT00517413|3627041|FG000|Overall Study|Death|13
2053896|NCT00517413|3627041|FG000|Overall Study|Protocol Violation|15
2053897|NCT00517413|3627041|FG000|Overall Study|Withdrawal by Subject|2
2053898|NCT00517413|3627041|FG000|Overall Study|Failure to return|1
2053899|NCT00517413|3627041|FG000|Overall Study|Other-Reasons|23
2053900|NCT00517634|3627102|FG000|Second Treatment Period|Withdrawal by Subject|0
2053901|NCT00517634|3627103|FG001|Second Treatment Period|Withdrawal by Subject|0
2053902|NCT00517634|3627104|FG002|Second Treatment Period|Withdrawal by Subject|0
2053903|NCT00517634|3627105|FG003|Second Treatment Period|Withdrawal by Subject|0
2053904|NCT00517634|3627106|FG004|Second Treatment Period|Withdrawal by Subject|1
2053905|NCT00517634|3627107|FG005|Second Treatment Period|Withdrawal by Subject|0
2053906|NCT00517751|3627115|FG000|Overall Study|Death|3
2053907|NCT00517751|3627115|FG000|Overall Study|Withdrawal by Subject|37
2053908|NCT00517751|3627115|FG000|Overall Study|Lost to Follow-up|4
2053909|NCT00517751|3627115|FG000|Overall Study|patient not over due|6
2053910|NCT00517751|3627115|FG000|Overall Study|Patient not due for visit|76
2053911|NCT00517751|3627115|FG000|Overall Study|Missing|3
2053912|NCT00517829|3627121|FG000|Overall Study|Adverse Event|22
2053913|NCT00517829|3627122|FG001|Overall Study|Adverse Event|34
2053914|NCT00517829|3627121|FG000|Overall Study|Disease Progression|39
2053915|NCT00517829|3627122|FG001|Overall Study|Disease Progression|32
2053916|NCT00517829|3627121|FG000|Overall Study|Patient Request|6
2053917|NCT00517829|3627122|FG001|Overall Study|Patient Request|5
2053918|NCT00517829|3627121|FG000|Overall Study|Investigator Request|5
2053919|NCT00517829|3627122|FG001|Overall Study|Investigator Request|3
2053920|NCT00517829|3627121|FG000|Overall Study|Other|3
2053921|NCT00517829|3627122|FG001|Overall Study|Other|1
2053922|NCT00517881|3627128|FG000|Overall Study|Protocol Violation|2
2053923|NCT00517881|3627128|FG000|Overall Study|Adverse Event|1
2053924|NCT00517881|3627128|FG000|Overall Study|Renal transplantation|2
2053925|NCT00517933|3627134|FG000|Period 1|Death|2
2053926|NCT00517933|3627135|FG001|Period 1|Death|1
2053927|NCT00517933|3627134|FG000|Period 1|Adverse Event|4
2053928|NCT00517933|3627135|FG001|Period 1|Adverse Event|4
2053929|NCT00517933|3627134|FG000|Period 1|Lost to Follow-up|2
2053930|NCT00517933|3627135|FG001|Period 1|Lost to Follow-up|0
2053931|NCT00517933|3627134|FG000|Period 1|Underwent lung transplant|0
2053932|NCT00517933|3627135|FG001|Period 1|Underwent lung transplant|1
2053933|NCT00517933|3627134|FG000|Period 2|Death|2
2053934|NCT00517933|3627135|FG001|Period 2|Death|4
2053935|NCT00517933|3627134|FG000|Period 2|Adverse Event|2
2053936|NCT00517933|3627135|FG001|Period 2|Adverse Event|4
2053937|NCT00517933|3627134|FG000|Period 2|Physician Decision|1
2053938|NCT00517933|3627135|FG001|Period 2|Physician Decision|0
2053939|NCT00517933|3627134|FG000|Period 2|Withdrawal by Subject|1
2053940|NCT00517933|3627135|FG001|Period 2|Withdrawal by Subject|3
2053941|NCT00517933|3627134|FG000|Period 2|Underwent lung transplant|0
2053942|NCT00517933|3627135|FG001|Period 2|Underwent lung transplant|2
2053943|NCT00518011|3627146|FG000|Overall Study|Death|1
2053944|NCT00518011|3627147|FG001|Overall Study|Death|1
2053945|NCT00518011|3627146|FG000|Overall Study|Adverse Event|2
2053946|NCT00518011|3627147|FG001|Overall Study|Adverse Event|3
2053947|NCT00518011|3627146|FG000|Overall Study|Disease Progression|2
2053948|NCT00518011|3627147|FG001|Overall Study|Disease Progression|2
2053949|NCT00518011|3627146|FG000|Overall Study|Other Reasons|3
2053950|NCT00518011|3627147|FG001|Overall Study|Other Reasons|2
2053951|NCT00518011|3627146|FG000|Overall Study|Withdrawal by Subject|1
2053952|NCT00518011|3627147|FG001|Overall Study|Withdrawal by Subject|0
2053953|NCT00518115|3627173|FG000|Overall Study|Adverse Event|6
2053954|NCT00518115|3627174|FG001|Overall Study|Adverse Event|1
2053955|NCT00518115|3627175|FG002|Overall Study|Adverse Event|5
2053956|NCT00518115|3627176|FG003|Overall Study|Adverse Event|6
2053957|NCT00518115|3627177|FG004|Overall Study|Adverse Event|5
2053958|NCT00518115|3627178|FG005|Overall Study|Adverse Event|5
2053959|NCT00518115|3627179|FG006|Overall Study|Adverse Event|5
2053960|NCT00518115|3627180|FG007|Overall Study|Adverse Event|10
2053961|NCT00518115|3627181|FG008|Overall Study|Adverse Event|2
2053962|NCT00518115|3627182|FG009|Overall Study|Adverse Event|9
2053963|NCT00518115|3627173|FG000|Overall Study|Lost to Follow-up|0
2053964|NCT00518115|3627174|FG001|Overall Study|Lost to Follow-up|0
2053965|NCT00518115|3627175|FG002|Overall Study|Lost to Follow-up|2
2053966|NCT00518115|3627176|FG003|Overall Study|Lost to Follow-up|3
2053967|NCT00518115|3627177|FG004|Overall Study|Lost to Follow-up|1
2053968|NCT00518115|3627178|FG005|Overall Study|Lost to Follow-up|3
2053969|NCT00518115|3627179|FG006|Overall Study|Lost to Follow-up|0
2053970|NCT00518115|3627180|FG007|Overall Study|Lost to Follow-up|1
2053971|NCT00518115|3627181|FG008|Overall Study|Lost to Follow-up|1
2053972|NCT00518115|3627182|FG009|Overall Study|Lost to Follow-up|1
2053973|NCT00518115|3627173|FG000|Overall Study|Protocol Violation|1
2053974|NCT00518115|3627174|FG001|Overall Study|Protocol Violation|3
2053975|NCT00518115|3627175|FG002|Overall Study|Protocol Violation|1
2053976|NCT00518115|3627176|FG003|Overall Study|Protocol Violation|0
2053977|NCT00518115|3627177|FG004|Overall Study|Protocol Violation|0
2053978|NCT00518115|3627178|FG005|Overall Study|Protocol Violation|0
2053979|NCT00518115|3627179|FG006|Overall Study|Protocol Violation|0
2053980|NCT00518115|3627180|FG007|Overall Study|Protocol Violation|0
2053981|NCT00518115|3627181|FG008|Overall Study|Protocol Violation|0
2053982|NCT00518115|3627182|FG009|Overall Study|Protocol Violation|0
2053983|NCT00518115|3627173|FG000|Overall Study|Withdrawal by Subject|1
2053984|NCT00518115|3627174|FG001|Overall Study|Withdrawal by Subject|1
2053985|NCT00518115|3627175|FG002|Overall Study|Withdrawal by Subject|5
2053986|NCT00518115|3627176|FG003|Overall Study|Withdrawal by Subject|0
2053987|NCT00518115|3627177|FG004|Overall Study|Withdrawal by Subject|2
2053988|NCT00518115|3627178|FG005|Overall Study|Withdrawal by Subject|1
2053989|NCT00518115|3627179|FG006|Overall Study|Withdrawal by Subject|0
2053990|NCT00518115|3627180|FG007|Overall Study|Withdrawal by Subject|2
2053991|NCT00518115|3627181|FG008|Overall Study|Withdrawal by Subject|1
2053992|NCT00518115|3627182|FG009|Overall Study|Withdrawal by Subject|3
2053993|NCT00518115|3627173|FG000|Overall Study|Lack of Efficacy|1
2053994|NCT00518115|3627174|FG001|Overall Study|Lack of Efficacy|0
2053995|NCT00518115|3627175|FG002|Overall Study|Lack of Efficacy|1
2053996|NCT00518115|3627176|FG003|Overall Study|Lack of Efficacy|1
2053997|NCT00518115|3627177|FG004|Overall Study|Lack of Efficacy|0
2053998|NCT00518115|3627178|FG005|Overall Study|Lack of Efficacy|0
2053999|NCT00518115|3627179|FG006|Overall Study|Lack of Efficacy|0
2054000|NCT00518115|3627180|FG007|Overall Study|Lack of Efficacy|1
2054001|NCT00518115|3627181|FG008|Overall Study|Lack of Efficacy|0
2054002|NCT00518115|3627182|FG009|Overall Study|Lack of Efficacy|0
2054003|NCT00518115|3627173|FG000|Overall Study|Non-Compliance|1
2054004|NCT00518115|3627174|FG001|Overall Study|Non-Compliance|0
2054005|NCT00518115|3627175|FG002|Overall Study|Non-Compliance|1
2054006|NCT00518115|3627176|FG003|Overall Study|Non-Compliance|0
2054007|NCT00518115|3627177|FG004|Overall Study|Non-Compliance|1
2054008|NCT00518115|3627178|FG005|Overall Study|Non-Compliance|1
2054009|NCT00518115|3627179|FG006|Overall Study|Non-Compliance|1
2054010|NCT00518115|3627180|FG007|Overall Study|Non-Compliance|1
2054011|NCT00518115|3627181|FG008|Overall Study|Non-Compliance|0
2054012|NCT00518115|3627182|FG009|Overall Study|Non-Compliance|1
2054013|NCT00518115|3627173|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1
2054014|NCT00518115|3627174|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1
2054015|NCT00518115|3627175|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0
2054016|NCT00518115|3627176|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0
2054017|NCT00518115|3627177|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0
2054018|NCT00518115|3627178|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4
2054019|NCT00518115|3627179|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0
2054020|NCT00518115|3627180|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0
2054021|NCT00518115|3627181|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0
2054022|NCT00518115|3627182|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0
2054023|NCT00518115|3627173|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1
2054024|NCT00518115|3627174|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0
2054025|NCT00518115|3627175|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0
2054026|NCT00518115|3627176|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0
2054027|NCT00518115|3627177|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0
2054028|NCT00518115|3627178|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0
2054029|NCT00518115|3627179|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0
2054030|NCT00518115|3627180|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0
2054031|NCT00518115|3627181|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0
2054032|NCT00518115|3627182|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0
2054033|NCT00518115|3627173|FG000|Overall Study|Different Monotherapy Diabetic Drug|0
2054034|NCT00518115|3627174|FG001|Overall Study|Different Monotherapy Diabetic Drug|0
2054035|NCT00518115|3627175|FG002|Overall Study|Different Monotherapy Diabetic Drug|1
2054036|NCT00518115|3627176|FG003|Overall Study|Different Monotherapy Diabetic Drug|0
2054037|NCT00518115|3627177|FG004|Overall Study|Different Monotherapy Diabetic Drug|0
2054038|NCT00518115|3627178|FG005|Overall Study|Different Monotherapy Diabetic Drug|0
2054039|NCT00518115|3627179|FG006|Overall Study|Different Monotherapy Diabetic Drug|0
2054040|NCT00518115|3627180|FG007|Overall Study|Different Monotherapy Diabetic Drug|0
2054041|NCT00518115|3627181|FG008|Overall Study|Different Monotherapy Diabetic Drug|1
2054042|NCT00518115|3627182|FG009|Overall Study|Different Monotherapy Diabetic Drug|0
2054043|NCT00518115|3627173|FG000|Overall Study|Wrong Monotherapy Administered|0
2054044|NCT00518115|3627174|FG001|Overall Study|Wrong Monotherapy Administered|0
2054045|NCT00518115|3627175|FG002|Overall Study|Wrong Monotherapy Administered|1
2054046|NCT00518115|3627176|FG003|Overall Study|Wrong Monotherapy Administered|0
2054047|NCT00518115|3627177|FG004|Overall Study|Wrong Monotherapy Administered|0
2054048|NCT00518115|3627178|FG005|Overall Study|Wrong Monotherapy Administered|0
2054049|NCT00518115|3627179|FG006|Overall Study|Wrong Monotherapy Administered|1
2054050|NCT00518115|3627180|FG007|Overall Study|Wrong Monotherapy Administered|0
2054051|NCT00518115|3627181|FG008|Overall Study|Wrong Monotherapy Administered|0
2054052|NCT00518115|3627182|FG009|Overall Study|Wrong Monotherapy Administered|0
2054053|NCT00518115|3627173|FG000|Overall Study|Violation of Exclusion Criteria|0
2054054|NCT00518115|3627174|FG001|Overall Study|Violation of Exclusion Criteria|0
2054055|NCT00518115|3627175|FG002|Overall Study|Violation of Exclusion Criteria|0
2054056|NCT00518115|3627176|FG003|Overall Study|Violation of Exclusion Criteria|1
2054057|NCT00518115|3627177|FG004|Overall Study|Violation of Exclusion Criteria|0
2054058|NCT00518115|3627178|FG005|Overall Study|Violation of Exclusion Criteria|0
2054059|NCT00518115|3627179|FG006|Overall Study|Violation of Exclusion Criteria|1
2054060|NCT00518115|3627180|FG007|Overall Study|Violation of Exclusion Criteria|0
2054061|NCT00518115|3627181|FG008|Overall Study|Violation of Exclusion Criteria|0
2209430|NCT01644643|3849069|FG003|Overall Study|Other Eligibility criteria|2
2209431|NCT01644734|3849089|FG000|Overall Study|Adverse Event|4
2209432|NCT01644734|3849089|FG000|Overall Study|Lost to Follow-up|17
2209433|NCT01644734|3849089|FG000|Overall Study|Reasons other than stated above|7
2209434|NCT01644734|3849089|FG000|Overall Study|Missing documentation|238
2209435|NCT01644890|3849095|FG000|Overall Study|Adverse Event|7
2209436|NCT01644890|3849096|FG001|Overall Study|Adverse Event|20
2209437|NCT01644890|3849095|FG000|Overall Study|Death|1
2209438|NCT01644890|3849096|FG001|Overall Study|Death|3
2209439|NCT01644890|3849095|FG000|Overall Study|Physician Decision|3
2209440|NCT01644890|3849096|FG001|Overall Study|Physician Decision|9
2209441|NCT01644890|3849095|FG000|Overall Study|Protocol Violation|6
2209442|NCT01644890|3849096|FG001|Overall Study|Protocol Violation|7
2209443|NCT01644890|3849095|FG000|Overall Study|Withdrawal by Subject|19
2209444|NCT01644890|3849096|FG001|Overall Study|Withdrawal by Subject|27
2209445|NCT01644890|3849095|FG000|Overall Study|Progression Disease|160
2209446|NCT01644890|3849096|FG001|Overall Study|Progression Disease|131
2209447|NCT01644890|3849095|FG000|Overall Study|Clinical Progression|6
2209448|NCT01644890|3849096|FG001|Overall Study|Clinical Progression|6
2209449|NCT01644890|3849095|FG000|Overall Study|> 28 days since last dose of study drug|6
2209450|NCT01644890|3849096|FG001|Overall Study|> 28 days since last dose of study drug|3
2209451|NCT01644890|3849095|FG000|Overall Study|Other|8
2209452|NCT01644890|3849096|FG001|Overall Study|Other|9
2209453|NCT01645111|3849120|FG000|Overall Study|Did not require Clevidipine|15
2209454|NCT01645176|3849124|FG000|Overall Study|Lack of Efficacy|4
2209455|NCT01645176|3849124|FG000|Overall Study|did not complete final MRI|1
2209456|NCT01645280|3849133|FG000|Overall Study|Death|0
2209457|NCT01645280|3849134|FG001|Overall Study|Death|1
2209458|NCT01645280|3849135|FG002|Overall Study|Death|0
2209459|NCT01645280|3849136|FG003|Overall Study|Death|0
2209460|NCT01645280|3849137|FG004|Overall Study|Death|0
2209461|NCT01645280|3849133|FG000|Overall Study|Withdrawal by Subject|4
2209462|NCT01645280|3849134|FG001|Overall Study|Withdrawal by Subject|0
2054062|NCT00518115|3627182|FG009|Overall Study|Violation of Exclusion Criteria|0
2054063|NCT00518115|3627173|FG000|Overall Study|Family Emergency; Had to Go to England|0
2054064|NCT00518115|3627174|FG001|Overall Study|Family Emergency; Had to Go to England|0
2054065|NCT00518115|3627175|FG002|Overall Study|Family Emergency; Had to Go to England|0
2054066|NCT00518115|3627176|FG003|Overall Study|Family Emergency; Had to Go to England|0
2054067|NCT00518115|3627177|FG004|Overall Study|Family Emergency; Had to Go to England|1
2054068|NCT00518115|3627178|FG005|Overall Study|Family Emergency; Had to Go to England|0
2054069|NCT00518115|3627179|FG006|Overall Study|Family Emergency; Had to Go to England|0
2054070|NCT00518115|3627180|FG007|Overall Study|Family Emergency; Had to Go to England|0
2054071|NCT00518115|3627181|FG008|Overall Study|Family Emergency; Had to Go to England|0
2209463|NCT01645280|3849135|FG002|Overall Study|Withdrawal by Subject|2
2054072|NCT00518115|3627182|FG009|Overall Study|Family Emergency; Had to Go to England|0
2054073|NCT00518115|3627173|FG000|Overall Study|Withdrew Consent|0
2054074|NCT00518115|3627174|FG001|Overall Study|Withdrew Consent|0
2054075|NCT00518115|3627175|FG002|Overall Study|Withdrew Consent|0
2054076|NCT00518115|3627176|FG003|Overall Study|Withdrew Consent|0
2054077|NCT00518115|3627177|FG004|Overall Study|Withdrew Consent|0
2054078|NCT00518115|3627178|FG005|Overall Study|Withdrew Consent|1
2054079|NCT00518115|3627179|FG006|Overall Study|Withdrew Consent|0
2054080|NCT00518115|3627180|FG007|Overall Study|Withdrew Consent|0
2054081|NCT00518115|3627181|FG008|Overall Study|Withdrew Consent|0
2054082|NCT00518115|3627182|FG009|Overall Study|Withdrew Consent|0
2054083|NCT00518115|3627173|FG000|Overall Study|Moved Out of State|0
2054084|NCT00518115|3627174|FG001|Overall Study|Moved Out of State|0
2054085|NCT00518115|3627175|FG002|Overall Study|Moved Out of State|0
2054086|NCT00518115|3627176|FG003|Overall Study|Moved Out of State|0
2054087|NCT00518115|3627177|FG004|Overall Study|Moved Out of State|0
2054088|NCT00518115|3627178|FG005|Overall Study|Moved Out of State|0
2054089|NCT00518115|3627179|FG006|Overall Study|Moved Out of State|0
2054090|NCT00518115|3627180|FG007|Overall Study|Moved Out of State|0
2054091|NCT00518115|3627181|FG008|Overall Study|Moved Out of State|0
2054092|NCT00518115|3627182|FG009|Overall Study|Moved Out of State|1
2054093|NCT00518180|3627212|FG000|Overall Study|Withdrawal by Subject|29
2054094|NCT00518180|3627213|FG001|Overall Study|Withdrawal by Subject|30
2054095|NCT00518180|3627214|FG002|Overall Study|Withdrawal by Subject|42
2054096|NCT00518180|3627212|FG000|Overall Study|Lost to Follow-up|30
2054097|NCT00518180|3627213|FG001|Overall Study|Lost to Follow-up|28
2054098|NCT00518180|3627214|FG002|Overall Study|Lost to Follow-up|34
2054099|NCT00518180|3627212|FG000|Overall Study|Administrative reason|0
2054100|NCT00518180|3627213|FG001|Overall Study|Administrative reason|2
2054101|NCT00518180|3627214|FG002|Overall Study|Administrative reason|2
2054102|NCT00518180|3627212|FG000|Overall Study|Protocol Violation|5
2054103|NCT00518180|3627213|FG001|Overall Study|Protocol Violation|7
2054104|NCT00518180|3627214|FG002|Overall Study|Protocol Violation|4
2054105|NCT00518180|3627212|FG000|Overall Study|Unable to classify|0
2054106|NCT00518180|3627213|FG001|Overall Study|Unable to classify|2
2054107|NCT00518180|3627214|FG002|Overall Study|Unable to classify|0
2054108|NCT00518180|3627212|FG000|Overall Study|Adverse Event|1
2054109|NCT00518180|3627213|FG001|Overall Study|Adverse Event|0
2054110|NCT00518180|3627214|FG002|Overall Study|Adverse Event|0
2054111|NCT00518206|3627233|FG000|Overall Study|Disease Progression Requiring Therapy|6
2054112|NCT00518206|3627234|FG001|Overall Study|Disease Progression Requiring Therapy|6
2054113|NCT00518206|3627233|FG000|Overall Study|Withdrawal by Subject|2
2054114|NCT00518206|3627234|FG001|Overall Study|Withdrawal by Subject|0
2054115|NCT00518206|3627233|FG000|Overall Study|Drug Supply Issue|1
2054116|NCT00518206|3627234|FG001|Overall Study|Drug Supply Issue|0
2054117|NCT00518206|3627233|FG000|Overall Study|Reason Unknown|1
2054118|NCT00518206|3627234|FG001|Overall Study|Reason Unknown|0
2054119|NCT00518206|3627233|FG000|Overall Study|Completion Status Unknown|1
2054120|NCT00518206|3627234|FG001|Overall Study|Completion Status Unknown|0
2054121|NCT00518284|3627244|FG000|Overall Study|Adverse Event|0
2054122|NCT00518284|3627245|FG001|Overall Study|Adverse Event|1
2054123|NCT00518284|3627246|FG002|Overall Study|Adverse Event|0
2054124|NCT00518284|3627247|FG003|Overall Study|Adverse Event|0
2054125|NCT00518284|3627244|FG000|Overall Study|Study Termination|0
2054126|NCT00518284|3627245|FG001|Overall Study|Study Termination|2
2054127|NCT00518284|3627246|FG002|Overall Study|Study Termination|1
2054128|NCT00518284|3627247|FG003|Overall Study|Study Termination|2
2054129|NCT00518323|3627261|FG000|Overall Study|Lack of Efficacy|14
2054130|NCT00518323|3627262|FG001|Overall Study|Lack of Efficacy|2
2054131|NCT00518323|3627263|FG002|Overall Study|Lack of Efficacy|4
2054132|NCT00518323|3627264|FG003|Overall Study|Lack of Efficacy|20
2054133|NCT00518323|3627261|FG000|Overall Study|Withdrawal by Subject|1
2209464|NCT01645280|3849136|FG003|Overall Study|Withdrawal by Subject|4
2054134|NCT00518323|3627262|FG001|Overall Study|Withdrawal by Subject|2
2054135|NCT00518323|3627263|FG002|Overall Study|Withdrawal by Subject|4
2054136|NCT00518323|3627264|FG003|Overall Study|Withdrawal by Subject|2
2054137|NCT00518323|3627261|FG000|Overall Study|Lost to Follow-up|0
2054138|NCT00518323|3627262|FG001|Overall Study|Lost to Follow-up|2
2054139|NCT00518323|3627263|FG002|Overall Study|Lost to Follow-up|1
2054140|NCT00518323|3627264|FG003|Overall Study|Lost to Follow-up|3
2054141|NCT00518323|3627261|FG000|Overall Study|Adverse Event|1
2054142|NCT00518323|3627262|FG001|Overall Study|Adverse Event|1
2054143|NCT00518323|3627263|FG002|Overall Study|Adverse Event|1
2054144|NCT00518323|3627264|FG003|Overall Study|Adverse Event|0
2054145|NCT00518323|3627261|FG000|Overall Study|Prohibited medication and others|3
2054146|NCT00518323|3627262|FG001|Overall Study|Prohibited medication and others|1
2054147|NCT00518323|3627263|FG002|Overall Study|Prohibited medication and others|1
2054148|NCT00518323|3627264|FG003|Overall Study|Prohibited medication and others|0
2054149|NCT00518336|3627276|FG000|Year 7|Lost to Follow-up|2
2054150|NCT00518336|3627277|FG001|Year 7|Lost to Follow-up|0
2054151|NCT00518336|3627276|FG000|Year 7|Could not attend in time|0
2054152|NCT00518336|3627277|FG001|Year 7|Could not attend in time|3
2054153|NCT00518336|3627276|FG000|Year 8|Lost to Follow-up|1
2054154|NCT00518336|3627277|FG001|Year 8|Lost to Follow-up|1
2054155|NCT00518336|3627276|FG000|Year 8|Could not attend in time|0
2054156|NCT00518336|3627277|FG001|Year 8|Could not attend in time|1
2300865|NCT02604407|3998588|FG001|Overall Study|Lost to Follow-up|1
2300866|NCT02604407|3998589|FG002|Overall Study|Lost to Follow-up|2
2300867|NCT02604407|3998587|FG000|Overall Study|Lack of Efficacy|1
2300868|NCT02604407|3998588|FG001|Overall Study|Lack of Efficacy|0
2300869|NCT02604407|3998589|FG002|Overall Study|Lack of Efficacy|0
2300870|NCT02604407|3998587|FG000|Overall Study|Other|3
2300871|NCT02604407|3998588|FG001|Overall Study|Other|1
2300872|NCT02604407|3998589|FG002|Overall Study|Other|4
2300873|NCT02604550|3998599|FG000|Overall Study|Lost to Follow-up|7
2300874|NCT02604550|3998600|FG001|Overall Study|Lost to Follow-up|6
2300875|NCT02604550|3998599|FG000|Overall Study|Withdrawal by Subject|0
2300876|NCT02604550|3998600|FG001|Overall Study|Withdrawal by Subject|1
2300877|NCT02604550|3998599|FG000|Overall Study|Incomplete data using paper journal|18
2300878|NCT02604550|3998600|FG001|Overall Study|Incomplete data using paper journal|19
2300879|NCT02604589|3998609|FG000|Overall Study|catheter dislodgement|0
2300880|NCT02604589|3998610|FG001|Overall Study|catheter dislodgement|0
2300881|NCT02604589|3998611|FG002|Overall Study|catheter dislodgement|1
2300882|NCT02605122|3998627|FG000|Overall Study|Withdrawal by Subject|4
2300883|NCT02605122|3998628|FG001|Overall Study|Withdrawal by Subject|1
2300884|NCT02605122|3998627|FG000|Overall Study|Lost to Follow-up|1
2300885|NCT02605122|3998628|FG001|Overall Study|Lost to Follow-up|1
2300886|NCT02605174|3998638|FG000|Overall Study|Adverse Event|0
2300887|NCT02605174|3998639|FG001|Overall Study|Adverse Event|0
2300888|NCT02605174|3998640|FG002|Overall Study|Adverse Event|1
2054157|NCT00518336|3627276|FG000|Year 9|Migrated/moved from study area|1
2054158|NCT00518336|3627277|FG001|Year 9|Migrated/moved from study area|1
2054159|NCT00518336|3627276|FG000|Year 9|Lost to Follow-up|3
2054160|NCT00518336|3627277|FG001|Year 9|Lost to Follow-up|0
2054161|NCT00518336|3627276|FG000|Year 9|Personal reasons|1
2054162|NCT00518336|3627277|FG001|Year 9|Personal reasons|0
2054163|NCT00518531|3627294|FG000|Treatment Period 1|Adverse Event|5
2054164|NCT00518531|3627295|FG001|Treatment Period 1|Adverse Event|0
2054165|NCT00518531|3627294|FG000|Treatment Period 1|Lost to Follow-up|5
2054166|NCT00518531|3627295|FG001|Treatment Period 1|Lost to Follow-up|3
2054167|NCT00518531|3627294|FG000|Treatment Period 1|Physician Decision|1
2054168|NCT00518531|3627295|FG001|Treatment Period 1|Physician Decision|0
2054169|NCT00518531|3627294|FG000|Treatment Period 1|Protocol Violation|2
2054170|NCT00518531|3627295|FG001|Treatment Period 1|Protocol Violation|0
2054171|NCT00518531|3627294|FG000|Treatment Period 1|Withdrawal by Subject|4
2054172|NCT00518531|3627295|FG001|Treatment Period 1|Withdrawal by Subject|6
2054173|NCT00518531|3627294|FG000|Treatment Period 1|Early crossover|1
2054174|NCT00518531|3627295|FG001|Treatment Period 1|Early crossover|3
2054175|NCT00518531|3627294|FG000|Treatment Period 2|Withdrawal by Subject|0
2054176|NCT00518531|3627295|FG001|Treatment Period 2|Withdrawal by Subject|8
2054177|NCT00518531|3627294|FG000|Treatment Period 2|Complete out of scheduled visit window|1
2054178|NCT00518531|3627295|FG001|Treatment Period 2|Complete out of scheduled visit window|2
2054179|NCT00518531|3627294|FG000|Treatment Period 2|Adverse Event|1
2054180|NCT00518531|3627295|FG001|Treatment Period 2|Adverse Event|7
2054181|NCT00518531|3627294|FG000|Treatment Period 2|Protocol-specified criteria|0
2054182|NCT00518531|3627295|FG001|Treatment Period 2|Protocol-specified criteria|1
2054183|NCT00518531|3627294|FG000|Treatment Period 2|Non-compliance|1
2054184|NCT00518531|3627295|FG001|Treatment Period 2|Non-compliance|2
2054185|NCT00518622|3627311|FG000|Overall Study|Lost to Follow-up|0
2054186|NCT00518622|3627312|FG001|Overall Study|Lost to Follow-up|0
2054187|NCT00518622|3627313|FG002|Overall Study|Lost to Follow-up|1
2054188|NCT00518622|3627314|FG003|Overall Study|Lost to Follow-up|0
2054189|NCT00518622|3627315|FG004|Overall Study|Lost to Follow-up|0
2054190|NCT00518622|3627316|FG005|Overall Study|Lost to Follow-up|0
2054191|NCT00518622|3627317|FG006|Overall Study|Lost to Follow-up|0
2054192|NCT00518622|3627318|FG007|Overall Study|Lost to Follow-up|0
2054193|NCT00518622|3627311|FG000|Overall Study|Study medication taken incorrectly|0
2054194|NCT00518622|3627312|FG001|Overall Study|Study medication taken incorrectly|1
2054195|NCT00518622|3627313|FG002|Overall Study|Study medication taken incorrectly|0
2054196|NCT00518622|3627314|FG003|Overall Study|Study medication taken incorrectly|0
2054197|NCT00518622|3627315|FG004|Overall Study|Study medication taken incorrectly|0
2054198|NCT00518622|3627316|FG005|Overall Study|Study medication taken incorrectly|0
2054199|NCT00518622|3627317|FG006|Overall Study|Study medication taken incorrectly|0
2054200|NCT00518622|3627318|FG007|Overall Study|Study medication taken incorrectly|0
2054201|NCT00518687|3627338|FG000|Overall Study|Adverse Event|201
2054202|NCT00518687|3627339|FG001|Overall Study|Adverse Event|177
2054203|NCT00518687|3627338|FG000|Overall Study|Lost to Follow-up|144
2054204|NCT00518687|3627339|FG001|Overall Study|Lost to Follow-up|155
2054205|NCT00518687|3627338|FG000|Overall Study|Physician Decision|42
2054206|NCT00518687|3627339|FG001|Overall Study|Physician Decision|48
2054207|NCT00518687|3627338|FG000|Overall Study|Progressive disease|2
2054208|NCT00518687|3627339|FG001|Overall Study|Progressive disease|2
2054209|NCT00518687|3627338|FG000|Overall Study|Protocol Violation|8
2054210|NCT00518687|3627339|FG001|Overall Study|Protocol Violation|10
2054211|NCT00518687|3627338|FG000|Overall Study|Study terminated by sponsor|930
2054212|NCT00518687|3627339|FG001|Overall Study|Study terminated by sponsor|918
2054213|NCT00518687|3627338|FG000|Overall Study|Withdrawal by Subject|110
2300889|NCT02605174|3998641|FG003|Overall Study|Adverse Event|0
2300890|NCT02605174|3998642|FG004|Overall Study|Adverse Event|4
2300891|NCT02605174|3998643|FG005|Overall Study|Adverse Event|0
2054214|NCT00518687|3627339|FG001|Overall Study|Withdrawal by Subject|110
2054215|NCT00518882|3627364|FG000|Double-Blind, Week 0-26|Adverse Event|23
2054216|NCT00518882|3627365|FG001|Double-Blind, Week 0-26|Adverse Event|31
2054217|NCT00518882|3627364|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1
2054218|NCT00518882|3627365|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0
2054219|NCT00518882|3627364|FG000|Double-Blind, Week 0-26|Protocol Violation|4
2054220|NCT00518882|3627365|FG001|Double-Blind, Week 0-26|Protocol Violation|3
2054221|NCT00518882|3627364|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1
2054222|NCT00518882|3627365|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1
2054223|NCT00518882|3627364|FG000|Double-Blind, Week 0-26|Lost to follow up|2
2054224|NCT00518882|3627365|FG001|Double-Blind, Week 0-26|Lost to follow up|1
2054225|NCT00518882|3627364|FG000|Double-Blind, Week 0-26|Subject decision|1
2054226|NCT00518882|3627365|FG001|Double-Blind, Week 0-26|Subject decision|1
2054227|NCT00518882|3627364|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1
2054228|NCT00518882|3627365|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3
2054229|NCT00518882|3627364|FG000|Double-Blind, Week 0-26|Loss of trust|0
2054230|NCT00518882|3627365|FG001|Double-Blind, Week 0-26|Loss of trust|1
2054231|NCT00518882|3627364|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
2054232|NCT00518882|3627365|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
2054233|NCT00518882|3627364|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0
2054234|NCT00518882|3627365|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2
2054235|NCT00518882|3627364|FG000|Double-Blind, Week 0-26|Mutual consent|0
2054236|NCT00518882|3627365|FG001|Double-Blind, Week 0-26|Mutual consent|1
2054237|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Adverse Event|3
2054238|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Adverse Event|9
2054239|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6
2054240|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5
2054241|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3
2054242|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4
2054243|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1
2054244|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2
2054245|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0
2054246|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1
2054247|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1
2054248|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1
2054249|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2
2054250|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1
2054251|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Change in treatment|1
2054252|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Change in treatment|1
2209465|NCT01645280|3849137|FG004|Overall Study|Withdrawal by Subject|5
2209466|NCT01645280|3849133|FG000|Overall Study|Lost to Follow-up|0
2209467|NCT01645280|3849134|FG001|Overall Study|Lost to Follow-up|0
2209468|NCT01645280|3849135|FG002|Overall Study|Lost to Follow-up|0
2209469|NCT01645280|3849136|FG003|Overall Study|Lost to Follow-up|2
2209470|NCT01645280|3849137|FG004|Overall Study|Lost to Follow-up|1
2209471|NCT01645280|3849133|FG000|Overall Study|Other|1
2209472|NCT01645280|3849134|FG001|Overall Study|Other|1
2209473|NCT01645280|3849135|FG002|Overall Study|Other|2
2209474|NCT01645280|3849136|FG003|Overall Study|Other|0
2209475|NCT01645280|3849137|FG004|Overall Study|Other|0
2209476|NCT01645280|3849133|FG000|Overall Study|Treatment not completed/Completed f/u|1
2209477|NCT01645280|3849134|FG001|Overall Study|Treatment not completed/Completed f/u|1
2209478|NCT01645280|3849135|FG002|Overall Study|Treatment not completed/Completed f/u|2
2209479|NCT01645280|3849136|FG003|Overall Study|Treatment not completed/Completed f/u|0
2209480|NCT01645280|3849137|FG004|Overall Study|Treatment not completed/Completed f/u|2
2209481|NCT01645735|3849165|FG000|Overall Study|Physician Decision|2
2209482|NCT01645735|3849166|FG001|Overall Study|Physician Decision|0
2209483|NCT01645735|3849165|FG000|Overall Study|Withdrawal by Subject|1
2209484|NCT01645735|3849166|FG001|Overall Study|Withdrawal by Subject|0
2209485|NCT01645735|3849165|FG000|Overall Study|Protocol Violation|1
2209486|NCT01645735|3849166|FG001|Overall Study|Protocol Violation|0
2209487|NCT01645735|3849165|FG000|Overall Study|Adverse Event|0
2209488|NCT01645735|3849166|FG001|Overall Study|Adverse Event|1
2209489|NCT01645930|3849173|FG000|Overall Study|Participants Ongoing on Study Treatment|22
2209490|NCT01645930|3849173|FG000|Overall Study|Progressive Disease|12
2209491|NCT01645930|3849173|FG000|Overall Study|Adverse Event|4
2209492|NCT01645930|3849173|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
2209493|NCT01645930|3849173|FG000|Overall Study|Withdrawal by Participant|2
2209494|NCT01645930|3849173|FG000|Overall Study|Reason not Defined|1
2209495|NCT01646021|3849179|FG000|Overall Study|Death|77
2209496|NCT01646021|3849180|FG001|Overall Study|Death|83
2209497|NCT01646021|3849179|FG000|Overall Study|Study Terminated by Sponsor|50
2209498|NCT01646021|3849180|FG001|Overall Study|Study Terminated by Sponsor|41
2209499|NCT01646021|3849179|FG000|Overall Study|Lost to Follow-up|2
2209500|NCT01646021|3849180|FG001|Overall Study|Lost to Follow-up|2
2209501|NCT01646021|3849179|FG000|Overall Study|Withdrawal by Subject|10
2209502|NCT01646021|3849180|FG001|Overall Study|Withdrawal by Subject|15
2209503|NCT01646073|3849188|FG000|Period A (12 Weeks)|Adverse Event|0
2209504|NCT01646073|3849189|FG001|Period A (12 Weeks)|Adverse Event|2
2209505|NCT01646073|3849188|FG000|Period A (12 Weeks)|Withdrawal by Subject|1
2209506|NCT01646073|3849189|FG001|Period A (12 Weeks)|Withdrawal by Subject|1
2209507|NCT01646073|3849188|FG000|Period A (12 Weeks)|Lack of Efficacy|1
2209508|NCT01646073|3849189|FG001|Period A (12 Weeks)|Lack of Efficacy|0
2209509|NCT01646073|3849188|FG000|Period A (12 Weeks)|Protocol Violation|0
2209510|NCT01646073|3849189|FG001|Period A (12 Weeks)|Protocol Violation|1
2209511|NCT01646073|3849188|FG000|Period A (12 Weeks)|Other|0
2209512|NCT01646073|3849189|FG001|Period A (12 Weeks)|Other|1
2209513|NCT01646073|3849188|FG000|Period B (12 Weeks)|Adverse Event|0
2209514|NCT01646073|3849189|FG001|Period B (12 Weeks)|Adverse Event|7
2209515|NCT01646073|3849188|FG000|Period B (12 Weeks)|Withdrawal by Subject|1
2209516|NCT01646073|3849189|FG001|Period B (12 Weeks)|Withdrawal by Subject|5
2209517|NCT01646073|3849188|FG000|Period B (12 Weeks)|Lost to Follow-up|0
2209518|NCT01646073|3849189|FG001|Period B (12 Weeks)|Lost to Follow-up|1
2209519|NCT01646125|3849200|FG000|Overall Study|Untreated|2
2209520|NCT01646125|3849201|FG001|Overall Study|Untreated|5
2209521|NCT01646125|3849200|FG000|Overall Study|Adverse Event|2
2209522|NCT01646125|3849201|FG001|Overall Study|Adverse Event|1
2209523|NCT01646125|3849200|FG000|Overall Study|Death|1
2209524|NCT01646125|3849201|FG001|Overall Study|Death|1
2209525|NCT01646125|3849200|FG000|Overall Study|Physician Decision|1
2209526|NCT01646125|3849201|FG001|Overall Study|Physician Decision|3
2209527|NCT01646125|3849200|FG000|Overall Study|Progressive disease|22
2209528|NCT01646125|3849201|FG001|Overall Study|Progressive disease|16
2209529|NCT01646125|3849200|FG000|Overall Study|Study terminated by sponsor|2
2209530|NCT01646125|3849201|FG001|Overall Study|Study terminated by sponsor|1
2209531|NCT01646125|3849200|FG000|Overall Study|Subject/Guardian decision|1
2209532|NCT01646125|3849201|FG001|Overall Study|Subject/Guardian decision|1
2209533|NCT01646138|3849213|FG000|Overall Study|Lost to Follow-up|0
2209534|NCT01646138|3849214|FG001|Overall Study|Lost to Follow-up|0
2209535|NCT01646138|3849215|FG002|Overall Study|Lost to Follow-up|0
2209536|NCT01646138|3849216|FG003|Overall Study|Lost to Follow-up|0
2209537|NCT01646138|3849217|FG004|Overall Study|Lost to Follow-up|2
2209538|NCT01646177|3849237|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
2209539|NCT01646177|3849238|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
2209540|NCT01646177|3849239|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
2209541|NCT01646177|3849240|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
2209542|NCT01646177|3849241|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
2209543|NCT01646177|3849242|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
2209544|NCT01646177|3849243|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
2209545|NCT01646177|3849244|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
2209546|NCT01646177|3849245|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
2209547|NCT01646177|3849246|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
2209548|NCT01646177|3849247|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
2209549|NCT01646177|3849248|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
2209550|NCT01646177|3849237|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
2209551|NCT01646177|3849238|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
2209552|NCT01646177|3849239|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
2209553|NCT01646177|3849240|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
2209554|NCT01646177|3849241|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
2209555|NCT01646177|3849242|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
2209556|NCT01646177|3849243|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
2209557|NCT01646177|3849244|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
2209558|NCT01646177|3849245|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
2209559|NCT01646177|3849246|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
2209560|NCT01646177|3849247|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
2209561|NCT01646177|3849248|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
2209562|NCT01646177|3849237|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
2209563|NCT01646177|3849238|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
2209564|NCT01646177|3849239|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
2209565|NCT01646177|3849240|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
2209566|NCT01646177|3849241|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
2209567|NCT01646177|3849242|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
2209568|NCT01646177|3849243|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
2209569|NCT01646177|3849244|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
2209570|NCT01646177|3849245|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
2209571|NCT01646177|3849246|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
2209572|NCT01646177|3849247|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
2209573|NCT01646177|3849248|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
2209574|NCT01646177|3849237|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
2209575|NCT01646177|3849238|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
2209576|NCT01646177|3849239|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
2209577|NCT01646177|3849240|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
2209578|NCT01646177|3849241|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
2209579|NCT01646177|3849242|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
2209580|NCT01646177|3849243|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
2209581|NCT01646177|3849244|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
2209582|NCT01646177|3849245|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
2209583|NCT01646177|3849246|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
2209584|NCT01646177|3849247|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
2209585|NCT01646177|3849248|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
2209586|NCT01646177|3849237|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2209587|NCT01646177|3849238|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2209588|NCT01646177|3849239|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
2209589|NCT01646177|3849240|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
2209590|NCT01646177|3849241|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2209591|NCT01646177|3849242|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2209592|NCT01646177|3849243|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2209593|NCT01646177|3849244|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2209594|NCT01646177|3849245|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2209595|NCT01646177|3849246|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2209596|NCT01646177|3849247|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2054253|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Creatine increased|1
2054254|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Creatine increased|0
2054255|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1
2054256|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0
2054257|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2
2054258|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0
2054259|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Subject decision|2
2054260|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Subject decision|0
2054261|NCT00518882|3627364|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
2054262|NCT00518882|3627365|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
2054263|NCT00518973|3627373|FG000|Overall Study|Withdrawal by Subject|3
2054264|NCT00518973|3627374|FG001|Overall Study|Withdrawal by Subject|2
2054265|NCT00518986|3627382|FG000|Overall Study|Adverse Event|12
2054266|NCT00518986|3627383|FG001|Overall Study|Adverse Event|7
2054267|NCT00518986|3627382|FG000|Overall Study|Lack of Efficacy|0
2054268|NCT00518986|3627383|FG001|Overall Study|Lack of Efficacy|2
2054269|NCT00518986|3627382|FG000|Overall Study|Lost to Follow-up|3
2054270|NCT00518986|3627383|FG001|Overall Study|Lost to Follow-up|2
2054271|NCT00518986|3627382|FG000|Overall Study|Physician Decision|0
2054272|NCT00518986|3627383|FG001|Overall Study|Physician Decision|3
2054273|NCT00518986|3627382|FG000|Overall Study|Protocol Violation|5
2054274|NCT00518986|3627383|FG001|Overall Study|Protocol Violation|7
2054275|NCT00518986|3627382|FG000|Overall Study|Withdrawal by Subject|4
2054276|NCT00518986|3627383|FG001|Overall Study|Withdrawal by Subject|4
2054277|NCT00518986|3627382|FG000|Overall Study|Non-Specific|2
2054278|NCT00518986|3627383|FG001|Overall Study|Non-Specific|1
2054279|NCT00519077|3627389|FG000|Overall Study|Death|6
2054280|NCT00519077|3627389|FG000|Overall Study|Other|2
2054281|NCT00519194|3627393|FG000|Overall Study|Withdrawal by Subject|9
2054282|NCT00519194|3627393|FG000|Overall Study|Death|9
2054283|NCT00519194|3627393|FG000|Overall Study|Lost to Follow-up|3
2054284|NCT00519285|3627399|FG000|Overall Study|Adverse Event|127
2054285|NCT00519285|3627400|FG001|Overall Study|Adverse Event|266
2054286|NCT00519285|3627399|FG000|Overall Study|Disease progression|334
2054287|NCT00519285|3627400|FG001|Overall Study|Disease progression|186
2054288|NCT00519285|3627399|FG000|Overall Study|Physician Decision|75
2054289|NCT00519285|3627400|FG001|Overall Study|Physician Decision|47
2054290|NCT00519285|3627399|FG000|Overall Study|Participant's request|53
2054291|NCT00519285|3627400|FG001|Overall Study|Participant's request|84
2054292|NCT00519285|3627399|FG000|Overall Study|Consent withdrawn|4
2054293|NCT00519285|3627400|FG001|Overall Study|Consent withdrawn|5
2054294|NCT00519285|3627399|FG000|Overall Study|Poor compliance to protocol|5
2054295|NCT00519285|3627400|FG001|Overall Study|Poor compliance to protocol|7
2054296|NCT00519285|3627399|FG000|Overall Study|Reason unspecified|5
2054297|NCT00519285|3627400|FG001|Overall Study|Reason unspecified|8
2054298|NCT00519285|3627399|FG000|Overall Study|Not treated|8
2054299|NCT00519285|3627400|FG001|Overall Study|Not treated|7
2054300|NCT00519285|3627399|FG000|Overall Study|Treatment ongoing|1
2054301|NCT00519285|3627400|FG001|Overall Study|Treatment ongoing|2
2054302|NCT00519376|3627406|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054303|NCT00519376|3627407|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054304|NCT00519376|3627408|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054305|NCT00519376|3627409|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054306|NCT00519376|3627410|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054307|NCT00519376|3627411|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054308|NCT00519376|3627412|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054309|NCT00519376|3627413|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054310|NCT00519376|3627414|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054311|NCT00519376|3627415|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054312|NCT00519376|3627416|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054313|NCT00519376|3627417|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054314|NCT00519376|3627418|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
2054315|NCT00519376|3627419|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054316|NCT00519376|3627420|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054317|NCT00519376|3627421|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2054318|NCT00519376|3627406|FG000|Treatment Period 4|Lost to Follow-up|0
2054319|NCT00519376|3627407|FG001|Treatment Period 4|Lost to Follow-up|0
2054320|NCT00519376|3627408|FG002|Treatment Period 4|Lost to Follow-up|1
2054321|NCT00519376|3627409|FG003|Treatment Period 4|Lost to Follow-up|0
2054322|NCT00519376|3627410|FG004|Treatment Period 4|Lost to Follow-up|0
2054323|NCT00519376|3627411|FG005|Treatment Period 4|Lost to Follow-up|0
2054324|NCT00519376|3627412|FG006|Treatment Period 4|Lost to Follow-up|0
2054325|NCT00519376|3627413|FG007|Treatment Period 4|Lost to Follow-up|0
2054326|NCT00519376|3627414|FG008|Treatment Period 4|Lost to Follow-up|0
2054327|NCT00519376|3627415|FG009|Treatment Period 4|Lost to Follow-up|0
2054328|NCT00519376|3627416|FG010|Treatment Period 4|Lost to Follow-up|0
2054329|NCT00519376|3627417|FG011|Treatment Period 4|Lost to Follow-up|0
2054330|NCT00519376|3627418|FG012|Treatment Period 4|Lost to Follow-up|0
2054331|NCT00519376|3627419|FG013|Treatment Period 4|Lost to Follow-up|0
2054332|NCT00519376|3627420|FG014|Treatment Period 4|Lost to Follow-up|0
2054333|NCT00519376|3627421|FG015|Treatment Period 4|Lost to Follow-up|0
2054334|NCT00519428|3627436|FG000|Overall Study|Adverse Event|5
2054335|NCT00519428|3627437|FG001|Overall Study|Adverse Event|2
2054336|NCT00519428|3627438|FG002|Overall Study|Adverse Event|10
2054337|NCT00519428|3627436|FG000|Overall Study|Lost to Follow-up|7
2054338|NCT00519428|3627437|FG001|Overall Study|Lost to Follow-up|7
2054339|NCT00519428|3627438|FG002|Overall Study|Lost to Follow-up|6
2054340|NCT00519428|3627436|FG000|Overall Study|Withdrawal by Subject|8
2054341|NCT00519428|3627437|FG001|Overall Study|Withdrawal by Subject|3
2054342|NCT00519428|3627438|FG002|Overall Study|Withdrawal by Subject|7
2209597|NCT01646177|3849248|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2209598|NCT01646177|3849237|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
2209599|NCT01646177|3849238|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
2209600|NCT01646177|3849239|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
2209601|NCT01646177|3849240|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
2209602|NCT01646177|3849241|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
2054343|NCT00519428|3627436|FG000|Overall Study|unstated|1
2054344|NCT00519428|3627437|FG001|Overall Study|unstated|3
2054345|NCT00519428|3627438|FG002|Overall Study|unstated|2
2054346|NCT00519532|3627449|FG000|Overall Study|Adverse Event|11
2054347|NCT00519532|3627449|FG000|Overall Study|Withdrawal by Subject|5
2054348|NCT00519532|3627449|FG000|Overall Study|Lost to Follow-up|2
2054349|NCT00519623|3627470|FG000|Overall Study|Adverse Event|1
2054350|NCT00519636|3627478|FG000|Treatment Period 1|Adverse Event|1
2054351|NCT00519636|3627479|FG001|Treatment Period 1|Adverse Event|0
2054352|NCT00519636|3627480|FG002|Treatment Period 1|Adverse Event|1
2054353|NCT00519636|3627481|FG003|Treatment Period 1|Adverse Event|0
2054354|NCT00519636|3627478|FG000|Treatment Period 1|Sponsor request due to missed visit|1
2054355|NCT00519636|3627479|FG001|Treatment Period 1|Sponsor request due to missed visit|0
2054356|NCT00519636|3627480|FG002|Treatment Period 1|Sponsor request due to missed visit|0
2054357|NCT00519636|3627481|FG003|Treatment Period 1|Sponsor request due to missed visit|0
2054358|NCT00519636|3627478|FG000|Washout Period|Adverse Event|2
2054359|NCT00519636|3627479|FG001|Washout Period|Adverse Event|1
2054360|NCT00519636|3627480|FG002|Washout Period|Adverse Event|1
2054361|NCT00519636|3627481|FG003|Washout Period|Adverse Event|0
2054362|NCT00519636|3627478|FG000|Washout Period|Lost to Follow-up|1
2054363|NCT00519636|3627479|FG001|Washout Period|Lost to Follow-up|0
2054364|NCT00519636|3627480|FG002|Washout Period|Lost to Follow-up|0
2054365|NCT00519636|3627481|FG003|Washout Period|Lost to Follow-up|0
2054366|NCT00519636|3627478|FG000|Washout Period|Protocol Violation|0
2054367|NCT00519636|3627479|FG001|Washout Period|Protocol Violation|0
2054368|NCT00519636|3627480|FG002|Washout Period|Protocol Violation|1
2054369|NCT00519636|3627481|FG003|Washout Period|Protocol Violation|2
2054370|NCT00519636|3627478|FG000|Washout Period|Withdrawal by Subject|1
2054371|NCT00519636|3627479|FG001|Washout Period|Withdrawal by Subject|0
2054372|NCT00519636|3627480|FG002|Washout Period|Withdrawal by Subject|1
2054373|NCT00519636|3627481|FG003|Washout Period|Withdrawal by Subject|0
2054374|NCT00519636|3627478|FG000|Washout Period|Failed to meet continuation criteria|14
2054375|NCT00519636|3627479|FG001|Washout Period|Failed to meet continuation criteria|11
2054376|NCT00519636|3627480|FG002|Washout Period|Failed to meet continuation criteria|9
2054377|NCT00519636|3627481|FG003|Washout Period|Failed to meet continuation criteria|3
2054378|NCT00519636|3627478|FG000|Washout Period|Out of pollen area > 48 hours|1
2054379|NCT00519636|3627479|FG001|Washout Period|Out of pollen area > 48 hours|0
2054380|NCT00519636|3627480|FG002|Washout Period|Out of pollen area > 48 hours|0
2054381|NCT00519636|3627481|FG003|Washout Period|Out of pollen area > 48 hours|0
2054382|NCT00519636|3627478|FG000|Washout Period|Participating in study at another site|1
2054383|NCT00519636|3627479|FG001|Washout Period|Participating in study at another site|0
2054384|NCT00519636|3627480|FG002|Washout Period|Participating in study at another site|0
2054385|NCT00519636|3627481|FG003|Washout Period|Participating in study at another site|0
2054386|NCT00519636|3627478|FG000|Washout Period|Non-compliant|0
2054387|NCT00519636|3627479|FG001|Washout Period|Non-compliant|1
2054388|NCT00519636|3627480|FG002|Washout Period|Non-compliant|0
2054389|NCT00519636|3627481|FG003|Washout Period|Non-compliant|0
2054390|NCT00519636|3627478|FG000|Washout Period|Per doctors request|0
2054391|NCT00519636|3627479|FG001|Washout Period|Per doctors request|1
2054392|NCT00519636|3627480|FG002|Washout Period|Per doctors request|0
2054393|NCT00519636|3627481|FG003|Washout Period|Per doctors request|0
2054394|NCT00519636|3627478|FG000|Washout Period|Subject randomized in error|0
2054395|NCT00519636|3627479|FG001|Washout Period|Subject randomized in error|0
2054396|NCT00519636|3627480|FG002|Washout Period|Subject randomized in error|1
2054397|NCT00519636|3627481|FG003|Washout Period|Subject randomized in error|0
2054398|NCT00519636|3627478|FG000|Washout Period|Prohibited medications|0
2054399|NCT00519636|3627479|FG001|Washout Period|Prohibited medications|0
2054400|NCT00519636|3627480|FG002|Washout Period|Prohibited medications|1
2054401|NCT00519636|3627481|FG003|Washout Period|Prohibited medications|0
2054402|NCT00519636|3627478|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0
2054403|NCT00519636|3627479|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0
2054404|NCT00519636|3627480|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0
2054405|NCT00519636|3627481|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1
2054406|NCT00519636|3627478|FG000|Treatment Period 2|Subject randomized in error|0
2054407|NCT00519636|3627479|FG001|Treatment Period 2|Subject randomized in error|1
2054408|NCT00519636|3627480|FG002|Treatment Period 2|Subject randomized in error|0
2054409|NCT00519636|3627481|FG003|Treatment Period 2|Subject randomized in error|0
2054410|NCT00519636|3627478|FG000|Treatment Period 2|Per doctors request|0
2054411|NCT00519636|3627479|FG001|Treatment Period 2|Per doctors request|0
2054412|NCT00519636|3627480|FG002|Treatment Period 2|Per doctors request|1
2054413|NCT00519636|3627481|FG003|Treatment Period 2|Per doctors request|0
2054414|NCT00519636|3627478|FG000|Treatment Period 2|Subject misrandomized|0
2054415|NCT00519636|3627479|FG001|Treatment Period 2|Subject misrandomized|0
2054416|NCT00519636|3627480|FG002|Treatment Period 2|Subject misrandomized|0
2054417|NCT00519636|3627481|FG003|Treatment Period 2|Subject misrandomized|1
2054418|NCT00519636|3627478|FG000|Post Study Period|Subject randomized in error|0
2054419|NCT00519636|3627479|FG001|Post Study Period|Subject randomized in error|0
2054420|NCT00519636|3627480|FG002|Post Study Period|Subject randomized in error|0
2054421|NCT00519636|3627481|FG003|Post Study Period|Subject randomized in error|1
2054422|NCT00519649|3627495|FG000|Overall Study|Withdrawal by Subject|1
2054423|NCT00519779|3627501|FG000|Overall Study|Withdrawal by Subject|0
2054424|NCT00519779|3627502|FG001|Overall Study|Withdrawal by Subject|1
2054425|NCT00519831|3627514|FG000|Overall Study|Adverse Event|3
2054426|NCT00519896|3627518|FG000|Overall Study|Protocol Violation|1
2054427|NCT00519896|3627518|FG000|Overall Study|Adverse Event|1
2054428|NCT00520013|3627525|FG000|Overall Study|Withdrawal by Subject|0
2054429|NCT00520013|3627526|FG001|Overall Study|Withdrawal by Subject|0
2054430|NCT00520013|3627527|FG002|Overall Study|Withdrawal by Subject|1
2054431|NCT00520013|3627525|FG000|Overall Study|Adverse Event|2
2054432|NCT00520013|3627526|FG001|Overall Study|Adverse Event|10
2054433|NCT00520013|3627527|FG002|Overall Study|Adverse Event|7
2054434|NCT00520013|3627525|FG000|Overall Study|Progressive Disease|7
2054435|NCT00520013|3627526|FG001|Overall Study|Progressive Disease|3
2054436|NCT00520013|3627527|FG002|Overall Study|Progressive Disease|0
2054437|NCT00520013|3627525|FG000|Overall Study|Clinical Progression|3
2054438|NCT00520013|3627526|FG001|Overall Study|Clinical Progression|1
2054439|NCT00520013|3627527|FG002|Overall Study|Clinical Progression|0
2054440|NCT00520013|3627525|FG000|Overall Study|Death|0
2054441|NCT00520013|3627526|FG001|Overall Study|Death|1
2054442|NCT00520013|3627527|FG002|Overall Study|Death|0
2054443|NCT00520013|3627525|FG000|Overall Study|Physician Decision|0
2054444|NCT00520013|3627526|FG001|Overall Study|Physician Decision|0
2054445|NCT00520013|3627527|FG002|Overall Study|Physician Decision|3
2054446|NCT00520039|3627535|FG000|Overall Study|Exclusion criteria met at first visit|7
2054447|NCT00520039|3627536|FG001|Overall Study|Exclusion criteria met at first visit|5
2054448|NCT00520130|3627546|FG000|Overall Study|Disease progression on study|4
2054449|NCT00520130|3627547|FG001|Overall Study|Disease progression on study|0
2054450|NCT00520130|3627546|FG000|Overall Study|Physician Decision|1
2054451|NCT00520130|3627547|FG001|Overall Study|Physician Decision|1
2054452|NCT00520299|3627579|FG000|Overall Study|Withdrawal by Subject|0
2054453|NCT00520299|3627580|FG001|Overall Study|Withdrawal by Subject|0
2054454|NCT00520299|3627581|FG002|Overall Study|Withdrawal by Subject|2
2054455|NCT00520299|3627579|FG000|Overall Study|Progressive disease|0
2054456|NCT00520299|3627580|FG001|Overall Study|Progressive disease|3
2054457|NCT00520299|3627581|FG002|Overall Study|Progressive disease|4
2054458|NCT00520351|3627591|FG000|First Intervention|Withdrawal by Subject|1
2054459|NCT00520351|3627592|FG001|First Intervention|Withdrawal by Subject|1
2054460|NCT00520403|3627598|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
2054461|NCT00520403|3627598|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4
2054462|NCT00520403|3627598|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
2054463|NCT00520403|3627598|FG000|Bevacizumab + IFN/Vinblastine|Death|2
2054464|NCT00520403|3627598|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
2177075|NCT01371656|3801160|FG000|Overall Study|Death|7
2177076|NCT01371656|3801161|FG001|Overall Study|Death|4
2054465|NCT00520403|3627598|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
2054466|NCT00520403|3627598|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1
2054467|NCT00520403|3627598|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
2054468|NCT00520481|3627608|FG000|Overall Study|Adverse Event|4
2054469|NCT00520481|3627609|FG001|Overall Study|Adverse Event|1
2054470|NCT00520481|3627608|FG000|Overall Study|Withdrawal by Subject|3
2054471|NCT00520481|3627609|FG001|Overall Study|Withdrawal by Subject|0
2054472|NCT00520494|3627617|FG000|Overall Study|Withdrawal by Subject|1
2054473|NCT00520533|3627621|FG000|Overall Study|Death|1
2054474|NCT00520533|3627621|FG000|Overall Study|Suspension of the study for safety reasons|1
2054475|NCT00520533|3627621|FG000|Overall Study|Withdrawal by Subject|1
2054476|NCT00520533|3627621|FG000|Overall Study|Physician Decision|1
2054477|NCT00520546|3627626|FG000|Overall Study|Withdrawal by Subject|1
2054478|NCT00520546|3627626|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5
2054479|NCT00520572|3627641|FG000|Overall Study|Adverse Event|9
2054480|NCT00520572|3627642|FG001|Overall Study|Adverse Event|3
2054481|NCT00520572|3627643|FG002|Overall Study|Adverse Event|6
2054482|NCT00520572|3627644|FG003|Overall Study|Adverse Event|9
2054483|NCT00520572|3627645|FG004|Overall Study|Adverse Event|7
2054484|NCT00520572|3627646|FG005|Overall Study|Adverse Event|2
2054485|NCT00520572|3627641|FG000|Overall Study|Withdrawal by Subject|0
2054486|NCT00520572|3627642|FG001|Overall Study|Withdrawal by Subject|9
2054487|NCT00520572|3627643|FG002|Overall Study|Withdrawal by Subject|5
2054488|NCT00520572|3627644|FG003|Overall Study|Withdrawal by Subject|2
2054489|NCT00520572|3627645|FG004|Overall Study|Withdrawal by Subject|2
2054490|NCT00520572|3627646|FG005|Overall Study|Withdrawal by Subject|0
2054491|NCT00520572|3627641|FG000|Overall Study|Protocol Violation|0
2054492|NCT00520572|3627642|FG001|Overall Study|Protocol Violation|0
2054493|NCT00520572|3627643|FG002|Overall Study|Protocol Violation|1
2054494|NCT00520572|3627644|FG003|Overall Study|Protocol Violation|0
2054495|NCT00520572|3627645|FG004|Overall Study|Protocol Violation|0
2054496|NCT00520572|3627646|FG005|Overall Study|Protocol Violation|0
2054497|NCT00520572|3627641|FG000|Overall Study|Lack of Efficacy|1
2054498|NCT00520572|3627642|FG001|Overall Study|Lack of Efficacy|1
2054499|NCT00520572|3627643|FG002|Overall Study|Lack of Efficacy|1
2054500|NCT00520572|3627644|FG003|Overall Study|Lack of Efficacy|2
2054501|NCT00520572|3627645|FG004|Overall Study|Lack of Efficacy|1
2054502|NCT00520572|3627646|FG005|Overall Study|Lack of Efficacy|0
2054503|NCT00520572|3627641|FG000|Overall Study|Lost to Follow-up|0
2054504|NCT00520572|3627642|FG001|Overall Study|Lost to Follow-up|0
2054505|NCT00520572|3627643|FG002|Overall Study|Lost to Follow-up|0
2054506|NCT00520572|3627644|FG003|Overall Study|Lost to Follow-up|0
2054507|NCT00520572|3627645|FG004|Overall Study|Lost to Follow-up|1
2054508|NCT00520572|3627646|FG005|Overall Study|Lost to Follow-up|0
2054509|NCT00520572|3627641|FG000|Overall Study|Incorrect enrollment|1
2054510|NCT00520572|3627642|FG001|Overall Study|Incorrect enrollment|0
2054511|NCT00520572|3627643|FG002|Overall Study|Incorrect enrollment|1
2054512|NCT00520572|3627644|FG003|Overall Study|Incorrect enrollment|0
2054513|NCT00520572|3627645|FG004|Overall Study|Incorrect enrollment|1
2054514|NCT00520572|3627646|FG005|Overall Study|Incorrect enrollment|0
2054515|NCT00520572|3627641|FG000|Overall Study|Oral corticotherapy for acute urticaria|0
2054516|NCT00520572|3627642|FG001|Overall Study|Oral corticotherapy for acute urticaria|1
2054517|NCT00520572|3627643|FG002|Overall Study|Oral corticotherapy for acute urticaria|0
2054518|NCT00520572|3627644|FG003|Overall Study|Oral corticotherapy for acute urticaria|0
2054519|NCT00520572|3627645|FG004|Overall Study|Oral corticotherapy for acute urticaria|0
2054520|NCT00520572|3627646|FG005|Overall Study|Oral corticotherapy for acute urticaria|0
2054521|NCT00520572|3627641|FG000|Overall Study|Long break in taking Medication|0
2054522|NCT00520572|3627642|FG001|Overall Study|Long break in taking Medication|0
2054523|NCT00520572|3627643|FG002|Overall Study|Long break in taking Medication|0
2054524|NCT00520572|3627644|FG003|Overall Study|Long break in taking Medication|1
2054525|NCT00520572|3627645|FG004|Overall Study|Long break in taking Medication|0
2054526|NCT00520572|3627646|FG005|Overall Study|Long break in taking Medication|0
2054527|NCT00520572|3627641|FG000|Overall Study|Did not receive Treatment|1
2054528|NCT00520572|3627642|FG001|Overall Study|Did not receive Treatment|0
2054529|NCT00520572|3627643|FG002|Overall Study|Did not receive Treatment|1
2054530|NCT00520572|3627644|FG003|Overall Study|Did not receive Treatment|0
2054531|NCT00520572|3627645|FG004|Overall Study|Did not receive Treatment|0
2054532|NCT00520572|3627646|FG005|Overall Study|Did not receive Treatment|0
2054533|NCT00520676|3627662|FG000|Overall Study|Death|84
2054534|NCT00520676|3627663|FG001|Overall Study|Death|81
2054535|NCT00520676|3627662|FG000|Overall Study|Lost to Follow-up|6
2054536|NCT00520676|3627663|FG001|Overall Study|Lost to Follow-up|10
2054537|NCT00520676|3627662|FG000|Overall Study|Physician Decision|4
2054538|NCT00520676|3627663|FG001|Overall Study|Physician Decision|1
2054539|NCT00520676|3627662|FG000|Overall Study|Withdrawal by Subject|7
2054540|NCT00520676|3627663|FG001|Overall Study|Withdrawal by Subject|11
2054541|NCT00520741|3627671|FG000|Overall Study|Adverse Event|16
2054542|NCT00520741|3627672|FG001|Overall Study|Adverse Event|56
2054543|NCT00520741|3627671|FG000|Overall Study|Lack of Efficacy|11
2054544|NCT00520741|3627672|FG001|Overall Study|Lack of Efficacy|30
2054545|NCT00520741|3627671|FG000|Overall Study|Withdrawal by Subject|0
2054546|NCT00520741|3627672|FG001|Overall Study|Withdrawal by Subject|11
2054547|NCT00520741|3627671|FG000|Overall Study|Protocol Violation|2
2054548|NCT00520741|3627672|FG001|Overall Study|Protocol Violation|15
2054549|NCT00520741|3627671|FG000|Overall Study|Unsatisfactory compliance of subject|4
2054550|NCT00520741|3627672|FG001|Overall Study|Unsatisfactory compliance of subject|3
2054551|NCT00520741|3627671|FG000|Overall Study|Lost to Follow-up|4
2054552|NCT00520741|3627672|FG001|Overall Study|Lost to Follow-up|4
2054553|NCT00520741|3627671|FG000|Overall Study|Other reasons for premature termination|0
2054554|NCT00520741|3627672|FG001|Overall Study|Other reasons for premature termination|6
2054555|NCT00520767|3627680|FG000|Overall Study|Death|2
2054556|NCT00520845|3627684|FG000|Overall Study|Death|3
2054557|NCT00520845|3627684|FG000|Overall Study|Adverse Event|4
2054558|NCT00520845|3627684|FG000|Overall Study|Disease Progression, relapse|13
2054559|NCT00520845|3627684|FG000|Overall Study|Withdrawal by Subject|1
2054560|NCT00520845|3627684|FG000|Overall Study|Alternative Therapy|1
2054561|NCT00520936|3627717|FG000|Overall Study|Physician Decision|0
2054562|NCT00520936|3627718|FG001|Overall Study|Physician Decision|2
2054563|NCT00520936|3627719|FG002|Overall Study|Physician Decision|1
2054564|NCT00520936|3627720|FG003|Overall Study|Physician Decision|0
2054565|NCT00520936|3627721|FG004|Overall Study|Physician Decision|0
2054566|NCT00520936|3627722|FG005|Overall Study|Physician Decision|0
2054567|NCT00520936|3627723|FG006|Overall Study|Physician Decision|0
2054568|NCT00520936|3627724|FG007|Overall Study|Physician Decision|0
2054569|NCT00520936|3627717|FG000|Overall Study|Withdrawal by Subject|0
2054570|NCT00520936|3627718|FG001|Overall Study|Withdrawal by Subject|0
2054571|NCT00520936|3627719|FG002|Overall Study|Withdrawal by Subject|0
2054572|NCT00520936|3627720|FG003|Overall Study|Withdrawal by Subject|0
2054573|NCT00520936|3627721|FG004|Overall Study|Withdrawal by Subject|0
2054574|NCT00520936|3627722|FG005|Overall Study|Withdrawal by Subject|0
2054575|NCT00520936|3627723|FG006|Overall Study|Withdrawal by Subject|0
2054576|NCT00520936|3627724|FG007|Overall Study|Withdrawal by Subject|1
2054577|NCT00520936|3627717|FG000|Overall Study|Toxicity Requiring Removal from Study|0
2054578|NCT00520936|3627718|FG001|Overall Study|Toxicity Requiring Removal from Study|1
2054579|NCT00520936|3627719|FG002|Overall Study|Toxicity Requiring Removal from Study|0
2054580|NCT00520936|3627720|FG003|Overall Study|Toxicity Requiring Removal from Study|0
2054581|NCT00520936|3627721|FG004|Overall Study|Toxicity Requiring Removal from Study|0
2054582|NCT00520936|3627722|FG005|Overall Study|Toxicity Requiring Removal from Study|0
2054583|NCT00520936|3627723|FG006|Overall Study|Toxicity Requiring Removal from Study|2
2054584|NCT00520936|3627724|FG007|Overall Study|Toxicity Requiring Removal from Study|0
2054585|NCT00520936|3627717|FG000|Overall Study|Death|0
2054586|NCT00520936|3627718|FG001|Overall Study|Death|0
2054587|NCT00520936|3627719|FG002|Overall Study|Death|0
2054588|NCT00520936|3627720|FG003|Overall Study|Death|0
2054589|NCT00520936|3627721|FG004|Overall Study|Death|0
2054590|NCT00520936|3627722|FG005|Overall Study|Death|0
2054591|NCT00520936|3627723|FG006|Overall Study|Death|1
2054592|NCT00520936|3627724|FG007|Overall Study|Death|0
2054593|NCT00520936|3627717|FG000|Overall Study|Protocol Violation|0
2054594|NCT00520936|3627718|FG001|Overall Study|Protocol Violation|1
2054595|NCT00520936|3627719|FG002|Overall Study|Protocol Violation|1
2054596|NCT00520936|3627720|FG003|Overall Study|Protocol Violation|0
2054597|NCT00520936|3627721|FG004|Overall Study|Protocol Violation|1
2054598|NCT00520936|3627722|FG005|Overall Study|Protocol Violation|0
2054599|NCT00520936|3627723|FG006|Overall Study|Protocol Violation|1
2054600|NCT00520936|3627724|FG007|Overall Study|Protocol Violation|0
2054601|NCT00520975|3627737|FG000|Overall Study|Disease progression|31
2209603|NCT01646177|3849242|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
2209604|NCT01646177|3849243|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
2209605|NCT01646177|3849244|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
2209606|NCT01646177|3849245|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
2209607|NCT01646177|3849246|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
2209608|NCT01646177|3849247|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
2209609|NCT01646177|3849248|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
2209610|NCT01646177|3849237|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0
2209611|NCT01646177|3849238|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0
2209612|NCT01646177|3849239|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0
2209613|NCT01646177|3849240|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0
2209614|NCT01646177|3849241|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16
2217678|NCT01709305|3860928|FG000|Phase 2|Clinical Adverse Event|0
2054602|NCT00520975|3627738|FG001|Overall Study|Disease progression|23
2054603|NCT00520975|3627737|FG000|Overall Study|Adverse Event|7
2054604|NCT00520975|3627738|FG001|Overall Study|Adverse Event|10
2054605|NCT00520975|3627737|FG000|Overall Study|Death|0
2054606|NCT00520975|3627738|FG001|Overall Study|Death|2
2054607|NCT00520975|3627737|FG000|Overall Study|Withdrawal by Subject|3
2054608|NCT00520975|3627738|FG001|Overall Study|Withdrawal by Subject|5
2054609|NCT00520975|3627737|FG000|Overall Study|Other therapy|2
2054610|NCT00520975|3627738|FG001|Overall Study|Other therapy|4
2054611|NCT00520975|3627737|FG000|Overall Study|Other reasons|4
2054612|NCT00520975|3627738|FG001|Overall Study|Other reasons|2
2054613|NCT00520975|3627737|FG000|Overall Study|Not start protocol therapy|1
2054614|NCT00520975|3627738|FG001|Overall Study|Not start protocol therapy|2
2054615|NCT00521001|3627744|FG000|Overall Study|Ineligible|1
2054616|NCT00521014|3627748|FG000|Overall Study|Inevaluable, not treated|1
2054617|NCT00521053|3627752|FG000|Observation Phase|Disease Progression|55
2054618|NCT00521053|3627752|FG000|Observation Phase|Additional PV-10 via alternate protocol|8
2054619|NCT00521053|3627752|FG000|Observation Phase|Death|2
2054620|NCT00521053|3627752|FG000|Observation Phase|Adverse Event|1
2054621|NCT00521053|3627752|FG000|Observation Phase|Other non-study melanoma treatment|1
2054622|NCT00521053|3627752|FG000|Observation Phase|Physician Decision|1
2054623|NCT00521079|3627761|FG000|Overall Study|Adverse Event|7
2054624|NCT00521079|3627762|FG001|Overall Study|Adverse Event|1
2054625|NCT00521079|3627761|FG000|Overall Study|Lost to Follow-up|2
2054626|NCT00521079|3627762|FG001|Overall Study|Lost to Follow-up|1
2054627|NCT00521079|3627761|FG000|Overall Study|Withdrawal by Subject|5
2054628|NCT00521079|3627762|FG001|Overall Study|Withdrawal by Subject|3
2054629|NCT00521144|3627773|FG000|Overall Study|Not Treated|0
2054630|NCT00521144|3627774|FG001|Overall Study|Not Treated|0
2054631|NCT00521144|3627775|FG002|Overall Study|Not Treated|0
2054632|NCT00521144|3627776|FG003|Overall Study|Not Treated|1
2054633|NCT00521144|3627777|FG004|Overall Study|Not Treated|0
2054634|NCT00521144|3627773|FG000|Overall Study|Adverse Event|0
2054635|NCT00521144|3627774|FG001|Overall Study|Adverse Event|1
2054636|NCT00521144|3627775|FG002|Overall Study|Adverse Event|0
2054637|NCT00521144|3627776|FG003|Overall Study|Adverse Event|0
2054638|NCT00521144|3627777|FG004|Overall Study|Adverse Event|1
2054639|NCT00521144|3627773|FG000|Overall Study|Progressive Disease|4
2054640|NCT00521144|3627774|FG001|Overall Study|Progressive Disease|2
2054641|NCT00521144|3627775|FG002|Overall Study|Progressive Disease|2
2054642|NCT00521144|3627776|FG003|Overall Study|Progressive Disease|0
2054643|NCT00521144|3627777|FG004|Overall Study|Progressive Disease|6
2105460|NCT00856986|3698010|FG004|Main Period, Weeks 0-26|Unclassified|0
2105461|NCT00856986|3698006|FG000|Extension Period, Weeks 26-52|Adverse Event|3
2105462|NCT00856986|3698007|FG001|Extension Period, Weeks 26-52|Adverse Event|3
2105463|NCT00856986|3698008|FG002|Extension Period, Weeks 26-52|Adverse Event|10
2105464|NCT00856986|3698009|FG003|Extension Period, Weeks 26-52|Adverse Event|0
2105465|NCT00856986|3698010|FG004|Extension Period, Weeks 26-52|Adverse Event|0
2105466|NCT00856986|3698006|FG000|Extension Period, Weeks 26-52|Protocol Violation|6
2105467|NCT00856986|3698007|FG001|Extension Period, Weeks 26-52|Protocol Violation|2
2105468|NCT00856986|3698008|FG002|Extension Period, Weeks 26-52|Protocol Violation|5
2105469|NCT00856986|3698009|FG003|Extension Period, Weeks 26-52|Protocol Violation|0
2105470|NCT00856986|3698010|FG004|Extension Period, Weeks 26-52|Protocol Violation|0
2105471|NCT00856986|3698006|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2
2105472|NCT00856986|3698007|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0
2105473|NCT00856986|3698008|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8
2105474|NCT00856986|3698009|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0
2105475|NCT00856986|3698010|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0
2105476|NCT00856986|3698006|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0
2105477|NCT00856986|3698007|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5
2105478|NCT00856986|3698008|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2
2105479|NCT00856986|3698009|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0
2105480|NCT00856986|3698010|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0
2105481|NCT00856986|3698006|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4
2105482|NCT00856986|3698007|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2
2105483|NCT00856986|3698008|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2
2105484|NCT00856986|3698009|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0
2105485|NCT00856986|3698010|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0
2105486|NCT00856986|3698006|FG000|Extension Period, Weeks 26-52|Unclassified|4
2105487|NCT00856986|3698007|FG001|Extension Period, Weeks 26-52|Unclassified|2
2105488|NCT00856986|3698008|FG002|Extension Period, Weeks 26-52|Unclassified|11
2105489|NCT00856986|3698009|FG003|Extension Period, Weeks 26-52|Unclassified|0
2105490|NCT00856986|3698010|FG004|Extension Period, Weeks 26-52|Unclassified|0
2105491|NCT00856999|3698022|FG000|Overall Study|Withdrawal by Subject|5
2105492|NCT00857207|3698029|FG000|Overall Study|Withdrawal by Subject|13
2105493|NCT00857207|3698030|FG001|Overall Study|Withdrawal by Subject|0
2105494|NCT00857207|3698029|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18
2105495|NCT00857207|3698030|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0
2105496|NCT00857207|3698029|FG000|Overall Study|Subject chose not to participate after signing consent|3
2105497|NCT00857207|3698030|FG001|Overall Study|Subject chose not to participate after signing consent|0
2105498|NCT00857220|3698037|FG000|Overall Study|Adverse Event|35
2105499|NCT00857220|3698037|FG000|Overall Study|Death|1
2105500|NCT00857220|3698037|FG000|Overall Study|Lack of Efficacy|11
2105501|NCT00857220|3698037|FG000|Overall Study|Lost to Follow-up|30
2105502|NCT00857220|3698037|FG000|Overall Study|Physician Decision|4
2105503|NCT00857220|3698037|FG000|Overall Study|Protocol Violation|16
2105504|NCT00857220|3698037|FG000|Overall Study|Withdrawal by Subject|67
2105505|NCT00857220|3698037|FG000|Overall Study|Clinical Hold|6
2105506|NCT00857220|3698037|FG000|Overall Study|Site Closed|5
2209615|NCT01646177|3849242|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34
2209616|NCT01646177|3849243|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43
2209617|NCT01646177|3849244|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30
2105507|NCT00857220|3698037|FG000|Overall Study|Miscellaneous|8
2054644|NCT00521339|3627789|FG000|Treatment Phase|Adverse Event|2
2054645|NCT00521339|3627790|FG001|Treatment Phase|Adverse Event|0
2054646|NCT00521339|3627791|FG002|Treatment Phase|Adverse Event|0
2054647|NCT00521339|3627789|FG000|Treatment Phase|Intolerability to study drug|2
2054648|NCT00521339|3627790|FG001|Treatment Phase|Intolerability to study drug|0
2054649|NCT00521339|3627791|FG002|Treatment Phase|Intolerability to study drug|0
2054650|NCT00521339|3627789|FG000|Treatment Phase|Lack of Efficacy|3
2054651|NCT00521339|3627790|FG001|Treatment Phase|Lack of Efficacy|0
2054652|NCT00521339|3627791|FG002|Treatment Phase|Lack of Efficacy|0
2054653|NCT00521339|3627789|FG000|Treatment Phase|Withdrawal by Subject|3
2054654|NCT00521339|3627790|FG001|Treatment Phase|Withdrawal by Subject|0
2054655|NCT00521339|3627791|FG002|Treatment Phase|Withdrawal by Subject|0
2054656|NCT00521339|3627789|FG000|Treatment Phase|Lost to Follow-up|1
2054657|NCT00521339|3627790|FG001|Treatment Phase|Lost to Follow-up|0
2054658|NCT00521339|3627791|FG002|Treatment Phase|Lost to Follow-up|0
2054659|NCT00521339|3627789|FG000|Treatment Phase|Protocol Violation|1
2054660|NCT00521339|3627790|FG001|Treatment Phase|Protocol Violation|0
2054661|NCT00521339|3627791|FG002|Treatment Phase|Protocol Violation|0
2054662|NCT00521339|3627789|FG000|Treatment Extension Phase|Withdrawal by Subject|0
2054663|NCT00521339|3627790|FG001|Treatment Extension Phase|Withdrawal by Subject|0
2054664|NCT00521339|3627791|FG002|Treatment Extension Phase|Withdrawal by Subject|2
2054665|NCT00521339|3627789|FG000|Treatment Extension Phase|Death|0
2054666|NCT00521339|3627790|FG001|Treatment Extension Phase|Death|0
2054667|NCT00521339|3627791|FG002|Treatment Extension Phase|Death|1
2054668|NCT00521365|3627821|FG000|Overall Study|Adverse Event|3
2054669|NCT00521365|3627821|FG000|Overall Study|Lost to Follow-up|6
2054670|NCT00521365|3627821|FG000|Overall Study|Protocol deviation|2
2054671|NCT00521365|3627821|FG000|Overall Study|Drug compliance|3
2054672|NCT00521365|3627821|FG000|Overall Study|Usage of not allowed drugs|6
2054673|NCT00521404|3627825|FG000|Overall Study|Adverse Event|13
2054674|NCT00521404|3627825|FG000|Overall Study|Disease Progression|33
2054675|NCT00521404|3627825|FG000|Overall Study|Investigator decision|5
2054676|NCT00521404|3627825|FG000|Overall Study|Withdrawal of consent|3
2054677|NCT00521404|3627825|FG000|Overall Study|Noncompliance or lack of cooperation|1
2054678|NCT00521404|3627825|FG000|Overall Study|Other|7
2054679|NCT00521586|3627840|FG000|Initial Vaccination (Year 0)|Subject request|8
2054680|NCT00521586|3627841|FG001|Initial Vaccination (Year 0)|Subject request|11
2054681|NCT00521586|3627840|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5
2054682|NCT00521586|3627841|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10
2054683|NCT00521586|3627840|FG000|Initial Vaccination (Year 0)|Protocol Violation|2
2054684|NCT00521586|3627841|FG001|Initial Vaccination (Year 0)|Protocol Violation|5
2054685|NCT00521586|3627840|FG000|Initial Vaccination (Year 0)|Other, unspecified|3
2054686|NCT00521586|3627841|FG001|Initial Vaccination (Year 0)|Other, unspecified|1
2054687|NCT00521586|3627840|FG000|Initial Vaccination (Year 0)|Investigator request|2
2054688|NCT00521586|3627841|FG001|Initial Vaccination (Year 0)|Investigator request|0
2054689|NCT00521586|3627840|FG000|Initial Vaccination (Year 0)|Adverse Event|0
2054690|NCT00521586|3627841|FG001|Initial Vaccination (Year 0)|Adverse Event|1
2054691|NCT00521586|3627840|FG000|Initial Vaccination (Year 0)|Death|1
2054692|NCT00521586|3627841|FG001|Initial Vaccination (Year 0)|Death|0
2054693|NCT00521586|3627840|FG000|Initial Vaccination (Year 0)|Failed to return|0
2054694|NCT00521586|3627841|FG001|Initial Vaccination (Year 0)|Failed to return|1
2054695|NCT00521586|3627840|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
2054696|NCT00521586|3627841|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
2054697|NCT00521586|3627840|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
2054698|NCT00521586|3627841|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
2054699|NCT00521586|3627840|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
2054700|NCT00521586|3627841|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
2054701|NCT00521586|3627840|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
2054702|NCT00521586|3627841|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
2054703|NCT00521586|3627840|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
2054704|NCT00521586|3627841|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
2054705|NCT00521586|3627840|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
2054706|NCT00521586|3627841|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
2054707|NCT00521586|3627840|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
2054708|NCT00521586|3627841|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
2054709|NCT00521586|3627840|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
2054710|NCT00521586|3627841|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
2054711|NCT00521586|3627840|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0
2054712|NCT00521586|3627841|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1
2177077|NCT01371656|3801160|FG000|Overall Study|Physician Decision|46
2177078|NCT01371656|3801161|FG001|Overall Study|Physician Decision|7
2177079|NCT01371656|3801160|FG000|Overall Study|Withdrawal by Subject|7
2177080|NCT01371656|3801161|FG001|Overall Study|Withdrawal by Subject|0
2177081|NCT01371656|3801160|FG000|Overall Study|Ineligible|4
2177082|NCT01371656|3801161|FG001|Overall Study|Ineligible|3
2177083|NCT01371708|3801170|FG000|Overall Study|Insufficient clinical response|3
2177084|NCT01371708|3801171|FG001|Overall Study|Insufficient clinical response|2
2177085|NCT01371708|3801172|FG002|Overall Study|Insufficient clinical response|0
2300892|NCT02605174|3998644|FG006|Overall Study|Adverse Event|0
2300893|NCT02605174|3998638|FG000|Overall Study|Lost to Follow-up|20
2300894|NCT02605174|3998639|FG001|Overall Study|Lost to Follow-up|7
2300895|NCT02605174|3998640|FG002|Overall Study|Lost to Follow-up|27
2300896|NCT02605174|3998641|FG003|Overall Study|Lost to Follow-up|10
2300897|NCT02605174|3998642|FG004|Overall Study|Lost to Follow-up|20
2300898|NCT02605174|3998643|FG005|Overall Study|Lost to Follow-up|10
2300899|NCT02605174|3998644|FG006|Overall Study|Lost to Follow-up|29
2300900|NCT02605174|3998638|FG000|Overall Study|Protocol Violation|10
2300901|NCT02605174|3998639|FG001|Overall Study|Protocol Violation|4
2300902|NCT02605174|3998640|FG002|Overall Study|Protocol Violation|14
2300903|NCT02605174|3998641|FG003|Overall Study|Protocol Violation|6
2300904|NCT02605174|3998642|FG004|Overall Study|Protocol Violation|7
2300905|NCT02605174|3998643|FG005|Overall Study|Protocol Violation|7
2300906|NCT02605174|3998644|FG006|Overall Study|Protocol Violation|12
2054713|NCT00521586|3627840|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1
2054714|NCT00521586|3627841|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4
2054715|NCT00521586|3627840|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
2054716|NCT00521586|3627841|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
2054717|NCT00522041|3627886|FG000|Overall Study|Adverse Event|9
2054718|NCT00522041|3627887|FG001|Overall Study|Adverse Event|3
2054719|NCT00522041|3627886|FG000|Overall Study|Protocol Violation|2
2054720|NCT00522041|3627887|FG001|Overall Study|Protocol Violation|0
2054721|NCT00522041|3627886|FG000|Overall Study|Lost to Follow-up|1
2054722|NCT00522041|3627887|FG001|Overall Study|Lost to Follow-up|4
2054723|NCT00522041|3627886|FG000|Overall Study|Voluntary withdrawal|5
2054724|NCT00522041|3627887|FG001|Overall Study|Voluntary withdrawal|4
2054725|NCT00522041|3627886|FG000|Overall Study|Did not receive treatment|0
2054726|NCT00522041|3627887|FG001|Overall Study|Did not receive treatment|1
2054727|NCT00522275|3627903|FG000|Overall Study|Adverse Event|35
2054728|NCT00522275|3627903|FG000|Overall Study|Lack of Efficacy|80
2054729|NCT00522275|3627903|FG000|Overall Study|Subject withdrew consent|16
2054730|NCT00522275|3627903|FG000|Overall Study|Protocol deviation|1
2054731|NCT00522275|3627903|FG000|Overall Study|Unsatisfactory compliance|11
2054732|NCT00522275|3627903|FG000|Overall Study|Lost to Follow-up|8
2054733|NCT00522275|3627903|FG000|Overall Study|Other: Subject wants to become pregnant|2
2054734|NCT00522275|3627903|FG000|Overall Study|Other: Subject is pregnant|2
2054735|NCT00522275|3627903|FG000|Overall Study|Other: Subject relocated|2
2054736|NCT00522275|3627903|FG000|Overall Study|Other: Subject arrested|1
2054737|NCT00522275|3627903|FG000|Overall Study|Other: Site / clinic closed|4
2054738|NCT00522275|3627903|FG000|Overall Study|Other: Travel to / from site difficulty|3
2054739|NCT00522275|3627903|FG000|Overall Study|Other: Sponsor request|2
2054740|NCT00522275|3627903|FG000|Overall Study|Other: Subject ran out of medication|1
2054741|NCT00522275|3627903|FG000|Overall Study|Other: Subject had surgery for epilepsy|2
2054742|NCT00522379|3627912|FG000|Overall Study|Adverse Event|12
2054743|NCT00522379|3627913|FG001|Overall Study|Adverse Event|15
2054744|NCT00522379|3627914|FG002|Overall Study|Adverse Event|12
2054745|NCT00522379|3627915|FG003|Overall Study|Adverse Event|5
2054746|NCT00522379|3627916|FG004|Overall Study|Adverse Event|17
2054747|NCT00522379|3627912|FG000|Overall Study|Lack of Efficacy|3
2054748|NCT00522379|3627913|FG001|Overall Study|Lack of Efficacy|0
2054749|NCT00522379|3627914|FG002|Overall Study|Lack of Efficacy|2
2054750|NCT00522379|3627915|FG003|Overall Study|Lack of Efficacy|2
2054751|NCT00522379|3627916|FG004|Overall Study|Lack of Efficacy|7
2054752|NCT00522379|3627912|FG000|Overall Study|Withdrawal by Subject|2
2054753|NCT00522379|3627913|FG001|Overall Study|Withdrawal by Subject|3
2054754|NCT00522379|3627914|FG002|Overall Study|Withdrawal by Subject|1
2054755|NCT00522379|3627915|FG003|Overall Study|Withdrawal by Subject|2
2054756|NCT00522379|3627916|FG004|Overall Study|Withdrawal by Subject|0
2054757|NCT00522379|3627912|FG000|Overall Study|Protocol Violation|1
2054758|NCT00522379|3627913|FG001|Overall Study|Protocol Violation|1
2054759|NCT00522379|3627914|FG002|Overall Study|Protocol Violation|2
2054760|NCT00522379|3627915|FG003|Overall Study|Protocol Violation|0
2054761|NCT00522379|3627916|FG004|Overall Study|Protocol Violation|0
2054762|NCT00522379|3627912|FG000|Overall Study|Unsatisfactory Subject Compliance|1
2054763|NCT00522379|3627913|FG001|Overall Study|Unsatisfactory Subject Compliance|2
2054764|NCT00522379|3627914|FG002|Overall Study|Unsatisfactory Subject Compliance|0
2054765|NCT00522379|3627915|FG003|Overall Study|Unsatisfactory Subject Compliance|0
2054766|NCT00522379|3627916|FG004|Overall Study|Unsatisfactory Subject Compliance|0
2054767|NCT00522379|3627912|FG000|Overall Study|Lost to Follow-up|1
2054768|NCT00522379|3627913|FG001|Overall Study|Lost to Follow-up|0
2054769|NCT00522379|3627914|FG002|Overall Study|Lost to Follow-up|4
2054770|NCT00522379|3627915|FG003|Overall Study|Lost to Follow-up|2
2054771|NCT00522379|3627916|FG004|Overall Study|Lost to Follow-up|2
2054772|NCT00522379|3627912|FG000|Overall Study|Randomization error|0
2054773|NCT00522379|3627913|FG001|Overall Study|Randomization error|0
2054774|NCT00522379|3627914|FG002|Overall Study|Randomization error|0
2054775|NCT00522379|3627915|FG003|Overall Study|Randomization error|0
2054776|NCT00522379|3627916|FG004|Overall Study|Randomization error|1
2054777|NCT00522379|3627912|FG000|Overall Study|Dispensing error|1
2054778|NCT00522379|3627913|FG001|Overall Study|Dispensing error|0
2054779|NCT00522379|3627914|FG002|Overall Study|Dispensing error|0
2054780|NCT00522379|3627915|FG003|Overall Study|Dispensing error|1
2300907|NCT02605174|3998638|FG000|Overall Study|Pregnancy|1
2054781|NCT00522379|3627916|FG004|Overall Study|Dispensing error|0
2054782|NCT00522379|3627912|FG000|Overall Study|Subject Moved|1
2054783|NCT00522379|3627913|FG001|Overall Study|Subject Moved|1
2054784|NCT00522379|3627914|FG002|Overall Study|Subject Moved|0
2054785|NCT00522379|3627915|FG003|Overall Study|Subject Moved|0
2054786|NCT00522379|3627916|FG004|Overall Study|Subject Moved|0
2054787|NCT00522379|3627912|FG000|Overall Study|Sponsor Request|0
2054788|NCT00522379|3627913|FG001|Overall Study|Sponsor Request|1
2054789|NCT00522379|3627914|FG002|Overall Study|Sponsor Request|0
2054790|NCT00522379|3627915|FG003|Overall Study|Sponsor Request|0
2054791|NCT00522379|3627916|FG004|Overall Study|Sponsor Request|0
2217679|NCT01709305|3860929|FG001|Phase 2|Clinical Adverse Event|10
2054792|NCT00522379|3627912|FG000|Overall Study|Family Problem|0
2054793|NCT00522379|3627913|FG001|Overall Study|Family Problem|0
2054794|NCT00522379|3627914|FG002|Overall Study|Family Problem|1
2054795|NCT00522379|3627915|FG003|Overall Study|Family Problem|0
2054796|NCT00522379|3627916|FG004|Overall Study|Family Problem|0
2054797|NCT00522379|3627912|FG000|Overall Study|Site Closed|0
2054798|NCT00522379|3627913|FG001|Overall Study|Site Closed|0
2054799|NCT00522379|3627914|FG002|Overall Study|Site Closed|0
2054800|NCT00522379|3627915|FG003|Overall Study|Site Closed|1
2054801|NCT00522379|3627916|FG004|Overall Study|Site Closed|0
2054802|NCT00522379|3627912|FG000|Overall Study|Subject Withdrawal|0
2054803|NCT00522379|3627913|FG001|Overall Study|Subject Withdrawal|0
2054804|NCT00522379|3627914|FG002|Overall Study|Subject Withdrawal|0
2054805|NCT00522379|3627915|FG003|Overall Study|Subject Withdrawal|1
2054806|NCT00522379|3627916|FG004|Overall Study|Subject Withdrawal|0
2054807|NCT00522392|3627930|FG000|Overall Study|Disease progression|0
2054808|NCT00522392|3627931|FG001|Overall Study|Disease progression|3
2054809|NCT00522392|3627930|FG000|Overall Study|Adverse Event|7
2054810|NCT00522392|3627931|FG001|Overall Study|Adverse Event|7
2054811|NCT00522392|3627930|FG000|Overall Study|Withdrawal by Subject|1
2054812|NCT00522392|3627931|FG001|Overall Study|Withdrawal by Subject|1
2054813|NCT00522392|3627930|FG000|Overall Study|Physician Decision|0
2054814|NCT00522392|3627931|FG001|Overall Study|Physician Decision|1
2054815|NCT00522392|3627930|FG000|Overall Study|Non-compliance|0
2054816|NCT00522392|3627931|FG001|Overall Study|Non-compliance|1
2054817|NCT00522418|3627939|FG000|Overall Study|Local IRB Consent Violation|5
2054818|NCT00522418|3627940|FG001|Overall Study|Local IRB Consent Violation|5
2054819|NCT00522418|3627939|FG000|Overall Study|Early Study Termination|46
2054820|NCT00522418|3627940|FG001|Overall Study|Early Study Termination|47
2054821|NCT00522418|3627939|FG000|Overall Study|Noncompliance|2
2054822|NCT00522418|3627940|FG001|Overall Study|Noncompliance|2
2054823|NCT00522418|3627939|FG000|Overall Study|Reason Not Specified|3
2054824|NCT00522418|3627940|FG001|Overall Study|Reason Not Specified|1
2054825|NCT00522418|3627939|FG000|Overall Study|Consent Withdraw|1
2054826|NCT00522418|3627940|FG001|Overall Study|Consent Withdraw|2
2054827|NCT00522418|3627939|FG000|Overall Study|Lack of Efficacy|0
2054828|NCT00522418|3627940|FG001|Overall Study|Lack of Efficacy|1
2054829|NCT00522431|3627948|FG000|Overall Study|Adverse Event|5
2054830|NCT00522431|3627948|FG000|Overall Study|Protocol Violation|2
2054831|NCT00522431|3627948|FG000|Overall Study|Withdrawal by Subject|2
2054832|NCT00522431|3627948|FG000|Overall Study|Subject non-compliance|1
2054833|NCT00522431|3627948|FG000|Overall Study|Other/unknown|1
2054834|NCT00522548|3627954|FG000|Overall Study|Adverse Event|2
2054835|NCT00522548|3627955|FG001|Overall Study|Adverse Event|2
2054836|NCT00522548|3627954|FG000|Overall Study|Withdrawal by Subject|0
2054837|NCT00522548|3627955|FG001|Overall Study|Withdrawal by Subject|2
2054838|NCT00522626|3627961|FG000|Overall Study|Lost to Follow-up|7
2054839|NCT00522873|3627971|FG000|Overall Study|Adverse Event|41
2054840|NCT00522873|3627972|FG001|Overall Study|Adverse Event|26
2054841|NCT00522873|3627971|FG000|Overall Study|Withdrawal by Subject|20
2054842|NCT00522873|3627972|FG001|Overall Study|Withdrawal by Subject|9
2054843|NCT00522873|3627971|FG000|Overall Study|Protocol Violation|14
2054844|NCT00522873|3627972|FG001|Overall Study|Protocol Violation|4
2054845|NCT00522873|3627971|FG000|Overall Study|Lost to Follow-up|11
2054846|NCT00522873|3627972|FG001|Overall Study|Lost to Follow-up|3
2054847|NCT00522873|3627971|FG000|Overall Study|Personal Reasons|8
2054848|NCT00522873|3627972|FG001|Overall Study|Personal Reasons|1
2054849|NCT00522873|3627971|FG000|Overall Study|Medication Errors|1
2054850|NCT00522873|3627972|FG001|Overall Study|Medication Errors|1
2054851|NCT00522873|3627971|FG000|Overall Study|Never Received Medication|1
2054852|NCT00522873|3627972|FG001|Overall Study|Never Received Medication|0
2054853|NCT00522951|3627991|FG000|Period 1|body motion|0
2054854|NCT00522951|3627992|FG001|Period 1|body motion|1
2054855|NCT00522951|3627991|FG000|Washout Period|Adverse Event|0
2054856|NCT00522951|3627992|FG001|Washout Period|Adverse Event|1
2054857|NCT00522951|3627991|FG000|Washout Period|Death|0
2054858|NCT00522951|3627992|FG001|Washout Period|Death|1
2054859|NCT00522951|3627991|FG000|Period 2|Withdrawal by Subject|1
2054860|NCT00522951|3627992|FG001|Period 2|Withdrawal by Subject|0
2054861|NCT00522951|3627991|FG000|Period 2|residual contrast medium|1
2054862|NCT00522951|3627992|FG001|Period 2|residual contrast medium|1
2054863|NCT00523341|3628017|FG000|Overall Study|Withdrawal by Subject|399
2054864|NCT00523341|3628018|FG001|Overall Study|Withdrawal by Subject|427
2054865|NCT00523341|3628017|FG000|Overall Study|Other|181
2054866|NCT00523341|3628018|FG001|Overall Study|Other|198
2054867|NCT00523341|3628017|FG000|Overall Study|Adverse Event|122
2054868|NCT00523341|3628018|FG001|Overall Study|Adverse Event|155
2054869|NCT00523341|3628017|FG000|Overall Study|Death|101
2054870|NCT00523341|3628018|FG001|Overall Study|Death|110
2054871|NCT00523341|3628017|FG000|Overall Study|Lost to Follow-up|73
2054872|NCT00523341|3628018|FG001|Overall Study|Lost to Follow-up|61
2054873|NCT00523341|3628017|FG000|Overall Study|Non-compliance|20
2054874|NCT00523341|3628018|FG001|Overall Study|Non-compliance|13
2054875|NCT00523341|3628017|FG000|Overall Study|Physician Decision|14
2054876|NCT00523341|3628018|FG001|Overall Study|Physician Decision|13
2054877|NCT00523341|3628017|FG000|Overall Study|Requirement for Alternative Therapy|4
2054878|NCT00523341|3628018|FG001|Overall Study|Requirement for Alternative Therapy|14
2054879|NCT00523341|3628017|FG000|Overall Study|Protocol Deviation|6
2054880|NCT00523341|3628018|FG001|Overall Study|Protocol Deviation|5
2054881|NCT00523341|3628017|FG000|Overall Study|Ineligibility Determined|3
2054882|NCT00523341|3628018|FG001|Overall Study|Ineligibility Determined|4
2054883|NCT00523341|3628017|FG000|Overall Study|Disease Progression|1
2054884|NCT00523341|3628018|FG001|Overall Study|Disease Progression|0
2054885|NCT00523367|3628024|FG000|Overall Study|19 screen failures|19
2054886|NCT00523367|3628024|FG000|Overall Study|4 Withdrawn by PI|4
2054887|NCT00523419|3628028|FG000|Overall Study|Adverse Event|1
2054888|NCT00523419|3628028|FG000|Overall Study|Withdrawal by Subject|1
2054889|NCT00523419|3628028|FG000|Overall Study|Physician Decision|2
2054890|NCT00523419|3628028|FG000|Overall Study|Progressive Disease|22
2054891|NCT00523419|3628028|FG000|Overall Study|Death due to Study Disease|4
2054892|NCT00523419|3628028|FG000|Overall Study|Death due to Adverse Event|2
2054893|NCT00523549|3628034|FG000|Overall Study|Adverse Event|6
2054894|NCT00523549|3628035|FG001|Overall Study|Adverse Event|3
2054895|NCT00523549|3628034|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2054896|NCT00523549|3628035|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2054897|NCT00523549|3628034|FG000|Overall Study|Protocol Deviation|3
2054898|NCT00523549|3628035|FG001|Overall Study|Protocol Deviation|1
2054899|NCT00523549|3628034|FG000|Overall Study|Patient withdrew consent|7
2054900|NCT00523549|3628035|FG001|Overall Study|Patient withdrew consent|6
2054901|NCT00523549|3628034|FG000|Overall Study|Lost to Follow-up|3
2054902|NCT00523549|3628035|FG001|Overall Study|Lost to Follow-up|5
2054903|NCT00523640|3628050|FG000|Overall Study|Death|1
2054904|NCT00523705|3628056|FG000|Overall Study|No time for study.|0
2054905|NCT00523705|3628057|FG001|Overall Study|No time for study.|1
2054906|NCT00523718|3628065|FG000|Overall Study|Withdrawal by Subject|1
2054907|NCT00523718|3628066|FG001|Overall Study|Withdrawal by Subject|0
2054908|NCT00523718|3628065|FG000|Overall Study|Protocol Violation|2
2054909|NCT00523718|3628066|FG001|Overall Study|Protocol Violation|0
2054910|NCT00523744|3628072|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
2054911|NCT00523744|3628072|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
2054912|NCT00523744|3628072|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
2054913|NCT00523744|3628072|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
2054914|NCT00523744|3628072|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
2054915|NCT00523744|3628072|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
2054916|NCT00523848|3628079|FG000|Overall Study|Adverse Event|11
2054917|NCT00523848|3628079|FG000|Overall Study|Withdrawal by Subject|2
2054918|NCT00523848|3628079|FG000|Overall Study|NOT TREATED (Became ineligible)|2
2054919|NCT00523848|3628079|FG000|Overall Study|Disease Progression|5
2054920|NCT00523848|3628079|FG000|Overall Study|Other, unspecified|4
2054921|NCT00523978|3628085|FG000|Overall Study|Withdrawal by Subject|3
2054922|NCT00523978|3628086|FG001|Overall Study|Withdrawal by Subject|7
2054923|NCT00523978|3628085|FG000|Overall Study|Screen Failures|5
2054924|NCT00523978|3628086|FG001|Overall Study|Screen Failures|1
2054925|NCT00523978|3628085|FG000|Overall Study|Death|1
2054926|NCT00523978|3628086|FG001|Overall Study|Death|0
2054927|NCT00523991|3628095|FG000|Overall Study|Adverse Event|6
2054928|NCT00523991|3628096|FG001|Overall Study|Adverse Event|5
2054929|NCT00523991|3628095|FG000|Overall Study|Protocol Violation|1
2054930|NCT00523991|3628096|FG001|Overall Study|Protocol Violation|4
2054931|NCT00523991|3628095|FG000|Overall Study|Lost to Follow-up|4
2054932|NCT00523991|3628096|FG001|Overall Study|Lost to Follow-up|1
2054933|NCT00523991|3628095|FG000|Overall Study|Withdrawal by Subject|7
2054934|NCT00523991|3628096|FG001|Overall Study|Withdrawal by Subject|17
2054935|NCT00523991|3628095|FG000|Overall Study|Other reason (not specified)|3
2054936|NCT00523991|3628096|FG001|Overall Study|Other reason (not specified)|0
2054937|NCT00524030|3628113|FG000|Overall Study|Lack of Efficacy|10
2054938|NCT00524030|3628114|FG001|Overall Study|Lack of Efficacy|24
2054939|NCT00524030|3628113|FG000|Overall Study|Lost to Follow-up|0
2054940|NCT00524030|3628114|FG001|Overall Study|Lost to Follow-up|2
2054941|NCT00524030|3628113|FG000|Overall Study|Withdrawal by Subject|3
2054942|NCT00524030|3628114|FG001|Overall Study|Withdrawal by Subject|8
2054943|NCT00524030|3628113|FG000|Overall Study|Noncompliance/Investigator discretion|0
2054944|NCT00524030|3628114|FG001|Overall Study|Noncompliance/Investigator discretion|2
2054945|NCT00524030|3628113|FG000|Overall Study|Protocol Violation|0
2054946|NCT00524030|3628114|FG001|Overall Study|Protocol Violation|1
2054947|NCT00524030|3628113|FG000|Overall Study|Pregnancy|1
2054948|NCT00524030|3628114|FG001|Overall Study|Pregnancy|0
2054949|NCT00524030|3628113|FG000|Overall Study|Adverse Event|3
2054950|NCT00524030|3628114|FG001|Overall Study|Adverse Event|21
2054951|NCT00524030|3628113|FG000|Overall Study|Death|0
2054952|NCT00524030|3628114|FG001|Overall Study|Death|1
2054953|NCT00524043|3628124|FG000|Overall Study|Lack of Efficacy|15
2054954|NCT00524043|3628125|FG001|Overall Study|Lack of Efficacy|13
2054955|NCT00524043|3628126|FG002|Overall Study|Lack of Efficacy|14
2054956|NCT00524043|3628124|FG000|Overall Study|Withdrawal by Subject|5
2054957|NCT00524043|3628125|FG001|Overall Study|Withdrawal by Subject|7
2054958|NCT00524043|3628126|FG002|Overall Study|Withdrawal by Subject|7
2054959|NCT00524043|3628124|FG000|Overall Study|Adverse Event|5
2054960|NCT00524043|3628125|FG001|Overall Study|Adverse Event|2
2054961|NCT00524043|3628126|FG002|Overall Study|Adverse Event|7
2054962|NCT00524043|3628124|FG000|Overall Study|Lost to Follow-up|3
2054963|NCT00524043|3628125|FG001|Overall Study|Lost to Follow-up|5
2054964|NCT00524043|3628126|FG002|Overall Study|Lost to Follow-up|3
2054965|NCT00524043|3628124|FG000|Overall Study|Various (eg, incarceration)|2
2054966|NCT00524043|3628125|FG001|Overall Study|Various (eg, incarceration)|1
2054967|NCT00524043|3628126|FG002|Overall Study|Various (eg, incarceration)|0
2054968|NCT00524121|3628134|FG000|Overall Study|Disease progression|6
2054969|NCT00524121|3628134|FG000|Overall Study|Adverse Event|4
2054970|NCT00524121|3628134|FG000|Overall Study|Patient refused|2
2054971|NCT00524121|3628134|FG000|Overall Study|Other|1
2054972|NCT00524121|3628134|FG000|Overall Study|Death|1
2054973|NCT00524121|3628134|FG000|Overall Study|Not treated (became ineligible)|4
2054974|NCT00524121|3628134|FG000|Overall Study|Not treated (changed mind)|1
2054975|NCT00524173|3628151|FG000|Overall Study|Lost to Follow-up|0
2054976|NCT00524173|3628152|FG001|Overall Study|Lost to Follow-up|1
2054977|NCT00524173|3628151|FG000|Overall Study|Death|1
2054978|NCT00524173|3628152|FG001|Overall Study|Death|0
2054979|NCT00524173|3628151|FG000|Overall Study|Had not reached endpoint at study close|4
2054980|NCT00524173|3628152|FG001|Overall Study|Had not reached endpoint at study close|1
2054981|NCT00524303|3628175|FG000|Overall Study|Lost to Follow-up|6
2054982|NCT00524303|3628176|FG001|Overall Study|Lost to Follow-up|0
2054983|NCT00524303|3628177|FG002|Overall Study|Lost to Follow-up|3
2054984|NCT00524303|3628175|FG000|Overall Study|Protocol Violation|0
2054985|NCT00524303|3628176|FG001|Overall Study|Protocol Violation|1
2054986|NCT00524303|3628177|FG002|Overall Study|Protocol Violation|1
2054987|NCT00524303|3628175|FG000|Overall Study|Withdrawal by Subject|3
2054988|NCT00524303|3628176|FG001|Overall Study|Withdrawal by Subject|0
2054989|NCT00524303|3628177|FG002|Overall Study|Withdrawal by Subject|4
2054990|NCT00524303|3628175|FG000|Overall Study|Death|0
2054991|NCT00524303|3628176|FG001|Overall Study|Death|2
2054992|NCT00524303|3628177|FG002|Overall Study|Death|3
2054993|NCT00524303|3628175|FG000|Overall Study|Adverse Event|1
2054994|NCT00524303|3628176|FG001|Overall Study|Adverse Event|2
2054995|NCT00524303|3628177|FG002|Overall Study|Adverse Event|3
2054996|NCT00524303|3628175|FG000|Overall Study|Did not Complete Study Dosing|1
2054997|NCT00524303|3628176|FG001|Overall Study|Did not Complete Study Dosing|0
2054998|NCT00524303|3628177|FG002|Overall Study|Did not Complete Study Dosing|0
2054999|NCT00524303|3628175|FG000|Overall Study|Worsening Peripheral Neuropathy|1
2055000|NCT00524303|3628176|FG001|Overall Study|Worsening Peripheral Neuropathy|0
2055001|NCT00524303|3628177|FG002|Overall Study|Worsening Peripheral Neuropathy|0
2055002|NCT00524303|3628175|FG000|Overall Study|Disease Progression|0
2055003|NCT00524303|3628176|FG001|Overall Study|Disease Progression|4
2055004|NCT00524303|3628177|FG002|Overall Study|Disease Progression|1
2055005|NCT00524303|3628175|FG000|Overall Study|Disease Recurrence|0
2055006|NCT00524303|3628176|FG001|Overall Study|Disease Recurrence|1
2055007|NCT00524303|3628177|FG002|Overall Study|Disease Recurrence|0
2055008|NCT00524303|3628175|FG000|Overall Study|Sponsor Request|0
2055009|NCT00524303|3628176|FG001|Overall Study|Sponsor Request|0
2055010|NCT00524303|3628177|FG002|Overall Study|Sponsor Request|1
2055011|NCT00524303|3628175|FG000|Overall Study|Physician Decision|0
2055012|NCT00524303|3628176|FG001|Overall Study|Physician Decision|0
2055013|NCT00524303|3628177|FG002|Overall Study|Physician Decision|1
2055014|NCT00524303|3628175|FG000|Overall Study|Completed 5 years|0
2055015|NCT00524303|3628176|FG001|Overall Study|Completed 5 years|0
2055016|NCT00524303|3628177|FG002|Overall Study|Completed 5 years|1
2055017|NCT00524316|3628188|FG000|Overall Study|Withdrawal by Subject|2
2055018|NCT00524316|3628188|FG000|Overall Study|Adverse Event|7
2055019|NCT00524316|3628188|FG000|Overall Study|Disease Progression|7
2055020|NCT00524368|3628198|FG000|Overall Study|Adverse Event|10
2055021|NCT00524368|3628199|FG001|Overall Study|Adverse Event|12
2055022|NCT00524368|3628198|FG000|Overall Study|Lost to Follow-up|9
2055023|NCT00524368|3628199|FG001|Overall Study|Lost to Follow-up|13
2177086|NCT01371708|3801170|FG000|Overall Study|Lost to Follow-up|5
2055024|NCT00524368|3628198|FG000|Overall Study|Withdrawal by Subject|4
2055025|NCT00524368|3628199|FG001|Overall Study|Withdrawal by Subject|5
2055026|NCT00524368|3628198|FG000|Overall Study|Non-compliant|8
2055027|NCT00524368|3628199|FG001|Overall Study|Non-compliant|9
2055028|NCT00524368|3628198|FG000|Overall Study|Reached a Virologic Endpoint|3
2055029|NCT00524368|3628199|FG001|Overall Study|Reached a Virologic Endpoint|2
2055030|NCT00524368|3628198|FG000|Overall Study|Sponsor's Decision|2
2055031|NCT00524368|3628199|FG001|Overall Study|Sponsor's Decision|0
2055032|NCT00524368|3628198|FG000|Overall Study|Ineligible to Continue the study|2
2055033|NCT00524368|3628199|FG001|Overall Study|Ineligible to Continue the study|5
2055034|NCT00524368|3628198|FG000|Overall Study|Other|3
2055035|NCT00524368|3628199|FG001|Overall Study|Other|2
2055036|NCT00524420|3628207|FG000|Overall Study|Lack of Efficacy|1
2055037|NCT00524420|3628208|FG001|Overall Study|Lack of Efficacy|0
2055038|NCT00524589|3628238|FG000|Overall Study|Withdrawal by Subject|2
2055039|NCT00524589|3628238|FG000|Overall Study|Disease Progression|16
2055040|NCT00524680|3628246|FG000|Overall Study|progression|0
2055041|NCT00524680|3628247|FG001|Overall Study|progression|0
2055042|NCT00524680|3628248|FG002|Overall Study|progression|0
2055043|NCT00524680|3628249|FG003|Overall Study|progression|1
2055044|NCT00524680|3628246|FG000|Overall Study|Adverse Event|2
2055045|NCT00524680|3628247|FG001|Overall Study|Adverse Event|0
2055046|NCT00524680|3628248|FG002|Overall Study|Adverse Event|0
2055047|NCT00524680|3628249|FG003|Overall Study|Adverse Event|1
2055048|NCT00524680|3628246|FG000|Overall Study|Other|0
2055049|NCT00524680|3628247|FG001|Overall Study|Other|1
2055050|NCT00524680|3628248|FG002|Overall Study|Other|2
2055051|NCT00524680|3628249|FG003|Overall Study|Other|3
2055052|NCT00524680|3628246|FG000|Overall Study|Withdrawal by Subject|1
2055053|NCT00524680|3628247|FG001|Overall Study|Withdrawal by Subject|0
2055054|NCT00524680|3628248|FG002|Overall Study|Withdrawal by Subject|1
2055055|NCT00524680|3628249|FG003|Overall Study|Withdrawal by Subject|1
2055056|NCT00524745|3628263|FG000|Overall Study|subject withdrawal or lost to follow up|34
2055057|NCT00524745|3628264|FG001|Overall Study|subject withdrawal or lost to follow up|13
2055058|NCT00524745|3628265|FG002|Overall Study|subject withdrawal or lost to follow up|29
2055059|NCT00524745|3628266|FG003|Overall Study|subject withdrawal or lost to follow up|22
2055060|NCT00524771|3628278|FG000|Overall Study|Protocol Violation|220
2055061|NCT00524771|3628279|FG001|Overall Study|Protocol Violation|585
2055062|NCT00525031|3628292|FG000|Overall Study|Disease Progression|1
2055063|NCT00525031|3628293|FG001|Overall Study|Disease Progression|1
2055064|NCT00525044|3628302|FG000|Overall Study|Lost to Follow-up|0
2055065|NCT00525044|3628303|FG001|Overall Study|Lost to Follow-up|1
2055066|NCT00525148|3628326|FG000|Overall Study|Other Adverse Event|3
2055067|NCT00525148|3628327|FG001|Overall Study|Other Adverse Event|5
2055068|NCT00525148|3628328|FG002|Overall Study|Other Adverse Event|1
2055069|NCT00525148|3628329|FG003|Overall Study|Other Adverse Event|8
2055070|NCT00525148|3628326|FG000|Overall Study|Progressive disease|18
2055071|NCT00525148|3628327|FG001|Overall Study|Progressive disease|30
2055072|NCT00525148|3628328|FG002|Overall Study|Progressive disease|6
2055073|NCT00525148|3628329|FG003|Overall Study|Progressive disease|49
2055074|NCT00525148|3628326|FG000|Overall Study|Refused continuation of study medication|0
2055075|NCT00525148|3628327|FG001|Overall Study|Refused continuation of study medication|2
2055076|NCT00525148|3628328|FG002|Overall Study|Refused continuation of study medication|0
2055077|NCT00525148|3628329|FG003|Overall Study|Refused continuation of study medication|1
2055078|NCT00525148|3628326|FG000|Overall Study|Other than stated|2
2055079|NCT00525148|3628327|FG001|Overall Study|Other than stated|1
2055080|NCT00525148|3628328|FG002|Overall Study|Other than stated|0
2055081|NCT00525148|3628329|FG003|Overall Study|Other than stated|3
2055082|NCT00525161|3628339|FG000|Overall Study|Adverse Event|1
2055083|NCT00525265|3628354|FG000|Overall Study|Protocol Violation|1
2055084|NCT00525265|3628355|FG001|Overall Study|Protocol Violation|0
2055085|NCT00525499|3628374|FG000|Overall Study|Lost to Follow-up|2
2055086|NCT00525499|3628375|FG001|Overall Study|Lost to Follow-up|4
2055087|NCT00525499|3628376|FG002|Overall Study|Lost to Follow-up|1
2055088|NCT00525499|3628377|FG003|Overall Study|Lost to Follow-up|4
2055089|NCT00525499|3628374|FG000|Overall Study|Adverse Event|0
2055090|NCT00525499|3628375|FG001|Overall Study|Adverse Event|1
2055091|NCT00525499|3628376|FG002|Overall Study|Adverse Event|0
2055092|NCT00525499|3628377|FG003|Overall Study|Adverse Event|1
2055093|NCT00525499|3628374|FG000|Overall Study|Withdrawal by Subject|5
2055094|NCT00525499|3628375|FG001|Overall Study|Withdrawal by Subject|1
2055095|NCT00525499|3628376|FG002|Overall Study|Withdrawal by Subject|5
2055096|NCT00525499|3628377|FG003|Overall Study|Withdrawal by Subject|2
2055097|NCT00525499|3628374|FG000|Overall Study|Protocol Violation|0
2055098|NCT00525499|3628375|FG001|Overall Study|Protocol Violation|1
2055099|NCT00525499|3628376|FG002|Overall Study|Protocol Violation|1
2055100|NCT00525499|3628377|FG003|Overall Study|Protocol Violation|0
2055101|NCT00525512|3628389|FG000|Double-Blind Phase|Adverse Event|48
2055102|NCT00525512|3628390|FG001|Double-Blind Phase|Adverse Event|28
2055103|NCT00525512|3628391|FG002|Double-Blind Phase|Adverse Event|0
2055104|NCT00525512|3628392|FG003|Double-Blind Phase|Adverse Event|0
2055105|NCT00525512|3628389|FG000|Double-Blind Phase|Protocol Violation|3
2055106|NCT00525512|3628390|FG001|Double-Blind Phase|Protocol Violation|1
2055107|NCT00525512|3628391|FG002|Double-Blind Phase|Protocol Violation|0
2055108|NCT00525512|3628392|FG003|Double-Blind Phase|Protocol Violation|0
2055109|NCT00525512|3628389|FG000|Double-Blind Phase|Lost to Follow-up|3
2055110|NCT00525512|3628390|FG001|Double-Blind Phase|Lost to Follow-up|7
2055111|NCT00525512|3628391|FG002|Double-Blind Phase|Lost to Follow-up|0
2055112|NCT00525512|3628392|FG003|Double-Blind Phase|Lost to Follow-up|0
2055113|NCT00525512|3628389|FG000|Double-Blind Phase|Withdrawal by Subject|17
2055114|NCT00525512|3628390|FG001|Double-Blind Phase|Withdrawal by Subject|12
2055115|NCT00525512|3628391|FG002|Double-Blind Phase|Withdrawal by Subject|0
2055116|NCT00525512|3628392|FG003|Double-Blind Phase|Withdrawal by Subject|0
2055117|NCT00525512|3628389|FG000|Double-Blind Phase|Lack of Efficacy|13
2055118|NCT00525512|3628390|FG001|Double-Blind Phase|Lack of Efficacy|5
2055119|NCT00525512|3628391|FG002|Double-Blind Phase|Lack of Efficacy|0
2055120|NCT00525512|3628392|FG003|Double-Blind Phase|Lack of Efficacy|0
2055121|NCT00525512|3628389|FG000|Double-Blind Phase|Other reason (not specified)|12
2055122|NCT00525512|3628390|FG001|Double-Blind Phase|Other reason (not specified)|13
2055123|NCT00525512|3628391|FG002|Double-Blind Phase|Other reason (not specified)|0
2055124|NCT00525512|3628392|FG003|Double-Blind Phase|Other reason (not specified)|0
2055125|NCT00525512|3628389|FG000|Open-Label Phase|Adverse Event|0
2055126|NCT00525512|3628390|FG001|Open-Label Phase|Adverse Event|0
2055127|NCT00525512|3628391|FG002|Open-Label Phase|Adverse Event|1
2055128|NCT00525512|3628392|FG003|Open-Label Phase|Adverse Event|0
2055129|NCT00525512|3628389|FG000|Open-Label Phase|Lost to Follow-up|0
2055130|NCT00525512|3628390|FG001|Open-Label Phase|Lost to Follow-up|0
2055131|NCT00525512|3628391|FG002|Open-Label Phase|Lost to Follow-up|1
2055132|NCT00525512|3628392|FG003|Open-Label Phase|Lost to Follow-up|0
2055133|NCT00525512|3628389|FG000|Open-Label Phase|Other reason (not specified)|0
2055134|NCT00525512|3628390|FG001|Open-Label Phase|Other reason (not specified)|0
2055135|NCT00525512|3628391|FG002|Open-Label Phase|Other reason (not specified)|4
2055136|NCT00525512|3628392|FG003|Open-Label Phase|Other reason (not specified)|5
2055137|NCT00525590|3628413|FG000|Overall Study|Adverse Event|3
2055138|NCT00525590|3628413|FG000|Overall Study|Physician Decision|3
2055139|NCT00525590|3628413|FG000|Overall Study|Withdrawal by Subject|16
2055140|NCT00525590|3628413|FG000|Overall Study|Lost to Follow-up|1
2055141|NCT00525590|3628413|FG000|Overall Study|Death|9
2055142|NCT00525590|3628413|FG000|Overall Study|Other|13
2055143|NCT00525785|3628437|FG000|Overall Study|Withdrawal by Subject|1
2055144|NCT00525785|3628437|FG000|Overall Study|Lack of Efficacy|1
2055145|NCT00525785|3628437|FG000|Overall Study|Physician Decision|1
2055146|NCT00525824|3628454|FG000|Overall Study|Adverse Event|7
2055147|NCT00525824|3628455|FG001|Overall Study|Adverse Event|11
2055148|NCT00525824|3628456|FG002|Overall Study|Adverse Event|6
2055149|NCT00525824|3628457|FG003|Overall Study|Adverse Event|7
2055150|NCT00525824|3628454|FG000|Overall Study|Withdrawal by Subject|5
2055151|NCT00525824|3628455|FG001|Overall Study|Withdrawal by Subject|9
2055152|NCT00525824|3628456|FG002|Overall Study|Withdrawal by Subject|3
2055153|NCT00525824|3628457|FG003|Overall Study|Withdrawal by Subject|4
2055154|NCT00525824|3628454|FG000|Overall Study|Lost to Follow-up|4
2055155|NCT00525824|3628455|FG001|Overall Study|Lost to Follow-up|2
2055156|NCT00525824|3628456|FG002|Overall Study|Lost to Follow-up|4
2055157|NCT00525824|3628457|FG003|Overall Study|Lost to Follow-up|0
2055158|NCT00525824|3628454|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1
2055159|NCT00525824|3628455|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2
2055160|NCT00525824|3628456|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1
2055161|NCT00525824|3628457|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2
2055162|NCT00525824|3628454|FG000|Overall Study|Severe non-compliance|0
2055163|NCT00525824|3628455|FG001|Overall Study|Severe non-compliance|1
2055164|NCT00525824|3628456|FG002|Overall Study|Severe non-compliance|1
2055165|NCT00525824|3628457|FG003|Overall Study|Severe non-compliance|1
2055166|NCT00525824|3628454|FG000|Overall Study|Safety reasons|1
2055167|NCT00525824|3628455|FG001|Overall Study|Safety reasons|0
2055168|NCT00525824|3628456|FG002|Overall Study|Safety reasons|1
2055169|NCT00525824|3628457|FG003|Overall Study|Safety reasons|0
2055170|NCT00525824|3628454|FG000|Overall Study|Other|1
2055171|NCT00525824|3628455|FG001|Overall Study|Other|3
2055172|NCT00525824|3628456|FG002|Overall Study|Other|3
2055173|NCT00525824|3628457|FG003|Overall Study|Other|1
2055174|NCT00525902|3628485|FG000|Overall Study|Lack of Efficacy|1
2055175|NCT00525915|3628491|FG000|Overall Study|Non-Compliance|0
2055176|NCT00525915|3628492|FG001|Overall Study|Non-Compliance|1
2055177|NCT00525915|3628491|FG000|Overall Study|Disease Progression|5
2055178|NCT00525915|3628492|FG001|Overall Study|Disease Progression|6
2055179|NCT00525915|3628491|FG000|Overall Study|Withdrawal by Subject|1
2055180|NCT00525915|3628492|FG001|Overall Study|Withdrawal by Subject|0
2055181|NCT00525915|3628491|FG000|Overall Study|Refused Surgery|1
2055182|NCT00525915|3628492|FG001|Overall Study|Refused Surgery|2
2055183|NCT00525915|3628491|FG000|Overall Study|Unrelated illness|1
2055184|NCT00525915|3628492|FG001|Overall Study|Unrelated illness|0
2055185|NCT00526071|3628507|FG000|Overall Study|Adverse Event|1
2055186|NCT00526071|3628507|FG000|Overall Study|Withdrawal by Subject|1
2055187|NCT00526071|3628507|FG000|Overall Study|Lack of Response to Study Drug|4
2055188|NCT00526097|3628517|FG000|Overall Study|Adverse Event|6
2055189|NCT00526097|3628518|FG001|Overall Study|Adverse Event|44
2055190|NCT00526097|3628517|FG000|Overall Study|Protocol Violation|4
2055191|NCT00526097|3628518|FG001|Overall Study|Protocol Violation|10
2055192|NCT00526097|3628517|FG000|Overall Study|Withdrawal by Subject|3
2055193|NCT00526097|3628518|FG001|Overall Study|Withdrawal by Subject|1
2055194|NCT00526097|3628517|FG000|Overall Study|Other|2
2055195|NCT00526097|3628518|FG001|Overall Study|Other|1
2055196|NCT00526110|3628526|FG000|Overall Study|Adverse Event|2
2055197|NCT00526110|3628527|FG001|Overall Study|Adverse Event|9
2055198|NCT00526110|3628526|FG000|Overall Study|Disease Progression|0
2055199|NCT00526110|3628527|FG001|Overall Study|Disease Progression|19
2055200|NCT00526110|3628526|FG000|Overall Study|Maximal Response|0
2055201|NCT00526110|3628527|FG001|Overall Study|Maximal Response|6
2055202|NCT00526110|3628526|FG000|Overall Study|Withdrawal by Subject|0
2055203|NCT00526110|3628527|FG001|Overall Study|Withdrawal by Subject|2
2055204|NCT00526110|3628526|FG000|Overall Study|Poor Tolerance|0
2055205|NCT00526110|3628527|FG001|Overall Study|Poor Tolerance|5
2055206|NCT00526162|3628542|FG000|Overall Study|Device not implanted|3
2055207|NCT00526630|3628578|FG000|First Intervention Period - 12 Weeks|Withdrawn|0
2055208|NCT00526630|3628579|FG001|First Intervention Period - 12 Weeks|Withdrawn|3
2055209|NCT00526630|3628578|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2
2055210|NCT00526630|3628579|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1
2055211|NCT00526656|3628587|FG000|Overall Study|Death|1
2055212|NCT00526656|3628587|FG000|Overall Study|Refused surgery|1
2055213|NCT00526669|3628592|FG000|Combined Treatment Phase|Lost to Follow-up|0
2055214|NCT00526669|3628593|FG001|Combined Treatment Phase|Lost to Follow-up|2
2055215|NCT00526669|3628592|FG000|Combined Treatment Phase|Withdrawal by Subject|0
2055216|NCT00526669|3628593|FG001|Combined Treatment Phase|Withdrawal by Subject|2
2055217|NCT00526669|3628592|FG000|Combined Treatment Phase|Sponsor Terminated Study|0
2055218|NCT00526669|3628593|FG001|Combined Treatment Phase|Sponsor Terminated Study|2
2055219|NCT00526669|3628592|FG000|Combined Treatment Phase|Death|0
2055220|NCT00526669|3628593|FG001|Combined Treatment Phase|Death|2
2055221|NCT00526799|3628601|FG000|Overall Study|Withdrawal by Subject|1
2055222|NCT00526799|3628602|FG001|Overall Study|Withdrawal by Subject|0
2055223|NCT00526799|3628601|FG000|Overall Study|Intercurrent Complicating Disease|0
2055224|NCT00526799|3628602|FG001|Overall Study|Intercurrent Complicating Disease|1
2055225|NCT00526890|3628608|FG000|Overall Study|Adverse Event|2
2055226|NCT00526994|3628615|FG000|Overall Study|Lost to Follow-up|98
2055227|NCT00526994|3628616|FG001|Overall Study|Lost to Follow-up|108
2055228|NCT00526994|3628617|FG002|Overall Study|Lost to Follow-up|96
2055229|NCT00526994|3628615|FG000|Overall Study|Death|4
2055230|NCT00526994|3628616|FG001|Overall Study|Death|3
2055231|NCT00526994|3628617|FG002|Overall Study|Death|3
2055232|NCT00526994|3628615|FG000|Overall Study|Withdrawal by Subject|2
2055233|NCT00526994|3628616|FG001|Overall Study|Withdrawal by Subject|7
2055234|NCT00526994|3628617|FG002|Overall Study|Withdrawal by Subject|5
2055235|NCT00526994|3628615|FG000|Overall Study|incarcerated, impaired, incomplete|4
2055236|NCT00526994|3628616|FG001|Overall Study|incarcerated, impaired, incomplete|3
2055237|NCT00526994|3628617|FG002|Overall Study|incarcerated, impaired, incomplete|3
2055238|NCT00527072|3628625|FG000|Overall Study|Adverse Event|13
2055239|NCT00527072|3628625|FG000|Overall Study|Lack of Efficacy|11
2055240|NCT00527072|3628625|FG000|Overall Study|Lost to Follow-up|3
2055241|NCT00527072|3628625|FG000|Overall Study|Protocol Violation|2
2055242|NCT00527072|3628625|FG000|Overall Study|Withdrawal by Subject|7
2055243|NCT00527111|3628640|FG000|Overall Study|Adverse Event|14
2055244|NCT00527111|3628641|FG001|Overall Study|Adverse Event|13
2055245|NCT00527111|3628640|FG000|Overall Study|Death|0
2055246|NCT00527111|3628641|FG001|Overall Study|Death|1
2055247|NCT00527111|3628640|FG000|Overall Study|Investigator Request|2
2055248|NCT00527111|3628641|FG001|Overall Study|Investigator Request|1
2055249|NCT00527111|3628640|FG000|Overall Study|Patient Request|2
2055250|NCT00527111|3628641|FG001|Overall Study|Patient Request|5
2055251|NCT00527111|3628640|FG000|Overall Study|Other|2
2055252|NCT00527111|3628641|FG001|Overall Study|Other|2
2055253|NCT00527319|3628659|FG000|Overall Study|Withdrawal by Subject|5
2055254|NCT00527319|3628660|FG001|Overall Study|Withdrawal by Subject|0
2055255|NCT00527319|3628661|FG002|Overall Study|Withdrawal by Subject|1
2055256|NCT00527319|3628659|FG000|Overall Study|Lost to Follow-up|1
2055257|NCT00527319|3628660|FG001|Overall Study|Lost to Follow-up|0
2055258|NCT00527319|3628661|FG002|Overall Study|Lost to Follow-up|0
2055259|NCT00527319|3628659|FG000|Overall Study|Death|0
2055260|NCT00527319|3628660|FG001|Overall Study|Death|3
2055261|NCT00527319|3628661|FG002|Overall Study|Death|1
2055262|NCT00527319|3628659|FG000|Overall Study|Intercurrent Medical Illness|0
2055263|NCT00527319|3628660|FG001|Overall Study|Intercurrent Medical Illness|1
2055264|NCT00527319|3628661|FG002|Overall Study|Intercurrent Medical Illness|3
2055265|NCT00527319|3628659|FG000|Overall Study|Adverse Event|0
2055266|NCT00527319|3628660|FG001|Overall Study|Adverse Event|0
2055267|NCT00527319|3628661|FG002|Overall Study|Adverse Event|1
2055268|NCT00527332|3628671|FG000|Overall Study|Protocol Violation|4
2055269|NCT00527332|3628672|FG001|Overall Study|Protocol Violation|8
2055270|NCT00527332|3628671|FG000|Overall Study|Withdrew consent|5
2055271|NCT00527332|3628672|FG001|Overall Study|Withdrew consent|1
2105508|NCT00857233|3698041|FG000|Overall Study|Adverse Event|24
2105509|NCT00857233|3698041|FG000|Overall Study|Lack of Efficacy|1
2105510|NCT00857233|3698041|FG000|Overall Study|Non-compliance|1
2105511|NCT00857233|3698041|FG000|Overall Study|Withdrawal of Consent|9
2105512|NCT00857233|3698041|FG000|Overall Study|Lost to Follow-up|4
2105513|NCT00857233|3698041|FG000|Overall Study|Nursing Home Placement|14
2105514|NCT00857233|3698041|FG000|Overall Study|Other Reasons|2
2105515|NCT00857246|3698045|FG000|Induction Regimen|Adverse Event|1
2105516|NCT00857246|3698045|FG000|Induction Regimen|disease-related complications|1
2105517|NCT00857246|3698045|FG000|Induction Regimen|Withdrawal by Subject|1
2300908|NCT02605174|3998639|FG001|Overall Study|Pregnancy|0
2105518|NCT00857246|3698045|FG000|Surgery (Curative)|disease progression|6
2105519|NCT00857246|3698045|FG000|ChemoRT|Withdrawal by Subject|1
2105520|NCT00857246|3698045|FG000|ChemoRT|Adverse Event|2
2105521|NCT00857259|3698055|FG000|Overall Study|Protocol Violation|1
2105522|NCT00857259|3698056|FG001|Overall Study|Protocol Violation|0
2105523|NCT00857259|3698057|FG002|Overall Study|Protocol Violation|1
2105524|NCT00857311|3698080|FG000|Overall Study|Lost to Follow-up|1
2055272|NCT00527397|3628678|FG000|Overall Study|Adverse Event|3
2055273|NCT00527397|3628678|FG000|Overall Study|Lack of Efficacy|1
2055274|NCT00527397|3628678|FG000|Overall Study|Protocol Violation|1
2055275|NCT00527397|3628678|FG000|Overall Study|Withdrawal by Subject|6
2055276|NCT00527397|3628678|FG000|Overall Study|Study terminated by sponsor|13
2055277|NCT00527423|3628685|FG000|Overall Study|Protocol Violation|1
2055278|NCT00527423|3628685|FG000|Overall Study|Adverse Event|5
2055279|NCT00527423|3628685|FG000|Overall Study|Physician Decision|4
2055280|NCT00527423|3628685|FG000|Overall Study|Withdrawal by Subject|10
2055281|NCT00527423|3628685|FG000|Overall Study|Lost to Follow-up|4
2055282|NCT00527423|3628685|FG000|Overall Study|OTHER|4
2055283|NCT00527423|3628685|FG000|Overall Study|Death|9
2055284|NCT00527488|3628704|FG000|Overall Study|Withdrawn prior to dosing|0
2055285|NCT00527488|3628705|FG001|Overall Study|Withdrawn prior to dosing|1
2055286|NCT00527488|3628706|FG002|Overall Study|Withdrawn prior to dosing|1
2055287|NCT00527488|3628707|FG003|Overall Study|Withdrawn prior to dosing|0
2055288|NCT00527514|3628717|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
2055289|NCT00527514|3628717|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
2055290|NCT00527514|3628717|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
2055291|NCT00527514|3628717|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
2055292|NCT00527514|3628717|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
2055293|NCT00527514|3628717|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
2055294|NCT00527514|3628717|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
2055295|NCT00527605|3628742|FG000|Overall Study|Adverse Event|3
2055296|NCT00527605|3628743|FG001|Overall Study|Adverse Event|0
2055297|NCT00527605|3628742|FG000|Overall Study|Withdrawal by Subject|3
2055298|NCT00527605|3628743|FG001|Overall Study|Withdrawal by Subject|7
2055299|NCT00527605|3628742|FG000|Overall Study|Lost to Follow-up|6
2055300|NCT00527605|3628743|FG001|Overall Study|Lost to Follow-up|2
2055301|NCT00527605|3628742|FG000|Overall Study|Protocol Violation|1
2055302|NCT00527605|3628743|FG001|Overall Study|Protocol Violation|2
2055303|NCT00527618|3628749|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3
2055304|NCT00527618|3628750|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1
2055305|NCT00527618|3628749|FG000|Week 1-12 (First Intervention)|Adverse Event|0
2055306|NCT00527618|3628750|FG001|Week 1-12 (First Intervention)|Adverse Event|1
2055307|NCT00527618|3628749|FG000|Week 13-14 (Washout)|Lost to Follow-up|1
2055308|NCT00527618|3628750|FG001|Week 13-14 (Washout)|Lost to Follow-up|0
2055309|NCT00527618|3628749|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0
2055310|NCT00527618|3628750|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1
2055311|NCT00527618|3628749|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
2055312|NCT00527618|3628750|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
2055313|NCT00527618|3628749|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
2055314|NCT00527618|3628750|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
2055315|NCT00527735|3628773|FG000|Overall Study|Disease progression|47
2055316|NCT00527735|3628774|FG001|Overall Study|Disease progression|61
2055317|NCT00527735|3628775|FG002|Overall Study|Disease progression|53
2055318|NCT00527735|3628773|FG000|Overall Study|Death|23
2209618|NCT01646177|3849245|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0
2055319|NCT00527735|3628774|FG001|Overall Study|Death|13
2055320|NCT00527735|3628775|FG002|Overall Study|Death|15
2055321|NCT00527735|3628773|FG000|Overall Study|Completed treatment in treatment phase|14
2055322|NCT00527735|3628774|FG001|Overall Study|Completed treatment in treatment phase|13
2055323|NCT00527735|3628775|FG002|Overall Study|Completed treatment in treatment phase|18
2055324|NCT00527735|3628773|FG000|Overall Study|Adverse Event|10
2055325|NCT00527735|3628774|FG001|Overall Study|Adverse Event|6
2055326|NCT00527735|3628775|FG002|Overall Study|Adverse Event|7
2055327|NCT00527735|3628773|FG000|Overall Study|Not identified|5
2055328|NCT00527735|3628774|FG001|Overall Study|Not identified|5
2055329|NCT00527735|3628775|FG002|Overall Study|Not identified|5
2055330|NCT00527735|3628773|FG000|Overall Study|Withdrawal by Subject|5
2055331|NCT00527735|3628774|FG001|Overall Study|Withdrawal by Subject|4
2055332|NCT00527735|3628775|FG002|Overall Study|Withdrawal by Subject|3
2055333|NCT00527735|3628773|FG000|Overall Study|No longer met study criteria|2
2055334|NCT00527735|3628774|FG001|Overall Study|No longer met study criteria|2
2055335|NCT00527735|3628775|FG002|Overall Study|No longer met study criteria|1
2055336|NCT00527735|3628773|FG000|Overall Study|Lost to Follow-up|0
2055337|NCT00527735|3628774|FG001|Overall Study|Lost to Follow-up|0
2055338|NCT00527735|3628775|FG002|Overall Study|Lost to Follow-up|3
2055339|NCT00527735|3628773|FG000|Overall Study|Poor compliance or noncompliance|0
2055340|NCT00527735|3628774|FG001|Overall Study|Poor compliance or noncompliance|1
2055341|NCT00527735|3628775|FG002|Overall Study|Poor compliance or noncompliance|1
2055342|NCT00527735|3628773|FG000|Overall Study|Completed treatment during maintenance|2
2055343|NCT00527735|3628774|FG001|Overall Study|Completed treatment during maintenance|2
2055344|NCT00527735|3628775|FG002|Overall Study|Completed treatment during maintenance|1
2055345|NCT00527787|3628797|FG000|Overall Study|Adverse Event|14
2055346|NCT00527787|3628798|FG001|Overall Study|Adverse Event|24
2055347|NCT00527787|3628797|FG000|Overall Study|Withdrawal by Subject|13
2055348|NCT00527787|3628798|FG001|Overall Study|Withdrawal by Subject|25
2055349|NCT00527787|3628797|FG000|Overall Study|Lost to Follow-up|5
2055350|NCT00527787|3628798|FG001|Overall Study|Lost to Follow-up|2
2055351|NCT00527787|3628797|FG000|Overall Study|Duodenal Ulcer|1
2055352|NCT00527787|3628798|FG001|Overall Study|Duodenal Ulcer|10
2055353|NCT00527787|3628797|FG000|Overall Study|misc|5
2055354|NCT00527787|3628798|FG001|Overall Study|misc|2
2055355|NCT00527826|3628806|FG000|Overall Study|Adverse Event|10
2055356|NCT00527826|3628807|FG001|Overall Study|Adverse Event|10
2055357|NCT00527826|3628806|FG000|Overall Study|Lost to Follow-up|3
2055358|NCT00527826|3628807|FG001|Overall Study|Lost to Follow-up|2
2055359|NCT00527826|3628806|FG000|Overall Study|Withdrawal by Subject|5
2055360|NCT00527826|3628807|FG001|Overall Study|Withdrawal by Subject|8
2055361|NCT00527826|3628806|FG000|Overall Study|Inclusion Criteria Not Met|3
2055362|NCT00527826|3628807|FG001|Overall Study|Inclusion Criteria Not Met|3
2055363|NCT00527826|3628806|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0
2055364|NCT00527826|3628807|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1
2055365|NCT00527826|3628806|FG000|Overall Study|Additional Intake of Viani forte|0
2055366|NCT00527826|3628807|FG001|Overall Study|Additional Intake of Viani forte|1
2055367|NCT00527826|3628806|FG000|Overall Study|Participant moved away|0
2055368|NCT00527826|3628807|FG001|Overall Study|Participant moved away|1
2055369|NCT00527904|3628823|FG000|Overall Study|Adverse Event|45
2055370|NCT00527904|3628823|FG000|Overall Study|Withdrawal by Subject|21
2055371|NCT00527904|3628823|FG000|Overall Study|Lost to Follow-up|8
2055372|NCT00527904|3628823|FG000|Overall Study|misc|22
2055373|NCT00528021|3628840|FG000|Overall Study|Lack of Efficacy|17
2055374|NCT00528021|3628841|FG001|Overall Study|Lack of Efficacy|13
2055375|NCT00528021|3628842|FG002|Overall Study|Lack of Efficacy|7
2055376|NCT00528021|3628843|FG003|Overall Study|Lack of Efficacy|9
2055377|NCT00528112|3628855|FG000|Treatment up to 3 Years|Adverse Event|313
2055378|NCT00528112|3628856|FG001|Treatment up to 3 Years|Adverse Event|278
2055379|NCT00528112|3628855|FG000|Treatment up to 3 Years|Withdrawal by Subject|26
2055380|NCT00528112|3628856|FG001|Treatment up to 3 Years|Withdrawal by Subject|31
2055381|NCT00528112|3628855|FG000|Treatment up to 3 Years|Protocol Violation|16
2055382|NCT00528112|3628856|FG001|Treatment up to 3 Years|Protocol Violation|16
2055383|NCT00528112|3628855|FG000|Treatment up to 3 Years|Death|0
2055384|NCT00528112|3628856|FG001|Treatment up to 3 Years|Death|1
2055385|NCT00528112|3628855|FG000|Treatment up to 3 Years|Lost to Follow-up|63
2055386|NCT00528112|3628856|FG001|Treatment up to 3 Years|Lost to Follow-up|61
2055387|NCT00528112|3628855|FG000|Treatment up to 3 Years|Pregnancy|9
2055388|NCT00528112|3628856|FG001|Treatment up to 3 Years|Pregnancy|10
2055389|NCT00528112|3628855|FG000|Treatment up to 3 Years|Other reasons|186
2055390|NCT00528112|3628856|FG001|Treatment up to 3 Years|Other reasons|186
2055391|NCT00528112|3628855|FG000|Extension Phase|Withdrawal by Subject|0
2055392|NCT00528112|3628856|FG001|Extension Phase|Withdrawal by Subject|3
2055393|NCT00528112|3628855|FG000|Extension Phase|Other reasons|0
2055394|NCT00528112|3628856|FG001|Extension Phase|Other reasons|100
2055395|NCT00528112|3628855|FG000|Extension Phase|Pregnancy|0
2055396|NCT00528112|3628856|FG001|Extension Phase|Pregnancy|3
2055397|NCT00528112|3628855|FG000|Extension Phase|Lost to Follow-up|0
2055398|NCT00528112|3628856|FG001|Extension Phase|Lost to Follow-up|12
2055399|NCT00528112|3628855|FG000|Extension Phase|Death|0
2055400|NCT00528112|3628856|FG001|Extension Phase|Death|1
2055401|NCT00528112|3628855|FG000|Extension Phase|Adverse Event|0
2055402|NCT00528112|3628856|FG001|Extension Phase|Adverse Event|36
2055403|NCT00528112|3628855|FG000|Extension Phase|Protocol Violation|0
2055404|NCT00528112|3628856|FG001|Extension Phase|Protocol Violation|2
2055405|NCT00528372|3628891|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
2055406|NCT00528372|3628892|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2055407|NCT00528372|3628893|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2055408|NCT00528372|3628894|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2055409|NCT00528372|3628895|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2055410|NCT00528372|3628896|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2055411|NCT00528372|3628897|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2055412|NCT00528372|3628898|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2055413|NCT00528372|3628899|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2055414|NCT00528372|3628891|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
2055415|NCT00528372|3628892|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
2055416|NCT00528372|3628893|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
2055417|NCT00528372|3628894|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
2055418|NCT00528372|3628895|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
2055419|NCT00528372|3628896|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
2055420|NCT00528372|3628897|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
2055421|NCT00528372|3628898|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
2055422|NCT00528372|3628899|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
2055423|NCT00528372|3628891|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
2055424|NCT00528372|3628892|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
2055425|NCT00528372|3628893|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
2055426|NCT00528372|3628894|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
2055427|NCT00528372|3628895|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
2055428|NCT00528372|3628896|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
2055429|NCT00528372|3628897|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
2055430|NCT00528372|3628898|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
2055431|NCT00528372|3628899|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
2055432|NCT00528372|3628891|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
2209619|NCT01646177|3849246|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0
2055433|NCT00528372|3628892|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
2055434|NCT00528372|3628893|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
2055435|NCT00528372|3628894|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
2055436|NCT00528372|3628895|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
2055437|NCT00528372|3628896|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
2055438|NCT00528372|3628897|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
2055439|NCT00528372|3628898|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
2055440|NCT00528372|3628899|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
2055441|NCT00528372|3628891|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2055442|NCT00528372|3628892|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2055443|NCT00528372|3628893|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2055444|NCT00528372|3628894|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
2055445|NCT00528372|3628895|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2055446|NCT00528372|3628896|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
2055447|NCT00528372|3628897|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2055448|NCT00528372|3628898|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2055449|NCT00528372|3628899|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2055450|NCT00528372|3628891|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
2055451|NCT00528372|3628892|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2055452|NCT00528372|3628893|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
2055453|NCT00528372|3628894|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2055454|NCT00528372|3628895|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2055455|NCT00528372|3628896|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
2055456|NCT00528372|3628897|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2055457|NCT00528372|3628898|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2055458|NCT00528372|3628899|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2055459|NCT00528372|3628891|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3
2055460|NCT00528372|3628892|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0
2055461|NCT00528372|3628893|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0
2055462|NCT00528372|3628894|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1
2055463|NCT00528372|3628895|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0
2055464|NCT00528372|3628896|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0
2055465|NCT00528372|3628897|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0
2055466|NCT00528372|3628898|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1
2055467|NCT00528372|3628899|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0
2055468|NCT00528372|3628891|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
2055469|NCT00528372|3628892|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
2055470|NCT00528372|3628893|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
2055471|NCT00528372|3628894|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
2055472|NCT00528372|3628895|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
2055473|NCT00528372|3628896|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
2055474|NCT00528372|3628897|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
2055475|NCT00528372|3628898|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
2055476|NCT00528372|3628899|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
2055477|NCT00528372|3628891|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
2055478|NCT00528372|3628892|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
2055479|NCT00528372|3628893|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
2055480|NCT00528372|3628894|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
2055481|NCT00528372|3628895|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
2055482|NCT00528372|3628896|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
2055483|NCT00528372|3628897|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
2055484|NCT00528372|3628898|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
2055485|NCT00528372|3628899|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
2055486|NCT00528372|3628891|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
2055487|NCT00528372|3628892|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
2055488|NCT00528372|3628893|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
2055489|NCT00528372|3628894|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
2055490|NCT00528372|3628895|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
2055491|NCT00528372|3628896|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
2055492|NCT00528372|3628897|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
2055493|NCT00528372|3628898|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
2055494|NCT00528372|3628899|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
2105525|NCT00857311|3698081|FG001|Overall Study|Lost to Follow-up|0
2217680|NCT01709305|3860930|FG002|Phase 2|Clinical Adverse Event|10
2055495|NCT00528372|3628891|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
2055496|NCT00528372|3628892|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
2055497|NCT00528372|3628893|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
2055498|NCT00528372|3628894|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
2055499|NCT00528372|3628895|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
2055500|NCT00528372|3628896|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
2055501|NCT00528372|3628897|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
2055502|NCT00528372|3628898|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
2055503|NCT00528372|3628899|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
2055504|NCT00528372|3628891|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
2055505|NCT00528372|3628892|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
2055506|NCT00528372|3628893|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
2055507|NCT00528372|3628894|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
2055508|NCT00528372|3628895|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
2055509|NCT00528372|3628896|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
2055510|NCT00528372|3628897|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
2055511|NCT00528372|3628898|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
2055512|NCT00528372|3628899|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
2055513|NCT00528372|3628891|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2055514|NCT00528372|3628892|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2055515|NCT00528372|3628893|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2055516|NCT00528372|3628894|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2055517|NCT00528372|3628895|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
2055518|NCT00528372|3628896|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
2055519|NCT00528372|3628897|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2055520|NCT00528372|3628898|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2055521|NCT00528372|3628899|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2055522|NCT00528372|3628891|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2055523|NCT00528372|3628892|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
2055524|NCT00528372|3628893|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2055525|NCT00528372|3628894|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2055526|NCT00528372|3628895|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2055527|NCT00528372|3628896|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2055528|NCT00528372|3628897|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
2055529|NCT00528372|3628898|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2055530|NCT00528372|3628899|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
2055531|NCT00528372|3628891|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2
2055532|NCT00528372|3628892|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2
2055533|NCT00528372|3628893|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1
2055534|NCT00528372|3628894|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2
2055535|NCT00528372|3628895|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3
2055536|NCT00528372|3628896|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0
2055537|NCT00528372|3628897|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3
2055538|NCT00528372|3628898|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1
2055539|NCT00528372|3628899|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0
2055540|NCT00528411|3628952|FG000|Overall Study|Adverse Event|4
2055541|NCT00528411|3628953|FG001|Overall Study|Adverse Event|0
2055542|NCT00528411|3628954|FG002|Overall Study|Adverse Event|1
2055543|NCT00528411|3628952|FG000|Overall Study|Incorrect Enrolment|1
2055544|NCT00528411|3628953|FG001|Overall Study|Incorrect Enrolment|1
2055545|NCT00528411|3628954|FG002|Overall Study|Incorrect Enrolment|0
2055546|NCT00528411|3628952|FG000|Overall Study|Severe non-compliance to protocol|0
2055547|NCT00528411|3628953|FG001|Overall Study|Severe non-compliance to protocol|1
2055548|NCT00528411|3628954|FG002|Overall Study|Severe non-compliance to protocol|0
2055549|NCT00528411|3628952|FG000|Overall Study|Prior commitment medication|0
2055550|NCT00528411|3628953|FG001|Overall Study|Prior commitment medication|1
2055551|NCT00528411|3628954|FG002|Overall Study|Prior commitment medication|0
2055552|NCT00528424|3628962|FG000|Overall Study|Lost to Follow-up|13
2055553|NCT00528424|3628962|FG000|Overall Study|Withdrew consent|2
2055554|NCT00528424|3628962|FG000|Overall Study|Administrative reason|2
2055555|NCT00528424|3628962|FG000|Overall Study|Other|12
2055556|NCT00528528|3628974|FG000|Overall Study|Lost to Follow-up|0
2055557|NCT00528528|3628975|FG001|Overall Study|Lost to Follow-up|0
2055558|NCT00528528|3628976|FG002|Overall Study|Lost to Follow-up|1
2055559|NCT00528528|3628977|FG003|Overall Study|Lost to Follow-up|1
2055560|NCT00528528|3628974|FG000|Overall Study|Ineligible to continue the trial|0
2055561|NCT00528528|3628975|FG001|Overall Study|Ineligible to continue the trial|0
2055562|NCT00528528|3628976|FG002|Overall Study|Ineligible to continue the trial|0
2055563|NCT00528528|3628977|FG003|Overall Study|Ineligible to continue the trial|1
2055564|NCT00528528|3628974|FG000|Overall Study|Other|0
2055565|NCT00528528|3628975|FG001|Overall Study|Other|1
2055566|NCT00528528|3628976|FG002|Overall Study|Other|0
2055567|NCT00528528|3628977|FG003|Overall Study|Other|0
2055568|NCT00528528|3628974|FG000|Overall Study|Withdrawal by Subject|3
2055569|NCT00528528|3628975|FG001|Overall Study|Withdrawal by Subject|2
2209620|NCT01646177|3849247|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0
2209621|NCT01646177|3849248|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0
2209622|NCT01646177|3849237|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
2055570|NCT00528528|3628976|FG002|Overall Study|Withdrawal by Subject|1
2055571|NCT00528528|3628977|FG003|Overall Study|Withdrawal by Subject|1
2055572|NCT00528528|3628974|FG000|Overall Study|Ongoing participant|0
2055573|NCT00528528|3628975|FG001|Overall Study|Ongoing participant|0
2055574|NCT00528528|3628976|FG002|Overall Study|Ongoing participant|1
2055575|NCT00528528|3628977|FG003|Overall Study|Ongoing participant|0
2055576|NCT00528567|3629000|FG000|Overall Study|Death|4
2055577|NCT00528567|3629001|FG001|Overall Study|Death|5
2055578|NCT00528567|3629000|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30
2055579|NCT00528567|3629001|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60
2055580|NCT00528567|3629000|FG000|Overall Study|Adverse Event/Intermittent Illness|255
2055581|NCT00528567|3629001|FG001|Overall Study|Adverse Event/Intermittent Illness|29
2055582|NCT00528567|3629000|FG000|Overall Study|Violation Criteria at Entry|3
2055583|NCT00528567|3629001|FG001|Overall Study|Violation Criteria at Entry|17
2055584|NCT00528567|3629000|FG000|Overall Study|Withdrew Consent|59
2055585|NCT00528567|3629001|FG001|Overall Study|Withdrew Consent|55
2055586|NCT00528567|3629000|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52
2055587|NCT00528567|3629001|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42
2055588|NCT00528567|3629000|FG000|Overall Study|Failure to Return|1
2055589|NCT00528567|3629001|FG001|Overall Study|Failure to Return|4
2055590|NCT00528567|3629000|FG000|Overall Study|Other Protocol Violation|5
2055591|NCT00528567|3629001|FG001|Overall Study|Other Protocol Violation|21
2055592|NCT00528567|3629000|FG000|Overall Study|Administrative/Other|22
2055593|NCT00528567|3629001|FG001|Overall Study|Administrative/Other|75
2055594|NCT00528606|3629025|FG000|Overall Study|Withdrew consent|4
2055595|NCT00528606|3629026|FG001|Overall Study|Withdrew consent|3
2055596|NCT00528606|3629025|FG000|Overall Study|Lost to Follow-up|4
2055597|NCT00528606|3629026|FG001|Overall Study|Lost to Follow-up|1
2055598|NCT00528606|3629025|FG000|Overall Study|Adverse Event|3
2055599|NCT00528606|3629026|FG001|Overall Study|Adverse Event|0
2055600|NCT00528606|3629025|FG000|Overall Study|Other|2
2055601|NCT00528606|3629026|FG001|Overall Study|Other|0
2055602|NCT00528645|3629032|FG000|Overall Study|Adverse Event|3
2055603|NCT00528801|3629043|FG000|Overall Study|Withdrawal by Subject|1
2055604|NCT00528801|3629044|FG001|Overall Study|Withdrawal by Subject|1
2055605|NCT00528801|3629043|FG000|Overall Study|Protocol Violation|11
2055606|NCT00528801|3629044|FG001|Overall Study|Protocol Violation|5
2055607|NCT00528801|3629043|FG000|Overall Study|Lost to Follow-up|15
2055608|NCT00528801|3629044|FG001|Overall Study|Lost to Follow-up|4
2055609|NCT00528801|3629043|FG000|Overall Study|Administrative Reasons|0
2055610|NCT00528801|3629044|FG001|Overall Study|Administrative Reasons|1
2055611|NCT00528840|3629050|FG000|Overall Study|Lost to Follow-up|10
2055612|NCT00528840|3629050|FG000|Overall Study|Adverse Event|1
2055613|NCT00528840|3629050|FG000|Overall Study|Withdrawal by Subject|17
2055614|NCT00528840|3629050|FG000|Overall Study|Death|2
2055615|NCT00528840|3629050|FG000|Overall Study|Administrative Reasons|1
2055616|NCT00528840|3629050|FG000|Overall Study|Other|2
2055617|NCT00528866|3629054|FG000|Overall Study|Protocol Violation|6
2055618|NCT00528879|3629063|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
2055619|NCT00528879|3629064|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
2055620|NCT00528879|3629065|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
2055621|NCT00528879|3629066|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
2055622|NCT00528879|3629063|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4
2055623|NCT00528879|3629064|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4
2055624|NCT00528879|3629065|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2
2055625|NCT00528879|3629066|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4
2055626|NCT00528879|3629063|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
2055627|NCT00528879|3629064|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
2055628|NCT00528879|3629065|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
2055629|NCT00528879|3629066|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
2055630|NCT00528879|3629063|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
2055631|NCT00528879|3629064|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
2055632|NCT00528879|3629065|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
2055633|NCT00528879|3629066|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
2055634|NCT00528879|3629063|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
2055635|NCT00528879|3629064|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
2055636|NCT00528879|3629065|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
2055637|NCT00528879|3629066|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
2055638|NCT00528879|3629063|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
2055639|NCT00528879|3629064|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
2055640|NCT00528879|3629065|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
2055641|NCT00528879|3629066|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
2055642|NCT00528879|3629063|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
2055643|NCT00528879|3629064|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
2055644|NCT00528879|3629065|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
2055645|NCT00528879|3629066|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
2055646|NCT00528879|3629063|FG000|Short-term Period (Day 1 to Week 24)|Other|0
2055647|NCT00528879|3629064|FG001|Short-term Period (Day 1 to Week 24)|Other|0
2055648|NCT00528879|3629065|FG002|Short-term Period (Day 1 to Week 24)|Other|1
2055649|NCT00528879|3629066|FG003|Short-term Period (Day 1 to Week 24)|Other|1
2055650|NCT00528879|3629063|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
2055651|NCT00528879|3629064|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
2055652|NCT00528879|3629065|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
2055653|NCT00528879|3629066|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
2055654|NCT00528879|3629063|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5
2055655|NCT00528879|3629064|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4
2055656|NCT00528879|3629065|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3
2055657|NCT00528879|3629066|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2
2055658|NCT00528879|3629063|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
2055659|NCT00528879|3629064|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
2055660|NCT00528879|3629065|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
2055661|NCT00528879|3629066|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
2055662|NCT00528879|3629063|FG000|Long-term Period (Weeks 24 to 102)|Death|0
2055663|NCT00528879|3629064|FG001|Long-term Period (Weeks 24 to 102)|Death|1
2055664|NCT00528879|3629065|FG002|Long-term Period (Weeks 24 to 102)|Death|0
2055665|NCT00528879|3629066|FG003|Long-term Period (Weeks 24 to 102)|Death|0
2055666|NCT00528879|3629063|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
2055667|NCT00528879|3629064|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
2055668|NCT00528879|3629065|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
2055669|NCT00528879|3629066|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
2055670|NCT00528879|3629063|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
2055671|NCT00528879|3629064|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
2055672|NCT00528879|3629065|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
2055673|NCT00528879|3629066|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
2055674|NCT00528879|3629063|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1
2055675|NCT00528879|3629064|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0
2055676|NCT00528879|3629065|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0
2055677|NCT00528879|3629066|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0
2055678|NCT00528879|3629063|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
2055679|NCT00528879|3629064|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
2055680|NCT00528879|3629065|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
2055681|NCT00528879|3629066|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
2055682|NCT00528931|3629076|FG000|Overall Study|Lost to Follow-up|1
2055683|NCT00528957|3629083|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
2055684|NCT00528957|3629084|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
2055685|NCT00528957|3629083|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
2055686|NCT00528957|3629084|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
2055687|NCT00528957|3629083|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
2055688|NCT00528957|3629084|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
2055689|NCT00528957|3629083|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
2055690|NCT00528957|3629084|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
2055691|NCT00528957|3629083|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0
2055692|NCT00528957|3629084|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1
2055693|NCT00528957|3629083|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
2055694|NCT00528957|3629084|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
2055695|NCT00528957|3629083|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
2055696|NCT00528957|3629084|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
2055697|NCT00528957|3629083|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
2055698|NCT00528957|3629084|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
2055699|NCT00528957|3629083|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
2055700|NCT00528957|3629084|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
2055701|NCT00528957|3629083|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
2055702|NCT00528957|3629084|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
2055703|NCT00528957|3629083|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
2055704|NCT00528957|3629084|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
2055705|NCT00528957|3629083|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
2055706|NCT00528957|3629084|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
2055707|NCT00528957|3629083|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
2055708|NCT00528957|3629084|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
2055709|NCT00528957|3629083|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
2055710|NCT00528957|3629084|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
2055711|NCT00528957|3629083|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
2055712|NCT00528957|3629084|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
2055713|NCT00528957|3629083|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
2055714|NCT00528957|3629084|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
2055715|NCT00528970|3629103|FG000|Overall Study|Adverse Event|6
2055716|NCT00528970|3629104|FG001|Overall Study|Adverse Event|8
2055717|NCT00528970|3629105|FG002|Overall Study|Adverse Event|5
2055718|NCT00528970|3629103|FG000|Overall Study|Lost to Follow-up|0
2055719|NCT00528970|3629104|FG001|Overall Study|Lost to Follow-up|0
2055720|NCT00528970|3629105|FG002|Overall Study|Lost to Follow-up|1
2055721|NCT00528970|3629103|FG000|Overall Study|Other than specified|2
2055722|NCT00528970|3629104|FG001|Overall Study|Other than specified|3
2055723|NCT00528970|3629105|FG002|Overall Study|Other than specified|3
2055724|NCT00528970|3629103|FG000|Overall Study|Protocol Violation|2
2055725|NCT00528970|3629104|FG001|Overall Study|Protocol Violation|1
2055726|NCT00528970|3629105|FG002|Overall Study|Protocol Violation|4
2055727|NCT00528970|3629103|FG000|Overall Study|Lack of Efficacy|0
2055728|NCT00528970|3629104|FG001|Overall Study|Lack of Efficacy|0
2055729|NCT00528970|3629105|FG002|Overall Study|Lack of Efficacy|1
2055730|NCT00528970|3629103|FG000|Overall Study|Withdrawal by Subject|4
2055731|NCT00528970|3629104|FG001|Overall Study|Withdrawal by Subject|3
2055732|NCT00528970|3629105|FG002|Overall Study|Withdrawal by Subject|5
2055733|NCT00528970|3629103|FG000|Overall Study|Randomized but not treated|0
2055734|NCT00528970|3629104|FG001|Overall Study|Randomized but not treated|0
2055735|NCT00528970|3629105|FG002|Overall Study|Randomized but not treated|1
2055736|NCT00528996|3629118|FG000|Overall Study|Other reasons than listing|6
2055737|NCT00528996|3629119|FG001|Overall Study|Other reasons than listing|7
2055738|NCT00528996|3629120|FG002|Overall Study|Other reasons than listing|14
2055739|NCT00528996|3629121|FG003|Overall Study|Other reasons than listing|11
2055740|NCT00528996|3629122|FG004|Overall Study|Other reasons than listing|5
2055741|NCT00528996|3629118|FG000|Overall Study|Refused continue medication|16
2055742|NCT00528996|3629119|FG001|Overall Study|Refused continue medication|0
2055743|NCT00528996|3629120|FG002|Overall Study|Refused continue medication|3
2055744|NCT00528996|3629121|FG003|Overall Study|Refused continue medication|3
2055745|NCT00528996|3629122|FG004|Overall Study|Refused continue medication|6
2055746|NCT00528996|3629118|FG000|Overall Study|Lost to Follow-up|2
2055747|NCT00528996|3629119|FG001|Overall Study|Lost to Follow-up|0
2055748|NCT00528996|3629120|FG002|Overall Study|Lost to Follow-up|4
2055749|NCT00528996|3629121|FG003|Overall Study|Lost to Follow-up|1
2055750|NCT00528996|3629122|FG004|Overall Study|Lost to Follow-up|3
2055751|NCT00528996|3629118|FG000|Overall Study|Protocol Violation|1
2055752|NCT00528996|3629119|FG001|Overall Study|Protocol Violation|2
2055753|NCT00528996|3629120|FG002|Overall Study|Protocol Violation|3
2055754|NCT00528996|3629121|FG003|Overall Study|Protocol Violation|3
2055755|NCT00528996|3629122|FG004|Overall Study|Protocol Violation|2
2055756|NCT00528996|3629118|FG000|Overall Study|Lack of Efficacy|7
2055757|NCT00528996|3629119|FG001|Overall Study|Lack of Efficacy|2
2055758|NCT00528996|3629120|FG002|Overall Study|Lack of Efficacy|1
2055759|NCT00528996|3629121|FG003|Overall Study|Lack of Efficacy|3
2055760|NCT00528996|3629122|FG004|Overall Study|Lack of Efficacy|3
2055761|NCT00528996|3629118|FG000|Overall Study|Adverse Event|32
2055762|NCT00528996|3629119|FG001|Overall Study|Adverse Event|13
2055763|NCT00528996|3629120|FG002|Overall Study|Adverse Event|18
2055764|NCT00528996|3629121|FG003|Overall Study|Adverse Event|29
2055765|NCT00528996|3629122|FG004|Overall Study|Adverse Event|18
2055766|NCT00529035|3629137|FG000|Overall Study|Withdrawal by Subject|1
2055767|NCT00529087|3629151|FG000|Overall Study|Adverse Event|10
2055768|NCT00529087|3629152|FG001|Overall Study|Adverse Event|13
2055769|NCT00529087|3629153|FG002|Overall Study|Adverse Event|4
2055770|NCT00529087|3629151|FG000|Overall Study|Lost to Follow-up|6
2055771|NCT00529087|3629152|FG001|Overall Study|Lost to Follow-up|4
2055772|NCT00529087|3629153|FG002|Overall Study|Lost to Follow-up|1
2055773|NCT00529087|3629151|FG000|Overall Study|Protocol Violation|8
2055774|NCT00529087|3629152|FG001|Overall Study|Protocol Violation|7
2055775|NCT00529087|3629153|FG002|Overall Study|Protocol Violation|6
2055776|NCT00529087|3629151|FG000|Overall Study|Withdrawal by Subject|3
2055777|NCT00529087|3629152|FG001|Overall Study|Withdrawal by Subject|3
2055778|NCT00529087|3629153|FG002|Overall Study|Withdrawal by Subject|3
2055779|NCT00529087|3629151|FG000|Overall Study|Protocol deviation|1
2055780|NCT00529087|3629152|FG001|Overall Study|Protocol deviation|1
2055781|NCT00529087|3629153|FG002|Overall Study|Protocol deviation|2
2055782|NCT00529100|3629174|FG000|Overall Study|Adverse Event|0
2055783|NCT00529100|3629175|FG001|Overall Study|Adverse Event|5
2055784|NCT00529100|3629174|FG000|Overall Study|Protocol Violation|0
2055785|NCT00529100|3629175|FG001|Overall Study|Protocol Violation|1
2055786|NCT00529100|3629174|FG000|Overall Study|Progressive Disease|0
2055787|NCT00529100|3629175|FG001|Overall Study|Progressive Disease|1
2055788|NCT00529100|3629174|FG000|Overall Study|Withdrawal by Subject|0
2055789|NCT00529100|3629175|FG001|Overall Study|Withdrawal by Subject|1
2055790|NCT00529100|3629174|FG000|Overall Study|Participant Ineligibility|0
2055791|NCT00529100|3629175|FG001|Overall Study|Participant Ineligibility|1
2055792|NCT00529217|3629224|FG000|Overall Study|Lack of Efficacy|2
2055793|NCT00529217|3629224|FG000|Overall Study|Unable to adhere to study schedule|2
2055794|NCT00529243|3629229|FG000|Overall Study|Adverse Event|1
2055795|NCT00529243|3629229|FG000|Overall Study|Death|1
2055796|NCT00529243|3629229|FG000|Overall Study|Relocated|1
2055797|NCT00529308|3629235|FG000|Overall Study|Withdrawal by Subject|1
2055798|NCT00529308|3629236|FG001|Overall Study|Withdrawal by Subject|1
2055799|NCT00529373|3629244|FG000|Base Study|Adverse Event|525
2055800|NCT00529373|3629245|FG001|Base Study|Adverse Event|470
2055801|NCT00529373|3629244|FG000|Base Study|Lack of Efficacy|16
2055802|NCT00529373|3629245|FG001|Base Study|Lack of Efficacy|75
2055803|NCT00529373|3629244|FG000|Base Study|Lost to Follow-up|221
2055804|NCT00529373|3629245|FG001|Base Study|Lost to Follow-up|208
2055805|NCT00529373|3629244|FG000|Base Study|Other Protocol Specified Criteria|19
2055806|NCT00529373|3629245|FG001|Base Study|Other Protocol Specified Criteria|20
2055807|NCT00529373|3629244|FG000|Base Study|Physician Decision|60
2055808|NCT00529373|3629245|FG001|Base Study|Physician Decision|52
2055809|NCT00529373|3629244|FG000|Base Study|Protocol Violation|48
2055810|NCT00529373|3629245|FG001|Base Study|Protocol Violation|38
2055811|NCT00529373|3629244|FG000|Base Study|Withdrawal by Subject|1062
2055812|NCT00529373|3629245|FG001|Base Study|Withdrawal by Subject|967
2055813|NCT00529373|3629244|FG000|Base Study|Did not continue into Extension|1795
2055814|NCT00529373|3629245|FG001|Base Study|Did not continue into Extension|2238
2055815|NCT00529373|3629244|FG000|First Extension Study|Adverse Event|162
2055816|NCT00529373|3629245|FG001|First Extension Study|Adverse Event|142
2055817|NCT00529373|3629244|FG000|First Extension Study|Lack of Efficacy|65
2055818|NCT00529373|3629245|FG001|First Extension Study|Lack of Efficacy|427
2055819|NCT00529373|3629244|FG000|First Extension Study|Lost to Follow-up|41
2055820|NCT00529373|3629245|FG001|First Extension Study|Lost to Follow-up|37
2055821|NCT00529373|3629244|FG000|First Extension Study|Other|27
2055822|NCT00529373|3629245|FG001|First Extension Study|Other|47
2055823|NCT00529373|3629244|FG000|First Extension Study|Physician Decision|50
2055824|NCT00529373|3629245|FG001|First Extension Study|Physician Decision|45
2055825|NCT00529373|3629244|FG000|First Extension Study|Protocol Violation|16
2055826|NCT00529373|3629245|FG001|First Extension Study|Protocol Violation|13
2055827|NCT00529373|3629244|FG000|First Extension Study|Withdrawal by Subject|296
2055828|NCT00529373|3629245|FG001|First Extension Study|Withdrawal by Subject|287
2055829|NCT00529373|3629244|FG000|First Extension Study|Disposition record non-existing|0
2055830|NCT00529373|3629245|FG001|First Extension Study|Disposition record non-existing|1
2055831|NCT00529373|3629244|FG000|First Extension Study|Discontinued after 5 years completion|208
2055832|NCT00529373|3629245|FG001|First Extension Study|Discontinued after 5 years completion|346
2055833|NCT00529373|3629244|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256
2055834|NCT00529373|3629245|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281
2209623|NCT01646177|3849238|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
2055835|NCT00529373|3629244|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
2055836|NCT00529373|3629245|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
2055837|NCT00529373|3629244|FG000|Second Extension Study|Adverse Event|101
2055838|NCT00529373|3629245|FG001|Second Extension Study|Adverse Event|51
2055839|NCT00529373|3629244|FG000|Second Extension Study|Lack of Efficacy|7
2055840|NCT00529373|3629245|FG001|Second Extension Study|Lack of Efficacy|15
2055841|NCT00529373|3629244|FG000|Second Extension Study|Lost to Follow-up|18
2055842|NCT00529373|3629245|FG001|Second Extension Study|Lost to Follow-up|12
2055843|NCT00529373|3629244|FG000|Second Extension Study|Other|7
2055844|NCT00529373|3629245|FG001|Second Extension Study|Other|12
2055845|NCT00529373|3629244|FG000|Second Extension Study|Physician Decision|63
2055846|NCT00529373|3629245|FG001|Second Extension Study|Physician Decision|26
2055847|NCT00529373|3629244|FG000|Second Extension Study|Protocol Violation|2
2055848|NCT00529373|3629245|FG001|Second Extension Study|Protocol Violation|1
2055849|NCT00529373|3629244|FG000|Second Extension Study|Withdrawal by Subject|97
2055850|NCT00529373|3629245|FG001|Second Extension Study|Withdrawal by Subject|75
2055851|NCT00529373|3629244|FG000|Second Extension Study|Status Missing|5
2055852|NCT00529373|3629245|FG001|Second Extension Study|Status Missing|5
2055853|NCT00529386|3629259|FG000|Overall Study|Lost to Follow-up|1
2055854|NCT00529399|3629266|FG000|Overall Study|Lost to Follow-up|1
2055855|NCT00529399|3629267|FG001|Overall Study|Lost to Follow-up|0
2055856|NCT00529399|3629268|FG002|Overall Study|Lost to Follow-up|1
2055857|NCT00529399|3629266|FG000|Overall Study|Withdrawal by Subject|1
2055858|NCT00529399|3629267|FG001|Overall Study|Withdrawal by Subject|0
2055859|NCT00529399|3629268|FG002|Overall Study|Withdrawal by Subject|1
2055860|NCT00529399|3629266|FG000|Overall Study|Non-compliant|0
2055861|NCT00529399|3629267|FG001|Overall Study|Non-compliant|1
2055862|NCT00529399|3629268|FG002|Overall Study|Non-compliant|0
2055863|NCT00529451|3629280|FG000|Overall Study|Subject withdrew consent|16
2055864|NCT00529451|3629281|FG001|Overall Study|Subject withdrew consent|21
2055865|NCT00529451|3629282|FG002|Overall Study|Subject withdrew consent|13
2055866|NCT00529451|3629283|FG003|Overall Study|Subject withdrew consent|12
2209624|NCT01646177|3849239|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
2055867|NCT00529451|3629280|FG000|Overall Study|Adverse Event|9
2055868|NCT00529451|3629281|FG001|Overall Study|Adverse Event|16
2055869|NCT00529451|3629282|FG002|Overall Study|Adverse Event|14
2055870|NCT00529451|3629283|FG003|Overall Study|Adverse Event|8
2055871|NCT00529451|3629280|FG000|Overall Study|Unsatisfactory therapeutic response|6
2055872|NCT00529451|3629281|FG001|Overall Study|Unsatisfactory therapeutic response|2
2055873|NCT00529451|3629282|FG002|Overall Study|Unsatisfactory therapeutic response|5
2055874|NCT00529451|3629283|FG003|Overall Study|Unsatisfactory therapeutic response|4
2055875|NCT00529451|3629280|FG000|Overall Study|Lost to Follow-up|4
2055876|NCT00529451|3629281|FG001|Overall Study|Lost to Follow-up|7
2055877|NCT00529451|3629282|FG002|Overall Study|Lost to Follow-up|4
2055878|NCT00529451|3629283|FG003|Overall Study|Lost to Follow-up|4
2055879|NCT00529451|3629280|FG000|Overall Study|Protocol deviation|1
2055880|NCT00529451|3629281|FG001|Overall Study|Protocol deviation|1
2055881|NCT00529451|3629282|FG002|Overall Study|Protocol deviation|4
2055882|NCT00529451|3629283|FG003|Overall Study|Protocol deviation|1
2055883|NCT00529451|3629280|FG000|Overall Study|Administrative problems|1
2055884|NCT00529451|3629281|FG001|Overall Study|Administrative problems|1
2055885|NCT00529451|3629282|FG002|Overall Study|Administrative problems|0
2055886|NCT00529451|3629283|FG003|Overall Study|Administrative problems|2
2055887|NCT00529516|3629299|FG000|Overall Study|Adverse Event|2
2055888|NCT00529516|3629300|FG001|Overall Study|Adverse Event|1
2055889|NCT00529516|3629301|FG002|Overall Study|Adverse Event|0
2055890|NCT00529516|3629299|FG000|Overall Study|Withdrawal by Subject|1
2055891|NCT00529516|3629300|FG001|Overall Study|Withdrawal by Subject|1
2055892|NCT00529516|3629301|FG002|Overall Study|Withdrawal by Subject|0
2055893|NCT00529516|3629299|FG000|Overall Study|Lost to Follow-up|0
2055894|NCT00529516|3629300|FG001|Overall Study|Lost to Follow-up|0
2055895|NCT00529516|3629301|FG002|Overall Study|Lost to Follow-up|1
2055896|NCT00529529|3629312|FG000|Overall Study|Adverse Event|12
2055897|NCT00529529|3629313|FG001|Overall Study|Adverse Event|17
2055898|NCT00529529|3629314|FG002|Overall Study|Adverse Event|8
2055899|NCT00529529|3629312|FG000|Overall Study|Subject withdrew consent|12
2055900|NCT00529529|3629313|FG001|Overall Study|Subject withdrew consent|9
2055901|NCT00529529|3629314|FG002|Overall Study|Subject withdrew consent|12
2055902|NCT00529529|3629312|FG000|Overall Study|Protocol deviation|8
2055903|NCT00529529|3629313|FG001|Overall Study|Protocol deviation|12
2055904|NCT00529529|3629314|FG002|Overall Study|Protocol deviation|5
2055905|NCT00529529|3629312|FG000|Overall Study|Lost to Follow-up|5
2055906|NCT00529529|3629313|FG001|Overall Study|Lost to Follow-up|3
2055907|NCT00529529|3629314|FG002|Overall Study|Lost to Follow-up|1
2055908|NCT00529529|3629312|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2055909|NCT00529529|3629313|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2055910|NCT00529529|3629314|FG002|Overall Study|Unsatisfactory therapeutic effect|2
2055911|NCT00529529|3629312|FG000|Overall Study|Death|2
2055912|NCT00529529|3629313|FG001|Overall Study|Death|0
2055913|NCT00529529|3629314|FG002|Overall Study|Death|0
2055914|NCT00529529|3629312|FG000|Overall Study|Abnormal test procedure result(s)|1
2055915|NCT00529529|3629313|FG001|Overall Study|Abnormal test procedure result(s)|0
2055916|NCT00529529|3629314|FG002|Overall Study|Abnormal test procedure result(s)|0
2055917|NCT00529529|3629312|FG000|Overall Study|Administrative problems|1
2055918|NCT00529529|3629313|FG001|Overall Study|Administrative problems|0
2055919|NCT00529529|3629314|FG002|Overall Study|Administrative problems|3
2055920|NCT00529542|3629324|FG000|Overall Study|Withdrawal by Subject|1
2055921|NCT00529542|3629325|FG001|Overall Study|Withdrawal by Subject|0
2055922|NCT00529542|3629324|FG000|Overall Study|Lost to Follow-up|0
2055923|NCT00529542|3629325|FG001|Overall Study|Lost to Follow-up|1
2055924|NCT00529568|3629346|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
2055925|NCT00529568|3629347|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
2055926|NCT00529568|3629348|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
2055927|NCT00529568|3629346|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
2055928|NCT00529568|3629347|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
2055929|NCT00529568|3629348|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
2055930|NCT00529568|3629346|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
2055931|NCT00529568|3629347|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
2055932|NCT00529568|3629348|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
2055933|NCT00529568|3629346|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
2055934|NCT00529568|3629347|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
2055935|NCT00529568|3629348|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
2055936|NCT00529568|3629346|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
2055937|NCT00529568|3629347|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
2055938|NCT00529568|3629348|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
2055939|NCT00529568|3629346|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
2055940|NCT00529568|3629347|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
2055941|NCT00529568|3629348|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
2055942|NCT00529568|3629346|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
2055943|NCT00529568|3629347|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
2055944|NCT00529568|3629348|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
2055945|NCT00529568|3629346|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
2055946|NCT00529568|3629347|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
2105526|NCT00857311|3698082|FG002|Overall Study|Lost to Follow-up|0
2055947|NCT00529568|3629348|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
2055948|NCT00529568|3629346|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
2055949|NCT00529568|3629347|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
2055950|NCT00529568|3629348|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
2055951|NCT00529568|3629346|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
2055952|NCT00529568|3629347|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
2055953|NCT00529568|3629348|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
2055954|NCT00529568|3629346|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
2055955|NCT00529568|3629347|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
2055956|NCT00529568|3629348|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
2055957|NCT00529633|3629359|FG000|Overall Study|Withdrawal by Subject|1
2055958|NCT00529633|3629360|FG001|Overall Study|Withdrawal by Subject|1
2055959|NCT00529659|3629368|FG000|Overall Study|Adverse Event|8
2055960|NCT00529659|3629369|FG001|Overall Study|Adverse Event|7
2055961|NCT00529659|3629368|FG000|Overall Study|Lost to Follow-up|0
2055962|NCT00529659|3629369|FG001|Overall Study|Lost to Follow-up|2
2055963|NCT00529659|3629368|FG000|Overall Study|Physician Decision|0
2055964|NCT00529659|3629369|FG001|Overall Study|Physician Decision|2
2055965|NCT00529659|3629368|FG000|Overall Study|Protocol Violation|2
2055966|NCT00529659|3629369|FG001|Overall Study|Protocol Violation|6
2055967|NCT00529659|3629368|FG000|Overall Study|Withdrawal by Subject|1
2055968|NCT00529659|3629369|FG001|Overall Study|Withdrawal by Subject|6
2055969|NCT00529789|3629375|FG000|Study Period II/III|Parent/Caregiver Decision|9
2055970|NCT00529789|3629375|FG000|Study Period II/III|Adverse Event|3
2055971|NCT00529789|3629375|FG000|Study Period II/III|Lack of Efficacy|2
2055972|NCT00529789|3629375|FG000|Study Period II/III|Withdrawal by Subject|1
2055973|NCT00529789|3629375|FG000|Study Period II/III|Protocol Violation|3
2055974|NCT00529789|3629375|FG000|Study Period II/III|Physician Decision|3
2055975|NCT00529789|3629375|FG000|Study Period II/III|Lost to Follow-up|3
2055976|NCT00529789|3629375|FG000|Study Period IV|Parent/Caregiver Decision|1
2055977|NCT00529789|3629375|FG000|Study Period IV|Adverse Event|1
2055978|NCT00529789|3629375|FG000|Study Period IV|Lack of Efficacy|1
2055979|NCT00529789|3629375|FG000|Study Period IV|Lost to Follow-up|3
2055980|NCT00529802|3629385|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
2055981|NCT00529802|3629385|FG000|Evaluable for Primary Endpoint|Worsening performance status|2
2055982|NCT00529802|3629385|FG000|Evaluable for Primary Endpoint|Adverse Event|2
2055983|NCT00529802|3629385|FG000|Evaluable for Primary Endpoint|Death|1
2055984|NCT00529802|3629385|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1
2055985|NCT00529802|3629385|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1
2055986|NCT00529802|3629385|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
2055987|NCT00529958|3629394|FG000|2-Year Follow-up|Lost to Follow-up|1
2055988|NCT00529958|3629395|FG001|2-Year Follow-up|Lost to Follow-up|2
2055989|NCT00529958|3629396|FG002|2-Year Follow-up|Lost to Follow-up|2
2055990|NCT00529958|3629394|FG000|2-Year Follow-up|Withdrawal by Subject|3
2055991|NCT00529958|3629395|FG001|2-Year Follow-up|Withdrawal by Subject|0
2055992|NCT00529958|3629396|FG002|2-Year Follow-up|Withdrawal by Subject|0
2055993|NCT00529958|3629394|FG000|5-Year Follow-up|Lost to Follow-up|2
2055994|NCT00529958|3629395|FG001|5-Year Follow-up|Lost to Follow-up|3
2055995|NCT00529958|3629396|FG002|5-Year Follow-up|Lost to Follow-up|1
2055996|NCT00529958|3629394|FG000|5-Year Follow-up|Withdrawal by Subject|1
2055997|NCT00529958|3629395|FG001|5-Year Follow-up|Withdrawal by Subject|0
2055998|NCT00529958|3629396|FG002|5-Year Follow-up|Withdrawal by Subject|0
2055999|NCT00530023|3629406|FG000|Overall Study|Withdrawal by Subject|0
2056000|NCT00530023|3629407|FG001|Overall Study|Withdrawal by Subject|1
2056001|NCT00530075|3629413|FG000|Overall Study|Adverse Event|1
2056002|NCT00530075|3629413|FG000|Overall Study|Death|1
2056003|NCT00530075|3629413|FG000|Overall Study|Lack of Efficacy|3
2056004|NCT00530075|3629413|FG000|Overall Study|Protocol Violation|1
2056005|NCT00530075|3629413|FG000|Overall Study|Withdrawal by Subject|1
2056006|NCT00530088|3629417|FG000|Overall Study|Disease Progression|4
2056007|NCT00530088|3629417|FG000|Overall Study|Physician Decision|4
2056008|NCT00530088|3629417|FG000|Overall Study|Other Not Specified|2
2056009|NCT00530218|3629421|FG000|Overall Study|CMV Not Detected|13
2056010|NCT00530218|3629421|FG000|Overall Study|Death|12
2056011|NCT00530257|3629428|FG000|Overall Study|Lost to Follow-up|1
2056012|NCT00530270|3629437|FG000|Overall Study|Protocol Violation|1
2056013|NCT00530270|3629438|FG001|Overall Study|Protocol Violation|0
2056014|NCT00530335|3629444|FG000|Overall Study|Adverse Event|3
2056015|NCT00530335|3629444|FG000|Overall Study|Protocol Violation|1
2056016|NCT00530335|3629444|FG000|Overall Study|Withdrawal by Subject|1
2056017|NCT00530335|3629444|FG000|Overall Study|Physician Decision|1
2056018|NCT00530348|3629450|FG000|Overall Study|Adverse Event|5
2056019|NCT00530348|3629451|FG001|Overall Study|Adverse Event|1
2056020|NCT00530348|3629450|FG000|Overall Study|Death|0
2056021|NCT00530348|3629451|FG001|Overall Study|Death|1
2056022|NCT00530348|3629450|FG000|Overall Study|Lack of Efficacy|2
2056023|NCT00530348|3629451|FG001|Overall Study|Lack of Efficacy|0
2056024|NCT00530348|3629450|FG000|Overall Study|Lost to Follow-up|0
2056025|NCT00530348|3629451|FG001|Overall Study|Lost to Follow-up|2
2056026|NCT00530348|3629450|FG000|Overall Study|Physician Decision|1
2056027|NCT00530348|3629451|FG001|Overall Study|Physician Decision|2
2056028|NCT00530348|3629450|FG000|Overall Study|Pregnancy|1
2056029|NCT00530348|3629451|FG001|Overall Study|Pregnancy|0
2056030|NCT00530348|3629450|FG000|Overall Study|Withdrawal by Subject|12
2056031|NCT00530348|3629451|FG001|Overall Study|Withdrawal by Subject|12
2056032|NCT00530348|3629450|FG000|Overall Study|Randomised in error|1
2056033|NCT00530348|3629451|FG001|Overall Study|Randomised in error|0
2056034|NCT00530348|3629450|FG000|Overall Study|Noncompliance with inclusion criterion 3|0
2056035|NCT00530348|3629451|FG001|Overall Study|Noncompliance with inclusion criterion 3|1
2056036|NCT00530439|3629459|FG000|Overall Study|GDM|9
2056037|NCT00530439|3629460|FG001|Overall Study|GDM|3
2056038|NCT00530439|3629459|FG000|Overall Study|Withdraw|18
2056039|NCT00530439|3629460|FG001|Overall Study|Withdraw|14
2056040|NCT00530439|3629459|FG000|Overall Study|Missed abortion|1
2056041|NCT00530439|3629460|FG001|Overall Study|Missed abortion|4
2056042|NCT00530439|3629459|FG000|Overall Study|Misclassification|2
2056043|NCT00530439|3629460|FG001|Overall Study|Misclassification|0
2056044|NCT00530439|3629459|FG000|Overall Study|Twin pregnancy|0
2056045|NCT00530439|3629460|FG001|Overall Study|Twin pregnancy|2
2056046|NCT00530439|3629459|FG000|Overall Study|Severe malformation/abortion|0
2056047|NCT00530439|3629460|FG001|Overall Study|Severe malformation/abortion|3
2056048|NCT00530504|3629466|FG000|Overall Study|Death|54
2056049|NCT00530504|3629466|FG000|Overall Study|Lost to Follow-up|26
2056050|NCT00530504|3629466|FG000|Overall Study|Withdrawal by Subject|39
2056051|NCT00530504|3629466|FG000|Overall Study|Exited study due to other reasons|33
2056052|NCT00530621|3629472|FG000|Overall Study|Adverse Event|11
2056053|NCT00530621|3629473|FG001|Overall Study|Adverse Event|8
2056054|NCT00530621|3629472|FG000|Overall Study|Physician Decision|2
2056055|NCT00530621|3629473|FG001|Overall Study|Physician Decision|4
2056056|NCT00530621|3629472|FG000|Overall Study|Progressive Disease (PD)|47
2056057|NCT00530621|3629473|FG001|Overall Study|Progressive Disease (PD)|40
2056058|NCT00530621|3629472|FG000|Overall Study|Sponsor Decision|12
2056059|NCT00530621|3629473|FG001|Overall Study|Sponsor Decision|15
2056060|NCT00530621|3629472|FG000|Overall Study|Subject Decision|4
2056061|NCT00530621|3629473|FG001|Overall Study|Subject Decision|7
2056062|NCT00530621|3629472|FG000|Overall Study|Death|3
2056063|NCT00530621|3629473|FG001|Overall Study|Death|6
2056064|NCT00530621|3629472|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1
2056065|NCT00530621|3629473|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0
2056066|NCT00530712|3629487|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2
2056067|NCT00530712|3629487|FG000|30 Day Follow-up Visit|Missed Visit|5
2056068|NCT00530712|3629487|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4
2056069|NCT00530712|3629487|FG000|6 Month Follow-up Visit|Missed Visit|3
2056070|NCT00530712|3629487|FG000|6 Month Follow-up Visit|Lost to Follow-up|3
2056071|NCT00530712|3629487|FG000|6 Month Follow-up Visit|Death|2
2056072|NCT00530712|3629487|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5
2056073|NCT00530712|3629487|FG000|12 Month Follow-up Visit|Missed Visit|3
2056074|NCT00530712|3629487|FG000|12 Month Follow-up Visit|Lost to Follow-up|7
2056075|NCT00530712|3629487|FG000|12 Month Follow-up Visit|Death|9
2056076|NCT00530777|3629514|FG000|Overall Study|Lost to Follow-up|0
2056077|NCT00530777|3629515|FG001|Overall Study|Lost to Follow-up|1
2056078|NCT00530777|3629514|FG000|Overall Study|Death|1
2056079|NCT00530777|3629515|FG001|Overall Study|Death|2
2056080|NCT00530777|3629514|FG000|Overall Study|Physician Decision|1
2056081|NCT00530777|3629515|FG001|Overall Study|Physician Decision|0
2056082|NCT00530777|3629514|FG000|Overall Study|Withdrawal by Subject|0
2056083|NCT00530777|3629515|FG001|Overall Study|Withdrawal by Subject|1
2056084|NCT00530777|3629514|FG000|Overall Study|Unable to adhere to visit schedule|5
2056085|NCT00530777|3629515|FG001|Overall Study|Unable to adhere to visit schedule|1
2056086|NCT00530790|3629521|FG000|Overall Study|Adverse Event|2
2056087|NCT00530790|3629521|FG000|Overall Study|Withdrawal by Subject|2
2056088|NCT00530790|3629521|FG000|Overall Study|Physician Decision|1
2056089|NCT00530816|3629537|FG000|Overall Study|Progressive Disease|16
2056090|NCT00530816|3629538|FG001|Overall Study|Progressive Disease|24
2056091|NCT00530816|3629539|FG002|Overall Study|Progressive Disease|24
2056092|NCT00530816|3629537|FG000|Overall Study|Adverse Event|6
2056093|NCT00530816|3629538|FG001|Overall Study|Adverse Event|13
2056094|NCT00530816|3629539|FG002|Overall Study|Adverse Event|7
2056095|NCT00530816|3629537|FG000|Overall Study|Other|3
2056096|NCT00530816|3629538|FG001|Overall Study|Other|3
2056097|NCT00530816|3629539|FG002|Overall Study|Other|4
2056098|NCT00530816|3629537|FG000|Overall Study|Withdrawal by Subject|1
2056099|NCT00530816|3629538|FG001|Overall Study|Withdrawal by Subject|2
2056100|NCT00530816|3629539|FG002|Overall Study|Withdrawal by Subject|6
2056101|NCT00530842|3629549|FG000|Overall Study|Adverse Event|10
2056102|NCT00530842|3629550|FG001|Overall Study|Adverse Event|6
2056103|NCT00530842|3629549|FG000|Overall Study|Lack of Efficacy|2
2056104|NCT00530842|3629550|FG001|Overall Study|Lack of Efficacy|1
2056105|NCT00530842|3629549|FG000|Overall Study|Lost to Follow-up|0
2056106|NCT00530842|3629550|FG001|Overall Study|Lost to Follow-up|4
2056107|NCT00530842|3629549|FG000|Overall Study|Protocol Violation|3
2056108|NCT00530842|3629550|FG001|Overall Study|Protocol Violation|2
2056109|NCT00530842|3629549|FG000|Overall Study|Withdrawal by Subject|4
2056110|NCT00530842|3629550|FG001|Overall Study|Withdrawal by Subject|5
2056111|NCT00530842|3629549|FG000|Overall Study|Individual different reasons|4
2056112|NCT00530842|3629550|FG001|Overall Study|Individual different reasons|3
2056113|NCT00530842|3629549|FG000|Period 1|Adverse Event|7
2056114|NCT00530842|3629550|FG001|Period 1|Adverse Event|3
2056115|NCT00530842|3629549|FG000|Period 1|Lack of Efficacy|1
2056116|NCT00530842|3629550|FG001|Period 1|Lack of Efficacy|1
2056117|NCT00530842|3629549|FG000|Period 1|Protocol Violation|2
2056118|NCT00530842|3629550|FG001|Period 1|Protocol Violation|1
2056119|NCT00530842|3629549|FG000|Period 1|Withdrawal by Subject|2
2056120|NCT00530842|3629550|FG001|Period 1|Withdrawal by Subject|3
2056121|NCT00530842|3629549|FG000|Period 1|Individual different reasons|2
2056122|NCT00530842|3629550|FG001|Period 1|Individual different reasons|3
2056123|NCT00530842|3629549|FG000|Period 2|Adverse Event|3
2056124|NCT00530842|3629550|FG001|Period 2|Adverse Event|3
2056125|NCT00530842|3629549|FG000|Period 2|Lack of Efficacy|1
2056126|NCT00530842|3629550|FG001|Period 2|Lack of Efficacy|0
2056127|NCT00530842|3629549|FG000|Period 2|Lost to Follow-up|0
2056128|NCT00530842|3629550|FG001|Period 2|Lost to Follow-up|4
2056129|NCT00530842|3629549|FG000|Period 2|Protocol Violation|1
2056130|NCT00530842|3629550|FG001|Period 2|Protocol Violation|0
2056131|NCT00530842|3629549|FG000|Period 2|Withdrawal by Subject|1
2056132|NCT00530842|3629550|FG001|Period 2|Withdrawal by Subject|2
2056133|NCT00530842|3629549|FG000|Period 2|Individual different reasons|2
2056134|NCT00530842|3629550|FG001|Period 2|Individual different reasons|0
2056135|NCT00530855|3629558|FG000|Overall Study|Lack of Efficacy|20
2056136|NCT00530855|3629558|FG000|Overall Study|Withdrawal by Subject|30
2056137|NCT00530855|3629558|FG000|Overall Study|Fatal Serious AE|3
2056138|NCT00530855|3629558|FG000|Overall Study|Non Fatal Serious AE|7
2056139|NCT00530855|3629558|FG000|Overall Study|Non Fatal Non Serious AE|12
2056140|NCT00530855|3629558|FG000|Overall Study|Protocol Violation|3
2056141|NCT00530855|3629558|FG000|Overall Study|Unsatisfactory compliance of subject|11
2056142|NCT00530855|3629558|FG000|Overall Study|Lost to Follow-up|9
2056143|NCT00530855|3629558|FG000|Overall Study|Other reason for premature termination|17
2056144|NCT00530894|3629566|FG000|Overall Study|Death|84
2056145|NCT00530894|3629567|FG001|Overall Study|Death|89
2056146|NCT00530894|3629568|FG002|Overall Study|Death|55
2056147|NCT00530894|3629569|FG003|Overall Study|Death|89
2056148|NCT00530894|3629566|FG000|Overall Study|Lost to Follow-up|1
2056149|NCT00530894|3629567|FG001|Overall Study|Lost to Follow-up|3
2056150|NCT00530894|3629568|FG002|Overall Study|Lost to Follow-up|0
2056151|NCT00530894|3629569|FG003|Overall Study|Lost to Follow-up|0
2056152|NCT00530894|3629566|FG000|Overall Study|Withdrawal by Subject|1
2056153|NCT00530894|3629567|FG001|Overall Study|Withdrawal by Subject|23
2056154|NCT00530894|3629568|FG002|Overall Study|Withdrawal by Subject|0
2056155|NCT00530894|3629569|FG003|Overall Study|Withdrawal by Subject|5
2056156|NCT00530894|3629566|FG000|Overall Study|Alive and censored prior to 1 year|2
2056157|NCT00530894|3629567|FG001|Overall Study|Alive and censored prior to 1 year|0
2056158|NCT00530894|3629568|FG002|Overall Study|Alive and censored prior to 1 year|0
2056159|NCT00530894|3629569|FG003|Overall Study|Alive and censored prior to 1 year|0
2056160|NCT00530920|3629584|FG000|Overall Study|Randomized but not treated|0
2056161|NCT00530920|3629585|FG001|Overall Study|Randomized but not treated|2
2056162|NCT00530920|3629586|FG002|Overall Study|Randomized but not treated|0
2056163|NCT00530920|3629584|FG000|Overall Study|Adverse Event|0
2056164|NCT00530920|3629585|FG001|Overall Study|Adverse Event|0
2056165|NCT00530920|3629586|FG002|Overall Study|Adverse Event|3
2056166|NCT00530920|3629584|FG000|Overall Study|Withdrawal by Subject|0
2056167|NCT00530920|3629585|FG001|Overall Study|Withdrawal by Subject|0
2056168|NCT00530920|3629586|FG002|Overall Study|Withdrawal by Subject|1
2056169|NCT00530946|3629599|FG000|Overall Study|Adverse Event|1
2056170|NCT00530946|3629600|FG001|Overall Study|Adverse Event|2
2056171|NCT00530946|3629601|FG002|Overall Study|Adverse Event|1
2056172|NCT00530946|3629602|FG003|Overall Study|Adverse Event|1
2056173|NCT00530946|3629599|FG000|Overall Study|Protocol Violation|0
2056174|NCT00530946|3629600|FG001|Overall Study|Protocol Violation|0
2056175|NCT00530946|3629601|FG002|Overall Study|Protocol Violation|0
2056176|NCT00530946|3629602|FG003|Overall Study|Protocol Violation|1
2056177|NCT00530946|3629599|FG000|Overall Study|Noncompliance|1
2056178|NCT00530946|3629600|FG001|Overall Study|Noncompliance|0
2056179|NCT00530946|3629601|FG002|Overall Study|Noncompliance|0
2056180|NCT00530946|3629602|FG003|Overall Study|Noncompliance|0
2056181|NCT00531011|3629614|FG000|Overall Study|Withdrawal by Subject|2
2056182|NCT00531011|3629615|FG001|Overall Study|Withdrawal by Subject|4
2056183|NCT00531011|3629614|FG000|Overall Study|Death|1
2056184|NCT00531011|3629615|FG001|Overall Study|Death|0
2056185|NCT00531011|3629614|FG000|Overall Study|Lost to Follow-up|1
2056186|NCT00531011|3629615|FG001|Overall Study|Lost to Follow-up|0
2056187|NCT00531011|3629614|FG000|Overall Study|Physician Decision|0
2056188|NCT00531011|3629615|FG001|Overall Study|Physician Decision|3
2056189|NCT00531050|3629627|FG000|Part 1: Period 1|Adverse Event|0
2056190|NCT00531050|3629628|FG001|Part 1: Period 1|Adverse Event|1
2056191|NCT00531050|3629629|FG002|Part 1: Period 1|Adverse Event|0
2056192|NCT00531050|3629630|FG003|Part 1: Period 1|Adverse Event|0
2056193|NCT00531050|3629631|FG004|Part 1: Period 1|Adverse Event|0
2056194|NCT00531050|3629632|FG005|Part 1: Period 1|Adverse Event|0
2056195|NCT00531050|3629627|FG000|Part 1: Period 1|Protocol Deviation|0
2056196|NCT00531050|3629628|FG001|Part 1: Period 1|Protocol Deviation|0
2056197|NCT00531050|3629629|FG002|Part 1: Period 1|Protocol Deviation|0
2056198|NCT00531050|3629630|FG003|Part 1: Period 1|Protocol Deviation|1
2056199|NCT00531050|3629631|FG004|Part 1: Period 1|Protocol Deviation|0
2056200|NCT00531050|3629632|FG005|Part 1: Period 1|Protocol Deviation|0
2056201|NCT00531050|3629627|FG000|Part 1: Period 3|Adverse Event|1
2056202|NCT00531050|3629628|FG001|Part 1: Period 3|Adverse Event|0
2056203|NCT00531050|3629629|FG002|Part 1: Period 3|Adverse Event|0
2056204|NCT00531050|3629630|FG003|Part 1: Period 3|Adverse Event|0
2056205|NCT00531050|3629631|FG004|Part 1: Period 3|Adverse Event|0
2056206|NCT00531050|3629632|FG005|Part 1: Period 3|Adverse Event|0
2056207|NCT00531050|3629627|FG000|Part 2: Period 1|Adverse Event|0
2056208|NCT00531050|3629628|FG001|Part 2: Period 1|Adverse Event|0
2217681|NCT01709305|3860931|FG003|Phase 2|Clinical Adverse Event|6
2056209|NCT00531050|3629629|FG002|Part 2: Period 1|Adverse Event|0
2056210|NCT00531050|3629630|FG003|Part 2: Period 1|Adverse Event|0
2056211|NCT00531050|3629631|FG004|Part 2: Period 1|Adverse Event|0
2056212|NCT00531050|3629632|FG005|Part 2: Period 1|Adverse Event|1
2056213|NCT00531050|3629627|FG000|Part 2: Period 3|Abnormal test procedure|1
2056214|NCT00531050|3629628|FG001|Part 2: Period 3|Abnormal test procedure|0
2056215|NCT00531050|3629629|FG002|Part 2: Period 3|Abnormal test procedure|0
2056216|NCT00531050|3629630|FG003|Part 2: Period 3|Abnormal test procedure|0
2056217|NCT00531050|3629631|FG004|Part 2: Period 3|Abnormal test procedure|0
2056218|NCT00531050|3629632|FG005|Part 2: Period 3|Abnormal test procedure|1
2056219|NCT00531206|3629649|FG000|Overall Study|Adverse Event related|5
2056220|NCT00531206|3629649|FG000|Overall Study|Lack of Efficacy|2
2056221|NCT00531206|3629649|FG000|Overall Study|Lost to Follow-up|5
2056222|NCT00531206|3629649|FG000|Overall Study|including non-related adverse events|8
2056223|NCT00531232|3629656|FG000|Overall Study|Investigator decision|0
2056224|NCT00531232|3629657|FG001|Overall Study|Investigator decision|0
2056225|NCT00531232|3629658|FG002|Overall Study|Investigator decision|4
2056226|NCT00531232|3629656|FG000|Overall Study|Participants refused further treatment|0
2056227|NCT00531232|3629657|FG001|Overall Study|Participants refused further treatment|1
2056228|NCT00531232|3629658|FG002|Overall Study|Participants refused further treatment|2
2056229|NCT00531232|3629656|FG000|Overall Study|Adverse events (AEs)|1
2056230|NCT00531232|3629657|FG001|Overall Study|Adverse events (AEs)|2
2056231|NCT00531232|3629658|FG002|Overall Study|Adverse events (AEs)|2
2056232|NCT00531232|3629656|FG000|Overall Study|Treatment failure|1
2056233|NCT00531232|3629657|FG001|Overall Study|Treatment failure|3
2056234|NCT00531232|3629658|FG002|Overall Study|Treatment failure|7
2056235|NCT00531232|3629656|FG000|Overall Study|Disease recurrence|0
2056236|NCT00531232|3629657|FG001|Overall Study|Disease recurrence|0
2056237|NCT00531232|3629658|FG002|Overall Study|Disease recurrence|1
2056238|NCT00531232|3629656|FG000|Overall Study|Deceased|2
2056239|NCT00531232|3629657|FG001|Overall Study|Deceased|2
2056240|NCT00531232|3629658|FG002|Overall Study|Deceased|2
2056241|NCT00531232|3629656|FG000|Overall Study|Withdrawal by Subject|0
2056242|NCT00531232|3629657|FG001|Overall Study|Withdrawal by Subject|1
2056243|NCT00531232|3629658|FG002|Overall Study|Withdrawal by Subject|2
2056244|NCT00531232|3629656|FG000|Overall Study|Other|0
2056245|NCT00531232|3629657|FG001|Overall Study|Other|0
2056246|NCT00531232|3629658|FG002|Overall Study|Other|5
2056247|NCT00531284|3629686|FG000|Overall Study|Progressive Disease|1
2056248|NCT00531284|3629687|FG001|Overall Study|Progressive Disease|3
2056249|NCT00531284|3629688|FG002|Overall Study|Progressive Disease|5
2056250|NCT00531284|3629689|FG003|Overall Study|Progressive Disease|42
2056251|NCT00531284|3629690|FG004|Overall Study|Progressive Disease|4
2056252|NCT00531284|3629691|FG005|Overall Study|Progressive Disease|4
2056253|NCT00531284|3629692|FG006|Overall Study|Progressive Disease|3
2056254|NCT00531284|3629693|FG007|Overall Study|Progressive Disease|8
2056255|NCT00531284|3629694|FG008|Overall Study|Progressive Disease|6
2056256|NCT00531284|3629695|FG009|Overall Study|Progressive Disease|3
2056257|NCT00531284|3629696|FG010|Overall Study|Progressive Disease|3
2056258|NCT00531284|3629697|FG011|Overall Study|Progressive Disease|14
2056259|NCT00531284|3629698|FG012|Overall Study|Progressive Disease|2
2056260|NCT00531284|3629699|FG013|Overall Study|Progressive Disease|1
2056261|NCT00531284|3629700|FG014|Overall Study|Progressive Disease|2
2056262|NCT00531284|3629701|FG015|Overall Study|Progressive Disease|11
2056263|NCT00531284|3629702|FG016|Overall Study|Progressive Disease|5
2056264|NCT00531284|3629686|FG000|Overall Study|Adverse Event|0
2056265|NCT00531284|3629687|FG001|Overall Study|Adverse Event|1
2056266|NCT00531284|3629688|FG002|Overall Study|Adverse Event|1
2056267|NCT00531284|3629689|FG003|Overall Study|Adverse Event|7
2056268|NCT00531284|3629690|FG004|Overall Study|Adverse Event|0
2056269|NCT00531284|3629691|FG005|Overall Study|Adverse Event|2
2056270|NCT00531284|3629692|FG006|Overall Study|Adverse Event|3
2056271|NCT00531284|3629693|FG007|Overall Study|Adverse Event|2
2056272|NCT00531284|3629694|FG008|Overall Study|Adverse Event|3
2056273|NCT00531284|3629695|FG009|Overall Study|Adverse Event|0
2056274|NCT00531284|3629696|FG010|Overall Study|Adverse Event|0
2056275|NCT00531284|3629697|FG011|Overall Study|Adverse Event|5
2056276|NCT00531284|3629698|FG012|Overall Study|Adverse Event|0
2056277|NCT00531284|3629699|FG013|Overall Study|Adverse Event|1
2056278|NCT00531284|3629700|FG014|Overall Study|Adverse Event|1
2056279|NCT00531284|3629701|FG015|Overall Study|Adverse Event|0
2056280|NCT00531284|3629702|FG016|Overall Study|Adverse Event|2
2056281|NCT00531284|3629686|FG000|Overall Study|Withdrawal by Subject|1
2056282|NCT00531284|3629687|FG001|Overall Study|Withdrawal by Subject|0
2056283|NCT00531284|3629688|FG002|Overall Study|Withdrawal by Subject|0
2056284|NCT00531284|3629689|FG003|Overall Study|Withdrawal by Subject|4
2056285|NCT00531284|3629690|FG004|Overall Study|Withdrawal by Subject|0
2056286|NCT00531284|3629691|FG005|Overall Study|Withdrawal by Subject|0
2056287|NCT00531284|3629692|FG006|Overall Study|Withdrawal by Subject|0
2056288|NCT00531284|3629693|FG007|Overall Study|Withdrawal by Subject|0
2056289|NCT00531284|3629694|FG008|Overall Study|Withdrawal by Subject|0
2056290|NCT00531284|3629695|FG009|Overall Study|Withdrawal by Subject|0
2056291|NCT00531284|3629696|FG010|Overall Study|Withdrawal by Subject|0
2056292|NCT00531284|3629697|FG011|Overall Study|Withdrawal by Subject|3
2056293|NCT00531284|3629698|FG012|Overall Study|Withdrawal by Subject|0
2056294|NCT00531284|3629699|FG013|Overall Study|Withdrawal by Subject|1
2056295|NCT00531284|3629700|FG014|Overall Study|Withdrawal by Subject|0
2056296|NCT00531284|3629701|FG015|Overall Study|Withdrawal by Subject|1
2056297|NCT00531284|3629702|FG016|Overall Study|Withdrawal by Subject|1
2056298|NCT00531284|3629686|FG000|Overall Study|Other|1
2056299|NCT00531284|3629687|FG001|Overall Study|Other|0
2056300|NCT00531284|3629688|FG002|Overall Study|Other|0
2056301|NCT00531284|3629689|FG003|Overall Study|Other|10
2056302|NCT00531284|3629690|FG004|Overall Study|Other|2
2056303|NCT00531284|3629691|FG005|Overall Study|Other|1
2056304|NCT00531284|3629692|FG006|Overall Study|Other|0
2056305|NCT00531284|3629693|FG007|Overall Study|Other|0
2056306|NCT00531284|3629694|FG008|Overall Study|Other|2
2056307|NCT00531284|3629695|FG009|Overall Study|Other|1
2056308|NCT00531284|3629696|FG010|Overall Study|Other|0
2056309|NCT00531284|3629697|FG011|Overall Study|Other|2
2056310|NCT00531284|3629698|FG012|Overall Study|Other|0
2056311|NCT00531284|3629699|FG013|Overall Study|Other|0
2056312|NCT00531284|3629700|FG014|Overall Study|Other|1
2056313|NCT00531284|3629701|FG015|Overall Study|Other|0
2056314|NCT00531284|3629702|FG016|Overall Study|Other|0
2056315|NCT00531427|3629760|FG000|Overall Study|Withdrawal by Subject|7
2056316|NCT00531427|3629761|FG001|Overall Study|Withdrawal by Subject|13
2056317|NCT00531427|3629760|FG000|Overall Study|Adverse Event|44
2056318|NCT00531427|3629761|FG001|Overall Study|Adverse Event|30
2056319|NCT00531427|3629760|FG000|Overall Study|Lost to Follow-up|4
2056320|NCT00531427|3629761|FG001|Overall Study|Lost to Follow-up|3
2056321|NCT00531427|3629760|FG000|Overall Study|Lack of Efficacy|14
2056322|NCT00531427|3629761|FG001|Overall Study|Lack of Efficacy|39
2056323|NCT00531427|3629760|FG000|Overall Study|Administrative|4
2056324|NCT00531427|3629761|FG001|Overall Study|Administrative|9
2056325|NCT00531479|3629779|FG000|Overall Study|Death|68
2056326|NCT00531479|3629780|FG001|Overall Study|Death|71
2056327|NCT00531479|3629779|FG000|Overall Study|Lost to Follow-up|0
2056328|NCT00531479|3629780|FG001|Overall Study|Lost to Follow-up|2
2056329|NCT00531479|3629779|FG000|Overall Study|Other|0
2056330|NCT00531479|3629780|FG001|Overall Study|Other|1
2056331|NCT00531479|3629779|FG000|Overall Study|Withdrawal by Subject|6
2056332|NCT00531479|3629780|FG001|Overall Study|Withdrawal by Subject|6
2056333|NCT00531479|3629779|FG000|Overall Study|Did not receive treatment|2
2056334|NCT00531479|3629780|FG001|Overall Study|Did not receive treatment|3
2056335|NCT00531752|3629811|FG000|First Double-blind Intervention Period|Adverse Event|2
2056336|NCT00531752|3629812|FG001|First Double-blind Intervention Period|Adverse Event|0
2056337|NCT00531752|3629813|FG002|First Double-blind Intervention Period|Adverse Event|1
2056338|NCT00531752|3629814|FG003|First Double-blind Intervention Period|Adverse Event|1
2056339|NCT00531752|3629811|FG000|First Double-blind Intervention Period|Other|1
2056340|NCT00531752|3629812|FG001|First Double-blind Intervention Period|Other|4
2056341|NCT00531752|3629813|FG002|First Double-blind Intervention Period|Other|4
2056342|NCT00531752|3629814|FG003|First Double-blind Intervention Period|Other|0
2056343|NCT00531752|3629811|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2
2056344|NCT00531752|3629812|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0
2056345|NCT00531752|3629813|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1
2056346|NCT00531752|3629814|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1
2056347|NCT00531752|3629811|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
2056348|NCT00531752|3629812|FG001|First Double-blind Intervention Period|Lost to Follow-up|0
2056349|NCT00531752|3629813|FG002|First Double-blind Intervention Period|Lost to Follow-up|1
2056350|NCT00531752|3629814|FG003|First Double-blind Intervention Period|Lost to Follow-up|1
2056351|NCT00531752|3629811|FG000|First Double-blind Intervention Period|Randomized but not treated|1
2056352|NCT00531752|3629812|FG001|First Double-blind Intervention Period|Randomized but not treated|0
2056353|NCT00531752|3629813|FG002|First Double-blind Intervention Period|Randomized but not treated|0
2056354|NCT00531752|3629814|FG003|First Double-blind Intervention Period|Randomized but not treated|0
2056355|NCT00531752|3629811|FG000|Second Double-blind Intervention Period|Adverse Event|1
2056356|NCT00531752|3629812|FG001|Second Double-blind Intervention Period|Adverse Event|1
2056357|NCT00531752|3629813|FG002|Second Double-blind Intervention Period|Adverse Event|0
2056358|NCT00531752|3629814|FG003|Second Double-blind Intervention Period|Adverse Event|0
2056359|NCT00531752|3629811|FG000|Second Double-blind Intervention Period|Other|1
2056360|NCT00531752|3629812|FG001|Second Double-blind Intervention Period|Other|1
2056361|NCT00531752|3629813|FG002|Second Double-blind Intervention Period|Other|0
2056362|NCT00531752|3629814|FG003|Second Double-blind Intervention Period|Other|0
2056363|NCT00531752|3629811|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
2056364|NCT00531752|3629812|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0
2056365|NCT00531752|3629813|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0
2056366|NCT00531752|3629814|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1
2056367|NCT00531752|3629811|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
2056368|NCT00531752|3629812|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0
2056369|NCT00531752|3629813|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0
2056370|NCT00531752|3629814|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1
2105527|NCT00857311|3698083|FG003|Overall Study|Lost to Follow-up|0
2105528|NCT00857389|3698089|FG000|Overall Study|Did not proceed to transplant|2
2105529|NCT00857415|3698095|FG000|Overall Study|Image acquisition failure|2
2105530|NCT00857415|3698096|FG001|Overall Study|Image acquisition failure|0
2105531|NCT00857415|3698095|FG000|Overall Study|Invalid image or not imaged|3
2105532|NCT00857415|3698096|FG001|Overall Study|Invalid image or not imaged|0
2209625|NCT01646177|3849240|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
2217682|NCT01709305|3860932|FG004|Phase 2|Clinical Adverse Event|11
2105533|NCT00857415|3698095|FG000|Overall Study|Subject still living at end of study|110
2105534|NCT00857415|3698096|FG001|Overall Study|Subject still living at end of study|0
2105535|NCT00857415|3698095|FG000|Overall Study|Deceased with no autopsy|2
2105536|NCT00857415|3698096|FG001|Overall Study|Deceased with no autopsy|0
2105537|NCT00857454|3698102|FG000|Overall Study|Withdrawal by Subject|2
2105538|NCT00857454|3698102|FG000|Overall Study|Lost to Follow-up|1
2105539|NCT00857454|3698102|FG000|Overall Study|Adverse Event|2
2105540|NCT00857454|3698102|FG000|Overall Study|Total Testosterone >1050 ng/dL|1
2105541|NCT00857454|3698102|FG000|Overall Study|Total Testosterone <300 ng/dL|8
2105542|NCT00857454|3698102|FG000|Overall Study|MTE09 enrollment criteria not met|6
2105543|NCT00857584|3698158|FG000|Overall Study|Lack of Efficacy|1
2105544|NCT00857584|3698159|FG001|Overall Study|Lack of Efficacy|2
2105545|NCT00857584|3698158|FG000|Overall Study|Adverse Event|2
2105546|NCT00857584|3698159|FG001|Overall Study|Adverse Event|2
2105547|NCT00857584|3698158|FG000|Overall Study|Physician Decision|1
2105548|NCT00857584|3698159|FG001|Overall Study|Physician Decision|1
2105549|NCT00857623|3698167|FG000|Overall Study|Adverse Event|5
2105550|NCT00857623|3698168|FG001|Overall Study|Adverse Event|2
2105551|NCT00857623|3698167|FG000|Overall Study|Study-specific discontinuation criteria|5
2105552|NCT00857623|3698168|FG001|Overall Study|Study-specific discontinuation criteria|3
2105553|NCT00857623|3698167|FG000|Overall Study|Withdrawal by Subject|2
2105554|NCT00857623|3698168|FG001|Overall Study|Withdrawal by Subject|1
2105555|NCT00857623|3698167|FG000|Overall Study|Lack of Efficacy|1
2105556|NCT00857623|3698168|FG001|Overall Study|Lack of Efficacy|1
2105557|NCT00857623|3698167|FG000|Overall Study|Severe non-compliance to protocol|1
2105558|NCT00857623|3698168|FG001|Overall Study|Severe non-compliance to protocol|1
2105559|NCT00857623|3698167|FG000|Overall Study|Intake of prohibited medication|0
2105560|NCT00857623|3698168|FG001|Overall Study|Intake of prohibited medication|1
2105561|NCT00857623|3698167|FG000|Overall Study|Positive for HEP C|0
2105562|NCT00857623|3698168|FG001|Overall Study|Positive for HEP C|1
2105563|NCT00857649|3698176|FG000|Overall Study|Adverse Event|15
2105564|NCT00857649|3698177|FG001|Overall Study|Adverse Event|10
2105565|NCT00857649|3698176|FG000|Overall Study|Non-compliance|1
2105566|NCT00857649|3698177|FG001|Overall Study|Non-compliance|1
2105567|NCT00857649|3698176|FG000|Overall Study|Protocol Violation|2
2105568|NCT00857649|3698177|FG001|Overall Study|Protocol Violation|2
2105569|NCT00857649|3698176|FG000|Overall Study|Withdrawal of Consent|10
2105570|NCT00857649|3698177|FG001|Overall Study|Withdrawal of Consent|7
2105571|NCT00857649|3698176|FG000|Overall Study|Nursing Home Placement|2
2105572|NCT00857649|3698177|FG001|Overall Study|Nursing Home Placement|9
2105573|NCT00857649|3698176|FG000|Overall Study|Other Reasons|1
2105574|NCT00857649|3698177|FG001|Overall Study|Other Reasons|3
2105575|NCT00857766|3698198|FG000|Overall Study|Adverse Event|13
2105576|NCT00857766|3698199|FG001|Overall Study|Adverse Event|12
2105577|NCT00857766|3698198|FG000|Overall Study|Protocol Violation|11
2105578|NCT00857766|3698199|FG001|Overall Study|Protocol Violation|11
2105579|NCT00857766|3698198|FG000|Overall Study|Lost to Follow-up|1
2105580|NCT00857766|3698199|FG001|Overall Study|Lost to Follow-up|0
2105581|NCT00857766|3698198|FG000|Overall Study|Investigator Discretion|2
2105582|NCT00857766|3698199|FG001|Overall Study|Investigator Discretion|3
2105583|NCT00857766|3698198|FG000|Overall Study|Participant Withdrew Consent|4
2105584|NCT00857766|3698199|FG001|Overall Study|Participant Withdrew Consent|4
2105585|NCT00857792|3698205|FG000|Overall Study|inadequate image quality for analysis|12
2105586|NCT00857818|3698211|FG000|Overall Study|Lack of Efficacy|1
2105587|NCT00857818|3698212|FG001|Overall Study|Lack of Efficacy|0
2105588|NCT00857818|3698211|FG000|Overall Study|Adverse Event|3
2105589|NCT00857818|3698212|FG001|Overall Study|Adverse Event|0
2105590|NCT00857818|3698211|FG000|Overall Study|Withdrawal by Subject|0
2105591|NCT00857818|3698212|FG001|Overall Study|Withdrawal by Subject|4
2105592|NCT00857818|3698211|FG000|Overall Study|Sponsor terminated study|6
2105593|NCT00857818|3698212|FG001|Overall Study|Sponsor terminated study|4
2105594|NCT00857818|3698211|FG000|Overall Study|Investigator decision|1
2105595|NCT00857818|3698212|FG001|Overall Study|Investigator decision|0
2105596|NCT00857896|3698230|FG000|Baseline to Week 4|Withdrawal by Subject|1
2105597|NCT00857948|3698239|FG000|Overall Study|Withdrawal by Subject|2
2105598|NCT00857948|3698240|FG001|Overall Study|Withdrawal by Subject|0
2105599|NCT00857948|3698241|FG002|Overall Study|Withdrawal by Subject|0
2056371|NCT00531934|3629856|FG000|Overall Study|Adverse Event|4
2056372|NCT00531934|3629857|FG001|Overall Study|Adverse Event|8
2056373|NCT00531934|3629856|FG000|Overall Study|Progression|52
2056374|NCT00531934|3629857|FG001|Overall Study|Progression|42
2056375|NCT00531934|3629856|FG000|Overall Study|Death|7
2056376|NCT00531934|3629857|FG001|Overall Study|Death|10
2056377|NCT00531934|3629856|FG000|Overall Study|Withdrawal by Subject|1
2056378|NCT00531934|3629857|FG001|Overall Study|Withdrawal by Subject|1
2056379|NCT00531934|3629856|FG000|Overall Study|Other|2
2056380|NCT00531934|3629857|FG001|Overall Study|Other|2
2056381|NCT00531947|3629865|FG000|Overall Study|Adverse Event|5
2056382|NCT00531947|3629866|FG001|Overall Study|Adverse Event|10
2056383|NCT00531947|3629865|FG000|Overall Study|Lost to Follow-up|12
2056384|NCT00531947|3629866|FG001|Overall Study|Lost to Follow-up|9
2056385|NCT00531947|3629865|FG000|Overall Study|Withdrawal by Subject|14
2056386|NCT00531947|3629866|FG001|Overall Study|Withdrawal by Subject|19
2209626|NCT01646177|3849241|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11
2209627|NCT01646177|3849242|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30
2209628|NCT01646177|3849243|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29
2209629|NCT01646177|3849244|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27
2209630|NCT01646177|3849245|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
2209631|NCT01646177|3849246|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
2209632|NCT01646177|3849247|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
2209633|NCT01646177|3849248|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
2209634|NCT01646177|3849237|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
2209635|NCT01646177|3849238|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
2209636|NCT01646177|3849239|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
2209637|NCT01646177|3849240|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
2209638|NCT01646177|3849241|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6
2209639|NCT01646177|3849242|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17
2209640|NCT01646177|3849243|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23
2209641|NCT01646177|3849244|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18
2209642|NCT01646177|3849245|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
2209643|NCT01646177|3849246|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
2209644|NCT01646177|3849247|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
2209645|NCT01646177|3849248|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
2209646|NCT01646177|3849237|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
2300909|NCT02605174|3998640|FG002|Overall Study|Pregnancy|0
2300910|NCT02605174|3998641|FG003|Overall Study|Pregnancy|2
2300911|NCT02605174|3998642|FG004|Overall Study|Pregnancy|0
2300912|NCT02605174|3998643|FG005|Overall Study|Pregnancy|0
2300913|NCT02605174|3998644|FG006|Overall Study|Pregnancy|0
2300914|NCT02605174|3998638|FG000|Overall Study|Withdrawal by Subject|9
2300915|NCT02605174|3998639|FG001|Overall Study|Withdrawal by Subject|6
2300916|NCT02605174|3998640|FG002|Overall Study|Withdrawal by Subject|14
2300917|NCT02605174|3998641|FG003|Overall Study|Withdrawal by Subject|11
2300918|NCT02605174|3998642|FG004|Overall Study|Withdrawal by Subject|6
2300919|NCT02605174|3998643|FG005|Overall Study|Withdrawal by Subject|4
2300920|NCT02605174|3998644|FG006|Overall Study|Withdrawal by Subject|15
2300921|NCT02605174|3998638|FG000|Overall Study|Physician Decision|2
2300922|NCT02605174|3998639|FG001|Overall Study|Physician Decision|0
2300923|NCT02605174|3998640|FG002|Overall Study|Physician Decision|0
2209647|NCT01646177|3849238|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
2209648|NCT01646177|3849239|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
2209649|NCT01646177|3849240|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
2209650|NCT01646177|3849241|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6
2209651|NCT01646177|3849242|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14
2209652|NCT01646177|3849243|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10
2209653|NCT01646177|3849244|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11
2209654|NCT01646177|3849245|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
2209655|NCT01646177|3849246|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
2209656|NCT01646177|3849247|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
2209657|NCT01646177|3849248|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
2209658|NCT01646177|3849237|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0
2209659|NCT01646177|3849238|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0
2209660|NCT01646177|3849239|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0
2209661|NCT01646177|3849240|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0
2209662|NCT01646177|3849241|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3
2209663|NCT01646177|3849242|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5
2209664|NCT01646177|3849243|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5
2217683|NCT01709305|3860928|FG000|Phase 2|Death|0
2300924|NCT02605174|3998641|FG003|Overall Study|Physician Decision|0
2300925|NCT02605174|3998642|FG004|Overall Study|Physician Decision|0
2300926|NCT02605174|3998643|FG005|Overall Study|Physician Decision|0
2056387|NCT00531947|3629865|FG000|Overall Study|Protocol Violation|2
2056388|NCT00531947|3629866|FG001|Overall Study|Protocol Violation|1
2209665|NCT01646177|3849244|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5
2209666|NCT01646177|3849245|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0
2209667|NCT01646177|3849246|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0
2209668|NCT01646177|3849247|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0
2209669|NCT01646177|3849248|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0
2209670|NCT01646177|3849237|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
2209671|NCT01646177|3849238|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
2209672|NCT01646177|3849239|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
2209673|NCT01646177|3849240|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
2209674|NCT01646177|3849241|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1
2209675|NCT01646177|3849242|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4
2209676|NCT01646177|3849243|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
2209677|NCT01646177|3849244|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5
2209678|NCT01646177|3849245|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
2209679|NCT01646177|3849246|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
2209680|NCT01646177|3849247|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
2209681|NCT01646177|3849248|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
2209682|NCT01646177|3849237|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
2209683|NCT01646177|3849238|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
2209684|NCT01646177|3849239|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
2209685|NCT01646177|3849240|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
2209686|NCT01646177|3849241|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3
2209687|NCT01646177|3849242|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
2209688|NCT01646177|3849243|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
2209689|NCT01646177|3849244|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
2209690|NCT01646177|3849245|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
2209691|NCT01646177|3849246|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
2209692|NCT01646177|3849247|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
2209693|NCT01646177|3849248|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
2209694|NCT01646177|3849237|FG000|Long-Term Extension Period (Week 12-264)|Death|0
2209695|NCT01646177|3849238|FG001|Long-Term Extension Period (Week 12-264)|Death|0
2300927|NCT02605174|3998644|FG006|Overall Study|Physician Decision|3
2300928|NCT02605174|3998638|FG000|Overall Study|Randomization Failure|22
2300929|NCT02605174|3998639|FG001|Overall Study|Randomization Failure|6
2300930|NCT02605174|3998640|FG002|Overall Study|Randomization Failure|20
2300931|NCT02605174|3998641|FG003|Overall Study|Randomization Failure|7
2300932|NCT02605174|3998642|FG004|Overall Study|Randomization Failure|16
2300933|NCT02605174|3998643|FG005|Overall Study|Randomization Failure|11
2300934|NCT02605174|3998644|FG006|Overall Study|Randomization Failure|30
2300935|NCT02605447|3998703|FG000|Overall Study|Death|66
2300936|NCT02605447|3998703|FG000|Overall Study|Physician Decision|1
2300937|NCT02605447|3998703|FG000|Overall Study|Lost to Follow-up|24
2300938|NCT02605447|3998703|FG000|Overall Study|Withdrawal by Subject|10
2300939|NCT02605447|3998703|FG000|Overall Study|Not disclosed|1
2300940|NCT02605642|3998710|FG000|Overall Study|Other|11
2300941|NCT02605642|3998711|FG001|Overall Study|Other|1
2300942|NCT02605642|3998710|FG000|Overall Study|Participant non-compliance|2
2300943|NCT02605642|3998711|FG001|Overall Study|Participant non-compliance|4
2300944|NCT02605642|3998710|FG000|Overall Study|Physician Decision|10
2300945|NCT02605642|3998711|FG001|Overall Study|Physician Decision|0
2300946|NCT02605642|3998710|FG000|Overall Study|Lost to Follow-up|12
2209696|NCT01646177|3849239|FG002|Long-Term Extension Period (Week 12-264)|Death|0
2209697|NCT01646177|3849240|FG003|Long-Term Extension Period (Week 12-264)|Death|0
2209698|NCT01646177|3849241|FG004|Long-Term Extension Period (Week 12-264)|Death|1
2209699|NCT01646177|3849242|FG005|Long-Term Extension Period (Week 12-264)|Death|3
2209700|NCT01646177|3849243|FG006|Long-Term Extension Period (Week 12-264)|Death|1
2209701|NCT01646177|3849244|FG007|Long-Term Extension Period (Week 12-264)|Death|3
2209702|NCT01646177|3849245|FG008|Long-Term Extension Period (Week 12-264)|Death|0
2209703|NCT01646177|3849246|FG009|Long-Term Extension Period (Week 12-264)|Death|0
2209704|NCT01646177|3849247|FG010|Long-Term Extension Period (Week 12-264)|Death|0
2300947|NCT02605642|3998711|FG001|Overall Study|Lost to Follow-up|1
2300948|NCT02605642|3998710|FG000|Overall Study|Adverse Event|14
2300949|NCT02605642|3998711|FG001|Overall Study|Adverse Event|2
2300950|NCT02605642|3998710|FG000|Overall Study|Withdrawal by Subject|23
2056389|NCT00531947|3629865|FG000|Overall Study|Non-Compliance|4
2209705|NCT01646177|3849248|FG011|Long-Term Extension Period (Week 12-264)|Death|0
2209706|NCT01646177|3849237|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
2209707|NCT01646177|3849238|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
2209708|NCT01646177|3849239|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
2209709|NCT01646177|3849240|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
2209710|NCT01646177|3849241|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
2300951|NCT02605642|3998711|FG001|Overall Study|Withdrawal by Subject|2
2300952|NCT02605642|3998710|FG000|Overall Study|Lack of response|24
2056390|NCT00531947|3629866|FG001|Overall Study|Non-Compliance|7
2056391|NCT00531947|3629865|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5
2056392|NCT00531947|3629866|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5
2056393|NCT00531960|3629874|FG000|Overall Study|Adverse Event|5
2056394|NCT00531960|3629875|FG001|Overall Study|Adverse Event|4
2056395|NCT00531960|3629874|FG000|Overall Study|Death|3
2056396|NCT00531960|3629875|FG001|Overall Study|Death|2
2056397|NCT00531960|3629874|FG000|Overall Study|Lack of Efficacy|42
2056398|NCT00531960|3629875|FG001|Overall Study|Lack of Efficacy|41
2056399|NCT00531960|3629874|FG000|Overall Study|Violation of Selection Criteria|2
2056400|NCT00531960|3629875|FG001|Overall Study|Violation of Selection Criteria|0
2056401|NCT00531960|3629874|FG000|Overall Study|Refused Treatment|5
2056402|NCT00531960|3629875|FG001|Overall Study|Refused Treatment|6
2056403|NCT00531960|3629874|FG000|Overall Study|Other|4
2056404|NCT00531960|3629875|FG001|Overall Study|Other|10
2056405|NCT00532129|3629881|FG000|Treatment Period|Adverse event/Serious adverse event|25
2056406|NCT00532129|3629881|FG000|Treatment Period|Physician Decision|15
2056407|NCT00532129|3629881|FG000|Treatment Period|Disease progression|3
2056408|NCT00532129|3629881|FG000|Treatment Period|Protocol Violation|1
2056409|NCT00532129|3629881|FG000|Treatment Period|Other|5
2056410|NCT00532129|3629881|FG000|Follow-up Period|Adverse event/Serious adverse event|1
2056411|NCT00532129|3629881|FG000|Follow-up Period|Disease progression|57
2056412|NCT00532129|3629881|FG000|Follow-up Period|Lost to Follow-up|1
2056413|NCT00532129|3629881|FG000|Follow-up Period|Other|6
2056414|NCT00532155|3629887|FG000|Overall Study|Adverse Event|66
2056415|NCT00532155|3629888|FG001|Overall Study|Adverse Event|123
2056416|NCT00532155|3629887|FG000|Overall Study|Lack of Efficacy|332
2056417|NCT00532155|3629888|FG001|Overall Study|Lack of Efficacy|255
2056418|NCT00532155|3629887|FG000|Overall Study|Protocol Violation|1
2056419|NCT00532155|3629888|FG001|Overall Study|Protocol Violation|3
2056420|NCT00532155|3629887|FG000|Overall Study|Lost to Follow-up|2
2056421|NCT00532155|3629888|FG001|Overall Study|Lost to Follow-up|0
2056422|NCT00532155|3629887|FG000|Overall Study|Physician Decision|16
2056423|NCT00532155|3629888|FG001|Overall Study|Physician Decision|15
2056424|NCT00532155|3629887|FG000|Overall Study|Withdrawal by Subject|23
2056425|NCT00532155|3629888|FG001|Overall Study|Withdrawal by Subject|44
2056426|NCT00532155|3629887|FG000|Overall Study|Consent withdrawn|5
2056427|NCT00532155|3629888|FG001|Overall Study|Consent withdrawn|7
2056428|NCT00532155|3629887|FG000|Overall Study|Moved|1
2056429|NCT00532155|3629888|FG001|Overall Study|Moved|0
2056430|NCT00532155|3629887|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1
2056431|NCT00532155|3629888|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0
2056432|NCT00532155|3629887|FG000|Overall Study|Occurence of a second cancer|0
2056433|NCT00532155|3629888|FG001|Overall Study|Occurence of a second cancer|1
2056434|NCT00532155|3629887|FG000|Overall Study|Occurence of a secondary cancer|0
2056435|NCT00532155|3629888|FG001|Overall Study|Occurence of a secondary cancer|1
2056436|NCT00532155|3629887|FG000|Overall Study|Promotor ended study|1
2209711|NCT01646177|3849242|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
2209712|NCT01646177|3849243|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
2209713|NCT01646177|3849244|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4
2209714|NCT01646177|3849245|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
2209715|NCT01646177|3849246|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
2209716|NCT01646177|3849247|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
2209717|NCT01646177|3849248|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
2209718|NCT01646177|3849237|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
2209719|NCT01646177|3849238|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
2209720|NCT01646177|3849239|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
2209721|NCT01646177|3849240|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
2209722|NCT01646177|3849241|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
2209723|NCT01646177|3849242|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
2209724|NCT01646177|3849243|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
2209725|NCT01646177|3849244|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1
2209726|NCT01646177|3849245|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
2209727|NCT01646177|3849246|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
2209728|NCT01646177|3849247|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
2209729|NCT01646177|3849248|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
2209730|NCT01646177|3849237|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
2209731|NCT01646177|3849238|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
2209732|NCT01646177|3849239|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
2209733|NCT01646177|3849240|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
2209734|NCT01646177|3849241|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
2209735|NCT01646177|3849242|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3
2300953|NCT02605642|3998711|FG001|Overall Study|Lack of response|11
2300954|NCT02605837|3998719|FG000|Overall Study|Adverse Event|3
2300955|NCT02605837|3998720|FG001|Overall Study|Adverse Event|1
2056437|NCT00532155|3629888|FG001|Overall Study|Promotor ended study|0
2056438|NCT00532155|3629887|FG000|Overall Study|Progressive disease (by incorrect scan)|0
2209736|NCT01646177|3849243|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2
2209737|NCT01646177|3849244|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1
2209738|NCT01646177|3849245|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
2209739|NCT01646177|3849246|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
2209740|NCT01646177|3849247|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
2209741|NCT01646177|3849248|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
2209742|NCT01646177|3849237|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
2056439|NCT00532155|3629888|FG001|Overall Study|Progressive disease (by incorrect scan)|1
2056440|NCT00532155|3629887|FG000|Overall Study|Had brain metastasis, was mis-randomized|1
2056441|NCT00532155|3629888|FG001|Overall Study|Had brain metastasis, was mis-randomized|0
2056442|NCT00532155|3629887|FG000|Overall Study|Study stopped|1
2056443|NCT00532155|3629888|FG001|Overall Study|Study stopped|0
2056444|NCT00532155|3629887|FG000|Overall Study|Study terminated by sponsor|1
2056445|NCT00532155|3629888|FG001|Overall Study|Study terminated by sponsor|0
2056446|NCT00532155|3629887|FG000|Overall Study|Study termination stop further treatment|4
2056447|NCT00532155|3629888|FG001|Overall Study|Study termination stop further treatment|0
2056448|NCT00532155|3629887|FG000|Overall Study|Did not receive study medication|2
2056449|NCT00532155|3629888|FG001|Overall Study|Did not receive study medication|6
2056450|NCT00532259|3629894|FG000|Overall Study|Withdrawal by Subject|2
2056451|NCT00532259|3629894|FG000|Overall Study|Adverse Event|1
2056452|NCT00532259|3629894|FG000|Overall Study|Death|1
2056453|NCT00532259|3629894|FG000|Overall Study|Lack of Efficacy|21
2056454|NCT00532259|3629894|FG000|Overall Study|Lost to Follow-up|3
2056455|NCT00532259|3629894|FG000|Overall Study|Physician Decision|3
2056456|NCT00532259|3629894|FG000|Overall Study|Protocol Violation|1
2056457|NCT00532298|3629905|FG000|Overall Study|Adverse Event|1
2056458|NCT00532298|3629906|FG001|Overall Study|Adverse Event|0
2056459|NCT00532298|3629907|FG002|Overall Study|Adverse Event|0
2056460|NCT00532298|3629908|FG003|Overall Study|Adverse Event|0
2056461|NCT00532298|3629909|FG004|Overall Study|Adverse Event|1
2056462|NCT00532298|3629910|FG005|Overall Study|Adverse Event|1
2056463|NCT00532298|3629905|FG000|Overall Study|Lost to Follow-up|1
2056464|NCT00532298|3629906|FG001|Overall Study|Lost to Follow-up|1
2056465|NCT00532298|3629907|FG002|Overall Study|Lost to Follow-up|1
2056466|NCT00532298|3629908|FG003|Overall Study|Lost to Follow-up|0
2056467|NCT00532298|3629909|FG004|Overall Study|Lost to Follow-up|0
2056468|NCT00532298|3629910|FG005|Overall Study|Lost to Follow-up|1
2056469|NCT00532441|3629924|FG000|Overall Study|Death|1
2056470|NCT00532441|3629925|FG001|Overall Study|Death|0
2056471|NCT00532493|3629940|FG000|Overall Study|Death|1
2056472|NCT00532493|3629941|FG001|Overall Study|Death|1
2056473|NCT00532493|3629940|FG000|Overall Study|Lost to Follow-up|10
2056474|NCT00532493|3629941|FG001|Overall Study|Lost to Follow-up|7
2056475|NCT00532493|3629940|FG000|Overall Study|Withdrawal by Subject|7
2056476|NCT00532493|3629941|FG001|Overall Study|Withdrawal by Subject|9
2056477|NCT00532493|3629940|FG000|Overall Study|Physician Decision|1
2056478|NCT00532493|3629941|FG001|Overall Study|Physician Decision|6
2056479|NCT00532493|3629940|FG000|Overall Study|Adverse Event|6
2056480|NCT00532493|3629941|FG001|Overall Study|Adverse Event|5
2056481|NCT00532493|3629940|FG000|Overall Study|Protocol Deviation|1
2056482|NCT00532493|3629941|FG001|Overall Study|Protocol Deviation|0
2056483|NCT00532493|3629940|FG000|Overall Study|Subject Moved Away|3
2056484|NCT00532493|3629941|FG001|Overall Study|Subject Moved Away|1
2056485|NCT00532493|3629940|FG000|Overall Study|Contraindicative Medication|1
2056486|NCT00532493|3629941|FG001|Overall Study|Contraindicative Medication|0
2056487|NCT00532779|3629952|FG000|Overall Study|Adverse Event|122
2056488|NCT00532779|3629953|FG001|Overall Study|Adverse Event|112
2056489|NCT00532779|3629954|FG002|Overall Study|Adverse Event|56
2056490|NCT00532779|3629952|FG000|Overall Study|Lost to Follow-up|76
2056491|NCT00532779|3629953|FG001|Overall Study|Lost to Follow-up|65
2056492|NCT00532779|3629954|FG002|Overall Study|Lost to Follow-up|66
2056493|NCT00532779|3629952|FG000|Overall Study|Withdrawal by Subject|63
2056494|NCT00532779|3629953|FG001|Overall Study|Withdrawal by Subject|60
2056495|NCT00532779|3629954|FG002|Overall Study|Withdrawal by Subject|90
2056496|NCT00532779|3629952|FG000|Overall Study|Lack of Efficacy|12
2056497|NCT00532779|3629953|FG001|Overall Study|Lack of Efficacy|12
2056498|NCT00532779|3629954|FG002|Overall Study|Lack of Efficacy|40
2056499|NCT00532779|3629952|FG000|Overall Study|Protocol Violation|5
2056500|NCT00532779|3629953|FG001|Overall Study|Protocol Violation|9
2056501|NCT00532779|3629954|FG002|Overall Study|Protocol Violation|7
2056502|NCT00532779|3629952|FG000|Overall Study|Pregnancy|2
2056503|NCT00532779|3629953|FG001|Overall Study|Pregnancy|5
2056504|NCT00532779|3629954|FG002|Overall Study|Pregnancy|3
2209743|NCT01646177|3849238|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
2209744|NCT01646177|3849239|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
2209745|NCT01646177|3849240|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
2056505|NCT00532779|3629952|FG000|Overall Study|Death|0
2056506|NCT00532779|3629953|FG001|Overall Study|Death|1
2056507|NCT00532779|3629954|FG002|Overall Study|Death|0
2056508|NCT00532779|3629952|FG000|Overall Study|Drug noncompliance, moved, other|14
2056509|NCT00532779|3629953|FG001|Overall Study|Drug noncompliance, moved, other|23
2056510|NCT00532779|3629954|FG002|Overall Study|Drug noncompliance, moved, other|29
2056511|NCT00532844|3629964|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0
2056512|NCT00532844|3629965|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1
2056513|NCT00532844|3629964|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1
2056514|NCT00532844|3629965|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0
2056515|NCT00532844|3629964|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1
2056516|NCT00532844|3629965|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0
2056517|NCT00532844|3629964|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1
2056518|NCT00532844|3629965|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0
2056519|NCT00532844|3629964|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1
2056520|NCT00532844|3629965|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0
2056521|NCT00532883|3629988|FG000|Overall Study|Adverse Event|1
2209746|NCT01646177|3849241|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
2209747|NCT01646177|3849242|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
2209748|NCT01646177|3849243|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
2209749|NCT01646177|3849244|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
2209750|NCT01646177|3849245|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13
2209751|NCT01646177|3849246|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28
2209752|NCT01646177|3849247|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34
2209753|NCT01646177|3849248|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30
2209754|NCT01646177|3849237|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
2209755|NCT01646177|3849238|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
2209756|NCT01646177|3849239|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
2209757|NCT01646177|3849240|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
2300956|NCT02605837|3998719|FG000|Overall Study|Non-Compliance with Study Drug|0
2300957|NCT02605837|3998720|FG001|Overall Study|Non-Compliance with Study Drug|1
2300958|NCT02605837|3998719|FG000|Overall Study|Withdrawal by Subject|8
2300959|NCT02605837|3998720|FG001|Overall Study|Withdrawal by Subject|8
2300960|NCT02605837|3998719|FG000|Overall Study|Physician Decision|0
2300961|NCT02605837|3998720|FG001|Overall Study|Physician Decision|1
2300962|NCT02605928|3998749|FG000|Overall Study|Model tuning phase|28
2300963|NCT02605928|3998749|FG000|Overall Study|Lack of Efficacy|5
2300964|NCT02605954|3998755|FG000|Overall Study|Adverse Event|5
2300965|NCT02605954|3998756|FG001|Overall Study|Adverse Event|1
2300966|NCT02605954|3998755|FG000|Overall Study|Investigator's Discretion|1
2300967|NCT02605954|3998756|FG001|Overall Study|Investigator's Discretion|0
2300968|NCT02605954|3998755|FG000|Overall Study|Non-Compliance with Study Drug|1
2300969|NCT02605954|3998756|FG001|Overall Study|Non-Compliance with Study Drug|0
2300970|NCT02605954|3998755|FG000|Overall Study|Withdrew Consent|2
2300971|NCT02605954|3998756|FG001|Overall Study|Withdrew Consent|2
2300972|NCT02605954|3998755|FG000|Overall Study|Lost to Follow-up|3
2300973|NCT02605954|3998756|FG001|Overall Study|Lost to Follow-up|0
2300974|NCT02605954|3998755|FG000|Overall Study|Randomized but not treated|0
2300975|NCT02605954|3998756|FG001|Overall Study|Randomized but not treated|1
2300976|NCT02606253|3998785|FG000|Overall Study|Adverse Event|2
2300977|NCT02606253|3998786|FG001|Overall Study|Adverse Event|0
2300978|NCT02606253|3998787|FG002|Overall Study|Adverse Event|0
2300979|NCT02606253|3998785|FG000|Overall Study|Protocol Violation|2
2300980|NCT02606253|3998786|FG001|Overall Study|Protocol Violation|1
2300981|NCT02606253|3998787|FG002|Overall Study|Protocol Violation|0
2300982|NCT02606253|3998785|FG000|Overall Study|Physician Decision|1
2056522|NCT00532883|3629989|FG001|Overall Study|Adverse Event|0
2056523|NCT00532883|3629990|FG002|Overall Study|Adverse Event|0
2056524|NCT00532883|3629991|FG003|Overall Study|Adverse Event|1
2056525|NCT00532883|3629988|FG000|Overall Study|Lost to Follow-up|1
2209758|NCT01646177|3849241|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
2209759|NCT01646177|3849242|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
2300983|NCT02606253|3998786|FG001|Overall Study|Physician Decision|1
2300984|NCT02606253|3998787|FG002|Overall Study|Physician Decision|0
2056526|NCT00532883|3629989|FG001|Overall Study|Lost to Follow-up|1
2056527|NCT00532883|3629990|FG002|Overall Study|Lost to Follow-up|1
2056528|NCT00532883|3629991|FG003|Overall Study|Lost to Follow-up|0
2056529|NCT00532883|3629988|FG000|Overall Study|Withdrawal by Subject|0
2056530|NCT00532883|3629989|FG001|Overall Study|Withdrawal by Subject|1
2056531|NCT00532883|3629990|FG002|Overall Study|Withdrawal by Subject|1
2056532|NCT00532883|3629991|FG003|Overall Study|Withdrawal by Subject|0
2056533|NCT00532883|3629988|FG000|Overall Study|Subject was Nonadherent|0
2056534|NCT00532883|3629989|FG001|Overall Study|Subject was Nonadherent|1
2056535|NCT00532883|3629990|FG002|Overall Study|Subject was Nonadherent|1
2056536|NCT00532883|3629991|FG003|Overall Study|Subject was Nonadherent|0
2056537|NCT00532883|3629988|FG000|Overall Study|Early Study Termination|4
2056538|NCT00532883|3629989|FG001|Overall Study|Early Study Termination|4
2056539|NCT00532883|3629990|FG002|Overall Study|Early Study Termination|1
2056540|NCT00532883|3629991|FG003|Overall Study|Early Study Termination|4
2056541|NCT00532935|3630003|FG000|Overall Study|Adverse Event|11
2056542|NCT00532935|3630004|FG001|Overall Study|Adverse Event|12
2056543|NCT00532935|3630003|FG000|Overall Study|Lack of Efficacy|0
2056544|NCT00532935|3630004|FG001|Overall Study|Lack of Efficacy|3
2300985|NCT02606643|3998817|FG000|Overall Study|did not meet inclusion criteria|1
2300986|NCT02606643|3998818|FG001|Overall Study|did not meet inclusion criteria|3
2300987|NCT02606877|3998846|FG000|Overall Study|Adverse Event|3
2056545|NCT00532935|3630003|FG000|Overall Study|Lost to Follow-up|10
2056546|NCT00532935|3630004|FG001|Overall Study|Lost to Follow-up|6
2056547|NCT00532935|3630003|FG000|Overall Study|Physician Decision|4
2056548|NCT00532935|3630004|FG001|Overall Study|Physician Decision|5
2056549|NCT00532935|3630003|FG000|Overall Study|Pregnancy|1
2056550|NCT00532935|3630004|FG001|Overall Study|Pregnancy|0
2209760|NCT01646177|3849243|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
2056551|NCT00532935|3630003|FG000|Overall Study|Protocol Violation|4
2056552|NCT00532935|3630004|FG001|Overall Study|Protocol Violation|2
2056553|NCT00532935|3630003|FG000|Overall Study|Withdrawal by Subject|10
2056554|NCT00532935|3630004|FG001|Overall Study|Withdrawal by Subject|9
2056555|NCT00532935|3630003|FG000|Overall Study|Protocol Specific Criteria|11
2056556|NCT00532935|3630004|FG001|Overall Study|Protocol Specific Criteria|15
2056557|NCT00532948|3630013|FG000|Overall Study|Protocol Violation|1
2056558|NCT00532948|3630014|FG001|Overall Study|Protocol Violation|0
2056559|NCT00532948|3630015|FG002|Overall Study|Protocol Violation|0
2056560|NCT00532948|3630013|FG000|Overall Study|Death|3
2056561|NCT00532948|3630014|FG001|Overall Study|Death|3
2056562|NCT00532948|3630015|FG002|Overall Study|Death|4
2056563|NCT00532948|3630013|FG000|Overall Study|Violation of selection criteria at entry|0
2056564|NCT00532948|3630014|FG001|Overall Study|Violation of selection criteria at entry|1
2056565|NCT00532948|3630015|FG002|Overall Study|Violation of selection criteria at entry|0
2056566|NCT00532948|3630013|FG000|Overall Study|Failure to return|0
2056567|NCT00532948|3630014|FG001|Overall Study|Failure to return|1
2056568|NCT00532948|3630015|FG002|Overall Study|Failure to return|0
2056569|NCT00533273|3630046|FG000|Double-blind|Withdrew consent|0
2056570|NCT00533273|3630047|FG001|Double-blind|Withdrew consent|2
2056571|NCT00533273|3630046|FG000|Open-label|Withdrawal by Subject|6
2056572|NCT00533273|3630047|FG001|Open-label|Withdrawal by Subject|0
2056573|NCT00533429|3630055|FG000|Overall Study|Adverse Event|3
2056574|NCT00533429|3630056|FG001|Overall Study|Adverse Event|1
2056575|NCT00533429|3630055|FG000|Overall Study|Death|1
2056576|NCT00533429|3630056|FG001|Overall Study|Death|0
2056577|NCT00533429|3630055|FG000|Overall Study|Withdrawal by Subject|2
2056578|NCT00533429|3630056|FG001|Overall Study|Withdrawal by Subject|0
2056579|NCT00533429|3630055|FG000|Overall Study|Progressive Disease|12
2056580|NCT00533429|3630056|FG001|Overall Study|Progressive Disease|13
2056581|NCT00533429|3630055|FG000|Overall Study|Symptomatic deterioration|1
2056582|NCT00533429|3630056|FG001|Overall Study|Symptomatic deterioration|2
2056583|NCT00533507|3630075|FG000|Overall Study|Withdrawal by Subject|1
2056584|NCT00533702|3630086|FG000|Overall Study|Withdrawal by Subject|3
2056585|NCT00533702|3630087|FG001|Overall Study|Withdrawal by Subject|1
2056586|NCT00533702|3630086|FG000|Overall Study|Found ineligible after randomization|2
2056587|NCT00533702|3630087|FG001|Overall Study|Found ineligible after randomization|1
2056588|NCT00533845|3630095|FG000|Overall Study|Physician Decision|1
2056589|NCT00533845|3630096|FG001|Overall Study|Physician Decision|0
2056590|NCT00533897|3630105|FG000|Lead-in (LI) Period 1|Adverse Event|1
2056591|NCT00533897|3630106|FG001|Lead-in (LI) Period 1|Adverse Event|0
2056592|NCT00533897|3630107|FG002|Lead-in (LI) Period 1|Adverse Event|0
2056593|NCT00533897|3630108|FG003|Lead-in (LI) Period 1|Adverse Event|0
2056594|NCT00533897|3630109|FG004|Lead-in (LI) Period 1|Adverse Event|0
2056595|NCT00533897|3630110|FG005|Lead-in (LI) Period 1|Adverse Event|0
2056596|NCT00533897|3630111|FG006|Lead-in (LI) Period 1|Adverse Event|0
2056597|NCT00533897|3630112|FG007|Lead-in (LI) Period 1|Adverse Event|0
2056598|NCT00533897|3630105|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2
2056599|NCT00533897|3630106|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2056600|NCT00533897|3630107|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2056601|NCT00533897|3630108|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2056602|NCT00533897|3630109|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2056603|NCT00533897|3630110|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2056604|NCT00533897|3630111|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2056605|NCT00533897|3630112|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2056606|NCT00533897|3630105|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1
2056607|NCT00533897|3630106|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0
2056608|NCT00533897|3630107|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0
2056609|NCT00533897|3630108|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0
2056610|NCT00533897|3630109|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0
2056611|NCT00533897|3630110|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0
2056612|NCT00533897|3630111|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0
2056613|NCT00533897|3630112|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0
2056614|NCT00533897|3630105|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
2056615|NCT00533897|3630106|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2056616|NCT00533897|3630107|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2056617|NCT00533897|3630108|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2056618|NCT00533897|3630109|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2056619|NCT00533897|3630110|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2056620|NCT00533897|3630111|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2056621|NCT00533897|3630112|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2056622|NCT00533897|3630105|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3
2056623|NCT00533897|3630106|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0
2056624|NCT00533897|3630107|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0
2056625|NCT00533897|3630108|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0
2056626|NCT00533897|3630109|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0
2056627|NCT00533897|3630110|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0
2056628|NCT00533897|3630111|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0
2056629|NCT00533897|3630112|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0
2056630|NCT00533897|3630105|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
2056631|NCT00533897|3630106|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2056632|NCT00533897|3630107|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2056633|NCT00533897|3630108|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2056634|NCT00533897|3630109|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2056635|NCT00533897|3630110|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2056636|NCT00533897|3630111|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2056637|NCT00533897|3630112|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2056638|NCT00533897|3630105|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2056639|NCT00533897|3630106|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
2056640|NCT00533897|3630107|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
2056641|NCT00533897|3630108|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2056642|NCT00533897|3630109|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2056643|NCT00533897|3630110|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2056644|NCT00533897|3630111|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2056645|NCT00533897|3630112|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2056646|NCT00533897|3630105|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2056647|NCT00533897|3630106|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2056648|NCT00533897|3630107|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
2056649|NCT00533897|3630108|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2056650|NCT00533897|3630109|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2056651|NCT00533897|3630110|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2056652|NCT00533897|3630111|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2056653|NCT00533897|3630112|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2056654|NCT00533897|3630105|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2056655|NCT00533897|3630106|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2056656|NCT00533897|3630107|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2056657|NCT00533897|3630108|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2056658|NCT00533897|3630109|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2056659|NCT00533897|3630110|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
2056660|NCT00533897|3630111|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2056661|NCT00533897|3630112|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2056662|NCT00533897|3630105|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2056663|NCT00533897|3630106|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2056664|NCT00533897|3630107|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2056665|NCT00533897|3630108|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2056666|NCT00533897|3630109|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2056667|NCT00533897|3630110|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
2056668|NCT00533897|3630111|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2056669|NCT00533897|3630112|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2056670|NCT00533897|3630105|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0
2056671|NCT00533897|3630106|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0
2056672|NCT00533897|3630107|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0
2056673|NCT00533897|3630108|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0
2056674|NCT00533897|3630109|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0
2056675|NCT00533897|3630110|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0
2056676|NCT00533897|3630111|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2
2056677|NCT00533897|3630112|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5
2056678|NCT00533897|3630105|FG000|Long Term Extension (LTE)|Death|0
2056679|NCT00533897|3630106|FG001|Long Term Extension (LTE)|Death|0
2056680|NCT00533897|3630107|FG002|Long Term Extension (LTE)|Death|0
2056681|NCT00533897|3630108|FG003|Long Term Extension (LTE)|Death|0
2056682|NCT00533897|3630109|FG004|Long Term Extension (LTE)|Death|0
2056683|NCT00533897|3630110|FG005|Long Term Extension (LTE)|Death|0
2056684|NCT00533897|3630111|FG006|Long Term Extension (LTE)|Death|1
2056685|NCT00533897|3630112|FG007|Long Term Extension (LTE)|Death|3
2056686|NCT00533897|3630105|FG000|Long Term Extension (LTE)|Lack of Efficacy|0
2056687|NCT00533897|3630106|FG001|Long Term Extension (LTE)|Lack of Efficacy|0
2056688|NCT00533897|3630107|FG002|Long Term Extension (LTE)|Lack of Efficacy|0
2056689|NCT00533897|3630108|FG003|Long Term Extension (LTE)|Lack of Efficacy|0
2056690|NCT00533897|3630109|FG004|Long Term Extension (LTE)|Lack of Efficacy|0
2056691|NCT00533897|3630110|FG005|Long Term Extension (LTE)|Lack of Efficacy|0
2056692|NCT00533897|3630111|FG006|Long Term Extension (LTE)|Lack of Efficacy|5
2056693|NCT00533897|3630112|FG007|Long Term Extension (LTE)|Lack of Efficacy|3
2056694|NCT00533897|3630105|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0
2056695|NCT00533897|3630106|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0
2056696|NCT00533897|3630107|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0
2209761|NCT01646177|3849244|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
2209762|NCT01646177|3849245|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7
2056697|NCT00533897|3630108|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0
2056698|NCT00533897|3630109|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0
2056699|NCT00533897|3630110|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0
2056700|NCT00533897|3630111|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1
2056701|NCT00533897|3630112|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0
2056702|NCT00533897|3630105|FG000|Long Term Extension (LTE)|Adverse Event|0
2056703|NCT00533897|3630106|FG001|Long Term Extension (LTE)|Adverse Event|0
2056704|NCT00533897|3630107|FG002|Long Term Extension (LTE)|Adverse Event|0
2056705|NCT00533897|3630108|FG003|Long Term Extension (LTE)|Adverse Event|0
2056706|NCT00533897|3630109|FG004|Long Term Extension (LTE)|Adverse Event|0
2056707|NCT00533897|3630110|FG005|Long Term Extension (LTE)|Adverse Event|0
2056708|NCT00533897|3630111|FG006|Long Term Extension (LTE)|Adverse Event|2
2056709|NCT00533897|3630112|FG007|Long Term Extension (LTE)|Adverse Event|5
2056710|NCT00533897|3630105|FG000|Long Term Extension (LTE)|Pregnancy|0
2056711|NCT00533897|3630106|FG001|Long Term Extension (LTE)|Pregnancy|0
2056712|NCT00533897|3630107|FG002|Long Term Extension (LTE)|Pregnancy|0
2056713|NCT00533897|3630108|FG003|Long Term Extension (LTE)|Pregnancy|0
2056714|NCT00533897|3630109|FG004|Long Term Extension (LTE)|Pregnancy|0
2056715|NCT00533897|3630110|FG005|Long Term Extension (LTE)|Pregnancy|0
2056716|NCT00533897|3630111|FG006|Long Term Extension (LTE)|Pregnancy|0
2056717|NCT00533897|3630112|FG007|Long Term Extension (LTE)|Pregnancy|2
2056718|NCT00533897|3630105|FG000|Long Term Extension (LTE)|Lost to Follow-up|0
2056719|NCT00533897|3630106|FG001|Long Term Extension (LTE)|Lost to Follow-up|0
2056720|NCT00533897|3630107|FG002|Long Term Extension (LTE)|Lost to Follow-up|0
2056721|NCT00533897|3630108|FG003|Long Term Extension (LTE)|Lost to Follow-up|0
2056722|NCT00533897|3630109|FG004|Long Term Extension (LTE)|Lost to Follow-up|0
2056723|NCT00533897|3630110|FG005|Long Term Extension (LTE)|Lost to Follow-up|0
2056724|NCT00533897|3630111|FG006|Long Term Extension (LTE)|Lost to Follow-up|1
2056725|NCT00533897|3630112|FG007|Long Term Extension (LTE)|Lost to Follow-up|1
2056726|NCT00533897|3630105|FG000|Long Term Extension (LTE)|Other|0
2056727|NCT00533897|3630106|FG001|Long Term Extension (LTE)|Other|0
2056728|NCT00533897|3630107|FG002|Long Term Extension (LTE)|Other|0
2056729|NCT00533897|3630108|FG003|Long Term Extension (LTE)|Other|0
2056730|NCT00533897|3630109|FG004|Long Term Extension (LTE)|Other|0
2056731|NCT00533897|3630110|FG005|Long Term Extension (LTE)|Other|0
2056732|NCT00533897|3630111|FG006|Long Term Extension (LTE)|Other|1
2056733|NCT00533897|3630112|FG007|Long Term Extension (LTE)|Other|6
2056734|NCT00533949|3630156|FG000|Overall Study|Protocol Violation|12
2056735|NCT00533949|3630157|FG001|Overall Study|Protocol Violation|12
2056736|NCT00533949|3630158|FG002|Overall Study|Protocol Violation|9
2056737|NCT00533949|3630159|FG003|Overall Study|Protocol Violation|9
2217684|NCT01709305|3860929|FG001|Phase 2|Death|0
2056738|NCT00533949|3630156|FG000|Overall Study|Withdrawal by Subject|3
2056739|NCT00533949|3630157|FG001|Overall Study|Withdrawal by Subject|2
2056740|NCT00533949|3630158|FG002|Overall Study|Withdrawal by Subject|1
2056741|NCT00533949|3630159|FG003|Overall Study|Withdrawal by Subject|1
2056742|NCT00534092|3630188|FG000|Overall Study|Lost to Follow-up|1
2056743|NCT00534092|3630189|FG001|Overall Study|Lost to Follow-up|0
2056744|NCT00534092|3630188|FG000|Overall Study|personal reasons/family concerns|1
2056745|NCT00534092|3630189|FG001|Overall Study|personal reasons/family concerns|0
2056746|NCT00534105|3630199|FG000|Overall Study|Lost to Follow-up|23
2056747|NCT00534105|3630200|FG001|Overall Study|Lost to Follow-up|39
2056748|NCT00534248|3630235|FG000|Overall Study|Adverse Event|19
2056749|NCT00534248|3630236|FG001|Overall Study|Adverse Event|29
2056750|NCT00534248|3630235|FG000|Overall Study|Lost to Follow-up|353
2056751|NCT00534248|3630236|FG001|Overall Study|Lost to Follow-up|375
2056752|NCT00534248|3630235|FG000|Overall Study|Other protocol specified criteria|13
2056753|NCT00534248|3630236|FG001|Overall Study|Other protocol specified criteria|3
2056754|NCT00534248|3630235|FG000|Overall Study|Physician Decision|10
2056755|NCT00534248|3630236|FG001|Overall Study|Physician Decision|7
2056756|NCT00534248|3630235|FG000|Overall Study|Protocol Violation|3
2056757|NCT00534248|3630236|FG001|Overall Study|Protocol Violation|4
2056758|NCT00534248|3630235|FG000|Overall Study|Withdrawal by Subject|263
2056759|NCT00534248|3630236|FG001|Overall Study|Withdrawal by Subject|255
2056760|NCT00534313|3630246|FG000|Short-term Period|Adverse Event|1
2056761|NCT00534313|3630247|FG001|Short-term Period|Adverse Event|2
2056762|NCT00534313|3630248|FG002|Short-term Period|Adverse Event|1
2056763|NCT00534313|3630249|FG003|Short-term Period|Adverse Event|3
2056764|NCT00534313|3630246|FG000|Short-term Period|Lack of Efficacy|3
2056765|NCT00534313|3630247|FG001|Short-term Period|Lack of Efficacy|4
2056766|NCT00534313|3630248|FG002|Short-term Period|Lack of Efficacy|0
2056767|NCT00534313|3630249|FG003|Short-term Period|Lack of Efficacy|3
2056768|NCT00534313|3630246|FG000|Short-term Period|Participant not meeting study criteria|0
2056769|NCT00534313|3630247|FG001|Short-term Period|Participant not meeting study criteria|0
2056770|NCT00534313|3630248|FG002|Short-term Period|Participant not meeting study criteria|0
2105600|NCT00857948|3698242|FG003|Overall Study|Withdrawal by Subject|0
2056771|NCT00534313|3630249|FG003|Short-term Period|Participant not meeting study criteria|1
2056772|NCT00534313|3630246|FG000|Short-term Period|Participant withdrew consent|2
2056773|NCT00534313|3630247|FG001|Short-term Period|Participant withdrew consent|0
2056774|NCT00534313|3630248|FG002|Short-term Period|Participant withdrew consent|0
2056775|NCT00534313|3630249|FG003|Short-term Period|Participant withdrew consent|2
2056776|NCT00534313|3630246|FG000|Short-term Period|Pregnancy|0
2056777|NCT00534313|3630247|FG001|Short-term Period|Pregnancy|0
2056778|NCT00534313|3630248|FG002|Short-term Period|Pregnancy|1
2056779|NCT00534313|3630249|FG003|Short-term Period|Pregnancy|0
2056780|NCT00534313|3630246|FG000|Long-term Period|Adverse Event|2
2056781|NCT00534313|3630247|FG001|Long-term Period|Adverse Event|1
2056782|NCT00534313|3630248|FG002|Long-term Period|Adverse Event|0
2056783|NCT00534313|3630249|FG003|Long-term Period|Adverse Event|1
2056784|NCT00534313|3630246|FG000|Long-term Period|Lack of Efficacy|14
2056785|NCT00534313|3630247|FG001|Long-term Period|Lack of Efficacy|10
2056786|NCT00534313|3630248|FG002|Long-term Period|Lack of Efficacy|14
2056787|NCT00534313|3630249|FG003|Long-term Period|Lack of Efficacy|12
2056788|NCT00534313|3630246|FG000|Long-term Period|Lost to Follow-up|1
2056789|NCT00534313|3630247|FG001|Long-term Period|Lost to Follow-up|2
2056790|NCT00534313|3630248|FG002|Long-term Period|Lost to Follow-up|0
2056791|NCT00534313|3630249|FG003|Long-term Period|Lost to Follow-up|0
2056792|NCT00534313|3630246|FG000|Long-term Period|Withdrawal by Subject|2
2056793|NCT00534313|3630247|FG001|Long-term Period|Withdrawal by Subject|2
2056794|NCT00534313|3630248|FG002|Long-term Period|Withdrawal by Subject|0
2056795|NCT00534313|3630249|FG003|Long-term Period|Withdrawal by Subject|0
2056796|NCT00534313|3630246|FG000|Long-term Period|No longer meets study criteria|0
2056797|NCT00534313|3630247|FG001|Long-term Period|No longer meets study criteria|1
2056798|NCT00534313|3630248|FG002|Long-term Period|No longer meets study criteria|0
2056799|NCT00534313|3630249|FG003|Long-term Period|No longer meets study criteria|0
2056800|NCT00534313|3630246|FG000|Long-term Period|Poor compliance/noncompliance|0
2056801|NCT00534313|3630247|FG001|Long-term Period|Poor compliance/noncompliance|1
2056802|NCT00534313|3630248|FG002|Long-term Period|Poor compliance/noncompliance|1
2056803|NCT00534313|3630249|FG003|Long-term Period|Poor compliance/noncompliance|0
2056804|NCT00534313|3630246|FG000|Long-term Period|Administrative reason by sponsor|17
2056805|NCT00534313|3630247|FG001|Long-term Period|Administrative reason by sponsor|15
2056806|NCT00534313|3630248|FG002|Long-term Period|Administrative reason by sponsor|26
2056807|NCT00534313|3630249|FG003|Long-term Period|Administrative reason by sponsor|18
2056808|NCT00534313|3630246|FG000|Long-term Period|Other|1
2056809|NCT00534313|3630247|FG001|Long-term Period|Other|2
2056810|NCT00534313|3630248|FG002|Long-term Period|Other|2
2056811|NCT00534313|3630249|FG003|Long-term Period|Other|2
2056812|NCT00534352|3630294|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
2056813|NCT00534352|3630294|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
2056814|NCT00534352|3630294|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
2056815|NCT00534352|3630294|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
2300988|NCT02606877|3998847|FG001|Overall Study|Adverse Event|0
2300989|NCT02606877|3998846|FG000|Overall Study|Non-compliance with protocol|0
2300990|NCT02606877|3998847|FG001|Overall Study|Non-compliance with protocol|1
2300991|NCT02606877|3998846|FG000|Overall Study|Other than listed above|1
2300992|NCT02606877|3998847|FG001|Overall Study|Other than listed above|0
2300993|NCT02607228|3998876|FG000|Overall Study|Progressive Disease|4
2300994|NCT02607228|3998877|FG001|Overall Study|Progressive Disease|3
2300995|NCT02607228|3998878|FG002|Overall Study|Progressive Disease|1
2300996|NCT02607228|3998879|FG003|Overall Study|Progressive Disease|5
2300997|NCT02607228|3998880|FG004|Overall Study|Progressive Disease|4
2300998|NCT02607228|3998881|FG005|Overall Study|Progressive Disease|3
2300999|NCT02607228|3998882|FG006|Overall Study|Progressive Disease|1
2301000|NCT02607228|3998876|FG000|Overall Study|Adverse Event|1
2301001|NCT02607228|3998877|FG001|Overall Study|Adverse Event|0
2301002|NCT02607228|3998878|FG002|Overall Study|Adverse Event|1
2301003|NCT02607228|3998879|FG003|Overall Study|Adverse Event|0
2301004|NCT02607228|3998880|FG004|Overall Study|Adverse Event|1
2301005|NCT02607228|3998881|FG005|Overall Study|Adverse Event|1
2301006|NCT02607228|3998882|FG006|Overall Study|Adverse Event|1
2301007|NCT02607228|3998876|FG000|Overall Study|Investigator's Discretion|0
2301008|NCT02607228|3998877|FG001|Overall Study|Investigator's Discretion|0
2301009|NCT02607228|3998878|FG002|Overall Study|Investigator's Discretion|1
2301010|NCT02607228|3998879|FG003|Overall Study|Investigator's Discretion|0
2301011|NCT02607228|3998880|FG004|Overall Study|Investigator's Discretion|0
2301012|NCT02607228|3998881|FG005|Overall Study|Investigator's Discretion|1
2301013|NCT02607228|3998882|FG006|Overall Study|Investigator's Discretion|0
2301014|NCT02607228|3998876|FG000|Overall Study|Withdrew Consent|0
2301015|NCT02607228|3998877|FG001|Overall Study|Withdrew Consent|1
2301016|NCT02607228|3998878|FG002|Overall Study|Withdrew Consent|0
2301017|NCT02607228|3998879|FG003|Overall Study|Withdrew Consent|0
2301018|NCT02607228|3998880|FG004|Overall Study|Withdrew Consent|0
2301019|NCT02607228|3998881|FG005|Overall Study|Withdrew Consent|1
2301020|NCT02607228|3998882|FG006|Overall Study|Withdrew Consent|0
2301021|NCT02607228|3998876|FG000|Overall Study|Study Terminated by Sponsor|0
2301022|NCT02607228|3998877|FG001|Overall Study|Study Terminated by Sponsor|0
2301023|NCT02607228|3998878|FG002|Overall Study|Study Terminated by Sponsor|0
2301024|NCT02607228|3998879|FG003|Overall Study|Study Terminated by Sponsor|1
2056816|NCT00534352|3630294|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
2056817|NCT00534352|3630294|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
2056818|NCT00534404|3630321|FG000|Overall Study|Death|0
2056819|NCT00534404|3630322|FG001|Overall Study|Death|0
2056820|NCT00534404|3630323|FG002|Overall Study|Death|2
2056821|NCT00534404|3630321|FG000|Overall Study|Withdrawal by Subject|8
2056822|NCT00534404|3630322|FG001|Overall Study|Withdrawal by Subject|2
2056823|NCT00534404|3630323|FG002|Overall Study|Withdrawal by Subject|38
2056824|NCT00534404|3630321|FG000|Overall Study|Removed by study staff|2
2056825|NCT00534404|3630322|FG001|Overall Study|Removed by study staff|3
2056826|NCT00534404|3630323|FG002|Overall Study|Removed by study staff|1
2056827|NCT00534404|3630321|FG000|Overall Study|Lost to Follow-up|170
2056828|NCT00534404|3630322|FG001|Overall Study|Lost to Follow-up|138
2056829|NCT00534404|3630323|FG002|Overall Study|Lost to Follow-up|201
2056830|NCT00534495|3630337|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0
2056831|NCT00534495|3630338|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1
2056832|NCT00534495|3630339|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0
2056833|NCT00534495|3630337|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1
2056834|NCT00534495|3630338|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0
2056835|NCT00534495|3630339|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0
2056836|NCT00534495|3630337|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
2056837|NCT00534495|3630338|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
2056838|NCT00534495|3630339|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
2056839|NCT00534495|3630337|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
2056840|NCT00534495|3630338|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
2056841|NCT00534495|3630339|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
2056842|NCT00534495|3630337|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
2056843|NCT00534495|3630338|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
2056844|NCT00534495|3630339|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
2056845|NCT00534495|3630337|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
2056846|NCT00534495|3630338|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
2056847|NCT00534495|3630339|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
2056848|NCT00534495|3630337|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
2056849|NCT00534495|3630338|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
2056850|NCT00534495|3630339|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
2056851|NCT00534495|3630337|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
2056852|NCT00534495|3630338|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
2056853|NCT00534495|3630339|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
2056854|NCT00534495|3630337|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0
2056855|NCT00534495|3630338|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0
2056856|NCT00534495|3630339|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2
2056857|NCT00534599|3630352|FG000|Overall Study|Adverse Event|25
2056858|NCT00534599|3630353|FG001|Overall Study|Adverse Event|4
2056859|NCT00534599|3630352|FG000|Overall Study|Incorrect enrollment|2
2056860|NCT00534599|3630353|FG001|Overall Study|Incorrect enrollment|1
2056861|NCT00534599|3630352|FG000|Overall Study|Mis-randomization|2
2056862|NCT00534599|3630353|FG001|Overall Study|Mis-randomization|2
2056863|NCT00534599|3630352|FG000|Overall Study|Developed study-specific d/c criteria|5
2056864|NCT00534599|3630353|FG001|Overall Study|Developed study-specific d/c criteria|0
2056865|NCT00534599|3630352|FG000|Overall Study|Lack of Efficacy|0
2056866|NCT00534599|3630353|FG001|Overall Study|Lack of Efficacy|1
2056867|NCT00534599|3630352|FG000|Overall Study|Generalized anxiety disorder worsened|0
2056868|NCT00534599|3630353|FG001|Overall Study|Generalized anxiety disorder worsened|1
2056869|NCT00534599|3630352|FG000|Overall Study|Protocol Violation|1
2056870|NCT00534599|3630353|FG001|Overall Study|Protocol Violation|3
2056871|NCT00534599|3630352|FG000|Overall Study|Lost to Follow-up|11
2056872|NCT00534599|3630353|FG001|Overall Study|Lost to Follow-up|14
2056873|NCT00534599|3630352|FG000|Overall Study|Withdrawal by Subject|4
2056874|NCT00534599|3630353|FG001|Overall Study|Withdrawal by Subject|6
2056875|NCT00534599|3630352|FG000|Overall Study|Other|7
2056876|NCT00534599|3630353|FG001|Overall Study|Other|0
2209763|NCT01646177|3849246|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21
2217685|NCT01709305|3860930|FG002|Phase 2|Death|1
2056877|NCT00534638|3630361|FG000|Overall Study|Withdrawal by Subject|3
2056878|NCT00534638|3630362|FG001|Overall Study|Withdrawal by Subject|4
2056879|NCT00534638|3630361|FG000|Overall Study|Migrated/moved from study area|13
2056880|NCT00534638|3630362|FG001|Overall Study|Migrated/moved from study area|11
2056881|NCT00534638|3630361|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83
2056882|NCT00534638|3630362|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117
2056883|NCT00534638|3630361|FG000|Overall Study|Lost to follow-up, complete vaccination|4707
2056884|NCT00534638|3630362|FG001|Overall Study|Lost to follow-up, complete vaccination|10757
2056885|NCT00534638|3630361|FG000|Overall Study|Other|1685
2056886|NCT00534638|3630362|FG001|Overall Study|Other|902
2056887|NCT00535132|3630446|FG000|Safety Analysis Set|Did Not Receive Study Medication|2
2056888|NCT00535132|3630447|FG001|Safety Analysis Set|Did Not Receive Study Medication|2
2056889|NCT00535132|3630446|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
2056890|NCT00535132|3630447|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
2056891|NCT00535145|3630455|FG000|Phase I|Adverse Event|3
2056892|NCT00535145|3630455|FG000|Phase I|Lost to Follow-up|7
2056893|NCT00535145|3630455|FG000|Phase I|Withdrawal by Subject|6
2056894|NCT00535145|3630455|FG000|Phase I|(eligibility)|8
2056895|NCT00535145|3630455|FG000|Phase I|(protocol violation)|1
2056896|NCT00535145|3630455|FG000|Phase I|(PI decision)|1
2056897|NCT00535145|3630455|FG000|Phase I|(diagnosis)|3
2056898|NCT00535145|3630455|FG000|Phase II|Adverse Event|2
2056899|NCT00535145|3630455|FG000|Phase II|Lack of Efficacy|1
2056900|NCT00535145|3630455|FG000|Phase II|Lost to Follow-up|5
2056901|NCT00535145|3630455|FG000|Phase II|Withdrawal by Subject|5
2056902|NCT00535145|3630455|FG000|Phase II|Subject non-compliance|2
2056903|NCT00535223|3630465|FG000|Overall Study|Withdrawal by Subject|4
2056904|NCT00535223|3630466|FG001|Overall Study|Withdrawal by Subject|1
2056905|NCT00535236|3630482|FG000|Overall Study|Adverse Event|1
2056906|NCT00535236|3630483|FG001|Overall Study|Adverse Event|0
2056907|NCT00535236|3630484|FG002|Overall Study|Adverse Event|9
2056908|NCT00535236|3630485|FG003|Overall Study|Adverse Event|3
2056909|NCT00535236|3630486|FG004|Overall Study|Adverse Event|3
2056910|NCT00535236|3630487|FG005|Overall Study|Adverse Event|0
2056911|NCT00535236|3630488|FG006|Overall Study|Adverse Event|5
2056912|NCT00535236|3630489|FG007|Overall Study|Adverse Event|1
2056913|NCT00535236|3630490|FG008|Overall Study|Adverse Event|2
2056914|NCT00535236|3630491|FG009|Overall Study|Adverse Event|1
2056915|NCT00535236|3630482|FG000|Overall Study|Lost to Follow-up|1
2056916|NCT00535236|3630483|FG001|Overall Study|Lost to Follow-up|2
2056917|NCT00535236|3630484|FG002|Overall Study|Lost to Follow-up|0
2056918|NCT00535236|3630485|FG003|Overall Study|Lost to Follow-up|0
2056919|NCT00535236|3630486|FG004|Overall Study|Lost to Follow-up|2
2056920|NCT00535236|3630487|FG005|Overall Study|Lost to Follow-up|0
2056921|NCT00535236|3630488|FG006|Overall Study|Lost to Follow-up|0
2056922|NCT00535236|3630489|FG007|Overall Study|Lost to Follow-up|0
2056923|NCT00535236|3630490|FG008|Overall Study|Lost to Follow-up|6
2056924|NCT00535236|3630491|FG009|Overall Study|Lost to Follow-up|1
2056925|NCT00535236|3630482|FG000|Overall Study|Physician Decision|0
2056926|NCT00535236|3630483|FG001|Overall Study|Physician Decision|0
2056927|NCT00535236|3630484|FG002|Overall Study|Physician Decision|0
2056928|NCT00535236|3630485|FG003|Overall Study|Physician Decision|0
2056929|NCT00535236|3630486|FG004|Overall Study|Physician Decision|1
2056930|NCT00535236|3630487|FG005|Overall Study|Physician Decision|0
2056931|NCT00535236|3630488|FG006|Overall Study|Physician Decision|1
2056932|NCT00535236|3630489|FG007|Overall Study|Physician Decision|0
2056933|NCT00535236|3630490|FG008|Overall Study|Physician Decision|0
2056934|NCT00535236|3630491|FG009|Overall Study|Physician Decision|0
2056935|NCT00535236|3630482|FG000|Overall Study|Protocol Violation|2
2056936|NCT00535236|3630483|FG001|Overall Study|Protocol Violation|0
2056937|NCT00535236|3630484|FG002|Overall Study|Protocol Violation|1
2056938|NCT00535236|3630485|FG003|Overall Study|Protocol Violation|0
2209764|NCT01646177|3849247|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
2209765|NCT01646177|3849248|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
2209766|NCT01646177|3849237|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
2209767|NCT01646177|3849238|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
2209768|NCT01646177|3849239|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
2209769|NCT01646177|3849240|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
2209770|NCT01646177|3849241|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
2209771|NCT01646177|3849242|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
2209772|NCT01646177|3849243|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
2209773|NCT01646177|3849244|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
2056939|NCT00535236|3630486|FG004|Overall Study|Protocol Violation|0
2056940|NCT00535236|3630487|FG005|Overall Study|Protocol Violation|0
2056941|NCT00535236|3630488|FG006|Overall Study|Protocol Violation|0
2056942|NCT00535236|3630489|FG007|Overall Study|Protocol Violation|0
2056943|NCT00535236|3630490|FG008|Overall Study|Protocol Violation|1
2056944|NCT00535236|3630491|FG009|Overall Study|Protocol Violation|0
2056945|NCT00535236|3630482|FG000|Overall Study|Withdrawal by Subject|3
2056946|NCT00535236|3630483|FG001|Overall Study|Withdrawal by Subject|0
2056947|NCT00535236|3630484|FG002|Overall Study|Withdrawal by Subject|2
2056948|NCT00535236|3630485|FG003|Overall Study|Withdrawal by Subject|1
2056949|NCT00535236|3630486|FG004|Overall Study|Withdrawal by Subject|6
2056950|NCT00535236|3630487|FG005|Overall Study|Withdrawal by Subject|1
2056951|NCT00535236|3630488|FG006|Overall Study|Withdrawal by Subject|5
2056952|NCT00535236|3630489|FG007|Overall Study|Withdrawal by Subject|0
2056953|NCT00535236|3630490|FG008|Overall Study|Withdrawal by Subject|4
2056954|NCT00535236|3630491|FG009|Overall Study|Withdrawal by Subject|2
2056955|NCT00535288|3630521|FG000|Overall Study|Adverse Event|20
2056956|NCT00535288|3630522|FG001|Overall Study|Adverse Event|19
2056957|NCT00535288|3630523|FG002|Overall Study|Adverse Event|25
2056958|NCT00535288|3630524|FG003|Overall Study|Adverse Event|20
2056959|NCT00535288|3630525|FG004|Overall Study|Adverse Event|30
2056960|NCT00535288|3630521|FG000|Overall Study|Lost to Follow-up|0
2056961|NCT00535288|3630522|FG001|Overall Study|Lost to Follow-up|3
2056962|NCT00535288|3630523|FG002|Overall Study|Lost to Follow-up|0
2056963|NCT00535288|3630524|FG003|Overall Study|Lost to Follow-up|0
2056964|NCT00535288|3630525|FG004|Overall Study|Lost to Follow-up|0
2056965|NCT00535288|3630521|FG000|Overall Study|Lack of Efficacy|26
2056966|NCT00535288|3630522|FG001|Overall Study|Lack of Efficacy|3
2056967|NCT00535288|3630523|FG002|Overall Study|Lack of Efficacy|4
2056968|NCT00535288|3630524|FG003|Overall Study|Lack of Efficacy|4
2056969|NCT00535288|3630525|FG004|Overall Study|Lack of Efficacy|7
2056970|NCT00535288|3630521|FG000|Overall Study|Unwilling to cooperate|6
2056971|NCT00535288|3630522|FG001|Overall Study|Unwilling to cooperate|6
2056972|NCT00535288|3630523|FG002|Overall Study|Unwilling to cooperate|3
2056973|NCT00535288|3630524|FG003|Overall Study|Unwilling to cooperate|3
2056974|NCT00535288|3630525|FG004|Overall Study|Unwilling to cooperate|4
2056975|NCT00535288|3630521|FG000|Overall Study|Other|2
2056976|NCT00535288|3630522|FG001|Overall Study|Other|1
2056977|NCT00535288|3630523|FG002|Overall Study|Other|1
2056978|NCT00535288|3630524|FG003|Overall Study|Other|2
2056979|NCT00535288|3630525|FG004|Overall Study|Other|1
2056980|NCT00535496|3630559|FG000|Overall Study|Lost to Follow-up|0
2056981|NCT00535496|3630560|FG001|Overall Study|Lost to Follow-up|1
2056982|NCT00535496|3630561|FG002|Overall Study|Lost to Follow-up|0
2056983|NCT00535496|3630562|FG003|Overall Study|Lost to Follow-up|0
2056984|NCT00535496|3630559|FG000|Overall Study|Not treated with sugammadex|0
2056985|NCT00535496|3630560|FG001|Overall Study|Not treated with sugammadex|1
2056986|NCT00535496|3630561|FG002|Overall Study|Not treated with sugammadex|0
2056987|NCT00535496|3630562|FG003|Overall Study|Not treated with sugammadex|0
2056988|NCT00535626|3630593|FG000|Overall Study|Death|15
2056989|NCT00535626|3630593|FG000|Overall Study|Lost to Follow-up|29
2056990|NCT00535626|3630593|FG000|Overall Study|Withdrawal by Subject|20
2056991|NCT00535626|3630593|FG000|Overall Study|Removal/revision of study component|8
2056992|NCT00535626|3630593|FG000|Overall Study|Subject terminated|31
2056993|NCT00535626|3630593|FG000|Overall Study|Unable to return|2
2056994|NCT00535730|3630604|FG000|Overall Study|Adverse Event|1
2056995|NCT00535730|3630605|FG001|Overall Study|Adverse Event|1
2056996|NCT00535730|3630604|FG000|Overall Study|Lost to Follow-up|0
2056997|NCT00535730|3630605|FG001|Overall Study|Lost to Follow-up|1
2056998|NCT00535730|3630604|FG000|Overall Study|Physician Decision|0
2056999|NCT00535730|3630605|FG001|Overall Study|Physician Decision|1
2057000|NCT00535730|3630604|FG000|Overall Study|Protocol Violation|1
2057001|NCT00535730|3630605|FG001|Overall Study|Protocol Violation|0
2057002|NCT00535730|3630604|FG000|Overall Study|Withdrawal by Subject|0
2057003|NCT00535730|3630605|FG001|Overall Study|Withdrawal by Subject|4
2057004|NCT00535847|3630742|FG000|Overall Study|Adverse Event|5
2057005|NCT00535847|3630743|FG001|Overall Study|Adverse Event|3
2057006|NCT00535847|3630744|FG002|Overall Study|Adverse Event|2
2057007|NCT00535847|3630742|FG000|Overall Study|Non compliance|1
2057008|NCT00535847|3630743|FG001|Overall Study|Non compliance|1
2057009|NCT00535847|3630744|FG002|Overall Study|Non compliance|0
2057010|NCT00535847|3630742|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16
2057011|NCT00535847|3630743|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10
2057012|NCT00535847|3630744|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0
2057013|NCT00536107|3630782|FG000|Overall Study|Death|5
2057014|NCT00536107|3630783|FG001|Overall Study|Death|1
2057015|NCT00536107|3630782|FG000|Overall Study|Incorrect enrolment|1
2057016|NCT00536107|3630783|FG001|Overall Study|Incorrect enrolment|0
2057017|NCT00536107|3630782|FG000|Overall Study|Withdrawal by Subject|0
2057018|NCT00536107|3630783|FG001|Overall Study|Withdrawal by Subject|1
2057019|NCT00536107|3630782|FG000|Overall Study|Study Termination|2
2057020|NCT00536107|3630783|FG001|Overall Study|Study Termination|4
2057021|NCT00536120|3630791|FG000|Overall Study|Lost to Follow-up|1
2057022|NCT00536120|3630792|FG001|Overall Study|Lost to Follow-up|0
2057023|NCT00536120|3630791|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3
2057024|NCT00536120|3630792|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0
2057025|NCT00536120|3630791|FG000|Overall Study|Non-compliance|1
2057026|NCT00536120|3630792|FG001|Overall Study|Non-compliance|0
2057027|NCT00536120|3630791|FG000|Overall Study|Sponsor Decision Due to Lab Values|1
2057028|NCT00536120|3630792|FG001|Overall Study|Sponsor Decision Due to Lab Values|0
2057029|NCT00536120|3630791|FG000|Overall Study|Steroid Use|0
2057030|NCT00536120|3630792|FG001|Overall Study|Steroid Use|2
2057031|NCT00536120|3630791|FG000|Overall Study|Missed Study Visit|0
2057032|NCT00536120|3630792|FG001|Overall Study|Missed Study Visit|1
2057033|NCT00536198|3630809|FG000|Overall Study|Lost to Follow-up|15
2057034|NCT00536198|3630810|FG001|Overall Study|Lost to Follow-up|14
2057035|NCT00536198|3630809|FG000|Overall Study|Withdrawal by Subject|16
2057036|NCT00536198|3630810|FG001|Overall Study|Withdrawal by Subject|12
2057037|NCT00536198|3630809|FG000|Overall Study|Adverse Event|2
2057038|NCT00536198|3630810|FG001|Overall Study|Adverse Event|2
2057039|NCT00536198|3630809|FG000|Overall Study|Rescue|3
2057040|NCT00536198|3630810|FG001|Overall Study|Rescue|9
2057041|NCT00536198|3630809|FG000|Overall Study|Pregnancy|1
2057042|NCT00536198|3630810|FG001|Overall Study|Pregnancy|1
2057043|NCT00536198|3630809|FG000|Overall Study|Protocol Violation|0
2057044|NCT00536198|3630810|FG001|Overall Study|Protocol Violation|1
2057045|NCT00536263|3630821|FG000|Overall Study|Adverse Event|5
2057046|NCT00536263|3630822|FG001|Overall Study|Adverse Event|5
2057047|NCT00536263|3630823|FG002|Overall Study|Adverse Event|7
2057048|NCT00536263|3630821|FG000|Overall Study|Lost to Follow-up|3
2057049|NCT00536263|3630822|FG001|Overall Study|Lost to Follow-up|4
2057050|NCT00536263|3630823|FG002|Overall Study|Lost to Follow-up|4
2057051|NCT00536263|3630821|FG000|Overall Study|Subject withdrew - not treatment related|2
2057052|NCT00536263|3630822|FG001|Overall Study|Subject withdrew - not treatment related|0
2057053|NCT00536263|3630823|FG002|Overall Study|Subject withdrew - not treatment related|5
2057054|NCT00536263|3630821|FG000|Overall Study|Subject withdrew - treatment related|0
2057055|NCT00536263|3630822|FG001|Overall Study|Subject withdrew - treatment related|3
2057056|NCT00536263|3630823|FG002|Overall Study|Subject withdrew - treatment related|2
2057057|NCT00536263|3630821|FG000|Overall Study|Noncompliance with protocol|0
2057058|NCT00536263|3630822|FG001|Overall Study|Noncompliance with protocol|0
2057059|NCT00536263|3630823|FG002|Overall Study|Noncompliance with protocol|1
2057060|NCT00536263|3630821|FG000|Overall Study|Did not meet protocol eligibility|1
2057061|NCT00536263|3630822|FG001|Overall Study|Did not meet protocol eligibility|2
2057062|NCT00536263|3630823|FG002|Overall Study|Did not meet protocol eligibility|2
2057063|NCT00536471|3630845|FG000|Overall Study|Lost to Follow-up|48
2057064|NCT00536471|3630846|FG001|Overall Study|Lost to Follow-up|23
2057065|NCT00536471|3630847|FG002|Overall Study|Lost to Follow-up|48
2057066|NCT00536471|3630848|FG003|Overall Study|Lost to Follow-up|22
2057067|NCT00536471|3630845|FG000|Overall Study|Adverse Event|32
2057068|NCT00536471|3630846|FG001|Overall Study|Adverse Event|16
2057069|NCT00536471|3630847|FG002|Overall Study|Adverse Event|28
2057070|NCT00536471|3630848|FG003|Overall Study|Adverse Event|13
2057071|NCT00536471|3630845|FG000|Overall Study|Withdrawal by Subject|40
2057072|NCT00536471|3630846|FG001|Overall Study|Withdrawal by Subject|24
2057073|NCT00536471|3630847|FG002|Overall Study|Withdrawal by Subject|43
2057074|NCT00536471|3630848|FG003|Overall Study|Withdrawal by Subject|21
2057075|NCT00536471|3630845|FG000|Overall Study|Lack of Efficacy|17
2057076|NCT00536471|3630846|FG001|Overall Study|Lack of Efficacy|18
2057077|NCT00536471|3630847|FG002|Overall Study|Lack of Efficacy|11
2057078|NCT00536471|3630848|FG003|Overall Study|Lack of Efficacy|9
2057079|NCT00536471|3630845|FG000|Overall Study|Protocol Violation|8
2057080|NCT00536471|3630846|FG001|Overall Study|Protocol Violation|1
2057081|NCT00536471|3630847|FG002|Overall Study|Protocol Violation|2
2057082|NCT00536471|3630848|FG003|Overall Study|Protocol Violation|3
2057083|NCT00536471|3630845|FG000|Overall Study|Physician Decision|11
2057084|NCT00536471|3630846|FG001|Overall Study|Physician Decision|1
2057085|NCT00536471|3630847|FG002|Overall Study|Physician Decision|3
2057086|NCT00536471|3630848|FG003|Overall Study|Physician Decision|2
2057087|NCT00536471|3630845|FG000|Overall Study|Death|0
2057088|NCT00536471|3630846|FG001|Overall Study|Death|0
2057089|NCT00536471|3630847|FG002|Overall Study|Death|1
2057090|NCT00536471|3630848|FG003|Overall Study|Death|2
2057091|NCT00536471|3630845|FG000|Overall Study|Sponsor Decision|0
2057092|NCT00536471|3630846|FG001|Overall Study|Sponsor Decision|1
2057093|NCT00536471|3630847|FG002|Overall Study|Sponsor Decision|3
2057094|NCT00536471|3630848|FG003|Overall Study|Sponsor Decision|2
2057095|NCT00536484|3630867|FG000|Overall Study|Adverse Event|21
2057096|NCT00536484|3630868|FG001|Overall Study|Adverse Event|34
2057097|NCT00536484|3630867|FG000|Overall Study|Withdrawal by Subject|11
2057098|NCT00536484|3630868|FG001|Overall Study|Withdrawal by Subject|11
2057099|NCT00536484|3630867|FG000|Overall Study|Lost to Follow-up|8
2057100|NCT00536484|3630868|FG001|Overall Study|Lost to Follow-up|6
2057101|NCT00536484|3630867|FG000|Overall Study|Lack of Efficacy|16
2057102|NCT00536484|3630868|FG001|Overall Study|Lack of Efficacy|5
2057103|NCT00536484|3630867|FG000|Overall Study|Other|4
2057104|NCT00536484|3630868|FG001|Overall Study|Other|0
2057105|NCT00536510|3630876|FG000|Overall Study|Adverse Event|27
2057106|NCT00536510|3630877|FG001|Overall Study|Adverse Event|4
2057107|NCT00536510|3630876|FG000|Overall Study|Lost to Follow-up|11
2057108|NCT00536510|3630877|FG001|Overall Study|Lost to Follow-up|8
2057109|NCT00536510|3630876|FG000|Overall Study|Protocol Violation|4
2057110|NCT00536510|3630877|FG001|Overall Study|Protocol Violation|5
2057111|NCT00536510|3630876|FG000|Overall Study|Withdrawal by Subject|16
2057112|NCT00536510|3630877|FG001|Overall Study|Withdrawal by Subject|9
2057113|NCT00536510|3630876|FG000|Overall Study|Flushing with Product|20
2057114|NCT00536510|3630877|FG001|Overall Study|Flushing with Product|0
2057115|NCT00536510|3630876|FG000|Overall Study|Laboratory Adverse Event|2
2057116|NCT00536510|3630877|FG001|Overall Study|Laboratory Adverse Event|1
2057117|NCT00536510|3630876|FG000|Overall Study|Patient Discontinued for Other Reasons|2
2057118|NCT00536510|3630877|FG001|Overall Study|Patient Discontinued for Other Reasons|2
2057119|NCT00536575|3630883|FG000|Overall Study|Withdrawal by Subject|1
2057120|NCT00536575|3630883|FG000|Overall Study|Death|1
2057121|NCT00536731|3630911|FG000|Overall Study|Adverse Event|3
2057122|NCT00536731|3630912|FG001|Overall Study|Adverse Event|2
2057123|NCT00536731|3630913|FG002|Overall Study|Adverse Event|3
2057124|NCT00536731|3630911|FG000|Overall Study|Withdrawal by Subject|0
2057125|NCT00536731|3630912|FG001|Overall Study|Withdrawal by Subject|2
2057126|NCT00536731|3630913|FG002|Overall Study|Withdrawal by Subject|0
2057127|NCT00536731|3630911|FG000|Overall Study|Intake of prohibited conc. medication|0
2057128|NCT00536731|3630912|FG001|Overall Study|Intake of prohibited conc. medication|0
2057129|NCT00536731|3630913|FG002|Overall Study|Intake of prohibited conc. medication|1
2057130|NCT00536731|3630911|FG000|Overall Study|Safety reasons|0
2057131|NCT00536731|3630912|FG001|Overall Study|Safety reasons|0
2057132|NCT00536731|3630913|FG002|Overall Study|Safety reasons|1
2057133|NCT00536731|3630911|FG000|Overall Study|Other|1
2057134|NCT00536731|3630912|FG001|Overall Study|Other|1
2057135|NCT00536731|3630913|FG002|Overall Study|Other|0
2057136|NCT00536744|3630923|FG000|Overall Study|Adverse Event|13
2057137|NCT00536744|3630924|FG001|Overall Study|Adverse Event|10
2057138|NCT00536744|3630923|FG000|Overall Study|Death|2
2057139|NCT00536744|3630924|FG001|Overall Study|Death|1
2057140|NCT00536744|3630923|FG000|Overall Study|Physician Decision|3
2057141|NCT00536744|3630924|FG001|Overall Study|Physician Decision|1
2057142|NCT00536744|3630923|FG000|Overall Study|Lost to Follow-up|3
2057143|NCT00536744|3630924|FG001|Overall Study|Lost to Follow-up|5
2057144|NCT00536744|3630923|FG000|Overall Study|Withdrawal by Subject|7
2057145|NCT00536744|3630924|FG001|Overall Study|Withdrawal by Subject|8
2057146|NCT00536744|3630923|FG000|Overall Study|PI tried alternative treatment|1
2057147|NCT00536744|3630924|FG001|Overall Study|PI tried alternative treatment|3
2057148|NCT00536809|3630930|FG000|Phase II|Adverse Event|1
2057149|NCT00536809|3630930|FG000|Phase II|Referred for surgical resection|1
2057150|NCT00536874|3630934|FG000|Overall Study|Adverse Event|1
2057151|NCT00536874|3630934|FG000|Overall Study|Death|2
2057152|NCT00536874|3630934|FG000|Overall Study|Withdrawal by Subject|1
2057153|NCT00536939|3630947|FG000|Overall Study|Withdrawal by Subject|1
2057154|NCT00536939|3630948|FG001|Overall Study|Withdrawal by Subject|0
2057155|NCT00536939|3630947|FG000|Overall Study|Other Complicating Disease|1
2057156|NCT00536939|3630948|FG001|Overall Study|Other Complicating Disease|0
2057157|NCT00536991|3630953|FG000|Overall Study|Withdrawal by Subject|10
2057158|NCT00536991|3630953|FG000|Overall Study|Physician Decision|1
2057159|NCT00536991|3630953|FG000|Overall Study|patient ineligible|2
2057160|NCT00537017|3630958|FG000|Treatment Phase|Adverse Event|19
2057161|NCT00537017|3630958|FG000|Treatment Phase|Withdrawal by Subject|13
2057162|NCT00537017|3630958|FG000|Treatment Phase|Protocol Violation|2
2057163|NCT00537017|3630958|FG000|Follow-up Phase|Withdrawal by Subject|9
2057164|NCT00537030|3630962|FG000|Overall Study|Physician Decision|2
2057165|NCT00537030|3630962|FG000|Overall Study|Withdrawal by Subject|2
2057166|NCT00537030|3630962|FG000|Overall Study|≥ Grade 2 allergy|7
2057167|NCT00537030|3630962|FG000|Overall Study|Disease progression/ relapse during Tx|1
2057168|NCT00537030|3630962|FG000|Overall Study|Ineligible|2
2057169|NCT00537030|3630962|FG000|Overall Study|Inevaluable|2
2057170|NCT00537056|3630966|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5
2057171|NCT00537082|3630975|FG000|Overall Study|Adverse Event|6
2057172|NCT00537082|3630976|FG001|Overall Study|Adverse Event|6
2057173|NCT00537082|3630977|FG002|Overall Study|Adverse Event|3
2057174|NCT00537082|3630975|FG000|Overall Study|Protocol Violation|0
2057175|NCT00537082|3630976|FG001|Overall Study|Protocol Violation|2
2057176|NCT00537082|3630977|FG002|Overall Study|Protocol Violation|1
2057177|NCT00537082|3630975|FG000|Overall Study|Lack of Efficacy|0
2057178|NCT00537082|3630976|FG001|Overall Study|Lack of Efficacy|0
2057179|NCT00537082|3630977|FG002|Overall Study|Lack of Efficacy|2
2057180|NCT00537082|3630975|FG000|Overall Study|Withdrawal by Subject|0
2057181|NCT00537082|3630976|FG001|Overall Study|Withdrawal by Subject|1
2057182|NCT00537082|3630977|FG002|Overall Study|Withdrawal by Subject|0
2057183|NCT00537082|3630975|FG000|Overall Study|Discontinued before initiating treatment|3
2057184|NCT00537082|3630976|FG001|Overall Study|Discontinued before initiating treatment|0
2057185|NCT00537082|3630977|FG002|Overall Study|Discontinued before initiating treatment|0
2057186|NCT00537095|3630987|FG000|Overall Study|surgery|1
2057187|NCT00537095|3630988|FG001|Overall Study|surgery|0
2057188|NCT00537095|3630987|FG000|Overall Study|Adverse Event|24
2057189|NCT00537095|3630988|FG001|Overall Study|Adverse Event|4
2057190|NCT00537095|3630987|FG000|Overall Study|disease progression|21
2057191|NCT00537095|3630988|FG001|Overall Study|disease progression|48
2057192|NCT00537095|3630987|FG000|Overall Study|Death|3
2057193|NCT00537095|3630988|FG001|Overall Study|Death|1
2057194|NCT00537095|3630987|FG000|Overall Study|Withdrawal by Subject|2
2057195|NCT00537095|3630988|FG001|Overall Study|Withdrawal by Subject|2
2057196|NCT00537095|3630987|FG000|Overall Study|subjective disease progression|0
2057197|NCT00537095|3630988|FG001|Overall Study|subjective disease progression|1
2057198|NCT00537095|3630987|FG000|Overall Study|Incorrect enrolment|0
2057199|NCT00537095|3630988|FG001|Overall Study|Incorrect enrolment|1
2057200|NCT00537238|3630996|FG000|Overall Study|Death|1
2057201|NCT00537238|3630997|FG001|Overall Study|Death|2
2057202|NCT00537238|3630996|FG000|Overall Study|Adverse Event|31
2057203|NCT00537238|3630997|FG001|Overall Study|Adverse Event|22
2057204|NCT00537238|3630996|FG000|Overall Study|Lack of Efficacy|20
2057205|NCT00537238|3630997|FG001|Overall Study|Lack of Efficacy|21
2057206|NCT00537238|3630996|FG000|Overall Study|Lost to Follow-up|12
2057207|NCT00537238|3630997|FG001|Overall Study|Lost to Follow-up|8
2057208|NCT00537238|3630996|FG000|Overall Study|Withdrawal by Subject|51
2057209|NCT00537238|3630997|FG001|Overall Study|Withdrawal by Subject|47
2057210|NCT00537238|3630996|FG000|Overall Study|Protocol Violation|15
2057211|NCT00537238|3630997|FG001|Overall Study|Protocol Violation|19
2057212|NCT00537238|3630996|FG000|Overall Study|Does not meet entrance criteria|0
2057213|NCT00537238|3630997|FG001|Overall Study|Does not meet entrance criteria|2
2057214|NCT00537238|3630996|FG000|Overall Study|Other|44
2057215|NCT00537238|3630997|FG001|Overall Study|Other|52
2057216|NCT00537277|3631003|FG000|Overall Study|Adverse Event|1
2057217|NCT00537277|3631003|FG000|Overall Study|Lack of Efficacy|2
2057218|NCT00537277|3631003|FG000|Overall Study|Lost to Follow-up|12
2057219|NCT00537277|3631003|FG000|Overall Study|Protocol Violation|11
2057220|NCT00537277|3631003|FG000|Overall Study|Unclassified|4
2057221|NCT00537277|3631003|FG000|Overall Study|Inability to tolerate trial medication|4
2057222|NCT00537277|3631003|FG000|Overall Study|Non-compliance with trial procedures|15
2057223|NCT00537303|3631013|FG000|Overall Study|Adverse Event|1
2057224|NCT00537303|3631014|FG001|Overall Study|Adverse Event|4
2057225|NCT00537303|3631013|FG000|Overall Study|Lack of Efficacy|6
2057226|NCT00537303|3631014|FG001|Overall Study|Lack of Efficacy|7
2057227|NCT00537303|3631013|FG000|Overall Study|Protocol Violation|8
2057228|NCT00537303|3631014|FG001|Overall Study|Protocol Violation|4
2057229|NCT00537303|3631013|FG000|Overall Study|Withdrawal criteria|3
2057230|NCT00537303|3631014|FG001|Overall Study|Withdrawal criteria|3
2057231|NCT00537303|3631013|FG000|Overall Study|Unclassified|8
2057232|NCT00537303|3631014|FG001|Overall Study|Unclassified|7
2057233|NCT00537316|3631026|FG000|Part 1|Adverse Event|7
2057234|NCT00537316|3631027|FG001|Part 1|Adverse Event|11
2057235|NCT00537316|3631028|FG002|Part 1|Adverse Event|8
2057236|NCT00537316|3631029|FG003|Part 1|Adverse Event|0
2057237|NCT00537316|3631030|FG004|Part 1|Adverse Event|0
2057238|NCT00537316|3631031|FG005|Part 1|Adverse Event|0
2057239|NCT00537316|3631032|FG006|Part 1|Adverse Event|0
2057240|NCT00537316|3631026|FG000|Part 1|Protocol defined clinical event|1
2057241|NCT00537316|3631027|FG001|Part 1|Protocol defined clinical event|0
2057242|NCT00537316|3631028|FG002|Part 1|Protocol defined clinical event|0
2057243|NCT00537316|3631029|FG003|Part 1|Protocol defined clinical event|0
2057244|NCT00537316|3631030|FG004|Part 1|Protocol defined clinical event|0
2057245|NCT00537316|3631031|FG005|Part 1|Protocol defined clinical event|0
2057246|NCT00537316|3631032|FG006|Part 1|Protocol defined clinical event|0
2057247|NCT00537316|3631026|FG000|Part 1|Lost to Follow-up|1
2057248|NCT00537316|3631027|FG001|Part 1|Lost to Follow-up|0
2057249|NCT00537316|3631028|FG002|Part 1|Lost to Follow-up|0
2057250|NCT00537316|3631029|FG003|Part 1|Lost to Follow-up|0
2057251|NCT00537316|3631030|FG004|Part 1|Lost to Follow-up|0
2057252|NCT00537316|3631031|FG005|Part 1|Lost to Follow-up|0
2057253|NCT00537316|3631032|FG006|Part 1|Lost to Follow-up|0
2057254|NCT00537316|3631026|FG000|Part 1|Withdrawal by Subject|3
2057255|NCT00537316|3631027|FG001|Part 1|Withdrawal by Subject|8
2057256|NCT00537316|3631028|FG002|Part 1|Withdrawal by Subject|4
2057257|NCT00537316|3631029|FG003|Part 1|Withdrawal by Subject|0
2057258|NCT00537316|3631030|FG004|Part 1|Withdrawal by Subject|0
2057259|NCT00537316|3631031|FG005|Part 1|Withdrawal by Subject|0
2057260|NCT00537316|3631032|FG006|Part 1|Withdrawal by Subject|0
2057261|NCT00537316|3631026|FG000|Part 1|Protocol Violation|1
2057262|NCT00537316|3631027|FG001|Part 1|Protocol Violation|5
2057263|NCT00537316|3631028|FG002|Part 1|Protocol Violation|1
2057264|NCT00537316|3631029|FG003|Part 1|Protocol Violation|0
2057265|NCT00537316|3631030|FG004|Part 1|Protocol Violation|0
2057266|NCT00537316|3631031|FG005|Part 1|Protocol Violation|0
2057267|NCT00537316|3631032|FG006|Part 1|Protocol Violation|0
2057268|NCT00537316|3631026|FG000|Part 1|Did not meet protocol eligibility|1
2057269|NCT00537316|3631027|FG001|Part 1|Did not meet protocol eligibility|3
2057270|NCT00537316|3631028|FG002|Part 1|Did not meet protocol eligibility|2
2057271|NCT00537316|3631029|FG003|Part 1|Did not meet protocol eligibility|0
2057272|NCT00537316|3631030|FG004|Part 1|Did not meet protocol eligibility|0
2057273|NCT00537316|3631031|FG005|Part 1|Did not meet protocol eligibility|0
2057274|NCT00537316|3631032|FG006|Part 1|Did not meet protocol eligibility|0
2057275|NCT00537316|3631026|FG000|Part 1|Administrative|0
2057276|NCT00537316|3631027|FG001|Part 1|Administrative|0
2057277|NCT00537316|3631028|FG002|Part 1|Administrative|2
2057278|NCT00537316|3631029|FG003|Part 1|Administrative|0
2057279|NCT00537316|3631030|FG004|Part 1|Administrative|0
2057280|NCT00537316|3631031|FG005|Part 1|Administrative|0
2057281|NCT00537316|3631032|FG006|Part 1|Administrative|0
2057282|NCT00537316|3631026|FG000|Part 2|Never entered follow-up|0
2057283|NCT00537316|3631027|FG001|Part 2|Never entered follow-up|0
2057284|NCT00537316|3631028|FG002|Part 2|Never entered follow-up|0
2057285|NCT00537316|3631029|FG003|Part 2|Never entered follow-up|0
2057286|NCT00537316|3631030|FG004|Part 2|Never entered follow-up|0
2057287|NCT00537316|3631031|FG005|Part 2|Never entered follow-up|0
2057288|NCT00537316|3631032|FG006|Part 2|Never entered follow-up|1
2057289|NCT00537316|3631026|FG000|Part 2|Adverse Event|4
2057290|NCT00537316|3631027|FG001|Part 2|Adverse Event|0
2057291|NCT00537316|3631028|FG002|Part 2|Adverse Event|2
2057292|NCT00537316|3631029|FG003|Part 2|Adverse Event|0
2057293|NCT00537316|3631030|FG004|Part 2|Adverse Event|0
2057294|NCT00537316|3631031|FG005|Part 2|Adverse Event|0
2057295|NCT00537316|3631032|FG006|Part 2|Adverse Event|0
2057296|NCT00537316|3631026|FG000|Part 2|Lost to Follow-up|1
2057297|NCT00537316|3631027|FG001|Part 2|Lost to Follow-up|0
2057298|NCT00537316|3631028|FG002|Part 2|Lost to Follow-up|2
2057299|NCT00537316|3631029|FG003|Part 2|Lost to Follow-up|0
2057300|NCT00537316|3631030|FG004|Part 2|Lost to Follow-up|0
2057301|NCT00537316|3631031|FG005|Part 2|Lost to Follow-up|0
2057302|NCT00537316|3631032|FG006|Part 2|Lost to Follow-up|0
2057303|NCT00537316|3631026|FG000|Part 2|Withdrawal by Subject|5
2057304|NCT00537316|3631027|FG001|Part 2|Withdrawal by Subject|1
2057305|NCT00537316|3631028|FG002|Part 2|Withdrawal by Subject|4
2057306|NCT00537316|3631029|FG003|Part 2|Withdrawal by Subject|0
2057307|NCT00537316|3631030|FG004|Part 2|Withdrawal by Subject|0
2057308|NCT00537316|3631031|FG005|Part 2|Withdrawal by Subject|0
2057309|NCT00537316|3631032|FG006|Part 2|Withdrawal by Subject|0
2057310|NCT00537316|3631026|FG000|Part 2|Administrative|16
2057311|NCT00537316|3631027|FG001|Part 2|Administrative|8
2057312|NCT00537316|3631028|FG002|Part 2|Administrative|24
2057313|NCT00537316|3631029|FG003|Part 2|Administrative|3
2057314|NCT00537316|3631030|FG004|Part 2|Administrative|1
2057315|NCT00537316|3631031|FG005|Part 2|Administrative|4
2057316|NCT00537316|3631032|FG006|Part 2|Administrative|1
2057317|NCT00537329|3631051|FG000|Overall Study|Death|10
2057318|NCT00537329|3631051|FG000|Overall Study|Adverse Event|3
2057319|NCT00537329|3631051|FG000|Overall Study|Lack of Efficacy|2
2057320|NCT00537329|3631051|FG000|Overall Study|Lost to Follow-up|6
2057321|NCT00537329|3631051|FG000|Overall Study|Withdrawal by Subject|4
2057322|NCT00537329|3631051|FG000|Overall Study|Other|1
2057323|NCT00537381|3631057|FG000|Overall Study|Adverse Event|13
2057324|NCT00537381|3631058|FG001|Overall Study|Adverse Event|9
2057325|NCT00537381|3631057|FG000|Overall Study|Death|3
2057326|NCT00537381|3631058|FG001|Overall Study|Death|3
2057327|NCT00537381|3631057|FG000|Overall Study|Withdrawal by Subject|5
2057328|NCT00537381|3631058|FG001|Overall Study|Withdrawal by Subject|14
2057329|NCT00537381|3631057|FG000|Overall Study|Physician Decision|7
2057330|NCT00537381|3631058|FG001|Overall Study|Physician Decision|6
2057331|NCT00537381|3631057|FG000|Overall Study|Disease Progression|9
2057332|NCT00537381|3631058|FG001|Overall Study|Disease Progression|18
2057333|NCT00537381|3631057|FG000|Overall Study|Sponsor decision|14
2057334|NCT00537381|3631058|FG001|Overall Study|Sponsor decision|9
2057335|NCT00537381|3631057|FG000|Overall Study|Other|5
2057336|NCT00537381|3631058|FG001|Overall Study|Other|3
2057337|NCT00537394|3631069|FG000|First Year of Follow-up|Death|7
2057338|NCT00537394|3631070|FG001|First Year of Follow-up|Death|0
2057339|NCT00537394|3631071|FG002|First Year of Follow-up|Death|0
2057340|NCT00537394|3631069|FG000|First Year of Follow-up|Severe debilitation|1
2057341|NCT00537394|3631070|FG001|First Year of Follow-up|Severe debilitation|0
2057342|NCT00537394|3631071|FG002|First Year of Follow-up|Severe debilitation|1
2057343|NCT00537394|3631069|FG000|First Year of Follow-up|Withdrawal by Subject|3
2057344|NCT00537394|3631070|FG001|First Year of Follow-up|Withdrawal by Subject|6
2057345|NCT00537394|3631071|FG002|First Year of Follow-up|Withdrawal by Subject|1
2057346|NCT00537394|3631069|FG000|First Year of Follow-up|Lost to Follow-up|1
2057347|NCT00537394|3631070|FG001|First Year of Follow-up|Lost to Follow-up|5
2057348|NCT00537394|3631071|FG002|First Year of Follow-up|Lost to Follow-up|1
2057349|NCT00537394|3631069|FG000|2nd Year of Follow-up|Death|4
2057350|NCT00537394|3631070|FG001|2nd Year of Follow-up|Death|1
2057351|NCT00537394|3631071|FG002|2nd Year of Follow-up|Death|2
2057352|NCT00537394|3631069|FG000|2nd Year of Follow-up|Withdrawal by Subject|0
2057353|NCT00537394|3631070|FG001|2nd Year of Follow-up|Withdrawal by Subject|1
2057354|NCT00537394|3631071|FG002|2nd Year of Follow-up|Withdrawal by Subject|2
2057355|NCT00537394|3631069|FG000|2nd Year of Follow-up|Lost to Follow-up|6
2057356|NCT00537394|3631070|FG001|2nd Year of Follow-up|Lost to Follow-up|7
2057357|NCT00537394|3631071|FG002|2nd Year of Follow-up|Lost to Follow-up|2
2057358|NCT00537394|3631069|FG000|2nd Year of Follow-up|Clinic site closure|1
2057359|NCT00537394|3631070|FG001|2nd Year of Follow-up|Clinic site closure|0
2057360|NCT00537394|3631071|FG002|2nd Year of Follow-up|Clinic site closure|0
2105601|NCT00857948|3698239|FG000|Overall Study|Protocol Violation|1
2105602|NCT00857948|3698240|FG001|Overall Study|Protocol Violation|0
2105603|NCT00857948|3698241|FG002|Overall Study|Protocol Violation|1
2105604|NCT00857948|3698242|FG003|Overall Study|Protocol Violation|0
2105605|NCT00858117|3698271|FG000|Treatment on Study|Adverse Event|2
2105606|NCT00858117|3698271|FG000|Follow up for 5 Years|Death|4
2105607|NCT00858117|3698271|FG000|Follow up for 5 Years|No further data collected for study|9
2105608|NCT00858143|3698280|FG000|Overall Study|Adverse Event|16
2105609|NCT00858143|3698280|FG000|Overall Study|Lack of Efficacy|4
2105610|NCT00858143|3698280|FG000|Overall Study|Death|7
2105611|NCT00858143|3698280|FG000|Overall Study|Other|23
2105612|NCT00858208|3698284|FG000|Overall Study|Adverse Event|3
2105613|NCT00858208|3698284|FG000|Overall Study|Lost to Follow-up|26
2105614|NCT00858208|3698284|FG000|Overall Study|Participant refused|40
2105615|NCT00858208|3698284|FG000|Overall Study|Other|10
2105616|NCT00858234|3698288|FG000|Overall Study|Adverse Event|6
2105617|NCT00858234|3698288|FG000|Overall Study|Progressive disease|2
2105618|NCT00858234|3698288|FG000|Overall Study|Status unknown|1
2105619|NCT00858247|3698294|FG000|Baseline Assessment|Withdrawal by Subject|1
2105620|NCT00858247|3698295|FG001|Baseline Assessment|Withdrawal by Subject|1
2105621|NCT00858247|3698294|FG000|Baseline Assessment|Poor IV access|1
2105622|NCT00858247|3698295|FG001|Baseline Assessment|Poor IV access|0
2105623|NCT00858247|3698294|FG000|Baseline Assessment|Protocol Violation|0
2105624|NCT00858247|3698295|FG001|Baseline Assessment|Protocol Violation|1
2105625|NCT00858247|3698294|FG000|Week 12 Follow-up|Withdrawal by Subject|0
2105626|NCT00858247|3698295|FG001|Week 12 Follow-up|Withdrawal by Subject|1
2105627|NCT00858364|3698303|FG000|Overall Study|Administrative Decision|3
2105628|NCT00858364|3698304|FG001|Overall Study|Administrative Decision|2
2105629|NCT00858364|3698303|FG000|Overall Study|Adverse Event|5
2105630|NCT00858364|3698304|FG001|Overall Study|Adverse Event|2
2105631|NCT00858364|3698303|FG000|Overall Study|Withdrawal by Subject|44
2105632|NCT00858364|3698304|FG001|Overall Study|Withdrawal by Subject|118
2105633|NCT00858364|3698303|FG000|Overall Study|Ineligibility Determined|1
2105634|NCT00858364|3698304|FG001|Overall Study|Ineligibility Determined|10
2105635|NCT00858364|3698303|FG000|Overall Study|Lost to Follow-up|24
2057361|NCT00537485|3631104|FG000|Overall Study|Adverse Event|10
2057362|NCT00537485|3631105|FG001|Overall Study|Adverse Event|5
2057363|NCT00537485|3631104|FG000|Overall Study|Withdrawal by Subject|3
2057364|NCT00537485|3631105|FG001|Overall Study|Withdrawal by Subject|2
2057365|NCT00537485|3631104|FG000|Overall Study|Withdrawal by Subject|1
2057366|NCT00537485|3631105|FG001|Overall Study|Withdrawal by Subject|3
2057367|NCT00537485|3631104|FG000|Overall Study|Physician Decision|1
2057368|NCT00537485|3631105|FG001|Overall Study|Physician Decision|0
2057369|NCT00537745|3631166|FG000|Overall Study|Did not meet eligibility criteria|2
2057370|NCT00537745|3631166|FG000|Overall Study|Withdrawal by Subject|2
2057371|NCT00537745|3631166|FG000|Overall Study|Subject unable to provide Interlock info|1
2057372|NCT00537771|3631173|FG000|Overall Study|Withdrawal by Subject|6
2057373|NCT00537771|3631174|FG001|Overall Study|Withdrawal by Subject|23
2057374|NCT00537771|3631173|FG000|Overall Study|Adverse Event|8
2057375|NCT00537771|3631174|FG001|Overall Study|Adverse Event|15
2057376|NCT00537771|3631173|FG000|Overall Study|Lost to Follow-up|9
2057377|NCT00537771|3631174|FG001|Overall Study|Lost to Follow-up|15
2057378|NCT00537771|3631173|FG000|Overall Study|Protocol Violation|2
2057379|NCT00537771|3631174|FG001|Overall Study|Protocol Violation|6
2057380|NCT00537771|3631173|FG000|Overall Study|Severe Non-Compliance to Protocol|4
2057381|NCT00537771|3631174|FG001|Overall Study|Severe Non-Compliance to Protocol|2
2057382|NCT00537810|3631184|FG000|Overall Study|Withdrawal by Subject|4
2057383|NCT00537810|3631185|FG001|Overall Study|Withdrawal by Subject|11
2057384|NCT00537810|3631186|FG002|Overall Study|Withdrawal by Subject|4
2057385|NCT00537810|3631187|FG003|Overall Study|Withdrawal by Subject|3
2057386|NCT00537810|3631184|FG000|Overall Study|Medically withdrawn|2
2057387|NCT00537810|3631185|FG001|Overall Study|Medically withdrawn|2
2057388|NCT00537810|3631186|FG002|Overall Study|Medically withdrawn|0
2057389|NCT00537810|3631187|FG003|Overall Study|Medically withdrawn|1
2057390|NCT00537823|3631199|FG000|Overall Study|Adverse Event|2
2057391|NCT00537823|3631200|FG001|Overall Study|Adverse Event|0
2057392|NCT00537940|3631209|FG000|Overall Study|Adverse Event|20
2057393|NCT00537940|3631210|FG001|Overall Study|Adverse Event|19
2057394|NCT00537940|3631209|FG000|Overall Study|Lack of Efficacy|8
2057395|NCT00537940|3631210|FG001|Overall Study|Lack of Efficacy|16
2057396|NCT00537940|3631209|FG000|Overall Study|Lost to Follow-up|23
2057397|NCT00537940|3631210|FG001|Overall Study|Lost to Follow-up|29
2057398|NCT00537940|3631209|FG000|Overall Study|Withdrawal by Subject|113
2057399|NCT00537940|3631210|FG001|Overall Study|Withdrawal by Subject|95
2057400|NCT00537940|3631209|FG000|Overall Study|Protocol Violation|6
2057401|NCT00537940|3631210|FG001|Overall Study|Protocol Violation|4
2057402|NCT00537940|3631209|FG000|Overall Study|Pregnancy|1
2057403|NCT00537940|3631210|FG001|Overall Study|Pregnancy|1
2057404|NCT00537940|3631209|FG000|Overall Study|Study terminated by sponsor|2
2057405|NCT00537940|3631210|FG001|Overall Study|Study terminated by sponsor|3
2057406|NCT00537940|3631209|FG000|Overall Study|Other|10
2057407|NCT00537940|3631210|FG001|Overall Study|Other|12
2057408|NCT00537979|3631218|FG000|Overall Study|Adverse Event|2
2057409|NCT00537979|3631219|FG001|Overall Study|Adverse Event|2
2057410|NCT00537979|3631218|FG000|Overall Study|Withdrawal by Subject|1
2057411|NCT00537979|3631219|FG001|Overall Study|Withdrawal by Subject|4
2057412|NCT00537979|3631218|FG000|Overall Study|Lost to Follow-up|1
2057413|NCT00537979|3631219|FG001|Overall Study|Lost to Follow-up|4
2057414|NCT00537979|3631218|FG000|Overall Study|Lack of Efficacy|0
2057415|NCT00537979|3631219|FG001|Overall Study|Lack of Efficacy|1
2057416|NCT00537979|3631218|FG000|Overall Study|Non-compliance with treatment/procedure|2
2057417|NCT00537979|3631219|FG001|Overall Study|Non-compliance with treatment/procedure|2
2057418|NCT00537979|3631218|FG000|Overall Study|Death|0
2057419|NCT00537979|3631219|FG001|Overall Study|Death|3
2057420|NCT00537979|3631218|FG000|Overall Study|Kidney transplant|0
2057421|NCT00537979|3631219|FG001|Overall Study|Kidney transplant|3
2057422|NCT00537979|3631218|FG000|Overall Study|Heart failure|0
2057423|NCT00537979|3631219|FG001|Overall Study|Heart failure|1
2057424|NCT00538291|3631240|FG000|Overall Study|Adverse Event|2
2057425|NCT00538291|3631240|FG000|Overall Study|Withdrawal by Subject|1
2057426|NCT00538473|3631273|FG000|Overall Study|Adverse Event|1
2057427|NCT00538473|3631274|FG001|Overall Study|Adverse Event|0
2057428|NCT00538590|3631295|FG000|Overall Study|Death|1
2057429|NCT00538590|3631296|FG001|Overall Study|Death|0
2057430|NCT00538629|3631311|FG000|Overall Study|At subject's request|1
2057431|NCT00538629|3631311|FG000|Overall Study|Adverse Event|2
2057432|NCT00538629|3631311|FG000|Overall Study|Lack of Efficacy|12
2057433|NCT00538629|3631311|FG000|Overall Study|Lost to Follow-up|6
2177087|NCT01371708|3801171|FG001|Overall Study|Lost to Follow-up|9
2057434|NCT00538629|3631311|FG000|Overall Study|Subject's untimely distrust of medicine|1
2057435|NCT00538681|3631329|FG000|Overall Study|Progressive Disease|7
2057436|NCT00538681|3631330|FG001|Overall Study|Progressive Disease|0
2057437|NCT00538681|3631331|FG002|Overall Study|Progressive Disease|1
2057438|NCT00538681|3631332|FG003|Overall Study|Progressive Disease|0
2057439|NCT00538681|3631329|FG000|Overall Study|Sponsor Decision|1
2057440|NCT00538681|3631330|FG001|Overall Study|Sponsor Decision|3
2057441|NCT00538681|3631331|FG002|Overall Study|Sponsor Decision|8
2057442|NCT00538681|3631332|FG003|Overall Study|Sponsor Decision|9
2057443|NCT00538681|3631329|FG000|Overall Study|Adverse Event|1
2057444|NCT00538681|3631330|FG001|Overall Study|Adverse Event|1
2057445|NCT00538681|3631331|FG002|Overall Study|Adverse Event|1
2301025|NCT02607228|3998880|FG004|Overall Study|Study Terminated by Sponsor|0
2301026|NCT02607228|3998881|FG005|Overall Study|Study Terminated by Sponsor|0
2301027|NCT02607228|3998882|FG006|Overall Study|Study Terminated by Sponsor|0
2301028|NCT02607280|3998920|FG000|Overall Study|Adverse Event|4
2301029|NCT02607280|3998921|FG001|Overall Study|Adverse Event|0
2301030|NCT02607280|3998920|FG000|Overall Study|Decrease in CrCl <15|0
2301031|NCT02607280|3998921|FG001|Overall Study|Decrease in CrCl <15|1
2301032|NCT02607306|3998930|FG000|Overall Study|Adverse Event|8
2301033|NCT02607306|3998931|FG001|Overall Study|Adverse Event|6
2301034|NCT02607306|3998932|FG002|Overall Study|Adverse Event|6
2301035|NCT02607306|3998930|FG000|Overall Study|Unclassified|1
2301036|NCT02607306|3998931|FG001|Overall Study|Unclassified|4
2301037|NCT02607306|3998932|FG002|Overall Study|Unclassified|0
2301038|NCT02607306|3998930|FG000|Overall Study|Withdrawal by Subject|8
2301039|NCT02607306|3998931|FG001|Overall Study|Withdrawal by Subject|10
2301040|NCT02607306|3998932|FG002|Overall Study|Withdrawal by Subject|2
2301041|NCT02607306|3998930|FG000|Overall Study|Lack of Efficacy|0
2301042|NCT02607306|3998931|FG001|Overall Study|Lack of Efficacy|1
2301043|NCT02607306|3998932|FG002|Overall Study|Lack of Efficacy|1
2301044|NCT02607306|3998930|FG000|Overall Study|Protocol Violation|4
2301045|NCT02607306|3998931|FG001|Overall Study|Protocol Violation|2
2301046|NCT02607306|3998932|FG002|Overall Study|Protocol Violation|1
2301047|NCT02607735|3998952|FG000|Primary Study|Randomized but Never Treated|1
2301048|NCT02607735|3998953|FG001|Primary Study|Randomized but Never Treated|0
2301049|NCT02607735|3998954|FG002|Primary Study|Randomized but Never Treated|0
2301050|NCT02607735|3998952|FG000|Primary Study|Lost to Follow-up|4
2301051|NCT02607735|3998953|FG001|Primary Study|Lost to Follow-up|0
2301052|NCT02607735|3998954|FG002|Primary Study|Lost to Follow-up|0
2301053|NCT02607735|3998952|FG000|Primary Study|Withdrew Consent|2
2301054|NCT02607735|3998953|FG001|Primary Study|Withdrew Consent|0
2301055|NCT02607735|3998954|FG002|Primary Study|Withdrew Consent|0
2301056|NCT02607735|3998952|FG000|Deferred Treatment Substudy|Lost to Follow-up|0
2301057|NCT02607735|3998953|FG001|Deferred Treatment Substudy|Lost to Follow-up|0
2301058|NCT02607735|3998954|FG002|Deferred Treatment Substudy|Lost to Follow-up|4
2301059|NCT02607735|3998952|FG000|Deferred Treatment Substudy|Withdrew Consent|0
2301060|NCT02607735|3998953|FG001|Deferred Treatment Substudy|Withdrew Consent|0
2301061|NCT02607735|3998954|FG002|Deferred Treatment Substudy|Withdrew Consent|1
2301062|NCT02607800|3998964|FG000|Overall Study|Lost to Follow-up|7
2301063|NCT02607800|3998965|FG001|Overall Study|Lost to Follow-up|10
2301064|NCT02607800|3998964|FG000|Overall Study|Withdrew Consent|2
2301065|NCT02607800|3998965|FG001|Overall Study|Withdrew Consent|0
2301066|NCT02607800|3998964|FG000|Overall Study|Randomized/Enrolled but Not Treated|1
2301067|NCT02607800|3998965|FG001|Overall Study|Randomized/Enrolled but Not Treated|1
2301068|NCT02607865|3998976|FG000|Overall Study|Lost to Follow-up|9
2301069|NCT02607865|3998977|FG001|Overall Study|Lost to Follow-up|7
2301070|NCT02607865|3998978|FG002|Overall Study|Lost to Follow-up|7
2301071|NCT02607865|3998979|FG003|Overall Study|Lost to Follow-up|5
2301072|NCT02607865|3998976|FG000|Overall Study|Withdrawal by Subject|18
2301073|NCT02607865|3998977|FG001|Overall Study|Withdrawal by Subject|18
2301074|NCT02607865|3998978|FG002|Overall Study|Withdrawal by Subject|17
2301075|NCT02607865|3998979|FG003|Overall Study|Withdrawal by Subject|8
2301076|NCT02607865|3998976|FG000|Overall Study|Death|5
2301077|NCT02607865|3998977|FG001|Overall Study|Death|4
2301078|NCT02607865|3998978|FG002|Overall Study|Death|1
2301079|NCT02607865|3998979|FG003|Overall Study|Death|3
2301080|NCT02607865|3998976|FG000|Overall Study|Unclassified|1
2301081|NCT02607865|3998977|FG001|Overall Study|Unclassified|1
2301082|NCT02607865|3998978|FG002|Overall Study|Unclassified|2
2057446|NCT00538681|3631332|FG003|Overall Study|Adverse Event|0
2057447|NCT00538681|3631329|FG000|Overall Study|Death|0
2057448|NCT00538681|3631330|FG001|Overall Study|Death|0
2057449|NCT00538681|3631331|FG002|Overall Study|Death|1
2057450|NCT00538681|3631332|FG003|Overall Study|Death|1
2057451|NCT00538681|3631329|FG000|Overall Study|Investigator Decision|0
2057452|NCT00538681|3631330|FG001|Overall Study|Investigator Decision|0
2057453|NCT00538681|3631331|FG002|Overall Study|Investigator Decision|0
2057454|NCT00538681|3631332|FG003|Overall Study|Investigator Decision|1
2057455|NCT00538733|3631343|FG000|Overall Study|Adverse Event|8
2057456|NCT00538733|3631343|FG000|Overall Study|Death|1
2057457|NCT00538733|3631343|FG000|Overall Study|declined to participate|2
2057458|NCT00538733|3631343|FG000|Overall Study|still on therapy|1
2057459|NCT00538785|3631361|FG000|Overall Study|Death|9
2057460|NCT00538785|3631362|FG001|Overall Study|Death|10
2057461|NCT00538785|3631361|FG000|Overall Study|Withdrawal of consent|9
2057462|NCT00538785|3631362|FG001|Overall Study|Withdrawal of consent|7
2057463|NCT00538785|3631361|FG000|Overall Study|Lost to Follow-up|1
2301083|NCT02607865|3998979|FG003|Overall Study|Unclassified|0
2301084|NCT02607930|3998991|FG000|Double-Blinded Phase|Randomized and Never Treated|2
2301085|NCT02607930|3998992|FG001|Double-Blinded Phase|Randomized and Never Treated|0
2301086|NCT02607930|3998991|FG000|Double-Blinded Phase|Adverse Event|0
2057464|NCT00538785|3631362|FG001|Overall Study|Lost to Follow-up|0
2057465|NCT00538902|3631389|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
2301087|NCT02607930|3998992|FG001|Double-Blinded Phase|Adverse Event|4
2301088|NCT02607930|3998991|FG000|Double-Blinded Phase|Death|2
2301089|NCT02607930|3998992|FG001|Double-Blinded Phase|Death|1
2057466|NCT00538902|3631390|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
2057467|NCT00538902|3631391|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
2209774|NCT01646177|3849245|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4
2209775|NCT01646177|3849246|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8
2209776|NCT01646177|3849247|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
2057468|NCT00538902|3631389|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
2057469|NCT00538902|3631390|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
2057470|NCT00538902|3631391|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
2057471|NCT00538902|3631389|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
2057472|NCT00538902|3631390|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
2057473|NCT00538902|3631391|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
2057474|NCT00538902|3631389|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
2057475|NCT00538902|3631390|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
2057476|NCT00538902|3631391|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
2057477|NCT00538902|3631389|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
2057478|NCT00538902|3631390|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
2057479|NCT00538902|3631391|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
2057480|NCT00538902|3631389|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
2057481|NCT00538902|3631390|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
2057482|NCT00538902|3631391|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
2057483|NCT00538902|3631389|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
2057484|NCT00538902|3631390|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
2057485|NCT00538902|3631391|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
2057486|NCT00538902|3631389|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18
2057487|NCT00538902|3631390|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25
2057488|NCT00538902|3631391|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22
2057489|NCT00539006|3631409|FG000|Pre-treatment|Other|0
2057490|NCT00539006|3631410|FG001|Pre-treatment|Other|1
2057491|NCT00539006|3631411|FG002|Pre-treatment|Other|0
2057492|NCT00539006|3631412|FG003|Pre-treatment|Other|0
2057493|NCT00539006|3631409|FG000|Treatment Period 1|Lost to Follow-up|0
2057494|NCT00539006|3631410|FG001|Treatment Period 1|Lost to Follow-up|0
2057495|NCT00539006|3631411|FG002|Treatment Period 1|Lost to Follow-up|1
2057496|NCT00539006|3631412|FG003|Treatment Period 1|Lost to Follow-up|0
2057497|NCT00539006|3631409|FG000|Treatment Period 1|Protocol Violation|0
2057498|NCT00539006|3631410|FG001|Treatment Period 1|Protocol Violation|0
2057499|NCT00539006|3631411|FG002|Treatment Period 1|Protocol Violation|1
2057500|NCT00539006|3631412|FG003|Treatment Period 1|Protocol Violation|0
2057501|NCT00539006|3631409|FG000|Treatment Period 1|Lack of Efficacy|0
2057502|NCT00539006|3631410|FG001|Treatment Period 1|Lack of Efficacy|0
2057503|NCT00539006|3631411|FG002|Treatment Period 1|Lack of Efficacy|0
2057504|NCT00539006|3631412|FG003|Treatment Period 1|Lack of Efficacy|1
2057505|NCT00539006|3631409|FG000|Washout|Adverse Event|2
2057506|NCT00539006|3631410|FG001|Washout|Adverse Event|1
2057507|NCT00539006|3631411|FG002|Washout|Adverse Event|0
2057508|NCT00539006|3631412|FG003|Washout|Adverse Event|0
2209777|NCT01646177|3849248|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
2209778|NCT01646177|3849237|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
2209779|NCT01646177|3849238|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
2209780|NCT01646177|3849239|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
2209781|NCT01646177|3849240|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
2209782|NCT01646177|3849241|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
2209783|NCT01646177|3849242|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
2209784|NCT01646177|3849243|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
2057509|NCT00539006|3631409|FG000|Washout|Protocol Violation|1
2057510|NCT00539006|3631410|FG001|Washout|Protocol Violation|1
2057511|NCT00539006|3631411|FG002|Washout|Protocol Violation|0
2057512|NCT00539006|3631412|FG003|Washout|Protocol Violation|0
2057513|NCT00539006|3631409|FG000|Washout|Withdrawal by Subject|0
2057514|NCT00539006|3631410|FG001|Washout|Withdrawal by Subject|2
2057515|NCT00539006|3631411|FG002|Washout|Withdrawal by Subject|0
2057516|NCT00539006|3631412|FG003|Washout|Withdrawal by Subject|0
2057517|NCT00539006|3631409|FG000|Washout|Failed to meet continuation criteria|16
2057518|NCT00539006|3631410|FG001|Washout|Failed to meet continuation criteria|5
2057519|NCT00539006|3631411|FG002|Washout|Failed to meet continuation criteria|14
2057520|NCT00539006|3631412|FG003|Washout|Failed to meet continuation criteria|6
2057521|NCT00539006|3631409|FG000|Washout|Other|1
2057522|NCT00539006|3631410|FG001|Washout|Other|1
2057523|NCT00539006|3631411|FG002|Washout|Other|2
2057524|NCT00539006|3631412|FG003|Washout|Other|3
2057525|NCT00539006|3631409|FG000|Treatment Period 2|Protocol Violation|1
2057526|NCT00539006|3631410|FG001|Treatment Period 2|Protocol Violation|0
2057527|NCT00539006|3631411|FG002|Treatment Period 2|Protocol Violation|0
2057528|NCT00539006|3631412|FG003|Treatment Period 2|Protocol Violation|0
2057529|NCT00539006|3631409|FG000|Treatment Period 2|Other|0
2057530|NCT00539006|3631410|FG001|Treatment Period 2|Other|1
2057531|NCT00539006|3631411|FG002|Treatment Period 2|Other|0
2057532|NCT00539006|3631412|FG003|Treatment Period 2|Other|0
2057533|NCT00539032|3631430|FG000|Overall Study|Withdrawal by Subject|2
2057534|NCT00539032|3631431|FG001|Overall Study|Withdrawal by Subject|1
2057535|NCT00539188|3631448|FG000|Overall Study|Withdrawal by Subject|1
2057536|NCT00539188|3631449|FG001|Overall Study|Withdrawal by Subject|0
2057537|NCT00539188|3631448|FG000|Overall Study|Lost to Follow-up|2
2057538|NCT00539188|3631449|FG001|Overall Study|Lost to Follow-up|1
2057539|NCT00539240|3631458|FG000|Overall Study|Withdrawal by Subject|0
2057540|NCT00539240|3631459|FG001|Overall Study|Withdrawal by Subject|2
2057541|NCT00539240|3631460|FG002|Overall Study|Withdrawal by Subject|0
2057542|NCT00539240|3631458|FG000|Overall Study|Protocol Violation|1
2057543|NCT00539240|3631459|FG001|Overall Study|Protocol Violation|1
2057544|NCT00539240|3631460|FG002|Overall Study|Protocol Violation|4
2057545|NCT00539240|3631458|FG000|Overall Study|Lost to Follow-up|2
2057546|NCT00539240|3631459|FG001|Overall Study|Lost to Follow-up|3
2057547|NCT00539240|3631460|FG002|Overall Study|Lost to Follow-up|1
2057548|NCT00539240|3631458|FG000|Overall Study|Adverse Event|3
2209785|NCT01646177|3849244|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
2209786|NCT01646177|3849245|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4
2057549|NCT00539240|3631459|FG001|Overall Study|Adverse Event|1
2057550|NCT00539240|3631460|FG002|Overall Study|Adverse Event|10
2057551|NCT00539279|3631474|FG000|Treatment|Withdrawal by Subject|10
2057552|NCT00539279|3631475|FG001|Treatment|Withdrawal by Subject|8
2057553|NCT00539279|3631474|FG000|Treatment|Death|1
2057554|NCT00539279|3631475|FG001|Treatment|Death|0
2057555|NCT00539279|3631474|FG000|Post-Treatment Assessment|Lost to Follow-up|12
2057556|NCT00539279|3631475|FG001|Post-Treatment Assessment|Lost to Follow-up|9
2057557|NCT00539279|3631474|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1
2057558|NCT00539279|3631475|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7
2209787|NCT01646177|3849246|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
2209788|NCT01646177|3849247|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8
2209789|NCT01646177|3849248|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
2209790|NCT01646177|3849237|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
2209791|NCT01646177|3849238|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
2209792|NCT01646177|3849239|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
2209793|NCT01646177|3849240|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
2209794|NCT01646177|3849241|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
2057559|NCT00539305|3631483|FG000|Overall Study|Adverse Event|1
2057560|NCT00539305|3631484|FG001|Overall Study|Adverse Event|0
2057561|NCT00539305|3631483|FG000|Overall Study|Substance Use|0
2057562|NCT00539305|3631484|FG001|Overall Study|Substance Use|1
2057563|NCT00539305|3631483|FG000|Overall Study|Withdrawal by Subject|0
2057564|NCT00539305|3631484|FG001|Overall Study|Withdrawal by Subject|1
2057565|NCT00539500|3631490|FG000|Overall Study|Disease Progression|1
2057566|NCT00539500|3631490|FG000|Overall Study|Lost to Follow-up|2
2057567|NCT00539513|3631496|FG000|Overall Study|Withdrawal by Subject|2
2057568|NCT00539513|3631497|FG001|Overall Study|Withdrawal by Subject|1
2057569|NCT00539513|3631496|FG000|Overall Study|Lost to Follow-up|0
2057570|NCT00539513|3631497|FG001|Overall Study|Lost to Follow-up|1
2057571|NCT00539591|3631528|FG000|Overall Study|Toxicity|3
2057572|NCT00539591|3631529|FG001|Overall Study|Toxicity|0
2057573|NCT00539591|3631530|FG002|Overall Study|Toxicity|0
2057574|NCT00539591|3631528|FG000|Overall Study|Disease progression|2
2057575|NCT00539591|3631529|FG001|Overall Study|Disease progression|2
2057576|NCT00539591|3631530|FG002|Overall Study|Disease progression|3
2057577|NCT00539734|3631574|FG000|Overall Study|Protocol Violation|1
2057578|NCT00539864|3631580|FG000|Overall Study|Lost to Follow-up|0
2057579|NCT00539864|3631581|FG001|Overall Study|Lost to Follow-up|1
2057580|NCT00539864|3631580|FG000|Overall Study|Withdrawal by Subject|1
2057581|NCT00539864|3631581|FG001|Overall Study|Withdrawal by Subject|1
2057582|NCT00539981|3631598|FG000|Overall Study|Adverse events (AE)|3
2057583|NCT00539981|3631599|FG001|Overall Study|Adverse events (AE)|3
2057584|NCT00539981|3631598|FG000|Overall Study|Lost to Follow-up|260
2057585|NCT00539981|3631599|FG001|Overall Study|Lost to Follow-up|251
2057586|NCT00539981|3631598|FG000|Overall Study|Withdrew consent|22
2057587|NCT00539981|3631599|FG001|Overall Study|Withdrew consent|14
2057588|NCT00539981|3631598|FG000|Overall Study|Death|1
2057589|NCT00539981|3631599|FG001|Overall Study|Death|1
2057590|NCT00539981|3631598|FG000|Overall Study|Other reason-unspecified|9
2057591|NCT00539981|3631599|FG001|Overall Study|Other reason-unspecified|13
2057592|NCT00539994|3631611|FG000|Overall Study|Lost to Follow-up|2
2057593|NCT00539994|3631612|FG001|Overall Study|Lost to Follow-up|1
2057594|NCT00539994|3631613|FG002|Overall Study|Lost to Follow-up|0
2057595|NCT00539994|3631611|FG000|Overall Study|Withdrawal by Subject|1
2057596|NCT00539994|3631612|FG001|Overall Study|Withdrawal by Subject|0
2057597|NCT00539994|3631613|FG002|Overall Study|Withdrawal by Subject|1
2057598|NCT00539994|3631611|FG000|Overall Study|Physician Decision|0
2057599|NCT00539994|3631612|FG001|Overall Study|Physician Decision|0
2057600|NCT00539994|3631613|FG002|Overall Study|Physician Decision|1
2057601|NCT00540046|3631640|FG000|Overall Study|Lost to Follow-up|33
2057602|NCT00540046|3631641|FG001|Overall Study|Lost to Follow-up|23
2057603|NCT00540124|3631652|FG000|Overall Study|Adverse Event|0
2057604|NCT00540124|3631653|FG001|Overall Study|Adverse Event|2
2057605|NCT00540124|3631654|FG002|Overall Study|Adverse Event|1
2057606|NCT00540124|3631652|FG000|Overall Study|Entry Criteria Not Met|2
2057607|NCT00540124|3631653|FG001|Overall Study|Entry Criteria Not Met|0
2057608|NCT00540124|3631654|FG002|Overall Study|Entry Criteria Not Met|0
2057609|NCT00540124|3631652|FG000|Overall Study|Lack of Efficacy|1
2057610|NCT00540124|3631653|FG001|Overall Study|Lack of Efficacy|0
2057611|NCT00540124|3631654|FG002|Overall Study|Lack of Efficacy|0
2057612|NCT00540124|3631652|FG000|Overall Study|Withdrawal by Subject|1
2057613|NCT00540124|3631653|FG001|Overall Study|Withdrawal by Subject|1
2057614|NCT00540124|3631654|FG002|Overall Study|Withdrawal by Subject|0
2057615|NCT00540228|3631667|FG000|Overall Study|Adverse Event|2
2057616|NCT00540228|3631668|FG001|Overall Study|Adverse Event|0
2057617|NCT00540228|3631669|FG002|Overall Study|Adverse Event|0
2057618|NCT00540228|3631670|FG003|Overall Study|Adverse Event|0
2057619|NCT00540228|3631671|FG004|Overall Study|Adverse Event|0
2057620|NCT00540228|3631667|FG000|Overall Study|Lost to Follow-up|1
2057621|NCT00540228|3631668|FG001|Overall Study|Lost to Follow-up|1
2057622|NCT00540228|3631669|FG002|Overall Study|Lost to Follow-up|0
2057623|NCT00540228|3631670|FG003|Overall Study|Lost to Follow-up|0
2057624|NCT00540228|3631671|FG004|Overall Study|Lost to Follow-up|0
2057625|NCT00540293|3631683|FG000|Overall Study|Adverse event related to study drug|10
2057626|NCT00540293|3631683|FG000|Overall Study|Adverse event not related to study drug|7
2057627|NCT00540293|3631683|FG000|Overall Study|Withdrawal by Subject|6
2057628|NCT00540293|3631683|FG000|Overall Study|Protocol violation, & subject schedule|12
2057629|NCT00540423|3631695|FG000|Double-Blind Treatment Period|Adverse Event|0
2057630|NCT00540423|3631696|FG001|Double-Blind Treatment Period|Adverse Event|1
2057631|NCT00540423|3631697|FG002|Double-Blind Treatment Period|Adverse Event|0
2057632|NCT00540423|3631695|FG000|Open-Label Treatment Period|Lack of Efficacy|0
2057633|NCT00540423|3631696|FG001|Open-Label Treatment Period|Lack of Efficacy|0
2057634|NCT00540423|3631697|FG002|Open-Label Treatment Period|Lack of Efficacy|2
2057635|NCT00540436|3631715|FG000|First 12-Week Treatment Period|Adverse Event|1
2057636|NCT00540436|3631715|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1
2057637|NCT00540436|3631715|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1
2057638|NCT00540436|3631715|FG000|Second 12-Week Treatment Period|Adverse Event|1
2057639|NCT00540449|3631721|FG000|Overall Study|Adverse Event|12
2057640|NCT00540449|3631722|FG001|Overall Study|Adverse Event|32
2057641|NCT00540449|3631721|FG000|Overall Study|Sponsor's Decision|1
2057642|NCT00540449|3631722|FG001|Overall Study|Sponsor's Decision|1
2057643|NCT00540449|3631721|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
2057644|NCT00540449|3631722|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
2057645|NCT00540449|3631721|FG000|Overall Study|Lost to Follow-up|19
2057646|NCT00540449|3631722|FG001|Overall Study|Lost to Follow-up|17
2057647|NCT00540449|3631721|FG000|Overall Study|Subject Non-Compliant|7
2057648|NCT00540449|3631722|FG001|Overall Study|Subject Non-Compliant|5
2057649|NCT00540449|3631721|FG000|Overall Study|Subject Reached A Virologic Endpoint|32
2057650|NCT00540449|3631722|FG001|Overall Study|Subject Reached A Virologic Endpoint|8
2057651|NCT00540449|3631721|FG000|Overall Study|Withdrawal by Subject|10
2057652|NCT00540449|3631722|FG001|Overall Study|Withdrawal by Subject|10
2057653|NCT00540449|3631721|FG000|Overall Study|Other|1
2057654|NCT00540449|3631722|FG001|Overall Study|Other|4
2057655|NCT00540514|3631730|FG000|Overall Study|Still on treatment|3
2057656|NCT00540514|3631731|FG001|Overall Study|Still on treatment|0
2057657|NCT00540514|3631730|FG000|Overall Study|Unacceptable Toxicity|61
2057658|NCT00540514|3631731|FG001|Overall Study|Unacceptable Toxicity|62
2057659|NCT00540514|3631730|FG000|Overall Study|Adverse Event|20
2057660|NCT00540514|3631731|FG001|Overall Study|Adverse Event|24
2057661|NCT00540514|3631730|FG000|Overall Study|Physician Decision|86
2057662|NCT00540514|3631731|FG001|Overall Study|Physician Decision|99
2057663|NCT00540514|3631730|FG000|Overall Study|Protocol Deviation|3
2057664|NCT00540514|3631731|FG001|Overall Study|Protocol Deviation|4
2057665|NCT00540514|3631730|FG000|Overall Study|Lost to Follow-up|1
2057666|NCT00540514|3631731|FG001|Overall Study|Lost to Follow-up|1
2057667|NCT00540514|3631730|FG000|Overall Study|Withdrawal by Subject|65
2057668|NCT00540514|3631731|FG001|Overall Study|Withdrawal by Subject|67
2057669|NCT00540514|3631730|FG000|Overall Study|Excluded prior to treatment|7
2057670|NCT00540514|3631731|FG001|Overall Study|Excluded prior to treatment|7
2057671|NCT00540514|3631730|FG000|Overall Study|Paclitaxel not available|0
2057672|NCT00540514|3631731|FG001|Overall Study|Paclitaxel not available|2
2057673|NCT00540592|3631752|FG000|Overall Study|Adverse Event|0
2057674|NCT00540592|3631753|FG001|Overall Study|Adverse Event|1
2057675|NCT00540592|3631754|FG002|Overall Study|Adverse Event|0
2057676|NCT00540592|3631755|FG003|Overall Study|Adverse Event|0
2057677|NCT00540592|3631756|FG004|Overall Study|Adverse Event|1
2057678|NCT00540592|3631757|FG005|Overall Study|Adverse Event|0
2057679|NCT00540592|3631758|FG006|Overall Study|Adverse Event|0
2177088|NCT01371708|3801172|FG002|Overall Study|Lost to Follow-up|7
2057680|NCT00540592|3631759|FG007|Overall Study|Adverse Event|1
2057681|NCT00540592|3631760|FG008|Overall Study|Adverse Event|1
2057682|NCT00540592|3631761|FG009|Overall Study|Adverse Event|2
2057683|NCT00540592|3631752|FG000|Overall Study|Lost to Follow-up|2
2057684|NCT00540592|3631753|FG001|Overall Study|Lost to Follow-up|0
2057685|NCT00540592|3631754|FG002|Overall Study|Lost to Follow-up|0
2057686|NCT00540592|3631755|FG003|Overall Study|Lost to Follow-up|0
2057687|NCT00540592|3631756|FG004|Overall Study|Lost to Follow-up|0
2057688|NCT00540592|3631757|FG005|Overall Study|Lost to Follow-up|0
2057689|NCT00540592|3631758|FG006|Overall Study|Lost to Follow-up|0
2057690|NCT00540592|3631759|FG007|Overall Study|Lost to Follow-up|0
2057691|NCT00540592|3631760|FG008|Overall Study|Lost to Follow-up|0
2057692|NCT00540592|3631761|FG009|Overall Study|Lost to Follow-up|0
2057693|NCT00540592|3631752|FG000|Overall Study|Withdrawal by Subject|0
2057694|NCT00540592|3631753|FG001|Overall Study|Withdrawal by Subject|0
2057695|NCT00540592|3631754|FG002|Overall Study|Withdrawal by Subject|1
2057696|NCT00540592|3631755|FG003|Overall Study|Withdrawal by Subject|1
2057697|NCT00540592|3631756|FG004|Overall Study|Withdrawal by Subject|0
2057698|NCT00540592|3631757|FG005|Overall Study|Withdrawal by Subject|0
2057699|NCT00540592|3631758|FG006|Overall Study|Withdrawal by Subject|0
2057700|NCT00540592|3631759|FG007|Overall Study|Withdrawal by Subject|0
2057701|NCT00540592|3631760|FG008|Overall Study|Withdrawal by Subject|0
2057702|NCT00540592|3631761|FG009|Overall Study|Withdrawal by Subject|0
2057703|NCT00540644|3631785|FG000|Overall Study|Adverse Event|3
2057704|NCT00540644|3631786|FG001|Overall Study|Adverse Event|1
2057705|NCT00540644|3631785|FG000|Overall Study|Disease Progression|3
2057706|NCT00540644|3631786|FG001|Overall Study|Disease Progression|1
2057707|NCT00540644|3631785|FG000|Overall Study|Physician Decision|0
2057708|NCT00540644|3631786|FG001|Overall Study|Physician Decision|5
2057709|NCT00540644|3631785|FG000|Overall Study|Withdrawal by Subject|2
2057710|NCT00540644|3631786|FG001|Overall Study|Withdrawal by Subject|2
2057711|NCT00540644|3631785|FG000|Overall Study|Noncomplilance|1
2057712|NCT00540644|3631786|FG001|Overall Study|Noncomplilance|0
2057713|NCT00541034|3631827|FG000|Overall Study|Non-Compliance|3
2057714|NCT00541099|3631831|FG000|Overall Study|Ineligible|3
2057715|NCT00541229|3631852|FG000|Treatment Period I (Week 1)|Physician Decision|0
2057716|NCT00541229|3631853|FG001|Treatment Period I (Week 1)|Physician Decision|0
2057717|NCT00541229|3631854|FG002|Treatment Period I (Week 1)|Physician Decision|1
2057718|NCT00541229|3631855|FG003|Treatment Period I (Week 1)|Physician Decision|0
2057719|NCT00541229|3631856|FG004|Treatment Period I (Week 1)|Physician Decision|0
2057720|NCT00541229|3631857|FG005|Treatment Period I (Week 1)|Physician Decision|0
2057721|NCT00541229|3631852|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0
2057722|NCT00541229|3631853|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0
2057723|NCT00541229|3631854|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0
2057724|NCT00541229|3631855|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0
2057725|NCT00541229|3631856|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0
2057726|NCT00541229|3631857|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1
2057727|NCT00541229|3631852|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0
2057728|NCT00541229|3631853|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0
2057729|NCT00541229|3631854|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0
2057730|NCT00541229|3631855|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0
2057731|NCT00541229|3631856|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0
2057732|NCT00541229|3631857|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1
2057733|NCT00541229|3631852|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
2057734|NCT00541229|3631853|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
2057735|NCT00541229|3631854|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
2057736|NCT00541229|3631855|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
2057737|NCT00541229|3631856|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
2057738|NCT00541229|3631857|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
2057739|NCT00541229|3631852|FG000|Washout Period I (Week 2-5)|Adverse Event|1
2057740|NCT00541229|3631853|FG001|Washout Period I (Week 2-5)|Adverse Event|0
2057741|NCT00541229|3631854|FG002|Washout Period I (Week 2-5)|Adverse Event|1
2057742|NCT00541229|3631855|FG003|Washout Period I (Week 2-5)|Adverse Event|0
2057743|NCT00541229|3631856|FG004|Washout Period I (Week 2-5)|Adverse Event|0
2057744|NCT00541229|3631857|FG005|Washout Period I (Week 2-5)|Adverse Event|0
2057745|NCT00541229|3631852|FG000|Washout Period I (Week 2-5)|Physician Decision|0
2057746|NCT00541229|3631853|FG001|Washout Period I (Week 2-5)|Physician Decision|0
2057747|NCT00541229|3631854|FG002|Washout Period I (Week 2-5)|Physician Decision|0
2057748|NCT00541229|3631855|FG003|Washout Period I (Week 2-5)|Physician Decision|1
2057749|NCT00541229|3631856|FG004|Washout Period I (Week 2-5)|Physician Decision|0
2057750|NCT00541229|3631857|FG005|Washout Period I (Week 2-5)|Physician Decision|0
2057751|NCT00541229|3631852|FG000|Washout Period I (Week 2-5)|Protocol Violation|0
2057752|NCT00541229|3631853|FG001|Washout Period I (Week 2-5)|Protocol Violation|0
2057753|NCT00541229|3631854|FG002|Washout Period I (Week 2-5)|Protocol Violation|0
2057754|NCT00541229|3631855|FG003|Washout Period I (Week 2-5)|Protocol Violation|0
2057755|NCT00541229|3631856|FG004|Washout Period I (Week 2-5)|Protocol Violation|0
2057756|NCT00541229|3631857|FG005|Washout Period I (Week 2-5)|Protocol Violation|1
2057757|NCT00541229|3631852|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
2057758|NCT00541229|3631853|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
2057759|NCT00541229|3631854|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
2057760|NCT00541229|3631855|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
2057761|NCT00541229|3631856|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
2057762|NCT00541229|3631857|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
2057763|NCT00541229|3631852|FG000|Treatment Period II (Week 6)|Protocol Violation|0
2057764|NCT00541229|3631853|FG001|Treatment Period II (Week 6)|Protocol Violation|0
2057765|NCT00541229|3631854|FG002|Treatment Period II (Week 6)|Protocol Violation|0
2057766|NCT00541229|3631855|FG003|Treatment Period II (Week 6)|Protocol Violation|0
2057767|NCT00541229|3631856|FG004|Treatment Period II (Week 6)|Protocol Violation|1
2057768|NCT00541229|3631857|FG005|Treatment Period II (Week 6)|Protocol Violation|1
2057769|NCT00541229|3631852|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
2057770|NCT00541229|3631853|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
2057771|NCT00541229|3631854|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
2057772|NCT00541229|3631855|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
2057773|NCT00541229|3631856|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
2057774|NCT00541229|3631857|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
2057775|NCT00541229|3631852|FG000|Washout Period II (Week 7-10)|Protocol Violation|1
2057776|NCT00541229|3631853|FG001|Washout Period II (Week 7-10)|Protocol Violation|0
2057777|NCT00541229|3631854|FG002|Washout Period II (Week 7-10)|Protocol Violation|0
2057778|NCT00541229|3631855|FG003|Washout Period II (Week 7-10)|Protocol Violation|0
2057779|NCT00541229|3631856|FG004|Washout Period II (Week 7-10)|Protocol Violation|0
2057780|NCT00541229|3631857|FG005|Washout Period II (Week 7-10)|Protocol Violation|0
2057781|NCT00541229|3631852|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0
2057782|NCT00541229|3631853|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0
2057783|NCT00541229|3631854|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0
2057784|NCT00541229|3631855|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0
2057785|NCT00541229|3631856|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1
2057786|NCT00541229|3631857|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0
2057787|NCT00541229|3631852|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
2057788|NCT00541229|3631853|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
2057789|NCT00541229|3631854|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
2057790|NCT00541229|3631855|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
2057791|NCT00541229|3631856|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
2057792|NCT00541229|3631857|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
2057793|NCT00541229|3631852|FG000|Treatment Period III (Week 11)|Adverse Event|0
2057794|NCT00541229|3631853|FG001|Treatment Period III (Week 11)|Adverse Event|0
2057795|NCT00541229|3631854|FG002|Treatment Period III (Week 11)|Adverse Event|0
2057796|NCT00541229|3631855|FG003|Treatment Period III (Week 11)|Adverse Event|0
2057797|NCT00541229|3631856|FG004|Treatment Period III (Week 11)|Adverse Event|1
2057798|NCT00541229|3631857|FG005|Treatment Period III (Week 11)|Adverse Event|0
2057799|NCT00541229|3631852|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0
2057800|NCT00541229|3631853|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0
2057801|NCT00541229|3631854|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0
2057802|NCT00541229|3631855|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0
2057803|NCT00541229|3631856|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0
2217686|NCT01709305|3860931|FG003|Phase 2|Death|0
2057804|NCT00541229|3631857|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1
2057805|NCT00541229|3631852|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
2057806|NCT00541229|3631853|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
2057807|NCT00541229|3631854|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
2057808|NCT00541229|3631855|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
2057809|NCT00541229|3631856|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
2057810|NCT00541229|3631857|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
2057811|NCT00541307|3631874|FG000|Overall Study|Death|5
2057812|NCT00541307|3631874|FG000|Overall Study|Physician Decision|3
2057813|NCT00541307|3631874|FG000|Overall Study|Withdrawal by Subject|6
2057814|NCT00541307|3631874|FG000|Overall Study|Lost to Follow-up|4
2057815|NCT00541307|3631874|FG000|Overall Study|Subject returned early (outside window)|1
2057816|NCT00541307|3631874|FG000|Overall Study|Surgical Bypass|5
2057817|NCT00541346|3631878|FG000|Follow-up|Adverse Event|1
2057818|NCT00541385|3631884|FG000|Overall Study|Adverse Event|6
2057819|NCT00541385|3631885|FG001|Overall Study|Adverse Event|3
2057820|NCT00541385|3631884|FG000|Overall Study|Withdrawal by Subject|2
2057821|NCT00541385|3631885|FG001|Overall Study|Withdrawal by Subject|2
2057822|NCT00541385|3631884|FG000|Overall Study|Lost to Follow-up|6
2057823|NCT00541385|3631885|FG001|Overall Study|Lost to Follow-up|1
2057824|NCT00541385|3631884|FG000|Overall Study|Parasite reappearance/malaria|67
2057825|NCT00541385|3631885|FG001|Overall Study|Parasite reappearance/malaria|32
2057826|NCT00541450|3631893|FG000|Phase A|Adverse Event|3
2057827|NCT00541450|3631894|FG001|Phase A|Adverse Event|0
2057828|NCT00541450|3631893|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0
2057829|NCT00541450|3631894|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2
2057830|NCT00541450|3631893|FG000|Phase A|Hyperglycemia|0
2057831|NCT00541450|3631894|FG001|Phase A|Hyperglycemia|1
2057832|NCT00541450|3631893|FG000|Phase A|Lost to Follow-up|6
2301090|NCT02607930|3998991|FG000|Double-Blinded Phase|Investigator's Discretion|6
2301091|NCT02607930|3998992|FG001|Double-Blinded Phase|Investigator's Discretion|3
2301092|NCT02607930|3998991|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|3
2301093|NCT02607930|3998992|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|5
2301094|NCT02607930|3998991|FG000|Double-Blinded Phase|Protocol Violation|2
2301095|NCT02607930|3998992|FG001|Double-Blinded Phase|Protocol Violation|3
2301096|NCT02607930|3998991|FG000|Double-Blinded Phase|Withdrew Consent|14
2057833|NCT00541450|3631894|FG001|Phase A|Lost to Follow-up|4
2057834|NCT00541450|3631893|FG000|Phase A|Physician Decision|2
2057835|NCT00541450|3631894|FG001|Phase A|Physician Decision|0
2057836|NCT00541450|3631893|FG000|Phase A|Protocol Violation|2
2057837|NCT00541450|3631894|FG001|Phase A|Protocol Violation|3
2057838|NCT00541450|3631893|FG000|Phase A|Withdrawal by Subject|7
2057839|NCT00541450|3631894|FG001|Phase A|Withdrawal by Subject|7
2057840|NCT00541450|3631893|FG000|Phase B|Adverse Event|6
2057841|NCT00541450|3631894|FG001|Phase B|Adverse Event|6
2057842|NCT00541450|3631893|FG000|Phase B|Hyperglycemia|10
2057843|NCT00541450|3631894|FG001|Phase B|Hyperglycemia|9
2057844|NCT00541450|3631893|FG000|Phase B|Lost to Follow-up|6
2057845|NCT00541450|3631894|FG001|Phase B|Lost to Follow-up|4
2057846|NCT00541450|3631893|FG000|Phase B|Physician Decision|4
2057847|NCT00541450|3631894|FG001|Phase B|Physician Decision|2
2057848|NCT00541450|3631893|FG000|Phase B|Pregnancy|0
2057849|NCT00541450|3631894|FG001|Phase B|Pregnancy|1
2057850|NCT00541450|3631893|FG000|Phase B|Protocol Violation|3
2057851|NCT00541450|3631894|FG001|Phase B|Protocol Violation|3
2057852|NCT00541450|3631893|FG000|Phase B|Withdrawal by Subject|8
2057853|NCT00541450|3631894|FG001|Phase B|Withdrawal by Subject|6
2057854|NCT00541658|3631911|FG000|Overall Study|Adverse Event|28
2057855|NCT00541658|3631912|FG001|Overall Study|Adverse Event|37
2057856|NCT00541658|3631913|FG002|Overall Study|Adverse Event|25
2057857|NCT00541658|3631911|FG000|Overall Study|Physician Decision|0
2057858|NCT00541658|3631912|FG001|Overall Study|Physician Decision|0
2057859|NCT00541658|3631913|FG002|Overall Study|Physician Decision|4
2057860|NCT00541658|3631911|FG000|Overall Study|Lost to Follow-up|3
2057861|NCT00541658|3631912|FG001|Overall Study|Lost to Follow-up|3
2057862|NCT00541658|3631913|FG002|Overall Study|Lost to Follow-up|6
2057863|NCT00541658|3631911|FG000|Overall Study|Protocol Violation|0
2057864|NCT00541658|3631912|FG001|Overall Study|Protocol Violation|1
2057865|NCT00541658|3631913|FG002|Overall Study|Protocol Violation|1
2057866|NCT00541658|3631911|FG000|Overall Study|Withdrawal by Subject|28
2057867|NCT00541658|3631912|FG001|Overall Study|Withdrawal by Subject|32
2057868|NCT00541658|3631913|FG002|Overall Study|Withdrawal by Subject|32
2057869|NCT00541658|3631911|FG000|Overall Study|Took No Study Drug|1
2057870|NCT00541658|3631912|FG001|Overall Study|Took No Study Drug|0
2057871|NCT00541658|3631913|FG002|Overall Study|Took No Study Drug|0
2057872|NCT00541775|3631935|FG000|Overall Study|Adverse Event|3
2057873|NCT00541775|3631936|FG001|Overall Study|Adverse Event|2
2057874|NCT00541775|3631937|FG002|Overall Study|Adverse Event|1
2057875|NCT00541775|3631935|FG000|Overall Study|Lack of Efficacy|0
2057876|NCT00541775|3631936|FG001|Overall Study|Lack of Efficacy|0
2057877|NCT00541775|3631937|FG002|Overall Study|Lack of Efficacy|3
2057878|NCT00541775|3631935|FG000|Overall Study|Lost to Follow-up|0
2057879|NCT00541775|3631936|FG001|Overall Study|Lost to Follow-up|0
2057880|NCT00541775|3631937|FG002|Overall Study|Lost to Follow-up|2
2057881|NCT00541775|3631935|FG000|Overall Study|Protocol Violation|1
2057882|NCT00541775|3631936|FG001|Overall Study|Protocol Violation|0
2057883|NCT00541775|3631937|FG002|Overall Study|Protocol Violation|0
2057884|NCT00541775|3631935|FG000|Overall Study|Withdrawal by Subject and Other|5
2057885|NCT00541775|3631936|FG001|Overall Study|Withdrawal by Subject and Other|0
2057886|NCT00541775|3631937|FG002|Overall Study|Withdrawal by Subject and Other|2
2057887|NCT00541866|3631950|FG000|Overall Study|Adverse Event|3
2057888|NCT00541866|3631951|FG001|Overall Study|Adverse Event|0
2057889|NCT00541866|3631952|FG002|Overall Study|Adverse Event|0
2057890|NCT00541866|3631953|FG003|Overall Study|Adverse Event|0
2057891|NCT00541866|3631954|FG004|Overall Study|Adverse Event|0
2057892|NCT00541866|3631950|FG000|Overall Study|Death|1
2057893|NCT00541866|3631951|FG001|Overall Study|Death|0
2057894|NCT00541866|3631952|FG002|Overall Study|Death|0
2057895|NCT00541866|3631953|FG003|Overall Study|Death|0
2057896|NCT00541866|3631954|FG004|Overall Study|Death|0
2057897|NCT00541866|3631950|FG000|Overall Study|Lack of Efficacy|19
2057898|NCT00541866|3631951|FG001|Overall Study|Lack of Efficacy|15
2057899|NCT00541866|3631952|FG002|Overall Study|Lack of Efficacy|10
2057900|NCT00541866|3631953|FG003|Overall Study|Lack of Efficacy|12
2057901|NCT00541866|3631954|FG004|Overall Study|Lack of Efficacy|14
2057902|NCT00541866|3631950|FG000|Overall Study|Not Reported or Other|11
2057903|NCT00541866|3631951|FG001|Overall Study|Not Reported or Other|3
2057904|NCT00541866|3631952|FG002|Overall Study|Not Reported or Other|3
2057905|NCT00541866|3631953|FG003|Overall Study|Not Reported or Other|3
2057906|NCT00541866|3631954|FG004|Overall Study|Not Reported or Other|1
2057907|NCT00541866|3631950|FG000|Overall Study|Physician Decision|0
2057908|NCT00541866|3631951|FG001|Overall Study|Physician Decision|0
2057909|NCT00541866|3631952|FG002|Overall Study|Physician Decision|2
2057910|NCT00541866|3631953|FG003|Overall Study|Physician Decision|1
2057911|NCT00541866|3631954|FG004|Overall Study|Physician Decision|0
2057912|NCT00541931|3631984|FG000|Overall Study|Adverse Event|1
2057913|NCT00541931|3631985|FG001|Overall Study|Adverse Event|0
2057914|NCT00541931|3631984|FG000|Overall Study|Lost to Follow-up|3
2057915|NCT00541931|3631985|FG001|Overall Study|Lost to Follow-up|3
2057916|NCT00541931|3631984|FG000|Overall Study|Withdrawal by Subject|1
2057917|NCT00541931|3631985|FG001|Overall Study|Withdrawal by Subject|0
2057918|NCT00541931|3631984|FG000|Overall Study|Transportation Issue|0
2057919|NCT00541931|3631985|FG001|Overall Study|Transportation Issue|1
2057920|NCT00541970|3631997|FG000|Month 7|Protocol Violation|9
2057921|NCT00541970|3631998|FG001|Month 7|Protocol Violation|13
2057922|NCT00541970|3631999|FG002|Month 7|Protocol Violation|11
2057923|NCT00541970|3632000|FG003|Month 7|Protocol Violation|5
2057924|NCT00541970|3631997|FG000|Month 12|Adverse Event|0
2057925|NCT00541970|3631998|FG001|Month 12|Adverse Event|1
2057926|NCT00541970|3631999|FG002|Month 12|Adverse Event|1
2057927|NCT00541970|3632000|FG003|Month 12|Adverse Event|1
2057928|NCT00541970|3631997|FG000|Month 12|Protocol Violation|12
2057929|NCT00541970|3631998|FG001|Month 12|Protocol Violation|21
2057930|NCT00541970|3631999|FG002|Month 12|Protocol Violation|20
2057931|NCT00541970|3632000|FG003|Month 12|Protocol Violation|15
2057932|NCT00541970|3631997|FG000|Month 18|Adverse Event|0
2057933|NCT00541970|3631998|FG001|Month 18|Adverse Event|1
2057934|NCT00541970|3631999|FG002|Month 18|Adverse Event|1
2057935|NCT00541970|3632000|FG003|Month 18|Adverse Event|1
2057936|NCT00541970|3631997|FG000|Month 18|Protocol Violation|14
2057937|NCT00541970|3631998|FG001|Month 18|Protocol Violation|23
2057938|NCT00541970|3631999|FG002|Month 18|Protocol Violation|24
2057939|NCT00541970|3632000|FG003|Month 18|Protocol Violation|16
2057940|NCT00541970|3631997|FG000|Month 24|Adverse Event|0
2057941|NCT00541970|3631998|FG001|Month 24|Adverse Event|1
2057942|NCT00541970|3631999|FG002|Month 24|Adverse Event|1
2057943|NCT00541970|3632000|FG003|Month 24|Adverse Event|1
2057944|NCT00541970|3631997|FG000|Month 24|Protocol Violation|29
2057945|NCT00541970|3631998|FG001|Month 24|Protocol Violation|31
2057946|NCT00541970|3631999|FG002|Month 24|Protocol Violation|31
2057947|NCT00541970|3632000|FG003|Month 24|Protocol Violation|21
2057948|NCT00541970|3631997|FG000|Month 36|Protocol Violation|61
2057949|NCT00541970|3631998|FG001|Month 36|Protocol Violation|66
2057950|NCT00541970|3631999|FG002|Month 36|Protocol Violation|66
2057951|NCT00541970|3632000|FG003|Month 36|Protocol Violation|60
2057952|NCT00541970|3631997|FG000|Month 48|Withdrawal by Subject|2
2057953|NCT00541970|3631998|FG001|Month 48|Withdrawal by Subject|4
2057954|NCT00541970|3631999|FG002|Month 48|Withdrawal by Subject|4
2057955|NCT00541970|3632000|FG003|Month 48|Withdrawal by Subject|2
2057956|NCT00541970|3631997|FG000|Month 48|Other|3
2057957|NCT00541970|3631998|FG001|Month 48|Other|1
2057958|NCT00541970|3631999|FG002|Month 48|Other|1
2057959|NCT00541970|3632000|FG003|Month 48|Other|0
2057960|NCT00541970|3631997|FG000|Month 48|Lost to Follow-up|66
2057961|NCT00541970|3631998|FG001|Month 48|Lost to Follow-up|68
2057962|NCT00541970|3631999|FG002|Month 48|Lost to Follow-up|68
2057963|NCT00541970|3632000|FG003|Month 48|Lost to Follow-up|73
2057964|NCT00541970|3631997|FG000|Month 60|Protocol Violation|78
2057965|NCT00541970|3631998|FG001|Month 60|Protocol Violation|77
2057966|NCT00541970|3631999|FG002|Month 60|Protocol Violation|82
2057967|NCT00541970|3632000|FG003|Month 60|Protocol Violation|72
2057968|NCT00542178|3632016|FG000|Overall Study|did not complete year 4 follow-up|75
2057969|NCT00542178|3632017|FG001|Overall Study|did not complete year 4 follow-up|80
2057970|NCT00542178|3632018|FG002|Overall Study|did not complete year 4 follow-up|74
2057971|NCT00542178|3632019|FG003|Overall Study|did not complete year 4 follow-up|62
2057972|NCT00542178|3632020|FG004|Overall Study|did not complete year 4 follow-up|64
2057973|NCT00542178|3632021|FG005|Overall Study|did not complete year 4 follow-up|89
2057974|NCT00542178|3632022|FG006|Overall Study|did not complete year 4 follow-up|87
2057975|NCT00542178|3632023|FG007|Overall Study|did not complete year 4 follow-up|85
2057976|NCT00542191|3632037|FG000|Overall Study|Death|3
2057977|NCT00542269|3632044|FG000|Overall Study|Adverse Event|10
2057978|NCT00542269|3632045|FG001|Overall Study|Adverse Event|4
2057979|NCT00542269|3632046|FG002|Overall Study|Adverse Event|5
2057980|NCT00542269|3632044|FG000|Overall Study|Protocol Violation|1
2057981|NCT00542269|3632045|FG001|Overall Study|Protocol Violation|1
2057982|NCT00542269|3632046|FG002|Overall Study|Protocol Violation|0
2057983|NCT00542269|3632044|FG000|Overall Study|Withdrawal by Subject|1
2057984|NCT00542269|3632045|FG001|Overall Study|Withdrawal by Subject|0
2057985|NCT00542269|3632046|FG002|Overall Study|Withdrawal by Subject|0
2057986|NCT00542269|3632044|FG000|Overall Study|Administrative problems|1
2057987|NCT00542269|3632045|FG001|Overall Study|Administrative problems|1
2057988|NCT00542269|3632046|FG002|Overall Study|Administrative problems|1
2057989|NCT00542321|3632062|FG000|Overall Study|Death|0
2057990|NCT00542321|3632063|FG001|Overall Study|Death|1
2057991|NCT00542386|3632075|FG000|Overall Study|Adverse Event|1
2057992|NCT00542386|3632076|FG001|Overall Study|Adverse Event|7
2209795|NCT01646177|3849242|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
2209796|NCT01646177|3849243|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
2057993|NCT00542386|3632077|FG002|Overall Study|Adverse Event|7
2057994|NCT00542386|3632078|FG003|Overall Study|Adverse Event|8
2057995|NCT00542386|3632079|FG004|Overall Study|Adverse Event|13
2057996|NCT00542386|3632080|FG005|Overall Study|Adverse Event|4
2057997|NCT00542386|3632075|FG000|Overall Study|Death|0
2057998|NCT00542386|3632076|FG001|Overall Study|Death|0
2057999|NCT00542386|3632077|FG002|Overall Study|Death|1
2058000|NCT00542386|3632078|FG003|Overall Study|Death|2
2058001|NCT00542386|3632079|FG004|Overall Study|Death|1
2058002|NCT00542386|3632080|FG005|Overall Study|Death|2
2058003|NCT00542386|3632075|FG000|Overall Study|Lack of Efficacy|32
2058004|NCT00542386|3632076|FG001|Overall Study|Lack of Efficacy|12
2058005|NCT00542386|3632077|FG002|Overall Study|Lack of Efficacy|10
2058006|NCT00542386|3632078|FG003|Overall Study|Lack of Efficacy|13
2209797|NCT01646177|3849244|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
2209798|NCT01646177|3849245|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1
2209799|NCT01646177|3849246|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6
2209800|NCT01646177|3849247|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4
2209801|NCT01646177|3849248|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7
2209802|NCT01646177|3849237|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
2209803|NCT01646177|3849238|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
2209804|NCT01646177|3849239|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
2209805|NCT01646177|3849240|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
2301097|NCT02607930|3998992|FG001|Double-Blinded Phase|Withdrew Consent|18
2058007|NCT00542386|3632079|FG004|Overall Study|Lack of Efficacy|7
2058008|NCT00542386|3632080|FG005|Overall Study|Lack of Efficacy|31
2058009|NCT00542386|3632075|FG000|Overall Study|Physician Decision|1
2058010|NCT00542386|3632076|FG001|Overall Study|Physician Decision|0
2058011|NCT00542386|3632077|FG002|Overall Study|Physician Decision|0
2058012|NCT00542386|3632078|FG003|Overall Study|Physician Decision|1
2058013|NCT00542386|3632079|FG004|Overall Study|Physician Decision|0
2058014|NCT00542386|3632080|FG005|Overall Study|Physician Decision|0
2058015|NCT00542386|3632075|FG000|Overall Study|Protocol Violation|0
2058016|NCT00542386|3632076|FG001|Overall Study|Protocol Violation|0
2058017|NCT00542386|3632077|FG002|Overall Study|Protocol Violation|1
2058018|NCT00542386|3632078|FG003|Overall Study|Protocol Violation|0
2058019|NCT00542386|3632079|FG004|Overall Study|Protocol Violation|0
2058020|NCT00542386|3632080|FG005|Overall Study|Protocol Violation|4
2058021|NCT00542386|3632075|FG000|Overall Study|Withdrawal by Subject|5
2058022|NCT00542386|3632076|FG001|Overall Study|Withdrawal by Subject|8
2058023|NCT00542386|3632077|FG002|Overall Study|Withdrawal by Subject|10
2058024|NCT00542386|3632078|FG003|Overall Study|Withdrawal by Subject|11
2058025|NCT00542386|3632079|FG004|Overall Study|Withdrawal by Subject|15
2058026|NCT00542386|3632080|FG005|Overall Study|Withdrawal by Subject|7
2058027|NCT00542386|3632075|FG000|Overall Study|Other Reasons|4
2058028|NCT00542386|3632076|FG001|Overall Study|Other Reasons|1
2058029|NCT00542386|3632077|FG002|Overall Study|Other Reasons|4
2058030|NCT00542386|3632078|FG003|Overall Study|Other Reasons|3
2058031|NCT00542386|3632079|FG004|Overall Study|Other Reasons|4
2058032|NCT00542386|3632080|FG005|Overall Study|Other Reasons|2
2058033|NCT00542425|3632099|FG000|Initial 24 Weeks|Administrative reasons|0
2058034|NCT00542425|3632100|FG001|Initial 24 Weeks|Administrative reasons|0
2058035|NCT00542425|3632101|FG002|Initial 24 Weeks|Administrative reasons|1
2058036|NCT00542425|3632102|FG003|Initial 24 Weeks|Administrative reasons|1
2058037|NCT00542425|3632103|FG004|Initial 24 Weeks|Administrative reasons|0
2058038|NCT00542425|3632099|FG000|Initial 24 Weeks|Adverse Event|0
2058039|NCT00542425|3632100|FG001|Initial 24 Weeks|Adverse Event|1
2058040|NCT00542425|3632101|FG002|Initial 24 Weeks|Adverse Event|1
2058041|NCT00542425|3632102|FG003|Initial 24 Weeks|Adverse Event|3
2058042|NCT00542425|3632103|FG004|Initial 24 Weeks|Adverse Event|2
2058043|NCT00542425|3632099|FG000|Initial 24 Weeks|Inability to complete procedures|0
2058044|NCT00542425|3632100|FG001|Initial 24 Weeks|Inability to complete procedures|3
2058045|NCT00542425|3632101|FG002|Initial 24 Weeks|Inability to complete procedures|2
2058046|NCT00542425|3632102|FG003|Initial 24 Weeks|Inability to complete procedures|1
2058047|NCT00542425|3632103|FG004|Initial 24 Weeks|Inability to complete procedures|2
2058048|NCT00542425|3632099|FG000|Initial 24 Weeks|Lost to Follow-up|2
2058049|NCT00542425|3632100|FG001|Initial 24 Weeks|Lost to Follow-up|2
2058050|NCT00542425|3632101|FG002|Initial 24 Weeks|Lost to Follow-up|1
2058051|NCT00542425|3632102|FG003|Initial 24 Weeks|Lost to Follow-up|0
2058052|NCT00542425|3632103|FG004|Initial 24 Weeks|Lost to Follow-up|0
2058053|NCT00542425|3632099|FG000|Initial 24 Weeks|Non-compliance|0
2058054|NCT00542425|3632100|FG001|Initial 24 Weeks|Non-compliance|0
2058055|NCT00542425|3632101|FG002|Initial 24 Weeks|Non-compliance|0
2058056|NCT00542425|3632102|FG003|Initial 24 Weeks|Non-compliance|1
2058057|NCT00542425|3632103|FG004|Initial 24 Weeks|Non-compliance|1
2058058|NCT00542425|3632099|FG000|Initial 24 Weeks|Protocol Violation|0
2058059|NCT00542425|3632100|FG001|Initial 24 Weeks|Protocol Violation|0
2058060|NCT00542425|3632101|FG002|Initial 24 Weeks|Protocol Violation|0
2058061|NCT00542425|3632102|FG003|Initial 24 Weeks|Protocol Violation|1
2058062|NCT00542425|3632103|FG004|Initial 24 Weeks|Protocol Violation|0
2301098|NCT02607930|3998991|FG000|Double-Blinded Phase|Lost to Follow-up|25
2301099|NCT02607930|3998992|FG001|Double-Blinded Phase|Lost to Follow-up|19
2301100|NCT02607930|3998991|FG000|Open-Label Extension Phase|Still in Study up to Data Cut Date for OL Week 48|237
2301101|NCT02607930|3998992|FG001|Open-Label Extension Phase|Still in Study up to Data Cut Date for OL Week 48|240
2301102|NCT02607930|3998991|FG000|Open-Label Extension Phase|Adverse Event|2
2301103|NCT02607930|3998992|FG001|Open-Label Extension Phase|Adverse Event|0
2301104|NCT02607930|3998991|FG000|Open-Label Extension Phase|Death|1
2301105|NCT02607930|3998992|FG001|Open-Label Extension Phase|Death|1
2301106|NCT02607930|3998991|FG000|Open-Label Extension Phase|Investigator's Discretion|0
2058063|NCT00542425|3632099|FG000|Initial 24 Weeks|Refusal of treatment|2
2058064|NCT00542425|3632100|FG001|Initial 24 Weeks|Refusal of treatment|2
2058065|NCT00542425|3632101|FG002|Initial 24 Weeks|Refusal of treatment|1
2058066|NCT00542425|3632102|FG003|Initial 24 Weeks|Refusal of treatment|4
2058067|NCT00542425|3632103|FG004|Initial 24 Weeks|Refusal of treatment|1
2058068|NCT00542425|3632099|FG000|Initial 24 Weeks|Other|0
2058069|NCT00542425|3632100|FG001|Initial 24 Weeks|Other|2
2058070|NCT00542425|3632101|FG002|Initial 24 Weeks|Other|1
2058071|NCT00542425|3632102|FG003|Initial 24 Weeks|Other|0
2058072|NCT00542425|3632103|FG004|Initial 24 Weeks|Other|0
2058073|NCT00542425|3632099|FG000|Extended 24 Weeks of Treatment|Adverse Event|0
2058074|NCT00542425|3632100|FG001|Extended 24 Weeks of Treatment|Adverse Event|0
2058075|NCT00542425|3632101|FG002|Extended 24 Weeks of Treatment|Adverse Event|1
2058076|NCT00542425|3632102|FG003|Extended 24 Weeks of Treatment|Adverse Event|1
2058077|NCT00542425|3632103|FG004|Extended 24 Weeks of Treatment|Adverse Event|0
2058078|NCT00542425|3632099|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0
2058079|NCT00542425|3632100|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0
2058080|NCT00542425|3632101|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1
2058081|NCT00542425|3632102|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0
2058082|NCT00542425|3632103|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0
2058083|NCT00542425|3632099|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0
2058084|NCT00542425|3632100|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1
2058085|NCT00542425|3632101|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0
2058086|NCT00542425|3632102|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0
2058087|NCT00542425|3632103|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0
2058088|NCT00542425|3632099|FG000|Extended 24 Weeks of Treatment|Other|1
2058089|NCT00542425|3632100|FG001|Extended 24 Weeks of Treatment|Other|1
2058090|NCT00542425|3632101|FG002|Extended 24 Weeks of Treatment|Other|0
2058091|NCT00542425|3632102|FG003|Extended 24 Weeks of Treatment|Other|0
2058092|NCT00542425|3632103|FG004|Extended 24 Weeks of Treatment|Other|1
2058093|NCT00542789|3632134|FG000|Overall Study|Adverse Event|18
2058094|NCT00542789|3632135|FG001|Overall Study|Adverse Event|17
2058095|NCT00542789|3632134|FG000|Overall Study|Withdrawal by Subject|7
2058096|NCT00542789|3632135|FG001|Overall Study|Withdrawal by Subject|3
2058097|NCT00542789|3632134|FG000|Overall Study|Protocol Violation|8
2058098|NCT00542789|3632135|FG001|Overall Study|Protocol Violation|1
2058099|NCT00542789|3632134|FG000|Overall Study|Recurrence of Gastric Ulcer|8
2058100|NCT00542789|3632135|FG001|Overall Study|Recurrence of Gastric Ulcer|57
2058101|NCT00542815|3632144|FG000|Overall Study|Adverse Event|19
2058102|NCT00542815|3632145|FG001|Overall Study|Adverse Event|6
2058103|NCT00542815|3632146|FG002|Overall Study|Adverse Event|9
2058104|NCT00542815|3632144|FG000|Overall Study|Death|10
2058105|NCT00542815|3632145|FG001|Overall Study|Death|7
2058106|NCT00542815|3632146|FG002|Overall Study|Death|3
2058107|NCT00542815|3632144|FG000|Overall Study|Lack of Efficacy|9
2058108|NCT00542815|3632145|FG001|Overall Study|Lack of Efficacy|2
2058109|NCT00542815|3632146|FG002|Overall Study|Lack of Efficacy|0
2058110|NCT00542815|3632144|FG000|Overall Study|Physician Decision|2
2058111|NCT00542815|3632145|FG001|Overall Study|Physician Decision|1
2058112|NCT00542815|3632146|FG002|Overall Study|Physician Decision|0
2058113|NCT00542815|3632144|FG000|Overall Study|Protocol Violation|1
2058114|NCT00542815|3632145|FG001|Overall Study|Protocol Violation|1
2058115|NCT00542815|3632146|FG002|Overall Study|Protocol Violation|2
2058116|NCT00542815|3632144|FG000|Overall Study|Withdrawal by Subject|41
2058117|NCT00542815|3632145|FG001|Overall Study|Withdrawal by Subject|5
2058118|NCT00542815|3632146|FG002|Overall Study|Withdrawal by Subject|8
2058119|NCT00542815|3632144|FG000|Overall Study|Other reasons|24
2058120|NCT00542815|3632145|FG001|Overall Study|Other reasons|10
2058121|NCT00542815|3632146|FG002|Overall Study|Other reasons|10
2058122|NCT00542828|3632154|FG000|Overall Study|Physician Decision|1
2058123|NCT00542828|3632154|FG000|Overall Study|Need for Prohibited Treatment|3
2058124|NCT00542828|3632154|FG000|Overall Study|Study Prematurely Discontinued|7
2058125|NCT00542828|3632154|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2
2058126|NCT00542880|3632160|FG000|Period 1|Eligibility criteria not fulfilled|2
2058127|NCT00542880|3632161|FG001|Period 1|Eligibility criteria not fulfilled|6
2058128|NCT00542880|3632160|FG000|Period 1|Adverse Event|2
2058129|NCT00542880|3632161|FG001|Period 1|Adverse Event|2
2058130|NCT00542880|3632160|FG000|Period 1|Development of study-specific criteria|1
2058131|NCT00542880|3632161|FG001|Period 1|Development of study-specific criteria|2
2058132|NCT00542880|3632160|FG000|Period 1|Withdrawal by Subject|1
2058133|NCT00542880|3632161|FG001|Period 1|Withdrawal by Subject|1
2058134|NCT00542880|3632160|FG000|Period 1|Protocol Violation|0
2058135|NCT00542880|3632161|FG001|Period 1|Protocol Violation|1
2058136|NCT00542880|3632160|FG000|Period 2|Adverse Event|5
2058137|NCT00542880|3632161|FG001|Period 2|Adverse Event|7
2058138|NCT00542880|3632160|FG000|Period 2|Eligibility not fulfilled|0
2058139|NCT00542880|3632161|FG001|Period 2|Eligibility not fulfilled|1
2058140|NCT00542880|3632160|FG000|Period 2|Discontinuation criteria|2
2058141|NCT00542880|3632161|FG001|Period 2|Discontinuation criteria|0
2058142|NCT00542880|3632160|FG000|Period 2|Severe non-compliance|0
2058143|NCT00542880|3632161|FG001|Period 2|Severe non-compliance|1
2058144|NCT00542880|3632160|FG000|Period 2|Other|0
2058145|NCT00542880|3632161|FG001|Period 2|Other|1
2058146|NCT00542880|3632160|FG000|Period 3|Adverse Event|0
2058147|NCT00542880|3632161|FG001|Period 3|Adverse Event|2
2058148|NCT00542919|3632171|FG000|Overall Study|Adverse Event|1
2058149|NCT00542919|3632172|FG001|Overall Study|Adverse Event|5
2058150|NCT00542919|3632173|FG002|Overall Study|Adverse Event|1
2058151|NCT00542919|3632171|FG000|Overall Study|Withdrawal by Subject|1
2058152|NCT00542919|3632172|FG001|Overall Study|Withdrawal by Subject|0
2058153|NCT00542919|3632173|FG002|Overall Study|Withdrawal by Subject|3
2058154|NCT00542919|3632171|FG000|Overall Study|Physician Decision|2
2058155|NCT00542919|3632172|FG001|Overall Study|Physician Decision|2
2058156|NCT00542919|3632173|FG002|Overall Study|Physician Decision|1
2058157|NCT00542919|3632171|FG000|Overall Study|Sponsor Decision|1
2058158|NCT00542919|3632172|FG001|Overall Study|Sponsor Decision|0
2058159|NCT00542919|3632173|FG002|Overall Study|Sponsor Decision|0
2058160|NCT00542919|3632171|FG000|Overall Study|Lost to Follow-up|2
2177089|NCT01371708|3801170|FG000|Overall Study|Protocol Violation|2
2301107|NCT02607930|3998992|FG001|Open-Label Extension Phase|Investigator's Discretion|1
2301108|NCT02607930|3998991|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|1
2301109|NCT02607930|3998992|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0
2301110|NCT02607930|3998991|FG000|Open-Label Extension Phase|Protocol Violation|1
2301111|NCT02607930|3998992|FG001|Open-Label Extension Phase|Protocol Violation|1
2301112|NCT02607930|3998991|FG000|Open-Label Extension Phase|Withdrew Consent|4
2301113|NCT02607930|3998992|FG001|Open-Label Extension Phase|Withdrew Consent|6
2301114|NCT02607930|3998991|FG000|Open-Label Extension Phase|Lost to Follow-up|6
2301115|NCT02607930|3998992|FG001|Open-Label Extension Phase|Lost to Follow-up|5
2301116|NCT02607956|3999002|FG000|Double-Blinded Phase|Randomized and Never Treated|7
2301117|NCT02607956|3999003|FG001|Double-Blinded Phase|Randomized and Never Treated|5
2301118|NCT02607956|3999002|FG000|Double-Blinded Phase|Adverse Event|4
2301119|NCT02607956|3999003|FG001|Double-Blinded Phase|Adverse Event|3
2301120|NCT02607956|3999002|FG000|Double-Blinded Phase|Death|4
2301121|NCT02607956|3999003|FG001|Double-Blinded Phase|Death|4
2301122|NCT02607956|3999002|FG000|Double-Blinded Phase|Investigator's Discretion|7
2301123|NCT02607956|3999003|FG001|Double-Blinded Phase|Investigator's Discretion|2
2301124|NCT02607956|3999002|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0
2301125|NCT02607956|3999003|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3
2301126|NCT02607956|3999002|FG000|Double-Blinded Phase|Protocol Violation|3
2301127|NCT02607956|3999003|FG001|Double-Blinded Phase|Protocol Violation|1
2301128|NCT02607956|3999002|FG000|Double-Blinded Phase|Withdrew Consent|17
2301129|NCT02607956|3999003|FG001|Double-Blinded Phase|Withdrew Consent|19
2301130|NCT02607956|3999002|FG000|Double-Blinded Phase|Lost to Follow-up|19
2301131|NCT02607956|3999003|FG001|Double-Blinded Phase|Lost to Follow-up|16
2301132|NCT02607956|3999002|FG000|Open-Label Extension Phase|Still in Study up to Data Cut Date For OL Week 48|244
2301133|NCT02607956|3999003|FG001|Open-Label Extension Phase|Still in Study up to Data Cut Date For OL Week 48|254
2301134|NCT02607956|3999002|FG000|Open-Label Extension Phase|Investigator's Discretion|0
2301135|NCT02607956|3999003|FG001|Open-Label Extension Phase|Investigator's Discretion|1
2301136|NCT02607956|3999002|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|1
2301137|NCT02607956|3999003|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0
2301138|NCT02607956|3999002|FG000|Open-Label Extension Phase|Withdrew Consent|6
2301139|NCT02607956|3999003|FG001|Open-Label Extension Phase|Withdrew Consent|5
2301140|NCT02607956|3999002|FG000|Open-Label Extension Phase|Lost to Follow-up|3
2301141|NCT02607956|3999003|FG001|Open-Label Extension Phase|Lost to Follow-up|5
2301142|NCT02608099|3999013|FG000|Overall Study|Ablation procedure not initiated|3
2301143|NCT02608099|3999014|FG001|Overall Study|Ablation procedure not initiated|2
2301144|NCT02608450|3999044|FG000|Overall Study|Lost to Follow-up|39
2301145|NCT02608450|3999045|FG001|Overall Study|Lost to Follow-up|32
2301146|NCT02608450|3999044|FG000|Overall Study|Withdrawal by Subject|21
2301147|NCT02608450|3999045|FG001|Overall Study|Withdrawal by Subject|15
2301148|NCT02608450|3999044|FG000|Overall Study|Adverse Event|3
2301149|NCT02608450|3999045|FG001|Overall Study|Adverse Event|6
2301150|NCT02608450|3999044|FG000|Overall Study|Withdrawal by parent|2
2301151|NCT02608450|3999045|FG001|Overall Study|Withdrawal by parent|3
2301152|NCT02608450|3999044|FG000|Overall Study|Lack of Efficacy|0
2301153|NCT02608450|3999045|FG001|Overall Study|Lack of Efficacy|3
2301154|NCT02608450|3999044|FG000|Overall Study|Noncompliance with study drug|0
2301155|NCT02608450|3999045|FG001|Overall Study|Noncompliance with study drug|2
2301156|NCT02608450|3999044|FG000|Overall Study|Physician Decision|0
2301157|NCT02608450|3999045|FG001|Overall Study|Physician Decision|1
2301158|NCT02608450|3999044|FG000|Overall Study|Pregnancy|0
2301159|NCT02608450|3999045|FG001|Overall Study|Pregnancy|1
2301160|NCT02608450|3999044|FG000|Overall Study|Progressive disease|1
2301161|NCT02608450|3999045|FG001|Overall Study|Progressive disease|0
2301162|NCT02608450|3999044|FG000|Overall Study|Multiple reasons|0
2301163|NCT02608450|3999045|FG001|Overall Study|Multiple reasons|2
2321507|NCT02960490|4036047|FG002|Re-randomized Participants: 12 Weeks|Other|0
2321508|NCT02960490|4036048|FG003|Re-randomized Participants: 12 Weeks|Other|1
2321509|NCT02960490|4036049|FG004|Re-randomized Participants: 12 Weeks|Other|0
2321510|NCT02960490|4036050|FG005|Re-randomized Participants: 12 Weeks|Other|0
2321511|NCT02960490|4036051|FG006|Re-randomized Participants: 12 Weeks|Other|0
2321512|NCT02960490|4036052|FG007|Re-randomized Participants: 12 Weeks|Other|0
2321513|NCT02960490|4036053|FG008|Re-randomized Participants: 12 Weeks|Other|0
2321514|NCT02960490|4036054|FG009|Re-randomized Participants: 12 Weeks|Other|0
2321515|NCT02960490|4036045|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
2321516|NCT02960490|4036046|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
2353774|NCT02044302|4107110|FG001|Overall Study|study terminated|0
2058161|NCT00542919|3632172|FG001|Overall Study|Lost to Follow-up|0
2058162|NCT00542919|3632173|FG002|Overall Study|Lost to Follow-up|1
2058163|NCT00542997|3632200|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2
2058164|NCT00542997|3632200|FG000|Wash in / Wash Out Period|Adverse Event|3
2058165|NCT00542997|3632200|FG000|Efficacy Period|Adverse Event|3
2058166|NCT00543062|3632207|FG000|Overall Study|Withdrawal by Subject|1
2058167|NCT00543062|3632208|FG001|Overall Study|Withdrawal by Subject|0
2058168|NCT00543062|3632209|FG002|Overall Study|Withdrawal by Subject|2
2058169|NCT00543062|3632210|FG003|Overall Study|Withdrawal by Subject|0
2058170|NCT00543062|3632207|FG000|Overall Study|Adverse Event|0
2058171|NCT00543062|3632208|FG001|Overall Study|Adverse Event|1
2058172|NCT00543062|3632209|FG002|Overall Study|Adverse Event|1
2058173|NCT00543062|3632210|FG003|Overall Study|Adverse Event|1
2058174|NCT00543062|3632207|FG000|Overall Study|Protocol Violation|1
2058175|NCT00543062|3632208|FG001|Overall Study|Protocol Violation|0
2058176|NCT00543062|3632209|FG002|Overall Study|Protocol Violation|0
2058177|NCT00543062|3632210|FG003|Overall Study|Protocol Violation|0
2105636|NCT00858364|3698304|FG001|Overall Study|Lost to Follow-up|54
2105637|NCT00858364|3698303|FG000|Overall Study|Noncompliance|3
2105638|NCT00858364|3698304|FG001|Overall Study|Noncompliance|4
2105639|NCT00858364|3698303|FG000|Overall Study|Protocol Deviation|0
2105640|NCT00858364|3698304|FG001|Overall Study|Protocol Deviation|2
2105641|NCT00858364|3698303|FG000|Overall Study|Other|9
2105642|NCT00858364|3698304|FG001|Overall Study|Other|17
2105643|NCT00858364|3698303|FG000|Overall Study|Missing|1
2105644|NCT00858364|3698304|FG001|Overall Study|Missing|1
2105645|NCT00858364|3698303|FG000|Overall Study|Still on-study|114
2105646|NCT00858364|3698304|FG001|Overall Study|Still on-study|247
2105647|NCT00858403|3698319|FG000|Overall Study|Withdrawal by Subject|1
2105648|NCT00858403|3698319|FG000|Overall Study|Death|3
2105649|NCT00858403|3698319|FG000|Overall Study|Disease Progression|1
2105650|NCT00858442|3698325|FG000|Compression:Start to Finish|Lost to Follow-up|1
2105651|NCT00858442|3698326|FG001|Compression:Start to Finish|Lost to Follow-up|3
2105652|NCT00858637|3698357|FG000|Active Comparison Phase|Adverse Event|14
2105653|NCT00858637|3698358|FG001|Active Comparison Phase|Adverse Event|0
2105654|NCT00858637|3698359|FG002|Active Comparison Phase|Adverse Event|0
2105655|NCT00858637|3698360|FG003|Active Comparison Phase|Adverse Event|9
2105656|NCT00858637|3698361|FG004|Active Comparison Phase|Adverse Event|0
2105657|NCT00858637|3698362|FG005|Active Comparison Phase|Adverse Event|0
2105658|NCT00858637|3698357|FG000|Active Comparison Phase|Death|1
2105659|NCT00858637|3698358|FG001|Active Comparison Phase|Death|0
2105660|NCT00858637|3698359|FG002|Active Comparison Phase|Death|0
2105661|NCT00858637|3698360|FG003|Active Comparison Phase|Death|1
2105662|NCT00858637|3698361|FG004|Active Comparison Phase|Death|0
2105663|NCT00858637|3698362|FG005|Active Comparison Phase|Death|0
2105664|NCT00858637|3698357|FG000|Active Comparison Phase|Physician Decision|1
2105665|NCT00858637|3698358|FG001|Active Comparison Phase|Physician Decision|0
2105666|NCT00858637|3698359|FG002|Active Comparison Phase|Physician Decision|0
2105667|NCT00858637|3698360|FG003|Active Comparison Phase|Physician Decision|1
2105668|NCT00858637|3698361|FG004|Active Comparison Phase|Physician Decision|0
2105669|NCT00858637|3698362|FG005|Active Comparison Phase|Physician Decision|0
2105670|NCT00858637|3698357|FG000|Active Comparison Phase|Withdrawal by Subject|7
2105671|NCT00858637|3698358|FG001|Active Comparison Phase|Withdrawal by Subject|0
2105672|NCT00858637|3698359|FG002|Active Comparison Phase|Withdrawal by Subject|0
2105673|NCT00858637|3698360|FG003|Active Comparison Phase|Withdrawal by Subject|6
2105674|NCT00858637|3698361|FG004|Active Comparison Phase|Withdrawal by Subject|0
2105675|NCT00858637|3698362|FG005|Active Comparison Phase|Withdrawal by Subject|0
2105676|NCT00858637|3698357|FG000|Active Comparison Phase|Other Reasons|1
2105677|NCT00858637|3698358|FG001|Active Comparison Phase|Other Reasons|0
2105678|NCT00858637|3698359|FG002|Active Comparison Phase|Other Reasons|0
2105679|NCT00858637|3698360|FG003|Active Comparison Phase|Other Reasons|1
2105680|NCT00858637|3698361|FG004|Active Comparison Phase|Other Reasons|0
2105681|NCT00858637|3698362|FG005|Active Comparison Phase|Other Reasons|0
2105682|NCT00858637|3698357|FG000|Placebo-controlled Withdrawal Phase|Death|0
2105683|NCT00858637|3698358|FG001|Placebo-controlled Withdrawal Phase|Death|0
2105684|NCT00858637|3698359|FG002|Placebo-controlled Withdrawal Phase|Death|1
2105685|NCT00858637|3698360|FG003|Placebo-controlled Withdrawal Phase|Death|0
2105686|NCT00858637|3698361|FG004|Placebo-controlled Withdrawal Phase|Death|1
2105687|NCT00858637|3698362|FG005|Placebo-controlled Withdrawal Phase|Death|0
2105688|NCT00858637|3698357|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
2105689|NCT00858637|3698358|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
2105690|NCT00858637|3698359|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
2105691|NCT00858637|3698360|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
2105692|NCT00858637|3698361|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
2105693|NCT00858637|3698362|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
2105694|NCT00858780|3698376|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
2105695|NCT00858780|3698377|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
2105696|NCT00858780|3698378|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
2105697|NCT00858780|3698379|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
2105698|NCT00858780|3698380|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
2177090|NCT01371708|3801171|FG001|Overall Study|Protocol Violation|1
2177091|NCT01371708|3801172|FG002|Overall Study|Protocol Violation|2
2301164|NCT02608476|3999067|FG000|Overall Study|Withdrawal by Subject|30
2301165|NCT02608476|3999068|FG001|Overall Study|Withdrawal by Subject|37
2301166|NCT02608476|3999067|FG000|Overall Study|Lost to Follow-up|24
2301167|NCT02608476|3999068|FG001|Overall Study|Lost to Follow-up|24
2301168|NCT02608476|3999067|FG000|Overall Study|Adverse Event|2
2301169|NCT02608476|3999068|FG001|Overall Study|Adverse Event|8
2301170|NCT02608476|3999067|FG000|Overall Study|Withdrawal by Parent/Guardian|5
2301171|NCT02608476|3999068|FG001|Overall Study|Withdrawal by Parent/Guardian|4
2301172|NCT02608476|3999067|FG000|Overall Study|Noncompliance with treatment|1
2301173|NCT02608476|3999068|FG001|Overall Study|Noncompliance with treatment|5
2301174|NCT02608476|3999067|FG000|Overall Study|Lack of Efficacy|3
2301175|NCT02608476|3999068|FG001|Overall Study|Lack of Efficacy|1
2301176|NCT02608476|3999067|FG000|Overall Study|Other|0
2301177|NCT02608476|3999068|FG001|Overall Study|Other|1
2301178|NCT02608476|3999067|FG000|Overall Study|Physician Decision|1
2301179|NCT02608476|3999068|FG001|Overall Study|Physician Decision|0
2301180|NCT02608476|3999067|FG000|Overall Study|Pregnancy|0
2301181|NCT02608476|3999068|FG001|Overall Study|Pregnancy|1
2301182|NCT02608476|3999067|FG000|Overall Study|Progressive disease|1
2301183|NCT02608476|3999068|FG001|Overall Study|Progressive disease|0
2301184|NCT02608684|3999083|FG000|Overall Study|Physician Decision|2
2301185|NCT02608684|3999083|FG000|Overall Study|Withdrawal by Subject|1
2301186|NCT02608879|3999090|FG000|Overall Study|Lost to Follow-up|1
2301187|NCT02608879|3999091|FG001|Overall Study|Lost to Follow-up|0
2301188|NCT02608879|3999092|FG002|Overall Study|Lost to Follow-up|0
2301189|NCT02608879|3999090|FG000|Overall Study|Did not meet continuation criteria|0
2301190|NCT02608879|3999091|FG001|Overall Study|Did not meet continuation criteria|0
2301191|NCT02608879|3999092|FG002|Overall Study|Did not meet continuation criteria|3
2301192|NCT02608892|3999102|FG000|Overall Study|Lost to Follow-up|1
2301193|NCT02608892|3999103|FG001|Overall Study|Lost to Follow-up|0
2301194|NCT02609178|3999130|FG000|First Crown|Withdrawal by Subject|0
2301195|NCT02609178|3999131|FG001|First Crown|Withdrawal by Subject|0
2301196|NCT02609178|3999132|FG002|First Crown|Withdrawal by Subject|1
2058178|NCT00543140|3632247|FG000|Overall Study|Lost to Follow-up|33
2058179|NCT00543140|3632247|FG000|Overall Study|Withdrawal by Subject|13
2058180|NCT00543140|3632247|FG000|Overall Study|Protocol Violation|10
2058181|NCT00543140|3632247|FG000|Overall Study|Insufficient weight loss|10
2058182|NCT00543140|3632247|FG000|Overall Study|SAE leading to explant of SAGB|3
2058183|NCT00543140|3632247|FG000|Overall Study|Death|1
2058184|NCT00543140|3632247|FG000|Overall Study|Subject moved|1
2058185|NCT00543140|3632247|FG000|Overall Study|Conversion to different procedure|1
2058186|NCT00543296|3632251|FG000|Overall Study|Physician Decision|7
2058187|NCT00543309|3632258|FG000|Overall Study|Physician Decision|0
2058188|NCT00543309|3632259|FG001|Overall Study|Physician Decision|1
2058189|NCT00543309|3632260|FG002|Overall Study|Physician Decision|0
2058190|NCT00543387|3632278|FG000|Panel 1 + Panel 2|Adverse Event|0
2058191|NCT00543387|3632279|FG001|Panel 1 + Panel 2|Adverse Event|1
2058192|NCT00543387|3632280|FG002|Panel 1 + Panel 2|Adverse Event|0
2058193|NCT00543387|3632281|FG003|Panel 1 + Panel 2|Adverse Event|0
2058194|NCT00543387|3632282|FG004|Panel 1 + Panel 2|Adverse Event|0
2058195|NCT00543387|3632283|FG005|Panel 1 + Panel 2|Adverse Event|0
2058196|NCT00543387|3632284|FG006|Panel 1 + Panel 2|Adverse Event|0
2058197|NCT00543387|3632285|FG007|Panel 1 + Panel 2|Adverse Event|1
2058198|NCT00543387|3632286|FG008|Panel 1 + Panel 2|Adverse Event|1
2058199|NCT00543387|3632287|FG009|Panel 1 + Panel 2|Adverse Event|0
2058200|NCT00543387|3632288|FG010|Panel 1 + Panel 2|Adverse Event|0
2058201|NCT00543387|3632278|FG000|Panel 1 + Panel 2|Physician Decision|0
2058202|NCT00543387|3632279|FG001|Panel 1 + Panel 2|Physician Decision|0
2058203|NCT00543387|3632280|FG002|Panel 1 + Panel 2|Physician Decision|1
2058204|NCT00543387|3632281|FG003|Panel 1 + Panel 2|Physician Decision|0
2058205|NCT00543387|3632282|FG004|Panel 1 + Panel 2|Physician Decision|0
2058206|NCT00543387|3632283|FG005|Panel 1 + Panel 2|Physician Decision|0
2058207|NCT00543387|3632284|FG006|Panel 1 + Panel 2|Physician Decision|0
2058208|NCT00543387|3632285|FG007|Panel 1 + Panel 2|Physician Decision|1
2058209|NCT00543387|3632286|FG008|Panel 1 + Panel 2|Physician Decision|0
2058210|NCT00543387|3632287|FG009|Panel 1 + Panel 2|Physician Decision|0
2058211|NCT00543387|3632288|FG010|Panel 1 + Panel 2|Physician Decision|0
2058212|NCT00543387|3632278|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3
2058213|NCT00543387|3632279|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2
2058214|NCT00543387|3632280|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2
2058215|NCT00543387|3632281|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3
2058216|NCT00543387|3632282|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3
2058217|NCT00543387|3632283|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3
2058218|NCT00543387|3632284|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5
2058219|NCT00543387|3632285|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4
2058220|NCT00543387|3632286|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4
2058221|NCT00543387|3632287|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0
2058222|NCT00543387|3632288|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0
2058223|NCT00543387|3632278|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0
2058224|NCT00543387|3632279|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0
2058225|NCT00543387|3632280|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0
2301197|NCT02609178|3999133|FG003|First Crown|Withdrawal by Subject|1
2301198|NCT02609178|3999134|FG004|First Crown|Withdrawal by Subject|0
2058226|NCT00543387|3632281|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0
2058227|NCT00543387|3632282|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0
2058228|NCT00543387|3632283|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0
2058229|NCT00543387|3632284|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1
2058230|NCT00543387|3632285|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0
2058231|NCT00543387|3632286|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0
2058232|NCT00543387|3632287|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0
2058233|NCT00543387|3632288|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0
2058234|NCT00543387|3632278|FG000|Crossover Participants|Progressive Disease|0
2058235|NCT00543387|3632279|FG001|Crossover Participants|Progressive Disease|0
2058236|NCT00543387|3632280|FG002|Crossover Participants|Progressive Disease|0
2058237|NCT00543387|3632281|FG003|Crossover Participants|Progressive Disease|0
2058238|NCT00543387|3632282|FG004|Crossover Participants|Progressive Disease|0
2058239|NCT00543387|3632283|FG005|Crossover Participants|Progressive Disease|0
2058240|NCT00543387|3632284|FG006|Crossover Participants|Progressive Disease|0
2058241|NCT00543387|3632285|FG007|Crossover Participants|Progressive Disease|0
2058242|NCT00543387|3632286|FG008|Crossover Participants|Progressive Disease|0
2058243|NCT00543387|3632287|FG009|Crossover Participants|Progressive Disease|1
2058244|NCT00543387|3632288|FG010|Crossover Participants|Progressive Disease|2
2058245|NCT00543387|3632278|FG000|Crossover Participants|Study Terminated by Sponsor|0
2058246|NCT00543387|3632279|FG001|Crossover Participants|Study Terminated by Sponsor|0
2058247|NCT00543387|3632280|FG002|Crossover Participants|Study Terminated by Sponsor|0
2058248|NCT00543387|3632281|FG003|Crossover Participants|Study Terminated by Sponsor|0
2058249|NCT00543387|3632282|FG004|Crossover Participants|Study Terminated by Sponsor|0
2058250|NCT00543387|3632283|FG005|Crossover Participants|Study Terminated by Sponsor|0
2058251|NCT00543387|3632284|FG006|Crossover Participants|Study Terminated by Sponsor|0
2058252|NCT00543387|3632285|FG007|Crossover Participants|Study Terminated by Sponsor|0
2058253|NCT00543387|3632286|FG008|Crossover Participants|Study Terminated by Sponsor|0
2058254|NCT00543387|3632287|FG009|Crossover Participants|Study Terminated by Sponsor|0
2058255|NCT00543387|3632288|FG010|Crossover Participants|Study Terminated by Sponsor|1
2058256|NCT00543439|3632332|FG000|Period 1|Adverse Event|0
2058257|NCT00543439|3632333|FG001|Period 1|Adverse Event|2
2058258|NCT00543439|3632334|FG002|Period 1|Adverse Event|1
2058259|NCT00543439|3632332|FG000|Period 1|Withdrawal by Subject|1
2058260|NCT00543439|3632333|FG001|Period 1|Withdrawal by Subject|1
2058261|NCT00543439|3632334|FG002|Period 1|Withdrawal by Subject|0
2058262|NCT00543439|3632332|FG000|Period 1|Physician Decision|0
2058263|NCT00543439|3632333|FG001|Period 1|Physician Decision|0
2058264|NCT00543439|3632334|FG002|Period 1|Physician Decision|1
2058265|NCT00543439|3632332|FG000|Period 2|Protocol Violation|1
2058266|NCT00543439|3632333|FG001|Period 2|Protocol Violation|0
2058267|NCT00543439|3632334|FG002|Period 2|Protocol Violation|1
2058268|NCT00543439|3632332|FG000|Period 2|Adverse Event|0
2058269|NCT00543439|3632333|FG001|Period 2|Adverse Event|1
2058270|NCT00543439|3632334|FG002|Period 2|Adverse Event|1
2058271|NCT00543543|3632355|FG000|Base Study|Adverse Event|1
2058272|NCT00543543|3632356|FG001|Base Study|Adverse Event|11
2058273|NCT00543543|3632357|FG002|Base Study|Adverse Event|0
2058274|NCT00543543|3632358|FG003|Base Study|Adverse Event|5
2058275|NCT00543543|3632355|FG000|Base Study|Lost to Follow-up|12
2058276|NCT00543543|3632356|FG001|Base Study|Lost to Follow-up|749
2058277|NCT00543543|3632357|FG002|Base Study|Lost to Follow-up|9
2058278|NCT00543543|3632358|FG003|Base Study|Lost to Follow-up|701
2058279|NCT00543543|3632355|FG000|Base Study|Physician Decision|0
2058280|NCT00543543|3632356|FG001|Base Study|Physician Decision|4
2058281|NCT00543543|3632357|FG002|Base Study|Physician Decision|0
2058282|NCT00543543|3632358|FG003|Base Study|Physician Decision|7
2058283|NCT00543543|3632355|FG000|Base Study|Protocol Violation|0
2058284|NCT00543543|3632356|FG001|Base Study|Protocol Violation|6
2058285|NCT00543543|3632357|FG002|Base Study|Protocol Violation|0
2058286|NCT00543543|3632358|FG003|Base Study|Protocol Violation|6
2058287|NCT00543543|3632355|FG000|Base Study|Withdrawal by Subject|7
2058288|NCT00543543|3632356|FG001|Base Study|Withdrawal by Subject|482
2058289|NCT00543543|3632357|FG002|Base Study|Withdrawal by Subject|5
2058290|NCT00543543|3632358|FG003|Base Study|Withdrawal by Subject|503
2058291|NCT00543543|3632355|FG000|Extension Study|Adverse Event|0
2058292|NCT00543543|3632356|FG001|Extension Study|Adverse Event|0
2058293|NCT00543543|3632357|FG002|Extension Study|Adverse Event|0
2058294|NCT00543543|3632358|FG003|Extension Study|Adverse Event|5
2058295|NCT00543543|3632355|FG000|Extension Study|Lost to Follow-up|0
2058296|NCT00543543|3632356|FG001|Extension Study|Lost to Follow-up|0
2058297|NCT00543543|3632357|FG002|Extension Study|Lost to Follow-up|0
2058298|NCT00543543|3632358|FG003|Extension Study|Lost to Follow-up|77
2058299|NCT00543543|3632355|FG000|Extension Study|Physician Decision|0
2058300|NCT00543543|3632356|FG001|Extension Study|Physician Decision|0
2058301|NCT00543543|3632357|FG002|Extension Study|Physician Decision|0
2058302|NCT00543543|3632358|FG003|Extension Study|Physician Decision|7
2058303|NCT00543543|3632355|FG000|Extension Study|Pregnancy|0
2058304|NCT00543543|3632356|FG001|Extension Study|Pregnancy|0
2058305|NCT00543543|3632357|FG002|Extension Study|Pregnancy|0
2058306|NCT00543543|3632358|FG003|Extension Study|Pregnancy|6
2058307|NCT00543543|3632355|FG000|Extension Study|Protocol Violation|0
2058308|NCT00543543|3632356|FG001|Extension Study|Protocol Violation|0
2058309|NCT00543543|3632357|FG002|Extension Study|Protocol Violation|0
2058310|NCT00543543|3632358|FG003|Extension Study|Protocol Violation|11
2058311|NCT00543543|3632355|FG000|Extension Study|Withdrawal by Subject|0
2058312|NCT00543543|3632356|FG001|Extension Study|Withdrawal by Subject|0
2058313|NCT00543543|3632357|FG002|Extension Study|Withdrawal by Subject|0
2058314|NCT00543543|3632358|FG003|Extension Study|Withdrawal by Subject|120
2058315|NCT00543569|3632377|FG000|Overall Study|Death|2
2058316|NCT00543569|3632378|FG001|Overall Study|Death|2
2058317|NCT00543569|3632379|FG002|Overall Study|Death|3
2058318|NCT00543569|3632380|FG003|Overall Study|Death|1
2058319|NCT00543569|3632377|FG000|Overall Study|Lost to Follow-up|0
2058320|NCT00543569|3632378|FG001|Overall Study|Lost to Follow-up|0
2058321|NCT00543569|3632379|FG002|Overall Study|Lost to Follow-up|1
2058322|NCT00543569|3632380|FG003|Overall Study|Lost to Follow-up|1
2058323|NCT00543569|3632377|FG000|Overall Study|Miscellaneous Reasons|7
2058324|NCT00543569|3632378|FG001|Overall Study|Miscellaneous Reasons|3
2058325|NCT00543569|3632379|FG002|Overall Study|Miscellaneous Reasons|11
2058326|NCT00543569|3632380|FG003|Overall Study|Miscellaneous Reasons|4
2058327|NCT00543569|3632377|FG000|Overall Study|Randomized but never received study drug|3
2058328|NCT00543569|3632378|FG001|Overall Study|Randomized but never received study drug|3
2058329|NCT00543569|3632379|FG002|Overall Study|Randomized but never received study drug|5
2058330|NCT00543569|3632380|FG003|Overall Study|Randomized but never received study drug|3
2058331|NCT00543725|3632392|FG000|Overall Study|Adverse Event|18
2058332|NCT00543725|3632393|FG001|Overall Study|Adverse Event|27
2058333|NCT00543725|3632392|FG000|Overall Study|Sponsor's Decision|0
2058334|NCT00543725|3632393|FG001|Overall Study|Sponsor's Decision|1
2058335|NCT00543725|3632392|FG000|Overall Study|Subject Non-Compliant|4
2058336|NCT00543725|3632393|FG001|Overall Study|Subject Non-Compliant|4
2058337|NCT00543725|3632392|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
2058338|NCT00543725|3632393|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
2058339|NCT00543725|3632392|FG000|Overall Study|Subject Reached A Virologic Endpoint|22
2058340|NCT00543725|3632393|FG001|Overall Study|Subject Reached A Virologic Endpoint|14
2058341|NCT00543725|3632392|FG000|Overall Study|Protocol Violation|0
2058342|NCT00543725|3632393|FG001|Overall Study|Protocol Violation|1
2058343|NCT00543725|3632392|FG000|Overall Study|Withdrawal by Subject|4
2058344|NCT00543725|3632393|FG001|Overall Study|Withdrawal by Subject|13
2058345|NCT00543725|3632392|FG000|Overall Study|Lost to Follow-up|15
2058346|NCT00543725|3632393|FG001|Overall Study|Lost to Follow-up|11
2058347|NCT00543725|3632392|FG000|Overall Study|Other|3
2058348|NCT00543725|3632393|FG001|Overall Study|Other|3
2058349|NCT00543803|3632412|FG000|Overall Study|Adverse Event|14
2209806|NCT01646177|3849241|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
2209807|NCT01646177|3849242|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
2058350|NCT00543803|3632412|FG000|Overall Study|Lack of Efficacy|22
2058351|NCT00543803|3632412|FG000|Overall Study|Lost to Follow-up|20
2058352|NCT00543803|3632412|FG000|Overall Study|Other|86
2058353|NCT00543855|3632422|FG000|Overall Study|Adverse Event|3
2058354|NCT00543855|3632423|FG001|Overall Study|Adverse Event|1
2058355|NCT00543855|3632424|FG002|Overall Study|Adverse Event|3
2058356|NCT00543855|3632425|FG003|Overall Study|Adverse Event|4
2058357|NCT00543855|3632422|FG000|Overall Study|Lost to Follow-up|0
2058358|NCT00543855|3632423|FG001|Overall Study|Lost to Follow-up|0
2058359|NCT00543855|3632424|FG002|Overall Study|Lost to Follow-up|1
2058360|NCT00543855|3632425|FG003|Overall Study|Lost to Follow-up|0
2058361|NCT00543855|3632422|FG000|Overall Study|Withdrawal by Subject|0
2058362|NCT00543855|3632423|FG001|Overall Study|Withdrawal by Subject|1
2058363|NCT00543855|3632424|FG002|Overall Study|Withdrawal by Subject|2
2058364|NCT00543855|3632425|FG003|Overall Study|Withdrawal by Subject|0
2058365|NCT00543855|3632422|FG000|Overall Study|Protocol Violation|1
2058366|NCT00543855|3632423|FG001|Overall Study|Protocol Violation|0
2058367|NCT00543855|3632424|FG002|Overall Study|Protocol Violation|0
2058368|NCT00543855|3632425|FG003|Overall Study|Protocol Violation|0
2058369|NCT00543985|3632435|FG000|Overall Study|Withdrawal by Subject|4
2058370|NCT00544167|3632456|FG000|Overall Study|Adverse Event|21
2058371|NCT00544167|3632456|FG000|Overall Study|Physician Decision|8
2058372|NCT00544440|3632460|FG000|Overall Study|Other|1
2058373|NCT00544440|3632460|FG000|Overall Study|Adverse Event|1
2058374|NCT00544440|3632460|FG000|Overall Study|Withdrawal by Subject|2
2058375|NCT00544440|3632460|FG000|Overall Study|Subject Non-compliance|1
2058376|NCT00544440|3632460|FG000|Overall Study|Progressive Disease|47
2058377|NCT00544440|3632460|FG000|Overall Study|Other|5
2058378|NCT00544544|3632464|FG000|Overall Study|Withdrawal by Subject|1
2058379|NCT00544544|3632464|FG000|Overall Study|Adverse Event|1
2058380|NCT00544544|3632464|FG000|Overall Study|Lost to Follow-up|1
2058381|NCT00544557|3632468|FG000|Overall Study|Adverse Event|140
2058382|NCT00544557|3632468|FG000|Overall Study|Lack of Efficacy|196
2058383|NCT00544557|3632468|FG000|Overall Study|Other|98
2058384|NCT00544648|3632474|FG000|Overall Study|Withdrawal by Subject|1
2058385|NCT00544648|3632475|FG001|Overall Study|Withdrawal by Subject|0
2058386|NCT00544648|3632474|FG000|Overall Study|Adverse Event|1
2058387|NCT00544648|3632475|FG001|Overall Study|Adverse Event|1
2058388|NCT00544648|3632474|FG000|Overall Study|progression of disease|1
2058389|NCT00544648|3632475|FG001|Overall Study|progression of disease|0
2058390|NCT00544817|3632500|FG000|Combined Modality|Lack of Efficacy|2
2058391|NCT00544817|3632500|FG000|Combined Modality|Worsening Neurologic Symptoms|2
2058392|NCT00544817|3632500|FG000|Combined Modality|Adverse Event|2
2058393|NCT00544817|3632500|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1
2058394|NCT00544817|3632500|FG000|No Treatment Interval|Lack of Efficacy|8
2058395|NCT00544817|3632500|FG000|No Treatment Interval|Physician Decision|3
2058396|NCT00544817|3632500|FG000|No Treatment Interval|Adverse Event|1
2058397|NCT00544817|3632500|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15
2058398|NCT00544817|3632500|FG000|Follow-up Systemic Therapy|Physician Decision|3
2058399|NCT00544817|3632500|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
2058400|NCT00544869|3632507|FG000|Overall Study|Rsolution of congenitive symptoms|3
2058401|NCT00544869|3632508|FG001|Overall Study|Rsolution of congenitive symptoms|0
2058402|NCT00544869|3632509|FG002|Overall Study|Rsolution of congenitive symptoms|0
2058403|NCT00544869|3632507|FG000|Overall Study|Adverse Event|6
2058404|NCT00544869|3632508|FG001|Overall Study|Adverse Event|1
2058405|NCT00544869|3632509|FG002|Overall Study|Adverse Event|0
2058406|NCT00544869|3632507|FG000|Overall Study|Lack of Efficacy|1
2058407|NCT00544869|3632508|FG001|Overall Study|Lack of Efficacy|1
2058408|NCT00544869|3632509|FG002|Overall Study|Lack of Efficacy|0
2058409|NCT00544869|3632507|FG000|Overall Study|Physician Decision|2
2058410|NCT00544869|3632508|FG001|Overall Study|Physician Decision|0
2058411|NCT00544869|3632509|FG002|Overall Study|Physician Decision|0
2058412|NCT00544882|3632519|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
2058413|NCT00544882|3632520|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
2058414|NCT00544882|3632521|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
2058415|NCT00544882|3632519|FG000|Cycle 1: Run-in Cycle|Adverse Event|1
2058416|NCT00544882|3632520|FG001|Cycle 1: Run-in Cycle|Adverse Event|0
2058417|NCT00544882|3632521|FG002|Cycle 1: Run-in Cycle|Adverse Event|0
2058418|NCT00544882|3632519|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
2058419|NCT00544882|3632520|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
2058420|NCT00544882|3632521|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
2058421|NCT00544882|3632519|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
2058422|NCT00544882|3632520|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
2058423|NCT00544882|3632521|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
2058424|NCT00544882|3632519|FG000|Cycle 3: Follow-up|Noncompliance|0
2058425|NCT00544882|3632520|FG001|Cycle 3: Follow-up|Noncompliance|1
2058426|NCT00544882|3632521|FG002|Cycle 3: Follow-up|Noncompliance|0
2058427|NCT00544882|3632519|FG000|Cycle 3: Follow-up|Pregnancy|0
2058428|NCT00544882|3632520|FG001|Cycle 3: Follow-up|Pregnancy|1
2058429|NCT00544882|3632521|FG002|Cycle 3: Follow-up|Pregnancy|0
2058430|NCT00545051|3632542|FG000|Overall Study|Adverse Event|7
2058431|NCT00545051|3632543|FG001|Overall Study|Adverse Event|3
2058432|NCT00545051|3632542|FG000|Overall Study|Death|1
2058433|NCT00545051|3632543|FG001|Overall Study|Death|0
2058434|NCT00545051|3632542|FG000|Overall Study|Violation of inclusion/exclusion|0
2058435|NCT00545051|3632543|FG001|Overall Study|Violation of inclusion/exclusion|2
2058436|NCT00545051|3632542|FG000|Overall Study|Protocol Violation|1
2058437|NCT00545051|3632543|FG001|Overall Study|Protocol Violation|0
2058438|NCT00545051|3632542|FG000|Overall Study|Withdrawal by Subject|0
2058439|NCT00545051|3632543|FG001|Overall Study|Withdrawal by Subject|1
2058440|NCT00545051|3632542|FG000|Overall Study|Administrative reasons|0
2058441|NCT00545051|3632543|FG001|Overall Study|Administrative reasons|1
2058442|NCT00545064|3632549|FG000|Overall Study|Lost to Follow-up|3
2058443|NCT00545064|3632549|FG000|Overall Study|Withdrawal by Subject|2
2058444|NCT00545064|3632549|FG000|Overall Study|did not complete course of treatment|1
2058445|NCT00545064|3632549|FG000|Overall Study|cancel all appointments, no rebooking|1
2058446|NCT00545064|3632549|FG000|Overall Study|inclement weather|1
2058447|NCT00545077|3632557|FG000|Overall Study|Treatment not received|5
2058448|NCT00545077|3632558|FG001|Overall Study|Treatment not received|1
2058449|NCT00545077|3632557|FG000|Overall Study|Disease Progression|131
2058450|NCT00545077|3632558|FG001|Overall Study|Disease Progression|98
2058451|NCT00545077|3632557|FG000|Overall Study|Withdrawal by Subject|3
2058452|NCT00545077|3632558|FG001|Overall Study|Withdrawal by Subject|14
2058453|NCT00545077|3632557|FG000|Overall Study|Physician Decision|6
2058454|NCT00545077|3632558|FG001|Overall Study|Physician Decision|3
2058455|NCT00545077|3632557|FG000|Overall Study|Lost to Follow-up|2
2058456|NCT00545077|3632558|FG001|Overall Study|Lost to Follow-up|0
2058457|NCT00545077|3632557|FG000|Overall Study|Protocol Violation|1
2058458|NCT00545077|3632558|FG001|Overall Study|Protocol Violation|0
2058459|NCT00545077|3632557|FG000|Overall Study|Adverse Event|0
2058460|NCT00545077|3632558|FG001|Overall Study|Adverse Event|31
2058461|NCT00545077|3632557|FG000|Overall Study|Death|0
2058462|NCT00545077|3632558|FG001|Overall Study|Death|8
2058463|NCT00545103|3632568|FG000|Overall Study|Lack of Efficacy|48
2058464|NCT00545103|3632569|FG001|Overall Study|Lack of Efficacy|45
2058465|NCT00545103|3632570|FG002|Overall Study|Lack of Efficacy|31
2058466|NCT00545103|3632571|FG003|Overall Study|Lack of Efficacy|27
2058467|NCT00545103|3632568|FG000|Overall Study|Withdrawal by Subject|6
2058468|NCT00545103|3632569|FG001|Overall Study|Withdrawal by Subject|10
2058469|NCT00545103|3632570|FG002|Overall Study|Withdrawal by Subject|18
2058470|NCT00545103|3632571|FG003|Overall Study|Withdrawal by Subject|22
2058471|NCT00545103|3632568|FG000|Overall Study|Adverse Event|11
2058472|NCT00545103|3632569|FG001|Overall Study|Adverse Event|12
2058473|NCT00545103|3632570|FG002|Overall Study|Adverse Event|17
2058474|NCT00545103|3632571|FG003|Overall Study|Adverse Event|10
2058475|NCT00545103|3632568|FG000|Overall Study|Lost to Follow-up|4
2058476|NCT00545103|3632569|FG001|Overall Study|Lost to Follow-up|6
2058477|NCT00545103|3632570|FG002|Overall Study|Lost to Follow-up|3
2058478|NCT00545103|3632571|FG003|Overall Study|Lost to Follow-up|4
2058479|NCT00545103|3632568|FG000|Overall Study|Protocol Violation|1
2058480|NCT00545103|3632569|FG001|Overall Study|Protocol Violation|2
2058481|NCT00545103|3632570|FG002|Overall Study|Protocol Violation|3
2058482|NCT00545103|3632571|FG003|Overall Study|Protocol Violation|0
2058483|NCT00545103|3632568|FG000|Overall Study|Suspected recurrence of diverticulitis|1
2058484|NCT00545103|3632569|FG001|Overall Study|Suspected recurrence of diverticulitis|0
2058485|NCT00545103|3632570|FG002|Overall Study|Suspected recurrence of diverticulitis|0
2058486|NCT00545103|3632571|FG003|Overall Study|Suspected recurrence of diverticulitis|3
2058487|NCT00545103|3632568|FG000|Overall Study|Difficult to open package|0
2209808|NCT01646177|3849243|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
2209809|NCT01646177|3849244|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
2209810|NCT01646177|3849245|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1
2209811|NCT01646177|3849246|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
2209812|NCT01646177|3849247|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
2209813|NCT01646177|3849248|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3
2209814|NCT01646177|3849237|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
2209815|NCT01646177|3849238|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
2209816|NCT01646177|3849239|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
2209817|NCT01646177|3849240|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
2209818|NCT01646177|3849241|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
2058488|NCT00545103|3632569|FG001|Overall Study|Difficult to open package|0
2058489|NCT00545103|3632570|FG002|Overall Study|Difficult to open package|0
2058490|NCT00545103|3632571|FG003|Overall Study|Difficult to open package|1
2058491|NCT00545103|3632568|FG000|Overall Study|Investigational product not taken|1
2058492|NCT00545103|3632569|FG001|Overall Study|Investigational product not taken|0
2058493|NCT00545103|3632570|FG002|Overall Study|Investigational product not taken|0
2058494|NCT00545103|3632571|FG003|Overall Study|Investigational product not taken|1
2058495|NCT00545103|3632568|FG000|Overall Study|Wish to start a family|0
2058496|NCT00545103|3632569|FG001|Overall Study|Wish to start a family|0
2058497|NCT00545103|3632570|FG002|Overall Study|Wish to start a family|0
2058498|NCT00545103|3632571|FG003|Overall Study|Wish to start a family|1
2058499|NCT00545103|3632568|FG000|Overall Study|Diverticulitis crisis|0
2058500|NCT00545103|3632569|FG001|Overall Study|Diverticulitis crisis|0
2058501|NCT00545103|3632570|FG002|Overall Study|Diverticulitis crisis|0
2058502|NCT00545103|3632571|FG003|Overall Study|Diverticulitis crisis|1
2058503|NCT00545103|3632568|FG000|Overall Study|Personal reasons|1
2058504|NCT00545103|3632569|FG001|Overall Study|Personal reasons|0
2058505|NCT00545103|3632570|FG002|Overall Study|Personal reasons|0
2058506|NCT00545103|3632571|FG003|Overall Study|Personal reasons|0
2058507|NCT00545103|3632568|FG000|Overall Study|Subject's decision|1
2058508|NCT00545103|3632569|FG001|Overall Study|Subject's decision|0
2058509|NCT00545103|3632570|FG002|Overall Study|Subject's decision|0
2058510|NCT00545103|3632571|FG003|Overall Study|Subject's decision|0
2058511|NCT00545103|3632568|FG000|Overall Study|Noncompliance|0
2058512|NCT00545103|3632569|FG001|Overall Study|Noncompliance|1
2058513|NCT00545103|3632570|FG002|Overall Study|Noncompliance|0
2058514|NCT00545103|3632571|FG003|Overall Study|Noncompliance|0
2058515|NCT00545103|3632568|FG000|Overall Study|Investigator decision|0
2058516|NCT00545103|3632569|FG001|Overall Study|Investigator decision|0
2058517|NCT00545103|3632570|FG002|Overall Study|Investigator decision|1
2058518|NCT00545103|3632571|FG003|Overall Study|Investigator decision|0
2058519|NCT00545103|3632568|FG000|Overall Study|Subject moved|0
2058520|NCT00545103|3632569|FG001|Overall Study|Subject moved|1
2058521|NCT00545103|3632570|FG002|Overall Study|Subject moved|0
2058522|NCT00545103|3632571|FG003|Overall Study|Subject moved|0
2058523|NCT00545103|3632568|FG000|Overall Study|Use of prohibited medication|0
2058524|NCT00545103|3632569|FG001|Overall Study|Use of prohibited medication|0
2058525|NCT00545103|3632570|FG002|Overall Study|Use of prohibited medication|1
2058526|NCT00545103|3632571|FG003|Overall Study|Use of prohibited medication|0
2058527|NCT00545103|3632568|FG000|Overall Study|Does not want to take study drug anymore|1
2058528|NCT00545103|3632569|FG001|Overall Study|Does not want to take study drug anymore|0
2058529|NCT00545103|3632570|FG002|Overall Study|Does not want to take study drug anymore|1
2058530|NCT00545103|3632571|FG003|Overall Study|Does not want to take study drug anymore|0
2058531|NCT00545103|3632568|FG000|Overall Study|Subject met endpoint under protocol v. 1|0
2058532|NCT00545103|3632569|FG001|Overall Study|Subject met endpoint under protocol v. 1|0
2058533|NCT00545103|3632570|FG002|Overall Study|Subject met endpoint under protocol v. 1|1
2058534|NCT00545103|3632571|FG003|Overall Study|Subject met endpoint under protocol v. 1|0
2058535|NCT00545103|3632568|FG000|Overall Study|Death|0
2058536|NCT00545103|3632569|FG001|Overall Study|Death|1
2058537|NCT00545103|3632570|FG002|Overall Study|Death|0
2058538|NCT00545103|3632571|FG003|Overall Study|Death|0
2058539|NCT00545168|3632588|FG000|Overall Study|Lost to Follow-up|5
2058540|NCT00545168|3632589|FG001|Overall Study|Lost to Follow-up|5
2058541|NCT00545168|3632590|FG002|Overall Study|Lost to Follow-up|5
2058542|NCT00545168|3632588|FG000|Overall Study|Withdrawal by Subject|9
2058543|NCT00545168|3632589|FG001|Overall Study|Withdrawal by Subject|0
2058544|NCT00545168|3632590|FG002|Overall Study|Withdrawal by Subject|13
2058545|NCT00545168|3632588|FG000|Overall Study|Protocol Violation|1
2058546|NCT00545168|3632589|FG001|Overall Study|Protocol Violation|0
2058547|NCT00545168|3632590|FG002|Overall Study|Protocol Violation|1
2058548|NCT00545168|3632588|FG000|Overall Study|Visit for Day 21 was not done in error|1
2058549|NCT00545168|3632589|FG001|Overall Study|Visit for Day 21 was not done in error|0
2058550|NCT00545168|3632590|FG002|Overall Study|Visit for Day 21 was not done in error|2
2058551|NCT00545233|3632610|FG000|Overall Study|Adverse Event|10
2058552|NCT00545233|3632611|FG001|Overall Study|Adverse Event|5
2058553|NCT00545233|3632610|FG000|Overall Study|Violation of Selection Criteria at Entry|5
2058554|NCT00545233|3632611|FG001|Overall Study|Violation of Selection Criteria at Entry|1
2058555|NCT00545233|3632610|FG000|Overall Study|Protocol Violation|2
2058556|NCT00545233|3632611|FG001|Overall Study|Protocol Violation|0
2058557|NCT00545233|3632610|FG000|Overall Study|Refused Treatment|9
2058558|NCT00545233|3632611|FG001|Overall Study|Refused Treatment|7
2058559|NCT00545233|3632610|FG000|Overall Study|Failure to Return|4
2058560|NCT00545233|3632611|FG001|Overall Study|Failure to Return|6
2058561|NCT00545233|3632610|FG000|Overall Study|Insufficient response|14
2058562|NCT00545233|3632611|FG001|Overall Study|Insufficient response|15
2058563|NCT00545233|3632610|FG000|Overall Study|Physician Decision|2
2058564|NCT00545233|3632611|FG001|Overall Study|Physician Decision|1
2301199|NCT02609178|3999135|FG005|First Crown|Withdrawal by Subject|0
2301200|NCT02609399|3999157|FG000|Influenza Season 2015-2016|Lost to Follow-up|3
2301201|NCT02609399|3999158|FG001|Influenza Season 2015-2016|Lost to Follow-up|2
2301202|NCT02609399|3999157|FG000|Influenza Season 2016-2017|Lost to Follow-up|8
2301203|NCT02609399|3999158|FG001|Influenza Season 2016-2017|Lost to Follow-up|5
2301204|NCT02609399|3999157|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1
2301205|NCT02609399|3999158|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0
2301206|NCT02609607|3999168|FG000|Overall Study|Lost to Follow-up|0
2301207|NCT02609607|3999169|FG001|Overall Study|Lost to Follow-up|1
2301208|NCT02609633|3999177|FG000|Overall Study|Consent Withdrawn|0
2301209|NCT02609633|3999178|FG001|Overall Study|Consent Withdrawn|1
2301210|NCT02609633|3999177|FG000|Overall Study|Protocol Deviation|1
2301211|NCT02609633|3999178|FG001|Overall Study|Protocol Deviation|0
2301212|NCT02609633|3999177|FG000|Overall Study|Non-Compliant with Study Procedures|2
2301213|NCT02609633|3999178|FG001|Overall Study|Non-Compliant with Study Procedures|0
2301214|NCT02609633|3999177|FG000|Overall Study|Reason not Specified|2
2301215|NCT02609633|3999178|FG001|Overall Study|Reason not Specified|1
2301216|NCT02609659|3999185|FG000|Overall Study|Adverse Event|1
2301217|NCT02609659|3999185|FG000|Overall Study|Lost to Follow-up|6
2301218|NCT02609659|3999185|FG000|Overall Study|Other|1
2301219|NCT02609672|3999191|FG000|Overall Study|Lost to Follow-up|3
2301220|NCT02609672|3999192|FG001|Overall Study|Lost to Follow-up|1
2301221|NCT02609984|3999208|FG000|Overall Study|Death|29
2301222|NCT02609984|3999209|FG001|Overall Study|Death|26
2301223|NCT02609984|3999208|FG000|Overall Study|Participation Discontinued by Sponsor|12
2301224|NCT02609984|3999209|FG001|Overall Study|Participation Discontinued by Sponsor|10
2301225|NCT02609984|3999208|FG000|Overall Study|Lost to Follow-up|1
2301226|NCT02609984|3999209|FG001|Overall Study|Lost to Follow-up|2
2301227|NCT02609984|3999208|FG000|Overall Study|Withdrawal by Subject|0
2301228|NCT02609984|3999209|FG001|Overall Study|Withdrawal by Subject|1
2301229|NCT02609984|3999208|FG000|Overall Study|Disease Progression|2
2301230|NCT02609984|3999209|FG001|Overall Study|Disease Progression|0
2301231|NCT02610140|3999217|FG000|Randomization and Treatment Period|Radiological progression|23
2301232|NCT02610140|3999218|FG001|Randomization and Treatment Period|Radiological progression|15
2301233|NCT02610140|3999217|FG000|Randomization and Treatment Period|Progressive disease - radiological|54
2301234|NCT02610140|3999218|FG001|Randomization and Treatment Period|Progressive disease - radiological|23
2301235|NCT02610140|3999217|FG000|Randomization and Treatment Period|Protocol Violation|1
2301236|NCT02610140|3999218|FG001|Randomization and Treatment Period|Protocol Violation|0
2301237|NCT02610140|3999217|FG000|Randomization and Treatment Period|Physician Decision|0
2301238|NCT02610140|3999218|FG001|Randomization and Treatment Period|Physician Decision|1
2301239|NCT02610140|3999217|FG000|Randomization and Treatment Period|Lack of Efficacy|1
2058565|NCT00545272|3632624|FG000|Overall Study|Protocol deviation|0
2058566|NCT00545272|3632625|FG001|Overall Study|Protocol deviation|1
2058567|NCT00545272|3632626|FG002|Overall Study|Protocol deviation|0
2058568|NCT00545272|3632627|FG003|Overall Study|Protocol deviation|1
2058569|NCT00545272|3632628|FG004|Overall Study|Protocol deviation|0
2058570|NCT00545272|3632629|FG005|Overall Study|Protocol deviation|1
2058571|NCT00545272|3632624|FG000|Overall Study|Adverse Event|0
2058572|NCT00545272|3632625|FG001|Overall Study|Adverse Event|0
2058573|NCT00545272|3632626|FG002|Overall Study|Adverse Event|1
2301240|NCT02610140|3999218|FG001|Randomization and Treatment Period|Lack of Efficacy|0
2301241|NCT02610140|3999217|FG000|Randomization and Treatment Period|Death|7
2301242|NCT02610140|3999218|FG001|Randomization and Treatment Period|Death|1
2058574|NCT00545272|3632627|FG003|Overall Study|Adverse Event|0
2058575|NCT00545272|3632628|FG004|Overall Study|Adverse Event|0
2058576|NCT00545272|3632629|FG005|Overall Study|Adverse Event|1
2058577|NCT00545272|3632624|FG000|Overall Study|Abnormal laboratory value(s)|0
2058578|NCT00545272|3632625|FG001|Overall Study|Abnormal laboratory value(s)|0
2058579|NCT00545272|3632626|FG002|Overall Study|Abnormal laboratory value(s)|0
2058580|NCT00545272|3632627|FG003|Overall Study|Abnormal laboratory value(s)|0
2058581|NCT00545272|3632628|FG004|Overall Study|Abnormal laboratory value(s)|0
2058582|NCT00545272|3632629|FG005|Overall Study|Abnormal laboratory value(s)|1
2058583|NCT00545272|3632624|FG000|Overall Study|Abnormal test procedure result(s)|0
2058584|NCT00545272|3632625|FG001|Overall Study|Abnormal test procedure result(s)|0
2058585|NCT00545272|3632626|FG002|Overall Study|Abnormal test procedure result(s)|0
2058586|NCT00545272|3632627|FG003|Overall Study|Abnormal test procedure result(s)|0
2058587|NCT00545272|3632628|FG004|Overall Study|Abnormal test procedure result(s)|1
2058588|NCT00545272|3632629|FG005|Overall Study|Abnormal test procedure result(s)|0
2058589|NCT00545272|3632624|FG000|Overall Study|Lost to Follow-up|0
2058590|NCT00545272|3632625|FG001|Overall Study|Lost to Follow-up|0
2058591|NCT00545272|3632626|FG002|Overall Study|Lost to Follow-up|0
2058592|NCT00545272|3632627|FG003|Overall Study|Lost to Follow-up|0
2058593|NCT00545272|3632628|FG004|Overall Study|Lost to Follow-up|1
2058594|NCT00545272|3632629|FG005|Overall Study|Lost to Follow-up|0
2058595|NCT00545298|3632646|FG000|Overall Study|Issues with Standard of Care|2
2058596|NCT00545298|3632647|FG001|Overall Study|Issues with Standard of Care|0
2058597|NCT00545298|3632648|FG002|Overall Study|Issues with Standard of Care|1
2058598|NCT00545363|3632661|FG000|Overall Study|Adverse Event|6
2058599|NCT00545363|3632662|FG001|Overall Study|Adverse Event|7
2058600|NCT00545363|3632661|FG000|Overall Study|Withdrawal by Subject|6
2058601|NCT00545363|3632662|FG001|Overall Study|Withdrawal by Subject|5
2058602|NCT00545363|3632661|FG000|Overall Study|Non-compliance|3
2058603|NCT00545363|3632662|FG001|Overall Study|Non-compliance|1
2058604|NCT00545363|3632661|FG000|Overall Study|Did not meet entry criteria|1
2058605|NCT00545363|3632662|FG001|Overall Study|Did not meet entry criteria|1
2058606|NCT00545363|3632661|FG000|Overall Study|Lost to Follow-up|2
2058607|NCT00545363|3632662|FG001|Overall Study|Lost to Follow-up|0
2058608|NCT00545363|3632661|FG000|Overall Study|Other|1
2058609|NCT00545363|3632662|FG001|Overall Study|Other|1
2058610|NCT00545402|3632670|FG000|Overall Study|Discontinuation of treatment|17
2058611|NCT00545402|3632671|FG001|Overall Study|Discontinuation of treatment|9
2058612|NCT00545402|3632670|FG000|Overall Study|Use of unauthorized immunosuppressant|8
2058613|NCT00545402|3632671|FG001|Overall Study|Use of unauthorized immunosuppressant|7
2058614|NCT00545402|3632670|FG000|Overall Study|Death|5
2058615|NCT00545402|3632671|FG001|Overall Study|Death|7
2058616|NCT00545402|3632670|FG000|Overall Study|Graft loss|2
2058617|NCT00545402|3632671|FG001|Overall Study|Graft loss|4
2058618|NCT00545402|3632670|FG000|Overall Study|Withdrawal by Subject|0
2058619|NCT00545402|3632671|FG001|Overall Study|Withdrawal by Subject|1
2058620|NCT00545402|3632670|FG000|Overall Study|Protocol Violation|1
2058621|NCT00545402|3632671|FG001|Overall Study|Protocol Violation|0
2058622|NCT00545402|3632670|FG000|Overall Study|Reason not specified|1
2058623|NCT00545402|3632671|FG001|Overall Study|Reason not specified|1
2058624|NCT00545441|3632679|FG000|Overall Study|Fistula draining at 6 months|2
2058625|NCT00545441|3632680|FG001|Overall Study|Fistula draining at 6 months|4
2058626|NCT00545441|3632679|FG000|Overall Study|Lost to Follow-up|9
2058627|NCT00545441|3632680|FG001|Overall Study|Lost to Follow-up|5
2058628|NCT00545441|3632679|FG000|Overall Study|Technical failure|0
2058629|NCT00545441|3632680|FG001|Overall Study|Technical failure|1
2058630|NCT00545441|3632679|FG000|Overall Study|Withdrawal by Subject|1
2058631|NCT00545441|3632680|FG001|Overall Study|Withdrawal by Subject|1
2058632|NCT00545441|3632679|FG000|Overall Study|Persistence or recurrence of fistula|5
2058633|NCT00545441|3632680|FG001|Overall Study|Persistence or recurrence of fistula|2
2058634|NCT00545441|3632679|FG000|Overall Study|Patients were not treated|1
2058635|NCT00545441|3632680|FG001|Overall Study|Patients were not treated|3
2058636|NCT00545532|3632688|FG000|Overall Study|Withdrawal by Subject|1
2058637|NCT00545532|3632689|FG001|Overall Study|Withdrawal by Subject|3
2058638|NCT00545532|3632688|FG000|Overall Study|Lost to Follow-up|5
2058639|NCT00545532|3632689|FG001|Overall Study|Lost to Follow-up|6
2058640|NCT00545532|3632688|FG000|Overall Study|Death|0
2058641|NCT00545532|3632689|FG001|Overall Study|Death|1
2058642|NCT00545571|3632697|FG000|Overall Study|Administrative Reasons|1
2058643|NCT00545571|3632697|FG000|Overall Study|Adverse Event|2
2058644|NCT00545571|3632697|FG000|Overall Study|Death|5
2058645|NCT00545571|3632697|FG000|Overall Study|Lack of Efficacy|1
2058646|NCT00545571|3632697|FG000|Overall Study|Protocol Violation|2
2058647|NCT00545571|3632697|FG000|Overall Study|Refused Treatment|1
2058648|NCT00545571|3632697|FG000|Overall Study|Screen Failure|16
2058649|NCT00545571|3632697|FG000|Overall Study|Transfusion|12
2058650|NCT00545571|3632697|FG000|Overall Study|Early Termination of Study|24
2058651|NCT00545571|3632697|FG000|Overall Study|Kidney Transplantation|3
2058652|NCT00545584|3632704|FG000|Overall Study|Only one reason for discontinuation|62
2058653|NCT00545584|3632705|FG001|Overall Study|Only one reason for discontinuation|61
2058654|NCT00545584|3632706|FG002|Overall Study|Only one reason for discontinuation|48
2058655|NCT00545584|3632704|FG000|Overall Study|Two or more reasons for discontinuation|17
2058656|NCT00545584|3632705|FG001|Overall Study|Two or more reasons for discontinuation|19
2180065|NCT01397825|3805927|FG000|Overall Study|Symptomatic Deterioration|2
2301243|NCT02610140|3999217|FG000|Randomization and Treatment Period|Withdrawal by Subject|12
2301244|NCT02610140|3999218|FG001|Randomization and Treatment Period|Withdrawal by Subject|12
2058657|NCT00545584|3632706|FG002|Overall Study|Two or more reasons for discontinuation|8
2058658|NCT00545688|3632744|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1
2058659|NCT00545688|3632745|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2
2058660|NCT00545688|3632746|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1
2058661|NCT00545688|3632747|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1
2058662|NCT00545688|3632744|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1
2058663|NCT00545688|3632745|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1
2058664|NCT00545688|3632746|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4
2058665|NCT00545688|3632747|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1
2058666|NCT00545688|3632744|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
2058667|NCT00545688|3632745|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
2058668|NCT00545688|3632746|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
2058669|NCT00545688|3632747|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
2058670|NCT00545688|3632744|FG000|Neo-Adjuvant Treatment Period|Death|0
2058671|NCT00545688|3632745|FG001|Neo-Adjuvant Treatment Period|Death|1
2058672|NCT00545688|3632746|FG002|Neo-Adjuvant Treatment Period|Death|0
2058673|NCT00545688|3632747|FG003|Neo-Adjuvant Treatment Period|Death|0
2058674|NCT00545688|3632744|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0
2058675|NCT00545688|3632745|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1
2058676|NCT00545688|3632746|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7
2058677|NCT00545688|3632747|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2
2058678|NCT00545688|3632744|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1
2058679|NCT00545688|3632745|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0
2058680|NCT00545688|3632746|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0
2058681|NCT00545688|3632747|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0
2058682|NCT00545688|3632744|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0
2058683|NCT00545688|3632745|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0
2058684|NCT00545688|3632746|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2
2058685|NCT00545688|3632747|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2
2058686|NCT00545688|3632744|FG000|Adjuvant Treatment Period|Disease Progression|3
2058687|NCT00545688|3632745|FG001|Adjuvant Treatment Period|Disease Progression|3
2058688|NCT00545688|3632746|FG002|Adjuvant Treatment Period|Disease Progression|0
2058689|NCT00545688|3632747|FG003|Adjuvant Treatment Period|Disease Progression|7
2058690|NCT00545688|3632744|FG000|Adjuvant Treatment Period|Refused Treatment|1
2058691|NCT00545688|3632745|FG001|Adjuvant Treatment Period|Refused Treatment|1
2058692|NCT00545688|3632746|FG002|Adjuvant Treatment Period|Refused Treatment|1
2058693|NCT00545688|3632747|FG003|Adjuvant Treatment Period|Refused Treatment|5
2058694|NCT00545688|3632744|FG000|Adjuvant Treatment Period|Lost to Follow-up|1
2058695|NCT00545688|3632745|FG001|Adjuvant Treatment Period|Lost to Follow-up|0
2058696|NCT00545688|3632746|FG002|Adjuvant Treatment Period|Lost to Follow-up|1
2058697|NCT00545688|3632747|FG003|Adjuvant Treatment Period|Lost to Follow-up|0
2058698|NCT00545688|3632744|FG000|Adjuvant Treatment Period|Adverse Event|0
2058699|NCT00545688|3632745|FG001|Adjuvant Treatment Period|Adverse Event|3
2058700|NCT00545688|3632746|FG002|Adjuvant Treatment Period|Adverse Event|2
2058701|NCT00545688|3632747|FG003|Adjuvant Treatment Period|Adverse Event|2
2058702|NCT00545688|3632744|FG000|Adjuvant Treatment Period|Unknown Reason|0
2058703|NCT00545688|3632745|FG001|Adjuvant Treatment Period|Unknown Reason|1
2058704|NCT00545688|3632746|FG002|Adjuvant Treatment Period|Unknown Reason|0
2058705|NCT00545688|3632747|FG003|Adjuvant Treatment Period|Unknown Reason|0
2058706|NCT00545688|3632744|FG000|Follow-Up Period|Death|4
2058707|NCT00545688|3632745|FG001|Follow-Up Period|Death|2
2058708|NCT00545688|3632746|FG002|Follow-Up Period|Death|2
2058709|NCT00545688|3632747|FG003|Follow-Up Period|Death|6
2058710|NCT00545688|3632744|FG000|Follow-Up Period|Disease Progression|6
2058711|NCT00545688|3632745|FG001|Follow-Up Period|Disease Progression|5
2058712|NCT00545688|3632746|FG002|Follow-Up Period|Disease Progression|9
2058713|NCT00545688|3632747|FG003|Follow-Up Period|Disease Progression|9
2058714|NCT00545688|3632744|FG000|Follow-Up Period|Refused Treatment|6
2058715|NCT00545688|3632745|FG001|Follow-Up Period|Refused Treatment|2
2058716|NCT00545688|3632746|FG002|Follow-Up Period|Refused Treatment|0
2058717|NCT00545688|3632747|FG003|Follow-Up Period|Refused Treatment|2
2058718|NCT00545688|3632744|FG000|Follow-Up Period|Lost to Follow-up|3
2058719|NCT00545688|3632745|FG001|Follow-Up Period|Lost to Follow-up|3
2058720|NCT00545688|3632746|FG002|Follow-Up Period|Lost to Follow-up|3
2058721|NCT00545688|3632747|FG003|Follow-Up Period|Lost to Follow-up|1
2058722|NCT00545688|3632744|FG000|Follow-Up Period|Unspecified Reason|2
2058723|NCT00545688|3632745|FG001|Follow-Up Period|Unspecified Reason|5
2058724|NCT00545688|3632746|FG002|Follow-Up Period|Unspecified Reason|6
2058725|NCT00545688|3632747|FG003|Follow-Up Period|Unspecified Reason|8
2058726|NCT00545688|3632744|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0
2058727|NCT00545688|3632745|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2
2058728|NCT00545688|3632746|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0
2058729|NCT00545688|3632747|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1
2058730|NCT00545714|3632760|FG000|Induction Phase (6 Months)|Physician Decision|3
2058731|NCT00545714|3632760|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6
2058732|NCT00545714|3632760|FG000|Induction Phase (6 Months)|Disease Progression|1
2058733|NCT00545714|3632760|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2
2108159|NCT00878553|3702001|FG000|Sleep Study|car accident|1
2058734|NCT00545714|3632760|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
2058735|NCT00545714|3632760|FG000|Maintenance Phase (36 Months)|Disease Progression|9
2058736|NCT00545714|3632760|FG000|Maintenance Phase (36 Months)|Physician Decision|1
2058737|NCT00545714|3632760|FG000|Maintenance Phase (36 Months)|Protocol Violation|1
2058738|NCT00545714|3632760|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3
2058739|NCT00545714|3632760|FG000|Maintenance Phase (36 Months)|Death|2
2058740|NCT00545740|3632768|FG000|Overall Study|Lack of Efficacy|34
2058741|NCT00545740|3632769|FG001|Overall Study|Lack of Efficacy|35
2058742|NCT00545740|3632770|FG002|Overall Study|Lack of Efficacy|47
2058743|NCT00545740|3632771|FG003|Overall Study|Lack of Efficacy|36
2058744|NCT00545740|3632768|FG000|Overall Study|Withdrawal by Subject|17
2058745|NCT00545740|3632769|FG001|Overall Study|Withdrawal by Subject|15
2058746|NCT00545740|3632770|FG002|Overall Study|Withdrawal by Subject|16
2058747|NCT00545740|3632771|FG003|Overall Study|Withdrawal by Subject|18
2058748|NCT00545740|3632768|FG000|Overall Study|Adverse Event|10
2058749|NCT00545740|3632769|FG001|Overall Study|Adverse Event|18
2058750|NCT00545740|3632770|FG002|Overall Study|Adverse Event|19
2058751|NCT00545740|3632771|FG003|Overall Study|Adverse Event|9
2058752|NCT00545740|3632768|FG000|Overall Study|Lost to Follow-up|7
2058753|NCT00545740|3632769|FG001|Overall Study|Lost to Follow-up|5
2058754|NCT00545740|3632770|FG002|Overall Study|Lost to Follow-up|5
2058755|NCT00545740|3632771|FG003|Overall Study|Lost to Follow-up|6
2058756|NCT00545740|3632768|FG000|Overall Study|Protocol Violation|1
2058757|NCT00545740|3632769|FG001|Overall Study|Protocol Violation|3
2058758|NCT00545740|3632770|FG002|Overall Study|Protocol Violation|1
2058759|NCT00545740|3632771|FG003|Overall Study|Protocol Violation|0
2058760|NCT00545740|3632768|FG000|Overall Study|Non-compliance|0
2058761|NCT00545740|3632769|FG001|Overall Study|Non-compliance|2
2058762|NCT00545740|3632770|FG002|Overall Study|Non-compliance|1
2058763|NCT00545740|3632771|FG003|Overall Study|Non-compliance|0
2058764|NCT00545740|3632768|FG000|Overall Study|Moved|2
2058765|NCT00545740|3632769|FG001|Overall Study|Moved|0
2058766|NCT00545740|3632770|FG002|Overall Study|Moved|1
2058767|NCT00545740|3632771|FG003|Overall Study|Moved|0
2058768|NCT00545740|3632768|FG000|Overall Study|Diverticulitis attack|0
2058769|NCT00545740|3632769|FG001|Overall Study|Diverticulitis attack|0
2058770|NCT00545740|3632770|FG002|Overall Study|Diverticulitis attack|1
2058771|NCT00545740|3632771|FG003|Overall Study|Diverticulitis attack|1
2058772|NCT00545740|3632768|FG000|Overall Study|Suspected Diverticulitis Recurrence|1
2058773|NCT00545740|3632769|FG001|Overall Study|Suspected Diverticulitis Recurrence|1
2058774|NCT00545740|3632770|FG002|Overall Study|Suspected Diverticulitis Recurrence|1
2058775|NCT00545740|3632771|FG003|Overall Study|Suspected Diverticulitis Recurrence|1
2058776|NCT00545740|3632768|FG000|Overall Study|Site closure|1
2058777|NCT00545740|3632769|FG001|Overall Study|Site closure|0
2301245|NCT02610140|3999217|FG000|Randomization and Treatment Period|Adverse Event|44
2301246|NCT02610140|3999218|FG001|Randomization and Treatment Period|Adverse Event|13
2301247|NCT02610140|3999217|FG000|Randomization and Treatment Period|Progressive disease - clinical|12
2058778|NCT00545740|3632770|FG002|Overall Study|Site closure|0
2058779|NCT00545740|3632771|FG003|Overall Study|Site closure|0
2058780|NCT00545740|3632768|FG000|Overall Study|Missed visit|1
2058781|NCT00545740|3632769|FG001|Overall Study|Missed visit|0
2058782|NCT00545740|3632770|FG002|Overall Study|Missed visit|0
2058783|NCT00545740|3632771|FG003|Overall Study|Missed visit|0
2058784|NCT00545740|3632768|FG000|Overall Study|Physician Decision|0
2058785|NCT00545740|3632769|FG001|Overall Study|Physician Decision|0
2058786|NCT00545740|3632770|FG002|Overall Study|Physician Decision|3
2058787|NCT00545740|3632771|FG003|Overall Study|Physician Decision|0
2058788|NCT00545740|3632768|FG000|Overall Study|Accepted only monthly telephone calls|1
2058789|NCT00545740|3632769|FG001|Overall Study|Accepted only monthly telephone calls|0
2058790|NCT00545740|3632770|FG002|Overall Study|Accepted only monthly telephone calls|0
2058791|NCT00545740|3632771|FG003|Overall Study|Accepted only monthly telephone calls|0
2058792|NCT00545740|3632768|FG000|Overall Study|Sponsor decision|0
2058793|NCT00545740|3632769|FG001|Overall Study|Sponsor decision|1
2058794|NCT00545740|3632770|FG002|Overall Study|Sponsor decision|0
2058795|NCT00545740|3632771|FG003|Overall Study|Sponsor decision|0
2058796|NCT00545740|3632768|FG000|Overall Study|Lack of time|0
2058797|NCT00545740|3632769|FG001|Overall Study|Lack of time|1
2058798|NCT00545740|3632770|FG002|Overall Study|Lack of time|0
2058799|NCT00545740|3632771|FG003|Overall Study|Lack of time|0
2058800|NCT00545740|3632768|FG000|Overall Study|Non-adherence to visits|0
2058801|NCT00545740|3632769|FG001|Overall Study|Non-adherence to visits|1
2058802|NCT00545740|3632770|FG002|Overall Study|Non-adherence to visits|0
2058803|NCT00545740|3632771|FG003|Overall Study|Non-adherence to visits|0
2058804|NCT00545740|3632768|FG000|Overall Study|Patient difficulties|0
2058805|NCT00545740|3632769|FG001|Overall Study|Patient difficulties|1
2058806|NCT00545740|3632770|FG002|Overall Study|Patient difficulties|0
2058807|NCT00545740|3632771|FG003|Overall Study|Patient difficulties|0
2058808|NCT00545740|3632768|FG000|Overall Study|Husband against study|0
2058809|NCT00545740|3632769|FG001|Overall Study|Husband against study|0
2058810|NCT00545740|3632770|FG002|Overall Study|Husband against study|1
2058811|NCT00545740|3632771|FG003|Overall Study|Husband against study|0
2058812|NCT00545753|3632784|FG000|Overall Study|Withdrawal by Subject|0
2301248|NCT02610140|3999218|FG001|Randomization and Treatment Period|Progressive disease - clinical|5
2058813|NCT00545753|3632785|FG001|Overall Study|Withdrawal by Subject|1
2058814|NCT00545753|3632786|FG002|Overall Study|Withdrawal by Subject|10
2058815|NCT00545753|3632784|FG000|Overall Study|Lost to Follow-up|13
2058816|NCT00545753|3632785|FG001|Overall Study|Lost to Follow-up|3
2058817|NCT00545753|3632786|FG002|Overall Study|Lost to Follow-up|12
2058818|NCT00545753|3632784|FG000|Overall Study|Protocol Violation|3
2058819|NCT00545753|3632785|FG001|Overall Study|Protocol Violation|1
2058820|NCT00545753|3632786|FG002|Overall Study|Protocol Violation|4
2058821|NCT00545779|3632795|FG000|Overall Study|Violation of selection criteria at entry|8
2058822|NCT00545779|3632795|FG000|Overall Study|Other protocol violation|1
2058823|NCT00545779|3632795|FG000|Overall Study|Did not cooperate|7
2058824|NCT00545779|3632795|FG000|Overall Study|Withdrawal by Subject|20
2058825|NCT00545779|3632795|FG000|Overall Study|Adverse Event/intercurrent illness|5
2058826|NCT00545779|3632795|FG000|Overall Study|Failure to return|3
2058827|NCT00545792|3632799|FG000|Overall Study|Withdrawal by Subject|1
2058828|NCT00545818|3632805|FG000|Overall Study|Protocol Violation|1
2058829|NCT00545818|3632806|FG001|Overall Study|Protocol Violation|0
2058830|NCT00545818|3632805|FG000|Overall Study|Adverse Event|1
2058831|NCT00545818|3632806|FG001|Overall Study|Adverse Event|1
2058832|NCT00545818|3632805|FG000|Overall Study|Lost to Follow-up|1
2058833|NCT00545818|3632806|FG001|Overall Study|Lost to Follow-up|6
2058834|NCT00545948|3632815|FG000|Overall Study|Not Treated|1
2058835|NCT00545948|3632816|FG001|Overall Study|Not Treated|1
2058836|NCT00545948|3632817|FG002|Overall Study|Not Treated|7
2058837|NCT00546000|3632835|FG000|Overall Study|Adverse Event|1
2058838|NCT00546000|3632835|FG000|Overall Study|Lost to Follow-up|1
2058839|NCT00546000|3632835|FG000|Overall Study|Baseline HPA Axis Supression|2
2058840|NCT00546078|3632841|FG000|Overall Study|Lost to Follow-up|1
2058841|NCT00546078|3632842|FG001|Overall Study|Lost to Follow-up|3
2058842|NCT00546078|3632841|FG000|Overall Study|Withdrawal by Subject|2
2058843|NCT00546078|3632842|FG001|Overall Study|Withdrawal by Subject|3
2058844|NCT00546078|3632841|FG000|Overall Study|Other reason|1
2058845|NCT00546078|3632842|FG001|Overall Study|Other reason|1
2058846|NCT00546117|3632854|FG000|Overall Study|Withdrawal by Subject|3
2058847|NCT00546117|3632855|FG001|Overall Study|Withdrawal by Subject|0
2058848|NCT00546117|3632854|FG000|Overall Study|Inability to schedule follow-up visit|1
2058849|NCT00546117|3632855|FG001|Overall Study|Inability to schedule follow-up visit|0
2058850|NCT00546260|3632873|FG000|Overall Study|Drug not given pre diagnostic angiogr|8
2058851|NCT00546260|3632874|FG001|Overall Study|Drug not given pre diagnostic angiogr|2
2058852|NCT00546351|3632880|FG000|Overall Study|Adverse Event|76
2058853|NCT00546351|3632880|FG000|Overall Study|Lack of Efficacy|15
2058854|NCT00546351|3632880|FG000|Overall Study|Withdrawal by Subject|109
2058855|NCT00546351|3632880|FG000|Overall Study|Lost to Follow-up|9
2058856|NCT00546351|3632880|FG000|Overall Study|Protocol Deviation|1
2058857|NCT00546351|3632880|FG000|Overall Study|Unsatisfactory compliance|9
2058858|NCT00546351|3632880|FG000|Overall Study|Other reasons for premature termination|17
2058859|NCT00546364|3632887|FG000|Overall Study|Disease progression|5
2058860|NCT00546364|3632888|FG001|Overall Study|Disease progression|11
2058861|NCT00546364|3632889|FG002|Overall Study|Disease progression|8
2058862|NCT00546364|3632887|FG000|Overall Study|Completed and off treatment|1
2058863|NCT00546364|3632888|FG001|Overall Study|Completed and off treatment|0
2058864|NCT00546364|3632889|FG002|Overall Study|Completed and off treatment|2
2058865|NCT00546364|3632887|FG000|Overall Study|Administrative reason by sponsor|1
2058866|NCT00546364|3632888|FG001|Overall Study|Administrative reason by sponsor|0
2058867|NCT00546364|3632889|FG002|Overall Study|Administrative reason by sponsor|0
2058868|NCT00546364|3632887|FG000|Overall Study|Poor compliance/noncompliance|0
2058869|NCT00546364|3632888|FG001|Overall Study|Poor compliance/noncompliance|0
2058870|NCT00546364|3632889|FG002|Overall Study|Poor compliance/noncompliance|1
2058871|NCT00546364|3632887|FG000|Overall Study|No longer meets study criteria|1
2058872|NCT00546364|3632888|FG001|Overall Study|No longer meets study criteria|1
2058873|NCT00546364|3632889|FG002|Overall Study|No longer meets study criteria|0
2058874|NCT00546364|3632887|FG000|Overall Study|Withdrawal by Subject|5
2058875|NCT00546364|3632888|FG001|Overall Study|Withdrawal by Subject|6
2058876|NCT00546364|3632889|FG002|Overall Study|Withdrawal by Subject|3
2058877|NCT00546364|3632887|FG000|Overall Study|Prior taxotere|1
2058878|NCT00546364|3632888|FG001|Overall Study|Prior taxotere|0
2058879|NCT00546364|3632889|FG002|Overall Study|Prior taxotere|0
2058880|NCT00546364|3632887|FG000|Overall Study|Mixed response|1
2058881|NCT00546364|3632888|FG001|Overall Study|Mixed response|0
2058882|NCT00546364|3632889|FG002|Overall Study|Mixed response|0
2058883|NCT00546364|3632887|FG000|Overall Study|Palliative treatment|1
2058884|NCT00546364|3632888|FG001|Overall Study|Palliative treatment|0
2058885|NCT00546364|3632889|FG002|Overall Study|Palliative treatment|1
2058886|NCT00546364|3632887|FG000|Overall Study|Target lesions resected|1
2058887|NCT00546364|3632888|FG001|Overall Study|Target lesions resected|0
2058888|NCT00546364|3632889|FG002|Overall Study|Target lesions resected|0
2058889|NCT00546364|3632887|FG000|Overall Study|Physician Decision|0
2058890|NCT00546364|3632888|FG001|Overall Study|Physician Decision|0
2058891|NCT00546364|3632889|FG002|Overall Study|Physician Decision|1
2058892|NCT00546364|3632887|FG000|Overall Study|Sponsor decision|0
2058893|NCT00546364|3632888|FG001|Overall Study|Sponsor decision|0
2058894|NCT00546364|3632889|FG002|Overall Study|Sponsor decision|1
2058895|NCT00546377|3632897|FG000|Overall Study|Deemed ineligible|1
2058896|NCT00546377|3632897|FG000|Overall Study|Adverse Event|6
2058897|NCT00546481|3632917|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
2058898|NCT00546481|3632918|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
2058899|NCT00546481|3632919|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
2058900|NCT00546481|3632917|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
2058901|NCT00546481|3632918|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
2058902|NCT00546481|3632919|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
2058903|NCT00546481|3632917|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
2058904|NCT00546481|3632918|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
2058905|NCT00546481|3632919|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
2058906|NCT00546481|3632917|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
2058907|NCT00546481|3632918|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
2058908|NCT00546481|3632919|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
2058909|NCT00546481|3632917|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
2058910|NCT00546481|3632918|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
2058911|NCT00546481|3632919|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
2058912|NCT00546481|3632917|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
2058913|NCT00546481|3632918|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
2058914|NCT00546481|3632919|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
2058915|NCT00546481|3632917|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0
2058916|NCT00546481|3632918|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0
2058917|NCT00546481|3632919|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2
2058918|NCT00546481|3632917|FG000|Maintenance Phase (CERA)|Kidney transplantation|0
2058919|NCT00546481|3632918|FG001|Maintenance Phase (CERA)|Kidney transplantation|0
2058920|NCT00546481|3632919|FG002|Maintenance Phase (CERA)|Kidney transplantation|1
2058921|NCT00546481|3632917|FG000|Maintenance Phase (CERA)|Other Reason|0
2058922|NCT00546481|3632918|FG001|Maintenance Phase (CERA)|Other Reason|0
2058923|NCT00546481|3632919|FG002|Maintenance Phase (CERA)|Other Reason|1
2058924|NCT00546572|3632929|FG000|Vax 1 / Year 0|Randomized, not treated|1
2058925|NCT00546572|3632930|FG001|Vax 1 / Year 0|Randomized, not treated|1
2058926|NCT00546572|3632929|FG000|Vax 1 / Year 0|Withdrawal by Subject|3
2058927|NCT00546572|3632930|FG001|Vax 1 / Year 0|Withdrawal by Subject|2
2058928|NCT00546572|3632929|FG000|Vax 1 / Year 0|Protocol Violation|3
2058929|NCT00546572|3632930|FG001|Vax 1 / Year 0|Protocol Violation|4
2058930|NCT00546572|3632929|FG000|Vax 1 / Year 0|Death|2
2058931|NCT00546572|3632930|FG001|Vax 1 / Year 0|Death|2
2058932|NCT00546572|3632929|FG000|Vax 1 / Year 0|Adverse Event|0
2058933|NCT00546572|3632930|FG001|Vax 1 / Year 0|Adverse Event|1
2058934|NCT00546572|3632929|FG000|Vax 1 / Year 0|Lost to Follow-up|0
2058935|NCT00546572|3632930|FG001|Vax 1 / Year 0|Lost to Follow-up|1
2058936|NCT00546572|3632929|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
2058937|NCT00546572|3632930|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
2058938|NCT00546572|3632929|FG000|Vax 2 / Year 1|Other|1
2058939|NCT00546572|3632930|FG001|Vax 2 / Year 1|Other|1
2058940|NCT00546572|3632929|FG000|Vax 2 / Year 1|Adverse Event|1
2058941|NCT00546572|3632930|FG001|Vax 2 / Year 1|Adverse Event|0
2058942|NCT00546572|3632929|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
2058943|NCT00546572|3632930|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
2058944|NCT00546637|3632949|FG000|Overall Study|Adverse Event|46
2058945|NCT00546637|3632950|FG001|Overall Study|Adverse Event|20
2058946|NCT00546637|3632949|FG000|Overall Study|Lack of Efficacy|5
2058947|NCT00546637|3632950|FG001|Overall Study|Lack of Efficacy|5
2058948|NCT00546637|3632949|FG000|Overall Study|Lost to Follow-up|2
2058949|NCT00546637|3632950|FG001|Overall Study|Lost to Follow-up|2
2058950|NCT00546637|3632949|FG000|Overall Study|Other|10
2058951|NCT00546637|3632950|FG001|Overall Study|Other|12
2301249|NCT02610140|3999217|FG000|Randomization and Treatment Period|Ongoing but not completed|9
2301250|NCT02610140|3999218|FG001|Randomization and Treatment Period|Ongoing but not completed|2
2301251|NCT02610140|3999217|FG000|Randomization and Treatment Period|Not treated|3
2301252|NCT02610140|3999218|FG001|Randomization and Treatment Period|Not treated|10
2301253|NCT02610140|3999217|FG000|Safety Follow-up|Other|0
2058952|NCT00546637|3632949|FG000|Overall Study|Withdrawal by Subject|7
2058953|NCT00546637|3632950|FG001|Overall Study|Withdrawal by Subject|9
2058954|NCT00546637|3632949|FG000|Overall Study|Randomized, but not treated|3
2058955|NCT00546637|3632950|FG001|Overall Study|Randomized, but not treated|1
2058956|NCT00546715|3632960|FG000|Overall Study|Withdrawal by Subject|0
2058957|NCT00546715|3632961|FG001|Overall Study|Withdrawal by Subject|1
2058958|NCT00546715|3632962|FG002|Overall Study|Withdrawal by Subject|0
2058959|NCT00546715|3632963|FG003|Overall Study|Withdrawal by Subject|0
2058960|NCT00546819|3632984|FG000|Overall Study|Adverse Event|2
2058961|NCT00546819|3632985|FG001|Overall Study|Adverse Event|3
2058962|NCT00546819|3632984|FG000|Overall Study|Lost to Follow-up|2
2058963|NCT00546819|3632985|FG001|Overall Study|Lost to Follow-up|1
2058964|NCT00546819|3632984|FG000|Overall Study|Withdrawal by Subject|4
2058965|NCT00546819|3632985|FG001|Overall Study|Withdrawal by Subject|2
2058966|NCT00546871|3632991|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
2058967|NCT00546871|3632992|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
2301254|NCT02610140|3999218|FG001|Safety Follow-up|Other|2
2301255|NCT02610140|3999217|FG000|Safety Follow-up|Lost to Follow-up|1
2301256|NCT02610140|3999218|FG001|Safety Follow-up|Lost to Follow-up|0
2301257|NCT02610140|3999217|FG000|Safety Follow-up|No follow-up|5
2058968|NCT00546871|3632991|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
2058969|NCT00546871|3632992|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
2058970|NCT00546871|3632991|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
2058971|NCT00546871|3632992|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
2058972|NCT00546871|3632991|FG000|Study Extension Period|Protocol Violation|1
2058973|NCT00546871|3632992|FG001|Study Extension Period|Protocol Violation|0
2058974|NCT00546871|3632991|FG000|Study Extension Period|Withdrawal by Subject|0
2058975|NCT00546871|3632992|FG001|Study Extension Period|Withdrawal by Subject|1
2058976|NCT00546910|3633041|FG000|Overall Study|Adverse Event|2
2058977|NCT00546910|3633042|FG001|Overall Study|Adverse Event|3
2058978|NCT00546910|3633041|FG000|Overall Study|Lack of Efficacy|5
2058979|NCT00546910|3633042|FG001|Overall Study|Lack of Efficacy|7
2058980|NCT00546910|3633041|FG000|Overall Study|Physician Decision|0
2058981|NCT00546910|3633042|FG001|Overall Study|Physician Decision|1
2058982|NCT00546910|3633041|FG000|Overall Study|Withdrawal by Subject|2
2058983|NCT00546910|3633042|FG001|Overall Study|Withdrawal by Subject|0
2058984|NCT00547118|3633054|FG000|Overall Study|Did not qualify prior to starting drug|1
2058985|NCT00547118|3633055|FG001|Overall Study|Did not qualify prior to starting drug|1
2058986|NCT00547118|3633054|FG000|Overall Study|Study suspended|7
2058987|NCT00547118|3633055|FG001|Overall Study|Study suspended|8
2058988|NCT00547157|3633065|FG000|Overall Study|Other|1
2058989|NCT00547157|3633066|FG001|Overall Study|Other|0
2058990|NCT00547157|3633065|FG000|Overall Study|Death|38
2058991|NCT00547157|3633066|FG001|Overall Study|Death|18
2058992|NCT00547157|3633065|FG000|Overall Study|Withdrawal by Subject|3
2058993|NCT00547157|3633066|FG001|Overall Study|Withdrawal by Subject|1
2058994|NCT00547157|3633065|FG000|Overall Study|Administrative decision|3
2058995|NCT00547157|3633066|FG001|Overall Study|Administrative decision|2
2058996|NCT00547157|3633065|FG000|Overall Study|Lost to Follow-up|4
2058997|NCT00547157|3633066|FG001|Overall Study|Lost to Follow-up|2
2058998|NCT00547248|3633076|FG000|Overall Study|Protocol Violation|0
2058999|NCT00547248|3633077|FG001|Overall Study|Protocol Violation|0
2059000|NCT00547248|3633078|FG002|Overall Study|Protocol Violation|1
2059001|NCT00547248|3633079|FG003|Overall Study|Protocol Violation|1
2059002|NCT00547248|3633076|FG000|Overall Study|Migrated/moved from study area|0
2059003|NCT00547248|3633077|FG001|Overall Study|Migrated/moved from study area|0
2059004|NCT00547248|3633078|FG002|Overall Study|Migrated/moved from study area|2
2059005|NCT00547248|3633079|FG003|Overall Study|Migrated/moved from study area|0
2059006|NCT00547248|3633076|FG000|Overall Study|Withdrawal by Subject|0
2059007|NCT00547248|3633077|FG001|Overall Study|Withdrawal by Subject|0
2059008|NCT00547248|3633078|FG002|Overall Study|Withdrawal by Subject|7
2209819|NCT01646177|3849242|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
2209820|NCT01646177|3849243|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
2209821|NCT01646177|3849244|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
2209822|NCT01646177|3849245|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
2209823|NCT01646177|3849246|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
2209824|NCT01646177|3849247|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
2209825|NCT01646177|3849248|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3
2209826|NCT01646177|3849237|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
2209827|NCT01646177|3849238|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
2301258|NCT02610140|3999218|FG001|Safety Follow-up|No follow-up|3
2059009|NCT00547248|3633079|FG003|Overall Study|Withdrawal by Subject|1
2059010|NCT00547365|3633092|FG000|Overall Study|Physician Decision|1
2059011|NCT00547365|3633092|FG000|Overall Study|Lost to Follow-up|1
2059012|NCT00547365|3633092|FG000|Overall Study|Protocol Violation|2
2059013|NCT00547365|3633092|FG000|Overall Study|death (not related to study)|4
2059014|NCT00547378|3633100|FG000|Randomized Cohort|Withdrawal by Subject|7
2059015|NCT00547378|3633101|FG001|Randomized Cohort|Withdrawal by Subject|5
2059016|NCT00547378|3633102|FG002|Randomized Cohort|Withdrawal by Subject|0
2059017|NCT00547378|3633100|FG000|Randomized Cohort|Death|0
2059018|NCT00547378|3633101|FG001|Randomized Cohort|Death|1
2059019|NCT00547378|3633102|FG002|Randomized Cohort|Death|0
2059020|NCT00547378|3633100|FG000|Randomized Cohort|Lost to Follow-up|1
2059021|NCT00547378|3633101|FG001|Randomized Cohort|Lost to Follow-up|0
2059022|NCT00547378|3633102|FG002|Randomized Cohort|Lost to Follow-up|0
2059023|NCT00547378|3633100|FG000|Randomized Cohort|Adverse Event|1
2059024|NCT00547378|3633101|FG001|Randomized Cohort|Adverse Event|0
2059025|NCT00547378|3633102|FG002|Randomized Cohort|Adverse Event|0
2059026|NCT00547378|3633100|FG000|Randomized Cohort|Other reasons|2
2059027|NCT00547378|3633101|FG001|Randomized Cohort|Other reasons|0
2059028|NCT00547378|3633102|FG002|Randomized Cohort|Other reasons|0
2059029|NCT00547378|3633100|FG000|All Implanted Cohort|Withdrawal by Subject|5
2059030|NCT00547378|3633101|FG001|All Implanted Cohort|Withdrawal by Subject|4
2059031|NCT00547378|3633102|FG002|All Implanted Cohort|Withdrawal by Subject|27
2059032|NCT00547378|3633100|FG000|All Implanted Cohort|Adverse Event|4
2059033|NCT00547378|3633101|FG001|All Implanted Cohort|Adverse Event|10
2059034|NCT00547378|3633102|FG002|All Implanted Cohort|Adverse Event|17
2059035|NCT00547378|3633100|FG000|All Implanted Cohort|Lost to Follow-up|0
2059036|NCT00547378|3633101|FG001|All Implanted Cohort|Lost to Follow-up|1
2059037|NCT00547378|3633102|FG002|All Implanted Cohort|Lost to Follow-up|14
2059038|NCT00547378|3633100|FG000|All Implanted Cohort|Death|3
2059039|NCT00547378|3633101|FG001|All Implanted Cohort|Death|1
2059040|NCT00547378|3633102|FG002|All Implanted Cohort|Death|4
2059041|NCT00547378|3633100|FG000|All Implanted Cohort|Physician Decision|0
2059042|NCT00547378|3633101|FG001|All Implanted Cohort|Physician Decision|2
2059043|NCT00547378|3633102|FG002|All Implanted Cohort|Physician Decision|6
2059044|NCT00547378|3633100|FG000|All Implanted Cohort|Site closure|2
2059045|NCT00547378|3633101|FG001|All Implanted Cohort|Site closure|0
2059046|NCT00547378|3633102|FG002|All Implanted Cohort|Site closure|1
2059047|NCT00547378|3633100|FG000|All Implanted Cohort|Other reasons|1
2059048|NCT00547378|3633101|FG001|All Implanted Cohort|Other reasons|0
2059049|NCT00547378|3633102|FG002|All Implanted Cohort|Other reasons|1
2059050|NCT00547521|3633112|FG000|Short Term Study (4 Months)|Adverse Event|1
2059051|NCT00547521|3633113|FG001|Short Term Study (4 Months)|Adverse Event|0
2059052|NCT00547521|3633112|FG000|Short Term Study (4 Months)|Lack of Efficacy|0
2059053|NCT00547521|3633113|FG001|Short Term Study (4 Months)|Lack of Efficacy|2
2059054|NCT00547521|3633112|FG000|Short Term Study (4 Months)|Withdrawal of consent|0
2059055|NCT00547521|3633113|FG001|Short Term Study (4 Months)|Withdrawal of consent|1
2059056|NCT00547521|3633112|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
2059057|NCT00547521|3633113|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
2059058|NCT00547521|3633112|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0
2059059|NCT00547521|3633113|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14
2059060|NCT00547521|3633112|FG000|Long Term Extension (LTE) Study|Adverse Event|0
2059061|NCT00547521|3633113|FG001|Long Term Extension (LTE) Study|Adverse Event|9
2059062|NCT00547521|3633112|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0
2059063|NCT00547521|3633113|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3
2059064|NCT00547521|3633112|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0
2059065|NCT00547521|3633113|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2
2059066|NCT00547521|3633112|FG000|Long Term Extension (LTE) Study|Other|0
2059067|NCT00547521|3633113|FG001|Long Term Extension (LTE) Study|Other|2
2059068|NCT00547521|3633112|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
2059069|NCT00547521|3633113|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
2059070|NCT00547534|3633126|FG000|Overall Study|Adverse Event|7
2059071|NCT00547534|3633126|FG000|Overall Study|Disease Progression|4
2059072|NCT00547703|3633163|FG000|Overall Study|Lost to Follow-up|1
2059073|NCT00547703|3633164|FG001|Overall Study|Lost to Follow-up|0
2059074|NCT00547911|3633197|FG000|Overall Study|Adverse Event|0
2059075|NCT00547911|3633198|FG001|Overall Study|Adverse Event|0
2059076|NCT00547911|3633199|FG002|Overall Study|Adverse Event|0
2059077|NCT00547911|3633200|FG003|Overall Study|Adverse Event|1
2059078|NCT00547911|3633201|FG004|Overall Study|Adverse Event|0
2059079|NCT00547911|3633202|FG005|Overall Study|Adverse Event|0
2059080|NCT00548145|3633232|FG000|Overall Study|Death|0
2059081|NCT00548145|3633233|FG001|Overall Study|Death|1
2059082|NCT00548145|3633232|FG000|Overall Study|Withdrawal by Subject|0
2059083|NCT00548145|3633233|FG001|Overall Study|Withdrawal by Subject|2
2059084|NCT00548145|3633232|FG000|Overall Study|Physician Decision|1
2059085|NCT00548145|3633233|FG001|Overall Study|Physician Decision|1
2059086|NCT00548184|3633248|FG000|Overall Study|Adverse Event|3
2059087|NCT00548184|3633248|FG000|Overall Study|took other drug|1
2059088|NCT00548184|3633248|FG000|Overall Study|Found Her2 negative|1
2059089|NCT00548249|3633268|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
2059090|NCT00548249|3633269|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
2059091|NCT00548249|3633270|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
2059092|NCT00548249|3633271|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
2059093|NCT00548249|3633272|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
2059094|NCT00548249|3633268|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5
2059095|NCT00548249|3633269|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1
2059096|NCT00548249|3633270|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3
2059097|NCT00548249|3633271|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1
2059098|NCT00548249|3633272|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2
2059099|NCT00548249|3633268|FG000|Overall Study|Protocol Violation|1
2059100|NCT00548249|3633269|FG001|Overall Study|Protocol Violation|1
2059101|NCT00548249|3633270|FG002|Overall Study|Protocol Violation|4
2059102|NCT00548249|3633271|FG003|Overall Study|Protocol Violation|0
2059103|NCT00548249|3633272|FG004|Overall Study|Protocol Violation|3
2059104|NCT00548249|3633268|FG000|Overall Study|Miscellaneous|2
2059105|NCT00548249|3633269|FG001|Overall Study|Miscellaneous|3
2059106|NCT00548249|3633270|FG002|Overall Study|Miscellaneous|2
2059107|NCT00548249|3633271|FG003|Overall Study|Miscellaneous|0
2059108|NCT00548249|3633272|FG004|Overall Study|Miscellaneous|2
2059109|NCT00548249|3633268|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
2177092|NCT01371708|3801170|FG000|Overall Study|No longer willing to participate|7
2059110|NCT00548249|3633269|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
2059111|NCT00548249|3633270|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
2059112|NCT00548249|3633271|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
2059113|NCT00548249|3633272|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
2059114|NCT00548249|3633268|FG000|Overall Study|Adverse Event|2
2059115|NCT00548249|3633269|FG001|Overall Study|Adverse Event|2
2059116|NCT00548249|3633270|FG002|Overall Study|Adverse Event|0
2059117|NCT00548249|3633271|FG003|Overall Study|Adverse Event|1
2059118|NCT00548249|3633272|FG004|Overall Study|Adverse Event|1
2059119|NCT00548249|3633268|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0
2059120|NCT00548249|3633269|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0
2059121|NCT00548249|3633270|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1
2059122|NCT00548249|3633271|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3
2059123|NCT00548249|3633272|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2
2059124|NCT00548249|3633268|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0
2059125|NCT00548249|3633269|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0
2059126|NCT00548249|3633270|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1
2059127|NCT00548249|3633271|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2
2059128|NCT00548249|3633272|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2
2059129|NCT00548249|3633268|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
2059130|NCT00548249|3633269|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
2059131|NCT00548249|3633270|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
2059132|NCT00548249|3633271|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
2059133|NCT00548249|3633272|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
2059134|NCT00548249|3633268|FG000|Overall Study|Prolonged hospitalization|0
2059135|NCT00548249|3633269|FG001|Overall Study|Prolonged hospitalization|0
2059136|NCT00548249|3633270|FG002|Overall Study|Prolonged hospitalization|2
2059137|NCT00548249|3633271|FG003|Overall Study|Prolonged hospitalization|1
2059138|NCT00548249|3633272|FG004|Overall Study|Prolonged hospitalization|0
2059139|NCT00548249|3633268|FG000|Overall Study|Withdrawal by Subject|2
2059140|NCT00548249|3633269|FG001|Overall Study|Withdrawal by Subject|0
2059141|NCT00548249|3633270|FG002|Overall Study|Withdrawal by Subject|0
2059142|NCT00548249|3633271|FG003|Overall Study|Withdrawal by Subject|0
2059143|NCT00548249|3633272|FG004|Overall Study|Withdrawal by Subject|0
2059144|NCT00548249|3633268|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
2059145|NCT00548249|3633269|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
2059146|NCT00548249|3633270|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
2059147|NCT00548249|3633271|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
2059148|NCT00548249|3633272|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
2059149|NCT00548249|3633268|FG000|Overall Study|Sponsor's request|0
2059150|NCT00548249|3633269|FG001|Overall Study|Sponsor's request|0
2059151|NCT00548249|3633270|FG002|Overall Study|Sponsor's request|0
2059152|NCT00548249|3633271|FG003|Overall Study|Sponsor's request|1
2059153|NCT00548249|3633272|FG004|Overall Study|Sponsor's request|0
2059154|NCT00548262|3633284|FG000|Overall Study|Death|21
2059155|NCT00548262|3633284|FG000|Overall Study|Adverse Event|2
2059156|NCT00548262|3633284|FG000|Overall Study|Lack of Efficacy|4
2059157|NCT00548262|3633284|FG000|Overall Study|Lost to Follow-up|1
2059158|NCT00548262|3633284|FG000|Overall Study|Other|3
2059159|NCT00548262|3633284|FG000|Overall Study|Withdrawal by Subject|1
2059160|NCT00548340|3633291|FG000|Overall Study|Protocol Violation|2
2059161|NCT00548340|3633292|FG001|Overall Study|Protocol Violation|3
2059162|NCT00548340|3633293|FG002|Overall Study|Protocol Violation|3
2059163|NCT00548340|3633291|FG000|Overall Study|Adverse Event|2
2059164|NCT00548340|3633292|FG001|Overall Study|Adverse Event|2
2059165|NCT00548340|3633293|FG002|Overall Study|Adverse Event|2
2059166|NCT00548340|3633291|FG000|Overall Study|Lost to Follow-up|1
2059167|NCT00548340|3633292|FG001|Overall Study|Lost to Follow-up|1
2059168|NCT00548340|3633293|FG002|Overall Study|Lost to Follow-up|0
2059169|NCT00548340|3633291|FG000|Overall Study|Withdrawal by Subject|2
2059170|NCT00548340|3633292|FG001|Overall Study|Withdrawal by Subject|4
2059171|NCT00548340|3633293|FG002|Overall Study|Withdrawal by Subject|3
2059172|NCT00548340|3633291|FG000|Overall Study|Other|1
2059173|NCT00548340|3633292|FG001|Overall Study|Other|1
2059174|NCT00548340|3633293|FG002|Overall Study|Other|1
2059175|NCT00548405|3633304|FG000|Overall Study|Adverse Event|6
2059176|NCT00548405|3633305|FG001|Overall Study|Adverse Event|2
2059177|NCT00548405|3633306|FG002|Overall Study|Adverse Event|0
2059178|NCT00548405|3633304|FG000|Overall Study|Lack of Efficacy|6
2059179|NCT00548405|3633305|FG001|Overall Study|Lack of Efficacy|0
2059180|NCT00548405|3633306|FG002|Overall Study|Lack of Efficacy|0
2059181|NCT00548405|3633304|FG000|Overall Study|Physician Decision|3
2059182|NCT00548405|3633305|FG001|Overall Study|Physician Decision|4
2059183|NCT00548405|3633306|FG002|Overall Study|Physician Decision|1
2059184|NCT00548405|3633304|FG000|Overall Study|Pregnancy|1
2059185|NCT00548405|3633305|FG001|Overall Study|Pregnancy|0
2059186|NCT00548405|3633306|FG002|Overall Study|Pregnancy|0
2059187|NCT00548405|3633304|FG000|Overall Study|Protocol Violation|1
2059188|NCT00548405|3633305|FG001|Overall Study|Protocol Violation|0
2059189|NCT00548405|3633306|FG002|Overall Study|Protocol Violation|0
2059190|NCT00548405|3633304|FG000|Overall Study|Withdrawal by Subject|36
2059191|NCT00548405|3633305|FG001|Overall Study|Withdrawal by Subject|12
2059192|NCT00548405|3633306|FG002|Overall Study|Withdrawal by Subject|5
2059193|NCT00548405|3633304|FG000|Overall Study|Lost to Follow-up|1
2059194|NCT00548405|3633305|FG001|Overall Study|Lost to Follow-up|1
2059195|NCT00548405|3633306|FG002|Overall Study|Lost to Follow-up|2
2059196|NCT00548405|3633304|FG000|Overall Study|Death|0
2059197|NCT00548405|3633305|FG001|Overall Study|Death|1
2059198|NCT00548405|3633306|FG002|Overall Study|Death|1
2059199|NCT00548405|3633304|FG000|Overall Study|Sponsor decision|1
2059200|NCT00548405|3633305|FG001|Overall Study|Sponsor decision|0
2059201|NCT00548405|3633306|FG002|Overall Study|Sponsor decision|0
2059202|NCT00548405|3633304|FG000|Overall Study|Randomized but not treated|1
2059203|NCT00548405|3633305|FG001|Overall Study|Randomized but not treated|0
2059204|NCT00548405|3633306|FG002|Overall Study|Randomized but not treated|0
2105699|NCT00858780|3698376|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
2105700|NCT00858780|3698377|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
2105701|NCT00858780|3698378|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
2105702|NCT00858780|3698379|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
2105703|NCT00858780|3698380|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
2105704|NCT00858780|3698376|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
2105705|NCT00858780|3698377|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
2105706|NCT00858780|3698378|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
2105707|NCT00858780|3698379|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
2105708|NCT00858780|3698380|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
2105709|NCT00858780|3698376|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0
2105710|NCT00858780|3698377|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1
2105711|NCT00858780|3698378|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0
2105712|NCT00858780|3698379|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0
2105713|NCT00858780|3698380|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0
2105714|NCT00858780|3698376|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
2105715|NCT00858780|3698377|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
2105716|NCT00858780|3698378|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
2105717|NCT00858780|3698379|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
2105718|NCT00858780|3698380|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
2105719|NCT00858780|3698376|FG000|OL Re-Treatment (Failure to Week 48)|Other|0
2105720|NCT00858780|3698377|FG001|OL Re-Treatment (Failure to Week 48)|Other|0
2105721|NCT00858780|3698378|FG002|OL Re-Treatment (Failure to Week 48)|Other|0
2105722|NCT00858780|3698379|FG003|OL Re-Treatment (Failure to Week 48)|Other|0
2105723|NCT00858780|3698380|FG004|OL Re-Treatment (Failure to Week 48)|Other|1
2105724|NCT00858832|3698392|FG000|Overall Study|became ineligible: delivered vaginally|1
2105725|NCT00858832|3698393|FG001|Overall Study|became ineligible: delivered vaginally|0
2105726|NCT00858832|3698392|FG000|Overall Study|Adverse Event|0
2105727|NCT00858832|3698393|FG001|Overall Study|Adverse Event|1
2105728|NCT00858845|3698401|FG000|Overall Study|Patient underwent heart transplant.|0
2105729|NCT00858845|3698402|FG001|Overall Study|Patient underwent heart transplant.|1
2105730|NCT00858988|3698418|FG000|Analysis|Lactulose unable to be detected in urine|2
2105731|NCT00858988|3698419|FG001|Analysis|Lactulose unable to be detected in urine|1
2105732|NCT00859014|3698425|FG000|Overall Study|Death|4
2105733|NCT00859014|3698425|FG000|Overall Study|Lost to Follow-up|1
2105734|NCT00859222|3698476|FG000|Overall Study|Adverse Event|2
2105735|NCT00859222|3698477|FG001|Overall Study|Adverse Event|3
2105736|NCT00859222|3698478|FG002|Overall Study|Adverse Event|6
2105737|NCT00859222|3698479|FG003|Overall Study|Adverse Event|24
2105738|NCT00859222|3698480|FG004|Overall Study|Adverse Event|15
2105739|NCT00859222|3698476|FG000|Overall Study|DLT|1
2105740|NCT00859222|3698477|FG001|Overall Study|DLT|0
2105741|NCT00859222|3698478|FG002|Overall Study|DLT|0
2105742|NCT00859222|3698479|FG003|Overall Study|DLT|0
2105743|NCT00859222|3698480|FG004|Overall Study|DLT|0
2105744|NCT00859313|3698495|FG000|Overall Study|Lack of Efficacy|2
2105745|NCT00859313|3698495|FG000|Overall Study|Adverse Event|1
2105746|NCT00859313|3698495|FG000|Overall Study|staff error|1
2105747|NCT00859456|3698503|FG000|Overall Study|Adverse Event|3
2105748|NCT00859456|3698503|FG000|Overall Study|Progressive disease|2
2105749|NCT00859456|3698503|FG000|Overall Study|Non-compliance|3
2105750|NCT00859469|3698507|FG000|Overall Study|Adverse Event|2
2105751|NCT00859469|3698507|FG000|Overall Study|Lack of Efficacy|9
2105752|NCT00859469|3698507|FG000|Overall Study|Withdrawal by Subject|1
2105753|NCT00859469|3698507|FG000|Overall Study|Death|16
2105754|NCT00859547|3698524|FG000|Overall Study|Lost to Follow-up|1
2105755|NCT00859547|3698524|FG000|Overall Study|Parent withdrew consent|1
2105756|NCT00859573|3698530|FG000|Overall Study|Withdrawal by Subject|4
2105757|NCT00859573|3698531|FG001|Overall Study|Withdrawal by Subject|1
2105758|NCT00859573|3698530|FG000|Overall Study|Physician Decision|1
2105759|NCT00859573|3698531|FG001|Overall Study|Physician Decision|1
2105760|NCT00859586|3698537|FG000|Overall Study|Donors|4
2105761|NCT00859638|3698543|FG000|Overall Study|Lost to Follow-up|6
2105762|NCT00859638|3698544|FG001|Overall Study|Lost to Follow-up|1
2105763|NCT00859638|3698543|FG000|Overall Study|Withdrawal by Subject|3
2105764|NCT00859638|3698544|FG001|Overall Study|Withdrawal by Subject|2
2105765|NCT00859638|3698543|FG000|Overall Study|Ill health|1
2105766|NCT00859638|3698544|FG001|Overall Study|Ill health|1
2105767|NCT00859898|3698567|FG000|Overall Study|Lack of Efficacy|0
2105768|NCT00859898|3698568|FG001|Overall Study|Lack of Efficacy|1
2105769|NCT00859898|3698569|FG002|Overall Study|Lack of Efficacy|1
2105770|NCT00859898|3698567|FG000|Overall Study|Adverse Event|4
2105771|NCT00859898|3698568|FG001|Overall Study|Adverse Event|9
2105772|NCT00859898|3698569|FG002|Overall Study|Adverse Event|8
2059205|NCT00548548|3633329|FG000|Overall Study|Death|345
2059206|NCT00548548|3633330|FG001|Overall Study|Death|348
2059207|NCT00548548|3633329|FG000|Overall Study|Lost to Follow-up|17
2059208|NCT00548548|3633330|FG001|Overall Study|Lost to Follow-up|18
2059209|NCT00548717|3633360|FG000|Overall Study|Death|5
2059210|NCT00548717|3633361|FG001|Overall Study|Death|2
2059211|NCT00548717|3633360|FG000|Overall Study|Relapse|3
2059212|NCT00548717|3633361|FG001|Overall Study|Relapse|0
2059213|NCT00548717|3633360|FG000|Overall Study|Alternative treatment for GVHD|1
2059214|NCT00548717|3633361|FG001|Overall Study|Alternative treatment for GVHD|0
2059215|NCT00548808|3633372|FG000|Overall Study|Lost to Follow-up|9
2059216|NCT00548808|3633373|FG001|Overall Study|Lost to Follow-up|3
2059217|NCT00548808|3633372|FG000|Overall Study|Protocol Violation|8
2059218|NCT00548808|3633373|FG001|Overall Study|Protocol Violation|8
2059219|NCT00548808|3633372|FG000|Overall Study|Withdrawal by Subject|8
2059220|NCT00548808|3633373|FG001|Overall Study|Withdrawal by Subject|4
2059221|NCT00548808|3633372|FG000|Overall Study|Physician Decision|6
2059222|NCT00548808|3633373|FG001|Overall Study|Physician Decision|3
2059223|NCT00548808|3633372|FG000|Overall Study|Adverse Event|4
2059224|NCT00548808|3633373|FG001|Overall Study|Adverse Event|5
2059225|NCT00548808|3633372|FG000|Overall Study|Death|2
2059226|NCT00548808|3633373|FG001|Overall Study|Death|0
2059227|NCT00548808|3633372|FG000|Overall Study|Entry Criteria Not Met|2
2059228|NCT00548808|3633373|FG001|Overall Study|Entry Criteria Not Met|2
2059229|NCT00548808|3633372|FG000|Overall Study|Lack of Efficacy|2
2059230|NCT00548808|3633373|FG001|Overall Study|Lack of Efficacy|0
2059231|NCT00548808|3633372|FG000|Overall Study|Sponsor Decision|1
2059232|NCT00548808|3633373|FG001|Overall Study|Sponsor Decision|1
2059233|NCT00548847|3633379|FG000|Overall Study|Disease progression|7
2059234|NCT00549055|3633402|FG000|Overall Study|Adverse Event|4
2059235|NCT00549055|3633402|FG000|Overall Study|Lack of Efficacy|18
2059236|NCT00549055|3633402|FG000|Overall Study|Stabilization|5
2059237|NCT00549055|3633402|FG000|Overall Study|Progression to fibrosis|2
2059238|NCT00549055|3633402|FG000|Overall Study|Decrease of size|1
2059239|NCT00549055|3633402|FG000|Overall Study|Active choroidal neovascula increased|1
2059240|NCT00549055|3633402|FG000|Overall Study|Vitreous hemorrhage|1
2059241|NCT00549055|3633402|FG000|Overall Study|Growth choroidal neovascularisation|1
2059242|NCT00549055|3633402|FG000|Overall Study|Choroidal neovascularization|1
2059243|NCT00549055|3633402|FG000|Overall Study|Very low visual acuity (VA)|1
2059244|NCT00549198|3633417|FG000|Overall Study|Adverse Event|28
2059245|NCT00549198|3633418|FG001|Overall Study|Adverse Event|26
2059246|NCT00549198|3633417|FG000|Overall Study|Insufficient Viral Load Response|4
2059247|NCT00549198|3633418|FG001|Overall Study|Insufficient Viral Load Response|2
2059248|NCT00549198|3633417|FG000|Overall Study|Protocol-defined Virological Failure|7
2059249|NCT00549198|3633418|FG001|Overall Study|Protocol-defined Virological Failure|0
2059250|NCT00549198|3633417|FG000|Overall Study|Non-compliance|2
2059251|NCT00549198|3633418|FG001|Overall Study|Non-compliance|4
2059252|NCT00549198|3633417|FG000|Overall Study|Lost to Follow-up|7
2059253|NCT00549198|3633418|FG001|Overall Study|Lost to Follow-up|8
2059254|NCT00549198|3633417|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3
2059255|NCT00549198|3633418|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0
2059256|NCT00549198|3633417|FG000|Overall Study|Protocol Violation|7
2059257|NCT00549198|3633418|FG001|Overall Study|Protocol Violation|2
2059258|NCT00549198|3633417|FG000|Overall Study|Investigator Decision|4
2059259|NCT00549198|3633418|FG001|Overall Study|Investigator Decision|3
2059260|NCT00549198|3633417|FG000|Overall Study|Withdrawal by Subject|7
2059261|NCT00549198|3633418|FG001|Overall Study|Withdrawal by Subject|7
2059262|NCT00549198|3633417|FG000|Overall Study|Disease Progression|1
2059263|NCT00549198|3633418|FG001|Overall Study|Disease Progression|0
2059264|NCT00549198|3633417|FG000|Overall Study|Participant Moved|2
2059265|NCT00549198|3633418|FG001|Overall Study|Participant Moved|0
2059266|NCT00549198|3633417|FG000|Overall Study|Participant not able to perform Week 96|1
2059267|NCT00549198|3633418|FG001|Overall Study|Participant not able to perform Week 96|0
2059268|NCT00549198|3633417|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1
2059269|NCT00549198|3633418|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0
2059270|NCT00549198|3633417|FG000|Overall Study|Prohibited Medication|1
2059271|NCT00549198|3633418|FG001|Overall Study|Prohibited Medication|2
2059272|NCT00549198|3633417|FG000|Overall Study|Participant planning pregnancy|1
2059273|NCT00549198|3633418|FG001|Overall Study|Participant planning pregnancy|0
2059274|NCT00549198|3633417|FG000|Overall Study|Participant overweight, no scan possible|1
2059275|NCT00549198|3633418|FG001|Overall Study|Participant overweight, no scan possible|0
2059276|NCT00549198|3633417|FG000|Overall Study|No scan facilities|0
2059277|NCT00549198|3633418|FG001|Overall Study|No scan facilities|2
2059278|NCT00549198|3633417|FG000|Overall Study|Pregnancy|0
2059279|NCT00549198|3633418|FG001|Overall Study|Pregnancy|3
2059280|NCT00549198|3633417|FG000|Overall Study|Not Exposed to Study Drug|3
2059281|NCT00549198|3633418|FG001|Overall Study|Not Exposed to Study Drug|4
2059282|NCT00549302|3633426|FG000|Double-Blind|Death|2
2059283|NCT00549302|3633427|FG001|Double-Blind|Death|9
2059284|NCT00549302|3633428|FG002|Double-Blind|Death|0
2059285|NCT00549302|3633426|FG000|Double-Blind|Adverse Event|3
2059286|NCT00549302|3633427|FG001|Double-Blind|Adverse Event|16
2059287|NCT00549302|3633428|FG002|Double-Blind|Adverse Event|0
2059288|NCT00549302|3633426|FG000|Double-Blind|Withdrawal by Subject|3
2059289|NCT00549302|3633427|FG001|Double-Blind|Withdrawal by Subject|8
2059290|NCT00549302|3633428|FG002|Double-Blind|Withdrawal by Subject|0
2059291|NCT00549302|3633426|FG000|Double-Blind|Investigator Decision|1
2059292|NCT00549302|3633427|FG001|Double-Blind|Investigator Decision|5
2059293|NCT00549302|3633428|FG002|Double-Blind|Investigator Decision|0
2059294|NCT00549302|3633426|FG000|Double-Blind|Sponsor Decision|0
2059295|NCT00549302|3633427|FG001|Double-Blind|Sponsor Decision|1
2059296|NCT00549302|3633428|FG002|Double-Blind|Sponsor Decision|0
2059297|NCT00549302|3633426|FG000|Double-Blind|Lost to Follow-up|1
2059298|NCT00549302|3633427|FG001|Double-Blind|Lost to Follow-up|2
2059299|NCT00549302|3633428|FG002|Double-Blind|Lost to Follow-up|0
2059300|NCT00549302|3633426|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
2059301|NCT00549302|3633427|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
2059302|NCT00549302|3633428|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
2059303|NCT00549302|3633426|FG000|Double-Blind|New condition or starts new therapy|0
2059304|NCT00549302|3633427|FG001|Double-Blind|New condition or starts new therapy|2
2059305|NCT00549302|3633428|FG002|Double-Blind|New condition or starts new therapy|0
2059306|NCT00549302|3633426|FG000|Open-Label|Adverse Event|0
2059307|NCT00549302|3633427|FG001|Open-Label|Adverse Event|0
2059308|NCT00549302|3633428|FG002|Open-Label|Adverse Event|11
2059309|NCT00549302|3633426|FG000|Open-Label|Death|0
2059310|NCT00549302|3633427|FG001|Open-Label|Death|0
2059311|NCT00549302|3633428|FG002|Open-Label|Death|40
2059312|NCT00549302|3633426|FG000|Open-Label|Investigator Decision|0
2059313|NCT00549302|3633427|FG001|Open-Label|Investigator Decision|0
2059314|NCT00549302|3633428|FG002|Open-Label|Investigator Decision|5
2059315|NCT00549302|3633426|FG000|Open-Label|Lost to Follow-up|0
2059316|NCT00549302|3633427|FG001|Open-Label|Lost to Follow-up|0
2059317|NCT00549302|3633428|FG002|Open-Label|Lost to Follow-up|2
2059318|NCT00549302|3633426|FG000|Open-Label|Other|0
2059319|NCT00549302|3633427|FG001|Open-Label|Other|0
2059320|NCT00549302|3633428|FG002|Open-Label|Other|3
2059321|NCT00549302|3633426|FG000|Open-Label|New drug pulmonary atrial hypertension|0
2059322|NCT00549302|3633427|FG001|Open-Label|New drug pulmonary atrial hypertension|0
2059323|NCT00549302|3633428|FG002|Open-Label|New drug pulmonary atrial hypertension|2
2059324|NCT00549302|3633426|FG000|Open-Label|Withdrawal by Subject|0
2059325|NCT00549302|3633427|FG001|Open-Label|Withdrawal by Subject|0
2059326|NCT00549302|3633428|FG002|Open-Label|Withdrawal by Subject|6
2059327|NCT00549445|3633449|FG000|Overall Study|Sputum & Blood Samples Not Available|15
2059328|NCT00549445|3633450|FG001|Overall Study|Sputum & Blood Samples Not Available|17
2059329|NCT00549549|3633460|FG000|Overall Study|Adverse Event|5
2059330|NCT00549549|3633461|FG001|Overall Study|Adverse Event|3
2059331|NCT00549549|3633462|FG002|Overall Study|Adverse Event|1
2059332|NCT00549549|3633463|FG003|Overall Study|Adverse Event|9
2059333|NCT00549549|3633460|FG000|Overall Study|Lack of Efficacy|9
2059334|NCT00549549|3633461|FG001|Overall Study|Lack of Efficacy|6
2059335|NCT00549549|3633462|FG002|Overall Study|Lack of Efficacy|4
2059336|NCT00549549|3633463|FG003|Overall Study|Lack of Efficacy|2
2059337|NCT00549549|3633460|FG000|Overall Study|Lost to Follow-up|1
2059338|NCT00549549|3633461|FG001|Overall Study|Lost to Follow-up|0
2059339|NCT00549549|3633462|FG002|Overall Study|Lost to Follow-up|1
2059340|NCT00549549|3633463|FG003|Overall Study|Lost to Follow-up|2
2059341|NCT00549549|3633460|FG000|Overall Study|Withdrawal by Subject|0
2059342|NCT00549549|3633461|FG001|Overall Study|Withdrawal by Subject|4
2059343|NCT00549549|3633462|FG002|Overall Study|Withdrawal by Subject|1
2059344|NCT00549549|3633463|FG003|Overall Study|Withdrawal by Subject|0
2059345|NCT00549549|3633460|FG000|Overall Study|Other|9
2059346|NCT00549549|3633461|FG001|Overall Study|Other|9
2059347|NCT00549549|3633462|FG002|Overall Study|Other|9
2059348|NCT00549549|3633463|FG003|Overall Study|Other|11
2059349|NCT00549549|3633460|FG000|Overall Study|Randomized but not treated|0
2059350|NCT00549549|3633461|FG001|Overall Study|Randomized but not treated|0
2059351|NCT00549549|3633462|FG002|Overall Study|Randomized but not treated|1
2059352|NCT00549549|3633463|FG003|Overall Study|Randomized but not treated|1
2059353|NCT00549562|3633473|FG000|Overall Study|Adverse Event|1
2059354|NCT00549562|3633473|FG000|Overall Study|Lack of Efficacy|1
2059355|NCT00549601|3633480|FG000|Randomized|Protocol Violation|0
2059356|NCT00549601|3633481|FG001|Randomized|Protocol Violation|0
2059357|NCT00549601|3633482|FG002|Randomized|Protocol Violation|1
2059358|NCT00549601|3633480|FG000|Randomized|Withdrawal by Subject|0
2059359|NCT00549601|3633481|FG001|Randomized|Withdrawal by Subject|1
2059360|NCT00549601|3633482|FG002|Randomized|Withdrawal by Subject|1
2059361|NCT00549601|3633480|FG000|Received Study Drug|Adverse Event|2
2059362|NCT00549601|3633481|FG001|Received Study Drug|Adverse Event|5
2059363|NCT00549601|3633482|FG002|Received Study Drug|Adverse Event|1
2059364|NCT00549601|3633480|FG000|Received Study Drug|Death|0
2059365|NCT00549601|3633481|FG001|Received Study Drug|Death|1
2059366|NCT00549601|3633482|FG002|Received Study Drug|Death|0
2059367|NCT00549601|3633480|FG000|Received Study Drug|Lost to Follow-up|0
2059368|NCT00549601|3633481|FG001|Received Study Drug|Lost to Follow-up|1
2059369|NCT00549601|3633482|FG002|Received Study Drug|Lost to Follow-up|1
2059370|NCT00549601|3633480|FG000|Received Study Drug|Protocol Violation|3
2059371|NCT00549601|3633481|FG001|Received Study Drug|Protocol Violation|4
2059372|NCT00549601|3633482|FG002|Received Study Drug|Protocol Violation|1
2059373|NCT00549601|3633480|FG000|Received Study Drug|Withdrawal by Subject|2
2059374|NCT00549601|3633481|FG001|Received Study Drug|Withdrawal by Subject|0
2059375|NCT00549601|3633482|FG002|Received Study Drug|Withdrawal by Subject|1
2059376|NCT00549640|3633494|FG000|Overall Study|Withdrawal by Subject|6
2059377|NCT00549640|3633495|FG001|Overall Study|Withdrawal by Subject|12
2059378|NCT00549640|3633494|FG000|Overall Study|Adverse Event|5
2059379|NCT00549640|3633495|FG001|Overall Study|Adverse Event|0
2059380|NCT00549640|3633494|FG000|Overall Study|Lost to Follow-up|7
2059381|NCT00549640|3633495|FG001|Overall Study|Lost to Follow-up|4
2059382|NCT00549718|3633505|FG000|Overall Study|Insufficient clinical response|20
2059383|NCT00549718|3633506|FG001|Overall Study|Insufficient clinical response|7
2059384|NCT00549718|3633507|FG002|Overall Study|Insufficient clinical response|18
2059385|NCT00549718|3633508|FG003|Overall Study|Insufficient clinical response|32
2059386|NCT00549718|3633505|FG000|Overall Study|Adverse Event|6
2059387|NCT00549718|3633506|FG001|Overall Study|Adverse Event|8
2059388|NCT00549718|3633507|FG002|Overall Study|Adverse Event|7
2059389|NCT00549718|3633508|FG003|Overall Study|Adverse Event|3
2059390|NCT00549718|3633505|FG000|Overall Study|Lost to Follow-up|4
2059391|NCT00549718|3633506|FG001|Overall Study|Lost to Follow-up|2
2059392|NCT00549718|3633507|FG002|Overall Study|Lost to Follow-up|0
2059393|NCT00549718|3633508|FG003|Overall Study|Lost to Follow-up|6
2059394|NCT00549718|3633505|FG000|Overall Study|Withdrawal by Subject|9
2059395|NCT00549718|3633506|FG001|Overall Study|Withdrawal by Subject|18
2059396|NCT00549718|3633507|FG002|Overall Study|Withdrawal by Subject|12
2059397|NCT00549718|3633508|FG003|Overall Study|Withdrawal by Subject|13
2059398|NCT00549718|3633505|FG000|Overall Study|Administrative|2
2059399|NCT00549718|3633506|FG001|Overall Study|Administrative|2
2059400|NCT00549718|3633507|FG002|Overall Study|Administrative|2
2059401|NCT00549718|3633508|FG003|Overall Study|Administrative|1
2059402|NCT00549757|3633520|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590
2059403|NCT00549757|3633521|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462
2059404|NCT00549757|3633520|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
2059405|NCT00549757|3633521|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
2059406|NCT00549757|3633520|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
2059407|NCT00549757|3633521|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
2059408|NCT00549757|3633520|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
2059409|NCT00549757|3633521|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
2059410|NCT00549757|3633520|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
2059411|NCT00549757|3633521|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
2059412|NCT00549757|3633520|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
2059413|NCT00549757|3633521|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
2059414|NCT00549757|3633520|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
2059415|NCT00549757|3633521|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
2059416|NCT00549757|3633520|FG000|Active Treatment Phase: Max. 50 Months|Death|188
2059417|NCT00549757|3633521|FG001|Active Treatment Phase: Max. 50 Months|Death|200
2059418|NCT00549757|3633520|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353
2059419|NCT00549757|3633521|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380
2059420|NCT00549757|3633520|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
2059421|NCT00549757|3633521|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
2059422|NCT00549757|3633520|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8
2059423|NCT00549757|3633521|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9
2059424|NCT00549757|3633520|FG000|Extension Period (in Average 9 Months)|Death|143
2059425|NCT00549757|3633521|FG001|Extension Period (in Average 9 Months)|Death|136
2059426|NCT00549757|3633520|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52
2059427|NCT00549757|3633521|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47
2059428|NCT00549757|3633520|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
2059429|NCT00549757|3633521|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
2059430|NCT00549757|3633520|FG000|Extension Period (in Average 9 Months)|Patient's request|421
2059431|NCT00549757|3633521|FG001|Extension Period (in Average 9 Months)|Patient's request|436
2059432|NCT00549770|3633541|FG000|Overall Study|Protocol deviation|1
2059433|NCT00549770|3633542|FG001|Overall Study|Protocol deviation|1
2059434|NCT00549770|3633543|FG002|Overall Study|Protocol deviation|1
2059435|NCT00549770|3633544|FG003|Overall Study|Protocol deviation|2
2059436|NCT00549770|3633545|FG004|Overall Study|Protocol deviation|2
2059437|NCT00549770|3633546|FG005|Overall Study|Protocol deviation|2
2059438|NCT00549770|3633547|FG006|Overall Study|Protocol deviation|1
2059439|NCT00549770|3633548|FG007|Overall Study|Protocol deviation|2
2059440|NCT00549770|3633541|FG000|Overall Study|Administrative problems|0
2059441|NCT00549770|3633542|FG001|Overall Study|Administrative problems|1
2059442|NCT00549770|3633543|FG002|Overall Study|Administrative problems|0
2059443|NCT00549770|3633544|FG003|Overall Study|Administrative problems|0
2059444|NCT00549770|3633545|FG004|Overall Study|Administrative problems|0
2059445|NCT00549770|3633546|FG005|Overall Study|Administrative problems|0
2059446|NCT00549770|3633547|FG006|Overall Study|Administrative problems|0
2059447|NCT00549770|3633548|FG007|Overall Study|Administrative problems|1
2059448|NCT00549770|3633541|FG000|Overall Study|Lost to Follow-up|0
2059449|NCT00549770|3633542|FG001|Overall Study|Lost to Follow-up|0
2059450|NCT00549770|3633543|FG002|Overall Study|Lost to Follow-up|2
2059451|NCT00549770|3633544|FG003|Overall Study|Lost to Follow-up|2
2301259|NCT02610140|3999217|FG000|Safety Follow-up|Death|12
2301260|NCT02610140|3999218|FG001|Safety Follow-up|Death|2
2301261|NCT02610140|3999217|FG000|Safety Follow-up|Deterioration of general conditions|15
2301262|NCT02610140|3999218|FG001|Safety Follow-up|Deterioration of general conditions|5
2301263|NCT02610140|3999217|FG000|Safety Follow-up|Withdrawal by Subject|12
2301264|NCT02610140|3999218|FG001|Safety Follow-up|Withdrawal by Subject|12
2301265|NCT02610140|3999217|FG000|Active Follow-up|Progressive disease - radiological|30
2301266|NCT02610140|3999218|FG001|Active Follow-up|Progressive disease - radiological|22
2301267|NCT02610140|3999217|FG000|Active Follow-up|Death|8
2301268|NCT02610140|3999218|FG001|Active Follow-up|Death|1
2301269|NCT02610140|3999217|FG000|Active Follow-up|Withdrawal by Subject|4
2301270|NCT02610140|3999218|FG001|Active Follow-up|Withdrawal by Subject|0
2301271|NCT02610140|3999217|FG000|Active Follow-up|Progressive disease - clinical|1
2301272|NCT02610140|3999218|FG001|Active Follow-up|Progressive disease - clinical|2
2059452|NCT00549770|3633545|FG004|Overall Study|Lost to Follow-up|3
2059453|NCT00549770|3633546|FG005|Overall Study|Lost to Follow-up|2
2301273|NCT02610140|3999217|FG000|Active Follow-up|Deterioration of general conditions|1
2301274|NCT02610140|3999218|FG001|Active Follow-up|Deterioration of general conditions|0
2301275|NCT02610140|3999217|FG000|Active Follow-up|Ongoing but not completed|4
2301276|NCT02610140|3999218|FG001|Active Follow-up|Ongoing but not completed|1
2059454|NCT00549770|3633547|FG006|Overall Study|Lost to Follow-up|0
2059455|NCT00549770|3633548|FG007|Overall Study|Lost to Follow-up|0
2059456|NCT00549770|3633541|FG000|Overall Study|Withdrawal by Subject|4
2059457|NCT00549770|3633542|FG001|Overall Study|Withdrawal by Subject|6
2059458|NCT00549770|3633543|FG002|Overall Study|Withdrawal by Subject|4
2059459|NCT00549770|3633544|FG003|Overall Study|Withdrawal by Subject|5
2059460|NCT00549770|3633545|FG004|Overall Study|Withdrawal by Subject|6
2059461|NCT00549770|3633546|FG005|Overall Study|Withdrawal by Subject|6
2059462|NCT00549770|3633547|FG006|Overall Study|Withdrawal by Subject|4
2059463|NCT00549770|3633548|FG007|Overall Study|Withdrawal by Subject|9
2059464|NCT00549770|3633541|FG000|Overall Study|Lack of Efficacy|1
2059465|NCT00549770|3633542|FG001|Overall Study|Lack of Efficacy|0
2059466|NCT00549770|3633543|FG002|Overall Study|Lack of Efficacy|2
2059467|NCT00549770|3633544|FG003|Overall Study|Lack of Efficacy|3
2059468|NCT00549770|3633545|FG004|Overall Study|Lack of Efficacy|5
2059469|NCT00549770|3633546|FG005|Overall Study|Lack of Efficacy|1
2059470|NCT00549770|3633547|FG006|Overall Study|Lack of Efficacy|3
2059471|NCT00549770|3633548|FG007|Overall Study|Lack of Efficacy|8
2059472|NCT00549770|3633541|FG000|Overall Study|Abnormal test procedure results|0
2059473|NCT00549770|3633542|FG001|Overall Study|Abnormal test procedure results|0
2059474|NCT00549770|3633543|FG002|Overall Study|Abnormal test procedure results|0
2059475|NCT00549770|3633544|FG003|Overall Study|Abnormal test procedure results|2
2059476|NCT00549770|3633545|FG004|Overall Study|Abnormal test procedure results|0
2059477|NCT00549770|3633546|FG005|Overall Study|Abnormal test procedure results|1
2059478|NCT00549770|3633547|FG006|Overall Study|Abnormal test procedure results|1
2059479|NCT00549770|3633548|FG007|Overall Study|Abnormal test procedure results|1
2059480|NCT00549770|3633541|FG000|Overall Study|Abnormal laboratory values|0
2059481|NCT00549770|3633542|FG001|Overall Study|Abnormal laboratory values|0
2059482|NCT00549770|3633543|FG002|Overall Study|Abnormal laboratory values|0
2059483|NCT00549770|3633544|FG003|Overall Study|Abnormal laboratory values|0
2059484|NCT00549770|3633545|FG004|Overall Study|Abnormal laboratory values|0
2059485|NCT00549770|3633546|FG005|Overall Study|Abnormal laboratory values|1
2059486|NCT00549770|3633547|FG006|Overall Study|Abnormal laboratory values|0
2059487|NCT00549770|3633548|FG007|Overall Study|Abnormal laboratory values|0
2059488|NCT00549770|3633541|FG000|Overall Study|Adverse Event|1
2059489|NCT00549770|3633542|FG001|Overall Study|Adverse Event|3
2059490|NCT00549770|3633543|FG002|Overall Study|Adverse Event|1
2059491|NCT00549770|3633544|FG003|Overall Study|Adverse Event|2
2059492|NCT00549770|3633545|FG004|Overall Study|Adverse Event|1
2059493|NCT00549770|3633546|FG005|Overall Study|Adverse Event|0
2059494|NCT00549770|3633547|FG006|Overall Study|Adverse Event|5
2059495|NCT00549770|3633548|FG007|Overall Study|Adverse Event|4
2059496|NCT00549900|3633579|FG000|Overall Study|Adverse Event|1
2059497|NCT00549939|3633586|FG000|12-week Double Blind Treatment Period|Adverse Event|1
2059498|NCT00549939|3633587|FG001|12-week Double Blind Treatment Period|Adverse Event|1
2059499|NCT00549939|3633588|FG002|12-week Double Blind Treatment Period|Adverse Event|2
2059500|NCT00549939|3633586|FG000|12-week Double Blind Treatment Period|Too many blood draws|0
2059501|NCT00549939|3633587|FG001|12-week Double Blind Treatment Period|Too many blood draws|1
2059502|NCT00549939|3633588|FG002|12-week Double Blind Treatment Period|Too many blood draws|0
2059503|NCT00549939|3633586|FG000|40-week Open Label Treatment Period|Adverse Event|0
2059504|NCT00549939|3633587|FG001|40-week Open Label Treatment Period|Adverse Event|2
2059505|NCT00549939|3633588|FG002|40-week Open Label Treatment Period|Adverse Event|1
2059506|NCT00549939|3633586|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0
2059507|NCT00549939|3633587|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1
2059508|NCT00549939|3633588|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0
2301277|NCT02610140|3999217|FG000|Long-term Follow-up|Death|86
2301278|NCT02610140|3999218|FG001|Long-term Follow-up|Death|44
2059509|NCT00549939|3633586|FG000|40-week Open Label Treatment Period|Protocol Violation|0
2059510|NCT00549939|3633587|FG001|40-week Open Label Treatment Period|Protocol Violation|1
2059511|NCT00549939|3633588|FG002|40-week Open Label Treatment Period|Protocol Violation|0
2059512|NCT00549939|3633586|FG000|40-week Open Label Treatment Period|Other|0
2059513|NCT00549939|3633587|FG001|40-week Open Label Treatment Period|Other|1
2059514|NCT00549939|3633588|FG002|40-week Open Label Treatment Period|Other|4
2059515|NCT00550043|3633603|FG000|Overall Study|Adverse Event|0
2059516|NCT00550043|3633604|FG001|Overall Study|Adverse Event|0
2059517|NCT00550043|3633605|FG002|Overall Study|Adverse Event|0
2059518|NCT00550043|3633606|FG003|Overall Study|Adverse Event|1
2059519|NCT00550043|3633607|FG004|Overall Study|Adverse Event|1
2059520|NCT00550043|3633603|FG000|Overall Study|Subject Withdrew Consent|0
2059521|NCT00550043|3633604|FG001|Overall Study|Subject Withdrew Consent|2
2059522|NCT00550043|3633605|FG002|Overall Study|Subject Withdrew Consent|1
2059523|NCT00550043|3633606|FG003|Overall Study|Subject Withdrew Consent|0
2059524|NCT00550043|3633607|FG004|Overall Study|Subject Withdrew Consent|0
2059525|NCT00550043|3633603|FG000|Overall Study|Other Reasons- Unspecified|0
2059526|NCT00550043|3633604|FG001|Overall Study|Other Reasons- Unspecified|1
2059527|NCT00550043|3633605|FG002|Overall Study|Other Reasons- Unspecified|0
2059528|NCT00550043|3633606|FG003|Overall Study|Other Reasons- Unspecified|1
2059529|NCT00550043|3633607|FG004|Overall Study|Other Reasons- Unspecified|0
2059530|NCT00550147|3633619|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
2059531|NCT00550147|3633619|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
2059532|NCT00550147|3633619|FG000|Quetiapine Addition Treatment Period|Adverse Event|3
2059533|NCT00550147|3633619|FG000|Quetiapine Addition Treatment Period|Noncompliance|2
2059534|NCT00550147|3633619|FG000|Quetiapine Addition Treatment Period|Moved out of state|1
2059535|NCT00550173|3633635|FG000|Overall Study|Death|45
2059536|NCT00550173|3633636|FG001|Overall Study|Death|38
2059537|NCT00550173|3633637|FG002|Overall Study|Death|50
2059538|NCT00550173|3633635|FG000|Overall Study|Physician Decision|1
2059539|NCT00550173|3633636|FG001|Overall Study|Physician Decision|2
2059540|NCT00550173|3633637|FG002|Overall Study|Physician Decision|2
2059541|NCT00550173|3633635|FG000|Overall Study|Withdrawal by Subject|9
2059542|NCT00550173|3633636|FG001|Overall Study|Withdrawal by Subject|12
2059543|NCT00550173|3633637|FG002|Overall Study|Withdrawal by Subject|17
2059544|NCT00550173|3633635|FG000|Overall Study|Sponsor Decision|13
2059545|NCT00550173|3633636|FG001|Overall Study|Sponsor Decision|7
2059546|NCT00550173|3633637|FG002|Overall Study|Sponsor Decision|1
2059547|NCT00550173|3633635|FG000|Overall Study|Lost to Follow-up|4
2059548|NCT00550173|3633636|FG001|Overall Study|Lost to Follow-up|4
2059549|NCT00550173|3633637|FG002|Overall Study|Lost to Follow-up|3
2059550|NCT00550238|3633646|FG000|Overall Study|Adverse Event|88
2059551|NCT00550238|3633646|FG000|Overall Study|Death|34
2059552|NCT00550238|3633646|FG000|Overall Study|Disease progression|46
2059553|NCT00550238|3633646|FG000|Overall Study|Withdrawal by Subject|167
2059554|NCT00550238|3633646|FG000|Overall Study|Physician Decision|31
2059555|NCT00550238|3633646|FG000|Overall Study|Patient noncompliance|25
2059556|NCT00550238|3633646|FG000|Overall Study|Lost to Follow-up|13
2059557|NCT00550238|3633646|FG000|Overall Study|Sponsor decision|55
2059558|NCT00550407|3633685|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
2059559|NCT00550407|3633686|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
2059560|NCT00550407|3633687|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
2059561|NCT00550407|3633685|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
2059562|NCT00550407|3633686|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
2059563|NCT00550407|3633687|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
2059564|NCT00550407|3633685|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
2059565|NCT00550407|3633686|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
2059566|NCT00550407|3633687|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
2059567|NCT00550407|3633685|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
2059568|NCT00550407|3633686|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
2059569|NCT00550407|3633687|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
2059570|NCT00550407|3633685|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
2059571|NCT00550407|3633686|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
2059572|NCT00550407|3633687|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
2059573|NCT00550407|3633685|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
2059574|NCT00550407|3633686|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
2059575|NCT00550407|3633687|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
2059576|NCT00550407|3633685|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
2059577|NCT00550407|3633686|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
2059578|NCT00550407|3633687|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
2059579|NCT00550407|3633685|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
2059580|NCT00550407|3633686|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
2059581|NCT00550407|3633687|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
2059582|NCT00550407|3633685|FG000|26-Week Randomized Phase|Adverse Event|0
2059583|NCT00550407|3633686|FG001|26-Week Randomized Phase|Adverse Event|5
2059584|NCT00550407|3633687|FG002|26-Week Randomized Phase|Adverse Event|2
2059585|NCT00550407|3633685|FG000|26-Week Randomized Phase|Lack of Efficacy|0
2059586|NCT00550407|3633686|FG001|26-Week Randomized Phase|Lack of Efficacy|36
2059587|NCT00550407|3633687|FG002|26-Week Randomized Phase|Lack of Efficacy|19
2059588|NCT00550407|3633685|FG000|26-Week Randomized Phase|Investigator Discretion|0
2059589|NCT00550407|3633686|FG001|26-Week Randomized Phase|Investigator Discretion|1
2059590|NCT00550407|3633687|FG002|26-Week Randomized Phase|Investigator Discretion|0
2059591|NCT00550407|3633685|FG000|26-Week Randomized Phase|Withdrawal by Subject|0
2059592|NCT00550407|3633686|FG001|26-Week Randomized Phase|Withdrawal by Subject|1
2059593|NCT00550407|3633687|FG002|26-Week Randomized Phase|Withdrawal by Subject|3
2059594|NCT00550420|3633695|FG000|Overall Study|Adverse Event|28
2059595|NCT00550420|3633695|FG000|Overall Study|Lost to Follow-up|8
2059596|NCT00550420|3633695|FG000|Overall Study|Protocol Violation|11
2059597|NCT00550420|3633695|FG000|Overall Study|Withdrawal by Subject|30
2059598|NCT00550420|3633695|FG000|Overall Study|Still in study at termination|206
2059599|NCT00550420|3633695|FG000|Overall Study|Missing|2
2059600|NCT00550420|3633695|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12
2059601|NCT00550420|3633695|FG000|Overall Study|Investigators opinion|1
2059602|NCT00550420|3633695|FG000|Overall Study|Lack of curative effect|1
2059603|NCT00550420|3633695|FG000|Overall Study|Unethical stop of enrollment|2
2059604|NCT00550420|3633695|FG000|Overall Study|Caregiver's decision to withdraw|1
2059605|NCT00550420|3633695|FG000|Overall Study|Out of Electrocardiogram criteria|1
2059606|NCT00550420|3633695|FG000|Overall Study|Exclusion criteria|1
2059607|NCT00550420|3633695|FG000|Overall Study|Prohibited medicine|1
2059608|NCT00550446|3633708|FG000|Up To Week 12|Adverse Event|2
2059609|NCT00550446|3633709|FG001|Up To Week 12|Adverse Event|2
2209828|NCT01646177|3849239|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
2209829|NCT01646177|3849240|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
2209830|NCT01646177|3849241|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
2059610|NCT00550446|3633710|FG002|Up To Week 12|Adverse Event|0
2059611|NCT00550446|3633711|FG003|Up To Week 12|Adverse Event|0
2059612|NCT00550446|3633712|FG004|Up To Week 12|Adverse Event|2
2059613|NCT00550446|3633713|FG005|Up To Week 12|Adverse Event|2
2059614|NCT00550446|3633714|FG006|Up To Week 12|Adverse Event|1
2059615|NCT00550446|3633715|FG007|Up To Week 12|Adverse Event|0
2059616|NCT00550446|3633716|FG008|Up To Week 12|Adverse Event|0
2059617|NCT00550446|3633717|FG009|Up To Week 12|Adverse Event|0
2059618|NCT00550446|3633718|FG010|Up To Week 12|Adverse Event|0
2059619|NCT00550446|3633708|FG000|Up To Week 12|Lack of Efficacy|3
2059620|NCT00550446|3633709|FG001|Up To Week 12|Lack of Efficacy|1
2059621|NCT00550446|3633710|FG002|Up To Week 12|Lack of Efficacy|0
2059622|NCT00550446|3633711|FG003|Up To Week 12|Lack of Efficacy|1
2059623|NCT00550446|3633712|FG004|Up To Week 12|Lack of Efficacy|0
2059624|NCT00550446|3633713|FG005|Up To Week 12|Lack of Efficacy|3
2059625|NCT00550446|3633714|FG006|Up To Week 12|Lack of Efficacy|3
2059626|NCT00550446|3633715|FG007|Up To Week 12|Lack of Efficacy|0
2059627|NCT00550446|3633716|FG008|Up To Week 12|Lack of Efficacy|0
2059628|NCT00550446|3633717|FG009|Up To Week 12|Lack of Efficacy|0
2059629|NCT00550446|3633718|FG010|Up To Week 12|Lack of Efficacy|0
2059630|NCT00550446|3633708|FG000|Up To Week 12|Lost to Follow-up|0
2059631|NCT00550446|3633709|FG001|Up To Week 12|Lost to Follow-up|1
2059632|NCT00550446|3633710|FG002|Up To Week 12|Lost to Follow-up|0
2059633|NCT00550446|3633711|FG003|Up To Week 12|Lost to Follow-up|0
2059634|NCT00550446|3633712|FG004|Up To Week 12|Lost to Follow-up|1
2059635|NCT00550446|3633713|FG005|Up To Week 12|Lost to Follow-up|1
2059636|NCT00550446|3633714|FG006|Up To Week 12|Lost to Follow-up|2
2059637|NCT00550446|3633715|FG007|Up To Week 12|Lost to Follow-up|0
2059638|NCT00550446|3633716|FG008|Up To Week 12|Lost to Follow-up|0
2059639|NCT00550446|3633717|FG009|Up To Week 12|Lost to Follow-up|0
2059640|NCT00550446|3633718|FG010|Up To Week 12|Lost to Follow-up|0
2059641|NCT00550446|3633708|FG000|Up To Week 12|Withdrawal by Subject|2
2059642|NCT00550446|3633709|FG001|Up To Week 12|Withdrawal by Subject|0
2059643|NCT00550446|3633710|FG002|Up To Week 12|Withdrawal by Subject|3
2059644|NCT00550446|3633711|FG003|Up To Week 12|Withdrawal by Subject|2
2059645|NCT00550446|3633712|FG004|Up To Week 12|Withdrawal by Subject|0
2059646|NCT00550446|3633713|FG005|Up To Week 12|Withdrawal by Subject|1
2059647|NCT00550446|3633714|FG006|Up To Week 12|Withdrawal by Subject|3
2059648|NCT00550446|3633715|FG007|Up To Week 12|Withdrawal by Subject|0
2059649|NCT00550446|3633716|FG008|Up To Week 12|Withdrawal by Subject|0
2059650|NCT00550446|3633717|FG009|Up To Week 12|Withdrawal by Subject|0
2059651|NCT00550446|3633718|FG010|Up To Week 12|Withdrawal by Subject|0
2059652|NCT00550446|3633708|FG000|Up To Week 12|Other|3
2059653|NCT00550446|3633709|FG001|Up To Week 12|Other|0
2059654|NCT00550446|3633710|FG002|Up To Week 12|Other|0
2059655|NCT00550446|3633711|FG003|Up To Week 12|Other|0
2059656|NCT00550446|3633712|FG004|Up To Week 12|Other|0
2059657|NCT00550446|3633713|FG005|Up To Week 12|Other|1
2059658|NCT00550446|3633714|FG006|Up To Week 12|Other|4
2059659|NCT00550446|3633715|FG007|Up To Week 12|Other|0
2059660|NCT00550446|3633716|FG008|Up To Week 12|Other|0
2059661|NCT00550446|3633717|FG009|Up To Week 12|Other|0
2059662|NCT00550446|3633718|FG010|Up To Week 12|Other|0
2059663|NCT00550446|3633708|FG000|Up To Week 12|Randomized not treated|0
2059664|NCT00550446|3633709|FG001|Up To Week 12|Randomized not treated|1
2059665|NCT00550446|3633710|FG002|Up To Week 12|Randomized not treated|1
2059666|NCT00550446|3633711|FG003|Up To Week 12|Randomized not treated|0
2059667|NCT00550446|3633712|FG004|Up To Week 12|Randomized not treated|0
2059668|NCT00550446|3633713|FG005|Up To Week 12|Randomized not treated|0
2059669|NCT00550446|3633714|FG006|Up To Week 12|Randomized not treated|0
2059670|NCT00550446|3633715|FG007|Up To Week 12|Randomized not treated|0
2059671|NCT00550446|3633716|FG008|Up To Week 12|Randomized not treated|0
2059672|NCT00550446|3633717|FG009|Up To Week 12|Randomized not treated|0
2059673|NCT00550446|3633718|FG010|Up To Week 12|Randomized not treated|0
2059674|NCT00550446|3633708|FG000|Post Week 12|Adverse Event|2
2059675|NCT00550446|3633709|FG001|Post Week 12|Adverse Event|1
2059676|NCT00550446|3633710|FG002|Post Week 12|Adverse Event|1
2059677|NCT00550446|3633711|FG003|Post Week 12|Adverse Event|1
2059678|NCT00550446|3633712|FG004|Post Week 12|Adverse Event|1
2059679|NCT00550446|3633713|FG005|Post Week 12|Adverse Event|1
2059680|NCT00550446|3633714|FG006|Post Week 12|Adverse Event|0
2059681|NCT00550446|3633715|FG007|Post Week 12|Adverse Event|0
2059682|NCT00550446|3633716|FG008|Post Week 12|Adverse Event|0
2059683|NCT00550446|3633717|FG009|Post Week 12|Adverse Event|4
2059684|NCT00550446|3633718|FG010|Post Week 12|Adverse Event|0
2059685|NCT00550446|3633708|FG000|Post Week 12|Lack of Efficacy|0
2059686|NCT00550446|3633709|FG001|Post Week 12|Lack of Efficacy|0
2059687|NCT00550446|3633710|FG002|Post Week 12|Lack of Efficacy|1
2059688|NCT00550446|3633711|FG003|Post Week 12|Lack of Efficacy|0
2059689|NCT00550446|3633712|FG004|Post Week 12|Lack of Efficacy|0
2059690|NCT00550446|3633713|FG005|Post Week 12|Lack of Efficacy|0
2059691|NCT00550446|3633714|FG006|Post Week 12|Lack of Efficacy|0
2059692|NCT00550446|3633715|FG007|Post Week 12|Lack of Efficacy|1
2059693|NCT00550446|3633716|FG008|Post Week 12|Lack of Efficacy|1
2059694|NCT00550446|3633717|FG009|Post Week 12|Lack of Efficacy|2
2059695|NCT00550446|3633718|FG010|Post Week 12|Lack of Efficacy|1
2059696|NCT00550446|3633708|FG000|Post Week 12|Lost to Follow-up|0
2059697|NCT00550446|3633709|FG001|Post Week 12|Lost to Follow-up|0
2059698|NCT00550446|3633710|FG002|Post Week 12|Lost to Follow-up|1
2059699|NCT00550446|3633711|FG003|Post Week 12|Lost to Follow-up|1
2059700|NCT00550446|3633712|FG004|Post Week 12|Lost to Follow-up|0
2059701|NCT00550446|3633713|FG005|Post Week 12|Lost to Follow-up|0
2059702|NCT00550446|3633714|FG006|Post Week 12|Lost to Follow-up|1
2059703|NCT00550446|3633715|FG007|Post Week 12|Lost to Follow-up|0
2059704|NCT00550446|3633716|FG008|Post Week 12|Lost to Follow-up|0
2059705|NCT00550446|3633717|FG009|Post Week 12|Lost to Follow-up|0
2059706|NCT00550446|3633718|FG010|Post Week 12|Lost to Follow-up|0
2059707|NCT00550446|3633708|FG000|Post Week 12|Withdrawal by Subject|0
2059708|NCT00550446|3633709|FG001|Post Week 12|Withdrawal by Subject|0
2059709|NCT00550446|3633710|FG002|Post Week 12|Withdrawal by Subject|0
2059710|NCT00550446|3633711|FG003|Post Week 12|Withdrawal by Subject|0
2059711|NCT00550446|3633712|FG004|Post Week 12|Withdrawal by Subject|1
2059712|NCT00550446|3633713|FG005|Post Week 12|Withdrawal by Subject|0
2059713|NCT00550446|3633714|FG006|Post Week 12|Withdrawal by Subject|0
2059714|NCT00550446|3633715|FG007|Post Week 12|Withdrawal by Subject|0
2059715|NCT00550446|3633716|FG008|Post Week 12|Withdrawal by Subject|0
2059716|NCT00550446|3633717|FG009|Post Week 12|Withdrawal by Subject|0
2059717|NCT00550446|3633718|FG010|Post Week 12|Withdrawal by Subject|0
2059718|NCT00550446|3633708|FG000|Post Week 12|Other|1
2059719|NCT00550446|3633709|FG001|Post Week 12|Other|1
2059720|NCT00550446|3633710|FG002|Post Week 12|Other|0
2059721|NCT00550446|3633711|FG003|Post Week 12|Other|1
2059722|NCT00550446|3633712|FG004|Post Week 12|Other|0
2059723|NCT00550446|3633713|FG005|Post Week 12|Other|0
2059724|NCT00550446|3633714|FG006|Post Week 12|Other|1
2059725|NCT00550446|3633715|FG007|Post Week 12|Other|0
2059726|NCT00550446|3633716|FG008|Post Week 12|Other|1
2059727|NCT00550446|3633717|FG009|Post Week 12|Other|1
2059728|NCT00550446|3633718|FG010|Post Week 12|Other|0
2059729|NCT00550459|3633758|FG000|Overall Study|Adverse Event|0
2059730|NCT00550459|3633759|FG001|Overall Study|Adverse Event|2
2059731|NCT00550459|3633758|FG000|Overall Study|Withdrawal by Subject|1
2059732|NCT00550459|3633759|FG001|Overall Study|Withdrawal by Subject|1
2059733|NCT00550537|3633765|FG000|Overall Study|Death|18
2059734|NCT00550537|3633765|FG000|Overall Study|Adverse Event|20
2059735|NCT00550537|3633765|FG000|Overall Study|Disease progression before|46
2059736|NCT00550537|3633765|FG000|Overall Study|Withdrawal by Subject|7
2059737|NCT00550537|3633765|FG000|Overall Study|Change in treatment plan|4
2059738|NCT00550537|3633765|FG000|Overall Study|Other complicating ilness|3
2059739|NCT00550537|3633765|FG000|Overall Study|Declining performance status|2
2059740|NCT00550537|3633765|FG000|Overall Study|Treated closer to home|4
2059741|NCT00550550|3633776|FG000|Overall Study|Adverse Event|13
2301279|NCT02610140|3999217|FG000|Long-term Follow-up|Withdrawal by Subject|6
2301280|NCT02610140|3999218|FG001|Long-term Follow-up|Withdrawal by Subject|3
2301281|NCT02610140|3999217|FG000|Long-term Follow-up|Lost to Follow-up|1
2059742|NCT00550550|3633777|FG001|Overall Study|Adverse Event|5
2059743|NCT00550550|3633776|FG000|Overall Study|Treatment Failure|0
2059744|NCT00550550|3633777|FG001|Overall Study|Treatment Failure|1
2059745|NCT00550550|3633776|FG000|Overall Study|Lost to Follow-up|4
2059746|NCT00550550|3633777|FG001|Overall Study|Lost to Follow-up|0
2059747|NCT00550550|3633776|FG000|Overall Study|Withdrawal by Subject|10
2059748|NCT00550550|3633777|FG001|Overall Study|Withdrawal by Subject|8
2059749|NCT00550550|3633776|FG000|Overall Study|Protocol Violation|5
2059750|NCT00550550|3633777|FG001|Overall Study|Protocol Violation|14
2059751|NCT00550550|3633776|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
2059752|NCT00550550|3633777|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
2059753|NCT00550550|3633776|FG000|Overall Study|Randomized But Not Treated|1
2059754|NCT00550550|3633777|FG001|Overall Study|Randomized But Not Treated|0
2059755|NCT00550615|3633791|FG000|Overall Study|Withdrawal by Subject|0
2059756|NCT00550615|3633792|FG001|Overall Study|Withdrawal by Subject|0
2059757|NCT00550615|3633793|FG002|Overall Study|Withdrawal by Subject|2
2059758|NCT00550615|3633794|FG003|Overall Study|Withdrawal by Subject|3
2059759|NCT00550615|3633791|FG000|Overall Study|Not evaluable|0
2059760|NCT00550615|3633792|FG001|Overall Study|Not evaluable|0
2059761|NCT00550615|3633793|FG002|Overall Study|Not evaluable|2
2059762|NCT00550615|3633794|FG003|Overall Study|Not evaluable|7
2059763|NCT00550680|3633804|FG000|Overall Study|Administrative Reasons|1
2059764|NCT00550680|3633804|FG000|Overall Study|Adverse Event|5
2059765|NCT00550680|3633804|FG000|Overall Study|Death|3
2059766|NCT00550680|3633804|FG000|Overall Study|Early Improvement|1
2059767|NCT00550680|3633804|FG000|Overall Study|Lost to Follow-up|3
2059768|NCT00550680|3633804|FG000|Overall Study|Lack of Efficacy|1
2059769|NCT00550680|3633804|FG000|Overall Study|Other|10
2059770|NCT00550680|3633804|FG000|Overall Study|Protocol Violation|7
2059771|NCT00550680|3633804|FG000|Overall Study|Refused Treatment|19
2059772|NCT00550680|3633804|FG000|Overall Study|Screen Failure|6
2059773|NCT00550732|3633808|FG000|Overall Study|Death|4
2059774|NCT00550732|3633808|FG000|Overall Study|Withdrawal by Subject|2
2059775|NCT00550732|3633808|FG000|Overall Study|Physician Decision|2
2059776|NCT00550732|3633808|FG000|Overall Study|Lost to Follow-up|1
2059777|NCT00550732|3633808|FG000|Overall Study|Palliative care|1
2059778|NCT00550732|3633808|FG000|Overall Study|Adverse Event|1
2059779|NCT00550745|3633815|FG000|Overall Study|Death|20
2059780|NCT00550745|3633816|FG001|Overall Study|Death|16
2059781|NCT00550745|3633815|FG000|Overall Study|Lost to Follow-up|45
2059782|NCT00550745|3633816|FG001|Overall Study|Lost to Follow-up|30
2059783|NCT00550745|3633815|FG000|Overall Study|Physician Decision|0
2059784|NCT00550745|3633816|FG001|Overall Study|Physician Decision|2
2059785|NCT00550745|3633815|FG000|Overall Study|Protocol Violation|4
2059786|NCT00550745|3633816|FG001|Overall Study|Protocol Violation|2
2059787|NCT00550745|3633815|FG000|Overall Study|Withdrawal by Subject|17
2059788|NCT00550745|3633816|FG001|Overall Study|Withdrawal by Subject|10
2059789|NCT00550745|3633815|FG000|Overall Study|Screen failure|1
2059790|NCT00550745|3633816|FG001|Overall Study|Screen failure|0
2059791|NCT00550771|3633824|FG000|Overall Study|Adverse Event|11
2059792|NCT00550771|3633825|FG001|Overall Study|Adverse Event|3
2059793|NCT00550771|3633824|FG000|Overall Study|Discontinued for study-related reasons|0
2059794|NCT00550771|3633825|FG001|Overall Study|Discontinued for study-related reasons|1
2059795|NCT00550771|3633824|FG000|Overall Study|Physician Decision|2
2059796|NCT00550771|3633825|FG001|Overall Study|Physician Decision|0
2059797|NCT00550771|3633824|FG000|Overall Study|Withdrawal by Subject|0
2059798|NCT00550771|3633825|FG001|Overall Study|Withdrawal by Subject|1
2059799|NCT00550771|3633824|FG000|Overall Study|Protocol Violation|4
2059800|NCT00550771|3633825|FG001|Overall Study|Protocol Violation|5
2059801|NCT00550836|3633833|FG000|Overall Study|Withdrawal by Subject|3
2059802|NCT00550836|3633834|FG001|Overall Study|Withdrawal by Subject|9
2059803|NCT00550953|3633859|FG000|Overall Study|Adverse Event|4
2059804|NCT00550953|3633860|FG001|Overall Study|Adverse Event|3
2059805|NCT00550953|3633859|FG000|Overall Study|Not able to visit the site|2
2059806|NCT00550953|3633860|FG001|Overall Study|Not able to visit the site|3
2059807|NCT00551031|3633871|FG000|Overall Study|Adverse Event|0
2059808|NCT00551031|3633872|FG001|Overall Study|Adverse Event|1
2059809|NCT00551031|3633873|FG002|Overall Study|Adverse Event|0
2059810|NCT00551031|3633874|FG003|Overall Study|Adverse Event|0
2059811|NCT00551031|3633875|FG004|Overall Study|Adverse Event|0
2059812|NCT00551031|3633871|FG000|Overall Study|Protocol Violation|1
2059813|NCT00551031|3633872|FG001|Overall Study|Protocol Violation|1
2059814|NCT00551031|3633873|FG002|Overall Study|Protocol Violation|0
2059815|NCT00551031|3633874|FG003|Overall Study|Protocol Violation|0
2059816|NCT00551031|3633875|FG004|Overall Study|Protocol Violation|0
2059817|NCT00551031|3633871|FG000|Overall Study|Lost to Follow-up|0
2059818|NCT00551031|3633872|FG001|Overall Study|Lost to Follow-up|1
2177093|NCT01371708|3801171|FG001|Overall Study|No longer willing to participate|7
2177094|NCT01371708|3801172|FG002|Overall Study|No longer willing to participate|13
2177095|NCT01371708|3801170|FG000|Overall Study|Medication error/not related to AE|0
2177096|NCT01371708|3801171|FG001|Overall Study|Medication error/not related to AE|1
2177097|NCT01371708|3801172|FG002|Overall Study|Medication error/not related to AE|0
2177098|NCT01371708|3801170|FG000|Overall Study|Other|3
2177099|NCT01371708|3801171|FG001|Overall Study|Other|2
2177100|NCT01371708|3801172|FG002|Overall Study|Other|4
2177101|NCT01371708|3801170|FG000|Overall Study|Adverse Event|5
2059819|NCT00551031|3633873|FG002|Overall Study|Lost to Follow-up|0
2059820|NCT00551031|3633874|FG003|Overall Study|Lost to Follow-up|1
2059821|NCT00551031|3633875|FG004|Overall Study|Lost to Follow-up|1
2059822|NCT00551031|3633871|FG000|Overall Study|Withdrawal by Subject|0
2059823|NCT00551031|3633872|FG001|Overall Study|Withdrawal by Subject|4
2059824|NCT00551031|3633873|FG002|Overall Study|Withdrawal by Subject|1
2059825|NCT00551031|3633874|FG003|Overall Study|Withdrawal by Subject|2
2059826|NCT00551031|3633875|FG004|Overall Study|Withdrawal by Subject|0
2059827|NCT00551031|3633871|FG000|Overall Study|Serious Adverse Event|0
2059828|NCT00551031|3633872|FG001|Overall Study|Serious Adverse Event|2
2059829|NCT00551031|3633873|FG002|Overall Study|Serious Adverse Event|1
2059830|NCT00551031|3633874|FG003|Overall Study|Serious Adverse Event|0
2059831|NCT00551031|3633875|FG004|Overall Study|Serious Adverse Event|0
2059832|NCT00551031|3633871|FG000|Overall Study|Did not receive vaccine|1
2059833|NCT00551031|3633872|FG001|Overall Study|Did not receive vaccine|2
2059834|NCT00551031|3633873|FG002|Overall Study|Did not receive vaccine|0
2059835|NCT00551031|3633874|FG003|Overall Study|Did not receive vaccine|0
2059836|NCT00551031|3633875|FG004|Overall Study|Did not receive vaccine|0
2059837|NCT00551135|3633895|FG000|Overall Study|Adverse Event|1
2059838|NCT00551135|3633896|FG001|Overall Study|Adverse Event|0
2059839|NCT00551135|3633897|FG002|Overall Study|Adverse Event|1
2059840|NCT00551135|3633898|FG003|Overall Study|Adverse Event|1
2059841|NCT00551135|3633895|FG000|Overall Study|Lost to Follow-up|0
2059842|NCT00551135|3633896|FG001|Overall Study|Lost to Follow-up|0
2059843|NCT00551135|3633897|FG002|Overall Study|Lost to Follow-up|0
2059844|NCT00551135|3633898|FG003|Overall Study|Lost to Follow-up|1
2059845|NCT00551135|3633895|FG000|Overall Study|Other|3
2059846|NCT00551135|3633896|FG001|Overall Study|Other|2
2059847|NCT00551135|3633897|FG002|Overall Study|Other|1
2059848|NCT00551135|3633898|FG003|Overall Study|Other|2
2059849|NCT00551135|3633895|FG000|Overall Study|Withdrawal by Subject|1
2059850|NCT00551135|3633896|FG001|Overall Study|Withdrawal by Subject|0
2059851|NCT00551135|3633897|FG002|Overall Study|Withdrawal by Subject|3
2059852|NCT00551135|3633898|FG003|Overall Study|Withdrawal by Subject|1
2059853|NCT00551161|3633908|FG000|Overall Study|Withdrawal by Subject|1
2059854|NCT00551213|3633933|FG000|Overall Study|Adverse Event|6
2059855|NCT00551213|3633934|FG001|Overall Study|Adverse Event|3
2059856|NCT00551213|3633933|FG000|Overall Study|Progressive Disease|41
2059857|NCT00551213|3633934|FG001|Overall Study|Progressive Disease|12
2059858|NCT00551213|3633933|FG000|Overall Study|Withdrawal by Subject|2
2059859|NCT00551213|3633934|FG001|Overall Study|Withdrawal by Subject|0
2059860|NCT00551213|3633933|FG000|Overall Study|Not Treated|1
2059861|NCT00551213|3633934|FG001|Overall Study|Not Treated|2
2059862|NCT00551291|3633940|FG000|Overall Study|Physician Decision|1
2059863|NCT00551369|3633944|FG000|Overall Study|Protocol Violation|5
2059864|NCT00551369|3633944|FG000|Overall Study|Withdrawal by Subject|1
2059865|NCT00551369|3633944|FG000|Overall Study|Not treated per protocol and re|1
2059866|NCT00551421|3633948|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
2059867|NCT00551460|3633953|FG000|Overall Study|Adverse Event|1
2059868|NCT00551460|3633953|FG000|Overall Study|Withdrawal by Subject|1
2059869|NCT00551460|3633953|FG000|Overall Study|Physician Decision|1
2059870|NCT00551460|3633953|FG000|Overall Study|Death|7
2059871|NCT00551460|3633953|FG000|Overall Study|Ineligible|4
2059872|NCT00551460|3633953|FG000|Overall Study|Not analyzable (did not start treatment)|4
2059873|NCT00551525|3633957|FG000|Overall Study|Protocol Violation|5
2059874|NCT00551642|3633963|FG000|Treatment Period|Protocol Deviation|6
2059875|NCT00551642|3633964|FG001|Treatment Period|Protocol Deviation|11
2059876|NCT00551642|3633963|FG000|Treatment Period|Delivery device failure|1
2059877|NCT00551642|3633964|FG001|Treatment Period|Delivery device failure|3
2059878|NCT00551642|3633963|FG000|Treatment Period|Physician Decision|0
2059879|NCT00551642|3633964|FG001|Treatment Period|Physician Decision|1
2059880|NCT00551642|3633963|FG000|Treatment Period|Death|33
2059881|NCT00551642|3633964|FG001|Treatment Period|Death|31
2059882|NCT00551642|3633963|FG000|Treatment Period|Inclusion/Exclusion criteria|4
2059883|NCT00551642|3633964|FG001|Treatment Period|Inclusion/Exclusion criteria|4
2059884|NCT00551642|3633963|FG000|Treatment Period|Adverse Event|15
2059885|NCT00551642|3633964|FG001|Treatment Period|Adverse Event|12
2059886|NCT00551642|3633963|FG000|Treatment Period|Withdrawal by Subject|2
2059887|NCT00551642|3633964|FG001|Treatment Period|Withdrawal by Subject|1
2059888|NCT00551759|3634002|FG000|Overall Study|Adverse Event|7
2059889|NCT00551759|3634002|FG000|Overall Study|Death|5
2059890|NCT00551759|3634002|FG000|Overall Study|Ineligible|1
2059891|NCT00552058|3634008|FG000|Overall Study|Adverse Event|8
2059892|NCT00552058|3634009|FG001|Overall Study|Adverse Event|7
2059893|NCT00552058|3634008|FG000|Overall Study|Lack of Efficacy|1
2059894|NCT00552058|3634009|FG001|Overall Study|Lack of Efficacy|5
2059895|NCT00552058|3634008|FG000|Overall Study|Lost to Follow-up|1
2059896|NCT00552058|3634009|FG001|Overall Study|Lost to Follow-up|0
2059897|NCT00552058|3634008|FG000|Overall Study|Withdrawal by Subject|4
2059898|NCT00552058|3634009|FG001|Overall Study|Withdrawal by Subject|4
2059899|NCT00552058|3634008|FG000|Overall Study|Other: Protocol Violation|0
2059900|NCT00552058|3634009|FG001|Overall Study|Other: Protocol Violation|1
2059901|NCT00552058|3634008|FG000|Overall Study|Other: Non Compliance|1
2059902|NCT00552058|3634009|FG001|Overall Study|Other: Non Compliance|2
2059903|NCT00552058|3634008|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0
2059904|NCT00552058|3634009|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1
2059905|NCT00552058|3634008|FG000|Overall Study|Other: Low CDAI score, entry violation|0
2059906|NCT00552058|3634009|FG001|Overall Study|Other: Low CDAI score, entry violation|1
2301282|NCT02610140|3999218|FG001|Long-term Follow-up|Lost to Follow-up|2
2301283|NCT02610140|3999217|FG000|Long-term Follow-up|Ongoing but not completed|30
2059907|NCT00552058|3634008|FG000|Overall Study|Other: Positive Stool Result|0
2059908|NCT00552058|3634009|FG001|Overall Study|Other: Positive Stool Result|1
2059909|NCT00552058|3634008|FG000|Overall Study|Other: Randomized in error|0
2059910|NCT00552058|3634009|FG001|Overall Study|Other: Randomized in error|1
2059911|NCT00552058|3634008|FG000|Overall Study|Other: Sponsors Decision|0
2059912|NCT00552058|3634009|FG001|Overall Study|Other: Sponsors Decision|1
2059913|NCT00552058|3634008|FG000|Overall Study|Other: Early Roll Over|1
2059914|NCT00552058|3634009|FG001|Overall Study|Other: Early Roll Over|0
2059915|NCT00552071|3634017|FG000|Overall Study|Adverse Event|1
2059916|NCT00552071|3634018|FG001|Overall Study|Adverse Event|0
2059917|NCT00552071|3634017|FG000|Overall Study|Lack of Efficacy|1
2059918|NCT00552071|3634018|FG001|Overall Study|Lack of Efficacy|0
2059919|NCT00552071|3634017|FG000|Overall Study|Physician Decision|1
2059920|NCT00552071|3634018|FG001|Overall Study|Physician Decision|0
2059921|NCT00552071|3634017|FG000|Overall Study|Pregnancy|1
2059922|NCT00552071|3634018|FG001|Overall Study|Pregnancy|0
2059923|NCT00552071|3634017|FG000|Overall Study|Death|0
2059924|NCT00552071|3634018|FG001|Overall Study|Death|1
2059925|NCT00552071|3634017|FG000|Overall Study|Withdrawal by Subject|0
2059926|NCT00552071|3634018|FG001|Overall Study|Withdrawal by Subject|1
2059927|NCT00552084|3634028|FG000|Overall Study|Adverse Event|2
2059928|NCT00552084|3634029|FG001|Overall Study|Adverse Event|3
2059929|NCT00552084|3634028|FG000|Overall Study|Withdrawal by Subject|4
2059930|NCT00552084|3634029|FG001|Overall Study|Withdrawal by Subject|5
2059931|NCT00552084|3634028|FG000|Overall Study|Protocol Violation|1
2059932|NCT00552084|3634029|FG001|Overall Study|Protocol Violation|0
2059933|NCT00552084|3634028|FG000|Overall Study|change in anti-arrythmic drug|1
2059934|NCT00552084|3634029|FG001|Overall Study|change in anti-arrythmic drug|1
2059935|NCT00552110|3634040|FG000|Overall Study|Serious or Life-Threatening AE|0
2059936|NCT00552110|3634041|FG001|Overall Study|Serious or Life-Threatening AE|0
2059937|NCT00552110|3634042|FG002|Overall Study|Serious or Life-Threatening AE|1
2059938|NCT00552110|3634043|FG003|Overall Study|Serious or Life-Threatening AE|0
2059939|NCT00552110|3634044|FG004|Overall Study|Serious or Life-Threatening AE|0
2059940|NCT00552110|3634040|FG000|Overall Study|Lack of Efficacy|1
2059941|NCT00552110|3634041|FG001|Overall Study|Lack of Efficacy|0
2059942|NCT00552110|3634042|FG002|Overall Study|Lack of Efficacy|0
2059943|NCT00552110|3634043|FG003|Overall Study|Lack of Efficacy|1
2059944|NCT00552110|3634044|FG004|Overall Study|Lack of Efficacy|4
2059945|NCT00552110|3634040|FG000|Overall Study|Withdrawal by Subject|0
2059946|NCT00552110|3634041|FG001|Overall Study|Withdrawal by Subject|2
2059947|NCT00552110|3634042|FG002|Overall Study|Withdrawal by Subject|0
2059948|NCT00552110|3634043|FG003|Overall Study|Withdrawal by Subject|3
2059949|NCT00552110|3634044|FG004|Overall Study|Withdrawal by Subject|2
2059950|NCT00552110|3634040|FG000|Overall Study|Lost to Follow-up|0
2059951|NCT00552110|3634041|FG001|Overall Study|Lost to Follow-up|0
2059952|NCT00552110|3634042|FG002|Overall Study|Lost to Follow-up|0
2059953|NCT00552110|3634043|FG003|Overall Study|Lost to Follow-up|1
2059954|NCT00552110|3634044|FG004|Overall Study|Lost to Follow-up|1
2059955|NCT00552110|3634040|FG000|Overall Study|Failed to Comply With Study Requirements|1
2059956|NCT00552110|3634041|FG001|Overall Study|Failed to Comply With Study Requirements|1
2059957|NCT00552110|3634042|FG002|Overall Study|Failed to Comply With Study Requirements|1
2059958|NCT00552110|3634043|FG003|Overall Study|Failed to Comply With Study Requirements|0
2059959|NCT00552110|3634044|FG004|Overall Study|Failed to Comply With Study Requirements|1
2059960|NCT00552110|3634040|FG000|Overall Study|Withdrawn per Sponsor|0
2059961|NCT00552110|3634041|FG001|Overall Study|Withdrawn per Sponsor|1
2059962|NCT00552110|3634042|FG002|Overall Study|Withdrawn per Sponsor|0
2059963|NCT00552110|3634043|FG003|Overall Study|Withdrawn per Sponsor|0
2059964|NCT00552110|3634044|FG004|Overall Study|Withdrawn per Sponsor|1
2059965|NCT00552110|3634040|FG000|Overall Study|Use of Prohibited Medication|1
2059966|NCT00552110|3634041|FG001|Overall Study|Use of Prohibited Medication|1
2059967|NCT00552110|3634042|FG002|Overall Study|Use of Prohibited Medication|0
2059968|NCT00552110|3634043|FG003|Overall Study|Use of Prohibited Medication|0
2059969|NCT00552110|3634044|FG004|Overall Study|Use of Prohibited Medication|0
2059970|NCT00552110|3634040|FG000|Overall Study|Delay of Study due to Relabeling|0
2059971|NCT00552110|3634041|FG001|Overall Study|Delay of Study due to Relabeling|0
2059972|NCT00552110|3634042|FG002|Overall Study|Delay of Study due to Relabeling|0
2059973|NCT00552110|3634043|FG003|Overall Study|Delay of Study due to Relabeling|1
2059974|NCT00552110|3634044|FG004|Overall Study|Delay of Study due to Relabeling|0
2059975|NCT00552110|3634040|FG000|Overall Study|Increased Blood Pressure at Visit 2|0
2059976|NCT00552110|3634041|FG001|Overall Study|Increased Blood Pressure at Visit 2|0
2059977|NCT00552110|3634042|FG002|Overall Study|Increased Blood Pressure at Visit 2|0
2059978|NCT00552110|3634043|FG003|Overall Study|Increased Blood Pressure at Visit 2|1
2059979|NCT00552110|3634044|FG004|Overall Study|Increased Blood Pressure at Visit 2|0
2059980|NCT00552110|3634040|FG000|Overall Study|Nonserious Adverse Event (AE)|1
2059981|NCT00552110|3634041|FG001|Overall Study|Nonserious Adverse Event (AE)|0
2059982|NCT00552110|3634042|FG002|Overall Study|Nonserious Adverse Event (AE)|0
2059983|NCT00552110|3634043|FG003|Overall Study|Nonserious Adverse Event (AE)|1
2059984|NCT00552110|3634044|FG004|Overall Study|Nonserious Adverse Event (AE)|0
2059985|NCT00552175|3634059|FG000|Overall Study|Lack of Efficacy|2
2059986|NCT00552175|3634060|FG001|Overall Study|Lack of Efficacy|0
2059987|NCT00552175|3634061|FG002|Overall Study|Lack of Efficacy|1
2059988|NCT00552175|3634059|FG000|Overall Study|Adverse Event|9
2059989|NCT00552175|3634060|FG001|Overall Study|Adverse Event|9
2059990|NCT00552175|3634061|FG002|Overall Study|Adverse Event|10
2059991|NCT00552175|3634059|FG000|Overall Study|Withdrawal by Subject|2
2059992|NCT00552175|3634060|FG001|Overall Study|Withdrawal by Subject|2
2059993|NCT00552175|3634061|FG002|Overall Study|Withdrawal by Subject|1
2059994|NCT00552175|3634059|FG000|Overall Study|Lost to Follow-up|0
2059995|NCT00552175|3634060|FG001|Overall Study|Lost to Follow-up|0
2059996|NCT00552175|3634061|FG002|Overall Study|Lost to Follow-up|1
2059997|NCT00552175|3634059|FG000|Overall Study|Entry Criteria Not Met|1
2059998|NCT00552175|3634060|FG001|Overall Study|Entry Criteria Not Met|1
2059999|NCT00552175|3634061|FG002|Overall Study|Entry Criteria Not Met|0
2060000|NCT00552175|3634059|FG000|Overall Study|Reason Not Specified|3
2060001|NCT00552175|3634060|FG001|Overall Study|Reason Not Specified|1
2060002|NCT00552175|3634061|FG002|Overall Study|Reason Not Specified|1
2060003|NCT00552188|3634072|FG000|Overall Study|Adverse Event|0
2060004|NCT00552188|3634073|FG001|Overall Study|Adverse Event|2
2060005|NCT00552188|3634072|FG000|Overall Study|Lost to Follow-up|2
2060006|NCT00552188|3634073|FG001|Overall Study|Lost to Follow-up|1
2060007|NCT00552188|3634072|FG000|Overall Study|Withdrawal of consent|0
2060008|NCT00552188|3634073|FG001|Overall Study|Withdrawal of consent|1
2060009|NCT00552188|3634072|FG000|Overall Study|Subject returned to home country|0
2060010|NCT00552188|3634073|FG001|Overall Study|Subject returned to home country|1
2060011|NCT00552240|3634081|FG000|Overall Study|Adverse Event|9
2060012|NCT00552240|3634082|FG001|Overall Study|Adverse Event|9
2060013|NCT00552240|3634081|FG000|Overall Study|Protocol Violation|1
2060014|NCT00552240|3634082|FG001|Overall Study|Protocol Violation|1
2060015|NCT00552240|3634081|FG000|Overall Study|Lost to Follow-up|5
2060016|NCT00552240|3634082|FG001|Overall Study|Lost to Follow-up|6
2060017|NCT00552240|3634081|FG000|Overall Study|Withdrawal by Subject|2
2060018|NCT00552240|3634082|FG001|Overall Study|Withdrawal by Subject|2
2060019|NCT00552240|3634081|FG000|Overall Study|Lack of Efficacy|6
2060020|NCT00552240|3634082|FG001|Overall Study|Lack of Efficacy|0
2060021|NCT00552240|3634081|FG000|Overall Study|Other|1
2060022|NCT00552240|3634082|FG001|Overall Study|Other|0
2060023|NCT00552279|3634090|FG000|Overall Study|Adverse Event|0
2060024|NCT00552279|3634091|FG001|Overall Study|Adverse Event|1
2301284|NCT02610140|3999218|FG001|Long-term Follow-up|Ongoing but not completed|17
2301285|NCT02610192|3999224|FG000|Overall Study|Received other treatment|8
2301286|NCT02610192|3999224|FG000|Overall Study|Physician Decision|1
2301287|NCT02610231|3999228|FG000|Overall Study|Withdrawal by Subject|27
2301288|NCT02610231|3999228|FG000|Overall Study|Adverse Event|20
2301289|NCT02610231|3999228|FG000|Overall Study|Death|5
2301290|NCT02610231|3999228|FG000|Overall Study|Surgery|2
2301291|NCT02610231|3999228|FG000|Overall Study|Physician Decision|1
2301292|NCT02610231|3999228|FG000|Overall Study|Non Compliance|2
2301293|NCT02610231|3999228|FG000|Overall Study|Other|3
2301294|NCT02610725|3999244|FG000|Overall Study|Lost to Follow-up|197
2301295|NCT02610725|3999244|FG000|Overall Study|self-reported contraindication|9
2301296|NCT02610777|3999250|FG000|Overall Study|Ongoing in Follow-up|14
2301297|NCT02610777|3999251|FG001|Overall Study|Ongoing in Follow-up|12
2301298|NCT02610777|3999250|FG000|Overall Study|Withdrawal by Subject|1
2301299|NCT02610777|3999251|FG001|Overall Study|Withdrawal by Subject|2
2301300|NCT02610777|3999250|FG000|Overall Study|Other|0
2301301|NCT02610777|3999251|FG001|Overall Study|Other|1
2301302|NCT02610777|3999250|FG000|Overall Study|Ongoing on Treatment|6
2301303|NCT02610777|3999251|FG001|Overall Study|Ongoing on Treatment|7
2301304|NCT02610816|3999259|FG000|Phase 1|Withdrawal by Subject|2
2301305|NCT02610816|3999260|FG001|Phase 1|Withdrawal by Subject|6
2301306|NCT02610816|3999261|FG002|Phase 1|Withdrawal by Subject|0
2301307|NCT02610816|3999262|FG003|Phase 1|Withdrawal by Subject|0
2301308|NCT02610816|3999259|FG000|Phase 1|Lost to Follow-up|2
2301309|NCT02610816|3999260|FG001|Phase 1|Lost to Follow-up|1
2301310|NCT02610816|3999261|FG002|Phase 1|Lost to Follow-up|0
2301311|NCT02610816|3999262|FG003|Phase 1|Lost to Follow-up|0
2301312|NCT02610816|3999259|FG000|Phase 1|Physician Decision|0
2301313|NCT02610816|3999260|FG001|Phase 1|Physician Decision|1
2301314|NCT02610816|3999261|FG002|Phase 1|Physician Decision|0
2301315|NCT02610816|3999262|FG003|Phase 1|Physician Decision|0
2301316|NCT02610816|3999259|FG000|Phase 2|Withdrawal by Subject|0
2301317|NCT02610816|3999260|FG001|Phase 2|Withdrawal by Subject|0
2301318|NCT02610816|3999261|FG002|Phase 2|Withdrawal by Subject|9
2060025|NCT00552279|3634090|FG000|Overall Study|Withdrawal by Subject|12
2060026|NCT00552279|3634091|FG001|Overall Study|Withdrawal by Subject|1
2060027|NCT00552279|3634090|FG000|Overall Study|Lost to Follow-up|1
2301319|NCT02610816|3999262|FG003|Phase 2|Withdrawal by Subject|3
2301320|NCT02610816|3999259|FG000|Phase 2|Lost to Follow-up|0
2301321|NCT02610816|3999260|FG001|Phase 2|Lost to Follow-up|0
2301322|NCT02610816|3999261|FG002|Phase 2|Lost to Follow-up|2
2301323|NCT02610816|3999262|FG003|Phase 2|Lost to Follow-up|0
2301324|NCT02610816|3999259|FG000|Phase 2|Physician Decision|0
2060028|NCT00552279|3634091|FG001|Overall Study|Lost to Follow-up|0
2060029|NCT00552279|3634090|FG000|Overall Study|Other|1
2060030|NCT00552279|3634091|FG001|Overall Study|Other|1
2301325|NCT02610816|3999260|FG001|Phase 2|Physician Decision|0
2301326|NCT02610816|3999261|FG002|Phase 2|Physician Decision|0
2060031|NCT00552305|3634097|FG000|Overall Study|Adverse Event|43
2060032|NCT00552305|3634097|FG000|Overall Study|Lack of Efficacy|120
2060033|NCT00552305|3634097|FG000|Overall Study|Lost to Follow-up|4
2060034|NCT00552305|3634097|FG000|Overall Study|Protocol Violation|3
2060035|NCT00552305|3634097|FG000|Overall Study|Withdrawal by Subject|44
2060036|NCT00552305|3634097|FG000|Overall Study|Lack of efficacy/withdrew consent|1
2060037|NCT00552305|3634097|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3
2060038|NCT00552305|3634097|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
2060039|NCT00552305|3634097|FG000|Overall Study|Unsatisfactory compliance|11
2060040|NCT00552305|3634097|FG000|Overall Study|Poor compliance/lost to follow-up|1
2060041|NCT00552305|3634097|FG000|Overall Study|AE/Other: prohibited drug required|1
2060042|NCT00552305|3634097|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1
2060043|NCT00552305|3634097|FG000|Overall Study|Other: Site closed|4
2060044|NCT00552305|3634097|FG000|Overall Study|Other: Personal problems|1
2060045|NCT00552305|3634097|FG000|Overall Study|Other: Unable to attend visits|1
2060046|NCT00552305|3634097|FG000|Overall Study|Other: Subject underwent surgery|4
2060047|NCT00552305|3634097|FG000|Overall Study|Other: Subject became pregnant|1
2060048|NCT00552305|3634097|FG000|Overall Study|Other: Health problems, not drug related|1
2060049|NCT00552305|3634097|FG000|Overall Study|Other: Subject moved from area|2
2060050|NCT00552305|3634097|FG000|Overall Study|Other: Subject incarcerated|1
2060051|NCT00552305|3634097|FG000|Overall Study|Other: Subject went to rehab|1
2060052|NCT00552344|3634101|FG000|Overall Study|Lack of Efficacy|55
2060053|NCT00552344|3634101|FG000|Overall Study|Loss of efficacy|75
2060054|NCT00552344|3634101|FG000|Overall Study|Lost to Follow-up|8
2060055|NCT00552344|3634101|FG000|Overall Study|Withdrawal by Subject|48
2060056|NCT00552344|3634101|FG000|Overall Study|SAE, non-fatal|6
2060057|NCT00552344|3634101|FG000|Overall Study|AE, non-serious non-fatal|38
2060058|NCT00552344|3634101|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
2060059|NCT00552344|3634101|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
2060060|NCT00552344|3634101|FG000|Overall Study|Other Reason|22
2060061|NCT00552396|3634113|FG000|Overall Study|protocol withdrawal criteria|3
2060062|NCT00552396|3634114|FG001|Overall Study|protocol withdrawal criteria|3
2060063|NCT00552396|3634115|FG002|Overall Study|protocol withdrawal criteria|3
2060064|NCT00552396|3634116|FG003|Overall Study|protocol withdrawal criteria|6
2060065|NCT00552396|3634117|FG004|Overall Study|protocol withdrawal criteria|3
2060066|NCT00552396|3634118|FG005|Overall Study|protocol withdrawal criteria|3
2060067|NCT00552396|3634119|FG006|Overall Study|protocol withdrawal criteria|9
2060068|NCT00552513|3634177|FG000|Overall Study|Lost to Follow-up|5
2060069|NCT00552513|3634178|FG001|Overall Study|Lost to Follow-up|1
2060070|NCT00552578|3634188|FG000|Overall Study|Lost to Follow-up|1
2060071|NCT00552578|3634189|FG001|Overall Study|Lost to Follow-up|1
2060072|NCT00552617|3634205|FG000|Overall Study|Not Treated|0
2060073|NCT00552617|3634206|FG001|Overall Study|Not Treated|0
2060074|NCT00552617|3634207|FG002|Overall Study|Not Treated|1
2301327|NCT02610816|3999262|FG003|Phase 2|Physician Decision|2
2301328|NCT02610816|3999259|FG000|Phase 2|Pregnancy|0
2301329|NCT02610816|3999260|FG001|Phase 2|Pregnancy|0
2301330|NCT02610816|3999261|FG002|Phase 2|Pregnancy|0
2301331|NCT02610816|3999262|FG003|Phase 2|Pregnancy|1
2301332|NCT02610842|3999272|FG000|Overall Study|Lost to Follow-up|5
2301333|NCT02611362|3999328|FG000|Overall Study|Withdrawal by Subject|7
2301334|NCT02611362|3999329|FG001|Overall Study|Withdrawal by Subject|2
2301335|NCT02611362|3999328|FG000|Overall Study|Lost to Follow-up|2
2301336|NCT02611362|3999329|FG001|Overall Study|Lost to Follow-up|4
2301337|NCT02611479|3999336|FG000|Baseline Enrollment|Exited study|13
2301338|NCT02611479|3999336|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
2301339|NCT02611479|3999336|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
2301340|NCT02611479|3999336|FG000|Data Cleaning|No baseline function or pain metrics|2
2301341|NCT02611752|3999342|FG000|Overall Study|Adverse Event|0
2301342|NCT02611752|3999343|FG001|Overall Study|Adverse Event|1
2301343|NCT02611778|3999373|FG000|Overall Study|Withdrawal by Subject|2
2301344|NCT02611778|3999374|FG001|Overall Study|Withdrawal by Subject|8
2301345|NCT02611778|3999373|FG000|Overall Study|Adverse Event|1
2301346|NCT02611778|3999374|FG001|Overall Study|Adverse Event|2
2301347|NCT02611778|3999373|FG000|Overall Study|Death|2
2301348|NCT02611778|3999374|FG001|Overall Study|Death|1
2301349|NCT02611778|3999373|FG000|Overall Study|Protocol Violation|1
2301350|NCT02611778|3999374|FG001|Overall Study|Protocol Violation|0
2301351|NCT02611778|3999373|FG000|Overall Study|Lost to Follow-up|3
2301352|NCT02611778|3999374|FG001|Overall Study|Lost to Follow-up|1
2301353|NCT02611778|3999373|FG000|Overall Study|Need for alternative treatment|1
2301354|NCT02611778|3999374|FG001|Overall Study|Need for alternative treatment|0
2301355|NCT02611778|3999373|FG000|Overall Study|Other Reason|2
2060075|NCT00552617|3634208|FG003|Overall Study|Not Treated|0
2060076|NCT00552617|3634209|FG004|Overall Study|Not Treated|0
2060077|NCT00552617|3634210|FG005|Overall Study|Not Treated|0
2060078|NCT00552617|3634211|FG006|Overall Study|Not Treated|0
2060079|NCT00552617|3634212|FG007|Overall Study|Not Treated|0
2060080|NCT00552617|3634213|FG008|Overall Study|Not Treated|0
2060081|NCT00552617|3634214|FG009|Overall Study|Not Treated|1
2060082|NCT00552617|3634205|FG000|Overall Study|Lost to Follow-up|0
2301356|NCT02611778|3999374|FG001|Overall Study|Other Reason|1
2301357|NCT02611817|3999384|FG000|Open-label Induction Phase|Reason not Specified|9
2301358|NCT02611817|3999385|FG001|Open-label Induction Phase|Reason not Specified|0
2060083|NCT00552617|3634206|FG001|Overall Study|Lost to Follow-up|0
2060084|NCT00552617|3634207|FG002|Overall Study|Lost to Follow-up|0
2060085|NCT00552617|3634208|FG003|Overall Study|Lost to Follow-up|1
2060086|NCT00552617|3634209|FG004|Overall Study|Lost to Follow-up|0
2060087|NCT00552617|3634210|FG005|Overall Study|Lost to Follow-up|2
2060088|NCT00552617|3634211|FG006|Overall Study|Lost to Follow-up|0
2060089|NCT00552617|3634212|FG007|Overall Study|Lost to Follow-up|0
2060090|NCT00552617|3634213|FG008|Overall Study|Lost to Follow-up|2
2060091|NCT00552617|3634214|FG009|Overall Study|Lost to Follow-up|0
2060092|NCT00552669|3634238|FG000|Overall Study|Death|3
2060093|NCT00552669|3634239|FG001|Overall Study|Death|7
2060094|NCT00552760|3634256|FG000|Overall Study|Adverse Event|3
2060095|NCT00552760|3634257|FG001|Overall Study|Adverse Event|5
2060096|NCT00552760|3634256|FG000|Overall Study|Relapsed- Depressed Event|10
2060097|NCT00552760|3634257|FG001|Overall Study|Relapsed- Depressed Event|16
2060098|NCT00552760|3634256|FG000|Overall Study|Relapse- Manic Event|3
2060099|NCT00552760|3634257|FG001|Overall Study|Relapse- Manic Event|3
2060100|NCT00552760|3634256|FG000|Overall Study|Relapsed- Mixed Event|3
2060101|NCT00552760|3634257|FG001|Overall Study|Relapsed- Mixed Event|5
2060102|NCT00552760|3634256|FG000|Overall Study|Protocol Violation|0
2060103|NCT00552760|3634257|FG001|Overall Study|Protocol Violation|1
2060104|NCT00552760|3634256|FG000|Overall Study|Lost to Follow-up|1
2060105|NCT00552760|3634257|FG001|Overall Study|Lost to Follow-up|1
2060106|NCT00552760|3634256|FG000|Overall Study|Non-compliance|1
2060107|NCT00552760|3634257|FG001|Overall Study|Non-compliance|1
2060108|NCT00552760|3634256|FG000|Overall Study|Medical Condition|1
2060109|NCT00552760|3634257|FG001|Overall Study|Medical Condition|1
2060110|NCT00552760|3634256|FG000|Overall Study|Withdrawal by Subject|3
2060111|NCT00552760|3634257|FG001|Overall Study|Withdrawal by Subject|0
2060112|NCT00552760|3634256|FG000|Overall Study|Medication Change|1
2060113|NCT00552760|3634257|FG001|Overall Study|Medication Change|0
2060114|NCT00552929|3634286|FG000|Overall Study|Lost to Follow-up|0
2060115|NCT00552929|3634287|FG001|Overall Study|Lost to Follow-up|0
2060116|NCT00552929|3634288|FG002|Overall Study|Lost to Follow-up|0
2060117|NCT00552929|3634289|FG003|Overall Study|Lost to Follow-up|0
2060118|NCT00552929|3634290|FG004|Overall Study|Lost to Follow-up|0
2060119|NCT00552929|3634291|FG005|Overall Study|Lost to Follow-up|0
2060120|NCT00552929|3634292|FG006|Overall Study|Lost to Follow-up|0
2060121|NCT00552929|3634293|FG007|Overall Study|Lost to Follow-up|0
2060122|NCT00552929|3634294|FG008|Overall Study|Lost to Follow-up|1
2060123|NCT00552929|3634295|FG009|Overall Study|Lost to Follow-up|0
2060124|NCT00552929|3634286|FG000|Overall Study|Not Eligible|0
2060125|NCT00552929|3634287|FG001|Overall Study|Not Eligible|0
2060126|NCT00552929|3634288|FG002|Overall Study|Not Eligible|0
2060127|NCT00552929|3634289|FG003|Overall Study|Not Eligible|0
2060128|NCT00552929|3634290|FG004|Overall Study|Not Eligible|0
2060129|NCT00552929|3634291|FG005|Overall Study|Not Eligible|1
2060130|NCT00552929|3634292|FG006|Overall Study|Not Eligible|0
2060131|NCT00552929|3634293|FG007|Overall Study|Not Eligible|0
2060132|NCT00552929|3634294|FG008|Overall Study|Not Eligible|0
2060133|NCT00552929|3634295|FG009|Overall Study|Not Eligible|0
2060134|NCT00553059|3634319|FG000|Overall Study|Deemed ineligible|1
2060135|NCT00553059|3634320|FG001|Overall Study|Deemed ineligible|1
2060136|NCT00553059|3634319|FG000|Overall Study|Drug supply not available|0
2060137|NCT00553059|3634320|FG001|Overall Study|Drug supply not available|1
2060138|NCT00553150|3634336|FG000|Overall Study|Withdrawal by Subject|0
2060139|NCT00553150|3634337|FG001|Overall Study|Withdrawal by Subject|0
2060140|NCT00553150|3634338|FG002|Overall Study|Withdrawal by Subject|0
2060141|NCT00553150|3634339|FG003|Overall Study|Withdrawal by Subject|2
2060142|NCT00553150|3634336|FG000|Overall Study|Protocol Violation|0
2060143|NCT00553150|3634337|FG001|Overall Study|Protocol Violation|0
2060144|NCT00553150|3634338|FG002|Overall Study|Protocol Violation|0
2060145|NCT00553150|3634339|FG003|Overall Study|Protocol Violation|1
2060146|NCT00553150|3634336|FG000|Overall Study|Ineligible|0
2060147|NCT00553150|3634337|FG001|Overall Study|Ineligible|0
2060148|NCT00553150|3634338|FG002|Overall Study|Ineligible|0
2060149|NCT00553150|3634339|FG003|Overall Study|Ineligible|1
2060150|NCT00553202|3634361|FG000|Overall Study|Death|16
2060151|NCT00553202|3634361|FG000|Overall Study|Lost to Follow-up|1
2060152|NCT00553202|3634361|FG000|Overall Study|Physician Decision|28
2060153|NCT00553202|3634361|FG000|Overall Study|Withdrawal by Subject|1
2060154|NCT00553202|3634361|FG000|Overall Study|No donor identified|16
2060155|NCT00553202|3634361|FG000|Overall Study|Fails to meet organ function|6
2060156|NCT00553254|3634368|FG000|Overall Study|Death|3
2060157|NCT00553254|3634369|FG001|Overall Study|Death|6
2060158|NCT00553254|3634370|FG002|Overall Study|Death|25
2060159|NCT00553254|3634368|FG000|Overall Study|Lost to Follow-up|0
2060160|NCT00553254|3634369|FG001|Overall Study|Lost to Follow-up|0
2060161|NCT00553254|3634370|FG002|Overall Study|Lost to Follow-up|2
2060162|NCT00553254|3634368|FG000|Overall Study|Withdrawal by Subject|2
2060163|NCT00553254|3634369|FG001|Overall Study|Withdrawal by Subject|0
2060164|NCT00553254|3634370|FG002|Overall Study|Withdrawal by Subject|2
2060165|NCT00553254|3634368|FG000|Overall Study|Study terminated by Sponsor|0
2060166|NCT00553254|3634369|FG001|Overall Study|Study terminated by Sponsor|0
2060167|NCT00553254|3634370|FG002|Overall Study|Study terminated by Sponsor|1
2060168|NCT00553254|3634368|FG000|Overall Study|Other|1
2060169|NCT00553254|3634369|FG001|Overall Study|Other|0
2060170|NCT00553254|3634370|FG002|Overall Study|Other|13
2060171|NCT00553267|3634385|FG000|Overall Study|Adverse Event|8
2060172|NCT00553267|3634386|FG001|Overall Study|Adverse Event|10
2060173|NCT00553267|3634387|FG002|Overall Study|Adverse Event|5
2060174|NCT00553267|3634385|FG000|Overall Study|Non compliant with protocol|3
2060175|NCT00553267|3634386|FG001|Overall Study|Non compliant with protocol|3
2060176|NCT00553267|3634387|FG002|Overall Study|Non compliant with protocol|2
2060177|NCT00553267|3634385|FG000|Overall Study|Lost to Follow-up|0
2060178|NCT00553267|3634386|FG001|Overall Study|Lost to Follow-up|0
2060179|NCT00553267|3634387|FG002|Overall Study|Lost to Follow-up|1
2060180|NCT00553267|3634385|FG000|Overall Study|Consent withdrawn|2
2060181|NCT00553267|3634386|FG001|Overall Study|Consent withdrawn|3
2060182|NCT00553267|3634387|FG002|Overall Study|Consent withdrawn|1
2060183|NCT00553267|3634385|FG000|Overall Study|Specified category|1
2060184|NCT00553267|3634386|FG001|Overall Study|Specified category|2
2060185|NCT00553267|3634387|FG002|Overall Study|Specified category|1
2060186|NCT00553280|3634395|FG000|Overall Study|Adverse Event|19
2060187|NCT00553280|3634395|FG000|Overall Study|Lack of Efficacy|3
2060188|NCT00553280|3634395|FG000|Overall Study|Withdrawal by Subject|3
2060189|NCT00553280|3634395|FG000|Overall Study|Physician Decision|1
2060190|NCT00553319|3634402|FG000|Overall Study|Lost to Follow-up|10
2060191|NCT00553319|3634403|FG001|Overall Study|Lost to Follow-up|9
2060192|NCT00553319|3634404|FG002|Overall Study|Lost to Follow-up|5
2060193|NCT00553319|3634402|FG000|Overall Study|wanted treatment elsewhere|2
2060194|NCT00553319|3634403|FG001|Overall Study|wanted treatment elsewhere|1
2060195|NCT00553319|3634404|FG002|Overall Study|wanted treatment elsewhere|1
2060196|NCT00553319|3634402|FG000|Overall Study|non-compliance|0
2060197|NCT00553319|3634403|FG001|Overall Study|non-compliance|0
2060198|NCT00553319|3634404|FG002|Overall Study|non-compliance|2
2060199|NCT00553319|3634402|FG000|Overall Study|incarceration|1
2060200|NCT00553319|3634403|FG001|Overall Study|incarceration|0
2060201|NCT00553319|3634404|FG002|Overall Study|incarceration|0
2060202|NCT00553319|3634402|FG000|Overall Study|moved|1
2060203|NCT00553319|3634403|FG001|Overall Study|moved|0
2060204|NCT00553319|3634404|FG002|Overall Study|moved|1
2105773|NCT00859898|3698567|FG000|Overall Study|Withdrawal by Subject|11
2105774|NCT00859898|3698568|FG001|Overall Study|Withdrawal by Subject|8
2105775|NCT00859898|3698569|FG002|Overall Study|Withdrawal by Subject|11
2105776|NCT00859898|3698567|FG000|Overall Study|Death|0
2105777|NCT00859898|3698568|FG001|Overall Study|Death|0
2105778|NCT00859898|3698569|FG002|Overall Study|Death|1
2105779|NCT00859898|3698567|FG000|Overall Study|Lost to Follow-up|10
2105780|NCT00859898|3698568|FG001|Overall Study|Lost to Follow-up|11
2105781|NCT00859898|3698569|FG002|Overall Study|Lost to Follow-up|5
2105782|NCT00859898|3698567|FG000|Overall Study|poor/non-compliance|2
2105783|NCT00859898|3698568|FG001|Overall Study|poor/non-compliance|0
2105784|NCT00859898|3698569|FG002|Overall Study|poor/non-compliance|0
2105785|NCT00859898|3698567|FG000|Overall Study|No longer meets criteria|0
2105786|NCT00859898|3698568|FG001|Overall Study|No longer meets criteria|1
2105787|NCT00859898|3698569|FG002|Overall Study|No longer meets criteria|0
2105788|NCT00859898|3698567|FG000|Overall Study|non-specified|1
2105789|NCT00859898|3698568|FG001|Overall Study|non-specified|1
2105790|NCT00859898|3698569|FG002|Overall Study|non-specified|1
2105791|NCT00859937|3698580|FG000|Overall Study|Protocol Violation|1
2105792|NCT00859937|3698581|FG001|Overall Study|Protocol Violation|0
2108160|NCT00878553|3702002|FG001|Sleep Study|car accident|0
2108161|NCT00878553|3702003|FG002|Sleep Study|car accident|0
2108162|NCT00878553|3702004|FG003|Sleep Study|car accident|0
2108163|NCT00878553|3702005|FG004|Sleep Study|car accident|0
2108164|NCT00878553|3702001|FG000|Sleep Study|family emergency|1
2108165|NCT00878553|3702002|FG001|Sleep Study|family emergency|0
2108166|NCT00878553|3702003|FG002|Sleep Study|family emergency|0
2108167|NCT00878553|3702004|FG003|Sleep Study|family emergency|0
2108168|NCT00878553|3702005|FG004|Sleep Study|family emergency|0
2108169|NCT00878553|3702001|FG000|PK Study|Withdrawal by Subject|0
2108170|NCT00878553|3702002|FG001|PK Study|Withdrawal by Subject|0
2108171|NCT00878553|3702003|FG002|PK Study|Withdrawal by Subject|0
2108172|NCT00878553|3702004|FG003|PK Study|Withdrawal by Subject|1
2108173|NCT00878553|3702005|FG004|PK Study|Withdrawal by Subject|0
2108174|NCT00878709|3702033|FG000|Overall Study|Withdrawal by Subject|197
2108175|NCT00878709|3702034|FG001|Overall Study|Withdrawal by Subject|120
2108176|NCT00878709|3702033|FG000|Overall Study|Lost to Follow-up|35
2108177|NCT00878709|3702034|FG001|Overall Study|Lost to Follow-up|33
2108178|NCT00878709|3702033|FG000|Overall Study|Other Reasons|93
2108179|NCT00878709|3702034|FG001|Overall Study|Other Reasons|84
2108180|NCT00878722|3702049|FG000|Overall Study|Progressive disease|3
2108181|NCT00878722|3702050|FG001|Overall Study|Progressive disease|3
2108182|NCT00878722|3702051|FG002|Overall Study|Progressive disease|3
2108183|NCT00878722|3702052|FG003|Overall Study|Progressive disease|7
2108184|NCT00878722|3702053|FG004|Overall Study|Progressive disease|7
2108185|NCT00878722|3702054|FG005|Overall Study|Progressive disease|1
2108186|NCT00878722|3702055|FG006|Overall Study|Progressive disease|4
2108187|NCT00878722|3702056|FG007|Overall Study|Progressive disease|3
2108188|NCT00878722|3702049|FG000|Overall Study|Death|0
2108189|NCT00878722|3702050|FG001|Overall Study|Death|0
2108190|NCT00878722|3702051|FG002|Overall Study|Death|0
2108191|NCT00878722|3702052|FG003|Overall Study|Death|1
2108192|NCT00878722|3702053|FG004|Overall Study|Death|0
2060205|NCT00553332|3634412|FG000|Overall Study|ineligible, incorrect diagnosis|1
2060206|NCT00553358|3634419|FG000|Overall Study|Randomized but did not receive treatment|3
2060207|NCT00553358|3634420|FG001|Overall Study|Randomized but did not receive treatment|3
2060208|NCT00553358|3634421|FG002|Overall Study|Randomized but did not receive treatment|1
2060209|NCT00553358|3634419|FG000|Overall Study|Lost to Follow-up|22
2060210|NCT00553358|3634420|FG001|Overall Study|Lost to Follow-up|26
2060211|NCT00553358|3634421|FG002|Overall Study|Lost to Follow-up|18
2060212|NCT00553358|3634419|FG000|Overall Study|Withdrew completely|23
2060213|NCT00553358|3634420|FG001|Overall Study|Withdrew completely|33
2060214|NCT00553358|3634421|FG002|Overall Study|Withdrew completely|34
2060215|NCT00553358|3634419|FG000|Overall Study|Died during clinical follow-up|25
2060216|NCT00553358|3634420|FG001|Overall Study|Died during clinical follow-up|29
2060217|NCT00553358|3634421|FG002|Overall Study|Died during clinical follow-up|32
2060218|NCT00553358|3634419|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4
2060219|NCT00553358|3634420|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
2060220|NCT00553358|3634421|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
2060221|NCT00553358|3634419|FG000|Overall Study|Died after clinical follow-up ended|1
2060222|NCT00553358|3634420|FG001|Overall Study|Died after clinical follow-up ended|2
2060223|NCT00553358|3634421|FG002|Overall Study|Died after clinical follow-up ended|0
2060224|NCT00553358|3634419|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
2060225|NCT00553358|3634420|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
2060226|NCT00553358|3634421|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
2060227|NCT00553436|3634444|FG000|Overall Study|Conversion to another procedure|1
2060228|NCT00553462|3634448|FG000|Overall Study|Adverse Event|4
2060229|NCT00553462|3634448|FG000|Overall Study|Progression|4
2060230|NCT00553462|3634448|FG000|Overall Study|Withdrawal by Subject|5
2060231|NCT00553462|3634448|FG000|Overall Study|Physician Decision|1
2060232|NCT00553475|3634455|FG000|Overall Study|Adverse Event|7
2060233|NCT00553475|3634456|FG001|Overall Study|Adverse Event|17
2060234|NCT00553475|3634457|FG002|Overall Study|Adverse Event|13
2060235|NCT00553475|3634455|FG000|Overall Study|Lack of Efficacy|7
2060236|NCT00553475|3634456|FG001|Overall Study|Lack of Efficacy|1
2301359|NCT02611817|3999386|FG002|Open-label Induction Phase|Reason not Specified|0
2301360|NCT02611817|3999384|FG000|Open-label Induction Phase|Lack of Efficacy|8
2301361|NCT02611817|3999385|FG001|Open-label Induction Phase|Lack of Efficacy|0
2301362|NCT02611817|3999386|FG002|Open-label Induction Phase|Lack of Efficacy|0
2301363|NCT02611817|3999384|FG000|Open-label Induction Phase|Pregnancy|1
2301364|NCT02611817|3999385|FG001|Open-label Induction Phase|Pregnancy|0
2301365|NCT02611817|3999386|FG002|Open-label Induction Phase|Pregnancy|0
2301366|NCT02611817|3999384|FG000|Open-label Induction Phase|Withdrawal by Subject|9
2301367|NCT02611817|3999385|FG001|Open-label Induction Phase|Withdrawal by Subject|0
2301368|NCT02611817|3999386|FG002|Open-label Induction Phase|Withdrawal by Subject|0
2301369|NCT02611817|3999384|FG000|Open-label Induction Phase|Lost to Follow-up|2
2301370|NCT02611817|3999385|FG001|Open-label Induction Phase|Lost to Follow-up|0
2301371|NCT02611817|3999386|FG002|Open-label Induction Phase|Lost to Follow-up|0
2301372|NCT02611817|3999384|FG000|Open-label Induction Phase|Protocol Violation|5
2301373|NCT02611817|3999385|FG001|Open-label Induction Phase|Protocol Violation|0
2301374|NCT02611817|3999386|FG002|Open-label Induction Phase|Protocol Violation|0
2301375|NCT02611817|3999384|FG000|Open-label Induction Phase|Adverse Event|16
2301376|NCT02611817|3999385|FG001|Open-label Induction Phase|Adverse Event|0
2301377|NCT02611817|3999386|FG002|Open-label Induction Phase|Adverse Event|0
2301378|NCT02611817|3999384|FG000|Double-blind Maintenance Phase|Adverse Event|0
2301379|NCT02611817|3999385|FG001|Double-blind Maintenance Phase|Adverse Event|12
2301380|NCT02611817|3999386|FG002|Double-blind Maintenance Phase|Adverse Event|11
2301381|NCT02611817|3999384|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0
2301382|NCT02611817|3999385|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1
2301383|NCT02611817|3999386|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0
2301384|NCT02611817|3999384|FG000|Double-blind Maintenance Phase|Reason not Specified|0
2301385|NCT02611817|3999385|FG001|Double-blind Maintenance Phase|Reason not Specified|1
2301386|NCT02611817|3999386|FG002|Double-blind Maintenance Phase|Reason not Specified|2
2301387|NCT02611817|3999384|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0
2301388|NCT02611817|3999385|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43
2301389|NCT02611817|3999386|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78
2301390|NCT02611817|3999384|FG000|Double-blind Maintenance Phase|Pregnancy|0
2301391|NCT02611817|3999385|FG001|Double-blind Maintenance Phase|Pregnancy|0
2301392|NCT02611817|3999386|FG002|Double-blind Maintenance Phase|Pregnancy|1
2301393|NCT02611817|3999384|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0
2301394|NCT02611817|3999385|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5
2301395|NCT02611817|3999386|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14
2301396|NCT02611817|3999384|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0
2301397|NCT02611817|3999385|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0
2301398|NCT02611817|3999386|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1
2301399|NCT02611830|3999397|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9
2301400|NCT02611830|3999398|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0
2353775|NCT02046226|4107114|FG000|Overall Study|Lost to Follow-up|7
2060237|NCT00553475|3634457|FG002|Overall Study|Lack of Efficacy|0
2060238|NCT00553475|3634455|FG000|Overall Study|Withdrawal by Subject|1
2060239|NCT00553475|3634456|FG001|Overall Study|Withdrawal by Subject|1
2060240|NCT00553475|3634457|FG002|Overall Study|Withdrawal by Subject|0
2060241|NCT00553475|3634455|FG000|Overall Study|Physician Decision|1
2060242|NCT00553475|3634456|FG001|Overall Study|Physician Decision|0
2060243|NCT00553475|3634457|FG002|Overall Study|Physician Decision|0
2060244|NCT00553475|3634455|FG000|Overall Study|Due to moving|0
2060245|NCT00553475|3634456|FG001|Overall Study|Due to moving|1
2060246|NCT00553475|3634457|FG002|Overall Study|Due to moving|0
2060247|NCT00553501|3634467|FG000|Overall Study|Adverse Event|2
2060248|NCT00553501|3634467|FG000|Overall Study|Death|1
2060249|NCT00553501|3634467|FG000|Overall Study|Progression|1
2060250|NCT00553514|3634476|FG000|Overall Study|Protocol deviation|0
2060251|NCT00553514|3634477|FG001|Overall Study|Protocol deviation|0
2060252|NCT00553514|3634478|FG002|Overall Study|Protocol deviation|0
2060253|NCT00553514|3634479|FG003|Overall Study|Protocol deviation|1
2060254|NCT00553514|3634480|FG004|Overall Study|Protocol deviation|0
2060255|NCT00553514|3634476|FG000|Overall Study|Lack of ovarian response|4
2060256|NCT00553514|3634477|FG001|Overall Study|Lack of ovarian response|5
2060257|NCT00553514|3634478|FG002|Overall Study|Lack of ovarian response|5
2060258|NCT00553514|3634479|FG003|Overall Study|Lack of ovarian response|5
2060259|NCT00553514|3634480|FG004|Overall Study|Lack of ovarian response|6
2060260|NCT00553514|3634476|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3
2060261|NCT00553514|3634477|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0
2060262|NCT00553514|3634478|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1
2060263|NCT00553514|3634479|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0
2060264|NCT00553514|3634480|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0
2060265|NCT00553514|3634476|FG000|Overall Study|Risk of multiple pregnancy|0
2060266|NCT00553514|3634477|FG001|Overall Study|Risk of multiple pregnancy|2
2060267|NCT00553514|3634478|FG002|Overall Study|Risk of multiple pregnancy|0
2060268|NCT00553514|3634479|FG003|Overall Study|Risk of multiple pregnancy|1
2060269|NCT00553514|3634480|FG004|Overall Study|Risk of multiple pregnancy|0
2060270|NCT00553514|3634476|FG000|Overall Study|Other|1
2060271|NCT00553514|3634477|FG001|Overall Study|Other|1
2060272|NCT00553514|3634478|FG002|Overall Study|Other|0
2060273|NCT00553514|3634479|FG003|Overall Study|Other|0
2060274|NCT00553514|3634480|FG004|Overall Study|Other|1
2060275|NCT00553540|3634494|FG000|Overall Study|discharged after first visit|2
2060276|NCT00553540|3634495|FG001|Overall Study|discharged after first visit|5
2060277|NCT00553605|3634503|FG000|Overall Study|Did not meet entrance criteria|1
2060278|NCT00553605|3634504|FG001|Overall Study|Did not meet entrance criteria|3
2060279|NCT00553605|3634503|FG000|Overall Study|Did not receive full dose|1
2060280|NCT00553605|3634504|FG001|Overall Study|Did not receive full dose|0
2060281|NCT00553605|3634503|FG000|Overall Study|Randomized but not treated|2
2060282|NCT00553605|3634504|FG001|Overall Study|Randomized but not treated|0
2060283|NCT00553631|3634512|FG000|Overall Study|Withdrawal by Subject|0
2060284|NCT00553631|3634513|FG001|Overall Study|Withdrawal by Subject|1
2060285|NCT00553631|3634512|FG000|Overall Study|Lost to Follow-up|1
2060286|NCT00553631|3634513|FG001|Overall Study|Lost to Follow-up|0
2060287|NCT00553644|3634519|FG000|Overall Study|Adverse Event|17
2060288|NCT00553644|3634519|FG000|Overall Study|Withdrawal by Subject|4
2060289|NCT00553644|3634519|FG000|Overall Study|Physician Decision|1
2060290|NCT00553644|3634519|FG000|Overall Study|Alternative therapy|6
2060291|NCT00553696|3634527|FG000|Overall Study|Adverse Event|2
2060292|NCT00553696|3634528|FG001|Overall Study|Adverse Event|4
2060293|NCT00553696|3634529|FG002|Overall Study|Adverse Event|0
2060294|NCT00553696|3634530|FG003|Overall Study|Adverse Event|1
2060295|NCT00553696|3634527|FG000|Overall Study|Global deterioration of health status|0
2060296|NCT00553696|3634528|FG001|Overall Study|Global deterioration of health status|2
2060297|NCT00553696|3634529|FG002|Overall Study|Global deterioration of health status|0
2060298|NCT00553696|3634530|FG003|Overall Study|Global deterioration of health status|0
2060299|NCT00553696|3634527|FG000|Overall Study|Objective progression or relapse|2
2060300|NCT00553696|3634528|FG001|Overall Study|Objective progression or relapse|9
2060301|NCT00553696|3634529|FG002|Overall Study|Objective progression or relapse|6
2060302|NCT00553696|3634530|FG003|Overall Study|Objective progression or relapse|0
2060303|NCT00553696|3634527|FG000|Overall Study|Withdrawal by Subject|0
2060304|NCT00553696|3634528|FG001|Overall Study|Withdrawal by Subject|1
2060305|NCT00553696|3634529|FG002|Overall Study|Withdrawal by Subject|0
2060306|NCT00553696|3634530|FG003|Overall Study|Withdrawal by Subject|0
2060307|NCT00553787|3634553|FG000|Overall Study|Adverse Event|34
2060308|NCT00553787|3634554|FG001|Overall Study|Adverse Event|21
2060309|NCT00553787|3634555|FG002|Overall Study|Adverse Event|67
2060310|NCT00553787|3634553|FG000|Overall Study|Lost to Follow-up|132
2060311|NCT00553787|3634554|FG001|Overall Study|Lost to Follow-up|44
2060312|NCT00553787|3634555|FG002|Overall Study|Lost to Follow-up|78
2060313|NCT00553787|3634553|FG000|Overall Study|Withdrawal by Subject|151
2060314|NCT00553787|3634554|FG001|Overall Study|Withdrawal by Subject|40
2060315|NCT00553787|3634555|FG002|Overall Study|Withdrawal by Subject|83
2060316|NCT00553787|3634553|FG000|Overall Study|Lack of Efficacy|31
2060317|NCT00553787|3634554|FG001|Overall Study|Lack of Efficacy|1
2060318|NCT00553787|3634555|FG002|Overall Study|Lack of Efficacy|3
2060319|NCT00553787|3634553|FG000|Overall Study|Pregnancy|0
2060320|NCT00553787|3634554|FG001|Overall Study|Pregnancy|1
2060321|NCT00553787|3634555|FG002|Overall Study|Pregnancy|2
2060322|NCT00553787|3634553|FG000|Overall Study|non compliance|4
2060323|NCT00553787|3634554|FG001|Overall Study|non compliance|0
2060324|NCT00553787|3634555|FG002|Overall Study|non compliance|11
2209831|NCT01646177|3849242|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
2209832|NCT01646177|3849243|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
2209833|NCT01646177|3849244|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
2209834|NCT01646177|3849245|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
2209835|NCT01646177|3849246|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
2209836|NCT01646177|3849247|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
2209837|NCT01646177|3849248|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
2209838|NCT01646177|3849237|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0
2209839|NCT01646177|3849238|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0
2209840|NCT01646177|3849239|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0
2060325|NCT00553787|3634553|FG000|Overall Study|Requirement for restricted medication|8
2060326|NCT00553787|3634554|FG001|Overall Study|Requirement for restricted medication|7
2060327|NCT00553787|3634555|FG002|Overall Study|Requirement for restricted medication|5
2060328|NCT00553787|3634553|FG000|Overall Study|Other|18
2060329|NCT00553787|3634554|FG001|Overall Study|Other|10
2060330|NCT00553787|3634555|FG002|Overall Study|Other|13
2060331|NCT00554099|3634587|FG000|Treatment Period (12 Weeks)|Adverse Event|3
2060332|NCT00554099|3634588|FG001|Treatment Period (12 Weeks)|Adverse Event|5
2060333|NCT00554099|3634589|FG002|Treatment Period (12 Weeks)|Adverse Event|1
2060334|NCT00554099|3634587|FG000|Treatment Period (12 Weeks)|Physician Decision|3
2060335|NCT00554099|3634588|FG001|Treatment Period (12 Weeks)|Physician Decision|0
2060336|NCT00554099|3634589|FG002|Treatment Period (12 Weeks)|Physician Decision|0
2060337|NCT00554099|3634587|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1
2060338|NCT00554099|3634588|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0
2060339|NCT00554099|3634589|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2
2060340|NCT00554099|3634587|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
2060341|NCT00554099|3634588|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
2060342|NCT00554099|3634589|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
2060343|NCT00554099|3634587|FG000|Treatment Period (12 Weeks)|Protocol Violation|0
2060344|NCT00554099|3634588|FG001|Treatment Period (12 Weeks)|Protocol Violation|0
2060345|NCT00554099|3634589|FG002|Treatment Period (12 Weeks)|Protocol Violation|2
2209841|NCT01646177|3849240|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0
2301401|NCT02611830|3999399|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0
2301402|NCT02611830|3999400|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0
2060346|NCT00554099|3634587|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4
2060347|NCT00554099|3634588|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1
2060348|NCT00554099|3634589|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4
2301403|NCT02611830|3999397|FG000|OL Induction Phase|Significant Protocol Deviation|4
2301404|NCT02611830|3999398|FG001|OL Induction Phase|Significant Protocol Deviation|0
2301405|NCT02611830|3999399|FG002|OL Induction Phase|Significant Protocol Deviation|0
2301406|NCT02611830|3999400|FG003|OL Induction Phase|Significant Protocol Deviation|0
2301407|NCT02611830|3999397|FG000|OL Induction Phase|Voluntary Withdrawal|5
2301408|NCT02611830|3999398|FG001|OL Induction Phase|Voluntary Withdrawal|0
2301409|NCT02611830|3999399|FG002|OL Induction Phase|Voluntary Withdrawal|0
2301410|NCT02611830|3999400|FG003|OL Induction Phase|Voluntary Withdrawal|0
2301411|NCT02611830|3999397|FG000|OL Induction Phase|Lack of Efficacy|9
2301412|NCT02611830|3999398|FG001|OL Induction Phase|Lack of Efficacy|0
2301413|NCT02611830|3999399|FG002|OL Induction Phase|Lack of Efficacy|0
2301414|NCT02611830|3999400|FG003|OL Induction Phase|Lack of Efficacy|0
2301415|NCT02611830|3999397|FG000|OL Induction Phase|Reason not specified|3
2301416|NCT02611830|3999398|FG001|OL Induction Phase|Reason not specified|0
2301417|NCT02611830|3999399|FG002|OL Induction Phase|Reason not specified|0
2301418|NCT02611830|3999400|FG003|OL Induction Phase|Reason not specified|0
2301419|NCT02611830|3999397|FG000|Maintenance Phase|Lack of Efficacy|0
2301420|NCT02611830|3999398|FG001|Maintenance Phase|Lack of Efficacy|29
2301421|NCT02611830|3999399|FG002|Maintenance Phase|Lack of Efficacy|18
2301422|NCT02611830|3999400|FG003|Maintenance Phase|Lack of Efficacy|6
2301423|NCT02611830|3999397|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0
2301424|NCT02611830|3999398|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5
2301425|NCT02611830|3999399|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5
2301426|NCT02611830|3999400|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2
2301427|NCT02611830|3999397|FG000|Maintenance Phase|Significant Protocol Deviation|0
2301428|NCT02611830|3999398|FG001|Maintenance Phase|Significant Protocol Deviation|0
2301429|NCT02611830|3999399|FG002|Maintenance Phase|Significant Protocol Deviation|1
2301430|NCT02611830|3999400|FG003|Maintenance Phase|Significant Protocol Deviation|1
2301431|NCT02611830|3999397|FG000|Maintenance Phase|Lost to Follow-up|0
2301432|NCT02611830|3999398|FG001|Maintenance Phase|Lost to Follow-up|0
2060349|NCT00554099|3634587|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
2060350|NCT00554099|3634588|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
2060351|NCT00554099|3634589|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
2060352|NCT00554099|3634587|FG000|Non-Treatment Phase (9 Months)|Relapse|2
2060353|NCT00554099|3634588|FG001|Non-Treatment Phase (9 Months)|Relapse|1
2060354|NCT00554099|3634589|FG002|Non-Treatment Phase (9 Months)|Relapse|1
2060355|NCT00554099|3634587|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
2060356|NCT00554099|3634588|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
2060357|NCT00554099|3634589|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
2060358|NCT00554216|3634600|FG000|Overall Study|Lost to Follow-up|92
2060359|NCT00554216|3634601|FG001|Overall Study|Lost to Follow-up|31
2060360|NCT00554216|3634602|FG002|Overall Study|Lost to Follow-up|63
2060361|NCT00554216|3634600|FG000|Overall Study|Adverse Event|16
2060362|NCT00554216|3634601|FG001|Overall Study|Adverse Event|16
2060363|NCT00554216|3634602|FG002|Overall Study|Adverse Event|36
2060364|NCT00554216|3634600|FG000|Overall Study|Withdrawal by Subject|92
2060365|NCT00554216|3634601|FG001|Overall Study|Withdrawal by Subject|31
2060366|NCT00554216|3634602|FG002|Overall Study|Withdrawal by Subject|43
2060367|NCT00554216|3634600|FG000|Overall Study|Non compliance|10
2060368|NCT00554216|3634601|FG001|Overall Study|Non compliance|4
2060369|NCT00554216|3634602|FG002|Overall Study|Non compliance|5
2060370|NCT00554216|3634600|FG000|Overall Study|Pregnancy|2
2060371|NCT00554216|3634601|FG001|Overall Study|Pregnancy|1
2060372|NCT00554216|3634602|FG002|Overall Study|Pregnancy|14
2060373|NCT00554216|3634600|FG000|Overall Study|Restricted med|3
2060374|NCT00554216|3634601|FG001|Overall Study|Restricted med|1
2060375|NCT00554216|3634602|FG002|Overall Study|Restricted med|1
2060376|NCT00554216|3634600|FG000|Overall Study|Other|12
2060377|NCT00554216|3634601|FG001|Overall Study|Other|7
2060378|NCT00554216|3634602|FG002|Overall Study|Other|10
2060379|NCT00554216|3634600|FG000|Overall Study|Lack of Efficacy|15
2060380|NCT00554216|3634601|FG001|Overall Study|Lack of Efficacy|3
2060381|NCT00554216|3634602|FG002|Overall Study|Lack of Efficacy|0
2060382|NCT00554229|3634612|FG000|Overall Study|Lost to Follow-up|3
2060383|NCT00554229|3634613|FG001|Overall Study|Lost to Follow-up|6
2060384|NCT00554229|3634612|FG000|Overall Study|Withdrawal by Subject|29
2060385|NCT00554229|3634613|FG001|Overall Study|Withdrawal by Subject|37
2060386|NCT00554229|3634612|FG000|Overall Study|Adverse Event|71
2060387|NCT00554229|3634613|FG001|Overall Study|Adverse Event|39
2060388|NCT00554229|3634612|FG000|Overall Study|Protocol Violation|3
2177102|NCT01371708|3801171|FG001|Overall Study|Adverse Event|8
2301433|NCT02611830|3999399|FG002|Maintenance Phase|Lost to Follow-up|0
2301434|NCT02611830|3999400|FG003|Maintenance Phase|Lost to Follow-up|1
2301435|NCT02611830|3999397|FG000|Maintenance Phase|Voluntary Withdrawal|0
2301436|NCT02611830|3999398|FG001|Maintenance Phase|Voluntary Withdrawal|1
2301437|NCT02611830|3999399|FG002|Maintenance Phase|Voluntary Withdrawal|2
2301438|NCT02611830|3999400|FG003|Maintenance Phase|Voluntary Withdrawal|5
2301439|NCT02611830|3999397|FG000|Maintenance Phase|Pregnancy|0
2301440|NCT02611830|3999398|FG001|Maintenance Phase|Pregnancy|0
2301441|NCT02611830|3999399|FG002|Maintenance Phase|Pregnancy|1
2301442|NCT02611830|3999400|FG003|Maintenance Phase|Pregnancy|0
2301443|NCT02611830|3999397|FG000|Maintenance Phase|Reason not specified|0
2301444|NCT02611830|3999398|FG001|Maintenance Phase|Reason not specified|1
2301445|NCT02611830|3999399|FG002|Maintenance Phase|Reason not specified|4
2301446|NCT02611830|3999400|FG003|Maintenance Phase|Reason not specified|0
2301447|NCT02611882|3999412|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33
2301448|NCT02611882|3999413|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0
2301449|NCT02611882|3999414|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0
2301450|NCT02612064|3999423|FG000|Overall Study|Withdrawal by Subject|1
2301451|NCT02612064|3999424|FG001|Overall Study|Withdrawal by Subject|1
2301452|NCT02612064|3999423|FG000|Overall Study|Other|0
2301453|NCT02612064|3999424|FG001|Overall Study|Other|2
2301454|NCT02612077|3999430|FG000|Overall Study|Adverse Event|3
2301455|NCT02612077|3999430|FG000|Overall Study|Withdrawal by Subject|9
2301456|NCT02612077|3999430|FG000|Overall Study|Protocol Violation|28
2301457|NCT02612077|3999430|FG000|Overall Study|Lost to Follow-up|20
2301458|NCT02612077|3999430|FG000|Overall Study|Death|377
2301459|NCT02612077|3999430|FG000|Overall Study|Moved or Changed Medical Team|23
2301460|NCT02612077|3999430|FG000|Overall Study|Enrollment in a Clinical Trial|1
2301461|NCT02612077|3999430|FG000|Overall Study|Disease Progression|3
2301462|NCT02612077|3999430|FG000|Overall Study|Unknown reason|2
2301463|NCT02612155|3999439|FG000|Overall Study|Death|1
2301464|NCT02612155|3999440|FG001|Overall Study|Death|1
2301465|NCT02612155|3999439|FG000|Overall Study|Lost to Follow-up|2
2301466|NCT02612155|3999440|FG001|Overall Study|Lost to Follow-up|2
2301467|NCT02612194|3999449|FG000|Overall Study|Death|5
2301468|NCT02612194|3999450|FG001|Overall Study|Death|0
2301469|NCT02612194|3999451|FG002|Overall Study|Death|2
2301470|NCT02612194|3999449|FG000|Overall Study|Early Study Termination|1
2301471|NCT02612194|3999450|FG001|Overall Study|Early Study Termination|0
2301472|NCT02612194|3999451|FG002|Overall Study|Early Study Termination|0
2301473|NCT02612428|3999460|FG000|VTL-308|Death|14
2301474|NCT02612428|3999461|FG001|VTL-308|Death|16
2301475|NCT02612428|3999460|FG000|VTL-308|Withdrawal by Subject|0
2301476|NCT02612428|3999461|FG001|VTL-308|Withdrawal by Subject|1
2060389|NCT00554229|3634613|FG001|Overall Study|Protocol Violation|3
2060390|NCT00554229|3634612|FG000|Overall Study|Reason not otherwise captured, eg; death|119
2060391|NCT00554229|3634613|FG001|Overall Study|Reason not otherwise captured, eg; death|140
2301477|NCT02612428|3999460|FG000|VTL-308E|Death|9
2060392|NCT00554229|3634612|FG000|Overall Study|Randomised but no treatment received|1
2060393|NCT00554229|3634613|FG001|Overall Study|Randomised but no treatment received|0
2060394|NCT00554515|3634634|FG000|Overall Study|Withdrawal by Subject|3
2060395|NCT00554515|3634634|FG000|Overall Study|Disease progression|52
2060396|NCT00554515|3634634|FG000|Overall Study|Physician Decision|18
2060397|NCT00554515|3634634|FG000|Overall Study|Withdrawal by Subject|11
2060398|NCT00554515|3634634|FG000|Overall Study|Adverse Event|9
2060399|NCT00554515|3634634|FG000|Overall Study|Death|2
2060400|NCT00554515|3634634|FG000|Overall Study|Achieved Stable Disease|7
2060401|NCT00554515|3634634|FG000|Overall Study|Other|1
2060402|NCT00554515|3634634|FG000|Overall Study|Misc|15
2060403|NCT00554619|3634659|FG000|Overall Study|Adverse Event|1
2060404|NCT00554619|3634659|FG000|Overall Study|Physician Decision|1
2060405|NCT00554619|3634659|FG000|Overall Study|Liver Function Test Abnormality|1
2060406|NCT00554788|3634680|FG000|Overall Study|Adverse Event|0
2060407|NCT00554788|3634681|FG001|Overall Study|Adverse Event|1
2060408|NCT00554788|3634682|FG002|Overall Study|Adverse Event|2
2060409|NCT00554788|3634680|FG000|Overall Study|Lost to Follow-up|4
2060410|NCT00554788|3634681|FG001|Overall Study|Lost to Follow-up|3
2060411|NCT00554788|3634682|FG002|Overall Study|Lost to Follow-up|3
2060412|NCT00554788|3634680|FG000|Overall Study|Physician Decision|1
2060413|NCT00554788|3634681|FG001|Overall Study|Physician Decision|1
2060414|NCT00554788|3634682|FG002|Overall Study|Physician Decision|3
2060415|NCT00554788|3634680|FG000|Overall Study|Withdrawal by Subject|0
2060416|NCT00554788|3634681|FG001|Overall Study|Withdrawal by Subject|0
2060417|NCT00554788|3634682|FG002|Overall Study|Withdrawal by Subject|1
2060418|NCT00554788|3634680|FG000|Overall Study|Refusal of further protocol therapy|0
2060419|NCT00554788|3634681|FG001|Overall Study|Refusal of further protocol therapy|1
2060420|NCT00554788|3634682|FG002|Overall Study|Refusal of further protocol therapy|1
2209842|NCT01646177|3849241|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0
2209843|NCT01646177|3849242|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0
2209844|NCT01646177|3849243|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0
2209845|NCT01646177|3849244|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0
2209846|NCT01646177|3849245|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1
2209847|NCT01646177|3849246|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0
2209848|NCT01646177|3849247|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1
2209849|NCT01646177|3849248|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1
2209850|NCT01646177|3849237|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
2209851|NCT01646177|3849238|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
2209852|NCT01646177|3849239|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
2209853|NCT01646177|3849240|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
2209854|NCT01646177|3849241|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
2209855|NCT01646177|3849242|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
2209856|NCT01646177|3849243|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
2209857|NCT01646177|3849244|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
2209858|NCT01646177|3849245|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
2209859|NCT01646177|3849246|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
2209860|NCT01646177|3849247|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
2209861|NCT01646177|3849248|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
2209862|NCT01646203|3849271|FG000|Overall Study|Adverse Event|2
2209863|NCT01646203|3849272|FG001|Overall Study|Adverse Event|0
2209864|NCT01646203|3849273|FG002|Overall Study|Adverse Event|1
2301478|NCT02612428|3999461|FG001|VTL-308E|Death|7
2301479|NCT02612428|3999460|FG000|VTL-308E|Lost to Follow-up|2
2301480|NCT02612428|3999461|FG001|VTL-308E|Lost to Follow-up|0
2301481|NCT02612610|3999471|FG000|Overall Study|Withdrawal by Subject|1
2301482|NCT02612610|3999472|FG001|Overall Study|Withdrawal by Subject|1
2060421|NCT00554788|3634680|FG000|Overall Study|Progressive disease|0
2301483|NCT02612610|3999473|FG002|Overall Study|Withdrawal by Subject|0
2301484|NCT02612610|3999474|FG003|Overall Study|Withdrawal by Subject|2
2301485|NCT02612610|3999471|FG000|Overall Study|Adverse Event|2
2301486|NCT02612610|3999472|FG001|Overall Study|Adverse Event|2
2301487|NCT02612610|3999473|FG002|Overall Study|Adverse Event|3
2301488|NCT02612610|3999474|FG003|Overall Study|Adverse Event|10
2301489|NCT02612610|3999471|FG000|Overall Study|Lost to Follow-up|0
2301490|NCT02612610|3999472|FG001|Overall Study|Lost to Follow-up|1
2301491|NCT02612610|3999473|FG002|Overall Study|Lost to Follow-up|0
2301492|NCT02612610|3999474|FG003|Overall Study|Lost to Follow-up|0
2301493|NCT02612610|3999471|FG000|Overall Study|Protocol Violation|0
2301494|NCT02612610|3999472|FG001|Overall Study|Protocol Violation|1
2301495|NCT02612610|3999473|FG002|Overall Study|Protocol Violation|1
2301496|NCT02612610|3999474|FG003|Overall Study|Protocol Violation|0
2301497|NCT02612610|3999471|FG000|Overall Study|Lack of Efficacy|1
2060422|NCT00554788|3634681|FG001|Overall Study|Progressive disease|0
2060423|NCT00554788|3634682|FG002|Overall Study|Progressive disease|3
2060424|NCT00554788|3634680|FG000|Overall Study|Ineligible|2
2060425|NCT00554788|3634681|FG001|Overall Study|Ineligible|0
2209865|NCT01646203|3849271|FG000|Overall Study|Withdrawal by Subject|0
2301498|NCT02612610|3999472|FG001|Overall Study|Lack of Efficacy|2
2301499|NCT02612610|3999473|FG002|Overall Study|Lack of Efficacy|0
2301500|NCT02612610|3999474|FG003|Overall Study|Lack of Efficacy|1
2060426|NCT00554788|3634682|FG002|Overall Study|Ineligible|1
2060427|NCT00554801|3634693|FG000|Overall Study|left area before completion|5
2060428|NCT00554801|3634694|FG001|Overall Study|left area before completion|0
2060429|NCT00554801|3634693|FG000|Overall Study|Withdrawal by Subject|14
2209866|NCT01646203|3849272|FG001|Overall Study|Withdrawal by Subject|1
2060430|NCT00554801|3634694|FG001|Overall Study|Withdrawal by Subject|0
2060431|NCT00554840|3634704|FG000|Overall Study|Physician Decision|0
2060432|NCT00554840|3634705|FG001|Overall Study|Physician Decision|1
2060433|NCT00555061|3634753|FG000|Overall Study|Adverse Event|3
2060434|NCT00555061|3634753|FG000|Overall Study|Protocol Violation|1
2060435|NCT00555061|3634753|FG000|Overall Study|Lost to Follow-up|2
2060436|NCT00555061|3634753|FG000|Overall Study|Withdrawal by Subject|2
2060437|NCT00555061|3634753|FG000|Overall Study|Participant enrolled, but never treated|1
2060438|NCT00555217|3634776|FG000|Overall Study|Withdrawal by Subject|35
2060439|NCT00555217|3634777|FG001|Overall Study|Withdrawal by Subject|31
2060440|NCT00555217|3634776|FG000|Overall Study|Lost to Follow-up|19
2060441|NCT00555217|3634777|FG001|Overall Study|Lost to Follow-up|20
2060442|NCT00555217|3634776|FG000|Overall Study|close out sites|21
2060443|NCT00555217|3634777|FG001|Overall Study|close out sites|17
2060444|NCT00555321|3634788|FG000|Treatment Phase up to 12-months|Adverse Event|6
2060445|NCT00555321|3634789|FG001|Treatment Phase up to 12-months|Adverse Event|7
2060446|NCT00555321|3634790|FG002|Treatment Phase up to 12-months|Adverse Event|11
2060447|NCT00555321|3634791|FG003|Treatment Phase up to 12-months|Adverse Event|7
2060448|NCT00555321|3634792|FG004|Treatment Phase up to 12-months|Adverse Event|18
2060449|NCT00555321|3634788|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1
2060450|NCT00555321|3634789|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0
2060451|NCT00555321|3634790|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1
2060452|NCT00555321|3634791|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0
2060453|NCT00555321|3634792|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0
2060454|NCT00555321|3634788|FG000|Treatment Phase up to 12-months|Death|2
2060455|NCT00555321|3634789|FG001|Treatment Phase up to 12-months|Death|1
2060456|NCT00555321|3634790|FG002|Treatment Phase up to 12-months|Death|4
2060457|NCT00555321|3634791|FG003|Treatment Phase up to 12-months|Death|0
2060458|NCT00555321|3634792|FG004|Treatment Phase up to 12-months|Death|0
2060459|NCT00555321|3634788|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9
2060460|NCT00555321|3634789|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8
2060461|NCT00555321|3634790|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5
2060462|NCT00555321|3634791|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0
2060463|NCT00555321|3634792|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0
2060464|NCT00555321|3634788|FG000|Treatment Phase up to 12-months|Other Reason|1
2060465|NCT00555321|3634789|FG001|Treatment Phase up to 12-months|Other Reason|3
2060466|NCT00555321|3634790|FG002|Treatment Phase up to 12-months|Other Reason|2
2060467|NCT00555321|3634791|FG003|Treatment Phase up to 12-months|Other Reason|0
2060468|NCT00555321|3634792|FG004|Treatment Phase up to 12-months|Other Reason|0
2060469|NCT00555321|3634788|FG000|Treatment Phase up to 12-months|Never treated|2
2060470|NCT00555321|3634789|FG001|Treatment Phase up to 12-months|Never treated|3
2060471|NCT00555321|3634790|FG002|Treatment Phase up to 12-months|Never treated|1
2060472|NCT00555321|3634791|FG003|Treatment Phase up to 12-months|Never treated|0
2060473|NCT00555321|3634792|FG004|Treatment Phase up to 12-months|Never treated|4
2060474|NCT00555321|3634788|FG000|Long-term Extension Phase|Adverse Event|2
2060475|NCT00555321|3634789|FG001|Long-term Extension Phase|Adverse Event|5
2060476|NCT00555321|3634790|FG002|Long-term Extension Phase|Adverse Event|2
2060477|NCT00555321|3634791|FG003|Long-term Extension Phase|Adverse Event|1
2060478|NCT00555321|3634792|FG004|Long-term Extension Phase|Adverse Event|0
2060479|NCT00555321|3634788|FG000|Long-term Extension Phase|Withdrawal by Subject|2
2060480|NCT00555321|3634789|FG001|Long-term Extension Phase|Withdrawal by Subject|1
2060481|NCT00555321|3634790|FG002|Long-term Extension Phase|Withdrawal by Subject|2
2060482|NCT00555321|3634791|FG003|Long-term Extension Phase|Withdrawal by Subject|3
2060483|NCT00555321|3634792|FG004|Long-term Extension Phase|Withdrawal by Subject|2
2060484|NCT00555321|3634788|FG000|Long-term Extension Phase|Administrative reason by sponsor|23
2060485|NCT00555321|3634789|FG001|Long-term Extension Phase|Administrative reason by sponsor|21
2060486|NCT00555321|3634790|FG002|Long-term Extension Phase|Administrative reason by sponsor|18
2060487|NCT00555321|3634791|FG003|Long-term Extension Phase|Administrative reason by sponsor|31
2060488|NCT00555321|3634792|FG004|Long-term Extension Phase|Administrative reason by sponsor|23
2060489|NCT00555321|3634788|FG000|Long-term Extension Phase|Death|2
2060490|NCT00555321|3634789|FG001|Long-term Extension Phase|Death|0
2060491|NCT00555321|3634790|FG002|Long-term Extension Phase|Death|0
2060492|NCT00555321|3634791|FG003|Long-term Extension Phase|Death|3
2060493|NCT00555321|3634792|FG004|Long-term Extension Phase|Death|0
2060494|NCT00555321|3634788|FG000|Long-term Extension Phase|Participant did not meet study criteria|0
2060495|NCT00555321|3634789|FG001|Long-term Extension Phase|Participant did not meet study criteria|0
2060496|NCT00555321|3634790|FG002|Long-term Extension Phase|Participant did not meet study criteria|0
2060497|NCT00555321|3634791|FG003|Long-term Extension Phase|Participant did not meet study criteria|0
2060498|NCT00555321|3634792|FG004|Long-term Extension Phase|Participant did not meet study criteria|1
2060499|NCT00555321|3634788|FG000|Long-term Extension Phase|Other Reason|1
2060500|NCT00555321|3634789|FG001|Long-term Extension Phase|Other Reason|0
2060501|NCT00555321|3634790|FG002|Long-term Extension Phase|Other Reason|2
2060502|NCT00555321|3634791|FG003|Long-term Extension Phase|Other Reason|0
2060503|NCT00555321|3634792|FG004|Long-term Extension Phase|Other Reason|0
2060504|NCT00555425|3634821|FG000|Overall Study|Missed Medication > 1 wk|34
2060505|NCT00555425|3634822|FG001|Overall Study|Missed Medication > 1 wk|15
2060506|NCT00555425|3634821|FG000|Overall Study|Missed 3 physician management visits|1
2060507|NCT00555425|3634822|FG001|Overall Study|Missed 3 physician management visits|0
2060508|NCT00555425|3634821|FG000|Overall Study|Met criteria for protective transfer|16
2060509|NCT00555425|3634822|FG001|Overall Study|Met criteria for protective transfer|3
2060510|NCT00555425|3634821|FG000|Overall Study|Became pregnant and transferred care|0
2060511|NCT00555425|3634822|FG001|Overall Study|Became pregnant and transferred care|1
2060512|NCT00555438|3634828|FG000|10 Days Post-operative|Death|4
2060513|NCT00555438|3634828|FG000|Between 10 Days and 30 Days Postoperativ|Death|5
2060514|NCT00555477|3634843|FG000|Overall Study|Adverse Event|0
2060515|NCT00555477|3634844|FG001|Overall Study|Adverse Event|9
2060516|NCT00555477|3634843|FG000|Overall Study|Withdrawal by Subject|1
2060517|NCT00555477|3634844|FG001|Overall Study|Withdrawal by Subject|2
2060518|NCT00555477|3634843|FG000|Overall Study|Physician Decision|1
2301501|NCT02612610|3999471|FG000|Overall Study|Physician Decision|0
2301502|NCT02612610|3999472|FG001|Overall Study|Physician Decision|1
2301503|NCT02612610|3999473|FG002|Overall Study|Physician Decision|0
2301504|NCT02612610|3999474|FG003|Overall Study|Physician Decision|0
2301505|NCT02612610|3999471|FG000|Overall Study|Noncompliance|1
2301506|NCT02612610|3999472|FG001|Overall Study|Noncompliance|0
2301507|NCT02612610|3999473|FG002|Overall Study|Noncompliance|0
2301508|NCT02612610|3999474|FG003|Overall Study|Noncompliance|0
2301509|NCT02612610|3999471|FG000|Overall Study|Cough Improvement|0
2301510|NCT02612610|3999472|FG001|Overall Study|Cough Improvement|0
2301511|NCT02612610|3999473|FG002|Overall Study|Cough Improvement|1
2301512|NCT02612610|3999474|FG003|Overall Study|Cough Improvement|0
2301513|NCT02612623|3999488|FG000|Overall Study|Withdrawal by Subject|0
2301514|NCT02612623|3999489|FG001|Overall Study|Withdrawal by Subject|1
2301515|NCT02612623|3999490|FG002|Overall Study|Withdrawal by Subject|0
2301516|NCT02612623|3999491|FG003|Overall Study|Withdrawal by Subject|0
2301517|NCT02612623|3999488|FG000|Overall Study|Adverse Event|1
2301518|NCT02612623|3999489|FG001|Overall Study|Adverse Event|0
2301519|NCT02612623|3999490|FG002|Overall Study|Adverse Event|1
2301520|NCT02612623|3999491|FG003|Overall Study|Adverse Event|0
2301521|NCT02612727|3999514|FG000|Overall Study|Parent request|4
2301522|NCT02612727|3999515|FG001|Overall Study|Parent request|1
2301523|NCT02612727|3999514|FG000|Overall Study|Needed treatment incompatible with PT|1
2301524|NCT02612727|3999515|FG001|Overall Study|Needed treatment incompatible with PT|1
2301525|NCT02612727|3999514|FG000|Overall Study|Direct hyperbilirubinemia|0
2301526|NCT02612727|3999515|FG001|Overall Study|Direct hyperbilirubinemia|2
2301527|NCT02612779|3999523|FG000|Overall Study|Administrative reason by sponsor|4
2301528|NCT02612779|3999524|FG001|Overall Study|Administrative reason by sponsor|1
2301529|NCT02612779|3999523|FG000|Overall Study|No longer meet study criteria|0
2301530|NCT02612779|3999524|FG001|Overall Study|No longer meet study criteria|1
2301531|NCT02612779|3999523|FG000|Overall Study|Disease progression|29
2301532|NCT02612779|3999524|FG001|Overall Study|Disease progression|2
2301533|NCT02612779|3999523|FG000|Overall Study|Study drug toxicity|10
2301534|NCT02612779|3999524|FG001|Overall Study|Study drug toxicity|1
2301535|NCT02612779|3999523|FG000|Overall Study|Death|1
2301536|NCT02612779|3999524|FG001|Overall Study|Death|0
2301537|NCT02612779|3999523|FG000|Overall Study|Adverse event unrelated to study drug|5
2301538|NCT02612779|3999524|FG001|Overall Study|Adverse event unrelated to study drug|0
2301539|NCT02612779|3999523|FG000|Overall Study|Participant withdrew consent|4
2301540|NCT02612779|3999524|FG001|Overall Study|Participant withdrew consent|0
2301541|NCT02612779|3999523|FG000|Overall Study|Lost to Follow-up|1
2301542|NCT02612779|3999524|FG001|Overall Study|Lost to Follow-up|0
2301543|NCT02612779|3999523|FG000|Overall Study|Maximum clinical benefit|10
2301544|NCT02612779|3999524|FG001|Overall Study|Maximum clinical benefit|1
2301545|NCT02612779|3999523|FG000|Overall Study|Other reasons|4
2301546|NCT02612779|3999524|FG001|Overall Study|Other reasons|0
2301547|NCT02612909|3999549|FG000|Phase 2|Withdrawal by Subject|2
2301548|NCT02612909|3999550|FG001|Phase 2|Withdrawal by Subject|5
2301549|NCT02612909|3999551|FG002|Phase 2|Withdrawal by Subject|0
2301550|NCT02612909|3999552|FG003|Phase 2|Withdrawal by Subject|0
2301551|NCT02612909|3999553|FG004|Phase 2|Withdrawal by Subject|0
2301552|NCT02612909|3999549|FG000|Phase 2|Pregnancy|0
2301553|NCT02612909|3999550|FG001|Phase 2|Pregnancy|0
2301554|NCT02612909|3999551|FG002|Phase 2|Pregnancy|1
2301555|NCT02612909|3999552|FG003|Phase 2|Pregnancy|0
2301556|NCT02612909|3999553|FG004|Phase 2|Pregnancy|0
2301557|NCT02612909|3999549|FG000|Phase 3|Withdrawal by Subject|0
2301558|NCT02612909|3999550|FG001|Phase 3|Withdrawal by Subject|0
2301559|NCT02612909|3999551|FG002|Phase 3|Withdrawal by Subject|0
2301560|NCT02612909|3999552|FG003|Phase 3|Withdrawal by Subject|1
2301561|NCT02612909|3999553|FG004|Phase 3|Withdrawal by Subject|0
2301562|NCT02613169|3999578|FG000|Overall Study|Withdrawal by Subject|4
2301563|NCT02613169|3999579|FG001|Overall Study|Withdrawal by Subject|1
2301564|NCT02613169|3999578|FG000|Overall Study|Lost to Follow-up|0
2060519|NCT00555477|3634844|FG001|Overall Study|Physician Decision|2
2301565|NCT02613169|3999579|FG001|Overall Study|Lost to Follow-up|5
2301566|NCT02613169|3999578|FG000|Overall Study|HIV|0
2177103|NCT01371708|3801172|FG002|Overall Study|Adverse Event|12
2177104|NCT01371708|3801170|FG000|Overall Study|Started but did not receive treatment|1
2060520|NCT00555568|3634852|FG000|Overall Study|Lost to Follow-up|26
2060521|NCT00555568|3634853|FG001|Overall Study|Lost to Follow-up|16
2060522|NCT00555568|3634854|FG002|Overall Study|Lost to Follow-up|16
2060523|NCT00555620|3634872|FG000|Overall Study|Death|0
2060524|NCT00555620|3634873|FG001|Overall Study|Death|1
2060525|NCT00555620|3634874|FG002|Overall Study|Death|0
2060526|NCT00555620|3634875|FG003|Overall Study|Death|0
2060527|NCT00555620|3634876|FG004|Overall Study|Death|0
2060528|NCT00555620|3634877|FG005|Overall Study|Death|1
2060529|NCT00555620|3634872|FG000|Overall Study|Study terminated by sponsor|0
2060530|NCT00555620|3634873|FG001|Overall Study|Study terminated by sponsor|0
2060531|NCT00555620|3634874|FG002|Overall Study|Study terminated by sponsor|1
2060532|NCT00555620|3634875|FG003|Overall Study|Study terminated by sponsor|0
2060533|NCT00555620|3634876|FG004|Overall Study|Study terminated by sponsor|0
2060534|NCT00555620|3634877|FG005|Overall Study|Study terminated by sponsor|0
2060535|NCT00555620|3634872|FG000|Overall Study|Adverse Event|0
2060536|NCT00555620|3634873|FG001|Overall Study|Adverse Event|0
2060537|NCT00555620|3634874|FG002|Overall Study|Adverse Event|1
2060538|NCT00555620|3634875|FG003|Overall Study|Adverse Event|5
2060539|NCT00555620|3634876|FG004|Overall Study|Adverse Event|0
2301567|NCT02613169|3999579|FG001|Overall Study|HIV|2
2301568|NCT02613169|3999578|FG000|Overall Study|No TB infection endpoint|14
2301569|NCT02613169|3999579|FG001|Overall Study|No TB infection endpoint|9
2301570|NCT02613182|3999585|FG000|Overall Study|Death|6
2301571|NCT02613182|3999585|FG000|Overall Study|Physician Decision|1
2301572|NCT02613182|3999585|FG000|Overall Study|Study Terminated by Sponsor|21
2301573|NCT02613182|3999585|FG000|Overall Study|Withdrawal by Subject|6
2301574|NCT02613208|3999589|FG000|Overall Study|Withdrawal by Subject|1
2301575|NCT02613208|3999589|FG000|Overall Study|Change of address|2
2301576|NCT02613208|3999589|FG000|Overall Study|Physician Decision|2
2301577|NCT02613208|3999589|FG000|Overall Study|Lost to Follow-up|5
2301578|NCT02613208|3999589|FG000|Overall Study|Death|37
2301579|NCT02613221|3999593|FG000|Overall Study|Lack of efficacy (exacerbation)|50
2301580|NCT02613221|3999593|FG000|Overall Study|Adverse Event|2
2301581|NCT02613221|3999593|FG000|Overall Study|Voluntary Discontinuation|1
2301582|NCT02613221|3999593|FG000|Overall Study|Delayed Treatment|1
2301583|NCT02613221|3999593|FG000|Overall Study|Enrolled but Not Treated|1
2301584|NCT02613364|3999604|FG000|Overall Study|Other|19
2301585|NCT02613364|3999605|FG001|Overall Study|Other|29
2301586|NCT02613364|3999606|FG002|Overall Study|Other|17
2301587|NCT02613364|3999604|FG000|Overall Study|Too time consuming|21
2301588|NCT02613364|3999605|FG001|Overall Study|Too time consuming|26
2301589|NCT02613364|3999606|FG002|Overall Study|Too time consuming|26
2301590|NCT02613364|3999604|FG000|Overall Study|Withdrawal by Subject|13
2301591|NCT02613364|3999605|FG001|Overall Study|Withdrawal by Subject|18
2301592|NCT02613364|3999606|FG002|Overall Study|Withdrawal by Subject|17
2301593|NCT02613364|3999604|FG000|Overall Study|Medical|12
2301594|NCT02613364|3999605|FG001|Overall Study|Medical|13
2301595|NCT02613364|3999606|FG002|Overall Study|Medical|9
2301596|NCT02613364|3999604|FG000|Overall Study|Disliked Study Procedure|1
2301597|NCT02613364|3999605|FG001|Overall Study|Disliked Study Procedure|1
2301598|NCT02613364|3999606|FG002|Overall Study|Disliked Study Procedure|4
2301599|NCT02613364|3999604|FG000|Overall Study|Disliked Intervention|0
2301600|NCT02613364|3999605|FG001|Overall Study|Disliked Intervention|3
2301601|NCT02613364|3999606|FG002|Overall Study|Disliked Intervention|3
2301602|NCT02613403|3999618|FG000|Overall Study|Lost to Follow-up|0
2301603|NCT02613403|3999619|FG001|Overall Study|Lost to Follow-up|1
2301604|NCT02613403|3999620|FG002|Overall Study|Lost to Follow-up|0
2301605|NCT02613403|3999621|FG003|Overall Study|Lost to Follow-up|0
2301606|NCT02613403|3999622|FG004|Overall Study|Lost to Follow-up|0
2301607|NCT02613403|3999618|FG000|Overall Study|Withdrawal by Subject|2
2301608|NCT02613403|3999619|FG001|Overall Study|Withdrawal by Subject|0
2301609|NCT02613403|3999620|FG002|Overall Study|Withdrawal by Subject|0
2301610|NCT02613403|3999621|FG003|Overall Study|Withdrawal by Subject|0
2301611|NCT02613403|3999622|FG004|Overall Study|Withdrawal by Subject|0
2301612|NCT02613481|3999632|FG000|Overall Study|Lost to Follow-up|7
2301613|NCT02613481|3999632|FG000|Overall Study|Withdrawal by Subject|2
2301614|NCT02613507|3999638|FG000|Overall Study|Disease Progression|237
2301615|NCT02613507|3999639|FG001|Overall Study|Disease Progression|109
2301616|NCT02613507|3999638|FG000|Overall Study|Study Drug Toxicity|15
2301617|NCT02613507|3999639|FG001|Overall Study|Study Drug Toxicity|14
2060540|NCT00555620|3634877|FG005|Overall Study|Adverse Event|1
2060541|NCT00555620|3634872|FG000|Overall Study|Objective progression or relapse|6
2060542|NCT00555620|3634873|FG001|Overall Study|Objective progression or relapse|5
2060543|NCT00555620|3634874|FG002|Overall Study|Objective progression or relapse|12
2060544|NCT00555620|3634875|FG003|Overall Study|Objective progression or relapse|17
2301618|NCT02613507|3999638|FG000|Overall Study|Death|3
2301619|NCT02613507|3999639|FG001|Overall Study|Death|0
2301620|NCT02613507|3999638|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17
2301621|NCT02613507|3999639|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
2301622|NCT02613507|3999638|FG000|Overall Study|Request to Discontinue Study Treatment|8
2301623|NCT02613507|3999639|FG001|Overall Study|Request to Discontinue Study Treatment|17
2301624|NCT02613507|3999638|FG000|Overall Study|Participant Withdrew Consent|0
2060545|NCT00555620|3634876|FG004|Overall Study|Objective progression or relapse|3
2060546|NCT00555620|3634877|FG005|Overall Study|Objective progression or relapse|16
2060547|NCT00555620|3634872|FG000|Overall Study|Participant refused treatment|0
2060548|NCT00555620|3634873|FG001|Overall Study|Participant refused treatment|1
2060549|NCT00555620|3634874|FG002|Overall Study|Participant refused treatment|1
2060550|NCT00555620|3634875|FG003|Overall Study|Participant refused treatment|0
2060551|NCT00555620|3634876|FG004|Overall Study|Participant refused treatment|0
2060552|NCT00555620|3634877|FG005|Overall Study|Participant refused treatment|1
2060553|NCT00555620|3634872|FG000|Overall Study|Other|0
2060554|NCT00555620|3634873|FG001|Overall Study|Other|0
2060555|NCT00555620|3634874|FG002|Overall Study|Other|0
2060556|NCT00555620|3634875|FG003|Overall Study|Other|1
2060557|NCT00555620|3634876|FG004|Overall Study|Other|0
2060558|NCT00555620|3634877|FG005|Overall Study|Other|3
2060559|NCT00555672|3634897|FG000|Overall Study|Death|0
2060560|NCT00555672|3634898|FG001|Overall Study|Death|2
2060561|NCT00555672|3634897|FG000|Overall Study|Adverse Event|8
2060562|NCT00555672|3634898|FG001|Overall Study|Adverse Event|2
2060563|NCT00555672|3634897|FG000|Overall Study|Objective progression or relapse|11
2060564|NCT00555672|3634898|FG001|Overall Study|Objective progression or relapse|5
2060565|NCT00555672|3634897|FG000|Overall Study|Other|3
2060566|NCT00555672|3634898|FG001|Overall Study|Other|1
2060567|NCT00555672|3634897|FG000|Overall Study|Participant refused|2
2060568|NCT00555672|3634898|FG001|Overall Study|Participant refused|0
2060569|NCT00555906|3634935|FG000|Phase 1|Objective Progression or Relapse|3
2060570|NCT00555906|3634936|FG001|Phase 1|Objective Progression or Relapse|5
2060571|NCT00555906|3634937|FG002|Phase 1|Objective Progression or Relapse|3
2060572|NCT00555906|3634938|FG003|Phase 1|Objective Progression or Relapse|1
2060573|NCT00555906|3634939|FG004|Phase 1|Objective Progression or Relapse|0
2060574|NCT00555906|3634935|FG000|Phase 1|Global Deterioration of Health Status|0
2060575|NCT00555906|3634936|FG001|Phase 1|Global Deterioration of Health Status|1
2060576|NCT00555906|3634937|FG002|Phase 1|Global Deterioration of Health Status|1
2060577|NCT00555906|3634938|FG003|Phase 1|Global Deterioration of Health Status|1
2060578|NCT00555906|3634939|FG004|Phase 1|Global Deterioration of Health Status|0
2060579|NCT00555906|3634935|FG000|Phase 1|Adverse Event|0
2060580|NCT00555906|3634936|FG001|Phase 1|Adverse Event|0
2060581|NCT00555906|3634937|FG002|Phase 1|Adverse Event|3
2060582|NCT00555906|3634938|FG003|Phase 1|Adverse Event|2
2060583|NCT00555906|3634939|FG004|Phase 1|Adverse Event|0
2060584|NCT00555906|3634935|FG000|Phase 1|Withdrawal by Subject|0
2060585|NCT00555906|3634936|FG001|Phase 1|Withdrawal by Subject|0
2060586|NCT00555906|3634937|FG002|Phase 1|Withdrawal by Subject|0
2060587|NCT00555906|3634938|FG003|Phase 1|Withdrawal by Subject|1
2060588|NCT00555906|3634939|FG004|Phase 1|Withdrawal by Subject|0
2060589|NCT00555906|3634935|FG000|Phase 2|Adverse Event|0
2060590|NCT00555906|3634936|FG001|Phase 2|Adverse Event|0
2060591|NCT00555906|3634937|FG002|Phase 2|Adverse Event|0
2060592|NCT00555906|3634938|FG003|Phase 2|Adverse Event|0
2060593|NCT00555906|3634939|FG004|Phase 2|Adverse Event|4
2060594|NCT00555906|3634935|FG000|Phase 2|Global Deterioration of Health Status|0
2060595|NCT00555906|3634936|FG001|Phase 2|Global Deterioration of Health Status|0
2060596|NCT00555906|3634937|FG002|Phase 2|Global Deterioration of Health Status|0
2060597|NCT00555906|3634938|FG003|Phase 2|Global Deterioration of Health Status|0
2060598|NCT00555906|3634939|FG004|Phase 2|Global Deterioration of Health Status|2
2060599|NCT00555906|3634935|FG000|Phase 2|Objective Progression or Relapse|0
2060600|NCT00555906|3634936|FG001|Phase 2|Objective Progression or Relapse|0
2060601|NCT00555906|3634937|FG002|Phase 2|Objective Progression or Relapse|0
2060602|NCT00555906|3634938|FG003|Phase 2|Objective Progression or Relapse|0
2060603|NCT00555906|3634939|FG004|Phase 2|Objective Progression or Relapse|16
2060604|NCT00555906|3634935|FG000|Phase 2|Withdrawal by Subject|0
2060605|NCT00555906|3634936|FG001|Phase 2|Withdrawal by Subject|0
2060606|NCT00555906|3634937|FG002|Phase 2|Withdrawal by Subject|0
2060607|NCT00555906|3634938|FG003|Phase 2|Withdrawal by Subject|0
2060608|NCT00555906|3634939|FG004|Phase 2|Withdrawal by Subject|2
2060609|NCT00555906|3634935|FG000|Phase 2|Other|0
2060610|NCT00555906|3634936|FG001|Phase 2|Other|0
2060611|NCT00555906|3634937|FG002|Phase 2|Other|0
2060612|NCT00555906|3634938|FG003|Phase 2|Other|0
2060613|NCT00555906|3634939|FG004|Phase 2|Other|6
2060614|NCT00555906|3634935|FG000|Phase 2|Randomized but not Treated|0
2060615|NCT00555906|3634936|FG001|Phase 2|Randomized but not Treated|0
2060616|NCT00555906|3634937|FG002|Phase 2|Randomized but not Treated|0
2177105|NCT01371708|3801171|FG001|Overall Study|Started but did not receive treatment|0
2177106|NCT01371708|3801172|FG002|Overall Study|Started but did not receive treatment|1
2177107|NCT01371721|3801185|FG000|Overall Study|Adverse Event|5
2177108|NCT01371721|3801186|FG001|Overall Study|Adverse Event|4
2177109|NCT01371721|3801187|FG002|Overall Study|Adverse Event|5
2177110|NCT01371721|3801185|FG000|Overall Study|Protocol Violation|6
2177111|NCT01371721|3801186|FG001|Overall Study|Protocol Violation|4
2177112|NCT01371721|3801187|FG002|Overall Study|Protocol Violation|5
2060617|NCT00555906|3634938|FG003|Phase 2|Randomized but not Treated|0
2060618|NCT00555906|3634939|FG004|Phase 2|Randomized but not Treated|2
2060619|NCT00555971|3634956|FG000|Overall Study|Adverse Event|1
2060620|NCT00555971|3634957|FG001|Overall Study|Adverse Event|1
2060621|NCT00556322|3634991|FG000|Overall Study|Insufficient therapeutic response|158
2209867|NCT01646203|3849273|FG002|Overall Study|Withdrawal by Subject|0
2209868|NCT01646203|3849271|FG000|Overall Study|Physician's Decision|0
2060622|NCT00556322|3634992|FG001|Overall Study|Insufficient therapeutic response|168
2060623|NCT00556322|3634991|FG000|Overall Study|Adverse Event|7
2060624|NCT00556322|3634992|FG001|Overall Study|Adverse Event|4
2060625|NCT00556322|3634991|FG000|Overall Study|Other|4
2060626|NCT00556322|3634992|FG001|Overall Study|Other|1
2060627|NCT00556322|3634991|FG000|Overall Study|Lost to Follow-up|5
2060628|NCT00556322|3634992|FG001|Overall Study|Lost to Follow-up|3
2060629|NCT00556322|3634991|FG000|Overall Study|Withdrawal by Subject|19
2060630|NCT00556322|3634992|FG001|Overall Study|Withdrawal by Subject|7
2060631|NCT00556322|3634991|FG000|Overall Study|Protocol Violation|5
2060632|NCT00556322|3634992|FG001|Overall Study|Protocol Violation|1
2060633|NCT00556322|3634991|FG000|Overall Study|Ongoing at data cutoff|3
2060634|NCT00556322|3634992|FG001|Overall Study|Ongoing at data cutoff|5
2060635|NCT00556322|3634991|FG000|Overall Study|Death|20
2060636|NCT00556322|3634992|FG001|Overall Study|Death|14
2060637|NCT00556374|3635003|FG000|Overall Study|Withdrawal by Subject|190
2060638|NCT00556374|3635004|FG001|Overall Study|Withdrawal by Subject|172
2060639|NCT00556374|3635003|FG000|Overall Study|Death|50
2060640|NCT00556374|3635004|FG001|Overall Study|Death|43
2060641|NCT00556374|3635003|FG000|Overall Study|Lost to Follow-up|7
2060642|NCT00556374|3635004|FG001|Overall Study|Lost to Follow-up|5
2060643|NCT00556426|3635010|FG000|Overall Study|Withdrawal by Subject|3
2060644|NCT00556426|3635010|FG000|Overall Study|Death|6
2060645|NCT00556439|3635019|FG000|Study Entry to Week 12|Lack of Efficacy|5
2060646|NCT00556439|3635020|FG001|Study Entry to Week 12|Lack of Efficacy|0
2060647|NCT00556439|3635021|FG002|Study Entry to Week 12|Lack of Efficacy|6
2060648|NCT00556439|3635022|FG003|Study Entry to Week 12|Lack of Efficacy|0
2060649|NCT00556439|3635019|FG000|Study Entry to Week 12|Physician Decision|1
2060650|NCT00556439|3635020|FG001|Study Entry to Week 12|Physician Decision|0
2060651|NCT00556439|3635021|FG002|Study Entry to Week 12|Physician Decision|0
2060652|NCT00556439|3635022|FG003|Study Entry to Week 12|Physician Decision|0
2060653|NCT00556439|3635019|FG000|Study Entry to Week 12|Withdrawal by Subject|1
2060654|NCT00556439|3635020|FG001|Study Entry to Week 12|Withdrawal by Subject|0
2060655|NCT00556439|3635021|FG002|Study Entry to Week 12|Withdrawal by Subject|1
2060656|NCT00556439|3635022|FG003|Study Entry to Week 12|Withdrawal by Subject|0
2060657|NCT00556439|3635019|FG000|Study Entry to Week 12|Recurrent infection|1
2060658|NCT00556439|3635020|FG001|Study Entry to Week 12|Recurrent infection|0
2060659|NCT00556439|3635021|FG002|Study Entry to Week 12|Recurrent infection|0
2060660|NCT00556439|3635022|FG003|Study Entry to Week 12|Recurrent infection|0
2060661|NCT00556439|3635019|FG000|Study Entry to Week 12|Malignancy|0
2060662|NCT00556439|3635020|FG001|Study Entry to Week 12|Malignancy|0
2060663|NCT00556439|3635021|FG002|Study Entry to Week 12|Malignancy|1
2060664|NCT00556439|3635022|FG003|Study Entry to Week 12|Malignancy|0
2060665|NCT00556439|3635019|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
2060666|NCT00556439|3635020|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
2060667|NCT00556439|3635021|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
2060668|NCT00556439|3635022|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
2060669|NCT00556439|3635019|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1
2060670|NCT00556439|3635020|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0
2060671|NCT00556439|3635021|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0
2060672|NCT00556439|3635022|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0
2060673|NCT00556439|3635019|FG000|After Week 12 (Randomized Study Period)|Malignancy|0
2060674|NCT00556439|3635020|FG001|After Week 12 (Randomized Study Period)|Malignancy|1
2209869|NCT01646203|3849272|FG001|Overall Study|Physician's Decision|1
2209870|NCT01646203|3849273|FG002|Overall Study|Physician's Decision|0
2209871|NCT01646216|3849288|FG000|Overall Study|Baseline step length difference (<5cm)|10
2209872|NCT01646216|3849289|FG001|Overall Study|Baseline step length difference (<5cm)|10
2209873|NCT01646216|3849288|FG000|Overall Study|Did not complete training|0
2209874|NCT01646216|3849289|FG001|Overall Study|Did not complete training|2
2209875|NCT01646216|3849288|FG000|Overall Study|Investigator decision|1
2209876|NCT01646216|3849289|FG001|Overall Study|Investigator decision|1
2209877|NCT01646255|3849301|FG000|Overall Study|Adverse Event|7
2209878|NCT01646255|3849302|FG001|Overall Study|Adverse Event|8
2209879|NCT01646255|3849301|FG000|Overall Study|Lack of Efficacy|2
2209880|NCT01646255|3849302|FG001|Overall Study|Lack of Efficacy|0
2209881|NCT01646255|3849301|FG000|Overall Study|Withdrawal by Subject|10
2209882|NCT01646255|3849302|FG001|Overall Study|Withdrawal by Subject|6
2209883|NCT01646255|3849301|FG000|Overall Study|Compliance is not well|1
2209884|NCT01646255|3849302|FG001|Overall Study|Compliance is not well|0
2209885|NCT01646255|3849301|FG000|Overall Study|Inclusion Criteria Deviation|1
2209886|NCT01646255|3849302|FG001|Overall Study|Inclusion Criteria Deviation|0
2209887|NCT01646268|3849311|FG000|Overall Study|Adverse Event|6
2209888|NCT01646268|3849312|FG001|Overall Study|Adverse Event|7
2209889|NCT01646268|3849311|FG000|Overall Study|Lack of Efficacy|1
2209890|NCT01646268|3849312|FG001|Overall Study|Lack of Efficacy|3
2209891|NCT01646268|3849311|FG000|Overall Study|Protocol Violation|0
2209892|NCT01646268|3849312|FG001|Overall Study|Protocol Violation|1
2209893|NCT01646268|3849311|FG000|Overall Study|Withdrawal by Subject|2
2209894|NCT01646268|3849312|FG001|Overall Study|Withdrawal by Subject|5
2209895|NCT01646268|3849311|FG000|Overall Study|Other|2
2209896|NCT01646268|3849312|FG001|Overall Study|Other|0
2209897|NCT01646320|3849320|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3
2209898|NCT01646320|3849321|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0
2209899|NCT01646320|3849320|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
2209900|NCT01646320|3849321|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
2209901|NCT01646320|3849320|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2
2209902|NCT01646320|3849321|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2
2209903|NCT01646320|3849320|FG000|Short-term Period (Day 1 to Week 24)|Other|1
2060675|NCT00556439|3635021|FG002|After Week 12 (Randomized Study Period)|Malignancy|0
2060676|NCT00556439|3635022|FG003|After Week 12 (Randomized Study Period)|Malignancy|1
2060677|NCT00556439|3635019|FG000|After Week 12 (Randomized Study Period)|Severe infection|1
2060678|NCT00556439|3635020|FG001|After Week 12 (Randomized Study Period)|Severe infection|0
2060679|NCT00556439|3635021|FG002|After Week 12 (Randomized Study Period)|Severe infection|0
2060680|NCT00556439|3635022|FG003|After Week 12 (Randomized Study Period)|Severe infection|0
2060681|NCT00556673|3635091|FG000|Overall Study|Protocol deviation|3
2060682|NCT00556673|3635092|FG001|Overall Study|Protocol deviation|2
2060683|NCT00556712|3635102|FG000|Overall Study|Adverse Event|7
2060684|NCT00556712|3635103|FG001|Overall Study|Adverse Event|19
2060685|NCT00556712|3635102|FG000|Overall Study|Death|5
2060686|NCT00556712|3635103|FG001|Overall Study|Death|10
2060687|NCT00556712|3635102|FG000|Overall Study|Progressive Disease|383
2060688|NCT00556712|3635103|FG001|Overall Study|Progressive Disease|320
2060689|NCT00556712|3635102|FG000|Overall Study|Protocol Violation|3
2060690|NCT00556712|3635103|FG001|Overall Study|Protocol Violation|2
2060691|NCT00556712|3635102|FG000|Overall Study|Refused Treatment|17
2060692|NCT00556712|3635103|FG001|Overall Study|Refused Treatment|16
2060693|NCT00556712|3635102|FG000|Overall Study|Failure to Return|2
2060694|NCT00556712|3635103|FG001|Overall Study|Failure to Return|3
2060695|NCT00556712|3635102|FG000|Overall Study|Other|2
2060696|NCT00556712|3635103|FG001|Overall Study|Other|2
2060697|NCT00556712|3635102|FG000|Overall Study|Ongoing at Data Cutoff|32
2060698|NCT00556712|3635103|FG001|Overall Study|Ongoing at Data Cutoff|66
2060699|NCT00556894|3635129|FG000|Overall Study|Adverse Event|2
2060700|NCT00556894|3635130|FG001|Overall Study|Adverse Event|3
2060701|NCT00556894|3635131|FG002|Overall Study|Adverse Event|3
2060702|NCT00556894|3635129|FG000|Overall Study|Death|1
2060703|NCT00556894|3635130|FG001|Overall Study|Death|0
2060704|NCT00556894|3635131|FG002|Overall Study|Death|0
2060705|NCT00556894|3635129|FG000|Overall Study|regulatory decision in Bulgaria|10
2060706|NCT00556894|3635130|FG001|Overall Study|regulatory decision in Bulgaria|14
2060707|NCT00556894|3635131|FG002|Overall Study|regulatory decision in Bulgaria|13
2060708|NCT00556894|3635129|FG000|Overall Study|Change in therapy|2
2060709|NCT00556894|3635130|FG001|Overall Study|Change in therapy|1
2060710|NCT00556894|3635131|FG002|Overall Study|Change in therapy|2
2060711|NCT00556894|3635129|FG000|Overall Study|Withdrawal by Subject|1
2060712|NCT00556894|3635130|FG001|Overall Study|Withdrawal by Subject|1
2060713|NCT00556894|3635131|FG002|Overall Study|Withdrawal by Subject|1
2060714|NCT00556933|3635143|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2
2060715|NCT00556933|3635144|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3
2060716|NCT00556933|3635145|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3
2060717|NCT00556933|3635146|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0
2060718|NCT00556933|3635143|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
2060719|NCT00556933|3635144|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
2060720|NCT00556933|3635145|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
2060721|NCT00556933|3635146|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
2060722|NCT00556933|3635143|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
2060723|NCT00556933|3635144|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
2060724|NCT00556933|3635145|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
2060725|NCT00556933|3635146|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
2060726|NCT00556933|3635143|FG000|Single vs. Divided-dose rATG Induction|Death|0
2060727|NCT00556933|3635144|FG001|Single vs. Divided-dose rATG Induction|Death|1
2060728|NCT00556933|3635145|FG002|Single vs. Divided-dose rATG Induction|Death|0
2060729|NCT00556933|3635146|FG003|Single vs. Divided-dose rATG Induction|Death|0
2060730|NCT00556933|3635143|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
2060731|NCT00556933|3635144|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
2060732|NCT00556933|3635145|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
2060733|NCT00556933|3635146|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
2060734|NCT00556933|3635143|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
2060735|NCT00556933|3635144|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
2060736|NCT00556933|3635145|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
2060737|NCT00556933|3635146|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
2060738|NCT00556933|3635143|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
2060739|NCT00556933|3635144|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
2060740|NCT00556933|3635145|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
2060741|NCT00556933|3635146|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
2060742|NCT00556933|3635143|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
2060743|NCT00556933|3635144|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
2060744|NCT00556933|3635145|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
2060745|NCT00556933|3635146|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
2060746|NCT00556933|3635143|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
2060747|NCT00556933|3635144|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
2060748|NCT00556933|3635145|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
2060749|NCT00556933|3635146|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
2060750|NCT00556933|3635143|FG000|CNI Withdrawal vs. Minimization|Graft loss|0
2060751|NCT00556933|3635144|FG001|CNI Withdrawal vs. Minimization|Graft loss|1
2060752|NCT00556933|3635145|FG002|CNI Withdrawal vs. Minimization|Graft loss|2
2060753|NCT00556933|3635146|FG003|CNI Withdrawal vs. Minimization|Graft loss|0
2060754|NCT00556933|3635143|FG000|CNI Withdrawal vs. Minimization|Death|0
2060755|NCT00556933|3635144|FG001|CNI Withdrawal vs. Minimization|Death|0
2060756|NCT00556933|3635145|FG002|CNI Withdrawal vs. Minimization|Death|0
2060757|NCT00556933|3635146|FG003|CNI Withdrawal vs. Minimization|Death|1
2060758|NCT00556998|3635173|FG000|Voriconazole Intravenous (IV)|Adverse Event|1
2060759|NCT00556998|3635173|FG000|Voriconazole Intravenous (IV)|Other|4
2060760|NCT00556998|3635173|FG000|Voriconazole Oral|Adverse Event|1
2060761|NCT00556998|3635173|FG000|Voriconazole Oral|Intolerant of oral treatment|1
2060762|NCT00557076|3635183|FG000|Overall Study|Unblinding|0
2060763|NCT00557076|3635184|FG001|Overall Study|Unblinding|1
2060764|NCT00557193|3635190|FG000|Induction|Adverse Event|2
2060765|NCT00557193|3635191|FG001|Induction|Adverse Event|0
2060766|NCT00557193|3635192|FG002|Induction|Adverse Event|0
2060767|NCT00557193|3635193|FG003|Induction|Adverse Event|0
2060768|NCT00557193|3635194|FG004|Induction|Adverse Event|0
2060769|NCT00557193|3635195|FG005|Induction|Adverse Event|0
2301625|NCT02613507|3999639|FG001|Overall Study|Participant Withdrew Consent|2
2301626|NCT02613507|3999638|FG000|Overall Study|Lost to Follow-up|1
2301627|NCT02613507|3999639|FG001|Overall Study|Lost to Follow-up|0
2301628|NCT02613507|3999638|FG000|Overall Study|Maximum Clinical Benefit|4
2301629|NCT02613507|3999639|FG001|Overall Study|Maximum Clinical Benefit|10
2301630|NCT02613507|3999638|FG000|Overall Study|Brain Radiotherapy Activity Limited|1
2301631|NCT02613507|3999639|FG001|Overall Study|Brain Radiotherapy Activity Limited|0
2301632|NCT02613507|3999638|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
2301633|NCT02613507|3999639|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
2301634|NCT02613507|3999638|FG000|Overall Study|Randomized but not Treated|1
2301635|NCT02613507|3999639|FG001|Overall Study|Randomized but not Treated|10
2301636|NCT02613572|3999648|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1
2301637|NCT02613572|3999649|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
2301638|NCT02613572|3999650|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
2301639|NCT02613572|3999648|FG000|Phase II: Double-Blind Rand Plac Control|Death|0
2301640|NCT02613572|3999649|FG001|Phase II: Double-Blind Rand Plac Control|Death|1
2301641|NCT02613572|3999650|FG002|Phase II: Double-Blind Rand Plac Control|Death|0
2301642|NCT02613871|3999662|FG000|Overall Study|Death|2
2301643|NCT02613871|3999662|FG000|Overall Study|Withdrew Consent|1
2301644|NCT02613884|3999666|FG000|Overall Study|Death|1
2301645|NCT02613884|3999666|FG000|Overall Study|Lost to Follow-up|1
2301646|NCT02613910|3999685|FG000|Overall Study|Termination of study|1
2301647|NCT02614079|3999689|FG000|Overall Study|Withdrawal by Subject|1
2301648|NCT02614131|3999700|FG000|Overall Study|Withdrawal by Subject|1
2301649|NCT02614131|3999701|FG001|Overall Study|Withdrawal by Subject|0
2301650|NCT02614131|3999702|FG002|Overall Study|Withdrawal by Subject|0
2301651|NCT02614131|3999703|FG003|Overall Study|Withdrawal by Subject|0
2301652|NCT02614131|3999704|FG004|Overall Study|Withdrawal by Subject|0
2301653|NCT02614131|3999705|FG005|Overall Study|Withdrawal by Subject|0
2301654|NCT02614131|3999706|FG006|Overall Study|Withdrawal by Subject|0
2301655|NCT02614131|3999700|FG000|Overall Study|Adverse Event|0
2301656|NCT02614131|3999701|FG001|Overall Study|Adverse Event|0
2301657|NCT02614131|3999702|FG002|Overall Study|Adverse Event|0
2301658|NCT02614131|3999703|FG003|Overall Study|Adverse Event|0
2301659|NCT02614131|3999704|FG004|Overall Study|Adverse Event|0
2301660|NCT02614131|3999705|FG005|Overall Study|Adverse Event|0
2301661|NCT02614131|3999706|FG006|Overall Study|Adverse Event|1
2301662|NCT02614183|3999731|FG000|Double Blind Treatment Phase|Adverse Event|10
2301663|NCT02614183|3999732|FG001|Double Blind Treatment Phase|Adverse Event|9
2301664|NCT02614183|3999733|FG002|Double Blind Treatment Phase|Adverse Event|7
2301665|NCT02614183|3999731|FG000|Double Blind Treatment Phase|Lack of Efficacy|10
2301666|NCT02614183|3999732|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
2301667|NCT02614183|3999733|FG002|Double Blind Treatment Phase|Lack of Efficacy|2
2301668|NCT02614183|3999731|FG000|Double Blind Treatment Phase|Lost to Follow-up|18
2301669|NCT02614183|3999732|FG001|Double Blind Treatment Phase|Lost to Follow-up|9
2060770|NCT00557193|3635190|FG000|Induction|Death|6
2060771|NCT00557193|3635191|FG001|Induction|Death|0
2060772|NCT00557193|3635192|FG002|Induction|Death|0
2060773|NCT00557193|3635193|FG003|Induction|Death|0
2301670|NCT02614183|3999733|FG002|Double Blind Treatment Phase|Lost to Follow-up|5
2301671|NCT02614183|3999731|FG000|Double Blind Treatment Phase|Physician Decision|7
2301672|NCT02614183|3999732|FG001|Double Blind Treatment Phase|Physician Decision|3
2060774|NCT00557193|3635194|FG004|Induction|Death|0
2060775|NCT00557193|3635195|FG005|Induction|Death|0
2060776|NCT00557193|3635190|FG000|Induction|Physician Decision|3
2060777|NCT00557193|3635191|FG001|Induction|Physician Decision|0
2060778|NCT00557193|3635192|FG002|Induction|Physician Decision|0
2060779|NCT00557193|3635193|FG003|Induction|Physician Decision|0
2060780|NCT00557193|3635194|FG004|Induction|Physician Decision|0
2060781|NCT00557193|3635195|FG005|Induction|Physician Decision|0
2060782|NCT00557193|3635190|FG000|Induction|Withdrawal by Subject|1
2060783|NCT00557193|3635191|FG001|Induction|Withdrawal by Subject|0
2060784|NCT00557193|3635192|FG002|Induction|Withdrawal by Subject|0
2060785|NCT00557193|3635193|FG003|Induction|Withdrawal by Subject|0
2060786|NCT00557193|3635194|FG004|Induction|Withdrawal by Subject|0
2060787|NCT00557193|3635195|FG005|Induction|Withdrawal by Subject|0
2060788|NCT00557193|3635190|FG000|Induction|Refusal of Further Protocol Therapy|2
2060789|NCT00557193|3635191|FG001|Induction|Refusal of Further Protocol Therapy|0
2060790|NCT00557193|3635192|FG002|Induction|Refusal of Further Protocol Therapy|0
2060791|NCT00557193|3635193|FG003|Induction|Refusal of Further Protocol Therapy|0
2060792|NCT00557193|3635194|FG004|Induction|Refusal of Further Protocol Therapy|0
2060793|NCT00557193|3635195|FG005|Induction|Refusal of Further Protocol Therapy|0
2060794|NCT00557193|3635190|FG000|Induction|Ineligible|8
2301673|NCT02614183|3999733|FG002|Double Blind Treatment Phase|Physician Decision|2
2301674|NCT02614183|3999731|FG000|Double Blind Treatment Phase|Pregnancy|2
2301675|NCT02614183|3999732|FG001|Double Blind Treatment Phase|Pregnancy|1
2301676|NCT02614183|3999733|FG002|Double Blind Treatment Phase|Pregnancy|3
2301677|NCT02614183|3999731|FG000|Double Blind Treatment Phase|Protocol Violation|2
2301678|NCT02614183|3999732|FG001|Double Blind Treatment Phase|Protocol Violation|2
2301679|NCT02614183|3999733|FG002|Double Blind Treatment Phase|Protocol Violation|2
2301680|NCT02614183|3999731|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33
2301681|NCT02614183|3999732|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
2301682|NCT02614183|3999733|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16
2301683|NCT02614183|3999731|FG000|Double Blind Treatment Phase|Did not receive study drug|1
2301684|NCT02614183|3999732|FG001|Double Blind Treatment Phase|Did not receive study drug|1
2301685|NCT02614183|3999733|FG002|Double Blind Treatment Phase|Did not receive study drug|2
2301686|NCT02614183|3999731|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5
2301687|NCT02614183|3999732|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
2301688|NCT02614183|3999733|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5
2301689|NCT02614183|3999731|FG000|Post Treatment Follow-up Phase|Physician Decision|5
2301690|NCT02614183|3999732|FG001|Post Treatment Follow-up Phase|Physician Decision|1
2301691|NCT02614183|3999733|FG002|Post Treatment Follow-up Phase|Physician Decision|2
2301692|NCT02614183|3999731|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
2301693|NCT02614183|3999732|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
2301694|NCT02614183|3999733|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
2301695|NCT02614183|3999731|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7
2301696|NCT02614183|3999732|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2
2301697|NCT02614183|3999733|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
2301698|NCT02614196|3999753|FG000|Double Blind Treatment Phase|Adverse Event|8
2301699|NCT02614196|3999754|FG001|Double Blind Treatment Phase|Adverse Event|5
2301700|NCT02614196|3999755|FG002|Double Blind Treatment Phase|Adverse Event|9
2301701|NCT02614196|3999756|FG003|Double Blind Treatment Phase|Adverse Event|0
2301702|NCT02614196|3999757|FG004|Double Blind Treatment Phase|Adverse Event|0
2301703|NCT02614196|3999758|FG005|Double Blind Treatment Phase|Adverse Event|0
2301704|NCT02614196|3999753|FG000|Double Blind Treatment Phase|Lack of Efficacy|6
2301705|NCT02614196|3999754|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
2301706|NCT02614196|3999755|FG002|Double Blind Treatment Phase|Lack of Efficacy|1
2301707|NCT02614196|3999756|FG003|Double Blind Treatment Phase|Lack of Efficacy|0
2301708|NCT02614196|3999757|FG004|Double Blind Treatment Phase|Lack of Efficacy|0
2301709|NCT02614196|3999758|FG005|Double Blind Treatment Phase|Lack of Efficacy|0
2301710|NCT02614196|3999753|FG000|Double Blind Treatment Phase|Lost to Follow-up|10
2301711|NCT02614196|3999754|FG001|Double Blind Treatment Phase|Lost to Follow-up|7
2301712|NCT02614196|3999755|FG002|Double Blind Treatment Phase|Lost to Follow-up|1
2301713|NCT02614196|3999756|FG003|Double Blind Treatment Phase|Lost to Follow-up|0
2301714|NCT02614196|3999757|FG004|Double Blind Treatment Phase|Lost to Follow-up|0
2301715|NCT02614196|3999758|FG005|Double Blind Treatment Phase|Lost to Follow-up|0
2301716|NCT02614196|3999753|FG000|Double Blind Treatment Phase|Physician Decision|4
2301717|NCT02614196|3999754|FG001|Double Blind Treatment Phase|Physician Decision|0
2301718|NCT02614196|3999755|FG002|Double Blind Treatment Phase|Physician Decision|2
2301719|NCT02614196|3999756|FG003|Double Blind Treatment Phase|Physician Decision|0
2301720|NCT02614196|3999757|FG004|Double Blind Treatment Phase|Physician Decision|0
2301721|NCT02614196|3999758|FG005|Double Blind Treatment Phase|Physician Decision|0
2301722|NCT02614196|3999753|FG000|Double Blind Treatment Phase|Pregnancy|1
2301723|NCT02614196|3999754|FG001|Double Blind Treatment Phase|Pregnancy|2
2301724|NCT02614196|3999755|FG002|Double Blind Treatment Phase|Pregnancy|0
2060795|NCT00557193|3635191|FG001|Induction|Ineligible|0
2060796|NCT00557193|3635192|FG002|Induction|Ineligible|0
2060797|NCT00557193|3635193|FG003|Induction|Ineligible|0
2060798|NCT00557193|3635194|FG004|Induction|Ineligible|0
2060799|NCT00557193|3635195|FG005|Induction|Ineligible|0
2060800|NCT00557193|3635190|FG000|Induction|Inevaluable for post Induction|2
2060801|NCT00557193|3635191|FG001|Induction|Inevaluable for post Induction|0
2060802|NCT00557193|3635192|FG002|Induction|Inevaluable for post Induction|0
2060803|NCT00557193|3635193|FG003|Induction|Inevaluable for post Induction|0
2301725|NCT02614196|3999756|FG003|Double Blind Treatment Phase|Pregnancy|0
2301726|NCT02614196|3999757|FG004|Double Blind Treatment Phase|Pregnancy|0
2301727|NCT02614196|3999758|FG005|Double Blind Treatment Phase|Pregnancy|0
2301728|NCT02614196|3999753|FG000|Double Blind Treatment Phase|Protocol Violation|5
2301729|NCT02614196|3999754|FG001|Double Blind Treatment Phase|Protocol Violation|2
2301730|NCT02614196|3999755|FG002|Double Blind Treatment Phase|Protocol Violation|1
2301731|NCT02614196|3999756|FG003|Double Blind Treatment Phase|Protocol Violation|0
2301732|NCT02614196|3999757|FG004|Double Blind Treatment Phase|Protocol Violation|1
2301733|NCT02614196|3999758|FG005|Double Blind Treatment Phase|Protocol Violation|0
2301734|NCT02614196|3999753|FG000|Double Blind Treatment Phase|Terminated by sponsor|1
2301735|NCT02614196|3999754|FG001|Double Blind Treatment Phase|Terminated by sponsor|0
2301736|NCT02614196|3999755|FG002|Double Blind Treatment Phase|Terminated by sponsor|0
2301737|NCT02614196|3999756|FG003|Double Blind Treatment Phase|Terminated by sponsor|0
2301738|NCT02614196|3999757|FG004|Double Blind Treatment Phase|Terminated by sponsor|0
2301739|NCT02614196|3999758|FG005|Double Blind Treatment Phase|Terminated by sponsor|0
2301740|NCT02614196|3999753|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39
2301741|NCT02614196|3999754|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
2301742|NCT02614196|3999755|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14
2301743|NCT02614196|3999756|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4
2301744|NCT02614196|3999757|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0
2301745|NCT02614196|3999758|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0
2301746|NCT02614196|3999753|FG000|Double Blind Treatment Phase|Did not receive study drug|2
2301747|NCT02614196|3999754|FG001|Double Blind Treatment Phase|Did not receive study drug|2
2301748|NCT02614196|3999755|FG002|Double Blind Treatment Phase|Did not receive study drug|3
2301749|NCT02614196|3999756|FG003|Double Blind Treatment Phase|Did not receive study drug|0
2301750|NCT02614196|3999757|FG004|Double Blind Treatment Phase|Did not receive study drug|0
2301751|NCT02614196|3999758|FG005|Double Blind Treatment Phase|Did not receive study drug|0
2301752|NCT02614196|3999753|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8
2301753|NCT02614196|3999754|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
2301754|NCT02614196|3999755|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3
2301755|NCT02614196|3999756|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0
2301756|NCT02614196|3999757|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1
2301757|NCT02614196|3999758|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0
2301758|NCT02614196|3999753|FG000|Post Treatment Follow-up Phase|Pregnancy|2
2301759|NCT02614196|3999754|FG001|Post Treatment Follow-up Phase|Pregnancy|0
2301760|NCT02614196|3999755|FG002|Post Treatment Follow-up Phase|Pregnancy|0
2301761|NCT02614196|3999756|FG003|Post Treatment Follow-up Phase|Pregnancy|0
2301762|NCT02614196|3999757|FG004|Post Treatment Follow-up Phase|Pregnancy|0
2301763|NCT02614196|3999758|FG005|Post Treatment Follow-up Phase|Pregnancy|0
2301764|NCT02614196|3999753|FG000|Post Treatment Follow-up Phase|Protocol Violation|0
2301765|NCT02614196|3999754|FG001|Post Treatment Follow-up Phase|Protocol Violation|1
2301766|NCT02614196|3999755|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
2301767|NCT02614196|3999756|FG003|Post Treatment Follow-up Phase|Protocol Violation|0
2301768|NCT02614196|3999757|FG004|Post Treatment Follow-up Phase|Protocol Violation|1
2301769|NCT02614196|3999758|FG005|Post Treatment Follow-up Phase|Protocol Violation|0
2301770|NCT02614196|3999753|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10
2301771|NCT02614196|3999754|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
2301772|NCT02614196|3999755|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
2301773|NCT02614196|3999756|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1
2301774|NCT02614196|3999757|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0
2301775|NCT02614196|3999758|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0
2301776|NCT02614261|3999798|FG000|Overall Study|Adverse Event|6
2301777|NCT02614261|3999799|FG001|Overall Study|Adverse Event|3
2301778|NCT02614261|3999800|FG002|Overall Study|Adverse Event|2
2301779|NCT02614261|3999798|FG000|Overall Study|Lack of Efficacy|4
2301780|NCT02614261|3999799|FG001|Overall Study|Lack of Efficacy|0
2301781|NCT02614261|3999800|FG002|Overall Study|Lack of Efficacy|0
2301782|NCT02614261|3999798|FG000|Overall Study|Lost to Follow-up|10
2301783|NCT02614261|3999799|FG001|Overall Study|Lost to Follow-up|4
2301784|NCT02614261|3999800|FG002|Overall Study|Lost to Follow-up|1
2301785|NCT02614261|3999798|FG000|Overall Study|Physician Decision|2
2301786|NCT02614261|3999799|FG001|Overall Study|Physician Decision|1
2301787|NCT02614261|3999800|FG002|Overall Study|Physician Decision|1
2301788|NCT02614261|3999798|FG000|Overall Study|Pregnancy|2
2301789|NCT02614261|3999799|FG001|Overall Study|Pregnancy|2
2301790|NCT02614261|3999800|FG002|Overall Study|Pregnancy|0
2301791|NCT02614261|3999798|FG000|Overall Study|Protocol Violation|6
2301792|NCT02614261|3999799|FG001|Overall Study|Protocol Violation|1
2301793|NCT02614261|3999800|FG002|Overall Study|Protocol Violation|0
2301794|NCT02614261|3999798|FG000|Overall Study|Withdrawal by Subject|19
2301795|NCT02614261|3999799|FG001|Overall Study|Withdrawal by Subject|4
2301796|NCT02614261|3999800|FG002|Overall Study|Withdrawal by Subject|7
2060804|NCT00557193|3635194|FG004|Induction|Inevaluable for post Induction|0
2060805|NCT00557193|3635195|FG005|Induction|Inevaluable for post Induction|0
2060806|NCT00557193|3635190|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2
2060807|NCT00557193|3635191|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0
2060808|NCT00557193|3635192|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0
2060809|NCT00557193|3635193|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0
2060810|NCT00557193|3635194|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0
2301797|NCT02614287|3999822|FG000|Open Label (OL) Treatment Phase|Adverse Event|7
2301798|NCT02614287|3999823|FG001|Open Label (OL) Treatment Phase|Adverse Event|6
2301799|NCT02614287|3999822|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13
2301800|NCT02614287|3999823|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5
2301801|NCT02614287|3999822|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7
2301802|NCT02614287|3999823|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4
2301803|NCT02614287|3999822|FG000|Open Label (OL) Treatment Phase|Physician Decision|1
2301804|NCT02614287|3999823|FG001|Open Label (OL) Treatment Phase|Physician Decision|0
2301805|NCT02614287|3999822|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
2301806|NCT02614287|3999823|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
2301807|NCT02614287|3999822|FG000|Post Treatment Follow-up Phase|Adverse Event|1
2301808|NCT02614287|3999823|FG001|Post Treatment Follow-up Phase|Adverse Event|0
2301809|NCT02614287|3999822|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2
2301810|NCT02614287|3999823|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2
2301811|NCT02614287|3999822|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6
2301812|NCT02614287|3999823|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3
2301813|NCT02614560|3999845|FG000|Overall Study|Death|6
2301814|NCT02614560|3999846|FG001|Overall Study|Death|2
2301815|NCT02614703|3999854|FG000|Overall Study|Withdrawal by Subject|7
2301816|NCT02614703|3999855|FG001|Overall Study|Withdrawal by Subject|1
2301817|NCT02614729|3999863|FG000|Overall Study|Withdrawal by Subject|1
2301818|NCT02614729|3999864|FG001|Overall Study|Withdrawal by Subject|0
2301819|NCT02614794|3999874|FG000|Overall Study|On treatment|118
2301820|NCT02614794|3999875|FG001|Overall Study|On treatment|27
2301821|NCT02614794|3999874|FG000|Overall Study|In long term follow up|148
2301822|NCT02614794|3999875|FG001|Overall Study|In long term follow up|85
2301823|NCT02614794|3999874|FG000|Overall Study|Death|126
2301824|NCT02614794|3999875|FG001|Overall Study|Death|84
2301825|NCT02614794|3999874|FG000|Overall Study|Withdrawal by Subject|16
2301826|NCT02614794|3999875|FG001|Overall Study|Withdrawal by Subject|5
2301827|NCT02614794|3999874|FG000|Overall Study|Lost to Follow-up|2
2301828|NCT02614794|3999875|FG001|Overall Study|Lost to Follow-up|0
2301829|NCT02614794|3999874|FG000|Overall Study|Physician Decision|0
2301830|NCT02614794|3999875|FG001|Overall Study|Physician Decision|1
2301831|NCT02615145|3999894|FG000|Overall Study|Did Not Start Treatment|0
2301832|NCT02615145|3999895|FG001|Overall Study|Did Not Start Treatment|0
2301833|NCT02615145|3999896|FG002|Overall Study|Did Not Start Treatment|1
2301834|NCT02615145|3999897|FG003|Overall Study|Did Not Start Treatment|1
2301835|NCT02615145|3999894|FG000|Overall Study|Failure to Return|20
2301836|NCT02615145|3999895|FG001|Overall Study|Failure to Return|10
2301837|NCT02615145|3999896|FG002|Overall Study|Failure to Return|7
2301838|NCT02615145|3999897|FG003|Overall Study|Failure to Return|0
2301839|NCT02615145|3999894|FG000|Overall Study|Death|2
2301840|NCT02615145|3999895|FG001|Overall Study|Death|3
2301841|NCT02615145|3999896|FG002|Overall Study|Death|0
2301842|NCT02615145|3999897|FG003|Overall Study|Death|0
2301843|NCT02615145|3999894|FG000|Overall Study|Other, Not Specified|5
2301844|NCT02615145|3999895|FG001|Overall Study|Other, Not Specified|2
2301845|NCT02615145|3999896|FG002|Overall Study|Other, Not Specified|0
2301846|NCT02615145|3999897|FG003|Overall Study|Other, Not Specified|0
2301847|NCT02615171|3999938|FG000|Overall Study|Lost to Follow-up|2
2301848|NCT02615171|3999939|FG001|Overall Study|Lost to Follow-up|1
2301849|NCT02615249|3999945|FG000|Overall Study|Withdrawal by Subject|1
2301850|NCT02615470|3999952|FG000|Overall Study|Lost to Follow-up|21
2301851|NCT02615470|3999953|FG001|Overall Study|Lost to Follow-up|32
2301852|NCT02615509|3999959|FG000|Overall Study|Lost to Follow-up|134
2301853|NCT02615509|3999959|FG000|Overall Study|Death|4
2301854|NCT02615509|3999959|FG000|Overall Study|Withdrawal by Subject|8
2301855|NCT02616029|3999992|FG000|Overall Study|Adverse Event|1
2301856|NCT02616029|3999993|FG001|Overall Study|Adverse Event|0
2301857|NCT02616029|3999992|FG000|Overall Study|Death|0
2301858|NCT02616029|3999993|FG001|Overall Study|Death|1
2301859|NCT02616029|3999992|FG000|Overall Study|Protocol Violation|1
2301860|NCT02616029|3999993|FG001|Overall Study|Protocol Violation|0
2301861|NCT02616029|3999992|FG000|Overall Study|Withdrew Consent|1
2301862|NCT02616029|3999993|FG001|Overall Study|Withdrew Consent|0
2301863|NCT02616029|3999992|FG000|Overall Study|Enrolled and Never Treated|1
2301864|NCT02616029|3999993|FG001|Overall Study|Enrolled and Never Treated|1
2301865|NCT02616380|4000008|FG000|Overall Study|Lost to Follow-up|1
2301866|NCT02616380|4000008|FG000|Overall Study|Other|2
2301867|NCT02616393|4000015|FG000|Overall Study|Death|5
2301868|NCT02616393|4000016|FG001|Overall Study|Death|12
2301869|NCT02616393|4000017|FG002|Overall Study|Death|1
2301870|NCT02616393|4000015|FG000|Overall Study|Termination by Sponsor|4
2301871|NCT02616393|4000016|FG001|Overall Study|Termination by Sponsor|5
2301872|NCT02616393|4000017|FG002|Overall Study|Termination by Sponsor|2
2301873|NCT02616393|4000015|FG000|Overall Study|Other|3
2060811|NCT00557193|3635195|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0
2060812|NCT00557193|3635190|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
2060813|NCT00557193|3635191|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1
2060814|NCT00557193|3635192|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2
2060815|NCT00557193|3635193|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1
2060816|NCT00557193|3635194|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0
2060817|NCT00557193|3635195|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3
2060818|NCT00557193|3635190|FG000|Post Induction Therapy by Tx Assignment|Death|0
2060819|NCT00557193|3635191|FG001|Post Induction Therapy by Tx Assignment|Death|0
2060820|NCT00557193|3635192|FG002|Post Induction Therapy by Tx Assignment|Death|2
2060821|NCT00557193|3635193|FG003|Post Induction Therapy by Tx Assignment|Death|0
2060822|NCT00557193|3635194|FG004|Post Induction Therapy by Tx Assignment|Death|2
2060823|NCT00557193|3635195|FG005|Post Induction Therapy by Tx Assignment|Death|2
2301874|NCT02616393|4000016|FG001|Overall Study|Other|0
2301875|NCT02616393|4000017|FG002|Overall Study|Other|0
2301876|NCT02616393|4000015|FG000|Overall Study|Withdrawal by Subject|1
2301877|NCT02616393|4000016|FG001|Overall Study|Withdrawal by Subject|1
2301878|NCT02616393|4000017|FG002|Overall Study|Withdrawal by Subject|0
2301879|NCT02616393|4000015|FG000|Overall Study|Lost to Follow-up|0
2301880|NCT02616393|4000016|FG001|Overall Study|Lost to Follow-up|2
2301881|NCT02616393|4000017|FG002|Overall Study|Lost to Follow-up|0
2301882|NCT02616601|4000060|FG000|Overall Study|Withdrawal by Subject|4
2301883|NCT02616601|4000061|FG001|Overall Study|Withdrawal by Subject|4
2301884|NCT02616601|4000062|FG002|Overall Study|Withdrawal by Subject|3
2301885|NCT02616601|4000060|FG000|Overall Study|Adverse Event|2
2301886|NCT02616601|4000061|FG001|Overall Study|Adverse Event|0
2301887|NCT02616601|4000062|FG002|Overall Study|Adverse Event|2
2301888|NCT02616601|4000060|FG000|Overall Study|Death|1
2301889|NCT02616601|4000061|FG001|Overall Study|Death|0
2301890|NCT02616601|4000062|FG002|Overall Study|Death|0
2301891|NCT02616601|4000060|FG000|Overall Study|Lost to Follow-up|1
2301892|NCT02616601|4000061|FG001|Overall Study|Lost to Follow-up|0
2301893|NCT02616601|4000062|FG002|Overall Study|Lost to Follow-up|1
2301894|NCT02616601|4000060|FG000|Overall Study|Non-Compliance with Test Article|1
2301895|NCT02616601|4000061|FG001|Overall Study|Non-Compliance with Test Article|0
2301896|NCT02616601|4000062|FG002|Overall Study|Non-Compliance with Test Article|1
2301897|NCT02616614|4000073|FG000|Overall Study|Withdrawal by Subject|10
2301898|NCT02616614|4000074|FG001|Overall Study|Withdrawal by Subject|5
2301899|NCT02616614|4000075|FG002|Overall Study|Withdrawal by Subject|6
2301900|NCT02616614|4000073|FG000|Overall Study|Physician Decision|2
2301901|NCT02616614|4000074|FG001|Overall Study|Physician Decision|1
2301902|NCT02616614|4000075|FG002|Overall Study|Physician Decision|0
2301903|NCT02616614|4000073|FG000|Overall Study|Adverse Event|1
2301904|NCT02616614|4000074|FG001|Overall Study|Adverse Event|4
2301905|NCT02616614|4000075|FG002|Overall Study|Adverse Event|1
2301906|NCT02616614|4000073|FG000|Overall Study|Protocol Violation|0
2301907|NCT02616614|4000074|FG001|Overall Study|Protocol Violation|3
2301908|NCT02616614|4000075|FG002|Overall Study|Protocol Violation|1
2301909|NCT02616614|4000073|FG000|Overall Study|Prohibited Medication|12
2301910|NCT02616614|4000074|FG001|Overall Study|Prohibited Medication|9
2301911|NCT02616614|4000075|FG002|Overall Study|Prohibited Medication|5
2301912|NCT02616614|4000073|FG000|Overall Study|More than 3 applications missed|6
2301913|NCT02616614|4000074|FG001|Overall Study|More than 3 applications missed|8
2301914|NCT02616614|4000075|FG002|Overall Study|More than 3 applications missed|1
2301915|NCT02616614|4000073|FG000|Overall Study|Lost to Follow-up|31
2301916|NCT02616614|4000074|FG001|Overall Study|Lost to Follow-up|28
2301917|NCT02616614|4000075|FG002|Overall Study|Lost to Follow-up|13
2301918|NCT02616614|4000073|FG000|Overall Study|Pregnancy|2
2301919|NCT02616614|4000074|FG001|Overall Study|Pregnancy|0
2301920|NCT02616614|4000075|FG002|Overall Study|Pregnancy|1
2301921|NCT02616614|4000073|FG000|Overall Study|Other|1
2301922|NCT02616614|4000074|FG001|Overall Study|Other|2
2301923|NCT02616614|4000075|FG002|Overall Study|Other|1
2301924|NCT02616783|4000086|FG000|Overall Study|Randomized but Not Treated|1
2301925|NCT02616783|4000087|FG001|Overall Study|Randomized but Not Treated|0
2301926|NCT02616783|4000086|FG000|Overall Study|Adverse Event|1
2301927|NCT02616783|4000087|FG001|Overall Study|Adverse Event|0
2301928|NCT02616783|4000086|FG000|Overall Study|Death|1
2301929|NCT02616783|4000087|FG001|Overall Study|Death|0
2301930|NCT02616783|4000086|FG000|Overall Study|Non-Compliance with Study Drug|1
2301931|NCT02616783|4000087|FG001|Overall Study|Non-Compliance with Study Drug|0
2301932|NCT02616783|4000086|FG000|Overall Study|Protocol Violation|1
2301933|NCT02616783|4000087|FG001|Overall Study|Protocol Violation|1
2301934|NCT02616783|4000086|FG000|Overall Study|Withdrew Consent|1
2301935|NCT02616783|4000087|FG001|Overall Study|Withdrew Consent|1
2301936|NCT02616900|4000093|FG000|Overall Study|Lack of Efficacy|7
2301937|NCT02616900|4000093|FG000|Overall Study|Lost to Follow-up|2
2301938|NCT02616900|4000093|FG000|Overall Study|Protocol Violation|5
2301939|NCT02616900|4000093|FG000|Overall Study|Withdrawal by Subject|3
2301940|NCT02616900|4000093|FG000|Overall Study|Incomplete data|6
2301941|NCT02617589|4000099|FG000|All Randomized|Request to discontinue study treatment|1
2301942|NCT02617589|4000100|FG001|All Randomized|Request to discontinue study treatment|3
2301943|NCT02617589|4000099|FG000|All Randomized|Participant Withdrew Consent|1
2060824|NCT00557193|3635190|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
2060825|NCT00557193|3635191|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3
2060826|NCT00557193|3635192|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5
2060827|NCT00557193|3635193|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1
2060828|NCT00557193|3635194|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2
2060829|NCT00557193|3635195|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2
2060830|NCT00557193|3635190|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
2060831|NCT00557193|3635191|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
2060832|NCT00557193|3635192|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
2060833|NCT00557193|3635193|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
2060834|NCT00557193|3635194|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
2060835|NCT00557193|3635195|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
2060836|NCT00557193|3635190|FG000|Post Induction Therapy by Tx Assignment|Relapse|0
2060837|NCT00557193|3635191|FG001|Post Induction Therapy by Tx Assignment|Relapse|5
2060838|NCT00557193|3635192|FG002|Post Induction Therapy by Tx Assignment|Relapse|16
2060839|NCT00557193|3635193|FG003|Post Induction Therapy by Tx Assignment|Relapse|3
2060840|NCT00557193|3635194|FG004|Post Induction Therapy by Tx Assignment|Relapse|1
2060841|NCT00557193|3635195|FG005|Post Induction Therapy by Tx Assignment|Relapse|20
2060842|NCT00557193|3635190|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
2060843|NCT00557193|3635191|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
2060844|NCT00557193|3635192|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
2060845|NCT00557193|3635193|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
2060846|NCT00557193|3635194|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
2060847|NCT00557193|3635195|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
2060848|NCT00557193|3635190|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
2060849|NCT00557193|3635191|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
2060850|NCT00557193|3635192|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
2060851|NCT00557193|3635193|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
2060852|NCT00557193|3635194|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
2060853|NCT00557193|3635195|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
2060854|NCT00557193|3635190|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0
2060855|NCT00557193|3635191|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0
2060856|NCT00557193|3635192|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4
2060857|NCT00557193|3635193|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0
2060858|NCT00557193|3635194|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0
2060859|NCT00557193|3635195|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5
2060860|NCT00557245|3635223|FG000|Overall Study|Lost to Follow-up|7
2060861|NCT00557245|3635224|FG001|Overall Study|Lost to Follow-up|8
2060862|NCT00557245|3635225|FG002|Overall Study|Lost to Follow-up|10
2060863|NCT00557245|3635223|FG000|Overall Study|Ineligible|5
2060864|NCT00557245|3635224|FG001|Overall Study|Ineligible|4
2060865|NCT00557245|3635225|FG002|Overall Study|Ineligible|2
2060866|NCT00557310|3635245|FG000|Main Study (0 - 18 Months)|Adverse Event|4
2060867|NCT00557310|3635245|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1
2060868|NCT00557310|3635245|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1
2060869|NCT00557310|3635245|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
2060870|NCT00557310|3635245|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2
2060871|NCT00557310|3635245|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1
2060872|NCT00557323|3635249|FG000|Overall Study|Death|3
2060873|NCT00557323|3635249|FG000|Overall Study|Withdrawal by Subject|2
2301944|NCT02617589|4000100|FG001|All Randomized|Participant Withdrew Consent|2
2301945|NCT02617589|4000099|FG000|Treatment Period|Other Reasons|2
2301946|NCT02617589|4000100|FG001|Treatment Period|Other Reasons|2
2301947|NCT02617589|4000099|FG000|Treatment Period|Not reported|1
2301948|NCT02617589|4000100|FG001|Treatment Period|Not reported|0
2301949|NCT02617589|4000099|FG000|Treatment Period|Poor/Non compliance|1
2301950|NCT02617589|4000100|FG001|Treatment Period|Poor/Non compliance|1
2301951|NCT02617589|4000099|FG000|Treatment Period|Maximum Clinical Benefit|0
2301952|NCT02617589|4000100|FG001|Treatment Period|Maximum Clinical Benefit|2
2301953|NCT02617589|4000099|FG000|Treatment Period|Participant Withdrew Consent|2
2301954|NCT02617589|4000100|FG001|Treatment Period|Participant Withdrew Consent|6
2301955|NCT02617589|4000099|FG000|Treatment Period|Participant Request to discontinue|12
2301956|NCT02617589|4000100|FG001|Treatment Period|Participant Request to discontinue|20
2301957|NCT02617589|4000099|FG000|Treatment Period|Adverse event unrelated to study drug|15
2301958|NCT02617589|4000100|FG001|Treatment Period|Adverse event unrelated to study drug|9
2301959|NCT02617589|4000099|FG000|Treatment Period|Death|1
2301960|NCT02617589|4000100|FG001|Treatment Period|Death|1
2301961|NCT02617589|4000099|FG000|Treatment Period|Study Drug Toxicity|26
2301962|NCT02617589|4000100|FG001|Treatment Period|Study Drug Toxicity|20
2301963|NCT02617589|4000099|FG000|Treatment Period|Disease Progression|214
2301964|NCT02617589|4000100|FG001|Treatment Period|Disease Progression|137
2301965|NCT02617589|4000099|FG000|Treatment Period|Completed Treatment|0
2301966|NCT02617589|4000100|FG001|Treatment Period|Completed Treatment|76
2301967|NCT02617628|4000108|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62
2301968|NCT02617628|4000109|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61
2321517|NCT02960490|4036047|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
2321518|NCT02960490|4036048|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
2321519|NCT02960490|4036049|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
2060874|NCT00557323|3635249|FG000|Overall Study|Administrative change|2
2060875|NCT00557440|3635285|FG000|Treatment Period 1|Adverse Event|0
2060876|NCT00557440|3635286|FG001|Treatment Period 1|Adverse Event|0
2321520|NCT02960490|4036050|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
2321521|NCT02960490|4036051|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3
2321522|NCT02960490|4036052|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
2321523|NCT02960490|4036053|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
2321524|NCT02960490|4036054|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
2321525|NCT02960490|4036045|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
2321526|NCT02960490|4036046|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
2321527|NCT02960490|4036047|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
2321528|NCT02960490|4036048|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
2321529|NCT02960490|4036049|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
2321530|NCT02960490|4036050|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
2321531|NCT02960490|4036051|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
2321532|NCT02960490|4036052|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1
2321533|NCT02960490|4036053|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
2321534|NCT02960490|4036054|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
2321535|NCT02960490|4036045|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
2321536|NCT02960490|4036046|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
2321537|NCT02960490|4036047|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
2321538|NCT02960490|4036048|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
2321539|NCT02960490|4036049|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
2321540|NCT02960490|4036050|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
2321541|NCT02960490|4036051|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4
2321542|NCT02960490|4036052|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
2321543|NCT02960490|4036053|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
2321544|NCT02960490|4036054|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7
2321545|NCT02960490|4036045|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
2321546|NCT02960490|4036046|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
2321547|NCT02960490|4036047|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
2321548|NCT02960490|4036048|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
2321549|NCT02960490|4036049|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
2321550|NCT02960490|4036050|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
2321551|NCT02960490|4036051|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2
2321552|NCT02960490|4036052|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
2321553|NCT02960490|4036053|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
2321554|NCT02960490|4036054|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
2321555|NCT02960490|4036045|FG000|Extension Phase(Open-label): 80 Weeks|Other|0
2321556|NCT02960490|4036046|FG001|Extension Phase(Open-label): 80 Weeks|Other|0
2321557|NCT02960490|4036047|FG002|Extension Phase(Open-label): 80 Weeks|Other|0
2321558|NCT02960490|4036048|FG003|Extension Phase(Open-label): 80 Weeks|Other|0
2321559|NCT02960490|4036049|FG004|Extension Phase(Open-label): 80 Weeks|Other|0
2321560|NCT02960490|4036050|FG005|Extension Phase(Open-label): 80 Weeks|Other|0
2321561|NCT02960490|4036051|FG006|Extension Phase(Open-label): 80 Weeks|Other|0
2321562|NCT02960490|4036052|FG007|Extension Phase(Open-label): 80 Weeks|Other|1
2321563|NCT02960490|4036053|FG008|Extension Phase(Open-label): 80 Weeks|Other|0
2321564|NCT02960490|4036054|FG009|Extension Phase(Open-label): 80 Weeks|Other|0
2321565|NCT02960854|4036078|FG000|Overall Study|Not Disclosed|2
2321566|NCT02960854|4036079|FG001|Overall Study|Not Disclosed|2
2321567|NCT02960854|4036078|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
2321568|NCT02960854|4036079|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
2321569|NCT02960854|4036078|FG000|Overall Study|Subject Withdrew Consent|0
2321570|NCT02960854|4036079|FG001|Overall Study|Subject Withdrew Consent|1
2321571|NCT02960854|4036078|FG000|Overall Study|Death|4
2321572|NCT02960854|4036079|FG001|Overall Study|Death|6
2321573|NCT02960893|4036087|FG000|Randomization Phase (8-week)|Adverse Event|5
2321574|NCT02960893|4036088|FG001|Randomization Phase (8-week)|Adverse Event|0
2321575|NCT02960893|4036087|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2
2321576|NCT02960893|4036088|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1
2321577|NCT02960893|4036087|FG000|Randomization Phase (8-week)|Reason Not Specified|0
2321578|NCT02960893|4036088|FG001|Randomization Phase (8-week)|Reason Not Specified|1
2321579|NCT02960893|4036087|FG000|Extension Phase (48-week)|Adverse Event|2
2060877|NCT00557440|3635287|FG002|Treatment Period 1|Adverse Event|1
2321580|NCT02960893|4036088|FG001|Extension Phase (48-week)|Adverse Event|3
2060878|NCT00557466|3635301|FG000|Overall Study|Adverse Event|3
2060879|NCT00557466|3635302|FG001|Overall Study|Adverse Event|1
2060880|NCT00557466|3635303|FG002|Overall Study|Adverse Event|4
2060881|NCT00557466|3635304|FG003|Overall Study|Adverse Event|1
2060882|NCT00557466|3635305|FG004|Overall Study|Adverse Event|2
2060883|NCT00557466|3635306|FG005|Overall Study|Adverse Event|4
2060884|NCT00557466|3635301|FG000|Overall Study|Abnormal laboratory value(s)|1
2060885|NCT00557466|3635302|FG001|Overall Study|Abnormal laboratory value(s)|2
2060886|NCT00557466|3635303|FG002|Overall Study|Abnormal laboratory value(s)|0
2060887|NCT00557466|3635304|FG003|Overall Study|Abnormal laboratory value(s)|0
2060888|NCT00557466|3635305|FG004|Overall Study|Abnormal laboratory value(s)|0
2060889|NCT00557466|3635306|FG005|Overall Study|Abnormal laboratory value(s)|0
2060890|NCT00557466|3635301|FG000|Overall Study|Protocol deviation|0
2060891|NCT00557466|3635302|FG001|Overall Study|Protocol deviation|1
2060892|NCT00557466|3635303|FG002|Overall Study|Protocol deviation|0
2060893|NCT00557466|3635304|FG003|Overall Study|Protocol deviation|2
2060894|NCT00557466|3635305|FG004|Overall Study|Protocol deviation|0
2060895|NCT00557466|3635306|FG005|Overall Study|Protocol deviation|0
2060896|NCT00557466|3635301|FG000|Overall Study|Subject withdrew consent|0
2060897|NCT00557466|3635302|FG001|Overall Study|Subject withdrew consent|0
2209904|NCT01646320|3849321|FG001|Short-term Period (Day 1 to Week 24)|Other|0
2209905|NCT01646320|3849320|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
2301969|NCT02618382|4000197|FG000|Overall Study|Physician Decision|1
2301970|NCT02618382|4000197|FG000|Overall Study|Withdrawal by Subject|1
2301971|NCT02618382|4000197|FG000|Overall Study|Protocol Violation|1
2301972|NCT02618616|4000207|FG000|Overall Study|Lack of Efficacy|4
2301973|NCT02618616|4000208|FG001|Overall Study|Lack of Efficacy|0
2301974|NCT02618616|4000207|FG000|Overall Study|Pregnancy|0
2301975|NCT02618616|4000208|FG001|Overall Study|Pregnancy|1
2301976|NCT02618616|4000207|FG000|Overall Study|Adverse Event|8
2301977|NCT02618616|4000208|FG001|Overall Study|Adverse Event|0
2301978|NCT02618616|4000207|FG000|Overall Study|Failure to comply with dosing/evaluation|1
2301979|NCT02618616|4000208|FG001|Overall Study|Failure to comply with dosing/evaluation|0
2301980|NCT02618616|4000207|FG000|Overall Study|Consent withdrawn by subject|8
2301981|NCT02618616|4000208|FG001|Overall Study|Consent withdrawn by subject|5
2301982|NCT02618616|4000207|FG000|Overall Study|Lost to Follow-up|0
2301983|NCT02618616|4000208|FG001|Overall Study|Lost to Follow-up|1
2301984|NCT02618759|4000241|FG000|Overall Study|Lost to Follow-up|0
2301985|NCT02618759|4000242|FG001|Overall Study|Lost to Follow-up|1
2301986|NCT02618759|4000241|FG000|Overall Study|Withdrawal by Subject|1
2301987|NCT02618759|4000242|FG001|Overall Study|Withdrawal by Subject|0
2301988|NCT02618759|4000241|FG000|Overall Study|Other Reasons|1
2301989|NCT02618759|4000242|FG001|Overall Study|Other Reasons|4
2301990|NCT02618928|4000268|FG000|Overall Study|Failure to Return|28
2301991|NCT02618928|4000268|FG000|Overall Study|Insufficient Virological Response|1
2301992|NCT02618928|4000268|FG000|Overall Study|Withdrawal by Subject|2
2301993|NCT02618928|4000268|FG000|Overall Study|Death|3
2301994|NCT02618928|4000268|FG000|Overall Study|Other|11
2301995|NCT02618928|4000268|FG000|Overall Study|Missing|6
2301996|NCT02618928|4000268|FG000|Overall Study|Treatment Never Started|7
2301997|NCT02618967|4000283|FG000|Overall Study|Lost to Follow-up|0
2301998|NCT02618967|4000284|FG001|Overall Study|Lost to Follow-up|0
2301999|NCT02618967|4000285|FG002|Overall Study|Lost to Follow-up|1
2302000|NCT02618967|4000286|FG003|Overall Study|Lost to Follow-up|0
2302001|NCT02618967|4000287|FG004|Overall Study|Lost to Follow-up|2
2302002|NCT02618967|4000288|FG005|Overall Study|Lost to Follow-up|0
2302003|NCT02618967|4000289|FG006|Overall Study|Lost to Follow-up|0
2302004|NCT02618967|4000290|FG007|Overall Study|Lost to Follow-up|0
2302005|NCT02618967|4000283|FG000|Overall Study|Withdrawal by Subject|1
2302006|NCT02618967|4000284|FG001|Overall Study|Withdrawal by Subject|0
2302007|NCT02618967|4000285|FG002|Overall Study|Withdrawal by Subject|0
2302008|NCT02618967|4000286|FG003|Overall Study|Withdrawal by Subject|0
2302009|NCT02618967|4000287|FG004|Overall Study|Withdrawal by Subject|0
2302010|NCT02618967|4000288|FG005|Overall Study|Withdrawal by Subject|0
2302011|NCT02618967|4000289|FG006|Overall Study|Withdrawal by Subject|0
2302012|NCT02618967|4000290|FG007|Overall Study|Withdrawal by Subject|0
2302013|NCT02619175|4000310|FG000|Overall Study|Withdrawal by Subject|1
2302014|NCT02619175|4000311|FG001|Overall Study|Withdrawal by Subject|0
2302015|NCT02619175|4000310|FG000|Overall Study|foot pain|1
2302016|NCT02619175|4000311|FG001|Overall Study|foot pain|0
2302017|NCT02619617|4000369|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
2302018|NCT02619617|4000370|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
2302019|NCT02619617|4000369|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0
2302020|NCT02619617|4000370|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3
2302021|NCT02620020|4000391|FG000|Overall Study|Adverse Event|8
2302022|NCT02620020|4000392|FG001|Overall Study|Adverse Event|4
2302023|NCT02620020|4000393|FG002|Overall Study|Adverse Event|3
2302024|NCT02620020|4000394|FG003|Overall Study|Adverse Event|5
2302025|NCT02620020|4000391|FG000|Overall Study|Lost to Follow-up|4
2060898|NCT00557466|3635303|FG002|Overall Study|Subject withdrew consent|0
2060899|NCT00557466|3635304|FG003|Overall Study|Subject withdrew consent|0
2060900|NCT00557466|3635305|FG004|Overall Study|Subject withdrew consent|1
2060901|NCT00557466|3635306|FG005|Overall Study|Subject withdrew consent|2
2302026|NCT02620020|4000392|FG001|Overall Study|Lost to Follow-up|8
2060902|NCT00557466|3635301|FG000|Overall Study|Administrative problems|0
2060903|NCT00557466|3635302|FG001|Overall Study|Administrative problems|1
2060904|NCT00557466|3635303|FG002|Overall Study|Administrative problems|1
2209906|NCT01646320|3849321|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
2209907|NCT01646320|3849320|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
2209908|NCT01646320|3849321|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
2302027|NCT02620020|4000393|FG002|Overall Study|Lost to Follow-up|1
2302028|NCT02620020|4000394|FG003|Overall Study|Lost to Follow-up|4
2302029|NCT02620020|4000391|FG000|Overall Study|Physician Decision|7
2302030|NCT02620020|4000392|FG001|Overall Study|Physician Decision|4
2302031|NCT02620020|4000393|FG002|Overall Study|Physician Decision|3
2302032|NCT02620020|4000394|FG003|Overall Study|Physician Decision|4
2302033|NCT02620020|4000391|FG000|Overall Study|Protocol Violation|5
2302034|NCT02620020|4000392|FG001|Overall Study|Protocol Violation|2
2302035|NCT02620020|4000393|FG002|Overall Study|Protocol Violation|1
2302036|NCT02620020|4000394|FG003|Overall Study|Protocol Violation|1
2302037|NCT02620020|4000391|FG000|Overall Study|Withdrawal by Subject|20
2302038|NCT02620020|4000392|FG001|Overall Study|Withdrawal by Subject|16
2302039|NCT02620020|4000393|FG002|Overall Study|Withdrawal by Subject|17
2302040|NCT02620020|4000394|FG003|Overall Study|Withdrawal by Subject|12
2302041|NCT02620020|4000391|FG000|Overall Study|Death|0
2302042|NCT02620020|4000392|FG001|Overall Study|Death|1
2302043|NCT02620020|4000393|FG002|Overall Study|Death|0
2302044|NCT02620020|4000394|FG003|Overall Study|Death|0
2302045|NCT02620384|4000406|FG000|Overall Study|Adverse Event|2
2302046|NCT02620384|4000407|FG001|Overall Study|Adverse Event|1
2302047|NCT02620384|4000406|FG000|Overall Study|Discharged prior to 2nd dose|2
2302048|NCT02620384|4000407|FG001|Overall Study|Discharged prior to 2nd dose|5
2302049|NCT02620384|4000406|FG000|Overall Study|Drug shortage prevented 2nd dose|0
2302050|NCT02620384|4000407|FG001|Overall Study|Drug shortage prevented 2nd dose|1
2302051|NCT02620787|4000430|FG000|Overall Study|Adverse Event|1
2302052|NCT02620787|4000431|FG001|Overall Study|Adverse Event|0
2302053|NCT02620787|4000430|FG000|Overall Study|Eligibility Criteria Not Met|1
2302054|NCT02620787|4000431|FG001|Overall Study|Eligibility Criteria Not Met|0
2302055|NCT02621034|4000462|FG000|Overall Study|Lost to Follow-up|3
2302056|NCT02621034|4000463|FG001|Overall Study|Lost to Follow-up|2
2302057|NCT02621034|4000464|FG002|Overall Study|Lost to Follow-up|5
2302058|NCT02621047|4000477|FG000|Overall Study|Adverse Event|0
2302059|NCT02621047|4000478|FG001|Overall Study|Adverse Event|0
2302060|NCT02621047|4000479|FG002|Overall Study|Adverse Event|1
2302061|NCT02621073|4000499|FG000|Overall Study|Lost to Follow-up|0
2302062|NCT02621073|4000500|FG001|Overall Study|Lost to Follow-up|1
2302063|NCT02621073|4000499|FG000|Overall Study|Physician Decision|3
2302064|NCT02621073|4000500|FG001|Overall Study|Physician Decision|2
2302065|NCT02621606|4000513|FG000|Overall Study|Withdrawal by Subject|0
2302066|NCT02621606|4000514|FG001|Overall Study|Withdrawal by Subject|1
2302067|NCT02621606|4000515|FG002|Overall Study|Withdrawal by Subject|0
2302068|NCT02621931|4000544|FG000|Overall Study|Death|0
2302069|NCT02621931|4000545|FG001|Overall Study|Death|1
2302070|NCT02621931|4000546|FG002|Overall Study|Death|0
2302071|NCT02621931|4000544|FG000|Overall Study|Adverse Event|8
2302072|NCT02621931|4000545|FG001|Overall Study|Adverse Event|5
2302073|NCT02621931|4000546|FG002|Overall Study|Adverse Event|7
2302074|NCT02621931|4000544|FG000|Overall Study|Withdrawal by Subject|12
2302075|NCT02621931|4000545|FG001|Overall Study|Withdrawal by Subject|10
2302076|NCT02621931|4000546|FG002|Overall Study|Withdrawal by Subject|11
2302077|NCT02621931|4000544|FG000|Overall Study|Protocol Violation|2
2302078|NCT02621931|4000545|FG001|Overall Study|Protocol Violation|2
2302079|NCT02621931|4000546|FG002|Overall Study|Protocol Violation|2
2302080|NCT02621931|4000544|FG000|Overall Study|Pregnancy|2
2302081|NCT02621931|4000545|FG001|Overall Study|Pregnancy|0
2302082|NCT02621931|4000546|FG002|Overall Study|Pregnancy|0
2302083|NCT02621931|4000544|FG000|Overall Study|Noncompliance to study procedures|0
2302084|NCT02621931|4000545|FG001|Overall Study|Noncompliance to study procedures|1
2302085|NCT02621931|4000546|FG002|Overall Study|Noncompliance to study procedures|2
2302086|NCT02621931|4000544|FG000|Overall Study|Lost to Follow-up|8
2302087|NCT02621931|4000545|FG001|Overall Study|Lost to Follow-up|7
2302088|NCT02621931|4000546|FG002|Overall Study|Lost to Follow-up|10
2302089|NCT02621931|4000544|FG000|Overall Study|Lack of Efficacy|0
2302090|NCT02621931|4000545|FG001|Overall Study|Lack of Efficacy|0
2302091|NCT02621931|4000546|FG002|Overall Study|Lack of Efficacy|1
2302092|NCT02621931|4000544|FG000|Overall Study|Other|1
2302093|NCT02621931|4000545|FG001|Overall Study|Other|1
2302094|NCT02621931|4000546|FG002|Overall Study|Other|3
2302095|NCT02622074|4000571|FG000|Overall Study|Death|4
2302096|NCT02622074|4000572|FG001|Overall Study|Death|0
2302097|NCT02622074|4000573|FG002|Overall Study|Death|0
2302098|NCT02622074|4000574|FG003|Overall Study|Death|1
2302099|NCT02622074|4000575|FG004|Overall Study|Death|1
2302100|NCT02622074|4000576|FG005|Overall Study|Death|0
2302101|NCT02622074|4000571|FG000|Overall Study|Withdrawal by Subject|0
2302102|NCT02622074|4000572|FG001|Overall Study|Withdrawal by Subject|1
2302103|NCT02622074|4000573|FG002|Overall Study|Withdrawal by Subject|0
2302104|NCT02622074|4000574|FG003|Overall Study|Withdrawal by Subject|0
2302105|NCT02622074|4000575|FG004|Overall Study|Withdrawal by Subject|0
2302106|NCT02622074|4000576|FG005|Overall Study|Withdrawal by Subject|0
2060905|NCT00557466|3635304|FG003|Overall Study|Administrative problems|0
2060906|NCT00557466|3635305|FG004|Overall Study|Administrative problems|0
2060907|NCT00557466|3635306|FG005|Overall Study|Administrative problems|0
2060908|NCT00557466|3635301|FG000|Overall Study|Abnormal test procedure results|0
2060909|NCT00557466|3635302|FG001|Overall Study|Abnormal test procedure results|0
2302107|NCT02622113|4000592|FG000|Overall Study|Adverse Event|4
2302108|NCT02622113|4000593|FG001|Overall Study|Adverse Event|4
2302109|NCT02622113|4000592|FG000|Overall Study|Physician Decision|0
2302110|NCT02622113|4000593|FG001|Overall Study|Physician Decision|1
2302111|NCT02622113|4000592|FG000|Overall Study|Withdrawal by Subject|0
2302112|NCT02622113|4000593|FG001|Overall Study|Withdrawal by Subject|2
2302113|NCT02622113|4000592|FG000|Overall Study|Stopping Criteria|1
2302114|NCT02622113|4000593|FG001|Overall Study|Stopping Criteria|3
2302115|NCT02622321|4000627|FG000|Overall Study|Withdrawal by Subject|2
2302116|NCT02622321|4000628|FG001|Overall Study|Withdrawal by Subject|0
2302117|NCT02622321|4000629|FG002|Overall Study|Withdrawal by Subject|0
2302118|NCT02622321|4000630|FG003|Overall Study|Withdrawal by Subject|0
2302119|NCT02622321|4000627|FG000|Overall Study|Death|0
2302120|NCT02622321|4000628|FG001|Overall Study|Death|0
2302121|NCT02622321|4000629|FG002|Overall Study|Death|1
2302122|NCT02622321|4000630|FG003|Overall Study|Death|0
2302123|NCT02622321|4000627|FG000|Overall Study|Physician Decision|1
2302124|NCT02622321|4000628|FG001|Overall Study|Physician Decision|0
2302125|NCT02622321|4000629|FG002|Overall Study|Physician Decision|0
2302126|NCT02622321|4000630|FG003|Overall Study|Physician Decision|0
2302127|NCT02622568|4000656|FG000|Overall Study|Lost to Follow-up|5
2302128|NCT02622568|4000657|FG001|Overall Study|Lost to Follow-up|5
2302129|NCT02622724|4000665|FG000|Overall Study|Death|51
2302130|NCT02622724|4000666|FG001|Overall Study|Death|53
2302131|NCT02622724|4000665|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4
2302132|NCT02622724|4000666|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7
2302133|NCT02622724|4000665|FG000|Overall Study|Early termination of study|38
2302134|NCT02622724|4000666|FG001|Overall Study|Early termination of study|43
2302135|NCT02623218|4000683|FG000|Overall Study|Lost to Follow-up|0
2302136|NCT02623218|4000684|FG001|Overall Study|Lost to Follow-up|1
2302137|NCT02623218|4000685|FG002|Overall Study|Lost to Follow-up|0
2302138|NCT02623218|4000686|FG003|Overall Study|Lost to Follow-up|0
2302139|NCT02623218|4000687|FG004|Overall Study|Lost to Follow-up|0
2302140|NCT02623322|4000702|FG000|Overall Study|Lost to Follow-up|2
2302141|NCT02623322|4000703|FG001|Overall Study|Lost to Follow-up|1
2302142|NCT02623322|4000704|FG002|Overall Study|Lost to Follow-up|0
2302143|NCT02623335|4000716|FG000|Overall Study|Death|8
2302144|NCT02623335|4000717|FG001|Overall Study|Death|7
2302145|NCT02623335|4000716|FG000|Overall Study|Lost to Follow-up|15
2302146|NCT02623335|4000717|FG001|Overall Study|Lost to Follow-up|23
2302147|NCT02623335|4000716|FG000|Overall Study|Withdrawal by Subject|2
2302148|NCT02623335|4000717|FG001|Overall Study|Withdrawal by Subject|5
2302149|NCT02623335|4000716|FG000|Overall Study|Protocol Violation|2
2302150|NCT02623335|4000717|FG001|Overall Study|Protocol Violation|1
2302151|NCT02623361|4000734|FG000|Overall Study|Protocol Violation|0
2302152|NCT02623361|4000735|FG001|Overall Study|Protocol Violation|1
2302153|NCT02623361|4000734|FG000|Overall Study|Withdrawal by Subject|0
2302154|NCT02623361|4000735|FG001|Overall Study|Withdrawal by Subject|1
2302155|NCT02623725|4000743|FG000|Overall Study|Non compliance with protocol|9
2302156|NCT02623725|4000744|FG001|Overall Study|Non compliance with protocol|3
2302157|NCT02623725|4000743|FG000|Overall Study|Serious adverse event|0
2302158|NCT02623725|4000744|FG001|Overall Study|Serious adverse event|2
2302159|NCT02623725|4000743|FG000|Overall Study|Withdrawal by Subject|7
2302160|NCT02623725|4000744|FG001|Overall Study|Withdrawal by Subject|1
2302161|NCT02623829|4000763|FG000|Overall Study|Lost to Follow-up|1
2302162|NCT02623829|4000764|FG001|Overall Study|Lost to Follow-up|1
2302163|NCT02624050|4000781|FG000|Overall Study|Physician Decision|4
2302164|NCT02624050|4000782|FG001|Overall Study|Physician Decision|0
2302165|NCT02624050|4000781|FG000|Overall Study|Protocol Violation|2
2302166|NCT02624050|4000782|FG001|Overall Study|Protocol Violation|0
2302167|NCT02624284|4000800|FG000|Overall Study|Withdrawal by Subject|3
2302168|NCT02624284|4000801|FG001|Overall Study|Withdrawal by Subject|6
2302169|NCT02624284|4000802|FG002|Overall Study|Withdrawal by Subject|3
2302170|NCT02624284|4000800|FG000|Overall Study|Protocol Violation|9
2302171|NCT02624284|4000801|FG001|Overall Study|Protocol Violation|10
2302172|NCT02624284|4000802|FG002|Overall Study|Protocol Violation|7
2302173|NCT02624284|4000800|FG000|Overall Study|Revealed exclusionary condition|2
2302174|NCT02624284|4000801|FG001|Overall Study|Revealed exclusionary condition|2
2302175|NCT02624284|4000802|FG002|Overall Study|Revealed exclusionary condition|0
2302176|NCT02624284|4000800|FG000|Overall Study|Adverse Event|0
2302177|NCT02624284|4000801|FG001|Overall Study|Adverse Event|0
2302178|NCT02624284|4000802|FG002|Overall Study|Adverse Event|1
2302179|NCT02624492|4000817|FG000|Overall Study|Adverse Event|2
2302180|NCT02624492|4000818|FG001|Overall Study|Adverse Event|2
2302181|NCT02624492|4000819|FG002|Overall Study|Adverse Event|2
2302182|NCT02624492|4000817|FG000|Overall Study|Progressive disease|0
2302183|NCT02624492|4000818|FG001|Overall Study|Progressive disease|2
2302184|NCT02624492|4000819|FG002|Overall Study|Progressive disease|3
2302185|NCT02624687|4000829|FG000|Overall Study|Withdrawal by Subject|1
2302186|NCT02624687|4000830|FG001|Overall Study|Withdrawal by Subject|1
2060910|NCT00557466|3635303|FG002|Overall Study|Abnormal test procedure results|1
2060911|NCT00557466|3635304|FG003|Overall Study|Abnormal test procedure results|0
2060912|NCT00557466|3635305|FG004|Overall Study|Abnormal test procedure results|0
2060913|NCT00557466|3635306|FG005|Overall Study|Abnormal test procedure results|0
2060914|NCT00557466|3635301|FG000|Overall Study|Lost to Follow-up|0
2060915|NCT00557466|3635302|FG001|Overall Study|Lost to Follow-up|0
2060916|NCT00557466|3635303|FG002|Overall Study|Lost to Follow-up|0
2060917|NCT00557466|3635304|FG003|Overall Study|Lost to Follow-up|1
2060918|NCT00557466|3635305|FG004|Overall Study|Lost to Follow-up|0
2060919|NCT00557466|3635306|FG005|Overall Study|Lost to Follow-up|0
2060920|NCT00557492|3635320|FG000|Overall Study|Change in health insurance|1
2060921|NCT00557505|3635333|FG000|Overall Study|Death|0
2060922|NCT00557505|3635334|FG001|Overall Study|Death|0
2060923|NCT00557505|3635335|FG002|Overall Study|Death|0
2060924|NCT00557505|3635336|FG003|Overall Study|Death|0
2060925|NCT00557505|3635337|FG004|Overall Study|Death|0
2060926|NCT00557505|3635338|FG005|Overall Study|Death|0
2060927|NCT00557505|3635339|FG006|Overall Study|Death|0
2060928|NCT00557505|3635340|FG007|Overall Study|Death|0
2060929|NCT00557505|3635341|FG008|Overall Study|Death|1
2060930|NCT00557505|3635333|FG000|Overall Study|Adverse Event|0
2060931|NCT00557505|3635334|FG001|Overall Study|Adverse Event|0
2060932|NCT00557505|3635335|FG002|Overall Study|Adverse Event|1
2060933|NCT00557505|3635336|FG003|Overall Study|Adverse Event|0
2060934|NCT00557505|3635337|FG004|Overall Study|Adverse Event|0
2060935|NCT00557505|3635338|FG005|Overall Study|Adverse Event|0
2060936|NCT00557505|3635339|FG006|Overall Study|Adverse Event|1
2060937|NCT00557505|3635340|FG007|Overall Study|Adverse Event|0
2060938|NCT00557505|3635341|FG008|Overall Study|Adverse Event|0
2060939|NCT00557505|3635333|FG000|Overall Study|Global deterioration of health|1
2060940|NCT00557505|3635334|FG001|Overall Study|Global deterioration of health|0
2060941|NCT00557505|3635335|FG002|Overall Study|Global deterioration of health|0
2060942|NCT00557505|3635336|FG003|Overall Study|Global deterioration of health|0
2060943|NCT00557505|3635337|FG004|Overall Study|Global deterioration of health|0
2060944|NCT00557505|3635338|FG005|Overall Study|Global deterioration of health|0
2060945|NCT00557505|3635339|FG006|Overall Study|Global deterioration of health|0
2060946|NCT00557505|3635340|FG007|Overall Study|Global deterioration of health|0
2060947|NCT00557505|3635341|FG008|Overall Study|Global deterioration of health|0
2060948|NCT00557505|3635333|FG000|Overall Study|Objective progression or relapse|2
2060949|NCT00557505|3635334|FG001|Overall Study|Objective progression or relapse|3
2060950|NCT00557505|3635335|FG002|Overall Study|Objective progression or relapse|3
2060951|NCT00557505|3635336|FG003|Overall Study|Objective progression or relapse|2
2060952|NCT00557505|3635337|FG004|Overall Study|Objective progression or relapse|2
2060953|NCT00557505|3635338|FG005|Overall Study|Objective progression or relapse|3
2060954|NCT00557505|3635339|FG006|Overall Study|Objective progression or relapse|2
2060955|NCT00557505|3635340|FG007|Overall Study|Objective progression or relapse|5
2060956|NCT00557505|3635341|FG008|Overall Study|Objective progression or relapse|15
2060957|NCT00557505|3635333|FG000|Overall Study|Withdrawal by Subject|0
2060958|NCT00557505|3635334|FG001|Overall Study|Withdrawal by Subject|0
2060959|NCT00557505|3635335|FG002|Overall Study|Withdrawal by Subject|0
2060960|NCT00557505|3635336|FG003|Overall Study|Withdrawal by Subject|1
2060961|NCT00557505|3635337|FG004|Overall Study|Withdrawal by Subject|0
2060962|NCT00557505|3635338|FG005|Overall Study|Withdrawal by Subject|0
2060963|NCT00557505|3635339|FG006|Overall Study|Withdrawal by Subject|0
2060964|NCT00557505|3635340|FG007|Overall Study|Withdrawal by Subject|0
2060965|NCT00557505|3635341|FG008|Overall Study|Withdrawal by Subject|1
2060966|NCT00557622|3635366|FG000|4-Week Run-in Phase|Withdrawal by Subject|1
2060967|NCT00557622|3635367|FG001|4-Week Run-in Phase|Withdrawal by Subject|0
2060968|NCT00557622|3635366|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1
2060969|NCT00557622|3635367|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0
2060970|NCT00557622|3635366|FG000|12-Week Treatment Phase|Lost to Follow-up|0
2060971|NCT00557622|3635367|FG001|12-Week Treatment Phase|Lost to Follow-up|1
2060972|NCT00557830|3635376|FG000|Screening Treatment Phase|Withdrawal by Subject|1
2060973|NCT00557830|3635377|FG001|Screening Treatment Phase|Withdrawal by Subject|0
2060974|NCT00557830|3635378|FG002|Screening Treatment Phase|Withdrawal by Subject|0
2060975|NCT00557830|3635376|FG000|Screening Treatment Phase|Adverse Event|2
2060976|NCT00557830|3635377|FG001|Screening Treatment Phase|Adverse Event|0
2060977|NCT00557830|3635378|FG002|Screening Treatment Phase|Adverse Event|0
2060978|NCT00557830|3635376|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3
2060979|NCT00557830|3635377|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0
2302187|NCT02624687|4000829|FG000|Overall Study|medical leave from work|0
2302188|NCT02624687|4000830|FG001|Overall Study|medical leave from work|1
2302189|NCT02624713|4000849|FG000|Overall Study|Lost to Follow-up|14
2302190|NCT02624713|4000850|FG001|Overall Study|Lost to Follow-up|0
2302191|NCT02624791|4000857|FG000|Overall Study|Withdrawal by Subject|2
2060980|NCT00557830|3635378|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0
2060981|NCT00557856|3635386|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3
2060982|NCT00557856|3635387|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5
2060983|NCT00557856|3635388|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3
2060984|NCT00557856|3635389|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1
2060985|NCT00557856|3635390|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3
2060986|NCT00557856|3635391|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2
2060987|NCT00557856|3635392|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5
2060988|NCT00557856|3635393|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3
2060989|NCT00557856|3635394|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0
2060990|NCT00557856|3635386|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
2060991|NCT00557856|3635387|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2302192|NCT02624791|4000858|FG001|Overall Study|Withdrawal by Subject|0
2302193|NCT02624791|4000859|FG002|Overall Study|Withdrawal by Subject|0
2302194|NCT02624791|4000860|FG003|Overall Study|Withdrawal by Subject|0
2302195|NCT02624791|4000861|FG004|Overall Study|Withdrawal by Subject|0
2302196|NCT02624791|4000862|FG005|Overall Study|Withdrawal by Subject|0
2302197|NCT02624986|4000887|FG000|Overall Study|Death|0
2302198|NCT02624986|4000888|FG001|Overall Study|Death|1
2302199|NCT02624986|4000889|FG002|Overall Study|Death|2
2302200|NCT02624986|4000890|FG003|Overall Study|Death|2
2302201|NCT02624986|4000891|FG004|Overall Study|Death|2
2302202|NCT02624986|4000892|FG005|Overall Study|Death|0
2302203|NCT02624986|4000893|FG006|Overall Study|Death|0
2302204|NCT02624986|4000894|FG007|Overall Study|Death|1
2302205|NCT02624986|4000887|FG000|Overall Study|Study Terminated by Sponsor|1
2302206|NCT02624986|4000888|FG001|Overall Study|Study Terminated by Sponsor|1
2302207|NCT02624986|4000889|FG002|Overall Study|Study Terminated by Sponsor|0
2302208|NCT02624986|4000890|FG003|Overall Study|Study Terminated by Sponsor|1
2302209|NCT02624986|4000891|FG004|Overall Study|Study Terminated by Sponsor|2
2302210|NCT02624986|4000892|FG005|Overall Study|Study Terminated by Sponsor|2
2302211|NCT02624986|4000893|FG006|Overall Study|Study Terminated by Sponsor|4
2302212|NCT02624986|4000894|FG007|Overall Study|Study Terminated by Sponsor|3
2302213|NCT02624986|4000887|FG000|Overall Study|Progressive Disease|0
2302214|NCT02624986|4000888|FG001|Overall Study|Progressive Disease|1
2302215|NCT02624986|4000889|FG002|Overall Study|Progressive Disease|0
2302216|NCT02624986|4000890|FG003|Overall Study|Progressive Disease|0
2302217|NCT02624986|4000891|FG004|Overall Study|Progressive Disease|0
2302218|NCT02624986|4000892|FG005|Overall Study|Progressive Disease|0
2302219|NCT02624986|4000893|FG006|Overall Study|Progressive Disease|0
2302220|NCT02624986|4000894|FG007|Overall Study|Progressive Disease|0
2302221|NCT02624986|4000887|FG000|Overall Study|Protocol Violation|1
2302222|NCT02624986|4000888|FG001|Overall Study|Protocol Violation|0
2302223|NCT02624986|4000889|FG002|Overall Study|Protocol Violation|0
2302224|NCT02624986|4000890|FG003|Overall Study|Protocol Violation|0
2302225|NCT02624986|4000891|FG004|Overall Study|Protocol Violation|0
2302226|NCT02624986|4000892|FG005|Overall Study|Protocol Violation|0
2302227|NCT02624986|4000893|FG006|Overall Study|Protocol Violation|0
2302228|NCT02624986|4000894|FG007|Overall Study|Protocol Violation|0
2302229|NCT02624986|4000887|FG000|Overall Study|Withdrawal by Subject|0
2302230|NCT02624986|4000888|FG001|Overall Study|Withdrawal by Subject|0
2302231|NCT02624986|4000889|FG002|Overall Study|Withdrawal by Subject|0
2302232|NCT02624986|4000890|FG003|Overall Study|Withdrawal by Subject|0
2302233|NCT02624986|4000891|FG004|Overall Study|Withdrawal by Subject|0
2302234|NCT02624986|4000892|FG005|Overall Study|Withdrawal by Subject|0
2302235|NCT02624986|4000893|FG006|Overall Study|Withdrawal by Subject|0
2302236|NCT02624986|4000894|FG007|Overall Study|Withdrawal by Subject|1
2302237|NCT02625220|4000950|FG000|Overall Study|Adverse Event|2
2302238|NCT02625220|4000950|FG000|Overall Study|Lost to Follow-up|2
2302239|NCT02625220|4000950|FG000|Overall Study|Protocol Violation|1
2302240|NCT02625220|4000950|FG000|Overall Study|Study discontinued at site|2
2302241|NCT02625233|4000956|FG000|Overall Study|Adverse Event|2
2302242|NCT02625233|4000957|FG001|Overall Study|Adverse Event|0
2302243|NCT02625259|4000968|FG000|First Intervention (Day 1)|Other|0
2302244|NCT02625259|4000969|FG001|First Intervention (Day 1)|Other|0
2302245|NCT02625259|4000970|FG002|First Intervention (Day 1)|Other|1
2302246|NCT02625259|4000971|FG003|First Intervention (Day 1)|Other|0
2302247|NCT02625259|4000972|FG004|First Intervention (Day 1)|Other|0
2302248|NCT02625259|4000968|FG000|First Intervention (Day 1)|Adverse Event|2
2302249|NCT02625259|4000969|FG001|First Intervention (Day 1)|Adverse Event|1
2302250|NCT02625259|4000970|FG002|First Intervention (Day 1)|Adverse Event|0
2302251|NCT02625259|4000971|FG003|First Intervention (Day 1)|Adverse Event|0
2302252|NCT02625259|4000972|FG004|First Intervention (Day 1)|Adverse Event|0
2302253|NCT02625259|4000968|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
2302254|NCT02625259|4000969|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
2302255|NCT02625259|4000970|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
2302256|NCT02625259|4000971|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
2302257|NCT02625259|4000972|FG004|First Intervention (Day 1)|Withdrawal by Subject|0
2302258|NCT02625324|4000998|FG000|30-Day Follow-up for Primary Endpoint|Death|1
2302259|NCT02625324|4000998|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
2302260|NCT02625324|4000998|FG000|6-Month Follow-up Subject Accountability|Death|5
2302261|NCT02625324|4000998|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
2302262|NCT02625324|4000998|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
2302263|NCT02625324|4000998|FG000|12-Month Follow-up Secondary Endpoint|Death|4
2302264|NCT02625324|4000998|FG000|24-Month Follow-up Secondary Endpoint|Death|2
2302265|NCT02625324|4000998|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
2060992|NCT00557856|3635388|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
2060993|NCT00557856|3635389|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2060994|NCT00557856|3635390|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2060995|NCT00557856|3635391|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2060996|NCT00557856|3635392|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2060997|NCT00557856|3635393|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2060998|NCT00557856|3635394|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2060999|NCT00557856|3635386|FG000|Part 1: Dose Escalation Phase|Adverse Event|1
2061000|NCT00557856|3635387|FG001|Part 1: Dose Escalation Phase|Adverse Event|0
2061001|NCT00557856|3635388|FG002|Part 1: Dose Escalation Phase|Adverse Event|1
2061002|NCT00557856|3635389|FG003|Part 1: Dose Escalation Phase|Adverse Event|1
2061003|NCT00557856|3635390|FG004|Part 1: Dose Escalation Phase|Adverse Event|1
2061004|NCT00557856|3635391|FG005|Part 1: Dose Escalation Phase|Adverse Event|3
2061005|NCT00557856|3635392|FG006|Part 1: Dose Escalation Phase|Adverse Event|1
2061006|NCT00557856|3635393|FG007|Part 1: Dose Escalation Phase|Adverse Event|2
2061007|NCT00557856|3635394|FG008|Part 1: Dose Escalation Phase|Adverse Event|0
2061008|NCT00557856|3635386|FG000|Part 1: Dose Escalation Phase|Other|0
2061009|NCT00557856|3635387|FG001|Part 1: Dose Escalation Phase|Other|0
2061010|NCT00557856|3635388|FG002|Part 1: Dose Escalation Phase|Other|1
2061011|NCT00557856|3635389|FG003|Part 1: Dose Escalation Phase|Other|1
2061012|NCT00557856|3635390|FG004|Part 1: Dose Escalation Phase|Other|0
2061013|NCT00557856|3635391|FG005|Part 1: Dose Escalation Phase|Other|0
2061014|NCT00557856|3635392|FG006|Part 1: Dose Escalation Phase|Other|0
2061015|NCT00557856|3635393|FG007|Part 1: Dose Escalation Phase|Other|1
2061016|NCT00557856|3635394|FG008|Part 1: Dose Escalation Phase|Other|0
2061017|NCT00557856|3635386|FG000|Part 1: Dose Escalation Phase|Death|0
2061018|NCT00557856|3635387|FG001|Part 1: Dose Escalation Phase|Death|0
2302266|NCT02625324|4000998|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
2302267|NCT02625324|4000998|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28
2302268|NCT02625610|4001036|FG000|Overall Study|Ongoing|34
2302269|NCT02625610|4001037|FG001|Overall Study|Ongoing|54
2302270|NCT02625623|4001045|FG000|Overall Study|Participants randomized but not treated|9
2302271|NCT02625623|4001046|FG001|Overall Study|Participants randomized but not treated|1
2302272|NCT02625909|4001060|FG000|Overall Study|Death|2
2302273|NCT02625909|4001061|FG001|Overall Study|Death|0
2302274|NCT02625909|4001060|FG000|Overall Study|Lost to Follow-up|3
2302275|NCT02625909|4001061|FG001|Overall Study|Lost to Follow-up|5
2302276|NCT02625909|4001060|FG000|Overall Study|Lack of Efficacy|9
2302277|NCT02625909|4001061|FG001|Overall Study|Lack of Efficacy|2
2302278|NCT02625909|4001060|FG000|Overall Study|Reinfection|3
2302279|NCT02625909|4001061|FG001|Overall Study|Reinfection|2
2302280|NCT02625922|4001069|FG000|Overall Study|Non-availability of IMP|1
2302281|NCT02625922|4001070|FG001|Overall Study|Non-availability of IMP|1
2302282|NCT02625922|4001069|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1
2302283|NCT02625922|4001070|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1
2302284|NCT02625974|4001081|FG000|Overall Study|Adverse Event|12
2302285|NCT02625974|4001082|FG001|Overall Study|Adverse Event|2
2302286|NCT02625974|4001081|FG000|Overall Study|Withdrawal by Subject|3
2302287|NCT02625974|4001082|FG001|Overall Study|Withdrawal by Subject|1
2302288|NCT02625974|4001081|FG000|Overall Study|positive parasitemia|1
2302289|NCT02625974|4001082|FG001|Overall Study|positive parasitemia|0
2302290|NCT02625974|4001081|FG000|Overall Study|non-compliance with study drug|0
2302291|NCT02625974|4001082|FG001|Overall Study|non-compliance with study drug|2
2302292|NCT02625974|4001081|FG000|Overall Study|Protocol Violation|0
2302293|NCT02625974|4001082|FG001|Overall Study|Protocol Violation|1
2302294|NCT02626000|4001124|FG000|Overall Study|Decision by Sponsor|1
2302295|NCT02626000|4001124|FG000|Overall Study|Death|29
2302296|NCT02626026|4001135|FG000|Overall Study|Randomized but Never Treated|0
2302297|NCT02626026|4001136|FG001|Overall Study|Randomized but Never Treated|0
2302298|NCT02626026|4001137|FG002|Overall Study|Randomized but Never Treated|0
2302299|NCT02626026|4001138|FG003|Overall Study|Randomized but Never Treated|0
2302300|NCT02626026|4001139|FG004|Overall Study|Randomized but Never Treated|1
2302301|NCT02626026|4001140|FG005|Overall Study|Randomized but Never Treated|0
2302302|NCT02626182|4001181|FG000|Overall Study|Adverse Event|2
2302303|NCT02626182|4001182|FG001|Overall Study|Adverse Event|0
2302304|NCT02626780|4001208|FG000|Overall Study|Withdrawal by Subject|3
2302305|NCT02626819|4001214|FG000|Overall Study|Lost to Follow-up|3
2302306|NCT02626819|4001215|FG001|Overall Study|Lost to Follow-up|2
2302307|NCT02626819|4001214|FG000|Overall Study|Withdrawal by Subject|1
2302308|NCT02626819|4001215|FG001|Overall Study|Withdrawal by Subject|0
2302309|NCT02626819|4001214|FG000|Overall Study|Diagnosed w/ catastrophic illness|0
2302310|NCT02626819|4001215|FG001|Overall Study|Diagnosed w/ catastrophic illness|1
2302311|NCT02627144|4001252|FG000|Overall Study|Serious adverse event|32
2302312|NCT02627144|4001252|FG000|Overall Study|Cancer progression|171
2302313|NCT02627144|4001252|FG000|Overall Study|Death from cancer|20
2302314|NCT02627144|4001252|FG000|Overall Study|Death from other cause|8
2302315|NCT02627144|4001252|FG000|Overall Study|Refusal of treatment / poor cooperation|38
2061019|NCT00557856|3635388|FG002|Part 1: Dose Escalation Phase|Death|0
2061020|NCT00557856|3635389|FG003|Part 1: Dose Escalation Phase|Death|0
2061021|NCT00557856|3635390|FG004|Part 1: Dose Escalation Phase|Death|0
2061022|NCT00557856|3635391|FG005|Part 1: Dose Escalation Phase|Death|1
2061023|NCT00557856|3635392|FG006|Part 1: Dose Escalation Phase|Death|0
2061024|NCT00557856|3635393|FG007|Part 1: Dose Escalation Phase|Death|0
2061025|NCT00557856|3635394|FG008|Part 1: Dose Escalation Phase|Death|0
2061026|NCT00557856|3635386|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0
2061027|NCT00557856|3635387|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0
2061028|NCT00557856|3635388|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0
2061029|NCT00557856|3635389|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0
2061030|NCT00557856|3635390|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0
2061031|NCT00557856|3635391|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2
2061032|NCT00557856|3635392|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1
2061033|NCT00557856|3635393|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0
2061034|NCT00557856|3635394|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0
2061035|NCT00557856|3635386|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2
2061036|NCT00557856|3635387|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0
2061037|NCT00557856|3635388|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0
2061038|NCT00557856|3635389|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0
2061039|NCT00557856|3635390|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0
2209909|NCT01646320|3849320|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
2302316|NCT02627144|4001252|FG000|Overall Study|Administrative reasons|65
2302317|NCT02627144|4001252|FG000|Overall Study|Lost to Follow-up|8
2302318|NCT02627144|4001252|FG000|Overall Study|Enrolled, not treated|6
2302319|NCT02627144|4001252|FG000|Overall Study|Other|17
2302320|NCT02627495|4001256|FG000|Overall Study|Withdrawal by Subject|4
2302321|NCT02627677|4001263|FG000|Overall Study|Adverse event (not progressive disease)|1
2302322|NCT02627677|4001264|FG001|Overall Study|Adverse event (not progressive disease)|4
2302323|NCT02627677|4001265|FG002|Overall Study|Adverse event (not progressive disease)|1
2302324|NCT02627677|4001263|FG000|Overall Study|Progressive disease|1
2302325|NCT02627677|4001264|FG001|Overall Study|Progressive disease|3
2302326|NCT02627677|4001265|FG002|Overall Study|Progressive disease|0
2302327|NCT02627677|4001263|FG000|Overall Study|Lack of Efficacy|1
2302328|NCT02627677|4001264|FG001|Overall Study|Lack of Efficacy|2
2302329|NCT02627677|4001265|FG002|Overall Study|Lack of Efficacy|0
2302330|NCT02627677|4001263|FG000|Overall Study|Lost to Follow-up|0
2302331|NCT02627677|4001264|FG001|Overall Study|Lost to Follow-up|0
2302332|NCT02627677|4001265|FG002|Overall Study|Lost to Follow-up|1
2302333|NCT02627677|4001263|FG000|Overall Study|Pregnancy|0
2302334|NCT02627677|4001264|FG001|Overall Study|Pregnancy|1
2302335|NCT02627677|4001265|FG002|Overall Study|Pregnancy|0
2302336|NCT02627677|4001263|FG000|Overall Study|Study Terminated by Sponsor|5
2302337|NCT02627677|4001264|FG001|Overall Study|Study Terminated by Sponsor|10
2302338|NCT02627677|4001265|FG002|Overall Study|Study Terminated by Sponsor|6
2302339|NCT02627677|4001263|FG000|Overall Study|Physician Decision|0
2302340|NCT02627677|4001264|FG001|Overall Study|Physician Decision|0
2302341|NCT02627677|4001265|FG002|Overall Study|Physician Decision|2
2302342|NCT02627677|4001263|FG000|Overall Study|Withdrawal by Subject|2
2302343|NCT02627677|4001264|FG001|Overall Study|Withdrawal by Subject|1
2302344|NCT02627677|4001265|FG002|Overall Study|Withdrawal by Subject|1
2302345|NCT02627677|4001263|FG000|Overall Study|Reason not Specified|0
2302346|NCT02627677|4001264|FG001|Overall Study|Reason not Specified|0
2302347|NCT02627677|4001265|FG002|Overall Study|Reason not Specified|1
2302348|NCT02627677|4001263|FG000|Overall Study|Randomized but not Treated|1
2302349|NCT02627677|4001264|FG001|Overall Study|Randomized but not Treated|0
2302350|NCT02627677|4001265|FG002|Overall Study|Randomized but not Treated|0
2302351|NCT02628028|4001296|FG000|Dosing Period|Withdrawal by Subject|0
2302352|NCT02628028|4001297|FG001|Dosing Period|Withdrawal by Subject|0
2302353|NCT02628028|4001298|FG002|Dosing Period|Withdrawal by Subject|1
2302354|NCT02628028|4001299|FG003|Dosing Period|Withdrawal by Subject|0
2302355|NCT02628028|4001300|FG004|Dosing Period|Withdrawal by Subject|2
2302356|NCT02628028|4001301|FG005|Dosing Period|Withdrawal by Subject|4
2302357|NCT02628028|4001302|FG006|Dosing Period|Withdrawal by Subject|1
2302358|NCT02628028|4001303|FG007|Dosing Period|Withdrawal by Subject|1
2302359|NCT02628028|4001296|FG000|Dosing Period|Adverse Event|0
2302360|NCT02628028|4001297|FG001|Dosing Period|Adverse Event|0
2302361|NCT02628028|4001298|FG002|Dosing Period|Adverse Event|0
2302362|NCT02628028|4001299|FG003|Dosing Period|Adverse Event|0
2302363|NCT02628028|4001300|FG004|Dosing Period|Adverse Event|2
2302364|NCT02628028|4001301|FG005|Dosing Period|Adverse Event|1
2302365|NCT02628028|4001302|FG006|Dosing Period|Adverse Event|3
2302366|NCT02628028|4001303|FG007|Dosing Period|Adverse Event|2
2302367|NCT02628028|4001296|FG000|Dosing Period|Death|0
2302368|NCT02628028|4001297|FG001|Dosing Period|Death|0
2302369|NCT02628028|4001298|FG002|Dosing Period|Death|0
2302370|NCT02628028|4001299|FG003|Dosing Period|Death|0
2302371|NCT02628028|4001300|FG004|Dosing Period|Death|0
2302372|NCT02628028|4001301|FG005|Dosing Period|Death|0
2302373|NCT02628028|4001302|FG006|Dosing Period|Death|0
2302374|NCT02628028|4001303|FG007|Dosing Period|Death|1
2302375|NCT02628028|4001296|FG000|Dosing Period|Lack of Efficacy|0
2061040|NCT00557856|3635391|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0
2061041|NCT00557856|3635392|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0
2061042|NCT00557856|3635393|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0
2061043|NCT00557856|3635394|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0
2061044|NCT00557856|3635386|FG000|Part 2: Exploratory Phase|objective progression or relapse|0
2061045|NCT00557856|3635387|FG001|Part 2: Exploratory Phase|objective progression or relapse|0
2061046|NCT00557856|3635388|FG002|Part 2: Exploratory Phase|objective progression or relapse|0
2061047|NCT00557856|3635389|FG003|Part 2: Exploratory Phase|objective progression or relapse|0
2061048|NCT00557856|3635390|FG004|Part 2: Exploratory Phase|objective progression or relapse|0
2061049|NCT00557856|3635391|FG005|Part 2: Exploratory Phase|objective progression or relapse|0
2061050|NCT00557856|3635392|FG006|Part 2: Exploratory Phase|objective progression or relapse|0
2302376|NCT02628028|4001297|FG001|Dosing Period|Lack of Efficacy|0
2302377|NCT02628028|4001298|FG002|Dosing Period|Lack of Efficacy|0
2302378|NCT02628028|4001299|FG003|Dosing Period|Lack of Efficacy|0
2302379|NCT02628028|4001300|FG004|Dosing Period|Lack of Efficacy|3
2302380|NCT02628028|4001301|FG005|Dosing Period|Lack of Efficacy|0
2302381|NCT02628028|4001302|FG006|Dosing Period|Lack of Efficacy|1
2302382|NCT02628028|4001303|FG007|Dosing Period|Lack of Efficacy|0
2302383|NCT02628028|4001296|FG000|Dosing Period|Study Terminated by Sponsor|0
2302384|NCT02628028|4001297|FG001|Dosing Period|Study Terminated by Sponsor|0
2302385|NCT02628028|4001298|FG002|Dosing Period|Study Terminated by Sponsor|0
2302386|NCT02628028|4001299|FG003|Dosing Period|Study Terminated by Sponsor|0
2302387|NCT02628028|4001300|FG004|Dosing Period|Study Terminated by Sponsor|7
2302388|NCT02628028|4001301|FG005|Dosing Period|Study Terminated by Sponsor|6
2302389|NCT02628028|4001302|FG006|Dosing Period|Study Terminated by Sponsor|7
2302390|NCT02628028|4001303|FG007|Dosing Period|Study Terminated by Sponsor|7
2302391|NCT02628028|4001296|FG000|Dosing Period|Physician Decision|0
2302392|NCT02628028|4001297|FG001|Dosing Period|Physician Decision|0
2302393|NCT02628028|4001298|FG002|Dosing Period|Physician Decision|0
2302394|NCT02628028|4001299|FG003|Dosing Period|Physician Decision|0
2302395|NCT02628028|4001300|FG004|Dosing Period|Physician Decision|0
2302396|NCT02628028|4001301|FG005|Dosing Period|Physician Decision|1
2302397|NCT02628028|4001302|FG006|Dosing Period|Physician Decision|0
2302398|NCT02628028|4001303|FG007|Dosing Period|Physician Decision|0
2302399|NCT02628028|4001296|FG000|Dosing Period|Site Terminated by Sponsor|0
2302400|NCT02628028|4001297|FG001|Dosing Period|Site Terminated by Sponsor|0
2302401|NCT02628028|4001298|FG002|Dosing Period|Site Terminated by Sponsor|0
2302402|NCT02628028|4001299|FG003|Dosing Period|Site Terminated by Sponsor|0
2302403|NCT02628028|4001300|FG004|Dosing Period|Site Terminated by Sponsor|0
2302404|NCT02628028|4001301|FG005|Dosing Period|Site Terminated by Sponsor|1
2302405|NCT02628028|4001302|FG006|Dosing Period|Site Terminated by Sponsor|1
2302406|NCT02628028|4001303|FG007|Dosing Period|Site Terminated by Sponsor|0
2302407|NCT02628028|4001296|FG000|Dosing Period|Lost to Follow-up|0
2302408|NCT02628028|4001297|FG001|Dosing Period|Lost to Follow-up|0
2302409|NCT02628028|4001298|FG002|Dosing Period|Lost to Follow-up|0
2302410|NCT02628028|4001299|FG003|Dosing Period|Lost to Follow-up|0
2302411|NCT02628028|4001300|FG004|Dosing Period|Lost to Follow-up|0
2302412|NCT02628028|4001301|FG005|Dosing Period|Lost to Follow-up|0
2302413|NCT02628028|4001302|FG006|Dosing Period|Lost to Follow-up|1
2302414|NCT02628028|4001303|FG007|Dosing Period|Lost to Follow-up|0
2302415|NCT02628028|4001296|FG000|Dosing Period|Other|0
2302416|NCT02628028|4001297|FG001|Dosing Period|Other|0
2302417|NCT02628028|4001298|FG002|Dosing Period|Other|0
2302418|NCT02628028|4001299|FG003|Dosing Period|Other|0
2302419|NCT02628028|4001300|FG004|Dosing Period|Other|2
2302420|NCT02628028|4001301|FG005|Dosing Period|Other|1
2302421|NCT02628028|4001302|FG006|Dosing Period|Other|2
2302422|NCT02628028|4001303|FG007|Dosing Period|Other|4
2302423|NCT02628028|4001296|FG000|Long-term Extension (LTE) Period|Adverse Event|0
2302424|NCT02628028|4001297|FG001|Long-term Extension (LTE) Period|Adverse Event|0
2302425|NCT02628028|4001298|FG002|Long-term Extension (LTE) Period|Adverse Event|0
2302426|NCT02628028|4001299|FG003|Long-term Extension (LTE) Period|Adverse Event|0
2302427|NCT02628028|4001300|FG004|Long-term Extension (LTE) Period|Adverse Event|0
2302428|NCT02628028|4001301|FG005|Long-term Extension (LTE) Period|Adverse Event|1
2302429|NCT02628028|4001302|FG006|Long-term Extension (LTE) Period|Adverse Event|0
2302430|NCT02628028|4001303|FG007|Long-term Extension (LTE) Period|Adverse Event|3
2302431|NCT02628028|4001296|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0
2302432|NCT02628028|4001297|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0
2302433|NCT02628028|4001298|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0
2302434|NCT02628028|4001299|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0
2302435|NCT02628028|4001300|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0
2302436|NCT02628028|4001301|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2
2302437|NCT02628028|4001302|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0
2302438|NCT02628028|4001303|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1
2302439|NCT02628028|4001296|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2302440|NCT02628028|4001297|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2302441|NCT02628028|4001298|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2302442|NCT02628028|4001299|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2302443|NCT02628028|4001300|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2061051|NCT00557856|3635393|FG007|Part 2: Exploratory Phase|objective progression or relapse|0
2061052|NCT00557856|3635394|FG008|Part 2: Exploratory Phase|objective progression or relapse|15
2061053|NCT00557856|3635386|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0
2061054|NCT00557856|3635387|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0
2061055|NCT00557856|3635388|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0
2061056|NCT00557856|3635389|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0
2061057|NCT00557856|3635390|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0
2061058|NCT00557856|3635391|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0
2302444|NCT02628028|4001301|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
2302445|NCT02628028|4001302|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
2302446|NCT02628028|4001303|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
2302447|NCT02628028|4001296|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2302448|NCT02628028|4001297|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2302449|NCT02628028|4001298|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2302450|NCT02628028|4001299|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2302451|NCT02628028|4001300|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2302452|NCT02628028|4001301|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2
2302453|NCT02628028|4001302|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3
2302454|NCT02628028|4001303|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3
2302455|NCT02628028|4001296|FG000|Long-term Extension (LTE) Period|Other|0
2302456|NCT02628028|4001297|FG001|Long-term Extension (LTE) Period|Other|0
2302457|NCT02628028|4001298|FG002|Long-term Extension (LTE) Period|Other|0
2302458|NCT02628028|4001299|FG003|Long-term Extension (LTE) Period|Other|0
2302459|NCT02628028|4001300|FG004|Long-term Extension (LTE) Period|Other|0
2302460|NCT02628028|4001301|FG005|Long-term Extension (LTE) Period|Other|3
2302461|NCT02628028|4001302|FG006|Long-term Extension (LTE) Period|Other|4
2302462|NCT02628028|4001303|FG007|Long-term Extension (LTE) Period|Other|3
2321581|NCT02960893|4036087|FG000|Extension Phase (48-week)|Withdrawal by Subject|8
2321582|NCT02960893|4036088|FG001|Extension Phase (48-week)|Withdrawal by Subject|8
2321583|NCT02960893|4036087|FG000|Extension Phase (48-week)|Other Reason|2
2321584|NCT02960893|4036088|FG001|Extension Phase (48-week)|Other Reason|1
2321585|NCT02960893|4036087|FG000|Extension Phase (48-week)|Lost to Follow-up|1
2321586|NCT02960893|4036088|FG001|Extension Phase (48-week)|Lost to Follow-up|1
2321587|NCT02960893|4036087|FG000|Extension Phase (48-week)|Sponsors Decision|1
2321588|NCT02960893|4036088|FG001|Extension Phase (48-week)|Sponsors Decision|0
2321589|NCT02961218|4036121|FG000|Overall Study|Lost to Follow-up|0
2321590|NCT02961218|4036122|FG001|Overall Study|Lost to Follow-up|2
2321591|NCT02961218|4036121|FG000|Overall Study|Physician Decision|0
2321592|NCT02961218|4036122|FG001|Overall Study|Physician Decision|2
2321593|NCT02961218|4036121|FG000|Overall Study|Subject/Guardian Decision|3
2321594|NCT02961218|4036122|FG001|Overall Study|Subject/Guardian Decision|1
2321595|NCT02961244|4036132|FG000|Overall Study|Protocol Violation|0
2321596|NCT02961244|4036133|FG001|Overall Study|Protocol Violation|1
2321597|NCT02961244|4036132|FG000|Overall Study|Withdrawal by Subject|1
2321598|NCT02961244|4036133|FG001|Overall Study|Withdrawal by Subject|2
2321599|NCT02961244|4036132|FG000|Overall Study|Surgery plan change after study approval|0
2321600|NCT02961244|4036133|FG001|Overall Study|Surgery plan change after study approval|2
2321601|NCT02961244|4036132|FG000|Overall Study|Lost to Follow-up|0
2321602|NCT02961244|4036133|FG001|Overall Study|Lost to Follow-up|2
2321603|NCT02961244|4036132|FG000|Overall Study|İnadequate data|0
2321604|NCT02961244|4036133|FG001|Overall Study|İnadequate data|2
2321605|NCT02961374|4036139|FG000|Overall Study|Adverse Event|4
2321606|NCT02961751|4036143|FG000|Overall Study|Lost to Follow-up|11
2321607|NCT02961751|4036143|FG000|Overall Study|Physician Decision|2
2321608|NCT02961751|4036143|FG000|Overall Study|Not Eligible at Enrollment|1
2321609|NCT02961751|4036143|FG000|Overall Study|Protocol Violation|1
2321610|NCT02961764|4036149|FG000|Overall Study|Protocol Violation|0
2321611|NCT02961764|4036150|FG001|Overall Study|Protocol Violation|1
2321612|NCT02961764|4036149|FG000|Overall Study|Death|2
2321613|NCT02961764|4036150|FG001|Overall Study|Death|0
2321614|NCT02961764|4036149|FG000|Overall Study|Lost to Follow-up|35
2321615|NCT02961764|4036150|FG001|Overall Study|Lost to Follow-up|24
2321616|NCT02961764|4036149|FG000|Overall Study|Withdrawal by Subject|2
2321617|NCT02961764|4036150|FG001|Overall Study|Withdrawal by Subject|0
2321618|NCT02961790|4036160|FG000|Overall Study|Canceled|4
2321619|NCT02961790|4036161|FG001|Overall Study|Canceled|5
2321620|NCT02961790|4036162|FG002|Overall Study|Canceled|1
2321621|NCT02961790|4036163|FG003|Overall Study|Canceled|4
2321622|NCT02961790|4036160|FG000|Overall Study|without baseline data|4
2321623|NCT02961790|4036161|FG001|Overall Study|without baseline data|0
2321624|NCT02961790|4036162|FG002|Overall Study|without baseline data|1
2321625|NCT02961790|4036163|FG003|Overall Study|without baseline data|0
2321626|NCT02961790|4036160|FG000|Overall Study|without post baseline data|7
2321627|NCT02961790|4036161|FG001|Overall Study|without post baseline data|6
2321628|NCT02961790|4036162|FG002|Overall Study|without post baseline data|4
2321629|NCT02961790|4036163|FG003|Overall Study|without post baseline data|1
2321630|NCT02961920|4036180|FG000|Overall Study|did not achive stydy protocol schedule|1
2321631|NCT02961920|4036181|FG001|Overall Study|did not achive stydy protocol schedule|1
2321632|NCT02962284|4036202|FG000|Overall Study|Death|2
2321633|NCT02962284|4036203|FG001|Overall Study|Death|0
2061059|NCT00557856|3635392|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0
2061060|NCT00557856|3635393|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0
2061061|NCT00557856|3635394|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1
2061062|NCT00557856|3635386|FG000|Part 2: Exploratory Phase|Adverse Event|0
2061063|NCT00557856|3635387|FG001|Part 2: Exploratory Phase|Adverse Event|0
2061064|NCT00557856|3635388|FG002|Part 2: Exploratory Phase|Adverse Event|0
2061065|NCT00557856|3635389|FG003|Part 2: Exploratory Phase|Adverse Event|0
2061066|NCT00557856|3635390|FG004|Part 2: Exploratory Phase|Adverse Event|0
2061067|NCT00557856|3635391|FG005|Part 2: Exploratory Phase|Adverse Event|0
2061068|NCT00557856|3635392|FG006|Part 2: Exploratory Phase|Adverse Event|0
2061069|NCT00557856|3635393|FG007|Part 2: Exploratory Phase|Adverse Event|0
2061070|NCT00557856|3635394|FG008|Part 2: Exploratory Phase|Adverse Event|4
2061071|NCT00557856|3635386|FG000|Part 2: Exploratory Phase|Other|0
2061072|NCT00557856|3635387|FG001|Part 2: Exploratory Phase|Other|0
2061073|NCT00557856|3635388|FG002|Part 2: Exploratory Phase|Other|0
2061074|NCT00557856|3635389|FG003|Part 2: Exploratory Phase|Other|0
2061075|NCT00557856|3635390|FG004|Part 2: Exploratory Phase|Other|0
2061076|NCT00557856|3635391|FG005|Part 2: Exploratory Phase|Other|0
2061077|NCT00557856|3635392|FG006|Part 2: Exploratory Phase|Other|0
2061078|NCT00557856|3635393|FG007|Part 2: Exploratory Phase|Other|0
2061079|NCT00557856|3635394|FG008|Part 2: Exploratory Phase|Other|1
2061080|NCT00557856|3635386|FG000|Part 2: Exploratory Phase|Death|0
2061081|NCT00557856|3635387|FG001|Part 2: Exploratory Phase|Death|0
2061082|NCT00557856|3635388|FG002|Part 2: Exploratory Phase|Death|0
2061083|NCT00557856|3635389|FG003|Part 2: Exploratory Phase|Death|0
2061084|NCT00557856|3635390|FG004|Part 2: Exploratory Phase|Death|0
2061085|NCT00557856|3635391|FG005|Part 2: Exploratory Phase|Death|0
2061086|NCT00557856|3635392|FG006|Part 2: Exploratory Phase|Death|0
2061087|NCT00557856|3635393|FG007|Part 2: Exploratory Phase|Death|0
2061088|NCT00557856|3635394|FG008|Part 2: Exploratory Phase|Death|2
2061089|NCT00557856|3635386|FG000|Part 2: Exploratory Phase|global deterioration of health status|0
2061090|NCT00557856|3635387|FG001|Part 2: Exploratory Phase|global deterioration of health status|0
2061091|NCT00557856|3635388|FG002|Part 2: Exploratory Phase|global deterioration of health status|0
2061092|NCT00557856|3635389|FG003|Part 2: Exploratory Phase|global deterioration of health status|0
2061093|NCT00557856|3635390|FG004|Part 2: Exploratory Phase|global deterioration of health status|0
2061094|NCT00557856|3635391|FG005|Part 2: Exploratory Phase|global deterioration of health status|0
2061095|NCT00557856|3635392|FG006|Part 2: Exploratory Phase|global deterioration of health status|0
2061096|NCT00557856|3635393|FG007|Part 2: Exploratory Phase|global deterioration of health status|0
2061097|NCT00557856|3635394|FG008|Part 2: Exploratory Phase|global deterioration of health status|1
2061098|NCT00558025|3635437|FG000|Overall Study|Adverse Event|1
2061099|NCT00558025|3635438|FG001|Overall Study|Adverse Event|1
2061100|NCT00558025|3635437|FG000|Overall Study|Withdrawal by Subject|2
2061101|NCT00558025|3635438|FG001|Overall Study|Withdrawal by Subject|2
2061102|NCT00558025|3635437|FG000|Overall Study|Protocol Violation|1
2061103|NCT00558025|3635438|FG001|Overall Study|Protocol Violation|0
2061104|NCT00558064|3635446|FG000|Overall Study|Adverse Event|3
2061105|NCT00558064|3635447|FG001|Overall Study|Adverse Event|2
2061106|NCT00558064|3635446|FG000|Overall Study|Lack of Efficacy|0
2061107|NCT00558064|3635447|FG001|Overall Study|Lack of Efficacy|1
2061108|NCT00558064|3635446|FG000|Overall Study|Protocol Violation|1
2061109|NCT00558064|3635447|FG001|Overall Study|Protocol Violation|0
2061110|NCT00558064|3635446|FG000|Overall Study|Lost to Follow-up|0
2061111|NCT00558064|3635447|FG001|Overall Study|Lost to Follow-up|1
2061112|NCT00558064|3635446|FG000|Overall Study|Withdrawal by Subject|0
2061113|NCT00558064|3635447|FG001|Overall Study|Withdrawal by Subject|1
2061114|NCT00558064|3635446|FG000|Overall Study|No visit within allowance period|1
2061115|NCT00558064|3635447|FG001|Overall Study|No visit within allowance period|0
2061116|NCT00558103|3635458|FG000|Randomized Treatment Phase|Lost to Follow-up|2
2061117|NCT00558103|3635459|FG001|Randomized Treatment Phase|Lost to Follow-up|2
2061118|NCT00558103|3635460|FG002|Randomized Treatment Phase|Lost to Follow-up|2
2061119|NCT00558103|3635461|FG003|Randomized Treatment Phase|Lost to Follow-up|1
2061120|NCT00558103|3635462|FG004|Randomized Treatment Phase|Lost to Follow-up|3
2061121|NCT00558103|3635463|FG005|Randomized Treatment Phase|Lost to Follow-up|0
2061122|NCT00558103|3635458|FG000|Randomized Treatment Phase|Withdrawal by Subject|2
2061123|NCT00558103|3635459|FG001|Randomized Treatment Phase|Withdrawal by Subject|2
2061124|NCT00558103|3635460|FG002|Randomized Treatment Phase|Withdrawal by Subject|0
2061125|NCT00558103|3635461|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
2061126|NCT00558103|3635462|FG004|Randomized Treatment Phase|Withdrawal by Subject|1
2061127|NCT00558103|3635463|FG005|Randomized Treatment Phase|Withdrawal by Subject|0
2061128|NCT00558103|3635458|FG000|Randomized Treatment Phase|Disease Progression|1
2061129|NCT00558103|3635459|FG001|Randomized Treatment Phase|Disease Progression|0
2061130|NCT00558103|3635460|FG002|Randomized Treatment Phase|Disease Progression|1
2061131|NCT00558103|3635461|FG003|Randomized Treatment Phase|Disease Progression|0
2061132|NCT00558103|3635462|FG004|Randomized Treatment Phase|Disease Progression|0
2061133|NCT00558103|3635463|FG005|Randomized Treatment Phase|Disease Progression|0
2061134|NCT00558103|3635458|FG000|Randomized Treatment Phase|Adverse Event|0
2061135|NCT00558103|3635459|FG001|Randomized Treatment Phase|Adverse Event|0
2061136|NCT00558103|3635460|FG002|Randomized Treatment Phase|Adverse Event|0
2061137|NCT00558103|3635461|FG003|Randomized Treatment Phase|Adverse Event|1
2061138|NCT00558103|3635462|FG004|Randomized Treatment Phase|Adverse Event|1
2061139|NCT00558103|3635463|FG005|Randomized Treatment Phase|Adverse Event|0
2061140|NCT00558103|3635458|FG000|Monotherapy Extension Phase|Protocol Violation|0
2061141|NCT00558103|3635459|FG001|Monotherapy Extension Phase|Protocol Violation|0
2061142|NCT00558103|3635460|FG002|Monotherapy Extension Phase|Protocol Violation|0
2061143|NCT00558103|3635461|FG003|Monotherapy Extension Phase|Protocol Violation|0
2061144|NCT00558103|3635462|FG004|Monotherapy Extension Phase|Protocol Violation|0
2302463|NCT02628418|4001353|FG000|Overall Study|Lost to Follow-up|1
2302464|NCT02628418|4001354|FG001|Overall Study|Lost to Follow-up|2
2302465|NCT02628444|4001369|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1
2061145|NCT00558103|3635463|FG005|Monotherapy Extension Phase|Protocol Violation|1
2061146|NCT00558103|3635458|FG000|Monotherapy Extension Phase|Disease Progression|0
2061147|NCT00558103|3635459|FG001|Monotherapy Extension Phase|Disease Progression|0
2061148|NCT00558103|3635460|FG002|Monotherapy Extension Phase|Disease Progression|0
2061149|NCT00558103|3635461|FG003|Monotherapy Extension Phase|Disease Progression|0
2061150|NCT00558103|3635462|FG004|Monotherapy Extension Phase|Disease Progression|0
2061151|NCT00558103|3635463|FG005|Monotherapy Extension Phase|Disease Progression|8
2061152|NCT00558259|3635485|FG000|Overall Study|Adverse Event|50
2061153|NCT00558259|3635486|FG001|Overall Study|Adverse Event|81
2061154|NCT00558259|3635485|FG000|Overall Study|Protocol Violation|9
2209910|NCT01646320|3849321|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
2061155|NCT00558259|3635486|FG001|Overall Study|Protocol Violation|5
2061156|NCT00558259|3635485|FG000|Overall Study|Withdrawal by Subject|12
2061157|NCT00558259|3635486|FG001|Overall Study|Withdrawal by Subject|13
2061158|NCT00558272|3635494|FG000|Overall Study|Adverse Event|10
2061159|NCT00558272|3635495|FG001|Overall Study|Adverse Event|0
2061160|NCT00558272|3635494|FG000|Overall Study|Death|1
2061161|NCT00558272|3635495|FG001|Overall Study|Death|0
2061162|NCT00558272|3635494|FG000|Overall Study|Dev. of study specific discon. criteria|1
2061163|NCT00558272|3635495|FG001|Overall Study|Dev. of study specific discon. criteria|0
2061164|NCT00558272|3635494|FG000|Overall Study|AZ study team decision|0
2061165|NCT00558272|3635495|FG001|Overall Study|AZ study team decision|1
2061166|NCT00558272|3635494|FG000|Overall Study|Incorrectly enrolled|1
2061167|NCT00558272|3635495|FG001|Overall Study|Incorrectly enrolled|0
2061168|NCT00558272|3635494|FG000|Overall Study|Withdrawal by Subject|0
2061169|NCT00558272|3635495|FG001|Overall Study|Withdrawal by Subject|1
2061170|NCT00558285|3635506|FG000|Overall Study|Adverse Event|1
2061171|NCT00558285|3635507|FG001|Overall Study|Adverse Event|1
2061172|NCT00558285|3635508|FG002|Overall Study|Adverse Event|4
2061173|NCT00558285|3635509|FG003|Overall Study|Adverse Event|1
2061174|NCT00558285|3635510|FG004|Overall Study|Adverse Event|2
2061175|NCT00558285|3635506|FG000|Overall Study|Abnormal test procedure result(s)|1
2061176|NCT00558285|3635507|FG001|Overall Study|Abnormal test procedure result(s)|0
2061177|NCT00558285|3635508|FG002|Overall Study|Abnormal test procedure result(s)|0
2061178|NCT00558285|3635509|FG003|Overall Study|Abnormal test procedure result(s)|0
2061179|NCT00558285|3635510|FG004|Overall Study|Abnormal test procedure result(s)|0
2061180|NCT00558285|3635506|FG000|Overall Study|Subject withdrew consent|2
2061181|NCT00558285|3635507|FG001|Overall Study|Subject withdrew consent|0
2061182|NCT00558285|3635508|FG002|Overall Study|Subject withdrew consent|1
2061183|NCT00558285|3635509|FG003|Overall Study|Subject withdrew consent|1
2061184|NCT00558285|3635510|FG004|Overall Study|Subject withdrew consent|1
2061185|NCT00558285|3635506|FG000|Overall Study|Lost to Follow-up|1
2061186|NCT00558285|3635507|FG001|Overall Study|Lost to Follow-up|1
2061187|NCT00558285|3635508|FG002|Overall Study|Lost to Follow-up|0
2061188|NCT00558285|3635509|FG003|Overall Study|Lost to Follow-up|0
2061189|NCT00558285|3635510|FG004|Overall Study|Lost to Follow-up|0
2061190|NCT00558285|3635506|FG000|Overall Study|Administrative problems|0
2061191|NCT00558285|3635507|FG001|Overall Study|Administrative problems|0
2061192|NCT00558285|3635508|FG002|Overall Study|Administrative problems|0
2061193|NCT00558285|3635509|FG003|Overall Study|Administrative problems|1
2061194|NCT00558285|3635510|FG004|Overall Study|Administrative problems|1
2061195|NCT00558285|3635506|FG000|Overall Study|Protocol deviation|1
2061196|NCT00558285|3635507|FG001|Overall Study|Protocol deviation|1
2061197|NCT00558285|3635508|FG002|Overall Study|Protocol deviation|0
2061198|NCT00558285|3635509|FG003|Overall Study|Protocol deviation|1
2061199|NCT00558285|3635510|FG004|Overall Study|Protocol deviation|0
2061200|NCT00558363|3635524|FG000|Overall Study|Physician Decision|18
2061201|NCT00558363|3635525|FG001|Overall Study|Physician Decision|4
2061202|NCT00558363|3635524|FG000|Overall Study|Withdrawal by Subject|11
2061203|NCT00558363|3635525|FG001|Overall Study|Withdrawal by Subject|4
2061204|NCT00558363|3635524|FG000|Overall Study|Adverse Event|5
2061205|NCT00558363|3635525|FG001|Overall Study|Adverse Event|5
2061206|NCT00558363|3635524|FG000|Overall Study|Lack of Efficacy|2
2061207|NCT00558363|3635525|FG001|Overall Study|Lack of Efficacy|2
2061208|NCT00558363|3635524|FG000|Overall Study|Protocol Violation|2
2061209|NCT00558363|3635525|FG001|Overall Study|Protocol Violation|1
2061210|NCT00558363|3635524|FG000|Overall Study|Lost to Follow-up|0
2061211|NCT00558363|3635525|FG001|Overall Study|Lost to Follow-up|1
2061212|NCT00558363|3635524|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32
2209911|NCT01646320|3849320|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
2217687|NCT01709305|3860932|FG004|Phase 2|Death|0
2061213|NCT00558363|3635525|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16
2061214|NCT00558363|3635524|FG000|Overall Study|Randomized in Error|1
2061215|NCT00558363|3635525|FG001|Overall Study|Randomized in Error|2
2061216|NCT00558363|3635524|FG000|Overall Study|Hospitalized; Unable to Continue|0
2061217|NCT00558363|3635525|FG001|Overall Study|Hospitalized; Unable to Continue|1
2061218|NCT00558428|3635535|FG000|Overall Study|Adverse Event|6
2061219|NCT00558428|3635536|FG001|Overall Study|Adverse Event|22
2061220|NCT00558428|3635537|FG002|Overall Study|Adverse Event|3
2061221|NCT00558428|3635538|FG003|Overall Study|Adverse Event|4
2061222|NCT00558428|3635535|FG000|Overall Study|Lost to Follow-up|0
2061223|NCT00558428|3635536|FG001|Overall Study|Lost to Follow-up|1
2061224|NCT00558428|3635537|FG002|Overall Study|Lost to Follow-up|0
2061225|NCT00558428|3635538|FG003|Overall Study|Lost to Follow-up|0
2061226|NCT00558428|3635535|FG000|Overall Study|Lack of Efficacy|0
2061227|NCT00558428|3635536|FG001|Overall Study|Lack of Efficacy|0
2061228|NCT00558428|3635537|FG002|Overall Study|Lack of Efficacy|1
2061229|NCT00558428|3635538|FG003|Overall Study|Lack of Efficacy|2
2061230|NCT00558428|3635535|FG000|Overall Study|Non compliant with protocol|1
2061231|NCT00558428|3635536|FG001|Overall Study|Non compliant with protocol|0
2061232|NCT00558428|3635537|FG002|Overall Study|Non compliant with protocol|0
2061233|NCT00558428|3635538|FG003|Overall Study|Non compliant with protocol|3
2061234|NCT00558428|3635535|FG000|Overall Study|Consent withdrawn|2
2061235|NCT00558428|3635536|FG001|Overall Study|Consent withdrawn|1
2061236|NCT00558428|3635537|FG002|Overall Study|Consent withdrawn|0
2061237|NCT00558428|3635538|FG003|Overall Study|Consent withdrawn|1
2061238|NCT00558428|3635535|FG000|Overall Study|Other|3
2061239|NCT00558428|3635536|FG001|Overall Study|Other|0
2061240|NCT00558428|3635537|FG002|Overall Study|Other|0
2061241|NCT00558428|3635538|FG003|Overall Study|Other|1
2061242|NCT00558467|3635550|FG000|Overall Study|Adverse Event|1
2061243|NCT00558467|3635551|FG001|Overall Study|Adverse Event|2
2061244|NCT00558467|3635550|FG000|Overall Study|Lack of Efficacy|0
2061245|NCT00558467|3635551|FG001|Overall Study|Lack of Efficacy|1
2061246|NCT00558467|3635550|FG000|Overall Study|Patient moving out of state|0
2061247|NCT00558467|3635551|FG001|Overall Study|Patient moving out of state|1
2061248|NCT00558519|3635557|FG000|Overall Study|Ph+|20
2061249|NCT00558519|3635557|FG000|Overall Study|Ineligible|1
2061250|NCT00558519|3635557|FG000|Overall Study|Insufficient data|1
2061251|NCT00558519|3635557|FG000|Overall Study|Never received treatment|1
2105793|NCT00860028|3698611|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
2105794|NCT00860028|3698612|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
2105795|NCT00860067|3698623|FG000|Overall Study|Lost to Follow-up|46
2105796|NCT00860067|3698624|FG001|Overall Study|Lost to Follow-up|9
2105797|NCT00860067|3698625|FG002|Overall Study|Lost to Follow-up|9
2105798|NCT00860067|3698623|FG000|Overall Study|Withdrawal by Subject|4
2105799|NCT00860067|3698624|FG001|Overall Study|Withdrawal by Subject|0
2105800|NCT00860067|3698625|FG002|Overall Study|Withdrawal by Subject|0
2105801|NCT00860067|3698623|FG000|Overall Study|Pregnancy|1
2105802|NCT00860067|3698624|FG001|Overall Study|Pregnancy|0
2105803|NCT00860067|3698625|FG002|Overall Study|Pregnancy|0
2105804|NCT00860262|3698643|FG000|Overall Study|Adverse Event|9
2105805|NCT00860262|3698644|FG001|Overall Study|Adverse Event|6
2105806|NCT00860262|3698645|FG002|Overall Study|Adverse Event|7
2105807|NCT00860262|3698643|FG000|Overall Study|Protocol Violation|0
2105808|NCT00860262|3698644|FG001|Overall Study|Protocol Violation|1
2105809|NCT00860262|3698645|FG002|Overall Study|Protocol Violation|0
2105810|NCT00860262|3698643|FG000|Overall Study|Lost to Follow-up|2
2105811|NCT00860262|3698644|FG001|Overall Study|Lost to Follow-up|0
2105812|NCT00860262|3698645|FG002|Overall Study|Lost to Follow-up|1
2105813|NCT00860262|3698643|FG000|Overall Study|Withdrawal by Subject|4
2105814|NCT00860262|3698644|FG001|Overall Study|Withdrawal by Subject|8
2105815|NCT00860262|3698645|FG002|Overall Study|Withdrawal by Subject|6
2105816|NCT00860262|3698643|FG000|Overall Study|Lack of Efficacy|0
2105817|NCT00860262|3698644|FG001|Overall Study|Lack of Efficacy|4
2105818|NCT00860262|3698645|FG002|Overall Study|Lack of Efficacy|3
2105819|NCT00860262|3698643|FG000|Overall Study|Other|5
2105820|NCT00860262|3698644|FG001|Overall Study|Other|3
2105821|NCT00860262|3698645|FG002|Overall Study|Other|1
2105822|NCT00860405|3698679|FG000|Overall Study|Main reason: Follow-up data not complete|5
2105823|NCT00860405|3698680|FG001|Overall Study|Main reason: Follow-up data not complete|4
2105824|NCT00860470|3698692|FG000|Overall Study|Death|6
2105825|NCT00860470|3698693|FG001|Overall Study|Death|10
2105826|NCT00860470|3698692|FG000|Overall Study|Moved away|8
2105827|NCT00860470|3698693|FG001|Overall Study|Moved away|10
2105828|NCT00860470|3698692|FG000|Overall Study|Lost to Follow-up|34
2105829|NCT00860470|3698693|FG001|Overall Study|Lost to Follow-up|39
2105830|NCT00860574|3698703|FG000|Overall Study|Death|2
2105831|NCT00860574|3698703|FG000|Overall Study|Relapse|1
2105832|NCT00860743|3698713|FG000|Overall Study|Withdrawal by Subject|3
2105833|NCT00860743|3698714|FG001|Overall Study|Withdrawal by Subject|0
2105834|NCT00860951|3698747|FG000|Overall Study|Withdrawal by Subject|2
2105835|NCT00860951|3698747|FG000|Overall Study|Lost to Follow-up|5
2105836|NCT00861198|3698762|FG000|Overall Study|SpyGlass Failed|5
2105837|NCT00861341|3698770|FG000|Overall Study|Withdrawal by Subject|2
2105838|NCT00861380|3698781|FG000|Overall Study|Withdrawal Information not recorded|8427
2105839|NCT00861380|3698782|FG001|Overall Study|Withdrawal Information not recorded|9112
2061252|NCT00558636|3635591|FG000|Treatment|Adverse Event|9
2061253|NCT00558636|3635592|FG001|Treatment|Adverse Event|2
2061254|NCT00558636|3635591|FG000|Treatment|Withdrawal by Subject|2
2061255|NCT00558636|3635592|FG001|Treatment|Withdrawal by Subject|0
2061256|NCT00558636|3635591|FG000|Treatment|Premature termination of the study|35
2061257|NCT00558636|3635592|FG001|Treatment|Premature termination of the study|37
2061258|NCT00558636|3635591|FG000|Treatment|Disease progression|1
2061259|NCT00558636|3635592|FG001|Treatment|Disease progression|5
2061260|NCT00558636|3635591|FG000|Follow-up|Premature termination of the study|12
2061261|NCT00558636|3635592|FG001|Follow-up|Premature termination of the study|7
2061262|NCT00558701|3635600|FG000|Overall Study|Protocol Deviations|1
2061263|NCT00558701|3635601|FG001|Overall Study|Protocol Deviations|4
2061264|NCT00558753|3635609|FG000|Overall Study|Lost to Follow-up|5
2061265|NCT00558753|3635610|FG001|Overall Study|Lost to Follow-up|7
2061266|NCT00558831|3635632|FG000|Overall Study|Lost to Follow-up|1
2061267|NCT00558896|3635667|FG000|Overall Study|Adverse Event|1
2061268|NCT00558896|3635668|FG001|Overall Study|Adverse Event|1
2061269|NCT00558896|3635669|FG002|Overall Study|Adverse Event|1
2061270|NCT00558896|3635670|FG003|Overall Study|Adverse Event|3
2061271|NCT00558896|3635671|FG004|Overall Study|Adverse Event|4
2061272|NCT00558896|3635672|FG005|Overall Study|Adverse Event|10
2061273|NCT00558896|3635673|FG006|Overall Study|Adverse Event|3
2061274|NCT00558896|3635667|FG000|Overall Study|Death|3
2061275|NCT00558896|3635668|FG001|Overall Study|Death|0
2061276|NCT00558896|3635669|FG002|Overall Study|Death|2
2061277|NCT00558896|3635670|FG003|Overall Study|Death|3
2061278|NCT00558896|3635671|FG004|Overall Study|Death|2
2061279|NCT00558896|3635672|FG005|Overall Study|Death|2
2061280|NCT00558896|3635673|FG006|Overall Study|Death|6
2061281|NCT00558896|3635667|FG000|Overall Study|Withdrawal by Subject|2
2061282|NCT00558896|3635668|FG001|Overall Study|Withdrawal by Subject|1
2061283|NCT00558896|3635669|FG002|Overall Study|Withdrawal by Subject|1
2061284|NCT00558896|3635670|FG003|Overall Study|Withdrawal by Subject|1
2061285|NCT00558896|3635671|FG004|Overall Study|Withdrawal by Subject|1
2061286|NCT00558896|3635672|FG005|Overall Study|Withdrawal by Subject|5
2061287|NCT00558896|3635673|FG006|Overall Study|Withdrawal by Subject|5
2061288|NCT00558896|3635667|FG000|Overall Study|Alternative Treatment|2
2061289|NCT00558896|3635668|FG001|Overall Study|Alternative Treatment|2
2061290|NCT00558896|3635669|FG002|Overall Study|Alternative Treatment|0
2061291|NCT00558896|3635670|FG003|Overall Study|Alternative Treatment|2
2061292|NCT00558896|3635671|FG004|Overall Study|Alternative Treatment|6
2061293|NCT00558896|3635672|FG005|Overall Study|Alternative Treatment|7
2061294|NCT00558896|3635673|FG006|Overall Study|Alternative Treatment|1
2061295|NCT00558896|3635667|FG000|Overall Study|Physician discretion|3
2209912|NCT01646320|3849321|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
2209913|NCT01646320|3849320|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4
2209914|NCT01646320|3849321|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2
2209915|NCT01646320|3849320|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
2209916|NCT01646320|3849321|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
2061296|NCT00558896|3635668|FG001|Overall Study|Physician discretion|2
2061297|NCT00558896|3635669|FG002|Overall Study|Physician discretion|1
2061298|NCT00558896|3635670|FG003|Overall Study|Physician discretion|2
2061299|NCT00558896|3635671|FG004|Overall Study|Physician discretion|1
2061300|NCT00558896|3635672|FG005|Overall Study|Physician discretion|3
2061301|NCT00558896|3635673|FG006|Overall Study|Physician discretion|3
2061302|NCT00558896|3635667|FG000|Overall Study|Continues on treatment|10
2061303|NCT00558896|3635668|FG001|Overall Study|Continues on treatment|1
2061304|NCT00558896|3635669|FG002|Overall Study|Continues on treatment|0
2061305|NCT00558896|3635670|FG003|Overall Study|Continues on treatment|1
2061306|NCT00558896|3635671|FG004|Overall Study|Continues on treatment|9
2061307|NCT00558896|3635672|FG005|Overall Study|Continues on treatment|25
2061308|NCT00558896|3635673|FG006|Overall Study|Continues on treatment|6
2061309|NCT00559104|3635695|FG000|Overall Study|Lack of Efficacy|9
2061310|NCT00559104|3635696|FG001|Overall Study|Lack of Efficacy|0
2061311|NCT00559273|3635704|FG000|Correction Period (20 Weeks)|Death|3
2061312|NCT00559273|3635705|FG001|Correction Period (20 Weeks)|Death|4
2061313|NCT00559273|3635704|FG000|Correction Period (20 Weeks)|Adverse Event|2
2061314|NCT00559273|3635705|FG001|Correction Period (20 Weeks)|Adverse Event|1
2061315|NCT00559273|3635704|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2
2061316|NCT00559273|3635705|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6
2061317|NCT00559273|3635704|FG000|Correction Period (20 Weeks)|Participant treated by another center|0
2061318|NCT00559273|3635705|FG001|Correction Period (20 Weeks)|Participant treated by another center|1
2061319|NCT00559273|3635704|FG000|Correction Period (20 Weeks)|Did not received study treatment|2
2061320|NCT00559273|3635705|FG001|Correction Period (20 Weeks)|Did not received study treatment|0
2061321|NCT00559273|3635704|FG000|Evaluation Period (8 Weeks)|Death|1
2061322|NCT00559273|3635705|FG001|Evaluation Period (8 Weeks)|Death|3
2061323|NCT00559273|3635704|FG000|Evaluation Period (8 Weeks)|Adverse Event|0
2061324|NCT00559273|3635705|FG001|Evaluation Period (8 Weeks)|Adverse Event|1
2061325|NCT00559273|3635704|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
2061326|NCT00559273|3635705|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
2061327|NCT00559273|3635704|FG000|Evaluation Period (8 Weeks)|Physician Decision|0
2061328|NCT00559273|3635705|FG001|Evaluation Period (8 Weeks)|Physician Decision|1
2061329|NCT00559364|3635713|FG000|Overall Study|Inclusion/exclusion criteria failure|1
2061330|NCT00559364|3635714|FG001|Overall Study|Inclusion/exclusion criteria failure|0
2061331|NCT00559377|3635720|FG000|Overall Study|Withdrawal by Subject|9
2061332|NCT00559507|3635736|FG000|Overall Study|Not treated, patient ineligible|3
2061333|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Adverse Event|17
2061334|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Adverse Event|25
2061335|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11
2061336|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5
2061337|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0
2061338|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6
2061339|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
2061340|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
2061341|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Death|1
2061342|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Death|1
2061343|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
2061344|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
2061345|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6
2061346|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1
2061347|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3
2061348|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0
2061349|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Missed Doses|0
2061350|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Missed Doses|1
2061351|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0
2061352|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1
2061353|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
2061354|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
2061355|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Early Discontinuation|0
2061356|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Early Discontinuation|1
2061357|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1
2061358|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0
2061359|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
2061360|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
2061361|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Investigator Decision|0
2061362|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Investigator Decision|1
2061363|NCT00559585|3635742|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1
2061364|NCT00559585|3635743|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0
2061365|NCT00559585|3635742|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
2061366|NCT00559585|3635743|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
2061367|NCT00559585|3635742|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100
2061368|NCT00559585|3635743|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0
2061369|NCT00559585|3635742|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
2061370|NCT00559585|3635743|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
2061371|NCT00559585|3635742|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16
2061372|NCT00559585|3635743|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0
2061373|NCT00559585|3635742|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
2061374|NCT00559585|3635743|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
2061375|NCT00559585|3635742|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
2061376|NCT00559585|3635743|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
2061377|NCT00559585|3635742|FG000|Open Label LT Period Main + Sub-Study|Death|20
2061378|NCT00559585|3635743|FG001|Open Label LT Period Main + Sub-Study|Death|0
2061379|NCT00559585|3635742|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1
2061380|NCT00559585|3635743|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0
2061381|NCT00559585|3635742|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
2061382|NCT00559585|3635743|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
2061383|NCT00559585|3635742|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
2061384|NCT00559585|3635743|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
2061385|NCT00559585|3635742|FG000|Open Label LT Period Main + Sub-Study|non-specified|71
2061386|NCT00559585|3635743|FG001|Open Label LT Period Main + Sub-Study|non-specified|0
2061387|NCT00559585|3635742|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1
2061388|NCT00559585|3635743|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0
2061389|NCT00559637|3635760|FG000|Overall Study|Adverse Event|22
2061390|NCT00559637|3635760|FG000|Overall Study|Withdrawal by Subject|4
2061391|NCT00559637|3635760|FG000|Overall Study|Protocol Violation|6
2061392|NCT00559637|3635760|FG000|Overall Study|Withdrawal criteria fulfilled|4
2061393|NCT00559637|3635760|FG000|Overall Study|Failure to return|6
2061394|NCT00559637|3635760|FG000|Overall Study|Insufficient response|3
2061395|NCT00559637|3635760|FG000|Overall Study|Started requiring dialysis after month 7|2
2061396|NCT00559637|3635760|FG000|Overall Study|Suspected lung cancer|1
2061397|NCT00559637|3635760|FG000|Overall Study|Participation in another study|1
2061398|NCT00559637|3635760|FG000|Overall Study|Delayed administration of C.E.R.A|1
2061399|NCT00559637|3635760|FG000|Overall Study|Change of center|1
2061400|NCT00559637|3635760|FG000|Overall Study|Change of home|1
2061401|NCT00559637|3635760|FG000|Overall Study|Inclusion or exclusion criteria violated|2
2061402|NCT00559754|3635764|FG000|Overall Study|Disease progression|1
2061403|NCT00559754|3635764|FG000|Overall Study|Adverse Event|5
2061404|NCT00559754|3635764|FG000|Overall Study|Protocol Violation|1
2061405|NCT00559754|3635764|FG000|Overall Study|Investigator criteria|2
2061406|NCT00559754|3635764|FG000|Overall Study|Withdrawal by Subject|2
2061407|NCT00559845|3635768|FG000|Overall Study|Withdrew Consent|1
2061408|NCT00559845|3635768|FG000|Overall Study|Disease Progression|1
2061409|NCT00559845|3635768|FG000|Overall Study|Adverse Event|3
2061410|NCT00559845|3635768|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
2061411|NCT00559845|3635768|FG000|Overall Study|Premature Surgery-Investigator Decision|1
2061412|NCT00559949|3635776|FG000|Overall Study|Progressive Disease during cycle 1|1
2061413|NCT00559949|3635776|FG000|Overall Study|Adverse Event|1
2061414|NCT00559949|3635776|FG000|Overall Study|Withdrawal by Subject|4
2061415|NCT00559949|3635776|FG000|Overall Study|No disease evaluation per protocol|1
2061416|NCT00559962|3635788|FG000|Overall Study|Adverse Event|1
2061417|NCT00559962|3635789|FG001|Overall Study|Adverse Event|7
2061418|NCT00559962|3635790|FG002|Overall Study|Adverse Event|8
2061419|NCT00559962|3635791|FG003|Overall Study|Adverse Event|5
2061420|NCT00559962|3635792|FG004|Overall Study|Adverse Event|11
2061421|NCT00559962|3635793|FG005|Overall Study|Adverse Event|4
2061422|NCT00559962|3635794|FG006|Overall Study|Adverse Event|4
2061423|NCT00559962|3635795|FG007|Overall Study|Adverse Event|2
2061424|NCT00559962|3635788|FG000|Overall Study|Lost to Follow-up|0
2061425|NCT00559962|3635789|FG001|Overall Study|Lost to Follow-up|1
2061426|NCT00559962|3635790|FG002|Overall Study|Lost to Follow-up|0
2061427|NCT00559962|3635791|FG003|Overall Study|Lost to Follow-up|0
2061428|NCT00559962|3635792|FG004|Overall Study|Lost to Follow-up|0
2061429|NCT00559962|3635793|FG005|Overall Study|Lost to Follow-up|0
2061430|NCT00559962|3635794|FG006|Overall Study|Lost to Follow-up|0
2061431|NCT00559962|3635795|FG007|Overall Study|Lost to Follow-up|0
2061432|NCT00559962|3635788|FG000|Overall Study|Withdrawal by Subject|1
2061433|NCT00559962|3635789|FG001|Overall Study|Withdrawal by Subject|1
2061434|NCT00559962|3635790|FG002|Overall Study|Withdrawal by Subject|2
2061435|NCT00559962|3635791|FG003|Overall Study|Withdrawal by Subject|0
2061436|NCT00559962|3635792|FG004|Overall Study|Withdrawal by Subject|3
2061437|NCT00559962|3635793|FG005|Overall Study|Withdrawal by Subject|1
2061438|NCT00559962|3635794|FG006|Overall Study|Withdrawal by Subject|0
2061439|NCT00559962|3635795|FG007|Overall Study|Withdrawal by Subject|2
2061440|NCT00559962|3635788|FG000|Overall Study|Inclusion/exclusion criteria not met|0
2061441|NCT00559962|3635789|FG001|Overall Study|Inclusion/exclusion criteria not met|0
2061442|NCT00559962|3635790|FG002|Overall Study|Inclusion/exclusion criteria not met|0
2209917|NCT01646320|3849320|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
2209918|NCT01646320|3849321|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
2209919|NCT01646385|3849333|FG000|Overall Study|Death|202
2209920|NCT01646385|3849334|FG001|Overall Study|Death|222
2209921|NCT01646385|3849333|FG000|Overall Study|Switched to alternate biologic|636
2209922|NCT01646385|3849334|FG001|Overall Study|Switched to alternate biologic|649
2209923|NCT01646398|3849342|FG000|Overall Study|Withdrawal by Subject|1
2209924|NCT01646398|3849343|FG001|Overall Study|Withdrawal by Subject|0
2209925|NCT01646645|3849349|FG000|Overall Study|No Treated|1
2061443|NCT00559962|3635791|FG003|Overall Study|Inclusion/exclusion criteria not met|0
2061444|NCT00559962|3635792|FG004|Overall Study|Inclusion/exclusion criteria not met|0
2061445|NCT00559962|3635793|FG005|Overall Study|Inclusion/exclusion criteria not met|0
2061446|NCT00559962|3635794|FG006|Overall Study|Inclusion/exclusion criteria not met|1
2061447|NCT00559962|3635795|FG007|Overall Study|Inclusion/exclusion criteria not met|0
2061448|NCT00559988|3635816|FG000|Overall Study|Death|147
2061449|NCT00559988|3635817|FG001|Overall Study|Death|140
2061450|NCT00559988|3635816|FG000|Overall Study|Withdrawal by Subject|152
2061451|NCT00559988|3635817|FG001|Overall Study|Withdrawal by Subject|139
2061452|NCT00559988|3635816|FG000|Overall Study|Lost to Follow-up|42
2061453|NCT00559988|3635817|FG001|Overall Study|Lost to Follow-up|56
2061454|NCT00559988|3635816|FG000|Overall Study|ICD device explanted|10
2061455|NCT00559988|3635817|FG001|Overall Study|ICD device explanted|17
2061456|NCT00560066|3635825|FG000|Overall Study|Death|2
2061457|NCT00560066|3635826|FG001|Overall Study|Death|1
2061458|NCT00560066|3635825|FG000|Overall Study|Withdrawal by Subject|0
2061459|NCT00560066|3635826|FG001|Overall Study|Withdrawal by Subject|3
2209926|NCT01646645|3849349|FG000|Overall Study|Inevaluable Donor|29
2061460|NCT00560066|3635825|FG000|Overall Study|Lost to Follow-up|4
2061461|NCT00560066|3635826|FG001|Overall Study|Lost to Follow-up|10
2061462|NCT00560066|3635825|FG000|Overall Study|Protocol Violation|0
2061463|NCT00560066|3635826|FG001|Overall Study|Protocol Violation|1
2061464|NCT00560066|3635825|FG000|Overall Study|Administrative reason|0
2061465|NCT00560066|3635826|FG001|Overall Study|Administrative reason|5
2061466|NCT00560066|3635825|FG000|Overall Study|Missing primary reason|0
2061467|NCT00560066|3635826|FG001|Overall Study|Missing primary reason|2
2061468|NCT00560105|3635839|FG000|Overall Study|musculoskeletal chest discomfort with us|1
2108193|NCT00878722|3702054|FG005|Overall Study|Death|1
2061469|NCT00560105|3635840|FG001|Overall Study|musculoskeletal chest discomfort with us|2
2061470|NCT00560235|3635849|FG000|Phase 1|Discontinued|8
2061471|NCT00560235|3635850|FG001|Phase 1|Discontinued|0
2061472|NCT00560235|3635851|FG002|Phase 1|Discontinued|0
2061473|NCT00560235|3635849|FG000|Phase 1B|Discontinued|0
2061474|NCT00560235|3635850|FG001|Phase 1B|Discontinued|19
2061475|NCT00560235|3635851|FG002|Phase 1B|Discontinued|0
2061476|NCT00560235|3635849|FG000|Phase 2|Discontinued|0
2061477|NCT00560235|3635850|FG001|Phase 2|Discontinued|0
2061478|NCT00560235|3635851|FG002|Phase 2|Discontinued|96
2061479|NCT00560235|3635849|FG000|Phase 2|Ongoing at Date of Cut-Off|0
2061480|NCT00560235|3635850|FG001|Phase 2|Ongoing at Date of Cut-Off|0
2061481|NCT00560235|3635851|FG002|Phase 2|Ongoing at Date of Cut-Off|1
2061482|NCT00560313|3635869|FG000|Overall Study|Adverse Events or Death|2
2061483|NCT00560313|3635869|FG000|Overall Study|Withdrawal by Subject|2
2061484|NCT00560313|3635869|FG000|Overall Study|Lost to Follow-up|1
2061485|NCT00560313|3635869|FG000|Overall Study|Protocol Violation|1
2061486|NCT00560352|3635891|FG000|Overall Study|Adverse event unrelated to study drug|2
2061487|NCT00560352|3635892|FG001|Overall Study|Adverse event unrelated to study drug|1
2061488|NCT00560352|3635893|FG002|Overall Study|Adverse event unrelated to study drug|1
2061489|NCT00560352|3635891|FG000|Overall Study|Study drug toxicity|3
2061490|NCT00560352|3635892|FG001|Overall Study|Study drug toxicity|0
2061491|NCT00560352|3635893|FG002|Overall Study|Study drug toxicity|1
2061492|NCT00560352|3635891|FG000|Overall Study|Disease progression|0
2061493|NCT00560352|3635892|FG001|Overall Study|Disease progression|1
2061494|NCT00560352|3635893|FG002|Overall Study|Disease progression|1
2061495|NCT00560352|3635891|FG000|Overall Study|Withdrawal by Subject|1
2061496|NCT00560352|3635892|FG001|Overall Study|Withdrawal by Subject|1
2061497|NCT00560352|3635893|FG002|Overall Study|Withdrawal by Subject|1
2061498|NCT00560352|3635891|FG000|Overall Study|Maximum clinical benefit|1
2061499|NCT00560352|3635892|FG001|Overall Study|Maximum clinical benefit|0
2061500|NCT00560352|3635893|FG002|Overall Study|Maximum clinical benefit|0
2061501|NCT00560391|3635910|FG000|Overall Study|Still on treatment|0
2061502|NCT00560391|3635911|FG001|Overall Study|Still on treatment|0
2061503|NCT00560391|3635912|FG002|Overall Study|Still on treatment|0
2061504|NCT00560391|3635913|FG003|Overall Study|Still on treatment|1
2061505|NCT00560391|3635914|FG004|Overall Study|Still on treatment|2
2061506|NCT00560404|3635929|FG000|Overall Study|Adverse Event|2
2061507|NCT00560404|3635930|FG001|Overall Study|Adverse Event|3
2061508|NCT00560404|3635929|FG000|Overall Study|Death|3
2061509|NCT00560404|3635930|FG001|Overall Study|Death|3
2061510|NCT00560404|3635929|FG000|Overall Study|Protocol Violation|12
2061511|NCT00560404|3635930|FG001|Overall Study|Protocol Violation|7
2061512|NCT00560404|3635929|FG000|Overall Study|Administrative Reasons|1
2061513|NCT00560404|3635930|FG001|Overall Study|Administrative Reasons|1
2061514|NCT00560404|3635929|FG000|Overall Study|Withdrew Consent|4
2061515|NCT00560404|3635930|FG001|Overall Study|Withdrew Consent|0
2061516|NCT00560404|3635929|FG000|Overall Study|Failure to return|1
2061517|NCT00560404|3635930|FG001|Overall Study|Failure to return|2
2061518|NCT00560404|3635929|FG000|Overall Study|Other withdrawal reason|13
2061519|NCT00560404|3635930|FG001|Overall Study|Other withdrawal reason|5
2061520|NCT00560417|3635938|FG000|Overall Study|Adverse Event|3
2061521|NCT00560417|3635939|FG001|Overall Study|Adverse Event|2
2061522|NCT00560417|3635938|FG000|Overall Study|Entry Criteria Not Met|1
2061523|NCT00560417|3635939|FG001|Overall Study|Entry Criteria Not Met|0
2061524|NCT00560417|3635938|FG000|Overall Study|Lost to Follow-up|0
2061525|NCT00560417|3635939|FG001|Overall Study|Lost to Follow-up|1
2061526|NCT00560417|3635938|FG000|Overall Study|Physician Decision|2
2061527|NCT00560417|3635939|FG001|Overall Study|Physician Decision|6
2061528|NCT00560417|3635938|FG000|Overall Study|Protocol Violation|6
2061529|NCT00560417|3635939|FG001|Overall Study|Protocol Violation|5
2061530|NCT00560417|3635938|FG000|Overall Study|Sponsor Decision|2
2061531|NCT00560417|3635939|FG001|Overall Study|Sponsor Decision|0
2061532|NCT00560417|3635938|FG000|Overall Study|Withdrawal by Subject|3
2061533|NCT00560417|3635939|FG001|Overall Study|Withdrawal by Subject|3
2061534|NCT00560508|3635947|FG000|12 Week Double-blind Period|Adverse Event|3
2061535|NCT00560508|3635948|FG001|12 Week Double-blind Period|Adverse Event|2
2061536|NCT00560508|3635947|FG000|12 Week Double-blind Period|Protocol Violation|1
2061537|NCT00560508|3635948|FG001|12 Week Double-blind Period|Protocol Violation|0
2061538|NCT00560508|3635947|FG000|12 Week Double-blind Period|Withdrawal by Subject|1
2061539|NCT00560508|3635948|FG001|12 Week Double-blind Period|Withdrawal by Subject|1
2061540|NCT00560508|3635947|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6
2061541|NCT00560508|3635948|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6
2061542|NCT00560508|3635947|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
2061543|NCT00560508|3635948|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
2061544|NCT00560508|3635947|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
2061545|NCT00560508|3635948|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
2061546|NCT00560508|3635947|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
2061547|NCT00560508|3635948|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
2061548|NCT00560573|3635968|FG000|Overall Study|Death|4
2209927|NCT01646827|3849383|FG000|Overall Study|Lost to Follow-up|0
2061549|NCT00560573|3635969|FG001|Overall Study|Death|1
2061550|NCT00560573|3635970|FG002|Overall Study|Death|4
2209928|NCT01646827|3849384|FG001|Overall Study|Lost to Follow-up|3
2209929|NCT01646827|3849383|FG000|Overall Study|Physician Decision|1
2209930|NCT01646827|3849384|FG001|Overall Study|Physician Decision|2
2209931|NCT01646827|3849383|FG000|Overall Study|Withdrawal by Subject|1
2061551|NCT00560573|3635971|FG003|Overall Study|Death|5
2061552|NCT00560573|3635972|FG004|Overall Study|Death|1
2061553|NCT00560573|3635973|FG005|Overall Study|Death|10
2061554|NCT00560573|3635968|FG000|Overall Study|Lost to Follow-up|0
2061555|NCT00560573|3635969|FG001|Overall Study|Lost to Follow-up|0
2061556|NCT00560573|3635970|FG002|Overall Study|Lost to Follow-up|0
2061557|NCT00560573|3635971|FG003|Overall Study|Lost to Follow-up|1
2061558|NCT00560573|3635972|FG004|Overall Study|Lost to Follow-up|1
2061559|NCT00560573|3635973|FG005|Overall Study|Lost to Follow-up|0
2061560|NCT00560573|3635968|FG000|Overall Study|Withdrawal by Subject|0
2061561|NCT00560573|3635969|FG001|Overall Study|Withdrawal by Subject|0
2061562|NCT00560573|3635970|FG002|Overall Study|Withdrawal by Subject|0
2061563|NCT00560573|3635971|FG003|Overall Study|Withdrawal by Subject|1
2061564|NCT00560573|3635972|FG004|Overall Study|Withdrawal by Subject|1
2061565|NCT00560573|3635973|FG005|Overall Study|Withdrawal by Subject|0
2061566|NCT00560573|3635968|FG000|Overall Study|Other|2
2061567|NCT00560573|3635969|FG001|Overall Study|Other|2
2061568|NCT00560573|3635970|FG002|Overall Study|Other|2
2061569|NCT00560573|3635971|FG003|Overall Study|Other|3
2061570|NCT00560573|3635972|FG004|Overall Study|Other|3
2061571|NCT00560573|3635973|FG005|Overall Study|Other|3
2061572|NCT00560573|3635968|FG000|Overall Study|Enrolled, not treated|0
2061573|NCT00560573|3635969|FG001|Overall Study|Enrolled, not treated|0
2061574|NCT00560573|3635970|FG002|Overall Study|Enrolled, not treated|0
2061575|NCT00560573|3635971|FG003|Overall Study|Enrolled, not treated|0
2061576|NCT00560573|3635972|FG004|Overall Study|Enrolled, not treated|1
2061577|NCT00560573|3635973|FG005|Overall Study|Enrolled, not treated|0
2061578|NCT00560703|3636014|FG000|Overall Study|Adverse Event|0
2061579|NCT00560703|3636015|FG001|Overall Study|Adverse Event|2
2061580|NCT00560703|3636014|FG000|Overall Study|Protocol Violation|0
2061581|NCT00560703|3636015|FG001|Overall Study|Protocol Violation|2
2061582|NCT00560703|3636014|FG000|Overall Study|Withdrawal by Subject|0
2061583|NCT00560703|3636015|FG001|Overall Study|Withdrawal by Subject|1
2061584|NCT00560703|3636014|FG000|Overall Study|non-compliance|0
2061585|NCT00560703|3636015|FG001|Overall Study|non-compliance|1
2061586|NCT00560755|3636021|FG000|Overall Study|Protocol Violation|15
2061587|NCT00560755|3636021|FG000|Overall Study|Withdrawal by Subject|26
2061588|NCT00560755|3636021|FG000|Overall Study|Lost to Follow-up|9
2061589|NCT00560755|3636021|FG000|Overall Study|Adverse Event|8
2061590|NCT00560755|3636021|FG000|Overall Study|Physician Decision|2
2061591|NCT00560794|3636026|FG000|Overall Study|Adverse Event|2
2061592|NCT00560794|3636026|FG000|Overall Study|Patient was not Compliant|1
2061593|NCT00560794|3636026|FG000|Overall Study|Minimal Residual Disease Relapse|1
2061594|NCT00560794|3636026|FG000|Overall Study|Hematological Relapse|1
2061595|NCT00560794|3636026|FG000|Overall Study|Received Bone Marrow Transplant|6
2061596|NCT00560833|3636037|FG000|Overall Study|Adverse Event|16
2061597|NCT00560833|3636038|FG001|Overall Study|Adverse Event|10
2061598|NCT00560833|3636039|FG002|Overall Study|Adverse Event|25
2061599|NCT00560833|3636040|FG003|Overall Study|Adverse Event|23
2061600|NCT00560833|3636041|FG004|Overall Study|Adverse Event|35
2061601|NCT00560833|3636037|FG000|Overall Study|Lost to Follow-up|0
2061602|NCT00560833|3636038|FG001|Overall Study|Lost to Follow-up|0
2061603|NCT00560833|3636039|FG002|Overall Study|Lost to Follow-up|1
2061604|NCT00560833|3636040|FG003|Overall Study|Lost to Follow-up|0
2061605|NCT00560833|3636041|FG004|Overall Study|Lost to Follow-up|0
2061606|NCT00560833|3636037|FG000|Overall Study|Lack of Efficacy|22
2061607|NCT00560833|3636038|FG001|Overall Study|Lack of Efficacy|9
2061608|NCT00560833|3636039|FG002|Overall Study|Lack of Efficacy|6
2061609|NCT00560833|3636040|FG003|Overall Study|Lack of Efficacy|4
2061610|NCT00560833|3636041|FG004|Overall Study|Lack of Efficacy|4
2061611|NCT00560833|3636037|FG000|Overall Study|Participant uncooperative|5
2061612|NCT00560833|3636038|FG001|Overall Study|Participant uncooperative|5
2061613|NCT00560833|3636039|FG002|Overall Study|Participant uncooperative|4
2061614|NCT00560833|3636040|FG003|Overall Study|Participant uncooperative|4
2061615|NCT00560833|3636041|FG004|Overall Study|Participant uncooperative|2
2061616|NCT00560833|3636037|FG000|Overall Study|Other|1
2061617|NCT00560833|3636038|FG001|Overall Study|Other|1
2061618|NCT00560833|3636039|FG002|Overall Study|Other|3
2061619|NCT00560833|3636040|FG003|Overall Study|Other|0
2061620|NCT00560833|3636041|FG004|Overall Study|Other|0
2061621|NCT00560833|3636037|FG000|Overall Study|Never received drug|0
2061622|NCT00560833|3636038|FG001|Overall Study|Never received drug|1
2061623|NCT00560833|3636039|FG002|Overall Study|Never received drug|0
2061624|NCT00560833|3636040|FG003|Overall Study|Never received drug|0
2061625|NCT00560833|3636041|FG004|Overall Study|Never received drug|1
2061626|NCT00560885|3636063|FG000|Overall Study|Death|7
2061627|NCT00560885|3636063|FG000|Overall Study|Withdrawal by Subject|1
2061628|NCT00560937|3636069|FG000|Overall Study|Withdrawal by Subject|0
2061629|NCT00560937|3636070|FG001|Overall Study|Withdrawal by Subject|1
2061630|NCT00560937|3636069|FG000|Overall Study|Physician Decision|1
2061631|NCT00560937|3636070|FG001|Overall Study|Physician Decision|1
2061632|NCT00560950|3636078|FG000|Overall Study|Lost to Follow-up|1
2061633|NCT00560950|3636079|FG001|Overall Study|Lost to Follow-up|0
2061634|NCT00561015|3636102|FG000|Overall Study|Adverse Event|0
2061635|NCT00561015|3636103|FG001|Overall Study|Adverse Event|0
2061636|NCT00561015|3636104|FG002|Overall Study|Adverse Event|0
2061637|NCT00561015|3636105|FG003|Overall Study|Adverse Event|0
2061638|NCT00561015|3636106|FG004|Overall Study|Adverse Event|1
2061639|NCT00561015|3636107|FG005|Overall Study|Adverse Event|0
2061640|NCT00561015|3636102|FG000|Overall Study|Lost to Follow-up|2
2061641|NCT00561015|3636103|FG001|Overall Study|Lost to Follow-up|0
2061642|NCT00561015|3636104|FG002|Overall Study|Lost to Follow-up|0
2061643|NCT00561015|3636105|FG003|Overall Study|Lost to Follow-up|1
2061644|NCT00561015|3636106|FG004|Overall Study|Lost to Follow-up|0
2061645|NCT00561015|3636107|FG005|Overall Study|Lost to Follow-up|3
2061646|NCT00561015|3636102|FG000|Overall Study|Participant non-compliance|2
2061647|NCT00561015|3636103|FG001|Overall Study|Participant non-compliance|0
2061648|NCT00561015|3636104|FG002|Overall Study|Participant non-compliance|0
2061649|NCT00561015|3636105|FG003|Overall Study|Participant non-compliance|0
2061650|NCT00561015|3636106|FG004|Overall Study|Participant non-compliance|0
2061651|NCT00561015|3636107|FG005|Overall Study|Participant non-compliance|0
2061652|NCT00561080|3636128|FG000|Vaccination Period (up to Month 4)|Adverse Event|0
2061653|NCT00561080|3636129|FG001|Vaccination Period (up to Month 4)|Adverse Event|4
2061654|NCT00561080|3636130|FG002|Vaccination Period (up to Month 4)|Adverse Event|6
2061655|NCT00561080|3636128|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
2061656|NCT00561080|3636129|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
2061657|NCT00561080|3636130|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
2061658|NCT00561080|3636128|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0
2061659|NCT00561080|3636129|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1
2061660|NCT00561080|3636130|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3
2061661|NCT00561080|3636128|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
2061662|NCT00561080|3636129|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
2061663|NCT00561080|3636130|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
2061664|NCT00561080|3636128|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0
2061665|NCT00561080|3636129|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1
2061666|NCT00561080|3636130|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0
2061667|NCT00561080|3636128|FG000|Vaccination Period (up to Month 4)|Other|0
2061668|NCT00561080|3636129|FG001|Vaccination Period (up to Month 4)|Other|2
2061669|NCT00561080|3636130|FG002|Vaccination Period (up to Month 4)|Other|1
2061670|NCT00561080|3636128|FG000|12-month Post Last Dose Follow-up|Adverse Event|3
2061671|NCT00561080|3636129|FG001|12-month Post Last Dose Follow-up|Adverse Event|3
2061672|NCT00561080|3636130|FG002|12-month Post Last Dose Follow-up|Adverse Event|1
2061673|NCT00561080|3636128|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0
2061674|NCT00561080|3636129|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0
2061675|NCT00561080|3636130|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4
2061676|NCT00561080|3636128|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
2061677|NCT00561080|3636129|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
2061678|NCT00561080|3636130|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
2061679|NCT00561080|3636128|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2
2061680|NCT00561080|3636129|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0
2061681|NCT00561080|3636130|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0
2061682|NCT00561340|3636151|FG000|Overall Study|refused to drink pediasure|6
2061683|NCT00561340|3636152|FG001|Overall Study|refused to drink pediasure|0
2061684|NCT00561353|3636168|FG000|Overall Study|Subject reached a virologic endpoint|2
2061685|NCT00561353|3636169|FG001|Overall Study|Subject reached a virologic endpoint|1
2061686|NCT00561353|3636170|FG002|Overall Study|Subject reached a virologic endpoint|1
2061687|NCT00561353|3636171|FG003|Overall Study|Subject reached a virologic endpoint|4
2061688|NCT00561353|3636172|FG004|Overall Study|Subject reached a virologic endpoint|1
2061689|NCT00561353|3636173|FG005|Overall Study|Subject reached a virologic endpoint|3
2061690|NCT00561353|3636174|FG006|Overall Study|Subject reached a virologic endpoint|4
2061691|NCT00561353|3636175|FG007|Overall Study|Subject reached a virologic endpoint|4
2061692|NCT00561353|3636176|FG008|Overall Study|Subject reached a virologic endpoint|5
2061693|NCT00561353|3636177|FG009|Overall Study|Subject reached a virologic endpoint|0
2061694|NCT00561353|3636168|FG000|Overall Study|Subject ineligible to continue the trial|0
2061695|NCT00561353|3636169|FG001|Overall Study|Subject ineligible to continue the trial|0
2061696|NCT00561353|3636170|FG002|Overall Study|Subject ineligible to continue the trial|0
2061697|NCT00561353|3636171|FG003|Overall Study|Subject ineligible to continue the trial|0
2061698|NCT00561353|3636172|FG004|Overall Study|Subject ineligible to continue the trial|0
2061699|NCT00561353|3636173|FG005|Overall Study|Subject ineligible to continue the trial|1
2061700|NCT00561353|3636174|FG006|Overall Study|Subject ineligible to continue the trial|1
2061701|NCT00561353|3636175|FG007|Overall Study|Subject ineligible to continue the trial|0
2061702|NCT00561353|3636176|FG008|Overall Study|Subject ineligible to continue the trial|2
2061703|NCT00561353|3636177|FG009|Overall Study|Subject ineligible to continue the trial|1
2061704|NCT00561353|3636168|FG000|Overall Study|Other|1
2061705|NCT00561353|3636169|FG001|Overall Study|Other|0
2061706|NCT00561353|3636170|FG002|Overall Study|Other|1
2061707|NCT00561353|3636171|FG003|Overall Study|Other|0
2061708|NCT00561353|3636172|FG004|Overall Study|Other|0
2061709|NCT00561353|3636173|FG005|Overall Study|Other|2
2061710|NCT00561353|3636174|FG006|Overall Study|Other|0
2061711|NCT00561353|3636175|FG007|Overall Study|Other|0
2061712|NCT00561353|3636176|FG008|Overall Study|Other|0
2061713|NCT00561353|3636177|FG009|Overall Study|Other|0
2061714|NCT00561353|3636168|FG000|Overall Study|Adverse Event|0
2061715|NCT00561353|3636169|FG001|Overall Study|Adverse Event|0
2061716|NCT00561353|3636170|FG002|Overall Study|Adverse Event|0
2061717|NCT00561353|3636171|FG003|Overall Study|Adverse Event|2
2061718|NCT00561353|3636172|FG004|Overall Study|Adverse Event|0
2061719|NCT00561353|3636173|FG005|Overall Study|Adverse Event|0
2061720|NCT00561353|3636174|FG006|Overall Study|Adverse Event|1
2061721|NCT00561353|3636175|FG007|Overall Study|Adverse Event|0
2061722|NCT00561353|3636176|FG008|Overall Study|Adverse Event|0
2061723|NCT00561353|3636177|FG009|Overall Study|Adverse Event|1
2061724|NCT00561353|3636168|FG000|Overall Study|Lost to Follow-up|2
2061725|NCT00561353|3636169|FG001|Overall Study|Lost to Follow-up|0
2061726|NCT00561353|3636170|FG002|Overall Study|Lost to Follow-up|1
2061727|NCT00561353|3636171|FG003|Overall Study|Lost to Follow-up|0
2061728|NCT00561353|3636172|FG004|Overall Study|Lost to Follow-up|0
2061729|NCT00561353|3636173|FG005|Overall Study|Lost to Follow-up|0
2061730|NCT00561353|3636174|FG006|Overall Study|Lost to Follow-up|0
2061731|NCT00561353|3636175|FG007|Overall Study|Lost to Follow-up|0
2061732|NCT00561353|3636176|FG008|Overall Study|Lost to Follow-up|0
2061733|NCT00561353|3636177|FG009|Overall Study|Lost to Follow-up|0
2061734|NCT00561353|3636168|FG000|Overall Study|Withdrawal by Subject|0
2061735|NCT00561353|3636169|FG001|Overall Study|Withdrawal by Subject|2
2061736|NCT00561353|3636170|FG002|Overall Study|Withdrawal by Subject|0
2061737|NCT00561353|3636171|FG003|Overall Study|Withdrawal by Subject|0
2061738|NCT00561353|3636172|FG004|Overall Study|Withdrawal by Subject|0
2061739|NCT00561353|3636173|FG005|Overall Study|Withdrawal by Subject|0
2061740|NCT00561353|3636174|FG006|Overall Study|Withdrawal by Subject|0
2061741|NCT00561353|3636175|FG007|Overall Study|Withdrawal by Subject|0
2061742|NCT00561353|3636176|FG008|Overall Study|Withdrawal by Subject|0
2061743|NCT00561353|3636177|FG009|Overall Study|Withdrawal by Subject|0
2061744|NCT00561392|3636239|FG000|Overall Study|Adverse Event|38
2061745|NCT00561392|3636239|FG000|Overall Study|Lack of Efficacy|2
2061746|NCT00561392|3636239|FG000|Overall Study|Protocol Violation|1
2061747|NCT00561392|3636239|FG000|Overall Study|Withdrawal by Subject|8
2061748|NCT00561392|3636239|FG000|Overall Study|Administrative problems|4
2061749|NCT00561470|3636262|FG000|Overall Study|Adverse Event|74
2061750|NCT00561470|3636263|FG001|Overall Study|Adverse Event|163
2061751|NCT00561470|3636262|FG000|Overall Study|Disease progression|437
2061752|NCT00561470|3636263|FG001|Overall Study|Disease progression|305
2061753|NCT00561470|3636262|FG000|Overall Study|poor compliance to protocol|4
2061754|NCT00561470|3636263|FG001|Overall Study|poor compliance to protocol|4
2061755|NCT00561470|3636262|FG000|Overall Study|Lost to Follow-up|2
2061756|NCT00561470|3636263|FG001|Overall Study|Lost to Follow-up|0
2061757|NCT00561470|3636262|FG000|Overall Study|Physician Decision|21
2061758|NCT00561470|3636263|FG001|Overall Study|Physician Decision|20
2061759|NCT00561470|3636262|FG000|Overall Study|Consent Withdrawn|2
2061760|NCT00561470|3636263|FG001|Overall Study|Consent Withdrawn|6
2061761|NCT00561470|3636262|FG000|Overall Study|Subject request|43
2061762|NCT00561470|3636263|FG001|Overall Study|Subject request|77
2061763|NCT00561470|3636262|FG000|Overall Study|Metastatic surgery|10
2061764|NCT00561470|3636263|FG001|Overall Study|Metastatic surgery|12
2061765|NCT00561470|3636262|FG000|Overall Study|Unauthorized procedure|3
2061766|NCT00561470|3636263|FG001|Overall Study|Unauthorized procedure|1
2061767|NCT00561470|3636262|FG000|Overall Study|Randomized but not treated|5
2061768|NCT00561470|3636263|FG001|Overall Study|Randomized but not treated|5
2061769|NCT00561470|3636262|FG000|Overall Study|Missed visit window|1
2061770|NCT00561470|3636263|FG001|Overall Study|Missed visit window|4
2061771|NCT00561470|3636262|FG000|Overall Study|Planning surgery|1
2061772|NCT00561470|3636263|FG001|Overall Study|Planning surgery|1
2061773|NCT00561470|3636262|FG000|Overall Study|Ongoing Treatment|11
2061774|NCT00561470|3636263|FG001|Overall Study|Ongoing Treatment|14
2061775|NCT00561574|3636273|FG000|Overall Study|Adverse Event|21
2061776|NCT00561574|3636274|FG001|Overall Study|Adverse Event|24
2061777|NCT00561574|3636273|FG000|Overall Study|Lack of Efficacy|11
2061778|NCT00561574|3636274|FG001|Overall Study|Lack of Efficacy|21
2061779|NCT00561574|3636273|FG000|Overall Study|Withdrawal by Subject|4
2061780|NCT00561574|3636274|FG001|Overall Study|Withdrawal by Subject|4
2061781|NCT00561574|3636273|FG000|Overall Study|Reason Unrelated to Trial|6
2061782|NCT00561574|3636274|FG001|Overall Study|Reason Unrelated to Trial|2
2061783|NCT00561574|3636273|FG000|Overall Study|Lost to Follow-up|1
2061784|NCT00561574|3636274|FG001|Overall Study|Lost to Follow-up|0
2061785|NCT00561574|3636273|FG000|Overall Study|Other|5
2061786|NCT00561574|3636274|FG001|Overall Study|Other|7
2061787|NCT00561652|3636293|FG000|Overall Study|Withdrawal by Subject|0
2061788|NCT00561652|3636294|FG001|Overall Study|Withdrawal by Subject|1
2061789|NCT00561678|3636302|FG000|Overall Study|Withdrawal by Subject|4
2061790|NCT00561678|3636303|FG001|Overall Study|Withdrawal by Subject|3
2061791|NCT00561678|3636302|FG000|Overall Study|surgery cancelled|1
2061792|NCT00561678|3636303|FG001|Overall Study|surgery cancelled|1
2061793|NCT00561678|3636302|FG000|Overall Study|surgery rescheduled to different site|2
2061794|NCT00561678|3636303|FG001|Overall Study|surgery rescheduled to different site|2
2061795|NCT00561678|3636302|FG000|Overall Study|anesthesia provider refusal|1
2061796|NCT00561678|3636303|FG001|Overall Study|anesthesia provider refusal|0
2061797|NCT00561730|3636309|FG000|Overall Study|Adverse Event|2
2061798|NCT00561730|3636309|FG000|Overall Study|Handling of the drug|1
2061799|NCT00561730|3636309|FG000|Overall Study|Lost to Follow-up|5
2061800|NCT00561730|3636309|FG000|Overall Study|Not specified reasons|1
2061801|NCT00561821|3636319|FG000|Overall Study|Not treated|0
2061802|NCT00561821|3636320|FG001|Overall Study|Not treated|0
2061803|NCT00561821|3636321|FG002|Overall Study|Not treated|1
2061804|NCT00561821|3636322|FG003|Overall Study|Not treated|0
2061805|NCT00561821|3636319|FG000|Overall Study|Withdrawal by Subject|0
2061806|NCT00561821|3636320|FG001|Overall Study|Withdrawal by Subject|1
2061807|NCT00561821|3636321|FG002|Overall Study|Withdrawal by Subject|0
2061808|NCT00561821|3636322|FG003|Overall Study|Withdrawal by Subject|2
2061809|NCT00561821|3636319|FG000|Overall Study|Reasons not related to trial|2
2061810|NCT00561821|3636320|FG001|Overall Study|Reasons not related to trial|1
2061811|NCT00561821|3636321|FG002|Overall Study|Reasons not related to trial|0
2061812|NCT00561821|3636322|FG003|Overall Study|Reasons not related to trial|0
2061813|NCT00561821|3636319|FG000|Overall Study|Other (reason not specified)|1
2061814|NCT00561821|3636320|FG001|Overall Study|Other (reason not specified)|1
2061815|NCT00561821|3636321|FG002|Overall Study|Other (reason not specified)|0
2061816|NCT00561821|3636322|FG003|Overall Study|Other (reason not specified)|0
2061817|NCT00561821|3636319|FG000|Overall Study|Adverse Event|2
2061818|NCT00561821|3636320|FG001|Overall Study|Adverse Event|3
2061819|NCT00561821|3636321|FG002|Overall Study|Adverse Event|1
2061820|NCT00561821|3636322|FG003|Overall Study|Adverse Event|1
2061821|NCT00561925|3636339|FG000|14 Day Lead-In Period|Adverse Event|38
2061822|NCT00561925|3636340|FG001|14 Day Lead-In Period|Adverse Event|0
2061823|NCT00561925|3636341|FG002|14 Day Lead-In Period|Adverse Event|0
2061824|NCT00561925|3636342|FG003|14 Day Lead-In Period|Adverse Event|0
2061825|NCT00561925|3636343|FG004|14 Day Lead-In Period|Adverse Event|0
2061826|NCT00561925|3636339|FG000|14 Day Lead-In Period|In/Exclusion criteria|4
2061827|NCT00561925|3636340|FG001|14 Day Lead-In Period|In/Exclusion criteria|0
2061828|NCT00561925|3636341|FG002|14 Day Lead-In Period|In/Exclusion criteria|0
2061829|NCT00561925|3636342|FG003|14 Day Lead-In Period|In/Exclusion criteria|0
2061830|NCT00561925|3636343|FG004|14 Day Lead-In Period|In/Exclusion criteria|0
2061831|NCT00561925|3636339|FG000|14 Day Lead-In Period|Lost to Follow-up|4
2061832|NCT00561925|3636340|FG001|14 Day Lead-In Period|Lost to Follow-up|0
2061833|NCT00561925|3636341|FG002|14 Day Lead-In Period|Lost to Follow-up|0
2061834|NCT00561925|3636342|FG003|14 Day Lead-In Period|Lost to Follow-up|0
2061835|NCT00561925|3636343|FG004|14 Day Lead-In Period|Lost to Follow-up|0
2061836|NCT00561925|3636339|FG000|14 Day Lead-In Period|Withdrawal by Subject|4
2061837|NCT00561925|3636340|FG001|14 Day Lead-In Period|Withdrawal by Subject|0
2061838|NCT00561925|3636341|FG002|14 Day Lead-In Period|Withdrawal by Subject|0
2061839|NCT00561925|3636342|FG003|14 Day Lead-In Period|Withdrawal by Subject|0
2061840|NCT00561925|3636343|FG004|14 Day Lead-In Period|Withdrawal by Subject|0
2061841|NCT00561925|3636339|FG000|14 Day Lead-In Period|Other|5
2061842|NCT00561925|3636340|FG001|14 Day Lead-In Period|Other|0
2061843|NCT00561925|3636341|FG002|14 Day Lead-In Period|Other|0
2061844|NCT00561925|3636342|FG003|14 Day Lead-In Period|Other|0
2061845|NCT00561925|3636343|FG004|14 Day Lead-In Period|Other|0
2061846|NCT00561925|3636339|FG000|144-week Double-blind, Double-dummy|Adverse Event|0
2061847|NCT00561925|3636340|FG001|144-week Double-blind, Double-dummy|Adverse Event|48
2061848|NCT00561925|3636341|FG002|144-week Double-blind, Double-dummy|Adverse Event|43
2061849|NCT00561925|3636342|FG003|144-week Double-blind, Double-dummy|Adverse Event|0
2061850|NCT00561925|3636343|FG004|144-week Double-blind, Double-dummy|Adverse Event|0
2061851|NCT00561925|3636339|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0
2061852|NCT00561925|3636340|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15
2061853|NCT00561925|3636341|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9
2061854|NCT00561925|3636342|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0
2061855|NCT00561925|3636343|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0
2061856|NCT00561925|3636339|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0
2061857|NCT00561925|3636340|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15
2061858|NCT00561925|3636341|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12
2061859|NCT00561925|3636342|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0
2061860|NCT00561925|3636343|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0
2061861|NCT00561925|3636339|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
2061862|NCT00561925|3636340|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
2061863|NCT00561925|3636341|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
2061864|NCT00561925|3636342|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
2061865|NCT00561925|3636343|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
2061866|NCT00561925|3636339|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0
2061867|NCT00561925|3636340|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36
2061868|NCT00561925|3636341|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33
2061869|NCT00561925|3636342|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0
2061870|NCT00561925|3636343|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0
2061871|NCT00561925|3636339|FG000|144-week Double-blind, Double-dummy|Pregnancy|0
2061872|NCT00561925|3636340|FG001|144-week Double-blind, Double-dummy|Pregnancy|1
2061873|NCT00561925|3636341|FG002|144-week Double-blind, Double-dummy|Pregnancy|9
2061874|NCT00561925|3636342|FG003|144-week Double-blind, Double-dummy|Pregnancy|0
2061875|NCT00561925|3636343|FG004|144-week Double-blind, Double-dummy|Pregnancy|0
2061876|NCT00561925|3636339|FG000|144-week Double-blind, Double-dummy|Death|0
2061877|NCT00561925|3636340|FG001|144-week Double-blind, Double-dummy|Death|6
2061878|NCT00561925|3636341|FG002|144-week Double-blind, Double-dummy|Death|3
2061879|NCT00561925|3636342|FG003|144-week Double-blind, Double-dummy|Death|0
2061880|NCT00561925|3636343|FG004|144-week Double-blind, Double-dummy|Death|0
2061881|NCT00561925|3636339|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0
2061882|NCT00561925|3636340|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2
2061883|NCT00561925|3636341|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0
2061884|NCT00561925|3636342|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0
2061885|NCT00561925|3636343|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0
2061886|NCT00561925|3636339|FG000|144-week Double-blind, Double-dummy|Other|0
2061887|NCT00561925|3636340|FG001|144-week Double-blind, Double-dummy|Other|8
2061888|NCT00561925|3636341|FG002|144-week Double-blind, Double-dummy|Other|11
2061889|NCT00561925|3636342|FG003|144-week Double-blind, Double-dummy|Other|0
2061890|NCT00561925|3636343|FG004|144-week Double-blind, Double-dummy|Other|0
2061891|NCT00561925|3636339|FG000|Open-Label Extension Period|Declined entry into extension period|0
2061892|NCT00561925|3636340|FG001|Open-Label Extension Period|Declined entry into extension period|0
2061893|NCT00561925|3636341|FG002|Open-Label Extension Period|Declined entry into extension period|0
2061894|NCT00561925|3636342|FG003|Open-Label Extension Period|Declined entry into extension period|43
2061895|NCT00561925|3636343|FG004|Open-Label Extension Period|Declined entry into extension period|50
2061896|NCT00561951|3636364|FG000|Overall Study|Adverse Event|11
2061897|NCT00561951|3636365|FG001|Overall Study|Adverse Event|14
2061898|NCT00561951|3636366|FG002|Overall Study|Adverse Event|14
2061899|NCT00561951|3636364|FG000|Overall Study|Lack of Efficacy|5
2061900|NCT00561951|3636365|FG001|Overall Study|Lack of Efficacy|3
2061901|NCT00561951|3636366|FG002|Overall Study|Lack of Efficacy|2
2061902|NCT00561951|3636364|FG000|Overall Study|Lost to Follow-up|1
2061903|NCT00561951|3636365|FG001|Overall Study|Lost to Follow-up|1
2061904|NCT00561951|3636366|FG002|Overall Study|Lost to Follow-up|0
2061905|NCT00561951|3636364|FG000|Overall Study|Withdrawal by Subject|10
2061906|NCT00561951|3636365|FG001|Overall Study|Withdrawal by Subject|9
2061907|NCT00561951|3636366|FG002|Overall Study|Withdrawal by Subject|10
2061908|NCT00561951|3636364|FG000|Overall Study|Protocol Violation|4
2061909|NCT00561951|3636365|FG001|Overall Study|Protocol Violation|3
2061910|NCT00561951|3636366|FG002|Overall Study|Protocol Violation|4
2061911|NCT00561951|3636364|FG000|Overall Study|Physician Decision|1
2061912|NCT00561951|3636365|FG001|Overall Study|Physician Decision|0
2061913|NCT00561951|3636366|FG002|Overall Study|Physician Decision|0
2061914|NCT00561951|3636364|FG000|Overall Study|Pregnancy|0
2061915|NCT00561951|3636365|FG001|Overall Study|Pregnancy|1
2061916|NCT00561951|3636366|FG002|Overall Study|Pregnancy|0
2061917|NCT00561951|3636364|FG000|Overall Study|Meet Withdrawal Criterion|0
2061918|NCT00561951|3636365|FG001|Overall Study|Meet Withdrawal Criterion|1
2061919|NCT00561951|3636366|FG002|Overall Study|Meet Withdrawal Criterion|1
2061920|NCT00561951|3636364|FG000|Overall Study|Adverse Event Occured Before Treatment|1
2061921|NCT00561951|3636365|FG001|Overall Study|Adverse Event Occured Before Treatment|2
2061922|NCT00561951|3636366|FG002|Overall Study|Adverse Event Occured Before Treatment|1
2061923|NCT00561977|3636377|FG000|Overall Study|Withdrawal by Subject|0
2061924|NCT00561977|3636378|FG001|Overall Study|Withdrawal by Subject|2
2061925|NCT00561977|3636379|FG002|Overall Study|Withdrawal by Subject|1
2061926|NCT00561977|3636377|FG000|Overall Study|Pregnancy|0
2061927|NCT00561977|3636378|FG001|Overall Study|Pregnancy|1
2061928|NCT00561977|3636379|FG002|Overall Study|Pregnancy|1
2061929|NCT00562094|3636387|FG000|Overall Study|Lost to Follow-up|62
2061930|NCT00562120|3636395|FG000|First Intervention Period|Adverse Event|1
2061931|NCT00562120|3636396|FG001|First Intervention Period|Adverse Event|0
2061932|NCT00562120|3636397|FG002|First Intervention Period|Adverse Event|0
2061933|NCT00562120|3636398|FG003|First Intervention Period|Adverse Event|0
2061934|NCT00562120|3636395|FG000|First Intervention Period|Randomized but not Treated|1
2061935|NCT00562120|3636396|FG001|First Intervention Period|Randomized but not Treated|0
2061936|NCT00562120|3636397|FG002|First Intervention Period|Randomized but not Treated|0
2061937|NCT00562120|3636398|FG003|First Intervention Period|Randomized but not Treated|0
2061938|NCT00562159|3636410|FG000|Overall Study|Adverse Event|11
2061939|NCT00562159|3636411|FG001|Overall Study|Adverse Event|8
2061940|NCT00562159|3636410|FG000|Overall Study|Lost to Follow-up|5
2061941|NCT00562159|3636411|FG001|Overall Study|Lost to Follow-up|4
2061942|NCT00562159|3636410|FG000|Overall Study|Withdrawal by Subject|9
2061943|NCT00562159|3636411|FG001|Overall Study|Withdrawal by Subject|8
2061944|NCT00562159|3636410|FG000|Overall Study|Protocol Violation|12
2061945|NCT00562159|3636411|FG001|Overall Study|Protocol Violation|12
2061946|NCT00562159|3636410|FG000|Overall Study|Did not meet protocol eligibility|1
2061947|NCT00562159|3636411|FG001|Overall Study|Did not meet protocol eligibility|1
2061948|NCT00562302|3636420|FG000|Overall Study|Lost to Follow-up|3
2061949|NCT00562302|3636421|FG001|Overall Study|Lost to Follow-up|3
2061950|NCT00562302|3636420|FG000|Overall Study|Adverse Event|0
2061951|NCT00562302|3636421|FG001|Overall Study|Adverse Event|6
2061952|NCT00562302|3636420|FG000|Overall Study|Non-compliance|1
2061953|NCT00562302|3636421|FG001|Overall Study|Non-compliance|2
2061954|NCT00562302|3636420|FG000|Overall Study|Withdrawal by Subject|7
2061955|NCT00562302|3636421|FG001|Overall Study|Withdrawal by Subject|8
2061956|NCT00562302|3636420|FG000|Overall Study|Death|1
2061957|NCT00562302|3636421|FG001|Overall Study|Death|2
2061958|NCT00562302|3636420|FG000|Overall Study|Lung resection prior to study completion|7
2061959|NCT00562302|3636421|FG001|Overall Study|Lung resection prior to study completion|7
2061960|NCT00562302|3636420|FG000|Overall Study|Not stated|1
2061961|NCT00562302|3636421|FG001|Overall Study|Not stated|4
2061962|NCT00562354|3636439|FG000|Overall Study|Physician Decision|0
2061963|NCT00562354|3636440|FG001|Overall Study|Physician Decision|1
2061964|NCT00562354|3636439|FG000|Overall Study|Lost to Follow-up|0
2061965|NCT00562354|3636440|FG001|Overall Study|Lost to Follow-up|1
2061966|NCT00562484|3636450|FG000|Overall Study|Adverse Event|6
2061967|NCT00562484|3636451|FG001|Overall Study|Adverse Event|1
2061968|NCT00562484|3636450|FG000|Overall Study|Protocol Violation|11
2061969|NCT00562484|3636451|FG001|Overall Study|Protocol Violation|2
2061970|NCT00562484|3636450|FG000|Overall Study|Withdrawal by Subject|12
2061971|NCT00562484|3636451|FG001|Overall Study|Withdrawal by Subject|9
2061972|NCT00562484|3636450|FG000|Overall Study|Moved away from the study area|20
2061973|NCT00562484|3636451|FG001|Overall Study|Moved away from the study area|9
2061974|NCT00562484|3636450|FG000|Overall Study|Lost to Follow-up|132
2061975|NCT00562484|3636451|FG001|Overall Study|Lost to Follow-up|71
2061976|NCT00562484|3636450|FG000|Overall Study|Reason not provided or not specified|25
2061977|NCT00562484|3636451|FG001|Overall Study|Reason not provided or not specified|12
2061978|NCT00562588|3636459|FG000|Overall Study|Adverse Event|40
2061979|NCT00562588|3636460|FG001|Overall Study|Adverse Event|58
2061980|NCT00562588|3636459|FG000|Overall Study|Protocol Violation|30
2061981|NCT00562588|3636460|FG001|Overall Study|Protocol Violation|26
2061982|NCT00562588|3636459|FG000|Overall Study|Lost to Follow-up|12
2061983|NCT00562588|3636460|FG001|Overall Study|Lost to Follow-up|4
2061984|NCT00562588|3636459|FG000|Overall Study|Withdrawal by Subject|10
2061985|NCT00562588|3636460|FG001|Overall Study|Withdrawal by Subject|9
2061986|NCT00562588|3636459|FG000|Overall Study|Other|0
2061987|NCT00562588|3636460|FG001|Overall Study|Other|2
2061988|NCT00562627|3636469|FG000|Overall Study|Protocol Violation|1
2061989|NCT00562627|3636470|FG001|Overall Study|Protocol Violation|1
2061990|NCT00562627|3636471|FG002|Overall Study|Protocol Violation|1
2061991|NCT00562718|3636479|FG000|Overall Study|Death|1
2061992|NCT00562718|3636479|FG000|Overall Study|Withdrawal by Subject|3
2061993|NCT00562718|3636479|FG000|Overall Study|Adverse Event|4
2061994|NCT00562718|3636479|FG000|Overall Study|Lack of Efficacy|2
2061995|NCT00562718|3636479|FG000|Overall Study|not stated|1
2061996|NCT00562861|3636485|FG000|Overall Study|Adverse Event|1
2061997|NCT00562861|3636486|FG001|Overall Study|Adverse Event|1
2061998|NCT00562861|3636485|FG000|Overall Study|Lack of Efficacy|5
2061999|NCT00562861|3636486|FG001|Overall Study|Lack of Efficacy|5
2062000|NCT00562861|3636485|FG000|Overall Study|noncompliance, moved|7
2062001|NCT00562861|3636486|FG001|Overall Study|noncompliance, moved|2
2062002|NCT00562861|3636485|FG000|Overall Study|Lost to Follow-up|7
2062003|NCT00562861|3636486|FG001|Overall Study|Lost to Follow-up|3
2062004|NCT00562965|3636494|FG000|Overall Study|Withdrawal by Subject|0
2062005|NCT00562965|3636495|FG001|Overall Study|Withdrawal by Subject|1
2062006|NCT00562965|3636494|FG000|Overall Study|Death|2
2062007|NCT00562965|3636495|FG001|Overall Study|Death|4
2062008|NCT00562965|3636494|FG000|Overall Study|Lost to Follow-up|1
2062009|NCT00562965|3636495|FG001|Overall Study|Lost to Follow-up|0
2062010|NCT00562965|3636494|FG000|Overall Study|Other|0
2062011|NCT00562965|3636495|FG001|Overall Study|Other|1
2062012|NCT00562978|3636503|FG000|Overall Study|Patient had imaging dose only|1
2062013|NCT00562978|3636504|FG001|Overall Study|Patient had imaging dose only|11
2062014|NCT00563186|3636512|FG000|Overall Study|LOS<48 hours|97
2062015|NCT00563186|3636513|FG001|Overall Study|LOS<48 hours|74
2062016|NCT00563186|3636512|FG000|Overall Study|Incomplete data|1
2062017|NCT00563186|3636513|FG001|Overall Study|Incomplete data|1
2062018|NCT00563316|3636533|FG000|Overall Study|Adverse Event|2
2062019|NCT00563316|3636533|FG000|Overall Study|Physician Decision|1
2062020|NCT00563316|3636533|FG000|Overall Study|Lost to Follow-up|2
2062021|NCT00563316|3636533|FG000|Overall Study|Death|1
2062022|NCT00563316|3636533|FG000|Overall Study|On-going in study as of 16 July 2009.|5
2062023|NCT00563316|3636533|FG000|Overall Study|Other|1
2062024|NCT00563368|3636548|FG000|Overall Study|Lost to Follow-up|14
2062025|NCT00563368|3636549|FG001|Overall Study|Lost to Follow-up|14
2062026|NCT00563368|3636550|FG002|Overall Study|Lost to Follow-up|12
2062027|NCT00563368|3636551|FG003|Overall Study|Lost to Follow-up|6
2062028|NCT00563368|3636552|FG004|Overall Study|Lost to Follow-up|9
2062029|NCT00563368|3636553|FG005|Overall Study|Lost to Follow-up|8
2062030|NCT00563368|3636554|FG006|Overall Study|Lost to Follow-up|9
2062031|NCT00563368|3636548|FG000|Overall Study|Adverse Event|3
2062032|NCT00563368|3636549|FG001|Overall Study|Adverse Event|4
2062033|NCT00563368|3636550|FG002|Overall Study|Adverse Event|5
2062034|NCT00563368|3636551|FG003|Overall Study|Adverse Event|9
2062035|NCT00563368|3636552|FG004|Overall Study|Adverse Event|6
2062036|NCT00563368|3636553|FG005|Overall Study|Adverse Event|10
2062037|NCT00563368|3636554|FG006|Overall Study|Adverse Event|17
2209932|NCT01646827|3849384|FG001|Overall Study|Withdrawal by Subject|0
2209933|NCT01647282|3849403|FG000|Overall Study|Physician Decision|7
2209934|NCT01647282|3849404|FG001|Overall Study|Physician Decision|5
2209935|NCT01647516|3849426|FG000|Induction Period (IP)|Physician Decision|2
2209936|NCT01647516|3849427|FG001|Induction Period (IP)|Physician Decision|0
2209937|NCT01647516|3849428|FG002|Induction Period (IP)|Physician Decision|0
2209938|NCT01647516|3849429|FG003|Induction Period (IP)|Physician Decision|0
2209939|NCT01647516|3849430|FG004|Induction Period (IP)|Physician Decision|0
2209940|NCT01647516|3849431|FG005|Induction Period (IP)|Physician Decision|0
2062038|NCT00563368|3636548|FG000|Overall Study|Withdrawal by Subject|11
2062039|NCT00563368|3636549|FG001|Overall Study|Withdrawal by Subject|6
2062040|NCT00563368|3636550|FG002|Overall Study|Withdrawal by Subject|5
2062041|NCT00563368|3636551|FG003|Overall Study|Withdrawal by Subject|7
2062042|NCT00563368|3636552|FG004|Overall Study|Withdrawal by Subject|8
2062043|NCT00563368|3636553|FG005|Overall Study|Withdrawal by Subject|5
2062044|NCT00563368|3636554|FG006|Overall Study|Withdrawal by Subject|4
2062045|NCT00563368|3636548|FG000|Overall Study|protocol non-compliance|1
2062046|NCT00563368|3636549|FG001|Overall Study|protocol non-compliance|1
2062047|NCT00563368|3636550|FG002|Overall Study|protocol non-compliance|2
2062048|NCT00563368|3636551|FG003|Overall Study|protocol non-compliance|1
2209941|NCT01647516|3849426|FG000|Induction Period (IP)|Adverse Event|1
2209942|NCT01647516|3849427|FG001|Induction Period (IP)|Adverse Event|2
2209943|NCT01647516|3849428|FG002|Induction Period (IP)|Adverse Event|0
2209944|NCT01647516|3849429|FG003|Induction Period (IP)|Adverse Event|0
2209945|NCT01647516|3849430|FG004|Induction Period (IP)|Adverse Event|0
2209946|NCT01647516|3849431|FG005|Induction Period (IP)|Adverse Event|0
2209947|NCT01647516|3849426|FG000|Induction Period (IP)|Withdrawal by Subject|1
2209948|NCT01647516|3849427|FG001|Induction Period (IP)|Withdrawal by Subject|0
2209949|NCT01647516|3849428|FG002|Induction Period (IP)|Withdrawal by Subject|3
2209950|NCT01647516|3849429|FG003|Induction Period (IP)|Withdrawal by Subject|0
2209951|NCT01647516|3849430|FG004|Induction Period (IP)|Withdrawal by Subject|0
2209952|NCT01647516|3849431|FG005|Induction Period (IP)|Withdrawal by Subject|0
2209953|NCT01647516|3849426|FG000|Induction Period (IP)|Participant Choice|0
2209954|NCT01647516|3849427|FG001|Induction Period (IP)|Participant Choice|0
2209955|NCT01647516|3849428|FG002|Induction Period (IP)|Participant Choice|1
2209956|NCT01647516|3849429|FG003|Induction Period (IP)|Participant Choice|0
2209957|NCT01647516|3849430|FG004|Induction Period (IP)|Participant Choice|0
2209958|NCT01647516|3849431|FG005|Induction Period (IP)|Participant Choice|0
2209959|NCT01647516|3849426|FG000|Induction Period (IP)|Lack of Efficacy|1
2209960|NCT01647516|3849427|FG001|Induction Period (IP)|Lack of Efficacy|0
2209961|NCT01647516|3849428|FG002|Induction Period (IP)|Lack of Efficacy|0
2209962|NCT01647516|3849429|FG003|Induction Period (IP)|Lack of Efficacy|0
2209963|NCT01647516|3849430|FG004|Induction Period (IP)|Lack of Efficacy|0
2209964|NCT01647516|3849431|FG005|Induction Period (IP)|Lack of Efficacy|0
2209965|NCT01647516|3849426|FG000|Induction Period (IP)|No study drug received|1
2209966|NCT01647516|3849427|FG001|Induction Period (IP)|No study drug received|1
2209967|NCT01647516|3849428|FG002|Induction Period (IP)|No study drug received|0
2209968|NCT01647516|3849429|FG003|Induction Period (IP)|No study drug received|0
2209969|NCT01647516|3849430|FG004|Induction Period (IP)|No study drug received|0
2209970|NCT01647516|3849431|FG005|Induction Period (IP)|No study drug received|0
2209971|NCT01647516|3849426|FG000|Maintenance Period (MP)|Adverse Event|2
2062049|NCT00563368|3636552|FG004|Overall Study|protocol non-compliance|0
2062050|NCT00563368|3636553|FG005|Overall Study|protocol non-compliance|1
2062051|NCT00563368|3636554|FG006|Overall Study|protocol non-compliance|3
2062052|NCT00563368|3636548|FG000|Overall Study|Pregnancy|1
2062053|NCT00563368|3636549|FG001|Overall Study|Pregnancy|0
2062054|NCT00563368|3636550|FG002|Overall Study|Pregnancy|1
2062055|NCT00563368|3636551|FG003|Overall Study|Pregnancy|2
2062056|NCT00563368|3636552|FG004|Overall Study|Pregnancy|1
2062057|NCT00563368|3636553|FG005|Overall Study|Pregnancy|2
2062058|NCT00563368|3636554|FG006|Overall Study|Pregnancy|0
2062059|NCT00563368|3636548|FG000|Overall Study|requirement for restricted medication|0
2062060|NCT00563368|3636549|FG001|Overall Study|requirement for restricted medication|0
2062061|NCT00563368|3636550|FG002|Overall Study|requirement for restricted medication|2
2062062|NCT00563368|3636551|FG003|Overall Study|requirement for restricted medication|0
2062063|NCT00563368|3636552|FG004|Overall Study|requirement for restricted medication|0
2062064|NCT00563368|3636553|FG005|Overall Study|requirement for restricted medication|0
2062065|NCT00563368|3636554|FG006|Overall Study|requirement for restricted medication|0
2062066|NCT00563368|3636548|FG000|Overall Study|Other|5
2062067|NCT00563368|3636549|FG001|Overall Study|Other|5
2062068|NCT00563368|3636550|FG002|Overall Study|Other|3
2062069|NCT00563368|3636551|FG003|Overall Study|Other|4
2062070|NCT00563368|3636552|FG004|Overall Study|Other|4
2062071|NCT00563368|3636553|FG005|Overall Study|Other|4
2062072|NCT00563368|3636554|FG006|Overall Study|Other|0
2062073|NCT00563381|3636572|FG000|Overall Study|Adverse Event|264
2062074|NCT00563381|3636573|FG001|Overall Study|Adverse Event|292
2062075|NCT00563381|3636572|FG000|Overall Study|Protocol Violation|66
2209972|NCT01647516|3849427|FG001|Maintenance Period (MP)|Adverse Event|1
2209973|NCT01647516|3849428|FG002|Maintenance Period (MP)|Adverse Event|0
2209974|NCT01647516|3849429|FG003|Maintenance Period (MP)|Adverse Event|0
2062076|NCT00563381|3636573|FG001|Overall Study|Protocol Violation|74
2062077|NCT00563381|3636572|FG000|Overall Study|Lost to Follow-up|7
2062078|NCT00563381|3636573|FG001|Overall Study|Lost to Follow-up|15
2062079|NCT00563381|3636572|FG000|Overall Study|Withdrawal by Subject|192
2062080|NCT00563381|3636573|FG001|Overall Study|Withdrawal by Subject|209
2062081|NCT00563381|3636572|FG000|Overall Study|Lack of Efficacy|32
2062082|NCT00563381|3636573|FG001|Overall Study|Lack of Efficacy|24
2062083|NCT00563381|3636572|FG000|Overall Study|Individual different reasons|24
2062084|NCT00563381|3636573|FG001|Overall Study|Individual different reasons|34
2062085|NCT00563706|3636588|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
2062086|NCT00563706|3636589|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
2062087|NCT00563706|3636590|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
2062088|NCT00563706|3636591|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
2062089|NCT00563706|3636592|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
2062090|NCT00563706|3636593|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
2062091|NCT00563706|3636594|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
2062092|NCT00563706|3636595|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
2062093|NCT00563706|3636596|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
2062094|NCT00563706|3636588|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
2062095|NCT00563706|3636589|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
2062096|NCT00563706|3636590|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
2062097|NCT00563706|3636591|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
2062098|NCT00563706|3636592|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
2062099|NCT00563706|3636593|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
2062100|NCT00563706|3636594|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
2062101|NCT00563706|3636595|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
2062102|NCT00563706|3636596|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
2062103|NCT00563706|3636588|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
2062104|NCT00563706|3636589|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
2062105|NCT00563706|3636590|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
2062106|NCT00563706|3636591|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
2062107|NCT00563706|3636592|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
2062108|NCT00563706|3636593|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
2062109|NCT00563706|3636594|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
2062110|NCT00563706|3636595|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
2062111|NCT00563706|3636596|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
2062112|NCT00563706|3636588|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
2062113|NCT00563706|3636589|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2062114|NCT00563706|3636590|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2062115|NCT00563706|3636591|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2062116|NCT00563706|3636592|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2062117|NCT00563706|3636593|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2062118|NCT00563706|3636594|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2062119|NCT00563706|3636595|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
2062120|NCT00563706|3636596|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2062121|NCT00563706|3636588|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0
2062122|NCT00563706|3636589|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0
2062123|NCT00563706|3636590|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0
2062124|NCT00563706|3636591|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0
2062125|NCT00563706|3636592|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0
2062126|NCT00563706|3636593|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0
2062127|NCT00563706|3636594|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0
2062128|NCT00563706|3636595|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1
2062129|NCT00563706|3636596|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2
2062130|NCT00563784|3636616|FG000|Overall Study|Withdrawal by Subject|2
2062131|NCT00563784|3636616|FG000|Overall Study|Screen Failures|20
2062132|NCT00563797|3636622|FG000|Overall Study|Lost to Follow-up|7
2062133|NCT00563797|3636623|FG001|Overall Study|Lost to Follow-up|2
2062134|NCT00564018|3636634|FG000|Overall Study|Withdrawal by Subject|2
2062135|NCT00564018|3636635|FG001|Overall Study|Withdrawal by Subject|3
2062136|NCT00564018|3636636|FG002|Overall Study|Withdrawal by Subject|1
2062137|NCT00564070|3636646|FG000|Overall Study|Lost to Follow-up|9
2062138|NCT00564070|3636647|FG001|Overall Study|Lost to Follow-up|7
2062139|NCT00564070|3636646|FG000|Overall Study|Worsening depression, referred to care|3
2062140|NCT00564070|3636647|FG001|Overall Study|Worsening depression, referred to care|0
2062141|NCT00564278|3636659|FG000|Overall Study|Lost to Follow-up|35
2062142|NCT00564278|3636660|FG001|Overall Study|Lost to Follow-up|33
2062143|NCT00564278|3636659|FG000|Overall Study|Physician Decision|1
2062144|NCT00564278|3636660|FG001|Overall Study|Physician Decision|2
2062145|NCT00564278|3636659|FG000|Overall Study|Withdrawal by Subject|11
2062146|NCT00564278|3636660|FG001|Overall Study|Withdrawal by Subject|7
2062147|NCT00564395|3636666|FG000|First Intervention (10 Days)|Withdrawal by Subject|1
2062148|NCT00564395|3636667|FG001|First Intervention (10 Days)|Withdrawal by Subject|0
2062149|NCT00564395|3636666|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1
2062150|NCT00564395|3636667|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2
2062151|NCT00564486|3636709|FG000|Overall Study|Adverse Event|0
2062152|NCT00564486|3636710|FG001|Overall Study|Adverse Event|1
2062153|NCT00564486|3636711|FG002|Overall Study|Adverse Event|0
2062154|NCT00564486|3636712|FG003|Overall Study|Adverse Event|0
2062155|NCT00564486|3636709|FG000|Overall Study|Withdrawal by Subject|4
2062156|NCT00564486|3636710|FG001|Overall Study|Withdrawal by Subject|0
2062157|NCT00564486|3636711|FG002|Overall Study|Withdrawal by Subject|0
2062158|NCT00564486|3636712|FG003|Overall Study|Withdrawal by Subject|5
2062159|NCT00564486|3636709|FG000|Overall Study|Subject refused to have blood drawn|0
2062160|NCT00564486|3636710|FG001|Overall Study|Subject refused to have blood drawn|0
2062161|NCT00564486|3636711|FG002|Overall Study|Subject refused to have blood drawn|1
2062162|NCT00564486|3636712|FG003|Overall Study|Subject refused to have blood drawn|0
2062163|NCT00564486|3636709|FG000|Overall Study|Lost to Follow-up|3
2062164|NCT00564486|3636710|FG001|Overall Study|Lost to Follow-up|0
2062165|NCT00564486|3636711|FG002|Overall Study|Lost to Follow-up|2
2062166|NCT00564486|3636712|FG003|Overall Study|Lost to Follow-up|2
2062167|NCT00564629|3636728|FG000|Overall Study|Vomited within 2 hours of receiving drug|15
2062168|NCT00564629|3636729|FG001|Overall Study|Vomited within 2 hours of receiving drug|9
2062169|NCT00564733|3636751|FG000|Overall Study|Withdrawal by Subject|4
2062170|NCT00564733|3636751|FG000|Overall Study|Ineligible|5
2062171|NCT00564850|3636755|FG000|Overall Study|Protocol Violation|2
2062172|NCT00564889|3636759|FG000|Overall Study|Death|7
2062173|NCT00564889|3636759|FG000|Overall Study|Adverse Event|12
2062174|NCT00564889|3636759|FG000|Overall Study|Alternative treatment|3
2062175|NCT00564889|3636759|FG000|Overall Study|Disease progression|3
2062176|NCT00564889|3636759|FG000|Overall Study|Other, not specified|4
2062177|NCT00564902|3636766|FG000|Overall Study|Withdrawal by Subject|0
2062178|NCT00564902|3636767|FG001|Overall Study|Withdrawal by Subject|3
2062179|NCT00564902|3636768|FG002|Overall Study|Withdrawal by Subject|4
2062180|NCT00564902|3636766|FG000|Overall Study|Death|1
2062181|NCT00564902|3636767|FG001|Overall Study|Death|1
2062182|NCT00564902|3636768|FG002|Overall Study|Death|0
2105840|NCT00861380|3698783|FG002|Overall Study|Withdrawal Information not recorded|8872
2105841|NCT00861380|3698784|FG003|Overall Study|Withdrawal Information not recorded|3689
2105842|NCT00861380|3698785|FG004|Overall Study|Withdrawal Information not recorded|1812
2105843|NCT00861380|3698786|FG005|Overall Study|Withdrawal Information not recorded|6249
2105844|NCT00861380|3698787|FG006|Overall Study|Withdrawal Information not recorded|3020
2105845|NCT00861471|3698820|FG000|Overall Study|Withdrawal by Subject|1
2105846|NCT00861471|3698820|FG000|Overall Study|Adverse Event|2
2105847|NCT00861471|3698820|FG000|Overall Study|Lack of Efficacy|3
2105848|NCT00861471|3698820|FG000|Overall Study|treatment for lumbar laminectomy|1
2105849|NCT00861471|3698820|FG000|Overall Study|Physician Decision|2
2105850|NCT00861614|3698842|FG000|Overall Study|Disease Progression|182
2105851|NCT00861614|3698843|FG001|Overall Study|Disease Progression|263
2105852|NCT00861614|3698842|FG000|Overall Study|Study Drug Toxicity|79
2105853|NCT00861614|3698843|FG001|Overall Study|Study Drug Toxicity|6
2105854|NCT00861614|3698842|FG000|Overall Study|Death|32
2105855|NCT00861614|3698843|FG001|Overall Study|Death|19
2105856|NCT00861614|3698842|FG000|Overall Study|Adverse Event|27
2105857|NCT00861614|3698843|FG001|Overall Study|Adverse Event|23
2105858|NCT00861614|3698842|FG000|Overall Study|Withdrawal by Subject|34
2105859|NCT00861614|3698843|FG001|Overall Study|Withdrawal by Subject|35
2105860|NCT00861614|3698842|FG000|Overall Study|Other|17
2105861|NCT00861614|3698843|FG001|Overall Study|Other|22
2105862|NCT00861692|3698849|FG000|Overall Study|Death|6
2105863|NCT00861744|3698857|FG000|Overall Study|Adverse Event|0
2105864|NCT00861744|3698858|FG001|Overall Study|Adverse Event|0
2105865|NCT00861744|3698859|FG002|Overall Study|Adverse Event|0
2105866|NCT00861744|3698860|FG003|Overall Study|Adverse Event|1
2105867|NCT00861744|3698857|FG000|Overall Study|Lost to Follow-up|7
2105868|NCT00861744|3698858|FG001|Overall Study|Lost to Follow-up|19
2105869|NCT00861744|3698859|FG002|Overall Study|Lost to Follow-up|17
2105870|NCT00861744|3698860|FG003|Overall Study|Lost to Follow-up|12
2105871|NCT00861744|3698857|FG000|Overall Study|Withdrawal by Subject|10
2105872|NCT00861744|3698858|FG001|Overall Study|Withdrawal by Subject|6
2105873|NCT00861744|3698859|FG002|Overall Study|Withdrawal by Subject|6
2105874|NCT00861744|3698860|FG003|Overall Study|Withdrawal by Subject|19
2105875|NCT00861744|3698857|FG000|Overall Study|Protocol Violation|0
2105876|NCT00861744|3698858|FG001|Overall Study|Protocol Violation|1
2105877|NCT00861744|3698859|FG002|Overall Study|Protocol Violation|0
2105878|NCT00861744|3698860|FG003|Overall Study|Protocol Violation|0
2105879|NCT00861744|3698857|FG000|Overall Study|Migration from study area|0
2105880|NCT00861744|3698858|FG001|Overall Study|Migration from study area|3
2105881|NCT00861744|3698859|FG002|Overall Study|Migration from study area|1
2105882|NCT00861744|3698860|FG003|Overall Study|Migration from study area|0
2105883|NCT00861744|3698857|FG000|Overall Study|Blood draws|0
2105884|NCT00861744|3698858|FG001|Overall Study|Blood draws|0
2105885|NCT00861744|3698859|FG002|Overall Study|Blood draws|0
2105886|NCT00861744|3698860|FG003|Overall Study|Blood draws|1
2105887|NCT00861757|3698874|FG000|Overall Study|Adverse Event|1
2105888|NCT00861757|3698875|FG001|Overall Study|Adverse Event|5
2062183|NCT00565058|3636796|FG000|Overall Study|Adverse Event|1
2062184|NCT00565058|3636797|FG001|Overall Study|Adverse Event|0
2062185|NCT00565136|3636822|FG000|Overall Study|Lost to Follow-up|1
2062186|NCT00565136|3636822|FG000|Overall Study|Withdrawal by Subject|1
2062187|NCT00565136|3636822|FG000|Overall Study|Protocol Violation|1
2062188|NCT00565409|3636838|FG000|Period 1 Open Label|Adverse Event|17
2062189|NCT00565409|3636839|FG001|Period 1 Open Label|Adverse Event|0
2062190|NCT00565409|3636840|FG002|Period 1 Open Label|Adverse Event|0
2062191|NCT00565409|3636841|FG003|Period 1 Open Label|Adverse Event|0
2062192|NCT00565409|3636838|FG000|Period 1 Open Label|Death|2
2062193|NCT00565409|3636839|FG001|Period 1 Open Label|Death|0
2062194|NCT00565409|3636840|FG002|Period 1 Open Label|Death|0
2062195|NCT00565409|3636841|FG003|Period 1 Open Label|Death|0
2062196|NCT00565409|3636838|FG000|Period 1 Open Label|Lost to Follow-up|1
2062197|NCT00565409|3636839|FG001|Period 1 Open Label|Lost to Follow-up|0
2062198|NCT00565409|3636840|FG002|Period 1 Open Label|Lost to Follow-up|0
2062199|NCT00565409|3636841|FG003|Period 1 Open Label|Lost to Follow-up|0
2062200|NCT00565409|3636838|FG000|Period 1 Open Label|Other|21
2062201|NCT00565409|3636839|FG001|Period 1 Open Label|Other|0
2062202|NCT00565409|3636840|FG002|Period 1 Open Label|Other|0
2062203|NCT00565409|3636841|FG003|Period 1 Open Label|Other|0
2062204|NCT00565409|3636838|FG000|Period 1 Open Label|Protocol Violation|14
2062205|NCT00565409|3636839|FG001|Period 1 Open Label|Protocol Violation|0
2062206|NCT00565409|3636840|FG002|Period 1 Open Label|Protocol Violation|0
2062207|NCT00565409|3636841|FG003|Period 1 Open Label|Protocol Violation|0
2062208|NCT00565409|3636838|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
2062209|NCT00565409|3636839|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
2062210|NCT00565409|3636840|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
2062211|NCT00565409|3636841|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
2062212|NCT00565409|3636838|FG000|Period 1 Open Label|no conclusion of participation record|1
2062213|NCT00565409|3636839|FG001|Period 1 Open Label|no conclusion of participation record|0
2062214|NCT00565409|3636840|FG002|Period 1 Open Label|no conclusion of participation record|0
2062215|NCT00565409|3636841|FG003|Period 1 Open Label|no conclusion of participation record|0
2062216|NCT00565409|3636838|FG000|After Period 1, Prior to Period 2|did not meet criteria|152
2062217|NCT00565409|3636839|FG001|After Period 1, Prior to Period 2|did not meet criteria|0
2062218|NCT00565409|3636840|FG002|After Period 1, Prior to Period 2|did not meet criteria|0
2062219|NCT00565409|3636841|FG003|After Period 1, Prior to Period 2|did not meet criteria|0
2062220|NCT00565409|3636838|FG000|Period 2 Double-Blind|Adverse Event|0
2062221|NCT00565409|3636839|FG001|Period 2 Double-Blind|Adverse Event|7
2062222|NCT00565409|3636840|FG002|Period 2 Double-Blind|Adverse Event|4
2062223|NCT00565409|3636841|FG003|Period 2 Double-Blind|Adverse Event|5
2062224|NCT00565409|3636838|FG000|Period 2 Double-Blind|Death|0
2062225|NCT00565409|3636839|FG001|Period 2 Double-Blind|Death|2
2062226|NCT00565409|3636840|FG002|Period 2 Double-Blind|Death|0
2209975|NCT01647516|3849430|FG004|Maintenance Period (MP)|Adverse Event|0
2209976|NCT01647516|3849431|FG005|Maintenance Period (MP)|Adverse Event|0
2209977|NCT01647516|3849426|FG000|Maintenance Period (MP)|Non-compliance|1
2209978|NCT01647516|3849427|FG001|Maintenance Period (MP)|Non-compliance|0
2209979|NCT01647516|3849428|FG002|Maintenance Period (MP)|Non-compliance|0
2209980|NCT01647516|3849429|FG003|Maintenance Period (MP)|Non-compliance|0
2062227|NCT00565409|3636841|FG003|Period 2 Double-Blind|Death|0
2062228|NCT00565409|3636838|FG000|Period 2 Double-Blind|Protocol Violation|0
2062229|NCT00565409|3636839|FG001|Period 2 Double-Blind|Protocol Violation|4
2062230|NCT00565409|3636840|FG002|Period 2 Double-Blind|Protocol Violation|6
2062231|NCT00565409|3636841|FG003|Period 2 Double-Blind|Protocol Violation|2
2062232|NCT00565409|3636838|FG000|Period 2 Double-Blind|Lost to Follow-up|0
2062233|NCT00565409|3636839|FG001|Period 2 Double-Blind|Lost to Follow-up|0
2062234|NCT00565409|3636840|FG002|Period 2 Double-Blind|Lost to Follow-up|1
2062235|NCT00565409|3636841|FG003|Period 2 Double-Blind|Lost to Follow-up|0
2062236|NCT00565409|3636838|FG000|Period 2 Double-Blind|Other|0
2062237|NCT00565409|3636839|FG001|Period 2 Double-Blind|Other|4
2062238|NCT00565409|3636840|FG002|Period 2 Double-Blind|Other|5
2062239|NCT00565409|3636841|FG003|Period 2 Double-Blind|Other|9
2062240|NCT00565409|3636838|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
2062241|NCT00565409|3636839|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
2062242|NCT00565409|3636840|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
2062243|NCT00565409|3636841|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
2062244|NCT00565448|3636853|FG000|Overall Study|Adverse Event|1
2062245|NCT00565448|3636854|FG001|Overall Study|Adverse Event|2
2062246|NCT00565448|3636853|FG000|Overall Study|Disease progression|1
2062247|NCT00565448|3636854|FG001|Overall Study|Disease progression|0
2062248|NCT00565448|3636853|FG000|Overall Study|Withdrawal by Subject|1
2209981|NCT01647516|3849430|FG004|Maintenance Period (MP)|Non-compliance|0
2062249|NCT00565448|3636854|FG001|Overall Study|Withdrawal by Subject|0
2062250|NCT00565604|3636863|FG000|Overall Study|Failure to treat|2
2062251|NCT00565604|3636863|FG000|Overall Study|Lost to Follow-up|2
2062252|NCT00565617|3636867|FG000|Overall Study|Withdrawal by Subject|1
2062253|NCT00565721|3636890|FG000|Overall Study|Screen Failure|2
2062254|NCT00565721|3636890|FG000|Overall Study|Lost to Follow-up|6
2062255|NCT00565721|3636890|FG000|Overall Study|Technical Problems|1
2062256|NCT00565721|3636890|FG000|Overall Study|Physician Decision|2
2062257|NCT00565721|3636890|FG000|Overall Study|Other reasons|6
2062258|NCT00565747|3636911|FG000|Overall Study|No embryo transfer|67
2062259|NCT00565747|3636912|FG001|Overall Study|No embryo transfer|73
2062260|NCT00565773|3636918|FG000|Overall Study|Withdrawal by Subject|1
2062261|NCT00565773|3636918|FG000|Overall Study|Physician Decision|1
2062262|NCT00565812|3636925|FG000|Overall Study|Death|2
2062263|NCT00565812|3636926|FG001|Overall Study|Death|1
2062264|NCT00565812|3636927|FG002|Overall Study|Death|3
2062265|NCT00565812|3636925|FG000|Overall Study|Did not Meet Entrance Criteria|1
2062266|NCT00565812|3636926|FG001|Overall Study|Did not Meet Entrance Criteria|0
2062267|NCT00565812|3636927|FG002|Overall Study|Did not Meet Entrance Criteria|1
2062268|NCT00565812|3636925|FG000|Overall Study|Lost to Follow-up|10
2062269|NCT00565812|3636926|FG001|Overall Study|Lost to Follow-up|8
2062270|NCT00565812|3636927|FG002|Overall Study|Lost to Follow-up|8
2302466|NCT02628444|4001370|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
2302467|NCT02628444|4001371|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
2302468|NCT02628444|4001372|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
2321634|NCT02962284|4036202|FG000|Overall Study|Progressive disease|2
2062271|NCT00565812|3636925|FG000|Overall Study|Withdrawal by Subject|58
2062272|NCT00565812|3636926|FG001|Overall Study|Withdrawal by Subject|47
2062273|NCT00565812|3636927|FG002|Overall Study|Withdrawal by Subject|48
2062274|NCT00565812|3636925|FG000|Overall Study|Work Schedule|5
2062275|NCT00565812|3636926|FG001|Overall Study|Work Schedule|3
2062276|NCT00565812|3636927|FG002|Overall Study|Work Schedule|1
2062277|NCT00565812|3636925|FG000|Overall Study|Protocol Violation|2
2062278|NCT00565812|3636926|FG001|Overall Study|Protocol Violation|6
2062279|NCT00565812|3636927|FG002|Overall Study|Protocol Violation|4
2062280|NCT00565812|3636925|FG000|Overall Study|Adverse Event|41
2062281|NCT00565812|3636926|FG001|Overall Study|Adverse Event|54
2062282|NCT00565812|3636927|FG002|Overall Study|Adverse Event|40
2062283|NCT00565812|3636925|FG000|Overall Study|Jury Duty|1
2062284|NCT00565812|3636926|FG001|Overall Study|Jury Duty|0
2062285|NCT00565812|3636927|FG002|Overall Study|Jury Duty|0
2062286|NCT00565812|3636925|FG000|Overall Study|Relocated Out of Area|5
2062287|NCT00565812|3636926|FG001|Overall Study|Relocated Out of Area|8
2062288|NCT00565812|3636927|FG002|Overall Study|Relocated Out of Area|9
2062289|NCT00565812|3636925|FG000|Overall Study|Sponsor Decision|1
2062290|NCT00565812|3636926|FG001|Overall Study|Sponsor Decision|5
2062291|NCT00565812|3636927|FG002|Overall Study|Sponsor Decision|1
2062292|NCT00565812|3636925|FG000|Overall Study|Domestic Reasons|7
2062293|NCT00565812|3636926|FG001|Overall Study|Domestic Reasons|1
2062294|NCT00565812|3636927|FG002|Overall Study|Domestic Reasons|3
2062295|NCT00565812|3636925|FG000|Overall Study|Research Site Closure|6
2062296|NCT00565812|3636926|FG001|Overall Study|Research Site Closure|1
2062297|NCT00565812|3636927|FG002|Overall Study|Research Site Closure|8
2062298|NCT00565812|3636925|FG000|Overall Study|Surgical Intervention|0
2062299|NCT00565812|3636926|FG001|Overall Study|Surgical Intervention|1
2062300|NCT00565812|3636927|FG002|Overall Study|Surgical Intervention|2
2062301|NCT00565812|3636925|FG000|Overall Study|Low Compliance|1
2062302|NCT00565812|3636926|FG001|Overall Study|Low Compliance|0
2062303|NCT00565812|3636927|FG002|Overall Study|Low Compliance|1
2062304|NCT00565812|3636925|FG000|Overall Study|Follow-up Visit Not Completed|2
2062305|NCT00565812|3636926|FG001|Overall Study|Follow-up Visit Not Completed|0
2062306|NCT00565812|3636927|FG002|Overall Study|Follow-up Visit Not Completed|1
2062307|NCT00565812|3636925|FG000|Overall Study|Physician Decision|2
2062308|NCT00565812|3636926|FG001|Overall Study|Physician Decision|0
2062309|NCT00565812|3636927|FG002|Overall Study|Physician Decision|0
2062310|NCT00566020|3636959|FG000|6-week Dosage Adjustment Phase|Adverse Event|5
2062311|NCT00566020|3636960|FG001|6-week Dosage Adjustment Phase|Adverse Event|0
2062312|NCT00566020|3636959|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2
2062313|NCT00566020|3636960|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0
2062314|NCT00566020|3636959|FG000|46-week Long-term Administration Phase|Adverse Event|0
2062315|NCT00566020|3636960|FG001|46-week Long-term Administration Phase|Adverse Event|7
2062316|NCT00566020|3636959|FG000|46-week Long-term Administration Phase|Physician Decision|0
2062317|NCT00566020|3636960|FG001|46-week Long-term Administration Phase|Physician Decision|7
2062318|NCT00566020|3636959|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0
2062319|NCT00566020|3636960|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2
2062320|NCT00566020|3636959|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
2062321|NCT00566020|3636960|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
2062322|NCT00566098|3636965|FG000|Collection of MILs|Withdrawal by Subject|1
2062323|NCT00566098|3636965|FG000|Collection of MILs|Relapsed|1
2062324|NCT00566098|3636965|FG000|Generation of MILs Product|Relapsed|1
2062325|NCT00566098|3636965|FG000|Administration of ASCT+MILs|Death|10
2062326|NCT00566098|3636965|FG000|Administration of ASCT+MILs|Lack of Efficacy|8
2062327|NCT00566111|3636972|FG000|Overall Study|Adverse Event|0
2062328|NCT00566111|3636973|FG001|Overall Study|Adverse Event|2
2062329|NCT00566228|3636990|FG000|Overall Study|Withdrawal by Subject|1
2062330|NCT00566228|3636991|FG001|Overall Study|Withdrawal by Subject|0
2062331|NCT00566228|3636990|FG000|Overall Study|Attempt to mobilize stem cells failed|2
2062332|NCT00566228|3636991|FG001|Overall Study|Attempt to mobilize stem cells failed|2
2062333|NCT00566228|3636990|FG000|Overall Study|Unable to collect sufficient CD34 cells|3
2062334|NCT00566228|3636991|FG001|Overall Study|Unable to collect sufficient CD34 cells|2
2062335|NCT00566228|3636990|FG000|Overall Study|progressed before infusion could occur|0
2062336|NCT00566228|3636991|FG001|Overall Study|progressed before infusion could occur|1
2062337|NCT00566254|3636999|FG000|Overall Study|Adverse Event|3
2062338|NCT00566254|3637000|FG001|Overall Study|Adverse Event|1
2062339|NCT00566254|3636999|FG000|Overall Study|Protocol Violation|1
2062340|NCT00566254|3637000|FG001|Overall Study|Protocol Violation|3
2062341|NCT00566254|3636999|FG000|Overall Study|Withdrawal by Subject|1
2062342|NCT00566254|3637000|FG001|Overall Study|Withdrawal by Subject|2
2062343|NCT00566254|3636999|FG000|Overall Study|Lack of Efficacy|5
2062344|NCT00566254|3637000|FG001|Overall Study|Lack of Efficacy|6
2062345|NCT00566254|3636999|FG000|Overall Study|Other|0
2062346|NCT00566254|3637000|FG001|Overall Study|Other|2
2062347|NCT00566501|3637008|FG000|Overall Study|Adverse Event|68
2062348|NCT00566501|3637009|FG001|Overall Study|Adverse Event|59
2062349|NCT00566501|3637008|FG000|Overall Study|Medication Non-compliance|5
2062350|NCT00566501|3637009|FG001|Overall Study|Medication Non-compliance|0
2062351|NCT00566501|3637008|FG000|Overall Study|Protocol Violation|2
2062352|NCT00566501|3637009|FG001|Overall Study|Protocol Violation|2
2062353|NCT00566501|3637008|FG000|Overall Study|Request of Investigator or Sponsor|6
2062354|NCT00566501|3637009|FG001|Overall Study|Request of Investigator or Sponsor|7
2062355|NCT00566501|3637008|FG000|Overall Study|Withdrawal by Subject|33
2062356|NCT00566501|3637009|FG001|Overall Study|Withdrawal by Subject|30
2062357|NCT00566501|3637008|FG000|Overall Study|Lack of Efficacy|8
2062358|NCT00566501|3637009|FG001|Overall Study|Lack of Efficacy|3
2062359|NCT00566501|3637008|FG000|Overall Study|Other|25
2302469|NCT02628444|4001373|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
2302470|NCT02628444|4001374|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
2302471|NCT02628444|4001375|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
2302472|NCT02628444|4001376|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
2302473|NCT02628444|4001377|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
2302474|NCT02628444|4001369|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
2302475|NCT02628444|4001370|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4
2302476|NCT02628444|4001371|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3
2302477|NCT02628444|4001372|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
2302478|NCT02628444|4001373|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
2302479|NCT02628444|4001374|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
2302480|NCT02628444|4001375|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
2302481|NCT02628444|4001376|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
2302482|NCT02628444|4001377|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
2302483|NCT02628444|4001369|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21
2302484|NCT02628444|4001370|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16
2302485|NCT02628444|4001371|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25
2302486|NCT02628444|4001372|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
2302487|NCT02628444|4001373|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
2302488|NCT02628444|4001374|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
2302489|NCT02628444|4001375|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
2302490|NCT02628444|4001376|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
2302491|NCT02628444|4001377|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
2302492|NCT02628444|4001369|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
2302493|NCT02628444|4001370|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16
2302494|NCT02628444|4001371|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
2302495|NCT02628444|4001372|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
2302496|NCT02628444|4001373|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
2302497|NCT02628444|4001374|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
2321635|NCT02962284|4036203|FG001|Overall Study|Progressive disease|3
2062360|NCT00566501|3637009|FG001|Overall Study|Other|21
2062361|NCT00566527|3637018|FG000|Overall Study|Reason not provided|3
2062362|NCT00566527|3637019|FG001|Overall Study|Reason not provided|11
2062363|NCT00566527|3637020|FG002|Overall Study|Reason not provided|10
2062364|NCT00566527|3637018|FG000|Overall Study|Adverse Event|2
2062365|NCT00566527|3637019|FG001|Overall Study|Adverse Event|0
2062366|NCT00566527|3637020|FG002|Overall Study|Adverse Event|1
2062367|NCT00566527|3637018|FG000|Overall Study|Physician Decision|3
2062368|NCT00566527|3637019|FG001|Overall Study|Physician Decision|8
2062369|NCT00566527|3637020|FG002|Overall Study|Physician Decision|20
2062370|NCT00566527|3637018|FG000|Overall Study|Lost to Follow-up|3
2062371|NCT00566527|3637019|FG001|Overall Study|Lost to Follow-up|4
2062372|NCT00566527|3637020|FG002|Overall Study|Lost to Follow-up|4
2062373|NCT00566527|3637018|FG000|Overall Study|Withdrawal by Subject|6
2062374|NCT00566527|3637019|FG001|Overall Study|Withdrawal by Subject|43
2062375|NCT00566527|3637020|FG002|Overall Study|Withdrawal by Subject|43
2062376|NCT00566631|3637043|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18
2209982|NCT01647516|3849431|FG005|Maintenance Period (MP)|Non-compliance|0
2062377|NCT00566631|3637043|FG000|Part 1: Core Treatment Phase|Physician Decision|1
2062378|NCT00566631|3637043|FG000|Part 1: Core Treatment Phase|Adverse Event|9
2062379|NCT00566631|3637043|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4
2062380|NCT00566631|3637043|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26
2062381|NCT00566631|3637043|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
2062382|NCT00566631|3637043|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1
2062383|NCT00566631|3637043|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95
2062384|NCT00566631|3637043|FG000|Part 2: Extension Phase|Lack of Efficacy|25
2062385|NCT00566631|3637043|FG000|Part 2: Extension Phase|Withdrawal by Subject|34
2062386|NCT00566631|3637043|FG000|Part 2: Extension Phase|Adverse Event|11
2062387|NCT00566631|3637043|FG000|Part 2: Extension Phase|Lost to Follow-up|6
2062388|NCT00566631|3637043|FG000|Part 2: Extension Phase|Death|1
2062389|NCT00566631|3637043|FG000|Part 2: Extension Phase|Other|5
2062390|NCT00566696|3637047|FG000|Overall Study|Met Exclusion Criteria|2
2062391|NCT00566696|3637047|FG000|Overall Study|Muromonab not available|1
2062392|NCT00566696|3637047|FG000|Overall Study|Health Status Change|1
2062393|NCT00566696|3637047|FG000|Overall Study|Physician Decision|1
2062394|NCT00566696|3637047|FG000|Overall Study|Non-Patient Donors|37
2062395|NCT00566709|3637053|FG000|Overall Study|Protocol Violation|5
2062396|NCT00566709|3637054|FG001|Overall Study|Protocol Violation|0
2062397|NCT00566722|3637063|FG000|Overall Study|Adverse Event|0
2062398|NCT00566722|3637064|FG001|Overall Study|Adverse Event|1
2062399|NCT00566722|3637065|FG002|Overall Study|Adverse Event|0
2062400|NCT00566722|3637063|FG000|Overall Study|Withdrawal by Subject|0
2062401|NCT00566722|3637064|FG001|Overall Study|Withdrawal by Subject|0
2062402|NCT00566722|3637065|FG002|Overall Study|Withdrawal by Subject|1
2062403|NCT00566722|3637063|FG000|Overall Study|Lost to Follow-up|1
2062404|NCT00566722|3637064|FG001|Overall Study|Lost to Follow-up|1
2062405|NCT00566722|3637065|FG002|Overall Study|Lost to Follow-up|1
2062406|NCT00566722|3637063|FG000|Overall Study|Lack of Efficacy|1
2062407|NCT00566722|3637064|FG001|Overall Study|Lack of Efficacy|2
2062408|NCT00566722|3637065|FG002|Overall Study|Lack of Efficacy|4
2062409|NCT00566722|3637063|FG000|Overall Study|Did not meet exclusion criteria|0
2062410|NCT00566722|3637064|FG001|Overall Study|Did not meet exclusion criteria|0
2062411|NCT00566722|3637065|FG002|Overall Study|Did not meet exclusion criteria|2
2062412|NCT00566722|3637063|FG000|Overall Study|Serious adverse event|0
2062413|NCT00566722|3637064|FG001|Overall Study|Serious adverse event|1
2062414|NCT00566722|3637065|FG002|Overall Study|Serious adverse event|0
2062415|NCT00566722|3637063|FG000|Overall Study|Noncompliant with drug administration|0
2062416|NCT00566722|3637064|FG001|Overall Study|Noncompliant with drug administration|0
2062417|NCT00566722|3637065|FG002|Overall Study|Noncompliant with drug administration|1
2062418|NCT00566735|3637078|FG000|Overall Study|Withdrawal by Subject|0
2062419|NCT00566735|3637079|FG001|Overall Study|Withdrawal by Subject|1
2062420|NCT00566735|3637078|FG000|Overall Study|Refused neuropsychological testing|2
2062421|NCT00566735|3637079|FG001|Overall Study|Refused neuropsychological testing|5
2062422|NCT00566735|3637078|FG000|Overall Study|Switched into a manic episode|0
2062423|NCT00566735|3637079|FG001|Overall Study|Switched into a manic episode|1
2062424|NCT00566852|3637096|FG000|Overall Study|Protocol Violation|22
2062425|NCT00566852|3637097|FG001|Overall Study|Protocol Violation|24
2062426|NCT00566852|3637096|FG000|Overall Study|Death|95
2062427|NCT00566852|3637097|FG001|Overall Study|Death|78
2062428|NCT00566852|3637096|FG000|Overall Study|Withdrawal by Subject|30
2062429|NCT00566852|3637097|FG001|Overall Study|Withdrawal by Subject|25
2062430|NCT00566852|3637096|FG000|Overall Study|Patient refusal|37
2062431|NCT00566852|3637097|FG001|Overall Study|Patient refusal|37
2062432|NCT00566852|3637096|FG000|Overall Study|Not tested due to disability|6
2062433|NCT00566852|3637097|FG001|Overall Study|Not tested due to disability|12
2062434|NCT00566852|3637096|FG000|Overall Study|Missing reason not specified|1
2062435|NCT00566852|3637097|FG001|Overall Study|Missing reason not specified|2
2062436|NCT00566852|3637096|FG000|Overall Study|Missing reason not reported|16
2062437|NCT00566852|3637097|FG001|Overall Study|Missing reason not reported|20
2062438|NCT00566982|3637146|FG000|Overall Study|Adverse Event|6
2062439|NCT00566982|3637147|FG001|Overall Study|Adverse Event|48
2062440|NCT00566982|3637146|FG000|Overall Study|Withdrawal by Subject|1
2062441|NCT00566982|3637147|FG001|Overall Study|Withdrawal by Subject|14
2062442|NCT00566982|3637146|FG000|Overall Study|Protocol Violation|1
2062443|NCT00566982|3637147|FG001|Overall Study|Protocol Violation|4
2062444|NCT00566982|3637146|FG000|Overall Study|Lost to Follow-up|0
2062445|NCT00566982|3637147|FG001|Overall Study|Lost to Follow-up|1
2062446|NCT00566982|3637146|FG000|Overall Study|Other-family problems & doctor's request|0
2062447|NCT00566982|3637147|FG001|Overall Study|Other-family problems & doctor's request|2
2062448|NCT00567112|3637165|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0
2062449|NCT00567112|3637166|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1
2062450|NCT00567112|3637167|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0
2062451|NCT00567112|3637165|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2
2062452|NCT00567112|3637166|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0
2062453|NCT00567112|3637167|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0
2062454|NCT00567112|3637165|FG000|Washout Period 3 (3 Days)|Protocol Violation|1
2062455|NCT00567112|3637166|FG001|Washout Period 3 (3 Days)|Protocol Violation|0
2062456|NCT00567112|3637167|FG002|Washout Period 3 (3 Days)|Protocol Violation|0
2062457|NCT00567164|3637179|FG000|Overall Study|Withdrawal by Subject|171
2062458|NCT00567164|3637180|FG001|Overall Study|Withdrawal by Subject|21
2062459|NCT00567164|3637181|FG002|Overall Study|Withdrawal by Subject|17
2062460|NCT00567164|3637179|FG000|Overall Study|Protocol Violation|23
2062461|NCT00567164|3637180|FG001|Overall Study|Protocol Violation|4
2062462|NCT00567164|3637181|FG002|Overall Study|Protocol Violation|2
2062463|NCT00567164|3637179|FG000|Overall Study|Adverse Event|92
2062464|NCT00567164|3637180|FG001|Overall Study|Adverse Event|13
2062465|NCT00567164|3637181|FG002|Overall Study|Adverse Event|9
2062466|NCT00567164|3637179|FG000|Overall Study|Death|0
2062467|NCT00567164|3637180|FG001|Overall Study|Death|0
2062468|NCT00567164|3637181|FG002|Overall Study|Death|1
2062469|NCT00567164|3637179|FG000|Overall Study|Lost to Follow-up|202
2062470|NCT00567164|3637180|FG001|Overall Study|Lost to Follow-up|23
2062471|NCT00567164|3637181|FG002|Overall Study|Lost to Follow-up|21
2062472|NCT00567164|3637179|FG000|Overall Study|Pregnancy|20
2062473|NCT00567164|3637180|FG001|Overall Study|Pregnancy|4
2062474|NCT00567164|3637181|FG002|Overall Study|Pregnancy|6
2062475|NCT00567164|3637179|FG000|Overall Study|Primary Reason coded as 'Other'|37
2062476|NCT00567164|3637180|FG001|Overall Study|Primary Reason coded as 'Other'|8
2062477|NCT00567164|3637181|FG002|Overall Study|Primary Reason coded as 'Other'|16
2062478|NCT00567164|3637179|FG000|Overall Study|Missing|1
2062479|NCT00567164|3637180|FG001|Overall Study|Missing|0
2062480|NCT00567164|3637181|FG002|Overall Study|Missing|0
2062481|NCT00567190|3637195|FG000|Overall Study|Death|235
2062482|NCT00567190|3637196|FG001|Overall Study|Death|280
2062483|NCT00567190|3637195|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48
2062484|NCT00567190|3637196|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53
2062485|NCT00567255|3637222|FG000|Overall Study|Adverse Event|241
2062486|NCT00567255|3637223|FG001|Overall Study|Adverse Event|68
2062487|NCT00567255|3637222|FG000|Overall Study|Lost to Follow-up|77
2062488|NCT00567255|3637223|FG001|Overall Study|Lost to Follow-up|48
2062489|NCT00567255|3637222|FG000|Overall Study|Withdrawal by Subject|75
2062490|NCT00567255|3637223|FG001|Overall Study|Withdrawal by Subject|56
2062491|NCT00567255|3637222|FG000|Overall Study|Lack of Efficacy|19
2062492|NCT00567255|3637223|FG001|Overall Study|Lack of Efficacy|33
2062493|NCT00567255|3637222|FG000|Overall Study|Protocol Violation|20
2062494|NCT00567255|3637223|FG001|Overall Study|Protocol Violation|8
2062495|NCT00567255|3637222|FG000|Overall Study|Pregnancy|6
2062496|NCT00567255|3637223|FG001|Overall Study|Pregnancy|0
2062497|NCT00567255|3637222|FG000|Overall Study|Drug noncompliance,moved,other|25
2062498|NCT00567255|3637223|FG001|Overall Study|Drug noncompliance,moved,other|15
2062499|NCT00567268|3637229|FG000|Overall Study|Protocol Violation|7
2062500|NCT00567268|3637229|FG000|Overall Study|Lost to Follow-up|36
2062501|NCT00567268|3637229|FG000|Overall Study|No Visit After First Day of Treatment|2
2062502|NCT00567268|3637229|FG000|Overall Study|No Drug Administration|4
2062503|NCT00567268|3637229|FG000|Overall Study|"Safety Evaluation Not Assessable"|1
2062504|NCT00567359|3637286|FG000|Overall Study|Withdrawal by Subject|1
2209983|NCT01647516|3849426|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
2062505|NCT00567398|3637292|FG000|Overall Study|Adverse Event|6
2062506|NCT00567398|3637293|FG001|Overall Study|Adverse Event|14
2062507|NCT00567398|3637292|FG000|Overall Study|Physician Decision|0
2062508|NCT00567398|3637293|FG001|Overall Study|Physician Decision|4
2062509|NCT00567398|3637292|FG000|Overall Study|Withdrawal by Subject|0
2062510|NCT00567398|3637293|FG001|Overall Study|Withdrawal by Subject|2
2062511|NCT00567398|3637292|FG000|Overall Study|Renal Transplantation|0
2062512|NCT00567398|3637293|FG001|Overall Study|Renal Transplantation|3
2062513|NCT00567398|3637292|FG000|Overall Study|Other|1
2062514|NCT00567398|3637293|FG001|Overall Study|Other|0
2062515|NCT00567476|3637301|FG000|Overall Study|Adverse Event|2
2062516|NCT00567476|3637302|FG001|Overall Study|Adverse Event|0
2062517|NCT00567476|3637301|FG000|Overall Study|Pregnancy|1
2062518|NCT00567476|3637302|FG001|Overall Study|Pregnancy|0
2062519|NCT00567476|3637301|FG000|Overall Study|Protocol Violation|4
2062520|NCT00567476|3637302|FG001|Overall Study|Protocol Violation|1
2062521|NCT00567476|3637301|FG000|Overall Study|Lost to Follow-up|0
2062522|NCT00567476|3637302|FG001|Overall Study|Lost to Follow-up|1
2062523|NCT00567476|3637301|FG000|Overall Study|Administrative issues|1
2062524|NCT00567476|3637302|FG001|Overall Study|Administrative issues|0
2062525|NCT00567476|3637301|FG000|Overall Study|Medical Decision|0
2062526|NCT00567476|3637302|FG001|Overall Study|Medical Decision|1
2062527|NCT00567476|3637301|FG000|Overall Study|Non-adherence to protocol|0
2062528|NCT00567476|3637302|FG001|Overall Study|Non-adherence to protocol|1
2062529|NCT00567489|3637310|FG000|Overall Study|Adverse Event|6
2062530|NCT00567489|3637311|FG001|Overall Study|Adverse Event|14
2062531|NCT00567489|3637310|FG000|Overall Study|Physician Decision|0
2062532|NCT00567489|3637311|FG001|Overall Study|Physician Decision|4
2062533|NCT00567489|3637310|FG000|Overall Study|Withdrawal by Subject|0
2062534|NCT00567489|3637311|FG001|Overall Study|Withdrawal by Subject|2
2062535|NCT00567489|3637310|FG000|Overall Study|Renal Transplantation|0
2062536|NCT00567489|3637311|FG001|Overall Study|Renal Transplantation|3
2062537|NCT00567489|3637310|FG000|Overall Study|Other|1
2062538|NCT00567489|3637311|FG001|Overall Study|Other|0
2062539|NCT00567502|3637321|FG000|Overall Study|Lost to Follow-up|91
2062540|NCT00567502|3637322|FG001|Overall Study|Lost to Follow-up|14
2062541|NCT00567502|3637323|FG002|Overall Study|Lost to Follow-up|351
2062542|NCT00567502|3637324|FG003|Overall Study|Lost to Follow-up|2
2062543|NCT00567502|3637321|FG000|Overall Study|Death|65
2062544|NCT00567502|3637322|FG001|Overall Study|Death|16
2062545|NCT00567502|3637323|FG002|Overall Study|Death|360
2062546|NCT00567502|3637324|FG003|Overall Study|Death|5
2062547|NCT00567502|3637321|FG000|Overall Study|Other|64
2062548|NCT00567502|3637322|FG001|Overall Study|Other|2
2062549|NCT00567502|3637323|FG002|Overall Study|Other|134
2062550|NCT00567502|3637324|FG003|Overall Study|Other|6
2062551|NCT00567502|3637321|FG000|Overall Study|Participant request|12
2062552|NCT00567502|3637322|FG001|Overall Study|Participant request|1
2062553|NCT00567502|3637323|FG002|Overall Study|Participant request|33
2062554|NCT00567502|3637324|FG003|Overall Study|Participant request|1
2062555|NCT00567502|3637321|FG000|Overall Study|Sponsor request|9
2062556|NCT00567502|3637322|FG001|Overall Study|Sponsor request|0
2062557|NCT00567502|3637323|FG002|Overall Study|Sponsor request|30
2062558|NCT00567502|3637324|FG003|Overall Study|Sponsor request|1
2062559|NCT00567502|3637321|FG000|Overall Study|Never Initiated Treatment|0
2062560|NCT00567502|3637322|FG001|Overall Study|Never Initiated Treatment|0
2062561|NCT00567502|3637323|FG002|Overall Study|Never Initiated Treatment|0
2062562|NCT00567502|3637324|FG003|Overall Study|Never Initiated Treatment|72
2062563|NCT00567541|3637347|FG000|Overall Study|Adverse Event|0
2062564|NCT00567541|3637348|FG001|Overall Study|Adverse Event|1
2062565|NCT00567593|3637354|FG000|Overall Study|Adverse Event|1
2062566|NCT00567593|3637354|FG000|Overall Study|Physician Decision|1
2062567|NCT00567879|3637385|FG000|Overall Study|Adverse Event|2
2062568|NCT00567879|3637386|FG001|Overall Study|Adverse Event|0
2062569|NCT00567879|3637387|FG002|Overall Study|Adverse Event|1
2062570|NCT00567879|3637388|FG003|Overall Study|Adverse Event|0
2062571|NCT00567879|3637389|FG004|Overall Study|Adverse Event|1
2062572|NCT00567879|3637390|FG005|Overall Study|Adverse Event|0
2062573|NCT00567879|3637385|FG000|Overall Study|Abnormal test procedure(s)|0
2062574|NCT00567879|3637386|FG001|Overall Study|Abnormal test procedure(s)|0
2062575|NCT00567879|3637387|FG002|Overall Study|Abnormal test procedure(s)|1
2062576|NCT00567879|3637388|FG003|Overall Study|Abnormal test procedure(s)|0
2062577|NCT00567879|3637389|FG004|Overall Study|Abnormal test procedure(s)|0
2062578|NCT00567879|3637390|FG005|Overall Study|Abnormal test procedure(s)|0
2062579|NCT00567879|3637385|FG000|Overall Study|Withdrawal by Subject|0
2062580|NCT00567879|3637386|FG001|Overall Study|Withdrawal by Subject|0
2062581|NCT00567879|3637387|FG002|Overall Study|Withdrawal by Subject|3
2062582|NCT00567879|3637388|FG003|Overall Study|Withdrawal by Subject|1
2062583|NCT00567879|3637389|FG004|Overall Study|Withdrawal by Subject|0
2062584|NCT00567879|3637390|FG005|Overall Study|Withdrawal by Subject|0
2062585|NCT00567879|3637385|FG000|Overall Study|New cancer therapy|0
2062586|NCT00567879|3637386|FG001|Overall Study|New cancer therapy|0
2062587|NCT00567879|3637387|FG002|Overall Study|New cancer therapy|1
2062588|NCT00567879|3637388|FG003|Overall Study|New cancer therapy|0
2062589|NCT00567879|3637389|FG004|Overall Study|New cancer therapy|0
2062590|NCT00567879|3637390|FG005|Overall Study|New cancer therapy|0
2062591|NCT00567879|3637385|FG000|Overall Study|Disease progression|5
2062592|NCT00567879|3637386|FG001|Overall Study|Disease progression|7
2062593|NCT00567879|3637387|FG002|Overall Study|Disease progression|15
2062594|NCT00567879|3637388|FG003|Overall Study|Disease progression|5
2062595|NCT00567879|3637389|FG004|Overall Study|Disease progression|11
2062596|NCT00567879|3637390|FG005|Overall Study|Disease progression|3
2062597|NCT00567892|3637410|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
2062598|NCT00567892|3637411|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
2062599|NCT00567892|3637412|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
2062600|NCT00567892|3637413|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
2062601|NCT00567892|3637410|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
2062602|NCT00567892|3637411|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
2062603|NCT00567892|3637412|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
2062604|NCT00567892|3637413|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
2062605|NCT00567996|3637428|FG000|Overall Study|Adverse Event|18
2062606|NCT00567996|3637429|FG001|Overall Study|Adverse Event|16
2062607|NCT00567996|3637430|FG002|Overall Study|Adverse Event|13
2062608|NCT00567996|3637428|FG000|Overall Study|Protocol Deviation|9
2062609|NCT00567996|3637429|FG001|Overall Study|Protocol Deviation|11
2062610|NCT00567996|3637430|FG002|Overall Study|Protocol Deviation|13
2062611|NCT00567996|3637428|FG000|Overall Study|Withdrawal by Subject|8
2062612|NCT00567996|3637429|FG001|Overall Study|Withdrawal by Subject|12
2062613|NCT00567996|3637430|FG002|Overall Study|Withdrawal by Subject|22
2062614|NCT00567996|3637428|FG000|Overall Study|Abnormal Lab value(s)|2
2062615|NCT00567996|3637429|FG001|Overall Study|Abnormal Lab value(s)|1
2062616|NCT00567996|3637430|FG002|Overall Study|Abnormal Lab value(s)|2
2062617|NCT00567996|3637428|FG000|Overall Study|Abnormal test procedure result(s)|2
2062618|NCT00567996|3637429|FG001|Overall Study|Abnormal test procedure result(s)|1
2062619|NCT00567996|3637430|FG002|Overall Study|Abnormal test procedure result(s)|1
2062620|NCT00567996|3637428|FG000|Overall Study|Lost to Follow-up|2
2062621|NCT00567996|3637429|FG001|Overall Study|Lost to Follow-up|5
2062622|NCT00567996|3637430|FG002|Overall Study|Lost to Follow-up|2
2062623|NCT00567996|3637428|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2062624|NCT00567996|3637429|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2062625|NCT00567996|3637430|FG002|Overall Study|Unsatisfactory therapeutic effect|15
2062626|NCT00567996|3637428|FG000|Overall Study|Administrative problems|1
2062627|NCT00567996|3637429|FG001|Overall Study|Administrative problems|1
2062628|NCT00567996|3637430|FG002|Overall Study|Administrative problems|0
2062629|NCT00567996|3637428|FG000|Overall Study|Death|1
2062630|NCT00567996|3637429|FG001|Overall Study|Death|0
2062631|NCT00567996|3637430|FG002|Overall Study|Death|2
2062632|NCT00567996|3637428|FG000|Overall Study|Patient's inability to use the device|0
2062633|NCT00567996|3637429|FG001|Overall Study|Patient's inability to use the device|1
2062634|NCT00567996|3637430|FG002|Overall Study|Patient's inability to use the device|0
2062635|NCT00568061|3637454|FG000|Overall Study|Inclusion / exclusion criteria|5
2062636|NCT00568061|3637455|FG001|Overall Study|Inclusion / exclusion criteria|1
2062637|NCT00568061|3637454|FG000|Overall Study|Adverse Event|0
2062638|NCT00568061|3637455|FG001|Overall Study|Adverse Event|1
2062639|NCT00568126|3637473|FG000|Overall Study|Adverse Event|3
2062640|NCT00568126|3637474|FG001|Overall Study|Adverse Event|0
2062641|NCT00568126|3637473|FG000|Overall Study|Withdrawal by Subject|2
2062642|NCT00568126|3637474|FG001|Overall Study|Withdrawal by Subject|3
2062643|NCT00568126|3637473|FG000|Overall Study|Lost to Follow-up|4
2062644|NCT00568126|3637474|FG001|Overall Study|Lost to Follow-up|3
2062645|NCT00568126|3637473|FG000|Overall Study|Lack of Efficacy|0
2062646|NCT00568126|3637474|FG001|Overall Study|Lack of Efficacy|1
2062647|NCT00568126|3637473|FG000|Overall Study|Physician Decision|2
2062648|NCT00568126|3637474|FG001|Overall Study|Physician Decision|2
2062649|NCT00568321|3637483|FG000|Overall Study|Adverse Event|1
2062650|NCT00568321|3637484|FG001|Overall Study|Adverse Event|0
2062651|NCT00568321|3637485|FG002|Overall Study|Adverse Event|0
2062652|NCT00568321|3637483|FG000|Overall Study|Lack of Efficacy|8
2062653|NCT00568321|3637484|FG001|Overall Study|Lack of Efficacy|5
2062654|NCT00568321|3637485|FG002|Overall Study|Lack of Efficacy|6
2062655|NCT00568321|3637483|FG000|Overall Study|Lost to Follow-up|0
2062656|NCT00568321|3637484|FG001|Overall Study|Lost to Follow-up|0
2062657|NCT00568321|3637485|FG002|Overall Study|Lost to Follow-up|1
2062658|NCT00568321|3637483|FG000|Overall Study|Withdrawal by Subject|2
2062659|NCT00568321|3637484|FG001|Overall Study|Withdrawal by Subject|0
2062660|NCT00568321|3637485|FG002|Overall Study|Withdrawal by Subject|0
2062661|NCT00568321|3637483|FG000|Overall Study|Protocol Violation|0
2062662|NCT00568321|3637484|FG001|Overall Study|Protocol Violation|0
2062663|NCT00568321|3637485|FG002|Overall Study|Protocol Violation|1
2062664|NCT00568321|3637483|FG000|Overall Study|Randomized, not treated|2
2062665|NCT00568321|3637484|FG001|Overall Study|Randomized, not treated|0
2062666|NCT00568321|3637485|FG002|Overall Study|Randomized, not treated|1
2062667|NCT00568334|3637497|FG000|Overall Study|Withdrawal by Subject|0
2062668|NCT00568334|3637498|FG001|Overall Study|Withdrawal by Subject|1
2062669|NCT00568334|3637497|FG000|Overall Study|Lost to Follow-up|1
2062670|NCT00568334|3637498|FG001|Overall Study|Lost to Follow-up|0
2062671|NCT00568399|3637513|FG000|Overall Study|Death|2
2062672|NCT00568399|3637513|FG000|Overall Study|Adverse Event|5
2062673|NCT00568399|3637513|FG000|Overall Study|Withdrawal by Subject|8
2062674|NCT00568451|3637521|FG000|Overall Study|Disease Progression|0
2062675|NCT00568451|3637522|FG001|Overall Study|Disease Progression|0
2062676|NCT00568451|3637523|FG002|Overall Study|Disease Progression|2
2062677|NCT00568451|3637524|FG003|Overall Study|Disease Progression|7
2062678|NCT00568555|3637537|FG000|Overall Study|Withdrawal by Subject|1
2062679|NCT00568555|3637538|FG001|Overall Study|Withdrawal by Subject|1
2302498|NCT02628444|4001375|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
2302499|NCT02628444|4001376|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
2302500|NCT02628444|4001377|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
2302501|NCT02628444|4001369|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
2302502|NCT02628444|4001370|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3
2302503|NCT02628444|4001371|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
2302504|NCT02628444|4001372|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
2302505|NCT02628444|4001373|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
2302506|NCT02628444|4001374|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
2302507|NCT02628444|4001375|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
2302508|NCT02628444|4001376|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
2302509|NCT02628444|4001377|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
2302510|NCT02628444|4001369|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
2302511|NCT02628444|4001370|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
2062680|NCT00568685|3637558|FG000|Overall Study|Adverse Event|2
2062681|NCT00568685|3637559|FG001|Overall Study|Adverse Event|3
2062682|NCT00568685|3637560|FG002|Overall Study|Adverse Event|3
2062683|NCT00568685|3637558|FG000|Overall Study|Withdrawal by Subject|7
2062684|NCT00568685|3637559|FG001|Overall Study|Withdrawal by Subject|2
2062685|NCT00568685|3637560|FG002|Overall Study|Withdrawal by Subject|2
2062686|NCT00568685|3637558|FG000|Overall Study|Protocol Violation|1
2062687|NCT00568685|3637559|FG001|Overall Study|Protocol Violation|0
2062688|NCT00568685|3637560|FG002|Overall Study|Protocol Violation|0
2105889|NCT00861757|3698876|FG002|Overall Study|Adverse Event|7
2105890|NCT00861757|3698877|FG003|Overall Study|Adverse Event|2
2062689|NCT00568776|3637576|FG000|Overall Study|Adverse Event|8
2062690|NCT00568776|3637577|FG001|Overall Study|Adverse Event|8
2062691|NCT00568776|3637578|FG002|Overall Study|Adverse Event|10
2062692|NCT00568776|3637579|FG003|Overall Study|Adverse Event|8
2062693|NCT00568776|3637576|FG000|Overall Study|Death|0
2062694|NCT00568776|3637577|FG001|Overall Study|Death|1
2062695|NCT00568776|3637578|FG002|Overall Study|Death|4
2062696|NCT00568776|3637579|FG003|Overall Study|Death|3
2062697|NCT00568776|3637576|FG000|Overall Study|Physician Decision|0
2062698|NCT00568776|3637577|FG001|Overall Study|Physician Decision|2
2062699|NCT00568776|3637578|FG002|Overall Study|Physician Decision|0
2062700|NCT00568776|3637579|FG003|Overall Study|Physician Decision|0
2062701|NCT00568776|3637576|FG000|Overall Study|Lack of Efficacy|2
2062702|NCT00568776|3637577|FG001|Overall Study|Lack of Efficacy|2
2062703|NCT00568776|3637578|FG002|Overall Study|Lack of Efficacy|2
2062704|NCT00568776|3637579|FG003|Overall Study|Lack of Efficacy|4
2062705|NCT00568776|3637576|FG000|Overall Study|Lost to Follow-up|1
2062706|NCT00568776|3637577|FG001|Overall Study|Lost to Follow-up|1
2062707|NCT00568776|3637578|FG002|Overall Study|Lost to Follow-up|1
2062708|NCT00568776|3637579|FG003|Overall Study|Lost to Follow-up|1
2062709|NCT00568776|3637576|FG000|Overall Study|Protocol Violation|1
2062710|NCT00568776|3637577|FG001|Overall Study|Protocol Violation|0
2062711|NCT00568776|3637578|FG002|Overall Study|Protocol Violation|1
2062712|NCT00568776|3637579|FG003|Overall Study|Protocol Violation|1
2062713|NCT00568776|3637576|FG000|Overall Study|Withdrawal by Subject|13
2062714|NCT00568776|3637577|FG001|Overall Study|Withdrawal by Subject|15
2062715|NCT00568776|3637578|FG002|Overall Study|Withdrawal by Subject|13
2062716|NCT00568776|3637579|FG003|Overall Study|Withdrawal by Subject|7
2062717|NCT00568776|3637576|FG000|Overall Study|Loss of Caregiver|0
2062718|NCT00568776|3637577|FG001|Overall Study|Loss of Caregiver|2
2062719|NCT00568776|3637578|FG002|Overall Study|Loss of Caregiver|1
2062720|NCT00568776|3637579|FG003|Overall Study|Loss of Caregiver|2
2062721|NCT00568776|3637576|FG000|Overall Study|Sponsor Decision|2
2062722|NCT00568776|3637577|FG001|Overall Study|Sponsor Decision|2
2062723|NCT00568776|3637578|FG002|Overall Study|Sponsor Decision|41
2062724|NCT00568776|3637579|FG003|Overall Study|Sponsor Decision|42
2062725|NCT00568776|3637576|FG000|Overall Study|Miscellaeneous|3
2062726|NCT00568776|3637577|FG001|Overall Study|Miscellaeneous|3
2062727|NCT00568776|3637578|FG002|Overall Study|Miscellaeneous|1
2062728|NCT00568776|3637579|FG003|Overall Study|Miscellaeneous|4
2062729|NCT00568958|3637600|FG000|Allocation|Withdrawal by Subject|7
2062730|NCT00568958|3637601|FG001|Allocation|Withdrawal by Subject|3
2062731|NCT00568958|3637600|FG000|Allocation|Physician Decision|2
2062732|NCT00568958|3637601|FG001|Allocation|Physician Decision|0
2062733|NCT00568958|3637600|FG000|Follow-Up|Withdrawal by Subject|6
2062734|NCT00568958|3637601|FG001|Follow-Up|Withdrawal by Subject|6
2062735|NCT00568958|3637600|FG000|Follow-Up|Physician Decision|1
2062736|NCT00568958|3637601|FG001|Follow-Up|Physician Decision|1
2062737|NCT00568958|3637600|FG000|Follow-Up|Family Emergency|1
2062738|NCT00568958|3637601|FG001|Follow-Up|Family Emergency|0
2062739|NCT00568958|3637600|FG000|Follow-Up|Adverse Event|1
2062740|NCT00568958|3637601|FG001|Follow-Up|Adverse Event|0
2062741|NCT00569127|3637626|FG000|Overall Study|Adverse Event|57
2062742|NCT00569127|3637627|FG001|Overall Study|Adverse Event|47
2062743|NCT00569127|3637626|FG000|Overall Study|Withdrawal by Subject|13
2062744|NCT00569127|3637627|FG001|Overall Study|Withdrawal by Subject|27
2062745|NCT00569127|3637626|FG000|Overall Study|Progression|99
2062746|NCT00569127|3637627|FG001|Overall Study|Progression|100
2062747|NCT00569127|3637626|FG000|Overall Study|Death|4
2062748|NCT00569127|3637627|FG001|Overall Study|Death|3
2062749|NCT00569127|3637626|FG000|Overall Study|Other|20
2062750|NCT00569127|3637627|FG001|Overall Study|Other|19
2062751|NCT00569127|3637626|FG000|Overall Study|Lost to Follow-up|0
2062752|NCT00569127|3637627|FG001|Overall Study|Lost to Follow-up|3
2062753|NCT00569127|3637626|FG000|Overall Study|Not Eligible|14
2062754|NCT00569127|3637627|FG001|Overall Study|Not Eligible|11
2062755|NCT00569127|3637626|FG000|Overall Study|Still on Treatment|7
2062756|NCT00569127|3637627|FG001|Overall Study|Still on Treatment|3
2062757|NCT00569166|3637636|FG000|Overall Study|Withdrawal by Subject|7
2062758|NCT00569166|3637637|FG001|Overall Study|Withdrawal by Subject|5
2062759|NCT00569166|3637638|FG002|Overall Study|Withdrawal by Subject|3
2062760|NCT00569166|3637636|FG000|Overall Study|Lost to Follow-up|2
2062761|NCT00569166|3637637|FG001|Overall Study|Lost to Follow-up|1
2062762|NCT00569166|3637638|FG002|Overall Study|Lost to Follow-up|1
2062763|NCT00569231|3637659|FG000|Overall Study|Study unrelated surgery|1
2062764|NCT00569231|3637659|FG000|Overall Study|Airfare expense|2
2062765|NCT00569231|3637659|FG000|Overall Study|Withdrawal by Subject|1
2062766|NCT00569231|3637659|FG000|Overall Study|Car accident injury|1
2062767|NCT00569231|3637659|FG000|Overall Study|Non-compliance|2
2062768|NCT00569270|3637663|FG000|Period: First Intervention|Protocol Violation|0
2062769|NCT00569270|3637664|FG001|Period: First Intervention|Protocol Violation|1
2062770|NCT00569374|3637683|FG000|Overall Study|Withdrawal by Subject|4
2062771|NCT00569582|3637696|FG000|Overall Study|Withdrawal by Subject|5
2062772|NCT00569582|3637696|FG000|Overall Study|Death|2
2062773|NCT00569582|3637696|FG000|Overall Study|Adverse Event|7
2062774|NCT00569582|3637696|FG000|Overall Study|Subject was too ill to travel.|1
2062775|NCT00569582|3637696|FG000|Overall Study|Subject was non-compliant.|1
2062776|NCT00569777|3637710|FG000|Overall Study|Withdrawal by Subject|4
2062777|NCT00569777|3637711|FG001|Overall Study|Withdrawal by Subject|0
2062778|NCT00569777|3637710|FG000|Overall Study|Adverse Event|3
2062779|NCT00569777|3637711|FG001|Overall Study|Adverse Event|0
2062780|NCT00569777|3637710|FG000|Overall Study|Lost to Follow-up|1
2062781|NCT00569777|3637711|FG001|Overall Study|Lost to Follow-up|0
2062782|NCT00569777|3637710|FG000|Overall Study|scheduled eye surgery|0
2062783|NCT00569777|3637711|FG001|Overall Study|scheduled eye surgery|1
2062784|NCT00569777|3637710|FG000|Overall Study|did not meet exclusion criteria|1
2062785|NCT00569777|3637711|FG001|Overall Study|did not meet exclusion criteria|2
2062786|NCT00569777|3637710|FG000|Overall Study|pregnant|1
2062787|NCT00569777|3637711|FG001|Overall Study|pregnant|0
2062788|NCT00569803|3637725|FG000|Overall Study|Lost to Follow-up|1
2062789|NCT00569803|3637726|FG001|Overall Study|Lost to Follow-up|0
2062790|NCT00569803|3637727|FG002|Overall Study|Lost to Follow-up|0
2062791|NCT00569803|3637728|FG003|Overall Study|Lost to Follow-up|0
2062792|NCT00569803|3637729|FG004|Overall Study|Lost to Follow-up|0
2062793|NCT00569803|3637730|FG005|Overall Study|Lost to Follow-up|0
2062794|NCT00569803|3637731|FG006|Overall Study|Lost to Follow-up|0
2062795|NCT00569803|3637732|FG007|Overall Study|Lost to Follow-up|0
2062796|NCT00569803|3637725|FG000|Overall Study|injection syringe leaked during dosing|0
2062797|NCT00569803|3637726|FG001|Overall Study|injection syringe leaked during dosing|0
2062798|NCT00569803|3637727|FG002|Overall Study|injection syringe leaked during dosing|0
2062799|NCT00569803|3637728|FG003|Overall Study|injection syringe leaked during dosing|1
2062800|NCT00569803|3637729|FG004|Overall Study|injection syringe leaked during dosing|0
2062801|NCT00569803|3637730|FG005|Overall Study|injection syringe leaked during dosing|0
2062802|NCT00569803|3637731|FG006|Overall Study|injection syringe leaked during dosing|0
2062803|NCT00569803|3637732|FG007|Overall Study|injection syringe leaked during dosing|0
2062804|NCT00569803|3637725|FG000|Overall Study|Withdrawal by Subject|0
2062805|NCT00569803|3637726|FG001|Overall Study|Withdrawal by Subject|0
2062806|NCT00569803|3637727|FG002|Overall Study|Withdrawal by Subject|0
2062807|NCT00569803|3637728|FG003|Overall Study|Withdrawal by Subject|0
2062808|NCT00569803|3637729|FG004|Overall Study|Withdrawal by Subject|0
2062809|NCT00569803|3637730|FG005|Overall Study|Withdrawal by Subject|0
2062810|NCT00569803|3637731|FG006|Overall Study|Withdrawal by Subject|0
2062811|NCT00569803|3637732|FG007|Overall Study|Withdrawal by Subject|1
2062812|NCT00569946|3637758|FG000|Overall Study|Adverse Event|16
2062813|NCT00569946|3637758|FG000|Overall Study|Objective Progression or Relapse|42
2062814|NCT00569946|3637758|FG000|Overall Study|Global Deterioration of Health Status|1
2062815|NCT00570037|3637764|FG000|Overall Study|Could not reach for 6-8 week contact|44
2062816|NCT00570037|3637765|FG001|Overall Study|Could not reach for 6-8 week contact|69
2062817|NCT00570063|3637773|FG000|Overall Study|Adverse Event|4
2062818|NCT00570063|3637774|FG001|Overall Study|Adverse Event|1
2062819|NCT00570063|3637773|FG000|Overall Study|Lack of Efficacy|0
2062820|NCT00570063|3637774|FG001|Overall Study|Lack of Efficacy|1
2062821|NCT00570063|3637773|FG000|Overall Study|Withdrawal by Subject|4
2062822|NCT00570063|3637774|FG001|Overall Study|Withdrawal by Subject|3
2062823|NCT00570063|3637773|FG000|Overall Study|Sponsor's Decision|7
2062824|NCT00570063|3637774|FG001|Overall Study|Sponsor's Decision|3
2062825|NCT00570128|3637791|FG000|Overall Study|Adverse Event|1
2062826|NCT00570128|3637792|FG001|Overall Study|Adverse Event|0
2062827|NCT00570128|3637791|FG000|Overall Study|Lost to Follow-up|1
2062828|NCT00570128|3637792|FG001|Overall Study|Lost to Follow-up|0
2062829|NCT00570128|3637791|FG000|Overall Study|Withdrawal by Subject|2
2062830|NCT00570128|3637792|FG001|Overall Study|Withdrawal by Subject|0
2062831|NCT00570141|3637798|FG000|Overall Study|Adverse Event|1
2062832|NCT00570141|3637798|FG000|Overall Study|Missed visits|1
2062833|NCT00570141|3637798|FG000|Overall Study|Lost to Follow-up|1
2062834|NCT00570232|3637802|FG000|Overall Study|Adverse Event|10
2062835|NCT00570232|3637802|FG000|Overall Study|discontinued due to medical condition|3
2062836|NCT00570232|3637802|FG000|Overall Study|discontinued due to recurrence|8
2062837|NCT00570232|3637802|FG000|Overall Study|discontinued due to noncompliance|2
2062838|NCT00570310|3637808|FG000|Overall Study|Adverse Event|1
2062839|NCT00570310|3637809|FG001|Overall Study|Adverse Event|2
2062840|NCT00570310|3637808|FG000|Overall Study|Lack of Efficacy|1
2062841|NCT00570310|3637809|FG001|Overall Study|Lack of Efficacy|4
2062842|NCT00570323|3637817|FG000|Started Treatment After Randomization|Withdrawal by Subject|0
2062843|NCT00570323|3637818|FG001|Started Treatment After Randomization|Withdrawal by Subject|1
2062844|NCT00570323|3637817|FG000|Started Treatment After Randomization|Protocol Violation|1
2062845|NCT00570323|3637818|FG001|Started Treatment After Randomization|Protocol Violation|0
2062846|NCT00570323|3637817|FG000|Started Treatment After Randomization|Physician Decision|1
2062847|NCT00570323|3637818|FG001|Started Treatment After Randomization|Physician Decision|0
2062848|NCT00570323|3637817|FG000|Complete Study After Start|Lost to Follow-up|0
2062849|NCT00570323|3637818|FG001|Complete Study After Start|Lost to Follow-up|1
2062850|NCT00570323|3637817|FG000|Complete Study After Start|Withdrawal by Subject|2
2062851|NCT00570323|3637818|FG001|Complete Study After Start|Withdrawal by Subject|0
2062852|NCT00570323|3637817|FG000|Complete Study After Start|Physician Decision|1
2062853|NCT00570323|3637818|FG001|Complete Study After Start|Physician Decision|0
2105891|NCT00861757|3698874|FG000|Overall Study|Entry Criteria Not Met|1
2105892|NCT00861757|3698875|FG001|Overall Study|Entry Criteria Not Met|2
2105893|NCT00861757|3698876|FG002|Overall Study|Entry Criteria Not Met|1
2062854|NCT00570401|3637848|FG000|Overall Study|Adverse Event|2
2062855|NCT00570492|3637854|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
2062856|NCT00570492|3637855|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
2062857|NCT00570492|3637856|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
2062858|NCT00570492|3637854|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
2062859|NCT00570492|3637855|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
2062860|NCT00570492|3637856|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
2062861|NCT00570492|3637854|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56
2062862|NCT00570492|3637855|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0
2062863|NCT00570492|3637856|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0
2062864|NCT00570492|3637854|FG000|16-week Single-blind Baseline Period|Protocol Violation|15
2062865|NCT00570492|3637855|FG001|16-week Single-blind Baseline Period|Protocol Violation|0
2062866|NCT00570492|3637856|FG002|16-week Single-blind Baseline Period|Protocol Violation|0
2062867|NCT00570492|3637854|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2
2062868|NCT00570492|3637855|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0
2062869|NCT00570492|3637856|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0
2062870|NCT00570492|3637854|FG000|16-week Single-blind Baseline Period|Adverse Event|1
2062871|NCT00570492|3637855|FG001|16-week Single-blind Baseline Period|Adverse Event|0
2062872|NCT00570492|3637856|FG002|16-week Single-blind Baseline Period|Adverse Event|0
2062873|NCT00570492|3637854|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
2062874|NCT00570492|3637855|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
2062875|NCT00570492|3637856|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
2062876|NCT00570492|3637854|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
2062877|NCT00570492|3637855|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20
2062878|NCT00570492|3637856|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20
2062879|NCT00570492|3637854|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
2062880|NCT00570492|3637855|FG001|52-week Double-blind Treatment Period|Protocol Violation|12
2062881|NCT00570492|3637856|FG002|52-week Double-blind Treatment Period|Protocol Violation|15
2062882|NCT00570492|3637854|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
2062883|NCT00570492|3637855|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5
2062884|NCT00570492|3637856|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7
2062885|NCT00570492|3637854|FG000|52-week Double-blind Treatment Period|Adverse Event|0
2062886|NCT00570492|3637855|FG001|52-week Double-blind Treatment Period|Adverse Event|5
2062887|NCT00570492|3637856|FG002|52-week Double-blind Treatment Period|Adverse Event|5
2062888|NCT00570492|3637854|FG000|52-week Double-blind Treatment Period|Physician Decision|0
2062889|NCT00570492|3637855|FG001|52-week Double-blind Treatment Period|Physician Decision|2
2062890|NCT00570492|3637856|FG002|52-week Double-blind Treatment Period|Physician Decision|4
2062891|NCT00570492|3637854|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
2062892|NCT00570492|3637855|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3
2062893|NCT00570492|3637856|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0
2062894|NCT00570492|3637854|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
2062895|NCT00570492|3637855|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
2062896|NCT00570492|3637856|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
2062897|NCT00570505|3637862|FG000|Overall Study|Adverse Event|7
2062898|NCT00570505|3637862|FG000|Overall Study|Withdrawal by Subject|7
2062899|NCT00570505|3637862|FG000|Overall Study|Lost to Follow-up|23
2062900|NCT00570505|3637862|FG000|Overall Study|Other loss to follow-up|4
2062901|NCT00570661|3637866|FG000|Overall Study|Disease worsening|5
2062902|NCT00570661|3637866|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1
2062903|NCT00570661|3637866|FG000|Overall Study|Adverse Event|1
2062904|NCT00570674|3637871|FG000|Overall Study|Withdrawal by Subject|0
2062905|NCT00570674|3637872|FG001|Overall Study|Withdrawal by Subject|0
2062906|NCT00570674|3637873|FG002|Overall Study|Withdrawal by Subject|1
2062907|NCT00570674|3637874|FG003|Overall Study|Withdrawal by Subject|0
2062908|NCT00570674|3637875|FG004|Overall Study|Withdrawal by Subject|0
2062909|NCT00570674|3637876|FG005|Overall Study|Withdrawal by Subject|0
2062910|NCT00570674|3637877|FG006|Overall Study|Withdrawal by Subject|0
2062911|NCT00570687|3637890|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062912|NCT00570687|3637891|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062913|NCT00570687|3637892|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062914|NCT00570687|3637893|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062915|NCT00570687|3637894|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
2062916|NCT00570687|3637895|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
2062917|NCT00570687|3637896|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
2062918|NCT00570687|3637897|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
2062919|NCT00570687|3637898|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
2062920|NCT00570687|3637899|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
2062921|NCT00570687|3637890|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062922|NCT00570687|3637891|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062923|NCT00570687|3637892|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062924|NCT00570687|3637893|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062925|NCT00570687|3637894|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062926|NCT00570687|3637895|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062927|NCT00570687|3637896|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062928|NCT00570687|3637897|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062929|NCT00570687|3637898|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
2062930|NCT00570687|3637899|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062931|NCT00570687|3637890|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062932|NCT00570687|3637891|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062933|NCT00570687|3637892|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062934|NCT00570687|3637893|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062935|NCT00570687|3637894|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062936|NCT00570687|3637895|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062937|NCT00570687|3637896|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
2062938|NCT00570687|3637897|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062939|NCT00570687|3637898|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062940|NCT00570687|3637899|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2062941|NCT00570713|3637919|FG000|Overall Study|Adverse Event|16
2062942|NCT00570713|3637920|FG001|Overall Study|Adverse Event|9
2062943|NCT00570713|3637919|FG000|Overall Study|Death|7
2062944|NCT00570713|3637920|FG001|Overall Study|Death|7
2062945|NCT00570713|3637919|FG000|Overall Study|Lack of Efficacy|40
2062946|NCT00570713|3637920|FG001|Overall Study|Lack of Efficacy|49
2062947|NCT00570713|3637919|FG000|Overall Study|Physician Decision|2
2062948|NCT00570713|3637920|FG001|Overall Study|Physician Decision|2
2062949|NCT00570713|3637919|FG000|Overall Study|Withdrawal by Subject|3
2062950|NCT00570713|3637920|FG001|Overall Study|Withdrawal by Subject|3
2062951|NCT00570713|3637919|FG000|Overall Study|Discontinuation of Study by the Sponsor|10
2062952|NCT00570713|3637920|FG001|Overall Study|Discontinuation of Study by the Sponsor|7
2062953|NCT00570739|3637930|FG000|Overall Study|Adverse Event|8
2062954|NCT00570739|3637931|FG001|Overall Study|Adverse Event|6
2062955|NCT00570739|3637932|FG002|Overall Study|Adverse Event|2
2062956|NCT00570739|3637933|FG003|Overall Study|Adverse Event|2
2062957|NCT00570739|3637930|FG000|Overall Study|Lost to Follow-up|4
2062958|NCT00570739|3637931|FG001|Overall Study|Lost to Follow-up|5
2062959|NCT00570739|3637932|FG002|Overall Study|Lost to Follow-up|4
2062960|NCT00570739|3637933|FG003|Overall Study|Lost to Follow-up|1
2062961|NCT00570739|3637930|FG000|Overall Study|Physician Decision|1
2062962|NCT00570739|3637931|FG001|Overall Study|Physician Decision|1
2062963|NCT00570739|3637932|FG002|Overall Study|Physician Decision|0
2062964|NCT00570739|3637933|FG003|Overall Study|Physician Decision|0
2062965|NCT00570739|3637930|FG000|Overall Study|Withdrawal by Subject|7
2062966|NCT00570739|3637931|FG001|Overall Study|Withdrawal by Subject|7
2062967|NCT00570739|3637932|FG002|Overall Study|Withdrawal by Subject|3
2062968|NCT00570739|3637933|FG003|Overall Study|Withdrawal by Subject|5
2062969|NCT00570739|3637930|FG000|Overall Study|Required restricted medication|0
2062970|NCT00570739|3637931|FG001|Overall Study|Required restricted medication|0
2062971|NCT00570739|3637932|FG002|Overall Study|Required restricted medication|1
2062972|NCT00570739|3637933|FG003|Overall Study|Required restricted medication|0
2062973|NCT00570739|3637930|FG000|Overall Study|Met discontinuation criteria|1
2062974|NCT00570739|3637931|FG001|Overall Study|Met discontinuation criteria|0
2062975|NCT00570739|3637932|FG002|Overall Study|Met discontinuation criteria|1
2062976|NCT00570739|3637933|FG003|Overall Study|Met discontinuation criteria|1
2062977|NCT00570739|3637930|FG000|Overall Study|Other|0
2062978|NCT00570739|3637931|FG001|Overall Study|Other|2
2062979|NCT00570739|3637932|FG002|Overall Study|Other|5
2062980|NCT00570739|3637933|FG003|Overall Study|Other|3
2062981|NCT00570765|3637966|FG000|DB Phase|Withdrawal by Subject|1
2062982|NCT00570765|3637967|FG001|DB Phase|Withdrawal by Subject|0
2062983|NCT00570765|3637968|FG002|DB Phase|Withdrawal by Subject|0
2062984|NCT00570765|3637969|FG003|DB Phase|Withdrawal by Subject|0
2062985|NCT00570765|3637966|FG000|DB Phase|Protocol Violation|0
2062986|NCT00570765|3637967|FG001|DB Phase|Protocol Violation|1
2062987|NCT00570765|3637968|FG002|DB Phase|Protocol Violation|0
2062988|NCT00570765|3637969|FG003|DB Phase|Protocol Violation|0
2062989|NCT00570765|3637966|FG000|DB Phase|Adverse Event|3
2062990|NCT00570765|3637967|FG001|DB Phase|Adverse Event|6
2062991|NCT00570765|3637968|FG002|DB Phase|Adverse Event|0
2062992|NCT00570765|3637969|FG003|DB Phase|Adverse Event|0
2062993|NCT00570765|3637966|FG000|DB Phase|Did Not Receive Study Drug|0
2062994|NCT00570765|3637967|FG001|DB Phase|Did Not Receive Study Drug|0
2062995|NCT00570765|3637968|FG002|DB Phase|Did Not Receive Study Drug|1
2062996|NCT00570765|3637969|FG003|DB Phase|Did Not Receive Study Drug|0
2062997|NCT00570765|3637966|FG000|LTSE Phase|Withdrawal by Subject|0
2062998|NCT00570765|3637967|FG001|LTSE Phase|Withdrawal by Subject|0
2062999|NCT00570765|3637968|FG002|LTSE Phase|Withdrawal by Subject|0
2063000|NCT00570765|3637969|FG003|LTSE Phase|Withdrawal by Subject|1
2063001|NCT00570765|3637966|FG000|LTSE Phase|Adverse Event|0
2063002|NCT00570765|3637967|FG001|LTSE Phase|Adverse Event|0
2063003|NCT00570765|3637968|FG002|LTSE Phase|Adverse Event|0
2063004|NCT00570765|3637969|FG003|LTSE Phase|Adverse Event|7
2063005|NCT00570765|3637966|FG000|LTSE Phase|Physician Decision|0
2063006|NCT00570765|3637967|FG001|LTSE Phase|Physician Decision|0
2063007|NCT00570765|3637968|FG002|LTSE Phase|Physician Decision|0
2063008|NCT00570765|3637969|FG003|LTSE Phase|Physician Decision|4
2063009|NCT00570778|3637980|FG000|Overall Study|Protocol deviation|2
2063010|NCT00570778|3637981|FG001|Overall Study|Protocol deviation|1
2063011|NCT00570778|3637982|FG002|Overall Study|Protocol deviation|2
2063012|NCT00570778|3637983|FG003|Overall Study|Protocol deviation|2
2063013|NCT00570778|3637980|FG000|Overall Study|Adverse Event|0
2063014|NCT00570778|3637981|FG001|Overall Study|Adverse Event|1
2063015|NCT00570778|3637982|FG002|Overall Study|Adverse Event|4
2063016|NCT00570778|3637983|FG003|Overall Study|Adverse Event|1
2063017|NCT00570778|3637980|FG000|Overall Study|Subject withdrew consent|0
2063018|NCT00570778|3637981|FG001|Overall Study|Subject withdrew consent|1
2063019|NCT00570778|3637982|FG002|Overall Study|Subject withdrew consent|0
2063020|NCT00570778|3637983|FG003|Overall Study|Subject withdrew consent|1
2063021|NCT00570778|3637980|FG000|Overall Study|Abnormal test procedure|1
2063022|NCT00570778|3637981|FG001|Overall Study|Abnormal test procedure|0
2063023|NCT00570778|3637982|FG002|Overall Study|Abnormal test procedure|0
2063024|NCT00570778|3637983|FG003|Overall Study|Abnormal test procedure|0
2063025|NCT00570778|3637980|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2063026|NCT00570778|3637981|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2063027|NCT00570778|3637982|FG002|Overall Study|Unsatisfactory therapeutic effect|0
2063028|NCT00570778|3637983|FG003|Overall Study|Unsatisfactory therapeutic effect|0
2063029|NCT00570778|3637980|FG000|Overall Study|Lost to Follow-up|0
2063030|NCT00570778|3637981|FG001|Overall Study|Lost to Follow-up|0
2063031|NCT00570778|3637982|FG002|Overall Study|Lost to Follow-up|1
2063032|NCT00570778|3637983|FG003|Overall Study|Lost to Follow-up|0
2063033|NCT00570778|3637980|FG000|Overall Study|Subject no longer requires study drug|0
2063034|NCT00570778|3637981|FG001|Overall Study|Subject no longer requires study drug|1
2063035|NCT00570778|3637982|FG002|Overall Study|Subject no longer requires study drug|0
2063036|NCT00570778|3637983|FG003|Overall Study|Subject no longer requires study drug|0
2209984|NCT01647516|3849427|FG001|Maintenance Period (MP)|Withdrawal by Subject|1
2063037|NCT00570908|3637993|FG000|Overall Study|Adverse Event|5
2063038|NCT00570908|3637993|FG000|Overall Study|Withdrawal by Subject|2
2063039|NCT00570921|3637997|FG000|Overall Study|Protocol Violation|1
2063040|NCT00570921|3637997|FG000|Overall Study|Physician Decision|1
2063041|NCT00571038|3638012|FG000|Overall Study|Lost to Follow-up|1
2063042|NCT00571038|3638013|FG001|Overall Study|Lost to Follow-up|4
2063043|NCT00571038|3638012|FG000|Overall Study|Death|7
2063044|NCT00571038|3638013|FG001|Overall Study|Death|5
2063045|NCT00571038|3638012|FG000|Overall Study|Withdrawal by Subject|1
2063046|NCT00571038|3638013|FG001|Overall Study|Withdrawal by Subject|3
2063047|NCT00571038|3638012|FG000|Overall Study|Moved out of state|2
2063048|NCT00571038|3638013|FG001|Overall Study|Moved out of state|2
2063049|NCT00571064|3638019|FG000|Overall Study|Adverse Event|13
2063050|NCT00571064|3638019|FG000|Overall Study|Protocol Violation|4
2063051|NCT00571064|3638019|FG000|Overall Study|Withdrawal by Subject|2
2063052|NCT00571064|3638019|FG000|Overall Study|Other|2
2063053|NCT00571103|3638024|FG000|Overall Study|Withdrawal by Subject|1
2063054|NCT00571103|3638024|FG000|Overall Study|Lost to Follow-up|1
2063055|NCT00571519|3638076|FG000|Overall Study|Subject withdrew consent|0
2063056|NCT00571519|3638077|FG001|Overall Study|Subject withdrew consent|1
2063057|NCT00571519|3638078|FG002|Overall Study|Subject withdrew consent|0
2063058|NCT00571519|3638079|FG003|Overall Study|Subject withdrew consent|2
2063059|NCT00571519|3638080|FG004|Overall Study|Subject withdrew consent|1
2063060|NCT00571519|3638081|FG005|Overall Study|Subject withdrew consent|1
2063061|NCT00571519|3638082|FG006|Overall Study|Subject withdrew consent|2
2063062|NCT00571519|3638076|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1
2063063|NCT00571519|3638077|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0
2063064|NCT00571519|3638078|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1
2063065|NCT00571519|3638079|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1
2063066|NCT00571519|3638080|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0
2063067|NCT00571519|3638081|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0
2063068|NCT00571519|3638082|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0
2063069|NCT00571519|3638076|FG000|Overall Study|Therapeutic failure/lack of efficacy|0
2063070|NCT00571519|3638077|FG001|Overall Study|Therapeutic failure/lack of efficacy|1
2063071|NCT00571519|3638078|FG002|Overall Study|Therapeutic failure/lack of efficacy|0
2063072|NCT00571519|3638079|FG003|Overall Study|Therapeutic failure/lack of efficacy|0
2063073|NCT00571519|3638080|FG004|Overall Study|Therapeutic failure/lack of efficacy|0
2063074|NCT00571519|3638081|FG005|Overall Study|Therapeutic failure/lack of efficacy|0
2063075|NCT00571519|3638082|FG006|Overall Study|Therapeutic failure/lack of efficacy|0
2063076|NCT00571519|3638076|FG000|Overall Study|Termination of study by Sponsor|2
2063077|NCT00571519|3638077|FG001|Overall Study|Termination of study by Sponsor|7
2063078|NCT00571519|3638078|FG002|Overall Study|Termination of study by Sponsor|10
2063079|NCT00571519|3638079|FG003|Overall Study|Termination of study by Sponsor|24
2063080|NCT00571519|3638080|FG004|Overall Study|Termination of study by Sponsor|8
2063081|NCT00571519|3638081|FG005|Overall Study|Termination of study by Sponsor|9
2063082|NCT00571519|3638082|FG006|Overall Study|Termination of study by Sponsor|22
2063083|NCT00571519|3638076|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
2063084|NCT00571519|3638077|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
2063085|NCT00571519|3638078|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1
2063086|NCT00571519|3638079|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
2063087|NCT00571519|3638080|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
2063088|NCT00571519|3638081|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
2063089|NCT00571519|3638082|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
2063090|NCT00571649|3638100|FG000|Treatment Period|Adverse Event|438
2063091|NCT00571649|3638101|FG001|Treatment Period|Adverse Event|385
2063092|NCT00571649|3638100|FG000|Treatment Period|Clinical endpoint reached|50
2063093|NCT00571649|3638101|FG001|Treatment Period|Clinical endpoint reached|56
2063094|NCT00571649|3638100|FG000|Treatment Period|Withdrawal by Subject|285
2063095|NCT00571649|3638101|FG001|Treatment Period|Withdrawal by Subject|255
2063096|NCT00571649|3638100|FG000|Treatment Period|Death|76
2063097|NCT00571649|3638101|FG001|Treatment Period|Death|59
2063098|NCT00571649|3638100|FG000|Treatment Period|Physician Decision|8
2302512|NCT02628444|4001371|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
2302513|NCT02628444|4001372|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1
2302514|NCT02628444|4001373|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
2302515|NCT02628444|4001374|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
2302516|NCT02628444|4001375|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
2302517|NCT02628444|4001376|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
2302518|NCT02628444|4001377|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
2302519|NCT02628444|4001369|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
2302520|NCT02628444|4001370|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
2302521|NCT02628444|4001371|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
2302522|NCT02628444|4001372|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
2302523|NCT02628444|4001373|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
2302524|NCT02628444|4001374|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
2302525|NCT02628444|4001375|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81
2302526|NCT02628444|4001376|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84
2302527|NCT02628444|4001377|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85
2302528|NCT02628444|4001369|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
2302529|NCT02628444|4001370|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
2302530|NCT02628444|4001371|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
2302531|NCT02628444|4001372|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5
2302532|NCT02628444|4001373|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6
2302533|NCT02628444|4001374|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10
2302534|NCT02628444|4001375|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12
2302535|NCT02628444|4001376|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11
2302536|NCT02628444|4001377|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9
2302537|NCT02628444|4001369|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
2302538|NCT02628444|4001370|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
2302539|NCT02628444|4001371|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
2302540|NCT02628444|4001372|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
2302541|NCT02628444|4001373|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
2302542|NCT02628444|4001374|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
2302543|NCT02628444|4001375|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
2302544|NCT02628444|4001376|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2
2302545|NCT02628444|4001377|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
2302546|NCT02628444|4001369|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
2302547|NCT02628444|4001370|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
2302548|NCT02628444|4001371|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
2302549|NCT02628444|4001372|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
2302550|NCT02628444|4001373|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
2302551|NCT02628444|4001374|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
2302552|NCT02628444|4001375|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3
2302553|NCT02628444|4001376|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
2302554|NCT02628444|4001377|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
2302555|NCT02628600|4001404|FG000|Overall Study|Death|2
2302556|NCT02628600|4001405|FG001|Overall Study|Death|1
2302557|NCT02628600|4001404|FG000|Overall Study|Adverse Event|3
2302558|NCT02628600|4001405|FG001|Overall Study|Adverse Event|20
2302559|NCT02628600|4001404|FG000|Overall Study|Protocol Violation|0
2302560|NCT02628600|4001405|FG001|Overall Study|Protocol Violation|1
2302561|NCT02628600|4001404|FG000|Overall Study|Lack of Efficacy|2
2302562|NCT02628600|4001405|FG001|Overall Study|Lack of Efficacy|0
2302563|NCT02628600|4001404|FG000|Overall Study|Withdrawal by Subject|13
2063099|NCT00571649|3638101|FG001|Treatment Period|Physician Decision|9
2063100|NCT00571649|3638100|FG000|Treatment Period|Lost to Follow-up|43
2063101|NCT00571649|3638101|FG001|Treatment Period|Lost to Follow-up|41
2063102|NCT00571649|3638100|FG000|Treatment Period|Non-compliant with study medication|88
2063103|NCT00571649|3638101|FG001|Treatment Period|Non-compliant with study medication|89
2063104|NCT00571649|3638100|FG000|Treatment Period|Patient convenience|11
2063105|NCT00571649|3638101|FG001|Treatment Period|Patient convenience|13
2063106|NCT00571649|3638100|FG000|Treatment Period|Protocol Violation|90
2063107|NCT00571649|3638101|FG001|Treatment Period|Protocol Violation|92
2063108|NCT00571649|3638100|FG000|Treatment Period|Technical problems|3
2063109|NCT00571649|3638101|FG001|Treatment Period|Technical problems|5
2063110|NCT00571649|3638100|FG000|Follow-up Period|Adverse Event|46
2063111|NCT00571649|3638101|FG001|Follow-up Period|Adverse Event|40
2063112|NCT00571649|3638100|FG000|Follow-up Period|Clinical endpoint reached|5
2063113|NCT00571649|3638101|FG001|Follow-up Period|Clinical endpoint reached|2
2063114|NCT00571649|3638100|FG000|Follow-up Period|Withdrawal by Subject|119
2063115|NCT00571649|3638101|FG001|Follow-up Period|Withdrawal by Subject|115
2063116|NCT00571649|3638100|FG000|Follow-up Period|Death|132
2063117|NCT00571649|3638101|FG001|Follow-up Period|Death|133
2063118|NCT00571649|3638100|FG000|Follow-up Period|Physician Decision|7
2063119|NCT00571649|3638101|FG001|Follow-up Period|Physician Decision|13
2063120|NCT00571649|3638100|FG000|Follow-up Period|Lost to Follow-up|95
2063121|NCT00571649|3638101|FG001|Follow-up Period|Lost to Follow-up|92
2063122|NCT00571649|3638100|FG000|Follow-up Period|Patient convenience|136
2063123|NCT00571649|3638101|FG001|Follow-up Period|Patient convenience|121
2063124|NCT00571649|3638100|FG000|Follow-up Period|Protocol Violation|5
2063125|NCT00571649|3638101|FG001|Follow-up Period|Protocol Violation|12
2063126|NCT00571662|3638107|FG000|Overall Study|Withdrawal by Subject|2
2063127|NCT00571662|3638107|FG000|Overall Study|psychiatric instability|1
2063128|NCT00571662|3638107|FG000|Overall Study|Adverse Event|5
2063129|NCT00571688|3638115|FG000|Overall Study|Lost to Follow-up|3
2063130|NCT00571688|3638116|FG001|Overall Study|Lost to Follow-up|6
2063131|NCT00571688|3638115|FG000|Overall Study|subject did not tolerate Consta|1
2063132|NCT00571688|3638116|FG001|Overall Study|subject did not tolerate Consta|0
2063133|NCT00571688|3638115|FG000|Overall Study|subject moved out of the area|1
2063134|NCT00571688|3638116|FG001|Overall Study|subject moved out of the area|0
2063135|NCT00571701|3638124|FG000|First Intervention 12 Months|Withdrawal by Subject|2
2063136|NCT00571701|3638125|FG001|First Intervention 12 Months|Withdrawal by Subject|1
2063137|NCT00571701|3638124|FG000|First Intervention 12 Months|Death|1
2063138|NCT00571701|3638125|FG001|First Intervention 12 Months|Death|0
2063139|NCT00571701|3638124|FG000|Second Intervention 12 Months|Adverse Event|0
2063140|NCT00571701|3638125|FG001|Second Intervention 12 Months|Adverse Event|1
2063141|NCT00571701|3638124|FG000|Second Intervention 12 Months|Withdrawal by Subject|3
2063142|NCT00571701|3638125|FG001|Second Intervention 12 Months|Withdrawal by Subject|0
2063143|NCT00571948|3638151|FG000|Overall Study|Lost to Follow-up|2
2063144|NCT00571948|3638152|FG001|Overall Study|Lost to Follow-up|0
2063145|NCT00571948|3638151|FG000|Overall Study|Withdrawal by Subject|1
2063146|NCT00571948|3638152|FG001|Overall Study|Withdrawal by Subject|2
2063147|NCT00571948|3638151|FG000|Overall Study|Protocol Violation|3
2063148|NCT00571948|3638152|FG001|Overall Study|Protocol Violation|3
2063149|NCT00571948|3638151|FG000|Overall Study|infant refused study meal|3
2063150|NCT00571948|3638152|FG001|Overall Study|infant refused study meal|4
2063151|NCT00571948|3638151|FG000|Overall Study|Parent were afraid of blood colection|2
2063152|NCT00571948|3638152|FG001|Overall Study|Parent were afraid of blood colection|5
2063153|NCT00572039|3638178|FG000|Overall Study|Withdrawal by Subject|9
2063154|NCT00572039|3638179|FG001|Overall Study|Withdrawal by Subject|6
2063155|NCT00572039|3638178|FG000|Overall Study|Death|2
2063156|NCT00572039|3638179|FG001|Overall Study|Death|3
2063157|NCT00572039|3638178|FG000|Overall Study|Ill|5
2063158|NCT00572039|3638179|FG001|Overall Study|Ill|1
2063159|NCT00572156|3638202|FG000|Overall Study|Adverse Event|3
2063160|NCT00572156|3638203|FG001|Overall Study|Adverse Event|1
2063161|NCT00572156|3638204|FG002|Overall Study|Adverse Event|5
2063162|NCT00572156|3638205|FG003|Overall Study|Adverse Event|1
2063163|NCT00572156|3638202|FG000|Overall Study|Lost to Follow-up|1
2063164|NCT00572156|3638203|FG001|Overall Study|Lost to Follow-up|1
2063165|NCT00572156|3638204|FG002|Overall Study|Lost to Follow-up|1
2063166|NCT00572156|3638205|FG003|Overall Study|Lost to Follow-up|0
2063167|NCT00572156|3638202|FG000|Overall Study|Protocol Violation|1
2063168|NCT00572156|3638203|FG001|Overall Study|Protocol Violation|2
2063169|NCT00572156|3638204|FG002|Overall Study|Protocol Violation|0
2063170|NCT00572156|3638205|FG003|Overall Study|Protocol Violation|2
2063171|NCT00572156|3638202|FG000|Overall Study|Patient/Parent Decision|1
2063172|NCT00572156|3638203|FG001|Overall Study|Patient/Parent Decision|6
2063173|NCT00572156|3638204|FG002|Overall Study|Patient/Parent Decision|4
2063174|NCT00572156|3638205|FG003|Overall Study|Patient/Parent Decision|3
2063175|NCT00572156|3638202|FG000|Overall Study|Sponsor Decision|20
2063176|NCT00572156|3638203|FG001|Overall Study|Sponsor Decision|16
2063177|NCT00572156|3638204|FG002|Overall Study|Sponsor Decision|17
2063178|NCT00572156|3638205|FG003|Overall Study|Sponsor Decision|19
2063179|NCT00572195|3638215|FG000|Overall Study|Withdrawal by Subject|50
2063180|NCT00572195|3638215|FG000|Overall Study|Death|9
2063181|NCT00572195|3638215|FG000|Overall Study|Adverse Event|4
2063182|NCT00572195|3638215|FG000|Overall Study|Lost to Follow-up|5
2063183|NCT00572455|3638242|FG000|Stage I (14 Days)|Adverse Event|0
2063184|NCT00572455|3638243|FG001|Stage I (14 Days)|Adverse Event|0
2063185|NCT00572455|3638244|FG002|Stage I (14 Days)|Adverse Event|0
2063186|NCT00572455|3638245|FG003|Stage I (14 Days)|Adverse Event|0
2063187|NCT00572455|3638246|FG004|Stage I (14 Days)|Adverse Event|0
2063188|NCT00572455|3638247|FG005|Stage I (14 Days)|Adverse Event|3
2063189|NCT00572455|3638248|FG006|Stage I (14 Days)|Adverse Event|0
2063190|NCT00572455|3638249|FG007|Stage I (14 Days)|Adverse Event|0
2063191|NCT00572455|3638250|FG008|Stage I (14 Days)|Adverse Event|0
2063192|NCT00572455|3638251|FG009|Stage I (14 Days)|Adverse Event|0
2063193|NCT00572455|3638252|FG010|Stage I (14 Days)|Adverse Event|0
2063194|NCT00572455|3638253|FG011|Stage I (14 Days)|Adverse Event|0
2063195|NCT00572455|3638254|FG012|Stage I (14 Days)|Adverse Event|0
2063196|NCT00572455|3638255|FG013|Stage I (14 Days)|Adverse Event|0
2063197|NCT00572455|3638242|FG000|Stage I (14 Days)|Other|0
2063198|NCT00572455|3638243|FG001|Stage I (14 Days)|Other|0
2063199|NCT00572455|3638244|FG002|Stage I (14 Days)|Other|0
2063200|NCT00572455|3638245|FG003|Stage I (14 Days)|Other|0
2063201|NCT00572455|3638246|FG004|Stage I (14 Days)|Other|1
2063202|NCT00572455|3638247|FG005|Stage I (14 Days)|Other|0
2063203|NCT00572455|3638248|FG006|Stage I (14 Days)|Other|0
2063204|NCT00572455|3638249|FG007|Stage I (14 Days)|Other|0
2063205|NCT00572455|3638250|FG008|Stage I (14 Days)|Other|0
2063206|NCT00572455|3638251|FG009|Stage I (14 Days)|Other|0
2063207|NCT00572455|3638252|FG010|Stage I (14 Days)|Other|0
2063208|NCT00572455|3638253|FG011|Stage I (14 Days)|Other|0
2063209|NCT00572455|3638254|FG012|Stage I (14 Days)|Other|0
2063210|NCT00572455|3638255|FG013|Stage I (14 Days)|Other|0
2063211|NCT00572455|3638242|FG000|Stage II (28 Days)|Adverse Event|0
2063212|NCT00572455|3638243|FG001|Stage II (28 Days)|Adverse Event|0
2063213|NCT00572455|3638244|FG002|Stage II (28 Days)|Adverse Event|0
2063214|NCT00572455|3638245|FG003|Stage II (28 Days)|Adverse Event|0
2063215|NCT00572455|3638246|FG004|Stage II (28 Days)|Adverse Event|0
2063216|NCT00572455|3638247|FG005|Stage II (28 Days)|Adverse Event|0
2063217|NCT00572455|3638248|FG006|Stage II (28 Days)|Adverse Event|0
2063218|NCT00572455|3638249|FG007|Stage II (28 Days)|Adverse Event|0
2063219|NCT00572455|3638250|FG008|Stage II (28 Days)|Adverse Event|1
2063220|NCT00572455|3638251|FG009|Stage II (28 Days)|Adverse Event|3
2063221|NCT00572455|3638252|FG010|Stage II (28 Days)|Adverse Event|3
2063222|NCT00572455|3638253|FG011|Stage II (28 Days)|Adverse Event|4
2063223|NCT00572455|3638254|FG012|Stage II (28 Days)|Adverse Event|5
2063224|NCT00572455|3638255|FG013|Stage II (28 Days)|Adverse Event|1
2063225|NCT00572455|3638242|FG000|Stage II (28 Days)|Death|0
2063226|NCT00572455|3638243|FG001|Stage II (28 Days)|Death|0
2063227|NCT00572455|3638244|FG002|Stage II (28 Days)|Death|0
2063228|NCT00572455|3638245|FG003|Stage II (28 Days)|Death|0
2063229|NCT00572455|3638246|FG004|Stage II (28 Days)|Death|0
2063230|NCT00572455|3638247|FG005|Stage II (28 Days)|Death|0
2063231|NCT00572455|3638248|FG006|Stage II (28 Days)|Death|0
2063232|NCT00572455|3638249|FG007|Stage II (28 Days)|Death|0
2063233|NCT00572455|3638250|FG008|Stage II (28 Days)|Death|1
2063234|NCT00572455|3638251|FG009|Stage II (28 Days)|Death|0
2063235|NCT00572455|3638252|FG010|Stage II (28 Days)|Death|0
2063236|NCT00572455|3638253|FG011|Stage II (28 Days)|Death|0
2063237|NCT00572455|3638254|FG012|Stage II (28 Days)|Death|0
2063238|NCT00572455|3638255|FG013|Stage II (28 Days)|Death|0
2063239|NCT00572455|3638242|FG000|Stage II (28 Days)|Withdrawal by Subject|0
2063240|NCT00572455|3638243|FG001|Stage II (28 Days)|Withdrawal by Subject|0
2063241|NCT00572455|3638244|FG002|Stage II (28 Days)|Withdrawal by Subject|0
2063242|NCT00572455|3638245|FG003|Stage II (28 Days)|Withdrawal by Subject|0
2063243|NCT00572455|3638246|FG004|Stage II (28 Days)|Withdrawal by Subject|0
2063244|NCT00572455|3638247|FG005|Stage II (28 Days)|Withdrawal by Subject|0
2063245|NCT00572455|3638248|FG006|Stage II (28 Days)|Withdrawal by Subject|0
2302564|NCT02628600|4001405|FG001|Overall Study|Withdrawal by Subject|8
2302565|NCT02628600|4001404|FG000|Overall Study|Lost to Follow-up|1
2302566|NCT02628600|4001405|FG001|Overall Study|Lost to Follow-up|0
2302567|NCT02628600|4001404|FG000|Overall Study|Physician Decision|2
2302568|NCT02628600|4001405|FG001|Overall Study|Physician Decision|2
2302569|NCT02628600|4001404|FG000|Overall Study|Other not specified|1
2302570|NCT02628600|4001405|FG001|Overall Study|Other not specified|0
2302571|NCT02628743|4001411|FG000|Overall Study|Other|3
2302572|NCT02628743|4001411|FG000|Overall Study|Withdrawal by Subject|50
2302573|NCT02628743|4001411|FG000|Overall Study|Study Terminated by Sponsor|76
2302574|NCT02628743|4001411|FG000|Overall Study|Physician Decision|2
2302575|NCT02628769|4001415|FG000|First Intervention|Adverse Event|1
2063246|NCT00572455|3638249|FG007|Stage II (28 Days)|Withdrawal by Subject|1
2063247|NCT00572455|3638250|FG008|Stage II (28 Days)|Withdrawal by Subject|0
2063248|NCT00572455|3638251|FG009|Stage II (28 Days)|Withdrawal by Subject|0
2063249|NCT00572455|3638252|FG010|Stage II (28 Days)|Withdrawal by Subject|2
2063250|NCT00572455|3638253|FG011|Stage II (28 Days)|Withdrawal by Subject|0
2063251|NCT00572455|3638254|FG012|Stage II (28 Days)|Withdrawal by Subject|0
2063252|NCT00572455|3638255|FG013|Stage II (28 Days)|Withdrawal by Subject|0
2063253|NCT00572455|3638242|FG000|Stage II (28 Days)|Other|0
2063254|NCT00572455|3638243|FG001|Stage II (28 Days)|Other|0
2063255|NCT00572455|3638244|FG002|Stage II (28 Days)|Other|0
2063256|NCT00572455|3638245|FG003|Stage II (28 Days)|Other|0
2063257|NCT00572455|3638246|FG004|Stage II (28 Days)|Other|0
2302576|NCT02628769|4001416|FG001|First Intervention|Adverse Event|0
2063258|NCT00572455|3638247|FG005|Stage II (28 Days)|Other|0
2063259|NCT00572455|3638248|FG006|Stage II (28 Days)|Other|0
2063260|NCT00572455|3638249|FG007|Stage II (28 Days)|Other|0
2063261|NCT00572455|3638250|FG008|Stage II (28 Days)|Other|1
2063262|NCT00572455|3638251|FG009|Stage II (28 Days)|Other|0
2063263|NCT00572455|3638252|FG010|Stage II (28 Days)|Other|0
2063264|NCT00572455|3638253|FG011|Stage II (28 Days)|Other|0
2063265|NCT00572455|3638254|FG012|Stage II (28 Days)|Other|0
2063266|NCT00572455|3638255|FG013|Stage II (28 Days)|Other|0
2063267|NCT00572455|3638242|FG000|Stage II (28 Days)|Randomized, but not treated|0
2063268|NCT00572455|3638243|FG001|Stage II (28 Days)|Randomized, but not treated|0
2063269|NCT00572455|3638244|FG002|Stage II (28 Days)|Randomized, but not treated|0
2063270|NCT00572455|3638245|FG003|Stage II (28 Days)|Randomized, but not treated|0
2063271|NCT00572455|3638246|FG004|Stage II (28 Days)|Randomized, but not treated|0
2063272|NCT00572455|3638247|FG005|Stage II (28 Days)|Randomized, but not treated|0
2063273|NCT00572455|3638248|FG006|Stage II (28 Days)|Randomized, but not treated|0
2063274|NCT00572455|3638249|FG007|Stage II (28 Days)|Randomized, but not treated|0
2063275|NCT00572455|3638250|FG008|Stage II (28 Days)|Randomized, but not treated|0
2063276|NCT00572455|3638251|FG009|Stage II (28 Days)|Randomized, but not treated|0
2063277|NCT00572455|3638252|FG010|Stage II (28 Days)|Randomized, but not treated|0
2063278|NCT00572455|3638253|FG011|Stage II (28 Days)|Randomized, but not treated|0
2063279|NCT00572455|3638254|FG012|Stage II (28 Days)|Randomized, but not treated|0
2063280|NCT00572455|3638255|FG013|Stage II (28 Days)|Randomized, but not treated|1
2063281|NCT00572533|3638296|FG000|Overall Study|Death|4
2063282|NCT00572533|3638297|FG001|Overall Study|Death|1
2063283|NCT00572533|3638296|FG000|Overall Study|Received Kidney Transplant|2
2063284|NCT00572533|3638297|FG001|Overall Study|Received Kidney Transplant|1
2063285|NCT00572533|3638296|FG000|Overall Study|Social Issues|1
2063286|NCT00572533|3638297|FG001|Overall Study|Social Issues|0
2063287|NCT00572533|3638296|FG000|Overall Study|Transfer out of Facility|0
2063288|NCT00572533|3638297|FG001|Overall Study|Transfer out of Facility|1
2063289|NCT00572572|3638305|FG000|Overall Study|Withdrawal by Subject|3
2063290|NCT00572572|3638306|FG001|Overall Study|Withdrawal by Subject|6
2063291|NCT00572624|3638314|FG000|Overall Study|Lost to Follow-up|10
2063292|NCT00572624|3638315|FG001|Overall Study|Lost to Follow-up|4
2063293|NCT00572624|3638314|FG000|Overall Study|Wanted to do a different diet program|1
2063294|NCT00572624|3638315|FG001|Overall Study|Wanted to do a different diet program|0
2063295|NCT00572624|3638314|FG000|Overall Study|Medication change|1
2063296|NCT00572624|3638315|FG001|Overall Study|Medication change|0
2063297|NCT00572624|3638314|FG000|Overall Study|Started a new job-- no time for study|1
2063298|NCT00572624|3638315|FG001|Overall Study|Started a new job-- no time for study|0
2063299|NCT00572624|3638314|FG000|Overall Study|Admitted to being a smoker|1
2063300|NCT00572624|3638315|FG001|Overall Study|Admitted to being a smoker|0
2209985|NCT01647516|3849428|FG002|Maintenance Period (MP)|Withdrawal by Subject|1
2209986|NCT01647516|3849429|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
2209987|NCT01647516|3849430|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
2209988|NCT01647516|3849431|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
2063301|NCT00572624|3638314|FG000|Overall Study|Refused to do the stress test|1
2063302|NCT00572624|3638315|FG001|Overall Study|Refused to do the stress test|0
2063303|NCT00572624|3638314|FG000|Overall Study|Problem with vascular access|1
2063304|NCT00572624|3638315|FG001|Overall Study|Problem with vascular access|0
2063305|NCT00572624|3638314|FG000|Overall Study|Health issues unrelated to the study|1
2063306|NCT00572624|3638315|FG001|Overall Study|Health issues unrelated to the study|0
2063307|NCT00572728|3638321|FG000|Overall Study|Withdrawal by Subject|10
2063308|NCT00572728|3638321|FG000|Overall Study|Ineligible|3
2063309|NCT00572728|3638321|FG000|Overall Study|Enrolled under Amendment 4|5
2063310|NCT00572728|3638321|FG000|Overall Study|Offstudy due to complicating disease|1
2063311|NCT00572728|3638321|FG000|Overall Study|FLT1 not completed|4
2063312|NCT00572728|3638321|FG000|Overall Study|First Chemotherapy not initiated|2
2063313|NCT00572728|3638321|FG000|Overall Study|FLT2 not completed|5
2063314|NCT00572728|3638321|FG000|Overall Study|Second chemotherapy not initiated|1
2063315|NCT00572728|3638321|FG000|Overall Study|FLT2 after second chemotherapy initiated|7
2063316|NCT00572728|3638321|FG000|Overall Study|Pathology missing|1
2063317|NCT00572832|3638329|FG000|Overall Study|Lost to Follow-up|0
2063318|NCT00572832|3638330|FG001|Overall Study|Lost to Follow-up|11
2063319|NCT00572832|3638329|FG000|Overall Study|Pregnancy|0
2063320|NCT00572832|3638330|FG001|Overall Study|Pregnancy|1
2063321|NCT00572910|3638351|FG000|Overall Study|Adverse Event|1
2063322|NCT00572910|3638352|FG001|Overall Study|Adverse Event|2
2063323|NCT00572910|3638353|FG002|Overall Study|Adverse Event|0
2063324|NCT00572910|3638354|FG003|Overall Study|Adverse Event|2
2063325|NCT00572910|3638355|FG004|Overall Study|Adverse Event|0
2063326|NCT00572910|3638356|FG005|Overall Study|Adverse Event|0
2063327|NCT00572910|3638357|FG006|Overall Study|Adverse Event|4
2063328|NCT00572910|3638358|FG007|Overall Study|Adverse Event|2
2063329|NCT00572910|3638359|FG008|Overall Study|Adverse Event|1
2063330|NCT00572910|3638360|FG009|Overall Study|Adverse Event|3
2063331|NCT00572910|3638361|FG010|Overall Study|Adverse Event|2
2063332|NCT00572910|3638351|FG000|Overall Study|Lost to Follow-up|0
2063333|NCT00572910|3638352|FG001|Overall Study|Lost to Follow-up|1
2063334|NCT00572910|3638353|FG002|Overall Study|Lost to Follow-up|1
2063335|NCT00572910|3638354|FG003|Overall Study|Lost to Follow-up|2
2209989|NCT01647516|3849426|FG000|Maintenance Period (MP)|Lack of Efficacy|1
2063336|NCT00572910|3638355|FG004|Overall Study|Lost to Follow-up|1
2063337|NCT00572910|3638356|FG005|Overall Study|Lost to Follow-up|0
2063338|NCT00572910|3638357|FG006|Overall Study|Lost to Follow-up|0
2063339|NCT00572910|3638358|FG007|Overall Study|Lost to Follow-up|0
2063340|NCT00572910|3638359|FG008|Overall Study|Lost to Follow-up|0
2063341|NCT00572910|3638360|FG009|Overall Study|Lost to Follow-up|1
2063342|NCT00572910|3638361|FG010|Overall Study|Lost to Follow-up|0
2063343|NCT00572910|3638351|FG000|Overall Study|Withdrawal by Subject|3
2177113|NCT01371721|3801185|FG000|Overall Study|Lost to Follow-up|8
2177114|NCT01371721|3801186|FG001|Overall Study|Lost to Follow-up|2
2177115|NCT01371721|3801187|FG002|Overall Study|Lost to Follow-up|6
2177116|NCT01371721|3801185|FG000|Overall Study|Withdrawal by Subject|5
2177117|NCT01371721|3801186|FG001|Overall Study|Withdrawal by Subject|7
2177118|NCT01371721|3801187|FG002|Overall Study|Withdrawal by Subject|11
2177119|NCT01371721|3801185|FG000|Overall Study|Other|2
2177120|NCT01371721|3801186|FG001|Overall Study|Other|3
2177121|NCT01371721|3801187|FG002|Overall Study|Other|0
2177122|NCT01371721|3801185|FG000|Overall Study|Lack of Efficacy|2
2177123|NCT01371721|3801186|FG001|Overall Study|Lack of Efficacy|4
2177124|NCT01371721|3801187|FG002|Overall Study|Lack of Efficacy|3
2177125|NCT01371721|3801185|FG000|Overall Study|Randomized but not treated|1
2177126|NCT01371721|3801186|FG001|Overall Study|Randomized but not treated|0
2177127|NCT01371721|3801187|FG002|Overall Study|Randomized but not treated|0
2177128|NCT01371734|3801200|FG000|Overall Study|Other|2
2177129|NCT01371734|3801201|FG001|Overall Study|Other|1
2177130|NCT01371734|3801202|FG002|Overall Study|Other|2
2177131|NCT01371734|3801200|FG000|Overall Study|Withdrawal by Subject|3
2177132|NCT01371734|3801201|FG001|Overall Study|Withdrawal by Subject|4
2063344|NCT00572910|3638352|FG001|Overall Study|Withdrawal by Subject|0
2063345|NCT00572910|3638353|FG002|Overall Study|Withdrawal by Subject|1
2063346|NCT00572910|3638354|FG003|Overall Study|Withdrawal by Subject|0
2063347|NCT00572910|3638355|FG004|Overall Study|Withdrawal by Subject|1
2063348|NCT00572910|3638356|FG005|Overall Study|Withdrawal by Subject|3
2063349|NCT00572910|3638357|FG006|Overall Study|Withdrawal by Subject|0
2063350|NCT00572910|3638358|FG007|Overall Study|Withdrawal by Subject|2
2063351|NCT00572910|3638359|FG008|Overall Study|Withdrawal by Subject|2
2063352|NCT00572910|3638360|FG009|Overall Study|Withdrawal by Subject|2
2063353|NCT00572910|3638361|FG010|Overall Study|Withdrawal by Subject|1
2063354|NCT00573066|3638409|FG000|Overall Study|Exclusion criteria|18
2063355|NCT00573066|3638409|FG000|Overall Study|IV malfunction|1
2063356|NCT00573066|3638409|FG000|Overall Study|Postoperative bleeding|1
2063357|NCT00573131|3638415|FG000|Overall Study|Withdrawal by Subject|10
2063358|NCT00573131|3638416|FG001|Overall Study|Withdrawal by Subject|8
2063359|NCT00573144|3638424|FG000|Overall Study|Withdrawal by Subject|2
2063360|NCT00573144|3638425|FG001|Overall Study|Withdrawal by Subject|3
2063361|NCT00573170|3638431|FG000|First Treatment Period|Did Not Treat Attack 1|0
2063362|NCT00573170|3638432|FG001|First Treatment Period|Did Not Treat Attack 1|0
2063363|NCT00573170|3638433|FG002|First Treatment Period|Did Not Treat Attack 1|0
2063364|NCT00573170|3638434|FG003|First Treatment Period|Did Not Treat Attack 1|0
2063365|NCT00573170|3638435|FG004|First Treatment Period|Did Not Treat Attack 1|1
2063366|NCT00573170|3638436|FG005|First Treatment Period|Did Not Treat Attack 1|0
2063367|NCT00573170|3638431|FG000|First Washout Period|Adverse Event|1
2063368|NCT00573170|3638432|FG001|First Washout Period|Adverse Event|1
2063369|NCT00573170|3638433|FG002|First Washout Period|Adverse Event|0
2063370|NCT00573170|3638434|FG003|First Washout Period|Adverse Event|0
2063371|NCT00573170|3638435|FG004|First Washout Period|Adverse Event|0
2063372|NCT00573170|3638436|FG005|First Washout Period|Adverse Event|1
2063373|NCT00573170|3638431|FG000|First Washout Period|Lack of Efficacy|0
2063374|NCT00573170|3638432|FG001|First Washout Period|Lack of Efficacy|0
2063375|NCT00573170|3638433|FG002|First Washout Period|Lack of Efficacy|0
2063376|NCT00573170|3638434|FG003|First Washout Period|Lack of Efficacy|0
2063377|NCT00573170|3638435|FG004|First Washout Period|Lack of Efficacy|0
2063378|NCT00573170|3638436|FG005|First Washout Period|Lack of Efficacy|1
2063379|NCT00573170|3638431|FG000|First Washout Period|Lost to Follow-up|1
2063380|NCT00573170|3638432|FG001|First Washout Period|Lost to Follow-up|1
2063381|NCT00573170|3638433|FG002|First Washout Period|Lost to Follow-up|0
2063382|NCT00573170|3638434|FG003|First Washout Period|Lost to Follow-up|2
2063383|NCT00573170|3638435|FG004|First Washout Period|Lost to Follow-up|0
2063384|NCT00573170|3638436|FG005|First Washout Period|Lost to Follow-up|2
2063385|NCT00573170|3638431|FG000|First Washout Period|Withdrawal by Subject|2
2063386|NCT00573170|3638432|FG001|First Washout Period|Withdrawal by Subject|0
2063387|NCT00573170|3638433|FG002|First Washout Period|Withdrawal by Subject|0
2063388|NCT00573170|3638434|FG003|First Washout Period|Withdrawal by Subject|2
2063389|NCT00573170|3638435|FG004|First Washout Period|Withdrawal by Subject|3
2063390|NCT00573170|3638436|FG005|First Washout Period|Withdrawal by Subject|3
2063391|NCT00573170|3638431|FG000|First Washout Period|Other|4
2063392|NCT00573170|3638432|FG001|First Washout Period|Other|0
2177133|NCT01371734|3801202|FG002|Overall Study|Withdrawal by Subject|9
2177134|NCT01371734|3801200|FG000|Overall Study|Lost to Follow-up|5
2209990|NCT01647516|3849427|FG001|Maintenance Period (MP)|Lack of Efficacy|4
2063393|NCT00573170|3638433|FG002|First Washout Period|Other|1
2177135|NCT01371734|3801201|FG001|Overall Study|Lost to Follow-up|3
2063394|NCT00573170|3638434|FG003|First Washout Period|Other|1
2063395|NCT00573170|3638435|FG004|First Washout Period|Other|0
2063396|NCT00573170|3638436|FG005|First Washout Period|Other|0
2063397|NCT00573170|3638431|FG000|Second Washout Period|Adverse Event|1
2063398|NCT00573170|3638432|FG001|Second Washout Period|Adverse Event|0
2302577|NCT02628769|4001415|FG000|First Intervention|Withdrawal by Subject|0
2302578|NCT02628769|4001416|FG001|First Intervention|Withdrawal by Subject|1
2302579|NCT02628769|4001415|FG000|Second Intervention|Adverse Event|2
2302580|NCT02628769|4001416|FG001|Second Intervention|Adverse Event|0
2302581|NCT02628769|4001415|FG000|Second Intervention|Physician Decision|0
2302582|NCT02628769|4001416|FG001|Second Intervention|Physician Decision|1
2302583|NCT02628873|4001424|FG000|Break (1 Hour)|Withdrawal by Subject|0
2302584|NCT02628873|4001425|FG001|Break (1 Hour)|Withdrawal by Subject|1
2302585|NCT02628873|4001424|FG000|Second Test (1 Hour)|Physician Decision|1
2302586|NCT02628873|4001425|FG001|Second Test (1 Hour)|Physician Decision|0
2302587|NCT02628938|4001434|FG000|Overall Study|Did not attend the follow up recall|2
2302588|NCT02628938|4001435|FG001|Overall Study|Did not attend the follow up recall|2
2302589|NCT02628938|4001436|FG002|Overall Study|Did not attend the follow up recall|1
2063399|NCT00573170|3638433|FG002|Second Washout Period|Adverse Event|0
2063400|NCT00573170|3638434|FG003|Second Washout Period|Adverse Event|0
2063401|NCT00573170|3638435|FG004|Second Washout Period|Adverse Event|1
2063402|NCT00573170|3638436|FG005|Second Washout Period|Adverse Event|0
2063403|NCT00573170|3638431|FG000|Second Washout Period|Protocol Violation|2
2063404|NCT00573170|3638432|FG001|Second Washout Period|Protocol Violation|1
2063405|NCT00573170|3638433|FG002|Second Washout Period|Protocol Violation|1
2063406|NCT00573170|3638434|FG003|Second Washout Period|Protocol Violation|0
2063407|NCT00573170|3638435|FG004|Second Washout Period|Protocol Violation|0
2063408|NCT00573170|3638436|FG005|Second Washout Period|Protocol Violation|0
2063409|NCT00573170|3638431|FG000|Second Washout Period|Withdrawal by Subject|1
2063410|NCT00573170|3638432|FG001|Second Washout Period|Withdrawal by Subject|1
2063411|NCT00573170|3638433|FG002|Second Washout Period|Withdrawal by Subject|2
2063412|NCT00573170|3638434|FG003|Second Washout Period|Withdrawal by Subject|0
2063413|NCT00573170|3638435|FG004|Second Washout Period|Withdrawal by Subject|1
2063414|NCT00573170|3638436|FG005|Second Washout Period|Withdrawal by Subject|0
2063415|NCT00573170|3638431|FG000|Second Washout Period|Lost to Follow-up|0
2063416|NCT00573170|3638432|FG001|Second Washout Period|Lost to Follow-up|0
2063417|NCT00573170|3638433|FG002|Second Washout Period|Lost to Follow-up|0
2063418|NCT00573170|3638434|FG003|Second Washout Period|Lost to Follow-up|1
2063419|NCT00573170|3638435|FG004|Second Washout Period|Lost to Follow-up|0
2063420|NCT00573170|3638436|FG005|Second Washout Period|Lost to Follow-up|0
2063421|NCT00573170|3638431|FG000|Second Washout Period|Other|1
2063422|NCT00573170|3638432|FG001|Second Washout Period|Other|2
2063423|NCT00573170|3638433|FG002|Second Washout Period|Other|1
2063424|NCT00573170|3638434|FG003|Second Washout Period|Other|4
2063425|NCT00573170|3638435|FG004|Second Washout Period|Other|6
2063426|NCT00573170|3638436|FG005|Second Washout Period|Other|2
2063427|NCT00573170|3638431|FG000|Third Treatment Period|Withdrawal by Subject|1
2063428|NCT00573170|3638432|FG001|Third Treatment Period|Withdrawal by Subject|0
2063429|NCT00573170|3638433|FG002|Third Treatment Period|Withdrawal by Subject|0
2063430|NCT00573170|3638434|FG003|Third Treatment Period|Withdrawal by Subject|0
2063431|NCT00573170|3638435|FG004|Third Treatment Period|Withdrawal by Subject|0
2063432|NCT00573170|3638436|FG005|Third Treatment Period|Withdrawal by Subject|0
2063433|NCT00573170|3638431|FG000|Third Treatment Period|Lost to Follow-up|0
2063434|NCT00573170|3638432|FG001|Third Treatment Period|Lost to Follow-up|0
2063435|NCT00573170|3638433|FG002|Third Treatment Period|Lost to Follow-up|0
2063436|NCT00573170|3638434|FG003|Third Treatment Period|Lost to Follow-up|0
2063437|NCT00573170|3638435|FG004|Third Treatment Period|Lost to Follow-up|0
2063438|NCT00573170|3638436|FG005|Third Treatment Period|Lost to Follow-up|2
2063439|NCT00573183|3638455|FG000|Overall Study|Lost to Follow-up|52
2063440|NCT00573183|3638456|FG001|Overall Study|Lost to Follow-up|50
2063441|NCT00573183|3638455|FG000|Overall Study|Withdrawal by Subject|8
2063442|NCT00573183|3638456|FG001|Overall Study|Withdrawal by Subject|2
2063443|NCT00573183|3638455|FG000|Overall Study|Death|0
2063444|NCT00573183|3638456|FG001|Overall Study|Death|1
2063445|NCT00573183|3638455|FG000|Overall Study|Adverse Event|2
2063446|NCT00573183|3638456|FG001|Overall Study|Adverse Event|0
2063447|NCT00573183|3638455|FG000|Overall Study|Incarceration|5
2063448|NCT00573183|3638456|FG001|Overall Study|Incarceration|8
2063449|NCT00573183|3638455|FG000|Overall Study|Other|5
2063450|NCT00573183|3638456|FG001|Overall Study|Other|2
2063451|NCT00573248|3638466|FG000|Overall Study|scheduling conflicts|15
2063452|NCT00573248|3638467|FG001|Overall Study|scheduling conflicts|11
2063453|NCT00573313|3638497|FG000|Overall Study|Protocol Violation|5
2063454|NCT00573313|3638498|FG001|Overall Study|Protocol Violation|0
2063455|NCT00573313|3638499|FG002|Overall Study|Protocol Violation|6
2063456|NCT00573313|3638500|FG003|Overall Study|Protocol Violation|0
2063457|NCT00573430|3638510|FG000|Overall Study|Incorrect enrollment of randomization|0
2063458|NCT00573430|3638511|FG001|Overall Study|Incorrect enrollment of randomization|4
2063459|NCT00573430|3638512|FG002|Overall Study|Incorrect enrollment of randomization|3
2063460|NCT00573430|3638510|FG000|Overall Study|Adverse Event|0
2302590|NCT02628938|4001434|FG000|Overall Study|Failure to comply with the instructions|3
2063461|NCT00573430|3638511|FG001|Overall Study|Adverse Event|0
2063462|NCT00573430|3638512|FG002|Overall Study|Adverse Event|2
2063463|NCT00573430|3638510|FG000|Overall Study|Withdrawal by Subject|1
2063464|NCT00573430|3638511|FG001|Overall Study|Withdrawal by Subject|0
2063465|NCT00573430|3638512|FG002|Overall Study|Withdrawal by Subject|1
2063466|NCT00573430|3638510|FG000|Overall Study|Protocol Violation|0
2063467|NCT00573430|3638511|FG001|Overall Study|Protocol Violation|1
2063468|NCT00573430|3638512|FG002|Overall Study|Protocol Violation|1
2063469|NCT00573430|3638510|FG000|Overall Study|Eligibility criteria not fulfilled|0
2063470|NCT00573430|3638511|FG001|Overall Study|Eligibility criteria not fulfilled|0
2063471|NCT00573430|3638512|FG002|Overall Study|Eligibility criteria not fulfilled|3
2063472|NCT00573443|3638523|FG000|Double-Blind Phase|Lost to Follow-up|1
2063473|NCT00573443|3638524|FG001|Double-Blind Phase|Lost to Follow-up|3
2063474|NCT00573443|3638525|FG002|Double-Blind Phase|Lost to Follow-up|2
2063475|NCT00573443|3638523|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1
2063476|NCT00573443|3638524|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0
2063477|NCT00573443|3638525|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1
2063478|NCT00573443|3638523|FG000|Double-Blind Phase|Adverse Event|1
2063479|NCT00573443|3638524|FG001|Double-Blind Phase|Adverse Event|5
2063480|NCT00573443|3638525|FG002|Double-Blind Phase|Adverse Event|0
2063481|NCT00573443|3638523|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2
2063482|NCT00573443|3638524|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3
2063483|NCT00573443|3638525|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1
2063484|NCT00573443|3638523|FG000|Double-Blind Phase|Medication refusal due to AE|2
2063485|NCT00573443|3638524|FG001|Double-Blind Phase|Medication refusal due to AE|2
2063486|NCT00573443|3638525|FG002|Double-Blind Phase|Medication refusal due to AE|0
2063487|NCT00573443|3638523|FG000|Double-Blind Phase|Withdrawal by Subject|2
2063488|NCT00573443|3638524|FG001|Double-Blind Phase|Withdrawal by Subject|2
2063489|NCT00573443|3638525|FG002|Double-Blind Phase|Withdrawal by Subject|7
2063490|NCT00573443|3638523|FG000|Double-Blind Phase|Protocol Violation|0
2063491|NCT00573443|3638524|FG001|Double-Blind Phase|Protocol Violation|2
2063492|NCT00573443|3638525|FG002|Double-Blind Phase|Protocol Violation|1
2063493|NCT00573443|3638523|FG000|Double-Blind Phase|Other|0
2063494|NCT00573443|3638524|FG001|Double-Blind Phase|Other|2
2063495|NCT00573443|3638525|FG002|Double-Blind Phase|Other|3
2063496|NCT00573443|3638523|FG000|Open-Label Extension Phase|Lost to Follow-up|1
2063497|NCT00573443|3638524|FG001|Open-Label Extension Phase|Lost to Follow-up|0
2063498|NCT00573443|3638525|FG002|Open-Label Extension Phase|Lost to Follow-up|0
2063499|NCT00573443|3638523|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2
2063500|NCT00573443|3638524|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0
2063501|NCT00573443|3638525|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0
2063502|NCT00573443|3638523|FG000|Open-Label Extension Phase|Adverse Event|3
2063503|NCT00573443|3638524|FG001|Open-Label Extension Phase|Adverse Event|0
2063504|NCT00573443|3638525|FG002|Open-Label Extension Phase|Adverse Event|0
2063505|NCT00573443|3638523|FG000|Open-Label Extension Phase|Serious Adverse Event|5
2063506|NCT00573443|3638524|FG001|Open-Label Extension Phase|Serious Adverse Event|0
2063507|NCT00573443|3638525|FG002|Open-Label Extension Phase|Serious Adverse Event|0
2063508|NCT00573443|3638523|FG000|Open-Label Extension Phase|Withdrawal by Subject|3
2063509|NCT00573443|3638524|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
2063510|NCT00573443|3638525|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
2063511|NCT00573443|3638523|FG000|Open-Label Extension Phase|Protocol Violation|2
2063512|NCT00573443|3638524|FG001|Open-Label Extension Phase|Protocol Violation|0
2063513|NCT00573443|3638525|FG002|Open-Label Extension Phase|Protocol Violation|0
2063514|NCT00573443|3638523|FG000|Open-Label Extension Phase|Other|2
2063515|NCT00573443|3638524|FG001|Open-Label Extension Phase|Other|0
2063516|NCT00573443|3638525|FG002|Open-Label Extension Phase|Other|0
2063517|NCT00573469|3638537|FG000|Overall Study|Adverse Event|1
2063518|NCT00573469|3638538|FG001|Overall Study|Adverse Event|1
2063519|NCT00573469|3638539|FG002|Overall Study|Adverse Event|1
2063520|NCT00573469|3638537|FG000|Overall Study|Withdrawal by Subject|0
2063521|NCT00573469|3638538|FG001|Overall Study|Withdrawal by Subject|2
2063522|NCT00573469|3638539|FG002|Overall Study|Withdrawal by Subject|0
2063523|NCT00573469|3638537|FG000|Overall Study|Other|5
2063524|NCT00573469|3638538|FG001|Overall Study|Other|1
2063525|NCT00573469|3638539|FG002|Overall Study|Other|3
2063526|NCT00573534|3638556|FG000|Overall Study|oppositional behavior|3
2063527|NCT00573755|3638563|FG000|Overall Study|Still receiving treatment|1
2063528|NCT00573755|3638564|FG001|Overall Study|Still receiving treatment|0
2063529|NCT00573768|3638573|FG000|Overall Study|Adverse Event|1
2063530|NCT00573768|3638574|FG001|Overall Study|Adverse Event|1
2063531|NCT00573768|3638575|FG002|Overall Study|Adverse Event|2
2063532|NCT00573768|3638573|FG000|Overall Study|Protocol Violation|1
2063533|NCT00573768|3638574|FG001|Overall Study|Protocol Violation|0
2063534|NCT00573768|3638575|FG002|Overall Study|Protocol Violation|1
2063535|NCT00573768|3638573|FG000|Overall Study|Withdrawal by Subject|0
2063536|NCT00573768|3638574|FG001|Overall Study|Withdrawal by Subject|1
2063537|NCT00573768|3638575|FG002|Overall Study|Withdrawal by Subject|0
2063538|NCT00573768|3638573|FG000|Overall Study|Lost to Follow-up|0
2063539|NCT00573768|3638574|FG001|Overall Study|Lost to Follow-up|0
2063540|NCT00573768|3638575|FG002|Overall Study|Lost to Follow-up|1
2063541|NCT00573794|3638583|FG000|Overall Study|Adverse Event|81
2063542|NCT00573794|3638583|FG000|Overall Study|Withdrew Consent|90
2063543|NCT00573794|3638583|FG000|Overall Study|Lost to Follow-up|13
2063544|NCT00573794|3638583|FG000|Overall Study|Protocol Violation|6
2063545|NCT00573794|3638583|FG000|Overall Study|Lack of Efficacy|94
2063546|NCT00573794|3638583|FG000|Overall Study|Other|46
2063547|NCT00573833|3638587|FG000|Overall Study|Not Treated|2
2063548|NCT00573859|3638591|FG000|Medication Versus Placebo|Scheduling conflicts|12
2063549|NCT00573859|3638591|FG000|Smoking Versus Abstinence|Scheduling conflicts|12
2063550|NCT00574119|3638630|FG000|Overall Study|Adverse Event|1
2063551|NCT00574119|3638630|FG000|Overall Study|Protocol Violation|1
2063552|NCT00574119|3638630|FG000|Overall Study|Withdrawal by Subject|1
2063553|NCT00574119|3638630|FG000|Overall Study|Physician Decision|1
2063554|NCT00574145|3638636|FG000|Overall Study|Withdrawal by Subject|2
2063555|NCT00574145|3638637|FG001|Overall Study|Withdrawal by Subject|1
2063556|NCT00574249|3638657|FG000|Overall Study|Adverse Event|6
2063557|NCT00574249|3638658|FG001|Overall Study|Adverse Event|18
2063558|NCT00574249|3638657|FG000|Overall Study|Lack of Efficacy|5
2063559|NCT00574249|3638658|FG001|Overall Study|Lack of Efficacy|3
2063560|NCT00574249|3638657|FG000|Overall Study|Lost to Follow-up|4
2063561|NCT00574249|3638658|FG001|Overall Study|Lost to Follow-up|3
2063562|NCT00574249|3638657|FG000|Overall Study|Protocol Violation|5
2063563|NCT00574249|3638658|FG001|Overall Study|Protocol Violation|2
2063564|NCT00574249|3638657|FG000|Overall Study|History of carcinoma|1
2063565|NCT00574249|3638658|FG001|Overall Study|History of carcinoma|0
2063566|NCT00574249|3638657|FG000|Overall Study|Withdrawal by Subject|3
2063567|NCT00574249|3638658|FG001|Overall Study|Withdrawal by Subject|0
2063568|NCT00574249|3638657|FG000|Overall Study|Physician Decision|1
2063569|NCT00574249|3638658|FG001|Overall Study|Physician Decision|0
2063570|NCT00574249|3638657|FG000|Overall Study|Pregnancy|1
2063571|NCT00574249|3638658|FG001|Overall Study|Pregnancy|0
2063572|NCT00574249|3638657|FG000|Overall Study|Excluded by company|0
2063573|NCT00574249|3638658|FG001|Overall Study|Excluded by company|1
2063574|NCT00574249|3638657|FG000|Overall Study|PPD test taken twice|0
2063575|NCT00574249|3638658|FG001|Overall Study|PPD test taken twice|1
2063576|NCT00574275|3638666|FG000|Overall Study|Randomized but not treated|2
2063577|NCT00574275|3638667|FG001|Overall Study|Randomized but not treated|3
2063578|NCT00574275|3638666|FG000|Overall Study|Adverse Event|32
2063579|NCT00574275|3638667|FG001|Overall Study|Adverse Event|76
2063580|NCT00574275|3638666|FG000|Overall Study|Disease progression|160
2063581|NCT00574275|3638667|FG001|Overall Study|Disease progression|146
2063582|NCT00574275|3638666|FG000|Overall Study|Lost to Follow-up|2
2063583|NCT00574275|3638667|FG001|Overall Study|Lost to Follow-up|1
2063584|NCT00574275|3638666|FG000|Overall Study|Study stopped based on DMC decision|62
2063585|NCT00574275|3638667|FG001|Overall Study|Study stopped based on DMC decision|23
2063586|NCT00574275|3638666|FG000|Overall Study|Withdrawal by Subject|15
2063587|NCT00574275|3638667|FG001|Overall Study|Withdrawal by Subject|17
2063588|NCT00574275|3638666|FG000|Overall Study|Error calculating tumor measurement|1
2063589|NCT00574275|3638667|FG001|Overall Study|Error calculating tumor measurement|0
2063590|NCT00574275|3638666|FG000|Overall Study|Physician Decision|1
2063591|NCT00574275|3638667|FG001|Overall Study|Physician Decision|1
2063592|NCT00574275|3638666|FG000|Overall Study|Protocol Violation|0
2063593|NCT00574275|3638667|FG001|Overall Study|Protocol Violation|1
2063594|NCT00574275|3638666|FG000|Overall Study|Patient and Investigator decision|0
2063595|NCT00574275|3638667|FG001|Overall Study|Patient and Investigator decision|1
2063596|NCT00574275|3638666|FG000|Overall Study|Insurance change|0
2063597|NCT00574275|3638667|FG001|Overall Study|Insurance change|1
2063598|NCT00574275|3638666|FG000|Overall Study|Operation for curative intent|0
2063599|NCT00574275|3638667|FG001|Overall Study|Operation for curative intent|1
2063600|NCT00574288|3638680|FG000|Overall Study|Adverse Event|2
2063601|NCT00574288|3638681|FG001|Overall Study|Adverse Event|0
2063602|NCT00574288|3638682|FG002|Overall Study|Adverse Event|0
2063603|NCT00574288|3638683|FG003|Overall Study|Adverse Event|0
2063604|NCT00574288|3638684|FG004|Overall Study|Adverse Event|1
2063605|NCT00574288|3638685|FG005|Overall Study|Adverse Event|0
2063606|NCT00574288|3638686|FG006|Overall Study|Adverse Event|0
2063607|NCT00574288|3638680|FG000|Overall Study|Death|0
2063608|NCT00574288|3638681|FG001|Overall Study|Death|0
2063609|NCT00574288|3638682|FG002|Overall Study|Death|0
2063610|NCT00574288|3638683|FG003|Overall Study|Death|0
2063611|NCT00574288|3638684|FG004|Overall Study|Death|0
2063612|NCT00574288|3638685|FG005|Overall Study|Death|25
2063613|NCT00574288|3638686|FG006|Overall Study|Death|21
2063614|NCT00574288|3638680|FG000|Overall Study|Lost to Follow-up|0
2063615|NCT00574288|3638681|FG001|Overall Study|Lost to Follow-up|0
2063616|NCT00574288|3638682|FG002|Overall Study|Lost to Follow-up|0
2063617|NCT00574288|3638683|FG003|Overall Study|Lost to Follow-up|0
2063618|NCT00574288|3638684|FG004|Overall Study|Lost to Follow-up|0
2063619|NCT00574288|3638685|FG005|Overall Study|Lost to Follow-up|1
2063620|NCT00574288|3638686|FG006|Overall Study|Lost to Follow-up|2
2063621|NCT00574288|3638680|FG000|Overall Study|Study Terminated By Sponsor|0
2063622|NCT00574288|3638681|FG001|Overall Study|Study Terminated By Sponsor|0
2063623|NCT00574288|3638682|FG002|Overall Study|Study Terminated By Sponsor|0
2063624|NCT00574288|3638683|FG003|Overall Study|Study Terminated By Sponsor|0
2063625|NCT00574288|3638684|FG004|Overall Study|Study Terminated By Sponsor|0
2063626|NCT00574288|3638685|FG005|Overall Study|Study Terminated By Sponsor|0
2063627|NCT00574288|3638686|FG006|Overall Study|Study Terminated By Sponsor|5
2063628|NCT00574288|3638680|FG000|Overall Study|Progressive Disease|17
2063629|NCT00574288|3638681|FG001|Overall Study|Progressive Disease|2
2063630|NCT00574288|3638682|FG002|Overall Study|Progressive Disease|3
2063631|NCT00574288|3638683|FG003|Overall Study|Progressive Disease|2
2063632|NCT00574288|3638684|FG004|Overall Study|Progressive Disease|1
2063633|NCT00574288|3638685|FG005|Overall Study|Progressive Disease|0
2063634|NCT00574288|3638686|FG006|Overall Study|Progressive Disease|0
2063635|NCT00574288|3638680|FG000|Overall Study|Other|1
2063636|NCT00574288|3638681|FG001|Overall Study|Other|1
2063637|NCT00574288|3638682|FG002|Overall Study|Other|0
2209991|NCT01647516|3849428|FG002|Maintenance Period (MP)|Lack of Efficacy|1
2209992|NCT01647516|3849429|FG003|Maintenance Period (MP)|Lack of Efficacy|0
2063638|NCT00574288|3638683|FG003|Overall Study|Other|0
2063639|NCT00574288|3638684|FG004|Overall Study|Other|0
2063640|NCT00574288|3638685|FG005|Overall Study|Other|0
2063641|NCT00574288|3638686|FG006|Overall Study|Other|0
2063642|NCT00574405|3638721|FG000|Overall Study|Withdrawal by Subject|3
2063643|NCT00574405|3638722|FG001|Overall Study|Withdrawal by Subject|2
2063644|NCT00574795|3638790|FG000|Infant Series|Withdrawal by Subject|2
2063645|NCT00574795|3638790|FG000|Infant Series|Protocol Violation|2
2063646|NCT00574795|3638790|FG000|Infant Series|Adverse Event|1
2063647|NCT00574795|3638790|FG000|After Infant Series|Withdrawal by Subject|1
2063648|NCT00574795|3638790|FG000|After Infant Series|Adverse Event|2
2209993|NCT01647516|3849430|FG004|Maintenance Period (MP)|Lack of Efficacy|0
2209994|NCT01647516|3849431|FG005|Maintenance Period (MP)|Lack of Efficacy|0
2209995|NCT01647516|3849426|FG000|Open-Label Period|Adverse Event|0
2209996|NCT01647516|3849427|FG001|Open-Label Period|Adverse Event|0
2063649|NCT00574795|3638790|FG000|Toddler Dose|Withdrawal by Subject|1
2063650|NCT00574847|3638820|FG000|Overall Study|Adverse Event|2
2063651|NCT00574847|3638821|FG001|Overall Study|Adverse Event|0
2063652|NCT00574847|3638820|FG000|Overall Study|Death|1
2063653|NCT00574847|3638821|FG001|Overall Study|Death|0
2063654|NCT00574847|3638820|FG000|Overall Study|Withdrawal by Subject|2
2063655|NCT00574847|3638821|FG001|Overall Study|Withdrawal by Subject|2
2063656|NCT00574847|3638820|FG000|Overall Study|Physician Decision|1
2063657|NCT00574847|3638821|FG001|Overall Study|Physician Decision|0
2063658|NCT00574847|3638820|FG000|Overall Study|Did not receive medication (declined)|2
2063659|NCT00574847|3638821|FG001|Overall Study|Did not receive medication (declined)|5
2063660|NCT00574873|3638829|FG000|Overall Study|Withdrawal by Subject|18
2063661|NCT00574873|3638830|FG001|Overall Study|Withdrawal by Subject|19
2063662|NCT00574873|3638829|FG000|Overall Study|Investigator request|18
2063663|NCT00574873|3638830|FG001|Overall Study|Investigator request|8
2063664|NCT00574873|3638829|FG000|Overall Study|Death|15
2063665|NCT00574873|3638830|FG001|Overall Study|Death|14
2063666|NCT00574873|3638829|FG000|Overall Study|Lost to Follow-up|14
2063667|NCT00574873|3638830|FG001|Overall Study|Lost to Follow-up|5
2063668|NCT00574873|3638829|FG000|Overall Study|Other|40
2063669|NCT00574873|3638830|FG001|Overall Study|Other|4
2063670|NCT00574873|3638829|FG000|Overall Study|Discontinuation of study by sponsor|5
2063671|NCT00574873|3638830|FG001|Overall Study|Discontinuation of study by sponsor|199
2063672|NCT00574873|3638829|FG000|Overall Study|Blank, site closed per local regulations|2
2063673|NCT00574873|3638830|FG001|Overall Study|Blank, site closed per local regulations|2
2063674|NCT00574873|3638829|FG000|Overall Study|Extension Study|126
2063675|NCT00574873|3638830|FG001|Overall Study|Extension Study|0
2063676|NCT00574912|3638836|FG000|Overall Study|Could not place IV lines.|3
2063677|NCT00574912|3638836|FG000|Overall Study|scheduling conflicts|3
2063678|NCT00574912|3638836|FG000|Overall Study|Physician Decision|2
2063679|NCT00574951|3638848|FG000|Overall Study|Ineligible - improper prior treatment|1
2063680|NCT00575042|3638889|FG000|Overall Study|Adverse Event|2
2063681|NCT00575042|3638889|FG000|Overall Study|Lost to Follow-up|1
2063682|NCT00575094|3638894|FG000|Overall Study|Adverse Event|2
2063683|NCT00575094|3638894|FG000|Overall Study|Withdrawal by Subject|1
2063684|NCT00575328|3638931|FG000|Overall Study|Adverse Event|1
2063685|NCT00575328|3638932|FG001|Overall Study|Adverse Event|1
2063686|NCT00575328|3638931|FG000|Overall Study|Lost to Follow-up|2
2063687|NCT00575328|3638932|FG001|Overall Study|Lost to Follow-up|1
2063688|NCT00575380|3638949|FG000|Overall Study|Withdrawal by Subject|1
2063689|NCT00575380|3638950|FG001|Overall Study|Withdrawal by Subject|0
2063690|NCT00575380|3638949|FG000|Overall Study|Adverse Event|0
2063691|NCT00575380|3638950|FG001|Overall Study|Adverse Event|1
2063692|NCT00575380|3638949|FG000|Overall Study|Various|0
2063693|NCT00575380|3638950|FG001|Overall Study|Various|2
2063694|NCT00575510|3638959|FG000|Overall Study|Lost to Follow-up|4
2063695|NCT00575510|3638960|FG001|Overall Study|Lost to Follow-up|6
2063696|NCT00575510|3638961|FG002|Overall Study|Lost to Follow-up|9
2063697|NCT00575510|3638959|FG000|Overall Study|Withdrawal by Subject|1
2063698|NCT00575510|3638960|FG001|Overall Study|Withdrawal by Subject|0
2063699|NCT00575510|3638961|FG002|Overall Study|Withdrawal by Subject|0
2063700|NCT00575510|3638959|FG000|Overall Study|Clinic Called Patient|7
2063701|NCT00575510|3638960|FG001|Overall Study|Clinic Called Patient|7
2209997|NCT01647516|3849428|FG002|Open-Label Period|Adverse Event|0
2209998|NCT01647516|3849429|FG003|Open-Label Period|Adverse Event|5
2209999|NCT01647516|3849430|FG004|Open-Label Period|Adverse Event|6
2063702|NCT00575510|3638961|FG002|Overall Study|Clinic Called Patient|7
2063703|NCT00575510|3638959|FG000|Overall Study|Pregnancy|0
2063704|NCT00575510|3638960|FG001|Overall Study|Pregnancy|0
2210000|NCT01647516|3849431|FG005|Open-Label Period|Adverse Event|3
2063705|NCT00575510|3638961|FG002|Overall Study|Pregnancy|1
2105894|NCT00861757|3698877|FG003|Overall Study|Entry Criteria Not Met|1
2105895|NCT00861757|3698874|FG000|Overall Study|Lack of Efficacy|3
2105896|NCT00861757|3698875|FG001|Overall Study|Lack of Efficacy|1
2105897|NCT00861757|3698876|FG002|Overall Study|Lack of Efficacy|0
2105898|NCT00861757|3698877|FG003|Overall Study|Lack of Efficacy|1
2105899|NCT00861757|3698874|FG000|Overall Study|Lost to Follow-up|1
2105900|NCT00861757|3698875|FG001|Overall Study|Lost to Follow-up|0
2105901|NCT00861757|3698876|FG002|Overall Study|Lost to Follow-up|1
2105902|NCT00861757|3698877|FG003|Overall Study|Lost to Follow-up|1
2105903|NCT00861757|3698874|FG000|Overall Study|Physician Decision|0
2105904|NCT00861757|3698875|FG001|Overall Study|Physician Decision|0
2105905|NCT00861757|3698876|FG002|Overall Study|Physician Decision|0
2105906|NCT00861757|3698877|FG003|Overall Study|Physician Decision|1
2105907|NCT00861757|3698874|FG000|Overall Study|Protocol Violation|2
2105908|NCT00861757|3698875|FG001|Overall Study|Protocol Violation|2
2105909|NCT00861757|3698876|FG002|Overall Study|Protocol Violation|4
2105910|NCT00861757|3698877|FG003|Overall Study|Protocol Violation|1
2105911|NCT00861757|3698874|FG000|Overall Study|Withdrawal by Subject|1
2105912|NCT00861757|3698875|FG001|Overall Study|Withdrawal by Subject|5
2105913|NCT00861757|3698876|FG002|Overall Study|Withdrawal by Subject|5
2105914|NCT00861757|3698877|FG003|Overall Study|Withdrawal by Subject|2
2105915|NCT00862082|3698897|FG000|Overall Study|Sponsor decision to terminate the study|5
2105916|NCT00862082|3698898|FG001|Overall Study|Sponsor decision to terminate the study|0
2105917|NCT00862082|3698897|FG000|Overall Study|Withdrawal by Subject|0
2105918|NCT00862082|3698898|FG001|Overall Study|Withdrawal by Subject|1
2105919|NCT00862121|3698913|FG000|Overall Study|Adverse Event|1
2105920|NCT00862121|3698914|FG001|Overall Study|Adverse Event|2
2105921|NCT00862121|3698913|FG000|Overall Study|Lack of Efficacy|0
2105922|NCT00862121|3698914|FG001|Overall Study|Lack of Efficacy|3
2105923|NCT00862121|3698913|FG000|Overall Study|Protocol Violation|0
2105924|NCT00862121|3698914|FG001|Overall Study|Protocol Violation|1
2105925|NCT00862121|3698913|FG000|Overall Study|Exclusion criterion violation|0
2105926|NCT00862121|3698914|FG001|Overall Study|Exclusion criterion violation|1
2105927|NCT00862121|3698913|FG000|Overall Study|Incorrect randomisation|0
2105928|NCT00862121|3698914|FG001|Overall Study|Incorrect randomisation|1
2105929|NCT00862134|3698922|FG000|Overall Study|Death|1
2105930|NCT00862134|3698923|FG001|Overall Study|Death|0
2105931|NCT00862134|3698922|FG000|Overall Study|Physician Decision|0
2105932|NCT00862134|3698923|FG001|Overall Study|Physician Decision|1
2105933|NCT00862134|3698922|FG000|Overall Study|Withdrawal by Subject|1
2105934|NCT00862134|3698923|FG001|Overall Study|Withdrawal by Subject|2
2105935|NCT00862134|3698922|FG000|Overall Study|Sponsor terminated study|5
2105936|NCT00862134|3698923|FG001|Overall Study|Sponsor terminated study|7
2105937|NCT00862134|3698922|FG000|Overall Study|Adverse Event|2
2105938|NCT00862134|3698923|FG001|Overall Study|Adverse Event|2
2302591|NCT02628938|4001435|FG001|Overall Study|Failure to comply with the instructions|0
2302592|NCT02628938|4001436|FG002|Overall Study|Failure to comply with the instructions|3
2302593|NCT02629133|4001459|FG000|Overall Study|Lost to Follow-up|3
2210001|NCT01647516|3849426|FG000|Open-Label Period|Pregnancy|0
2210002|NCT01647516|3849427|FG001|Open-Label Period|Pregnancy|0
2210003|NCT01647516|3849428|FG002|Open-Label Period|Pregnancy|0
2210004|NCT01647516|3849429|FG003|Open-Label Period|Pregnancy|0
2210005|NCT01647516|3849430|FG004|Open-Label Period|Pregnancy|0
2210006|NCT01647516|3849431|FG005|Open-Label Period|Pregnancy|1
2105939|NCT00862134|3698922|FG000|Overall Study|Withdrew prior to dosing|2
2105940|NCT00862134|3698923|FG001|Overall Study|Withdrew prior to dosing|0
2105941|NCT00862277|3698937|FG000|Overall Study|Protocol Violation|1
2105942|NCT00862277|3698938|FG001|Overall Study|Protocol Violation|2
2105943|NCT00862277|3698939|FG002|Overall Study|Protocol Violation|5
2105944|NCT00862459|3698954|FG000|Overall Study|Lost to Follow-up|1
2105945|NCT00862459|3698955|FG001|Overall Study|Lost to Follow-up|2
2105946|NCT00862459|3698956|FG002|Overall Study|Lost to Follow-up|2
2105947|NCT00862459|3698954|FG000|Overall Study|Protocol Violation|1
2105948|NCT00862459|3698955|FG001|Overall Study|Protocol Violation|0
2105949|NCT00862459|3698956|FG002|Overall Study|Protocol Violation|0
2105950|NCT00862459|3698954|FG000|Overall Study|Withdrawal by Subject|1
2105951|NCT00862459|3698955|FG001|Overall Study|Withdrawal by Subject|1
2105952|NCT00862459|3698956|FG002|Overall Study|Withdrawal by Subject|3
2105953|NCT00862459|3698954|FG000|Overall Study|Adverse Event|0
2105954|NCT00862459|3698955|FG001|Overall Study|Adverse Event|1
2105955|NCT00862459|3698956|FG002|Overall Study|Adverse Event|0
2105956|NCT00862459|3698954|FG000|Overall Study|Personal reasons|1
2210007|NCT01647516|3849426|FG000|Open-Label Period|Non-compliance|0
2105957|NCT00862459|3698955|FG001|Overall Study|Personal reasons|0
2105958|NCT00862459|3698956|FG002|Overall Study|Personal reasons|0
2105959|NCT00862459|3698954|FG000|Overall Study|Operation|1
2105960|NCT00862459|3698955|FG001|Overall Study|Operation|1
2105961|NCT00862459|3698956|FG002|Overall Study|Operation|0
2105962|NCT00862459|3698954|FG000|Overall Study|Intravenous (IV) site problems|1
2105963|NCT00862459|3698955|FG001|Overall Study|Intravenous (IV) site problems|0
2105964|NCT00862459|3698956|FG002|Overall Study|Intravenous (IV) site problems|1
2105965|NCT00862459|3698954|FG000|Overall Study|Unable to hold still for imaging|0
2105966|NCT00862459|3698955|FG001|Overall Study|Unable to hold still for imaging|1
2210008|NCT01647516|3849427|FG001|Open-Label Period|Non-compliance|0
2302594|NCT02629133|4001460|FG001|Overall Study|Lost to Follow-up|1
2302595|NCT02629133|4001459|FG000|Overall Study|Withdrawal by Subject|1
2302596|NCT02629133|4001460|FG001|Overall Study|Withdrawal by Subject|1
2302597|NCT02629822|4001475|FG000|Base Study|Lost to Follow-up|2
2302598|NCT02629822|4001475|FG000|Base Study|Non-Compliance With Study Drug|1
2302599|NCT02629822|4001475|FG000|Extension Study|Adverse Event|1
2302600|NCT02629822|4001475|FG000|Extension Study|Lost to Follow-up|1
2302601|NCT02629861|4001483|FG000|Overall Study|Adverse Event|7
2302602|NCT02629861|4001484|FG001|Overall Study|Adverse Event|5
2302603|NCT02629861|4001485|FG002|Overall Study|Adverse Event|4
2302604|NCT02629861|4001483|FG000|Overall Study|Withdrawal by Subject|5
2063706|NCT00575588|3638972|FG000|Overall Study|Adverse Event|11
2063707|NCT00575588|3638973|FG001|Overall Study|Adverse Event|13
2063708|NCT00575588|3638972|FG000|Overall Study|Withdrawal by Subject|27
2063709|NCT00575588|3638973|FG001|Overall Study|Withdrawal by Subject|31
2063710|NCT00575588|3638972|FG000|Overall Study|Lost to Follow-up|1
2063711|NCT00575588|3638973|FG001|Overall Study|Lost to Follow-up|3
2063712|NCT00575588|3638972|FG000|Overall Study|Death|4
2063713|NCT00575588|3638973|FG001|Overall Study|Death|2
2063714|NCT00575588|3638972|FG000|Overall Study|Incorrect enrollment|8
2063715|NCT00575588|3638973|FG001|Overall Study|Incorrect enrollment|4
2063716|NCT00575588|3638972|FG000|Overall Study|Study specific discontinuation criteria|203
2063717|NCT00575588|3638973|FG001|Overall Study|Study specific discontinuation criteria|218
2063718|NCT00575588|3638972|FG000|Overall Study|Severe non-compliance to protocol|5
2063719|NCT00575588|3638973|FG001|Overall Study|Severe non-compliance to protocol|7
2063720|NCT00575588|3638972|FG000|Overall Study|Safety reasons|2
2063721|NCT00575588|3638973|FG001|Overall Study|Safety reasons|1
2063722|NCT00575588|3638972|FG000|Overall Study|Elevated triglyceride|1
2063723|NCT00575588|3638973|FG001|Overall Study|Elevated triglyceride|0
2063724|NCT00575588|3638972|FG000|Overall Study|Patient moved|1
2063725|NCT00575588|3638973|FG001|Overall Study|Patient moved|3
2063726|NCT00575588|3638972|FG000|Overall Study|Impossible to determine HbA1c|0
2063727|NCT00575588|3638973|FG001|Overall Study|Impossible to determine HbA1c|1
2063728|NCT00575666|3638981|FG000|Overall Study|Withdrawal by Subject|3
2063729|NCT00575666|3638982|FG001|Overall Study|Withdrawal by Subject|2
2063730|NCT00575666|3638981|FG000|Overall Study|Physician Decision|1
2063731|NCT00575666|3638982|FG001|Overall Study|Physician Decision|1
2063732|NCT00576056|3638996|FG000|Overall Study|Adverse Event|1
2063733|NCT00576056|3638996|FG000|Overall Study|Death|1
2063734|NCT00576056|3638996|FG000|Overall Study|Lack of Efficacy|1
2063735|NCT00576056|3638996|FG000|Overall Study|Withdrawal by Subject|2
2063736|NCT00576056|3638996|FG000|Overall Study|did not meet eligibility criteria|8
2063737|NCT00576056|3638996|FG000|Overall Study|Physician Decision|1
2063738|NCT00576199|3639004|FG000|Overall Study|Adverse Event|12
2063739|NCT00576199|3639004|FG000|Overall Study|Insufficient Therapeutic Response|14
2063740|NCT00576199|3639004|FG000|Overall Study|Refused Treatment|2
2063741|NCT00576199|3639004|FG000|Overall Study|Reason Unspecified|2
2063742|NCT00576303|3639017|FG000|Dose Titration Period|Early withdrawal|17
2063743|NCT00576303|3639017|FG000|Efficacy Evaluation Period|Early withdrawal|5
2063744|NCT00576303|3639017|FG000|Long Term Safety Period|Early withdrawal|16
2063745|NCT00576316|3639021|FG000|Overall Study|Adverse Event|9
2063746|NCT00576316|3639021|FG000|Overall Study|Withdrawal by Subject|2
2063747|NCT00576316|3639021|FG000|Overall Study|Protocol Violation|9
2063748|NCT00576381|3639025|FG000|Overall Study|Reoperation|3
2063749|NCT00576381|3639025|FG000|Overall Study|Adverse Event|4
2063750|NCT00576407|3639029|FG000|Overall Study|Death|7
2063751|NCT00576407|3639029|FG000|Overall Study|Physician Decision|1
2063752|NCT00576420|3639037|FG000|Overall Study|Death|0
2063753|NCT00576420|3639038|FG001|Overall Study|Death|0
2063754|NCT00576420|3639039|FG002|Overall Study|Death|1
2063755|NCT00576472|3639103|FG000|MPH In-Lab Phase|Declined participation in medication pha|0
2063756|NCT00576472|3639104|FG001|MPH In-Lab Phase|Declined participation in medication pha|0
2063757|NCT00576472|3639105|FG002|MPH In-Lab Phase|Declined participation in medication pha|0
2063758|NCT00576472|3639106|FG003|MPH In-Lab Phase|Declined participation in medication pha|75
2063759|NCT00576472|3639107|FG004|MPH In-Lab Phase|Declined participation in medication pha|0
2063760|NCT00576472|3639108|FG005|MPH In-Lab Phase|Declined participation in medication pha|0
2063761|NCT00576472|3639109|FG006|MPH In-Lab Phase|Declined participation in medication pha|0
2063762|NCT00576472|3639110|FG007|MPH In-Lab Phase|Declined participation in medication pha|0
2063763|NCT00576472|3639111|FG008|MPH In-Lab Phase|Declined participation in medication pha|0
2063764|NCT00576472|3639112|FG009|MPH In-Lab Phase|Declined participation in medication pha|0
2063765|NCT00576472|3639113|FG010|MPH In-Lab Phase|Declined participation in medication pha|0
2063766|NCT00576472|3639114|FG011|MPH In-Lab Phase|Declined participation in medication pha|0
2063767|NCT00576472|3639115|FG012|MPH In-Lab Phase|Declined participation in medication pha|0
2063768|NCT00576472|3639116|FG013|MPH In-Lab Phase|Declined participation in medication pha|0
2063769|NCT00576472|3639117|FG014|MPH In-Lab Phase|Declined participation in medication pha|0
2063770|NCT00576472|3639103|FG000|MPH In-Lab Phase|Lost to Follow-up|0
2063771|NCT00576472|3639104|FG001|MPH In-Lab Phase|Lost to Follow-up|0
2063772|NCT00576472|3639105|FG002|MPH In-Lab Phase|Lost to Follow-up|0
2063773|NCT00576472|3639106|FG003|MPH In-Lab Phase|Lost to Follow-up|1
2063774|NCT00576472|3639107|FG004|MPH In-Lab Phase|Lost to Follow-up|0
2302605|NCT02629861|4001484|FG001|Overall Study|Withdrawal by Subject|8
2063775|NCT00576472|3639108|FG005|MPH In-Lab Phase|Lost to Follow-up|0
2063776|NCT00576472|3639109|FG006|MPH In-Lab Phase|Lost to Follow-up|0
2063777|NCT00576472|3639110|FG007|MPH In-Lab Phase|Lost to Follow-up|0
2063778|NCT00576472|3639111|FG008|MPH In-Lab Phase|Lost to Follow-up|0
2063779|NCT00576472|3639112|FG009|MPH In-Lab Phase|Lost to Follow-up|0
2063780|NCT00576472|3639113|FG010|MPH In-Lab Phase|Lost to Follow-up|0
2063781|NCT00576472|3639114|FG011|MPH In-Lab Phase|Lost to Follow-up|0
2063782|NCT00576472|3639115|FG012|MPH In-Lab Phase|Lost to Follow-up|0
2063783|NCT00576472|3639116|FG013|MPH In-Lab Phase|Lost to Follow-up|0
2063784|NCT00576472|3639117|FG014|MPH In-Lab Phase|Lost to Follow-up|0
2063785|NCT00576472|3639103|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063786|NCT00576472|3639104|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063787|NCT00576472|3639105|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063788|NCT00576472|3639106|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
2063789|NCT00576472|3639107|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063790|NCT00576472|3639108|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063791|NCT00576472|3639109|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063792|NCT00576472|3639110|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063793|NCT00576472|3639111|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063794|NCT00576472|3639112|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063795|NCT00576472|3639113|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063796|NCT00576472|3639114|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063797|NCT00576472|3639115|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063798|NCT00576472|3639116|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063799|NCT00576472|3639117|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2063800|NCT00576472|3639103|FG000|MPH In-Lab Phase|No attention/academic problems|0
2063801|NCT00576472|3639104|FG001|MPH In-Lab Phase|No attention/academic problems|0
2063802|NCT00576472|3639105|FG002|MPH In-Lab Phase|No attention/academic problems|0
2063803|NCT00576472|3639106|FG003|MPH In-Lab Phase|No attention/academic problems|245
2063804|NCT00576472|3639107|FG004|MPH In-Lab Phase|No attention/academic problems|0
2063805|NCT00576472|3639108|FG005|MPH In-Lab Phase|No attention/academic problems|0
2063806|NCT00576472|3639109|FG006|MPH In-Lab Phase|No attention/academic problems|0
2063807|NCT00576472|3639110|FG007|MPH In-Lab Phase|No attention/academic problems|0
2063808|NCT00576472|3639111|FG008|MPH In-Lab Phase|No attention/academic problems|0
2063809|NCT00576472|3639112|FG009|MPH In-Lab Phase|No attention/academic problems|0
2063810|NCT00576472|3639113|FG010|MPH In-Lab Phase|No attention/academic problems|0
2063811|NCT00576472|3639114|FG011|MPH In-Lab Phase|No attention/academic problems|0
2063812|NCT00576472|3639115|FG012|MPH In-Lab Phase|No attention/academic problems|0
2063813|NCT00576472|3639116|FG013|MPH In-Lab Phase|No attention/academic problems|0
2063814|NCT00576472|3639117|FG014|MPH In-Lab Phase|No attention/academic problems|0
2063815|NCT00576472|3639103|FG000|MPH In-Lab Phase|Psychiatric exclusion|0
2063816|NCT00576472|3639104|FG001|MPH In-Lab Phase|Psychiatric exclusion|0
2063817|NCT00576472|3639105|FG002|MPH In-Lab Phase|Psychiatric exclusion|0
2063818|NCT00576472|3639106|FG003|MPH In-Lab Phase|Psychiatric exclusion|10
2063819|NCT00576472|3639107|FG004|MPH In-Lab Phase|Psychiatric exclusion|0
2063820|NCT00576472|3639108|FG005|MPH In-Lab Phase|Psychiatric exclusion|0
2063821|NCT00576472|3639109|FG006|MPH In-Lab Phase|Psychiatric exclusion|0
2063822|NCT00576472|3639110|FG007|MPH In-Lab Phase|Psychiatric exclusion|0
2063823|NCT00576472|3639111|FG008|MPH In-Lab Phase|Psychiatric exclusion|0
2063824|NCT00576472|3639112|FG009|MPH In-Lab Phase|Psychiatric exclusion|0
2063825|NCT00576472|3639113|FG010|MPH In-Lab Phase|Psychiatric exclusion|0
2063826|NCT00576472|3639114|FG011|MPH In-Lab Phase|Psychiatric exclusion|0
2063827|NCT00576472|3639115|FG012|MPH In-Lab Phase|Psychiatric exclusion|0
2063828|NCT00576472|3639116|FG013|MPH In-Lab Phase|Psychiatric exclusion|0
2063829|NCT00576472|3639117|FG014|MPH In-Lab Phase|Psychiatric exclusion|0
2063830|NCT00576472|3639103|FG000|MPH Cross Over Phase|Withdrawal by Subject|0
2063831|NCT00576472|3639104|FG001|MPH Cross Over Phase|Withdrawal by Subject|0
2063832|NCT00576472|3639105|FG002|MPH Cross Over Phase|Withdrawal by Subject|0
2063833|NCT00576472|3639106|FG003|MPH Cross Over Phase|Withdrawal by Subject|0
2063834|NCT00576472|3639107|FG004|MPH Cross Over Phase|Withdrawal by Subject|0
2063835|NCT00576472|3639108|FG005|MPH Cross Over Phase|Withdrawal by Subject|0
2063836|NCT00576472|3639109|FG006|MPH Cross Over Phase|Withdrawal by Subject|6
2063837|NCT00576472|3639110|FG007|MPH Cross Over Phase|Withdrawal by Subject|0
2063838|NCT00576472|3639111|FG008|MPH Cross Over Phase|Withdrawal by Subject|0
2063839|NCT00576472|3639112|FG009|MPH Cross Over Phase|Withdrawal by Subject|0
2063840|NCT00576472|3639113|FG010|MPH Cross Over Phase|Withdrawal by Subject|0
2063841|NCT00576472|3639114|FG011|MPH Cross Over Phase|Withdrawal by Subject|0
2063842|NCT00576472|3639115|FG012|MPH Cross Over Phase|Withdrawal by Subject|0
2063843|NCT00576472|3639116|FG013|MPH Cross Over Phase|Withdrawal by Subject|0
2063844|NCT00576472|3639117|FG014|MPH Cross Over Phase|Withdrawal by Subject|0
2063845|NCT00576472|3639103|FG000|MPH Cross Over Phase|Ineligible due to disease|0
2063846|NCT00576472|3639104|FG001|MPH Cross Over Phase|Ineligible due to disease|0
2063847|NCT00576472|3639105|FG002|MPH Cross Over Phase|Ineligible due to disease|0
2063848|NCT00576472|3639106|FG003|MPH Cross Over Phase|Ineligible due to disease|0
2063849|NCT00576472|3639107|FG004|MPH Cross Over Phase|Ineligible due to disease|0
2063850|NCT00576472|3639108|FG005|MPH Cross Over Phase|Ineligible due to disease|0
2063851|NCT00576472|3639109|FG006|MPH Cross Over Phase|Ineligible due to disease|2
2063852|NCT00576472|3639110|FG007|MPH Cross Over Phase|Ineligible due to disease|0
2302606|NCT02629861|4001485|FG002|Overall Study|Withdrawal by Subject|13
2302607|NCT02629861|4001483|FG000|Overall Study|Protocol Violation|2
2302608|NCT02629861|4001484|FG001|Overall Study|Protocol Violation|3
2302609|NCT02629861|4001485|FG002|Overall Study|Protocol Violation|7
2302610|NCT02629861|4001483|FG000|Overall Study|Lost to Follow-up|12
2302611|NCT02629861|4001484|FG001|Overall Study|Lost to Follow-up|9
2302612|NCT02629861|4001485|FG002|Overall Study|Lost to Follow-up|4
2302613|NCT02629861|4001483|FG000|Overall Study|Other|1
2302614|NCT02629861|4001484|FG001|Overall Study|Other|1
2302615|NCT02629861|4001485|FG002|Overall Study|Other|0
2302616|NCT02629861|4001483|FG000|Overall Study|Pregnancy|2
2063853|NCT00576472|3639111|FG008|MPH Cross Over Phase|Ineligible due to disease|0
2063854|NCT00576472|3639112|FG009|MPH Cross Over Phase|Ineligible due to disease|0
2063855|NCT00576472|3639113|FG010|MPH Cross Over Phase|Ineligible due to disease|0
2063856|NCT00576472|3639114|FG011|MPH Cross Over Phase|Ineligible due to disease|0
2063857|NCT00576472|3639115|FG012|MPH Cross Over Phase|Ineligible due to disease|0
2063858|NCT00576472|3639116|FG013|MPH Cross Over Phase|Ineligible due to disease|0
2063859|NCT00576472|3639117|FG014|MPH Cross Over Phase|Ineligible due to disease|0
2063860|NCT00576472|3639103|FG000|MPH Cross Over Phase|Physician Decision|0
2063861|NCT00576472|3639104|FG001|MPH Cross Over Phase|Physician Decision|0
2063862|NCT00576472|3639105|FG002|MPH Cross Over Phase|Physician Decision|0
2063863|NCT00576472|3639106|FG003|MPH Cross Over Phase|Physician Decision|0
2063864|NCT00576472|3639107|FG004|MPH Cross Over Phase|Physician Decision|0
2063865|NCT00576472|3639108|FG005|MPH Cross Over Phase|Physician Decision|0
2063866|NCT00576472|3639109|FG006|MPH Cross Over Phase|Physician Decision|4
2063867|NCT00576472|3639110|FG007|MPH Cross Over Phase|Physician Decision|0
2063868|NCT00576472|3639111|FG008|MPH Cross Over Phase|Physician Decision|0
2210009|NCT01647516|3849428|FG002|Open-Label Period|Non-compliance|0
2210010|NCT01647516|3849429|FG003|Open-Label Period|Non-compliance|1
2063869|NCT00576472|3639112|FG009|MPH Cross Over Phase|Physician Decision|0
2063870|NCT00576472|3639113|FG010|MPH Cross Over Phase|Physician Decision|0
2063871|NCT00576472|3639114|FG011|MPH Cross Over Phase|Physician Decision|0
2063872|NCT00576472|3639115|FG012|MPH Cross Over Phase|Physician Decision|0
2063873|NCT00576472|3639116|FG013|MPH Cross Over Phase|Physician Decision|0
2063874|NCT00576472|3639117|FG014|MPH Cross Over Phase|Physician Decision|0
2063875|NCT00576472|3639103|FG000|MPH Cross Over Phase|Did not complete cross over phase|0
2063876|NCT00576472|3639104|FG001|MPH Cross Over Phase|Did not complete cross over phase|0
2063877|NCT00576472|3639105|FG002|MPH Cross Over Phase|Did not complete cross over phase|0
2063878|NCT00576472|3639106|FG003|MPH Cross Over Phase|Did not complete cross over phase|0
2063879|NCT00576472|3639107|FG004|MPH Cross Over Phase|Did not complete cross over phase|0
2063880|NCT00576472|3639108|FG005|MPH Cross Over Phase|Did not complete cross over phase|0
2063881|NCT00576472|3639109|FG006|MPH Cross Over Phase|Did not complete cross over phase|0
2063882|NCT00576472|3639110|FG007|MPH Cross Over Phase|Did not complete cross over phase|0
2063883|NCT00576472|3639111|FG008|MPH Cross Over Phase|Did not complete cross over phase|2
2063884|NCT00576472|3639112|FG009|MPH Cross Over Phase|Did not complete cross over phase|0
2063885|NCT00576472|3639113|FG010|MPH Cross Over Phase|Did not complete cross over phase|1
2063886|NCT00576472|3639114|FG011|MPH Cross Over Phase|Did not complete cross over phase|1
2063887|NCT00576472|3639115|FG012|MPH Cross Over Phase|Did not complete cross over phase|0
2063888|NCT00576472|3639116|FG013|MPH Cross Over Phase|Did not complete cross over phase|0
2063889|NCT00576472|3639117|FG014|MPH Cross Over Phase|Did not complete cross over phase|0
2063890|NCT00576472|3639103|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0
2063891|NCT00576472|3639104|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0
2063892|NCT00576472|3639105|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0
2063893|NCT00576472|3639106|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0
2063894|NCT00576472|3639107|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0
2063895|NCT00576472|3639108|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0
2063896|NCT00576472|3639109|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0
2063897|NCT00576472|3639110|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0
2063898|NCT00576472|3639111|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0
2063899|NCT00576472|3639112|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0
2063900|NCT00576472|3639113|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0
2063901|NCT00576472|3639114|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0
2063902|NCT00576472|3639115|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0
2063903|NCT00576472|3639116|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16
2063904|NCT00576472|3639117|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0
2063905|NCT00576472|3639103|FG000|MPH Home Maintenance Phase|Declined to participate|0
2063906|NCT00576472|3639104|FG001|MPH Home Maintenance Phase|Declined to participate|0
2063907|NCT00576472|3639105|FG002|MPH Home Maintenance Phase|Declined to participate|0
2210011|NCT01647516|3849430|FG004|Open-Label Period|Non-compliance|0
2210012|NCT01647516|3849431|FG005|Open-Label Period|Non-compliance|1
2210013|NCT01647516|3849426|FG000|Open-Label Period|Physician Decision|0
2210014|NCT01647516|3849427|FG001|Open-Label Period|Physician Decision|0
2210015|NCT01647516|3849428|FG002|Open-Label Period|Physician Decision|0
2302617|NCT02629861|4001484|FG001|Overall Study|Pregnancy|1
2210016|NCT01647516|3849429|FG003|Open-Label Period|Physician Decision|1
2210017|NCT01647516|3849430|FG004|Open-Label Period|Physician Decision|1
2063908|NCT00576472|3639106|FG003|MPH Home Maintenance Phase|Declined to participate|0
2063909|NCT00576472|3639107|FG004|MPH Home Maintenance Phase|Declined to participate|0
2063910|NCT00576472|3639108|FG005|MPH Home Maintenance Phase|Declined to participate|0
2063911|NCT00576472|3639109|FG006|MPH Home Maintenance Phase|Declined to participate|0
2063912|NCT00576472|3639110|FG007|MPH Home Maintenance Phase|Declined to participate|0
2063913|NCT00576472|3639111|FG008|MPH Home Maintenance Phase|Declined to participate|0
2063914|NCT00576472|3639112|FG009|MPH Home Maintenance Phase|Declined to participate|0
2063915|NCT00576472|3639113|FG010|MPH Home Maintenance Phase|Declined to participate|0
2063916|NCT00576472|3639114|FG011|MPH Home Maintenance Phase|Declined to participate|0
2063917|NCT00576472|3639115|FG012|MPH Home Maintenance Phase|Declined to participate|0
2063918|NCT00576472|3639116|FG013|MPH Home Maintenance Phase|Declined to participate|7
2063919|NCT00576472|3639117|FG014|MPH Home Maintenance Phase|Declined to participate|0
2210018|NCT01647516|3849431|FG005|Open-Label Period|Physician Decision|0
2210019|NCT01647516|3849426|FG000|Open-Label Period|Withdrawal by Subject|0
2210020|NCT01647516|3849427|FG001|Open-Label Period|Withdrawal by Subject|0
2210021|NCT01647516|3849428|FG002|Open-Label Period|Withdrawal by Subject|0
2210022|NCT01647516|3849429|FG003|Open-Label Period|Withdrawal by Subject|9
2063920|NCT00576472|3639103|FG000|MPH Home Maintenance Phase|Insufficient data|0
2063921|NCT00576472|3639104|FG001|MPH Home Maintenance Phase|Insufficient data|0
2063922|NCT00576472|3639105|FG002|MPH Home Maintenance Phase|Insufficient data|0
2063923|NCT00576472|3639106|FG003|MPH Home Maintenance Phase|Insufficient data|0
2063924|NCT00576472|3639107|FG004|MPH Home Maintenance Phase|Insufficient data|0
2063925|NCT00576472|3639108|FG005|MPH Home Maintenance Phase|Insufficient data|0
2063926|NCT00576472|3639109|FG006|MPH Home Maintenance Phase|Insufficient data|0
2063927|NCT00576472|3639110|FG007|MPH Home Maintenance Phase|Insufficient data|0
2063928|NCT00576472|3639111|FG008|MPH Home Maintenance Phase|Insufficient data|0
2063929|NCT00576472|3639112|FG009|MPH Home Maintenance Phase|Insufficient data|0
2063930|NCT00576472|3639113|FG010|MPH Home Maintenance Phase|Insufficient data|0
2063931|NCT00576472|3639114|FG011|MPH Home Maintenance Phase|Insufficient data|0
2063932|NCT00576472|3639115|FG012|MPH Home Maintenance Phase|Insufficient data|0
2063933|NCT00576472|3639116|FG013|MPH Home Maintenance Phase|Insufficient data|4
2063934|NCT00576472|3639117|FG014|MPH Home Maintenance Phase|Insufficient data|0
2063935|NCT00576472|3639103|FG000|MPH Home Maintenance Phase|Side effects|0
2063936|NCT00576472|3639104|FG001|MPH Home Maintenance Phase|Side effects|0
2063937|NCT00576472|3639105|FG002|MPH Home Maintenance Phase|Side effects|0
2063938|NCT00576472|3639106|FG003|MPH Home Maintenance Phase|Side effects|0
2063939|NCT00576472|3639107|FG004|MPH Home Maintenance Phase|Side effects|0
2063940|NCT00576472|3639108|FG005|MPH Home Maintenance Phase|Side effects|0
2063941|NCT00576472|3639109|FG006|MPH Home Maintenance Phase|Side effects|0
2063942|NCT00576472|3639110|FG007|MPH Home Maintenance Phase|Side effects|0
2063943|NCT00576472|3639111|FG008|MPH Home Maintenance Phase|Side effects|0
2063944|NCT00576472|3639112|FG009|MPH Home Maintenance Phase|Side effects|0
2063945|NCT00576472|3639113|FG010|MPH Home Maintenance Phase|Side effects|0
2063946|NCT00576472|3639114|FG011|MPH Home Maintenance Phase|Side effects|0
2063947|NCT00576472|3639115|FG012|MPH Home Maintenance Phase|Side effects|0
2063948|NCT00576472|3639116|FG013|MPH Home Maintenance Phase|Side effects|0
2063949|NCT00576472|3639117|FG014|MPH Home Maintenance Phase|Side effects|8
2063950|NCT00576472|3639103|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063951|NCT00576472|3639104|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063952|NCT00576472|3639105|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063953|NCT00576472|3639106|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063954|NCT00576472|3639107|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063955|NCT00576472|3639108|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063956|NCT00576472|3639109|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063957|NCT00576472|3639110|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063958|NCT00576472|3639111|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063959|NCT00576472|3639112|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063960|NCT00576472|3639113|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063961|NCT00576472|3639114|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063962|NCT00576472|3639115|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063963|NCT00576472|3639116|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0
2063964|NCT00576472|3639117|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6
2063965|NCT00576472|3639103|FG000|MPH Home Maintenance Phase|Medical reasons|0
2063966|NCT00576472|3639104|FG001|MPH Home Maintenance Phase|Medical reasons|0
2063967|NCT00576472|3639105|FG002|MPH Home Maintenance Phase|Medical reasons|0
2063968|NCT00576472|3639106|FG003|MPH Home Maintenance Phase|Medical reasons|0
2063969|NCT00576472|3639107|FG004|MPH Home Maintenance Phase|Medical reasons|0
2063970|NCT00576472|3639108|FG005|MPH Home Maintenance Phase|Medical reasons|0
2063971|NCT00576472|3639109|FG006|MPH Home Maintenance Phase|Medical reasons|0
2063972|NCT00576472|3639110|FG007|MPH Home Maintenance Phase|Medical reasons|0
2063973|NCT00576472|3639111|FG008|MPH Home Maintenance Phase|Medical reasons|0
2063974|NCT00576472|3639112|FG009|MPH Home Maintenance Phase|Medical reasons|0
2210023|NCT01647516|3849430|FG004|Open-Label Period|Withdrawal by Subject|11
2063975|NCT00576472|3639113|FG010|MPH Home Maintenance Phase|Medical reasons|0
2063976|NCT00576472|3639114|FG011|MPH Home Maintenance Phase|Medical reasons|0
2063977|NCT00576472|3639115|FG012|MPH Home Maintenance Phase|Medical reasons|0
2063978|NCT00576472|3639116|FG013|MPH Home Maintenance Phase|Medical reasons|0
2063979|NCT00576472|3639117|FG014|MPH Home Maintenance Phase|Medical reasons|6
2063980|NCT00576472|3639103|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0
2063981|NCT00576472|3639104|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0
2063982|NCT00576472|3639105|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0
2063983|NCT00576472|3639106|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0
2063984|NCT00576472|3639107|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0
2063985|NCT00576472|3639108|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0
2063986|NCT00576472|3639109|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0
2063987|NCT00576472|3639110|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0
2063988|NCT00576472|3639111|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0
2063989|NCT00576472|3639112|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0
2063990|NCT00576472|3639113|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0
2063991|NCT00576472|3639114|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0
2063992|NCT00576472|3639115|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0
2063993|NCT00576472|3639116|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0
2063994|NCT00576472|3639117|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3
2063995|NCT00576576|3639148|FG000|Overall Study|Lost to Follow-up|6
2063996|NCT00576576|3639148|FG000|Overall Study|Protocol Violation|1
2063997|NCT00576628|3639152|FG000|Overall Study|Adverse Event|11
2063998|NCT00576628|3639152|FG000|Overall Study|Death|2
2063999|NCT00576628|3639152|FG000|Overall Study|Failure to return|1
2064000|NCT00576628|3639152|FG000|Overall Study|Refused Treatment|8
2064001|NCT00576628|3639152|FG000|Overall Study|Pregnancy|1
2064002|NCT00576628|3639152|FG000|Overall Study|RBC transfusion|1
2064003|NCT00576628|3639152|FG000|Overall Study|Progression of Kidney Disease|1
2064004|NCT00576628|3639152|FG000|Overall Study|Progression of Renal Failure|1
2064005|NCT00576628|3639152|FG000|Overall Study|The patient move into other town|1
2064006|NCT00576628|3639152|FG000|Overall Study|Transplantation|1
2064007|NCT00576628|3639152|FG000|Overall Study|Dialysis|15
2064008|NCT00576693|3639163|FG000|Overall Study|Lost to Follow-up|7
2064009|NCT00576693|3639164|FG001|Overall Study|Lost to Follow-up|11
2302618|NCT02629861|4001485|FG002|Overall Study|Pregnancy|0
2302619|NCT02629965|4001493|FG000|Period 1|Adverse Event|1
2302620|NCT02629965|4001494|FG001|Period 1|Adverse Event|0
2302621|NCT02629965|4001493|FG000|Period 1|Unexpected worsening of disease|2
2302622|NCT02629965|4001494|FG001|Period 1|Unexpected worsening of disease|0
2302623|NCT02629965|4001493|FG000|Period 1|Other than listed above|1
2302624|NCT02629965|4001494|FG001|Period 1|Other than listed above|2
2064010|NCT00576693|3639163|FG000|Overall Study|Withdrawal by Subject|3
2064011|NCT00576693|3639164|FG001|Overall Study|Withdrawal by Subject|13
2064012|NCT00576732|3639173|FG000|DOUBLE BLIND|Adverse Event|0
2064013|NCT00576732|3639174|FG001|DOUBLE BLIND|Adverse Event|0
2064014|NCT00576732|3639175|FG002|DOUBLE BLIND|Adverse Event|1
2064015|NCT00576732|3639176|FG003|DOUBLE BLIND|Adverse Event|0
2064016|NCT00576732|3639177|FG004|DOUBLE BLIND|Adverse Event|0
2064017|NCT00576732|3639178|FG005|DOUBLE BLIND|Adverse Event|0
2064018|NCT00576732|3639173|FG000|DOUBLE BLIND|Lost to Follow-up|0
2064019|NCT00576732|3639174|FG001|DOUBLE BLIND|Lost to Follow-up|1
2064020|NCT00576732|3639175|FG002|DOUBLE BLIND|Lost to Follow-up|1
2064021|NCT00576732|3639176|FG003|DOUBLE BLIND|Lost to Follow-up|0
2064022|NCT00576732|3639177|FG004|DOUBLE BLIND|Lost to Follow-up|0
2064023|NCT00576732|3639178|FG005|DOUBLE BLIND|Lost to Follow-up|0
2064024|NCT00576732|3639173|FG000|DOUBLE BLIND|Withdrawal by Subject|1
2064025|NCT00576732|3639174|FG001|DOUBLE BLIND|Withdrawal by Subject|1
2064026|NCT00576732|3639175|FG002|DOUBLE BLIND|Withdrawal by Subject|3
2064027|NCT00576732|3639176|FG003|DOUBLE BLIND|Withdrawal by Subject|0
2064028|NCT00576732|3639177|FG004|DOUBLE BLIND|Withdrawal by Subject|0
2064029|NCT00576732|3639178|FG005|DOUBLE BLIND|Withdrawal by Subject|0
2064030|NCT00576732|3639173|FG000|DOUBLE BLIND|OTHER|0
2064031|NCT00576732|3639174|FG001|DOUBLE BLIND|OTHER|2
2064032|NCT00576732|3639175|FG002|DOUBLE BLIND|OTHER|1
2064033|NCT00576732|3639176|FG003|DOUBLE BLIND|OTHER|0
2064034|NCT00576732|3639177|FG004|DOUBLE BLIND|OTHER|0
2064035|NCT00576732|3639178|FG005|DOUBLE BLIND|OTHER|0
2064036|NCT00576732|3639173|FG000|DOUBLE BLIND|Lack of Efficacy|6
2064037|NCT00576732|3639174|FG001|DOUBLE BLIND|Lack of Efficacy|1
2064038|NCT00576732|3639175|FG002|DOUBLE BLIND|Lack of Efficacy|0
2064039|NCT00576732|3639176|FG003|DOUBLE BLIND|Lack of Efficacy|0
2064040|NCT00576732|3639177|FG004|DOUBLE BLIND|Lack of Efficacy|0
2064041|NCT00576732|3639178|FG005|DOUBLE BLIND|Lack of Efficacy|0
2064042|NCT00576732|3639173|FG000|DOUBLE BLIND|Protocol Violation|1
2064043|NCT00576732|3639174|FG001|DOUBLE BLIND|Protocol Violation|0
2064044|NCT00576732|3639175|FG002|DOUBLE BLIND|Protocol Violation|0
2064045|NCT00576732|3639176|FG003|DOUBLE BLIND|Protocol Violation|0
2064046|NCT00576732|3639177|FG004|DOUBLE BLIND|Protocol Violation|0
2064047|NCT00576732|3639178|FG005|DOUBLE BLIND|Protocol Violation|0
2064048|NCT00576732|3639173|FG000|OPEN LABEL|Adverse Event|0
2064049|NCT00576732|3639174|FG001|OPEN LABEL|Adverse Event|0
2064050|NCT00576732|3639175|FG002|OPEN LABEL|Adverse Event|0
2064051|NCT00576732|3639176|FG003|OPEN LABEL|Adverse Event|4
2064052|NCT00576732|3639177|FG004|OPEN LABEL|Adverse Event|0
2064053|NCT00576732|3639178|FG005|OPEN LABEL|Adverse Event|1
2064054|NCT00576732|3639173|FG000|OPEN LABEL|Lost to Follow-up|0
2064055|NCT00576732|3639174|FG001|OPEN LABEL|Lost to Follow-up|0
2064056|NCT00576732|3639175|FG002|OPEN LABEL|Lost to Follow-up|0
2064057|NCT00576732|3639176|FG003|OPEN LABEL|Lost to Follow-up|2
2064058|NCT00576732|3639177|FG004|OPEN LABEL|Lost to Follow-up|1
2064059|NCT00576732|3639178|FG005|OPEN LABEL|Lost to Follow-up|1
2064060|NCT00576732|3639173|FG000|OPEN LABEL|Withdrawal by Subject|0
2064061|NCT00576732|3639174|FG001|OPEN LABEL|Withdrawal by Subject|0
2064062|NCT00576732|3639175|FG002|OPEN LABEL|Withdrawal by Subject|0
2064063|NCT00576732|3639176|FG003|OPEN LABEL|Withdrawal by Subject|1
2064064|NCT00576732|3639177|FG004|OPEN LABEL|Withdrawal by Subject|0
2064065|NCT00576732|3639178|FG005|OPEN LABEL|Withdrawal by Subject|1
2064066|NCT00576732|3639173|FG000|OPEN LABEL|OTHER|0
2064067|NCT00576732|3639174|FG001|OPEN LABEL|OTHER|0
2064068|NCT00576732|3639175|FG002|OPEN LABEL|OTHER|0
2064069|NCT00576732|3639176|FG003|OPEN LABEL|OTHER|0
2064070|NCT00576732|3639177|FG004|OPEN LABEL|OTHER|0
2064071|NCT00576732|3639178|FG005|OPEN LABEL|OTHER|2
2064072|NCT00576732|3639173|FG000|OPEN LABEL|Lack of Efficacy|0
2064073|NCT00576732|3639174|FG001|OPEN LABEL|Lack of Efficacy|0
2064074|NCT00576732|3639175|FG002|OPEN LABEL|Lack of Efficacy|0
2064075|NCT00576732|3639176|FG003|OPEN LABEL|Lack of Efficacy|2
2064076|NCT00576732|3639177|FG004|OPEN LABEL|Lack of Efficacy|2
2064077|NCT00576732|3639178|FG005|OPEN LABEL|Lack of Efficacy|3
2064078|NCT00576732|3639173|FG000|OPEN LABEL|Protocol Violation|0
2064079|NCT00576732|3639174|FG001|OPEN LABEL|Protocol Violation|0
2064080|NCT00576732|3639175|FG002|OPEN LABEL|Protocol Violation|0
2064081|NCT00576732|3639176|FG003|OPEN LABEL|Protocol Violation|2
2064082|NCT00576732|3639177|FG004|OPEN LABEL|Protocol Violation|1
2064083|NCT00576732|3639178|FG005|OPEN LABEL|Protocol Violation|0
2210024|NCT01647516|3849431|FG005|Open-Label Period|Withdrawal by Subject|6
2210025|NCT01647516|3849426|FG000|Open-Label Period|Lost to Follow-up|0
2210026|NCT01647516|3849427|FG001|Open-Label Period|Lost to Follow-up|0
2064084|NCT00576758|3639192|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3
2064085|NCT00576758|3639193|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3
2064086|NCT00576758|3639192|FG000|Induction Treatment Period|Insufficient therapeutic response|2
2064087|NCT00576758|3639193|FG001|Induction Treatment Period|Insufficient therapeutic response|0
2064088|NCT00576758|3639192|FG000|Induction Treatment Period|Violation of selection criteria at entry|1
2064089|NCT00576758|3639193|FG001|Induction Treatment Period|Violation of selection criteria at entry|1
2064090|NCT00576758|3639192|FG000|Induction Treatment Period|Death|1
2064091|NCT00576758|3639193|FG001|Induction Treatment Period|Death|0
2064092|NCT00576758|3639192|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
2064093|NCT00576758|3639193|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
2064094|NCT00576758|3639192|FG000|Induction Treatment Period|Withdrew consent|1
2064095|NCT00576758|3639193|FG001|Induction Treatment Period|Withdrew consent|0
2064096|NCT00576758|3639192|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6
2064097|NCT00576758|3639193|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7
2064098|NCT00576758|3639192|FG000|Extension Treatment Period|Death|1
2064099|NCT00576758|3639193|FG001|Extension Treatment Period|Death|1
2064100|NCT00576758|3639192|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2
2064101|NCT00576758|3639193|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1
2064102|NCT00576758|3639192|FG000|Extension Treatment Period|Insufficient therapeutic response|30
2064103|NCT00576758|3639193|FG001|Extension Treatment Period|Insufficient therapeutic response|33
2064104|NCT00576758|3639192|FG000|Extension Treatment Period|Administrative/Other|3
2064105|NCT00576758|3639193|FG001|Extension Treatment Period|Administrative/Other|1
2064106|NCT00576758|3639192|FG000|Follow-up Period|Administrative/Other|6
2064107|NCT00576758|3639193|FG001|Follow-up Period|Administrative/Other|8
2064108|NCT00576758|3639192|FG000|Follow-up Period|Death|3
2064109|NCT00576758|3639193|FG001|Follow-up Period|Death|3
2064110|NCT00576758|3639192|FG000|Follow-up Period|Insufficient therapeutic response|16
2064111|NCT00576758|3639193|FG001|Follow-up Period|Insufficient therapeutic response|5
2064112|NCT00576758|3639192|FG000|Follow-up Period|Withdrew consent|2
2064113|NCT00576758|3639193|FG001|Follow-up Period|Withdrew consent|1
2064114|NCT00576823|3639203|FG000|12-week Efficacy Phase|Parent's schedule issue|1
2064115|NCT00576823|3639204|FG001|12-week Efficacy Phase|Parent's schedule issue|0
2064116|NCT00576823|3639205|FG002|12-week Efficacy Phase|Parent's schedule issue|0
2064117|NCT00576823|3639203|FG000|40-week Safety Extension Phase|Lack of Efficacy|1
2064118|NCT00576823|3639204|FG001|40-week Safety Extension Phase|Lack of Efficacy|0
2064119|NCT00576823|3639205|FG002|40-week Safety Extension Phase|Lack of Efficacy|0
2064120|NCT00576836|3639216|FG000|Overall Study|Death|0
2064121|NCT00576836|3639217|FG001|Overall Study|Death|1
2064122|NCT00576836|3639216|FG000|Overall Study|Physician Decision|0
2064123|NCT00576836|3639217|FG001|Overall Study|Physician Decision|1
2064124|NCT00576901|3639221|FG000|Overall Study|Withdrawal by Subject|1
2064125|NCT00576901|3639221|FG000|Overall Study|Disease course|1
2064126|NCT00576901|3639221|FG000|Overall Study|Protocol Violation|1
2064127|NCT00576927|3639227|FG000|Clinical Assessment|Lack of Efficacy|24
2064128|NCT00576927|3639227|FG000|Clinical Assessment|Death|1
2064129|NCT00576927|3639227|FG000|Clinical Assessment|Withdrawal by Subject|10
2064130|NCT00576927|3639227|FG000|Clinical Assessment|Physician Decision|1
2210027|NCT01647516|3849428|FG002|Open-Label Period|Lost to Follow-up|0
2064131|NCT00576927|3639227|FG000|Baseline|Physician Decision|9
2064132|NCT00576927|3639227|FG000|Baseline|Medication Change by PCP of subject|1
2064133|NCT00576927|3639227|FG000|Baseline|Withdrawal by Subject|3
2064134|NCT00576927|3639227|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
2064135|NCT00576927|3639227|FG000|Sleep Hygiene Behavioral Intervention|Death|1
2064136|NCT00576927|3639227|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
2064137|NCT00576927|3639227|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
2064138|NCT00576927|3639227|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
2064139|NCT00577005|3639235|FG000|Overall Study|Lost to Follow-up|3
2064140|NCT00577005|3639236|FG001|Overall Study|Lost to Follow-up|2
2064141|NCT00577005|3639235|FG000|Overall Study|Withdrawal by Subject|2
2064142|NCT00577005|3639236|FG001|Overall Study|Withdrawal by Subject|1
2064143|NCT00577031|3639245|FG000|Overall Study|Adverse Event|52
2064144|NCT00577031|3639245|FG000|Overall Study|Progression of disease|93
2064145|NCT00577031|3639245|FG000|Overall Study|Protocol Violation|5
2064146|NCT00577031|3639245|FG000|Overall Study|Participant withdrew consent|13
2064147|NCT00577031|3639245|FG000|Overall Study|Participant non-compliance|5
2064148|NCT00577031|3639245|FG000|Overall Study|Need for surgery|17
2064149|NCT00577031|3639245|FG000|Overall Study|Medical decision|14
2064150|NCT00577031|3639245|FG000|Overall Study|Death|6
2064151|NCT00577096|3639269|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3
2064152|NCT00577096|3639270|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2
2064153|NCT00577096|3639269|FG000|Short Term Participation|Withdrawal by Subject|3
2064154|NCT00577096|3639270|FG001|Short Term Participation|Withdrawal by Subject|5
2064155|NCT00577096|3639269|FG000|Short Term Participation|Death|1
2064156|NCT00577096|3639270|FG001|Short Term Participation|Death|1
2064157|NCT00577122|3639278|FG000|Overall Study|Adverse Event|0
2064158|NCT00577122|3639279|FG001|Overall Study|Adverse Event|2
2064159|NCT00577122|3639278|FG000|Overall Study|Progression, relapse during active trt|6
2064160|NCT00577122|3639279|FG001|Overall Study|Progression, relapse during active trt|8
2064161|NCT00577122|3639278|FG000|Overall Study|Prog, refract disease during active trt|8
2064162|NCT00577122|3639279|FG001|Overall Study|Prog, refract disease during active trt|5
2064163|NCT00577122|3639278|FG000|Overall Study|Alternative Therapy|0
2064164|NCT00577122|3639279|FG001|Overall Study|Alternative Therapy|1
2064165|NCT00577382|3639305|FG000|Overall Study|Adverse Event|0
2064166|NCT00577382|3639306|FG001|Overall Study|Adverse Event|6
2064167|NCT00577382|3639305|FG000|Overall Study|Withdrawal by Subject|0
2064168|NCT00577382|3639306|FG001|Overall Study|Withdrawal by Subject|1
2210028|NCT01647516|3849429|FG003|Open-Label Period|Lost to Follow-up|1
2210029|NCT01647516|3849430|FG004|Open-Label Period|Lost to Follow-up|0
2210030|NCT01647516|3849431|FG005|Open-Label Period|Lost to Follow-up|1
2210031|NCT01647516|3849426|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0
2210032|NCT01647516|3849427|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0
2210033|NCT01647516|3849428|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0
2210034|NCT01647516|3849429|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18
2210035|NCT01647516|3849430|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13
2210036|NCT01647516|3849431|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23
2210037|NCT01647516|3849426|FG000|Open-Label Period|Lack of Efficacy|0
2210038|NCT01647516|3849427|FG001|Open-Label Period|Lack of Efficacy|0
2210039|NCT01647516|3849428|FG002|Open-Label Period|Lack of Efficacy|0
2210040|NCT01647516|3849429|FG003|Open-Label Period|Lack of Efficacy|7
2210041|NCT01647516|3849430|FG004|Open-Label Period|Lack of Efficacy|9
2210042|NCT01647516|3849431|FG005|Open-Label Period|Lack of Efficacy|10
2210043|NCT01647516|3849426|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0
2210044|NCT01647516|3849427|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0
2210045|NCT01647516|3849428|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0
2210046|NCT01647516|3849429|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7
2210047|NCT01647516|3849430|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9
2210048|NCT01647516|3849431|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10
2064169|NCT00577382|3639305|FG000|Overall Study|Progressive Disease|17
2064170|NCT00577382|3639306|FG001|Overall Study|Progressive Disease|19
2064171|NCT00577382|3639305|FG000|Overall Study|Intercurrent Illness|1
2064172|NCT00577382|3639306|FG001|Overall Study|Intercurrent Illness|2
2064173|NCT00577382|3639305|FG000|Overall Study|Death|1
2064174|NCT00577382|3639306|FG001|Overall Study|Death|1
2064175|NCT00577382|3639305|FG000|Overall Study|Lost to Follow-up|2
2064176|NCT00577382|3639306|FG001|Overall Study|Lost to Follow-up|2
2064177|NCT00577408|3639314|FG000|Overall Study|Stopped attending study visits|9
2064178|NCT00577408|3639315|FG001|Overall Study|Stopped attending study visits|11
2064179|NCT00577408|3639314|FG000|Overall Study|Continued opioid use|3
2064180|NCT00577408|3639315|FG001|Overall Study|Continued opioid use|2
2064181|NCT00577408|3639314|FG000|Overall Study|Non-compliance with study meds|0
2064182|NCT00577408|3639315|FG001|Overall Study|Non-compliance with study meds|3
2064183|NCT00577408|3639314|FG000|Overall Study|Refused Oral Naltrexone|0
2064184|NCT00577408|3639315|FG001|Overall Study|Refused Oral Naltrexone|1
2064185|NCT00577408|3639314|FG000|Overall Study|Moved out of state|0
2064186|NCT00577408|3639315|FG001|Overall Study|Moved out of state|1
2064187|NCT00577408|3639314|FG000|Overall Study|Scheduling Issues|0
2064188|NCT00577408|3639315|FG001|Overall Study|Scheduling Issues|3
2064189|NCT00577408|3639314|FG000|Overall Study|Death|0
2064190|NCT00577408|3639315|FG001|Overall Study|Death|1
2064191|NCT00577408|3639314|FG000|Overall Study|Psychiatric hospitalization|0
2064192|NCT00577408|3639315|FG001|Overall Study|Psychiatric hospitalization|1
2064193|NCT00577460|3639324|FG000|Overall Study|Adverse Event|11
2064194|NCT00577460|3639325|FG001|Overall Study|Adverse Event|7
2064195|NCT00577460|3639326|FG002|Overall Study|Adverse Event|14
2064196|NCT00577460|3639324|FG000|Overall Study|Protocol Violation|0
2064197|NCT00577460|3639325|FG001|Overall Study|Protocol Violation|1
2064198|NCT00577460|3639326|FG002|Overall Study|Protocol Violation|1
2064199|NCT00577460|3639324|FG000|Overall Study|Lost to Follow-up|0
2064200|NCT00577460|3639325|FG001|Overall Study|Lost to Follow-up|3
2064201|NCT00577460|3639326|FG002|Overall Study|Lost to Follow-up|4
2064202|NCT00577460|3639324|FG000|Overall Study|Withdrawal by Subject|5
2064203|NCT00577460|3639325|FG001|Overall Study|Withdrawal by Subject|5
2064204|NCT00577460|3639326|FG002|Overall Study|Withdrawal by Subject|6
2064205|NCT00577460|3639324|FG000|Overall Study|Other|0
2064206|NCT00577460|3639325|FG001|Overall Study|Other|3
2064207|NCT00577460|3639326|FG002|Overall Study|Other|2
2064208|NCT00577473|3639343|FG000|Overall Study|Protocol Violation|1
2064209|NCT00577473|3639344|FG001|Overall Study|Protocol Violation|4
2064210|NCT00577473|3639343|FG000|Overall Study|Adverse Event|8
2064211|NCT00577473|3639344|FG001|Overall Study|Adverse Event|5
2064212|NCT00577473|3639343|FG000|Overall Study|Withdrawal by Subject|2
2064213|NCT00577473|3639344|FG001|Overall Study|Withdrawal by Subject|6
2064214|NCT00577473|3639343|FG000|Overall Study|Physician Decision|2
2064215|NCT00577473|3639344|FG001|Overall Study|Physician Decision|2
2064216|NCT00577473|3639343|FG000|Overall Study|Lack of Efficacy|8
2064217|NCT00577473|3639344|FG001|Overall Study|Lack of Efficacy|7
2064218|NCT00577629|3639367|FG000|Treatment Period|Death|1
2064219|NCT00577629|3639367|FG000|Long Term Follow-Up|Death|15
2064220|NCT00577629|3639367|FG000|Long Term Follow-Up|Lost to Follow-up|5
2064221|NCT00577629|3639367|FG000|Long Term Follow-Up|Withdrawal by Subject|4
2064222|NCT00577629|3639367|FG000|Long Term Follow-Up|Physician Decision|1
2064223|NCT00577642|3639373|FG000|Overall Study|Clinical Disease Progression|1
2064224|NCT00577655|3639379|FG000|Overall Study|Patient Request|0
2064225|NCT00577655|3639380|FG001|Overall Study|Patient Request|2
2064226|NCT00577655|3639379|FG000|Overall Study|Protocol Violation|0
2064227|NCT00577655|3639380|FG001|Overall Study|Protocol Violation|1
2064228|NCT00577655|3639379|FG000|Overall Study|Lost to Follow-up|1
2064229|NCT00577655|3639380|FG001|Overall Study|Lost to Follow-up|1
2064230|NCT00577707|3639387|FG000|Overall Study|Withdrawal by Subject|3
2064231|NCT00577720|3639395|FG000|Overall Study|Adverse Event|2
2064232|NCT00577720|3639396|FG001|Overall Study|Adverse Event|1
2064233|NCT00577720|3639397|FG002|Overall Study|Adverse Event|0
2064234|NCT00577720|3639398|FG003|Overall Study|Adverse Event|4
2064235|NCT00577720|3639395|FG000|Overall Study|Lost to Follow-up|0
2064236|NCT00577720|3639396|FG001|Overall Study|Lost to Follow-up|0
2064237|NCT00577720|3639397|FG002|Overall Study|Lost to Follow-up|1
2064238|NCT00577720|3639398|FG003|Overall Study|Lost to Follow-up|0
2064239|NCT00577720|3639395|FG000|Overall Study|Protocol Violation|0
2064240|NCT00577720|3639396|FG001|Overall Study|Protocol Violation|0
2064241|NCT00577720|3639397|FG002|Overall Study|Protocol Violation|0
2064242|NCT00577720|3639398|FG003|Overall Study|Protocol Violation|1
2064243|NCT00577720|3639395|FG000|Overall Study|Withdrawal by Subject|2
2064244|NCT00577720|3639396|FG001|Overall Study|Withdrawal by Subject|0
2064245|NCT00577720|3639397|FG002|Overall Study|Withdrawal by Subject|0
2064246|NCT00577720|3639398|FG003|Overall Study|Withdrawal by Subject|2
2064247|NCT00577824|3639411|FG000|Overall Study|Adverse Event|6
2064248|NCT00577824|3639412|FG001|Overall Study|Adverse Event|18
2064249|NCT00577824|3639413|FG002|Overall Study|Adverse Event|1
2064250|NCT00577824|3639411|FG000|Overall Study|Patient decision|0
2064251|NCT00577824|3639412|FG001|Overall Study|Patient decision|1
2064252|NCT00577824|3639413|FG002|Overall Study|Patient decision|1
2064253|NCT00577824|3639411|FG000|Overall Study|Protocol Violation|1
2064254|NCT00577824|3639412|FG001|Overall Study|Protocol Violation|1
2064255|NCT00577824|3639413|FG002|Overall Study|Protocol Violation|0
2064256|NCT00577863|3639423|FG000|Overall Study|Adverse Event|4
2064257|NCT00577863|3639424|FG001|Overall Study|Adverse Event|2
2064258|NCT00577863|3639423|FG000|Overall Study|Death|1
2064259|NCT00577863|3639424|FG001|Overall Study|Death|0
2064260|NCT00577863|3639423|FG000|Overall Study|Lost to Follow-up|2
2064261|NCT00577863|3639424|FG001|Overall Study|Lost to Follow-up|2
2064262|NCT00577863|3639423|FG000|Overall Study|Entry Criteria Exclusion|1
2064263|NCT00577863|3639424|FG001|Overall Study|Entry Criteria Exclusion|0
2064264|NCT00577863|3639423|FG000|Overall Study|Withdrawal by Subject|0
2064265|NCT00577863|3639424|FG001|Overall Study|Withdrawal by Subject|2
2064266|NCT00577863|3639423|FG000|Overall Study|Sponsor Decision|2
2064267|NCT00577863|3639424|FG001|Overall Study|Sponsor Decision|7
2064268|NCT00577863|3639423|FG000|Overall Study|Did Not Receive at Least One Injection|0
2064269|NCT00577863|3639424|FG001|Overall Study|Did Not Receive at Least One Injection|1
2064270|NCT00577889|3639433|FG000|Overall Study|Withdrawal by Subject|1
2064271|NCT00577889|3639434|FG001|Overall Study|Withdrawal by Subject|0
2064272|NCT00577889|3639435|FG002|Overall Study|Withdrawal by Subject|0
2064273|NCT00577993|3639446|FG000|Overall Study|Adverse Event|1
2064274|NCT00577993|3639447|FG001|Overall Study|Adverse Event|0
2064275|NCT00577993|3639448|FG002|Overall Study|Adverse Event|0
2064276|NCT00577993|3639446|FG000|Overall Study|Death|0
2064277|NCT00577993|3639447|FG001|Overall Study|Death|1
2064278|NCT00577993|3639448|FG002|Overall Study|Death|1
2064279|NCT00577993|3639446|FG000|Overall Study|Lack of Efficacy|0
2064280|NCT00577993|3639447|FG001|Overall Study|Lack of Efficacy|1
2064281|NCT00577993|3639448|FG002|Overall Study|Lack of Efficacy|0
2064282|NCT00577993|3639446|FG000|Overall Study|Protocol Violation|2
2064283|NCT00577993|3639447|FG001|Overall Study|Protocol Violation|3
2064284|NCT00577993|3639448|FG002|Overall Study|Protocol Violation|0
2064285|NCT00577993|3639446|FG000|Overall Study|Withdrawal by Subject|1
2064286|NCT00577993|3639447|FG001|Overall Study|Withdrawal by Subject|0
2064287|NCT00577993|3639448|FG002|Overall Study|Withdrawal by Subject|2
2064288|NCT00577993|3639446|FG000|Overall Study|Conversion|2
2064289|NCT00577993|3639447|FG001|Overall Study|Conversion|5
2064290|NCT00577993|3639448|FG002|Overall Study|Conversion|0
2064291|NCT00577993|3639446|FG000|Overall Study|Uninsured|1
2064292|NCT00577993|3639447|FG001|Overall Study|Uninsured|0
2064293|NCT00577993|3639448|FG002|Overall Study|Uninsured|0
2064294|NCT00578136|3639461|FG000|Overall Study|Not given intervention|1
2064295|NCT00578136|3639462|FG001|Overall Study|Not given intervention|1
2064296|NCT00578175|3639471|FG000|Overall Study|Adverse Event|0
2064297|NCT00578175|3639472|FG001|Overall Study|Adverse Event|1
2064298|NCT00578175|3639473|FG002|Overall Study|Adverse Event|1
2064299|NCT00578175|3639471|FG000|Overall Study|Other reasons|70
2064300|NCT00578175|3639472|FG001|Overall Study|Other reasons|42
2064301|NCT00578175|3639473|FG002|Overall Study|Other reasons|23
2064302|NCT00578227|3639499|FG000|Overall Study|Lost to Follow-up|0
2064303|NCT00578227|3639500|FG001|Overall Study|Lost to Follow-up|1
2064304|NCT00578227|3639501|FG002|Overall Study|Lost to Follow-up|1
2064305|NCT00578227|3639499|FG000|Overall Study|Withdrawal by Subject|5
2064306|NCT00578227|3639500|FG001|Overall Study|Withdrawal by Subject|1
2064307|NCT00578227|3639501|FG002|Overall Study|Withdrawal by Subject|3
2064308|NCT00578292|3639520|FG000|Overall Study|Death|1
2064309|NCT00578292|3639520|FG000|Overall Study|Graft failure|2
2064310|NCT00578318|3639545|FG000|Overall Study|Lost to Follow-up|2
2064311|NCT00578318|3639546|FG001|Overall Study|Lost to Follow-up|0
2064312|NCT00578318|3639545|FG000|Overall Study|Physician Decision|1
2064313|NCT00578318|3639546|FG001|Overall Study|Physician Decision|0
2064314|NCT00578344|3639561|FG000|Overall Study|Insurance problems|1
2064315|NCT00578344|3639561|FG000|Overall Study|Graft failure|1
2064316|NCT00578448|3639586|FG000|Day 1 up to 3 Years of Planned Study|Death|1
2064317|NCT00578448|3639586|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1
2064318|NCT00578448|3639586|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
2064319|NCT00578448|3639586|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1
2064320|NCT00578565|3639613|FG000|Overall Study|Adverse Event|3
2064321|NCT00578643|3639627|FG000|Overall Study|Death|1
2064322|NCT00578643|3639627|FG000|Overall Study|Lost to Follow-up|1
2064323|NCT00578786|3639652|FG000|Overall Study|Adverse Event|27
2064324|NCT00578786|3639653|FG001|Overall Study|Adverse Event|37
2064325|NCT00578786|3639654|FG002|Overall Study|Adverse Event|17
2064326|NCT00578786|3639652|FG000|Overall Study|Lack of Efficacy|2
2064327|NCT00578786|3639653|FG001|Overall Study|Lack of Efficacy|5
2064328|NCT00578786|3639654|FG002|Overall Study|Lack of Efficacy|2
2064329|NCT00578786|3639652|FG000|Overall Study|Early Escape from Prior Study|2
2064330|NCT00578786|3639653|FG001|Overall Study|Early Escape from Prior Study|1
2064331|NCT00578786|3639654|FG002|Overall Study|Early Escape from Prior Study|2
2064332|NCT00578786|3639652|FG000|Overall Study|Withdrawal by Subject|7
2064333|NCT00578786|3639653|FG001|Overall Study|Withdrawal by Subject|8
2064334|NCT00578786|3639654|FG002|Overall Study|Withdrawal by Subject|5
2064335|NCT00578786|3639652|FG000|Overall Study|Protocol Violation|0
2064336|NCT00578786|3639653|FG001|Overall Study|Protocol Violation|3
2064337|NCT00578786|3639654|FG002|Overall Study|Protocol Violation|1
2064338|NCT00578786|3639652|FG000|Overall Study|Physician Decision|1
2064339|NCT00578786|3639653|FG001|Overall Study|Physician Decision|0
2064340|NCT00578786|3639654|FG002|Overall Study|Physician Decision|1
2064341|NCT00578786|3639652|FG000|Overall Study|Sponsor Decision|0
2064342|NCT00578786|3639653|FG001|Overall Study|Sponsor Decision|0
2064343|NCT00578786|3639654|FG002|Overall Study|Sponsor Decision|1
2064344|NCT00578786|3639652|FG000|Overall Study|Lost to Follow-up|0
2064345|NCT00578786|3639653|FG001|Overall Study|Lost to Follow-up|4
2064346|NCT00578786|3639654|FG002|Overall Study|Lost to Follow-up|0
2064347|NCT00578786|3639652|FG000|Overall Study|Pregnancy|0
2064348|NCT00578786|3639653|FG001|Overall Study|Pregnancy|1
2064349|NCT00578786|3639654|FG002|Overall Study|Pregnancy|0
2064350|NCT00578786|3639652|FG000|Overall Study|Not Otherwise Specified|0
2064351|NCT00578786|3639653|FG001|Overall Study|Not Otherwise Specified|4
2064352|NCT00578786|3639654|FG002|Overall Study|Not Otherwise Specified|1
2064353|NCT00578786|3639652|FG000|Overall Study|Qualified but Not Enrolled in Extension|0
2064354|NCT00578786|3639653|FG001|Overall Study|Qualified but Not Enrolled in Extension|3
2064355|NCT00578786|3639654|FG002|Overall Study|Qualified but Not Enrolled in Extension|0
2064356|NCT00578812|3639674|FG000|Overall Study|Not treated|6
2064357|NCT00578812|3639675|FG001|Overall Study|Not treated|7
2064358|NCT00578864|3639684|FG000|Overall Study|Death|1
2064359|NCT00578864|3639685|FG001|Overall Study|Death|0
2064360|NCT00578877|3639693|FG000|Overall Study|Lost to Follow-up|8
2064361|NCT00578877|3639694|FG001|Overall Study|Lost to Follow-up|10
2064362|NCT00578877|3639693|FG000|Overall Study|early discontinue|61
2064363|NCT00578877|3639694|FG001|Overall Study|early discontinue|101
2064364|NCT00578877|3639693|FG000|Overall Study|did not provide follow-up data|12
2064365|NCT00578877|3639694|FG001|Overall Study|did not provide follow-up data|17
2064366|NCT00578942|3639722|FG000|Overall Study|Lost to Follow-up|1
2064367|NCT00579059|3639742|FG000|Overall Study|Study Canceled at 1 Year|21
2064368|NCT00579059|3639743|FG001|Overall Study|Study Canceled at 1 Year|10
2064369|NCT00579098|3639751|FG000|Overall Study|Lost to Follow-up|2
2064370|NCT00579098|3639752|FG001|Overall Study|Lost to Follow-up|0
2064371|NCT00579098|3639751|FG000|Overall Study|Adverse Event|2
2064372|NCT00579098|3639752|FG001|Overall Study|Adverse Event|3
2064373|NCT00579098|3639751|FG000|Overall Study|Withdrawal by Subject|2
2064374|NCT00579098|3639752|FG001|Overall Study|Withdrawal by Subject|3
2064375|NCT00579098|3639751|FG000|Overall Study|AF returned after ablation|3
2064376|NCT00579098|3639752|FG001|Overall Study|AF returned after ablation|2
2064377|NCT00579345|3639792|FG000|Overall Study|Withdrawal by Subject|2
2064378|NCT00579345|3639793|FG001|Overall Study|Withdrawal by Subject|0
2064379|NCT00579345|3639794|FG002|Overall Study|Withdrawal by Subject|0
2064380|NCT00579345|3639795|FG003|Overall Study|Withdrawal by Subject|0
2064381|NCT00579345|3639796|FG004|Overall Study|Withdrawal by Subject|0
2064382|NCT00579345|3639797|FG005|Overall Study|Withdrawal by Subject|0
2064383|NCT00579345|3639798|FG006|Overall Study|Withdrawal by Subject|0
2064384|NCT00579345|3639799|FG007|Overall Study|Withdrawal by Subject|1
2064385|NCT00579345|3639792|FG000|Overall Study|Lost to Follow-up|1
2064386|NCT00579345|3639793|FG001|Overall Study|Lost to Follow-up|0
2064387|NCT00579345|3639794|FG002|Overall Study|Lost to Follow-up|0
2064388|NCT00579345|3639795|FG003|Overall Study|Lost to Follow-up|0
2064389|NCT00579345|3639796|FG004|Overall Study|Lost to Follow-up|0
2064390|NCT00579345|3639797|FG005|Overall Study|Lost to Follow-up|0
2064391|NCT00579345|3639798|FG006|Overall Study|Lost to Follow-up|0
2064392|NCT00579345|3639799|FG007|Overall Study|Lost to Follow-up|0
2064393|NCT00579345|3639792|FG000|Overall Study|Adverse Event|0
2064394|NCT00579345|3639793|FG001|Overall Study|Adverse Event|0
2064395|NCT00579345|3639794|FG002|Overall Study|Adverse Event|1
2064396|NCT00579345|3639795|FG003|Overall Study|Adverse Event|0
2064397|NCT00579345|3639796|FG004|Overall Study|Adverse Event|0
2064398|NCT00579345|3639797|FG005|Overall Study|Adverse Event|0
2064399|NCT00579345|3639798|FG006|Overall Study|Adverse Event|0
2064400|NCT00579345|3639799|FG007|Overall Study|Adverse Event|0
2064401|NCT00579345|3639792|FG000|Overall Study|Protocol Violation|1
2064402|NCT00579345|3639793|FG001|Overall Study|Protocol Violation|0
2064403|NCT00579345|3639794|FG002|Overall Study|Protocol Violation|0
2064404|NCT00579345|3639795|FG003|Overall Study|Protocol Violation|0
2064405|NCT00579345|3639796|FG004|Overall Study|Protocol Violation|0
2064406|NCT00579345|3639797|FG005|Overall Study|Protocol Violation|0
2064407|NCT00579345|3639798|FG006|Overall Study|Protocol Violation|0
2064408|NCT00579345|3639799|FG007|Overall Study|Protocol Violation|1
2064409|NCT00579345|3639792|FG000|Overall Study|Death|1
2064410|NCT00579345|3639793|FG001|Overall Study|Death|1
2064411|NCT00579345|3639794|FG002|Overall Study|Death|1
2064412|NCT00579345|3639795|FG003|Overall Study|Death|1
2064413|NCT00579345|3639796|FG004|Overall Study|Death|0
2064414|NCT00579345|3639797|FG005|Overall Study|Death|0
2064415|NCT00579345|3639798|FG006|Overall Study|Death|0
2064416|NCT00579345|3639799|FG007|Overall Study|Death|0
2064417|NCT00579501|3639836|FG000|Overall Study|Death|1
2064418|NCT00579501|3639836|FG000|Overall Study|End of neoadjuvant therapy|25
2064419|NCT00579501|3639836|FG000|Overall Study|toxicity|1
2064420|NCT00579501|3639836|FG000|Overall Study|Secondary lesion|1
2064421|NCT00579501|3639836|FG000|Overall Study|Radiation therapy before surgery|1
2064422|NCT00579527|3639840|FG000|Overall Study|Death|4
2064423|NCT00579553|3639847|FG000|Overall Study|Lost to Follow-up|16
2064424|NCT00579553|3639848|FG001|Overall Study|Lost to Follow-up|13
2064425|NCT00579670|3639859|FG000|Overall Study|Death|1
2064426|NCT00579670|3639860|FG001|Overall Study|Death|0
2064427|NCT00579670|3639861|FG002|Overall Study|Death|0
2064428|NCT00579670|3639862|FG003|Overall Study|Death|0
2064429|NCT00579670|3639863|FG004|Overall Study|Death|0
2064430|NCT00579670|3639859|FG000|Overall Study|Adverse Event|1
2064431|NCT00579670|3639860|FG001|Overall Study|Adverse Event|0
2064432|NCT00579670|3639861|FG002|Overall Study|Adverse Event|1
2064433|NCT00579670|3639862|FG003|Overall Study|Adverse Event|2
2064434|NCT00579670|3639863|FG004|Overall Study|Adverse Event|0
2064435|NCT00579670|3639859|FG000|Overall Study|Lack of Efficacy|0
2064436|NCT00579670|3639860|FG001|Overall Study|Lack of Efficacy|0
2064437|NCT00579670|3639861|FG002|Overall Study|Lack of Efficacy|1
2064438|NCT00579670|3639862|FG003|Overall Study|Lack of Efficacy|14
2064439|NCT00579670|3639863|FG004|Overall Study|Lack of Efficacy|0
2064440|NCT00579670|3639859|FG000|Overall Study|Lost to Follow-up|0
2064441|NCT00579670|3639860|FG001|Overall Study|Lost to Follow-up|1
2064442|NCT00579670|3639861|FG002|Overall Study|Lost to Follow-up|0
2064443|NCT00579670|3639862|FG003|Overall Study|Lost to Follow-up|4
2064444|NCT00579670|3639863|FG004|Overall Study|Lost to Follow-up|0
2064445|NCT00579670|3639859|FG000|Overall Study|Other|0
2064446|NCT00579670|3639860|FG001|Overall Study|Other|0
2064447|NCT00579670|3639861|FG002|Overall Study|Other|1
2064448|NCT00579670|3639862|FG003|Overall Study|Other|2
2064449|NCT00579670|3639863|FG004|Overall Study|Other|0
2064450|NCT00579670|3639859|FG000|Overall Study|Withdrawal by Subject|0
2064451|NCT00579670|3639860|FG001|Overall Study|Withdrawal by Subject|0
2064452|NCT00579670|3639861|FG002|Overall Study|Withdrawal by Subject|1
2064453|NCT00579670|3639862|FG003|Overall Study|Withdrawal by Subject|0
2064454|NCT00579670|3639863|FG004|Overall Study|Withdrawal by Subject|0
2064455|NCT00579982|3639910|FG000|Overall Study|Adverse Event|4
2064456|NCT00579982|3639910|FG000|Overall Study|Protocol Violation|4
2064457|NCT00580034|3639914|FG000|Overall Study|Toxicity|10
2064458|NCT00580034|3639915|FG001|Overall Study|Toxicity|0
2064459|NCT00580047|3639922|FG000|Overall Study|Lost to Follow-up|1
2064460|NCT00580047|3639923|FG001|Overall Study|Lost to Follow-up|1
2064461|NCT00580047|3639924|FG002|Overall Study|Lost to Follow-up|0
2064462|NCT00580047|3639922|FG000|Overall Study|Withdrawal by Subject|1
2064463|NCT00580047|3639923|FG001|Overall Study|Withdrawal by Subject|1
2064464|NCT00580047|3639924|FG002|Overall Study|Withdrawal by Subject|2
2064465|NCT00580047|3639922|FG000|Overall Study|Withdrawal by Subject|1
2064466|NCT00580047|3639923|FG001|Overall Study|Withdrawal by Subject|0
2064467|NCT00580047|3639924|FG002|Overall Study|Withdrawal by Subject|0
2064468|NCT00580606|3639984|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
2064469|NCT00580606|3639985|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
2064470|NCT00580606|3639984|FG000|Open Label (OL)|Withdrawal by Subject|4
2064471|NCT00580606|3639985|FG001|Open Label (OL)|Withdrawal by Subject|6
2064472|NCT00580606|3639984|FG000|Open Label (OL)|Dosing Symptoms|0
2064473|NCT00580606|3639985|FG001|Open Label (OL)|Dosing Symptoms|1
2064474|NCT00580606|3639984|FG000|Open Label (OL)|Lost to Follow-up|0
2064475|NCT00580606|3639985|FG001|Open Label (OL)|Lost to Follow-up|1
2064476|NCT00580606|3639984|FG000|Open Label (OL)|Pregnancy|0
2064477|NCT00580606|3639985|FG001|Open Label (OL)|Pregnancy|1
2064478|NCT00580606|3639984|FG000|Open Label (OL)|Non-compliance|2
2064479|NCT00580606|3639985|FG001|Open Label (OL)|Non-compliance|0
2064480|NCT00580606|3639984|FG000|Open Label (OL)|Physician Decision|1
2064481|NCT00580606|3639985|FG001|Open Label (OL)|Physician Decision|1
2064482|NCT00580606|3639984|FG000|Open Label (OL)|Needed Prohibited Medication|0
2064483|NCT00580606|3639985|FG001|Open Label (OL)|Needed Prohibited Medication|1
2105967|NCT00862459|3698956|FG002|Overall Study|Unable to hold still for imaging|0
2105968|NCT00862459|3698954|FG000|Overall Study|Inclusion/exclusion criteria not met|0
2105969|NCT00862459|3698955|FG001|Overall Study|Inclusion/exclusion criteria not met|1
2105970|NCT00862459|3698956|FG002|Overall Study|Inclusion/exclusion criteria not met|0
2105971|NCT00862459|3698954|FG000|Overall Study|Administrative problems|0
2105972|NCT00862459|3698955|FG001|Overall Study|Administrative problems|1
2105973|NCT00862459|3698956|FG002|Overall Study|Administrative problems|0
2105974|NCT00862641|3698999|FG000|Overall Study|Randomized, but drug not received|1
2105975|NCT00862641|3699000|FG001|Overall Study|Randomized, but drug not received|4
2105976|NCT00862641|3699001|FG002|Overall Study|Randomized, but drug not received|1
2105977|NCT00862641|3699002|FG003|Overall Study|Randomized, but drug not received|4
2105978|NCT00862654|3699016|FG000|Overall Study|Lack of Efficacy|1
2105979|NCT00862654|3699017|FG001|Overall Study|Lack of Efficacy|0
2105980|NCT00862654|3699018|FG002|Overall Study|Lack of Efficacy|1
2105981|NCT00862654|3699019|FG003|Overall Study|Lack of Efficacy|0
2105982|NCT00862654|3699016|FG000|Overall Study|Lost to Follow-up|1
2105983|NCT00862654|3699017|FG001|Overall Study|Lost to Follow-up|2
2105984|NCT00862654|3699018|FG002|Overall Study|Lost to Follow-up|1
2105985|NCT00862654|3699019|FG003|Overall Study|Lost to Follow-up|3
2105986|NCT00862654|3699016|FG000|Overall Study|Adverse Event|0
2105987|NCT00862654|3699017|FG001|Overall Study|Adverse Event|1
2105988|NCT00862654|3699018|FG002|Overall Study|Adverse Event|1
2105989|NCT00862654|3699019|FG003|Overall Study|Adverse Event|0
2105990|NCT00862654|3699016|FG000|Overall Study|Pregnancy|1
2105991|NCT00862654|3699017|FG001|Overall Study|Pregnancy|1
2105992|NCT00862654|3699018|FG002|Overall Study|Pregnancy|0
2105993|NCT00862654|3699019|FG003|Overall Study|Pregnancy|0
2105994|NCT00862654|3699016|FG000|Overall Study|Withdrawal by Subject|2
2105995|NCT00862654|3699017|FG001|Overall Study|Withdrawal by Subject|2
2105996|NCT00862654|3699018|FG002|Overall Study|Withdrawal by Subject|2
2105997|NCT00862654|3699019|FG003|Overall Study|Withdrawal by Subject|3
2105998|NCT00862654|3699016|FG000|Overall Study|Subject mistake|0
2105999|NCT00862654|3699017|FG001|Overall Study|Subject mistake|1
2106000|NCT00862654|3699018|FG002|Overall Study|Subject mistake|0
2106001|NCT00862654|3699019|FG003|Overall Study|Subject mistake|0
2106002|NCT00862654|3699016|FG000|Overall Study|Familly constraint|0
2106003|NCT00862654|3699017|FG001|Overall Study|Familly constraint|1
2106004|NCT00862654|3699018|FG002|Overall Study|Familly constraint|0
2106005|NCT00862654|3699019|FG003|Overall Study|Familly constraint|0
2106006|NCT00862654|3699016|FG000|Overall Study|Never used study drugs|1
2106007|NCT00862654|3699017|FG001|Overall Study|Never used study drugs|0
2106008|NCT00862654|3699018|FG002|Overall Study|Never used study drugs|0
2106009|NCT00862654|3699019|FG003|Overall Study|Never used study drugs|0
2106010|NCT00862654|3699016|FG000|Overall Study|Included after end of inclusions|0
2106011|NCT00862654|3699017|FG001|Overall Study|Included after end of inclusions|0
2106012|NCT00862654|3699018|FG002|Overall Study|Included after end of inclusions|1
2106013|NCT00862654|3699019|FG003|Overall Study|Included after end of inclusions|0
2106014|NCT00862719|3699033|FG000|Overall Study|Disease Progression|5
2064484|NCT00580723|3640025|FG000|Overall Study|Did not want to participate in extension|3
2064485|NCT00580723|3640025|FG000|Overall Study|Lost to Follow-up|5
2064486|NCT00580788|3640033|FG000|Overall Study|Adverse Event|0
2064487|NCT00580788|3640034|FG001|Overall Study|Adverse Event|0
2064488|NCT00580788|3640035|FG002|Overall Study|Adverse Event|0
2064489|NCT00580788|3640036|FG003|Overall Study|Adverse Event|1
2064490|NCT00580801|3640056|FG000|Overall Study|Physician Decision|1
2064491|NCT00580801|3640057|FG001|Overall Study|Physician Decision|0
2064492|NCT00580801|3640058|FG002|Overall Study|Physician Decision|0
2064493|NCT00580801|3640056|FG000|Overall Study|Adverse Event|2
2064494|NCT00580801|3640057|FG001|Overall Study|Adverse Event|0
2064495|NCT00580801|3640058|FG002|Overall Study|Adverse Event|0
2064496|NCT00580801|3640056|FG000|Overall Study|Lost to Follow-up|2
2064497|NCT00580801|3640057|FG001|Overall Study|Lost to Follow-up|0
2064498|NCT00580801|3640058|FG002|Overall Study|Lost to Follow-up|0
2064499|NCT00580801|3640056|FG000|Overall Study|Reached a virologic endpoint|0
2064500|NCT00580801|3640057|FG001|Overall Study|Reached a virologic endpoint|1
2064501|NCT00580801|3640058|FG002|Overall Study|Reached a virologic endpoint|2
2064502|NCT00580801|3640056|FG000|Overall Study|Participant non-compliant|0
2064503|NCT00580801|3640057|FG001|Overall Study|Participant non-compliant|0
2064504|NCT00580801|3640058|FG002|Overall Study|Participant non-compliant|1
2064505|NCT00580801|3640056|FG000|Overall Study|Travel|1
2064506|NCT00580801|3640057|FG001|Overall Study|Travel|0
2064507|NCT00580801|3640058|FG002|Overall Study|Travel|0
2064508|NCT00580840|3640066|FG000|Run-in|Adverse Event|17
2064509|NCT00580840|3640067|FG001|Run-in|Adverse Event|0
2064510|NCT00580840|3640068|FG002|Run-in|Adverse Event|0
2064511|NCT00580840|3640069|FG003|Run-in|Adverse Event|0
2064512|NCT00580840|3640066|FG000|Run-in|Lack of Efficacy|93
2064513|NCT00580840|3640067|FG001|Run-in|Lack of Efficacy|0
2064514|NCT00580840|3640068|FG002|Run-in|Lack of Efficacy|0
2064515|NCT00580840|3640069|FG003|Run-in|Lack of Efficacy|0
2064516|NCT00580840|3640066|FG000|Run-in|Loss of Efficacy|1
2064517|NCT00580840|3640067|FG001|Run-in|Loss of Efficacy|0
2064518|NCT00580840|3640068|FG002|Run-in|Loss of Efficacy|0
2064519|NCT00580840|3640069|FG003|Run-in|Loss of Efficacy|0
2064520|NCT00580840|3640066|FG000|Run-in|Lost to Follow-up|4
2064521|NCT00580840|3640067|FG001|Run-in|Lost to Follow-up|0
2064522|NCT00580840|3640068|FG002|Run-in|Lost to Follow-up|0
2064523|NCT00580840|3640069|FG003|Run-in|Lost to Follow-up|0
2064524|NCT00580840|3640066|FG000|Run-in|Withdrawal by Subject|5
2064525|NCT00580840|3640067|FG001|Run-in|Withdrawal by Subject|0
2064526|NCT00580840|3640068|FG002|Run-in|Withdrawal by Subject|0
2064527|NCT00580840|3640069|FG003|Run-in|Withdrawal by Subject|0
2064528|NCT00580840|3640066|FG000|Run-in|Other: Per Sponsor Request|2
2064529|NCT00580840|3640067|FG001|Run-in|Other: Per Sponsor Request|0
2064530|NCT00580840|3640068|FG002|Run-in|Other: Per Sponsor Request|0
2064531|NCT00580840|3640069|FG003|Run-in|Other: Per Sponsor Request|0
2064532|NCT00580840|3640066|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1
2064533|NCT00580840|3640067|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0
2064534|NCT00580840|3640068|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0
2064535|NCT00580840|3640069|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0
2064536|NCT00580840|3640066|FG000|Run-in|Other: Exclusionary Lab Value|1
2064537|NCT00580840|3640067|FG001|Run-in|Other: Exclusionary Lab Value|0
2064538|NCT00580840|3640068|FG002|Run-in|Other: Exclusionary Lab Value|0
2064539|NCT00580840|3640069|FG003|Run-in|Other: Exclusionary Lab Value|0
2064540|NCT00580840|3640066|FG000|Double-Blind|Adverse Event|0
2064541|NCT00580840|3640067|FG001|Double-Blind|Adverse Event|3
2064542|NCT00580840|3640068|FG002|Double-Blind|Adverse Event|4
2064543|NCT00580840|3640069|FG003|Double-Blind|Adverse Event|1
2064544|NCT00580840|3640066|FG000|Double-Blind|Loss of Efficacy|0
2064545|NCT00580840|3640067|FG001|Double-Blind|Loss of Efficacy|1
2064546|NCT00580840|3640068|FG002|Double-Blind|Loss of Efficacy|2
2064547|NCT00580840|3640069|FG003|Double-Blind|Loss of Efficacy|10
2064548|NCT00580840|3640066|FG000|Double-Blind|Lost to Follow-up|0
2064549|NCT00580840|3640067|FG001|Double-Blind|Lost to Follow-up|1
2064550|NCT00580840|3640068|FG002|Double-Blind|Lost to Follow-up|0
2064551|NCT00580840|3640069|FG003|Double-Blind|Lost to Follow-up|2
2064552|NCT00580840|3640066|FG000|Double-Blind|Withdrawal by Subject|0
2064553|NCT00580840|3640067|FG001|Double-Blind|Withdrawal by Subject|1
2064554|NCT00580840|3640068|FG002|Double-Blind|Withdrawal by Subject|2
2064555|NCT00580840|3640069|FG003|Double-Blind|Withdrawal by Subject|2
2064556|NCT00580840|3640066|FG000|Double-Blind|Other: Discontinued Methotrexate|0
2064557|NCT00580840|3640067|FG001|Double-Blind|Other: Discontinued Methotrexate|1
2064558|NCT00580840|3640068|FG002|Double-Blind|Other: Discontinued Methotrexate|0
2064559|NCT00580840|3640069|FG003|Double-Blind|Other: Discontinued Methotrexate|0
2064560|NCT00580840|3640066|FG000|Double-Blind|Other: Forbidden Medication|0
2064561|NCT00580840|3640067|FG001|Double-Blind|Other: Forbidden Medication|0
2064562|NCT00580840|3640068|FG002|Double-Blind|Other: Forbidden Medication|1
2064563|NCT00580840|3640069|FG003|Double-Blind|Other: Forbidden Medication|0
2064564|NCT00580866|3640094|FG000|Overall Study|Lost to Follow-up|2
2064565|NCT00580866|3640095|FG001|Overall Study|Lost to Follow-up|2
2064566|NCT00580970|3640112|FG000|Pre-treatment|Non-compliance|1
2064567|NCT00580970|3640112|FG000|Treatment (Lovastatin)|Non-compliance|6
2064568|NCT00580970|3640112|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7
2064569|NCT00580970|3640112|FG000|Treatment (Lovastatin)|Physician Decision|4
2064570|NCT00580970|3640112|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1
2064571|NCT00580970|3640112|FG000|Treatment (Lovastatin)|Death|1
2064572|NCT00580983|3640116|FG000|Overall Study|Did not complete 12 mon post RT studies|7
2064573|NCT00581100|3640133|FG000|Overall Study|Death|1
2064574|NCT00581100|3640134|FG001|Overall Study|Death|0
2064575|NCT00581100|3640133|FG000|Overall Study|Adverse Event|2
2064576|NCT00581100|3640134|FG001|Overall Study|Adverse Event|1
2064577|NCT00581100|3640133|FG000|Overall Study|Withdrawal by Subject|1
2064578|NCT00581100|3640134|FG001|Overall Study|Withdrawal by Subject|4
2064579|NCT00581100|3640133|FG000|Overall Study|Other|3
2064580|NCT00581100|3640134|FG001|Overall Study|Other|0
2064581|NCT00581308|3640156|FG000|Pre Discharge|Lost to Follow-up|1
2064582|NCT00581308|3640156|FG000|Pre Discharge|Device Removed|1
2064583|NCT00581308|3640156|FG000|Month 1|Lost to Follow-up|3
2064584|NCT00581308|3640156|FG000|Month 1|Withdrawal by Subject|2
2064585|NCT00581308|3640156|FG000|Month 1|Device Removed|2
2064586|NCT00581308|3640156|FG000|Month 1|Uknown|1
2064587|NCT00581308|3640156|FG000|Month 6|Lost to Follow-up|1
2064588|NCT00581308|3640156|FG000|Month 6|Withdrawal by Subject|2
2064589|NCT00581308|3640156|FG000|Month 12|Death|1
2064590|NCT00581308|3640156|FG000|Month 12|Lost to Follow-up|14
2064591|NCT00581308|3640156|FG000|Month 12|Withdrawal by Subject|3
2064592|NCT00581308|3640156|FG000|Month 12|Device Removed|1
2064593|NCT00581308|3640156|FG000|Month 12|Other|1
2064594|NCT00581360|3640172|FG000|Overall Study|Withdrawal by Subject|1
2064595|NCT00581542|3640204|FG000|Overall Study|they met an exclusion criteria|2
2064596|NCT00581542|3640205|FG001|Overall Study|they met an exclusion criteria|2
2064597|NCT00581542|3640204|FG000|Overall Study|Lost to Follow-up|9
2064598|NCT00581542|3640205|FG001|Overall Study|Lost to Follow-up|21
2064599|NCT00581555|3640215|FG000|Overall Study|Adverse Event|4
2064600|NCT00581555|3640216|FG001|Overall Study|Adverse Event|3
2064601|NCT00581555|3640215|FG000|Overall Study|Physician Decision|3
2064602|NCT00581555|3640216|FG001|Overall Study|Physician Decision|2
2064603|NCT00581555|3640215|FG000|Overall Study|Withdrawal by Subject|18
2064604|NCT00581555|3640216|FG001|Overall Study|Withdrawal by Subject|9
2064605|NCT00581555|3640215|FG000|Overall Study|Lost to Follow-up|2
2064606|NCT00581555|3640216|FG001|Overall Study|Lost to Follow-up|2
2064607|NCT00581555|3640215|FG000|Overall Study|Other reasons|16
2064608|NCT00581555|3640216|FG001|Overall Study|Other reasons|4
2064609|NCT00581776|3640231|FG000|Overall Study|Disease progression or no response|3
2064610|NCT00581828|3640235|FG000|Overall Study|Protocol Violation|1
2064611|NCT00581893|3640250|FG000|Second Intervention (1 Month)|Lost to Follow-up|3
2064612|NCT00581893|3640251|FG001|Second Intervention (1 Month)|Lost to Follow-up|2
2064613|NCT00581919|3640257|FG000|Overall Study|Adverse Event|8
2064614|NCT00581919|3640257|FG000|Overall Study|Death|1
2064615|NCT00581919|3640257|FG000|Overall Study|Disease Progression|10
2064616|NCT00581919|3640257|FG000|Overall Study|Physician Decision|1
2064617|NCT00581919|3640257|FG000|Overall Study|Other Complicating Disease|1
2064618|NCT00581919|3640257|FG000|Overall Study|Started Non-Protocol Therapy|2
2064619|NCT00581919|3640257|FG000|Overall Study|Withdrawal by Subject|1
2064620|NCT00581945|3640264|FG000|Overall Study|Adverse Event|4
2064621|NCT00581945|3640265|FG001|Overall Study|Adverse Event|4
2064622|NCT00581945|3640264|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2064623|NCT00581945|3640265|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2064624|NCT00581945|3640264|FG000|Overall Study|Withdrawal by Subject|2
2064625|NCT00581945|3640265|FG001|Overall Study|Withdrawal by Subject|6
2064626|NCT00581945|3640264|FG000|Overall Study|Death|1
2064627|NCT00581945|3640265|FG001|Overall Study|Death|0
2064628|NCT00582010|3640278|FG000|Overall Study|Death|0
2064629|NCT00582010|3640279|FG001|Overall Study|Death|1
2064630|NCT00582114|3640291|FG000|Overall Study|Death|4
2064631|NCT00582114|3640292|FG001|Overall Study|Death|4
2064632|NCT00582114|3640291|FG000|Overall Study|Kidney Transplant|3
2064633|NCT00582114|3640292|FG001|Overall Study|Kidney Transplant|1
2064634|NCT00582114|3640291|FG000|Overall Study|Lost to Follow-up|7
2064635|NCT00582114|3640292|FG001|Overall Study|Lost to Follow-up|6
2064636|NCT00582114|3640291|FG000|Overall Study|Withdrawal by Subject|8
2064637|NCT00582114|3640292|FG001|Overall Study|Withdrawal by Subject|16
2064638|NCT00582114|3640291|FG000|Overall Study|Adverse Event|1
2064639|NCT00582114|3640292|FG001|Overall Study|Adverse Event|1
2064640|NCT00582114|3640291|FG000|Overall Study|Physician Decision|0
2064641|NCT00582114|3640292|FG001|Overall Study|Physician Decision|6
2064642|NCT00582114|3640291|FG000|Overall Study|Stopped by data safety monitoring board|19
2064643|NCT00582114|3640292|FG001|Overall Study|Stopped by data safety monitoring board|20
2064644|NCT00582166|3640298|FG000|Overall Study|Death|1
2064645|NCT00582166|3640298|FG000|Overall Study|Ineligible pathology|1
2064646|NCT00582309|3640309|FG000|Overall Study|Protocol Violation|0
2064647|NCT00582309|3640310|FG001|Overall Study|Protocol Violation|0
2064648|NCT00582309|3640311|FG002|Overall Study|Protocol Violation|2
2064649|NCT00582426|3640334|FG000|Overall Study|Lost to Follow-up|0
2064650|NCT00582426|3640335|FG001|Overall Study|Lost to Follow-up|2
2064651|NCT00582426|3640334|FG000|Overall Study|Adverse Event|4
2064652|NCT00582426|3640335|FG001|Overall Study|Adverse Event|2
2064653|NCT00582426|3640334|FG000|Overall Study|Protocol Violation|6
2064654|NCT00582426|3640335|FG001|Overall Study|Protocol Violation|2
2064655|NCT00582426|3640334|FG000|Overall Study|Death|4
2064656|NCT00582426|3640335|FG001|Overall Study|Death|3
2064657|NCT00582426|3640334|FG000|Overall Study|Withdrawal by Subject|3
2064658|NCT00582426|3640335|FG001|Overall Study|Withdrawal by Subject|2
2064659|NCT00582426|3640334|FG000|Overall Study|Disease Progression|2
2064660|NCT00582426|3640335|FG001|Overall Study|Disease Progression|2
2064661|NCT00582426|3640334|FG000|Overall Study|Use of illicit drugs|1
2064662|NCT00582426|3640335|FG001|Overall Study|Use of illicit drugs|0
2064663|NCT00582491|3640343|FG000|Overall Study|Withdrawal by Subject|1
2064664|NCT00582491|3640344|FG001|Overall Study|Withdrawal by Subject|0
2064665|NCT00582556|3640362|FG000|Overall Study|Withdrawal by Subject|0
2064666|NCT00582556|3640363|FG001|Overall Study|Withdrawal by Subject|1
2064667|NCT00582556|3640364|FG002|Overall Study|Withdrawal by Subject|1
2064668|NCT00582556|3640362|FG000|Overall Study|Physician Decision|0
2064669|NCT00582556|3640363|FG001|Overall Study|Physician Decision|0
2064670|NCT00582556|3640364|FG002|Overall Study|Physician Decision|1
2064671|NCT00582608|3640373|FG000|Overall Study|Not Treated|7
2064672|NCT00582608|3640373|FG000|Overall Study|Patient Ineligible|1
2064673|NCT00582608|3640373|FG000|Overall Study|Lack of accrual|4
2064674|NCT00582738|3640388|FG000|Overall Study|Administrative Problems|7
2064675|NCT00582738|3640389|FG001|Overall Study|Administrative Problems|8
2064676|NCT00582738|3640388|FG000|Overall Study|Adverse Event|0
2064677|NCT00582738|3640389|FG001|Overall Study|Adverse Event|5
2064678|NCT00582738|3640388|FG000|Overall Study|Graft Lost|0
2064679|NCT00582738|3640389|FG001|Overall Study|Graft Lost|1
2064680|NCT00582738|3640388|FG000|Overall Study|Other|1
2064681|NCT00582738|3640389|FG001|Overall Study|Other|0
2064682|NCT00582738|3640388|FG000|Overall Study|Protocol Violation|1
2064683|NCT00582738|3640389|FG001|Overall Study|Protocol Violation|1
2064684|NCT00582738|3640388|FG000|Overall Study|Withdrawal by Subject|0
2064685|NCT00582738|3640389|FG001|Overall Study|Withdrawal by Subject|3
2064686|NCT00582790|3640401|FG000|Overall Study|Rapid progression of disease|1
2064687|NCT00582816|3640406|FG000|Overall Study|Engraftment Failure|3
2064688|NCT00582907|3640414|FG000|1st Course|Withdrawal by Subject|1
2064689|NCT00582907|3640415|FG001|1st Course|Withdrawal by Subject|0
2064690|NCT00582907|3640416|FG002|1st Course|Withdrawal by Subject|0
2064691|NCT00582907|3640417|FG003|1st Course|Withdrawal by Subject|0
2064692|NCT00582907|3640414|FG000|1st Course|Lost to Follow-up|0
2064693|NCT00582907|3640415|FG001|1st Course|Lost to Follow-up|0
2064694|NCT00582907|3640416|FG002|1st Course|Lost to Follow-up|0
2064695|NCT00582907|3640417|FG003|1st Course|Lost to Follow-up|1
2064696|NCT00582907|3640414|FG000|2nd Course|Lack of Efficacy|1
2064697|NCT00582907|3640415|FG001|2nd Course|Lack of Efficacy|0
2064698|NCT00582907|3640416|FG002|2nd Course|Lack of Efficacy|0
2064699|NCT00582907|3640417|FG003|2nd Course|Lack of Efficacy|0
2064700|NCT00582933|3640423|FG000|Overall Study|Physician Decision|3
2064701|NCT00582972|3640431|FG000|Overall Study|Protocol Violation|2
2064702|NCT00583102|3640459|FG000|Overall Study|Adverse Event|3
2064703|NCT00583219|3640463|FG000|Phase 2|Withdrawal by Subject|1
2064704|NCT00583362|3640467|FG000|Overall Study|Adverse Event|44
2064705|NCT00583362|3640467|FG000|Overall Study|Lack of Efficacy|22
2064706|NCT00583362|3640467|FG000|Overall Study|Lost to Follow-up|4
2064707|NCT00583362|3640467|FG000|Overall Study|Non-compliance with study drug|28
2064708|NCT00583362|3640467|FG000|Overall Study|Pregnancy|7
2064709|NCT00583362|3640467|FG000|Overall Study|Miscommunication of visit window|5
2064710|NCT00583362|3640467|FG000|Overall Study|Current site closed|7
2064711|NCT00583362|3640467|FG000|Overall Study|Subject not dosed in LBSL99|1
2064712|NCT00583362|3640467|FG000|Overall Study|Subject moved out of the country/state|2
2064713|NCT00583362|3640467|FG000|Overall Study|Missed visits due to staff changes|1
2064714|NCT00583362|3640467|FG000|Overall Study|Misunderstanding of protocol|1
2064715|NCT00583362|3640467|FG000|Overall Study|Behavioral problems and non-compliance|1
2064716|NCT00583362|3640467|FG000|Overall Study|Sponsor request due to missed doses|1
2064717|NCT00583362|3640467|FG000|Overall Study|Physician Decision|19
2064718|NCT00583362|3640467|FG000|Overall Study|Protocol Violation|2
2064719|NCT00583362|3640467|FG000|Overall Study|Withdrawal by Subject|57
2064720|NCT00583453|3640486|FG000|Overall Study|discontinued intervention|0
2064721|NCT00583453|3640487|FG001|Overall Study|discontinued intervention|2
2064722|NCT00583557|3640504|FG000|Overall Study|Withdrawal by Subject|18
2064723|NCT00583557|3640504|FG000|Overall Study|Adverse Event|9
2064724|NCT00583557|3640504|FG000|Overall Study|Lack of Efficacy|31
2064725|NCT00583557|3640504|FG000|Overall Study|Lack of Compliance|5
2064726|NCT00583557|3640504|FG000|Overall Study|Other|5
2064727|NCT00583557|3640504|FG000|Overall Study|Did not receive belimumab in LBRA99|2
2064728|NCT00583596|3640508|FG000|Overall Study|Lost to Follow-up|110
2064729|NCT00583596|3640508|FG000|Overall Study|Excluded due to Hurricane Katrina|30
2064730|NCT00583596|3640508|FG000|Overall Study|Death|2
2064731|NCT00583596|3640508|FG000|Overall Study|Withdrawal by Subject|6
2064732|NCT00583596|3640508|FG000|Overall Study|Lost to Follow-up|94
2064733|NCT00583596|3640508|FG000|Overall Study|Data not complete|1
2064734|NCT00583596|3640508|FG000|Overall Study|Not consented|15
2064735|NCT00583596|3640508|FG000|Overall Study|Outside f-up window|26
2064736|NCT00583791|3640544|FG000|Overall Study|Other|67
2064737|NCT00583791|3640544|FG000|Overall Study|Death|6
2064738|NCT00583947|3640585|FG000|Cross-over Period|Adverse Event|2
2064739|NCT00583947|3640586|FG001|Cross-over Period|Adverse Event|0
2064740|NCT00583947|3640585|FG000|Cross-over Period|Withdrawal by Subject|2
2064741|NCT00583947|3640586|FG001|Cross-over Period|Withdrawal by Subject|0
2064742|NCT00583947|3640585|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0
2064743|NCT00583947|3640586|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1
2064744|NCT00583947|3640585|FG000|Cross-over Period|Other|1
2064745|NCT00583947|3640586|FG001|Cross-over Period|Other|1
2064746|NCT00584194|3640599|FG000|Overall Study|Other|135
2064747|NCT00584415|3640618|FG000|Overall Study|Adverse Event|7
2064748|NCT00584454|3640623|FG000|Overall Study|Adverse Event|1
2064749|NCT00584454|3640623|FG000|Overall Study|Relocation|1
2064750|NCT00584454|3640623|FG000|Overall Study|Clinical Hold|2
2064751|NCT00584727|3640641|FG000|First Intervention|Discontinuation|0
2064752|NCT00584727|3640642|FG001|First Intervention|Discontinuation|0
2064753|NCT00584727|3640643|FG002|First Intervention|Discontinuation|1
2064754|NCT00584727|3640644|FG003|First Intervention|Discontinuation|0
2064755|NCT00584727|3640645|FG004|First Intervention|Discontinuation|0
2064756|NCT00584727|3640646|FG005|First Intervention|Discontinuation|0
2064757|NCT00584727|3640641|FG000|Third Intervention|Protocol Violation|0
2064758|NCT00584727|3640642|FG001|Third Intervention|Protocol Violation|0
2064759|NCT00584727|3640643|FG002|Third Intervention|Protocol Violation|1
2064760|NCT00584727|3640644|FG003|Third Intervention|Protocol Violation|0
2064761|NCT00584727|3640645|FG004|Third Intervention|Protocol Violation|4
2064762|NCT00584727|3640646|FG005|Third Intervention|Protocol Violation|2
2064763|NCT00584740|3640659|FG000|Overall Study|Adverse Event|1
2064764|NCT00584740|3640660|FG001|Overall Study|Adverse Event|1
2064765|NCT00584740|3640659|FG000|Overall Study|Lack of Efficacy|8
2064766|NCT00584740|3640660|FG001|Overall Study|Lack of Efficacy|2
2064767|NCT00584740|3640659|FG000|Overall Study|Withdrawal by Subject|3
2064768|NCT00584740|3640660|FG001|Overall Study|Withdrawal by Subject|2
2064769|NCT00584740|3640659|FG000|Overall Study|Lost to Follow-up|0
2064770|NCT00584740|3640660|FG001|Overall Study|Lost to Follow-up|1
2064771|NCT00584805|3640666|FG000|Overall Study|No longer at risk of exposure|39
2064772|NCT00584805|3640666|FG000|Overall Study|Relocation|36
2064773|NCT00584805|3640666|FG000|Overall Study|Withdrawal by Subject|18
2064774|NCT00584805|3640666|FG000|Overall Study|Non-compliance|1
2064775|NCT00584805|3640666|FG000|Overall Study|Lost to follow up|3
2064776|NCT00584805|3640666|FG000|Overall Study|Screen failures|2
2064777|NCT00584844|3640700|FG000|Overall Study|Withdrawal by Subject|59
2064778|NCT00584844|3640700|FG000|Overall Study|Screen Failure|20
2064779|NCT00584870|3640715|FG000|Overall Study|Adverse Event|4
2064780|NCT00584870|3640716|FG001|Overall Study|Adverse Event|3
2064781|NCT00584870|3640717|FG002|Overall Study|Adverse Event|2
2064782|NCT00584870|3640715|FG000|Overall Study|Lost to Follow-up|4
2064783|NCT00584870|3640716|FG001|Overall Study|Lost to Follow-up|1
2064784|NCT00584870|3640717|FG002|Overall Study|Lost to Follow-up|1
2064785|NCT00584870|3640715|FG000|Overall Study|Lack of Efficacy|7
2064786|NCT00584870|3640716|FG001|Overall Study|Lack of Efficacy|14
2064787|NCT00584870|3640717|FG002|Overall Study|Lack of Efficacy|8
2064788|NCT00584870|3640715|FG000|Overall Study|Withdrawal by Subject|10
2064789|NCT00584870|3640716|FG001|Overall Study|Withdrawal by Subject|5
2064790|NCT00584870|3640717|FG002|Overall Study|Withdrawal by Subject|3
2064791|NCT00584870|3640715|FG000|Overall Study|Protocol Violation|1
2064792|NCT00584870|3640716|FG001|Overall Study|Protocol Violation|1
2064793|NCT00584870|3640717|FG002|Overall Study|Protocol Violation|2
2064794|NCT00584870|3640715|FG000|Overall Study|Did not met entrance criteria|1
2064795|NCT00584870|3640716|FG001|Overall Study|Did not met entrance criteria|0
2064796|NCT00584870|3640717|FG002|Overall Study|Did not met entrance criteria|0
2064797|NCT00584870|3640715|FG000|Overall Study|Other|2
2064798|NCT00584870|3640716|FG001|Overall Study|Other|0
2064799|NCT00584870|3640717|FG002|Overall Study|Other|0
2064800|NCT00584870|3640715|FG000|Overall Study|Randomized but not treated|0
2064801|NCT00584870|3640716|FG001|Overall Study|Randomized but not treated|1
2064802|NCT00584870|3640717|FG002|Overall Study|Randomized but not treated|2
2064803|NCT00584909|3640725|FG000|Overall Study|Adverse Event|4
2064804|NCT00584987|3640746|FG000|Overall Study|Protocol Violation|1
2302625|NCT02629965|4001493|FG000|Period 2|Adverse Event|1
2302626|NCT02629965|4001494|FG001|Period 2|Adverse Event|0
2302627|NCT02630186|4001531|FG000|Overall Study|Withdrawal by Subject|1
2302628|NCT02630251|4001539|FG000|Overall Study|Physician Decision|0
2302629|NCT02630251|4001540|FG001|Overall Study|Physician Decision|0
2064805|NCT00584987|3640747|FG001|Overall Study|Protocol Violation|1
2064806|NCT00584987|3640748|FG002|Overall Study|Protocol Violation|1
2064807|NCT00584987|3640749|FG003|Overall Study|Protocol Violation|0
2064808|NCT00584987|3640746|FG000|Overall Study|Adverse Event|0
2064809|NCT00584987|3640747|FG001|Overall Study|Adverse Event|0
2064810|NCT00584987|3640748|FG002|Overall Study|Adverse Event|0
2064811|NCT00584987|3640749|FG003|Overall Study|Adverse Event|1
2064812|NCT00585039|3640772|FG000|Overall Study|medication spilled|2
2064813|NCT00585039|3640773|FG001|Overall Study|medication spilled|0
2064814|NCT00585052|3640781|FG000|Overall Study|Withdrawal by Subject|1
2064815|NCT00585078|3640785|FG000|Overall Study|Withdrawal by Subject|4
2064816|NCT00585078|3640785|FG000|Overall Study|Poor performance status|1
2064817|NCT00585078|3640785|FG000|Overall Study|Disease Progression|24
2064818|NCT00585078|3640785|FG000|Overall Study|Adverse Event|10
2064819|NCT00585078|3640785|FG000|Overall Study|Death|1
2106015|NCT00862719|3699034|FG001|Overall Study|Disease Progression|0
2106016|NCT00862719|3699035|FG002|Overall Study|Disease Progression|1
2302630|NCT02630251|4001541|FG002|Overall Study|Physician Decision|1
2064820|NCT00585169|3640793|FG000|Overall Study|Withdrawal by Subject|1
2302631|NCT02630251|4001542|FG003|Overall Study|Physician Decision|0
2302632|NCT02630459|4001565|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
2302633|NCT02630459|4001566|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1
2302634|NCT02630459|4001567|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
2302635|NCT02630459|4001568|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2
2321636|NCT02962284|4036202|FG000|Overall Study|Withdrawal by Subject|1
2065010|NCT00585286|3640936|FG000|Overall Study|Lost to Follow-up|1
2065011|NCT00585312|3640942|FG000|Overall Study|Adverse Event|3
2065012|NCT00585312|3640943|FG001|Overall Study|Adverse Event|0
2065013|NCT00585312|3640942|FG000|Overall Study|Lack of Efficacy|6
2065014|NCT00585312|3640943|FG001|Overall Study|Lack of Efficacy|11
2065015|NCT00585312|3640942|FG000|Overall Study|Lost to Follow-up|1
2065016|NCT00585312|3640943|FG001|Overall Study|Lost to Follow-up|1
2065017|NCT00585312|3640942|FG000|Overall Study|Reason not specified|2
2065018|NCT00585312|3640943|FG001|Overall Study|Reason not specified|0
2065019|NCT00585312|3640942|FG000|Overall Study|Withdrawal by Subject|5
2065020|NCT00585312|3640943|FG001|Overall Study|Withdrawal by Subject|1
2065021|NCT00585312|3640942|FG000|Overall Study|Study terminated by the sponsor|34
2065022|NCT00585312|3640943|FG001|Overall Study|Study terminated by the sponsor|31
2065023|NCT00585325|3640951|FG000|Overall Study|Withdrawal by Subject|1
2065024|NCT00585325|3640952|FG001|Overall Study|Withdrawal by Subject|1
2065025|NCT00585351|3640964|FG000|Notification Period (Informed Consent)|Physician Decision|0
2065026|NCT00585351|3640965|FG001|Notification Period (Informed Consent)|Physician Decision|2
2065027|NCT00585351|3640966|FG002|Notification Period (Informed Consent)|Physician Decision|0
2065028|NCT00585351|3640967|FG003|Notification Period (Informed Consent)|Physician Decision|0
2210049|NCT01647516|3849426|FG000|Open-Label Period|No completion / discontinuation visit|0
2210050|NCT01647516|3849427|FG001|Open-Label Period|No completion / discontinuation visit|0
2065029|NCT00585351|3640968|FG004|Notification Period (Informed Consent)|Physician Decision|0
2065030|NCT00585351|3640969|FG005|Notification Period (Informed Consent)|Physician Decision|0
2065031|NCT00585351|3640970|FG006|Notification Period (Informed Consent)|Physician Decision|0
2065032|NCT00585351|3640971|FG007|Notification Period (Informed Consent)|Physician Decision|0
2065033|NCT00585351|3640964|FG000|Notification Period (Informed Consent)|Flight aborted|2
2065034|NCT00585351|3640965|FG001|Notification Period (Informed Consent)|Flight aborted|1
2065035|NCT00585351|3640966|FG002|Notification Period (Informed Consent)|Flight aborted|0
2065036|NCT00585351|3640967|FG003|Notification Period (Informed Consent)|Flight aborted|0
2065037|NCT00585351|3640968|FG004|Notification Period (Informed Consent)|Flight aborted|0
2065038|NCT00585351|3640969|FG005|Notification Period (Informed Consent)|Flight aborted|0
2065039|NCT00585351|3640970|FG006|Notification Period (Informed Consent)|Flight aborted|0
2065040|NCT00585351|3640971|FG007|Notification Period (Informed Consent)|Flight aborted|0
2065041|NCT00585351|3640964|FG000|Notification Period (Informed Consent)|No study medication on flight|0
2065042|NCT00585351|3640965|FG001|Notification Period (Informed Consent)|No study medication on flight|1
2065043|NCT00585351|3640966|FG002|Notification Period (Informed Consent)|No study medication on flight|0
2065044|NCT00585351|3640967|FG003|Notification Period (Informed Consent)|No study medication on flight|0
2065045|NCT00585351|3640968|FG004|Notification Period (Informed Consent)|No study medication on flight|0
2065046|NCT00585351|3640969|FG005|Notification Period (Informed Consent)|No study medication on flight|0
2065047|NCT00585351|3640970|FG006|Notification Period (Informed Consent)|No study medication on flight|0
2065048|NCT00585351|3640971|FG007|Notification Period (Informed Consent)|No study medication on flight|0
2065049|NCT00585351|3640964|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
2065050|NCT00585351|3640965|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
2065051|NCT00585351|3640966|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2065052|NCT00585351|3640967|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2065053|NCT00585351|3640968|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2065054|NCT00585351|3640969|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2065055|NCT00585351|3640970|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2065056|NCT00585351|3640971|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2065057|NCT00585351|3640964|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0
2065058|NCT00585351|3640965|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0
2065059|NCT00585351|3640966|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0
2065060|NCT00585351|3640967|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0
2065061|NCT00585351|3640968|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0
2065062|NCT00585351|3640969|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0
2065063|NCT00585351|3640970|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1
2065064|NCT00585351|3640971|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1
2065065|NCT00585351|3640964|FG000|Enrollment Period (Intervention)|Death|0
2065066|NCT00585351|3640965|FG001|Enrollment Period (Intervention)|Death|0
2065067|NCT00585351|3640966|FG002|Enrollment Period (Intervention)|Death|0
2065068|NCT00585351|3640967|FG003|Enrollment Period (Intervention)|Death|0
2065069|NCT00585351|3640968|FG004|Enrollment Period (Intervention)|Death|1
2065070|NCT00585351|3640969|FG005|Enrollment Period (Intervention)|Death|0
2065071|NCT00585351|3640970|FG006|Enrollment Period (Intervention)|Death|1
2065072|NCT00585351|3640971|FG007|Enrollment Period (Intervention)|Death|0
2065073|NCT00585351|3640964|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2065074|NCT00585351|3640965|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2065075|NCT00585351|3640966|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2065076|NCT00585351|3640967|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2065077|NCT00585351|3640968|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1
2065078|NCT00585351|3640969|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2
2065079|NCT00585351|3640970|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2065080|NCT00585351|3640971|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2065081|NCT00585468|3640989|FG000|First Intervention|Withdrawal by Subject|1
2065082|NCT00585468|3640990|FG001|First Intervention|Withdrawal by Subject|1
2065083|NCT00585533|3641002|FG000|Overall Study|objective or symptomatic progression|9
2065084|NCT00585546|3641006|FG000|Clenbuterol Treatment - up to 12 Months|Death|1
2065085|NCT00585546|3641006|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
2065086|NCT00585689|3641036|FG000|Overall Study|Received different ABI-007 schedule|3
2065087|NCT00585689|3641036|FG000|Overall Study|Adverse Event|1
2065088|NCT00585689|3641036|FG000|Overall Study|Patient Declined Surgery|1
2065089|NCT00585689|3641036|FG000|Overall Study|Patient had unresectable disease|1
2065090|NCT00585689|3641036|FG000|Overall Study|Death|1
2065091|NCT00585923|3641077|FG000|Overall Study|Physician decided not to continue|31
2065092|NCT00585923|3641078|FG001|Overall Study|Physician decided not to continue|33
2065093|NCT00585975|3641086|FG000|Overall Study|Withdrawal by Subject|3
2065094|NCT00585975|3641087|FG001|Overall Study|Withdrawal by Subject|3
2065095|NCT00585975|3641086|FG000|Overall Study|Lost to Follow-up|2
2065096|NCT00585975|3641087|FG001|Overall Study|Lost to Follow-up|1
2065097|NCT00585975|3641086|FG000|Overall Study|Enrollment met/over-enrolled|10
2065098|NCT00585975|3641087|FG001|Overall Study|Enrollment met/over-enrolled|9
2065099|NCT00586066|3641105|FG000|Overall Study|Lost to Follow-up|6
2065100|NCT00586066|3641106|FG001|Overall Study|Lost to Follow-up|3
2065101|NCT00586066|3641105|FG000|Overall Study|Lack of Efficacy|5
2065102|NCT00586066|3641106|FG001|Overall Study|Lack of Efficacy|3
2065103|NCT00586066|3641105|FG000|Overall Study|Adverse Event|2
2065104|NCT00586066|3641106|FG001|Overall Study|Adverse Event|2
2065105|NCT00586066|3641105|FG000|Overall Study|Physician Decision|1
2065106|NCT00586066|3641106|FG001|Overall Study|Physician Decision|0
2065107|NCT00586066|3641105|FG000|Overall Study|Withdrawal of consent|4
2065108|NCT00586066|3641106|FG001|Overall Study|Withdrawal of consent|2
2065109|NCT00586105|3641112|FG000|Overall Study|Adverse Event|4
2065110|NCT00586105|3641112|FG000|Overall Study|Death|2
2065111|NCT00586105|3641112|FG000|Overall Study|Protocol Violation|1
2065112|NCT00586105|3641112|FG000|Overall Study|Withdrawal by Subject|3
2065113|NCT00586105|3641112|FG000|Overall Study|Disease progression|19
2065114|NCT00586105|3641112|FG000|Overall Study|Switched to commercial drug|9
2065115|NCT00586105|3641112|FG000|Overall Study|Reason not reported|1
2065116|NCT00586157|3641116|FG000|First Intervention|Worsening behavior|1
2065117|NCT00586157|3641117|FG001|First Intervention|Worsening behavior|0
2065118|NCT00586157|3641116|FG000|Second Intervention|Withdrawal by Subject|1
2065119|NCT00586157|3641117|FG001|Second Intervention|Withdrawal by Subject|0
2065120|NCT00586157|3641116|FG000|Second Intervention|Worsening behavior|1
2065121|NCT00586157|3641117|FG001|Second Intervention|Worsening behavior|0
2065122|NCT00586157|3641116|FG000|Second Intervention|Adverse Event|0
2065123|NCT00586157|3641117|FG001|Second Intervention|Adverse Event|1
2065124|NCT00586313|3641150|FG000|Overall Study|Lack of Efficacy|2
2065125|NCT00586326|3641154|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6
2065126|NCT00586326|3641154|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
2065127|NCT00586326|3641154|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2
2065128|NCT00586326|3641154|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1
2065129|NCT00586326|3641154|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
2065130|NCT00586326|3641154|FG000|Enrollment to Device Placement-Enrolled|Other|1
2065131|NCT00586326|3641154|FG000|Device Placed toTreatment-ITT|Skin Distance|7
2065132|NCT00586326|3641154|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6
2065133|NCT00586326|3641154|FG000|Device Placed toTreatment-ITT|Microinvasion|1
2065134|NCT00586326|3641154|FG000|Device Placed toTreatment-ITT|Positive Margins|3
2065135|NCT00586326|3641154|FG000|Device Placed toTreatment-ITT|Physician Decision|1
2065136|NCT00586326|3641154|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
2065137|NCT00586326|3641154|FG000|Treated Through 5-yr Follow Up-Treated|Death|2
2106017|NCT00862719|3699036|FG003|Overall Study|Disease Progression|0
2065138|NCT00586326|3641154|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
2065139|NCT00586326|3641154|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
2065140|NCT00586326|3641154|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
2065141|NCT00586326|3641154|FG000|Treated Through 5-yr Follow Up-Treated|Other|2
2065142|NCT00586339|3641165|FG000|Overall Study|Withdrawal by Subject|1
2065143|NCT00586339|3641166|FG001|Overall Study|Withdrawal by Subject|3
2065144|NCT00586339|3641167|FG002|Overall Study|Withdrawal by Subject|1
2065145|NCT00586339|3641165|FG000|Overall Study|Migrated/moved from study area|3
2065146|NCT00586339|3641166|FG001|Overall Study|Migrated/moved from study area|2
2065147|NCT00586339|3641167|FG002|Overall Study|Migrated/moved from study area|4
2065148|NCT00586339|3641165|FG000|Overall Study|Lost to Follow-up|3
2065149|NCT00586339|3641166|FG001|Overall Study|Lost to Follow-up|2
2065150|NCT00586339|3641167|FG002|Overall Study|Lost to Follow-up|1
2065151|NCT00586469|3641177|FG000|Overall Study|Adverse Event|0
2065152|NCT00586469|3641178|FG001|Overall Study|Adverse Event|1
2065153|NCT00586495|3641193|FG000|Treatment Period|Adverse Event|11
2065154|NCT00586495|3641193|FG000|Treatment Period|Death|1
2065155|NCT00586495|3641193|FG000|Treatment Period|Protocol Violation|1
2065156|NCT00586495|3641193|FG000|Treatment Period|Withdrawal by Subject|1
2065157|NCT00586495|3641193|FG000|Treatment Period|Disease progression, recurrence/relapse|71
2065158|NCT00586495|3641193|FG000|Treatment Period|Switch to commercial drug|10
2065159|NCT00586495|3641193|FG000|Follow-up|Death|40
2065160|NCT00586495|3641193|FG000|Follow-up|Lost to Follow-up|1
2065161|NCT00586495|3641193|FG000|Follow-up|Withdrawal by Subject|4
2065162|NCT00586495|3641193|FG000|Follow-up|Protocol driven decision point|37
2065163|NCT00586495|3641193|FG000|Follow-up|Switch to commercial drug|10
2065164|NCT00586508|3641199|FG000|Overall Study|Progressive disease|52
2065165|NCT00586508|3641200|FG001|Overall Study|Progressive disease|8
2065166|NCT00586508|3641199|FG000|Overall Study|Death|0
2065167|NCT00586508|3641200|FG001|Overall Study|Death|1
2065168|NCT00586508|3641199|FG000|Overall Study|Adverse Event|12
2065169|NCT00586508|3641200|FG001|Overall Study|Adverse Event|4
2065170|NCT00586508|3641199|FG000|Overall Study|Withdrawal by Subject|4
2065171|NCT00586508|3641200|FG001|Overall Study|Withdrawal by Subject|0
2065172|NCT00586521|3641206|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
2065173|NCT00586612|3641216|FG000|Primary Phase|Protocol Violation|1
2065174|NCT00586612|3641217|FG001|Primary Phase|Protocol Violation|0
2065175|NCT00586612|3641216|FG000|Primary Phase|Lost to Follow-up|0
2065176|NCT00586612|3641217|FG001|Primary Phase|Lost to Follow-up|1
2065177|NCT00586612|3641216|FG000|Primary Phase|Withdrawal by Subject|0
2065178|NCT00586612|3641217|FG001|Primary Phase|Withdrawal by Subject|2
2065179|NCT00586612|3641216|FG000|Booster Phase|Lost to Follow-up|3
2065180|NCT00586612|3641217|FG001|Booster Phase|Lost to Follow-up|1
2065181|NCT00586625|3641225|FG000|Overall Study|Adverse Event|6
2065182|NCT00586625|3641226|FG001|Overall Study|Adverse Event|6
2065183|NCT00586625|3641225|FG000|Overall Study|Protocol Violation|3
2065184|NCT00586625|3641226|FG001|Overall Study|Protocol Violation|0
2065185|NCT00586625|3641225|FG000|Overall Study|Withdrawal by Subject|32
2065186|NCT00586625|3641226|FG001|Overall Study|Withdrawal by Subject|10
2065187|NCT00586625|3641225|FG000|Overall Study|Subject non-compliance|0
2065188|NCT00586625|3641226|FG001|Overall Study|Subject non-compliance|1
2065189|NCT00586625|3641225|FG000|Overall Study|Subject unable to return for visit|2
2065190|NCT00586625|3641226|FG001|Overall Study|Subject unable to return for visit|0
2065191|NCT00586664|3641235|FG000|Overall Study|Withdrawal by Subject|3
2065192|NCT00586664|3641236|FG001|Overall Study|Withdrawal by Subject|7
2065193|NCT00586664|3641237|FG002|Overall Study|Withdrawal by Subject|1
2065194|NCT00586664|3641235|FG000|Overall Study|Exclusion criteria met|2
2065195|NCT00586664|3641236|FG001|Overall Study|Exclusion criteria met|0
2065196|NCT00586664|3641237|FG002|Overall Study|Exclusion criteria met|0
2065197|NCT00586690|3641247|FG000|Overall Study|Death|2
2065198|NCT00586690|3641248|FG001|Overall Study|Death|0
2065199|NCT00586690|3641247|FG000|Overall Study|Disease Progression|10
2065200|NCT00586690|3641248|FG001|Overall Study|Disease Progression|0
2065201|NCT00586690|3641247|FG000|Overall Study|Adverse Event|1
2217688|NCT01709305|3860928|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0
2065202|NCT00586690|3641248|FG001|Overall Study|Adverse Event|0
2065203|NCT00586690|3641247|FG000|Overall Study|Lack of Efficacy|2
2065204|NCT00586690|3641248|FG001|Overall Study|Lack of Efficacy|0
2065205|NCT00586690|3641247|FG000|Overall Study|Lab can't accommodate|1
2065206|NCT00586690|3641248|FG001|Overall Study|Lab can't accommodate|0
2065207|NCT00586703|3641253|FG000|Overall Study|Death|12
2065208|NCT00586820|3641268|FG000|Overall Study|Unsuccessful PCI|1
2065209|NCT00586820|3641269|FG001|Overall Study|Unsuccessful PCI|0
2065210|NCT00586846|3641275|FG000|Overall Study|Physician Decision|1
2065211|NCT00586846|3641275|FG000|Overall Study|Death|1
2065212|NCT00586846|3641275|FG000|Overall Study|Evaluable for Toxicity Only|4
2065213|NCT00586898|3641279|FG000|Overall Study|Adverse Event|1
2065214|NCT00586898|3641279|FG000|Overall Study|Patiemt Non-compliance|1
2065215|NCT00586898|3641279|FG000|Overall Study|Evaluable for Toxicity Only|5
2065216|NCT00587054|3641296|FG000|Overall Study|Patient not treated|9
2065217|NCT00587158|3641323|FG000|Overall Study|Did not want to do 24 hr urine collect.|4
2065218|NCT00587158|3641324|FG001|Overall Study|Did not want to do 24 hr urine collect.|3
2065219|NCT00587158|3641323|FG000|Overall Study|Physician Decision|0
2065220|NCT00587158|3641324|FG001|Overall Study|Physician Decision|1
2065221|NCT00587158|3641323|FG000|Overall Study|Lost to Follow-up|1
2065222|NCT00587158|3641324|FG001|Overall Study|Lost to Follow-up|2
2065223|NCT00587158|3641323|FG000|Overall Study|Death|0
2065224|NCT00587158|3641324|FG001|Overall Study|Death|1
2065225|NCT00587158|3641323|FG000|Overall Study|Subject did not want to take study med|0
2065226|NCT00587158|3641324|FG001|Overall Study|Subject did not want to take study med|1
2065227|NCT00587171|3641332|FG000|Overall Study|Lost to Follow-up|1
2065228|NCT00587171|3641333|FG001|Overall Study|Lost to Follow-up|1
2065229|NCT00587288|3641341|FG000|Overall Study|Adverse Event|0
2065230|NCT00587288|3641342|FG001|Overall Study|Adverse Event|1
2065231|NCT00587288|3641341|FG000|Overall Study|Lack of Efficacy|2
2065232|NCT00587288|3641342|FG001|Overall Study|Lack of Efficacy|8
2065233|NCT00587288|3641341|FG000|Overall Study|Protocol Violation|1
2065234|NCT00587288|3641342|FG001|Overall Study|Protocol Violation|0
2065235|NCT00587431|3641352|FG000|Overall Study|Adverse Event|1
2065236|NCT00587431|3641353|FG001|Overall Study|Adverse Event|0
2065237|NCT00587431|3641352|FG000|Overall Study|Withdrawal by Subject|0
2065238|NCT00587431|3641353|FG001|Overall Study|Withdrawal by Subject|1
2065239|NCT00587457|3641365|FG000|Overall Study|Adverse Event|1
2065240|NCT00587457|3641366|FG001|Overall Study|Adverse Event|2
2065241|NCT00587457|3641367|FG002|Overall Study|Adverse Event|1
2065242|NCT00587457|3641365|FG000|Overall Study|Disease progression|2
2065243|NCT00587457|3641366|FG001|Overall Study|Disease progression|0
2065244|NCT00587457|3641367|FG002|Overall Study|Disease progression|2
2065245|NCT00587457|3641365|FG000|Overall Study|Initiation of alternative therapy|0
2065246|NCT00587457|3641366|FG001|Overall Study|Initiation of alternative therapy|1
2065247|NCT00587457|3641367|FG002|Overall Study|Initiation of alternative therapy|0
2065248|NCT00587457|3641365|FG000|Overall Study|Undefined|0
2065249|NCT00587457|3641366|FG001|Overall Study|Undefined|0
2065250|NCT00587457|3641367|FG002|Overall Study|Undefined|1
2065251|NCT00587457|3641365|FG000|Overall Study|Development of neutralizing Abs|0
2065252|NCT00587457|3641366|FG001|Overall Study|Development of neutralizing Abs|0
2065253|NCT00587457|3641367|FG002|Overall Study|Development of neutralizing Abs|1
2065254|NCT00587587|3641390|FG000|Overall Study|Lost to Follow-up|6
2065255|NCT00587587|3641391|FG001|Overall Study|Lost to Follow-up|1
2065256|NCT00587639|3641399|FG000|Overall Study|Withdrawal by Subject|1
2065257|NCT00587847|3641435|FG000|Overall Study|Lack of Efficacy|5
2065258|NCT00587847|3641435|FG000|Overall Study|Adverse Event|2
2106018|NCT00862719|3699033|FG000|Overall Study|Death|5
2106019|NCT00862719|3699034|FG001|Overall Study|Death|6
2106020|NCT00862719|3699035|FG002|Overall Study|Death|1
2106021|NCT00862719|3699036|FG003|Overall Study|Death|1
2106022|NCT00862719|3699033|FG000|Overall Study|Engraftment failure|0
2106023|NCT00862719|3699034|FG001|Overall Study|Engraftment failure|0
2106024|NCT00862719|3699035|FG002|Overall Study|Engraftment failure|1
2106025|NCT00862719|3699036|FG003|Overall Study|Engraftment failure|0
2106026|NCT00862719|3699033|FG000|Overall Study|Veno-Occlusive Disease|0
2106027|NCT00862719|3699034|FG001|Overall Study|Veno-Occlusive Disease|0
2106028|NCT00862719|3699035|FG002|Overall Study|Veno-Occlusive Disease|1
2106029|NCT00862719|3699036|FG003|Overall Study|Veno-Occlusive Disease|0
2106030|NCT00862823|3699068|FG000|First Intervention|Withdrawal by Subject|1
2106031|NCT00862823|3699069|FG001|First Intervention|Withdrawal by Subject|1
2106032|NCT00862836|3699074|FG000|Overall Study|Withdrawal by Subject|1
2106033|NCT00862849|3699078|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
2106034|NCT00862849|3699079|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
2106035|NCT00862849|3699080|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
2106036|NCT00862849|3699081|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
2106037|NCT00862849|3699082|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
2106038|NCT00862849|3699083|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
2106039|NCT00862849|3699078|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0
2106040|NCT00862849|3699079|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1
2106041|NCT00862849|3699080|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0
2106042|NCT00862849|3699081|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0
2106043|NCT00862849|3699082|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0
2106044|NCT00862849|3699083|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0
2106045|NCT00862940|3699093|FG000|Overall Study|Adverse Event|15
2210051|NCT01647516|3849428|FG002|Open-Label Period|No completion / discontinuation visit|0
2217689|NCT01709305|3860929|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0
2106046|NCT00862940|3699094|FG001|Overall Study|Adverse Event|12
2106047|NCT00862940|3699093|FG000|Overall Study|Lack of Efficacy|1
2106048|NCT00862940|3699094|FG001|Overall Study|Lack of Efficacy|3
2106049|NCT00862940|3699093|FG000|Overall Study|Protocol Violation|2
2106050|NCT00862940|3699094|FG001|Overall Study|Protocol Violation|5
2106051|NCT00862940|3699093|FG000|Overall Study|Withdrawal by Subject|4
2106052|NCT00862940|3699094|FG001|Overall Study|Withdrawal by Subject|6
2106053|NCT00862940|3699093|FG000|Overall Study|Non-compliance|4
2106054|NCT00862940|3699094|FG001|Overall Study|Non-compliance|0
2106055|NCT00862940|3699093|FG000|Overall Study|Lost to Follow-up|0
2106056|NCT00862940|3699094|FG001|Overall Study|Lost to Follow-up|1
2106057|NCT00862940|3699093|FG000|Overall Study|Administrative or other reason(s)|4
2106058|NCT00862940|3699094|FG001|Overall Study|Administrative or other reason(s)|3
2106059|NCT00862979|3699102|FG000|Overall Study|Adverse Event|6
2106060|NCT00862979|3699103|FG001|Overall Study|Adverse Event|3
2106061|NCT00862979|3699102|FG000|Overall Study|Protocol Violation|0
2065259|NCT04411680|3641450|FG000|Treatment Period|Adverse Event|3
2065260|NCT04411680|3641451|FG001|Treatment Period|Adverse Event|0
2065261|NCT04411680|3641450|FG000|Treatment Period|Discharged from hospital|18
2065262|NCT04411680|3641451|FG001|Treatment Period|Discharged from hospital|7
2065263|NCT04411680|3641450|FG000|Treatment Period|Missed 1 or more doses|8
2065264|NCT04411680|3641451|FG001|Treatment Period|Missed 1 or more doses|0
2065265|NCT04411680|3641450|FG000|Treatment Period|Transferred to another hospital|0
2065266|NCT04411680|3641451|FG001|Treatment Period|Transferred to another hospital|1
2065267|NCT04411680|3641450|FG000|Follow up Period|Withdrawal by Subject|2
2065268|NCT04411680|3641451|FG001|Follow up Period|Withdrawal by Subject|0
2065269|NCT04411680|3641450|FG000|Follow up Period|Lost to Follow-up|5
2065270|NCT04411680|3641451|FG001|Follow up Period|Lost to Follow-up|6
2065271|NCT04411680|3641450|FG000|Follow up Period|Death|11
2065272|NCT04411680|3641451|FG001|Follow up Period|Death|8
2065273|NCT04364984|3641460|FG000|Overall Study|Death|2
2065274|NCT04364984|3641461|FG001|Overall Study|Death|2
2065275|NCT04364984|3641462|FG002|Overall Study|Death|0
2065276|NCT03711266|3641502|FG000|Overall Study|Lost to Follow-up|10
2065277|NCT03655691|3641509|FG000|Overall Study|Adverse Event|0
2065278|NCT03655691|3641510|FG001|Overall Study|Adverse Event|0
2065279|NCT03655691|3641511|FG002|Overall Study|Adverse Event|1
2065280|NCT03655691|3641509|FG000|Overall Study|Lost to Follow-up|1
2065281|NCT03655691|3641510|FG001|Overall Study|Lost to Follow-up|1
2302636|NCT02630459|4001569|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
2302637|NCT02630459|4001570|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
2302638|NCT02630459|4001571|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
2302639|NCT02630459|4001572|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
2302640|NCT02630459|4001565|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
2302641|NCT02630459|4001566|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
2302642|NCT02630459|4001567|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1
2065282|NCT03655691|3641511|FG002|Overall Study|Lost to Follow-up|2
2065283|NCT03655691|3641509|FG000|Overall Study|Protocol Violation|0
2210052|NCT01647516|3849429|FG003|Open-Label Period|No completion / discontinuation visit|0
2210053|NCT01647516|3849430|FG004|Open-Label Period|No completion / discontinuation visit|2
2210054|NCT01647516|3849431|FG005|Open-Label Period|No completion / discontinuation visit|1
2210055|NCT01647542|3849449|FG000|Overall Study|Major Protocol Deviation|1
2210056|NCT01647542|3849450|FG001|Overall Study|Major Protocol Deviation|0
2210057|NCT01647542|3849451|FG002|Overall Study|Major Protocol Deviation|0
2210058|NCT01647542|3849449|FG000|Overall Study|Adverse Event|4
2210059|NCT01647542|3849450|FG001|Overall Study|Adverse Event|5
2065284|NCT03655691|3641510|FG001|Overall Study|Protocol Violation|1
2065285|NCT03655691|3641511|FG002|Overall Study|Protocol Violation|0
2065286|NCT03655691|3641509|FG000|Overall Study|Withdrawal by Subject|1
2065287|NCT03655691|3641510|FG001|Overall Study|Withdrawal by Subject|1
2065288|NCT03655691|3641511|FG002|Overall Study|Withdrawal by Subject|0
2065289|NCT03630393|3641521|FG000|Overall Study|Death|1
2065290|NCT03630393|3641522|FG001|Overall Study|Death|0
2065352|NCT02954406|3641630|FG003|Overall Study|Adverse Event|0
2065353|NCT02954406|3641631|FG004|Overall Study|Adverse Event|1
2065354|NCT02954406|3641632|FG005|Overall Study|Adverse Event|0
2065355|NCT02954406|3641633|FG006|Overall Study|Adverse Event|0
2065356|NCT02954406|3641634|FG007|Overall Study|Adverse Event|0
2065357|NCT02954406|3641635|FG008|Overall Study|Adverse Event|1
2065358|NCT02954406|3641636|FG009|Overall Study|Adverse Event|1
2065359|NCT02954406|3641637|FG010|Overall Study|Adverse Event|0
2210060|NCT01647542|3849451|FG002|Overall Study|Adverse Event|4
2210061|NCT01647542|3849449|FG000|Overall Study|Lost to Follow-up|0
2210062|NCT01647542|3849450|FG001|Overall Study|Lost to Follow-up|2
2210063|NCT01647542|3849451|FG002|Overall Study|Lost to Follow-up|2
2210064|NCT01647542|3849449|FG000|Overall Study|Withdrawal by Subject|6
2210065|NCT01647542|3849450|FG001|Overall Study|Withdrawal by Subject|4
2210066|NCT01647542|3849451|FG002|Overall Study|Withdrawal by Subject|0
2210067|NCT01647542|3849449|FG000|Overall Study|Study Termination|64
2210068|NCT01647542|3849450|FG001|Overall Study|Study Termination|61
2065360|NCT02954406|3641627|FG000|Overall Study|Progressive Disease|3
2065361|NCT02954406|3641628|FG001|Overall Study|Progressive Disease|4
2065362|NCT02954406|3641629|FG002|Overall Study|Progressive Disease|3
2065363|NCT02954406|3641630|FG003|Overall Study|Progressive Disease|4
2065364|NCT02954406|3641631|FG004|Overall Study|Progressive Disease|3
2065365|NCT02954406|3641632|FG005|Overall Study|Progressive Disease|3
2065366|NCT02954406|3641633|FG006|Overall Study|Progressive Disease|2
2065367|NCT02954406|3641634|FG007|Overall Study|Progressive Disease|2
2065368|NCT02954406|3641635|FG008|Overall Study|Progressive Disease|1
2210069|NCT01647542|3849451|FG002|Overall Study|Study Termination|65
2210070|NCT01647542|3849449|FG000|Overall Study|Lack of Efficacy|1
2210071|NCT01647542|3849450|FG001|Overall Study|Lack of Efficacy|1
2210072|NCT01647542|3849451|FG002|Overall Study|Lack of Efficacy|0
2210073|NCT01647542|3849449|FG000|Overall Study|Death|0
2210074|NCT01647542|3849450|FG001|Overall Study|Death|0
2210075|NCT01647542|3849451|FG002|Overall Study|Death|1
2065369|NCT02954406|3641636|FG009|Overall Study|Progressive Disease|1
2065370|NCT02954406|3641637|FG010|Overall Study|Progressive Disease|0
2210076|NCT01647711|3849473|FG000|Overall Study|Progressive disease|6
2210077|NCT01647711|3849474|FG001|Overall Study|Progressive disease|2
2210078|NCT01647711|3849475|FG002|Overall Study|Progressive disease|6
2210079|NCT01647711|3849476|FG003|Overall Study|Progressive disease|8
2210080|NCT01647711|3849477|FG004|Overall Study|Progressive disease|2
2210081|NCT01647711|3849473|FG000|Overall Study|Other adverse event|0
2210082|NCT01647711|3849474|FG001|Overall Study|Other adverse event|0
2210083|NCT01647711|3849475|FG002|Overall Study|Other adverse event|2
2210084|NCT01647711|3849476|FG003|Overall Study|Other adverse event|0
2210085|NCT01647711|3849477|FG004|Overall Study|Other adverse event|2
2210086|NCT01647711|3849473|FG000|Overall Study|Protocol Violation|0
2210087|NCT01647711|3849474|FG001|Overall Study|Protocol Violation|0
2210088|NCT01647711|3849475|FG002|Overall Study|Protocol Violation|0
2065291|NCT03359811|3641545|FG000|Overall Study|Protocol Violation|2
2065292|NCT03359811|3641546|FG001|Overall Study|Protocol Violation|0
2065293|NCT03249714|3641555|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1
2065294|NCT03249714|3641556|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1
2065295|NCT03249714|3641555|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1
2065296|NCT03249714|3641556|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1
2065297|NCT03249714|3641555|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1
2065298|NCT03249714|3641556|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0
2065299|NCT03249714|3641555|FG000|Open-label Treatment (Extension Part)|Adverse Event|2
2065300|NCT03249714|3641556|FG001|Open-label Treatment (Extension Part)|Adverse Event|0
2065301|NCT03096834|3641591|FG000|Double-Blind Treatment Epoch|Protocol deviation|2
2065302|NCT03096834|3641592|FG001|Double-Blind Treatment Epoch|Protocol deviation|1
2065303|NCT03096834|3641593|FG002|Double-Blind Treatment Epoch|Protocol deviation|0
2065304|NCT03096834|3641594|FG003|Double-Blind Treatment Epoch|Protocol deviation|0
2065305|NCT03096834|3641591|FG000|Double-Blind Treatment Epoch|Pregnancy|0
2065306|NCT03096834|3641592|FG001|Double-Blind Treatment Epoch|Pregnancy|1
2065307|NCT03096834|3641593|FG002|Double-Blind Treatment Epoch|Pregnancy|0
2065308|NCT03096834|3641594|FG003|Double-Blind Treatment Epoch|Pregnancy|0
2065309|NCT03096834|3641591|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1
2065310|NCT03096834|3641592|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1
2065311|NCT03096834|3641593|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0
2065312|NCT03096834|3641594|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0
2065313|NCT03096834|3641591|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0
2065314|NCT03096834|3641592|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0
2065315|NCT03096834|3641593|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15
2065316|NCT03096834|3641594|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15
2065317|NCT03096834|3641591|FG000|Open-Label Treatment Epoch|Adverse Event|0
2065318|NCT03096834|3641592|FG001|Open-Label Treatment Epoch|Adverse Event|0
2065319|NCT03096834|3641593|FG002|Open-Label Treatment Epoch|Adverse Event|5
2065320|NCT03096834|3641594|FG003|Open-Label Treatment Epoch|Adverse Event|6
2065321|NCT03096834|3641591|FG000|Open-Label Treatment Epoch|New therapy for study indication|0
2065322|NCT03096834|3641592|FG001|Open-Label Treatment Epoch|New therapy for study indication|0
2065323|NCT03096834|3641593|FG002|Open-Label Treatment Epoch|New therapy for study indication|1
2065324|NCT03096834|3641594|FG003|Open-Label Treatment Epoch|New therapy for study indication|1
2065325|NCT03096834|3641591|FG000|Open-Label Treatment Epoch|Physician Decision|0
2065326|NCT03096834|3641592|FG001|Open-Label Treatment Epoch|Physician Decision|0
2065327|NCT03096834|3641593|FG002|Open-Label Treatment Epoch|Physician Decision|1
2065328|NCT03096834|3641594|FG003|Open-Label Treatment Epoch|Physician Decision|0
2065329|NCT03096834|3641591|FG000|Open-Label Treatment Epoch|Pregnancy|0
2065330|NCT03096834|3641592|FG001|Open-Label Treatment Epoch|Pregnancy|0
2065331|NCT03096834|3641593|FG002|Open-Label Treatment Epoch|Pregnancy|1
2065332|NCT03096834|3641594|FG003|Open-Label Treatment Epoch|Pregnancy|0
2065333|NCT03096834|3641591|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0
2065334|NCT03096834|3641592|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0
2065335|NCT03096834|3641593|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9
2065336|NCT03096834|3641594|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17
2065337|NCT03096834|3641591|FG000|Safety Follow-Up Epoch|New therapy for study indication|0
2065338|NCT03096834|3641592|FG001|Safety Follow-Up Epoch|New therapy for study indication|0
2065339|NCT03096834|3641593|FG002|Safety Follow-Up Epoch|New therapy for study indication|0
2065340|NCT03096834|3641594|FG003|Safety Follow-Up Epoch|New therapy for study indication|1
2065341|NCT03096834|3641591|FG000|Safety Follow-Up Epoch|Protocol deviation|0
2065342|NCT03096834|3641592|FG001|Safety Follow-Up Epoch|Protocol deviation|0
2065343|NCT03096834|3641593|FG002|Safety Follow-Up Epoch|Protocol deviation|0
2065344|NCT03096834|3641594|FG003|Safety Follow-Up Epoch|Protocol deviation|1
2065345|NCT03096834|3641591|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0
2065346|NCT03096834|3641592|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0
2065347|NCT03096834|3641593|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1
2065348|NCT03096834|3641594|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0
2065349|NCT02954406|3641627|FG000|Overall Study|Adverse Event|0
2065350|NCT02954406|3641628|FG001|Overall Study|Adverse Event|1
2065351|NCT02954406|3641629|FG002|Overall Study|Adverse Event|0
2210089|NCT01647711|3849476|FG003|Overall Study|Protocol Violation|0
2210090|NCT01647711|3849477|FG004|Overall Study|Protocol Violation|1
2210091|NCT01647711|3849473|FG000|Overall Study|Refused to continue taking medication|0
2210092|NCT01647711|3849474|FG001|Overall Study|Refused to continue taking medication|0
2210093|NCT01647711|3849475|FG002|Overall Study|Refused to continue taking medication|0
2065371|NCT02954406|3641627|FG000|Overall Study|Symptomatic Deterioration|0
2065372|NCT02954406|3641628|FG001|Overall Study|Symptomatic Deterioration|1
2065373|NCT02954406|3641629|FG002|Overall Study|Symptomatic Deterioration|0
2065374|NCT02954406|3641630|FG003|Overall Study|Symptomatic Deterioration|0
2065375|NCT02954406|3641631|FG004|Overall Study|Symptomatic Deterioration|0
2065376|NCT02954406|3641632|FG005|Overall Study|Symptomatic Deterioration|0
2065377|NCT02954406|3641633|FG006|Overall Study|Symptomatic Deterioration|0
2065378|NCT02954406|3641634|FG007|Overall Study|Symptomatic Deterioration|0
2065379|NCT02954406|3641635|FG008|Overall Study|Symptomatic Deterioration|0
2065380|NCT02954406|3641636|FG009|Overall Study|Symptomatic Deterioration|0
2065381|NCT02954406|3641637|FG010|Overall Study|Symptomatic Deterioration|0
2065382|NCT02954406|3641627|FG000|Overall Study|Death|0
2065383|NCT02954406|3641628|FG001|Overall Study|Death|0
2065384|NCT02954406|3641629|FG002|Overall Study|Death|0
2065385|NCT02954406|3641630|FG003|Overall Study|Death|0
2065386|NCT02954406|3641631|FG004|Overall Study|Death|1
2065387|NCT02954406|3641632|FG005|Overall Study|Death|0
2065388|NCT02954406|3641633|FG006|Overall Study|Death|0
2065389|NCT02954406|3641634|FG007|Overall Study|Death|0
2065390|NCT02954406|3641635|FG008|Overall Study|Death|1
2065391|NCT02954406|3641636|FG009|Overall Study|Death|1
2065392|NCT02954406|3641637|FG010|Overall Study|Death|0
2065393|NCT02954406|3641627|FG000|Overall Study|Reason Not Specified|0
2065394|NCT02954406|3641628|FG001|Overall Study|Reason Not Specified|0
2065395|NCT02954406|3641629|FG002|Overall Study|Reason Not Specified|3
2065396|NCT02954406|3641630|FG003|Overall Study|Reason Not Specified|2
2065397|NCT02954406|3641631|FG004|Overall Study|Reason Not Specified|2
2065398|NCT02954406|3641632|FG005|Overall Study|Reason Not Specified|0
2065399|NCT02954406|3641633|FG006|Overall Study|Reason Not Specified|1
2065400|NCT02954406|3641634|FG007|Overall Study|Reason Not Specified|0
2065401|NCT02954406|3641635|FG008|Overall Study|Reason Not Specified|1
2065402|NCT02954406|3641636|FG009|Overall Study|Reason Not Specified|0
2065403|NCT02954406|3641637|FG010|Overall Study|Reason Not Specified|0
2065404|NCT02927145|3641672|FG000|Initial Recruitment|Withdrawal by Subject|0
2065405|NCT02927145|3641673|FG001|Initial Recruitment|Withdrawal by Subject|1
2065406|NCT02927145|3641674|FG002|Initial Recruitment|Withdrawal by Subject|1
2065407|NCT02927145|3641675|FG003|Initial Recruitment|Withdrawal by Subject|4
2065408|NCT02927145|3641676|FG004|Initial Recruitment|Withdrawal by Subject|1
2065409|NCT02927145|3641677|FG005|Initial Recruitment|Withdrawal by Subject|1
2065410|NCT02927145|3641678|FG006|Initial Recruitment|Withdrawal by Subject|0
2065411|NCT02927145|3641679|FG007|Initial Recruitment|Withdrawal by Subject|0
2065412|NCT02927145|3641680|FG008|Initial Recruitment|Withdrawal by Subject|2
2065413|NCT02927145|3641672|FG000|Initial Recruitment|Adverse Event|0
2065414|NCT02927145|3641673|FG001|Initial Recruitment|Adverse Event|0
2065415|NCT02927145|3641674|FG002|Initial Recruitment|Adverse Event|0
2065416|NCT02927145|3641675|FG003|Initial Recruitment|Adverse Event|0
2065417|NCT02927145|3641676|FG004|Initial Recruitment|Adverse Event|2
2065418|NCT02927145|3641677|FG005|Initial Recruitment|Adverse Event|0
2065419|NCT02927145|3641678|FG006|Initial Recruitment|Adverse Event|0
2065420|NCT02927145|3641679|FG007|Initial Recruitment|Adverse Event|0
2065421|NCT02927145|3641680|FG008|Initial Recruitment|Adverse Event|0
2065422|NCT02927145|3641672|FG000|Invitation for Additional Challenge|Pregnancy|0
2065423|NCT02927145|3641673|FG001|Invitation for Additional Challenge|Pregnancy|0
2065424|NCT02927145|3641674|FG002|Invitation for Additional Challenge|Pregnancy|0
2065425|NCT02927145|3641675|FG003|Invitation for Additional Challenge|Pregnancy|0
2065426|NCT02927145|3641676|FG004|Invitation for Additional Challenge|Pregnancy|0
2065427|NCT02927145|3641677|FG005|Invitation for Additional Challenge|Pregnancy|0
2065428|NCT02927145|3641678|FG006|Invitation for Additional Challenge|Pregnancy|1
2065429|NCT02927145|3641679|FG007|Invitation for Additional Challenge|Pregnancy|0
2065430|NCT02927145|3641680|FG008|Invitation for Additional Challenge|Pregnancy|0
2065431|NCT02910583|3641703|FG000|Overall Study|Withdrawal by Subject|6
2065432|NCT02910583|3641704|FG001|Overall Study|Withdrawal by Subject|7
2065433|NCT02910583|3641703|FG000|Overall Study|Other, Not Specified|1
2065434|NCT02910583|3641704|FG001|Overall Study|Other, Not Specified|0
2065435|NCT02598388|3641761|FG000|Overall Study|Lost to Follow-up|1
2065436|NCT02598388|3641762|FG001|Overall Study|Lost to Follow-up|0
2065437|NCT02598388|3641763|FG002|Overall Study|Lost to Follow-up|1
2065438|NCT02598388|3641764|FG003|Overall Study|Lost to Follow-up|0
2065439|NCT02598388|3641765|FG004|Overall Study|Lost to Follow-up|5
2065440|NCT02598388|3641766|FG005|Overall Study|Lost to Follow-up|1
2065441|NCT02598388|3641767|FG006|Overall Study|Lost to Follow-up|2
2065442|NCT02598388|3641768|FG007|Overall Study|Lost to Follow-up|1
2065443|NCT02598388|3641769|FG008|Overall Study|Lost to Follow-up|0
2065444|NCT02598388|3641770|FG009|Overall Study|Lost to Follow-up|0
2065445|NCT02598388|3641771|FG010|Overall Study|Lost to Follow-up|1
2065446|NCT02598388|3641772|FG011|Overall Study|Lost to Follow-up|0
2065447|NCT02598388|3641761|FG000|Overall Study|Withdrawal by Subject|0
2065448|NCT02598388|3641762|FG001|Overall Study|Withdrawal by Subject|0
2065449|NCT02598388|3641763|FG002|Overall Study|Withdrawal by Subject|0
2065450|NCT02598388|3641764|FG003|Overall Study|Withdrawal by Subject|0
2065451|NCT02598388|3641765|FG004|Overall Study|Withdrawal by Subject|2
2065452|NCT02598388|3641766|FG005|Overall Study|Withdrawal by Subject|0
2065453|NCT02598388|3641767|FG006|Overall Study|Withdrawal by Subject|2
2065454|NCT02598388|3641768|FG007|Overall Study|Withdrawal by Subject|0
2065455|NCT02598388|3641769|FG008|Overall Study|Withdrawal by Subject|0
2065456|NCT02598388|3641770|FG009|Overall Study|Withdrawal by Subject|1
2065457|NCT02598388|3641771|FG010|Overall Study|Withdrawal by Subject|0
2065458|NCT02598388|3641772|FG011|Overall Study|Withdrawal by Subject|0
2065459|NCT02598388|3641761|FG000|Overall Study|Other|0
2065460|NCT02598388|3641762|FG001|Overall Study|Other|0
2065461|NCT02598388|3641763|FG002|Overall Study|Other|1
2065462|NCT02598388|3641764|FG003|Overall Study|Other|0
2065463|NCT02598388|3641765|FG004|Overall Study|Other|3
2065464|NCT02598388|3641766|FG005|Overall Study|Other|0
2065465|NCT02598388|3641767|FG006|Overall Study|Other|1
2065466|NCT02598388|3641768|FG007|Overall Study|Other|0
2065467|NCT02598388|3641769|FG008|Overall Study|Other|0
2065468|NCT02598388|3641770|FG009|Overall Study|Other|0
2065469|NCT02598388|3641771|FG010|Overall Study|Other|0
2065470|NCT02598388|3641772|FG011|Overall Study|Other|0
2065471|NCT02493751|3641805|FG000|Overall Study|Withdrawal by Subject|2
2065472|NCT02493751|3641806|FG001|Overall Study|Withdrawal by Subject|8
2065473|NCT02493751|3641805|FG000|Overall Study|Death|6
2065474|NCT02493751|3641806|FG001|Overall Study|Death|13
2065475|NCT02493751|3641805|FG000|Overall Study|Lost to Follow-up|2
2065476|NCT02493751|3641806|FG001|Overall Study|Lost to Follow-up|3
2065477|NCT02493751|3641805|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6
2065478|NCT02493751|3641806|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15
2065479|NCT02285166|3641813|FG000|Overall Study|Case Report Forms Uncollected|564
2065480|NCT02285166|3641813|FG000|Overall Study|Protocol Deviation|402
2065481|NCT02278120|3641821|FG000|Overall Study|Progressive disease|122
2065482|NCT02278120|3641822|FG001|Overall Study|Progressive disease|174
2065483|NCT02278120|3641821|FG000|Overall Study|Patient/guardian decision|14
2065484|NCT02278120|3641822|FG001|Overall Study|Patient/guardian decision|8
2065485|NCT02278120|3641821|FG000|Overall Study|Adverse Event|12
2065486|NCT02278120|3641822|FG001|Overall Study|Adverse Event|10
2065487|NCT02278120|3641821|FG000|Overall Study|Physician Decision|8
2065488|NCT02278120|3641822|FG001|Overall Study|Physician Decision|19
2065489|NCT02278120|3641821|FG000|Overall Study|Death|3
2065490|NCT02278120|3641822|FG001|Overall Study|Death|3
2065491|NCT02278120|3641821|FG000|Overall Study|Lost to Follow-up|2
2065492|NCT02278120|3641822|FG001|Overall Study|Lost to Follow-up|0
2065493|NCT02278120|3641821|FG000|Overall Study|Protocol Violation|0
2065494|NCT02278120|3641822|FG001|Overall Study|Protocol Violation|2
2106062|NCT00862979|3699103|FG001|Overall Study|Protocol Violation|1
2106063|NCT00862979|3699102|FG000|Overall Study|Patient withdrew consent|2
2106064|NCT00862979|3699103|FG001|Overall Study|Patient withdrew consent|1
2106065|NCT00862979|3699102|FG000|Overall Study|Administrative problems|0
2106066|NCT00862979|3699103|FG001|Overall Study|Administrative problems|1
2210094|NCT01647711|3849476|FG003|Overall Study|Refused to continue taking medication|2
2210095|NCT01647711|3849477|FG004|Overall Study|Refused to continue taking medication|1
2210096|NCT01647711|3849473|FG000|Overall Study|Other reason not defined|0
2210097|NCT01647711|3849474|FG001|Overall Study|Other reason not defined|1
2210098|NCT01647711|3849475|FG002|Overall Study|Other reason not defined|1
2210099|NCT01647711|3849476|FG003|Overall Study|Other reason not defined|1
2210100|NCT01647711|3849477|FG004|Overall Study|Other reason not defined|0
2210101|NCT01647958|3849519|FG000|Initial Study|Lost to Follow-up|2
2210102|NCT01647958|3849520|FG001|Initial Study|Lost to Follow-up|3
2210103|NCT01647958|3849519|FG000|Continuation Phase|treatment received during Overall Study|39
2210104|NCT01647958|3849520|FG001|Continuation Phase|treatment received during Overall Study|0
2210105|NCT01647958|3849519|FG000|Extended Follow-up Phase|Lost to Follow-up|8
2210106|NCT01647958|3849520|FG001|Extended Follow-up Phase|Lost to Follow-up|0
2106067|NCT00862979|3699102|FG000|Overall Study|Death|0
2106068|NCT00862979|3699103|FG001|Overall Study|Death|1
2106069|NCT00862992|3699112|FG000|Overall Study|Adverse Event|2
2106070|NCT00862992|3699113|FG001|Overall Study|Adverse Event|1
2106071|NCT00862992|3699114|FG002|Overall Study|Adverse Event|1
2106072|NCT00862992|3699112|FG000|Overall Study|Physician Decision|1
2106073|NCT00862992|3699113|FG001|Overall Study|Physician Decision|0
2106074|NCT00862992|3699114|FG002|Overall Study|Physician Decision|0
2106075|NCT00862992|3699112|FG000|Overall Study|Withdrawal by Subject|0
2106076|NCT00862992|3699113|FG001|Overall Study|Withdrawal by Subject|0
2106077|NCT00862992|3699114|FG002|Overall Study|Withdrawal by Subject|2
2106078|NCT00863057|3699126|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
2106079|NCT00863057|3699127|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
2106080|NCT00863057|3699128|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
2106081|NCT00863057|3699129|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
2106082|NCT00863057|3699126|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
2106083|NCT00863057|3699127|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
2106084|NCT00863057|3699128|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
2106085|NCT00863057|3699129|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
2106086|NCT00863057|3699126|FG000|Period 2 (Weeks 6-10)|Adverse Event|0
2106087|NCT00863057|3699127|FG001|Period 2 (Weeks 6-10)|Adverse Event|1
2106088|NCT00863057|3699128|FG002|Period 2 (Weeks 6-10)|Adverse Event|1
2106089|NCT00863057|3699129|FG003|Period 2 (Weeks 6-10)|Adverse Event|0
2106090|NCT00863057|3699126|FG000|Period 2 (Weeks 6-10)|Physician Decision|0
2065495|NCT02075593|3641828|FG000|Overall Study|Withdrawal by Subject|1
2065496|NCT02075593|3641828|FG000|Overall Study|Treatment ongoing at the time of analysis|2
2065497|NCT00587860|3641845|FG000|Overall Study|Lost to Follow-up|2
2065498|NCT00587860|3641846|FG001|Overall Study|Lost to Follow-up|2
2065499|NCT00587860|3641845|FG000|Overall Study|Withdrawal by Subject|3
2065500|NCT00587860|3641846|FG001|Overall Study|Withdrawal by Subject|3
2065501|NCT00587964|3641852|FG000|Overall Study|Withdrawal by Subject|1
2065502|NCT00587964|3641852|FG000|Overall Study|Lost to Follow-up|1
2065503|NCT00587964|3641852|FG000|Overall Study|Patient found to be ineligible|1
2065504|NCT00587964|3641852|FG000|Overall Study|Patient did not receive intervention|5
2065505|NCT00587964|3641852|FG000|Overall Study|Progression of Disease|4
2065506|NCT00587990|3641859|FG000|Overall Study|Death|0
2065507|NCT00587990|3641860|FG001|Overall Study|Death|0
2065508|NCT00587990|3641861|FG002|Overall Study|Death|1
2065509|NCT00588094|3641869|FG000|Overall Study|Adverse Event|3
2065510|NCT00588094|3641869|FG000|Overall Study|Progression of Disease|2
2065511|NCT00588237|3641882|FG000|Overall Study|Evaluable for toxicity only|3
2065512|NCT00588237|3641882|FG000|Overall Study|Patien not treated|1
2065513|NCT00588341|3641886|FG000|Overall Study|Withdrawal by Subject|3
2065514|NCT00588341|3641886|FG000|Overall Study|Not treated due to metastatic disease|1
2065515|NCT00588341|3641886|FG000|Overall Study|Patient ineligible|1
2065516|NCT00588354|3641892|FG000|Baseline to 2 Weeks|Adverse Event|1
2065517|NCT00588354|3641893|FG001|Baseline to 2 Weeks|Adverse Event|0
2065518|NCT00588354|3641892|FG000|Baseline to 2 Weeks|Lack of Efficacy|1
2065519|NCT00588354|3641893|FG001|Baseline to 2 Weeks|Lack of Efficacy|0
2065520|NCT00588354|3641892|FG000|Baseline to 4 Weeks|Lost to Follow-up|0
2065521|NCT00588354|3641893|FG001|Baseline to 4 Weeks|Lost to Follow-up|1
2065522|NCT00588445|3641914|FG000|Overall Study|Protocol Violation|1
2065523|NCT00588445|3641914|FG000|Overall Study|Withdrawal by Subject|3
2065524|NCT00588445|3641914|FG000|Overall Study|Disease Progression|1
2065525|NCT00588445|3641914|FG000|Overall Study|Not Treated|10
2065526|NCT00588640|3641924|FG000|Overall Study|Physician Decision|1
2065527|NCT00588640|3641924|FG000|Overall Study|Ineligible Patient|1
2065528|NCT00588666|3641928|FG000|Overall Study|Adverse Event|4
2065529|NCT00588692|3641934|FG000|Overall Study|Withdrawal by Subject|4
2065530|NCT00588692|3641935|FG001|Overall Study|Withdrawal by Subject|2
2065531|NCT00588692|3641934|FG000|Overall Study|Hip Surgery|0
2065532|NCT00588692|3641935|FG001|Overall Study|Hip Surgery|1
2065533|NCT00588692|3641934|FG000|Overall Study|Severe Peptic Ulcer Disease|1
2065534|NCT00588692|3641935|FG001|Overall Study|Severe Peptic Ulcer Disease|0
2065535|NCT00588692|3641934|FG000|Overall Study|Cancer|1
2065536|NCT00588692|3641935|FG001|Overall Study|Cancer|0
2065537|NCT00588692|3641934|FG000|Overall Study|Death|1
2065538|NCT00588692|3641935|FG001|Overall Study|Death|0
2065539|NCT00588731|3641945|FG000|Overall Study|Withdrawal by Subject|3
2065540|NCT00588731|3641946|FG001|Overall Study|Withdrawal by Subject|2
2065541|NCT00588822|3641956|FG000|Overall Study|progression of disease|8
2065542|NCT00588848|3641962|FG000|Overall Study|Physician Decision|0
2065543|NCT00588848|3641963|FG001|Overall Study|Physician Decision|3
2065544|NCT00588952|3641977|FG000|Overall Study|Adverse Event|0
2065545|NCT00588952|3641978|FG001|Overall Study|Adverse Event|2
2065546|NCT00588952|3641977|FG000|Overall Study|Withdrawal by Subject|3
2065547|NCT00588952|3641978|FG001|Overall Study|Withdrawal by Subject|5
2065548|NCT00589108|3641997|FG000|Overall Study|Lost to Follow-up|1
2065549|NCT00589108|3641998|FG001|Overall Study|Lost to Follow-up|1
2065550|NCT00589108|3641999|FG002|Overall Study|Lost to Follow-up|1
2065551|NCT00589108|3641997|FG000|Overall Study|Death|3
2065552|NCT00589108|3641998|FG001|Overall Study|Death|3
2065553|NCT00589108|3641999|FG002|Overall Study|Death|4
2065554|NCT00589121|3642009|FG000|Overall Study|Protocol Violation|2
2065555|NCT00589121|3642010|FG001|Overall Study|Protocol Violation|6
2065556|NCT00589121|3642009|FG000|Overall Study|No protocol treatment received|0
2065557|NCT00589121|3642010|FG001|Overall Study|No protocol treatment received|1
2065558|NCT00589290|3642028|FG000|Overall Study|Withdrawal by Subject|1
2065559|NCT00589303|3642036|FG000|Overall Study|Withdrawal by Subject|2
2065560|NCT00589303|3642037|FG001|Overall Study|Withdrawal by Subject|1
2065561|NCT00589472|3642053|FG000|Overall Study|Adverse Event|1
2065562|NCT00589602|3642061|FG000|Overall Study|Did not collect enough CD34+ cells|1
2065563|NCT00589628|3642069|FG000|Overall Study|Lost to Follow-up|0
2065564|NCT00589628|3642070|FG001|Overall Study|Lost to Follow-up|1
2065565|NCT00589667|3642076|FG000|Overall Study|Adverse Event|2
2065566|NCT00589667|3642076|FG000|Overall Study|Withdrawal by Subject|1
2065567|NCT00589693|3642082|FG000|Overall Study|randomized in error|12
2065568|NCT00589693|3642083|FG001|Overall Study|randomized in error|6
2065569|NCT00589693|3642082|FG000|Overall Study|Adverse Event|4
2065570|NCT00589693|3642083|FG001|Overall Study|Adverse Event|4
2065571|NCT00589693|3642082|FG000|Overall Study|Death|26
2065572|NCT00589693|3642083|FG001|Overall Study|Death|16
2065573|NCT00589693|3642082|FG000|Overall Study|Lack of Efficacy|0
2065574|NCT00589693|3642083|FG001|Overall Study|Lack of Efficacy|1
2065575|NCT00589693|3642082|FG000|Overall Study|Lost to Follow-up|1
2065576|NCT00589693|3642083|FG001|Overall Study|Lost to Follow-up|0
2065577|NCT00589693|3642082|FG000|Overall Study|Physician Decision|0
2065578|NCT00589693|3642083|FG001|Overall Study|Physician Decision|1
2065579|NCT00589693|3642082|FG000|Overall Study|Protocol Violation|1
2065580|NCT00589693|3642083|FG001|Overall Study|Protocol Violation|1
2065581|NCT00589784|3642091|FG000|Overall Study|Withdrawal by Subject|0
2065582|NCT00589784|3642092|FG001|Overall Study|Withdrawal by Subject|6
2065583|NCT00589784|3642091|FG000|Overall Study|Patient inevaluable|1
2065584|NCT00589784|3642092|FG001|Overall Study|Patient inevaluable|0
2065585|NCT00589784|3642091|FG000|Overall Study|Adverse Event|0
2065586|NCT00589784|3642092|FG001|Overall Study|Adverse Event|4
2065587|NCT00589797|3642099|FG000|Overall Study|Death|1
2210107|NCT01648101|3849538|FG000|Titration Phase (4 Weeks)|Protocol Violation|2
2210108|NCT01648101|3849539|FG001|Titration Phase (4 Weeks)|Protocol Violation|1
2210109|NCT01648101|3849540|FG002|Titration Phase (4 Weeks)|Protocol Violation|2
2210110|NCT01648101|3849538|FG000|Titration Phase (4 Weeks)|Adverse Event|0
2210111|NCT01648101|3849539|FG001|Titration Phase (4 Weeks)|Adverse Event|2
2210112|NCT01648101|3849540|FG002|Titration Phase (4 Weeks)|Adverse Event|3
2210113|NCT01648101|3849538|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
2210114|NCT01648101|3849539|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
2210115|NCT01648101|3849540|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
2210116|NCT01648101|3849538|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1
2210117|NCT01648101|3849539|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0
2210118|NCT01648101|3849540|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1
2210119|NCT01648101|3849538|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
2210120|NCT01648101|3849539|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
2210121|NCT01648101|3849540|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
2210122|NCT01648101|3849538|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1
2210123|NCT01648101|3849539|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3
2210124|NCT01648101|3849540|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4
2210125|NCT01648101|3849538|FG000|Transition Phase (4 Weeks)|Adverse Event|4
2210126|NCT01648101|3849539|FG001|Transition Phase (4 Weeks)|Adverse Event|3
2210127|NCT01648101|3849540|FG002|Transition Phase (4 Weeks)|Adverse Event|2
2210128|NCT01648101|3849538|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0
2065588|NCT00589797|3642100|FG001|Overall Study|Death|0
2065589|NCT00589797|3642099|FG000|Overall Study|Lost to Follow-up|12
2065590|NCT00589797|3642100|FG001|Overall Study|Lost to Follow-up|9
2065591|NCT00589797|3642099|FG000|Overall Study|Physician Decision|8
2065592|NCT00589797|3642100|FG001|Overall Study|Physician Decision|3
2065593|NCT00589797|3642099|FG000|Overall Study|Withdrawal by Subject|6
2065594|NCT00589797|3642100|FG001|Overall Study|Withdrawal by Subject|5
2065595|NCT00589797|3642099|FG000|Overall Study|Non-Randomized Training Subjects|46
2065596|NCT00589797|3642100|FG001|Overall Study|Non-Randomized Training Subjects|6
2065597|NCT00589914|3642137|FG000|Overall Study|Adverse Event|19
2065598|NCT00589914|3642138|FG001|Overall Study|Adverse Event|10
2065599|NCT00589914|3642137|FG000|Overall Study|Death|2
2065600|NCT00589914|3642138|FG001|Overall Study|Death|0
2065601|NCT00589914|3642137|FG000|Overall Study|Lack of Efficacy|40
2065602|NCT00589914|3642138|FG001|Overall Study|Lack of Efficacy|43
2065603|NCT00589914|3642137|FG000|Overall Study|Lost to Follow-up|11
2065604|NCT00589914|3642138|FG001|Overall Study|Lost to Follow-up|18
2065605|NCT00589914|3642137|FG000|Overall Study|Pregnancy|1
2065606|NCT00589914|3642138|FG001|Overall Study|Pregnancy|0
2065607|NCT00589914|3642137|FG000|Overall Study|Withdrawal by Subject|55
2065608|NCT00589914|3642138|FG001|Overall Study|Withdrawal by Subject|49
2065609|NCT00589914|3642137|FG000|Overall Study|Other|22
2065610|NCT00589914|3642138|FG001|Overall Study|Other|17
2065611|NCT00589979|3642146|FG000|Run-In Period|Adverse Event|5
2065612|NCT00589979|3642147|FG001|Run-In Period|Adverse Event|0
2065613|NCT00589979|3642148|FG002|Run-In Period|Adverse Event|0
2065614|NCT00589979|3642146|FG000|Run-In Period|Protocol Violation|3
2065615|NCT00589979|3642147|FG001|Run-In Period|Protocol Violation|0
2065616|NCT00589979|3642148|FG002|Run-In Period|Protocol Violation|0
2065617|NCT00589979|3642146|FG000|Run-In Period|Did not qualify for randomization|54
2065618|NCT00589979|3642147|FG001|Run-In Period|Did not qualify for randomization|0
2065619|NCT00589979|3642148|FG002|Run-In Period|Did not qualify for randomization|0
2065620|NCT00589979|3642146|FG000|Run-In Period|Withdrawal by Subject|10
2065621|NCT00589979|3642147|FG001|Run-In Period|Withdrawal by Subject|0
2065622|NCT00589979|3642148|FG002|Run-In Period|Withdrawal by Subject|0
2065623|NCT00589979|3642146|FG000|Run-In Period|Informed Consent Withdrawn|4
2065624|NCT00589979|3642147|FG001|Run-In Period|Informed Consent Withdrawn|0
2065625|NCT00589979|3642148|FG002|Run-In Period|Informed Consent Withdrawn|0
2065626|NCT00589979|3642146|FG000|Double-Blind Treatment Period 1|Adverse Event|0
2065627|NCT00589979|3642147|FG001|Double-Blind Treatment Period 1|Adverse Event|1
2065628|NCT00589979|3642148|FG002|Double-Blind Treatment Period 1|Adverse Event|0
2065629|NCT00589979|3642146|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
2065630|NCT00589979|3642147|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
2065631|NCT00589979|3642148|FG002|Double-Blind Treatment Period 1|Protocol Violation|1
2065632|NCT00589979|3642146|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
2065633|NCT00589979|3642147|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0
2065634|NCT00589979|3642148|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1
2065635|NCT00589979|3642146|FG000|Double-Blind Treatment Period 2|Adverse Event|0
2210129|NCT01648101|3849539|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2
2210130|NCT01648101|3849540|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0
2065636|NCT00589979|3642147|FG001|Double-Blind Treatment Period 2|Adverse Event|1
2065637|NCT00589979|3642148|FG002|Double-Blind Treatment Period 2|Adverse Event|0
2065638|NCT00589979|3642146|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
2065639|NCT00589979|3642147|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0
2065640|NCT00589979|3642148|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1
2065641|NCT00589979|3642146|FG000|Double-Blind Treatment Period 2|Other|0
2065642|NCT00589979|3642147|FG001|Double-Blind Treatment Period 2|Other|0
2065643|NCT00589979|3642148|FG002|Double-Blind Treatment Period 2|Other|1
2065644|NCT00589979|3642146|FG000|Double-Blind Treatment Period 3|Protocol Violation|0
2065645|NCT00589979|3642147|FG001|Double-Blind Treatment Period 3|Protocol Violation|1
2065646|NCT00589979|3642148|FG002|Double-Blind Treatment Period 3|Protocol Violation|0
2065647|NCT00589979|3642146|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0
2065648|NCT00589979|3642147|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0
2065649|NCT00589979|3642148|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1
2065650|NCT00590031|3642176|FG000|Overall Study|Adverse Event|3
2065651|NCT00590031|3642176|FG000|Overall Study|Withdrawal by Subject|1
2065652|NCT00590031|3642176|FG000|Overall Study|Metastatic Disease|1
2065653|NCT00590031|3642176|FG000|Overall Study|Admin Hold|1
2065654|NCT00590044|3642182|FG000|Overall Study|Withdrawal by Subject|2
2065655|NCT00590044|3642183|FG001|Overall Study|Withdrawal by Subject|2
2065656|NCT00590044|3642182|FG000|Overall Study|wrong insulin arm assigned|1
2065657|NCT00590044|3642183|FG001|Overall Study|wrong insulin arm assigned|0
2065658|NCT00590044|3642182|FG000|Overall Study|Protocol Violation|1
2065659|NCT00590044|3642183|FG001|Overall Study|Protocol Violation|0
2065660|NCT00590317|3642212|FG000|Overall Study|Lack of Efficacy|1
2065661|NCT00590317|3642213|FG001|Overall Study|Lack of Efficacy|5
2065662|NCT00590564|3642241|FG000|Overall Study|Withdrawal by Subject|4
2065663|NCT00590564|3642241|FG000|Overall Study|Lost to Follow-up|6
2065664|NCT00590564|3642241|FG000|Overall Study|Protocol Violation|1
2065665|NCT00590564|3642241|FG000|Overall Study|Patient Found to be Ineligible|1
2065666|NCT00590564|3642241|FG000|Overall Study|Patient Non-compliance|6
2065667|NCT00590577|3642249|FG000|Overall Study|Lack of Efficacy|31
2065668|NCT00590577|3642250|FG001|Overall Study|Lack of Efficacy|28
2065669|NCT00590577|3642251|FG002|Overall Study|Lack of Efficacy|23
2065670|NCT00590577|3642252|FG003|Overall Study|Lack of Efficacy|45
2065671|NCT00590577|3642249|FG000|Overall Study|Withdrawal by Subject|23
2065672|NCT00590577|3642250|FG001|Overall Study|Withdrawal by Subject|28
2210131|NCT01648101|3849538|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0
2210132|NCT01648101|3849539|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0
2210133|NCT01648101|3849540|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2
2210134|NCT01648101|3849538|FG000|Transition Phase (4 Weeks)|Study Terminated|1
2210135|NCT01648101|3849539|FG001|Transition Phase (4 Weeks)|Study Terminated|0
2210136|NCT01648101|3849540|FG002|Transition Phase (4 Weeks)|Study Terminated|0
2210137|NCT01648101|3849538|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
2210138|NCT01648101|3849539|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
2210139|NCT01648101|3849540|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
2210140|NCT01648140|3849556|FG000|Overall Study|Physician Decision|1
2210141|NCT01648140|3849557|FG001|Overall Study|Physician Decision|0
2210142|NCT01648140|3849558|FG002|Overall Study|Physician Decision|0
2210143|NCT01648140|3849559|FG003|Overall Study|Physician Decision|0
2210144|NCT01648140|3849556|FG000|Overall Study|Lack of Efficacy|4
2210145|NCT01648140|3849557|FG001|Overall Study|Lack of Efficacy|7
2210146|NCT01648140|3849558|FG002|Overall Study|Lack of Efficacy|1
2210147|NCT01648140|3849559|FG003|Overall Study|Lack of Efficacy|0
2210148|NCT01648140|3849556|FG000|Overall Study|Adverse Event|3
2210149|NCT01648140|3849557|FG001|Overall Study|Adverse Event|1
2210150|NCT01648140|3849558|FG002|Overall Study|Adverse Event|2
2210151|NCT01648140|3849559|FG003|Overall Study|Adverse Event|0
2210152|NCT01648140|3849556|FG000|Overall Study|Withdrawal by Subject|2
2210153|NCT01648140|3849557|FG001|Overall Study|Withdrawal by Subject|3
2210154|NCT01648140|3849558|FG002|Overall Study|Withdrawal by Subject|3
2210155|NCT01648140|3849559|FG003|Overall Study|Withdrawal by Subject|2
2210156|NCT01648140|3849556|FG000|Overall Study|Lost to Follow-up|2
2210157|NCT01648140|3849557|FG001|Overall Study|Lost to Follow-up|1
2210158|NCT01648140|3849558|FG002|Overall Study|Lost to Follow-up|2
2210159|NCT01648140|3849559|FG003|Overall Study|Lost to Follow-up|0
2217490|NCT01708915|3860824|FG003|Overall Study|Other reasons than stated above|2
2217491|NCT01708941|3860838|FG000|Overall Study|Adverse Event|4
2217492|NCT01708941|3860839|FG001|Overall Study|Adverse Event|6
2217493|NCT01708941|3860840|FG002|Overall Study|Adverse Event|1
2217494|NCT01708941|3860841|FG003|Overall Study|Adverse Event|0
2217495|NCT01708941|3860838|FG000|Overall Study|Death|1
2217496|NCT01708941|3860839|FG001|Overall Study|Death|1
2065673|NCT00590577|3642251|FG002|Overall Study|Withdrawal by Subject|30
2065674|NCT00590577|3642252|FG003|Overall Study|Withdrawal by Subject|26
2065675|NCT00590577|3642249|FG000|Overall Study|Adverse Event|10
2065676|NCT00590577|3642250|FG001|Overall Study|Adverse Event|10
2065677|NCT00590577|3642251|FG002|Overall Study|Adverse Event|13
2217497|NCT01708941|3860840|FG002|Overall Study|Death|2
2217498|NCT01708941|3860841|FG003|Overall Study|Death|14
2217499|NCT01708941|3860838|FG000|Overall Study|Withdrawal by Subject|1
2217500|NCT01708941|3860839|FG001|Overall Study|Withdrawal by Subject|0
2217501|NCT01708941|3860840|FG002|Overall Study|Withdrawal by Subject|3
2065678|NCT00590577|3642252|FG003|Overall Study|Adverse Event|11
2065679|NCT00590577|3642249|FG000|Overall Study|Lost to Follow-up|12
2065680|NCT00590577|3642250|FG001|Overall Study|Lost to Follow-up|6
2065681|NCT00590577|3642251|FG002|Overall Study|Lost to Follow-up|6
2065682|NCT00590577|3642252|FG003|Overall Study|Lost to Follow-up|9
2065683|NCT00590577|3642249|FG000|Overall Study|Pregnancy|0
2065684|NCT00590577|3642250|FG001|Overall Study|Pregnancy|1
2065685|NCT00590577|3642251|FG002|Overall Study|Pregnancy|0
2065686|NCT00590577|3642252|FG003|Overall Study|Pregnancy|0
2065687|NCT00590577|3642249|FG000|Overall Study|Various reasons|1
2065688|NCT00590577|3642250|FG001|Overall Study|Various reasons|3
2065689|NCT00590577|3642251|FG002|Overall Study|Various reasons|1
2065690|NCT00590577|3642252|FG003|Overall Study|Various reasons|2
2065691|NCT00590590|3642265|FG000|Overall Study|Lack of Efficacy|1
2065692|NCT00590590|3642266|FG001|Overall Study|Lack of Efficacy|2
2065693|NCT00590590|3642267|FG002|Overall Study|Lack of Efficacy|0
2065694|NCT00590590|3642265|FG000|Overall Study|Adverse Event|1
2065695|NCT00590590|3642266|FG001|Overall Study|Adverse Event|0
2065696|NCT00590590|3642267|FG002|Overall Study|Adverse Event|0
2065697|NCT00590590|3642265|FG000|Overall Study|Protocol Violation|0
2065698|NCT00590590|3642266|FG001|Overall Study|Protocol Violation|0
2065699|NCT00590590|3642267|FG002|Overall Study|Protocol Violation|2
2065700|NCT00590590|3642265|FG000|Overall Study|Lost to Follow-up|4
2065701|NCT00590590|3642266|FG001|Overall Study|Lost to Follow-up|1
2065702|NCT00590590|3642267|FG002|Overall Study|Lost to Follow-up|2
2065703|NCT00590590|3642265|FG000|Overall Study|Withdrawal by Subject|0
2065704|NCT00590590|3642266|FG001|Overall Study|Withdrawal by Subject|1
2065705|NCT00590590|3642267|FG002|Overall Study|Withdrawal by Subject|1
2065706|NCT00590590|3642265|FG000|Overall Study|Did not complete due to study closure|1
2065707|NCT00590590|3642266|FG001|Overall Study|Did not complete due to study closure|1
2065708|NCT00590590|3642267|FG002|Overall Study|Did not complete due to study closure|1
2065709|NCT00590590|3642265|FG000|Overall Study|Did not complete study|0
2065710|NCT00590590|3642266|FG001|Overall Study|Did not complete study|1
2065711|NCT00590590|3642267|FG002|Overall Study|Did not complete study|0
2065712|NCT00590681|3642275|FG000|Overall Study|Withdrawal by Subject|7
2065713|NCT00590681|3642275|FG000|Overall Study|Adverse Event|8
2065714|NCT00590681|3642275|FG000|Overall Study|Death|3
2065715|NCT00590681|3642275|FG000|Overall Study|Lost to Follow-up|1
2065716|NCT00590681|3642275|FG000|Overall Study|disease progression|1
2065717|NCT00590720|3642290|FG000|Overall Study|Lost to Follow-up|1
2065718|NCT00590720|3642291|FG001|Overall Study|Lost to Follow-up|0
2065719|NCT00590720|3642290|FG000|Overall Study|Withdrawal by Subject|0
2065720|NCT00590720|3642291|FG001|Overall Study|Withdrawal by Subject|1
2065721|NCT00590759|3642297|FG000|Overall Study|Death|52
2065722|NCT00590759|3642297|FG000|Overall Study|Lost to Follow-up|28
2065723|NCT00590824|3642311|FG000|Overall Study|Disease could not be resected|0
2065724|NCT00590824|3642312|FG001|Overall Study|Disease could not be resected|2
2065725|NCT00590824|3642313|FG002|Overall Study|Disease could not be resected|1
2065726|NCT00590824|3642314|FG003|Overall Study|Disease could not be resected|0
2065727|NCT00590824|3642311|FG000|Overall Study|Adverse Event|0
2065728|NCT00590824|3642312|FG001|Overall Study|Adverse Event|0
2065729|NCT00590824|3642313|FG002|Overall Study|Adverse Event|0
2065730|NCT00590824|3642314|FG003|Overall Study|Adverse Event|1
2065731|NCT00590902|3642347|FG000|Overall Study|Death|1
2065732|NCT00590954|3642351|FG000|Overall Study|Inevaluable|2
2065733|NCT00590967|3642359|FG000|Overall Study|Withdrawal by Subject|1
2065734|NCT00590967|3642360|FG001|Overall Study|Withdrawal by Subject|1
2065735|NCT00590967|3642359|FG000|Overall Study|Ineligible|1
2065736|NCT00590967|3642360|FG001|Overall Study|Ineligible|0
2065737|NCT00590967|3642359|FG000|Overall Study|Poor performance status|0
2065738|NCT00590967|3642360|FG001|Overall Study|Poor performance status|1
2065739|NCT00590967|3642359|FG000|Overall Study|Non-compliant|0
2065740|NCT00590967|3642360|FG001|Overall Study|Non-compliant|2
2065741|NCT00590967|3642359|FG000|Overall Study|Did not sign consent form|0
2065742|NCT00590967|3642360|FG001|Overall Study|Did not sign consent form|1
2065743|NCT00590967|3642359|FG000|Overall Study|Did not receive chemo per protocol|1
2065744|NCT00590967|3642360|FG001|Overall Study|Did not receive chemo per protocol|0
2065745|NCT00590980|3642366|FG000|Overall Study|Did not meet all inclusion criteria|10
2065746|NCT00591006|3642370|FG000|Overall Study|Withdrawal by Subject|0
2065747|NCT00591006|3642371|FG001|Overall Study|Withdrawal by Subject|0
2065748|NCT00591006|3642372|FG002|Overall Study|Withdrawal by Subject|0
2065749|NCT00591006|3642373|FG003|Overall Study|Withdrawal by Subject|0
2065750|NCT00591006|3642374|FG004|Overall Study|Withdrawal by Subject|0
2065751|NCT00591006|3642375|FG005|Overall Study|Withdrawal by Subject|0
2065752|NCT00591006|3642376|FG006|Overall Study|Withdrawal by Subject|0
2065753|NCT00591006|3642377|FG007|Overall Study|Withdrawal by Subject|0
2065754|NCT00591006|3642378|FG008|Overall Study|Withdrawal by Subject|0
2065755|NCT00591006|3642379|FG009|Overall Study|Withdrawal by Subject|0
2065756|NCT00591006|3642380|FG010|Overall Study|Withdrawal by Subject|0
2065757|NCT00591006|3642381|FG011|Overall Study|Withdrawal by Subject|0
2065758|NCT00591006|3642382|FG012|Overall Study|Withdrawal by Subject|0
2065759|NCT00591006|3642383|FG013|Overall Study|Withdrawal by Subject|0
2065760|NCT00591006|3642384|FG014|Overall Study|Withdrawal by Subject|0
2065761|NCT00591006|3642385|FG015|Overall Study|Withdrawal by Subject|1
2065762|NCT00591006|3642386|FG016|Overall Study|Withdrawal by Subject|0
2065763|NCT00591006|3642387|FG017|Overall Study|Withdrawal by Subject|0
2065764|NCT00591006|3642388|FG018|Overall Study|Withdrawal by Subject|0
2065765|NCT00591006|3642389|FG019|Overall Study|Withdrawal by Subject|0
2065766|NCT00591006|3642390|FG020|Overall Study|Withdrawal by Subject|0
2065767|NCT00591006|3642391|FG021|Overall Study|Withdrawal by Subject|0
2065768|NCT00591006|3642392|FG022|Overall Study|Withdrawal by Subject|0
2065769|NCT00591006|3642393|FG023|Overall Study|Withdrawal by Subject|1
2065770|NCT00591006|3642370|FG000|Overall Study|Adverse Event|0
2065771|NCT00591006|3642371|FG001|Overall Study|Adverse Event|0
2065772|NCT00591006|3642372|FG002|Overall Study|Adverse Event|0
2065773|NCT00591006|3642373|FG003|Overall Study|Adverse Event|0
2065774|NCT00591006|3642374|FG004|Overall Study|Adverse Event|0
2065775|NCT00591006|3642375|FG005|Overall Study|Adverse Event|0
2065776|NCT00591006|3642376|FG006|Overall Study|Adverse Event|0
2065777|NCT00591006|3642377|FG007|Overall Study|Adverse Event|0
2065778|NCT00591006|3642378|FG008|Overall Study|Adverse Event|0
2065779|NCT00591006|3642379|FG009|Overall Study|Adverse Event|0
2065780|NCT00591006|3642380|FG010|Overall Study|Adverse Event|0
2065781|NCT00591006|3642381|FG011|Overall Study|Adverse Event|0
2065782|NCT00591006|3642382|FG012|Overall Study|Adverse Event|0
2065783|NCT00591006|3642383|FG013|Overall Study|Adverse Event|0
2065784|NCT00591006|3642384|FG014|Overall Study|Adverse Event|0
2065785|NCT00591006|3642385|FG015|Overall Study|Adverse Event|0
2065786|NCT00591006|3642386|FG016|Overall Study|Adverse Event|0
2065787|NCT00591006|3642387|FG017|Overall Study|Adverse Event|0
2065788|NCT00591006|3642388|FG018|Overall Study|Adverse Event|0
2065789|NCT00591006|3642389|FG019|Overall Study|Adverse Event|0
2065790|NCT00591006|3642390|FG020|Overall Study|Adverse Event|0
2065791|NCT00591006|3642391|FG021|Overall Study|Adverse Event|0
2065792|NCT00591006|3642392|FG022|Overall Study|Adverse Event|1
2065793|NCT00591006|3642393|FG023|Overall Study|Adverse Event|0
2065794|NCT00591149|3642423|FG000|Overall Study|Adverse Event|4
2065795|NCT00591149|3642423|FG000|Overall Study|Withdrawal by Subject|1
2065796|NCT00591214|3642427|FG000|Overall Study|Physician Decision|7
2065797|NCT00591214|3642427|FG000|Overall Study|Withdrawal by Subject|1
2065798|NCT00591253|3642443|FG000|Overall Study|Adverse Event|3
2065799|NCT00591253|3642444|FG001|Overall Study|Adverse Event|3
2065800|NCT00591253|3642445|FG002|Overall Study|Adverse Event|1
2065801|NCT00591253|3642443|FG000|Overall Study|Protocol Violation|2
2065802|NCT00591253|3642444|FG001|Overall Study|Protocol Violation|2
2065803|NCT00591253|3642445|FG002|Overall Study|Protocol Violation|2
2065804|NCT00591253|3642443|FG000|Overall Study|Lost to Follow-up|2
2065805|NCT00591253|3642444|FG001|Overall Study|Lost to Follow-up|4
2065806|NCT00591253|3642445|FG002|Overall Study|Lost to Follow-up|0
2065807|NCT00591253|3642443|FG000|Overall Study|Withdrawal by Subject|1
2065808|NCT00591253|3642444|FG001|Overall Study|Withdrawal by Subject|7
2065809|NCT00591253|3642445|FG002|Overall Study|Withdrawal by Subject|6
2065810|NCT00591253|3642443|FG000|Overall Study|Lack of Efficacy|1
2065811|NCT00591253|3642444|FG001|Overall Study|Lack of Efficacy|0
2065812|NCT00591253|3642445|FG002|Overall Study|Lack of Efficacy|3
2065813|NCT00591253|3642443|FG000|Overall Study|Other|5
2065814|NCT00591253|3642444|FG001|Overall Study|Other|5
2065815|NCT00591253|3642445|FG002|Overall Study|Other|3
2065816|NCT00591266|3642456|FG000|Overall Study|Adverse Event|2
2065817|NCT00591266|3642457|FG001|Overall Study|Adverse Event|2
2065818|NCT00591266|3642458|FG002|Overall Study|Adverse Event|3
2065819|NCT00591266|3642456|FG000|Overall Study|Lost to Follow-up|0
2065820|NCT00591266|3642457|FG001|Overall Study|Lost to Follow-up|1
2065821|NCT00591266|3642458|FG002|Overall Study|Lost to Follow-up|0
2065822|NCT00591266|3642456|FG000|Overall Study|Protocol Violation|0
2065823|NCT00591266|3642457|FG001|Overall Study|Protocol Violation|0
2065824|NCT00591266|3642458|FG002|Overall Study|Protocol Violation|1
2065825|NCT00591266|3642456|FG000|Overall Study|Withdrawal by Subject|6
2065826|NCT00591266|3642457|FG001|Overall Study|Withdrawal by Subject|2
2065827|NCT00591266|3642458|FG002|Overall Study|Withdrawal by Subject|5
2065828|NCT00591266|3642456|FG000|Overall Study|Lack of Efficacy|0
2065829|NCT00591266|3642457|FG001|Overall Study|Lack of Efficacy|2
2065830|NCT00591266|3642458|FG002|Overall Study|Lack of Efficacy|0
2065831|NCT00591266|3642456|FG000|Overall Study|Other|1
2065832|NCT00591266|3642457|FG001|Overall Study|Other|4
2065833|NCT00591266|3642458|FG002|Overall Study|Other|5
2065834|NCT00591344|3642478|FG000|Overall Study|Transportation issues|1
2065835|NCT00591344|3642479|FG001|Overall Study|Transportation issues|0
2065836|NCT00591344|3642478|FG000|Overall Study|Moved out of state|1
2065837|NCT00591344|3642479|FG001|Overall Study|Moved out of state|0
2065838|NCT00591344|3642478|FG000|Overall Study|Medical complications|1
2065839|NCT00591344|3642479|FG001|Overall Study|Medical complications|3
2065840|NCT00591344|3642478|FG000|Overall Study|Underwent DBS|2
2065841|NCT00591344|3642479|FG001|Overall Study|Underwent DBS|2
2065842|NCT00591344|3642478|FG000|Overall Study|Death|0
2065843|NCT00591344|3642479|FG001|Overall Study|Death|1
2065844|NCT00591344|3642478|FG000|Overall Study|Lost to Follow-up|0
2065845|NCT00591344|3642479|FG001|Overall Study|Lost to Follow-up|1
2065846|NCT00591344|3642478|FG000|Overall Study|Did not want to come off medication|0
2065847|NCT00591344|3642479|FG001|Overall Study|Did not want to come off medication|1
2065848|NCT00591370|3642489|FG000|Overall Study|Not Treated|2
2065849|NCT00591409|3642503|FG000|Overall Study|Not Treated|0
2065850|NCT00591409|3642504|FG001|Overall Study|Not Treated|0
2065851|NCT00591409|3642505|FG002|Overall Study|Not Treated|0
2065852|NCT00591409|3642506|FG003|Overall Study|Not Treated|0
2065853|NCT00591409|3642507|FG004|Overall Study|Not Treated|1
2065854|NCT00591409|3642508|FG005|Overall Study|Not Treated|0
2065855|NCT00591409|3642509|FG006|Overall Study|Not Treated|0
2065856|NCT00591409|3642510|FG007|Overall Study|Not Treated|0
2065857|NCT00591409|3642511|FG008|Overall Study|Not Treated|0
2065858|NCT00591409|3642512|FG009|Overall Study|Not Treated|1
2065859|NCT00591565|3642534|FG000|Overall Study|lost follow up, withdrawn|5
2065860|NCT00591578|3642541|FG000|Double-Blind Treatment Phase|Adverse Event|20
2065861|NCT00591578|3642542|FG001|Double-Blind Treatment Phase|Adverse Event|26
2065862|NCT00591578|3642543|FG002|Double-Blind Treatment Phase|Adverse Event|19
2065863|NCT00591578|3642541|FG000|Double-Blind Treatment Phase|Protocol Violation|3
2065864|NCT00591578|3642542|FG001|Double-Blind Treatment Phase|Protocol Violation|2
2065865|NCT00591578|3642543|FG002|Double-Blind Treatment Phase|Protocol Violation|3
2065866|NCT00591578|3642541|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12
2065867|NCT00591578|3642542|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12
2065868|NCT00591578|3642543|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11
2065869|NCT00591578|3642541|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22
2065870|NCT00591578|3642542|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22
2065871|NCT00591578|3642543|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22
2065872|NCT00591578|3642541|FG000|Double-Blind Treatment Phase|Pregnancy|1
2065873|NCT00591578|3642542|FG001|Double-Blind Treatment Phase|Pregnancy|0
2065874|NCT00591578|3642543|FG002|Double-Blind Treatment Phase|Pregnancy|0
2065875|NCT00591578|3642541|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16
2065876|NCT00591578|3642542|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9
2065877|NCT00591578|3642543|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25
2065878|NCT00591578|3642541|FG000|Double-Blind Treatment Phase|Other|4
2065879|NCT00591578|3642542|FG001|Double-Blind Treatment Phase|Other|9
2065880|NCT00591578|3642543|FG002|Double-Blind Treatment Phase|Other|4
2065881|NCT00591578|3642541|FG000|Open-Label Extension Phase|Adverse Event|3
2065882|NCT00591578|3642542|FG001|Open-Label Extension Phase|Adverse Event|5
2065883|NCT00591578|3642543|FG002|Open-Label Extension Phase|Adverse Event|0
2065884|NCT00591578|3642541|FG000|Open-Label Extension Phase|Lost to Follow-up|1
2065885|NCT00591578|3642542|FG001|Open-Label Extension Phase|Lost to Follow-up|4
2065886|NCT00591578|3642543|FG002|Open-Label Extension Phase|Lost to Follow-up|0
2065887|NCT00591578|3642541|FG000|Open-Label Extension Phase|Withdrawal by Subject|1
2065888|NCT00591578|3642542|FG001|Open-Label Extension Phase|Withdrawal by Subject|1
2065889|NCT00591578|3642543|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
2065890|NCT00591578|3642541|FG000|Open-Label Extension Phase|Other|1
2065891|NCT00591578|3642542|FG001|Open-Label Extension Phase|Other|0
2065892|NCT00591578|3642543|FG002|Open-Label Extension Phase|Other|0
2210160|NCT01648166|3849580|FG000|Overall Study|inadequate toenail samples|53
2210161|NCT01648166|3849581|FG001|Overall Study|inadequate toenail samples|100
2210162|NCT01648283|3849587|FG000|Overall Study|Withdrawal by Subject|14
2065893|NCT00591591|3642554|FG000|Overall Study|Withdrawal by Subject|1
2065894|NCT00591591|3642555|FG001|Overall Study|Withdrawal by Subject|37
2065895|NCT00591591|3642554|FG000|Overall Study|Lack of Efficacy|10
2065896|NCT00591591|3642555|FG001|Overall Study|Lack of Efficacy|2
2065897|NCT00591630|3642565|FG000|Overall Study|Death|0
2065898|NCT00591630|3642566|FG001|Overall Study|Death|0
2065899|NCT00591630|3642567|FG002|Overall Study|Death|1
2065900|NCT00591630|3642568|FG003|Overall Study|Death|0
2065901|NCT00591721|3642580|FG000|Overall Study|Withdrawal by Subject|10
2065902|NCT00591721|3642581|FG001|Overall Study|Withdrawal by Subject|10
2065903|NCT00591721|3642580|FG000|Overall Study|Lost to Follow-up|1
2065904|NCT00591721|3642581|FG001|Overall Study|Lost to Follow-up|4
2065905|NCT00591721|3642580|FG000|Overall Study|Intervention not received|10
2065906|NCT00591721|3642581|FG001|Overall Study|Intervention not received|8
2065907|NCT00591734|3642587|FG000|Overall Study|Lack of Efficacy|35
2065908|NCT00591734|3642587|FG000|Overall Study|Adverse Event|5
2065909|NCT00591734|3642587|FG000|Overall Study|Physician Decision|5
2065910|NCT00591734|3642587|FG000|Overall Study|Intercurrent Illness|8
2065911|NCT00591773|3642603|FG000|Overall Study|Adverse Event|9
2065912|NCT00591773|3642604|FG001|Overall Study|Adverse Event|9
2065913|NCT00591773|3642605|FG002|Overall Study|Adverse Event|6
2065914|NCT00591773|3642603|FG000|Overall Study|Protocol Violation|2
2065915|NCT00591773|3642604|FG001|Overall Study|Protocol Violation|3
2065916|NCT00591773|3642605|FG002|Overall Study|Protocol Violation|0
2065917|NCT00591773|3642603|FG000|Overall Study|Lost to Follow-up|1
2065918|NCT00591773|3642604|FG001|Overall Study|Lost to Follow-up|4
2065919|NCT00591773|3642605|FG002|Overall Study|Lost to Follow-up|1
2065920|NCT00591773|3642603|FG000|Overall Study|Withdrawal by Subject|2
2065921|NCT00591773|3642604|FG001|Overall Study|Withdrawal by Subject|5
2065922|NCT00591773|3642605|FG002|Overall Study|Withdrawal by Subject|3
2065923|NCT00591773|3642603|FG000|Overall Study|Lack of Efficacy|1
2065924|NCT00591773|3642604|FG001|Overall Study|Lack of Efficacy|2
2065925|NCT00591773|3642605|FG002|Overall Study|Lack of Efficacy|2
2065926|NCT00591773|3642603|FG000|Overall Study|Other|1
2065927|NCT00591773|3642604|FG001|Overall Study|Other|1
2065928|NCT00591773|3642605|FG002|Overall Study|Other|4
2065929|NCT00591786|3642623|FG000|Overall Study|Withdrawal of Informed Consent|0
2065930|NCT00591786|3642624|FG001|Overall Study|Withdrawal of Informed Consent|0
2065931|NCT00591786|3642625|FG002|Overall Study|Withdrawal of Informed Consent|1
2065932|NCT00591786|3642626|FG003|Overall Study|Withdrawal of Informed Consent|0
2065933|NCT00591786|3642627|FG004|Overall Study|Withdrawal of Informed Consent|0
2065934|NCT00591786|3642628|FG005|Overall Study|Withdrawal of Informed Consent|0
2065935|NCT00591786|3642629|FG006|Overall Study|Withdrawal of Informed Consent|0
2065936|NCT00591786|3642630|FG007|Overall Study|Withdrawal of Informed Consent|0
2065937|NCT00591786|3642631|FG008|Overall Study|Withdrawal of Informed Consent|0
2065938|NCT00591786|3642632|FG009|Overall Study|Withdrawal of Informed Consent|0
2210163|NCT01648348|3849629|FG000|Overall Study|Cancel|1
2210164|NCT01648348|3849630|FG001|Overall Study|Cancel|0
2210165|NCT01648348|3849631|FG002|Overall Study|Cancel|0
2210166|NCT01648348|3849632|FG003|Overall Study|Cancel|0
2065939|NCT00591838|3642686|FG000|Overall Study|Withdrawal by Subject|0
2065940|NCT00591838|3642687|FG001|Overall Study|Withdrawal by Subject|0
2065941|NCT00591838|3642688|FG002|Overall Study|Withdrawal by Subject|0
2065942|NCT00591838|3642689|FG003|Overall Study|Withdrawal by Subject|1
2065943|NCT00591838|3642690|FG004|Overall Study|Withdrawal by Subject|0
2065944|NCT00591851|3642703|FG000|Overall Study|Withdrawal by Subject|3
2065945|NCT00591851|3642703|FG000|Overall Study|Adverse Event|2
2065946|NCT00591851|3642703|FG000|Overall Study|Progressive Disease|1
2065947|NCT00591864|3642707|FG000|Overall Study|Incomplete Imaging|5
2065948|NCT00592072|3642719|FG000|Wash Out Period|Lost to Follow-up|1
2065949|NCT00592072|3642720|FG001|Wash Out Period|Lost to Follow-up|1
2065950|NCT00592319|3642753|FG000|Overall Study|Lost to Follow-up|0
2065951|NCT00592319|3642754|FG001|Overall Study|Lost to Follow-up|3
2065952|NCT00592358|3642762|FG000|Overall Study|Withdrawal by Subject|2
2065953|NCT00592358|3642762|FG000|Overall Study|Adverse Event|1
2065954|NCT00592358|3642762|FG000|Overall Study|Lack of Efficacy|2
2065955|NCT00592358|3642762|FG000|Overall Study|Inability to swallow pills|1
2065956|NCT00592384|3642768|FG000|Overall Study|Withdrawal by Subject|5
2065957|NCT00592384|3642769|FG001|Overall Study|Withdrawal by Subject|6
2065958|NCT00592501|3642799|FG000|Overall Study|Withdrawal by Subject|1
2065959|NCT00592501|3642799|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1
2065960|NCT00592553|3642806|FG000|Overall Study|Protocol Noncompliance|1
2065961|NCT00592553|3642807|FG001|Overall Study|Protocol Noncompliance|0
2065962|NCT00592553|3642808|FG002|Overall Study|Protocol Noncompliance|0
2065963|NCT00592631|3642818|FG000|Overall Study|Lost to Follow-up|0
2065964|NCT00592631|3642819|FG001|Overall Study|Lost to Follow-up|2
2065965|NCT00592683|3642827|FG000|Overall Study|Found ineligible|0
2065966|NCT00592683|3642828|FG001|Overall Study|Found ineligible|1
2065967|NCT00592683|3642827|FG000|Overall Study|Withdrawal by Subject|1
2065968|NCT00592683|3642828|FG001|Overall Study|Withdrawal by Subject|0
2065969|NCT00592683|3642827|FG000|Overall Study|Adverse Event|0
2065970|NCT00592683|3642828|FG001|Overall Study|Adverse Event|2
2065971|NCT00592683|3642827|FG000|Overall Study|Protocol Violation|1
2065972|NCT00592683|3642828|FG001|Overall Study|Protocol Violation|0
2065973|NCT00592683|3642827|FG000|Overall Study|Study drug expired|1
2065974|NCT00592683|3642828|FG001|Overall Study|Study drug expired|0
2065975|NCT00592683|3642827|FG000|Overall Study|Other|1
2065976|NCT00592683|3642828|FG001|Overall Study|Other|0
2065977|NCT00592683|3642827|FG000|Overall Study|Lost to Follow-up|0
2065978|NCT00592683|3642828|FG001|Overall Study|Lost to Follow-up|1
2065979|NCT00592774|3642846|FG000|Overall Study|Adverse Event|5
2065980|NCT00592774|3642847|FG001|Overall Study|Adverse Event|19
2065981|NCT00592774|3642848|FG002|Overall Study|Adverse Event|2
2065982|NCT00592774|3642849|FG003|Overall Study|Adverse Event|14
2065983|NCT00592774|3642850|FG004|Overall Study|Adverse Event|8
2210167|NCT01648348|3849633|FG004|Overall Study|Cancel|3
2065984|NCT00592774|3642846|FG000|Overall Study|Protocol Violation|0
2065985|NCT00592774|3642847|FG001|Overall Study|Protocol Violation|1
2065986|NCT00592774|3642848|FG002|Overall Study|Protocol Violation|0
2065987|NCT00592774|3642849|FG003|Overall Study|Protocol Violation|0
2065988|NCT00592774|3642850|FG004|Overall Study|Protocol Violation|1
2065989|NCT00592774|3642846|FG000|Overall Study|Withdrawal by Subject|3
2065990|NCT00592774|3642847|FG001|Overall Study|Withdrawal by Subject|7
2065991|NCT00592774|3642848|FG002|Overall Study|Withdrawal by Subject|0
2065992|NCT00592774|3642849|FG003|Overall Study|Withdrawal by Subject|0
2065993|NCT00592774|3642850|FG004|Overall Study|Withdrawal by Subject|0
2065994|NCT00592774|3642846|FG000|Overall Study|Lack of Efficacy|3
2065995|NCT00592774|3642847|FG001|Overall Study|Lack of Efficacy|3
2065996|NCT00592774|3642848|FG002|Overall Study|Lack of Efficacy|0
2065997|NCT00592774|3642849|FG003|Overall Study|Lack of Efficacy|0
2065998|NCT00592774|3642850|FG004|Overall Study|Lack of Efficacy|2
2065999|NCT00592774|3642846|FG000|Overall Study|Physician Decision|0
2066000|NCT00592774|3642847|FG001|Overall Study|Physician Decision|1
2066001|NCT00592774|3642848|FG002|Overall Study|Physician Decision|1
2066002|NCT00592774|3642849|FG003|Overall Study|Physician Decision|0
2066003|NCT00592774|3642850|FG004|Overall Study|Physician Decision|1
2066004|NCT00592774|3642846|FG000|Overall Study|Other|0
2066005|NCT00592774|3642847|FG001|Overall Study|Other|1
2066006|NCT00592774|3642848|FG002|Overall Study|Other|1
2066007|NCT00592774|3642849|FG003|Overall Study|Other|0
2066008|NCT00592774|3642850|FG004|Overall Study|Other|2
2210168|NCT01648348|3849634|FG005|Overall Study|Cancel|6
2066009|NCT00592839|3642865|FG000|Overall Study|Withdrawal by Subject|1
2066010|NCT00592839|3642866|FG001|Overall Study|Withdrawal by Subject|1
2066011|NCT00592839|3642867|FG002|Overall Study|Withdrawal by Subject|3
2066012|NCT00592839|3642865|FG000|Overall Study|Protocol Violation|1
2066013|NCT00592839|3642866|FG001|Overall Study|Protocol Violation|1
2066014|NCT00592839|3642867|FG002|Overall Study|Protocol Violation|2
2066015|NCT00592839|3642865|FG000|Overall Study|Adverse Event|0
2066016|NCT00592839|3642866|FG001|Overall Study|Adverse Event|1
2066017|NCT00592839|3642867|FG002|Overall Study|Adverse Event|0
2066018|NCT00592839|3642865|FG000|Overall Study|Lost to Follow-up|0
2066019|NCT00592839|3642866|FG001|Overall Study|Lost to Follow-up|1
2066020|NCT00592839|3642867|FG002|Overall Study|Lost to Follow-up|1
2066021|NCT00592852|3642875|FG000|Overall Study|Non-compliance|1
2066022|NCT00592852|3642875|FG000|Overall Study|Adverse Event|3
2066023|NCT00592852|3642875|FG000|Overall Study|Found ineligible|1
2066024|NCT00592852|3642875|FG000|Overall Study|Withdrawal by Subject|1
2066025|NCT00592904|3642883|FG000|Overall Study|Adverse Event|15
2066026|NCT00592904|3642884|FG001|Overall Study|Adverse Event|25
2066027|NCT00592904|3642885|FG002|Overall Study|Adverse Event|13
2066028|NCT00592904|3642886|FG003|Overall Study|Adverse Event|5
2066029|NCT00592904|3642883|FG000|Overall Study|Protocol Violation|1
2066030|NCT00592904|3642884|FG001|Overall Study|Protocol Violation|1
2066031|NCT00592904|3642885|FG002|Overall Study|Protocol Violation|0
2066032|NCT00592904|3642886|FG003|Overall Study|Protocol Violation|1
2066033|NCT00592904|3642883|FG000|Overall Study|Withdrawal by Subject|4
2066034|NCT00592904|3642884|FG001|Overall Study|Withdrawal by Subject|16
2066035|NCT00592904|3642885|FG002|Overall Study|Withdrawal by Subject|1
2066036|NCT00592904|3642886|FG003|Overall Study|Withdrawal by Subject|2
2066037|NCT00592904|3642883|FG000|Overall Study|Lack of Efficacy|2
2066038|NCT00592904|3642884|FG001|Overall Study|Lack of Efficacy|7
2066039|NCT00592904|3642885|FG002|Overall Study|Lack of Efficacy|2
2066040|NCT00592904|3642886|FG003|Overall Study|Lack of Efficacy|3
2066041|NCT00592904|3642883|FG000|Overall Study|Physician Decision|0
2066042|NCT00592904|3642884|FG001|Overall Study|Physician Decision|3
2066043|NCT00592904|3642885|FG002|Overall Study|Physician Decision|1
2066044|NCT00592904|3642886|FG003|Overall Study|Physician Decision|0
2066045|NCT00592904|3642883|FG000|Overall Study|Other|3
2066046|NCT00592904|3642884|FG001|Overall Study|Other|3
2066047|NCT00592904|3642885|FG002|Overall Study|Other|0
2066048|NCT00592904|3642886|FG003|Overall Study|Other|0
2302643|NCT02630459|4001568|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
2302644|NCT02630459|4001569|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
2302645|NCT02630459|4001570|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
2302646|NCT02630459|4001571|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
2302647|NCT02630459|4001572|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
2302648|NCT02630459|4001565|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2
2302649|NCT02630459|4001566|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
2066049|NCT00593112|3642907|FG000|Overall Study|Scan Anxiety|3
2066050|NCT00593112|3642908|FG001|Overall Study|Scan Anxiety|0
2066051|NCT00593112|3642907|FG000|Overall Study|Abnormal Scan|1
2066052|NCT00593112|3642908|FG001|Overall Study|Abnormal Scan|0
2066053|NCT00593112|3642907|FG000|Overall Study|Unreadable Scan|1
2066054|NCT00593112|3642908|FG001|Overall Study|Unreadable Scan|0
2066055|NCT00593112|3642907|FG000|Overall Study|Withdrawal by Subject|5
2066056|NCT00593112|3642908|FG001|Overall Study|Withdrawal by Subject|0
2066057|NCT00593333|3642916|FG000|Overall Study|Lost to Follow-up|10
2066058|NCT00593333|3642917|FG001|Overall Study|Lost to Follow-up|11
2066059|NCT00593385|3642937|FG000|Overall Study|Death|14
2066060|NCT00593385|3642937|FG000|Overall Study|Lost to Follow-up|17
2066061|NCT00593385|3642937|FG000|Overall Study|Withdrawal by Subject|9
2066062|NCT00593489|3642962|FG000|Allocation|did not attend workshop; allocation not|2
2066063|NCT00593489|3642963|FG001|Allocation|did not attend workshop; allocation not|1
2066064|NCT00593554|3642973|FG000|Overall Study|Death|1
2066065|NCT00593554|3642974|FG001|Overall Study|Death|2
2066066|NCT00593554|3642973|FG000|Overall Study|Physician Decision|0
2066067|NCT00593554|3642974|FG001|Overall Study|Physician Decision|1
2066068|NCT00593554|3642973|FG000|Overall Study|Withdrawal by Subject|1
2066069|NCT00593554|3642974|FG001|Overall Study|Withdrawal by Subject|0
2066070|NCT00593554|3642973|FG000|Overall Study|Disease Progression|1
2066071|NCT00593554|3642974|FG001|Overall Study|Disease Progression|2
2066072|NCT00593606|3642980|FG000|Overall Study|Adverse Event|13
2066073|NCT00593606|3642980|FG000|Overall Study|Withdrawal by Subject|1
2066074|NCT00593606|3642980|FG000|Overall Study|Protocol Violation|3
2066075|NCT00593606|3642980|FG000|Overall Study|Lost to Follow-up|2
2066076|NCT00593606|3642980|FG000|Overall Study|Run-In Failure|5
2066077|NCT00593606|3642980|FG000|Overall Study|Screen Failure|3
2066078|NCT00593684|3642990|FG000|Overall Study|Death|2
2066079|NCT00593684|3642991|FG001|Overall Study|Death|1
2066080|NCT00593736|3643001|FG000|Screening Period and Placebo Run-in|Adverse Event|0
2066081|NCT00593736|3643002|FG001|Screening Period and Placebo Run-in|Adverse Event|0
2066082|NCT00593736|3643003|FG002|Screening Period and Placebo Run-in|Adverse Event|0
2066083|NCT00593736|3643004|FG003|Screening Period and Placebo Run-in|Adverse Event|3
2066084|NCT00593736|3643001|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0
2066085|NCT00593736|3643002|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0
2066086|NCT00593736|3643003|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0
2066087|NCT00593736|3643004|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9
2066088|NCT00593736|3643001|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0
2066089|NCT00593736|3643002|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0
2066090|NCT00593736|3643003|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0
2066091|NCT00593736|3643004|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43
2066092|NCT00593736|3643001|FG000|Screening Period and Placebo Run-in|Study Termination|0
2066093|NCT00593736|3643002|FG001|Screening Period and Placebo Run-in|Study Termination|0
2066094|NCT00593736|3643003|FG002|Screening Period and Placebo Run-in|Study Termination|0
2066095|NCT00593736|3643004|FG003|Screening Period and Placebo Run-in|Study Termination|15
2066096|NCT00593736|3643001|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
2066097|NCT00593736|3643002|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
2066098|NCT00593736|3643003|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
2066099|NCT00593736|3643004|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
2066100|NCT00593736|3643001|FG000|Screening Period and Placebo Run-in|Various|0
2066101|NCT00593736|3643002|FG001|Screening Period and Placebo Run-in|Various|0
2066102|NCT00593736|3643003|FG002|Screening Period and Placebo Run-in|Various|0
2066103|NCT00593736|3643004|FG003|Screening Period and Placebo Run-in|Various|25
2066104|NCT00593736|3643001|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2
2066105|NCT00593736|3643002|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1
2066106|NCT00593736|3643003|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2
2066107|NCT00593736|3643004|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0
2066108|NCT00593736|3643001|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0
2066109|NCT00593736|3643002|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0
2066110|NCT00593736|3643003|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1
2066111|NCT00593736|3643004|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1
2066112|NCT00593736|3643001|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
2066113|NCT00593736|3643002|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
2066114|NCT00593736|3643003|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
2066115|NCT00593736|3643004|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
2066116|NCT00593736|3643001|FG000|Treatment Period and Placebo Run-out|Various|1
2066117|NCT00593736|3643002|FG001|Treatment Period and Placebo Run-out|Various|1
2066118|NCT00593736|3643003|FG002|Treatment Period and Placebo Run-out|Various|1
2066119|NCT00593736|3643004|FG003|Treatment Period and Placebo Run-out|Various|0
2066120|NCT00593814|3643016|FG000|Overall Study|Death|7
2066121|NCT00593814|3643017|FG001|Overall Study|Death|0
2066122|NCT00593814|3643016|FG000|Overall Study|Withdrawal by Subject|7
2066123|NCT00593814|3643017|FG001|Overall Study|Withdrawal by Subject|0
2066124|NCT00593814|3643016|FG000|Overall Study|Lost to Follow-up|7
2066125|NCT00593814|3643017|FG001|Overall Study|Lost to Follow-up|0
2066126|NCT00593814|3643016|FG000|Overall Study|Physician Decision|3
2066127|NCT00593814|3643017|FG001|Overall Study|Physician Decision|0
2066128|NCT00593827|3643025|FG000|Overall Study|On Active Treatment/Pending|0
2066129|NCT00593827|3643026|FG001|Overall Study|On Active Treatment/Pending|2
2066130|NCT00593840|3643032|FG000|Overall Study|Withdrawal by Subject|1
2066131|NCT00593918|3643042|FG000|Overall Study|Withdrawal by Subject|5
2066132|NCT00593918|3643043|FG001|Overall Study|Withdrawal by Subject|24
2106091|NCT00863057|3699127|FG001|Period 2 (Weeks 6-10)|Physician Decision|0
2106092|NCT00863057|3699128|FG002|Period 2 (Weeks 6-10)|Physician Decision|0
2106093|NCT00863057|3699129|FG003|Period 2 (Weeks 6-10)|Physician Decision|1
2106094|NCT00863304|3699187|FG000|Overall Study|Adverse Event|10
2106095|NCT00863304|3699188|FG001|Overall Study|Adverse Event|4
2106096|NCT00863304|3699189|FG002|Overall Study|Adverse Event|14
2106097|NCT00863304|3699190|FG003|Overall Study|Adverse Event|16
2106098|NCT00863304|3699187|FG000|Overall Study|Lost to Follow-up|1
2106099|NCT00863304|3699188|FG001|Overall Study|Lost to Follow-up|5
2106100|NCT00863304|3699189|FG002|Overall Study|Lost to Follow-up|4
2106101|NCT00863304|3699190|FG003|Overall Study|Lost to Follow-up|2
2106102|NCT00863304|3699187|FG000|Overall Study|Lack of Efficacy|57
2106103|NCT00863304|3699188|FG001|Overall Study|Lack of Efficacy|26
2210169|NCT01648348|3849629|FG000|Overall Study|Replaced for MTD analysis|1
2106104|NCT00863304|3699189|FG002|Overall Study|Lack of Efficacy|30
2106105|NCT00863304|3699190|FG003|Overall Study|Lack of Efficacy|28
2106106|NCT00863304|3699187|FG000|Overall Study|Withdrawal by Subject|19
2106107|NCT00863304|3699188|FG001|Overall Study|Withdrawal by Subject|14
2106108|NCT00863304|3699189|FG002|Overall Study|Withdrawal by Subject|20
2106109|NCT00863304|3699190|FG003|Overall Study|Withdrawal by Subject|18
2106110|NCT00863304|3699187|FG000|Overall Study|Other|1
2106111|NCT00863304|3699188|FG001|Overall Study|Other|0
2106112|NCT00863304|3699189|FG002|Overall Study|Other|0
2106113|NCT00863304|3699190|FG003|Overall Study|Other|1
2106114|NCT00863304|3699187|FG000|Overall Study|Protocol Violation|2
2106115|NCT00863304|3699188|FG001|Overall Study|Protocol Violation|6
2106116|NCT00863304|3699189|FG002|Overall Study|Protocol Violation|2
2106117|NCT00863304|3699190|FG003|Overall Study|Protocol Violation|0
2106118|NCT00863304|3699187|FG000|Overall Study|Randomized, but not Treated|3
2106119|NCT00863304|3699188|FG001|Overall Study|Randomized, but not Treated|1
2106120|NCT00863304|3699189|FG002|Overall Study|Randomized, but not Treated|4
2066133|NCT00593957|3643052|FG000|Overall Study|Physician Decision|0
2066134|NCT00593957|3643053|FG001|Overall Study|Physician Decision|1
2066135|NCT00593957|3643054|FG002|Overall Study|Physician Decision|2
2066136|NCT00594035|3643091|FG000|Overall Study|Lost to Follow-up|1
2066137|NCT00594035|3643092|FG001|Overall Study|Lost to Follow-up|1
2066138|NCT00594035|3643091|FG000|Overall Study|Withdrawal by Subject|1
2066139|NCT00594035|3643092|FG001|Overall Study|Withdrawal by Subject|0
2066140|NCT00594035|3643091|FG000|Overall Study|Subject transferred to nursing home|0
2066141|NCT00594035|3643092|FG001|Overall Study|Subject transferred to nursing home|1
2066142|NCT00594035|3643091|FG000|Overall Study|Subject couldn't return due to job|0
2066143|NCT00594035|3643092|FG001|Overall Study|Subject couldn't return due to job|1
2066144|NCT00594100|3643102|FG000|Procedure|Technical Failure|9
2066145|NCT00594100|3643102|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
2066146|NCT00594100|3643102|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
2066147|NCT00594100|3643102|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
2066148|NCT00594165|3643106|FG000|Overall Study|Major protocol violation|1
2066149|NCT00594165|3643106|FG000|Overall Study|Lack of Efficacy|12
2066150|NCT00594165|3643106|FG000|Overall Study|Adverse Event|52
2066151|NCT00594165|3643106|FG000|Overall Study|Unsatisfactory compliance of subject|6
2066152|NCT00594165|3643106|FG000|Overall Study|Subject withdrew consent|27
2066153|NCT00594165|3643106|FG000|Overall Study|Study ended per sponsor|102
2066154|NCT00594165|3643106|FG000|Overall Study|Lost to Follow-up|4
2066155|NCT00594165|3643106|FG000|Overall Study|Other: PI discretion|5
2066156|NCT00594165|3643106|FG000|Overall Study|Other: Subject moving|3
2066157|NCT00594165|3643106|FG000|Overall Study|Other: Brain surgery controlled symptoms|1
2066158|NCT00594165|3643106|FG000|Overall Study|Other: House bound; can't get to clinic|1
2066159|NCT00594165|3643106|FG000|Overall Study|Other: Subject enrolled in other trial|1
2066160|NCT00594165|3643106|FG000|Overall Study|Other: Site terminated participation|2
2066161|NCT00594178|3643110|FG000|Overall Study|Physician Decision|5
2066162|NCT00594204|3643116|FG000|Overall Study|Adverse Event|15
2066163|NCT00594204|3643117|FG001|Overall Study|Adverse Event|3
2066164|NCT00594204|3643116|FG000|Overall Study|Lost to Follow-up|9
2066165|NCT00594204|3643117|FG001|Overall Study|Lost to Follow-up|5
2066166|NCT00594204|3643116|FG000|Overall Study|Withdrawal by Subject|23
2066167|NCT00594204|3643117|FG001|Overall Study|Withdrawal by Subject|29
2210170|NCT01648348|3849630|FG001|Overall Study|Replaced for MTD analysis|0
2210171|NCT01648348|3849631|FG002|Overall Study|Replaced for MTD analysis|1
2210172|NCT01648348|3849632|FG003|Overall Study|Replaced for MTD analysis|0
2210173|NCT01648348|3849633|FG004|Overall Study|Replaced for MTD analysis|0
2210174|NCT01648348|3849634|FG005|Overall Study|Replaced for MTD analysis|0
2210175|NCT01648582|3849667|FG000|Overall Study|Adverse Event|6
2210176|NCT01648582|3849668|FG001|Overall Study|Adverse Event|11
2066168|NCT00594204|3643116|FG000|Overall Study|Other|4
2066169|NCT00594204|3643117|FG001|Overall Study|Other|3
2066170|NCT00594204|3643116|FG000|Overall Study|Lack of Efficacy|3
2066171|NCT00594204|3643117|FG001|Overall Study|Lack of Efficacy|4
2066172|NCT00594204|3643116|FG000|Overall Study|Randomized but not treated|4
2066173|NCT00594204|3643117|FG001|Overall Study|Randomized but not treated|1
2066174|NCT00594386|3643141|FG000|Overall Study|Major protocol violation|2
2066175|NCT00594386|3643141|FG000|Overall Study|Lack of Efficacy|12
2066176|NCT00594386|3643141|FG000|Overall Study|Adverse Event|68
2066177|NCT00594386|3643141|FG000|Overall Study|Unsatisfactory compliance of subject|11
2066178|NCT00594386|3643141|FG000|Overall Study|Subject withdrew consent|35
2066179|NCT00594386|3643141|FG000|Overall Study|Study ended per sponsor|115
2066180|NCT00594386|3643141|FG000|Overall Study|Lost to Follow-up|6
2066181|NCT00594386|3643141|FG000|Overall Study|Other: Patient went off patch (hospital)|1
2066182|NCT00594386|3643141|FG000|Overall Study|Other: Subject moved to Seattle|1
2066183|NCT00594386|3643141|FG000|Overall Study|Other: Subject admitted to nursing home|1
2066184|NCT00594386|3643141|FG000|Overall Study|Other: Study terminated per investigator|2
2066185|NCT00594386|3643141|FG000|Overall Study|Other: Sponsor closure of study|1
2066186|NCT00594386|3643141|FG000|Overall Study|Other: Site terminated participation|1
2066187|NCT00594386|3643141|FG000|Overall Study|Other: Patient wants prescription Neupro|1
2066188|NCT00594386|3643141|FG000|Overall Study|Other: Loss of drivers license|1
2066189|NCT00594399|3643147|FG000|Initial 3 Month Counseling|Not ready to exercise|1
2066190|NCT00594399|3643148|FG001|Initial 3 Month Counseling|Not ready to exercise|0
2066191|NCT00594399|3643149|FG002|Initial 3 Month Counseling|Not ready to exercise|0
2066192|NCT00594399|3643147|FG000|Initial 3 Month Counseling|Lack of Interest|3
2066193|NCT00594399|3643148|FG001|Initial 3 Month Counseling|Lack of Interest|3
2066194|NCT00594399|3643149|FG002|Initial 3 Month Counseling|Lack of Interest|0
2066195|NCT00594399|3643147|FG000|Initial 3 Month Counseling|Personal issues|2
2066196|NCT00594399|3643148|FG001|Initial 3 Month Counseling|Personal issues|0
2066197|NCT00594399|3643149|FG002|Initial 3 Month Counseling|Personal issues|0
2066198|NCT00594399|3643147|FG000|Initial 3 Month Counseling|Too busy|7
2066199|NCT00594399|3643148|FG001|Initial 3 Month Counseling|Too busy|1
2066200|NCT00594399|3643149|FG002|Initial 3 Month Counseling|Too busy|0
2066201|NCT00594399|3643147|FG000|Initial 3 Month Counseling|Pain|2
2066202|NCT00594399|3643148|FG001|Initial 3 Month Counseling|Pain|0
2066203|NCT00594399|3643149|FG002|Initial 3 Month Counseling|Pain|0
2066204|NCT00594399|3643147|FG000|Initial 3 Month Counseling|Moved|1
2066205|NCT00594399|3643148|FG001|Initial 3 Month Counseling|Moved|0
2066206|NCT00594399|3643149|FG002|Initial 3 Month Counseling|Moved|0
2066207|NCT00594399|3643147|FG000|Initial 3 Month Counseling|Family illness|1
2066208|NCT00594399|3643148|FG001|Initial 3 Month Counseling|Family illness|0
2066209|NCT00594399|3643149|FG002|Initial 3 Month Counseling|Family illness|0
2066210|NCT00594399|3643147|FG000|Rerandomization Arm 1 Only|Death|2
2066211|NCT00594399|3643148|FG001|Rerandomization Arm 1 Only|Death|1
2066212|NCT00594399|3643149|FG002|Rerandomization Arm 1 Only|Death|0
2066213|NCT00594399|3643147|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0
2066214|NCT00594399|3643148|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3
2066215|NCT00594399|3643149|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0
2066216|NCT00594464|3643168|FG000|Overall Study|Withdrawal by Subject|1
2066217|NCT00594464|3643168|FG000|Overall Study|Delay in operation|2
2066218|NCT00594516|3643178|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
2066219|NCT00594516|3643179|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
2066220|NCT00594516|3643180|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
2066221|NCT00594516|3643178|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
2066222|NCT00594516|3643179|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
2066223|NCT00594516|3643180|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
2066224|NCT00594516|3643178|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16
2066225|NCT00594516|3643179|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0
2066226|NCT00594516|3643180|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0
2066227|NCT00594516|3643178|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
2066228|NCT00594516|3643179|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
2066229|NCT00594516|3643180|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
2066230|NCT00594516|3643178|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
2066231|NCT00594516|3643179|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
2066232|NCT00594516|3643180|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
2066233|NCT00594516|3643178|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
2066234|NCT00594516|3643179|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
2066235|NCT00594516|3643180|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
2066236|NCT00594516|3643178|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
2066237|NCT00594516|3643179|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
2066238|NCT00594516|3643180|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
2066239|NCT00594516|3643178|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
2066240|NCT00594516|3643179|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
2066241|NCT00594516|3643180|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
2066242|NCT00594516|3643178|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
2066243|NCT00594516|3643179|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
2066244|NCT00594516|3643180|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
2066245|NCT00594568|3643187|FG000|Initial Treatment|Adverse Event|51
2066246|NCT00594568|3643188|FG001|Initial Treatment|Adverse Event|121
2066247|NCT00594568|3643189|FG002|Initial Treatment|Adverse Event|144
2066248|NCT00594568|3643187|FG000|Initial Treatment|Death|6
2066249|NCT00594568|3643188|FG001|Initial Treatment|Death|11
2066250|NCT00594568|3643189|FG002|Initial Treatment|Death|15
2066251|NCT00594568|3643187|FG000|Initial Treatment|Lost to Follow-up|4
2066252|NCT00594568|3643188|FG001|Initial Treatment|Lost to Follow-up|1
2066253|NCT00594568|3643189|FG002|Initial Treatment|Lost to Follow-up|4
2066254|NCT00594568|3643187|FG000|Initial Treatment|Physician Decision|3
2066255|NCT00594568|3643188|FG001|Initial Treatment|Physician Decision|2
2066256|NCT00594568|3643189|FG002|Initial Treatment|Physician Decision|4
2066257|NCT00594568|3643187|FG000|Initial Treatment|Protocol Violation|2
2066258|NCT00594568|3643188|FG001|Initial Treatment|Protocol Violation|2
2066259|NCT00594568|3643189|FG002|Initial Treatment|Protocol Violation|5
2066260|NCT00594568|3643187|FG000|Initial Treatment|Withdrawal by Subject|25
2066261|NCT00594568|3643188|FG001|Initial Treatment|Withdrawal by Subject|31
2066262|NCT00594568|3643189|FG002|Initial Treatment|Withdrawal by Subject|46
2066263|NCT00594568|3643187|FG000|Initial Treatment|Sponsor decision|193
2066264|NCT00594568|3643188|FG001|Initial Treatment|Sponsor decision|142
2066265|NCT00594568|3643189|FG002|Initial Treatment|Sponsor decision|147
2066266|NCT00594568|3643187|FG000|Initial Treatment|Caregiver decision|21
2066267|NCT00594568|3643188|FG001|Initial Treatment|Caregiver decision|36
2066268|NCT00594568|3643189|FG002|Initial Treatment|Caregiver decision|36
2066269|NCT00594568|3643187|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
2066270|NCT00594568|3643188|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
2066271|NCT00594568|3643189|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
2066272|NCT00594568|3643187|FG000|Initial Treatment|Entry criteria exclusion|0
2066273|NCT00594568|3643188|FG001|Initial Treatment|Entry criteria exclusion|1
2066274|NCT00594568|3643189|FG002|Initial Treatment|Entry criteria exclusion|1
2066275|NCT00594568|3643187|FG000|Delayed Start|Death|0
2066276|NCT00594568|3643188|FG001|Delayed Start|Death|0
2066277|NCT00594568|3643189|FG002|Delayed Start|Death|1
2066278|NCT00594568|3643187|FG000|Delayed Start|Adverse Event|12
2066279|NCT00594568|3643188|FG001|Delayed Start|Adverse Event|2
2066280|NCT00594568|3643189|FG002|Delayed Start|Adverse Event|2
2066281|NCT00594568|3643187|FG000|Delayed Start|Withdrawal by Subject|4
2066282|NCT00594568|3643188|FG001|Delayed Start|Withdrawal by Subject|3
2302650|NCT02630459|4001567|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4
2302651|NCT02630459|4001568|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
2302652|NCT02630459|4001569|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
2302653|NCT02630459|4001570|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
2302654|NCT02630459|4001571|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
2302655|NCT02630459|4001572|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
2302656|NCT02630459|4001565|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1
2302657|NCT02630459|4001566|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
2302658|NCT02630459|4001567|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
2066283|NCT00594568|3643189|FG002|Delayed Start|Withdrawal by Subject|0
2066284|NCT00594568|3643187|FG000|Delayed Start|Physician Decision|0
2066285|NCT00594568|3643188|FG001|Delayed Start|Physician Decision|0
2066286|NCT00594568|3643189|FG002|Delayed Start|Physician Decision|1
2066287|NCT00594568|3643187|FG000|Delayed Start|Lost to Follow-up|0
2066288|NCT00594568|3643188|FG001|Delayed Start|Lost to Follow-up|0
2066289|NCT00594568|3643189|FG002|Delayed Start|Lost to Follow-up|1
2066290|NCT00594568|3643187|FG000|Delayed Start|Caregiver Decision|5
2066291|NCT00594568|3643188|FG001|Delayed Start|Caregiver Decision|6
2066292|NCT00594568|3643189|FG002|Delayed Start|Caregiver Decision|2
2066293|NCT00594568|3643187|FG000|Delayed Start|Sponsor Decision|77
2066294|NCT00594568|3643188|FG001|Delayed Start|Sponsor Decision|66
2066295|NCT00594568|3643189|FG002|Delayed Start|Sponsor Decision|59
2066296|NCT00594568|3643187|FG000|Safety Follow Up (SFU)-Optional|Death|0
2210177|NCT01648582|3849669|FG002|Overall Study|Adverse Event|2
2210178|NCT01648582|3849667|FG000|Overall Study|Lost to Follow-up|9
2210179|NCT01648582|3849668|FG001|Overall Study|Lost to Follow-up|6
2210180|NCT01648582|3849669|FG002|Overall Study|Lost to Follow-up|8
2210181|NCT01648582|3849667|FG000|Overall Study|Protocol Violation|1
2210182|NCT01648582|3849668|FG001|Overall Study|Protocol Violation|2
2210183|NCT01648582|3849669|FG002|Overall Study|Protocol Violation|1
2210184|NCT01648582|3849667|FG000|Overall Study|Withdrawal by Subject|15
2210185|NCT01648582|3849668|FG001|Overall Study|Withdrawal by Subject|17
2210186|NCT01648582|3849669|FG002|Overall Study|Withdrawal by Subject|17
2210187|NCT01648582|3849667|FG000|Overall Study|Physician Decision|0
2210188|NCT01648582|3849668|FG001|Overall Study|Physician Decision|1
2210189|NCT01648582|3849669|FG002|Overall Study|Physician Decision|3
2210190|NCT01648582|3849667|FG000|Overall Study|Death|1
2210191|NCT01648582|3849668|FG001|Overall Study|Death|0
2210192|NCT01648582|3849669|FG002|Overall Study|Death|0
2210193|NCT01648582|3849667|FG000|Overall Study|Sponsor Decision|0
2210194|NCT01648582|3849668|FG001|Overall Study|Sponsor Decision|1
2066297|NCT00594568|3643188|FG001|Safety Follow Up (SFU)-Optional|Death|1
2066298|NCT00594568|3643189|FG002|Safety Follow Up (SFU)-Optional|Death|0
2066299|NCT00594568|3643187|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5
2066300|NCT00594568|3643188|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0
2066301|NCT00594568|3643189|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0
2066302|NCT00594568|3643187|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
2066303|NCT00594568|3643188|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
2066304|NCT00594568|3643189|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
2066305|NCT00594568|3643187|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
2066306|NCT00594568|3643188|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
2066307|NCT00594568|3643189|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
2066308|NCT00594568|3643187|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
2066309|NCT00594568|3643188|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
2066310|NCT00594568|3643189|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
2066311|NCT00594568|3643187|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
2066312|NCT00594568|3643188|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
2066313|NCT00594568|3643189|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
2066314|NCT00594646|3643205|FG000|Overall Study|Withdrawal by Subject|1
2066315|NCT00594646|3643205|FG000|Overall Study|Lost to Follow-up|15
2066316|NCT00594659|3643213|FG000|Overall Study|Lost to Follow-up|13
2066317|NCT00594659|3643214|FG001|Overall Study|Lost to Follow-up|9
2066318|NCT00594659|3643215|FG002|Overall Study|Lost to Follow-up|7
2066319|NCT00594815|3643227|FG000|Overall Study|Never Treated|3
2066320|NCT00594815|3643227|FG000|Overall Study|Withdrawal by Subject|2
2066321|NCT00594815|3643227|FG000|Overall Study|Toxicity|4
2066322|NCT00594854|3643233|FG000|Overall Study|Study terminated|7
2066323|NCT00594854|3643234|FG001|Overall Study|Study terminated|10
2066324|NCT00594880|3643242|FG000|Overall Study|Withdrawal by Subject|1
2066325|NCT00594880|3643243|FG001|Overall Study|Withdrawal by Subject|1
2066326|NCT00594880|3643242|FG000|Overall Study|Lost to Follow-up|1
2066327|NCT00594880|3643243|FG001|Overall Study|Lost to Follow-up|0
2066328|NCT00594906|3643255|FG000|Overall Study|Physician Decision|1
2066329|NCT00594906|3643256|FG001|Overall Study|Physician Decision|0
2066330|NCT00594906|3643255|FG000|Overall Study|Physician Decision|0
2066331|NCT00594906|3643256|FG001|Overall Study|Physician Decision|1
2066332|NCT00594906|3643255|FG000|Overall Study|Death|0
2210195|NCT01648582|3849669|FG002|Overall Study|Sponsor Decision|1
2210196|NCT01648699|3849680|FG000|Overall Study|Death|1
2210197|NCT01648699|3849680|FG000|Overall Study|Lost to Follow-up|2
2210198|NCT01648699|3849680|FG000|Overall Study|Unspecified/unable to complete 4 visits|2
2066333|NCT00594906|3643256|FG001|Overall Study|Death|1
2066334|NCT00594932|3643264|FG000|First 3 Months|Withdrawal by Subject|1
2066335|NCT00594932|3643265|FG001|First 3 Months|Withdrawal by Subject|3
2066336|NCT00594932|3643264|FG000|Final 3 Months|Withdrawal by Subject|4
2066337|NCT00594932|3643265|FG001|Final 3 Months|Withdrawal by Subject|3
2066338|NCT00594958|3643285|FG000|Overall Study|Withdrawal by Subject|1
2066339|NCT00594958|3643286|FG001|Overall Study|Withdrawal by Subject|0
2066340|NCT00594958|3643287|FG002|Overall Study|Withdrawal by Subject|1
2066341|NCT00594958|3643285|FG000|Overall Study|Adverse Event|4
2066342|NCT00594958|3643286|FG001|Overall Study|Adverse Event|1
2066343|NCT00594958|3643287|FG002|Overall Study|Adverse Event|2
2066344|NCT00594958|3643285|FG000|Overall Study|Pregnancy|0
2066345|NCT00594958|3643286|FG001|Overall Study|Pregnancy|2
2066346|NCT00594958|3643287|FG002|Overall Study|Pregnancy|0
2066347|NCT00594958|3643285|FG000|Overall Study|Protocol Violation|1
2066348|NCT00594958|3643286|FG001|Overall Study|Protocol Violation|0
2066349|NCT00594958|3643287|FG002|Overall Study|Protocol Violation|2
2066350|NCT00594958|3643285|FG000|Overall Study|Lost to Follow-up|5
2066351|NCT00594958|3643286|FG001|Overall Study|Lost to Follow-up|0
2066352|NCT00594958|3643287|FG002|Overall Study|Lost to Follow-up|3
2066353|NCT00594958|3643285|FG000|Overall Study|administrative|3
2066354|NCT00594958|3643286|FG001|Overall Study|administrative|0
2066355|NCT00594958|3643287|FG002|Overall Study|administrative|2
2066356|NCT00595075|3643308|FG000|Overall Study|Withdrawal by Subject|1
2066357|NCT00595075|3643309|FG001|Overall Study|Withdrawal by Subject|0
2066358|NCT00595127|3643345|FG000|Overall Study|Death|6
2066359|NCT00595127|3643345|FG000|Overall Study|Relapsed|3
2066360|NCT00595127|3643345|FG000|Overall Study|joined another trial|1
2066361|NCT00595309|3643384|FG000|Overall Study|Lost to Follow-up|1
2066362|NCT00595309|3643384|FG000|Overall Study|planned vaccination against yellow fever|1
2066363|NCT00595309|3643384|FG000|Overall Study|acute infection after V0|1
2066364|NCT00595309|3643384|FG000|Overall Study|personal reason|1
2066365|NCT00595335|3643390|FG000|Baseline to Six Months|Withdrawal by Subject|0
2066366|NCT00595335|3643391|FG001|Baseline to Six Months|Withdrawal by Subject|1
2066367|NCT00595335|3643390|FG000|Baseline to Six Months|Disease Progression|1
2066368|NCT00595335|3643391|FG001|Baseline to Six Months|Disease Progression|1
2066369|NCT00595335|3643390|FG000|Baseline to Six Months|Adverse Event|1
2066370|NCT00595335|3643391|FG001|Baseline to Six Months|Adverse Event|0
2066371|NCT00595335|3643390|FG000|Six Months to Twelve Months|Withdrawal by Subject|0
2066372|NCT00595335|3643391|FG001|Six Months to Twelve Months|Withdrawal by Subject|1
2066373|NCT00595335|3643390|FG000|Six Months to Twelve Months|Disease Progression|1
2066374|NCT00595335|3643391|FG001|Six Months to Twelve Months|Disease Progression|0
2066375|NCT00595413|3643414|FG000|Overall Study|Adverse Event|0
2066376|NCT00595413|3643415|FG001|Overall Study|Adverse Event|2
2066377|NCT00595413|3643416|FG002|Overall Study|Adverse Event|1
2066378|NCT00595413|3643417|FG003|Overall Study|Adverse Event|1
2066379|NCT00595413|3643414|FG000|Overall Study|Lost to Follow-up|2
2066380|NCT00595413|3643415|FG001|Overall Study|Lost to Follow-up|2
2066381|NCT00595413|3643416|FG002|Overall Study|Lost to Follow-up|1
2066382|NCT00595413|3643417|FG003|Overall Study|Lost to Follow-up|3
2066383|NCT00595413|3643414|FG000|Overall Study|Death|0
2066384|NCT00595413|3643415|FG001|Overall Study|Death|0
2066385|NCT00595413|3643416|FG002|Overall Study|Death|1
2066386|NCT00595413|3643417|FG003|Overall Study|Death|0
2066387|NCT00595413|3643414|FG000|Overall Study|Other|5
2066388|NCT00595413|3643415|FG001|Overall Study|Other|1
2066389|NCT00595413|3643416|FG002|Overall Study|Other|5
2066390|NCT00595413|3643417|FG003|Overall Study|Other|0
2066391|NCT00595465|3643430|FG000|Overall Study|Adverse Event|4
2066392|NCT00595465|3643431|FG001|Overall Study|Adverse Event|3
2066393|NCT00595465|3643432|FG002|Overall Study|Adverse Event|3
2066394|NCT00595465|3643430|FG000|Overall Study|Pregnancy|0
2066395|NCT00595465|3643431|FG001|Overall Study|Pregnancy|0
2066396|NCT00595465|3643432|FG002|Overall Study|Pregnancy|1
2066397|NCT00595465|3643430|FG000|Overall Study|Protocol Violation|2
2066398|NCT00595465|3643431|FG001|Overall Study|Protocol Violation|1
2066399|NCT00595465|3643432|FG002|Overall Study|Protocol Violation|0
2066400|NCT00595465|3643430|FG000|Overall Study|Lost to Follow-up|0
2066401|NCT00595465|3643431|FG001|Overall Study|Lost to Follow-up|0
2066402|NCT00595465|3643432|FG002|Overall Study|Lost to Follow-up|2
2066403|NCT00595465|3643430|FG000|Overall Study|administrative reason|0
2066404|NCT00595465|3643431|FG001|Overall Study|administrative reason|0
2066405|NCT00595465|3643432|FG002|Overall Study|administrative reason|1
2066406|NCT00595478|3643442|FG000|36-week Follow-up Period|Lost to Follow-up|5
2066407|NCT00595478|3643443|FG001|36-week Follow-up Period|Lost to Follow-up|4
2066408|NCT00595478|3643442|FG000|36-week Follow-up Period|Withdrawal by Subject|4
2066409|NCT00595478|3643443|FG001|36-week Follow-up Period|Withdrawal by Subject|4
2066410|NCT00595504|3643451|FG000|Overall Study|Withdrawal by Subject|1
2066411|NCT00595504|3643452|FG001|Overall Study|Withdrawal by Subject|3
2066412|NCT00595504|3643451|FG000|Overall Study|Physician Decision|1
2066413|NCT00595504|3643452|FG001|Overall Study|Physician Decision|0
2066414|NCT00595517|3643458|FG000|Overall Study|Adverse Event|6
2066415|NCT00595517|3643458|FG000|Overall Study|Withdrawal by Subject|4
2066416|NCT00595517|3643458|FG000|Overall Study|Protocol Violation|2
2066417|NCT00595517|3643458|FG000|Overall Study|Recurrence of ulcer|5
2066418|NCT00595517|3643458|FG000|Overall Study|usage of prohibited treatment|1
2066419|NCT00595517|3643458|FG000|Overall Study|No intention to attend regularly|1
2066420|NCT00595621|3643478|FG000|Open Label Run in|Adverse Event|1
2066421|NCT00595621|3643479|FG001|Open Label Run in|Adverse Event|0
2066422|NCT00595621|3643478|FG000|Open Label Run in|Physician Decision|1
2066423|NCT00595621|3643479|FG001|Open Label Run in|Physician Decision|0
2066424|NCT00595621|3643478|FG000|Open Label Run in|Withdrawal by Subject|1
2066425|NCT00595621|3643479|FG001|Open Label Run in|Withdrawal by Subject|0
2066426|NCT00595621|3643478|FG000|Randomization and Study|Adverse Event|2
2066427|NCT00595621|3643479|FG001|Randomization and Study|Adverse Event|0
2066428|NCT00595621|3643478|FG000|Randomization and Study|Withdrawal by Subject|0
2066429|NCT00595621|3643479|FG001|Randomization and Study|Withdrawal by Subject|1
2066430|NCT00595764|3643488|FG000|Overall Study|Protocol Violation|24
2066431|NCT00595764|3643489|FG001|Overall Study|Protocol Violation|19
2066432|NCT00595764|3643488|FG000|Overall Study|Missed Medication >1 week|10
2066433|NCT00595764|3643489|FG001|Overall Study|Missed Medication >1 week|17
2066434|NCT00595764|3643488|FG000|Overall Study|Missed 3 PM visits|1
2066435|NCT00595764|3643489|FG001|Overall Study|Missed 3 PM visits|7
2066436|NCT00595764|3643488|FG000|Overall Study|Withdrawal by Subject|4
2066437|NCT00595764|3643489|FG001|Overall Study|Withdrawal by Subject|0
2066438|NCT00595868|3643510|FG000|Overall Study|Lost to Follow-up|45
2066439|NCT00595868|3643511|FG001|Overall Study|Lost to Follow-up|50
2066440|NCT00595959|3643531|FG000|Overall Study|Withdrawal by Subject|1
2066441|NCT00595959|3643531|FG000|Overall Study|Lost to Follow-up|1
2066442|NCT00596011|3643537|FG000|Overall Study|Withdrawal by Subject|2
2066443|NCT00596011|3643538|FG001|Overall Study|Withdrawal by Subject|3
2066444|NCT00596011|3643537|FG000|Overall Study|Adverse Event|11
2066445|NCT00596011|3643538|FG001|Overall Study|Adverse Event|7
2066446|NCT00596362|3643574|FG000|Overall Study|Progressive Disease|1
2066447|NCT00596427|3643580|FG000|Overall Study|Withdrawal by Subject|2
2066448|NCT00596427|3643581|FG001|Overall Study|Withdrawal by Subject|2
2066449|NCT00596427|3643580|FG000|Overall Study|Increased Fasting Triacylglycerol level|1
2066450|NCT00596427|3643581|FG001|Overall Study|Increased Fasting Triacylglycerol level|0
2066451|NCT00596427|3643580|FG000|Overall Study|Protocol Violation|1
2066452|NCT00596427|3643581|FG001|Overall Study|Protocol Violation|0
2066453|NCT00596466|3643606|FG000|Overall Study|Lack of Efficacy|5
2066454|NCT00596466|3643606|FG000|Overall Study|Adverse Event|4
2066455|NCT00596466|3643606|FG000|Overall Study|Withdrawal by Subject|2
2066456|NCT00596466|3643606|FG000|Overall Study|Protocol Violation|2
2066457|NCT00596466|3643606|FG000|Overall Study|Unpecified|2
2066458|NCT00596466|3643606|FG000|Overall Study|Enrolled, not treated|2
2066459|NCT00596635|3643625|FG000|Overall Study|Lost to Follow-up|0
2066460|NCT00596635|3643626|FG001|Overall Study|Lost to Follow-up|2
2066461|NCT00596635|3643627|FG002|Overall Study|Lost to Follow-up|0
2066462|NCT00596635|3643625|FG000|Overall Study|Treatment for symptomatic UTI|4
2066463|NCT00596635|3643626|FG001|Overall Study|Treatment for symptomatic UTI|6
2066464|NCT00596635|3643627|FG002|Overall Study|Treatment for symptomatic UTI|3
2066465|NCT00596635|3643625|FG000|Overall Study|Hip fracture|2
2066466|NCT00596635|3643626|FG001|Overall Study|Hip fracture|3
2066467|NCT00596635|3643627|FG002|Overall Study|Hip fracture|3
2066468|NCT00596635|3643625|FG000|Overall Study|Could not provide urine specimen|1
2066469|NCT00596635|3643626|FG001|Overall Study|Could not provide urine specimen|2
2066470|NCT00596635|3643627|FG002|Overall Study|Could not provide urine specimen|2
2066471|NCT00596687|3643637|FG000|Overall Study|< 24 hours of insulin treatment|8
2066472|NCT00596687|3643638|FG001|Overall Study|< 24 hours of insulin treatment|6
2066473|NCT00596687|3643637|FG000|Overall Study|continuous insulin infusion during TPN|2
2066474|NCT00596687|3643638|FG001|Overall Study|continuous insulin infusion during TPN|1
2066475|NCT00596687|3643637|FG000|Overall Study|Withdrawal by Subject|3
2066476|NCT00596687|3643638|FG001|Overall Study|Withdrawal by Subject|1
2066477|NCT00596687|3643637|FG000|Overall Study|cancelled surgery|1
2066478|NCT00596687|3643638|FG001|Overall Study|cancelled surgery|1
2066479|NCT00596752|3643646|FG000|Overall Study|Other Reason|44
2066480|NCT00596752|3643647|FG001|Overall Study|Other Reason|49
2066481|NCT00596752|3643646|FG000|Overall Study|Adverse Event|34
2066482|NCT00596752|3643647|FG001|Overall Study|Adverse Event|34
2066483|NCT00596752|3643646|FG000|Overall Study|Lost to Follow-up|22
2066484|NCT00596752|3643647|FG001|Overall Study|Lost to Follow-up|38
2066485|NCT00596752|3643646|FG000|Overall Study|Withdrawal by Subject|12
2066486|NCT00596752|3643647|FG001|Overall Study|Withdrawal by Subject|9
2066487|NCT00596752|3643646|FG000|Overall Study|Unsatisfactory Compliance|9
2066488|NCT00596752|3643647|FG001|Overall Study|Unsatisfactory Compliance|6
2066489|NCT00596752|3643646|FG000|Overall Study|Lack of Efficacy|4
2066490|NCT00596752|3643647|FG001|Overall Study|Lack of Efficacy|7
2066491|NCT00596752|3643646|FG000|Overall Study|Protocol Violation|1
2066492|NCT00596752|3643647|FG001|Overall Study|Protocol Violation|0
2066493|NCT00596817|3643656|FG000|Open-label Period|Adverse Event|0
2066494|NCT00596817|3643657|FG001|Open-label Period|Adverse Event|49
2066495|NCT00596817|3643656|FG000|Open-label Period|Lack of Efficacy|0
2066496|NCT00596817|3643657|FG001|Open-label Period|Lack of Efficacy|33
2066497|NCT00596817|3643656|FG000|Open-label Period|Other Reasons|0
2066498|NCT00596817|3643657|FG001|Open-label Period|Other Reasons|65
2066499|NCT00596817|3643656|FG000|Open-label Period to Double-blind Period|Adverse Event|0
2066500|NCT00596817|3643657|FG001|Open-label Period to Double-blind Period|Adverse Event|5
2210199|NCT01648764|3849707|FG000|Overall Study|Progressive Disease|0
2210200|NCT01648764|3849708|FG001|Overall Study|Progressive Disease|1
2210201|NCT01648764|3849709|FG002|Overall Study|Progressive Disease|0
2210202|NCT01648764|3849710|FG003|Overall Study|Progressive Disease|0
2210203|NCT01648764|3849711|FG004|Overall Study|Progressive Disease|0
2210204|NCT01648764|3849712|FG005|Overall Study|Progressive Disease|1
2210205|NCT01648764|3849713|FG006|Overall Study|Progressive Disease|1
2210206|NCT01648764|3849714|FG007|Overall Study|Progressive Disease|0
2210207|NCT01648764|3849715|FG008|Overall Study|Progressive Disease|0
2210208|NCT01648764|3849716|FG009|Overall Study|Progressive Disease|2
2210209|NCT01648764|3849717|FG010|Overall Study|Progressive Disease|0
2210210|NCT01648764|3849718|FG011|Overall Study|Progressive Disease|1
2210211|NCT01648764|3849719|FG012|Overall Study|Progressive Disease|2
2210212|NCT01648764|3849720|FG013|Overall Study|Progressive Disease|1
2210213|NCT01648764|3849707|FG000|Overall Study|Adverse Event|0
2210214|NCT01648764|3849708|FG001|Overall Study|Adverse Event|0
2210215|NCT01648764|3849709|FG002|Overall Study|Adverse Event|0
2210216|NCT01648764|3849710|FG003|Overall Study|Adverse Event|0
2210217|NCT01648764|3849711|FG004|Overall Study|Adverse Event|0
2210218|NCT01648764|3849712|FG005|Overall Study|Adverse Event|1
2210219|NCT01648764|3849713|FG006|Overall Study|Adverse Event|0
2210220|NCT01648764|3849714|FG007|Overall Study|Adverse Event|0
2066501|NCT00596817|3643656|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0
2066502|NCT00596817|3643657|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24
2066503|NCT00596817|3643656|FG000|Open-label Period to Double-blind Period|Not Eligible|0
2066504|NCT00596817|3643657|FG001|Open-label Period to Double-blind Period|Not Eligible|49
2066505|NCT00596817|3643656|FG000|Open-label Period to Double-blind Period|Other Reasons|0
2066506|NCT00596817|3643657|FG001|Open-label Period to Double-blind Period|Other Reasons|14
2066507|NCT00596817|3643656|FG000|Double-blind Period|Adverse Event|5
2066508|NCT00596817|3643657|FG001|Double-blind Period|Adverse Event|16
2066509|NCT00596817|3643656|FG000|Double-blind Period|Lack of Efficacy|52
2066510|NCT00596817|3643657|FG001|Double-blind Period|Lack of Efficacy|28
2066511|NCT00596817|3643656|FG000|Double-blind Period|Non-compliance With Study Product|3
2066512|NCT00596817|3643657|FG001|Double-blind Period|Non-compliance With Study Product|4
2066513|NCT00596817|3643656|FG000|Double-blind Period|Protocol Violation|11
2066514|NCT00596817|3643657|FG001|Double-blind Period|Protocol Violation|8
2066515|NCT00596817|3643656|FG000|Double-blind Period|Withdrawal of Consent|7
2066516|NCT00596817|3643657|FG001|Double-blind Period|Withdrawal of Consent|3
2066517|NCT00596817|3643656|FG000|Double-blind Period|Lost to Follow-up|0
2066518|NCT00596817|3643657|FG001|Double-blind Period|Lost to Follow-up|2
2066519|NCT00596817|3643656|FG000|Double-blind Period|Other Reasons|10
2066520|NCT00596817|3643657|FG001|Double-blind Period|Other Reasons|18
2066521|NCT00596830|3643666|FG000|Overall Study|Death|258
2066522|NCT00596830|3643667|FG001|Overall Study|Death|247
2066523|NCT00596830|3643666|FG000|Overall Study|Lost to Follow-up|7
2066524|NCT00596830|3643667|FG001|Overall Study|Lost to Follow-up|11
2066525|NCT00596830|3643666|FG000|Overall Study|Withdrawal by Subject|22
2066526|NCT00596830|3643667|FG001|Overall Study|Withdrawal by Subject|12
2066527|NCT00596830|3643666|FG000|Overall Study|Study terminated by sponsor|51
2066528|NCT00596830|3643667|FG001|Overall Study|Study terminated by sponsor|62
2066529|NCT00596830|3643666|FG000|Overall Study|Follow-up was discontinued|1
2210221|NCT01648764|3849715|FG008|Overall Study|Adverse Event|0
2210222|NCT01648764|3849716|FG009|Overall Study|Adverse Event|1
2066530|NCT00596830|3643667|FG001|Overall Study|Follow-up was discontinued|0
2066531|NCT00596830|3643666|FG000|Overall Study|Randomized but not treated|3
2066532|NCT00596830|3643667|FG001|Overall Study|Randomized but not treated|7
2066533|NCT00596934|3643673|FG000|Overall Study|Protocol Violation|1
2066534|NCT00596934|3643673|FG000|Overall Study|Withdrawal by Subject|1
2066535|NCT00596960|3643681|FG000|Overall Study|Death|1
2066536|NCT00596960|3643682|FG001|Overall Study|Death|2
2066537|NCT00596960|3643681|FG000|Overall Study|Lost to Follow-up|6
2066538|NCT00596960|3643682|FG001|Overall Study|Lost to Follow-up|5
2066539|NCT00596960|3643681|FG000|Overall Study|Withdrawal by Subject|1
2066540|NCT00596960|3643682|FG001|Overall Study|Withdrawal by Subject|0
2066541|NCT00596960|3643681|FG000|Overall Study|Incarcerated|2
2066542|NCT00596960|3643682|FG001|Overall Study|Incarcerated|0
2066543|NCT00596960|3643681|FG000|Overall Study|Physician Decision|1
2066544|NCT00596960|3643682|FG001|Overall Study|Physician Decision|0
2066545|NCT00596960|3643681|FG000|Overall Study|Protocol Violation|0
2066546|NCT00596960|3643682|FG001|Overall Study|Protocol Violation|1
2066547|NCT00596960|3643681|FG000|Overall Study|No alcohol use data|0
2066548|NCT00596960|3643682|FG001|Overall Study|No alcohol use data|1
2066549|NCT00597012|3643690|FG000|Overall Study|Death|1
2066550|NCT00597012|3643691|FG001|Overall Study|Death|1
2066551|NCT00597012|3643690|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3
2066552|NCT00597012|3643691|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1
2066553|NCT00597012|3643690|FG000|Overall Study|Withdrawal by Subject|7
2066554|NCT00597012|3643691|FG001|Overall Study|Withdrawal by Subject|4
2066555|NCT00597012|3643690|FG000|Overall Study|Ineligible|2
2066556|NCT00597012|3643691|FG001|Overall Study|Ineligible|0
2066557|NCT00597012|3643690|FG000|Overall Study|Lost to Follow-up|0
2066558|NCT00597012|3643691|FG001|Overall Study|Lost to Follow-up|2
2066559|NCT00597116|3643712|FG000|Overall Study|Adverse Event|2
2066560|NCT00597116|3643713|FG001|Overall Study|Adverse Event|1
2066561|NCT00597116|3643712|FG000|Overall Study|Withdrawal by Subject|0
2066562|NCT00597116|3643713|FG001|Overall Study|Withdrawal by Subject|2
2066563|NCT00597116|3643712|FG000|Overall Study|Physician Decision|0
2066564|NCT00597116|3643713|FG001|Overall Study|Physician Decision|1
2066565|NCT00597116|3643712|FG000|Overall Study|Death|0
2066566|NCT00597116|3643713|FG001|Overall Study|Death|1
2066567|NCT00597116|3643712|FG000|Overall Study|Lost to Follow-up|1
2066568|NCT00597116|3643713|FG001|Overall Study|Lost to Follow-up|0
2066569|NCT00597116|3643712|FG000|Overall Study|Progressive disease|11
2066570|NCT00597116|3643713|FG001|Overall Study|Progressive disease|6
2066571|NCT00597207|3643721|FG000|Overall Study|Lost to Follow-up|5
2066572|NCT00597207|3643722|FG001|Overall Study|Lost to Follow-up|7
2066573|NCT00597376|3643763|FG000|Overall Study|Withdrawal by Subject|4
2302659|NCT02630459|4001568|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
2302660|NCT02630459|4001569|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
2302661|NCT02630459|4001570|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
2302662|NCT02630459|4001571|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
2302663|NCT02630459|4001572|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
2302664|NCT02630459|4001565|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
2302665|NCT02630459|4001566|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
2302666|NCT02630459|4001567|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
2302667|NCT02630459|4001568|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
2302668|NCT02630459|4001569|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4
2302669|NCT02630459|4001570|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1
2302670|NCT02630459|4001571|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
2302671|NCT02630459|4001572|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
2302672|NCT02630459|4001565|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0
2302673|NCT02630459|4001566|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0
2302674|NCT02630459|4001567|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0
2302675|NCT02630459|4001568|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0
2302676|NCT02630459|4001569|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24
2302677|NCT02630459|4001570|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3
2302678|NCT02630459|4001571|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0
2302679|NCT02630459|4001572|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0
2302680|NCT02630459|4001565|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
2302681|NCT02630459|4001566|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
2302682|NCT02630459|4001567|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
2302683|NCT02630459|4001568|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
2302684|NCT02630459|4001569|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1
2302685|NCT02630459|4001570|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
2066574|NCT00597376|3643764|FG001|Overall Study|Withdrawal by Subject|3
2066575|NCT00597376|3643763|FG000|Overall Study|Adverse Event|4
2066576|NCT00597376|3643764|FG001|Overall Study|Adverse Event|1
2066577|NCT00597506|3643791|FG000|Overall Study|Subject is being followed for survival|1
2066578|NCT00597519|3643795|FG000|Overall Study|Death|1
2066579|NCT00597584|3643814|FG000|Overall Study|Adverse Event|4
2066580|NCT00597584|3643815|FG001|Overall Study|Adverse Event|2
2066581|NCT00597584|3643814|FG000|Overall Study|Death|53
2066582|NCT00597584|3643815|FG001|Overall Study|Death|30
2066583|NCT00597584|3643814|FG000|Overall Study|Lack of Efficacy|1
2066584|NCT00597584|3643815|FG001|Overall Study|Lack of Efficacy|0
2066585|NCT00597584|3643814|FG000|Overall Study|Lost to Follow-up|2
2066586|NCT00597584|3643815|FG001|Overall Study|Lost to Follow-up|4
2066587|NCT00597584|3643814|FG000|Overall Study|Physician Decision|3
2066588|NCT00597584|3643815|FG001|Overall Study|Physician Decision|0
2066589|NCT00597584|3643814|FG000|Overall Study|Pregnancy|2
2066590|NCT00597584|3643815|FG001|Overall Study|Pregnancy|0
2066591|NCT00597584|3643814|FG000|Overall Study|Withdrawal by Subject|44
2066592|NCT00597584|3643815|FG001|Overall Study|Withdrawal by Subject|12
2066593|NCT00597584|3643814|FG000|Overall Study|Discontinued Dialysis|0
2066594|NCT00597584|3643815|FG001|Overall Study|Discontinued Dialysis|1
2066595|NCT00597584|3643814|FG000|Overall Study|Lost ability to consent|1
2066596|NCT00597584|3643815|FG001|Overall Study|Lost ability to consent|1
2066597|NCT00597584|3643814|FG000|Overall Study|Never dosed|1
2066598|NCT00597584|3643815|FG001|Overall Study|Never dosed|0
2066599|NCT00597584|3643814|FG000|Overall Study|Relocation|8
2066600|NCT00597584|3643815|FG001|Overall Study|Relocation|6
2066601|NCT00597584|3643814|FG000|Overall Study|Renal transplant|9
2066602|NCT00597584|3643815|FG001|Overall Study|Renal transplant|7
2066603|NCT00597701|3643834|FG000|Overall Study|Withdrawal by Subject|5
2066604|NCT00597701|3643835|FG001|Overall Study|Withdrawal by Subject|5
2066605|NCT00597701|3643834|FG000|Overall Study|Death|0
2066606|NCT00597701|3643835|FG001|Overall Study|Death|1
2066607|NCT00597701|3643834|FG000|Overall Study|Physician Decision|2
2066608|NCT00597701|3643835|FG001|Overall Study|Physician Decision|0
2066609|NCT00597701|3643834|FG000|Overall Study|Did not start intervention (pharmacy er)|0
2066610|NCT00597701|3643835|FG001|Overall Study|Did not start intervention (pharmacy er)|2
2066611|NCT00597714|3643843|FG000|Overall Study|Death|56
2066612|NCT00597714|3643844|FG001|Overall Study|Death|46
2066613|NCT00597714|3643845|FG002|Overall Study|Death|0
2066614|NCT00597714|3643843|FG000|Overall Study|Recipient death|0
2066615|NCT00597714|3643844|FG001|Overall Study|Recipient death|0
2066616|NCT00597714|3643845|FG002|Overall Study|Recipient death|10
2066617|NCT00597753|3643878|FG000|Overall Study|Adverse Event|6
2066618|NCT00597753|3643879|FG001|Overall Study|Adverse Event|2
2066619|NCT00597753|3643878|FG000|Overall Study|Death|55
2066620|NCT00597753|3643879|FG001|Overall Study|Death|29
2066621|NCT00597753|3643878|FG000|Overall Study|Lack of Efficacy|2
2066622|NCT00597753|3643879|FG001|Overall Study|Lack of Efficacy|0
2066623|NCT00597753|3643878|FG000|Overall Study|Lost to Follow-up|10
2066624|NCT00597753|3643879|FG001|Overall Study|Lost to Follow-up|3
2066625|NCT00597753|3643878|FG000|Overall Study|Physician Decision|5
2066626|NCT00597753|3643879|FG001|Overall Study|Physician Decision|1
2066627|NCT00597753|3643878|FG000|Overall Study|Pregnancy|1
2066628|NCT00597753|3643879|FG001|Overall Study|Pregnancy|0
2066629|NCT00597753|3643878|FG000|Overall Study|Withdrawal by Subject|35
2066630|NCT00597753|3643879|FG001|Overall Study|Withdrawal by Subject|12
2066631|NCT00597753|3643878|FG000|Overall Study|Discontinued Dialysis|0
2066632|NCT00597753|3643879|FG001|Overall Study|Discontinued Dialysis|1
2066633|NCT00597753|3643878|FG000|Overall Study|Never dosed|2
2066634|NCT00597753|3643879|FG001|Overall Study|Never dosed|0
2066635|NCT00597753|3643878|FG000|Overall Study|Noncompliance|2
2066636|NCT00597753|3643879|FG001|Overall Study|Noncompliance|1
2066637|NCT00597753|3643878|FG000|Overall Study|Relocation|17
2066638|NCT00597753|3643879|FG001|Overall Study|Relocation|6
2066639|NCT00597753|3643878|FG000|Overall Study|Renal transplant|10
2066640|NCT00597753|3643879|FG001|Overall Study|Renal transplant|3
2066641|NCT00597753|3643878|FG000|Overall Study|Site closed by sponsor|19
2066642|NCT00597753|3643879|FG001|Overall Study|Site closed by sponsor|7
2066643|NCT00597753|3643878|FG000|Overall Study|Site elected to close|2
2066644|NCT00597753|3643879|FG001|Overall Study|Site elected to close|4
2066645|NCT00597766|3643888|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1
2066646|NCT00597766|3643889|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0
2066647|NCT00597766|3643890|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0
2066648|NCT00597766|3643888|FG000|Follow-up 2, Week 8|Lost to Follow-up|0
2066649|NCT00597766|3643889|FG001|Follow-up 2, Week 8|Lost to Follow-up|0
2066650|NCT00597766|3643890|FG002|Follow-up 2, Week 8|Lost to Follow-up|1
2066651|NCT00598078|3643942|FG000|Period 2 (Day 2)|Adverse Event|1
2066652|NCT00598078|3643943|FG001|Period 2 (Day 2)|Adverse Event|0
2066653|NCT00598273|3643954|FG000|Overall Study|Adverse Event|4
2066654|NCT00598273|3643955|FG001|Overall Study|Adverse Event|5
2066655|NCT00598273|3643956|FG002|Overall Study|Adverse Event|2
2066656|NCT00598273|3643954|FG000|Overall Study|Death|6
2066657|NCT00598273|3643955|FG001|Overall Study|Death|12
2066658|NCT00598273|3643956|FG002|Overall Study|Death|8
2066659|NCT00598273|3643954|FG000|Overall Study|Lost to Follow-up|8
2066660|NCT00598273|3643955|FG001|Overall Study|Lost to Follow-up|3
2066661|NCT00598273|3643956|FG002|Overall Study|Lost to Follow-up|5
2066662|NCT00598273|3643954|FG000|Overall Study|Physician Decision|0
2066663|NCT00598273|3643955|FG001|Overall Study|Physician Decision|0
2066664|NCT00598273|3643956|FG002|Overall Study|Physician Decision|1
2066665|NCT00598273|3643954|FG000|Overall Study|Withdrawal by Subject|12
2066666|NCT00598273|3643955|FG001|Overall Study|Withdrawal by Subject|10
2066667|NCT00598273|3643956|FG002|Overall Study|Withdrawal by Subject|10
2066668|NCT00598273|3643954|FG000|Overall Study|Noncompliance|3
2066669|NCT00598273|3643955|FG001|Overall Study|Noncompliance|2
2066670|NCT00598273|3643956|FG002|Overall Study|Noncompliance|3
2066671|NCT00598273|3643954|FG000|Overall Study|Relocation|0
2066672|NCT00598273|3643955|FG001|Overall Study|Relocation|2
2066673|NCT00598273|3643956|FG002|Overall Study|Relocation|4
2066674|NCT00598273|3643954|FG000|Overall Study|Renal transplant|1
2066675|NCT00598273|3643955|FG001|Overall Study|Renal transplant|0
2066676|NCT00598273|3643956|FG002|Overall Study|Renal transplant|1
2066677|NCT00598273|3643954|FG000|Overall Study|Site elected to close|1
2066678|NCT00598273|3643955|FG001|Overall Study|Site elected to close|0
2066679|NCT00598273|3643956|FG002|Overall Study|Site elected to close|0
2066680|NCT00598273|3643954|FG000|Overall Study|Started dialysis|6
2066681|NCT00598273|3643955|FG001|Overall Study|Started dialysis|4
2066682|NCT00598273|3643956|FG002|Overall Study|Started dialysis|5
2177136|NCT01371734|3801202|FG002|Overall Study|Lost to Follow-up|1
2177137|NCT01371734|3801200|FG000|Overall Study|Protocol Violation|3
2177138|NCT01371734|3801201|FG001|Overall Study|Protocol Violation|1
2177139|NCT01371734|3801202|FG002|Overall Study|Protocol Violation|2
2177140|NCT01371734|3801200|FG000|Overall Study|Adverse Event|8
2177141|NCT01371734|3801201|FG001|Overall Study|Adverse Event|8
2177142|NCT01371734|3801202|FG002|Overall Study|Adverse Event|3
2177143|NCT01371734|3801200|FG000|Overall Study|Lack of Efficacy|2
2177144|NCT01371734|3801201|FG001|Overall Study|Lack of Efficacy|2
2210223|NCT01648764|3849717|FG010|Overall Study|Adverse Event|0
2066683|NCT00598442|3643967|FG000|Overall Study|Adverse Event|3
2066684|NCT00598442|3643968|FG001|Overall Study|Adverse Event|0
2066685|NCT00598442|3643969|FG002|Overall Study|Adverse Event|0
2066686|NCT00598442|3643967|FG000|Overall Study|Death|19
2066687|NCT00598442|3643968|FG001|Overall Study|Death|11
2066688|NCT00598442|3643969|FG002|Overall Study|Death|11
2066689|NCT00598442|3643967|FG000|Overall Study|Lost to Follow-up|4
2066690|NCT00598442|3643968|FG001|Overall Study|Lost to Follow-up|3
2066691|NCT00598442|3643969|FG002|Overall Study|Lost to Follow-up|3
2210224|NCT01648764|3849718|FG011|Overall Study|Adverse Event|3
2210225|NCT01648764|3849719|FG012|Overall Study|Adverse Event|1
2066692|NCT00598442|3643967|FG000|Overall Study|Physician Decision|2
2066693|NCT00598442|3643968|FG001|Overall Study|Physician Decision|1
2066694|NCT00598442|3643969|FG002|Overall Study|Physician Decision|1
2066695|NCT00598442|3643967|FG000|Overall Study|Withdrawal by Subject|8
2066696|NCT00598442|3643968|FG001|Overall Study|Withdrawal by Subject|16
2066697|NCT00598442|3643969|FG002|Overall Study|Withdrawal by Subject|6
2066698|NCT00598442|3643967|FG000|Overall Study|Noncompliance|0
2066699|NCT00598442|3643968|FG001|Overall Study|Noncompliance|2
2066700|NCT00598442|3643969|FG002|Overall Study|Noncompliance|1
2066701|NCT00598442|3643967|FG000|Overall Study|Relocation|1
2066702|NCT00598442|3643968|FG001|Overall Study|Relocation|4
2066703|NCT00598442|3643969|FG002|Overall Study|Relocation|0
2066704|NCT00598442|3643967|FG000|Overall Study|Renal transplant|0
2066705|NCT00598442|3643968|FG001|Overall Study|Renal transplant|0
2066706|NCT00598442|3643969|FG002|Overall Study|Renal transplant|1
2066707|NCT00598442|3643967|FG000|Overall Study|Site closed by sponsor|5
2066708|NCT00598442|3643968|FG001|Overall Study|Site closed by sponsor|2
2066709|NCT00598442|3643969|FG002|Overall Study|Site closed by sponsor|1
2066710|NCT00598442|3643967|FG000|Overall Study|Started dialysis|1
2066711|NCT00598442|3643968|FG001|Overall Study|Started dialysis|0
2066712|NCT00598442|3643969|FG002|Overall Study|Started dialysis|0
2066713|NCT00598481|3643977|FG000|Treatment|Physician Decision|1
2106121|NCT00863304|3699190|FG003|Overall Study|Randomized, but not Treated|1
2106122|NCT00863304|3699187|FG000|Overall Study|Entered extension study|101
2106123|NCT00863304|3699188|FG001|Overall Study|Entered extension study|129
2106124|NCT00863304|3699189|FG002|Overall Study|Entered extension study|113
2106125|NCT00863304|3699190|FG003|Overall Study|Entered extension study|125
2106126|NCT00863317|3699204|FG000|Overall Study|Lost to Follow-up|8
2106127|NCT00863317|3699205|FG001|Overall Study|Lost to Follow-up|9
2106128|NCT00863655|3699236|FG000|Overall Study|Protocol Violation|4
2106129|NCT00863655|3699237|FG001|Overall Study|Protocol Violation|0
2106130|NCT00863655|3699236|FG000|Overall Study|Adverse Event|52
2106131|NCT00863655|3699237|FG001|Overall Study|Adverse Event|8
2106132|NCT00863655|3699236|FG000|Overall Study|Withdrawal by Subject|47
2106133|NCT00863655|3699237|FG001|Overall Study|Withdrawal by Subject|7
2106134|NCT00863655|3699236|FG000|Overall Study|Administrative problems|1
2106135|NCT00863655|3699237|FG001|Overall Study|Administrative problems|0
2106136|NCT00863655|3699236|FG000|Overall Study|Death|7
2106137|NCT00863655|3699237|FG001|Overall Study|Death|1
2106138|NCT00863655|3699236|FG000|Overall Study|New cancer therapy|5
2106139|NCT00863655|3699237|FG001|Overall Study|New cancer therapy|1
2106140|NCT00863655|3699236|FG000|Overall Study|Disease progression|364
2106141|NCT00863655|3699237|FG001|Overall Study|Disease progression|221
2106142|NCT00863655|3699236|FG000|Overall Study|Treatment completed as per protocol|5
2106143|NCT00863655|3699237|FG001|Overall Study|Treatment completed as per protocol|1
2106144|NCT00863681|3699246|FG000|Overall Study|Other|2
2106145|NCT00863681|3699247|FG001|Overall Study|Other|0
2106146|NCT00863681|3699248|FG002|Overall Study|Other|0
2106147|NCT00863681|3699246|FG000|Overall Study|Missing|1
2106148|NCT00863681|3699247|FG001|Overall Study|Missing|0
2210226|NCT01648764|3849720|FG013|Overall Study|Adverse Event|1
2106149|NCT00863681|3699248|FG002|Overall Study|Missing|0
2106150|NCT00863681|3699246|FG000|Overall Study|Death|40
2106151|NCT00863681|3699247|FG001|Overall Study|Death|23
2106152|NCT00863681|3699248|FG002|Overall Study|Death|6
2066714|NCT00598559|3643991|FG000|Overall Study|Adverse Event|11
2066715|NCT00598559|3643992|FG001|Overall Study|Adverse Event|7
2066716|NCT00598559|3643993|FG002|Overall Study|Adverse Event|0
2066717|NCT00598559|3643991|FG000|Overall Study|Withdrawal by Subject|2
2066718|NCT00598559|3643992|FG001|Overall Study|Withdrawal by Subject|2
2066719|NCT00598559|3643993|FG002|Overall Study|Withdrawal by Subject|0
2066720|NCT00598559|3643991|FG000|Overall Study|Protocol Non-compliance|1
2066721|NCT00598559|3643992|FG001|Overall Study|Protocol Non-compliance|0
2066722|NCT00598559|3643993|FG002|Overall Study|Protocol Non-compliance|0
2066723|NCT00598559|3643991|FG000|Overall Study|Early discharge from hospital|9
2066724|NCT00598559|3643992|FG001|Overall Study|Early discharge from hospital|12
2066725|NCT00598559|3643993|FG002|Overall Study|Early discharge from hospital|3
2066726|NCT00598559|3643991|FG000|Overall Study|Subject unable/unwilling to attend visit|4
2066727|NCT00598559|3643992|FG001|Overall Study|Subject unable/unwilling to attend visit|7
2066728|NCT00598559|3643993|FG002|Overall Study|Subject unable/unwilling to attend visit|0
2066729|NCT00598585|3644003|FG000|Overall Study|Lost to Follow-up|1
2066730|NCT00598585|3644004|FG001|Overall Study|Lost to Follow-up|0
2066731|NCT00598650|3644010|FG000|Overall Study|Withdrawal by Subject|3
2066732|NCT00598650|3644010|FG000|Overall Study|Adverse Event|18
2066733|NCT00598650|3644010|FG000|Overall Study|No treatment for 3 weeks|1
2066734|NCT00598650|3644010|FG000|Overall Study|Not eligible|1
2066735|NCT00598650|3644010|FG000|Overall Study|Prohibited Concomitant Medication|2
2066736|NCT00598650|3644010|FG000|Overall Study|Physician Decision|2
2066737|NCT00598702|3644044|FG000|Overall Study|Other|0
2066738|NCT00598702|3644045|FG001|Overall Study|Other|2
2066739|NCT00598702|3644046|FG002|Overall Study|Other|0
2066740|NCT00598702|3644047|FG003|Overall Study|Other|0
2066741|NCT00598702|3644048|FG004|Overall Study|Other|0
2066742|NCT00598702|3644049|FG005|Overall Study|Other|1
2066743|NCT00598702|3644050|FG006|Overall Study|Other|0
2066744|NCT00598702|3644051|FG007|Overall Study|Other|0
2066745|NCT00598702|3644044|FG000|Overall Study|Early discharge from hospital|0
2066746|NCT00598702|3644045|FG001|Overall Study|Early discharge from hospital|0
2066747|NCT00598702|3644046|FG002|Overall Study|Early discharge from hospital|2
2066748|NCT00598702|3644047|FG003|Overall Study|Early discharge from hospital|5
2066749|NCT00598702|3644048|FG004|Overall Study|Early discharge from hospital|0
2066750|NCT00598702|3644049|FG005|Overall Study|Early discharge from hospital|10
2066751|NCT00598702|3644050|FG006|Overall Study|Early discharge from hospital|1
2066752|NCT00598702|3644051|FG007|Overall Study|Early discharge from hospital|0
2066753|NCT00598702|3644044|FG000|Overall Study|Adverse Event|0
2066754|NCT00598702|3644045|FG001|Overall Study|Adverse Event|0
2066755|NCT00598702|3644046|FG002|Overall Study|Adverse Event|0
2066756|NCT00598702|3644047|FG003|Overall Study|Adverse Event|1
2066757|NCT00598702|3644048|FG004|Overall Study|Adverse Event|0
2066758|NCT00598702|3644049|FG005|Overall Study|Adverse Event|0
2066759|NCT00598702|3644050|FG006|Overall Study|Adverse Event|0
2066760|NCT00598702|3644051|FG007|Overall Study|Adverse Event|0
2066761|NCT00598702|3644044|FG000|Overall Study|Withdrawal by Subject|0
2066762|NCT00598702|3644045|FG001|Overall Study|Withdrawal by Subject|0
2066763|NCT00598702|3644046|FG002|Overall Study|Withdrawal by Subject|0
2066764|NCT00598702|3644047|FG003|Overall Study|Withdrawal by Subject|1
2066765|NCT00598702|3644048|FG004|Overall Study|Withdrawal by Subject|1
2066766|NCT00598702|3644049|FG005|Overall Study|Withdrawal by Subject|0
2066767|NCT00598702|3644050|FG006|Overall Study|Withdrawal by Subject|0
2066768|NCT00598702|3644051|FG007|Overall Study|Withdrawal by Subject|0
2066769|NCT00598702|3644044|FG000|Overall Study|Physician Decision|0
2066770|NCT00598702|3644045|FG001|Overall Study|Physician Decision|0
2066771|NCT00598702|3644046|FG002|Overall Study|Physician Decision|0
2066772|NCT00598702|3644047|FG003|Overall Study|Physician Decision|0
2066773|NCT00598702|3644048|FG004|Overall Study|Physician Decision|1
2066774|NCT00598702|3644049|FG005|Overall Study|Physician Decision|0
2066775|NCT00598702|3644050|FG006|Overall Study|Physician Decision|0
2066776|NCT00598702|3644051|FG007|Overall Study|Physician Decision|0
2066777|NCT00598702|3644044|FG000|Overall Study|Dose limiting toxicity|0
2066778|NCT00598702|3644045|FG001|Overall Study|Dose limiting toxicity|0
2066779|NCT00598702|3644046|FG002|Overall Study|Dose limiting toxicity|0
2066780|NCT00598702|3644047|FG003|Overall Study|Dose limiting toxicity|1
2066781|NCT00598702|3644048|FG004|Overall Study|Dose limiting toxicity|1
2066782|NCT00598702|3644049|FG005|Overall Study|Dose limiting toxicity|1
2066783|NCT00598702|3644050|FG006|Overall Study|Dose limiting toxicity|0
2066784|NCT00598702|3644051|FG007|Overall Study|Dose limiting toxicity|0
2066785|NCT00598832|3644084|FG000|Overall Study|Lack of Efficacy|3
2066786|NCT00598832|3644085|FG001|Overall Study|Lack of Efficacy|7
2066787|NCT00598832|3644084|FG000|Overall Study|Adverse Event|6
2066788|NCT00598832|3644085|FG001|Overall Study|Adverse Event|2
2066789|NCT00598832|3644084|FG000|Overall Study|Withdrawal by Subject|25
2066790|NCT00598832|3644085|FG001|Overall Study|Withdrawal by Subject|36
2066791|NCT00598832|3644084|FG000|Overall Study|Protocol Violation|0
2066792|NCT00598832|3644085|FG001|Overall Study|Protocol Violation|2
2066793|NCT00598832|3644084|FG000|Overall Study|Lost to Follow-up|24
2066794|NCT00598832|3644085|FG001|Overall Study|Lost to Follow-up|29
2066795|NCT00598832|3644084|FG000|Overall Study|Pregnancy|2
2066796|NCT00598832|3644085|FG001|Overall Study|Pregnancy|2
2066797|NCT00598832|3644084|FG000|Overall Study|Physician Decision|1
2066798|NCT00598832|3644085|FG001|Overall Study|Physician Decision|4
2066799|NCT00598832|3644084|FG000|Overall Study|Non compliance|1
2066800|NCT00598832|3644085|FG001|Overall Study|Non compliance|0
2066801|NCT00598871|3644093|FG000|Overall Study|Adverse Event|0
2066802|NCT00598871|3644094|FG001|Overall Study|Adverse Event|1
2066803|NCT00598975|3644102|FG000|Overall Study|Adverse Event|1
2066804|NCT00598975|3644103|FG001|Overall Study|Adverse Event|1
2066805|NCT00598975|3644102|FG000|Overall Study|Brain metastases|1
2066806|NCT00598975|3644103|FG001|Overall Study|Brain metastases|0
2066807|NCT00598975|3644102|FG000|Overall Study|Withdrawal by Subject|1
2066808|NCT00598975|3644103|FG001|Overall Study|Withdrawal by Subject|1
2066809|NCT00598975|3644102|FG000|Overall Study|Withdrawal of consent|0
2066810|NCT00598975|3644103|FG001|Overall Study|Withdrawal of consent|1
2066811|NCT00598975|3644102|FG000|Overall Study|Disease progression|8
2066812|NCT00598975|3644103|FG001|Overall Study|Disease progression|3
2066813|NCT00598975|3644102|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1
2066814|NCT00598975|3644103|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0
2066815|NCT00599196|3644124|FG000|Overall Study|Lack of Efficacy|22
2066816|NCT00599196|3644124|FG000|Overall Study|Adverse Event|93
2066817|NCT00599196|3644124|FG000|Overall Study|Unsatisfactory compliance of subject|3
2066818|NCT00599196|3644124|FG000|Overall Study|Subject withdrew consent|43
2066819|NCT00599196|3644124|FG000|Overall Study|Study ended per sponsor|197
2066820|NCT00599196|3644124|FG000|Overall Study|Lost to Follow-up|17
2066821|NCT00599196|3644124|FG000|Overall Study|Other: Patient Leaving For Israel|1
2066822|NCT00599196|3644124|FG000|Overall Study|Other: Spouse Withdrew Consent|1
2066823|NCT00599196|3644124|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
2066824|NCT00599196|3644124|FG000|Overall Study|Other: Pt Moved To Australia|1
2066825|NCT00599196|3644124|FG000|Overall Study|Other: Patient Stopped Due To Moving|1
2066826|NCT00599196|3644124|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1
2066827|NCT00599313|3644142|FG000|Overall Study|Adverse Event|19
2066828|NCT00599313|3644142|FG000|Overall Study|Disease Progression|12
2066829|NCT00599313|3644142|FG000|Overall Study|Patient Request|4
2066830|NCT00599313|3644142|FG000|Overall Study|Ineligible|1
2066831|NCT00599326|3644146|FG000|Overall Study|Lost to Follow-up|1
2066832|NCT00599326|3644146|FG000|Overall Study|Noncompliant|1
2066833|NCT00599339|3644150|FG000|Overall Study|Adverse Event|79
2066834|NCT00599339|3644150|FG000|Overall Study|Withdrawal by Subject|137
2066835|NCT00599339|3644150|FG000|Overall Study|Other Reason|179
2066836|NCT00599339|3644150|FG000|Overall Study|Lost to Follow-up|221
2066837|NCT00599339|3644150|FG000|Overall Study|No valid data consent|36
2066838|NCT00599339|3644150|FG000|Overall Study|Study Termination Status Unknown|12
2066839|NCT00599521|3644174|FG000|Overall Study|Lack of Efficacy|4
2066840|NCT00599521|3644175|FG001|Overall Study|Lack of Efficacy|8
2066841|NCT00599521|3644174|FG000|Overall Study|Adverse Event|4
2066842|NCT00599521|3644175|FG001|Overall Study|Adverse Event|1
2066843|NCT00599521|3644174|FG000|Overall Study|Withdrawal by Subject|28
2066844|NCT00599521|3644175|FG001|Overall Study|Withdrawal by Subject|34
2066845|NCT00599521|3644174|FG000|Overall Study|Protocol Violation|1
2066846|NCT00599521|3644175|FG001|Overall Study|Protocol Violation|1
2066847|NCT00599521|3644174|FG000|Overall Study|Lost to Follow-up|23
2066848|NCT00599521|3644175|FG001|Overall Study|Lost to Follow-up|23
2066849|NCT00599521|3644174|FG000|Overall Study|Pregnancy|0
2066850|NCT00599521|3644175|FG001|Overall Study|Pregnancy|2
2066851|NCT00599638|3644185|FG000|First Intervention Period (2 Weeks)|Adverse Event|1
2066852|NCT00599638|3644186|FG001|First Intervention Period (2 Weeks)|Adverse Event|0
2066853|NCT00599638|3644187|FG002|First Intervention Period (2 Weeks)|Adverse Event|3
2066854|NCT00599638|3644188|FG003|First Intervention Period (2 Weeks)|Adverse Event|2
2066855|NCT00599638|3644185|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
2066856|NCT00599638|3644186|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
2066857|NCT00599638|3644187|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
2066858|NCT00599638|3644188|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
2066859|NCT00599638|3644185|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0
2066860|NCT00599638|3644186|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1
2066861|NCT00599638|3644187|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0
2066862|NCT00599638|3644188|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1
2066863|NCT00599638|3644185|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0
2066864|NCT00599638|3644186|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1
2066865|NCT00599638|3644187|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0
2066866|NCT00599638|3644188|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1
2066867|NCT00599638|3644185|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
2066868|NCT00599638|3644186|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0
2066869|NCT00599638|3644187|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0
2066870|NCT00599638|3644188|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1
2066871|NCT00599638|3644185|FG000|Washout Period (2 Weeks)|Adverse Event|0
2066872|NCT00599638|3644186|FG001|Washout Period (2 Weeks)|Adverse Event|0
2066873|NCT00599638|3644187|FG002|Washout Period (2 Weeks)|Adverse Event|0
2066874|NCT00599638|3644188|FG003|Washout Period (2 Weeks)|Adverse Event|1
2066875|NCT00599638|3644185|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0
2066876|NCT00599638|3644186|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0
2066877|NCT00599638|3644187|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0
2066878|NCT00599638|3644188|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1
2066879|NCT00599638|3644185|FG000|Washout Period (2 Weeks)|Protocol Violation|0
2066880|NCT00599638|3644186|FG001|Washout Period (2 Weeks)|Protocol Violation|1
2066881|NCT00599638|3644187|FG002|Washout Period (2 Weeks)|Protocol Violation|0
2066882|NCT00599638|3644188|FG003|Washout Period (2 Weeks)|Protocol Violation|0
2066883|NCT00599638|3644185|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1
2066884|NCT00599638|3644186|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0
2066885|NCT00599638|3644187|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0
2066886|NCT00599638|3644188|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0
2066887|NCT00599755|3644196|FG000|Overall Study|Adverse Event|11
2066888|NCT00599755|3644196|FG000|Overall Study|Withdrawal by Subject|2
2066889|NCT00599755|3644196|FG000|Overall Study|Progression of Disease|3
2066890|NCT00599755|3644196|FG000|Overall Study|Other Reason|2
2066891|NCT00599755|3644196|FG000|Overall Study|No data available|1
2066892|NCT00599924|3644220|FG000|Overall Study|Lack of Efficacy|3
2066893|NCT00599924|3644221|FG001|Overall Study|Lack of Efficacy|5
2066894|NCT00599924|3644222|FG002|Overall Study|Lack of Efficacy|1
2066895|NCT00599924|3644223|FG003|Overall Study|Lack of Efficacy|2
2066896|NCT00599924|3644224|FG004|Overall Study|Lack of Efficacy|3
2066897|NCT00599924|3644225|FG005|Overall Study|Lack of Efficacy|2
2066898|NCT00599924|3644226|FG006|Overall Study|Lack of Efficacy|0
2066899|NCT00599924|3644220|FG000|Overall Study|Adverse Event|0
2066900|NCT00599924|3644221|FG001|Overall Study|Adverse Event|0
2066901|NCT00599924|3644222|FG002|Overall Study|Adverse Event|0
2066902|NCT00599924|3644223|FG003|Overall Study|Adverse Event|2
2066903|NCT00599924|3644224|FG004|Overall Study|Adverse Event|0
2066904|NCT00599924|3644225|FG005|Overall Study|Adverse Event|0
2066905|NCT00599924|3644226|FG006|Overall Study|Adverse Event|2
2066906|NCT00599924|3644220|FG000|Overall Study|Death|0
2066907|NCT00599924|3644221|FG001|Overall Study|Death|0
2066908|NCT00599924|3644222|FG002|Overall Study|Death|0
2066909|NCT00599924|3644223|FG003|Overall Study|Death|2
2066910|NCT00599924|3644224|FG004|Overall Study|Death|0
2066911|NCT00599924|3644225|FG005|Overall Study|Death|2
2066912|NCT00599924|3644226|FG006|Overall Study|Death|1
2066913|NCT00599924|3644220|FG000|Overall Study|Protocol Violation|0
2066914|NCT00599924|3644221|FG001|Overall Study|Protocol Violation|0
2066915|NCT00599924|3644222|FG002|Overall Study|Protocol Violation|0
2066916|NCT00599924|3644223|FG003|Overall Study|Protocol Violation|1
2066917|NCT00599924|3644224|FG004|Overall Study|Protocol Violation|0
2066918|NCT00599924|3644225|FG005|Overall Study|Protocol Violation|0
2066919|NCT00599924|3644226|FG006|Overall Study|Protocol Violation|0
2066920|NCT00599924|3644220|FG000|Overall Study|Withdrawal by Subject|0
2066921|NCT00599924|3644221|FG001|Overall Study|Withdrawal by Subject|0
2066922|NCT00599924|3644222|FG002|Overall Study|Withdrawal by Subject|1
2066923|NCT00599924|3644223|FG003|Overall Study|Withdrawal by Subject|0
2066924|NCT00599924|3644224|FG004|Overall Study|Withdrawal by Subject|1
2066925|NCT00599924|3644225|FG005|Overall Study|Withdrawal by Subject|0
2066926|NCT00599924|3644226|FG006|Overall Study|Withdrawal by Subject|0
2066927|NCT00599924|3644220|FG000|Overall Study|Other|0
2066928|NCT00599924|3644221|FG001|Overall Study|Other|0
2066929|NCT00599924|3644222|FG002|Overall Study|Other|0
2066930|NCT00599924|3644223|FG003|Overall Study|Other|1
2066931|NCT00599924|3644224|FG004|Overall Study|Other|2
2066932|NCT00599924|3644225|FG005|Overall Study|Other|0
2066933|NCT00599924|3644226|FG006|Overall Study|Other|2
2066934|NCT00600028|3644257|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
2066935|NCT00600028|3644258|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
2066936|NCT00600028|3644257|FG000|First Intervention (12 Weeks)|Adverse Event|0
2066937|NCT00600028|3644258|FG001|First Intervention (12 Weeks)|Adverse Event|1
2066938|NCT00600028|3644257|FG000|Second Intervention (12 Weeks)|Adverse Event|0
2066939|NCT00600028|3644258|FG001|Second Intervention (12 Weeks)|Adverse Event|2
2066940|NCT00600067|3644269|FG000|Overall Study|Adverse Event|0
2066941|NCT00600067|3644270|FG001|Overall Study|Adverse Event|1
2066942|NCT00600067|3644269|FG000|Overall Study|Lost to Follow-up|2
2066943|NCT00600067|3644270|FG001|Overall Study|Lost to Follow-up|3
2066944|NCT00600067|3644269|FG000|Overall Study|protocol non-compliance|0
2066945|NCT00600067|3644270|FG001|Overall Study|protocol non-compliance|3
2066946|NCT00600067|3644269|FG000|Overall Study|Lack of Efficacy|1
2066947|NCT00600067|3644270|FG001|Overall Study|Lack of Efficacy|0
2066948|NCT00600106|3644286|FG000|Overall Study|Withdrawal by Subject|1
2066949|NCT00600106|3644287|FG001|Overall Study|Withdrawal by Subject|1
2066950|NCT00600119|3644299|FG000|Single-blind Placebo run-in Period|Other - Not specified|1
2066951|NCT00600119|3644300|FG001|Single-blind Placebo run-in Period|Other - Not specified|0
2066952|NCT00600119|3644301|FG002|Single-blind Placebo run-in Period|Other - Not specified|0
2066953|NCT00600119|3644302|FG003|Single-blind Placebo run-in Period|Other - Not specified|0
2066954|NCT00600119|3644303|FG004|Single-blind Placebo run-in Period|Other - Not specified|1
2066955|NCT00600119|3644304|FG005|Single-blind Placebo run-in Period|Other - Not specified|1
2066956|NCT00600119|3644299|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
2066957|NCT00600119|3644300|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
2066958|NCT00600119|3644301|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
2066959|NCT00600119|3644302|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
2066960|NCT00600119|3644303|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
2066961|NCT00600119|3644304|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
2066962|NCT00600119|3644299|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0
2066963|NCT00600119|3644300|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0
2066964|NCT00600119|3644301|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1
2066965|NCT00600119|3644302|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0
2066966|NCT00600119|3644303|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1
2066967|NCT00600119|3644304|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0
2066968|NCT00600119|3644299|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1
2066969|NCT00600119|3644300|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0
2066970|NCT00600119|3644301|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0
2066971|NCT00600119|3644302|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0
2066972|NCT00600119|3644303|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0
2066973|NCT00600119|3644304|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0
2066974|NCT00600119|3644299|FG000|Single-blind Placebo run-in Period|Adverse Event|0
2066975|NCT00600119|3644300|FG001|Single-blind Placebo run-in Period|Adverse Event|0
2066976|NCT00600119|3644301|FG002|Single-blind Placebo run-in Period|Adverse Event|0
2066977|NCT00600119|3644302|FG003|Single-blind Placebo run-in Period|Adverse Event|1
2066978|NCT00600119|3644303|FG004|Single-blind Placebo run-in Period|Adverse Event|0
2066979|NCT00600119|3644304|FG005|Single-blind Placebo run-in Period|Adverse Event|1
2066980|NCT00600119|3644299|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2
2066981|NCT00600119|3644300|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1
2066982|NCT00600119|3644301|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0
2066983|NCT00600119|3644302|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0
2066984|NCT00600119|3644303|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0
2066985|NCT00600119|3644304|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0
2066986|NCT00600119|3644299|FG000|Double-blind Treatment Period|Withdrawal by Subject|2
2066987|NCT00600119|3644300|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
2066988|NCT00600119|3644301|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
2066989|NCT00600119|3644302|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
2066990|NCT00600119|3644303|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
2066991|NCT00600119|3644304|FG005|Double-blind Treatment Period|Withdrawal by Subject|3
2066992|NCT00600119|3644299|FG000|Double-blind Treatment Period|Other|0
2066993|NCT00600119|3644300|FG001|Double-blind Treatment Period|Other|0
2066994|NCT00600119|3644301|FG002|Double-blind Treatment Period|Other|0
2066995|NCT00600119|3644302|FG003|Double-blind Treatment Period|Other|0
2066996|NCT00600119|3644303|FG004|Double-blind Treatment Period|Other|2
2066997|NCT00600119|3644304|FG005|Double-blind Treatment Period|Other|1
2066998|NCT00600119|3644299|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
2066999|NCT00600119|3644300|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
2067000|NCT00600119|3644301|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
2067001|NCT00600119|3644302|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
2067002|NCT00600119|3644303|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
2067003|NCT00600119|3644304|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
2067004|NCT00600119|3644299|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
2067005|NCT00600119|3644300|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
2067006|NCT00600119|3644301|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
2067007|NCT00600119|3644302|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
2067008|NCT00600119|3644303|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
2067009|NCT00600119|3644304|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
2067010|NCT00600119|3644299|FG000|Double-blind Treatment Period|Sponsor Decision|0
2067011|NCT00600119|3644300|FG001|Double-blind Treatment Period|Sponsor Decision|1
2067012|NCT00600119|3644301|FG002|Double-blind Treatment Period|Sponsor Decision|0
2067013|NCT00600119|3644302|FG003|Double-blind Treatment Period|Sponsor Decision|0
2067014|NCT00600119|3644303|FG004|Double-blind Treatment Period|Sponsor Decision|1
2067015|NCT00600119|3644304|FG005|Double-blind Treatment Period|Sponsor Decision|0
2067016|NCT00600119|3644299|FG000|Double-blind Treatment Period|Physician Decision|2
2067017|NCT00600119|3644300|FG001|Double-blind Treatment Period|Physician Decision|0
2067018|NCT00600119|3644301|FG002|Double-blind Treatment Period|Physician Decision|0
2067019|NCT00600119|3644302|FG003|Double-blind Treatment Period|Physician Decision|0
2067020|NCT00600119|3644303|FG004|Double-blind Treatment Period|Physician Decision|0
2067021|NCT00600119|3644304|FG005|Double-blind Treatment Period|Physician Decision|0
2067022|NCT00600119|3644299|FG000|Double-blind Treatment Period|Lost to Follow-up|0
2067023|NCT00600119|3644300|FG001|Double-blind Treatment Period|Lost to Follow-up|1
2067024|NCT00600119|3644301|FG002|Double-blind Treatment Period|Lost to Follow-up|0
2067025|NCT00600119|3644302|FG003|Double-blind Treatment Period|Lost to Follow-up|0
2067026|NCT00600119|3644303|FG004|Double-blind Treatment Period|Lost to Follow-up|0
2067027|NCT00600119|3644304|FG005|Double-blind Treatment Period|Lost to Follow-up|0
2067028|NCT00600119|3644299|FG000|Double-blind Treatment Period|Adverse Event|1
2067029|NCT00600119|3644300|FG001|Double-blind Treatment Period|Adverse Event|1
2067030|NCT00600119|3644301|FG002|Double-blind Treatment Period|Adverse Event|0
2067031|NCT00600119|3644302|FG003|Double-blind Treatment Period|Adverse Event|1
2067032|NCT00600119|3644303|FG004|Double-blind Treatment Period|Adverse Event|2
2067033|NCT00600119|3644304|FG005|Double-blind Treatment Period|Adverse Event|10
2067034|NCT00600119|3644299|FG000|Follow-up Period|Adverse Event|0
2067035|NCT00600119|3644300|FG001|Follow-up Period|Adverse Event|0
2067036|NCT00600119|3644301|FG002|Follow-up Period|Adverse Event|0
2067037|NCT00600119|3644302|FG003|Follow-up Period|Adverse Event|0
2067038|NCT00600119|3644303|FG004|Follow-up Period|Adverse Event|0
2067039|NCT00600119|3644304|FG005|Follow-up Period|Adverse Event|1
2067040|NCT00600119|3644299|FG000|Follow-up Period|Other|1
2067041|NCT00600119|3644300|FG001|Follow-up Period|Other|0
2067042|NCT00600119|3644301|FG002|Follow-up Period|Other|0
2067043|NCT00600119|3644302|FG003|Follow-up Period|Other|0
2067044|NCT00600119|3644303|FG004|Follow-up Period|Other|0
2067045|NCT00600119|3644304|FG005|Follow-up Period|Other|0
2067046|NCT00600171|3644324|FG000|Overall Study|Adverse Event|0
2067047|NCT00600171|3644325|FG001|Overall Study|Adverse Event|1
2067048|NCT00600171|3644326|FG002|Overall Study|Adverse Event|0
2067049|NCT00600171|3644327|FG003|Overall Study|Adverse Event|0
2067050|NCT00600171|3644328|FG004|Overall Study|Adverse Event|1
2067051|NCT00600171|3644329|FG005|Overall Study|Adverse Event|0
2067052|NCT00600171|3644324|FG000|Overall Study|Lack of Efficacy|9
2067053|NCT00600171|3644325|FG001|Overall Study|Lack of Efficacy|12
2067054|NCT00600171|3644326|FG002|Overall Study|Lack of Efficacy|3
2067055|NCT00600171|3644327|FG003|Overall Study|Lack of Efficacy|5
2067056|NCT00600171|3644328|FG004|Overall Study|Lack of Efficacy|4
2067057|NCT00600171|3644329|FG005|Overall Study|Lack of Efficacy|0
2067058|NCT00600171|3644324|FG000|Overall Study|Protocol Violation|1
2067059|NCT00600171|3644325|FG001|Overall Study|Protocol Violation|2
2067060|NCT00600171|3644326|FG002|Overall Study|Protocol Violation|0
2067061|NCT00600171|3644327|FG003|Overall Study|Protocol Violation|1
2067062|NCT00600171|3644328|FG004|Overall Study|Protocol Violation|0
2067063|NCT00600171|3644329|FG005|Overall Study|Protocol Violation|0
2067064|NCT00600171|3644324|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
2067065|NCT00600171|3644325|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
2067066|NCT00600171|3644326|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7
2067067|NCT00600171|3644327|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3
2067068|NCT00600171|3644328|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2
2067069|NCT00600171|3644329|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2
2067070|NCT00600171|3644324|FG000|Overall Study|Withdrawal by Subject|3
2067071|NCT00600171|3644325|FG001|Overall Study|Withdrawal by Subject|0
2067072|NCT00600171|3644326|FG002|Overall Study|Withdrawal by Subject|0
2067073|NCT00600171|3644327|FG003|Overall Study|Withdrawal by Subject|1
2067074|NCT00600171|3644328|FG004|Overall Study|Withdrawal by Subject|1
2067075|NCT00600171|3644329|FG005|Overall Study|Withdrawal by Subject|1
2067076|NCT00600171|3644324|FG000|Overall Study|Physician Decision|0
2067077|NCT00600171|3644325|FG001|Overall Study|Physician Decision|1
2302686|NCT02630459|4001571|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
2302687|NCT02630459|4001572|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
2302688|NCT02630563|4001597|FG000|Overall Study|Administrative|1
2302689|NCT02630693|4001604|FG000|Overall Study|No receive treatment|0
2302690|NCT02630693|4001605|FG001|Overall Study|No receive treatment|1
2302691|NCT02630706|4001614|FG000|Overall Study|Adverse Event|2
2302692|NCT02630706|4001615|FG001|Overall Study|Adverse Event|1
2302693|NCT02630706|4001616|FG002|Overall Study|Adverse Event|1
2302694|NCT02630706|4001614|FG000|Overall Study|Lost to Follow-up|0
2302695|NCT02630706|4001615|FG001|Overall Study|Lost to Follow-up|1
2302696|NCT02630706|4001616|FG002|Overall Study|Lost to Follow-up|2
2302697|NCT02630706|4001614|FG000|Overall Study|Physician Decision|1
2302698|NCT02630706|4001615|FG001|Overall Study|Physician Decision|1
2302699|NCT02630706|4001616|FG002|Overall Study|Physician Decision|0
2302700|NCT02630706|4001614|FG000|Overall Study|Pregnancy|0
2302701|NCT02630706|4001615|FG001|Overall Study|Pregnancy|1
2302702|NCT02630706|4001616|FG002|Overall Study|Pregnancy|0
2302703|NCT02630706|4001614|FG000|Overall Study|Withdrawal by Subject|4
2302704|NCT02630706|4001615|FG001|Overall Study|Withdrawal by Subject|5
2067078|NCT00600171|3644326|FG002|Overall Study|Physician Decision|0
2067079|NCT00600171|3644327|FG003|Overall Study|Physician Decision|1
2067080|NCT00600171|3644328|FG004|Overall Study|Physician Decision|0
2067081|NCT00600171|3644329|FG005|Overall Study|Physician Decision|2
2067082|NCT00600171|3644324|FG000|Overall Study|Lost to Follow-up|0
2067083|NCT00600171|3644325|FG001|Overall Study|Lost to Follow-up|0
2067084|NCT00600171|3644326|FG002|Overall Study|Lost to Follow-up|0
2067085|NCT00600171|3644327|FG003|Overall Study|Lost to Follow-up|1
2067086|NCT00600171|3644328|FG004|Overall Study|Lost to Follow-up|0
2067087|NCT00600171|3644329|FG005|Overall Study|Lost to Follow-up|0
2067088|NCT00600353|3644356|FG000|Overall Study|history of malignancy within 5 years|1
2067089|NCT00600353|3644357|FG001|Overall Study|history of malignancy within 5 years|0
2067090|NCT00600353|3644356|FG000|Overall Study|History of prepartive regimen|0
2067091|NCT00600353|3644357|FG001|Overall Study|History of prepartive regimen|1
2067092|NCT00600613|3644363|FG000|Overall Study|Protocol Deviation|1
2067093|NCT00600756|3644404|FG000|Analysis After 6 Months|Adverse Event|43
2067094|NCT00600756|3644405|FG001|Analysis After 6 Months|Adverse Event|33
2067095|NCT00600756|3644404|FG000|Analysis After 6 Months|Withdrawal by Subject|38
2067096|NCT00600756|3644405|FG001|Analysis After 6 Months|Withdrawal by Subject|30
2067097|NCT00600756|3644404|FG000|Analysis After 6 Months|Incorrect Enrollment|12
2067098|NCT00600756|3644405|FG001|Analysis After 6 Months|Incorrect Enrollment|21
2067099|NCT00600756|3644404|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11
2067100|NCT00600756|3644405|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14
2067101|NCT00600756|3644404|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11
2067102|NCT00600756|3644405|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11
2067103|NCT00600756|3644404|FG000|Analysis After 6 Months|Lost to Follow-up|10
2067104|NCT00600756|3644405|FG001|Analysis After 6 Months|Lost to Follow-up|8
2067105|NCT00600756|3644404|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6
2067106|NCT00600756|3644405|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3
2067107|NCT00600756|3644404|FG000|Overall Study Analysis After 12 Months|Adverse Event|53
2067108|NCT00600756|3644405|FG001|Overall Study Analysis After 12 Months|Adverse Event|44
2067109|NCT00600756|3644404|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
2067110|NCT00600756|3644405|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
2067111|NCT00600756|3644404|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21
2067112|NCT00600756|3644405|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29
2067113|NCT00600756|3644404|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
2067114|NCT00600756|3644405|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
2067115|NCT00600756|3644404|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
2067116|NCT00600756|3644405|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
2067117|NCT00600756|3644404|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16
2067118|NCT00600756|3644405|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13
2067119|NCT00600756|3644404|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
2067120|NCT00600756|3644405|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
2067121|NCT00600821|3644413|FG000|Overall Study|Death|45
2067122|NCT00600821|3644414|FG001|Overall Study|Death|46
2067123|NCT00600821|3644413|FG000|Overall Study|Lost to Follow-up|2
2067124|NCT00600821|3644414|FG001|Overall Study|Lost to Follow-up|2
2067125|NCT00600821|3644413|FG000|Overall Study|Withdrawal by Subject|1
2067126|NCT00600821|3644414|FG001|Overall Study|Withdrawal by Subject|1
2067127|NCT00600821|3644413|FG000|Overall Study|Terminated by sponsor|8
2067128|NCT00600821|3644414|FG001|Overall Study|Terminated by sponsor|6
2067129|NCT00600821|3644413|FG000|Overall Study|Objective progression or relapse|0
2067130|NCT00600821|3644414|FG001|Overall Study|Objective progression or relapse|1
2067131|NCT00600821|3644413|FG000|Overall Study|Randomized but not treated|0
2067132|NCT00600821|3644414|FG001|Overall Study|Randomized but not treated|1
2067133|NCT00600821|3644413|FG000|Overall Study|Other|2
2067134|NCT00600821|3644414|FG001|Overall Study|Other|3
2067135|NCT00600886|3644424|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
2067136|NCT00600886|3644425|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
2067137|NCT00600886|3644424|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
2067138|NCT00600886|3644425|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
2067139|NCT00600886|3644424|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
2067140|NCT00600886|3644425|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
2067141|NCT00600886|3644424|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
2067142|NCT00600886|3644425|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
2067143|NCT00600886|3644424|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
2067144|NCT00600886|3644425|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
2067145|NCT00600886|3644424|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
2067146|NCT00600886|3644425|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
2067147|NCT00600886|3644424|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
2067148|NCT00600886|3644425|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
2067149|NCT00600886|3644424|FG000|Core Phase - Full Analysis Set (FAS)|Death|0
2067150|NCT00600886|3644425|FG001|Core Phase - Full Analysis Set (FAS)|Death|1
2067151|NCT00600886|3644424|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
2067152|NCT00600886|3644425|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
2067153|NCT00600886|3644424|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3
2067154|NCT00600886|3644425|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3
2067155|NCT00600886|3644424|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9
2067156|NCT00600886|3644425|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3
2067157|NCT00600886|3644424|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3
2067158|NCT00600886|3644425|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1
2067159|NCT00600886|3644424|FG000|Extension - Same Treatment (FAS)|Adverse Event|4
2302705|NCT02630706|4001616|FG002|Overall Study|Withdrawal by Subject|7
2302706|NCT02630966|4001644|FG000|Overall Study|Adverse Event|1
2302707|NCT02630966|4001645|FG001|Overall Study|Adverse Event|3
2321637|NCT02962284|4036203|FG001|Overall Study|Withdrawal by Subject|0
2067160|NCT00600886|3644425|FG001|Extension - Same Treatment (FAS)|Adverse Event|1
2067161|NCT00600886|3644424|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
2067162|NCT00600886|3644425|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
2067163|NCT00600886|3644424|FG000|Extension - Same Treatment (FAS)|Death|1
2067164|NCT00600886|3644425|FG001|Extension - Same Treatment (FAS)|Death|1
2067165|NCT00600886|3644424|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
2067166|NCT00600886|3644425|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
2067167|NCT00600886|3644424|FG000|Extension - After Crossover (CAS)|Adverse Event|19
2067168|NCT00600886|3644425|FG001|Extension - After Crossover (CAS)|Adverse Event|1
2067169|NCT00600886|3644424|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19
2067170|NCT00600886|3644425|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4
2067171|NCT00600886|3644424|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13
2302708|NCT02630966|4001644|FG000|Overall Study|Significant Protocol Deviation|0
2302709|NCT02630966|4001645|FG001|Overall Study|Significant Protocol Deviation|2
2302710|NCT02630966|4001644|FG000|Overall Study|Voluntary Withdrawal|1
2302711|NCT02630966|4001645|FG001|Overall Study|Voluntary Withdrawal|1
2302712|NCT02630966|4001644|FG000|Overall Study|Lack of Efficacy|0
2302713|NCT02630966|4001645|FG001|Overall Study|Lack of Efficacy|2
2302714|NCT02631538|4001677|FG000|Treatment Period (Up to Week 52)|Adverse Event|1
2302715|NCT02631538|4001678|FG001|Treatment Period (Up to Week 52)|Adverse Event|5
2302716|NCT02631538|4001679|FG002|Treatment Period (Up to Week 52)|Adverse Event|2
2302717|NCT02631538|4001680|FG003|Treatment Period (Up to Week 52)|Adverse Event|2
2302718|NCT02631538|4001677|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
2302719|NCT02631538|4001678|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
2302720|NCT02631538|4001679|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2
2067172|NCT00600886|3644425|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4
2067173|NCT00600886|3644424|FG000|Extension - After Crossover (CAS)|Administrative Problems|4
2067174|NCT00600886|3644425|FG001|Extension - After Crossover (CAS)|Administrative Problems|4
2067175|NCT00600886|3644424|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
2067176|NCT00600886|3644425|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
2067177|NCT00600886|3644424|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
2067178|NCT00600886|3644425|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
2067179|NCT00600886|3644424|FG000|Extension - After Crossover (CAS)|Death|1
2067180|NCT00600886|3644425|FG001|Extension - After Crossover (CAS)|Death|0
2067181|NCT00600938|3644456|FG000|Core Study|Abnormal test procedure result(s)|3
2067182|NCT00600938|3644457|FG001|Core Study|Abnormal test procedure result(s)|2
2067183|NCT00600938|3644458|FG002|Core Study|Abnormal test procedure result(s)|0
2067184|NCT00600938|3644459|FG003|Core Study|Abnormal test procedure result(s)|0
2067185|NCT00600938|3644456|FG000|Core Study|Unsatisfactory therapeutic effect|1
2067186|NCT00600938|3644457|FG001|Core Study|Unsatisfactory therapeutic effect|2
2067187|NCT00600938|3644458|FG002|Core Study|Unsatisfactory therapeutic effect|0
2067188|NCT00600938|3644459|FG003|Core Study|Unsatisfactory therapeutic effect|0
2210227|NCT01648764|3849707|FG000|Overall Study|Death|0
2210228|NCT01648764|3849708|FG001|Overall Study|Death|0
2210229|NCT01648764|3849709|FG002|Overall Study|Death|0
2210230|NCT01648764|3849710|FG003|Overall Study|Death|0
2210231|NCT01648764|3849711|FG004|Overall Study|Death|0
2210232|NCT01648764|3849712|FG005|Overall Study|Death|0
2210233|NCT01648764|3849713|FG006|Overall Study|Death|1
2210234|NCT01648764|3849714|FG007|Overall Study|Death|0
2210235|NCT01648764|3849715|FG008|Overall Study|Death|0
2210236|NCT01648764|3849716|FG009|Overall Study|Death|0
2210237|NCT01648764|3849717|FG010|Overall Study|Death|0
2210238|NCT01648764|3849718|FG011|Overall Study|Death|0
2210239|NCT01648764|3849719|FG012|Overall Study|Death|0
2210240|NCT01648764|3849720|FG013|Overall Study|Death|1
2210241|NCT01648764|3849707|FG000|Overall Study|Withdrawal by Subject|0
2210242|NCT01648764|3849708|FG001|Overall Study|Withdrawal by Subject|0
2067189|NCT00600938|3644456|FG000|Core Study|Patient withdrew consent|7
2067190|NCT00600938|3644457|FG001|Core Study|Patient withdrew consent|12
2067191|NCT00600938|3644458|FG002|Core Study|Patient withdrew consent|0
2067192|NCT00600938|3644459|FG003|Core Study|Patient withdrew consent|0
2067193|NCT00600938|3644456|FG000|Core Study|Lost to Follow-up|3
2067194|NCT00600938|3644457|FG001|Core Study|Lost to Follow-up|2
2067195|NCT00600938|3644458|FG002|Core Study|Lost to Follow-up|0
2067196|NCT00600938|3644459|FG003|Core Study|Lost to Follow-up|0
2067197|NCT00600938|3644456|FG000|Core Study|Death|1
2067198|NCT00600938|3644457|FG001|Core Study|Death|1
2067199|NCT00600938|3644458|FG002|Core Study|Death|0
2067200|NCT00600938|3644459|FG003|Core Study|Death|0
2067201|NCT00600938|3644456|FG000|Core Study|Protocol Violation|1
2067202|NCT00600938|3644457|FG001|Core Study|Protocol Violation|2
2067203|NCT00600938|3644458|FG002|Core Study|Protocol Violation|0
2067204|NCT00600938|3644459|FG003|Core Study|Protocol Violation|0
2067205|NCT00600938|3644456|FG000|Extension Study|Adverse Event|1
2067206|NCT00600938|3644457|FG001|Extension Study|Adverse Event|0
2067207|NCT00600938|3644458|FG002|Extension Study|Adverse Event|2
2067208|NCT00600938|3644459|FG003|Extension Study|Adverse Event|0
2067209|NCT00600938|3644456|FG000|Extension Study|Abnormal test procedure results|0
2067210|NCT00600938|3644457|FG001|Extension Study|Abnormal test procedure results|1
2210243|NCT01648764|3849709|FG002|Overall Study|Withdrawal by Subject|0
2210244|NCT01648764|3849710|FG003|Overall Study|Withdrawal by Subject|0
2067211|NCT00600938|3644458|FG002|Extension Study|Abnormal test procedure results|1
2067212|NCT00600938|3644459|FG003|Extension Study|Abnormal test procedure results|1
2067213|NCT00600938|3644456|FG000|Extension Study|Unsatisfactory therapeutic effect|4
2067214|NCT00600938|3644457|FG001|Extension Study|Unsatisfactory therapeutic effect|1
2067215|NCT00600938|3644458|FG002|Extension Study|Unsatisfactory therapeutic effect|1
2067216|NCT00600938|3644459|FG003|Extension Study|Unsatisfactory therapeutic effect|0
2067217|NCT00600938|3644456|FG000|Extension Study|Withdrawal by Subject|2
2067218|NCT00600938|3644457|FG001|Extension Study|Withdrawal by Subject|2
2067219|NCT00600938|3644458|FG002|Extension Study|Withdrawal by Subject|3
2067220|NCT00600938|3644459|FG003|Extension Study|Withdrawal by Subject|0
2067221|NCT00600938|3644456|FG000|Extension Study|Lost to Follow-up|1
2067222|NCT00600938|3644457|FG001|Extension Study|Lost to Follow-up|1
2067223|NCT00600938|3644458|FG002|Extension Study|Lost to Follow-up|2
2067224|NCT00600938|3644459|FG003|Extension Study|Lost to Follow-up|0
2067225|NCT00600938|3644456|FG000|Extension Study|Death|1
2067226|NCT00600938|3644457|FG001|Extension Study|Death|0
2302721|NCT02631538|4001680|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5
2302722|NCT02631538|4001677|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1
2302723|NCT02631538|4001678|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1
2302724|NCT02631538|4001679|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0
2302725|NCT02631538|4001680|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0
2302726|NCT02631538|4001677|FG000|Treatment Period (Up to Week 52)|Physician Decision|1
2302727|NCT02631538|4001678|FG001|Treatment Period (Up to Week 52)|Physician Decision|0
2302728|NCT02631538|4001679|FG002|Treatment Period (Up to Week 52)|Physician Decision|0
2302729|NCT02631538|4001680|FG003|Treatment Period (Up to Week 52)|Physician Decision|1
2302730|NCT02631538|4001677|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0
2302731|NCT02631538|4001678|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0
2302732|NCT02631538|4001679|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1
2302733|NCT02631538|4001680|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0
2302734|NCT02631538|4001677|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
2302735|NCT02631538|4001678|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
2302736|NCT02631538|4001679|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
2302737|NCT02631538|4001680|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
2302738|NCT02631551|4001694|FG000|Overall Study|Adverse Event|1
2302739|NCT02631551|4001695|FG001|Overall Study|Adverse Event|2
2302740|NCT02631551|4001696|FG002|Overall Study|Adverse Event|4
2302741|NCT02631551|4001697|FG003|Overall Study|Adverse Event|0
2302742|NCT02631551|4001694|FG000|Overall Study|Lack of Efficacy|0
2302743|NCT02631551|4001695|FG001|Overall Study|Lack of Efficacy|0
2302744|NCT02631551|4001696|FG002|Overall Study|Lack of Efficacy|1
2302745|NCT02631551|4001697|FG003|Overall Study|Lack of Efficacy|0
2302746|NCT02631551|4001694|FG000|Overall Study|Lost to Follow-up|1
2302747|NCT02631551|4001695|FG001|Overall Study|Lost to Follow-up|2
2302748|NCT02631551|4001696|FG002|Overall Study|Lost to Follow-up|0
2302749|NCT02631551|4001697|FG003|Overall Study|Lost to Follow-up|3
2302750|NCT02631551|4001694|FG000|Overall Study|Withdrawal by Subject|2
2302751|NCT02631551|4001695|FG001|Overall Study|Withdrawal by Subject|2
2302752|NCT02631551|4001696|FG002|Overall Study|Withdrawal by Subject|0
2302753|NCT02631551|4001697|FG003|Overall Study|Withdrawal by Subject|5
2302754|NCT02631551|4001694|FG000|Overall Study|Protocol deviation|3
2302755|NCT02631551|4001695|FG001|Overall Study|Protocol deviation|6
2302756|NCT02631551|4001696|FG002|Overall Study|Protocol deviation|3
2302757|NCT02631551|4001697|FG003|Overall Study|Protocol deviation|0
2302758|NCT02631551|4001694|FG000|Overall Study|Non-compliance with study procedures|0
2302759|NCT02631551|4001695|FG001|Overall Study|Non-compliance with study procedures|0
2302760|NCT02631551|4001696|FG002|Overall Study|Non-compliance with study procedures|1
2302761|NCT02631551|4001697|FG003|Overall Study|Non-compliance with study procedures|1
2302762|NCT02631551|4001694|FG000|Overall Study|Non-compliance with study drug|1
2302763|NCT02631551|4001695|FG001|Overall Study|Non-compliance with study drug|0
2302764|NCT02631551|4001696|FG002|Overall Study|Non-compliance with study drug|0
2302765|NCT02631551|4001697|FG003|Overall Study|Non-compliance with study drug|0
2302766|NCT02631551|4001694|FG000|Overall Study|Other, specific reasons not collected|5
2302767|NCT02631551|4001695|FG001|Overall Study|Other, specific reasons not collected|7
2302768|NCT02631551|4001696|FG002|Overall Study|Other, specific reasons not collected|2
2302769|NCT02631551|4001697|FG003|Overall Study|Other, specific reasons not collected|2
2302770|NCT02631577|4001709|FG000|Overall Study|Death|1
2302771|NCT02631577|4001710|FG001|Overall Study|Death|7
2302772|NCT02631577|4001709|FG000|Overall Study|Withdrawal by Subject|0
2302773|NCT02631577|4001710|FG001|Overall Study|Withdrawal by Subject|3
2302774|NCT02631746|4001720|FG000|Overall Study|Lack of Efficacy|3
2302775|NCT02631850|4001737|FG000|Treatment Period|Lost to Follow-up|0
2302776|NCT02631850|4001738|FG001|Treatment Period|Lost to Follow-up|1
2302777|NCT02631850|4001739|FG002|Treatment Period|Lost to Follow-up|0
2302778|NCT02631850|4001740|FG003|Treatment Period|Lost to Follow-up|0
2302779|NCT02631850|4001737|FG000|Treatment Period|Protocol Violation|1
2302780|NCT02631850|4001738|FG001|Treatment Period|Protocol Violation|0
2302781|NCT02631850|4001739|FG002|Treatment Period|Protocol Violation|0
2302782|NCT02631850|4001740|FG003|Treatment Period|Protocol Violation|0
2302783|NCT02631850|4001737|FG000|Treatment Period|Withdrawal by Subject|0
2067227|NCT00600938|3644458|FG002|Extension Study|Death|0
2067228|NCT00600938|3644459|FG003|Extension Study|Death|0
2067229|NCT00601107|3644488|FG000|Overall Study|Adverse Event|0
2067230|NCT00601107|3644489|FG001|Overall Study|Adverse Event|1
2067231|NCT00601107|3644490|FG002|Overall Study|Adverse Event|3
2067232|NCT00601107|3644491|FG003|Overall Study|Adverse Event|0
2067233|NCT00601107|3644488|FG000|Overall Study|Withdrawal by Subject|5
2067234|NCT00601107|3644489|FG001|Overall Study|Withdrawal by Subject|4
2067235|NCT00601107|3644490|FG002|Overall Study|Withdrawal by Subject|7
2067236|NCT00601107|3644491|FG003|Overall Study|Withdrawal by Subject|4
2067237|NCT00601107|3644488|FG000|Overall Study|Lost to Follow-up|3
2067238|NCT00601107|3644489|FG001|Overall Study|Lost to Follow-up|3
2067239|NCT00601107|3644490|FG002|Overall Study|Lost to Follow-up|0
2067240|NCT00601107|3644491|FG003|Overall Study|Lost to Follow-up|3
2067241|NCT00601107|3644488|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
2067242|NCT00601107|3644489|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
2067243|NCT00601107|3644490|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
2067244|NCT00601107|3644491|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
2067245|NCT00601107|3644488|FG000|Overall Study|Worsening of Psoriasis|4
2067246|NCT00601107|3644489|FG001|Overall Study|Worsening of Psoriasis|1
2067247|NCT00601107|3644490|FG002|Overall Study|Worsening of Psoriasis|1
2067248|NCT00601107|3644491|FG003|Overall Study|Worsening of Psoriasis|4
2067249|NCT00601107|3644488|FG000|Overall Study|Undefined|1
2067250|NCT00601107|3644489|FG001|Overall Study|Undefined|0
2067251|NCT00601107|3644490|FG002|Overall Study|Undefined|1
2067252|NCT00601107|3644491|FG003|Overall Study|Undefined|0
2067253|NCT00601172|3644507|FG000|Overall Study|Adverse Event|43
2067254|NCT00601172|3644508|FG001|Overall Study|Adverse Event|32
2067255|NCT00601172|3644507|FG000|Overall Study|Lack of Efficacy|11
2067256|NCT00601172|3644508|FG001|Overall Study|Lack of Efficacy|12
2067257|NCT00601172|3644507|FG000|Overall Study|Protocol Violation|2
2067258|NCT00601172|3644508|FG001|Overall Study|Protocol Violation|5
2067259|NCT00601172|3644507|FG000|Overall Study|Lost to Follow-up|4
2067260|NCT00601172|3644508|FG001|Overall Study|Lost to Follow-up|3
2067261|NCT00601172|3644507|FG000|Overall Study|Physician Decision|27
2067262|NCT00601172|3644508|FG001|Overall Study|Physician Decision|28
2067263|NCT00601172|3644507|FG000|Overall Study|Withdrawal by Subject|35
2067264|NCT00601172|3644508|FG001|Overall Study|Withdrawal by Subject|27
2067265|NCT00601172|3644507|FG000|Overall Study|Did not meet continuation criteria|19
2067266|NCT00601172|3644508|FG001|Overall Study|Did not meet continuation criteria|20
2067267|NCT00601250|3644517|FG000|Overall Study|Adverse Event|3
2067268|NCT00601250|3644518|FG001|Overall Study|Adverse Event|9
2067269|NCT00601250|3644517|FG000|Overall Study|Protocol Violation|3
2067270|NCT00601250|3644518|FG001|Overall Study|Protocol Violation|2
2067271|NCT00601250|3644517|FG000|Overall Study|Lost to Follow-up|2
2067272|NCT00601250|3644518|FG001|Overall Study|Lost to Follow-up|6
2067273|NCT00601250|3644517|FG000|Overall Study|Withdrawal by Subject|4
2067274|NCT00601250|3644518|FG001|Overall Study|Withdrawal by Subject|13
2067275|NCT00601250|3644517|FG000|Overall Study|Other incl. lack of efficacy|2
2067276|NCT00601250|3644518|FG001|Overall Study|Other incl. lack of efficacy|9
2067277|NCT00601354|3644526|FG000|Overall Study|Lost to Follow-up|4
2067278|NCT00601354|3644527|FG001|Overall Study|Lost to Follow-up|5
2067279|NCT00601419|3644537|FG000|Overall Study|Lost to Follow-up|3
2067280|NCT00601419|3644537|FG000|Overall Study|Missed Visits|1
2067281|NCT00601458|3644560|FG000|Overall Study|Dosing Error|1
2067282|NCT00601458|3644561|FG001|Overall Study|Dosing Error|0
2067283|NCT00601458|3644562|FG002|Overall Study|Dosing Error|0
2067284|NCT00601458|3644560|FG000|Overall Study|Incomplete Data|0
2067285|NCT00601458|3644561|FG001|Overall Study|Incomplete Data|2
2067286|NCT00601458|3644562|FG002|Overall Study|Incomplete Data|0
2067287|NCT00601458|3644560|FG000|Overall Study|Protocol Violation|3
2067288|NCT00601458|3644561|FG001|Overall Study|Protocol Violation|2
2067289|NCT00601458|3644562|FG002|Overall Study|Protocol Violation|1
2067290|NCT00601458|3644560|FG000|Overall Study|Early Termination|0
2067291|NCT00601458|3644561|FG001|Overall Study|Early Termination|1
2067292|NCT00601458|3644562|FG002|Overall Study|Early Termination|1
2067293|NCT00601484|3644572|FG000|Overall Study|Adverse Event|0
2067294|NCT00601484|3644573|FG001|Overall Study|Adverse Event|1
2067295|NCT00601484|3644572|FG000|Overall Study|Lost to Follow-up|4
2067296|NCT00601484|3644573|FG001|Overall Study|Lost to Follow-up|3
2067297|NCT00601484|3644572|FG000|Overall Study|Lack of Efficacy|0
2067298|NCT00601484|3644573|FG001|Overall Study|Lack of Efficacy|2
2067299|NCT00601484|3644572|FG000|Overall Study|Withdrawal by Subject|1
2067300|NCT00601484|3644573|FG001|Overall Study|Withdrawal by Subject|1
2067301|NCT00601484|3644572|FG000|Overall Study|Randomized, but not treated|0
2067302|NCT00601484|3644573|FG001|Overall Study|Randomized, but not treated|1
2067303|NCT00601523|3644581|FG000|Overall Study|Adverse Event|42
2067304|NCT00601523|3644582|FG001|Overall Study|Adverse Event|14
2067305|NCT00601523|3644581|FG000|Overall Study|Lack of Efficacy|3
2067306|NCT00601523|3644582|FG001|Overall Study|Lack of Efficacy|0
2067307|NCT00601523|3644581|FG000|Overall Study|Protocol Violation|5
2067308|NCT00601523|3644582|FG001|Overall Study|Protocol Violation|1
2067309|NCT00601523|3644581|FG000|Overall Study|Lost to Follow-up|0
2067310|NCT00601523|3644582|FG001|Overall Study|Lost to Follow-up|1
2067311|NCT00601523|3644581|FG000|Overall Study|Withdrawal by Subject|18
2067312|NCT00601523|3644582|FG001|Overall Study|Withdrawal by Subject|9
2067313|NCT00601523|3644581|FG000|Overall Study|Other|9
2067314|NCT00601523|3644582|FG001|Overall Study|Other|1
2067315|NCT00601640|3644595|FG000|Overall Study|Withdrawal by Subject|3
2067316|NCT00601640|3644596|FG001|Overall Study|Withdrawal by Subject|0
2067317|NCT00601640|3644597|FG002|Overall Study|Withdrawal by Subject|7
2067318|NCT00601640|3644595|FG000|Overall Study|Death|1
2067319|NCT00601640|3644596|FG001|Overall Study|Death|0
2067320|NCT00601640|3644597|FG002|Overall Study|Death|0
2067321|NCT00601640|3644595|FG000|Overall Study|Adverse Event|0
2067322|NCT00601640|3644596|FG001|Overall Study|Adverse Event|4
2067323|NCT00601640|3644597|FG002|Overall Study|Adverse Event|2
2067324|NCT00601640|3644595|FG000|Overall Study|intercurrent illness|1
2067325|NCT00601640|3644596|FG001|Overall Study|intercurrent illness|0
2067326|NCT00601640|3644597|FG002|Overall Study|intercurrent illness|0
2067327|NCT00601640|3644595|FG000|Overall Study|change in eligibility status|0
2067328|NCT00601640|3644596|FG001|Overall Study|change in eligibility status|1
2067329|NCT00601640|3644597|FG002|Overall Study|change in eligibility status|1
2067330|NCT00601705|3644607|FG000|Overall Study|Withdrawal by Subject|1
2067331|NCT00601835|3644663|FG000|Overall Study|Withdrawal by Subject|9
2067332|NCT00601835|3644664|FG001|Overall Study|Withdrawal by Subject|6
2067333|NCT00601835|3644663|FG000|Overall Study|Physician Decision|1
2067334|NCT00601835|3644664|FG001|Overall Study|Physician Decision|0
2067335|NCT00601835|3644663|FG000|Overall Study|Lost to Follow-up|37
2067336|NCT00601835|3644664|FG001|Overall Study|Lost to Follow-up|5
2067337|NCT00601835|3644663|FG000|Overall Study|Adverse Event|1
2067338|NCT00601835|3644664|FG001|Overall Study|Adverse Event|1
2067339|NCT00601835|3644663|FG000|Overall Study|Relocate|12
2067340|NCT00601835|3644664|FG001|Overall Study|Relocate|2
2067341|NCT00602420|3644740|FG000|Overall Study|Death|1
2067342|NCT00602420|3644741|FG001|Overall Study|Death|4
2067343|NCT00602420|3644740|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
2067344|NCT00602420|3644741|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
2067345|NCT00602420|3644740|FG000|Overall Study|Withdrawal by Subject|18
2067346|NCT00602420|3644741|FG001|Overall Study|Withdrawal by Subject|17
2067347|NCT00602420|3644740|FG000|Overall Study|Adverse Event|1
2067348|NCT00602420|3644741|FG001|Overall Study|Adverse Event|0
2067349|NCT00602472|3644776|FG000|Overall Study|Adverse Event|5
2067350|NCT00602472|3644777|FG001|Overall Study|Adverse Event|23
2067351|NCT00602472|3644776|FG000|Overall Study|Protocol Violation|4
2067352|NCT00602472|3644777|FG001|Overall Study|Protocol Violation|19
2067353|NCT00602472|3644776|FG000|Overall Study|Withdrawal by Subject|8
2067354|NCT00602472|3644777|FG001|Overall Study|Withdrawal by Subject|14
2067355|NCT00602472|3644776|FG000|Overall Study|Other incl. lack of efficacy|4
2067356|NCT00602472|3644777|FG001|Overall Study|Other incl. lack of efficacy|2
2067357|NCT00602537|3644785|FG000|12 Week Double Blind Comparison|Adverse Event|2
2067358|NCT00602537|3644786|FG001|12 Week Double Blind Comparison|Adverse Event|5
2067359|NCT00602537|3644785|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13
2067360|NCT00602537|3644786|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23
2067361|NCT00602537|3644785|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5
2067362|NCT00602537|3644786|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6
2067363|NCT00602537|3644785|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3
2067364|NCT00602537|3644786|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13
2067365|NCT00602537|3644785|FG000|Follow Up Study Comparison|Adverse Event|1
2067366|NCT00602537|3644786|FG001|Follow Up Study Comparison|Adverse Event|0
2067367|NCT00602537|3644785|FG000|Follow Up Study Comparison|Lost to Follow-up|8
2067368|NCT00602537|3644786|FG001|Follow Up Study Comparison|Lost to Follow-up|1
2067369|NCT00602537|3644785|FG000|Follow Up Study Comparison|Withdrawal by Subject|2
2067370|NCT00602537|3644786|FG001|Follow Up Study Comparison|Withdrawal by Subject|2
2067371|NCT00602797|3644801|FG000|Overall Study|Adverse Event|1
2067372|NCT00602927|3644812|FG000|Period 1: 13 Days|Protocol Violation|2
2067373|NCT00602927|3644813|FG001|Period 1: 13 Days|Protocol Violation|4
2067374|NCT00602927|3644812|FG000|Period 1: 13 Days|MRI scanner technical issue|1
2067375|NCT00602927|3644813|FG001|Period 1: 13 Days|MRI scanner technical issue|0
2067376|NCT00602927|3644812|FG000|Period 1: 13 Days|Time|1
2067377|NCT00602927|3644813|FG001|Period 1: 13 Days|Time|0
2067378|NCT00602927|3644812|FG000|Period 1: 13 Days|Claustrophobia|0
2067379|NCT00602927|3644813|FG001|Period 1: 13 Days|Claustrophobia|1
2067380|NCT00602927|3644812|FG000|Period 2: 14 Days|Protocol Violation|0
2067381|NCT00602927|3644813|FG001|Period 2: 14 Days|Protocol Violation|2
2067382|NCT00602927|3644812|FG000|Period 3: 13 Days|Protocol Violation|0
2067383|NCT00602927|3644813|FG001|Period 3: 13 Days|Protocol Violation|1
2177145|NCT01371734|3801202|FG002|Overall Study|Lack of Efficacy|0
2177146|NCT01371747|3801216|FG000|Overall Study|Adverse Event|4
2177147|NCT01371747|3801217|FG001|Overall Study|Adverse Event|2
2177148|NCT01371747|3801218|FG002|Overall Study|Adverse Event|7
2177149|NCT01371747|3801219|FG003|Overall Study|Adverse Event|2
2177150|NCT01371747|3801220|FG004|Overall Study|Adverse Event|2
2177151|NCT01371747|3801221|FG005|Overall Study|Adverse Event|2
2177152|NCT01371747|3801216|FG000|Overall Study|Death|1
2177153|NCT01371747|3801217|FG001|Overall Study|Death|0
2177154|NCT01371747|3801218|FG002|Overall Study|Death|4
2177155|NCT01371747|3801219|FG003|Overall Study|Death|1
2177156|NCT01371747|3801220|FG004|Overall Study|Death|2
2177157|NCT01371747|3801221|FG005|Overall Study|Death|0
2067384|NCT00602927|3644812|FG000|Period 3: 13 Days|MRI data quality|2
2067385|NCT00602927|3644813|FG001|Period 3: 13 Days|MRI data quality|2
2067386|NCT00602979|3644845|FG000|Overall Study|Lost to Follow-up|3
2067387|NCT00602979|3644846|FG001|Overall Study|Lost to Follow-up|2
2067388|NCT00602979|3644847|FG002|Overall Study|Lost to Follow-up|3
2067389|NCT00602979|3644848|FG003|Overall Study|Lost to Follow-up|2
2067390|NCT00602979|3644849|FG004|Overall Study|Lost to Follow-up|3
2067391|NCT00602979|3644845|FG000|Overall Study|Failed Intubation|0
2067392|NCT00602979|3644846|FG001|Overall Study|Failed Intubation|1
2067393|NCT00602979|3644847|FG002|Overall Study|Failed Intubation|0
2067394|NCT00602979|3644848|FG003|Overall Study|Failed Intubation|1
2067395|NCT00602979|3644849|FG004|Overall Study|Failed Intubation|0
2067396|NCT00603239|3644881|FG000|Overall Study|Adverse Event|4
2067397|NCT00603239|3644882|FG001|Overall Study|Adverse Event|1
2067398|NCT00603239|3644881|FG000|Overall Study|Entry criteria not met|0
2067399|NCT00603239|3644882|FG001|Overall Study|Entry criteria not met|1
2067400|NCT00603239|3644881|FG000|Overall Study|Loss of glucose control|3
2067401|NCT00603239|3644882|FG001|Overall Study|Loss of glucose control|0
2067402|NCT00603239|3644881|FG000|Overall Study|Lost to Follow-up|2
2067403|NCT00603239|3644882|FG001|Overall Study|Lost to Follow-up|1
2067404|NCT00603239|3644881|FG000|Overall Study|Physician Decision|2
2067405|NCT00603239|3644882|FG001|Overall Study|Physician Decision|0
2067406|NCT00603239|3644881|FG000|Overall Study|Protocol Violation|2
2067407|NCT00603239|3644882|FG001|Overall Study|Protocol Violation|0
2067408|NCT00603239|3644881|FG000|Overall Study|Subject decision|2
2067409|NCT00603239|3644882|FG001|Overall Study|Subject decision|1
2067410|NCT00603265|3644891|FG000|Overall Study|Adverse Event|2
2067411|NCT00603265|3644892|FG001|Overall Study|Adverse Event|11
2067412|NCT00603265|3644893|FG002|Overall Study|Adverse Event|1
2067413|NCT00603265|3644891|FG000|Overall Study|Withdrawal by Subject|1
2067414|NCT00603265|3644892|FG001|Overall Study|Withdrawal by Subject|2
2067415|NCT00603265|3644893|FG002|Overall Study|Withdrawal by Subject|1
2067416|NCT00603265|3644891|FG000|Overall Study|Lack of Efficacy|3
2067417|NCT00603265|3644892|FG001|Overall Study|Lack of Efficacy|0
2067418|NCT00603265|3644893|FG002|Overall Study|Lack of Efficacy|3
2067419|NCT00603265|3644891|FG000|Overall Study|Lost to Follow-up|0
2067420|NCT00603265|3644892|FG001|Overall Study|Lost to Follow-up|1
2067421|NCT00603265|3644893|FG002|Overall Study|Lost to Follow-up|0
2067422|NCT00603265|3644891|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0
2067423|NCT00603265|3644892|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1
2067424|NCT00603265|3644893|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0
2067425|NCT00603265|3644891|FG000|Overall Study|Participant Left Country, No Responses|0
2067426|NCT00603265|3644892|FG001|Overall Study|Participant Left Country, No Responses|1
2067427|NCT00603265|3644893|FG002|Overall Study|Participant Left Country, No Responses|0
2067428|NCT00603265|3644891|FG000|Overall Study|Protocol Violation|1
2067429|NCT00603265|3644892|FG001|Overall Study|Protocol Violation|0
2067430|NCT00603265|3644893|FG002|Overall Study|Protocol Violation|0
2067431|NCT00603278|3644907|FG000|Overall Study|Lack of Efficacy|35
2067432|NCT00603278|3644908|FG001|Overall Study|Lack of Efficacy|10
2067433|NCT00603278|3644909|FG002|Overall Study|Lack of Efficacy|11
2067434|NCT00603278|3644910|FG003|Overall Study|Lack of Efficacy|8
2067435|NCT00603278|3644911|FG004|Overall Study|Lack of Efficacy|7
2067436|NCT00603278|3644912|FG005|Overall Study|Lack of Efficacy|14
2067437|NCT00603278|3644907|FG000|Overall Study|Adverse Event|0
2067438|NCT00603278|3644908|FG001|Overall Study|Adverse Event|3
2067439|NCT00603278|3644909|FG002|Overall Study|Adverse Event|1
2067440|NCT00603278|3644910|FG003|Overall Study|Adverse Event|0
2067441|NCT00603278|3644911|FG004|Overall Study|Adverse Event|2
2067442|NCT00603278|3644912|FG005|Overall Study|Adverse Event|1
2067443|NCT00603278|3644907|FG000|Overall Study|Withdrawal by Subject|2
2067444|NCT00603278|3644908|FG001|Overall Study|Withdrawal by Subject|3
2067445|NCT00603278|3644909|FG002|Overall Study|Withdrawal by Subject|1
2067446|NCT00603278|3644910|FG003|Overall Study|Withdrawal by Subject|2
2067447|NCT00603278|3644911|FG004|Overall Study|Withdrawal by Subject|1
2067448|NCT00603278|3644912|FG005|Overall Study|Withdrawal by Subject|2
2067449|NCT00603278|3644907|FG000|Overall Study|Protocol Violation|3
2067450|NCT00603278|3644908|FG001|Overall Study|Protocol Violation|0
2067451|NCT00603278|3644909|FG002|Overall Study|Protocol Violation|1
2067452|NCT00603278|3644910|FG003|Overall Study|Protocol Violation|1
2067453|NCT00603278|3644911|FG004|Overall Study|Protocol Violation|0
2067454|NCT00603278|3644912|FG005|Overall Study|Protocol Violation|1
2067455|NCT00603278|3644907|FG000|Overall Study|Physician Decision|0
2067456|NCT00603278|3644908|FG001|Overall Study|Physician Decision|1
2067457|NCT00603278|3644909|FG002|Overall Study|Physician Decision|0
2067458|NCT00603278|3644910|FG003|Overall Study|Physician Decision|0
2067459|NCT00603278|3644911|FG004|Overall Study|Physician Decision|2
2067460|NCT00603278|3644912|FG005|Overall Study|Physician Decision|1
2067461|NCT00603278|3644907|FG000|Overall Study|Lost to Follow-up|1
2067462|NCT00603278|3644908|FG001|Overall Study|Lost to Follow-up|0
2067463|NCT00603278|3644909|FG002|Overall Study|Lost to Follow-up|0
2067464|NCT00603278|3644910|FG003|Overall Study|Lost to Follow-up|0
2067465|NCT00603278|3644911|FG004|Overall Study|Lost to Follow-up|1
2067466|NCT00603278|3644912|FG005|Overall Study|Lost to Follow-up|0
2067467|NCT00603304|3644941|FG000|Overall Study|Lost to Follow-up|5
2067468|NCT00603304|3644942|FG001|Overall Study|Lost to Follow-up|7
2067469|NCT00603304|3644941|FG000|Overall Study|Withdrawal by Subject|8
2067470|NCT00603304|3644942|FG001|Overall Study|Withdrawal by Subject|5
2067471|NCT00603304|3644941|FG000|Overall Study|Protocol Violation|1
2067472|NCT00603304|3644942|FG001|Overall Study|Protocol Violation|0
2067473|NCT00603304|3644941|FG000|Overall Study|Adverse Event|4
2067474|NCT00603304|3644942|FG001|Overall Study|Adverse Event|2
2067475|NCT00603304|3644941|FG000|Overall Study|Unacceptable Treatment Toxicity|5
2067476|NCT00603304|3644942|FG001|Overall Study|Unacceptable Treatment Toxicity|8
2067477|NCT00603304|3644941|FG000|Overall Study|Crossed Over to Open Label Therapy|3
2067478|NCT00603304|3644942|FG001|Overall Study|Crossed Over to Open Label Therapy|3
2067479|NCT00603304|3644941|FG000|Overall Study|Exclusionary Medication|2
2067480|NCT00603304|3644942|FG001|Overall Study|Exclusionary Medication|3
2067481|NCT00603304|3644941|FG000|Overall Study|Non-Compliant|0
2067482|NCT00603304|3644942|FG001|Overall Study|Non-Compliant|1
2067483|NCT00603304|3644941|FG000|Overall Study|Moved Away|0
2067484|NCT00603304|3644942|FG001|Overall Study|Moved Away|2
2067485|NCT00603304|3644941|FG000|Overall Study|Other|2
2067486|NCT00603304|3644942|FG001|Overall Study|Other|0
2067487|NCT00603304|3644941|FG000|Overall Study|Patient Decision|2
2067488|NCT00603304|3644942|FG001|Overall Study|Patient Decision|0
2067489|NCT00603382|3644956|FG000|Overall Study|Adverse Event|0
2067490|NCT00603382|3644957|FG001|Overall Study|Adverse Event|1
2067491|NCT00603382|3644958|FG002|Overall Study|Adverse Event|1
2067492|NCT00603382|3644959|FG003|Overall Study|Adverse Event|2
2067493|NCT00603382|3644960|FG004|Overall Study|Adverse Event|1
2067494|NCT00603382|3644961|FG005|Overall Study|Adverse Event|2
2067495|NCT00603382|3644956|FG000|Overall Study|Lack of Efficacy|14
2067496|NCT00603382|3644957|FG001|Overall Study|Lack of Efficacy|9
2067497|NCT00603382|3644958|FG002|Overall Study|Lack of Efficacy|3
2067498|NCT00603382|3644959|FG003|Overall Study|Lack of Efficacy|6
2067499|NCT00603382|3644960|FG004|Overall Study|Lack of Efficacy|6
2067500|NCT00603382|3644961|FG005|Overall Study|Lack of Efficacy|11
2067501|NCT00603382|3644956|FG000|Overall Study|Protocol Violation|1
2067502|NCT00603382|3644957|FG001|Overall Study|Protocol Violation|0
2067503|NCT00603382|3644958|FG002|Overall Study|Protocol Violation|1
2067504|NCT00603382|3644959|FG003|Overall Study|Protocol Violation|2
2067505|NCT00603382|3644960|FG004|Overall Study|Protocol Violation|1
2067506|NCT00603382|3644961|FG005|Overall Study|Protocol Violation|0
2067507|NCT00603382|3644956|FG000|Overall Study|Lost to Follow-up|0
2067508|NCT00603382|3644957|FG001|Overall Study|Lost to Follow-up|1
2067509|NCT00603382|3644958|FG002|Overall Study|Lost to Follow-up|1
2067510|NCT00603382|3644959|FG003|Overall Study|Lost to Follow-up|1
2067511|NCT00603382|3644960|FG004|Overall Study|Lost to Follow-up|0
2067512|NCT00603382|3644961|FG005|Overall Study|Lost to Follow-up|1
2067513|NCT00603382|3644956|FG000|Overall Study|Physician Decision|0
2067514|NCT00603382|3644957|FG001|Overall Study|Physician Decision|0
2067515|NCT00603382|3644958|FG002|Overall Study|Physician Decision|2
2067516|NCT00603382|3644959|FG003|Overall Study|Physician Decision|0
2067517|NCT00603382|3644960|FG004|Overall Study|Physician Decision|1
2067518|NCT00603382|3644961|FG005|Overall Study|Physician Decision|3
2067519|NCT00603382|3644956|FG000|Overall Study|Withdrawal by Subject|3
2067520|NCT00603382|3644957|FG001|Overall Study|Withdrawal by Subject|3
2067521|NCT00603382|3644958|FG002|Overall Study|Withdrawal by Subject|1
2067522|NCT00603382|3644959|FG003|Overall Study|Withdrawal by Subject|1
2067523|NCT00603382|3644960|FG004|Overall Study|Withdrawal by Subject|0
2067524|NCT00603382|3644961|FG005|Overall Study|Withdrawal by Subject|1
2067525|NCT00603447|3644987|FG000|Overall Study|Adverse Event|0
2067526|NCT00603447|3644988|FG001|Overall Study|Adverse Event|1
2067527|NCT00603447|3644989|FG002|Overall Study|Adverse Event|1
2067528|NCT00603447|3644990|FG003|Overall Study|Adverse Event|2
2067529|NCT00603447|3644991|FG004|Overall Study|Adverse Event|1
2067530|NCT00603447|3644992|FG005|Overall Study|Adverse Event|2
2067531|NCT00603447|3644993|FG006|Overall Study|Adverse Event|10
2067532|NCT00603447|3644987|FG000|Overall Study|Other|0
2067533|NCT00603447|3644988|FG001|Overall Study|Other|0
2067534|NCT00603447|3644989|FG002|Overall Study|Other|1
2067535|NCT00603447|3644990|FG003|Overall Study|Other|0
2067536|NCT00603447|3644991|FG004|Overall Study|Other|3
2067537|NCT00603447|3644992|FG005|Overall Study|Other|0
2067538|NCT00603447|3644993|FG006|Overall Study|Other|13
2067539|NCT00603447|3644987|FG000|Overall Study|Withdrew Consent|0
2067540|NCT00603447|3644988|FG001|Overall Study|Withdrew Consent|2
2067541|NCT00603447|3644989|FG002|Overall Study|Withdrew Consent|0
2067542|NCT00603447|3644990|FG003|Overall Study|Withdrew Consent|0
2067543|NCT00603447|3644991|FG004|Overall Study|Withdrew Consent|1
2067544|NCT00603447|3644992|FG005|Overall Study|Withdrew Consent|0
2067545|NCT00603447|3644993|FG006|Overall Study|Withdrew Consent|1
2067546|NCT00603473|3645009|FG000|Overall Study|Adverse Event|4
2067547|NCT00603473|3645009|FG000|Overall Study|Lack of Efficacy|4
2067548|NCT00603473|3645009|FG000|Overall Study|Protocol Violation|1
2067549|NCT00603512|3645018|FG000|Overall Study|Adverse Event|0
2067550|NCT00603512|3645019|FG001|Overall Study|Adverse Event|2
2067551|NCT00603512|3645020|FG002|Overall Study|Adverse Event|4
2067552|NCT00603512|3645021|FG003|Overall Study|Adverse Event|4
2067553|NCT00603512|3645022|FG004|Overall Study|Adverse Event|2
2067554|NCT00603512|3645018|FG000|Overall Study|Lack of Efficacy|0
2067555|NCT00603512|3645019|FG001|Overall Study|Lack of Efficacy|1
2067556|NCT00603512|3645020|FG002|Overall Study|Lack of Efficacy|0
2067557|NCT00603512|3645021|FG003|Overall Study|Lack of Efficacy|0
2067558|NCT00603512|3645022|FG004|Overall Study|Lack of Efficacy|1
2067559|NCT00603512|3645018|FG000|Overall Study|Other|2
2067560|NCT00603512|3645019|FG001|Overall Study|Other|1
2067561|NCT00603512|3645020|FG002|Overall Study|Other|0
2067562|NCT00603512|3645021|FG003|Overall Study|Other|1
2067563|NCT00603512|3645022|FG004|Overall Study|Other|1
2067564|NCT00603512|3645018|FG000|Overall Study|Withdrawal by Subject|0
2067565|NCT00603512|3645019|FG001|Overall Study|Withdrawal by Subject|0
2067566|NCT00603512|3645020|FG002|Overall Study|Withdrawal by Subject|0
2067567|NCT00603512|3645021|FG003|Overall Study|Withdrawal by Subject|0
2067568|NCT00603512|3645022|FG004|Overall Study|Withdrawal by Subject|1
2067569|NCT00603512|3645018|FG000|Overall Study|Randomized but not treated|0
2067570|NCT00603512|3645019|FG001|Overall Study|Randomized but not treated|1
2067571|NCT00603512|3645020|FG002|Overall Study|Randomized but not treated|1
2067572|NCT00603512|3645021|FG003|Overall Study|Randomized but not treated|2
2067573|NCT00603512|3645022|FG004|Overall Study|Randomized but not treated|0
2067574|NCT00603525|3645036|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3
2067575|NCT00603525|3645037|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9
2067576|NCT00603525|3645038|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
2067577|NCT00603525|3645036|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
2067578|NCT00603525|3645037|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
2067579|NCT00603525|3645038|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
2067580|NCT00603525|3645036|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1
2067581|NCT00603525|3645037|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2
2067582|NCT00603525|3645038|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
2067583|NCT00603525|3645036|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
2067584|NCT00603525|3645037|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
2067585|NCT00603525|3645038|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
2067586|NCT00603525|3645036|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
2067587|NCT00603525|3645037|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
2067588|NCT00603525|3645038|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
2067589|NCT00603525|3645036|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0
2067590|NCT00603525|3645037|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1
2067591|NCT00603525|3645038|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0
2067592|NCT00603525|3645036|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
2067593|NCT00603525|3645037|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
2067594|NCT00603525|3645038|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
2067595|NCT00603525|3645036|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
2067596|NCT00603525|3645037|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12
2067597|NCT00603525|3645038|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
2067598|NCT00603525|3645036|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
2067599|NCT00603525|3645037|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
2067600|NCT00603525|3645038|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
2067601|NCT00603525|3645036|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
2067602|NCT00603525|3645037|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1
2067603|NCT00603525|3645038|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
2067604|NCT00603525|3645036|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
2067605|NCT00603525|3645037|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
2067606|NCT00603525|3645038|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
2067607|NCT00603525|3645036|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
2067608|NCT00603525|3645037|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
2067609|NCT00603525|3645038|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
2067610|NCT00603525|3645036|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
2067611|NCT00603525|3645037|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2
2067612|NCT00603525|3645038|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
2067613|NCT00603525|3645036|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
2067614|NCT00603525|3645037|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
2067615|NCT00603525|3645038|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
2067616|NCT00603525|3645036|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
2067617|NCT00603525|3645037|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
2067618|NCT00603525|3645038|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
2067619|NCT00603538|3645052|FG000|Overall Study|Adverse Event|0
2067620|NCT00603538|3645053|FG001|Overall Study|Adverse Event|4
2067621|NCT00603538|3645054|FG002|Overall Study|Adverse Event|2
2067622|NCT00603538|3645052|FG000|Overall Study|Objective progression or relapse|3
2067623|NCT00603538|3645053|FG001|Overall Study|Objective progression or relapse|0
2067624|NCT00603538|3645054|FG002|Overall Study|Objective progression or relapse|0
2067625|NCT00603590|3645076|FG000|Overall Study|Did not attend study clinic|39
2067626|NCT00603590|3645077|FG001|Overall Study|Did not attend study clinic|30
2067627|NCT00603590|3645076|FG000|Overall Study|Refused blood test|5
2067628|NCT00603590|3645077|FG001|Overall Study|Refused blood test|1
2067629|NCT00603590|3645076|FG000|Overall Study|Patient discontinued study drug|22
2067630|NCT00603590|3645077|FG001|Overall Study|Patient discontinued study drug|15
2067631|NCT00603590|3645076|FG000|Overall Study|Adverse Event|2
2067632|NCT00603590|3645077|FG001|Overall Study|Adverse Event|0
2067633|NCT00603590|3645076|FG000|Overall Study|Lost to Follow-up|8
2067634|NCT00603590|3645077|FG001|Overall Study|Lost to Follow-up|4
2067635|NCT00603590|3645076|FG000|Overall Study|Cardiovascular event|0
2067636|NCT00603590|3645077|FG001|Overall Study|Cardiovascular event|1
2067637|NCT00603733|3645115|FG000|Active Phase ITT|Adverse Event|8
2067638|NCT00603733|3645116|FG001|Active Phase ITT|Adverse Event|7
2177158|NCT01371747|3801216|FG000|Overall Study|Abnormal Renal Function|0
2177159|NCT01371747|3801217|FG001|Overall Study|Abnormal Renal Function|2
2177160|NCT01371747|3801218|FG002|Overall Study|Abnormal Renal Function|0
2177161|NCT01371747|3801219|FG003|Overall Study|Abnormal Renal Function|1
2177162|NCT01371747|3801220|FG004|Overall Study|Abnormal Renal Function|0
2177163|NCT01371747|3801221|FG005|Overall Study|Abnormal Renal Function|1
2177164|NCT01371747|3801216|FG000|Overall Study|High Serum Potassium Results|1
2177165|NCT01371747|3801217|FG001|Overall Study|High Serum Potassium Results|1
2177166|NCT01371747|3801218|FG002|Overall Study|High Serum Potassium Results|1
2177167|NCT01371747|3801219|FG003|Overall Study|High Serum Potassium Results|2
2177168|NCT01371747|3801220|FG004|Overall Study|High Serum Potassium Results|0
2177169|NCT01371747|3801221|FG005|Overall Study|High Serum Potassium Results|2
2177170|NCT01371747|3801216|FG000|Overall Study|Low Serum Potassium Results|1
2177171|NCT01371747|3801217|FG001|Overall Study|Low Serum Potassium Results|1
2177172|NCT01371747|3801218|FG002|Overall Study|Low Serum Potassium Results|1
2177173|NCT01371747|3801219|FG003|Overall Study|Low Serum Potassium Results|1
2177174|NCT01371747|3801220|FG004|Overall Study|Low Serum Potassium Results|0
2177175|NCT01371747|3801221|FG005|Overall Study|Low Serum Potassium Results|3
2177176|NCT01371747|3801216|FG000|Overall Study|Protocol Violation|0
2177177|NCT01371747|3801217|FG001|Overall Study|Protocol Violation|0
2177178|NCT01371747|3801218|FG002|Overall Study|Protocol Violation|1
2177179|NCT01371747|3801219|FG003|Overall Study|Protocol Violation|0
2067639|NCT00603733|3645115|FG000|Active Phase ITT|Withdrawal by Subject|0
2067640|NCT00603733|3645116|FG001|Active Phase ITT|Withdrawal by Subject|3
2067641|NCT00603733|3645115|FG000|Active Phase ITT|Lost to Follow-up|0
2067642|NCT00603733|3645116|FG001|Active Phase ITT|Lost to Follow-up|1
2067643|NCT00603733|3645115|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1
2067644|NCT00603733|3645116|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3
2067645|NCT00603733|3645115|FG000|Active Phase ITT|Lack of Efficacy|1
2067646|NCT00603733|3645116|FG001|Active Phase ITT|Lack of Efficacy|2
2067647|NCT00603733|3645115|FG000|Active Phase ITT|Subject moved, site closed|1
2067648|NCT00603733|3645116|FG001|Active Phase ITT|Subject moved, site closed|1
2067649|NCT00603733|3645115|FG000|Run-In Phase - 4 Weeks|Adverse Event|2
2067650|NCT00603733|3645116|FG001|Run-In Phase - 4 Weeks|Adverse Event|1
2067651|NCT00603733|3645115|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
2067652|NCT00603733|3645116|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
2067653|NCT00603733|3645115|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1
2067654|NCT00603733|3645116|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0
2067655|NCT00603733|3645115|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
2067656|NCT00603733|3645116|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
2067657|NCT00603733|3645115|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2
2067658|NCT00603733|3645116|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1
2067659|NCT00603733|3645115|FG000|Maintenance Phase ITT|Adverse Event|3
2067660|NCT00603733|3645116|FG001|Maintenance Phase ITT|Adverse Event|6
2067661|NCT00603733|3645115|FG000|Maintenance Phase ITT|Withdrawal by Subject|1
2067662|NCT00603733|3645116|FG001|Maintenance Phase ITT|Withdrawal by Subject|0
2067663|NCT00603733|3645115|FG000|Maintenance Phase ITT|Protocol Violation|1
2067664|NCT00603733|3645116|FG001|Maintenance Phase ITT|Protocol Violation|1
2067665|NCT00603733|3645115|FG000|Maintenance Phase ITT|Lost to Follow-up|0
2067666|NCT00603733|3645116|FG001|Maintenance Phase ITT|Lost to Follow-up|1
2067667|NCT00603733|3645115|FG000|Maintenance Phase ITT|Lack of Efficacy|2
2067668|NCT00603733|3645116|FG001|Maintenance Phase ITT|Lack of Efficacy|2
2067669|NCT00603733|3645115|FG000|Maintenance Phase ITT|Physician Decision|0
2067670|NCT00603733|3645116|FG001|Maintenance Phase ITT|Physician Decision|1
2067671|NCT00603733|3645115|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
2067672|NCT00603733|3645116|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
2067673|NCT00603746|3645128|FG000|Overall Study|Adverse Event|2
2067674|NCT00603746|3645129|FG001|Overall Study|Adverse Event|3
2067675|NCT00603746|3645130|FG002|Overall Study|Adverse Event|0
2067676|NCT00603746|3645131|FG003|Overall Study|Adverse Event|1
2067677|NCT00603746|3645132|FG004|Overall Study|Adverse Event|0
2067678|NCT00603746|3645133|FG005|Overall Study|Adverse Event|4
2067679|NCT00603746|3645128|FG000|Overall Study|Lack of Efficacy|34
2067680|NCT00603746|3645129|FG001|Overall Study|Lack of Efficacy|11
2067681|NCT00603746|3645130|FG002|Overall Study|Lack of Efficacy|6
2067682|NCT00603746|3645131|FG003|Overall Study|Lack of Efficacy|11
2067683|NCT00603746|3645132|FG004|Overall Study|Lack of Efficacy|12
2067684|NCT00603746|3645133|FG005|Overall Study|Lack of Efficacy|8
2067685|NCT00603746|3645128|FG000|Overall Study|Protocol Violation|0
2067686|NCT00603746|3645129|FG001|Overall Study|Protocol Violation|3
2067687|NCT00603746|3645130|FG002|Overall Study|Protocol Violation|1
2067688|NCT00603746|3645131|FG003|Overall Study|Protocol Violation|0
2067689|NCT00603746|3645132|FG004|Overall Study|Protocol Violation|1
2067690|NCT00603746|3645133|FG005|Overall Study|Protocol Violation|0
2067691|NCT00603746|3645128|FG000|Overall Study|Lost to Follow-up|0
2067692|NCT00603746|3645129|FG001|Overall Study|Lost to Follow-up|1
2067693|NCT00603746|3645130|FG002|Overall Study|Lost to Follow-up|1
2067694|NCT00603746|3645131|FG003|Overall Study|Lost to Follow-up|0
2067695|NCT00603746|3645132|FG004|Overall Study|Lost to Follow-up|0
2067696|NCT00603746|3645133|FG005|Overall Study|Lost to Follow-up|0
2067697|NCT00603746|3645128|FG000|Overall Study|Physician Decision|1
2067698|NCT00603746|3645129|FG001|Overall Study|Physician Decision|0
2067699|NCT00603746|3645130|FG002|Overall Study|Physician Decision|0
2067700|NCT00603746|3645131|FG003|Overall Study|Physician Decision|0
2067701|NCT00603746|3645132|FG004|Overall Study|Physician Decision|1
2067702|NCT00603746|3645133|FG005|Overall Study|Physician Decision|0
2067703|NCT00603746|3645128|FG000|Overall Study|Withdrawal by Subject|1
2067704|NCT00603746|3645129|FG001|Overall Study|Withdrawal by Subject|0
2067705|NCT00603746|3645130|FG002|Overall Study|Withdrawal by Subject|0
2067706|NCT00603746|3645131|FG003|Overall Study|Withdrawal by Subject|1
2067707|NCT00603746|3645132|FG004|Overall Study|Withdrawal by Subject|3
2067708|NCT00603746|3645133|FG005|Overall Study|Withdrawal by Subject|1
2067709|NCT00603798|3645150|FG000|Overall Study|Adverse Event|4
2067710|NCT00603798|3645151|FG001|Overall Study|Adverse Event|2
2067711|NCT00603798|3645152|FG002|Overall Study|Adverse Event|1
2067712|NCT00603798|3645150|FG000|Overall Study|Withdrawal by Subject|4
2067713|NCT00603798|3645151|FG001|Overall Study|Withdrawal by Subject|3
2067714|NCT00603798|3645152|FG002|Overall Study|Withdrawal by Subject|4
2067715|NCT00603798|3645150|FG000|Overall Study|Lost to Follow-up|1
2067716|NCT00603798|3645151|FG001|Overall Study|Lost to Follow-up|0
2067717|NCT00603798|3645152|FG002|Overall Study|Lost to Follow-up|1
2067718|NCT00603798|3645150|FG000|Overall Study|Non-compliance with study procedures|0
2067719|NCT00603798|3645151|FG001|Overall Study|Non-compliance with study procedures|1
2067720|NCT00603798|3645152|FG002|Overall Study|Non-compliance with study procedures|0
2067721|NCT00603798|3645150|FG000|Overall Study|Not due to AE|1
2067722|NCT00603798|3645151|FG001|Overall Study|Not due to AE|1
2067723|NCT00603798|3645152|FG002|Overall Study|Not due to AE|4
2067724|NCT00603837|3645162|FG000|Overall Study|Physician Decision|3
2067725|NCT00603837|3645163|FG001|Overall Study|Physician Decision|0
2106153|NCT00863681|3699246|FG000|Overall Study|Withdrawal by Subject|12
2106154|NCT00863681|3699247|FG001|Overall Study|Withdrawal by Subject|5
2106155|NCT00863681|3699248|FG002|Overall Study|Withdrawal by Subject|2
2106156|NCT00863681|3699246|FG000|Overall Study|Protocol Violation|2
2106157|NCT00863681|3699247|FG001|Overall Study|Protocol Violation|0
2106158|NCT00863681|3699248|FG002|Overall Study|Protocol Violation|0
2106159|NCT00863681|3699246|FG000|Overall Study|Lost to Follow-up|3
2210245|NCT01648764|3849711|FG004|Overall Study|Withdrawal by Subject|0
2210246|NCT01648764|3849712|FG005|Overall Study|Withdrawal by Subject|0
2106160|NCT00863681|3699247|FG001|Overall Study|Lost to Follow-up|0
2106161|NCT00863681|3699248|FG002|Overall Study|Lost to Follow-up|3
2106162|NCT00863681|3699246|FG000|Overall Study|Adverse Event|28
2106163|NCT00863681|3699247|FG001|Overall Study|Adverse Event|10
2106164|NCT00863681|3699248|FG002|Overall Study|Adverse Event|6
2106165|NCT00863681|3699246|FG000|Overall Study|Lack of Efficacy|2
2106166|NCT00863681|3699247|FG001|Overall Study|Lack of Efficacy|2
2106167|NCT00863681|3699248|FG002|Overall Study|Lack of Efficacy|1
2106168|NCT00863681|3699246|FG000|Overall Study|Non-compliance with study drug|1
2106169|NCT00863681|3699247|FG001|Overall Study|Non-compliance with study drug|3
2106170|NCT00863681|3699248|FG002|Overall Study|Non-compliance with study drug|0
2106171|NCT00863707|3699258|FG000|Overall Study|Randomized, but drug not received|4
2106172|NCT00863707|3699259|FG001|Overall Study|Randomized, but drug not received|3
2106173|NCT00863746|3699267|FG000|Treatment|Not treated|4
2106174|NCT00863746|3699268|FG001|Treatment|Not treated|2
2106175|NCT00863746|3699267|FG000|Treatment|Adverse Event|41
2106176|NCT00863746|3699268|FG001|Treatment|Adverse Event|16
2106177|NCT00863746|3699267|FG000|Treatment|non-compliant with study medication|4
2106178|NCT00863746|3699268|FG001|Treatment|non-compliant with study medication|0
2106179|NCT00863746|3699267|FG000|Treatment|Consent withdrawn|15
2106180|NCT00863746|3699268|FG001|Treatment|Consent withdrawn|14
2106181|NCT00863746|3699267|FG000|Treatment|Lost to Follow-up|1
2106182|NCT00863746|3699268|FG001|Treatment|Lost to Follow-up|0
2106183|NCT00863746|3699267|FG000|Treatment|Protocol Violation|5
2106184|NCT00863746|3699268|FG001|Treatment|Protocol Violation|3
2106185|NCT00863746|3699267|FG000|Treatment|Other|1
2106186|NCT00863746|3699268|FG001|Treatment|Other|0
2106187|NCT00863746|3699267|FG000|Survival Follow up|Death|244
2106188|NCT00863746|3699268|FG001|Survival Follow up|Death|271
2106189|NCT00863746|3699267|FG000|Survival Follow up|Lost to Follow-up|2
2106190|NCT00863746|3699268|FG001|Survival Follow up|Lost to Follow-up|1
2106191|NCT00863746|3699267|FG000|Survival Follow up|Consent Withdrawn|7
2106192|NCT00863746|3699268|FG001|Survival Follow up|Consent Withdrawn|8
2106193|NCT00863772|3699277|FG000|Overall Study|Adverse Event|1
2106194|NCT00863772|3699278|FG001|Overall Study|Adverse Event|4
2106195|NCT00863772|3699279|FG002|Overall Study|Adverse Event|0
2106196|NCT00863772|3699277|FG000|Overall Study|Lack of Efficacy|4
2106197|NCT00863772|3699278|FG001|Overall Study|Lack of Efficacy|2
2106198|NCT00863772|3699279|FG002|Overall Study|Lack of Efficacy|4
2106199|NCT00863772|3699277|FG000|Overall Study|Lost to Follow-up|5
2106200|NCT00863772|3699278|FG001|Overall Study|Lost to Follow-up|1
2106201|NCT00863772|3699279|FG002|Overall Study|Lost to Follow-up|1
2302784|NCT02631850|4001738|FG001|Treatment Period|Withdrawal by Subject|5
2302785|NCT02631850|4001739|FG002|Treatment Period|Withdrawal by Subject|2
2302786|NCT02631850|4001740|FG003|Treatment Period|Withdrawal by Subject|2
2302787|NCT02631850|4001737|FG000|Treatment Period|Adverse Event|1
2302788|NCT02631850|4001738|FG001|Treatment Period|Adverse Event|0
2302789|NCT02631850|4001739|FG002|Treatment Period|Adverse Event|2
2302790|NCT02631850|4001740|FG003|Treatment Period|Adverse Event|3
2302791|NCT02631850|4001737|FG000|Treatment Period|Family medical issue|1
2302792|NCT02631850|4001738|FG001|Treatment Period|Family medical issue|0
2302793|NCT02631850|4001739|FG002|Treatment Period|Family medical issue|0
2302794|NCT02631850|4001740|FG003|Treatment Period|Family medical issue|0
2302795|NCT02631850|4001737|FG000|6 Month Follow up|Lost to Follow-up|5
2302796|NCT02631850|4001738|FG001|6 Month Follow up|Lost to Follow-up|8
2302797|NCT02631850|4001739|FG002|6 Month Follow up|Lost to Follow-up|3
2302798|NCT02631850|4001740|FG003|6 Month Follow up|Lost to Follow-up|5
2302799|NCT02631850|4001737|FG000|6 Month Follow up|Withdrawal by Subject|1
2302800|NCT02631850|4001738|FG001|6 Month Follow up|Withdrawal by Subject|0
2302801|NCT02631850|4001739|FG002|6 Month Follow up|Withdrawal by Subject|0
2302802|NCT02631850|4001740|FG003|6 Month Follow up|Withdrawal by Subject|2
2302803|NCT02631850|4001737|FG000|6 Month Follow up|Adverse Event|1
2302804|NCT02631850|4001738|FG001|6 Month Follow up|Adverse Event|4
2302805|NCT02631850|4001739|FG002|6 Month Follow up|Adverse Event|1
2302806|NCT02631850|4001740|FG003|6 Month Follow up|Adverse Event|3
2302807|NCT02631850|4001737|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0
2302808|NCT02631850|4001738|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
2302809|NCT02631850|4001739|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2
2302810|NCT02631850|4001740|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
2302811|NCT02631876|4001753|FG000|Overall Study|Death|96
2302812|NCT02631876|4001754|FG001|Overall Study|Death|50
2302813|NCT02631876|4001753|FG000|Overall Study|Investigator's discretion|1
2302814|NCT02631876|4001754|FG001|Overall Study|Investigator's discretion|0
2302815|NCT02631876|4001753|FG000|Overall Study|Lost to Follow-up|2
2302816|NCT02631876|4001754|FG001|Overall Study|Lost to Follow-up|0
2302817|NCT02631876|4001753|FG000|Overall Study|Withdrawal by Subject|16
2302818|NCT02631876|4001754|FG001|Overall Study|Withdrawal by Subject|9
2302819|NCT02631876|4001753|FG000|Overall Study|Other than specified|4
2302820|NCT02631876|4001754|FG001|Overall Study|Other than specified|4
2302821|NCT02632110|4001775|FG000|Overall Study|Withdrawal by Subject|1
2302822|NCT02632110|4001776|FG001|Overall Study|Withdrawal by Subject|1
2302823|NCT02632110|4001777|FG002|Overall Study|Withdrawal by Subject|0
2302824|NCT02632110|4001778|FG003|Overall Study|Withdrawal by Subject|0
2302825|NCT02632110|4001779|FG004|Overall Study|Withdrawal by Subject|1
2302826|NCT02632110|4001780|FG005|Overall Study|Withdrawal by Subject|1
2302827|NCT02632110|4001781|FG006|Overall Study|Withdrawal by Subject|3
2302828|NCT02632110|4001782|FG007|Overall Study|Withdrawal by Subject|3
2302829|NCT02632110|4001783|FG008|Overall Study|Withdrawal by Subject|1
2302830|NCT02632110|4001784|FG009|Overall Study|Withdrawal by Subject|1
2302831|NCT02632552|4001859|FG000|Overall Study|Lost to Follow-up|14
2302832|NCT02632552|4001860|FG001|Overall Study|Lost to Follow-up|8
2302833|NCT02632552|4001859|FG000|Overall Study|Withdrawal by Subject|2
2302834|NCT02632552|4001860|FG001|Overall Study|Withdrawal by Subject|0
2302835|NCT02632552|4001859|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7
2302836|NCT02632552|4001860|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2
2302837|NCT02632747|4001869|FG000|Wash-out Period|Adverse Event|1
2302838|NCT02632747|4001870|FG001|Wash-out Period|Adverse Event|0
2302839|NCT02632786|4001878|FG000|Overall Study|Adverse Event|2
2302840|NCT02632786|4001879|FG001|Overall Study|Adverse Event|1
2302841|NCT02632786|4001878|FG000|Overall Study|Death|3
2302842|NCT02632786|4001879|FG001|Overall Study|Death|2
2302843|NCT02632786|4001878|FG000|Overall Study|Physician Decision|5
2302844|NCT02632786|4001879|FG001|Overall Study|Physician Decision|4
2302845|NCT02632786|4001878|FG000|Overall Study|Withdrawal by Subject|1
2302846|NCT02632786|4001879|FG001|Overall Study|Withdrawal by Subject|0
2302847|NCT02632838|4001897|FG000|Overall Study|Withdrawal by Subject|3
2302848|NCT02632838|4001898|FG001|Overall Study|Withdrawal by Subject|0
2302849|NCT02632838|4001897|FG000|Overall Study|Lost to Follow-up|0
2302850|NCT02632838|4001898|FG001|Overall Study|Lost to Follow-up|2
2302851|NCT02633020|4001910|FG000|Overall Study|Adverse Event|1
2302852|NCT02633020|4001911|FG001|Overall Study|Adverse Event|0
2302853|NCT02633046|4001917|FG000|Overall Study|Adverse Event|8
2302854|NCT02633046|4001917|FG000|Overall Study|Physician Decision|7
2302855|NCT02633046|4001917|FG000|Overall Study|Withdrawal by Subject|8
2302856|NCT02633046|4001917|FG000|Overall Study|Increased proteinuria|2
2302857|NCT02633046|4001917|FG000|Overall Study|Participant decided not to continue with open label extension|1
2302858|NCT02633046|4001917|FG000|Overall Study|Mutual decision patient and physician|1
2302859|NCT02633215|4001923|FG000|Overall Study|Lost to Follow-up|2
2302860|NCT02633215|4001924|FG001|Overall Study|Lost to Follow-up|3
2302861|NCT02633306|4001930|FG000|Overall Study|Withdrawal by Subject|3
2302862|NCT02633501|4001964|FG000|Overall Study|Adverse Event|0
2302863|NCT02633501|4001965|FG001|Overall Study|Adverse Event|0
2302864|NCT02633501|4001966|FG002|Overall Study|Adverse Event|1
2302865|NCT02633501|4001967|FG003|Overall Study|Adverse Event|0
2302866|NCT02633501|4001968|FG004|Overall Study|Adverse Event|1
2302867|NCT02633501|4001969|FG005|Overall Study|Adverse Event|1
2302868|NCT02633501|4001964|FG000|Overall Study|Withdrawal by Subject|2
2302869|NCT02633501|4001965|FG001|Overall Study|Withdrawal by Subject|1
2302870|NCT02633501|4001966|FG002|Overall Study|Withdrawal by Subject|2
2302871|NCT02633501|4001967|FG003|Overall Study|Withdrawal by Subject|2
2302872|NCT02633501|4001968|FG004|Overall Study|Withdrawal by Subject|1
2302873|NCT02633501|4001969|FG005|Overall Study|Withdrawal by Subject|3
2302874|NCT02633501|4001964|FG000|Overall Study|Various other reasons|0
2302875|NCT02633501|4001965|FG001|Overall Study|Various other reasons|2
2302876|NCT02633501|4001966|FG002|Overall Study|Various other reasons|4
2302877|NCT02633501|4001967|FG003|Overall Study|Various other reasons|1
2302878|NCT02633501|4001968|FG004|Overall Study|Various other reasons|7
2302879|NCT02633501|4001969|FG005|Overall Study|Various other reasons|11
2302880|NCT02633501|4001964|FG000|Overall Study|Lost to Follow-up|0
2302881|NCT02633501|4001965|FG001|Overall Study|Lost to Follow-up|0
2302882|NCT02633501|4001966|FG002|Overall Study|Lost to Follow-up|0
2302883|NCT02633501|4001967|FG003|Overall Study|Lost to Follow-up|1
2302884|NCT02633501|4001968|FG004|Overall Study|Lost to Follow-up|2
2302885|NCT02633501|4001969|FG005|Overall Study|Lost to Follow-up|0
2302886|NCT02633527|4001993|FG000|Overall Study|Failed to meet eligibility|0
2302887|NCT02633527|4001994|FG001|Overall Study|Failed to meet eligibility|1
2302888|NCT02633527|4001995|FG002|Overall Study|Failed to meet eligibility|1
2302889|NCT02633527|4001996|FG003|Overall Study|Failed to meet eligibility|0
2302890|NCT02633527|4001997|FG004|Overall Study|Failed to meet eligibility|1
2302891|NCT02633527|4001993|FG000|Overall Study|Adverse Event|0
2302892|NCT02633527|4001994|FG001|Overall Study|Adverse Event|4
2302893|NCT02633527|4001995|FG002|Overall Study|Adverse Event|3
2302894|NCT02633527|4001996|FG003|Overall Study|Adverse Event|1
2302895|NCT02633527|4001997|FG004|Overall Study|Adverse Event|5
2302896|NCT02633527|4001993|FG000|Overall Study|Lost to Follow-up|1
2302897|NCT02633527|4001994|FG001|Overall Study|Lost to Follow-up|2
2302898|NCT02633527|4001995|FG002|Overall Study|Lost to Follow-up|5
2302899|NCT02633527|4001996|FG003|Overall Study|Lost to Follow-up|5
2302900|NCT02633527|4001997|FG004|Overall Study|Lost to Follow-up|4
2302901|NCT02633527|4001993|FG000|Overall Study|Withdrawal by Subject|0
2302902|NCT02633527|4001994|FG001|Overall Study|Withdrawal by Subject|3
2302903|NCT02633527|4001995|FG002|Overall Study|Withdrawal by Subject|5
2302904|NCT02633527|4001996|FG003|Overall Study|Withdrawal by Subject|4
2302905|NCT02633527|4001997|FG004|Overall Study|Withdrawal by Subject|4
2302906|NCT02633527|4001993|FG000|Overall Study|Protocol Violation|0
2302907|NCT02633527|4001994|FG001|Overall Study|Protocol Violation|1
2302908|NCT02633527|4001995|FG002|Overall Study|Protocol Violation|1
2302909|NCT02633527|4001996|FG003|Overall Study|Protocol Violation|1
2302910|NCT02633527|4001997|FG004|Overall Study|Protocol Violation|1
2302911|NCT02633527|4001993|FG000|Overall Study|Physician Decision|0
2302912|NCT02633527|4001994|FG001|Overall Study|Physician Decision|0
2302913|NCT02633527|4001995|FG002|Overall Study|Physician Decision|0
2302914|NCT02633527|4001996|FG003|Overall Study|Physician Decision|0
2302915|NCT02633527|4001997|FG004|Overall Study|Physician Decision|1
2302916|NCT02633527|4001993|FG000|Overall Study|Administrative reason|1
2302917|NCT02633527|4001994|FG001|Overall Study|Administrative reason|0
2302918|NCT02633527|4001995|FG002|Overall Study|Administrative reason|0
2302919|NCT02633527|4001996|FG003|Overall Study|Administrative reason|1
2302920|NCT02633527|4001997|FG004|Overall Study|Administrative reason|0
2302921|NCT02633527|4001993|FG000|Overall Study|Multiple reasons|1
2302922|NCT02633527|4001994|FG001|Overall Study|Multiple reasons|0
2302923|NCT02633527|4001995|FG002|Overall Study|Multiple reasons|2
2302924|NCT02633527|4001996|FG003|Overall Study|Multiple reasons|2
2302925|NCT02633527|4001997|FG004|Overall Study|Multiple reasons|1
2302926|NCT02633787|4002018|FG000|Overall Study|Withdrawal by Subject|1
2302927|NCT02633800|4002024|FG000|Overall Study|Death|3
2302928|NCT02633800|4002025|FG001|Overall Study|Death|3
2302929|NCT02633800|4002024|FG000|Overall Study|Reason not provided|1
2302930|NCT02633800|4002025|FG001|Overall Study|Reason not provided|0
2302931|NCT02633800|4002024|FG000|Overall Study|Radiologic(al) progression|23
2302932|NCT02633800|4002025|FG001|Overall Study|Radiologic(al) progression|23
2302933|NCT02633800|4002024|FG000|Overall Study|Clinical progression|3
2302934|NCT02633800|4002025|FG001|Overall Study|Clinical progression|6
2302935|NCT02633800|4002024|FG000|Overall Study|Study terminated by sponsor|6
2302936|NCT02633800|4002025|FG001|Overall Study|Study terminated by sponsor|5
2302937|NCT02633800|4002024|FG000|Overall Study|Adverse event, non-fatal|7
2302938|NCT02633800|4002025|FG001|Overall Study|Adverse event, non-fatal|2
2302939|NCT02633800|4002024|FG000|Overall Study|Withdrawal by Subject|0
2302940|NCT02633800|4002025|FG001|Overall Study|Withdrawal by Subject|3
2302941|NCT02633800|4002024|FG000|Overall Study|Patient Request|1
2302942|NCT02633800|4002025|FG001|Overall Study|Patient Request|1
2302943|NCT02634151|4002067|FG000|Overall Study|Withdrawal by Subject|1
2302944|NCT02634151|4002068|FG001|Overall Study|Withdrawal by Subject|0
2302945|NCT02634151|4002067|FG000|Overall Study|Non-Compliance|0
2302946|NCT02634151|4002068|FG001|Overall Study|Non-Compliance|1
2302947|NCT02634151|4002067|FG000|Overall Study|Other|0
2302948|NCT02634151|4002068|FG001|Overall Study|Other|1
2302949|NCT02634320|4002083|FG000|Overall Study|Adverse Event|2
2302950|NCT02634320|4002083|FG000|Overall Study|Lost to Follow-up|3
2302951|NCT02634320|4002083|FG000|Overall Study|Moved out of area|2
2302952|NCT02634320|4002083|FG000|Overall Study|Out of window for study visits|1
2302953|NCT02634320|4002083|FG000|Overall Study|Protocol Violation|1
2302954|NCT02634320|4002083|FG000|Overall Study|Withdrawal by Subject|5
2302955|NCT02634320|4002083|FG000|Overall Study|Lack of Efficacy|2
2302956|NCT02634333|4002089|FG000|Overall Study|Completed out of Window|3
2302957|NCT02634333|4002090|FG001|Overall Study|Completed out of Window|2
2302958|NCT02634333|4002089|FG000|Overall Study|Missed Visit|5
2302959|NCT02634333|4002090|FG001|Overall Study|Missed Visit|2
2302960|NCT02634333|4002089|FG000|Overall Study|Lost to Follow-up|12
2302961|NCT02634333|4002090|FG001|Overall Study|Lost to Follow-up|7
2302962|NCT02634333|4002089|FG000|Overall Study|Withdrawal by Subject|9
2302963|NCT02634333|4002090|FG001|Overall Study|Withdrawal by Subject|13
2302964|NCT02634333|4002089|FG000|Overall Study|Death|11
2302965|NCT02634333|4002090|FG001|Overall Study|Death|8
2302966|NCT02634346|4002100|FG000|Overall Study|Withdrawal by Subject|8
2302967|NCT02634346|4002101|FG001|Overall Study|Withdrawal by Subject|9
2302968|NCT02634346|4002102|FG002|Overall Study|Withdrawal by Subject|8
2302969|NCT02634346|4002100|FG000|Overall Study|Adverse Event|2
2302970|NCT02634346|4002101|FG001|Overall Study|Adverse Event|2
2302971|NCT02634346|4002102|FG002|Overall Study|Adverse Event|7
2302972|NCT02634346|4002100|FG000|Overall Study|Lack of Efficacy|1
2302973|NCT02634346|4002101|FG001|Overall Study|Lack of Efficacy|2
2302974|NCT02634346|4002102|FG002|Overall Study|Lack of Efficacy|8
2302975|NCT02634346|4002100|FG000|Overall Study|Lost to Follow-up|1
2302976|NCT02634346|4002101|FG001|Overall Study|Lost to Follow-up|0
2302977|NCT02634346|4002102|FG002|Overall Study|Lost to Follow-up|0
2302978|NCT02634346|4002100|FG000|Overall Study|Protocol Violation|0
2302979|NCT02634346|4002101|FG001|Overall Study|Protocol Violation|1
2302980|NCT02634346|4002102|FG002|Overall Study|Protocol Violation|0
2302981|NCT02634580|4002114|FG000|Double-blind Treatment Period|Subject Request|1
2302982|NCT02634580|4002115|FG001|Double-blind Treatment Period|Subject Request|0
2302983|NCT02634580|4002116|FG002|Double-blind Treatment Period|Subject Request|1
2302984|NCT02634580|4002117|FG003|Double-blind Treatment Period|Subject Request|1
2302985|NCT02634580|4002114|FG000|Open-label Extension Period|Withdrawal by Subject|0
2302986|NCT02634580|4002115|FG001|Open-label Extension Period|Withdrawal by Subject|1
2302987|NCT02634580|4002116|FG002|Open-label Extension Period|Withdrawal by Subject|0
2302988|NCT02634580|4002117|FG003|Open-label Extension Period|Withdrawal by Subject|1
2302989|NCT02634788|4002147|FG000|Overall Study|Adverse Event|0
2302990|NCT02634788|4002148|FG001|Overall Study|Adverse Event|8
2302991|NCT02634788|4002149|FG002|Overall Study|Adverse Event|3
2302992|NCT02634788|4002150|FG003|Overall Study|Adverse Event|1
2302993|NCT02634788|4002147|FG000|Overall Study|Lack of Efficacy|4
2302994|NCT02634788|4002148|FG001|Overall Study|Lack of Efficacy|0
2302995|NCT02634788|4002149|FG002|Overall Study|Lack of Efficacy|1
2302996|NCT02634788|4002150|FG003|Overall Study|Lack of Efficacy|4
2302997|NCT02634788|4002147|FG000|Overall Study|Lost to Follow-up|0
2302998|NCT02634788|4002148|FG001|Overall Study|Lost to Follow-up|1
2302999|NCT02634788|4002149|FG002|Overall Study|Lost to Follow-up|0
2303000|NCT02634788|4002150|FG003|Overall Study|Lost to Follow-up|0
2303001|NCT02634788|4002147|FG000|Overall Study|Withdrawal by Subject|0
2303002|NCT02634788|4002148|FG001|Overall Study|Withdrawal by Subject|1
2303003|NCT02634788|4002149|FG002|Overall Study|Withdrawal by Subject|1
2303004|NCT02634788|4002150|FG003|Overall Study|Withdrawal by Subject|0
2303005|NCT02634801|4002163|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2
2303006|NCT02634801|4002164|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20
2303007|NCT02634801|4002165|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0
2303008|NCT02634801|4002163|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
2303009|NCT02634801|4002164|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
2303010|NCT02634801|4002165|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
2303011|NCT02634801|4002163|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
2303012|NCT02634801|4002164|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
2303013|NCT02634801|4002165|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
2303014|NCT02634801|4002163|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
2303015|NCT02634801|4002164|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
2303016|NCT02634801|4002165|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
2303017|NCT02634801|4002163|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
2303018|NCT02634801|4002164|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
2303019|NCT02634801|4002165|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
2303020|NCT02634801|4002163|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0
2067726|NCT00603915|3645186|FG000|Overall Study|Physician Decision|1
2067727|NCT00603941|3645193|FG000|Overall Study|Disease progression|6
2067728|NCT00603941|3645194|FG001|Overall Study|Disease progression|7
2067729|NCT00603941|3645195|FG002|Overall Study|Disease progression|1
2067730|NCT00603941|3645193|FG000|Overall Study|Adverse Event|1
2067731|NCT00603941|3645194|FG001|Overall Study|Adverse Event|0
2067732|NCT00603941|3645195|FG002|Overall Study|Adverse Event|1
2067733|NCT00603941|3645193|FG000|Overall Study|Physician Decision|0
2303021|NCT02634801|4002164|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0
2303022|NCT02634801|4002165|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1
2067734|NCT00603941|3645194|FG001|Overall Study|Physician Decision|1
2067735|NCT00603941|3645195|FG002|Overall Study|Physician Decision|0
2067736|NCT00603941|3645193|FG000|Overall Study|Withdrawal by Subject|0
2067737|NCT00603941|3645194|FG001|Overall Study|Withdrawal by Subject|2
2067738|NCT00603941|3645195|FG002|Overall Study|Withdrawal by Subject|0
2067739|NCT00603980|3645204|FG000|Study Qualification|Protocol Violation|3
2067740|NCT00603980|3645204|FG000|Study Qualification|Inconsistent data reporting|13
2067741|NCT00603980|3645204|FG000|Main Study|14th subject completed trial|1
2067742|NCT00604162|3645246|FG000|Overall Study|Physician Decision|3
2067743|NCT00604162|3645246|FG000|Overall Study|Withdrawal by Subject|1
2067744|NCT00604175|3645256|FG000|Entry Through Week 28|Death|2
2067745|NCT00604175|3645257|FG001|Entry Through Week 28|Death|0
2067746|NCT00604175|3645258|FG002|Entry Through Week 28|Death|0
2067747|NCT00604175|3645256|FG000|Entry Through Week 28|Withdrawal by Subject|1
2067748|NCT00604175|3645257|FG001|Entry Through Week 28|Withdrawal by Subject|0
2067749|NCT00604175|3645258|FG002|Entry Through Week 28|Withdrawal by Subject|0
2067750|NCT00604175|3645256|FG000|Entry Through Week 28|Lost to Follow-up|4
2067751|NCT00604175|3645257|FG001|Entry Through Week 28|Lost to Follow-up|3
2067752|NCT00604175|3645258|FG002|Entry Through Week 28|Lost to Follow-up|0
2067753|NCT00604175|3645256|FG000|Entry Through Week 28|Ineligible|1
2067754|NCT00604175|3645257|FG001|Entry Through Week 28|Ineligible|0
2067755|NCT00604175|3645258|FG002|Entry Through Week 28|Ineligible|0
2067756|NCT00604175|3645256|FG000|Entry Through Week 28|Did not start intervention|2
2067757|NCT00604175|3645257|FG001|Entry Through Week 28|Did not start intervention|0
2067758|NCT00604175|3645258|FG002|Entry Through Week 28|Did not start intervention|1
2067759|NCT00604175|3645256|FG000|Week 29 Through Week 72|Death|0
2067760|NCT00604175|3645257|FG001|Week 29 Through Week 72|Death|0
2067761|NCT00604175|3645258|FG002|Week 29 Through Week 72|Death|1
2067762|NCT00604175|3645256|FG000|Week 29 Through Week 72|Lost to Follow-up|12
2067763|NCT00604175|3645257|FG001|Week 29 Through Week 72|Lost to Follow-up|6
2067764|NCT00604175|3645258|FG002|Week 29 Through Week 72|Lost to Follow-up|2
2067765|NCT00604175|3645256|FG000|Week 29 Through Week 72|Site closure|0
2067766|NCT00604175|3645257|FG001|Week 29 Through Week 72|Site closure|1
2067767|NCT00604175|3645258|FG002|Week 29 Through Week 72|Site closure|0
2067768|NCT00604175|3645256|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0
2067769|NCT00604175|3645257|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0
2067770|NCT00604175|3645258|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1
2067771|NCT00604188|3645292|FG000|Overall Study|Adverse Event|1
2067772|NCT00604188|3645293|FG001|Overall Study|Adverse Event|4
2067773|NCT00604188|3645292|FG000|Overall Study|Lost to Follow-up|17
2067774|NCT00604188|3645293|FG001|Overall Study|Lost to Follow-up|15
2067775|NCT00604188|3645292|FG000|Overall Study|Withdrawal by Subject|5
2067776|NCT00604188|3645293|FG001|Overall Study|Withdrawal by Subject|1
2067777|NCT00604188|3645292|FG000|Overall Study|Non-compliance with protocol|4
2067778|NCT00604188|3645293|FG001|Overall Study|Non-compliance with protocol|4
2067779|NCT00604188|3645292|FG000|Overall Study|Did not receive study drug|0
2067780|NCT00604188|3645293|FG001|Overall Study|Did not receive study drug|1
2067781|NCT00604214|3645301|FG000|Baseline to Day 28|Death|223
2067782|NCT00604214|3645302|FG001|Baseline to Day 28|Death|202
2067783|NCT00604214|3645301|FG000|Baseline to Day 28|Lost to Follow-up|2
2067784|NCT00604214|3645302|FG001|Baseline to Day 28|Lost to Follow-up|4
2067785|NCT00604214|3645301|FG000|Baseline to Day 28|Withdrawal by Subject|3
2067786|NCT00604214|3645302|FG001|Baseline to Day 28|Withdrawal by Subject|7
2067787|NCT00604214|3645301|FG000|Day 29 to Day 90|Death|64
2067788|NCT00604214|3645302|FG001|Day 29 to Day 90|Death|67
2067789|NCT00604214|3645301|FG000|Day 29 to Day 90|Lost to Follow-up|4
2067790|NCT00604214|3645302|FG001|Day 29 to Day 90|Lost to Follow-up|6
2067791|NCT00604214|3645301|FG000|Day 29 to Day 90|Withdrawal by Subject|0
2067792|NCT00604214|3645302|FG001|Day 29 to Day 90|Withdrawal by Subject|6
2067793|NCT00604214|3645301|FG000|Day 91 to Day 180|Death|19
2067794|NCT00604214|3645302|FG001|Day 91 to Day 180|Death|23
2067795|NCT00604214|3645301|FG000|Day 91 to Day 180|Lost to Follow-up|6
2067796|NCT00604214|3645302|FG001|Day 91 to Day 180|Lost to Follow-up|8
2067797|NCT00604214|3645301|FG000|Day 91 to Day 180|Withdrawal by Subject|1
2067798|NCT00604214|3645302|FG001|Day 91 to Day 180|Withdrawal by Subject|1
2067799|NCT00604279|3645310|FG000|Overall Study|Lack of Efficacy|22
2067800|NCT00604279|3645311|FG001|Overall Study|Lack of Efficacy|9
2067801|NCT00604279|3645310|FG000|Overall Study|Lost to Follow-up|9
2067802|NCT00604279|3645311|FG001|Overall Study|Lost to Follow-up|14
2067803|NCT00604279|3645310|FG000|Overall Study|Pregnancy|2
2067804|NCT00604279|3645311|FG001|Overall Study|Pregnancy|0
2067805|NCT00604279|3645310|FG000|Overall Study|Protocol Violation|3
2067806|NCT00604279|3645311|FG001|Overall Study|Protocol Violation|1
2067807|NCT00604279|3645310|FG000|Overall Study|Withdrawal by Subject|16
2067808|NCT00604279|3645311|FG001|Overall Study|Withdrawal by Subject|5
2067809|NCT00604279|3645310|FG000|Overall Study|Adverse Event|4
2067810|NCT00604279|3645311|FG001|Overall Study|Adverse Event|5
2067811|NCT00604279|3645310|FG000|Overall Study|Other|8
2067812|NCT00604279|3645311|FG001|Overall Study|Other|4
2067813|NCT00604383|3645319|FG000|Overall Study|Withdrawal by Subject|33
2067814|NCT00604383|3645320|FG001|Overall Study|Withdrawal by Subject|31
2067815|NCT00604383|3645319|FG000|Overall Study|Lost to Follow-up|24
2067816|NCT00604383|3645320|FG001|Overall Study|Lost to Follow-up|19
2067817|NCT00604383|3645319|FG000|Overall Study|Death|14
2067818|NCT00604383|3645320|FG001|Overall Study|Death|22
2067819|NCT00604383|3645319|FG000|Overall Study|Adverse Event|16
2067820|NCT00604383|3645320|FG001|Overall Study|Adverse Event|9
2067821|NCT00604383|3645319|FG000|Overall Study|Physician Decision|0
2067822|NCT00604383|3645320|FG001|Overall Study|Physician Decision|3
2067823|NCT00604565|3645343|FG000|Overall Study|Study terminated|0
2067824|NCT00604565|3645344|FG001|Overall Study|Study terminated|3
2067825|NCT00604669|3645350|FG000|Overall Study|lack of information in chart|7
2067826|NCT00604695|3645356|FG000|Overall Study|Did not receive first bolus.|0
2067827|NCT00604695|3645357|FG001|Overall Study|Did not receive first bolus.|4
2067828|NCT00604708|3645365|FG000|Overall Study|Withdrawal by Subject|9
2067829|NCT00604708|3645366|FG001|Overall Study|Withdrawal by Subject|10
2067830|NCT00604708|3645365|FG000|Overall Study|Protocol Violation|2
2067831|NCT00604708|3645366|FG001|Overall Study|Protocol Violation|8
2067832|NCT00604708|3645365|FG000|Overall Study|Lost to Follow-up|5
2067833|NCT00604708|3645366|FG001|Overall Study|Lost to Follow-up|5
2067834|NCT00604708|3645365|FG000|Overall Study|administrative reasons|9
2067835|NCT00604708|3645366|FG001|Overall Study|administrative reasons|11
2067836|NCT00604708|3645365|FG000|Overall Study|Adverse Event|6
2067837|NCT00604708|3645366|FG001|Overall Study|Adverse Event|6
2067838|NCT00604721|3645372|FG000|Overall Study|Physician Decision|1
2067839|NCT00604721|3645372|FG000|Overall Study|Withdrawal by Subject|1
2067840|NCT00604786|3645379|FG000|Overall Study|Lost to Follow-up|2
2067841|NCT00604786|3645380|FG001|Overall Study|Lost to Follow-up|0
2067842|NCT00604825|3645390|FG000|Overall Study|Adverse Event|2
2067843|NCT00604825|3645391|FG001|Overall Study|Adverse Event|6
2067844|NCT00604825|3645392|FG002|Overall Study|Adverse Event|7
2067845|NCT00604825|3645393|FG003|Overall Study|Adverse Event|4
2067846|NCT00604825|3645390|FG000|Overall Study|Lost to Follow-up|0
2067847|NCT00604825|3645391|FG001|Overall Study|Lost to Follow-up|3
2067848|NCT00604825|3645392|FG002|Overall Study|Lost to Follow-up|1
2067849|NCT00604825|3645393|FG003|Overall Study|Lost to Follow-up|0
2067850|NCT00604825|3645390|FG000|Overall Study|Protocol Violation|0
2067851|NCT00604825|3645391|FG001|Overall Study|Protocol Violation|1
2067852|NCT00604825|3645392|FG002|Overall Study|Protocol Violation|0
2067853|NCT00604825|3645393|FG003|Overall Study|Protocol Violation|0
2067854|NCT00604825|3645390|FG000|Overall Study|Withdrawal by Subject|4
2067855|NCT00604825|3645391|FG001|Overall Study|Withdrawal by Subject|3
2067856|NCT00604825|3645392|FG002|Overall Study|Withdrawal by Subject|5
2067857|NCT00604825|3645393|FG003|Overall Study|Withdrawal by Subject|5
2067858|NCT00604825|3645390|FG000|Overall Study|Lack of Efficacy|3
2067859|NCT00604825|3645391|FG001|Overall Study|Lack of Efficacy|2
2067860|NCT00604825|3645392|FG002|Overall Study|Lack of Efficacy|1
2067861|NCT00604825|3645393|FG003|Overall Study|Lack of Efficacy|0
2067862|NCT00604825|3645390|FG000|Overall Study|Did not meet eligibility criteria|0
2067863|NCT00604825|3645391|FG001|Overall Study|Did not meet eligibility criteria|0
2067864|NCT00604825|3645392|FG002|Overall Study|Did not meet eligibility criteria|2
2067865|NCT00604825|3645393|FG003|Overall Study|Did not meet eligibility criteria|0
2067866|NCT00604825|3645390|FG000|Overall Study|Physician Decision|0
2067867|NCT00604825|3645391|FG001|Overall Study|Physician Decision|0
2067868|NCT00604825|3645392|FG002|Overall Study|Physician Decision|0
2067869|NCT00604825|3645393|FG003|Overall Study|Physician Decision|1
2067870|NCT00604825|3645390|FG000|Overall Study|Exclusion criterion met|0
2067871|NCT00604825|3645391|FG001|Overall Study|Exclusion criterion met|0
2067872|NCT00604825|3645392|FG002|Overall Study|Exclusion criterion met|0
2067873|NCT00604825|3645393|FG003|Overall Study|Exclusion criterion met|1
2067874|NCT00605033|3645427|FG000|Overall Study|Adverse Event|2
2067875|NCT00605033|3645428|FG001|Overall Study|Adverse Event|2
2067876|NCT00605033|3645427|FG000|Overall Study|Lost to Follow-up|1
2067877|NCT00605033|3645428|FG001|Overall Study|Lost to Follow-up|1
2067878|NCT00605033|3645427|FG000|Overall Study|Withdrawal by Subject|3
2067879|NCT00605033|3645428|FG001|Overall Study|Withdrawal by Subject|4
2067880|NCT00605033|3645427|FG000|Overall Study|Protocol Violation|1
2067881|NCT00605033|3645428|FG001|Overall Study|Protocol Violation|1
2067882|NCT00605085|3645449|FG000|Overall Study|Withdrawal by Subject|8
2067883|NCT00605085|3645450|FG001|Overall Study|Withdrawal by Subject|5
2067884|NCT00605085|3645449|FG000|Overall Study|Adverse Event|9
2067885|NCT00605085|3645450|FG001|Overall Study|Adverse Event|5
2067886|NCT00605085|3645449|FG000|Overall Study|Pregnancy|2
2067887|NCT00605085|3645450|FG001|Overall Study|Pregnancy|0
2067888|NCT00605085|3645449|FG000|Overall Study|Protocol Violation|3
2067889|NCT00605085|3645450|FG001|Overall Study|Protocol Violation|2
2067890|NCT00605085|3645449|FG000|Overall Study|Lost to Follow-up|10
2067891|NCT00605085|3645450|FG001|Overall Study|Lost to Follow-up|5
2067892|NCT00605085|3645449|FG000|Overall Study|administrative reasons|18
2067893|NCT00605085|3645450|FG001|Overall Study|administrative reasons|8
2067894|NCT00605176|3645463|FG000|Overall Study|Adverse Event|2
2067895|NCT00605176|3645464|FG001|Overall Study|Adverse Event|1
2067896|NCT00605176|3645465|FG002|Overall Study|Adverse Event|3
2067897|NCT00605176|3645463|FG000|Overall Study|Withdrawal by Subject|4
2067898|NCT00605176|3645464|FG001|Overall Study|Withdrawal by Subject|2
2067899|NCT00605176|3645465|FG002|Overall Study|Withdrawal by Subject|4
2067900|NCT00605176|3645463|FG000|Overall Study|Lost to Follow-up|2
2067901|NCT00605176|3645464|FG001|Overall Study|Lost to Follow-up|2
2067902|NCT00605176|3645465|FG002|Overall Study|Lost to Follow-up|1
2067903|NCT00605176|3645463|FG000|Overall Study|Non-complicance with study procedures|1
2067904|NCT00605176|3645464|FG001|Overall Study|Non-complicance with study procedures|0
2067905|NCT00605176|3645465|FG002|Overall Study|Non-complicance with study procedures|0
2067906|NCT00605176|3645463|FG000|Overall Study|Use of concomitant therapy|1
2067907|NCT00605176|3645464|FG001|Overall Study|Use of concomitant therapy|0
2067908|NCT00605176|3645465|FG002|Overall Study|Use of concomitant therapy|1
2067909|NCT00605176|3645463|FG000|Overall Study|Other (not due to AE)|1
2067910|NCT00605176|3645464|FG001|Overall Study|Other (not due to AE)|1
2067911|NCT00605176|3645465|FG002|Overall Study|Other (not due to AE)|0
2067912|NCT00605189|3645476|FG000|Overall Study|Adverse Event|1
2067913|NCT00605189|3645477|FG001|Overall Study|Adverse Event|0
2067914|NCT00605189|3645478|FG002|Overall Study|Adverse Event|0
2067915|NCT00605189|3645476|FG000|Overall Study|Other|2
2067916|NCT00605189|3645477|FG001|Overall Study|Other|2
2067917|NCT00605189|3645478|FG002|Overall Study|Other|0
2067918|NCT00605267|3645495|FG000|Overall Study|Adverse Event|0
2067919|NCT00605267|3645496|FG001|Overall Study|Adverse Event|1
2067920|NCT00605267|3645495|FG000|Overall Study|Lack of Efficacy|1
2067921|NCT00605267|3645496|FG001|Overall Study|Lack of Efficacy|5
2067922|NCT00605267|3645495|FG000|Overall Study|Withdrawal by Subject|2
2067923|NCT00605267|3645496|FG001|Overall Study|Withdrawal by Subject|3
2067924|NCT00605280|3645506|FG000|Year 1|Protocol Violation|0
2067925|NCT00605280|3645507|FG001|Year 1|Protocol Violation|0
2067926|NCT00605280|3645508|FG002|Year 1|Protocol Violation|0
2067927|NCT00605280|3645509|FG003|Year 1|Protocol Violation|1
2067928|NCT00605280|3645506|FG000|Year 1|Adverse Event|3
2067929|NCT00605280|3645507|FG001|Year 1|Adverse Event|1
2067930|NCT00605280|3645508|FG002|Year 1|Adverse Event|1
2067931|NCT00605280|3645509|FG003|Year 1|Adverse Event|5
2067932|NCT00605280|3645506|FG000|Year 1|Physician Decision|7
2067933|NCT00605280|3645507|FG001|Year 1|Physician Decision|4
2067934|NCT00605280|3645508|FG002|Year 1|Physician Decision|0
2067935|NCT00605280|3645509|FG003|Year 1|Physician Decision|6
2067936|NCT00605280|3645506|FG000|Year 1|Withdrawal by Subject|2
2067937|NCT00605280|3645507|FG001|Year 1|Withdrawal by Subject|4
2067938|NCT00605280|3645508|FG002|Year 1|Withdrawal by Subject|0
2067939|NCT00605280|3645509|FG003|Year 1|Withdrawal by Subject|4
2067940|NCT00605280|3645506|FG000|Year 1|Other|2
2067941|NCT00605280|3645507|FG001|Year 1|Other|1
2210247|NCT01648764|3849713|FG006|Overall Study|Withdrawal by Subject|2
2067942|NCT00605280|3645508|FG002|Year 1|Other|0
2067943|NCT00605280|3645509|FG003|Year 1|Other|1
2210248|NCT01648764|3849714|FG007|Overall Study|Withdrawal by Subject|0
2210249|NCT01648764|3849715|FG008|Overall Study|Withdrawal by Subject|0
2210250|NCT01648764|3849716|FG009|Overall Study|Withdrawal by Subject|0
2210251|NCT01648764|3849717|FG010|Overall Study|Withdrawal by Subject|0
2210252|NCT01648764|3849718|FG011|Overall Study|Withdrawal by Subject|0
2210253|NCT01648764|3849719|FG012|Overall Study|Withdrawal by Subject|1
2210254|NCT01648764|3849720|FG013|Overall Study|Withdrawal by Subject|0
2210255|NCT01648764|3849707|FG000|Overall Study|Investigator Decision|0
2210256|NCT01648764|3849708|FG001|Overall Study|Investigator Decision|0
2210257|NCT01648764|3849709|FG002|Overall Study|Investigator Decision|0
2067944|NCT00605280|3645506|FG000|Year 1|Lost to Follow-up or Patient non-comply|5
2067945|NCT00605280|3645507|FG001|Year 1|Lost to Follow-up or Patient non-comply|1
2067946|NCT00605280|3645508|FG002|Year 1|Lost to Follow-up or Patient non-comply|0
2067947|NCT00605280|3645509|FG003|Year 1|Lost to Follow-up or Patient non-comply|2
2067948|NCT00605280|3645506|FG000|Year 2|Adverse Event|4
2067949|NCT00605280|3645507|FG001|Year 2|Adverse Event|0
2067950|NCT00605280|3645508|FG002|Year 2|Adverse Event|2
2067951|NCT00605280|3645509|FG003|Year 2|Adverse Event|4
2067952|NCT00605280|3645506|FG000|Year 2|Physician Decision|11
2067953|NCT00605280|3645507|FG001|Year 2|Physician Decision|6
2067954|NCT00605280|3645508|FG002|Year 2|Physician Decision|4
2067955|NCT00605280|3645509|FG003|Year 2|Physician Decision|11
2067956|NCT00605280|3645506|FG000|Year 2|Withdrawal by Subject|4
2067957|NCT00605280|3645507|FG001|Year 2|Withdrawal by Subject|0
2067958|NCT00605280|3645508|FG002|Year 2|Withdrawal by Subject|0
2067959|NCT00605280|3645509|FG003|Year 2|Withdrawal by Subject|4
2067960|NCT00605280|3645506|FG000|Year 2|Other|1
2067961|NCT00605280|3645507|FG001|Year 2|Other|0
2067962|NCT00605280|3645508|FG002|Year 2|Other|0
2067963|NCT00605280|3645509|FG003|Year 2|Other|1
2067964|NCT00605280|3645506|FG000|Year 2|Lost to Follow-up or Patient non-comply|4
2067965|NCT00605280|3645507|FG001|Year 2|Lost to Follow-up or Patient non-comply|0
2067966|NCT00605280|3645508|FG002|Year 2|Lost to Follow-up or Patient non-comply|0
2067967|NCT00605280|3645509|FG003|Year 2|Lost to Follow-up or Patient non-comply|2
2067968|NCT00605280|3645506|FG000|Year 3 Extension|Adverse Event|2
2067969|NCT00605280|3645507|FG001|Year 3 Extension|Adverse Event|0
2067970|NCT00605280|3645508|FG002|Year 3 Extension|Adverse Event|0
2067971|NCT00605280|3645509|FG003|Year 3 Extension|Adverse Event|2
2067972|NCT00605280|3645506|FG000|Year 3 Extension|Physician Decision|0
2067973|NCT00605280|3645507|FG001|Year 3 Extension|Physician Decision|0
2067974|NCT00605280|3645508|FG002|Year 3 Extension|Physician Decision|0
2067975|NCT00605280|3645509|FG003|Year 3 Extension|Physician Decision|2
2067976|NCT00605280|3645506|FG000|Year 3 Extension|Withdrawal by Subject|2
2067977|NCT00605280|3645507|FG001|Year 3 Extension|Withdrawal by Subject|0
2067978|NCT00605280|3645508|FG002|Year 3 Extension|Withdrawal by Subject|0
2067979|NCT00605280|3645509|FG003|Year 3 Extension|Withdrawal by Subject|5
2067980|NCT00605280|3645506|FG000|Year 3 Extension|Other|2
2067981|NCT00605280|3645507|FG001|Year 3 Extension|Other|0
2067982|NCT00605280|3645508|FG002|Year 3 Extension|Other|0
2067983|NCT00605280|3645509|FG003|Year 3 Extension|Other|0
2067984|NCT00605280|3645506|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
2067985|NCT00605280|3645507|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
2067986|NCT00605280|3645508|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
2067987|NCT00605280|3645509|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
2067988|NCT00605293|3645521|FG000|Overall Study|Death|2
2067989|NCT00605293|3645522|FG001|Overall Study|Death|1
2067990|NCT00605293|3645521|FG000|Overall Study|Insufficient Therapeutic Response|2
2067991|NCT00605293|3645522|FG001|Overall Study|Insufficient Therapeutic Response|0
2067992|NCT00605293|3645521|FG000|Overall Study|Adverse Event|1
2067993|NCT00605293|3645522|FG001|Overall Study|Adverse Event|0
2067994|NCT00605293|3645521|FG000|Overall Study|Holidays Dialysis Out|1
2067995|NCT00605293|3645522|FG001|Overall Study|Holidays Dialysis Out|0
2067996|NCT00605293|3645521|FG000|Overall Study|Blood Transfusion|7
2067997|NCT00605293|3645522|FG001|Overall Study|Blood Transfusion|1
2067998|NCT00605293|3645521|FG000|Overall Study|Renal Transplantation|3
2067999|NCT00605293|3645522|FG001|Overall Study|Renal Transplantation|1
2068000|NCT00605293|3645521|FG000|Overall Study|Incorrect Epoetin Beta Administration|1
2068001|NCT00605293|3645522|FG001|Overall Study|Incorrect Epoetin Beta Administration|0
2068002|NCT00605293|3645521|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0
2068003|NCT00605293|3645522|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1
2068004|NCT00605293|3645521|FG000|Overall Study|Principal Investigator Decision|0
2068005|NCT00605293|3645522|FG001|Overall Study|Principal Investigator Decision|1
2068006|NCT00605306|3645530|FG000|Overall Study|Adverse Event|0
2068007|NCT00605306|3645531|FG001|Overall Study|Adverse Event|1
2068008|NCT00605319|3645537|FG000|Overall Study|Adverse Event|6
2068009|NCT00605345|3645549|FG000|Overall Study|Withdrawal by Subject|1
2068010|NCT00605345|3645550|FG001|Overall Study|Withdrawal by Subject|0
2068011|NCT00605345|3645549|FG000|Overall Study|Adverse Event|0
2068012|NCT00605345|3645550|FG001|Overall Study|Adverse Event|1
2068013|NCT00605345|3645549|FG000|Overall Study|Protocol Violation|0
2068014|NCT00605345|3645550|FG001|Overall Study|Protocol Violation|2
2068015|NCT00605475|3645593|FG000|Overall Study|Abnormal Laboratory Values|0
2068016|NCT00605475|3645594|FG001|Overall Study|Abnormal Laboratory Values|0
2068017|NCT00605475|3645595|FG002|Overall Study|Abnormal Laboratory Values|0
2068018|NCT00605475|3645596|FG003|Overall Study|Abnormal Laboratory Values|0
2303023|NCT02634801|4002163|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
2303024|NCT02634801|4002164|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
2303025|NCT02634801|4002165|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
2303026|NCT02634801|4002163|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
2303027|NCT02634801|4002164|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
2303028|NCT02634801|4002165|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
2303029|NCT02634801|4002163|FG000|Extension Period (Weeks 24 to 36)|Missing|1
2303030|NCT02634801|4002164|FG001|Extension Period (Weeks 24 to 36)|Missing|0
2303031|NCT02634801|4002165|FG002|Extension Period (Weeks 24 to 36)|Missing|0
2303032|NCT02634801|4002163|FG000|Follow-up Period|Lost to Follow-up|3
2303033|NCT02634801|4002164|FG001|Follow-up Period|Lost to Follow-up|1
2303034|NCT02634801|4002165|FG002|Follow-up Period|Lost to Follow-up|2
2303035|NCT02634801|4002163|FG000|Follow-up Period|Physician Decision|0
2303036|NCT02634801|4002164|FG001|Follow-up Period|Physician Decision|0
2303037|NCT02634801|4002165|FG002|Follow-up Period|Physician Decision|1
2303038|NCT02634801|4002163|FG000|Follow-up Period|Withdrawal by Subject|1
2303039|NCT02634801|4002164|FG001|Follow-up Period|Withdrawal by Subject|2
2303040|NCT02634801|4002165|FG002|Follow-up Period|Withdrawal by Subject|5
2303041|NCT02634801|4002163|FG000|Follow-up Period|Adverse Event|1
2303042|NCT02634801|4002164|FG001|Follow-up Period|Adverse Event|5
2303043|NCT02634801|4002165|FG002|Follow-up Period|Adverse Event|0
2303044|NCT02634983|4002190|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
2303045|NCT02634983|4002191|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
2303046|NCT02635204|4002208|FG000|Overall Study|Adverse Event|1
2303047|NCT02635204|4002209|FG001|Overall Study|Adverse Event|0
2303048|NCT02635204|4002208|FG000|Overall Study|Lost to Follow-up|1
2303049|NCT02635204|4002209|FG001|Overall Study|Lost to Follow-up|1
2303050|NCT02635347|4002217|FG000|Overall Study|Failed screening|20
2303051|NCT02635347|4002218|FG001|Overall Study|Failed screening|7
2303052|NCT02635386|4002230|FG000|Overall Study|Pregnancy|2
2303053|NCT02635386|4002231|FG001|Overall Study|Pregnancy|0
2303054|NCT02635386|4002232|FG002|Overall Study|Pregnancy|0
2068019|NCT00605475|3645597|FG004|Overall Study|Abnormal Laboratory Values|0
2068020|NCT00605475|3645598|FG005|Overall Study|Abnormal Laboratory Values|0
2068021|NCT00605475|3645599|FG006|Overall Study|Abnormal Laboratory Values|0
2068022|NCT00605475|3645600|FG007|Overall Study|Abnormal Laboratory Values|0
2068023|NCT00605475|3645601|FG008|Overall Study|Abnormal Laboratory Values|1
2068024|NCT00605475|3645602|FG009|Overall Study|Abnormal Laboratory Values|0
2068025|NCT00605475|3645593|FG000|Overall Study|Administrative problems|0
2303055|NCT02635386|4002233|FG003|Overall Study|Pregnancy|0
2303056|NCT02635386|4002234|FG004|Overall Study|Pregnancy|2
2303057|NCT02635386|4002230|FG000|Overall Study|Withdrawal by Subject|1
2303058|NCT02635386|4002231|FG001|Overall Study|Withdrawal by Subject|1
2068026|NCT00605475|3645594|FG001|Overall Study|Administrative problems|0
2068027|NCT00605475|3645595|FG002|Overall Study|Administrative problems|0
2068028|NCT00605475|3645596|FG003|Overall Study|Administrative problems|0
2068029|NCT00605475|3645597|FG004|Overall Study|Administrative problems|0
2068030|NCT00605475|3645598|FG005|Overall Study|Administrative problems|0
2068031|NCT00605475|3645599|FG006|Overall Study|Administrative problems|1
2068032|NCT00605475|3645600|FG007|Overall Study|Administrative problems|0
2068033|NCT00605475|3645601|FG008|Overall Study|Administrative problems|0
2068034|NCT00605475|3645602|FG009|Overall Study|Administrative problems|0
2068035|NCT00605475|3645593|FG000|Overall Study|Lost to Follow-up|0
2068036|NCT00605475|3645594|FG001|Overall Study|Lost to Follow-up|0
2068037|NCT00605475|3645595|FG002|Overall Study|Lost to Follow-up|0
2068038|NCT00605475|3645596|FG003|Overall Study|Lost to Follow-up|0
2068039|NCT00605475|3645597|FG004|Overall Study|Lost to Follow-up|0
2068040|NCT00605475|3645598|FG005|Overall Study|Lost to Follow-up|0
2068041|NCT00605475|3645599|FG006|Overall Study|Lost to Follow-up|0
2068042|NCT00605475|3645600|FG007|Overall Study|Lost to Follow-up|0
2068043|NCT00605475|3645601|FG008|Overall Study|Lost to Follow-up|1
2068044|NCT00605475|3645602|FG009|Overall Study|Lost to Follow-up|1
2068045|NCT00605475|3645593|FG000|Overall Study|Protocol Violation|0
2068046|NCT00605475|3645594|FG001|Overall Study|Protocol Violation|0
2068047|NCT00605475|3645595|FG002|Overall Study|Protocol Violation|0
2068048|NCT00605475|3645596|FG003|Overall Study|Protocol Violation|0
2068049|NCT00605475|3645597|FG004|Overall Study|Protocol Violation|1
2068050|NCT00605475|3645598|FG005|Overall Study|Protocol Violation|0
2068051|NCT00605475|3645599|FG006|Overall Study|Protocol Violation|0
2068052|NCT00605475|3645600|FG007|Overall Study|Protocol Violation|0
2068053|NCT00605475|3645601|FG008|Overall Study|Protocol Violation|0
2068054|NCT00605475|3645602|FG009|Overall Study|Protocol Violation|0
2068055|NCT00605475|3645593|FG000|Overall Study|Withdrawal by Subject|0
2068056|NCT00605475|3645594|FG001|Overall Study|Withdrawal by Subject|0
2068057|NCT00605475|3645595|FG002|Overall Study|Withdrawal by Subject|0
2068058|NCT00605475|3645596|FG003|Overall Study|Withdrawal by Subject|0
2068059|NCT00605475|3645597|FG004|Overall Study|Withdrawal by Subject|0
2068060|NCT00605475|3645598|FG005|Overall Study|Withdrawal by Subject|2
2068061|NCT00605475|3645599|FG006|Overall Study|Withdrawal by Subject|0
2068062|NCT00605475|3645600|FG007|Overall Study|Withdrawal by Subject|0
2068063|NCT00605475|3645601|FG008|Overall Study|Withdrawal by Subject|0
2068064|NCT00605475|3645602|FG009|Overall Study|Withdrawal by Subject|1
2068065|NCT00605540|3645645|FG000|Overall Study|Death|15
2068066|NCT00605540|3645645|FG000|Overall Study|Lost to Follow-up|23
2068067|NCT00605566|3645649|FG000|Overall Study|Adverse Event|1
2068068|NCT00605566|3645649|FG000|Overall Study|Clinical deterioration|1
2068069|NCT00605566|3645649|FG000|Overall Study|Poor compliance in run-in period|1
2068070|NCT00605657|3645674|FG000|Overall Study|Adverse Event|1
2068071|NCT00605657|3645674|FG000|Overall Study|Protocol Violation|1
2068072|NCT00605722|3645687|FG000|Overall Study|Adverse Event|6
2068073|NCT00605722|3645687|FG000|Overall Study|Insufficient therapeutic response|44
2068074|NCT00605722|3645687|FG000|Overall Study|Failure to return|1
2068075|NCT00605813|3645691|FG000|Overall Study|Protocol Violation|25
2068076|NCT00605839|3645716|FG000|Overall Study|Protocol Violation|1
2068077|NCT00605839|3645717|FG001|Overall Study|Protocol Violation|0
2068078|NCT00605839|3645718|FG002|Overall Study|Protocol Violation|0
2068079|NCT00605865|3645726|FG000|Overall Study|Protocol Violation|115
2068080|NCT00605917|3645767|FG000|Overall Study|Protocol Violation|79
2068081|NCT00606008|3645802|FG000|Overall Study|Adverse Event|1
2068082|NCT00606008|3645802|FG000|Overall Study|Withdrawal by Subject|4
2068083|NCT00606021|3645812|FG000|Induction Phase|Death|73
2068084|NCT00606021|3645813|FG001|Induction Phase|Death|0
2068085|NCT00606021|3645814|FG002|Induction Phase|Death|0
2068086|NCT00606021|3645812|FG000|Induction Phase|Physician Decision|2
2068087|NCT00606021|3645813|FG001|Induction Phase|Physician Decision|0
2068088|NCT00606021|3645814|FG002|Induction Phase|Physician Decision|0
2068089|NCT00606021|3645812|FG000|Induction Phase|Withdrawal by Subject|2
2068090|NCT00606021|3645813|FG001|Induction Phase|Withdrawal by Subject|0
2068091|NCT00606021|3645814|FG002|Induction Phase|Withdrawal by Subject|0
2068092|NCT00606021|3645812|FG000|Induction Phase|Lost to Follow-up|10
2068093|NCT00606021|3645813|FG001|Induction Phase|Lost to Follow-up|0
2068094|NCT00606021|3645814|FG002|Induction Phase|Lost to Follow-up|0
2068095|NCT00606021|3645812|FG000|Maintenance Phase|Death|0
2068096|NCT00606021|3645813|FG001|Maintenance Phase|Death|17
2068097|NCT00606021|3645814|FG002|Maintenance Phase|Death|15
2068098|NCT00606021|3645812|FG000|Maintenance Phase|Physician Decision|0
2068099|NCT00606021|3645813|FG001|Maintenance Phase|Physician Decision|1
2068100|NCT00606021|3645814|FG002|Maintenance Phase|Physician Decision|0
2068101|NCT00606021|3645812|FG000|Maintenance Phase|Lost to Follow-up|0
2068102|NCT00606021|3645813|FG001|Maintenance Phase|Lost to Follow-up|5
2068103|NCT00606021|3645814|FG002|Maintenance Phase|Lost to Follow-up|2
2068104|NCT00606034|3645822|FG000|Overall Study|incarceration|1
2068105|NCT00606086|3645834|FG000|Overall Study|Adverse Event|1
2068106|NCT00606086|3645835|FG001|Overall Study|Adverse Event|1
2068107|NCT00606086|3645834|FG000|Overall Study|Lost to Follow-up|4
2068108|NCT00606086|3645835|FG001|Overall Study|Lost to Follow-up|8
2068109|NCT00606086|3645834|FG000|Overall Study|Protocol Violation|1
2068110|NCT00606086|3645835|FG001|Overall Study|Protocol Violation|0
2068111|NCT00606086|3645834|FG000|Overall Study|Withdrawal by Subject|5
2068112|NCT00606086|3645835|FG001|Overall Study|Withdrawal by Subject|3
2068113|NCT00606086|3645834|FG000|Overall Study|Non-compliance|0
2210258|NCT01648764|3849710|FG003|Overall Study|Investigator Decision|0
2210259|NCT01648764|3849711|FG004|Overall Study|Investigator Decision|0
2210260|NCT01648764|3849712|FG005|Overall Study|Investigator Decision|0
2303059|NCT02635386|4002232|FG002|Overall Study|Withdrawal by Subject|0
2068114|NCT00606086|3645835|FG001|Overall Study|Non-compliance|1
2068115|NCT00606086|3645834|FG000|Overall Study|Randomized, not treated|1
2068116|NCT00606086|3645835|FG001|Overall Study|Randomized, not treated|2
2068117|NCT00606177|3645852|FG000|Overall Study|Adverse Event|9
2068118|NCT00606177|3645853|FG001|Overall Study|Adverse Event|5
2068119|NCT00606177|3645852|FG000|Overall Study|Lack of Efficacy|3
2303060|NCT02635386|4002233|FG003|Overall Study|Withdrawal by Subject|1
2303061|NCT02635386|4002234|FG004|Overall Study|Withdrawal by Subject|0
2303062|NCT02635386|4002230|FG000|Overall Study|Physician Decision|0
2303063|NCT02635386|4002231|FG001|Overall Study|Physician Decision|1
2303064|NCT02635386|4002232|FG002|Overall Study|Physician Decision|0
2303065|NCT02635386|4002233|FG003|Overall Study|Physician Decision|0
2068120|NCT00606177|3645853|FG001|Overall Study|Lack of Efficacy|7
2068121|NCT00606177|3645852|FG000|Overall Study|Physician Decision|1
2068122|NCT00606177|3645853|FG001|Overall Study|Physician Decision|0
2068123|NCT00606177|3645852|FG000|Overall Study|Protocol Violation|1
2068124|NCT00606177|3645853|FG001|Overall Study|Protocol Violation|4
2068125|NCT00606177|3645852|FG000|Overall Study|Withdrawal by Subject|5
2068126|NCT00606177|3645853|FG001|Overall Study|Withdrawal by Subject|6
2068127|NCT00606177|3645852|FG000|Overall Study|Progression to depressive phase|6
2068128|NCT00606177|3645853|FG001|Overall Study|Progression to depressive phase|1
2068129|NCT00606177|3645852|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1
2068130|NCT00606177|3645853|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1
2068131|NCT00606177|3645852|FG000|Overall Study|Change of residence or other commitments|1
2068132|NCT00606177|3645853|FG001|Overall Study|Change of residence or other commitments|1
2068133|NCT00606229|3645859|FG000|Overall Study|Adverse Event|11
2068134|NCT00606229|3645859|FG000|Overall Study|Lack of Efficacy|1
2068135|NCT00606229|3645859|FG000|Overall Study|Withdrawal by Subject|4
2068136|NCT00606229|3645859|FG000|Overall Study|does not meet inclusion criterion 1-3|4
2068137|NCT00606229|3645859|FG000|Overall Study|change of residence or other commitments|2
2068138|NCT00606281|3645865|FG000|Overall Study|Adverse Event|11
2068139|NCT00606281|3645866|FG001|Overall Study|Adverse Event|12
2068140|NCT00606281|3645865|FG000|Overall Study|Death|1
2068141|NCT00606281|3645866|FG001|Overall Study|Death|0
2068142|NCT00606281|3645865|FG000|Overall Study|Lack of Efficacy|28
2068143|NCT00606281|3645866|FG001|Overall Study|Lack of Efficacy|35
2303066|NCT02635386|4002234|FG004|Overall Study|Physician Decision|0
2303067|NCT02635386|4002230|FG000|Overall Study|Moved Out of State|0
2303068|NCT02635386|4002231|FG001|Overall Study|Moved Out of State|1
2303069|NCT02635386|4002232|FG002|Overall Study|Moved Out of State|0
2303070|NCT02635386|4002233|FG003|Overall Study|Moved Out of State|0
2303071|NCT02635386|4002234|FG004|Overall Study|Moved Out of State|0
2303072|NCT02635386|4002230|FG000|Overall Study|Noncompliant|0
2303073|NCT02635386|4002231|FG001|Overall Study|Noncompliant|2
2303074|NCT02635386|4002232|FG002|Overall Study|Noncompliant|1
2303075|NCT02635386|4002233|FG003|Overall Study|Noncompliant|1
2303076|NCT02635386|4002234|FG004|Overall Study|Noncompliant|1
2303077|NCT02635386|4002230|FG000|Overall Study|side effects|0
2303078|NCT02635386|4002231|FG001|Overall Study|side effects|0
2303079|NCT02635386|4002232|FG002|Overall Study|side effects|1
2303080|NCT02635386|4002233|FG003|Overall Study|side effects|4
2303081|NCT02635386|4002234|FG004|Overall Study|side effects|6
2303082|NCT02635386|4002230|FG000|Overall Study|needed other major surgery|0
2303083|NCT02635386|4002231|FG001|Overall Study|needed other major surgery|1
2303084|NCT02635386|4002232|FG002|Overall Study|needed other major surgery|0
2303085|NCT02635386|4002233|FG003|Overall Study|needed other major surgery|0
2303086|NCT02635386|4002234|FG004|Overall Study|needed other major surgery|0
2303087|NCT02635386|4002230|FG000|Overall Study|Other medical problems not drug related|0
2303088|NCT02635386|4002231|FG001|Overall Study|Other medical problems not drug related|0
2303089|NCT02635386|4002232|FG002|Overall Study|Other medical problems not drug related|0
2303090|NCT02635386|4002233|FG003|Overall Study|Other medical problems not drug related|1
2303091|NCT02635386|4002234|FG004|Overall Study|Other medical problems not drug related|0
2303092|NCT02635646|4002271|FG000|Overall Study|Lost to Follow-up|24
2303093|NCT02635646|4002272|FG001|Overall Study|Lost to Follow-up|25
2303094|NCT02635646|4002271|FG000|Overall Study|Pregnancy|1
2303095|NCT02635646|4002272|FG001|Overall Study|Pregnancy|1
2303096|NCT02635724|4002287|FG000|Overall Study|Withdrawal by Subject|0
2303097|NCT02635724|4002288|FG001|Overall Study|Withdrawal by Subject|1
2303098|NCT02635724|4002289|FG002|Overall Study|Withdrawal by Subject|0
2303099|NCT02635737|4002297|FG000|Overall Study|Protocol Violation|1
2303100|NCT02635984|4002311|FG000|Overall Study|Lost to Follow-up|2
2303101|NCT02635984|4002312|FG001|Overall Study|Lost to Follow-up|4
2303102|NCT02635984|4002311|FG000|Overall Study|Study Arm Closed|1
2303103|NCT02635984|4002312|FG001|Overall Study|Study Arm Closed|0
2303104|NCT02636361|4002324|FG000|Period 4|Physician Decision|0
2068144|NCT00606281|3645865|FG000|Overall Study|Physician Decision|0
2068145|NCT00606281|3645866|FG001|Overall Study|Physician Decision|1
2068146|NCT00606281|3645865|FG000|Overall Study|Protocol Violation|3
2068147|NCT00606281|3645866|FG001|Overall Study|Protocol Violation|3
2068148|NCT00606281|3645865|FG000|Overall Study|Withdrawal by Subject|11
2068149|NCT00606281|3645866|FG001|Overall Study|Withdrawal by Subject|13
2068150|NCT00606281|3645865|FG000|Overall Study|Progression to depressive phase|1
2068151|NCT00606281|3645866|FG001|Overall Study|Progression to depressive phase|1
2068152|NCT00606281|3645865|FG000|Overall Study|Change of residence or other commitments|1
2068153|NCT00606281|3645866|FG001|Overall Study|Change of residence or other commitments|1
2068154|NCT00606294|3645874|FG000|Overall Study|Withdrawal by Subject|36
2068155|NCT00606294|3645875|FG001|Overall Study|Withdrawal by Subject|0
2068156|NCT00606307|3645881|FG000|Overall Study|Adverse Event|2
2068157|NCT00606307|3645881|FG000|Overall Study|Withdrawal by Subject|2
2068158|NCT00606307|3645881|FG000|Overall Study|Disease progression|6
2068159|NCT00606307|3645881|FG000|Overall Study|QTc prolongation|1
2068160|NCT00606320|3645885|FG000|Overall Study|Adverse Event|3
2068161|NCT00606320|3645885|FG000|Overall Study|Lack of Efficacy|5
2068162|NCT00606320|3645885|FG000|Overall Study|Physician Decision|7
2068163|NCT00606320|3645885|FG000|Overall Study|Protocol Violation|8
2068164|NCT00606320|3645885|FG000|Overall Study|Withdrawal by Subject|10
2068165|NCT00606320|3645885|FG000|Overall Study|Progression to depressive phase|4
2068166|NCT00606502|3645900|FG000|Randomization|Randomized but not treated|3
2068167|NCT00606502|3645901|FG001|Randomization|Randomized but not treated|0
2068168|NCT00606502|3645900|FG000|Treatment|Treatment ongoing at time of data cutoff|0
2068169|NCT00606502|3645901|FG001|Treatment|Treatment ongoing at time of data cutoff|3
2068170|NCT00606580|3645923|FG000|Overall Study|Lost to Follow-up|1
2068171|NCT00606580|3645924|FG001|Overall Study|Lost to Follow-up|1
2068172|NCT00606580|3645925|FG002|Overall Study|Lost to Follow-up|4
2068173|NCT00606580|3645923|FG000|Overall Study|Clinical failures|1
2068174|NCT00606580|3645924|FG001|Overall Study|Clinical failures|0
2068175|NCT00606580|3645925|FG002|Overall Study|Clinical failures|12
2068176|NCT00606580|3645923|FG000|Overall Study|Withdrawal by investigator|0
2068177|NCT00606580|3645924|FG001|Overall Study|Withdrawal by investigator|1
2068178|NCT00606580|3645925|FG002|Overall Study|Withdrawal by investigator|6
2068179|NCT00606580|3645923|FG000|Overall Study|Withdrawal by Subject|0
2068180|NCT00606580|3645924|FG001|Overall Study|Withdrawal by Subject|1
2068181|NCT00606580|3645925|FG002|Overall Study|Withdrawal by Subject|0
2068182|NCT00606593|3645933|FG000|Overall Study|Adverse Event|0
2068183|NCT00606593|3645934|FG001|Overall Study|Adverse Event|0
2068184|NCT00606593|3645935|FG002|Overall Study|Adverse Event|0
2068185|NCT00606593|3645936|FG003|Overall Study|Adverse Event|1
2068186|NCT00606593|3645937|FG004|Overall Study|Adverse Event|1
2068187|NCT00606593|3645938|FG005|Overall Study|Adverse Event|0
2068188|NCT00606593|3645939|FG006|Overall Study|Adverse Event|1
2068189|NCT00606593|3645940|FG007|Overall Study|Adverse Event|2
2068190|NCT00606593|3645941|FG008|Overall Study|Adverse Event|1
2068191|NCT00606593|3645942|FG009|Overall Study|Adverse Event|0
2068192|NCT00606593|3645933|FG000|Overall Study|Withdrawal of consent|1
2068193|NCT00606593|3645934|FG001|Overall Study|Withdrawal of consent|0
2068194|NCT00606593|3645935|FG002|Overall Study|Withdrawal of consent|1
2068195|NCT00606593|3645936|FG003|Overall Study|Withdrawal of consent|0
2068196|NCT00606593|3645937|FG004|Overall Study|Withdrawal of consent|0
2068197|NCT00606593|3645938|FG005|Overall Study|Withdrawal of consent|0
2068198|NCT00606593|3645939|FG006|Overall Study|Withdrawal of consent|0
2068199|NCT00606593|3645940|FG007|Overall Study|Withdrawal of consent|0
2068200|NCT00606593|3645941|FG008|Overall Study|Withdrawal of consent|0
2068201|NCT00606593|3645942|FG009|Overall Study|Withdrawal of consent|0
2068202|NCT00606593|3645933|FG000|Overall Study|Administrative/Other|0
2068203|NCT00606593|3645934|FG001|Overall Study|Administrative/Other|0
2068204|NCT00606593|3645935|FG002|Overall Study|Administrative/Other|1
2068205|NCT00606593|3645936|FG003|Overall Study|Administrative/Other|0
2068206|NCT00606593|3645937|FG004|Overall Study|Administrative/Other|0
2068207|NCT00606593|3645938|FG005|Overall Study|Administrative/Other|0
2068208|NCT00606593|3645939|FG006|Overall Study|Administrative/Other|0
2068209|NCT00606593|3645940|FG007|Overall Study|Administrative/Other|0
2068210|NCT00606593|3645941|FG008|Overall Study|Administrative/Other|0
2068211|NCT00606593|3645942|FG009|Overall Study|Administrative/Other|0
2068212|NCT00606632|3645955|FG000|Overall Study|Withdrawal by Subject|13
2068213|NCT00606632|3645955|FG000|Overall Study|Miscellaneous reasons|9
2068214|NCT00606684|3645970|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
2068215|NCT00606684|3645971|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2068216|NCT00606684|3645972|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2068217|NCT00606684|3645973|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2068218|NCT00606684|3645974|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2068219|NCT00606684|3645975|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2068220|NCT00606684|3645976|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2068221|NCT00606684|3645970|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
2068222|NCT00606684|3645971|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2068223|NCT00606684|3645972|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2068224|NCT00606684|3645973|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2068225|NCT00606684|3645974|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2068226|NCT00606684|3645975|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2068227|NCT00606684|3645976|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2068228|NCT00606684|3645970|FG000|2-week Single-Blind Run-in Period|Physician Decision|18
2068229|NCT00606684|3645971|FG001|2-week Single-Blind Run-in Period|Physician Decision|0
2068230|NCT00606684|3645972|FG002|2-week Single-Blind Run-in Period|Physician Decision|0
2068231|NCT00606684|3645973|FG003|2-week Single-Blind Run-in Period|Physician Decision|0
2068232|NCT00606684|3645974|FG004|2-week Single-Blind Run-in Period|Physician Decision|0
2068233|NCT00606684|3645975|FG005|2-week Single-Blind Run-in Period|Physician Decision|0
2068234|NCT00606684|3645976|FG006|2-week Single-Blind Run-in Period|Physician Decision|0
2068235|NCT00606684|3645970|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
2068236|NCT00606684|3645971|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2068237|NCT00606684|3645972|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2068238|NCT00606684|3645973|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2068239|NCT00606684|3645974|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2068240|NCT00606684|3645975|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2068241|NCT00606684|3645976|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2068242|NCT00606684|3645970|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5
2068243|NCT00606684|3645971|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2068244|NCT00606684|3645972|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2068245|NCT00606684|3645973|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2068246|NCT00606684|3645974|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2068247|NCT00606684|3645975|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2068248|NCT00606684|3645976|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2068249|NCT00606684|3645970|FG000|2-week Single-Blind Run-in Period|Adverse Event|2
2068250|NCT00606684|3645971|FG001|2-week Single-Blind Run-in Period|Adverse Event|0
2068251|NCT00606684|3645972|FG002|2-week Single-Blind Run-in Period|Adverse Event|0
2068252|NCT00606684|3645973|FG003|2-week Single-Blind Run-in Period|Adverse Event|0
2068253|NCT00606684|3645974|FG004|2-week Single-Blind Run-in Period|Adverse Event|0
2068254|NCT00606684|3645975|FG005|2-week Single-Blind Run-in Period|Adverse Event|0
2068255|NCT00606684|3645976|FG006|2-week Single-Blind Run-in Period|Adverse Event|0
2068256|NCT00606684|3645970|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
2068257|NCT00606684|3645971|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2068258|NCT00606684|3645972|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2068259|NCT00606684|3645973|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2068260|NCT00606684|3645974|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2068261|NCT00606684|3645975|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2068262|NCT00606684|3645976|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2068263|NCT00606684|3645970|FG000|Double-Blind Treatment Period|Adverse Event|0
2068264|NCT00606684|3645971|FG001|Double-Blind Treatment Period|Adverse Event|3
2068265|NCT00606684|3645972|FG002|Double-Blind Treatment Period|Adverse Event|2
2068266|NCT00606684|3645973|FG003|Double-Blind Treatment Period|Adverse Event|4
2068267|NCT00606684|3645974|FG004|Double-Blind Treatment Period|Adverse Event|2
2068268|NCT00606684|3645975|FG005|Double-Blind Treatment Period|Adverse Event|0
2068269|NCT00606684|3645976|FG006|Double-Blind Treatment Period|Adverse Event|1
2068270|NCT00606684|3645970|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
2068271|NCT00606684|3645971|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
2068272|NCT00606684|3645972|FG002|Double-Blind Treatment Period|Lack of Efficacy|0
2068273|NCT00606684|3645973|FG003|Double-Blind Treatment Period|Lack of Efficacy|0
2068274|NCT00606684|3645974|FG004|Double-Blind Treatment Period|Lack of Efficacy|1
2068275|NCT00606684|3645975|FG005|Double-Blind Treatment Period|Lack of Efficacy|0
2068276|NCT00606684|3645976|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
2068277|NCT00606684|3645970|FG000|Double-Blind Treatment Period|Protocol Violation|0
2068278|NCT00606684|3645971|FG001|Double-Blind Treatment Period|Protocol Violation|5
2068279|NCT00606684|3645972|FG002|Double-Blind Treatment Period|Protocol Violation|5
2068280|NCT00606684|3645973|FG003|Double-Blind Treatment Period|Protocol Violation|3
2068281|NCT00606684|3645974|FG004|Double-Blind Treatment Period|Protocol Violation|0
2068282|NCT00606684|3645975|FG005|Double-Blind Treatment Period|Protocol Violation|3
2068283|NCT00606684|3645976|FG006|Double-Blind Treatment Period|Protocol Violation|4
2068284|NCT00606684|3645970|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
2068285|NCT00606684|3645971|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
2068286|NCT00606684|3645972|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
2068287|NCT00606684|3645973|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
2303105|NCT02636361|4002325|FG001|Period 4|Physician Decision|0
2303106|NCT02636361|4002326|FG002|Period 4|Physician Decision|0
2303107|NCT02636361|4002327|FG003|Period 4|Physician Decision|1
2303108|NCT02636361|4002328|FG004|Period 4|Physician Decision|0
2303109|NCT02636595|4002342|FG000|Overall Study|Lost to Follow-up|1
2303110|NCT02636595|4002342|FG000|Overall Study|Other|1
2303111|NCT02636608|4002346|FG000|Overall Study|Failure to Return|4
2303112|NCT02636608|4002346|FG000|Overall Study|Insufficient Virological Response|1
2303113|NCT02636608|4002346|FG000|Overall Study|Death|3
2303114|NCT02636608|4002346|FG000|Overall Study|Other|2
2068288|NCT00606684|3645974|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
2210261|NCT01648764|3849713|FG006|Overall Study|Investigator Decision|1
2210262|NCT01648764|3849714|FG007|Overall Study|Investigator Decision|0
2303115|NCT02636608|4002346|FG000|Overall Study|Did Not Receive Treatment|1
2068289|NCT00606684|3645975|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
2068290|NCT00606684|3645976|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
2068291|NCT00606684|3645970|FG000|Double-Blind Treatment Period|Physician Decision|0
2068292|NCT00606684|3645971|FG001|Double-Blind Treatment Period|Physician Decision|5
2068293|NCT00606684|3645972|FG002|Double-Blind Treatment Period|Physician Decision|1
2068294|NCT00606684|3645973|FG003|Double-Blind Treatment Period|Physician Decision|0
2068295|NCT00606684|3645974|FG004|Double-Blind Treatment Period|Physician Decision|3
2068296|NCT00606684|3645975|FG005|Double-Blind Treatment Period|Physician Decision|1
2068297|NCT00606684|3645976|FG006|Double-Blind Treatment Period|Physician Decision|2
2068298|NCT00606684|3645970|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
2068299|NCT00606684|3645971|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
2068300|NCT00606684|3645972|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1
2068301|NCT00606684|3645973|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2
2068302|NCT00606684|3645974|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1
2068303|NCT00606684|3645975|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2
2068304|NCT00606684|3645976|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0
2068305|NCT00606801|3645992|FG000|Intervention|Protocol Violation|3
2068306|NCT00606801|3645993|FG001|Intervention|Protocol Violation|3
2068307|NCT00606892|3646003|FG000|First Intervention|Protocol Violation|1
2068308|NCT00606892|3646004|FG001|First Intervention|Protocol Violation|4
2068309|NCT00606905|3646038|FG000|Overall Study|No Pregnancy|9
2068310|NCT00606905|3646039|FG001|Overall Study|No Pregnancy|6
2068311|NCT00606905|3646038|FG000|Overall Study|Non-Index Pregnancy|1
2068312|NCT00606905|3646039|FG001|Overall Study|Non-Index Pregnancy|4
2068313|NCT00606905|3646038|FG000|Overall Study|Withdrew|5
2068314|NCT00606905|3646039|FG001|Overall Study|Withdrew|5
2068315|NCT00606931|3646045|FG000|Overall Study|Withdrawal by Subject|3
2068316|NCT00607022|3646061|FG000|Overall Study|Withdrawal by Subject|1
2068317|NCT00607022|3646062|FG001|Overall Study|Withdrawal by Subject|0
2068318|NCT00607022|3646063|FG002|Overall Study|Withdrawal by Subject|0
2068319|NCT00607048|3646073|FG000|Overall Study|Adverse Event|0
2068320|NCT00607048|3646074|FG001|Overall Study|Adverse Event|1
2068321|NCT00607048|3646075|FG002|Overall Study|Adverse Event|0
2068322|NCT00607048|3646076|FG003|Overall Study|Adverse Event|0
2068323|NCT00607048|3646077|FG004|Overall Study|Adverse Event|4
2068324|NCT00607048|3646078|FG005|Overall Study|Adverse Event|0
2068325|NCT00607048|3646073|FG000|Overall Study|Global deterioration of health|1
2068326|NCT00607048|3646074|FG001|Overall Study|Global deterioration of health|0
2068327|NCT00607048|3646075|FG002|Overall Study|Global deterioration of health|0
2068328|NCT00607048|3646076|FG003|Overall Study|Global deterioration of health|0
2068329|NCT00607048|3646077|FG004|Overall Study|Global deterioration of health|0
2068330|NCT00607048|3646078|FG005|Overall Study|Global deterioration of health|0
2068331|NCT00607048|3646073|FG000|Overall Study|Objective disease progression - relapse|1
2068332|NCT00607048|3646074|FG001|Overall Study|Objective disease progression - relapse|2
2068333|NCT00607048|3646075|FG002|Overall Study|Objective disease progression - relapse|4
2303116|NCT02636699|4002355|FG000|Overall Study|Adverse Event|4
2303117|NCT02636699|4002356|FG001|Overall Study|Adverse Event|0
2303118|NCT02636699|4002355|FG000|Overall Study|Lost to Follow-up|3
2303119|NCT02636699|4002356|FG001|Overall Study|Lost to Follow-up|3
2303120|NCT02636699|4002355|FG000|Overall Study|Non-compliance with the investigational product (IP)|2
2303121|NCT02636699|4002356|FG001|Overall Study|Non-compliance with the investigational product (IP)|0
2303122|NCT02636699|4002355|FG000|Overall Study|Physician Decision|0
2303123|NCT02636699|4002356|FG001|Overall Study|Physician Decision|1
2303124|NCT02636699|4002355|FG000|Overall Study|Withdrawal by Subject|13
2303125|NCT02636699|4002356|FG001|Overall Study|Withdrawal by Subject|6
2303126|NCT02636699|4002355|FG000|Overall Study|Other|3
2303127|NCT02636699|4002356|FG001|Overall Study|Other|1
2303128|NCT02636725|4002367|FG000|Baseline|Adverse Event|1
2303129|NCT02636725|4002367|FG000|Baseline|Lack of Efficacy|2
2303130|NCT02636868|4002374|FG000|Overall Study|Death|0
2303131|NCT02636868|4002375|FG001|Overall Study|Death|1
2303132|NCT02636868|4002376|FG002|Overall Study|Death|2
2303133|NCT02636907|4002384|FG000|Autoinjector Assessment Period|Adverse Event|2
2303134|NCT02636907|4002384|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2
2068334|NCT00607048|3646076|FG003|Overall Study|Objective disease progression - relapse|2
2068335|NCT00607048|3646077|FG004|Overall Study|Objective disease progression - relapse|2
2068336|NCT00607048|3646078|FG005|Overall Study|Objective disease progression - relapse|2
2068337|NCT00607048|3646073|FG000|Overall Study|Withdrawal by Subject|0
2068338|NCT00607048|3646074|FG001|Overall Study|Withdrawal by Subject|0
2068339|NCT00607048|3646075|FG002|Overall Study|Withdrawal by Subject|0
2068340|NCT00607048|3646076|FG003|Overall Study|Withdrawal by Subject|1
2068341|NCT00607048|3646077|FG004|Overall Study|Withdrawal by Subject|0
2068342|NCT00607048|3646078|FG005|Overall Study|Withdrawal by Subject|2
2068343|NCT00607048|3646073|FG000|Overall Study|Other|1
2068344|NCT00607048|3646074|FG001|Overall Study|Other|1
2068345|NCT00607048|3646075|FG002|Overall Study|Other|0
2068346|NCT00607048|3646076|FG003|Overall Study|Other|0
2068347|NCT00607048|3646077|FG004|Overall Study|Other|0
2068348|NCT00607048|3646078|FG005|Overall Study|Other|1
2068349|NCT00607087|3646097|FG000|Overall Study|Withdrawal by Subject|9
2068350|NCT00607087|3646098|FG001|Overall Study|Withdrawal by Subject|4
2068351|NCT00607087|3646099|FG002|Overall Study|Withdrawal by Subject|4
2068352|NCT00607087|3646097|FG000|Overall Study|Adverse Event|3
2068353|NCT00607087|3646098|FG001|Overall Study|Adverse Event|2
2068354|NCT00607087|3646099|FG002|Overall Study|Adverse Event|3
2068355|NCT00607087|3646097|FG000|Overall Study|Other reason|1
2068356|NCT00607087|3646098|FG001|Overall Study|Other reason|5
2068357|NCT00607087|3646099|FG002|Overall Study|Other reason|2
2068358|NCT00607087|3646097|FG000|Overall Study|Poor compliance to protocol|1
2068359|NCT00607087|3646098|FG001|Overall Study|Poor compliance to protocol|0
2068360|NCT00607087|3646099|FG002|Overall Study|Poor compliance to protocol|1
2068361|NCT00607087|3646097|FG000|Overall Study|Lost to Follow-up|1
2068362|NCT00607087|3646098|FG001|Overall Study|Lost to Follow-up|0
2068363|NCT00607087|3646099|FG002|Overall Study|Lost to Follow-up|0
2068364|NCT00607087|3646097|FG000|Period 1|Withdrawal by Subject|7
2068365|NCT00607087|3646098|FG001|Period 1|Withdrawal by Subject|2
2068366|NCT00607087|3646099|FG002|Period 1|Withdrawal by Subject|3
2068367|NCT00607087|3646097|FG000|Period 1|Adverse Event|3
2068368|NCT00607087|3646098|FG001|Period 1|Adverse Event|0
2068369|NCT00607087|3646099|FG002|Period 1|Adverse Event|0
2068370|NCT00607087|3646097|FG000|Period 1|Poor compliance to protocol|1
2068371|NCT00607087|3646098|FG001|Period 1|Poor compliance to protocol|0
2068372|NCT00607087|3646099|FG002|Period 1|Poor compliance to protocol|0
2210263|NCT01648764|3849715|FG008|Overall Study|Investigator Decision|0
2068373|NCT00607087|3646097|FG000|Period 1|Lost to Follow-up|1
2068374|NCT00607087|3646098|FG001|Period 1|Lost to Follow-up|0
2068375|NCT00607087|3646099|FG002|Period 1|Lost to Follow-up|0
2068376|NCT00607087|3646097|FG000|Period 1|Other reason|0
2068377|NCT00607087|3646098|FG001|Period 1|Other reason|4
2068378|NCT00607087|3646099|FG002|Period 1|Other reason|2
2068379|NCT00607087|3646097|FG000|Period 2|Withdrawal by Subject|0
2210264|NCT01648764|3849716|FG009|Overall Study|Investigator Decision|0
2210265|NCT01648764|3849717|FG010|Overall Study|Investigator Decision|0
2210266|NCT01648764|3849718|FG011|Overall Study|Investigator Decision|1
2210267|NCT01648764|3849719|FG012|Overall Study|Investigator Decision|0
2303135|NCT02636907|4002384|FG000|Extension Phase|Adverse Event|2
2068380|NCT00607087|3646098|FG001|Period 2|Withdrawal by Subject|1
2068381|NCT00607087|3646099|FG002|Period 2|Withdrawal by Subject|1
2068382|NCT00607087|3646097|FG000|Period 2|Other reason|1
2068383|NCT00607087|3646098|FG001|Period 2|Other reason|1
2068384|NCT00607087|3646099|FG002|Period 2|Other reason|0
2068385|NCT00607087|3646097|FG000|Period 2|Adverse Event|0
2068386|NCT00607087|3646098|FG001|Period 2|Adverse Event|1
2068387|NCT00607087|3646099|FG002|Period 2|Adverse Event|3
2068388|NCT00607087|3646097|FG000|Period 2|Poor compliance to protocol|0
2068389|NCT00607087|3646098|FG001|Period 2|Poor compliance to protocol|0
2068390|NCT00607087|3646099|FG002|Period 2|Poor compliance to protocol|1
2068391|NCT00607087|3646097|FG000|Period 3|Withdrawal by Subject|2
2068392|NCT00607087|3646098|FG001|Period 3|Withdrawal by Subject|1
2068393|NCT00607087|3646099|FG002|Period 3|Withdrawal by Subject|0
2068394|NCT00607087|3646097|FG000|Period 3|Adverse Event|0
2068395|NCT00607087|3646098|FG001|Period 3|Adverse Event|1
2068396|NCT00607087|3646099|FG002|Period 3|Adverse Event|0
2068397|NCT00607373|3646150|FG000|Treatment Period|Adverse Event|0
2303136|NCT02636907|4002384|FG000|Extension Phase|Withdrawal by Subject|4
2303137|NCT02636907|4002384|FG000|Extension Phase|Physician Decision|1
2303138|NCT02636907|4002384|FG000|Extension Phase|Lost to Follow-up|2
2303139|NCT02636907|4002384|FG000|Extension Phase|Lack of Efficacy|1
2303140|NCT02637037|4002390|FG000|Overall Study|Positive drug screen at admission|1
2303141|NCT02637037|4002391|FG001|Overall Study|Positive drug screen at admission|0
2303142|NCT02637037|4002390|FG000|Overall Study|Withdrawal by Subject|2
2303143|NCT02637037|4002391|FG001|Overall Study|Withdrawal by Subject|1
2068398|NCT00607373|3646151|FG001|Treatment Period|Adverse Event|4
2068399|NCT00607373|3646150|FG000|Treatment Period|Physician Decision|0
2068400|NCT00607373|3646151|FG001|Treatment Period|Physician Decision|1
2068401|NCT00607373|3646150|FG000|Treatment Period|Withdrawal by Subject|0
2068402|NCT00607373|3646151|FG001|Treatment Period|Withdrawal by Subject|1
2068403|NCT00607373|3646150|FG000|Follow-up Period|Other|0
2303144|NCT02637037|4002390|FG000|Overall Study|Adverse Event|1
2068404|NCT00607373|3646151|FG001|Follow-up Period|Other|1
2068405|NCT00607373|3646150|FG000|Follow-up Period|Protocol Violation|0
2068406|NCT00607373|3646151|FG001|Follow-up Period|Protocol Violation|1
2068407|NCT00607373|3646150|FG000|Follow-up Period|Withdrawal by Subject|1
2068408|NCT00607373|3646151|FG001|Follow-up Period|Withdrawal by Subject|3
2068409|NCT00607386|3646157|FG000|Overall Study|Physician Decision|1
2068410|NCT00607724|3646199|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7
2068411|NCT00607724|3646200|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8
2068412|NCT00607724|3646201|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4
2068413|NCT00607724|3646202|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
2068414|NCT00607724|3646203|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
2068415|NCT00607724|3646204|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
2068416|NCT00607724|3646205|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
2068417|NCT00607724|3646199|FG000|Stage 2: Expanded Cohort|Adverse Event|0
2210268|NCT01648764|3849720|FG013|Overall Study|Investigator Decision|0
2210269|NCT01648790|3849754|FG000|Treatment 3|Withdrawal by Subject|0
2068418|NCT00607724|3646200|FG001|Stage 2: Expanded Cohort|Adverse Event|0
2068419|NCT00607724|3646201|FG002|Stage 2: Expanded Cohort|Adverse Event|0
2068420|NCT00607724|3646202|FG003|Stage 2: Expanded Cohort|Adverse Event|0
2068421|NCT00607724|3646203|FG004|Stage 2: Expanded Cohort|Adverse Event|0
2068422|NCT00607724|3646204|FG005|Stage 2: Expanded Cohort|Adverse Event|0
2068423|NCT00607724|3646205|FG006|Stage 2: Expanded Cohort|Adverse Event|1
2068424|NCT00607724|3646199|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
2068425|NCT00607724|3646200|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
2068426|NCT00607724|3646201|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
2068427|NCT00607724|3646202|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4
2068428|NCT00607724|3646203|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8
2068429|NCT00607724|3646204|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11
2068430|NCT00607724|3646205|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10
2068431|NCT00607724|3646199|FG000|Stage 2: Expanded Cohort|Physician Decision|0
2068432|NCT00607724|3646200|FG001|Stage 2: Expanded Cohort|Physician Decision|0
2068433|NCT00607724|3646201|FG002|Stage 2: Expanded Cohort|Physician Decision|0
2068434|NCT00607724|3646202|FG003|Stage 2: Expanded Cohort|Physician Decision|0
2068435|NCT00607724|3646203|FG004|Stage 2: Expanded Cohort|Physician Decision|1
2068436|NCT00607724|3646204|FG005|Stage 2: Expanded Cohort|Physician Decision|1
2068437|NCT00607724|3646205|FG006|Stage 2: Expanded Cohort|Physician Decision|0
2068438|NCT00607724|3646199|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2068439|NCT00607724|3646200|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2068440|NCT00607724|3646201|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2068441|NCT00607724|3646202|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1
2068442|NCT00607724|3646203|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2068443|NCT00607724|3646204|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2068444|NCT00607724|3646205|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2068445|NCT00607789|3646231|FG000|Overall Study|Adverse Event|3
2068446|NCT00607789|3646232|FG001|Overall Study|Adverse Event|0
2068447|NCT00607789|3646231|FG000|Overall Study|Lack of Efficacy|0
2068448|NCT00607789|3646232|FG001|Overall Study|Lack of Efficacy|1
2068449|NCT00607789|3646231|FG000|Overall Study|Inadequate adherence|3
2068450|NCT00607789|3646232|FG001|Overall Study|Inadequate adherence|0
2068451|NCT00607789|3646231|FG000|Overall Study|Lost to Follow-up|0
2068452|NCT00607789|3646232|FG001|Overall Study|Lost to Follow-up|5
2068453|NCT00607789|3646231|FG000|Overall Study|Withdrawal by Subject|1
2068454|NCT00607789|3646232|FG001|Overall Study|Withdrawal by Subject|0
2068455|NCT00607880|3646260|FG000|Overall Study|Unable to place port due to occlusion|1
2068456|NCT00607880|3646261|FG001|Overall Study|Unable to place port due to occlusion|0
2068457|NCT00607893|3646269|FG000|Overall Study|Lost to Follow-up|4
2068458|NCT00607893|3646270|FG001|Overall Study|Lost to Follow-up|0
2068459|NCT00607893|3646269|FG000|Overall Study|withdrew due to loss of interest|0
2068460|NCT00607893|3646270|FG001|Overall Study|withdrew due to loss of interest|1
2068461|NCT00607893|3646269|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0
2068462|NCT00607893|3646270|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1
2068463|NCT00607893|3646269|FG000|Overall Study|withdrew could not tolerate CPAP|0
2068464|NCT00607893|3646270|FG001|Overall Study|withdrew could not tolerate CPAP|1
2068465|NCT00607893|3646269|FG000|Overall Study|Declined to be treated|1
2068466|NCT00607893|3646270|FG001|Overall Study|Declined to be treated|0
2068467|NCT00607893|3646269|FG000|Overall Study|Withdrew due to hypertensive urgency|1
2068468|NCT00607893|3646270|FG001|Overall Study|Withdrew due to hypertensive urgency|1
2068469|NCT00607919|3646280|FG000|Acute Phase|Adverse Event|9
2068470|NCT00607919|3646281|FG001|Acute Phase|Adverse Event|2
2068471|NCT00607919|3646280|FG000|Acute Phase|Entry Criteria Not Met|1
2068472|NCT00607919|3646281|FG001|Acute Phase|Entry Criteria Not Met|1
2068473|NCT00607919|3646280|FG000|Acute Phase|Lack of Efficacy|1
2068474|NCT00607919|3646281|FG001|Acute Phase|Lack of Efficacy|2
2068475|NCT00607919|3646280|FG000|Acute Phase|Lost to Follow-up|9
2210270|NCT01648790|3849755|FG001|Treatment 3|Withdrawal by Subject|0
2068476|NCT00607919|3646281|FG001|Acute Phase|Lost to Follow-up|3
2068477|NCT00607919|3646280|FG000|Acute Phase|Parent/Caregiver Decision|6
2068478|NCT00607919|3646281|FG001|Acute Phase|Parent/Caregiver Decision|4
2068479|NCT00607919|3646280|FG000|Acute Phase|Protocol Violation|5
2068480|NCT00607919|3646281|FG001|Acute Phase|Protocol Violation|1
2068481|NCT00607919|3646280|FG000|Acute Phase|Withdrawal by Subject|3
2068482|NCT00607919|3646281|FG001|Acute Phase|Withdrawal by Subject|3
2068483|NCT00607919|3646280|FG000|Open-Label Phase|Adverse Event|1
2068484|NCT00607919|3646281|FG001|Open-Label Phase|Adverse Event|5
2068485|NCT00607919|3646280|FG000|Open-Label Phase|Lost to Follow-up|4
2068486|NCT00607919|3646281|FG001|Open-Label Phase|Lost to Follow-up|1
2068487|NCT00607919|3646280|FG000|Open-Label Phase|Protocol Violation|2
2068488|NCT00607919|3646281|FG001|Open-Label Phase|Protocol Violation|2
2068489|NCT00607919|3646280|FG000|Open-Label Phase|Withdrawal by Subject|2
2068490|NCT00607919|3646281|FG001|Open-Label Phase|Withdrawal by Subject|2
2210271|NCT01648790|3849756|FG002|Treatment 3|Withdrawal by Subject|0
2210272|NCT01648790|3849757|FG003|Treatment 3|Withdrawal by Subject|1
2303145|NCT02637037|4002391|FG001|Overall Study|Adverse Event|0
2303146|NCT02637063|4002412|FG000|Overall Study|Lost to Follow-up|3
2303147|NCT02637063|4002413|FG001|Overall Study|Lost to Follow-up|2
2303148|NCT02637063|4002414|FG002|Overall Study|Lost to Follow-up|3
2303149|NCT02637063|4002412|FG000|Overall Study|Withdrawal by Subject|2
2303150|NCT02637063|4002413|FG001|Overall Study|Withdrawal by Subject|2
2303151|NCT02637063|4002414|FG002|Overall Study|Withdrawal by Subject|3
2303152|NCT02637076|4002424|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
2303153|NCT02637076|4002425|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
2303154|NCT02637076|4002424|FG000|Overall Study|Withdrawal by Subject|0
2303155|NCT02637076|4002425|FG001|Overall Study|Withdrawal by Subject|4
2303156|NCT02637141|4002434|FG000|Overall Study|Adverse Event|1
2303157|NCT02637141|4002435|FG001|Overall Study|Adverse Event|1
2303158|NCT02637141|4002436|FG002|Overall Study|Adverse Event|0
2303159|NCT02637141|4002434|FG000|Overall Study|Withdrawal by Subject|1
2303160|NCT02637141|4002435|FG001|Overall Study|Withdrawal by Subject|1
2303161|NCT02637141|4002436|FG002|Overall Study|Withdrawal by Subject|1
2303162|NCT02637232|4002444|FG000|Overall Study|Lost to Follow-up|42
2303163|NCT02637232|4002444|FG000|Overall Study|Adverse Event|11
2303164|NCT02637232|4002444|FG000|Overall Study|patient 's decision|2
2068491|NCT00607919|3646280|FG000|Open-Label Phase|Parent/Caregiver Decision|1
2068492|NCT00607919|3646281|FG001|Open-Label Phase|Parent/Caregiver Decision|2
2068493|NCT00607997|3646293|FG000|Overall Study|Lack of Efficacy|6
2068494|NCT00607997|3646294|FG001|Overall Study|Lack of Efficacy|20
2068495|NCT00607997|3646295|FG002|Overall Study|Lack of Efficacy|14
2068496|NCT00607997|3646296|FG003|Overall Study|Lack of Efficacy|10
2068497|NCT00607997|3646293|FG000|Overall Study|Death|8
2303165|NCT02637323|4002450|FG000|Overall Study|Lost to Follow-up|2
2303166|NCT02637323|4002451|FG001|Overall Study|Lost to Follow-up|0
2303167|NCT02637323|4002450|FG000|Overall Study|Protocol Violation|0
2303168|NCT02637323|4002451|FG001|Overall Study|Protocol Violation|1
2321638|NCT02962648|4036231|FG000|Overall Study|Withdrawal by Subject|3
2321639|NCT02962648|4036231|FG000|Overall Study|Lost to Follow-up|3
2321640|NCT02962648|4036231|FG000|Overall Study|Physician Decision|1
2321641|NCT02962648|4036231|FG000|Overall Study|Subject had problems with transportation|2
2321642|NCT02962674|4036235|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49
2321643|NCT02962739|4036252|FG000|Overall Study|Withdrawal by Subject|0
2321644|NCT02962739|4036253|FG001|Overall Study|Withdrawal by Subject|1
2321645|NCT02962739|4036254|FG002|Overall Study|Withdrawal by Subject|0
2321646|NCT02962739|4036255|FG003|Overall Study|Withdrawal by Subject|0
2321647|NCT02962739|4036256|FG004|Overall Study|Withdrawal by Subject|0
2321648|NCT02962739|4036257|FG005|Overall Study|Withdrawal by Subject|0
2321649|NCT02962739|4036252|FG000|Overall Study|Protocol Violation|0
2321650|NCT02962739|4036253|FG001|Overall Study|Protocol Violation|0
2321651|NCT02962739|4036254|FG002|Overall Study|Protocol Violation|1
2321652|NCT02962739|4036255|FG003|Overall Study|Protocol Violation|0
2321653|NCT02962739|4036256|FG004|Overall Study|Protocol Violation|1
2321654|NCT02962739|4036257|FG005|Overall Study|Protocol Violation|0
2321655|NCT02962765|4036263|FG000|Overall Study|Protocol Violation|9
2321656|NCT02962765|4036263|FG000|Overall Study|Withdrawal by Subject|3
2321657|NCT02962765|4036263|FG000|Overall Study|Lost to Follow-up|1
2321658|NCT02962765|4036263|FG000|Overall Study|Death|1
2321659|NCT02962765|4036263|FG000|Overall Study|Limited access to study medication|3
2321660|NCT02962882|4036274|FG000|Overall Study|Adverse Event|2
2321661|NCT02962882|4036274|FG000|Overall Study|Withdrawal by Subject|2
2321662|NCT02962882|4036274|FG000|Overall Study|Transfer from ICU|32
2321663|NCT02962908|4036283|FG000|Overall Study|Lost to Follow-up|0
2321664|NCT02962908|4036284|FG001|Overall Study|Lost to Follow-up|3
2321665|NCT02962908|4036285|FG002|Overall Study|Lost to Follow-up|0
2321666|NCT02962908|4036286|FG003|Overall Study|Lost to Follow-up|1
2321667|NCT02962908|4036283|FG000|Overall Study|Withdrawal by Subject|0
2321668|NCT02962908|4036284|FG001|Overall Study|Withdrawal by Subject|3
2068498|NCT00607997|3646294|FG001|Overall Study|Death|5
2068499|NCT00607997|3646295|FG002|Overall Study|Death|2
2068500|NCT00607997|3646296|FG003|Overall Study|Death|5
2068501|NCT00607997|3646293|FG000|Overall Study|Adverse Event|3
2321669|NCT02962908|4036285|FG002|Overall Study|Withdrawal by Subject|0
2321670|NCT02962908|4036286|FG003|Overall Study|Withdrawal by Subject|2
2068502|NCT00607997|3646294|FG001|Overall Study|Adverse Event|1
2068503|NCT00607997|3646295|FG002|Overall Study|Adverse Event|2
2068504|NCT00607997|3646296|FG003|Overall Study|Adverse Event|0
2068505|NCT00607997|3646293|FG000|Overall Study|Physician Decision|4
2068506|NCT00607997|3646294|FG001|Overall Study|Physician Decision|1
2068507|NCT00607997|3646295|FG002|Overall Study|Physician Decision|0
2068508|NCT00607997|3646296|FG003|Overall Study|Physician Decision|0
2068509|NCT00607997|3646293|FG000|Overall Study|Relapse, recurrent illness|4
2068510|NCT00607997|3646294|FG001|Overall Study|Relapse, recurrent illness|0
2068511|NCT00607997|3646295|FG002|Overall Study|Relapse, recurrent illness|2
2068512|NCT00607997|3646296|FG003|Overall Study|Relapse, recurrent illness|0
2068513|NCT00607997|3646293|FG000|Overall Study|Other without explanation|2
2068514|NCT00607997|3646294|FG001|Overall Study|Other without explanation|0
2068515|NCT00607997|3646295|FG002|Overall Study|Other without explanation|4
2068516|NCT00607997|3646296|FG003|Overall Study|Other without explanation|1
2068517|NCT00608023|3646314|FG000|Overall Study|Withdrawal by Subject|8
2068518|NCT00608023|3646315|FG001|Overall Study|Withdrawal by Subject|10
2068519|NCT00608023|3646316|FG002|Overall Study|Withdrawal by Subject|7
2068520|NCT00608023|3646314|FG000|Overall Study|Adverse Event|1
2068521|NCT00608023|3646315|FG001|Overall Study|Adverse Event|4
2068522|NCT00608023|3646316|FG002|Overall Study|Adverse Event|5
2068523|NCT00608023|3646314|FG000|Overall Study|Lost to Follow-up|2
2068524|NCT00608023|3646315|FG001|Overall Study|Lost to Follow-up|2
2068525|NCT00608023|3646316|FG002|Overall Study|Lost to Follow-up|1
2068526|NCT00608023|3646314|FG000|Overall Study|Protocol Violation|1
2068527|NCT00608023|3646315|FG001|Overall Study|Protocol Violation|3
2068528|NCT00608023|3646316|FG002|Overall Study|Protocol Violation|1
2068529|NCT00608023|3646314|FG000|Overall Study|Unknown reason|0
2068530|NCT00608023|3646315|FG001|Overall Study|Unknown reason|3
2068531|NCT00608023|3646316|FG002|Overall Study|Unknown reason|0
2106202|NCT00863772|3699277|FG000|Overall Study|Protocol Violation|2
2106203|NCT00863772|3699278|FG001|Overall Study|Protocol Violation|0
2106204|NCT00863772|3699279|FG002|Overall Study|Protocol Violation|2
2106205|NCT00863772|3699277|FG000|Overall Study|Withdrawal by Subject|4
2106206|NCT00863772|3699278|FG001|Overall Study|Withdrawal by Subject|7
2106207|NCT00863772|3699279|FG002|Overall Study|Withdrawal by Subject|5
2106208|NCT00863772|3699277|FG000|Overall Study|Study terminated by sponsor|44
2106209|NCT00863772|3699278|FG001|Overall Study|Study terminated by sponsor|45
2106210|NCT00863772|3699279|FG002|Overall Study|Study terminated by sponsor|36
2106211|NCT00863772|3699277|FG000|Overall Study|Entered extension study|6
2106212|NCT00863772|3699278|FG001|Overall Study|Entered extension study|4
2106213|NCT00863772|3699279|FG002|Overall Study|Entered extension study|9
2106214|NCT00863772|3699277|FG000|Overall Study|Other|1
2106215|NCT00863772|3699278|FG001|Overall Study|Other|2
2106216|NCT00863772|3699279|FG002|Overall Study|Other|4
2106217|NCT00863772|3699277|FG000|Overall Study|Randomized but not Treated|1
2106218|NCT00863772|3699278|FG001|Overall Study|Randomized but not Treated|0
2303169|NCT02637557|4002471|FG000|Overall Study|Adverse Event|3
2303170|NCT02637557|4002472|FG001|Overall Study|Adverse Event|1
2303171|NCT02637557|4002473|FG002|Overall Study|Adverse Event|3
2303172|NCT02637557|4002474|FG003|Overall Study|Adverse Event|3
2303173|NCT02637557|4002471|FG000|Overall Study|Lost to Follow-up|1
2303174|NCT02637557|4002472|FG001|Overall Study|Lost to Follow-up|1
2303175|NCT02637557|4002473|FG002|Overall Study|Lost to Follow-up|0
2303176|NCT02637557|4002474|FG003|Overall Study|Lost to Follow-up|1
2303177|NCT02637557|4002471|FG000|Overall Study|Physician Decision|1
2303178|NCT02637557|4002472|FG001|Overall Study|Physician Decision|0
2303179|NCT02637557|4002473|FG002|Overall Study|Physician Decision|0
2303180|NCT02637557|4002474|FG003|Overall Study|Physician Decision|0
2303181|NCT02637557|4002471|FG000|Overall Study|Protocol Violation|2
2303182|NCT02637557|4002472|FG001|Overall Study|Protocol Violation|0
2303183|NCT02637557|4002473|FG002|Overall Study|Protocol Violation|2
2303184|NCT02637557|4002474|FG003|Overall Study|Protocol Violation|1
2106219|NCT00863772|3699279|FG002|Overall Study|Randomized but not Treated|0
2106220|NCT00863798|3699290|FG000|Overall Study|Adverse Event|5
2106221|NCT00863798|3699291|FG001|Overall Study|Adverse Event|2
2106222|NCT00863798|3699292|FG002|Overall Study|Adverse Event|4
2106223|NCT00863798|3699290|FG000|Overall Study|Participant failed to return|2
2106224|NCT00863798|3699291|FG001|Overall Study|Participant failed to return|1
2106225|NCT00863798|3699292|FG002|Overall Study|Participant failed to return|0
2106226|NCT00863798|3699290|FG000|Overall Study|Investigator request|1
2106227|NCT00863798|3699291|FG001|Overall Study|Investigator request|2
2106228|NCT00863798|3699292|FG002|Overall Study|Investigator request|1
2106229|NCT00863798|3699290|FG000|Overall Study|Lack of Efficacy|4
2106230|NCT00863798|3699291|FG001|Overall Study|Lack of Efficacy|3
2106231|NCT00863798|3699292|FG002|Overall Study|Lack of Efficacy|6
2106232|NCT00863798|3699290|FG000|Overall Study|Lost to Follow-up|6
2106233|NCT00863798|3699291|FG001|Overall Study|Lost to Follow-up|9
2106234|NCT00863798|3699292|FG002|Overall Study|Lost to Follow-up|5
2106235|NCT00863798|3699290|FG000|Overall Study|Other|2
2106236|NCT00863798|3699291|FG001|Overall Study|Other|3
2106237|NCT00863798|3699292|FG002|Overall Study|Other|1
2106238|NCT00863798|3699290|FG000|Overall Study|Protocol Violation|0
2106239|NCT00863798|3699291|FG001|Overall Study|Protocol Violation|1
2303185|NCT02637557|4002471|FG000|Overall Study|Withdrawal by Subject|1
2303186|NCT02637557|4002472|FG001|Overall Study|Withdrawal by Subject|3
2068532|NCT00608205|3646374|FG000|Overall Study|Adverse Event|3
2068533|NCT00608205|3646375|FG001|Overall Study|Adverse Event|2
2068534|NCT00608205|3646374|FG000|Overall Study|Patient non-compliant|0
2068535|NCT00608205|3646375|FG001|Overall Study|Patient non-compliant|1
2068536|NCT00608244|3646383|FG000|Overall Study|Adverse Event|1
2068537|NCT00608244|3646383|FG000|Overall Study|Low trough levels|1
2068538|NCT00608322|3646391|FG000|Overall Study|Death|2
2068539|NCT00608322|3646392|FG001|Overall Study|Death|1
2068540|NCT00608426|3646400|FG000|Overall Study|Death|32
2068541|NCT00608426|3646401|FG001|Overall Study|Death|36
2068542|NCT00608426|3646400|FG000|Overall Study|Lost to Follow-up|485
2068543|NCT00608426|3646401|FG001|Overall Study|Lost to Follow-up|521
2068544|NCT00608426|3646400|FG000|Overall Study|refused, health issues, wrong address|319
2068545|NCT00608426|3646401|FG001|Overall Study|refused, health issues, wrong address|348
2068546|NCT00608517|3646419|FG000|Overall Study|Death|1
2068547|NCT00608517|3646420|FG001|Overall Study|Death|0
2068548|NCT00608517|3646421|FG002|Overall Study|Death|0
2068549|NCT00608530|3646434|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
2068550|NCT00608530|3646435|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
2068551|NCT00608530|3646436|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
2068552|NCT00608530|3646437|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
2068553|NCT00608530|3646434|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
2068554|NCT00608530|3646435|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
2068555|NCT00608530|3646436|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
2068556|NCT00608530|3646437|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
2068557|NCT00608530|3646434|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
2068558|NCT00608530|3646435|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
2068559|NCT00608530|3646436|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
2068560|NCT00608530|3646437|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
2068561|NCT00608530|3646434|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0
2068562|NCT00608530|3646435|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0
2068563|NCT00608530|3646436|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2
2068564|NCT00608530|3646437|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0
2068565|NCT00608530|3646434|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0
2068566|NCT00608530|3646435|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0
2068567|NCT00608530|3646436|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4
2303187|NCT02637557|4002473|FG002|Overall Study|Withdrawal by Subject|4
2303188|NCT02637557|4002474|FG003|Overall Study|Withdrawal by Subject|2
2303189|NCT02637856|4002506|FG000|Main Study (Baseline to Week 100)|Adverse Event|9
2303190|NCT02637856|4002507|FG001|Main Study (Baseline to Week 100)|Adverse Event|0
2303191|NCT02637856|4002506|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5
2303192|NCT02637856|4002507|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0
2303193|NCT02637856|4002506|FG000|Main Study (Baseline to Week 100)|Physician Decision|2
2303194|NCT02637856|4002507|FG001|Main Study (Baseline to Week 100)|Physician Decision|0
2303195|NCT02637856|4002506|FG000|Main Study (Baseline to Week 100)|Pregnancy|7
2303196|NCT02637856|4002507|FG001|Main Study (Baseline to Week 100)|Pregnancy|0
2303197|NCT02637856|4002506|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
2303198|NCT02637856|4002507|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
2303199|NCT02637856|4002506|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2
2303200|NCT02637856|4002507|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0
2303201|NCT02637856|4002506|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
2303202|NCT02637856|4002507|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
2303203|NCT02637856|4002506|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1
2303204|NCT02637856|4002507|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0
2303205|NCT02637856|4002506|FG000|Main Study (Baseline to Week 100)|Incarceration|1
2303206|NCT02637856|4002507|FG001|Main Study (Baseline to Week 100)|Incarceration|0
2303207|NCT02637856|4002506|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
2303208|NCT02637856|4002507|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
2303209|NCT02637856|4002506|FG000|Main Study (Baseline to Week 100)|Site Closing|6
2303210|NCT02637856|4002507|FG001|Main Study (Baseline to Week 100)|Site Closing|0
2303211|NCT02637856|4002506|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
2303212|NCT02637856|4002507|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
2303213|NCT02637856|4002506|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
2303214|NCT02637856|4002507|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
2303215|NCT02637895|4002515|FG000|Overall Study|Lost to Follow-up|4
2303216|NCT02637895|4002516|FG001|Overall Study|Lost to Follow-up|0
2303217|NCT02637895|4002515|FG000|Overall Study|Protocol Violation|0
2303218|NCT02637895|4002516|FG001|Overall Study|Protocol Violation|1
2303219|NCT02637895|4002515|FG000|Overall Study|Lack of Efficacy|1
2303220|NCT02637895|4002516|FG001|Overall Study|Lack of Efficacy|0
2303221|NCT02637895|4002515|FG000|Overall Study|Withdrawal by Subject|1
2303222|NCT02637895|4002516|FG001|Overall Study|Withdrawal by Subject|1
2303223|NCT02637895|4002515|FG000|Overall Study|Abnormal baseline lab|0
2303224|NCT02637895|4002516|FG001|Overall Study|Abnormal baseline lab|1
2303225|NCT02638012|4002536|FG000|Overall Study|Lost to Follow-up|1
2068568|NCT00608530|3646437|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1
2068569|NCT00608530|3646434|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
2068570|NCT00608530|3646435|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
2068571|NCT00608530|3646436|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
2068572|NCT00608530|3646437|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
2068573|NCT00608543|3646452|FG000|Overall Study|Adverse Event|4
2068574|NCT00608569|3646459|FG000|Overall Study|Death|4
2068575|NCT00608569|3646460|FG001|Overall Study|Death|3
2068576|NCT00608569|3646459|FG000|Overall Study|Lost to Follow-up|4
2068577|NCT00608569|3646460|FG001|Overall Study|Lost to Follow-up|5
2068578|NCT00608569|3646459|FG000|Overall Study|Withdrawal by Subject|1
2068579|NCT00608569|3646460|FG001|Overall Study|Withdrawal by Subject|0
2068580|NCT00608569|3646459|FG000|Overall Study|Adverse Event|1
2068581|NCT00608569|3646460|FG001|Overall Study|Adverse Event|0
2068582|NCT00608569|3646459|FG000|Overall Study|Unable to adhere with study requirements|0
2068583|NCT00608569|3646460|FG001|Overall Study|Unable to adhere with study requirements|1
2068584|NCT00608582|3646468|FG000|Overall Study|Lost to Follow-up|2
2068585|NCT00608582|3646469|FG001|Overall Study|Lost to Follow-up|0
2068586|NCT00608582|3646468|FG000|Overall Study|No Best Response in Phase 1 located|1
2068587|NCT00608582|3646469|FG001|Overall Study|No Best Response in Phase 1 located|1
2068588|NCT00608582|3646468|FG000|Overall Study|Illicit Drug Use|1
2068589|NCT00608582|3646469|FG001|Overall Study|Illicit Drug Use|0
2210273|NCT01648790|3849758|FG004|Treatment 3|Withdrawal by Subject|0
2210274|NCT01649232|3849784|FG000|Overall Study|Physician Decision|2
2068590|NCT00608582|3646468|FG000|Overall Study|Early stage Design Change|0
2068591|NCT00608582|3646469|FG001|Overall Study|Early stage Design Change|3
2068592|NCT00608829|3646492|FG000|Overall Study|Death|6
2068593|NCT00608829|3646492|FG000|Overall Study|Withdrawal by Subject|4
2068594|NCT00608829|3646492|FG000|Overall Study|Subject refuses to follow up or return.|5
2068595|NCT00608842|3646500|FG000|Overall Study|Participant's Request|0
2068596|NCT00608842|3646501|FG001|Overall Study|Participant's Request|1
2068597|NCT00608842|3646502|FG002|Overall Study|Participant's Request|2
2068598|NCT00608842|3646503|FG003|Overall Study|Participant's Request|1
2068599|NCT00608842|3646500|FG000|Overall Study|Lost to Follow-up|1
2068600|NCT00608842|3646501|FG001|Overall Study|Lost to Follow-up|0
2068601|NCT00608842|3646502|FG002|Overall Study|Lost to Follow-up|0
2068602|NCT00608842|3646503|FG003|Overall Study|Lost to Follow-up|0
2068603|NCT00608868|3646513|FG000|Overall Study|Withdrawal by Subject|7
2068604|NCT00608868|3646513|FG000|Overall Study|Protocol Violation|3
2068605|NCT00608868|3646513|FG000|Overall Study|Lost to Follow-up|2
2068606|NCT00608868|3646513|FG000|Overall Study|Adverse Event|1
2068607|NCT00608868|3646513|FG000|Overall Study|Physician Decision|2
2068608|NCT00608881|3646519|FG000|Overall Study|Death|22
2068609|NCT00608881|3646520|FG001|Overall Study|Death|13
2068610|NCT00608881|3646519|FG000|Overall Study|Adverse Event|5
2068611|NCT00608881|3646520|FG001|Overall Study|Adverse Event|3
2068612|NCT00608881|3646519|FG000|Overall Study|Lost to Follow-up|28
2068613|NCT00608881|3646520|FG001|Overall Study|Lost to Follow-up|14
2068614|NCT00608881|3646519|FG000|Overall Study|Withdrawal by Subject|18
2068615|NCT00608881|3646520|FG001|Overall Study|Withdrawal by Subject|29
2068616|NCT00608881|3646519|FG000|Overall Study|Physician Decision|5
2068617|NCT00608881|3646520|FG001|Overall Study|Physician Decision|5
2068618|NCT00608881|3646519|FG000|Overall Study|Institutionalized|1
2068619|NCT00608881|3646520|FG001|Overall Study|Institutionalized|2
2068620|NCT00608894|3646528|FG000|Overall Study|Withdrawal by Subject|0
2068621|NCT00608894|3646529|FG001|Overall Study|Withdrawal by Subject|2
2068622|NCT00608907|3646540|FG000|Overall Study|Adverse Event|6
2068623|NCT00608907|3646541|FG001|Overall Study|Adverse Event|0
2068624|NCT00608907|3646542|FG002|Overall Study|Adverse Event|1
2068625|NCT00608907|3646540|FG000|Overall Study|Death|1
2068626|NCT00608907|3646541|FG001|Overall Study|Death|0
2068627|NCT00608907|3646542|FG002|Overall Study|Death|0
2068628|NCT00608907|3646540|FG000|Overall Study|Withdrawal by Subject|4
2068629|NCT00608907|3646541|FG001|Overall Study|Withdrawal by Subject|0
2068630|NCT00608907|3646542|FG002|Overall Study|Withdrawal by Subject|0
2068631|NCT00608907|3646540|FG000|Overall Study|Progressive Disease|1
2068632|NCT00608907|3646541|FG001|Overall Study|Progressive Disease|0
2068633|NCT00608907|3646542|FG002|Overall Study|Progressive Disease|0
2068634|NCT00608959|3646552|FG000|Part 1|Did not meet eligibility criteria|1
2068635|NCT00608985|3646566|FG000|Overall Study|Adverse Event|2
2068636|NCT00608985|3646567|FG001|Overall Study|Adverse Event|7
2303226|NCT02638103|4002553|FG000|Overall Study|Adverse Event|13
2303227|NCT02638103|4002554|FG001|Overall Study|Adverse Event|12
2303228|NCT02638103|4002555|FG002|Overall Study|Adverse Event|19
2303229|NCT02638103|4002556|FG003|Overall Study|Adverse Event|12
2303230|NCT02638103|4002553|FG000|Overall Study|Withdrawal by Subject|43
2303231|NCT02638103|4002554|FG001|Overall Study|Withdrawal by Subject|53
2303232|NCT02638103|4002555|FG002|Overall Study|Withdrawal by Subject|30
2303233|NCT02638103|4002556|FG003|Overall Study|Withdrawal by Subject|61
2303234|NCT02638103|4002553|FG000|Overall Study|Protocol Violation|1
2303235|NCT02638103|4002554|FG001|Overall Study|Protocol Violation|2
2068637|NCT00608985|3646568|FG002|Overall Study|Adverse Event|4
2068638|NCT00608985|3646569|FG003|Overall Study|Adverse Event|6
2068639|NCT00608985|3646566|FG000|Overall Study|Administrative/Other|7
2210275|NCT01649232|3849785|FG001|Overall Study|Physician Decision|0
2210276|NCT01649271|3849799|FG000|Overall Study|Progressive disease|4
2068640|NCT00608985|3646567|FG001|Overall Study|Administrative/Other|4
2068641|NCT00608985|3646568|FG002|Overall Study|Administrative/Other|1
2068642|NCT00608985|3646569|FG003|Overall Study|Administrative/Other|2
2068643|NCT00608985|3646566|FG000|Overall Study|Withdrawal of Consent|5
2068644|NCT00608985|3646567|FG001|Overall Study|Withdrawal of Consent|1
2068645|NCT00608985|3646568|FG002|Overall Study|Withdrawal of Consent|1
2068646|NCT00608985|3646569|FG003|Overall Study|Withdrawal of Consent|1
2068647|NCT00608985|3646566|FG000|Overall Study|Lost to Follow-up|2
2068648|NCT00608985|3646567|FG001|Overall Study|Lost to Follow-up|1
2068649|NCT00608985|3646568|FG002|Overall Study|Lost to Follow-up|0
2068650|NCT00608985|3646569|FG003|Overall Study|Lost to Follow-up|0
2068651|NCT00609167|3646586|FG000|Overall Study|Withdrawal by Subject|1
2068652|NCT00609167|3646587|FG001|Overall Study|Withdrawal by Subject|0
2068653|NCT00609167|3646586|FG000|Overall Study|Lack of Efficacy|1
2068654|NCT00609167|3646587|FG001|Overall Study|Lack of Efficacy|0
2068655|NCT00609167|3646586|FG000|Overall Study|Adverse Event|5
2068656|NCT00609167|3646587|FG001|Overall Study|Adverse Event|1
2068657|NCT00609167|3646586|FG000|Overall Study|Disease Progression|1
2068658|NCT00609167|3646587|FG001|Overall Study|Disease Progression|0
2068659|NCT00609167|3646586|FG000|Overall Study|Stem Cell Transplant|0
2068660|NCT00609167|3646587|FG001|Overall Study|Stem Cell Transplant|6
2068661|NCT00609245|3646593|FG000|Overall Study|Adverse Event|1
2068662|NCT00609336|3646608|FG000|Overall Study|Protocol Violation|3
2068663|NCT00609336|3646608|FG000|Overall Study|Death|1
2068664|NCT00609336|3646608|FG000|Overall Study|LA or Met at Surgery|9
2068665|NCT00609362|3646615|FG000|Overall Study|Withdrawal by Subject|2
2068666|NCT00609362|3646616|FG001|Overall Study|Withdrawal by Subject|1
2068667|NCT00609362|3646615|FG000|Overall Study|Adverse Event|1
2068668|NCT00609362|3646616|FG001|Overall Study|Adverse Event|0
2068669|NCT00609466|3646625|FG000|Overall Study|Withdrawal by Subject|0
2068670|NCT00609466|3646626|FG001|Overall Study|Withdrawal by Subject|1
2068671|NCT00609466|3646627|FG002|Overall Study|Withdrawal by Subject|1
2068672|NCT00609466|3646625|FG000|Overall Study|Adverse Event|2
2068673|NCT00609466|3646626|FG001|Overall Study|Adverse Event|3
2068674|NCT00609466|3646627|FG002|Overall Study|Adverse Event|1
2068675|NCT00609466|3646625|FG000|Overall Study|Lack of Efficacy|0
2068676|NCT00609466|3646626|FG001|Overall Study|Lack of Efficacy|2
2068677|NCT00609466|3646627|FG002|Overall Study|Lack of Efficacy|2
2068678|NCT00609492|3646638|FG000|Overall Study|Withdrawal by Subject|0
2068679|NCT00609492|3646639|FG001|Overall Study|Withdrawal by Subject|2
2068680|NCT00609492|3646640|FG002|Overall Study|Withdrawal by Subject|3
2068681|NCT00609492|3646638|FG000|Overall Study|Lost to Follow-up|1
2068682|NCT00609492|3646639|FG001|Overall Study|Lost to Follow-up|1
2068683|NCT00609492|3646640|FG002|Overall Study|Lost to Follow-up|4
2068684|NCT00609518|3646652|FG000|Overall Study|Death from Study Disease|32
2068685|NCT00609518|3646653|FG001|Overall Study|Death from Study Disease|32
2068686|NCT00609518|3646652|FG000|Overall Study|Withdrawal by Subject|5
2068687|NCT00609518|3646653|FG001|Overall Study|Withdrawal by Subject|3
2068688|NCT00609518|3646652|FG000|Overall Study|Lost to Follow-up|3
2068689|NCT00609518|3646653|FG001|Overall Study|Lost to Follow-up|0
2068690|NCT00609518|3646652|FG000|Overall Study|Physician Decision|1
2068691|NCT00609518|3646653|FG001|Overall Study|Physician Decision|3
2068692|NCT00609518|3646652|FG000|Overall Study|Death from Adverse Event|2
2068693|NCT00609518|3646653|FG001|Overall Study|Death from Adverse Event|2
2068694|NCT00609609|3646661|FG000|Overall Study|Withdrawal by Subject|2
2068695|NCT00609609|3646662|FG001|Overall Study|Withdrawal by Subject|0
2068696|NCT00609609|3646661|FG000|Overall Study|Progression|4
2068697|NCT00609609|3646662|FG001|Overall Study|Progression|2
2068698|NCT00609622|3646670|FG000|Overall Study|Adverse Event|14
2068699|NCT00609622|3646671|FG001|Overall Study|Adverse Event|10
2068700|NCT00609622|3646670|FG000|Overall Study|Withdrawal by Subject|4
2068701|NCT00609622|3646671|FG001|Overall Study|Withdrawal by Subject|20
2068702|NCT00609622|3646670|FG000|Overall Study|Death|1
2068703|NCT00609622|3646671|FG001|Overall Study|Death|4
2068704|NCT00609622|3646670|FG000|Overall Study|Protocol Violation|1
2068705|NCT00609622|3646671|FG001|Overall Study|Protocol Violation|1
2068706|NCT00609622|3646670|FG000|Overall Study|Objective progression or relapse|47
2068707|NCT00609622|3646671|FG001|Overall Study|Objective progression or relapse|41
2210277|NCT01649271|3849800|FG001|Overall Study|Progressive disease|5
2210278|NCT01649271|3849799|FG000|Overall Study|Other Adverse Event|0
2210279|NCT01649271|3849800|FG001|Overall Study|Other Adverse Event|2
2210280|NCT01649271|3849799|FG000|Overall Study|Withdrawal by Subject|1
2210281|NCT01649271|3849800|FG001|Overall Study|Withdrawal by Subject|0
2210282|NCT01649271|3849799|FG000|Overall Study|Other than stated above|1
2210283|NCT01649271|3849800|FG001|Overall Study|Other than stated above|0
2210284|NCT01649297|3849812|FG000|Overall Study|Adverse Event|5
2210285|NCT01649297|3849813|FG001|Overall Study|Adverse Event|5
2210286|NCT01649297|3849814|FG002|Overall Study|Adverse Event|4
2068708|NCT00609622|3646670|FG000|Overall Study|Study terminated by sponsor|16
2068709|NCT00609622|3646671|FG001|Overall Study|Study terminated by sponsor|3
2068710|NCT00609622|3646670|FG000|Overall Study|Other|7
2210287|NCT01649297|3849815|FG003|Overall Study|Adverse Event|13
2210288|NCT01649297|3849816|FG004|Overall Study|Adverse Event|1
2068711|NCT00609622|3646671|FG001|Overall Study|Other|14
2068712|NCT00609622|3646670|FG000|Overall Study|Global deterioration of health status|6
2068713|NCT00609622|3646671|FG001|Overall Study|Global deterioration of health status|2
2068714|NCT00609674|3646679|FG000|Overall Study|Adverse Event|1
2068715|NCT00609674|3646680|FG001|Overall Study|Adverse Event|1
2068716|NCT00609674|3646679|FG000|Overall Study|Protocol Violation|3
2068717|NCT00609674|3646680|FG001|Overall Study|Protocol Violation|5
2068718|NCT00609674|3646679|FG000|Overall Study|Lost to Follow-up|1
2068719|NCT00609674|3646680|FG001|Overall Study|Lost to Follow-up|0
2068720|NCT00609674|3646679|FG000|Overall Study|Withdrew consent|2
2068721|NCT00609674|3646680|FG001|Overall Study|Withdrew consent|1
2068722|NCT00609869|3646702|FG000|Overall Study|Withdrawn, ischemic stroke|1
2068723|NCT00609869|3646702|FG000|Overall Study|Severe hematologic toxicity|1
2068724|NCT00609869|3646702|FG000|Overall Study|Withdrawal by Subject|1
2068725|NCT00609869|3646702|FG000|Overall Study|Seizures|1
2068726|NCT00609869|3646702|FG000|Overall Study|Severe tumor flare reaction|1
2068727|NCT00609869|3646702|FG000|Overall Study|Hepatitis B infection|1
2068728|NCT00609869|3646702|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1
2068729|NCT00609869|3646702|FG000|Overall Study|Mantle cell: not evaluable|4
2068730|NCT00609947|3646706|FG000|Overall Study|Death|1
2068731|NCT00609973|3646713|FG000|Overall Study|Adverse Event|2
2068732|NCT00609973|3646714|FG001|Overall Study|Adverse Event|1
2068733|NCT00609973|3646713|FG000|Overall Study|Protocol Violation|4
2068734|NCT00609973|3646714|FG001|Overall Study|Protocol Violation|3
2068735|NCT00609973|3646713|FG000|Overall Study|Lost to Follow-up|2
2068736|NCT00609973|3646714|FG001|Overall Study|Lost to Follow-up|1
2068737|NCT00609973|3646713|FG000|Overall Study|Withdrawal by Subject|0
2068738|NCT00609973|3646714|FG001|Overall Study|Withdrawal by Subject|1
2068739|NCT00609986|3646722|FG000|Overall Study|Did not receive transplant or treatment|8
2068740|NCT00609986|3646723|FG001|Overall Study|Did not receive transplant or treatment|3
2068741|NCT00610129|3646733|FG000|Overall Study|Not treated since patients ineligible|3
2068742|NCT00610155|3646737|FG000|Period 1|Withdrawal by Subject|0
2068743|NCT00610155|3646738|FG001|Period 1|Withdrawal by Subject|0
2068744|NCT00610155|3646739|FG002|Period 1|Withdrawal by Subject|1
2068745|NCT00610155|3646740|FG003|Period 1|Withdrawal by Subject|0
2068746|NCT00610155|3646741|FG004|Period 1|Withdrawal by Subject|0
2068747|NCT00610155|3646742|FG005|Period 1|Withdrawal by Subject|0
2068748|NCT00610155|3646737|FG000|Period 3|Adverse Event|1
2068749|NCT00610155|3646738|FG001|Period 3|Adverse Event|0
2068750|NCT00610155|3646739|FG002|Period 3|Adverse Event|0
2068751|NCT00610155|3646740|FG003|Period 3|Adverse Event|0
2068752|NCT00610155|3646741|FG004|Period 3|Adverse Event|0
2068753|NCT00610155|3646742|FG005|Period 3|Adverse Event|0
2068754|NCT00610168|3646752|FG000|Overall Study|Withdrawal by Subject|2
2068755|NCT00610168|3646753|FG001|Overall Study|Withdrawal by Subject|0
2068756|NCT00610207|3646759|FG000|Overall Study|Lost to Follow-up|3
2068757|NCT00610363|3646769|FG000|Overall Study|Non-compliance with protocol|0
2068758|NCT00610363|3646770|FG001|Overall Study|Non-compliance with protocol|1
2068759|NCT00610363|3646769|FG000|Overall Study|Adverse Event|3
2068760|NCT00610363|3646770|FG001|Overall Study|Adverse Event|1
2068761|NCT00610363|3646769|FG000|Overall Study|Lack of Efficacy|2
2068762|NCT00610363|3646770|FG001|Overall Study|Lack of Efficacy|0
2068763|NCT00610363|3646769|FG000|Overall Study|Lost to Follow-up|4
2068764|NCT00610363|3646770|FG001|Overall Study|Lost to Follow-up|0
2068765|NCT00610363|3646769|FG000|Overall Study|Withdrawal by Subject|1
2068766|NCT00610363|3646770|FG001|Overall Study|Withdrawal by Subject|0
2068767|NCT00610363|3646769|FG000|Overall Study|Other than specified above|1
2068768|NCT00610363|3646770|FG001|Overall Study|Other than specified above|1
2068769|NCT00610441|3646794|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1
2068770|NCT00610441|3646795|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1
2068771|NCT00610441|3646796|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4
2068772|NCT00610441|3646797|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1
2068773|NCT00610441|3646794|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
2068774|NCT00610441|3646795|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
2068775|NCT00610441|3646796|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
2068776|NCT00610441|3646797|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
2068777|NCT00610441|3646794|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
2068778|NCT00610441|3646795|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
2068779|NCT00610441|3646796|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
2068780|NCT00610441|3646797|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
2068781|NCT00610441|3646794|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
2068782|NCT00610441|3646795|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
2068783|NCT00610441|3646796|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
2068784|NCT00610441|3646797|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
2068785|NCT00610441|3646794|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0
2068786|NCT00610441|3646795|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0
2068787|NCT00610441|3646796|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2
2068788|NCT00610441|3646797|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0
2068789|NCT00610441|3646794|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
2068790|NCT00610441|3646795|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
2068791|NCT00610441|3646796|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
2068792|NCT00610441|3646797|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
2068793|NCT00610441|3646794|FG000|Treatment Period 2 - 3 Weeks|Other|1
2068794|NCT00610441|3646795|FG001|Treatment Period 2 - 3 Weeks|Other|1
2068795|NCT00610441|3646796|FG002|Treatment Period 2 - 3 Weeks|Other|0
2068796|NCT00610441|3646797|FG003|Treatment Period 2 - 3 Weeks|Other|1
2068797|NCT00610441|3646794|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0
2068798|NCT00610441|3646795|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0
2068799|NCT00610441|3646796|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0
2068800|NCT00610441|3646797|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1
2068801|NCT00610441|3646794|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
2068802|NCT00610441|3646795|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
2068803|NCT00610441|3646796|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
2068804|NCT00610441|3646797|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
2068805|NCT00610649|3646829|FG000|Overall Study|Adverse Event|1
2068806|NCT00610649|3646830|FG001|Overall Study|Adverse Event|0
2068807|NCT00610649|3646831|FG002|Overall Study|Adverse Event|0
2068808|NCT00610649|3646832|FG003|Overall Study|Adverse Event|0
2068809|NCT00610649|3646833|FG004|Overall Study|Adverse Event|0
2068810|NCT00610649|3646834|FG005|Overall Study|Adverse Event|0
2068811|NCT00610649|3646835|FG006|Overall Study|Adverse Event|0
2210289|NCT01649297|3849812|FG000|Overall Study|Lack of Efficacy|0
2210290|NCT01649297|3849813|FG001|Overall Study|Lack of Efficacy|0
2210291|NCT01649297|3849814|FG002|Overall Study|Lack of Efficacy|0
2210292|NCT01649297|3849815|FG003|Overall Study|Lack of Efficacy|0
2210293|NCT01649297|3849816|FG004|Overall Study|Lack of Efficacy|1
2210294|NCT01649297|3849812|FG000|Overall Study|Non compliant with Protocol|1
2210295|NCT01649297|3849813|FG001|Overall Study|Non compliant with Protocol|0
2210296|NCT01649297|3849814|FG002|Overall Study|Non compliant with Protocol|3
2210297|NCT01649297|3849815|FG003|Overall Study|Non compliant with Protocol|2
2210298|NCT01649297|3849816|FG004|Overall Study|Non compliant with Protocol|1
2068812|NCT00610649|3646836|FG007|Overall Study|Adverse Event|0
2068813|NCT00610649|3646837|FG008|Overall Study|Adverse Event|0
2068814|NCT00610649|3646838|FG009|Overall Study|Adverse Event|0
2068815|NCT00610649|3646839|FG010|Overall Study|Adverse Event|1
2068816|NCT00610649|3646829|FG000|Overall Study|Family Emergency|0
2068817|NCT00610649|3646830|FG001|Overall Study|Family Emergency|1
2068818|NCT00610649|3646831|FG002|Overall Study|Family Emergency|0
2068819|NCT00610649|3646832|FG003|Overall Study|Family Emergency|0
2068820|NCT00610649|3646833|FG004|Overall Study|Family Emergency|0
2068821|NCT00610649|3646834|FG005|Overall Study|Family Emergency|0
2068822|NCT00610649|3646835|FG006|Overall Study|Family Emergency|0
2068823|NCT00610649|3646836|FG007|Overall Study|Family Emergency|0
2068824|NCT00610649|3646837|FG008|Overall Study|Family Emergency|0
2068825|NCT00610649|3646838|FG009|Overall Study|Family Emergency|0
2068826|NCT00610649|3646839|FG010|Overall Study|Family Emergency|0
2068827|NCT00610649|3646829|FG000|Overall Study|Withdrawal by Subject|0
2068828|NCT00610649|3646830|FG001|Overall Study|Withdrawal by Subject|0
2068829|NCT00610649|3646831|FG002|Overall Study|Withdrawal by Subject|0
2068830|NCT00610649|3646832|FG003|Overall Study|Withdrawal by Subject|0
2068831|NCT00610649|3646833|FG004|Overall Study|Withdrawal by Subject|0
2068832|NCT00610649|3646834|FG005|Overall Study|Withdrawal by Subject|0
2068833|NCT00610649|3646835|FG006|Overall Study|Withdrawal by Subject|0
2068834|NCT00610649|3646836|FG007|Overall Study|Withdrawal by Subject|0
2068835|NCT00610649|3646837|FG008|Overall Study|Withdrawal by Subject|0
2068836|NCT00610649|3646838|FG009|Overall Study|Withdrawal by Subject|1
2068837|NCT00610649|3646839|FG010|Overall Study|Withdrawal by Subject|0
2068838|NCT00610675|3646863|FG000|Overall Study|Untreated|4
2068839|NCT00610675|3646863|FG000|Overall Study|Adverse Event|67
2068840|NCT00610675|3646863|FG000|Overall Study|Insufficient Effect|31
2068841|NCT00610675|3646863|FG000|Overall Study|Withdrawal by Subject|28
2068842|NCT00610675|3646863|FG000|Overall Study|Reasons unrelated to trial|27
2068843|NCT00610675|3646863|FG000|Overall Study|Lack of Compliance|7
2068844|NCT00610675|3646863|FG000|Overall Study|Lost to Follow-up|31
2068845|NCT00610675|3646863|FG000|Overall Study|Other reason (not specified)|25
2068846|NCT00610714|3646891|FG000|Overall Study|Adverse Event|3
2068847|NCT00610714|3646892|FG001|Overall Study|Adverse Event|1
2068848|NCT00610714|3646891|FG000|Overall Study|Death|12
2068849|NCT00610714|3646892|FG001|Overall Study|Death|18
2068850|NCT00610714|3646891|FG000|Overall Study|Withdrawal by Subject|9
2068851|NCT00610714|3646892|FG001|Overall Study|Withdrawal by Subject|3
2068852|NCT00610714|3646891|FG000|Overall Study|Study completion at 120 PFS events|2
2068853|NCT00610714|3646892|FG001|Overall Study|Study completion at 120 PFS events|2
2068854|NCT00610857|3646931|FG000|Overall Study|Not evaluable for response|2
2068855|NCT00610935|3646941|FG000|Overall Study|Lost to Follow-up|0
2210299|NCT01649297|3849812|FG000|Overall Study|Lost to Follow-up|1
2210300|NCT01649297|3849813|FG001|Overall Study|Lost to Follow-up|1
2210301|NCT01649297|3849814|FG002|Overall Study|Lost to Follow-up|4
2210302|NCT01649297|3849815|FG003|Overall Study|Lost to Follow-up|3
2068856|NCT00610935|3646942|FG001|Overall Study|Lost to Follow-up|1
2068857|NCT00610935|3646941|FG000|Overall Study|Withdrawal by Subject|0
2068858|NCT00610935|3646942|FG001|Overall Study|Withdrawal by Subject|2
2068859|NCT00610935|3646941|FG000|Overall Study|Sponsor Discontinuation|1
2068860|NCT00610935|3646942|FG001|Overall Study|Sponsor Discontinuation|0
2068861|NCT00611026|3646960|FG000|Randomized to Double-blind Treatment|Not treated|2
2068862|NCT00611026|3646961|FG001|Randomized to Double-blind Treatment|Not treated|1
2068863|NCT00611026|3646962|FG002|Randomized to Double-blind Treatment|Not treated|3
2068864|NCT00611026|3646960|FG000|Double-blind Treatment Period|Death|1
2068865|NCT00611026|3646961|FG001|Double-blind Treatment Period|Death|0
2068866|NCT00611026|3646962|FG002|Double-blind Treatment Period|Death|0
2068867|NCT00611026|3646960|FG000|Double-blind Treatment Period|Adverse Event|9
2068868|NCT00611026|3646961|FG001|Double-blind Treatment Period|Adverse Event|28
2068869|NCT00611026|3646962|FG002|Double-blind Treatment Period|Adverse Event|46
2068870|NCT00611026|3646960|FG000|Double-blind Treatment Period|Lack of Efficacy|11
2068871|NCT00611026|3646961|FG001|Double-blind Treatment Period|Lack of Efficacy|10
2068872|NCT00611026|3646962|FG002|Double-blind Treatment Period|Lack of Efficacy|4
2068873|NCT00611026|3646960|FG000|Double-blind Treatment Period|Lost to Follow-up|6
2068874|NCT00611026|3646961|FG001|Double-blind Treatment Period|Lost to Follow-up|11
2068875|NCT00611026|3646962|FG002|Double-blind Treatment Period|Lost to Follow-up|14
2068876|NCT00611026|3646960|FG000|Double-blind Treatment Period|Withdrawal by Subject|7
2068877|NCT00611026|3646961|FG001|Double-blind Treatment Period|Withdrawal by Subject|19
2068878|NCT00611026|3646962|FG002|Double-blind Treatment Period|Withdrawal by Subject|16
2068879|NCT00611026|3646960|FG000|Double-blind Treatment Period|Other|13
2068880|NCT00611026|3646961|FG001|Double-blind Treatment Period|Other|20
2068881|NCT00611026|3646962|FG002|Double-blind Treatment Period|Other|18
2068882|NCT00611130|3646974|FG000|Overall Study|Lost to Follow-up|25
2068883|NCT00611130|3646975|FG001|Overall Study|Lost to Follow-up|29
2068884|NCT00611130|3646974|FG000|Overall Study|Protocol noncompliance|7
2068885|NCT00611130|3646975|FG001|Overall Study|Protocol noncompliance|6
2068886|NCT00611130|3646974|FG000|Overall Study|Withdrawal by Subject|6
2068887|NCT00611130|3646975|FG001|Overall Study|Withdrawal by Subject|5
2068888|NCT00611130|3646974|FG000|Overall Study|Other|5
2068889|NCT00611130|3646975|FG001|Overall Study|Other|4
2068890|NCT00611130|3646974|FG000|Overall Study|Incarceration|3
2068891|NCT00611130|3646975|FG001|Overall Study|Incarceration|2
2068892|NCT00611130|3646974|FG000|Overall Study|Administrative|1
2210303|NCT01649297|3849816|FG004|Overall Study|Lost to Follow-up|0
2210304|NCT01649297|3849812|FG000|Overall Study|Patient withdrawal (not due to AE)|3
2210305|NCT01649297|3849813|FG001|Overall Study|Patient withdrawal (not due to AE)|6
2210306|NCT01649297|3849814|FG002|Overall Study|Patient withdrawal (not due to AE)|4
2210307|NCT01649297|3849815|FG003|Overall Study|Patient withdrawal (not due to AE)|1
2210308|NCT01649297|3849816|FG004|Overall Study|Patient withdrawal (not due to AE)|1
2210309|NCT01649297|3849812|FG000|Overall Study|For other reason|4
2210310|NCT01649297|3849813|FG001|Overall Study|For other reason|1
2210311|NCT01649297|3849814|FG002|Overall Study|For other reason|2
2210312|NCT01649297|3849815|FG003|Overall Study|For other reason|0
2210313|NCT01649297|3849816|FG004|Overall Study|For other reason|0
2210314|NCT01649375|3849840|FG000|Up to Week 16|Adverse Event|2
2210315|NCT01649375|3849841|FG001|Up to Week 16|Adverse Event|5
2210316|NCT01649375|3849842|FG002|Up to Week 16|Adverse Event|4
2210317|NCT01649375|3849843|FG003|Up to Week 16|Adverse Event|0
2210318|NCT01649375|3849844|FG004|Up to Week 16|Adverse Event|0
2210319|NCT01649375|3849840|FG000|Up to Week 16|Lack of Efficacy|0
2210320|NCT01649375|3849841|FG001|Up to Week 16|Lack of Efficacy|0
2210321|NCT01649375|3849842|FG002|Up to Week 16|Lack of Efficacy|1
2210322|NCT01649375|3849843|FG003|Up to Week 16|Lack of Efficacy|0
2210323|NCT01649375|3849844|FG004|Up to Week 16|Lack of Efficacy|0
2210324|NCT01649375|3849840|FG000|Up to Week 16|Physician Decision|0
2068893|NCT00611130|3646975|FG001|Overall Study|Administrative|1
2068894|NCT00611130|3646974|FG000|Overall Study|Adverse Event|1
2068895|NCT00611130|3646975|FG001|Overall Study|Adverse Event|0
2068896|NCT00611130|3646974|FG000|Overall Study|Death|1
2068897|NCT00611130|3646975|FG001|Overall Study|Death|0
2068898|NCT00611247|3646984|FG000|Overall Study|Death|1
2068899|NCT00611247|3646985|FG001|Overall Study|Death|5
2068900|NCT00611247|3646984|FG000|Overall Study|Lack of Efficacy|1
2068901|NCT00611247|3646985|FG001|Overall Study|Lack of Efficacy|16
2068902|NCT00611455|3647025|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2
2068903|NCT00611455|3647026|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8
2210325|NCT01649375|3849841|FG001|Up to Week 16|Physician Decision|0
2210326|NCT01649375|3849842|FG002|Up to Week 16|Physician Decision|1
2210327|NCT01649375|3849843|FG003|Up to Week 16|Physician Decision|0
2210328|NCT01649375|3849844|FG004|Up to Week 16|Physician Decision|0
2210329|NCT01649375|3849840|FG000|Up to Week 16|Withdrawal by Subject|2
2210330|NCT01649375|3849841|FG001|Up to Week 16|Withdrawal by Subject|1
2210331|NCT01649375|3849842|FG002|Up to Week 16|Withdrawal by Subject|2
2210332|NCT01649375|3849843|FG003|Up to Week 16|Withdrawal by Subject|0
2210333|NCT01649375|3849844|FG004|Up to Week 16|Withdrawal by Subject|0
2210334|NCT01649375|3849840|FG000|Up to Week 16|Death|1
2210335|NCT01649375|3849841|FG001|Up to Week 16|Death|0
2210336|NCT01649375|3849842|FG002|Up to Week 16|Death|0
2068904|NCT00611455|3647027|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
2068905|NCT00611455|3647025|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
2068906|NCT00611455|3647026|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
2068907|NCT00611455|3647027|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
2068908|NCT00611455|3647025|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4
2068909|NCT00611455|3647026|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1
2068910|NCT00611455|3647027|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
2068911|NCT00611455|3647025|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
2068912|NCT00611455|3647026|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
2068913|NCT00611455|3647027|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
2068914|NCT00611455|3647025|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
2068915|NCT00611455|3647026|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
2068916|NCT00611455|3647027|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
2068917|NCT00611455|3647025|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
2068918|NCT00611455|3647026|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
2068919|NCT00611455|3647027|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
2068920|NCT00611455|3647025|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
2068921|NCT00611455|3647026|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17
2068922|NCT00611455|3647027|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
2068923|NCT00611455|3647025|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
2068924|NCT00611455|3647026|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
2068925|NCT00611455|3647027|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
2068926|NCT00611455|3647025|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
2068927|NCT00611455|3647026|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3
2068928|NCT00611455|3647027|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
2068929|NCT00611455|3647025|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
2303236|NCT02638103|4002555|FG002|Overall Study|Protocol Violation|1
2303237|NCT02638103|4002556|FG003|Overall Study|Protocol Violation|4
2303238|NCT02638103|4002553|FG000|Overall Study|Pregnancy|2
2303239|NCT02638103|4002554|FG001|Overall Study|Pregnancy|3
2303240|NCT02638103|4002555|FG002|Overall Study|Pregnancy|0
2303241|NCT02638103|4002556|FG003|Overall Study|Pregnancy|1
2303242|NCT02638103|4002553|FG000|Overall Study|Non-compliance to Study Procedures|2
2303243|NCT02638103|4002554|FG001|Overall Study|Non-compliance to Study Procedures|1
2303244|NCT02638103|4002555|FG002|Overall Study|Non-compliance to Study Procedures|1
2303245|NCT02638103|4002556|FG003|Overall Study|Non-compliance to Study Procedures|1
2303246|NCT02638103|4002553|FG000|Overall Study|Lost to Follow-up|26
2303247|NCT02638103|4002554|FG001|Overall Study|Lost to Follow-up|33
2303248|NCT02638103|4002555|FG002|Overall Study|Lost to Follow-up|20
2303249|NCT02638103|4002556|FG003|Overall Study|Lost to Follow-up|37
2303250|NCT02638103|4002553|FG000|Overall Study|Lack of Efficacy|14
2303251|NCT02638103|4002554|FG001|Overall Study|Lack of Efficacy|10
2068930|NCT00611455|3647026|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
2068931|NCT00611455|3647027|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
2068932|NCT00611455|3647025|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
2068933|NCT00611455|3647026|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
2068934|NCT00611455|3647027|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
2068935|NCT00611455|3647025|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
2068936|NCT00611455|3647026|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
2068937|NCT00611455|3647027|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
2068938|NCT00611455|3647025|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
2068939|NCT00611455|3647026|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5
2068940|NCT00611455|3647027|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
2068941|NCT00611455|3647025|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
2068942|NCT00611455|3647026|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
2068943|NCT00611455|3647027|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
2068944|NCT00611455|3647025|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0
2068945|NCT00611455|3647026|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0
2068946|NCT00611455|3647027|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30
2068947|NCT00611455|3647025|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
2068948|NCT00611455|3647026|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
2068949|NCT00611455|3647027|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
2068950|NCT00611455|3647025|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
2068951|NCT00611455|3647026|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
2068952|NCT00611455|3647027|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
2068953|NCT00611455|3647025|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
2068954|NCT00611455|3647026|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
2068955|NCT00611455|3647027|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
2068956|NCT00611455|3647025|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
2068957|NCT00611455|3647026|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
2068958|NCT00611455|3647027|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
2068959|NCT00611455|3647025|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
2068960|NCT00611455|3647026|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
2068961|NCT00611455|3647027|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
2068962|NCT00611455|3647025|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
2068963|NCT00611455|3647026|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
2068964|NCT00611455|3647027|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
2303252|NCT02638103|4002555|FG002|Overall Study|Lack of Efficacy|12
2068965|NCT00611533|3647044|FG000|First Intervention (6 Weeks)|Never started study|0
2068966|NCT00611533|3647045|FG001|First Intervention (6 Weeks)|Never started study|1
2068967|NCT00611533|3647044|FG000|First Intervention (6 Weeks)|Adverse Event|0
2068968|NCT00611533|3647045|FG001|First Intervention (6 Weeks)|Adverse Event|1
2068969|NCT00611533|3647044|FG000|Second Intervention (6 Weeks)|Adverse Event|0
2068970|NCT00611533|3647045|FG001|Second Intervention (6 Weeks)|Adverse Event|2
2068971|NCT00611559|3647055|FG000|Overall Study|Lost to Follow-up|0
2068972|NCT00611559|3647056|FG001|Overall Study|Lost to Follow-up|1
2068973|NCT00611559|3647057|FG002|Overall Study|Lost to Follow-up|0
2068974|NCT00611559|3647055|FG000|Overall Study|Protocol Violation|1
2068975|NCT00611559|3647056|FG001|Overall Study|Protocol Violation|0
2068976|NCT00611559|3647057|FG002|Overall Study|Protocol Violation|1
2068977|NCT00611715|3647072|FG000|Overall Study|Disease Progression|24
2068978|NCT00611715|3647073|FG001|Overall Study|Disease Progression|4
2068979|NCT00611715|3647072|FG000|Overall Study|Withdrawal by Subject|5
2068980|NCT00611715|3647073|FG001|Overall Study|Withdrawal by Subject|1
2068981|NCT00611715|3647072|FG000|Overall Study|Adverse Event|9
2068982|NCT00611715|3647073|FG001|Overall Study|Adverse Event|1
2068983|NCT00611715|3647072|FG000|Overall Study|Death|1
2068984|NCT00611715|3647073|FG001|Overall Study|Death|0
2068985|NCT00611715|3647072|FG000|Overall Study|two patients are still on treatment|2
2068986|NCT00611715|3647073|FG001|Overall Study|two patients are still on treatment|0
2068987|NCT00611767|3647087|FG000|Overall Study|Withdrawal by Subject|4
2068988|NCT00611767|3647088|FG001|Overall Study|Withdrawal by Subject|1
2068989|NCT00611767|3647087|FG000|Overall Study|Thiopental not available|3
2068990|NCT00611767|3647088|FG001|Overall Study|Thiopental not available|0
2068991|NCT00611767|3647087|FG000|Overall Study|didn't like the medication|1
2068992|NCT00611767|3647088|FG001|Overall Study|didn't like the medication|1
2068993|NCT00611767|3647087|FG000|Overall Study|Physician Decision|1
2068994|NCT00611767|3647088|FG001|Overall Study|Physician Decision|0
2068995|NCT00611806|3647096|FG000|Overall Study|Withdrawal by Subject|8
2068996|NCT00611806|3647097|FG001|Overall Study|Withdrawal by Subject|2
2068997|NCT00611806|3647096|FG000|Overall Study|Adverse Event|2
2068998|NCT00611806|3647097|FG001|Overall Study|Adverse Event|1
2068999|NCT00611806|3647096|FG000|Overall Study|Lost to Follow-up|6
2069000|NCT00611806|3647097|FG001|Overall Study|Lost to Follow-up|0
2069001|NCT00611858|3647103|FG000|Overall Study|Adverse Event|2
2069002|NCT00611858|3647103|FG000|Overall Study|Withdrawal by Subject|2
2069003|NCT00611884|3647113|FG000|Overall Study|Adverse Event|1
2069004|NCT00611884|3647114|FG001|Overall Study|Adverse Event|0
2069005|NCT00611884|3647115|FG002|Overall Study|Adverse Event|0
2069006|NCT00611884|3647116|FG003|Overall Study|Adverse Event|1
2069007|NCT00611884|3647113|FG000|Overall Study|Non-Compliance|1
2069008|NCT00611884|3647114|FG001|Overall Study|Non-Compliance|4
2069009|NCT00611884|3647115|FG002|Overall Study|Non-Compliance|2
2069010|NCT00611884|3647116|FG003|Overall Study|Non-Compliance|2
2069011|NCT00611884|3647113|FG000|Overall Study|Lack of Efficacy|0
2069012|NCT00611884|3647114|FG001|Overall Study|Lack of Efficacy|1
2069013|NCT00611884|3647115|FG002|Overall Study|Lack of Efficacy|0
2069014|NCT00611884|3647116|FG003|Overall Study|Lack of Efficacy|0
2069015|NCT00611884|3647113|FG000|Overall Study|Unclassified|7
2069016|NCT00611884|3647114|FG001|Overall Study|Unclassified|4
2069017|NCT00611884|3647115|FG002|Overall Study|Unclassified|2
2069018|NCT00611884|3647116|FG003|Overall Study|Unclassified|3
2069019|NCT00611923|3647137|FG000|Overall Study|Withdrawal by Subject|2
2069020|NCT00611923|3647138|FG001|Overall Study|Withdrawal by Subject|2
2069021|NCT00611975|3647148|FG000|Overall Study|Withdrawal by Subject|3
2069022|NCT00611975|3647149|FG001|Overall Study|Withdrawal by Subject|7
2069023|NCT00611975|3647148|FG000|Overall Study|Pregnancy|2
2069024|NCT00611975|3647149|FG001|Overall Study|Pregnancy|1
2069025|NCT00612040|3647158|FG000|Overall Study|Adverse Event|0
2069026|NCT00612040|3647159|FG001|Overall Study|Adverse Event|2
2069027|NCT00612040|3647160|FG002|Overall Study|Adverse Event|1
2069028|NCT00612040|3647158|FG000|Overall Study|Protocol Violation|1
2069029|NCT00612040|3647159|FG001|Overall Study|Protocol Violation|2
2069030|NCT00612040|3647160|FG002|Overall Study|Protocol Violation|1
2069031|NCT00612040|3647158|FG000|Overall Study|Lack of Efficacy|2
2069032|NCT00612040|3647159|FG001|Overall Study|Lack of Efficacy|1
2069033|NCT00612040|3647160|FG002|Overall Study|Lack of Efficacy|0
2069034|NCT00612040|3647158|FG000|Overall Study|Unclassified|2
2069035|NCT00612040|3647159|FG001|Overall Study|Unclassified|2
2069036|NCT00612040|3647160|FG002|Overall Study|Unclassified|5
2069037|NCT00612066|3647168|FG000|Overall Study|Adverse Event|1
2069038|NCT00612105|3647174|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18
2069039|NCT00612105|3647175|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1
2069040|NCT00612105|3647174|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
2069041|NCT00612105|3647175|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
2069042|NCT00612105|3647174|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
2069043|NCT00612105|3647175|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
2069044|NCT00612105|3647174|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1
2069045|NCT00612105|3647175|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1
2069046|NCT00612105|3647174|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
2069047|NCT00612105|3647175|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
2069048|NCT00612105|3647174|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
2069049|NCT00612105|3647175|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
2069050|NCT00612105|3647174|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
2069051|NCT00612105|3647175|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
2069052|NCT00612105|3647174|FG000|Period Title 1: 6-Week Titration Phase|Other|0
2069053|NCT00612105|3647175|FG001|Period Title 1: 6-Week Titration Phase|Other|1
2069054|NCT00612105|3647174|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
2069055|NCT00612105|3647175|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
2069056|NCT00612105|3647174|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
2069057|NCT00612105|3647175|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
2069058|NCT00612105|3647174|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
2069059|NCT00612105|3647175|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
2069060|NCT00612105|3647174|FG000|Period Title 3: 3-Week Taper Phase|Other|1
2069061|NCT00612105|3647175|FG001|Period Title 3: 3-Week Taper Phase|Other|0
2069062|NCT00612313|3647205|FG000|Overall Study|Withdrawal by Subject|6
2069063|NCT00612313|3647206|FG001|Overall Study|Withdrawal by Subject|9
2069064|NCT00612313|3647205|FG000|Overall Study|Lost to Follow-up|11
2069065|NCT00612313|3647206|FG001|Overall Study|Lost to Follow-up|4
2069066|NCT00612352|3647224|FG000|Overall Study|Adverse Event|1
2069067|NCT00612352|3647225|FG001|Overall Study|Adverse Event|0
2069068|NCT00612352|3647224|FG000|Overall Study|Withdrawal by Subject|3
2069069|NCT00612352|3647225|FG001|Overall Study|Withdrawal by Subject|5
2069070|NCT00612352|3647224|FG000|Overall Study|moved out of state|1
2069071|NCT00612352|3647225|FG001|Overall Study|moved out of state|0
2069072|NCT00612352|3647224|FG000|Overall Study|didn't return calls/show up on test date|4
2069073|NCT00612352|3647225|FG001|Overall Study|didn't return calls/show up on test date|1
2069074|NCT00612456|3647245|FG000|Overall Study|Adverse Event|1
2069075|NCT00612456|3647246|FG001|Overall Study|Adverse Event|0
2069076|NCT00612456|3647247|FG002|Overall Study|Adverse Event|0
2069077|NCT00612456|3647245|FG000|Overall Study|Lack of Efficacy|1
2069078|NCT00612456|3647246|FG001|Overall Study|Lack of Efficacy|1
2069079|NCT00612456|3647247|FG002|Overall Study|Lack of Efficacy|0
2069080|NCT00612456|3647245|FG000|Overall Study|Withdrawal by Subject|0
2069081|NCT00612456|3647246|FG001|Overall Study|Withdrawal by Subject|1
2069082|NCT00612456|3647247|FG002|Overall Study|Withdrawal by Subject|0
2069083|NCT00612508|3647259|FG000|Overall Study|Withdrawal by Subject|3
2069084|NCT00612508|3647260|FG001|Overall Study|Withdrawal by Subject|4
2069085|NCT00612534|3647272|FG000|Overall Study|Adverse Event|0
2069086|NCT00612534|3647273|FG001|Overall Study|Adverse Event|4
2069087|NCT00612534|3647274|FG002|Overall Study|Adverse Event|2
2069088|NCT00612534|3647275|FG003|Overall Study|Adverse Event|1
2069089|NCT00612534|3647272|FG000|Overall Study|Lack of Efficacy|13
2069090|NCT00612534|3647273|FG001|Overall Study|Lack of Efficacy|12
2069091|NCT00612534|3647274|FG002|Overall Study|Lack of Efficacy|5
2069092|NCT00612534|3647275|FG003|Overall Study|Lack of Efficacy|16
2069093|NCT00612534|3647272|FG000|Overall Study|Other Reason|0
2069094|NCT00612534|3647273|FG001|Overall Study|Other Reason|1
2069095|NCT00612534|3647274|FG002|Overall Study|Other Reason|0
2069096|NCT00612534|3647275|FG003|Overall Study|Other Reason|0
2303253|NCT02638103|4002556|FG003|Overall Study|Lack of Efficacy|22
2303254|NCT02638103|4002553|FG000|Overall Study|Other than specified|5
2303255|NCT02638103|4002554|FG001|Overall Study|Other than specified|4
2303256|NCT02638103|4002555|FG002|Overall Study|Other than specified|2
2303257|NCT02638103|4002556|FG003|Overall Study|Other than specified|4
2303258|NCT02638259|4002596|FG000|Treatment Period 1|Adverse Event|1
2303259|NCT02638259|4002597|FG001|Treatment Period 1|Adverse Event|5
2303260|NCT02638259|4002596|FG000|Treatment Period 1|Death|0
2303261|NCT02638259|4002597|FG001|Treatment Period 1|Death|1
2303262|NCT02638259|4002596|FG000|Treatment Period 1|Lack of Efficacy|0
2303263|NCT02638259|4002597|FG001|Treatment Period 1|Lack of Efficacy|1
2303264|NCT02638259|4002596|FG000|Treatment Period 1|Protocol Violation|0
2303265|NCT02638259|4002597|FG001|Treatment Period 1|Protocol Violation|3
2303266|NCT02638259|4002596|FG000|Treatment Period 1|Withdrawal by Subject|4
2303267|NCT02638259|4002597|FG001|Treatment Period 1|Withdrawal by Subject|6
2303268|NCT02638259|4002596|FG000|Treatment Period 1|Withdrawn per sponsor decision|0
2303269|NCT02638259|4002597|FG001|Treatment Period 1|Withdrawn per sponsor decision|2
2303270|NCT02638259|4002596|FG000|Treatment Period 2|Adverse Event|5
2303271|NCT02638259|4002597|FG001|Treatment Period 2|Adverse Event|4
2303272|NCT02638259|4002596|FG000|Treatment Period 2|Withdrawal by Subject|1
2303273|NCT02638259|4002597|FG001|Treatment Period 2|Withdrawal by Subject|7
2303274|NCT02638337|4002609|FG000|Overall Study|Adverse Event|6
2303275|NCT02638337|4002610|FG001|Overall Study|Adverse Event|10
2303276|NCT02638337|4002609|FG000|Overall Study|Protocol Violation|3
2303277|NCT02638337|4002610|FG001|Overall Study|Protocol Violation|0
2303278|NCT02638337|4002609|FG000|Overall Study|Withdrawal by Subject|13
2303279|NCT02638337|4002610|FG001|Overall Study|Withdrawal by Subject|16
2303280|NCT02638337|4002609|FG000|Overall Study|Lost to Follow-up|7
2303281|NCT02638337|4002610|FG001|Overall Study|Lost to Follow-up|7
2303282|NCT02638337|4002609|FG000|Overall Study|Other - Miscellaneous|4
2303283|NCT02638337|4002610|FG001|Overall Study|Other - Miscellaneous|3
2303284|NCT02638493|4002619|FG000|Overall Study|Inability to provide semen samples|2
2069097|NCT00612586|3647321|FG000|Overall Study|Adverse Event|6
2069098|NCT00612586|3647322|FG001|Overall Study|Adverse Event|2
2069099|NCT00612586|3647321|FG000|Overall Study|Death|1
2069100|NCT00612586|3647322|FG001|Overall Study|Death|0
2069101|NCT00612586|3647321|FG000|Overall Study|Entry Criteria Not Met|0
2069102|NCT00612586|3647322|FG001|Overall Study|Entry Criteria Not Met|2
2069103|NCT00612586|3647321|FG000|Overall Study|Withdrawal by Subject|7
2069104|NCT00612586|3647322|FG001|Overall Study|Withdrawal by Subject|9
2069105|NCT00612586|3647321|FG000|Overall Study|Physician Decision|1
2069106|NCT00612586|3647322|FG001|Overall Study|Physician Decision|2
2069107|NCT00612586|3647321|FG000|Overall Study|Sponsor Decision|1
2069108|NCT00612586|3647322|FG001|Overall Study|Sponsor Decision|1
2069109|NCT00612586|3647321|FG000|Overall Study|Progressive Disease|26
2069110|NCT00612586|3647322|FG001|Overall Study|Progressive Disease|24
2069111|NCT00612586|3647321|FG000|Overall Study|Randomized and Not Treated|1
2069112|NCT00612586|3647322|FG001|Overall Study|Randomized and Not Treated|1
2069113|NCT00612690|3647331|FG000|Overall Study|Lost to Follow-up|72
2069114|NCT00612690|3647332|FG001|Overall Study|Lost to Follow-up|98
2069115|NCT00612690|3647331|FG000|Overall Study|Withdrawal by Subject|32
2069116|NCT00612690|3647332|FG001|Overall Study|Withdrawal by Subject|20
2069117|NCT00612690|3647331|FG000|Overall Study|Withdrawal by Site|11
2069118|NCT00612690|3647332|FG001|Overall Study|Withdrawal by Site|0
2069119|NCT00612807|3647371|FG000|Overall Study|Withdrawal by Subject|2
2069120|NCT00612807|3647372|FG001|Overall Study|Withdrawal by Subject|0
2069121|NCT00613015|3647394|FG000|Overall Study|Lost to Follow-up|0
2069122|NCT00613015|3647395|FG001|Overall Study|Lost to Follow-up|1
2069123|NCT00613015|3647396|FG002|Overall Study|Lost to Follow-up|3
2069124|NCT00613015|3647397|FG003|Overall Study|Lost to Follow-up|3
2069125|NCT00613015|3647398|FG004|Overall Study|Lost to Follow-up|2
2069126|NCT00613015|3647399|FG005|Overall Study|Lost to Follow-up|3
2106240|NCT00863798|3699292|FG002|Overall Study|Protocol Violation|1
2106241|NCT00863798|3699290|FG000|Overall Study|Withdrawal by Subject|8
2106242|NCT00863798|3699291|FG001|Overall Study|Withdrawal by Subject|7
2106243|NCT00863798|3699292|FG002|Overall Study|Withdrawal by Subject|4
2106244|NCT00863798|3699290|FG000|Overall Study|Randomized not treated|4
2106245|NCT00863798|3699291|FG001|Overall Study|Randomized not treated|2
2106246|NCT00863798|3699292|FG002|Overall Study|Randomized not treated|3
2106247|NCT00863928|3699302|FG000|Overall Study|Protocol Violation|26
2106248|NCT00863928|3699303|FG001|Overall Study|Protocol Violation|0
2106249|NCT00863928|3699302|FG000|Overall Study|Withdrawal by Subject|3
2106250|NCT00863928|3699303|FG001|Overall Study|Withdrawal by Subject|0
2106251|NCT00863928|3699302|FG000|Overall Study|surgery cancellation|4
2106252|NCT00863928|3699303|FG001|Overall Study|surgery cancellation|0
2106253|NCT00863928|3699302|FG000|Overall Study|medication allergy|3
2106254|NCT00863928|3699303|FG001|Overall Study|medication allergy|0
2106255|NCT00864097|3699330|FG000|Overall Study|Death|0
2106256|NCT00864097|3699331|FG001|Overall Study|Death|1
2106257|NCT00864097|3699332|FG002|Overall Study|Death|0
2106258|NCT00864097|3699333|FG003|Overall Study|Death|0
2106259|NCT00864097|3699330|FG000|Overall Study|Adverse Event|6
2106260|NCT00864097|3699331|FG001|Overall Study|Adverse Event|8
2106261|NCT00864097|3699332|FG002|Overall Study|Adverse Event|11
2106262|NCT00864097|3699333|FG003|Overall Study|Adverse Event|9
2106263|NCT00864097|3699330|FG000|Overall Study|Lack of Efficacy|9
2106264|NCT00864097|3699331|FG001|Overall Study|Lack of Efficacy|3
2106265|NCT00864097|3699332|FG002|Overall Study|Lack of Efficacy|7
2106266|NCT00864097|3699333|FG003|Overall Study|Lack of Efficacy|2
2106267|NCT00864097|3699330|FG000|Overall Study|Lost to Follow-up|0
2106268|NCT00864097|3699331|FG001|Overall Study|Lost to Follow-up|1
2106269|NCT00864097|3699332|FG002|Overall Study|Lost to Follow-up|0
2106270|NCT00864097|3699333|FG003|Overall Study|Lost to Follow-up|1
2106271|NCT00864097|3699330|FG000|Overall Study|Withdrawal by Subject|15
2106272|NCT00864097|3699331|FG001|Overall Study|Withdrawal by Subject|11
2106273|NCT00864097|3699332|FG002|Overall Study|Withdrawal by Subject|11
2106274|NCT00864097|3699333|FG003|Overall Study|Withdrawal by Subject|12
2106275|NCT00864097|3699330|FG000|Overall Study|Protocol Violation|2
2106276|NCT00864097|3699331|FG001|Overall Study|Protocol Violation|1
2106277|NCT00864097|3699332|FG002|Overall Study|Protocol Violation|0
2106278|NCT00864097|3699333|FG003|Overall Study|Protocol Violation|1
2106279|NCT00864097|3699330|FG000|Overall Study|Terminated by sponsor|105
2106280|NCT00864097|3699331|FG001|Overall Study|Terminated by sponsor|112
2106281|NCT00864097|3699332|FG002|Overall Study|Terminated by sponsor|102
2106282|NCT00864097|3699333|FG003|Overall Study|Terminated by sponsor|99
2106283|NCT00864097|3699330|FG000|Overall Study|Randomized but not treated|2
2106284|NCT00864097|3699331|FG001|Overall Study|Randomized but not treated|0
2106285|NCT00864097|3699332|FG002|Overall Study|Randomized but not treated|1
2106286|NCT00864097|3699333|FG003|Overall Study|Randomized but not treated|0
2106287|NCT00864097|3699330|FG000|Overall Study|Other|0
2106288|NCT00864097|3699331|FG001|Overall Study|Other|0
2106289|NCT00864097|3699332|FG002|Overall Study|Other|0
2106290|NCT00864097|3699333|FG003|Overall Study|Other|1
2106291|NCT00864253|3699354|FG000|Overall Study|Adverse Event|56
2106292|NCT00864253|3699355|FG001|Overall Study|Adverse Event|11
2106293|NCT00864253|3699354|FG000|Overall Study|Unrelated Adverse Event|3
2106294|NCT00864253|3699355|FG001|Overall Study|Unrelated Adverse Event|1
2106295|NCT00864253|3699354|FG000|Overall Study|Physician Decision|11
2069127|NCT00613080|3647422|FG000|Overall Study|Ineligible / no protocol treatment|11
2069128|NCT00613106|3647428|FG000|Overall Study|Adverse Event|3
2069129|NCT00613106|3647429|FG001|Overall Study|Adverse Event|1
2069130|NCT00613106|3647428|FG000|Overall Study|Withdrawal by Subject|6
2069131|NCT00613106|3647429|FG001|Overall Study|Withdrawal by Subject|3
2069132|NCT00613106|3647428|FG000|Overall Study|Lost to Follow-up|7
2069133|NCT00613106|3647429|FG001|Overall Study|Lost to Follow-up|2
2069134|NCT00613106|3647428|FG000|Overall Study|misc|4
2069135|NCT00613106|3647429|FG001|Overall Study|misc|3
2069136|NCT00613171|3647435|FG000|Overall Study|Adverse Event|7
2069137|NCT00613171|3647435|FG000|Overall Study|Withdrawal by Subject|3
2069138|NCT00613171|3647435|FG000|Overall Study|Reason not Specified|4
2069139|NCT00613301|3647440|FG000|Overall Study|Adverse Event|49
2069140|NCT00613301|3647440|FG000|Overall Study|Lost to Follow-up|88
2069141|NCT00613301|3647440|FG000|Overall Study|Withdrawal by Subject|5
2069142|NCT00613301|3647440|FG000|Overall Study|Death|6
2069143|NCT00613301|3647440|FG000|Overall Study|Lack of Efficacy|13
2069144|NCT00613301|3647440|FG000|Overall Study|Physician Decision|2
2069145|NCT00613301|3647440|FG000|Overall Study|No data was collected|53
2069146|NCT00613301|3647440|FG000|Overall Study|Irregularly enrolled patients|12
2069147|NCT00613314|3647445|FG000|Overall Study|Adverse Event|5
2069148|NCT00613314|3647445|FG000|Overall Study|Protocol Violation|14
2069149|NCT00613314|3647445|FG000|Overall Study|Lost to Follow-up|46
2069150|NCT00613314|3647445|FG000|Overall Study|Other reason not defined above|90
2069151|NCT00613327|3647449|FG000|Overall Study|Adverse Event|38
2303285|NCT02638493|4002620|FG001|Overall Study|Inability to provide semen samples|0
2303286|NCT02638493|4002621|FG002|Overall Study|Inability to provide semen samples|0
2303287|NCT02638623|4002642|FG000|Overall Study|Surgery timing|5
2303288|NCT02638623|4002643|FG001|Overall Study|Surgery timing|6
2303289|NCT02638623|4002642|FG000|Overall Study|Not given intervention|2
2303290|NCT02638623|4002643|FG001|Overall Study|Not given intervention|0
2303291|NCT02638948|4002653|FG000|Overall Study|Withdrawal by Subject|4
2303292|NCT02638948|4002654|FG001|Overall Study|Withdrawal by Subject|5
2303293|NCT02638948|4002655|FG002|Overall Study|Withdrawal by Subject|3
2303294|NCT02638948|4002656|FG003|Overall Study|Withdrawal by Subject|1
2303295|NCT02638948|4002653|FG000|Overall Study|Administrative Reason by Sponsor|0
2303296|NCT02638948|4002654|FG001|Overall Study|Administrative Reason by Sponsor|1
2303297|NCT02638948|4002655|FG002|Overall Study|Administrative Reason by Sponsor|0
2303298|NCT02638948|4002656|FG003|Overall Study|Administrative Reason by Sponsor|4
2303299|NCT02638948|4002653|FG000|Overall Study|Adverse Event|0
2303300|NCT02638948|4002654|FG001|Overall Study|Adverse Event|0
2303301|NCT02638948|4002655|FG002|Overall Study|Adverse Event|1
2303302|NCT02638948|4002656|FG003|Overall Study|Adverse Event|1
2303303|NCT02638948|4002653|FG000|Overall Study|Lack of Efficacy|1
2303304|NCT02638948|4002654|FG001|Overall Study|Lack of Efficacy|1
2303305|NCT02638948|4002655|FG002|Overall Study|Lack of Efficacy|0
2303306|NCT02638948|4002656|FG003|Overall Study|Lack of Efficacy|0
2303307|NCT02638948|4002653|FG000|Overall Study|Lost to Follow-up|0
2303308|NCT02638948|4002654|FG001|Overall Study|Lost to Follow-up|0
2303309|NCT02638948|4002655|FG002|Overall Study|Lost to Follow-up|1
2303310|NCT02638948|4002656|FG003|Overall Study|Lost to Follow-up|1
2303311|NCT02638948|4002653|FG000|Overall Study|Poor/Non-Compliance|0
2303312|NCT02638948|4002654|FG001|Overall Study|Poor/Non-Compliance|2
2303313|NCT02638948|4002655|FG002|Overall Study|Poor/Non-Compliance|1
2303314|NCT02638948|4002656|FG003|Overall Study|Poor/Non-Compliance|0
2303315|NCT02638948|4002653|FG000|Overall Study|Participant no longer met study criteria|0
2303316|NCT02638948|4002654|FG001|Overall Study|Participant no longer met study criteria|1
2303317|NCT02638948|4002655|FG002|Overall Study|Participant no longer met study criteria|0
2303318|NCT02638948|4002656|FG003|Overall Study|Participant no longer met study criteria|0
2303319|NCT02638948|4002653|FG000|Overall Study|Other than specified above|4
2303320|NCT02638948|4002654|FG001|Overall Study|Other than specified above|1
2303321|NCT02638948|4002655|FG002|Overall Study|Other than specified above|1
2303322|NCT02638948|4002656|FG003|Overall Study|Other than specified above|1
2303323|NCT02639052|4002678|FG000|Overall Study|Lost to Follow-up|1
2303324|NCT02639182|4002686|FG000|Overall Study|Disease Progression|50
2303325|NCT02639182|4002687|FG001|Overall Study|Disease Progression|49
2303326|NCT02639182|4002686|FG000|Overall Study|Adverse Event|7
2303327|NCT02639182|4002687|FG001|Overall Study|Adverse Event|5
2303328|NCT02639182|4002686|FG000|Overall Study|Physician Decision|3
2303329|NCT02639182|4002687|FG001|Overall Study|Physician Decision|3
2303330|NCT02639182|4002686|FG000|Overall Study|Withdrew Consent|5
2303331|NCT02639182|4002687|FG001|Overall Study|Withdrew Consent|4
2303332|NCT02639182|4002686|FG000|Overall Study|Lost to Follow-up|0
2303333|NCT02639182|4002687|FG001|Overall Study|Lost to Follow-up|1
2303334|NCT02639182|4002686|FG000|Overall Study|Study Closure|1
2303335|NCT02639182|4002687|FG001|Overall Study|Study Closure|2
2303336|NCT02639182|4002686|FG000|Overall Study|Sponsor Ended Study|0
2303337|NCT02639182|4002687|FG001|Overall Study|Sponsor Ended Study|1
2303338|NCT02639182|4002686|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1
2303339|NCT02639182|4002687|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1
2303340|NCT02639247|4002695|FG000|Overall Study|Lost to Follow-up|2
2303341|NCT02639247|4002696|FG001|Overall Study|Lost to Follow-up|1
2303342|NCT02639247|4002695|FG000|Overall Study|Death|2
2303343|NCT02639247|4002696|FG001|Overall Study|Death|0
2069152|NCT00613327|3647449|FG000|Overall Study|Lost to Follow-up|8
2069153|NCT00613327|3647449|FG000|Overall Study|Withdrawal by Subject|6
2069154|NCT00613327|3647449|FG000|Overall Study|Protocol Violation|2
2069155|NCT00613327|3647449|FG000|Overall Study|Other|47
2069156|NCT00613366|3647455|FG000|Overall Study|Withdrawal by Subject|3
2069157|NCT00613366|3647456|FG001|Overall Study|Withdrawal by Subject|2
2069158|NCT00613509|3647486|FG000|Cycle 1|Adverse Event|2
2069159|NCT00613509|3647487|FG001|Cycle 1|Adverse Event|1
2069160|NCT00613509|3647486|FG000|Cycle 1|Disease Progression|2
2069161|NCT00613509|3647487|FG001|Cycle 1|Disease Progression|6
2069162|NCT00613509|3647486|FG000|Cycle 1|Unacceptable Toxicity|1
2069163|NCT00613509|3647487|FG001|Cycle 1|Unacceptable Toxicity|0
2069164|NCT00613509|3647486|FG000|Cycle 1|Other administrative reason|0
2069165|NCT00613509|3647487|FG001|Cycle 1|Other administrative reason|1
2069166|NCT00613574|3647493|FG000|Overall Study|Adverse Event|3
2069167|NCT00613574|3647493|FG000|Overall Study|Lost to Follow-up|2
2069168|NCT00613574|3647493|FG000|Overall Study|Other|1
2069169|NCT00613626|3647500|FG000|Overall Study|Ineligible|0
2069170|NCT00613626|3647501|FG001|Overall Study|Ineligible|1
2069171|NCT00613626|3647502|FG002|Overall Study|Ineligible|0
2069172|NCT00613821|3647511|FG000|Overall Study|Withdrawal by Subject|1
2069173|NCT00613821|3647512|FG001|Overall Study|Withdrawal by Subject|0
2069174|NCT00613821|3647511|FG000|Overall Study|Physician Decision|1
2069175|NCT00613821|3647512|FG001|Overall Study|Physician Decision|1
2069176|NCT00613834|3647520|FG000|Overall Study|Withdrawal by Subject|0
2069177|NCT00613834|3647521|FG001|Overall Study|Withdrawal by Subject|3
2069178|NCT00613925|3647531|FG000|Overall Study|1 did not tolerate outpatient biopsy|0
2069179|NCT00613925|3647532|FG001|Overall Study|1 did not tolerate outpatient biopsy|1
2069180|NCT00613938|3647542|FG000|Overall Study|Withdrawal by Subject|2
2069181|NCT00613938|3647543|FG001|Overall Study|Withdrawal by Subject|4
2069182|NCT00613938|3647544|FG002|Overall Study|Withdrawal by Subject|9
2069183|NCT00613938|3647545|FG003|Overall Study|Withdrawal by Subject|9
2069184|NCT00613938|3647542|FG000|Overall Study|Adverse Event|1
2069185|NCT00613938|3647543|FG001|Overall Study|Adverse Event|4
2069186|NCT00613938|3647544|FG002|Overall Study|Adverse Event|8
2069187|NCT00613938|3647545|FG003|Overall Study|Adverse Event|5
2069188|NCT00613938|3647542|FG000|Overall Study|Lack of Efficacy|16
2069189|NCT00613938|3647543|FG001|Overall Study|Lack of Efficacy|18
2069190|NCT00613938|3647544|FG002|Overall Study|Lack of Efficacy|5
2069191|NCT00613938|3647545|FG003|Overall Study|Lack of Efficacy|9
2069192|NCT00613938|3647542|FG000|Overall Study|Other|1
2069193|NCT00613938|3647543|FG001|Overall Study|Other|2
2069194|NCT00613938|3647544|FG002|Overall Study|Other|1
2069195|NCT00613938|3647545|FG003|Overall Study|Other|3
2069196|NCT00613951|3647558|FG000|Overall Study|Adverse Event|1
2069197|NCT00613951|3647559|FG001|Overall Study|Adverse Event|0
2069198|NCT00613951|3647560|FG002|Overall Study|Adverse Event|1
2069199|NCT00613951|3647558|FG000|Overall Study|Lack of Efficacy|0
2069200|NCT00613951|3647559|FG001|Overall Study|Lack of Efficacy|1
2069201|NCT00613951|3647560|FG002|Overall Study|Lack of Efficacy|1
2069202|NCT00613951|3647558|FG000|Overall Study|Protocol Violation|1
2069203|NCT00613951|3647559|FG001|Overall Study|Protocol Violation|1
2069204|NCT00613951|3647560|FG002|Overall Study|Protocol Violation|1
2069205|NCT00613951|3647558|FG000|Overall Study|Unclassified|5
2069206|NCT00613951|3647559|FG001|Overall Study|Unclassified|3
2069207|NCT00613951|3647560|FG002|Overall Study|Unclassified|2
2069208|NCT00614055|3647574|FG000|Overall Study|Adverse Event|1
2069209|NCT00614055|3647575|FG001|Overall Study|Adverse Event|0
2069210|NCT00614055|3647576|FG002|Overall Study|Adverse Event|0
2069211|NCT00614055|3647574|FG000|Overall Study|Protocol Violation|2
2069212|NCT00614055|3647575|FG001|Overall Study|Protocol Violation|2
2303344|NCT02639247|4002695|FG000|Overall Study|Withdrew Consent|0
2303345|NCT02639247|4002696|FG001|Overall Study|Withdrew Consent|1
2303346|NCT02639247|4002695|FG000|Overall Study|Protocol Violation|1
2303347|NCT02639247|4002696|FG001|Overall Study|Protocol Violation|0
2303348|NCT02639338|4002713|FG000|Overall Study|Lost to Follow-up|2
2303349|NCT02639338|4002714|FG001|Overall Study|Lost to Follow-up|2
2303350|NCT02639338|4002713|FG000|Overall Study|Withdrew Consent|1
2303351|NCT02639338|4002714|FG001|Overall Study|Withdrew Consent|2
2303352|NCT02639338|4002713|FG000|Overall Study|Death|1
2303353|NCT02639338|4002714|FG001|Overall Study|Death|0
2069213|NCT00614055|3647576|FG002|Overall Study|Protocol Violation|1
2069214|NCT00614055|3647574|FG000|Overall Study|Lack of Efficacy|0
2069215|NCT00614055|3647575|FG001|Overall Study|Lack of Efficacy|0
2069216|NCT00614055|3647576|FG002|Overall Study|Lack of Efficacy|2
2069217|NCT00614055|3647574|FG000|Overall Study|Unclassified|1
2069218|NCT00614055|3647575|FG001|Overall Study|Unclassified|4
2069219|NCT00614055|3647576|FG002|Overall Study|Unclassified|2
2069220|NCT00614120|3647591|FG000|Overall Study|Adverse Event|9
2069221|NCT00614120|3647592|FG001|Overall Study|Adverse Event|22
2069222|NCT00614120|3647593|FG002|Overall Study|Adverse Event|30
2069223|NCT00614120|3647594|FG003|Overall Study|Adverse Event|3
2069224|NCT00614120|3647591|FG000|Overall Study|Lack of Efficacy|3
2069225|NCT00614120|3647592|FG001|Overall Study|Lack of Efficacy|3
2069226|NCT00614120|3647593|FG002|Overall Study|Lack of Efficacy|2
2069227|NCT00614120|3647594|FG003|Overall Study|Lack of Efficacy|2
2303354|NCT02639338|4002713|FG000|Overall Study|Randomized but Not Treated|0
2303355|NCT02639338|4002714|FG001|Overall Study|Randomized but Not Treated|1
2069228|NCT00614120|3647591|FG000|Overall Study|Protocol Violation|2
2069229|NCT00614120|3647592|FG001|Overall Study|Protocol Violation|5
2069230|NCT00614120|3647593|FG002|Overall Study|Protocol Violation|3
2069231|NCT00614120|3647594|FG003|Overall Study|Protocol Violation|1
2069232|NCT00614120|3647591|FG000|Overall Study|Withdrawal criteria|1
2069233|NCT00614120|3647592|FG001|Overall Study|Withdrawal criteria|0
2069234|NCT00614120|3647593|FG002|Overall Study|Withdrawal criteria|0
2069235|NCT00614120|3647594|FG003|Overall Study|Withdrawal criteria|0
2069236|NCT00614120|3647591|FG000|Overall Study|Withdrawal by Subject|9
2069237|NCT00614120|3647592|FG001|Overall Study|Withdrawal by Subject|10
2069238|NCT00614120|3647593|FG002|Overall Study|Withdrawal by Subject|16
2069239|NCT00614120|3647594|FG003|Overall Study|Withdrawal by Subject|3
2069240|NCT00614120|3647591|FG000|Overall Study|Did not meet trial criteria|0
2069241|NCT00614120|3647592|FG001|Overall Study|Did not meet trial criteria|1
2069242|NCT00614120|3647593|FG002|Overall Study|Did not meet trial criteria|1
2069243|NCT00614120|3647594|FG003|Overall Study|Did not meet trial criteria|1
2069244|NCT00614120|3647591|FG000|Overall Study|hCG positive (not pregnant)|0
2210337|NCT01649375|3849843|FG003|Up to Week 16|Death|0
2210338|NCT01649375|3849844|FG004|Up to Week 16|Death|0
2210339|NCT01649375|3849840|FG000|Week 16 up to Week 260|Lack of Efficacy|7
2210340|NCT01649375|3849841|FG001|Week 16 up to Week 260|Lack of Efficacy|4
2069245|NCT00614120|3647592|FG001|Overall Study|hCG positive (not pregnant)|0
2069246|NCT00614120|3647593|FG002|Overall Study|hCG positive (not pregnant)|1
2069247|NCT00614120|3647594|FG003|Overall Study|hCG positive (not pregnant)|0
2069248|NCT00614120|3647591|FG000|Overall Study|Hypoglycaemia|0
2069249|NCT00614120|3647592|FG001|Overall Study|Hypoglycaemia|0
2069250|NCT00614120|3647593|FG002|Overall Study|Hypoglycaemia|0
2069251|NCT00614120|3647594|FG003|Overall Study|Hypoglycaemia|1
2069252|NCT00614120|3647591|FG000|Overall Study|Lack of trial product|3
2069253|NCT00614120|3647592|FG001|Overall Study|Lack of trial product|3
2069254|NCT00614120|3647593|FG002|Overall Study|Lack of trial product|2
2069255|NCT00614120|3647594|FG003|Overall Study|Lack of trial product|0
2069256|NCT00614120|3647591|FG000|Overall Study|Late syphilis, latent|1
2069257|NCT00614120|3647592|FG001|Overall Study|Late syphilis, latent|0
2069258|NCT00614120|3647593|FG002|Overall Study|Late syphilis, latent|0
2069259|NCT00614120|3647594|FG003|Overall Study|Late syphilis, latent|0
2069260|NCT00614120|3647591|FG000|Overall Study|Taken inhibition medication eg Prandin|0
2069261|NCT00614120|3647592|FG001|Overall Study|Taken inhibition medication eg Prandin|0
2069262|NCT00614120|3647593|FG002|Overall Study|Taken inhibition medication eg Prandin|1
2069263|NCT00614120|3647594|FG003|Overall Study|Taken inhibition medication eg Prandin|1
2069264|NCT00614120|3647591|FG000|Overall Study|Lost to Follow-up|1
2069265|NCT00614120|3647592|FG001|Overall Study|Lost to Follow-up|2
2069266|NCT00614120|3647593|FG002|Overall Study|Lost to Follow-up|3
2069267|NCT00614120|3647594|FG003|Overall Study|Lost to Follow-up|4
2069268|NCT00614380|3647621|FG000|Overall Study|Adverse Event|14
2069269|NCT00614380|3647622|FG001|Overall Study|Adverse Event|4
2069270|NCT00614380|3647623|FG002|Overall Study|Adverse Event|0
2069271|NCT00614380|3647624|FG003|Overall Study|Adverse Event|0
2069272|NCT00614380|3647621|FG000|Overall Study|Lost to Follow-up|6
2069273|NCT00614380|3647622|FG001|Overall Study|Lost to Follow-up|1
2069274|NCT00614380|3647623|FG002|Overall Study|Lost to Follow-up|0
2069275|NCT00614380|3647624|FG003|Overall Study|Lost to Follow-up|0
2069276|NCT00614380|3647621|FG000|Overall Study|Non compliant with the protocol|12
2069277|NCT00614380|3647622|FG001|Overall Study|Non compliant with the protocol|2
2069278|NCT00614380|3647623|FG002|Overall Study|Non compliant with the protocol|1
2069279|NCT00614380|3647624|FG003|Overall Study|Non compliant with the protocol|2
2069280|NCT00614380|3647621|FG000|Overall Study|Consent withdrawn|3
2069281|NCT00614380|3647622|FG001|Overall Study|Consent withdrawn|1
2069282|NCT00614380|3647623|FG002|Overall Study|Consent withdrawn|0
2069283|NCT00614380|3647624|FG003|Overall Study|Consent withdrawn|0
2069284|NCT00614393|3647644|FG000|Overall Study|Adverse Event|20
2069285|NCT00614393|3647645|FG001|Overall Study|Adverse Event|2
2069286|NCT00614393|3647646|FG002|Overall Study|Adverse Event|3
2069287|NCT00614393|3647647|FG003|Overall Study|Adverse Event|13
2069288|NCT00614393|3647648|FG004|Overall Study|Adverse Event|21
2069289|NCT00614393|3647644|FG000|Overall Study|Lost to Follow-up|0
2069290|NCT00614393|3647645|FG001|Overall Study|Lost to Follow-up|0
2069291|NCT00614393|3647646|FG002|Overall Study|Lost to Follow-up|0
2069292|NCT00614393|3647647|FG003|Overall Study|Lost to Follow-up|1
2069293|NCT00614393|3647648|FG004|Overall Study|Lost to Follow-up|2
2069294|NCT00614393|3647644|FG000|Overall Study|Physician Decision|17
2069295|NCT00614393|3647645|FG001|Overall Study|Physician Decision|0
2069296|NCT00614393|3647646|FG002|Overall Study|Physician Decision|1
2069297|NCT00614393|3647647|FG003|Overall Study|Physician Decision|8
2069298|NCT00614393|3647648|FG004|Overall Study|Physician Decision|9
2069299|NCT00614393|3647644|FG000|Overall Study|Progressive Disease|118
2069300|NCT00614393|3647645|FG001|Overall Study|Progressive Disease|5
2069301|NCT00614393|3647646|FG002|Overall Study|Progressive Disease|5
2069302|NCT00614393|3647647|FG003|Overall Study|Progressive Disease|138
2210341|NCT01649375|3849842|FG002|Week 16 up to Week 260|Lack of Efficacy|0
2069303|NCT00614393|3647648|FG004|Overall Study|Progressive Disease|130
2069304|NCT00614393|3647644|FG000|Overall Study|Protocol Violation|1
2069305|NCT00614393|3647645|FG001|Overall Study|Protocol Violation|0
2069306|NCT00614393|3647646|FG002|Overall Study|Protocol Violation|0
2069307|NCT00614393|3647647|FG003|Overall Study|Protocol Violation|0
2069308|NCT00614393|3647648|FG004|Overall Study|Protocol Violation|0
2069309|NCT00614393|3647644|FG000|Overall Study|Terminated by Sponsor|0
2069310|NCT00614393|3647645|FG001|Overall Study|Terminated by Sponsor|0
2069311|NCT00614393|3647646|FG002|Overall Study|Terminated by Sponsor|0
2069312|NCT00614393|3647647|FG003|Overall Study|Terminated by Sponsor|0
2069313|NCT00614393|3647648|FG004|Overall Study|Terminated by Sponsor|1
2069314|NCT00614393|3647644|FG000|Overall Study|Withdrawal by Subject|20
2069315|NCT00614393|3647645|FG001|Overall Study|Withdrawal by Subject|1
2069316|NCT00614393|3647646|FG002|Overall Study|Withdrawal by Subject|1
2069317|NCT00614393|3647647|FG003|Overall Study|Withdrawal by Subject|16
2069318|NCT00614393|3647648|FG004|Overall Study|Withdrawal by Subject|13
2069319|NCT00614393|3647644|FG000|Overall Study|Other|4
2069320|NCT00614393|3647645|FG001|Overall Study|Other|0
2069321|NCT00614393|3647646|FG002|Overall Study|Other|0
2069322|NCT00614393|3647647|FG003|Overall Study|Other|4
2069323|NCT00614393|3647648|FG004|Overall Study|Other|2
2069324|NCT00614393|3647644|FG000|Overall Study|Not Treated|0
2069325|NCT00614393|3647645|FG001|Overall Study|Not Treated|0
2069326|NCT00614393|3647646|FG002|Overall Study|Not Treated|0
2069327|NCT00614393|3647647|FG003|Overall Study|Not Treated|0
2069328|NCT00614393|3647648|FG004|Overall Study|Not Treated|2
2069329|NCT00614523|3647698|FG000|Overall Study|Adverse Event|4
2069330|NCT00614523|3647699|FG001|Overall Study|Adverse Event|20
2069331|NCT00614523|3647698|FG000|Overall Study|Death|5
2069332|NCT00614523|3647699|FG001|Overall Study|Death|8
2069333|NCT00614523|3647698|FG000|Overall Study|Lack of Efficacy|9
2069334|NCT00614523|3647699|FG001|Overall Study|Lack of Efficacy|11
2069335|NCT00614523|3647698|FG000|Overall Study|Lost to Follow-up|0
2069336|NCT00614523|3647699|FG001|Overall Study|Lost to Follow-up|1
2069337|NCT00614523|3647698|FG000|Overall Study|Protocol Violation|3
2069338|NCT00614523|3647699|FG001|Overall Study|Protocol Violation|2
2069339|NCT00614523|3647698|FG000|Overall Study|Withdrawal by Subject|12
2069340|NCT00614523|3647699|FG001|Overall Study|Withdrawal by Subject|22
2069341|NCT00614523|3647698|FG000|Overall Study|Other|6
2069342|NCT00614523|3647699|FG001|Overall Study|Other|11
2069343|NCT00614523|3647698|FG000|Overall Study|Ineligibility Determined|1
2069344|NCT00614523|3647699|FG001|Overall Study|Ineligibility Determined|2
2069345|NCT00614523|3647698|FG000|Overall Study|Disease Progression|0
2069346|NCT00614523|3647699|FG001|Overall Study|Disease Progression|8
2069347|NCT00614523|3647698|FG000|Overall Study|Administrative Decision|23
2069348|NCT00614523|3647699|FG001|Overall Study|Administrative Decision|46
2069349|NCT00614575|3647705|FG000|Overall Study|Adverse Event|106
2069350|NCT00614575|3647705|FG000|Overall Study|Lost to Follow-up|55
2069351|NCT00614575|3647705|FG000|Overall Study|Lack of Efficacy|14
2069352|NCT00614575|3647705|FG000|Overall Study|Withdrawal by Subject|6
2069353|NCT00614575|3647705|FG000|Overall Study|Death|3
2069354|NCT00614575|3647705|FG000|Overall Study|Physician Decision|2
2069355|NCT00614575|3647705|FG000|Overall Study|No data were collected.|18
2069356|NCT00614575|3647705|FG000|Overall Study|Irregularly enrolled patients|23
2069357|NCT00614575|3647705|FG000|Overall Study|No treatment|1
2069358|NCT00614614|3647711|FG000|Primary Vaccination Phase|Adverse Event|6
2069359|NCT00614614|3647712|FG001|Primary Vaccination Phase|Adverse Event|0
2069360|NCT00614614|3647713|FG002|Primary Vaccination Phase|Adverse Event|0
2069361|NCT00614614|3647714|FG003|Primary Vaccination Phase|Adverse Event|0
2069362|NCT00614614|3647715|FG004|Primary Vaccination Phase|Adverse Event|0
2069363|NCT00614614|3647711|FG000|Primary Vaccination Phase|Withdrawal by Subject|45
2069364|NCT00614614|3647712|FG001|Primary Vaccination Phase|Withdrawal by Subject|6
2069365|NCT00614614|3647713|FG002|Primary Vaccination Phase|Withdrawal by Subject|0
2069366|NCT00614614|3647714|FG003|Primary Vaccination Phase|Withdrawal by Subject|0
2069367|NCT00614614|3647715|FG004|Primary Vaccination Phase|Withdrawal by Subject|0
2069368|NCT00614614|3647711|FG000|Primary Vaccination Phase|Lost to Follow-up|26
2069369|NCT00614614|3647712|FG001|Primary Vaccination Phase|Lost to Follow-up|8
2069370|NCT00614614|3647713|FG002|Primary Vaccination Phase|Lost to Follow-up|0
2069371|NCT00614614|3647714|FG003|Primary Vaccination Phase|Lost to Follow-up|0
2069372|NCT00614614|3647715|FG004|Primary Vaccination Phase|Lost to Follow-up|0
2069373|NCT00614614|3647711|FG000|Primary Vaccination Phase|Protocol Violation|9
2069374|NCT00614614|3647712|FG001|Primary Vaccination Phase|Protocol Violation|3
2210342|NCT01649375|3849843|FG003|Week 16 up to Week 260|Lack of Efficacy|4
2210343|NCT01649375|3849844|FG004|Week 16 up to Week 260|Lack of Efficacy|2
2210344|NCT01649375|3849840|FG000|Week 16 up to Week 260|Non-compliance|0
2210345|NCT01649375|3849841|FG001|Week 16 up to Week 260|Non-compliance|1
2210346|NCT01649375|3849842|FG002|Week 16 up to Week 260|Non-compliance|0
2210347|NCT01649375|3849843|FG003|Week 16 up to Week 260|Non-compliance|1
2210348|NCT01649375|3849844|FG004|Week 16 up to Week 260|Non-compliance|0
2210349|NCT01649375|3849840|FG000|Week 16 up to Week 260|Physician Decision|0
2210350|NCT01649375|3849841|FG001|Week 16 up to Week 260|Physician Decision|2
2210351|NCT01649375|3849842|FG002|Week 16 up to Week 260|Physician Decision|0
2210352|NCT01649375|3849843|FG003|Week 16 up to Week 260|Physician Decision|0
2069375|NCT00614614|3647713|FG002|Primary Vaccination Phase|Protocol Violation|0
2069376|NCT00614614|3647714|FG003|Primary Vaccination Phase|Protocol Violation|0
2069377|NCT00614614|3647715|FG004|Primary Vaccination Phase|Protocol Violation|0
2069378|NCT00614614|3647711|FG000|Primary Vaccination Phase|Other|4
2069379|NCT00614614|3647712|FG001|Primary Vaccination Phase|Other|0
2210353|NCT01649375|3849844|FG004|Week 16 up to Week 260|Physician Decision|0
2069380|NCT00614614|3647713|FG002|Primary Vaccination Phase|Other|0
2069381|NCT00614614|3647714|FG003|Primary Vaccination Phase|Other|0
2069382|NCT00614614|3647715|FG004|Primary Vaccination Phase|Other|0
2069383|NCT00614614|3647711|FG000|Booster Vaccination Phase|Adverse Event|0
2069384|NCT00614614|3647712|FG001|Booster Vaccination Phase|Adverse Event|0
2069385|NCT00614614|3647713|FG002|Booster Vaccination Phase|Adverse Event|1
2069386|NCT00614614|3647714|FG003|Booster Vaccination Phase|Adverse Event|1
2069387|NCT00614614|3647715|FG004|Booster Vaccination Phase|Adverse Event|0
2069388|NCT00614614|3647711|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
2069389|NCT00614614|3647712|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
2069390|NCT00614614|3647713|FG002|Booster Vaccination Phase|Withdrawal by Subject|4
2069391|NCT00614614|3647714|FG003|Booster Vaccination Phase|Withdrawal by Subject|3
2069392|NCT00614614|3647715|FG004|Booster Vaccination Phase|Withdrawal by Subject|4
2069393|NCT00614614|3647711|FG000|Booster Vaccination Phase|Lost to Follow-up|0
2069394|NCT00614614|3647712|FG001|Booster Vaccination Phase|Lost to Follow-up|5
2069395|NCT00614614|3647713|FG002|Booster Vaccination Phase|Lost to Follow-up|17
2069396|NCT00614614|3647714|FG003|Booster Vaccination Phase|Lost to Follow-up|10
2069397|NCT00614614|3647715|FG004|Booster Vaccination Phase|Lost to Follow-up|8
2069398|NCT00614614|3647711|FG000|Booster Vaccination Phase|Protocol Violation|0
2069399|NCT00614614|3647712|FG001|Booster Vaccination Phase|Protocol Violation|0
2069400|NCT00614614|3647713|FG002|Booster Vaccination Phase|Protocol Violation|2
2069401|NCT00614614|3647714|FG003|Booster Vaccination Phase|Protocol Violation|3
2069402|NCT00614614|3647715|FG004|Booster Vaccination Phase|Protocol Violation|0
2069403|NCT00614614|3647711|FG000|Booster Vaccination Phase|Other|0
2069404|NCT00614614|3647712|FG001|Booster Vaccination Phase|Other|1
2069405|NCT00614614|3647713|FG002|Booster Vaccination Phase|Other|3
2069406|NCT00614614|3647714|FG003|Booster Vaccination Phase|Other|2
2069407|NCT00614614|3647715|FG004|Booster Vaccination Phase|Other|1
2069408|NCT00614744|3647732|FG000|Overall Study|Lost to Follow-up|5
2069409|NCT00614744|3647733|FG001|Overall Study|Lost to Follow-up|4
2069410|NCT00614744|3647732|FG000|Overall Study|Incomplete for Behavior Issues|0
2069411|NCT00614744|3647733|FG001|Overall Study|Incomplete for Behavior Issues|2
2069412|NCT00614822|3647739|FG000|Overall Study|Adverse Event|3
2069413|NCT00614874|3647744|FG000|Overall Study|Protocol Violation|1
2069414|NCT00614874|3647744|FG000|Overall Study|Withdrawal by Subject|1
2069415|NCT00614926|3647754|FG000|Overall Study|Burden of travel|1
2069416|NCT00614926|3647755|FG001|Overall Study|Burden of travel|0
2069417|NCT00614926|3647754|FG000|Overall Study|Adverse Event|3
2069418|NCT00614926|3647755|FG001|Overall Study|Adverse Event|0
2069419|NCT00614939|3647763|FG000|Overall Study|Withdrawal by Subject|10
2069420|NCT00614939|3647764|FG001|Overall Study|Withdrawal by Subject|17
2069421|NCT00614939|3647763|FG000|Overall Study|Study specific discontinuation criteris|13
2069422|NCT00614939|3647764|FG001|Overall Study|Study specific discontinuation criteris|16
2069423|NCT00614939|3647763|FG000|Overall Study|Adverse Event|2
2069424|NCT00614939|3647764|FG001|Overall Study|Adverse Event|5
2069425|NCT00614939|3647763|FG000|Overall Study|Incorrect enrollment|1
2069426|NCT00614939|3647764|FG001|Overall Study|Incorrect enrollment|2
2069427|NCT00614939|3647763|FG000|Overall Study|Death|4
2069428|NCT00614939|3647764|FG001|Overall Study|Death|3
2069429|NCT00614939|3647763|FG000|Overall Study|Poor/non-compliance|4
2069430|NCT00614939|3647764|FG001|Overall Study|Poor/non-compliance|0
2069431|NCT00614939|3647763|FG000|Overall Study|Hospitalized due to kidney transplant|1
2069432|NCT00614939|3647764|FG001|Overall Study|Hospitalized due to kidney transplant|0
2069433|NCT00614991|3647776|FG000|Overall Study|Adverse Event|3
2069434|NCT00614991|3647777|FG001|Overall Study|Adverse Event|3
2069435|NCT00614991|3647778|FG002|Overall Study|Adverse Event|0
2069436|NCT00614991|3647779|FG003|Overall Study|Adverse Event|0
2069437|NCT00614991|3647780|FG004|Overall Study|Adverse Event|1
2069438|NCT00614991|3647781|FG005|Overall Study|Adverse Event|0
2069439|NCT00615017|3647806|FG000|Overall Study|Adverse Event|0
2069440|NCT00615017|3647807|FG001|Overall Study|Adverse Event|1
2069441|NCT00615017|3647808|FG002|Overall Study|Adverse Event|2
2069442|NCT00615017|3647809|FG003|Overall Study|Adverse Event|0
2069443|NCT00615017|3647810|FG004|Overall Study|Adverse Event|0
2069444|NCT00615017|3647811|FG005|Overall Study|Adverse Event|1
2069445|NCT00615017|3647806|FG000|Overall Study|Death|0
2069446|NCT00615017|3647807|FG001|Overall Study|Death|0
2069447|NCT00615017|3647808|FG002|Overall Study|Death|2
2069448|NCT00615017|3647809|FG003|Overall Study|Death|0
2069449|NCT00615017|3647810|FG004|Overall Study|Death|1
2069450|NCT00615017|3647811|FG005|Overall Study|Death|1
2069451|NCT00615017|3647806|FG000|Overall Study|Sepsis resolved|0
2069452|NCT00615017|3647807|FG001|Overall Study|Sepsis resolved|0
2069453|NCT00615017|3647808|FG002|Overall Study|Sepsis resolved|1
2303356|NCT02639559|4002758|FG000|Overall Study|Mobilization failure|0
2303357|NCT02639559|4002759|FG001|Overall Study|Mobilization failure|3
2303358|NCT02639559|4002758|FG000|Overall Study|Issues with vascular acess|1
2069454|NCT00615017|3647809|FG003|Overall Study|Sepsis resolved|0
2069455|NCT00615017|3647810|FG004|Overall Study|Sepsis resolved|0
2069456|NCT00615017|3647811|FG005|Overall Study|Sepsis resolved|0
2069457|NCT00615017|3647806|FG000|Overall Study|Transferred out of Intensive Care Unit|0
2069458|NCT00615017|3647807|FG001|Overall Study|Transferred out of Intensive Care Unit|0
2303359|NCT02639559|4002759|FG001|Overall Study|Issues with vascular acess|0
2069459|NCT00615017|3647808|FG002|Overall Study|Transferred out of Intensive Care Unit|0
2069460|NCT00615017|3647809|FG003|Overall Study|Transferred out of Intensive Care Unit|1
2069461|NCT00615017|3647810|FG004|Overall Study|Transferred out of Intensive Care Unit|0
2069462|NCT00615017|3647811|FG005|Overall Study|Transferred out of Intensive Care Unit|0
2069463|NCT00615017|3647806|FG000|Overall Study|Physician discontinued drug|0
2069464|NCT00615017|3647807|FG001|Overall Study|Physician discontinued drug|0
2069465|NCT00615017|3647808|FG002|Overall Study|Physician discontinued drug|0
2069466|NCT00615017|3647809|FG003|Overall Study|Physician discontinued drug|0
2069467|NCT00615017|3647810|FG004|Overall Study|Physician discontinued drug|0
2069468|NCT00615017|3647811|FG005|Overall Study|Physician discontinued drug|1
2069469|NCT00615030|3647825|FG000|Period I|Administrative problem|0
2069470|NCT00615030|3647826|FG001|Period I|Administrative problem|0
2069471|NCT00615030|3647827|FG002|Period I|Administrative problem|0
2069472|NCT00615030|3647828|FG003|Period I|Administrative problem|0
2069473|NCT00615030|3647829|FG004|Period I|Administrative problem|1
2069474|NCT00615030|3647830|FG005|Period I|Administrative problem|0
2069475|NCT00615030|3647831|FG006|Period I|Administrative problem|0
2069476|NCT00615030|3647832|FG007|Period I|Administrative problem|0
2069477|NCT00615030|3647833|FG008|Period I|Administrative problem|0
2069478|NCT00615030|3647834|FG009|Period I|Administrative problem|0
2069479|NCT00615030|3647835|FG010|Period I|Administrative problem|0
2069480|NCT00615030|3647836|FG011|Period I|Administrative problem|0
2069481|NCT00615030|3647825|FG000|Period I|Protocol deviation|1
2069482|NCT00615030|3647826|FG001|Period I|Protocol deviation|0
2069483|NCT00615030|3647827|FG002|Period I|Protocol deviation|0
2069484|NCT00615030|3647828|FG003|Period I|Protocol deviation|0
2069485|NCT00615030|3647829|FG004|Period I|Protocol deviation|0
2069486|NCT00615030|3647830|FG005|Period I|Protocol deviation|0
2069487|NCT00615030|3647831|FG006|Period I|Protocol deviation|0
2069488|NCT00615030|3647832|FG007|Period I|Protocol deviation|0
2069489|NCT00615030|3647833|FG008|Period I|Protocol deviation|0
2069490|NCT00615030|3647834|FG009|Period I|Protocol deviation|0
2069491|NCT00615030|3647835|FG010|Period I|Protocol deviation|0
2069492|NCT00615030|3647836|FG011|Period I|Protocol deviation|0
2069493|NCT00615030|3647825|FG000|Period I|Subject withdrew consent|0
2069494|NCT00615030|3647826|FG001|Period I|Subject withdrew consent|0
2210354|NCT01649375|3849840|FG000|Week 16 up to Week 260|Technical issues|0
2210355|NCT01649375|3849841|FG001|Week 16 up to Week 260|Technical issues|1
2210356|NCT01649375|3849842|FG002|Week 16 up to Week 260|Technical issues|0
2210357|NCT01649375|3849843|FG003|Week 16 up to Week 260|Technical issues|1
2210358|NCT01649375|3849844|FG004|Week 16 up to Week 260|Technical issues|0
2210359|NCT01649375|3849840|FG000|Week 16 up to Week 260|Withdrawal by Subject|7
2210360|NCT01649375|3849841|FG001|Week 16 up to Week 260|Withdrawal by Subject|2
2210361|NCT01649375|3849842|FG002|Week 16 up to Week 260|Withdrawal by Subject|0
2210362|NCT01649375|3849843|FG003|Week 16 up to Week 260|Withdrawal by Subject|3
2210363|NCT01649375|3849844|FG004|Week 16 up to Week 260|Withdrawal by Subject|1
2210364|NCT01649375|3849840|FG000|Week 16 up to Week 260|Death|1
2210365|NCT01649375|3849841|FG001|Week 16 up to Week 260|Death|1
2069495|NCT00615030|3647827|FG002|Period I|Subject withdrew consent|0
2069496|NCT00615030|3647828|FG003|Period I|Subject withdrew consent|0
2069497|NCT00615030|3647829|FG004|Period I|Subject withdrew consent|0
2069498|NCT00615030|3647830|FG005|Period I|Subject withdrew consent|0
2069499|NCT00615030|3647831|FG006|Period I|Subject withdrew consent|0
2069500|NCT00615030|3647832|FG007|Period I|Subject withdrew consent|0
2069501|NCT00615030|3647833|FG008|Period I|Subject withdrew consent|1
2069502|NCT00615030|3647834|FG009|Period I|Subject withdrew consent|0
2069503|NCT00615030|3647835|FG010|Period I|Subject withdrew consent|1
2069504|NCT00615030|3647836|FG011|Period I|Subject withdrew consent|1
2069505|NCT00615030|3647825|FG000|Period I|Abnormal laboratory value(s)|0
2069506|NCT00615030|3647826|FG001|Period I|Abnormal laboratory value(s)|0
2069507|NCT00615030|3647827|FG002|Period I|Abnormal laboratory value(s)|0
2069508|NCT00615030|3647828|FG003|Period I|Abnormal laboratory value(s)|0
2069509|NCT00615030|3647829|FG004|Period I|Abnormal laboratory value(s)|0
2069510|NCT00615030|3647830|FG005|Period I|Abnormal laboratory value(s)|1
2069511|NCT00615030|3647831|FG006|Period I|Abnormal laboratory value(s)|0
2069512|NCT00615030|3647832|FG007|Period I|Abnormal laboratory value(s)|0
2069513|NCT00615030|3647833|FG008|Period I|Abnormal laboratory value(s)|0
2069514|NCT00615030|3647834|FG009|Period I|Abnormal laboratory value(s)|0
2069515|NCT00615030|3647835|FG010|Period I|Abnormal laboratory value(s)|0
2069516|NCT00615030|3647836|FG011|Period I|Abnormal laboratory value(s)|0
2069517|NCT00615030|3647825|FG000|Period II|Adverse Event|0
2069518|NCT00615030|3647826|FG001|Period II|Adverse Event|0
2069519|NCT00615030|3647827|FG002|Period II|Adverse Event|1
2069520|NCT00615030|3647828|FG003|Period II|Adverse Event|0
2069521|NCT00615030|3647829|FG004|Period II|Adverse Event|0
2069522|NCT00615030|3647830|FG005|Period II|Adverse Event|0
2069523|NCT00615030|3647831|FG006|Period II|Adverse Event|0
2069524|NCT00615030|3647832|FG007|Period II|Adverse Event|0
2069525|NCT00615030|3647833|FG008|Period II|Adverse Event|1
2069526|NCT00615030|3647834|FG009|Period II|Adverse Event|0
2069527|NCT00615030|3647835|FG010|Period II|Adverse Event|0
2069528|NCT00615030|3647836|FG011|Period II|Adverse Event|0
2069529|NCT00615030|3647825|FG000|Period II|Subject withdrew consent|0
2069530|NCT00615030|3647826|FG001|Period II|Subject withdrew consent|0
2069531|NCT00615030|3647827|FG002|Period II|Subject withdrew consent|0
2069532|NCT00615030|3647828|FG003|Period II|Subject withdrew consent|1
2069533|NCT00615030|3647829|FG004|Period II|Subject withdrew consent|0
2069534|NCT00615030|3647830|FG005|Period II|Subject withdrew consent|0
2069535|NCT00615030|3647831|FG006|Period II|Subject withdrew consent|1
2069536|NCT00615030|3647832|FG007|Period II|Subject withdrew consent|0
2069537|NCT00615030|3647833|FG008|Period II|Subject withdrew consent|0
2069538|NCT00615030|3647834|FG009|Period II|Subject withdrew consent|0
2069539|NCT00615030|3647835|FG010|Period II|Subject withdrew consent|0
2069540|NCT00615030|3647836|FG011|Period II|Subject withdrew consent|0
2069541|NCT00615030|3647825|FG000|Period III|Administrative problems|1
2069542|NCT00615030|3647826|FG001|Period III|Administrative problems|0
2069543|NCT00615030|3647827|FG002|Period III|Administrative problems|0
2069544|NCT00615030|3647828|FG003|Period III|Administrative problems|1
2069545|NCT00615030|3647829|FG004|Period III|Administrative problems|0
2069546|NCT00615030|3647830|FG005|Period III|Administrative problems|0
2210366|NCT01649375|3849842|FG002|Week 16 up to Week 260|Death|0
2210367|NCT01649375|3849843|FG003|Week 16 up to Week 260|Death|0
2210368|NCT01649375|3849844|FG004|Week 16 up to Week 260|Death|0
2210369|NCT01649375|3849840|FG000|Week 16 up to Week 260|Adverse Event|5
2210370|NCT01649375|3849841|FG001|Week 16 up to Week 260|Adverse Event|2
2210371|NCT01649375|3849842|FG002|Week 16 up to Week 260|Adverse Event|0
2210372|NCT01649375|3849843|FG003|Week 16 up to Week 260|Adverse Event|3
2210373|NCT01649375|3849844|FG004|Week 16 up to Week 260|Adverse Event|2
2210374|NCT01649427|3849854|FG000|Overall Study|Adverse Event|1
2210375|NCT01649427|3849855|FG001|Overall Study|Adverse Event|1
2210376|NCT01649427|3849854|FG000|Overall Study|Withdrawal by Subject|8
2210377|NCT01649427|3849855|FG001|Overall Study|Withdrawal by Subject|7
2210378|NCT01649427|3849854|FG000|Overall Study|Lost to Follow-up|0
2210379|NCT01649427|3849855|FG001|Overall Study|Lost to Follow-up|1
2069547|NCT00615030|3647831|FG006|Period III|Administrative problems|0
2069548|NCT00615030|3647832|FG007|Period III|Administrative problems|0
2069549|NCT00615030|3647833|FG008|Period III|Administrative problems|0
2069550|NCT00615030|3647834|FG009|Period III|Administrative problems|0
2069551|NCT00615030|3647835|FG010|Period III|Administrative problems|0
2069552|NCT00615030|3647836|FG011|Period III|Administrative problems|0
2069553|NCT00615056|3647854|FG000|Overall Study|Death|31
2069554|NCT00615056|3647855|FG001|Overall Study|Death|31
2069555|NCT00615056|3647856|FG002|Overall Study|Death|21
2069556|NCT00615056|3647857|FG003|Overall Study|Death|23
2069557|NCT00615056|3647854|FG000|Overall Study|Lost to Follow-up|1
2069558|NCT00615056|3647855|FG001|Overall Study|Lost to Follow-up|2
2069559|NCT00615056|3647856|FG002|Overall Study|Lost to Follow-up|4
2069560|NCT00615056|3647857|FG003|Overall Study|Lost to Follow-up|5
2069561|NCT00615056|3647854|FG000|Overall Study|Other|13
2069562|NCT00615056|3647855|FG001|Overall Study|Other|15
2069563|NCT00615056|3647856|FG002|Overall Study|Other|10
2069564|NCT00615056|3647857|FG003|Overall Study|Other|7
2069565|NCT00615056|3647854|FG000|Overall Study|Objective progression or relapse|0
2069566|NCT00615056|3647855|FG001|Overall Study|Objective progression or relapse|2
2069567|NCT00615056|3647856|FG002|Overall Study|Objective progression or relapse|0
2069568|NCT00615056|3647857|FG003|Overall Study|Objective progression or relapse|0
2069569|NCT00615056|3647854|FG000|Overall Study|Withdrawal by Subject|0
2069570|NCT00615056|3647855|FG001|Overall Study|Withdrawal by Subject|1
2069571|NCT00615056|3647856|FG002|Overall Study|Withdrawal by Subject|1
2069572|NCT00615056|3647857|FG003|Overall Study|Withdrawal by Subject|0
2069573|NCT00615056|3647854|FG000|Overall Study|Discontinued by Sponsor|1
2069574|NCT00615056|3647855|FG001|Overall Study|Discontinued by Sponsor|0
2069575|NCT00615056|3647856|FG002|Overall Study|Discontinued by Sponsor|0
2069576|NCT00615056|3647857|FG003|Overall Study|Discontinued by Sponsor|0
2069577|NCT00615056|3647854|FG000|Overall Study|Randomized but not treated|3
2069578|NCT00615056|3647855|FG001|Overall Study|Randomized but not treated|0
2069579|NCT00615056|3647856|FG002|Overall Study|Randomized but not treated|0
2069580|NCT00615056|3647857|FG003|Overall Study|Randomized but not treated|0
2069581|NCT00615069|3647867|FG000|Overall Study|Death|10
2069582|NCT00615069|3647867|FG000|Overall Study|Physician Decision|2
2069583|NCT00615069|3647867|FG000|Overall Study|Withdrawal by Subject|4
2069584|NCT00615108|3647871|FG000|Overall Study|Adverse Event|122
2069585|NCT00615108|3647871|FG000|Overall Study|Other|370
2069586|NCT00615108|3647871|FG000|Overall Study|Lost to Follow-up|15
2303360|NCT02640053|4002794|FG000|Overall Study|Withdrawal by Subject|2
2303361|NCT02640053|4002795|FG001|Overall Study|Withdrawal by Subject|1
2303362|NCT02640053|4002794|FG000|Overall Study|Adverse Event|1
2303363|NCT02640053|4002795|FG001|Overall Study|Adverse Event|1
2303364|NCT02640053|4002794|FG000|Overall Study|Alternative Therapy|1
2303365|NCT02640053|4002795|FG001|Overall Study|Alternative Therapy|1
2303366|NCT02640053|4002794|FG000|Overall Study|Chemo regimen changed after 1st Rx|0
2303367|NCT02640053|4002795|FG001|Overall Study|Chemo regimen changed after 1st Rx|1
2303368|NCT02640157|4002804|FG000|Overall Study|Adverse Event|2
2069587|NCT00615199|3647881|FG000|Overall Study|Adverse Event|3
2069588|NCT00615199|3647882|FG001|Overall Study|Adverse Event|1
2069589|NCT00615199|3647883|FG002|Overall Study|Adverse Event|1
2069590|NCT00615199|3647884|FG003|Overall Study|Adverse Event|0
2069591|NCT00615199|3647881|FG000|Overall Study|Lack of Efficacy|2
2069592|NCT00615199|3647882|FG001|Overall Study|Lack of Efficacy|0
2069593|NCT00615199|3647883|FG002|Overall Study|Lack of Efficacy|0
2069594|NCT00615199|3647884|FG003|Overall Study|Lack of Efficacy|1
2069595|NCT00615199|3647881|FG000|Overall Study|Lost to Follow-up|1
2069596|NCT00615199|3647882|FG001|Overall Study|Lost to Follow-up|0
2069597|NCT00615199|3647883|FG002|Overall Study|Lost to Follow-up|0
2069598|NCT00615199|3647884|FG003|Overall Study|Lost to Follow-up|0
2069599|NCT00615199|3647881|FG000|Overall Study|Other|0
2069600|NCT00615199|3647882|FG001|Overall Study|Other|0
2069601|NCT00615199|3647883|FG002|Overall Study|Other|0
2069602|NCT00615199|3647884|FG003|Overall Study|Other|1
2069603|NCT00615199|3647881|FG000|Overall Study|Withdrawal by Subject|2
2069604|NCT00615199|3647882|FG001|Overall Study|Withdrawal by Subject|1
2069605|NCT00615199|3647883|FG002|Overall Study|Withdrawal by Subject|0
2069606|NCT00615199|3647884|FG003|Overall Study|Withdrawal by Subject|0
2069607|NCT00615264|3647896|FG000|Overall Study|Withdrawal by Subject|17
2069608|NCT00615264|3647897|FG001|Overall Study|Withdrawal by Subject|19
2069609|NCT00615264|3647896|FG000|Overall Study|Lost to Follow-up|6
2069610|NCT00615264|3647897|FG001|Overall Study|Lost to Follow-up|13
2069611|NCT00615264|3647896|FG000|Overall Study|Adverse Event|8
2069612|NCT00615264|3647897|FG001|Overall Study|Adverse Event|5
2069613|NCT00615264|3647896|FG000|Overall Study|Death|1
2069614|NCT00615264|3647897|FG001|Overall Study|Death|1
2069615|NCT00615264|3647896|FG000|Overall Study|Protocol Violation|11
2069616|NCT00615264|3647897|FG001|Overall Study|Protocol Violation|7
2069617|NCT00615264|3647896|FG000|Overall Study|Not defined|7
2069618|NCT00615264|3647897|FG001|Overall Study|Not defined|4
2069619|NCT00615264|3647896|FG000|Overall Study|Dermal Hypersensitivity|0
2069620|NCT00615264|3647897|FG001|Overall Study|Dermal Hypersensitivity|3
2069621|NCT00615290|3647903|FG000|Overall Study|Adverse Event|2
2069622|NCT00615290|3647903|FG000|Overall Study|Lost to Follow-up|3
2069623|NCT00615290|3647903|FG000|Overall Study|Withdrawal by Subject|1
2069624|NCT00615290|3647903|FG000|Overall Study|Other|2
2069625|NCT00615459|3647934|FG000|Period I|Adverse Event|2
2069626|NCT00615459|3647935|FG001|Period I|Adverse Event|0
2069627|NCT00615459|3647936|FG002|Period I|Adverse Event|1
2069628|NCT00615459|3647937|FG003|Period I|Adverse Event|0
2069629|NCT00615459|3647934|FG000|Period I|Subject withdrew consent|1
2069630|NCT00615459|3647935|FG001|Period I|Subject withdrew consent|0
2069631|NCT00615459|3647936|FG002|Period I|Subject withdrew consent|0
2069632|NCT00615459|3647937|FG003|Period I|Subject withdrew consent|1
2069633|NCT00615459|3647934|FG000|Period I|Abnormal test procedure results|1
2069634|NCT00615459|3647935|FG001|Period I|Abnormal test procedure results|1
2069635|NCT00615459|3647936|FG002|Period I|Abnormal test procedure results|1
2069636|NCT00615459|3647937|FG003|Period I|Abnormal test procedure results|0
2069637|NCT00615459|3647934|FG000|Period II|Adverse Event|1
2069638|NCT00615459|3647935|FG001|Period II|Adverse Event|0
2069639|NCT00615459|3647936|FG002|Period II|Adverse Event|0
2069640|NCT00615459|3647937|FG003|Period II|Adverse Event|0
2069641|NCT00615459|3647934|FG000|Period II|Lost to Follow-up|0
2069642|NCT00615459|3647935|FG001|Period II|Lost to Follow-up|0
2069643|NCT00615459|3647936|FG002|Period II|Lost to Follow-up|0
2069644|NCT00615459|3647937|FG003|Period II|Lost to Follow-up|1
2069645|NCT00615459|3647934|FG000|Period III|Adverse Event|0
2069646|NCT00615459|3647935|FG001|Period III|Adverse Event|1
2069647|NCT00615459|3647936|FG002|Period III|Adverse Event|0
2069648|NCT00615459|3647937|FG003|Period III|Adverse Event|0
2069649|NCT00615459|3647934|FG000|Period III|Administrative problems|0
2069650|NCT00615459|3647935|FG001|Period III|Administrative problems|1
2069651|NCT00615459|3647936|FG002|Period III|Administrative problems|1
2069652|NCT00615459|3647937|FG003|Period III|Administrative problems|0
2069653|NCT00615459|3647934|FG000|Period III|Unsatisfactory therapeutic effect|0
2069654|NCT00615459|3647935|FG001|Period III|Unsatisfactory therapeutic effect|1
2069655|NCT00615459|3647936|FG002|Period III|Unsatisfactory therapeutic effect|0
2069656|NCT00615459|3647937|FG003|Period III|Unsatisfactory therapeutic effect|0
2069657|NCT00615550|3647958|FG000|Overall Study|Lost to Follow-up|6
2069658|NCT00615550|3647959|FG001|Overall Study|Lost to Follow-up|1
2069659|NCT00615719|3647970|FG000|Overall Study|Physician Decision|5
2069660|NCT00615836|3647982|FG000|Extension Study (FE992026 CS31)|Adverse Event|7
2069661|NCT00615836|3647983|FG001|Extension Study (FE992026 CS31)|Adverse Event|12
2069662|NCT00615836|3647984|FG002|Extension Study (FE992026 CS31)|Adverse Event|15
2069663|NCT00615836|3647985|FG003|Extension Study (FE992026 CS31)|Adverse Event|13
2069664|NCT00615836|3647986|FG004|Extension Study (FE992026 CS31)|Adverse Event|0
2069665|NCT00615836|3647982|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
2069666|NCT00615836|3647983|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
2069667|NCT00615836|3647984|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
2069668|NCT00615836|3647985|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
2069669|NCT00615836|3647986|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
2069670|NCT00615836|3647982|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
2069671|NCT00615836|3647983|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
2069672|NCT00615836|3647984|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
2069673|NCT00615836|3647985|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
2069674|NCT00615836|3647986|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
2069675|NCT00615836|3647982|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4
2069676|NCT00615836|3647983|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5
2069677|NCT00615836|3647984|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2
2069678|NCT00615836|3647985|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3
2069679|NCT00615836|3647986|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0
2069680|NCT00615836|3647982|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
2069681|NCT00615836|3647983|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
2069682|NCT00615836|3647984|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
2069683|NCT00615836|3647985|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
2069684|NCT00615836|3647986|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
2069685|NCT00615836|3647982|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10
2069686|NCT00615836|3647983|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14
2069687|NCT00615836|3647984|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5
2069688|NCT00615836|3647985|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10
2069689|NCT00615836|3647986|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0
2069690|NCT00615836|3647982|FG000|Extension Study (FE992026 CS31)|Other|10
2069691|NCT00615836|3647983|FG001|Extension Study (FE992026 CS31)|Other|7
2069692|NCT00615836|3647984|FG002|Extension Study (FE992026 CS31)|Other|8
2069693|NCT00615836|3647985|FG003|Extension Study (FE992026 CS31)|Other|8
2069694|NCT00615836|3647986|FG004|Extension Study (FE992026 CS31)|Other|0
2069695|NCT00615836|3647982|FG000|Extension Study (FE992026 CS31)|Not reported|6
2069696|NCT00615836|3647983|FG001|Extension Study (FE992026 CS31)|Not reported|4
2069697|NCT00615836|3647984|FG002|Extension Study (FE992026 CS31)|Not reported|1
2069698|NCT00615836|3647985|FG003|Extension Study (FE992026 CS31)|Not reported|4
2069699|NCT00615836|3647986|FG004|Extension Study (FE992026 CS31)|Not reported|0
2069700|NCT00615836|3647982|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
2069701|NCT00615836|3647983|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
2069702|NCT00615836|3647984|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
2069703|NCT00615836|3647985|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
2069704|NCT00615836|3647986|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
2069705|NCT00615901|3648002|FG000|Overall Study|Withdrawal by Subject|2
2069706|NCT00615901|3648002|FG000|Overall Study|Adverse Event|7
2069707|NCT00615914|3648006|FG000|Overall Study|Adverse Event|274
2303369|NCT02640157|4002805|FG001|Overall Study|Adverse Event|2
2303370|NCT02640157|4002806|FG002|Overall Study|Adverse Event|1
2303371|NCT02640157|4002804|FG000|Overall Study|Withdrew consent|2
2303372|NCT02640157|4002805|FG001|Overall Study|Withdrew consent|0
2303373|NCT02640157|4002806|FG002|Overall Study|Withdrew consent|2
2303374|NCT02640157|4002804|FG000|Overall Study|Lost to Follow-up|9
2303375|NCT02640157|4002805|FG001|Overall Study|Lost to Follow-up|2
2303376|NCT02640157|4002806|FG002|Overall Study|Lost to Follow-up|7
2303377|NCT02640157|4002804|FG000|Overall Study|Randomized in error; did not receive Tx|0
2303378|NCT02640157|4002805|FG001|Overall Study|Randomized in error; did not receive Tx|1
2303379|NCT02640157|4002806|FG002|Overall Study|Randomized in error; did not receive Tx|0
2303380|NCT02640235|4002817|FG000|Overall Study|Withdrawal by Subject|7
2303381|NCT02640235|4002818|FG001|Overall Study|Withdrawal by Subject|6
2303382|NCT02640235|4002817|FG000|Overall Study|Lost to Follow-up|4
2303383|NCT02640235|4002818|FG001|Overall Study|Lost to Follow-up|3
2303384|NCT02640235|4002817|FG000|Overall Study|Death|2
2303385|NCT02640235|4002818|FG001|Overall Study|Death|3
2303386|NCT02640235|4002817|FG000|Overall Study|Other|1
2303387|NCT02640235|4002818|FG001|Overall Study|Other|2
2303388|NCT02640404|4002826|FG000|Overall Study|Protocol Violation|1
2303389|NCT02640404|4002827|FG001|Overall Study|Protocol Violation|0
2303390|NCT02640404|4002826|FG000|Overall Study|Withdrawal by Subject|1
2303391|NCT02640404|4002827|FG001|Overall Study|Withdrawal by Subject|0
2303392|NCT02640482|4002835|FG000|Overall Study|Lost to Follow-up|3
2303393|NCT02640482|4002836|FG001|Overall Study|Lost to Follow-up|0
2303394|NCT02640547|4002842|FG000|Overall Study|Failure to Return|1
2303395|NCT02640547|4002842|FG000|Overall Study|Withdrawal by Subject|1
2303396|NCT02640547|4002842|FG000|Overall Study|Death|6
2303397|NCT02640547|4002842|FG000|Overall Study|Miscellaneous|3
2303398|NCT02640612|4002857|FG000|Overall Study|Adverse Event|6
2303399|NCT02640612|4002858|FG001|Overall Study|Adverse Event|7
2303400|NCT02640612|4002859|FG002|Overall Study|Adverse Event|2
2303401|NCT02640612|4002857|FG000|Overall Study|Death|1
2303402|NCT02640612|4002858|FG001|Overall Study|Death|0
2303403|NCT02640612|4002859|FG002|Overall Study|Death|0
2303404|NCT02640612|4002857|FG000|Overall Study|Withdrawal by Subject|10
2303405|NCT02640612|4002858|FG001|Overall Study|Withdrawal by Subject|3
2303406|NCT02640612|4002859|FG002|Overall Study|Withdrawal by Subject|3
2303407|NCT02640612|4002857|FG000|Overall Study|Lost to Follow-up|4
2303408|NCT02640612|4002858|FG001|Overall Study|Lost to Follow-up|1
2303409|NCT02640612|4002859|FG002|Overall Study|Lost to Follow-up|1
2303410|NCT02640612|4002857|FG000|Overall Study|Protocol Violation|0
2303411|NCT02640612|4002858|FG001|Overall Study|Protocol Violation|2
2303412|NCT02640612|4002859|FG002|Overall Study|Protocol Violation|0
2303413|NCT02640612|4002857|FG000|Overall Study|Lack of Efficacy|1
2303414|NCT02640612|4002858|FG001|Overall Study|Lack of Efficacy|1
2303415|NCT02640612|4002859|FG002|Overall Study|Lack of Efficacy|0
2303416|NCT02640755|4002878|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
2069708|NCT00615914|3648006|FG000|Overall Study|Death|20
2069709|NCT00615914|3648006|FG000|Overall Study|Lack of Efficacy|59
2069710|NCT00615914|3648006|FG000|Overall Study|Lost to Follow-up|187
2069711|NCT00615914|3648006|FG000|Overall Study|Withdrawal by Subject|16
2069712|NCT00615914|3648006|FG000|Overall Study|Physician Decision|4
2069713|NCT00615914|3648006|FG000|Overall Study|No data was collected.|65
2069714|NCT00615914|3648006|FG000|Overall Study|No treatment|2
2069715|NCT00615914|3648006|FG000|Overall Study|Irregularly enrolled patients|10
2069716|NCT00615992|3648020|FG000|Overall Study|Protocol Violation|67
2069717|NCT00616018|3648024|FG000|Overall Study|Protocol Violation|3
2069718|NCT00616239|3648048|FG000|Overall Study|Withdrawal by Subject|2
2069719|NCT00616421|3648055|FG000|Overall Study|Withdrawal by Subject|9
2069720|NCT00616421|3648056|FG001|Overall Study|Withdrawal by Subject|11
2069721|NCT00616421|3648057|FG002|Overall Study|Withdrawal by Subject|8
2069722|NCT00616421|3648055|FG000|Overall Study|Lost to Follow-up|12
2069723|NCT00616421|3648056|FG001|Overall Study|Lost to Follow-up|26
2069724|NCT00616421|3648057|FG002|Overall Study|Lost to Follow-up|30
2069725|NCT00616421|3648055|FG000|Overall Study|Inappropriate enrollment|3
2069726|NCT00616421|3648056|FG001|Overall Study|Inappropriate enrollment|0
2069727|NCT00616421|3648057|FG002|Overall Study|Inappropriate enrollment|1
2069728|NCT00616421|3648055|FG000|Overall Study|Administrative reason|1
2069729|NCT00616421|3648056|FG001|Overall Study|Administrative reason|0
2069730|NCT00616421|3648057|FG002|Overall Study|Administrative reason|0
2069731|NCT00616421|3648055|FG000|Overall Study|Protocol Violation|0
2069732|NCT00616421|3648056|FG001|Overall Study|Protocol Violation|1
2069733|NCT00616421|3648057|FG002|Overall Study|Protocol Violation|2
2069734|NCT00616421|3648055|FG000|Overall Study|Unable to classify|1
2069735|NCT00616421|3648056|FG001|Overall Study|Unable to classify|0
2069736|NCT00616421|3648057|FG002|Overall Study|Unable to classify|0
2069737|NCT00616434|3648081|FG000|Overall Study|Adverse Event|5
2069738|NCT00616434|3648082|FG001|Overall Study|Adverse Event|2
2069739|NCT00616434|3648081|FG000|Overall Study|Physician Decision|0
2069740|NCT00616434|3648082|FG001|Overall Study|Physician Decision|4
2069741|NCT00616434|3648081|FG000|Overall Study|Withdrawal by Subject|1
2069742|NCT00616434|3648082|FG001|Overall Study|Withdrawal by Subject|1
2069743|NCT00616434|3648081|FG000|Overall Study|Protocol deviation|0
2069744|NCT00616434|3648082|FG001|Overall Study|Protocol deviation|1
2069745|NCT00616629|3648093|FG000|Overall Study|Protocol Violation|1
2069746|NCT00616629|3648094|FG001|Overall Study|Protocol Violation|2
2069747|NCT00616629|3648095|FG002|Overall Study|Protocol Violation|1
2069748|NCT00616629|3648096|FG003|Overall Study|Protocol Violation|0
2069749|NCT00616629|3648097|FG004|Overall Study|Protocol Violation|0
2069750|NCT00616629|3648093|FG000|Overall Study|AV-block|1
2069751|NCT00616629|3648094|FG001|Overall Study|AV-block|0
2069752|NCT00616629|3648095|FG002|Overall Study|AV-block|0
2069753|NCT00616629|3648096|FG003|Overall Study|AV-block|0
2069754|NCT00616629|3648097|FG004|Overall Study|AV-block|0
2069755|NCT00616655|3648112|FG000|Overall Study|Adverse Event|10
2069756|NCT00616655|3648113|FG001|Overall Study|Adverse Event|7
2069757|NCT00616655|3648114|FG002|Overall Study|Adverse Event|12
2069758|NCT00616655|3648112|FG000|Overall Study|Lack of Efficacy|5
2069759|NCT00616655|3648113|FG001|Overall Study|Lack of Efficacy|5
2069760|NCT00616655|3648114|FG002|Overall Study|Lack of Efficacy|5
2069761|NCT00616655|3648112|FG000|Overall Study|Lost to Follow-up|3
2069762|NCT00616655|3648113|FG001|Overall Study|Lost to Follow-up|12
2069763|NCT00616655|3648114|FG002|Overall Study|Lost to Follow-up|10
2069764|NCT00616655|3648112|FG000|Overall Study|Protocol Violation|2
2069765|NCT00616655|3648113|FG001|Overall Study|Protocol Violation|4
2069766|NCT00616655|3648114|FG002|Overall Study|Protocol Violation|3
2069767|NCT00616655|3648112|FG000|Overall Study|Withdrawal by Subject|9
2069768|NCT00616655|3648113|FG001|Overall Study|Withdrawal by Subject|7
2069769|NCT00616655|3648114|FG002|Overall Study|Withdrawal by Subject|11
2069770|NCT00616655|3648112|FG000|Overall Study|Does not meet in/ex criteria|0
2069771|NCT00616655|3648113|FG001|Overall Study|Does not meet in/ex criteria|0
2069772|NCT00616655|3648114|FG002|Overall Study|Does not meet in/ex criteria|2
2069773|NCT00616655|3648112|FG000|Overall Study|Other|6
2069774|NCT00616655|3648113|FG001|Overall Study|Other|6
2069775|NCT00616655|3648114|FG002|Overall Study|Other|5
2069776|NCT00616902|3648133|FG000|Overall Study|Termination of study|6
2069777|NCT00616902|3648134|FG001|Overall Study|Termination of study|6
2303417|NCT02640755|4002879|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
2303418|NCT02640755|4002878|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
2303419|NCT02640755|4002879|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
2303420|NCT02640755|4002878|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
2303421|NCT02640755|4002879|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
2303422|NCT02641080|4002910|FG000|Overall Study|Physician Decision|2
2303423|NCT02641080|4002911|FG001|Overall Study|Physician Decision|0
2303424|NCT02641080|4002910|FG000|Overall Study|Withdrawal by Subject|0
2303425|NCT02641080|4002911|FG001|Overall Study|Withdrawal by Subject|1
2303426|NCT02641080|4002910|FG000|Overall Study|Rehab Center denied use of pumps|0
2069778|NCT00616928|3648144|FG000|Overall Study|Adverse Event|6
2069779|NCT00616928|3648145|FG001|Overall Study|Adverse Event|3
2069780|NCT00616928|3648146|FG002|Overall Study|Adverse Event|2
2069781|NCT00616928|3648147|FG003|Overall Study|Adverse Event|2
2069782|NCT00616928|3648144|FG000|Overall Study|Other|51
2069783|NCT00616928|3648145|FG001|Overall Study|Other|8
2069784|NCT00616928|3648146|FG002|Overall Study|Other|15
2069785|NCT00616928|3648147|FG003|Overall Study|Other|5
2069786|NCT00616928|3648144|FG000|Overall Study|Lost to Follow-up|5
2069787|NCT00616928|3648145|FG001|Overall Study|Lost to Follow-up|7
2069788|NCT00616928|3648146|FG002|Overall Study|Lost to Follow-up|0
2303427|NCT02641080|4002911|FG001|Overall Study|Rehab Center denied use of pumps|3
2303428|NCT02641080|4002910|FG000|Overall Study|Lost to Follow-up|0
2303429|NCT02641080|4002911|FG001|Overall Study|Lost to Follow-up|3
2303430|NCT02641379|4002949|FG000|Overall Study|Exclusion criterion during screening|1
2303431|NCT02641379|4002950|FG001|Overall Study|Exclusion criterion during screening|0
2303432|NCT02641379|4002951|FG002|Overall Study|Exclusion criterion during screening|0
2303433|NCT02641379|4002952|FG003|Overall Study|Exclusion criterion during screening|1
2303434|NCT02641379|4002953|FG004|Overall Study|Exclusion criterion during screening|2
2303435|NCT02641379|4002954|FG005|Overall Study|Exclusion criterion during screening|0
2303436|NCT02641379|4002955|FG006|Overall Study|Exclusion criterion during screening|0
2303437|NCT02641379|4002956|FG007|Overall Study|Exclusion criterion during screening|0
2303438|NCT02641379|4002957|FG008|Overall Study|Exclusion criterion during screening|0
2303439|NCT02641379|4002958|FG009|Overall Study|Exclusion criterion during screening|0
2303440|NCT02641379|4002959|FG010|Overall Study|Exclusion criterion during screening|0
2303441|NCT02641379|4002949|FG000|Overall Study|Withdrawal of informed consent|0
2303442|NCT02641379|4002950|FG001|Overall Study|Withdrawal of informed consent|1
2303443|NCT02641379|4002951|FG002|Overall Study|Withdrawal of informed consent|0
2303444|NCT02641379|4002952|FG003|Overall Study|Withdrawal of informed consent|0
2303445|NCT02641379|4002953|FG004|Overall Study|Withdrawal of informed consent|0
2303446|NCT02641379|4002954|FG005|Overall Study|Withdrawal of informed consent|0
2303447|NCT02641379|4002955|FG006|Overall Study|Withdrawal of informed consent|0
2303448|NCT02641379|4002956|FG007|Overall Study|Withdrawal of informed consent|1
2303449|NCT02641379|4002957|FG008|Overall Study|Withdrawal of informed consent|0
2303450|NCT02641379|4002958|FG009|Overall Study|Withdrawal of informed consent|0
2303451|NCT02641379|4002959|FG010|Overall Study|Withdrawal of informed consent|0
2303452|NCT02641379|4002949|FG000|Overall Study|Adverse Event|7
2303453|NCT02641379|4002950|FG001|Overall Study|Adverse Event|8
2303454|NCT02641379|4002951|FG002|Overall Study|Adverse Event|2
2303455|NCT02641379|4002952|FG003|Overall Study|Adverse Event|2
2303456|NCT02641379|4002953|FG004|Overall Study|Adverse Event|5
2303457|NCT02641379|4002954|FG005|Overall Study|Adverse Event|1
2303458|NCT02641379|4002955|FG006|Overall Study|Adverse Event|5
2303459|NCT02641379|4002956|FG007|Overall Study|Adverse Event|0
2303460|NCT02641379|4002957|FG008|Overall Study|Adverse Event|1
2303461|NCT02641379|4002958|FG009|Overall Study|Adverse Event|1
2303462|NCT02641379|4002959|FG010|Overall Study|Adverse Event|5
2303463|NCT02641379|4002949|FG000|Overall Study|Lack of Efficacy|0
2303464|NCT02641379|4002950|FG001|Overall Study|Lack of Efficacy|0
2303465|NCT02641379|4002951|FG002|Overall Study|Lack of Efficacy|2
2303466|NCT02641379|4002952|FG003|Overall Study|Lack of Efficacy|0
2303467|NCT02641379|4002953|FG004|Overall Study|Lack of Efficacy|0
2303468|NCT02641379|4002954|FG005|Overall Study|Lack of Efficacy|2
2303469|NCT02641379|4002955|FG006|Overall Study|Lack of Efficacy|0
2303470|NCT02641379|4002956|FG007|Overall Study|Lack of Efficacy|5
2303471|NCT02641379|4002957|FG008|Overall Study|Lack of Efficacy|0
2303472|NCT02641379|4002958|FG009|Overall Study|Lack of Efficacy|0
2303473|NCT02641379|4002959|FG010|Overall Study|Lack of Efficacy|0
2303474|NCT02641379|4002949|FG000|Overall Study|Participant unable to attend study visit|4
2303475|NCT02641379|4002950|FG001|Overall Study|Participant unable to attend study visit|10
2303476|NCT02641379|4002951|FG002|Overall Study|Participant unable to attend study visit|1
2303477|NCT02641379|4002952|FG003|Overall Study|Participant unable to attend study visit|2
2303478|NCT02641379|4002953|FG004|Overall Study|Participant unable to attend study visit|5
2303479|NCT02641379|4002954|FG005|Overall Study|Participant unable to attend study visit|1
2303480|NCT02641379|4002955|FG006|Overall Study|Participant unable to attend study visit|1
2303481|NCT02641379|4002956|FG007|Overall Study|Participant unable to attend study visit|1
2303482|NCT02641379|4002957|FG008|Overall Study|Participant unable to attend study visit|0
2303483|NCT02641379|4002958|FG009|Overall Study|Participant unable to attend study visit|2
2303484|NCT02641379|4002959|FG010|Overall Study|Participant unable to attend study visit|0
2303485|NCT02641379|4002949|FG000|Overall Study|Participant's compliance|0
2303486|NCT02641379|4002950|FG001|Overall Study|Participant's compliance|1
2303487|NCT02641379|4002951|FG002|Overall Study|Participant's compliance|0
2303488|NCT02641379|4002952|FG003|Overall Study|Participant's compliance|1
2303489|NCT02641379|4002953|FG004|Overall Study|Participant's compliance|0
2303490|NCT02641379|4002954|FG005|Overall Study|Participant's compliance|2
2303491|NCT02641379|4002955|FG006|Overall Study|Participant's compliance|0
2303492|NCT02641379|4002956|FG007|Overall Study|Participant's compliance|0
2303493|NCT02641379|4002957|FG008|Overall Study|Participant's compliance|1
2303494|NCT02641379|4002958|FG009|Overall Study|Participant's compliance|1
2303495|NCT02641379|4002959|FG010|Overall Study|Participant's compliance|1
2303496|NCT02641379|4002949|FG000|Overall Study|Participant cannot be reached|4
2069789|NCT00616928|3648147|FG003|Overall Study|Lost to Follow-up|0
2069790|NCT00616941|3648172|FG000|Overall Study|Progressive Disease|1
2069791|NCT00616941|3648173|FG001|Overall Study|Progressive Disease|2
2069792|NCT00616941|3648174|FG002|Overall Study|Progressive Disease|1
2069793|NCT00616941|3648172|FG000|Overall Study|Adverse Event|0
2069794|NCT00616941|3648173|FG001|Overall Study|Adverse Event|1
2069795|NCT00616941|3648174|FG002|Overall Study|Adverse Event|1
2069796|NCT00616941|3648172|FG000|Overall Study|Subject Non-compliance|0
2069797|NCT00616941|3648173|FG001|Overall Study|Subject Non-compliance|0
2069798|NCT00616941|3648174|FG002|Overall Study|Subject Non-compliance|1
2069799|NCT00616941|3648172|FG000|Overall Study|Unrelated Medical Illness/Complication|0
2069800|NCT00616941|3648173|FG001|Overall Study|Unrelated Medical Illness/Complication|2
2069801|NCT00616941|3648174|FG002|Overall Study|Unrelated Medical Illness/Complication|0
2069802|NCT00616941|3648172|FG000|Overall Study|Vaccination Suspended|0
2069803|NCT00616941|3648173|FG001|Overall Study|Vaccination Suspended|0
2069804|NCT00616941|3648174|FG002|Overall Study|Vaccination Suspended|3
2069805|NCT00617084|3648197|FG000|Overall Study|Withdrawal by Subject|5
2069806|NCT00617084|3648198|FG001|Overall Study|Withdrawal by Subject|7
2069807|NCT00617084|3648197|FG000|Overall Study|Missed 12 Months visit|16
2069808|NCT00617084|3648198|FG001|Overall Study|Missed 12 Months visit|19
2069809|NCT00617123|3648217|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36
2069810|NCT00617123|3648218|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24
2069811|NCT00617123|3648217|FG000|Referral Screening Period|Did Not Wish To Continue|3
2303497|NCT02641379|4002950|FG001|Overall Study|Participant cannot be reached|4
2303498|NCT02641379|4002951|FG002|Overall Study|Participant cannot be reached|0
2303499|NCT02641379|4002952|FG003|Overall Study|Participant cannot be reached|8
2303500|NCT02641379|4002953|FG004|Overall Study|Participant cannot be reached|2
2303501|NCT02641379|4002954|FG005|Overall Study|Participant cannot be reached|1
2303502|NCT02641379|4002955|FG006|Overall Study|Participant cannot be reached|0
2303503|NCT02641379|4002956|FG007|Overall Study|Participant cannot be reached|1
2303504|NCT02641379|4002957|FG008|Overall Study|Participant cannot be reached|0
2303505|NCT02641379|4002958|FG009|Overall Study|Participant cannot be reached|2
2303506|NCT02641379|4002959|FG010|Overall Study|Participant cannot be reached|1
2303507|NCT02641379|4002949|FG000|Overall Study|PCR positive at Week 24|15
2303508|NCT02641379|4002950|FG001|Overall Study|PCR positive at Week 24|21
2303509|NCT02641379|4002951|FG002|Overall Study|PCR positive at Week 24|62
2303510|NCT02641379|4002952|FG003|Overall Study|PCR positive at Week 24|0
2303511|NCT02641379|4002953|FG004|Overall Study|PCR positive at Week 24|0
2303512|NCT02641379|4002954|FG005|Overall Study|PCR positive at Week 24|6
2303513|NCT02641379|4002955|FG006|Overall Study|PCR positive at Week 24|3
2303514|NCT02641379|4002956|FG007|Overall Study|PCR positive at Week 24|8
2303515|NCT02641379|4002957|FG008|Overall Study|PCR positive at Week 24|0
2303516|NCT02641379|4002958|FG009|Overall Study|PCR positive at Week 24|1
2303517|NCT02641379|4002959|FG010|Overall Study|PCR positive at Week 24|0
2303518|NCT02641379|4002949|FG000|Overall Study|PCR positive at follow up 2|1
2303519|NCT02641379|4002950|FG001|Overall Study|PCR positive at follow up 2|0
2303520|NCT02641379|4002951|FG002|Overall Study|PCR positive at follow up 2|0
2303521|NCT02641379|4002952|FG003|Overall Study|PCR positive at follow up 2|0
2303522|NCT02641379|4002953|FG004|Overall Study|PCR positive at follow up 2|0
2303523|NCT02641379|4002954|FG005|Overall Study|PCR positive at follow up 2|0
2303524|NCT02641379|4002955|FG006|Overall Study|PCR positive at follow up 2|0
2303525|NCT02641379|4002956|FG007|Overall Study|PCR positive at follow up 2|0
2303526|NCT02641379|4002957|FG008|Overall Study|PCR positive at follow up 2|0
2303527|NCT02641379|4002958|FG009|Overall Study|PCR positive at follow up 2|0
2303528|NCT02641379|4002959|FG010|Overall Study|PCR positive at follow up 2|0
2303529|NCT02641379|4002949|FG000|Overall Study|Participant showed relapse|1
2303530|NCT02641379|4002950|FG001|Overall Study|Participant showed relapse|0
2303531|NCT02641379|4002951|FG002|Overall Study|Participant showed relapse|0
2303532|NCT02641379|4002952|FG003|Overall Study|Participant showed relapse|0
2303533|NCT02641379|4002953|FG004|Overall Study|Participant showed relapse|0
2303534|NCT02641379|4002954|FG005|Overall Study|Participant showed relapse|0
2303535|NCT02641379|4002955|FG006|Overall Study|Participant showed relapse|1
2303536|NCT02641379|4002956|FG007|Overall Study|Participant showed relapse|0
2303537|NCT02641379|4002957|FG008|Overall Study|Participant showed relapse|0
2303538|NCT02641379|4002958|FG009|Overall Study|Participant showed relapse|0
2303539|NCT02641379|4002959|FG010|Overall Study|Participant showed relapse|0
2303540|NCT02641379|4002949|FG000|Overall Study|Participant stopped study/treatment|1
2303541|NCT02641379|4002950|FG001|Overall Study|Participant stopped study/treatment|3
2303542|NCT02641379|4002951|FG002|Overall Study|Participant stopped study/treatment|1
2303543|NCT02641379|4002952|FG003|Overall Study|Participant stopped study/treatment|0
2303544|NCT02641379|4002953|FG004|Overall Study|Participant stopped study/treatment|0
2303545|NCT02641379|4002954|FG005|Overall Study|Participant stopped study/treatment|1
2303546|NCT02641379|4002955|FG006|Overall Study|Participant stopped study/treatment|2
2303547|NCT02641379|4002956|FG007|Overall Study|Participant stopped study/treatment|0
2303548|NCT02641379|4002957|FG008|Overall Study|Participant stopped study/treatment|1
2303549|NCT02641379|4002958|FG009|Overall Study|Participant stopped study/treatment|0
2303550|NCT02641379|4002959|FG010|Overall Study|Participant stopped study/treatment|0
2303551|NCT02641379|4002949|FG000|Overall Study|Therapy stopped due to misunderstanding|1
2303552|NCT02641379|4002950|FG001|Overall Study|Therapy stopped due to misunderstanding|0
2303553|NCT02641379|4002951|FG002|Overall Study|Therapy stopped due to misunderstanding|0
2069812|NCT00617123|3648218|FG001|Referral Screening Period|Did Not Wish To Continue|1
2069813|NCT00617123|3648217|FG000|Referral Screening Period|Adverse Event|0
2069814|NCT00617123|3648218|FG001|Referral Screening Period|Adverse Event|1
2069815|NCT00617123|3648217|FG000|Study Treatment Period|Withdrawal by Subject|8
2069816|NCT00617123|3648218|FG001|Study Treatment Period|Withdrawal by Subject|12
2069817|NCT00617123|3648217|FG000|Study Treatment Period|Adverse Event|7
2069818|NCT00617123|3648218|FG001|Study Treatment Period|Adverse Event|3
2069819|NCT00617123|3648217|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2
2069820|NCT00617123|3648218|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0
2069821|NCT00617123|3648217|FG000|Study Treatment Period|Noncompliance with Protocol|0
2069822|NCT00617123|3648218|FG001|Study Treatment Period|Noncompliance with Protocol|1
2069823|NCT00617201|3648239|FG000|Overall Study|Lost to Follow-up|9
2069824|NCT00617201|3648240|FG001|Overall Study|Lost to Follow-up|13
2069825|NCT00617240|3648250|FG000|Overall Study|Lack of Efficacy|1
2069826|NCT00617240|3648251|FG001|Overall Study|Lack of Efficacy|0
2069827|NCT00617279|3648259|FG000|Overall Study|Study terminated by Sponsor|10
2069828|NCT00617279|3648260|FG001|Overall Study|Study terminated by Sponsor|15
2069829|NCT00617279|3648259|FG000|Overall Study|Graft abandonment|2
2069830|NCT00617279|3648260|FG001|Overall Study|Graft abandonment|0
2069831|NCT00617279|3648259|FG000|Overall Study|Lost to Follow-up|1
2069832|NCT00617279|3648260|FG001|Overall Study|Lost to Follow-up|0
2069833|NCT00617279|3648259|FG000|Overall Study|Death|1
2069834|NCT00617279|3648260|FG001|Overall Study|Death|2
2069835|NCT00617305|3648269|FG000|Overall Study|Adverse Event|4
2069836|NCT00617305|3648270|FG001|Overall Study|Adverse Event|0
2069837|NCT00617305|3648271|FG002|Overall Study|Adverse Event|0
2069838|NCT00617305|3648269|FG000|Overall Study|Death|1
2069839|NCT00617305|3648270|FG001|Overall Study|Death|0
2069840|NCT00617305|3648271|FG002|Overall Study|Death|0
2303554|NCT02641379|4002952|FG003|Overall Study|Therapy stopped due to misunderstanding|0
2303555|NCT02641379|4002953|FG004|Overall Study|Therapy stopped due to misunderstanding|0
2303556|NCT02641379|4002954|FG005|Overall Study|Therapy stopped due to misunderstanding|0
2303557|NCT02641379|4002955|FG006|Overall Study|Therapy stopped due to misunderstanding|0
2303558|NCT02641379|4002956|FG007|Overall Study|Therapy stopped due to misunderstanding|0
2303559|NCT02641379|4002957|FG008|Overall Study|Therapy stopped due to misunderstanding|0
2303560|NCT02641379|4002958|FG009|Overall Study|Therapy stopped due to misunderstanding|0
2303561|NCT02641379|4002959|FG010|Overall Study|Therapy stopped due to misunderstanding|0
2303562|NCT02641379|4002949|FG000|Overall Study|Financial problems|0
2303563|NCT02641379|4002950|FG001|Overall Study|Financial problems|1
2303564|NCT02641379|4002951|FG002|Overall Study|Financial problems|0
2303565|NCT02641379|4002952|FG003|Overall Study|Financial problems|0
2303566|NCT02641379|4002953|FG004|Overall Study|Financial problems|0
2303567|NCT02641379|4002954|FG005|Overall Study|Financial problems|0
2303568|NCT02641379|4002955|FG006|Overall Study|Financial problems|0
2303569|NCT02641379|4002956|FG007|Overall Study|Financial problems|0
2303570|NCT02641379|4002957|FG008|Overall Study|Financial problems|0
2303571|NCT02641379|4002958|FG009|Overall Study|Financial problems|0
2303572|NCT02641379|4002959|FG010|Overall Study|Financial problems|0
2303573|NCT02641379|4002949|FG000|Overall Study|PCR positive at Week 68|0
2303574|NCT02641379|4002950|FG001|Overall Study|PCR positive at Week 68|1
2303575|NCT02641379|4002951|FG002|Overall Study|PCR positive at Week 68|0
2303576|NCT02641379|4002952|FG003|Overall Study|PCR positive at Week 68|0
2303577|NCT02641379|4002953|FG004|Overall Study|PCR positive at Week 68|0
2303578|NCT02641379|4002954|FG005|Overall Study|PCR positive at Week 68|0
2303579|NCT02641379|4002955|FG006|Overall Study|PCR positive at Week 68|0
2303580|NCT02641379|4002956|FG007|Overall Study|PCR positive at Week 68|0
2303581|NCT02641379|4002957|FG008|Overall Study|PCR positive at Week 68|0
2303582|NCT02641379|4002958|FG009|Overall Study|PCR positive at Week 68|0
2303583|NCT02641379|4002959|FG010|Overall Study|PCR positive at Week 68|0
2303584|NCT02641379|4002949|FG000|Overall Study|PCR positive at Week 48|0
2303585|NCT02641379|4002950|FG001|Overall Study|PCR positive at Week 48|1
2303586|NCT02641379|4002951|FG002|Overall Study|PCR positive at Week 48|0
2303587|NCT02641379|4002952|FG003|Overall Study|PCR positive at Week 48|0
2303588|NCT02641379|4002953|FG004|Overall Study|PCR positive at Week 48|0
2303589|NCT02641379|4002954|FG005|Overall Study|PCR positive at Week 48|0
2303590|NCT02641379|4002955|FG006|Overall Study|PCR positive at Week 48|0
2303591|NCT02641379|4002956|FG007|Overall Study|PCR positive at Week 48|0
2303592|NCT02641379|4002957|FG008|Overall Study|PCR positive at Week 48|0
2303593|NCT02641379|4002958|FG009|Overall Study|PCR positive at Week 48|0
2303594|NCT02641379|4002959|FG010|Overall Study|PCR positive at Week 48|0
2303595|NCT02641379|4002949|FG000|Overall Study|PCR not performed at Week 12|0
2303596|NCT02641379|4002950|FG001|Overall Study|PCR not performed at Week 12|0
2303597|NCT02641379|4002951|FG002|Overall Study|PCR not performed at Week 12|1
2303598|NCT02641379|4002952|FG003|Overall Study|PCR not performed at Week 12|0
2303599|NCT02641379|4002953|FG004|Overall Study|PCR not performed at Week 12|0
2303600|NCT02641379|4002954|FG005|Overall Study|PCR not performed at Week 12|0
2303601|NCT02641379|4002955|FG006|Overall Study|PCR not performed at Week 12|0
2303602|NCT02641379|4002956|FG007|Overall Study|PCR not performed at Week 12|0
2303603|NCT02641379|4002957|FG008|Overall Study|PCR not performed at Week 12|0
2303604|NCT02641379|4002958|FG009|Overall Study|PCR not performed at Week 12|0
2069841|NCT00617305|3648269|FG000|Overall Study|Physician Decision|1
2069842|NCT00617305|3648270|FG001|Overall Study|Physician Decision|0
2069843|NCT00617305|3648271|FG002|Overall Study|Physician Decision|0
2069844|NCT00617305|3648269|FG000|Overall Study|Protocol Violation|1
2069845|NCT00617305|3648270|FG001|Overall Study|Protocol Violation|0
2069846|NCT00617305|3648271|FG002|Overall Study|Protocol Violation|1
2069847|NCT00617305|3648269|FG000|Overall Study|Withdrawal by Subject|1
2069848|NCT00617305|3648270|FG001|Overall Study|Withdrawal by Subject|0
2069849|NCT00617305|3648271|FG002|Overall Study|Withdrawal by Subject|0
2069850|NCT00617344|3648285|FG000|Overall Study|Serious adverse event|1
2069851|NCT00617344|3648286|FG001|Overall Study|Serious adverse event|0
2069852|NCT00617344|3648287|FG002|Overall Study|Serious adverse event|0
2069853|NCT00617344|3648285|FG000|Overall Study|Other Adverse Event|1
2069854|NCT00617344|3648286|FG001|Overall Study|Other Adverse Event|1
2069855|NCT00617344|3648287|FG002|Overall Study|Other Adverse Event|0
2069856|NCT00617344|3648285|FG000|Overall Study|Protocol Violation|10
2069857|NCT00617344|3648286|FG001|Overall Study|Protocol Violation|8
2069858|NCT00617344|3648287|FG002|Overall Study|Protocol Violation|5
2069859|NCT00617344|3648285|FG000|Overall Study|Lost to Follow-up|5
2069860|NCT00617344|3648286|FG001|Overall Study|Lost to Follow-up|4
2069861|NCT00617344|3648287|FG002|Overall Study|Lost to Follow-up|1
2069862|NCT00617344|3648285|FG000|Overall Study|Withdrawal by Subject|8
2069863|NCT00617344|3648286|FG001|Overall Study|Withdrawal by Subject|9
2069864|NCT00617344|3648287|FG002|Overall Study|Withdrawal by Subject|2
2069865|NCT00617357|3648295|FG000|Overall Study|Lost to Follow-up|7
2069866|NCT00617357|3648295|FG000|Overall Study|Death|5
2069867|NCT00617357|3648295|FG000|Overall Study|insurance concerns|2
2069868|NCT00617357|3648295|FG000|Overall Study|Withdrawal by Subject|1
2069869|NCT00617357|3648295|FG000|Overall Study|Physician Decision|1
2069870|NCT00617409|3648307|FG000|Overall Study|Withdrawal by Subject|4
2069871|NCT00617409|3648308|FG001|Overall Study|Withdrawal by Subject|1
2069872|NCT00617409|3648309|FG002|Overall Study|Withdrawal by Subject|2
2303605|NCT02641379|4002959|FG010|Overall Study|PCR not performed at Week 12|0
2303606|NCT02641379|4002949|FG000|Overall Study|No PCR at baseline|0
2303607|NCT02641379|4002950|FG001|Overall Study|No PCR at baseline|0
2303608|NCT02641379|4002951|FG002|Overall Study|No PCR at baseline|1
2303609|NCT02641379|4002952|FG003|Overall Study|No PCR at baseline|0
2303610|NCT02641379|4002953|FG004|Overall Study|No PCR at baseline|0
2303611|NCT02641379|4002954|FG005|Overall Study|No PCR at baseline|0
2303612|NCT02641379|4002955|FG006|Overall Study|No PCR at baseline|0
2303613|NCT02641379|4002956|FG007|Overall Study|No PCR at baseline|0
2303614|NCT02641379|4002957|FG008|Overall Study|No PCR at baseline|0
2303615|NCT02641379|4002958|FG009|Overall Study|No PCR at baseline|0
2303616|NCT02641379|4002959|FG010|Overall Study|No PCR at baseline|0
2303617|NCT02641379|4002949|FG000|Overall Study|PCR positive at Week 28|0
2303618|NCT02641379|4002950|FG001|Overall Study|PCR positive at Week 28|0
2303619|NCT02641379|4002951|FG002|Overall Study|PCR positive at Week 28|1
2303620|NCT02641379|4002952|FG003|Overall Study|PCR positive at Week 28|0
2303621|NCT02641379|4002953|FG004|Overall Study|PCR positive at Week 28|0
2303622|NCT02641379|4002954|FG005|Overall Study|PCR positive at Week 28|0
2303623|NCT02641379|4002955|FG006|Overall Study|PCR positive at Week 28|0
2303624|NCT02641379|4002956|FG007|Overall Study|PCR positive at Week 28|0
2303625|NCT02641379|4002957|FG008|Overall Study|PCR positive at Week 28|0
2303626|NCT02641379|4002958|FG009|Overall Study|PCR positive at Week 28|0
2303627|NCT02641379|4002959|FG010|Overall Study|PCR positive at Week 28|0
2303628|NCT02641379|4002949|FG000|Overall Study|PCR sample for Week 4 not drawn|0
2303629|NCT02641379|4002950|FG001|Overall Study|PCR sample for Week 4 not drawn|0
2303630|NCT02641379|4002951|FG002|Overall Study|PCR sample for Week 4 not drawn|0
2303631|NCT02641379|4002952|FG003|Overall Study|PCR sample for Week 4 not drawn|1
2303632|NCT02641379|4002953|FG004|Overall Study|PCR sample for Week 4 not drawn|0
2303633|NCT02641379|4002954|FG005|Overall Study|PCR sample for Week 4 not drawn|0
2303634|NCT02641379|4002955|FG006|Overall Study|PCR sample for Week 4 not drawn|0
2303635|NCT02641379|4002956|FG007|Overall Study|PCR sample for Week 4 not drawn|0
2303636|NCT02641379|4002957|FG008|Overall Study|PCR sample for Week 4 not drawn|0
2303637|NCT02641379|4002958|FG009|Overall Study|PCR sample for Week 4 not drawn|0
2303638|NCT02641379|4002959|FG010|Overall Study|PCR sample for Week 4 not drawn|0
2303639|NCT02641379|4002949|FG000|Overall Study|Inclusion criteria not fulfilled|0
2303640|NCT02641379|4002950|FG001|Overall Study|Inclusion criteria not fulfilled|0
2303641|NCT02641379|4002951|FG002|Overall Study|Inclusion criteria not fulfilled|0
2303642|NCT02641379|4002952|FG003|Overall Study|Inclusion criteria not fulfilled|1
2303643|NCT02641379|4002953|FG004|Overall Study|Inclusion criteria not fulfilled|0
2303644|NCT02641379|4002954|FG005|Overall Study|Inclusion criteria not fulfilled|0
2303645|NCT02641379|4002955|FG006|Overall Study|Inclusion criteria not fulfilled|0
2303646|NCT02641379|4002956|FG007|Overall Study|Inclusion criteria not fulfilled|0
2303647|NCT02641379|4002957|FG008|Overall Study|Inclusion criteria not fulfilled|0
2303648|NCT02641379|4002958|FG009|Overall Study|Inclusion criteria not fulfilled|0
2303649|NCT02641379|4002959|FG010|Overall Study|Inclusion criteria not fulfilled|0
2069873|NCT00617409|3648307|FG000|Overall Study|Adverse Event|0
2069874|NCT00617409|3648308|FG001|Overall Study|Adverse Event|2
2069875|NCT00617409|3648309|FG002|Overall Study|Adverse Event|3
2303650|NCT02641379|4002949|FG000|Overall Study|Baseline viral load unavailable|0
2303651|NCT02641379|4002950|FG001|Overall Study|Baseline viral load unavailable|0
2069876|NCT00617409|3648307|FG000|Overall Study|Disease Progression|8
2069877|NCT00617409|3648308|FG001|Overall Study|Disease Progression|8
2069878|NCT00617409|3648309|FG002|Overall Study|Disease Progression|18
2069879|NCT00617409|3648307|FG000|Overall Study|Death|3
2069880|NCT00617409|3648308|FG001|Overall Study|Death|5
2069881|NCT00617409|3648309|FG002|Overall Study|Death|4
2069882|NCT00617409|3648307|FG000|Overall Study|Alternative Therapy|1
2069883|NCT00617409|3648308|FG001|Overall Study|Alternative Therapy|2
2069884|NCT00617409|3648309|FG002|Overall Study|Alternative Therapy|0
2069885|NCT00617461|3648318|FG000|First Treatment Intervention Period|Adverse Event|2
2069886|NCT00617461|3648319|FG001|First Treatment Intervention Period|Adverse Event|0
2069887|NCT00617461|3648318|FG000|First Treatment Intervention Period|Lack of Efficacy|1
2069888|NCT00617461|3648319|FG001|First Treatment Intervention Period|Lack of Efficacy|0
2069889|NCT00617461|3648318|FG000|First Treatment Intervention Period|Protocol Violation|2
2069890|NCT00617461|3648319|FG001|First Treatment Intervention Period|Protocol Violation|1
2069891|NCT00617461|3648318|FG000|First Treatment Intervention Period|Lost to Follow-up|0
2069892|NCT00617461|3648319|FG001|First Treatment Intervention Period|Lost to Follow-up|1
2069893|NCT00617461|3648318|FG000|First Treatment Intervention Period|Investigator Discretion|1
2069894|NCT00617461|3648319|FG001|First Treatment Intervention Period|Investigator Discretion|1
2069895|NCT00617461|3648318|FG000|First Treatment Intervention Period|Withdrawal by Subject|4
2069896|NCT00617461|3648319|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
2069897|NCT00617461|3648318|FG000|4-Day Crossover Period|Withdrawal by Subject|1
2069898|NCT00617461|3648319|FG001|4-Day Crossover Period|Withdrawal by Subject|0
2069899|NCT00617461|3648318|FG000|Second Treatment Intervention Period|Adverse Event|0
2069900|NCT00617461|3648319|FG001|Second Treatment Intervention Period|Adverse Event|1
2069901|NCT00617461|3648318|FG000|Second Treatment Intervention Period|Lack of Efficacy|0
2069902|NCT00617461|3648319|FG001|Second Treatment Intervention Period|Lack of Efficacy|3
2069903|NCT00617461|3648318|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1
2069904|NCT00617461|3648319|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0
2069905|NCT00617461|3648318|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
2069906|NCT00617461|3648319|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
2303652|NCT02641379|4002951|FG002|Overall Study|Baseline viral load unavailable|0
2303653|NCT02641379|4002952|FG003|Overall Study|Baseline viral load unavailable|1
2303654|NCT02641379|4002953|FG004|Overall Study|Baseline viral load unavailable|0
2303655|NCT02641379|4002954|FG005|Overall Study|Baseline viral load unavailable|0
2303656|NCT02641379|4002955|FG006|Overall Study|Baseline viral load unavailable|0
2303657|NCT02641379|4002956|FG007|Overall Study|Baseline viral load unavailable|0
2303658|NCT02641379|4002957|FG008|Overall Study|Baseline viral load unavailable|0
2303659|NCT02641379|4002958|FG009|Overall Study|Baseline viral load unavailable|0
2303660|NCT02641379|4002959|FG010|Overall Study|Baseline viral load unavailable|0
2303661|NCT02641379|4002949|FG000|Overall Study|Blood could not be drawn|0
2303662|NCT02641379|4002950|FG001|Overall Study|Blood could not be drawn|0
2303663|NCT02641379|4002951|FG002|Overall Study|Blood could not be drawn|0
2303664|NCT02641379|4002952|FG003|Overall Study|Blood could not be drawn|0
2303665|NCT02641379|4002953|FG004|Overall Study|Blood could not be drawn|1
2303666|NCT02641379|4002954|FG005|Overall Study|Blood could not be drawn|0
2303667|NCT02641379|4002955|FG006|Overall Study|Blood could not be drawn|0
2303668|NCT02641379|4002956|FG007|Overall Study|Blood could not be drawn|0
2303669|NCT02641379|4002957|FG008|Overall Study|Blood could not be drawn|0
2303670|NCT02641379|4002958|FG009|Overall Study|Blood could not be drawn|0
2303671|NCT02641379|4002959|FG010|Overall Study|Blood could not be drawn|0
2303672|NCT02641379|4002949|FG000|Overall Study|Protocol Violation|0
2303673|NCT02641379|4002950|FG001|Overall Study|Protocol Violation|0
2303674|NCT02641379|4002951|FG002|Overall Study|Protocol Violation|0
2303675|NCT02641379|4002952|FG003|Overall Study|Protocol Violation|0
2303676|NCT02641379|4002953|FG004|Overall Study|Protocol Violation|2
2303677|NCT02641379|4002954|FG005|Overall Study|Protocol Violation|0
2303678|NCT02641379|4002955|FG006|Overall Study|Protocol Violation|0
2303679|NCT02641379|4002956|FG007|Overall Study|Protocol Violation|0
2303680|NCT02641379|4002957|FG008|Overall Study|Protocol Violation|1
2303681|NCT02641379|4002958|FG009|Overall Study|Protocol Violation|0
2303682|NCT02641379|4002959|FG010|Overall Study|Protocol Violation|0
2303683|NCT02641379|4002949|FG000|Overall Study|Participation in sili rescue study|0
2303684|NCT02641379|4002950|FG001|Overall Study|Participation in sili rescue study|0
2303685|NCT02641379|4002951|FG002|Overall Study|Participation in sili rescue study|0
2303686|NCT02641379|4002952|FG003|Overall Study|Participation in sili rescue study|0
2303687|NCT02641379|4002953|FG004|Overall Study|Participation in sili rescue study|0
2303688|NCT02641379|4002954|FG005|Overall Study|Participation in sili rescue study|1
2303689|NCT02641379|4002955|FG006|Overall Study|Participation in sili rescue study|0
2303690|NCT02641379|4002956|FG007|Overall Study|Participation in sili rescue study|0
2303691|NCT02641379|4002957|FG008|Overall Study|Participation in sili rescue study|0
2303692|NCT02641379|4002958|FG009|Overall Study|Participation in sili rescue study|0
2303693|NCT02641379|4002959|FG010|Overall Study|Participation in sili rescue study|0
2303694|NCT02641379|4002949|FG000|Overall Study|Lost to Follow-up|0
2303695|NCT02641379|4002950|FG001|Overall Study|Lost to Follow-up|0
2303696|NCT02641379|4002951|FG002|Overall Study|Lost to Follow-up|0
2303697|NCT02641379|4002952|FG003|Overall Study|Lost to Follow-up|0
2303698|NCT02641379|4002953|FG004|Overall Study|Lost to Follow-up|0
2069907|NCT00617591|3648346|FG000|Overall Study|Withdrew consent during Induction|4
2069908|NCT00617591|3648346|FG000|Overall Study|Withdrew consent during Maintenance|6
2069909|NCT00617604|3648353|FG000|Overall Study|Death|2
2069910|NCT00617604|3648354|FG001|Overall Study|Death|1
2069911|NCT00617604|3648353|FG000|Overall Study|Lost to Follow-up|1
2069912|NCT00617604|3648354|FG001|Overall Study|Lost to Follow-up|0
2069913|NCT00617604|3648353|FG000|Overall Study|Miscellaneous Reasons|8
2069914|NCT00617604|3648354|FG001|Overall Study|Miscellaneous Reasons|10
2069915|NCT00617604|3648353|FG000|Overall Study|Withdrawal by Subject|4
2069916|NCT00617604|3648354|FG001|Overall Study|Withdrawal by Subject|6
2069917|NCT00617604|3648353|FG000|Overall Study|Randomized but Never Received Study Drug|3
2069918|NCT00617604|3648354|FG001|Overall Study|Randomized but Never Received Study Drug|3
2069919|NCT00617669|3648362|FG000|Overall Study|Withdrawal by Subject|71
2069920|NCT00617669|3648363|FG001|Overall Study|Withdrawal by Subject|77
2069921|NCT00617669|3648362|FG000|Overall Study|Lost to Follow-up|3
2069922|NCT00617669|3648363|FG001|Overall Study|Lost to Follow-up|2
2069923|NCT00617669|3648362|FG000|Overall Study|Adverse Event|87
2069924|NCT00617669|3648363|FG001|Overall Study|Adverse Event|76
2069925|NCT00617669|3648362|FG000|Overall Study|Protocol Violation|2
2069926|NCT00617669|3648363|FG001|Overall Study|Protocol Violation|3
2069927|NCT00617669|3648362|FG000|Overall Study|Reason not otherwise captured, eg; death|265
2069928|NCT00617669|3648363|FG001|Overall Study|Reason not otherwise captured, eg; death|290
2069929|NCT00617669|3648362|FG000|Overall Study|Patients randomized but not treated|2
2069930|NCT00617669|3648363|FG001|Overall Study|Patients randomized but not treated|3
2069931|NCT00617734|3648371|FG000|Overall Study|Withdrew Consent|2
2069932|NCT00617734|3648372|FG001|Overall Study|Withdrew Consent|0
2069933|NCT00617734|3648371|FG000|Overall Study|Adverse Event|4
2210380|NCT01649427|3849854|FG000|Overall Study|Graft loss|0
2210381|NCT01649427|3849855|FG001|Overall Study|Graft loss|1
2210382|NCT01649427|3849854|FG000|Overall Study|Surgical problems during nephrectomy|2
2210383|NCT01649427|3849855|FG001|Overall Study|Surgical problems during nephrectomy|2
2210384|NCT01649557|3849864|FG000|Overall Study|Lost to Follow-up|5
2210385|NCT01649557|3849865|FG001|Overall Study|Lost to Follow-up|0
2210386|NCT01649557|3849866|FG002|Overall Study|Lost to Follow-up|3
2210387|NCT01649557|3849864|FG000|Overall Study|Adverse Event|7
2210388|NCT01649557|3849865|FG001|Overall Study|Adverse Event|5
2069934|NCT00617734|3648372|FG001|Overall Study|Adverse Event|1
2069935|NCT00617734|3648371|FG000|Overall Study|Protocol Violation|1
2069936|NCT00617734|3648372|FG001|Overall Study|Protocol Violation|0
2069937|NCT00617734|3648371|FG000|Overall Study|Found Ineligible After Randomization|1
2069938|NCT00617734|3648372|FG001|Overall Study|Found Ineligible After Randomization|4
2069939|NCT00617734|3648371|FG000|Overall Study|Lost to Follow-up|0
2069940|NCT00617734|3648372|FG001|Overall Study|Lost to Follow-up|1
2069941|NCT00617773|3648378|FG000|Overall Study|Physician Decision|1
2069942|NCT00617773|3648378|FG000|Overall Study|Lack of compliance with the protocol|1
2069943|NCT00617773|3648378|FG000|Overall Study|Withdrawal by Subject|1
2303699|NCT02641379|4002954|FG005|Overall Study|Lost to Follow-up|0
2303700|NCT02641379|4002955|FG006|Overall Study|Lost to Follow-up|0
2303701|NCT02641379|4002956|FG007|Overall Study|Lost to Follow-up|0
2303702|NCT02641379|4002957|FG008|Overall Study|Lost to Follow-up|1
2303703|NCT02641379|4002958|FG009|Overall Study|Lost to Follow-up|0
2303704|NCT02641379|4002959|FG010|Overall Study|Lost to Follow-up|0
2303705|NCT02641379|4002949|FG000|Overall Study|Source data not found|0
2303706|NCT02641379|4002950|FG001|Overall Study|Source data not found|0
2303707|NCT02641379|4002951|FG002|Overall Study|Source data not found|0
2303708|NCT02641379|4002952|FG003|Overall Study|Source data not found|0
2303709|NCT02641379|4002953|FG004|Overall Study|Source data not found|0
2303710|NCT02641379|4002954|FG005|Overall Study|Source data not found|1
2303711|NCT02641379|4002955|FG006|Overall Study|Source data not found|0
2303712|NCT02641379|4002956|FG007|Overall Study|Source data not found|0
2303713|NCT02641379|4002957|FG008|Overall Study|Source data not found|0
2303714|NCT02641379|4002958|FG009|Overall Study|Source data not found|0
2303715|NCT02641379|4002959|FG010|Overall Study|Source data not found|0
2303716|NCT02641379|4002949|FG000|Overall Study|Participant showed weight reduction|0
2303717|NCT02641379|4002950|FG001|Overall Study|Participant showed weight reduction|0
2303718|NCT02641379|4002951|FG002|Overall Study|Participant showed weight reduction|0
2303719|NCT02641379|4002952|FG003|Overall Study|Participant showed weight reduction|0
2303720|NCT02641379|4002953|FG004|Overall Study|Participant showed weight reduction|0
2303721|NCT02641379|4002954|FG005|Overall Study|Participant showed weight reduction|0
2303722|NCT02641379|4002955|FG006|Overall Study|Participant showed weight reduction|0
2303723|NCT02641379|4002956|FG007|Overall Study|Participant showed weight reduction|1
2303724|NCT02641379|4002957|FG008|Overall Study|Participant showed weight reduction|0
2303725|NCT02641379|4002958|FG009|Overall Study|Participant showed weight reduction|0
2303726|NCT02641379|4002959|FG010|Overall Study|Participant showed weight reduction|0
2303727|NCT02641379|4002949|FG000|Overall Study|Non-response Week 12|0
2303728|NCT02641379|4002950|FG001|Overall Study|Non-response Week 12|0
2303729|NCT02641379|4002951|FG002|Overall Study|Non-response Week 12|0
2303730|NCT02641379|4002952|FG003|Overall Study|Non-response Week 12|0
2303731|NCT02641379|4002953|FG004|Overall Study|Non-response Week 12|0
2303732|NCT02641379|4002954|FG005|Overall Study|Non-response Week 12|0
2303733|NCT02641379|4002955|FG006|Overall Study|Non-response Week 12|0
2069944|NCT00617773|3648378|FG000|Overall Study|Death|1
2069945|NCT00617773|3648378|FG000|Overall Study|Progressive disease|19
2069946|NCT00617773|3648378|FG000|Overall Study|Protocol Violation|1
2069947|NCT00617851|3648386|FG000|Overall Study|Death|0
2069948|NCT00617851|3648387|FG001|Overall Study|Death|0
2069949|NCT00617851|3648388|FG002|Overall Study|Death|0
2069950|NCT00617851|3648389|FG003|Overall Study|Death|1
2069951|NCT00617851|3648386|FG000|Overall Study|Withdrawal by Subject|14
2069952|NCT00617851|3648387|FG001|Overall Study|Withdrawal by Subject|7
2069953|NCT00617851|3648388|FG002|Overall Study|Withdrawal by Subject|12
2069954|NCT00617851|3648389|FG003|Overall Study|Withdrawal by Subject|4
2069955|NCT00617851|3648386|FG000|Overall Study|Lost to Follow-up|27
2069956|NCT00617851|3648387|FG001|Overall Study|Lost to Follow-up|29
2069957|NCT00617851|3648388|FG002|Overall Study|Lost to Follow-up|31
2069958|NCT00617851|3648389|FG003|Overall Study|Lost to Follow-up|19
2069959|NCT00617851|3648386|FG000|Overall Study|Inappropriate Enrollment|5
2069960|NCT00617851|3648387|FG001|Overall Study|Inappropriate Enrollment|4
2069961|NCT00617851|3648388|FG002|Overall Study|Inappropriate Enrollment|1
2069962|NCT00617851|3648389|FG003|Overall Study|Inappropriate Enrollment|1
2069963|NCT00617851|3648386|FG000|Overall Study|Unable to classify|1
2069964|NCT00617851|3648387|FG001|Overall Study|Unable to classify|0
2069965|NCT00617851|3648388|FG002|Overall Study|Unable to classify|1
2069966|NCT00617851|3648389|FG003|Overall Study|Unable to classify|0
2069967|NCT00617890|3648413|FG000|Overall Study|Treatment ongoing at data cut-off|0
2069968|NCT00617890|3648414|FG001|Overall Study|Treatment ongoing at data cut-off|0
2069969|NCT00617890|3648415|FG002|Overall Study|Treatment ongoing at data cut-off|0
2210389|NCT01649557|3849866|FG002|Overall Study|Adverse Event|1
2069970|NCT00617890|3648416|FG003|Overall Study|Treatment ongoing at data cut-off|5
2069971|NCT00617890|3648413|FG000|Overall Study|Lack of Efficacy|23
2069972|NCT00617890|3648414|FG001|Overall Study|Lack of Efficacy|26
2069973|NCT00617890|3648415|FG002|Overall Study|Lack of Efficacy|30
2303734|NCT02641379|4002956|FG007|Overall Study|Non-response Week 12|1
2303735|NCT02641379|4002957|FG008|Overall Study|Non-response Week 12|0
2303736|NCT02641379|4002958|FG009|Overall Study|Non-response Week 12|0
2303737|NCT02641379|4002959|FG010|Overall Study|Non-response Week 12|0
2303738|NCT02641379|4002949|FG000|Overall Study|No 2 Log drop at Week 12|0
2303739|NCT02641379|4002950|FG001|Overall Study|No 2 Log drop at Week 12|0
2303740|NCT02641379|4002951|FG002|Overall Study|No 2 Log drop at Week 12|0
2303741|NCT02641379|4002952|FG003|Overall Study|No 2 Log drop at Week 12|0
2303742|NCT02641379|4002953|FG004|Overall Study|No 2 Log drop at Week 12|0
2303743|NCT02641379|4002954|FG005|Overall Study|No 2 Log drop at Week 12|0
2303744|NCT02641379|4002955|FG006|Overall Study|No 2 Log drop at Week 12|0
2303745|NCT02641379|4002956|FG007|Overall Study|No 2 Log drop at Week 12|0
2303746|NCT02641379|4002957|FG008|Overall Study|No 2 Log drop at Week 12|0
2303747|NCT02641379|4002958|FG009|Overall Study|No 2 Log drop at Week 12|0
2303748|NCT02641379|4002959|FG010|Overall Study|No 2 Log drop at Week 12|1
2303749|NCT02641379|4002949|FG000|Overall Study|Negative PCR result|0
2303750|NCT02641379|4002950|FG001|Overall Study|Negative PCR result|0
2303751|NCT02641379|4002951|FG002|Overall Study|Negative PCR result|0
2303752|NCT02641379|4002952|FG003|Overall Study|Negative PCR result|0
2303753|NCT02641379|4002953|FG004|Overall Study|Negative PCR result|0
2303754|NCT02641379|4002954|FG005|Overall Study|Negative PCR result|0
2303755|NCT02641379|4002955|FG006|Overall Study|Negative PCR result|0
2303756|NCT02641379|4002956|FG007|Overall Study|Negative PCR result|0
2303757|NCT02641379|4002957|FG008|Overall Study|Negative PCR result|0
2303758|NCT02641379|4002958|FG009|Overall Study|Negative PCR result|1
2303759|NCT02641379|4002959|FG010|Overall Study|Negative PCR result|0
2303760|NCT02641379|4002949|FG000|Overall Study|Participant's PCR high|0
2303761|NCT02641379|4002950|FG001|Overall Study|Participant's PCR high|0
2303762|NCT02641379|4002951|FG002|Overall Study|Participant's PCR high|0
2303763|NCT02641379|4002952|FG003|Overall Study|Participant's PCR high|0
2303764|NCT02641379|4002953|FG004|Overall Study|Participant's PCR high|0
2303765|NCT02641379|4002954|FG005|Overall Study|Participant's PCR high|0
2303766|NCT02641379|4002955|FG006|Overall Study|Participant's PCR high|0
2303767|NCT02641379|4002956|FG007|Overall Study|Participant's PCR high|1
2303768|NCT02641379|4002957|FG008|Overall Study|Participant's PCR high|0
2303769|NCT02641379|4002958|FG009|Overall Study|Participant's PCR high|0
2303770|NCT02641379|4002959|FG010|Overall Study|Participant's PCR high|0
2303771|NCT02641379|4002949|FG000|Overall Study|Participant treated after Week 24|0
2303772|NCT02641379|4002950|FG001|Overall Study|Participant treated after Week 24|0
2303773|NCT02641379|4002951|FG002|Overall Study|Participant treated after Week 24|0
2303774|NCT02641379|4002952|FG003|Overall Study|Participant treated after Week 24|0
2303775|NCT02641379|4002953|FG004|Overall Study|Participant treated after Week 24|0
2303776|NCT02641379|4002954|FG005|Overall Study|Participant treated after Week 24|0
2303777|NCT02641379|4002955|FG006|Overall Study|Participant treated after Week 24|0
2303778|NCT02641379|4002956|FG007|Overall Study|Participant treated after Week 24|0
2303779|NCT02641379|4002957|FG008|Overall Study|Participant treated after Week 24|1
2069974|NCT00617890|3648416|FG003|Overall Study|Lack of Efficacy|97
2069975|NCT00617890|3648413|FG000|Overall Study|Lost to Follow-up|0
2069976|NCT00617890|3648414|FG001|Overall Study|Lost to Follow-up|0
2069977|NCT00617890|3648415|FG002|Overall Study|Lost to Follow-up|1
2069978|NCT00617890|3648416|FG003|Overall Study|Lost to Follow-up|2
2069979|NCT00617890|3648413|FG000|Overall Study|Withdrawal by Subject|4
2303780|NCT02641379|4002958|FG009|Overall Study|Participant treated after Week 24|0
2303781|NCT02641379|4002959|FG010|Overall Study|Participant treated after Week 24|0
2303782|NCT02641379|4002949|FG000|Overall Study|Missing PCR result at Week 8|0
2303783|NCT02641379|4002950|FG001|Overall Study|Missing PCR result at Week 8|0
2303784|NCT02641379|4002951|FG002|Overall Study|Missing PCR result at Week 8|0
2303785|NCT02641379|4002952|FG003|Overall Study|Missing PCR result at Week 8|0
2303786|NCT02641379|4002953|FG004|Overall Study|Missing PCR result at Week 8|0
2303787|NCT02641379|4002954|FG005|Overall Study|Missing PCR result at Week 8|0
2303788|NCT02641379|4002955|FG006|Overall Study|Missing PCR result at Week 8|0
2303789|NCT02641379|4002956|FG007|Overall Study|Missing PCR result at Week 8|0
2303790|NCT02641379|4002957|FG008|Overall Study|Missing PCR result at Week 8|0
2303791|NCT02641379|4002958|FG009|Overall Study|Missing PCR result at Week 8|1
2303792|NCT02641379|4002959|FG010|Overall Study|Missing PCR result at Week 8|0
2303793|NCT02641379|4002949|FG000|Overall Study|PCR positive|0
2303794|NCT02641379|4002950|FG001|Overall Study|PCR positive|0
2303795|NCT02641379|4002951|FG002|Overall Study|PCR positive|0
2303796|NCT02641379|4002952|FG003|Overall Study|PCR positive|0
2303797|NCT02641379|4002953|FG004|Overall Study|PCR positive|0
2303798|NCT02641379|4002954|FG005|Overall Study|PCR positive|0
2303799|NCT02641379|4002955|FG006|Overall Study|PCR positive|1
2303800|NCT02641379|4002956|FG007|Overall Study|PCR positive|0
2303801|NCT02641379|4002957|FG008|Overall Study|PCR positive|0
2303802|NCT02641379|4002958|FG009|Overall Study|PCR positive|0
2303803|NCT02641379|4002959|FG010|Overall Study|PCR positive|0
2303804|NCT02641392|4002991|FG000|Overall Study|Lost to Follow-up|0
2303805|NCT02641392|4002992|FG001|Overall Study|Lost to Follow-up|0
2303806|NCT02641392|4002993|FG002|Overall Study|Lost to Follow-up|2
2303807|NCT02641392|4002991|FG000|Overall Study|Withdrawal by Subject|0
2303808|NCT02641392|4002992|FG001|Overall Study|Withdrawal by Subject|0
2303809|NCT02641392|4002993|FG002|Overall Study|Withdrawal by Subject|17
2303810|NCT02641392|4002991|FG000|Overall Study|Adverse Event|0
2303811|NCT02641392|4002992|FG001|Overall Study|Adverse Event|1
2303812|NCT02641392|4002993|FG002|Overall Study|Adverse Event|25
2303813|NCT02641392|4002991|FG000|Overall Study|Study Terminated by Sponsor|4
2303814|NCT02641392|4002992|FG001|Overall Study|Study Terminated by Sponsor|12
2303815|NCT02641392|4002993|FG002|Overall Study|Study Terminated by Sponsor|144
2303816|NCT02641392|4002991|FG000|Overall Study|Lack of Efficacy|0
2303817|NCT02641392|4002992|FG001|Overall Study|Lack of Efficacy|0
2303818|NCT02641392|4002993|FG002|Overall Study|Lack of Efficacy|101
2303819|NCT02641392|4002991|FG000|Overall Study|Miscellaneous|0
2303820|NCT02641392|4002992|FG001|Overall Study|Miscellaneous|0
2303821|NCT02641392|4002993|FG002|Overall Study|Miscellaneous|3
2303822|NCT02641392|4002991|FG000|Overall Study|Death|0
2303823|NCT02641392|4002992|FG001|Overall Study|Death|0
2303824|NCT02641392|4002993|FG002|Overall Study|Death|1
2303825|NCT02641587|4003025|FG000|Confinement Period|Adverse Event|1
2303826|NCT02641587|4003026|FG001|Confinement Period|Adverse Event|0
2303827|NCT02641587|4003025|FG000|Confinement Period|Withdrawal by Subject|2
2303828|NCT02641587|4003026|FG001|Confinement Period|Withdrawal by Subject|1
2303829|NCT02641587|4003025|FG000|Ambulatory Period|Withdrawal by Subject|1
2303830|NCT02641587|4003026|FG001|Ambulatory Period|Withdrawal by Subject|0
2303831|NCT02641730|4003052|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
2303832|NCT02641730|4003053|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2303833|NCT02641730|4003054|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2303834|NCT02641730|4003055|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
2303835|NCT02641730|4003056|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
2303836|NCT02641730|4003052|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
2303837|NCT02641730|4003053|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1
2303838|NCT02641730|4003054|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1
2303839|NCT02641730|4003055|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5
2303840|NCT02641730|4003056|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4
2303841|NCT02641730|4003052|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
2303842|NCT02641730|4003053|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
2303843|NCT02641730|4003054|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
2303844|NCT02641730|4003055|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
2303845|NCT02641730|4003056|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
2303846|NCT02641730|4003052|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
2303847|NCT02641730|4003053|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0
2303848|NCT02641730|4003054|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
2303849|NCT02641730|4003055|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1
2303850|NCT02641730|4003056|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1
2303851|NCT02641730|4003052|FG000|After Controlled Period (Week 16 - 52)|Other|0
2303852|NCT02641730|4003053|FG001|After Controlled Period (Week 16 - 52)|Other|1
2303853|NCT02641730|4003054|FG002|After Controlled Period (Week 16 - 52)|Other|1
2303854|NCT02641730|4003055|FG003|After Controlled Period (Week 16 - 52)|Other|0
2303855|NCT02641730|4003056|FG004|After Controlled Period (Week 16 - 52)|Other|1
2303856|NCT02641730|4003052|FG000|Observational Period (Week 60 - Week 84)|Other|0
2303857|NCT02641730|4003053|FG001|Observational Period (Week 60 - Week 84)|Other|0
2303858|NCT02641730|4003054|FG002|Observational Period (Week 60 - Week 84)|Other|0
2069980|NCT00617890|3648414|FG001|Overall Study|Withdrawal by Subject|1
2069981|NCT00617890|3648415|FG002|Overall Study|Withdrawal by Subject|0
2069982|NCT00617890|3648416|FG003|Overall Study|Withdrawal by Subject|2
2069983|NCT00617890|3648413|FG000|Overall Study|Protocol Violation|2
2069984|NCT00617890|3648414|FG001|Overall Study|Protocol Violation|1
2069985|NCT00617890|3648415|FG002|Overall Study|Protocol Violation|0
2069986|NCT00617890|3648416|FG003|Overall Study|Protocol Violation|0
2069987|NCT00617890|3648413|FG000|Overall Study|Adverse Event|1
2069988|NCT00617890|3648414|FG001|Overall Study|Adverse Event|0
2069989|NCT00617890|3648415|FG002|Overall Study|Adverse Event|3
2069990|NCT00617890|3648416|FG003|Overall Study|Adverse Event|8
2069991|NCT00617890|3648413|FG000|Overall Study|Not treated|1
2069992|NCT00617890|3648414|FG001|Overall Study|Not treated|0
2069993|NCT00617890|3648415|FG002|Overall Study|Not treated|1
2069994|NCT00617890|3648416|FG003|Overall Study|Not treated|1
2069995|NCT00617903|3648431|FG000|Overall Study|Withdrawal by Subject|2
2069996|NCT00617903|3648432|FG001|Overall Study|Withdrawal by Subject|3
2069997|NCT00617903|3648431|FG000|Overall Study|Lost to Follow-up|1
2069998|NCT00617903|3648432|FG001|Overall Study|Lost to Follow-up|1
2069999|NCT00617903|3648431|FG000|Overall Study|Lack of Efficacy|0
2070000|NCT00617903|3648432|FG001|Overall Study|Lack of Efficacy|1
2070001|NCT00617903|3648431|FG000|Overall Study|Adverse Event|0
2070002|NCT00617903|3648432|FG001|Overall Study|Adverse Event|1
2070003|NCT00617903|3648431|FG000|Overall Study|noncompliance|0
2070004|NCT00617903|3648432|FG001|Overall Study|noncompliance|1
2070005|NCT00617929|3648438|FG000|Overall Study|Physician Decision|1
2070006|NCT00618072|3648469|FG000|Overall Study|Lost to Follow-up|2
2070007|NCT00618072|3648470|FG001|Overall Study|Lost to Follow-up|0
2070008|NCT00618072|3648471|FG002|Overall Study|Lost to Follow-up|3
2070009|NCT00618072|3648469|FG000|Overall Study|Physician Decision|0
2070010|NCT00618072|3648470|FG001|Overall Study|Physician Decision|1
2070011|NCT00618072|3648471|FG002|Overall Study|Physician Decision|1
2106296|NCT00864253|3699355|FG001|Overall Study|Physician Decision|15
2106297|NCT00864253|3699354|FG000|Overall Study|Protocol Violation|0
2106298|NCT00864253|3699355|FG001|Overall Study|Protocol Violation|2
2106299|NCT00864253|3699354|FG000|Overall Study|Lost to Follow-up|1
2106300|NCT00864253|3699355|FG001|Overall Study|Lost to Follow-up|1
2106301|NCT00864253|3699354|FG000|Overall Study|Withdrawal by Subject|18
2106302|NCT00864253|3699355|FG001|Overall Study|Withdrawal by Subject|18
2303859|NCT02641730|4003055|FG003|Observational Period (Week 60 - Week 84)|Other|0
2303860|NCT02641730|4003056|FG004|Observational Period (Week 60 - Week 84)|Other|1
2303861|NCT02642159|4003095|FG000|Overall Study|Randomized but not treated|1
2303862|NCT02642159|4003096|FG001|Overall Study|Randomized but not treated|0
2303863|NCT02642159|4003095|FG000|Overall Study|Adverse Event|10
2303864|NCT02642159|4003096|FG001|Overall Study|Adverse Event|4
2303865|NCT02642159|4003095|FG000|Overall Study|Withdrawal by Subject|9
2303866|NCT02642159|4003096|FG001|Overall Study|Withdrawal by Subject|1
2303867|NCT02642159|4003095|FG000|Overall Study|Poor compliance to study protocol|1
2303868|NCT02642159|4003096|FG001|Overall Study|Poor compliance to study protocol|0
2303869|NCT02642159|4003095|FG000|Overall Study|Other than specified above|10
2303870|NCT02642159|4003096|FG001|Overall Study|Other than specified above|3
2303871|NCT02642432|4003121|FG000|Overall Study|Adverse Event|2
2303872|NCT02642432|4003121|FG000|Overall Study|Withdrew Consent|1
2303873|NCT02642432|4003121|FG000|Overall Study|Lost to Follow-up|2
2303874|NCT02642432|4003121|FG000|Overall Study|Other|3
2303875|NCT02642614|4003142|FG000|Overall Study|Adverse Event|1
2303876|NCT02642614|4003143|FG001|Overall Study|Adverse Event|1
2303877|NCT02642614|4003144|FG002|Overall Study|Adverse Event|2
2303878|NCT02642614|4003145|FG003|Overall Study|Adverse Event|2
2303879|NCT02642614|4003142|FG000|Overall Study|Lost to Follow-up|1
2303880|NCT02642614|4003143|FG001|Overall Study|Lost to Follow-up|0
2303881|NCT02642614|4003144|FG002|Overall Study|Lost to Follow-up|0
2303882|NCT02642614|4003145|FG003|Overall Study|Lost to Follow-up|0
2303883|NCT02642614|4003142|FG000|Overall Study|Withdrawal by Subject|1
2303884|NCT02642614|4003143|FG001|Overall Study|Withdrawal by Subject|1
2303885|NCT02642614|4003144|FG002|Overall Study|Withdrawal by Subject|0
2303886|NCT02642614|4003145|FG003|Overall Study|Withdrawal by Subject|0
2303887|NCT02642653|4003165|FG000|Overall Study|Adverse Event|2
2303888|NCT02642653|4003166|FG001|Overall Study|Adverse Event|0
2303889|NCT02642679|4003172|FG000|Overall Study|Withdrawal by Subject|1
2303890|NCT02642679|4003172|FG000|Overall Study|Physician Decision|1
2303891|NCT02642679|4003172|FG000|Overall Study|Physician Decision|1
2303892|NCT02643082|4003206|FG000|Period 1|Adverse Event|1
2303893|NCT02643082|4003207|FG001|Period 1|Adverse Event|0
2303894|NCT02643251|4003234|FG000|Overall Study|Adverse Event|3
2106303|NCT00864253|3699354|FG000|Overall Study|Death|1
2106304|NCT00864253|3699355|FG001|Overall Study|Death|0
2106305|NCT00864253|3699354|FG000|Overall Study|Ongoing|2
2106306|NCT00864253|3699355|FG001|Overall Study|Ongoing|3
2106307|NCT00864253|3699354|FG000|Overall Study|Untreated|7
2106308|NCT00864253|3699355|FG001|Overall Study|Untreated|7
2106309|NCT00864513|3699376|FG000|Overall Study|Withdrawal by Subject|3
2106310|NCT00864682|3699408|FG000|Overall Study|Protocol Violation|2
2303895|NCT02643251|4003235|FG001|Overall Study|Adverse Event|1
2303896|NCT02643251|4003234|FG000|Overall Study|Withdrawal by Subject|2
2303897|NCT02643251|4003235|FG001|Overall Study|Withdrawal by Subject|0
2303898|NCT02643251|4003234|FG000|Overall Study|Lost to Follow-up|4
2070012|NCT00618371|3648488|FG000|Overall Study|Withdrawal by Subject|2
2070013|NCT00618410|3648493|FG000|Washout Period (2 Weeks)|Physician Decision|0
2070014|NCT00618410|3648494|FG001|Washout Period (2 Weeks)|Physician Decision|1
2070015|NCT00618449|3648511|FG000|Overall Study|Lost to Follow-up|98
2070016|NCT00618449|3648512|FG001|Overall Study|Lost to Follow-up|110
2070017|NCT00618514|3648520|FG000|Overall Study|Lost to Follow-up|11
2070018|NCT00618514|3648521|FG001|Overall Study|Lost to Follow-up|12
2070019|NCT00618514|3648522|FG002|Overall Study|Lost to Follow-up|4
2070020|NCT00618618|3648537|FG000|Overall Study|Patient Request|0
2070021|NCT00618618|3648538|FG001|Overall Study|Patient Request|0
2070022|NCT00618618|3648539|FG002|Overall Study|Patient Request|2
2070023|NCT00618618|3648540|FG003|Overall Study|Patient Request|0
2070024|NCT00618618|3648537|FG000|Overall Study|Inability to Complete Study Procedures|0
2070025|NCT00618618|3648538|FG001|Overall Study|Inability to Complete Study Procedures|1
2070026|NCT00618618|3648539|FG002|Overall Study|Inability to Complete Study Procedures|0
2070027|NCT00618618|3648540|FG003|Overall Study|Inability to Complete Study Procedures|0
2070028|NCT00618618|3648537|FG000|Overall Study|Lost to Follow-up|3
2070029|NCT00618618|3648538|FG001|Overall Study|Lost to Follow-up|0
2070030|NCT00618618|3648539|FG002|Overall Study|Lost to Follow-up|0
2070031|NCT00618618|3648540|FG003|Overall Study|Lost to Follow-up|1
2070032|NCT00618618|3648537|FG000|Overall Study|Non-compliance|1
2070033|NCT00618618|3648538|FG001|Overall Study|Non-compliance|1
2070034|NCT00618618|3648539|FG002|Overall Study|Non-compliance|0
2070035|NCT00618618|3648540|FG003|Overall Study|Non-compliance|0
2070036|NCT00618618|3648537|FG000|Overall Study|Did Not Meet Entry Criteria|0
2070037|NCT00618618|3648538|FG001|Overall Study|Did Not Meet Entry Criteria|0
2070038|NCT00618618|3648539|FG002|Overall Study|Did Not Meet Entry Criteria|1
2070039|NCT00618618|3648540|FG003|Overall Study|Did Not Meet Entry Criteria|0
2070040|NCT00618618|3648537|FG000|Overall Study|Death|0
2070041|NCT00618618|3648538|FG001|Overall Study|Death|1
2303899|NCT02643251|4003235|FG001|Overall Study|Lost to Follow-up|1
2303900|NCT02643251|4003234|FG000|Overall Study|Protocol Violation|1
2303901|NCT02643251|4003235|FG001|Overall Study|Protocol Violation|0
2303902|NCT02643251|4003234|FG000|Overall Study|PI Decision to terminate patient|1
2303903|NCT02643251|4003235|FG001|Overall Study|PI Decision to terminate patient|0
2303904|NCT02643355|4003243|FG000|Overall Study|Withdrawal by Subject|1
2303905|NCT02643355|4003244|FG001|Overall Study|Withdrawal by Subject|3
2303906|NCT02643355|4003243|FG000|Overall Study|Protocol Violation|0
2303907|NCT02643355|4003244|FG001|Overall Study|Protocol Violation|2
2303908|NCT02643394|4003252|FG000|Overall Study|Protocol Violation|4
2303909|NCT02643394|4003253|FG001|Overall Study|Protocol Violation|5
2303910|NCT02643472|4003271|FG000|Overall Study|Death|2
2303911|NCT02643472|4003272|FG001|Overall Study|Death|5
2303912|NCT02643472|4003271|FG000|Overall Study|Withdrawal by Subject|3
2303913|NCT02643472|4003272|FG001|Overall Study|Withdrawal by Subject|2
2303914|NCT02643472|4003271|FG000|Overall Study|Protocol Violation|0
2303915|NCT02643472|4003272|FG001|Overall Study|Protocol Violation|1
2303916|NCT02643472|4003271|FG000|Overall Study|Lost to Follow-up|22
2303917|NCT02643472|4003272|FG001|Overall Study|Lost to Follow-up|26
2303918|NCT02643628|4003292|FG000|Overall Study|Lost to Follow-up|1
2303919|NCT02643628|4003293|FG001|Overall Study|Lost to Follow-up|4
2303920|NCT02643628|4003292|FG000|Overall Study|Withdrawal by Subject|0
2303921|NCT02643628|4003293|FG001|Overall Study|Withdrawal by Subject|1
2303922|NCT02643628|4003292|FG000|Overall Study|Relocated out of state|0
2303923|NCT02643628|4003293|FG001|Overall Study|Relocated out of state|1
2303924|NCT02643693|4003301|FG000|Overall Study|Physician Decision|0
2303925|NCT02643693|4003302|FG001|Overall Study|Physician Decision|1
2303926|NCT02643693|4003303|FG002|Overall Study|Physician Decision|0
2303927|NCT02643693|4003304|FG003|Overall Study|Physician Decision|0
2303928|NCT02643693|4003305|FG004|Overall Study|Physician Decision|0
2303929|NCT02643693|4003306|FG005|Overall Study|Physician Decision|0
2303930|NCT02643693|4003301|FG000|Overall Study|Withdrawal by Subject|0
2303931|NCT02643693|4003302|FG001|Overall Study|Withdrawal by Subject|1
2303932|NCT02643693|4003303|FG002|Overall Study|Withdrawal by Subject|0
2303933|NCT02643693|4003304|FG003|Overall Study|Withdrawal by Subject|0
2303934|NCT02643693|4003305|FG004|Overall Study|Withdrawal by Subject|0
2303935|NCT02643693|4003306|FG005|Overall Study|Withdrawal by Subject|0
2303936|NCT02643693|4003301|FG000|Overall Study|Protocol Adherence Issues|2
2303937|NCT02643693|4003302|FG001|Overall Study|Protocol Adherence Issues|0
2303938|NCT02643693|4003303|FG002|Overall Study|Protocol Adherence Issues|1
2303939|NCT02643693|4003304|FG003|Overall Study|Protocol Adherence Issues|0
2303940|NCT02643693|4003305|FG004|Overall Study|Protocol Adherence Issues|0
2303941|NCT02643693|4003306|FG005|Overall Study|Protocol Adherence Issues|1
2303942|NCT02644096|4003343|FG000|Overall Study|Withdrawal by Subject|28
2303943|NCT02644096|4003344|FG001|Overall Study|Withdrawal by Subject|25
2303944|NCT02644109|4003352|FG000|Overall Study|Adverse Event|0
2303945|NCT02644109|4003353|FG001|Overall Study|Adverse Event|4
2070042|NCT00618618|3648539|FG002|Overall Study|Death|0
2070043|NCT00618618|3648540|FG003|Overall Study|Death|0
2070044|NCT00618722|3648555|FG000|Overall Study|Refusal of Treatment|0
2070045|NCT00618722|3648556|FG001|Overall Study|Refusal of Treatment|0
2070046|NCT00618722|3648557|FG002|Overall Study|Refusal of Treatment|1
2070047|NCT00618722|3648558|FG003|Overall Study|Refusal of Treatment|0
2303946|NCT02644122|4003359|FG000|Overall Study|Withdrawal by Subject|1
2070048|NCT00618722|3648555|FG000|Overall Study|Patient Request|1
2070049|NCT00618722|3648556|FG001|Overall Study|Patient Request|1
2070050|NCT00618722|3648557|FG002|Overall Study|Patient Request|1
2070051|NCT00618722|3648558|FG003|Overall Study|Patient Request|1
2070052|NCT00618722|3648555|FG000|Overall Study|Inability to Complete Study Procedure|0
2070053|NCT00618722|3648556|FG001|Overall Study|Inability to Complete Study Procedure|1
2070054|NCT00618722|3648557|FG002|Overall Study|Inability to Complete Study Procedure|0
2070055|NCT00618722|3648558|FG003|Overall Study|Inability to Complete Study Procedure|0
2070056|NCT00618722|3648555|FG000|Overall Study|Lost to Follow-up|2
2070057|NCT00618722|3648556|FG001|Overall Study|Lost to Follow-up|0
2070058|NCT00618722|3648557|FG002|Overall Study|Lost to Follow-up|0
2070059|NCT00618722|3648558|FG003|Overall Study|Lost to Follow-up|2
2070060|NCT00618722|3648555|FG000|Overall Study|Miscellaneous Reasons|0
2070061|NCT00618722|3648556|FG001|Overall Study|Miscellaneous Reasons|0
2070062|NCT00618722|3648557|FG002|Overall Study|Miscellaneous Reasons|1
2070063|NCT00618722|3648558|FG003|Overall Study|Miscellaneous Reasons|1
2070064|NCT00618748|3648571|FG000|Overall Study|Adverse Event|4
2070065|NCT00618748|3648572|FG001|Overall Study|Adverse Event|3
2070066|NCT00618748|3648573|FG002|Overall Study|Adverse Event|8
2070067|NCT00618748|3648571|FG000|Overall Study|Physician Decision|3
2070068|NCT00618748|3648572|FG001|Overall Study|Physician Decision|1
2070069|NCT00618748|3648573|FG002|Overall Study|Physician Decision|1
2070070|NCT00618748|3648571|FG000|Overall Study|Withdrawal by Subject|4
2070071|NCT00618748|3648572|FG001|Overall Study|Withdrawal by Subject|1
2303947|NCT02644343|4003381|FG000|Overall Study|Withdrawal by Subject|1
2303948|NCT02644356|4003385|FG000|Overall Study|Withdrawal by Subject|2
2303949|NCT02644668|4003392|FG000|Overall Study|Adverse Event|2
2303950|NCT02644668|4003393|FG001|Overall Study|Adverse Event|0
2303951|NCT02644668|4003394|FG002|Overall Study|Adverse Event|1
2303952|NCT02644668|4003392|FG000|Overall Study|Protocol Violation|0
2303953|NCT02644668|4003393|FG001|Overall Study|Protocol Violation|0
2303954|NCT02644668|4003394|FG002|Overall Study|Protocol Violation|1
2303955|NCT02644668|4003392|FG000|Overall Study|Withdrawal by Subject|0
2303956|NCT02644668|4003393|FG001|Overall Study|Withdrawal by Subject|0
2303957|NCT02644668|4003394|FG002|Overall Study|Withdrawal by Subject|1
2303958|NCT02645409|4003462|FG000|Overall Study|Withdrawal by Subject|3
2303959|NCT02645409|4003463|FG001|Overall Study|Withdrawal by Subject|0
2303960|NCT02645409|4003462|FG000|Overall Study|Physician Decision|1
2303961|NCT02645409|4003463|FG001|Overall Study|Physician Decision|0
2303962|NCT02646124|4003484|FG000|Overall Study|Lost to Follow-up|0
2303963|NCT02646124|4003485|FG001|Overall Study|Lost to Follow-up|2
2303964|NCT02646332|4003493|FG000|Overall Study|Lost to Follow-up|0
2303965|NCT02646332|4003494|FG001|Overall Study|Lost to Follow-up|3
2303966|NCT02646423|4003511|FG000|Overall Study|Adverse Event|5
2303967|NCT02646423|4003512|FG001|Overall Study|Adverse Event|7
2303968|NCT02646423|4003511|FG000|Overall Study|Ineligible|2
2303969|NCT02646423|4003512|FG001|Overall Study|Ineligible|1
2321671|NCT02962908|4036283|FG000|Overall Study|Protocol Violation|0
2321672|NCT02962908|4036284|FG001|Overall Study|Protocol Violation|1
2321673|NCT02962908|4036285|FG002|Overall Study|Protocol Violation|0
2321674|NCT02962908|4036286|FG003|Overall Study|Protocol Violation|0
2321675|NCT02962908|4036283|FG000|Overall Study|Physician Decision|0
2321676|NCT02962908|4036284|FG001|Overall Study|Physician Decision|1
2321677|NCT02962908|4036285|FG002|Overall Study|Physician Decision|0
2321678|NCT02962908|4036286|FG003|Overall Study|Physician Decision|0
2321679|NCT02962960|4036314|FG000|Overall Study|Withdrawal by Subject|1
2321680|NCT02962960|4036315|FG001|Overall Study|Withdrawal by Subject|1
2321681|NCT02962960|4036316|FG002|Overall Study|Withdrawal by Subject|0
2321682|NCT02962960|4036314|FG000|Overall Study|Adverse Event|1
2321683|NCT02962960|4036315|FG001|Overall Study|Adverse Event|1
2321684|NCT02962960|4036316|FG002|Overall Study|Adverse Event|0
2321685|NCT02962960|4036314|FG000|Overall Study|Protocol Violation|1
2321686|NCT02962960|4036315|FG001|Overall Study|Protocol Violation|0
2321687|NCT02962960|4036316|FG002|Overall Study|Protocol Violation|0
2321688|NCT02963311|4036326|FG000|Overall Study|Withdrawal by Subject|1
2321689|NCT02963311|4036326|FG000|Overall Study|Screen Failure|4
2321690|NCT02963441|4036361|FG000|Overall Study|Protocol violation or withdrawn|8
2321691|NCT02963441|4036361|FG000|Overall Study|Ungradeable by FPRC or IDx|40
2321692|NCT02963441|4036361|FG000|Overall Study|IDx-DR insufficient quality|33
2321693|NCT02963506|4036371|FG000|Double-Blind Period|Adverse Event|0
2321694|NCT02963506|4036372|FG001|Double-Blind Period|Adverse Event|0
2321695|NCT02963506|4036373|FG002|Double-Blind Period|Adverse Event|1
2321696|NCT02963506|4036374|FG003|Double-Blind Period|Adverse Event|0
2321697|NCT02963506|4036375|FG004|Double-Blind Period|Adverse Event|0
2321698|NCT02963506|4036376|FG005|Double-Blind Period|Adverse Event|0
2321699|NCT02963506|4036377|FG006|Double-Blind Period|Adverse Event|0
2321700|NCT02963506|4036378|FG007|Double-Blind Period|Adverse Event|0
2321701|NCT02963506|4036379|FG008|Double-Blind Period|Adverse Event|0
2321702|NCT02963506|4036380|FG009|Double-Blind Period|Adverse Event|0
2321703|NCT02963506|4036381|FG010|Double-Blind Period|Adverse Event|0
2070072|NCT00618748|3648573|FG002|Overall Study|Withdrawal by Subject|5
2070073|NCT00618774|3648583|FG000|Overall Study|Adverse Event|5
2070074|NCT00618774|3648584|FG001|Overall Study|Adverse Event|3
2321704|NCT02963506|4036382|FG011|Double-Blind Period|Adverse Event|0
2321705|NCT02963506|4036383|FG012|Double-Blind Period|Adverse Event|0
2321706|NCT02963506|4036371|FG000|Double-Blind Period|Death|0
2070075|NCT00618774|3648583|FG000|Overall Study|Withdrawal by Subject|1
2210390|NCT01649557|3849864|FG000|Overall Study|Met withdrawal criteria|4
2210391|NCT01649557|3849865|FG001|Overall Study|Met withdrawal criteria|0
2210392|NCT01649557|3849866|FG002|Overall Study|Met withdrawal criteria|0
2210393|NCT01649557|3849864|FG000|Overall Study|Physician Decision|8
2210394|NCT01649557|3849865|FG001|Overall Study|Physician Decision|2
2303970|NCT02646566|4003530|FG000|Overall Study|Lost to Follow-up|5
2303971|NCT02646566|4003531|FG001|Overall Study|Lost to Follow-up|4
2303972|NCT02646566|4003532|FG002|Overall Study|Lost to Follow-up|5
2303973|NCT02646566|4003530|FG000|Overall Study|Treatment failure|1
2303974|NCT02646566|4003531|FG001|Overall Study|Treatment failure|0
2303975|NCT02646566|4003532|FG002|Overall Study|Treatment failure|0
2303976|NCT02646618|4003542|FG000|Overall Study|Lost to Follow-up|10
2303977|NCT02646618|4003543|FG001|Overall Study|Lost to Follow-up|14
2303978|NCT02646891|4003587|FG000|Overall Study|Adverse Event|0
2303979|NCT02646891|4003588|FG001|Overall Study|Adverse Event|1
2303980|NCT02646891|4003589|FG002|Overall Study|Adverse Event|0
2303981|NCT02646891|4003590|FG003|Overall Study|Adverse Event|0
2303982|NCT02646891|4003591|FG004|Overall Study|Adverse Event|0
2303983|NCT02646891|4003592|FG005|Overall Study|Adverse Event|0
2303984|NCT02646891|4003593|FG006|Overall Study|Adverse Event|0
2303985|NCT02646891|4003594|FG007|Overall Study|Adverse Event|0
2303986|NCT02646891|4003595|FG008|Overall Study|Adverse Event|0
2303987|NCT02646891|4003596|FG009|Overall Study|Adverse Event|0
2303988|NCT02646891|4003587|FG000|Overall Study|Lost to Follow-up|0
2210395|NCT01649557|3849866|FG002|Overall Study|Physician Decision|1
2210396|NCT01649557|3849864|FG000|Overall Study|Withdrawal by Subject|15
2210397|NCT01649557|3849865|FG001|Overall Study|Withdrawal by Subject|5
2303989|NCT02646891|4003588|FG001|Overall Study|Lost to Follow-up|0
2303990|NCT02646891|4003589|FG002|Overall Study|Lost to Follow-up|0
2303991|NCT02646891|4003590|FG003|Overall Study|Lost to Follow-up|0
2303992|NCT02646891|4003591|FG004|Overall Study|Lost to Follow-up|0
2303993|NCT02646891|4003592|FG005|Overall Study|Lost to Follow-up|0
2303994|NCT02646891|4003593|FG006|Overall Study|Lost to Follow-up|2
2303995|NCT02646891|4003594|FG007|Overall Study|Lost to Follow-up|2
2303996|NCT02646891|4003595|FG008|Overall Study|Lost to Follow-up|2
2303997|NCT02646891|4003596|FG009|Overall Study|Lost to Follow-up|2
2303998|NCT02646891|4003587|FG000|Overall Study|Protocol Violation|0
2303999|NCT02646891|4003588|FG001|Overall Study|Protocol Violation|0
2304000|NCT02646891|4003589|FG002|Overall Study|Protocol Violation|0
2304001|NCT02646891|4003590|FG003|Overall Study|Protocol Violation|0
2304002|NCT02646891|4003591|FG004|Overall Study|Protocol Violation|0
2304003|NCT02646891|4003592|FG005|Overall Study|Protocol Violation|0
2304004|NCT02646891|4003593|FG006|Overall Study|Protocol Violation|1
2304005|NCT02646891|4003594|FG007|Overall Study|Protocol Violation|1
2304006|NCT02646891|4003595|FG008|Overall Study|Protocol Violation|0
2304007|NCT02646891|4003596|FG009|Overall Study|Protocol Violation|0
2304008|NCT02646891|4003587|FG000|Overall Study|Withdrawal by Subject|2
2304009|NCT02646891|4003588|FG001|Overall Study|Withdrawal by Subject|0
2304010|NCT02646891|4003589|FG002|Overall Study|Withdrawal by Subject|1
2304011|NCT02646891|4003590|FG003|Overall Study|Withdrawal by Subject|0
2304012|NCT02646891|4003591|FG004|Overall Study|Withdrawal by Subject|0
2304013|NCT02646891|4003592|FG005|Overall Study|Withdrawal by Subject|0
2304014|NCT02646891|4003593|FG006|Overall Study|Withdrawal by Subject|5
2304015|NCT02646891|4003594|FG007|Overall Study|Withdrawal by Subject|9
2304016|NCT02646891|4003595|FG008|Overall Study|Withdrawal by Subject|7
2304017|NCT02646891|4003596|FG009|Overall Study|Withdrawal by Subject|3
2304018|NCT02646891|4003587|FG000|Overall Study|Death|0
2304019|NCT02646891|4003588|FG001|Overall Study|Death|0
2304020|NCT02646891|4003589|FG002|Overall Study|Death|0
2304021|NCT02646891|4003590|FG003|Overall Study|Death|0
2304022|NCT02646891|4003591|FG004|Overall Study|Death|0
2304023|NCT02646891|4003592|FG005|Overall Study|Death|0
2304024|NCT02646891|4003593|FG006|Overall Study|Death|1
2304025|NCT02646891|4003594|FG007|Overall Study|Death|1
2304026|NCT02646891|4003595|FG008|Overall Study|Death|1
2304027|NCT02646891|4003596|FG009|Overall Study|Death|0
2304028|NCT02647281|4003662|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2304029|NCT02647281|4003663|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2304030|NCT02647281|4003664|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2304031|NCT02647281|4003665|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2304032|NCT02647281|4003666|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2304033|NCT02647281|4003667|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2304034|NCT02647281|4003668|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2304035|NCT02647281|4003669|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2304036|NCT02647281|4003670|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
2304037|NCT02647320|4003704|FG000|Overall Study|Adverse Event|0
2304038|NCT02647320|4003705|FG001|Overall Study|Adverse Event|1
2304039|NCT02647320|4003706|FG002|Overall Study|Adverse Event|3
2304040|NCT02647320|4003707|FG003|Overall Study|Adverse Event|2
2304041|NCT02647320|4003708|FG004|Overall Study|Adverse Event|1
2304042|NCT02647320|4003704|FG000|Overall Study|Protocol Violation|0
2304043|NCT02647320|4003705|FG001|Overall Study|Protocol Violation|0
2304044|NCT02647320|4003706|FG002|Overall Study|Protocol Violation|3
2304045|NCT02647320|4003707|FG003|Overall Study|Protocol Violation|0
2210398|NCT01649557|3849866|FG002|Overall Study|Withdrawal by Subject|4
2210399|NCT01649557|3849864|FG000|Overall Study|Protocol deviation|0
2210400|NCT01649557|3849865|FG001|Overall Study|Protocol deviation|2
2210401|NCT01649557|3849866|FG002|Overall Study|Protocol deviation|0
2210402|NCT01649557|3849864|FG000|Overall Study|Lack of Efficacy|5
2210403|NCT01649557|3849865|FG001|Overall Study|Lack of Efficacy|0
2210404|NCT01649557|3849866|FG002|Overall Study|Lack of Efficacy|0
2210405|NCT01649765|3849894|FG000|Overall Study|Adverse Event|5
2210406|NCT01649765|3849895|FG001|Overall Study|Adverse Event|3
2210407|NCT01649765|3849894|FG000|Overall Study|Lack of Efficacy|1
2210408|NCT01649765|3849895|FG001|Overall Study|Lack of Efficacy|1
2304046|NCT02647320|4003708|FG004|Overall Study|Protocol Violation|0
2070076|NCT00618774|3648584|FG001|Overall Study|Withdrawal by Subject|0
2070077|NCT00618787|3648592|FG000|Overall Study|Adverse Event|0
2070078|NCT00618787|3648593|FG001|Overall Study|Adverse Event|1
2070079|NCT00618787|3648592|FG000|Overall Study|Withdrawal by Subject|2
2070080|NCT00618787|3648593|FG001|Overall Study|Withdrawal by Subject|1
2070081|NCT00618787|3648592|FG000|Overall Study|Lost to Follow-up|1
2070082|NCT00618787|3648593|FG001|Overall Study|Lost to Follow-up|0
2070083|NCT00618813|3648599|FG000|Overall Study|Lack of Efficacy|1
2070084|NCT00618813|3648599|FG000|Overall Study|Physician Decision|2
2070085|NCT00618813|3648599|FG000|Overall Study|Withdrawal by Subject|1
2070086|NCT00618826|3648603|FG000|Overall Study|Adverse Event|1
2070087|NCT00618956|3648630|FG000|Overall Study|Adverse Event|10
2070088|NCT00618956|3648631|FG001|Overall Study|Adverse Event|34
2070089|NCT00618956|3648630|FG000|Overall Study|Lack of Efficacy|2
2070090|NCT00618956|3648631|FG001|Overall Study|Lack of Efficacy|1
2070091|NCT00618956|3648630|FG000|Overall Study|Withdrawal by Subject|5
2070092|NCT00618956|3648631|FG001|Overall Study|Withdrawal by Subject|7
2070093|NCT00618956|3648630|FG000|Overall Study|Lost to Follow-up|4
2070094|NCT00618956|3648631|FG001|Overall Study|Lost to Follow-up|5
2070095|NCT00618956|3648630|FG000|Overall Study|Protocol Violation|2
2304047|NCT02647320|4003704|FG000|Overall Study|Withdrawal by Subject|7
2304048|NCT02647320|4003705|FG001|Overall Study|Withdrawal by Subject|4
2304049|NCT02647320|4003706|FG002|Overall Study|Withdrawal by Subject|2
2304050|NCT02647320|4003707|FG003|Overall Study|Withdrawal by Subject|2
2304051|NCT02647320|4003708|FG004|Overall Study|Withdrawal by Subject|7
2304052|NCT02647320|4003704|FG000|Overall Study|Persistent hyperglycemia|0
2304053|NCT02647320|4003705|FG001|Overall Study|Persistent hyperglycemia|1
2304054|NCT02647320|4003706|FG002|Overall Study|Persistent hyperglycemia|1
2304055|NCT02647320|4003707|FG003|Overall Study|Persistent hyperglycemia|1
2304056|NCT02647320|4003708|FG004|Overall Study|Persistent hyperglycemia|1
2304057|NCT02647320|4003704|FG000|Overall Study|Study terminated by sponsor|1
2304058|NCT02647320|4003705|FG001|Overall Study|Study terminated by sponsor|1
2304059|NCT02647320|4003706|FG002|Overall Study|Study terminated by sponsor|1
2304060|NCT02647320|4003707|FG003|Overall Study|Study terminated by sponsor|1
2304061|NCT02647320|4003708|FG004|Overall Study|Study terminated by sponsor|2
2304062|NCT02647320|4003704|FG000|Overall Study|Reason not provided|0
2304063|NCT02647320|4003705|FG001|Overall Study|Reason not provided|0
2304064|NCT02647320|4003706|FG002|Overall Study|Reason not provided|1
2304065|NCT02647320|4003707|FG003|Overall Study|Reason not provided|0
2304066|NCT02647320|4003708|FG004|Overall Study|Reason not provided|2
2304067|NCT02647320|4003704|FG000|Overall Study|Lost to Follow-up|1
2304068|NCT02647320|4003705|FG001|Overall Study|Lost to Follow-up|1
2304069|NCT02647320|4003706|FG002|Overall Study|Lost to Follow-up|0
2304070|NCT02647320|4003707|FG003|Overall Study|Lost to Follow-up|0
2304071|NCT02647320|4003708|FG004|Overall Study|Lost to Follow-up|0
2304072|NCT02647320|4003704|FG000|Overall Study|Develop anemia|1
2304073|NCT02647320|4003705|FG001|Overall Study|Develop anemia|0
2304074|NCT02647320|4003706|FG002|Overall Study|Develop anemia|0
2304075|NCT02647320|4003707|FG003|Overall Study|Develop anemia|0
2304076|NCT02647320|4003708|FG004|Overall Study|Develop anemia|0
2304077|NCT02647320|4003704|FG000|Overall Study|Lack of Efficacy|0
2304078|NCT02647320|4003705|FG001|Overall Study|Lack of Efficacy|0
2304079|NCT02647320|4003706|FG002|Overall Study|Lack of Efficacy|0
2304080|NCT02647320|4003707|FG003|Overall Study|Lack of Efficacy|1
2304081|NCT02647320|4003708|FG004|Overall Study|Lack of Efficacy|0
2304082|NCT02647320|4003704|FG000|Overall Study|Disposition Missing Due to Fire at Site|2
2304083|NCT02647320|4003705|FG001|Overall Study|Disposition Missing Due to Fire at Site|3
2304084|NCT02647320|4003706|FG002|Overall Study|Disposition Missing Due to Fire at Site|4
2304085|NCT02647320|4003707|FG003|Overall Study|Disposition Missing Due to Fire at Site|3
2304086|NCT02647320|4003708|FG004|Overall Study|Disposition Missing Due to Fire at Site|4
2304087|NCT02647645|4003728|FG000|Overall Study|Lost to Follow-up|2
2304088|NCT02647645|4003729|FG001|Overall Study|Lost to Follow-up|1
2304089|NCT02647658|4003737|FG000|Overall Study|Consent refusal|15
2304090|NCT02647658|4003738|FG001|Overall Study|Consent refusal|24
2304091|NCT02647788|4003746|FG000|Overall Study|Lost to Follow-up|13
2304092|NCT02647788|4003747|FG001|Overall Study|Lost to Follow-up|11
2304093|NCT02647788|4003746|FG000|Overall Study|Did not want opiate|0
2304094|NCT02647788|4003747|FG001|Overall Study|Did not want opiate|1
2070096|NCT00618956|3648631|FG001|Overall Study|Protocol Violation|2
2070097|NCT00618956|3648630|FG000|Overall Study|did not meet criteria, non-compliance|2
2070098|NCT00618956|3648631|FG001|Overall Study|did not meet criteria, non-compliance|1
2070099|NCT00618982|3648643|FG000|Overall Study|Adverse Event|23
2070100|NCT00618982|3648643|FG000|Overall Study|Withdrawal by Subject|1
2070101|NCT00618982|3648643|FG000|Overall Study|Protocol Violation|1
2070102|NCT00618982|3648643|FG000|Overall Study|ongoing, still treated with study med.|25
2070103|NCT00618995|3648650|FG000|Period 1|Adverse Event|0
2070104|NCT00618995|3648651|FG001|Period 1|Adverse Event|0
2070105|NCT00618995|3648652|FG002|Period 1|Adverse Event|1
2070106|NCT00618995|3648653|FG003|Period 1|Adverse Event|0
2070107|NCT00618995|3648650|FG000|Period 1|Protocol Violation|0
2070108|NCT00618995|3648651|FG001|Period 1|Protocol Violation|1
2070109|NCT00618995|3648652|FG002|Period 1|Protocol Violation|1
2070110|NCT00618995|3648653|FG003|Period 1|Protocol Violation|0
2210409|NCT01649765|3849894|FG000|Overall Study|Physician Decision|0
2210410|NCT01649765|3849895|FG001|Overall Study|Physician Decision|3
2210411|NCT01649765|3849894|FG000|Overall Study|Protocol Violation|1
2304095|NCT02647788|4003746|FG000|Overall Study|Withdrawal by Subject|1
2304096|NCT02647788|4003747|FG001|Overall Study|Withdrawal by Subject|0
2304097|NCT02647788|4003746|FG000|Overall Study|Felt itchy with assigned medication|1
2304098|NCT02647788|4003747|FG001|Overall Study|Felt itchy with assigned medication|0
2304099|NCT02647788|4003746|FG000|Overall Study|Felt nauseous with assigned medication|1
2304100|NCT02647788|4003747|FG001|Overall Study|Felt nauseous with assigned medication|1
2304101|NCT02647866|4003758|FG000|Overall Study|Adverse Event|0
2304102|NCT02647866|4003759|FG001|Overall Study|Adverse Event|0
2304103|NCT02647866|4003760|FG002|Overall Study|Adverse Event|2
2304104|NCT02647866|4003761|FG003|Overall Study|Adverse Event|2
2304105|NCT02647866|4003762|FG004|Overall Study|Adverse Event|1
2304106|NCT02647866|4003758|FG000|Overall Study|Disease Worsening|3
2304107|NCT02647866|4003759|FG001|Overall Study|Disease Worsening|1
2304108|NCT02647866|4003760|FG002|Overall Study|Disease Worsening|0
2304109|NCT02647866|4003761|FG003|Overall Study|Disease Worsening|0
2304110|NCT02647866|4003762|FG004|Overall Study|Disease Worsening|1
2304111|NCT02647866|4003758|FG000|Overall Study|Withdrawal by Subject|1
2304112|NCT02647866|4003759|FG001|Overall Study|Withdrawal by Subject|1
2304113|NCT02647866|4003760|FG002|Overall Study|Withdrawal by Subject|2
2304114|NCT02647866|4003761|FG003|Overall Study|Withdrawal by Subject|4
2304115|NCT02647866|4003762|FG004|Overall Study|Withdrawal by Subject|4
2304116|NCT02647866|4003758|FG000|Overall Study|Physician Decision|0
2304117|NCT02647866|4003759|FG001|Overall Study|Physician Decision|1
2304118|NCT02647866|4003760|FG002|Overall Study|Physician Decision|1
2304119|NCT02647866|4003761|FG003|Overall Study|Physician Decision|0
2304120|NCT02647866|4003762|FG004|Overall Study|Physician Decision|2
2304121|NCT02647866|4003758|FG000|Overall Study|Death|0
2304122|NCT02647866|4003759|FG001|Overall Study|Death|1
2304123|NCT02647866|4003760|FG002|Overall Study|Death|0
2304124|NCT02647866|4003761|FG003|Overall Study|Death|0
2304125|NCT02647866|4003762|FG004|Overall Study|Death|0
2304126|NCT02647866|4003758|FG000|Overall Study|Subject moved to different country|1
2304127|NCT02647866|4003759|FG001|Overall Study|Subject moved to different country|0
2304128|NCT02647866|4003760|FG002|Overall Study|Subject moved to different country|0
2304129|NCT02647866|4003761|FG003|Overall Study|Subject moved to different country|0
2304130|NCT02647866|4003762|FG004|Overall Study|Subject moved to different country|0
2304131|NCT02647905|4003782|FG000|Overall Study|Lost to Follow-up|1
2304132|NCT02647905|4003782|FG000|Overall Study|Withdrawal by Subject|2
2304133|NCT02647944|4003788|FG000|Overall Study|Withdrawal by Subject|0
2304134|NCT02647944|4003789|FG001|Overall Study|Withdrawal by Subject|3
2304135|NCT02647944|4003788|FG000|Overall Study|Adverse Event|2
2304136|NCT02647944|4003789|FG001|Overall Study|Adverse Event|0
2304137|NCT02648204|4003812|FG000|Overall Study|Withdrawal by Subject|12
2304138|NCT02648204|4003813|FG001|Overall Study|Withdrawal by Subject|8
2304139|NCT02648204|4003814|FG002|Overall Study|Withdrawal by Subject|2
2304140|NCT02648204|4003815|FG003|Overall Study|Withdrawal by Subject|6
2304141|NCT02648204|4003812|FG000|Overall Study|Lost to Follow-up|5
2210412|NCT01649765|3849895|FG001|Overall Study|Protocol Violation|0
2210413|NCT01649765|3849894|FG000|Overall Study|Withdrawal by Subject|2
2210414|NCT01649765|3849895|FG001|Overall Study|Withdrawal by Subject|1
2210415|NCT01649791|3849902|FG000|Overall Study|Disease Progression|2
2210416|NCT01649791|3849902|FG000|Overall Study|Adverse Event|1
2210417|NCT01649804|3849906|FG000|Overall Study|Administrative/Other|8
2210418|NCT01649856|3849912|FG000|Overall Study|Withdrawal by Subject|14
2210419|NCT01649856|3849913|FG001|Overall Study|Withdrawal by Subject|14
2210420|NCT01649856|3849912|FG000|Overall Study|Protocol Violation|4
2210421|NCT01649856|3849913|FG001|Overall Study|Protocol Violation|4
2210422|NCT01649856|3849912|FG000|Overall Study|Treatment Failure|1
2304142|NCT02648204|4003813|FG001|Overall Study|Lost to Follow-up|8
2304143|NCT02648204|4003814|FG002|Overall Study|Lost to Follow-up|4
2304144|NCT02648204|4003815|FG003|Overall Study|Lost to Follow-up|6
2304145|NCT02648204|4003812|FG000|Overall Study|Missing follow-up information|4
2304146|NCT02648204|4003813|FG001|Overall Study|Missing follow-up information|4
2304147|NCT02648204|4003814|FG002|Overall Study|Missing follow-up information|4
2304148|NCT02648204|4003815|FG003|Overall Study|Missing follow-up information|2
2304149|NCT02648204|4003812|FG000|Overall Study|Death|1
2304150|NCT02648204|4003813|FG001|Overall Study|Death|1
2304151|NCT02648204|4003814|FG002|Overall Study|Death|2
2070111|NCT00618995|3648650|FG000|Period 2|Protocol Violation|0
2070112|NCT00618995|3648651|FG001|Period 2|Protocol Violation|0
2070113|NCT00618995|3648652|FG002|Period 2|Protocol Violation|1
2070114|NCT00618995|3648653|FG003|Period 2|Protocol Violation|0
2070115|NCT00618995|3648650|FG000|Period 4|Adverse Event|1
2070116|NCT00618995|3648651|FG001|Period 4|Adverse Event|0
2070117|NCT00618995|3648652|FG002|Period 4|Adverse Event|0
2070118|NCT00618995|3648653|FG003|Period 4|Adverse Event|0
2070119|NCT00619099|3648681|FG000|Overall Study|Progressive Disease|7
2070120|NCT00619099|3648682|FG001|Overall Study|Progressive Disease|5
2070121|NCT00619099|3648681|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2
2070122|NCT00619099|3648682|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1
2070123|NCT00619099|3648681|FG000|Overall Study|Adverse Event|4
2070124|NCT00619099|3648682|FG001|Overall Study|Adverse Event|3
2070125|NCT00619099|3648681|FG000|Overall Study|Emergence of Clinically Significant Lab|1
2070126|NCT00619099|3648682|FG001|Overall Study|Emergence of Clinically Significant Lab|2
2070127|NCT00619099|3648681|FG000|Overall Study|Withdrawal by Subject|10
2070128|NCT00619099|3648682|FG001|Overall Study|Withdrawal by Subject|2
2070129|NCT00619099|3648681|FG000|Overall Study|Physician Decision|9
2070130|NCT00619099|3648682|FG001|Overall Study|Physician Decision|6
2070131|NCT00619112|3648690|FG000|Overall Study|Adverse Event|1
2070132|NCT00619112|3648691|FG001|Overall Study|Adverse Event|2
2070133|NCT00619177|3648700|FG000|Overall Study|Adverse Event|18
2070134|NCT00619177|3648700|FG000|Overall Study|Lost to Follow-up|2
2070135|NCT00619177|3648700|FG000|Overall Study|Lack of Efficacy|1
2070136|NCT00619177|3648700|FG000|Overall Study|Missing termination information|481
2070137|NCT00619177|3648700|FG000|Overall Study|Not specified reasons|6
2070138|NCT00619229|3648715|FG000|Overall Study|Withdrawal by Subject|1
2070139|NCT00619229|3648716|FG001|Overall Study|Withdrawal by Subject|1
2070140|NCT00619229|3648715|FG000|Overall Study|Lost to Follow-up|1
2070141|NCT00619229|3648716|FG001|Overall Study|Lost to Follow-up|0
2070142|NCT00619229|3648715|FG000|Overall Study|Termination of the Study by the Sponsor|1
2070143|NCT00619229|3648716|FG001|Overall Study|Termination of the Study by the Sponsor|1
2070144|NCT00619229|3648715|FG000|Overall Study|Investigator planned Cataract Operation|1
2070145|NCT00619229|3648716|FG001|Overall Study|Investigator planned Cataract Operation|0
2070146|NCT00619307|3648733|FG000|Overall Study|Adverse Event|0
2070147|NCT00619307|3648734|FG001|Overall Study|Adverse Event|1
2070148|NCT00619307|3648733|FG000|Overall Study|Lost to Follow-up|0
2070149|NCT00619307|3648734|FG001|Overall Study|Lost to Follow-up|1
2070150|NCT00619307|3648733|FG000|Overall Study|Protocol Violation|3
2070151|NCT00619307|3648734|FG001|Overall Study|Protocol Violation|0
2070152|NCT00619307|3648733|FG000|Overall Study|Withdrew consent|1
2070153|NCT00619307|3648734|FG001|Overall Study|Withdrew consent|0
2070154|NCT00619307|3648733|FG000|Overall Study|Severe migraine|0
2070155|NCT00619307|3648734|FG001|Overall Study|Severe migraine|1
2070156|NCT00619307|3648733|FG000|Overall Study|MS attack plus steroids|0
2070157|NCT00619307|3648734|FG001|Overall Study|MS attack plus steroids|1
2070158|NCT00619359|3648742|FG000|Overall Study|Adverse Event|32
2070159|NCT00619359|3648743|FG001|Overall Study|Adverse Event|36
2070160|NCT00619359|3648742|FG000|Overall Study|Lost to Follow-up|12
2070161|NCT00619359|3648743|FG001|Overall Study|Lost to Follow-up|16
2070162|NCT00619359|3648742|FG000|Overall Study|Physician Decision|0
2070163|NCT00619359|3648743|FG001|Overall Study|Physician Decision|7
2070164|NCT00619359|3648742|FG000|Overall Study|Protocol Violation|1
2070165|NCT00619359|3648743|FG001|Overall Study|Protocol Violation|1
2070166|NCT00619359|3648742|FG000|Overall Study|Withdrawal by Subject|19
2070167|NCT00619359|3648743|FG001|Overall Study|Withdrawal by Subject|20
2070168|NCT00619359|3648742|FG000|Overall Study|Progressive Disease|3
2070169|NCT00619359|3648743|FG001|Overall Study|Progressive Disease|1
2070170|NCT00619385|3648752|FG000|Overall Study|Adverse Event|0
2070171|NCT00619385|3648753|FG001|Overall Study|Adverse Event|0
2070172|NCT00619385|3648754|FG002|Overall Study|Adverse Event|3
2070173|NCT00619385|3648752|FG000|Overall Study|Other|1
2070174|NCT00619385|3648753|FG001|Overall Study|Other|2
2070175|NCT00619385|3648754|FG002|Overall Study|Other|1
2070176|NCT00619476|3648769|FG000|Overall Study|Adverse Event|12
2070177|NCT00619476|3648770|FG001|Overall Study|Adverse Event|6
2070178|NCT00619476|3648771|FG002|Overall Study|Adverse Event|12
2070179|NCT00619476|3648772|FG003|Overall Study|Adverse Event|16
2070180|NCT00619476|3648769|FG000|Overall Study|Lack of Efficacy|6
2070181|NCT00619476|3648770|FG001|Overall Study|Lack of Efficacy|1
2070182|NCT00619476|3648771|FG002|Overall Study|Lack of Efficacy|1
2070183|NCT00619476|3648772|FG003|Overall Study|Lack of Efficacy|4
2070184|NCT00619476|3648769|FG000|Overall Study|Protocol Violation|5
2070185|NCT00619476|3648770|FG001|Overall Study|Protocol Violation|4
2070186|NCT00619476|3648771|FG002|Overall Study|Protocol Violation|4
2070187|NCT00619476|3648772|FG003|Overall Study|Protocol Violation|9
2070188|NCT00619476|3648769|FG000|Overall Study|Lost to Follow-up|1
2070189|NCT00619476|3648770|FG001|Overall Study|Lost to Follow-up|2
2070190|NCT00619476|3648771|FG002|Overall Study|Lost to Follow-up|0
2070191|NCT00619476|3648772|FG003|Overall Study|Lost to Follow-up|1
2070192|NCT00619476|3648769|FG000|Overall Study|Investigator Discretion|2
2070193|NCT00619476|3648770|FG001|Overall Study|Investigator Discretion|2
2070194|NCT00619476|3648771|FG002|Overall Study|Investigator Discretion|2
2070195|NCT00619476|3648772|FG003|Overall Study|Investigator Discretion|0
2070196|NCT00619476|3648769|FG000|Overall Study|Withdrawal by Subject|5
2070197|NCT00619476|3648770|FG001|Overall Study|Withdrawal by Subject|7
2070198|NCT00619476|3648771|FG002|Overall Study|Withdrawal by Subject|5
2070199|NCT00619476|3648772|FG003|Overall Study|Withdrawal by Subject|4
2070200|NCT00619489|3648784|FG000|Overall Study|Adverse Event|0
2070201|NCT00619489|3648785|FG001|Overall Study|Adverse Event|7
2070202|NCT00619489|3648784|FG000|Overall Study|Withdrawal by Subject|1
2070203|NCT00619489|3648785|FG001|Overall Study|Withdrawal by Subject|1
2070204|NCT00619489|3648784|FG000|Overall Study|Lack of Efficacy|0
2070205|NCT00619489|3648785|FG001|Overall Study|Lack of Efficacy|11
2070206|NCT00619489|3648784|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22
2070207|NCT00619489|3648785|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15
2070208|NCT00619502|3648793|FG000|Overall Study|Lost to Follow-up|8
2070209|NCT00619502|3648794|FG001|Overall Study|Lost to Follow-up|10
2070210|NCT00619619|3648810|FG000|Overall Study|Physician Decision|0
2070211|NCT00619619|3648811|FG001|Overall Study|Physician Decision|0
2070212|NCT00619619|3648812|FG002|Overall Study|Physician Decision|1
2070213|NCT00619619|3648813|FG003|Overall Study|Physician Decision|0
2070214|NCT00619619|3648814|FG004|Overall Study|Physician Decision|0
2070215|NCT00619619|3648815|FG005|Overall Study|Physician Decision|0
2070216|NCT00619619|3648816|FG006|Overall Study|Physician Decision|0
2070217|NCT00619619|3648817|FG007|Overall Study|Physician Decision|0
2070218|NCT00619619|3648810|FG000|Overall Study|Protocol Violation|0
2070219|NCT00619619|3648811|FG001|Overall Study|Protocol Violation|0
2070220|NCT00619619|3648812|FG002|Overall Study|Protocol Violation|0
2070221|NCT00619619|3648813|FG003|Overall Study|Protocol Violation|1
2070222|NCT00619619|3648814|FG004|Overall Study|Protocol Violation|0
2070223|NCT00619619|3648815|FG005|Overall Study|Protocol Violation|0
2070224|NCT00619619|3648816|FG006|Overall Study|Protocol Violation|1
2070225|NCT00619619|3648817|FG007|Overall Study|Protocol Violation|1
2070226|NCT00619619|3648810|FG000|Overall Study|Adverse Event|0
2070227|NCT00619619|3648811|FG001|Overall Study|Adverse Event|0
2070228|NCT00619619|3648812|FG002|Overall Study|Adverse Event|0
2070229|NCT00619619|3648813|FG003|Overall Study|Adverse Event|0
2070230|NCT00619619|3648814|FG004|Overall Study|Adverse Event|2
2070231|NCT00619619|3648815|FG005|Overall Study|Adverse Event|0
2070232|NCT00619619|3648816|FG006|Overall Study|Adverse Event|0
2070233|NCT00619619|3648817|FG007|Overall Study|Adverse Event|2
2070234|NCT00619645|3648838|FG000|Overall Study|Adverse Event|1
2070235|NCT00619801|3648862|FG000|Overall Study|Lack of Efficacy|0
2070236|NCT00619801|3648863|FG001|Overall Study|Lack of Efficacy|1
2070237|NCT00619801|3648862|FG000|Overall Study|Withdrawal by Subject|1
2070238|NCT00619801|3648863|FG001|Overall Study|Withdrawal by Subject|1
2070239|NCT00619801|3648862|FG000|Overall Study|Loss of efficacy|0
2070240|NCT00619801|3648863|FG001|Overall Study|Loss of efficacy|1
2070241|NCT00619827|3648871|FG000|Overall Study|Adverse Event|1
2070242|NCT00619827|3648872|FG001|Overall Study|Adverse Event|2
2070243|NCT00619827|3648871|FG000|Overall Study|Withdrawal by Subject|2
2070244|NCT00619827|3648872|FG001|Overall Study|Withdrawal by Subject|2
2070245|NCT00619866|3648881|FG000|Weeks 1 - 12|Adverse Event|0
2070246|NCT00619866|3648882|FG001|Weeks 1 - 12|Adverse Event|1
2070247|NCT00619866|3648883|FG002|Weeks 1 - 12|Adverse Event|2
2070248|NCT00619866|3648884|FG003|Weeks 1 - 12|Adverse Event|0
2070249|NCT00619866|3648885|FG004|Weeks 1 - 12|Adverse Event|0
2070250|NCT00619866|3648881|FG000|Weeks 1 - 12|Non-compliance|0
2070251|NCT00619866|3648882|FG001|Weeks 1 - 12|Non-compliance|0
2070252|NCT00619866|3648883|FG002|Weeks 1 - 12|Non-compliance|1
2070253|NCT00619866|3648884|FG003|Weeks 1 - 12|Non-compliance|0
2070254|NCT00619866|3648885|FG004|Weeks 1 - 12|Non-compliance|0
2070255|NCT00619866|3648881|FG000|Weeks 1 - 12|Withdrawal by Subject|7
2070256|NCT00619866|3648882|FG001|Weeks 1 - 12|Withdrawal by Subject|2
2070257|NCT00619866|3648883|FG002|Weeks 1 - 12|Withdrawal by Subject|4
2070258|NCT00619866|3648884|FG003|Weeks 1 - 12|Withdrawal by Subject|0
2070259|NCT00619866|3648885|FG004|Weeks 1 - 12|Withdrawal by Subject|0
2070260|NCT00619866|3648881|FG000|Weeks 1 - 12|Lack of Efficacy|3
2070261|NCT00619866|3648882|FG001|Weeks 1 - 12|Lack of Efficacy|2
2070262|NCT00619866|3648883|FG002|Weeks 1 - 12|Lack of Efficacy|1
2070263|NCT00619866|3648884|FG003|Weeks 1 - 12|Lack of Efficacy|0
2070264|NCT00619866|3648885|FG004|Weeks 1 - 12|Lack of Efficacy|0
2070265|NCT00619866|3648881|FG000|Weeks 1 - 12|Lost to Follow-up|4
2070266|NCT00619866|3648882|FG001|Weeks 1 - 12|Lost to Follow-up|0
2070267|NCT00619866|3648883|FG002|Weeks 1 - 12|Lost to Follow-up|2
2070268|NCT00619866|3648884|FG003|Weeks 1 - 12|Lost to Follow-up|0
2070269|NCT00619866|3648885|FG004|Weeks 1 - 12|Lost to Follow-up|0
2070270|NCT00619866|3648881|FG000|Weeks 1 - 12|Sponsor Decision|0
2070271|NCT00619866|3648882|FG001|Weeks 1 - 12|Sponsor Decision|1
2070272|NCT00619866|3648883|FG002|Weeks 1 - 12|Sponsor Decision|0
2070273|NCT00619866|3648884|FG003|Weeks 1 - 12|Sponsor Decision|0
2070274|NCT00619866|3648885|FG004|Weeks 1 - 12|Sponsor Decision|0
2070275|NCT00619866|3648881|FG000|Weeks 13 - 24|Adverse Event|0
2070276|NCT00619866|3648882|FG001|Weeks 13 - 24|Adverse Event|0
2070277|NCT00619866|3648883|FG002|Weeks 13 - 24|Adverse Event|2
2070278|NCT00619866|3648884|FG003|Weeks 13 - 24|Adverse Event|1
2070279|NCT00619866|3648885|FG004|Weeks 13 - 24|Adverse Event|0
2070280|NCT00619866|3648881|FG000|Weeks 13 - 24|Protocol Deviation|0
2070281|NCT00619866|3648882|FG001|Weeks 13 - 24|Protocol Deviation|0
2070282|NCT00619866|3648883|FG002|Weeks 13 - 24|Protocol Deviation|0
2070283|NCT00619866|3648884|FG003|Weeks 13 - 24|Protocol Deviation|1
2070284|NCT00619866|3648885|FG004|Weeks 13 - 24|Protocol Deviation|0
2070285|NCT00619866|3648881|FG000|Weeks 13 - 24|Withdrawal by Subject|0
2070286|NCT00619866|3648882|FG001|Weeks 13 - 24|Withdrawal by Subject|3
2070287|NCT00619866|3648883|FG002|Weeks 13 - 24|Withdrawal by Subject|2
2070288|NCT00619866|3648884|FG003|Weeks 13 - 24|Withdrawal by Subject|2
2070289|NCT00619866|3648885|FG004|Weeks 13 - 24|Withdrawal by Subject|2
2070290|NCT00619866|3648881|FG000|Weeks 13 - 24|Non-compliance|0
2070291|NCT00619866|3648882|FG001|Weeks 13 - 24|Non-compliance|1
2070292|NCT00619866|3648883|FG002|Weeks 13 - 24|Non-compliance|1
2070293|NCT00619866|3648884|FG003|Weeks 13 - 24|Non-compliance|0
2070294|NCT00619866|3648885|FG004|Weeks 13 - 24|Non-compliance|0
2070295|NCT00619866|3648881|FG000|Weeks 13 - 24|Lost to Follow-up|0
2070296|NCT00619866|3648882|FG001|Weeks 13 - 24|Lost to Follow-up|3
2070297|NCT00619866|3648883|FG002|Weeks 13 - 24|Lost to Follow-up|0
2070298|NCT00619866|3648884|FG003|Weeks 13 - 24|Lost to Follow-up|0
2070299|NCT00619866|3648885|FG004|Weeks 13 - 24|Lost to Follow-up|0
2070300|NCT00619892|3648899|FG000|Overall Study|Adverse Event|3
2070301|NCT00619892|3648900|FG001|Overall Study|Adverse Event|0
2070302|NCT00619892|3648899|FG000|Overall Study|Lost to Follow-up|0
2070303|NCT00619892|3648900|FG001|Overall Study|Lost to Follow-up|1
2070304|NCT00619892|3648899|FG000|Overall Study|Intercurrent illness|0
2070305|NCT00619892|3648900|FG001|Overall Study|Intercurrent illness|1
2070306|NCT00619918|3648910|FG000|Overall Study|Withdrawal by Subject|4
2070307|NCT00619918|3648911|FG001|Overall Study|Withdrawal by Subject|3
2070308|NCT00619918|3648910|FG000|Overall Study|Physician Decision|8
2070309|NCT00619918|3648911|FG001|Overall Study|Physician Decision|8
2070310|NCT00619918|3648910|FG000|Overall Study|Transfer to outside facility|3
2070311|NCT00619918|3648911|FG001|Overall Study|Transfer to outside facility|3
2070312|NCT00619918|3648910|FG000|Overall Study|Left before receiving first dose|5
2070313|NCT00619918|3648911|FG001|Overall Study|Left before receiving first dose|8
2070314|NCT00619957|3648919|FG000|Month 24 Double-Blind|Adverse Event|9
2070315|NCT00619957|3648920|FG001|Month 24 Double-Blind|Adverse Event|7
2070316|NCT00619957|3648919|FG000|Month 24 Double-Blind|Protocol Violation|1
2070317|NCT00619957|3648920|FG001|Month 24 Double-Blind|Protocol Violation|0
2070318|NCT00619957|3648919|FG000|Month 24 Double-Blind|Withdrawal by Subject|7
2070319|NCT00619957|3648920|FG001|Month 24 Double-Blind|Withdrawal by Subject|9
2070320|NCT00619957|3648919|FG000|Month 24 Double-Blind|Lost to Follow-up|1
2070321|NCT00619957|3648920|FG001|Month 24 Double-Blind|Lost to Follow-up|0
2070322|NCT00619957|3648919|FG000|Month 24 Double-Blind|Did not take any study medication|0
2070323|NCT00619957|3648920|FG001|Month 24 Double-Blind|Did not take any study medication|1
2070324|NCT00619957|3648919|FG000|Month 48 Open-Label|Adverse Event|4
2070325|NCT00619957|3648920|FG001|Month 48 Open-Label|Adverse Event|4
2070326|NCT00619957|3648919|FG000|Month 48 Open-Label|Lost to Follow-up|2
2070327|NCT00619957|3648920|FG001|Month 48 Open-Label|Lost to Follow-up|4
2070328|NCT00619957|3648919|FG000|Month 48 Open-Label|Withdrawal by Subject|6
2070329|NCT00619957|3648920|FG001|Month 48 Open-Label|Withdrawal by Subject|9
2070330|NCT00619983|3648947|FG000|Test Drug Alone|Withdrawal by Subject|1
2070331|NCT00619983|3648948|FG001|Test Drug Alone|Withdrawal by Subject|0
2070332|NCT00619983|3648949|FG002|Test Drug Alone|Withdrawal by Subject|0
2070333|NCT00619983|3648950|FG003|Test Drug Alone|Withdrawal by Subject|1
2070334|NCT00619983|3648947|FG000|Test Drug Alone|Failure of daily diary device|1
2070335|NCT00619983|3648948|FG001|Test Drug Alone|Failure of daily diary device|1
2070336|NCT00619983|3648949|FG002|Test Drug Alone|Failure of daily diary device|2
2070337|NCT00619983|3648950|FG003|Test Drug Alone|Failure of daily diary device|2
2070338|NCT00620022|3648960|FG000|Treatment Period 1|Adverse Event|4
2070339|NCT00620022|3648961|FG001|Treatment Period 1|Adverse Event|6
2070340|NCT00620022|3648960|FG000|Treatment Period 1|Subject withdrew consent|1
2070341|NCT00620022|3648961|FG001|Treatment Period 1|Subject withdrew consent|0
2070342|NCT00620022|3648960|FG000|Treatment Period 2|Adverse Event|2
2070343|NCT00620022|3648961|FG001|Treatment Period 2|Adverse Event|2
2070344|NCT00620074|3648972|FG000|Overall Study|Adverse Event|1
2070345|NCT00620113|3648980|FG000|Overall Study|Adverse Event|3
2070346|NCT00620113|3648981|FG001|Overall Study|Adverse Event|2
2070347|NCT00620113|3648982|FG002|Overall Study|Adverse Event|2
2070348|NCT00620113|3648983|FG003|Overall Study|Adverse Event|1
2070349|NCT00620113|3648980|FG000|Overall Study|Lack of Efficacy|2
2070350|NCT00620113|3648981|FG001|Overall Study|Lack of Efficacy|3
2070351|NCT00620113|3648982|FG002|Overall Study|Lack of Efficacy|0
2070352|NCT00620113|3648983|FG003|Overall Study|Lack of Efficacy|2
2070353|NCT00620113|3648980|FG000|Overall Study|Physician Decision|1
2070354|NCT00620113|3648981|FG001|Overall Study|Physician Decision|0
2070355|NCT00620113|3648982|FG002|Overall Study|Physician Decision|0
2070356|NCT00620113|3648983|FG003|Overall Study|Physician Decision|2
2070357|NCT00620113|3648980|FG000|Overall Study|Protocol Violation|2
2070358|NCT00620113|3648981|FG001|Overall Study|Protocol Violation|1
2070359|NCT00620113|3648982|FG002|Overall Study|Protocol Violation|0
2070360|NCT00620113|3648983|FG003|Overall Study|Protocol Violation|0
2070361|NCT00620113|3648980|FG000|Overall Study|Withdrawal by Subject|5
2070362|NCT00620113|3648981|FG001|Overall Study|Withdrawal by Subject|1
2070363|NCT00620113|3648982|FG002|Overall Study|Withdrawal by Subject|3
2070364|NCT00620113|3648983|FG003|Overall Study|Withdrawal by Subject|5
2070365|NCT00620282|3649019|FG000|Overall Study|Adverse Event|0
2070366|NCT00620282|3649020|FG001|Overall Study|Adverse Event|1
2070367|NCT00620282|3649021|FG002|Overall Study|Adverse Event|0
2070368|NCT00620282|3649019|FG000|Overall Study|Arterial line unable to be placed|0
2070369|NCT00620282|3649020|FG001|Overall Study|Arterial line unable to be placed|0
2070370|NCT00620282|3649021|FG002|Overall Study|Arterial line unable to be placed|1
2070371|NCT00620282|3649019|FG000|Overall Study|Withdrawal by Subject|0
2070372|NCT00620282|3649020|FG001|Overall Study|Withdrawal by Subject|1
2070373|NCT00620282|3649021|FG002|Overall Study|Withdrawal by Subject|0
2070374|NCT00620321|3649031|FG000|Overall Study|Adverse Event|1
2070375|NCT00620321|3649032|FG001|Overall Study|Adverse Event|1
2070376|NCT00620321|3649031|FG000|Overall Study|Death|1
2070377|NCT00620321|3649032|FG001|Overall Study|Death|1
2070378|NCT00620321|3649031|FG000|Overall Study|Physician Decision|0
2070379|NCT00620321|3649032|FG001|Overall Study|Physician Decision|7
2070380|NCT00620321|3649031|FG000|Overall Study|Progressive Disease|5
2070381|NCT00620321|3649032|FG001|Overall Study|Progressive Disease|5
2070382|NCT00620321|3649031|FG000|Overall Study|Sponsor Decision|0
2070383|NCT00620321|3649032|FG001|Overall Study|Sponsor Decision|1
2070384|NCT00620321|3649031|FG000|Overall Study|Withdrawal by Subject|1
2070385|NCT00620321|3649032|FG001|Overall Study|Withdrawal by Subject|1
2070386|NCT00620373|3649038|FG000|Overall Study|Unverified cancer status|33
2070387|NCT00620542|3649071|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12
2070388|NCT00620542|3649072|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15
2070389|NCT00620542|3649073|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0
2070390|NCT00620542|3649074|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0
2070391|NCT00620542|3649071|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406
2070392|NCT00620542|3649072|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409
2070393|NCT00620542|3649073|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
2070394|NCT00620542|3649074|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
2070395|NCT00620542|3649071|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
2070396|NCT00620542|3649072|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
2070397|NCT00620542|3649073|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
2070398|NCT00620542|3649074|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
2070399|NCT00620542|3649071|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
2070400|NCT00620542|3649072|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
2070401|NCT00620542|3649073|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
2070402|NCT00620542|3649074|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
2070403|NCT00620542|3649071|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0
2070404|NCT00620542|3649072|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1
2070405|NCT00620542|3649073|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
2070406|NCT00620542|3649074|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
2070407|NCT00620542|3649071|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0
2070408|NCT00620542|3649072|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1
2070409|NCT00620542|3649073|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0
2070410|NCT00620542|3649074|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0
2070411|NCT00620542|3649071|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4
2070412|NCT00620542|3649072|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4
2070413|NCT00620542|3649073|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0
2070414|NCT00620542|3649074|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0
2070415|NCT00620542|3649071|FG000|Part B (2 Year Core Study)|Adverse Event|0
2070416|NCT00620542|3649072|FG001|Part B (2 Year Core Study)|Adverse Event|0
2070417|NCT00620542|3649073|FG002|Part B (2 Year Core Study)|Adverse Event|46
2070418|NCT00620542|3649074|FG003|Part B (2 Year Core Study)|Adverse Event|49
2070419|NCT00620542|3649071|FG000|Part B (2 Year Core Study)|Protocol Violation|0
2070420|NCT00620542|3649072|FG001|Part B (2 Year Core Study)|Protocol Violation|0
2070421|NCT00620542|3649073|FG002|Part B (2 Year Core Study)|Protocol Violation|3
2304152|NCT02648204|4003815|FG003|Overall Study|Death|2
2304153|NCT02648204|4003812|FG000|Overall Study|Adverse Event|0
2304154|NCT02648204|4003813|FG001|Overall Study|Adverse Event|0
2304155|NCT02648204|4003814|FG002|Overall Study|Adverse Event|1
2304156|NCT02648204|4003815|FG003|Overall Study|Adverse Event|0
2304157|NCT02648217|4003827|FG000|Overall Study|Adverse Event|0
2304158|NCT02648217|4003828|FG001|Overall Study|Adverse Event|1
2304159|NCT02648217|4003827|FG000|Overall Study|Lost to Follow-up|1
2070422|NCT00620542|3649074|FG003|Part B (2 Year Core Study)|Protocol Violation|5
2070423|NCT00620542|3649071|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0
2070424|NCT00620542|3649072|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0
2070425|NCT00620542|3649073|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55
2070426|NCT00620542|3649074|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54
2070427|NCT00620542|3649071|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0
2070428|NCT00620542|3649072|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0
2070429|NCT00620542|3649073|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20
2070430|NCT00620542|3649074|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9
2070431|NCT00620542|3649071|FG000|Part B (2 Year Core Study)|Protocol Violation|0
2070432|NCT00620542|3649072|FG001|Part B (2 Year Core Study)|Protocol Violation|0
2070433|NCT00620542|3649073|FG002|Part B (2 Year Core Study)|Protocol Violation|13
2070434|NCT00620542|3649074|FG003|Part B (2 Year Core Study)|Protocol Violation|16
2304160|NCT02648217|4003828|FG001|Overall Study|Lost to Follow-up|1
2304161|NCT02648217|4003827|FG000|Overall Study|Withdrawal by Subject|4
2070435|NCT00620542|3649071|FG000|Part B (2 Year Core Study)|Safety reasons|0
2070436|NCT00620542|3649072|FG001|Part B (2 Year Core Study)|Safety reasons|0
2070437|NCT00620542|3649073|FG002|Part B (2 Year Core Study)|Safety reasons|2
2210423|NCT01649856|3849913|FG001|Overall Study|Treatment Failure|1
2210424|NCT01649856|3849912|FG000|Overall Study|Death|69
2210425|NCT01649856|3849913|FG001|Overall Study|Death|34
2210426|NCT01649856|3849912|FG000|Overall Study|Stable or Progressed Disease|5
2210427|NCT01649856|3849913|FG001|Overall Study|Stable or Progressed Disease|3
2210428|NCT01649856|3849912|FG000|Overall Study|Lost to Follow-up|20
2210429|NCT01649856|3849913|FG001|Overall Study|Lost to Follow-up|16
2070438|NCT00620542|3649074|FG003|Part B (2 Year Core Study)|Safety reasons|3
2070439|NCT00620542|3649071|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
2070440|NCT00620542|3649072|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
2070441|NCT00620542|3649073|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
2070442|NCT00620542|3649074|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
2070443|NCT00620542|3649071|FG000|Part B (2 Year Core Study)|IVUS not available|0
2070444|NCT00620542|3649072|FG001|Part B (2 Year Core Study)|IVUS not available|0
2070445|NCT00620542|3649073|FG002|Part B (2 Year Core Study)|IVUS not available|3
2070446|NCT00620542|3649074|FG003|Part B (2 Year Core Study)|IVUS not available|2
2070447|NCT00620555|3649082|FG000|Overall Study|Adverse Event|4
2070448|NCT00620555|3649082|FG000|Overall Study|Protocol Violation|2
2070449|NCT00620555|3649082|FG000|Overall Study|Lack of Efficacy|12
2070450|NCT00620555|3649082|FG000|Overall Study|Withdrawal by Subject|1
2070451|NCT00620555|3649082|FG000|Overall Study|Choice of other treatment|1
2070452|NCT00620555|3649082|FG000|Overall Study|Visit failure against planned|1
2070453|NCT00620659|3649086|FG000|Treatment Period 1|Adverse Event|1
2070454|NCT00620659|3649087|FG001|Treatment Period 1|Adverse Event|0
2070455|NCT00620659|3649088|FG002|Treatment Period 1|Adverse Event|0
2070456|NCT00620659|3649089|FG003|Treatment Period 1|Adverse Event|3
2070457|NCT00620659|3649090|FG004|Treatment Period 1|Adverse Event|0
2070458|NCT00620659|3649091|FG005|Treatment Period 1|Adverse Event|0
2070459|NCT00620659|3649086|FG000|Treatment Period 1|Protocol Violation|1
2070460|NCT00620659|3649087|FG001|Treatment Period 1|Protocol Violation|0
2070461|NCT00620659|3649088|FG002|Treatment Period 1|Protocol Violation|0
2070462|NCT00620659|3649089|FG003|Treatment Period 1|Protocol Violation|0
2070463|NCT00620659|3649090|FG004|Treatment Period 1|Protocol Violation|0
2070464|NCT00620659|3649091|FG005|Treatment Period 1|Protocol Violation|0
2070465|NCT00620659|3649086|FG000|Treatment Period 1|Withdrawal by Subject|1
2070466|NCT00620659|3649087|FG001|Treatment Period 1|Withdrawal by Subject|0
2070467|NCT00620659|3649088|FG002|Treatment Period 1|Withdrawal by Subject|1
2070468|NCT00620659|3649089|FG003|Treatment Period 1|Withdrawal by Subject|0
2070469|NCT00620659|3649090|FG004|Treatment Period 1|Withdrawal by Subject|1
2070470|NCT00620659|3649091|FG005|Treatment Period 1|Withdrawal by Subject|0
2070471|NCT00620659|3649086|FG000|Placebo Washout Period 1|Withdrawal by Subject|0
2070472|NCT00620659|3649087|FG001|Placebo Washout Period 1|Withdrawal by Subject|0
2070473|NCT00620659|3649088|FG002|Placebo Washout Period 1|Withdrawal by Subject|0
2070474|NCT00620659|3649089|FG003|Placebo Washout Period 1|Withdrawal by Subject|1
2070475|NCT00620659|3649090|FG004|Placebo Washout Period 1|Withdrawal by Subject|0
2070476|NCT00620659|3649091|FG005|Placebo Washout Period 1|Withdrawal by Subject|0
2070477|NCT00620659|3649086|FG000|Treatment Period 2|Adverse Event|0
2070478|NCT00620659|3649087|FG001|Treatment Period 2|Adverse Event|3
2070479|NCT00620659|3649088|FG002|Treatment Period 2|Adverse Event|0
2070480|NCT00620659|3649089|FG003|Treatment Period 2|Adverse Event|0
2070481|NCT00620659|3649090|FG004|Treatment Period 2|Adverse Event|2
2070482|NCT00620659|3649091|FG005|Treatment Period 2|Adverse Event|0
2070483|NCT00620659|3649086|FG000|Treatment Period 2|Withdrawal by Subject|0
2070484|NCT00620659|3649087|FG001|Treatment Period 2|Withdrawal by Subject|0
2070485|NCT00620659|3649088|FG002|Treatment Period 2|Withdrawal by Subject|1
2070486|NCT00620659|3649089|FG003|Treatment Period 2|Withdrawal by Subject|0
2070487|NCT00620659|3649090|FG004|Treatment Period 2|Withdrawal by Subject|3
2070488|NCT00620659|3649091|FG005|Treatment Period 2|Withdrawal by Subject|0
2070489|NCT00620659|3649086|FG000|Placebo Washout Period 2|Adverse Event|2
2070490|NCT00620659|3649087|FG001|Placebo Washout Period 2|Adverse Event|0
2070491|NCT00620659|3649088|FG002|Placebo Washout Period 2|Adverse Event|0
2070492|NCT00620659|3649089|FG003|Placebo Washout Period 2|Adverse Event|0
2070493|NCT00620659|3649090|FG004|Placebo Washout Period 2|Adverse Event|0
2070494|NCT00620659|3649091|FG005|Placebo Washout Period 2|Adverse Event|0
2070495|NCT00620659|3649086|FG000|Treatment Period 3|Adverse Event|0
2070496|NCT00620659|3649087|FG001|Treatment Period 3|Adverse Event|2
2070497|NCT00620659|3649088|FG002|Treatment Period 3|Adverse Event|0
2070498|NCT00620659|3649089|FG003|Treatment Period 3|Adverse Event|0
2070499|NCT00620659|3649090|FG004|Treatment Period 3|Adverse Event|0
2070500|NCT00620659|3649091|FG005|Treatment Period 3|Adverse Event|0
2070501|NCT00620659|3649086|FG000|Treatment Period 3|Withdrawal by Subject|0
2070502|NCT00620659|3649087|FG001|Treatment Period 3|Withdrawal by Subject|0
2070503|NCT00620659|3649088|FG002|Treatment Period 3|Withdrawal by Subject|0
2070504|NCT00620659|3649089|FG003|Treatment Period 3|Withdrawal by Subject|1
2070505|NCT00620659|3649090|FG004|Treatment Period 3|Withdrawal by Subject|0
2070506|NCT00620659|3649091|FG005|Treatment Period 3|Withdrawal by Subject|0
2070507|NCT00620750|3649112|FG000|Overall Study|Lost to Follow-up|25
2070508|NCT00620763|3649116|FG000|Period: First Intervention|Withdrawal by Subject|0
2070509|NCT00620763|3649117|FG001|Period: First Intervention|Withdrawal by Subject|2
2070510|NCT00620763|3649116|FG000|Period: First Intervention|Protocol Violation|0
2070511|NCT00620763|3649117|FG001|Period: First Intervention|Protocol Violation|3
2070512|NCT00620763|3649116|FG000|Period: Second Intervention|Withdrawal by Subject|1
2070513|NCT00620763|3649117|FG001|Period: Second Intervention|Withdrawal by Subject|0
2070514|NCT00620776|3649125|FG000|Overall Study|Did not receive treatment|3
2070515|NCT00620776|3649126|FG001|Overall Study|Did not receive treatment|5
2070516|NCT00620776|3649125|FG000|Overall Study|Adverse Event|2
2070517|NCT00620776|3649126|FG001|Overall Study|Adverse Event|3
2070518|NCT00620776|3649125|FG000|Overall Study|Lack of Efficacy|2
2070519|NCT00620776|3649126|FG001|Overall Study|Lack of Efficacy|1
2070520|NCT00620776|3649125|FG000|Overall Study|Lost to Follow-up|2
2070521|NCT00620776|3649126|FG001|Overall Study|Lost to Follow-up|5
2070522|NCT00620776|3649125|FG000|Overall Study|Withdrawal by Subject|3
2070523|NCT00620776|3649126|FG001|Overall Study|Withdrawal by Subject|2
2070524|NCT00620815|3649135|FG000|Overall Study|Adverse Event|1
2070525|NCT00620815|3649136|FG001|Overall Study|Adverse Event|1
2070526|NCT00620815|3649137|FG002|Overall Study|Adverse Event|2
2070527|NCT00620815|3649135|FG000|Overall Study|Withdrawal by Subject|1
2070528|NCT00620815|3649136|FG001|Overall Study|Withdrawal by Subject|2
2070529|NCT00620815|3649137|FG002|Overall Study|Withdrawal by Subject|0
2070530|NCT00620815|3649135|FG000|Overall Study|Lost to Follow-up|1
2070531|NCT00620815|3649136|FG001|Overall Study|Lost to Follow-up|6
2070532|NCT00620815|3649137|FG002|Overall Study|Lost to Follow-up|3
2070533|NCT00620815|3649135|FG000|Overall Study|Inappropriate enrolment|0
2070534|NCT00620815|3649136|FG001|Overall Study|Inappropriate enrolment|0
2070535|NCT00620815|3649137|FG002|Overall Study|Inappropriate enrolment|1
2070536|NCT00620815|3649135|FG000|Overall Study|Protocol Violation|1
2070537|NCT00620815|3649136|FG001|Overall Study|Protocol Violation|2
2070538|NCT00620815|3649137|FG002|Overall Study|Protocol Violation|1
2070539|NCT00620854|3649176|FG000|Washout 1|Withdrawal by Subject|0
2070540|NCT00620854|3649177|FG001|Washout 1|Withdrawal by Subject|0
2070541|NCT00620854|3649178|FG002|Washout 1|Withdrawal by Subject|1
2070542|NCT00620854|3649179|FG003|Washout 1|Withdrawal by Subject|1
2070543|NCT00620854|3649180|FG004|Washout 1|Withdrawal by Subject|0
2070544|NCT00620854|3649181|FG005|Washout 1|Withdrawal by Subject|0
2070545|NCT00621023|3649196|FG000|Overall Study|Death|5
2070546|NCT00621023|3649196|FG000|Overall Study|Follow up discontinued|1
2070547|NCT00621140|3649211|FG000|Overall Study|Adverse Event|4
2070548|NCT00621140|3649212|FG001|Overall Study|Adverse Event|5
2070549|NCT00621140|3649211|FG000|Overall Study|Lost to Follow-up|1
2070550|NCT00621140|3649212|FG001|Overall Study|Lost to Follow-up|2
2070551|NCT00621140|3649211|FG000|Overall Study|Withdrawal by Subject|4
2070552|NCT00621140|3649212|FG001|Overall Study|Withdrawal by Subject|6
2070553|NCT00621140|3649211|FG000|Overall Study|Other incl. lack of efficacy|6
2210430|NCT01649856|3849912|FG000|Overall Study|Lack of Compliance|6
2210431|NCT01649856|3849913|FG001|Overall Study|Lack of Compliance|1
2070554|NCT00621140|3649212|FG001|Overall Study|Other incl. lack of efficacy|5
2070555|NCT00621153|3649220|FG000|Overall Study|Safety Reason|8
2070556|NCT00621153|3649221|FG001|Overall Study|Safety Reason|7
2070557|NCT00621153|3649220|FG000|Overall Study|Adverse Event|3
2070558|NCT00621153|3649221|FG001|Overall Study|Adverse Event|2
2070559|NCT00621153|3649220|FG000|Overall Study|Lost to Follow-up|5
2070560|NCT00621153|3649221|FG001|Overall Study|Lost to Follow-up|1
2070561|NCT00621153|3649220|FG000|Overall Study|Withdrawal by Subject|4
2070562|NCT00621153|3649221|FG001|Overall Study|Withdrawal by Subject|5
2070563|NCT00621192|3649248|FG000|Overall Study|Withdrawal by Subject|0
2070564|NCT00621192|3649249|FG001|Overall Study|Withdrawal by Subject|0
2070565|NCT00621192|3649250|FG002|Overall Study|Withdrawal by Subject|2
2070566|NCT00621192|3649251|FG003|Overall Study|Withdrawal by Subject|0
2070567|NCT00621192|3649248|FG000|Overall Study|Physician Decision|1
2070568|NCT00621192|3649249|FG001|Overall Study|Physician Decision|3
2070569|NCT00621192|3649250|FG002|Overall Study|Physician Decision|0
2070570|NCT00621192|3649251|FG003|Overall Study|Physician Decision|0
2070571|NCT00621192|3649248|FG000|Overall Study|Protocol Violation|1
2070572|NCT00621192|3649249|FG001|Overall Study|Protocol Violation|0
2070573|NCT00621192|3649250|FG002|Overall Study|Protocol Violation|0
2070574|NCT00621192|3649251|FG003|Overall Study|Protocol Violation|1
2070575|NCT00621192|3649248|FG000|Overall Study|Adverse Event|0
2070576|NCT00621192|3649249|FG001|Overall Study|Adverse Event|1
2070577|NCT00621192|3649250|FG002|Overall Study|Adverse Event|0
2070578|NCT00621192|3649251|FG003|Overall Study|Adverse Event|1
2070579|NCT00621192|3649248|FG000|Overall Study|Death|2
2070580|NCT00621192|3649249|FG001|Overall Study|Death|5
2070581|NCT00621192|3649250|FG002|Overall Study|Death|0
2070582|NCT00621192|3649251|FG003|Overall Study|Death|0
2070583|NCT00621192|3649248|FG000|Overall Study|Final Assessments not Completed|0
2070584|NCT00621192|3649249|FG001|Overall Study|Final Assessments not Completed|0
2070585|NCT00621192|3649250|FG002|Overall Study|Final Assessments not Completed|3
2070586|NCT00621192|3649251|FG003|Overall Study|Final Assessments not Completed|1
2070587|NCT00621244|3649265|FG000|Overall Study|Withdrawal by Subject|7
2070588|NCT00621244|3649266|FG001|Overall Study|Withdrawal by Subject|3
2070589|NCT00621244|3649267|FG002|Overall Study|Withdrawal by Subject|3
2070590|NCT00621244|3649268|FG003|Overall Study|Withdrawal by Subject|3
2070591|NCT00621244|3649265|FG000|Overall Study|Disease progression|44
2070592|NCT00621244|3649266|FG001|Overall Study|Disease progression|20
2070593|NCT00621244|3649267|FG002|Overall Study|Disease progression|20
2070594|NCT00621244|3649268|FG003|Overall Study|Disease progression|15
2070595|NCT00621244|3649265|FG000|Overall Study|Death|3
2070596|NCT00621244|3649266|FG001|Overall Study|Death|3
2070597|NCT00621244|3649267|FG002|Overall Study|Death|1
2070598|NCT00621244|3649268|FG003|Overall Study|Death|1
2070599|NCT00621244|3649265|FG000|Overall Study|Adverse Event|27
2070600|NCT00621244|3649266|FG001|Overall Study|Adverse Event|7
2070601|NCT00621244|3649267|FG002|Overall Study|Adverse Event|9
2070602|NCT00621244|3649268|FG003|Overall Study|Adverse Event|2
2070603|NCT00621244|3649265|FG000|Overall Study|Administrative problems|5
2070604|NCT00621244|3649266|FG001|Overall Study|Administrative problems|1
2070605|NCT00621244|3649267|FG002|Overall Study|Administrative problems|0
2070606|NCT00621244|3649268|FG003|Overall Study|Administrative problems|2
2070607|NCT00621257|3649347|FG000|Overall Study|Lost to Follow-up|4
2070608|NCT00621257|3649348|FG001|Overall Study|Lost to Follow-up|0
2070609|NCT00621257|3649349|FG002|Overall Study|Lost to Follow-up|2
2070610|NCT00621257|3649350|FG003|Overall Study|Lost to Follow-up|4
2070611|NCT00621257|3649351|FG004|Overall Study|Lost to Follow-up|7
2070612|NCT00621257|3649347|FG000|Overall Study|Adverse Event|0
2070613|NCT00621257|3649348|FG001|Overall Study|Adverse Event|1
2070614|NCT00621257|3649349|FG002|Overall Study|Adverse Event|1
2070615|NCT00621257|3649350|FG003|Overall Study|Adverse Event|0
2070616|NCT00621257|3649351|FG004|Overall Study|Adverse Event|0
2070617|NCT00621257|3649347|FG000|Overall Study|Physician Decision|0
2070618|NCT00621257|3649348|FG001|Overall Study|Physician Decision|2
2070619|NCT00621257|3649349|FG002|Overall Study|Physician Decision|0
2070620|NCT00621257|3649350|FG003|Overall Study|Physician Decision|1
2070621|NCT00621257|3649351|FG004|Overall Study|Physician Decision|1
2070622|NCT00621257|3649347|FG000|Overall Study|Withdrawal by Subject|0
2070623|NCT00621257|3649348|FG001|Overall Study|Withdrawal by Subject|0
2070624|NCT00621257|3649349|FG002|Overall Study|Withdrawal by Subject|0
2070625|NCT00621257|3649350|FG003|Overall Study|Withdrawal by Subject|1
2070626|NCT00621257|3649351|FG004|Overall Study|Withdrawal by Subject|1
2070627|NCT00621296|3649363|FG000|Overall Study|Adverse Event|2
2070628|NCT00621296|3649363|FG000|Overall Study|Lack of Efficacy|1
2070629|NCT00621296|3649363|FG000|Overall Study|Physician Decision|7
2070630|NCT00621296|3649363|FG000|Overall Study|Unmatch Criteria|1
2070631|NCT00621296|3649363|FG000|Overall Study|Stopping Criteria|3
2070632|NCT00621309|3649367|FG000|Overall Study|Withdrawal by Subject|2
2070633|NCT00621309|3649368|FG001|Overall Study|Withdrawal by Subject|0
2070634|NCT00621309|3649369|FG002|Overall Study|Withdrawal by Subject|1
2070635|NCT00621309|3649370|FG003|Overall Study|Withdrawal by Subject|1
2070636|NCT00621309|3649371|FG004|Overall Study|Withdrawal by Subject|1
2070637|NCT00621309|3649372|FG005|Overall Study|Withdrawal by Subject|1
2070638|NCT00621322|3649384|FG000|Overall Study|Lost to Follow-up|0
2070639|NCT00621322|3649385|FG001|Overall Study|Lost to Follow-up|0
2070640|NCT00621322|3649386|FG002|Overall Study|Lost to Follow-up|0
2070641|NCT00621322|3649387|FG003|Overall Study|Lost to Follow-up|0
2070642|NCT00621322|3649388|FG004|Overall Study|Lost to Follow-up|1
2070643|NCT00621322|3649389|FG005|Overall Study|Lost to Follow-up|0
2070644|NCT00621322|3649384|FG000|Overall Study|Physician Decision|0
2070645|NCT00621322|3649385|FG001|Overall Study|Physician Decision|0
2070646|NCT00621322|3649386|FG002|Overall Study|Physician Decision|1
2070647|NCT00621322|3649387|FG003|Overall Study|Physician Decision|1
2070648|NCT00621322|3649388|FG004|Overall Study|Physician Decision|0
2070649|NCT00621322|3649389|FG005|Overall Study|Physician Decision|0
2070650|NCT00621322|3649384|FG000|Overall Study|Withdrawal by Subject|0
2070651|NCT00621322|3649385|FG001|Overall Study|Withdrawal by Subject|0
2070652|NCT00621322|3649386|FG002|Overall Study|Withdrawal by Subject|0
2070653|NCT00621322|3649387|FG003|Overall Study|Withdrawal by Subject|1
2070654|NCT00621322|3649388|FG004|Overall Study|Withdrawal by Subject|0
2070655|NCT00621322|3649389|FG005|Overall Study|Withdrawal by Subject|2
2070656|NCT00621322|3649384|FG000|Overall Study|Migrated/moved from study area|1
2070657|NCT00621322|3649385|FG001|Overall Study|Migrated/moved from study area|0
2070658|NCT00621322|3649386|FG002|Overall Study|Migrated/moved from study area|1
2070659|NCT00621322|3649387|FG003|Overall Study|Migrated/moved from study area|1
2070660|NCT00621322|3649388|FG004|Overall Study|Migrated/moved from study area|0
2070661|NCT00621322|3649389|FG005|Overall Study|Migrated/moved from study area|2
2070662|NCT00621504|3649418|FG000|Overall Study|Adverse Event|1
2070663|NCT00621504|3649419|FG001|Overall Study|Adverse Event|3
2070664|NCT00621504|3649418|FG000|Overall Study|At the request of sponsor/investigator|1
2070665|NCT00621504|3649419|FG001|Overall Study|At the request of sponsor/investigator|0
2070666|NCT00621504|3649418|FG000|Overall Study|Withdrew consent|9
2070667|NCT00621504|3649419|FG001|Overall Study|Withdrew consent|6
2070668|NCT00621504|3649418|FG000|Overall Study|Lost to Follow-up|8
2070669|NCT00621504|3649419|FG001|Overall Study|Lost to Follow-up|10
2070670|NCT00621504|3649418|FG000|Overall Study|Other|1
2070671|NCT00621504|3649419|FG001|Overall Study|Other|0
2070672|NCT00621504|3649418|FG000|Overall Study|Death|6
2070673|NCT00621504|3649419|FG001|Overall Study|Death|6
2070674|NCT00621517|3649427|FG000|Overall Study|Lost to Follow-up|3
2070675|NCT00621517|3649428|FG001|Overall Study|Lost to Follow-up|3
2070676|NCT00621517|3649427|FG000|Overall Study|Withdrawal by Subject|3
2070677|NCT00621517|3649428|FG001|Overall Study|Withdrawal by Subject|4
2070678|NCT00621517|3649427|FG000|Overall Study|Adverse Event|1
2070679|NCT00621517|3649428|FG001|Overall Study|Adverse Event|0
2070680|NCT00621543|3649446|FG000|Overall Study|Lost to Follow-up|23
2070681|NCT00621582|3649450|FG000|Overall Study|Adverse Event|7
2070682|NCT00621582|3649450|FG000|Overall Study|Protocol Violation|57
2070683|NCT00621582|3649450|FG000|Overall Study|Lost to Follow-up|24
2070684|NCT00621582|3649450|FG000|Overall Study|issues not identified by investigators|18
2070685|NCT00621621|3649457|FG000|Overall Study|Subjects were exited at EP study|30
2070686|NCT00621621|3649458|FG001|Overall Study|Subjects were exited at EP study|0
2070687|NCT00621751|3649478|FG000|Overall Study|Adverse Event|0
2070688|NCT00621751|3649479|FG001|Overall Study|Adverse Event|1
2070689|NCT00621764|3649489|FG000|Overall Study|Protocol Violation|0
2070690|NCT00621764|3649490|FG001|Overall Study|Protocol Violation|0
2070691|NCT00621764|3649491|FG002|Overall Study|Protocol Violation|0
2070692|NCT00621764|3649492|FG003|Overall Study|Protocol Violation|1
2070693|NCT00621777|3649505|FG000|Open Phase|Adverse Event|20
2070694|NCT00621777|3649506|FG001|Open Phase|Adverse Event|0
2070695|NCT00621777|3649505|FG000|Open Phase|Did not abstain during open phase|56
2070696|NCT00621777|3649506|FG001|Open Phase|Did not abstain during open phase|0
2070697|NCT00621777|3649505|FG000|Open Phase|Withdrawal by Subject|17
2070698|NCT00621777|3649506|FG001|Open Phase|Withdrawal by Subject|0
2070699|NCT00621777|3649505|FG000|Open Phase|administrative|13
2070700|NCT00621777|3649506|FG001|Open Phase|administrative|0
2070701|NCT00621777|3649505|FG000|Open Phase|Lost to Follow-up|10
2070702|NCT00621777|3649506|FG001|Open Phase|Lost to Follow-up|0
2070703|NCT00621777|3649505|FG000|Randomized Phase|Adverse Event|3
2070704|NCT00621777|3649506|FG001|Randomized Phase|Adverse Event|3
2070705|NCT00621777|3649505|FG000|Randomized Phase|Lost to Follow-up|3
2070706|NCT00621777|3649506|FG001|Randomized Phase|Lost to Follow-up|3
2070707|NCT00621777|3649505|FG000|Randomized Phase|Withdrawal by Subject|1
2070708|NCT00621777|3649506|FG001|Randomized Phase|Withdrawal by Subject|9
2070709|NCT00621777|3649505|FG000|Randomized Phase|administrative|0
2070710|NCT00621777|3649506|FG001|Randomized Phase|administrative|3
2070711|NCT00621777|3649505|FG000|Randomized Phase|Death|0
2070712|NCT00621777|3649506|FG001|Randomized Phase|Death|1
2070713|NCT00621842|3649514|FG000|Overall Study|Adverse Event|6
2070714|NCT00621842|3649514|FG000|Overall Study|Withdrawal by Subject|7
2070715|NCT00621842|3649514|FG000|Overall Study|Protocol Violation|4
2070716|NCT00621842|3649514|FG000|Overall Study|Lack of Efficacy|2
2070717|NCT00621855|3649523|FG000|Overall Study|Adverse Event|32
2070718|NCT00621855|3649524|FG001|Overall Study|Adverse Event|31
2070719|NCT00621855|3649525|FG002|Overall Study|Adverse Event|48
2070720|NCT00621855|3649526|FG003|Overall Study|Adverse Event|34
2070721|NCT00621855|3649527|FG004|Overall Study|Adverse Event|31
2070722|NCT00621855|3649523|FG000|Overall Study|Lost to Follow-up|0
2070723|NCT00621855|3649524|FG001|Overall Study|Lost to Follow-up|1
2070724|NCT00621855|3649525|FG002|Overall Study|Lost to Follow-up|3
2070725|NCT00621855|3649526|FG003|Overall Study|Lost to Follow-up|4
2070726|NCT00621855|3649527|FG004|Overall Study|Lost to Follow-up|1
2070727|NCT00621855|3649523|FG000|Overall Study|Protocol Violation|16
2070728|NCT00621855|3649524|FG001|Overall Study|Protocol Violation|8
2070729|NCT00621855|3649525|FG002|Overall Study|Protocol Violation|6
2070730|NCT00621855|3649526|FG003|Overall Study|Protocol Violation|7
2070731|NCT00621855|3649527|FG004|Overall Study|Protocol Violation|8
2070732|NCT00621855|3649523|FG000|Overall Study|Withdrawal by Subject|16
2070733|NCT00621855|3649524|FG001|Overall Study|Withdrawal by Subject|11
2070734|NCT00621855|3649525|FG002|Overall Study|Withdrawal by Subject|13
2070735|NCT00621855|3649526|FG003|Overall Study|Withdrawal by Subject|13
2070736|NCT00621855|3649527|FG004|Overall Study|Withdrawal by Subject|9
2070737|NCT00621855|3649523|FG000|Overall Study|Other|9
2070738|NCT00621855|3649524|FG001|Overall Study|Other|7
2070739|NCT00621855|3649525|FG002|Overall Study|Other|6
2070740|NCT00621855|3649526|FG003|Overall Study|Other|5
2070741|NCT00621855|3649527|FG004|Overall Study|Other|4
2070742|NCT00621855|3649523|FG000|Overall Study|Patients did not receive study drug|3
2070743|NCT00621855|3649524|FG001|Overall Study|Patients did not receive study drug|3
2070744|NCT00621855|3649525|FG002|Overall Study|Patients did not receive study drug|5
2070745|NCT00621855|3649526|FG003|Overall Study|Patients did not receive study drug|4
2070746|NCT00621855|3649527|FG004|Overall Study|Patients did not receive study drug|2
2070747|NCT00621959|3649555|FG000|Overall Study|Adverse Event|4
2070748|NCT00621959|3649556|FG001|Overall Study|Adverse Event|2
2070749|NCT00621959|3649555|FG000|Overall Study|Lack of Efficacy|1
2070750|NCT00621959|3649556|FG001|Overall Study|Lack of Efficacy|1
2070751|NCT00621959|3649555|FG000|Overall Study|Lost to Follow-up|0
2070752|NCT00621959|3649556|FG001|Overall Study|Lost to Follow-up|2
2070753|NCT00621959|3649555|FG000|Overall Study|Withdrawal by Subject|1
2070754|NCT00621959|3649556|FG001|Overall Study|Withdrawal by Subject|1
2070755|NCT00621959|3649555|FG000|Overall Study|Other|1
2070756|NCT00621959|3649556|FG001|Overall Study|Other|3
2070757|NCT00621985|3649562|FG000|Dexamethasone Admission|Adverse Event|1
2070758|NCT00622180|3649568|FG000|Overall Study|Lost to Follow-up|1
2070759|NCT00622180|3649569|FG001|Overall Study|Lost to Follow-up|2
2070760|NCT00622284|3649577|FG000|Overall Study|Lack of Efficacy|45
2070761|NCT00622284|3649578|FG001|Overall Study|Lack of Efficacy|15
2070762|NCT00622284|3649577|FG000|Overall Study|Adverse Event|61
2070763|NCT00622284|3649578|FG001|Overall Study|Adverse Event|90
2070764|NCT00622284|3649577|FG000|Overall Study|Protocol Violation|12
2070765|NCT00622284|3649578|FG001|Overall Study|Protocol Violation|5
2070766|NCT00622284|3649577|FG000|Overall Study|Lost to Follow-up|11
2070767|NCT00622284|3649578|FG001|Overall Study|Lost to Follow-up|13
2070768|NCT00622284|3649577|FG000|Overall Study|Withdrawal by Subject|27
2070769|NCT00622284|3649578|FG001|Overall Study|Withdrawal by Subject|24
2070770|NCT00622284|3649577|FG000|Overall Study|Other reason (not specified)|33
2070771|NCT00622284|3649578|FG001|Overall Study|Other reason (not specified)|24
2070772|NCT00622336|3649584|FG000|Treatment Phase|Progression of Disease|181
2070773|NCT00622336|3649584|FG000|Treatment Phase|Adverse Event|46
2070774|NCT00622336|3649584|FG000|Treatment Phase|Other|40
2070775|NCT00622336|3649584|FG000|Treatment Phase|Death|14
2070776|NCT00622336|3649584|FG000|Treatment Phase|Lack of therapeutic effect|13
2070777|NCT00622336|3649584|FG000|Treatment Phase|Withdrawal by Subject|13
2070778|NCT00622336|3649584|FG000|Treatment Phase|Lost to Follow-up|2
2070779|NCT00622336|3649584|FG000|Extension Phase|Adverse Event|2
2070780|NCT00622336|3649584|FG000|Extension Phase|Progressive Disease|6
2070781|NCT00622336|3649584|FG000|Extension Phase|Lack of therapeutic effect|2
2070782|NCT00622336|3649584|FG000|Extension Phase|Withdrawal by Subject|1
2070783|NCT00622336|3649584|FG000|Extension Phase|Lost to Follow-up|1
2070784|NCT00622336|3649584|FG000|Extension Phase|Other|9
2106311|NCT00864682|3699409|FG001|Overall Study|Protocol Violation|1
2106312|NCT00864682|3699410|FG002|Overall Study|Protocol Violation|2
2106313|NCT00864721|3699424|FG000|Overall Study|Patient request|11
2106314|NCT00864721|3699424|FG000|Overall Study|Hospitalized|1
2106315|NCT00864721|3699424|FG000|Overall Study|Drug hold/delay more than 4 weeks|1
2106316|NCT00864721|3699424|FG000|Overall Study|Adverse Event|21
2106317|NCT00864851|3699431|FG000|Overall Study|Withdrawal by Subject|0
2106318|NCT00864851|3699432|FG001|Overall Study|Withdrawal by Subject|1
2106319|NCT00864851|3699433|FG002|Overall Study|Withdrawal by Subject|0
2106320|NCT00864851|3699431|FG000|Overall Study|Physician Decision|1
2106321|NCT00864851|3699432|FG001|Overall Study|Physician Decision|0
2106322|NCT00864851|3699433|FG002|Overall Study|Physician Decision|0
2106323|NCT00864851|3699431|FG000|Overall Study|Death|1
2106324|NCT00864851|3699432|FG001|Overall Study|Death|0
2106325|NCT00864851|3699433|FG002|Overall Study|Death|0
2106326|NCT00864851|3699431|FG000|Overall Study|Patient uncooperative|1
2106327|NCT00864851|3699432|FG001|Overall Study|Patient uncooperative|0
2106328|NCT00864851|3699433|FG002|Overall Study|Patient uncooperative|0
2106329|NCT00864916|3699445|FG000|Overall Study|Lost to Follow-up|4
2106330|NCT00864916|3699446|FG001|Overall Study|Lost to Follow-up|4
2106331|NCT00864916|3699445|FG000|Overall Study|Protocol Violation|1
2106332|NCT00864916|3699446|FG001|Overall Study|Protocol Violation|0
2106333|NCT00864916|3699445|FG000|Overall Study|Withdrawal by Subject|1
2106334|NCT00864916|3699446|FG001|Overall Study|Withdrawal by Subject|0
2106335|NCT00865020|3699454|FG000|Overall Study|Withdrawal by Subject|22
2106336|NCT00865020|3699455|FG001|Overall Study|Withdrawal by Subject|16
2106337|NCT00865020|3699454|FG000|Overall Study|Adverse Event|9
2106338|NCT00865020|3699455|FG001|Overall Study|Adverse Event|14
2106339|NCT00865020|3699454|FG000|Overall Study|Abnormal test procedure result(s)|6
2106340|NCT00865020|3699455|FG001|Overall Study|Abnormal test procedure result(s)|8
2106341|NCT00865020|3699454|FG000|Overall Study|Lost to Follow-up|6
2106342|NCT00865020|3699455|FG001|Overall Study|Lost to Follow-up|4
2106343|NCT00865020|3699454|FG000|Overall Study|Protocol deviation|4
2106344|NCT00865020|3699455|FG001|Overall Study|Protocol deviation|1
2106345|NCT00865020|3699454|FG000|Overall Study|Administrative problems|0
2106346|NCT00865020|3699455|FG001|Overall Study|Administrative problems|2
2106347|NCT00865020|3699454|FG000|Overall Study|Abnormal laboratory value(s)|0
2106348|NCT00865020|3699455|FG001|Overall Study|Abnormal laboratory value(s)|1
2106349|NCT00865020|3699454|FG000|Overall Study|Death|0
2106350|NCT00865020|3699455|FG001|Overall Study|Death|1
2106351|NCT00865020|3699454|FG000|Overall Study|Randomized but discontinued|2
2106352|NCT00865020|3699455|FG001|Overall Study|Randomized but discontinued|4
2106353|NCT00865046|3699464|FG000|Overall Study|Lost to Follow-up|1
2106354|NCT00865046|3699465|FG001|Overall Study|Lost to Follow-up|4
2106355|NCT00865046|3699466|FG002|Overall Study|Lost to Follow-up|0
2106356|NCT00865046|3699464|FG000|Overall Study|Death|0
2106357|NCT00865046|3699465|FG001|Overall Study|Death|1
2106358|NCT00865046|3699466|FG002|Overall Study|Death|1
2106359|NCT00865046|3699464|FG000|Overall Study|Withdrawal by Subject|5
2106360|NCT00865046|3699465|FG001|Overall Study|Withdrawal by Subject|0
2106361|NCT00865046|3699466|FG002|Overall Study|Withdrawal by Subject|0
2106362|NCT00865098|3699474|FG000|Overall Study|Progressive disease|1
2106363|NCT00865124|3699481|FG000|Overall Study|Physician Decision|2
2106364|NCT00865124|3699482|FG001|Overall Study|Physician Decision|1
2106365|NCT00865124|3699483|FG002|Overall Study|Physician Decision|0
2106366|NCT00865124|3699481|FG000|Overall Study|Withdrawn consent|2
2106367|NCT00865124|3699482|FG001|Overall Study|Withdrawn consent|0
2106368|NCT00865124|3699483|FG002|Overall Study|Withdrawn consent|0
2106369|NCT00865189|3699493|FG000|Overall Study|Other|1
2106370|NCT00865189|3699494|FG001|Overall Study|Other|2
2106371|NCT00865189|3699493|FG000|Overall Study|Death|4
2106372|NCT00865189|3699494|FG001|Overall Study|Death|11
2106373|NCT00865189|3699493|FG000|Overall Study|Lost to Follow-up|6
2106374|NCT00865189|3699494|FG001|Overall Study|Lost to Follow-up|6
2106375|NCT00865189|3699493|FG000|Overall Study|Withdrawal by Subject|1
2106376|NCT00865189|3699494|FG001|Overall Study|Withdrawal by Subject|0
2106377|NCT00865280|3699512|FG000|Overall Study|Withdrawal by Subject|4
2070785|NCT00622388|3649590|FG000|Overall Study|Disease Progression|47
2070786|NCT00622388|3649590|FG000|Overall Study|Adverse Event|6
2070787|NCT00622388|3649590|FG000|Overall Study|Protocol Violation|3
2070788|NCT00622388|3649590|FG000|Overall Study|Participant Refusal|1
2070789|NCT00622388|3649590|FG000|Overall Study|Death|3
2070790|NCT00622388|3649590|FG000|Overall Study|Received Alternate Anticancer Therapy|8
2070791|NCT00622388|3649590|FG000|Overall Study|Took Prohibited Medication|2
2070792|NCT00622388|3649590|FG000|Overall Study|Withdrew Consent|1
2070793|NCT00622388|3649590|FG000|Overall Study|Insurance Expired|1
2070794|NCT00622401|3649598|FG000|Overall Study|Disease progression prior to treatment|3
2070795|NCT00622401|3649599|FG001|Overall Study|Disease progression prior to treatment|2
2070796|NCT00622401|3649600|FG002|Overall Study|Disease progression prior to treatment|0
2070797|NCT00622440|3649620|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4
2070798|NCT00622440|3649621|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1
2070799|NCT00622440|3649620|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
2070800|NCT00622440|3649621|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
2070801|NCT00622440|3649620|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
2070802|NCT00622440|3649621|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
2070803|NCT00622440|3649620|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
2070804|NCT00622440|3649621|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
2070805|NCT00622466|3649627|FG000|Overall Study|Death|1
2070806|NCT00622466|3649627|FG000|Overall Study|Adverse Event|1
2070807|NCT00622466|3649627|FG000|Overall Study|Withdrawal by Subject|2
2070808|NCT00622505|3649633|FG000|Overall Study|Adverse Event|9
2070809|NCT00622505|3649634|FG001|Overall Study|Adverse Event|7
2070810|NCT00622505|3649633|FG000|Overall Study|Abnormal Laboratory Value(s)|3
2070811|NCT00622505|3649634|FG001|Overall Study|Abnormal Laboratory Value(s)|5
2070812|NCT00622505|3649633|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
2070813|NCT00622505|3649634|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
2070814|NCT00622505|3649633|FG000|Overall Study|Withdrawal by Subject|12
2070815|NCT00622505|3649634|FG001|Overall Study|Withdrawal by Subject|5
2070816|NCT00622505|3649633|FG000|Overall Study|Administrative Problems|2
2070817|NCT00622505|3649634|FG001|Overall Study|Administrative Problems|4
2070818|NCT00622505|3649633|FG000|Overall Study|Death|2
2070819|NCT00622505|3649634|FG001|Overall Study|Death|2
2070820|NCT00622635|3649653|FG000|Treatment Period 1|Adverse Event|0
2070821|NCT00622635|3649654|FG001|Treatment Period 1|Adverse Event|0
2070822|NCT00622635|3649655|FG002|Treatment Period 1|Adverse Event|1
2070823|NCT00622635|3649656|FG003|Treatment Period 1|Adverse Event|0
2070824|NCT00622635|3649657|FG004|Treatment Period 1|Adverse Event|0
2070825|NCT00622635|3649658|FG005|Treatment Period 1|Adverse Event|0
2070826|NCT00622635|3649653|FG000|Treatment Period 1|Withdrawal by Subject|0
2070827|NCT00622635|3649654|FG001|Treatment Period 1|Withdrawal by Subject|1
2070828|NCT00622635|3649655|FG002|Treatment Period 1|Withdrawal by Subject|0
2070829|NCT00622635|3649656|FG003|Treatment Period 1|Withdrawal by Subject|0
2070830|NCT00622635|3649657|FG004|Treatment Period 1|Withdrawal by Subject|0
2070831|NCT00622635|3649658|FG005|Treatment Period 1|Withdrawal by Subject|0
2070832|NCT00622635|3649653|FG000|Treatment Period 1|Abnormal test procedure result(s)|0
2070833|NCT00622635|3649654|FG001|Treatment Period 1|Abnormal test procedure result(s)|0
2070834|NCT00622635|3649655|FG002|Treatment Period 1|Abnormal test procedure result(s)|0
2070835|NCT00622635|3649656|FG003|Treatment Period 1|Abnormal test procedure result(s)|0
2070836|NCT00622635|3649657|FG004|Treatment Period 1|Abnormal test procedure result(s)|1
2070837|NCT00622635|3649658|FG005|Treatment Period 1|Abnormal test procedure result(s)|0
2070838|NCT00622635|3649653|FG000|Treatment Period 2|Adverse Event|1
2070839|NCT00622635|3649654|FG001|Treatment Period 2|Adverse Event|0
2070840|NCT00622635|3649655|FG002|Treatment Period 2|Adverse Event|0
2070841|NCT00622635|3649656|FG003|Treatment Period 2|Adverse Event|0
2070842|NCT00622635|3649657|FG004|Treatment Period 2|Adverse Event|0
2070843|NCT00622635|3649658|FG005|Treatment Period 2|Adverse Event|0
2070844|NCT00622635|3649653|FG000|Treatment Period 3|Adverse Event|0
2070845|NCT00622635|3649654|FG001|Treatment Period 3|Adverse Event|0
2070846|NCT00622635|3649655|FG002|Treatment Period 3|Adverse Event|0
2070847|NCT00622635|3649656|FG003|Treatment Period 3|Adverse Event|2
2070848|NCT00622635|3649657|FG004|Treatment Period 3|Adverse Event|0
2070849|NCT00622635|3649658|FG005|Treatment Period 3|Adverse Event|0
2070850|NCT00622635|3649653|FG000|Treatment Period 3|Withdrawal by Subject|0
2070851|NCT00622635|3649654|FG001|Treatment Period 3|Withdrawal by Subject|0
2070852|NCT00622635|3649655|FG002|Treatment Period 3|Withdrawal by Subject|0
2070853|NCT00622635|3649656|FG003|Treatment Period 3|Withdrawal by Subject|1
2070854|NCT00622635|3649657|FG004|Treatment Period 3|Withdrawal by Subject|0
2070855|NCT00622635|3649658|FG005|Treatment Period 3|Withdrawal by Subject|0
2070856|NCT00622700|3649669|FG000|Core Treatment Period|Randomized but Not Treated|0
2070857|NCT00622700|3649670|FG001|Core Treatment Period|Randomized but Not Treated|2
2070858|NCT00622700|3649671|FG002|Core Treatment Period|Randomized but Not Treated|2
2070859|NCT00622700|3649672|FG003|Core Treatment Period|Randomized but Not Treated|0
2070860|NCT00622700|3649673|FG004|Core Treatment Period|Randomized but Not Treated|0
2070861|NCT00622700|3649674|FG005|Core Treatment Period|Randomized but Not Treated|0
2070862|NCT00622700|3649675|FG006|Core Treatment Period|Randomized but Not Treated|0
2070863|NCT00622700|3649669|FG000|Core Treatment Period|Adverse Event|18
2070864|NCT00622700|3649670|FG001|Core Treatment Period|Adverse Event|25
2070865|NCT00622700|3649671|FG002|Core Treatment Period|Adverse Event|18
2070866|NCT00622700|3649672|FG003|Core Treatment Period|Adverse Event|0
2070867|NCT00622700|3649673|FG004|Core Treatment Period|Adverse Event|0
2070868|NCT00622700|3649674|FG005|Core Treatment Period|Adverse Event|0
2070869|NCT00622700|3649675|FG006|Core Treatment Period|Adverse Event|0
2070870|NCT00622700|3649669|FG000|Core Treatment Period|Lack of Efficacy|19
2070871|NCT00622700|3649670|FG001|Core Treatment Period|Lack of Efficacy|6
2070872|NCT00622700|3649671|FG002|Core Treatment Period|Lack of Efficacy|12
2070873|NCT00622700|3649672|FG003|Core Treatment Period|Lack of Efficacy|0
2070874|NCT00622700|3649673|FG004|Core Treatment Period|Lack of Efficacy|0
2070875|NCT00622700|3649674|FG005|Core Treatment Period|Lack of Efficacy|0
2070876|NCT00622700|3649675|FG006|Core Treatment Period|Lack of Efficacy|0
2070877|NCT00622700|3649669|FG000|Core Treatment Period|Lost to Follow-up|1
2070878|NCT00622700|3649670|FG001|Core Treatment Period|Lost to Follow-up|1
2070879|NCT00622700|3649671|FG002|Core Treatment Period|Lost to Follow-up|1
2070880|NCT00622700|3649672|FG003|Core Treatment Period|Lost to Follow-up|0
2070881|NCT00622700|3649673|FG004|Core Treatment Period|Lost to Follow-up|0
2070882|NCT00622700|3649674|FG005|Core Treatment Period|Lost to Follow-up|0
2070883|NCT00622700|3649675|FG006|Core Treatment Period|Lost to Follow-up|0
2070884|NCT00622700|3649669|FG000|Core Treatment Period|Death|1
2070885|NCT00622700|3649670|FG001|Core Treatment Period|Death|0
2070886|NCT00622700|3649671|FG002|Core Treatment Period|Death|0
2070887|NCT00622700|3649672|FG003|Core Treatment Period|Death|0
2070888|NCT00622700|3649673|FG004|Core Treatment Period|Death|0
2070889|NCT00622700|3649674|FG005|Core Treatment Period|Death|0
2070890|NCT00622700|3649675|FG006|Core Treatment Period|Death|0
2070891|NCT00622700|3649669|FG000|Core Treatment Period|Progressive Disease|3
2070892|NCT00622700|3649670|FG001|Core Treatment Period|Progressive Disease|1
2070893|NCT00622700|3649671|FG002|Core Treatment Period|Progressive Disease|0
2070894|NCT00622700|3649672|FG003|Core Treatment Period|Progressive Disease|0
2070895|NCT00622700|3649673|FG004|Core Treatment Period|Progressive Disease|0
2070896|NCT00622700|3649674|FG005|Core Treatment Period|Progressive Disease|0
2070897|NCT00622700|3649675|FG006|Core Treatment Period|Progressive Disease|0
2070898|NCT00622700|3649669|FG000|Core Treatment Period|Withdrawal by Subject|12
2070899|NCT00622700|3649670|FG001|Core Treatment Period|Withdrawal by Subject|18
2070900|NCT00622700|3649671|FG002|Core Treatment Period|Withdrawal by Subject|15
2070901|NCT00622700|3649672|FG003|Core Treatment Period|Withdrawal by Subject|0
2070902|NCT00622700|3649673|FG004|Core Treatment Period|Withdrawal by Subject|0
2070903|NCT00622700|3649674|FG005|Core Treatment Period|Withdrawal by Subject|0
2070904|NCT00622700|3649675|FG006|Core Treatment Period|Withdrawal by Subject|0
2070905|NCT00622700|3649669|FG000|Core Treatment Period|Other than specified above|2
2070906|NCT00622700|3649670|FG001|Core Treatment Period|Other than specified above|2
2070907|NCT00622700|3649671|FG002|Core Treatment Period|Other than specified above|5
2070908|NCT00622700|3649672|FG003|Core Treatment Period|Other than specified above|0
2070909|NCT00622700|3649673|FG004|Core Treatment Period|Other than specified above|0
2070910|NCT00622700|3649674|FG005|Core Treatment Period|Other than specified above|0
2070911|NCT00622700|3649675|FG006|Core Treatment Period|Other than specified above|0
2070912|NCT00622700|3649669|FG000|Extension Treatment Period|Adverse Event|0
2070913|NCT00622700|3649670|FG001|Extension Treatment Period|Adverse Event|0
2070914|NCT00622700|3649671|FG002|Extension Treatment Period|Adverse Event|0
2070915|NCT00622700|3649672|FG003|Extension Treatment Period|Adverse Event|5
2070916|NCT00622700|3649673|FG004|Extension Treatment Period|Adverse Event|9
2070917|NCT00622700|3649674|FG005|Extension Treatment Period|Adverse Event|6
2070918|NCT00622700|3649675|FG006|Extension Treatment Period|Adverse Event|8
2070919|NCT00622700|3649669|FG000|Extension Treatment Period|Lack of Efficacy|0
2070920|NCT00622700|3649670|FG001|Extension Treatment Period|Lack of Efficacy|0
2070921|NCT00622700|3649671|FG002|Extension Treatment Period|Lack of Efficacy|0
2070922|NCT00622700|3649672|FG003|Extension Treatment Period|Lack of Efficacy|2
2070923|NCT00622700|3649673|FG004|Extension Treatment Period|Lack of Efficacy|8
2070924|NCT00622700|3649674|FG005|Extension Treatment Period|Lack of Efficacy|1
2070925|NCT00622700|3649675|FG006|Extension Treatment Period|Lack of Efficacy|9
2070926|NCT00622700|3649669|FG000|Extension Treatment Period|Protocol Violation|0
2070927|NCT00622700|3649670|FG001|Extension Treatment Period|Protocol Violation|0
2070928|NCT00622700|3649671|FG002|Extension Treatment Period|Protocol Violation|0
2070929|NCT00622700|3649672|FG003|Extension Treatment Period|Protocol Violation|0
2070930|NCT00622700|3649673|FG004|Extension Treatment Period|Protocol Violation|0
2304162|NCT02648217|4003828|FG001|Overall Study|Withdrawal by Subject|3
2304163|NCT02648217|4003827|FG000|Overall Study|Unclassified|5
2304164|NCT02648217|4003828|FG001|Overall Study|Unclassified|0
2304165|NCT02648438|4003841|FG000|Overall Study|Eligibility criteria not fulfilled|0
2304166|NCT02648438|4003842|FG001|Overall Study|Eligibility criteria not fulfilled|2
2304167|NCT02648438|4003843|FG002|Overall Study|Eligibility criteria not fulfilled|0
2070931|NCT00622700|3649674|FG005|Extension Treatment Period|Protocol Violation|2
2070932|NCT00622700|3649675|FG006|Extension Treatment Period|Protocol Violation|0
2070933|NCT00622700|3649669|FG000|Extension Treatment Period|Lost to Follow-up|0
2070934|NCT00622700|3649670|FG001|Extension Treatment Period|Lost to Follow-up|0
2070935|NCT00622700|3649671|FG002|Extension Treatment Period|Lost to Follow-up|0
2304168|NCT02648438|4003841|FG000|Overall Study|Protocol Violation|2
2070936|NCT00622700|3649672|FG003|Extension Treatment Period|Lost to Follow-up|0
2070937|NCT00622700|3649673|FG004|Extension Treatment Period|Lost to Follow-up|1
2070938|NCT00622700|3649674|FG005|Extension Treatment Period|Lost to Follow-up|0
2070939|NCT00622700|3649675|FG006|Extension Treatment Period|Lost to Follow-up|0
2070940|NCT00622700|3649669|FG000|Extension Treatment Period|Progressive Disease|0
2070941|NCT00622700|3649670|FG001|Extension Treatment Period|Progressive Disease|0
2070942|NCT00622700|3649671|FG002|Extension Treatment Period|Progressive Disease|0
2070943|NCT00622700|3649672|FG003|Extension Treatment Period|Progressive Disease|1
2070944|NCT00622700|3649673|FG004|Extension Treatment Period|Progressive Disease|2
2070945|NCT00622700|3649674|FG005|Extension Treatment Period|Progressive Disease|0
2070946|NCT00622700|3649675|FG006|Extension Treatment Period|Progressive Disease|2
2070947|NCT00622700|3649669|FG000|Extension Treatment Period|Withdrawal by Subject|0
2070948|NCT00622700|3649670|FG001|Extension Treatment Period|Withdrawal by Subject|0
2070949|NCT00622700|3649671|FG002|Extension Treatment Period|Withdrawal by Subject|0
2070950|NCT00622700|3649672|FG003|Extension Treatment Period|Withdrawal by Subject|11
2070951|NCT00622700|3649673|FG004|Extension Treatment Period|Withdrawal by Subject|16
2070952|NCT00622700|3649674|FG005|Extension Treatment Period|Withdrawal by Subject|6
2070953|NCT00622700|3649675|FG006|Extension Treatment Period|Withdrawal by Subject|10
2070954|NCT00622700|3649669|FG000|Extension Treatment Period|Missing|0
2070955|NCT00622700|3649670|FG001|Extension Treatment Period|Missing|0
2070956|NCT00622700|3649671|FG002|Extension Treatment Period|Missing|0
2070957|NCT00622700|3649672|FG003|Extension Treatment Period|Missing|2
2070958|NCT00622700|3649673|FG004|Extension Treatment Period|Missing|3
2070959|NCT00622700|3649674|FG005|Extension Treatment Period|Missing|1
2070960|NCT00622700|3649675|FG006|Extension Treatment Period|Missing|0
2070961|NCT00622700|3649669|FG000|Extension Treatment Period|Other than specified above|0
2070962|NCT00622700|3649670|FG001|Extension Treatment Period|Other than specified above|0
2070963|NCT00622700|3649671|FG002|Extension Treatment Period|Other than specified above|0
2070964|NCT00622700|3649672|FG003|Extension Treatment Period|Other than specified above|0
2070965|NCT00622700|3649673|FG004|Extension Treatment Period|Other than specified above|0
2070966|NCT00622700|3649674|FG005|Extension Treatment Period|Other than specified above|1
2070967|NCT00622700|3649675|FG006|Extension Treatment Period|Other than specified above|1
2070968|NCT00622713|3649692|FG000|Overall Study|Adverse Event|35
2070969|NCT00622713|3649692|FG000|Overall Study|Administrative problems|4
2070970|NCT00622713|3649692|FG000|Overall Study|Withdrawal by Subject|11
2070971|NCT00622713|3649692|FG000|Overall Study|Lost to Follow-up|5
2070972|NCT00622713|3649692|FG000|Overall Study|Death|2
2070973|NCT00622713|3649692|FG000|Overall Study|Subject no longer required study drug|1
2070974|NCT00622713|3649692|FG000|Overall Study|Did not meet eligibility criteria|1
2070975|NCT00622726|3649698|FG000|March, 2008 to August, 2010|Death|5
2070976|NCT00622726|3649699|FG001|March, 2008 to August, 2010|Death|2
2070977|NCT00622726|3649698|FG000|August, 2010 to April, 2013|Death|1
2070978|NCT00622726|3649699|FG001|August, 2010 to April, 2013|Death|5
2070979|NCT00622739|3649711|FG000|Overall Study|Physician Decision|1
2070980|NCT00622739|3649712|FG001|Overall Study|Physician Decision|0
2070981|NCT00622739|3649711|FG000|Overall Study|Adverse Event|1
2070982|NCT00622739|3649712|FG001|Overall Study|Adverse Event|2
2070983|NCT00622739|3649711|FG000|Overall Study|Lack of Efficacy|0
2070984|NCT00622739|3649712|FG001|Overall Study|Lack of Efficacy|2
2070985|NCT00622739|3649711|FG000|Overall Study|Withdrawal by Subject|0
2070986|NCT00622739|3649712|FG001|Overall Study|Withdrawal by Subject|1
2070987|NCT00622739|3649711|FG000|Overall Study|Lost to Follow-up|0
2070988|NCT00622739|3649712|FG001|Overall Study|Lost to Follow-up|1
2070989|NCT00622869|3649723|FG000|Overall Study|Subject Withdrew Consent|13
2070990|NCT00622869|3649724|FG001|Overall Study|Subject Withdrew Consent|17
2070991|NCT00622869|3649725|FG002|Overall Study|Subject Withdrew Consent|11
2070992|NCT00622869|3649723|FG000|Overall Study|Administrative Problems|11
2070993|NCT00622869|3649724|FG001|Overall Study|Administrative Problems|17
2070994|NCT00622869|3649725|FG002|Overall Study|Administrative Problems|13
2070995|NCT00622869|3649723|FG000|Overall Study|Death|12
2070996|NCT00622869|3649724|FG001|Overall Study|Death|15
2070997|NCT00622869|3649725|FG002|Overall Study|Death|10
2070998|NCT00622869|3649723|FG000|Overall Study|Lost to Follow-up|2
2070999|NCT00622869|3649724|FG001|Overall Study|Lost to Follow-up|4
2071000|NCT00622869|3649725|FG002|Overall Study|Lost to Follow-up|2
2071001|NCT00622869|3649723|FG000|Overall Study|Graft Loss|5
2304169|NCT02648438|4003842|FG001|Overall Study|Protocol Violation|0
2304170|NCT02648438|4003843|FG002|Overall Study|Protocol Violation|0
2071002|NCT00622869|3649724|FG001|Overall Study|Graft Loss|3
2071003|NCT00622869|3649725|FG002|Overall Study|Graft Loss|2
2071004|NCT00622869|3649723|FG000|Overall Study|Missing|0
2071005|NCT00622869|3649724|FG001|Overall Study|Missing|1
2210432|NCT01649856|3849912|FG000|Overall Study|Other|20
2210433|NCT01649856|3849913|FG001|Overall Study|Other|5
2071006|NCT00622869|3649725|FG002|Overall Study|Missing|1
2071007|NCT00622908|3649742|FG000|Overall Study|Protocol Violation|1
2071008|NCT00622908|3649743|FG001|Overall Study|Protocol Violation|0
2071009|NCT00622908|3649742|FG000|Overall Study|Adverse Event|0
2071010|NCT00622908|3649743|FG001|Overall Study|Adverse Event|1
2071011|NCT00622908|3649742|FG000|Overall Study|Lack of Efficacy|1
2071012|NCT00622908|3649743|FG001|Overall Study|Lack of Efficacy|7
2304171|NCT02648438|4003841|FG000|Overall Study|Withdrawal by Subject|1
2071013|NCT00622908|3649742|FG000|Overall Study|Lost to Follow-up|1
2071014|NCT00622908|3649743|FG001|Overall Study|Lost to Follow-up|0
2071015|NCT00622908|3649742|FG000|Overall Study|Refusal|0
2071016|NCT00622908|3649743|FG001|Overall Study|Refusal|1
2071017|NCT00622908|3649742|FG000|Overall Study|Termination by study sponser|0
2071018|NCT00622908|3649743|FG001|Overall Study|Termination by study sponser|1
2071019|NCT00623103|3649755|FG000|Overall Study|Adverse Event|70
2071020|NCT00623103|3649756|FG001|Overall Study|Adverse Event|60
2071021|NCT00623103|3649755|FG000|Overall Study|Unsatisfactory therapeutic effect|4
2071022|NCT00623103|3649756|FG001|Overall Study|Unsatisfactory therapeutic effect|12
2071023|NCT00623103|3649755|FG000|Overall Study|Withdrawal by Subject|18
2071024|NCT00623103|3649756|FG001|Overall Study|Withdrawal by Subject|24
2071025|NCT00623103|3649755|FG000|Overall Study|Lost to Follow-up|4
2071026|NCT00623103|3649756|FG001|Overall Study|Lost to Follow-up|1
2071027|NCT00623103|3649755|FG000|Overall Study|Administrative problems|2
2071028|NCT00623103|3649756|FG001|Overall Study|Administrative problems|4
2071029|NCT00623103|3649755|FG000|Overall Study|Death|11
2071030|NCT00623103|3649756|FG001|Overall Study|Death|11
2071031|NCT00623103|3649755|FG000|Overall Study|Protocol deviation|2
2071032|NCT00623103|3649756|FG001|Overall Study|Protocol deviation|1
2071033|NCT00623194|3649775|FG000|Overall Study|Lack of Efficacy|1
2071034|NCT00623194|3649775|FG000|Overall Study|Protocol Violation|3
2071035|NCT00623194|3649775|FG000|Overall Study|Unclassified|1
2210434|NCT01649869|3849921|FG000|Overall Study|Family member illness|1
2210435|NCT01649869|3849922|FG001|Overall Study|Family member illness|0
2071036|NCT00623233|3649779|FG000|Overall Study|Adverse Event|10
2071037|NCT00623233|3649779|FG000|Overall Study|Physician Decision|10
2071038|NCT00623233|3649779|FG000|Overall Study|Lost to Follow-up|1
2071039|NCT00623233|3649779|FG000|Overall Study|Withdrawal by Subject|3
2071040|NCT00623363|3649785|FG000|Overall Study|Adverse Event|2
2071041|NCT00623363|3649786|FG001|Overall Study|Adverse Event|2
2071042|NCT00623428|3649795|FG000|Treatment Period|Adverse event/intercurrent illness|0
2071043|NCT00623428|3649796|FG001|Treatment Period|Adverse event/intercurrent illness|9
2071044|NCT00623428|3649795|FG000|Treatment Period|Death|0
2071045|NCT00623428|3649796|FG001|Treatment Period|Death|1
2071046|NCT00623428|3649795|FG000|Treatment Period|Did not cooperate / refused treatment|0
2071047|NCT00623428|3649796|FG001|Treatment Period|Did not cooperate / refused treatment|13
2071048|NCT00623428|3649795|FG000|Treatment Period|Insufficient therapeutic response|0
2071049|NCT00623428|3649796|FG001|Treatment Period|Insufficient therapeutic response|2
2071050|NCT00623428|3649795|FG000|Treatment Period|Other|0
2071051|NCT00623428|3649796|FG001|Treatment Period|Other|1
2071052|NCT00623428|3649795|FG000|Treatment Period|Withdrawal by Subject|0
2071053|NCT00623428|3649796|FG001|Treatment Period|Withdrawal by Subject|1
2071054|NCT00623428|3649795|FG000|Follow-up Period|Relapse post-treatment|11
2071055|NCT00623428|3649796|FG001|Follow-up Period|Relapse post-treatment|3
2071056|NCT00623428|3649795|FG000|Follow-up Period|Failure to return|10
2071057|NCT00623428|3649796|FG001|Follow-up Period|Failure to return|2
2071058|NCT00623428|3649795|FG000|Follow-up Period|Patient withdrew consent|5
2071059|NCT00623428|3649796|FG001|Follow-up Period|Patient withdrew consent|4
2071060|NCT00623428|3649795|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2
2071061|NCT00623428|3649796|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1
2071062|NCT00623428|3649795|FG000|Follow-up Period|Did not cooperate|0
2071063|NCT00623428|3649796|FG001|Follow-up Period|Did not cooperate|3
2071064|NCT00623428|3649795|FG000|Follow-up Period|Reason not specified|1
2071065|NCT00623428|3649796|FG001|Follow-up Period|Reason not specified|1
2071066|NCT00623428|3649795|FG000|Follow-up Period|Death|0
2071067|NCT00623428|3649796|FG001|Follow-up Period|Death|1
2071068|NCT00623467|3649806|FG000|Overall Study|Lost to Follow-up|1
2071069|NCT00623467|3649806|FG000|Overall Study|Protocol Violation|4
2071070|NCT00623467|3649806|FG000|Overall Study|Withdrawal by Subject|2
2071071|NCT00623480|3649814|FG000|Overall Study|Lost to Follow-up|0
2071072|NCT00623480|3649815|FG001|Overall Study|Lost to Follow-up|1
2071073|NCT00623480|3649814|FG000|Overall Study|Withdrawal by Subject|2
2071074|NCT00623480|3649815|FG001|Overall Study|Withdrawal by Subject|4
2071075|NCT00623480|3649814|FG000|Overall Study|Lack of Efficacy|1
2071076|NCT00623480|3649815|FG001|Overall Study|Lack of Efficacy|0
2071077|NCT00623480|3649814|FG000|Overall Study|Non-compliant with study medication|4
2071078|NCT00623480|3649815|FG001|Overall Study|Non-compliant with study medication|0
2071079|NCT00623480|3649814|FG000|Overall Study|Protocol Violation|0
2071080|NCT00623480|3649815|FG001|Overall Study|Protocol Violation|1
2071081|NCT00623480|3649814|FG000|Overall Study|Site closed by sponsor|0
2071082|NCT00623480|3649815|FG001|Overall Study|Site closed by sponsor|1
2071083|NCT00623545|3649830|FG000|Overall Study|Adverse Event|6
2071084|NCT00623545|3649830|FG000|Overall Study|Withdrawal by Subject|4
2071085|NCT00623597|3649837|FG000|Overall Study|Failed to return|1
2071086|NCT00623597|3649838|FG001|Overall Study|Failed to return|0
2071087|NCT00623623|3649848|FG000|Overall Study|Previous enrolment into this study|1
2071088|NCT00623623|3649849|FG001|Overall Study|Previous enrolment into this study|1
2071089|NCT00623727|3649874|FG000|Double Blind (DB)|Adverse Event|1
2071090|NCT00623727|3649875|FG001|Double Blind (DB)|Adverse Event|3
2071091|NCT00623727|3649874|FG000|Double Blind (DB)|Physician Decision|0
2071092|NCT00623727|3649875|FG001|Double Blind (DB)|Physician Decision|1
2071093|NCT00623727|3649874|FG000|Double Blind (DB)|Withdrawal by Subject|8
2071094|NCT00623727|3649875|FG001|Double Blind (DB)|Withdrawal by Subject|2
2071095|NCT00623727|3649874|FG000|Double Blind (DB)|Lack of Efficacy|2
2071096|NCT00623727|3649875|FG001|Double Blind (DB)|Lack of Efficacy|2
2071097|NCT00623727|3649874|FG000|Double Blind (DB)|Termination of the double-blind period|22
2071098|NCT00623727|3649875|FG001|Double Blind (DB)|Termination of the double-blind period|21
2071099|NCT00623727|3649874|FG000|Double Blind (DB)|Lost to Follow-up|1
2071100|NCT00623727|3649875|FG001|Double Blind (DB)|Lost to Follow-up|1
2071101|NCT00623727|3649874|FG000|Double Blind (DB)|Protocol Violation|2
2071102|NCT00623727|3649875|FG001|Double Blind (DB)|Protocol Violation|2
2071103|NCT00623727|3649874|FG000|Open Label Follow-up|Withdrawal by Subject|0
2071104|NCT00623727|3649875|FG001|Open Label Follow-up|Withdrawal by Subject|1
2071105|NCT00623727|3649874|FG000|Open Label Follow-up|Study termination|0
2071106|NCT00623727|3649875|FG001|Open Label Follow-up|Study termination|6
2071107|NCT00623727|3649874|FG000|Open Label Follow-up|Participant convenience|0
2071108|NCT00623727|3649875|FG001|Open Label Follow-up|Participant convenience|1
2071109|NCT00623766|3649885|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36
2071110|NCT00623766|3649886|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16
2071111|NCT00623766|3649885|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
2071112|NCT00623766|3649886|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
2071113|NCT00623766|3649885|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
2071114|NCT00623766|3649886|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
2071115|NCT00623766|3649885|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
2071116|NCT00623766|3649886|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
2071117|NCT00623766|3649885|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
2071118|NCT00623766|3649886|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
2071119|NCT00623779|3649899|FG000|Overall Study|Adverse Event|1
2071120|NCT00623779|3649900|FG001|Overall Study|Adverse Event|3
2071121|NCT00623779|3649901|FG002|Overall Study|Adverse Event|0
2071122|NCT00623779|3649899|FG000|Overall Study|Criteria from CSR|2
2071123|NCT00623779|3649900|FG001|Overall Study|Criteria from CSR|0
2071124|NCT00623779|3649901|FG002|Overall Study|Criteria from CSR|1
2071125|NCT00623805|3649911|FG000|Overall Study|Adverse Event|9
2071126|NCT00623805|3649912|FG001|Overall Study|Adverse Event|6
2071127|NCT00623805|3649911|FG000|Overall Study|Death|2
2071128|NCT00623805|3649912|FG001|Overall Study|Death|0
2071129|NCT00623805|3649911|FG000|Overall Study|Lack of Efficacy|3
2071130|NCT00623805|3649912|FG001|Overall Study|Lack of Efficacy|7
2071131|NCT00623805|3649911|FG000|Overall Study|Lost to Follow-up|2
2071132|NCT00623805|3649912|FG001|Overall Study|Lost to Follow-up|2
2071133|NCT00623805|3649911|FG000|Overall Study|Protocol Violation|1
2071134|NCT00623805|3649912|FG001|Overall Study|Protocol Violation|1
2071135|NCT00623805|3649911|FG000|Overall Study|Reason not Specified|3
2071136|NCT00623805|3649912|FG001|Overall Study|Reason not Specified|6
2071137|NCT00623831|3649920|FG000|Overall Study|Withdrawal by Subject|1
2071138|NCT00623831|3649921|FG001|Overall Study|Withdrawal by Subject|0
2071139|NCT00623831|3649920|FG000|Overall Study|Progressive Disease|0
2071140|NCT00623831|3649921|FG001|Overall Study|Progressive Disease|1
2071141|NCT00623935|3649930|FG000|Overall Study|Death|1
2071142|NCT00623935|3649930|FG000|Overall Study|Patient Declined Transplant|1
2071143|NCT00624052|3649949|FG000|Overall Study|Adverse Event|7
2071144|NCT00624052|3649950|FG001|Overall Study|Adverse Event|6
2071145|NCT00624052|3649951|FG002|Overall Study|Adverse Event|0
2071146|NCT00624052|3649952|FG003|Overall Study|Adverse Event|3
2071147|NCT00624052|3649949|FG000|Overall Study|Lack of Efficacy|1
2071148|NCT00624052|3649950|FG001|Overall Study|Lack of Efficacy|1
2071149|NCT00624052|3649951|FG002|Overall Study|Lack of Efficacy|0
2071150|NCT00624052|3649952|FG003|Overall Study|Lack of Efficacy|0
2071151|NCT00624052|3649949|FG000|Overall Study|Lost to Follow-up|2
2071152|NCT00624052|3649950|FG001|Overall Study|Lost to Follow-up|3
2071153|NCT00624052|3649951|FG002|Overall Study|Lost to Follow-up|1
2071154|NCT00624052|3649952|FG003|Overall Study|Lost to Follow-up|0
2071155|NCT00624052|3649949|FG000|Overall Study|Non compliant with the protocol|2
2071156|NCT00624052|3649950|FG001|Overall Study|Non compliant with the protocol|1
2071157|NCT00624052|3649951|FG002|Overall Study|Non compliant with the protocol|1
2071158|NCT00624052|3649952|FG003|Overall Study|Non compliant with the protocol|1
2071159|NCT00624052|3649949|FG000|Overall Study|Consent withdrawn|3
2071160|NCT00624052|3649950|FG001|Overall Study|Consent withdrawn|1
2071161|NCT00624052|3649951|FG002|Overall Study|Consent withdrawn|1
2071162|NCT00624052|3649952|FG003|Overall Study|Consent withdrawn|0
2071163|NCT00624052|3649949|FG000|Overall Study|Changed job/ran out if meds|0
2071164|NCT00624052|3649950|FG001|Overall Study|Changed job/ran out if meds|2
2071165|NCT00624052|3649951|FG002|Overall Study|Changed job/ran out if meds|0
2071166|NCT00624052|3649952|FG003|Overall Study|Changed job/ran out if meds|0
2071167|NCT00624065|3649968|FG000|Overall Study|Adverse Event|5
2071168|NCT00624065|3649969|FG001|Overall Study|Adverse Event|6
2071169|NCT00624065|3649968|FG000|Overall Study|Lost to Follow-up|4
2071170|NCT00624065|3649969|FG001|Overall Study|Lost to Follow-up|1
2071171|NCT00624065|3649968|FG000|Overall Study|Consent withdrawn|6
2071172|NCT00624065|3649969|FG001|Overall Study|Consent withdrawn|5
2071173|NCT00624065|3649968|FG000|Overall Study|Lack of Efficacy|0
2071174|NCT00624065|3649969|FG001|Overall Study|Lack of Efficacy|3
2106378|NCT00865280|3699513|FG001|Overall Study|Withdrawal by Subject|1
2071175|NCT00624065|3649968|FG000|Overall Study|Met protocol-defined stopping criteria|4
2071176|NCT00624065|3649969|FG001|Overall Study|Met protocol-defined stopping criteria|9
2071177|NCT00624286|3650020|FG000|Overall Study|Protocol Deviation|7
2071178|NCT00624286|3650021|FG001|Overall Study|Protocol Deviation|9
2071179|NCT00624286|3650020|FG000|Overall Study|Adverse Event|6
2071180|NCT00624286|3650021|FG001|Overall Study|Adverse Event|3
2071181|NCT00624286|3650020|FG000|Overall Study|Withdrawal by Subject|5
2071182|NCT00624286|3650021|FG001|Overall Study|Withdrawal by Subject|4
2071183|NCT00624286|3650020|FG000|Overall Study|Lost to Follow-up|3
2071184|NCT00624286|3650021|FG001|Overall Study|Lost to Follow-up|2
2071185|NCT00624286|3650020|FG000|Overall Study|Administrative problems|3
2071186|NCT00624286|3650021|FG001|Overall Study|Administrative problems|0
2071187|NCT00624286|3650020|FG000|Overall Study|Lack of Efficacy|1
2071188|NCT00624286|3650021|FG001|Overall Study|Lack of Efficacy|6
2071189|NCT00624286|3650020|FG000|Overall Study|Not stated|0
2071190|NCT00624286|3650021|FG001|Overall Study|Not stated|1
2071191|NCT00624286|3650020|FG000|Overall Study|Abnormal test procedure result(s)|0
2071192|NCT00624286|3650021|FG001|Overall Study|Abnormal test procedure result(s)|1
2071193|NCT00624286|3650020|FG000|Overall Study|Death|0
2071194|NCT00624286|3650021|FG001|Overall Study|Death|1
2071195|NCT00624338|3650030|FG000|Overall Study|Adverse Event|14
2071196|NCT00624338|3650031|FG001|Overall Study|Adverse Event|14
2071197|NCT00624338|3650032|FG002|Overall Study|Adverse Event|18
2071198|NCT00624338|3650030|FG000|Overall Study|Lost to Follow-up|1
2071199|NCT00624338|3650031|FG001|Overall Study|Lost to Follow-up|0
2071200|NCT00624338|3650032|FG002|Overall Study|Lost to Follow-up|0
2071201|NCT00624338|3650030|FG000|Overall Study|Lack of Efficacy|11
2071202|NCT00624338|3650031|FG001|Overall Study|Lack of Efficacy|3
2071203|NCT00624338|3650032|FG002|Overall Study|Lack of Efficacy|14
2071204|NCT00624338|3650030|FG000|Overall Study|Protocol Violation|3
2071205|NCT00624338|3650031|FG001|Overall Study|Protocol Violation|3
2071206|NCT00624338|3650032|FG002|Overall Study|Protocol Violation|2
2071207|NCT00624338|3650030|FG000|Overall Study|Death|0
2071208|NCT00624338|3650031|FG001|Overall Study|Death|2
2071209|NCT00624338|3650032|FG002|Overall Study|Death|0
2071210|NCT00624338|3650030|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1
2071211|NCT00624338|3650031|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0
2071212|NCT00624338|3650032|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0
2071213|NCT00624338|3650030|FG000|Overall Study|Termination of 150 mg group by Sponsor|0
2071214|NCT00624338|3650031|FG001|Overall Study|Termination of 150 mg group by Sponsor|55
2071215|NCT00624338|3650032|FG002|Overall Study|Termination of 150 mg group by Sponsor|0
2071216|NCT00624338|3650030|FG000|Overall Study|Other|15
2071217|NCT00624338|3650031|FG001|Overall Study|Other|5
2071218|NCT00624338|3650032|FG002|Overall Study|Other|9
2071219|NCT00624338|3650030|FG000|Overall Study|Randomized but not treated|2
2071220|NCT00624338|3650031|FG001|Overall Study|Randomized but not treated|1
2071221|NCT00624338|3650032|FG002|Overall Study|Randomized but not treated|3
2071222|NCT00624377|3650040|FG000|Overall Study|Lost to Follow-up|355
2071223|NCT00624377|3650040|FG000|Overall Study|Withdrawal by Subject|100
2071224|NCT00624377|3650040|FG000|Overall Study|Adverse Event|14
2071225|NCT00624377|3650040|FG000|Overall Study|Other|91
2071226|NCT00624377|3650040|FG000|Overall Study|Non-evaluable population|84
2071227|NCT00624468|3650092|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13
2071228|NCT00624468|3650093|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12
2071229|NCT00624468|3650094|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0
2071230|NCT00624468|3650095|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0
2071231|NCT00624468|3650092|FG000|Double-blind Period|Withdrew Prematurely|1
2071232|NCT00624468|3650093|FG001|Double-blind Period|Withdrew Prematurely|1
2071233|NCT00624468|3650094|FG002|Double-blind Period|Withdrew Prematurely|0
2071234|NCT00624468|3650095|FG003|Double-blind Period|Withdrew Prematurely|0
2071235|NCT00624468|3650092|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0
2071236|NCT00624468|3650093|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0
2071237|NCT00624468|3650094|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1
2071238|NCT00624468|3650095|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2
2071239|NCT00624468|3650092|FG000|Safety Follow-up (SFU) Period|Other|0
2071240|NCT00624468|3650093|FG001|Safety Follow-up (SFU) Period|Other|0
2071241|NCT00624468|3650094|FG002|Safety Follow-up (SFU) Period|Other|1
2071242|NCT00624468|3650095|FG003|Safety Follow-up (SFU) Period|Other|1
2071243|NCT00624520|3650105|FG000|Overall Study|Withdrawal by Subject|12
2071244|NCT00624520|3650106|FG001|Overall Study|Withdrawal by Subject|7
2071245|NCT00624520|3650105|FG000|Overall Study|Death|0
2071246|NCT00624520|3650106|FG001|Overall Study|Death|1
2071247|NCT00624585|3650129|FG000|Overall Study|Death|3
2071248|NCT00624585|3650129|FG000|Overall Study|Disease Progression|6
2071249|NCT00624585|3650129|FG000|Overall Study|Adverse Event|3
2071250|NCT00624780|3650139|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7
2071251|NCT00624780|3650140|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5
2071252|NCT00624780|3650141|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15
2071253|NCT00624780|3650142|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3
2071254|NCT00624780|3650143|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9
2071255|NCT00624780|3650144|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5
2071256|NCT00624780|3650139|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
2071257|NCT00624780|3650140|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
2071258|NCT00624780|3650141|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
2071259|NCT00624780|3650142|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
2071260|NCT00624780|3650143|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
2071261|NCT00624780|3650144|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
2071262|NCT00624780|3650139|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
2071263|NCT00624780|3650140|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
2071264|NCT00624780|3650141|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
2071265|NCT00624780|3650142|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
2071266|NCT00624780|3650143|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
2071267|NCT00624780|3650144|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
2071268|NCT00624780|3650139|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
2071269|NCT00624780|3650140|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
2071270|NCT00624780|3650141|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
2071271|NCT00624780|3650142|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
2071272|NCT00624780|3650143|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
2071273|NCT00624780|3650144|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
2071274|NCT00624780|3650139|FG000|Treatment Optimization (Up to Week 12)|Other|10
2071275|NCT00624780|3650140|FG001|Treatment Optimization (Up to Week 12)|Other|4
2071276|NCT00624780|3650141|FG002|Treatment Optimization (Up to Week 12)|Other|8
2071277|NCT00624780|3650142|FG003|Treatment Optimization (Up to Week 12)|Other|2
2071278|NCT00624780|3650143|FG004|Treatment Optimization (Up to Week 12)|Other|9
2071279|NCT00624780|3650144|FG005|Treatment Optimization (Up to Week 12)|Other|0
2071280|NCT00624780|3650139|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
2071281|NCT00624780|3650140|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
2071282|NCT00624780|3650141|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
2071283|NCT00624780|3650142|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
2071284|NCT00624780|3650143|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
2071285|NCT00624780|3650144|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
2071286|NCT00624780|3650139|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
2071287|NCT00624780|3650140|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
2071288|NCT00624780|3650141|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
2071289|NCT00624780|3650142|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
2071290|NCT00624780|3650143|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
2071291|NCT00624780|3650144|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
2071292|NCT00624780|3650139|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
2071293|NCT00624780|3650140|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
2071294|NCT00624780|3650141|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
2071295|NCT00624780|3650142|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
2071296|NCT00624780|3650143|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
2071297|NCT00624780|3650144|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
2071298|NCT00624780|3650139|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
2071299|NCT00624780|3650140|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
2071300|NCT00624780|3650141|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
2071301|NCT00624780|3650142|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
2071302|NCT00624780|3650143|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
2071303|NCT00624780|3650144|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
2071304|NCT00624780|3650139|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5
2071305|NCT00624780|3650140|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3
2071306|NCT00624780|3650141|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4
2071307|NCT00624780|3650142|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1
2071308|NCT00624780|3650143|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4
2071309|NCT00624780|3650144|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3
2071310|NCT00624780|3650139|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1
2071311|NCT00624780|3650140|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0
2071312|NCT00624780|3650141|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2
2071313|NCT00624780|3650142|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1
2071314|NCT00624780|3650143|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0
2071315|NCT00624780|3650144|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1
2071316|NCT00624780|3650139|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
2071317|NCT00624780|3650140|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
2071318|NCT00624780|3650141|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
2071319|NCT00624780|3650142|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
2071320|NCT00624780|3650143|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
2071321|NCT00624780|3650144|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
2071322|NCT00624780|3650139|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
2071323|NCT00624780|3650140|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
2071324|NCT00624780|3650141|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
2071325|NCT00624780|3650142|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
2071326|NCT00624780|3650143|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
2071327|NCT00624780|3650144|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
2071328|NCT00624780|3650139|FG000|Follow-up (Week 26)|Death|0
2071329|NCT00624780|3650140|FG001|Follow-up (Week 26)|Death|0
2071330|NCT00624780|3650141|FG002|Follow-up (Week 26)|Death|1
2071331|NCT00624780|3650142|FG003|Follow-up (Week 26)|Death|0
2071332|NCT00624780|3650143|FG004|Follow-up (Week 26)|Death|0
2071333|NCT00624780|3650144|FG005|Follow-up (Week 26)|Death|0
2071334|NCT00624780|3650139|FG000|Follow-up (Week 26)|Adverse Event|0
2071335|NCT00624780|3650140|FG001|Follow-up (Week 26)|Adverse Event|0
2071336|NCT00624780|3650141|FG002|Follow-up (Week 26)|Adverse Event|0
2071337|NCT00624780|3650142|FG003|Follow-up (Week 26)|Adverse Event|0
2071338|NCT00624780|3650143|FG004|Follow-up (Week 26)|Adverse Event|1
2071339|NCT00624780|3650144|FG005|Follow-up (Week 26)|Adverse Event|0
2071340|NCT00624780|3650139|FG000|Follow-up (Week 26)|Lost to Follow-up|0
2071341|NCT00624780|3650140|FG001|Follow-up (Week 26)|Lost to Follow-up|0
2071342|NCT00624780|3650141|FG002|Follow-up (Week 26)|Lost to Follow-up|1
2071343|NCT00624780|3650142|FG003|Follow-up (Week 26)|Lost to Follow-up|0
2071344|NCT00624780|3650143|FG004|Follow-up (Week 26)|Lost to Follow-up|1
2071345|NCT00624780|3650144|FG005|Follow-up (Week 26)|Lost to Follow-up|0
2071346|NCT00624780|3650139|FG000|Follow-up (Week 26)|Withdrawal by Subject|1
2071347|NCT00624780|3650140|FG001|Follow-up (Week 26)|Withdrawal by Subject|0
2071348|NCT00624780|3650141|FG002|Follow-up (Week 26)|Withdrawal by Subject|0
2071349|NCT00624780|3650142|FG003|Follow-up (Week 26)|Withdrawal by Subject|0
2071350|NCT00624780|3650143|FG004|Follow-up (Week 26)|Withdrawal by Subject|0
2071351|NCT00624780|3650144|FG005|Follow-up (Week 26)|Withdrawal by Subject|0
2071352|NCT00624780|3650139|FG000|Follow-up (Week 26)|Other|1
2071353|NCT00624780|3650140|FG001|Follow-up (Week 26)|Other|1
2071354|NCT00624780|3650141|FG002|Follow-up (Week 26)|Other|0
2071355|NCT00624780|3650142|FG003|Follow-up (Week 26)|Other|0
2071356|NCT00624780|3650143|FG004|Follow-up (Week 26)|Other|0
2071357|NCT00624780|3650144|FG005|Follow-up (Week 26)|Other|0
2071358|NCT00624819|3650174|FG000|Follow-up Period: Year 4|Parents decision|0
2071359|NCT00624819|3650175|FG001|Follow-up Period: Year 4|Parents decision|0
2071360|NCT00624819|3650176|FG002|Follow-up Period: Year 4|Parents decision|1
2071361|NCT00624819|3650177|FG003|Follow-up Period: Year 4|Parents decision|0
2071362|NCT00624819|3650174|FG000|Follow-up Period: Year 4|Lost to Follow-up|1
2071363|NCT00624819|3650175|FG001|Follow-up Period: Year 4|Lost to Follow-up|1
2071364|NCT00624819|3650176|FG002|Follow-up Period: Year 4|Lost to Follow-up|0
2071365|NCT00624819|3650177|FG003|Follow-up Period: Year 4|Lost to Follow-up|0
2071366|NCT00624832|3650191|FG000|Overall Study|Adverse Event|0
2071367|NCT00624832|3650192|FG001|Overall Study|Adverse Event|1
2071368|NCT00624832|3650193|FG002|Overall Study|Adverse Event|0
2071369|NCT00624832|3650194|FG003|Overall Study|Adverse Event|1
2071370|NCT00624832|3650191|FG000|Overall Study|Abnormal Laboratory Value|2
2071371|NCT00624832|3650192|FG001|Overall Study|Abnormal Laboratory Value|0
2071372|NCT00624832|3650193|FG002|Overall Study|Abnormal Laboratory Value|0
2071373|NCT00624832|3650194|FG003|Overall Study|Abnormal Laboratory Value|0
2071374|NCT00625131|3650229|FG000|Overall Study|Lost to Follow-up|3
2071375|NCT00625131|3650230|FG001|Overall Study|Lost to Follow-up|2
2071376|NCT00625131|3650231|FG002|Overall Study|Lost to Follow-up|0
2071377|NCT00625131|3650229|FG000|Overall Study|Withdrawal by Subject|1
2071378|NCT00625131|3650230|FG001|Overall Study|Withdrawal by Subject|0
2071379|NCT00625131|3650231|FG002|Overall Study|Withdrawal by Subject|5
2071380|NCT00625183|3650237|FG000|Overall Study|Disease Progression|1
2071381|NCT00625365|3650243|FG000|Overall Study|Withdrawal by Subject|1
2071382|NCT00625365|3650243|FG000|Overall Study|No IV access|5
2071383|NCT00625365|3650243|FG000|Overall Study|VSD|1
2071384|NCT00625443|3650280|FG000|Overall Study|Adverse Event|1
2071385|NCT00625443|3650281|FG001|Overall Study|Adverse Event|4
2071386|NCT00625443|3650282|FG002|Overall Study|Adverse Event|0
2071387|NCT00625443|3650280|FG000|Overall Study|Non-compliance with protocol|0
2071388|NCT00625443|3650281|FG001|Overall Study|Non-compliance with protocol|1
2071389|NCT00625443|3650282|FG002|Overall Study|Non-compliance with protocol|0
2071390|NCT00625443|3650280|FG000|Overall Study|Platelet count increase >=500,000/mm3|1
2071391|NCT00625443|3650281|FG001|Overall Study|Platelet count increase >=500,000/mm3|0
2071392|NCT00625443|3650282|FG002|Overall Study|Platelet count increase >=500,000/mm3|0
2071393|NCT00625443|3650280|FG000|Overall Study|Withdrawal by Subject|0
2071394|NCT00625443|3650281|FG001|Overall Study|Withdrawal by Subject|1
2071395|NCT00625443|3650282|FG002|Overall Study|Withdrawal by Subject|2
2071396|NCT00625443|3650280|FG000|Overall Study|Physician Decision|0
2071397|NCT00625443|3650281|FG001|Overall Study|Physician Decision|4
2071398|NCT00625443|3650282|FG002|Overall Study|Physician Decision|2
2071399|NCT00625443|3650280|FG000|Overall Study|Other|0
2071400|NCT00625443|3650281|FG001|Overall Study|Other|1
2071401|NCT00625443|3650282|FG002|Overall Study|Other|1
2071402|NCT00625807|3650300|FG000|Overall Study|schedule conflict|2
2071403|NCT00625807|3650301|FG001|Overall Study|schedule conflict|8
2071404|NCT00625820|3650309|FG000|Overall Study|Withdrawal by Subject|1
2071405|NCT00625846|3650318|FG000|Overall Study|Withdrawal by Subject|2
2071406|NCT00625846|3650319|FG001|Overall Study|Withdrawal by Subject|0
2071407|NCT00625846|3650320|FG002|Overall Study|Withdrawal by Subject|1
2071408|NCT00625846|3650321|FG003|Overall Study|Withdrawal by Subject|2
2071409|NCT00625872|3650337|FG000|Overall Study|Withdrawal by Subject|1
2071410|NCT00625872|3650338|FG001|Overall Study|Withdrawal by Subject|0
2071411|NCT00625872|3650337|FG000|Overall Study|Does not meet inclusion criteria|1
2071412|NCT00625872|3650338|FG001|Overall Study|Does not meet inclusion criteria|0
2071413|NCT00625872|3650337|FG000|Overall Study|Terminated by sponsor|2
2071414|NCT00625872|3650338|FG001|Overall Study|Terminated by sponsor|5
2071415|NCT00625872|3650337|FG000|Overall Study|Randomized but not treated|0
2071416|NCT00625872|3650338|FG001|Overall Study|Randomized but not treated|1
2071417|NCT00626028|3650352|FG000|Overall Study|Adverse Event|1
2071418|NCT00626028|3650353|FG001|Overall Study|Adverse Event|1
2071419|NCT00626028|3650352|FG000|Overall Study|Device Failure|0
2071420|NCT00626028|3650353|FG001|Overall Study|Device Failure|1
2071421|NCT00626028|3650352|FG000|Overall Study|Physician Decision|2
2071422|NCT00626028|3650353|FG001|Overall Study|Physician Decision|1
2071423|NCT00626028|3650352|FG000|Overall Study|Inclusion/Exclusion Criteria|3
2071424|NCT00626028|3650353|FG001|Overall Study|Inclusion/Exclusion Criteria|6
2071425|NCT00626093|3650359|FG000|Overall Study|Lost to Follow-up|5
2071426|NCT00626093|3650359|FG000|Overall Study|Death|1
2071427|NCT00626093|3650359|FG000|Overall Study|Physician Decision|4
2071428|NCT00626093|3650359|FG000|Overall Study|Withdrawal by Subject|6
2071429|NCT00626093|3650359|FG000|Overall Study|Protocol Violation|1
2071430|NCT00626093|3650359|FG000|Overall Study|One of the required devices not implante|6
2071431|NCT00626197|3650366|FG000|Overall Study|Did not cooperate|2
2071432|NCT00626197|3650367|FG001|Overall Study|Did not cooperate|6
2071433|NCT00626197|3650368|FG002|Overall Study|Did not cooperate|1
2071434|NCT00626197|3650366|FG000|Overall Study|Failure to return|6
2071435|NCT00626197|3650367|FG001|Overall Study|Failure to return|5
2071436|NCT00626197|3650368|FG002|Overall Study|Failure to return|6
2071437|NCT00626197|3650366|FG000|Overall Study|Adverse event, serious fatal|3
2071438|NCT00626197|3650367|FG001|Overall Study|Adverse event, serious fatal|6
2071439|NCT00626197|3650368|FG002|Overall Study|Adverse event, serious fatal|6
2071440|NCT00626197|3650366|FG000|Overall Study|Adverse Event|1
2071441|NCT00626197|3650367|FG001|Overall Study|Adverse Event|1
2071442|NCT00626197|3650368|FG002|Overall Study|Adverse Event|2
2071443|NCT00626197|3650366|FG000|Overall Study|Withdrawal by Subject|17
2071444|NCT00626197|3650367|FG001|Overall Study|Withdrawal by Subject|17
2071445|NCT00626197|3650368|FG002|Overall Study|Withdrawal by Subject|7
2071446|NCT00626197|3650366|FG000|Overall Study|Administrative reasons|15
2071447|NCT00626197|3650367|FG001|Overall Study|Administrative reasons|19
2071448|NCT00626197|3650368|FG002|Overall Study|Administrative reasons|55
2071449|NCT00626275|3650386|FG000|Part A - Treatment Period 1|Adverse Event|1
2071450|NCT00626275|3650387|FG001|Part A - Treatment Period 1|Adverse Event|0
2071451|NCT00626275|3650388|FG002|Part A - Treatment Period 1|Adverse Event|0
2071452|NCT00626275|3650389|FG003|Part A - Treatment Period 1|Adverse Event|0
2071453|NCT00626275|3650390|FG004|Part A - Treatment Period 1|Adverse Event|0
2071454|NCT00626275|3650391|FG005|Part A - Treatment Period 1|Adverse Event|0
2071455|NCT00626275|3650392|FG006|Part A - Treatment Period 1|Adverse Event|0
2071456|NCT00626275|3650393|FG007|Part A - Treatment Period 1|Adverse Event|0
2071457|NCT00626275|3650386|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0
2071458|NCT00626275|3650387|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0
2071459|NCT00626275|3650388|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1
2071460|NCT00626275|3650389|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0
2071461|NCT00626275|3650390|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0
2071462|NCT00626275|3650391|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0
2071463|NCT00626275|3650392|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0
2071464|NCT00626275|3650393|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0
2071465|NCT00626275|3650386|FG000|Part B|Lost to Follow-up|0
2071466|NCT00626275|3650387|FG001|Part B|Lost to Follow-up|0
2071467|NCT00626275|3650388|FG002|Part B|Lost to Follow-up|0
2071468|NCT00626275|3650389|FG003|Part B|Lost to Follow-up|0
2071469|NCT00626275|3650390|FG004|Part B|Lost to Follow-up|0
2071470|NCT00626275|3650391|FG005|Part B|Lost to Follow-up|0
2071471|NCT00626275|3650392|FG006|Part B|Lost to Follow-up|1
2071472|NCT00626275|3650393|FG007|Part B|Lost to Follow-up|0
2071473|NCT00626275|3650386|FG000|Part B|Withdrawal by Subject|0
2071474|NCT00626275|3650387|FG001|Part B|Withdrawal by Subject|0
2071475|NCT00626275|3650388|FG002|Part B|Withdrawal by Subject|0
2071476|NCT00626275|3650389|FG003|Part B|Withdrawal by Subject|0
2071477|NCT00626275|3650390|FG004|Part B|Withdrawal by Subject|0
2071478|NCT00626275|3650391|FG005|Part B|Withdrawal by Subject|0
2071479|NCT00626275|3650392|FG006|Part B|Withdrawal by Subject|0
2071480|NCT00626275|3650393|FG007|Part B|Withdrawal by Subject|1
2071481|NCT00626327|3650410|FG000|Overall Study|Withdrawal by Subject|21
2071482|NCT00626327|3650411|FG001|Overall Study|Withdrawal by Subject|29
2071483|NCT00626327|3650412|FG002|Overall Study|Withdrawal by Subject|30
2071484|NCT00626327|3650410|FG000|Overall Study|Adverse Event|1
2071485|NCT00626327|3650411|FG001|Overall Study|Adverse Event|0
2071486|NCT00626327|3650412|FG002|Overall Study|Adverse Event|0
2071487|NCT00626327|3650410|FG000|Overall Study|Lost to Follow-up|24
2071488|NCT00626327|3650411|FG001|Overall Study|Lost to Follow-up|21
2071489|NCT00626327|3650412|FG002|Overall Study|Lost to Follow-up|23
2071490|NCT00626327|3650410|FG000|Overall Study|Inappropriate enrollment|4
2071491|NCT00626327|3650411|FG001|Overall Study|Inappropriate enrollment|5
2071492|NCT00626327|3650412|FG002|Overall Study|Inappropriate enrollment|3
2071493|NCT00626327|3650410|FG000|Overall Study|Administrative Reason|2
2071494|NCT00626327|3650411|FG001|Overall Study|Administrative Reason|0
2071495|NCT00626327|3650412|FG002|Overall Study|Administrative Reason|6
2071496|NCT00626327|3650410|FG000|Overall Study|Protocol Violation|26
2071497|NCT00626327|3650411|FG001|Overall Study|Protocol Violation|4
2071498|NCT00626327|3650412|FG002|Overall Study|Protocol Violation|26
2071499|NCT00626392|3650447|FG000|Run-in Period|Adverse Event|0
2071500|NCT00626392|3650448|FG001|Run-in Period|Adverse Event|0
2071501|NCT00626392|3650449|FG002|Run-in Period|Adverse Event|1
2071502|NCT00626392|3650450|FG003|Run-in Period|Adverse Event|0
2071503|NCT00626392|3650451|FG004|Run-in Period|Adverse Event|1
2071504|NCT00626392|3650452|FG005|Run-in Period|Adverse Event|0
2071505|NCT00626392|3650447|FG000|Run-in Period|Withdrawal by Subject|0
2071506|NCT00626392|3650448|FG001|Run-in Period|Withdrawal by Subject|1
2071507|NCT00626392|3650449|FG002|Run-in Period|Withdrawal by Subject|1
2071508|NCT00626392|3650450|FG003|Run-in Period|Withdrawal by Subject|1
2071509|NCT00626392|3650451|FG004|Run-in Period|Withdrawal by Subject|3
2071510|NCT00626392|3650452|FG005|Run-in Period|Withdrawal by Subject|1
2071511|NCT00626392|3650447|FG000|Run-in Period|Noncompliance|1
2071512|NCT00626392|3650448|FG001|Run-in Period|Noncompliance|0
2071513|NCT00626392|3650449|FG002|Run-in Period|Noncompliance|1
2071514|NCT00626392|3650450|FG003|Run-in Period|Noncompliance|0
2071515|NCT00626392|3650451|FG004|Run-in Period|Noncompliance|0
2071516|NCT00626392|3650452|FG005|Run-in Period|Noncompliance|0
2071517|NCT00626392|3650447|FG000|Coadministration Period|Adverse Event|3
2071518|NCT00626392|3650448|FG001|Coadministration Period|Adverse Event|1
2071519|NCT00626392|3650449|FG002|Coadministration Period|Adverse Event|7
2071520|NCT00626392|3650450|FG003|Coadministration Period|Adverse Event|4
2071521|NCT00626392|3650451|FG004|Coadministration Period|Adverse Event|3
2071522|NCT00626392|3650452|FG005|Coadministration Period|Adverse Event|4
2071523|NCT00626392|3650447|FG000|Coadministration Period|Withdrawal by Subject|1
2071524|NCT00626392|3650448|FG001|Coadministration Period|Withdrawal by Subject|1
2071525|NCT00626392|3650449|FG002|Coadministration Period|Withdrawal by Subject|0
2071526|NCT00626392|3650450|FG003|Coadministration Period|Withdrawal by Subject|1
2071527|NCT00626392|3650451|FG004|Coadministration Period|Withdrawal by Subject|0
2071528|NCT00626392|3650452|FG005|Coadministration Period|Withdrawal by Subject|1
2071529|NCT00626392|3650447|FG000|Coadministration Period|Protocol Violation|0
2071530|NCT00626392|3650448|FG001|Coadministration Period|Protocol Violation|1
2071531|NCT00626392|3650449|FG002|Coadministration Period|Protocol Violation|0
2071532|NCT00626392|3650450|FG003|Coadministration Period|Protocol Violation|1
2071533|NCT00626392|3650451|FG004|Coadministration Period|Protocol Violation|1
2071534|NCT00626392|3650452|FG005|Coadministration Period|Protocol Violation|0
2071535|NCT00626392|3650447|FG000|Coadministration Period|Other|0
2071536|NCT00626392|3650448|FG001|Coadministration Period|Other|2
2071537|NCT00626392|3650449|FG002|Coadministration Period|Other|3
2071538|NCT00626392|3650450|FG003|Coadministration Period|Other|1
2071539|NCT00626392|3650451|FG004|Coadministration Period|Other|1
2071540|NCT00626392|3650452|FG005|Coadministration Period|Other|1
2071541|NCT00626405|3650460|FG000|Overall Study|Deemed Ineligible|1
2071542|NCT00626405|3650461|FG001|Overall Study|Deemed Ineligible|0
2071543|NCT00626405|3650460|FG000|Overall Study|Withdrawal by Subject|0
2071544|NCT00626405|3650461|FG001|Overall Study|Withdrawal by Subject|1
2071545|NCT00626522|3650482|FG000|Overall Study|Protocol Violation|0
2071546|NCT00626522|3650483|FG001|Overall Study|Protocol Violation|0
2071547|NCT00626522|3650484|FG002|Overall Study|Protocol Violation|0
2071548|NCT00626522|3650485|FG003|Overall Study|Protocol Violation|0
2071549|NCT00626522|3650486|FG004|Overall Study|Protocol Violation|1
2071550|NCT00626522|3650487|FG005|Overall Study|Protocol Violation|0
2071551|NCT00626522|3650482|FG000|Overall Study|Adverse Event|2
2071552|NCT00626522|3650483|FG001|Overall Study|Adverse Event|1
2071553|NCT00626522|3650484|FG002|Overall Study|Adverse Event|2
2071554|NCT00626522|3650485|FG003|Overall Study|Adverse Event|0
2071555|NCT00626522|3650486|FG004|Overall Study|Adverse Event|1
2071556|NCT00626522|3650487|FG005|Overall Study|Adverse Event|1
2071557|NCT00626522|3650482|FG000|Overall Study|Withdrawal by Subject|2
2071558|NCT00626522|3650483|FG001|Overall Study|Withdrawal by Subject|5
2071559|NCT00626522|3650484|FG002|Overall Study|Withdrawal by Subject|5
2071560|NCT00626522|3650485|FG003|Overall Study|Withdrawal by Subject|0
2071561|NCT00626522|3650486|FG004|Overall Study|Withdrawal by Subject|4
2071562|NCT00626522|3650487|FG005|Overall Study|Withdrawal by Subject|1
2071563|NCT00626522|3650482|FG000|Overall Study|COPD exacerbation|0
2071564|NCT00626522|3650483|FG001|Overall Study|COPD exacerbation|0
2071565|NCT00626522|3650484|FG002|Overall Study|COPD exacerbation|0
2071566|NCT00626522|3650485|FG003|Overall Study|COPD exacerbation|1
2071567|NCT00626522|3650486|FG004|Overall Study|COPD exacerbation|1
2071568|NCT00626522|3650487|FG005|Overall Study|COPD exacerbation|0
2071569|NCT00626522|3650482|FG000|Overall Study|Lost to Follow-up|0
2071570|NCT00626522|3650483|FG001|Overall Study|Lost to Follow-up|1
2071571|NCT00626522|3650484|FG002|Overall Study|Lost to Follow-up|0
2071572|NCT00626522|3650485|FG003|Overall Study|Lost to Follow-up|0
2071573|NCT00626522|3650486|FG004|Overall Study|Lost to Follow-up|0
2071574|NCT00626522|3650487|FG005|Overall Study|Lost to Follow-up|0
2071575|NCT00626522|3650482|FG000|Overall Study|Inconsistent reason reported|1
2071576|NCT00626522|3650483|FG001|Overall Study|Inconsistent reason reported|0
2071577|NCT00626522|3650484|FG002|Overall Study|Inconsistent reason reported|0
2177180|NCT01371747|3801220|FG004|Overall Study|Protocol Violation|0
2304172|NCT02648438|4003842|FG001|Overall Study|Withdrawal by Subject|1
2304173|NCT02648438|4003843|FG002|Overall Study|Withdrawal by Subject|0
2304174|NCT02648932|4003874|FG000|Overall Study|No transplant|3
2304175|NCT02648932|4003875|FG001|Overall Study|No transplant|1
2304176|NCT02649218|4003928|FG000|Overall Study|Adverse Event|8
2304177|NCT02649218|4003928|FG000|Overall Study|Lack of Efficacy|8
2304178|NCT02649218|4003928|FG000|Overall Study|Pregnancy|3
2304179|NCT02649218|4003928|FG000|Overall Study|Protocol Violation|3
2304180|NCT02649218|4003928|FG000|Overall Study|Physician Decision|1
2304181|NCT02649218|4003928|FG000|Overall Study|Withdrawal by Subject|2
2304182|NCT02649231|4003937|FG000|Overall Study|Adverse Event|0
2304183|NCT02649231|4003938|FG001|Overall Study|Adverse Event|0
2304184|NCT02649231|4003939|FG002|Overall Study|Adverse Event|0
2071578|NCT00626522|3650485|FG003|Overall Study|Inconsistent reason reported|0
2071579|NCT00626522|3650486|FG004|Overall Study|Inconsistent reason reported|0
2071580|NCT00626522|3650487|FG005|Overall Study|Inconsistent reason reported|0
2071581|NCT00626522|3650482|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1
2071582|NCT00626522|3650483|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0
2071583|NCT00626522|3650484|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1
2071584|NCT00626522|3650485|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1
2071585|NCT00626522|3650486|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0
2071586|NCT00626522|3650487|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0
2071587|NCT00626548|3650503|FG000|Overall Study|Adverse Event|164
2071588|NCT00626548|3650504|FG001|Overall Study|Adverse Event|44
2071589|NCT00626548|3650503|FG000|Overall Study|Withdrawal by Subject|42
2071590|NCT00626548|3650504|FG001|Overall Study|Withdrawal by Subject|46
2071591|NCT00626548|3650503|FG000|Overall Study|Protocol Violation|4
2071592|NCT00626548|3650504|FG001|Overall Study|Protocol Violation|11
2071593|NCT00626548|3650503|FG000|Overall Study|Lost to Follow-up|2
2071594|NCT00626548|3650504|FG001|Overall Study|Lost to Follow-up|2
2071595|NCT00626548|3650503|FG000|Overall Study|Other termination reason|493
2071596|NCT00626548|3650504|FG001|Overall Study|Other termination reason|613
2071597|NCT00626639|3650533|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2
2071598|NCT00626639|3650534|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2
2071599|NCT00626795|3650565|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0
2071600|NCT00626795|3650566|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1
2071601|NCT00626795|3650567|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0
2071602|NCT00626795|3650565|FG000|Blinded Treatment|Lack of Efficacy|2
2071603|NCT00626795|3650566|FG001|Blinded Treatment|Lack of Efficacy|0
2071604|NCT00626795|3650567|FG002|Blinded Treatment|Lack of Efficacy|0
2071605|NCT00626795|3650565|FG000|Blinded Treatment|Unacceptable adverse event|0
2071606|NCT00626795|3650566|FG001|Blinded Treatment|Unacceptable adverse event|0
2071607|NCT00626795|3650567|FG002|Blinded Treatment|Unacceptable adverse event|1
2071608|NCT00626795|3650565|FG000|Blinded Treatment|Protocol Violation|0
2071609|NCT00626795|3650566|FG001|Blinded Treatment|Protocol Violation|1
2071610|NCT00626795|3650567|FG002|Blinded Treatment|Protocol Violation|1
2071611|NCT00626795|3650565|FG000|Blinded Treatment|Withdrawal by Subject|1
2071612|NCT00626795|3650566|FG001|Blinded Treatment|Withdrawal by Subject|1
2071613|NCT00626795|3650567|FG002|Blinded Treatment|Withdrawal by Subject|0
2071614|NCT00626795|3650565|FG000|Blinded Treatment|Other reasons|2
2071615|NCT00626795|3650566|FG001|Blinded Treatment|Other reasons|0
2071616|NCT00626795|3650567|FG002|Blinded Treatment|Other reasons|2
2071617|NCT00626795|3650565|FG000|Blinded Treatment|Missing reason for withdrawal|5
2071618|NCT00626795|3650566|FG001|Blinded Treatment|Missing reason for withdrawal|3
2071619|NCT00626795|3650567|FG002|Blinded Treatment|Missing reason for withdrawal|5
2071620|NCT00626821|3650596|FG000|Overall Study|Adverse Event|44
2071621|NCT00626821|3650596|FG000|Overall Study|Protocol Violation|33
2071622|NCT00626821|3650596|FG000|Overall Study|Withdrawal by Subject|10
2071623|NCT00626821|3650596|FG000|Overall Study|Physician Decision|9
2071624|NCT00626821|3650596|FG000|Overall Study|Product dysfunction|21
2071625|NCT00626821|3650596|FG000|Overall Study|other/unknown reason|104
2071626|NCT00626925|3650620|FG000|Overall Study|Lost to Follow-up|1
2071627|NCT00626925|3650621|FG001|Overall Study|Lost to Follow-up|2
2071628|NCT00626925|3650620|FG000|Overall Study|relapse|1
2071629|NCT00626925|3650621|FG001|Overall Study|relapse|0
2071630|NCT00626925|3650620|FG000|Overall Study|Adverse effect|6
2071631|NCT00626925|3650621|FG001|Overall Study|Adverse effect|2
2071632|NCT00626925|3650620|FG000|Overall Study|Lack of Efficacy|1
2071633|NCT00626925|3650621|FG001|Overall Study|Lack of Efficacy|4
2071634|NCT00626925|3650620|FG000|Overall Study|Time constraints|3
2071635|NCT00626925|3650621|FG001|Overall Study|Time constraints|1
2071636|NCT00627016|3650643|FG000|Overall Study|Adverse Event|1
2071637|NCT00627016|3650644|FG001|Overall Study|Adverse Event|1
2071638|NCT00627016|3650643|FG000|Overall Study|Protocol Violation|0
2071639|NCT00627016|3650644|FG001|Overall Study|Protocol Violation|2
2304185|NCT02649231|4003940|FG003|Overall Study|Adverse Event|1
2304186|NCT02649231|4003937|FG000|Overall Study|Lost to Follow-up|2
2304187|NCT02649231|4003938|FG001|Overall Study|Lost to Follow-up|1
2071640|NCT00627016|3650643|FG000|Overall Study|Lost to Follow-up|0
2071641|NCT00627016|3650644|FG001|Overall Study|Lost to Follow-up|1
2071642|NCT00627016|3650643|FG000|Overall Study|Withdrawal by Subject|2
2071643|NCT00627016|3650644|FG001|Overall Study|Withdrawal by Subject|1
2071644|NCT00627016|3650643|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
2071645|NCT00627016|3650644|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
2071646|NCT00627016|3650643|FG000|Overall Study|Lack of Efficacy|1
2071647|NCT00627016|3650644|FG001|Overall Study|Lack of Efficacy|0
2071648|NCT00627016|3650643|FG000|Overall Study|Placed on Excluded Drugs|1
2071649|NCT00627016|3650644|FG001|Overall Study|Placed on Excluded Drugs|0
2071650|NCT00627016|3650643|FG000|Overall Study|Pregnancy|1
2071651|NCT00627016|3650644|FG001|Overall Study|Pregnancy|0
2071652|NCT00627042|3650650|FG000|Overall Study|Withdrawal by Subject|2
2071653|NCT00627094|3650656|FG000|Overall Study|Adverse Event|8
2071654|NCT00627094|3650657|FG001|Overall Study|Adverse Event|7
2071655|NCT00627094|3650656|FG000|Overall Study|Lost to Follow-up|1
2071656|NCT00627094|3650657|FG001|Overall Study|Lost to Follow-up|0
2071657|NCT00627094|3650656|FG000|Overall Study|Withdrawal by Subject|1
2071658|NCT00627094|3650657|FG001|Overall Study|Withdrawal by Subject|1
2071659|NCT00627094|3650656|FG000|Overall Study|ulcer healed|1
2071660|NCT00627094|3650657|FG001|Overall Study|ulcer healed|7
2071661|NCT00627094|3650656|FG000|Overall Study|Other reason|1
2071662|NCT00627094|3650657|FG001|Overall Study|Other reason|0
2071663|NCT00627393|3650677|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5
2071664|NCT00627393|3650678|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3
2071665|NCT00627393|3650677|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
2071666|NCT00627393|3650678|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
2071667|NCT00627393|3650677|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
2071668|NCT00627393|3650678|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
2071669|NCT00627393|3650677|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
2071670|NCT00627393|3650678|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
2106379|NCT00865280|3699512|FG000|Overall Study|End of Treatment/Lost to Follow-up|0
2106380|NCT00865280|3699513|FG001|Overall Study|End of Treatment/Lost to Follow-up|1
2106381|NCT00865280|3699512|FG000|Overall Study|Adverse Event/Lost to Follow-up|1
2106382|NCT00865280|3699513|FG001|Overall Study|Adverse Event/Lost to Follow-up|0
2106383|NCT00865280|3699512|FG000|Overall Study|Exclusion Condition|1
2106384|NCT00865280|3699513|FG001|Overall Study|Exclusion Condition|0
2106385|NCT00865280|3699512|FG000|Overall Study|Adverse Event|0
2106386|NCT00865280|3699513|FG001|Overall Study|Adverse Event|1
2106387|NCT00865306|3699521|FG000|Controlled Trial|Lost to Follow-up|1
2106388|NCT00865306|3699522|FG001|Controlled Trial|Lost to Follow-up|1
2106389|NCT00865306|3699521|FG000|Controlled Trial|Difficulty commuting|2
2106390|NCT00865306|3699522|FG001|Controlled Trial|Difficulty commuting|0
2106391|NCT00865306|3699521|FG000|Controlled Trial|Improved btw baseline and first session|1
2106392|NCT00865306|3699522|FG001|Controlled Trial|Improved btw baseline and first session|0
2106393|NCT00865306|3699521|FG000|Controlled Trial|Sought treatment for conduct disorder|1
2106394|NCT00865306|3699522|FG001|Controlled Trial|Sought treatment for conduct disorder|0
2106395|NCT00865306|3699521|FG000|Controlled Trial|Withdrawal by Subject|0
2106396|NCT00865306|3699522|FG001|Controlled Trial|Withdrawal by Subject|1
2106397|NCT00865345|3699528|FG000|Overall Study|Withdrawal by Subject|2
2106398|NCT00865566|3699534|FG000|Overall Study|Death|1
2106399|NCT00865566|3699535|FG001|Overall Study|Death|11
2106400|NCT00865566|3699534|FG000|Overall Study|Lost to Follow-up|314
2106401|NCT00865566|3699535|FG001|Overall Study|Lost to Follow-up|315
2106402|NCT00865566|3699534|FG000|Overall Study|Withdrawal by Subject|45
2106403|NCT00865566|3699535|FG001|Overall Study|Withdrawal by Subject|65
2106404|NCT00865566|3699534|FG000|Overall Study|Physician Decision|0
2106405|NCT00865566|3699535|FG001|Overall Study|Physician Decision|1
2106406|NCT00865566|3699534|FG000|Overall Study|Participant relocated|78
2106407|NCT00865566|3699535|FG001|Overall Study|Participant relocated|107
2106408|NCT00865566|3699534|FG000|Overall Study|Participant unable to adhere|27
2106409|NCT00865566|3699535|FG001|Overall Study|Participant unable to adhere|42
2106410|NCT00865566|3699534|FG000|Overall Study|Other; N=245 due to early study closure|154
2106411|NCT00865566|3699535|FG001|Overall Study|Other; N=245 due to early study closure|139
2106412|NCT00865566|3699534|FG000|Overall Study|HIV infection|5
2106413|NCT00865566|3699535|FG001|Overall Study|HIV infection|7
2106414|NCT00865709|3699543|FG000|Treatment|Adverse Event|9
2106415|NCT00865709|3699544|FG001|Treatment|Adverse Event|6
2106416|NCT00865709|3699543|FG000|Treatment|Withdrawal by Subject|10
2106417|NCT00865709|3699544|FG001|Treatment|Withdrawal by Subject|7
2106418|NCT00865709|3699543|FG000|Treatment|Physician Decision|3
2106419|NCT00865709|3699544|FG001|Treatment|Physician Decision|2
2106420|NCT00865709|3699543|FG000|Treatment|Surgery|8
2106421|NCT00865709|3699544|FG001|Treatment|Surgery|3
2106422|NCT00865904|3699557|FG000|Overall Study|Randomized but not Treated|2
2106423|NCT00865904|3699558|FG001|Overall Study|Randomized but not Treated|0
2106424|NCT00865904|3699559|FG002|Overall Study|Randomized but not Treated|0
2106425|NCT00865904|3699560|FG003|Overall Study|Randomized but not Treated|1
2106426|NCT00865904|3699561|FG004|Overall Study|Randomized but not Treated|1
2106427|NCT00866047|3699590|FG000|Treatment Period|Progressive disease|13
2106428|NCT00866047|3699590|FG000|Treatment Period|Adverse Event|16
2106429|NCT00866047|3699590|FG000|Treatment Period|Physician Decision|14
2106430|NCT00866047|3699590|FG000|Treatment Period|Withdrawal by Subject|5
2106431|NCT00866047|3699590|FG000|Follow-up Period|Lost to Follow-up|5
2106432|NCT00866177|3699594|FG000|Overall Study|Withdrawal by Subject|1
2071671|NCT00627445|3650705|FG000|Overall Study|Adverse Event|3
2071672|NCT00627445|3650706|FG001|Overall Study|Adverse Event|3
2071673|NCT00627445|3650705|FG000|Overall Study|Lack of Efficacy|0
2071674|NCT00627445|3650706|FG001|Overall Study|Lack of Efficacy|1
2071675|NCT00627445|3650705|FG000|Overall Study|Other|6
2071676|NCT00627445|3650706|FG001|Overall Study|Other|8
2071677|NCT00627458|3650717|FG000|Overall Study|Migrated from study area|1
2071678|NCT00627458|3650718|FG001|Overall Study|Migrated from study area|0
2071679|NCT00627458|3650719|FG002|Overall Study|Migrated from study area|1
2071680|NCT00627458|3650717|FG000|Overall Study|Withdrawal by Subject|2
2071681|NCT00627458|3650718|FG001|Overall Study|Withdrawal by Subject|6
2071682|NCT00627458|3650719|FG002|Overall Study|Withdrawal by Subject|5
2071683|NCT00627458|3650717|FG000|Overall Study|Lost to Follow-up|1
2071684|NCT00627458|3650718|FG001|Overall Study|Lost to Follow-up|1
2071685|NCT00627458|3650719|FG002|Overall Study|Lost to Follow-up|0
2071686|NCT00627497|3650732|FG000|Overall Study|Lost to Follow-up|1
2071687|NCT00627497|3650733|FG001|Overall Study|Lost to Follow-up|1
2071688|NCT00627497|3650734|FG002|Overall Study|Lost to Follow-up|0
2071689|NCT00627497|3650735|FG003|Overall Study|Lost to Follow-up|0
2071690|NCT00627523|3650747|FG000|Overall Study|Lack of Efficacy|1
2071691|NCT00627523|3650748|FG001|Overall Study|Lack of Efficacy|0
2071692|NCT00627523|3650747|FG000|Overall Study|Withdrawal by Subject|0
2071693|NCT00627523|3650748|FG001|Overall Study|Withdrawal by Subject|2
2071694|NCT00627523|3650747|FG000|Overall Study|Other|1
2071695|NCT00627523|3650748|FG001|Overall Study|Other|0
2071696|NCT00627705|3650769|FG000|Overall Study|Unwilling to take the compound (taste)|1
2071697|NCT00627705|3650770|FG001|Overall Study|Unwilling to take the compound (taste)|3
2071698|NCT00627705|3650769|FG000|Overall Study|Adverse Event|1
2071699|NCT00627705|3650770|FG001|Overall Study|Adverse Event|0
2071700|NCT00627705|3650769|FG000|Overall Study|Withdrawal by Subject|0
2071701|NCT00627705|3650770|FG001|Overall Study|Withdrawal by Subject|2
2071702|NCT00627705|3650769|FG000|Overall Study|Lost to Follow-up|0
2071703|NCT00627705|3650770|FG001|Overall Study|Lost to Follow-up|1
2071704|NCT00627926|3650785|FG000|Overall Study|Adverse Event|26
2071705|NCT00627926|3650786|FG001|Overall Study|Adverse Event|37
2071706|NCT00627926|3650787|FG002|Overall Study|Adverse Event|36
2071707|NCT00627926|3650785|FG000|Overall Study|Death|1
2071708|NCT00627926|3650786|FG001|Overall Study|Death|0
2071709|NCT00627926|3650787|FG002|Overall Study|Death|0
2071710|NCT00627926|3650785|FG000|Overall Study|Lost to Follow-up|4
2071711|NCT00627926|3650786|FG001|Overall Study|Lost to Follow-up|3
2071712|NCT00627926|3650787|FG002|Overall Study|Lost to Follow-up|4
2071713|NCT00627926|3650785|FG000|Overall Study|Withdrawal by Subject|2
2071714|NCT00627926|3650786|FG001|Overall Study|Withdrawal by Subject|1
2210436|NCT01649869|3849921|FG000|Overall Study|Required treatment outside protocol|1
2071715|NCT00627926|3650787|FG002|Overall Study|Withdrawal by Subject|0
2071716|NCT00627926|3650785|FG000|Overall Study|Lack of Efficacy|118
2071717|NCT00627926|3650786|FG001|Overall Study|Lack of Efficacy|40
2071718|NCT00627926|3650787|FG002|Overall Study|Lack of Efficacy|38
2071719|NCT00627926|3650785|FG000|Overall Study|Noncompliance/unspecified|8
2071720|NCT00627926|3650786|FG001|Overall Study|Noncompliance/unspecified|23
2071721|NCT00627926|3650787|FG002|Overall Study|Noncompliance/unspecified|17
2071722|NCT00628030|3650806|FG000|Baseline to Post-Assessment|Lost to Follow-up|28
2071723|NCT00628030|3650807|FG001|Baseline to Post-Assessment|Lost to Follow-up|29
2071724|NCT00628030|3650806|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5
2071725|NCT00628030|3650807|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0
2071726|NCT00628030|3650806|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32
2071727|NCT00628030|3650807|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30
2071728|NCT00628108|3650815|FG000|Overall Study|Adverse Event|0
2071729|NCT00628108|3650816|FG001|Overall Study|Adverse Event|3
2071730|NCT00628108|3650815|FG000|Overall Study|Withdrawal by Subject|1
2071731|NCT00628108|3650816|FG001|Overall Study|Withdrawal by Subject|0
2071732|NCT00628212|3650842|FG000|Overall Study|Adverse Event|2
2071733|NCT00628212|3650843|FG001|Overall Study|Adverse Event|0
2071734|NCT00628212|3650844|FG002|Overall Study|Adverse Event|1
2071735|NCT00628212|3650845|FG003|Overall Study|Adverse Event|2
2071736|NCT00628212|3650842|FG000|Overall Study|Physician Decision|1
2071737|NCT00628212|3650843|FG001|Overall Study|Physician Decision|1
2071738|NCT00628212|3650844|FG002|Overall Study|Physician Decision|2
2071739|NCT00628212|3650845|FG003|Overall Study|Physician Decision|3
2071740|NCT00628251|3650858|FG000|Randomised Part|Withdrawal by Subject|0
2071741|NCT00628251|3650859|FG001|Randomised Part|Withdrawal by Subject|0
2071742|NCT00628251|3650860|FG002|Randomised Part|Withdrawal by Subject|1
2071743|NCT00628251|3650858|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1
2071744|NCT00628251|3650859|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2
2071745|NCT00628251|3650860|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3
2071746|NCT00628251|3650858|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
2071747|NCT00628251|3650859|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
2071748|NCT00628251|3650860|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
2071749|NCT00628251|3650858|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
2071750|NCT00628251|3650859|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
2210437|NCT01649869|3849922|FG001|Overall Study|Required treatment outside protocol|0
2071751|NCT00628251|3650860|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
2071752|NCT00628251|3650858|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0
2071753|NCT00628251|3650859|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1
2071754|NCT00628251|3650860|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6
2071755|NCT00628251|3650858|FG000|Ongoing Initial Study Treatment at DCO|Other|1
2071756|NCT00628251|3650859|FG001|Ongoing Initial Study Treatment at DCO|Other|0
2071757|NCT00628251|3650860|FG002|Ongoing Initial Study Treatment at DCO|Other|2
2071758|NCT00628355|3650872|FG000|Overall Study|Withdrawal by Subject|1
2071759|NCT00628355|3650873|FG001|Overall Study|Withdrawal by Subject|1
2071760|NCT00628446|3650901|FG000|Overall Study|Lost to Follow-up|3
2071761|NCT00628446|3650901|FG000|Overall Study|Withdrawal by Subject|1
2071762|NCT00628446|3650901|FG000|Overall Study|Protocol Violation|3
2071763|NCT00628758|3650934|FG000|Overall Study|Adverse Event|2
2071764|NCT00628758|3650935|FG001|Overall Study|Adverse Event|3
2071765|NCT00628758|3650934|FG000|Overall Study|Withdrawal by Subject|6
2071766|NCT00628758|3650935|FG001|Overall Study|Withdrawal by Subject|3
2071767|NCT00628758|3650934|FG000|Overall Study|Death|1
2071768|NCT00628758|3650935|FG001|Overall Study|Death|0
2071769|NCT00628758|3650934|FG000|Overall Study|Protocol Violation|5
2071770|NCT00628758|3650935|FG001|Overall Study|Protocol Violation|1
2071771|NCT00628758|3650934|FG000|Overall Study|Lost to Follow-up|25
2071772|NCT00628758|3650935|FG001|Overall Study|Lost to Follow-up|31
2071773|NCT00628758|3650934|FG000|Overall Study|Pregnancy|2
2071774|NCT00628758|3650935|FG001|Overall Study|Pregnancy|2
2071775|NCT00628758|3650934|FG000|Overall Study|Investigator Moved|3
2210438|NCT01649869|3849921|FG000|Overall Study|Severe hearing loss borderline eligible|0
2210439|NCT01649869|3849922|FG001|Overall Study|Severe hearing loss borderline eligible|1
2210440|NCT01650194|3849940|FG000|Overall Study|Progressive Disease (PD)|35
2210441|NCT01650194|3849940|FG000|Overall Study|Withdrawal by Subject|2
2210442|NCT01650194|3849940|FG000|Overall Study|Miscellaneous|10
2210443|NCT01650246|3849945|FG000|Overall Study|Adverse Event|23
2210444|NCT01650246|3849945|FG000|Overall Study|Protocol Violation|5
2210445|NCT01650246|3849945|FG000|Overall Study|Sponsor terminated study|53
2210446|NCT01650246|3849945|FG000|Overall Study|Lost to Follow-up|5
2210447|NCT01650246|3849945|FG000|Overall Study|Withdrawal by Subject|26
2071776|NCT00628758|3650935|FG001|Overall Study|Investigator Moved|0
2071777|NCT00628758|3650934|FG000|Overall Study|Treatment Failure|0
2071778|NCT00628758|3650935|FG001|Overall Study|Treatment Failure|2
2071779|NCT00628862|3650946|FG000|Overall Study|Adverse Event|6
2071780|NCT00628862|3650947|FG001|Overall Study|Adverse Event|8
2071781|NCT00628862|3650948|FG002|Overall Study|Adverse Event|10
2071782|NCT00628862|3650946|FG000|Overall Study|Withdrawal by Subject|4
2071783|NCT00628862|3650947|FG001|Overall Study|Withdrawal by Subject|6
2071784|NCT00628862|3650948|FG002|Overall Study|Withdrawal by Subject|11
2071785|NCT00628862|3650946|FG000|Overall Study|Lost to Follow-up|0
2071786|NCT00628862|3650947|FG001|Overall Study|Lost to Follow-up|2
2071787|NCT00628862|3650948|FG002|Overall Study|Lost to Follow-up|1
2071788|NCT00628862|3650946|FG000|Overall Study|Protocol Violation|1
2071789|NCT00628862|3650947|FG001|Overall Study|Protocol Violation|0
2071790|NCT00628862|3650948|FG002|Overall Study|Protocol Violation|0
2071791|NCT00628862|3650946|FG000|Overall Study|COPD Exacerbation|0
2071792|NCT00628862|3650947|FG001|Overall Study|COPD Exacerbation|1
2071793|NCT00628862|3650948|FG002|Overall Study|COPD Exacerbation|0
2071794|NCT00628927|3650967|FG000|Overall Study|Problems performing blood draw|6
2071795|NCT00628927|3650968|FG001|Overall Study|Problems performing blood draw|0
2071796|NCT00628927|3650967|FG000|Overall Study|Lost to Follow-up|1
2071797|NCT00628927|3650968|FG001|Overall Study|Lost to Follow-up|0
2071798|NCT00628927|3650967|FG000|Overall Study|Equipment failure|1
2071799|NCT00628927|3650968|FG001|Overall Study|Equipment failure|0
2071800|NCT00629083|3650990|FG000|Overall Study|Adverse Event|0
2071801|NCT00629083|3650991|FG001|Overall Study|Adverse Event|2
2071802|NCT00629083|3650990|FG000|Overall Study|Lack of Efficacy|3
2071803|NCT00629083|3650991|FG001|Overall Study|Lack of Efficacy|1
2071804|NCT00629083|3650990|FG000|Overall Study|Withdrawal by Subject|10
2071805|NCT00629083|3650991|FG001|Overall Study|Withdrawal by Subject|2
2210448|NCT01650246|3849945|FG000|Overall Study|Death|1
2210449|NCT01650246|3849945|FG000|Overall Study|Lack of Efficacy|30
2210450|NCT01650259|3849951|FG000|Overall Study|Improvement|105
2210451|NCT01650259|3849952|FG001|Overall Study|Improvement|0
2210452|NCT01650259|3849951|FG000|Overall Study|Adverse Event|127
2210453|NCT01650259|3849952|FG001|Overall Study|Adverse Event|0
2071806|NCT00629083|3650990|FG000|Overall Study|Lost to Follow-up|12
2071807|NCT00629083|3650991|FG001|Overall Study|Lost to Follow-up|8
2071808|NCT00629083|3650990|FG000|Overall Study|Moved out of country/state|2
2071809|NCT00629083|3650991|FG001|Overall Study|Moved out of country/state|1
2071810|NCT00629083|3650990|FG000|Overall Study|Refused to return for 12 month visit|1
2071811|NCT00629083|3650991|FG001|Overall Study|Refused to return for 12 month visit|0
2071812|NCT00629239|3651010|FG000|Overall Study|Adverse Event|7
2071813|NCT00629239|3651011|FG001|Overall Study|Adverse Event|4
2210454|NCT01650259|3849951|FG000|Overall Study|Lack of Efficacy|143
2210455|NCT01650259|3849952|FG001|Overall Study|Lack of Efficacy|0
2210456|NCT01650259|3849951|FG000|Overall Study|Lost to Follow-up|435
2071814|NCT00629239|3651010|FG000|Overall Study|Physician Decision|1
2071815|NCT00629239|3651011|FG001|Overall Study|Physician Decision|0
2071816|NCT00629265|3651019|FG000|Overall Study|Lost to Follow-up|4
2071817|NCT00629265|3651020|FG001|Overall Study|Lost to Follow-up|5
2071818|NCT00629265|3651019|FG000|Overall Study|Withdrawal by Subject|11
2071819|NCT00629265|3651020|FG001|Overall Study|Withdrawal by Subject|8
2071820|NCT00629265|3651019|FG000|Overall Study|Death|1
2071821|NCT00629265|3651020|FG001|Overall Study|Death|0
2071822|NCT00629265|3651019|FG000|Overall Study|Adverse Event|2
2071823|NCT00629265|3651020|FG001|Overall Study|Adverse Event|0
2071824|NCT00629265|3651019|FG000|Overall Study|HNC Recurrence|4
2071825|NCT00629265|3651020|FG001|Overall Study|HNC Recurrence|0
2071826|NCT00629265|3651019|FG000|Overall Study|Other CA Requiring Treatment|1
2071827|NCT00629265|3651020|FG001|Overall Study|Other CA Requiring Treatment|3
2071828|NCT00629265|3651019|FG000|Overall Study|Needed Esophageal Dilation|4
2071829|NCT00629265|3651020|FG001|Overall Study|Needed Esophageal Dilation|1
2071830|NCT00629265|3651019|FG000|Overall Study|Unrelated Medical Complications|3
2071831|NCT00629265|3651020|FG001|Overall Study|Unrelated Medical Complications|1
2071832|NCT00629265|3651019|FG000|Overall Study|Unknown Reason|2
2071833|NCT00629265|3651020|FG001|Overall Study|Unknown Reason|2
2071834|NCT00629707|3651036|FG000|Overall Study|Withdrawal by Subject|0
2071835|NCT00629707|3651037|FG001|Overall Study|Withdrawal by Subject|1
2071836|NCT00629707|3651036|FG000|Overall Study|Physician Decision|0
2071837|NCT00629707|3651037|FG001|Overall Study|Physician Decision|1
2071838|NCT00629772|3651045|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1
2071839|NCT00629772|3651046|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1
2071840|NCT00629772|3651045|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
2071841|NCT00629772|3651046|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
2071842|NCT00630032|3651055|FG000|Overall Study|Death|55
2071843|NCT00630032|3651056|FG001|Overall Study|Death|49
2071844|NCT00630032|3651055|FG000|Overall Study|Withdrawal by Subject|3
2071845|NCT00630032|3651056|FG001|Overall Study|Withdrawal by Subject|2
2071846|NCT00630032|3651055|FG000|Overall Study|Lost to Follow-up|18
2071847|NCT00630032|3651056|FG001|Overall Study|Lost to Follow-up|31
2071848|NCT00630032|3651055|FG000|Overall Study|Protocol Violation|1
2071849|NCT00630032|3651056|FG001|Overall Study|Protocol Violation|0
2071850|NCT00630032|3651055|FG000|Overall Study|Patient has moved|1
2071851|NCT00630032|3651056|FG001|Overall Study|Patient has moved|1
2071852|NCT00630032|3651055|FG000|Overall Study|Disease progression|1
2071853|NCT00630032|3651056|FG001|Overall Study|Disease progression|1
2071854|NCT00630032|3651055|FG000|Overall Study|End of monitoring in US centers|11
2071855|NCT00630032|3651056|FG001|Overall Study|End of monitoring in US centers|11
2071856|NCT00630058|3651064|FG000|Overall Study|Adverse Event|1
2071857|NCT00630058|3651065|FG001|Overall Study|Adverse Event|1
2071858|NCT00630058|3651064|FG000|Overall Study|Withdrawal by Subject|0
2071859|NCT00630058|3651065|FG001|Overall Study|Withdrawal by Subject|1
2071860|NCT00630058|3651064|FG000|Overall Study|stopping criteria|3
2071861|NCT00630058|3651065|FG001|Overall Study|stopping criteria|2
2071862|NCT00630305|3651084|FG000|Overall Study|Withdrawal by Subject|1
2071863|NCT00630305|3651084|FG000|Overall Study|Inability to insert contact lens|1
2071864|NCT00630331|3651100|FG000|Overall Study|Death|2
2071865|NCT00630331|3651101|FG001|Overall Study|Death|1
2071866|NCT00630331|3651102|FG002|Overall Study|Death|1
2071867|NCT00630331|3651100|FG000|Overall Study|Adverse Event|1
2071868|NCT00630331|3651101|FG001|Overall Study|Adverse Event|0
2071869|NCT00630331|3651102|FG002|Overall Study|Adverse Event|0
2071870|NCT00630331|3651100|FG000|Overall Study|Withdrawal by Subject|12
2071871|NCT00630331|3651101|FG001|Overall Study|Withdrawal by Subject|7
2071872|NCT00630331|3651102|FG002|Overall Study|Withdrawal by Subject|5
2071873|NCT00630331|3651100|FG000|Overall Study|Lost to Follow-up|175
2071874|NCT00630331|3651101|FG001|Overall Study|Lost to Follow-up|143
2071875|NCT00630331|3651102|FG002|Overall Study|Lost to Follow-up|170
2071876|NCT00630331|3651100|FG000|Overall Study|Inappropriate enrollment|3
2071877|NCT00630331|3651101|FG001|Overall Study|Inappropriate enrollment|6
2071878|NCT00630331|3651102|FG002|Overall Study|Inappropriate enrollment|3
2071879|NCT00630331|3651100|FG000|Overall Study|Unable to classify|9
2071880|NCT00630331|3651101|FG001|Overall Study|Unable to classify|4
2071881|NCT00630331|3651102|FG002|Overall Study|Unable to classify|3
2071882|NCT00630331|3651100|FG000|Overall Study|Protocol Violation|4
2071883|NCT00630331|3651101|FG001|Overall Study|Protocol Violation|5
2071884|NCT00630331|3651102|FG002|Overall Study|Protocol Violation|6
2071885|NCT00630344|3651110|FG000|Overall Study|Adverse Event|5
2071886|NCT00630344|3651110|FG000|Overall Study|Progressive Disease|19
2071887|NCT00630344|3651110|FG000|Overall Study|Physician Decision|9
2071888|NCT00630344|3651110|FG000|Overall Study|Withdrawal by Subject|1
2071889|NCT00630344|3651110|FG000|Overall Study|Intercurrent Illness|1
2071890|NCT00630344|3651110|FG000|Overall Study|Other|1
2071891|NCT00630396|3651115|FG000|Overall Study|Death|4
2071892|NCT00630396|3651115|FG000|Overall Study|Lost to Follow-up|3
2071893|NCT00630539|3651128|FG000|Overall Study|Adverse Event|1
2071894|NCT00630539|3651129|FG001|Overall Study|Adverse Event|3
2071895|NCT00630539|3651130|FG002|Overall Study|Adverse Event|1
2071896|NCT00630539|3651131|FG003|Overall Study|Adverse Event|2
2071897|NCT00630539|3651128|FG000|Overall Study|Withdrawal by Subject|0
2071898|NCT00630539|3651129|FG001|Overall Study|Withdrawal by Subject|1
2071899|NCT00630539|3651130|FG002|Overall Study|Withdrawal by Subject|0
2071900|NCT00630539|3651131|FG003|Overall Study|Withdrawal by Subject|1
2071901|NCT00630747|3651163|FG000|Overall Study|Death|1
2071902|NCT00630747|3651163|FG000|Overall Study|Transferred to Study TKT031NPU|7
2071903|NCT00630747|3651163|FG000|Overall Study|Returned to country of origin|1
2071904|NCT00630786|3651170|FG000|Overall Study|Physician Decision|0
2071905|NCT00630786|3651171|FG001|Overall Study|Physician Decision|0
2071906|NCT00630786|3651172|FG002|Overall Study|Physician Decision|1
2071907|NCT00630786|3651170|FG000|Overall Study|Withdrawal by Subject|0
2071908|NCT00630786|3651171|FG001|Overall Study|Withdrawal by Subject|1
2071909|NCT00630786|3651172|FG002|Overall Study|Withdrawal by Subject|1
2071910|NCT00630786|3651170|FG000|Overall Study|Lost to Follow-up|0
2071911|NCT00630786|3651171|FG001|Overall Study|Lost to Follow-up|1
2071912|NCT00630786|3651172|FG002|Overall Study|Lost to Follow-up|0
2071913|NCT00630786|3651170|FG000|Overall Study|Other|1
2071914|NCT00630786|3651171|FG001|Overall Study|Other|0
2071915|NCT00630786|3651172|FG002|Overall Study|Other|0
2071916|NCT00630812|3651180|FG000|Randomisation to First Dose|Adverse Event|1
2071917|NCT00630812|3651181|FG001|Randomisation to First Dose|Adverse Event|1
2071918|NCT00630812|3651180|FG000|Randomisation to First Dose|Withdrawal by Subject|2
2071919|NCT00630812|3651181|FG001|Randomisation to First Dose|Withdrawal by Subject|3
2071920|NCT00630812|3651180|FG000|Randomisation to First Dose|Lost to Follow-up|1
2071921|NCT00630812|3651181|FG001|Randomisation to First Dose|Lost to Follow-up|0
2071922|NCT00630812|3651180|FG000|Randomisation to First Dose|Protocol Violation|4
2071923|NCT00630812|3651181|FG001|Randomisation to First Dose|Protocol Violation|1
2071924|NCT00630812|3651180|FG000|Double Blind Treatment Period|Adverse Event|13
2071925|NCT00630812|3651181|FG001|Double Blind Treatment Period|Adverse Event|5
2071926|NCT00630812|3651180|FG000|Double Blind Treatment Period|Lost to Follow-up|1
2071927|NCT00630812|3651181|FG001|Double Blind Treatment Period|Lost to Follow-up|0
2071928|NCT00630812|3651180|FG000|Double Blind Treatment Period|Physician Decision|2
2071929|NCT00630812|3651181|FG001|Double Blind Treatment Period|Physician Decision|1
2071930|NCT00630812|3651180|FG000|Double Blind Treatment Period|Protocol Violation|1
2071931|NCT00630812|3651181|FG001|Double Blind Treatment Period|Protocol Violation|0
2071932|NCT00630812|3651180|FG000|Double Blind Treatment Period|Withdrawal by Subject|13
2071933|NCT00630812|3651181|FG001|Double Blind Treatment Period|Withdrawal by Subject|7
2071934|NCT00630812|3651180|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1
2071935|NCT00630812|3651181|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0
2071936|NCT00630812|3651180|FG000|Double Blind Treatment Period|Non-compliance|0
2071937|NCT00630812|3651181|FG001|Double Blind Treatment Period|Non-compliance|1
2071938|NCT00630825|3651191|FG000|Overall Study|Adverse Event|4
2071939|NCT00630825|3651192|FG001|Overall Study|Adverse Event|4
2071940|NCT00630825|3651193|FG002|Overall Study|Adverse Event|3
2071941|NCT00630825|3651194|FG003|Overall Study|Adverse Event|1
2071942|NCT00630825|3651191|FG000|Overall Study|Entry Criteria Not Met|1
2071943|NCT00630825|3651192|FG001|Overall Study|Entry Criteria Not Met|0
2071944|NCT00630825|3651193|FG002|Overall Study|Entry Criteria Not Met|2
2071945|NCT00630825|3651194|FG003|Overall Study|Entry Criteria Not Met|1
2071946|NCT00630825|3651191|FG000|Overall Study|Lost to Follow-up|1
2071947|NCT00630825|3651192|FG001|Overall Study|Lost to Follow-up|1
2071948|NCT00630825|3651193|FG002|Overall Study|Lost to Follow-up|1
2071949|NCT00630825|3651194|FG003|Overall Study|Lost to Follow-up|1
2071950|NCT00630825|3651191|FG000|Overall Study|Physician Decision|1
2071951|NCT00630825|3651192|FG001|Overall Study|Physician Decision|0
2071952|NCT00630825|3651193|FG002|Overall Study|Physician Decision|0
2071953|NCT00630825|3651194|FG003|Overall Study|Physician Decision|0
2071954|NCT00630825|3651191|FG000|Overall Study|Withdrawal by Subject|2
2071955|NCT00630825|3651192|FG001|Overall Study|Withdrawal by Subject|2
2071956|NCT00630825|3651193|FG002|Overall Study|Withdrawal by Subject|2
2071957|NCT00630825|3651194|FG003|Overall Study|Withdrawal by Subject|3
2071958|NCT00630838|3651206|FG000|Overall Study|Death|0
2071959|NCT00630838|3651207|FG001|Overall Study|Death|1
2071960|NCT00630838|3651206|FG000|Overall Study|Lost to Follow-up|0
2071961|NCT00630838|3651207|FG001|Overall Study|Lost to Follow-up|1
2071962|NCT00630864|3651215|FG000|Part 1 (up to Week 6)|Adverse Event|1
2071963|NCT00630864|3651215|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
2071964|NCT00630877|3651222|FG000|Overall Study|Adverse Event|11
2071965|NCT00630877|3651223|FG001|Overall Study|Adverse Event|8
2071966|NCT00630877|3651224|FG002|Overall Study|Adverse Event|7
2071967|NCT00630877|3651222|FG000|Overall Study|Withdrawal by Subject|3
2071968|NCT00630877|3651223|FG001|Overall Study|Withdrawal by Subject|4
2071969|NCT00630877|3651224|FG002|Overall Study|Withdrawal by Subject|0
2071970|NCT00630877|3651222|FG000|Overall Study|Lost to Follow-up|2
2071971|NCT00630877|3651223|FG001|Overall Study|Lost to Follow-up|0
2071972|NCT00630877|3651224|FG002|Overall Study|Lost to Follow-up|0
2071973|NCT00630877|3651222|FG000|Overall Study|Noncompliance|2
2071974|NCT00630877|3651223|FG001|Overall Study|Noncompliance|3
2071975|NCT00630877|3651224|FG002|Overall Study|Noncompliance|1
2071976|NCT00630877|3651222|FG000|Overall Study|Protocol violation|1
2071977|NCT00630877|3651223|FG001|Overall Study|Protocol violation|0
2071978|NCT00630877|3651224|FG002|Overall Study|Protocol violation|1
2071979|NCT00630877|3651222|FG000|Overall Study|Personal reasons|0
2071980|NCT00630877|3651223|FG001|Overall Study|Personal reasons|0
2071981|NCT00630877|3651224|FG002|Overall Study|Personal reasons|1
2071982|NCT00630916|3651236|FG000|Overall Study|Death|110
2071983|NCT00630916|3651236|FG000|Overall Study|Explant|8
2071984|NCT00630916|3651236|FG000|Overall Study|Lost to Follow-up|5
2071985|NCT00630916|3651236|FG000|Overall Study|Withdrawal by Subject|30
2071986|NCT00630916|3651236|FG000|Overall Study|Protocol Violation|7
2071987|NCT00630916|3651236|FG000|Overall Study|Physician Decision|47
2071988|NCT00630916|3651236|FG000|Overall Study|Lack of Efficacy|3
2071989|NCT00630994|3651253|FG000|Overall Study|Adverse Event|1
2071990|NCT00630994|3651253|FG000|Overall Study|Disease Progression|1
2071991|NCT00630994|3651253|FG000|Overall Study|Lack of Efficacy|1
2071992|NCT00630994|3651253|FG000|Overall Study|Other|1
2071993|NCT00631007|3651263|FG000|Overall Study|Adverse Event|0
2071994|NCT00631007|3651264|FG001|Overall Study|Adverse Event|2
2071995|NCT00631007|3651265|FG002|Overall Study|Adverse Event|0
2071996|NCT00631007|3651266|FG003|Overall Study|Adverse Event|2
2071997|NCT00631007|3651267|FG004|Overall Study|Adverse Event|3
2071998|NCT00631007|3651268|FG005|Overall Study|Adverse Event|2
2071999|NCT00631007|3651263|FG000|Overall Study|Lost to Follow-up|2
2072000|NCT00631007|3651264|FG001|Overall Study|Lost to Follow-up|1
2072001|NCT00631007|3651265|FG002|Overall Study|Lost to Follow-up|2
2072002|NCT00631007|3651266|FG003|Overall Study|Lost to Follow-up|4
2072003|NCT00631007|3651267|FG004|Overall Study|Lost to Follow-up|5
2072004|NCT00631007|3651268|FG005|Overall Study|Lost to Follow-up|3
2072005|NCT00631007|3651263|FG000|Overall Study|Physician Decision|1
2072006|NCT00631007|3651264|FG001|Overall Study|Physician Decision|0
2072007|NCT00631007|3651265|FG002|Overall Study|Physician Decision|1
2072008|NCT00631007|3651266|FG003|Overall Study|Physician Decision|0
2072009|NCT00631007|3651267|FG004|Overall Study|Physician Decision|0
2072010|NCT00631007|3651268|FG005|Overall Study|Physician Decision|2
2072011|NCT00631007|3651263|FG000|Overall Study|Persistent Hyperglycemia|2
2072012|NCT00631007|3651264|FG001|Overall Study|Persistent Hyperglycemia|2
2072013|NCT00631007|3651265|FG002|Overall Study|Persistent Hyperglycemia|5
2072014|NCT00631007|3651266|FG003|Overall Study|Persistent Hyperglycemia|1
2072015|NCT00631007|3651267|FG004|Overall Study|Persistent Hyperglycemia|2
2072016|NCT00631007|3651268|FG005|Overall Study|Persistent Hyperglycemia|5
2072017|NCT00631007|3651263|FG000|Overall Study|Withdrawal by Subject|4
2072018|NCT00631007|3651264|FG001|Overall Study|Withdrawal by Subject|5
2072019|NCT00631007|3651265|FG002|Overall Study|Withdrawal by Subject|2
2072020|NCT00631007|3651266|FG003|Overall Study|Withdrawal by Subject|2
2072021|NCT00631007|3651267|FG004|Overall Study|Withdrawal by Subject|1
2072022|NCT00631007|3651268|FG005|Overall Study|Withdrawal by Subject|3
2072023|NCT00631007|3651263|FG000|Overall Study|Other|2
2072024|NCT00631007|3651264|FG001|Overall Study|Other|1
2072025|NCT00631007|3651265|FG002|Overall Study|Other|0
2072026|NCT00631007|3651266|FG003|Overall Study|Other|0
2072027|NCT00631007|3651267|FG004|Overall Study|Other|1
2072028|NCT00631007|3651268|FG005|Overall Study|Other|0
2072029|NCT00631020|3651282|FG000|Overall Study|Lost to Follow-up|7
2072030|NCT00631020|3651282|FG000|Overall Study|Incarcerated|1
2072031|NCT00631163|3651286|FG000|Number of Participants in Year 1|Adverse Event|12
2072032|NCT00631163|3651286|FG000|Number of Participants in Year 1|Withdrawal by Subject|8
2072033|NCT00631163|3651286|FG000|Number of Participants in Year 1|Death|6
2072034|NCT00631163|3651286|FG000|Number of Participants in Year 1|Lost to Follow-up|1
2072035|NCT00631163|3651286|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1
2072036|NCT00631163|3651286|FG000|Number of Participants in Year 1|Administrative problems|6
2072037|NCT00631163|3651286|FG000|Number of Participants in Year 2|Withdrawal by Subject|2
2072038|NCT00631163|3651286|FG000|Number of Participants in Year 2|Adverse Event|1
2072039|NCT00631163|3651286|FG000|Number of Participants in Year 2|Protocol Violation|1
2072040|NCT00631163|3651286|FG000|Number of Participants in Year 2|Abnormal laboratory value|1
2072041|NCT00631189|3651301|FG000|Initial Phase|Protocol Violation|347
2072042|NCT00631189|3651302|FG001|Initial Phase|Protocol Violation|0
2072043|NCT00631189|3651303|FG002|Initial Phase|Protocol Violation|0
2072044|NCT00631189|3651304|FG003|Initial Phase|Protocol Violation|0
2072045|NCT00631189|3651301|FG000|Initial Phase|Withdrawal by Subject|4
2072046|NCT00631189|3651302|FG001|Initial Phase|Withdrawal by Subject|0
2072047|NCT00631189|3651303|FG002|Initial Phase|Withdrawal by Subject|0
2072048|NCT00631189|3651304|FG003|Initial Phase|Withdrawal by Subject|0
2072049|NCT00631189|3651301|FG000|Treatment Phase|Withdrawal by Subject|0
2072050|NCT00631189|3651302|FG001|Treatment Phase|Withdrawal by Subject|2
2072051|NCT00631189|3651303|FG002|Treatment Phase|Withdrawal by Subject|1
2072052|NCT00631189|3651304|FG003|Treatment Phase|Withdrawal by Subject|1
2072053|NCT00631189|3651301|FG000|Treatment Phase|Protocol Violation|0
2072054|NCT00631189|3651302|FG001|Treatment Phase|Protocol Violation|1
2072055|NCT00631189|3651303|FG002|Treatment Phase|Protocol Violation|6
2072056|NCT00631189|3651304|FG003|Treatment Phase|Protocol Violation|2
2072057|NCT00631189|3651301|FG000|Treatment Phase|Adverse Event|0
2072058|NCT00631189|3651302|FG001|Treatment Phase|Adverse Event|3
2072059|NCT00631189|3651303|FG002|Treatment Phase|Adverse Event|2
2072060|NCT00631189|3651304|FG003|Treatment Phase|Adverse Event|4
2072061|NCT00631189|3651301|FG000|Treatment Phase|Lost to Follow-up|0
2072062|NCT00631189|3651302|FG001|Treatment Phase|Lost to Follow-up|1
2072063|NCT00631189|3651303|FG002|Treatment Phase|Lost to Follow-up|0
2072064|NCT00631189|3651304|FG003|Treatment Phase|Lost to Follow-up|0
2072065|NCT00631189|3651301|FG000|Treatment Phase|Pregnancy|0
2072066|NCT00631189|3651302|FG001|Treatment Phase|Pregnancy|0
2304188|NCT02649231|4003939|FG002|Overall Study|Lost to Follow-up|1
2304189|NCT02649231|4003940|FG003|Overall Study|Lost to Follow-up|0
2304190|NCT02649231|4003937|FG000|Overall Study|Withdrawal by Subject|0
2304191|NCT02649231|4003938|FG001|Overall Study|Withdrawal by Subject|1
2304192|NCT02649231|4003939|FG002|Overall Study|Withdrawal by Subject|0
2304193|NCT02649231|4003940|FG003|Overall Study|Withdrawal by Subject|1
2304194|NCT02649231|4003937|FG000|Overall Study|Protocol Violation|2
2304195|NCT02649231|4003938|FG001|Overall Study|Protocol Violation|1
2072067|NCT00631189|3651303|FG002|Treatment Phase|Pregnancy|1
2072068|NCT00631189|3651304|FG003|Treatment Phase|Pregnancy|0
2072069|NCT00631189|3651301|FG000|Treatment Phase|patient did not take pravastatin|0
2072070|NCT00631189|3651302|FG001|Treatment Phase|patient did not take pravastatin|0
2072071|NCT00631189|3651303|FG002|Treatment Phase|patient did not take pravastatin|1
2072072|NCT00631189|3651304|FG003|Treatment Phase|patient did not take pravastatin|0
2072073|NCT00631371|3651335|FG000|Overall Study|Lost to Follow-up|24
2072074|NCT00631371|3651336|FG001|Overall Study|Lost to Follow-up|19
2072075|NCT00631371|3651335|FG000|Overall Study|Other reason|5
2072076|NCT00631371|3651336|FG001|Overall Study|Other reason|12
2072077|NCT00631371|3651335|FG000|Overall Study|subject request|38
2072078|NCT00631371|3651336|FG001|Overall Study|subject request|45
2072079|NCT00631371|3651335|FG000|Overall Study|Discontinuation of study by Sponsor|70
2072080|NCT00631371|3651336|FG001|Overall Study|Discontinuation of study by Sponsor|76
2072081|NCT00631371|3651335|FG000|Overall Study|Death|263
2072082|NCT00631371|3651336|FG001|Overall Study|Death|239
2072083|NCT00631410|3651344|FG000|Overall Study|Adverse Event|1
2072084|NCT00631410|3651345|FG001|Overall Study|Adverse Event|3
2072085|NCT00631410|3651344|FG000|Overall Study|Objective Progression or Relapse|4
2072086|NCT00631410|3651345|FG001|Overall Study|Objective Progression or Relapse|3
2072087|NCT00631410|3651344|FG000|Overall Study|Surgery|1
2072088|NCT00631410|3651345|FG001|Overall Study|Surgery|0
2072089|NCT00631475|3651365|FG000|Overall Study|Death|18
2072090|NCT00631475|3651365|FG000|Overall Study|Adverse Event|14
2072091|NCT00631475|3651365|FG000|Overall Study|Withdrew consent|5
2072092|NCT00631475|3651365|FG000|Overall Study|Preparation for lung transplant|8
2072093|NCT00631488|3651372|FG000|Overall Study|Adverse Event|1
2072094|NCT00631488|3651373|FG001|Overall Study|Adverse Event|0
2072095|NCT00631488|3651374|FG002|Overall Study|Adverse Event|0
2072096|NCT00631488|3651372|FG000|Overall Study|Lost to Follow-up|2
2072097|NCT00631488|3651373|FG001|Overall Study|Lost to Follow-up|2
2072098|NCT00631488|3651374|FG002|Overall Study|Lost to Follow-up|0
2072099|NCT00631488|3651372|FG000|Overall Study|Physician Decision|1
2072100|NCT00631488|3651373|FG001|Overall Study|Physician Decision|0
2072101|NCT00631488|3651374|FG002|Overall Study|Physician Decision|1
2072102|NCT00631488|3651372|FG000|Overall Study|Protocol Violation|0
2072103|NCT00631488|3651373|FG001|Overall Study|Protocol Violation|0
2072104|NCT00631488|3651374|FG002|Overall Study|Protocol Violation|1
2072105|NCT00631540|3651382|FG000|Overall Study|Withdrawal by Subject|5
2072106|NCT00631540|3651382|FG000|Overall Study|Death|4
2072107|NCT00631540|3651382|FG000|Overall Study|Lost to Follow-up|2
2072108|NCT00631540|3651382|FG000|Overall Study|Core Lab Data Unavailable|3
2072109|NCT00631657|3651401|FG000|6-Month Treatment Period|Adverse Event|47
2072110|NCT00631657|3651402|FG001|6-Month Treatment Period|Adverse Event|0
2072111|NCT00631657|3651403|FG002|6-Month Treatment Period|Adverse Event|7
2072112|NCT00631657|3651401|FG000|6-Month Treatment Period|Withdrawal by Subject|14
2072113|NCT00631657|3651402|FG001|6-Month Treatment Period|Withdrawal by Subject|0
2072114|NCT00631657|3651403|FG002|6-Month Treatment Period|Withdrawal by Subject|5
2072115|NCT00631657|3651401|FG000|6-Month Treatment Period|Lack of Efficacy|34
2072116|NCT00631657|3651402|FG001|6-Month Treatment Period|Lack of Efficacy|0
2210457|NCT01650259|3849952|FG001|Overall Study|Lost to Follow-up|0
2210458|NCT01650259|3849951|FG000|Overall Study|Patients had no visit after entry|70
2072117|NCT00631657|3651403|FG002|6-Month Treatment Period|Lack of Efficacy|25
2072118|NCT00631657|3651401|FG000|6-Month Treatment Period|Lost to Follow-up|7
2072119|NCT00631657|3651402|FG001|6-Month Treatment Period|Lost to Follow-up|0
2072120|NCT00631657|3651403|FG002|6-Month Treatment Period|Lost to Follow-up|2
2072121|NCT00631657|3651401|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
2072122|NCT00631657|3651402|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
2072123|NCT00631657|3651403|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
2072124|NCT00631657|3651401|FG000|6-Month Treatment Period|Other|16
2072125|NCT00631657|3651402|FG001|6-Month Treatment Period|Other|0
2072126|NCT00631657|3651403|FG002|6-Month Treatment Period|Other|4
2072127|NCT00631657|3651401|FG000|6-Month Treatment Period|Not Treated|2
2072128|NCT00631657|3651402|FG001|6-Month Treatment Period|Not Treated|0
2072129|NCT00631657|3651403|FG002|6-Month Treatment Period|Not Treated|1
2072130|NCT00631657|3651401|FG000|7-Day Discontinuation Period|Not Treated|1
2304196|NCT02649231|4003939|FG002|Overall Study|Protocol Violation|1
2072131|NCT00631657|3651402|FG001|7-Day Discontinuation Period|Not Treated|1
2072132|NCT00631657|3651403|FG002|7-Day Discontinuation Period|Not Treated|1
2072133|NCT00631657|3651401|FG000|7-Day Discontinuation Period|Other|1
2072134|NCT00631657|3651402|FG001|7-Day Discontinuation Period|Other|0
2072135|NCT00631657|3651403|FG002|7-Day Discontinuation Period|Other|0
2072136|NCT00631696|3651429|FG000|Overall Study|Entered, not randomized to treatment|1
2072137|NCT00631696|3651430|FG001|Overall Study|Entered, not randomized to treatment|1
2072138|NCT00631696|3651429|FG000|Overall Study|Discontinued after database release date|1
2072139|NCT00631696|3651430|FG001|Overall Study|Discontinued after database release date|0
2072140|NCT00631696|3651429|FG000|Overall Study|Follow up after database release date|1
2072141|NCT00631696|3651430|FG001|Overall Study|Follow up after database release date|0
2072142|NCT00631696|3651429|FG000|Overall Study|Lost to Follow-up|7
2072143|NCT00631696|3651430|FG001|Overall Study|Lost to Follow-up|10
2072144|NCT00631696|3651429|FG000|Overall Study|Withdrawal by Subject|2
2072145|NCT00631696|3651430|FG001|Overall Study|Withdrawal by Subject|9
2072146|NCT00631696|3651429|FG000|Overall Study|Other|8
2072147|NCT00631696|3651430|FG001|Overall Study|Other|8
2072148|NCT00631696|3651429|FG000|Overall Study|Protocol Violation|9
2072149|NCT00631696|3651430|FG001|Overall Study|Protocol Violation|9
2072150|NCT00631696|3651429|FG000|Overall Study|Study terminated by sponsor|3
2072151|NCT00631696|3651430|FG001|Overall Study|Study terminated by sponsor|3
2072152|NCT00631696|3651429|FG000|Overall Study|Adverse Event|5
2072153|NCT00631696|3651430|FG001|Overall Study|Adverse Event|0
2072154|NCT00631917|3651452|FG000|Overall Study|Adverse Event|34
2072155|NCT00631917|3651453|FG001|Overall Study|Adverse Event|45
2072156|NCT00631917|3651452|FG000|Overall Study|Abnormal laboratory value(s)|2
2072157|NCT00631917|3651453|FG001|Overall Study|Abnormal laboratory value(s)|1
2072158|NCT00631917|3651452|FG000|Overall Study|Abnormal test procedure result(s)|3
2072159|NCT00631917|3651453|FG001|Overall Study|Abnormal test procedure result(s)|2
2072160|NCT00631917|3651452|FG000|Overall Study|Unsatisfactory therapeutic effect|8
2072161|NCT00631917|3651453|FG001|Overall Study|Unsatisfactory therapeutic effect|14
2072162|NCT00631917|3651452|FG000|Overall Study|No longer required study drug|0
2072163|NCT00631917|3651453|FG001|Overall Study|No longer required study drug|1
2072164|NCT00631917|3651452|FG000|Overall Study|Protocol deviation|6
2072165|NCT00631917|3651453|FG001|Overall Study|Protocol deviation|5
2072166|NCT00631917|3651452|FG000|Overall Study|Subject withdrew consent|25
2072167|NCT00631917|3651453|FG001|Overall Study|Subject withdrew consent|33
2072168|NCT00631917|3651452|FG000|Overall Study|Lost to Follow-up|7
2072169|NCT00631917|3651453|FG001|Overall Study|Lost to Follow-up|7
2072170|NCT00631917|3651452|FG000|Overall Study|Administrative problems|2
2072171|NCT00631917|3651453|FG001|Overall Study|Administrative problems|0
2072172|NCT00631917|3651452|FG000|Overall Study|Death|1
2072173|NCT00631917|3651453|FG001|Overall Study|Death|0
2072174|NCT00631969|3651461|FG000|Overall Study|Adverse Event|3
2072175|NCT00631969|3651462|FG001|Overall Study|Adverse Event|1
2072176|NCT00631969|3651461|FG000|Overall Study|Lack of Efficacy|2
2072177|NCT00631969|3651462|FG001|Overall Study|Lack of Efficacy|8
2072178|NCT00631969|3651461|FG000|Overall Study|Lost to Follow-up|2
2072179|NCT00631969|3651462|FG001|Overall Study|Lost to Follow-up|1
2072180|NCT00631969|3651461|FG000|Overall Study|Protocol Violation|1
2072181|NCT00631969|3651462|FG001|Overall Study|Protocol Violation|1
2072182|NCT00631969|3651461|FG000|Overall Study|Consent Withdrawn|5
2072183|NCT00631969|3651462|FG001|Overall Study|Consent Withdrawn|7
2072184|NCT00631969|3651461|FG000|Overall Study|Noncompliant With Study Medication|0
2072185|NCT00631969|3651462|FG001|Overall Study|Noncompliant With Study Medication|1
2072186|NCT00631969|3651461|FG000|Overall Study|No Drug Exposure|2
2072187|NCT00631969|3651462|FG001|Overall Study|No Drug Exposure|2
2072188|NCT00632021|3651472|FG000|Overall Study|Withdrawal/death|4
2072189|NCT00632021|3651473|FG001|Overall Study|Withdrawal/death|7
2072190|NCT00632099|3651482|FG000|Overall Study|Lost to Follow-up|3
2072191|NCT00632099|3651483|FG001|Overall Study|Lost to Follow-up|3
2072192|NCT00632125|3651489|FG000|Overall Study|Death|82
2072193|NCT00632125|3651489|FG000|Overall Study|Withdrawal by Subject|44
2072194|NCT00632125|3651489|FG000|Overall Study|Adverse Event|36
2072195|NCT00632125|3651489|FG000|Overall Study|Renal transplantation|17
2072196|NCT00632125|3651489|FG000|Overall Study|Need for systemic immunosuppressive medi|8
2072197|NCT00632125|3651489|FG000|Overall Study|Non-compliance|8
2072198|NCT00632125|3651489|FG000|Overall Study|Development of uncontrolled hypertension|5
2072199|NCT00632125|3651489|FG000|Overall Study|Moved to other dialysis unit, etc.|102
2072200|NCT00632203|3651495|FG000|Overall Study|Did not start study treatment|1
2177181|NCT01371747|3801221|FG005|Overall Study|Protocol Violation|0
2072201|NCT00632203|3651496|FG001|Overall Study|Did not start study treatment|0
2072202|NCT00632229|3651504|FG000|Overall Study|Adverse Event|6
2072203|NCT00632229|3651505|FG001|Overall Study|Adverse Event|0
2072204|NCT00632229|3651504|FG000|Overall Study|Lost to Follow-up|0
2072205|NCT00632229|3651505|FG001|Overall Study|Lost to Follow-up|3
2072206|NCT00632229|3651504|FG000|Overall Study|Lack of Efficacy|0
2072207|NCT00632229|3651505|FG001|Overall Study|Lack of Efficacy|2
2072208|NCT00632229|3651504|FG000|Overall Study|Undisclosed reasons within the first wee|0
2072209|NCT00632229|3651505|FG001|Overall Study|Undisclosed reasons within the first wee|1
2072210|NCT00632359|3651515|FG000|Overall Study|Withdrawal by Subject|2
2072211|NCT00632424|3651532|FG000|Overall Study|Disease Progression|17
2072212|NCT00632424|3651532|FG000|Overall Study|Study Drug Toxicity|1
2072213|NCT00632463|3651549|FG000|Overall Study|Adverse Event|0
2072214|NCT00632463|3651550|FG001|Overall Study|Adverse Event|1
2072215|NCT00632463|3651551|FG002|Overall Study|Adverse Event|0
2072216|NCT00632502|3651574|FG000|Overall Study|Adverse Event|0
2072217|NCT00632502|3651575|FG001|Overall Study|Adverse Event|1
2072218|NCT00632502|3651574|FG000|Overall Study|Randomized not treated|3
2072219|NCT00632502|3651575|FG001|Overall Study|Randomized not treated|0
2072220|NCT00632541|3651582|FG000|Overall Study|Adverse Event|7
2072221|NCT00632736|3651604|FG000|Overall Study|Adverse Event|104
2072222|NCT00632736|3651604|FG000|Overall Study|Lost to Follow-up|15
2072223|NCT00632736|3651604|FG000|Overall Study|Protocol Violation|14
2072224|NCT00632736|3651604|FG000|Overall Study|Withdrawal by Subject|99
2072225|NCT00632736|3651604|FG000|Overall Study|Lack of Efficacy|5
2072226|NCT00632736|3651604|FG000|Overall Study|Sponsor terminated study|5
2072227|NCT00632736|3651604|FG000|Overall Study|Non-compliance|10
2072228|NCT00632736|3651604|FG000|Overall Study|Other|16
2072229|NCT00632749|3651622|FG000|Overall Study|Progressive disease|3
2072230|NCT00632749|3651623|FG001|Overall Study|Progressive disease|2
2072231|NCT00632749|3651624|FG002|Overall Study|Progressive disease|2
2072232|NCT00632749|3651625|FG003|Overall Study|Progressive disease|2
2072233|NCT00632749|3651626|FG004|Overall Study|Progressive disease|4
2072234|NCT00632749|3651627|FG005|Overall Study|Progressive disease|4
2072235|NCT00632749|3651628|FG006|Overall Study|Progressive disease|3
2072236|NCT00632749|3651629|FG007|Overall Study|Progressive disease|2
2072237|NCT00632749|3651630|FG008|Overall Study|Progressive disease|3
2072238|NCT00632749|3651631|FG009|Overall Study|Progressive disease|2
2072239|NCT00632749|3651632|FG010|Overall Study|Progressive disease|4
2072240|NCT00632749|3651633|FG011|Overall Study|Progressive disease|3
2072241|NCT00632749|3651634|FG012|Overall Study|Progressive disease|2
2072242|NCT00632749|3651635|FG013|Overall Study|Progressive disease|4
2072243|NCT00632749|3651622|FG000|Overall Study|Other Adverse event|1
2072244|NCT00632749|3651623|FG001|Overall Study|Other Adverse event|1
2072245|NCT00632749|3651624|FG002|Overall Study|Other Adverse event|1
2072246|NCT00632749|3651625|FG003|Overall Study|Other Adverse event|1
2072247|NCT00632749|3651626|FG004|Overall Study|Other Adverse event|2
2072248|NCT00632749|3651627|FG005|Overall Study|Other Adverse event|4
2072249|NCT00632749|3651628|FG006|Overall Study|Other Adverse event|1
2072250|NCT00632749|3651629|FG007|Overall Study|Other Adverse event|2
2072251|NCT00632749|3651630|FG008|Overall Study|Other Adverse event|2
2072252|NCT00632749|3651631|FG009|Overall Study|Other Adverse event|0
2072253|NCT00632749|3651632|FG010|Overall Study|Other Adverse event|1
2072254|NCT00632749|3651633|FG011|Overall Study|Other Adverse event|0
2072255|NCT00632749|3651634|FG012|Overall Study|Other Adverse event|1
2072256|NCT00632749|3651635|FG013|Overall Study|Other Adverse event|0
2304197|NCT02649231|4003940|FG003|Overall Study|Protocol Violation|0
2304198|NCT02649439|4003961|FG000|Overall Study|Switched to alternative treatment|6
2304199|NCT02649439|4003962|FG001|Overall Study|Switched to alternative treatment|4
2304200|NCT02649439|4003961|FG000|Overall Study|Patient decision|1
2304201|NCT02649439|4003962|FG001|Overall Study|Patient decision|0
2304202|NCT02649439|4003961|FG000|Overall Study|Patient going out of country|1
2304203|NCT02649439|4003962|FG001|Overall Study|Patient going out of country|0
2304204|NCT02649439|4003961|FG000|Overall Study|To start finasteride|1
2304205|NCT02649439|4003962|FG001|Overall Study|To start finasteride|0
2304206|NCT02649439|4003961|FG000|Overall Study|Physician Decision|1
2304207|NCT02649439|4003962|FG001|Overall Study|Physician Decision|0
2304208|NCT02649439|4003961|FG000|Overall Study|Disease progression on study|12
2304209|NCT02649439|4003962|FG001|Overall Study|Disease progression on study|13
2304210|NCT02649439|4003961|FG000|Overall Study|Refused further treatment|1
2304211|NCT02649439|4003962|FG001|Overall Study|Refused further treatment|0
2304212|NCT02649439|4003961|FG000|Overall Study|Refused further follow up|2
2304213|NCT02649439|4003962|FG001|Overall Study|Refused further follow up|7
2304214|NCT02649439|4003961|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1
2072257|NCT00632749|3651622|FG000|Overall Study|Refuse to continue medication|0
2072258|NCT00632749|3651623|FG001|Overall Study|Refuse to continue medication|0
2304215|NCT02649439|4003962|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0
2304216|NCT02649439|4003961|FG000|Overall Study|No treatment, per protocol|1
2072259|NCT00632749|3651624|FG002|Overall Study|Refuse to continue medication|0
2072260|NCT00632749|3651625|FG003|Overall Study|Refuse to continue medication|1
2072261|NCT00632749|3651626|FG004|Overall Study|Refuse to continue medication|0
2072262|NCT00632749|3651627|FG005|Overall Study|Refuse to continue medication|0
2072263|NCT00632749|3651628|FG006|Overall Study|Refuse to continue medication|0
2072264|NCT00632749|3651629|FG007|Overall Study|Refuse to continue medication|0
2072265|NCT00632749|3651630|FG008|Overall Study|Refuse to continue medication|0
2072266|NCT00632749|3651631|FG009|Overall Study|Refuse to continue medication|1
2072267|NCT00632749|3651632|FG010|Overall Study|Refuse to continue medication|0
2072268|NCT00632749|3651633|FG011|Overall Study|Refuse to continue medication|0
2072269|NCT00632749|3651634|FG012|Overall Study|Refuse to continue medication|0
2072270|NCT00632749|3651635|FG013|Overall Study|Refuse to continue medication|0
2072271|NCT00632749|3651622|FG000|Overall Study|Reason other than those specified above|0
2072272|NCT00632749|3651623|FG001|Overall Study|Reason other than those specified above|2
2072273|NCT00632749|3651624|FG002|Overall Study|Reason other than those specified above|0
2072274|NCT00632749|3651625|FG003|Overall Study|Reason other than those specified above|0
2072275|NCT00632749|3651626|FG004|Overall Study|Reason other than those specified above|1
2072276|NCT00632749|3651627|FG005|Overall Study|Reason other than those specified above|0
2072277|NCT00632749|3651628|FG006|Overall Study|Reason other than those specified above|1
2072278|NCT00632749|3651629|FG007|Overall Study|Reason other than those specified above|0
2072279|NCT00632749|3651630|FG008|Overall Study|Reason other than those specified above|0
2072280|NCT00632749|3651631|FG009|Overall Study|Reason other than those specified above|0
2072281|NCT00632749|3651632|FG010|Overall Study|Reason other than those specified above|2
2072282|NCT00632749|3651633|FG011|Overall Study|Reason other than those specified above|1
2072283|NCT00632749|3651634|FG012|Overall Study|Reason other than those specified above|0
2072284|NCT00632749|3651635|FG013|Overall Study|Reason other than those specified above|2
2072285|NCT00632827|3651684|FG000|Overall Study|Excluded after GVD (Not evaluable)|2
2072286|NCT00632827|3651684|FG000|Overall Study|Death|2
2072287|NCT00632827|3651684|FG000|Overall Study|Adverse Event|5
2072288|NCT00632827|3651684|FG000|Overall Study|Lost to Follow-up|1
2072289|NCT00632931|3651689|FG000|Part 1, Period 1|Protocol Violation|1
2072290|NCT00632931|3651690|FG001|Part 1, Period 1|Protocol Violation|0
2072291|NCT00632931|3651691|FG002|Part 1, Period 1|Protocol Violation|0
2072292|NCT00632931|3651689|FG000|Part 1, Period 1|Withdrawal by Subject|1
2072293|NCT00632931|3651690|FG001|Part 1, Period 1|Withdrawal by Subject|0
2072294|NCT00632931|3651691|FG002|Part 1, Period 1|Withdrawal by Subject|0
2072295|NCT00632931|3651689|FG000|Part 2|Adverse Event|0
2072296|NCT00632931|3651690|FG001|Part 2|Adverse Event|0
2072297|NCT00632931|3651691|FG002|Part 2|Adverse Event|3
2072298|NCT00632931|3651689|FG000|Part 2|Death|0
2072299|NCT00632931|3651690|FG001|Part 2|Death|0
2072300|NCT00632931|3651691|FG002|Part 2|Death|1
2072301|NCT00632931|3651689|FG000|Part 2|Lack of Efficacy|0
2072302|NCT00632931|3651690|FG001|Part 2|Lack of Efficacy|0
2072303|NCT00632931|3651691|FG002|Part 2|Lack of Efficacy|17
2072304|NCT00632931|3651689|FG000|Part 2|Withdrawal by Subject|0
2072305|NCT00632931|3651690|FG001|Part 2|Withdrawal by Subject|0
2072306|NCT00632931|3651691|FG002|Part 2|Withdrawal by Subject|3
2072307|NCT00633022|3651724|FG000|Overall Study|Adverse Event|1
2072308|NCT00633022|3651725|FG001|Overall Study|Adverse Event|0
2072309|NCT00633022|3651726|FG002|Overall Study|Adverse Event|5
2072310|NCT00633022|3651724|FG000|Overall Study|Physician Decision|0
2072311|NCT00633022|3651725|FG001|Overall Study|Physician Decision|1
2072312|NCT00633022|3651726|FG002|Overall Study|Physician Decision|0
2072313|NCT00633074|3651736|FG000|Overall Study|Adverse Event|1
2072314|NCT00633074|3651737|FG001|Overall Study|Adverse Event|0
2106433|NCT00866177|3699594|FG000|Overall Study|Not Treated|151
2106434|NCT00866281|3699600|FG000|Overall Study|Adverse Event|1
2106435|NCT00866281|3699601|FG001|Overall Study|Adverse Event|0
2106436|NCT00866281|3699600|FG000|Overall Study|Withdrawal by participants|3
2106437|NCT00866281|3699601|FG001|Overall Study|Withdrawal by participants|0
2106438|NCT00866281|3699600|FG000|Overall Study|Disease progression|3
2106439|NCT00866281|3699601|FG001|Overall Study|Disease progression|11
2106440|NCT00866281|3699600|FG000|Overall Study|New cancer therapy|0
2106441|NCT00866281|3699601|FG001|Overall Study|New cancer therapy|4
2106442|NCT00866294|3699613|FG000|Overall Study|Adverse Event|12
2106443|NCT00866294|3699614|FG001|Overall Study|Adverse Event|13
2106444|NCT00866294|3699615|FG002|Overall Study|Adverse Event|9
2106445|NCT00866294|3699613|FG000|Overall Study|Lack of Efficacy|7
2106446|NCT00866294|3699614|FG001|Overall Study|Lack of Efficacy|1
2106447|NCT00866294|3699615|FG002|Overall Study|Lack of Efficacy|0
2106448|NCT00866294|3699613|FG000|Overall Study|Protocol Violation|2
2106449|NCT00866294|3699614|FG001|Overall Study|Protocol Violation|0
2106450|NCT00866294|3699615|FG002|Overall Study|Protocol Violation|0
2106451|NCT00866294|3699613|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5
2106452|NCT00866294|3699614|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
2106453|NCT00866294|3699615|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1
2106454|NCT00866294|3699613|FG000|Overall Study|Lost to Follow-up|1
2106455|NCT00866294|3699614|FG001|Overall Study|Lost to Follow-up|3
2106456|NCT00866294|3699615|FG002|Overall Study|Lost to Follow-up|0
2106457|NCT00866294|3699613|FG000|Overall Study|Physician Decision|6
2106458|NCT00866294|3699614|FG001|Overall Study|Physician Decision|2
2106459|NCT00866294|3699615|FG002|Overall Study|Physician Decision|1
2106460|NCT00866307|3699631|FG000|Induction|Adverse Event|5
2106461|NCT00866307|3699632|FG001|Induction|Adverse Event|0
2106462|NCT00866307|3699633|FG002|Induction|Adverse Event|0
2106463|NCT00866307|3699631|FG000|Induction|Death|2
2106464|NCT00866307|3699632|FG001|Induction|Death|0
2106465|NCT00866307|3699633|FG002|Induction|Death|0
2106466|NCT00866307|3699631|FG000|Induction|Physician Decision|5
2106467|NCT00866307|3699632|FG001|Induction|Physician Decision|0
2072315|NCT00633126|3651743|FG000|Overall Study|Did not receive full dose|1
2072316|NCT00633139|3651750|FG000|Overall Study|Non compliance|0
2072317|NCT00633139|3651751|FG001|Overall Study|Non compliance|0
2072318|NCT00633139|3651752|FG002|Overall Study|Non compliance|1
2072319|NCT00633139|3651750|FG000|Overall Study|Withdrawal by Subject|0
2072320|NCT00633139|3651751|FG001|Overall Study|Withdrawal by Subject|1
2072321|NCT00633139|3651752|FG002|Overall Study|Withdrawal by Subject|0
2072322|NCT00633152|3651762|FG000|Overall Study|Adverse Event|1
2072323|NCT00633152|3651763|FG001|Overall Study|Adverse Event|0
2072324|NCT00633152|3651762|FG000|Overall Study|Randomized, did not receive study drug|5
2072325|NCT00633152|3651763|FG001|Overall Study|Randomized, did not receive study drug|2
2072326|NCT00633152|3651762|FG000|Overall Study|Withdrawal by Subject|1
2072327|NCT00633152|3651763|FG001|Overall Study|Withdrawal by Subject|1
2072328|NCT00633152|3651762|FG000|Overall Study|Lost to Follow-up|4
2072329|NCT00633152|3651763|FG001|Overall Study|Lost to Follow-up|1
2072330|NCT00633152|3651762|FG000|Overall Study|Miscellaneous Other|3
2072331|NCT00633152|3651763|FG001|Overall Study|Miscellaneous Other|2
2072332|NCT00633217|3651773|FG000|Overall Study|Adverse Event|5
2072333|NCT00633217|3651774|FG001|Overall Study|Adverse Event|9
2072334|NCT00633217|3651773|FG000|Overall Study|Lack of Efficacy|0
2072335|NCT00633217|3651774|FG001|Overall Study|Lack of Efficacy|2
2072336|NCT00633217|3651773|FG000|Overall Study|Protocol Violation|3
2072337|NCT00633217|3651774|FG001|Overall Study|Protocol Violation|7
2072338|NCT00633217|3651773|FG000|Overall Study|Lost to Follow-up|2
2072339|NCT00633217|3651774|FG001|Overall Study|Lost to Follow-up|2
2072340|NCT00633217|3651773|FG000|Overall Study|Investigator Discretion|2
2072341|NCT00633217|3651774|FG001|Overall Study|Investigator Discretion|0
2072342|NCT00633217|3651773|FG000|Overall Study|Withdrew Consent|3
2072343|NCT00633217|3651774|FG001|Overall Study|Withdrew Consent|3
2072344|NCT00633243|3651782|FG000|Overall Study|Withdrawal by Subject|0
2072345|NCT00633243|3651783|FG001|Overall Study|Withdrawal by Subject|1
2072346|NCT00633243|3651782|FG000|Overall Study|incarceration|0
2072347|NCT00633243|3651783|FG001|Overall Study|incarceration|2
2072348|NCT00633243|3651782|FG000|Overall Study|Homeless--no refrigeration for meds|0
2072349|NCT00633243|3651783|FG001|Overall Study|Homeless--no refrigeration for meds|1
2072350|NCT00633243|3651782|FG000|Overall Study|Not comfortable with self-injecting|0
2072351|NCT00633243|3651783|FG001|Overall Study|Not comfortable with self-injecting|1
2072352|NCT00633243|3651782|FG000|Overall Study|Mental Health--Depression|0
2072353|NCT00633243|3651783|FG001|Overall Study|Mental Health--Depression|1
2072354|NCT00633243|3651782|FG000|Overall Study|Couldn't tolerate side-effects|1
2072355|NCT00633243|3651783|FG001|Overall Study|Couldn't tolerate side-effects|1
2072356|NCT00633360|3651800|FG000|Overall Study|Lost to Follow-up|1
2072357|NCT00633360|3651801|FG001|Overall Study|Lost to Follow-up|1
2072358|NCT00633360|3651800|FG000|Overall Study|Adverse Event|3
2072359|NCT00633360|3651801|FG001|Overall Study|Adverse Event|1
2072360|NCT00633360|3651800|FG000|Overall Study|Protocol Violation|0
2072361|NCT00633360|3651801|FG001|Overall Study|Protocol Violation|1
2072362|NCT00633464|3651820|FG000|Overall Study|Never Treated (Not met study criteria)|0
2072363|NCT00633464|3651821|FG001|Overall Study|Never Treated (Not met study criteria)|1
2072364|NCT00633464|3651820|FG000|Overall Study|Never Treated (Randomized in error)|0
2072365|NCT00633464|3651821|FG001|Overall Study|Never Treated (Randomized in error)|1
2072366|NCT00633477|3651829|FG000|Overall Study|Death|1
2072367|NCT00633477|3651830|FG001|Overall Study|Death|0
2072368|NCT00633477|3651829|FG000|Overall Study|Randomized but not treated|1
2072369|NCT00633477|3651830|FG001|Overall Study|Randomized but not treated|0
2072370|NCT00633594|3651839|FG000|Overall Study|Adverse Event|0
2072371|NCT00633594|3651840|FG001|Overall Study|Adverse Event|4
2072372|NCT00633594|3651841|FG002|Overall Study|Adverse Event|7
2072373|NCT00633594|3651839|FG000|Overall Study|Death|0
2072374|NCT00633594|3651840|FG001|Overall Study|Death|1
2072375|NCT00633594|3651841|FG002|Overall Study|Death|2
2072376|NCT00633594|3651839|FG000|Overall Study|Disease Progression|0
2072377|NCT00633594|3651840|FG001|Overall Study|Disease Progression|0
2072378|NCT00633594|3651841|FG002|Overall Study|Disease Progression|1
2072379|NCT00633750|3651852|FG000|Overall Study|Adverse Event|2
2072380|NCT00633750|3651852|FG000|Overall Study|Withdrawal by Subject|3
2072381|NCT00633880|3651870|FG000|Open Label Titration|Lack of Efficacy|1
2072382|NCT00633880|3651871|FG001|Open Label Titration|Lack of Efficacy|0
2072383|NCT00633880|3651872|FG002|Open Label Titration|Lack of Efficacy|0
2072384|NCT00633880|3651870|FG000|Open Label Titration|Adverse Event|13
2072385|NCT00633880|3651871|FG001|Open Label Titration|Adverse Event|0
2072386|NCT00633880|3651872|FG002|Open Label Titration|Adverse Event|0
2072387|NCT00633880|3651870|FG000|Open Label Titration|Treatment Failure|55
2072388|NCT00633880|3651871|FG001|Open Label Titration|Treatment Failure|0
2072389|NCT00633880|3651872|FG002|Open Label Titration|Treatment Failure|0
2072390|NCT00633880|3651870|FG000|Open Label Titration|Protocol Violation|6
2072391|NCT00633880|3651871|FG001|Open Label Titration|Protocol Violation|0
2072392|NCT00633880|3651872|FG002|Open Label Titration|Protocol Violation|0
2072393|NCT00633880|3651870|FG000|Open Label Titration|Physician Decision|1
2072394|NCT00633880|3651871|FG001|Open Label Titration|Physician Decision|0
2072395|NCT00633880|3651872|FG002|Open Label Titration|Physician Decision|0
2072396|NCT00633880|3651870|FG000|Open Label Titration|Withdrawal by Subject|4
2072397|NCT00633880|3651871|FG001|Open Label Titration|Withdrawal by Subject|0
2072398|NCT00633880|3651872|FG002|Open Label Titration|Withdrawal by Subject|0
2072399|NCT00633893|3651882|FG000|Overall Study|Death|1
2072400|NCT00633893|3651883|FG001|Overall Study|Death|3
2072401|NCT00633893|3651884|FG002|Overall Study|Death|9
2072402|NCT00633893|3651882|FG000|Overall Study|Adverse Event|65
2072403|NCT00633893|3651883|FG001|Overall Study|Adverse Event|58
2072404|NCT00633893|3651884|FG002|Overall Study|Adverse Event|126
2072405|NCT00633893|3651882|FG000|Overall Study|Withdrawal by Subject|7
2072406|NCT00633893|3651883|FG001|Overall Study|Withdrawal by Subject|12
2072407|NCT00633893|3651884|FG002|Overall Study|Withdrawal by Subject|6
2072408|NCT00633893|3651882|FG000|Overall Study|Lost to Follow-up|2
2072409|NCT00633893|3651883|FG001|Overall Study|Lost to Follow-up|4
2072410|NCT00633893|3651884|FG002|Overall Study|Lost to Follow-up|8
2072411|NCT00633893|3651882|FG000|Overall Study|Poor/non-compliance|5
2072412|NCT00633893|3651883|FG001|Overall Study|Poor/non-compliance|12
2072413|NCT00633893|3651884|FG002|Overall Study|Poor/non-compliance|3
2072414|NCT00633893|3651882|FG000|Overall Study|Pregnancy|2
2072415|NCT00633893|3651883|FG001|Overall Study|Pregnancy|1
2072416|NCT00633893|3651884|FG002|Overall Study|Pregnancy|1
2072417|NCT00633893|3651882|FG000|Overall Study|Not meet/no longer meets criteria|4
2072418|NCT00633893|3651883|FG001|Overall Study|Not meet/no longer meets criteria|6
2072419|NCT00633893|3651884|FG002|Overall Study|Not meet/no longer meets criteria|4
2072420|NCT00633893|3651882|FG000|Overall Study|Other|28
2072421|NCT00633893|3651883|FG001|Overall Study|Other|33
2072422|NCT00633893|3651884|FG002|Overall Study|Other|31
2072423|NCT00633932|3651904|FG000|Overall Study|Adverse Event|1
2072424|NCT00633932|3651905|FG001|Overall Study|Adverse Event|3
2072425|NCT00633932|3651906|FG002|Overall Study|Adverse Event|4
2072426|NCT00633932|3651904|FG000|Overall Study|Withdrawal by Subject|3
2072427|NCT00633932|3651905|FG001|Overall Study|Withdrawal by Subject|9
2072428|NCT00633932|3651906|FG002|Overall Study|Withdrawal by Subject|1
2072429|NCT00633932|3651904|FG000|Overall Study|Lost to Follow-up|1
2072430|NCT00633932|3651905|FG001|Overall Study|Lost to Follow-up|0
2072431|NCT00633932|3651906|FG002|Overall Study|Lost to Follow-up|2
2072432|NCT00633932|3651904|FG000|Overall Study|Protocol Violation|5
2072433|NCT00633932|3651905|FG001|Overall Study|Protocol Violation|2
2072434|NCT00633932|3651906|FG002|Overall Study|Protocol Violation|3
2072435|NCT00633932|3651904|FG000|Overall Study|Physician Decision|0
2072436|NCT00633932|3651905|FG001|Overall Study|Physician Decision|0
2072437|NCT00633932|3651906|FG002|Overall Study|Physician Decision|1
2072438|NCT00633932|3651904|FG000|Overall Study|Doctor's judgement|1
2072439|NCT00633932|3651905|FG001|Overall Study|Doctor's judgement|0
2072440|NCT00633932|3651906|FG002|Overall Study|Doctor's judgement|0
2072441|NCT00633932|3651904|FG000|Overall Study|Moved Away|1
2072442|NCT00633932|3651905|FG001|Overall Study|Moved Away|0
2072443|NCT00633932|3651906|FG002|Overall Study|Moved Away|0
2072444|NCT00633945|3651914|FG000|Overall Study|Physician Decision|2
2072445|NCT00633984|3651922|FG000|Overall Study|Lost to Follow-up|0
2072446|NCT00633984|3651923|FG001|Overall Study|Lost to Follow-up|6
2072447|NCT00633984|3651922|FG000|Overall Study|Withdrawal by Subject|8
2072448|NCT00633984|3651923|FG001|Overall Study|Withdrawal by Subject|7
2072449|NCT00633984|3651922|FG000|Overall Study|Hospitalized|1
2072450|NCT00633984|3651923|FG001|Overall Study|Hospitalized|0
2072451|NCT00634036|3651931|FG000|Overall Study|Lost to Follow-up|1
2072452|NCT00634036|3651932|FG001|Overall Study|Lost to Follow-up|1
2072453|NCT00634036|3651931|FG000|Overall Study|Withdrawal by Subject|1
2072454|NCT00634036|3651932|FG001|Overall Study|Withdrawal by Subject|1
2072455|NCT00634049|3651938|FG000|Overall Study|Never received study drug|1
2072456|NCT00634049|3651938|FG000|Overall Study|Died prior to receiving study drug|1
2072457|NCT00634049|3651938|FG000|Overall Study|Screening failure|1
2072458|NCT00634088|3651975|FG000|Time Period 1: Dose Level 1|Disease progression|2
2072459|NCT00634088|3651976|FG001|Time Period 1: Dose Level 1|Disease progression|0
2072460|NCT00634088|3651977|FG002|Time Period 1: Dose Level 1|Disease progression|0
2072461|NCT00634088|3651978|FG003|Time Period 1: Dose Level 1|Disease progression|0
2072462|NCT00634088|3651975|FG000|Time Period 1: Dose Level 1|Physician Decision|1
2072463|NCT00634088|3651976|FG001|Time Period 1: Dose Level 1|Physician Decision|0
2072464|NCT00634088|3651977|FG002|Time Period 1: Dose Level 1|Physician Decision|0
2072465|NCT00634088|3651978|FG003|Time Period 1: Dose Level 1|Physician Decision|0
2072466|NCT00634088|3651975|FG000|Time Period 1: Dose Level 1|Adverse Event|3
2072467|NCT00634088|3651976|FG001|Time Period 1: Dose Level 1|Adverse Event|0
2072468|NCT00634088|3651977|FG002|Time Period 1: Dose Level 1|Adverse Event|0
2072469|NCT00634088|3651978|FG003|Time Period 1: Dose Level 1|Adverse Event|0
2072470|NCT00634088|3651975|FG000|Time Period 2: Dose Level 2|Adverse Event|0
2072471|NCT00634088|3651976|FG001|Time Period 2: Dose Level 2|Adverse Event|2
2072472|NCT00634088|3651977|FG002|Time Period 2: Dose Level 2|Adverse Event|0
2072473|NCT00634088|3651978|FG003|Time Period 2: Dose Level 2|Adverse Event|0
2072474|NCT00634088|3651975|FG000|Time Period 2: Dose Level 2|Progressive disease|0
2072475|NCT00634088|3651976|FG001|Time Period 2: Dose Level 2|Progressive disease|1
2072476|NCT00634088|3651977|FG002|Time Period 2: Dose Level 2|Progressive disease|0
2072477|NCT00634088|3651978|FG003|Time Period 2: Dose Level 2|Progressive disease|0
2072478|NCT00634088|3651975|FG000|Time Period 3: Dose Level 3|Progressive disease|0
2072479|NCT00634088|3651976|FG001|Time Period 3: Dose Level 3|Progressive disease|0
2072480|NCT00634088|3651977|FG002|Time Period 3: Dose Level 3|Progressive disease|1
2072481|NCT00634088|3651978|FG003|Time Period 3: Dose Level 3|Progressive disease|0
2072482|NCT00634101|3651990|FG000|Overall Study|Study Terminated|3
2072483|NCT00634101|3651991|FG001|Overall Study|Study Terminated|3
2072484|NCT00634101|3651990|FG000|Overall Study|Lost to Follow-up|2
2072485|NCT00634101|3651991|FG001|Overall Study|Lost to Follow-up|0
2072486|NCT00634114|3652000|FG000|Overall Study|Adverse Event|6
2072487|NCT00634114|3652001|FG001|Overall Study|Adverse Event|8
2072488|NCT00634114|3652002|FG002|Overall Study|Adverse Event|3
2072489|NCT00634114|3652000|FG000|Overall Study|Withdrawal by Subject|9
2072490|NCT00634114|3652001|FG001|Overall Study|Withdrawal by Subject|6
2072491|NCT00634114|3652002|FG002|Overall Study|Withdrawal by Subject|11
2072492|NCT00634114|3652000|FG000|Overall Study|Lost to Follow-up|0
2072493|NCT00634114|3652001|FG001|Overall Study|Lost to Follow-up|0
2072494|NCT00634114|3652002|FG002|Overall Study|Lost to Follow-up|1
2072495|NCT00634114|3652000|FG000|Overall Study|Protocol Violation|3
2072496|NCT00634114|3652001|FG001|Overall Study|Protocol Violation|3
2072497|NCT00634114|3652002|FG002|Overall Study|Protocol Violation|1
2072498|NCT00634114|3652000|FG000|Overall Study|Pregnancy|1
2072499|NCT00634114|3652001|FG001|Overall Study|Pregnancy|0
2072500|NCT00634114|3652002|FG002|Overall Study|Pregnancy|0
2072501|NCT00634114|3652000|FG000|Overall Study|Incorrect enrolment|0
2072502|NCT00634114|3652001|FG001|Overall Study|Incorrect enrolment|1
2072503|NCT00634114|3652002|FG002|Overall Study|Incorrect enrolment|0
2072504|NCT00634114|3652000|FG000|Overall Study|Recurrence of reflux esophagitis|5
2072505|NCT00634114|3652001|FG001|Overall Study|Recurrence of reflux esophagitis|15
2072506|NCT00634114|3652002|FG002|Overall Study|Recurrence of reflux esophagitis|21
2072507|NCT00634114|3652000|FG000|Overall Study|Difficult to continue|3
2072508|NCT00634114|3652001|FG001|Overall Study|Difficult to continue|1
2072509|NCT00634114|3652002|FG002|Overall Study|Difficult to continue|1
2072510|NCT00634114|3652000|FG000|Overall Study|Other reason|1
2072511|NCT00634114|3652001|FG001|Overall Study|Other reason|1
2072512|NCT00634114|3652002|FG002|Overall Study|Other reason|1
2072513|NCT00634179|3652019|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1
2072514|NCT00634244|3652029|FG000|Overall Study|Never started treatment|0
2072515|NCT00634244|3652030|FG001|Overall Study|Never started treatment|1
2072516|NCT00634244|3652031|FG002|Overall Study|Never started treatment|0
2072517|NCT00634244|3652029|FG000|Overall Study|Death|1
2072518|NCT00634244|3652030|FG001|Overall Study|Death|6
2072519|NCT00634244|3652031|FG002|Overall Study|Death|0
2072520|NCT00634244|3652029|FG000|Overall Study|Adverse Event|0
2072521|NCT00634244|3652030|FG001|Overall Study|Adverse Event|2
2072522|NCT00634244|3652031|FG002|Overall Study|Adverse Event|0
2072523|NCT00634244|3652029|FG000|Overall Study|Withdrawal by Subject|0
2072524|NCT00634244|3652030|FG001|Overall Study|Withdrawal by Subject|1
2072525|NCT00634244|3652031|FG002|Overall Study|Withdrawal by Subject|0
2072526|NCT00634244|3652029|FG000|Overall Study|Physician Decision|0
2072527|NCT00634244|3652030|FG001|Overall Study|Physician Decision|1
2072528|NCT00634244|3652031|FG002|Overall Study|Physician Decision|0
2072529|NCT00634244|3652029|FG000|Overall Study|Disease progression/relapse|0
2072530|NCT00634244|3652030|FG001|Overall Study|Disease progression/relapse|1
2072531|NCT00634244|3652031|FG002|Overall Study|Disease progression/relapse|0
2072532|NCT00634244|3652029|FG000|Overall Study|Other complicating disease|0
2072533|NCT00634244|3652030|FG001|Overall Study|Other complicating disease|1
2072534|NCT00634244|3652031|FG002|Overall Study|Other complicating disease|0
2072535|NCT00634504|3652062|FG000|Overall Study|Protocol Violation|1
2072536|NCT00634504|3652063|FG001|Overall Study|Protocol Violation|0
2072537|NCT00634543|3652071|FG000|Overall Study|Other|1
2072538|NCT00634543|3652072|FG001|Overall Study|Other|2
2072539|NCT00634543|3652071|FG000|Overall Study|Protocol Violation|3
2072540|NCT00634543|3652072|FG001|Overall Study|Protocol Violation|3
2072541|NCT00634543|3652071|FG000|Overall Study|Adverse Event|11
2072542|NCT00634543|3652072|FG001|Overall Study|Adverse Event|11
2072543|NCT00634543|3652071|FG000|Overall Study|Withdrawal by Subject|4
2072544|NCT00634543|3652072|FG001|Overall Study|Withdrawal by Subject|4
2072545|NCT00634543|3652071|FG000|Overall Study|Lost to Follow-up|0
2072546|NCT00634543|3652072|FG001|Overall Study|Lost to Follow-up|1
2072547|NCT00634569|3652080|FG000|Overall Study|Withdrawal by Subject|0
2072548|NCT00634569|3652081|FG001|Overall Study|Withdrawal by Subject|4
2072549|NCT00634569|3652080|FG000|Overall Study|Physician Decision|0
2072550|NCT00634569|3652081|FG001|Overall Study|Physician Decision|1
2072551|NCT00634647|3652095|FG000|Overall Study|death on study|3
2072552|NCT00634647|3652095|FG000|Overall Study|refused further treatment|3
2072553|NCT00634647|3652095|FG000|Overall Study|declined to participate before treatment|1
2072554|NCT00634751|3652103|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1
2072555|NCT00634751|3652104|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0
2072556|NCT00634751|3652105|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0
2072557|NCT00634751|3652106|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0
2072558|NCT00634751|3652103|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0
2072559|NCT00634751|3652104|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1
2072560|NCT00634751|3652105|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0
2072561|NCT00634751|3652106|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0
2072562|NCT00634751|3652103|FG000|Pancreatic and Bilial Tract Cancer|Death|0
2072563|NCT00634751|3652104|FG001|Pancreatic and Bilial Tract Cancer|Death|0
2072564|NCT00634751|3652105|FG002|Pancreatic and Bilial Tract Cancer|Death|1
2072565|NCT00634751|3652106|FG003|Pancreatic and Bilial Tract Cancer|Death|1
2072566|NCT00634803|3652119|FG000|Overall Study|Lost to Follow-up|6
2072567|NCT00634803|3652120|FG001|Overall Study|Lost to Follow-up|7
2072568|NCT00634803|3652121|FG002|Overall Study|Lost to Follow-up|7
2072569|NCT00634842|3652131|FG000|Overall Study|Adverse Event|2
2072570|NCT00634842|3652132|FG001|Overall Study|Adverse Event|3
2072571|NCT00634842|3652131|FG000|Overall Study|Protocol Violation|8
2072572|NCT00634842|3652132|FG001|Overall Study|Protocol Violation|4
2072573|NCT00634842|3652131|FG000|Overall Study|Move to another state|1
2072574|NCT00634842|3652132|FG001|Overall Study|Move to another state|0
2072575|NCT00634842|3652131|FG000|Overall Study|Inclusion criteria were not met|1
2072576|NCT00634842|3652132|FG001|Overall Study|Inclusion criteria were not met|0
2072577|NCT00634842|3652131|FG000|Overall Study|Lost to Follow-up|1
2072578|NCT00634842|3652132|FG001|Overall Study|Lost to Follow-up|2
2072579|NCT00634842|3652131|FG000|Overall Study|Physician Decision|1
2072580|NCT00634842|3652132|FG001|Overall Study|Physician Decision|0
2072581|NCT00634842|3652131|FG000|Overall Study|Withdrawal by Subject|1
2072582|NCT00634842|3652132|FG001|Overall Study|Withdrawal by Subject|3
2072583|NCT00634842|3652131|FG000|Overall Study|Lack of time and intolerance to drug|0
2072584|NCT00634842|3652132|FG001|Overall Study|Lack of time and intolerance to drug|1
2072585|NCT00634842|3652131|FG000|Overall Study|Discontinued due to injection|0
2072586|NCT00634842|3652132|FG001|Overall Study|Discontinued due to injection|2
2072587|NCT00634842|3652131|FG000|Overall Study|No need of study drug to treat diabetes|0
2072588|NCT00634842|3652132|FG001|Overall Study|No need of study drug to treat diabetes|1
2072589|NCT00634842|3652131|FG000|Overall Study|No wish to keep taking Avandia|0
2072590|NCT00634842|3652132|FG001|Overall Study|No wish to keep taking Avandia|1
2072591|NCT00634842|3652131|FG000|Overall Study|Subject off study drug for too long|0
2072592|NCT00634842|3652132|FG001|Overall Study|Subject off study drug for too long|1
2072593|NCT00634907|3652140|FG000|Overall Study|Withdrawal by Subject|3
2072594|NCT00634907|3652141|FG001|Overall Study|Withdrawal by Subject|0
2072595|NCT00634907|3652140|FG000|Overall Study|Physician Decision|3
2072596|NCT00634907|3652141|FG001|Overall Study|Physician Decision|9
2072597|NCT00634907|3652140|FG000|Overall Study|Withdrawal by Subject|11
2072598|NCT00634907|3652141|FG001|Overall Study|Withdrawal by Subject|8
2072599|NCT00634920|3652150|FG000|Period 1 - Pre-Randomization|Adverse Event|0
2072600|NCT00634920|3652151|FG001|Period 1 - Pre-Randomization|Adverse Event|0
2072601|NCT00634920|3652152|FG002|Period 1 - Pre-Randomization|Adverse Event|36
2072602|NCT00634920|3652150|FG000|Period 1 - Pre-Randomization|Wound healing problems|0
2072603|NCT00634920|3652151|FG001|Period 1 - Pre-Randomization|Wound healing problems|0
2072604|NCT00634920|3652152|FG002|Period 1 - Pre-Randomization|Wound healing problems|16
2072605|NCT00634920|3652150|FG000|Period 1 - Pre-Randomization|Rejections|0
2072606|NCT00634920|3652151|FG001|Period 1 - Pre-Randomization|Rejections|0
2072607|NCT00634920|3652152|FG002|Period 1 - Pre-Randomization|Rejections|55
2072608|NCT00634920|3652150|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0
2072609|NCT00634920|3652151|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0
2072610|NCT00634920|3652152|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21
2072611|NCT00634920|3652150|FG000|Period 1 - Pre-Randomization|Non-Compliance|0
2072612|NCT00634920|3652151|FG001|Period 1 - Pre-Randomization|Non-Compliance|0
2072613|NCT00634920|3652152|FG002|Period 1 - Pre-Randomization|Non-Compliance|3
2072614|NCT00634920|3652150|FG000|Period 1 - Pre-Randomization|Other issues|0
2072615|NCT00634920|3652151|FG001|Period 1 - Pre-Randomization|Other issues|0
2072616|NCT00634920|3652152|FG002|Period 1 - Pre-Randomization|Other issues|6
2072617|NCT00634920|3652150|FG000|Period 2 - Post-Randomization|Adverse Event|37
2072618|NCT00634920|3652151|FG001|Period 2 - Post-Randomization|Adverse Event|9
2072619|NCT00634920|3652152|FG002|Period 2 - Post-Randomization|Adverse Event|0
2072620|NCT00634920|3652150|FG000|Period 2 - Post-Randomization|Rejection|11
2072621|NCT00634920|3652151|FG001|Period 2 - Post-Randomization|Rejection|5
2072622|NCT00634920|3652152|FG002|Period 2 - Post-Randomization|Rejection|0
2072623|NCT00634920|3652150|FG000|Period 2 - Post-Randomization|Death|2
2072624|NCT00634920|3652151|FG001|Period 2 - Post-Randomization|Death|5
2072625|NCT00634920|3652152|FG002|Period 2 - Post-Randomization|Death|0
2072626|NCT00634920|3652150|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
2072627|NCT00634920|3652151|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
2072628|NCT00634920|3652152|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
2072629|NCT00634920|3652150|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2
2072630|NCT00634920|3652151|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0
2072631|NCT00634920|3652152|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0
2072632|NCT00634933|3652161|FG000|Part A: Baseline to Week 24|Adverse Event|4
2072633|NCT00634933|3652162|FG001|Part A: Baseline to Week 24|Adverse Event|4
2072634|NCT00634933|3652163|FG002|Part A: Baseline to Week 24|Adverse Event|8
2072635|NCT00634933|3652164|FG003|Part A: Baseline to Week 24|Adverse Event|0
2072636|NCT00634933|3652165|FG004|Part A: Baseline to Week 24|Adverse Event|0
2072637|NCT00634933|3652161|FG000|Part A: Baseline to Week 24|Death|1
2072638|NCT00634933|3652162|FG001|Part A: Baseline to Week 24|Death|0
2072639|NCT00634933|3652163|FG002|Part A: Baseline to Week 24|Death|0
2072640|NCT00634933|3652164|FG003|Part A: Baseline to Week 24|Death|0
2072641|NCT00634933|3652165|FG004|Part A: Baseline to Week 24|Death|0
2072642|NCT00634933|3652161|FG000|Part A: Baseline to Week 24|Failed to Return|1
2072643|NCT00634933|3652162|FG001|Part A: Baseline to Week 24|Failed to Return|0
2072644|NCT00634933|3652163|FG002|Part A: Baseline to Week 24|Failed to Return|0
2072645|NCT00634933|3652164|FG003|Part A: Baseline to Week 24|Failed to Return|0
2072646|NCT00634933|3652165|FG004|Part A: Baseline to Week 24|Failed to Return|0
2072647|NCT00634933|3652161|FG000|Part A: Baseline to Week 24|Investigator Request|1
2072648|NCT00634933|3652162|FG001|Part A: Baseline to Week 24|Investigator Request|1
2072649|NCT00634933|3652163|FG002|Part A: Baseline to Week 24|Investigator Request|1
2072650|NCT00634933|3652164|FG003|Part A: Baseline to Week 24|Investigator Request|0
2072651|NCT00634933|3652165|FG004|Part A: Baseline to Week 24|Investigator Request|0
2072652|NCT00634933|3652161|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0
2072653|NCT00634933|3652162|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1
2072654|NCT00634933|3652163|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1
2072655|NCT00634933|3652164|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0
2072656|NCT00634933|3652165|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0
2072657|NCT00634933|3652161|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0
2072658|NCT00634933|3652162|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3
2072659|NCT00634933|3652163|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3
2072660|NCT00634933|3652164|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0
2072661|NCT00634933|3652165|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0
2072662|NCT00634933|3652161|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3
2072663|NCT00634933|3652162|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1
2072664|NCT00634933|3652163|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0
2072665|NCT00634933|3652164|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0
2072666|NCT00634933|3652165|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0
2072667|NCT00634933|3652161|FG000|Part A: Baseline to Week 24|Other|1
2072668|NCT00634933|3652162|FG001|Part A: Baseline to Week 24|Other|8
2072669|NCT00634933|3652163|FG002|Part A: Baseline to Week 24|Other|5
2072670|NCT00634933|3652164|FG003|Part A: Baseline to Week 24|Other|0
2072671|NCT00634933|3652165|FG004|Part A: Baseline to Week 24|Other|0
2072672|NCT00634933|3652161|FG000|Between Part A and Part B|Physician Decision|0
2072673|NCT00634933|3652162|FG001|Between Part A and Part B|Physician Decision|1
2072674|NCT00634933|3652163|FG002|Between Part A and Part B|Physician Decision|0
2072675|NCT00634933|3652164|FG003|Between Part A and Part B|Physician Decision|0
2072676|NCT00634933|3652165|FG004|Between Part A and Part B|Physician Decision|0
2072677|NCT00634933|3652161|FG000|Part B: Week 24 to Week 52|Adverse Event|0
2072678|NCT00634933|3652162|FG001|Part B: Week 24 to Week 52|Adverse Event|1
2072679|NCT00634933|3652163|FG002|Part B: Week 24 to Week 52|Adverse Event|1
2072680|NCT00634933|3652164|FG003|Part B: Week 24 to Week 52|Adverse Event|1
2072681|NCT00634933|3652165|FG004|Part B: Week 24 to Week 52|Adverse Event|0
2072682|NCT00634933|3652161|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
2072683|NCT00634933|3652162|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
2072684|NCT00634933|3652163|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
2072685|NCT00634933|3652164|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
2072686|NCT00634933|3652165|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
2072687|NCT00634933|3652161|FG000|Part B: Week 24 to Week 52|Physician Decision|0
2072688|NCT00634933|3652162|FG001|Part B: Week 24 to Week 52|Physician Decision|1
2072689|NCT00634933|3652163|FG002|Part B: Week 24 to Week 52|Physician Decision|1
2072690|NCT00634933|3652164|FG003|Part B: Week 24 to Week 52|Physician Decision|0
2072691|NCT00634933|3652165|FG004|Part B: Week 24 to Week 52|Physician Decision|0
2072692|NCT00634933|3652161|FG000|Part B: Week 24 to Week 52|Protocol Violation|0
2072693|NCT00634933|3652162|FG001|Part B: Week 24 to Week 52|Protocol Violation|0
2072694|NCT00634933|3652163|FG002|Part B: Week 24 to Week 52|Protocol Violation|0
2072695|NCT00634933|3652164|FG003|Part B: Week 24 to Week 52|Protocol Violation|0
2072696|NCT00634933|3652165|FG004|Part B: Week 24 to Week 52|Protocol Violation|1
2072697|NCT00634933|3652161|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0
2072698|NCT00634933|3652162|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0
2072699|NCT00634933|3652163|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0
2072700|NCT00634933|3652164|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2
2072701|NCT00634933|3652165|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1
2072702|NCT00634933|3652161|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0
2072703|NCT00634933|3652162|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1
2072704|NCT00634933|3652163|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1
2072705|NCT00634933|3652164|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0
2072706|NCT00634933|3652165|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0
2072707|NCT00634933|3652161|FG000|Part B: Week 24 to Week 52|Other|0
2072708|NCT00634933|3652162|FG001|Part B: Week 24 to Week 52|Other|0
2072709|NCT00634933|3652163|FG002|Part B: Week 24 to Week 52|Other|5
2072710|NCT00634933|3652164|FG003|Part B: Week 24 to Week 52|Other|0
2072711|NCT00634933|3652165|FG004|Part B: Week 24 to Week 52|Other|1
2072712|NCT00635024|3652177|FG000|Overall Study|Adverse Event|1
2072713|NCT00635050|3652181|FG000|Overall Study|Withdrawal by Subject|1
2072714|NCT00635089|3652188|FG000|Overall Study|Adverse Event|7
2072715|NCT00635089|3652188|FG000|Overall Study|Lack of Efficacy|28
2072716|NCT00635089|3652188|FG000|Overall Study|Protocol Deviation|4
2072717|NCT00635089|3652188|FG000|Overall Study|Lost to Follow-up|8
2072718|NCT00635089|3652188|FG000|Overall Study|Other|31
2072719|NCT00635102|3652207|FG000|Overall Study|Withdrawal by Subject|7
2072720|NCT00635102|3652208|FG001|Overall Study|Withdrawal by Subject|8
2072721|NCT00635154|3652225|FG000|Overall Study|Alternative Treatment|8
2072722|NCT00635154|3652225|FG000|Overall Study|Other|4
2072723|NCT00635154|3652225|FG000|Overall Study|Still on treatment|21
2072724|NCT00635219|3652236|FG000|Overall Study|Adverse Event|12
2072725|NCT00635219|3652237|FG001|Overall Study|Adverse Event|10
2072726|NCT00635219|3652238|FG002|Overall Study|Adverse Event|18
2072727|NCT00635219|3652239|FG003|Overall Study|Adverse Event|15
2072728|NCT00635219|3652240|FG004|Overall Study|Adverse Event|19
2072729|NCT00635219|3652236|FG000|Overall Study|Lack of Efficacy|5
2072730|NCT00635219|3652237|FG001|Overall Study|Lack of Efficacy|6
2072731|NCT00635219|3652238|FG002|Overall Study|Lack of Efficacy|3
2072732|NCT00635219|3652239|FG003|Overall Study|Lack of Efficacy|4
2072733|NCT00635219|3652240|FG004|Overall Study|Lack of Efficacy|6
2072734|NCT00635219|3652236|FG000|Overall Study|Non-compliance With Study Product|0
2072735|NCT00635219|3652237|FG001|Overall Study|Non-compliance With Study Product|0
2072736|NCT00635219|3652238|FG002|Overall Study|Non-compliance With Study Product|0
2072737|NCT00635219|3652239|FG003|Overall Study|Non-compliance With Study Product|2
2072738|NCT00635219|3652240|FG004|Overall Study|Non-compliance With Study Product|1
2072739|NCT00635219|3652236|FG000|Overall Study|Protocol Violation|0
2072740|NCT00635219|3652237|FG001|Overall Study|Protocol Violation|2
2072741|NCT00635219|3652238|FG002|Overall Study|Protocol Violation|3
2072742|NCT00635219|3652239|FG003|Overall Study|Protocol Violation|2
2072743|NCT00635219|3652240|FG004|Overall Study|Protocol Violation|4
2072744|NCT00635219|3652236|FG000|Overall Study|Withdrawal of Consent|8
2072745|NCT00635219|3652237|FG001|Overall Study|Withdrawal of Consent|6
2072746|NCT00635219|3652238|FG002|Overall Study|Withdrawal of Consent|8
2072747|NCT00635219|3652239|FG003|Overall Study|Withdrawal of Consent|11
2072748|NCT00635219|3652240|FG004|Overall Study|Withdrawal of Consent|8
2072749|NCT00635219|3652236|FG000|Overall Study|Lost to Follow-up|0
2072750|NCT00635219|3652237|FG001|Overall Study|Lost to Follow-up|0
2072751|NCT00635219|3652238|FG002|Overall Study|Lost to Follow-up|2
2072752|NCT00635219|3652239|FG003|Overall Study|Lost to Follow-up|0
2072753|NCT00635219|3652240|FG004|Overall Study|Lost to Follow-up|3
2072754|NCT00635219|3652236|FG000|Overall Study|Administrative or Other Reasons|0
2072755|NCT00635219|3652237|FG001|Overall Study|Administrative or Other Reasons|1
2072756|NCT00635219|3652238|FG002|Overall Study|Administrative or Other Reasons|1
2072757|NCT00635219|3652239|FG003|Overall Study|Administrative or Other Reasons|0
2072758|NCT00635219|3652240|FG004|Overall Study|Administrative or Other Reasons|1
2072759|NCT00635349|3652275|FG000|Overall Study|Other|8
2072760|NCT00635349|3652276|FG001|Overall Study|Other|6
2072761|NCT00635349|3652275|FG000|Overall Study|Protocol Violation|18
2072762|NCT00635349|3652276|FG001|Overall Study|Protocol Violation|22
2072763|NCT00635349|3652275|FG000|Overall Study|Withdrawal by Subject|3
2072764|NCT00635349|3652276|FG001|Overall Study|Withdrawal by Subject|8
2072765|NCT00635349|3652275|FG000|Overall Study|Lost to Follow-up|4
2072766|NCT00635349|3652276|FG001|Overall Study|Lost to Follow-up|3
2072767|NCT00635349|3652275|FG000|Overall Study|Adverse Event|11
2072768|NCT00635349|3652276|FG001|Overall Study|Adverse Event|9
2072769|NCT00635427|3652296|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0
2072770|NCT00635427|3652297|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0
2072771|NCT00635427|3652298|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1
2072772|NCT00635427|3652299|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0
2072773|NCT00635427|3652300|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0
2072774|NCT00635427|3652296|FG000|Overall Study|Death|0
2072775|NCT00635427|3652297|FG001|Overall Study|Death|0
2072776|NCT00635427|3652298|FG002|Overall Study|Death|0
2072777|NCT00635427|3652299|FG003|Overall Study|Death|1
2072778|NCT00635427|3652300|FG004|Overall Study|Death|0
2072779|NCT00635427|3652296|FG000|Overall Study|Termination Of Study By Sponsor|12
2072780|NCT00635427|3652297|FG001|Overall Study|Termination Of Study By Sponsor|6
2072781|NCT00635427|3652298|FG002|Overall Study|Termination Of Study By Sponsor|10
2072782|NCT00635427|3652299|FG003|Overall Study|Termination Of Study By Sponsor|6
2072783|NCT00635427|3652300|FG004|Overall Study|Termination Of Study By Sponsor|6
2072784|NCT00635427|3652296|FG000|Overall Study|Withdrawal Of Consent|0
2072785|NCT00635427|3652297|FG001|Overall Study|Withdrawal Of Consent|0
2072786|NCT00635427|3652298|FG002|Overall Study|Withdrawal Of Consent|0
2072787|NCT00635427|3652299|FG003|Overall Study|Withdrawal Of Consent|2
2072788|NCT00635427|3652300|FG004|Overall Study|Withdrawal Of Consent|2
2072789|NCT00635492|3652330|FG000|Overall Study|Death|12
2072790|NCT00635492|3652331|FG001|Overall Study|Death|40
2072791|NCT00635492|3652330|FG000|Overall Study|Lost to Follow-up|151
2072792|NCT00635492|3652331|FG001|Overall Study|Lost to Follow-up|172
2072793|NCT00635492|3652330|FG000|Overall Study|Physician Decision|32
2072794|NCT00635492|3652331|FG001|Overall Study|Physician Decision|22
2072795|NCT00635492|3652330|FG000|Overall Study|Sponsor decision|2
2072796|NCT00635492|3652331|FG001|Overall Study|Sponsor decision|3
2072797|NCT00635492|3652330|FG000|Overall Study|Withdrawal by Subject|82
2072798|NCT00635492|3652331|FG001|Overall Study|Withdrawal by Subject|45
2072799|NCT00635570|3652343|FG000|Overall Study|Lost to Follow-up|8
2072800|NCT00635570|3652344|FG001|Overall Study|Lost to Follow-up|8
2072801|NCT00635570|3652343|FG000|Overall Study|Withdrawal by Subject|1
2072802|NCT00635570|3652344|FG001|Overall Study|Withdrawal by Subject|1
2072803|NCT00635570|3652343|FG000|Overall Study|Adverse Event|2
2072804|NCT00635570|3652344|FG001|Overall Study|Adverse Event|0
2072805|NCT00635570|3652343|FG000|Overall Study|Physician Decision|1
2072806|NCT00635570|3652344|FG001|Overall Study|Physician Decision|0
2072807|NCT00635570|3652343|FG000|Overall Study|Did not complete survey|2
2072808|NCT00635570|3652344|FG001|Overall Study|Did not complete survey|1
2072809|NCT00635570|3652343|FG000|Overall Study|Early termination(No sexual activity)|1
2072810|NCT00635570|3652344|FG001|Overall Study|Early termination(No sexual activity)|1
2072811|NCT00635648|3652359|FG000|Overall Study|Adverse Event|12
2072812|NCT00635648|3652359|FG000|Overall Study|Withdrawal by Subject|9
2072813|NCT00635648|3652359|FG000|Overall Study|Physician Decision|4
2072814|NCT00635648|3652359|FG000|Overall Study|Rapid progression of baseline disease|4
2072815|NCT00635648|3652359|FG000|Overall Study|Use of other antifungal agent needed|1
2072816|NCT00635648|3652359|FG000|Overall Study|No improvement after 7-10 days treatment|4
2072817|NCT00635648|3652359|FG000|Overall Study|Noncompliance with protocol|1
2072818|NCT00635648|3652359|FG000|Overall Study|Other reason|2
2072819|NCT00635661|3652363|FG000|Overall Study|Withdrawal by Subject|4
2072820|NCT00635778|3652392|FG000|Overall Study|Adverse Event|1
2072821|NCT00635778|3652393|FG001|Overall Study|Adverse Event|0
2072822|NCT00635778|3652394|FG002|Overall Study|Adverse Event|0
2072823|NCT00635778|3652395|FG003|Overall Study|Adverse Event|3
2072824|NCT00635778|3652396|FG004|Overall Study|Adverse Event|3
2072825|NCT00635778|3652397|FG005|Overall Study|Adverse Event|6
2072826|NCT00635778|3652398|FG006|Overall Study|Adverse Event|1
2072827|NCT00635778|3652392|FG000|Overall Study|Withdrawal by Subject|0
2072828|NCT00635778|3652393|FG001|Overall Study|Withdrawal by Subject|0
2072829|NCT00635778|3652394|FG002|Overall Study|Withdrawal by Subject|0
2072830|NCT00635778|3652395|FG003|Overall Study|Withdrawal by Subject|1
2072831|NCT00635778|3652396|FG004|Overall Study|Withdrawal by Subject|0
2072832|NCT00635778|3652397|FG005|Overall Study|Withdrawal by Subject|1
2072833|NCT00635778|3652398|FG006|Overall Study|Withdrawal by Subject|1
2072834|NCT00635778|3652392|FG000|Overall Study|Progressive disease|0
2072835|NCT00635778|3652393|FG001|Overall Study|Progressive disease|3
2072836|NCT00635778|3652394|FG002|Overall Study|Progressive disease|3
2072837|NCT00635778|3652395|FG003|Overall Study|Progressive disease|4
2072838|NCT00635778|3652396|FG004|Overall Study|Progressive disease|5
2072839|NCT00635778|3652397|FG005|Overall Study|Progressive disease|14
2072840|NCT00635778|3652398|FG006|Overall Study|Progressive disease|4
2072841|NCT00635804|3652423|FG000|Overall Study|Adverse Event|0
2072842|NCT00635804|3652424|FG001|Overall Study|Adverse Event|0
2072843|NCT00635804|3652425|FG002|Overall Study|Adverse Event|0
2072844|NCT00635804|3652426|FG003|Overall Study|Adverse Event|0
2072845|NCT00635804|3652427|FG004|Overall Study|Adverse Event|0
2072846|NCT00635804|3652428|FG005|Overall Study|Adverse Event|1
2072847|NCT00635804|3652429|FG006|Overall Study|Adverse Event|0
2072848|NCT00635804|3652430|FG007|Overall Study|Adverse Event|0
2072849|NCT00635804|3652423|FG000|Overall Study|Withdrawal by Subject|1
2072850|NCT00635804|3652424|FG001|Overall Study|Withdrawal by Subject|0
2072851|NCT00635804|3652425|FG002|Overall Study|Withdrawal by Subject|0
2072852|NCT00635804|3652426|FG003|Overall Study|Withdrawal by Subject|0
2072853|NCT00635804|3652427|FG004|Overall Study|Withdrawal by Subject|0
2072854|NCT00635804|3652428|FG005|Overall Study|Withdrawal by Subject|0
2072855|NCT00635804|3652429|FG006|Overall Study|Withdrawal by Subject|0
2072856|NCT00635804|3652430|FG007|Overall Study|Withdrawal by Subject|0
2072857|NCT00635999|3652482|FG000|Overall Study|Withdrawal by Subject|4
2072858|NCT00635999|3652483|FG001|Overall Study|Withdrawal by Subject|2
2072859|NCT00635999|3652484|FG002|Overall Study|Withdrawal by Subject|1
2072860|NCT00636155|3652505|FG000|Overall Study|Adverse Event|8
2072861|NCT00636155|3652505|FG000|Overall Study|Lack of Efficacy|1
2072862|NCT00636155|3652505|FG000|Overall Study|Withdrawal by Subject|3
2072863|NCT00636155|3652505|FG000|Overall Study|Stem cell transplant|1
2072864|NCT00636155|3652505|FG000|Overall Study|Physician Decision|5
2072865|NCT00636168|3652511|FG000|Randomized to Study Drug|Withdrawal by Subject|2
2072866|NCT00636168|3652512|FG001|Randomized to Study Drug|Withdrawal by Subject|2
2072867|NCT00636168|3652511|FG000|Randomized to Study Drug|Adverse Event|1
2072868|NCT00636168|3652512|FG001|Randomized to Study Drug|Adverse Event|0
2072869|NCT00636168|3652511|FG000|Randomized to Study Drug|No longer meets study criteria|1
2072870|NCT00636168|3652512|FG001|Randomized to Study Drug|No longer meets study criteria|0
2072871|NCT00636168|3652511|FG000|Treated With Study Drug|Recurrence of disease|135
2072872|NCT00636168|3652512|FG001|Treated With Study Drug|Recurrence of disease|282
2072873|NCT00636168|3652511|FG000|Treated With Study Drug|Adverse Event|250
2072874|NCT00636168|3652512|FG001|Treated With Study Drug|Adverse Event|22
2072875|NCT00636168|3652511|FG000|Treated With Study Drug|Participant withdrew consent|16
2072876|NCT00636168|3652512|FG001|Treated With Study Drug|Participant withdrew consent|21
2072877|NCT00636168|3652511|FG000|Treated With Study Drug|Poor/non-compliance|1
2072878|NCT00636168|3652512|FG001|Treated With Study Drug|Poor/non-compliance|3
2072879|NCT00636168|3652511|FG000|Treated With Study Drug|Death|3
2072880|NCT00636168|3652512|FG001|Treated With Study Drug|Death|0
2072881|NCT00636168|3652511|FG000|Treated With Study Drug|Pregnancy|1
2072882|NCT00636168|3652512|FG001|Treated With Study Drug|Pregnancy|0
2072883|NCT00636168|3652511|FG000|Treated With Study Drug|No longer meets study criteria|1
2072884|NCT00636168|3652512|FG001|Treated With Study Drug|No longer meets study criteria|0
2072885|NCT00636168|3652511|FG000|Treated With Study Drug|Other reason|1
2072886|NCT00636168|3652512|FG001|Treated With Study Drug|Other reason|3
2072887|NCT00636168|3652511|FG000|Long Term Follow-Up|Lost to Follow-up|3
2072888|NCT00636168|3652512|FG001|Long Term Follow-Up|Lost to Follow-up|3
2072889|NCT00636168|3652511|FG000|Long Term Follow-Up|Participant withdrew consent|0
2072890|NCT00636168|3652512|FG001|Long Term Follow-Up|Participant withdrew consent|2
2072891|NCT00636168|3652511|FG000|Long Term Follow-Up|Death|8
2072892|NCT00636168|3652512|FG001|Long Term Follow-Up|Death|9
2072893|NCT00636181|3652521|FG000|Overall Study|Withdrawal by Subject|8
2072894|NCT00636181|3652522|FG001|Overall Study|Withdrawal by Subject|6
2072895|NCT00636181|3652523|FG002|Overall Study|Withdrawal by Subject|10
2072896|NCT00636194|3652533|FG000|Overall Study|Study related symptoms and complaints|1
2072897|NCT00636194|3652534|FG001|Overall Study|Study related symptoms and complaints|0
2072898|NCT00636194|3652533|FG000|Overall Study|Protocol Violation|2
2072899|NCT00636194|3652534|FG001|Overall Study|Protocol Violation|0
2072900|NCT00636207|3652543|FG000|Overall Study|Adverse Event|1
2072901|NCT00636207|3652544|FG001|Overall Study|Adverse Event|0
2072902|NCT00636207|3652545|FG002|Overall Study|Adverse Event|0
2072903|NCT00636207|3652546|FG003|Overall Study|Adverse Event|0
2072904|NCT00636207|3652547|FG004|Overall Study|Adverse Event|0
2072905|NCT00636207|3652548|FG005|Overall Study|Adverse Event|0
2072906|NCT00636207|3652549|FG006|Overall Study|Adverse Event|0
2072907|NCT00636207|3652543|FG000|Overall Study|Withdrawal by Subject|0
2072908|NCT00636207|3652544|FG001|Overall Study|Withdrawal by Subject|1
2072909|NCT00636207|3652545|FG002|Overall Study|Withdrawal by Subject|0
2072910|NCT00636207|3652546|FG003|Overall Study|Withdrawal by Subject|0
2072911|NCT00636207|3652547|FG004|Overall Study|Withdrawal by Subject|1
2072912|NCT00636207|3652548|FG005|Overall Study|Withdrawal by Subject|0
2072913|NCT00636207|3652549|FG006|Overall Study|Withdrawal by Subject|0
2072914|NCT00636363|3652577|FG000|Overall Study|Conjunctivitis|0
2072915|NCT00636363|3652578|FG001|Overall Study|Conjunctivitis|0
2072916|NCT00636363|3652579|FG002|Overall Study|Conjunctivitis|1
2072917|NCT00636363|3652577|FG000|Overall Study|Adverse Event|0
2072918|NCT00636363|3652578|FG001|Overall Study|Adverse Event|0
2072919|NCT00636363|3652579|FG002|Overall Study|Adverse Event|1
2072920|NCT00636363|3652577|FG000|Overall Study|Positive slit lamp finding|0
2072921|NCT00636363|3652578|FG001|Overall Study|Positive slit lamp finding|2
2072922|NCT00636363|3652579|FG002|Overall Study|Positive slit lamp finding|1
2072923|NCT00636363|3652577|FG000|Overall Study|Study related symptoms/complaints|8
2072924|NCT00636363|3652578|FG001|Overall Study|Study related symptoms/complaints|7
2072925|NCT00636363|3652579|FG002|Overall Study|Study related symptoms/complaints|4
2072926|NCT00636363|3652577|FG000|Overall Study|Met ineligibility criteria|0
2072927|NCT00636363|3652578|FG001|Overall Study|Met ineligibility criteria|0
2072928|NCT00636363|3652579|FG002|Overall Study|Met ineligibility criteria|3
2072929|NCT00636363|3652577|FG000|Overall Study|Missed > 1 visit|0
2072930|NCT00636363|3652578|FG001|Overall Study|Missed > 1 visit|1
2072931|NCT00636363|3652579|FG002|Overall Study|Missed > 1 visit|3
2072932|NCT00636363|3652577|FG000|Overall Study|Lack of motivation|1
2072933|NCT00636363|3652578|FG001|Overall Study|Lack of motivation|0
2072934|NCT00636363|3652579|FG002|Overall Study|Lack of motivation|1
2072935|NCT00636363|3652577|FG000|Overall Study|Protocol Violation|0
2072936|NCT00636363|3652578|FG001|Overall Study|Protocol Violation|3
2072937|NCT00636363|3652579|FG002|Overall Study|Protocol Violation|0
2072938|NCT00636363|3652577|FG000|Overall Study|Lost to Follow-up|3
2072939|NCT00636363|3652578|FG001|Overall Study|Lost to Follow-up|4
2072940|NCT00636363|3652579|FG002|Overall Study|Lost to Follow-up|2
2072941|NCT00636363|3652577|FG000|Overall Study|Withdrawal by Subject|1
2072942|NCT00636363|3652578|FG001|Overall Study|Withdrawal by Subject|3
2072943|NCT00636363|3652579|FG002|Overall Study|Withdrawal by Subject|2
2072944|NCT00636441|3652601|FG000|Overall Study|Adverse Event|0
2072945|NCT00636441|3652602|FG001|Overall Study|Adverse Event|1
2072946|NCT00636441|3652603|FG002|Overall Study|Adverse Event|1
2072947|NCT00636441|3652604|FG003|Overall Study|Adverse Event|0
2072948|NCT00636441|3652605|FG004|Overall Study|Adverse Event|0
2072949|NCT00636441|3652606|FG005|Overall Study|Adverse Event|1
2072950|NCT00636441|3652607|FG006|Overall Study|Adverse Event|0
2072951|NCT00636441|3652601|FG000|Overall Study|Late, ineligible|0
2072952|NCT00636441|3652602|FG001|Overall Study|Late, ineligible|0
2072953|NCT00636441|3652603|FG002|Overall Study|Late, ineligible|0
2072954|NCT00636441|3652604|FG003|Overall Study|Late, ineligible|0
2072955|NCT00636441|3652605|FG004|Overall Study|Late, ineligible|0
2072956|NCT00636441|3652606|FG005|Overall Study|Late, ineligible|0
2072957|NCT00636441|3652607|FG006|Overall Study|Late, ineligible|1
2072958|NCT00636441|3652601|FG000|Overall Study|Screen Failure|0
2072959|NCT00636441|3652602|FG001|Overall Study|Screen Failure|0
2072960|NCT00636441|3652603|FG002|Overall Study|Screen Failure|0
2072961|NCT00636441|3652604|FG003|Overall Study|Screen Failure|0
2072962|NCT00636441|3652605|FG004|Overall Study|Screen Failure|0
2072963|NCT00636441|3652606|FG005|Overall Study|Screen Failure|0
2072964|NCT00636441|3652607|FG006|Overall Study|Screen Failure|17
2072965|NCT00636506|3652618|FG000|Overall Study|Lost to Follow-up|8
2072966|NCT00636506|3652618|FG000|Overall Study|Explanted|1
2072967|NCT00636506|3652618|FG000|Overall Study|Withdrawal by Subject|6
2072968|NCT00636506|3652618|FG000|Overall Study|Procedure aborted|1
2072969|NCT00636610|3652642|FG000|Overall Study|Adverse Event|4
2072970|NCT00636610|3652643|FG001|Overall Study|Adverse Event|4
2072971|NCT00636610|3652642|FG000|Overall Study|Death|6
2072972|NCT00636610|3652643|FG001|Overall Study|Death|3
2072973|NCT00636610|3652642|FG000|Overall Study|Physician decision to withdraw patient|15
2072974|NCT00636610|3652643|FG001|Overall Study|Physician decision to withdraw patient|9
2072975|NCT00636610|3652642|FG000|Overall Study|Subject decision to withdraw|15
2072976|NCT00636610|3652643|FG001|Overall Study|Subject decision to withdraw|11
2072977|NCT00636610|3652642|FG000|Overall Study|Disease progression - radiographic|41
2072978|NCT00636610|3652643|FG001|Overall Study|Disease progression - radiographic|51
2072979|NCT00636610|3652642|FG000|Overall Study|Disease progression - clinical|8
2072980|NCT00636610|3652643|FG001|Overall Study|Disease progression - clinical|3
2072981|NCT00636610|3652642|FG000|Overall Study|Reason for discontinuation not available|3
2072982|NCT00636610|3652643|FG001|Overall Study|Reason for discontinuation not available|2
2072983|NCT00636636|3652653|FG000|Overall Study|Other reason|4
2072984|NCT00636636|3652654|FG001|Overall Study|Other reason|6
2072985|NCT00636636|3652653|FG000|Overall Study|Adverse Event|19
2072986|NCT00636636|3652654|FG001|Overall Study|Adverse Event|8
2072987|NCT00636636|3652653|FG000|Overall Study|Lack of Efficacy|7
2072988|NCT00636636|3652654|FG001|Overall Study|Lack of Efficacy|12
2072989|NCT00636636|3652653|FG000|Overall Study|Protocol Violation|2
2072990|NCT00636636|3652654|FG001|Overall Study|Protocol Violation|2
2072991|NCT00636636|3652653|FG000|Overall Study|Lost to Follow-up|0
2072992|NCT00636636|3652654|FG001|Overall Study|Lost to Follow-up|1
2072993|NCT00636636|3652653|FG000|Overall Study|Death|0
2072994|NCT00636636|3652654|FG001|Overall Study|Death|1
2072995|NCT00636636|3652653|FG000|Overall Study|Withdrawal by Subject|4
2072996|NCT00636636|3652654|FG001|Overall Study|Withdrawal by Subject|9
2072997|NCT00636675|3652675|FG000|Overall Study|Lost to Follow-up|121
2072998|NCT00636675|3652676|FG001|Overall Study|Lost to Follow-up|31
2072999|NCT00636675|3652675|FG000|Overall Study|Withdrawal by Subject|19
2073000|NCT00636675|3652676|FG001|Overall Study|Withdrawal by Subject|10
2073001|NCT00636792|3652691|FG000|Overall Study|Adverse Event|16
2073002|NCT00636792|3652691|FG000|Overall Study|Physician Decision|7
2073003|NCT00636792|3652691|FG000|Overall Study|Progressive Disease|4
2073004|NCT00636792|3652691|FG000|Overall Study|Withdrawal by Subject|3
2073005|NCT00636792|3652691|FG000|Overall Study|Other|3
2073006|NCT00636818|3652699|FG000|Overall Study|Adverse Event|1
2073007|NCT00636818|3652699|FG000|Overall Study|Lost to Follow-up|2
2073008|NCT00636818|3652699|FG000|Overall Study|Entry Criteria Exclusion|3
2073009|NCT00636818|3652699|FG000|Overall Study|Protocol Violation|1
2073010|NCT00636818|3652699|FG000|Overall Study|Withdrawal by Subject|4
2073011|NCT00636961|3652705|FG000|Period 1|Administrative problems|1
2073012|NCT00636961|3652706|FG001|Period 1|Administrative problems|1
2073013|NCT00636961|3652705|FG000|Period 2|Adverse Event|1
2073014|NCT00636961|3652706|FG001|Period 2|Adverse Event|0
2073015|NCT00636987|3652712|FG000|Overall Study|Death|44
2073016|NCT00636987|3652712|FG000|Overall Study|Explanted|13
2073017|NCT00636987|3652712|FG000|Overall Study|Lost to Follow-up|63
2073018|NCT00636987|3652712|FG000|Overall Study|5 year visit window not complete|69
2073019|NCT00637000|3652722|FG000|Overall Study|Withdrawal by Subject|4
2073020|NCT00637000|3652723|FG001|Overall Study|Withdrawal by Subject|3
2073021|NCT00637156|3652731|FG000|Overall Study|Withdrawal by Subject|0
2073022|NCT00637156|3652732|FG001|Overall Study|Withdrawal by Subject|7
2073023|NCT00637156|3652731|FG000|Overall Study|Death|0
2073024|NCT00637156|3652732|FG001|Overall Study|Death|1
2073025|NCT00637156|3652731|FG000|Overall Study|Lost to Follow-up|10
2073026|NCT00637156|3652732|FG001|Overall Study|Lost to Follow-up|16
2073027|NCT00637195|3652740|FG000|Overall Study|Lost to Follow-up|1
2073028|NCT00637195|3652741|FG001|Overall Study|Lost to Follow-up|0
2073029|NCT00637195|3652740|FG000|Overall Study|Other|2
2073030|NCT00637195|3652741|FG001|Overall Study|Other|0
2073031|NCT00637195|3652740|FG000|Overall Study|Withdrawal by Subject|0
2073032|NCT00637195|3652741|FG001|Overall Study|Withdrawal by Subject|1
2073033|NCT00637273|3652761|FG000|Overall Study|Adverse Event|11
2073034|NCT00637273|3652762|FG001|Overall Study|Adverse Event|5
2073035|NCT00637273|3652763|FG002|Overall Study|Adverse Event|7
2073036|NCT00637273|3652761|FG000|Overall Study|Lost to Follow-up|8
2073037|NCT00637273|3652762|FG001|Overall Study|Lost to Follow-up|9
2073038|NCT00637273|3652763|FG002|Overall Study|Lost to Follow-up|13
2073039|NCT00637273|3652761|FG000|Overall Study|Protocol Violation|2
2073040|NCT00637273|3652762|FG001|Overall Study|Protocol Violation|4
2073041|NCT00637273|3652763|FG002|Overall Study|Protocol Violation|1
2073042|NCT00637273|3652761|FG000|Overall Study|Withdrawal of Consent|18
2073043|NCT00637273|3652762|FG001|Overall Study|Withdrawal of Consent|6
2073044|NCT00637273|3652763|FG002|Overall Study|Withdrawal of Consent|18
2073045|NCT00637273|3652761|FG000|Overall Study|Investigator Decision|1
2073046|NCT00637273|3652762|FG001|Overall Study|Investigator Decision|3
2073047|NCT00637273|3652763|FG002|Overall Study|Investigator Decision|1
2073048|NCT00637273|3652761|FG000|Overall Study|Administrative|2
2073049|NCT00637273|3652762|FG001|Overall Study|Administrative|0
2073050|NCT00637273|3652763|FG002|Overall Study|Administrative|0
2073051|NCT00637273|3652761|FG000|Overall Study|Loss of Glucose Control|1
2073052|NCT00637273|3652762|FG001|Overall Study|Loss of Glucose Control|1
2073053|NCT00637273|3652763|FG002|Overall Study|Loss of Glucose Control|1
2073054|NCT00637377|3652784|FG000|Overall Study|Adverse Event|2
2073055|NCT00637377|3652785|FG001|Overall Study|Adverse Event|6
2073056|NCT00637377|3652786|FG002|Overall Study|Adverse Event|8
2073057|NCT00637377|3652787|FG003|Overall Study|Adverse Event|9
2073058|NCT00637377|3652784|FG000|Overall Study|Death|1
2073059|NCT00637377|3652785|FG001|Overall Study|Death|3
2073060|NCT00637377|3652786|FG002|Overall Study|Death|2
2073061|NCT00637377|3652787|FG003|Overall Study|Death|1
2073062|NCT00637377|3652784|FG000|Overall Study|Lack of Efficacy|0
2210459|NCT01650259|3849952|FG001|Overall Study|Patients had no visit after entry|0
2210460|NCT01650259|3849951|FG000|Overall Study|CRF not collected|98
2210461|NCT01650259|3849952|FG001|Overall Study|CRF not collected|82
2210462|NCT01650259|3849951|FG000|Overall Study|Not treated|1
2210463|NCT01650259|3849952|FG001|Overall Study|Not treated|7
2210464|NCT01650259|3849951|FG000|Overall Study|Other than listed|64
2210465|NCT01650259|3849952|FG001|Overall Study|Other than listed|146
2210466|NCT01650285|3849956|FG000|Overall Study|Adverse Event|1
2210467|NCT01650519|3850012|FG000|Overall Study|Withdrawal by Subject|1
2210468|NCT01650519|3850013|FG001|Overall Study|Withdrawal by Subject|0
2210469|NCT01650558|3850033|FG000|Overall Study|Migration out of study area|61
2210470|NCT01650558|3850034|FG001|Overall Study|Migration out of study area|71
2210471|NCT01650558|3850035|FG002|Overall Study|Migration out of study area|56
2210472|NCT01650558|3850033|FG000|Overall Study|Lost to Follow-up|10
2210473|NCT01650558|3850034|FG001|Overall Study|Lost to Follow-up|13
2210474|NCT01650558|3850035|FG002|Overall Study|Lost to Follow-up|6
2210475|NCT01650558|3850033|FG000|Overall Study|Death|10
2210476|NCT01650558|3850034|FG001|Overall Study|Death|6
2210477|NCT01650558|3850035|FG002|Overall Study|Death|8
2210478|NCT01650558|3850033|FG000|Overall Study|Withdrawal by Subject|1
2210479|NCT01650558|3850034|FG001|Overall Study|Withdrawal by Subject|1
2210480|NCT01650558|3850035|FG002|Overall Study|Withdrawal by Subject|3
2210481|NCT01650558|3850033|FG000|Overall Study|Non-compliant participant|1
2210482|NCT01650558|3850034|FG001|Overall Study|Non-compliant participant|0
2210483|NCT01650558|3850035|FG002|Overall Study|Non-compliant participant|2
2210484|NCT01650558|3850033|FG000|Overall Study|Physician Decision|0
2210485|NCT01650558|3850034|FG001|Overall Study|Physician Decision|1
2210486|NCT01650558|3850035|FG002|Overall Study|Physician Decision|0
2210487|NCT01650636|3850053|FG000|Washout up to 5 Months|Withdrawal by Subject|4
2210488|NCT01650636|3850054|FG001|Washout up to 5 Months|Withdrawal by Subject|8
2210489|NCT01650636|3850053|FG000|Washout up to 5 Months|Physician Decision|2
2210490|NCT01650636|3850054|FG001|Washout up to 5 Months|Physician Decision|2
2210491|NCT01650636|3850053|FG000|Washout up to 5 Months|Death|1
2210492|NCT01650636|3850054|FG001|Washout up to 5 Months|Death|0
2210493|NCT01650636|3850053|FG000|Washout up to 5 Months|Lost to Follow-up|2
2210494|NCT01650636|3850054|FG001|Washout up to 5 Months|Lost to Follow-up|8
2210495|NCT01650636|3850053|FG000|Washout up to 9 Months|Withdrawal by Subject|4
2210496|NCT01650636|3850054|FG001|Washout up to 9 Months|Withdrawal by Subject|2
2210497|NCT01650636|3850053|FG000|Washout up to 9 Months|Lost to Follow-up|2
2073063|NCT00637377|3652785|FG001|Overall Study|Lack of Efficacy|0
2073064|NCT00637377|3652786|FG002|Overall Study|Lack of Efficacy|1
2073065|NCT00637377|3652787|FG003|Overall Study|Lack of Efficacy|1
2073066|NCT00637377|3652784|FG000|Overall Study|Lost to Follow-up|4
2073067|NCT00637377|3652785|FG001|Overall Study|Lost to Follow-up|1
2073068|NCT00637377|3652786|FG002|Overall Study|Lost to Follow-up|2
2073069|NCT00637377|3652787|FG003|Overall Study|Lost to Follow-up|2
2073070|NCT00637377|3652784|FG000|Overall Study|Protocol Violation|2
2073071|NCT00637377|3652785|FG001|Overall Study|Protocol Violation|1
2073072|NCT00637377|3652786|FG002|Overall Study|Protocol Violation|1
2073073|NCT00637377|3652787|FG003|Overall Study|Protocol Violation|0
2073074|NCT00637377|3652784|FG000|Overall Study|Withdrawal by Subject|11
2073075|NCT00637377|3652785|FG001|Overall Study|Withdrawal by Subject|15
2073076|NCT00637377|3652786|FG002|Overall Study|Withdrawal by Subject|13
2073077|NCT00637377|3652787|FG003|Overall Study|Withdrawal by Subject|11
2073078|NCT00637377|3652784|FG000|Overall Study|Other (no further information available)|7
2073079|NCT00637377|3652785|FG001|Overall Study|Other (no further information available)|6
2073080|NCT00637377|3652786|FG002|Overall Study|Other (no further information available)|10
2073081|NCT00637377|3652787|FG003|Overall Study|Other (no further information available)|5
2073082|NCT00637572|3652808|FG000|Overall Study|Adverse Event|1
2073083|NCT00637572|3652809|FG001|Overall Study|Adverse Event|2
2073084|NCT00637572|3652808|FG000|Overall Study|Death|0
2073085|NCT00637572|3652809|FG001|Overall Study|Death|1
2073086|NCT00637572|3652808|FG000|Overall Study|Lost to Follow-up|0
2073087|NCT00637572|3652809|FG001|Overall Study|Lost to Follow-up|1
2073088|NCT00637572|3652808|FG000|Overall Study|Physician Decision|1
2073089|NCT00637572|3652809|FG001|Overall Study|Physician Decision|1
2073090|NCT00637572|3652808|FG000|Overall Study|Withdrawal by Subject|0
2073091|NCT00637572|3652809|FG001|Overall Study|Withdrawal by Subject|2
2073092|NCT00637572|3652808|FG000|Overall Study|Illicit Drug Use|1
2073093|NCT00637572|3652809|FG001|Overall Study|Illicit Drug Use|0
2210498|NCT01650636|3850054|FG001|Washout up to 9 Months|Lost to Follow-up|1
2210499|NCT01650779|3850060|FG000|Overall Study|Withdrawal by Subject|1
2073094|NCT00638027|3652839|FG000|Overall Study|Adverse Event|0
2073095|NCT00638027|3652840|FG001|Overall Study|Adverse Event|2
2073096|NCT00638157|3652848|FG000|Overall Study|Adverse Event|0
2073097|NCT00638157|3652849|FG001|Overall Study|Adverse Event|1
2073098|NCT00638157|3652848|FG000|Overall Study|Clinical (symptomatic) failure|1
2073099|NCT00638157|3652849|FG001|Overall Study|Clinical (symptomatic) failure|1
2073100|NCT00638157|3652848|FG000|Overall Study|Microbiological failure|1
2073101|NCT00638157|3652849|FG001|Overall Study|Microbiological failure|0
2073102|NCT00638157|3652848|FG000|Overall Study|Lost to Follow-up|1
2073103|NCT00638157|3652849|FG001|Overall Study|Lost to Follow-up|0
2073104|NCT00638157|3652848|FG000|Overall Study|Physician Decision|1
2073105|NCT00638157|3652849|FG001|Overall Study|Physician Decision|0
2073106|NCT00638157|3652848|FG000|Overall Study|Other|1
2073107|NCT00638157|3652849|FG001|Overall Study|Other|2
2073108|NCT00638157|3652848|FG000|Overall Study|Randomized, not treated|2
2073109|NCT00638157|3652849|FG001|Overall Study|Randomized, not treated|0
2106468|NCT00866307|3699633|FG002|Induction|Physician Decision|0
2106469|NCT00866307|3699631|FG000|Induction|Progressive Disease|1
2106470|NCT00866307|3699632|FG001|Induction|Progressive Disease|0
2106471|NCT00866307|3699633|FG002|Induction|Progressive Disease|0
2106472|NCT00866307|3699631|FG000|Induction|Identification of Patients with Day 29 M|3
2106473|NCT00866307|3699632|FG001|Induction|Identification of Patients with Day 29 M|0
2106474|NCT00866307|3699633|FG002|Induction|Identification of Patients with Day 29 M|0
2106475|NCT00866307|3699631|FG000|Induction|Inadequate cytognetic samples th|1
2106476|NCT00866307|3699632|FG001|Induction|Inadequate cytognetic samples th|0
2106477|NCT00866307|3699633|FG002|Induction|Inadequate cytognetic samples th|0
2106478|NCT00866307|3699631|FG000|Induction|Improper post-induction consent|2
2106479|NCT00866307|3699632|FG001|Induction|Improper post-induction consent|0
2106480|NCT00866307|3699633|FG002|Induction|Improper post-induction consent|0
2106481|NCT00866307|3699631|FG000|Induction|Study was closed at the time|1
2106482|NCT00866307|3699632|FG001|Induction|Study was closed at the time|0
2106483|NCT00866307|3699633|FG002|Induction|Study was closed at the time|0
2106484|NCT00866307|3699631|FG000|Consolidation/Maintenance|Adverse Event|0
2106485|NCT00866307|3699632|FG001|Consolidation/Maintenance|Adverse Event|0
2106486|NCT00866307|3699633|FG002|Consolidation/Maintenance|Adverse Event|8
2106487|NCT00866307|3699631|FG000|Consolidation/Maintenance|Death|0
2106488|NCT00866307|3699632|FG001|Consolidation/Maintenance|Death|0
2106489|NCT00866307|3699633|FG002|Consolidation/Maintenance|Death|1
2106490|NCT00866307|3699631|FG000|Consolidation/Maintenance|Physician Decision|0
2106491|NCT00866307|3699632|FG001|Consolidation/Maintenance|Physician Decision|3
2106492|NCT00866307|3699633|FG002|Consolidation/Maintenance|Physician Decision|2
2106493|NCT00866307|3699631|FG000|Consolidation/Maintenance|Withdrawal by Subject|0
2106494|NCT00866307|3699632|FG001|Consolidation/Maintenance|Withdrawal by Subject|1
2106495|NCT00866307|3699633|FG002|Consolidation/Maintenance|Withdrawal by Subject|1
2106496|NCT00866307|3699631|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
2106497|NCT00866307|3699632|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
2106498|NCT00866307|3699633|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
2304217|NCT02649439|4003962|FG001|Overall Study|No treatment, per protocol|0
2304218|NCT02649439|4003961|FG000|Overall Study|PSA DT makes ineligible|0
2304219|NCT02649439|4003962|FG001|Overall Study|PSA DT makes ineligible|1
2304220|NCT02649439|4003961|FG000|Overall Study|Rising PSA No Mets|0
2304221|NCT02649439|4003962|FG001|Overall Study|Rising PSA No Mets|1
2304222|NCT02649439|4003961|FG000|Overall Study|Rising PSA|0
2304223|NCT02649439|4003962|FG001|Overall Study|Rising PSA|1
2304224|NCT02649439|4003961|FG000|Overall Study|Signed follow up protocol|0
2304225|NCT02649439|4003962|FG001|Overall Study|Signed follow up protocol|1
2304226|NCT02649634|4004029|FG000|Overall Study|Withdrawal by Subject|3
2304227|NCT02649634|4004030|FG001|Overall Study|Withdrawal by Subject|5
2304228|NCT02649634|4004029|FG000|Overall Study|Lost to Follow-up|0
2304229|NCT02649634|4004030|FG001|Overall Study|Lost to Follow-up|1
2304230|NCT02649894|4004044|FG000|Overall Study|Adverse Event|1
2304231|NCT02649894|4004045|FG001|Overall Study|Adverse Event|0
2304232|NCT02649894|4004044|FG000|Overall Study|Physician Decision|0
2304233|NCT02649894|4004045|FG001|Overall Study|Physician Decision|1
2304234|NCT02649894|4004044|FG000|Overall Study|Withdrawal by Subject|5
2304235|NCT02649894|4004045|FG001|Overall Study|Withdrawal by Subject|2
2304236|NCT02649894|4004044|FG000|Overall Study|Lost to Follow-up|2
2304237|NCT02649894|4004045|FG001|Overall Study|Lost to Follow-up|1
2304238|NCT02649894|4004044|FG000|Overall Study|Death|30
2106499|NCT00866307|3699631|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0
2106500|NCT00866307|3699632|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3
2106501|NCT00866307|3699633|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1
2106502|NCT00866307|3699631|FG000|Consolidation/Maintenance|Therapy error|0
2106503|NCT00866307|3699632|FG001|Consolidation/Maintenance|Therapy error|1
2106504|NCT00866307|3699633|FG002|Consolidation/Maintenance|Therapy error|0
2106505|NCT00866307|3699631|FG000|Consolidation/Maintenance|Non-compliance|0
2106506|NCT00866307|3699632|FG001|Consolidation/Maintenance|Non-compliance|0
2106507|NCT00866307|3699633|FG002|Consolidation/Maintenance|Non-compliance|1
2106508|NCT00866307|3699631|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0
2106509|NCT00866307|3699632|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1
2106510|NCT00866307|3699633|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0
2106511|NCT00866320|3699639|FG000|Overall Study|Withdrawal by Subject|4
2304239|NCT02649894|4004045|FG001|Overall Study|Death|7
2304240|NCT02649894|4004044|FG000|Overall Study|Other, not specified|6
2304241|NCT02649894|4004045|FG001|Overall Study|Other, not specified|0
2073110|NCT00638183|3652856|FG000|Overall Study|Adverse Event|23
2073111|NCT00638183|3652856|FG000|Overall Study|Lack of Efficacy|14
2073112|NCT00638183|3652856|FG000|Overall Study|Physician Decision|9
2073113|NCT00638183|3652856|FG000|Overall Study|Lost to Follow-up|46
2073114|NCT00638183|3652856|FG000|Overall Study|Other reason not defined above|27
2073115|NCT00638235|3652869|FG000|Overall Study|Lost to Follow-up|31
2073116|NCT00638235|3652870|FG001|Overall Study|Lost to Follow-up|3
2073117|NCT00638235|3652871|FG002|Overall Study|Lost to Follow-up|18
2073118|NCT00638235|3652872|FG003|Overall Study|Lost to Follow-up|10
2073119|NCT00638235|3652873|FG004|Overall Study|Lost to Follow-up|13
2073120|NCT00638235|3652874|FG005|Overall Study|Lost to Follow-up|26
2073121|NCT00638235|3652875|FG006|Overall Study|Lost to Follow-up|0
2073122|NCT00638235|3652876|FG007|Overall Study|Lost to Follow-up|1
2073123|NCT00638235|3652877|FG008|Overall Study|Lost to Follow-up|18
2073124|NCT00638378|3652926|FG000|Overall Study|Death|2
2073125|NCT00638378|3652926|FG000|Overall Study|Adverse Event|1
2073126|NCT00638378|3652926|FG000|Overall Study|Disease progression|15
2073127|NCT00638378|3652926|FG000|Overall Study|Physician Decision|4
2073128|NCT00638404|3652932|FG000|Overall Study|Physician Decision|8
2073129|NCT00638404|3652933|FG001|Overall Study|Physician Decision|0
2073130|NCT00638443|3652943|FG000|First Intervention|Adverse Event|2
2073131|NCT00638443|3652944|FG001|First Intervention|Adverse Event|1
2073132|NCT00638456|3652954|FG000|Overall Study|Withdrawal by Subject|6
2073133|NCT00638456|3652955|FG001|Overall Study|Withdrawal by Subject|2
2073134|NCT00638508|3652963|FG000|Overall Study|Physician Decision|5
2073135|NCT00638508|3652964|FG001|Overall Study|Physician Decision|2
2073136|NCT00638690|3652981|FG000|Overall Study|Death|655
2073137|NCT00638690|3652982|FG001|Overall Study|Death|335
2073138|NCT00638690|3652981|FG000|Overall Study|Withdrawal by Subject|22
2073139|NCT00638690|3652982|FG001|Overall Study|Withdrawal by Subject|5
2073140|NCT00638690|3652981|FG000|Overall Study|Lost to Follow-up|4
2073141|NCT00638690|3652982|FG001|Overall Study|Lost to Follow-up|2
2073142|NCT00638846|3653008|FG000|Overall Study|Adverse Event|0
2073143|NCT00638846|3653009|FG001|Overall Study|Adverse Event|1
2073144|NCT00638846|3653008|FG000|Overall Study|Lost to Follow-up|3
2073145|NCT00638846|3653009|FG001|Overall Study|Lost to Follow-up|2
2073146|NCT00638846|3653008|FG000|Overall Study|lens issue|1
2073147|NCT00638846|3653009|FG001|Overall Study|lens issue|3
2073148|NCT00638963|3653031|FG000|Overall Study|Withdrawal by Subject|1
2073149|NCT00638963|3653032|FG001|Overall Study|Withdrawal by Subject|0
2073150|NCT00638989|3653041|FG000|Overall Study|Lost to Follow-up|0
2073151|NCT00638989|3653042|FG001|Overall Study|Lost to Follow-up|0
2073152|NCT00638989|3653043|FG002|Overall Study|Lost to Follow-up|1
2073153|NCT00639002|3653053|FG000|Overall Study|Death|1
2073154|NCT00639002|3653053|FG000|Overall Study|Adverse Event|1
2073155|NCT00639002|3653053|FG000|Overall Study|Protocol Violation|1
2073156|NCT00639002|3653053|FG000|Overall Study|Disease progression|3
2073157|NCT00639002|3653053|FG000|Overall Study|Physician Decision|6
2073158|NCT00639002|3653053|FG000|Overall Study|Lack of Efficacy|1
2073159|NCT00639223|3653078|FG000|Overall Study|Lost to Follow-up|0
2073160|NCT00639223|3653079|FG001|Overall Study|Lost to Follow-up|2
2073161|NCT00639379|3653085|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2
2073162|NCT00639379|3653086|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0
2073163|NCT00639379|3653085|FG000|Period 1 - 2 Weeks|lens issue|3
2073164|NCT00639379|3653086|FG001|Period 1 - 2 Weeks|lens issue|0
2073165|NCT00639457|3653115|FG000|Overall Study|Withdrawal by Subject|2
2073166|NCT00639457|3653116|FG001|Overall Study|Withdrawal by Subject|3
2073167|NCT00639509|3653122|FG000|Overall Study|Death|1
2073168|NCT00639678|3653130|FG000|Overall Study|Withdrawal by Subject|3
2073169|NCT00639678|3653131|FG001|Overall Study|Withdrawal by Subject|0
2073170|NCT00639678|3653132|FG002|Overall Study|Withdrawal by Subject|4
2073171|NCT00639678|3653133|FG003|Overall Study|Withdrawal by Subject|0
2073172|NCT00639678|3653130|FG000|Overall Study|Lost to Follow-up|1
2073173|NCT00639678|3653131|FG001|Overall Study|Lost to Follow-up|0
2073174|NCT00639678|3653132|FG002|Overall Study|Lost to Follow-up|6
2073175|NCT00639678|3653133|FG003|Overall Study|Lost to Follow-up|0
2073176|NCT00639678|3653130|FG000|Overall Study|Adverse Event|0
2073177|NCT00639678|3653131|FG001|Overall Study|Adverse Event|1
2073178|NCT00639678|3653132|FG002|Overall Study|Adverse Event|0
2073179|NCT00639678|3653133|FG003|Overall Study|Adverse Event|0
2073180|NCT00639678|3653130|FG000|Overall Study|Lack of Compliance|0
2073181|NCT00639678|3653131|FG001|Overall Study|Lack of Compliance|0
2073182|NCT00639678|3653132|FG002|Overall Study|Lack of Compliance|1
2073183|NCT00639678|3653133|FG003|Overall Study|Lack of Compliance|0
2073184|NCT00639769|3653149|FG000|Overall Study|Death|2
2073185|NCT00639769|3653149|FG000|Overall Study|Adverse Event|7
2073186|NCT00639769|3653149|FG000|Overall Study|Lack of Efficacy|1
2073187|NCT00639769|3653149|FG000|Overall Study|Disease progression|26
2073188|NCT00639769|3653149|FG000|Overall Study|Withdrawal by Subject|4
2073189|NCT00640016|3653161|FG000|Overall Study|Withdrawal by Subject|0
2073190|NCT00640016|3653162|FG001|Overall Study|Withdrawal by Subject|1
2073191|NCT00640016|3653163|FG002|Overall Study|Withdrawal by Subject|0
2073192|NCT00640016|3653164|FG003|Overall Study|Withdrawal by Subject|0
2073193|NCT00640016|3653161|FG000|Overall Study|Study termination|2
2073194|NCT00640016|3653162|FG001|Overall Study|Study termination|1
2073195|NCT00640016|3653163|FG002|Overall Study|Study termination|3
2073196|NCT00640016|3653164|FG003|Overall Study|Study termination|2
2073197|NCT00640016|3653161|FG000|Overall Study|Adverse Event|0
2073198|NCT00640016|3653162|FG001|Overall Study|Adverse Event|0
2073199|NCT00640016|3653163|FG002|Overall Study|Adverse Event|0
2073200|NCT00640016|3653164|FG003|Overall Study|Adverse Event|1
2073201|NCT00640042|3653181|FG000|Enrollment|Did not receive study drug|83
2073202|NCT00640133|3653187|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1
2073203|NCT00640133|3653188|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0
2073204|NCT00640133|3653187|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
2073205|NCT00640133|3653188|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
2073206|NCT00640133|3653187|FG000|Open Label Phase (Month 4-12)|Adverse Event|1
2073207|NCT00640133|3653188|FG001|Open Label Phase (Month 4-12)|Adverse Event|0
2073208|NCT00640146|3653198|FG000|Overall Study|Adverse Event|2
2073209|NCT00640146|3653199|FG001|Overall Study|Adverse Event|0
2073210|NCT00640146|3653198|FG000|Overall Study|Lost to Follow-up|0
2073211|NCT00640146|3653199|FG001|Overall Study|Lost to Follow-up|1
2073212|NCT00640146|3653198|FG000|Overall Study|Lack of Efficacy|0
2073213|NCT00640146|3653199|FG001|Overall Study|Lack of Efficacy|1
2073214|NCT00640146|3653198|FG000|Overall Study|Withdrawal by Subject|1
2073215|NCT00640146|3653199|FG001|Overall Study|Withdrawal by Subject|1
2073216|NCT00640146|3653198|FG000|Overall Study|Randomized but not treated|1
2073217|NCT00640146|3653199|FG001|Overall Study|Randomized but not treated|3
2073218|NCT00640224|3653209|FG000|Overall Study|Lost to Follow-up|5
2073219|NCT00640224|3653210|FG001|Overall Study|Lost to Follow-up|2
2073220|NCT00640224|3653211|FG002|Overall Study|Lost to Follow-up|0
2073221|NCT00640224|3653212|FG003|Overall Study|Lost to Follow-up|0
2073222|NCT00640224|3653209|FG000|Overall Study|Withdrawal by Subject|1
2073223|NCT00640224|3653210|FG001|Overall Study|Withdrawal by Subject|0
2073224|NCT00640224|3653211|FG002|Overall Study|Withdrawal by Subject|0
2073225|NCT00640224|3653212|FG003|Overall Study|Withdrawal by Subject|0
2073226|NCT00640224|3653209|FG000|Overall Study|Headaches|0
2073227|NCT00640224|3653210|FG001|Overall Study|Headaches|1
2073228|NCT00640224|3653211|FG002|Overall Study|Headaches|0
2073229|NCT00640224|3653212|FG003|Overall Study|Headaches|0
2073230|NCT00640289|3653325|FG000|Overall Study|Death|3
2073231|NCT00640289|3653325|FG000|Overall Study|Withdrawal by Subject|1
2073232|NCT00640289|3653325|FG000|Overall Study|Lost to Follow-up|1
2073233|NCT00640289|3653325|FG000|Overall Study|Data collected under different amendment|2
2073234|NCT00640289|3653325|FG000|Overall Study|Transferred to another center|1
2073235|NCT00640289|3653325|FG000|Overall Study|Missing status|5
2073236|NCT00640315|3653331|FG000|Overall Study|Withdrawal by Subject|0
2073237|NCT00640315|3653332|FG001|Overall Study|Withdrawal by Subject|1
2073238|NCT00640328|3653344|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0
2073239|NCT00640328|3653345|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1
2073240|NCT00640328|3653346|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0
2073241|NCT00640328|3653347|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0
2073242|NCT00640328|3653348|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0
2073243|NCT00640328|3653349|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0
2073244|NCT00640328|3653344|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0
2073245|NCT00640328|3653345|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0
2073246|NCT00640328|3653346|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0
2073247|NCT00640328|3653347|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0
2073248|NCT00640328|3653348|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1
2073249|NCT00640328|3653349|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0
2073250|NCT00640328|3653344|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
2073251|NCT00640328|3653345|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
2073252|NCT00640328|3653346|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
2073253|NCT00640328|3653347|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
2073254|NCT00640328|3653348|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
2073255|NCT00640328|3653349|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
2073256|NCT00640328|3653344|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
2073257|NCT00640328|3653345|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
2073258|NCT00640328|3653346|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
2073259|NCT00640328|3653347|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
2073260|NCT00640328|3653348|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
2073261|NCT00640328|3653349|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
2073262|NCT00640341|3653373|FG000|Overall Study|Adverse Event|0
2073263|NCT00640341|3653374|FG001|Overall Study|Adverse Event|0
2073264|NCT00640341|3653375|FG002|Overall Study|Adverse Event|1
2073265|NCT00640341|3653373|FG000|Overall Study|Positive Slit Lamp Findings|0
2073266|NCT00640341|3653374|FG001|Overall Study|Positive Slit Lamp Findings|0
2073267|NCT00640341|3653375|FG002|Overall Study|Positive Slit Lamp Findings|1
2073268|NCT00640341|3653373|FG000|Overall Study|Study Related Symptoms/Complaints|2
2073269|NCT00640341|3653374|FG001|Overall Study|Study Related Symptoms/Complaints|1
2073270|NCT00640341|3653375|FG002|Overall Study|Study Related Symptoms/Complaints|2
2073271|NCT00640341|3653373|FG000|Overall Study|Inability to Maintain Wearing Schedule|1
2073272|NCT00640341|3653374|FG001|Overall Study|Inability to Maintain Wearing Schedule|1
2073273|NCT00640341|3653375|FG002|Overall Study|Inability to Maintain Wearing Schedule|0
2073274|NCT00640341|3653373|FG000|Overall Study|Failure to Follow Subject Instructions|1
2073275|NCT00640341|3653374|FG001|Overall Study|Failure to Follow Subject Instructions|0
2073276|NCT00640341|3653375|FG002|Overall Study|Failure to Follow Subject Instructions|0
2073277|NCT00640341|3653373|FG000|Overall Study|Lost to Follow-up|2
2073278|NCT00640341|3653374|FG001|Overall Study|Lost to Follow-up|0
2073279|NCT00640341|3653375|FG002|Overall Study|Lost to Follow-up|0
2073280|NCT00640341|3653373|FG000|Overall Study|Withdrawal by Subject|4
2073281|NCT00640341|3653374|FG001|Overall Study|Withdrawal by Subject|0
2073282|NCT00640341|3653375|FG002|Overall Study|Withdrawal by Subject|1
2073283|NCT00640341|3653373|FG000|Overall Study|Unacceptable Lens Movement|1
2073284|NCT00640341|3653374|FG001|Overall Study|Unacceptable Lens Movement|0
2073285|NCT00640341|3653375|FG002|Overall Study|Unacceptable Lens Movement|0
2073286|NCT00640341|3653373|FG000|Overall Study|Poor fit/Uncomfortable|4
2073287|NCT00640341|3653374|FG001|Overall Study|Poor fit/Uncomfortable|0
2073288|NCT00640341|3653375|FG002|Overall Study|Poor fit/Uncomfortable|0
2073289|NCT00640341|3653373|FG000|Overall Study|Ineligable at Baseline|5
2073290|NCT00640341|3653374|FG001|Overall Study|Ineligable at Baseline|3
2073291|NCT00640341|3653375|FG002|Overall Study|Ineligable at Baseline|2
2073292|NCT00640341|3653373|FG000|Overall Study|Adverse event and positive slit lamp|1
2073293|NCT00640341|3653374|FG001|Overall Study|Adverse event and positive slit lamp|0
2073294|NCT00640341|3653375|FG002|Overall Study|Adverse event and positive slit lamp|0
2073295|NCT00640393|3653383|FG000|Part 1|Lost to Follow-up|2
2073296|NCT00640393|3653384|FG001|Part 1|Lost to Follow-up|0
2073297|NCT00640393|3653385|FG002|Part 1|Lost to Follow-up|0
2073298|NCT00640393|3653383|FG000|Part 1|Withdrawal by Subject|3
2073299|NCT00640393|3653384|FG001|Part 1|Withdrawal by Subject|0
2073300|NCT00640393|3653385|FG002|Part 1|Withdrawal by Subject|0
2073301|NCT00640393|3653383|FG000|Randomization|Withdrawn per protocol|17
2073302|NCT00640393|3653384|FG001|Randomization|Withdrawn per protocol|0
2073303|NCT00640393|3653385|FG002|Randomization|Withdrawn per protocol|0
2073304|NCT00640393|3653383|FG000|Randomization|Never randomized by site|2
2073305|NCT00640393|3653384|FG001|Randomization|Never randomized by site|0
2073306|NCT00640393|3653385|FG002|Randomization|Never randomized by site|0
2073307|NCT00640393|3653383|FG000|Part 2|Lost to Follow-up|0
2073308|NCT00640393|3653384|FG001|Part 2|Lost to Follow-up|2
2073309|NCT00640393|3653385|FG002|Part 2|Lost to Follow-up|2
2073310|NCT00640393|3653383|FG000|Part 2|Withdrawal by Subject|0
2073311|NCT00640393|3653384|FG001|Part 2|Withdrawal by Subject|6
2073312|NCT00640393|3653385|FG002|Part 2|Withdrawal by Subject|1
2073313|NCT00640393|3653383|FG000|Part 2|Non-adherence|0
2073314|NCT00640393|3653384|FG001|Part 2|Non-adherence|1
2073315|NCT00640393|3653385|FG002|Part 2|Non-adherence|0
2073316|NCT00640393|3653383|FG000|Part 2|Adverse Event|0
2073317|NCT00640393|3653384|FG001|Part 2|Adverse Event|1
2073318|NCT00640393|3653385|FG002|Part 2|Adverse Event|0
2073319|NCT00640510|3653395|FG000|Overall Study|Lack of Efficacy|0
2073320|NCT00640510|3653396|FG001|Overall Study|Lack of Efficacy|1
2304242|NCT02650128|4004051|FG000|Overall Study|Death|2
2304243|NCT02650284|4004081|FG000|Overall Study|Lost to Follow-up|3
2304244|NCT02650284|4004082|FG001|Overall Study|Lost to Follow-up|3
2304245|NCT02650284|4004081|FG000|Overall Study|Consent incorrectly taken|0
2304246|NCT02650284|4004082|FG001|Overall Study|Consent incorrectly taken|1
2073321|NCT00640510|3653395|FG000|Overall Study|Protocol Violation|1
2073322|NCT00640510|3653396|FG001|Overall Study|Protocol Violation|0
2073323|NCT00640510|3653395|FG000|Overall Study|Physician Decision|0
2073324|NCT00640510|3653396|FG001|Overall Study|Physician Decision|1
2073325|NCT00640562|3653404|FG000|Overall Study|Adverse Event|8
2073326|NCT00640562|3653405|FG001|Overall Study|Adverse Event|5
2073327|NCT00640562|3653404|FG000|Overall Study|Lack of Efficacy|1
2073328|NCT00640562|3653405|FG001|Overall Study|Lack of Efficacy|4
2073329|NCT00640562|3653404|FG000|Overall Study|Protocol Violation|2
2073330|NCT00640562|3653405|FG001|Overall Study|Protocol Violation|4
2073331|NCT00640562|3653404|FG000|Overall Study|Withdrawal by Subject|6
2073332|NCT00640562|3653405|FG001|Overall Study|Withdrawal by Subject|10
2073333|NCT00640562|3653404|FG000|Overall Study|Known risperidone intolerance|0
2073334|NCT00640562|3653405|FG001|Overall Study|Known risperidone intolerance|1
2304247|NCT02650466|4004097|FG000|Overall Study|Physician Decision|1
2073335|NCT00640562|3653404|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0
2073336|NCT00640562|3653405|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1
2073337|NCT00640562|3653404|FG000|Overall Study|Low study drug dose|0
2073338|NCT00640562|3653405|FG001|Overall Study|Low study drug dose|1
2073339|NCT00640562|3653404|FG000|Overall Study|Glycosylated Hemoglobin >8|1
2073340|NCT00640562|3653405|FG001|Overall Study|Glycosylated Hemoglobin >8|0
2073341|NCT00640601|3653411|FG000|Overall Study|Adverse Event|43
2073342|NCT00640601|3653411|FG000|Overall Study|Withdrawal by Subject|20
2073343|NCT00640601|3653411|FG000|Overall Study|Protocol Violation|6
2073344|NCT00640601|3653411|FG000|Overall Study|Lack of Efficacy|16
2073345|NCT00640601|3653411|FG000|Overall Study|Lost to Follow-up|9
2073346|NCT00640601|3653411|FG000|Overall Study|Physician Decision|8
2073347|NCT00640601|3653411|FG000|Overall Study|treatment naive, combination therapy|10
2073348|NCT00640614|3653417|FG000|Overall Study|Lost to Follow-up|1
2073349|NCT00640614|3653418|FG001|Overall Study|Lost to Follow-up|0
2073350|NCT00640835|3653483|FG000|Overall Study|Adverse Event|5
2073351|NCT00640835|3653484|FG001|Overall Study|Adverse Event|3
2073352|NCT00640835|3653483|FG000|Overall Study|Withdrawal by Subject|12
2073353|NCT00640835|3653484|FG001|Overall Study|Withdrawal by Subject|14
2073354|NCT00640835|3653483|FG000|Overall Study|Physician Decision|10
2073355|NCT00640835|3653484|FG001|Overall Study|Physician Decision|14
2073356|NCT00640835|3653483|FG000|Overall Study|Sponsor's Decision|11
2073357|NCT00640835|3653484|FG001|Overall Study|Sponsor's Decision|7
2073358|NCT00640835|3653483|FG000|Overall Study|Protocol Violation|2
2073359|NCT00640835|3653484|FG001|Overall Study|Protocol Violation|2
2073360|NCT00640835|3653483|FG000|Overall Study|Lost to Follow-up|17
2073361|NCT00640835|3653484|FG001|Overall Study|Lost to Follow-up|13
2073362|NCT00640835|3653483|FG000|Overall Study|Other Reason|19
2073363|NCT00640835|3653484|FG001|Overall Study|Other Reason|4
2073364|NCT00640926|3653493|FG000|Overall Study|Adverse Event|2
2073365|NCT00640926|3653494|FG001|Overall Study|Adverse Event|3
2073366|NCT00640926|3653495|FG002|Overall Study|Adverse Event|2
2073367|NCT00640926|3653493|FG000|Overall Study|Lack of Efficacy|0
2073368|NCT00640926|3653494|FG001|Overall Study|Lack of Efficacy|2
2073369|NCT00640926|3653495|FG002|Overall Study|Lack of Efficacy|1
2073370|NCT00640926|3653493|FG000|Overall Study|Protocol Violation|2
2073371|NCT00640926|3653494|FG001|Overall Study|Protocol Violation|0
2073372|NCT00640926|3653495|FG002|Overall Study|Protocol Violation|2
2073373|NCT00640926|3653493|FG000|Overall Study|Lost to Follow-up|3
2073374|NCT00640926|3653494|FG001|Overall Study|Lost to Follow-up|1
2073375|NCT00640926|3653495|FG002|Overall Study|Lost to Follow-up|2
2073376|NCT00640926|3653493|FG000|Overall Study|Withdrawal by Subject|1
2210500|NCT01650805|3850066|FG000|Overall Study|Withdrawal by Subject|1
2210501|NCT01650805|3850067|FG001|Overall Study|Withdrawal by Subject|0
2073377|NCT00640926|3653494|FG001|Overall Study|Withdrawal by Subject|0
2073378|NCT00640926|3653495|FG002|Overall Study|Withdrawal by Subject|1
2073379|NCT00641043|3653509|FG000|Overall Study|Adverse Event|6
2073380|NCT00641043|3653510|FG001|Overall Study|Adverse Event|4
2073381|NCT00641043|3653509|FG000|Overall Study|Protocol Violation|2
2073382|NCT00641043|3653510|FG001|Overall Study|Protocol Violation|3
2073383|NCT00641043|3653509|FG000|Overall Study|Lost to Follow-up|3
2073384|NCT00641043|3653510|FG001|Overall Study|Lost to Follow-up|2
2073385|NCT00641043|3653509|FG000|Overall Study|Withdrawal by Subject|4
2073386|NCT00641043|3653510|FG001|Overall Study|Withdrawal by Subject|4
2073387|NCT00641043|3653509|FG000|Overall Study|Other incl. lack of efficacy|4
2073388|NCT00641043|3653510|FG001|Overall Study|Other incl. lack of efficacy|2
2073389|NCT00641056|3653518|FG000|Overall Study|Adverse Event|12
2073390|NCT00641056|3653519|FG001|Overall Study|Adverse Event|2
2073391|NCT00641056|3653518|FG000|Overall Study|Lost to Follow-up|2
2073392|NCT00641056|3653519|FG001|Overall Study|Lost to Follow-up|1
2073393|NCT00641056|3653518|FG000|Overall Study|Physician Decision|3
2073394|NCT00641056|3653519|FG001|Overall Study|Physician Decision|1
2073395|NCT00641056|3653518|FG000|Overall Study|Protocol Violation|2
2073396|NCT00641056|3653519|FG001|Overall Study|Protocol Violation|0
2073397|NCT00641056|3653518|FG000|Overall Study|Entry Criteria Not Met|3
2073398|NCT00641056|3653519|FG001|Overall Study|Entry Criteria Not Met|0
2073399|NCT00641056|3653518|FG000|Overall Study|Subject Decision|6
2073400|NCT00641056|3653519|FG001|Overall Study|Subject Decision|19
2073401|NCT00641056|3653518|FG000|Overall Study|Sponsor Decision|1
2073402|NCT00641056|3653519|FG001|Overall Study|Sponsor Decision|2
2073403|NCT00641147|3653531|FG000|Completed 4 Months.|Physician Decision|1
2073404|NCT00641147|3653532|FG001|Completed 4 Months.|Physician Decision|0
2073405|NCT00641147|3653531|FG000|Completed 4 Months.|Adverse Event|1
2073406|NCT00641147|3653532|FG001|Completed 4 Months.|Adverse Event|0
2073407|NCT00641147|3653531|FG000|Completed 8 Months.|Physician Decision|2
2073408|NCT00641147|3653532|FG001|Completed 8 Months.|Physician Decision|1
2073409|NCT00641147|3653531|FG000|Completed 8 Months.|non compliance|1
2073410|NCT00641147|3653532|FG001|Completed 8 Months.|non compliance|0
2073411|NCT00641147|3653531|FG000|Completed 8 Months.|Withdrawal by Subject|0
2073412|NCT00641147|3653532|FG001|Completed 8 Months.|Withdrawal by Subject|1
2073413|NCT00641147|3653531|FG000|Completed 12 Months.|Physician Decision|1
2073414|NCT00641147|3653532|FG001|Completed 12 Months.|Physician Decision|1
2073415|NCT00641147|3653531|FG000|Completed 12 Months.|Withdrawal by Subject|0
2073416|NCT00641147|3653532|FG001|Completed 12 Months.|Withdrawal by Subject|1
2073417|NCT00641147|3653531|FG000|Completed 16 Months.|Physician Decision|1
2073418|NCT00641147|3653532|FG001|Completed 16 Months.|Physician Decision|0
2073419|NCT00641147|3653531|FG000|Completed 16 Months.|Lost to Follow-up|1
2073420|NCT00641147|3653532|FG001|Completed 16 Months.|Lost to Follow-up|0
2073421|NCT00641667|3653553|FG000|Overall Study|Withdrawal by Subject|1
2073422|NCT00641667|3653553|FG000|Overall Study|Adverse Event|1
2073423|NCT00641667|3653553|FG000|Overall Study|Physician Decision|1
2073424|NCT00641667|3653553|FG000|Overall Study|Worsening of underlying disease|3
2073425|NCT00641706|3653559|FG000|Overall Study|Adverse Event|2
2073426|NCT00641706|3653560|FG001|Overall Study|Adverse Event|1
2073427|NCT00641706|3653559|FG000|Overall Study|Withdrawal by Subject|6
2073428|NCT00641706|3653560|FG001|Overall Study|Withdrawal by Subject|1
2073429|NCT00641706|3653559|FG000|Overall Study|Clinical Decline|1
2073430|NCT00641706|3653560|FG001|Overall Study|Clinical Decline|0
2073431|NCT00641706|3653559|FG000|Overall Study|Lead Investigator Decision|0
2073432|NCT00641706|3653560|FG001|Overall Study|Lead Investigator Decision|1
2073433|NCT00641719|3653568|FG000|Overall Study|Lack of Efficacy|1
2073434|NCT00641719|3653569|FG001|Overall Study|Lack of Efficacy|2
2073435|NCT00641719|3653568|FG000|Overall Study|Adverse Event|24
2073436|NCT00641719|3653569|FG001|Overall Study|Adverse Event|29
2073437|NCT00641719|3653568|FG000|Overall Study|Withdrawal by Subject|4
2073438|NCT00641719|3653569|FG001|Overall Study|Withdrawal by Subject|4
2073439|NCT00641719|3653568|FG000|Overall Study|Reason Not Specified|1
2073440|NCT00641719|3653569|FG001|Overall Study|Reason Not Specified|2
2073441|NCT00642018|3653604|FG000|Overall Study|Adverse Event|11
2073442|NCT00642018|3653605|FG001|Overall Study|Adverse Event|36
2073443|NCT00642018|3653604|FG000|Overall Study|Withdrawal by Subject|4
2073444|NCT00642018|3653605|FG001|Overall Study|Withdrawal by Subject|10
2073445|NCT00642018|3653604|FG000|Overall Study|Progressive Disease|13
2073446|NCT00642018|3653605|FG001|Overall Study|Progressive Disease|18
2073447|NCT00642018|3653604|FG000|Overall Study|Physician Decision|0
2073448|NCT00642018|3653605|FG001|Overall Study|Physician Decision|10
2073449|NCT00642018|3653604|FG000|Overall Study|Protocol Violation|0
2073450|NCT00642018|3653605|FG001|Overall Study|Protocol Violation|1
2073451|NCT00642018|3653604|FG000|Overall Study|Death|0
2073452|NCT00642018|3653605|FG001|Overall Study|Death|3
2073453|NCT00642018|3653604|FG000|Overall Study|Entry Criteria Not Met|0
2073454|NCT00642018|3653605|FG001|Overall Study|Entry Criteria Not Met|1
2073455|NCT00642174|3653614|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0
2073456|NCT00642174|3653615|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1
2073457|NCT00642278|3653628|FG000|Overall Study|Adverse Event|2
2073458|NCT00642278|3653629|FG001|Overall Study|Adverse Event|1
2073459|NCT00642278|3653630|FG002|Overall Study|Adverse Event|3
2073460|NCT00642278|3653631|FG003|Overall Study|Adverse Event|1
2073461|NCT00642278|3653632|FG004|Overall Study|Adverse Event|2
2073462|NCT00642278|3653633|FG005|Overall Study|Adverse Event|2
2073463|NCT00642278|3653634|FG006|Overall Study|Adverse Event|0
2073464|NCT00642278|3653628|FG000|Overall Study|Lack of Efficacy|0
2073465|NCT00642278|3653629|FG001|Overall Study|Lack of Efficacy|1
2073466|NCT00642278|3653630|FG002|Overall Study|Lack of Efficacy|0
2073467|NCT00642278|3653631|FG003|Overall Study|Lack of Efficacy|0
2073468|NCT00642278|3653632|FG004|Overall Study|Lack of Efficacy|0
2073469|NCT00642278|3653633|FG005|Overall Study|Lack of Efficacy|0
2073470|NCT00642278|3653634|FG006|Overall Study|Lack of Efficacy|0
2177182|NCT01371747|3801216|FG000|Overall Study|Non-Compliance|3
2177183|NCT01371747|3801217|FG001|Overall Study|Non-Compliance|4
2177184|NCT01371747|3801218|FG002|Overall Study|Non-Compliance|3
2177185|NCT01371747|3801219|FG003|Overall Study|Non-Compliance|0
2177186|NCT01371747|3801220|FG004|Overall Study|Non-Compliance|0
2177187|NCT01371747|3801221|FG005|Overall Study|Non-Compliance|1
2177188|NCT01371747|3801216|FG000|Overall Study|Physician Decision|0
2177189|NCT01371747|3801217|FG001|Overall Study|Physician Decision|0
2177190|NCT01371747|3801218|FG002|Overall Study|Physician Decision|0
2177191|NCT01371747|3801219|FG003|Overall Study|Physician Decision|0
2177192|NCT01371747|3801220|FG004|Overall Study|Physician Decision|1
2177193|NCT01371747|3801221|FG005|Overall Study|Physician Decision|0
2177194|NCT01371747|3801216|FG000|Overall Study|Withdrawal by Subject|6
2177195|NCT01371747|3801217|FG001|Overall Study|Withdrawal by Subject|12
2177196|NCT01371747|3801218|FG002|Overall Study|Withdrawal by Subject|5
2177197|NCT01371747|3801219|FG003|Overall Study|Withdrawal by Subject|2
2177198|NCT01371747|3801220|FG004|Overall Study|Withdrawal by Subject|2
2177199|NCT01371747|3801221|FG005|Overall Study|Withdrawal by Subject|4
2177200|NCT01371747|3801216|FG000|Overall Study|Other Reasons|2
2177201|NCT01371747|3801217|FG001|Overall Study|Other Reasons|1
2177202|NCT01371747|3801218|FG002|Overall Study|Other Reasons|2
2177203|NCT01371747|3801219|FG003|Overall Study|Other Reasons|0
2177204|NCT01371747|3801220|FG004|Overall Study|Other Reasons|0
2177205|NCT01371747|3801221|FG005|Overall Study|Other Reasons|1
2177206|NCT01371825|3801245|FG000|Overall Study|Death|4
2177207|NCT01371838|3801251|FG000|Overall Study|Withdrawal by Subject|27
2177208|NCT01371838|3801252|FG001|Overall Study|Withdrawal by Subject|33
2177209|NCT01371838|3801251|FG000|Overall Study|Lost to Follow-up|10
2177210|NCT01371838|3801252|FG001|Overall Study|Lost to Follow-up|20
2177211|NCT01371838|3801251|FG000|Overall Study|Death|3
2177212|NCT01371838|3801252|FG001|Overall Study|Death|4
2177213|NCT01371838|3801251|FG000|Overall Study|Protocol Violation|3
2177214|NCT01371838|3801252|FG001|Overall Study|Protocol Violation|0
2177215|NCT01371838|3801251|FG000|Overall Study|Investigator Decision|3
2177216|NCT01371838|3801252|FG001|Overall Study|Investigator Decision|8
2177217|NCT01371838|3801251|FG000|Overall Study|Last follow-up visit not conducted|2
2177218|NCT01371838|3801252|FG001|Overall Study|Last follow-up visit not conducted|0
2177219|NCT01371838|3801251|FG000|Overall Study|Lack of therapeutic response|0
2177220|NCT01371838|3801252|FG001|Overall Study|Lack of therapeutic response|1
2177221|NCT01371838|3801251|FG000|Overall Study|Surgery|1
2177222|NCT01371838|3801252|FG001|Overall Study|Surgery|0
2177223|NCT01371851|3801260|FG000|Overall Study|Lost to Follow-up|5
2177224|NCT01371851|3801261|FG001|Overall Study|Lost to Follow-up|8
2177225|NCT01371851|3801260|FG000|Overall Study|was arrested and put in jail|0
2177226|NCT01371851|3801261|FG001|Overall Study|was arrested and put in jail|1
2177227|NCT01371851|3801260|FG000|Overall Study|non study related adverse event|1
2073471|NCT00642278|3653628|FG000|Overall Study|Lost to Follow-up|5
2073472|NCT00642278|3653629|FG001|Overall Study|Lost to Follow-up|1
2073473|NCT00642278|3653630|FG002|Overall Study|Lost to Follow-up|0
2073474|NCT00642278|3653631|FG003|Overall Study|Lost to Follow-up|1
2073475|NCT00642278|3653632|FG004|Overall Study|Lost to Follow-up|0
2210502|NCT01650831|3850073|FG000|Overall Study|Screen failure|1
2210503|NCT01651000|3850092|FG000|Overall Study|Adverse Event|2
2210504|NCT01651000|3850093|FG001|Overall Study|Adverse Event|8
2210505|NCT01651000|3850092|FG000|Overall Study|Lost to Follow-up|3
2210506|NCT01651000|3850093|FG001|Overall Study|Lost to Follow-up|2
2073476|NCT00642278|3653633|FG005|Overall Study|Lost to Follow-up|1
2073477|NCT00642278|3653634|FG006|Overall Study|Lost to Follow-up|1
2073478|NCT00642278|3653628|FG000|Overall Study|Physician Decision|0
2073479|NCT00642278|3653629|FG001|Overall Study|Physician Decision|0
2073480|NCT00642278|3653630|FG002|Overall Study|Physician Decision|0
2073481|NCT00642278|3653631|FG003|Overall Study|Physician Decision|1
2073482|NCT00642278|3653632|FG004|Overall Study|Physician Decision|0
2073483|NCT00642278|3653633|FG005|Overall Study|Physician Decision|0
2073484|NCT00642278|3653634|FG006|Overall Study|Physician Decision|0
2073485|NCT00642278|3653628|FG000|Overall Study|Protocol Violation|0
2073486|NCT00642278|3653629|FG001|Overall Study|Protocol Violation|0
2073487|NCT00642278|3653630|FG002|Overall Study|Protocol Violation|1
2073488|NCT00642278|3653631|FG003|Overall Study|Protocol Violation|1
2073489|NCT00642278|3653632|FG004|Overall Study|Protocol Violation|0
2073490|NCT00642278|3653633|FG005|Overall Study|Protocol Violation|1
2073491|NCT00642278|3653634|FG006|Overall Study|Protocol Violation|2
2073492|NCT00642278|3653628|FG000|Overall Study|Withdrawal by Subject|1
2073493|NCT00642278|3653629|FG001|Overall Study|Withdrawal by Subject|1
2073494|NCT00642278|3653630|FG002|Overall Study|Withdrawal by Subject|1
2073495|NCT00642278|3653631|FG003|Overall Study|Withdrawal by Subject|3
2073496|NCT00642278|3653632|FG004|Overall Study|Withdrawal by Subject|6
2073497|NCT00642278|3653633|FG005|Overall Study|Withdrawal by Subject|2
2073498|NCT00642278|3653634|FG006|Overall Study|Withdrawal by Subject|2
2073499|NCT00642278|3653628|FG000|Overall Study|Noncompliance with study drug regimen|0
2073500|NCT00642278|3653629|FG001|Overall Study|Noncompliance with study drug regimen|0
2073501|NCT00642278|3653630|FG002|Overall Study|Noncompliance with study drug regimen|0
2073502|NCT00642278|3653631|FG003|Overall Study|Noncompliance with study drug regimen|1
2073503|NCT00642278|3653632|FG004|Overall Study|Noncompliance with study drug regimen|0
2073504|NCT00642278|3653633|FG005|Overall Study|Noncompliance with study drug regimen|0
2073505|NCT00642278|3653634|FG006|Overall Study|Noncompliance with study drug regimen|0
2073506|NCT00642278|3653628|FG000|Overall Study|Other|2
2073507|NCT00642278|3653629|FG001|Overall Study|Other|1
2073508|NCT00642278|3653630|FG002|Overall Study|Other|0
2073509|NCT00642278|3653631|FG003|Overall Study|Other|1
2073510|NCT00642278|3653632|FG004|Overall Study|Other|0
2073511|NCT00642278|3653633|FG005|Overall Study|Other|1
2073512|NCT00642278|3653634|FG006|Overall Study|Other|0
2073513|NCT00642304|3653650|FG000|Overall Study|Adverse Event|1
2073514|NCT00642304|3653650|FG000|Overall Study|Death|1
2073515|NCT00642304|3653650|FG000|Overall Study|Blood transfusion|2
2073516|NCT00642304|3653650|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1
2073517|NCT00642304|3653650|FG000|Overall Study|Transplantation|1
2073518|NCT00642356|3653656|FG000|Overall Study|Adverse Event|1
2073519|NCT00642356|3653657|FG001|Overall Study|Adverse Event|0
2073520|NCT00642356|3653656|FG000|Overall Study|Protocol Violation|0
2073521|NCT00642356|3653657|FG001|Overall Study|Protocol Violation|3
2073522|NCT00642356|3653656|FG000|Overall Study|Lack of Efficacy|1
2073523|NCT00642356|3653657|FG001|Overall Study|Lack of Efficacy|0
2073524|NCT00642369|3653665|FG000|Overall Study|Adverse Event|2
2073525|NCT00642369|3653666|FG001|Overall Study|Adverse Event|3
2073526|NCT00642369|3653665|FG000|Overall Study|Withdrawal by Subject|1
2073527|NCT00642369|3653666|FG001|Overall Study|Withdrawal by Subject|0
2073528|NCT00642369|3653665|FG000|Overall Study|misdiagnosis|0
2073529|NCT00642369|3653666|FG001|Overall Study|misdiagnosis|1
2073530|NCT00642369|3653665|FG000|Overall Study|Lack of Efficacy|2
2073531|NCT00642369|3653666|FG001|Overall Study|Lack of Efficacy|2
2073532|NCT00642460|3653676|FG000|Part I: 12 Week Double-Blind|Adverse Event|0
2073533|NCT00642460|3653677|FG001|Part I: 12 Week Double-Blind|Adverse Event|1
2073534|NCT00642460|3653678|FG002|Part I: 12 Week Double-Blind|Adverse Event|1
2073535|NCT00642460|3653679|FG003|Part I: 12 Week Double-Blind|Adverse Event|0
2073536|NCT00642460|3653680|FG004|Part I: 12 Week Double-Blind|Adverse Event|0
2073537|NCT00642460|3653681|FG005|Part I: 12 Week Double-Blind|Adverse Event|0
2073538|NCT00642460|3653676|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1
2073539|NCT00642460|3653677|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0
2073540|NCT00642460|3653678|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0
2073541|NCT00642460|3653679|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0
2073542|NCT00642460|3653680|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0
2073543|NCT00642460|3653681|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0
2073544|NCT00642460|3653676|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4
2073545|NCT00642460|3653677|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2
2073546|NCT00642460|3653678|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0
2073547|NCT00642460|3653679|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0
2073548|NCT00642460|3653680|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0
2073549|NCT00642460|3653681|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0
2210507|NCT01651000|3850092|FG000|Overall Study|Protocol Violation|0
2210508|NCT01651000|3850093|FG001|Overall Study|Protocol Violation|3
2073550|NCT00642460|3653676|FG000|Part II: Open-Label Up to Week 92|Death|0
2073551|NCT00642460|3653677|FG001|Part II: Open-Label Up to Week 92|Death|1
2073552|NCT00642460|3653678|FG002|Part II: Open-Label Up to Week 92|Death|0
2073553|NCT00642460|3653679|FG003|Part II: Open-Label Up to Week 92|Death|2
2073554|NCT00642460|3653680|FG004|Part II: Open-Label Up to Week 92|Death|0
2073555|NCT00642460|3653681|FG005|Part II: Open-Label Up to Week 92|Death|0
2073556|NCT00642460|3653676|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
2073557|NCT00642460|3653677|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
2073558|NCT00642460|3653678|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
2073559|NCT00642460|3653679|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
2073560|NCT00642460|3653680|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
2073561|NCT00642460|3653681|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
2210509|NCT01651000|3850092|FG000|Overall Study|Withdrawal by Subject|2
2210510|NCT01651000|3850093|FG001|Overall Study|Withdrawal by Subject|10
2210511|NCT01651000|3850092|FG000|Overall Study|Subject noncompliance|0
2073562|NCT00642460|3653676|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3
2073563|NCT00642460|3653677|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1
2073564|NCT00642460|3653678|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0
2073565|NCT00642460|3653679|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0
2073566|NCT00642460|3653680|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0
2073567|NCT00642460|3653681|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0
2073568|NCT00642460|3653676|FG000|Part II: Open-Label Up to Week 92|Failure to return|0
2073569|NCT00642460|3653677|FG001|Part II: Open-Label Up to Week 92|Failure to return|1
2073570|NCT00642460|3653678|FG002|Part II: Open-Label Up to Week 92|Failure to return|0
2073571|NCT00642460|3653679|FG003|Part II: Open-Label Up to Week 92|Failure to return|0
2073572|NCT00642460|3653680|FG004|Part II: Open-Label Up to Week 92|Failure to return|0
2073573|NCT00642460|3653681|FG005|Part II: Open-Label Up to Week 92|Failure to return|0
2073574|NCT00642460|3653676|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0
2073575|NCT00642460|3653677|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0
2073576|NCT00642460|3653678|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0
2073577|NCT00642460|3653679|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1
2073578|NCT00642460|3653680|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0
2073579|NCT00642460|3653681|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0
2073580|NCT00642460|3653676|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0
2073581|NCT00642460|3653677|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0
2073582|NCT00642460|3653678|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0
2073583|NCT00642460|3653679|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0
2073584|NCT00642460|3653680|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7
2073585|NCT00642460|3653681|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6
2073586|NCT00642460|3653676|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
2073587|NCT00642460|3653677|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
2073588|NCT00642460|3653678|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
2073589|NCT00642460|3653679|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
2073590|NCT00642460|3653680|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
2073591|NCT00642460|3653681|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
2073592|NCT00642460|3653676|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
2073593|NCT00642460|3653677|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
2073594|NCT00642460|3653678|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
2073595|NCT00642460|3653679|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
2073596|NCT00642460|3653680|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
2073597|NCT00642460|3653681|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
2073598|NCT00642460|3653676|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
2073599|NCT00642460|3653677|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
2073600|NCT00642460|3653678|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
2073601|NCT00642460|3653679|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
2073602|NCT00642460|3653680|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
2073603|NCT00642460|3653681|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
2073604|NCT00642460|3653676|FG000|Part III: Open-Label Up to Week 260|Other|0
2073605|NCT00642460|3653677|FG001|Part III: Open-Label Up to Week 260|Other|0
2073606|NCT00642460|3653678|FG002|Part III: Open-Label Up to Week 260|Other|0
2073607|NCT00642460|3653679|FG003|Part III: Open-Label Up to Week 260|Other|0
2073608|NCT00642460|3653680|FG004|Part III: Open-Label Up to Week 260|Other|2
2073609|NCT00642460|3653681|FG005|Part III: Open-Label Up to Week 260|Other|2
2073610|NCT00642460|3653676|FG000|Part III: Open-Label Up to Week 260|Death|0
2073611|NCT00642460|3653677|FG001|Part III: Open-Label Up to Week 260|Death|0
2073612|NCT00642460|3653678|FG002|Part III: Open-Label Up to Week 260|Death|0
2073613|NCT00642460|3653679|FG003|Part III: Open-Label Up to Week 260|Death|0
2073614|NCT00642460|3653680|FG004|Part III: Open-Label Up to Week 260|Death|0
2073615|NCT00642460|3653681|FG005|Part III: Open-Label Up to Week 260|Death|3
2073616|NCT00642460|3653676|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0
2106512|NCT00866320|3699639|FG000|Overall Study|Death|2
2073617|NCT00642460|3653677|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0
2073618|NCT00642460|3653678|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0
2073619|NCT00642460|3653679|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0
2073620|NCT00642460|3653680|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0
2073621|NCT00642460|3653681|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1
2073622|NCT00642460|3653676|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0
2073623|NCT00642460|3653677|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0
2073624|NCT00642460|3653678|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0
2177228|NCT01371851|3801261|FG001|Overall Study|non study related adverse event|0
2177229|NCT01371851|3801260|FG000|Overall Study|Blood Pressure outside study parameters|2
2177230|NCT01371851|3801261|FG001|Overall Study|Blood Pressure outside study parameters|0
2177231|NCT01371877|3801269|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0
2177232|NCT01371877|3801270|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4
2177233|NCT01371994|3801278|FG000|Overall Study|Adverse Event|3
2177234|NCT01371994|3801279|FG001|Overall Study|Adverse Event|6
2177235|NCT01371994|3801278|FG000|Overall Study|Lack of Efficacy|3
2177236|NCT01371994|3801279|FG001|Overall Study|Lack of Efficacy|0
2177237|NCT01371994|3801278|FG000|Overall Study|Withdrawal by Subject|13
2073625|NCT00642460|3653679|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0
2073626|NCT00642460|3653680|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8
2073627|NCT00642460|3653681|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3
2073628|NCT00642473|3653693|FG000|Overall Study|Withdrawal by Subject|0
2073629|NCT00642473|3653694|FG001|Overall Study|Withdrawal by Subject|5
2073630|NCT00642473|3653693|FG000|Overall Study|Progression or death|2
2073631|NCT00642473|3653694|FG001|Overall Study|Progression or death|4
2073632|NCT00642473|3653693|FG000|Overall Study|Other|2
2073633|NCT00642473|3653694|FG001|Overall Study|Other|2
2073634|NCT00642616|3653707|FG000|Overall Study|Adverse Event|2
2073635|NCT00642616|3653708|FG001|Overall Study|Adverse Event|0
2073636|NCT00642616|3653709|FG002|Overall Study|Adverse Event|1
2073637|NCT00642616|3653710|FG003|Overall Study|Adverse Event|0
2073638|NCT00642616|3653707|FG000|Overall Study|Study Terminated by Sponsor|7
2073639|NCT00642616|3653708|FG001|Overall Study|Study Terminated by Sponsor|6
2073640|NCT00642616|3653709|FG002|Overall Study|Study Terminated by Sponsor|4
2073641|NCT00642616|3653710|FG003|Overall Study|Study Terminated by Sponsor|5
2073642|NCT00642616|3653707|FG000|Overall Study|Withdrawal by Subject|0
2073643|NCT00642616|3653708|FG001|Overall Study|Withdrawal by Subject|1
2073644|NCT00642616|3653709|FG002|Overall Study|Withdrawal by Subject|1
2073645|NCT00642616|3653710|FG003|Overall Study|Withdrawal by Subject|1
2073646|NCT00642616|3653707|FG000|Overall Study|Protocol Violation|0
2073647|NCT00642616|3653708|FG001|Overall Study|Protocol Violation|0
2073648|NCT00642616|3653709|FG002|Overall Study|Protocol Violation|2
2073649|NCT00642616|3653710|FG003|Overall Study|Protocol Violation|0
2073650|NCT00642616|3653707|FG000|Overall Study|Physician Decision|0
2073651|NCT00642616|3653708|FG001|Overall Study|Physician Decision|0
2073652|NCT00642616|3653709|FG002|Overall Study|Physician Decision|1
2073653|NCT00642616|3653710|FG003|Overall Study|Physician Decision|1
2073654|NCT00642642|3653722|FG000|Treatment & Follow Up|Adverse Event|2
2073655|NCT00642642|3653722|FG000|Treatment & Follow Up|Withdrawal by Subject|5
2073656|NCT00642642|3653722|FG000|Treatment & Follow Up|Lost to Follow-up|10
2073657|NCT00642668|3653732|FG000|Overall Study|Lost to Follow-up|1
2073658|NCT00642668|3653732|FG000|Overall Study|Adverse Event|2
2073659|NCT00642668|3653732|FG000|Overall Study|Death|2
2073660|NCT00642668|3653732|FG000|Overall Study|Insufficient Therapeutic Response|1
2073661|NCT00642668|3653732|FG000|Overall Study|Failure to Return|1
2073662|NCT00642668|3653732|FG000|Overall Study|Dialysis Initiation|5
2073663|NCT00642668|3653732|FG000|Overall Study|Blood Transfusion|2
2073664|NCT00642707|3653749|FG000|Overall Study|Adverse Event|0
2073665|NCT00642707|3653750|FG001|Overall Study|Adverse Event|0
2073666|NCT00642707|3653751|FG002|Overall Study|Adverse Event|0
2073667|NCT00642707|3653752|FG003|Overall Study|Adverse Event|2
2073668|NCT00642707|3653749|FG000|Overall Study|Withdrawal by Subject|1
2073669|NCT00642707|3653750|FG001|Overall Study|Withdrawal by Subject|0
2073670|NCT00642707|3653751|FG002|Overall Study|Withdrawal by Subject|0
2073671|NCT00642707|3653752|FG003|Overall Study|Withdrawal by Subject|0
2073672|NCT00642746|3653764|FG000|Overall Study|Patient unevaluable|1
2073673|NCT00642746|3653765|FG001|Overall Study|Patient unevaluable|0
2073674|NCT00642759|3653771|FG000|Overall Study|Protocol Violation|1
2073675|NCT00642772|3653776|FG000|Overall Study|Lost to Follow-up|3
2073676|NCT00642772|3653776|FG000|Overall Study|Withdrawal by Subject|7
2073677|NCT00642811|3653786|FG000|Overall Study|Adverse Event|2
2073678|NCT00642811|3653787|FG001|Overall Study|Adverse Event|3
2073679|NCT00642811|3653788|FG002|Overall Study|Adverse Event|0
2073680|NCT00642811|3653789|FG003|Overall Study|Adverse Event|0
2073681|NCT00642811|3653790|FG004|Overall Study|Adverse Event|0
2073682|NCT00642811|3653791|FG005|Overall Study|Adverse Event|1
2073683|NCT00642811|3653786|FG000|Overall Study|Developement of discontinuation criteria|0
2073684|NCT00642811|3653787|FG001|Overall Study|Developement of discontinuation criteria|0
2073685|NCT00642811|3653788|FG002|Overall Study|Developement of discontinuation criteria|0
2073686|NCT00642811|3653789|FG003|Overall Study|Developement of discontinuation criteria|0
2177238|NCT01371994|3801279|FG001|Overall Study|Withdrawal by Subject|7
2073687|NCT00642811|3653790|FG004|Overall Study|Developement of discontinuation criteria|1
2073688|NCT00642811|3653791|FG005|Overall Study|Developement of discontinuation criteria|0
2073689|NCT00642811|3653786|FG000|Overall Study|Severe Non-compliance to protocol|1
2073690|NCT00642811|3653787|FG001|Overall Study|Severe Non-compliance to protocol|0
2073691|NCT00642811|3653788|FG002|Overall Study|Severe Non-compliance to protocol|0
2073692|NCT00642811|3653789|FG003|Overall Study|Severe Non-compliance to protocol|0
2073693|NCT00642811|3653790|FG004|Overall Study|Severe Non-compliance to protocol|0
2073694|NCT00642811|3653791|FG005|Overall Study|Severe Non-compliance to protocol|0
2073695|NCT00642811|3653786|FG000|Overall Study|Other|0
2073696|NCT00642811|3653787|FG001|Overall Study|Other|1
2073697|NCT00642811|3653788|FG002|Overall Study|Other|0
2073698|NCT00642811|3653789|FG003|Overall Study|Other|1
2073699|NCT00642811|3653790|FG004|Overall Study|Other|0
2073700|NCT00642811|3653791|FG005|Overall Study|Other|0
2073701|NCT00642850|3653805|FG000|Overall Study|Death|7
2073702|NCT00642850|3653805|FG000|Overall Study|Adverse Event|2
2073703|NCT00642850|3653805|FG000|Overall Study|Lack of Efficacy|1
2073704|NCT00642850|3653805|FG000|Overall Study|Protocol Violation|2
2073705|NCT00642850|3653805|FG000|Overall Study|Kidney transplantation|8
2073706|NCT00642850|3653805|FG000|Overall Study|Blood transfusion|6
2177239|NCT01371994|3801278|FG000|Overall Study|Lost to Follow-up|1
2177240|NCT01371994|3801279|FG001|Overall Study|Lost to Follow-up|1
2073707|NCT00642850|3653805|FG000|Overall Study|Other reasons|7
2073708|NCT00642902|3653813|FG000|Overall Study|Adverse Event|0
2073709|NCT00642902|3653814|FG001|Overall Study|Adverse Event|1
2073710|NCT00642902|3653815|FG002|Overall Study|Adverse Event|3
2073711|NCT00642902|3653816|FG003|Overall Study|Adverse Event|1
2073712|NCT00642902|3653813|FG000|Overall Study|Lost to Follow-up|1
2073713|NCT00642902|3653814|FG001|Overall Study|Lost to Follow-up|1
2073714|NCT00642902|3653815|FG002|Overall Study|Lost to Follow-up|0
2073715|NCT00642902|3653816|FG003|Overall Study|Lost to Follow-up|0
2073716|NCT00642902|3653813|FG000|Overall Study|Lack of Efficacy|0
2073717|NCT00642902|3653814|FG001|Overall Study|Lack of Efficacy|3
2073718|NCT00642902|3653815|FG002|Overall Study|Lack of Efficacy|3
2073719|NCT00642902|3653816|FG003|Overall Study|Lack of Efficacy|0
2073720|NCT00642902|3653813|FG000|Overall Study|Death|1
2073721|NCT00642902|3653814|FG001|Overall Study|Death|0
2073722|NCT00642902|3653815|FG002|Overall Study|Death|0
2073723|NCT00642902|3653816|FG003|Overall Study|Death|0
2073724|NCT00642902|3653813|FG000|Overall Study|Premature termination of clinical trial|37
2073725|NCT00642902|3653814|FG001|Overall Study|Premature termination of clinical trial|32
2073726|NCT00642902|3653815|FG002|Overall Study|Premature termination of clinical trial|35
2073727|NCT00642902|3653816|FG003|Overall Study|Premature termination of clinical trial|35
2073728|NCT00642902|3653813|FG000|Overall Study|Randomized, but not treated|0
2073729|NCT00642902|3653814|FG001|Overall Study|Randomized, but not treated|0
2073730|NCT00642902|3653815|FG002|Overall Study|Randomized, but not treated|1
2073731|NCT00642902|3653816|FG003|Overall Study|Randomized, but not treated|0
2073732|NCT00642902|3653813|FG000|Overall Study|Other|1
2073733|NCT00642902|3653814|FG001|Overall Study|Other|5
2073734|NCT00642902|3653815|FG002|Overall Study|Other|1
2073735|NCT00642902|3653816|FG003|Overall Study|Other|4
2073736|NCT00642941|3653838|FG000|Overall Study|Physician Decision|3
2073737|NCT00642941|3653839|FG001|Overall Study|Physician Decision|1
2073738|NCT00642941|3653840|FG002|Overall Study|Physician Decision|0
2073739|NCT00642941|3653841|FG003|Overall Study|Physician Decision|0
2073740|NCT00642941|3653842|FG004|Overall Study|Physician Decision|0
2073741|NCT00642941|3653843|FG005|Overall Study|Physician Decision|0
2073742|NCT00642941|3653844|FG006|Overall Study|Physician Decision|1
2073743|NCT00642941|3653845|FG007|Overall Study|Physician Decision|0
2073744|NCT00642941|3653846|FG008|Overall Study|Physician Decision|0
2073745|NCT00642941|3653847|FG009|Overall Study|Physician Decision|1
2073746|NCT00642941|3653848|FG010|Overall Study|Physician Decision|0
2073747|NCT00642941|3653849|FG011|Overall Study|Physician Decision|1
2073748|NCT00642941|3653838|FG000|Overall Study|Death|4
2073749|NCT00642941|3653839|FG001|Overall Study|Death|0
2073750|NCT00642941|3653840|FG002|Overall Study|Death|1
2073751|NCT00642941|3653841|FG003|Overall Study|Death|1
2073752|NCT00642941|3653842|FG004|Overall Study|Death|2
2073753|NCT00642941|3653843|FG005|Overall Study|Death|1
2073754|NCT00642941|3653844|FG006|Overall Study|Death|0
2073755|NCT00642941|3653845|FG007|Overall Study|Death|0
2073756|NCT00642941|3653846|FG008|Overall Study|Death|0
2073757|NCT00642941|3653847|FG009|Overall Study|Death|0
2073758|NCT00642941|3653848|FG010|Overall Study|Death|0
2073759|NCT00642941|3653849|FG011|Overall Study|Death|1
2073760|NCT00642941|3653838|FG000|Overall Study|Study closed by Sponsor|0
2073761|NCT00642941|3653839|FG001|Overall Study|Study closed by Sponsor|1
2073762|NCT00642941|3653840|FG002|Overall Study|Study closed by Sponsor|0
2073763|NCT00642941|3653841|FG003|Overall Study|Study closed by Sponsor|0
2073764|NCT00642941|3653842|FG004|Overall Study|Study closed by Sponsor|0
2073765|NCT00642941|3653843|FG005|Overall Study|Study closed by Sponsor|0
2073766|NCT00642941|3653844|FG006|Overall Study|Study closed by Sponsor|0
2073767|NCT00642941|3653845|FG007|Overall Study|Study closed by Sponsor|0
2073768|NCT00642941|3653846|FG008|Overall Study|Study closed by Sponsor|0
2177241|NCT01371994|3801278|FG000|Overall Study|Protocol Violation|24
2073769|NCT00642941|3653847|FG009|Overall Study|Study closed by Sponsor|0
2073770|NCT00642941|3653848|FG010|Overall Study|Study closed by Sponsor|0
2073771|NCT00642941|3653849|FG011|Overall Study|Study closed by Sponsor|0
2073772|NCT00642941|3653838|FG000|Overall Study|Withdrawal by Subject|1
2073773|NCT00642941|3653839|FG001|Overall Study|Withdrawal by Subject|0
2073774|NCT00642941|3653840|FG002|Overall Study|Withdrawal by Subject|0
2073775|NCT00642941|3653841|FG003|Overall Study|Withdrawal by Subject|2
2073776|NCT00642941|3653842|FG004|Overall Study|Withdrawal by Subject|0
2073777|NCT00642941|3653843|FG005|Overall Study|Withdrawal by Subject|0
2073778|NCT00642941|3653844|FG006|Overall Study|Withdrawal by Subject|2
2073779|NCT00642941|3653845|FG007|Overall Study|Withdrawal by Subject|0
2073780|NCT00642941|3653846|FG008|Overall Study|Withdrawal by Subject|1
2073781|NCT00642941|3653847|FG009|Overall Study|Withdrawal by Subject|0
2073782|NCT00642941|3653848|FG010|Overall Study|Withdrawal by Subject|0
2073783|NCT00642941|3653849|FG011|Overall Study|Withdrawal by Subject|1
2073784|NCT00642941|3653838|FG000|Overall Study|Protocol Violation|0
2073785|NCT00642941|3653839|FG001|Overall Study|Protocol Violation|0
2073786|NCT00642941|3653840|FG002|Overall Study|Protocol Violation|0
2073787|NCT00642941|3653841|FG003|Overall Study|Protocol Violation|0
2073788|NCT00642941|3653842|FG004|Overall Study|Protocol Violation|0
2073789|NCT00642941|3653843|FG005|Overall Study|Protocol Violation|0
2073790|NCT00642941|3653844|FG006|Overall Study|Protocol Violation|1
2073791|NCT00642941|3653845|FG007|Overall Study|Protocol Violation|0
2073792|NCT00642941|3653846|FG008|Overall Study|Protocol Violation|0
2073793|NCT00642941|3653847|FG009|Overall Study|Protocol Violation|0
2073794|NCT00642941|3653848|FG010|Overall Study|Protocol Violation|0
2073795|NCT00642941|3653849|FG011|Overall Study|Protocol Violation|0
2073796|NCT00642941|3653838|FG000|Overall Study|Adverse Event|1
2073797|NCT00642941|3653839|FG001|Overall Study|Adverse Event|1
2073798|NCT00642941|3653840|FG002|Overall Study|Adverse Event|0
2073799|NCT00642941|3653841|FG003|Overall Study|Adverse Event|0
2073800|NCT00642941|3653842|FG004|Overall Study|Adverse Event|0
2073801|NCT00642941|3653843|FG005|Overall Study|Adverse Event|0
2073802|NCT00642941|3653844|FG006|Overall Study|Adverse Event|1
2073803|NCT00642941|3653845|FG007|Overall Study|Adverse Event|1
2073804|NCT00642941|3653846|FG008|Overall Study|Adverse Event|0
2073805|NCT00642941|3653847|FG009|Overall Study|Adverse Event|1
2073806|NCT00642941|3653848|FG010|Overall Study|Adverse Event|0
2073807|NCT00642941|3653849|FG011|Overall Study|Adverse Event|0
2073808|NCT00642941|3653838|FG000|Overall Study|Other|1
2073809|NCT00642941|3653839|FG001|Overall Study|Other|1
2073810|NCT00642941|3653840|FG002|Overall Study|Other|1
2073811|NCT00642941|3653841|FG003|Overall Study|Other|1
2073812|NCT00642941|3653842|FG004|Overall Study|Other|0
2073813|NCT00642941|3653843|FG005|Overall Study|Other|1
2073814|NCT00642941|3653844|FG006|Overall Study|Other|0
2073815|NCT00642941|3653845|FG007|Overall Study|Other|1
2073816|NCT00642941|3653846|FG008|Overall Study|Other|0
2073817|NCT00642941|3653847|FG009|Overall Study|Other|0
2073818|NCT00642941|3653848|FG010|Overall Study|Other|0
2073819|NCT00642941|3653849|FG011|Overall Study|Other|1
2073820|NCT00642941|3653838|FG000|Overall Study|Disease progression|60
2073821|NCT00642941|3653839|FG001|Overall Study|Disease progression|50
2073822|NCT00642941|3653840|FG002|Overall Study|Disease progression|5
2073823|NCT00642941|3653841|FG003|Overall Study|Disease progression|36
2073824|NCT00642941|3653842|FG004|Overall Study|Disease progression|23
2073825|NCT00642941|3653843|FG005|Overall Study|Disease progression|39
2073826|NCT00642941|3653844|FG006|Overall Study|Disease progression|18
2073827|NCT00642941|3653845|FG007|Overall Study|Disease progression|12
2073828|NCT00642941|3653846|FG008|Overall Study|Disease progression|10
2073829|NCT00642941|3653847|FG009|Overall Study|Disease progression|7
2073830|NCT00642941|3653848|FG010|Overall Study|Disease progression|12
2073831|NCT00642941|3653849|FG011|Overall Study|Disease progression|7
2073832|NCT00642954|3653901|FG000|Overall Study|Progressive Disease|3
2073833|NCT00642954|3653902|FG001|Overall Study|Progressive Disease|3
2073834|NCT00642954|3653903|FG002|Overall Study|Progressive Disease|3
2073835|NCT00642954|3653904|FG003|Overall Study|Progressive Disease|3
2073836|NCT00642954|3653905|FG004|Overall Study|Progressive Disease|9
2073837|NCT00642954|3653901|FG000|Overall Study|Withdrawal by Subject|0
2073838|NCT00642954|3653902|FG001|Overall Study|Withdrawal by Subject|0
2073839|NCT00642954|3653903|FG002|Overall Study|Withdrawal by Subject|0
2073840|NCT00642954|3653904|FG003|Overall Study|Withdrawal by Subject|0
2073841|NCT00642954|3653905|FG004|Overall Study|Withdrawal by Subject|1
2073842|NCT00642954|3653901|FG000|Overall Study|Adverse Event|1
2073843|NCT00642954|3653902|FG001|Overall Study|Adverse Event|1
2073844|NCT00642954|3653903|FG002|Overall Study|Adverse Event|0
2073845|NCT00642954|3653904|FG003|Overall Study|Adverse Event|0
2073846|NCT00642954|3653905|FG004|Overall Study|Adverse Event|6
2073847|NCT00642993|3653919|FG000|Overall Study|Adverse Event|85
2073848|NCT00642993|3653920|FG001|Overall Study|Adverse Event|4
2073849|NCT00642993|3653919|FG000|Overall Study|Lost to Follow-up|8
2073850|NCT00642993|3653920|FG001|Overall Study|Lost to Follow-up|4
2073851|NCT00642993|3653919|FG000|Overall Study|Withdrew - reason unrelated to treatment|11
2073852|NCT00642993|3653920|FG001|Overall Study|Withdrew - reason unrelated to treatment|3
2073853|NCT00642993|3653919|FG000|Overall Study|Protocol Violation|1
2073854|NCT00642993|3653920|FG001|Overall Study|Protocol Violation|4
2073855|NCT00642993|3653919|FG000|Overall Study|Did not meet protocol eligibility|0
2073856|NCT00642993|3653920|FG001|Overall Study|Did not meet protocol eligibility|1
2073857|NCT00642993|3653919|FG000|Overall Study|Administrative|1
2073858|NCT00642993|3653920|FG001|Overall Study|Administrative|0
2073859|NCT00643006|3653928|FG000|Overall Study|Lost to Follow-up|5
2073860|NCT00643006|3653929|FG001|Overall Study|Lost to Follow-up|4
2073861|NCT00643123|3653952|FG000|Overall Study|Lost to Follow-up|4
2073862|NCT00643123|3653953|FG001|Overall Study|Lost to Follow-up|0
2073863|NCT00643123|3653952|FG000|Overall Study|Withdrawal by Subject|1
2073864|NCT00643123|3653953|FG001|Overall Study|Withdrawal by Subject|1
2073865|NCT00643162|3653961|FG000|Overall Study|Withdrawal by Subject|1
2073866|NCT00643162|3653962|FG001|Overall Study|Withdrawal by Subject|1
2073867|NCT00643201|3653970|FG000|Randomized, Completed 6 Months of Study|Death|20
2073868|NCT00643201|3653971|FG001|Randomized, Completed 6 Months of Study|Death|26
2073869|NCT00643201|3653970|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150
2073870|NCT00643201|3653971|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182
2073871|NCT00643201|3653970|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
2073872|NCT00643201|3653971|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
2073873|NCT00643201|3653970|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
2073874|NCT00643201|3653971|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
2073875|NCT00643201|3653970|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
2073876|NCT00643201|3653971|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
2073877|NCT00643201|3653970|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3
2073878|NCT00643201|3653971|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2
2073879|NCT00643201|3653970|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
2073880|NCT00643201|3653971|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
2073881|NCT00643201|3653970|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1
2073882|NCT00643201|3653971|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1
2073883|NCT00643201|3653970|FG000|Randomized, Completed 6 Months of Study|Other|107
2073884|NCT00643201|3653971|FG001|Randomized, Completed 6 Months of Study|Other|107
2073885|NCT00643201|3653970|FG000|Completed Study Follow Up|Death|28
2073886|NCT00643201|3653971|FG001|Completed Study Follow Up|Death|34
2073887|NCT00643201|3653970|FG000|Completed Study Follow Up|Withdrawal by Subject|23
2073888|NCT00643201|3653971|FG001|Completed Study Follow Up|Withdrawal by Subject|29
2073889|NCT00643201|3653970|FG000|Completed Study Follow Up|Lost to Follow-up|18
2073890|NCT00643201|3653971|FG001|Completed Study Follow Up|Lost to Follow-up|16
2073891|NCT00643201|3653970|FG000|Completed Study Follow Up|non-specified|1
2073892|NCT00643201|3653971|FG001|Completed Study Follow Up|non-specified|0
2073893|NCT00643279|3653981|FG000|Overall Study|Death|13
2073894|NCT00643279|3653982|FG001|Overall Study|Death|11
2073895|NCT00643279|3653981|FG000|Overall Study|Withdrawal by Subject|3
2073896|NCT00643279|3653982|FG001|Overall Study|Withdrawal by Subject|0
2073897|NCT00643279|3653981|FG000|Overall Study|Lost to Follow-up|0
2073898|NCT00643279|3653982|FG001|Overall Study|Lost to Follow-up|1
2073899|NCT00643279|3653981|FG000|Overall Study|Physician Decision|0
2073900|NCT00643279|3653982|FG001|Overall Study|Physician Decision|1
2073901|NCT00643448|3653993|FG000|Overall Study|Lack of Efficacy|2
2073902|NCT00643448|3653994|FG001|Overall Study|Lack of Efficacy|0
2073903|NCT00643448|3653995|FG002|Overall Study|Lack of Efficacy|4
2073904|NCT00643448|3653993|FG000|Overall Study|Adverse Event|2
2073905|NCT00643448|3653994|FG001|Overall Study|Adverse Event|2
2073906|NCT00643448|3653995|FG002|Overall Study|Adverse Event|2
2073907|NCT00643448|3653993|FG000|Overall Study|QTcF>550 ms|0
2073908|NCT00643448|3653994|FG001|Overall Study|QTcF>550 ms|3
2073909|NCT00643448|3653995|FG002|Overall Study|QTcF>550 ms|0
2073910|NCT00643487|3654005|FG000|Overall Study|Technical difficulty|3
2073911|NCT00643565|3654011|FG000|Overall Study|Death|12
2073912|NCT00643565|3654012|FG001|Overall Study|Death|11
2073913|NCT00643565|3654011|FG000|Overall Study|Withdrawal by Subject|4
2073914|NCT00643565|3654012|FG001|Overall Study|Withdrawal by Subject|1
2073915|NCT00643565|3654011|FG000|Overall Study|Lost to Follow-up|0
2073916|NCT00643565|3654012|FG001|Overall Study|Lost to Follow-up|6
2073917|NCT00643565|3654011|FG000|Overall Study|Other|7
2073918|NCT00643565|3654012|FG001|Overall Study|Other|8
2073919|NCT00643565|3654011|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0
2073920|NCT00643565|3654012|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1
2073921|NCT00643565|3654011|FG000|Overall Study|Recurrence of Disease|2
2073922|NCT00643565|3654012|FG001|Overall Study|Recurrence of Disease|1
2073923|NCT00643565|3654011|FG000|Overall Study|Progression of Disease|18
2073924|NCT00643565|3654012|FG001|Overall Study|Progression of Disease|14
2073925|NCT00643565|3654011|FG000|Overall Study|Protocol Violation|3
2073926|NCT00643565|3654012|FG001|Overall Study|Protocol Violation|0
2073927|NCT00643565|3654011|FG000|Overall Study|Did Not Cooperate|0
2073928|NCT00643565|3654012|FG001|Overall Study|Did Not Cooperate|1
2073929|NCT00643565|3654011|FG000|Overall Study|Administrative|22
2073930|NCT00643565|3654012|FG001|Overall Study|Administrative|16
2073931|NCT00643565|3654011|FG000|Overall Study|Adverse Event|5
2073932|NCT00643565|3654012|FG001|Overall Study|Adverse Event|8
2073933|NCT00643604|3654028|FG000|Overall Study|Death|1
2073934|NCT00643682|3654034|FG000|Overall Study|did not keep appointment|522
2073935|NCT00643682|3654035|FG001|Overall Study|did not keep appointment|509
2073936|NCT00643760|3654046|FG000|Overall Study|Adverse Event|11
2073937|NCT00643760|3654047|FG001|Overall Study|Adverse Event|5
2073938|NCT00643760|3654048|FG002|Overall Study|Adverse Event|12
2073939|NCT00643760|3654049|FG003|Overall Study|Adverse Event|21
2073940|NCT00643760|3654050|FG004|Overall Study|Adverse Event|6
2073941|NCT00643760|3654046|FG000|Overall Study|Lack of Efficacy|3
2073942|NCT00643760|3654047|FG001|Overall Study|Lack of Efficacy|1
2073943|NCT00643760|3654048|FG002|Overall Study|Lack of Efficacy|0
2073944|NCT00643760|3654049|FG003|Overall Study|Lack of Efficacy|4
2073945|NCT00643760|3654050|FG004|Overall Study|Lack of Efficacy|3
2073946|NCT00643760|3654046|FG000|Overall Study|Protocol Violation|7
2073947|NCT00643760|3654047|FG001|Overall Study|Protocol Violation|6
2073948|NCT00643760|3654048|FG002|Overall Study|Protocol Violation|4
2073949|NCT00643760|3654049|FG003|Overall Study|Protocol Violation|4
2073950|NCT00643760|3654050|FG004|Overall Study|Protocol Violation|6
2073951|NCT00643760|3654046|FG000|Overall Study|Lost to Follow-up|6
2073952|NCT00643760|3654047|FG001|Overall Study|Lost to Follow-up|2
2073953|NCT00643760|3654048|FG002|Overall Study|Lost to Follow-up|1
2073954|NCT00643760|3654049|FG003|Overall Study|Lost to Follow-up|3
2073955|NCT00643760|3654050|FG004|Overall Study|Lost to Follow-up|3
2073956|NCT00643760|3654046|FG000|Overall Study|Investigator Discretion|0
2073957|NCT00643760|3654047|FG001|Overall Study|Investigator Discretion|0
2073958|NCT00643760|3654048|FG002|Overall Study|Investigator Discretion|0
2073959|NCT00643760|3654049|FG003|Overall Study|Investigator Discretion|2
2073960|NCT00643760|3654050|FG004|Overall Study|Investigator Discretion|0
2073961|NCT00643760|3654046|FG000|Overall Study|Withdrawal by Subject|3
2073962|NCT00643760|3654047|FG001|Overall Study|Withdrawal by Subject|1
2073963|NCT00643760|3654048|FG002|Overall Study|Withdrawal by Subject|2
2073964|NCT00643760|3654049|FG003|Overall Study|Withdrawal by Subject|4
2073965|NCT00643760|3654050|FG004|Overall Study|Withdrawal by Subject|1
2073966|NCT00643851|3654065|FG000|Overall Study|Death|0
2073967|NCT00643851|3654066|FG001|Overall Study|Death|1
2073968|NCT00643851|3654067|FG002|Overall Study|Death|0
2073969|NCT00643851|3654065|FG000|Overall Study|Lack of Efficacy|0
2073970|NCT00643851|3654066|FG001|Overall Study|Lack of Efficacy|1
2073971|NCT00643851|3654067|FG002|Overall Study|Lack of Efficacy|0
2073972|NCT00643851|3654065|FG000|Overall Study|Adverse Event|2
2073973|NCT00643851|3654066|FG001|Overall Study|Adverse Event|6
2073974|NCT00643851|3654067|FG002|Overall Study|Adverse Event|6
2073975|NCT00643851|3654065|FG000|Overall Study|Lost to Follow-up|4
2073976|NCT00643851|3654066|FG001|Overall Study|Lost to Follow-up|6
2073977|NCT00643851|3654067|FG002|Overall Study|Lost to Follow-up|9
2073978|NCT00643851|3654065|FG000|Overall Study|Withdrawal by Subject|8
2073979|NCT00643851|3654066|FG001|Overall Study|Withdrawal by Subject|15
2073980|NCT00643851|3654067|FG002|Overall Study|Withdrawal by Subject|9
2073981|NCT00643851|3654065|FG000|Overall Study|Non-compl., not met criteria, etc.|3
2073982|NCT00643851|3654066|FG001|Overall Study|Non-compl., not met criteria, etc.|4
2073983|NCT00643851|3654067|FG002|Overall Study|Non-compl., not met criteria, etc.|6
2073984|NCT00643916|3654086|FG000|Overall Study|Protocol Violation|0
2073985|NCT00643916|3654087|FG001|Overall Study|Protocol Violation|1
2073986|NCT00643916|3654088|FG002|Overall Study|Protocol Violation|1
2073987|NCT00643916|3654089|FG003|Overall Study|Protocol Violation|1
2073988|NCT00643916|3654090|FG004|Overall Study|Protocol Violation|0
2073989|NCT00643916|3654091|FG005|Overall Study|Protocol Violation|0
2073990|NCT00643916|3654086|FG000|Overall Study|Lost to Follow-up|0
2073991|NCT00643916|3654087|FG001|Overall Study|Lost to Follow-up|1
2073992|NCT00643916|3654088|FG002|Overall Study|Lost to Follow-up|0
2073993|NCT00643916|3654089|FG003|Overall Study|Lost to Follow-up|0
2073994|NCT00643916|3654090|FG004|Overall Study|Lost to Follow-up|0
2073995|NCT00643916|3654091|FG005|Overall Study|Lost to Follow-up|0
2073996|NCT00643916|3654086|FG000|Overall Study|Withdrawal by Subject|2
2073997|NCT00643916|3654087|FG001|Overall Study|Withdrawal by Subject|2
2073998|NCT00643916|3654088|FG002|Overall Study|Withdrawal by Subject|2
2073999|NCT00643916|3654089|FG003|Overall Study|Withdrawal by Subject|1
2074000|NCT00643916|3654090|FG004|Overall Study|Withdrawal by Subject|0
2074001|NCT00643916|3654091|FG005|Overall Study|Withdrawal by Subject|1
2074002|NCT00643916|3654086|FG000|Overall Study|Not Vaccinated|2
2074003|NCT00643916|3654087|FG001|Overall Study|Not Vaccinated|2
2304248|NCT02650466|4004097|FG000|Overall Study|Withdrawal by Subject|5
2304249|NCT02650466|4004097|FG000|Overall Study|Lost to Follow-up|1
2304250|NCT02650895|4004118|FG000|Overall Study|Withdrawal by Subject|0
2304251|NCT02650895|4004119|FG001|Overall Study|Withdrawal by Subject|1
2074004|NCT00643916|3654088|FG002|Overall Study|Not Vaccinated|3
2074005|NCT00643916|3654089|FG003|Overall Study|Not Vaccinated|0
2074006|NCT00643916|3654090|FG004|Overall Study|Not Vaccinated|2
2074007|NCT00643916|3654091|FG005|Overall Study|Not Vaccinated|0
2106513|NCT00866333|3699648|FG000|Overall Study|Withdrawal of consent|0
2106514|NCT00866333|3699649|FG001|Overall Study|Withdrawal of consent|1
2106515|NCT00866333|3699650|FG002|Overall Study|Withdrawal of consent|2
2106516|NCT00866333|3699648|FG000|Overall Study|Reason not Specified|3
2106517|NCT00866333|3699649|FG001|Overall Study|Reason not Specified|1
2106518|NCT00866333|3699650|FG002|Overall Study|Reason not Specified|1
2106519|NCT00866333|3699648|FG000|Overall Study|Study Terminated by Sponsor|2
2106520|NCT00866333|3699649|FG001|Overall Study|Study Terminated by Sponsor|5
2106521|NCT00866333|3699650|FG002|Overall Study|Study Terminated by Sponsor|9
2106522|NCT00866359|3699660|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5
2106523|NCT00866359|3699661|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4
2074008|NCT00644059|3654108|FG000|Overall Study|Lost to Follow-up|37
2074009|NCT00644059|3654109|FG001|Overall Study|Lost to Follow-up|34
2074010|NCT00644059|3654110|FG002|Overall Study|Lost to Follow-up|16
2074011|NCT00644059|3654108|FG000|Overall Study|Withdrawal by Subject|52
2074012|NCT00644059|3654109|FG001|Overall Study|Withdrawal by Subject|60
2074013|NCT00644059|3654110|FG002|Overall Study|Withdrawal by Subject|30
2074014|NCT00644059|3654108|FG000|Overall Study|Adverse Event|8
2074015|NCT00644059|3654109|FG001|Overall Study|Adverse Event|5
2074016|NCT00644059|3654110|FG002|Overall Study|Adverse Event|1
2074017|NCT00644059|3654108|FG000|Overall Study|Inappropriate Enrollment|1
2074018|NCT00644059|3654109|FG001|Overall Study|Inappropriate Enrollment|3
2074019|NCT00644059|3654110|FG002|Overall Study|Inappropriate Enrollment|0
2074020|NCT00644059|3654108|FG000|Overall Study|Protocol Deviation/violation|20
2074021|NCT00644059|3654109|FG001|Overall Study|Protocol Deviation/violation|19
2074022|NCT00644059|3654110|FG002|Overall Study|Protocol Deviation/violation|15
2074023|NCT00644059|3654108|FG000|Overall Study|Unable to classify|6
2074024|NCT00644059|3654109|FG001|Overall Study|Unable to classify|2
2074025|NCT00644059|3654110|FG002|Overall Study|Unable to classify|3
2074026|NCT00644228|3654170|FG000|Randomization & Eligibility|Ineligible|31
2074027|NCT00644228|3654171|FG001|Randomization & Eligibility|Ineligible|21
2074028|NCT00644228|3654170|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
2074029|NCT00644228|3654171|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
2074030|NCT00644228|3654170|FG000|Randomization & Eligibility|Invalid Consent|0
2074031|NCT00644228|3654171|FG001|Randomization & Eligibility|Invalid Consent|1
2074032|NCT00644228|3654170|FG000|Induction Therapy|Adverse Event|22
2074033|NCT00644228|3654171|FG001|Induction Therapy|Adverse Event|55
2074034|NCT00644228|3654170|FG000|Induction Therapy|Withdrawal by Subject|10
2074035|NCT00644228|3654171|FG001|Induction Therapy|Withdrawal by Subject|3
2074036|NCT00644228|3654170|FG000|Induction Therapy|Progression/Relapse|24
2074037|NCT00644228|3654171|FG001|Induction Therapy|Progression/Relapse|12
2074038|NCT00644228|3654170|FG000|Induction Therapy|Death|3
2074039|NCT00644228|3654171|FG001|Induction Therapy|Death|7
2074040|NCT00644228|3654170|FG000|Induction Therapy|Not Protocol-Specified|24
2074041|NCT00644228|3654171|FG001|Induction Therapy|Not Protocol-Specified|28
2074042|NCT00644228|3654170|FG000|Maintenance|Adverse Event|27
2074043|NCT00644228|3654171|FG001|Maintenance|Adverse Event|31
2074044|NCT00644228|3654170|FG000|Maintenance|Withdrawal by Subject|6
2074045|NCT00644228|3654171|FG001|Maintenance|Withdrawal by Subject|4
2074046|NCT00644228|3654170|FG000|Maintenance|Progression/Relapse|67
2074047|NCT00644228|3654171|FG001|Maintenance|Progression/Relapse|42
2074048|NCT00644228|3654170|FG000|Maintenance|Death|3
2074049|NCT00644228|3654171|FG001|Maintenance|Death|3
2074050|NCT00644228|3654170|FG000|Maintenance|Not Protocol-Specified|14
2074051|NCT00644228|3654171|FG001|Maintenance|Not Protocol-Specified|15
2074052|NCT00644228|3654170|FG000|Maintenance|On Treatment|26
2074053|NCT00644228|3654171|FG001|Maintenance|On Treatment|40
2074054|NCT00644332|3654186|FG000|Overall Study|Adverse Event|11
2074055|NCT00644332|3654186|FG000|Overall Study|Withdrawal by Subject|6
2074056|NCT00644332|3654186|FG000|Overall Study|Completion Status Unknown|2
2074057|NCT00644332|3654186|FG000|Overall Study|Did Not Meet Eligibility Requirements|1
2074058|NCT00644332|3654186|FG000|Overall Study|Could Not Attend Scheduled Visits|1
2074059|NCT00644358|3654190|FG000|Overall Study|Adverse Event|124
2074060|NCT00644358|3654190|FG000|Overall Study|Lost to Follow-up|105
2074061|NCT00644358|3654190|FG000|Overall Study|Consent Withdrawal|64
2074062|NCT00644358|3654190|FG000|Overall Study|Lack of Effectiveness|39
2074063|NCT00644358|3654190|FG000|Overall Study|Protocol Violation|5
2074064|NCT00644358|3654190|FG000|Overall Study|Noncompliance|14
2074065|NCT00644358|3654190|FG000|Overall Study|Other Unspecified|11
2074066|NCT00644423|3654196|FG000|Overall Study|Lost to Follow-up|1
2074067|NCT00644423|3654197|FG001|Overall Study|Lost to Follow-up|1
2074068|NCT00644787|3654216|FG000|Period 1: Titration Phase|Adverse Event|11
2074069|NCT00644787|3654217|FG001|Period 1: Titration Phase|Adverse Event|0
2074070|NCT00644787|3654218|FG002|Period 1: Titration Phase|Adverse Event|0
2074071|NCT00644787|3654216|FG000|Period 1: Titration Phase|Withdrawal by Subject|2
2074072|NCT00644787|3654217|FG001|Period 1: Titration Phase|Withdrawal by Subject|0
2074073|NCT00644787|3654218|FG002|Period 1: Titration Phase|Withdrawal by Subject|0
2074074|NCT00644787|3654216|FG000|Period 1: Titration Phase|Physician Decision|1
2074075|NCT00644787|3654217|FG001|Period 1: Titration Phase|Physician Decision|0
2074076|NCT00644787|3654218|FG002|Period 1: Titration Phase|Physician Decision|0
2074077|NCT00644787|3654216|FG000|Period 1: Titration Phase|Worsening of underlying disease|5
2074078|NCT00644787|3654217|FG001|Period 1: Titration Phase|Worsening of underlying disease|0
2074079|NCT00644787|3654218|FG002|Period 1: Titration Phase|Worsening of underlying disease|0
2074080|NCT00644787|3654216|FG000|Period 1: Titration Phase|Worsening of complications|1
2074081|NCT00644787|3654217|FG001|Period 1: Titration Phase|Worsening of complications|0
2074082|NCT00644787|3654218|FG002|Period 1: Titration Phase|Worsening of complications|0
2074083|NCT00644787|3654216|FG000|Period 1: Titration Phase|Worsening of symptoms|1
2074084|NCT00644787|3654217|FG001|Period 1: Titration Phase|Worsening of symptoms|0
2074085|NCT00644787|3654218|FG002|Period 1: Titration Phase|Worsening of symptoms|0
2074086|NCT00644787|3654216|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
2074087|NCT00644787|3654217|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
2108194|NCT00878722|3702055|FG006|Overall Study|Death|0
2074088|NCT00644787|3654218|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
2074089|NCT00644787|3654216|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3
2074090|NCT00644787|3654217|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0
2074091|NCT00644787|3654218|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0
2074092|NCT00644787|3654216|FG000|Period 2: Double Blind Phase|Adverse Event|0
2074093|NCT00644787|3654217|FG001|Period 2: Double Blind Phase|Adverse Event|2
2074094|NCT00644787|3654218|FG002|Period 2: Double Blind Phase|Adverse Event|4
2074095|NCT00644787|3654216|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0
2074096|NCT00644787|3654217|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1
2074097|NCT00644787|3654218|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0
2074098|NCT00644787|3654216|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0
2074099|NCT00644787|3654217|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6
2074100|NCT00644787|3654218|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2
2074101|NCT00644787|3654216|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0
2074102|NCT00644787|3654217|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0
2074103|NCT00644787|3654218|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1
2074104|NCT00644878|3654226|FG000|Overall Study|Adverse Event|2
2074105|NCT00644878|3654226|FG000|Overall Study|Abnormal laboratory value|3
2074106|NCT00644878|3654226|FG000|Overall Study|Protocol deviation|2
2074107|NCT00644878|3654226|FG000|Overall Study|Treatment duration completed as per protocol|11
2074108|NCT00644917|3654230|FG000|Overall Study|Withdrawal by Subject|2
2074109|NCT00644969|3654240|FG000|Treatment Phase|Randomized, not treated|1
2074110|NCT00644969|3654241|FG001|Treatment Phase|Randomized, not treated|0
2074111|NCT00644969|3654240|FG000|Treatment Phase|Adverse Event|3
2074112|NCT00644969|3654241|FG001|Treatment Phase|Adverse Event|0
2074113|NCT00644969|3654240|FG000|Treatment Phase|Withdrawal by Subject|4
2074114|NCT00644969|3654241|FG001|Treatment Phase|Withdrawal by Subject|0
2074115|NCT00644969|3654240|FG000|Treatment Phase|Lost to Follow-up|2
2074116|NCT00644969|3654241|FG001|Treatment Phase|Lost to Follow-up|2
2074117|NCT00644969|3654240|FG000|Treatment Phase|Other|4
2074118|NCT00644969|3654241|FG001|Treatment Phase|Other|1
2074119|NCT00644969|3654240|FG000|Post Treatment Phase|Death|1
2074120|NCT00644969|3654241|FG001|Post Treatment Phase|Death|0
2074121|NCT00644969|3654240|FG000|Post Treatment Phase|Withdrawal by Subject|4
2074122|NCT00644969|3654241|FG001|Post Treatment Phase|Withdrawal by Subject|2
2074123|NCT00644969|3654240|FG000|Post Treatment Phase|Lost to Follow-up|4
2074124|NCT00644969|3654241|FG001|Post Treatment Phase|Lost to Follow-up|1
2074125|NCT00644969|3654240|FG000|Post Treatment Phase|Other|1
2074126|NCT00644969|3654241|FG001|Post Treatment Phase|Other|0
2074127|NCT00644995|3654249|FG000|Overall Study|Lost to Follow-up|1
2074128|NCT00644995|3654250|FG001|Overall Study|Lost to Follow-up|4
2074129|NCT00644995|3654249|FG000|Overall Study|Refused|1
2074130|NCT00644995|3654250|FG001|Overall Study|Refused|0
2074131|NCT00645099|3654269|FG000|Overall Study|Lack of Efficacy|15
2074132|NCT00645099|3654270|FG001|Overall Study|Lack of Efficacy|6
2074133|NCT00645099|3654269|FG000|Overall Study|Withdrawal by Subject|30
2074134|NCT00645099|3654270|FG001|Overall Study|Withdrawal by Subject|22
2074135|NCT00645099|3654269|FG000|Overall Study|Lost to Follow-up|6
2074136|NCT00645099|3654270|FG001|Overall Study|Lost to Follow-up|4
2074137|NCT00645099|3654269|FG000|Overall Study|Adverse Event|11
2074138|NCT00645099|3654270|FG001|Overall Study|Adverse Event|5
2074139|NCT00645099|3654269|FG000|Overall Study|Other|9
2074140|NCT00645099|3654270|FG001|Overall Study|Other|5
2074141|NCT00645164|3654276|FG000|Overall Study|Lost to Follow-up|2
2074142|NCT00645164|3654276|FG000|Overall Study|Withdrawal by Subject|4
2074143|NCT00645164|3654276|FG000|Overall Study|Protocol Violation|1
2074144|NCT00645411|3654288|FG000|Overall Study|Adverse Event|0
2074145|NCT00645411|3654289|FG001|Overall Study|Adverse Event|0
2074146|NCT00645411|3654290|FG002|Overall Study|Adverse Event|0
2074147|NCT00645411|3654291|FG003|Overall Study|Adverse Event|2
2074148|NCT00645411|3654288|FG000|Overall Study|Withdrawal by Subject|2
2074149|NCT00645411|3654289|FG001|Overall Study|Withdrawal by Subject|1
2074150|NCT00645411|3654290|FG002|Overall Study|Withdrawal by Subject|19
2074151|NCT00645411|3654291|FG003|Overall Study|Withdrawal by Subject|21
2074152|NCT00645411|3654288|FG000|Overall Study|Lost to Follow-up|10
2074153|NCT00645411|3654289|FG001|Overall Study|Lost to Follow-up|5
2074154|NCT00645411|3654290|FG002|Overall Study|Lost to Follow-up|124
2074155|NCT00645411|3654291|FG003|Overall Study|Lost to Follow-up|75
2074156|NCT00645411|3654288|FG000|Overall Study|Protocol Violation|1
2074157|NCT00645411|3654289|FG001|Overall Study|Protocol Violation|0
2074158|NCT00645411|3654290|FG002|Overall Study|Protocol Violation|1
2074159|NCT00645411|3654291|FG003|Overall Study|Protocol Violation|0
2074160|NCT00645411|3654288|FG000|Overall Study|Inappropriate enrollment|0
2074161|NCT00645411|3654289|FG001|Overall Study|Inappropriate enrollment|0
2074162|NCT00645411|3654290|FG002|Overall Study|Inappropriate enrollment|4
2074163|NCT00645411|3654291|FG003|Overall Study|Inappropriate enrollment|1
2074164|NCT00645411|3654288|FG000|Overall Study|Unable to classify|0
2074165|NCT00645411|3654289|FG001|Overall Study|Unable to classify|0
2074166|NCT00645411|3654290|FG002|Overall Study|Unable to classify|3
2074167|NCT00645411|3654291|FG003|Overall Study|Unable to classify|4
2074168|NCT00645528|3654317|FG000|Overall Study|Did not show up for Visit 2|7
2074169|NCT00645593|3654323|FG000|Overall Study|Later found to be ineligible|1
2074170|NCT00645593|3654324|FG001|Overall Study|Later found to be ineligible|0
2074171|NCT00645671|3654332|FG000|Overall Study|Protocol Violation|1
2074172|NCT00645671|3654333|FG001|Overall Study|Protocol Violation|0
2074173|NCT00645671|3654332|FG000|Overall Study|Withdrawal by Subject|0
2074174|NCT00645671|3654333|FG001|Overall Study|Withdrawal by Subject|4
2074175|NCT00645671|3654332|FG000|Overall Study|Adverse Event|0
2074176|NCT00645671|3654333|FG001|Overall Study|Adverse Event|1
2074177|NCT00645671|3654332|FG000|Overall Study|Physician Decision|0
2074178|NCT00645671|3654333|FG001|Overall Study|Physician Decision|1
2074179|NCT00645788|3654363|FG000|Overall Study|Did not receive study drug|1
2074180|NCT00645788|3654364|FG001|Overall Study|Did not receive study drug|1
2074181|NCT00645788|3654365|FG002|Overall Study|Did not receive study drug|0
2074182|NCT00645788|3654366|FG003|Overall Study|Did not receive study drug|0
2074183|NCT00645788|3654363|FG000|Overall Study|Adverse Event|4
2074184|NCT00645788|3654364|FG001|Overall Study|Adverse Event|9
2074185|NCT00645788|3654365|FG002|Overall Study|Adverse Event|5
2074186|NCT00645788|3654366|FG003|Overall Study|Adverse Event|3
2074187|NCT00645788|3654363|FG000|Overall Study|Lost to Follow-up|1
2074188|NCT00645788|3654364|FG001|Overall Study|Lost to Follow-up|0
2074189|NCT00645788|3654365|FG002|Overall Study|Lost to Follow-up|0
2074190|NCT00645788|3654366|FG003|Overall Study|Lost to Follow-up|0
2074191|NCT00645788|3654363|FG000|Overall Study|Protocol Violation|1
2074192|NCT00645788|3654364|FG001|Overall Study|Protocol Violation|0
2074193|NCT00645788|3654365|FG002|Overall Study|Protocol Violation|2
2074194|NCT00645788|3654366|FG003|Overall Study|Protocol Violation|0
2074195|NCT00645788|3654363|FG000|Overall Study|Withdrawal by Subject|0
2074196|NCT00645788|3654364|FG001|Overall Study|Withdrawal by Subject|1
2074197|NCT00645788|3654365|FG002|Overall Study|Withdrawal by Subject|0
2074198|NCT00645788|3654366|FG003|Overall Study|Withdrawal by Subject|2
2074199|NCT00645788|3654363|FG000|Overall Study|Pulmonary exacerbation|13
2074200|NCT00645788|3654364|FG001|Overall Study|Pulmonary exacerbation|16
2074201|NCT00645788|3654365|FG002|Overall Study|Pulmonary exacerbation|11
2074202|NCT00645788|3654366|FG003|Overall Study|Pulmonary exacerbation|9
2074203|NCT00645840|3654385|FG000|Overall Study|Protocol Violation|3
2074204|NCT00645853|3654391|FG000|Overall Study|Adverse Event|18
2074205|NCT00645853|3654392|FG001|Overall Study|Adverse Event|7
2074206|NCT00645853|3654391|FG000|Overall Study|AZ study closure in Hungary|60
2074207|NCT00645853|3654392|FG001|Overall Study|AZ study closure in Hungary|40
2074208|NCT00645853|3654391|FG000|Overall Study|Withdrawal by Subject|5
2074209|NCT00645853|3654392|FG001|Overall Study|Withdrawal by Subject|2
2074210|NCT00645853|3654391|FG000|Overall Study|Protocol Violation|0
2074211|NCT00645853|3654392|FG001|Overall Study|Protocol Violation|2
2074212|NCT00645853|3654391|FG000|Overall Study|Discontinuation criteria|2
2074213|NCT00645853|3654392|FG001|Overall Study|Discontinuation criteria|2
2074214|NCT00645853|3654391|FG000|Overall Study|recall of ICF, planned operation, death|7
2074215|NCT00645853|3654392|FG001|Overall Study|recall of ICF, planned operation, death|4
2074216|NCT00645944|3654400|FG000|Randomized|Withdrawal by Subject|1
2074217|NCT00645944|3654401|FG001|Randomized|Withdrawal by Subject|2
2074218|NCT00645944|3654400|FG000|Received Medication|Adverse Event|2
2074219|NCT00645944|3654401|FG001|Received Medication|Adverse Event|1
2074220|NCT00645944|3654400|FG000|Received Medication|Withdrawal by Subject|1
2074221|NCT00645944|3654401|FG001|Received Medication|Withdrawal by Subject|1
2074222|NCT00645944|3654400|FG000|Received Medication|Lost to Follow-up|1
2074223|NCT00645944|3654401|FG001|Received Medication|Lost to Follow-up|0
2074224|NCT00645944|3654400|FG000|Received Medication|Protocol Violation|2
2074225|NCT00645944|3654401|FG001|Received Medication|Protocol Violation|1
2074226|NCT00646113|3654420|FG000|Overall Study|Lost to Follow-up|5
2074227|NCT00646113|3654420|FG000|Overall Study|Adverse Event|3
2074228|NCT00646399|3654426|FG000|Overall Study|Death|63
2074229|NCT00646399|3654427|FG001|Overall Study|Death|53
2074230|NCT00646399|3654426|FG000|Overall Study|Withdrawal by Subject|9
2074231|NCT00646399|3654427|FG001|Overall Study|Withdrawal by Subject|10
2074232|NCT00646399|3654426|FG000|Overall Study|Other Reason|11
2074233|NCT00646399|3654427|FG001|Overall Study|Other Reason|11
2074234|NCT00646451|3654433|FG000|Overall Study|Adverse Event|3
2074235|NCT00646451|3654434|FG001|Overall Study|Adverse Event|0
2074236|NCT00646451|3654433|FG000|Overall Study|Exacerbation of pre-existing condition|1
2074237|NCT00646451|3654434|FG001|Overall Study|Exacerbation of pre-existing condition|0
2074238|NCT00646776|3654479|FG000|Overall Study|Adverse Event|1
2074239|NCT00646776|3654480|FG001|Overall Study|Adverse Event|9
2074240|NCT00646776|3654479|FG000|Overall Study|Investigator discretion|0
2074241|NCT00646776|3654480|FG001|Overall Study|Investigator discretion|4
2074242|NCT00646906|3654493|FG000|Crossover Period 1|Withdrawal by Subject|1
2074243|NCT00646906|3654494|FG001|Crossover Period 1|Withdrawal by Subject|0
2074244|NCT00646906|3654495|FG002|Crossover Period 1|Withdrawal by Subject|0
2074245|NCT00646906|3654496|FG003|Crossover Period 1|Withdrawal by Subject|0
2074246|NCT00646906|3654497|FG004|Crossover Period 1|Withdrawal by Subject|0
2074247|NCT00646906|3654498|FG005|Crossover Period 1|Withdrawal by Subject|1
2074248|NCT00646906|3654499|FG006|Crossover Period 1|Withdrawal by Subject|0
2074249|NCT00646906|3654493|FG000|Crossover Period 2|Withdrawal by Subject|0
2074250|NCT00646906|3654494|FG001|Crossover Period 2|Withdrawal by Subject|1
2074251|NCT00646906|3654495|FG002|Crossover Period 2|Withdrawal by Subject|2
2074252|NCT00646906|3654496|FG003|Crossover Period 2|Withdrawal by Subject|1
2074253|NCT00646906|3654497|FG004|Crossover Period 2|Withdrawal by Subject|0
2074254|NCT00646906|3654498|FG005|Crossover Period 2|Withdrawal by Subject|0
2074255|NCT00646906|3654499|FG006|Crossover Period 2|Withdrawal by Subject|0
2074256|NCT00646906|3654493|FG000|Crossover Period 2|Physician Decision|0
2074257|NCT00646906|3654494|FG001|Crossover Period 2|Physician Decision|0
2074258|NCT00646906|3654495|FG002|Crossover Period 2|Physician Decision|0
2074259|NCT00646906|3654496|FG003|Crossover Period 2|Physician Decision|0
2074260|NCT00646906|3654497|FG004|Crossover Period 2|Physician Decision|0
2074261|NCT00646906|3654498|FG005|Crossover Period 2|Physician Decision|0
2074262|NCT00646906|3654499|FG006|Crossover Period 2|Physician Decision|1
2074263|NCT00646958|3654515|FG000|Overall Study|Lack of Efficacy|1
2074264|NCT00646958|3654516|FG001|Overall Study|Lack of Efficacy|0
2074265|NCT00646958|3654517|FG002|Overall Study|Lack of Efficacy|0
2074266|NCT00646958|3654515|FG000|Overall Study|Adverse Event|4
2074267|NCT00646958|3654516|FG001|Overall Study|Adverse Event|0
2074268|NCT00646958|3654517|FG002|Overall Study|Adverse Event|0
2074269|NCT00646958|3654515|FG000|Overall Study|Lost to Follow-up|1
2074270|NCT00646958|3654516|FG001|Overall Study|Lost to Follow-up|5
2074271|NCT00646958|3654517|FG002|Overall Study|Lost to Follow-up|7
2074272|NCT00646958|3654515|FG000|Overall Study|Protocol Violation|1
2074273|NCT00646958|3654516|FG001|Overall Study|Protocol Violation|1
2074274|NCT00646958|3654517|FG002|Overall Study|Protocol Violation|0
2074275|NCT00646958|3654515|FG000|Overall Study|Abnormal screening lab tests|1
2074276|NCT00646958|3654516|FG001|Overall Study|Abnormal screening lab tests|1
2074277|NCT00646958|3654517|FG002|Overall Study|Abnormal screening lab tests|0
2074278|NCT00646958|3654515|FG000|Overall Study|Withdrawal by Subject|1
2074279|NCT00646958|3654516|FG001|Overall Study|Withdrawal by Subject|2
2074280|NCT00646958|3654517|FG002|Overall Study|Withdrawal by Subject|0
2074281|NCT00646958|3654515|FG000|Overall Study|Did not receive study drug|2
2074282|NCT00646958|3654516|FG001|Overall Study|Did not receive study drug|0
2074283|NCT00646958|3654517|FG002|Overall Study|Did not receive study drug|2
2074284|NCT00647270|3654528|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
2074285|NCT00647270|3654529|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
2074286|NCT00647270|3654530|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
2074287|NCT00647270|3654528|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
2074288|NCT00647270|3654529|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
2074289|NCT00647270|3654530|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
2074290|NCT00647270|3654528|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
2074291|NCT00647270|3654529|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
2074292|NCT00647270|3654530|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
2074293|NCT00647270|3654528|FG000|Period 1, Placebo-control (12 Weeks)|Other|4
2074294|NCT00647270|3654529|FG001|Period 1, Placebo-control (12 Weeks)|Other|4
2074295|NCT00647270|3654530|FG002|Period 1, Placebo-control (12 Weeks)|Other|8
2074296|NCT00647270|3654528|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
2074297|NCT00647270|3654529|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
2074298|NCT00647270|3654530|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
2074299|NCT00647270|3654528|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
2074300|NCT00647270|3654529|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
2108195|NCT00878722|3702056|FG007|Overall Study|Death|2
2210512|NCT01651000|3850093|FG001|Overall Study|Subject noncompliance|3
2210513|NCT01651000|3850092|FG000|Overall Study|Lack of Efficacy|1
2210514|NCT01651000|3850093|FG001|Overall Study|Lack of Efficacy|1
2210515|NCT01651000|3850092|FG000|Overall Study|Physician Decision|1
2210516|NCT01651000|3850093|FG001|Overall Study|Physician Decision|0
2210517|NCT01651000|3850092|FG000|Overall Study|Administrative reason|1
2210518|NCT01651000|3850093|FG001|Overall Study|Administrative reason|0
2210519|NCT01651000|3850092|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
2210520|NCT01651000|3850093|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
2210521|NCT01651039|3850099|FG000|Overall Study|Non-evaluables|5
2210522|NCT01651039|3850099|FG000|Overall Study|Physician Decision|2
2210523|NCT01651039|3850099|FG000|Overall Study|Withdrawal by Subject|1
2210524|NCT01651039|3850099|FG000|Overall Study|Progressive Disease|22
2210525|NCT01651052|3850103|FG000|Overall Study|Death|21
2210526|NCT01651052|3850103|FG000|Overall Study|Explant|1
2210527|NCT01651052|3850103|FG000|Overall Study|Withdrawal by Subject|1
2210528|NCT01651052|3850103|FG000|Overall Study|Lost to Follow-up|3
2210529|NCT01651117|3850119|FG000|Overall Study|Death|2
2210530|NCT01651117|3850120|FG001|Overall Study|Death|3
2210531|NCT01651117|3850121|FG002|Overall Study|Death|2
2210532|NCT01651117|3850122|FG003|Overall Study|Death|2
2210533|NCT01651208|3850158|FG000|Overall Study|Lost to Follow-up|14
2210534|NCT01651208|3850159|FG001|Overall Study|Lost to Follow-up|16
2210535|NCT01651260|3850166|FG000|Overall Study|unable to apply product|3
2210536|NCT01651780|3850202|FG000|Overall Study|Physician decision: No 30-day visit|2
2210537|NCT01651780|3850203|FG001|Overall Study|Physician decision: No 30-day visit|1
2210538|NCT01651780|3850202|FG000|Overall Study|Reason Not Specified: No 30-day visit|2
2210539|NCT01651780|3850203|FG001|Overall Study|Reason Not Specified: No 30-day visit|2
2210540|NCT01651780|3850202|FG000|Overall Study|Withdrawal by Subject|2
2210541|NCT01651780|3850203|FG001|Overall Study|Withdrawal by Subject|0
2210542|NCT01651780|3850202|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
2210543|NCT01651780|3850203|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2210544|NCT01651780|3850202|FG000|Overall Study|Lost to Follow-up|1
2210545|NCT01651780|3850203|FG001|Overall Study|Lost to Follow-up|2
2210546|NCT01651780|3850202|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1
2210547|NCT01651780|3850203|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5
2210548|NCT01651936|3850254|FG000|Base Study|Adverse Event|3
2210549|NCT01651936|3850255|FG001|Base Study|Adverse Event|0
2210550|NCT01651936|3850256|FG002|Base Study|Adverse Event|0
2210551|NCT01651936|3850254|FG000|Base Study|Withdrawal by Subject|1
2210552|NCT01651936|3850255|FG001|Base Study|Withdrawal by Subject|1
2210553|NCT01651936|3850256|FG002|Base Study|Withdrawal by Subject|0
2210554|NCT01651936|3850254|FG000|Base Study|Early Escape|2
2210555|NCT01651936|3850255|FG001|Base Study|Early Escape|8
2210556|NCT01651936|3850256|FG002|Base Study|Early Escape|0
2210557|NCT01651936|3850254|FG000|Base Study|Study terminated by sponsor|21
2210558|NCT01651936|3850255|FG001|Base Study|Study terminated by sponsor|16
2210559|NCT01651936|3850256|FG002|Base Study|Study terminated by sponsor|0
2210560|NCT01651936|3850254|FG000|Extension Study|Lack of Efficacy|0
2210561|NCT01651936|3850255|FG001|Extension Study|Lack of Efficacy|0
2210562|NCT01651936|3850256|FG002|Extension Study|Lack of Efficacy|1
2210563|NCT01651936|3850254|FG000|Extension Study|Study terminated by sponsor|0
2210564|NCT01651936|3850255|FG001|Extension Study|Study terminated by sponsor|0
2210565|NCT01651936|3850256|FG002|Extension Study|Study terminated by sponsor|13
2210566|NCT01651949|3850266|FG000|Overall Study|Unknown status|4
2210567|NCT01651949|3850267|FG001|Overall Study|Unknown status|4
2210568|NCT01651949|3850268|FG002|Overall Study|Unknown status|0
2210569|NCT01651949|3850266|FG000|Overall Study|Lost to Follow-up|30
2210570|NCT01651949|3850267|FG001|Overall Study|Lost to Follow-up|56
2210571|NCT01651949|3850268|FG002|Overall Study|Lost to Follow-up|20
2210572|NCT01651949|3850266|FG000|Overall Study|Protocol Violation|0
2210573|NCT01651949|3850267|FG001|Overall Study|Protocol Violation|2
2210574|NCT01651949|3850268|FG002|Overall Study|Protocol Violation|1
2210575|NCT01651949|3850266|FG000|Overall Study|Physician Decision|0
2210576|NCT01651949|3850267|FG001|Overall Study|Physician Decision|2
2210577|NCT01651949|3850268|FG002|Overall Study|Physician Decision|0
2210578|NCT01651949|3850266|FG000|Overall Study|Adverse Event|0
2210579|NCT01651949|3850267|FG001|Overall Study|Adverse Event|2
2210580|NCT01651949|3850268|FG002|Overall Study|Adverse Event|1
2210581|NCT01651949|3850266|FG000|Overall Study|Screen failure|2
2210582|NCT01651949|3850267|FG001|Overall Study|Screen failure|2
2210583|NCT01651949|3850268|FG002|Overall Study|Screen failure|0
2210584|NCT01651949|3850266|FG000|Overall Study|Withdrawal by Subject|17
2210585|NCT01651949|3850267|FG001|Overall Study|Withdrawal by Subject|18
2210586|NCT01651949|3850268|FG002|Overall Study|Withdrawal by Subject|9
2210587|NCT01652287|3850297|FG000|Overall Study|Withdrawal by Subject|2
2210588|NCT01652287|3850298|FG001|Overall Study|Withdrawal by Subject|0
2210589|NCT01652469|3850306|FG000|Overall Study|Withdrawal by Subject|1
2210590|NCT01652469|3850307|FG001|Overall Study|Withdrawal by Subject|4
2210591|NCT01652469|3850306|FG000|Overall Study|Lost to Follow-up|0
2210592|NCT01652469|3850307|FG001|Overall Study|Lost to Follow-up|2
2210593|NCT01652573|3850326|FG000|Overall Study|Adverse Event|0
2210594|NCT01652573|3850327|FG001|Overall Study|Adverse Event|1
2210595|NCT01652664|3850335|FG000|Overall Study|Treatment Failure|5
2210596|NCT01652664|3850336|FG001|Overall Study|Treatment Failure|1
2210597|NCT01652664|3850335|FG000|Overall Study|Inadequate IOP control|1
2210598|NCT01652664|3850336|FG001|Overall Study|Inadequate IOP control|0
2210599|NCT01652690|3850345|FG000|Overall Study|Withdrawal by Subject|16
2210600|NCT01652690|3850346|FG001|Overall Study|Withdrawal by Subject|4
2210601|NCT01652690|3850345|FG000|Overall Study|Other|8
2210602|NCT01652690|3850346|FG001|Overall Study|Other|9
2210603|NCT01652690|3850345|FG000|Overall Study|Lost to Follow-up|6
2210604|NCT01652690|3850346|FG001|Overall Study|Lost to Follow-up|6
2210605|NCT01652690|3850345|FG000|Overall Study|Death|5
2210606|NCT01652690|3850346|FG001|Overall Study|Death|2
2210607|NCT01652703|3850358|FG000|Overall Study|Withdrawal by Subject|0
2210608|NCT01652703|3850359|FG001|Overall Study|Withdrawal by Subject|1
2210609|NCT01652703|3850360|FG002|Overall Study|Withdrawal by Subject|3
2210610|NCT01652703|3850361|FG003|Overall Study|Withdrawal by Subject|1
2210611|NCT01652703|3850362|FG004|Overall Study|Withdrawal by Subject|0
2210612|NCT01652703|3850363|FG005|Overall Study|Withdrawal by Subject|1
2210613|NCT01652703|3850358|FG000|Overall Study|Other|0
2210614|NCT01652703|3850359|FG001|Overall Study|Other|0
2210615|NCT01652703|3850360|FG002|Overall Study|Other|0
2210616|NCT01652703|3850361|FG003|Overall Study|Other|1
2210617|NCT01652703|3850362|FG004|Overall Study|Other|1
2210618|NCT01652703|3850363|FG005|Overall Study|Other|1
2210619|NCT01652716|3850379|FG000|Overall Study|Loss of glucose control|1
2210620|NCT01652716|3850380|FG001|Overall Study|Loss of glucose control|0
2210621|NCT01652716|3850379|FG000|Overall Study|Administrative|0
2210622|NCT01652716|3850380|FG001|Overall Study|Administrative|2
2210623|NCT01652716|3850379|FG000|Overall Study|Investigator decision|1
2210624|NCT01652716|3850380|FG001|Overall Study|Investigator decision|4
2210625|NCT01652716|3850379|FG000|Overall Study|Lost to Follow-up|12
2210626|NCT01652716|3850380|FG001|Overall Study|Lost to Follow-up|11
2210627|NCT01652716|3850379|FG000|Overall Study|Protocol Violation|2
2210628|NCT01652716|3850380|FG001|Overall Study|Protocol Violation|1
2210629|NCT01652716|3850379|FG000|Overall Study|Adverse Event|7
2210630|NCT01652716|3850380|FG001|Overall Study|Adverse Event|10
2210631|NCT01652716|3850379|FG000|Overall Study|Withdrawal by Subject|33
2210632|NCT01652716|3850380|FG001|Overall Study|Withdrawal by Subject|18
2210633|NCT01652729|3850389|FG000|Overall Study|Withdrawal by Subject|14
2210634|NCT01652729|3850390|FG001|Overall Study|Withdrawal by Subject|7
2210635|NCT01652729|3850391|FG002|Overall Study|Withdrawal by Subject|7
2210636|NCT01652729|3850389|FG000|Overall Study|Adverse Event|4
2210637|NCT01652729|3850390|FG001|Overall Study|Adverse Event|0
2210638|NCT01652729|3850391|FG002|Overall Study|Adverse Event|3
2210639|NCT01652729|3850389|FG000|Overall Study|Physician Decision|1
2210640|NCT01652729|3850390|FG001|Overall Study|Physician Decision|0
2210641|NCT01652729|3850391|FG002|Overall Study|Physician Decision|1
2210642|NCT01652729|3850389|FG000|Overall Study|Protocol Violation|1
2210643|NCT01652729|3850390|FG001|Overall Study|Protocol Violation|0
2210644|NCT01652729|3850391|FG002|Overall Study|Protocol Violation|0
2210645|NCT01652729|3850389|FG000|Overall Study|Lost to Follow-up|6
2210646|NCT01652729|3850390|FG001|Overall Study|Lost to Follow-up|6
2210647|NCT01652729|3850391|FG002|Overall Study|Lost to Follow-up|3
2210648|NCT01652729|3850389|FG000|Overall Study|Administrative|1
2210649|NCT01652729|3850390|FG001|Overall Study|Administrative|0
2210650|NCT01652729|3850391|FG002|Overall Study|Administrative|0
2210651|NCT01652872|3850401|FG000|Overall Study|Death|36
2210652|NCT01652872|3850402|FG001|Overall Study|Death|39
2210653|NCT01652872|3850401|FG000|Overall Study|Lost to Follow-up|28
2210654|NCT01652872|3850402|FG001|Overall Study|Lost to Follow-up|23
2210655|NCT01652872|3850401|FG000|Overall Study|Decision by sponsor|5
2210656|NCT01652872|3850402|FG001|Overall Study|Decision by sponsor|7
2210657|NCT01652872|3850401|FG000|Overall Study|Withdrawal by Subject|76
2210658|NCT01652872|3850402|FG001|Overall Study|Withdrawal by Subject|84
2210659|NCT01652885|3850408|FG000|Overall Study|Adverse Event|1
2210660|NCT01653132|3850437|FG000|First Intervention|Protocol Violation|1
2210661|NCT01653132|3850438|FG001|First Intervention|Protocol Violation|0
2210662|NCT01653158|3850448|FG000|Overall Study|Death|0
2210663|NCT01653158|3850449|FG001|Overall Study|Death|0
2210664|NCT01653158|3850450|FG002|Overall Study|Death|0
2210665|NCT01653158|3850451|FG003|Overall Study|Death|1
2210666|NCT01653158|3850452|FG004|Overall Study|Death|0
2210667|NCT01653158|3850453|FG005|Overall Study|Death|0
2210668|NCT01653158|3850454|FG006|Overall Study|Death|0
2210669|NCT01653158|3850455|FG007|Overall Study|Death|2
2210670|NCT01653158|3850448|FG000|Overall Study|Adverse Event|0
2210671|NCT01653158|3850449|FG001|Overall Study|Adverse Event|0
2210672|NCT01653158|3850450|FG002|Overall Study|Adverse Event|0
2210673|NCT01653158|3850451|FG003|Overall Study|Adverse Event|1
2210674|NCT01653158|3850452|FG004|Overall Study|Adverse Event|0
2210675|NCT01653158|3850453|FG005|Overall Study|Adverse Event|0
2210676|NCT01653158|3850454|FG006|Overall Study|Adverse Event|0
2210677|NCT01653158|3850455|FG007|Overall Study|Adverse Event|3
2210678|NCT01653158|3850448|FG000|Overall Study|Other|0
2210679|NCT01653158|3850449|FG001|Overall Study|Other|0
2210680|NCT01653158|3850450|FG002|Overall Study|Other|0
2210681|NCT01653158|3850451|FG003|Overall Study|Other|0
2210682|NCT01653158|3850452|FG004|Overall Study|Other|0
2210683|NCT01653158|3850453|FG005|Overall Study|Other|0
2210684|NCT01653158|3850454|FG006|Overall Study|Other|0
2210685|NCT01653158|3850455|FG007|Overall Study|Other|1
2210686|NCT01653158|3850448|FG000|Overall Study|Progressive disease|0
2210687|NCT01653158|3850449|FG001|Overall Study|Progressive disease|0
2210688|NCT01653158|3850450|FG002|Overall Study|Progressive disease|0
2210689|NCT01653158|3850451|FG003|Overall Study|Progressive disease|0
2210690|NCT01653158|3850452|FG004|Overall Study|Progressive disease|1
2210691|NCT01653158|3850453|FG005|Overall Study|Progressive disease|1
2210692|NCT01653158|3850454|FG006|Overall Study|Progressive disease|2
2210693|NCT01653158|3850455|FG007|Overall Study|Progressive disease|9
2210694|NCT01653158|3850448|FG000|Overall Study|Withdrawal by Subject|1
2210695|NCT01653158|3850449|FG001|Overall Study|Withdrawal by Subject|0
2210696|NCT01653158|3850450|FG002|Overall Study|Withdrawal by Subject|0
2210697|NCT01653158|3850451|FG003|Overall Study|Withdrawal by Subject|0
2210698|NCT01653158|3850452|FG004|Overall Study|Withdrawal by Subject|0
2074301|NCT00647270|3654530|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
2074302|NCT00647270|3654528|FG000|Period 2, Placebo Switched to Adalimumab|Other|2
2074303|NCT00647270|3654529|FG001|Period 2, Placebo Switched to Adalimumab|Other|6
2074304|NCT00647270|3654530|FG002|Period 2, Placebo Switched to Adalimumab|Other|0
2074305|NCT00647296|3654545|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
2074306|NCT00647296|3654546|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
2074307|NCT00647296|3654547|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
2074308|NCT00647296|3654548|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1
2074309|NCT00647296|3654545|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
2074310|NCT00647296|3654546|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
2074311|NCT00647296|3654547|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
2210699|NCT01653158|3850453|FG005|Overall Study|Withdrawal by Subject|0
2210700|NCT01653158|3850454|FG006|Overall Study|Withdrawal by Subject|0
2210701|NCT01653158|3850455|FG007|Overall Study|Withdrawal by Subject|0
2074312|NCT00647296|3654548|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
2074313|NCT00647296|3654545|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
2074314|NCT00647296|3654546|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1
2074315|NCT00647296|3654547|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
2074316|NCT00647296|3654548|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
2074317|NCT00647296|3654545|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1
2074318|NCT00647296|3654546|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
2074319|NCT00647296|3654547|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
2074320|NCT00647296|3654548|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
2074321|NCT00647296|3654545|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1
2074322|NCT00647296|3654546|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
2074323|NCT00647296|3654547|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
2074324|NCT00647296|3654548|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
2074325|NCT00647296|3654545|FG000|Part 2: 4-week Placebo Washout|Death|3
2074326|NCT00647296|3654546|FG001|Part 2: 4-week Placebo Washout|Death|0
2074327|NCT00647296|3654547|FG002|Part 2: 4-week Placebo Washout|Death|0
2074328|NCT00647296|3654548|FG003|Part 2: 4-week Placebo Washout|Death|0
2074329|NCT00647296|3654545|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
2074330|NCT00647296|3654546|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5
2074331|NCT00647296|3654547|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
2074332|NCT00647296|3654548|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4
2074333|NCT00647296|3654545|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
2074334|NCT00647296|3654546|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1
2074335|NCT00647296|3654547|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
2074336|NCT00647296|3654548|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4
2074337|NCT00647296|3654545|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
2074338|NCT00647296|3654546|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1
2074339|NCT00647296|3654547|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
2074340|NCT00647296|3654548|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
2074341|NCT00647296|3654545|FG000|Part 2: 76-week Double-Blind Treatment|Death|0
2074342|NCT00647296|3654546|FG001|Part 2: 76-week Double-Blind Treatment|Death|7
2074343|NCT00647296|3654547|FG002|Part 2: 76-week Double-Blind Treatment|Death|0
2074344|NCT00647296|3654548|FG003|Part 2: 76-week Double-Blind Treatment|Death|5
2074345|NCT00647296|3654545|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
2074346|NCT00647296|3654546|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
2074347|NCT00647296|3654547|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
2074348|NCT00647296|3654548|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
2074349|NCT00647348|3654572|FG000|Overall Study|Lost to Follow-up|3
2074350|NCT00647348|3654573|FG001|Overall Study|Lost to Follow-up|6
2074351|NCT00647556|3654590|FG000|Overall Study|Adverse Event|0
2074352|NCT00647556|3654591|FG001|Overall Study|Adverse Event|1
2074353|NCT00647556|3654590|FG000|Overall Study|Lost to Follow-up|1
2074354|NCT00647556|3654591|FG001|Overall Study|Lost to Follow-up|0
2074355|NCT00647556|3654590|FG000|Overall Study|Protocol Violation|0
2074356|NCT00647556|3654591|FG001|Overall Study|Protocol Violation|1
2074357|NCT00647556|3654590|FG000|Overall Study|Withdrawal by Subject|1
2074358|NCT00647556|3654591|FG001|Overall Study|Withdrawal by Subject|0
2074359|NCT00647556|3654590|FG000|Overall Study|Surgery for pre-existing neck pain|1
2074360|NCT00647556|3654591|FG001|Overall Study|Surgery for pre-existing neck pain|0
2074361|NCT00647699|3654599|FG000|Overall Study|Lost to Follow-up|5
2074362|NCT00647699|3654600|FG001|Overall Study|Lost to Follow-up|4
2074363|NCT00647699|3654599|FG000|Overall Study|Withdrawal by Subject|3
2074364|NCT00647699|3654600|FG001|Overall Study|Withdrawal by Subject|8
2074365|NCT00648037|3654617|FG000|Overall Study|Not Treated|1
2074366|NCT00648037|3654617|FG000|Overall Study|Withdrawal by Subject|1
2074367|NCT00648037|3654617|FG000|Overall Study|Adverse Event|11
2074368|NCT00648037|3654617|FG000|Overall Study|Relapse|2
2074369|NCT00648037|3654617|FG000|Overall Study|Other|1
2074370|NCT00648167|3654634|FG000|Overall Study|Adverse Event|6
2074371|NCT00648167|3654634|FG000|Overall Study|unable to swallow tablets|1
2074372|NCT00648739|3654760|FG000|Overall Study|Adverse Event|1
2074373|NCT00648739|3654761|FG001|Overall Study|Adverse Event|0
2074374|NCT00648739|3654762|FG002|Overall Study|Adverse Event|1
2074375|NCT00648739|3654763|FG003|Overall Study|Adverse Event|2
2074376|NCT00648739|3654764|FG004|Overall Study|Adverse Event|1
2074377|NCT00648739|3654765|FG005|Overall Study|Adverse Event|0
2074378|NCT00648739|3654766|FG006|Overall Study|Adverse Event|0
2074379|NCT00648739|3654760|FG000|Overall Study|Withdrawal by Subject|1
2074380|NCT00648739|3654761|FG001|Overall Study|Withdrawal by Subject|0
2074381|NCT00648739|3654762|FG002|Overall Study|Withdrawal by Subject|1
2074382|NCT00648739|3654763|FG003|Overall Study|Withdrawal by Subject|0
2074383|NCT00648739|3654764|FG004|Overall Study|Withdrawal by Subject|0
2074384|NCT00648739|3654765|FG005|Overall Study|Withdrawal by Subject|2
2074385|NCT00648739|3654766|FG006|Overall Study|Withdrawal by Subject|0
2074386|NCT00648739|3654760|FG000|Overall Study|Lack of Efficacy|0
2074387|NCT00648739|3654761|FG001|Overall Study|Lack of Efficacy|0
2074388|NCT00648739|3654762|FG002|Overall Study|Lack of Efficacy|0
2074389|NCT00648739|3654763|FG003|Overall Study|Lack of Efficacy|0
2074390|NCT00648739|3654764|FG004|Overall Study|Lack of Efficacy|1
2074391|NCT00648739|3654765|FG005|Overall Study|Lack of Efficacy|2
2074392|NCT00648739|3654766|FG006|Overall Study|Lack of Efficacy|0
2074393|NCT00648739|3654760|FG000|Overall Study|Investigator Considered it Advisable|0
2074394|NCT00648739|3654761|FG001|Overall Study|Investigator Considered it Advisable|0
2074395|NCT00648739|3654762|FG002|Overall Study|Investigator Considered it Advisable|0
2074396|NCT00648739|3654763|FG003|Overall Study|Investigator Considered it Advisable|0
2074397|NCT00648739|3654764|FG004|Overall Study|Investigator Considered it Advisable|0
2074398|NCT00648739|3654765|FG005|Overall Study|Investigator Considered it Advisable|1
2074399|NCT00648739|3654766|FG006|Overall Study|Investigator Considered it Advisable|1
2074400|NCT00648739|3654760|FG000|Overall Study|Death|0
2074401|NCT00648739|3654761|FG001|Overall Study|Death|1
2074402|NCT00648739|3654762|FG002|Overall Study|Death|0
2074403|NCT00648739|3654763|FG003|Overall Study|Death|0
2074404|NCT00648739|3654764|FG004|Overall Study|Death|0
2074405|NCT00648739|3654765|FG005|Overall Study|Death|0
2074406|NCT00648739|3654766|FG006|Overall Study|Death|0
2074407|NCT00648739|3654760|FG000|Overall Study|Positive Human Anti-human Antibody|0
2074408|NCT00648739|3654761|FG001|Overall Study|Positive Human Anti-human Antibody|0
2074409|NCT00648739|3654762|FG002|Overall Study|Positive Human Anti-human Antibody|1
2074410|NCT00648739|3654763|FG003|Overall Study|Positive Human Anti-human Antibody|0
2074411|NCT00648739|3654764|FG004|Overall Study|Positive Human Anti-human Antibody|0
2074412|NCT00648739|3654765|FG005|Overall Study|Positive Human Anti-human Antibody|0
2074413|NCT00648739|3654766|FG006|Overall Study|Positive Human Anti-human Antibody|0
2074414|NCT00648739|3654760|FG000|Overall Study|Follow-up Visits Not Completed|0
2074415|NCT00648739|3654761|FG001|Overall Study|Follow-up Visits Not Completed|1
2074416|NCT00648739|3654762|FG002|Overall Study|Follow-up Visits Not Completed|0
2074417|NCT00648739|3654763|FG003|Overall Study|Follow-up Visits Not Completed|0
2074418|NCT00648739|3654764|FG004|Overall Study|Follow-up Visits Not Completed|0
2074419|NCT00648739|3654765|FG005|Overall Study|Follow-up Visits Not Completed|0
2074420|NCT00648739|3654766|FG006|Overall Study|Follow-up Visits Not Completed|0
2074421|NCT00649220|3654792|FG000|Overall Study|Adverse Event|2
2074422|NCT00649220|3654792|FG000|Overall Study|Withdrawal by Subject|1
2074423|NCT00649389|3654800|FG000|Overall Study|Adverse Event|22
2074424|NCT00649389|3654801|FG001|Overall Study|Adverse Event|46
2074425|NCT00649389|3654802|FG002|Overall Study|Adverse Event|38
2074426|NCT00649389|3654803|FG003|Overall Study|Adverse Event|48
2074427|NCT00649389|3654800|FG000|Overall Study|Lost to Follow-up|15
2074428|NCT00649389|3654801|FG001|Overall Study|Lost to Follow-up|17
2074429|NCT00649389|3654802|FG002|Overall Study|Lost to Follow-up|21
2074430|NCT00649389|3654803|FG003|Overall Study|Lost to Follow-up|26
2074431|NCT00649389|3654800|FG000|Overall Study|Protocol Violation|11
2074432|NCT00649389|3654801|FG001|Overall Study|Protocol Violation|13
2074433|NCT00649389|3654802|FG002|Overall Study|Protocol Violation|9
2074434|NCT00649389|3654803|FG003|Overall Study|Protocol Violation|8
2074435|NCT00649389|3654800|FG000|Overall Study|Withdrawal by Subject|20
2074436|NCT00649389|3654801|FG001|Overall Study|Withdrawal by Subject|21
2074437|NCT00649389|3654802|FG002|Overall Study|Withdrawal by Subject|19
2074438|NCT00649389|3654803|FG003|Overall Study|Withdrawal by Subject|23
2074439|NCT00649389|3654800|FG000|Overall Study|Other|3
2074440|NCT00649389|3654801|FG001|Overall Study|Other|9
2074441|NCT00649389|3654802|FG002|Overall Study|Other|1
2074442|NCT00649389|3654803|FG003|Overall Study|Other|6
2074443|NCT00649428|3654815|FG000|Overall Study|Adverse Event|2
2074444|NCT00649428|3654816|FG001|Overall Study|Adverse Event|2
2074445|NCT00649428|3654815|FG000|Overall Study|Withdrawal by Subject|6
2074446|NCT00649428|3654816|FG001|Overall Study|Withdrawal by Subject|6
2074447|NCT00649428|3654815|FG000|Overall Study|Lost to Follow-up|1
2074448|NCT00649428|3654816|FG001|Overall Study|Lost to Follow-up|3
2074449|NCT00649428|3654815|FG000|Overall Study|Insufficient manufacturing yield|5
2074450|NCT00649428|3654816|FG001|Overall Study|Insufficient manufacturing yield|1
2074451|NCT00649428|3654815|FG000|Overall Study|Protocol Violation|6
2074452|NCT00649428|3654816|FG001|Overall Study|Protocol Violation|2
2074453|NCT00649428|3654815|FG000|Overall Study|Physician Decision|0
2074454|NCT00649428|3654816|FG001|Overall Study|Physician Decision|1
2074455|NCT00650091|3654842|FG000|Amended Study Design|Withdrawal by Subject|12
2074456|NCT00650091|3654843|FG001|Amended Study Design|Withdrawal by Subject|11
2074457|NCT00650091|3654844|FG002|Amended Study Design|Withdrawal by Subject|0
2074458|NCT00650091|3654842|FG000|Amended Study Design|Physician Decision|5
2074459|NCT00650091|3654843|FG001|Amended Study Design|Physician Decision|0
2074460|NCT00650091|3654844|FG002|Amended Study Design|Physician Decision|0
2074461|NCT00650091|3654842|FG000|Amended Study Design|Adverse Event|1
2074462|NCT00650091|3654843|FG001|Amended Study Design|Adverse Event|4
2074463|NCT00650091|3654844|FG002|Amended Study Design|Adverse Event|0
2074464|NCT00650091|3654842|FG000|Amended Study Design|Lung transplantation|4
2074465|NCT00650091|3654843|FG001|Amended Study Design|Lung transplantation|2
2074466|NCT00650091|3654844|FG002|Amended Study Design|Lung transplantation|0
2074467|NCT00650091|3654842|FG000|Amended Study Design|Other|1
2074468|NCT00650091|3654843|FG001|Amended Study Design|Other|3
2074469|NCT00650091|3654844|FG002|Amended Study Design|Other|0
2074470|NCT00650104|3654852|FG000|Overall Study|Adverse Event|17
2074471|NCT00650104|3654852|FG000|Overall Study|Death|2
2074472|NCT00650104|3654852|FG000|Overall Study|Withdrawal by Subject|11
2074473|NCT00650104|3654852|FG000|Overall Study|Physician Decision|7
2074474|NCT00650104|3654852|FG000|Overall Study|Lost to Follow-up|1
2074475|NCT00650104|3654852|FG000|Overall Study|Non-compliance|2
2074476|NCT00650104|3654852|FG000|Overall Study|Sponsor Terminated Dosing|1
2074477|NCT00650585|3654872|FG000|Overall Study|Lost to Follow-up|505
2074478|NCT00650585|3654873|FG001|Overall Study|Lost to Follow-up|482
2074479|NCT00650585|3654872|FG000|Overall Study|No parental consent|935
2074480|NCT00650585|3654873|FG001|Overall Study|No parental consent|866
2074481|NCT00650585|3654872|FG000|Overall Study|Excluded/ruled ineligible|357
2074482|NCT00650585|3654873|FG001|Overall Study|Excluded/ruled ineligible|129
2074483|NCT00650767|3654883|FG000|Overall Study|Adverse Event|0
2074484|NCT00650767|3654884|FG001|Overall Study|Adverse Event|3
2074485|NCT00650767|3654885|FG002|Overall Study|Adverse Event|10
2074486|NCT00650767|3654886|FG003|Overall Study|Adverse Event|8
2074487|NCT00650767|3654883|FG000|Overall Study|Death|1
2074488|NCT00650767|3654884|FG001|Overall Study|Death|0
2074489|NCT00650767|3654885|FG002|Overall Study|Death|0
2074490|NCT00650767|3654886|FG003|Overall Study|Death|0
2074491|NCT00650767|3654883|FG000|Overall Study|Withdrawal by Subject|2
2074492|NCT00650767|3654884|FG001|Overall Study|Withdrawal by Subject|4
2074493|NCT00650767|3654885|FG002|Overall Study|Withdrawal by Subject|3
2074494|NCT00650767|3654886|FG003|Overall Study|Withdrawal by Subject|3
2074495|NCT00650767|3654883|FG000|Overall Study|Lost to Follow-up|1
2074496|NCT00650767|3654884|FG001|Overall Study|Lost to Follow-up|1
2074497|NCT00650767|3654885|FG002|Overall Study|Lost to Follow-up|1
2074498|NCT00650767|3654886|FG003|Overall Study|Lost to Follow-up|0
2074499|NCT00650767|3654883|FG000|Overall Study|Other|1
2074500|NCT00650767|3654884|FG001|Overall Study|Other|1
2074501|NCT00650767|3654885|FG002|Overall Study|Other|0
2074502|NCT00650767|3654886|FG003|Overall Study|Other|0
2074503|NCT00650806|3654900|FG000|Overall Study|Adverse Event|0
2074504|NCT00650806|3654901|FG001|Overall Study|Adverse Event|5
2074505|NCT00650806|3654902|FG002|Overall Study|Adverse Event|3
2074506|NCT00650806|3654903|FG003|Overall Study|Adverse Event|4
2074507|NCT00650806|3654900|FG000|Overall Study|Lost to Follow-up|7
2074508|NCT00650806|3654901|FG001|Overall Study|Lost to Follow-up|6
2074509|NCT00650806|3654902|FG002|Overall Study|Lost to Follow-up|11
2074510|NCT00650806|3654903|FG003|Overall Study|Lost to Follow-up|10
2074511|NCT00650806|3654900|FG000|Overall Study|Protocol Violation|0
2074512|NCT00650806|3654901|FG001|Overall Study|Protocol Violation|0
2074513|NCT00650806|3654902|FG002|Overall Study|Protocol Violation|0
2074514|NCT00650806|3654903|FG003|Overall Study|Protocol Violation|1
2074515|NCT00650806|3654900|FG000|Overall Study|Pregnancy|0
2074516|NCT00650806|3654901|FG001|Overall Study|Pregnancy|0
2074517|NCT00650806|3654902|FG002|Overall Study|Pregnancy|0
2074518|NCT00650806|3654903|FG003|Overall Study|Pregnancy|1
2074519|NCT00650806|3654900|FG000|Overall Study|Withdrawal by Subject|7
2074520|NCT00650806|3654901|FG001|Overall Study|Withdrawal by Subject|5
2074521|NCT00650806|3654902|FG002|Overall Study|Withdrawal by Subject|8
2074522|NCT00650806|3654903|FG003|Overall Study|Withdrawal by Subject|6
2074523|NCT00650806|3654900|FG000|Overall Study|Noncompliance with study drug regimen|1
2074524|NCT00650806|3654901|FG001|Overall Study|Noncompliance with study drug regimen|1
2074525|NCT00650806|3654902|FG002|Overall Study|Noncompliance with study drug regimen|0
2074526|NCT00650806|3654903|FG003|Overall Study|Noncompliance with study drug regimen|0
2074527|NCT00650806|3654900|FG000|Overall Study|Study terminated by sponsor|2
2074528|NCT00650806|3654901|FG001|Overall Study|Study terminated by sponsor|3
2074529|NCT00650806|3654902|FG002|Overall Study|Study terminated by sponsor|5
2074530|NCT00650806|3654903|FG003|Overall Study|Study terminated by sponsor|4
2074531|NCT00650806|3654900|FG000|Overall Study|Other|1
2074532|NCT00650806|3654901|FG001|Overall Study|Other|1
2074533|NCT00650806|3654902|FG002|Overall Study|Other|2
2074534|NCT00650806|3654903|FG003|Overall Study|Other|0
2074535|NCT00650845|3654917|FG000|Overall Study|Withdrawal by Subject|5
2074536|NCT00650845|3654918|FG001|Overall Study|Withdrawal by Subject|0
2074537|NCT00650845|3654917|FG000|Overall Study|Protocol Violation|0
2074538|NCT00650845|3654918|FG001|Overall Study|Protocol Violation|13
2074539|NCT00651118|3654955|FG000|Overall Study|Adverse Event|4
2074540|NCT00651118|3654956|FG001|Overall Study|Adverse Event|0
2074541|NCT00651118|3654957|FG002|Overall Study|Adverse Event|1
2074542|NCT00651118|3654958|FG003|Overall Study|Adverse Event|1
2074543|NCT00651118|3654955|FG000|Overall Study|Protocol Violation|2
2074544|NCT00651118|3654956|FG001|Overall Study|Protocol Violation|2
2074545|NCT00651118|3654957|FG002|Overall Study|Protocol Violation|6
2074546|NCT00651118|3654958|FG003|Overall Study|Protocol Violation|2
2074547|NCT00651118|3654955|FG000|Overall Study|Lost to Follow-up|2
2074548|NCT00651118|3654956|FG001|Overall Study|Lost to Follow-up|0
2074549|NCT00651118|3654957|FG002|Overall Study|Lost to Follow-up|1
2074550|NCT00651118|3654958|FG003|Overall Study|Lost to Follow-up|2
2074551|NCT00651118|3654955|FG000|Overall Study|administrative|1
2074552|NCT00651118|3654956|FG001|Overall Study|administrative|4
2074553|NCT00651118|3654957|FG002|Overall Study|administrative|2
2074554|NCT00651118|3654958|FG003|Overall Study|administrative|1
2074555|NCT00651118|3654955|FG000|Overall Study|Withdrawal by Subject|0
2074556|NCT00651118|3654956|FG001|Overall Study|Withdrawal by Subject|1
2074557|NCT00651118|3654957|FG002|Overall Study|Withdrawal by Subject|1
2074558|NCT00651118|3654958|FG003|Overall Study|Withdrawal by Subject|1
2074559|NCT00651157|3654971|FG000|Overall Study|Death|1
2074560|NCT00651157|3654971|FG000|Overall Study|Protocol Violation|1
2074561|NCT00651183|3654977|FG000|Overall Study|Lack of Efficacy|1
2074562|NCT00651183|3654978|FG001|Overall Study|Lack of Efficacy|0
2074563|NCT00651183|3654977|FG000|Overall Study|Efficacy insufficient + patients wish|0
2074564|NCT00651183|3654978|FG001|Overall Study|Efficacy insufficient + patients wish|1
2074565|NCT00651183|3654977|FG000|Overall Study|Tolerability insufficient|5
2074566|NCT00651183|3654978|FG001|Overall Study|Tolerability insufficient|2
2074567|NCT00651183|3654977|FG000|Overall Study|Tolerability insufficient +Patients wish|0
2074568|NCT00651183|3654978|FG001|Overall Study|Tolerability insufficient +Patients wish|1
2074569|NCT00651183|3654977|FG000|Overall Study|Withdrawal by Subject|6
2074570|NCT00651183|3654978|FG001|Overall Study|Withdrawal by Subject|3
2074571|NCT00651183|3654977|FG000|Overall Study|Lost to Follow-up|3
2074572|NCT00651183|3654978|FG001|Overall Study|Lost to Follow-up|1
2074573|NCT00651183|3654977|FG000|Overall Study|Other reasons|4
2074574|NCT00651183|3654978|FG001|Overall Study|Other reasons|2
2074575|NCT00651183|3654977|FG000|Overall Study|missing|1
2074576|NCT00651183|3654978|FG001|Overall Study|missing|0
2074577|NCT00651261|3654986|FG000|Overall Study|Adverse Event|32
2074578|NCT00651261|3654987|FG001|Overall Study|Adverse Event|22
2074579|NCT00651261|3654986|FG000|Overall Study|Death|18
2074580|NCT00651261|3654987|FG001|Overall Study|Death|18
2074581|NCT00651261|3654986|FG000|Overall Study|Withdrawal by Subject|22
2074582|NCT00651261|3654987|FG001|Overall Study|Withdrawal by Subject|40
2074583|NCT00651261|3654986|FG000|Overall Study|Induction failure|24
2074584|NCT00651261|3654987|FG001|Overall Study|Induction failure|35
2074585|NCT00651261|3654986|FG000|Overall Study|Disease progression|58
2074586|NCT00651261|3654987|FG001|Overall Study|Disease progression|58
2074587|NCT00651261|3654986|FG000|Overall Study|Alternative therapy|109
2074588|NCT00651261|3654987|FG001|Overall Study|Alternative therapy|107
2074589|NCT00651261|3654986|FG000|Overall Study|Other disease or participant decisions|23
2074590|NCT00651261|3654987|FG001|Overall Study|Other disease or participant decisions|23
2074591|NCT00651261|3654986|FG000|Overall Study|Never treated|5
2074592|NCT00651261|3654987|FG001|Overall Study|Never treated|3
2074593|NCT00651313|3654995|FG000|Overall Study|Adverse Event|0
2074594|NCT00651313|3654996|FG001|Overall Study|Adverse Event|1
2074595|NCT00651313|3654995|FG000|Overall Study|Withdrawal by Subject|3
2074596|NCT00651313|3654996|FG001|Overall Study|Withdrawal by Subject|1
2074597|NCT00651313|3654995|FG000|Overall Study|Lost to Follow-up|1
2074598|NCT00651313|3654996|FG001|Overall Study|Lost to Follow-up|1
2074599|NCT00651313|3654995|FG000|Overall Study|Adminstrative Discontinuation|2
2210702|NCT01653262|3850482|FG000|Overall Study|Lack of Efficacy|1
2074600|NCT00651313|3654996|FG001|Overall Study|Adminstrative Discontinuation|3
2074601|NCT00651664|3655035|FG000|Overall Study|Occurrence of Adverse Event(s)|0
2074602|NCT00651664|3655036|FG001|Overall Study|Occurrence of Adverse Event(s)|0
2074603|NCT00651664|3655037|FG002|Overall Study|Occurrence of Adverse Event(s)|0
2074604|NCT00651664|3655038|FG003|Overall Study|Occurrence of Adverse Event(s)|0
2074605|NCT00651664|3655039|FG004|Overall Study|Occurrence of Adverse Event(s)|0
2074606|NCT00651664|3655040|FG005|Overall Study|Occurrence of Adverse Event(s)|0
2074607|NCT00651664|3655041|FG006|Overall Study|Occurrence of Adverse Event(s)|1
2074608|NCT00651664|3655042|FG007|Overall Study|Occurrence of Adverse Event(s)|0
2074609|NCT00651664|3655043|FG008|Overall Study|Occurrence of Adverse Event(s)|1
2074610|NCT00651664|3655044|FG009|Overall Study|Occurrence of Adverse Event(s)|0
2074611|NCT00651664|3655035|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
2074612|NCT00651664|3655036|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
2074613|NCT00651664|3655037|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
2074614|NCT00651664|3655038|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
2074615|NCT00651664|3655039|FG004|Overall Study|Unsatisfactory Therapeutic Response|1
2074616|NCT00651664|3655040|FG005|Overall Study|Unsatisfactory Therapeutic Response|1
2074617|NCT00651664|3655041|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
2074618|NCT00651664|3655042|FG007|Overall Study|Unsatisfactory Therapeutic Response|1
2074619|NCT00651664|3655043|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
2074620|NCT00651664|3655044|FG009|Overall Study|Unsatisfactory Therapeutic Response|1
2074621|NCT00651664|3655035|FG000|Overall Study|Progressive Disease|3
2074622|NCT00651664|3655036|FG001|Overall Study|Progressive Disease|3
2074623|NCT00651664|3655037|FG002|Overall Study|Progressive Disease|3
2074624|NCT00651664|3655038|FG003|Overall Study|Progressive Disease|12
2074625|NCT00651664|3655039|FG004|Overall Study|Progressive Disease|4
2074626|NCT00651664|3655040|FG005|Overall Study|Progressive Disease|1
2074627|NCT00651664|3655041|FG006|Overall Study|Progressive Disease|3
2074628|NCT00651664|3655042|FG007|Overall Study|Progressive Disease|6
2074629|NCT00651664|3655043|FG008|Overall Study|Progressive Disease|5
2074630|NCT00651664|3655044|FG009|Overall Study|Progressive Disease|5
2074631|NCT00651664|3655035|FG000|Overall Study|Patient Declined Further Treatment|0
2074632|NCT00651664|3655036|FG001|Overall Study|Patient Declined Further Treatment|0
2074633|NCT00651664|3655037|FG002|Overall Study|Patient Declined Further Treatment|0
2074634|NCT00651664|3655038|FG003|Overall Study|Patient Declined Further Treatment|1
2074635|NCT00651664|3655039|FG004|Overall Study|Patient Declined Further Treatment|1
2074636|NCT00651664|3655040|FG005|Overall Study|Patient Declined Further Treatment|1
2074637|NCT00651664|3655041|FG006|Overall Study|Patient Declined Further Treatment|0
2074638|NCT00651664|3655042|FG007|Overall Study|Patient Declined Further Treatment|0
2074639|NCT00651664|3655043|FG008|Overall Study|Patient Declined Further Treatment|0
2074640|NCT00651664|3655044|FG009|Overall Study|Patient Declined Further Treatment|1
2074641|NCT00651664|3655035|FG000|Overall Study|Symptomatic Deterioration|0
2074642|NCT00651664|3655036|FG001|Overall Study|Symptomatic Deterioration|0
2074643|NCT00651664|3655037|FG002|Overall Study|Symptomatic Deterioration|0
2074644|NCT00651664|3655038|FG003|Overall Study|Symptomatic Deterioration|1
2074645|NCT00651664|3655039|FG004|Overall Study|Symptomatic Deterioration|0
2074646|NCT00651664|3655040|FG005|Overall Study|Symptomatic Deterioration|0
2074647|NCT00651664|3655041|FG006|Overall Study|Symptomatic Deterioration|1
2074648|NCT00651664|3655042|FG007|Overall Study|Symptomatic Deterioration|0
2074649|NCT00651664|3655043|FG008|Overall Study|Symptomatic Deterioration|1
2210703|NCT01653262|3850482|FG000|Overall Study|SAE, non-fatal|1
2210704|NCT01653262|3850482|FG000|Overall Study|AE, non-serious non-fatal|1
2210705|NCT01653327|3850497|FG000|Overall Study|Withdrawal by Subject|1
2210706|NCT01653704|3850538|FG000|Overall Study|Technical failure during recording|1
2210707|NCT01653704|3850539|FG001|Overall Study|Technical failure during recording|1
2210708|NCT01653704|3850538|FG000|Overall Study|Performance not reflective of training|1
2210709|NCT01653704|3850539|FG001|Overall Study|Performance not reflective of training|0
2210710|NCT01653743|3850547|FG000|Overall Study|Withdrawal by Subject|1
2210711|NCT01653743|3850548|FG001|Overall Study|Withdrawal by Subject|0
2210712|NCT01653743|3850547|FG000|Overall Study|Investigator discretion|3
2210713|NCT01653743|3850548|FG001|Overall Study|Investigator discretion|0
2210714|NCT01653782|3850557|FG000|Overall Study|Withdrawal by Subject|9
2210715|NCT01653782|3850558|FG001|Overall Study|Withdrawal by Subject|15
2210716|NCT01653782|3850559|FG002|Overall Study|Withdrawal by Subject|4
2210717|NCT01653782|3850557|FG000|Overall Study|Lost to Follow-up|7
2210718|NCT01653782|3850558|FG001|Overall Study|Lost to Follow-up|3
2210719|NCT01653782|3850559|FG002|Overall Study|Lost to Follow-up|2
2210720|NCT01653847|3850569|FG000|Overall Study|Withdrawal by Subject|1
2074650|NCT00651664|3655044|FG009|Overall Study|Symptomatic Deterioration|0
2074651|NCT00651664|3655035|FG000|Overall Study|Reason not Specified|0
2074652|NCT00651664|3655036|FG001|Overall Study|Reason not Specified|0
2074653|NCT00651664|3655037|FG002|Overall Study|Reason not Specified|0
2074654|NCT00651664|3655038|FG003|Overall Study|Reason not Specified|0
2074655|NCT00651664|3655039|FG004|Overall Study|Reason not Specified|0
2074656|NCT00651664|3655040|FG005|Overall Study|Reason not Specified|0
2074657|NCT00651664|3655041|FG006|Overall Study|Reason not Specified|1
2074658|NCT00651664|3655042|FG007|Overall Study|Reason not Specified|0
2074659|NCT00651664|3655043|FG008|Overall Study|Reason not Specified|0
2074660|NCT00651664|3655044|FG009|Overall Study|Reason not Specified|0
2074661|NCT00651755|3655070|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
2074662|NCT00651755|3655071|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
2074663|NCT00651755|3655070|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0
2074664|NCT00651755|3655071|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1
2074665|NCT00651820|3655091|FG000|Overall Study|Lost to Follow-up|2
2074666|NCT00651924|3655099|FG000|Overall Study|Withdrawal by PI|0
2074667|NCT00651924|3655100|FG001|Overall Study|Withdrawal by PI|2
2074668|NCT00651924|3655099|FG000|Overall Study|Withdrawal by Subject|0
2074669|NCT00651924|3655100|FG001|Overall Study|Withdrawal by Subject|5
2074670|NCT00651937|3655108|FG000|Overall Study|Withdrawal by Subject|4
2074671|NCT00651937|3655109|FG001|Overall Study|Withdrawal by Subject|1
2074672|NCT00652028|3655119|FG000|Overall Study|Adverse Event|1
2074673|NCT00652028|3655120|FG001|Overall Study|Adverse Event|0
2074674|NCT00652028|3655121|FG002|Overall Study|Adverse Event|0
2074675|NCT00652028|3655122|FG003|Overall Study|Adverse Event|0
2074676|NCT00652028|3655119|FG000|Overall Study|No Longer Meets Entry Criteria|0
2074677|NCT00652028|3655120|FG001|Overall Study|No Longer Meets Entry Criteria|1
2074678|NCT00652028|3655121|FG002|Overall Study|No Longer Meets Entry Criteria|0
2074679|NCT00652028|3655122|FG003|Overall Study|No Longer Meets Entry Criteria|0
2074680|NCT00652028|3655119|FG000|Overall Study|Physician Decision|0
2074681|NCT00652028|3655120|FG001|Overall Study|Physician Decision|0
2074682|NCT00652028|3655121|FG002|Overall Study|Physician Decision|1
2074683|NCT00652028|3655122|FG003|Overall Study|Physician Decision|0
2074684|NCT00652093|3655144|FG000|Overall Study|Withdrawal by Subject|0
2074685|NCT00652093|3655145|FG001|Overall Study|Withdrawal by Subject|0
2074686|NCT00652093|3655146|FG002|Overall Study|Withdrawal by Subject|1
2074687|NCT00652093|3655147|FG003|Overall Study|Withdrawal by Subject|0
2074688|NCT00652093|3655148|FG004|Overall Study|Withdrawal by Subject|1
2074689|NCT00652093|3655149|FG005|Overall Study|Withdrawal by Subject|0
2074690|NCT00652093|3655144|FG000|Overall Study|Physician Decision|0
2074691|NCT00652093|3655145|FG001|Overall Study|Physician Decision|0
2074692|NCT00652093|3655146|FG002|Overall Study|Physician Decision|0
2074693|NCT00652093|3655147|FG003|Overall Study|Physician Decision|0
2074694|NCT00652093|3655148|FG004|Overall Study|Physician Decision|1
2074695|NCT00652093|3655149|FG005|Overall Study|Physician Decision|0
2074696|NCT00652340|3655185|FG000|Overall Study|Had not progressed.|4
2074697|NCT00652340|3655186|FG001|Overall Study|Had not progressed.|3
2074698|NCT00652366|3655197|FG000|Overall Study|Adverse Event|8
2074699|NCT00652366|3655198|FG001|Overall Study|Adverse Event|4
2074700|NCT00652366|3655199|FG002|Overall Study|Adverse Event|7
2074701|NCT00652366|3655200|FG003|Overall Study|Adverse Event|17
2210721|NCT01653847|3850570|FG001|Overall Study|Withdrawal by Subject|0
2074702|NCT00652366|3655201|FG004|Overall Study|Adverse Event|13
2074703|NCT00652366|3655197|FG000|Overall Study|Death|5
2074704|NCT00652366|3655198|FG001|Overall Study|Death|4
2074705|NCT00652366|3655199|FG002|Overall Study|Death|1
2074706|NCT00652366|3655200|FG003|Overall Study|Death|8
2074707|NCT00652366|3655201|FG004|Overall Study|Death|5
2074708|NCT00652366|3655197|FG000|Overall Study|Lack of Efficacy|84
2074709|NCT00652366|3655198|FG001|Overall Study|Lack of Efficacy|58
2074710|NCT00652366|3655199|FG002|Overall Study|Lack of Efficacy|53
2074711|NCT00652366|3655200|FG003|Overall Study|Lack of Efficacy|133
2074712|NCT00652366|3655201|FG004|Overall Study|Lack of Efficacy|13
2074713|NCT00652366|3655197|FG000|Overall Study|Violation of Selection Criteria|0
2074714|NCT00652366|3655198|FG001|Overall Study|Violation of Selection Criteria|0
2074715|NCT00652366|3655199|FG002|Overall Study|Violation of Selection Criteria|1
2074716|NCT00652366|3655200|FG003|Overall Study|Violation of Selection Criteria|0
2074717|NCT00652366|3655201|FG004|Overall Study|Violation of Selection Criteria|0
2074718|NCT00652366|3655197|FG000|Overall Study|Protocol Violation|1
2074719|NCT00652366|3655198|FG001|Overall Study|Protocol Violation|0
2074720|NCT00652366|3655199|FG002|Overall Study|Protocol Violation|0
2074721|NCT00652366|3655200|FG003|Overall Study|Protocol Violation|0
2074722|NCT00652366|3655201|FG004|Overall Study|Protocol Violation|0
2074723|NCT00652366|3655197|FG000|Overall Study|Refused treatment|3
2074724|NCT00652366|3655198|FG001|Overall Study|Refused treatment|7
2074725|NCT00652366|3655199|FG002|Overall Study|Refused treatment|6
2074726|NCT00652366|3655200|FG003|Overall Study|Refused treatment|17
2074727|NCT00652366|3655201|FG004|Overall Study|Refused treatment|5
2074728|NCT00652366|3655197|FG000|Overall Study|Other|5
2074729|NCT00652366|3655198|FG001|Overall Study|Other|2
2074730|NCT00652366|3655199|FG002|Overall Study|Other|3
2074731|NCT00652366|3655200|FG003|Overall Study|Other|4
2074732|NCT00652366|3655201|FG004|Overall Study|Other|0
2074733|NCT00652626|3655222|FG000|Initial Treatment Phase|Adverse Event|0
2074734|NCT00652626|3655223|FG001|Initial Treatment Phase|Adverse Event|0
2074735|NCT00652626|3655224|FG002|Initial Treatment Phase|Adverse Event|0
2074736|NCT00652626|3655225|FG003|Initial Treatment Phase|Adverse Event|0
2074737|NCT00652626|3655226|FG004|Initial Treatment Phase|Adverse Event|1
2074738|NCT00652626|3655227|FG005|Initial Treatment Phase|Adverse Event|0
2074739|NCT00652626|3655228|FG006|Initial Treatment Phase|Adverse Event|0
2074740|NCT00652626|3655222|FG000|Initial Treatment Phase|Protocol Violation|0
2074741|NCT00652626|3655223|FG001|Initial Treatment Phase|Protocol Violation|0
2074742|NCT00652626|3655224|FG002|Initial Treatment Phase|Protocol Violation|0
2074743|NCT00652626|3655225|FG003|Initial Treatment Phase|Protocol Violation|1
2074744|NCT00652626|3655226|FG004|Initial Treatment Phase|Protocol Violation|0
2074745|NCT00652626|3655227|FG005|Initial Treatment Phase|Protocol Violation|0
2074746|NCT00652626|3655228|FG006|Initial Treatment Phase|Protocol Violation|0
2074747|NCT00652626|3655222|FG000|Initial Treatment Phase|Physician Decision|0
2074748|NCT00652626|3655223|FG001|Initial Treatment Phase|Physician Decision|0
2074749|NCT00652626|3655224|FG002|Initial Treatment Phase|Physician Decision|0
2074750|NCT00652626|3655225|FG003|Initial Treatment Phase|Physician Decision|0
2074751|NCT00652626|3655226|FG004|Initial Treatment Phase|Physician Decision|1
2074752|NCT00652626|3655227|FG005|Initial Treatment Phase|Physician Decision|0
2074753|NCT00652626|3655228|FG006|Initial Treatment Phase|Physician Decision|0
2074754|NCT00652626|3655222|FG000|Initial Treatment Phase|Sponsor Request|0
2074755|NCT00652626|3655223|FG001|Initial Treatment Phase|Sponsor Request|0
2074756|NCT00652626|3655224|FG002|Initial Treatment Phase|Sponsor Request|1
2074757|NCT00652626|3655225|FG003|Initial Treatment Phase|Sponsor Request|0
2074758|NCT00652626|3655226|FG004|Initial Treatment Phase|Sponsor Request|0
2074759|NCT00652626|3655227|FG005|Initial Treatment Phase|Sponsor Request|0
2074760|NCT00652626|3655228|FG006|Initial Treatment Phase|Sponsor Request|0
2074761|NCT00652626|3655222|FG000|Initial Treatment Phase|Lost to Follow-up|0
2074762|NCT00652626|3655223|FG001|Initial Treatment Phase|Lost to Follow-up|0
2074763|NCT00652626|3655224|FG002|Initial Treatment Phase|Lost to Follow-up|0
2074764|NCT00652626|3655225|FG003|Initial Treatment Phase|Lost to Follow-up|0
2074765|NCT00652626|3655226|FG004|Initial Treatment Phase|Lost to Follow-up|1
2074766|NCT00652626|3655227|FG005|Initial Treatment Phase|Lost to Follow-up|0
2074767|NCT00652626|3655228|FG006|Initial Treatment Phase|Lost to Follow-up|0
2074768|NCT00652626|3655222|FG000|Extension Phase|Withdrawal by Subject|0
2074769|NCT00652626|3655223|FG001|Extension Phase|Withdrawal by Subject|0
2074770|NCT00652626|3655224|FG002|Extension Phase|Withdrawal by Subject|0
2074771|NCT00652626|3655225|FG003|Extension Phase|Withdrawal by Subject|0
2074772|NCT00652626|3655226|FG004|Extension Phase|Withdrawal by Subject|0
2074773|NCT00652626|3655227|FG005|Extension Phase|Withdrawal by Subject|2
2074774|NCT00652626|3655228|FG006|Extension Phase|Withdrawal by Subject|0
2074775|NCT00652626|3655222|FG000|Extension Phase|Adverse Event|0
2074776|NCT00652626|3655223|FG001|Extension Phase|Adverse Event|0
2074777|NCT00652626|3655224|FG002|Extension Phase|Adverse Event|0
2074778|NCT00652626|3655225|FG003|Extension Phase|Adverse Event|0
2074779|NCT00652626|3655226|FG004|Extension Phase|Adverse Event|0
2074780|NCT00652626|3655227|FG005|Extension Phase|Adverse Event|2
2074781|NCT00652626|3655228|FG006|Extension Phase|Adverse Event|1
2074782|NCT00652626|3655222|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0
2074783|NCT00652626|3655223|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0
2108196|NCT00878722|3702049|FG000|Overall Study|Adverse Event|0
2074784|NCT00652626|3655224|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0
2074785|NCT00652626|3655225|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0
2074786|NCT00652626|3655226|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0
2074787|NCT00652626|3655227|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6
2074788|NCT00652626|3655228|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0
2074789|NCT00652626|3655222|FG000|Extension Phase|Physician Decision|0
2074790|NCT00652626|3655223|FG001|Extension Phase|Physician Decision|0
2074791|NCT00652626|3655224|FG002|Extension Phase|Physician Decision|0
2074792|NCT00652626|3655225|FG003|Extension Phase|Physician Decision|0
2074793|NCT00652626|3655226|FG004|Extension Phase|Physician Decision|0
2074794|NCT00652626|3655227|FG005|Extension Phase|Physician Decision|1
2074795|NCT00652626|3655228|FG006|Extension Phase|Physician Decision|1
2074796|NCT00652626|3655222|FG000|Extension Phase|Death|0
2074797|NCT00652626|3655223|FG001|Extension Phase|Death|0
2074798|NCT00652626|3655224|FG002|Extension Phase|Death|0
2074799|NCT00652626|3655225|FG003|Extension Phase|Death|0
2074800|NCT00652626|3655226|FG004|Extension Phase|Death|0
2074801|NCT00652626|3655227|FG005|Extension Phase|Death|1
2074802|NCT00652626|3655228|FG006|Extension Phase|Death|1
2074803|NCT00652743|3655249|FG000|Months 12-18|Lost to Follow-up|1
2074804|NCT00652743|3655250|FG001|Months 12-18|Lost to Follow-up|2
2074805|NCT00652743|3655251|FG002|Months 12-18|Lost to Follow-up|7
2074806|NCT00652743|3655249|FG000|Months 24-30|Other|5
2074807|NCT00652743|3655250|FG001|Months 24-30|Other|1
2074808|NCT00652743|3655251|FG002|Months 24-30|Other|11
2074809|NCT00652743|3655249|FG000|Months 36-42|Serious Adverse Events|0
2074810|NCT00652743|3655250|FG001|Months 36-42|Serious Adverse Events|1
2074811|NCT00652743|3655251|FG002|Months 36-42|Serious Adverse Events|1
2074812|NCT00652743|3655249|FG000|Months 36-42|Withdrawal by Subject|1
2074813|NCT00652743|3655250|FG001|Months 36-42|Withdrawal by Subject|1
2074814|NCT00652743|3655251|FG002|Months 36-42|Withdrawal by Subject|0
2074815|NCT00652743|3655249|FG000|Months 36-42|Lost to Follow-up|0
2074816|NCT00652743|3655250|FG001|Months 36-42|Lost to Follow-up|1
2074817|NCT00652743|3655251|FG002|Months 36-42|Lost to Follow-up|0
2074818|NCT00652743|3655249|FG000|Months 36-42|Migrated/moved from study area|1
2074819|NCT00652743|3655250|FG001|Months 36-42|Migrated/moved from study area|0
2074820|NCT00652743|3655251|FG002|Months 36-42|Migrated/moved from study area|0
2074821|NCT00652743|3655249|FG000|Months 36-42|Other|4
2074822|NCT00652743|3655250|FG001|Months 36-42|Other|2
2074823|NCT00652743|3655251|FG002|Months 36-42|Other|8
2074824|NCT00652834|3655262|FG000|Overall Study|Withdrawal by Subject|3
2074825|NCT00652834|3655262|FG000|Overall Study|Lost to Follow-up|2
2074826|NCT00652899|3655266|FG000|Overall Study|Death|1
2074827|NCT00652899|3655266|FG000|Overall Study|Treating physician decision|1
2074828|NCT00652938|3655277|FG000|Overall Study|Adverse Event|1
2074829|NCT00652938|3655278|FG001|Overall Study|Adverse Event|0
2074830|NCT00652938|3655279|FG002|Overall Study|Adverse Event|2
2074831|NCT00652938|3655277|FG000|Overall Study|Withdrawal by Subject|0
2074832|NCT00652938|3655278|FG001|Overall Study|Withdrawal by Subject|6
2074833|NCT00652938|3655279|FG002|Overall Study|Withdrawal by Subject|1
2074834|NCT00652938|3655277|FG000|Overall Study|Lost to Follow-up|0
2074835|NCT00652938|3655278|FG001|Overall Study|Lost to Follow-up|0
2074836|NCT00652938|3655279|FG002|Overall Study|Lost to Follow-up|2
2074837|NCT00652938|3655277|FG000|Overall Study|fear of blood sampling|0
2074838|NCT00652938|3655278|FG001|Overall Study|fear of blood sampling|1
2074839|NCT00652938|3655279|FG002|Overall Study|fear of blood sampling|0
2074840|NCT00652951|3655290|FG000|Booster Phase|Adverse event, non-fatal|0
2074841|NCT00652951|3655291|FG001|Booster Phase|Adverse event, non-fatal|1
2074842|NCT00652951|3655292|FG002|Booster Phase|Adverse event, non-fatal|0
2074843|NCT00652951|3655290|FG000|Booster Phase|Other|1
2074844|NCT00652951|3655291|FG001|Booster Phase|Other|0
2074845|NCT00652951|3655292|FG002|Booster Phase|Other|0
2074846|NCT00653068|3655304|FG000|Overall Study|Death|9
2074847|NCT00653068|3655304|FG000|Overall Study|Lack of Efficacy|34
2074848|NCT00653068|3655304|FG000|Overall Study|Physician Decision|4
2074849|NCT00653068|3655304|FG000|Overall Study|Withdrawal by Subject|1
2074850|NCT00653068|3655304|FG000|Overall Study|Ineligible|2
2106524|NCT00866359|3699662|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0
2106525|NCT00866359|3699663|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0
2106526|NCT00866359|3699660|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
2106527|NCT00866359|3699661|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
2106528|NCT00866359|3699662|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
2106529|NCT00866359|3699663|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
2106530|NCT00866359|3699660|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
2106531|NCT00866359|3699661|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
2106532|NCT00866359|3699662|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
2106533|NCT00866359|3699663|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
2106534|NCT00866359|3699660|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1
2106535|NCT00866359|3699661|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1
2106536|NCT00866359|3699662|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0
2106537|NCT00866359|3699663|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0
2106538|NCT00866359|3699660|FG000|Treatment Phase (Days 1 to 85)|Other|1
2106539|NCT00866359|3699661|FG001|Treatment Phase (Days 1 to 85)|Other|0
2074851|NCT00653159|3655322|FG000|Overall Study|Adverse Event|4
2074852|NCT00653159|3655323|FG001|Overall Study|Adverse Event|1
2074853|NCT00653159|3655322|FG000|Overall Study|Lost to Follow-up|1
2074854|NCT00653159|3655323|FG001|Overall Study|Lost to Follow-up|2
2074855|NCT00653224|3655331|FG000|Overall Study|Adverse Event|2
2074856|NCT00653224|3655332|FG001|Overall Study|Adverse Event|1
2074857|NCT00653224|3655331|FG000|Overall Study|Lack of Efficacy|1
2074858|NCT00653224|3655332|FG001|Overall Study|Lack of Efficacy|2
2074859|NCT00653224|3655331|FG000|Overall Study|Loss of efficacy|1
2074860|NCT00653224|3655332|FG001|Overall Study|Loss of efficacy|0
2074861|NCT00653224|3655331|FG000|Overall Study|Lost to Follow-up|1
2074862|NCT00653224|3655332|FG001|Overall Study|Lost to Follow-up|0
2074863|NCT00653224|3655331|FG000|Overall Study|Other|2
2074864|NCT00653224|3655332|FG001|Overall Study|Other|4
2074865|NCT00653263|3655338|FG000|Overall Study|Withdrawal by Subject|1
2074866|NCT00653263|3655338|FG000|Overall Study|Physician Decision|1
2074867|NCT00653328|3655342|FG000|Overall Study|Withdrawal by Subject|1
2074868|NCT00653328|3655342|FG000|Overall Study|Adverse Event|2
2074869|NCT00653328|3655342|FG000|Overall Study|Disease progression|10
2074870|NCT00653328|3655342|FG000|Overall Study|Drug manufacturer no longing making drug|2
2074871|NCT00653432|3655348|FG000|Overall Study|Adverse Event|4
2074872|NCT00653432|3655349|FG001|Overall Study|Adverse Event|1
2074873|NCT00653432|3655348|FG000|Overall Study|Withdrawal by Subject|4
2074874|NCT00653432|3655349|FG001|Overall Study|Withdrawal by Subject|5
2074875|NCT00653432|3655348|FG000|Overall Study|Lost to Follow-up|7
2074876|NCT00653432|3655349|FG001|Overall Study|Lost to Follow-up|6
2074877|NCT00653432|3655348|FG000|Overall Study|Use/Need of Con Therapy|2
2074878|NCT00653432|3655349|FG001|Overall Study|Use/Need of Con Therapy|1
2074879|NCT00653432|3655348|FG000|Overall Study|Other - Reason Not Provided|5
2074880|NCT00653432|3655349|FG001|Overall Study|Other - Reason Not Provided|3
2074881|NCT00653939|3655366|FG000|Overall Study|Adverse Event|1
2074882|NCT00653939|3655367|FG001|Overall Study|Adverse Event|3
2074883|NCT00653939|3655366|FG000|Overall Study|Withdrawal by Subject|3
2074884|NCT00653939|3655367|FG001|Overall Study|Withdrawal by Subject|3
2074885|NCT00653939|3655366|FG000|Overall Study|Physician Decision|4
2074886|NCT00653939|3655367|FG001|Overall Study|Physician Decision|0
2074887|NCT00653939|3655366|FG000|Overall Study|Disease Progression|2
2074888|NCT00653939|3655367|FG001|Overall Study|Disease Progression|3
2304252|NCT02650895|4004120|FG002|Overall Study|Withdrawal by Subject|0
2304253|NCT02650895|4004121|FG003|Overall Study|Withdrawal by Subject|0
2074889|NCT00653939|3655366|FG000|Overall Study|Other|2
2074890|NCT00653939|3655367|FG001|Overall Study|Other|6
2074891|NCT00653991|3655377|FG000|3 Month Follow-up|Participant would not respond|150
2074892|NCT00653991|3655378|FG001|3 Month Follow-up|Participant would not respond|157
2074893|NCT00653991|3655377|FG000|6 Month Follow-up|Participant would not respond|133
2074894|NCT00653991|3655378|FG001|6 Month Follow-up|Participant would not respond|141
2074895|NCT00654004|3655388|FG000|Overall Study|Lost to Follow-up|1
2074896|NCT00654004|3655389|FG001|Overall Study|Lost to Follow-up|0
2074897|NCT00654186|3655421|FG000|Overall Study|Withdrawal by Subject|5
2074898|NCT00654238|3655425|FG000|Overall Study|Screen Failures|4
2074899|NCT00654355|3655449|FG000|Overall Study|Lost to Follow-up|2
2074900|NCT00654355|3655450|FG001|Overall Study|Lost to Follow-up|2
2074901|NCT00654368|3655459|FG000|Overall Study|Ineligibility determined|6
2074902|NCT00654368|3655460|FG001|Overall Study|Ineligibility determined|0
2074903|NCT00654368|3655461|FG002|Overall Study|Ineligibility determined|0
2074904|NCT00654368|3655459|FG000|Overall Study|Protocol deviation|3
2074905|NCT00654368|3655460|FG001|Overall Study|Protocol deviation|2
2074906|NCT00654368|3655461|FG002|Overall Study|Protocol deviation|1
2074907|NCT00654368|3655459|FG000|Overall Study|Non-compliance|2
2074908|NCT00654368|3655460|FG001|Overall Study|Non-compliance|1
2074909|NCT00654368|3655461|FG002|Overall Study|Non-compliance|2
2074910|NCT00654368|3655459|FG000|Overall Study|Withdrawal by Subject|5
2074911|NCT00654368|3655460|FG001|Overall Study|Withdrawal by Subject|2
2074912|NCT00654368|3655461|FG002|Overall Study|Withdrawal by Subject|2
2074913|NCT00654368|3655459|FG000|Overall Study|Disease progression|21
2074914|NCT00654368|3655460|FG001|Overall Study|Disease progression|31
2074915|NCT00654368|3655461|FG002|Overall Study|Disease progression|13
2074916|NCT00654368|3655459|FG000|Overall Study|Requirement for alternative therapy|1
2074917|NCT00654368|3655460|FG001|Overall Study|Requirement for alternative therapy|1
2074918|NCT00654368|3655461|FG002|Overall Study|Requirement for alternative therapy|1
2074919|NCT00654368|3655459|FG000|Overall Study|Physician Decision|0
2074920|NCT00654368|3655460|FG001|Overall Study|Physician Decision|0
2074921|NCT00654368|3655461|FG002|Overall Study|Physician Decision|2
2074922|NCT00654368|3655459|FG000|Overall Study|Death|1
2074923|NCT00654368|3655460|FG001|Overall Study|Death|0
2074924|NCT00654368|3655461|FG002|Overall Study|Death|0
2074925|NCT00654368|3655459|FG000|Overall Study|Pregnancy|0
2074926|NCT00654368|3655460|FG001|Overall Study|Pregnancy|0
2074927|NCT00654368|3655461|FG002|Overall Study|Pregnancy|2
2074928|NCT00654368|3655459|FG000|Overall Study|Other|0
2074929|NCT00654368|3655460|FG001|Overall Study|Other|2
2074930|NCT00654368|3655461|FG002|Overall Study|Other|3
2074931|NCT00654368|3655459|FG000|Overall Study|Adverse Event|14
2074932|NCT00654368|3655460|FG001|Overall Study|Adverse Event|9
2304254|NCT02650895|4004122|FG004|Overall Study|Withdrawal by Subject|0
2074933|NCT00654368|3655461|FG002|Overall Study|Adverse Event|6
2074934|NCT00654381|3655472|FG000|1st Stage|Adverse Event|3
2074935|NCT00654381|3655473|FG001|1st Stage|Adverse Event|3
2074936|NCT00654381|3655474|FG002|1st Stage|Adverse Event|3
2074937|NCT00654381|3655475|FG003|1st Stage|Adverse Event|3
2074938|NCT00654381|3655476|FG004|1st Stage|Adverse Event|2
2074939|NCT00654381|3655477|FG005|1st Stage|Adverse Event|1
2074940|NCT00654381|3655472|FG000|1st Stage|Withdrawal by Subject|0
2074941|NCT00654381|3655473|FG001|1st Stage|Withdrawal by Subject|0
2074942|NCT00654381|3655474|FG002|1st Stage|Withdrawal by Subject|0
2074943|NCT00654381|3655475|FG003|1st Stage|Withdrawal by Subject|1
2074944|NCT00654381|3655476|FG004|1st Stage|Withdrawal by Subject|0
2210722|NCT01653912|3850578|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2210723|NCT01653912|3850579|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
2210724|NCT01653912|3850580|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2210725|NCT01653912|3850581|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2210726|NCT01653912|3850582|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2210727|NCT01653912|3850583|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2210728|NCT01653912|3850578|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2210729|NCT01653912|3850579|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2210730|NCT01653912|3850580|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
2210731|NCT01653912|3850581|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2210732|NCT01653912|3850582|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2074945|NCT00654381|3655477|FG005|1st Stage|Withdrawal by Subject|1
2304255|NCT02650895|4004123|FG005|Overall Study|Withdrawal by Subject|0
2074946|NCT00654381|3655472|FG000|1st Stage|Investigator's decision|0
2074947|NCT00654381|3655473|FG001|1st Stage|Investigator's decision|0
2074948|NCT00654381|3655474|FG002|1st Stage|Investigator's decision|0
2074949|NCT00654381|3655475|FG003|1st Stage|Investigator's decision|1
2074950|NCT00654381|3655476|FG004|1st Stage|Investigator's decision|0
2074951|NCT00654381|3655477|FG005|1st Stage|Investigator's decision|0
2074952|NCT00654381|3655472|FG000|2nd Stage|Adverse Event|2
2074953|NCT00654381|3655473|FG001|2nd Stage|Adverse Event|0
2074954|NCT00654381|3655474|FG002|2nd Stage|Adverse Event|2
2074955|NCT00654381|3655475|FG003|2nd Stage|Adverse Event|3
2074956|NCT00654381|3655476|FG004|2nd Stage|Adverse Event|7
2074957|NCT00654381|3655477|FG005|2nd Stage|Adverse Event|2
2074958|NCT00654381|3655472|FG000|2nd Stage|Withdrawal by Subject|0
2074959|NCT00654381|3655473|FG001|2nd Stage|Withdrawal by Subject|0
2074960|NCT00654381|3655474|FG002|2nd Stage|Withdrawal by Subject|0
2074961|NCT00654381|3655475|FG003|2nd Stage|Withdrawal by Subject|0
2074962|NCT00654381|3655476|FG004|2nd Stage|Withdrawal by Subject|1
2074963|NCT00654381|3655477|FG005|2nd Stage|Withdrawal by Subject|1
2074964|NCT00654381|3655472|FG000|2nd Stage|Investigator's decision|0
2074965|NCT00654381|3655473|FG001|2nd Stage|Investigator's decision|0
2074966|NCT00654381|3655474|FG002|2nd Stage|Investigator's decision|1
2074967|NCT00654381|3655475|FG003|2nd Stage|Investigator's decision|1
2074968|NCT00654381|3655476|FG004|2nd Stage|Investigator's decision|0
2074969|NCT00654381|3655477|FG005|2nd Stage|Investigator's decision|0
2074970|NCT00654381|3655472|FG000|Extension Stage|Adverse Event|1
2210733|NCT01653912|3850583|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2074971|NCT00654381|3655473|FG001|Extension Stage|Adverse Event|2
2074972|NCT00654381|3655474|FG002|Extension Stage|Adverse Event|9
2074973|NCT00654381|3655475|FG003|Extension Stage|Adverse Event|7
2074974|NCT00654381|3655476|FG004|Extension Stage|Adverse Event|1
2074975|NCT00654381|3655477|FG005|Extension Stage|Adverse Event|1
2074976|NCT00654381|3655472|FG000|Extension Stage|Protocol Violation|0
2074977|NCT00654381|3655473|FG001|Extension Stage|Protocol Violation|0
2074978|NCT00654381|3655474|FG002|Extension Stage|Protocol Violation|0
2074979|NCT00654381|3655475|FG003|Extension Stage|Protocol Violation|1
2074980|NCT00654381|3655476|FG004|Extension Stage|Protocol Violation|0
2074981|NCT00654381|3655477|FG005|Extension Stage|Protocol Violation|0
2074982|NCT00654381|3655472|FG000|Extension Stage|Lack of Efficacy|0
2074983|NCT00654381|3655473|FG001|Extension Stage|Lack of Efficacy|0
2074984|NCT00654381|3655474|FG002|Extension Stage|Lack of Efficacy|1
2074985|NCT00654381|3655475|FG003|Extension Stage|Lack of Efficacy|0
2074986|NCT00654381|3655476|FG004|Extension Stage|Lack of Efficacy|0
2074987|NCT00654381|3655477|FG005|Extension Stage|Lack of Efficacy|0
2074988|NCT00654381|3655472|FG000|Extension Stage|Withdrawal by Subject|0
2074989|NCT00654381|3655473|FG001|Extension Stage|Withdrawal by Subject|0
2074990|NCT00654381|3655474|FG002|Extension Stage|Withdrawal by Subject|1
2074991|NCT00654381|3655475|FG003|Extension Stage|Withdrawal by Subject|1
2074992|NCT00654381|3655476|FG004|Extension Stage|Withdrawal by Subject|1
2074993|NCT00654381|3655477|FG005|Extension Stage|Withdrawal by Subject|1
2074994|NCT00654381|3655472|FG000|Extension Stage|Closure of the trial site|0
2074995|NCT00654381|3655473|FG001|Extension Stage|Closure of the trial site|0
2074996|NCT00654381|3655474|FG002|Extension Stage|Closure of the trial site|0
2074997|NCT00654381|3655475|FG003|Extension Stage|Closure of the trial site|0
2074998|NCT00654381|3655476|FG004|Extension Stage|Closure of the trial site|1
2074999|NCT00654381|3655477|FG005|Extension Stage|Closure of the trial site|1
2075000|NCT00654420|3655498|FG000|Phase I (Dose Escalation)|Adverse Event|0
2075001|NCT00654420|3655499|FG001|Phase I (Dose Escalation)|Adverse Event|1
2075002|NCT00654420|3655500|FG002|Phase I (Dose Escalation)|Adverse Event|0
2075003|NCT00654420|3655501|FG003|Phase I (Dose Escalation)|Adverse Event|0
2075004|NCT00654420|3655498|FG000|Phase I (Dose Escalation)|Progressive Disease|4
2075005|NCT00654420|3655499|FG001|Phase I (Dose Escalation)|Progressive Disease|15
2075006|NCT00654420|3655500|FG002|Phase I (Dose Escalation)|Progressive Disease|0
2075007|NCT00654420|3655501|FG003|Phase I (Dose Escalation)|Progressive Disease|0
2075008|NCT00654420|3655498|FG000|Phase II|Adverse Event|0
2075009|NCT00654420|3655499|FG001|Phase II|Adverse Event|0
2075010|NCT00654420|3655500|FG002|Phase II|Adverse Event|3
2075011|NCT00654420|3655501|FG003|Phase II|Adverse Event|3
2075012|NCT00654420|3655498|FG000|Phase II|Lost to Follow-up|0
2075013|NCT00654420|3655499|FG001|Phase II|Lost to Follow-up|0
2075014|NCT00654420|3655500|FG002|Phase II|Lost to Follow-up|0
2075015|NCT00654420|3655501|FG003|Phase II|Lost to Follow-up|1
2075016|NCT00654420|3655498|FG000|Phase II|Physician Decision|0
2075017|NCT00654420|3655499|FG001|Phase II|Physician Decision|0
2075018|NCT00654420|3655500|FG002|Phase II|Physician Decision|0
2075019|NCT00654420|3655501|FG003|Phase II|Physician Decision|4
2075020|NCT00654420|3655498|FG000|Phase II|Progressive Disease|0
2075021|NCT00654420|3655499|FG001|Phase II|Progressive Disease|0
2075022|NCT00654420|3655500|FG002|Phase II|Progressive Disease|29
2075023|NCT00654420|3655501|FG003|Phase II|Progressive Disease|29
2075024|NCT00654420|3655498|FG000|Phase II|Withdrawal by Subject|0
2075025|NCT00654420|3655499|FG001|Phase II|Withdrawal by Subject|0
2075026|NCT00654420|3655500|FG002|Phase II|Withdrawal by Subject|4
2075027|NCT00654420|3655501|FG003|Phase II|Withdrawal by Subject|1
2075028|NCT00654420|3655498|FG000|Phase II|Missing Disposition Record|0
2075029|NCT00654420|3655499|FG001|Phase II|Missing Disposition Record|0
2075030|NCT00654420|3655500|FG002|Phase II|Missing Disposition Record|1
2075031|NCT00654420|3655501|FG003|Phase II|Missing Disposition Record|0
2075032|NCT00654498|3655513|FG000|Overall Study|Not Treated|1
2075033|NCT00654498|3655514|FG001|Overall Study|Not Treated|0
2075034|NCT00654498|3655513|FG000|Overall Study|Adverse Event|6
2075035|NCT00654498|3655514|FG001|Overall Study|Adverse Event|1
2075036|NCT00654498|3655513|FG000|Overall Study|Protocol Violation|1
2075037|NCT00654498|3655514|FG001|Overall Study|Protocol Violation|1
2075038|NCT00654498|3655513|FG000|Overall Study|Lost to Follow-up|1
2075039|NCT00654498|3655514|FG001|Overall Study|Lost to Follow-up|5
2075040|NCT00654498|3655513|FG000|Overall Study|Withdrawal by Subject|1
2075041|NCT00654498|3655514|FG001|Overall Study|Withdrawal by Subject|0
2075042|NCT00654498|3655513|FG000|Overall Study|Other reason not defined above|4
2075043|NCT00654498|3655514|FG001|Overall Study|Other reason not defined above|5
2075044|NCT00654641|3655552|FG000|Overall Study|Lost to Follow-up|2
2075045|NCT00654641|3655553|FG001|Overall Study|Lost to Follow-up|3
2075046|NCT00654732|3655565|FG000|Overall Study|Adverse Event|4
2075047|NCT00654732|3655566|FG001|Overall Study|Adverse Event|6
2075048|NCT00654745|3655572|FG000|Overall Study|Adverse Event|12
2075049|NCT00654745|3655572|FG000|Overall Study|Lost to Follow-up|7
2075050|NCT00654745|3655572|FG000|Overall Study|Protocol Violation|11
2075051|NCT00654745|3655572|FG000|Overall Study|Withdrawal by Subject|10
2075052|NCT00654745|3655572|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3
2075053|NCT00654875|3655597|FG000|Overall Study|Adverse Event|5
2075054|NCT00654875|3655598|FG001|Overall Study|Adverse Event|5
2075055|NCT00654875|3655597|FG000|Overall Study|Withdrawal by Subject|4
2075056|NCT00654875|3655598|FG001|Overall Study|Withdrawal by Subject|4
2075057|NCT00654875|3655597|FG000|Overall Study|Protocol Violation|3
2075058|NCT00654875|3655598|FG001|Overall Study|Protocol Violation|3
2075059|NCT00654875|3655597|FG000|Overall Study|Lack of Efficacy|2
2075060|NCT00654875|3655598|FG001|Overall Study|Lack of Efficacy|2
2075061|NCT00654875|3655597|FG000|Overall Study|Lost to Follow-up|1
2075062|NCT00654875|3655598|FG001|Overall Study|Lost to Follow-up|3
2075063|NCT00654875|3655597|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
2075064|NCT00654875|3655598|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
2075065|NCT00654875|3655597|FG000|Overall Study|Administrative Problems|1
2075066|NCT00654875|3655598|FG001|Overall Study|Administrative Problems|0
2075067|NCT00654901|3655608|FG000|Overall Study|Lost to Follow-up|1
2075068|NCT00654901|3655609|FG001|Overall Study|Lost to Follow-up|0
2075069|NCT00654901|3655610|FG002|Overall Study|Lost to Follow-up|1
2075070|NCT00654901|3655611|FG003|Overall Study|Lost to Follow-up|0
2075071|NCT00654901|3655608|FG000|Overall Study|Withdrawal by Subject|3
2075072|NCT00654901|3655609|FG001|Overall Study|Withdrawal by Subject|0
2075073|NCT00654901|3655610|FG002|Overall Study|Withdrawal by Subject|1
2075074|NCT00654901|3655611|FG003|Overall Study|Withdrawal by Subject|0
2075075|NCT00654940|3655627|FG000|Period 1|Adverse Event|0
2075076|NCT00654940|3655628|FG001|Period 1|Adverse Event|1
2075077|NCT00654940|3655627|FG000|Period 1|Intolerable Pain Level|1
2075078|NCT00654940|3655628|FG001|Period 1|Intolerable Pain Level|0
2075079|NCT00655356|3655664|FG000|Overall Study|Withdrawal by Subject|3
2075080|NCT00655356|3655665|FG001|Overall Study|Withdrawal by Subject|4
2075081|NCT00655356|3655664|FG000|Overall Study|Sponsor Request|10
2075082|NCT00655356|3655665|FG001|Overall Study|Sponsor Request|4
2075083|NCT00655356|3655664|FG000|Overall Study|Adverse Event|1
2075084|NCT00655356|3655665|FG001|Overall Study|Adverse Event|1
2075085|NCT00655356|3655664|FG000|Overall Study|Protocol Violation|2
2075086|NCT00655356|3655665|FG001|Overall Study|Protocol Violation|1
2075087|NCT00655356|3655664|FG000|Overall Study|Other Reason|1
2075088|NCT00655356|3655665|FG001|Overall Study|Other Reason|0
2075089|NCT00655486|3655680|FG000|Overall Study|Adverse Event|10
2075090|NCT00655486|3655680|FG000|Overall Study|Lack of Efficacy|8
2075091|NCT00655486|3655680|FG000|Overall Study|Withdrawal by Subject|4
2075092|NCT00655486|3655680|FG000|Overall Study|Protocol Violation|1
2075093|NCT00655486|3655680|FG000|Overall Study|Unsatisfactory compliance|2
2075094|NCT00655486|3655680|FG000|Overall Study|Other: Pregnancy|1
2075095|NCT00655486|3655680|FG000|Overall Study|Other: Could not tolerate BID dosing|1
2075096|NCT00655486|3655680|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
2075097|NCT00655499|3655684|FG000|Overall Study|not eligible|4
2075098|NCT00655551|3655701|FG000|All Periods Combined|Adverse Event|0
2075099|NCT00655551|3655702|FG001|All Periods Combined|Adverse Event|3
2075100|NCT00655551|3655703|FG002|All Periods Combined|Adverse Event|4
2075101|NCT00655551|3655701|FG000|Period 2 (up to 7 Days)|Adverse Event|0
2075102|NCT00655551|3655702|FG001|Period 2 (up to 7 Days)|Adverse Event|1
2075103|NCT00655551|3655703|FG002|Period 2 (up to 7 Days)|Adverse Event|0
2075104|NCT00655551|3655701|FG000|Period 3 (up to 7 Days)|Adverse Event|0
2075105|NCT00655551|3655702|FG001|Period 3 (up to 7 Days)|Adverse Event|0
2075106|NCT00655551|3655703|FG002|Period 3 (up to 7 Days)|Adverse Event|4
2075107|NCT00655551|3655701|FG000|Period 4 (up to 7 Days)|Adverse Event|0
2075108|NCT00655551|3655702|FG001|Period 4 (up to 7 Days)|Adverse Event|2
2075109|NCT00655551|3655703|FG002|Period 4 (up to 7 Days)|Adverse Event|0
2075110|NCT00655564|3655711|FG000|Overall Study|Adverse Event|1
2075111|NCT00655564|3655711|FG000|Overall Study|Lost to Follow-up|1
2075112|NCT00655564|3655711|FG000|Overall Study|Desired Alternate Therapy|1
2075113|NCT00655629|3655718|FG000|Overall Study|Adverse Event|4
2075114|NCT00655629|3655719|FG001|Overall Study|Adverse Event|1
2075115|NCT00655629|3655718|FG000|Overall Study|Lack of Efficacy|2
2075116|NCT00655629|3655719|FG001|Overall Study|Lack of Efficacy|12
2075117|NCT00655629|3655718|FG000|Overall Study|Lost to Follow-up|4
2075118|NCT00655629|3655719|FG001|Overall Study|Lost to Follow-up|3
2075119|NCT00655629|3655718|FG000|Overall Study|Protocol Violation|5
2075120|NCT00655629|3655719|FG001|Overall Study|Protocol Violation|3
2075121|NCT00655629|3655718|FG000|Overall Study|consent withdrawn|6
2075122|NCT00655629|3655719|FG001|Overall Study|consent withdrawn|4
2075123|NCT00655668|3655742|FG000|Overall Study|Adverse Event|6
2075124|NCT00655668|3655742|FG000|Overall Study|Death|5
2075125|NCT00655668|3655742|FG000|Overall Study|Disease Progression|27
2075126|NCT00655668|3655742|FG000|Overall Study|Study Terminated|9
2075127|NCT00655668|3655742|FG000|Overall Study|Other|1
2075128|NCT00655668|3655742|FG000|Overall Study|New Lymphoma Treatment Started|4
2075129|NCT00655668|3655742|FG000|Overall Study|Withdrawal by Subject|2
2075130|NCT00655733|3655753|FG000|Overall Study|Lost to Follow-up|2
2075131|NCT00655733|3655754|FG001|Overall Study|Lost to Follow-up|2
2075132|NCT00655733|3655753|FG000|Overall Study|Adverse Event|2
2075133|NCT00655733|3655754|FG001|Overall Study|Adverse Event|2
2075134|NCT00655733|3655753|FG000|Overall Study|Withdrawal by Subject|3
2075135|NCT00655733|3655754|FG001|Overall Study|Withdrawal by Subject|3
2075136|NCT00655733|3655753|FG000|Overall Study|Physician Decision|0
2075137|NCT00655733|3655754|FG001|Overall Study|Physician Decision|1
2075138|NCT00655746|3655762|FG000|Overall Study|Withdrawal by Subject|1
2075139|NCT00655850|3655780|FG000|Overall Study|Death|2
2075140|NCT00655850|3655780|FG000|Overall Study|Withdrawal by Subject|1
2075141|NCT00655863|3655789|FG000|Overall Study|Lost to Follow-up|0
2075142|NCT00655863|3655790|FG001|Overall Study|Lost to Follow-up|0
2075143|NCT00655863|3655791|FG002|Overall Study|Lost to Follow-up|1
2075144|NCT00655876|3655801|FG000|Overall Study|Protocol Violation|9
2075145|NCT00655876|3655802|FG001|Overall Study|Protocol Violation|7
2075146|NCT00655889|3655808|FG000|Overall Study|Inadequate cell growth|1
2075147|NCT00655889|3655808|FG000|Overall Study|Protocol Violation|1
2075148|NCT00655928|3655814|FG000|Overall Study|Withdrawal by Subject|2
2075149|NCT00655928|3655815|FG001|Overall Study|Withdrawal by Subject|1
2075150|NCT00655928|3655814|FG000|Overall Study|Physician Decision|1
2075151|NCT00655928|3655815|FG001|Overall Study|Physician Decision|1
2075152|NCT00655980|3655824|FG000|Overall Study|surgery canceled; or subject or anesthes|26
2075153|NCT00655980|3655825|FG001|Overall Study|surgery canceled; or subject or anesthes|31
2075154|NCT00655980|3655826|FG002|Overall Study|surgery canceled; or subject or anesthes|5
2075155|NCT00656019|3655841|FG000|Overall Study|Not Eligible|10
2075156|NCT00656019|3655842|FG001|Overall Study|Not Eligible|0
2075157|NCT00656019|3655843|FG002|Overall Study|Not Eligible|0
2075158|NCT00656019|3655844|FG003|Overall Study|Not Eligible|0
2075159|NCT00656019|3655841|FG000|Overall Study|Withdrawal by Subject|2
2075160|NCT00656019|3655842|FG001|Overall Study|Withdrawal by Subject|0
2075161|NCT00656019|3655843|FG002|Overall Study|Withdrawal by Subject|0
2075162|NCT00656019|3655844|FG003|Overall Study|Withdrawal by Subject|0
2075163|NCT00656019|3655841|FG000|Overall Study|Lost to Follow-up|2
2075164|NCT00656019|3655842|FG001|Overall Study|Lost to Follow-up|1
2075165|NCT00656019|3655843|FG002|Overall Study|Lost to Follow-up|0
2075166|NCT00656019|3655844|FG003|Overall Study|Lost to Follow-up|0
2075167|NCT00656058|3655854|FG000|Overall Study|Withdrawal by Subject|2
2075168|NCT00656058|3655854|FG000|Overall Study|Withdrawal by Subject|4
2075169|NCT00656084|3655858|FG000|Overall Study|Adverse Event|4
2075170|NCT00656084|3655858|FG000|Overall Study|Withdrawal by Subject|1
2075171|NCT00656084|3655858|FG000|Overall Study|Patient Request|1
2075172|NCT00656084|3655858|FG000|Overall Study|Investigator Request|1
2075173|NCT00656136|3655864|FG000|Overall Study|Progressive disease|177
2075174|NCT00656136|3655865|FG001|Overall Study|Progressive disease|322
2075175|NCT00656136|3655864|FG000|Overall Study|Other Adverse Event|5
2075176|NCT00656136|3655865|FG001|Overall Study|Other Adverse Event|51
2075177|NCT00656136|3655864|FG000|Overall Study|Protocol Violation|2
2075178|NCT00656136|3655865|FG001|Overall Study|Protocol Violation|3
2075179|NCT00656136|3655864|FG000|Overall Study|Patient refused to take study medication|7
2075180|NCT00656136|3655865|FG001|Overall Study|Patient refused to take study medication|10
2075181|NCT00656136|3655864|FG000|Overall Study|Unknown and others|4
2075182|NCT00656136|3655865|FG001|Overall Study|Unknown and others|4
2075183|NCT00656175|3655873|FG000|Overall Study|Adverse Event|1
2075184|NCT00656175|3655874|FG001|Overall Study|Adverse Event|0
2075185|NCT00656175|3655873|FG000|Overall Study|Transportation issues|0
2075186|NCT00656175|3655874|FG001|Overall Study|Transportation issues|1
2075187|NCT00656292|3655891|FG000|Overall Study|Withdrawal by Subject|2
2075188|NCT00656292|3655892|FG001|Overall Study|Withdrawal by Subject|3
2075189|NCT00656292|3655891|FG000|Overall Study|Screen failure|1
2075190|NCT00656292|3655892|FG001|Overall Study|Screen failure|2
2075191|NCT00656370|3655907|FG000|Overall Study|Screen Failures|7
2075192|NCT00656370|3655907|FG000|Overall Study|Alternates|3
2075193|NCT00656474|3655923|FG000|Overall Study|Other Reason|1
2075194|NCT00656513|3655944|FG000|Overall Study|Protocol Violation|1
2075195|NCT00656513|3655945|FG001|Overall Study|Protocol Violation|0
2075196|NCT00656513|3655946|FG002|Overall Study|Protocol Violation|2
2075197|NCT00656513|3655944|FG000|Overall Study|Withdrawal by Subject|0
2075198|NCT00656513|3655945|FG001|Overall Study|Withdrawal by Subject|11
2075199|NCT00656513|3655946|FG002|Overall Study|Withdrawal by Subject|4
2075200|NCT00656513|3655944|FG000|Overall Study|Death|0
2075201|NCT00656513|3655945|FG001|Overall Study|Death|0
2075202|NCT00656513|3655946|FG002|Overall Study|Death|1
2304256|NCT02650921|4004142|FG000|Overall Study|Withdrawal by Subject|4
2304257|NCT02650921|4004142|FG000|Overall Study|Lost to Follow-up|2
2304258|NCT02650921|4004142|FG000|Overall Study|Adverse Event|1
2304259|NCT02650921|4004142|FG000|Overall Study|Due to Medical Condition|1
2304260|NCT02651116|4004158|FG000|Overall Study|Adverse Event|0
2304261|NCT02651116|4004159|FG001|Overall Study|Adverse Event|1
2304262|NCT02651116|4004158|FG000|Overall Study|No Longer Willing To Participate In Study|1
2075203|NCT00656513|3655944|FG000|Overall Study|Missing data|0
2075204|NCT00656513|3655945|FG001|Overall Study|Missing data|11
2075205|NCT00656513|3655946|FG002|Overall Study|Missing data|9
2075206|NCT00656513|3655944|FG000|Overall Study|Incomplete treatment|3
2210734|NCT01653912|3850578|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2304263|NCT02651116|4004159|FG001|Overall Study|No Longer Willing To Participate In Study|0
2075207|NCT00656513|3655945|FG001|Overall Study|Incomplete treatment|0
2075208|NCT00656513|3655946|FG002|Overall Study|Incomplete treatment|0
2075209|NCT00656513|3655944|FG000|Overall Study|Treatment completed outside of timeframe|0
2075210|NCT00656513|3655945|FG001|Overall Study|Treatment completed outside of timeframe|3
2075211|NCT00656513|3655946|FG002|Overall Study|Treatment completed outside of timeframe|1
2075212|NCT00656513|3655944|FG000|Overall Study|Missing baseline form|0
2075213|NCT00656513|3655945|FG001|Overall Study|Missing baseline form|5
2075214|NCT00656513|3655946|FG002|Overall Study|Missing baseline form|5
2075215|NCT00656617|3655954|FG000|Overall Study|Adverse Event|1
2075216|NCT00656617|3655954|FG000|Overall Study|Death|2
2075217|NCT00656617|3655954|FG000|Overall Study|Insurance Issues|2
2075218|NCT00656617|3655954|FG000|Overall Study|Move to different clinical trial|2
2075219|NCT00656669|3655976|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
2075220|NCT00656669|3655976|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
2075221|NCT00656669|3655976|FG000|AC (Cycles 6-9)|Adverse Event|1
2075222|NCT00656669|3655976|FG000|AC (Cycles 6-9)|Did not start segment 3|1
2075223|NCT00656799|3655985|FG000|Overall Study|Death|2
2075224|NCT00656851|3655991|FG000|Overall Study|Withdrawal by Subject|0
2075225|NCT00656851|3655992|FG001|Overall Study|Withdrawal by Subject|4
2075226|NCT00657020|3656007|FG000|PERIOD 1|Adverse Event|0
2075227|NCT00657020|3656008|FG001|PERIOD 1|Adverse Event|1
2075228|NCT00657046|3656023|FG000|Overall Study|Adverse Event|1
2075229|NCT00657046|3656024|FG001|Overall Study|Adverse Event|1
2075230|NCT00657046|3656025|FG002|Overall Study|Adverse Event|0
2075231|NCT00657046|3656023|FG000|Overall Study|Protocol Violation|2
2075232|NCT00657046|3656024|FG001|Overall Study|Protocol Violation|2
2075233|NCT00657046|3656025|FG002|Overall Study|Protocol Violation|0
2075234|NCT00657046|3656023|FG000|Overall Study|Withdrawal by Subject|1
2075235|NCT00657046|3656024|FG001|Overall Study|Withdrawal by Subject|0
2075236|NCT00657046|3656025|FG002|Overall Study|Withdrawal by Subject|0
2075237|NCT00657046|3656023|FG000|Overall Study|Death|0
2075238|NCT00657046|3656024|FG001|Overall Study|Death|0
2075239|NCT00657046|3656025|FG002|Overall Study|Death|1
2075240|NCT00657046|3656023|FG000|Overall Study|Surgery|0
2075241|NCT00657046|3656024|FG001|Overall Study|Surgery|0
2075242|NCT00657046|3656025|FG002|Overall Study|Surgery|1
2075243|NCT00657150|3656035|FG000|Overall Study|Adverse Event|19
2075244|NCT00657150|3656036|FG001|Overall Study|Adverse Event|10
2075245|NCT00657150|3656035|FG000|Overall Study|Non-compliant with protocol|5
2075246|NCT00657150|3656036|FG001|Overall Study|Non-compliant with protocol|9
2075247|NCT00657150|3656035|FG000|Overall Study|Lost to Follow-up|2
2075248|NCT00657150|3656036|FG001|Overall Study|Lost to Follow-up|0
2075249|NCT00657150|3656035|FG000|Overall Study|Withdrawal by Subject|51
2075250|NCT00657150|3656036|FG001|Overall Study|Withdrawal by Subject|36
2075251|NCT00657150|3656035|FG000|Overall Study|Other|38
2075252|NCT00657150|3656036|FG001|Overall Study|Other|38
2075253|NCT00657150|3656035|FG000|Treatment|Adverse Event|60
2075254|NCT00657150|3656036|FG001|Treatment|Adverse Event|53
2075255|NCT00657150|3656035|FG000|Treatment|Non-compliant with protocol|10
2075256|NCT00657150|3656036|FG001|Treatment|Non-compliant with protocol|9
2075257|NCT00657150|3656035|FG000|Treatment|Lost to Follow-up|1
2075258|NCT00657150|3656036|FG001|Treatment|Lost to Follow-up|0
2075259|NCT00657150|3656035|FG000|Treatment|Withdrawal by Subject|23
2075260|NCT00657150|3656036|FG001|Treatment|Withdrawal by Subject|20
2075261|NCT00657150|3656035|FG000|Treatment|Other|13
2075262|NCT00657150|3656036|FG001|Treatment|Other|15
2075263|NCT00657267|3656042|FG000|Overall Study|Progressive disease|45
2075264|NCT00657267|3656042|FG000|Overall Study|Adverse Event|9
2075265|NCT00657358|3656052|FG000|Overall Study|Lack of Efficacy|6
2075266|NCT00657371|3656057|FG000|Overall Study|Poor bowel preparation|15
2075267|NCT00657371|3656057|FG000|Overall Study|Unable to intubate the cecum|5
2075268|NCT00657371|3656057|FG000|Overall Study|Protocol Violation|2
2075269|NCT00657371|3656057|FG000|Overall Study|Device- related reasons|13
2075270|NCT00657371|3656057|FG000|Overall Study|Pre-existing medical condition|4
2075271|NCT00657540|3656063|FG000|Overall Study|Lost to Follow-up|1
2075272|NCT00657540|3656064|FG001|Overall Study|Lost to Follow-up|4
2075273|NCT00657618|3656074|FG000|Overall Study|Adverse Event|32
2075274|NCT00657618|3656074|FG000|Overall Study|Withdrawal by Subject|8
2075275|NCT00657618|3656074|FG000|Overall Study|negative for leishmaniasis|2
2075276|NCT00657618|3656074|FG000|Overall Study|didn't start due to schedule conflicts|1
2075277|NCT00657709|3656087|FG000|Overall Study|AE or Death|7
2075278|NCT00657709|3656088|FG001|Overall Study|AE or Death|7
2075279|NCT00657709|3656089|FG002|Overall Study|AE or Death|6
2075280|NCT00657709|3656090|FG003|Overall Study|AE or Death|7
2075281|NCT00657709|3656091|FG004|Overall Study|AE or Death|1
2075282|NCT00657709|3656087|FG000|Overall Study|Withdrawal by Subject|7
2075283|NCT00657709|3656088|FG001|Overall Study|Withdrawal by Subject|15
2075284|NCT00657709|3656089|FG002|Overall Study|Withdrawal by Subject|15
2075285|NCT00657709|3656090|FG003|Overall Study|Withdrawal by Subject|5
2075286|NCT00657709|3656091|FG004|Overall Study|Withdrawal by Subject|9
2075287|NCT00657709|3656087|FG000|Overall Study|Lost to Follow-up|9
2075288|NCT00657709|3656088|FG001|Overall Study|Lost to Follow-up|9
2075289|NCT00657709|3656089|FG002|Overall Study|Lost to Follow-up|7
2075290|NCT00657709|3656090|FG003|Overall Study|Lost to Follow-up|1
2075291|NCT00657709|3656091|FG004|Overall Study|Lost to Follow-up|21
2075292|NCT00657709|3656087|FG000|Overall Study|Protocol Violation|0
2075293|NCT00657709|3656088|FG001|Overall Study|Protocol Violation|2
2075294|NCT00657709|3656089|FG002|Overall Study|Protocol Violation|0
2075295|NCT00657709|3656090|FG003|Overall Study|Protocol Violation|1
2075296|NCT00657709|3656091|FG004|Overall Study|Protocol Violation|2
2075297|NCT00658021|3656120|FG000|28-Week Treatment Period|Adverse Event|3
2075298|NCT00658021|3656121|FG001|28-Week Treatment Period|Adverse Event|1
2075299|NCT00658021|3656122|FG002|28-Week Treatment Period|Adverse Event|0
2075300|NCT00658021|3656120|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0
2075301|NCT00658021|3656121|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2
2075302|NCT00658021|3656122|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0
2075303|NCT00658021|3656120|FG000|28-Week Treatment Period|Protocol Violation|0
2075304|NCT00658021|3656121|FG001|28-Week Treatment Period|Protocol Violation|2
2075305|NCT00658021|3656122|FG002|28-Week Treatment Period|Protocol Violation|1
2075306|NCT00658021|3656120|FG000|28-Week Treatment Period|Withdrawal by Subject|1
2075307|NCT00658021|3656121|FG001|28-Week Treatment Period|Withdrawal by Subject|1
2075308|NCT00658021|3656122|FG002|28-Week Treatment Period|Withdrawal by Subject|3
2075309|NCT00658021|3656120|FG000|28-Week Treatment Period|Physician Decision|1
2075310|NCT00658021|3656121|FG001|28-Week Treatment Period|Physician Decision|2
2075311|NCT00658021|3656122|FG002|28-Week Treatment Period|Physician Decision|1
2075312|NCT00658021|3656120|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1
2075313|NCT00658021|3656121|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1
2075314|NCT00658021|3656122|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1
2075315|NCT00658021|3656120|FG000|28-Week Treatment Period|Loss of glucose control|1
2075316|NCT00658021|3656121|FG001|28-Week Treatment Period|Loss of glucose control|1
2075317|NCT00658021|3656122|FG002|28-Week Treatment Period|Loss of glucose control|10
2075318|NCT00658021|3656120|FG000|28-Week Treatment Period|Other|2
2075319|NCT00658021|3656121|FG001|28-Week Treatment Period|Other|3
2075320|NCT00658021|3656122|FG002|28-Week Treatment Period|Other|1
2075321|NCT00658021|3656120|FG000|28-Week Treatment Period|Did not receive treatment|2
2075322|NCT00658021|3656121|FG001|28-Week Treatment Period|Did not receive treatment|0
2075323|NCT00658021|3656122|FG002|28-Week Treatment Period|Did not receive treatment|0
2075324|NCT00658021|3656120|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0
2075325|NCT00658021|3656121|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1
2075326|NCT00658021|3656122|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0
2075327|NCT00658021|3656120|FG000|Long-term Safety Follow-up Period|Physician Decision|0
2075328|NCT00658021|3656121|FG001|Long-term Safety Follow-up Period|Physician Decision|2
2075329|NCT00658021|3656122|FG002|Long-term Safety Follow-up Period|Physician Decision|0
2075330|NCT00658320|3656143|FG000|Core Study: 12 Months|Subject withdrew consent|5
2177242|NCT01371994|3801279|FG001|Overall Study|Protocol Violation|17
2177243|NCT01371994|3801278|FG000|Overall Study|Randomized but Never Received Study Drug|6
2177244|NCT01371994|3801279|FG001|Overall Study|Randomized but Never Received Study Drug|6
2177245|NCT01371994|3801278|FG000|Overall Study|Physician Decision|1
2177246|NCT01371994|3801279|FG001|Overall Study|Physician Decision|1
2177247|NCT01371994|3801278|FG000|Overall Study|Miscellaneous Reasons|6
2177248|NCT01371994|3801279|FG001|Overall Study|Miscellaneous Reasons|4
2177249|NCT01372085|3801295|FG000|Washout Period 2|Physician Decision|0
2177250|NCT01372085|3801296|FG001|Washout Period 2|Physician Decision|0
2177251|NCT01372085|3801297|FG002|Washout Period 2|Physician Decision|0
2177252|NCT01372085|3801298|FG003|Washout Period 2|Physician Decision|0
2177253|NCT01372085|3801299|FG004|Washout Period 2|Physician Decision|1
2177254|NCT01372085|3801300|FG005|Washout Period 2|Physician Decision|0
2177255|NCT01372085|3801301|FG006|Washout Period 2|Physician Decision|0
2177256|NCT01372085|3801302|FG007|Washout Period 2|Physician Decision|0
2177257|NCT01372085|3801303|FG008|Washout Period 2|Physician Decision|0
2075331|NCT00658320|3656144|FG001|Core Study: 12 Months|Subject withdrew consent|3
2075332|NCT00658320|3656143|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
2075333|NCT00658320|3656144|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
2075334|NCT00658320|3656143|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
2075335|NCT00658320|3656144|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
2075336|NCT00658320|3656143|FG000|Extension Study: After Month 24|Subject withdrew consent|2
2075337|NCT00658320|3656144|FG001|Extension Study: After Month 24|Subject withdrew consent|0
2075338|NCT00658333|3656154|FG000|Overall Study|Adverse Event|2
2075339|NCT00658333|3656155|FG001|Overall Study|Adverse Event|1
2075340|NCT00658359|3656164|FG000|Overall Study|Death|3
2075341|NCT00658359|3656165|FG001|Overall Study|Death|1
2075342|NCT00658359|3656166|FG002|Overall Study|Death|2
2075343|NCT00658359|3656164|FG000|Overall Study|Adverse Event|13
2075344|NCT00658359|3656165|FG001|Overall Study|Adverse Event|6
2075345|NCT00658359|3656166|FG002|Overall Study|Adverse Event|9
2075346|NCT00658359|3656164|FG000|Overall Study|Protocol Violation|1
2075347|NCT00658359|3656165|FG001|Overall Study|Protocol Violation|0
2075348|NCT00658359|3656166|FG002|Overall Study|Protocol Violation|0
2075349|NCT00658359|3656164|FG000|Overall Study|Includes protocol Amendments 3 and 4|2
2075350|NCT00658359|3656165|FG001|Overall Study|Includes protocol Amendments 3 and 4|31
2075351|NCT00658359|3656166|FG002|Overall Study|Includes protocol Amendments 3 and 4|29
2075352|NCT00658359|3656164|FG000|Overall Study|Withdrawal by Subject|7
2075353|NCT00658359|3656165|FG001|Overall Study|Withdrawal by Subject|4
2075354|NCT00658359|3656166|FG002|Overall Study|Withdrawal by Subject|2
2075355|NCT00658359|3656164|FG000|Overall Study|Lost to Follow-up|2
2075356|NCT00658359|3656165|FG001|Overall Study|Lost to Follow-up|2
2075357|NCT00658359|3656166|FG002|Overall Study|Lost to Follow-up|4
2075358|NCT00658359|3656164|FG000|Overall Study|Lack of Efficacy|0
2075359|NCT00658359|3656165|FG001|Overall Study|Lack of Efficacy|1
2075360|NCT00658359|3656166|FG002|Overall Study|Lack of Efficacy|0
2075361|NCT00658528|3656199|FG000|Overall Study|Adverse Event|5
2075362|NCT00658528|3656200|FG001|Overall Study|Adverse Event|7
2075363|NCT00658528|3656199|FG000|Overall Study|Lost to Follow-up|14
2075364|NCT00658528|3656200|FG001|Overall Study|Lost to Follow-up|22
2075365|NCT00658528|3656199|FG000|Overall Study|Withdrawal by Subject|8
2075366|NCT00658528|3656200|FG001|Overall Study|Withdrawal by Subject|6
2075367|NCT00658528|3656199|FG000|Overall Study|Withdrawal of consent|5
2075368|NCT00658528|3656200|FG001|Overall Study|Withdrawal of consent|6
2075369|NCT00658528|3656199|FG000|Overall Study|Other|8
2075370|NCT00658528|3656200|FG001|Overall Study|Other|4
2075371|NCT00658541|3656206|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
2075372|NCT00658541|3656207|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
2075373|NCT00658541|3656206|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
2075374|NCT00658541|3656207|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
2210735|NCT01653912|3850579|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2210736|NCT01653912|3850580|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2210737|NCT01653912|3850581|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
2210738|NCT01653912|3850582|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2075375|NCT00658567|3656216|FG000|Overall Study|Adverse Event|5
2075376|NCT00658567|3656217|FG001|Overall Study|Adverse Event|2
2075377|NCT00658567|3656218|FG002|Overall Study|Adverse Event|3
2075378|NCT00658567|3656216|FG000|Overall Study|Voluntary Withdrawal of Consent|2
2075379|NCT00658567|3656217|FG001|Overall Study|Voluntary Withdrawal of Consent|0
2075380|NCT00658567|3656218|FG002|Overall Study|Voluntary Withdrawal of Consent|2
2075381|NCT00658567|3656216|FG000|Overall Study|Physician Decision|0
2075382|NCT00658567|3656217|FG001|Overall Study|Physician Decision|1
2075383|NCT00658567|3656218|FG002|Overall Study|Physician Decision|0
2075384|NCT00658567|3656216|FG000|Overall Study|At Discretion of Sponsor|1
2075385|NCT00658567|3656217|FG001|Overall Study|At Discretion of Sponsor|1
2177258|NCT01372085|3801304|FG009|Washout Period 2|Physician Decision|0
2304264|NCT02651155|4004167|FG000|Overall Study|Pretreatment Event/Adverse Event|1
2304265|NCT02651155|4004168|FG001|Overall Study|Pretreatment Event/Adverse Event|2
2304266|NCT02651155|4004167|FG000|Overall Study|Voluntary Withdrawal|5
2304267|NCT02651155|4004168|FG001|Overall Study|Voluntary Withdrawal|0
2075386|NCT00658567|3656218|FG002|Overall Study|At Discretion of Sponsor|1
2210739|NCT01653912|3850583|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2210740|NCT01653912|3850578|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2210741|NCT01653912|3850579|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2210742|NCT01653912|3850580|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2106540|NCT00866359|3699662|FG002|Treatment Phase (Days 1 to 85)|Other|0
2106541|NCT00866359|3699663|FG003|Treatment Phase (Days 1 to 85)|Other|0
2106542|NCT00866359|3699660|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0
2106543|NCT00866359|3699661|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0
2106544|NCT00866359|3699662|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1
2106545|NCT00866359|3699663|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3
2106546|NCT00866606|3699690|FG000|Overall Study|Lost to Follow-up|3
2106547|NCT00866606|3699690|FG000|Overall Study|Adverse Event|1
2106548|NCT00866619|3699698|FG000|Overall Study|Adverse Event|112
2106549|NCT00866619|3699699|FG001|Overall Study|Adverse Event|106
2106550|NCT00866619|3699700|FG002|Overall Study|Adverse Event|47
2106551|NCT00866619|3699701|FG003|Overall Study|Adverse Event|44
2106552|NCT00866619|3699698|FG000|Overall Study|Protocol Violation|2
2106553|NCT00866619|3699699|FG001|Overall Study|Protocol Violation|39
2106554|NCT00866619|3699700|FG002|Overall Study|Protocol Violation|2
2106555|NCT00866619|3699701|FG003|Overall Study|Protocol Violation|17
2106556|NCT00866619|3699698|FG000|Overall Study|Withdrawal by Subject|587
2106557|NCT00866619|3699699|FG001|Overall Study|Withdrawal by Subject|295
2106558|NCT00866619|3699700|FG002|Overall Study|Withdrawal by Subject|272
2106559|NCT00866619|3699701|FG003|Overall Study|Withdrawal by Subject|144
2106560|NCT00866619|3699698|FG000|Overall Study|Lost to Follow-up|1145
2106561|NCT00866619|3699699|FG001|Overall Study|Lost to Follow-up|830
2106562|NCT00866619|3699700|FG002|Overall Study|Lost to Follow-up|568
2106563|NCT00866619|3699701|FG003|Overall Study|Lost to Follow-up|425
2106564|NCT00866658|3699738|FG000|Overall Study|Adverse Event|5
2106565|NCT00866658|3699739|FG001|Overall Study|Adverse Event|14
2106566|NCT00866658|3699738|FG000|Overall Study|Lack of Efficacy|2
2106567|NCT00866658|3699739|FG001|Overall Study|Lack of Efficacy|1
2106568|NCT00866658|3699738|FG000|Overall Study|Withdrawal by Subject|1
2106569|NCT00866658|3699739|FG001|Overall Study|Withdrawal by Subject|0
2106570|NCT00866658|3699738|FG000|Overall Study|Protocol Violation|1
2106571|NCT00866658|3699739|FG001|Overall Study|Protocol Violation|1
2106572|NCT00866658|3699738|FG000|Overall Study|Familial and Personal Reasons|4
2106573|NCT00866658|3699739|FG001|Overall Study|Familial and Personal Reasons|5
2106574|NCT00866697|3699747|FG000|Overall Study|Study closed/terminated|156
2106575|NCT00866697|3699748|FG001|Overall Study|Study closed/terminated|138
2106576|NCT00866697|3699747|FG000|Overall Study|Lost to Follow-up|22
2210743|NCT01653912|3850581|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
2210744|NCT01653912|3850582|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2210745|NCT01653912|3850583|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2210746|NCT01653912|3850578|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0
2210747|NCT01653912|3850579|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0
2210748|NCT01653912|3850580|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0
2210749|NCT01653912|3850581|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0
2210750|NCT01653912|3850582|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0
2210751|NCT01653912|3850583|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1
2210752|NCT01653912|3850578|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2210753|NCT01653912|3850579|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2210754|NCT01653912|3850580|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2210755|NCT01653912|3850581|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2106577|NCT00866697|3699748|FG001|Overall Study|Lost to Follow-up|28
2106578|NCT00866697|3699747|FG000|Overall Study|Physician Decision|3
2106579|NCT00866697|3699748|FG001|Overall Study|Physician Decision|5
2106580|NCT00866697|3699747|FG000|Overall Study|Withdrawal by Subject|33
2106581|NCT00866697|3699748|FG001|Overall Study|Withdrawal by Subject|57
2106582|NCT00866723|3699754|FG000|Overall Study|Withdrawal by Subject|1
2106583|NCT00866723|3699754|FG000|Overall Study|Disease Progression|4
2106584|NCT00866775|3699764|FG000|Overall Study|Adverse Event|5
2106585|NCT00866775|3699765|FG001|Overall Study|Adverse Event|19
2106586|NCT00866775|3699764|FG000|Overall Study|Death|1
2106587|NCT00866775|3699765|FG001|Overall Study|Death|0
2106588|NCT00866775|3699764|FG000|Overall Study|Lost to Follow-up|0
2106589|NCT00866775|3699765|FG001|Overall Study|Lost to Follow-up|4
2106590|NCT00866775|3699764|FG000|Overall Study|Physician Decision|0
2106591|NCT00866775|3699765|FG001|Overall Study|Physician Decision|3
2106592|NCT00866775|3699764|FG000|Overall Study|Protocol Violation|3
2106593|NCT00866775|3699765|FG001|Overall Study|Protocol Violation|4
2106594|NCT00866775|3699764|FG000|Overall Study|Withdrawal by Subject|4
2106595|NCT00866775|3699765|FG001|Overall Study|Withdrawal by Subject|4
2106596|NCT00866775|3699764|FG000|Overall Study|met exit criteria|23
2106597|NCT00866775|3699765|FG001|Overall Study|met exit criteria|17
2106598|NCT00866775|3699764|FG000|Overall Study|discontinued due to communication error|0
2106599|NCT00866775|3699765|FG001|Overall Study|discontinued due to communication error|1
2106600|NCT00866788|3699777|FG000|Overall Study|Adverse Event|0
2106601|NCT00866788|3699778|FG001|Overall Study|Adverse Event|2
2106602|NCT00866788|3699779|FG002|Overall Study|Adverse Event|0
2106603|NCT00866788|3699780|FG003|Overall Study|Adverse Event|1
2075387|NCT00658606|3656228|FG000|Overall Study|Adverse Event|2
2075388|NCT00658606|3656229|FG001|Overall Study|Adverse Event|1
2075389|NCT00658606|3656228|FG000|Overall Study|Lack of Efficacy|6
2075390|NCT00658606|3656229|FG001|Overall Study|Lack of Efficacy|3
2075391|NCT00658606|3656228|FG000|Overall Study|Lost to Follow-up|1
2075392|NCT00658606|3656229|FG001|Overall Study|Lost to Follow-up|0
2075393|NCT00658606|3656228|FG000|Overall Study|Withdrawal by Subject|7
2075394|NCT00658606|3656229|FG001|Overall Study|Withdrawal by Subject|16
2075395|NCT00658606|3656228|FG000|Overall Study|Lack of Compliance|0
2075396|NCT00658606|3656229|FG001|Overall Study|Lack of Compliance|3
2075397|NCT00658632|3656255|FG000|Overall Study|Adverse Event|13
2075398|NCT00658632|3656256|FG001|Overall Study|Adverse Event|11
2075399|NCT00658632|3656255|FG000|Overall Study|Lost to Follow-up|25
2075400|NCT00658632|3656256|FG001|Overall Study|Lost to Follow-up|23
2075401|NCT00658632|3656255|FG000|Overall Study|Withdrawal by Subject|10
2075402|NCT00658632|3656256|FG001|Overall Study|Withdrawal by Subject|7
2075403|NCT00658632|3656255|FG000|Overall Study|Lack of Efficacy|0
2075404|NCT00658632|3656256|FG001|Overall Study|Lack of Efficacy|1
2075405|NCT00658632|3656255|FG000|Overall Study|Withdrawal of consent|8
2075406|NCT00658632|3656256|FG001|Overall Study|Withdrawal of consent|14
2075407|NCT00658632|3656255|FG000|Overall Study|Pregnancy|1
2075408|NCT00658632|3656256|FG001|Overall Study|Pregnancy|1
2075409|NCT00658632|3656255|FG000|Overall Study|Other|7
2075410|NCT00658632|3656256|FG001|Overall Study|Other|8
2075411|NCT00658658|3656267|FG000|Overall Study|Withdrawal by Subject|0
2075412|NCT00658658|3656268|FG001|Overall Study|Withdrawal by Subject|1
2075413|NCT00658658|3656269|FG002|Overall Study|Withdrawal by Subject|0
2075414|NCT00658658|3656270|FG003|Overall Study|Withdrawal by Subject|0
2075415|NCT00658658|3656271|FG004|Overall Study|Withdrawal by Subject|0
2075416|NCT00658658|3656267|FG000|Overall Study|Death|4
2075417|NCT00658658|3656268|FG001|Overall Study|Death|0
2075418|NCT00658658|3656269|FG002|Overall Study|Death|0
2075419|NCT00658658|3656270|FG003|Overall Study|Death|1
2075420|NCT00658658|3656271|FG004|Overall Study|Death|1
2075421|NCT00658658|3656267|FG000|Overall Study|Disease Progression|0
2075422|NCT00658658|3656268|FG001|Overall Study|Disease Progression|1
2075423|NCT00658658|3656269|FG002|Overall Study|Disease Progression|0
2075424|NCT00658658|3656270|FG003|Overall Study|Disease Progression|1
2075425|NCT00658658|3656271|FG004|Overall Study|Disease Progression|3
2075426|NCT00658658|3656267|FG000|Overall Study|Protocol-specified Criteria|1
2075427|NCT00658658|3656268|FG001|Overall Study|Protocol-specified Criteria|0
2075428|NCT00658658|3656269|FG002|Overall Study|Protocol-specified Criteria|0
2075429|NCT00658658|3656270|FG003|Overall Study|Protocol-specified Criteria|0
2075430|NCT00658658|3656271|FG004|Overall Study|Protocol-specified Criteria|0
2075431|NCT00658658|3656267|FG000|Overall Study|Other|0
2075432|NCT00658658|3656268|FG001|Overall Study|Other|0
2075433|NCT00658658|3656269|FG002|Overall Study|Other|0
2075434|NCT00658658|3656270|FG003|Overall Study|Other|0
2075435|NCT00658658|3656271|FG004|Overall Study|Other|1
2075436|NCT00658684|3656286|FG000|Overall Study|Adverse Event|10
2075437|NCT00658684|3656287|FG001|Overall Study|Adverse Event|8
2075438|NCT00658684|3656288|FG002|Overall Study|Adverse Event|2
2075439|NCT00658684|3656289|FG003|Overall Study|Adverse Event|0
2075440|NCT00658684|3656286|FG000|Overall Study|Withdrawal by Subject|6
2075441|NCT00658684|3656287|FG001|Overall Study|Withdrawal by Subject|4
2075442|NCT00658684|3656288|FG002|Overall Study|Withdrawal by Subject|1
2075443|NCT00658684|3656289|FG003|Overall Study|Withdrawal by Subject|1
2075444|NCT00658684|3656286|FG000|Overall Study|Lack of Efficacy|1
2075445|NCT00658684|3656287|FG001|Overall Study|Lack of Efficacy|1
2075446|NCT00658684|3656288|FG002|Overall Study|Lack of Efficacy|0
2075447|NCT00658684|3656289|FG003|Overall Study|Lack of Efficacy|0
2075448|NCT00658684|3656286|FG000|Overall Study|Protocol Violation|1
2075449|NCT00658684|3656287|FG001|Overall Study|Protocol Violation|1
2075450|NCT00658684|3656288|FG002|Overall Study|Protocol Violation|0
2075451|NCT00658684|3656289|FG003|Overall Study|Protocol Violation|0
2075452|NCT00658684|3656286|FG000|Overall Study|Pregnancy|1
2075453|NCT00658684|3656287|FG001|Overall Study|Pregnancy|1
2075454|NCT00658684|3656288|FG002|Overall Study|Pregnancy|0
2075455|NCT00658684|3656289|FG003|Overall Study|Pregnancy|0
2075456|NCT00658723|3656307|FG000|Overall Study|Lost to Follow-up|0
2075457|NCT00658723|3656308|FG001|Overall Study|Lost to Follow-up|2
2075458|NCT00658723|3656309|FG002|Overall Study|Lost to Follow-up|2
2075459|NCT00658723|3656307|FG000|Overall Study|Death|2
2075460|NCT00658723|3656308|FG001|Overall Study|Death|1
2075461|NCT00658723|3656309|FG002|Overall Study|Death|4
2075462|NCT00658723|3656307|FG000|Overall Study|Scheduling Issue|1
2075463|NCT00658723|3656308|FG001|Overall Study|Scheduling Issue|1
2075464|NCT00658723|3656309|FG002|Overall Study|Scheduling Issue|0
2075465|NCT00658723|3656307|FG000|Overall Study|Withdrawal by Subject|1
2075466|NCT00658723|3656308|FG001|Overall Study|Withdrawal by Subject|0
2075467|NCT00658723|3656309|FG002|Overall Study|Withdrawal by Subject|1
2075468|NCT00658775|3656331|FG000|Overall Study|Adverse Event|4
2075469|NCT00658775|3656332|FG001|Overall Study|Adverse Event|6
2075470|NCT00658775|3656331|FG000|Overall Study|Lost to Follow-up|17
2075471|NCT00658775|3656332|FG001|Overall Study|Lost to Follow-up|18
2075472|NCT00658775|3656331|FG000|Overall Study|Withdrawal by Subject|6
2075473|NCT00658775|3656332|FG001|Overall Study|Withdrawal by Subject|4
2075474|NCT00658775|3656331|FG000|Overall Study|Withdrawal of consent|8
2075475|NCT00658775|3656332|FG001|Overall Study|Withdrawal of consent|7
2075476|NCT00658775|3656331|FG000|Overall Study|Other|7
2075477|NCT00658775|3656332|FG001|Overall Study|Other|8
2075478|NCT00658788|3656338|FG000|Overall Study|Adverse Event|11
2075479|NCT00658788|3656338|FG000|Overall Study|Withdrawal by Subject|13
2075480|NCT00658788|3656338|FG000|Overall Study|Lost to Follow-up|18
2075481|NCT00658788|3656338|FG000|Overall Study|Treatment Discontinuation|32
2075482|NCT00658814|3656353|FG000|Remission Induction Chemotherapy|Adverse Event|1
2075483|NCT00658814|3656354|FG001|Remission Induction Chemotherapy|Adverse Event|3
2075484|NCT00658814|3656353|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3
2075485|NCT00658814|3656354|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4
2075486|NCT00658814|3656353|FG000|Remission Induction Chemotherapy|Progression/Relapse|0
2075487|NCT00658814|3656354|FG001|Remission Induction Chemotherapy|Progression/Relapse|1
2075488|NCT00658814|3656353|FG000|Remission Induction Chemotherapy|Death|1
2075489|NCT00658814|3656354|FG001|Remission Induction Chemotherapy|Death|4
2075490|NCT00658814|3656353|FG000|Remission Induction Chemotherapy|Not protocol specified|2
2075491|NCT00658814|3656354|FG001|Remission Induction Chemotherapy|Not protocol specified|4
2075492|NCT00658814|3656353|FG000|Remission Induction Chemotherapy|Not eligible|1
2075493|NCT00658814|3656354|FG001|Remission Induction Chemotherapy|Not eligible|2
2075494|NCT00658814|3656353|FG000|Consolidation Therapy|Not protocol specified|0
2075495|NCT00658814|3656354|FG001|Consolidation Therapy|Not protocol specified|1
2075496|NCT00658814|3656353|FG000|Consolidation Therapy|Not eligible|2
2075497|NCT00658814|3656354|FG001|Consolidation Therapy|Not eligible|2
2075498|NCT00658814|3656353|FG000|Maintenance Therapy|Adverse Event|1
2075499|NCT00658814|3656354|FG001|Maintenance Therapy|Adverse Event|1
2075500|NCT00658814|3656353|FG000|Maintenance Therapy|Not protocol specified|1
2075501|NCT00658814|3656354|FG001|Maintenance Therapy|Not protocol specified|0
2075502|NCT00658814|3656353|FG000|Maintenance Therapy|Not eligible|1
2075503|NCT00658814|3656354|FG001|Maintenance Therapy|Not eligible|0
2075504|NCT00658879|3656364|FG000|Overall Study|Protocol Violation|1
2075505|NCT00658996|3656368|FG000|First Intervention|Positive slit lamp finding|1
2075506|NCT00658996|3656369|FG001|First Intervention|Positive slit lamp finding|0
2075507|NCT00658996|3656368|FG000|First Intervention|Lack of lenses|0
2075508|NCT00658996|3656369|FG001|First Intervention|Lack of lenses|1
2075509|NCT00658996|3656368|FG000|Crossover Period|Physician Decision|1
2075510|NCT00658996|3656369|FG001|Crossover Period|Physician Decision|0
2075511|NCT00658996|3656368|FG000|Crossover Period|Ineligible|1
2075512|NCT00658996|3656369|FG001|Crossover Period|Ineligible|1
2075513|NCT00658996|3656368|FG000|Second Intervention|Developed a stye on upper lid|1
2075514|NCT00658996|3656369|FG001|Second Intervention|Developed a stye on upper lid|0
2075515|NCT00658996|3656368|FG000|Second Intervention|Positive slit lamp finding|0
2075516|NCT00658996|3656369|FG001|Second Intervention|Positive slit lamp finding|1
2075517|NCT00659230|3656386|FG000|Overall Study|Lost to Follow-up|2
2075518|NCT00659230|3656387|FG001|Overall Study|Lost to Follow-up|5
2075519|NCT00659230|3656386|FG000|Overall Study|Lost source documentation|5
2075520|NCT00659230|3656387|FG001|Overall Study|Lost source documentation|4
2075521|NCT00659230|3656386|FG000|Overall Study|Did not return post-randomization|2
2075522|NCT00659230|3656387|FG001|Overall Study|Did not return post-randomization|3
2075523|NCT00659269|3656395|FG000|Overall Study|Physician Decision|1
2075524|NCT00659269|3656396|FG001|Overall Study|Physician Decision|1
2075525|NCT00659334|3656427|FG000|Overall Study|Screen Failure|8
2075526|NCT00659334|3656428|FG001|Overall Study|Screen Failure|5
2075527|NCT00659334|3656429|FG002|Overall Study|Screen Failure|0
2075528|NCT00659334|3656430|FG003|Overall Study|Screen Failure|0
2075529|NCT00659334|3656431|FG004|Overall Study|Screen Failure|0
2075530|NCT00659334|3656432|FG005|Overall Study|Screen Failure|0
2075531|NCT00659334|3656433|FG006|Overall Study|Screen Failure|1
2075532|NCT00659373|3656457|FG000|Overall Study|Withdrawal by Subject|3
2075533|NCT00659373|3656458|FG001|Overall Study|Withdrawal by Subject|5
2075534|NCT00659373|3656457|FG000|Overall Study|Assessment Missed|2
2075535|NCT00659373|3656458|FG001|Overall Study|Assessment Missed|2
2075536|NCT00659425|3656474|FG000|Overall Study|Disease progression|1
2075537|NCT00659425|3656475|FG001|Overall Study|Disease progression|0
2075538|NCT00659425|3656476|FG002|Overall Study|Disease progression|0
2075539|NCT00659425|3656477|FG003|Overall Study|Disease progression|1
2075540|NCT00659425|3656478|FG004|Overall Study|Disease progression|0
2075541|NCT00659425|3656479|FG005|Overall Study|Disease progression|2
2075542|NCT00659425|3656480|FG006|Overall Study|Disease progression|4
2075543|NCT00659425|3656481|FG007|Overall Study|Disease progression|3
2075544|NCT00659425|3656482|FG008|Overall Study|Disease progression|5
2075545|NCT00659425|3656483|FG009|Overall Study|Disease progression|3
2075546|NCT00659425|3656474|FG000|Overall Study|Death|0
2075547|NCT00659425|3656475|FG001|Overall Study|Death|0
2075548|NCT00659425|3656476|FG002|Overall Study|Death|0
2075549|NCT00659425|3656477|FG003|Overall Study|Death|1
2075550|NCT00659425|3656478|FG004|Overall Study|Death|0
2075551|NCT00659425|3656479|FG005|Overall Study|Death|0
2075552|NCT00659425|3656480|FG006|Overall Study|Death|1
2075553|NCT00659425|3656481|FG007|Overall Study|Death|0
2075554|NCT00659425|3656482|FG008|Overall Study|Death|0
2075555|NCT00659425|3656483|FG009|Overall Study|Death|0
2075556|NCT00659425|3656474|FG000|Overall Study|Adverse Event|0
2075557|NCT00659425|3656475|FG001|Overall Study|Adverse Event|0
2075558|NCT00659425|3656476|FG002|Overall Study|Adverse Event|0
2075559|NCT00659425|3656477|FG003|Overall Study|Adverse Event|0
2075560|NCT00659425|3656478|FG004|Overall Study|Adverse Event|0
2075561|NCT00659425|3656479|FG005|Overall Study|Adverse Event|1
2075562|NCT00659425|3656480|FG006|Overall Study|Adverse Event|0
2075563|NCT00659425|3656481|FG007|Overall Study|Adverse Event|3
2075564|NCT00659425|3656482|FG008|Overall Study|Adverse Event|1
2075565|NCT00659425|3656483|FG009|Overall Study|Adverse Event|4
2075566|NCT00659425|3656474|FG000|Overall Study|Investigator Discretion|0
2075567|NCT00659425|3656475|FG001|Overall Study|Investigator Discretion|0
2075568|NCT00659425|3656476|FG002|Overall Study|Investigator Discretion|0
2075569|NCT00659425|3656477|FG003|Overall Study|Investigator Discretion|0
2075570|NCT00659425|3656478|FG004|Overall Study|Investigator Discretion|0
2075571|NCT00659425|3656479|FG005|Overall Study|Investigator Discretion|1
2075572|NCT00659425|3656480|FG006|Overall Study|Investigator Discretion|0
2075573|NCT00659425|3656481|FG007|Overall Study|Investigator Discretion|3
2075574|NCT00659425|3656482|FG008|Overall Study|Investigator Discretion|0
2075575|NCT00659425|3656483|FG009|Overall Study|Investigator Discretion|0
2075576|NCT00659425|3656474|FG000|Overall Study|Other|0
2075577|NCT00659425|3656475|FG001|Overall Study|Other|1
2075578|NCT00659425|3656476|FG002|Overall Study|Other|1
2075579|NCT00659425|3656477|FG003|Overall Study|Other|2
2075580|NCT00659425|3656478|FG004|Overall Study|Other|4
2075581|NCT00659425|3656479|FG005|Overall Study|Other|0
2075582|NCT00659425|3656480|FG006|Overall Study|Other|3
2075583|NCT00659425|3656481|FG007|Overall Study|Other|2
2075584|NCT00659425|3656482|FG008|Overall Study|Other|0
2075585|NCT00659425|3656483|FG009|Overall Study|Other|6
2075586|NCT00659438|3656520|FG000|Overall Study|Withdrawal by Subject|2
2075587|NCT00659438|3656521|FG001|Overall Study|Withdrawal by Subject|2
2075588|NCT00659438|3656520|FG000|Overall Study|Death|11
2075589|NCT00659438|3656521|FG001|Overall Study|Death|6
2075590|NCT00659438|3656520|FG000|Overall Study|Lost to Follow-up|1
2075591|NCT00659438|3656521|FG001|Overall Study|Lost to Follow-up|0
2075592|NCT00659490|3656530|FG000|Overall Study|Lost to Follow-up|2
2075593|NCT00659490|3656531|FG001|Overall Study|Lost to Follow-up|0
2075594|NCT00659490|3656532|FG002|Overall Study|Lost to Follow-up|1
2075595|NCT00659529|3656540|FG000|Overall Study|Withdrawal by Subject|4
2075596|NCT00659529|3656540|FG000|Overall Study|Protocol Violation|3
2075597|NCT00659529|3656540|FG000|Overall Study|Screen failure|9
2075598|NCT00659581|3656544|FG000|Overall Study|Adverse Event|1006
2075599|NCT00659581|3656544|FG000|Overall Study|Lack of Efficacy|1183
2075600|NCT00659581|3656544|FG000|Overall Study|Other|6393
2075601|NCT00659607|3656548|FG000|Overall Study|No blood pressure recorded|147
2075602|NCT00659607|3656548|FG000|Overall Study|Unknown measuring date of blood pressure|85
2075603|NCT00659607|3656548|FG000|Overall Study|'Unable to evaluate' for the final asses|67
2075604|NCT00659607|3656548|FG000|Overall Study|No recorded efficacy data|15
2075605|NCT00659607|3656548|FG000|Overall Study|Inconsistent BP measuring date|2
2075606|NCT00659815|3656597|FG000|Overall Study|Study related symptoms and complaints|2
2075607|NCT00659815|3656598|FG001|Overall Study|Study related symptoms and complaints|1
2075608|NCT00659815|3656597|FG000|Overall Study|Inability to maintain wearing schedule|1
2075609|NCT00659815|3656598|FG001|Overall Study|Inability to maintain wearing schedule|2
2075610|NCT00659815|3656597|FG000|Overall Study|Withdrawal by Subject|1
2075611|NCT00659815|3656598|FG001|Overall Study|Withdrawal by Subject|1
2075612|NCT00659880|3656608|FG000|Overall Study|Lost to Follow-up|5
2075613|NCT00659984|3656622|FG000|Overall Study|Adverse Event|1
2075614|NCT00660010|3656632|FG000|Overall Study|Withdrawal by Subject|2
2075615|NCT00660010|3656632|FG000|Overall Study|Lost to Follow-up|3
2075616|NCT00660010|3656632|FG000|Overall Study|Adverse Event|1
2075617|NCT00660010|3656632|FG000|Overall Study|Noncompliance with visit schedule|3
2075618|NCT00660023|3656636|FG000|Overall Study|Adverse Event|2
2075619|NCT00660023|3656636|FG000|Overall Study|Death|8
2075620|NCT00660023|3656636|FG000|Overall Study|Blood Transfusion|5
2075621|NCT00660023|3656636|FG000|Overall Study|Renal Transplantation|3
2075622|NCT00660023|3656636|FG000|Overall Study|Withdrawal by Subject|1
2075623|NCT00660023|3656636|FG000|Overall Study|Missed Pregnancy Test|1
2075624|NCT00660023|3656636|FG000|Overall Study|Other Screening Failure|9
2075625|NCT00660179|3656656|FG000|Overall Study|Death|44
2075626|NCT00660179|3656657|FG001|Overall Study|Death|47
2075627|NCT00660179|3656658|FG002|Overall Study|Death|34
2075628|NCT00660179|3656656|FG000|Overall Study|Withdrawal of consent|4
2075629|NCT00660179|3656657|FG001|Overall Study|Withdrawal of consent|6
2075630|NCT00660179|3656658|FG002|Overall Study|Withdrawal of consent|4
2075631|NCT00660179|3656656|FG000|Overall Study|Lost to Follow-up|7
2075632|NCT00660179|3656657|FG001|Overall Study|Lost to Follow-up|5
2075633|NCT00660179|3656658|FG002|Overall Study|Lost to Follow-up|2
2075634|NCT00660179|3656656|FG000|Overall Study|Administrative reason|0
2075635|NCT00660179|3656657|FG001|Overall Study|Administrative reason|0
2075636|NCT00660179|3656658|FG002|Overall Study|Administrative reason|1
2075637|NCT00660179|3656656|FG000|Overall Study|Incorrect randomization|1
2075638|NCT00660179|3656657|FG001|Overall Study|Incorrect randomization|0
2075639|NCT00660179|3656658|FG002|Overall Study|Incorrect randomization|0
2075640|NCT00660192|3656668|FG000|Overall Study|Lost to Follow-up|2
2075641|NCT00660192|3656669|FG001|Overall Study|Lost to Follow-up|3
2075642|NCT00660309|3656677|FG000|Overall Study|Adverse Event|2
2075643|NCT00660309|3656678|FG001|Overall Study|Adverse Event|0
2075644|NCT00660309|3656677|FG000|Overall Study|Withdrawal by Subject|0
2075645|NCT00660309|3656678|FG001|Overall Study|Withdrawal by Subject|3
2075646|NCT00660387|3656687|FG000|Overall Study|Adverse Event|1
2075647|NCT00660387|3656688|FG001|Overall Study|Adverse Event|2
2075648|NCT00660387|3656687|FG000|Overall Study|Lack of Efficacy|0
2075649|NCT00660387|3656688|FG001|Overall Study|Lack of Efficacy|1
2075650|NCT00660387|3656687|FG000|Overall Study|Protocol Violation|1
2075651|NCT00660387|3656688|FG001|Overall Study|Protocol Violation|0
2075652|NCT00660400|3656694|FG000|Overall Study|Lack of insurance approval|1
2075653|NCT00660400|3656694|FG000|Overall Study|Suboptimal organ function|1
2075654|NCT00660400|3656694|FG000|Overall Study|Intracranial hemorrhage|1
2075655|NCT00660400|3656694|FG000|Overall Study|Withdrawal by Subject|1
2075656|NCT00660660|3656742|FG000|Overall Study|Adverse Event|1
2075657|NCT00660660|3656743|FG001|Overall Study|Adverse Event|0
2075658|NCT00660660|3656742|FG000|Overall Study|Lost to Follow-up|0
2075659|NCT00660660|3656743|FG001|Overall Study|Lost to Follow-up|6
2075660|NCT00660660|3656742|FG000|Overall Study|Lack of Efficacy|0
2075661|NCT00660660|3656743|FG001|Overall Study|Lack of Efficacy|2
2075662|NCT00660660|3656742|FG000|Overall Study|Withdrawal by Subject|3
2075663|NCT00660660|3656743|FG001|Overall Study|Withdrawal by Subject|0
2075664|NCT00660660|3656742|FG000|Overall Study|Incorrect enrollment and other|0
2075665|NCT00660660|3656743|FG001|Overall Study|Incorrect enrollment and other|1
2075666|NCT00660660|3656742|FG000|Overall Study|New medication after randomization|1
2075667|NCT00660660|3656743|FG001|Overall Study|New medication after randomization|0
2075668|NCT00660699|3656749|FG000|Overall Study|Withdrawal by Subject|2
2075669|NCT00660790|3656753|FG000|Baseline to 3 Months|Death|1
2075670|NCT00660790|3656753|FG000|Baseline to 3 Months|Withdrawal by Subject|2
2075671|NCT00660790|3656753|FG000|3 Months to 2 Years|Withdrawal by Subject|17
2075672|NCT00660816|3656759|FG000|Overall Study|Adverse Event|1
2075673|NCT00660816|3656760|FG001|Overall Study|Adverse Event|2
2075674|NCT00660816|3656759|FG000|Overall Study|Withdrawal by Subject|1
2075675|NCT00660816|3656760|FG001|Overall Study|Withdrawal by Subject|0
2075676|NCT00660816|3656759|FG000|Overall Study|Death|0
2075677|NCT00660816|3656760|FG001|Overall Study|Death|2
2075678|NCT00660816|3656759|FG000|Overall Study|Lack of Efficacy|1
2075679|NCT00660816|3656760|FG001|Overall Study|Lack of Efficacy|0
2075680|NCT00660816|3656759|FG000|Overall Study|Physician Decision|0
2075681|NCT00660816|3656760|FG001|Overall Study|Physician Decision|2
2075682|NCT00660816|3656759|FG000|Overall Study|Protocol Violation|1
2075683|NCT00660816|3656760|FG001|Overall Study|Protocol Violation|0
2075684|NCT00660816|3656759|FG000|Overall Study|Disease Progression|16
2075685|NCT00660816|3656760|FG001|Overall Study|Disease Progression|12
2075686|NCT00660816|3656759|FG000|Overall Study|Complicating Disease|0
2075687|NCT00660816|3656760|FG001|Overall Study|Complicating Disease|1
2075688|NCT00660829|3656768|FG000|Overall Study|Adverse Event|3
2075689|NCT00660829|3656769|FG001|Overall Study|Adverse Event|4
2075690|NCT00660829|3656768|FG000|Overall Study|Lack of Efficacy|2
2075691|NCT00660829|3656769|FG001|Overall Study|Lack of Efficacy|3
2075692|NCT00660829|3656768|FG000|Overall Study|Non-Compliance|0
2075693|NCT00660829|3656769|FG001|Overall Study|Non-Compliance|4
2075694|NCT00660829|3656768|FG000|Overall Study|Withdrawal by Subject|1
2075695|NCT00660829|3656769|FG001|Overall Study|Withdrawal by Subject|2
2075696|NCT00660829|3656768|FG000|Overall Study|Lost to Follow-up|3
2075697|NCT00660829|3656769|FG001|Overall Study|Lost to Follow-up|2
2075698|NCT00660829|3656768|FG000|Overall Study|Other|9
2075699|NCT00660829|3656769|FG001|Overall Study|Other|4
2075700|NCT00660907|3656777|FG000|Overall Study|Incorrect Enrollment|1
2075701|NCT00660907|3656778|FG001|Overall Study|Incorrect Enrollment|1
2075702|NCT00660907|3656777|FG000|Overall Study|Adverse Event|33
2075703|NCT00660907|3656778|FG001|Overall Study|Adverse Event|19
2075704|NCT00660907|3656777|FG000|Overall Study|Subject No Longer Meets Study Criteria|6
2075705|NCT00660907|3656778|FG001|Overall Study|Subject No Longer Meets Study Criteria|27
2075706|NCT00660907|3656777|FG000|Overall Study|Withdrawal by Subject|23
2075707|NCT00660907|3656778|FG001|Overall Study|Withdrawal by Subject|32
2075708|NCT00660907|3656777|FG000|Overall Study|Lost to Follow-up|3
2075709|NCT00660907|3656778|FG001|Overall Study|Lost to Follow-up|3
2075710|NCT00660907|3656777|FG000|Overall Study|Poor/Non-Compliance|5
2075711|NCT00660907|3656778|FG001|Overall Study|Poor/Non-Compliance|1
2075712|NCT00660907|3656777|FG000|Overall Study|Safety|1
2075713|NCT00660907|3656778|FG001|Overall Study|Safety|0
2075714|NCT00660907|3656777|FG000|Overall Study|Death|1
2075715|NCT00660907|3656778|FG001|Overall Study|Death|3
2075716|NCT00660907|3656777|FG000|Overall Study|Various|11
2075717|NCT00660907|3656778|FG001|Overall Study|Various|8
2075718|NCT00661089|3656806|FG000|Overall Study|1 subject withdrawal|0
2075719|NCT00661089|3656807|FG001|Overall Study|1 subject withdrawal|1
2075720|NCT00661089|3656806|FG000|Overall Study|death at 8 weeks due to new stroke|0
2075721|NCT00661089|3656807|FG001|Overall Study|death at 8 weeks due to new stroke|1
2075722|NCT00661193|3656843|FG000|Overall Study|Adverse Event|2
2075723|NCT00661193|3656844|FG001|Overall Study|Adverse Event|1
2075724|NCT00661193|3656843|FG000|Overall Study|Withdrawal by Subject|3
2075725|NCT00661193|3656844|FG001|Overall Study|Withdrawal by Subject|1
2075726|NCT00661193|3656843|FG000|Overall Study|Progression|27
2075727|NCT00661193|3656844|FG001|Overall Study|Progression|24
2075728|NCT00661193|3656843|FG000|Overall Study|Not protocol specified|1
2075729|NCT00661193|3656844|FG001|Overall Study|Not protocol specified|0
2075730|NCT00661258|3656852|FG000|Overall Study|Death|1
2075731|NCT00661258|3656853|FG001|Overall Study|Death|0
2075732|NCT00661258|3656852|FG000|Overall Study|caught by police and in detox center|2
2075733|NCT00661258|3656853|FG001|Overall Study|caught by police and in detox center|1
2075734|NCT00661271|3656861|FG000|Overall Study|Lost to Follow-up|28
2075735|NCT00661271|3656862|FG001|Overall Study|Lost to Follow-up|25
2075736|NCT00661362|3656870|FG000|Overall Study|Adverse Event|5
2075737|NCT00661362|3656871|FG001|Overall Study|Adverse Event|4
2075738|NCT00661362|3656870|FG000|Overall Study|Incorrect enrollment|2
2075739|NCT00661362|3656871|FG001|Overall Study|Incorrect enrollment|0
2075740|NCT00661362|3656870|FG000|Overall Study|Study specific discontinuation criteria|4
2075741|NCT00661362|3656871|FG001|Overall Study|Study specific discontinuation criteria|11
2075742|NCT00661362|3656870|FG000|Overall Study|Withdrawal by Subject|13
2075743|NCT00661362|3656871|FG001|Overall Study|Withdrawal by Subject|23
2075744|NCT00661362|3656870|FG000|Overall Study|Lost to Follow-up|3
2075745|NCT00661362|3656871|FG001|Overall Study|Lost to Follow-up|1
2075746|NCT00661362|3656870|FG000|Overall Study|Severe non-compliance to protocol|0
2075747|NCT00661362|3656871|FG001|Overall Study|Severe non-compliance to protocol|1
2075748|NCT00661362|3656870|FG000|Overall Study|Safety reasons|1
2075749|NCT00661362|3656871|FG001|Overall Study|Safety reasons|0
2075750|NCT00661362|3656870|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
2075751|NCT00661362|3656871|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
2075752|NCT00661388|3656877|FG000|Overall Study|Adverse Event|14
2075753|NCT00661388|3656877|FG000|Overall Study|Protocol Violation|7
2075754|NCT00661388|3656877|FG000|Overall Study|Renal transplantation|1
2075755|NCT00661388|3656877|FG000|Overall Study|Dialysis initiation|1
2075756|NCT00661388|3656877|FG000|Overall Study|Administrative reasons|1
2075757|NCT00661427|3656883|FG000|Overall Study|Adverse Event|5
2075758|NCT00661427|3656884|FG001|Overall Study|Adverse Event|5
2075759|NCT00661427|3656883|FG000|Overall Study|Patient not treated|0
2075760|NCT00661427|3656884|FG001|Overall Study|Patient not treated|2
2075761|NCT00661492|3656912|FG000|Overall Study|Adverse Event|16
2075762|NCT00661492|3656913|FG001|Overall Study|Adverse Event|13
2075763|NCT00661492|3656912|FG000|Overall Study|Disease Progression|44
2075764|NCT00661492|3656913|FG001|Overall Study|Disease Progression|14
2075765|NCT00661492|3656912|FG000|Overall Study|Patient Request|6
2075766|NCT00661492|3656913|FG001|Overall Study|Patient Request|1
2075767|NCT00661492|3656912|FG000|Overall Study|Investigator Request|1
2075768|NCT00661492|3656913|FG001|Overall Study|Investigator Request|0
2075769|NCT00661492|3656912|FG000|Overall Study|Lost to Follow-up|0
2075770|NCT00661492|3656913|FG001|Overall Study|Lost to Follow-up|1
2075771|NCT00661492|3656912|FG000|Overall Study|Other|1
2075772|NCT00661492|3656913|FG001|Overall Study|Other|0
2075773|NCT00661505|3656919|FG000|Overall Study|Adverse Event|3
2075774|NCT00661505|3656919|FG000|Overall Study|Protocol Violation|14
2075775|NCT00661505|3656919|FG000|Overall Study|Withdrawal by Subject|8
2075776|NCT00661505|3656919|FG000|Overall Study|Lost to Follow-up|3
2075777|NCT00661505|3656919|FG000|Overall Study|Other|2
2075778|NCT00661531|3656924|FG000|Overall Study|Withdrawal by Subject|3
2075779|NCT00661609|3656958|FG000|Overall Study|Adverse Event|4
2075780|NCT00661609|3656958|FG000|Overall Study|Death|20
2075781|NCT00661609|3656958|FG000|Overall Study|Withdrawal by Subject|2
2075782|NCT00661609|3656958|FG000|Overall Study|PI Decision|1
2075783|NCT00661609|3656958|FG000|Overall Study|Survival follow up stage discontinued|11
2075784|NCT00661609|3656958|FG000|Overall Study|Disease progression|3
2075785|NCT00661622|3656964|FG000|Overall Study|Protocol Violation|1
2075786|NCT00661622|3656965|FG001|Overall Study|Protocol Violation|0
2075787|NCT00661661|3656974|FG000|Overall Study|Adverse Event|99
2075788|NCT00661661|3656975|FG001|Overall Study|Adverse Event|24
2075789|NCT00661661|3656974|FG000|Overall Study|Lack of Efficacy|3
2075790|NCT00661661|3656975|FG001|Overall Study|Lack of Efficacy|2
2075791|NCT00661661|3656974|FG000|Overall Study|Lost to Follow-up|0
2075792|NCT00661661|3656975|FG001|Overall Study|Lost to Follow-up|1
2075793|NCT00661661|3656974|FG000|Overall Study|Withdrawal by Subject|15
2075794|NCT00661661|3656975|FG001|Overall Study|Withdrawal by Subject|5
2075795|NCT00661661|3656974|FG000|Overall Study|Other|22
2075796|NCT00661661|3656975|FG001|Overall Study|Other|7
2075797|NCT00661661|3656974|FG000|Overall Study|Not assigned treatment|1
2075798|NCT00661661|3656975|FG001|Overall Study|Not assigned treatment|0
2075799|NCT00661687|3656996|FG000|Overall Study|Study related symptoms and complaints|5
2075800|NCT00661687|3656996|FG000|Overall Study|Positive slit lamp findings|4
2075801|NCT00661687|3656996|FG000|Overall Study|Inability to maintain wearing schedule|3
2075802|NCT00661687|3656996|FG000|Overall Study|Physician Decision|1
2075803|NCT00661687|3656996|FG000|Overall Study|Adverse Event|2
2075804|NCT00661713|3657010|FG000|Overall Study|Death|1
2075805|NCT00661713|3657011|FG001|Overall Study|Death|0
2075806|NCT00661713|3657012|FG002|Overall Study|Death|0
2075807|NCT00661713|3657013|FG003|Overall Study|Death|0
2075808|NCT00661713|3657014|FG004|Overall Study|Death|1
2075809|NCT00661713|3657015|FG005|Overall Study|Death|0
2075810|NCT00661713|3657016|FG006|Overall Study|Death|0
2075811|NCT00661713|3657017|FG007|Overall Study|Death|0
2075812|NCT00661713|3657010|FG000|Overall Study|Unable to Classify|1
2075813|NCT00661713|3657011|FG001|Overall Study|Unable to Classify|0
2075814|NCT00661713|3657012|FG002|Overall Study|Unable to Classify|0
2075815|NCT00661713|3657013|FG003|Overall Study|Unable to Classify|0
2075816|NCT00661713|3657014|FG004|Overall Study|Unable to Classify|0
2075817|NCT00661713|3657015|FG005|Overall Study|Unable to Classify|0
2075818|NCT00661713|3657016|FG006|Overall Study|Unable to Classify|0
2075819|NCT00661713|3657017|FG007|Overall Study|Unable to Classify|0
2075820|NCT00661713|3657010|FG000|Overall Study|Protocol Violation|1
2075821|NCT00661713|3657011|FG001|Overall Study|Protocol Violation|6
2075822|NCT00661713|3657012|FG002|Overall Study|Protocol Violation|3
2075823|NCT00661713|3657013|FG003|Overall Study|Protocol Violation|3
2075824|NCT00661713|3657014|FG004|Overall Study|Protocol Violation|0
2075825|NCT00661713|3657015|FG005|Overall Study|Protocol Violation|2
2075826|NCT00661713|3657016|FG006|Overall Study|Protocol Violation|2
2075827|NCT00661713|3657017|FG007|Overall Study|Protocol Violation|1
2075828|NCT00661713|3657010|FG000|Overall Study|Withdrawal by Subject|11
2075829|NCT00661713|3657011|FG001|Overall Study|Withdrawal by Subject|25
2075830|NCT00661713|3657012|FG002|Overall Study|Withdrawal by Subject|12
2075831|NCT00661713|3657013|FG003|Overall Study|Withdrawal by Subject|21
2075832|NCT00661713|3657014|FG004|Overall Study|Withdrawal by Subject|12
2075833|NCT00661713|3657015|FG005|Overall Study|Withdrawal by Subject|26
2075834|NCT00661713|3657016|FG006|Overall Study|Withdrawal by Subject|45
2075835|NCT00661713|3657017|FG007|Overall Study|Withdrawal by Subject|9
2075836|NCT00661713|3657010|FG000|Overall Study|Lost to Follow-up|2
2075837|NCT00661713|3657011|FG001|Overall Study|Lost to Follow-up|7
2075838|NCT00661713|3657012|FG002|Overall Study|Lost to Follow-up|2
2075839|NCT00661713|3657013|FG003|Overall Study|Lost to Follow-up|2
2075840|NCT00661713|3657014|FG004|Overall Study|Lost to Follow-up|5
2075841|NCT00661713|3657015|FG005|Overall Study|Lost to Follow-up|7
2075842|NCT00661713|3657016|FG006|Overall Study|Lost to Follow-up|14
2075843|NCT00661713|3657017|FG007|Overall Study|Lost to Follow-up|1
2075844|NCT00661713|3657010|FG000|Overall Study|Administrative Reason|0
2075845|NCT00661713|3657011|FG001|Overall Study|Administrative Reason|1
2075846|NCT00661713|3657012|FG002|Overall Study|Administrative Reason|0
2075847|NCT00661713|3657013|FG003|Overall Study|Administrative Reason|2
2075848|NCT00661713|3657014|FG004|Overall Study|Administrative Reason|2
2075849|NCT00661713|3657015|FG005|Overall Study|Administrative Reason|2
2075850|NCT00661713|3657016|FG006|Overall Study|Administrative Reason|1
2075851|NCT00661713|3657017|FG007|Overall Study|Administrative Reason|0
2075852|NCT00661713|3657010|FG000|Overall Study|Adverse Event|0
2075853|NCT00661713|3657011|FG001|Overall Study|Adverse Event|0
2075854|NCT00661713|3657012|FG002|Overall Study|Adverse Event|0
2075855|NCT00661713|3657013|FG003|Overall Study|Adverse Event|0
2075856|NCT00661713|3657014|FG004|Overall Study|Adverse Event|0
2075857|NCT00661713|3657015|FG005|Overall Study|Adverse Event|0
2075858|NCT00661713|3657016|FG006|Overall Study|Adverse Event|1
2075859|NCT00661713|3657017|FG007|Overall Study|Adverse Event|0
2075860|NCT00661713|3657010|FG000|Overall Study|Inappropriate Enrollment|0
2075861|NCT00661713|3657011|FG001|Overall Study|Inappropriate Enrollment|0
2075862|NCT00661713|3657012|FG002|Overall Study|Inappropriate Enrollment|0
2075863|NCT00661713|3657013|FG003|Overall Study|Inappropriate Enrollment|0
2075864|NCT00661713|3657014|FG004|Overall Study|Inappropriate Enrollment|0
2075865|NCT00661713|3657015|FG005|Overall Study|Inappropriate Enrollment|0
2075866|NCT00661713|3657016|FG006|Overall Study|Inappropriate Enrollment|1
2075867|NCT00661713|3657017|FG007|Overall Study|Inappropriate Enrollment|0
2075868|NCT00661726|3657037|FG000|Overall Study|Adverse Event|1
2075869|NCT00661778|3657041|FG000|Overall Study|Disease Progression|23
2075870|NCT00661778|3657041|FG000|Overall Study|Adverse Event|18
2075871|NCT00661778|3657041|FG000|Overall Study|Reason not Specified|6
2075872|NCT00661778|3657041|FG000|Overall Study|Protocol Violation|2
2075873|NCT00661778|3657041|FG000|Overall Study|Withdrawal of Consent|1
2075874|NCT00661830|3657047|FG000|Overall Study|Death|37
2075875|NCT00661830|3657048|FG001|Overall Study|Death|33
2075876|NCT00661830|3657047|FG000|Overall Study|Lost to Follow-up|1
2075877|NCT00661830|3657048|FG001|Overall Study|Lost to Follow-up|3
2075878|NCT00661830|3657047|FG000|Overall Study|Withdrawal by Subject|1
2075879|NCT00661830|3657048|FG001|Overall Study|Withdrawal by Subject|1
2075880|NCT00661830|3657047|FG000|Overall Study|Other reason|1
2075881|NCT00661830|3657048|FG001|Overall Study|Other reason|5
2075882|NCT00661999|3657079|FG000|Overall Study|Adverse Event|11
2075883|NCT00661999|3657080|FG001|Overall Study|Adverse Event|5
2075884|NCT00661999|3657081|FG002|Overall Study|Adverse Event|8
2075885|NCT00661999|3657079|FG000|Overall Study|Death|8
2075886|NCT00661999|3657080|FG001|Overall Study|Death|6
2075887|NCT00661999|3657081|FG002|Overall Study|Death|3
2075888|NCT00661999|3657079|FG000|Overall Study|Other Reasons|5
2075889|NCT00661999|3657080|FG001|Overall Study|Other Reasons|12
2075890|NCT00661999|3657081|FG002|Overall Study|Other Reasons|23
2075891|NCT00661999|3657079|FG000|Overall Study|Withdrawal by Subject|30
2075892|NCT00661999|3657080|FG001|Overall Study|Withdrawal by Subject|23
2075893|NCT00661999|3657081|FG002|Overall Study|Withdrawal by Subject|14
2075894|NCT00661999|3657079|FG000|Overall Study|Alternative Treatment|1
2075895|NCT00661999|3657080|FG001|Overall Study|Alternative Treatment|0
2075896|NCT00661999|3657081|FG002|Overall Study|Alternative Treatment|0
2075897|NCT00661999|3657079|FG000|Overall Study|Other Medical Problems|4
2075898|NCT00661999|3657080|FG001|Overall Study|Other Medical Problems|4
2075899|NCT00661999|3657081|FG002|Overall Study|Other Medical Problems|9
2075900|NCT00662012|3657089|FG000|Overall Study|Lost to Follow-up|85
2075901|NCT00662012|3657089|FG000|Overall Study|Death|1
2075902|NCT00662012|3657089|FG000|Overall Study|Withdrawal by Subject|1
2075903|NCT00662025|3657093|FG000|Overall Study|Objective progression or relapse|51
2075904|NCT00662025|3657093|FG000|Overall Study|Adverse Event|7
2075905|NCT00662025|3657093|FG000|Overall Study|Withdrawal by Subject|1
2075906|NCT00662025|3657093|FG000|Overall Study|Results of other clinical study|2
2075907|NCT00662025|3657093|FG000|Overall Study|Target lesion cannot be evaluated|1
2075908|NCT00662025|3657093|FG000|Overall Study|Domestic circumstances|1
2075909|NCT00662038|3657097|FG000|Overall Study|Reason not specified|3
2075910|NCT00662038|3657097|FG000|Overall Study|Withdrawn consent|22
2075911|NCT00662038|3657097|FG000|Overall Study|Withdrawal by Subject|83
2075912|NCT00662038|3657097|FG000|Overall Study|Sponsor decision|1
2075913|NCT00662038|3657097|FG000|Overall Study|Physician Decision|19
2075914|NCT00662038|3657097|FG000|Overall Study|Lung transplantation|44
2075915|NCT00662038|3657097|FG000|Overall Study|Lost to Follow-up|1
2075916|NCT00662038|3657097|FG000|Overall Study|Death|95
2075917|NCT00662038|3657097|FG000|Overall Study|Adverse Event|358
2075918|NCT00662038|3657097|FG000|Overall Study|Continued treatment|5
2075919|NCT00662129|3657101|FG000|Overall Study|Protocol Violation|1
2075920|NCT00662129|3657101|FG000|Overall Study|Cancel prior to beginning treatment|1
2075921|NCT00662129|3657101|FG000|Overall Study|Ineligible|1
2075922|NCT00662259|3657128|FG000|Overall Study|Adverse Event|2
2075923|NCT00662259|3657129|FG001|Overall Study|Adverse Event|0
2075924|NCT00662311|3657142|FG000|Overall Study|Respiratory Infection|1
2075925|NCT00662311|3657143|FG001|Overall Study|Respiratory Infection|0
2075926|NCT00662311|3657144|FG002|Overall Study|Respiratory Infection|0
2075927|NCT00662363|3657154|FG000|Overall Study|Withdrawal by Subject|6
2075928|NCT00662363|3657155|FG001|Overall Study|Withdrawal by Subject|5
2075929|NCT00662363|3657154|FG000|Overall Study|Adverse Event|0
2075930|NCT00662363|3657155|FG001|Overall Study|Adverse Event|3
2075931|NCT00662363|3657154|FG000|Overall Study|Discharged early from rehab|4
2075932|NCT00662363|3657155|FG001|Overall Study|Discharged early from rehab|1
2075933|NCT00662363|3657154|FG000|Overall Study|Protocol Violation|1
2075934|NCT00662363|3657155|FG001|Overall Study|Protocol Violation|1
2075935|NCT00662532|3657165|FG000|Overall Study|Adverse Event|0
2075936|NCT00662532|3657166|FG001|Overall Study|Adverse Event|1
2075937|NCT00662532|3657165|FG000|Overall Study|Lost to Follow-up|0
2075938|NCT00662532|3657166|FG001|Overall Study|Lost to Follow-up|1
2075939|NCT00662558|3657183|FG000|Overall Study|Adverse Event|21
2075940|NCT00662558|3657184|FG001|Overall Study|Adverse Event|59
2075941|NCT00662558|3657183|FG000|Overall Study|Lack of Efficacy|4
2075942|NCT00662558|3657184|FG001|Overall Study|Lack of Efficacy|7
2075943|NCT00662558|3657183|FG000|Overall Study|Lost to Follow-up|13
2075944|NCT00662558|3657184|FG001|Overall Study|Lost to Follow-up|10
2075945|NCT00662558|3657183|FG000|Overall Study|Other|9
2075946|NCT00662558|3657184|FG001|Overall Study|Other|14
2075947|NCT00662558|3657183|FG000|Overall Study|Withdrawal by Subject|7
2075948|NCT00662558|3657184|FG001|Overall Study|Withdrawal by Subject|12
2075949|NCT00662558|3657183|FG000|Overall Study|Randomized But Did Not Receive Treatment|2
2075950|NCT00662558|3657184|FG001|Overall Study|Randomized But Did Not Receive Treatment|8
2075951|NCT00662649|3657194|FG000|Core Study (24 Months)|Withdrawal by Subject|31
2075952|NCT00662649|3657195|FG001|Core Study (24 Months)|Withdrawal by Subject|17
2075953|NCT00662649|3657196|FG002|Core Study (24 Months)|Withdrawal by Subject|28
2075954|NCT00662649|3657197|FG003|Core Study (24 Months)|Withdrawal by Subject|0
2075955|NCT00662649|3657198|FG004|Core Study (24 Months)|Withdrawal by Subject|0
2075956|NCT00662649|3657194|FG000|Core Study (24 Months)|Adverse Event|22
2075957|NCT00662649|3657195|FG001|Core Study (24 Months)|Adverse Event|13
2075958|NCT00662649|3657196|FG002|Core Study (24 Months)|Adverse Event|18
2075959|NCT00662649|3657197|FG003|Core Study (24 Months)|Adverse Event|0
2075960|NCT00662649|3657198|FG004|Core Study (24 Months)|Adverse Event|0
2075961|NCT00662649|3657194|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
2075962|NCT00662649|3657195|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
2075963|NCT00662649|3657196|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
2075964|NCT00662649|3657197|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
2075965|NCT00662649|3657198|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
2075966|NCT00662649|3657194|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20
2075967|NCT00662649|3657195|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9
2075968|NCT00662649|3657196|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1
2075969|NCT00662649|3657197|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0
2075970|NCT00662649|3657198|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0
2075971|NCT00662649|3657194|FG000|Core Study (24 Months)|Lost to Follow-up|3
2075972|NCT00662649|3657195|FG001|Core Study (24 Months)|Lost to Follow-up|5
2075973|NCT00662649|3657196|FG002|Core Study (24 Months)|Lost to Follow-up|7
2075974|NCT00662649|3657197|FG003|Core Study (24 Months)|Lost to Follow-up|0
2075975|NCT00662649|3657198|FG004|Core Study (24 Months)|Lost to Follow-up|0
2075976|NCT00662649|3657194|FG000|Core Study (24 Months)|Protocol Violation|5
2075977|NCT00662649|3657195|FG001|Core Study (24 Months)|Protocol Violation|5
2075978|NCT00662649|3657196|FG002|Core Study (24 Months)|Protocol Violation|4
2075979|NCT00662649|3657197|FG003|Core Study (24 Months)|Protocol Violation|0
2075980|NCT00662649|3657198|FG004|Core Study (24 Months)|Protocol Violation|0
2075981|NCT00662649|3657194|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2
2075982|NCT00662649|3657195|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1
2075983|NCT00662649|3657196|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1
2075984|NCT00662649|3657197|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0
2075985|NCT00662649|3657198|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0
2075986|NCT00662649|3657194|FG000|Core Study (24 Months)|Death|1
2075987|NCT00662649|3657195|FG001|Core Study (24 Months)|Death|0
2075988|NCT00662649|3657196|FG002|Core Study (24 Months)|Death|2
2075989|NCT00662649|3657197|FG003|Core Study (24 Months)|Death|0
2075990|NCT00662649|3657198|FG004|Core Study (24 Months)|Death|0
2075991|NCT00662649|3657194|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
2075992|NCT00662649|3657195|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
2075993|NCT00662649|3657196|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
2075994|NCT00662649|3657197|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
2075995|NCT00662649|3657198|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
2075996|NCT00662649|3657194|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
2075997|NCT00662649|3657195|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
2075998|NCT00662649|3657196|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
2075999|NCT00662649|3657197|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
2076000|NCT00662649|3657198|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
2076001|NCT00662649|3657194|FG000|Extension Study (Month 24 to 60)|Administrative problems|0
2076002|NCT00662649|3657195|FG001|Extension Study (Month 24 to 60)|Administrative problems|0
2076003|NCT00662649|3657196|FG002|Extension Study (Month 24 to 60)|Administrative problems|0
2076004|NCT00662649|3657197|FG003|Extension Study (Month 24 to 60)|Administrative problems|1
2076005|NCT00662649|3657198|FG004|Extension Study (Month 24 to 60)|Administrative problems|0
2076006|NCT00662649|3657194|FG000|Extension Study (Month 24 to 60)|Adverse Event|6
2076007|NCT00662649|3657195|FG001|Extension Study (Month 24 to 60)|Adverse Event|9
2076008|NCT00662649|3657196|FG002|Extension Study (Month 24 to 60)|Adverse Event|0
2076009|NCT00662649|3657197|FG003|Extension Study (Month 24 to 60)|Adverse Event|6
2076010|NCT00662649|3657198|FG004|Extension Study (Month 24 to 60)|Adverse Event|10
2076011|NCT00662649|3657194|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2
2076012|NCT00662649|3657195|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0
2076013|NCT00662649|3657196|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0
2076014|NCT00662649|3657197|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1
2076015|NCT00662649|3657198|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1
2076016|NCT00662649|3657194|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1
2076017|NCT00662649|3657195|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1
2076018|NCT00662649|3657196|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0
2076019|NCT00662649|3657197|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0
2076020|NCT00662649|3657198|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0
2076021|NCT00662649|3657194|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19
2076022|NCT00662649|3657195|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23
2076023|NCT00662649|3657196|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0
2076024|NCT00662649|3657197|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15
2076025|NCT00662649|3657198|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9
2076026|NCT00662649|3657194|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
2076027|NCT00662649|3657195|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
2076028|NCT00662649|3657196|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
2076029|NCT00662649|3657197|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
2076030|NCT00662649|3657198|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
2076031|NCT00662649|3657194|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
2076032|NCT00662649|3657195|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
2076033|NCT00662649|3657196|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
2076034|NCT00662649|3657197|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
2076035|NCT00662649|3657198|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
2106604|NCT00866788|3699777|FG000|Overall Study|Lost to Follow-up|1
2106605|NCT00866788|3699778|FG001|Overall Study|Lost to Follow-up|1
2106606|NCT00866788|3699779|FG002|Overall Study|Lost to Follow-up|0
2106607|NCT00866788|3699780|FG003|Overall Study|Lost to Follow-up|2
2106608|NCT00866788|3699777|FG000|Overall Study|Withdrawal by Subject|2
2106609|NCT00866788|3699778|FG001|Overall Study|Withdrawal by Subject|1
2106610|NCT00866788|3699779|FG002|Overall Study|Withdrawal by Subject|0
2106611|NCT00866788|3699780|FG003|Overall Study|Withdrawal by Subject|1
2106612|NCT00866788|3699777|FG000|Overall Study|Pregnancy|0
2106613|NCT00866788|3699778|FG001|Overall Study|Pregnancy|1
2106614|NCT00866788|3699779|FG002|Overall Study|Pregnancy|0
2106615|NCT00866788|3699780|FG003|Overall Study|Pregnancy|0
2106616|NCT00866788|3699777|FG000|Overall Study|Disease progression|3
2106617|NCT00866788|3699778|FG001|Overall Study|Disease progression|1
2106618|NCT00866788|3699779|FG002|Overall Study|Disease progression|1
2106619|NCT00866788|3699780|FG003|Overall Study|Disease progression|0
2076036|NCT00662831|3657234|FG000|Overall Study|Death|4
2076037|NCT00662831|3657235|FG001|Overall Study|Death|1
2076038|NCT00662831|3657234|FG000|Overall Study|Lack of Efficacy|6
2076039|NCT00662831|3657235|FG001|Overall Study|Lack of Efficacy|6
2076040|NCT00662831|3657234|FG000|Overall Study|Lost to Follow-up|1
2076041|NCT00662831|3657235|FG001|Overall Study|Lost to Follow-up|0
2076042|NCT00662831|3657234|FG000|Overall Study|Withdrawal by Subject|2
2076043|NCT00662831|3657235|FG001|Overall Study|Withdrawal by Subject|1
2076044|NCT00662831|3657234|FG000|Overall Study|Other|62
2076045|NCT00662831|3657235|FG001|Overall Study|Other|31
2076046|NCT00662831|3657234|FG000|Overall Study|Protocol Violation|8
2076047|NCT00662831|3657235|FG001|Overall Study|Protocol Violation|4
2076048|NCT00662831|3657234|FG000|Overall Study|Adverse Event|23
2076049|NCT00662831|3657235|FG001|Overall Study|Adverse Event|16
2076050|NCT00662857|3657241|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0
2076051|NCT00662857|3657242|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1
2076052|NCT00662857|3657241|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
2076053|NCT00662857|3657242|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
2076054|NCT00662857|3657241|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
2076055|NCT00662857|3657242|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
2076056|NCT00662909|3657254|FG000|Overall Study|Adverse Event|17
2076057|NCT00662909|3657255|FG001|Overall Study|Adverse Event|18
2076058|NCT00662909|3657256|FG002|Overall Study|Adverse Event|19
2076059|NCT00662909|3657254|FG000|Overall Study|Lack of Efficacy|9
2076060|NCT00662909|3657255|FG001|Overall Study|Lack of Efficacy|1
2076061|NCT00662909|3657256|FG002|Overall Study|Lack of Efficacy|5
2076062|NCT00662909|3657254|FG000|Overall Study|Withdrawal by Subject|29
2076063|NCT00662909|3657255|FG001|Overall Study|Withdrawal by Subject|22
2076064|NCT00662909|3657256|FG002|Overall Study|Withdrawal by Subject|16
2076065|NCT00662909|3657254|FG000|Overall Study|Lost to Follow-up|2
2076066|NCT00662909|3657255|FG001|Overall Study|Lost to Follow-up|9
2076067|NCT00662909|3657256|FG002|Overall Study|Lost to Follow-up|3
2076068|NCT00662909|3657254|FG000|Overall Study|Protocol Violation|7
2076069|NCT00662909|3657255|FG001|Overall Study|Protocol Violation|4
2076070|NCT00662909|3657256|FG002|Overall Study|Protocol Violation|5
2076071|NCT00662909|3657254|FG000|Overall Study|Randomized- never received study drug|1
2076072|NCT00662909|3657255|FG001|Overall Study|Randomized- never received study drug|0
2076073|NCT00662909|3657256|FG002|Overall Study|Randomized- never received study drug|0
2076074|NCT00662909|3657254|FG000|Overall Study|Non-compliance with study procedures|3
2076075|NCT00662909|3657255|FG001|Overall Study|Non-compliance with study procedures|3
2076076|NCT00662909|3657256|FG002|Overall Study|Non-compliance with study procedures|2
2076077|NCT00662909|3657254|FG000|Overall Study|Physician Decision|1
2076078|NCT00662909|3657255|FG001|Overall Study|Physician Decision|1
2076079|NCT00662909|3657256|FG002|Overall Study|Physician Decision|2
2076080|NCT00662909|3657254|FG000|Overall Study|Eligibility criterion not met|0
2076081|NCT00662909|3657255|FG001|Overall Study|Eligibility criterion not met|1
2076082|NCT00662909|3657256|FG002|Overall Study|Eligibility criterion not met|1
2076083|NCT00663026|3657267|FG000|Overall Study|Lost to Follow-up|1
2076084|NCT00663026|3657268|FG001|Overall Study|Lost to Follow-up|0
2076085|NCT00663026|3657269|FG002|Overall Study|Lost to Follow-up|0
2076086|NCT00663026|3657267|FG000|Overall Study|Other|1
2076087|NCT00663026|3657268|FG001|Overall Study|Other|2
2076088|NCT00663026|3657269|FG002|Overall Study|Other|0
2076089|NCT00663026|3657267|FG000|Overall Study|Adverse Event|0
2076090|NCT00663026|3657268|FG001|Overall Study|Adverse Event|2
2076091|NCT00663026|3657269|FG002|Overall Study|Adverse Event|3
2076092|NCT00663026|3657267|FG000|Overall Study|Caregiver Request|0
2076093|NCT00663026|3657268|FG001|Overall Study|Caregiver Request|2
2076094|NCT00663026|3657269|FG002|Overall Study|Caregiver Request|0
2076095|NCT00663026|3657267|FG000|Overall Study|Withdrawal by Subject|0
2076096|NCT00663026|3657268|FG001|Overall Study|Withdrawal by Subject|0
2076097|NCT00663026|3657269|FG002|Overall Study|Withdrawal by Subject|1
2076098|NCT00663117|3657288|FG000|Overall Study|Lack of Efficacy|1
2076099|NCT00663117|3657289|FG001|Overall Study|Lack of Efficacy|0
2076100|NCT00663208|3657317|FG000|Treatment Period|Lost to Follow-up|0
2076101|NCT00663208|3657318|FG001|Treatment Period|Lost to Follow-up|1
2076102|NCT00663208|3657319|FG002|Treatment Period|Lost to Follow-up|0
2076103|NCT00663208|3657320|FG003|Treatment Period|Lost to Follow-up|0
2076104|NCT00663208|3657321|FG004|Treatment Period|Lost to Follow-up|0
2076105|NCT00663208|3657322|FG005|Treatment Period|Lost to Follow-up|0
2076106|NCT00663208|3657323|FG006|Treatment Period|Lost to Follow-up|0
2076107|NCT00663208|3657317|FG000|Follow-up Period|Lost to Follow-up|2
2076108|NCT00663208|3657318|FG001|Follow-up Period|Lost to Follow-up|0
2076109|NCT00663208|3657319|FG002|Follow-up Period|Lost to Follow-up|3
2076110|NCT00663208|3657320|FG003|Follow-up Period|Lost to Follow-up|2
2076111|NCT00663208|3657321|FG004|Follow-up Period|Lost to Follow-up|0
2076112|NCT00663208|3657322|FG005|Follow-up Period|Lost to Follow-up|0
2076113|NCT00663208|3657323|FG006|Follow-up Period|Lost to Follow-up|0
2076114|NCT00663208|3657317|FG000|Follow-up Period|Other reason|1
2076115|NCT00663208|3657318|FG001|Follow-up Period|Other reason|0
2076116|NCT00663208|3657319|FG002|Follow-up Period|Other reason|0
2076117|NCT00663208|3657320|FG003|Follow-up Period|Other reason|0
2076118|NCT00663208|3657321|FG004|Follow-up Period|Other reason|0
2076119|NCT00663208|3657322|FG005|Follow-up Period|Other reason|0
2076120|NCT00663208|3657323|FG006|Follow-up Period|Other reason|1
2076121|NCT00663234|3657341|FG000|Overall Study|Not willing to adhere to requirements|1
2076122|NCT00663260|3657352|FG000|Overall Study|Lack of Efficacy|2
2076123|NCT00663260|3657353|FG001|Overall Study|Lack of Efficacy|0
2076124|NCT00663260|3657354|FG002|Overall Study|Lack of Efficacy|0
2076125|NCT00663260|3657352|FG000|Overall Study|Adverse Event|12
2076126|NCT00663260|3657353|FG001|Overall Study|Adverse Event|7
2076127|NCT00663260|3657354|FG002|Overall Study|Adverse Event|6
2076128|NCT00663260|3657352|FG000|Overall Study|Withdrawal by Subject|3
2304268|NCT02651194|4004174|FG000|Overall Study|Lost to Follow-up|3
2304269|NCT02651194|4004174|FG000|Overall Study|Other|2
2304270|NCT02651220|4004181|FG000|Overall Study|Adverse Event|1
2304271|NCT02651220|4004182|FG001|Overall Study|Adverse Event|5
2304272|NCT02651220|4004183|FG002|Overall Study|Adverse Event|1
2304273|NCT02651220|4004181|FG000|Overall Study|Lost to Follow-up|8
2076129|NCT00663260|3657353|FG001|Overall Study|Withdrawal by Subject|1
2076130|NCT00663260|3657354|FG002|Overall Study|Withdrawal by Subject|6
2076131|NCT00663260|3657352|FG000|Overall Study|Death|1
2076132|NCT00663260|3657353|FG001|Overall Study|Death|0
2076133|NCT00663260|3657354|FG002|Overall Study|Death|1
2076134|NCT00663260|3657352|FG000|Overall Study|Lost to Follow-up|0
2076135|NCT00663260|3657353|FG001|Overall Study|Lost to Follow-up|1
2076136|NCT00663260|3657354|FG002|Overall Study|Lost to Follow-up|0
2076137|NCT00663260|3657352|FG000|Overall Study|non-compliance, not met criteria, etc.|3
2076138|NCT00663260|3657353|FG001|Overall Study|non-compliance, not met criteria, etc.|2
2076139|NCT00663260|3657354|FG002|Overall Study|non-compliance, not met criteria, etc.|3
2076140|NCT00663702|3657368|FG000|Overall Study|Adverse Event|8
2076141|NCT00663702|3657369|FG001|Overall Study|Adverse Event|4
2076142|NCT00663702|3657368|FG000|Overall Study|Withdrawal by Subject|3
2076143|NCT00663702|3657369|FG001|Overall Study|Withdrawal by Subject|1
2076144|NCT00663702|3657368|FG000|Overall Study|Pregnancy|0
2076145|NCT00663702|3657369|FG001|Overall Study|Pregnancy|1
2076146|NCT00663702|3657368|FG000|Overall Study|Lost to Follow-up|3
2076147|NCT00663702|3657369|FG001|Overall Study|Lost to Follow-up|0
2076148|NCT00663702|3657368|FG000|Overall Study|Death|1
2076149|NCT00663702|3657369|FG001|Overall Study|Death|1
2076150|NCT00663702|3657368|FG000|Overall Study|Lack of Efficacy|3
2076151|NCT00663702|3657369|FG001|Overall Study|Lack of Efficacy|3
2076152|NCT00663858|3657398|FG000|Overall Study|Adverse Event|9
2076153|NCT00663858|3657399|FG001|Overall Study|Adverse Event|1
2076154|NCT00663858|3657400|FG002|Overall Study|Adverse Event|6
2076155|NCT00663858|3657398|FG000|Overall Study|Lack of Efficacy|5
2076156|NCT00663858|3657399|FG001|Overall Study|Lack of Efficacy|1
2076157|NCT00663858|3657400|FG002|Overall Study|Lack of Efficacy|3
2076158|NCT00663858|3657398|FG000|Overall Study|Withdrawal by Subject|7
2076159|NCT00663858|3657399|FG001|Overall Study|Withdrawal by Subject|3
2076160|NCT00663858|3657400|FG002|Overall Study|Withdrawal by Subject|3
2304274|NCT02651220|4004182|FG001|Overall Study|Lost to Follow-up|14
2304275|NCT02651220|4004183|FG002|Overall Study|Lost to Follow-up|14
2304276|NCT02651220|4004181|FG000|Overall Study|Non-Compliance with Study Drug|4
2304277|NCT02651220|4004182|FG001|Overall Study|Non-Compliance with Study Drug|0
2304278|NCT02651220|4004183|FG002|Overall Study|Non-Compliance with Study Drug|1
2304279|NCT02651220|4004181|FG000|Overall Study|Pregnancy|1
2304280|NCT02651220|4004182|FG001|Overall Study|Pregnancy|0
2304281|NCT02651220|4004183|FG002|Overall Study|Pregnancy|1
2304282|NCT02651220|4004181|FG000|Overall Study|Protocol Violation|0
2304283|NCT02651220|4004182|FG001|Overall Study|Protocol Violation|0
2304284|NCT02651220|4004183|FG002|Overall Study|Protocol Violation|1
2304285|NCT02651220|4004181|FG000|Overall Study|Withdrawal by Subject|5
2304286|NCT02651220|4004182|FG001|Overall Study|Withdrawal by Subject|6
2304287|NCT02651220|4004183|FG002|Overall Study|Withdrawal by Subject|8
2304288|NCT02651220|4004181|FG000|Overall Study|Miscellaneous|4
2304289|NCT02651220|4004182|FG001|Overall Study|Miscellaneous|1
2304290|NCT02651220|4004183|FG002|Overall Study|Miscellaneous|2
2304291|NCT02651220|4004181|FG000|Overall Study|Withdrawal by Parent/Guardian|0
2304292|NCT02651220|4004182|FG001|Overall Study|Withdrawal by Parent/Guardian|1
2304293|NCT02651220|4004183|FG002|Overall Study|Withdrawal by Parent/Guardian|1
2304294|NCT02651467|4004232|FG000|Overall Study|Withdrawal by Subject|0
2304295|NCT02651467|4004233|FG001|Overall Study|Withdrawal by Subject|0
2304296|NCT02651467|4004234|FG002|Overall Study|Withdrawal by Subject|2
2304297|NCT02651467|4004232|FG000|Overall Study|Other (Not specified)|1
2304298|NCT02651467|4004233|FG001|Overall Study|Other (Not specified)|0
2304299|NCT02651467|4004234|FG002|Overall Study|Other (Not specified)|2
2304300|NCT02651688|4004267|FG000|Overall Study|Non-compliance|0
2304301|NCT02651688|4004268|FG001|Overall Study|Non-compliance|0
2304302|NCT02651688|4004269|FG002|Overall Study|Non-compliance|1
2304303|NCT02651688|4004267|FG000|Overall Study|Principal Investigator (PI) decision|0
2304304|NCT02651688|4004268|FG001|Overall Study|Principal Investigator (PI) decision|2
2304305|NCT02651688|4004269|FG002|Overall Study|Principal Investigator (PI) decision|0
2304306|NCT02651688|4004267|FG000|Overall Study|Lost to Follow-up|1
2076161|NCT00663858|3657398|FG000|Overall Study|Protocol Violation|5
2076162|NCT00663858|3657399|FG001|Overall Study|Protocol Violation|3
2076163|NCT00663858|3657400|FG002|Overall Study|Protocol Violation|4
2076164|NCT00663858|3657398|FG000|Overall Study|Other|8
2076165|NCT00663858|3657399|FG001|Overall Study|Other|2
2076166|NCT00663858|3657400|FG002|Overall Study|Other|4
2076167|NCT00663871|3657410|FG000|Overall Study|Lost to Follow-up|5
2076168|NCT00663871|3657411|FG001|Overall Study|Lost to Follow-up|5
2076169|NCT00663871|3657410|FG000|Overall Study|Withdrawal by Subject|5
2076170|NCT00663871|3657411|FG001|Overall Study|Withdrawal by Subject|2
2076171|NCT00663923|3657419|FG000|Overall Study|Lost to Follow-up|2
2076172|NCT00663962|3657427|FG000|Overall Study|somnolence|1
2076173|NCT00663962|3657428|FG001|Overall Study|somnolence|0
2076174|NCT00664105|3657434|FG000|Overall Study|Death|3
2076175|NCT00664105|3657434|FG000|Overall Study|Withdrawal by Subject|5
2076176|NCT00664105|3657434|FG000|Overall Study|Adverse Event|9
2076177|NCT00664105|3657434|FG000|Overall Study|Disease progression|7
2076178|NCT00664209|3657439|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7
2076179|NCT00664209|3657439|FG000|Study Treatment Period|Physician Decision|4
2076180|NCT00664209|3657439|FG000|Study Treatment Period|Withdrawal by Subject|2
2076181|NCT00664326|3657444|FG000|Overall Study|Adverse Event|14
2076182|NCT00664326|3657444|FG000|Overall Study|Noncompliance with study medication|3
2076183|NCT00664326|3657444|FG000|Overall Study|Withdrawal by Subject|1
2076184|NCT00664326|3657444|FG000|Overall Study|Physician Decision|1
2076185|NCT00664326|3657444|FG000|Overall Study|Other Reasons|3
2076186|NCT00664326|3657444|FG000|Overall Study|Death|2
2076187|NCT00664326|3657444|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24
2076188|NCT00664521|3657454|FG000|Overall Study|Adverse Event|4
2076189|NCT00664521|3657455|FG001|Overall Study|Adverse Event|1
2076190|NCT00664521|3657454|FG000|Overall Study|Lost to Follow-up|1
2076191|NCT00664521|3657455|FG001|Overall Study|Lost to Follow-up|0
2076192|NCT00664521|3657454|FG000|Overall Study|Other|1
2076193|NCT00664521|3657455|FG001|Overall Study|Other|0
2076194|NCT00664534|3657463|FG000|Overall Study|Adverse Event|2
2076195|NCT00664534|3657464|FG001|Overall Study|Adverse Event|3
2076196|NCT00664534|3657463|FG000|Overall Study|Lost to Follow-up|6
2076197|NCT00664534|3657464|FG001|Overall Study|Lost to Follow-up|10
2076198|NCT00664534|3657463|FG000|Overall Study|Protocol Violation|10
2076199|NCT00664534|3657464|FG001|Overall Study|Protocol Violation|8
2076200|NCT00664534|3657463|FG000|Overall Study|Withdrawal by Subject|7
2076201|NCT00664534|3657464|FG001|Overall Study|Withdrawal by Subject|6
2076202|NCT00664534|3657463|FG000|Overall Study|Physician Decision|8
2076203|NCT00664534|3657464|FG001|Overall Study|Physician Decision|0
2076204|NCT00664534|3657463|FG000|Overall Study|Sponsor decision|8
2076205|NCT00664534|3657464|FG001|Overall Study|Sponsor decision|6
2076206|NCT00664560|3657473|FG000|Overall Study|Adverse Event|19
2076207|NCT00664560|3657474|FG001|Overall Study|Adverse Event|16
2076208|NCT00664560|3657475|FG002|Overall Study|Adverse Event|7
2076209|NCT00664560|3657473|FG000|Overall Study|Withdrawal by Subject|9
2076210|NCT00664560|3657474|FG001|Overall Study|Withdrawal by Subject|13
2076211|NCT00664560|3657475|FG002|Overall Study|Withdrawal by Subject|7
2076212|NCT00664560|3657473|FG000|Overall Study|Lost to Follow-up|0
2076213|NCT00664560|3657474|FG001|Overall Study|Lost to Follow-up|2
2076214|NCT00664560|3657475|FG002|Overall Study|Lost to Follow-up|0
2076215|NCT00664560|3657473|FG000|Overall Study|Other|11
2076216|NCT00664560|3657474|FG001|Overall Study|Other|4
2076217|NCT00664560|3657475|FG002|Overall Study|Other|5
2076218|NCT00664742|3657483|FG000|Overall Study|Withdrawn due to adverse events|3
2076219|NCT00664742|3657483|FG000|Overall Study|Withdrawal by Subject|31
2076220|NCT00664742|3657483|FG000|Overall Study|Lost to Follow-up|92
2076221|NCT00664859|3657499|FG000|Overall Study|Adverse Event|2
2076222|NCT00664859|3657500|FG001|Overall Study|Adverse Event|1
2076223|NCT00664859|3657501|FG002|Overall Study|Adverse Event|3
2076224|NCT00664859|3657499|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
2076225|NCT00664859|3657500|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
2076226|NCT00664859|3657501|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
2076227|NCT00664859|3657499|FG000|Overall Study|Noncompliance with protocol|1
2076228|NCT00664859|3657500|FG001|Overall Study|Noncompliance with protocol|0
2076229|NCT00664859|3657501|FG002|Overall Study|Noncompliance with protocol|4
2076230|NCT00664859|3657499|FG000|Overall Study|Laboratory abnormality|2
2076231|NCT00664859|3657500|FG001|Overall Study|Laboratory abnormality|1
2076232|NCT00664859|3657501|FG002|Overall Study|Laboratory abnormality|4
2076233|NCT00664859|3657499|FG000|Overall Study|Withdrawal by Subject|4
2076234|NCT00664859|3657500|FG001|Overall Study|Withdrawal by Subject|1
2076235|NCT00664859|3657501|FG002|Overall Study|Withdrawal by Subject|3
2076236|NCT00664859|3657499|FG000|Overall Study|Lost to Follow-up|2
2076237|NCT00664859|3657500|FG001|Overall Study|Lost to Follow-up|2
2076238|NCT00664859|3657501|FG002|Overall Study|Lost to Follow-up|1
2076239|NCT00664859|3657499|FG000|Overall Study|Other|0
2076240|NCT00664859|3657500|FG001|Overall Study|Other|1
2076241|NCT00664859|3657501|FG002|Overall Study|Other|2
2076242|NCT00665002|3657509|FG000|Overall Study|Progression/relapse during treatment|11
2076243|NCT00665002|3657509|FG000|Overall Study|Cytogenetic resistance|1
2076244|NCT00665353|3657517|FG000|Study Step 1|Adverse Event|1
2076245|NCT00665353|3657517|FG000|Study Step 1|Withdrawal by Subject|2
2076246|NCT00665353|3657517|FG000|Study Step 2|Lost to Follow-up|2
2076247|NCT00665353|3657517|FG000|Study Step 2|Lack of Efficacy|12
2076248|NCT00665366|3657523|FG000|Overall Study|Lack of Efficacy|11
2076249|NCT00665366|3657524|FG001|Overall Study|Lack of Efficacy|10
2076250|NCT00665366|3657523|FG000|Overall Study|Adverse Event|25
2076251|NCT00665366|3657524|FG001|Overall Study|Adverse Event|23
2076252|NCT00665366|3657523|FG000|Overall Study|Withdrawal by Subject|11
2076253|NCT00665366|3657524|FG001|Overall Study|Withdrawal by Subject|14
2076254|NCT00665366|3657523|FG000|Overall Study|Lost to Follow-up|3
2076255|NCT00665366|3657524|FG001|Overall Study|Lost to Follow-up|5
2076256|NCT00665366|3657523|FG000|Overall Study|Poor compliance/noncompliance|3
2076257|NCT00665366|3657524|FG001|Overall Study|Poor compliance/noncompliance|5
2076258|NCT00665366|3657523|FG000|Overall Study|Pregnancy|1
2076259|NCT00665366|3657524|FG001|Overall Study|Pregnancy|0
2076260|NCT00665366|3657523|FG000|Overall Study|No longer meets study criteria|0
2076261|NCT00665366|3657524|FG001|Overall Study|No longer meets study criteria|1
2076262|NCT00665366|3657523|FG000|Overall Study|Other reasons|4
2076263|NCT00665366|3657524|FG001|Overall Study|Other reasons|1
2076264|NCT00665392|3657530|FG000|Overall Study|not treated|1
2076265|NCT00665431|3657538|FG000|Overall Study|Adverse Event|16
2076266|NCT00665431|3657539|FG001|Overall Study|Adverse Event|22
2076267|NCT00665431|3657540|FG002|Overall Study|Adverse Event|6
2076268|NCT00665431|3657538|FG000|Overall Study|Withdrawal by Subject|17
2076269|NCT00665431|3657539|FG001|Overall Study|Withdrawal by Subject|25
2076270|NCT00665431|3657540|FG002|Overall Study|Withdrawal by Subject|15
2076271|NCT00665431|3657538|FG000|Overall Study|Lost to Follow-up|3
2076272|NCT00665431|3657539|FG001|Overall Study|Lost to Follow-up|3
2076273|NCT00665431|3657540|FG002|Overall Study|Lost to Follow-up|1
2076274|NCT00665431|3657538|FG000|Overall Study|Other|4
2076275|NCT00665431|3657539|FG001|Overall Study|Other|7
2076276|NCT00665431|3657540|FG002|Overall Study|Other|2
2076277|NCT00665561|3657563|FG000|Overall Study|Death recorded on subject summary pages|75
2076278|NCT00665561|3657564|FG001|Overall Study|Death recorded on subject summary pages|75
2076279|NCT00665561|3657563|FG000|Overall Study|Does not meet entrance criteria|19
2076280|NCT00665561|3657564|FG001|Overall Study|Does not meet entrance criteria|21
2076281|NCT00665561|3657563|FG000|Overall Study|Lost to Follow-up|203
2076282|NCT00665561|3657564|FG001|Overall Study|Lost to Follow-up|264
2076283|NCT00665561|3657563|FG000|Overall Study|Withdrawal by Subject|74
2076284|NCT00665561|3657564|FG001|Overall Study|Withdrawal by Subject|65
2076285|NCT00665561|3657563|FG000|Overall Study|Other|123
2076286|NCT00665561|3657564|FG001|Overall Study|Other|108
2076287|NCT00665561|3657563|FG000|Overall Study|Site closed|8
2076288|NCT00665561|3657564|FG001|Overall Study|Site closed|0
2076289|NCT00665561|3657563|FG000|Overall Study|Withdrawn due to pregnancy|0
2076290|NCT00665561|3657564|FG001|Overall Study|Withdrawn due to pregnancy|1
2076291|NCT00665626|3657572|FG000|Overall Study|Lack of Efficacy|8
2076292|NCT00665626|3657573|FG001|Overall Study|Lack of Efficacy|5
2076293|NCT00665626|3657572|FG000|Overall Study|Lost to Follow-up|0
2076294|NCT00665626|3657573|FG001|Overall Study|Lost to Follow-up|2
2076295|NCT00665626|3657572|FG000|Overall Study|Withdrawal by Subject|0
2076296|NCT00665626|3657573|FG001|Overall Study|Withdrawal by Subject|1
2076297|NCT00665626|3657572|FG000|Overall Study|Protocol Violation|0
2210756|NCT01653912|3850582|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2210757|NCT01653912|3850583|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6
2210758|NCT01653912|3850578|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2076298|NCT00665626|3657573|FG001|Overall Study|Protocol Violation|2
2076299|NCT00665626|3657572|FG000|Overall Study|Adverse Event|1
2076300|NCT00665626|3657573|FG001|Overall Study|Adverse Event|9
2076301|NCT00665626|3657572|FG000|Overall Study|Due to exclusion criteria|0
2076302|NCT00665626|3657573|FG001|Overall Study|Due to exclusion criteria|1
2076303|NCT00665626|3657572|FG000|Overall Study|Did not fulfil inclusion criteria|0
2076304|NCT00665626|3657573|FG001|Overall Study|Did not fulfil inclusion criteria|1
2076305|NCT00665626|3657572|FG000|Overall Study|Unably to comply with dosing regimen|0
2076306|NCT00665626|3657573|FG001|Overall Study|Unably to comply with dosing regimen|1
2076307|NCT00665626|3657572|FG000|Overall Study|Death|1
2076308|NCT00665626|3657573|FG001|Overall Study|Death|0
2076309|NCT00665652|3657579|FG000|Overall Study|Adverse Event|4
2076310|NCT00665652|3657579|FG000|Overall Study|Death|1
2076311|NCT00665652|3657579|FG000|Overall Study|No longer met inclusion criteria.|1
2076312|NCT00665847|3657587|FG000|Overall Study|Adverse Event|8
2076313|NCT00665847|3657587|FG000|Overall Study|Withdrawal by Subject|2
2076314|NCT00665847|3657587|FG000|Overall Study|Subject non-compliant|8
2076315|NCT00665847|3657587|FG000|Overall Study|Subject reached a virologic endpoint|4
2076316|NCT00665847|3657587|FG000|Overall Study|Resistance to TMC125|1
2076317|NCT00665847|3657587|FG000|Overall Study|Subject ineligible to continue the trial|1
2076318|NCT00665847|3657587|FG000|Overall Study|Switch to Commercial Medication|1
2076319|NCT00665925|3657595|FG000|Overall Study|Lack of Efficacy|10
2076320|NCT00665925|3657596|FG001|Overall Study|Lack of Efficacy|8
2076321|NCT00665925|3657597|FG002|Overall Study|Lack of Efficacy|9
2076322|NCT00665925|3657598|FG003|Overall Study|Lack of Efficacy|8
2076323|NCT00665925|3657595|FG000|Overall Study|Lost to Follow-up|1
2076324|NCT00665925|3657596|FG001|Overall Study|Lost to Follow-up|2
2076325|NCT00665925|3657597|FG002|Overall Study|Lost to Follow-up|2
2076326|NCT00665925|3657598|FG003|Overall Study|Lost to Follow-up|2
2076327|NCT00665925|3657595|FG000|Overall Study|Withdrawal by Subject|2
2076328|NCT00665925|3657596|FG001|Overall Study|Withdrawal by Subject|2
2076329|NCT00665925|3657597|FG002|Overall Study|Withdrawal by Subject|3
2076330|NCT00665925|3657598|FG003|Overall Study|Withdrawal by Subject|2
2076331|NCT00665925|3657595|FG000|Overall Study|Physician Decision|0
2076332|NCT00665925|3657596|FG001|Overall Study|Physician Decision|0
2076333|NCT00665925|3657597|FG002|Overall Study|Physician Decision|1
2076334|NCT00665925|3657598|FG003|Overall Study|Physician Decision|2
2076335|NCT00665925|3657595|FG000|Overall Study|Severe Non-Compliance to Protocol|0
2076336|NCT00665925|3657596|FG001|Overall Study|Severe Non-Compliance to Protocol|0
2076337|NCT00665925|3657597|FG002|Overall Study|Severe Non-Compliance to Protocol|1
2076338|NCT00665925|3657598|FG003|Overall Study|Severe Non-Compliance to Protocol|1
2076339|NCT00665925|3657595|FG000|Overall Study|Adverse Event|1
2076340|NCT00665925|3657596|FG001|Overall Study|Adverse Event|5
2076341|NCT00665925|3657597|FG002|Overall Study|Adverse Event|10
2076342|NCT00665925|3657598|FG003|Overall Study|Adverse Event|5
2076343|NCT00665925|3657595|FG000|Overall Study|Enrolled by mistake|0
2076344|NCT00665925|3657596|FG001|Overall Study|Enrolled by mistake|0
2076345|NCT00665925|3657597|FG002|Overall Study|Enrolled by mistake|0
2076346|NCT00665925|3657598|FG003|Overall Study|Enrolled by mistake|1
2076347|NCT00665925|3657595|FG000|Overall Study|Due to exclusion criteria|1
2076348|NCT00665925|3657596|FG001|Overall Study|Due to exclusion criteria|0
2076349|NCT00665925|3657597|FG002|Overall Study|Due to exclusion criteria|0
2076350|NCT00665925|3657598|FG003|Overall Study|Due to exclusion criteria|0
2076351|NCT00666198|3657619|FG000|Overall Study|Protocol Violation|10
2076352|NCT00666198|3657619|FG000|Overall Study|No Visit After First Day of Treatment|13
2076353|NCT00666198|3657619|FG000|Overall Study|Safety Not Assessable|6
2076354|NCT00666198|3657619|FG000|Overall Study|No Drug Administration|4
2076355|NCT00666211|3657625|FG000|Overall Study|Withdrawal by Subject|10
2076356|NCT00666211|3657626|FG001|Overall Study|Withdrawal by Subject|13
2076357|NCT00666211|3657625|FG000|Overall Study|went off medication, no more pain|1
2076358|NCT00666211|3657626|FG001|Overall Study|went off medication, no more pain|0
2076359|NCT00666211|3657625|FG000|Overall Study|patient non-compliant|6
2076360|NCT00666211|3657626|FG001|Overall Study|patient non-compliant|6
2076361|NCT00666211|3657625|FG000|Overall Study|disease progression|1
2076362|NCT00666211|3657626|FG001|Overall Study|disease progression|8
2076363|NCT00666211|3657625|FG000|Overall Study|Lost to Follow-up|2
2076364|NCT00666211|3657626|FG001|Overall Study|Lost to Follow-up|0
2076365|NCT00666211|3657625|FG000|Overall Study|toxicity|0
2076366|NCT00666211|3657626|FG001|Overall Study|toxicity|2
2076367|NCT00666211|3657625|FG000|Overall Study|hospital admission|0
2076368|NCT00666211|3657626|FG001|Overall Study|hospital admission|5
2076369|NCT00666211|3657625|FG000|Overall Study|Death|0
2076370|NCT00666211|3657626|FG001|Overall Study|Death|2
2076371|NCT00666211|3657625|FG000|Overall Study|off tx for other complicating disease|0
2076372|NCT00666211|3657626|FG001|Overall Study|off tx for other complicating disease|1
2076373|NCT00666211|3657625|FG000|Overall Study|Physician Decision|0
2076374|NCT00666211|3657626|FG001|Overall Study|Physician Decision|1
2076375|NCT00666224|3657634|FG000|Double-Blind|Adverse Event|15
2076376|NCT00666224|3657635|FG001|Double-Blind|Adverse Event|5
2076377|NCT00666224|3657634|FG000|Double-Blind|Lost to Follow-up|2
2076378|NCT00666224|3657635|FG001|Double-Blind|Lost to Follow-up|2
2076379|NCT00666224|3657634|FG000|Double-Blind|Withdrawal by Subject|18
2076380|NCT00666224|3657635|FG001|Double-Blind|Withdrawal by Subject|14
2076381|NCT00666224|3657634|FG000|Double-Blind|Physician Decision|0
2076382|NCT00666224|3657635|FG001|Double-Blind|Physician Decision|3
2076383|NCT00666224|3657634|FG000|Double-Blind|Sponsor decision|1
2076384|NCT00666224|3657635|FG001|Double-Blind|Sponsor decision|0
2076385|NCT00666224|3657634|FG000|Double-Blind|Pregnancy|3
2076386|NCT00666224|3657635|FG001|Double-Blind|Pregnancy|2
2076387|NCT00666224|3657634|FG000|Double-Blind|Noncompliance|1
2076388|NCT00666224|3657635|FG001|Double-Blind|Noncompliance|0
2076389|NCT00666224|3657634|FG000|Double-Blind|Death|1
2076390|NCT00666224|3657635|FG001|Double-Blind|Death|0
2076391|NCT00666224|3657634|FG000|Double-Blind|Undefined/Unknown|4
2076392|NCT00666224|3657635|FG001|Double-Blind|Undefined/Unknown|1
2076393|NCT00666224|3657634|FG000|Open-Label|Adverse Event|8
2076394|NCT00666224|3657635|FG001|Open-Label|Adverse Event|43
2076395|NCT00666224|3657634|FG000|Open-Label|Lost to Follow-up|4
2076396|NCT00666224|3657635|FG001|Open-Label|Lost to Follow-up|5
2076397|NCT00666224|3657634|FG000|Open-Label|Withdrawal by Subject|12
2076398|NCT00666224|3657635|FG001|Open-Label|Withdrawal by Subject|25
2076399|NCT00666224|3657634|FG000|Open-Label|Physician Decision|7
2076400|NCT00666224|3657635|FG001|Open-Label|Physician Decision|5
2076401|NCT00666224|3657634|FG000|Open-Label|Pregnancy|1
2076402|NCT00666224|3657635|FG001|Open-Label|Pregnancy|5
2076403|NCT00666224|3657634|FG000|Open-Label|Noncompliance|2
2076404|NCT00666224|3657635|FG001|Open-Label|Noncompliance|1
2076405|NCT00666224|3657634|FG000|Open-Label|Undefined/Unknown|1
2076406|NCT00666224|3657635|FG001|Open-Label|Undefined/Unknown|1
2076407|NCT00666263|3657642|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
2076408|NCT00666263|3657643|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
2076409|NCT00666263|3657642|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1
2076410|NCT00666263|3657643|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0
2076411|NCT00666263|3657642|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
2076412|NCT00666263|3657643|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
2076413|NCT00666276|3657688|FG000|Overall Study|Protocol Violation|34
2076414|NCT00666328|3657711|FG000|Overall Study|Death|2
2076415|NCT00666328|3657711|FG000|Overall Study|Lost to Follow-up|2
2076416|NCT00666328|3657711|FG000|Overall Study|No longer met eligibility criteria|1
2076417|NCT00666458|3657725|FG000|Overall Study|Adverse Event|8
2076418|NCT00666458|3657726|FG001|Overall Study|Adverse Event|7
2076419|NCT00666458|3657725|FG000|Overall Study|Withdrawal by Subject|5
2076420|NCT00666458|3657726|FG001|Overall Study|Withdrawal by Subject|4
2076421|NCT00666458|3657725|FG000|Overall Study|Lost to Follow-up|0
2076422|NCT00666458|3657726|FG001|Overall Study|Lost to Follow-up|3
2076423|NCT00666458|3657725|FG000|Overall Study|Administrative reason by sponsor|1
2076424|NCT00666458|3657726|FG001|Overall Study|Administrative reason by sponsor|1
2076425|NCT00666458|3657725|FG000|Overall Study|Incorrect enrollment|7
2076426|NCT00666458|3657726|FG001|Overall Study|Incorrect enrollment|1
2076427|NCT00666458|3657725|FG000|Overall Study|Study specific discontinuation criteria|14
2076428|NCT00666458|3657726|FG001|Overall Study|Study specific discontinuation criteria|7
2076429|NCT00666458|3657725|FG000|Overall Study|Severe non-compliance to the protocol|1
2076430|NCT00666458|3657726|FG001|Overall Study|Severe non-compliance to the protocol|1
2076431|NCT00666458|3657725|FG000|Overall Study|Safety reasons|1
2076432|NCT00666458|3657726|FG001|Overall Study|Safety reasons|0
2076433|NCT00666458|3657725|FG000|Overall Study|Medical history of anemia|1
2076434|NCT00666458|3657726|FG001|Overall Study|Medical history of anemia|0
2076435|NCT00666536|3657734|FG000|Overall Study|Adverse Event|9
2076436|NCT00666536|3657735|FG001|Overall Study|Adverse Event|19
2076437|NCT00666536|3657734|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2076438|NCT00666536|3657735|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2076439|NCT00666536|3657734|FG000|Overall Study|Protocol deviation(s)|8
2076440|NCT00666536|3657735|FG001|Overall Study|Protocol deviation(s)|6
2076441|NCT00666536|3657734|FG000|Overall Study|Withdrawal by Subject|10
2076442|NCT00666536|3657735|FG001|Overall Study|Withdrawal by Subject|9
2076443|NCT00666536|3657734|FG000|Overall Study|Lost to Follow-up|4
2076444|NCT00666536|3657735|FG001|Overall Study|Lost to Follow-up|3
2076445|NCT00666562|3657744|FG000|Overall Study|Withdrawal by Subject|0
2076446|NCT00666562|3657745|FG001|Overall Study|Withdrawal by Subject|1
2076447|NCT00666562|3657746|FG002|Overall Study|Withdrawal by Subject|0
2076448|NCT00666562|3657744|FG000|Overall Study|Concomitant Medication|0
2076449|NCT00666562|3657745|FG001|Overall Study|Concomitant Medication|1
2076450|NCT00666562|3657746|FG002|Overall Study|Concomitant Medication|0
2076451|NCT00666588|3657765|FG000|Overall Study|ineligible|2
2076452|NCT00666588|3657766|FG001|Overall Study|ineligible|0
2076453|NCT00666588|3657767|FG002|Overall Study|ineligible|0
2076454|NCT00666588|3657768|FG003|Overall Study|ineligible|2
2076455|NCT00666588|3657765|FG000|Overall Study|inevaluable|2
2076456|NCT00666588|3657766|FG001|Overall Study|inevaluable|0
2076457|NCT00666588|3657767|FG002|Overall Study|inevaluable|0
2076458|NCT00666588|3657768|FG003|Overall Study|inevaluable|0
2076459|NCT00666679|3657784|FG000|First Intervention|Lost to Follow-up|1
2076460|NCT00666679|3657785|FG001|First Intervention|Lost to Follow-up|0
2076461|NCT00666679|3657784|FG000|First Intervention|Protocol Violation|1
2076462|NCT00666679|3657785|FG001|First Intervention|Protocol Violation|0
2076463|NCT00666679|3657784|FG000|First Intervention|Withdrawal by Subject|1
2076464|NCT00666679|3657785|FG001|First Intervention|Withdrawal by Subject|0
2076465|NCT00666679|3657784|FG000|First Intervention|Randomized did not start treatment|1
2076466|NCT00666679|3657785|FG001|First Intervention|Randomized did not start treatment|1
2076467|NCT00666679|3657784|FG000|Washout Period of 1 Week|Lost to Follow-up|0
2076468|NCT00666679|3657785|FG001|Washout Period of 1 Week|Lost to Follow-up|1
2076469|NCT00666679|3657784|FG000|Washout Period of 1 Week|Protocol Violation|0
2076470|NCT00666679|3657785|FG001|Washout Period of 1 Week|Protocol Violation|1
2076471|NCT00666679|3657784|FG000|Second Intervention|Adverse Event|1
2076472|NCT00666679|3657785|FG001|Second Intervention|Adverse Event|0
2076473|NCT00666679|3657784|FG000|Second Intervention|Death|0
2076474|NCT00666679|3657785|FG001|Second Intervention|Death|1
2076475|NCT00666705|3657791|FG000|Overall Study|Withdrawal by Subject|1
2076476|NCT00666718|3657802|FG000|Overall Study|Adverse Event|0
2076477|NCT00666718|3657803|FG001|Overall Study|Adverse Event|1
2076478|NCT00666718|3657802|FG000|Overall Study|Death|1
2076479|NCT00666718|3657803|FG001|Overall Study|Death|0
2076480|NCT00666718|3657802|FG000|Overall Study|Lost to Follow-up|1
2076481|NCT00666718|3657803|FG001|Overall Study|Lost to Follow-up|0
2076482|NCT00666718|3657802|FG000|Overall Study|Entry Criteria Not Met|2
2076483|NCT00666718|3657803|FG001|Overall Study|Entry Criteria Not Met|0
2076484|NCT00666718|3657802|FG000|Overall Study|Protocol Violation|1
2076485|NCT00666718|3657803|FG001|Overall Study|Protocol Violation|3
2076486|NCT00666718|3657802|FG000|Overall Study|Withdrawal by Subject|7
2076487|NCT00666718|3657803|FG001|Overall Study|Withdrawal by Subject|12
2076488|NCT00666718|3657802|FG000|Overall Study|Physician Decision|0
2076489|NCT00666718|3657803|FG001|Overall Study|Physician Decision|2
2076490|NCT00666757|3657811|FG000|Overall Study|Lost to Follow-up|39
2076491|NCT00666757|3657812|FG001|Overall Study|Lost to Follow-up|35
2076492|NCT00666757|3657811|FG000|Overall Study|Protocol Violation|23
2076493|NCT00666757|3657812|FG001|Overall Study|Protocol Violation|24
2076494|NCT00666757|3657811|FG000|Overall Study|Adverse Event|22
2076495|NCT00666757|3657812|FG001|Overall Study|Adverse Event|12
2076496|NCT00666757|3657811|FG000|Overall Study|Withdrawal by Subject|13
2076497|NCT00666757|3657812|FG001|Overall Study|Withdrawal by Subject|17
2076498|NCT00666757|3657811|FG000|Overall Study|Lack of Efficacy|3
2076499|NCT00666757|3657812|FG001|Overall Study|Lack of Efficacy|6
2076500|NCT00666757|3657811|FG000|Overall Study|Physician Decision|0
2076501|NCT00666757|3657812|FG001|Overall Study|Physician Decision|2
2076502|NCT00666757|3657811|FG000|Overall Study|Sponsor decision|0
2076503|NCT00666757|3657812|FG001|Overall Study|Sponsor decision|1
2076504|NCT00666835|3657823|FG000|Overall Study|Withdrawal by Subject|5
2076505|NCT00666835|3657824|FG001|Overall Study|Withdrawal by Subject|2
2076506|NCT00666835|3657823|FG000|Overall Study|Lack of Efficacy|0
2076507|NCT00666835|3657824|FG001|Overall Study|Lack of Efficacy|1
2076508|NCT00666835|3657823|FG000|Overall Study|Incl./excl. not fulfilled|7
2076509|NCT00666835|3657824|FG001|Overall Study|Incl./excl. not fulfilled|2
2076510|NCT00666835|3657823|FG000|Overall Study|Adverse Event|7
2076511|NCT00666835|3657824|FG001|Overall Study|Adverse Event|6
2076512|NCT00666835|3657823|FG000|Overall Study|Protocol Violation|2
2076513|NCT00666835|3657824|FG001|Overall Study|Protocol Violation|0
2076514|NCT00666835|3657823|FG000|Overall Study|Death|15
2076515|NCT00666835|3657824|FG001|Overall Study|Death|4
2076516|NCT00666835|3657823|FG000|Overall Study|Kidney Transplantation (NTX)|10
2076517|NCT00666835|3657824|FG001|Overall Study|Kidney Transplantation (NTX)|2
2076518|NCT00666835|3657823|FG000|Overall Study|Hemoglobulin concentration|4
2076519|NCT00666835|3657824|FG001|Overall Study|Hemoglobulin concentration|3
2076520|NCT00666835|3657823|FG000|Overall Study|Planned operation|2
2076521|NCT00666835|3657824|FG001|Overall Study|Planned operation|0
2076522|NCT00666835|3657823|FG000|Overall Study|Physician Decision|1
2076523|NCT00666835|3657824|FG001|Overall Study|Physician Decision|2
2076524|NCT00666926|3657844|FG000|Overall Study|Adverse Event|0
2076525|NCT00666926|3657845|FG001|Overall Study|Adverse Event|0
2076526|NCT00666926|3657846|FG002|Overall Study|Adverse Event|0
2076527|NCT00666926|3657847|FG003|Overall Study|Adverse Event|0
2076528|NCT00666926|3657848|FG004|Overall Study|Adverse Event|0
2076529|NCT00666926|3657849|FG005|Overall Study|Adverse Event|0
2076530|NCT00666926|3657850|FG006|Overall Study|Adverse Event|0
2076531|NCT00666926|3657851|FG007|Overall Study|Adverse Event|0
2076532|NCT00666926|3657852|FG008|Overall Study|Adverse Event|0
2076533|NCT00666926|3657853|FG009|Overall Study|Adverse Event|2
2076534|NCT00666926|3657854|FG010|Overall Study|Adverse Event|2
2076535|NCT00666926|3657855|FG011|Overall Study|Adverse Event|2
2076536|NCT00666926|3657856|FG012|Overall Study|Adverse Event|0
2076537|NCT00666926|3657857|FG013|Overall Study|Adverse Event|1
2076538|NCT00666926|3657858|FG014|Overall Study|Adverse Event|0
2076539|NCT00666926|3657859|FG015|Overall Study|Adverse Event|0
2076540|NCT00666926|3657844|FG000|Overall Study|Laboratory abnormality|0
2076541|NCT00666926|3657845|FG001|Overall Study|Laboratory abnormality|0
2076542|NCT00666926|3657846|FG002|Overall Study|Laboratory abnormality|0
2076543|NCT00666926|3657847|FG003|Overall Study|Laboratory abnormality|0
2076544|NCT00666926|3657848|FG004|Overall Study|Laboratory abnormality|0
2076545|NCT00666926|3657849|FG005|Overall Study|Laboratory abnormality|0
2076546|NCT00666926|3657850|FG006|Overall Study|Laboratory abnormality|0
2076547|NCT00666926|3657851|FG007|Overall Study|Laboratory abnormality|0
2210759|NCT01653912|3850579|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2210760|NCT01653912|3850580|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2210761|NCT01653912|3850581|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2210762|NCT01653912|3850582|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2210763|NCT01653912|3850583|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
2210764|NCT01654224|3850608|FG000|Overall Study|Lost to Follow-up|2
2210765|NCT01654224|3850609|FG001|Overall Study|Lost to Follow-up|2
2210766|NCT01654224|3850608|FG000|Overall Study|Did not receive allocation|1
2210767|NCT01654224|3850609|FG001|Overall Study|Did not receive allocation|8
2210768|NCT01654224|3850608|FG000|Overall Study|Insufficient blood sample|3
2210769|NCT01654224|3850609|FG001|Overall Study|Insufficient blood sample|2
2210770|NCT01654250|3850617|FG000|Overall Study|Lost to Follow-up|1
2210771|NCT01654250|3850618|FG001|Overall Study|Lost to Follow-up|0
2210772|NCT01654276|3850647|FG000|Overall Study|Lack of Efficacy|1
2210773|NCT01654276|3850647|FG000|Overall Study|Lost to Follow-up|4
2076548|NCT00666926|3657852|FG008|Overall Study|Laboratory abnormality|0
2076549|NCT00666926|3657853|FG009|Overall Study|Laboratory abnormality|0
2076550|NCT00666926|3657854|FG010|Overall Study|Laboratory abnormality|1
2076551|NCT00666926|3657855|FG011|Overall Study|Laboratory abnormality|0
2076552|NCT00666926|3657856|FG012|Overall Study|Laboratory abnormality|0
2076553|NCT00666926|3657857|FG013|Overall Study|Laboratory abnormality|0
2076554|NCT00666926|3657858|FG014|Overall Study|Laboratory abnormality|0
2076555|NCT00666926|3657859|FG015|Overall Study|Laboratory abnormality|1
2076556|NCT00666926|3657844|FG000|Overall Study|Lack of Efficacy|0
2076557|NCT00666926|3657845|FG001|Overall Study|Lack of Efficacy|0
2076558|NCT00666926|3657846|FG002|Overall Study|Lack of Efficacy|0
2076559|NCT00666926|3657847|FG003|Overall Study|Lack of Efficacy|0
2076560|NCT00666926|3657848|FG004|Overall Study|Lack of Efficacy|0
2076561|NCT00666926|3657849|FG005|Overall Study|Lack of Efficacy|1
2076562|NCT00666926|3657850|FG006|Overall Study|Lack of Efficacy|0
2076563|NCT00666926|3657851|FG007|Overall Study|Lack of Efficacy|0
2076564|NCT00666926|3657852|FG008|Overall Study|Lack of Efficacy|0
2076565|NCT00666926|3657853|FG009|Overall Study|Lack of Efficacy|0
2076566|NCT00666926|3657854|FG010|Overall Study|Lack of Efficacy|0
2076567|NCT00666926|3657855|FG011|Overall Study|Lack of Efficacy|1
2076568|NCT00666926|3657856|FG012|Overall Study|Lack of Efficacy|0
2076569|NCT00666926|3657857|FG013|Overall Study|Lack of Efficacy|0
2076570|NCT00666926|3657858|FG014|Overall Study|Lack of Efficacy|0
2210774|NCT01654276|3850647|FG000|Overall Study|Withdrawal by Subject|1
2076571|NCT00666926|3657859|FG015|Overall Study|Lack of Efficacy|0
2076572|NCT00666926|3657844|FG000|Overall Study|Lost to Follow-up|0
2076573|NCT00666926|3657845|FG001|Overall Study|Lost to Follow-up|0
2076574|NCT00666926|3657846|FG002|Overall Study|Lost to Follow-up|0
2076575|NCT00666926|3657847|FG003|Overall Study|Lost to Follow-up|1
2076576|NCT00666926|3657848|FG004|Overall Study|Lost to Follow-up|0
2076577|NCT00666926|3657849|FG005|Overall Study|Lost to Follow-up|0
2076578|NCT00666926|3657850|FG006|Overall Study|Lost to Follow-up|0
2076579|NCT00666926|3657851|FG007|Overall Study|Lost to Follow-up|0
2076580|NCT00666926|3657852|FG008|Overall Study|Lost to Follow-up|0
2076581|NCT00666926|3657853|FG009|Overall Study|Lost to Follow-up|0
2076582|NCT00666926|3657854|FG010|Overall Study|Lost to Follow-up|0
2076583|NCT00666926|3657855|FG011|Overall Study|Lost to Follow-up|0
2076584|NCT00666926|3657856|FG012|Overall Study|Lost to Follow-up|0
2076585|NCT00666926|3657857|FG013|Overall Study|Lost to Follow-up|0
2076586|NCT00666926|3657858|FG014|Overall Study|Lost to Follow-up|0
2076587|NCT00666926|3657859|FG015|Overall Study|Lost to Follow-up|0
2076588|NCT00666926|3657844|FG000|Overall Study|Other|2
2076589|NCT00666926|3657845|FG001|Overall Study|Other|4
2076590|NCT00666926|3657846|FG002|Overall Study|Other|3
2076591|NCT00666926|3657847|FG003|Overall Study|Other|3
2076592|NCT00666926|3657848|FG004|Overall Study|Other|3
2076593|NCT00666926|3657849|FG005|Overall Study|Other|3
2076594|NCT00666926|3657850|FG006|Overall Study|Other|4
2076595|NCT00666926|3657851|FG007|Overall Study|Other|0
2076596|NCT00666926|3657852|FG008|Overall Study|Other|3
2076597|NCT00666926|3657853|FG009|Overall Study|Other|5
2076598|NCT00666926|3657854|FG010|Overall Study|Other|3
2076599|NCT00666926|3657855|FG011|Overall Study|Other|26
2076600|NCT00666926|3657856|FG012|Overall Study|Other|3
2076601|NCT00666926|3657857|FG013|Overall Study|Other|2
2076602|NCT00666926|3657858|FG014|Overall Study|Other|4
2076603|NCT00666926|3657859|FG015|Overall Study|Other|4
2076604|NCT00666926|3657844|FG000|Overall Study|Withdrawal by Subject|0
2076605|NCT00666926|3657845|FG001|Overall Study|Withdrawal by Subject|0
2076606|NCT00666926|3657846|FG002|Overall Study|Withdrawal by Subject|0
2076607|NCT00666926|3657847|FG003|Overall Study|Withdrawal by Subject|0
2076608|NCT00666926|3657848|FG004|Overall Study|Withdrawal by Subject|0
2076609|NCT00666926|3657849|FG005|Overall Study|Withdrawal by Subject|0
2076610|NCT00666926|3657850|FG006|Overall Study|Withdrawal by Subject|0
2076611|NCT00666926|3657851|FG007|Overall Study|Withdrawal by Subject|1
2076612|NCT00666926|3657852|FG008|Overall Study|Withdrawal by Subject|0
2076613|NCT00666926|3657853|FG009|Overall Study|Withdrawal by Subject|3
2076614|NCT00666926|3657854|FG010|Overall Study|Withdrawal by Subject|0
2076615|NCT00666926|3657855|FG011|Overall Study|Withdrawal by Subject|3
2076616|NCT00666926|3657856|FG012|Overall Study|Withdrawal by Subject|0
2076617|NCT00666926|3657857|FG013|Overall Study|Withdrawal by Subject|1
2076618|NCT00666926|3657858|FG014|Overall Study|Withdrawal by Subject|3
2076619|NCT00666926|3657859|FG015|Overall Study|Withdrawal by Subject|3
2076620|NCT00666926|3657844|FG000|Overall Study|Death|0
2076621|NCT00666926|3657845|FG001|Overall Study|Death|0
2076622|NCT00666926|3657846|FG002|Overall Study|Death|0
2076623|NCT00666926|3657847|FG003|Overall Study|Death|0
2076624|NCT00666926|3657848|FG004|Overall Study|Death|0
2076625|NCT00666926|3657849|FG005|Overall Study|Death|0
2076626|NCT00666926|3657850|FG006|Overall Study|Death|0
2076627|NCT00666926|3657851|FG007|Overall Study|Death|0
2076628|NCT00666926|3657852|FG008|Overall Study|Death|0
2076629|NCT00666926|3657853|FG009|Overall Study|Death|0
2076630|NCT00666926|3657854|FG010|Overall Study|Death|0
2076631|NCT00666926|3657855|FG011|Overall Study|Death|1
2076632|NCT00666926|3657856|FG012|Overall Study|Death|0
2076633|NCT00666926|3657857|FG013|Overall Study|Death|0
2076634|NCT00666926|3657858|FG014|Overall Study|Death|0
2076635|NCT00666926|3657859|FG015|Overall Study|Death|0
2076636|NCT00666965|3657914|FG000|Overall Study|Adverse Event|0
2076637|NCT00666965|3657915|FG001|Overall Study|Adverse Event|2
2076638|NCT00666965|3657916|FG002|Overall Study|Adverse Event|1
2076639|NCT00666965|3657917|FG003|Overall Study|Adverse Event|9
2076640|NCT00666965|3657914|FG000|Overall Study|Lack of Efficacy|1
2076641|NCT00666965|3657915|FG001|Overall Study|Lack of Efficacy|1
2076642|NCT00666965|3657916|FG002|Overall Study|Lack of Efficacy|0
2076643|NCT00666965|3657917|FG003|Overall Study|Lack of Efficacy|0
2076644|NCT00666965|3657914|FG000|Overall Study|Protocol Violation|0
2076645|NCT00666965|3657915|FG001|Overall Study|Protocol Violation|0
2076646|NCT00666965|3657916|FG002|Overall Study|Protocol Violation|0
2076647|NCT00666965|3657917|FG003|Overall Study|Protocol Violation|2
2076648|NCT00666965|3657914|FG000|Overall Study|Discontinuation criteria|2
2076649|NCT00666965|3657915|FG001|Overall Study|Discontinuation criteria|1
2076650|NCT00666965|3657916|FG002|Overall Study|Discontinuation criteria|1
2076651|NCT00666965|3657917|FG003|Overall Study|Discontinuation criteria|2
2076652|NCT00666965|3657914|FG000|Overall Study|Withdrawal by Subject|0
2076653|NCT00666965|3657915|FG001|Overall Study|Withdrawal by Subject|0
2076654|NCT00666965|3657916|FG002|Overall Study|Withdrawal by Subject|0
2076655|NCT00666965|3657917|FG003|Overall Study|Withdrawal by Subject|2
2076656|NCT00667095|3657949|FG000|Overall Study|Withdrawal by Subject|0
2076657|NCT00667095|3657950|FG001|Overall Study|Withdrawal by Subject|1
2076658|NCT00667225|3657967|FG000|Overall Study|Subject had no more lesions to treat.|1
2076659|NCT00667225|3657968|FG001|Overall Study|Subject had no more lesions to treat.|0
2076660|NCT00667225|3657967|FG000|Overall Study|Lost to Follow-up|0
2076661|NCT00667225|3657968|FG001|Overall Study|Lost to Follow-up|1
2076662|NCT00667251|3657976|FG000|Overall Study|Adverse Event|13
2076663|NCT00667251|3657977|FG001|Overall Study|Adverse Event|4
2076664|NCT00667251|3657976|FG000|Overall Study|Withdrawal by Subject|6
2076665|NCT00667251|3657977|FG001|Overall Study|Withdrawal by Subject|2
2076666|NCT00667251|3657976|FG000|Overall Study|Other/missing|46
2076667|NCT00667251|3657977|FG001|Overall Study|Other/missing|84
2076668|NCT00667251|3657976|FG000|Overall Study|Intercurrent Illness|4
2076669|NCT00667251|3657977|FG001|Overall Study|Intercurrent Illness|3
2076670|NCT00667251|3657976|FG000|Overall Study|Symptomatic progression|1
2076671|NCT00667251|3657977|FG001|Overall Study|Symptomatic progression|2
2076672|NCT00667277|3657983|FG000|Overall Study|Withdrawal by Subject|2
2076673|NCT00667342|3657990|FG000|Overall Study|Protocol Violation|1
2076674|NCT00667342|3657991|FG001|Overall Study|Protocol Violation|0
2076675|NCT00667342|3657992|FG002|Overall Study|Protocol Violation|0
2076676|NCT00667342|3657990|FG000|Overall Study|Withdrawal by Subject|1
2076677|NCT00667342|3657991|FG001|Overall Study|Withdrawal by Subject|0
2076678|NCT00667342|3657992|FG002|Overall Study|Withdrawal by Subject|0
2076679|NCT00667342|3657990|FG000|Overall Study|Physician Decision|3
2076680|NCT00667342|3657991|FG001|Overall Study|Physician Decision|0
2076681|NCT00667342|3657992|FG002|Overall Study|Physician Decision|0
2076682|NCT00667342|3657990|FG000|Overall Study|Relapse or tumor progression|9
2076683|NCT00667342|3657991|FG001|Overall Study|Relapse or tumor progression|0
2076684|NCT00667342|3657992|FG002|Overall Study|Relapse or tumor progression|7
2076685|NCT00667342|3657990|FG000|Overall Study|Adverse Event|0
2076686|NCT00667342|3657991|FG001|Overall Study|Adverse Event|0
2076687|NCT00667342|3657992|FG002|Overall Study|Adverse Event|1
2076688|NCT00667342|3657990|FG000|Overall Study|Ineligible|0
2076689|NCT00667342|3657991|FG001|Overall Study|Ineligible|0
2076690|NCT00667342|3657992|FG002|Overall Study|Ineligible|1
2076691|NCT00667355|3658006|FG000|Overall Study|Adverse Event|5
2076692|NCT00667355|3658006|FG000|Overall Study|Lost to Follow-up|1
2076693|NCT00667355|3658006|FG000|Overall Study|Other reason was not specified|5
2076694|NCT00667368|3658012|FG000|Overall Study|Lost to Follow-up|176
2076695|NCT00667368|3658013|FG001|Overall Study|Lost to Follow-up|155
2076696|NCT00667368|3658012|FG000|Overall Study|Discontinued early|24
2076697|NCT00667368|3658013|FG001|Overall Study|Discontinued early|17
2076698|NCT00667394|3658030|FG000|Overall Study|Adverse Event|3
2076699|NCT00667394|3658031|FG001|Overall Study|Adverse Event|0
2210775|NCT01654289|3850654|FG000|Overall Study|Withdrawal by Subject|10
2210776|NCT01654289|3850655|FG001|Overall Study|Withdrawal by Subject|8
2210777|NCT01654289|3850656|FG002|Overall Study|Withdrawal by Subject|5
2210778|NCT01654289|3850654|FG000|Overall Study|Withdrew from intervention only|17
2210779|NCT01654289|3850655|FG001|Overall Study|Withdrew from intervention only|20
2210780|NCT01654289|3850656|FG002|Overall Study|Withdrew from intervention only|0
2217502|NCT01708941|3860841|FG003|Overall Study|Withdrawal by Subject|4
2217503|NCT01708941|3860838|FG000|Overall Study|Disease progression|9
2217504|NCT01708941|3860839|FG001|Overall Study|Disease progression|10
2217505|NCT01708941|3860840|FG002|Overall Study|Disease progression|8
2217506|NCT01708941|3860841|FG003|Overall Study|Disease progression|0
2217507|NCT01708941|3860838|FG000|Overall Study|Alternative therapy|0
2217508|NCT01708941|3860839|FG001|Overall Study|Alternative therapy|0
2217509|NCT01708941|3860840|FG002|Overall Study|Alternative therapy|2
2217510|NCT01708941|3860841|FG003|Overall Study|Alternative therapy|0
2217511|NCT01708941|3860838|FG000|Overall Study|Ineligible and never started treatment|1
2217512|NCT01708941|3860839|FG001|Overall Study|Ineligible and never started treatment|0
2217513|NCT01708941|3860840|FG002|Overall Study|Ineligible and never started treatment|1
2076700|NCT00667394|3658030|FG000|Overall Study|Progressive disease|1
2076701|NCT00667394|3658031|FG001|Overall Study|Progressive disease|0
2076702|NCT00667420|3658037|FG000|Overall Study|Adverse Event|2
2076703|NCT00667420|3658037|FG000|Overall Study|Lack of Efficacy|5
2076704|NCT00667420|3658037|FG000|Overall Study|Physician Decision|1
2076705|NCT00667420|3658037|FG000|Overall Study|Withdrawal by Subject|2
2076706|NCT00667446|3658044|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13
2076707|NCT00667446|3658045|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15
2076708|NCT00667446|3658044|FG000|Treatment Period (36 Months)|Other|2
2076709|NCT00667446|3658045|FG001|Treatment Period (36 Months)|Other|2
2076710|NCT00667446|3658044|FG000|Treatment Period (36 Months)|Personal reasons|2
2076711|NCT00667446|3658045|FG001|Treatment Period (36 Months)|Personal reasons|2
2076712|NCT00667446|3658044|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0
2076713|NCT00667446|3658045|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4
2076714|NCT00667446|3658044|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
2076715|NCT00667446|3658045|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
2076716|NCT00667446|3658044|FG000|Treatment Period (36 Months)|Lost to Follow-up|1
2076717|NCT00667446|3658045|FG001|Treatment Period (36 Months)|Lost to Follow-up|0
2076718|NCT00667446|3658044|FG000|Treatment Period (36 Months)|Protocol Violation|1
2076719|NCT00667446|3658045|FG001|Treatment Period (36 Months)|Protocol Violation|1
2076720|NCT00667446|3658044|FG000|Treatment Period (36 Months)|Therapeutic Failure|1
2076721|NCT00667446|3658045|FG001|Treatment Period (36 Months)|Therapeutic Failure|1
2076722|NCT00667446|3658044|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
2210781|NCT01654302|3850666|FG000|Second Intervention (Day 7)|Lost to Follow-up|1
2210782|NCT01654302|3850667|FG001|Second Intervention (Day 7)|Lost to Follow-up|1
2210783|NCT01654380|3850675|FG000|Part B, Period 1|Physician Decision|0
2076723|NCT00667446|3658045|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
2076724|NCT00667459|3658053|FG000|Overall Study|Death|0
2076725|NCT00667459|3658054|FG001|Overall Study|Death|2
2076726|NCT00667459|3658053|FG000|Overall Study|Lost to Follow-up|8
2076727|NCT00667459|3658054|FG001|Overall Study|Lost to Follow-up|43
2076728|NCT00667563|3658066|FG000|Overall Study|Protocol Violation|24
2076729|NCT00667576|3658075|FG000|Overall Study|Withdrawal by Subject|1
2076730|NCT00667576|3658076|FG001|Overall Study|Withdrawal by Subject|0
2076731|NCT00667576|3658077|FG002|Overall Study|Withdrawal by Subject|1
2076732|NCT00667576|3658078|FG003|Overall Study|Withdrawal by Subject|1
2076733|NCT00667576|3658079|FG004|Overall Study|Withdrawal by Subject|1
2076734|NCT00667576|3658075|FG000|Overall Study|Adverse Event|1
2076735|NCT00667576|3658076|FG001|Overall Study|Adverse Event|1
2076736|NCT00667576|3658077|FG002|Overall Study|Adverse Event|0
2076737|NCT00667576|3658078|FG003|Overall Study|Adverse Event|0
2076738|NCT00667576|3658079|FG004|Overall Study|Adverse Event|0
2076739|NCT00667576|3658075|FG000|Overall Study|Lost to Follow-up|0
2076740|NCT00667576|3658076|FG001|Overall Study|Lost to Follow-up|0
2076741|NCT00667576|3658077|FG002|Overall Study|Lost to Follow-up|1
2076742|NCT00667576|3658078|FG003|Overall Study|Lost to Follow-up|0
2076743|NCT00667576|3658079|FG004|Overall Study|Lost to Follow-up|0
2076744|NCT00667576|3658075|FG000|Overall Study|Protocol Violation|0
2076745|NCT00667576|3658076|FG001|Overall Study|Protocol Violation|0
2076746|NCT00667576|3658077|FG002|Overall Study|Protocol Violation|0
2076747|NCT00667576|3658078|FG003|Overall Study|Protocol Violation|1
2076748|NCT00667576|3658079|FG004|Overall Study|Protocol Violation|0
2210784|NCT01654380|3850676|FG001|Part B, Period 1|Physician Decision|0
2076749|NCT00667576|3658075|FG000|Overall Study|Physician Decision|0
2076750|NCT00667576|3658076|FG001|Overall Study|Physician Decision|0
2076751|NCT00667576|3658077|FG002|Overall Study|Physician Decision|0
2076752|NCT00667576|3658078|FG003|Overall Study|Physician Decision|1
2076753|NCT00667576|3658079|FG004|Overall Study|Physician Decision|0
2076754|NCT00667576|3658075|FG000|Overall Study|Missed Visit|0
2076755|NCT00667576|3658076|FG001|Overall Study|Missed Visit|0
2076756|NCT00667576|3658077|FG002|Overall Study|Missed Visit|0
2076757|NCT00667576|3658078|FG003|Overall Study|Missed Visit|1
2076758|NCT00667576|3658079|FG004|Overall Study|Missed Visit|0
2076759|NCT00667602|3658111|FG000|Overall Study|Withdrawal by Subject|4
2076760|NCT00667602|3658112|FG001|Overall Study|Withdrawal by Subject|9
2076761|NCT00667602|3658113|FG002|Overall Study|Withdrawal by Subject|10
2076762|NCT00667602|3658111|FG000|Overall Study|Lost to Follow-up|4
2076763|NCT00667602|3658112|FG001|Overall Study|Lost to Follow-up|5
2076764|NCT00667602|3658113|FG002|Overall Study|Lost to Follow-up|6
2076765|NCT00667602|3658111|FG000|Overall Study|Administrative reason|0
2076766|NCT00667602|3658112|FG001|Overall Study|Administrative reason|0
2076767|NCT00667602|3658113|FG002|Overall Study|Administrative reason|2
2076768|NCT00667602|3658111|FG000|Overall Study|Protocol Violation|0
2076769|NCT00667602|3658112|FG001|Overall Study|Protocol Violation|1
2076770|NCT00667602|3658113|FG002|Overall Study|Protocol Violation|0
2076771|NCT00667719|3658139|FG000|Overall Study|Adverse Event|39
2076772|NCT00667719|3658139|FG000|Overall Study|Abnormal Test Procedure|1
2076773|NCT00667719|3658139|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
2076774|NCT00667719|3658139|FG000|Overall Study|Protocol Violation|3
2076775|NCT00667719|3658139|FG000|Overall Study|Withdrawal by Subject|17
2076776|NCT00667719|3658139|FG000|Overall Study|Lost to Follow-up|8
2076777|NCT00667732|3658150|FG000|Run -In (8 Weeks)|Adverse Event|4
2076778|NCT00667732|3658151|FG001|Run -In (8 Weeks)|Adverse Event|0
2076779|NCT00667732|3658152|FG002|Run -In (8 Weeks)|Adverse Event|0
2076780|NCT00667732|3658150|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3
2076781|NCT00667732|3658151|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0
2076782|NCT00667732|3658152|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0
2076783|NCT00667732|3658150|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0
2076784|NCT00667732|3658151|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1
2076785|NCT00667732|3658152|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0
2076786|NCT00667810|3658176|FG000|Overall Study|Adverse Event|13
2076787|NCT00667810|3658177|FG001|Overall Study|Adverse Event|14
2076788|NCT00667810|3658178|FG002|Overall Study|Adverse Event|19
2076789|NCT00667810|3658179|FG003|Overall Study|Adverse Event|1
2076790|NCT00667810|3658176|FG000|Overall Study|Death|1
2076791|NCT00667810|3658177|FG001|Overall Study|Death|1
2076792|NCT00667810|3658178|FG002|Overall Study|Death|3
2076793|NCT00667810|3658179|FG003|Overall Study|Death|0
2076794|NCT00667810|3658176|FG000|Overall Study|Lack of Efficacy|1
2076795|NCT00667810|3658177|FG001|Overall Study|Lack of Efficacy|0
2076796|NCT00667810|3658178|FG002|Overall Study|Lack of Efficacy|2
2076797|NCT00667810|3658179|FG003|Overall Study|Lack of Efficacy|0
2076798|NCT00667810|3658176|FG000|Overall Study|Lost to Follow-up|1
2076799|NCT00667810|3658177|FG001|Overall Study|Lost to Follow-up|4
2076800|NCT00667810|3658178|FG002|Overall Study|Lost to Follow-up|2
2076801|NCT00667810|3658179|FG003|Overall Study|Lost to Follow-up|0
2076802|NCT00667810|3658176|FG000|Overall Study|Physician Decision|1
2076803|NCT00667810|3658177|FG001|Overall Study|Physician Decision|1
2076804|NCT00667810|3658178|FG002|Overall Study|Physician Decision|2
2076805|NCT00667810|3658179|FG003|Overall Study|Physician Decision|0
2076806|NCT00667810|3658176|FG000|Overall Study|Protocol Violation|0
2076807|NCT00667810|3658177|FG001|Overall Study|Protocol Violation|2
2076808|NCT00667810|3658178|FG002|Overall Study|Protocol Violation|0
2076809|NCT00667810|3658179|FG003|Overall Study|Protocol Violation|0
2076810|NCT00667810|3658176|FG000|Overall Study|Withdrawal by Subject|14
2076811|NCT00667810|3658177|FG001|Overall Study|Withdrawal by Subject|20
2076812|NCT00667810|3658178|FG002|Overall Study|Withdrawal by Subject|29
2076813|NCT00667810|3658179|FG003|Overall Study|Withdrawal by Subject|1
2076814|NCT00667810|3658176|FG000|Overall Study|Discontinuation of Study by Sponsor|130
2076815|NCT00667810|3658177|FG001|Overall Study|Discontinuation of Study by Sponsor|118
2076816|NCT00667810|3658178|FG002|Overall Study|Discontinuation of Study by Sponsor|155
2076817|NCT00667810|3658179|FG003|Overall Study|Discontinuation of Study by Sponsor|0
2076818|NCT00667810|3658176|FG000|Overall Study|Failed to Return|0
2076819|NCT00667810|3658177|FG001|Overall Study|Failed to Return|0
2076820|NCT00667810|3658178|FG002|Overall Study|Failed to Return|2
2076821|NCT00667810|3658179|FG003|Overall Study|Failed to Return|0
2076822|NCT00667810|3658176|FG000|Overall Study|Loss of Caregiver|0
2076823|NCT00667810|3658177|FG001|Overall Study|Loss of Caregiver|1
2076824|NCT00667810|3658178|FG002|Overall Study|Loss of Caregiver|3
2076825|NCT00667810|3658179|FG003|Overall Study|Loss of Caregiver|0
2076826|NCT00667810|3658176|FG000|Overall Study|Vasogenic Edema Recurrence|0
2076827|NCT00667810|3658177|FG001|Overall Study|Vasogenic Edema Recurrence|3
2076828|NCT00667810|3658178|FG002|Overall Study|Vasogenic Edema Recurrence|0
2076829|NCT00667810|3658179|FG003|Overall Study|Vasogenic Edema Recurrence|0
2076830|NCT00667810|3658176|FG000|Overall Study|Other|6
2076831|NCT00667810|3658177|FG001|Overall Study|Other|6
2076832|NCT00667810|3658178|FG002|Overall Study|Other|5
2076833|NCT00667810|3658179|FG003|Overall Study|Other|0
2076834|NCT00667862|3658206|FG000|Overall Study|Adverse Event|9
2076835|NCT00667862|3658206|FG000|Overall Study|Death|1
2076836|NCT00667862|3658206|FG000|Overall Study|Disease Progression|22
2076837|NCT00667862|3658206|FG000|Overall Study|Withdrawal by Subject|3
2076838|NCT00667875|3658213|FG000|Overall Study|Adverse Event|0
2076839|NCT00667875|3658214|FG001|Overall Study|Adverse Event|2
2076840|NCT00667875|3658215|FG002|Overall Study|Adverse Event|6
2076841|NCT00667875|3658213|FG000|Overall Study|Withdrawal by Subject|10
2076842|NCT00667875|3658214|FG001|Overall Study|Withdrawal by Subject|9
2076843|NCT00667875|3658215|FG002|Overall Study|Withdrawal by Subject|7
2076844|NCT00667888|3658231|FG000|Overall Study|Death|1
2076845|NCT00667888|3658232|FG001|Overall Study|Death|1
2076846|NCT00667888|3658231|FG000|Overall Study|Withdrawal by Subject|6
2076847|NCT00667888|3658232|FG001|Overall Study|Withdrawal by Subject|3
2076848|NCT00667888|3658231|FG000|Overall Study|Proceed with other treatment|3
2076849|NCT00667888|3658232|FG001|Overall Study|Proceed with other treatment|3
2076850|NCT00667888|3658231|FG000|Overall Study|Ineligible after SIM|0
2076851|NCT00667888|3658232|FG001|Overall Study|Ineligible after SIM|2
2076852|NCT00667992|3658240|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
2076853|NCT00667992|3658241|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
2076854|NCT00667992|3658240|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
2076855|NCT00667992|3658241|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
2076856|NCT00667992|3658240|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
2076857|NCT00667992|3658241|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
2076858|NCT00667992|3658240|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1
2076859|NCT00667992|3658241|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0
2076860|NCT00667992|3658240|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
2076861|NCT00667992|3658241|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
2076862|NCT00667992|3658240|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
2076863|NCT00667992|3658241|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
2076864|NCT00667992|3658240|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
2076865|NCT00667992|3658241|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
2076866|NCT00667992|3658240|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
2076867|NCT00667992|3658241|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
2076868|NCT00667992|3658240|FG000|Wash-out|Not within one doubling dilution|4
2076869|NCT00667992|3658241|FG001|Wash-out|Not within one doubling dilution|3
2076870|NCT00667992|3658240|FG000|Wash-out|Failure to wash-out|2
2076871|NCT00667992|3658241|FG001|Wash-out|Failure to wash-out|2
2076872|NCT00667992|3658240|FG000|Wash-out|Withdrawal by Subject|1
2076873|NCT00667992|3658241|FG001|Wash-out|Withdrawal by Subject|0
2076874|NCT00667992|3658240|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
2076875|NCT00667992|3658241|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
2076876|NCT00667992|3658240|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
2076877|NCT00667992|3658241|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
2076878|NCT00668148|3658257|FG000|Overall Study|Adverse Event|5
2076879|NCT00668148|3658257|FG000|Overall Study|Subject Non-compliance|1
2076880|NCT00668148|3658257|FG000|Overall Study|Progressive Disease Before Treatment|2
2076881|NCT00668148|3658257|FG000|Overall Study|Withdrawal of Consent|2
2076882|NCT00668200|3658272|FG000|Overall Study|Withdrawal by Subject|2
2076883|NCT00668200|3658272|FG000|Overall Study|Lost to Follow-up|1
2076884|NCT00668317|3658276|FG000|Overall Study|Adverse Event|2
2106620|NCT00866788|3699777|FG000|Overall Study|Physician Decision|0
2106621|NCT00866788|3699778|FG001|Overall Study|Physician Decision|0
2106622|NCT00866788|3699779|FG002|Overall Study|Physician Decision|1
2106623|NCT00866788|3699780|FG003|Overall Study|Physician Decision|1
2106624|NCT00866814|3699793|FG000|Overall Study|Lost to Follow-up|12
2106625|NCT00866814|3699793|FG000|Overall Study|Adverse Event|2
2106626|NCT00866814|3699793|FG000|Overall Study|Physician Decision|1
2106627|NCT00866814|3699793|FG000|Overall Study|Death|1
2106628|NCT00866814|3699793|FG000|Overall Study|No longer wished to participate|1
2106629|NCT00866814|3699793|FG000|Overall Study|Unable to meet follow-up requirements|2
2106630|NCT00866814|3699793|FG000|Overall Study|Moved to area without study site|1
2106631|NCT00866918|3699814|FG000|Overall Study|Death|1
2106632|NCT00866918|3699815|FG001|Overall Study|Death|5
2106633|NCT00866918|3699814|FG000|Overall Study|Lack of Efficacy|1
2106634|NCT00866918|3699815|FG001|Overall Study|Lack of Efficacy|1
2106635|NCT00866918|3699814|FG000|Overall Study|Physician Decision|10
2106636|NCT00866918|3699815|FG001|Overall Study|Physician Decision|2
2106637|NCT00866918|3699814|FG000|Overall Study|Ineligible|2
2106638|NCT00866918|3699815|FG001|Overall Study|Ineligible|4
2106639|NCT00866918|3699814|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
2106640|NCT00866918|3699815|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
2106641|NCT00866918|3699814|FG000|Overall Study|Secondary malignancy|1
2106642|NCT00866918|3699815|FG001|Overall Study|Secondary malignancy|0
2106643|NCT00867009|3699821|FG000|Induction Period|Nonserious Adverse Event|5
2106644|NCT00867009|3699821|FG000|Induction Period|Serious Adverse Event|10
2106645|NCT00867009|3699821|FG000|Induction Period|Death due to serious adverse event|6
2106646|NCT00867009|3699821|FG000|Induction Period|Death due to Study Disease|4
2106647|NCT00867009|3699821|FG000|Induction Period|Protocol Violation|1
2106648|NCT00867009|3699821|FG000|Induction Period|Withdrawal by Subject|8
2106649|NCT00867009|3699821|FG000|Induction Period|Physician Decision|3
2106650|NCT00867009|3699821|FG000|Induction Period|Progressive Disease (PD)|25
2106651|NCT00867009|3699821|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4
2106652|NCT00867035|3699827|FG000|Baseline to 1 Hour|Withdrawal by Subject|1
2106653|NCT00867035|3699828|FG001|Baseline to 1 Hour|Withdrawal by Subject|1
2106654|NCT00867035|3699827|FG000|Baseline to 1 Week|Withdrawal by Subject|1
2106655|NCT00867035|3699828|FG001|Baseline to 1 Week|Withdrawal by Subject|0
2106656|NCT00867087|3699834|FG000|Overall Study|Other|1
2106657|NCT00867087|3699834|FG000|Overall Study|Withdrawal by Subject|4
2106658|NCT00867087|3699834|FG000|Overall Study|Death|37
2106659|NCT00867113|3699895|FG000|Treatment Period|Adverse Event|15
2106660|NCT00867113|3699895|FG000|Treatment Period|Death|2
2106661|NCT00867113|3699895|FG000|Treatment Period|Withdrawal by Subject|19
2106662|NCT00867113|3699895|FG000|Treatment Period|Lost to Follow-up|3
2106663|NCT00867113|3699895|FG000|Treatment Period|Administrative problems|1
2106664|NCT00867113|3699895|FG000|Treatment Period|Disease progression/relapse|1
2106665|NCT00867113|3699895|FG000|Treatment Period|Protocol Violation|4
2106666|NCT00867113|3699895|FG000|Post Treatment After Survival Follow-up|Death|1
2106667|NCT00867113|3699895|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
2106668|NCT00867113|3699895|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5
2106669|NCT00867113|3699895|FG000|Post Treatment After Survival Follow-up|Administrative problems|4
2106670|NCT00867308|3699931|FG000|Overall Study|Death|1
2106671|NCT00867308|3699932|FG001|Overall Study|Death|0
2106672|NCT00867308|3699931|FG000|Overall Study|Adverse Event|1
2106673|NCT00867308|3699932|FG001|Overall Study|Adverse Event|4
2106674|NCT00867308|3699931|FG000|Overall Study|Lack of Efficacy|6
2106675|NCT00867308|3699932|FG001|Overall Study|Lack of Efficacy|12
2106676|NCT00867308|3699931|FG000|Overall Study|Withdrawal by Subject|1
2106677|NCT00867308|3699932|FG001|Overall Study|Withdrawal by Subject|2
2106678|NCT00867334|3699962|FG000|Overall Study|Withdrawal by Subject|0
2106679|NCT00867334|3699963|FG001|Overall Study|Withdrawal by Subject|1
2106680|NCT00867334|3699962|FG000|Overall Study|Withdrawal by Subject|1
2106681|NCT00867334|3699963|FG001|Overall Study|Withdrawal by Subject|0
2106682|NCT00867334|3699962|FG000|Overall Study|Withdrawal by Subject|1
2106683|NCT00867334|3699963|FG001|Overall Study|Withdrawal by Subject|0
2106684|NCT00867360|3699971|FG000|Overall Study|Withdrawal by Subject|1
2106685|NCT00867360|3699972|FG001|Overall Study|Withdrawal by Subject|0
2106686|NCT00867360|3699971|FG000|Overall Study|Physician Decision|0
2210785|NCT01654380|3850677|FG002|Part B, Period 1|Physician Decision|1
2210786|NCT01654380|3850678|FG003|Part B, Period 1|Physician Decision|0
2210787|NCT01654523|3850704|FG000|Overall Study|Withdrawal by Subject|1
2210788|NCT01654536|3850710|FG000|Overall Study|Lost to Follow-up|5
2210789|NCT01654536|3850711|FG001|Overall Study|Lost to Follow-up|5
2210790|NCT01654536|3850710|FG000|Overall Study|Physician Decision|12
2106687|NCT00867360|3699972|FG001|Overall Study|Physician Decision|1
2106688|NCT00867490|3699992|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5
2106689|NCT00867490|3699992|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
2106690|NCT00867490|3699992|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
2106691|NCT00867490|3699992|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
2210791|NCT01654536|3850711|FG001|Overall Study|Physician Decision|8
2210792|NCT01654536|3850710|FG000|Overall Study|Withdrawal by Subject|27
2076885|NCT00668395|3658287|FG000|Overall Study|Withdrawal by Subject|4
2076886|NCT00668395|3658288|FG001|Overall Study|Withdrawal by Subject|4
2076887|NCT00668395|3658289|FG002|Overall Study|Withdrawal by Subject|1
2076888|NCT00668395|3658287|FG000|Overall Study|Adverse Event|1
2076889|NCT00668395|3658288|FG001|Overall Study|Adverse Event|1
2076890|NCT00668395|3658289|FG002|Overall Study|Adverse Event|0
2076891|NCT00668395|3658287|FG000|Overall Study|Physician Decision|1
2076892|NCT00668395|3658288|FG001|Overall Study|Physician Decision|1
2076893|NCT00668395|3658289|FG002|Overall Study|Physician Decision|0
2076894|NCT00668707|3658325|FG000|Overall Study|Cancer Recurrence|58
2076895|NCT00668707|3658326|FG001|Overall Study|Cancer Recurrence|58
2076896|NCT00668707|3658325|FG000|Overall Study|Withdrawal by Subject|117
2076897|NCT00668707|3658326|FG001|Overall Study|Withdrawal by Subject|100
2076898|NCT00668707|3658325|FG000|Overall Study|Lost to Follow-up|3
2076899|NCT00668707|3658326|FG001|Overall Study|Lost to Follow-up|6
2076900|NCT00668707|3658325|FG000|Overall Study|Protocol Violation|10
2076901|NCT00668707|3658326|FG001|Overall Study|Protocol Violation|12
2076902|NCT00668707|3658325|FG000|Overall Study|Death|11
2076903|NCT00668707|3658326|FG001|Overall Study|Death|4
2076904|NCT00668733|3658339|FG000|Overall Study|Lost to Follow-up|2
2076905|NCT00668733|3658340|FG001|Overall Study|Lost to Follow-up|3
2076906|NCT00668733|3658339|FG000|Overall Study|Withdrawal by Subject|0
2076907|NCT00668733|3658340|FG001|Overall Study|Withdrawal by Subject|4
2076908|NCT00668746|3658348|FG000|Overall Study|Lost to Follow-up|2
2076909|NCT00668746|3658349|FG001|Overall Study|Lost to Follow-up|1
2076910|NCT00668863|3658369|FG000|Overall Study|Objective Progression or Relapse|42
2076911|NCT00668863|3658369|FG000|Overall Study|Adverse Event|13
2076912|NCT00668863|3658369|FG000|Overall Study|Study Terminated by Sponsor|8
2076913|NCT00668863|3658369|FG000|Overall Study|Global Deterioration of Health Status|4
2076914|NCT00668863|3658369|FG000|Overall Study|Withdrawal by Subject|1
2076915|NCT00668863|3658369|FG000|Overall Study|Surgery|1
2076916|NCT00668863|3658369|FG000|Overall Study|Subject's work scheduling problem|1
2076917|NCT00668863|3658369|FG000|Overall Study|Physician Decision|1
2076918|NCT00669032|3658392|FG000|Overall Study|Lost to Follow-up|6
2076919|NCT00669032|3658393|FG001|Overall Study|Lost to Follow-up|5
2076920|NCT00669032|3658392|FG000|Overall Study|Lack of Efficacy|8
2076921|NCT00669032|3658393|FG001|Overall Study|Lack of Efficacy|19
2076922|NCT00669032|3658392|FG000|Overall Study|Withdrawal by Subject|12
2076923|NCT00669032|3658393|FG001|Overall Study|Withdrawal by Subject|13
2076924|NCT00669032|3658392|FG000|Overall Study|Adverse Event|12
2076925|NCT00669032|3658393|FG001|Overall Study|Adverse Event|16
2076926|NCT00669032|3658392|FG000|Overall Study|Physician Decision|1
2076927|NCT00669032|3658393|FG001|Overall Study|Physician Decision|1
2076928|NCT00669032|3658392|FG000|Overall Study|No fulfilment of the selection criteria|5
2076929|NCT00669032|3658393|FG001|Overall Study|No fulfilment of the selection criteria|5
2076930|NCT00669071|3658399|FG000|Overall Study|Lost to Follow-up|3
2076931|NCT00669071|3658399|FG000|Overall Study|Final visit 40 days out of window|1
2076932|NCT00669110|3658407|FG000|Overall Study|Adverse Event|4
2076933|NCT00669110|3658408|FG001|Overall Study|Adverse Event|3
2076934|NCT00669110|3658407|FG000|Overall Study|Caregiver request|3
2076935|NCT00669110|3658408|FG001|Overall Study|Caregiver request|2
2076936|NCT00669110|3658407|FG000|Overall Study|Physician Decision|0
2076937|NCT00669110|3658408|FG001|Overall Study|Physician Decision|1
2076938|NCT00669110|3658407|FG000|Overall Study|Lost to Follow-up|1
2076939|NCT00669110|3658408|FG001|Overall Study|Lost to Follow-up|0
2076940|NCT00669110|3658407|FG000|Overall Study|Protocol Violation|0
2076941|NCT00669110|3658408|FG001|Overall Study|Protocol Violation|5
2210793|NCT01654536|3850711|FG001|Overall Study|Withdrawal by Subject|25
2210794|NCT01654549|3850720|FG000|Overall Study|H.pylori eradication not successful|0
2210795|NCT01654549|3850721|FG001|Overall Study|H.pylori eradication not successful|1
2210796|NCT01654601|3850733|FG000|1st Administration|Withdrawal by Subject|2
2210797|NCT01654601|3850734|FG001|1st Administration|Withdrawal by Subject|0
2210798|NCT01654601|3850733|FG000|1st Administration|Protocol Violation|0
2210799|NCT01654601|3850734|FG001|1st Administration|Protocol Violation|2
2210800|NCT01654601|3850733|FG000|2nd Administration|Adverse Event|1
2210801|NCT01654601|3850734|FG001|2nd Administration|Adverse Event|0
2210802|NCT01654601|3850733|FG000|2nd Administration|Protocol Violation|0
2210803|NCT01654601|3850734|FG001|2nd Administration|Protocol Violation|1
2210804|NCT01654666|3850743|FG000|Overall Study|Protocol Violation|7
2210805|NCT01654666|3850744|FG001|Overall Study|Protocol Violation|4
2210806|NCT01654666|3850745|FG002|Overall Study|Protocol Violation|8
2210807|NCT01654666|3850743|FG000|Overall Study|Lost to Follow-up|4
2210808|NCT01654666|3850744|FG001|Overall Study|Lost to Follow-up|5
2210809|NCT01654666|3850745|FG002|Overall Study|Lost to Follow-up|5
2210810|NCT01654666|3850743|FG000|Overall Study|Withdrawal by Subject|4
2210811|NCT01654666|3850744|FG001|Overall Study|Withdrawal by Subject|4
2210812|NCT01654666|3850745|FG002|Overall Study|Withdrawal by Subject|1
2210813|NCT01655069|3850789|FG000|Overall Study|Physician Decision|0
2210814|NCT01655069|3850790|FG001|Overall Study|Physician Decision|0
2210815|NCT01655069|3850791|FG002|Overall Study|Physician Decision|0
2076942|NCT00669110|3658407|FG000|Overall Study|Withdrawal by Subject|0
2210816|NCT01655069|3850792|FG003|Overall Study|Physician Decision|1
2210817|NCT01655069|3850789|FG000|Overall Study|Adverse Event|6
2210818|NCT01655069|3850790|FG001|Overall Study|Adverse Event|7
2210819|NCT01655069|3850791|FG002|Overall Study|Adverse Event|2
2210820|NCT01655069|3850792|FG003|Overall Study|Adverse Event|3
2210821|NCT01655069|3850789|FG000|Overall Study|Lack of Efficacy|0
2210822|NCT01655069|3850790|FG001|Overall Study|Lack of Efficacy|1
2210823|NCT01655069|3850791|FG002|Overall Study|Lack of Efficacy|0
2210824|NCT01655069|3850792|FG003|Overall Study|Lack of Efficacy|0
2210825|NCT01655069|3850789|FG000|Overall Study|No Treatment Needed|0
2210826|NCT01655069|3850790|FG001|Overall Study|No Treatment Needed|1
2210827|NCT01655069|3850791|FG002|Overall Study|No Treatment Needed|0
2210828|NCT01655069|3850792|FG003|Overall Study|No Treatment Needed|0
2210829|NCT01655069|3850789|FG000|Overall Study|Withdrawal by Subject|2
2210830|NCT01655069|3850790|FG001|Overall Study|Withdrawal by Subject|3
2210831|NCT01655069|3850791|FG002|Overall Study|Withdrawal by Subject|0
2210832|NCT01655069|3850792|FG003|Overall Study|Withdrawal by Subject|0
2210833|NCT01655381|3850814|FG000|Overall Study|Investigator Decision|1
2210834|NCT01655381|3850814|FG000|Overall Study|Moved to Another City|1
2210835|NCT01655381|3850814|FG000|Overall Study|Insufficient Treatment Response|1
2210836|NCT01655498|3850819|FG000|Overall Study|Unrelated health issue|2
2210837|NCT01655498|3850819|FG000|Overall Study|Protocol Violation|2
2210838|NCT01655498|3850819|FG000|Overall Study|Withdrawal by Subject|1
2210839|NCT01655693|3850838|FG000|Overall Study|Progression of Disease|92
2210840|NCT01655693|3850839|FG001|Overall Study|Progression of Disease|76
2210841|NCT01655693|3850840|FG002|Overall Study|Progression of Disease|58
2210842|NCT01655693|3850838|FG000|Overall Study|Death|8
2210843|NCT01655693|3850839|FG001|Overall Study|Death|9
2210844|NCT01655693|3850840|FG002|Overall Study|Death|12
2210845|NCT01655693|3850838|FG000|Overall Study|Serious Adverse Event|3
2210846|NCT01655693|3850839|FG001|Overall Study|Serious Adverse Event|15
2210847|NCT01655693|3850840|FG002|Overall Study|Serious Adverse Event|11
2210848|NCT01655693|3850838|FG000|Overall Study|Withdrawal by Subject|3
2210849|NCT01655693|3850839|FG001|Overall Study|Withdrawal by Subject|2
2210850|NCT01655693|3850840|FG002|Overall Study|Withdrawal by Subject|20
2210851|NCT01655693|3850838|FG000|Overall Study|Adverse Event|3
2210852|NCT01655693|3850839|FG001|Overall Study|Adverse Event|11
2210853|NCT01655693|3850840|FG002|Overall Study|Adverse Event|3
2210854|NCT01655693|3850838|FG000|Overall Study|Aggravation of Liver Dysfunction|5
2210855|NCT01655693|3850839|FG001|Overall Study|Aggravation of Liver Dysfunction|4
2210856|NCT01655693|3850840|FG002|Overall Study|Aggravation of Liver Dysfunction|0
2210857|NCT01655693|3850838|FG000|Overall Study|Non-Compliance|0
2210858|NCT01655693|3850839|FG001|Overall Study|Non-Compliance|0
2210859|NCT01655693|3850840|FG002|Overall Study|Non-Compliance|7
2210860|NCT01655693|3850838|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1
2210861|NCT01655693|3850839|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3
2210862|NCT01655693|3850840|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0
2210863|NCT01655693|3850838|FG000|Overall Study|Protocol Violation|1
2210864|NCT01655693|3850839|FG001|Overall Study|Protocol Violation|0
2210865|NCT01655693|3850840|FG002|Overall Study|Protocol Violation|3
2210866|NCT01655693|3850838|FG000|Overall Study|Lost to Follow-up|1
2210867|NCT01655693|3850839|FG001|Overall Study|Lost to Follow-up|0
2210868|NCT01655693|3850840|FG002|Overall Study|Lost to Follow-up|1
2210869|NCT01655693|3850838|FG000|Overall Study|Screening Failure|1
2210870|NCT01655693|3850839|FG001|Overall Study|Screening Failure|0
2210871|NCT01655693|3850840|FG002|Overall Study|Screening Failure|0
2210872|NCT01655693|3850838|FG000|Overall Study|Other|8
2210873|NCT01655693|3850839|FG001|Overall Study|Other|6
2210874|NCT01655693|3850840|FG002|Overall Study|Other|15
2210875|NCT01655823|3850867|FG000|Overall Study|Lost to Follow-up|0
2210876|NCT01655823|3850868|FG001|Overall Study|Lost to Follow-up|1
2210877|NCT01655823|3850869|FG002|Overall Study|Lost to Follow-up|0
2210878|NCT01655823|3850870|FG003|Overall Study|Lost to Follow-up|0
2210879|NCT01655823|3850871|FG004|Overall Study|Lost to Follow-up|1
2210880|NCT01655823|3850867|FG000|Overall Study|Withdrawal by Subject|0
2210881|NCT01655823|3850868|FG001|Overall Study|Withdrawal by Subject|1
2210882|NCT01655823|3850869|FG002|Overall Study|Withdrawal by Subject|0
2210883|NCT01655823|3850870|FG003|Overall Study|Withdrawal by Subject|1
2210884|NCT01655823|3850871|FG004|Overall Study|Withdrawal by Subject|0
2210885|NCT01655901|3850883|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1
2210886|NCT01655901|3850884|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1
2210887|NCT01655901|3850885|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1
2210888|NCT01655901|3850886|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0
2210889|NCT01655901|3850887|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1
2210890|NCT01655901|3850888|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0
2210891|NCT01656161|3850901|FG000|Overall Study|Death|3
2210892|NCT01656161|3850901|FG000|Overall Study|Adverse Event|2
2210893|NCT01656161|3850901|FG000|Overall Study|Protocol Violation|1
2210894|NCT01656161|3850901|FG000|Overall Study|Withdrawal by Subject|1
2210895|NCT01656200|3850917|FG000|Overall Study|Withdrawal by Subject|1
2210896|NCT01656304|3850927|FG000|Overall Study|Ineligible, uncontrolled hypertension|1
2210897|NCT01656395|3850937|FG000|Overall Study|Adverse Event|1
2210898|NCT01656395|3850938|FG001|Overall Study|Adverse Event|14
2210899|NCT01656395|3850939|FG002|Overall Study|Adverse Event|5
2210900|NCT01656395|3850940|FG003|Overall Study|Adverse Event|4
2210901|NCT01656395|3850941|FG004|Overall Study|Adverse Event|5
2210902|NCT01656395|3850942|FG005|Overall Study|Adverse Event|7
2210903|NCT01656395|3850943|FG006|Overall Study|Adverse Event|0
2210904|NCT01656395|3850944|FG007|Overall Study|Adverse Event|0
2210905|NCT01656395|3850937|FG000|Overall Study|Lack of Efficacy|1
2210906|NCT01656395|3850938|FG001|Overall Study|Lack of Efficacy|8
2210907|NCT01656395|3850939|FG002|Overall Study|Lack of Efficacy|6
2210908|NCT01656395|3850940|FG003|Overall Study|Lack of Efficacy|1
2210909|NCT01656395|3850941|FG004|Overall Study|Lack of Efficacy|1
2210910|NCT01656395|3850942|FG005|Overall Study|Lack of Efficacy|6
2210911|NCT01656395|3850943|FG006|Overall Study|Lack of Efficacy|0
2210912|NCT01656395|3850944|FG007|Overall Study|Lack of Efficacy|0
2210913|NCT01656395|3850937|FG000|Overall Study|Lost to Follow-up|1
2210914|NCT01656395|3850938|FG001|Overall Study|Lost to Follow-up|0
2210915|NCT01656395|3850939|FG002|Overall Study|Lost to Follow-up|0
2210916|NCT01656395|3850940|FG003|Overall Study|Lost to Follow-up|0
2210917|NCT01656395|3850941|FG004|Overall Study|Lost to Follow-up|0
2210918|NCT01656395|3850942|FG005|Overall Study|Lost to Follow-up|0
2210919|NCT01656395|3850943|FG006|Overall Study|Lost to Follow-up|0
2210920|NCT01656395|3850944|FG007|Overall Study|Lost to Follow-up|0
2210921|NCT01656395|3850937|FG000|Overall Study|Non-Compliance with Study Drug|1
2210922|NCT01656395|3850938|FG001|Overall Study|Non-Compliance with Study Drug|1
2076943|NCT00669110|3658408|FG001|Overall Study|Withdrawal by Subject|2
2076944|NCT00669162|3658414|FG000|Overall Study|Withdrawal by Subject|1
2076945|NCT00669240|3658431|FG000|Overall Study|Lack of Efficacy|33
2076946|NCT00669240|3658431|FG000|Overall Study|Withdrawal by Subject|42
2076947|NCT00669240|3658431|FG000|Overall Study|Lost to Follow-up|34
2076948|NCT00669240|3658431|FG000|Overall Study|Adverse Event|21
2076949|NCT00669240|3658431|FG000|Overall Study|Other|19
2076950|NCT00669240|3658431|FG000|Overall Study|Enrolled but not treated|15
2076951|NCT00669240|3658431|FG000|Overall Study|Enrolled but no dosing record|1
2076952|NCT00669318|3658444|FG000|Overall Study|Withdrawal by Subject|2
2076953|NCT00669331|3658450|FG000|Randomisation to First Dose|Adverse Event|1
2076954|NCT00669331|3658451|FG001|Randomisation to First Dose|Adverse Event|0
2076955|NCT00669331|3658450|FG000|Randomisation to First Dose|Protocol Violation|1
2076956|NCT00669331|3658451|FG001|Randomisation to First Dose|Protocol Violation|0
2076957|NCT00669331|3658450|FG000|Randomisation to First Dose|Withdrawal by Subject|3
2076958|NCT00669331|3658451|FG001|Randomisation to First Dose|Withdrawal by Subject|2
2076959|NCT00669331|3658450|FG000|Randomisation to First Dose|Lost to Follow-up|2
2076960|NCT00669331|3658451|FG001|Randomisation to First Dose|Lost to Follow-up|0
2076961|NCT00669331|3658450|FG000|Randomisation to First Dose|Death|1
2076962|NCT00669331|3658451|FG001|Randomisation to First Dose|Death|0
2076963|NCT00669331|3658450|FG000|Randomisation to First Dose|Sponsor decision|0
2076964|NCT00669331|3658451|FG001|Randomisation to First Dose|Sponsor decision|1
2076965|NCT00669331|3658450|FG000|Randomisation to First Dose|Randomised in error|3
2076966|NCT00669331|3658451|FG001|Randomisation to First Dose|Randomised in error|10
2076967|NCT00669331|3658450|FG000|Blinded Treatment Period|Adverse Event|16
2076968|NCT00669331|3658451|FG001|Blinded Treatment Period|Adverse Event|10
2076969|NCT00669331|3658450|FG000|Blinded Treatment Period|Protocol Violation|1
2076970|NCT00669331|3658451|FG001|Blinded Treatment Period|Protocol Violation|1
2076971|NCT00669331|3658450|FG000|Blinded Treatment Period|Withdrawal by Subject|17
2076972|NCT00669331|3658451|FG001|Blinded Treatment Period|Withdrawal by Subject|19
2076973|NCT00669331|3658450|FG000|Blinded Treatment Period|Lost to Follow-up|3
2076974|NCT00669331|3658451|FG001|Blinded Treatment Period|Lost to Follow-up|2
2076975|NCT00669331|3658450|FG000|Blinded Treatment Period|Death|0
2076976|NCT00669331|3658451|FG001|Blinded Treatment Period|Death|2
2076977|NCT00669331|3658450|FG000|Blinded Treatment Period|Physician Decision|3
2076978|NCT00669331|3658451|FG001|Blinded Treatment Period|Physician Decision|3
2076979|NCT00669331|3658450|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
2076980|NCT00669331|3658451|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
2076981|NCT00669396|3658470|FG000|Overall Study|Lost to Follow-up|10
2076982|NCT00669396|3658471|FG001|Overall Study|Lost to Follow-up|12
2076983|NCT00669409|3658483|FG000|Part 2|Withdrawal by Subject|0
2076984|NCT00669409|3658484|FG001|Part 2|Withdrawal by Subject|0
2076985|NCT00669409|3658485|FG002|Part 2|Withdrawal by Subject|0
2076986|NCT00669409|3658486|FG003|Part 2|Withdrawal by Subject|0
2076987|NCT00669409|3658487|FG004|Part 2|Withdrawal by Subject|0
2076988|NCT00669409|3658488|FG005|Part 2|Withdrawal by Subject|0
2076989|NCT00669409|3658489|FG006|Part 2|Withdrawal by Subject|0
2076990|NCT00669409|3658490|FG007|Part 2|Withdrawal by Subject|0
2076991|NCT00669409|3658491|FG008|Part 2|Withdrawal by Subject|0
2076992|NCT00669409|3658492|FG009|Part 2|Withdrawal by Subject|1
2076993|NCT00669409|3658493|FG010|Part 2|Withdrawal by Subject|0
2076994|NCT00669617|3658543|FG000|Period 1|Withdrawal by Subject|0
2076995|NCT00669617|3658544|FG001|Period 1|Withdrawal by Subject|0
2076996|NCT00669617|3658545|FG002|Period 1|Withdrawal by Subject|1
2076997|NCT00669617|3658546|FG003|Period 1|Withdrawal by Subject|0
2076998|NCT00669617|3658547|FG004|Period 1|Withdrawal by Subject|0
2076999|NCT00669617|3658543|FG000|Period 1|Protocol Deviation|0
2077000|NCT00669617|3658544|FG001|Period 1|Protocol Deviation|0
2077001|NCT00669617|3658545|FG002|Period 1|Protocol Deviation|0
2210923|NCT01656395|3850939|FG002|Overall Study|Non-Compliance with Study Drug|0
2210924|NCT01656395|3850940|FG003|Overall Study|Non-Compliance with Study Drug|0
2077002|NCT00669617|3658546|FG003|Period 1|Protocol Deviation|0
2077003|NCT00669617|3658547|FG004|Period 1|Protocol Deviation|1
2077004|NCT00669617|3658543|FG000|Period 3|Lost to Follow-up|1
2077005|NCT00669617|3658544|FG001|Period 3|Lost to Follow-up|0
2077006|NCT00669617|3658545|FG002|Period 3|Lost to Follow-up|0
2077007|NCT00669617|3658546|FG003|Period 3|Lost to Follow-up|0
2077008|NCT00669617|3658547|FG004|Period 3|Lost to Follow-up|0
2077009|NCT00669669|3658559|FG000|Overall Study|To late to start treatment|1
2077010|NCT00669864|3658568|FG000|Overall Study|Lost to Follow-up|2
2077011|NCT00669864|3658568|FG000|Overall Study|Protocol Violation|2
2077012|NCT00669864|3658568|FG000|Overall Study|Withdrawal by Subject|3
2077013|NCT00669864|3658568|FG000|Overall Study|Other|2
2077014|NCT00669877|3658572|FG000|Overall Study|Disease Progression/Death|4
2077015|NCT00669903|3658580|FG000|Overall Study|Adverse Event|0
2077016|NCT00669903|3658581|FG001|Overall Study|Adverse Event|1
2077017|NCT00669903|3658582|FG002|Overall Study|Adverse Event|3
2210925|NCT01656395|3850941|FG004|Overall Study|Non-Compliance with Study Drug|1
2210926|NCT01656395|3850942|FG005|Overall Study|Non-Compliance with Study Drug|1
2077018|NCT00669903|3658583|FG003|Overall Study|Adverse Event|1
2077019|NCT00669903|3658580|FG000|Overall Study|Withdrawal by Subject|0
2077020|NCT00669903|3658581|FG001|Overall Study|Withdrawal by Subject|2
2077021|NCT00669903|3658582|FG002|Overall Study|Withdrawal by Subject|2
2077022|NCT00669903|3658583|FG003|Overall Study|Withdrawal by Subject|2
2077023|NCT00669903|3658580|FG000|Overall Study|Lost to Follow-up|1
2077024|NCT00669903|3658581|FG001|Overall Study|Lost to Follow-up|1
2077025|NCT00669903|3658582|FG002|Overall Study|Lost to Follow-up|0
2077026|NCT00669903|3658583|FG003|Overall Study|Lost to Follow-up|1
2077027|NCT00669903|3658580|FG000|Overall Study|Protocol Violation|0
2077028|NCT00669903|3658581|FG001|Overall Study|Protocol Violation|1
2077029|NCT00669903|3658582|FG002|Overall Study|Protocol Violation|0
2077030|NCT00669903|3658583|FG003|Overall Study|Protocol Violation|0
2077031|NCT00669942|3658614|FG000|Parts 2 and 3|Adverse Event|0
2077032|NCT00669942|3658615|FG001|Parts 2 and 3|Adverse Event|0
2077033|NCT00669942|3658616|FG002|Parts 2 and 3|Adverse Event|0
2077034|NCT00669942|3658617|FG003|Parts 2 and 3|Adverse Event|0
2077035|NCT00669942|3658618|FG004|Parts 2 and 3|Adverse Event|0
2077036|NCT00669942|3658619|FG005|Parts 2 and 3|Adverse Event|0
2077037|NCT00669942|3658620|FG006|Parts 2 and 3|Adverse Event|0
2077038|NCT00669942|3658621|FG007|Parts 2 and 3|Adverse Event|2
2077039|NCT00669942|3658622|FG008|Parts 2 and 3|Adverse Event|1
2077040|NCT00669942|3658623|FG009|Parts 2 and 3|Adverse Event|0
2077041|NCT00669942|3658624|FG010|Parts 2 and 3|Adverse Event|0
2077042|NCT00669942|3658625|FG011|Parts 2 and 3|Adverse Event|0
2077043|NCT00669942|3658614|FG000|Parts 2 and 3|Withdrawal by Subject|0
2077044|NCT00669942|3658615|FG001|Parts 2 and 3|Withdrawal by Subject|0
2077045|NCT00669942|3658616|FG002|Parts 2 and 3|Withdrawal by Subject|0
2077046|NCT00669942|3658617|FG003|Parts 2 and 3|Withdrawal by Subject|0
2077047|NCT00669942|3658618|FG004|Parts 2 and 3|Withdrawal by Subject|0
2077048|NCT00669942|3658619|FG005|Parts 2 and 3|Withdrawal by Subject|1
2077049|NCT00669942|3658620|FG006|Parts 2 and 3|Withdrawal by Subject|0
2077050|NCT00669942|3658621|FG007|Parts 2 and 3|Withdrawal by Subject|0
2077051|NCT00669942|3658622|FG008|Parts 2 and 3|Withdrawal by Subject|2
2077052|NCT00669942|3658623|FG009|Parts 2 and 3|Withdrawal by Subject|0
2077053|NCT00669942|3658624|FG010|Parts 2 and 3|Withdrawal by Subject|0
2077054|NCT00669942|3658625|FG011|Parts 2 and 3|Withdrawal by Subject|0
2077055|NCT00669942|3658614|FG000|Parts 2 and 3|Protocol Violation|0
2077056|NCT00669942|3658615|FG001|Parts 2 and 3|Protocol Violation|0
2077057|NCT00669942|3658616|FG002|Parts 2 and 3|Protocol Violation|0
2077058|NCT00669942|3658617|FG003|Parts 2 and 3|Protocol Violation|0
2077059|NCT00669942|3658618|FG004|Parts 2 and 3|Protocol Violation|0
2077060|NCT00669942|3658619|FG005|Parts 2 and 3|Protocol Violation|1
2077061|NCT00669942|3658620|FG006|Parts 2 and 3|Protocol Violation|0
2077062|NCT00669942|3658621|FG007|Parts 2 and 3|Protocol Violation|0
2077063|NCT00669942|3658622|FG008|Parts 2 and 3|Protocol Violation|0
2077064|NCT00669942|3658623|FG009|Parts 2 and 3|Protocol Violation|0
2077065|NCT00669942|3658624|FG010|Parts 2 and 3|Protocol Violation|0
2077066|NCT00669942|3658625|FG011|Parts 2 and 3|Protocol Violation|0
2077067|NCT00669955|3658650|FG000|Overall Study|Adverse Event|3
2077068|NCT00669955|3658651|FG001|Overall Study|Adverse Event|5
2077069|NCT00669955|3658650|FG000|Overall Study|Death|0
2077070|NCT00669955|3658651|FG001|Overall Study|Death|1
2077071|NCT00669955|3658650|FG000|Overall Study|Withdrawal by Subject|2
2077072|NCT00669955|3658651|FG001|Overall Study|Withdrawal by Subject|3
2077073|NCT00669955|3658650|FG000|Overall Study|Lost to Follow-up|5
2077074|NCT00669955|3658651|FG001|Overall Study|Lost to Follow-up|7
2077075|NCT00669955|3658650|FG000|Overall Study|Protocol Violation|2
2077076|NCT00669955|3658651|FG001|Overall Study|Protocol Violation|7
2077077|NCT00669955|3658650|FG000|Overall Study|Investigator Sponsor Judgement|0
2077078|NCT00669955|3658651|FG001|Overall Study|Investigator Sponsor Judgement|1
2077079|NCT00669955|3658650|FG000|Overall Study|not compliant with study drug/visit|2
2077080|NCT00669955|3658651|FG001|Overall Study|not compliant with study drug/visit|3
2077081|NCT00670007|3658657|FG000|Overall Study|Drug abuse|1
2077082|NCT00670007|3658657|FG000|Overall Study|Lung transplant|1
2077083|NCT00670007|3658657|FG000|Overall Study|Travel/Vacation|1
2077084|NCT00670007|3658657|FG000|Overall Study|Adverse event, serious fatal|1
2077085|NCT00670007|3658657|FG000|Overall Study|Adverse Event|1
2077086|NCT00670007|3658657|FG000|Overall Study|Withdrawal by Subject|4
2077087|NCT00670046|3658664|FG000|Overall Study|Lost to Follow-up|1
2077088|NCT00670046|3658665|FG001|Overall Study|Lost to Follow-up|1
2077089|NCT00670046|3658664|FG000|Overall Study|Withdrawal by Subject|0
2077090|NCT00670046|3658665|FG001|Overall Study|Withdrawal by Subject|1
2077091|NCT00670111|3658674|FG000|Enrollment to One Month|Testing Failure|0
2077092|NCT00670111|3658675|FG001|Enrollment to One Month|Testing Failure|0
2077093|NCT00670111|3658676|FG002|Enrollment to One Month|Testing Failure|13
2077094|NCT00670111|3658674|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0
2077095|NCT00670111|3658675|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0
2077096|NCT00670111|3658676|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6
2077097|NCT00670111|3658674|FG000|Enrollment to One Month|Physician Decision|1
2077098|NCT00670111|3658675|FG001|Enrollment to One Month|Physician Decision|0
2077099|NCT00670111|3658676|FG002|Enrollment to One Month|Physician Decision|0
2077100|NCT00670228|3658695|FG000|Overall Study|Adverse Event|1
2077101|NCT00670228|3658696|FG001|Overall Study|Adverse Event|0
2077102|NCT00670228|3658695|FG000|Overall Study|Death or MACE|0
2077103|NCT00670228|3658696|FG001|Overall Study|Death or MACE|1
2077104|NCT00670228|3658695|FG000|Overall Study|Not treated|2
2077105|NCT00670228|3658696|FG001|Overall Study|Not treated|2
2077106|NCT00670228|3658695|FG000|Overall Study|Not meeting the selection criteria|2
2077107|NCT00670228|3658696|FG001|Overall Study|Not meeting the selection criteria|0
2077108|NCT00670306|3658721|FG000|Overall Study|Adverse Event|8
2077109|NCT00670306|3658721|FG000|Overall Study|Lack of Efficacy|10
2077110|NCT00670306|3658721|FG000|Overall Study|Withdrawal by Subject|9
2077111|NCT00670306|3658721|FG000|Overall Study|Physician Decision|1
2077112|NCT00670306|3658721|FG000|Overall Study|Lost to Follow-up|8
2077113|NCT00670306|3658721|FG000|Overall Study|incl/excl criterias did not meet|19
2077114|NCT00670449|3658729|FG000|Overall Study|Adverse Event|6
2077115|NCT00670449|3658730|FG001|Overall Study|Adverse Event|2
2077116|NCT00670449|3658731|FG002|Overall Study|Adverse Event|8
2077117|NCT00670449|3658732|FG003|Overall Study|Adverse Event|5
2077118|NCT00670449|3658729|FG000|Overall Study|Protocol Deviation|1
2077119|NCT00670449|3658730|FG001|Overall Study|Protocol Deviation|2
2077120|NCT00670449|3658731|FG002|Overall Study|Protocol Deviation|0
2077121|NCT00670449|3658732|FG003|Overall Study|Protocol Deviation|1
2077122|NCT00670449|3658729|FG000|Overall Study|Administrative Problems|0
2077123|NCT00670449|3658730|FG001|Overall Study|Administrative Problems|2
2077124|NCT00670449|3658731|FG002|Overall Study|Administrative Problems|0
2077125|NCT00670449|3658732|FG003|Overall Study|Administrative Problems|1
2077126|NCT00670449|3658729|FG000|Overall Study|Subject Withdrew Consent|0
2077127|NCT00670449|3658730|FG001|Overall Study|Subject Withdrew Consent|2
2077128|NCT00670449|3658731|FG002|Overall Study|Subject Withdrew Consent|0
2077129|NCT00670449|3658732|FG003|Overall Study|Subject Withdrew Consent|1
2077130|NCT00670449|3658729|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2
2077131|NCT00670449|3658730|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
2077132|NCT00670449|3658731|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
2077133|NCT00670449|3658732|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
2077134|NCT00670449|3658729|FG000|Overall Study|Abnormal Laboratory Value(s)|0
2077135|NCT00670449|3658730|FG001|Overall Study|Abnormal Laboratory Value(s)|2
2077136|NCT00670449|3658731|FG002|Overall Study|Abnormal Laboratory Value(s)|0
2077137|NCT00670449|3658732|FG003|Overall Study|Abnormal Laboratory Value(s)|0
2077138|NCT00670488|3658762|FG000|Overall Study|Adverse Event|0
2077139|NCT00670488|3658763|FG001|Overall Study|Adverse Event|7
2077140|NCT00670488|3658764|FG002|Overall Study|Adverse Event|0
2077141|NCT00670488|3658765|FG003|Overall Study|Adverse Event|3
2077142|NCT00670488|3658766|FG004|Overall Study|Adverse Event|1
2077143|NCT00670488|3658767|FG005|Overall Study|Adverse Event|1
2077144|NCT00670488|3658768|FG006|Overall Study|Adverse Event|5
2077145|NCT00670488|3658769|FG007|Overall Study|Adverse Event|1
2077146|NCT00670488|3658770|FG008|Overall Study|Adverse Event|0
2077147|NCT00670488|3658771|FG009|Overall Study|Adverse Event|1
2077148|NCT00670488|3658762|FG000|Overall Study|Physician Decision|1
2077149|NCT00670488|3658763|FG001|Overall Study|Physician Decision|9
2077150|NCT00670488|3658764|FG002|Overall Study|Physician Decision|0
2077151|NCT00670488|3658765|FG003|Overall Study|Physician Decision|1
2077152|NCT00670488|3658766|FG004|Overall Study|Physician Decision|0
2077153|NCT00670488|3658767|FG005|Overall Study|Physician Decision|0
2077154|NCT00670488|3658768|FG006|Overall Study|Physician Decision|0
2077155|NCT00670488|3658769|FG007|Overall Study|Physician Decision|0
2077156|NCT00670488|3658770|FG008|Overall Study|Physician Decision|0
2077157|NCT00670488|3658771|FG009|Overall Study|Physician Decision|0
2077158|NCT00670488|3658762|FG000|Overall Study|Progressive Disease|2
2077159|NCT00670488|3658763|FG001|Overall Study|Progressive Disease|41
2077160|NCT00670488|3658764|FG002|Overall Study|Progressive Disease|3
2077161|NCT00670488|3658765|FG003|Overall Study|Progressive Disease|2
2077162|NCT00670488|3658766|FG004|Overall Study|Progressive Disease|2
2077163|NCT00670488|3658767|FG005|Overall Study|Progressive Disease|4
2077164|NCT00670488|3658768|FG006|Overall Study|Progressive Disease|11
2077165|NCT00670488|3658769|FG007|Overall Study|Progressive Disease|2
2077166|NCT00670488|3658770|FG008|Overall Study|Progressive Disease|2
2077167|NCT00670488|3658771|FG009|Overall Study|Progressive Disease|1
2077168|NCT00670488|3658762|FG000|Overall Study|Withdrawal by Subject|0
2077169|NCT00670488|3658763|FG001|Overall Study|Withdrawal by Subject|1
2077170|NCT00670488|3658764|FG002|Overall Study|Withdrawal by Subject|0
2077171|NCT00670488|3658765|FG003|Overall Study|Withdrawal by Subject|1
2077172|NCT00670488|3658766|FG004|Overall Study|Withdrawal by Subject|0
2077173|NCT00670488|3658767|FG005|Overall Study|Withdrawal by Subject|0
2077174|NCT00670488|3658768|FG006|Overall Study|Withdrawal by Subject|1
2077175|NCT00670488|3658769|FG007|Overall Study|Withdrawal by Subject|0
2077176|NCT00670488|3658770|FG008|Overall Study|Withdrawal by Subject|1
2077177|NCT00670488|3658771|FG009|Overall Study|Withdrawal by Subject|0
2077178|NCT00670540|3658793|FG000|Overall Study|ineligible|17
2077179|NCT00670540|3658793|FG000|Overall Study|not living in France|348
2077180|NCT00670540|3658793|FG000|Overall Study|refused to participate|189
2077181|NCT00670540|3658793|FG000|Overall Study|controls randomised for no follow up|2770
2077182|NCT00670540|3658793|FG000|Overall Study|missing information inclusion criteria|1
2077183|NCT00670748|3658810|FG000|Overall Study|Death during treatment|1
2077184|NCT00670748|3658811|FG001|Overall Study|Death during treatment|1
2077185|NCT00670748|3658812|FG002|Overall Study|Death during treatment|1
2077186|NCT00670748|3658813|FG003|Overall Study|Death during treatment|0
2077187|NCT00670748|3658810|FG000|Overall Study|Not off study|2
2077188|NCT00670748|3658811|FG001|Overall Study|Not off study|1
2077189|NCT00670748|3658812|FG002|Overall Study|Not off study|1
2077190|NCT00670748|3658813|FG003|Overall Study|Not off study|1
2077191|NCT00670800|3658829|FG000|Overall Study|2 controls were insulin resistant|0
2077192|NCT00670800|3658830|FG001|Overall Study|2 controls were insulin resistant|2
2077193|NCT00670930|3658840|FG000|Overall Study|Adminstrative Problem|0
2077194|NCT00670930|3658841|FG001|Overall Study|Adminstrative Problem|1
2077195|NCT00670930|3658840|FG000|Overall Study|Lost to Follow-up|1
2077196|NCT00670930|3658841|FG001|Overall Study|Lost to Follow-up|0
2077197|NCT00671034|3658862|FG000|Overall Study|Adverse Event|5
2077198|NCT00671034|3658863|FG001|Overall Study|Adverse Event|7
2077199|NCT00671034|3658864|FG002|Overall Study|Adverse Event|1
2077200|NCT00671034|3658862|FG000|Overall Study|Death|3
2077201|NCT00671034|3658863|FG001|Overall Study|Death|2
2077202|NCT00671034|3658864|FG002|Overall Study|Death|1
2077203|NCT00671034|3658862|FG000|Overall Study|Physician Decision|12
2077204|NCT00671034|3658863|FG001|Overall Study|Physician Decision|4
2077205|NCT00671034|3658864|FG002|Overall Study|Physician Decision|5
2077206|NCT00671034|3658862|FG000|Overall Study|VHR ALL feature|8
2077207|NCT00671034|3658863|FG001|Overall Study|VHR ALL feature|3
2077208|NCT00671034|3658864|FG002|Overall Study|VHR ALL feature|5
2077209|NCT00671034|3658862|FG000|Overall Study|Refusal|5
2077210|NCT00671034|3658863|FG001|Overall Study|Refusal|3
2077211|NCT00671034|3658864|FG002|Overall Study|Refusal|5
2077212|NCT00671034|3658862|FG000|Overall Study|includes Alternative therapy, etc.|6
2077213|NCT00671034|3658863|FG001|Overall Study|includes Alternative therapy, etc.|1
2077214|NCT00671034|3658864|FG002|Overall Study|includes Alternative therapy, etc.|7
2077215|NCT00671060|3658875|FG000|Overall Study|Protocol Violation|1
2077216|NCT00671060|3658876|FG001|Overall Study|Protocol Violation|0
2077217|NCT00671060|3658875|FG000|Overall Study|Physician Decision|0
2077218|NCT00671060|3658876|FG001|Overall Study|Physician Decision|1
2077219|NCT00671437|3658891|FG000|Overall Study|Progressive disease before C1 week 8|8
2077220|NCT00671437|3658891|FG000|Overall Study|Cutaneous SCC of head and neck|3
2077221|NCT00671437|3658891|FG000|Overall Study|Adverse Event|3
2077222|NCT00671437|3658891|FG000|Overall Study|Ineligible post-hoc|1
2077223|NCT00671554|3658920|FG000|Overall Study|Disease progression|3
2077224|NCT00671658|3658925|FG000|Overall Study|Physician Decision|5
2077225|NCT00671749|3658952|FG000|Overall Study|Adverse Event|2
2077226|NCT00671749|3658952|FG000|Overall Study|Withdrawal by Subject|4
2077227|NCT00671749|3658952|FG000|Overall Study|Protocol Violation|1
2077228|NCT00671749|3658952|FG000|Overall Study|Lost to Follow-up|1
2077229|NCT00671788|3658956|FG000|Overall Study|Adverse Event|8
2077230|NCT00671788|3658956|FG000|Overall Study|Refused further treatment|3
2077231|NCT00671788|3658956|FG000|Overall Study|Ineligible|1
2077232|NCT00671788|3658956|FG000|Overall Study|MD Decision|1
2077233|NCT00671788|3658956|FG000|Overall Study|Other|1
2077234|NCT00671853|3658962|FG000|Overall Study|Lack of Efficacy|3
2077235|NCT00671853|3658963|FG001|Overall Study|Lack of Efficacy|7
2077236|NCT00671853|3658962|FG000|Overall Study|Adverse Event|7
2077237|NCT00671853|3658963|FG001|Overall Study|Adverse Event|1
2077238|NCT00671853|3658962|FG000|Overall Study|Withdrawal by Subject|1
2077239|NCT00671853|3658963|FG001|Overall Study|Withdrawal by Subject|5
2077240|NCT00671853|3658962|FG000|Overall Study|Lost to Follow-up|8
2077241|NCT00671853|3658963|FG001|Overall Study|Lost to Follow-up|8
2077242|NCT00671853|3658962|FG000|Overall Study|Physician Decision|0
2077243|NCT00671853|3658963|FG001|Overall Study|Physician Decision|2
2304307|NCT02651688|4004268|FG001|Overall Study|Lost to Follow-up|3
2304308|NCT02651688|4004269|FG002|Overall Study|Lost to Follow-up|0
2304309|NCT02651688|4004267|FG000|Overall Study|Withdrawal by Subject|1
2304310|NCT02651688|4004268|FG001|Overall Study|Withdrawal by Subject|0
2304311|NCT02651688|4004269|FG002|Overall Study|Withdrawal by Subject|2
2077244|NCT00671853|3658962|FG000|Overall Study|Non-adherence with study procedures|1
2077245|NCT00671853|3658963|FG001|Overall Study|Non-adherence with study procedures|4
2077246|NCT00671879|3658974|FG000|Overall Study|Withdrawal by Subject|0
2077247|NCT00671879|3658975|FG001|Overall Study|Withdrawal by Subject|4
2077248|NCT00671879|3658976|FG002|Overall Study|Withdrawal by Subject|6
2077249|NCT00671931|3658995|FG000|Overall Study|Physician Decision|1
2077250|NCT00671931|3658996|FG001|Overall Study|Physician Decision|0
2077251|NCT00671931|3658997|FG002|Overall Study|Physician Decision|0
2077252|NCT00671931|3658998|FG003|Overall Study|Physician Decision|2
2077253|NCT00671931|3658999|FG004|Overall Study|Physician Decision|1
2077254|NCT00672139|3659051|FG000|Overall Study|Death|14
2077255|NCT00672139|3659052|FG001|Overall Study|Death|23
2077256|NCT00672139|3659051|FG000|Overall Study|Withdrawal by Subject|2
2077257|NCT00672139|3659052|FG001|Overall Study|Withdrawal by Subject|11
2077258|NCT00672139|3659051|FG000|Overall Study|Adverse Event|4
2077259|NCT00672139|3659052|FG001|Overall Study|Adverse Event|7
2077260|NCT00672139|3659051|FG000|Overall Study|Physician Decision|2
2077261|NCT00672139|3659052|FG001|Overall Study|Physician Decision|0
2077262|NCT00672139|3659051|FG000|Overall Study|Lack of Efficacy|4
2077263|NCT00672139|3659052|FG001|Overall Study|Lack of Efficacy|1
2077264|NCT00672139|3659051|FG000|Overall Study|Protocol Violation|1
2077265|NCT00672139|3659052|FG001|Overall Study|Protocol Violation|1
2077266|NCT00672139|3659051|FG000|Overall Study|hospice discharge, caregiver requests|3
2077267|NCT00672139|3659052|FG001|Overall Study|hospice discharge, caregiver requests|2
2077268|NCT00672256|3659067|FG000|Overall Study|PI dropped, bad data|44
2077269|NCT00672477|3659091|FG000|Overall Study|Adverse Event|10
2077270|NCT00672477|3659092|FG001|Overall Study|Adverse Event|7
2077271|NCT00672477|3659091|FG000|Overall Study|Death|7
2077272|NCT00672477|3659092|FG001|Overall Study|Death|11
2077273|NCT00672477|3659091|FG000|Overall Study|Physician Decision|2
2077274|NCT00672477|3659092|FG001|Overall Study|Physician Decision|0
2077275|NCT00672477|3659091|FG000|Overall Study|Protocol Violation|1
2077276|NCT00672477|3659092|FG001|Overall Study|Protocol Violation|1
2077277|NCT00672477|3659091|FG000|Overall Study|Withdrawal by Subject|5
2077278|NCT00672477|3659092|FG001|Overall Study|Withdrawal by Subject|3
2077279|NCT00672477|3659091|FG000|Overall Study|Lack of Efficacy|1
2077280|NCT00672477|3659092|FG001|Overall Study|Lack of Efficacy|1
2077281|NCT00672477|3659091|FG000|Overall Study|no study drug for low GFR, health cond.|1
2077282|NCT00672477|3659092|FG001|Overall Study|no study drug for low GFR, health cond.|3
2077283|NCT00672490|3659100|FG000|Overall Study|Withdrawal by Subject|8
2077284|NCT00672490|3659101|FG001|Overall Study|Withdrawal by Subject|8
2077285|NCT00672490|3659100|FG000|Overall Study|Lack of Compliance|2
2077286|NCT00672490|3659101|FG001|Overall Study|Lack of Compliance|7
2077287|NCT00672490|3659100|FG000|Overall Study|Mismatch Include/Exclude Criteria|1
2077288|NCT00672490|3659101|FG001|Overall Study|Mismatch Include/Exclude Criteria|0
2077289|NCT00672490|3659100|FG000|Overall Study|Adverse Event|5
2077290|NCT00672490|3659101|FG001|Overall Study|Adverse Event|8
2077291|NCT00672490|3659100|FG000|Overall Study|Violation of Concomitant Medicine|1
2077292|NCT00672490|3659101|FG001|Overall Study|Violation of Concomitant Medicine|0
2077293|NCT00672490|3659100|FG000|Overall Study|Intolerance|0
2077294|NCT00672490|3659101|FG001|Overall Study|Intolerance|2
2077295|NCT00672490|3659100|FG000|Overall Study|Lost to Follow-up|1
2077296|NCT00672490|3659101|FG001|Overall Study|Lost to Follow-up|5
2077297|NCT00672490|3659100|FG000|Overall Study|No reason was provided|6
2077298|NCT00672490|3659101|FG001|Overall Study|No reason was provided|2
2077299|NCT00672555|3659107|FG000|Overall Study|Lost to Follow-up|4
2077300|NCT00672555|3659107|FG000|Overall Study|Did not want to answer questionnaire|2
2077301|NCT00672620|3659119|FG000|Overall Study|Adverse Event|7
2077302|NCT00672620|3659120|FG001|Overall Study|Adverse Event|7
2077303|NCT00672620|3659121|FG002|Overall Study|Adverse Event|12
2077304|NCT00672620|3659122|FG003|Overall Study|Adverse Event|17
2077305|NCT00672620|3659119|FG000|Overall Study|Lack of Efficacy|1
2077306|NCT00672620|3659120|FG001|Overall Study|Lack of Efficacy|2
2077307|NCT00672620|3659121|FG002|Overall Study|Lack of Efficacy|2
2077308|NCT00672620|3659122|FG003|Overall Study|Lack of Efficacy|0
2077309|NCT00672620|3659119|FG000|Overall Study|Noncompliance with Study Drug|3
2077310|NCT00672620|3659120|FG001|Overall Study|Noncompliance with Study Drug|4
2077311|NCT00672620|3659121|FG002|Overall Study|Noncompliance with Study Drug|0
2077312|NCT00672620|3659122|FG003|Overall Study|Noncompliance with Study Drug|2
2077313|NCT00672620|3659119|FG000|Overall Study|Protocol Deviations|5
2077314|NCT00672620|3659120|FG001|Overall Study|Protocol Deviations|7
2077315|NCT00672620|3659121|FG002|Overall Study|Protocol Deviations|2
2077316|NCT00672620|3659122|FG003|Overall Study|Protocol Deviations|5
2077317|NCT00672620|3659119|FG000|Overall Study|Withdrawal of Consent|6
2077318|NCT00672620|3659120|FG001|Overall Study|Withdrawal of Consent|12
2077319|NCT00672620|3659121|FG002|Overall Study|Withdrawal of Consent|5
2077320|NCT00672620|3659122|FG003|Overall Study|Withdrawal of Consent|6
2077321|NCT00672620|3659119|FG000|Overall Study|Lost to Follow-up|8
2077322|NCT00672620|3659120|FG001|Overall Study|Lost to Follow-up|19
2077323|NCT00672620|3659121|FG002|Overall Study|Lost to Follow-up|8
2077324|NCT00672620|3659122|FG003|Overall Study|Lost to Follow-up|11
2077325|NCT00672620|3659119|FG000|Overall Study|Reason not Specified|3
2077326|NCT00672620|3659120|FG001|Overall Study|Reason not Specified|3
2077327|NCT00672620|3659121|FG002|Overall Study|Reason not Specified|2
2077328|NCT00672620|3659122|FG003|Overall Study|Reason not Specified|1
2077329|NCT00672633|3659134|FG000|Overall Study|Withdrawal by Subject|0
2077330|NCT00672633|3659135|FG001|Overall Study|Withdrawal by Subject|1
2077331|NCT00672646|3659144|FG000|Overall Study|Lost to Follow-up|0
2077332|NCT00672646|3659145|FG001|Overall Study|Lost to Follow-up|1
2077333|NCT00672646|3659146|FG002|Overall Study|Lost to Follow-up|2
2077334|NCT00672646|3659144|FG000|Overall Study|Withdrawal by Subject|0
2077335|NCT00672646|3659145|FG001|Overall Study|Withdrawal by Subject|0
2077336|NCT00672646|3659146|FG002|Overall Study|Withdrawal by Subject|1
2077337|NCT00672841|3659161|FG000|Overall Study|Comfort care|1
2077338|NCT00672841|3659162|FG001|Overall Study|Comfort care|4
2077339|NCT00672841|3659161|FG000|Overall Study|icteric specimens|0
2077340|NCT00672841|3659162|FG001|Overall Study|icteric specimens|3
2077341|NCT00672841|3659161|FG000|Overall Study|Antifungal therapy, negative glucan|0
2077342|NCT00672841|3659162|FG001|Overall Study|Antifungal therapy, negative glucan|4
2077343|NCT00672841|3659161|FG000|Overall Study|Adverse Event|0
2077344|NCT00672841|3659162|FG001|Overall Study|Adverse Event|3
2077345|NCT00672841|3659161|FG000|Overall Study|Pregnancy|0
2077346|NCT00672841|3659162|FG001|Overall Study|Pregnancy|1
2077347|NCT00672958|3659193|FG000|Overall Study|Adverse Event|11
2077348|NCT00672958|3659194|FG001|Overall Study|Adverse Event|9
2077349|NCT00672958|3659193|FG000|Overall Study|Lack of Efficacy|6
2077350|NCT00672958|3659194|FG001|Overall Study|Lack of Efficacy|11
2077351|NCT00672958|3659193|FG000|Overall Study|Non-compliance with study drug|2
2077352|NCT00672958|3659194|FG001|Overall Study|Non-compliance with study drug|3
2077353|NCT00672958|3659193|FG000|Overall Study|Protocol deviations|11
2077354|NCT00672958|3659194|FG001|Overall Study|Protocol deviations|5
2077355|NCT00672958|3659193|FG000|Overall Study|Voluntary withdrawal|12
2077356|NCT00672958|3659194|FG001|Overall Study|Voluntary withdrawal|8
2077357|NCT00672958|3659193|FG000|Overall Study|Lost to Follow-up|22
2077358|NCT00672958|3659194|FG001|Overall Study|Lost to Follow-up|17
2077359|NCT00672958|3659193|FG000|Overall Study|Reason not specified|0
2077360|NCT00672958|3659194|FG001|Overall Study|Reason not specified|3
2077361|NCT00672984|3659203|FG000|First Intervention|Adverse Event|5
2077362|NCT00672984|3659204|FG001|First Intervention|Adverse Event|0
2077363|NCT00672984|3659205|FG002|First Intervention|Adverse Event|0
2077364|NCT00672984|3659203|FG000|First Intervention|Withdrawal by Subject|1
2077365|NCT00672984|3659204|FG001|First Intervention|Withdrawal by Subject|2
2077366|NCT00672984|3659205|FG002|First Intervention|Withdrawal by Subject|2
2077367|NCT00672984|3659203|FG000|First Intervention|Sponsor decision|3
2077368|NCT00672984|3659204|FG001|First Intervention|Sponsor decision|0
2077369|NCT00672984|3659205|FG002|First Intervention|Sponsor decision|0
2077370|NCT00672984|3659203|FG000|Second Intervention|Non-compliance with facility policies|0
2077371|NCT00672984|3659204|FG001|Second Intervention|Non-compliance with facility policies|2
2077372|NCT00672984|3659205|FG002|Second Intervention|Non-compliance with facility policies|0
2077373|NCT00672984|3659203|FG000|Second Intervention|Withdrawal by Subject|0
2077374|NCT00672984|3659204|FG001|Second Intervention|Withdrawal by Subject|3
2077375|NCT00672984|3659205|FG002|Second Intervention|Withdrawal by Subject|0
2077376|NCT00672984|3659203|FG000|Second Intervention|Protocol Violation|0
2077377|NCT00672984|3659204|FG001|Second Intervention|Protocol Violation|1
2077378|NCT00672984|3659205|FG002|Second Intervention|Protocol Violation|1
2077379|NCT00672984|3659203|FG000|Third Intervention|Adverse Event|1
2077380|NCT00672984|3659204|FG001|Third Intervention|Adverse Event|0
2077381|NCT00672984|3659205|FG002|Third Intervention|Adverse Event|1
2077382|NCT00673049|3659217|FG000|Before Progression on Erlotinib|Randomized but not treated|3
2077383|NCT00673049|3659218|FG001|Before Progression on Erlotinib|Randomized but not treated|1
2077384|NCT00673049|3659219|FG002|Before Progression on Erlotinib|Randomized but not treated|0
2077385|NCT00673049|3659220|FG003|Before Progression on Erlotinib|Randomized but not treated|0
2077386|NCT00673049|3659217|FG000|Before Progression on Erlotinib|Death|235
2077387|NCT00673049|3659218|FG001|Before Progression on Erlotinib|Death|167
2077388|NCT00673049|3659219|FG002|Before Progression on Erlotinib|Death|1
2077389|NCT00673049|3659220|FG003|Before Progression on Erlotinib|Death|0
2077390|NCT00673049|3659217|FG000|Before Progression on Erlotinib|Lost to Follow-up|9
2077391|NCT00673049|3659218|FG001|Before Progression on Erlotinib|Lost to Follow-up|5
2077392|NCT00673049|3659219|FG002|Before Progression on Erlotinib|Lost to Follow-up|0
2077393|NCT00673049|3659220|FG003|Before Progression on Erlotinib|Lost to Follow-up|0
2077394|NCT00673049|3659217|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26
2077395|NCT00673049|3659218|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18
2077396|NCT00673049|3659219|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0
2077397|NCT00673049|3659220|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0
2077398|NCT00673049|3659217|FG000|Before Progression on Erlotinib|Other|1
2077399|NCT00673049|3659218|FG001|Before Progression on Erlotinib|Other|2
2077400|NCT00673049|3659219|FG002|Before Progression on Erlotinib|Other|0
2077401|NCT00673049|3659220|FG003|Before Progression on Erlotinib|Other|0
2077402|NCT00673049|3659217|FG000|Before Progression on Erlotinib|study terminated by sponsor|18
2077403|NCT00673049|3659218|FG001|Before Progression on Erlotinib|study terminated by sponsor|14
2077404|NCT00673049|3659219|FG002|Before Progression on Erlotinib|study terminated by sponsor|0
2077405|NCT00673049|3659220|FG003|Before Progression on Erlotinib|study terminated by sponsor|0
2077406|NCT00673049|3659217|FG000|Before Progression on Erlotinib|Switched to figitumumab|0
2077407|NCT00673049|3659218|FG001|Before Progression on Erlotinib|Switched to figitumumab|83
2077408|NCT00673049|3659219|FG002|Before Progression on Erlotinib|Switched to figitumumab|0
2077409|NCT00673049|3659220|FG003|Before Progression on Erlotinib|Switched to figitumumab|0
2077410|NCT00673049|3659217|FG000|After Progression on Erlotinib|Death|0
2077411|NCT00673049|3659218|FG001|After Progression on Erlotinib|Death|0
2077412|NCT00673049|3659219|FG002|After Progression on Erlotinib|Death|0
2077413|NCT00673049|3659220|FG003|After Progression on Erlotinib|Death|71
2077414|NCT00673049|3659217|FG000|After Progression on Erlotinib|Lost to Follow-up|0
2077415|NCT00673049|3659218|FG001|After Progression on Erlotinib|Lost to Follow-up|0
2077416|NCT00673049|3659219|FG002|After Progression on Erlotinib|Lost to Follow-up|0
2077417|NCT00673049|3659220|FG003|After Progression on Erlotinib|Lost to Follow-up|3
2077418|NCT00673049|3659217|FG000|After Progression on Erlotinib|Withdrawal by Subject|0
2077419|NCT00673049|3659218|FG001|After Progression on Erlotinib|Withdrawal by Subject|0
2077420|NCT00673049|3659219|FG002|After Progression on Erlotinib|Withdrawal by Subject|0
2077421|NCT00673049|3659220|FG003|After Progression on Erlotinib|Withdrawal by Subject|5
2077422|NCT00673049|3659217|FG000|After Progression on Erlotinib|study terminated by sponsor|0
2077423|NCT00673049|3659218|FG001|After Progression on Erlotinib|study terminated by sponsor|0
2077424|NCT00673049|3659219|FG002|After Progression on Erlotinib|study terminated by sponsor|0
2077425|NCT00673049|3659220|FG003|After Progression on Erlotinib|study terminated by sponsor|4
2077426|NCT00673231|3659256|FG000|Overall Study|Withdrawal by Subject|14
2077427|NCT00673231|3659257|FG001|Overall Study|Withdrawal by Subject|10
2077428|NCT00673231|3659258|FG002|Overall Study|Withdrawal by Subject|8
2077429|NCT00673231|3659259|FG003|Overall Study|Withdrawal by Subject|6
2077430|NCT00673231|3659256|FG000|Overall Study|Adverse Event|6
2077431|NCT00673231|3659257|FG001|Overall Study|Adverse Event|5
2077432|NCT00673231|3659258|FG002|Overall Study|Adverse Event|9
2077433|NCT00673231|3659259|FG003|Overall Study|Adverse Event|6
2077434|NCT00673231|3659256|FG000|Overall Study|Lost to Follow-up|1
2077435|NCT00673231|3659257|FG001|Overall Study|Lost to Follow-up|2
2077436|NCT00673231|3659258|FG002|Overall Study|Lost to Follow-up|1
2077437|NCT00673231|3659259|FG003|Overall Study|Lost to Follow-up|2
2077438|NCT00673231|3659256|FG000|Overall Study|Death|0
2077439|NCT00673231|3659257|FG001|Overall Study|Death|0
2077440|NCT00673231|3659258|FG002|Overall Study|Death|1
2077441|NCT00673231|3659259|FG003|Overall Study|Death|0
2077442|NCT00673231|3659256|FG000|Overall Study|Study criteria,compliance,safety, other|8
2077443|NCT00673231|3659257|FG001|Overall Study|Study criteria,compliance,safety, other|5
2077444|NCT00673231|3659258|FG002|Overall Study|Study criteria,compliance,safety, other|7
2077445|NCT00673231|3659259|FG003|Overall Study|Study criteria,compliance,safety, other|4
2077446|NCT00673257|3659278|FG000|Overall Study|Withdrawal by Subject|4
2077447|NCT00673257|3659278|FG000|Overall Study|Unable to obtain specimen|1
2077448|NCT00673387|3659290|FG000|Overall Study|Withdrawal by Subject|15
2077449|NCT00673387|3659291|FG001|Overall Study|Withdrawal by Subject|16
2077450|NCT00673387|3659292|FG002|Overall Study|Withdrawal by Subject|20
2077451|NCT00673387|3659293|FG003|Overall Study|Withdrawal by Subject|16
2077452|NCT00673387|3659294|FG004|Overall Study|Withdrawal by Subject|18
2077453|NCT00673387|3659295|FG005|Overall Study|Withdrawal by Subject|21
2077454|NCT00673387|3659296|FG006|Overall Study|Withdrawal by Subject|15
2077455|NCT00673387|3659297|FG007|Overall Study|Withdrawal by Subject|21
2077456|NCT00673387|3659290|FG000|Overall Study|Adverse Event|3
2077457|NCT00673387|3659291|FG001|Overall Study|Adverse Event|1
2077458|NCT00673387|3659292|FG002|Overall Study|Adverse Event|5
2077459|NCT00673387|3659293|FG003|Overall Study|Adverse Event|2
2077460|NCT00673387|3659294|FG004|Overall Study|Adverse Event|6
2077461|NCT00673387|3659295|FG005|Overall Study|Adverse Event|2
2077462|NCT00673387|3659296|FG006|Overall Study|Adverse Event|5
2077463|NCT00673387|3659297|FG007|Overall Study|Adverse Event|5
2077464|NCT00673387|3659290|FG000|Overall Study|Physician Decision|0
2077465|NCT00673387|3659291|FG001|Overall Study|Physician Decision|0
2077466|NCT00673387|3659292|FG002|Overall Study|Physician Decision|0
2077467|NCT00673387|3659293|FG003|Overall Study|Physician Decision|0
2077468|NCT00673387|3659294|FG004|Overall Study|Physician Decision|0
2077469|NCT00673387|3659295|FG005|Overall Study|Physician Decision|5
2077470|NCT00673387|3659296|FG006|Overall Study|Physician Decision|1
2077471|NCT00673387|3659297|FG007|Overall Study|Physician Decision|1
2077472|NCT00673387|3659290|FG000|Overall Study|Protocol Violation|3
2077473|NCT00673387|3659291|FG001|Overall Study|Protocol Violation|0
2077474|NCT00673387|3659292|FG002|Overall Study|Protocol Violation|1
2077475|NCT00673387|3659293|FG003|Overall Study|Protocol Violation|2
2077476|NCT00673387|3659294|FG004|Overall Study|Protocol Violation|0
2077477|NCT00673387|3659295|FG005|Overall Study|Protocol Violation|1
2077478|NCT00673387|3659296|FG006|Overall Study|Protocol Violation|1
2077479|NCT00673387|3659297|FG007|Overall Study|Protocol Violation|3
2077480|NCT00673387|3659290|FG000|Overall Study|Lost to Follow-up|8
2077481|NCT00673387|3659291|FG001|Overall Study|Lost to Follow-up|6
2077482|NCT00673387|3659292|FG002|Overall Study|Lost to Follow-up|5
2077483|NCT00673387|3659293|FG003|Overall Study|Lost to Follow-up|6
2077484|NCT00673387|3659294|FG004|Overall Study|Lost to Follow-up|6
2077485|NCT00673387|3659295|FG005|Overall Study|Lost to Follow-up|5
2077486|NCT00673387|3659296|FG006|Overall Study|Lost to Follow-up|8
2077487|NCT00673387|3659297|FG007|Overall Study|Lost to Follow-up|5
2106692|NCT00867490|3699992|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
2106693|NCT00867503|3699999|FG000|Overall Study|Withdrawal by Subject|1
2106694|NCT00867568|3700009|FG000|Overall Study|Lack of Efficacy|10
2106695|NCT00867568|3700009|FG000|Overall Study|Adverse Event|4
2077488|NCT00673452|3659342|FG000|Acute Double-Blind Phase|Adverse Event|41
2077489|NCT00673452|3659343|FG001|Acute Double-Blind Phase|Adverse Event|24
2077490|NCT00673452|3659342|FG000|Acute Double-Blind Phase|Lack of Efficacy|9
2077491|NCT00673452|3659343|FG001|Acute Double-Blind Phase|Lack of Efficacy|14
2077492|NCT00673452|3659342|FG000|Acute Double-Blind Phase|Lost to Follow-up|16
2077493|NCT00673452|3659343|FG001|Acute Double-Blind Phase|Lost to Follow-up|19
2077494|NCT00673452|3659342|FG000|Acute Double-Blind Phase|Physician Decision|0
2077495|NCT00673452|3659343|FG001|Acute Double-Blind Phase|Physician Decision|6
2077496|NCT00673452|3659342|FG000|Acute Double-Blind Phase|Protocol Violation|5
2077497|NCT00673452|3659343|FG001|Acute Double-Blind Phase|Protocol Violation|3
2077498|NCT00673452|3659342|FG000|Acute Double-Blind Phase|Sponsor Decision|0
2077499|NCT00673452|3659343|FG001|Acute Double-Blind Phase|Sponsor Decision|1
2077500|NCT00673452|3659342|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16
2077501|NCT00673452|3659343|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13
2210927|NCT01656395|3850943|FG006|Overall Study|Non-Compliance with Study Drug|0
2077502|NCT00673452|3659342|FG000|Continuation Double-Blind Phase|Adverse Event|5
2077503|NCT00673452|3659343|FG001|Continuation Double-Blind Phase|Adverse Event|13
2077504|NCT00673452|3659342|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9
2077505|NCT00673452|3659343|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5
2077506|NCT00673452|3659342|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4
2077507|NCT00673452|3659343|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5
2077508|NCT00673452|3659342|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2
2077509|NCT00673452|3659343|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5
2077510|NCT00673452|3659342|FG000|Continuation Double-Blind Phase|Protocol Violation|2
2077511|NCT00673452|3659343|FG001|Continuation Double-Blind Phase|Protocol Violation|3
2077512|NCT00673452|3659342|FG000|Continuation Double-Blind Phase|Sponsor Decision|0
2077513|NCT00673452|3659343|FG001|Continuation Double-Blind Phase|Sponsor Decision|3
2077514|NCT00673452|3659342|FG000|Continuation Double-Blind Phase|Physician Decision|2
2077515|NCT00673452|3659343|FG001|Continuation Double-Blind Phase|Physician Decision|0
2077516|NCT00673452|3659342|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
2077517|NCT00673452|3659343|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
2077518|NCT00673465|3659349|FG000|Part 1/Period 1 (United States)|Protocol Violation|0
2077519|NCT00673465|3659350|FG001|Part 1/Period 1 (United States)|Protocol Violation|0
2077520|NCT00673465|3659351|FG002|Part 1/Period 1 (United States)|Protocol Violation|0
2077521|NCT00673465|3659352|FG003|Part 1/Period 1 (United States)|Protocol Violation|0
2077522|NCT00673465|3659353|FG004|Part 1/Period 1 (United States)|Protocol Violation|1
2077523|NCT00673465|3659354|FG005|Part 1/Period 1 (United States)|Protocol Violation|1
2077524|NCT00673465|3659355|FG006|Part 1/Period 1 (United States)|Protocol Violation|0
2077525|NCT00673465|3659356|FG007|Part 1/Period 1 (United States)|Protocol Violation|0
2077526|NCT00673465|3659357|FG008|Part 1/Period 1 (United States)|Protocol Violation|0
2077527|NCT00673465|3659358|FG009|Part 1/Period 1 (United States)|Protocol Violation|0
2077528|NCT00673465|3659359|FG010|Part 1/Period 1 (United States)|Protocol Violation|0
2077529|NCT00673465|3659360|FG011|Part 1/Period 1 (United States)|Protocol Violation|0
2077530|NCT00673465|3659349|FG000|Part 1/Period 2 (United States)|Protocol Violation|0
2077531|NCT00673465|3659350|FG001|Part 1/Period 2 (United States)|Protocol Violation|0
2077532|NCT00673465|3659351|FG002|Part 1/Period 2 (United States)|Protocol Violation|0
2077533|NCT00673465|3659352|FG003|Part 1/Period 2 (United States)|Protocol Violation|0
2077534|NCT00673465|3659353|FG004|Part 1/Period 2 (United States)|Protocol Violation|1
2077535|NCT00673465|3659354|FG005|Part 1/Period 2 (United States)|Protocol Violation|0
2077536|NCT00673465|3659355|FG006|Part 1/Period 2 (United States)|Protocol Violation|0
2077537|NCT00673465|3659356|FG007|Part 1/Period 2 (United States)|Protocol Violation|0
2077538|NCT00673465|3659357|FG008|Part 1/Period 2 (United States)|Protocol Violation|0
2077539|NCT00673465|3659358|FG009|Part 1/Period 2 (United States)|Protocol Violation|0
2077540|NCT00673465|3659359|FG010|Part 1/Period 2 (United States)|Protocol Violation|0
2077541|NCT00673465|3659360|FG011|Part 1/Period 2 (United States)|Protocol Violation|0
2077542|NCT00673660|3659368|FG000|Overall Study|Lost to Follow-up|107
2077543|NCT00673673|3659377|FG000|Overall Study|Progressive disease|27
2077544|NCT00673673|3659377|FG000|Overall Study|Adverse Event|4
2077545|NCT00673673|3659377|FG000|Overall Study|Withdrawal by Subject|3
2077546|NCT00673673|3659377|FG000|Overall Study|Investigators' discretion|2
2077547|NCT00673790|3659404|FG000|Overall Study|Adverse Event|23
2077548|NCT00673790|3659405|FG001|Overall Study|Adverse Event|14
2077549|NCT00673790|3659406|FG002|Overall Study|Adverse Event|2
2077550|NCT00673790|3659404|FG000|Overall Study|Lack of Efficacy|2
2077551|NCT00673790|3659405|FG001|Overall Study|Lack of Efficacy|2
2077552|NCT00673790|3659406|FG002|Overall Study|Lack of Efficacy|2
2077553|NCT00673790|3659404|FG000|Overall Study|Protocol Violation|6
2077554|NCT00673790|3659405|FG001|Overall Study|Protocol Violation|9
2077555|NCT00673790|3659406|FG002|Overall Study|Protocol Violation|1
2077556|NCT00673790|3659404|FG000|Overall Study|Withdrawal by Subject|7
2077557|NCT00673790|3659405|FG001|Overall Study|Withdrawal by Subject|4
2077558|NCT00673790|3659406|FG002|Overall Study|Withdrawal by Subject|1
2077559|NCT00673790|3659404|FG000|Overall Study|Lost to Follow-up|6
2077560|NCT00673790|3659405|FG001|Overall Study|Lost to Follow-up|6
2077561|NCT00673790|3659406|FG002|Overall Study|Lost to Follow-up|5
2077562|NCT00673790|3659404|FG000|Overall Study|Sponsor Terminated due to PI oversight|0
2077563|NCT00673790|3659405|FG001|Overall Study|Sponsor Terminated due to PI oversight|1
2077564|NCT00673790|3659406|FG002|Overall Study|Sponsor Terminated due to PI oversight|0
2077565|NCT00673790|3659404|FG000|Overall Study|Poor compliance|1
2077566|NCT00673790|3659405|FG001|Overall Study|Poor compliance|0
2077567|NCT00673790|3659406|FG002|Overall Study|Poor compliance|0
2077568|NCT00673790|3659404|FG000|Overall Study|Participated in two Nebivolol studies|0
2077569|NCT00673790|3659405|FG001|Overall Study|Participated in two Nebivolol studies|0
2077570|NCT00673790|3659406|FG002|Overall Study|Participated in two Nebivolol studies|1
2077571|NCT00673790|3659404|FG000|Overall Study|Unconfirmed pregnancy|0
2077572|NCT00673790|3659405|FG001|Overall Study|Unconfirmed pregnancy|1
2077573|NCT00673790|3659406|FG002|Overall Study|Unconfirmed pregnancy|0
2077574|NCT00673790|3659404|FG000|Overall Study|Randomization criteria not met|0
2077575|NCT00673790|3659405|FG001|Overall Study|Randomization criteria not met|1
2077576|NCT00673790|3659406|FG002|Overall Study|Randomization criteria not met|0
2077577|NCT00673816|3659415|FG000|Overall Study|Adverse Event|1
2077578|NCT00673816|3659415|FG000|Overall Study|Withdrawal by Subject|1
2077579|NCT00673881|3659427|FG000|Overall Study|Withdrawal by Subject|1
2077580|NCT00673894|3659433|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1
2077581|NCT00673894|3659434|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0
2077582|NCT00673894|3659433|FG000|First Intervention 4 Weeks|Adverse Event|1
2077583|NCT00673894|3659434|FG001|First Intervention 4 Weeks|Adverse Event|0
2077584|NCT00673920|3659448|FG000|Baseline up to Week 48|Withdrew consent|1
2077585|NCT00673920|3659449|FG001|Baseline up to Week 48|Withdrew consent|0
2077586|NCT00673920|3659450|FG002|Baseline up to Week 48|Withdrew consent|2
2077587|NCT00673920|3659451|FG003|Baseline up to Week 48|Withdrew consent|0
2077588|NCT00673920|3659452|FG004|Baseline up to Week 48|Withdrew consent|0
2077589|NCT00673920|3659453|FG005|Baseline up to Week 48|Withdrew consent|0
2077590|NCT00673920|3659454|FG006|Baseline up to Week 48|Withdrew consent|0
2077591|NCT00673920|3659455|FG007|Baseline up to Week 48|Withdrew consent|0
2077592|NCT00673920|3659448|FG000|Baseline up to Week 48|Refused treatment|1
2077593|NCT00673920|3659449|FG001|Baseline up to Week 48|Refused treatment|0
2077594|NCT00673920|3659450|FG002|Baseline up to Week 48|Refused treatment|0
2077595|NCT00673920|3659451|FG003|Baseline up to Week 48|Refused treatment|0
2077596|NCT00673920|3659452|FG004|Baseline up to Week 48|Refused treatment|0
2077597|NCT00673920|3659453|FG005|Baseline up to Week 48|Refused treatment|0
2077598|NCT00673920|3659454|FG006|Baseline up to Week 48|Refused treatment|0
2077599|NCT00673920|3659455|FG007|Baseline up to Week 48|Refused treatment|0
2077600|NCT00673920|3659448|FG000|Baseline up to Week 48|Insufficient therapeutic response|2
2077601|NCT00673920|3659449|FG001|Baseline up to Week 48|Insufficient therapeutic response|1
2077602|NCT00673920|3659450|FG002|Baseline up to Week 48|Insufficient therapeutic response|0
2077603|NCT00673920|3659451|FG003|Baseline up to Week 48|Insufficient therapeutic response|0
2077604|NCT00673920|3659452|FG004|Baseline up to Week 48|Insufficient therapeutic response|0
2077605|NCT00673920|3659453|FG005|Baseline up to Week 48|Insufficient therapeutic response|0
2077606|NCT00673920|3659454|FG006|Baseline up to Week 48|Insufficient therapeutic response|0
2077607|NCT00673920|3659455|FG007|Baseline up to Week 48|Insufficient therapeutic response|0
2077608|NCT00673920|3659448|FG000|Baseline up to Week 48|Protocol Violation|0
2077609|NCT00673920|3659449|FG001|Baseline up to Week 48|Protocol Violation|0
2077610|NCT00673920|3659450|FG002|Baseline up to Week 48|Protocol Violation|1
2077611|NCT00673920|3659451|FG003|Baseline up to Week 48|Protocol Violation|0
2077612|NCT00673920|3659452|FG004|Baseline up to Week 48|Protocol Violation|0
2077613|NCT00673920|3659453|FG005|Baseline up to Week 48|Protocol Violation|0
2077614|NCT00673920|3659454|FG006|Baseline up to Week 48|Protocol Violation|0
2077615|NCT00673920|3659455|FG007|Baseline up to Week 48|Protocol Violation|0
2077616|NCT00673920|3659448|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0
2077617|NCT00673920|3659449|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0
2077618|NCT00673920|3659450|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1
2077619|NCT00673920|3659451|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0
2077620|NCT00673920|3659452|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0
2077621|NCT00673920|3659453|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0
2077622|NCT00673920|3659454|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0
2077623|NCT00673920|3659455|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0
2077624|NCT00673920|3659448|FG000|Baseline up to Week 48|Administrative/Other|0
2077625|NCT00673920|3659449|FG001|Baseline up to Week 48|Administrative/Other|1
2077626|NCT00673920|3659450|FG002|Baseline up to Week 48|Administrative/Other|2
2077627|NCT00673920|3659451|FG003|Baseline up to Week 48|Administrative/Other|0
2077628|NCT00673920|3659452|FG004|Baseline up to Week 48|Administrative/Other|0
2077629|NCT00673920|3659453|FG005|Baseline up to Week 48|Administrative/Other|0
2077630|NCT00673920|3659454|FG006|Baseline up to Week 48|Administrative/Other|0
2077631|NCT00673920|3659455|FG007|Baseline up to Week 48|Administrative/Other|0
2077632|NCT00673920|3659448|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0
2077633|NCT00673920|3659449|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1
2077634|NCT00673920|3659450|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1
2077635|NCT00673920|3659451|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0
2077636|NCT00673920|3659452|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0
2077637|NCT00673920|3659453|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0
2077638|NCT00673920|3659454|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0
2077639|NCT00673920|3659455|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0
2077640|NCT00673920|3659448|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0
2077641|NCT00673920|3659449|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0
2077642|NCT00673920|3659450|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0
2077643|NCT00673920|3659451|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0
2077644|NCT00673920|3659452|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0
2077645|NCT00673920|3659453|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0
2077646|NCT00673920|3659454|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1
2077647|NCT00673920|3659455|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0
2077648|NCT00673920|3659448|FG000|Week 24 to Week 48|Failure to return|0
2077649|NCT00673920|3659449|FG001|Week 24 to Week 48|Failure to return|0
2077650|NCT00673920|3659450|FG002|Week 24 to Week 48|Failure to return|0
2077651|NCT00673920|3659451|FG003|Week 24 to Week 48|Failure to return|0
2077652|NCT00673920|3659452|FG004|Week 24 to Week 48|Failure to return|0
2077653|NCT00673920|3659453|FG005|Week 24 to Week 48|Failure to return|1
2077654|NCT00673920|3659454|FG006|Week 24 to Week 48|Failure to return|0
2077655|NCT00673920|3659455|FG007|Week 24 to Week 48|Failure to return|0
2077656|NCT00673920|3659448|FG000|Week 24 to Week 48|Insufficient therapeutic response|0
2077657|NCT00673920|3659449|FG001|Week 24 to Week 48|Insufficient therapeutic response|0
2077658|NCT00673920|3659450|FG002|Week 24 to Week 48|Insufficient therapeutic response|0
2077659|NCT00673920|3659451|FG003|Week 24 to Week 48|Insufficient therapeutic response|0
2077660|NCT00673920|3659452|FG004|Week 24 to Week 48|Insufficient therapeutic response|0
2077661|NCT00673920|3659453|FG005|Week 24 to Week 48|Insufficient therapeutic response|1
2077662|NCT00673920|3659454|FG006|Week 24 to Week 48|Insufficient therapeutic response|0
2077663|NCT00673920|3659455|FG007|Week 24 to Week 48|Insufficient therapeutic response|0
2077664|NCT00673920|3659448|FG000|Week 24 to Week 48|Death|0
2077665|NCT00673920|3659449|FG001|Week 24 to Week 48|Death|0
2077666|NCT00673920|3659450|FG002|Week 24 to Week 48|Death|0
2077667|NCT00673920|3659451|FG003|Week 24 to Week 48|Death|0
2077668|NCT00673920|3659452|FG004|Week 24 to Week 48|Death|0
2077669|NCT00673920|3659453|FG005|Week 24 to Week 48|Death|1
2077670|NCT00673920|3659454|FG006|Week 24 to Week 48|Death|0
2077671|NCT00673920|3659455|FG007|Week 24 to Week 48|Death|0
2077672|NCT00673920|3659448|FG000|Week 24 to Week 48|Adminstrative/Other|0
2077673|NCT00673920|3659449|FG001|Week 24 to Week 48|Adminstrative/Other|0
2077674|NCT00673920|3659450|FG002|Week 24 to Week 48|Adminstrative/Other|0
2077675|NCT00673920|3659451|FG003|Week 24 to Week 48|Adminstrative/Other|1
2077676|NCT00673920|3659452|FG004|Week 24 to Week 48|Adminstrative/Other|0
2077677|NCT00673920|3659453|FG005|Week 24 to Week 48|Adminstrative/Other|0
2077678|NCT00673920|3659454|FG006|Week 24 to Week 48|Adminstrative/Other|0
2077679|NCT00673920|3659455|FG007|Week 24 to Week 48|Adminstrative/Other|0
2077680|NCT00673933|3659477|FG000|Overall Study|Withdrawal by Subject|2
2077681|NCT00673933|3659477|FG000|Overall Study|Lost to Follow-up|1
2077682|NCT00674128|3659504|FG000|Overall Study|Withdrawal by Subject|25
2077683|NCT00674128|3659505|FG001|Overall Study|Withdrawal by Subject|23
2077684|NCT00674154|3659513|FG000|Overall Study|Withdrawal by Subject|3
2077685|NCT00674154|3659514|FG001|Overall Study|Withdrawal by Subject|1
2077686|NCT00674154|3659513|FG000|Overall Study|Did not want parathyroidectomy|0
2077687|NCT00674154|3659514|FG001|Overall Study|Did not want parathyroidectomy|2
2077688|NCT00674323|3659546|FG000|Overall Study|Adverse Event|0
2077689|NCT00674323|3659547|FG001|Overall Study|Adverse Event|1
2077690|NCT00674323|3659548|FG002|Overall Study|Adverse Event|0
2077691|NCT00674323|3659546|FG000|Overall Study|Protocol Violation|1
2077692|NCT00674323|3659547|FG001|Overall Study|Protocol Violation|0
2077693|NCT00674323|3659548|FG002|Overall Study|Protocol Violation|0
2077694|NCT00674362|3659558|FG000|Double Blind|Adverse Event|6
2077695|NCT00674362|3659559|FG001|Double Blind|Adverse Event|6
2077696|NCT00674362|3659558|FG000|Double Blind|Lack of Efficacy|2
2077697|NCT00674362|3659559|FG001|Double Blind|Lack of Efficacy|6
2077698|NCT00674362|3659558|FG000|Double Blind|Loss of efficacy|0
2077699|NCT00674362|3659559|FG001|Double Blind|Loss of efficacy|1
2077700|NCT00674362|3659558|FG000|Double Blind|Withdrawal by Subject|4
2077701|NCT00674362|3659559|FG001|Double Blind|Withdrawal by Subject|3
2077702|NCT00674362|3659558|FG000|Double Blind|Other: Loss of Patient Compliance|0
2077703|NCT00674362|3659559|FG001|Double Blind|Other: Loss of Patient Compliance|1
2077704|NCT00674362|3659558|FG000|Double Blind|Other: Surgery|0
2077705|NCT00674362|3659559|FG001|Double Blind|Other: Surgery|1
2077706|NCT00674362|3659558|FG000|Open Label|Adverse Event|1
2077707|NCT00674362|3659559|FG001|Open Label|Adverse Event|0
2077708|NCT00674362|3659558|FG000|Open Label|Other: Subject moved to extension study|1
2077709|NCT00674362|3659559|FG001|Open Label|Other: Subject moved to extension study|0
2077710|NCT00674570|3659590|FG000|Overall Study|Withdrawal by Subject|0
2077711|NCT00674570|3659591|FG001|Overall Study|Withdrawal by Subject|2
2077712|NCT00674570|3659592|FG002|Overall Study|Withdrawal by Subject|0
2077713|NCT00674661|3659641|FG000|Overall Study|Other|5
2077714|NCT00674661|3659642|FG001|Overall Study|Other|7
2077715|NCT00674661|3659641|FG000|Overall Study|Lost to Follow-up|6
2077716|NCT00674661|3659642|FG001|Overall Study|Lost to Follow-up|3
2077717|NCT00674661|3659641|FG000|Overall Study|Withdrawal by Subject|0
2077718|NCT00674661|3659642|FG001|Overall Study|Withdrawal by Subject|5
2077719|NCT00674700|3659651|FG000|Year 1|Adverse Event|17
2077720|NCT00674700|3659652|FG001|Year 1|Adverse Event|20
2077721|NCT00674700|3659653|FG002|Year 1|Adverse Event|5
2077722|NCT00674700|3659651|FG000|Year 1|Withdrawal by Subject|7
2077723|NCT00674700|3659652|FG001|Year 1|Withdrawal by Subject|7
2077724|NCT00674700|3659653|FG002|Year 1|Withdrawal by Subject|6
2077725|NCT00674700|3659651|FG000|Year 1|Any other reason not above-mentioned|7
2077726|NCT00674700|3659652|FG001|Year 1|Any other reason not above-mentioned|7
2077727|NCT00674700|3659653|FG002|Year 1|Any other reason not above-mentioned|6
2077728|NCT00674700|3659651|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0
2077729|NCT00674700|3659652|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1
2077730|NCT00674700|3659653|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1
2077731|NCT00674700|3659651|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
2077732|NCT00674700|3659652|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
2077733|NCT00674700|3659653|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
2077734|NCT00674700|3659651|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
2077735|NCT00674700|3659652|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
2077736|NCT00674700|3659653|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
2077737|NCT00674817|3659683|FG000|Period 1|Withdrawal by Subject|2
2077738|NCT00674817|3659683|FG000|Period 1|Protocol Violation|1
2077739|NCT00674817|3659683|FG000|Period 3|Adverse Event|1
2077740|NCT00674817|3659683|FG000|Period 3|Protocol Violation|1
2077741|NCT00674817|3659683|FG000|Period 4|Adverse Event|1
2077742|NCT00674973|3659699|FG000|Overall Study|Insufficient Therapeutic Response|77
2077743|NCT00674973|3659700|FG001|Overall Study|Insufficient Therapeutic Response|72
2077744|NCT00674973|3659699|FG000|Overall Study|Refused Treatment|1
2077745|NCT00674973|3659700|FG001|Overall Study|Refused Treatment|5
2077746|NCT00674973|3659699|FG000|Overall Study|Failure to Return|1
2077747|NCT00674973|3659700|FG001|Overall Study|Failure to Return|0
2077748|NCT00674973|3659699|FG000|Overall Study|Adverse Event|2
2077749|NCT00674973|3659700|FG001|Overall Study|Adverse Event|9
2077750|NCT00674973|3659699|FG000|Overall Study|Death|19
2077751|NCT00674973|3659700|FG001|Overall Study|Death|15
2077752|NCT00674973|3659699|FG000|Overall Study|Protocol Violation|0
2077753|NCT00674973|3659700|FG001|Overall Study|Protocol Violation|1
2077754|NCT00674986|3659708|FG000|Overall Study|Adverse Event|2
2077755|NCT00674986|3659709|FG001|Overall Study|Adverse Event|1
2077756|NCT00674986|3659708|FG000|Overall Study|Subject withdrew consent|12
2077757|NCT00674986|3659709|FG001|Overall Study|Subject withdrew consent|19
2077758|NCT00674986|3659708|FG000|Overall Study|Lost to Follow-up|25
2077759|NCT00674986|3659709|FG001|Overall Study|Lost to Follow-up|53
2077760|NCT00674986|3659708|FG000|Overall Study|Other reasons|4
2077761|NCT00674986|3659709|FG001|Overall Study|Other reasons|8
2077762|NCT00675025|3659718|FG000|Overall Study|Study Terminated by Sponsor|38
2077763|NCT00675025|3659719|FG001|Overall Study|Study Terminated by Sponsor|42
2077764|NCT00675025|3659718|FG000|Overall Study|Adverse Event|6
2077765|NCT00675025|3659719|FG001|Overall Study|Adverse Event|11
2077766|NCT00675025|3659718|FG000|Overall Study|Lost to Follow-up|6
2077767|NCT00675025|3659719|FG001|Overall Study|Lost to Follow-up|4
2077768|NCT00675025|3659718|FG000|Overall Study|Withdrawal by Subject|4
2077769|NCT00675025|3659719|FG001|Overall Study|Withdrawal by Subject|6
2077770|NCT00675103|3659725|FG000|Overall Study|Lack of Efficacy|2
2077771|NCT00675103|3659725|FG000|Overall Study|Adverse Event|1
2077772|NCT00675428|3659748|FG000|Overall Study|Disease Progression|2
2077773|NCT00675428|3659749|FG001|Overall Study|Disease Progression|2
2077774|NCT00675428|3659748|FG000|Overall Study|No Disease Response After Cycle 6|0
2077775|NCT00675428|3659749|FG001|Overall Study|No Disease Response After Cycle 6|1
2077776|NCT00675428|3659748|FG000|Overall Study|Physician Decision|1
2077777|NCT00675428|3659749|FG001|Overall Study|Physician Decision|0
2077778|NCT00675441|3659755|FG000|Overall Study|Withdrawal by Subject|2
2077779|NCT00675441|3659755|FG000|Overall Study|Death|1
2077780|NCT00675506|3659761|FG000|Overall Study|Lost to Follow-up|1
2077781|NCT00675506|3659762|FG001|Overall Study|Lost to Follow-up|5
2077782|NCT00675506|3659761|FG000|Overall Study|Lost interest|3
2077783|NCT00675506|3659762|FG001|Overall Study|Lost interest|5
2077784|NCT00675506|3659761|FG000|Overall Study|Elevated fasting glucose|2
2077785|NCT00675506|3659762|FG001|Overall Study|Elevated fasting glucose|1
2077786|NCT00675506|3659761|FG000|Overall Study|Elevated IGF-1 prior to treatment|1
2077787|NCT00675506|3659762|FG001|Overall Study|Elevated IGF-1 prior to treatment|0
2077788|NCT00675506|3659761|FG000|Overall Study|Elevated IGF-1|2
2077789|NCT00675506|3659762|FG001|Overall Study|Elevated IGF-1|0
2077790|NCT00675506|3659761|FG000|Overall Study|Hypersensitivity Reaction|1
2077791|NCT00675506|3659762|FG001|Overall Study|Hypersensitivity Reaction|0
2077792|NCT00675506|3659761|FG000|Overall Study|Disclosed history of cancer|1
2077793|NCT00675506|3659762|FG001|Overall Study|Disclosed history of cancer|0
2077794|NCT00675506|3659761|FG000|Overall Study|Declined participation|1
2077795|NCT00675506|3659762|FG001|Overall Study|Declined participation|0
2077796|NCT00675506|3659761|FG000|Overall Study|Schedule conflict|0
2077797|NCT00675506|3659762|FG001|Overall Study|Schedule conflict|1
2077798|NCT00675597|3659791|FG000|Overall Study|Withdrawal by Subject|3
2077799|NCT00675766|3659799|FG000|Overall Study|Lost to Follow-up|6
2077800|NCT00675766|3659800|FG001|Overall Study|Lost to Follow-up|5
2077801|NCT00675766|3659801|FG002|Overall Study|Lost to Follow-up|21
2077802|NCT00675766|3659802|FG003|Overall Study|Lost to Follow-up|26
2077803|NCT00675948|3659841|FG000|Overall Study|Adverse Event|23
2077804|NCT00675948|3659842|FG001|Overall Study|Adverse Event|1
2077805|NCT00675948|3659841|FG000|Overall Study|Lack of Efficacy|3
2077806|NCT00675948|3659842|FG001|Overall Study|Lack of Efficacy|0
2077807|NCT00675948|3659841|FG000|Overall Study|Withdrawal by Subject|7
2077808|NCT00675948|3659842|FG001|Overall Study|Withdrawal by Subject|0
2077809|NCT00675948|3659841|FG000|Overall Study|Lost to Follow-up|2
2077810|NCT00675948|3659842|FG001|Overall Study|Lost to Follow-up|0
2077811|NCT00675948|3659841|FG000|Overall Study|Protocol Violation|1
2077812|NCT00675948|3659842|FG001|Overall Study|Protocol Violation|0
2077813|NCT00675948|3659841|FG000|Overall Study|Pain under control|1
2077814|NCT00675948|3659842|FG001|Overall Study|Pain under control|0
2077815|NCT00675948|3659841|FG000|Overall Study|Sponsor decision|0
2077816|NCT00675948|3659842|FG001|Overall Study|Sponsor decision|1
2077817|NCT00675948|3659841|FG000|Overall Study|Patient died|1
2077818|NCT00675948|3659842|FG001|Overall Study|Patient died|0
2077819|NCT00675948|3659841|FG000|Overall Study|Patient unable to comply with diaries|1
2077820|NCT00675948|3659842|FG001|Overall Study|Patient unable to comply with diaries|0
2077821|NCT00675948|3659841|FG000|Overall Study|Patient feels unable to take medication|0
2077822|NCT00675948|3659842|FG001|Overall Study|Patient feels unable to take medication|1
2077823|NCT00676052|3659873|FG000|Overall Study|Adverse Event|0
2077824|NCT00676052|3659874|FG001|Overall Study|Adverse Event|1
2077825|NCT00676052|3659875|FG002|Overall Study|Adverse Event|1
2077826|NCT00676052|3659876|FG003|Overall Study|Adverse Event|2
2077827|NCT00676052|3659877|FG004|Overall Study|Adverse Event|2
2077828|NCT00676052|3659878|FG005|Overall Study|Adverse Event|2
2077829|NCT00676052|3659873|FG000|Overall Study|Lack of Efficacy|2
2077830|NCT00676052|3659874|FG001|Overall Study|Lack of Efficacy|2
2077831|NCT00676052|3659875|FG002|Overall Study|Lack of Efficacy|1
2077832|NCT00676052|3659876|FG003|Overall Study|Lack of Efficacy|1
2077833|NCT00676052|3659877|FG004|Overall Study|Lack of Efficacy|2
2077834|NCT00676052|3659878|FG005|Overall Study|Lack of Efficacy|1
2077835|NCT00676052|3659873|FG000|Overall Study|Protocol Violation|5
2077836|NCT00676052|3659874|FG001|Overall Study|Protocol Violation|3
2077837|NCT00676052|3659875|FG002|Overall Study|Protocol Violation|2
2077838|NCT00676052|3659876|FG003|Overall Study|Protocol Violation|2
2077839|NCT00676052|3659877|FG004|Overall Study|Protocol Violation|1
2077840|NCT00676052|3659878|FG005|Overall Study|Protocol Violation|2
2077841|NCT00676052|3659873|FG000|Overall Study|Lost to Follow-up|0
2077842|NCT00676052|3659874|FG001|Overall Study|Lost to Follow-up|0
2077843|NCT00676052|3659875|FG002|Overall Study|Lost to Follow-up|0
2077844|NCT00676052|3659876|FG003|Overall Study|Lost to Follow-up|0
2077845|NCT00676052|3659877|FG004|Overall Study|Lost to Follow-up|1
2077846|NCT00676052|3659878|FG005|Overall Study|Lost to Follow-up|0
2077847|NCT00676052|3659873|FG000|Overall Study|Physician Decision|1
2077848|NCT00676052|3659874|FG001|Overall Study|Physician Decision|1
2077849|NCT00676052|3659875|FG002|Overall Study|Physician Decision|1
2077850|NCT00676052|3659876|FG003|Overall Study|Physician Decision|0
2077851|NCT00676052|3659877|FG004|Overall Study|Physician Decision|0
2077852|NCT00676052|3659878|FG005|Overall Study|Physician Decision|1
2077853|NCT00676052|3659873|FG000|Overall Study|Withdrawal by Subject|1
2077854|NCT00676052|3659874|FG001|Overall Study|Withdrawal by Subject|0
2077855|NCT00676052|3659875|FG002|Overall Study|Withdrawal by Subject|1
2077856|NCT00676052|3659876|FG003|Overall Study|Withdrawal by Subject|0
2077857|NCT00676052|3659877|FG004|Overall Study|Withdrawal by Subject|0
2077858|NCT00676052|3659878|FG005|Overall Study|Withdrawal by Subject|0
2077859|NCT00676091|3659907|FG000|Infant Series|Parent or legal guardian request|10
2077860|NCT00676091|3659908|FG001|Infant Series|Parent or legal guardian request|8
2077861|NCT00676091|3659907|FG000|Infant Series|Protocol Violation|6
2077862|NCT00676091|3659908|FG001|Infant Series|Protocol Violation|3
2077863|NCT00676091|3659907|FG000|Infant Series|Adverse Event|2
2077864|NCT00676091|3659908|FG001|Infant Series|Adverse Event|3
2077865|NCT00676091|3659907|FG000|Infant Series|Failed to return|1
2077866|NCT00676091|3659908|FG001|Infant Series|Failed to return|3
2077867|NCT00676091|3659907|FG000|Infant Series|Lost to Follow-up|1
2077868|NCT00676091|3659908|FG001|Infant Series|Lost to Follow-up|0
2077869|NCT00676091|3659907|FG000|Infant Series|Died prior to receiving 7vPnC|0
2077870|NCT00676091|3659908|FG001|Infant Series|Died prior to receiving 7vPnC|1
2077871|NCT00676091|3659907|FG000|After Infant Series|Adverse Event|0
2077872|NCT00676091|3659908|FG001|After Infant Series|Adverse Event|1
2077873|NCT00676091|3659907|FG000|After Infant Series|Protocol Violation|0
2077874|NCT00676091|3659908|FG001|After Infant Series|Protocol Violation|1
2077875|NCT00676091|3659907|FG000|After Infant Series|Failed to return|1
2077876|NCT00676091|3659908|FG001|After Infant Series|Failed to return|1
2077877|NCT00676091|3659907|FG000|Toddler Dose|Failed to return|2
2077878|NCT00676091|3659908|FG001|Toddler Dose|Failed to return|0
2077879|NCT00676091|3659907|FG000|Toddler Dose|Parent or legal guardian request|1
2077880|NCT00676091|3659908|FG001|Toddler Dose|Parent or legal guardian request|0
2077881|NCT00676130|3659920|FG000|Overall Study|Lost to Follow-up|0
2077882|NCT00676130|3659921|FG001|Overall Study|Lost to Follow-up|1
2077883|NCT00676130|3659920|FG000|Overall Study|Found ineligible|3
2077884|NCT00676130|3659921|FG001|Overall Study|Found ineligible|2
2077885|NCT00676130|3659920|FG000|Overall Study|Withdrawal by Subject|0
2077886|NCT00676130|3659921|FG001|Overall Study|Withdrawal by Subject|1
2077887|NCT00676143|3659929|FG000|Overall Study|Adverse Event|34
2077888|NCT00676143|3659930|FG001|Overall Study|Adverse Event|60
2077889|NCT00676143|3659929|FG000|Overall Study|Death|4
2077890|NCT00676143|3659930|FG001|Overall Study|Death|4
2077891|NCT00676143|3659929|FG000|Overall Study|Lack of Efficacy|0
2077892|NCT00676143|3659930|FG001|Overall Study|Lack of Efficacy|6
2077893|NCT00676143|3659929|FG000|Overall Study|Lost to Follow-up|0
2077894|NCT00676143|3659930|FG001|Overall Study|Lost to Follow-up|13
2077895|NCT00676143|3659929|FG000|Overall Study|Physician Decision|5
2077896|NCT00676143|3659930|FG001|Overall Study|Physician Decision|8
2077897|NCT00676143|3659929|FG000|Overall Study|Protocol Violation|4
2077898|NCT00676143|3659930|FG001|Overall Study|Protocol Violation|8
2077899|NCT00676143|3659929|FG000|Overall Study|Withdrawal by Subject|24
2077900|NCT00676143|3659930|FG001|Overall Study|Withdrawal by Subject|42
2077901|NCT00676143|3659929|FG000|Overall Study|Discontinuation of study by sponsor|65
2077902|NCT00676143|3659930|FG001|Overall Study|Discontinuation of study by sponsor|88
2077903|NCT00676143|3659929|FG000|Overall Study|Failed to return|2
2077904|NCT00676143|3659930|FG001|Overall Study|Failed to return|1
2077905|NCT00676143|3659929|FG000|Overall Study|Loss of caregiver|5
2077906|NCT00676143|3659930|FG001|Overall Study|Loss of caregiver|3
2077907|NCT00676143|3659929|FG000|Overall Study|Other|11
2077908|NCT00676143|3659930|FG001|Overall Study|Other|20
2077909|NCT00676143|3659929|FG000|Overall Study|Participant participation unknown|1
2077910|NCT00676143|3659930|FG001|Overall Study|Participant participation unknown|4
2077911|NCT00676143|3659929|FG000|Overall Study|Vasogenic edema recurrence|1
2077912|NCT00676143|3659930|FG001|Overall Study|Vasogenic edema recurrence|3
2077913|NCT00676195|3659949|FG000|Overall Study|Lost to Follow-up|1
2077914|NCT00676195|3659949|FG000|Overall Study|Adverse Event|1
2077915|NCT00676195|3659949|FG000|Overall Study|Physician Decision|1
2077916|NCT00676208|3659956|FG000|Overall Study|Lost to Follow-up|0
2077917|NCT00676208|3659957|FG001|Overall Study|Lost to Follow-up|2
2077918|NCT00676208|3659956|FG000|Overall Study|Incomplete data|2
2077919|NCT00676208|3659957|FG001|Overall Study|Incomplete data|4
2077920|NCT00676338|3659969|FG000|Overall Study|Adverse Event|6
2077921|NCT00676338|3659970|FG001|Overall Study|Adverse Event|6
2077922|NCT00676338|3659971|FG002|Overall Study|Adverse Event|5
2077923|NCT00676338|3659972|FG003|Overall Study|Adverse Event|1
2077924|NCT00676338|3659969|FG000|Overall Study|Lost to Follow-up|4
2077925|NCT00676338|3659970|FG001|Overall Study|Lost to Follow-up|1
2077926|NCT00676338|3659971|FG002|Overall Study|Lost to Follow-up|3
2077927|NCT00676338|3659972|FG003|Overall Study|Lost to Follow-up|4
2077928|NCT00676338|3659969|FG000|Overall Study|Physician Decision|3
2077929|NCT00676338|3659970|FG001|Overall Study|Physician Decision|3
2077930|NCT00676338|3659971|FG002|Overall Study|Physician Decision|2
2077931|NCT00676338|3659972|FG003|Overall Study|Physician Decision|3
2077932|NCT00676338|3659969|FG000|Overall Study|Protocol Violation|5
2077933|NCT00676338|3659970|FG001|Overall Study|Protocol Violation|9
2077934|NCT00676338|3659971|FG002|Overall Study|Protocol Violation|2
2077935|NCT00676338|3659972|FG003|Overall Study|Protocol Violation|5
2077936|NCT00676338|3659969|FG000|Overall Study|Withdrawal by Subject|17
2077937|NCT00676338|3659970|FG001|Overall Study|Withdrawal by Subject|9
2077938|NCT00676338|3659971|FG002|Overall Study|Withdrawal by Subject|12
2077939|NCT00676338|3659972|FG003|Overall Study|Withdrawal by Subject|6
2077940|NCT00676338|3659969|FG000|Overall Study|Entry Criteria Not Met|0
2077941|NCT00676338|3659970|FG001|Overall Study|Entry Criteria Not Met|2
2077942|NCT00676338|3659971|FG002|Overall Study|Entry Criteria Not Met|1
2077943|NCT00676338|3659972|FG003|Overall Study|Entry Criteria Not Met|1
2077944|NCT00676338|3659969|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
2210928|NCT01656395|3850944|FG007|Overall Study|Non-Compliance with Study Drug|0
2210929|NCT01656395|3850937|FG000|Overall Study|Other|0
2210930|NCT01656395|3850938|FG001|Overall Study|Other|0
2210931|NCT01656395|3850939|FG002|Overall Study|Other|1
2210932|NCT01656395|3850940|FG003|Overall Study|Other|0
2210933|NCT01656395|3850941|FG004|Overall Study|Other|0
2210934|NCT01656395|3850942|FG005|Overall Study|Other|1
2210935|NCT01656395|3850943|FG006|Overall Study|Other|0
2210936|NCT01656395|3850944|FG007|Overall Study|Other|0
2210937|NCT01656395|3850937|FG000|Overall Study|Physician Decision|2
2210938|NCT01656395|3850938|FG001|Overall Study|Physician Decision|3
2210939|NCT01656395|3850939|FG002|Overall Study|Physician Decision|3
2210940|NCT01656395|3850940|FG003|Overall Study|Physician Decision|2
2210941|NCT01656395|3850941|FG004|Overall Study|Physician Decision|3
2210942|NCT01656395|3850942|FG005|Overall Study|Physician Decision|3
2210943|NCT01656395|3850943|FG006|Overall Study|Physician Decision|0
2210944|NCT01656395|3850944|FG007|Overall Study|Physician Decision|0
2210945|NCT01656395|3850937|FG000|Overall Study|Pregnancy|0
2210946|NCT01656395|3850938|FG001|Overall Study|Pregnancy|0
2210947|NCT01656395|3850939|FG002|Overall Study|Pregnancy|1
2210948|NCT01656395|3850940|FG003|Overall Study|Pregnancy|0
2210949|NCT01656395|3850941|FG004|Overall Study|Pregnancy|0
2077945|NCT00676338|3659970|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
2210950|NCT01656395|3850942|FG005|Overall Study|Pregnancy|0
2210951|NCT01656395|3850943|FG006|Overall Study|Pregnancy|0
2210952|NCT01656395|3850944|FG007|Overall Study|Pregnancy|0
2210953|NCT01656395|3850937|FG000|Overall Study|Progressive Disease|0
2210954|NCT01656395|3850938|FG001|Overall Study|Progressive Disease|0
2210955|NCT01656395|3850939|FG002|Overall Study|Progressive Disease|0
2210956|NCT01656395|3850940|FG003|Overall Study|Progressive Disease|0
2304312|NCT02651922|4004277|FG000|Overall Study|due to exclusion criteria|2
2077946|NCT00676338|3659971|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
2077947|NCT00676338|3659972|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
2077948|NCT00676403|3659999|FG000|Overall Study|Adverse Event|1
2077949|NCT00676403|3660000|FG001|Overall Study|Adverse Event|2
2077950|NCT00676403|3660001|FG002|Overall Study|Adverse Event|0
2077951|NCT00676403|3660002|FG003|Overall Study|Adverse Event|5
2077952|NCT00676403|3660003|FG004|Overall Study|Adverse Event|1
2077953|NCT00676403|3660004|FG005|Overall Study|Adverse Event|2
2077954|NCT00676403|3659999|FG000|Overall Study|Lost to Follow-up|0
2077955|NCT00676403|3660000|FG001|Overall Study|Lost to Follow-up|0
2077956|NCT00676403|3660001|FG002|Overall Study|Lost to Follow-up|0
2077957|NCT00676403|3660002|FG003|Overall Study|Lost to Follow-up|0
2077958|NCT00676403|3660003|FG004|Overall Study|Lost to Follow-up|0
2077959|NCT00676403|3660004|FG005|Overall Study|Lost to Follow-up|1
2077960|NCT00676403|3659999|FG000|Overall Study|Reason Unspecified|1
2077961|NCT00676403|3660000|FG001|Overall Study|Reason Unspecified|0
2077962|NCT00676403|3660001|FG002|Overall Study|Reason Unspecified|1
2077963|NCT00676403|3660002|FG003|Overall Study|Reason Unspecified|0
2077964|NCT00676403|3660003|FG004|Overall Study|Reason Unspecified|0
2077965|NCT00676403|3660004|FG005|Overall Study|Reason Unspecified|1
2077966|NCT00676403|3659999|FG000|Overall Study|Withdrawal by Subject|0
2077967|NCT00676403|3660000|FG001|Overall Study|Withdrawal by Subject|0
2077968|NCT00676403|3660001|FG002|Overall Study|Withdrawal by Subject|0
2077969|NCT00676403|3660002|FG003|Overall Study|Withdrawal by Subject|0
2077970|NCT00676403|3660003|FG004|Overall Study|Withdrawal by Subject|0
2077971|NCT00676403|3660004|FG005|Overall Study|Withdrawal by Subject|1
2077972|NCT00676520|3660024|FG000|Overall Study|Withdrawal by Subject|163
2077973|NCT00676520|3660024|FG000|Overall Study|Lost to Follow-up|162
2077974|NCT00676520|3660024|FG000|Overall Study|Death|159
2077975|NCT00676520|3660024|FG000|Overall Study|Physician Decision|20
2077976|NCT00676520|3660024|FG000|Overall Study|Ineligible for Randomization to DAPT|209
2077977|NCT00676520|3660024|FG000|Overall Study|Other Reason|18
2077978|NCT00676650|3660053|FG000|Overall Study|Death|45
2077979|NCT00676650|3660054|FG001|Overall Study|Death|14
2077980|NCT00676650|3660053|FG000|Overall Study|Adverse Event|159
2077981|NCT00676650|3660054|FG001|Overall Study|Adverse Event|21
2077982|NCT00676650|3660053|FG000|Overall Study|Global deterioration of health status|66
2077983|NCT00676650|3660054|FG001|Overall Study|Global deterioration of health status|31
2077984|NCT00676650|3660053|FG000|Overall Study|Lost to Follow-up|0
2077985|NCT00676650|3660054|FG001|Overall Study|Lost to Follow-up|1
2077986|NCT00676650|3660053|FG000|Overall Study|Objective progression or relapse|189
2077987|NCT00676650|3660054|FG001|Overall Study|Objective progression or relapse|140
2077988|NCT00676650|3660053|FG000|Overall Study|Other|14
2077989|NCT00676650|3660054|FG001|Overall Study|Other|10
2077990|NCT00676650|3660053|FG000|Overall Study|Protocol Violation|3
2077991|NCT00676650|3660054|FG001|Overall Study|Protocol Violation|1
2077992|NCT00676650|3660053|FG000|Overall Study|Study terminated by sponsor|57
2304313|NCT02651987|4004283|FG000|Overall Study|Adverse Event|2
2304314|NCT02651987|4004284|FG001|Overall Study|Adverse Event|2
2304315|NCT02651987|4004283|FG000|Overall Study|Consent Withdrawn|2
2304316|NCT02651987|4004284|FG001|Overall Study|Consent Withdrawn|0
2304317|NCT02651987|4004283|FG000|Overall Study|Local PD|0
2304318|NCT02651987|4004284|FG001|Overall Study|Local PD|2
2304319|NCT02651987|4004283|FG000|Overall Study|Investigator Decision|1
2304320|NCT02651987|4004284|FG001|Overall Study|Investigator Decision|1
2304321|NCT02652156|4004296|FG000|Overall Study|Physician Decision|1
2304322|NCT02652156|4004297|FG001|Overall Study|Physician Decision|0
2304323|NCT02652156|4004298|FG002|Overall Study|Physician Decision|0
2304324|NCT02652260|4004322|FG000|Overall Study|Pregnancy|0
2304325|NCT02652260|4004323|FG001|Overall Study|Pregnancy|1
2304326|NCT02652260|4004322|FG000|Overall Study|Withdrawal by Subject|0
2304327|NCT02652260|4004323|FG001|Overall Study|Withdrawal by Subject|1
2304328|NCT02652442|4004368|FG000|Centrifugation - Distance|Lost to Follow-up|1
2304329|NCT02652624|4004386|FG000|Randomized Phase|Pregnancy|3
2304330|NCT02652624|4004387|FG001|Randomized Phase|Pregnancy|1
2304331|NCT02652624|4004386|FG000|Randomized Phase|Investigator's Discretion|0
2304332|NCT02652624|4004387|FG001|Randomized Phase|Investigator's Discretion|2
2304333|NCT02652624|4004386|FG000|Randomized Phase|Death|0
2304334|NCT02652624|4004387|FG001|Randomized Phase|Death|1
2304335|NCT02652624|4004386|FG000|Randomized Phase|Lost to Follow-up|0
2304336|NCT02652624|4004387|FG001|Randomized Phase|Lost to Follow-up|1
2304337|NCT02652624|4004386|FG000|Extension Phase|Lost to Follow-up|3
2304338|NCT02652624|4004387|FG001|Extension Phase|Lost to Follow-up|1
2304339|NCT02652624|4004386|FG000|Extension Phase|Pregnancy|1
2304340|NCT02652624|4004387|FG001|Extension Phase|Pregnancy|1
2304341|NCT02652624|4004386|FG000|Extension Phase|Adverse Event|0
2304342|NCT02652624|4004387|FG001|Extension Phase|Adverse Event|1
2304343|NCT02652624|4004386|FG000|Extension Phase|Withdrew Consent|0
2077993|NCT00676650|3660054|FG001|Overall Study|Study terminated by sponsor|43
2077994|NCT00676650|3660053|FG000|Overall Study|Withdrawal by Subject|48
2077995|NCT00676650|3660054|FG001|Overall Study|Withdrawal by Subject|24
2077996|NCT00676650|3660053|FG000|Overall Study|Randomized but not treated|3
2304344|NCT02652624|4004387|FG001|Extension Phase|Withdrew Consent|1
2304345|NCT02652767|4004395|FG000|Overall Study|Death|2
2077997|NCT00676650|3660054|FG001|Overall Study|Randomized but not treated|4
2077998|NCT00676663|3660062|FG000|Overall Study|Death|43
2077999|NCT00676663|3660063|FG001|Overall Study|Death|27
2078000|NCT00676663|3660062|FG000|Overall Study|Withdrew Consent|1
2078001|NCT00676663|3660063|FG001|Overall Study|Withdrew Consent|8
2078002|NCT00676663|3660062|FG000|Overall Study|Lost to Follow-up|1
2078003|NCT00676663|3660063|FG001|Overall Study|Lost to Follow-up|3
2078004|NCT00676689|3660075|FG000|Overall Study|Screen Failure|2
2078005|NCT00676689|3660075|FG000|Overall Study|Death|2
2078006|NCT00676689|3660075|FG000|Overall Study|Lost to Follow-up|4
2078007|NCT00676689|3660075|FG000|Overall Study|Physician Decision|1
2078008|NCT00676689|3660075|FG000|Overall Study|Withdrawal by Subject|3
2078009|NCT00676689|3660075|FG000|Overall Study|Continuing FU|49
2078010|NCT00677014|3660115|FG000|Overall Study|Lost to Follow-up|20
2078011|NCT00677014|3660116|FG001|Overall Study|Lost to Follow-up|12
2078012|NCT00677014|3660117|FG002|Overall Study|Lost to Follow-up|24
2078013|NCT00677014|3660115|FG000|Overall Study|Death|6
2078014|NCT00677014|3660116|FG001|Overall Study|Death|15
2078015|NCT00677014|3660117|FG002|Overall Study|Death|7
2078016|NCT00677014|3660115|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18
2078017|NCT00677014|3660116|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14
2078018|NCT00677014|3660117|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18
2078019|NCT00677092|3660130|FG000|Overall Study|Adverse Event|1
2078020|NCT00677092|3660130|FG000|Overall Study|Lost to Follow-up|1
2078021|NCT00677092|3660130|FG000|Overall Study|Withdrawal by Subject|3
2078022|NCT00677092|3660130|FG000|Overall Study|Death Prior to Receiving Treatment|1
2078023|NCT00677235|3660137|FG000|Overall Study|Withdrawal by Subject|1
2078024|NCT00677235|3660138|FG001|Overall Study|Withdrawal by Subject|1
2078025|NCT00677235|3660137|FG000|Overall Study|Lost to Follow-up|2
2078026|NCT00677235|3660138|FG001|Overall Study|Lost to Follow-up|1
2078027|NCT00677235|3660137|FG000|Overall Study|Death|37
2078028|NCT00677235|3660138|FG001|Overall Study|Death|36
2078029|NCT00677235|3660137|FG000|Overall Study|Adverse Experience|1
2078030|NCT00677235|3660138|FG001|Overall Study|Adverse Experience|0
2078031|NCT00677352|3660146|FG000|Treatment Phase|Adverse Event|14
2078032|NCT00677352|3660147|FG001|Treatment Phase|Adverse Event|22
2078033|NCT00677352|3660146|FG000|Treatment Phase|Lack of Efficacy|2
2078034|NCT00677352|3660147|FG001|Treatment Phase|Lack of Efficacy|3
2078035|NCT00677352|3660146|FG000|Treatment Phase|Lost to Follow-up|0
2078036|NCT00677352|3660147|FG001|Treatment Phase|Lost to Follow-up|1
2078037|NCT00677352|3660146|FG000|Treatment Phase|Withdrawal by Subject|7
2078038|NCT00677352|3660147|FG001|Treatment Phase|Withdrawal by Subject|7
2078039|NCT00677352|3660146|FG000|Treatment Phase|Physician Decision|1
2078040|NCT00677352|3660147|FG001|Treatment Phase|Physician Decision|0
2078041|NCT00677352|3660146|FG000|Treatment Phase|Pregnancy|0
2078042|NCT00677352|3660147|FG001|Treatment Phase|Pregnancy|1
2078043|NCT00677352|3660146|FG000|Treatment Phase|Protocol Violation|1
2078044|NCT00677352|3660147|FG001|Treatment Phase|Protocol Violation|1
2078045|NCT00677352|3660146|FG000|Treatment Phase|Transference or work related matter|0
2078046|NCT00677352|3660147|FG001|Treatment Phase|Transference or work related matter|5
2078047|NCT00677352|3660146|FG000|Treatment Phase|Not treated|0
2078048|NCT00677352|3660147|FG001|Treatment Phase|Not treated|2
2078049|NCT00677352|3660146|FG000|Tapering Phase|Adverse Event|1
2078050|NCT00677352|3660147|FG001|Tapering Phase|Adverse Event|5
2078051|NCT00677352|3660146|FG000|Tapering Phase|Withdrawal by Subject|5
2078052|NCT00677352|3660147|FG001|Tapering Phase|Withdrawal by Subject|3
2078053|NCT00677352|3660146|FG000|Tapering Phase|Pregnancy|0
2078054|NCT00677352|3660147|FG001|Tapering Phase|Pregnancy|1
2078055|NCT00677352|3660146|FG000|Tapering Phase|Job transfer|0
2078056|NCT00677352|3660147|FG001|Tapering Phase|Job transfer|1
2078057|NCT00677365|3660157|FG000|Overall Study|Adverse Event|2
2078058|NCT00677365|3660158|FG001|Overall Study|Adverse Event|1
2078059|NCT00677365|3660159|FG002|Overall Study|Adverse Event|1
2078060|NCT00677365|3660160|FG003|Overall Study|Adverse Event|2
2078061|NCT00677365|3660157|FG000|Overall Study|Withdrawal by Subject|0
2078062|NCT00677365|3660158|FG001|Overall Study|Withdrawal by Subject|0
2078063|NCT00677365|3660159|FG002|Overall Study|Withdrawal by Subject|1
2078064|NCT00677365|3660160|FG003|Overall Study|Withdrawal by Subject|0
2304346|NCT02652767|4004395|FG000|Overall Study|Lost to Follow-up|1
2304347|NCT02652767|4004395|FG000|Overall Study|Withdrawal by Subject|1
2304348|NCT02653170|4004424|FG000|Overall Study|Withdrawal by Subject|3
2304349|NCT02653170|4004425|FG001|Overall Study|Withdrawal by Subject|8
2078065|NCT00677365|3660157|FG000|Overall Study|Other reason|0
2078066|NCT00677365|3660158|FG001|Overall Study|Other reason|0
2078067|NCT00677365|3660159|FG002|Overall Study|Other reason|0
2078068|NCT00677365|3660160|FG003|Overall Study|Other reason|1
2078069|NCT00677534|3660170|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1
2078070|NCT00677534|3660170|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
2078071|NCT00677534|3660170|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
2078072|NCT00677807|3660186|FG000|Overall Study|Adverse Event|4
2078073|NCT00677807|3660187|FG001|Overall Study|Adverse Event|1
2078074|NCT00677807|3660188|FG002|Overall Study|Adverse Event|6
2078075|NCT00677807|3660186|FG000|Overall Study|Lack of Efficacy|0
2078076|NCT00677807|3660187|FG001|Overall Study|Lack of Efficacy|0
2078077|NCT00677807|3660188|FG002|Overall Study|Lack of Efficacy|2
2078078|NCT00677807|3660186|FG000|Overall Study|Participant no longer needs study drug|0
2177259|NCT01372085|3801295|FG000|Washout Period 3|Withdrawal by Subject|0
2177260|NCT01372085|3801296|FG001|Washout Period 3|Withdrawal by Subject|0
2177261|NCT01372085|3801297|FG002|Washout Period 3|Withdrawal by Subject|0
2177262|NCT01372085|3801298|FG003|Washout Period 3|Withdrawal by Subject|0
2177263|NCT01372085|3801299|FG004|Washout Period 3|Withdrawal by Subject|0
2177264|NCT01372085|3801300|FG005|Washout Period 3|Withdrawal by Subject|2
2177265|NCT01372085|3801301|FG006|Washout Period 3|Withdrawal by Subject|0
2177266|NCT01372085|3801302|FG007|Washout Period 3|Withdrawal by Subject|0
2177267|NCT01372085|3801303|FG008|Washout Period 3|Withdrawal by Subject|0
2177268|NCT01372085|3801304|FG009|Washout Period 3|Withdrawal by Subject|0
2177269|NCT01372150|3801331|FG000|Overall Study|Lack of Efficacy|3
2177270|NCT01372150|3801332|FG001|Overall Study|Lack of Efficacy|0
2177271|NCT01372150|3801333|FG002|Overall Study|Lack of Efficacy|1
2177272|NCT01372150|3801331|FG000|Overall Study|Lost to Follow-up|4
2177273|NCT01372150|3801332|FG001|Overall Study|Lost to Follow-up|5
2210957|NCT01656395|3850941|FG004|Overall Study|Progressive Disease|0
2210958|NCT01656395|3850942|FG005|Overall Study|Progressive Disease|1
2210959|NCT01656395|3850943|FG006|Overall Study|Progressive Disease|0
2210960|NCT01656395|3850944|FG007|Overall Study|Progressive Disease|0
2210961|NCT01656395|3850937|FG000|Overall Study|Protocol Violation|6
2210962|NCT01656395|3850938|FG001|Overall Study|Protocol Violation|6
2210963|NCT01656395|3850939|FG002|Overall Study|Protocol Violation|9
2210964|NCT01656395|3850940|FG003|Overall Study|Protocol Violation|2
2210965|NCT01656395|3850941|FG004|Overall Study|Protocol Violation|4
2210966|NCT01656395|3850942|FG005|Overall Study|Protocol Violation|10
2210967|NCT01656395|3850943|FG006|Overall Study|Protocol Violation|0
2210968|NCT01656395|3850944|FG007|Overall Study|Protocol Violation|0
2210969|NCT01656395|3850937|FG000|Overall Study|Screen Failure|2
2210970|NCT01656395|3850938|FG001|Overall Study|Screen Failure|1
2210971|NCT01656395|3850939|FG002|Overall Study|Screen Failure|7
2210972|NCT01656395|3850940|FG003|Overall Study|Screen Failure|1
2210973|NCT01656395|3850941|FG004|Overall Study|Screen Failure|0
2210974|NCT01656395|3850942|FG005|Overall Study|Screen Failure|8
2210975|NCT01656395|3850943|FG006|Overall Study|Screen Failure|0
2210976|NCT01656395|3850944|FG007|Overall Study|Screen Failure|0
2210977|NCT01656395|3850937|FG000|Overall Study|Withdrawal by Subject|3
2210978|NCT01656395|3850938|FG001|Overall Study|Withdrawal by Subject|1
2210979|NCT01656395|3850939|FG002|Overall Study|Withdrawal by Subject|4
2210980|NCT01656395|3850940|FG003|Overall Study|Withdrawal by Subject|2
2210981|NCT01656395|3850941|FG004|Overall Study|Withdrawal by Subject|0
2210982|NCT01656395|3850942|FG005|Overall Study|Withdrawal by Subject|3
2210983|NCT01656395|3850943|FG006|Overall Study|Withdrawal by Subject|0
2210984|NCT01656395|3850944|FG007|Overall Study|Withdrawal by Subject|0
2210985|NCT01656408|3850968|FG000|Overall Study|Adverse Event|0
2210986|NCT01656408|3850969|FG001|Overall Study|Adverse Event|0
2210987|NCT01656408|3850970|FG002|Overall Study|Adverse Event|1
2210988|NCT01656408|3850971|FG003|Overall Study|Adverse Event|0
2210989|NCT01656408|3850972|FG004|Overall Study|Adverse Event|0
2210990|NCT01656408|3850973|FG005|Overall Study|Adverse Event|1
2210991|NCT01656408|3850974|FG006|Overall Study|Adverse Event|1
2210992|NCT01656408|3850975|FG007|Overall Study|Adverse Event|0
2210993|NCT01656408|3850976|FG008|Overall Study|Adverse Event|1
2210994|NCT01656408|3850977|FG009|Overall Study|Adverse Event|0
2210995|NCT01656408|3850968|FG000|Overall Study|Physician Decision|1
2210996|NCT01656408|3850969|FG001|Overall Study|Physician Decision|0
2078079|NCT00677807|3660187|FG001|Overall Study|Participant no longer needs study drug|0
2078080|NCT00677807|3660188|FG002|Overall Study|Participant no longer needs study drug|1
2078081|NCT00677807|3660186|FG000|Overall Study|Withdrawal by Subject|10
2078082|NCT00677807|3660187|FG001|Overall Study|Withdrawal by Subject|3
2078083|NCT00677807|3660188|FG002|Overall Study|Withdrawal by Subject|6
2078084|NCT00677807|3660186|FG000|Overall Study|Lost to Follow-up|2
2078085|NCT00677807|3660187|FG001|Overall Study|Lost to Follow-up|2
2078086|NCT00677807|3660188|FG002|Overall Study|Lost to Follow-up|2
2078087|NCT00677807|3660186|FG000|Overall Study|Administrative problems|1
2078088|NCT00677807|3660187|FG001|Overall Study|Administrative problems|1
2078089|NCT00677807|3660188|FG002|Overall Study|Administrative problems|2
2078090|NCT00677807|3660186|FG000|Overall Study|Death|0
2078091|NCT00677807|3660187|FG001|Overall Study|Death|1
2078092|NCT00677807|3660188|FG002|Overall Study|Death|1
2078093|NCT00677807|3660186|FG000|Overall Study|Protocol Deviation|1
2078094|NCT00677807|3660187|FG001|Overall Study|Protocol Deviation|3
2078095|NCT00677807|3660188|FG002|Overall Study|Protocol Deviation|0
2078096|NCT00677820|3660198|FG000|Overall Study|Lost to Follow-up|1
2210997|NCT01656408|3850970|FG002|Overall Study|Physician Decision|1
2210998|NCT01656408|3850971|FG003|Overall Study|Physician Decision|0
2210999|NCT01656408|3850972|FG004|Overall Study|Physician Decision|1
2211000|NCT01656408|3850973|FG005|Overall Study|Physician Decision|1
2211001|NCT01656408|3850974|FG006|Overall Study|Physician Decision|0
2211002|NCT01656408|3850975|FG007|Overall Study|Physician Decision|1
2211003|NCT01656408|3850976|FG008|Overall Study|Physician Decision|1
2211004|NCT01656408|3850977|FG009|Overall Study|Physician Decision|3
2211005|NCT01656733|3851055|FG000|Overall Study|No permission to collect birth outcomes|0
2211006|NCT01656733|3851056|FG001|Overall Study|No permission to collect birth outcomes|1
2211007|NCT01656733|3851055|FG000|Overall Study|Delivery at another hospital|0
2078097|NCT00677820|3660199|FG001|Overall Study|Lost to Follow-up|0
2078098|NCT00677833|3660209|FG000|Overall Study|Withdrawal by Subject|4
2078099|NCT00677833|3660210|FG001|Overall Study|Withdrawal by Subject|0
2078100|NCT00677833|3660211|FG002|Overall Study|Withdrawal by Subject|1
2078101|NCT00677833|3660212|FG003|Overall Study|Withdrawal by Subject|3
2078102|NCT00677833|3660209|FG000|Overall Study|Lost to Follow-up|0
2078103|NCT00677833|3660210|FG001|Overall Study|Lost to Follow-up|0
2078104|NCT00677833|3660211|FG002|Overall Study|Lost to Follow-up|1
2078105|NCT00677833|3660212|FG003|Overall Study|Lost to Follow-up|0
2078106|NCT00678080|3660244|FG000|Overall Study|Physician Decision|2
2078107|NCT00678080|3660245|FG001|Overall Study|Physician Decision|0
2078108|NCT00678080|3660244|FG000|Overall Study|Lost to Follow-up|1
2078109|NCT00678080|3660245|FG001|Overall Study|Lost to Follow-up|0
2078110|NCT00678080|3660244|FG000|Overall Study|Withdrawal by Subject|0
2078111|NCT00678080|3660245|FG001|Overall Study|Withdrawal by Subject|1
2078112|NCT00678210|3660255|FG000|Overall Study|Adverse Event|1
2078113|NCT00678210|3660256|FG001|Overall Study|Adverse Event|2
2078114|NCT00678210|3660257|FG002|Overall Study|Adverse Event|3
2078115|NCT00678210|3660258|FG003|Overall Study|Adverse Event|3
2078116|NCT00678210|3660255|FG000|Overall Study|Lack of Efficacy|2
2078117|NCT00678210|3660256|FG001|Overall Study|Lack of Efficacy|3
2078118|NCT00678210|3660257|FG002|Overall Study|Lack of Efficacy|1
2078119|NCT00678210|3660258|FG003|Overall Study|Lack of Efficacy|9
2078120|NCT00678210|3660255|FG000|Overall Study|Lost to Follow-up|4
2078121|NCT00678210|3660256|FG001|Overall Study|Lost to Follow-up|2
2078122|NCT00678210|3660257|FG002|Overall Study|Lost to Follow-up|0
2078123|NCT00678210|3660258|FG003|Overall Study|Lost to Follow-up|1
2078124|NCT00678210|3660255|FG000|Overall Study|Withdrawal by Subject|3
2078125|NCT00678210|3660256|FG001|Overall Study|Withdrawal by Subject|4
2078126|NCT00678210|3660257|FG002|Overall Study|Withdrawal by Subject|1
2078127|NCT00678210|3660258|FG003|Overall Study|Withdrawal by Subject|7
2078128|NCT00678210|3660255|FG000|Overall Study|Other|1
2078129|NCT00678210|3660256|FG001|Overall Study|Other|0
2078130|NCT00678210|3660257|FG002|Overall Study|Other|1
2078131|NCT00678210|3660258|FG003|Overall Study|Other|0
2078132|NCT00678301|3660283|FG000|Overall Study|Non-compliance with study procedures|0
2078133|NCT00678301|3660284|FG001|Overall Study|Non-compliance with study procedures|1
2078134|NCT00678301|3660283|FG000|Overall Study|Adverse Event|1
2078135|NCT00678301|3660284|FG001|Overall Study|Adverse Event|0
2078136|NCT00678301|3660283|FG000|Overall Study|Withdrawal by Subject|4
2078137|NCT00678301|3660284|FG001|Overall Study|Withdrawal by Subject|0
2078138|NCT00678301|3660283|FG000|Overall Study|Lost to Follow-up|3
2078139|NCT00678301|3660284|FG001|Overall Study|Lost to Follow-up|1
2078140|NCT00678379|3660293|FG000|Overall Study|Injection performed after tonsillectomy|2
2078141|NCT00678379|3660294|FG001|Overall Study|Injection performed after tonsillectomy|0
2078142|NCT00678379|3660295|FG002|Overall Study|Injection performed after tonsillectomy|1
2078143|NCT00678379|3660293|FG000|Overall Study|Incomplete Data|4
2078144|NCT00678379|3660294|FG001|Overall Study|Incomplete Data|3
2078145|NCT00678379|3660295|FG002|Overall Study|Incomplete Data|3
2078146|NCT00678392|3660305|FG000|Overall Study|Adverse Event|0
2078147|NCT00678392|3660306|FG001|Overall Study|Adverse Event|6
2078148|NCT00678392|3660305|FG000|Overall Study|Death|280
2078149|NCT00678392|3660306|FG001|Overall Study|Death|269
2078150|NCT00678392|3660305|FG000|Overall Study|Lost to Follow-up|15
2078151|NCT00678392|3660306|FG001|Overall Study|Lost to Follow-up|13
2078152|NCT00678392|3660305|FG000|Overall Study|Objective Progression or Relapse|3
2078153|NCT00678392|3660306|FG001|Overall Study|Objective Progression or Relapse|8
2078154|NCT00678392|3660305|FG000|Overall Study|Sponsor's Decision|1
2078155|NCT00678392|3660306|FG001|Overall Study|Sponsor's Decision|2
2078156|NCT00678392|3660305|FG000|Overall Study|Withdrawal by Subject|4
2078157|NCT00678392|3660306|FG001|Overall Study|Withdrawal by Subject|4
2078158|NCT00678392|3660305|FG000|Overall Study|Randomized But Not Treated|2
2078159|NCT00678392|3660306|FG001|Overall Study|Randomized But Not Treated|7
2078160|NCT00678392|3660305|FG000|Overall Study|Other|56
2078161|NCT00678392|3660306|FG001|Overall Study|Other|53
2106696|NCT00867568|3700009|FG000|Overall Study|Withdrawal by Subject|1
2106697|NCT00867815|3700027|FG000|Overall Study|Lost to Follow-up|1
2106698|NCT00868166|3700059|FG000|Overall Study|Death|58
2106699|NCT00868166|3700060|FG001|Overall Study|Death|65
2106700|NCT00868166|3700059|FG000|Overall Study|Withdrawal by Subject|33
2106701|NCT00868166|3700060|FG001|Overall Study|Withdrawal by Subject|25
2106702|NCT00868166|3700059|FG000|Overall Study|Protocol Violation|1
2106703|NCT00868166|3700060|FG001|Overall Study|Protocol Violation|0
2106704|NCT00868166|3700059|FG000|Overall Study|Lost to Follow-up|1
2106705|NCT00868166|3700060|FG001|Overall Study|Lost to Follow-up|3
2106706|NCT00868166|3700059|FG000|Overall Study|Adverse Event|9
2106707|NCT00868166|3700060|FG001|Overall Study|Adverse Event|10
2106708|NCT00868166|3700059|FG000|Overall Study|Lack of efficacy, logistics, unwell|9
2106709|NCT00868166|3700060|FG001|Overall Study|Lack of efficacy, logistics, unwell|10
2106710|NCT00868166|3700059|FG000|Overall Study|Non-compliance with IMP|1
2106711|NCT00868166|3700060|FG001|Overall Study|Non-compliance with IMP|1
2106712|NCT00868192|3700066|FG000|Overall Study|Ineligible|4
2106713|NCT00868231|3700091|FG000|Treatment Period 1|Adverse Event|0
2106714|NCT00868231|3700092|FG001|Treatment Period 1|Adverse Event|0
2106715|NCT00868231|3700093|FG002|Treatment Period 1|Adverse Event|0
2078162|NCT00678561|3660362|FG000|Overall Study|Adverse Event|0
2078163|NCT00678561|3660363|FG001|Overall Study|Adverse Event|1
2078164|NCT00678561|3660364|FG002|Overall Study|Adverse Event|1
2078165|NCT00678561|3660365|FG003|Overall Study|Adverse Event|0
2078166|NCT00678561|3660366|FG004|Overall Study|Adverse Event|1
2078167|NCT00678561|3660367|FG005|Overall Study|Adverse Event|0
2078168|NCT00678561|3660368|FG006|Overall Study|Adverse Event|0
2078169|NCT00678561|3660369|FG007|Overall Study|Adverse Event|0
2078170|NCT00678561|3660362|FG000|Overall Study|Protocol Violation|0
2078171|NCT00678561|3660363|FG001|Overall Study|Protocol Violation|0
2078172|NCT00678561|3660364|FG002|Overall Study|Protocol Violation|0
2078173|NCT00678561|3660365|FG003|Overall Study|Protocol Violation|0
2078174|NCT00678561|3660366|FG004|Overall Study|Protocol Violation|1
2078175|NCT00678561|3660367|FG005|Overall Study|Protocol Violation|1
2078176|NCT00678561|3660368|FG006|Overall Study|Protocol Violation|0
2078177|NCT00678561|3660369|FG007|Overall Study|Protocol Violation|0
2078178|NCT00678561|3660362|FG000|Overall Study|Withdrawal by Subject|0
2078179|NCT00678561|3660363|FG001|Overall Study|Withdrawal by Subject|0
2078180|NCT00678561|3660364|FG002|Overall Study|Withdrawal by Subject|0
2078181|NCT00678561|3660365|FG003|Overall Study|Withdrawal by Subject|0
2078182|NCT00678561|3660366|FG004|Overall Study|Withdrawal by Subject|0
2078183|NCT00678561|3660367|FG005|Overall Study|Withdrawal by Subject|0
2078184|NCT00678561|3660368|FG006|Overall Study|Withdrawal by Subject|0
2078185|NCT00678561|3660369|FG007|Overall Study|Withdrawal by Subject|1
2078186|NCT00678587|3660396|FG000|Overall Study|Adverse Event|3
2078187|NCT00678587|3660397|FG001|Overall Study|Adverse Event|3
2078188|NCT00678587|3660396|FG000|Overall Study|Lack of Efficacy|1
2078189|NCT00678587|3660397|FG001|Overall Study|Lack of Efficacy|0
2078190|NCT00678587|3660396|FG000|Overall Study|Protocol Violation|2
2078191|NCT00678587|3660397|FG001|Overall Study|Protocol Violation|1
2078192|NCT00678587|3660396|FG000|Overall Study|Study Closed/Terminated|1
2078193|NCT00678587|3660397|FG001|Overall Study|Study Closed/Terminated|0
2078194|NCT00678587|3660396|FG000|Overall Study|Lost to Follow-up|3
2078195|NCT00678587|3660397|FG001|Overall Study|Lost to Follow-up|5
2078196|NCT00678587|3660396|FG000|Overall Study|Investigator Discretion|2
2078197|NCT00678587|3660397|FG001|Overall Study|Investigator Discretion|6
2078198|NCT00678587|3660396|FG000|Overall Study|Withdrew Consent|8
2078199|NCT00678587|3660397|FG001|Overall Study|Withdrew Consent|3
2078200|NCT00678639|3660406|FG000|Overall Study|Lost to Follow-up at 30 days|2
2078201|NCT00678639|3660407|FG001|Overall Study|Lost to Follow-up at 30 days|0
2078202|NCT00678652|3660418|FG000|Overall Study|Protocol Violation|2
2078203|NCT00678652|3660419|FG001|Overall Study|Protocol Violation|0
2078204|NCT00678652|3660420|FG002|Overall Study|Protocol Violation|0
2078205|NCT00678652|3660421|FG003|Overall Study|Protocol Violation|0
2078206|NCT00678652|3660418|FG000|Overall Study|Pregnancy|0
2078207|NCT00678652|3660419|FG001|Overall Study|Pregnancy|0
2078208|NCT00678652|3660420|FG002|Overall Study|Pregnancy|1
2078209|NCT00678652|3660421|FG003|Overall Study|Pregnancy|0
2078210|NCT00678652|3660418|FG000|Overall Study|Relocation|1
2304350|NCT02653170|4004426|FG002|Overall Study|Withdrawal by Subject|3
2304351|NCT02653170|4004424|FG000|Overall Study|withdrawn by study team|2
2304352|NCT02653170|4004425|FG001|Overall Study|withdrawn by study team|4
2304353|NCT02653170|4004426|FG002|Overall Study|withdrawn by study team|5
2304354|NCT02653170|4004424|FG000|Overall Study|Lost to Follow-up|12
2304355|NCT02653170|4004425|FG001|Overall Study|Lost to Follow-up|4
2304356|NCT02653170|4004426|FG002|Overall Study|Lost to Follow-up|10
2304357|NCT02653300|4004443|FG000|Overall Study|Withdrawal by Subject|2
2078211|NCT00678652|3660419|FG001|Overall Study|Relocation|0
2078212|NCT00678652|3660420|FG002|Overall Study|Relocation|0
2078213|NCT00678652|3660421|FG003|Overall Study|Relocation|0
2078214|NCT00678691|3660433|FG000|Overall Study|Adverse Event|6
2078215|NCT00678691|3660434|FG001|Overall Study|Adverse Event|4
2078216|NCT00678795|3660442|FG000|Overall Study|Adverse Event|7
2078217|NCT00678795|3660443|FG001|Overall Study|Adverse Event|3
2078218|NCT00678795|3660442|FG000|Overall Study|Withdrawal by Subject|3
2078219|NCT00678795|3660443|FG001|Overall Study|Withdrawal by Subject|0
2078220|NCT00678795|3660442|FG000|Overall Study|Protocol Violation|0
2078221|NCT00678795|3660443|FG001|Overall Study|Protocol Violation|1
2078222|NCT00678795|3660442|FG000|Overall Study|Lost to Follow-up|0
2078223|NCT00678795|3660443|FG001|Overall Study|Lost to Follow-up|1
2078224|NCT00678795|3660442|FG000|Overall Study|Lack of Efficacy|1
2078225|NCT00678795|3660443|FG001|Overall Study|Lack of Efficacy|1
2304358|NCT02653326|4004449|FG000|Overall Study|Lost to Follow-up|10
2304359|NCT02653326|4004450|FG001|Overall Study|Lost to Follow-up|7
2304360|NCT02653625|4004544|FG000|Overall Study|Adverse Event|1
2304361|NCT02653625|4004544|FG000|Overall Study|Non-compliance with Study Drug|1
2304362|NCT02653625|4004544|FG000|Overall Study|Protocol Violation|1
2304363|NCT02653625|4004544|FG000|Overall Study|Suspected Drug Induced Liver Injury|1
2304364|NCT02653664|4004551|FG000|Post-Treatment|Withdrawal by Subject|6
2304365|NCT02653664|4004552|FG001|Post-Treatment|Withdrawal by Subject|5
2304366|NCT02653664|4004553|FG002|Post-Treatment|Withdrawal by Subject|7
2078226|NCT00678886|3660474|FG000|Overall Study|Withdrawal by Subject|0
2078227|NCT00678886|3660475|FG001|Overall Study|Withdrawal by Subject|0
2078228|NCT00678886|3660476|FG002|Overall Study|Withdrawal by Subject|4
2304367|NCT02653664|4004551|FG000|Post-Treatment|Lost to Follow-up|8
2078229|NCT00678886|3660477|FG003|Overall Study|Withdrawal by Subject|6
2304368|NCT02653664|4004552|FG001|Post-Treatment|Lost to Follow-up|1
2304369|NCT02653664|4004553|FG002|Post-Treatment|Lost to Follow-up|7
2304370|NCT02653664|4004551|FG000|3 Month Follow-Up|Withdrawal by Subject|9
2304371|NCT02653664|4004552|FG001|3 Month Follow-Up|Withdrawal by Subject|5
2304372|NCT02653664|4004553|FG002|3 Month Follow-Up|Withdrawal by Subject|9
2304373|NCT02653664|4004551|FG000|3 Month Follow-Up|Lost to Follow-up|9
2304374|NCT02653664|4004552|FG001|3 Month Follow-Up|Lost to Follow-up|8
2304375|NCT02653664|4004553|FG002|3 Month Follow-Up|Lost to Follow-up|16
2304376|NCT02653664|4004551|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
2304377|NCT02653664|4004552|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
2304378|NCT02653664|4004553|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
2304379|NCT02653664|4004551|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3
2304380|NCT02653664|4004552|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
2304381|NCT02653664|4004553|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
2304382|NCT02653664|4004551|FG000|6 Month Follow-Up|Withdrawal by Subject|13
2304383|NCT02653664|4004552|FG001|6 Month Follow-Up|Withdrawal by Subject|7
2304384|NCT02653664|4004553|FG002|6 Month Follow-Up|Withdrawal by Subject|14
2304385|NCT02653664|4004551|FG000|6 Month Follow-Up|Lost to Follow-up|10
2304386|NCT02653664|4004552|FG001|6 Month Follow-Up|Lost to Follow-up|11
2304387|NCT02653664|4004553|FG002|6 Month Follow-Up|Lost to Follow-up|9
2304388|NCT02653664|4004551|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
2078230|NCT00678886|3660474|FG000|Overall Study|Physician Decision|0
2078231|NCT00678886|3660475|FG001|Overall Study|Physician Decision|0
2078232|NCT00678886|3660476|FG002|Overall Study|Physician Decision|1
2078233|NCT00678886|3660477|FG003|Overall Study|Physician Decision|1
2078234|NCT00678886|3660474|FG000|Overall Study|Lost to Follow-up|0
2078235|NCT00678886|3660475|FG001|Overall Study|Lost to Follow-up|0
2078236|NCT00678886|3660476|FG002|Overall Study|Lost to Follow-up|3
2078237|NCT00678886|3660477|FG003|Overall Study|Lost to Follow-up|2
2078238|NCT00678886|3660474|FG000|Overall Study|Other|0
2078239|NCT00678886|3660475|FG001|Overall Study|Other|0
2078240|NCT00678886|3660476|FG002|Overall Study|Other|1
2078241|NCT00678886|3660477|FG003|Overall Study|Other|0
2078242|NCT00678899|3660486|FG000|Overall Study|Adverse Event|1
2078243|NCT00679029|3660491|FG000|Overall Study|Adverse Event|3
2078244|NCT00679029|3660491|FG000|Overall Study|Withdrawal by Subject|1
2078245|NCT00679029|3660491|FG000|Overall Study|Lost to Follow-up|1
2078246|NCT00679042|3660495|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2
2078247|NCT00679042|3660495|FG000|5-Year Follow Up|In follow-up (ongoing)|6
2078248|NCT00679042|3660495|FG000|5-Year Follow Up|Death|1
2078249|NCT00679042|3660495|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7
2078250|NCT00679042|3660495|FG000|10-Year Follow Up|In follow-up (ongoing)|5
2078251|NCT00679055|3660501|FG000|Overall Study|Adverse Event|0
2078252|NCT00679055|3660502|FG001|Overall Study|Adverse Event|1
2078253|NCT00679055|3660501|FG000|Overall Study|Other|0
2078254|NCT00679055|3660502|FG001|Overall Study|Other|3
2078255|NCT00679055|3660501|FG000|Overall Study|Study Terminated|2
2078256|NCT00679055|3660502|FG001|Overall Study|Study Terminated|1
2078257|NCT00679081|3660508|FG000|Overall Study|Lost to Follow-up|1
2078258|NCT00679172|3660521|FG000|Overall Study|Non-compliance|1
2078259|NCT00679172|3660522|FG001|Overall Study|Non-compliance|1
2078260|NCT00679172|3660523|FG002|Overall Study|Non-compliance|0
2078261|NCT00679172|3660524|FG003|Overall Study|Non-compliance|1
2078262|NCT00679172|3660525|FG004|Overall Study|Non-compliance|0
2078263|NCT00679172|3660521|FG000|Overall Study|Other not specified|0
2078264|NCT00679172|3660522|FG001|Overall Study|Other not specified|0
2078265|NCT00679172|3660523|FG002|Overall Study|Other not specified|1
2078266|NCT00679172|3660524|FG003|Overall Study|Other not specified|0
2078267|NCT00679172|3660525|FG004|Overall Study|Other not specified|0
2078268|NCT00679211|3660540|FG000|Overall Study|Progressive disease|82
2078269|NCT00679211|3660540|FG000|Overall Study|Adverse Event|7
2078270|NCT00679211|3660540|FG000|Overall Study|Withdrawal by Subject|2
2078271|NCT00679211|3660540|FG000|Overall Study|Physician Decision|5
2078272|NCT00679211|3660540|FG000|Overall Study|Refused to undergo protocol procedures|1
2078273|NCT00679211|3660540|FG000|Overall Study|Transferred to extension study TDM4529g|12
2078274|NCT00679211|3660540|FG000|Overall Study|Other|1
2078275|NCT00679263|3660549|FG000|Visit 2/Dose 1|Adverse Event|1
2078276|NCT00679263|3660550|FG001|Visit 2/Dose 1|Adverse Event|0
2078277|NCT00679263|3660551|FG002|Visit 2/Dose 1|Adverse Event|0
2078278|NCT00679263|3660549|FG000|Visit 2/Dose 1|subject not compliance|1
2078279|NCT00679263|3660550|FG001|Visit 2/Dose 1|subject not compliance|1
2078280|NCT00679263|3660551|FG002|Visit 2/Dose 1|subject not compliance|0
2078281|NCT00679289|3660562|FG000|Overall Study|Progressive disease|4
2078282|NCT00679289|3660563|FG001|Overall Study|Progressive disease|5
2078283|NCT00679289|3660564|FG002|Overall Study|Progressive disease|18
2078284|NCT00679289|3660562|FG000|Overall Study|Withdrawal by Subject|0
2078285|NCT00679289|3660563|FG001|Overall Study|Withdrawal by Subject|1
2078286|NCT00679289|3660564|FG002|Overall Study|Withdrawal by Subject|1
2078287|NCT00679289|3660562|FG000|Overall Study|Adverse Event|0
2078288|NCT00679289|3660563|FG001|Overall Study|Adverse Event|0
2078289|NCT00679289|3660564|FG002|Overall Study|Adverse Event|3
2078290|NCT00679289|3660562|FG000|Overall Study|Physician Decision|1
2078291|NCT00679289|3660563|FG001|Overall Study|Physician Decision|0
2078292|NCT00679289|3660564|FG002|Overall Study|Physician Decision|1
2078293|NCT00679302|3660576|FG000|Overall Study|Lost to Follow-up|8
2078294|NCT00679302|3660577|FG001|Overall Study|Lost to Follow-up|4
2078295|NCT00679341|3660585|FG000|Overall Study|Disease progression|42
2078296|NCT00679341|3660586|FG001|Overall Study|Disease progression|36
2078297|NCT00679341|3660585|FG000|Overall Study|Adverse Event|5
2078298|NCT00679341|3660586|FG001|Overall Study|Adverse Event|6
2078299|NCT00679341|3660585|FG000|Overall Study|Subject/guardian decision to discontinue|3
2078300|NCT00679341|3660586|FG001|Overall Study|Subject/guardian decision to discontinue|0
2078301|NCT00679341|3660585|FG000|Overall Study|Death|1
2211008|NCT01656733|3851056|FG001|Overall Study|Delivery at another hospital|2
2211009|NCT01656733|3851055|FG000|Overall Study|Spontaneous abortion|0
2304389|NCT02653664|4004552|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
2078302|NCT00679341|3660586|FG001|Overall Study|Death|1
2078303|NCT00679341|3660585|FG000|Overall Study|Other|1
2078304|NCT00679341|3660586|FG001|Overall Study|Other|0
2078305|NCT00679341|3660585|FG000|Overall Study|Physician Decision|1
2078306|NCT00679341|3660586|FG001|Overall Study|Physician Decision|0
2078307|NCT00679341|3660585|FG000|Overall Study|Not treated|0
2078308|NCT00679341|3660586|FG001|Overall Study|Not treated|2
2078309|NCT00679341|3660585|FG000|Overall Study|Physician/patient decision to withdraw|0
2078310|NCT00679341|3660586|FG001|Overall Study|Physician/patient decision to withdraw|6
2078311|NCT00679354|3660593|FG000|Overall Study|Death|3
2078312|NCT00679354|3660593|FG000|Overall Study|Lack of Efficacy|22
2078313|NCT00679354|3660593|FG000|Overall Study|Physician Decision|4
2078314|NCT00679354|3660593|FG000|Overall Study|Ineligible|1
2078315|NCT00679367|3660598|FG000|Overall Study|Adverse Event|7
2078316|NCT00679367|3660598|FG000|Overall Study|inability to swallow oral drugs|1
2078317|NCT00679367|3660598|FG000|Overall Study|Lack of Efficacy|3
2078318|NCT00679367|3660598|FG000|Overall Study|Withdrawal by Subject|1
2078319|NCT00679432|3660624|FG000|Overall Study|Adverse Event|5
2078320|NCT00679432|3660625|FG001|Overall Study|Adverse Event|6
2078321|NCT00679432|3660626|FG002|Overall Study|Adverse Event|10
2078322|NCT00679432|3660627|FG003|Overall Study|Adverse Event|7
2078323|NCT00679432|3660624|FG000|Overall Study|Protocol Violation|1
2078324|NCT00679432|3660625|FG001|Overall Study|Protocol Violation|1
2078325|NCT00679432|3660626|FG002|Overall Study|Protocol Violation|2
2078326|NCT00679432|3660627|FG003|Overall Study|Protocol Violation|1
2078327|NCT00679432|3660624|FG000|Overall Study|Withdrawal by Subject|8
2078328|NCT00679432|3660625|FG001|Overall Study|Withdrawal by Subject|11
2078329|NCT00679432|3660626|FG002|Overall Study|Withdrawal by Subject|10
2078330|NCT00679432|3660627|FG003|Overall Study|Withdrawal by Subject|9
2078331|NCT00679432|3660624|FG000|Overall Study|Lost to Follow-up|1
2078332|NCT00679432|3660625|FG001|Overall Study|Lost to Follow-up|5
2078333|NCT00679432|3660626|FG002|Overall Study|Lost to Follow-up|4
2078334|NCT00679432|3660627|FG003|Overall Study|Lost to Follow-up|2
2078335|NCT00679432|3660624|FG000|Overall Study|Physician Decision|3
2078336|NCT00679432|3660625|FG001|Overall Study|Physician Decision|2
2078337|NCT00679432|3660626|FG002|Overall Study|Physician Decision|2
2078338|NCT00679432|3660627|FG003|Overall Study|Physician Decision|2
2078339|NCT00679432|3660624|FG000|Overall Study|Sponsor decision|1
2078340|NCT00679432|3660625|FG001|Overall Study|Sponsor decision|0
2078341|NCT00679432|3660626|FG002|Overall Study|Sponsor decision|0
2078342|NCT00679432|3660627|FG003|Overall Study|Sponsor decision|0
2078343|NCT00679432|3660624|FG000|Overall Study|Lack of Efficacy|13
2078344|NCT00679432|3660625|FG001|Overall Study|Lack of Efficacy|9
2078345|NCT00679432|3660626|FG002|Overall Study|Lack of Efficacy|14
2078346|NCT00679432|3660627|FG003|Overall Study|Lack of Efficacy|8
2078347|NCT00679432|3660624|FG000|Overall Study|Infectious colitis, normal histology|5
2078348|NCT00679432|3660625|FG001|Overall Study|Infectious colitis, normal histology|4
2304390|NCT02653664|4004553|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
2304391|NCT02653664|4004551|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0
2304392|NCT02653664|4004552|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1
2304393|NCT02653664|4004553|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0
2304394|NCT02654002|4004596|FG000|Overall Study|Adverse Event|0
2304395|NCT02654002|4004597|FG001|Overall Study|Adverse Event|0
2304396|NCT02654002|4004598|FG002|Overall Study|Adverse Event|0
2304397|NCT02654002|4004599|FG003|Overall Study|Adverse Event|0
2304398|NCT02654002|4004600|FG004|Overall Study|Adverse Event|0
2304399|NCT02654002|4004601|FG005|Overall Study|Adverse Event|0
2304400|NCT02654002|4004602|FG006|Overall Study|Adverse Event|1
2304401|NCT02654002|4004603|FG007|Overall Study|Adverse Event|0
2304402|NCT02654002|4004604|FG008|Overall Study|Adverse Event|0
2304403|NCT02654002|4004596|FG000|Overall Study|Withdrew Consent|0
2078349|NCT00679432|3660626|FG002|Overall Study|Infectious colitis, normal histology|8
2078350|NCT00679432|3660627|FG003|Overall Study|Infectious colitis, normal histology|3
2078351|NCT00679432|3660624|FG000|Overall Study|Randomization error, return to prior Rx|0
2078352|NCT00679432|3660625|FG001|Overall Study|Randomization error, return to prior Rx|0
2078353|NCT00679432|3660626|FG002|Overall Study|Randomization error, return to prior Rx|3
2078354|NCT00679432|3660627|FG003|Overall Study|Randomization error, return to prior Rx|0
2078355|NCT00679549|3660639|FG000|Overall Study|dropout|2
2211010|NCT01656733|3851056|FG001|Overall Study|Spontaneous abortion|1
2078356|NCT00679549|3660640|FG001|Overall Study|dropout|4
2078357|NCT00679549|3660639|FG000|Overall Study|missing outcome echocardiograms|4
2078358|NCT00679549|3660640|FG001|Overall Study|missing outcome echocardiograms|5
2078359|NCT00679627|3660648|FG000|Overall Study|Death|41
2078360|NCT00679627|3660649|FG001|Overall Study|Death|29
2078361|NCT00679627|3660648|FG000|Overall Study|Adverse Event|43
2078362|NCT00679627|3660649|FG001|Overall Study|Adverse Event|53
2078363|NCT00679627|3660648|FG000|Overall Study|Withdrawal by Subject|168
2078364|NCT00679627|3660649|FG001|Overall Study|Withdrawal by Subject|172
2078365|NCT00679627|3660648|FG000|Overall Study|Lost to Follow-up|22
2078366|NCT00679627|3660649|FG001|Overall Study|Lost to Follow-up|26
2078367|NCT00679627|3660648|FG000|Overall Study|Early Study Closure|425
2078368|NCT00679627|3660649|FG001|Overall Study|Early Study Closure|405
2078369|NCT00679783|3660662|FG000|Overall Study|Adverse Event|0
2078370|NCT00679783|3660663|FG001|Overall Study|Adverse Event|0
2078371|NCT00679783|3660664|FG002|Overall Study|Adverse Event|0
2078372|NCT00679783|3660665|FG003|Overall Study|Adverse Event|3
2078373|NCT00679783|3660666|FG004|Overall Study|Adverse Event|0
2078374|NCT00679783|3660667|FG005|Overall Study|Adverse Event|0
2078375|NCT00679783|3660668|FG006|Overall Study|Adverse Event|1
2078376|NCT00679783|3660662|FG000|Overall Study|Lack of Efficacy|0
2078377|NCT00679783|3660663|FG001|Overall Study|Lack of Efficacy|1
2078378|NCT00679783|3660664|FG002|Overall Study|Lack of Efficacy|0
2078379|NCT00679783|3660665|FG003|Overall Study|Lack of Efficacy|2
2078380|NCT00679783|3660666|FG004|Overall Study|Lack of Efficacy|0
2078381|NCT00679783|3660667|FG005|Overall Study|Lack of Efficacy|0
2078382|NCT00679783|3660668|FG006|Overall Study|Lack of Efficacy|0
2078383|NCT00679783|3660662|FG000|Overall Study|Withdrawal by Subject|0
2078384|NCT00679783|3660663|FG001|Overall Study|Withdrawal by Subject|0
2078385|NCT00679783|3660664|FG002|Overall Study|Withdrawal by Subject|1
2078386|NCT00679783|3660665|FG003|Overall Study|Withdrawal by Subject|1
2078387|NCT00679783|3660666|FG004|Overall Study|Withdrawal by Subject|0
2078388|NCT00679783|3660667|FG005|Overall Study|Withdrawal by Subject|0
2078389|NCT00679783|3660668|FG006|Overall Study|Withdrawal by Subject|0
2078390|NCT00679783|3660662|FG000|Overall Study|Not Captured|0
2078391|NCT00679783|3660663|FG001|Overall Study|Not Captured|0
2078392|NCT00679783|3660664|FG002|Overall Study|Not Captured|0
2304404|NCT02654002|4004597|FG001|Overall Study|Withdrew Consent|0
2304405|NCT02654002|4004598|FG002|Overall Study|Withdrew Consent|0
2304406|NCT02654002|4004599|FG003|Overall Study|Withdrew Consent|0
2304407|NCT02654002|4004600|FG004|Overall Study|Withdrew Consent|0
2304408|NCT02654002|4004601|FG005|Overall Study|Withdrew Consent|1
2304409|NCT02654002|4004602|FG006|Overall Study|Withdrew Consent|0
2304410|NCT02654002|4004603|FG007|Overall Study|Withdrew Consent|1
2304411|NCT02654002|4004604|FG008|Overall Study|Withdrew Consent|0
2304412|NCT02654054|4004642|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
2304413|NCT02654054|4004643|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
2304414|NCT02654054|4004644|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
2304415|NCT02654054|4004642|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
2078393|NCT00679783|3660665|FG003|Overall Study|Not Captured|5
2078394|NCT00679783|3660666|FG004|Overall Study|Not Captured|0
2078395|NCT00679783|3660667|FG005|Overall Study|Not Captured|0
2078396|NCT00679783|3660668|FG006|Overall Study|Not Captured|0
2078397|NCT00679783|3660662|FG000|Overall Study|Ongoing at data cut-off|2
2078398|NCT00679783|3660663|FG001|Overall Study|Ongoing at data cut-off|2
2078399|NCT00679783|3660664|FG002|Overall Study|Ongoing at data cut-off|0
2078400|NCT00679783|3660665|FG003|Overall Study|Ongoing at data cut-off|9
2078401|NCT00679783|3660666|FG004|Overall Study|Ongoing at data cut-off|1
2078402|NCT00679783|3660667|FG005|Overall Study|Ongoing at data cut-off|0
2078403|NCT00679783|3660668|FG006|Overall Study|Ongoing at data cut-off|0
2078404|NCT00679913|3660686|FG000|Overall Study|Protocol Violation|18
2078405|NCT00679913|3660687|FG001|Overall Study|Protocol Violation|13
2304416|NCT02654054|4004643|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2304417|NCT02654054|4004644|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13
2304418|NCT02654054|4004642|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
2304419|NCT02654054|4004643|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
2304420|NCT02654054|4004644|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
2304421|NCT02654054|4004642|FG000|Post-Treatment Follow-Up Period|Other|1
2304422|NCT02654054|4004643|FG001|Post-Treatment Follow-Up Period|Other|0
2304423|NCT02654054|4004644|FG002|Post-Treatment Follow-Up Period|Other|4
2304424|NCT02654054|4004642|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
2304425|NCT02654054|4004643|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
2304426|NCT02654054|4004644|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4
2304427|NCT02654145|4004653|FG000|Overall Study|Lack of Efficacy|1
2304428|NCT02654145|4004653|FG000|Overall Study|Protocol Violation|1
2078406|NCT00679939|3660696|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17
2078407|NCT00679939|3660697|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13
2078408|NCT00679939|3660696|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14
2078409|NCT00679939|3660697|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12
2078410|NCT00679939|3660696|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5
2304429|NCT02654145|4004653|FG000|Overall Study|Withdrawal by Subject|5
2304430|NCT02654717|4004696|FG000|Overall Study|Adverse Event|2
2078411|NCT00679939|3660697|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0
2078412|NCT00679939|3660696|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1
2078413|NCT00679939|3660697|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0
2078414|NCT00679939|3660696|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
2078415|NCT00679939|3660697|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
2078416|NCT00679939|3660696|FG000|24-Week Open-Label (OL) Period|Adverse Event|0
2078417|NCT00679939|3660697|FG001|24-Week Open-Label (OL) Period|Adverse Event|1
2078418|NCT00679939|3660696|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1
2078419|NCT00679939|3660697|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1
2078420|NCT00679939|3660696|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
2078421|NCT00679939|3660697|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
2078422|NCT00679939|3660696|FG000|24-Week Open-Label (OL) Period|Physician Decision|1
2078423|NCT00679939|3660697|FG001|24-Week Open-Label (OL) Period|Physician Decision|0
2078424|NCT00679939|3660696|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
2078425|NCT00679939|3660697|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
2078426|NCT00680017|3660718|FG000|Overall Study|Adverse Event|13
2078427|NCT00680017|3660719|FG001|Overall Study|Adverse Event|7
2078428|NCT00680017|3660718|FG000|Overall Study|Withdrawal by Subject|2
2078429|NCT00680017|3660719|FG001|Overall Study|Withdrawal by Subject|5
2078430|NCT00680017|3660718|FG000|Overall Study|Lost to Follow-up|2
2078431|NCT00680017|3660719|FG001|Overall Study|Lost to Follow-up|0
2078432|NCT00680043|3660728|FG000|Overall Study|Withdrawal by Subject|1
2078433|NCT00680043|3660729|FG001|Overall Study|Withdrawal by Subject|0
2078434|NCT00680043|3660730|FG002|Overall Study|Withdrawal by Subject|0
2078435|NCT00680043|3660728|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0
2078436|NCT00680043|3660729|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1
2078437|NCT00680043|3660730|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0
2078438|NCT00680043|3660728|FG000|Overall Study|Renal Transplant|1
2078439|NCT00680043|3660729|FG001|Overall Study|Renal Transplant|0
2078440|NCT00680043|3660730|FG002|Overall Study|Renal Transplant|4
2078441|NCT00680056|3660740|FG000|First Intervention|Mainly Exacerbation of COPD|1
2078442|NCT00680056|3660741|FG001|First Intervention|Mainly Exacerbation of COPD|2
2078443|NCT00680056|3660740|FG000|Second Intervention|Protocol Violation|3
2078444|NCT00680056|3660741|FG001|Second Intervention|Protocol Violation|1
2078445|NCT00680121|3660750|FG000|Overall Study|Lost to Follow-up|27
2078446|NCT00680121|3660751|FG001|Overall Study|Lost to Follow-up|23
2078447|NCT00680186|3660759|FG000|Overall Study|Adverse Event|47
2078448|NCT00680186|3660760|FG001|Overall Study|Adverse Event|44
2078449|NCT00680186|3660759|FG000|Overall Study|Protocol Violation|31
2078450|NCT00680186|3660760|FG001|Overall Study|Protocol Violation|26
2078451|NCT00680186|3660759|FG000|Overall Study|Lost to Follow-up|11
2078452|NCT00680186|3660760|FG001|Overall Study|Lost to Follow-up|6
2078453|NCT00680186|3660759|FG000|Overall Study|Withdrawal by Subject|32
2078454|NCT00680186|3660760|FG001|Overall Study|Withdrawal by Subject|39
2078455|NCT00680186|3660759|FG000|Overall Study|Other|4
2078456|NCT00680186|3660760|FG001|Overall Study|Other|1
2078457|NCT00680368|3660770|FG000|Overall Study|not supervised, not eligible|15
2078458|NCT00680407|3660779|FG000|Overall Study|Lost to Follow-up|3
2078459|NCT00680407|3660780|FG001|Overall Study|Lost to Follow-up|3
2078460|NCT00680407|3660781|FG002|Overall Study|Lost to Follow-up|1
2078461|NCT00680407|3660779|FG000|Overall Study|Withdrawal by Subject|5
2078462|NCT00680407|3660780|FG001|Overall Study|Withdrawal by Subject|2
2078463|NCT00680407|3660781|FG002|Overall Study|Withdrawal by Subject|2
2078464|NCT00680745|3660824|FG000|Overall Study|Withdrawal by Subject|8
2078465|NCT00680745|3660825|FG001|Overall Study|Withdrawal by Subject|3
2078466|NCT00680745|3660826|FG002|Overall Study|Withdrawal by Subject|2
2078467|NCT00680745|3660827|FG003|Overall Study|Withdrawal by Subject|8
2078468|NCT00680745|3660824|FG000|Overall Study|Lost to Follow-up|0
2078469|NCT00680745|3660825|FG001|Overall Study|Lost to Follow-up|1
2078470|NCT00680745|3660826|FG002|Overall Study|Lost to Follow-up|1
2078471|NCT00680745|3660827|FG003|Overall Study|Lost to Follow-up|0
2078472|NCT00680745|3660824|FG000|Overall Study|Death|1
2078473|NCT00680745|3660825|FG001|Overall Study|Death|0
2078474|NCT00680745|3660826|FG002|Overall Study|Death|1
2078475|NCT00680745|3660827|FG003|Overall Study|Death|0
2078476|NCT00680745|3660824|FG000|Overall Study|Adverse Event|5
2078477|NCT00680745|3660825|FG001|Overall Study|Adverse Event|3
2078478|NCT00680745|3660826|FG002|Overall Study|Adverse Event|3
2078479|NCT00680745|3660827|FG003|Overall Study|Adverse Event|3
2078480|NCT00680745|3660824|FG000|Overall Study|Poor/Non-compliance|0
2078481|NCT00680745|3660825|FG001|Overall Study|Poor/Non-compliance|3
2078482|NCT00680745|3660826|FG002|Overall Study|Poor/Non-compliance|0
2078483|NCT00680745|3660827|FG003|Overall Study|Poor/Non-compliance|0
2078484|NCT00680745|3660824|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
2078485|NCT00680745|3660825|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
2078486|NCT00680745|3660826|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
2078487|NCT00680745|3660827|FG003|Overall Study|Subject No Longer Meets Study Criteria|2
2078488|NCT00680745|3660824|FG000|Overall Study|False Treatment|0
2078489|NCT00680745|3660825|FG001|Overall Study|False Treatment|1
2078490|NCT00680745|3660826|FG002|Overall Study|False Treatment|3
2078491|NCT00680745|3660827|FG003|Overall Study|False Treatment|0
2078492|NCT00680771|3660840|FG000|Overall Study|Withdrawal by Subject|1
2078493|NCT00680771|3660841|FG001|Overall Study|Withdrawal by Subject|0
2078494|NCT00680771|3660840|FG000|Overall Study|Sleep Apnea suspected after PSG|1
2078495|NCT00680771|3660841|FG001|Overall Study|Sleep Apnea suspected after PSG|0
2078496|NCT00680771|3660840|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
2078497|NCT00680771|3660841|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
2078498|NCT00680836|3660879|FG000|Overall Study|Withdrawal by Subject|3
2078499|NCT00680836|3660880|FG001|Overall Study|Withdrawal by Subject|0
2078500|NCT00680836|3660879|FG000|Overall Study|Lost to Follow-up|3
2078501|NCT00680836|3660880|FG001|Overall Study|Lost to Follow-up|1
2078502|NCT00680836|3660879|FG000|Overall Study|Physician Decision|2
2078503|NCT00680836|3660880|FG001|Overall Study|Physician Decision|1
2078504|NCT00680901|3660893|FG000|Overall Study|Lost to Follow-up|8
2078505|NCT00680901|3660894|FG001|Overall Study|Lost to Follow-up|8
2078506|NCT00680901|3660893|FG000|Overall Study|Withdrawal by Subject|4
2078507|NCT00680901|3660894|FG001|Overall Study|Withdrawal by Subject|13
2078508|NCT00680901|3660893|FG000|Overall Study|Physician Decision|0
2078509|NCT00680901|3660894|FG001|Overall Study|Physician Decision|1
2078510|NCT00680901|3660893|FG000|Overall Study|Ongoing: On Study Treatment|16
2078511|NCT00680901|3660894|FG001|Overall Study|Ongoing: On Study Treatment|13
2078512|NCT00680901|3660893|FG000|Overall Study|Ongoing: In Follow Up|45
2078513|NCT00680901|3660894|FG001|Overall Study|Ongoing: In Follow Up|41
2078514|NCT00680914|3660902|FG000|Overall Study|Consent withdrawal|6
2078515|NCT00680914|3660903|FG001|Overall Study|Consent withdrawal|3
2078516|NCT00680914|3660902|FG000|Overall Study|Lost to Follow-up|4
2078517|NCT00680914|3660903|FG001|Overall Study|Lost to Follow-up|0
2078518|NCT00680914|3660902|FG000|Overall Study|serious adverse event (SAE)|0
2078519|NCT00680914|3660903|FG001|Overall Study|serious adverse event (SAE)|1
2078520|NCT00680992|3660925|FG000|Overall Study|Complete Resection (as per protocol)|25
2078521|NCT00680992|3660926|FG001|Overall Study|Complete Resection (as per protocol)|121
2078522|NCT00680992|3660927|FG002|Overall Study|Complete Resection (as per protocol)|0
2211011|NCT01656759|3851064|FG000|Overall Study|Protocol Violation|2
2211012|NCT01656759|3851065|FG001|Overall Study|Protocol Violation|3
2078523|NCT00680992|3660925|FG000|Overall Study|Administrative Decision|83
2078524|NCT00680992|3660926|FG001|Overall Study|Administrative Decision|42
2078525|NCT00680992|3660927|FG002|Overall Study|Administrative Decision|5
2078526|NCT00680992|3660925|FG000|Overall Study|End of Trial|32
2078527|NCT00680992|3660926|FG001|Overall Study|End of Trial|12
2078528|NCT00680992|3660927|FG002|Overall Study|End of Trial|3
2078529|NCT00680992|3660925|FG000|Overall Study|Withdrawal by Subject|33
2078530|NCT00680992|3660926|FG001|Overall Study|Withdrawal by Subject|11
2078531|NCT00680992|3660927|FG002|Overall Study|Withdrawal by Subject|1
2078532|NCT00680992|3660925|FG000|Overall Study|Adverse Event|21
2078533|NCT00680992|3660926|FG001|Overall Study|Adverse Event|19
2078534|NCT00680992|3660927|FG002|Overall Study|Adverse Event|1
2078535|NCT00680992|3660925|FG000|Overall Study|Other|19
2078536|NCT00680992|3660926|FG001|Overall Study|Other|14
2078537|NCT00680992|3660927|FG002|Overall Study|Other|1
2078538|NCT00680992|3660925|FG000|Overall Study|Disease Progression|21
2078539|NCT00680992|3660926|FG001|Overall Study|Disease Progression|9
2078540|NCT00680992|3660927|FG002|Overall Study|Disease Progression|0
2078541|NCT00680992|3660925|FG000|Overall Study|Lost to Follow-up|12
2078542|NCT00680992|3660926|FG001|Overall Study|Lost to Follow-up|14
2078543|NCT00680992|3660927|FG002|Overall Study|Lost to Follow-up|0
2078544|NCT00680992|3660925|FG000|Overall Study|Noncompliance|4
2211013|NCT01656850|3851082|FG000|First Intervention (3 Months)|Withdrawal by Subject|3
2211014|NCT01656850|3851083|FG001|First Intervention (3 Months)|Withdrawal by Subject|4
2211015|NCT01656889|3851095|FG000|Treatment Period, 12 Weeks|Adverse Event|10
2211016|NCT01656889|3851096|FG001|Treatment Period, 12 Weeks|Adverse Event|4
2211017|NCT01656889|3851095|FG000|Treatment Period, 12 Weeks|Death|0
2211018|NCT01656889|3851096|FG001|Treatment Period, 12 Weeks|Death|1
2211019|NCT01656889|3851095|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1
2211020|NCT01656889|3851096|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1
2211021|NCT01656889|3851095|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1
2211022|NCT01656889|3851096|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2
2211023|NCT01656889|3851095|FG000|Treatment Period, 12 Weeks|Protocol Violation|0
2078545|NCT00680992|3660926|FG001|Overall Study|Noncompliance|6
2078546|NCT00680992|3660927|FG002|Overall Study|Noncompliance|0
2078547|NCT00680992|3660925|FG000|Overall Study|Requirement for Alternative Therapy|8
2078548|NCT00680992|3660926|FG001|Overall Study|Requirement for Alternative Therapy|2
2078549|NCT00680992|3660927|FG002|Overall Study|Requirement for Alternative Therapy|0
2078550|NCT00680992|3660925|FG000|Overall Study|Pregnancy|5
2078551|NCT00680992|3660926|FG001|Overall Study|Pregnancy|0
2078552|NCT00680992|3660927|FG002|Overall Study|Pregnancy|1
2078553|NCT00680992|3660925|FG000|Overall Study|Death|5
2078554|NCT00680992|3660926|FG001|Overall Study|Death|1
2078555|NCT00680992|3660927|FG002|Overall Study|Death|0
2078556|NCT00680992|3660925|FG000|Overall Study|Ineligibility Determined|0
2078557|NCT00680992|3660926|FG001|Overall Study|Ineligibility Determined|1
2078558|NCT00680992|3660927|FG002|Overall Study|Ineligibility Determined|0
2211024|NCT01656889|3851096|FG001|Treatment Period, 12 Weeks|Protocol Violation|1
2211025|NCT01656889|3851095|FG000|Treatment Period, 12 Weeks|Moved out of the area|0
2211026|NCT01656889|3851096|FG001|Treatment Period, 12 Weeks|Moved out of the area|2
2078559|NCT00681109|3660950|FG000|Overall Study|Lost to Follow-up|2
2078560|NCT00681109|3660951|FG001|Overall Study|Lost to Follow-up|6
2078561|NCT00681109|3660952|FG002|Overall Study|Lost to Follow-up|0
2078562|NCT00681187|3660965|FG000|Overall Study|Withdrawal by Subject|1
2078563|NCT00681187|3660966|FG001|Overall Study|Withdrawal by Subject|0
2078564|NCT00681187|3660965|FG000|Overall Study|Death|0
2078565|NCT00681187|3660966|FG001|Overall Study|Death|1
2078566|NCT00681187|3660965|FG000|Overall Study|Adverse Event|0
2078567|NCT00681187|3660966|FG001|Overall Study|Adverse Event|1
2078568|NCT00681564|3661015|FG000|Overall Study|Lost to Follow-up|6
2078569|NCT00681564|3661016|FG001|Overall Study|Lost to Follow-up|6
2078570|NCT00681564|3661015|FG000|Overall Study|Withdrawal by Subject|0
2078571|NCT00681564|3661016|FG001|Overall Study|Withdrawal by Subject|1
2078572|NCT00681564|3661015|FG000|Overall Study|Death|0
2078573|NCT00681564|3661016|FG001|Overall Study|Death|1
2078574|NCT00681590|3661024|FG000|Overall Study|Withdrawal by Subject|2
2078575|NCT00681590|3661025|FG001|Overall Study|Withdrawal by Subject|12
2211027|NCT01656889|3851095|FG000|Post Treatment Follow-Up, 3 Months|Death|1
2211028|NCT01656889|3851096|FG001|Post Treatment Follow-Up, 3 Months|Death|5
2211029|NCT01656889|3851095|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
2211030|NCT01656889|3851096|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
2211031|NCT01656889|3851095|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
2211032|NCT01656889|3851096|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
2211033|NCT01656889|3851095|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0
2211034|NCT01656889|3851096|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1
2211035|NCT01656967|3851104|FG000|Overall Study|faulty monitor|1
2211036|NCT01656967|3851105|FG001|Overall Study|faulty monitor|0
2211037|NCT01656967|3851104|FG000|Overall Study|unsuccessful ETT insertion|3
2211038|NCT01656967|3851105|FG001|Overall Study|unsuccessful ETT insertion|2
2211039|NCT01657019|3851115|FG000|Overall Study|Withdrawal by Subject|65
2211040|NCT01657019|3851115|FG000|Overall Study|Adverse Event|55
2211041|NCT01657019|3851115|FG000|Overall Study|Lost to Follow-up|48
2211042|NCT01657019|3851115|FG000|Overall Study|Protocol Violation|6
2211043|NCT01657019|3851115|FG000|Overall Study|Lack of Efficacy|3
2211044|NCT01657019|3851115|FG000|Overall Study|Other|58
2211045|NCT01657032|3851121|FG000|Overall Study|Lost to Follow-up|0
2211046|NCT01657032|3851122|FG001|Overall Study|Lost to Follow-up|7
2211047|NCT01657162|3851130|FG000|Overall Study|Adverse Event|26
2211048|NCT01657162|3851131|FG001|Overall Study|Adverse Event|36
2211049|NCT01657162|3851130|FG000|Overall Study|Withdrawal by Subject|13
2211050|NCT01657162|3851131|FG001|Overall Study|Withdrawal by Subject|13
2211051|NCT01657162|3851130|FG000|Overall Study|Continuing Significant Deterioration|9
2211052|NCT01657162|3851131|FG001|Overall Study|Continuing Significant Deterioration|3
2078576|NCT00681668|3661031|FG000|Overall Study|Protocol Violation|1
2078577|NCT00681668|3661031|FG000|Overall Study|Withdrawal by Subject|1
2078578|NCT00681811|3661037|FG000|Overall Study|Adverse Event|1
2078579|NCT00681811|3661038|FG001|Overall Study|Adverse Event|1
2078580|NCT00681811|3661037|FG000|Overall Study|Withdrawal by Subject|2
2078581|NCT00681811|3661038|FG001|Overall Study|Withdrawal by Subject|2
2078582|NCT00681811|3661037|FG000|Overall Study|Non-compliance|0
2078583|NCT00681811|3661038|FG001|Overall Study|Non-compliance|1
2078584|NCT00681824|3661058|FG000|Overall Study|withdrawn by investigator|0
2078585|NCT00681824|3661059|FG001|Overall Study|withdrawn by investigator|0
2078586|NCT00681824|3661060|FG002|Overall Study|withdrawn by investigator|1
2078587|NCT00681824|3661058|FG000|Overall Study|scheduling conflict|1
2078588|NCT00681824|3661059|FG001|Overall Study|scheduling conflict|0
2078589|NCT00681824|3661060|FG002|Overall Study|scheduling conflict|0
2078590|NCT00681824|3661058|FG000|Overall Study|Death|0
2078591|NCT00681824|3661059|FG001|Overall Study|Death|1
2078592|NCT00681824|3661060|FG002|Overall Study|Death|0
2078593|NCT00681863|3661068|FG000|Overall Study|Adverse Event|1
2078594|NCT00681863|3661068|FG000|Overall Study|Lost to Follow-up|2
2078595|NCT00681863|3661068|FG000|Overall Study|Lack of Efficacy|2
2078596|NCT00681863|3661068|FG000|Overall Study|Other|18
2078597|NCT00682435|3661089|FG000|Overall Study|Insufficient data|5
2078598|NCT00682435|3661089|FG000|Overall Study|Erroneously enrolled twice|2
2078599|NCT00682448|3661095|FG000|Overall Study|Adverse Event|1
2078600|NCT00682448|3661096|FG001|Overall Study|Adverse Event|2
2078601|NCT00682448|3661095|FG000|Overall Study|Lack of Efficacy|1
2078602|NCT00682448|3661096|FG001|Overall Study|Lack of Efficacy|0
2078603|NCT00682448|3661095|FG000|Overall Study|Lost to Follow-up|1
2078604|NCT00682448|3661096|FG001|Overall Study|Lost to Follow-up|3
2078605|NCT00682448|3661095|FG000|Overall Study|Pregnancy|0
2078606|NCT00682448|3661096|FG001|Overall Study|Pregnancy|1
2078607|NCT00682448|3661095|FG000|Overall Study|Withdrawal by Subject|2
2078608|NCT00682448|3661096|FG001|Overall Study|Withdrawal by Subject|0
2078609|NCT00682461|3661104|FG000|Overall Study|Adverse Event|5
2078610|NCT00682461|3661105|FG001|Overall Study|Adverse Event|7
2078611|NCT00682461|3661104|FG000|Overall Study|Lost to Follow-up|8
2078612|NCT00682461|3661105|FG001|Overall Study|Lost to Follow-up|5
2078613|NCT00682461|3661104|FG000|Overall Study|Withdrawal by Subject|12
2211053|NCT01657162|3851130|FG000|Overall Study|Refusal of Treatment|4
2211054|NCT01657162|3851131|FG001|Overall Study|Refusal of Treatment|6
2211055|NCT01657162|3851130|FG000|Overall Study|Lost to Follow-up|3
2211056|NCT01657162|3851131|FG001|Overall Study|Lost to Follow-up|4
2078614|NCT00682461|3661105|FG001|Overall Study|Withdrawal by Subject|19
2078615|NCT00682539|3661115|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
2078616|NCT00682539|3661116|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
2078617|NCT00682539|3661117|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
2078618|NCT00682539|3661115|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
2078619|NCT00682539|3661116|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
2078620|NCT00682539|3661117|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
2078621|NCT00682643|3661150|FG000|Overall Study|Adverse Event|12
2078622|NCT00682643|3661151|FG001|Overall Study|Adverse Event|23
2078623|NCT00682643|3661150|FG000|Overall Study|Lack of Efficacy|2
2078624|NCT00682643|3661151|FG001|Overall Study|Lack of Efficacy|0
2078625|NCT00682643|3661150|FG000|Overall Study|Protocol Violation|38
2078626|NCT00682643|3661151|FG001|Overall Study|Protocol Violation|76
2078627|NCT00682643|3661150|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
2078628|NCT00682643|3661151|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4
2078629|NCT00682643|3661150|FG000|Overall Study|Lost to Follow-up|1
2078630|NCT00682643|3661151|FG001|Overall Study|Lost to Follow-up|6
2078631|NCT00682643|3661150|FG000|Overall Study|Physician Decision|2
2078632|NCT00682643|3661151|FG001|Overall Study|Physician Decision|6
2078633|NCT00682643|3661150|FG000|Overall Study|Withdrawal by Subject|19
2078634|NCT00682643|3661151|FG001|Overall Study|Withdrawal by Subject|53
2078635|NCT00682643|3661150|FG000|Overall Study|Did Not Receive Study Drug|1
2078636|NCT00682643|3661151|FG001|Overall Study|Did Not Receive Study Drug|1
2078637|NCT00682786|3661173|FG000|Overall Study|Withdrawal by Subject|2
2078638|NCT00682786|3661174|FG001|Overall Study|Withdrawal by Subject|2
2078639|NCT00682786|3661173|FG000|Overall Study|Did not receive irinotecan|0
2078640|NCT00682786|3661174|FG001|Overall Study|Did not receive irinotecan|1
2078641|NCT00682890|3661214|FG000|Overall Study|Lost to Follow-up|1
2078642|NCT00682890|3661215|FG001|Overall Study|Lost to Follow-up|1
2078643|NCT00682890|3661214|FG000|Overall Study|subject moved away|0
2078644|NCT00682890|3661215|FG001|Overall Study|subject moved away|1
2078645|NCT00682890|3661214|FG000|Overall Study|heavy menstrual bleeding|1
2078646|NCT00682890|3661215|FG001|Overall Study|heavy menstrual bleeding|0
2078647|NCT00682929|3661224|FG000|Overall Study|Adverse Event|4
2078648|NCT00682929|3661225|FG001|Overall Study|Adverse Event|1
2078649|NCT00682929|3661226|FG002|Overall Study|Adverse Event|1
2078650|NCT00682929|3661224|FG000|Overall Study|Withdrawal by Subject|1
2078651|NCT00682929|3661225|FG001|Overall Study|Withdrawal by Subject|2
2078652|NCT00682929|3661226|FG002|Overall Study|Withdrawal by Subject|1
2078653|NCT00682929|3661224|FG000|Overall Study|dosing compliance < 80%|0
2078654|NCT00682929|3661225|FG001|Overall Study|dosing compliance < 80%|2
2078655|NCT00682929|3661226|FG002|Overall Study|dosing compliance < 80%|0
2078656|NCT00682929|3661224|FG000|Overall Study|lag in DEA renewal|1
2078657|NCT00682929|3661225|FG001|Overall Study|lag in DEA renewal|0
2078658|NCT00682929|3661226|FG002|Overall Study|lag in DEA renewal|0
2078659|NCT00683293|3661262|FG000|Overall Study|Withdrawal by Subject|2
2078660|NCT00683293|3661263|FG001|Overall Study|Withdrawal by Subject|3
2078661|NCT00683384|3661273|FG000|Overall Study|Death|1
2078662|NCT00683384|3661273|FG000|Overall Study|Adverse Event|1
2078663|NCT00683449|3661286|FG000|Overall Study|Lost to Follow-up|0
2078664|NCT00683449|3661287|FG001|Overall Study|Lost to Follow-up|1
2078665|NCT00683449|3661288|FG002|Overall Study|Lost to Follow-up|0
2078666|NCT00683449|3661289|FG003|Overall Study|Lost to Follow-up|0
2078667|NCT00683449|3661290|FG004|Overall Study|Lost to Follow-up|0
2078668|NCT00683475|3661309|FG000|Overall Study|Withdrawal by Subject|1
2078669|NCT00683475|3661310|FG001|Overall Study|Withdrawal by Subject|0
2078670|NCT00683475|3661309|FG000|Overall Study|Never Treated: Adverse Event|2
2078671|NCT00683475|3661310|FG001|Overall Study|Never Treated: Adverse Event|3
2078672|NCT00683475|3661309|FG000|Overall Study|Never Treated: Progressive Disease|1
2078673|NCT00683475|3661310|FG001|Overall Study|Never Treated: Progressive Disease|0
2078674|NCT00683592|3661319|FG000|Overall Study|Adverse Event|12
2078675|NCT00683592|3661320|FG001|Overall Study|Adverse Event|4
2078676|NCT00683592|3661319|FG000|Overall Study|Withdrawal by Subject|11
2078677|NCT00683592|3661320|FG001|Overall Study|Withdrawal by Subject|11
2078678|NCT00683592|3661319|FG000|Overall Study|Lost to Follow-up|17
2078679|NCT00683592|3661320|FG001|Overall Study|Lost to Follow-up|17
2078680|NCT00683592|3661319|FG000|Overall Study|Lack of Efficacy|3
2078681|NCT00683592|3661320|FG001|Overall Study|Lack of Efficacy|7
2078682|NCT00683592|3661319|FG000|Overall Study|Physician Decision|0
2078683|NCT00683592|3661320|FG001|Overall Study|Physician Decision|1
2078684|NCT00683592|3661319|FG000|Overall Study|Non-compliance|3
2304431|NCT02654717|4004697|FG001|Overall Study|Adverse Event|2
2304432|NCT02654717|4004696|FG000|Overall Study|Protocol Violation|1
2304433|NCT02654717|4004697|FG001|Overall Study|Protocol Violation|2
2304434|NCT02654717|4004696|FG000|Overall Study|Withdrawal by Subject|0
2304435|NCT02654717|4004697|FG001|Overall Study|Withdrawal by Subject|1
2304436|NCT02654717|4004696|FG000|Overall Study|Non-permitted medication|3
2304437|NCT02654717|4004697|FG001|Overall Study|Non-permitted medication|0
2078685|NCT00683592|3661320|FG001|Overall Study|Non-compliance|5
2078686|NCT00683592|3661319|FG000|Overall Study|Other|1
2078687|NCT00683592|3661320|FG001|Overall Study|Other|1
2078688|NCT00683618|3661329|FG000|Randomised Treatment Period|Withdrawal by Subject|4
2304438|NCT02654977|4004754|FG000|Overall Study|Death|1
2304439|NCT02654977|4004754|FG000|Overall Study|Lost to Follow-up|1
2078689|NCT00683618|3661330|FG001|Randomised Treatment Period|Withdrawal by Subject|1
2078690|NCT00683618|3661331|FG002|Randomised Treatment Period|Withdrawal by Subject|2
2078691|NCT00683618|3661329|FG000|Randomised Treatment Period|Protocol Violation|0
2078692|NCT00683618|3661330|FG001|Randomised Treatment Period|Protocol Violation|1
2078693|NCT00683618|3661331|FG002|Randomised Treatment Period|Protocol Violation|0
2078694|NCT00683618|3661329|FG000|Randomised Treatment Period|Adverse Event|2
2078695|NCT00683618|3661330|FG001|Randomised Treatment Period|Adverse Event|0
2078696|NCT00683618|3661331|FG002|Randomised Treatment Period|Adverse Event|2
2078697|NCT00683618|3661329|FG000|Randomised Treatment Period|Reason not provided|0
2078698|NCT00683618|3661330|FG001|Randomised Treatment Period|Reason not provided|0
2078699|NCT00683618|3661331|FG002|Randomised Treatment Period|Reason not provided|2
2078700|NCT00683618|3661329|FG000|Extension Treatment Period|Withdrawal by Subject|1
2078701|NCT00683618|3661330|FG001|Extension Treatment Period|Withdrawal by Subject|0
2078702|NCT00683618|3661331|FG002|Extension Treatment Period|Withdrawal by Subject|0
2078703|NCT00683618|3661329|FG000|Extension Treatment Period|Adverse Event|1
2078704|NCT00683618|3661330|FG001|Extension Treatment Period|Adverse Event|0
2078705|NCT00683618|3661331|FG002|Extension Treatment Period|Adverse Event|0
2078706|NCT00683618|3661329|FG000|Extension Treatment Period|Protocol Violation|1
2078707|NCT00683618|3661330|FG001|Extension Treatment Period|Protocol Violation|0
2078708|NCT00683618|3661331|FG002|Extension Treatment Period|Protocol Violation|0
2078709|NCT00683644|3661343|FG000|Overall Study|Withdrawal by Subject|4
2078710|NCT00683644|3661344|FG001|Overall Study|Withdrawal by Subject|2
2078711|NCT00683644|3661343|FG000|Overall Study|Lost to Follow-up|1
2078712|NCT00683644|3661344|FG001|Overall Study|Lost to Follow-up|4
2078713|NCT00683644|3661343|FG000|Overall Study|Adverse Event|1
2078714|NCT00683644|3661344|FG001|Overall Study|Adverse Event|2
2078715|NCT00683644|3661343|FG000|Overall Study|Low copper, other health problems,|7
2078716|NCT00683644|3661344|FG001|Overall Study|Low copper, other health problems,|6
2078717|NCT00683657|3661356|FG000|Overall Study|Adverse Event|0
2078718|NCT00683657|3661357|FG001|Overall Study|Adverse Event|1
2078719|NCT00683657|3661356|FG000|Overall Study|Subject Withdrew Consent|1
2078720|NCT00683657|3661357|FG001|Overall Study|Subject Withdrew Consent|0
2078721|NCT00683696|3661365|FG000|Overall Study|Withdrawn due to study closure|337
2078722|NCT00683696|3661366|FG001|Overall Study|Withdrawn due to study closure|338
2078723|NCT00683696|3661365|FG000|Overall Study|Withdrawn prior to study closure|13
2078724|NCT00683696|3661366|FG001|Overall Study|Withdrawn prior to study closure|28
2078725|NCT00683696|3661365|FG000|Overall Study|Lost to Follow-up|5
2078726|NCT00683696|3661366|FG001|Overall Study|Lost to Follow-up|6
2078727|NCT00683696|3661365|FG000|Overall Study|Vital status follow-up only|3
2078728|NCT00683696|3661366|FG001|Overall Study|Vital status follow-up only|3
2078729|NCT00683696|3661365|FG000|Overall Study|Death|46
2078730|NCT00683696|3661366|FG001|Overall Study|Death|30
2078731|NCT00683774|3661375|FG000|Overall Study|Withdrawal by Subject|0
2078732|NCT00683774|3661376|FG001|Overall Study|Withdrawal by Subject|1
2078733|NCT00683774|3661375|FG000|Overall Study|Physician Decision|3
2078734|NCT00683774|3661376|FG001|Overall Study|Physician Decision|0
2078735|NCT00683800|3661384|FG000|Overall Study|Adverse Event|195
2078736|NCT00683800|3661385|FG001|Overall Study|Adverse Event|102
2078737|NCT00683800|3661384|FG000|Overall Study|Death|0
2078738|NCT00683800|3661385|FG001|Overall Study|Death|1
2078739|NCT00683800|3661384|FG000|Overall Study|Lost to Follow-up|57
2078740|NCT00683800|3661385|FG001|Overall Study|Lost to Follow-up|44
2078741|NCT00683800|3661384|FG000|Overall Study|Other|5
2078742|NCT00683800|3661385|FG001|Overall Study|Other|2
2078743|NCT00683800|3661384|FG000|Overall Study|Protocol Violation|13
2078744|NCT00683800|3661385|FG001|Overall Study|Protocol Violation|16
2078745|NCT00683800|3661384|FG000|Overall Study|Withdrawal by Subject|66
2078746|NCT00683800|3661385|FG001|Overall Study|Withdrawal by Subject|64
2078747|NCT00683800|3661384|FG000|Overall Study|Lack of Efficacy|61
2078748|NCT00683800|3661385|FG001|Overall Study|Lack of Efficacy|104
2078749|NCT00683800|3661384|FG000|Overall Study|Randomized, not treated|35
2078750|NCT00683800|3661385|FG001|Overall Study|Randomized, not treated|33
2106716|NCT00868231|3700094|FG003|Treatment Period 1|Adverse Event|0
2106717|NCT00868231|3700095|FG004|Treatment Period 1|Adverse Event|1
2106718|NCT00868231|3700096|FG005|Treatment Period 1|Adverse Event|0
2106719|NCT00868231|3700091|FG000|Treatment Period 2|Adverse Event|1
2106720|NCT00868231|3700092|FG001|Treatment Period 2|Adverse Event|0
2106721|NCT00868231|3700093|FG002|Treatment Period 2|Adverse Event|0
2106722|NCT00868231|3700094|FG003|Treatment Period 2|Adverse Event|0
2106723|NCT00868231|3700095|FG004|Treatment Period 2|Adverse Event|0
2106724|NCT00868231|3700096|FG005|Treatment Period 2|Adverse Event|0
2106725|NCT00868231|3700091|FG000|Treatment Period 3|Adverse Event|0
2106726|NCT00868231|3700092|FG001|Treatment Period 3|Adverse Event|0
2106727|NCT00868231|3700093|FG002|Treatment Period 3|Adverse Event|1
2106728|NCT00868231|3700094|FG003|Treatment Period 3|Adverse Event|0
2106729|NCT00868231|3700095|FG004|Treatment Period 3|Adverse Event|0
2106730|NCT00868231|3700096|FG005|Treatment Period 3|Adverse Event|0
2106731|NCT00868296|3700106|FG000|Overall Study|Adverse Event|0
2106732|NCT00868296|3700107|FG001|Overall Study|Adverse Event|2
2106733|NCT00868296|3700106|FG000|Overall Study|Withdrawal by Subject|0
2106734|NCT00868296|3700107|FG001|Overall Study|Withdrawal by Subject|1
2106735|NCT00868439|3700142|FG000|Overall Study|Adverse Event|4
2106736|NCT00868439|3700143|FG001|Overall Study|Adverse Event|3
2078751|NCT00683878|3661424|FG000|Overall Study|Lack of Efficacy|3
2078752|NCT00683878|3661425|FG001|Overall Study|Lack of Efficacy|0
2078753|NCT00683878|3661426|FG002|Overall Study|Lack of Efficacy|1
2078754|NCT00683878|3661424|FG000|Overall Study|Adverse Event|4
2078755|NCT00683878|3661425|FG001|Overall Study|Adverse Event|3
2078756|NCT00683878|3661426|FG002|Overall Study|Adverse Event|3
2078757|NCT00683878|3661424|FG000|Overall Study|Withdrawal by Subject|9
2078758|NCT00683878|3661425|FG001|Overall Study|Withdrawal by Subject|8
2078759|NCT00683878|3661426|FG002|Overall Study|Withdrawal by Subject|6
2078760|NCT00683878|3661424|FG000|Overall Study|Death|0
2078761|NCT00683878|3661425|FG001|Overall Study|Death|1
2078762|NCT00683878|3661426|FG002|Overall Study|Death|0
2078763|NCT00683878|3661424|FG000|Overall Study|Lost to Follow-up|4
2078764|NCT00683878|3661425|FG001|Overall Study|Lost to Follow-up|2
2078765|NCT00683878|3661426|FG002|Overall Study|Lost to Follow-up|4
2078766|NCT00683878|3661424|FG000|Overall Study|Non-compliance, not met criteria etc.|3
2078767|NCT00683878|3661425|FG001|Overall Study|Non-compliance, not met criteria etc.|2
2078768|NCT00683878|3661426|FG002|Overall Study|Non-compliance, not met criteria etc.|0
2078769|NCT00683904|3661436|FG000|Dose Level 1|Disease progression|2
2078770|NCT00683904|3661437|FG001|Dose Level 1|Disease progression|0
2078771|NCT00683904|3661436|FG000|Dose Level 1|Adverse Event|1
2078772|NCT00683904|3661437|FG001|Dose Level 1|Adverse Event|0
2078773|NCT00683904|3661436|FG000|Dose Level 2|Adverse Event|0
2078774|NCT00683904|3661437|FG001|Dose Level 2|Adverse Event|2
2078775|NCT00684021|3661467|FG000|Overall Study|MRI Contraindicated|1
2078776|NCT00684021|3661468|FG001|Overall Study|MRI Contraindicated|1
2078777|NCT00684021|3661469|FG002|Overall Study|MRI Contraindicated|1
2078778|NCT00684021|3661470|FG003|Overall Study|MRI Contraindicated|0
2078779|NCT00684021|3661467|FG000|Overall Study|MRI not performed|0
2078780|NCT00684021|3661468|FG001|Overall Study|MRI not performed|1
2078781|NCT00684021|3661469|FG002|Overall Study|MRI not performed|1
2078782|NCT00684021|3661470|FG003|Overall Study|MRI not performed|2
2078783|NCT00684021|3661467|FG000|Overall Study|Death|1
2078784|NCT00684021|3661468|FG001|Overall Study|Death|0
2078785|NCT00684021|3661469|FG002|Overall Study|Death|0
2078786|NCT00684021|3661470|FG003|Overall Study|Death|0
2211057|NCT01657162|3851130|FG000|Overall Study|Death|2
2211058|NCT01657162|3851131|FG001|Overall Study|Death|3
2211059|NCT01657162|3851130|FG000|Overall Study|Inability to Complete Study Procedures|1
2211060|NCT01657162|3851131|FG001|Overall Study|Inability to Complete Study Procedures|7
2211061|NCT01657162|3851130|FG000|Overall Study|Protocol Violation|1
2211062|NCT01657162|3851131|FG001|Overall Study|Protocol Violation|0
2211063|NCT01657162|3851130|FG000|Overall Study|Hypersensitivity to Alendronate|0
2211064|NCT01657162|3851131|FG001|Overall Study|Hypersensitivity to Alendronate|1
2211065|NCT01657162|3851130|FG000|Overall Study|Other than Specified|0
2078787|NCT00684060|3661495|FG000|Overall Study|Lost to Follow-up|1
2078788|NCT00684060|3661496|FG001|Overall Study|Lost to Follow-up|0
2211066|NCT01657162|3851131|FG001|Overall Study|Other than Specified|2
2211067|NCT01657253|3851139|FG000|Overall Study|Lost to Follow-up|6
2211068|NCT01657253|3851140|FG001|Overall Study|Lost to Follow-up|5
2211069|NCT01657253|3851139|FG000|Overall Study|Withdrawal by Subject|11
2211070|NCT01657253|3851140|FG001|Overall Study|Withdrawal by Subject|12
2211071|NCT01657253|3851139|FG000|Overall Study|Adverse Event|0
2211072|NCT01657253|3851140|FG001|Overall Study|Adverse Event|1
2211073|NCT01657266|3851148|FG000|Overall Study|Lost to Follow-up|2
2211074|NCT01657266|3851149|FG001|Overall Study|Lost to Follow-up|2
2078789|NCT00684060|3661495|FG000|Overall Study|New stenosis identified|1
2078790|NCT00684060|3661496|FG001|Overall Study|New stenosis identified|0
2078791|NCT00684060|3661495|FG000|Overall Study|Unable to collect MRI|1
2078792|NCT00684060|3661496|FG001|Overall Study|Unable to collect MRI|2
2078793|NCT00684060|3661495|FG000|Overall Study|Death|0
2078794|NCT00684060|3661496|FG001|Overall Study|Death|1
2078795|NCT00684073|3661502|FG000|Selection|Selection/non-selection criteria|3
2078796|NCT00684073|3661502|FG000|Selection|Death|1
2078797|NCT00684073|3661502|FG000|Selection|noncompliance|1
2078798|NCT00684073|3661502|FG000|Selection|Lost to Follow-up|1
2078799|NCT00684073|3661502|FG000|Selection|request of the sponsor|1
2078800|NCT00684073|3661502|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
2078801|NCT00684177|3661523|FG000|Overall Study|Adverse Event|4
2078802|NCT00684177|3661524|FG001|Overall Study|Adverse Event|3
2078803|NCT00684177|3661523|FG000|Overall Study|Lack of Efficacy|10
2078804|NCT00684177|3661524|FG001|Overall Study|Lack of Efficacy|15
2078805|NCT00684177|3661523|FG000|Overall Study|Protocol Violation|1
2078806|NCT00684177|3661524|FG001|Overall Study|Protocol Violation|0
2078807|NCT00684177|3661523|FG000|Overall Study|Lost to Follow-up|2
2078808|NCT00684177|3661524|FG001|Overall Study|Lost to Follow-up|1
2078809|NCT00684177|3661523|FG000|Overall Study|Physician Decision|2
2078810|NCT00684177|3661524|FG001|Overall Study|Physician Decision|0
2078811|NCT00684177|3661523|FG000|Overall Study|Withdrawal by Subject|1
2078812|NCT00684177|3661524|FG001|Overall Study|Withdrawal by Subject|2
2078813|NCT00684177|3661523|FG000|Overall Study|Other|1
2078814|NCT00684177|3661524|FG001|Overall Study|Other|2
2078815|NCT00684203|3661536|FG000|Overall Study|Adverse Event|6
2078816|NCT00684203|3661537|FG001|Overall Study|Adverse Event|4
2078817|NCT00684203|3661538|FG002|Overall Study|Adverse Event|8
2078818|NCT00684203|3661539|FG003|Overall Study|Adverse Event|0
2078819|NCT00684203|3661540|FG004|Overall Study|Adverse Event|0
2078820|NCT00684203|3661541|FG005|Overall Study|Adverse Event|0
2078821|NCT00684203|3661536|FG000|Overall Study|Protocol-defined clinical event|3
2078822|NCT00684203|3661537|FG001|Overall Study|Protocol-defined clinical event|1
2078823|NCT00684203|3661538|FG002|Overall Study|Protocol-defined clinical event|0
2078824|NCT00684203|3661539|FG003|Overall Study|Protocol-defined clinical event|0
2078825|NCT00684203|3661540|FG004|Overall Study|Protocol-defined clinical event|0
2078826|NCT00684203|3661541|FG005|Overall Study|Protocol-defined clinical event|0
2078827|NCT00684203|3661536|FG000|Overall Study|Withdrawal by Subject|0
2078828|NCT00684203|3661537|FG001|Overall Study|Withdrawal by Subject|2
2078829|NCT00684203|3661538|FG002|Overall Study|Withdrawal by Subject|1
2078830|NCT00684203|3661539|FG003|Overall Study|Withdrawal by Subject|0
2078831|NCT00684203|3661540|FG004|Overall Study|Withdrawal by Subject|0
2078832|NCT00684203|3661541|FG005|Overall Study|Withdrawal by Subject|0
2078833|NCT00684203|3661536|FG000|Overall Study|Did not meet protocol eligibility|0
2078834|NCT00684203|3661537|FG001|Overall Study|Did not meet protocol eligibility|1
2078835|NCT00684203|3661538|FG002|Overall Study|Did not meet protocol eligibility|0
2211075|NCT01657266|3851148|FG000|Overall Study|Adverse Event|2
2211076|NCT01657266|3851149|FG001|Overall Study|Adverse Event|3
2211077|NCT01657292|3851155|FG000|Overall Study|Adverse Event|6
2211078|NCT01657292|3851155|FG000|Overall Study|Withdrawal by Subject|2
2211079|NCT01657292|3851155|FG000|Overall Study|Violation of eligibility criteria|1
2211080|NCT01657292|3851155|FG000|Overall Study|Change of therapy|1
2211081|NCT01657305|3851162|FG000|Overall Study|Lack of Wound Closure at Day 28|15
2211082|NCT01657305|3851162|FG000|Overall Study|Withdrawal by Subject|4
2211083|NCT01657305|3851162|FG000|Overall Study|Adverse Event|1
2211084|NCT01657305|3851162|FG000|Overall Study|Lost to Follow-up|1
2211085|NCT01657305|3851162|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4
2211086|NCT01657370|3851224|FG000|Overall Study|Withdrawal by Subject|0
2211087|NCT01657370|3851225|FG001|Overall Study|Withdrawal by Subject|0
2211088|NCT01657370|3851226|FG002|Overall Study|Withdrawal by Subject|1
2211089|NCT01657370|3851227|FG003|Overall Study|Withdrawal by Subject|0
2211090|NCT01657370|3851228|FG004|Overall Study|Withdrawal by Subject|0
2211091|NCT01657370|3851229|FG005|Overall Study|Withdrawal by Subject|1
2211092|NCT01657370|3851224|FG000|Overall Study|Physician Decision|2
2078836|NCT00684203|3661539|FG003|Overall Study|Did not meet protocol eligibility|0
2078837|NCT00684203|3661540|FG004|Overall Study|Did not meet protocol eligibility|0
2078838|NCT00684203|3661541|FG005|Overall Study|Did not meet protocol eligibility|0
2078839|NCT00684307|3661571|FG000|Overall Study|Adverse Event|11
2078840|NCT00684307|3661572|FG001|Overall Study|Adverse Event|6
2078841|NCT00684307|3661573|FG002|Overall Study|Adverse Event|15
2078842|NCT00684307|3661574|FG003|Overall Study|Adverse Event|16
2078843|NCT00684307|3661575|FG004|Overall Study|Adverse Event|8
2078844|NCT00684307|3661571|FG000|Overall Study|Development of increasing Liver Function|0
2078845|NCT00684307|3661572|FG001|Overall Study|Development of increasing Liver Function|2
2078846|NCT00684307|3661573|FG002|Overall Study|Development of increasing Liver Function|0
2078847|NCT00684307|3661574|FG003|Overall Study|Development of increasing Liver Function|1
2078848|NCT00684307|3661575|FG004|Overall Study|Development of increasing Liver Function|0
2078849|NCT00684307|3661571|FG000|Overall Study|Fullfillment of exclusion criteria|1
2078850|NCT00684307|3661572|FG001|Overall Study|Fullfillment of exclusion criteria|0
2078851|NCT00684307|3661573|FG002|Overall Study|Fullfillment of exclusion criteria|0
2078852|NCT00684307|3661574|FG003|Overall Study|Fullfillment of exclusion criteria|3
2078853|NCT00684307|3661575|FG004|Overall Study|Fullfillment of exclusion criteria|1
2078854|NCT00684307|3661571|FG000|Overall Study|Incorrect enrolment or randomization|4
2078855|NCT00684307|3661572|FG001|Overall Study|Incorrect enrolment or randomization|0
2078856|NCT00684307|3661573|FG002|Overall Study|Incorrect enrolment or randomization|0
2078857|NCT00684307|3661574|FG003|Overall Study|Incorrect enrolment or randomization|0
2078858|NCT00684307|3661575|FG004|Overall Study|Incorrect enrolment or randomization|0
2078859|NCT00684307|3661571|FG000|Overall Study|Interupted IP for more than 7 days|0
2078860|NCT00684307|3661572|FG001|Overall Study|Interupted IP for more than 7 days|4
2078861|NCT00684307|3661573|FG002|Overall Study|Interupted IP for more than 7 days|1
2078862|NCT00684307|3661574|FG003|Overall Study|Interupted IP for more than 7 days|3
2078863|NCT00684307|3661575|FG004|Overall Study|Interupted IP for more than 7 days|3
2078864|NCT00684307|3661571|FG000|Overall Study|Severe non compliance to protocol|1
2078865|NCT00684307|3661572|FG001|Overall Study|Severe non compliance to protocol|0
2078866|NCT00684307|3661573|FG002|Overall Study|Severe non compliance to protocol|0
2078867|NCT00684307|3661574|FG003|Overall Study|Severe non compliance to protocol|1
2078868|NCT00684307|3661575|FG004|Overall Study|Severe non compliance to protocol|2
2078869|NCT00684307|3661571|FG000|Overall Study|Participant not willing to continue|7
2078870|NCT00684307|3661572|FG001|Overall Study|Participant not willing to continue|10
2078871|NCT00684307|3661573|FG002|Overall Study|Participant not willing to continue|11
2078872|NCT00684307|3661574|FG003|Overall Study|Participant not willing to continue|5
2078873|NCT00684307|3661575|FG004|Overall Study|Participant not willing to continue|8
2078874|NCT00684307|3661571|FG000|Overall Study|Criteria from the CSR|0
2078875|NCT00684307|3661572|FG001|Overall Study|Criteria from the CSR|0
2078876|NCT00684307|3661573|FG002|Overall Study|Criteria from the CSR|1
2078877|NCT00684307|3661574|FG003|Overall Study|Criteria from the CSR|3
2211093|NCT01657370|3851225|FG001|Overall Study|Physician Decision|3
2078878|NCT00684307|3661575|FG004|Overall Study|Criteria from the CSR|3
2078879|NCT00684411|3661596|FG000|Overall Study|New Primary Cancer|1
2078880|NCT00684411|3661596|FG000|Overall Study|Disease Progression|10
2078881|NCT00684411|3661596|FG000|Overall Study|Adverse Event|1
2078882|NCT00684424|3661600|FG000|Overall Study|Adverse Event|1
2078883|NCT00684424|3661600|FG000|Overall Study|Lost to Follow-up|2
2078884|NCT00684424|3661600|FG000|Overall Study|Other|2
2078885|NCT00684515|3661608|FG000|Overall Study|Adverse Event|3
2078886|NCT00684515|3661609|FG001|Overall Study|Adverse Event|3
2078887|NCT00684515|3661610|FG002|Overall Study|Adverse Event|1
2078888|NCT00684515|3661608|FG000|Overall Study|Protocol-Defined Clinical Event|1
2078889|NCT00684515|3661609|FG001|Overall Study|Protocol-Defined Clinical Event|0
2078890|NCT00684515|3661610|FG002|Overall Study|Protocol-Defined Clinical Event|0
2078891|NCT00684567|3661637|FG000|Concomitant Radiotherapy Period|Adverse Event|2
2078892|NCT00684567|3661637|FG000|Monotherapy Period|Adverse Event|2
2078893|NCT00684567|3661637|FG000|Monotherapy Period|Death|1
2078894|NCT00684567|3661637|FG000|Monotherapy Period|Progression of primary disease|11
2078895|NCT00684593|3661643|FG000|Overall Study|Adverse Event|0
2078896|NCT00684593|3661644|FG001|Overall Study|Adverse Event|2
2078897|NCT00684645|3661650|FG000|Overall Study|Death|2
2078898|NCT00684645|3661650|FG000|Overall Study|Progressive disease|67
2078899|NCT00684645|3661650|FG000|Overall Study|Adverse Event|27
2078900|NCT00684645|3661650|FG000|Overall Study|Lost to Follow-up|3
2078901|NCT00684645|3661650|FG000|Overall Study|Other|15
2078902|NCT00684671|3661657|FG000|Overall Study|Adverse Event|1
2078903|NCT00684671|3661658|FG001|Overall Study|Adverse Event|0
2078904|NCT00684671|3661659|FG002|Overall Study|Adverse Event|0
2078905|NCT00684671|3661657|FG000|Overall Study|Lost to Follow-up|1
2078906|NCT00684671|3661658|FG001|Overall Study|Lost to Follow-up|0
2078907|NCT00684671|3661659|FG002|Overall Study|Lost to Follow-up|0
2078908|NCT00684671|3661657|FG000|Overall Study|Alcoholic dependance|1
2078909|NCT00684671|3661658|FG001|Overall Study|Alcoholic dependance|0
2078910|NCT00684671|3661659|FG002|Overall Study|Alcoholic dependance|0
2078911|NCT00684762|3661678|FG000|Washout Period of 7 Days|Withdrawal by Subject|2
2078912|NCT00684762|3661679|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
2078913|NCT00684814|3661717|FG000|Washout Period of 7 Days|Adverse Event|1
2078914|NCT00684814|3661718|FG001|Washout Period of 7 Days|Adverse Event|2
2078915|NCT00684814|3661717|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
2078916|NCT00684814|3661718|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
2078917|NCT00684814|3661717|FG000|Second Intervention|Adverse Event|1
2078918|NCT00684814|3661718|FG001|Second Intervention|Adverse Event|0
2078919|NCT00684996|3661735|FG000|Overall Study|Adverse Event|1
2078920|NCT00684996|3661735|FG000|Overall Study|Refusal unrelated to adverse event|1
2078921|NCT00684996|3661735|FG000|Overall Study|Progression/relapse|2
2078922|NCT00684996|3661735|FG000|Overall Study|Other reasons not protocol specified|1
2078923|NCT00685035|3661742|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
2078924|NCT00685035|3661743|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
2078925|NCT00685165|3661774|FG000|Washout Period of 14 Days|Adverse Event|1
2078926|NCT00685165|3661775|FG001|Washout Period of 14 Days|Adverse Event|0
2078927|NCT00685178|3661785|FG000|Overall Study|Adverse Event|1
2078928|NCT00685178|3661786|FG001|Overall Study|Adverse Event|5
2078929|NCT00685178|3661787|FG002|Overall Study|Adverse Event|2
2078930|NCT00685178|3661788|FG003|Overall Study|Adverse Event|4
2078931|NCT00685178|3661785|FG000|Overall Study|missed 3 consecutive methadone clin days|7
2078932|NCT00685178|3661786|FG001|Overall Study|missed 3 consecutive methadone clin days|5
2078933|NCT00685178|3661787|FG002|Overall Study|missed 3 consecutive methadone clin days|2
2078934|NCT00685178|3661788|FG003|Overall Study|missed 3 consecutive methadone clin days|6
2078935|NCT00685178|3661785|FG000|Overall Study|voluntary study discharge|4
2078936|NCT00685178|3661786|FG001|Overall Study|voluntary study discharge|5
2078937|NCT00685178|3661787|FG002|Overall Study|voluntary study discharge|1
2078938|NCT00685178|3661788|FG003|Overall Study|voluntary study discharge|1
2078939|NCT00685178|3661785|FG000|Overall Study|incarcerated|1
2078940|NCT00685178|3661786|FG001|Overall Study|incarcerated|3
2078941|NCT00685178|3661787|FG002|Overall Study|incarcerated|7
2078942|NCT00685178|3661788|FG003|Overall Study|incarcerated|0
2078943|NCT00685178|3661785|FG000|Overall Study|administrative (disciplinary) discharge|0
2078944|NCT00685178|3661786|FG001|Overall Study|administrative (disciplinary) discharge|1
2078945|NCT00685178|3661787|FG002|Overall Study|administrative (disciplinary) discharge|0
2078946|NCT00685178|3661788|FG003|Overall Study|administrative (disciplinary) discharge|2
2078947|NCT00685178|3661785|FG000|Overall Study|Pregnancy|0
2078948|NCT00685178|3661786|FG001|Overall Study|Pregnancy|0
2078949|NCT00685178|3661787|FG002|Overall Study|Pregnancy|0
2078950|NCT00685178|3661788|FG003|Overall Study|Pregnancy|1
2078951|NCT00685334|3661811|FG000|Overall Study|Withdrawal by Subject|5
2078952|NCT00685334|3661812|FG001|Overall Study|Withdrawal by Subject|6
2078953|NCT00685334|3661811|FG000|Overall Study|Lost to Follow-up|4
2078954|NCT00685334|3661812|FG001|Overall Study|Lost to Follow-up|0
2078955|NCT00685334|3661811|FG000|Overall Study|Chose to enter hospital|1
2078956|NCT00685334|3661812|FG001|Overall Study|Chose to enter hospital|1
2078957|NCT00685373|3661818|FG000|Overall Study|Adverse Event|3
2078958|NCT00685373|3661818|FG000|Overall Study|Withdrawal by Subject|5
2078959|NCT00685373|3661818|FG000|Overall Study|Lack of Efficacy|3
2078960|NCT00685373|3661818|FG000|Overall Study|Condition no longer requires study drug|1
2078961|NCT00685373|3661818|FG000|Overall Study|Lost to Follow-up|2
2078962|NCT00685373|3661818|FG000|Overall Study|Protocol Violation|1
2078963|NCT00685399|3661829|FG000|Treatment Period 1|Withdrawal by Subject|2
2078964|NCT00685399|3661830|FG001|Treatment Period 1|Withdrawal by Subject|0
2078965|NCT00685399|3661831|FG002|Treatment Period 1|Withdrawal by Subject|0
2078966|NCT00685399|3661832|FG003|Treatment Period 1|Withdrawal by Subject|0
2078967|NCT00685399|3661833|FG004|Treatment Period 1|Withdrawal by Subject|0
2078968|NCT00685399|3661834|FG005|Treatment Period 1|Withdrawal by Subject|0
2078969|NCT00685399|3661835|FG006|Treatment Period 1|Withdrawal by Subject|0
2078970|NCT00685399|3661836|FG007|Treatment Period 1|Withdrawal by Subject|0
2078971|NCT00685399|3661829|FG000|Treatment Period 1|Protocol Violation|1
2078972|NCT00685399|3661830|FG001|Treatment Period 1|Protocol Violation|0
2078973|NCT00685399|3661831|FG002|Treatment Period 1|Protocol Violation|0
2078974|NCT00685399|3661832|FG003|Treatment Period 1|Protocol Violation|0
2078975|NCT00685399|3661833|FG004|Treatment Period 1|Protocol Violation|0
2078976|NCT00685399|3661834|FG005|Treatment Period 1|Protocol Violation|0
2078977|NCT00685399|3661835|FG006|Treatment Period 1|Protocol Violation|0
2078978|NCT00685399|3661836|FG007|Treatment Period 1|Protocol Violation|0
2078979|NCT00685399|3661829|FG000|Treatment Period 1|Administrative|2
2078980|NCT00685399|3661830|FG001|Treatment Period 1|Administrative|0
2078981|NCT00685399|3661831|FG002|Treatment Period 1|Administrative|0
2078982|NCT00685399|3661832|FG003|Treatment Period 1|Administrative|0
2078983|NCT00685399|3661833|FG004|Treatment Period 1|Administrative|0
2078984|NCT00685399|3661834|FG005|Treatment Period 1|Administrative|0
2078985|NCT00685399|3661835|FG006|Treatment Period 1|Administrative|0
2078986|NCT00685399|3661836|FG007|Treatment Period 1|Administrative|0
2078987|NCT00685399|3661829|FG000|Treatment Period 1|Lack of Efficacy|1
2078988|NCT00685399|3661830|FG001|Treatment Period 1|Lack of Efficacy|0
2078989|NCT00685399|3661831|FG002|Treatment Period 1|Lack of Efficacy|0
2078990|NCT00685399|3661832|FG003|Treatment Period 1|Lack of Efficacy|0
2078991|NCT00685399|3661833|FG004|Treatment Period 1|Lack of Efficacy|0
2078992|NCT00685399|3661834|FG005|Treatment Period 1|Lack of Efficacy|0
2078993|NCT00685399|3661835|FG006|Treatment Period 1|Lack of Efficacy|0
2078994|NCT00685399|3661836|FG007|Treatment Period 1|Lack of Efficacy|0
2078995|NCT00685399|3661829|FG000|Treatment Period 2|Administrative Problems|0
2078996|NCT00685399|3661830|FG001|Treatment Period 2|Administrative Problems|2
2078997|NCT00685399|3661831|FG002|Treatment Period 2|Administrative Problems|1
2078998|NCT00685399|3661832|FG003|Treatment Period 2|Administrative Problems|0
2078999|NCT00685399|3661833|FG004|Treatment Period 2|Administrative Problems|0
2079000|NCT00685399|3661834|FG005|Treatment Period 2|Administrative Problems|0
2079001|NCT00685399|3661835|FG006|Treatment Period 2|Administrative Problems|0
2079002|NCT00685399|3661836|FG007|Treatment Period 2|Administrative Problems|0
2079003|NCT00685399|3661829|FG000|Treatment Period 2|Withdrawal by Subject|0
2079004|NCT00685399|3661830|FG001|Treatment Period 2|Withdrawal by Subject|0
2079005|NCT00685399|3661831|FG002|Treatment Period 2|Withdrawal by Subject|0
2079006|NCT00685399|3661832|FG003|Treatment Period 2|Withdrawal by Subject|0
2079007|NCT00685399|3661833|FG004|Treatment Period 2|Withdrawal by Subject|0
2079008|NCT00685399|3661834|FG005|Treatment Period 2|Withdrawal by Subject|0
2079009|NCT00685399|3661835|FG006|Treatment Period 2|Withdrawal by Subject|0
2079010|NCT00685399|3661836|FG007|Treatment Period 2|Withdrawal by Subject|2
2079011|NCT00685399|3661829|FG000|Treatment Period 2|Adverse Event|0
2079012|NCT00685399|3661830|FG001|Treatment Period 2|Adverse Event|0
2079013|NCT00685399|3661831|FG002|Treatment Period 2|Adverse Event|0
2079014|NCT00685399|3661832|FG003|Treatment Period 2|Adverse Event|0
2079015|NCT00685399|3661833|FG004|Treatment Period 2|Adverse Event|0
2079016|NCT00685399|3661834|FG005|Treatment Period 2|Adverse Event|1
2079017|NCT00685399|3661835|FG006|Treatment Period 2|Adverse Event|0
2304440|NCT02654977|4004754|FG000|Overall Study|Adverse Event|1
2304441|NCT02654977|4004754|FG000|Overall Study|Withdrawal by Subject|1
2304442|NCT02654977|4004754|FG000|Overall Study|Lack of Efficacy|3
2304443|NCT02655224|4004760|FG000|Overall Study|Adverse Event|1
2304444|NCT02655224|4004761|FG001|Overall Study|Adverse Event|1
2321707|NCT02963506|4036372|FG001|Double-Blind Period|Death|0
2321708|NCT02963506|4036373|FG002|Double-Blind Period|Death|0
2321709|NCT02963506|4036374|FG003|Double-Blind Period|Death|1
2321710|NCT02963506|4036375|FG004|Double-Blind Period|Death|0
2321711|NCT02963506|4036376|FG005|Double-Blind Period|Death|0
2321712|NCT02963506|4036377|FG006|Double-Blind Period|Death|0
2079018|NCT00685399|3661836|FG007|Treatment Period 2|Adverse Event|0
2079019|NCT00685399|3661829|FG000|Treatment Period 2|Lack of Efficacy|0
2079020|NCT00685399|3661830|FG001|Treatment Period 2|Lack of Efficacy|10
2079021|NCT00685399|3661831|FG002|Treatment Period 2|Lack of Efficacy|2
2079022|NCT00685399|3661832|FG003|Treatment Period 2|Lack of Efficacy|0
2079023|NCT00685399|3661833|FG004|Treatment Period 2|Lack of Efficacy|0
2079024|NCT00685399|3661834|FG005|Treatment Period 2|Lack of Efficacy|1
2079025|NCT00685399|3661835|FG006|Treatment Period 2|Lack of Efficacy|0
2079026|NCT00685399|3661836|FG007|Treatment Period 2|Lack of Efficacy|0
2321713|NCT02963506|4036378|FG007|Double-Blind Period|Death|0
2321714|NCT02963506|4036379|FG008|Double-Blind Period|Death|0
2321715|NCT02963506|4036380|FG009|Double-Blind Period|Death|0
2321716|NCT02963506|4036381|FG010|Double-Blind Period|Death|0
2321717|NCT02963506|4036382|FG011|Double-Blind Period|Death|0
2321718|NCT02963506|4036383|FG012|Double-Blind Period|Death|0
2079027|NCT00685399|3661829|FG000|Extension|Administrative Issues|0
2079028|NCT00685399|3661830|FG001|Extension|Administrative Issues|0
2079029|NCT00685399|3661831|FG002|Extension|Administrative Issues|0
2079030|NCT00685399|3661832|FG003|Extension|Administrative Issues|1
2079031|NCT00685399|3661833|FG004|Extension|Administrative Issues|0
2079032|NCT00685399|3661834|FG005|Extension|Administrative Issues|0
2079033|NCT00685399|3661835|FG006|Extension|Administrative Issues|0
2079034|NCT00685399|3661836|FG007|Extension|Administrative Issues|0
2079035|NCT00685399|3661829|FG000|Extension|Withdrawal by Subject|0
2079036|NCT00685399|3661830|FG001|Extension|Withdrawal by Subject|0
2079037|NCT00685399|3661831|FG002|Extension|Withdrawal by Subject|0
2079038|NCT00685399|3661832|FG003|Extension|Withdrawal by Subject|1
2079039|NCT00685399|3661833|FG004|Extension|Withdrawal by Subject|0
2079040|NCT00685399|3661834|FG005|Extension|Withdrawal by Subject|0
2079041|NCT00685399|3661835|FG006|Extension|Withdrawal by Subject|0
2079042|NCT00685399|3661836|FG007|Extension|Withdrawal by Subject|0
2079043|NCT00685399|3661829|FG000|Extension|Protocol Violation|0
2079044|NCT00685399|3661830|FG001|Extension|Protocol Violation|0
2079045|NCT00685399|3661831|FG002|Extension|Protocol Violation|0
2079046|NCT00685399|3661832|FG003|Extension|Protocol Violation|1
2079047|NCT00685399|3661833|FG004|Extension|Protocol Violation|0
2079048|NCT00685399|3661834|FG005|Extension|Protocol Violation|0
2079049|NCT00685399|3661835|FG006|Extension|Protocol Violation|0
2079050|NCT00685399|3661836|FG007|Extension|Protocol Violation|0
2079051|NCT00685399|3661829|FG000|Extension|Lack of Efficacy|0
2079052|NCT00685399|3661830|FG001|Extension|Lack of Efficacy|0
2079053|NCT00685399|3661831|FG002|Extension|Lack of Efficacy|0
2079054|NCT00685399|3661832|FG003|Extension|Lack of Efficacy|2
2079055|NCT00685399|3661833|FG004|Extension|Lack of Efficacy|0
2079056|NCT00685399|3661834|FG005|Extension|Lack of Efficacy|0
2079057|NCT00685399|3661835|FG006|Extension|Lack of Efficacy|0
2079058|NCT00685399|3661836|FG007|Extension|Lack of Efficacy|0
2079059|NCT00685399|3661829|FG000|Extension|Adverse Event|0
2079060|NCT00685399|3661830|FG001|Extension|Adverse Event|0
2079061|NCT00685399|3661831|FG002|Extension|Adverse Event|0
2079062|NCT00685399|3661832|FG003|Extension|Adverse Event|2
2079063|NCT00685399|3661833|FG004|Extension|Adverse Event|0
2079064|NCT00685399|3661834|FG005|Extension|Adverse Event|0
2079065|NCT00685399|3661835|FG006|Extension|Adverse Event|0
2079066|NCT00685399|3661836|FG007|Extension|Adverse Event|0
2079067|NCT00685685|3661906|FG000|Washout Period of 7 Days|Adverse Event|2
2079068|NCT00685685|3661907|FG001|Washout Period of 7 Days|Adverse Event|0
2079069|NCT00685685|3661906|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
2079070|NCT00685685|3661907|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
2079071|NCT00685698|3661913|FG000|Overall Study|Withdrawal by Subject|1
2079072|NCT00685698|3661913|FG000|Overall Study|Protocol Violation|6
2079073|NCT00685698|3661913|FG000|Overall Study|Adverse Event|3
2079074|NCT00685698|3661913|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1
2079075|NCT00685698|3661913|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1
2079076|NCT00685698|3661913|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
2079077|NCT00685750|3661936|FG000|Overall Study|Tumor sampling failure|0
2079078|NCT00685750|3661937|FG001|Overall Study|Tumor sampling failure|0
2079079|NCT00685750|3661938|FG002|Overall Study|Tumor sampling failure|1
2079080|NCT00685750|3661939|FG003|Overall Study|Tumor sampling failure|0
2079081|NCT00685750|3661940|FG004|Overall Study|Tumor sampling failure|0
2079082|NCT00685750|3661941|FG005|Overall Study|Tumor sampling failure|0
2079083|NCT00685750|3661942|FG006|Overall Study|Tumor sampling failure|0
2079084|NCT00685750|3661936|FG000|Overall Study|Patient didn't receive the treatment|0
2079085|NCT00685750|3661937|FG001|Overall Study|Patient didn't receive the treatment|0
2211094|NCT01657370|3851226|FG002|Overall Study|Physician Decision|1
2211095|NCT01657370|3851227|FG003|Overall Study|Physician Decision|2
2211096|NCT01657370|3851228|FG004|Overall Study|Physician Decision|5
2211097|NCT01657370|3851229|FG005|Overall Study|Physician Decision|0
2211098|NCT01657370|3851224|FG000|Overall Study|Lack of Qualifying Event|1
2211099|NCT01657370|3851225|FG001|Overall Study|Lack of Qualifying Event|0
2211100|NCT01657370|3851226|FG002|Overall Study|Lack of Qualifying Event|3
2211101|NCT01657370|3851227|FG003|Overall Study|Lack of Qualifying Event|2
2211102|NCT01657370|3851228|FG004|Overall Study|Lack of Qualifying Event|1
2211103|NCT01657370|3851229|FG005|Overall Study|Lack of Qualifying Event|2
2211104|NCT01657370|3851224|FG000|Overall Study|Adverse Event|0
2211105|NCT01657370|3851225|FG001|Overall Study|Adverse Event|0
2211106|NCT01657370|3851226|FG002|Overall Study|Adverse Event|0
2079086|NCT00685750|3661938|FG002|Overall Study|Patient didn't receive the treatment|0
2079087|NCT00685750|3661939|FG003|Overall Study|Patient didn't receive the treatment|0
2079088|NCT00685750|3661940|FG004|Overall Study|Patient didn't receive the treatment|0
2079089|NCT00685750|3661941|FG005|Overall Study|Patient didn't receive the treatment|0
2079090|NCT00685750|3661942|FG006|Overall Study|Patient didn't receive the treatment|1
2079091|NCT00685750|3661936|FG000|Overall Study|Eligibility criteria not fulfilled|0
2079092|NCT00685750|3661937|FG001|Overall Study|Eligibility criteria not fulfilled|0
2079093|NCT00685750|3661938|FG002|Overall Study|Eligibility criteria not fulfilled|1
2079094|NCT00685750|3661939|FG003|Overall Study|Eligibility criteria not fulfilled|0
2079095|NCT00685750|3661940|FG004|Overall Study|Eligibility criteria not fulfilled|0
2079096|NCT00685750|3661941|FG005|Overall Study|Eligibility criteria not fulfilled|0
2211107|NCT01657370|3851227|FG003|Overall Study|Adverse Event|0
2079097|NCT00685750|3661942|FG006|Overall Study|Eligibility criteria not fulfilled|0
2079098|NCT00685763|3661962|FG000|Overall Study|Intercurrent death-incomplete treatment|1
2079099|NCT00685763|3661962|FG000|Overall Study|Protocol Violation|1
2079100|NCT00685802|3661966|FG000|Washout Period of 7 Days|Protocol Violation|2
2079101|NCT00685802|3661967|FG001|Washout Period of 7 Days|Protocol Violation|0
2079102|NCT00685802|3661966|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
2079103|NCT00685802|3661967|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
2079104|NCT00685945|3661982|FG000|L-NMMA + Bradykinin|Physician Decision|1
2079105|NCT00686075|3662002|FG000|Overall Study|Withdrawal by Subject|4
2079106|NCT00686075|3662003|FG001|Overall Study|Withdrawal by Subject|3
2079107|NCT00686075|3662004|FG002|Overall Study|Withdrawal by Subject|3
2079108|NCT00686075|3662005|FG003|Overall Study|Withdrawal by Subject|7
2079109|NCT00686075|3662006|FG004|Overall Study|Withdrawal by Subject|1
2079110|NCT00686075|3662007|FG005|Overall Study|Withdrawal by Subject|0
2079111|NCT00686075|3662008|FG006|Overall Study|Withdrawal by Subject|0
2079112|NCT00686075|3662009|FG007|Overall Study|Withdrawal by Subject|2
2079113|NCT00686075|3662010|FG008|Overall Study|Withdrawal by Subject|4
2079114|NCT00686075|3662011|FG009|Overall Study|Withdrawal by Subject|6
2079115|NCT00686075|3662002|FG000|Overall Study|Lost to Follow-up|3
2079116|NCT00686075|3662003|FG001|Overall Study|Lost to Follow-up|6
2079117|NCT00686075|3662004|FG002|Overall Study|Lost to Follow-up|3
2079118|NCT00686075|3662005|FG003|Overall Study|Lost to Follow-up|2
2079119|NCT00686075|3662006|FG004|Overall Study|Lost to Follow-up|3
2079120|NCT00686075|3662007|FG005|Overall Study|Lost to Follow-up|3
2079121|NCT00686075|3662008|FG006|Overall Study|Lost to Follow-up|0
2079122|NCT00686075|3662009|FG007|Overall Study|Lost to Follow-up|0
2079123|NCT00686075|3662010|FG008|Overall Study|Lost to Follow-up|2
2079124|NCT00686075|3662011|FG009|Overall Study|Lost to Follow-up|3
2079125|NCT00686075|3662002|FG000|Overall Study|Other|1
2079126|NCT00686075|3662003|FG001|Overall Study|Other|1
2079127|NCT00686075|3662004|FG002|Overall Study|Other|0
2079128|NCT00686075|3662005|FG003|Overall Study|Other|0
2079129|NCT00686075|3662006|FG004|Overall Study|Other|0
2079130|NCT00686075|3662007|FG005|Overall Study|Other|0
2079131|NCT00686075|3662008|FG006|Overall Study|Other|0
2079132|NCT00686075|3662009|FG007|Overall Study|Other|0
2079133|NCT00686075|3662010|FG008|Overall Study|Other|0
2079134|NCT00686075|3662011|FG009|Overall Study|Other|1
2079135|NCT00686127|3662035|FG000|Overall Study|Withdrawal by Subject|14
2079136|NCT00686127|3662036|FG001|Overall Study|Withdrawal by Subject|6
2079137|NCT00686166|3662042|FG000|Overall Study|Adverse Event|7
2079138|NCT00686166|3662042|FG000|Overall Study|Withdrawal by Subject|1
2079139|NCT00686166|3662042|FG000|Overall Study|Progression/Relapse|1
2079140|NCT00686166|3662042|FG000|Overall Study|Death|1
2079141|NCT00686166|3662042|FG000|Overall Study|Not Protocol Specified|1
2079142|NCT00686166|3662042|FG000|Overall Study|Ineligible|5
2079143|NCT00686166|3662042|FG000|Overall Study|Did not begin protocol therapy|4
2079144|NCT00686205|3662053|FG000|Overall Study|Protocol Violation|127
2079145|NCT00686205|3662054|FG001|Overall Study|Protocol Violation|0
2079146|NCT00686205|3662053|FG000|Overall Study|Withdrawal by Subject|2
2079147|NCT00686205|3662054|FG001|Overall Study|Withdrawal by Subject|0
2079148|NCT00686205|3662053|FG000|Overall Study|Specimen handling procedure altered|5878
2079149|NCT00686205|3662054|FG001|Overall Study|Specimen handling procedure altered|0
2079150|NCT00686205|3662053|FG000|Overall Study|Specimens not confirmed HIV positive|0
2079151|NCT00686205|3662054|FG001|Overall Study|Specimens not confirmed HIV positive|981
2079152|NCT00686335|3662084|FG000|Run-in Period|Adverse Event|1
2079153|NCT00686335|3662084|FG000|Run-in Period|asthma exacerbation|1
2079154|NCT00686335|3662084|FG000|Run-in Period|violation of inclusion/exclusion criteri|3
2079155|NCT00686517|3662093|FG000|Treatment|Serious Adverse Event|1
2079156|NCT00686517|3662094|FG001|Treatment|Serious Adverse Event|2
2079157|NCT00686517|3662095|FG002|Treatment|Serious Adverse Event|1
2079158|NCT00686517|3662093|FG000|Treatment|Adverse Event|2
2079159|NCT00686517|3662094|FG001|Treatment|Adverse Event|0
2079160|NCT00686517|3662095|FG002|Treatment|Adverse Event|0
2079161|NCT00686517|3662093|FG000|Treatment|Poor Protocol Compliance|1
2079162|NCT00686517|3662094|FG001|Treatment|Poor Protocol Compliance|0
2079163|NCT00686517|3662095|FG002|Treatment|Poor Protocol Compliance|0
2079164|NCT00686517|3662093|FG000|Treatment|Protocol Violation|2
2079165|NCT00686517|3662094|FG001|Treatment|Protocol Violation|1
2079166|NCT00686517|3662095|FG002|Treatment|Protocol Violation|0
2079167|NCT00686543|3662107|FG000|Overall Study|Adverse Event|9
2079168|NCT00686543|3662108|FG001|Overall Study|Adverse Event|1
2079169|NCT00686543|3662109|FG002|Overall Study|Adverse Event|3
2079170|NCT00686543|3662110|FG003|Overall Study|Adverse Event|2
2079171|NCT00686543|3662107|FG000|Overall Study|Withdrawal by Subject|2
2079172|NCT00686543|3662108|FG001|Overall Study|Withdrawal by Subject|0
2079173|NCT00686543|3662109|FG002|Overall Study|Withdrawal by Subject|0
2079174|NCT00686543|3662110|FG003|Overall Study|Withdrawal by Subject|0
2079175|NCT00686543|3662107|FG000|Overall Study|Protocol Violation|3
2079176|NCT00686543|3662108|FG001|Overall Study|Protocol Violation|0
2079177|NCT00686543|3662109|FG002|Overall Study|Protocol Violation|2
2079178|NCT00686543|3662110|FG003|Overall Study|Protocol Violation|1
2079179|NCT00686595|3662131|FG000|Overall Study|Adverse Event|3
2079180|NCT00686595|3662131|FG000|Overall Study|Protocol Violation|1
2079181|NCT00686595|3662131|FG000|Overall Study|Lost to Follow-up|1
2079182|NCT00686595|3662131|FG000|Overall Study|Lack of Efficacy|1
2079183|NCT00686595|3662131|FG000|Overall Study|Poor Compliance|1
2079184|NCT00686634|3662135|FG000|Overall Study|Protocol Violation|6
2079185|NCT00686647|3662140|FG000|Overall Study|Lost to Follow-up|1
2079186|NCT00686647|3662140|FG000|Overall Study|Death|1
2079187|NCT00686686|3662145|FG000|Overall Study|Non-compliance|1
2079188|NCT00686686|3662145|FG000|Overall Study|Adverse Event|2
2079189|NCT00686686|3662145|FG000|Overall Study|Lost to Follow-up|3
2079190|NCT00686699|3662151|FG000|Treatment Period 1|Adverse Event|0
2079191|NCT00686699|3662152|FG001|Treatment Period 1|Adverse Event|2
2079192|NCT00686712|3662161|FG000|Overall Study|Protocol Violation|8
2079193|NCT00686712|3662162|FG001|Overall Study|Protocol Violation|8
2079194|NCT00686712|3662163|FG002|Overall Study|Protocol Violation|10
2079195|NCT00686712|3662161|FG000|Overall Study|Lost to Follow-up|1
2079196|NCT00686712|3662162|FG001|Overall Study|Lost to Follow-up|2
2079197|NCT00686712|3662163|FG002|Overall Study|Lost to Follow-up|3
2079198|NCT00686712|3662161|FG000|Overall Study|Adverse Event|1
2079199|NCT00686712|3662162|FG001|Overall Study|Adverse Event|1
2079200|NCT00686712|3662163|FG002|Overall Study|Adverse Event|0
2079201|NCT00686725|3662176|FG000|Overall Study|Adverse Event|1
2079202|NCT00686725|3662177|FG001|Overall Study|Adverse Event|1
2079203|NCT00686725|3662176|FG000|Overall Study|Progressive Disease|17
2079204|NCT00686725|3662177|FG001|Overall Study|Progressive Disease|23
2079205|NCT00686725|3662176|FG000|Overall Study|Lost to Follow-up|7
2079206|NCT00686725|3662177|FG001|Overall Study|Lost to Follow-up|5
2079207|NCT00686725|3662176|FG000|Overall Study|Death|6
2079208|NCT00686725|3662177|FG001|Overall Study|Death|3
2079209|NCT00686725|3662176|FG000|Overall Study|Withdrawal by Subject|13
2079210|NCT00686725|3662177|FG001|Overall Study|Withdrawal by Subject|4
2079211|NCT00686725|3662176|FG000|Overall Study|Protocol Violation|1
2079212|NCT00686725|3662177|FG001|Overall Study|Protocol Violation|3
2079213|NCT00686725|3662176|FG000|Overall Study|Other|1
2079214|NCT00686725|3662177|FG001|Overall Study|Other|3
2079215|NCT00686777|3662183|FG000|Overall Study|Adverse Event|2
2079216|NCT00686777|3662183|FG000|Overall Study|Pregnancy|1
2079217|NCT00686777|3662183|FG000|Overall Study|Withdrawal by Subject|2
2079218|NCT00686777|3662183|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4
2079219|NCT00686777|3662183|FG000|Overall Study|No Visit|1
2211108|NCT01657370|3851228|FG004|Overall Study|Adverse Event|1
2211109|NCT01657370|3851229|FG005|Overall Study|Adverse Event|0
2211110|NCT01657370|3851224|FG000|Overall Study|Protocol Violation|1
2211111|NCT01657370|3851225|FG001|Overall Study|Protocol Violation|1
2211112|NCT01657370|3851226|FG002|Overall Study|Protocol Violation|1
2211113|NCT01657370|3851227|FG003|Overall Study|Protocol Violation|1
2211114|NCT01657370|3851228|FG004|Overall Study|Protocol Violation|0
2211115|NCT01657370|3851229|FG005|Overall Study|Protocol Violation|0
2211116|NCT01657370|3851224|FG000|Overall Study|Lost to Follow-up|2
2211117|NCT01657370|3851225|FG001|Overall Study|Lost to Follow-up|0
2211118|NCT01657370|3851226|FG002|Overall Study|Lost to Follow-up|1
2211119|NCT01657370|3851227|FG003|Overall Study|Lost to Follow-up|0
2211120|NCT01657370|3851228|FG004|Overall Study|Lost to Follow-up|0
2211121|NCT01657370|3851229|FG005|Overall Study|Lost to Follow-up|1
2211122|NCT01657461|3851250|FG000|Overall Study|Death|9
2211123|NCT01657461|3851251|FG001|Overall Study|Death|12
2079220|NCT00686790|3662187|FG000|Overall Study|Adverse Event|2
2079221|NCT00686790|3662187|FG000|Overall Study|Withdrawal by Subject|1
2079222|NCT00686790|3662187|FG000|Overall Study|Death|1
2079223|NCT00686790|3662187|FG000|Overall Study|Lost to Follow-up|12
2079224|NCT00686829|3662204|FG000|Overall Study|Adverse Event|5
2079225|NCT00686829|3662204|FG000|Overall Study|Lack of Efficacy|6
2079226|NCT00686829|3662204|FG000|Overall Study|Lost to Follow-up|4
2079227|NCT00686829|3662204|FG000|Overall Study|Withdrawal by Subject|14
2211124|NCT01657461|3851250|FG000|Overall Study|Lost to Follow-up|0
2211125|NCT01657461|3851251|FG001|Overall Study|Lost to Follow-up|3
2079228|NCT00686829|3662204|FG000|Overall Study|Protocol Violation|3
2079229|NCT00686829|3662204|FG000|Overall Study|Sponsor discontinued VCV|47
2079230|NCT00686855|3662214|FG000|Overall Study|Lost to Follow-up|1
2079231|NCT00686855|3662215|FG001|Overall Study|Lost to Follow-up|0
2079232|NCT00686855|3662214|FG000|Overall Study|Progressive GVHD|0
2079233|NCT00686855|3662215|FG001|Overall Study|Progressive GVHD|1
2079234|NCT00686881|3662223|FG000|Overall Study|Withdrawal by Subject|11
2079235|NCT00686881|3662224|FG001|Overall Study|Withdrawal by Subject|18
2079236|NCT00686881|3662223|FG000|Overall Study|Lost to Follow-up|0
2079237|NCT00686881|3662224|FG001|Overall Study|Lost to Follow-up|1
2079238|NCT00686881|3662223|FG000|Overall Study|Treatment-related adverse event|10
2079239|NCT00686881|3662224|FG001|Overall Study|Treatment-related adverse event|9
2079240|NCT00686881|3662223|FG000|Overall Study|Met discontinuation criteria|5
2211126|NCT01657461|3851250|FG000|Overall Study|Physician Decision|0
2211127|NCT01657461|3851251|FG001|Overall Study|Physician Decision|2
2079241|NCT00686881|3662224|FG001|Overall Study|Met discontinuation criteria|0
2079242|NCT00686881|3662223|FG000|Overall Study|Onset of malignant tumor|11
2079243|NCT00686881|3662224|FG001|Overall Study|Onset of malignant tumor|11
2079244|NCT00686881|3662223|FG000|Overall Study|Lack of Efficacy|4
2079245|NCT00686881|3662224|FG001|Overall Study|Lack of Efficacy|3
2079246|NCT00686881|3662223|FG000|Overall Study|Physician Decision|1
2079247|NCT00686881|3662224|FG001|Overall Study|Physician Decision|0
2211128|NCT01657461|3851250|FG000|Overall Study|Withdrawal by Subject|1
2079248|NCT00686881|3662223|FG000|Overall Study|Circumstances of site|1
2079249|NCT00686881|3662224|FG001|Overall Study|Circumstances of site|1
2079250|NCT00686881|3662223|FG000|Overall Study|Did not meet protocol eligibility|1
2079251|NCT00686881|3662224|FG001|Overall Study|Did not meet protocol eligibility|0
2079252|NCT00686881|3662223|FG000|Overall Study|Irregular visits|1
2079253|NCT00686881|3662224|FG001|Overall Study|Irregular visits|0
2079254|NCT00686881|3662223|FG000|Overall Study|Study discontinuation|35
2079255|NCT00686881|3662224|FG001|Overall Study|Study discontinuation|32
2079256|NCT00686881|3662223|FG000|Overall Study|Never received study drug|2
2079257|NCT00686881|3662224|FG001|Overall Study|Never received study drug|6
2079258|NCT00686894|3662232|FG000|Overall Study|Relapse|2
2079259|NCT00686894|3662232|FG000|Overall Study|Protocol Violation|4
2079260|NCT00686920|3662238|FG000|Overall Study|Death|45
2079261|NCT00686920|3662239|FG001|Overall Study|Death|14
2079262|NCT00686920|3662238|FG000|Overall Study|Liver Transplant|23
2079263|NCT00686920|3662239|FG001|Overall Study|Liver Transplant|8
2079264|NCT00686920|3662238|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
2079265|NCT00686920|3662239|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
2079266|NCT00686920|3662238|FG000|Overall Study|Withdrawal by Subject|23
2079267|NCT00686920|3662239|FG001|Overall Study|Withdrawal by Subject|5
2079268|NCT00686920|3662238|FG000|Overall Study|Protocol Violation|2
2079269|NCT00686920|3662239|FG001|Overall Study|Protocol Violation|1
2079270|NCT00686920|3662238|FG000|Overall Study|Adverse Event|10
2079271|NCT00686920|3662239|FG001|Overall Study|Adverse Event|2
2079272|NCT00686920|3662238|FG000|Overall Study|Personal Reason|0
2079273|NCT00686920|3662239|FG001|Overall Study|Personal Reason|1
2079274|NCT00686920|3662238|FG000|Overall Study|Lost to Follow-up|15
2079275|NCT00686920|3662239|FG001|Overall Study|Lost to Follow-up|3
2079276|NCT00686920|3662238|FG000|Overall Study|Moved to Another State|1
2079277|NCT00686920|3662239|FG001|Overall Study|Moved to Another State|0
2079278|NCT00686920|3662238|FG000|Overall Study|Transferred to Nursing Home|1
2079279|NCT00686920|3662239|FG001|Overall Study|Transferred to Nursing Home|0
2079280|NCT00686920|3662238|FG000|Overall Study|Noncompliance|9
2079281|NCT00686920|3662239|FG001|Overall Study|Noncompliance|0
2079282|NCT00686920|3662238|FG000|Overall Study|Principal Investigator Decision|2
2079283|NCT00686920|3662239|FG001|Overall Study|Principal Investigator Decision|0
2079284|NCT00686959|3662247|FG000|Overall Study|Participants censored (no death events)|124
2079285|NCT00686959|3662248|FG001|Overall Study|Participants censored (no death events)|117
2079286|NCT00686998|3662257|FG000|Overall Study|Adverse Event|3
2079287|NCT00686998|3662258|FG001|Overall Study|Adverse Event|2
2079288|NCT00686998|3662259|FG002|Overall Study|Adverse Event|1
2079289|NCT00686998|3662257|FG000|Overall Study|Withdrawal by Subject|2
2079290|NCT00686998|3662258|FG001|Overall Study|Withdrawal by Subject|1
2079291|NCT00686998|3662259|FG002|Overall Study|Withdrawal by Subject|2
2079292|NCT00686998|3662257|FG000|Overall Study|Lack of Efficacy|7
2079293|NCT00686998|3662258|FG001|Overall Study|Lack of Efficacy|5
2079294|NCT00686998|3662259|FG002|Overall Study|Lack of Efficacy|0
2079295|NCT00686998|3662257|FG000|Overall Study|Other|0
2079296|NCT00686998|3662258|FG001|Overall Study|Other|0
2079297|NCT00686998|3662259|FG002|Overall Study|Other|1
2079298|NCT00686998|3662257|FG000|Overall Study|Safety Reasons|1
2079299|NCT00686998|3662258|FG001|Overall Study|Safety Reasons|0
2079300|NCT00686998|3662259|FG002|Overall Study|Safety Reasons|0
2079301|NCT00687193|3662298|FG000|Overall Study|Adverse Event|0
2079302|NCT00687193|3662299|FG001|Overall Study|Adverse Event|1
2079303|NCT00687193|3662300|FG002|Overall Study|Adverse Event|2
2079304|NCT00687193|3662301|FG003|Overall Study|Adverse Event|3
2079305|NCT00687193|3662302|FG004|Overall Study|Adverse Event|0
2079306|NCT00687193|3662303|FG005|Overall Study|Adverse Event|2
2079307|NCT00687193|3662298|FG000|Overall Study|Lack of Efficacy|1
2079308|NCT00687193|3662299|FG001|Overall Study|Lack of Efficacy|1
2079309|NCT00687193|3662300|FG002|Overall Study|Lack of Efficacy|0
2211129|NCT01657461|3851251|FG001|Overall Study|Withdrawal by Subject|3
2211130|NCT01657760|3851263|FG000|Overall Study|Withdrawal by Subject|0
2079310|NCT00687193|3662301|FG003|Overall Study|Lack of Efficacy|0
2079311|NCT00687193|3662302|FG004|Overall Study|Lack of Efficacy|0
2079312|NCT00687193|3662303|FG005|Overall Study|Lack of Efficacy|2
2079313|NCT00687193|3662298|FG000|Overall Study|Protocol Violation|1
2079314|NCT00687193|3662299|FG001|Overall Study|Protocol Violation|2
2079315|NCT00687193|3662300|FG002|Overall Study|Protocol Violation|0
2079316|NCT00687193|3662301|FG003|Overall Study|Protocol Violation|1
2079317|NCT00687193|3662302|FG004|Overall Study|Protocol Violation|2
2079318|NCT00687193|3662303|FG005|Overall Study|Protocol Violation|0
2079319|NCT00687219|3662320|FG000|Overall Study|Adverse Event|8
2079320|NCT00687219|3662320|FG000|Overall Study|Discontinuance criteria met|7
2079321|NCT00687219|3662320|FG000|Overall Study|HCV-RNA positive conversion|34
2079322|NCT00687219|3662320|FG000|Overall Study|Withdrawal by Subject|1
2079323|NCT00687219|3662320|FG000|Overall Study|Lack of Efficacy|1
2079324|NCT00687271|3662328|FG000|Overall Study|Adverse Event|1
2079325|NCT00687271|3662329|FG001|Overall Study|Adverse Event|3
2079326|NCT00687271|3662330|FG002|Overall Study|Adverse Event|1
2079327|NCT00687271|3662331|FG003|Overall Study|Adverse Event|0
2079328|NCT00687271|3662328|FG000|Overall Study|Lost to Follow-up|0
2079329|NCT00687271|3662329|FG001|Overall Study|Lost to Follow-up|1
2079330|NCT00687271|3662330|FG002|Overall Study|Lost to Follow-up|0
2079331|NCT00687271|3662331|FG003|Overall Study|Lost to Follow-up|0
2079332|NCT00687271|3662328|FG000|Overall Study|Protocol Violation|2
2079333|NCT00687271|3662329|FG001|Overall Study|Protocol Violation|1
2079334|NCT00687271|3662330|FG002|Overall Study|Protocol Violation|1
2079335|NCT00687271|3662331|FG003|Overall Study|Protocol Violation|0
2079336|NCT00687271|3662328|FG000|Overall Study|Withdrawal by Subject|0
2079337|NCT00687271|3662329|FG001|Overall Study|Withdrawal by Subject|1
2079338|NCT00687271|3662330|FG002|Overall Study|Withdrawal by Subject|3
2079339|NCT00687271|3662331|FG003|Overall Study|Withdrawal by Subject|0
2079340|NCT00687297|3662343|FG000|Randomization|Withdrawal by Subject|2
2079341|NCT00687297|3662344|FG001|Randomization|Withdrawal by Subject|0
2079342|NCT00687297|3662343|FG000|Randomization|Withdrew before treatment, ineligible|1
2079343|NCT00687297|3662344|FG001|Randomization|Withdrew before treatment, ineligible|1
2079344|NCT00687297|3662343|FG000|Induction|Withdrawal by Subject|4
2079345|NCT00687297|3662344|FG001|Induction|Withdrawal by Subject|4
2079346|NCT00687297|3662343|FG000|Induction|Adverse Event|16
2079347|NCT00687297|3662344|FG001|Induction|Adverse Event|15
2079348|NCT00687297|3662343|FG000|Induction|Death|7
2079349|NCT00687297|3662344|FG001|Induction|Death|11
2079350|NCT00687297|3662343|FG000|Induction|Lack of Efficacy|17
2079351|NCT00687297|3662344|FG001|Induction|Lack of Efficacy|21
2079352|NCT00687297|3662343|FG000|Induction|Ineligible|0
2079353|NCT00687297|3662344|FG001|Induction|Ineligible|1
2079354|NCT00687297|3662343|FG000|Induction|Patient Noncompliance|1
2079355|NCT00687297|3662344|FG001|Induction|Patient Noncompliance|0
2079356|NCT00687297|3662343|FG000|Induction|Physician Decision|0
2079357|NCT00687297|3662344|FG001|Induction|Physician Decision|2
2079358|NCT00687297|3662343|FG000|Induction|Other|0
2211131|NCT01657760|3851264|FG001|Overall Study|Withdrawal by Subject|0
2211132|NCT01657760|3851265|FG002|Overall Study|Withdrawal by Subject|0
2211133|NCT01657760|3851266|FG003|Overall Study|Withdrawal by Subject|1
2211134|NCT01657760|3851263|FG000|Overall Study|Physician Decision|1
2211135|NCT01657760|3851264|FG001|Overall Study|Physician Decision|1
2079359|NCT00687297|3662344|FG001|Induction|Other|1
2079360|NCT00687323|3662352|FG000|Overall Study|Death|25
2079361|NCT00687323|3662352|FG000|Overall Study|Withdrawal by Subject|1
2079362|NCT00687323|3662352|FG000|Overall Study|Excluded from efficacy evaluations|6
2079363|NCT00687323|3662352|FG000|Overall Study|Screen failure|148
2079364|NCT00687362|3662356|FG000|Overall Study|Protocol Violation|2
2079365|NCT00687362|3662356|FG000|Overall Study|Withdrawal by Subject|1
2079366|NCT00687401|3662360|FG000|Overall Study|Protocol Violation|7
2079367|NCT00687401|3662360|FG000|Overall Study|Adverse Event|6
2079368|NCT00687401|3662360|FG000|Overall Study|Lack of Efficacy|6
2079369|NCT00687401|3662360|FG000|Overall Study|Withdrawal by Subject|4
2079370|NCT00687401|3662360|FG000|Overall Study|Did not return for visit|3
2079371|NCT00687401|3662360|FG000|Overall Study|For reasons different from those above|4
2079372|NCT00687440|3662365|FG000|Overall Study|Adverse Event|3
2079373|NCT00687440|3662365|FG000|Overall Study|Lost to Follow-up|3
2079374|NCT00687440|3662365|FG000|Overall Study|Lack of Efficacy|2
2079375|NCT00687440|3662365|FG000|Overall Study|Death|2
2079376|NCT00687440|3662365|FG000|Overall Study|Other|1
2079377|NCT00687440|3662365|FG000|Overall Study|Missing|1
2079378|NCT00687609|3662382|FG000|Overall Study|Physician Decision|1
2079379|NCT00687609|3662382|FG000|Overall Study|Withdrawal by Subject|2
2079380|NCT00687739|3662405|FG000|Overall Study|Lost to Follow-up|2
2079381|NCT00687739|3662406|FG001|Overall Study|Lost to Follow-up|2
2079382|NCT00687739|3662407|FG002|Overall Study|Lost to Follow-up|1
2079383|NCT00687739|3662408|FG003|Overall Study|Lost to Follow-up|2
2079384|NCT00687739|3662405|FG000|Overall Study|Adverse Event|0
2079385|NCT00687739|3662406|FG001|Overall Study|Adverse Event|1
2079386|NCT00687739|3662407|FG002|Overall Study|Adverse Event|1
2079387|NCT00687739|3662408|FG003|Overall Study|Adverse Event|0
2079388|NCT00687804|3662423|FG000|Core Study|Adverse Event|5
2079389|NCT00687804|3662424|FG001|Core Study|Adverse Event|3
2079390|NCT00687804|3662425|FG002|Core Study|Adverse Event|3
2079391|NCT00687804|3662423|FG000|Core Study|Abnormal laboratory value(s)|1
2079392|NCT00687804|3662424|FG001|Core Study|Abnormal laboratory value(s)|0
2079393|NCT00687804|3662425|FG002|Core Study|Abnormal laboratory value(s)|0
2079394|NCT00687804|3662423|FG000|Core Study|Lack of Efficacy|1
2079395|NCT00687804|3662424|FG001|Core Study|Lack of Efficacy|1
2079396|NCT00687804|3662425|FG002|Core Study|Lack of Efficacy|1
2079397|NCT00687804|3662423|FG000|Core Study|Withdrawal by Subject|4
2079398|NCT00687804|3662424|FG001|Core Study|Withdrawal by Subject|7
2079399|NCT00687804|3662425|FG002|Core Study|Withdrawal by Subject|7
2079400|NCT00687804|3662423|FG000|Core Study|Lost to Follow-up|0
2079401|NCT00687804|3662424|FG001|Core Study|Lost to Follow-up|1
2079402|NCT00687804|3662425|FG002|Core Study|Lost to Follow-up|0
2079403|NCT00687804|3662423|FG000|Core Study|Death|2
2079404|NCT00687804|3662424|FG001|Core Study|Death|2
2079405|NCT00687804|3662425|FG002|Core Study|Death|2
2079406|NCT00687804|3662423|FG000|Core Study|Protocol Violation|1
2079407|NCT00687804|3662424|FG001|Core Study|Protocol Violation|1
2079408|NCT00687804|3662425|FG002|Core Study|Protocol Violation|0
2079409|NCT00687804|3662423|FG000|Open-Label Extension Study|Adverse Event|2
2079410|NCT00687804|3662424|FG001|Open-Label Extension Study|Adverse Event|2
2079411|NCT00687804|3662425|FG002|Open-Label Extension Study|Adverse Event|2
2079412|NCT00687804|3662423|FG000|Open-Label Extension Study|Subject withdrew consent|3
2079413|NCT00687804|3662424|FG001|Open-Label Extension Study|Subject withdrew consent|4
2079414|NCT00687804|3662425|FG002|Open-Label Extension Study|Subject withdrew consent|4
2079415|NCT00687804|3662423|FG000|Open-Label Extension Study|Lost to Follow-up|2
2079416|NCT00687804|3662424|FG001|Open-Label Extension Study|Lost to Follow-up|1
2079417|NCT00687804|3662425|FG002|Open-Label Extension Study|Lost to Follow-up|2
2079418|NCT00687804|3662423|FG000|Open-Label Extension Study|Administrative problems|1
2079419|NCT00687804|3662424|FG001|Open-Label Extension Study|Administrative problems|1
2079420|NCT00687804|3662425|FG002|Open-Label Extension Study|Administrative problems|0
2079421|NCT00687804|3662423|FG000|Open-Label Extension Study|Death|2
2079422|NCT00687804|3662424|FG001|Open-Label Extension Study|Death|3
2079423|NCT00687804|3662425|FG002|Open-Label Extension Study|Death|3
2079424|NCT00687973|3662463|FG000|Overall Study|Adverse Event|18
2079425|NCT00687973|3662464|FG001|Overall Study|Adverse Event|28
2079426|NCT00687973|3662463|FG000|Overall Study|Lack of Efficacy|2
2079427|NCT00687973|3662464|FG001|Overall Study|Lack of Efficacy|3
2079428|NCT00687973|3662463|FG000|Overall Study|Protocol Violation|1
2079429|NCT00687973|3662464|FG001|Overall Study|Protocol Violation|2
2079430|NCT00687973|3662463|FG000|Overall Study|Administrative Reasons|0
2079431|NCT00687973|3662464|FG001|Overall Study|Administrative Reasons|2
2079432|NCT00687973|3662463|FG000|Overall Study|Withdrawal by Subject|3
2079433|NCT00687973|3662464|FG001|Overall Study|Withdrawal by Subject|3
2106737|NCT00868439|3700142|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
2106738|NCT00868439|3700143|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
2106739|NCT00868439|3700142|FG000|Overall Study|Death|0
2106740|NCT00868439|3700143|FG001|Overall Study|Death|1
2106741|NCT00868439|3700142|FG000|Overall Study|Protocol Violation|1
2106742|NCT00868439|3700143|FG001|Overall Study|Protocol Violation|1
2106743|NCT00868439|3700142|FG000|Overall Study|Physician Decision|1
2106744|NCT00868439|3700143|FG001|Overall Study|Physician Decision|0
2106745|NCT00868439|3700142|FG000|Overall Study|Withdrawal by Subject|0
2106746|NCT00868439|3700143|FG001|Overall Study|Withdrawal by Subject|1
2106747|NCT00868517|3700162|FG000|Overall Study|Withdrawal by Subject|3
2106748|NCT00868517|3700163|FG001|Overall Study|Withdrawal by Subject|3
2106749|NCT00868517|3700164|FG002|Overall Study|Withdrawal by Subject|2
2106750|NCT00868517|3700162|FG000|Overall Study|Protocol Violation|1
2106751|NCT00868517|3700163|FG001|Overall Study|Protocol Violation|1
2106752|NCT00868517|3700164|FG002|Overall Study|Protocol Violation|0
2106753|NCT00868530|3700172|FG000|Overall Study|Adverse Event|3
2106754|NCT00868530|3700172|FG000|Overall Study|Lost to Follow-up|1
2106755|NCT00868608|3700179|FG000|Overall Study|Withdrawal by Subject|3
2106756|NCT00868608|3700180|FG001|Overall Study|Withdrawal by Subject|1
2106757|NCT00868608|3700181|FG002|Overall Study|Withdrawal by Subject|0
2106758|NCT00868608|3700179|FG000|Overall Study|Lost to Follow-up|3
2106759|NCT00868608|3700180|FG001|Overall Study|Lost to Follow-up|0
2106760|NCT00868608|3700181|FG002|Overall Study|Lost to Follow-up|1
2106761|NCT00868608|3700179|FG000|Overall Study|Death|16
2106762|NCT00868608|3700180|FG001|Overall Study|Death|2
2106763|NCT00868608|3700181|FG002|Overall Study|Death|4
2106764|NCT00868608|3700179|FG000|Overall Study|Other - Unspecified|1
2106765|NCT00868608|3700180|FG001|Overall Study|Other - Unspecified|0
2106766|NCT00868608|3700181|FG002|Overall Study|Other - Unspecified|0
2106767|NCT00868790|3700219|FG000|Period 1|Adverse Event|1
2106768|NCT00868790|3700220|FG001|Period 1|Adverse Event|0
2106769|NCT00868790|3700221|FG002|Period 1|Adverse Event|0
2106770|NCT00868790|3700222|FG003|Period 1|Adverse Event|0
2106771|NCT00868790|3700223|FG004|Period 1|Adverse Event|0
2106772|NCT00868790|3700224|FG005|Period 1|Adverse Event|0
2106773|NCT00868790|3700225|FG006|Period 1|Adverse Event|0
2106774|NCT00868790|3700226|FG007|Period 1|Adverse Event|3
2106775|NCT00868790|3700227|FG008|Period 1|Adverse Event|1
2106776|NCT00868790|3700228|FG009|Period 1|Adverse Event|0
2106777|NCT00868790|3700229|FG010|Period 1|Adverse Event|0
2106778|NCT00868790|3700230|FG011|Period 1|Adverse Event|0
2106779|NCT00868790|3700231|FG012|Period 1|Adverse Event|0
2106780|NCT00868790|3700232|FG013|Period 1|Adverse Event|1
2106781|NCT00868790|3700219|FG000|Period 1|Protocol Violation|1
2106782|NCT00868790|3700220|FG001|Period 1|Protocol Violation|0
2106783|NCT00868790|3700221|FG002|Period 1|Protocol Violation|0
2106784|NCT00868790|3700222|FG003|Period 1|Protocol Violation|0
2106785|NCT00868790|3700223|FG004|Period 1|Protocol Violation|0
2106786|NCT00868790|3700224|FG005|Period 1|Protocol Violation|0
2106787|NCT00868790|3700225|FG006|Period 1|Protocol Violation|0
2106788|NCT00868790|3700226|FG007|Period 1|Protocol Violation|0
2106789|NCT00868790|3700227|FG008|Period 1|Protocol Violation|0
2106790|NCT00868790|3700228|FG009|Period 1|Protocol Violation|0
2106791|NCT00868790|3700229|FG010|Period 1|Protocol Violation|0
2106792|NCT00868790|3700230|FG011|Period 1|Protocol Violation|0
2106793|NCT00868790|3700231|FG012|Period 1|Protocol Violation|0
2106794|NCT00868790|3700232|FG013|Period 1|Protocol Violation|0
2106795|NCT00868790|3700219|FG000|Period 1|Withdrawal by Subject|0
2106796|NCT00868790|3700220|FG001|Period 1|Withdrawal by Subject|1
2106797|NCT00868790|3700221|FG002|Period 1|Withdrawal by Subject|0
2106798|NCT00868790|3700222|FG003|Period 1|Withdrawal by Subject|0
2106799|NCT00868790|3700223|FG004|Period 1|Withdrawal by Subject|0
2106800|NCT00868790|3700224|FG005|Period 1|Withdrawal by Subject|0
2106801|NCT00868790|3700225|FG006|Period 1|Withdrawal by Subject|0
2079434|NCT00688064|3662473|FG000|Overall Study|Protocol Violation|0
2079435|NCT00688064|3662474|FG001|Overall Study|Protocol Violation|1
2079436|NCT00688064|3662473|FG000|Overall Study|Adverse Event|2
2079437|NCT00688064|3662474|FG001|Overall Study|Adverse Event|4
2079438|NCT00688064|3662473|FG000|Overall Study|Withdrawal by Subject|7
2079439|NCT00688064|3662474|FG001|Overall Study|Withdrawal by Subject|7
2079440|NCT00688064|3662473|FG000|Overall Study|Lost to Follow-up|10
2079441|NCT00688064|3662474|FG001|Overall Study|Lost to Follow-up|10
2079442|NCT00688064|3662473|FG000|Overall Study|Lack of Efficacy|0
2079443|NCT00688064|3662474|FG001|Overall Study|Lack of Efficacy|1
2079444|NCT00688064|3662473|FG000|Overall Study|Pregnancy|1
2079445|NCT00688064|3662474|FG001|Overall Study|Pregnancy|0
2079446|NCT00688064|3662473|FG000|Overall Study|Any other reasons|1
2304445|NCT02655237|4004769|FG000|Overall Study|Adverse Event|10
2304446|NCT02655237|4004770|FG001|Overall Study|Adverse Event|7
2304447|NCT02655237|4004769|FG000|Overall Study|Protocol Deviation|2
2304448|NCT02655237|4004770|FG001|Overall Study|Protocol Deviation|0
2304449|NCT02655237|4004769|FG000|Overall Study|Withdrawal by Participant|1
2304450|NCT02655237|4004770|FG001|Overall Study|Withdrawal by Participant|2
2304451|NCT02655237|4004769|FG000|Overall Study|Lack of Efficacy|0
2304452|NCT02655237|4004770|FG001|Overall Study|Lack of Efficacy|1
2304453|NCT02655237|4004769|FG000|Overall Study|Recovery Leading to Surgery|2
2304454|NCT02655237|4004770|FG001|Overall Study|Recovery Leading to Surgery|1
2304455|NCT02655237|4004769|FG000|Overall Study|Reduction of Hemoglobin Concentration|1
2304456|NCT02655237|4004770|FG001|Overall Study|Reduction of Hemoglobin Concentration|0
2304457|NCT02655237|4004769|FG000|Overall Study|Randomized but Not Treated|1
2304458|NCT02655237|4004770|FG001|Overall Study|Randomized but Not Treated|0
2304459|NCT02655419|4004787|FG000|Overall Study|Enrolled but not treated|1
2304460|NCT02655419|4004788|FG001|Overall Study|Enrolled but not treated|5
2304461|NCT02655419|4004787|FG000|Overall Study|Withdrawal by Subject|4
2304462|NCT02655419|4004788|FG001|Overall Study|Withdrawal by Subject|1
2304463|NCT02655419|4004787|FG000|Overall Study|Other|0
2304464|NCT02655419|4004788|FG001|Overall Study|Other|1
2304465|NCT02655666|4004826|FG000|Overall Study|Sponsor stopped this clinical research.|12
2304466|NCT02655679|4004835|FG000|Overall Study|Adverse Event|0
2304467|NCT02655679|4004836|FG001|Overall Study|Adverse Event|1
2304468|NCT02655679|4004837|FG002|Overall Study|Adverse Event|0
2304469|NCT02655679|4004838|FG003|Overall Study|Adverse Event|0
2304470|NCT02655679|4004839|FG004|Overall Study|Adverse Event|0
2304471|NCT02655679|4004835|FG000|Overall Study|Withdrawal by Subject|1
2304472|NCT02655679|4004836|FG001|Overall Study|Withdrawal by Subject|1
2304473|NCT02655679|4004837|FG002|Overall Study|Withdrawal by Subject|0
2304474|NCT02655679|4004838|FG003|Overall Study|Withdrawal by Subject|3
2304475|NCT02655679|4004839|FG004|Overall Study|Withdrawal by Subject|1
2304476|NCT02655679|4004835|FG000|Overall Study|Inability to Comply with the Protocol|1
2304477|NCT02655679|4004836|FG001|Overall Study|Inability to Comply with the Protocol|0
2304478|NCT02655679|4004837|FG002|Overall Study|Inability to Comply with the Protocol|0
2304479|NCT02655679|4004838|FG003|Overall Study|Inability to Comply with the Protocol|0
2304480|NCT02655679|4004839|FG004|Overall Study|Inability to Comply with the Protocol|0
2304481|NCT02655679|4004835|FG000|Overall Study|Lost to Follow-up|0
2304482|NCT02655679|4004836|FG001|Overall Study|Lost to Follow-up|1
2304483|NCT02655679|4004837|FG002|Overall Study|Lost to Follow-up|1
2304484|NCT02655679|4004838|FG003|Overall Study|Lost to Follow-up|1
2304485|NCT02655679|4004839|FG004|Overall Study|Lost to Follow-up|0
2304486|NCT02655679|4004835|FG000|Overall Study|Other Miscellaneous Reasons|1
2304487|NCT02655679|4004836|FG001|Overall Study|Other Miscellaneous Reasons|0
2304488|NCT02655679|4004837|FG002|Overall Study|Other Miscellaneous Reasons|0
2304489|NCT02655679|4004838|FG003|Overall Study|Other Miscellaneous Reasons|0
2304490|NCT02655679|4004839|FG004|Overall Study|Other Miscellaneous Reasons|0
2304491|NCT02655887|4004852|FG000|Overall Study|Lost to Follow-up|3
2304492|NCT02655887|4004852|FG000|Overall Study|Death|4
2304493|NCT02655887|4004852|FG000|Overall Study|Withdrawal by Subject|3
2304494|NCT02655887|4004852|FG000|Overall Study|Missed 12-month follow-up visit|4
2304495|NCT02656173|4004874|FG000|Overall Study|Deviation from the Eligible Criteria|3
2304496|NCT02656173|4004875|FG001|Overall Study|Deviation from the Eligible Criteria|2
2304497|NCT02656173|4004874|FG000|Overall Study|Adverse Event|7
2304498|NCT02656173|4004875|FG001|Overall Study|Adverse Event|5
2304499|NCT02656173|4004874|FG000|Overall Study|Withdrawal by Subject|1
2304500|NCT02656173|4004875|FG001|Overall Study|Withdrawal by Subject|3
2304501|NCT02656173|4004874|FG000|Overall Study|Protocol Violation|0
2304502|NCT02656173|4004875|FG001|Overall Study|Protocol Violation|1
2304503|NCT02656173|4004874|FG000|Overall Study|Miscellaneous|2
2304504|NCT02656173|4004875|FG001|Overall Study|Miscellaneous|0
2304505|NCT02656290|4004883|FG000|Overall Study|Subjects Remain On Study|26
2304506|NCT02656329|4004889|FG000|Overall Study|Lost to Follow-up|2
2304507|NCT02656329|4004890|FG001|Overall Study|Lost to Follow-up|3
2304508|NCT02656329|4004889|FG000|Overall Study|Withdrawal by Subject|7
2304509|NCT02656329|4004890|FG001|Overall Study|Withdrawal by Subject|6
2079447|NCT00688064|3662474|FG001|Overall Study|Any other reasons|3
2304510|NCT02656329|4004889|FG000|Overall Study|Study termination by Sponsor|150
2304511|NCT02656329|4004890|FG001|Overall Study|Study termination by Sponsor|142
2304512|NCT02656329|4004889|FG000|Overall Study|Other than specified above|5
2079448|NCT00688103|3662482|FG000|Overall Study|Adverse Event|4
2079449|NCT00688103|3662483|FG001|Overall Study|Adverse Event|1
2079450|NCT00688103|3662482|FG000|Overall Study|Lack of Efficacy|11
2079451|NCT00688103|3662483|FG001|Overall Study|Lack of Efficacy|1
2079452|NCT00688103|3662482|FG000|Overall Study|Withdrawal by Subject|4
2079453|NCT00688103|3662483|FG001|Overall Study|Withdrawal by Subject|2
2079454|NCT00688103|3662482|FG000|Overall Study|complex reasons|11
2079455|NCT00688103|3662483|FG001|Overall Study|complex reasons|9
2079456|NCT00688155|3662495|FG000|Overall Study|Withdrawal by Subject|2
2079457|NCT00688155|3662496|FG001|Overall Study|Withdrawal by Subject|2
2079458|NCT00688155|3662497|FG002|Overall Study|Withdrawal by Subject|1
2079459|NCT00688155|3662498|FG003|Overall Study|Withdrawal by Subject|1
2079460|NCT00688181|3662508|FG000|Overall Study|Lost to Follow-up|17
2079461|NCT00688181|3662508|FG000|Overall Study|Unknown Reason|4
2079462|NCT00688181|3662508|FG000|Overall Study|Non-clinical Reason|2
2079463|NCT00688259|3662516|FG000|Overall Study|Lost to Follow-up|2
2079464|NCT00688259|3662517|FG001|Overall Study|Lost to Follow-up|4
2079465|NCT00688259|3662516|FG000|Overall Study|Physician Decision|1
2079466|NCT00688259|3662517|FG001|Overall Study|Physician Decision|0
2079467|NCT00688259|3662516|FG000|Overall Study|Withdrawal by Subject|2
2079468|NCT00688259|3662517|FG001|Overall Study|Withdrawal by Subject|0
2079469|NCT00688259|3662516|FG000|Overall Study|Declined Interview|2
2079470|NCT00688259|3662517|FG001|Overall Study|Declined Interview|3
2079471|NCT00688259|3662516|FG000|Overall Study|Hospitalized at Follow-up|0
2079472|NCT00688259|3662517|FG001|Overall Study|Hospitalized at Follow-up|1
2079473|NCT00688324|3662523|FG000|Overall Study|Withdrawal by Subject|2
2079474|NCT00688324|3662523|FG000|Overall Study|Physician Decision|5
2079475|NCT00688324|3662523|FG000|Overall Study|Lost to Follow-up|1
2079476|NCT00688467|3662530|FG000|Treatment Period 1|Adverse Event|2
2079477|NCT00688467|3662531|FG001|Treatment Period 1|Adverse Event|1
2079478|NCT00688467|3662530|FG000|Treatment Period 1|Did not meet protocol eligibility|0
2079479|NCT00688467|3662531|FG001|Treatment Period 1|Did not meet protocol eligibility|1
2079480|NCT00688467|3662530|FG000|Treatment Period 2|Protocol Violation|0
2079481|NCT00688467|3662531|FG001|Treatment Period 2|Protocol Violation|1
2079482|NCT00688467|3662530|FG000|Treatment Period 2|Adverse Event|0
2211136|NCT01657760|3851265|FG002|Overall Study|Physician Decision|1
2211137|NCT01657760|3851266|FG003|Overall Study|Physician Decision|2
2211138|NCT01657799|3851281|FG000|Overall Study|Adverse Event Related to progression|6
2211139|NCT01657799|3851282|FG001|Overall Study|Adverse Event Related to progression|8
2211140|NCT01657799|3851283|FG002|Overall Study|Adverse Event Related to progression|12
2211141|NCT01657799|3851281|FG000|Overall Study|Adverse Event Not Related to Progression|5
2211142|NCT01657799|3851282|FG001|Overall Study|Adverse Event Not Related to Progression|4
2211143|NCT01657799|3851283|FG002|Overall Study|Adverse Event Not Related to Progression|4
2211144|NCT01657799|3851281|FG000|Overall Study|Withdrawal by Subject|13
2211145|NCT01657799|3851282|FG001|Overall Study|Withdrawal by Subject|10
2211146|NCT01657799|3851283|FG002|Overall Study|Withdrawal by Subject|10
2211147|NCT01657799|3851281|FG000|Overall Study|Lost to Follow-up|1
2211148|NCT01657799|3851282|FG001|Overall Study|Lost to Follow-up|0
2211149|NCT01657799|3851283|FG002|Overall Study|Lost to Follow-up|1
2211150|NCT01657799|3851281|FG000|Overall Study|Disease Progression|2
2211151|NCT01657799|3851282|FG001|Overall Study|Disease Progression|4
2079483|NCT00688467|3662531|FG001|Treatment Period 2|Adverse Event|1
2079484|NCT00688519|3662539|FG000|Overall Study|Adverse Event|2
2079485|NCT00688519|3662540|FG001|Overall Study|Adverse Event|3
2079486|NCT00688519|3662539|FG000|Overall Study|Lost to Follow-up|3
2079487|NCT00688519|3662540|FG001|Overall Study|Lost to Follow-up|3
2079488|NCT00688519|3662539|FG000|Overall Study|Lack of Efficacy|3
2079489|NCT00688519|3662540|FG001|Overall Study|Lack of Efficacy|1
2079490|NCT00688519|3662539|FG000|Overall Study|Withdrawal by Subject|7
2079491|NCT00688519|3662540|FG001|Overall Study|Withdrawal by Subject|6
2079492|NCT00688519|3662539|FG000|Overall Study|Prohibited medication|1
2079493|NCT00688519|3662540|FG001|Overall Study|Prohibited medication|0
2079494|NCT00688519|3662539|FG000|Overall Study|Non-compliance|0
2211152|NCT01657799|3851283|FG002|Overall Study|Disease Progression|4
2079495|NCT00688519|3662540|FG001|Overall Study|Non-compliance|1
2079496|NCT00688519|3662539|FG000|Overall Study|Subject moved out of state|1
2079497|NCT00688519|3662540|FG001|Overall Study|Subject moved out of state|0
2079498|NCT00688519|3662539|FG000|Overall Study|Investigator decision|1
2079499|NCT00688519|3662540|FG001|Overall Study|Investigator decision|0
2079500|NCT00688519|3662539|FG000|Overall Study|Subject moved out of area|1
2079501|NCT00688519|3662540|FG001|Overall Study|Subject moved out of area|0
2079502|NCT00688519|3662539|FG000|Overall Study|Pregnancy|0
2079503|NCT00688519|3662540|FG001|Overall Study|Pregnancy|1
2079504|NCT00688545|3662548|FG000|Overall Study|Lost to Follow-up|1
2079505|NCT00688545|3662549|FG001|Overall Study|Lost to Follow-up|4
2079506|NCT00688545|3662548|FG000|Overall Study|Insurance/cost of drug|0
2079507|NCT00688545|3662549|FG001|Overall Study|Insurance/cost of drug|1
2079508|NCT00688545|3662548|FG000|Overall Study|Withdrawal by Subject|2
2079509|NCT00688545|3662549|FG001|Overall Study|Withdrawal by Subject|3
2079510|NCT00688545|3662548|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2
2079511|NCT00688545|3662549|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7
2079512|NCT00688597|3662560|FG000|Overall Study|Adverse Event|2
2079513|NCT00688597|3662561|FG001|Overall Study|Adverse Event|0
2079514|NCT00688597|3662562|FG002|Overall Study|Adverse Event|0
2079515|NCT00688597|3662560|FG000|Overall Study|Physician Decision|1
2079516|NCT00688597|3662561|FG001|Overall Study|Physician Decision|0
2079517|NCT00688597|3662562|FG002|Overall Study|Physician Decision|0
2079518|NCT00688623|3662570|FG000|Overall Study|Adverse Event|22
2079519|NCT00688623|3662570|FG000|Overall Study|abnormal lab value|1
2079520|NCT00688623|3662570|FG000|Overall Study|Withdrawal by Subject|4
2079521|NCT00688623|3662570|FG000|Overall Study|Death|3
2079522|NCT00688623|3662570|FG000|Overall Study|disease progression|23
2079523|NCT00688623|3662570|FG000|Overall Study|Protocol Violation|2
2079524|NCT00688636|3662576|FG000|Overall Study|Adverse Event|2
2079525|NCT00688636|3662577|FG001|Overall Study|Adverse Event|1
2079526|NCT00688688|3662596|FG000|Overall Study|Eligibility criterion not met|7
2079527|NCT00688688|3662597|FG001|Overall Study|Eligibility criterion not met|7
2079528|NCT00688688|3662598|FG002|Overall Study|Eligibility criterion not met|10
2079529|NCT00688688|3662596|FG000|Overall Study|Adverse Event|52
2079530|NCT00688688|3662597|FG001|Overall Study|Adverse Event|51
2079531|NCT00688688|3662598|FG002|Overall Study|Adverse Event|50
2079532|NCT00688688|3662596|FG000|Overall Study|Lack of Efficacy|34
2079533|NCT00688688|3662597|FG001|Overall Study|Lack of Efficacy|25
2079534|NCT00688688|3662598|FG002|Overall Study|Lack of Efficacy|45
2079535|NCT00688688|3662596|FG000|Overall Study|Withdrawal by Subject|66
2079536|NCT00688688|3662597|FG001|Overall Study|Withdrawal by Subject|75
2079537|NCT00688688|3662598|FG002|Overall Study|Withdrawal by Subject|65
2079538|NCT00688688|3662596|FG000|Overall Study|Lost to Follow-up|14
2079539|NCT00688688|3662597|FG001|Overall Study|Lost to Follow-up|7
2079540|NCT00688688|3662598|FG002|Overall Study|Lost to Follow-up|7
2079541|NCT00688688|3662596|FG000|Overall Study|Protocol Violation|6
2079542|NCT00688688|3662597|FG001|Overall Study|Protocol Violation|9
2079543|NCT00688688|3662598|FG002|Overall Study|Protocol Violation|11
2079544|NCT00688688|3662596|FG000|Overall Study|Randomized but never received study drug|1
2079545|NCT00688688|3662597|FG001|Overall Study|Randomized but never received study drug|0
2079546|NCT00688688|3662598|FG002|Overall Study|Randomized but never received study drug|0
2079547|NCT00688688|3662596|FG000|Overall Study|Non-compliance with study procedures|5
2079548|NCT00688688|3662597|FG001|Overall Study|Non-compliance with study procedures|3
2079549|NCT00688688|3662598|FG002|Overall Study|Non-compliance with study procedures|4
2304513|NCT02656329|4004890|FG001|Overall Study|Other than specified above|6
2304514|NCT02656680|4004937|FG000|Overall Study|Lost to Follow-up|0
2304515|NCT02656680|4004938|FG001|Overall Study|Lost to Follow-up|1
2304516|NCT02656693|4004949|FG000|Overall Study|Pregnancy|1
2304517|NCT02656693|4004950|FG001|Overall Study|Pregnancy|1
2304518|NCT02656693|4004951|FG002|Overall Study|Pregnancy|1
2304519|NCT02656693|4004949|FG000|Overall Study|Bariatric surgery|0
2304520|NCT02656693|4004950|FG001|Overall Study|Bariatric surgery|1
2304521|NCT02656693|4004951|FG002|Overall Study|Bariatric surgery|2
2304522|NCT02657031|4004976|FG000|Overall Study|Adverse Event|1
2304523|NCT02657031|4004977|FG001|Overall Study|Adverse Event|2
2304524|NCT02657369|4004999|FG000|Overall Study|Death|27
2304525|NCT02657369|4004999|FG000|Overall Study|Study terminated by sponsor|7
2304526|NCT02657408|4005005|FG000|Overall Study|Adverse Event|3
2304527|NCT02657408|4005006|FG001|Overall Study|Adverse Event|7
2304528|NCT02657889|4005037|FG000|Overall Study|Death|5
2304529|NCT02657889|4005038|FG001|Overall Study|Death|2
2304530|NCT02657889|4005039|FG002|Overall Study|Death|20
2304531|NCT02657889|4005040|FG003|Overall Study|Death|34
2304532|NCT02657889|4005037|FG000|Overall Study|Lost to Follow-up|2
2304533|NCT02657889|4005038|FG001|Overall Study|Lost to Follow-up|0
2304534|NCT02657889|4005039|FG002|Overall Study|Lost to Follow-up|1
2304535|NCT02657889|4005040|FG003|Overall Study|Lost to Follow-up|2
2304536|NCT02657889|4005037|FG000|Overall Study|Withdrawal by Subject|0
2304537|NCT02657889|4005038|FG001|Overall Study|Withdrawal by Subject|0
2304538|NCT02657889|4005039|FG002|Overall Study|Withdrawal by Subject|8
2304539|NCT02657889|4005040|FG003|Overall Study|Withdrawal by Subject|0
2304540|NCT02657889|4005037|FG000|Overall Study|Ongoing in Study|0
2304541|NCT02657889|4005038|FG001|Overall Study|Ongoing in Study|5
2304542|NCT02657889|4005039|FG002|Overall Study|Ongoing in Study|24
2304543|NCT02657889|4005040|FG003|Overall Study|Ongoing in Study|19
2304544|NCT02658019|4005071|FG000|Overall Study|Adverse Event|1
2304545|NCT02658084|4005077|FG000|Overall Study|Withdrawal by Subject|1
2304546|NCT02658084|4005078|FG001|Overall Study|Withdrawal by Subject|0
2304547|NCT02658084|4005077|FG000|Overall Study|Study Termination|1
2304548|NCT02658084|4005078|FG001|Overall Study|Study Termination|0
2304549|NCT02658149|4005085|FG000|Overall Study|Physician Decision|1
2304550|NCT02658149|4005086|FG001|Overall Study|Physician Decision|0
2304551|NCT02658175|4005095|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1
2304552|NCT02658175|4005096|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
2304553|NCT02658175|4005097|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
2304554|NCT02658175|4005095|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6
2304555|NCT02658175|4005096|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2
2304556|NCT02658175|4005097|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0
2304557|NCT02658175|4005095|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8
2304558|NCT02658175|4005096|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5
2304559|NCT02658175|4005097|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0
2321719|NCT02963506|4036371|FG000|Double-Blind Period|Lost to Follow-up|0
2304560|NCT02658175|4005095|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1
2304561|NCT02658175|4005096|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
2304562|NCT02658175|4005097|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
2079550|NCT00688688|3662596|FG000|Overall Study|Taking exclusionary medications|1
2079551|NCT00688688|3662597|FG001|Overall Study|Taking exclusionary medications|0
2079552|NCT00688688|3662598|FG002|Overall Study|Taking exclusionary medications|0
2079553|NCT00688688|3662596|FG000|Overall Study|Site closure|0
2079554|NCT00688688|3662597|FG001|Overall Study|Site closure|1
2079555|NCT00688688|3662598|FG002|Overall Study|Site closure|0
2079556|NCT00688688|3662596|FG000|Overall Study|Violation of exclusion criterion|0
2079557|NCT00688688|3662597|FG001|Overall Study|Violation of exclusion criterion|1
2079558|NCT00688688|3662598|FG002|Overall Study|Violation of exclusion criterion|0
2079559|NCT00688701|3662609|FG000|Overall Study|Adverse Event|1
2079560|NCT00688701|3662610|FG001|Overall Study|Adverse Event|0
2079561|NCT00688701|3662611|FG002|Overall Study|Adverse Event|5
2079562|NCT00688701|3662612|FG003|Overall Study|Adverse Event|3
2079563|NCT00688701|3662609|FG000|Overall Study|Lack of Efficacy|0
2079564|NCT00688701|3662610|FG001|Overall Study|Lack of Efficacy|1
2079565|NCT00688701|3662611|FG002|Overall Study|Lack of Efficacy|0
2079566|NCT00688701|3662612|FG003|Overall Study|Lack of Efficacy|0
2079567|NCT00688701|3662609|FG000|Overall Study|Withdrawal by Subject|3
2079568|NCT00688701|3662610|FG001|Overall Study|Withdrawal by Subject|3
2079569|NCT00688701|3662611|FG002|Overall Study|Withdrawal by Subject|4
2079570|NCT00688701|3662612|FG003|Overall Study|Withdrawal by Subject|8
2079571|NCT00688701|3662609|FG000|Overall Study|Poor compliance to protocol|0
2079572|NCT00688701|3662610|FG001|Overall Study|Poor compliance to protocol|1
2079573|NCT00688701|3662611|FG002|Overall Study|Poor compliance to protocol|1
2079574|NCT00688701|3662612|FG003|Overall Study|Poor compliance to protocol|0
2079575|NCT00688740|3662625|FG000|Overall Study|Adverse Event|45
2079576|NCT00688740|3662626|FG001|Overall Study|Adverse Event|8
2079577|NCT00688740|3662625|FG000|Overall Study|Death|2
2079578|NCT00688740|3662626|FG001|Overall Study|Death|2
2079579|NCT00688740|3662625|FG000|Overall Study|Lost to Follow-up|0
2079580|NCT00688740|3662626|FG001|Overall Study|Lost to Follow-up|1
2079581|NCT00688740|3662625|FG000|Overall Study|Consent Withdrawn|17
2079582|NCT00688740|3662626|FG001|Overall Study|Consent Withdrawn|17
2079583|NCT00688740|3662625|FG000|Overall Study|Breast Cancer Relapse|1
2079584|NCT00688740|3662626|FG001|Overall Study|Breast Cancer Relapse|4
2211153|NCT01657799|3851281|FG000|Overall Study|Progressive Disease Clinical|7
2211154|NCT01657799|3851282|FG001|Overall Study|Progressive Disease Clinical|4
2211155|NCT01657799|3851283|FG002|Overall Study|Progressive Disease Clinical|7
2211156|NCT01657799|3851281|FG000|Overall Study|Radiographic & Clinical Progression|16
2211157|NCT01657799|3851282|FG001|Overall Study|Radiographic & Clinical Progression|11
2211158|NCT01657799|3851283|FG002|Overall Study|Radiographic & Clinical Progression|15
2211159|NCT01657799|3851281|FG000|Overall Study|Other|52
2211160|NCT01657799|3851282|FG001|Overall Study|Other|62
2211161|NCT01657799|3851283|FG002|Overall Study|Other|49
2079585|NCT00688740|3662625|FG000|Overall Study|Violation of Inclusion Criteria|1
2079586|NCT00688740|3662626|FG001|Overall Study|Violation of Inclusion Criteria|3
2079587|NCT00688753|3662632|FG000|Overall Study|Disease progression|55
2079588|NCT00688753|3662632|FG000|Overall Study|Missing|1
2079589|NCT00688753|3662632|FG000|Overall Study|Death|9
2079590|NCT00688753|3662632|FG000|Overall Study|Withdrawal by Subject|3
2079591|NCT00688753|3662632|FG000|Overall Study|Adverse Event|20
2079592|NCT00688753|3662632|FG000|Overall Study|Protocol Violation|1
2211162|NCT01657877|3851291|FG000|Overall Study|Withdrawal by Subject|4
2304563|NCT02658175|4005095|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4
2304564|NCT02658175|4005096|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0
2304565|NCT02658175|4005097|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1
2304566|NCT02658175|4005095|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7
2304567|NCT02658175|4005096|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
2304568|NCT02658175|4005097|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
2304569|NCT02658175|4005095|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1
2304570|NCT02658175|4005096|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0
2304571|NCT02658175|4005097|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1
2304572|NCT02658175|4005095|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8
2304573|NCT02658175|4005096|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2
2211163|NCT01657877|3851291|FG000|Overall Study|Protocol Violation|6
2304574|NCT02658175|4005097|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0
2304575|NCT02658175|4005095|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
2304576|NCT02658175|4005096|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
2304577|NCT02658175|4005097|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1
2304578|NCT02658175|4005095|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1
2304579|NCT02658175|4005096|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
2304580|NCT02658175|4005097|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
2211164|NCT01657877|3851291|FG000|Overall Study|Adverse Event|2
2211165|NCT01657877|3851291|FG000|Overall Study|Other Reason|2
2079593|NCT00688753|3662632|FG000|Overall Study|Lost to Follow-up|3
2079594|NCT00688844|3662636|FG000|Overall Study|Lost to Follow-up|10
2079595|NCT00688870|3662642|FG000|Infant Series|Parent or legal guardian request|4
2079596|NCT00688870|3662643|FG001|Infant Series|Parent or legal guardian request|0
2079597|NCT00688909|3662653|FG000|Overall Study|Adverse Event|28
2079598|NCT00688909|3662653|FG000|Overall Study|Patient withdrew consent|2
2079599|NCT00688909|3662653|FG000|Overall Study|Administrative problems|1
2079600|NCT00688909|3662653|FG000|Overall Study|Protocol Violation|2
2079601|NCT00689026|3662660|FG000|Overall Study|Withdrawal by Subject|13
2079602|NCT00689026|3662661|FG001|Overall Study|Withdrawal by Subject|6
2079603|NCT00689104|3662701|FG000|Overall Study|Eligibility criterion not met|5
2079604|NCT00689104|3662702|FG001|Overall Study|Eligibility criterion not met|8
2079605|NCT00689104|3662703|FG002|Overall Study|Eligibility criterion not met|0
2079606|NCT00689104|3662704|FG003|Overall Study|Eligibility criterion not met|4
2079607|NCT00689104|3662701|FG000|Overall Study|Adverse Event|13
2079608|NCT00689104|3662702|FG001|Overall Study|Adverse Event|25
2079609|NCT00689104|3662703|FG002|Overall Study|Adverse Event|16
2079610|NCT00689104|3662704|FG003|Overall Study|Adverse Event|24
2079611|NCT00689104|3662701|FG000|Overall Study|Lack of Efficacy|5
2079612|NCT00689104|3662702|FG001|Overall Study|Lack of Efficacy|6
2079613|NCT00689104|3662703|FG002|Overall Study|Lack of Efficacy|2
2079614|NCT00689104|3662704|FG003|Overall Study|Lack of Efficacy|3
2079615|NCT00689104|3662701|FG000|Overall Study|Withdrawal by Subject|12
2079616|NCT00689104|3662702|FG001|Overall Study|Withdrawal by Subject|11
2079617|NCT00689104|3662703|FG002|Overall Study|Withdrawal by Subject|18
2079618|NCT00689104|3662704|FG003|Overall Study|Withdrawal by Subject|11
2079619|NCT00689104|3662701|FG000|Overall Study|Lost to Follow-up|4
2079620|NCT00689104|3662702|FG001|Overall Study|Lost to Follow-up|3
2079621|NCT00689104|3662703|FG002|Overall Study|Lost to Follow-up|2
2079622|NCT00689104|3662704|FG003|Overall Study|Lost to Follow-up|5
2079623|NCT00689104|3662701|FG000|Overall Study|Protocol Violation|2
2079624|NCT00689104|3662702|FG001|Overall Study|Protocol Violation|3
2079625|NCT00689104|3662703|FG002|Overall Study|Protocol Violation|5
2079626|NCT00689104|3662704|FG003|Overall Study|Protocol Violation|3
2079627|NCT00689104|3662701|FG000|Overall Study|Randomized but never received study drug|2
2079628|NCT00689104|3662702|FG001|Overall Study|Randomized but never received study drug|1
2079629|NCT00689104|3662703|FG002|Overall Study|Randomized but never received study drug|1
2079630|NCT00689104|3662704|FG003|Overall Study|Randomized but never received study drug|0
2079631|NCT00689104|3662701|FG000|Overall Study|Physician Decision|1
2079632|NCT00689104|3662702|FG001|Overall Study|Physician Decision|0
2079633|NCT00689104|3662703|FG002|Overall Study|Physician Decision|0
2079634|NCT00689104|3662704|FG003|Overall Study|Physician Decision|0
2079635|NCT00689104|3662701|FG000|Overall Study|Non-compliance with study procedures|0
2079636|NCT00689104|3662702|FG001|Overall Study|Non-compliance with study procedures|0
2079637|NCT00689104|3662703|FG002|Overall Study|Non-compliance with study procedures|1
2079638|NCT00689104|3662704|FG003|Overall Study|Non-compliance with study procedures|0
2079639|NCT00689117|3662718|FG000|Overall Study|Adverse Event|6
2079640|NCT00689117|3662719|FG001|Overall Study|Adverse Event|0
2079641|NCT00689117|3662720|FG002|Overall Study|Adverse Event|5
2079642|NCT00689117|3662721|FG003|Overall Study|Adverse Event|0
2079643|NCT00689117|3662718|FG000|Overall Study|Lost to Follow-up|26
2079644|NCT00689117|3662719|FG001|Overall Study|Lost to Follow-up|19
2079645|NCT00689117|3662720|FG002|Overall Study|Lost to Follow-up|17
2079646|NCT00689117|3662721|FG003|Overall Study|Lost to Follow-up|11
2079647|NCT00689117|3662718|FG000|Overall Study|Lack of Efficacy|1
2079648|NCT00689117|3662719|FG001|Overall Study|Lack of Efficacy|2
2079649|NCT00689117|3662720|FG002|Overall Study|Lack of Efficacy|2
2079650|NCT00689117|3662721|FG003|Overall Study|Lack of Efficacy|2
2079651|NCT00689117|3662718|FG000|Overall Study|Non-Compliance with Study Treatment|3
2079652|NCT00689117|3662719|FG001|Overall Study|Non-Compliance with Study Treatment|3
2079653|NCT00689117|3662720|FG002|Overall Study|Non-Compliance with Study Treatment|3
2079654|NCT00689117|3662721|FG003|Overall Study|Non-Compliance with Study Treatment|1
2079655|NCT00689117|3662718|FG000|Overall Study|Withdrawal by Subject|19
2079656|NCT00689117|3662719|FG001|Overall Study|Withdrawal by Subject|18
2079657|NCT00689117|3662720|FG002|Overall Study|Withdrawal by Subject|26
2079658|NCT00689117|3662721|FG003|Overall Study|Withdrawal by Subject|13
2079659|NCT00689117|3662718|FG000|Overall Study|Unable to Comply with Visit Schedule|0
2079660|NCT00689117|3662719|FG001|Overall Study|Unable to Comply with Visit Schedule|0
2079661|NCT00689117|3662720|FG002|Overall Study|Unable to Comply with Visit Schedule|1
2079662|NCT00689117|3662721|FG003|Overall Study|Unable to Comply with Visit Schedule|1
2079663|NCT00689117|3662718|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
2079664|NCT00689117|3662719|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
2079665|NCT00689117|3662720|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2079666|NCT00689117|3662721|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2079667|NCT00689117|3662718|FG000|Overall Study|Non-compliance with Treatment Regimen|0
2079668|NCT00689117|3662719|FG001|Overall Study|Non-compliance with Treatment Regimen|1
2079669|NCT00689117|3662720|FG002|Overall Study|Non-compliance with Treatment Regimen|0
2079670|NCT00689117|3662721|FG003|Overall Study|Non-compliance with Treatment Regimen|0
2079671|NCT00689117|3662718|FG000|Overall Study|Change/Discontinuation of Birth Control|1
2106802|NCT00868790|3700226|FG007|Period 1|Withdrawal by Subject|0
2079672|NCT00689117|3662719|FG001|Overall Study|Change/Discontinuation of Birth Control|1
2079673|NCT00689117|3662720|FG002|Overall Study|Change/Discontinuation of Birth Control|1
2079674|NCT00689117|3662721|FG003|Overall Study|Change/Discontinuation of Birth Control|0
2079675|NCT00689117|3662718|FG000|Overall Study|Use of Prohibitive Medication|2
2079676|NCT00689117|3662719|FG001|Overall Study|Use of Prohibitive Medication|1
2079677|NCT00689117|3662720|FG002|Overall Study|Use of Prohibitive Medication|3
2079678|NCT00689117|3662721|FG003|Overall Study|Use of Prohibitive Medication|0
2079679|NCT00689117|3662718|FG000|Overall Study|Pregnancy|0
2079680|NCT00689117|3662719|FG001|Overall Study|Pregnancy|2
2079681|NCT00689117|3662720|FG002|Overall Study|Pregnancy|0
2079682|NCT00689117|3662721|FG003|Overall Study|Pregnancy|2
2079683|NCT00689117|3662718|FG000|Overall Study|Incarceration|2
2079684|NCT00689117|3662719|FG001|Overall Study|Incarceration|0
2079685|NCT00689117|3662720|FG002|Overall Study|Incarceration|0
2079686|NCT00689117|3662721|FG003|Overall Study|Incarceration|0
2079687|NCT00689117|3662718|FG000|Overall Study|Fear of Birth Defects|0
2079688|NCT00689117|3662719|FG001|Overall Study|Fear of Birth Defects|0
2079689|NCT00689117|3662720|FG002|Overall Study|Fear of Birth Defects|1
2079690|NCT00689117|3662721|FG003|Overall Study|Fear of Birth Defects|0
2079691|NCT00689117|3662718|FG000|Overall Study|Transportation|1
2079692|NCT00689117|3662719|FG001|Overall Study|Transportation|0
2079693|NCT00689117|3662720|FG002|Overall Study|Transportation|0
2079694|NCT00689117|3662721|FG003|Overall Study|Transportation|0
2079695|NCT00689117|3662718|FG000|Overall Study|Patient Withdrew from Study|0
2079696|NCT00689117|3662719|FG001|Overall Study|Patient Withdrew from Study|0
2079697|NCT00689117|3662720|FG002|Overall Study|Patient Withdrew from Study|0
2079698|NCT00689117|3662721|FG003|Overall Study|Patient Withdrew from Study|1
2079699|NCT00689117|3662718|FG000|Overall Study|Personal Reason|0
2079700|NCT00689117|3662719|FG001|Overall Study|Personal Reason|1
2079701|NCT00689117|3662720|FG002|Overall Study|Personal Reason|0
2079702|NCT00689117|3662721|FG003|Overall Study|Personal Reason|0
2079703|NCT00689117|3662718|FG000|Overall Study|Dispensing Error|0
2079704|NCT00689117|3662719|FG001|Overall Study|Dispensing Error|1
2079705|NCT00689117|3662720|FG002|Overall Study|Dispensing Error|0
2079706|NCT00689117|3662721|FG003|Overall Study|Dispensing Error|0
2079707|NCT00689221|3662733|FG000|Overall Study|Ongoing at cut-off date|39
2177274|NCT01372150|3801333|FG002|Overall Study|Lost to Follow-up|6
2177275|NCT01372150|3801331|FG000|Overall Study|Protocol Violation|1
2177276|NCT01372150|3801332|FG001|Overall Study|Protocol Violation|0
2177277|NCT01372150|3801333|FG002|Overall Study|Protocol Violation|3
2079708|NCT00689221|3662734|FG001|Overall Study|Ongoing at cut-off date|36
2304581|NCT02658448|4005114|FG000|Overall Study|Lost to Follow-up|1
2304582|NCT02658487|4005133|FG000|Overall Study|Death|2
2304583|NCT02658487|4005133|FG000|Overall Study|Disease progression|10
2304584|NCT02658487|4005133|FG000|Overall Study|Alternative therapy|1
2079709|NCT00689273|3662754|FG000|Overall Study|Adverse Event|3
2304585|NCT02658487|4005133|FG000|Overall Study|Adverse Event|1
2304586|NCT02658487|4005133|FG000|Overall Study|Treatment Failure, circulating blasts|1
2304587|NCT02658487|4005133|FG000|Overall Study|Refractory AML|1
2304588|NCT02658630|4005138|FG000|Overall Study|Withdrawal by Subject|4
2304589|NCT02658734|4005142|FG000|Overall Study|Adverse Event|2
2304590|NCT02658734|4005142|FG000|Overall Study|Death|4
2304591|NCT02658734|4005142|FG000|Overall Study|Lost to Follow-up|7
2304592|NCT02658734|4005142|FG000|Overall Study|Withdrawal of Consent|16
2304593|NCT02658734|4005142|FG000|Overall Study|Disease Progression|28
2304594|NCT02659020|4005171|FG000|Overall Study|Adverse Event|1
2304595|NCT02659020|4005172|FG001|Overall Study|Adverse Event|0
2304596|NCT02659020|4005173|FG002|Overall Study|Adverse Event|0
2304597|NCT02659020|4005174|FG003|Overall Study|Adverse Event|6
2304598|NCT02659020|4005175|FG004|Overall Study|Adverse Event|3
2304599|NCT02659020|4005176|FG005|Overall Study|Adverse Event|4
2304600|NCT02659020|4005177|FG006|Overall Study|Adverse Event|4
2304601|NCT02659020|4005171|FG000|Overall Study|Lost to Follow-up|1
2304602|NCT02659020|4005172|FG001|Overall Study|Lost to Follow-up|2
2304603|NCT02659020|4005173|FG002|Overall Study|Lost to Follow-up|1
2304604|NCT02659020|4005174|FG003|Overall Study|Lost to Follow-up|4
2304605|NCT02659020|4005175|FG004|Overall Study|Lost to Follow-up|1
2304606|NCT02659020|4005176|FG005|Overall Study|Lost to Follow-up|5
2304607|NCT02659020|4005177|FG006|Overall Study|Lost to Follow-up|0
2304608|NCT02659020|4005171|FG000|Overall Study|Physician Decision|0
2304609|NCT02659020|4005172|FG001|Overall Study|Physician Decision|0
2304610|NCT02659020|4005173|FG002|Overall Study|Physician Decision|1
2304611|NCT02659020|4005174|FG003|Overall Study|Physician Decision|1
2304612|NCT02659020|4005175|FG004|Overall Study|Physician Decision|6
2304613|NCT02659020|4005176|FG005|Overall Study|Physician Decision|3
2304614|NCT02659020|4005177|FG006|Overall Study|Physician Decision|1
2304615|NCT02659020|4005171|FG000|Overall Study|Withdrawal by Subject|2
2304616|NCT02659020|4005172|FG001|Overall Study|Withdrawal by Subject|3
2304617|NCT02659020|4005173|FG002|Overall Study|Withdrawal by Subject|1
2079710|NCT00689273|3662755|FG001|Overall Study|Adverse Event|1
2079711|NCT00689273|3662754|FG000|Overall Study|Lack of Efficacy|3
2079712|NCT00689273|3662755|FG001|Overall Study|Lack of Efficacy|0
2177278|NCT01372150|3801331|FG000|Overall Study|Withdrawal by Subject|2
2177279|NCT01372150|3801332|FG001|Overall Study|Withdrawal by Subject|7
2177280|NCT01372150|3801333|FG002|Overall Study|Withdrawal by Subject|2
2079713|NCT00689273|3662754|FG000|Overall Study|Lost to Follow-up|0
2079714|NCT00689273|3662755|FG001|Overall Study|Lost to Follow-up|2
2079715|NCT00689273|3662754|FG000|Overall Study|Other|6
2079716|NCT00689273|3662755|FG001|Overall Study|Other|2
2079717|NCT00689273|3662754|FG000|Overall Study|Randomized but not Treated|1
2079718|NCT00689273|3662755|FG001|Overall Study|Randomized but not Treated|0
2079719|NCT00689299|3662764|FG000|Overall Study|Adverse Event|2
2079720|NCT00689299|3662765|FG001|Overall Study|Adverse Event|1
2079721|NCT00689299|3662766|FG002|Overall Study|Adverse Event|1
2079722|NCT00689299|3662764|FG000|Overall Study|Lost to Follow-up|0
2079723|NCT00689299|3662765|FG001|Overall Study|Lost to Follow-up|1
2079724|NCT00689299|3662766|FG002|Overall Study|Lost to Follow-up|1
2079725|NCT00689299|3662764|FG000|Overall Study|Withdrawal by Subject|4
2079726|NCT00689299|3662765|FG001|Overall Study|Withdrawal by Subject|1
2079727|NCT00689299|3662766|FG002|Overall Study|Withdrawal by Subject|3
2079728|NCT00689299|3662764|FG000|Overall Study|Protocol Violation|1
2079729|NCT00689299|3662765|FG001|Overall Study|Protocol Violation|0
2079730|NCT00689299|3662766|FG002|Overall Study|Protocol Violation|0
2079731|NCT00689338|3662774|FG000|Overall Study|Death|65
2079732|NCT00689338|3662774|FG000|Overall Study|Adverse Event|13
2079733|NCT00689338|3662774|FG000|Overall Study|Insufficient Clinical Response|1
2079734|NCT00689338|3662774|FG000|Overall Study|Lack of Efficacy|6
2079735|NCT00689338|3662774|FG000|Overall Study|Other|8
2079736|NCT00689338|3662774|FG000|Overall Study|Did not Meet Entrance Criteria|27
2079737|NCT00689338|3662774|FG000|Overall Study|Lost to Follow-up|5
2079738|NCT00689338|3662774|FG000|Overall Study|Withdrawal by Subject|3
2079739|NCT00689338|3662774|FG000|Overall Study|Protocol Violation|15
2079740|NCT00689351|3662780|FG000|Infant Series of Dosing|Parent/legal guardian request|5
2079741|NCT00689351|3662781|FG001|Infant Series of Dosing|Parent/legal guardian request|0
2079742|NCT00689351|3662780|FG000|Infant Series of Dosing|Adverse Event|1
2079743|NCT00689351|3662781|FG001|Infant Series of Dosing|Adverse Event|0
2079744|NCT00689351|3662780|FG000|Infant Series of Dosing|Lost to Follow-up|0
2079745|NCT00689351|3662781|FG001|Infant Series of Dosing|Lost to Follow-up|1
2079746|NCT00689351|3662780|FG000|After Infant Series|Parent/legal guardian request|1
2079747|NCT00689351|3662781|FG001|After Infant Series|Parent/legal guardian request|0
2079748|NCT00689390|3662793|FG000|Overall Study|Adverse Event|19
2079749|NCT00689390|3662794|FG001|Overall Study|Adverse Event|0
2079750|NCT00689390|3662793|FG000|Overall Study|Lost to Follow-up|179
2079751|NCT00689390|3662794|FG001|Overall Study|Lost to Follow-up|7
2079752|NCT00689390|3662793|FG000|Overall Study|Withdrawal by Subject|117
2079753|NCT00689390|3662794|FG001|Overall Study|Withdrawal by Subject|3
2079754|NCT00689390|3662793|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52
2079755|NCT00689390|3662794|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0
2079756|NCT00689390|3662793|FG000|Overall Study|Non-Compliance With Protocol|21
2079757|NCT00689390|3662794|FG001|Overall Study|Non-Compliance With Protocol|0
2079758|NCT00689390|3662793|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
2079759|NCT00689390|3662794|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
2079760|NCT00689390|3662793|FG000|Overall Study|Administrative|37
2079761|NCT00689390|3662794|FG001|Overall Study|Administrative|0
2079762|NCT00689481|3662807|FG000|Overall Study|Adverse Event|7
2079763|NCT00689481|3662808|FG001|Overall Study|Adverse Event|1
2079764|NCT00689481|3662807|FG000|Overall Study|Lost to Follow-up|4
2079765|NCT00689481|3662808|FG001|Overall Study|Lost to Follow-up|3
2079766|NCT00689481|3662807|FG000|Overall Study|Lack of Efficacy|4
2079767|NCT00689481|3662808|FG001|Overall Study|Lack of Efficacy|3
2079768|NCT00689481|3662807|FG000|Overall Study|Non-compliance with study treatment|1
2079769|NCT00689481|3662808|FG001|Overall Study|Non-compliance with study treatment|1
2079770|NCT00689481|3662807|FG000|Overall Study|Withdrawal by Subject|8
2079771|NCT00689481|3662808|FG001|Overall Study|Withdrawal by Subject|4
2079772|NCT00689481|3662807|FG000|Overall Study|Excluded medication started during study|0
2079773|NCT00689481|3662808|FG001|Overall Study|Excluded medication started during study|1
2079774|NCT00689481|3662807|FG000|Overall Study|Subject early term, left on vacation|0
2079775|NCT00689481|3662808|FG001|Overall Study|Subject early term, left on vacation|1
2079776|NCT00689611|3662825|FG000|Overall Study|Death|6
2079777|NCT00689611|3662826|FG001|Overall Study|Death|9
2079778|NCT00689611|3662825|FG000|Overall Study|Withdrawal by Subject|8
2079779|NCT00689611|3662826|FG001|Overall Study|Withdrawal by Subject|9
2079780|NCT00689611|3662825|FG000|Overall Study|Lost to Follow-up|27
2079781|NCT00689611|3662826|FG001|Overall Study|Lost to Follow-up|28
2079782|NCT00689728|3662835|FG000|Double-Blind Treatment|Adverse Event|1
2079783|NCT00689728|3662836|FG001|Double-Blind Treatment|Adverse Event|0
2079784|NCT00689728|3662837|FG002|Double-Blind Treatment|Adverse Event|0
2079785|NCT00689728|3662835|FG000|Double-Blind Treatment|Protocol Violation|0
2079786|NCT00689728|3662836|FG001|Double-Blind Treatment|Protocol Violation|0
2079787|NCT00689728|3662837|FG002|Double-Blind Treatment|Protocol Violation|1
2079788|NCT00689728|3662835|FG000|Double-Blind Treatment|Withdrawal by Subject|3
2079789|NCT00689728|3662836|FG001|Double-Blind Treatment|Withdrawal by Subject|3
2079790|NCT00689728|3662837|FG002|Double-Blind Treatment|Withdrawal by Subject|2
2079791|NCT00689728|3662835|FG000|Double-Blind Treatment|Lack of Efficacy|0
2079792|NCT00689728|3662836|FG001|Double-Blind Treatment|Lack of Efficacy|1
2079793|NCT00689728|3662837|FG002|Double-Blind Treatment|Lack of Efficacy|2
2079794|NCT00689728|3662835|FG000|Rescue|Adverse Event|0
2079795|NCT00689728|3662836|FG001|Rescue|Adverse Event|1
2079796|NCT00689728|3662837|FG002|Rescue|Adverse Event|0
2079797|NCT00689728|3662835|FG000|Rescue|Withdrawal by Subject|1
2079798|NCT00689728|3662836|FG001|Rescue|Withdrawal by Subject|1
2079799|NCT00689728|3662837|FG002|Rescue|Withdrawal by Subject|1
2079800|NCT00689728|3662835|FG000|Optional Follow-Up|Adverse Event|1
2079801|NCT00689728|3662836|FG001|Optional Follow-Up|Adverse Event|0
2079802|NCT00689728|3662837|FG002|Optional Follow-Up|Adverse Event|0
2079803|NCT00689728|3662835|FG000|Optional Follow-Up|Lack of Efficacy|0
2079804|NCT00689728|3662836|FG001|Optional Follow-Up|Lack of Efficacy|1
2079805|NCT00689728|3662837|FG002|Optional Follow-Up|Lack of Efficacy|1
2079806|NCT00689728|3662835|FG000|Optional Follow-Up|Lost to Follow-up|0
2079807|NCT00689728|3662836|FG001|Optional Follow-Up|Lost to Follow-up|1
2079808|NCT00689728|3662837|FG002|Optional Follow-Up|Lost to Follow-up|1
2079809|NCT00689728|3662835|FG000|Optional Follow-Up|Protocol Violation|0
2079810|NCT00689728|3662836|FG001|Optional Follow-Up|Protocol Violation|0
2079811|NCT00689728|3662837|FG002|Optional Follow-Up|Protocol Violation|1
2079812|NCT00689728|3662835|FG000|Optional Follow-Up|Withdrawal by Subject|2
2079813|NCT00689728|3662836|FG001|Optional Follow-Up|Withdrawal by Subject|4
2079814|NCT00689728|3662837|FG002|Optional Follow-Up|Withdrawal by Subject|3
2079815|NCT00689793|3662868|FG000|Overall Study|Lost to Follow-up|4
2079816|NCT00689793|3662869|FG001|Overall Study|Lost to Follow-up|5
2079817|NCT00689871|3662890|FG000|Overall Study|Lost to Follow-up|123
2079818|NCT00689871|3662891|FG001|Overall Study|Lost to Follow-up|13
2079819|NCT00689871|3662892|FG002|Overall Study|Lost to Follow-up|37
2079820|NCT00689871|3662893|FG003|Overall Study|Lost to Follow-up|1
2079821|NCT00689871|3662890|FG000|Overall Study|Explanted of All Study Devices|36
2079822|NCT00689871|3662891|FG001|Overall Study|Explanted of All Study Devices|25
2079823|NCT00689871|3662892|FG002|Overall Study|Explanted of All Study Devices|29
2079824|NCT00689871|3662893|FG003|Overall Study|Explanted of All Study Devices|3
2079825|NCT00689871|3662890|FG000|Overall Study|Withdrawal by Subject|13
2079826|NCT00689871|3662891|FG001|Overall Study|Withdrawal by Subject|3
2079827|NCT00689871|3662892|FG002|Overall Study|Withdrawal by Subject|4
2079828|NCT00689871|3662893|FG003|Overall Study|Withdrawal by Subject|1
2079829|NCT00689871|3662890|FG000|Overall Study|Death|1
2079830|NCT00689871|3662891|FG001|Overall Study|Death|10
2079831|NCT00689871|3662892|FG002|Overall Study|Death|2
2079832|NCT00689871|3662893|FG003|Overall Study|Death|2
2079833|NCT00689871|3662890|FG000|Overall Study|Physician Decision|2
2079834|NCT00689871|3662891|FG001|Overall Study|Physician Decision|1
2079835|NCT00689871|3662892|FG002|Overall Study|Physician Decision|1
2079836|NCT00689871|3662893|FG003|Overall Study|Physician Decision|0
2079837|NCT00689936|3662906|FG000|Active Treatment Phase|Adverse Event|68
2079838|NCT00689936|3662907|FG001|Active Treatment Phase|Adverse Event|71
2079839|NCT00689936|3662908|FG002|Active Treatment Phase|Adverse Event|76
2079840|NCT00689936|3662906|FG000|Active Treatment Phase|Disease Progression|273
2079841|NCT00689936|3662907|FG001|Active Treatment Phase|Disease Progression|362
2079842|NCT00689936|3662908|FG002|Active Treatment Phase|Disease Progression|339
2079843|NCT00689936|3662906|FG000|Active Treatment Phase|Withdrawal by Subject|16
2079844|NCT00689936|3662907|FG001|Active Treatment Phase|Withdrawal by Subject|16
2079845|NCT00689936|3662908|FG002|Active Treatment Phase|Withdrawal by Subject|21
2304618|NCT02659020|4005174|FG003|Overall Study|Withdrawal by Subject|4
2304619|NCT02659020|4005175|FG004|Overall Study|Withdrawal by Subject|4
2304620|NCT02659020|4005176|FG005|Overall Study|Withdrawal by Subject|9
2304621|NCT02659020|4005177|FG006|Overall Study|Withdrawal by Subject|3
2304622|NCT02659020|4005171|FG000|Overall Study|Progressive Disease|2
2304623|NCT02659020|4005172|FG001|Overall Study|Progressive Disease|2
2304624|NCT02659020|4005173|FG002|Overall Study|Progressive Disease|2
2304625|NCT02659020|4005174|FG003|Overall Study|Progressive Disease|15
2304626|NCT02659020|4005175|FG004|Overall Study|Progressive Disease|6
2304627|NCT02659020|4005176|FG005|Overall Study|Progressive Disease|7
2304628|NCT02659020|4005177|FG006|Overall Study|Progressive Disease|6
2304629|NCT02659020|4005171|FG000|Overall Study|On Treatment|0
2304630|NCT02659020|4005172|FG001|Overall Study|On Treatment|0
2304631|NCT02659020|4005173|FG002|Overall Study|On Treatment|0
2304632|NCT02659020|4005174|FG003|Overall Study|On Treatment|0
2304633|NCT02659020|4005175|FG004|Overall Study|On Treatment|0
2304634|NCT02659020|4005176|FG005|Overall Study|On Treatment|0
2304635|NCT02659020|4005177|FG006|Overall Study|On Treatment|1
2304636|NCT02659059|4005202|FG000|Overall Study|Completed|1
2304637|NCT02659059|4005203|FG001|Overall Study|Completed|0
2304638|NCT02659059|4005202|FG000|Overall Study|Other reasons|8
2304639|NCT02659059|4005203|FG001|Overall Study|Other reasons|2
2304640|NCT02659059|4005202|FG000|Overall Study|Disease Progression|120
2304641|NCT02659059|4005203|FG001|Overall Study|Disease Progression|16
2304642|NCT02659059|4005202|FG000|Overall Study|Study Drug toxicity|37
2304643|NCT02659059|4005203|FG001|Overall Study|Study Drug toxicity|9
2304644|NCT02659059|4005202|FG000|Overall Study|Death|2
2304645|NCT02659059|4005203|FG001|Overall Study|Death|1
2304646|NCT02659059|4005202|FG000|Overall Study|Adverse Event unrelated to Study drug|22
2079846|NCT00689936|3662906|FG000|Active Treatment Phase|Death|60
2079847|NCT00689936|3662907|FG001|Active Treatment Phase|Death|28
2304647|NCT02659059|4005203|FG001|Overall Study|Adverse Event unrelated to Study drug|4
2304648|NCT02659059|4005202|FG000|Overall Study|Participant request to discontinue study treatment|5
2079848|NCT00689936|3662908|FG002|Active Treatment Phase|Death|37
2079849|NCT00689936|3662906|FG000|Active Treatment Phase|Lost to Follow-up|0
2079850|NCT00689936|3662907|FG001|Active Treatment Phase|Lost to Follow-up|2
2079851|NCT00689936|3662908|FG002|Active Treatment Phase|Lost to Follow-up|2
2079852|NCT00689936|3662906|FG000|Active Treatment Phase|Protocol Violation|2
2079853|NCT00689936|3662907|FG001|Active Treatment Phase|Protocol Violation|2
2079854|NCT00689936|3662908|FG002|Active Treatment Phase|Protocol Violation|4
2211166|NCT01657903|3851308|FG000|Overall Study|Lost to Follow-up|1
2079855|NCT00689936|3662906|FG000|Active Treatment Phase|Study Close Out|64
2079856|NCT00689936|3662907|FG001|Active Treatment Phase|Study Close Out|26
2079857|NCT00689936|3662908|FG002|Active Treatment Phase|Study Close Out|21
2079858|NCT00689936|3662906|FG000|Active Treatment Phase|Miscellaneous|52
2079859|NCT00689936|3662907|FG001|Active Treatment Phase|Miscellaneous|34
2079860|NCT00689936|3662908|FG002|Active Treatment Phase|Miscellaneous|47
2079861|NCT00689936|3662906|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
2079862|NCT00689936|3662907|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
2079863|NCT00689936|3662908|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
2079864|NCT00690378|3662962|FG000|Overall Study|Adverse Event|1
2079865|NCT00690378|3662963|FG001|Overall Study|Adverse Event|0
2079866|NCT00690378|3662962|FG000|Overall Study|Withdrawal by Subject|2
2079867|NCT00690378|3662963|FG001|Overall Study|Withdrawal by Subject|0
2079868|NCT00690378|3662962|FG000|Overall Study|Protocol Violation|1
2079869|NCT00690378|3662963|FG001|Overall Study|Protocol Violation|0
2079870|NCT00690378|3662962|FG000|Overall Study|Lost to Follow-up|2
2079871|NCT00690378|3662963|FG001|Overall Study|Lost to Follow-up|3
2079872|NCT00690378|3662962|FG000|Overall Study|Did not meet inc/exc criteria|13
2079873|NCT00690378|3662963|FG001|Overall Study|Did not meet inc/exc criteria|11
2079874|NCT00690378|3662962|FG000|Overall Study|Social problem|1
2079875|NCT00690378|3662963|FG001|Overall Study|Social problem|0
2079876|NCT00690430|3662971|FG000|Core Phase|Abnormal Laboratory value|0
2079877|NCT00690430|3662972|FG001|Core Phase|Abnormal Laboratory value|1
2079878|NCT00690430|3662973|FG002|Core Phase|Abnormal Laboratory value|0
2079879|NCT00690430|3662971|FG000|Core Phase|Adverse Event|5
2079880|NCT00690430|3662972|FG001|Core Phase|Adverse Event|1
2079881|NCT00690430|3662973|FG002|Core Phase|Adverse Event|0
2079882|NCT00690430|3662971|FG000|Core Phase|Death|0
2079883|NCT00690430|3662972|FG001|Core Phase|Death|2
2079884|NCT00690430|3662973|FG002|Core Phase|Death|0
2079885|NCT00690430|3662971|FG000|Core Phase|Protocol Violation|1
2079886|NCT00690430|3662972|FG001|Core Phase|Protocol Violation|0
2079887|NCT00690430|3662973|FG002|Core Phase|Protocol Violation|0
2079888|NCT00690430|3662971|FG000|Core Phase|Withdrawal by Subject|3
2079889|NCT00690430|3662972|FG001|Core Phase|Withdrawal by Subject|3
2079890|NCT00690430|3662973|FG002|Core Phase|Withdrawal by Subject|0
2079891|NCT00690430|3662971|FG000|Core Phase|Subject no longer requires study drug|1
2079892|NCT00690430|3662972|FG001|Core Phase|Subject no longer requires study drug|0
2079893|NCT00690430|3662973|FG002|Core Phase|Subject no longer requires study drug|0
2079894|NCT00690430|3662971|FG000|Core Phase|Lack of Efficacy|8
2079895|NCT00690430|3662972|FG001|Core Phase|Lack of Efficacy|10
2079896|NCT00690430|3662973|FG002|Core Phase|Lack of Efficacy|0
2079897|NCT00690430|3662971|FG000|Core Phase|Administrative Problems|0
2079898|NCT00690430|3662972|FG001|Core Phase|Administrative Problems|1
2304649|NCT02659059|4005203|FG001|Overall Study|Participant request to discontinue study treatment|0
2304650|NCT02659059|4005202|FG000|Overall Study|Participant withdrew consent|4
2304651|NCT02659059|4005203|FG001|Overall Study|Participant withdrew consent|0
2304652|NCT02659059|4005202|FG000|Overall Study|Lost to Follow-up|1
2304653|NCT02659059|4005203|FG001|Overall Study|Lost to Follow-up|0
2304654|NCT02659098|4005210|FG000|Overall Study|Withdrawal by Subject|7
2304655|NCT02659150|4005214|FG000|Subject Enrollment|Physician Decision|3
2304656|NCT02659150|4005214|FG000|Subject Enrollment|Withdrawal by Subject|2
2304657|NCT02659150|4005214|FG000|Baseline Imaging|Withdrawal by Subject|1
2304658|NCT02659150|4005214|FG000|Baseline Imaging|Physician Decision|1
2304659|NCT02659150|4005214|FG000|Study Drug Dosing|Adverse Event|1
2304660|NCT02659540|4005230|FG000|Overall Study|Adverse Event|3
2304661|NCT02659540|4005231|FG001|Overall Study|Adverse Event|2
2304662|NCT02659540|4005230|FG000|Overall Study|Death|1
2304663|NCT02659540|4005231|FG001|Overall Study|Death|0
2304664|NCT02659540|4005230|FG000|Overall Study|Progressive disease|2
2304665|NCT02659540|4005231|FG001|Overall Study|Progressive disease|6
2304666|NCT02659631|4005247|FG000|Overall Study|Lost to Follow-up|0
2304667|NCT02659631|4005248|FG001|Overall Study|Lost to Follow-up|0
2304668|NCT02659631|4005249|FG002|Overall Study|Lost to Follow-up|2
2304669|NCT02659631|4005250|FG003|Overall Study|Lost to Follow-up|0
2304670|NCT02659631|4005251|FG004|Overall Study|Lost to Follow-up|0
2304671|NCT02659631|4005252|FG005|Overall Study|Lost to Follow-up|1
2304672|NCT02659631|4005253|FG006|Overall Study|Lost to Follow-up|0
2304673|NCT02659631|4005254|FG007|Overall Study|Lost to Follow-up|0
2304674|NCT02659631|4005255|FG008|Overall Study|Lost to Follow-up|0
2304675|NCT02659631|4005256|FG009|Overall Study|Lost to Follow-up|0
2304676|NCT02659631|4005247|FG000|Overall Study|Withdrawal prior to treatment|0
2079899|NCT00690430|3662973|FG002|Core Phase|Administrative Problems|0
2079900|NCT00690430|3662971|FG000|Core Phase|Early Termination|0
2211167|NCT01657903|3851308|FG000|Overall Study|Withdrawal by Subject|1
2304677|NCT02659631|4005248|FG001|Overall Study|Withdrawal prior to treatment|0
2079901|NCT00690430|3662972|FG001|Core Phase|Early Termination|5
2079902|NCT00690430|3662973|FG002|Core Phase|Early Termination|0
2079903|NCT00690430|3662971|FG000|Extension Phase|Lack of Efficacy|3
2079904|NCT00690430|3662972|FG001|Extension Phase|Lack of Efficacy|1
2079905|NCT00690430|3662973|FG002|Extension Phase|Lack of Efficacy|4
2079906|NCT00690430|3662971|FG000|Extension Phase|Abnormal Lab Values|1
2079907|NCT00690430|3662972|FG001|Extension Phase|Abnormal Lab Values|0
2079908|NCT00690430|3662973|FG002|Extension Phase|Abnormal Lab Values|0
2079909|NCT00690430|3662971|FG000|Extension Phase|Abnormal test procedure results|1
2079910|NCT00690430|3662972|FG001|Extension Phase|Abnormal test procedure results|0
2079911|NCT00690430|3662973|FG002|Extension Phase|Abnormal test procedure results|0
2079912|NCT00690430|3662971|FG000|Extension Phase|Administrative Problems|0
2079913|NCT00690430|3662972|FG001|Extension Phase|Administrative Problems|1
2079914|NCT00690430|3662973|FG002|Extension Phase|Administrative Problems|1
2079915|NCT00690430|3662971|FG000|Extension Phase|Adverse Event|2
2079916|NCT00690430|3662972|FG001|Extension Phase|Adverse Event|1
2079917|NCT00690430|3662973|FG002|Extension Phase|Adverse Event|2
2079918|NCT00690430|3662971|FG000|Extension Phase|Death|1
2079919|NCT00690430|3662972|FG001|Extension Phase|Death|1
2211168|NCT01658020|3851321|FG000|Overall Study|Adverse Event|3
2211169|NCT01658020|3851322|FG001|Overall Study|Adverse Event|3
2211170|NCT01658020|3851321|FG000|Overall Study|Lost to Follow-up|1
2211171|NCT01658020|3851322|FG001|Overall Study|Lost to Follow-up|0
2211172|NCT01658020|3851321|FG000|Overall Study|Withdrawal by Subject|4
2211173|NCT01658020|3851322|FG001|Overall Study|Withdrawal by Subject|5
2211174|NCT01658020|3851321|FG000|Overall Study|Protocol Violation|0
2211175|NCT01658020|3851322|FG001|Overall Study|Protocol Violation|1
2211176|NCT01658072|3851338|FG000|Overall Study|Protocol Violation|4
2211177|NCT01658072|3851339|FG001|Overall Study|Protocol Violation|2
2211178|NCT01658150|3851345|FG000|Overall Study|Withdrawal by Subject|1
2304678|NCT02659631|4005249|FG002|Overall Study|Withdrawal prior to treatment|0
2304679|NCT02659631|4005250|FG003|Overall Study|Withdrawal prior to treatment|0
2304680|NCT02659631|4005251|FG004|Overall Study|Withdrawal prior to treatment|1
2304681|NCT02659631|4005252|FG005|Overall Study|Withdrawal prior to treatment|0
2304682|NCT02659631|4005253|FG006|Overall Study|Withdrawal prior to treatment|0
2304683|NCT02659631|4005254|FG007|Overall Study|Withdrawal prior to treatment|0
2304684|NCT02659631|4005255|FG008|Overall Study|Withdrawal prior to treatment|0
2304685|NCT02659631|4005256|FG009|Overall Study|Withdrawal prior to treatment|0
2304686|NCT02659631|4005247|FG000|Overall Study|Participant refused further follow-up|0
2304687|NCT02659631|4005248|FG001|Overall Study|Participant refused further follow-up|0
2304688|NCT02659631|4005249|FG002|Overall Study|Participant refused further follow-up|0
2304689|NCT02659631|4005250|FG003|Overall Study|Participant refused further follow-up|1
2304690|NCT02659631|4005251|FG004|Overall Study|Participant refused further follow-up|0
2304691|NCT02659631|4005252|FG005|Overall Study|Participant refused further follow-up|0
2304692|NCT02659631|4005253|FG006|Overall Study|Participant refused further follow-up|0
2304693|NCT02659631|4005254|FG007|Overall Study|Participant refused further follow-up|0
2304694|NCT02659631|4005255|FG008|Overall Study|Participant refused further follow-up|1
2304695|NCT02659631|4005256|FG009|Overall Study|Participant refused further follow-up|0
2304696|NCT02659631|4005247|FG000|Overall Study|Death (follow-up phase)|1
2304697|NCT02659631|4005248|FG001|Overall Study|Death (follow-up phase)|2
2304698|NCT02659631|4005249|FG002|Overall Study|Death (follow-up phase)|1
2304699|NCT02659631|4005250|FG003|Overall Study|Death (follow-up phase)|1
2304700|NCT02659631|4005251|FG004|Overall Study|Death (follow-up phase)|3
2304701|NCT02659631|4005252|FG005|Overall Study|Death (follow-up phase)|2
2304702|NCT02659631|4005253|FG006|Overall Study|Death (follow-up phase)|0
2304703|NCT02659631|4005254|FG007|Overall Study|Death (follow-up phase)|3
2304704|NCT02659631|4005255|FG008|Overall Study|Death (follow-up phase)|1
2304705|NCT02659631|4005256|FG009|Overall Study|Death (follow-up phase)|0
2304706|NCT02659631|4005247|FG000|Overall Study|Death (treatment phase)|0
2304707|NCT02659631|4005248|FG001|Overall Study|Death (treatment phase)|0
2304708|NCT02659631|4005249|FG002|Overall Study|Death (treatment phase)|0
2304709|NCT02659631|4005250|FG003|Overall Study|Death (treatment phase)|0
2304710|NCT02659631|4005251|FG004|Overall Study|Death (treatment phase)|1
2304711|NCT02659631|4005252|FG005|Overall Study|Death (treatment phase)|0
2304712|NCT02659631|4005253|FG006|Overall Study|Death (treatment phase)|1
2304713|NCT02659631|4005254|FG007|Overall Study|Death (treatment phase)|0
2304714|NCT02659631|4005255|FG008|Overall Study|Death (treatment phase)|0
2304715|NCT02659631|4005256|FG009|Overall Study|Death (treatment phase)|0
2304716|NCT02659943|4005298|FG000|Overall Study|Switched to alternative treatment|1
2304717|NCT02659943|4005299|FG001|Overall Study|Switched to alternative treatment|1
2304718|NCT02659943|4005300|FG002|Overall Study|Switched to alternative treatment|0
2304719|NCT02659943|4005301|FG003|Overall Study|Switched to alternative treatment|2
2304720|NCT02659943|4005302|FG004|Overall Study|Switched to alternative treatment|1
2304721|NCT02659943|4005303|FG005|Overall Study|Switched to alternative treatment|0
2304722|NCT02659943|4005304|FG006|Overall Study|Switched to alternative treatment|1
2079920|NCT00690430|3662973|FG002|Extension Phase|Death|1
2079921|NCT00690430|3662971|FG000|Extension Phase|Withdrawal by Subject|0
2211179|NCT01658436|3851359|FG000|Overall Study|Adverse Event|6
2211180|NCT01658436|3851360|FG001|Overall Study|Adverse Event|5
2211181|NCT01658436|3851359|FG000|Overall Study|Physician Decision|1
2079922|NCT00690430|3662972|FG001|Extension Phase|Withdrawal by Subject|0
2079923|NCT00690430|3662973|FG002|Extension Phase|Withdrawal by Subject|2
2079924|NCT00690430|3662971|FG000|Extension Phase|Early Termination|10
2079925|NCT00690430|3662972|FG001|Extension Phase|Early Termination|1
2079926|NCT00690430|3662973|FG002|Extension Phase|Early Termination|3
2079927|NCT00690443|3662984|FG000|Overall Study|Adverse Event|1
2079928|NCT00690443|3662985|FG001|Overall Study|Adverse Event|2
2079929|NCT00690482|3662993|FG000|Overall Study|Adverse Event|2
2079930|NCT00690482|3662994|FG001|Overall Study|Adverse Event|1
2211182|NCT01658436|3851360|FG001|Overall Study|Physician Decision|0
2304723|NCT02659943|4005298|FG000|Overall Study|Disease progression on study|0
2079931|NCT00690482|3662993|FG000|Overall Study|Incorrect enrolment|0
2079932|NCT00690482|3662994|FG001|Overall Study|Incorrect enrolment|1
2079933|NCT00690482|3662993|FG000|Overall Study|Study-specific discontinuation criteria|1
2079934|NCT00690482|3662994|FG001|Overall Study|Study-specific discontinuation criteria|0
2079935|NCT00690482|3662993|FG000|Overall Study|Intake of prohibited medicine|1
2079936|NCT00690482|3662994|FG001|Overall Study|Intake of prohibited medicine|0
2079937|NCT00690482|3662993|FG000|Overall Study|withdrew consent at rand.day|0
2079938|NCT00690482|3662994|FG001|Overall Study|withdrew consent at rand.day|1
2079939|NCT00690573|3663009|FG000|Overall Study|Lack of Efficacy|8
2079940|NCT00690573|3663009|FG000|Overall Study|Withdrawal by Subject|1
2079941|NCT00690612|3663013|FG000|Overall Study|Adverse Event|1
2079942|NCT00690612|3663013|FG000|Overall Study|Withdrawal by Subject|2
2079943|NCT00690755|3663024|FG000|Overall Study|Physician Decision|2
2079944|NCT00690755|3663025|FG001|Overall Study|Physician Decision|0
2079945|NCT00690755|3663026|FG002|Overall Study|Physician Decision|46
2079946|NCT00690755|3663027|FG003|Overall Study|Physician Decision|5
2079947|NCT00690755|3663028|FG004|Overall Study|Physician Decision|0
2079948|NCT00690755|3663029|FG005|Overall Study|Physician Decision|4
2079949|NCT00690755|3663030|FG006|Overall Study|Physician Decision|0
2079950|NCT00690794|3663048|FG000|Overall Study|Adverse Event|12
2079951|NCT00690794|3663049|FG001|Overall Study|Adverse Event|10
2079952|NCT00690794|3663048|FG000|Overall Study|Lost to Follow-up|1
2079953|NCT00690794|3663049|FG001|Overall Study|Lost to Follow-up|4
2079954|NCT00690794|3663048|FG000|Overall Study|Withdrawal by Subject|0
2079955|NCT00690794|3663049|FG001|Overall Study|Withdrawal by Subject|9
2079956|NCT00690794|3663048|FG000|Overall Study|Protocol Violation|6
2079957|NCT00690794|3663049|FG001|Overall Study|Protocol Violation|7
2079958|NCT00690794|3663048|FG000|Overall Study|Noncompliance|1
2079959|NCT00690794|3663049|FG001|Overall Study|Noncompliance|2
2079960|NCT00690794|3663048|FG000|Overall Study|Other not specified|1
2079961|NCT00690794|3663049|FG001|Overall Study|Other not specified|3
2079962|NCT00690820|3663057|FG000|Period 1|Withdrawal by Subject|0
2079963|NCT00690820|3663058|FG001|Period 1|Withdrawal by Subject|1
2079964|NCT00690898|3663068|FG000|SCREENING|Screen failure|18
2079965|NCT00690898|3663068|FG000|TREATMENT|Adverse Event|3
2079966|NCT00690898|3663068|FG000|TREATMENT|Lack of Efficacy|18
2079967|NCT00690898|3663068|FG000|TREATMENT|Withdrawal by Subject|4
2079968|NCT00690898|3663068|FG000|TREATMENT|Other (not otherwise specified)|1
2079969|NCT00691015|3663095|FG000|Overall Study|Refused further treatment|1
2079970|NCT00691028|3663102|FG000|Open-label Period|Adverse Event|0
2079971|NCT00691028|3663103|FG001|Open-label Period|Adverse Event|0
2079972|NCT00691028|3663104|FG002|Open-label Period|Adverse Event|0
2079973|NCT00691028|3663105|FG003|Open-label Period|Adverse Event|16
2079974|NCT00691028|3663102|FG000|Open-label Period|Withdrawal by Subject|0
2079975|NCT00691028|3663103|FG001|Open-label Period|Withdrawal by Subject|0
2079976|NCT00691028|3663104|FG002|Open-label Period|Withdrawal by Subject|0
2079977|NCT00691028|3663105|FG003|Open-label Period|Withdrawal by Subject|3
2079978|NCT00691028|3663102|FG000|Open-label Period|not come to a hospital|0
2079979|NCT00691028|3663103|FG001|Open-label Period|not come to a hospital|0
2304724|NCT02659943|4005299|FG001|Overall Study|Disease progression on study|1
2304725|NCT02659943|4005300|FG002|Overall Study|Disease progression on study|1
2304726|NCT02659943|4005301|FG003|Overall Study|Disease progression on study|1
2304727|NCT02659943|4005302|FG004|Overall Study|Disease progression on study|1
2304728|NCT02659943|4005303|FG005|Overall Study|Disease progression on study|4
2304729|NCT02659943|4005304|FG006|Overall Study|Disease progression on study|0
2304730|NCT02659943|4005298|FG000|Overall Study|Patient's condition per principal investigator|0
2304731|NCT02659943|4005299|FG001|Overall Study|Patient's condition per principal investigator|0
2304732|NCT02659943|4005300|FG002|Overall Study|Patient's condition per principal investigator|0
2304733|NCT02659943|4005301|FG003|Overall Study|Patient's condition per principal investigator|0
2304734|NCT02659943|4005302|FG004|Overall Study|Patient's condition per principal investigator|0
2304735|NCT02659943|4005303|FG005|Overall Study|Patient's condition per principal investigator|1
2079980|NCT00691028|3663104|FG002|Open-label Period|not come to a hospital|0
2079981|NCT00691028|3663105|FG003|Open-label Period|not come to a hospital|1
2079982|NCT00691028|3663102|FG000|Double-blind Period|Adverse Event|8
2079983|NCT00691028|3663103|FG001|Double-blind Period|Adverse Event|9
2079984|NCT00691028|3663104|FG002|Double-blind Period|Adverse Event|6
2079985|NCT00691028|3663105|FG003|Double-blind Period|Adverse Event|0
2079986|NCT00691028|3663102|FG000|Double-blind Period|Lack of Efficacy|4
2079987|NCT00691028|3663103|FG001|Double-blind Period|Lack of Efficacy|3
2079988|NCT00691028|3663104|FG002|Double-blind Period|Lack of Efficacy|2
2079989|NCT00691028|3663105|FG003|Double-blind Period|Lack of Efficacy|0
2079990|NCT00691028|3663102|FG000|Double-blind Period|Withdrawal by Subject|1
2079991|NCT00691028|3663103|FG001|Double-blind Period|Withdrawal by Subject|0
2079992|NCT00691028|3663104|FG002|Double-blind Period|Withdrawal by Subject|1
2079993|NCT00691028|3663105|FG003|Double-blind Period|Withdrawal by Subject|0
2079994|NCT00691028|3663102|FG000|Double-blind Period|not come to a hospital.|0
2079995|NCT00691028|3663103|FG001|Double-blind Period|not come to a hospital.|1
2079996|NCT00691028|3663104|FG002|Double-blind Period|not come to a hospital.|0
2079997|NCT00691028|3663105|FG003|Double-blind Period|not come to a hospital.|0
2079998|NCT00691054|3663117|FG000|Overall Study|Withdrawal by Subject|1
2079999|NCT00691093|3663123|FG000|Overall Study|Adverse Event|1
2080000|NCT00691093|3663123|FG000|Overall Study|Lost to Follow-up|1
2080001|NCT00691093|3663123|FG000|Overall Study|Lack of Efficacy|1
2080002|NCT00691093|3663123|FG000|Overall Study|Ongoing at Date of Cut-Off|4
2080003|NCT00691132|3663134|FG000|Overall Study|Adverse Event|2
2080004|NCT00691132|3663135|FG001|Overall Study|Adverse Event|3
2080005|NCT00691132|3663134|FG000|Overall Study|Withdrawal by Subject|10
2080006|NCT00691132|3663135|FG001|Overall Study|Withdrawal by Subject|10
2080007|NCT00691210|3663168|FG000|Overall Study|Progression of Disease|0
2080008|NCT00691210|3663169|FG001|Overall Study|Progression of Disease|0
2080009|NCT00691210|3663170|FG002|Overall Study|Progression of Disease|0
2080010|NCT00691210|3663171|FG003|Overall Study|Progression of Disease|2
2080011|NCT00691210|3663172|FG004|Overall Study|Progression of Disease|0
2080012|NCT00691210|3663173|FG005|Overall Study|Progression of Disease|0
2080013|NCT00691210|3663174|FG006|Overall Study|Progression of Disease|0
2080014|NCT00691210|3663175|FG007|Overall Study|Progression of Disease|0
2080015|NCT00691210|3663168|FG000|Overall Study|Lack of Efficacy|0
2080016|NCT00691210|3663169|FG001|Overall Study|Lack of Efficacy|0
2080017|NCT00691210|3663170|FG002|Overall Study|Lack of Efficacy|0
2080018|NCT00691210|3663171|FG003|Overall Study|Lack of Efficacy|1
2080019|NCT00691210|3663172|FG004|Overall Study|Lack of Efficacy|0
2080020|NCT00691210|3663173|FG005|Overall Study|Lack of Efficacy|1
2080021|NCT00691210|3663174|FG006|Overall Study|Lack of Efficacy|0
2080022|NCT00691210|3663175|FG007|Overall Study|Lack of Efficacy|0
2080023|NCT00691301|3663193|FG000|Overall Study|Adverse Event|10
2080024|NCT00691301|3663193|FG000|Overall Study|Death|2
2080025|NCT00691301|3663193|FG000|Overall Study|Lack of Efficacy|32
2080026|NCT00691301|3663193|FG000|Overall Study|Withdrawal by Subject|4
2080027|NCT00691301|3663193|FG000|Overall Study|Concurrent illness|2
2080028|NCT00691301|3663193|FG000|Overall Study|other reason|3
2080029|NCT00691301|3663193|FG000|Overall Study|Did not initiate study treatment|1
2080030|NCT00691483|3663214|FG000|Overall Study|Adverse Event|14
2080031|NCT00691483|3663215|FG001|Overall Study|Adverse Event|6
2080032|NCT00691483|3663214|FG000|Overall Study|Lost to Follow-up|17
2080033|NCT00691483|3663215|FG001|Overall Study|Lost to Follow-up|10
2080034|NCT00691483|3663214|FG000|Overall Study|Withdrawal by Subject|24
2080035|NCT00691483|3663215|FG001|Overall Study|Withdrawal by Subject|7
2080036|NCT00691483|3663214|FG000|Overall Study|Other known cause|6
2080037|NCT00691483|3663215|FG001|Overall Study|Other known cause|1
2080038|NCT00691483|3663214|FG000|Overall Study|Randomized by not treated|7
2080039|NCT00691483|3663215|FG001|Overall Study|Randomized by not treated|1
2080040|NCT00691704|3663239|FG000|Induction Therapy|Disease Progression|1
2080041|NCT00691704|3663239|FG000|Induction Therapy|Active Hepatitis|1
2080042|NCT00691704|3663239|FG000|Two Years of Maintenance Therapy|Disease Progression|8
2080043|NCT00691704|3663239|FG000|Two Years of Maintenance Therapy|Physician Decision|4
2080044|NCT00691704|3663239|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1
2080045|NCT00691938|3663263|FG000|Overall Study|QTc prolongation|1
2304736|NCT02659943|4005304|FG006|Overall Study|Patient's condition per principal investigator|0
2304737|NCT02659943|4005298|FG000|Overall Study|Ineligible|0
2304738|NCT02659943|4005299|FG001|Overall Study|Ineligible|0
2304739|NCT02659943|4005300|FG002|Overall Study|Ineligible|0
2304740|NCT02659943|4005301|FG003|Overall Study|Ineligible|0
2304741|NCT02659943|4005302|FG004|Overall Study|Ineligible|0
2304742|NCT02659943|4005303|FG005|Overall Study|Ineligible|0
2304743|NCT02659943|4005304|FG006|Overall Study|Ineligible|1
2304744|NCT02659943|4005298|FG000|Overall Study|No longer meets eligibility|0
2304745|NCT02659943|4005299|FG001|Overall Study|No longer meets eligibility|0
2304746|NCT02659943|4005300|FG002|Overall Study|No longer meets eligibility|0
2304747|NCT02659943|4005301|FG003|Overall Study|No longer meets eligibility|0
2304748|NCT02659943|4005302|FG004|Overall Study|No longer meets eligibility|0
2304749|NCT02659943|4005303|FG005|Overall Study|No longer meets eligibility|0
2304750|NCT02659943|4005304|FG006|Overall Study|No longer meets eligibility|1
2080046|NCT00691938|3663264|FG001|Overall Study|QTc prolongation|0
2080047|NCT00691938|3663265|FG002|Overall Study|QTc prolongation|0
2080048|NCT00691938|3663266|FG003|Overall Study|QTc prolongation|0
2080049|NCT00691938|3663267|FG004|Overall Study|QTc prolongation|0
2080050|NCT00691938|3663268|FG005|Overall Study|QTc prolongation|0
2080051|NCT00691938|3663269|FG006|Overall Study|QTc prolongation|0
2080052|NCT00692237|3663312|FG000|Overall Study|Withdrawal by Subject|1
2080053|NCT00692237|3663313|FG001|Overall Study|Withdrawal by Subject|3
2080054|NCT00692237|3663312|FG000|Overall Study|Adverse Event|0
2080055|NCT00692237|3663313|FG001|Overall Study|Adverse Event|1
2080056|NCT00692406|3663341|FG000|Overall Study|PI dropped, bad data|57
2080057|NCT00692770|3663367|FG000|Overall Study|Protocol Violation|2
2304751|NCT02659943|4005298|FG000|Overall Study|No treatment, per protocol|0
2080058|NCT00692770|3663368|FG001|Overall Study|Protocol Violation|7
2080059|NCT00692770|3663367|FG000|Overall Study|Withdrawal by Subject|97
2080060|NCT00692770|3663368|FG001|Overall Study|Withdrawal by Subject|36
2080061|NCT00692770|3663367|FG000|Overall Study|Adverse Event|136
2080062|NCT00692770|3663368|FG001|Overall Study|Adverse Event|41
2080063|NCT00692770|3663367|FG000|Overall Study|Death|10
2080064|NCT00692770|3663368|FG001|Overall Study|Death|5
2080065|NCT00692770|3663367|FG000|Overall Study|Lost to Follow-up|7
2080066|NCT00692770|3663368|FG001|Overall Study|Lost to Follow-up|3
2211183|NCT01658436|3851359|FG000|Overall Study|Progressive disease|12
2211184|NCT01658436|3851360|FG001|Overall Study|Progressive disease|4
2211185|NCT01658436|3851359|FG000|Overall Study|Study terminated by sponsor|0
2211186|NCT01658436|3851360|FG001|Overall Study|Study terminated by sponsor|1
2211187|NCT01658436|3851359|FG000|Overall Study|Subject/guardian decision|0
2211188|NCT01658436|3851360|FG001|Overall Study|Subject/guardian decision|1
2211189|NCT01658436|3851359|FG000|Overall Study|Death|1
2211190|NCT01658436|3851360|FG001|Overall Study|Death|0
2211191|NCT01658514|3851369|FG000|Overall Study|Protocol Violation|1
2211192|NCT01658514|3851370|FG001|Overall Study|Protocol Violation|0
2211193|NCT01658514|3851371|FG002|Overall Study|Protocol Violation|2
2080067|NCT00692770|3663367|FG000|Overall Study|Non-compliant with study medication|11
2080068|NCT00692770|3663368|FG001|Overall Study|Non-compliant with study medication|5
2080069|NCT00692770|3663367|FG000|Overall Study|Progression by clinical judgment|2
2080070|NCT00692770|3663368|FG001|Overall Study|Progression by clinical judgment|3
2080071|NCT00692770|3663367|FG000|Overall Study|Physician decision not protocol driven|10
2080072|NCT00692770|3663368|FG001|Overall Study|Physician decision not protocol driven|14
2080073|NCT00692770|3663367|FG000|Overall Study|Disease progression, recurrence/relapse|170
2080074|NCT00692770|3663368|FG001|Overall Study|Disease progression, recurrence/relapse|279
2080075|NCT00692770|3663367|FG000|Overall Study|Protocol driven decision point|3
2080076|NCT00692770|3663368|FG001|Overall Study|Protocol driven decision point|7
2080077|NCT00692770|3663367|FG000|Overall Study|Completed all planned assessments|79
2080078|NCT00692770|3663368|FG001|Overall Study|Completed all planned assessments|101
2080079|NCT00692770|3663367|FG000|Overall Study|Radiological and clinical progression|8
2080080|NCT00692770|3663368|FG001|Overall Study|Radiological and clinical progression|8
2080081|NCT00692770|3663367|FG000|Overall Study|Clinical endpoint reached|16
2080082|NCT00692770|3663368|FG001|Overall Study|Clinical endpoint reached|43
2080083|NCT00692770|3663367|FG000|Overall Study|Study terminated by sponsor|2
2080084|NCT00692770|3663368|FG001|Overall Study|Study terminated by sponsor|2
2080085|NCT00692770|3663367|FG000|Overall Study|Randomized but not treated|3
2080086|NCT00692770|3663368|FG001|Overall Study|Randomized but not treated|4
2080087|NCT00693225|3663412|FG000|Overall Study|Lost to Follow-up|1
2080088|NCT00693225|3663413|FG001|Overall Study|Lost to Follow-up|2
2080089|NCT00693225|3663412|FG000|Overall Study|Adverse Event|1
2080090|NCT00693225|3663413|FG001|Overall Study|Adverse Event|3
2080091|NCT00693420|3663425|FG000|Overall Study|Adverse Event|4
2080092|NCT00693420|3663426|FG001|Overall Study|Adverse Event|4
2080093|NCT00693420|3663425|FG000|Overall Study|Lost to Follow-up|0
2080094|NCT00693420|3663426|FG001|Overall Study|Lost to Follow-up|3
2080095|NCT00693420|3663425|FG000|Overall Study|Withdrawal by Subject|1
2080096|NCT00693420|3663426|FG001|Overall Study|Withdrawal by Subject|0
2080097|NCT00693420|3663425|FG000|Overall Study|Protocol Violation|0
2080098|NCT00693420|3663426|FG001|Overall Study|Protocol Violation|2
2080099|NCT00693420|3663425|FG000|Overall Study|Sponsor Request - Conflict of Interest|0
2080100|NCT00693420|3663426|FG001|Overall Study|Sponsor Request - Conflict of Interest|2
2080101|NCT00693420|3663425|FG000|Overall Study|Personal Reasons|1
2080102|NCT00693420|3663426|FG001|Overall Study|Personal Reasons|4
2080103|NCT00693472|3663436|FG000|Part 1|Adverse Event|1
2080104|NCT00693472|3663437|FG001|Part 1|Adverse Event|1
2080105|NCT00693472|3663438|FG002|Part 1|Adverse Event|0
2080106|NCT00693472|3663439|FG003|Part 1|Adverse Event|0
2080107|NCT00693472|3663436|FG000|Part 1|Lost to Follow-up|0
2080108|NCT00693472|3663437|FG001|Part 1|Lost to Follow-up|1
2080109|NCT00693472|3663438|FG002|Part 1|Lost to Follow-up|0
2080110|NCT00693472|3663439|FG003|Part 1|Lost to Follow-up|0
2080111|NCT00693472|3663436|FG000|Part 1|Withdrew - reason unrelated to treatment|5
2080112|NCT00693472|3663437|FG001|Part 1|Withdrew - reason unrelated to treatment|2
2080113|NCT00693472|3663438|FG002|Part 1|Withdrew - reason unrelated to treatment|0
2080114|NCT00693472|3663439|FG003|Part 1|Withdrew - reason unrelated to treatment|0
2080115|NCT00693472|3663436|FG000|Part 2|Adverse Event|0
2080116|NCT00693472|3663437|FG001|Part 2|Adverse Event|0
2080117|NCT00693472|3663438|FG002|Part 2|Adverse Event|1
2080118|NCT00693472|3663439|FG003|Part 2|Adverse Event|0
2080119|NCT00693472|3663436|FG000|Part 2|Withdrew - reason unrelated to treatment|0
2080120|NCT00693472|3663437|FG001|Part 2|Withdrew - reason unrelated to treatment|0
2080121|NCT00693472|3663438|FG002|Part 2|Withdrew - reason unrelated to treatment|1
2080122|NCT00693472|3663439|FG003|Part 2|Withdrew - reason unrelated to treatment|2
2080123|NCT00693693|3663484|FG000|Overall Study|Lost to Follow-up|1
2080124|NCT00693693|3663485|FG001|Overall Study|Lost to Follow-up|1
2080125|NCT00693693|3663486|FG002|Overall Study|Lost to Follow-up|2
2080126|NCT00693706|3663496|FG000|Overall Study|Protocol Violation|0
2080127|NCT00693706|3663497|FG001|Overall Study|Protocol Violation|1
2211194|NCT01658579|3851382|FG000|Treatment Period A|Other|0
2211195|NCT01658579|3851383|FG001|Treatment Period A|Other|0
2211196|NCT01658579|3851384|FG002|Treatment Period A|Other|1
2080128|NCT00693784|3663507|FG000|Overall Study|Lost to Follow-up|2
2080129|NCT00693784|3663507|FG000|Overall Study|Withdrawal by Subject|2
2080130|NCT00694096|3663533|FG000|Overall Study|Withdrawal by Subject|5
2106803|NCT00868790|3700227|FG008|Period 1|Withdrawal by Subject|0
2106804|NCT00868790|3700228|FG009|Period 1|Withdrawal by Subject|0
2106805|NCT00868790|3700229|FG010|Period 1|Withdrawal by Subject|0
2106806|NCT00868790|3700230|FG011|Period 1|Withdrawal by Subject|0
2106807|NCT00868790|3700231|FG012|Period 1|Withdrawal by Subject|0
2106808|NCT00868790|3700232|FG013|Period 1|Withdrawal by Subject|1
2106809|NCT00868790|3700219|FG000|Period 1|Abnormal Triglycerides|0
2106810|NCT00868790|3700220|FG001|Period 1|Abnormal Triglycerides|0
2106811|NCT00868790|3700221|FG002|Period 1|Abnormal Triglycerides|0
2106812|NCT00868790|3700222|FG003|Period 1|Abnormal Triglycerides|0
2106813|NCT00868790|3700223|FG004|Period 1|Abnormal Triglycerides|1
2106814|NCT00868790|3700224|FG005|Period 1|Abnormal Triglycerides|0
2106815|NCT00868790|3700225|FG006|Period 1|Abnormal Triglycerides|0
2106816|NCT00868790|3700226|FG007|Period 1|Abnormal Triglycerides|0
2106817|NCT00868790|3700227|FG008|Period 1|Abnormal Triglycerides|0
2106818|NCT00868790|3700228|FG009|Period 1|Abnormal Triglycerides|0
2106819|NCT00868790|3700229|FG010|Period 1|Abnormal Triglycerides|0
2106820|NCT00868790|3700230|FG011|Period 1|Abnormal Triglycerides|0
2106821|NCT00868790|3700231|FG012|Period 1|Abnormal Triglycerides|0
2106822|NCT00868790|3700232|FG013|Period 1|Abnormal Triglycerides|0
2106823|NCT00868790|3700219|FG000|Period 1|Lost to Follow-up|0
2106824|NCT00868790|3700220|FG001|Period 1|Lost to Follow-up|0
2106825|NCT00868790|3700221|FG002|Period 1|Lost to Follow-up|0
2106826|NCT00868790|3700222|FG003|Period 1|Lost to Follow-up|0
2106827|NCT00868790|3700223|FG004|Period 1|Lost to Follow-up|0
2106828|NCT00868790|3700224|FG005|Period 1|Lost to Follow-up|1
2106829|NCT00868790|3700225|FG006|Period 1|Lost to Follow-up|0
2106830|NCT00868790|3700226|FG007|Period 1|Lost to Follow-up|0
2106831|NCT00868790|3700227|FG008|Period 1|Lost to Follow-up|0
2106832|NCT00868790|3700228|FG009|Period 1|Lost to Follow-up|0
2106833|NCT00868790|3700229|FG010|Period 1|Lost to Follow-up|0
2106834|NCT00868790|3700230|FG011|Period 1|Lost to Follow-up|0
2106835|NCT00868790|3700231|FG012|Period 1|Lost to Follow-up|0
2106836|NCT00868790|3700232|FG013|Period 1|Lost to Follow-up|0
2106837|NCT00868790|3700219|FG000|Period 2|Adverse Event|0
2106838|NCT00868790|3700220|FG001|Period 2|Adverse Event|0
2106839|NCT00868790|3700221|FG002|Period 2|Adverse Event|0
2106840|NCT00868790|3700222|FG003|Period 2|Adverse Event|0
2106841|NCT00868790|3700223|FG004|Period 2|Adverse Event|0
2106842|NCT00868790|3700224|FG005|Period 2|Adverse Event|0
2106843|NCT00868790|3700225|FG006|Period 2|Adverse Event|0
2106844|NCT00868790|3700226|FG007|Period 2|Adverse Event|0
2106845|NCT00868790|3700227|FG008|Period 2|Adverse Event|1
2106846|NCT00868790|3700228|FG009|Period 2|Adverse Event|0
2304752|NCT02659943|4005299|FG001|Overall Study|No treatment, per protocol|0
2304753|NCT02659943|4005300|FG002|Overall Study|No treatment, per protocol|0
2304754|NCT02659943|4005301|FG003|Overall Study|No treatment, per protocol|0
2304755|NCT02659943|4005302|FG004|Overall Study|No treatment, per protocol|0
2304756|NCT02659943|4005303|FG005|Overall Study|No treatment, per protocol|0
2304757|NCT02659943|4005304|FG006|Overall Study|No treatment, per protocol|3
2304758|NCT02660138|4005332|FG000|Overall Study|Adverse Event|0
2304759|NCT02660138|4005333|FG001|Overall Study|Adverse Event|3
2304760|NCT02660138|4005334|FG002|Overall Study|Adverse Event|2
2304761|NCT02660138|4005332|FG000|Overall Study|Lack of Efficacy|1
2304762|NCT02660138|4005333|FG001|Overall Study|Lack of Efficacy|2
2304763|NCT02660138|4005334|FG002|Overall Study|Lack of Efficacy|1
2304764|NCT02660138|4005332|FG000|Overall Study|Withdrawal by Subject|7
2304765|NCT02660138|4005333|FG001|Overall Study|Withdrawal by Subject|6
2304766|NCT02660138|4005334|FG002|Overall Study|Withdrawal by Subject|6
2304767|NCT02660138|4005332|FG000|Overall Study|Lost to Follow-up|4
2304768|NCT02660138|4005333|FG001|Overall Study|Lost to Follow-up|4
2304769|NCT02660138|4005334|FG002|Overall Study|Lost to Follow-up|1
2304770|NCT02660138|4005332|FG000|Overall Study|Sponsor Decision to Terminate Study|57
2304771|NCT02660138|4005333|FG001|Overall Study|Sponsor Decision to Terminate Study|57
2304772|NCT02660138|4005334|FG002|Overall Study|Sponsor Decision to Terminate Study|62
2304773|NCT02660138|4005332|FG000|Overall Study|Other|1
2304774|NCT02660138|4005333|FG001|Overall Study|Other|1
2304775|NCT02660138|4005334|FG002|Overall Study|Other|0
2304776|NCT02660138|4005332|FG000|Overall Study|Not treated|0
2304777|NCT02660138|4005333|FG001|Overall Study|Not treated|1
2304778|NCT02660138|4005334|FG002|Overall Study|Not treated|0
2304779|NCT02660229|4005347|FG000|Overall Study|Adverse Event|2
2304780|NCT02660229|4005348|FG001|Overall Study|Adverse Event|0
2304781|NCT02660229|4005347|FG000|Overall Study|Withdrawal by Subject|0
2304782|NCT02660229|4005348|FG001|Overall Study|Withdrawal by Subject|1
2106847|NCT00868790|3700229|FG010|Period 2|Adverse Event|0
2106848|NCT00868790|3700230|FG011|Period 2|Adverse Event|0
2106849|NCT00868790|3700231|FG012|Period 2|Adverse Event|0
2106850|NCT00868790|3700232|FG013|Period 2|Adverse Event|0
2106851|NCT00868790|3700219|FG000|Period 2|Lost to Follow-up|0
2106852|NCT00868790|3700220|FG001|Period 2|Lost to Follow-up|1
2106853|NCT00868790|3700221|FG002|Period 2|Lost to Follow-up|0
2106854|NCT00868790|3700222|FG003|Period 2|Lost to Follow-up|0
2106855|NCT00868790|3700223|FG004|Period 2|Lost to Follow-up|0
2304783|NCT02660242|4005354|FG000|Glucose Tabs|Lost to Follow-up|1
2080131|NCT00694109|3663537|FG000|Overall Study|Physician Decision|3
2080132|NCT00694109|3663537|FG000|Overall Study|Adverse Event|74
2080133|NCT00694109|3663537|FG000|Overall Study|Not consent of more 2 years of treatment|18
2080134|NCT00694109|3663537|FG000|Overall Study|Lack of Efficacy|2
2080135|NCT00694109|3663537|FG000|Overall Study|Withdrawal by Subject|13
2080136|NCT00694109|3663537|FG000|Overall Study|Pregnancy|1
2080137|NCT00694109|3663537|FG000|Overall Study|Enrolled but not treated|1
2080138|NCT00694109|3663537|FG000|Overall Study|Other|2
2080139|NCT00694109|3663537|FG000|Overall Study|Consented but no additional treatment|3
2080140|NCT00694122|3663542|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
2080141|NCT00694122|3663543|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
2080142|NCT00694122|3663542|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1
2080143|NCT00694122|3663543|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1
2080144|NCT00694122|3663542|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
2080145|NCT00694122|3663543|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
2080146|NCT00694161|3663554|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
2080147|NCT00694161|3663554|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
2080148|NCT00694161|3663554|FG000|Part 2 (After Week 6 up to Month 12)|Death|1
2080149|NCT00694304|3663558|FG000|Overall Study|Adverse Event|42
2080150|NCT00694304|3663558|FG000|Overall Study|Lack of Efficacy|35
2080151|NCT00694304|3663558|FG000|Overall Study|Non-compliance With Study Product|16
2080152|NCT00694304|3663558|FG000|Overall Study|Protocol Violation|6
2080153|NCT00694304|3663558|FG000|Overall Study|Withdrawal of Consent|61
2080154|NCT00694304|3663558|FG000|Overall Study|Lost to Follow-up|15
2080155|NCT00694304|3663558|FG000|Overall Study|Administrative or Other Reasons|32
2080156|NCT00694356|3663565|FG000|Overall Study|Adverse Event|1
2080157|NCT00694356|3663566|FG001|Overall Study|Adverse Event|0
2080158|NCT00694356|3663567|FG002|Overall Study|Adverse Event|0
2080159|NCT00694356|3663565|FG000|Overall Study|Progressive Disease|2
2080160|NCT00694356|3663566|FG001|Overall Study|Progressive Disease|6
2080161|NCT00694356|3663567|FG002|Overall Study|Progressive Disease|6
2080162|NCT00694551|3663582|FG000|Overall Study|Disease Progression|1
2080163|NCT00694551|3663583|FG001|Overall Study|Disease Progression|0
2080164|NCT00694551|3663584|FG002|Overall Study|Disease Progression|1
2080165|NCT00694707|3663606|FG000|Overall Study|Did Not Receive Treatment|0
2211197|NCT01658579|3851385|FG003|Treatment Period A|Other|1
2304784|NCT02660242|4005354|FG000|Glucagon Injection|Lost to Follow-up|1
2304785|NCT02660359|4005370|FG000|Overall Study|Protocol Deviation|0
2304786|NCT02660359|4005371|FG001|Overall Study|Protocol Deviation|0
2304787|NCT02660359|4005372|FG002|Overall Study|Protocol Deviation|1
2304788|NCT02660359|4005370|FG000|Overall Study|Sponsor Decision to Terminate Study|73
2304789|NCT02660359|4005371|FG001|Overall Study|Sponsor Decision to Terminate Study|75
2304790|NCT02660359|4005372|FG002|Overall Study|Sponsor Decision to Terminate Study|71
2304791|NCT02660359|4005370|FG000|Overall Study|Lack of Efficacy|1
2304792|NCT02660359|4005371|FG001|Overall Study|Lack of Efficacy|1
2304793|NCT02660359|4005372|FG002|Overall Study|Lack of Efficacy|1
2304794|NCT02660359|4005370|FG000|Overall Study|Adverse Event|0
2304795|NCT02660359|4005371|FG001|Overall Study|Adverse Event|1
2304796|NCT02660359|4005372|FG002|Overall Study|Adverse Event|0
2304797|NCT02660359|4005370|FG000|Overall Study|Other|2
2304798|NCT02660359|4005371|FG001|Overall Study|Other|1
2304799|NCT02660359|4005372|FG002|Overall Study|Other|3
2304800|NCT02660359|4005370|FG000|Overall Study|Withdrawal by Subject|7
2304801|NCT02660359|4005371|FG001|Overall Study|Withdrawal by Subject|5
2304802|NCT02660359|4005372|FG002|Overall Study|Withdrawal by Subject|8
2304803|NCT02660359|4005370|FG000|Overall Study|Lost to Follow-up|3
2304804|NCT02660359|4005371|FG001|Overall Study|Lost to Follow-up|3
2304805|NCT02660359|4005372|FG002|Overall Study|Lost to Follow-up|0
2304806|NCT02660489|4005382|FG000|Overall Study|Lost to Follow-up|1
2304807|NCT02660489|4005383|FG001|Overall Study|Lost to Follow-up|1
2304808|NCT02660489|4005382|FG000|Overall Study|Adverse Event|1
2304809|NCT02660489|4005383|FG001|Overall Study|Adverse Event|3
2304810|NCT02660489|4005382|FG000|Overall Study|no rhinovirus infection|4
2304811|NCT02660489|4005383|FG001|Overall Study|no rhinovirus infection|4
2304812|NCT02660580|4005391|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
2304813|NCT02660580|4005392|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
2304814|NCT02660580|4005393|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
2304815|NCT02660580|4005394|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
2304816|NCT02660580|4005395|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
2304817|NCT02660580|4005391|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
2304818|NCT02660580|4005392|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
2304819|NCT02660580|4005393|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
2304820|NCT02660580|4005394|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
2304821|NCT02660580|4005395|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
2304822|NCT02660580|4005391|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1
2304823|NCT02660580|4005392|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2304824|NCT02660580|4005393|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2080166|NCT00694707|3663607|FG001|Overall Study|Did Not Receive Treatment|0
2080167|NCT00694707|3663608|FG002|Overall Study|Did Not Receive Treatment|1
2080168|NCT00694707|3663609|FG003|Overall Study|Did Not Receive Treatment|1
2304825|NCT02660580|4005394|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2304826|NCT02660580|4005395|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2304827|NCT02660580|4005391|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2304828|NCT02660580|4005392|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
2304829|NCT02660580|4005393|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2304830|NCT02660580|4005394|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2304831|NCT02660580|4005395|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2304832|NCT02660580|4005391|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2
2080169|NCT00694707|3663610|FG004|Overall Study|Did Not Receive Treatment|1
2080170|NCT00694707|3663606|FG000|Overall Study|Adverse Event|22
2080171|NCT00694707|3663607|FG001|Overall Study|Adverse Event|14
2080172|NCT00694707|3663608|FG002|Overall Study|Adverse Event|8
2080173|NCT00694707|3663609|FG003|Overall Study|Adverse Event|12
2080174|NCT00694707|3663610|FG004|Overall Study|Adverse Event|13
2304833|NCT02660580|4005392|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9
2304834|NCT02660580|4005393|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0
2304835|NCT02660580|4005394|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0
2304836|NCT02660580|4005395|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0
2304837|NCT02660580|4005391|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
2304838|NCT02660580|4005392|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
2304839|NCT02660580|4005393|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
2304840|NCT02660580|4005394|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
2304841|NCT02660580|4005395|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
2304842|NCT02660580|4005391|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
2304843|NCT02660580|4005392|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
2304844|NCT02660580|4005393|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
2304845|NCT02660580|4005394|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
2304846|NCT02660580|4005395|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
2304847|NCT02660580|4005391|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
2304848|NCT02660580|4005392|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
2304849|NCT02660580|4005393|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
2304850|NCT02660580|4005394|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
2304851|NCT02660580|4005395|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
2304852|NCT02660580|4005391|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
2304853|NCT02660580|4005392|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
2304854|NCT02660580|4005393|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
2304855|NCT02660580|4005394|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
2304856|NCT02660580|4005395|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
2304857|NCT02660580|4005391|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
2304858|NCT02660580|4005392|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
2304859|NCT02660580|4005393|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
2304860|NCT02660580|4005394|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
2304861|NCT02660580|4005395|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
2304862|NCT02660580|4005391|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
2304863|NCT02660580|4005392|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
2304864|NCT02660580|4005393|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
2304865|NCT02660580|4005394|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
2304866|NCT02660580|4005395|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
2304867|NCT02660580|4005391|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
2304868|NCT02660580|4005392|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
2304869|NCT02660580|4005393|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
2304870|NCT02660580|4005394|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
2304871|NCT02660580|4005395|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
2304872|NCT02660580|4005391|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
2304873|NCT02660580|4005392|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
2304874|NCT02660580|4005393|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
2304875|NCT02660580|4005394|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
2304876|NCT02660580|4005395|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
2304877|NCT02660944|4005446|FG000|Overall Study|Adverse Event|3
2304878|NCT02660944|4005447|FG001|Overall Study|Adverse Event|4
2304879|NCT02660944|4005446|FG000|Overall Study|Physician Decision|3
2304880|NCT02660944|4005447|FG001|Overall Study|Physician Decision|1
2304881|NCT02660944|4005446|FG000|Overall Study|Withdrawal by Subject|5
2304882|NCT02660944|4005447|FG001|Overall Study|Withdrawal by Subject|3
2304883|NCT02660944|4005446|FG000|Overall Study|Lost to Follow-up|4
2304884|NCT02660944|4005447|FG001|Overall Study|Lost to Follow-up|1
2304885|NCT02660944|4005446|FG000|Overall Study|Subject schedule|0
2304886|NCT02660944|4005447|FG001|Overall Study|Subject schedule|1
2304887|NCT02660944|4005446|FG000|Overall Study|Exclusion criteria met|2
2304888|NCT02660944|4005447|FG001|Overall Study|Exclusion criteria met|0
2304889|NCT02660983|4005455|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
2080175|NCT00694707|3663606|FG000|Overall Study|Insufficient Therapeutic Response|33
2080176|NCT00694707|3663607|FG001|Overall Study|Insufficient Therapeutic Response|18
2080177|NCT00694707|3663608|FG002|Overall Study|Insufficient Therapeutic Response|17
2080178|NCT00694707|3663609|FG003|Overall Study|Insufficient Therapeutic Response|15
2080179|NCT00694707|3663610|FG004|Overall Study|Insufficient Therapeutic Response|10
2080180|NCT00694707|3663606|FG000|Overall Study|Protocol Violation|1
2080181|NCT00694707|3663607|FG001|Overall Study|Protocol Violation|2
2080182|NCT00694707|3663608|FG002|Overall Study|Protocol Violation|1
2080183|NCT00694707|3663609|FG003|Overall Study|Protocol Violation|3
2080184|NCT00694707|3663610|FG004|Overall Study|Protocol Violation|1
2080185|NCT00694707|3663606|FG000|Overall Study|Withdrawal of Consent|14
2080186|NCT00694707|3663607|FG001|Overall Study|Withdrawal of Consent|18
2080187|NCT00694707|3663608|FG002|Overall Study|Withdrawal of Consent|22
2080188|NCT00694707|3663609|FG003|Overall Study|Withdrawal of Consent|16
2080189|NCT00694707|3663610|FG004|Overall Study|Withdrawal of Consent|15
2080190|NCT00694707|3663606|FG000|Overall Study|Lost to Follow-up|0
2080191|NCT00694707|3663607|FG001|Overall Study|Lost to Follow-up|1
2080192|NCT00694707|3663608|FG002|Overall Study|Lost to Follow-up|2
2080193|NCT00694707|3663609|FG003|Overall Study|Lost to Follow-up|0
2080194|NCT00694707|3663610|FG004|Overall Study|Lost to Follow-up|0
2080195|NCT00694707|3663606|FG000|Overall Study|Jeopardizing Parole Status|1
2080196|NCT00694707|3663607|FG001|Overall Study|Jeopardizing Parole Status|0
2080197|NCT00694707|3663608|FG002|Overall Study|Jeopardizing Parole Status|0
2080198|NCT00694707|3663609|FG003|Overall Study|Jeopardizing Parole Status|0
2080199|NCT00694707|3663610|FG004|Overall Study|Jeopardizing Parole Status|0
2080200|NCT00694707|3663606|FG000|Overall Study|Death in the Family|1
2080201|NCT00694707|3663607|FG001|Overall Study|Death in the Family|0
2080202|NCT00694707|3663608|FG002|Overall Study|Death in the Family|0
2080203|NCT00694707|3663609|FG003|Overall Study|Death in the Family|0
2080204|NCT00694707|3663610|FG004|Overall Study|Death in the Family|0
2080205|NCT00694707|3663606|FG000|Overall Study|Arrest by Police|0
2080206|NCT00694707|3663607|FG001|Overall Study|Arrest by Police|1
2080207|NCT00694707|3663608|FG002|Overall Study|Arrest by Police|0
2080208|NCT00694707|3663609|FG003|Overall Study|Arrest by Police|0
2080209|NCT00694707|3663610|FG004|Overall Study|Arrest by Police|0
2080210|NCT00694707|3663606|FG000|Overall Study|Administrative Reasons|0
2080211|NCT00694707|3663607|FG001|Overall Study|Administrative Reasons|1
2080212|NCT00694707|3663608|FG002|Overall Study|Administrative Reasons|0
2080213|NCT00694707|3663609|FG003|Overall Study|Administrative Reasons|2
2080214|NCT00694707|3663610|FG004|Overall Study|Administrative Reasons|0
2080215|NCT00694707|3663606|FG000|Overall Study|Notification of Past Head Injury|0
2080216|NCT00694707|3663607|FG001|Overall Study|Notification of Past Head Injury|0
2080217|NCT00694707|3663608|FG002|Overall Study|Notification of Past Head Injury|0
2080218|NCT00694707|3663609|FG003|Overall Study|Notification of Past Head Injury|1
2080219|NCT00694707|3663610|FG004|Overall Study|Notification of Past Head Injury|0
2080220|NCT00695019|3663625|FG000|Overall Study|Withdrawal by Subject|8
2080221|NCT00695019|3663626|FG001|Overall Study|Withdrawal by Subject|6
2080222|NCT00695019|3663627|FG002|Overall Study|Withdrawal by Subject|4
2304890|NCT02660983|4005456|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
2304891|NCT02660983|4005455|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
2304892|NCT02660983|4005456|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
2304893|NCT02660983|4005455|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
2304894|NCT02660983|4005456|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
2304895|NCT02660983|4005455|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
2304896|NCT02660983|4005456|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
2304897|NCT02660983|4005455|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
2304898|NCT02660983|4005456|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
2304899|NCT02660983|4005455|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1
2304900|NCT02660983|4005456|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3
2304901|NCT02660983|4005455|FG000|Open Label Extension Phase (24 Weeks)|Other|0
2304902|NCT02660983|4005456|FG001|Open Label Extension Phase (24 Weeks)|Other|1
2304903|NCT02661061|4005465|FG000|Overall Study|Lack of Efficacy|1
2304904|NCT02661061|4005466|FG001|Overall Study|Lack of Efficacy|1
2304905|NCT02661061|4005465|FG000|Overall Study|Withdrawal by Subject|1
2304906|NCT02661061|4005466|FG001|Overall Study|Withdrawal by Subject|1
2304907|NCT02661178|4005496|FG000|Part 1|Protocol Violation|1
2304908|NCT02661178|4005497|FG001|Part 1|Protocol Violation|0
2304909|NCT02661178|4005498|FG002|Part 1|Protocol Violation|0
2304910|NCT02661178|4005499|FG003|Part 1|Protocol Violation|0
2304911|NCT02661178|4005500|FG004|Part 1|Protocol Violation|0
2304912|NCT02661178|4005501|FG005|Part 1|Protocol Violation|0
2304913|NCT02661178|4005502|FG006|Part 1|Protocol Violation|0
2304914|NCT02661178|4005503|FG007|Part 1|Protocol Violation|0
2304915|NCT02661178|4005504|FG008|Part 1|Protocol Violation|0
2304916|NCT02661178|4005505|FG009|Part 1|Protocol Violation|0
2304917|NCT02661178|4005506|FG010|Part 1|Protocol Violation|0
2080223|NCT00695019|3663625|FG000|Overall Study|Protocol Violation|1
2080224|NCT00695019|3663626|FG001|Overall Study|Protocol Violation|3
2080225|NCT00695019|3663627|FG002|Overall Study|Protocol Violation|1
2080226|NCT00695019|3663625|FG000|Overall Study|Lack of Efficacy|0
2080227|NCT00695019|3663626|FG001|Overall Study|Lack of Efficacy|0
2080228|NCT00695019|3663627|FG002|Overall Study|Lack of Efficacy|1
2080229|NCT00695019|3663625|FG000|Overall Study|Various|4
2080230|NCT00695019|3663626|FG001|Overall Study|Various|5
2080231|NCT00695019|3663627|FG002|Overall Study|Various|4
2080232|NCT00695110|3663644|FG000|Treatment Period 1|Adverse Event|1
2080233|NCT00695110|3663644|FG000|Treatment Period 1|Withdrawal by Subject|2
2080234|NCT00695110|3663644|FG000|Treatment Period 3|Withdrawal by Subject|1
2080235|NCT00695110|3663644|FG000|Treatment Period 4|Adverse Event|1
2080236|NCT00695136|3663651|FG000|Overall Study|Withdrawal by Subject|1
2080237|NCT00695136|3663651|FG000|Overall Study|unrelated adverse event|1
2080238|NCT00695318|3663675|FG000|Overall Study|Lost to Follow-up|1
2080239|NCT00695318|3663676|FG001|Overall Study|Lost to Follow-up|0
2080240|NCT00695318|3663675|FG000|Overall Study|Withdrawal by Subject|2
2080241|NCT00695318|3663676|FG001|Overall Study|Withdrawal by Subject|0
2080242|NCT00695318|3663675|FG000|Overall Study|Death|1
2080243|NCT00695318|3663676|FG001|Overall Study|Death|1
2080244|NCT00695318|3663675|FG000|Overall Study|Study Terminated|1
2080245|NCT00695318|3663676|FG001|Overall Study|Study Terminated|0
2080246|NCT00695396|3663690|FG000|Overall Study|Study Closed Prematurely|5
2080247|NCT00695396|3663691|FG001|Overall Study|Study Closed Prematurely|6
2080248|NCT00695396|3663692|FG002|Overall Study|Study Closed Prematurely|8
2080249|NCT00695396|3663690|FG000|Overall Study|Withdrawal by Subject|2
2080250|NCT00695396|3663691|FG001|Overall Study|Withdrawal by Subject|2
2304918|NCT02661178|4005507|FG011|Part 1|Protocol Violation|0
2304919|NCT02661178|4005508|FG012|Part 1|Protocol Violation|0
2304920|NCT02661178|4005509|FG013|Part 1|Protocol Violation|0
2304921|NCT02661178|4005510|FG014|Part 1|Protocol Violation|0
2304922|NCT02661217|4005562|FG000|Overall Study|Physician Decision|12
2304923|NCT02661217|4005563|FG001|Overall Study|Physician Decision|15
2304924|NCT02661217|4005562|FG000|Overall Study|Lost to Follow-up|1
2304925|NCT02661217|4005563|FG001|Overall Study|Lost to Follow-up|4
2304926|NCT02661217|4005562|FG000|Overall Study|Protocol Deviation|0
2304927|NCT02661217|4005563|FG001|Overall Study|Protocol Deviation|4
2304928|NCT02661217|4005562|FG000|Overall Study|Non-compliance with study treatment|5
2304929|NCT02661217|4005563|FG001|Overall Study|Non-compliance with study treatment|5
2304930|NCT02661217|4005562|FG000|Overall Study|Death|21
2304931|NCT02661217|4005563|FG001|Overall Study|Death|15
2304932|NCT02661217|4005562|FG000|Overall Study|Adverse Event|10
2304933|NCT02661217|4005563|FG001|Overall Study|Adverse Event|8
2304934|NCT02661217|4005562|FG000|Overall Study|Withdrawal by Subject|15
2304935|NCT02661217|4005563|FG001|Overall Study|Withdrawal by Subject|19
2304936|NCT02661217|4005562|FG000|Overall Study|Did not enter follow-up epoch|7
2304937|NCT02661217|4005563|FG001|Overall Study|Did not enter follow-up epoch|10
2304938|NCT02661217|4005562|FG000|Overall Study|Death - no study drug received|1
2304939|NCT02661217|4005563|FG001|Overall Study|Death - no study drug received|2
2304940|NCT02661217|4005562|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3
2304941|NCT02661217|4005563|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1
2304942|NCT02661490|4005581|FG000|Overall Study|Lost to Follow-up|0
2304943|NCT02661490|4005582|FG001|Overall Study|Lost to Follow-up|1
2304944|NCT02661490|4005583|FG002|Overall Study|Lost to Follow-up|0
2304945|NCT02661490|4005584|FG003|Overall Study|Lost to Follow-up|0
2304946|NCT02661490|4005585|FG004|Overall Study|Lost to Follow-up|2
2304947|NCT02661490|4005581|FG000|Overall Study|Withdrawal by Subject|2
2304948|NCT02661490|4005582|FG001|Overall Study|Withdrawal by Subject|0
2304949|NCT02661490|4005583|FG002|Overall Study|Withdrawal by Subject|2
2304950|NCT02661490|4005584|FG003|Overall Study|Withdrawal by Subject|0
2304951|NCT02661490|4005585|FG004|Overall Study|Withdrawal by Subject|0
2304952|NCT02661490|4005581|FG000|Overall Study|Death|1
2304953|NCT02661490|4005582|FG001|Overall Study|Death|1
2304954|NCT02661490|4005583|FG002|Overall Study|Death|0
2304955|NCT02661490|4005584|FG003|Overall Study|Death|1
2304956|NCT02661490|4005585|FG004|Overall Study|Death|0
2304957|NCT02661490|4005581|FG000|Overall Study|Reason not Specified|0
2304958|NCT02661490|4005582|FG001|Overall Study|Reason not Specified|0
2304959|NCT02661490|4005583|FG002|Overall Study|Reason not Specified|0
2304960|NCT02661490|4005584|FG003|Overall Study|Reason not Specified|0
2304961|NCT02661490|4005585|FG004|Overall Study|Reason not Specified|1
2304962|NCT02661594|4005601|FG000|Overall Study|Protocol Violation|1
2304963|NCT02661594|4005602|FG001|Overall Study|Protocol Violation|0
2304964|NCT02661594|4005603|FG002|Overall Study|Protocol Violation|1
2304965|NCT02661594|4005604|FG003|Overall Study|Protocol Violation|0
2304966|NCT02661815|4005622|FG000|Overall Study|Withdrawal by Subject|1
2304967|NCT02661815|4005623|FG001|Overall Study|Withdrawal by Subject|0
2304968|NCT02661815|4005624|FG002|Overall Study|Withdrawal by Subject|0
2304969|NCT02661815|4005625|FG003|Overall Study|Withdrawal by Subject|0
2304970|NCT02662556|4005682|FG000|Overall Study|Adverse Event|4
2304971|NCT02662556|4005682|FG000|Overall Study|Lack of Efficacy|4
2304972|NCT02662569|4005691|FG000|Overall Study|Withdrawal by Subject|6
2080251|NCT00695396|3663692|FG002|Overall Study|Withdrawal by Subject|0
2304973|NCT02662569|4005692|FG001|Overall Study|Withdrawal by Subject|1
2304974|NCT02662569|4005693|FG002|Overall Study|Withdrawal by Subject|6
2304975|NCT02662569|4005694|FG003|Overall Study|Withdrawal by Subject|4
2304976|NCT02662569|4005691|FG000|Overall Study|Lost to Follow-up|1
2304977|NCT02662569|4005692|FG001|Overall Study|Lost to Follow-up|0
2304978|NCT02662569|4005693|FG002|Overall Study|Lost to Follow-up|0
2304979|NCT02662569|4005694|FG003|Overall Study|Lost to Follow-up|0
2080252|NCT00695565|3663726|FG000|Overall Study|Lost to Follow-up|4
2080253|NCT00695565|3663727|FG001|Overall Study|Lost to Follow-up|4
2080254|NCT00695565|3663726|FG000|Overall Study|Adverse Event|3
2080255|NCT00695565|3663727|FG001|Overall Study|Adverse Event|1
2080256|NCT00695565|3663726|FG000|Overall Study|Protocol Violation|3
2080257|NCT00695565|3663727|FG001|Overall Study|Protocol Violation|1
2080258|NCT00695565|3663726|FG000|Overall Study|Withdrawal by Subject|1
2080259|NCT00695565|3663727|FG001|Overall Study|Withdrawal by Subject|1
2080260|NCT00695565|3663726|FG000|Overall Study|Lack of Efficacy|1
2080261|NCT00695565|3663727|FG001|Overall Study|Lack of Efficacy|1
2080262|NCT00695565|3663726|FG000|Overall Study|Subject did not follow instructions|1
2080263|NCT00695565|3663727|FG001|Overall Study|Subject did not follow instructions|1
2080264|NCT00695669|3663746|FG000|Overall Study|Adverse Event|0
2080265|NCT00695669|3663747|FG001|Overall Study|Adverse Event|0
2080266|NCT00695669|3663748|FG002|Overall Study|Adverse Event|2
2080267|NCT00695669|3663749|FG003|Overall Study|Adverse Event|0
2080268|NCT00695669|3663746|FG000|Overall Study|Lost to Follow-up|4
2080269|NCT00695669|3663747|FG001|Overall Study|Lost to Follow-up|4
2080270|NCT00695669|3663748|FG002|Overall Study|Lost to Follow-up|1
2080271|NCT00695669|3663749|FG003|Overall Study|Lost to Follow-up|4
2080272|NCT00695786|3663766|FG000|Overall Study|Adverse Event|0
2080273|NCT00695786|3663767|FG001|Overall Study|Adverse Event|3
2080274|NCT00695786|3663768|FG002|Overall Study|Adverse Event|4
2080275|NCT00695786|3663769|FG003|Overall Study|Adverse Event|2
2080276|NCT00695786|3663766|FG000|Overall Study|Lost to Follow-up|0
2080277|NCT00695786|3663767|FG001|Overall Study|Lost to Follow-up|5
2080278|NCT00695786|3663768|FG002|Overall Study|Lost to Follow-up|1
2080279|NCT00695786|3663769|FG003|Overall Study|Lost to Follow-up|1
2080280|NCT00695786|3663766|FG000|Overall Study|Withdrawal by Subject|0
2080281|NCT00695786|3663767|FG001|Overall Study|Withdrawal by Subject|4
2080282|NCT00695786|3663768|FG002|Overall Study|Withdrawal by Subject|3
2080283|NCT00695786|3663769|FG003|Overall Study|Withdrawal by Subject|1
2080284|NCT00695786|3663766|FG000|Overall Study|Deemed Ineligible|1
2080285|NCT00695786|3663767|FG001|Overall Study|Deemed Ineligible|0
2080286|NCT00695786|3663768|FG002|Overall Study|Deemed Ineligible|0
2080287|NCT00695786|3663769|FG003|Overall Study|Deemed Ineligible|0
2080288|NCT00695786|3663766|FG000|Overall Study|Lack of Efficacy|0
2080289|NCT00695786|3663767|FG001|Overall Study|Lack of Efficacy|0
2080290|NCT00695786|3663768|FG002|Overall Study|Lack of Efficacy|0
2080291|NCT00695786|3663769|FG003|Overall Study|Lack of Efficacy|4
2080292|NCT00695864|3663779|FG000|Placebo|Withdrawal by Subject|1
2080293|NCT00695864|3663779|FG000|Placebo|Physician Decision|4
2304980|NCT02662582|4005706|FG000|Treatment Period 1 (14 Days)|Adverse Event|3
2304981|NCT02662582|4005707|FG001|Treatment Period 1 (14 Days)|Adverse Event|2
2304982|NCT02662582|4005706|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0
2304983|NCT02662582|4005707|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1
2304984|NCT02662582|4005706|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1
2304985|NCT02662582|4005707|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0
2304986|NCT02662582|4005706|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2304987|NCT02662582|4005707|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2304988|NCT02662764|4005718|FG000|Overall Study|Adverse Event|6
2304989|NCT02662764|4005718|FG000|Overall Study|Lack of Efficacy|8
2304990|NCT02662764|4005718|FG000|Overall Study|Protocol Violation|1
2304991|NCT02662764|4005718|FG000|Overall Study|Withdrawal by Subject|5
2304992|NCT02662764|4005718|FG000|Overall Study|Device failure|4
2304993|NCT02662764|4005718|FG000|Overall Study|Patient changed treatment|1
2304994|NCT02662764|4005718|FG000|Overall Study|Patient discharged prior to 24 hrs|5
2304995|NCT02663128|4005729|FG000|Period 2|Physician Decision|0
2304996|NCT02663128|4005730|FG001|Period 2|Physician Decision|0
2304997|NCT02663128|4005731|FG002|Period 2|Physician Decision|0
2304998|NCT02663128|4005732|FG003|Period 2|Physician Decision|0
2304999|NCT02663128|4005733|FG004|Period 2|Physician Decision|1
2305000|NCT02663128|4005734|FG005|Period 2|Physician Decision|0
2305001|NCT02663453|4005749|FG000|Overall Study|Death|4
2305002|NCT02663453|4005750|FG001|Overall Study|Death|4
2305003|NCT02663453|4005749|FG000|Overall Study|Withdrawal by Subject|1
2305004|NCT02663453|4005750|FG001|Overall Study|Withdrawal by Subject|0
2305005|NCT02663674|4005758|FG000|Overall Study|Lost to Follow-up|5
2305006|NCT02663674|4005759|FG001|Overall Study|Lost to Follow-up|4
2305007|NCT02663674|4005758|FG000|Overall Study|Withdrawal by Subject|1
2080294|NCT00695903|3663787|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0
2080295|NCT00695903|3663788|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2
2080296|NCT00695903|3663787|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
2080297|NCT00695903|3663788|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
2080298|NCT00695903|3663787|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1
2080299|NCT00695903|3663788|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0
2080300|NCT00695903|3663787|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
2106856|NCT00868790|3700224|FG005|Period 2|Lost to Follow-up|1
2305008|NCT02663674|4005759|FG001|Overall Study|Withdrawal by Subject|4
2305009|NCT02663674|4005758|FG000|Overall Study|Physician Decision|1
2305010|NCT02663674|4005759|FG001|Overall Study|Physician Decision|1
2305011|NCT02663674|4005758|FG000|Overall Study|Other Event (Health Related)|0
2305012|NCT02663674|4005759|FG001|Overall Study|Other Event (Health Related)|1
2080301|NCT00695903|3663788|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
2080302|NCT00695903|3663787|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0
2080303|NCT00695903|3663788|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1
2080304|NCT00695903|3663787|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1
2080305|NCT00695903|3663788|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2
2080306|NCT00695903|3663787|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
2080307|NCT00695903|3663788|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
2080308|NCT00695903|3663787|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
2080309|NCT00695903|3663788|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
2080310|NCT00695903|3663787|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0
2080311|NCT00695903|3663788|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1
2080312|NCT00695955|3663794|FG000|Cohort 1|Adverse Event|26
2080313|NCT00695955|3663794|FG000|Cohort 1|Protocol Violation|2
2080314|NCT00695955|3663794|FG000|Cohort 1|Lost to Follow-up|30
2080315|NCT00695955|3663794|FG000|Cohort 1|Withdrawal by Subject|25
2080316|NCT00695955|3663794|FG000|Cohort 1|Lack of Efficacy|3
2080317|NCT00695955|3663794|FG000|Cohort 1|Other|16
2080318|NCT00695955|3663794|FG000|Cohort 2|Adverse Event|24
2080319|NCT00695955|3663794|FG000|Cohort 2|Protocol Violation|5
2080320|NCT00695955|3663794|FG000|Cohort 2|Lost to Follow-up|38
2080321|NCT00695955|3663794|FG000|Cohort 2|Withdrawal by Subject|28
2080322|NCT00695955|3663794|FG000|Cohort 2|Lack of Efficacy|4
2080323|NCT00695955|3663794|FG000|Cohort 2|Other|5
2080324|NCT00696020|3663804|FG000|Overall Study|Adverse Event|3
2080325|NCT00696020|3663805|FG001|Overall Study|Adverse Event|1
2080326|NCT00696020|3663806|FG002|Overall Study|Adverse Event|2
2080327|NCT00696020|3663807|FG003|Overall Study|Adverse Event|1
2080328|NCT00696020|3663804|FG000|Overall Study|Lack of Efficacy|1
2305013|NCT02663687|4005770|FG000|Overall Study|Adverse Event|1
2305014|NCT02663687|4005771|FG001|Overall Study|Adverse Event|0
2305015|NCT02663687|4005772|FG002|Overall Study|Adverse Event|0
2305016|NCT02663687|4005773|FG003|Overall Study|Adverse Event|0
2305017|NCT02663687|4005774|FG004|Overall Study|Adverse Event|0
2305018|NCT02663687|4005770|FG000|Overall Study|Other|1
2305019|NCT02663687|4005771|FG001|Overall Study|Other|0
2305020|NCT02663687|4005772|FG002|Overall Study|Other|1
2305021|NCT02663687|4005773|FG003|Overall Study|Other|0
2305022|NCT02663687|4005774|FG004|Overall Study|Other|0
2305023|NCT02663817|4005799|FG000|Overall Study|Screen failure|2
2305024|NCT02663882|4005807|FG000|Overall Study|Lost to Follow-up|4
2305025|NCT02663882|4005808|FG001|Overall Study|Lost to Follow-up|2
2305026|NCT02663895|4005814|FG000|Overall Study|Adverse Event|3
2305027|NCT02663895|4005814|FG000|Overall Study|Physician Decision|2
2305028|NCT02663895|4005814|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1
2305029|NCT02663895|4005814|FG000|Overall Study|Withdrawal by Subject|1
2305030|NCT02664272|4005828|FG000|Overall Study|Fluoroscopic images not made available|2
2305031|NCT02664415|4005847|FG000|Overall Study|Adverse Event|1
2305032|NCT02664415|4005848|FG001|Overall Study|Adverse Event|0
2321720|NCT02963506|4036372|FG001|Double-Blind Period|Lost to Follow-up|1
2321721|NCT02963506|4036373|FG002|Double-Blind Period|Lost to Follow-up|0
2321722|NCT02963506|4036374|FG003|Double-Blind Period|Lost to Follow-up|0
2321723|NCT02963506|4036375|FG004|Double-Blind Period|Lost to Follow-up|0
2321724|NCT02963506|4036376|FG005|Double-Blind Period|Lost to Follow-up|0
2321725|NCT02963506|4036377|FG006|Double-Blind Period|Lost to Follow-up|0
2211198|NCT01658579|3851382|FG000|Treatment Period A|Adverse Event|1
2211199|NCT01658579|3851383|FG001|Treatment Period A|Adverse Event|0
2211200|NCT01658579|3851384|FG002|Treatment Period A|Adverse Event|0
2211201|NCT01658579|3851385|FG003|Treatment Period A|Adverse Event|0
2211202|NCT01658579|3851382|FG000|Treatment Period B|Other|0
2211203|NCT01658579|3851383|FG001|Treatment Period B|Other|0
2211204|NCT01658579|3851384|FG002|Treatment Period B|Other|0
2211205|NCT01658579|3851385|FG003|Treatment Period B|Other|1
2211206|NCT01658735|3851403|FG000|Overall Study|Lack of Efficacy|1
2211207|NCT01658735|3851404|FG001|Overall Study|Lack of Efficacy|0
2211208|NCT01658735|3851405|FG002|Overall Study|Lack of Efficacy|1
2211209|NCT01658735|3851403|FG000|Overall Study|Lost to Follow-up|1
2211210|NCT01658735|3851404|FG001|Overall Study|Lost to Follow-up|1
2211211|NCT01658735|3851405|FG002|Overall Study|Lost to Follow-up|0
2211212|NCT01658735|3851403|FG000|Overall Study|Protocol Violation|0
2211213|NCT01658735|3851404|FG001|Overall Study|Protocol Violation|1
2321726|NCT02963506|4036378|FG007|Double-Blind Period|Lost to Follow-up|0
2321727|NCT02963506|4036379|FG008|Double-Blind Period|Lost to Follow-up|0
2321728|NCT02963506|4036380|FG009|Double-Blind Period|Lost to Follow-up|0
2321729|NCT02963506|4036381|FG010|Double-Blind Period|Lost to Follow-up|0
2321730|NCT02963506|4036382|FG011|Double-Blind Period|Lost to Follow-up|0
2321731|NCT02963506|4036383|FG012|Double-Blind Period|Lost to Follow-up|0
2080329|NCT00696020|3663805|FG001|Overall Study|Lack of Efficacy|0
2080330|NCT00696020|3663806|FG002|Overall Study|Lack of Efficacy|0
2321732|NCT02963506|4036371|FG000|Double-Blind Period|Withdrawal by Subject|0
2211214|NCT01658735|3851405|FG002|Overall Study|Protocol Violation|0
2211215|NCT01658735|3851403|FG000|Overall Study|Withdrawal by Subject|3
2211216|NCT01658735|3851404|FG001|Overall Study|Withdrawal by Subject|5
2211217|NCT01658735|3851405|FG002|Overall Study|Withdrawal by Subject|3
2211218|NCT01658904|3851420|FG000|Overall Study|Principal Investigator discretion|2
2321733|NCT02963506|4036372|FG001|Double-Blind Period|Withdrawal by Subject|0
2080331|NCT00696020|3663807|FG003|Overall Study|Lack of Efficacy|0
2080332|NCT00696020|3663804|FG000|Overall Study|Protocol Violation|0
2080333|NCT00696020|3663805|FG001|Overall Study|Protocol Violation|0
2080334|NCT00696020|3663806|FG002|Overall Study|Protocol Violation|0
2080335|NCT00696020|3663807|FG003|Overall Study|Protocol Violation|1
2080336|NCT00696020|3663804|FG000|Overall Study|Withdrawal by Subject|0
2080337|NCT00696020|3663805|FG001|Overall Study|Withdrawal by Subject|1
2080338|NCT00696020|3663806|FG002|Overall Study|Withdrawal by Subject|0
2080339|NCT00696020|3663807|FG003|Overall Study|Withdrawal by Subject|1
2080340|NCT00696020|3663804|FG000|Overall Study|Other not stated above|0
2080341|NCT00696020|3663805|FG001|Overall Study|Other not stated above|0
2080342|NCT00696020|3663806|FG002|Overall Study|Other not stated above|1
2080343|NCT00696020|3663807|FG003|Overall Study|Other not stated above|1
2080344|NCT00696072|3663821|FG000|Overall Study|continuing active treatment|10
2080345|NCT00696072|3663822|FG001|Overall Study|continuing active treatment|13
2211219|NCT01658904|3851421|FG001|Overall Study|Principal Investigator discretion|0
2211220|NCT01658904|3851422|FG002|Overall Study|Principal Investigator discretion|0
2211221|NCT01658943|3851435|FG000|Overall Study|Adverse Event|6
2211222|NCT01658943|3851436|FG001|Overall Study|Adverse Event|13
2211223|NCT01658943|3851435|FG000|Overall Study|Withdrawal by Subject|9
2211224|NCT01658943|3851436|FG001|Overall Study|Withdrawal by Subject|2
2211225|NCT01658943|3851435|FG000|Overall Study|Progression/Relapse|39
2211226|NCT01658943|3851436|FG001|Overall Study|Progression/Relapse|40
2211227|NCT01658943|3851435|FG000|Overall Study|Death|4
2211228|NCT01658943|3851436|FG001|Overall Study|Death|2
2211229|NCT01658943|3851435|FG000|Overall Study|not protocol specified|4
2211230|NCT01658943|3851436|FG001|Overall Study|not protocol specified|1
2211231|NCT01658943|3851435|FG000|Overall Study|Not eligible|7
2211232|NCT01658943|3851436|FG001|Overall Study|Not eligible|9
2211233|NCT01658943|3851435|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1
2305033|NCT02665052|4005910|FG000|Overall Study|Lost to Follow-up|1
2305034|NCT02665052|4005911|FG001|Overall Study|Lost to Follow-up|0
2305035|NCT02665052|4005912|FG002|Overall Study|Lost to Follow-up|0
2305036|NCT02665052|4005913|FG003|Overall Study|Lost to Follow-up|0
2305037|NCT02665052|4005910|FG000|Overall Study|Withdrawal by Subject|1
2305038|NCT02665052|4005911|FG001|Overall Study|Withdrawal by Subject|1
2305039|NCT02665052|4005912|FG002|Overall Study|Withdrawal by Subject|0
2305040|NCT02665052|4005913|FG003|Overall Study|Withdrawal by Subject|5
2305041|NCT02665052|4005910|FG000|Overall Study|Adverse Event|1
2305042|NCT02665052|4005911|FG001|Overall Study|Adverse Event|1
2305043|NCT02665052|4005912|FG002|Overall Study|Adverse Event|0
2305044|NCT02665052|4005913|FG003|Overall Study|Adverse Event|0
2305045|NCT02665286|4005957|FG000|Overall Study|Lost to Follow-up|3
2305046|NCT02665286|4005958|FG001|Overall Study|Lost to Follow-up|2
2305047|NCT02665286|4005959|FG002|Overall Study|Lost to Follow-up|1
2305048|NCT02665455|4005976|FG000|Overall Study|Withdrawal by Subject|6
2305049|NCT02665455|4005976|FG000|Overall Study|Lost to Follow-up|1
2305050|NCT02665455|4005976|FG000|Overall Study|Adverse Event|1
2305051|NCT02665455|4005976|FG000|Overall Study|Protocol Violation|1
2305052|NCT02665689|4005991|FG000|Overall Study|Adverse Event|1
2305053|NCT02665689|4005992|FG001|Overall Study|Adverse Event|0
2305054|NCT02665689|4005991|FG000|Overall Study|Trial termination|1
2305055|NCT02665689|4005992|FG001|Overall Study|Trial termination|1
2305056|NCT02665689|4005991|FG000|Overall Study|Lost to Follow-up|0
2305057|NCT02665689|4005992|FG001|Overall Study|Lost to Follow-up|1
2305058|NCT02666222|4006024|FG000|Overall Study|Death|2
2305059|NCT02666430|4006043|FG000|Period 1|Lost to Follow-up|1
2305060|NCT02666430|4006044|FG001|Period 1|Lost to Follow-up|0
2305061|NCT02666430|4006043|FG000|Period 1|Adverse Event|0
2305062|NCT02666430|4006044|FG001|Period 1|Adverse Event|1
2305063|NCT02666430|4006043|FG000|Period 2|Withdrawal by Subject|1
2305064|NCT02666430|4006044|FG001|Period 2|Withdrawal by Subject|4
2305065|NCT02666430|4006043|FG000|Period 3|Lost to Follow-up|1
2305066|NCT02666430|4006044|FG001|Period 3|Lost to Follow-up|0
2305067|NCT02666664|4006073|FG000|Overall Study|Physician Decision|0
2305068|NCT02666664|4006074|FG001|Overall Study|Physician Decision|1
2305069|NCT02666664|4006073|FG000|Overall Study|Protocol Violation|0
2305070|NCT02666664|4006074|FG001|Overall Study|Protocol Violation|2
2305071|NCT02666664|4006073|FG000|Overall Study|Other|0
2305072|NCT02666664|4006074|FG001|Overall Study|Other|1
2305073|NCT02666664|4006073|FG000|Overall Study|Adverse Event|12
2305074|NCT02666664|4006074|FG001|Overall Study|Adverse Event|37
2305075|NCT02666664|4006073|FG000|Overall Study|Withdrawal by participant|23
2305076|NCT02666664|4006074|FG001|Overall Study|Withdrawal by participant|40
2080346|NCT00696072|3663821|FG000|Overall Study|Adverse Event|10
2211234|NCT01658943|3851436|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0
2211235|NCT01659021|3851453|FG000|Main Study|Adverse Event|2
2211236|NCT01659021|3851454|FG001|Main Study|Adverse Event|3
2211237|NCT01659021|3851453|FG000|Main Study|Lost to Follow-up|1
2211238|NCT01659021|3851454|FG001|Main Study|Lost to Follow-up|0
2211239|NCT01659021|3851453|FG000|Main Study|Unknown Reasons|2
2305077|NCT02666664|4006073|FG000|Overall Study|Sponsor decision|0
2305078|NCT02666664|4006074|FG001|Overall Study|Sponsor decision|1
2305079|NCT02666664|4006073|FG000|Overall Study|Lost to Follow-up|1
2305080|NCT02666664|4006074|FG001|Overall Study|Lost to Follow-up|2
2305081|NCT02667236|4006132|FG000|Overall Study|Adverse Event|1
2080347|NCT00696072|3663822|FG001|Overall Study|Adverse Event|6
2080348|NCT00696072|3663821|FG000|Overall Study|Patient Request|3
2080349|NCT00696072|3663822|FG001|Overall Study|Patient Request|7
2080350|NCT00696072|3663821|FG000|Overall Study|Investigator Request|1
2080351|NCT00696072|3663822|FG001|Overall Study|Investigator Request|4
2080352|NCT00696072|3663821|FG000|Overall Study|Sponsor Request|0
2080353|NCT00696072|3663822|FG001|Overall Study|Sponsor Request|1
2080354|NCT00696072|3663821|FG000|Overall Study|Disease Progression|32
2080355|NCT00696072|3663822|FG001|Overall Study|Disease Progression|30
2080356|NCT00696072|3663821|FG000|Overall Study|Non-specified|1
2080357|NCT00696072|3663822|FG001|Overall Study|Non-specified|2
2080358|NCT00696137|3663829|FG000|Overall Study|Withdrawal by Subject|2
2080359|NCT00696241|3663838|FG000|Overall Study|Adverse Event|11
2080360|NCT00696241|3663839|FG001|Overall Study|Adverse Event|3
2080361|NCT00696241|3663840|FG002|Overall Study|Adverse Event|6
2080362|NCT00696241|3663841|FG003|Overall Study|Adverse Event|4
2305082|NCT02667236|4006133|FG001|Overall Study|Adverse Event|1
2305083|NCT02667236|4006132|FG000|Overall Study|Withdrawal by Subject|2
2305084|NCT02667236|4006133|FG001|Overall Study|Withdrawal by Subject|0
2305085|NCT02667275|4006141|FG000|Overall Study|Protocol Violation|11
2305086|NCT02667275|4006142|FG001|Overall Study|Protocol Violation|7
2305087|NCT02667275|4006141|FG000|Overall Study|Lost to Follow-up|0
2305088|NCT02667275|4006142|FG001|Overall Study|Lost to Follow-up|2
2305089|NCT02667275|4006141|FG000|Overall Study|Withdrawal by Subject|0
2305090|NCT02667275|4006142|FG001|Overall Study|Withdrawal by Subject|5
2305091|NCT02667275|4006141|FG000|Overall Study|Discontinued early without completing|0
2305092|NCT02667275|4006142|FG001|Overall Study|Discontinued early without completing|1
2305093|NCT02667288|4006148|FG000|Overall Study|Protocol Violation|5
2305094|NCT02667288|4006148|FG000|Overall Study|Lost to Follow-up|3
2305095|NCT02667288|4006148|FG000|Overall Study|Withdrawal by Subject|5
2305096|NCT02667301|4006152|FG000|Overall Study|Adverse Event|1
2305097|NCT02667301|4006152|FG000|Overall Study|Lack of Efficacy|1
2305098|NCT02667457|4006164|FG000|Overall Study|Withdrawal by Subject|1
2305099|NCT02667457|4006165|FG001|Overall Study|Withdrawal by Subject|0
2305100|NCT02667457|4006164|FG000|Overall Study|Other Reason|0
2305101|NCT02667457|4006165|FG001|Overall Study|Other Reason|2
2305102|NCT02667626|4006174|FG000|Overall Study|Withdrawal by Subject|0
2305103|NCT02667626|4006175|FG001|Overall Study|Withdrawal by Subject|1
2305104|NCT02667912|4006198|FG000|Overall Study|Death|3
2305105|NCT02667912|4006199|FG001|Overall Study|Death|1
2305106|NCT02667912|4006198|FG000|Overall Study|Withdrawal by Subject|1
2305107|NCT02667912|4006199|FG001|Overall Study|Withdrawal by Subject|2
2305108|NCT02667912|4006198|FG000|Overall Study|Withdrawal by Subject|1
2305109|NCT02667912|4006199|FG001|Overall Study|Withdrawal by Subject|0
2305110|NCT02668185|4006223|FG000|First Intervention (4 Weeks)|Physician Decision|2
2305111|NCT02668185|4006224|FG001|First Intervention (4 Weeks)|Physician Decision|0
2305112|NCT02668185|4006223|FG000|Washout Period (2 Weeks)|Adverse Event|1
2305113|NCT02668185|4006224|FG001|Washout Period (2 Weeks)|Adverse Event|0
2305114|NCT02668185|4006223|FG000|Washout Period (2 Weeks)|Physician Decision|0
2305115|NCT02668185|4006224|FG001|Washout Period (2 Weeks)|Physician Decision|2
2305116|NCT02668185|4006223|FG000|Second Intervention (4 Weeks)|Physician Decision|1
2305117|NCT02668185|4006224|FG001|Second Intervention (4 Weeks)|Physician Decision|3
2305118|NCT02668302|4006237|FG000|Overall Study|Withdrawal by Subject|1
2305119|NCT02668302|4006238|FG001|Overall Study|Withdrawal by Subject|0
2305120|NCT02668393|4006246|FG000|Overall Study|Progressive disease|6
2305121|NCT02668393|4006247|FG001|Overall Study|Progressive disease|3
2305122|NCT02668393|4006246|FG000|Overall Study|Adverse Event|0
2305123|NCT02668393|4006247|FG001|Overall Study|Adverse Event|2
2305124|NCT02668393|4006246|FG000|Overall Study|Withdrawal from the trial|0
2305125|NCT02668393|4006247|FG001|Overall Study|Withdrawal from the trial|1
2305126|NCT02668393|4006246|FG000|Overall Study|Lack of benefit and side effects|1
2305127|NCT02668393|4006247|FG001|Overall Study|Lack of benefit and side effects|0
2305128|NCT02668640|4006263|FG000|Overall Study|Lost to Follow-up|13
2305129|NCT02668640|4006263|FG000|Overall Study|Other, not specified|1
2305130|NCT02668692|4006269|FG000|Overall Study|Adverse Event|1
2305131|NCT02668692|4006270|FG001|Overall Study|Adverse Event|0
2305132|NCT02669017|4006294|FG000|Overall Study|Death|1
2305133|NCT02669017|4006295|FG001|Overall Study|Death|2
2305134|NCT02669017|4006296|FG002|Overall Study|Death|2
2305135|NCT02669017|4006297|FG003|Overall Study|Death|3
2305136|NCT02669017|4006298|FG004|Overall Study|Death|8
2080363|NCT00696241|3663842|FG004|Overall Study|Adverse Event|5
2305137|NCT02669017|4006299|FG005|Overall Study|Death|18
2305138|NCT02669017|4006300|FG006|Overall Study|Death|10
2305139|NCT02669017|4006301|FG007|Overall Study|Death|47
2305140|NCT02669017|4006302|FG008|Overall Study|Death|20
2305141|NCT02669017|4006294|FG000|Overall Study|Withdrawal by Subject|0
2305142|NCT02669017|4006295|FG001|Overall Study|Withdrawal by Subject|0
2305143|NCT02669017|4006296|FG002|Overall Study|Withdrawal by Subject|0
2305144|NCT02669017|4006297|FG003|Overall Study|Withdrawal by Subject|1
2305145|NCT02669017|4006298|FG004|Overall Study|Withdrawal by Subject|2
2305146|NCT02669017|4006299|FG005|Overall Study|Withdrawal by Subject|0
2305147|NCT02669017|4006300|FG006|Overall Study|Withdrawal by Subject|0
2305148|NCT02669017|4006301|FG007|Overall Study|Withdrawal by Subject|2
2080364|NCT00696241|3663838|FG000|Overall Study|Protocol Violation|1
2080365|NCT00696241|3663839|FG001|Overall Study|Protocol Violation|1
2080366|NCT00696241|3663840|FG002|Overall Study|Protocol Violation|2
2080367|NCT00696241|3663841|FG003|Overall Study|Protocol Violation|0
2080368|NCT00696241|3663842|FG004|Overall Study|Protocol Violation|3
2080369|NCT00696241|3663838|FG000|Overall Study|Lost to Follow-up|1
2080370|NCT00696241|3663839|FG001|Overall Study|Lost to Follow-up|4
2080371|NCT00696241|3663840|FG002|Overall Study|Lost to Follow-up|1
2080372|NCT00696241|3663841|FG003|Overall Study|Lost to Follow-up|2
2080373|NCT00696241|3663842|FG004|Overall Study|Lost to Follow-up|0
2080374|NCT00696241|3663838|FG000|Overall Study|Withdrawal by Subject|4
2080375|NCT00696241|3663839|FG001|Overall Study|Withdrawal by Subject|8
2080376|NCT00696241|3663840|FG002|Overall Study|Withdrawal by Subject|6
2080377|NCT00696241|3663841|FG003|Overall Study|Withdrawal by Subject|1
2080378|NCT00696241|3663842|FG004|Overall Study|Withdrawal by Subject|0
2080379|NCT00696241|3663838|FG000|Overall Study|Lack of Efficacy|1
2080380|NCT00696241|3663839|FG001|Overall Study|Lack of Efficacy|5
2305149|NCT02669017|4006302|FG008|Overall Study|Withdrawal by Subject|2
2305150|NCT02669017|4006294|FG000|Overall Study|Lost to Follow-up|0
2305151|NCT02669017|4006295|FG001|Overall Study|Lost to Follow-up|0
2305152|NCT02669017|4006296|FG002|Overall Study|Lost to Follow-up|0
2305153|NCT02669017|4006297|FG003|Overall Study|Lost to Follow-up|0
2305154|NCT02669017|4006298|FG004|Overall Study|Lost to Follow-up|0
2305155|NCT02669017|4006299|FG005|Overall Study|Lost to Follow-up|0
2305156|NCT02669017|4006300|FG006|Overall Study|Lost to Follow-up|0
2305157|NCT02669017|4006301|FG007|Overall Study|Lost to Follow-up|0
2305158|NCT02669017|4006302|FG008|Overall Study|Lost to Follow-up|1
2305159|NCT02669017|4006294|FG000|Overall Study|Miscellaneous|0
2305160|NCT02669017|4006295|FG001|Overall Study|Miscellaneous|0
2305161|NCT02669017|4006296|FG002|Overall Study|Miscellaneous|0
2305162|NCT02669017|4006297|FG003|Overall Study|Miscellaneous|0
2305163|NCT02669017|4006298|FG004|Overall Study|Miscellaneous|2
2305164|NCT02669017|4006299|FG005|Overall Study|Miscellaneous|1
2305165|NCT02669017|4006300|FG006|Overall Study|Miscellaneous|1
2305166|NCT02669017|4006301|FG007|Overall Study|Miscellaneous|13
2305167|NCT02669017|4006302|FG008|Overall Study|Miscellaneous|2
2305168|NCT02669043|4006330|FG000|Overall Study|Didn't meet I/E criteria|4
2305169|NCT02669082|4006334|FG000|Overall Study|Adverse Event|1
2305170|NCT02669095|4006340|FG000|Overall Study|Adverse Event|1
2305171|NCT02669095|4006341|FG001|Overall Study|Adverse Event|0
2305172|NCT02669095|4006340|FG000|Overall Study|Unsatisfactory Lens Fitting|0
2305173|NCT02669095|4006341|FG001|Overall Study|Unsatisfactory Lens Fitting|1
2305174|NCT02669095|4006340|FG000|Overall Study|Torn Lens|0
2305175|NCT02669095|4006341|FG001|Overall Study|Torn Lens|1
2305176|NCT02669095|4006340|FG000|Overall Study|Visit 5 assessments not completed|0
2305177|NCT02669095|4006341|FG001|Overall Study|Visit 5 assessments not completed|1
2305178|NCT02669121|4006349|FG000|Overall Study|Adverse Event|4
2305179|NCT02669121|4006350|FG001|Overall Study|Adverse Event|5
2305180|NCT02669121|4006349|FG000|Overall Study|Lost to Follow-up|15
2305181|NCT02669121|4006350|FG001|Overall Study|Lost to Follow-up|27
2305182|NCT02669121|4006349|FG000|Overall Study|Withdrawal by Subject|132
2305183|NCT02669121|4006350|FG001|Overall Study|Withdrawal by Subject|140
2305184|NCT02669121|4006349|FG000|Overall Study|Pregnancy|0
2305185|NCT02669121|4006350|FG001|Overall Study|Pregnancy|1
2305186|NCT02669121|4006349|FG000|Overall Study|Discharged from US Military Active Service|117
2305187|NCT02669121|4006350|FG001|Overall Study|Discharged from US Military Active Service|91
2305188|NCT02669121|4006349|FG000|Overall Study|Reason not Specified|22
2305189|NCT02669121|4006350|FG001|Overall Study|Reason not Specified|18
2305190|NCT02669264|4006363|FG000|Overall Study|Death|5
2305191|NCT02669264|4006364|FG001|Overall Study|Death|5
2305192|NCT02669264|4006365|FG002|Overall Study|Death|3
2305193|NCT02669264|4006366|FG003|Overall Study|Death|3
2305194|NCT02669264|4006367|FG004|Overall Study|Death|3
2305195|NCT02669264|4006368|FG005|Overall Study|Death|6
2305196|NCT02669264|4006369|FG006|Overall Study|Death|3
2305197|NCT02669264|4006363|FG000|Overall Study|Withdrawal by Subject|0
2305198|NCT02669264|4006364|FG001|Overall Study|Withdrawal by Subject|1
2305199|NCT02669264|4006365|FG002|Overall Study|Withdrawal by Subject|0
2305200|NCT02669264|4006366|FG003|Overall Study|Withdrawal by Subject|0
2305201|NCT02669264|4006367|FG004|Overall Study|Withdrawal by Subject|1
2305202|NCT02669264|4006368|FG005|Overall Study|Withdrawal by Subject|0
2305203|NCT02669264|4006369|FG006|Overall Study|Withdrawal by Subject|0
2305204|NCT02669264|4006363|FG000|Overall Study|Lost to Follow-up|0
2305205|NCT02669264|4006364|FG001|Overall Study|Lost to Follow-up|0
2305206|NCT02669264|4006365|FG002|Overall Study|Lost to Follow-up|0
2305207|NCT02669264|4006366|FG003|Overall Study|Lost to Follow-up|0
2305208|NCT02669264|4006367|FG004|Overall Study|Lost to Follow-up|1
2305209|NCT02669264|4006368|FG005|Overall Study|Lost to Follow-up|0
2305210|NCT02669264|4006369|FG006|Overall Study|Lost to Follow-up|0
2305211|NCT02669264|4006363|FG000|Overall Study|Miscellaneous|0
2305212|NCT02669264|4006364|FG001|Overall Study|Miscellaneous|0
2305213|NCT02669264|4006365|FG002|Overall Study|Miscellaneous|0
2305214|NCT02669264|4006366|FG003|Overall Study|Miscellaneous|0
2305215|NCT02669264|4006367|FG004|Overall Study|Miscellaneous|0
2305216|NCT02669264|4006368|FG005|Overall Study|Miscellaneous|0
2305217|NCT02669264|4006369|FG006|Overall Study|Miscellaneous|2
2305218|NCT02669407|4006391|FG000|Overall Study|Physician Decision|3
2080381|NCT00696241|3663840|FG002|Overall Study|Lack of Efficacy|4
2080382|NCT00696241|3663841|FG003|Overall Study|Lack of Efficacy|5
2080383|NCT00696241|3663842|FG004|Overall Study|Lack of Efficacy|3
2080384|NCT00696241|3663838|FG000|Overall Study|Other|6
2080385|NCT00696241|3663839|FG001|Overall Study|Other|1
2080386|NCT00696241|3663840|FG002|Overall Study|Other|5
2080387|NCT00696241|3663841|FG003|Overall Study|Other|2
2080388|NCT00696241|3663842|FG004|Overall Study|Other|1
2080389|NCT00696384|3663859|FG000|Open Label Phase|Adverse Event|27
2080390|NCT00696384|3663860|FG001|Open Label Phase|Adverse Event|0
2080391|NCT00696384|3663861|FG002|Open Label Phase|Adverse Event|0
2080392|NCT00696384|3663859|FG000|Open Label Phase|Protocol Violation|18
2080393|NCT00696384|3663860|FG001|Open Label Phase|Protocol Violation|0
2080394|NCT00696384|3663861|FG002|Open Label Phase|Protocol Violation|0
2080395|NCT00696384|3663859|FG000|Open Label Phase|Lost to Follow-up|24
2080396|NCT00696384|3663860|FG001|Open Label Phase|Lost to Follow-up|0
2080397|NCT00696384|3663861|FG002|Open Label Phase|Lost to Follow-up|0
2305219|NCT02669433|4006398|FG000|Overall Study|Protocol Violation|0
2305220|NCT02669433|4006399|FG001|Overall Study|Protocol Violation|4
2305221|NCT02669433|4006400|FG002|Overall Study|Protocol Violation|1
2305222|NCT02669433|4006398|FG000|Overall Study|Disease Progression|1
2305223|NCT02669433|4006399|FG001|Overall Study|Disease Progression|0
2305224|NCT02669433|4006400|FG002|Overall Study|Disease Progression|0
2305225|NCT02669433|4006398|FG000|Overall Study|Physician Decision|1
2305226|NCT02669433|4006399|FG001|Overall Study|Physician Decision|1
2305227|NCT02669433|4006400|FG002|Overall Study|Physician Decision|0
2305228|NCT02669433|4006398|FG000|Overall Study|Adverse Event|6
2305229|NCT02669433|4006399|FG001|Overall Study|Adverse Event|7
2305230|NCT02669433|4006400|FG002|Overall Study|Adverse Event|10
2305231|NCT02669433|4006398|FG000|Overall Study|Sponsor Termination|1
2305232|NCT02669433|4006399|FG001|Overall Study|Sponsor Termination|0
2305233|NCT02669433|4006400|FG002|Overall Study|Sponsor Termination|1
2305234|NCT02669433|4006398|FG000|Overall Study|Withdrawal by Subject|5
2305235|NCT02669433|4006399|FG001|Overall Study|Withdrawal by Subject|1
2305236|NCT02669433|4006400|FG002|Overall Study|Withdrawal by Subject|0
2305237|NCT02669433|4006398|FG000|Overall Study|Withdrawal by Caregiver|1
2305238|NCT02669433|4006399|FG001|Overall Study|Withdrawal by Caregiver|0
2305239|NCT02669433|4006400|FG002|Overall Study|Withdrawal by Caregiver|2
2305240|NCT02669433|4006398|FG000|Overall Study|Death|0
2305241|NCT02669433|4006399|FG001|Overall Study|Death|1
2305242|NCT02669433|4006400|FG002|Overall Study|Death|1
2305243|NCT02669667|4006419|FG000|Overall Study|Lost to Follow-up|0
2305244|NCT02669667|4006420|FG001|Overall Study|Lost to Follow-up|0
2305245|NCT02669667|4006421|FG002|Overall Study|Lost to Follow-up|0
2305246|NCT02669667|4006422|FG003|Overall Study|Lost to Follow-up|0
2305247|NCT02669667|4006423|FG004|Overall Study|Lost to Follow-up|0
2305248|NCT02669667|4006424|FG005|Overall Study|Lost to Follow-up|1
2305249|NCT02669667|4006425|FG006|Overall Study|Lost to Follow-up|0
2305250|NCT02669758|4006447|FG000|Overall Study|Withdrawal by Subject|43
2305251|NCT02669758|4006447|FG000|Overall Study|Lost to Follow-up|19
2305252|NCT02669758|4006447|FG000|Overall Study|Adverse Event|16
2305253|NCT02669758|4006447|FG000|Overall Study|Non-Compliance with Study Drug|8
2305254|NCT02669758|4006447|FG000|Overall Study|Lack of Efficacy|5
2305255|NCT02669758|4006447|FG000|Overall Study|Pregnancy|1
2305256|NCT02669758|4006447|FG000|Overall Study|Study noncompliance|1
2305257|NCT02669758|4006447|FG000|Overall Study|Protocol Violation|1
2305258|NCT02669849|4006463|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
2305259|NCT02669849|4006464|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0
2305260|NCT02669849|4006465|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3
2305261|NCT02669849|4006463|FG000|Overall Study|Lost to Follow-up|1
2305262|NCT02669849|4006464|FG001|Overall Study|Lost to Follow-up|0
2305263|NCT02669849|4006465|FG002|Overall Study|Lost to Follow-up|3
2305264|NCT02669849|4006463|FG000|Overall Study|Death|1
2305265|NCT02669849|4006464|FG001|Overall Study|Death|1
2305266|NCT02669849|4006465|FG002|Overall Study|Death|2
2305267|NCT02669849|4006463|FG000|Overall Study|Study terminated by sponsor|16
2305268|NCT02669849|4006464|FG001|Overall Study|Study terminated by sponsor|1
2305269|NCT02669849|4006465|FG002|Overall Study|Study terminated by sponsor|14
2305270|NCT02669849|4006463|FG000|Overall Study|Other|0
2305271|NCT02669849|4006464|FG001|Overall Study|Other|0
2305272|NCT02669849|4006465|FG002|Overall Study|Other|2
2305273|NCT02669862|4006476|FG000|Overall Study|Lost to Follow-up|0
2305274|NCT02669862|4006477|FG001|Overall Study|Lost to Follow-up|2
2305275|NCT02669862|4006478|FG002|Overall Study|Lost to Follow-up|1
2305276|NCT02669862|4006476|FG000|Overall Study|Withdrawal by Subject|2
2305277|NCT02669862|4006477|FG001|Overall Study|Withdrawal by Subject|2
2305278|NCT02669862|4006478|FG002|Overall Study|Withdrawal by Subject|3
2305279|NCT02669862|4006476|FG000|Overall Study|moved|0
2080398|NCT00696384|3663859|FG000|Open Label Phase|Withdrawal by Subject|37
2305280|NCT02669862|4006477|FG001|Overall Study|moved|1
2305281|NCT02669862|4006478|FG002|Overall Study|moved|0
2305282|NCT02669862|4006476|FG000|Overall Study|Protocol Violation|0
2305283|NCT02669862|4006477|FG001|Overall Study|Protocol Violation|0
2305284|NCT02669862|4006478|FG002|Overall Study|Protocol Violation|1
2305285|NCT02669940|4006504|FG000|Overall Study|Failure to return|0
2305286|NCT02669940|4006505|FG001|Overall Study|Failure to return|3
2305287|NCT02669940|4006504|FG000|Overall Study|Insufficient follow-up data|1
2080399|NCT00696384|3663860|FG001|Open Label Phase|Withdrawal by Subject|0
2080400|NCT00696384|3663861|FG002|Open Label Phase|Withdrawal by Subject|0
2080401|NCT00696384|3663859|FG000|Open Label Phase|Other|6
2080402|NCT00696384|3663860|FG001|Open Label Phase|Other|0
2080403|NCT00696384|3663861|FG002|Open Label Phase|Other|0
2080404|NCT00696384|3663859|FG000|Open Label Phase|Lack of Efficacy|3
2305288|NCT02669940|4006505|FG001|Overall Study|Insufficient follow-up data|0
2305289|NCT02670083|4006520|FG000|Overall Study|Adverse Event|16
2305290|NCT02670083|4006521|FG001|Overall Study|Adverse Event|13
2305291|NCT02670083|4006520|FG000|Overall Study|Death|4
2305292|NCT02670083|4006521|FG001|Overall Study|Death|6
2305293|NCT02670083|4006520|FG000|Overall Study|Lost to Follow-up|2
2305294|NCT02670083|4006521|FG001|Overall Study|Lost to Follow-up|2
2305295|NCT02670083|4006520|FG000|Overall Study|Multiple Reasons|9
2305296|NCT02670083|4006521|FG001|Overall Study|Multiple Reasons|9
2305297|NCT02670083|4006520|FG000|Overall Study|Physician Decision|0
2305298|NCT02670083|4006521|FG001|Overall Study|Physician Decision|2
2305299|NCT02670083|4006520|FG000|Overall Study|Study Terminated By Sponsor|257
2305300|NCT02670083|4006521|FG001|Overall Study|Study Terminated By Sponsor|254
2305301|NCT02670083|4006520|FG000|Overall Study|Symptomatic Deterioration|0
2305302|NCT02670083|4006521|FG001|Overall Study|Symptomatic Deterioration|2
2305303|NCT02670083|4006520|FG000|Overall Study|Withdrawal by Subject|32
2305304|NCT02670083|4006521|FG001|Overall Study|Withdrawal by Subject|31
2305305|NCT02670083|4006520|FG000|Overall Study|Non-Compliance With Study Drug|1
2305306|NCT02670083|4006521|FG001|Overall Study|Non-Compliance With Study Drug|0
2305307|NCT02670122|4006528|FG000|Overall Study|Lost to Follow-up|4
2305308|NCT02670330|4006541|FG000|Overall Study|Protocol Deviation|1
2305309|NCT02670330|4006542|FG001|Overall Study|Protocol Deviation|0
2305310|NCT02670330|4006541|FG000|Overall Study|Study Terminated By Sponsor|36
2305311|NCT02670330|4006542|FG001|Overall Study|Study Terminated By Sponsor|43
2305312|NCT02670330|4006541|FG000|Overall Study|Adverse Event|1
2305313|NCT02670330|4006542|FG001|Overall Study|Adverse Event|3
2305314|NCT02670330|4006541|FG000|Overall Study|Withdrawal by Subject|34
2305315|NCT02670330|4006542|FG001|Overall Study|Withdrawal by Subject|29
2305316|NCT02670330|4006541|FG000|Overall Study|Lost to Follow-up|3
2305317|NCT02670330|4006542|FG001|Overall Study|Lost to Follow-up|2
2305318|NCT02670382|4006552|FG000|Placebo lead-in Phase|Withdrawal by Subject|2
2305319|NCT02670382|4006553|FG001|Placebo lead-in Phase|Withdrawal by Subject|1
2305320|NCT02670473|4006561|FG000|Overall Study|Withdrawal by Subject|1
2305321|NCT02670538|4006577|FG000|Overall Study|Withdrawal of Consent|8
2305322|NCT02670538|4006578|FG001|Overall Study|Withdrawal of Consent|6
2305323|NCT02670538|4006579|FG002|Overall Study|Withdrawal of Consent|5
2305324|NCT02670538|4006577|FG000|Overall Study|Lost to Follow-up|8
2305325|NCT02670538|4006578|FG001|Overall Study|Lost to Follow-up|12
2305326|NCT02670538|4006579|FG002|Overall Study|Lost to Follow-up|7
2305327|NCT02670538|4006577|FG000|Overall Study|Adverse Event|5
2305328|NCT02670538|4006578|FG001|Overall Study|Adverse Event|5
2305329|NCT02670538|4006579|FG002|Overall Study|Adverse Event|11
2305330|NCT02670538|4006577|FG000|Overall Study|Lack of Efficacy|7
2305331|NCT02670538|4006578|FG001|Overall Study|Lack of Efficacy|1
2305332|NCT02670538|4006579|FG002|Overall Study|Lack of Efficacy|2
2305333|NCT02670538|4006577|FG000|Overall Study|Protocol Violation|3
2305334|NCT02670538|4006578|FG001|Overall Study|Protocol Violation|4
2305335|NCT02670538|4006579|FG002|Overall Study|Protocol Violation|1
2305336|NCT02670538|4006577|FG000|Overall Study|Noncompliance with Study Drug|1
2305337|NCT02670538|4006578|FG001|Overall Study|Noncompliance with Study Drug|3
2305338|NCT02670538|4006579|FG002|Overall Study|Noncompliance with Study Drug|2
2305339|NCT02670538|4006577|FG000|Overall Study|Other Miscellaneous Reasons|0
2305340|NCT02670538|4006578|FG001|Overall Study|Other Miscellaneous Reasons|1
2305341|NCT02670538|4006579|FG002|Overall Study|Other Miscellaneous Reasons|2
2305342|NCT02670551|4006590|FG000|Overall Study|Adverse Event|4
2305343|NCT02670551|4006591|FG001|Overall Study|Adverse Event|7
2305344|NCT02670551|4006592|FG002|Overall Study|Adverse Event|9
2305345|NCT02670551|4006590|FG000|Overall Study|Lack of Efficacy|2
2305346|NCT02670551|4006591|FG001|Overall Study|Lack of Efficacy|0
2305347|NCT02670551|4006592|FG002|Overall Study|Lack of Efficacy|3
2305348|NCT02670551|4006590|FG000|Overall Study|Withdrawal of Consent|6
2305349|NCT02670551|4006591|FG001|Overall Study|Withdrawal of Consent|3
2305350|NCT02670551|4006592|FG002|Overall Study|Withdrawal of Consent|8
2305351|NCT02670551|4006590|FG000|Overall Study|Lost to Follow-up|5
2305352|NCT02670551|4006591|FG001|Overall Study|Lost to Follow-up|7
2080405|NCT00696384|3663860|FG001|Open Label Phase|Lack of Efficacy|0
2305353|NCT02670551|4006592|FG002|Overall Study|Lost to Follow-up|6
2305354|NCT02670551|4006590|FG000|Overall Study|Protocol Violation|1
2305355|NCT02670551|4006591|FG001|Overall Study|Protocol Violation|0
2305356|NCT02670551|4006592|FG002|Overall Study|Protocol Violation|0
2305357|NCT02670551|4006590|FG000|Overall Study|Noncompliance with study drug|3
2305358|NCT02670551|4006591|FG001|Overall Study|Noncompliance with study drug|3
2305359|NCT02670551|4006592|FG002|Overall Study|Noncompliance with study drug|2
2305360|NCT02670551|4006590|FG000|Overall Study|Other Miscellaneous Reasons|2
2305361|NCT02670551|4006591|FG001|Overall Study|Other Miscellaneous Reasons|3
2305362|NCT02670551|4006592|FG002|Overall Study|Other Miscellaneous Reasons|3
2305363|NCT02670551|4006590|FG000|Overall Study|Did Not Receive Treatment|5
2080406|NCT00696384|3663861|FG002|Open Label Phase|Lack of Efficacy|0
2080407|NCT00696384|3663859|FG000|Open Label Phase|Physician Decision|4
2080408|NCT00696384|3663860|FG001|Open Label Phase|Physician Decision|0
2080409|NCT00696384|3663861|FG002|Open Label Phase|Physician Decision|0
2305364|NCT02670551|4006591|FG001|Overall Study|Did Not Receive Treatment|3
2305365|NCT02670551|4006592|FG002|Overall Study|Did Not Receive Treatment|0
2305366|NCT02670915|4006621|FG000|Overall Study|Withdrawal by Subject|0
2305367|NCT02670915|4006622|FG001|Overall Study|Withdrawal by Subject|1
2305368|NCT02670915|4006623|FG002|Overall Study|Withdrawal by Subject|4
2305369|NCT02670915|4006621|FG000|Overall Study|Withdrawal by parent/guardian|4
2305370|NCT02670915|4006622|FG001|Overall Study|Withdrawal by parent/guardian|4
2305371|NCT02670915|4006623|FG002|Overall Study|Withdrawal by parent/guardian|1
2305372|NCT02670915|4006621|FG000|Overall Study|Unclassified|0
2305373|NCT02670915|4006622|FG001|Overall Study|Unclassified|3
2305374|NCT02670915|4006623|FG002|Overall Study|Unclassified|0
2305375|NCT02670928|4006633|FG000|Overall Study|Adverse Event|3
2305376|NCT02670928|4006634|FG001|Overall Study|Adverse Event|1
2305377|NCT02670928|4006633|FG000|Overall Study|Withdrawal by Subject|4
2305378|NCT02670928|4006634|FG001|Overall Study|Withdrawal by Subject|0
2305379|NCT02670928|4006633|FG000|Overall Study|Lost to Follow-up|1
2305380|NCT02670928|4006634|FG001|Overall Study|Lost to Follow-up|0
2305381|NCT02670928|4006633|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2
2305382|NCT02670928|4006634|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0
2305383|NCT02671266|4006646|FG000|Overall Study|Withdrawal by Subject|1
2305384|NCT02671266|4006647|FG001|Overall Study|Withdrawal by Subject|1
2305385|NCT02671422|4006653|FG000|Overall Study|Lost to Follow-up|1
2305386|NCT02671422|4006653|FG000|Overall Study|Adverse Event|68
2305387|NCT02671422|4006653|FG000|Overall Study|Lack of Efficacy|1
2305388|NCT02671422|4006653|FG000|Overall Study|Lost to Follow-up|4
2305389|NCT02671422|4006653|FG000|Overall Study|Withdrawal by Subject|7
2305390|NCT02671422|4006653|FG000|Overall Study|Progressive Disease|156
2305391|NCT02671422|4006653|FG000|Overall Study|Worsening of Disease|4
2305392|NCT02671422|4006653|FG000|Overall Study|Sponsor decision|5
2305393|NCT02671422|4006653|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8
2305394|NCT02671422|4006653|FG000|Overall Study|Not treated with Vargatef®|3
2305395|NCT02671422|4006653|FG000|Overall Study|Other not defined above|3
2305396|NCT02671500|4006657|FG000|Overall Study|Lack of Efficacy|12
2305397|NCT02671500|4006657|FG000|Overall Study|Lost to Follow-up|2
2305398|NCT02671760|4006665|FG000|Overall Study|Lost to Follow-up|0
2305399|NCT02671760|4006666|FG001|Overall Study|Lost to Follow-up|1
2305400|NCT02671760|4006667|FG002|Overall Study|Lost to Follow-up|0
2305401|NCT02672423|4006700|FG000|Period 1|Adverse Event|0
2305402|NCT02672423|4006701|FG001|Period 1|Adverse Event|0
2305403|NCT02672423|4006702|FG002|Period 1|Adverse Event|0
2305404|NCT02672423|4006703|FG003|Period 1|Adverse Event|0
2305405|NCT02672423|4006704|FG004|Period 1|Adverse Event|1
2305406|NCT02672423|4006705|FG005|Period 1|Adverse Event|0
2305407|NCT02672423|4006706|FG006|Period 1|Adverse Event|0
2305408|NCT02672423|4006707|FG007|Period 1|Adverse Event|0
2305409|NCT02672423|4006708|FG008|Period 1|Adverse Event|0
2305410|NCT02672423|4006709|FG009|Period 1|Adverse Event|0
2305411|NCT02672423|4006700|FG000|Period 2|Withdrawal by Subject|0
2305412|NCT02672423|4006701|FG001|Period 2|Withdrawal by Subject|0
2305413|NCT02672423|4006702|FG002|Period 2|Withdrawal by Subject|1
2305414|NCT02672423|4006703|FG003|Period 2|Withdrawal by Subject|0
2305415|NCT02672423|4006704|FG004|Period 2|Withdrawal by Subject|0
2305416|NCT02672423|4006705|FG005|Period 2|Withdrawal by Subject|0
2305417|NCT02672423|4006706|FG006|Period 2|Withdrawal by Subject|0
2305418|NCT02672423|4006707|FG007|Period 2|Withdrawal by Subject|0
2305419|NCT02672423|4006708|FG008|Period 2|Withdrawal by Subject|0
2305420|NCT02672423|4006709|FG009|Period 2|Withdrawal by Subject|0
2305421|NCT02672423|4006700|FG000|Period 3|Withdrawal by Subject|0
2305422|NCT02672423|4006701|FG001|Period 3|Withdrawal by Subject|0
2305423|NCT02672423|4006702|FG002|Period 3|Withdrawal by Subject|0
2305424|NCT02672423|4006703|FG003|Period 3|Withdrawal by Subject|0
2305425|NCT02672423|4006704|FG004|Period 3|Withdrawal by Subject|0
2305426|NCT02672423|4006705|FG005|Period 3|Withdrawal by Subject|0
2305427|NCT02672423|4006706|FG006|Period 3|Withdrawal by Subject|0
2305428|NCT02672423|4006707|FG007|Period 3|Withdrawal by Subject|1
2305429|NCT02672423|4006708|FG008|Period 3|Withdrawal by Subject|0
2305430|NCT02672423|4006709|FG009|Period 3|Withdrawal by Subject|0
2305431|NCT02672423|4006700|FG000|Period 3|Physician Decision|0
2305432|NCT02672423|4006701|FG001|Period 3|Physician Decision|0
2305433|NCT02672423|4006702|FG002|Period 3|Physician Decision|0
2305434|NCT02672423|4006703|FG003|Period 3|Physician Decision|0
2305435|NCT02672423|4006704|FG004|Period 3|Physician Decision|0
2305436|NCT02672423|4006705|FG005|Period 3|Physician Decision|1
2305437|NCT02672423|4006706|FG006|Period 3|Physician Decision|0
2305438|NCT02672423|4006707|FG007|Period 3|Physician Decision|0
2305439|NCT02672423|4006708|FG008|Period 3|Physician Decision|0
2305440|NCT02672423|4006709|FG009|Period 3|Physician Decision|0
2305441|NCT02672553|4006741|FG000|Overall Study|Death|3
2305442|NCT02672553|4006742|FG001|Overall Study|Death|5
2305443|NCT02672553|4006741|FG000|Overall Study|Valve Explant|1
2305444|NCT02672553|4006742|FG001|Overall Study|Valve Explant|0
2305445|NCT02672553|4006741|FG000|Overall Study|Conversion to Commercial Valve|3
2305446|NCT02672553|4006742|FG001|Overall Study|Conversion to Commercial Valve|0
2080410|NCT00696384|3663859|FG000|Double Blind Phase|Adverse Event|0
2080411|NCT00696384|3663860|FG001|Double Blind Phase|Adverse Event|2
2305447|NCT02672553|4006741|FG000|Overall Study|Withdrawal by Subject|3
2305448|NCT02672553|4006742|FG001|Overall Study|Withdrawal by Subject|3
2305449|NCT02672553|4006741|FG000|Overall Study|Intraoperative screen failure|2
2305450|NCT02672553|4006742|FG001|Overall Study|Intraoperative screen failure|0
2305451|NCT02672852|4006751|FG000|Part A1|Disease Worsening|1
2305452|NCT02672852|4006752|FG001|Part A1|Disease Worsening|0
2305453|NCT02672852|4006753|FG002|Part A1|Disease Worsening|0
2305454|NCT02672852|4006754|FG003|Part A1|Disease Worsening|0
2305455|NCT02672852|4006755|FG004|Part A1|Disease Worsening|0
2305456|NCT02672852|4006756|FG005|Part A1|Disease Worsening|0
2305457|NCT02672852|4006757|FG006|Part A1|Disease Worsening|0
2305458|NCT02672852|4006751|FG000|Part A1|Adverse Event|0
2305459|NCT02672852|4006752|FG001|Part A1|Adverse Event|1
2305460|NCT02672852|4006753|FG002|Part A1|Adverse Event|0
2305461|NCT02672852|4006754|FG003|Part A1|Adverse Event|0
2305462|NCT02672852|4006755|FG004|Part A1|Adverse Event|0
2305463|NCT02672852|4006756|FG005|Part A1|Adverse Event|0
2305464|NCT02672852|4006757|FG006|Part A1|Adverse Event|0
2305465|NCT02672852|4006751|FG000|Part A1|Lost to Follow-up|1
2305466|NCT02672852|4006752|FG001|Part A1|Lost to Follow-up|2
2305467|NCT02672852|4006753|FG002|Part A1|Lost to Follow-up|0
2305468|NCT02672852|4006754|FG003|Part A1|Lost to Follow-up|0
2305469|NCT02672852|4006755|FG004|Part A1|Lost to Follow-up|0
2305470|NCT02672852|4006756|FG005|Part A1|Lost to Follow-up|0
2305471|NCT02672852|4006757|FG006|Part A1|Lost to Follow-up|0
2305472|NCT02672852|4006751|FG000|Part A1|Withdrawal by Subject|1
2305473|NCT02672852|4006752|FG001|Part A1|Withdrawal by Subject|1
2305474|NCT02672852|4006753|FG002|Part A1|Withdrawal by Subject|0
2305475|NCT02672852|4006754|FG003|Part A1|Withdrawal by Subject|0
2305476|NCT02672852|4006755|FG004|Part A1|Withdrawal by Subject|0
2305477|NCT02672852|4006756|FG005|Part A1|Withdrawal by Subject|0
2305478|NCT02672852|4006757|FG006|Part A1|Withdrawal by Subject|0
2305479|NCT02672852|4006751|FG000|Part A2|Disease worsening|0
2305480|NCT02672852|4006752|FG001|Part A2|Disease worsening|0
2305481|NCT02672852|4006753|FG002|Part A2|Disease worsening|1
2305482|NCT02672852|4006754|FG003|Part A2|Disease worsening|0
2305483|NCT02672852|4006755|FG004|Part A2|Disease worsening|0
2305484|NCT02672852|4006756|FG005|Part A2|Disease worsening|0
2305485|NCT02672852|4006757|FG006|Part A2|Disease worsening|0
2305486|NCT02672852|4006751|FG000|Part A2|Adverse Event|0
2305487|NCT02672852|4006752|FG001|Part A2|Adverse Event|0
2305488|NCT02672852|4006753|FG002|Part A2|Adverse Event|3
2305489|NCT02672852|4006754|FG003|Part A2|Adverse Event|0
2305490|NCT02672852|4006755|FG004|Part A2|Adverse Event|0
2305491|NCT02672852|4006756|FG005|Part A2|Adverse Event|0
2305492|NCT02672852|4006757|FG006|Part A2|Adverse Event|0
2305493|NCT02672852|4006751|FG000|Part A2|Lost to Follow-up|0
2305494|NCT02672852|4006752|FG001|Part A2|Lost to Follow-up|0
2305495|NCT02672852|4006753|FG002|Part A2|Lost to Follow-up|2
2305496|NCT02672852|4006754|FG003|Part A2|Lost to Follow-up|0
2305497|NCT02672852|4006755|FG004|Part A2|Lost to Follow-up|0
2305498|NCT02672852|4006756|FG005|Part A2|Lost to Follow-up|0
2305499|NCT02672852|4006757|FG006|Part A2|Lost to Follow-up|0
2305500|NCT02672852|4006751|FG000|Part A2|Withdrawal by Subject|0
2305501|NCT02672852|4006752|FG001|Part A2|Withdrawal by Subject|0
2305502|NCT02672852|4006753|FG002|Part A2|Withdrawal by Subject|1
2305503|NCT02672852|4006754|FG003|Part A2|Withdrawal by Subject|0
2305504|NCT02672852|4006755|FG004|Part A2|Withdrawal by Subject|0
2305505|NCT02672852|4006756|FG005|Part A2|Withdrawal by Subject|0
2305506|NCT02672852|4006757|FG006|Part A2|Withdrawal by Subject|0
2305507|NCT02672852|4006751|FG000|Part A2|Other|0
2305508|NCT02672852|4006752|FG001|Part A2|Other|0
2305509|NCT02672852|4006753|FG002|Part A2|Other|3
2305510|NCT02672852|4006754|FG003|Part A2|Other|0
2305511|NCT02672852|4006755|FG004|Part A2|Other|0
2305512|NCT02672852|4006756|FG005|Part A2|Other|0
2305513|NCT02672852|4006757|FG006|Part A2|Other|0
2305514|NCT02672852|4006751|FG000|Part A2|Not entered in Part B|0
2305515|NCT02672852|4006752|FG001|Part A2|Not entered in Part B|0
2305516|NCT02672852|4006753|FG002|Part A2|Not entered in Part B|0
2305517|NCT02672852|4006754|FG003|Part A2|Not entered in Part B|4
2305518|NCT02672852|4006755|FG004|Part A2|Not entered in Part B|0
2305519|NCT02672852|4006756|FG005|Part A2|Not entered in Part B|0
2305520|NCT02672852|4006757|FG006|Part A2|Not entered in Part B|0
2305521|NCT02672852|4006751|FG000|Part B|Disease worsening|0
2305522|NCT02672852|4006752|FG001|Part B|Disease worsening|0
2305523|NCT02672852|4006753|FG002|Part B|Disease worsening|0
2305524|NCT02672852|4006754|FG003|Part B|Disease worsening|0
2305525|NCT02672852|4006755|FG004|Part B|Disease worsening|1
2305526|NCT02672852|4006756|FG005|Part B|Disease worsening|0
2305527|NCT02672852|4006757|FG006|Part B|Disease worsening|1
2305528|NCT02672852|4006751|FG000|Part B|Worsening pre-existing condition|0
2305529|NCT02672852|4006752|FG001|Part B|Worsening pre-existing condition|0
2305530|NCT02672852|4006753|FG002|Part B|Worsening pre-existing condition|0
2305531|NCT02672852|4006754|FG003|Part B|Worsening pre-existing condition|0
2305532|NCT02672852|4006755|FG004|Part B|Worsening pre-existing condition|0
2305533|NCT02672852|4006756|FG005|Part B|Worsening pre-existing condition|1
2305534|NCT02672852|4006757|FG006|Part B|Worsening pre-existing condition|0
2305535|NCT02672852|4006751|FG000|Part B|Other adverse event|0
2305536|NCT02672852|4006752|FG001|Part B|Other adverse event|0
2305537|NCT02672852|4006753|FG002|Part B|Other adverse event|0
2080412|NCT00696384|3663861|FG002|Double Blind Phase|Adverse Event|2
2080413|NCT00696384|3663859|FG000|Double Blind Phase|Lost to Follow-up|0
2080414|NCT00696384|3663860|FG001|Double Blind Phase|Lost to Follow-up|2
2080415|NCT00696384|3663861|FG002|Double Blind Phase|Lost to Follow-up|1
2080416|NCT00696384|3663859|FG000|Double Blind Phase|Withdrawal by Subject|0
2080417|NCT00696384|3663860|FG001|Double Blind Phase|Withdrawal by Subject|4
2080418|NCT00696384|3663861|FG002|Double Blind Phase|Withdrawal by Subject|3
2080419|NCT00696384|3663859|FG000|Double Blind Phase|Lack of Efficacy|0
2080420|NCT00696384|3663860|FG001|Double Blind Phase|Lack of Efficacy|1
2080421|NCT00696384|3663861|FG002|Double Blind Phase|Lack of Efficacy|0
2080422|NCT00696384|3663859|FG000|Double Blind Phase|Physician Decision|0
2080423|NCT00696384|3663860|FG001|Double Blind Phase|Physician Decision|2
2080424|NCT00696384|3663861|FG002|Double Blind Phase|Physician Decision|0
2080425|NCT00696410|3663872|FG000|Overall Study|Lost to Follow-up|2
2080426|NCT00696410|3663873|FG001|Overall Study|Lost to Follow-up|0
2080427|NCT00696410|3663872|FG000|Overall Study|Withdrawal by Subject|8
2080428|NCT00696410|3663873|FG001|Overall Study|Withdrawal by Subject|0
2080429|NCT00696410|3663872|FG000|Overall Study|Physician Decision|3
2080430|NCT00696410|3663873|FG001|Overall Study|Physician Decision|0
2080431|NCT00696423|3663886|FG000|Overall Study|Lost to Follow-up|0
2080432|NCT00696423|3663887|FG001|Overall Study|Lost to Follow-up|5
2080433|NCT00696436|3663898|FG000|Overall Study|Adverse Event|7
2080434|NCT00696436|3663899|FG001|Overall Study|Adverse Event|9
2080435|NCT00696436|3663900|FG002|Overall Study|Adverse Event|8
2080436|NCT00696436|3663901|FG003|Overall Study|Adverse Event|6
2080437|NCT00696436|3663902|FG004|Overall Study|Adverse Event|4
2080438|NCT00696436|3663898|FG000|Overall Study|Protocol Violation|3
2080439|NCT00696436|3663899|FG001|Overall Study|Protocol Violation|2
2080440|NCT00696436|3663900|FG002|Overall Study|Protocol Violation|2
2080441|NCT00696436|3663901|FG003|Overall Study|Protocol Violation|0
2080442|NCT00696436|3663902|FG004|Overall Study|Protocol Violation|1
2080443|NCT00696436|3663898|FG000|Overall Study|Lost to Follow-up|1
2080444|NCT00696436|3663899|FG001|Overall Study|Lost to Follow-up|6
2080445|NCT00696436|3663900|FG002|Overall Study|Lost to Follow-up|2
2080446|NCT00696436|3663901|FG003|Overall Study|Lost to Follow-up|4
2080447|NCT00696436|3663902|FG004|Overall Study|Lost to Follow-up|3
2080448|NCT00696436|3663898|FG000|Overall Study|Withdrawal by Subject|4
2080449|NCT00696436|3663899|FG001|Overall Study|Withdrawal by Subject|11
2080450|NCT00696436|3663900|FG002|Overall Study|Withdrawal by Subject|5
2080451|NCT00696436|3663901|FG003|Overall Study|Withdrawal by Subject|7
2080452|NCT00696436|3663902|FG004|Overall Study|Withdrawal by Subject|1
2080453|NCT00696436|3663898|FG000|Overall Study|Lack of Efficacy|3
2080454|NCT00696436|3663899|FG001|Overall Study|Lack of Efficacy|1
2080455|NCT00696436|3663900|FG002|Overall Study|Lack of Efficacy|5
2080456|NCT00696436|3663901|FG003|Overall Study|Lack of Efficacy|2
2080457|NCT00696436|3663902|FG004|Overall Study|Lack of Efficacy|4
2080458|NCT00696436|3663898|FG000|Overall Study|Participant Unavailability|2
2080459|NCT00696436|3663899|FG001|Overall Study|Participant Unavailability|0
2080460|NCT00696436|3663900|FG002|Overall Study|Participant Unavailability|2
2080461|NCT00696436|3663901|FG003|Overall Study|Participant Unavailability|1
2080462|NCT00696436|3663902|FG004|Overall Study|Participant Unavailability|0
2080463|NCT00696436|3663898|FG000|Overall Study|Administrative Error|2
2080464|NCT00696436|3663899|FG001|Overall Study|Administrative Error|0
2211240|NCT01659021|3851454|FG001|Main Study|Unknown Reasons|1
2211241|NCT01659021|3851453|FG000|Main Study|Physician Decision|34
2211242|NCT01659021|3851454|FG001|Main Study|Physician Decision|16
2211243|NCT01659021|3851453|FG000|Main Study|Withdrawal by Subject|19
2211244|NCT01659021|3851454|FG001|Main Study|Withdrawal by Subject|16
2211245|NCT01659021|3851453|FG000|Main Study|Study Terminated by Sponsor|16
2211246|NCT01659021|3851454|FG001|Main Study|Study Terminated by Sponsor|1
2211247|NCT01659021|3851453|FG000|Long-Term Follow Up|Lost to Follow-up|3
2080465|NCT00696436|3663900|FG002|Overall Study|Administrative Error|2
2080466|NCT00696436|3663901|FG003|Overall Study|Administrative Error|0
2080467|NCT00696436|3663902|FG004|Overall Study|Administrative Error|0
2080468|NCT00696436|3663898|FG000|Overall Study|Participant Non-compliance|0
2080469|NCT00696436|3663899|FG001|Overall Study|Participant Non-compliance|0
2080470|NCT00696436|3663900|FG002|Overall Study|Participant Non-compliance|1
2080471|NCT00696436|3663901|FG003|Overall Study|Participant Non-compliance|2
2080472|NCT00696436|3663902|FG004|Overall Study|Participant Non-compliance|0
2080473|NCT00696436|3663898|FG000|Overall Study|Administrative Decision|1
2080474|NCT00696436|3663899|FG001|Overall Study|Administrative Decision|0
2080475|NCT00696436|3663900|FG002|Overall Study|Administrative Decision|0
2080476|NCT00696436|3663901|FG003|Overall Study|Administrative Decision|0
2080477|NCT00696436|3663902|FG004|Overall Study|Administrative Decision|0
2080478|NCT00696436|3663898|FG000|Overall Study|Missing|0
2080479|NCT00696436|3663899|FG001|Overall Study|Missing|1
2080480|NCT00696436|3663900|FG002|Overall Study|Missing|1
2080481|NCT00696436|3663901|FG003|Overall Study|Missing|0
2080482|NCT00696436|3663902|FG004|Overall Study|Missing|0
2080483|NCT00696657|3663957|FG000|Overall Study|Protocol Violation|0
2080484|NCT00696657|3663958|FG001|Overall Study|Protocol Violation|0
2080485|NCT00696657|3663959|FG002|Overall Study|Protocol Violation|0
2080486|NCT00696657|3663960|FG003|Overall Study|Protocol Violation|0
2211248|NCT01659021|3851454|FG001|Long-Term Follow Up|Lost to Follow-up|3
2211249|NCT01659021|3851453|FG000|Long-Term Follow Up|Withdrawal by Subject|2
2211250|NCT01659021|3851454|FG001|Long-Term Follow Up|Withdrawal by Subject|1
2211251|NCT01659125|3851464|FG000|Overall Study|Withdrawal by Subject|2
2211252|NCT01659125|3851464|FG000|Overall Study|Lost to Follow-up|7
2211253|NCT01659125|3851464|FG000|Overall Study|Technical Problem|1
2211254|NCT01659125|3851464|FG000|Overall Study|Time Constraints|2
2211255|NCT01659125|3851464|FG000|Overall Study|Failed to Start Treatment|2
2211256|NCT01659255|3851485|FG000|Overall Study|Adverse Event|0
2211257|NCT01659255|3851486|FG001|Overall Study|Adverse Event|0
2211258|NCT01659255|3851487|FG002|Overall Study|Adverse Event|0
2211259|NCT01659255|3851488|FG003|Overall Study|Adverse Event|0
2211260|NCT01659255|3851489|FG004|Overall Study|Adverse Event|0
2211261|NCT01659255|3851490|FG005|Overall Study|Adverse Event|1
2211262|NCT01659255|3851491|FG006|Overall Study|Adverse Event|1
2211263|NCT01659255|3851492|FG007|Overall Study|Adverse Event|0
2211264|NCT01659255|3851493|FG008|Overall Study|Adverse Event|0
2211265|NCT01659255|3851494|FG009|Overall Study|Adverse Event|1
2211266|NCT01659255|3851495|FG010|Overall Study|Adverse Event|0
2211267|NCT01659255|3851496|FG011|Overall Study|Adverse Event|1
2211268|NCT01659255|3851497|FG012|Overall Study|Adverse Event|0
2211269|NCT01659255|3851498|FG013|Overall Study|Adverse Event|2
2211270|NCT01659255|3851499|FG014|Overall Study|Adverse Event|0
2211271|NCT01659255|3851500|FG015|Overall Study|Adverse Event|1
2211272|NCT01659255|3851501|FG016|Overall Study|Adverse Event|0
2211273|NCT01659255|3851485|FG000|Overall Study|Death|0
2211274|NCT01659255|3851486|FG001|Overall Study|Death|1
2211275|NCT01659255|3851487|FG002|Overall Study|Death|0
2211276|NCT01659255|3851488|FG003|Overall Study|Death|0
2211277|NCT01659255|3851489|FG004|Overall Study|Death|0
2305538|NCT02672852|4006754|FG003|Part B|Other adverse event|0
2305539|NCT02672852|4006755|FG004|Part B|Other adverse event|3
2305540|NCT02672852|4006756|FG005|Part B|Other adverse event|5
2305541|NCT02672852|4006757|FG006|Part B|Other adverse event|1
2305542|NCT02672852|4006751|FG000|Part B|Lost to Follow-up|0
2305543|NCT02672852|4006752|FG001|Part B|Lost to Follow-up|0
2080487|NCT00696657|3663961|FG004|Overall Study|Protocol Violation|0
2080488|NCT00696657|3663962|FG005|Overall Study|Protocol Violation|1
2080489|NCT00696657|3663963|FG006|Overall Study|Protocol Violation|0
2080490|NCT00696657|3663964|FG007|Overall Study|Protocol Violation|0
2080491|NCT00696657|3663965|FG008|Overall Study|Protocol Violation|1
2080492|NCT00696657|3663957|FG000|Overall Study|Lack of Efficacy|0
2080493|NCT00696657|3663958|FG001|Overall Study|Lack of Efficacy|1
2080494|NCT00696657|3663959|FG002|Overall Study|Lack of Efficacy|0
2080495|NCT00696657|3663960|FG003|Overall Study|Lack of Efficacy|0
2080496|NCT00696657|3663961|FG004|Overall Study|Lack of Efficacy|0
2080497|NCT00696657|3663962|FG005|Overall Study|Lack of Efficacy|0
2080498|NCT00696657|3663963|FG006|Overall Study|Lack of Efficacy|0
2080499|NCT00696657|3663964|FG007|Overall Study|Lack of Efficacy|0
2080500|NCT00696657|3663965|FG008|Overall Study|Lack of Efficacy|0
2080501|NCT00696657|3663957|FG000|Overall Study|Withdrawal criteria|1
2080502|NCT00696657|3663958|FG001|Overall Study|Withdrawal criteria|3
2080503|NCT00696657|3663959|FG002|Overall Study|Withdrawal criteria|2
2080504|NCT00696657|3663960|FG003|Overall Study|Withdrawal criteria|2
2080505|NCT00696657|3663961|FG004|Overall Study|Withdrawal criteria|0
2080506|NCT00696657|3663962|FG005|Overall Study|Withdrawal criteria|0
2080507|NCT00696657|3663963|FG006|Overall Study|Withdrawal criteria|1
2080508|NCT00696657|3663964|FG007|Overall Study|Withdrawal criteria|1
2080509|NCT00696657|3663965|FG008|Overall Study|Withdrawal criteria|2
2080510|NCT00696657|3663957|FG000|Overall Study|Unclassified|0
2080511|NCT00696657|3663958|FG001|Overall Study|Unclassified|1
2080512|NCT00696657|3663959|FG002|Overall Study|Unclassified|3
2080513|NCT00696657|3663960|FG003|Overall Study|Unclassified|2
2080514|NCT00696657|3663961|FG004|Overall Study|Unclassified|4
2080515|NCT00696657|3663962|FG005|Overall Study|Unclassified|2
2080516|NCT00696657|3663963|FG006|Overall Study|Unclassified|0
2080517|NCT00696657|3663964|FG007|Overall Study|Unclassified|0
2080518|NCT00696657|3663965|FG008|Overall Study|Unclassified|1
2080519|NCT00696657|3663957|FG000|Overall Study|Adverse Event|0
2080520|NCT00696657|3663958|FG001|Overall Study|Adverse Event|0
2080521|NCT00696657|3663959|FG002|Overall Study|Adverse Event|3
2080522|NCT00696657|3663960|FG003|Overall Study|Adverse Event|7
2080523|NCT00696657|3663961|FG004|Overall Study|Adverse Event|6
2080524|NCT00696657|3663962|FG005|Overall Study|Adverse Event|9
2080525|NCT00696657|3663963|FG006|Overall Study|Adverse Event|14
2080526|NCT00696657|3663964|FG007|Overall Study|Adverse Event|2
2080527|NCT00696657|3663965|FG008|Overall Study|Adverse Event|5
2080528|NCT00696696|3663985|FG000|Overall Study|Adverse Event|5
2080529|NCT00696696|3663985|FG000|Overall Study|Withdrawal by Subject|8
2080530|NCT00696696|3663985|FG000|Overall Study|Physician Decision|2
2211278|NCT01659255|3851490|FG005|Overall Study|Death|0
2211279|NCT01659255|3851491|FG006|Overall Study|Death|0
2211280|NCT01659255|3851492|FG007|Overall Study|Death|1
2211281|NCT01659255|3851493|FG008|Overall Study|Death|1
2211282|NCT01659255|3851494|FG009|Overall Study|Death|0
2211283|NCT01659255|3851495|FG010|Overall Study|Death|0
2211284|NCT01659255|3851496|FG011|Overall Study|Death|0
2211285|NCT01659255|3851497|FG012|Overall Study|Death|1
2211286|NCT01659255|3851498|FG013|Overall Study|Death|1
2211287|NCT01659255|3851499|FG014|Overall Study|Death|2
2211288|NCT01659255|3851500|FG015|Overall Study|Death|1
2305544|NCT02672852|4006753|FG002|Part B|Lost to Follow-up|0
2080531|NCT00696696|3663985|FG000|Overall Study|Death|3
2080532|NCT00696709|3663994|FG000|Overall Study|Withdrawal by Subject|1
2080533|NCT00696709|3663995|FG001|Overall Study|Withdrawal by Subject|2
2080534|NCT00696709|3663996|FG002|Overall Study|Withdrawal by Subject|1
2080535|NCT00696709|3663997|FG003|Overall Study|Withdrawal by Subject|4
2080536|NCT00696709|3663998|FG004|Overall Study|Withdrawal by Subject|3
2080537|NCT00696709|3663994|FG000|Overall Study|Protocol Violation|1
2080538|NCT00696709|3663995|FG001|Overall Study|Protocol Violation|0
2080539|NCT00696709|3663996|FG002|Overall Study|Protocol Violation|0
2080540|NCT00696709|3663997|FG003|Overall Study|Protocol Violation|0
2080541|NCT00696709|3663998|FG004|Overall Study|Protocol Violation|0
2080542|NCT00696709|3663994|FG000|Overall Study|Lost to Follow-up|1
2080543|NCT00696709|3663995|FG001|Overall Study|Lost to Follow-up|1
2080544|NCT00696709|3663996|FG002|Overall Study|Lost to Follow-up|0
2080545|NCT00696709|3663997|FG003|Overall Study|Lost to Follow-up|0
2080546|NCT00696709|3663998|FG004|Overall Study|Lost to Follow-up|0
2080547|NCT00696709|3663994|FG000|Overall Study|Adverse Event|0
2080548|NCT00696709|3663995|FG001|Overall Study|Adverse Event|0
2080549|NCT00696709|3663996|FG002|Overall Study|Adverse Event|0
2080550|NCT00696709|3663997|FG003|Overall Study|Adverse Event|1
2080551|NCT00696709|3663998|FG004|Overall Study|Adverse Event|0
2080552|NCT00696774|3664042|FG000|Period II|Adverse Event|0
2080553|NCT00696774|3664043|FG001|Period II|Adverse Event|0
2080554|NCT00696774|3664044|FG002|Period II|Adverse Event|15
2080555|NCT00696774|3664042|FG000|Period II|Lost to Follow-up|0
2080556|NCT00696774|3664043|FG001|Period II|Lost to Follow-up|0
2080557|NCT00696774|3664044|FG002|Period II|Lost to Follow-up|4
2080558|NCT00696774|3664042|FG000|Period II|Protocol Violation|0
2080559|NCT00696774|3664043|FG001|Period II|Protocol Violation|0
2080560|NCT00696774|3664044|FG002|Period II|Protocol Violation|11
2080561|NCT00696774|3664042|FG000|Period II|Withdrawal by Subject|0
2080562|NCT00696774|3664043|FG001|Period II|Withdrawal by Subject|0
2080563|NCT00696774|3664044|FG002|Period II|Withdrawal by Subject|4
2080564|NCT00696774|3664042|FG000|Period II|Sponsor Decision|0
2080565|NCT00696774|3664043|FG001|Period II|Sponsor Decision|0
2080566|NCT00696774|3664044|FG002|Period II|Sponsor Decision|0
2080567|NCT00696774|3664042|FG000|Period II|Lack of Efficacy|0
2080568|NCT00696774|3664043|FG001|Period II|Lack of Efficacy|0
2080569|NCT00696774|3664044|FG002|Period II|Lack of Efficacy|2
2080570|NCT00696774|3664042|FG000|Period III|Adverse Event|1
2080571|NCT00696774|3664043|FG001|Period III|Adverse Event|1
2080572|NCT00696774|3664044|FG002|Period III|Adverse Event|0
2080573|NCT00696774|3664042|FG000|Period III|Lost to Follow-up|2
2080574|NCT00696774|3664043|FG001|Period III|Lost to Follow-up|1
2080575|NCT00696774|3664044|FG002|Period III|Lost to Follow-up|0
2080576|NCT00696774|3664042|FG000|Period III|Protocol Violation|1
2080577|NCT00696774|3664043|FG001|Period III|Protocol Violation|1
2080578|NCT00696774|3664044|FG002|Period III|Protocol Violation|0
2080579|NCT00696774|3664042|FG000|Period III|Withdrawal by Subject|1
2080580|NCT00696774|3664043|FG001|Period III|Withdrawal by Subject|2
2080581|NCT00696774|3664044|FG002|Period III|Withdrawal by Subject|0
2080582|NCT00696774|3664042|FG000|Period III|Sponsor Decision|2
2080583|NCT00696774|3664043|FG001|Period III|Sponsor Decision|0
2080584|NCT00696774|3664044|FG002|Period III|Sponsor Decision|0
2080585|NCT00696774|3664042|FG000|Period III|Lack of Efficacy|0
2080586|NCT00696774|3664043|FG001|Period III|Lack of Efficacy|2
2080587|NCT00696774|3664044|FG002|Period III|Lack of Efficacy|0
2080588|NCT00696787|3664055|FG000|Overall Study|Adverse Event|1
2080589|NCT00696787|3664056|FG001|Overall Study|Adverse Event|0
2080590|NCT00696787|3664057|FG002|Overall Study|Adverse Event|6
2080591|NCT00696787|3664055|FG000|Overall Study|Discontinuation by Sponsor|9
2080592|NCT00696787|3664056|FG001|Overall Study|Discontinuation by Sponsor|13
2080593|NCT00696787|3664057|FG002|Overall Study|Discontinuation by Sponsor|14
2080594|NCT00696787|3664055|FG000|Overall Study|Lack of Efficacy|0
2080595|NCT00696787|3664056|FG001|Overall Study|Lack of Efficacy|1
2080596|NCT00696787|3664057|FG002|Overall Study|Lack of Efficacy|0
2080597|NCT00696787|3664055|FG000|Overall Study|Lost to Follow-up|4
2080598|NCT00696787|3664056|FG001|Overall Study|Lost to Follow-up|0
2080599|NCT00696787|3664057|FG002|Overall Study|Lost to Follow-up|3
2080600|NCT00696787|3664055|FG000|Overall Study|Withdrawal by Subject|0
2080601|NCT00696787|3664056|FG001|Overall Study|Withdrawal by Subject|3
2080602|NCT00696787|3664057|FG002|Overall Study|Withdrawal by Subject|2
2080603|NCT00696787|3664055|FG000|Overall Study|Failed to return|1
2080604|NCT00696787|3664056|FG001|Overall Study|Failed to return|3
2080605|NCT00696787|3664057|FG002|Overall Study|Failed to return|1
2080606|NCT00697073|3664065|FG000|Overall Study|Withdrawal by Subject|2
2080607|NCT00697073|3664065|FG000|Overall Study|Pregnancy|1
2080608|NCT00697073|3664065|FG000|Overall Study|non compliance and other|6
2080609|NCT00697112|3664069|FG000|Overall Study|Adverse Event|8
2080610|NCT00697112|3664069|FG000|Overall Study|Lost to Follow-up|1
2080611|NCT00697112|3664069|FG000|Overall Study|Did not meet inclusion criteria|1
2080612|NCT00697346|3664104|FG000|Overall Study|Adverse Event|4
2080613|NCT00697346|3664105|FG001|Overall Study|Adverse Event|5
2080614|NCT00697346|3664106|FG002|Overall Study|Adverse Event|0
2080615|NCT00697346|3664104|FG000|Overall Study|Progressive Disease|19
2080616|NCT00697346|3664105|FG001|Overall Study|Progressive Disease|18
2080617|NCT00697346|3664106|FG002|Overall Study|Progressive Disease|0
2080618|NCT00697346|3664104|FG000|Overall Study|Symptomatic Deterioration|0
2177281|NCT01372150|3801331|FG000|Overall Study|Other|1
2177282|NCT01372150|3801332|FG001|Overall Study|Other|0
2177283|NCT01372150|3801333|FG002|Overall Study|Other|2
2177284|NCT01372150|3801331|FG000|Overall Study|Adverse Event|2
2177285|NCT01372150|3801332|FG001|Overall Study|Adverse Event|1
2177286|NCT01372150|3801333|FG002|Overall Study|Adverse Event|2
2177287|NCT01372150|3801331|FG000|Overall Study|Randomized but not treated|0
2177288|NCT01372150|3801332|FG001|Overall Study|Randomized but not treated|1
2177289|NCT01372150|3801333|FG002|Overall Study|Randomized but not treated|0
2177290|NCT01372384|3801368|FG000|Overall Study|Progression of disease|3
2177291|NCT01372410|3801372|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1
2177292|NCT01372410|3801373|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1
2177293|NCT01372410|3801374|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2177294|NCT01372410|3801375|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2177295|NCT01372410|3801376|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1
2177296|NCT01372410|3801377|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2177297|NCT01372410|3801378|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2177298|NCT01372410|3801379|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2177299|NCT01372410|3801372|FG000|Treatment Period 1 (7 Days)|Adverse Event|0
2080619|NCT00697346|3664105|FG001|Overall Study|Symptomatic Deterioration|1
2080620|NCT00697346|3664106|FG002|Overall Study|Symptomatic Deterioration|0
2080621|NCT00697346|3664104|FG000|Overall Study|Withdrawal by Subject|2
2080622|NCT00697346|3664105|FG001|Overall Study|Withdrawal by Subject|2
2080623|NCT00697346|3664106|FG002|Overall Study|Withdrawal by Subject|0
2080624|NCT00697346|3664104|FG000|Overall Study|Reason not Specified|3
2080625|NCT00697346|3664105|FG001|Overall Study|Reason not Specified|0
2080626|NCT00697346|3664106|FG002|Overall Study|Reason not Specified|1
2080627|NCT00697463|3664133|FG000|Overall Study|Withdrawal by Subject|1
2080628|NCT00697515|3664137|FG000|Dose Optimization Period|Adverse Event|4
2080629|NCT00697515|3664138|FG001|Dose Optimization Period|Adverse Event|0
2080630|NCT00697515|3664137|FG000|Dose Optimization Period|Withdrawal by Subject|5
2080631|NCT00697515|3664138|FG001|Dose Optimization Period|Withdrawal by Subject|0
2080632|NCT00697515|3664137|FG000|Dose Optimization Period|Lost to Follow-up|2
2080633|NCT00697515|3664138|FG001|Dose Optimization Period|Lost to Follow-up|0
2080634|NCT00697515|3664137|FG000|Dose Optimization Period|sponsor request|2
2080635|NCT00697515|3664138|FG001|Dose Optimization Period|sponsor request|0
2080636|NCT00697515|3664137|FG000|Dose Optimization Period|called to active duty|1
2080637|NCT00697515|3664138|FG001|Dose Optimization Period|called to active duty|0
2080638|NCT00697515|3664137|FG000|Dose Optimization Period|elevated QTc|1
2080639|NCT00697515|3664138|FG001|Dose Optimization Period|elevated QTc|0
2080640|NCT00697515|3664137|FG000|First Intervention (Crossover Period)|Natural disaster|8
2080641|NCT00697515|3664138|FG001|First Intervention (Crossover Period)|Natural disaster|9
2080642|NCT00697515|3664137|FG000|First Intervention (Crossover Period)|Adverse Event|0
2080643|NCT00697515|3664138|FG001|First Intervention (Crossover Period)|Adverse Event|2
2080644|NCT00697515|3664137|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2
2080645|NCT00697515|3664138|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1
2080646|NCT00697515|3664137|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1
2080647|NCT00697515|3664138|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1
2080648|NCT00697593|3664154|FG000|Overall Study|Adverse Event|3
2080649|NCT00697593|3664154|FG000|Overall Study|Protocol Violation|1
2080650|NCT00697593|3664154|FG000|Overall Study|Lack of Efficacy|3
2080651|NCT00697593|3664154|FG000|Overall Study|Suspension of the study by sponsor|12
2080652|NCT00697619|3664160|FG000|Overall Study|Lack of Efficacy|2
2080653|NCT00697619|3664161|FG001|Overall Study|Lack of Efficacy|2
2080654|NCT00697619|3664160|FG000|Overall Study|Adverse Event|4
2080655|NCT00697619|3664161|FG001|Overall Study|Adverse Event|6
2080656|NCT00697788|3664176|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2080657|NCT00697788|3664177|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
2080658|NCT00697788|3664178|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2080659|NCT00697788|3664179|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2080660|NCT00697788|3664180|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2080661|NCT00697788|3664181|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2080662|NCT00697788|3664182|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2080663|NCT00697788|3664183|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2080664|NCT00697788|3664176|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2080665|NCT00697788|3664177|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2080666|NCT00697788|3664178|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2080667|NCT00697788|3664179|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2080668|NCT00697788|3664180|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
2080669|NCT00697788|3664181|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2080670|NCT00697788|3664182|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2080671|NCT00697788|3664183|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2080672|NCT00697827|3664225|FG000|Overall Study|enrolled but not treated|2
2080673|NCT00697827|3664226|FG001|Overall Study|enrolled but not treated|1
2080674|NCT00698204|3664259|FG000|Overall Study|Withdrawal by Subject|1
2080675|NCT00698204|3664260|FG001|Overall Study|Withdrawal by Subject|0
2080676|NCT00698451|3664268|FG000|Overall Study|Adverse Event|22
2080677|NCT00698451|3664268|FG000|Overall Study|Physician Decision|2
2080678|NCT00698451|3664268|FG000|Overall Study|Protocol Violation|6
2080679|NCT00698451|3664268|FG000|Overall Study|Withdrawal by Subject|6
2080680|NCT00698451|3664268|FG000|Overall Study|Disease progression|3
2080681|NCT00698516|3664272|FG000|Overall Study|Study Termination|2
2080682|NCT00698516|3664272|FG000|Overall Study|Withdrawal by Subject|3
2080683|NCT00698581|3664282|FG000|Overall Study|Lack of Efficacy|23
2080684|NCT00698581|3664283|FG001|Overall Study|Lack of Efficacy|11
2080685|NCT00698581|3664282|FG000|Overall Study|Withdrawal by Subject|6
2080686|NCT00698581|3664283|FG001|Overall Study|Withdrawal by Subject|0
2080687|NCT00698581|3664282|FG000|Overall Study|Other reason|9
2080688|NCT00698581|3664283|FG001|Overall Study|Other reason|1
2080689|NCT00698581|3664282|FG000|Overall Study|SAE, non-fatal|1
2080690|NCT00698581|3664283|FG001|Overall Study|SAE, non-fatal|0
2080691|NCT00698581|3664282|FG000|Overall Study|AE, non-serious non-fatal|4
2080692|NCT00698581|3664283|FG001|Overall Study|AE, non-serious non-fatal|0
2080693|NCT00698581|3664282|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2080694|NCT00698581|3664283|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2080695|NCT00698581|3664282|FG000|Overall Study|AE of unknown type|1
2080696|NCT00698581|3664283|FG001|Overall Study|AE of unknown type|0
2080697|NCT00698646|3664293|FG000|Overall Study|Adverse Event|8
2080698|NCT00698646|3664294|FG001|Overall Study|Adverse Event|7
2080699|NCT00698646|3664295|FG002|Overall Study|Adverse Event|8
2080700|NCT00698646|3664293|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11
2080701|NCT00698646|3664294|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11
2080702|NCT00698646|3664295|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7
2080703|NCT00698646|3664293|FG000|Overall Study|Protocol Deviation|6
2080704|NCT00698646|3664294|FG001|Overall Study|Protocol Deviation|2
2080705|NCT00698646|3664295|FG002|Overall Study|Protocol Deviation|3
2080706|NCT00698646|3664293|FG000|Overall Study|Withdrawal by Subject|10
2080707|NCT00698646|3664294|FG001|Overall Study|Withdrawal by Subject|11
2080708|NCT00698646|3664295|FG002|Overall Study|Withdrawal by Subject|8
2080709|NCT00698646|3664293|FG000|Overall Study|Lost to Follow-up|0
2080710|NCT00698646|3664294|FG001|Overall Study|Lost to Follow-up|0
2080711|NCT00698646|3664295|FG002|Overall Study|Lost to Follow-up|2
2080712|NCT00698646|3664293|FG000|Overall Study|Administrative problems|1
2080713|NCT00698646|3664294|FG001|Overall Study|Administrative problems|0
2080714|NCT00698646|3664295|FG002|Overall Study|Administrative problems|1
2080715|NCT00698685|3664303|FG000|Overall Study|Sister withdrew as donor|1
2080716|NCT00698685|3664303|FG000|Overall Study|Off study pre transplant by clinic MD|1
2080717|NCT00698841|3664307|FG000|Overall Study|Withdrawal by Subject|2
2080718|NCT00698841|3664307|FG000|Overall Study|Adverse Event|3
2080719|NCT00698841|3664307|FG000|Overall Study|Disease progression|7
2080720|NCT00698841|3664307|FG000|Overall Study|Failure to meet eligibility criteria|2
2080721|NCT00698841|3664307|FG000|Overall Study|Study drug toxicity|2
2080722|NCT00698841|3664307|FG000|Overall Study|Other|2
2080723|NCT00698932|3664317|FG000|Overall Study|Adverse Event|0
2080724|NCT00698932|3664318|FG001|Overall Study|Adverse Event|2
2080725|NCT00698932|3664317|FG000|Overall Study|Incorrect enrollment|0
2080726|NCT00698932|3664318|FG001|Overall Study|Incorrect enrollment|2
2080727|NCT00698932|3664317|FG000|Overall Study|Study specific discontinuation criteria|3
2080728|NCT00698932|3664318|FG001|Overall Study|Study specific discontinuation criteria|4
2080729|NCT00698932|3664317|FG000|Overall Study|Withdrawal by Subject|11
2080730|NCT00698932|3664318|FG001|Overall Study|Withdrawal by Subject|23
2080731|NCT00698932|3664317|FG000|Overall Study|Lost to Follow-up|6
2080732|NCT00698932|3664318|FG001|Overall Study|Lost to Follow-up|1
2080733|NCT00698932|3664317|FG000|Overall Study|Severe non-compliance to protocol|1
2080734|NCT00698932|3664318|FG001|Overall Study|Severe non-compliance to protocol|2
2080735|NCT00698932|3664317|FG000|Overall Study|Safety reasons|0
2080736|NCT00698932|3664318|FG001|Overall Study|Safety reasons|2
2080737|NCT00698932|3664317|FG000|Overall Study|Death|1
2080738|NCT00698932|3664318|FG001|Overall Study|Death|0
2080739|NCT00698997|3664326|FG000|Overall Study|Lost to Follow-up|3
2080740|NCT00698997|3664327|FG001|Overall Study|Lost to Follow-up|0
2080741|NCT00698997|3664326|FG000|Overall Study|Withdrawal by Subject|7
2080742|NCT00698997|3664327|FG001|Overall Study|Withdrawal by Subject|27
2080743|NCT00699153|3664353|FG000|Overall Study|Lost to Follow-up|1
2080744|NCT00699153|3664354|FG001|Overall Study|Lost to Follow-up|0
2080745|NCT00699153|3664353|FG000|Overall Study|Adverse Event|0
2080746|NCT00699153|3664354|FG001|Overall Study|Adverse Event|2
2080747|NCT00699153|3664353|FG000|Overall Study|Protocol Violation|1
2080748|NCT00699153|3664354|FG001|Overall Study|Protocol Violation|0
2080749|NCT00699153|3664353|FG000|Overall Study|Travel Problem|1
2080750|NCT00699153|3664354|FG001|Overall Study|Travel Problem|0
2080751|NCT00699192|3664363|FG000|Overall Study|Missing|1
2080752|NCT00699192|3664364|FG001|Overall Study|Missing|1
2080753|NCT00699192|3664365|FG002|Overall Study|Missing|1
2080754|NCT00699192|3664363|FG000|Overall Study|Adverse Event|9
2080755|NCT00699192|3664364|FG001|Overall Study|Adverse Event|4
2080756|NCT00699192|3664365|FG002|Overall Study|Adverse Event|3
2080757|NCT00699192|3664363|FG000|Overall Study|Abnormal test procedure result(s)|0
2080758|NCT00699192|3664364|FG001|Overall Study|Abnormal test procedure result(s)|0
2080759|NCT00699192|3664365|FG002|Overall Study|Abnormal test procedure result(s)|1
2080760|NCT00699192|3664363|FG000|Overall Study|Lack of Efficacy|0
2177300|NCT01372410|3801373|FG001|Treatment Period 1 (7 Days)|Adverse Event|1
2080761|NCT00699192|3664364|FG001|Overall Study|Lack of Efficacy|0
2080762|NCT00699192|3664365|FG002|Overall Study|Lack of Efficacy|1
2080763|NCT00699192|3664363|FG000|Overall Study|Withdrawal by Subject|3
2080764|NCT00699192|3664364|FG001|Overall Study|Withdrawal by Subject|2
2080765|NCT00699192|3664365|FG002|Overall Study|Withdrawal by Subject|4
2080766|NCT00699192|3664363|FG000|Overall Study|Administrative problems|1
2080767|NCT00699192|3664364|FG001|Overall Study|Administrative problems|3
2080768|NCT00699192|3664365|FG002|Overall Study|Administrative problems|1
2080769|NCT00699192|3664363|FG000|Overall Study|Protocol Violation|2
2080770|NCT00699192|3664364|FG001|Overall Study|Protocol Violation|2
2080771|NCT00699192|3664365|FG002|Overall Study|Protocol Violation|0
2080772|NCT00699283|3664379|FG000|Overall Study|Lack of Efficacy|15
2080773|NCT00699283|3664380|FG001|Overall Study|Lack of Efficacy|5
2080774|NCT00699283|3664379|FG000|Overall Study|Lost to Follow-up|2
2080775|NCT00699283|3664380|FG001|Overall Study|Lost to Follow-up|0
2080776|NCT00699283|3664379|FG000|Overall Study|Withdrawal by Subject|1
2080777|NCT00699283|3664380|FG001|Overall Study|Withdrawal by Subject|0
2080778|NCT00699283|3664379|FG000|Overall Study|Other Reason|5
2080779|NCT00699283|3664380|FG001|Overall Study|Other Reason|1
2080780|NCT00699283|3664379|FG000|Overall Study|SAE, non-fatal|1
2080781|NCT00699283|3664380|FG001|Overall Study|SAE, non-fatal|1
2080782|NCT00699283|3664379|FG000|Overall Study|AE, non-serious non-fatal|8
2080783|NCT00699283|3664380|FG001|Overall Study|AE, non-serious non-fatal|1
2080784|NCT00699283|3664379|FG000|Overall Study|AE of unknown type|1
2080785|NCT00699283|3664380|FG001|Overall Study|AE of unknown type|0
2080786|NCT00699335|3664385|FG000|Overall Study|Combination of multiple reasons|176
2080787|NCT00699335|3664385|FG000|Overall Study|Missing data|52
2080788|NCT00699348|3664392|FG000|Overall Study|Death|6
2080789|NCT00699348|3664392|FG000|Overall Study|Adverse Event|15
2080790|NCT00699348|3664392|FG000|Overall Study|Withdrawal by Subject|11
2080791|NCT00699348|3664392|FG000|Overall Study|Protocol Violation|10
2080792|NCT00699348|3664392|FG000|Overall Study|Lack of Efficacy|8
2080793|NCT00699348|3664392|FG000|Overall Study|Failure to return|1
2080794|NCT00699348|3664392|FG000|Overall Study|Blood transfusion|24
2080795|NCT00699348|3664392|FG000|Overall Study|Renal transplantation|10
2080796|NCT00699348|3664392|FG000|Overall Study|Other|5
2080797|NCT00699374|3664398|FG000|Overall Study|Death|93
2080798|NCT00699374|3664399|FG001|Overall Study|Death|83
2080799|NCT00699374|3664398|FG000|Overall Study|Adverse Event|70
2080800|NCT00699374|3664399|FG001|Overall Study|Adverse Event|67
2080801|NCT00699374|3664398|FG000|Overall Study|Global deterioration of health status|7
2080802|NCT00699374|3664399|FG001|Overall Study|Global deterioration of health status|8
2080803|NCT00699374|3664398|FG000|Overall Study|Lost to Follow-up|3
2080804|NCT00699374|3664399|FG001|Overall Study|Lost to Follow-up|5
2080805|NCT00699374|3664398|FG000|Overall Study|Withdrawal by Subject|34
2080806|NCT00699374|3664399|FG001|Overall Study|Withdrawal by Subject|44
2080807|NCT00699374|3664398|FG000|Overall Study|Objective progression or relapse|281
2080808|NCT00699374|3664399|FG001|Overall Study|Objective progression or relapse|277
2080809|NCT00699374|3664398|FG000|Overall Study|Other|18
2080810|NCT00699374|3664399|FG001|Overall Study|Other|15
2080811|NCT00699374|3664398|FG000|Overall Study|Protocol Violation|2
2080812|NCT00699374|3664399|FG001|Overall Study|Protocol Violation|6
2080813|NCT00699374|3664398|FG000|Overall Study|Study terminated by sponsor|13
2080814|NCT00699374|3664399|FG001|Overall Study|Study terminated by sponsor|28
2080815|NCT00699374|3664398|FG000|Overall Study|Randomized but not treated|4
2080816|NCT00699374|3664399|FG001|Overall Study|Randomized but not treated|2
2211289|NCT01659255|3851501|FG016|Overall Study|Death|0
2080817|NCT00699374|3664398|FG000|Overall Study|Died 28 days after last dose|5
2080818|NCT00699374|3664399|FG001|Overall Study|Died 28 days after last dose|9
2080819|NCT00699582|3664457|FG000|Overall Study|Adverse Event|4
2080820|NCT00699582|3664458|FG001|Overall Study|Adverse Event|11
2080821|NCT00699582|3664459|FG002|Overall Study|Adverse Event|23
2080822|NCT00699582|3664457|FG000|Overall Study|Withdrawal by Subject|6
2080823|NCT00699582|3664458|FG001|Overall Study|Withdrawal by Subject|7
2080824|NCT00699582|3664459|FG002|Overall Study|Withdrawal by Subject|4
2080825|NCT00699582|3664457|FG000|Overall Study|Lack of Efficacy|1
2080826|NCT00699582|3664458|FG001|Overall Study|Lack of Efficacy|0
2080827|NCT00699582|3664459|FG002|Overall Study|Lack of Efficacy|1
2080828|NCT00699582|3664457|FG000|Overall Study|Progressive Disease|1
2080829|NCT00699582|3664458|FG001|Overall Study|Progressive Disease|0
2080830|NCT00699582|3664459|FG002|Overall Study|Progressive Disease|0
2080831|NCT00699582|3664457|FG000|Overall Study|Administrative/Other|4
2080832|NCT00699582|3664458|FG001|Overall Study|Administrative/Other|3
2080833|NCT00699582|3664459|FG002|Overall Study|Administrative/Other|0
2080834|NCT00699582|3664457|FG000|Overall Study|Randomized, Not Treated|2
2177301|NCT01372410|3801374|FG002|Treatment Period 1 (7 Days)|Adverse Event|0
2177302|NCT01372410|3801375|FG003|Treatment Period 1 (7 Days)|Adverse Event|0
2177303|NCT01372410|3801376|FG004|Treatment Period 1 (7 Days)|Adverse Event|0
2177304|NCT01372410|3801377|FG005|Treatment Period 1 (7 Days)|Adverse Event|0
2177305|NCT01372410|3801378|FG006|Treatment Period 1 (7 Days)|Adverse Event|1
2177306|NCT01372410|3801379|FG007|Treatment Period 1 (7 Days)|Adverse Event|0
2177307|NCT01372410|3801372|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2180066|NCT01397825|3805928|FG001|Overall Study|Symptomatic Deterioration|0
2080835|NCT00699582|3664458|FG001|Overall Study|Randomized, Not Treated|1
2080836|NCT00699582|3664459|FG002|Overall Study|Randomized, Not Treated|0
2080837|NCT00699608|3664467|FG000|First Intervention|Withdrawal by Subject|0
2080838|NCT00699608|3664468|FG001|First Intervention|Withdrawal by Subject|0
2080839|NCT00699608|3664469|FG002|First Intervention|Withdrawal by Subject|1
2080840|NCT00699608|3664470|FG003|First Intervention|Withdrawal by Subject|0
2080841|NCT00699608|3664471|FG004|First Intervention|Withdrawal by Subject|0
2080842|NCT00699608|3664472|FG005|First Intervention|Withdrawal by Subject|0
2080843|NCT00699608|3664467|FG000|First Intervention|Protocol Violation|0
2080844|NCT00699608|3664468|FG001|First Intervention|Protocol Violation|0
2080845|NCT00699608|3664469|FG002|First Intervention|Protocol Violation|0
2080846|NCT00699608|3664470|FG003|First Intervention|Protocol Violation|0
2080847|NCT00699608|3664471|FG004|First Intervention|Protocol Violation|1
2080848|NCT00699608|3664472|FG005|First Intervention|Protocol Violation|0
2080849|NCT00699608|3664467|FG000|Second Intervention|Adverse Event|0
2080850|NCT00699608|3664468|FG001|Second Intervention|Adverse Event|0
2080851|NCT00699608|3664469|FG002|Second Intervention|Adverse Event|1
2080852|NCT00699608|3664470|FG003|Second Intervention|Adverse Event|0
2080853|NCT00699608|3664471|FG004|Second Intervention|Adverse Event|0
2080854|NCT00699608|3664472|FG005|Second Intervention|Adverse Event|0
2080855|NCT00699608|3664467|FG000|Second Intervention|Withdrawal by Subject|0
2080856|NCT00699608|3664468|FG001|Second Intervention|Withdrawal by Subject|0
2080857|NCT00699608|3664469|FG002|Second Intervention|Withdrawal by Subject|0
2080858|NCT00699608|3664470|FG003|Second Intervention|Withdrawal by Subject|1
2080859|NCT00699608|3664471|FG004|Second Intervention|Withdrawal by Subject|0
2080860|NCT00699608|3664472|FG005|Second Intervention|Withdrawal by Subject|0
2080861|NCT00699660|3664482|FG000|Overall Study|Lost to Follow-up|4
2080862|NCT00699660|3664483|FG001|Overall Study|Lost to Follow-up|2
2080863|NCT00699660|3664482|FG000|Overall Study|missing reports and recording failures|10
2080864|NCT00699660|3664483|FG001|Overall Study|missing reports and recording failures|6
2080865|NCT00699699|3664489|FG000|Overall Study|Adverse Event|36
2080866|NCT00699699|3664489|FG000|Overall Study|Individual different reasons|21
2080867|NCT00699751|3664495|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27
2080868|NCT00699751|3664496|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27
2080869|NCT00699751|3664495|FG000|Period 1: Without/Before Drug Switch|Death|28
2080870|NCT00699751|3664496|FG001|Period 1: Without/Before Drug Switch|Death|29
2080871|NCT00699751|3664495|FG000|Period 1: Without/Before Drug Switch|Subject Request|43
2080872|NCT00699751|3664496|FG001|Period 1: Without/Before Drug Switch|Subject Request|23
2080873|NCT00699751|3664495|FG000|Period 1: Without/Before Drug Switch|Other|30
2080874|NCT00699751|3664496|FG001|Period 1: Without/Before Drug Switch|Other|20
2080875|NCT00699751|3664495|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97
2080876|NCT00699751|3664496|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63
2080877|NCT00699751|3664495|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
2080878|NCT00699751|3664496|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
2080879|NCT00699751|3664495|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
2080880|NCT00699751|3664496|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
2080881|NCT00699751|3664495|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
2080882|NCT00699751|3664496|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
2080883|NCT00699816|3664514|FG000|Overall Study|Protocol Violation|1
2080884|NCT00699816|3664515|FG001|Overall Study|Protocol Violation|3
2080885|NCT00699907|3664524|FG000|Overall Study|Withdrawal by Subject|2
2080886|NCT00699907|3664525|FG001|Overall Study|Withdrawal by Subject|1
2080887|NCT00699907|3664526|FG002|Overall Study|Withdrawal by Subject|0
2080888|NCT00699907|3664524|FG000|Overall Study|No usable sample|0
2080889|NCT00699907|3664525|FG001|Overall Study|No usable sample|9
2080890|NCT00699907|3664526|FG002|Overall Study|No usable sample|8
2080891|NCT00699972|3664537|FG000|Overall Study|Adverse Event|7
2080892|NCT00699972|3664538|FG001|Overall Study|Adverse Event|9
2080893|NCT00699972|3664539|FG002|Overall Study|Adverse Event|24
2080894|NCT00699972|3664537|FG000|Overall Study|Lost to Follow-up|0
2080895|NCT00699972|3664538|FG001|Overall Study|Lost to Follow-up|2
2080896|NCT00699972|3664539|FG002|Overall Study|Lost to Follow-up|0
2080897|NCT00699972|3664537|FG000|Overall Study|Withdrawal by Subject|3
2080898|NCT00699972|3664538|FG001|Overall Study|Withdrawal by Subject|7
2080899|NCT00699972|3664539|FG002|Overall Study|Withdrawal by Subject|4
2080900|NCT00699972|3664537|FG000|Overall Study|Lack of Efficacy|2
2080901|NCT00699972|3664538|FG001|Overall Study|Lack of Efficacy|0
2080902|NCT00699972|3664539|FG002|Overall Study|Lack of Efficacy|2
2080903|NCT00699972|3664537|FG000|Overall Study|Administrative/Other|3
2080904|NCT00699972|3664538|FG001|Overall Study|Administrative/Other|1
2080905|NCT00699972|3664539|FG002|Overall Study|Administrative/Other|4
2080906|NCT00699972|3664537|FG000|Overall Study|Randomized, Not Treated|1
2080907|NCT00699972|3664538|FG001|Overall Study|Randomized, Not Treated|0
2080908|NCT00699972|3664539|FG002|Overall Study|Randomized, Not Treated|1
2080909|NCT00699998|3664551|FG000|Overall Study|Withdrawal by Subject|194
2080910|NCT00699998|3664552|FG001|Overall Study|Withdrawal by Subject|83
2080911|NCT00699998|3664553|FG002|Overall Study|Withdrawal by Subject|202
2080912|NCT00699998|3664554|FG003|Overall Study|Withdrawal by Subject|80
2080913|NCT00699998|3664551|FG000|Overall Study|Physician Decision|3
2080914|NCT00699998|3664552|FG001|Overall Study|Physician Decision|2
2080915|NCT00699998|3664553|FG002|Overall Study|Physician Decision|1
2080916|NCT00699998|3664554|FG003|Overall Study|Physician Decision|1
2080917|NCT00699998|3664551|FG000|Overall Study|Lost to Follow-up|2
2080918|NCT00699998|3664552|FG001|Overall Study|Lost to Follow-up|1
2080919|NCT00699998|3664553|FG002|Overall Study|Lost to Follow-up|3
2080920|NCT00699998|3664554|FG003|Overall Study|Lost to Follow-up|1
2080921|NCT00700011|3664571|FG000|Overall Study|Death|0
2080922|NCT00700011|3664572|FG001|Overall Study|Death|1
2080923|NCT00700102|3664613|FG000|Overall Study|Died|394
2080924|NCT00700102|3664614|FG001|Overall Study|Died|385
2080925|NCT00700102|3664613|FG000|Overall Study|Lost to Follow-up|8
2080926|NCT00700102|3664614|FG001|Overall Study|Lost to Follow-up|10
2080927|NCT00700115|3664622|FG000|Overall Study|Withdrawal by Subject|1
2080928|NCT00700115|3664623|FG001|Overall Study|Withdrawal by Subject|0
2080929|NCT00700115|3664622|FG000|Overall Study|Lost to Follow-up|0
2080930|NCT00700115|3664623|FG001|Overall Study|Lost to Follow-up|1
2106857|NCT00868790|3700225|FG006|Period 2|Lost to Follow-up|0
2106858|NCT00868790|3700226|FG007|Period 2|Lost to Follow-up|0
2106859|NCT00868790|3700227|FG008|Period 2|Lost to Follow-up|0
2106860|NCT00868790|3700228|FG009|Period 2|Lost to Follow-up|0
2106861|NCT00868790|3700229|FG010|Period 2|Lost to Follow-up|0
2106862|NCT00868790|3700230|FG011|Period 2|Lost to Follow-up|0
2106863|NCT00868790|3700231|FG012|Period 2|Lost to Follow-up|0
2106864|NCT00868790|3700232|FG013|Period 2|Lost to Follow-up|0
2106865|NCT00868790|3700219|FG000|Period 2|Withdrawal by Subject|0
2106866|NCT00868790|3700220|FG001|Period 2|Withdrawal by Subject|0
2106867|NCT00868790|3700221|FG002|Period 2|Withdrawal by Subject|0
2106868|NCT00868790|3700222|FG003|Period 2|Withdrawal by Subject|0
2106869|NCT00868790|3700223|FG004|Period 2|Withdrawal by Subject|0
2106870|NCT00868790|3700224|FG005|Period 2|Withdrawal by Subject|0
2106871|NCT00868790|3700225|FG006|Period 2|Withdrawal by Subject|0
2106872|NCT00868790|3700226|FG007|Period 2|Withdrawal by Subject|0
2106873|NCT00868790|3700227|FG008|Period 2|Withdrawal by Subject|1
2106874|NCT00868790|3700228|FG009|Period 2|Withdrawal by Subject|0
2106875|NCT00868790|3700229|FG010|Period 2|Withdrawal by Subject|0
2106876|NCT00868790|3700230|FG011|Period 2|Withdrawal by Subject|0
2106877|NCT00868790|3700231|FG012|Period 2|Withdrawal by Subject|0
2106878|NCT00868790|3700232|FG013|Period 2|Withdrawal by Subject|1
2106879|NCT00868790|3700219|FG000|Period 3|Adverse Event|0
2106880|NCT00868790|3700220|FG001|Period 3|Adverse Event|0
2106881|NCT00868790|3700221|FG002|Period 3|Adverse Event|0
2106882|NCT00868790|3700222|FG003|Period 3|Adverse Event|0
2106883|NCT00868790|3700223|FG004|Period 3|Adverse Event|0
2106884|NCT00868790|3700224|FG005|Period 3|Adverse Event|0
2106885|NCT00868790|3700225|FG006|Period 3|Adverse Event|0
2106886|NCT00868790|3700226|FG007|Period 3|Adverse Event|0
2106887|NCT00868790|3700227|FG008|Period 3|Adverse Event|0
2106888|NCT00868790|3700228|FG009|Period 3|Adverse Event|1
2106889|NCT00868790|3700229|FG010|Period 3|Adverse Event|0
2106890|NCT00868790|3700230|FG011|Period 3|Adverse Event|0
2106891|NCT00868790|3700231|FG012|Period 3|Adverse Event|0
2106892|NCT00868790|3700232|FG013|Period 3|Adverse Event|0
2106893|NCT00868790|3700219|FG000|Period 3|Protocol Violation|0
2106894|NCT00868790|3700220|FG001|Period 3|Protocol Violation|0
2106895|NCT00868790|3700221|FG002|Period 3|Protocol Violation|0
2106896|NCT00868790|3700222|FG003|Period 3|Protocol Violation|0
2106897|NCT00868790|3700223|FG004|Period 3|Protocol Violation|0
2106898|NCT00868790|3700224|FG005|Period 3|Protocol Violation|0
2106899|NCT00868790|3700225|FG006|Period 3|Protocol Violation|0
2106900|NCT00868790|3700226|FG007|Period 3|Protocol Violation|0
2106901|NCT00868790|3700227|FG008|Period 3|Protocol Violation|0
2106902|NCT00868790|3700228|FG009|Period 3|Protocol Violation|0
2106903|NCT00868790|3700229|FG010|Period 3|Protocol Violation|1
2106904|NCT00868790|3700230|FG011|Period 3|Protocol Violation|0
2106905|NCT00868790|3700231|FG012|Period 3|Protocol Violation|0
2106906|NCT00868790|3700232|FG013|Period 3|Protocol Violation|0
2106907|NCT00868790|3700219|FG000|Period 3|Study Terminated by Sponsor|0
2106908|NCT00868790|3700220|FG001|Period 3|Study Terminated by Sponsor|0
2106909|NCT00868790|3700221|FG002|Period 3|Study Terminated by Sponsor|0
2106910|NCT00868790|3700222|FG003|Period 3|Study Terminated by Sponsor|1
2106911|NCT00868790|3700223|FG004|Period 3|Study Terminated by Sponsor|0
2106912|NCT00868790|3700224|FG005|Period 3|Study Terminated by Sponsor|0
2106913|NCT00868790|3700225|FG006|Period 3|Study Terminated by Sponsor|0
2106914|NCT00868790|3700226|FG007|Period 3|Study Terminated by Sponsor|0
2106915|NCT00868790|3700227|FG008|Period 3|Study Terminated by Sponsor|0
2106916|NCT00868790|3700228|FG009|Period 3|Study Terminated by Sponsor|0
2106917|NCT00868790|3700229|FG010|Period 3|Study Terminated by Sponsor|0
2106918|NCT00868790|3700230|FG011|Period 3|Study Terminated by Sponsor|0
2106919|NCT00868790|3700231|FG012|Period 3|Study Terminated by Sponsor|0
2106920|NCT00868790|3700232|FG013|Period 3|Study Terminated by Sponsor|0
2106921|NCT00868790|3700219|FG000|Period 4|Adverse Event|0
2106922|NCT00868790|3700220|FG001|Period 4|Adverse Event|0
2106923|NCT00868790|3700221|FG002|Period 4|Adverse Event|0
2106924|NCT00868790|3700222|FG003|Period 4|Adverse Event|0
2106925|NCT00868790|3700223|FG004|Period 4|Adverse Event|0
2106926|NCT00868790|3700224|FG005|Period 4|Adverse Event|0
2106927|NCT00868790|3700225|FG006|Period 4|Adverse Event|0
2106928|NCT00868790|3700226|FG007|Period 4|Adverse Event|1
2106929|NCT00868790|3700227|FG008|Period 4|Adverse Event|0
2080931|NCT00700180|3664635|FG000|Overall Study|Death|99
2080932|NCT00700180|3664636|FG001|Overall Study|Death|114
2080933|NCT00700180|3664635|FG000|Overall Study|Alive on treatment|5
2080934|NCT00700180|3664636|FG001|Overall Study|Alive on treatment|3
2080935|NCT00700180|3664635|FG000|Overall Study|Alive in follow-up|46
2080936|NCT00700180|3664636|FG001|Overall Study|Alive in follow-up|27
2080937|NCT00700180|3664635|FG000|Overall Study|Lost to Follow-up|4
2080938|NCT00700180|3664636|FG001|Overall Study|Lost to Follow-up|5
2080939|NCT00700271|3664644|FG000|Overall Study|Adverse Event|4
2080940|NCT00700271|3664645|FG001|Overall Study|Adverse Event|6
2080941|NCT00700271|3664644|FG000|Overall Study|Protocol Violation|1
2080942|NCT00700271|3664645|FG001|Overall Study|Protocol Violation|0
2080943|NCT00700271|3664644|FG000|Overall Study|Administrative Reasons|1
2080944|NCT00700271|3664645|FG001|Overall Study|Administrative Reasons|0
2080945|NCT00700271|3664644|FG000|Overall Study|Withdrawal by Subject|6
2080946|NCT00700271|3664645|FG001|Overall Study|Withdrawal by Subject|4
2080947|NCT00700271|3664644|FG000|Overall Study|Lost to Follow-up|2
2080948|NCT00700271|3664645|FG001|Overall Study|Lost to Follow-up|2
2080949|NCT00700310|3664655|FG000|Overall Study|Adverse Event|6
2080950|NCT00700310|3664656|FG001|Overall Study|Adverse Event|10
2080951|NCT00700310|3664657|FG002|Overall Study|Adverse Event|5
2080952|NCT00700310|3664658|FG003|Overall Study|Adverse Event|11
2080953|NCT00700310|3664655|FG000|Overall Study|Lost to Follow-up|4
2080954|NCT00700310|3664656|FG001|Overall Study|Lost to Follow-up|1
2080955|NCT00700310|3664657|FG002|Overall Study|Lost to Follow-up|0
2080956|NCT00700310|3664658|FG003|Overall Study|Lost to Follow-up|1
2080957|NCT00700310|3664655|FG000|Overall Study|Withdrawal by Subject|8
2080958|NCT00700310|3664656|FG001|Overall Study|Withdrawal by Subject|9
2080959|NCT00700310|3664657|FG002|Overall Study|Withdrawal by Subject|8
2080960|NCT00700310|3664658|FG003|Overall Study|Withdrawal by Subject|8
2080961|NCT00700310|3664655|FG000|Overall Study|Lack of Efficacy|0
2080962|NCT00700310|3664656|FG001|Overall Study|Lack of Efficacy|3
2080963|NCT00700310|3664657|FG002|Overall Study|Lack of Efficacy|0
2080964|NCT00700310|3664658|FG003|Overall Study|Lack of Efficacy|1
2080965|NCT00700310|3664655|FG000|Overall Study|Administrative/Other|1
2080966|NCT00700310|3664656|FG001|Overall Study|Administrative/Other|3
2080967|NCT00700310|3664657|FG002|Overall Study|Administrative/Other|1
2080968|NCT00700310|3664658|FG003|Overall Study|Administrative/Other|3
2080969|NCT00700310|3664655|FG000|Overall Study|Randomized, Not Treated|2
2080970|NCT00700310|3664656|FG001|Overall Study|Randomized, Not Treated|0
2080971|NCT00700310|3664657|FG002|Overall Study|Randomized, Not Treated|2
2080972|NCT00700310|3664658|FG003|Overall Study|Randomized, Not Treated|2
2080973|NCT00700401|3664689|FG000|Overall Study|Detectable HCV RNA after Week 4|82
2080974|NCT00700401|3664689|FG000|Overall Study|Adverse Event|5
2080975|NCT00700401|3664689|FG000|Overall Study|Refused Treatment|2
2080976|NCT00700401|3664689|FG000|Overall Study|Lost to Follow-up|1
2080977|NCT00700401|3664689|FG000|Overall Study|Treatment never started|1
2080978|NCT00700401|3664689|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1
2080979|NCT00700401|3664689|FG000|Overall Study|Withdrawal by Subject|2
2080980|NCT00700427|3664693|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
2080981|NCT00700427|3664694|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
2080982|NCT00700427|3664695|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
2080983|NCT00700427|3664696|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
2080984|NCT00700427|3664697|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
2080985|NCT00700427|3664693|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
2080986|NCT00700427|3664694|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
2080987|NCT00700427|3664695|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
2080988|NCT00700427|3664696|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
2080989|NCT00700427|3664697|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
2080990|NCT00700427|3664693|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
2080991|NCT00700427|3664694|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
2080992|NCT00700427|3664695|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
2080993|NCT00700427|3664696|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
2080994|NCT00700427|3664697|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
2080995|NCT00700427|3664693|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
2080996|NCT00700427|3664694|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
2080997|NCT00700427|3664695|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
2080998|NCT00700427|3664696|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
2080999|NCT00700427|3664697|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
2081000|NCT00700427|3664693|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
2081001|NCT00700427|3664694|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
2081002|NCT00700427|3664695|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
2081003|NCT00700427|3664696|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
2081004|NCT00700427|3664697|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
2081005|NCT00700427|3664693|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
2081006|NCT00700427|3664694|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
2081007|NCT00700427|3664695|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
2081008|NCT00700427|3664696|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
2081009|NCT00700427|3664697|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
2081010|NCT00700427|3664693|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
2081011|NCT00700427|3664694|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
2305545|NCT02672852|4006754|FG003|Part B|Lost to Follow-up|0
2305546|NCT02672852|4006755|FG004|Part B|Lost to Follow-up|3
2305547|NCT02672852|4006756|FG005|Part B|Lost to Follow-up|4
2305548|NCT02672852|4006757|FG006|Part B|Lost to Follow-up|1
2305549|NCT02672852|4006751|FG000|Part B|Withdrawal by Subject|0
2305550|NCT02672852|4006752|FG001|Part B|Withdrawal by Subject|0
2305551|NCT02672852|4006753|FG002|Part B|Withdrawal by Subject|0
2081012|NCT00700427|3664695|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
2081013|NCT00700427|3664696|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
2081014|NCT00700427|3664697|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
2081015|NCT00700427|3664693|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
2081016|NCT00700427|3664694|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
2081017|NCT00700427|3664695|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
2081018|NCT00700427|3664696|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
2081019|NCT00700427|3664697|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
2081020|NCT00700427|3664693|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
2081021|NCT00700427|3664694|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
2081022|NCT00700427|3664695|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
2081023|NCT00700427|3664696|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
2081024|NCT00700427|3664697|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
2081025|NCT00700427|3664693|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0
2081026|NCT00700427|3664694|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50
2211290|NCT01659255|3851485|FG000|Overall Study|Progressive Disease|2
2081027|NCT00700427|3664695|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0
2081028|NCT00700427|3664696|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0
2081029|NCT00700427|3664697|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0
2081030|NCT00700427|3664693|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
2081031|NCT00700427|3664694|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
2081032|NCT00700427|3664695|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
2081033|NCT00700427|3664696|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
2081034|NCT00700427|3664697|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
2081035|NCT00700427|3664693|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
2081036|NCT00700427|3664694|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
2081037|NCT00700427|3664695|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
2081038|NCT00700427|3664696|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
2081039|NCT00700427|3664697|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
2081040|NCT00700427|3664693|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
2081041|NCT00700427|3664694|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
2081042|NCT00700427|3664695|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
2081043|NCT00700427|3664696|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
2081044|NCT00700427|3664697|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
2081045|NCT00700427|3664693|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
2081046|NCT00700427|3664694|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
2081047|NCT00700427|3664695|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
2081048|NCT00700427|3664696|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
2081049|NCT00700427|3664697|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
2081050|NCT00700427|3664693|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
2081051|NCT00700427|3664694|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
2081052|NCT00700427|3664695|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
2081053|NCT00700427|3664696|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
2081054|NCT00700427|3664697|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
2081055|NCT00700427|3664693|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
2081056|NCT00700427|3664694|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
2081057|NCT00700427|3664695|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
2081058|NCT00700427|3664696|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
2081059|NCT00700427|3664697|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
2081060|NCT00700427|3664693|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
2081061|NCT00700427|3664694|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
2081062|NCT00700427|3664695|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
2081063|NCT00700427|3664696|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
2081064|NCT00700427|3664697|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
2081065|NCT00700427|3664693|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0
2081066|NCT00700427|3664694|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2
2081067|NCT00700427|3664695|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0
2081068|NCT00700427|3664696|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0
2305552|NCT02672852|4006754|FG003|Part B|Withdrawal by Subject|0
2081069|NCT00700427|3664697|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0
2081070|NCT00700427|3664693|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
2081071|NCT00700427|3664694|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
2081072|NCT00700427|3664695|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
2081073|NCT00700427|3664696|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
2081074|NCT00700427|3664697|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
2081075|NCT00700427|3664693|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
2081076|NCT00700427|3664694|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
2081077|NCT00700427|3664695|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
2081078|NCT00700427|3664696|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
2081079|NCT00700427|3664697|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
2081080|NCT00700427|3664693|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
2081081|NCT00700427|3664694|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
2081082|NCT00700427|3664695|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
2081083|NCT00700427|3664696|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
2081084|NCT00700427|3664697|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
2081085|NCT00700427|3664693|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
2081086|NCT00700427|3664694|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
2081087|NCT00700427|3664695|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
2081088|NCT00700427|3664696|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
2081089|NCT00700427|3664697|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
2081090|NCT00700427|3664693|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
2081091|NCT00700427|3664694|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
2081092|NCT00700427|3664695|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
2081093|NCT00700427|3664696|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
2081094|NCT00700427|3664697|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
2081095|NCT00700427|3664693|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
2081096|NCT00700427|3664694|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
2081097|NCT00700427|3664695|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
2081098|NCT00700427|3664696|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
2081099|NCT00700427|3664697|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
2081100|NCT00700427|3664693|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
2081101|NCT00700427|3664694|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
2081102|NCT00700427|3664695|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
2081103|NCT00700427|3664696|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
2081104|NCT00700427|3664697|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
2081105|NCT00700427|3664693|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
2081106|NCT00700427|3664694|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
2081107|NCT00700427|3664695|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
2081108|NCT00700427|3664696|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
2081109|NCT00700427|3664697|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
2081110|NCT00700427|3664693|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0
2081111|NCT00700427|3664694|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0
2081112|NCT00700427|3664695|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1
2081113|NCT00700427|3664696|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1
2081114|NCT00700427|3664697|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0
2081115|NCT00700427|3664693|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
2081116|NCT00700427|3664694|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
2081117|NCT00700427|3664695|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
2081118|NCT00700427|3664696|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
2081119|NCT00700427|3664697|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
2081120|NCT00700427|3664693|FG000|Study Period 3B (Randomized Withdrawal)|Death|0
2081121|NCT00700427|3664694|FG001|Study Period 3B (Randomized Withdrawal)|Death|0
2081122|NCT00700427|3664695|FG002|Study Period 3B (Randomized Withdrawal)|Death|1
2081123|NCT00700427|3664696|FG003|Study Period 3B (Randomized Withdrawal)|Death|0
2081124|NCT00700427|3664697|FG004|Study Period 3B (Randomized Withdrawal)|Death|0
2081125|NCT00700427|3664693|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0
2081126|NCT00700427|3664694|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0
2081127|NCT00700427|3664695|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0
2081128|NCT00700427|3664696|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0
2081129|NCT00700427|3664697|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16
2081130|NCT00700427|3664693|FG000|Study Period 4 (Open-Label Extension)|Death|0
2081131|NCT00700427|3664694|FG001|Study Period 4 (Open-Label Extension)|Death|0
2081132|NCT00700427|3664695|FG002|Study Period 4 (Open-Label Extension)|Death|0
2081133|NCT00700427|3664696|FG003|Study Period 4 (Open-Label Extension)|Death|0
2081134|NCT00700427|3664697|FG004|Study Period 4 (Open-Label Extension)|Death|1
2081135|NCT00700427|3664693|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0
2081136|NCT00700427|3664694|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0
2081137|NCT00700427|3664695|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0
2081138|NCT00700427|3664696|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0
2081139|NCT00700427|3664697|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12
2081140|NCT00700427|3664693|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
2081141|NCT00700427|3664694|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
2081142|NCT00700427|3664695|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
2081143|NCT00700427|3664696|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
2081144|NCT00700427|3664697|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
2081145|NCT00700427|3664693|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0
2081146|NCT00700427|3664694|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0
2081147|NCT00700427|3664695|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0
2081148|NCT00700427|3664696|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0
2081149|NCT00700427|3664697|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2
2081150|NCT00700427|3664693|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
2081151|NCT00700427|3664694|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
2081152|NCT00700427|3664695|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
2081153|NCT00700427|3664696|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
2081154|NCT00700427|3664697|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
2081155|NCT00700427|3664693|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
2081156|NCT00700427|3664694|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
2081157|NCT00700427|3664695|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
2081158|NCT00700427|3664696|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
2081159|NCT00700427|3664697|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
2081160|NCT00700427|3664693|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
2081161|NCT00700427|3664694|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
2081162|NCT00700427|3664695|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
2081163|NCT00700427|3664696|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
2081164|NCT00700427|3664697|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
2081165|NCT00700427|3664693|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
2081166|NCT00700427|3664694|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
2081167|NCT00700427|3664695|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
2081168|NCT00700427|3664696|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
2081169|NCT00700427|3664697|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
2081170|NCT00700570|3664711|FG000|Overall Study|Adverse Event|2
2081171|NCT00700570|3664712|FG001|Overall Study|Adverse Event|6
2081172|NCT00700570|3664711|FG000|Overall Study|Discretion of Investigator or Sponsor|0
2081173|NCT00700570|3664712|FG001|Overall Study|Discretion of Investigator or Sponsor|3
2081174|NCT00700570|3664711|FG000|Overall Study|Disease Progression|8
2081175|NCT00700570|3664712|FG001|Overall Study|Disease Progression|11
2081176|NCT00700570|3664711|FG000|Overall Study|Withdrawal by Subject|1
2081177|NCT00700570|3664712|FG001|Overall Study|Withdrawal by Subject|6
2081178|NCT00700622|3664720|FG000|Overall Study|Adverse Event|4
2081179|NCT00700622|3664721|FG001|Overall Study|Adverse Event|0
2081180|NCT00700622|3664720|FG000|Overall Study|Lost to Follow-up|0
2081181|NCT00700622|3664721|FG001|Overall Study|Lost to Follow-up|1
2081182|NCT00700622|3664720|FG000|Overall Study|Physician Decision|2
2081183|NCT00700622|3664721|FG001|Overall Study|Physician Decision|1
2081184|NCT00700622|3664720|FG000|Overall Study|Protocol Violation|0
2081185|NCT00700622|3664721|FG001|Overall Study|Protocol Violation|1
2081186|NCT00700622|3664720|FG000|Overall Study|Withdrawal by Subject|4
2081187|NCT00700622|3664721|FG001|Overall Study|Withdrawal by Subject|1
2081188|NCT00700622|3664720|FG000|Overall Study|Other|3
2081189|NCT00700622|3664721|FG001|Overall Study|Other|1
2081190|NCT00700635|3664730|FG000|Overall Study|Adverse Event|1
2081191|NCT00700635|3664731|FG001|Overall Study|Adverse Event|0
2081192|NCT00700635|3664732|FG002|Overall Study|Adverse Event|0
2081193|NCT00700635|3664730|FG000|Overall Study|Lost to Follow-up|1
2081194|NCT00700635|3664731|FG001|Overall Study|Lost to Follow-up|3
2081195|NCT00700635|3664732|FG002|Overall Study|Lost to Follow-up|0
2081196|NCT00700635|3664730|FG000|Overall Study|Protocol Violation|2
2081197|NCT00700635|3664731|FG001|Overall Study|Protocol Violation|2
2081198|NCT00700635|3664732|FG002|Overall Study|Protocol Violation|0
2081199|NCT00700635|3664730|FG000|Overall Study|Withdrawal by Subject|7
2081200|NCT00700635|3664731|FG001|Overall Study|Withdrawal by Subject|3
2081201|NCT00700635|3664732|FG002|Overall Study|Withdrawal by Subject|1
2081202|NCT00700713|3664743|FG000|Overall Study|Protocol Violation|1
2081203|NCT00700713|3664744|FG001|Overall Study|Protocol Violation|0
2081204|NCT00700713|3664745|FG002|Overall Study|Protocol Violation|1
2081205|NCT00700713|3664743|FG000|Overall Study|Withdrawal by Subject|0
2081206|NCT00700713|3664744|FG001|Overall Study|Withdrawal by Subject|0
2081207|NCT00700713|3664745|FG002|Overall Study|Withdrawal by Subject|1
2081208|NCT00700739|3664755|FG000|Overall Study|Lost to Follow-up|4
2081209|NCT00700739|3664756|FG001|Overall Study|Lost to Follow-up|4
2081210|NCT00700752|3664763|FG000|First Intervention|Withdrawal by Subject|0
2081211|NCT00700752|3664764|FG001|First Intervention|Withdrawal by Subject|2
2081212|NCT00700804|3664772|FG000|Overall Study|Withdrawal by Subject|1
2081213|NCT00700804|3664773|FG001|Overall Study|Withdrawal by Subject|2
2081214|NCT00700804|3664772|FG000|Overall Study|Protocol Violation|1
2081215|NCT00700804|3664773|FG001|Overall Study|Protocol Violation|1
2081216|NCT00700804|3664772|FG000|Overall Study|Loose Stools|1
2081217|NCT00700804|3664773|FG001|Overall Study|Loose Stools|1
2081218|NCT00700817|3664784|FG000|Week 0-26 (Main Period)|Adverse Event|14
2081219|NCT00700817|3664785|FG001|Week 0-26 (Main Period)|Adverse Event|15
2081220|NCT00700817|3664786|FG002|Week 0-26 (Main Period)|Adverse Event|4
2081221|NCT00700817|3664787|FG003|Week 0-26 (Main Period)|Adverse Event|0
2081222|NCT00700817|3664788|FG004|Week 0-26 (Main Period)|Adverse Event|0
2081223|NCT00700817|3664784|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4
2081224|NCT00700817|3664785|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0
2081225|NCT00700817|3664786|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4
2081226|NCT00700817|3664787|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0
2081227|NCT00700817|3664788|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0
2081228|NCT00700817|3664784|FG000|Week 0-26 (Main Period)|Protocol Violation|14
2081229|NCT00700817|3664785|FG001|Week 0-26 (Main Period)|Protocol Violation|4
2081230|NCT00700817|3664786|FG002|Week 0-26 (Main Period)|Protocol Violation|4
2081231|NCT00700817|3664787|FG003|Week 0-26 (Main Period)|Protocol Violation|0
2081232|NCT00700817|3664788|FG004|Week 0-26 (Main Period)|Protocol Violation|0
2081233|NCT00700817|3664784|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10
2081234|NCT00700817|3664785|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7
2081235|NCT00700817|3664786|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5
2081236|NCT00700817|3664787|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0
2081237|NCT00700817|3664788|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0
2081238|NCT00700817|3664784|FG000|Week 0-26 (Main Period)|Unclassified|14
2081239|NCT00700817|3664785|FG001|Week 0-26 (Main Period)|Unclassified|4
2081240|NCT00700817|3664786|FG002|Week 0-26 (Main Period)|Unclassified|8
2081241|NCT00700817|3664787|FG003|Week 0-26 (Main Period)|Unclassified|0
2081242|NCT00700817|3664788|FG004|Week 0-26 (Main Period)|Unclassified|0
2081243|NCT00700817|3664784|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5
2081244|NCT00700817|3664785|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10
2081245|NCT00700817|3664786|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3
2081246|NCT00700817|3664787|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0
2081247|NCT00700817|3664788|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0
2081248|NCT00700817|3664784|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3
2211291|NCT01659255|3851486|FG001|Overall Study|Progressive Disease|0
2211292|NCT01659255|3851487|FG002|Overall Study|Progressive Disease|0
2211293|NCT01659255|3851488|FG003|Overall Study|Progressive Disease|0
2211294|NCT01659255|3851489|FG004|Overall Study|Progressive Disease|0
2211295|NCT01659255|3851490|FG005|Overall Study|Progressive Disease|0
2211296|NCT01659255|3851491|FG006|Overall Study|Progressive Disease|0
2211297|NCT01659255|3851492|FG007|Overall Study|Progressive Disease|1
2211298|NCT01659255|3851493|FG008|Overall Study|Progressive Disease|0
2211299|NCT01659255|3851494|FG009|Overall Study|Progressive Disease|2
2211300|NCT01659255|3851495|FG010|Overall Study|Progressive Disease|2
2211301|NCT01659255|3851496|FG011|Overall Study|Progressive Disease|3
2211302|NCT01659255|3851497|FG012|Overall Study|Progressive Disease|5
2211303|NCT01659255|3851498|FG013|Overall Study|Progressive Disease|13
2211304|NCT01659255|3851499|FG014|Overall Study|Progressive Disease|6
2211305|NCT01659255|3851500|FG015|Overall Study|Progressive Disease|2
2211306|NCT01659255|3851501|FG016|Overall Study|Progressive Disease|3
2211307|NCT01659255|3851485|FG000|Overall Study|Withdrew Consent|0
2211308|NCT01659255|3851486|FG001|Overall Study|Withdrew Consent|0
2211309|NCT01659255|3851487|FG002|Overall Study|Withdrew Consent|0
2211310|NCT01659255|3851488|FG003|Overall Study|Withdrew Consent|0
2211311|NCT01659255|3851489|FG004|Overall Study|Withdrew Consent|0
2211312|NCT01659255|3851490|FG005|Overall Study|Withdrew Consent|0
2211313|NCT01659255|3851491|FG006|Overall Study|Withdrew Consent|0
2211314|NCT01659255|3851492|FG007|Overall Study|Withdrew Consent|0
2211315|NCT01659255|3851493|FG008|Overall Study|Withdrew Consent|0
2211316|NCT01659255|3851494|FG009|Overall Study|Withdrew Consent|0
2211317|NCT01659255|3851495|FG010|Overall Study|Withdrew Consent|1
2211318|NCT01659255|3851496|FG011|Overall Study|Withdrew Consent|0
2211319|NCT01659255|3851497|FG012|Overall Study|Withdrew Consent|0
2211320|NCT01659255|3851498|FG013|Overall Study|Withdrew Consent|1
2211321|NCT01659255|3851499|FG014|Overall Study|Withdrew Consent|0
2211322|NCT01659255|3851500|FG015|Overall Study|Withdrew Consent|0
2211323|NCT01659255|3851501|FG016|Overall Study|Withdrew Consent|0
2211324|NCT01659255|3851485|FG000|Overall Study|Investigator Decision|0
2211325|NCT01659255|3851486|FG001|Overall Study|Investigator Decision|0
2211326|NCT01659255|3851487|FG002|Overall Study|Investigator Decision|0
2211327|NCT01659255|3851488|FG003|Overall Study|Investigator Decision|0
2211328|NCT01659255|3851489|FG004|Overall Study|Investigator Decision|0
2211329|NCT01659255|3851490|FG005|Overall Study|Investigator Decision|0
2211330|NCT01659255|3851491|FG006|Overall Study|Investigator Decision|0
2211331|NCT01659255|3851492|FG007|Overall Study|Investigator Decision|0
2211332|NCT01659255|3851493|FG008|Overall Study|Investigator Decision|0
2211333|NCT01659255|3851494|FG009|Overall Study|Investigator Decision|0
2211334|NCT01659255|3851495|FG010|Overall Study|Investigator Decision|0
2211335|NCT01659255|3851496|FG011|Overall Study|Investigator Decision|0
2211336|NCT01659255|3851497|FG012|Overall Study|Investigator Decision|1
2211337|NCT01659255|3851498|FG013|Overall Study|Investigator Decision|1
2211338|NCT01659255|3851499|FG014|Overall Study|Investigator Decision|0
2305553|NCT02672852|4006755|FG004|Part B|Withdrawal by Subject|5
2305554|NCT02672852|4006756|FG005|Part B|Withdrawal by Subject|0
2305555|NCT02672852|4006757|FG006|Part B|Withdrawal by Subject|7
2305556|NCT02672852|4006751|FG000|Part B|Other|0
2305557|NCT02672852|4006752|FG001|Part B|Other|0
2305558|NCT02672852|4006753|FG002|Part B|Other|0
2305559|NCT02672852|4006754|FG003|Part B|Other|0
2305560|NCT02672852|4006755|FG004|Part B|Other|4
2305561|NCT02672852|4006756|FG005|Part B|Other|1
2305562|NCT02672852|4006757|FG006|Part B|Other|2
2305563|NCT02673489|4006798|FG000|Treatment Period|Lost to Follow-up|3
2305564|NCT02673489|4006799|FG001|Treatment Period|Lost to Follow-up|0
2305565|NCT02673489|4006798|FG000|Treatment Period|Participant request to discontinue|1
2305566|NCT02673489|4006799|FG001|Treatment Period|Participant request to discontinue|1
2305567|NCT02673489|4006798|FG000|Treatment Period|Participant moved to another province|1
2305568|NCT02673489|4006799|FG001|Treatment Period|Participant moved to another province|0
2305569|NCT02673489|4006798|FG000|Treatment Period|Participant was incarcerated|0
2305570|NCT02673489|4006799|FG001|Treatment Period|Participant was incarcerated|1
2305571|NCT02673489|4006798|FG000|Treatment Period|Adverse Event|0
2305572|NCT02673489|4006799|FG001|Treatment Period|Adverse Event|1
2081249|NCT00700817|3664785|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2
2211339|NCT01659255|3851500|FG015|Overall Study|Investigator Decision|0
2211340|NCT01659255|3851501|FG016|Overall Study|Investigator Decision|0
2211341|NCT01659255|3851485|FG000|Overall Study|Sponsor's Decision|0
2211342|NCT01659255|3851486|FG001|Overall Study|Sponsor's Decision|0
2211343|NCT01659255|3851487|FG002|Overall Study|Sponsor's Decision|0
2211344|NCT01659255|3851488|FG003|Overall Study|Sponsor's Decision|0
2211345|NCT01659255|3851489|FG004|Overall Study|Sponsor's Decision|0
2211346|NCT01659255|3851490|FG005|Overall Study|Sponsor's Decision|0
2211347|NCT01659255|3851491|FG006|Overall Study|Sponsor's Decision|1
2211348|NCT01659255|3851492|FG007|Overall Study|Sponsor's Decision|0
2211349|NCT01659255|3851493|FG008|Overall Study|Sponsor's Decision|0
2211350|NCT01659255|3851494|FG009|Overall Study|Sponsor's Decision|0
2211351|NCT01659255|3851495|FG010|Overall Study|Sponsor's Decision|0
2211352|NCT01659255|3851496|FG011|Overall Study|Sponsor's Decision|0
2211353|NCT01659255|3851497|FG012|Overall Study|Sponsor's Decision|0
2211354|NCT01659255|3851498|FG013|Overall Study|Sponsor's Decision|0
2211355|NCT01659255|3851499|FG014|Overall Study|Sponsor's Decision|0
2211356|NCT01659255|3851500|FG015|Overall Study|Sponsor's Decision|0
2211357|NCT01659255|3851501|FG016|Overall Study|Sponsor's Decision|0
2211358|NCT01659255|3851485|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0
2211359|NCT01659255|3851486|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0
2211360|NCT01659255|3851487|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0
2211361|NCT01659255|3851488|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0
2211362|NCT01659255|3851489|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0
2081250|NCT00700817|3664786|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2
2081251|NCT00700817|3664787|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0
2081252|NCT00700817|3664788|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0
2081253|NCT00700817|3664784|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
2081254|NCT00700817|3664785|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
2081255|NCT00700817|3664786|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
2081256|NCT00700817|3664787|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
2081257|NCT00700817|3664788|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
2081258|NCT00700817|3664784|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
2081259|NCT00700817|3664785|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
2081260|NCT00700817|3664786|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
2081261|NCT00700817|3664787|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
2081262|NCT00700817|3664788|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
2081263|NCT00700817|3664784|FG000|Week 26-52 (Extension Period 1)|Unclassified|4
2081264|NCT00700817|3664785|FG001|Week 26-52 (Extension Period 1)|Unclassified|3
2081265|NCT00700817|3664786|FG002|Week 26-52 (Extension Period 1)|Unclassified|1
2081266|NCT00700817|3664787|FG003|Week 26-52 (Extension Period 1)|Unclassified|0
2081267|NCT00700817|3664788|FG004|Week 26-52 (Extension Period 1)|Unclassified|0
2081268|NCT00700817|3664784|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0
2081269|NCT00700817|3664785|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3
2081270|NCT00700817|3664786|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0
2081271|NCT00700817|3664787|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6
2081272|NCT00700817|3664788|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0
2081273|NCT00700817|3664784|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1
2081274|NCT00700817|3664785|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2
2081275|NCT00700817|3664786|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0
2081276|NCT00700817|3664787|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1
2081277|NCT00700817|3664788|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1
2081278|NCT00700817|3664784|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
2081279|NCT00700817|3664785|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
2305573|NCT02673489|4006798|FG000|Follow Up Period|Unable to return for week 24 follow-up|0
2305574|NCT02673489|4006799|FG001|Follow Up Period|Unable to return for week 24 follow-up|1
2305575|NCT02673489|4006798|FG000|Follow Up Period|Unable to return for follow-up|0
2081280|NCT00700817|3664786|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
2081281|NCT00700817|3664787|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
2081282|NCT00700817|3664788|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
2081283|NCT00700817|3664784|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
2081284|NCT00700817|3664785|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
2081285|NCT00700817|3664786|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
2081286|NCT00700817|3664787|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
2081287|NCT00700817|3664788|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
2081288|NCT00700817|3664784|FG000|Week 52-78 (Extension Period 2)|Unclassified|2
2081289|NCT00700817|3664785|FG001|Week 52-78 (Extension Period 2)|Unclassified|4
2081290|NCT00700817|3664786|FG002|Week 52-78 (Extension Period 2)|Unclassified|0
2081291|NCT00700817|3664787|FG003|Week 52-78 (Extension Period 2)|Unclassified|0
2081292|NCT00700817|3664788|FG004|Week 52-78 (Extension Period 2)|Unclassified|1
2081293|NCT00700882|3664798|FG000|Overall Study|Never received treatment|6
2081294|NCT00700882|3664798|FG000|Overall Study|Ineligible|2
2081295|NCT00700882|3664798|FG000|Overall Study|No KIT mutation|51
2081296|NCT00700999|3664813|FG000|Overall Study|Lost to Follow-up|7
2081297|NCT00700999|3664814|FG001|Overall Study|Lost to Follow-up|7
2081298|NCT00700999|3664813|FG000|Overall Study|Excluded - did not meet study criteria|0
2081299|NCT00700999|3664814|FG001|Overall Study|Excluded - did not meet study criteria|1
2081300|NCT00700999|3664813|FG000|Overall Study|Withdrawal by Subject|8
2081301|NCT00700999|3664814|FG001|Overall Study|Withdrawal by Subject|1
2081302|NCT00701038|3664822|FG000|Overall Study|study amended pilot group of patients|4
2081303|NCT00701038|3664823|FG001|Overall Study|study amended pilot group of patients|4
2081304|NCT00701051|3664831|FG000|Screening|Failed Screening|40
2081305|NCT00701051|3664832|FG001|Screening|Failed Screening|0
2081306|NCT00701051|3664833|FG002|Screening|Failed Screening|0
2081307|NCT00701051|3664831|FG000|Screening|Time conflicts|19
2081308|NCT00701051|3664832|FG001|Screening|Time conflicts|0
2081309|NCT00701051|3664833|FG002|Screening|Time conflicts|0
2081310|NCT00701051|3664831|FG000|Exercise Intervention|time conflict; non-study related illness|0
2081311|NCT00701051|3664832|FG001|Exercise Intervention|time conflict; non-study related illness|5
2081312|NCT00701051|3664833|FG002|Exercise Intervention|time conflict; non-study related illness|3
2081313|NCT00701064|3664841|FG000|Overall Study|Protocol Violation|1
2081314|NCT00701064|3664842|FG001|Overall Study|Protocol Violation|1
2081315|NCT00701064|3664841|FG000|Overall Study|Withdrawal by Subject|1
2081316|NCT00701064|3664842|FG001|Overall Study|Withdrawal by Subject|1
2081317|NCT00701064|3664841|FG000|Overall Study|initiated other PTSD treatment|2
2081318|NCT00701064|3664842|FG001|Overall Study|initiated other PTSD treatment|2
2081319|NCT00701090|3664850|FG000|Overall Study|Adverse Event|11
2081320|NCT00701090|3664851|FG001|Overall Study|Adverse Event|2
2081321|NCT00701090|3664850|FG000|Overall Study|Death|0
2081322|NCT00701090|3664851|FG001|Overall Study|Death|1
2081323|NCT00701090|3664850|FG000|Overall Study|Lack of Efficacy|5
2081324|NCT00701090|3664851|FG001|Overall Study|Lack of Efficacy|4
2081325|NCT00701090|3664850|FG000|Overall Study|Lost to Follow-up|9
2081326|NCT00701090|3664851|FG001|Overall Study|Lost to Follow-up|9
2081327|NCT00701090|3664850|FG000|Overall Study|Physician Decision|3
2081328|NCT00701090|3664851|FG001|Overall Study|Physician Decision|4
2081329|NCT00701090|3664850|FG000|Overall Study|Protocol Violation|2
2081330|NCT00701090|3664851|FG001|Overall Study|Protocol Violation|3
2081331|NCT00701090|3664850|FG000|Overall Study|Withdrawal by Subject|11
2081332|NCT00701090|3664851|FG001|Overall Study|Withdrawal by Subject|16
2081333|NCT00701090|3664850|FG000|Overall Study|Other|7
2081334|NCT00701090|3664851|FG001|Overall Study|Other|12
2081335|NCT00701103|3664868|FG000|Overall Study|Adverse Event|0
2081336|NCT00701103|3664869|FG001|Overall Study|Adverse Event|0
2081337|NCT00701103|3664870|FG002|Overall Study|Adverse Event|1
2081338|NCT00701103|3664871|FG003|Overall Study|Adverse Event|1
2081339|NCT00701103|3664872|FG004|Overall Study|Adverse Event|0
2081340|NCT00701103|3664873|FG005|Overall Study|Adverse Event|1
2081341|NCT00701103|3664874|FG006|Overall Study|Adverse Event|1
2081342|NCT00701103|3664875|FG007|Overall Study|Adverse Event|0
2081343|NCT00701103|3664876|FG008|Overall Study|Adverse Event|0
2081344|NCT00701103|3664877|FG009|Overall Study|Adverse Event|2
2081345|NCT00701103|3664878|FG010|Overall Study|Adverse Event|0
2081346|NCT00701103|3664868|FG000|Overall Study|Progressive Disease|5
2081347|NCT00701103|3664869|FG001|Overall Study|Progressive Disease|2
2081348|NCT00701103|3664870|FG002|Overall Study|Progressive Disease|6
2081349|NCT00701103|3664871|FG003|Overall Study|Progressive Disease|5
2081350|NCT00701103|3664872|FG004|Overall Study|Progressive Disease|6
2081351|NCT00701103|3664873|FG005|Overall Study|Progressive Disease|5
2081352|NCT00701103|3664874|FG006|Overall Study|Progressive Disease|7
2081353|NCT00701103|3664875|FG007|Overall Study|Progressive Disease|7
2081354|NCT00701103|3664876|FG008|Overall Study|Progressive Disease|8
2081355|NCT00701103|3664877|FG009|Overall Study|Progressive Disease|8
2081356|NCT00701103|3664878|FG010|Overall Study|Progressive Disease|11
2081357|NCT00701103|3664868|FG000|Overall Study|Withdrawal by Subject|0
2081358|NCT00701103|3664869|FG001|Overall Study|Withdrawal by Subject|1
2081359|NCT00701103|3664870|FG002|Overall Study|Withdrawal by Subject|1
2081360|NCT00701103|3664871|FG003|Overall Study|Withdrawal by Subject|0
2081361|NCT00701103|3664872|FG004|Overall Study|Withdrawal by Subject|0
2081362|NCT00701103|3664873|FG005|Overall Study|Withdrawal by Subject|0
2081363|NCT00701103|3664874|FG006|Overall Study|Withdrawal by Subject|0
2081364|NCT00701103|3664875|FG007|Overall Study|Withdrawal by Subject|0
2081365|NCT00701103|3664876|FG008|Overall Study|Withdrawal by Subject|0
2081366|NCT00701103|3664877|FG009|Overall Study|Withdrawal by Subject|0
2081367|NCT00701103|3664878|FG010|Overall Study|Withdrawal by Subject|0
2081368|NCT00701103|3664868|FG000|Overall Study|Other|0
2081369|NCT00701103|3664869|FG001|Overall Study|Other|0
2081370|NCT00701103|3664870|FG002|Overall Study|Other|0
2081371|NCT00701103|3664871|FG003|Overall Study|Other|0
2081372|NCT00701103|3664872|FG004|Overall Study|Other|0
2081373|NCT00701103|3664873|FG005|Overall Study|Other|0
2081374|NCT00701103|3664874|FG006|Overall Study|Other|0
2081375|NCT00701103|3664875|FG007|Overall Study|Other|0
2081376|NCT00701103|3664876|FG008|Overall Study|Other|1
2081377|NCT00701103|3664877|FG009|Overall Study|Other|1
2081378|NCT00701103|3664878|FG010|Overall Study|Other|0
2081379|NCT00701129|3664906|FG000|Overall Study|Death|2
2081380|NCT00701311|3664910|FG000|Overall Study|Lack of Efficacy|3
2081381|NCT00701311|3664910|FG000|Overall Study|Adverse Event|3
2081382|NCT00701311|3664910|FG000|Overall Study|Withdrawal by Subject|2
2081383|NCT00701363|3664918|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
2081384|NCT00701363|3664919|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
2081385|NCT00701363|3664920|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
2081386|NCT00701363|3664921|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
2081387|NCT00701363|3664918|FG000|Treatment Phase 1|Does not meet entry Criteria|1
2081388|NCT00701363|3664919|FG001|Treatment Phase 1|Does not meet entry Criteria|0
2081389|NCT00701363|3664920|FG002|Treatment Phase 1|Does not meet entry Criteria|0
2081390|NCT00701363|3664921|FG003|Treatment Phase 1|Does not meet entry Criteria|0
2081391|NCT00701363|3664918|FG000|Treatment Phase 1|Adverse Event|7
2081392|NCT00701363|3664919|FG001|Treatment Phase 1|Adverse Event|0
2081393|NCT00701363|3664920|FG002|Treatment Phase 1|Adverse Event|0
2081394|NCT00701363|3664921|FG003|Treatment Phase 1|Adverse Event|0
2081395|NCT00701363|3664918|FG000|Treatment Phase 1|Protocol Violation|1
2081396|NCT00701363|3664919|FG001|Treatment Phase 1|Protocol Violation|0
2081397|NCT00701363|3664920|FG002|Treatment Phase 1|Protocol Violation|0
2081398|NCT00701363|3664921|FG003|Treatment Phase 1|Protocol Violation|0
2081399|NCT00701363|3664918|FG000|Treatment Phase 1|Withdrawal by Subject|5
2081400|NCT00701363|3664919|FG001|Treatment Phase 1|Withdrawal by Subject|0
2081401|NCT00701363|3664920|FG002|Treatment Phase 1|Withdrawal by Subject|0
2081402|NCT00701363|3664921|FG003|Treatment Phase 1|Withdrawal by Subject|0
2081403|NCT00701363|3664918|FG000|Treatment Phase 1|Lack of Efficacy|1
2081404|NCT00701363|3664919|FG001|Treatment Phase 1|Lack of Efficacy|0
2081405|NCT00701363|3664920|FG002|Treatment Phase 1|Lack of Efficacy|0
2081406|NCT00701363|3664921|FG003|Treatment Phase 1|Lack of Efficacy|0
2081407|NCT00701363|3664918|FG000|Treatment Phase 2|Adverse Event|0
2081408|NCT00701363|3664919|FG001|Treatment Phase 2|Adverse Event|0
2081409|NCT00701363|3664920|FG002|Treatment Phase 2|Adverse Event|1
2081410|NCT00701363|3664921|FG003|Treatment Phase 2|Adverse Event|0
2081411|NCT00701363|3664918|FG000|Treatment Phase 2|Withdrawal by Subject|0
2081412|NCT00701363|3664919|FG001|Treatment Phase 2|Withdrawal by Subject|0
2081413|NCT00701363|3664920|FG002|Treatment Phase 2|Withdrawal by Subject|1
2081414|NCT00701363|3664921|FG003|Treatment Phase 2|Withdrawal by Subject|0
2081415|NCT00701415|3664965|FG000|Overall Study|Adverse Event|0
2081416|NCT00701415|3664966|FG001|Overall Study|Adverse Event|1
2081417|NCT00701415|3664965|FG000|Overall Study|Social/family issues and needle phobia|1
2081418|NCT00701415|3664966|FG001|Overall Study|Social/family issues and needle phobia|0
2081419|NCT00701441|3664974|FG000|Overall Study|failure in cpap compliance|0
2081420|NCT00701441|3664975|FG001|Overall Study|failure in cpap compliance|4
2081421|NCT00701558|3664985|FG000|Overall Study|Death|7
2081422|NCT00701558|3664985|FG000|Overall Study|Lost to Follow-up|8
2081423|NCT00701662|3664997|FG000|Overall Study|Lack of Efficacy|1
2081424|NCT00701701|3665016|FG000|Overall Study|Withdrawal by Subject|0
2081425|NCT00701701|3665017|FG001|Overall Study|Withdrawal by Subject|1
2081426|NCT00701701|3665016|FG000|Overall Study|Adverse Event|0
2081427|NCT00701701|3665017|FG001|Overall Study|Adverse Event|1
2081428|NCT00701727|3665037|FG000|First Treatment Period|Adverse Event|0
2081429|NCT00701727|3665038|FG001|First Treatment Period|Adverse Event|0
2081430|NCT00701727|3665037|FG000|First Treatment Period|Withdrawal by Subject|1
2081431|NCT00701727|3665038|FG001|First Treatment Period|Withdrawal by Subject|0
2081432|NCT00701727|3665037|FG000|First Treatment Period|sponsor decision|0
2081433|NCT00701727|3665038|FG001|First Treatment Period|sponsor decision|1
2081434|NCT00701727|3665037|FG000|First Treatment Period|Lost to Follow-up|0
2180067|NCT01397825|3805929|FG002|Overall Study|Symptomatic Deterioration|4
2081435|NCT00701727|3665038|FG001|First Treatment Period|Lost to Follow-up|1
2081436|NCT00701727|3665037|FG000|Second Treatment Period|Withdrawal by Subject|2
2081437|NCT00701727|3665038|FG001|Second Treatment Period|Withdrawal by Subject|0
2081438|NCT00701779|3665044|FG000|Overall Study|Adverse Event|6
2081439|NCT00701779|3665044|FG000|Overall Study|Lost to Follow-up|1
2081440|NCT00701779|3665044|FG000|Overall Study|Withdrawal by Subject|2
2081441|NCT00701805|3665052|FG000|Overall Study|Withdrawal by Subject|3
2081442|NCT00701805|3665053|FG001|Overall Study|Withdrawal by Subject|1
2081443|NCT00701805|3665054|FG002|Overall Study|Withdrawal by Subject|4
2081444|NCT00701805|3665055|FG003|Overall Study|Withdrawal by Subject|3
2081445|NCT00701805|3665052|FG000|Overall Study|Adverse Event|0
2081446|NCT00701805|3665053|FG001|Overall Study|Adverse Event|1
2081447|NCT00701805|3665054|FG002|Overall Study|Adverse Event|1
2081448|NCT00701805|3665055|FG003|Overall Study|Adverse Event|0
2081449|NCT00701805|3665052|FG000|Overall Study|Missed 7 consecutive doses|0
2081450|NCT00701805|3665053|FG001|Overall Study|Missed 7 consecutive doses|1
2081451|NCT00701805|3665054|FG002|Overall Study|Missed 7 consecutive doses|0
2081452|NCT00701805|3665055|FG003|Overall Study|Missed 7 consecutive doses|0
2081453|NCT00701805|3665052|FG000|Overall Study|Admitted to hospital for 2 weeks|0
2081454|NCT00701805|3665053|FG001|Overall Study|Admitted to hospital for 2 weeks|0
2081455|NCT00701805|3665054|FG002|Overall Study|Admitted to hospital for 2 weeks|1
2081456|NCT00701805|3665055|FG003|Overall Study|Admitted to hospital for 2 weeks|0
2081457|NCT00701805|3665052|FG000|Overall Study|Physician decision, change of therapy|0
2081458|NCT00701805|3665053|FG001|Overall Study|Physician decision, change of therapy|0
2081459|NCT00701805|3665054|FG002|Overall Study|Physician decision, change of therapy|0
2081460|NCT00701805|3665055|FG003|Overall Study|Physician decision, change of therapy|1
2081461|NCT00701805|3665052|FG000|Overall Study|Difficult to travel to dialysis site|0
2081462|NCT00701805|3665053|FG001|Overall Study|Difficult to travel to dialysis site|0
2081463|NCT00701805|3665054|FG002|Overall Study|Difficult to travel to dialysis site|1
2081464|NCT00701805|3665055|FG003|Overall Study|Difficult to travel to dialysis site|0
2081465|NCT00701805|3665052|FG000|Overall Study|Resumption criteria were not met|0
2081466|NCT00701805|3665053|FG001|Overall Study|Resumption criteria were not met|1
2081467|NCT00701805|3665054|FG002|Overall Study|Resumption criteria were not met|0
2081468|NCT00701805|3665055|FG003|Overall Study|Resumption criteria were not met|0
2081469|NCT00702052|3665083|FG000|Overall Study|Adverse Event|23
2081470|NCT00702052|3665083|FG000|Overall Study|Disease Progression|30
2081471|NCT00702052|3665083|FG000|Overall Study|Withdrawal by Subject|5
2081472|NCT00702143|3665090|FG000|Overall Study|Lost to Follow-up|0
2081473|NCT00702143|3665091|FG001|Overall Study|Lost to Follow-up|0
2081474|NCT00702143|3665092|FG002|Overall Study|Lost to Follow-up|1
2081475|NCT00702208|3665098|FG000|Overall Study|Lost to Follow-up|28
2081476|NCT00702208|3665098|FG000|Overall Study|Did not self-lavage|1
2081477|NCT00702208|3665098|FG000|Overall Study|Unsatisfactory colposcopy|2
2081478|NCT00702221|3665105|FG000|Overall Study|Adverse Event|4
2081479|NCT00702221|3665106|FG001|Overall Study|Adverse Event|3
2081480|NCT00702325|3665121|FG000|Overall Study|Adverse Event|1
2081481|NCT00702325|3665122|FG001|Overall Study|Adverse Event|0
2081482|NCT00702325|3665121|FG000|Overall Study|Withdrawal by Subject|7
2081483|NCT00702325|3665122|FG001|Overall Study|Withdrawal by Subject|7
2081484|NCT00702325|3665121|FG000|Overall Study|Lost to Follow-up|3
2081485|NCT00702325|3665122|FG001|Overall Study|Lost to Follow-up|4
2081486|NCT00702325|3665121|FG000|Overall Study|Incorrect enrollment|5
2081487|NCT00702325|3665122|FG001|Overall Study|Incorrect enrollment|7
2081488|NCT00702325|3665121|FG000|Overall Study|Developed study discontinuation criteria|18
2081489|NCT00702325|3665122|FG001|Overall Study|Developed study discontinuation criteria|28
2081490|NCT00702325|3665121|FG000|Overall Study|Severe noncompliance to protocol|3
2081491|NCT00702325|3665122|FG001|Overall Study|Severe noncompliance to protocol|3
2081492|NCT00702325|3665121|FG000|Overall Study|Termination due to lab results|1
2081493|NCT00702325|3665122|FG001|Overall Study|Termination due to lab results|0
2081494|NCT00702325|3665121|FG000|Overall Study|Didn't follow study medication dosage|0
2081495|NCT00702325|3665122|FG001|Overall Study|Didn't follow study medication dosage|2
2081496|NCT00702325|3665121|FG000|Overall Study|Withdrew consent|0
2081497|NCT00702325|3665122|FG001|Overall Study|Withdrew consent|1
2081498|NCT00702325|3665121|FG000|Overall Study|Incorrectly Discontinued|0
2081499|NCT00702325|3665122|FG001|Overall Study|Incorrectly Discontinued|1
2081500|NCT00702403|3665146|FG000|From Consent to Engraftment|Progressive leukemia|6
2081501|NCT00702403|3665146|FG000|From Consent to Engraftment|Critically ill|2
2081502|NCT00702403|3665146|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
2081503|NCT00702403|3665146|FG000|From Consent to Engraftment|Myocardial infarction|1
2081504|NCT00702403|3665146|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
2081505|NCT00702403|3665146|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
2081506|NCT00702403|3665146|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
2081507|NCT00702403|3665146|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
2081508|NCT00702403|3665146|FG000|From Engraftment to Study Completion|Non-compliance|2
2081509|NCT00702403|3665146|FG000|From Engraftment to Study Completion|Adenocarcinoma|1
2081510|NCT00702403|3665146|FG000|From Engraftment to Study Completion|Liver GVHD|1
2081511|NCT00702403|3665146|FG000|From Engraftment to Study Completion|Suicide|1
2081512|NCT00702403|3665146|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
2081513|NCT00702403|3665146|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
2081514|NCT00702403|3665146|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
2081515|NCT00702507|3665162|FG000|Initial Treatment Phase|Adverse Event|2
2081516|NCT00702507|3665162|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
2081517|NCT00702507|3665162|FG000|Initial Treatment Phase|Lost to Follow-up|2
2081518|NCT00702507|3665162|FG000|Initial Treatment Phase|Negative Candida Culture|34
2081519|NCT00702507|3665162|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
2081520|NCT00702507|3665162|FG000|Follow-up Phase|Protocol Violation|2
2081521|NCT00702507|3665162|FG000|Follow-up Phase|Lost to Follow-up|23
2081522|NCT00702507|3665162|FG000|Follow-up Phase|Late Enrollment|1
2081523|NCT00702650|3665167|FG000|Overall Study|Withdrawal by Subject|9
2081524|NCT00702650|3665167|FG000|Overall Study|Non-Compliance of Study Drug|3
2081525|NCT00702650|3665167|FG000|Overall Study|Lost to Follow-up|2
2081526|NCT00702650|3665167|FG000|Overall Study|Non-Compliance with Site Directives|1
2081527|NCT00702650|3665167|FG000|Overall Study|Sponsor Request|1
2081528|NCT00702650|3665167|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1
2081529|NCT00702650|3665167|FG000|Overall Study|Adverse Event|3
2081530|NCT00702689|3665171|FG000|Overall Study|Withdrawal by Subject|4
2081531|NCT00702689|3665171|FG000|Overall Study|Recurrent malignancy|1
2081532|NCT00702689|3665171|FG000|Overall Study|Adverse Event|1
2081533|NCT00702715|3665177|FG000|Overall Study|Lost to Follow-up|1
2081534|NCT00702715|3665178|FG001|Overall Study|Lost to Follow-up|0
2081535|NCT00702923|3665204|FG000|Overall Study|Adverse Event|1
2081536|NCT00702949|3665212|FG000|Overall Study|Refusal|3
2081537|NCT00702949|3665213|FG001|Overall Study|Refusal|2
2081538|NCT00702949|3665214|FG002|Overall Study|Refusal|2
2081539|NCT00702949|3665212|FG000|Overall Study|Adverse Event|1
2081540|NCT00702949|3665213|FG001|Overall Study|Adverse Event|6
2081541|NCT00702949|3665214|FG002|Overall Study|Adverse Event|3
2081542|NCT00702949|3665212|FG000|Overall Study|Other Medical Reason/unknown|1
2081543|NCT00702949|3665213|FG001|Overall Study|Other Medical Reason/unknown|1
2081544|NCT00702949|3665214|FG002|Overall Study|Other Medical Reason/unknown|3
2081545|NCT00703118|3665266|FG000|Overall Study|Adverse Event|1
2081546|NCT00703118|3665267|FG001|Overall Study|Adverse Event|2
2081547|NCT00703118|3665268|FG002|Overall Study|Adverse Event|2
2081548|NCT00703118|3665266|FG000|Overall Study|Subject Ineligible To Continue The Trial|6
2081549|NCT00703118|3665267|FG001|Overall Study|Subject Ineligible To Continue The Trial|3
2081550|NCT00703118|3665268|FG002|Overall Study|Subject Ineligible To Continue The Trial|2
2081551|NCT00703118|3665266|FG000|Overall Study|Lost to Follow-up|6
2081552|NCT00703118|3665267|FG001|Overall Study|Lost to Follow-up|4
2081553|NCT00703118|3665268|FG002|Overall Study|Lost to Follow-up|4
2081554|NCT00703118|3665266|FG000|Overall Study|Withdrawal by Subject|8
2081555|NCT00703118|3665267|FG001|Overall Study|Withdrawal by Subject|7
2081556|NCT00703118|3665268|FG002|Overall Study|Withdrawal by Subject|13
2081557|NCT00703118|3665266|FG000|Overall Study|Other|0
2081558|NCT00703118|3665267|FG001|Overall Study|Other|0
2081559|NCT00703118|3665268|FG002|Overall Study|Other|1
2081560|NCT00703157|3665281|FG000|Overall Study|Lost to Follow-up|0
2081561|NCT00703157|3665282|FG001|Overall Study|Lost to Follow-up|1
2081562|NCT00703157|3665281|FG000|Overall Study|source data permanently lost/ other|4
2081563|NCT00703157|3665282|FG001|Overall Study|source data permanently lost/ other|1
2081564|NCT00703677|3665328|FG000|Overall Study|Dropout-withdrawal not related to drug|3
2081565|NCT00703781|3665343|FG000|Overall Study|Withdrawal by Subject|1
2081566|NCT00703781|3665344|FG001|Overall Study|Withdrawal by Subject|2
2081567|NCT00703781|3665343|FG000|Overall Study|Cancelled surgery|1
2081568|NCT00703781|3665344|FG001|Overall Study|Cancelled surgery|0
2081569|NCT00703820|3665352|FG000|Overall Study|Adverse Event|12
2081570|NCT00703820|3665353|FG001|Overall Study|Adverse Event|17
2081571|NCT00703820|3665352|FG000|Overall Study|Death|5
2081572|NCT00703820|3665353|FG001|Overall Study|Death|0
2081573|NCT00703820|3665352|FG000|Overall Study|Lack of Efficacy|11
2081574|NCT00703820|3665353|FG001|Overall Study|Lack of Efficacy|11
2081575|NCT00703820|3665352|FG000|Overall Study|Received non-protocol therapy|1
2081576|NCT00703820|3665353|FG001|Overall Study|Received non-protocol therapy|0
2081577|NCT00703820|3665352|FG000|Overall Study|Physician Decision|4
2081578|NCT00703820|3665353|FG001|Overall Study|Physician Decision|5
2081579|NCT00703820|3665352|FG000|Overall Study|Withdrawal by Subject|2
2081580|NCT00703820|3665353|FG001|Overall Study|Withdrawal by Subject|1
2081581|NCT00703846|3665361|FG000|Overall Study|Adverse Event|8
2081582|NCT00703846|3665361|FG000|Overall Study|Lost to Follow-up|55
2081583|NCT00703846|3665361|FG000|Overall Study|Lack of Efficacy|15
2081584|NCT00703846|3665361|FG000|Overall Study|Noncompliance with Study Treatment|2
2081585|NCT00703846|3665361|FG000|Overall Study|Withdrawal by Subject|40
2081586|NCT00703846|3665361|FG000|Overall Study|Death|1
2081587|NCT00703846|3665361|FG000|Overall Study|Other|14
2081588|NCT00703846|3665361|FG000|Overall Study|Did Not Receive Study Drug|2
2081589|NCT00703911|3665365|FG000|Overall Study|Death|1
2081590|NCT00703911|3665365|FG000|Overall Study|Physician Decision|6
2081591|NCT00703911|3665365|FG000|Overall Study|Lost to Follow-up|1
2081592|NCT00703911|3665365|FG000|Overall Study|Withdrawal by Subject|2
2081593|NCT00703924|3665371|FG000|Overall Study|Withdrawal by Subject|1
2081594|NCT00703924|3665372|FG001|Overall Study|Withdrawal by Subject|1
2081595|NCT00703963|3665393|FG000|Overall Study|Withdrawal by Subject|7
2081596|NCT00703963|3665394|FG001|Overall Study|Withdrawal by Subject|13
2081597|NCT00703963|3665393|FG000|Overall Study|Physician Decision|0
2081598|NCT00703963|3665394|FG001|Overall Study|Physician Decision|1
2081599|NCT00704132|3665422|FG000|Overall Study|Clinical Adverse Experience|1
2081600|NCT00704132|3665423|FG001|Overall Study|Clinical Adverse Experience|0
2081601|NCT00704132|3665422|FG000|Overall Study|Lack of Efficacy|0
2081602|NCT00704132|3665423|FG001|Overall Study|Lack of Efficacy|1
2177308|NCT01372410|3801373|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2081603|NCT00704132|3665422|FG000|Overall Study|Withdrawal by Subject|0
2081604|NCT00704132|3665423|FG001|Overall Study|Withdrawal by Subject|1
2081605|NCT00704171|3665431|FG000|Overall Study|Withdrawal by Subject|1
2081606|NCT00704171|3665432|FG001|Overall Study|Withdrawal by Subject|0
2081607|NCT00704184|3665443|FG000|Double-Blind Treatment|Withdrawal by Subject|1
2081608|NCT00704184|3665444|FG001|Double-Blind Treatment|Withdrawal by Subject|0
2081609|NCT00704184|3665445|FG002|Double-Blind Treatment|Withdrawal by Subject|0
2081610|NCT00704184|3665446|FG003|Double-Blind Treatment|Withdrawal by Subject|0
2081611|NCT00704184|3665447|FG004|Double-Blind Treatment|Withdrawal by Subject|0
2081612|NCT00704184|3665443|FG000|Open-Label Treatment|Adverse Event|0
2081613|NCT00704184|3665444|FG001|Open-Label Treatment|Adverse Event|0
2081614|NCT00704184|3665445|FG002|Open-Label Treatment|Adverse Event|2
2081615|NCT00704184|3665446|FG003|Open-Label Treatment|Adverse Event|0
2081616|NCT00704184|3665447|FG004|Open-Label Treatment|Adverse Event|1
2081617|NCT00704184|3665443|FG000|Open-Label Treatment|Lack of Efficacy|0
2081618|NCT00704184|3665444|FG001|Open-Label Treatment|Lack of Efficacy|2
2081619|NCT00704184|3665445|FG002|Open-Label Treatment|Lack of Efficacy|2
2081620|NCT00704184|3665446|FG003|Open-Label Treatment|Lack of Efficacy|2
2081621|NCT00704184|3665447|FG004|Open-Label Treatment|Lack of Efficacy|1
2081622|NCT00704184|3665443|FG000|Open-Label Treatment|Physician Decision|0
2081623|NCT00704184|3665444|FG001|Open-Label Treatment|Physician Decision|0
2081624|NCT00704184|3665445|FG002|Open-Label Treatment|Physician Decision|0
2081625|NCT00704184|3665446|FG003|Open-Label Treatment|Physician Decision|0
2081626|NCT00704184|3665447|FG004|Open-Label Treatment|Physician Decision|1
2081627|NCT00704184|3665443|FG000|Open-Label Treatment|Withdrawal by Subject|1
2081628|NCT00704184|3665444|FG001|Open-Label Treatment|Withdrawal by Subject|0
2081629|NCT00704184|3665445|FG002|Open-Label Treatment|Withdrawal by Subject|0
2081630|NCT00704184|3665446|FG003|Open-Label Treatment|Withdrawal by Subject|3
2081631|NCT00704184|3665447|FG004|Open-Label Treatment|Withdrawal by Subject|0
2081632|NCT00704340|3665465|FG000|Overall Study|Lost to Follow-up|2
2081633|NCT00704340|3665466|FG001|Overall Study|Lost to Follow-up|1
2081634|NCT00704340|3665465|FG000|Overall Study|Death|0
2081635|NCT00704340|3665466|FG001|Overall Study|Death|1
2081636|NCT00704405|3665497|FG000|Overall Study (NC Population)|Adverse Event|1
2081637|NCT00704405|3665498|FG001|Overall Study (NC Population)|Adverse Event|0
2081638|NCT00704405|3665499|FG002|Overall Study (NC Population)|Adverse Event|0
2081639|NCT00704405|3665500|FG003|Overall Study (NC Population)|Adverse Event|0
2081640|NCT00704405|3665501|FG004|Overall Study (NC Population)|Adverse Event|0
2081641|NCT00704405|3665497|FG000|Overall Study (NC Population)|Lost to Follow-up|2
2081642|NCT00704405|3665498|FG001|Overall Study (NC Population)|Lost to Follow-up|1
2081643|NCT00704405|3665499|FG002|Overall Study (NC Population)|Lost to Follow-up|1
2081644|NCT00704405|3665500|FG003|Overall Study (NC Population)|Lost to Follow-up|2
2081645|NCT00704405|3665501|FG004|Overall Study (NC Population)|Lost to Follow-up|2
2081646|NCT00704405|3665497|FG000|Overall Study (NC Population)|Withdrawal by Subject|2
2081647|NCT00704405|3665498|FG001|Overall Study (NC Population)|Withdrawal by Subject|3
2081648|NCT00704405|3665499|FG002|Overall Study (NC Population)|Withdrawal by Subject|2
2081649|NCT00704405|3665500|FG003|Overall Study (NC Population)|Withdrawal by Subject|2
2081650|NCT00704405|3665501|FG004|Overall Study (NC Population)|Withdrawal by Subject|2
2081651|NCT00704405|3665497|FG000|Overall Study (NC Population)|Other|0
2081652|NCT00704405|3665498|FG001|Overall Study (NC Population)|Other|0
2081653|NCT00704405|3665499|FG002|Overall Study (NC Population)|Other|0
2081654|NCT00704405|3665500|FG003|Overall Study (NC Population)|Other|0
2081655|NCT00704405|3665501|FG004|Overall Study (NC Population)|Other|1
2081656|NCT00704405|3665497|FG000|Overall Study (C Population)|Withdrawal by Subject|1
2081657|NCT00704405|3665498|FG001|Overall Study (C Population)|Withdrawal by Subject|1
2081658|NCT00704405|3665499|FG002|Overall Study (C Population)|Withdrawal by Subject|1
2081659|NCT00704405|3665500|FG003|Overall Study (C Population)|Withdrawal by Subject|1
2081660|NCT00704405|3665501|FG004|Overall Study (C Population)|Withdrawal by Subject|0
2081661|NCT00704405|3665497|FG000|Overall Study (C Population)|Lost to Follow-up|0
2081662|NCT00704405|3665498|FG001|Overall Study (C Population)|Lost to Follow-up|2
2081663|NCT00704405|3665499|FG002|Overall Study (C Population)|Lost to Follow-up|0
2081664|NCT00704405|3665500|FG003|Overall Study (C Population)|Lost to Follow-up|0
2081665|NCT00704405|3665501|FG004|Overall Study (C Population)|Lost to Follow-up|0
2081666|NCT00704418|3665521|FG000|Overall Study|Withdrawal by Subject|2
2081667|NCT00704418|3665522|FG001|Overall Study|Withdrawal by Subject|0
2081668|NCT00704418|3665521|FG000|Overall Study|Over-enrolled/surgery postponed|3
2081669|NCT00704418|3665522|FG001|Overall Study|Over-enrolled/surgery postponed|6
2081670|NCT00704522|3665530|FG000|Overall Study|Lack of Efficacy|65
2081671|NCT00704522|3665531|FG001|Overall Study|Lack of Efficacy|17
2081672|NCT00704522|3665530|FG000|Overall Study|Failure to appear again at hospital|56
2081673|NCT00704522|3665531|FG001|Overall Study|Failure to appear again at hospital|10
2081674|NCT00704522|3665530|FG000|Overall Study|Withdrawal by Subject|17
2081675|NCT00704522|3665531|FG001|Overall Study|Withdrawal by Subject|8
2081676|NCT00704522|3665530|FG000|Overall Study|Adverse Event|9
2081677|NCT00704522|3665531|FG001|Overall Study|Adverse Event|1
2081678|NCT00704522|3665530|FG000|Overall Study|Undefined causes|9
2081679|NCT00704522|3665531|FG001|Overall Study|Undefined causes|7
2081680|NCT00704522|3665530|FG000|Overall Study|No information on therapy end|27
2081681|NCT00704522|3665531|FG001|Overall Study|No information on therapy end|2
2081682|NCT00704730|3665542|FG000|Overall Study|Adverse Event|35
2081683|NCT00704730|3665543|FG001|Overall Study|Adverse Event|9
2081684|NCT00704730|3665542|FG000|Overall Study|Death|11
2081685|NCT00704730|3665543|FG001|Overall Study|Death|5
2081686|NCT00704730|3665542|FG000|Overall Study|Physician Decision|2
2081687|NCT00704730|3665543|FG001|Overall Study|Physician Decision|0
2081688|NCT00704730|3665542|FG000|Overall Study|Did not receive drug|5
2081689|NCT00704730|3665543|FG001|Overall Study|Did not receive drug|2
2081690|NCT00704730|3665542|FG000|Overall Study|Disease progression per PI|58
2081691|NCT00704730|3665543|FG001|Overall Study|Disease progression per PI|67
2081692|NCT00704730|3665542|FG000|Overall Study|data unavailable|1
2081693|NCT00704730|3665543|FG001|Overall Study|data unavailable|0
2081694|NCT00704730|3665542|FG000|Overall Study|Withdrawal by Subject|9
2081695|NCT00704730|3665543|FG001|Overall Study|Withdrawal by Subject|13
2081696|NCT00704808|3665550|FG000|Overall Study|Discontinued prior to starting treatment|14
2081697|NCT00704808|3665550|FG000|Overall Study|Death|7
2081698|NCT00704808|3665550|FG000|Overall Study|Tumor progression|80
2081699|NCT00704808|3665550|FG000|Overall Study|Patient's decision|11
2081700|NCT00704808|3665550|FG000|Overall Study|Early therapy discontinuation|16
2081701|NCT00704808|3665550|FG000|Overall Study|Adverse Event|1
2081702|NCT00704808|3665550|FG000|Overall Study|Lost to Follow-up|1
2081703|NCT00704808|3665550|FG000|Overall Study|Treatment change|1
2081704|NCT00704964|3665585|FG000|Overall Study|Not completed on time|328
2081705|NCT00705016|3665606|FG000|Overall Study|Adverse Event|6
2177309|NCT01372410|3801374|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2177310|NCT01372410|3801375|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2177311|NCT01372410|3801376|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1
2177312|NCT01372410|3801377|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2211363|NCT01659255|3851490|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0
2211364|NCT01659255|3851491|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0
2211365|NCT01659255|3851492|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0
2211366|NCT01659255|3851493|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0
2211367|NCT01659255|3851494|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0
2211368|NCT01659255|3851495|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0
2211369|NCT01659255|3851496|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0
2211370|NCT01659255|3851497|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0
2211371|NCT01659255|3851498|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0
2211372|NCT01659255|3851499|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0
2211373|NCT01659255|3851500|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1
2211374|NCT01659255|3851501|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0
2211375|NCT01659255|3851485|FG000|Overall Study|Participant Went on to Have an Allograft|0
2211376|NCT01659255|3851486|FG001|Overall Study|Participant Went on to Have an Allograft|0
2211377|NCT01659255|3851487|FG002|Overall Study|Participant Went on to Have an Allograft|0
2211378|NCT01659255|3851488|FG003|Overall Study|Participant Went on to Have an Allograft|0
2211379|NCT01659255|3851489|FG004|Overall Study|Participant Went on to Have an Allograft|0
2211380|NCT01659255|3851490|FG005|Overall Study|Participant Went on to Have an Allograft|0
2211381|NCT01659255|3851491|FG006|Overall Study|Participant Went on to Have an Allograft|0
2211382|NCT01659255|3851492|FG007|Overall Study|Participant Went on to Have an Allograft|0
2211383|NCT01659255|3851493|FG008|Overall Study|Participant Went on to Have an Allograft|0
2211384|NCT01659255|3851494|FG009|Overall Study|Participant Went on to Have an Allograft|0
2211385|NCT01659255|3851495|FG010|Overall Study|Participant Went on to Have an Allograft|0
2211386|NCT01659255|3851496|FG011|Overall Study|Participant Went on to Have an Allograft|0
2211387|NCT01659255|3851497|FG012|Overall Study|Participant Went on to Have an Allograft|1
2211388|NCT01659255|3851498|FG013|Overall Study|Participant Went on to Have an Allograft|0
2211389|NCT01659255|3851499|FG014|Overall Study|Participant Went on to Have an Allograft|0
2211390|NCT01659255|3851500|FG015|Overall Study|Participant Went on to Have an Allograft|0
2211391|NCT01659255|3851501|FG016|Overall Study|Participant Went on to Have an Allograft|0
2211392|NCT01659320|3851548|FG000|Overall Study|Withdrawal by Subject|2
2211393|NCT01659320|3851548|FG000|Overall Study|Physician Decision|1
2211394|NCT01659567|3851552|FG000|Overall Study|Lack of Efficacy|22
2211395|NCT01659567|3851552|FG000|Overall Study|Switched to Pegferon|6
2211396|NCT01659567|3851552|FG000|Overall Study|Adverse Event|12
2081706|NCT00705016|3665607|FG001|Overall Study|Adverse Event|11
2081707|NCT00705016|3665608|FG002|Overall Study|Adverse Event|10
2177313|NCT01372410|3801378|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2177314|NCT01372410|3801379|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2177315|NCT01372410|3801372|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2177316|NCT01372410|3801373|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2177317|NCT01372410|3801374|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2081708|NCT00705016|3665606|FG000|Overall Study|Death|5
2081709|NCT00705016|3665607|FG001|Overall Study|Death|7
2081710|NCT00705016|3665608|FG002|Overall Study|Death|5
2081711|NCT00705016|3665606|FG000|Overall Study|Protocol Violation|0
2081712|NCT00705016|3665607|FG001|Overall Study|Protocol Violation|1
2081713|NCT00705016|3665608|FG002|Overall Study|Protocol Violation|1
2081714|NCT00705016|3665606|FG000|Overall Study|Withdrawal by Subject|4
2081715|NCT00705016|3665607|FG001|Overall Study|Withdrawal by Subject|3
2081716|NCT00705016|3665608|FG002|Overall Study|Withdrawal by Subject|2
2081717|NCT00705016|3665606|FG000|Overall Study|Progressive Disease|33
2081718|NCT00705016|3665607|FG001|Overall Study|Progressive Disease|29
2081719|NCT00705016|3665608|FG002|Overall Study|Progressive Disease|33
2081720|NCT00705016|3665606|FG000|Overall Study|Symptomatic Deterioration|3
2081721|NCT00705016|3665607|FG001|Overall Study|Symptomatic Deterioration|1
2081722|NCT00705016|3665608|FG002|Overall Study|Symptomatic Deterioration|1
2081723|NCT00705016|3665606|FG000|Overall Study|Other|9
2081724|NCT00705016|3665607|FG001|Overall Study|Other|6
2081725|NCT00705016|3665608|FG002|Overall Study|Other|6
2106930|NCT00868790|3700228|FG009|Period 4|Adverse Event|0
2106931|NCT00868790|3700229|FG010|Period 4|Adverse Event|1
2106932|NCT00868790|3700230|FG011|Period 4|Adverse Event|0
2106933|NCT00868790|3700231|FG012|Period 4|Adverse Event|1
2106934|NCT00868790|3700232|FG013|Period 4|Adverse Event|0
2106935|NCT00868790|3700219|FG000|Period 4|Lost to Follow-up|0
2106936|NCT00868790|3700220|FG001|Period 4|Lost to Follow-up|0
2106937|NCT00868790|3700221|FG002|Period 4|Lost to Follow-up|0
2106938|NCT00868790|3700222|FG003|Period 4|Lost to Follow-up|0
2106939|NCT00868790|3700223|FG004|Period 4|Lost to Follow-up|0
2106940|NCT00868790|3700224|FG005|Period 4|Lost to Follow-up|0
2106941|NCT00868790|3700225|FG006|Period 4|Lost to Follow-up|0
2106942|NCT00868790|3700226|FG007|Period 4|Lost to Follow-up|1
2106943|NCT00868790|3700227|FG008|Period 4|Lost to Follow-up|0
2106944|NCT00868790|3700228|FG009|Period 4|Lost to Follow-up|0
2106945|NCT00868790|3700229|FG010|Period 4|Lost to Follow-up|0
2106946|NCT00868790|3700230|FG011|Period 4|Lost to Follow-up|0
2106947|NCT00868790|3700231|FG012|Period 4|Lost to Follow-up|0
2106948|NCT00868790|3700232|FG013|Period 4|Lost to Follow-up|0
2106949|NCT00868790|3700219|FG000|Period 4|Study Terminated by Sponsor|2
2106950|NCT00868790|3700220|FG001|Period 4|Study Terminated by Sponsor|0
2106951|NCT00868790|3700221|FG002|Period 4|Study Terminated by Sponsor|0
2106952|NCT00868790|3700222|FG003|Period 4|Study Terminated by Sponsor|0
2106953|NCT00868790|3700223|FG004|Period 4|Study Terminated by Sponsor|0
2106954|NCT00868790|3700224|FG005|Period 4|Study Terminated by Sponsor|0
2106955|NCT00868790|3700225|FG006|Period 4|Study Terminated by Sponsor|0
2106956|NCT00868790|3700226|FG007|Period 4|Study Terminated by Sponsor|1
2106957|NCT00868790|3700227|FG008|Period 4|Study Terminated by Sponsor|2
2106958|NCT00868790|3700228|FG009|Period 4|Study Terminated by Sponsor|0
2106959|NCT00868790|3700229|FG010|Period 4|Study Terminated by Sponsor|2
2106960|NCT00868790|3700230|FG011|Period 4|Study Terminated by Sponsor|1
2106961|NCT00868790|3700231|FG012|Period 4|Study Terminated by Sponsor|0
2106962|NCT00868790|3700232|FG013|Period 4|Study Terminated by Sponsor|1
2106963|NCT00868790|3700219|FG000|Period 4|Abnormal ALT/AST|0
2106964|NCT00868790|3700220|FG001|Period 4|Abnormal ALT/AST|0
2106965|NCT00868790|3700221|FG002|Period 4|Abnormal ALT/AST|1
2106966|NCT00868790|3700222|FG003|Period 4|Abnormal ALT/AST|0
2106967|NCT00868790|3700223|FG004|Period 4|Abnormal ALT/AST|0
2106968|NCT00868790|3700224|FG005|Period 4|Abnormal ALT/AST|0
2106969|NCT00868790|3700225|FG006|Period 4|Abnormal ALT/AST|0
2106970|NCT00868790|3700226|FG007|Period 4|Abnormal ALT/AST|0
2106971|NCT00868790|3700227|FG008|Period 4|Abnormal ALT/AST|0
2106972|NCT00868790|3700228|FG009|Period 4|Abnormal ALT/AST|0
2106973|NCT00868790|3700229|FG010|Period 4|Abnormal ALT/AST|0
2106974|NCT00868790|3700230|FG011|Period 4|Abnormal ALT/AST|0
2106975|NCT00868790|3700231|FG012|Period 4|Abnormal ALT/AST|0
2106976|NCT00868790|3700232|FG013|Period 4|Abnormal ALT/AST|0
2106977|NCT00868790|3700219|FG000|Post-study|Withdrawal by Subject|0
2106978|NCT00868790|3700220|FG001|Post-study|Withdrawal by Subject|0
2106979|NCT00868790|3700221|FG002|Post-study|Withdrawal by Subject|0
2106980|NCT00868790|3700222|FG003|Post-study|Withdrawal by Subject|0
2106981|NCT00868790|3700223|FG004|Post-study|Withdrawal by Subject|1
2106982|NCT00868790|3700224|FG005|Post-study|Withdrawal by Subject|0
2106983|NCT00868790|3700225|FG006|Post-study|Withdrawal by Subject|0
2106984|NCT00868790|3700226|FG007|Post-study|Withdrawal by Subject|0
2106985|NCT00868790|3700227|FG008|Post-study|Withdrawal by Subject|0
2106986|NCT00868790|3700228|FG009|Post-study|Withdrawal by Subject|0
2106987|NCT00868790|3700229|FG010|Post-study|Withdrawal by Subject|0
2106988|NCT00868790|3700230|FG011|Post-study|Withdrawal by Subject|0
2106989|NCT00868790|3700231|FG012|Post-study|Withdrawal by Subject|0
2106990|NCT00868790|3700232|FG013|Post-study|Withdrawal by Subject|0
2106991|NCT00868790|3700219|FG000|Post-study|Excluded Medication|0
2106992|NCT00868790|3700220|FG001|Post-study|Excluded Medication|0
2106993|NCT00868790|3700221|FG002|Post-study|Excluded Medication|0
2106994|NCT00868790|3700222|FG003|Post-study|Excluded Medication|0
2106995|NCT00868790|3700223|FG004|Post-study|Excluded Medication|0
2106996|NCT00868790|3700224|FG005|Post-study|Excluded Medication|0
2106997|NCT00868790|3700225|FG006|Post-study|Excluded Medication|0
2106998|NCT00868790|3700226|FG007|Post-study|Excluded Medication|2
2106999|NCT00868790|3700227|FG008|Post-study|Excluded Medication|0
2107000|NCT00868790|3700228|FG009|Post-study|Excluded Medication|1
2107001|NCT00868790|3700229|FG010|Post-study|Excluded Medication|0
2107002|NCT00868790|3700230|FG011|Post-study|Excluded Medication|0
2107003|NCT00868790|3700231|FG012|Post-study|Excluded Medication|0
2107004|NCT00868790|3700232|FG013|Post-study|Excluded Medication|0
2107005|NCT00869024|3700254|FG000|Overall Study|Death|2
2107006|NCT00869024|3700255|FG001|Overall Study|Death|3
2081726|NCT00705146|3665626|FG000|Overall Study|Lost to Follow-up|1
2081727|NCT00705146|3665627|FG001|Overall Study|Lost to Follow-up|1
2081728|NCT00705159|3665637|FG000|Overall Study|Withdrawal by Subject|0
2081729|NCT00705159|3665638|FG001|Overall Study|Withdrawal by Subject|1
2081730|NCT00705159|3665639|FG002|Overall Study|Withdrawal by Subject|1
2081731|NCT00705159|3665640|FG003|Overall Study|Withdrawal by Subject|1
2081732|NCT00705159|3665637|FG000|Overall Study|Protocol Violation|0
2081733|NCT00705159|3665638|FG001|Overall Study|Protocol Violation|1
2081734|NCT00705159|3665639|FG002|Overall Study|Protocol Violation|0
2081735|NCT00705159|3665640|FG003|Overall Study|Protocol Violation|0
2081736|NCT00705159|3665637|FG000|Overall Study|Adverse Event|0
2081737|NCT00705159|3665638|FG001|Overall Study|Adverse Event|0
2081738|NCT00705159|3665639|FG002|Overall Study|Adverse Event|1
2081739|NCT00705159|3665640|FG003|Overall Study|Adverse Event|0
2081740|NCT00705159|3665637|FG000|Overall Study|Lost to Follow-up|0
2081741|NCT00705159|3665638|FG001|Overall Study|Lost to Follow-up|0
2081742|NCT00705159|3665639|FG002|Overall Study|Lost to Follow-up|3
2081743|NCT00705159|3665640|FG003|Overall Study|Lost to Follow-up|2
2081744|NCT00705159|3665637|FG000|Overall Study|Screen Failure|0
2081745|NCT00705159|3665638|FG001|Overall Study|Screen Failure|0
2211397|NCT01659567|3851552|FG000|Overall Study|Good result at early stage of treatment|5
2211398|NCT01659567|3851552|FG000|Overall Study|Withdrawal by Subject|64
2211399|NCT01659567|3851552|FG000|Overall Study|Progression of the main disease|1
2211400|NCT01659567|3851552|FG000|Overall Study|Other|13
2211401|NCT01659736|3851558|FG000|Treatment Period|Adverse Event|1
2305576|NCT02673489|4006799|FG001|Follow Up Period|Unable to return for follow-up|1
2081746|NCT00705159|3665639|FG002|Overall Study|Screen Failure|0
2081747|NCT00705159|3665640|FG003|Overall Study|Screen Failure|1
2081748|NCT00705224|3665650|FG000|Overall Study|Adverse Event|1
2081749|NCT00705224|3665650|FG000|Overall Study|Lack of Efficacy|2
2081750|NCT00705224|3665650|FG000|Overall Study|Withdrawal by Subject|3
2081751|NCT00705224|3665650|FG000|Overall Study|Lost to Follow-up|5
2081752|NCT00705250|3665657|FG000|Overall Study|Withdrawal by Subject|1
2081753|NCT00705250|3665657|FG000|Overall Study|Patient died in car accident|1
2081754|NCT00705263|3665661|FG000|Overall Study|Withdrawal by Subject|2
2081755|NCT00705289|3665665|FG000|Overall Study|Subject or treating physician's choice|131
2081756|NCT00705341|3665688|FG000|Phase 2: Trial|Withdrawal by Subject|0
2081757|NCT00705341|3665689|FG001|Phase 2: Trial|Withdrawal by Subject|0
2081758|NCT00705341|3665690|FG002|Phase 2: Trial|Withdrawal by Subject|6
2081759|NCT00705341|3665691|FG003|Phase 2: Trial|Withdrawal by Subject|4
2081760|NCT00705341|3665688|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0
2081761|NCT00705341|3665689|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0
2081762|NCT00705341|3665690|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1
2081763|NCT00705341|3665691|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0
2081764|NCT00705367|3665701|FG000|Long-term Extension Period|Adverse Event|2
2081765|NCT00705367|3665702|FG001|Long-term Extension Period|Adverse Event|0
2081766|NCT00705367|3665701|FG000|Long-term Extension Period|Withdrawal by Subject|2
2081767|NCT00705367|3665702|FG001|Long-term Extension Period|Withdrawal by Subject|0
2081768|NCT00705367|3665701|FG000|Long-term Extension Period|Lack of Efficacy|1
2081769|NCT00705367|3665702|FG001|Long-term Extension Period|Lack of Efficacy|0
2081770|NCT00705367|3665701|FG000|Long-term Extension Period|No longer met study criteria|1
2081771|NCT00705367|3665702|FG001|Long-term Extension Period|No longer met study criteria|0
2081772|NCT00705367|3665701|FG000|Long-term Extension Period|Administrative reason by sponsor|3
2081773|NCT00705367|3665702|FG001|Long-term Extension Period|Administrative reason by sponsor|0
2081774|NCT00705406|3665712|FG000|Overall Study|Lost to Follow-up|3
2081775|NCT00705406|3665713|FG001|Overall Study|Lost to Follow-up|3
2081776|NCT00705406|3665712|FG000|Overall Study|Did not receive study drug|1
2081777|NCT00705406|3665713|FG001|Overall Study|Did not receive study drug|2
2081778|NCT00705432|3665726|FG000|Treatment Period|Adverse Event|45
2081779|NCT00705432|3665727|FG001|Treatment Period|Adverse Event|37
2305577|NCT02673515|4006808|FG000|Overall Study|Lack of motivation|2
2305578|NCT02673515|4006809|FG001|Overall Study|Lack of motivation|1
2305579|NCT02673619|4006828|FG000|Overall Study|Lost to Follow-up|1
2305580|NCT02673619|4006829|FG001|Overall Study|Lost to Follow-up|0
2305581|NCT02673619|4006830|FG002|Overall Study|Lost to Follow-up|0
2305582|NCT02673619|4006831|FG003|Overall Study|Lost to Follow-up|0
2305583|NCT02673619|4006828|FG000|Overall Study|Withdrawal by Subject|1
2305584|NCT02673619|4006829|FG001|Overall Study|Withdrawal by Subject|1
2305585|NCT02673619|4006830|FG002|Overall Study|Withdrawal by Subject|1
2305586|NCT02673619|4006831|FG003|Overall Study|Withdrawal by Subject|0
2305587|NCT02673619|4006828|FG000|Overall Study|Adverse Event|0
2305588|NCT02673619|4006829|FG001|Overall Study|Adverse Event|0
2305589|NCT02673619|4006830|FG002|Overall Study|Adverse Event|1
2305590|NCT02673619|4006831|FG003|Overall Study|Adverse Event|0
2305591|NCT02673619|4006828|FG000|Overall Study|Lack of Efficacy|0
2305592|NCT02673619|4006829|FG001|Overall Study|Lack of Efficacy|0
2305593|NCT02673619|4006830|FG002|Overall Study|Lack of Efficacy|1
2305594|NCT02673619|4006831|FG003|Overall Study|Lack of Efficacy|0
2081780|NCT00705432|3665728|FG002|Treatment Period|Adverse Event|51
2081781|NCT00705432|3665729|FG003|Treatment Period|Adverse Event|12
2081782|NCT00705432|3665730|FG004|Treatment Period|Adverse Event|8
2081783|NCT00705432|3665731|FG005|Treatment Period|Adverse Event|9
2081784|NCT00705432|3665726|FG000|Treatment Period|Treatment failure|92
2081785|NCT00705432|3665727|FG001|Treatment Period|Treatment failure|42
2081786|NCT00705432|3665728|FG002|Treatment Period|Treatment failure|33
2081787|NCT00705432|3665729|FG003|Treatment Period|Treatment failure|25
2081788|NCT00705432|3665730|FG004|Treatment Period|Treatment failure|13
2081789|NCT00705432|3665731|FG005|Treatment Period|Treatment failure|14
2081790|NCT00705432|3665726|FG000|Treatment Period|Non medical reason|26
2081791|NCT00705432|3665727|FG001|Treatment Period|Non medical reason|32
2081792|NCT00705432|3665728|FG002|Treatment Period|Non medical reason|37
2081793|NCT00705432|3665729|FG003|Treatment Period|Non medical reason|4
2081794|NCT00705432|3665730|FG004|Treatment Period|Non medical reason|7
2081795|NCT00705432|3665731|FG005|Treatment Period|Non medical reason|7
2081796|NCT00705432|3665726|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2
2081797|NCT00705432|3665727|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1
2081798|NCT00705432|3665728|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1
2081799|NCT00705432|3665729|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0
2081800|NCT00705432|3665730|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0
2081801|NCT00705432|3665731|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0
2081802|NCT00705432|3665726|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69
2081803|NCT00705432|3665727|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42
2081804|NCT00705432|3665728|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24
2211402|NCT01659736|3851559|FG001|Treatment Period|Adverse Event|1
2211403|NCT01659736|3851558|FG000|Treatment Period|Protocol Violation|3
2211404|NCT01659736|3851559|FG001|Treatment Period|Protocol Violation|1
2211405|NCT01659736|3851558|FG000|Treatment Period|Withdrawal by Subject|1
2211406|NCT01659736|3851559|FG001|Treatment Period|Withdrawal by Subject|0
2211407|NCT01659736|3851558|FG000|3-month Follow-up|Lost to Follow-up|0
2081805|NCT00705432|3665729|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14
2081806|NCT00705432|3665730|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6
2081807|NCT00705432|3665731|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7
2081808|NCT00705484|3665744|FG000|Overall Study|Adverse Event|28
2081809|NCT00705484|3665745|FG001|Overall Study|Adverse Event|27
2081810|NCT00705484|3665744|FG000|Overall Study|Lost to Follow-up|169
2081811|NCT00705484|3665745|FG001|Overall Study|Lost to Follow-up|250
2081812|NCT00705484|3665744|FG000|Overall Study|Withdrawal by Subject|96
2081813|NCT00705484|3665745|FG001|Overall Study|Withdrawal by Subject|72
2081814|NCT00705484|3665744|FG000|Overall Study|Administrative|89
2081815|NCT00705484|3665745|FG001|Overall Study|Administrative|59
2081816|NCT00705523|3665755|FG000|Overall Study|Lost to Follow-up|2
2081817|NCT00705523|3665756|FG001|Overall Study|Lost to Follow-up|3
2081818|NCT00705536|3665764|FG000|Start Period 1|Withdrawal by Subject|0
2081819|NCT00705536|3665765|FG001|Start Period 1|Withdrawal by Subject|0
2081820|NCT00705536|3665766|FG002|Start Period 1|Withdrawal by Subject|0
2081821|NCT00705536|3665767|FG003|Start Period 1|Withdrawal by Subject|1
2081822|NCT00705575|3665788|FG000|Overall Study|Abnormal laboratory value(s)|0
2081823|NCT00705575|3665789|FG001|Overall Study|Abnormal laboratory value(s)|3
2081824|NCT00705575|3665788|FG000|Overall Study|Abnormal test procedure result(s)|2
2081825|NCT00705575|3665789|FG001|Overall Study|Abnormal test procedure result(s)|12
2081826|NCT00705575|3665788|FG000|Overall Study|Adverse Event|11
2081827|NCT00705575|3665789|FG001|Overall Study|Adverse Event|15
2081828|NCT00705575|3665788|FG000|Overall Study|Lost to Follow-up|3
2081829|NCT00705575|3665789|FG001|Overall Study|Lost to Follow-up|4
2081830|NCT00705575|3665788|FG000|Overall Study|Protocol Violation|2
2081831|NCT00705575|3665789|FG001|Overall Study|Protocol Violation|2
2081832|NCT00705575|3665788|FG000|Overall Study|Withdrawal by Subject|5
2081833|NCT00705575|3665789|FG001|Overall Study|Withdrawal by Subject|10
2081834|NCT00705614|3665797|FG000|Initial Intervention|Adverse Event|40
2081835|NCT00705614|3665798|FG001|Initial Intervention|Adverse Event|21
2081836|NCT00705614|3665797|FG000|Initial Intervention|Lost to Follow-up|310
2081837|NCT00705614|3665798|FG001|Initial Intervention|Lost to Follow-up|191
2081838|NCT00705614|3665797|FG000|Initial Intervention|Withdrawal by Subject|114
2081839|NCT00705614|3665798|FG001|Initial Intervention|Withdrawal by Subject|71
2081840|NCT00705614|3665797|FG000|Initial Intervention|Administrative Reason|51
2081841|NCT00705614|3665798|FG001|Initial Intervention|Administrative Reason|38
2081842|NCT00705614|3665797|FG000|Initial Intervention|Status completion unknown|3
2081843|NCT00705614|3665798|FG001|Initial Intervention|Status completion unknown|0
2081844|NCT00705614|3665797|FG000|Switch to Remicade|Adverse Event|0
2081845|NCT00705614|3665798|FG001|Switch to Remicade|Adverse Event|5
2081846|NCT00705614|3665797|FG000|Switch to Remicade|Lost to Follow-up|0
2081847|NCT00705614|3665798|FG001|Switch to Remicade|Lost to Follow-up|23
2081848|NCT00705614|3665797|FG000|Switch to Remicade|Withdrawal by Subject|0
2081849|NCT00705614|3665798|FG001|Switch to Remicade|Withdrawal by Subject|12
2081850|NCT00705614|3665797|FG000|Switch to Remicade|Administrative Reason|0
2081851|NCT00705614|3665798|FG001|Switch to Remicade|Administrative Reason|9
2081852|NCT00705666|3665810|FG000|Overall Study|No post-treatment questionnaire|279
2081853|NCT00705666|3665810|FG000|Overall Study|Withdrawal by Subject|21
2081854|NCT00705666|3665810|FG000|Overall Study|Physician Decision|7
2081855|NCT00705666|3665810|FG000|Overall Study|Lost to Follow-up|5
2081856|NCT00705666|3665810|FG000|Overall Study|Death|1
2081857|NCT00705666|3665810|FG000|Overall Study|Adverse Event|4
2081858|NCT00705666|3665810|FG000|Overall Study|Other|12
2081859|NCT00705666|3665810|FG000|Overall Study|Other|2
2081860|NCT00705666|3665810|FG000|Overall Study|Lack of data|3
2081861|NCT00705666|3665810|FG000|Overall Study|Untreated|5
2081862|NCT00705679|3665819|FG000|Overall Study|Adverse Event|1
2081863|NCT00705679|3665820|FG001|Overall Study|Adverse Event|1
2081864|NCT00705679|3665821|FG002|Overall Study|Adverse Event|0
2081865|NCT00705679|3665822|FG003|Overall Study|Adverse Event|0
2081866|NCT00705679|3665823|FG004|Overall Study|Adverse Event|0
2081867|NCT00705679|3665819|FG000|Overall Study|Death|0
2081868|NCT00705679|3665820|FG001|Overall Study|Death|0
2081869|NCT00705679|3665821|FG002|Overall Study|Death|3
2081870|NCT00705679|3665822|FG003|Overall Study|Death|2
2081871|NCT00705679|3665823|FG004|Overall Study|Death|1
2081872|NCT00705679|3665819|FG000|Overall Study|Lost to Follow-up|32
2081873|NCT00705679|3665820|FG001|Overall Study|Lost to Follow-up|60
2081874|NCT00705679|3665821|FG002|Overall Study|Lost to Follow-up|44
2081875|NCT00705679|3665822|FG003|Overall Study|Lost to Follow-up|30
2081876|NCT00705679|3665823|FG004|Overall Study|Lost to Follow-up|35
2081877|NCT00705679|3665819|FG000|Overall Study|Physician Decision|0
2081878|NCT00705679|3665820|FG001|Overall Study|Physician Decision|1
2081879|NCT00705679|3665821|FG002|Overall Study|Physician Decision|0
2081880|NCT00705679|3665822|FG003|Overall Study|Physician Decision|1
2081881|NCT00705679|3665823|FG004|Overall Study|Physician Decision|0
2081882|NCT00705679|3665819|FG000|Overall Study|Withdrawal by Subject|32
2081883|NCT00705679|3665820|FG001|Overall Study|Withdrawal by Subject|77
2081884|NCT00705679|3665821|FG002|Overall Study|Withdrawal by Subject|68
2081885|NCT00705679|3665822|FG003|Overall Study|Withdrawal by Subject|47
2081886|NCT00705679|3665823|FG004|Overall Study|Withdrawal by Subject|33
2081887|NCT00705718|3665842|FG000|Overall Study|Death|6
2081888|NCT00705718|3665843|FG001|Overall Study|Death|6
2081889|NCT00705718|3665842|FG000|Overall Study|Not due for Visit|0
2081890|NCT00705718|3665843|FG001|Overall Study|Not due for Visit|12
2081891|NCT00705718|3665842|FG000|Overall Study|Follow up not done|1
2081892|NCT00705718|3665843|FG001|Overall Study|Follow up not done|4
2081893|NCT00705757|3665852|FG000|Overall Study|Lack of Efficacy|5
2081894|NCT00705757|3665853|FG001|Overall Study|Lack of Efficacy|1
2081895|NCT00705757|3665854|FG002|Overall Study|Lack of Efficacy|3
2081896|NCT00705757|3665852|FG000|Overall Study|Lost to Follow-up|7
2081897|NCT00705757|3665853|FG001|Overall Study|Lost to Follow-up|6
2081898|NCT00705757|3665854|FG002|Overall Study|Lost to Follow-up|6
2081899|NCT00705757|3665852|FG000|Overall Study|Withdrawal by Subject|1
2081900|NCT00705757|3665853|FG001|Overall Study|Withdrawal by Subject|1
2081901|NCT00705757|3665854|FG002|Overall Study|Withdrawal by Subject|2
2081902|NCT00705783|3665864|FG000|Conversion Phase|Sponsor Discontinued Study|54
2081903|NCT00705783|3665865|FG001|Conversion Phase|Sponsor Discontinued Study|0
2081904|NCT00705783|3665866|FG002|Conversion Phase|Sponsor Discontinued Study|0
2081905|NCT00705783|3665864|FG000|Conversion Phase|Lost to Follow-up|13
2081906|NCT00705783|3665865|FG001|Conversion Phase|Lost to Follow-up|0
2081907|NCT00705783|3665866|FG002|Conversion Phase|Lost to Follow-up|0
2081908|NCT00705783|3665864|FG000|Conversion Phase|Met Withdrawal Criteria|4
2081909|NCT00705783|3665865|FG001|Conversion Phase|Met Withdrawal Criteria|0
2081910|NCT00705783|3665866|FG002|Conversion Phase|Met Withdrawal Criteria|0
2081911|NCT00705783|3665864|FG000|Conversion Phase|Withdrawn by Investigator|4
2081912|NCT00705783|3665865|FG001|Conversion Phase|Withdrawn by Investigator|0
2081913|NCT00705783|3665866|FG002|Conversion Phase|Withdrawn by Investigator|0
2081914|NCT00705783|3665864|FG000|Conversion Phase|Withdrew Consent|24
2081915|NCT00705783|3665865|FG001|Conversion Phase|Withdrew Consent|0
2081916|NCT00705783|3665866|FG002|Conversion Phase|Withdrew Consent|0
2081917|NCT00705783|3665864|FG000|Conversion Phase|Protocol Deviation|2
2081918|NCT00705783|3665865|FG001|Conversion Phase|Protocol Deviation|0
2081919|NCT00705783|3665866|FG002|Conversion Phase|Protocol Deviation|0
2081920|NCT00705783|3665864|FG000|Conversion Phase|Adverse Event|11
2081921|NCT00705783|3665865|FG001|Conversion Phase|Adverse Event|0
2081922|NCT00705783|3665866|FG002|Conversion Phase|Adverse Event|0
2081923|NCT00705783|3665864|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13
2081924|NCT00705783|3665865|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
2081925|NCT00705783|3665866|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
2081926|NCT00705783|3665864|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8
2081927|NCT00705783|3665865|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
2081928|NCT00705783|3665866|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
2081929|NCT00705783|3665864|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42
2081930|NCT00705783|3665865|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0
2081931|NCT00705783|3665866|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0
2081932|NCT00705783|3665864|FG000|Oral Stabilization Phase|Lost to Follow-up|7
2081933|NCT00705783|3665865|FG001|Oral Stabilization Phase|Lost to Follow-up|0
2081934|NCT00705783|3665866|FG002|Oral Stabilization Phase|Lost to Follow-up|0
2081935|NCT00705783|3665864|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19
2081936|NCT00705783|3665865|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
2081937|NCT00705783|3665866|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
2081938|NCT00705783|3665864|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12
2081939|NCT00705783|3665865|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
2107007|NCT00869024|3700254|FG000|Overall Study|Lost to Follow-up|0
2081940|NCT00705783|3665866|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
2081941|NCT00705783|3665864|FG000|Oral Stabilization Phase|Withdrew Consent|29
2081942|NCT00705783|3665865|FG001|Oral Stabilization Phase|Withdrew Consent|0
2081943|NCT00705783|3665866|FG002|Oral Stabilization Phase|Withdrew Consent|0
2081944|NCT00705783|3665864|FG000|Oral Stabilization Phase|Adverse Event|14
2177318|NCT01372410|3801375|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2177319|NCT01372410|3801376|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2177320|NCT01372410|3801377|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2177321|NCT01372410|3801378|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
2177322|NCT01372410|3801379|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2177323|NCT01372410|3801372|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
2177324|NCT01372410|3801373|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2177325|NCT01372410|3801374|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2177326|NCT01372410|3801375|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2177327|NCT01372410|3801376|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2177328|NCT01372410|3801377|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2177329|NCT01372410|3801378|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2177330|NCT01372410|3801379|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
2081945|NCT00705783|3665865|FG001|Oral Stabilization Phase|Adverse Event|0
2081946|NCT00705783|3665866|FG002|Oral Stabilization Phase|Adverse Event|0
2081947|NCT00705783|3665864|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
2081948|NCT00705783|3665865|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
2081949|NCT00705783|3665866|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
2081950|NCT00705783|3665864|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
2081951|NCT00705783|3665865|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
2081952|NCT00705783|3665866|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
2081953|NCT00705783|3665864|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86
2081954|NCT00705783|3665865|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0
2081955|NCT00705783|3665866|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0
2081956|NCT00705783|3665864|FG000|Depot Stabilization Phase|Lost to Follow-up|11
2081957|NCT00705783|3665865|FG001|Depot Stabilization Phase|Lost to Follow-up|0
2081958|NCT00705783|3665866|FG002|Depot Stabilization Phase|Lost to Follow-up|0
2081959|NCT00705783|3665864|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8
2081960|NCT00705783|3665865|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0
2081961|NCT00705783|3665866|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0
2081962|NCT00705783|3665864|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9
2081963|NCT00705783|3665865|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0
2081964|NCT00705783|3665866|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0
2081965|NCT00705783|3665864|FG000|Depot Stabilization Phase|Withdrew Consent|29
2081966|NCT00705783|3665865|FG001|Depot Stabilization Phase|Withdrew Consent|0
2081967|NCT00705783|3665866|FG002|Depot Stabilization Phase|Withdrew Consent|0
2081968|NCT00705783|3665864|FG000|Depot Stabilization Phase|Adverse Event|17
2081969|NCT00705783|3665865|FG001|Depot Stabilization Phase|Adverse Event|0
2081970|NCT00705783|3665866|FG002|Depot Stabilization Phase|Adverse Event|0
2081971|NCT00705783|3665864|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
2081972|NCT00705783|3665865|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
2081973|NCT00705783|3665866|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
2081974|NCT00705783|3665864|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
2081975|NCT00705783|3665865|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
2081976|NCT00705783|3665866|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
2081977|NCT00705783|3665864|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0
2081978|NCT00705783|3665865|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179
2081979|NCT00705783|3665866|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58
2081980|NCT00705783|3665864|FG000|Depot Maintenance Phase|Lost to Follow-up|0
2081981|NCT00705783|3665865|FG001|Depot Maintenance Phase|Lost to Follow-up|5
2081982|NCT00705783|3665866|FG002|Depot Maintenance Phase|Lost to Follow-up|3
2081983|NCT00705783|3665864|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
2081984|NCT00705783|3665865|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2
2081985|NCT00705783|3665866|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2
2081986|NCT00705783|3665864|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
2081987|NCT00705783|3665865|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
2081988|NCT00705783|3665866|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6
2081989|NCT00705783|3665864|FG000|Depot Maintenance Phase|Withdrew Consent|0
2081990|NCT00705783|3665865|FG001|Depot Maintenance Phase|Withdrew Consent|14
2081991|NCT00705783|3665866|FG002|Depot Maintenance Phase|Withdrew Consent|4
2081992|NCT00705783|3665864|FG000|Depot Maintenance Phase|Protocol Deviation|0
2081993|NCT00705783|3665865|FG001|Depot Maintenance Phase|Protocol Deviation|2
2081994|NCT00705783|3665866|FG002|Depot Maintenance Phase|Protocol Deviation|0
2081995|NCT00705783|3665864|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
2081996|NCT00705783|3665865|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
2081997|NCT00705783|3665866|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
2081998|NCT00705783|3665864|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
2081999|NCT00705783|3665865|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
2082000|NCT00705783|3665866|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
2082001|NCT00705783|3665864|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
2082002|NCT00705783|3665865|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
2082003|NCT00705783|3665866|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
2082004|NCT00705939|3665907|FG000|Overall Study|Protocol Violation|0
2082005|NCT00705939|3665908|FG001|Overall Study|Protocol Violation|0
2082006|NCT00705939|3665909|FG002|Overall Study|Protocol Violation|1
2082007|NCT00705939|3665907|FG000|Overall Study|Withdrawal by Subject|0
2082008|NCT00705939|3665908|FG001|Overall Study|Withdrawal by Subject|1
2082009|NCT00705939|3665909|FG002|Overall Study|Withdrawal by Subject|3
2082010|NCT00705939|3665907|FG000|Overall Study|Physician Decision|0
2082011|NCT00705939|3665908|FG001|Overall Study|Physician Decision|1
2082012|NCT00705939|3665909|FG002|Overall Study|Physician Decision|0
2082013|NCT00706004|3665918|FG000|Overall Study|Did not meet eligibility criteria|2
2082014|NCT00706030|3665927|FG000|Overall Study|Disease Progression|4
2082015|NCT00706030|3665928|FG001|Overall Study|Disease Progression|6
2082016|NCT00706030|3665929|FG002|Overall Study|Disease Progression|46
2082017|NCT00706030|3665930|FG003|Overall Study|Disease Progression|12
2082018|NCT00706030|3665927|FG000|Overall Study|Adverse Event|1
2082019|NCT00706030|3665928|FG001|Overall Study|Adverse Event|0
2082020|NCT00706030|3665929|FG002|Overall Study|Adverse Event|4
2082021|NCT00706030|3665930|FG003|Overall Study|Adverse Event|2
2082022|NCT00706030|3665927|FG000|Overall Study|Withdrawal by Subject|1
2082023|NCT00706030|3665928|FG001|Overall Study|Withdrawal by Subject|0
2082024|NCT00706030|3665929|FG002|Overall Study|Withdrawal by Subject|2
2082025|NCT00706030|3665930|FG003|Overall Study|Withdrawal by Subject|0
2082026|NCT00706030|3665927|FG000|Overall Study|Physician Decision|0
2082027|NCT00706030|3665928|FG001|Overall Study|Physician Decision|0
2082028|NCT00706030|3665929|FG002|Overall Study|Physician Decision|2
2082029|NCT00706030|3665930|FG003|Overall Study|Physician Decision|0
2082030|NCT00706030|3665927|FG000|Overall Study|Not recorded|0
2082031|NCT00706030|3665928|FG001|Overall Study|Not recorded|0
2082032|NCT00706030|3665929|FG002|Overall Study|Not recorded|2
2082033|NCT00706030|3665930|FG003|Overall Study|Not recorded|0
2082034|NCT00706030|3665927|FG000|Overall Study|Protocol Violation|0
2082035|NCT00706030|3665928|FG001|Overall Study|Protocol Violation|0
2082036|NCT00706030|3665929|FG002|Overall Study|Protocol Violation|1
2082037|NCT00706030|3665930|FG003|Overall Study|Protocol Violation|1
2082038|NCT00706030|3665927|FG000|Overall Study|Failed to return|0
2082039|NCT00706030|3665928|FG001|Overall Study|Failed to return|0
2082040|NCT00706030|3665929|FG002|Overall Study|Failed to return|1
2082041|NCT00706030|3665930|FG003|Overall Study|Failed to return|0
2082042|NCT00706030|3665927|FG000|Overall Study|Symptomatic Deterioration|0
2082043|NCT00706030|3665928|FG001|Overall Study|Symptomatic Deterioration|0
2082044|NCT00706030|3665929|FG002|Overall Study|Symptomatic Deterioration|1
2082045|NCT00706030|3665930|FG003|Overall Study|Symptomatic Deterioration|0
2082046|NCT00706030|3665927|FG000|Overall Study|No treatment received|0
2082047|NCT00706030|3665928|FG001|Overall Study|No treatment received|0
2211408|NCT01659736|3851559|FG001|3-month Follow-up|Lost to Follow-up|1
2211409|NCT01659853|3851567|FG000|Washout , 3 to 7 Days|Adverse Event|1
2082048|NCT00706030|3665929|FG002|Overall Study|No treatment received|0
2082049|NCT00706030|3665930|FG003|Overall Study|No treatment received|1
2082050|NCT00706030|3665927|FG000|Overall Study|Death|0
2082051|NCT00706030|3665928|FG001|Overall Study|Death|0
2082052|NCT00706030|3665929|FG002|Overall Study|Death|1
2082053|NCT00706030|3665930|FG003|Overall Study|Death|0
2082054|NCT00706095|3665944|FG000|Overall Study|Progressive Disease|4
2082055|NCT00706095|3665945|FG001|Overall Study|Progressive Disease|5
2082056|NCT00706095|3665946|FG002|Overall Study|Progressive Disease|3
2082057|NCT00706095|3665944|FG000|Overall Study|Clinical Progression|1
2082058|NCT00706095|3665945|FG001|Overall Study|Clinical Progression|2
2082059|NCT00706095|3665946|FG002|Overall Study|Clinical Progression|2
2082060|NCT00706095|3665944|FG000|Overall Study|Withdrawal by Subject|1
2082061|NCT00706095|3665945|FG001|Overall Study|Withdrawal by Subject|0
2082062|NCT00706095|3665946|FG002|Overall Study|Withdrawal by Subject|0
2082063|NCT00706134|3665983|FG000|Overall Study|Adverse Event|8
2082064|NCT00706134|3665984|FG001|Overall Study|Adverse Event|7
2082065|NCT00706134|3665985|FG002|Overall Study|Adverse Event|2
2305595|NCT02674061|4006860|FG000|Overall Study|Death|204
2305596|NCT02674061|4006861|FG001|Overall Study|Death|69
2305597|NCT02674061|4006860|FG000|Overall Study|Lost to Follow-up|1
2305598|NCT02674061|4006861|FG001|Overall Study|Lost to Follow-up|0
2305599|NCT02674061|4006860|FG000|Overall Study|Withdrawal by Subject|9
2305600|NCT02674061|4006861|FG001|Overall Study|Withdrawal by Subject|2
2305601|NCT02674061|4006860|FG000|Overall Study|Ongoing in Study|71
2305602|NCT02674061|4006861|FG001|Overall Study|Ongoing in Study|20
2305603|NCT02674334|4006869|FG000|Overall Study|Lost to Follow-up|5
2305604|NCT02674334|4006870|FG001|Overall Study|Lost to Follow-up|3
2305605|NCT02674334|4006869|FG000|Overall Study|participant difficulty breathing|1
2082066|NCT00706134|3665986|FG003|Overall Study|Adverse Event|3
2082067|NCT00706134|3665983|FG000|Overall Study|Lost to Follow-up|0
2305606|NCT02674334|4006870|FG001|Overall Study|participant difficulty breathing|0
2211410|NCT01659853|3851568|FG001|Washout , 3 to 7 Days|Adverse Event|0
2211411|NCT01659853|3851567|FG000|Washout , 3 to 7 Days|Protocol Violation|1
2082068|NCT00706134|3665984|FG001|Overall Study|Lost to Follow-up|1
2082069|NCT00706134|3665985|FG002|Overall Study|Lost to Follow-up|0
2082070|NCT00706134|3665986|FG003|Overall Study|Lost to Follow-up|0
2082071|NCT00706134|3665983|FG000|Overall Study|Protocol Violation|0
2082072|NCT00706134|3665984|FG001|Overall Study|Protocol Violation|6
2082073|NCT00706134|3665985|FG002|Overall Study|Protocol Violation|0
2082074|NCT00706134|3665986|FG003|Overall Study|Protocol Violation|3
2082075|NCT00706134|3665983|FG000|Overall Study|Withdrawal by Subject|1
2082076|NCT00706134|3665984|FG001|Overall Study|Withdrawal by Subject|2
2082077|NCT00706134|3665985|FG002|Overall Study|Withdrawal by Subject|1
2082078|NCT00706134|3665986|FG003|Overall Study|Withdrawal by Subject|0
2082079|NCT00706134|3665983|FG000|Overall Study|Unsatisfactory therapeutic effect|9
2082080|NCT00706134|3665984|FG001|Overall Study|Unsatisfactory therapeutic effect|3
2082081|NCT00706134|3665985|FG002|Overall Study|Unsatisfactory therapeutic effect|3
2082082|NCT00706134|3665986|FG003|Overall Study|Unsatisfactory therapeutic effect|5
2082083|NCT00706134|3665983|FG000|Overall Study|Did not meet study criteria|2
2082084|NCT00706134|3665984|FG001|Overall Study|Did not meet study criteria|0
2082085|NCT00706134|3665985|FG002|Overall Study|Did not meet study criteria|0
2082086|NCT00706134|3665986|FG003|Overall Study|Did not meet study criteria|0
2082087|NCT00706238|3665996|FG000|Overall Study|Disease progression|4
2082088|NCT00706238|3665996|FG000|Overall Study|Other|1
2082089|NCT00706342|3666011|FG000|Overall Study|Adverse Event|3
2082090|NCT00706342|3666011|FG000|Overall Study|Not responding to treatment|2
2082091|NCT00706342|3666011|FG000|Overall Study|Withdrawn due to failure to respond|1
2082092|NCT00706342|3666011|FG000|Overall Study|Death|1
2082093|NCT00706342|3666011|FG000|Overall Study|Withdrew from the study on his own.|1
2082094|NCT00706342|3666011|FG000|Overall Study|Investigator discretion|2
2082095|NCT00706342|3666011|FG000|Overall Study|Non-responder Week 12|1
2082096|NCT00706342|3666011|FG000|Overall Study|Ongoing|6
2082097|NCT00706342|3666011|FG000|Overall Study|WIthdrawal of consent|1
2082098|NCT00706355|3666019|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
2082099|NCT00706355|3666020|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
2082100|NCT00706355|3666021|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
2082101|NCT00706355|3666022|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
2082102|NCT00706355|3666019|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
2082103|NCT00706355|3666020|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
2082104|NCT00706355|3666021|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
2082105|NCT00706355|3666022|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
2082106|NCT00706355|3666019|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
2082107|NCT00706355|3666020|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
2082108|NCT00706355|3666021|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
2082109|NCT00706355|3666022|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
2082110|NCT00706355|3666019|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
2082111|NCT00706355|3666020|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
2082112|NCT00706355|3666021|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
2082113|NCT00706355|3666022|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
2082114|NCT00706355|3666019|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
2082115|NCT00706355|3666020|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
2082116|NCT00706355|3666021|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
2082117|NCT00706355|3666022|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
2082118|NCT00706355|3666019|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0
2082119|NCT00706355|3666020|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0
2082120|NCT00706355|3666021|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1
2082121|NCT00706355|3666022|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0
2082122|NCT00706355|3666019|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
2082123|NCT00706355|3666020|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
2082124|NCT00706355|3666021|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
2082125|NCT00706355|3666022|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
2082126|NCT00706355|3666019|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0
2082127|NCT00706355|3666020|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0
2082128|NCT00706355|3666021|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0
2082129|NCT00706355|3666022|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2
2082130|NCT00706355|3666019|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
2082131|NCT00706355|3666020|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
2082132|NCT00706355|3666021|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
2082133|NCT00706355|3666022|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
2082134|NCT00706381|3666038|FG000|Overall Study|Lost to Follow-up|0
2082135|NCT00706381|3666039|FG001|Overall Study|Lost to Follow-up|1
2082136|NCT00706381|3666040|FG002|Overall Study|Lost to Follow-up|1
2082137|NCT00706381|3666041|FG003|Overall Study|Lost to Follow-up|0
2082138|NCT00706433|3666071|FG000|Overall Study|Lost to Follow-up|3
2082139|NCT00706433|3666072|FG001|Overall Study|Lost to Follow-up|1
2082140|NCT00706433|3666073|FG002|Overall Study|Lost to Follow-up|6
2082141|NCT00706433|3666074|FG003|Overall Study|Lost to Follow-up|0
2082142|NCT00706433|3666071|FG000|Overall Study|Withdrawal by Subject|1
2082143|NCT00706433|3666072|FG001|Overall Study|Withdrawal by Subject|2
2082144|NCT00706433|3666073|FG002|Overall Study|Withdrawal by Subject|3
2082145|NCT00706433|3666074|FG003|Overall Study|Withdrawal by Subject|1
2082146|NCT00706433|3666071|FG000|Overall Study|Adverse Event|0
2082147|NCT00706433|3666072|FG001|Overall Study|Adverse Event|0
2082148|NCT00706433|3666073|FG002|Overall Study|Adverse Event|1
2082149|NCT00706433|3666074|FG003|Overall Study|Adverse Event|0
2082150|NCT00706433|3666071|FG000|Overall Study|Protocol Violation|1
2082151|NCT00706433|3666072|FG001|Overall Study|Protocol Violation|0
2082152|NCT00706433|3666073|FG002|Overall Study|Protocol Violation|0
2082153|NCT00706433|3666074|FG003|Overall Study|Protocol Violation|0
2082154|NCT00706433|3666071|FG000|Overall Study|new job|0
2082155|NCT00706433|3666072|FG001|Overall Study|new job|0
2082156|NCT00706433|3666073|FG002|Overall Study|new job|0
2082157|NCT00706433|3666074|FG003|Overall Study|new job|1
2082158|NCT00706511|3666117|FG000|Overall Study|Withdrawal by Subject|1
2082159|NCT00706511|3666118|FG001|Overall Study|Withdrawal by Subject|0
2082160|NCT00706511|3666119|FG002|Overall Study|Withdrawal by Subject|0
2082161|NCT00706511|3666120|FG003|Overall Study|Withdrawal by Subject|0
2082162|NCT00706628|3666160|FG000|Overall Study|Other Adverse Event|16
2082163|NCT00706628|3666161|FG001|Overall Study|Other Adverse Event|5
2082164|NCT00706628|3666162|FG002|Overall Study|Other Adverse Event|5
2082165|NCT00706628|3666163|FG003|Overall Study|Other Adverse Event|2
2082166|NCT00706628|3666160|FG000|Overall Study|Non compliant with protocol|0
2082167|NCT00706628|3666161|FG001|Overall Study|Non compliant with protocol|1
2082168|NCT00706628|3666162|FG002|Overall Study|Non compliant with protocol|0
2082169|NCT00706628|3666163|FG003|Overall Study|Non compliant with protocol|0
2082170|NCT00706628|3666160|FG000|Overall Study|Consent withdrawn|6
2082171|NCT00706628|3666161|FG001|Overall Study|Consent withdrawn|1
2082172|NCT00706628|3666162|FG002|Overall Study|Consent withdrawn|3
2082173|NCT00706628|3666163|FG003|Overall Study|Consent withdrawn|0
2082174|NCT00706628|3666160|FG000|Overall Study|Progressive disease|20
2082175|NCT00706628|3666161|FG001|Overall Study|Progressive disease|13
2082176|NCT00706628|3666162|FG002|Overall Study|Progressive disease|8
2082177|NCT00706628|3666163|FG003|Overall Study|Progressive disease|1
2082178|NCT00706628|3666160|FG000|Overall Study|Other than those stated above|4
2082179|NCT00706628|3666161|FG001|Overall Study|Other than those stated above|0
2082180|NCT00706628|3666162|FG002|Overall Study|Other than those stated above|0
2082181|NCT00706628|3666163|FG003|Overall Study|Other than those stated above|0
2082182|NCT00706628|3666160|FG000|Overall Study|Not treated|1
2082183|NCT00706628|3666161|FG001|Overall Study|Not treated|1
2082184|NCT00706628|3666162|FG002|Overall Study|Not treated|0
2082185|NCT00706628|3666163|FG003|Overall Study|Not treated|0
2082186|NCT00706641|3666176|FG000|Dasatinib Administration|Withdrawal by Subject|1
2082187|NCT00706641|3666176|FG000|Dasatinib Administration|Ineligible after start of therapy|1
2082188|NCT00706641|3666176|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1
2082189|NCT00706654|3666183|FG000|Conversion Phase|Lost to Follow-up|4
2082190|NCT00706654|3666184|FG001|Conversion Phase|Lost to Follow-up|0
2082191|NCT00706654|3666185|FG002|Conversion Phase|Lost to Follow-up|0
2082192|NCT00706654|3666186|FG003|Conversion Phase|Lost to Follow-up|0
2082193|NCT00706654|3666183|FG000|Conversion Phase|Sponsor Discontinued Trial|8
2082194|NCT00706654|3666184|FG001|Conversion Phase|Sponsor Discontinued Trial|0
2082195|NCT00706654|3666185|FG002|Conversion Phase|Sponsor Discontinued Trial|0
2082196|NCT00706654|3666186|FG003|Conversion Phase|Sponsor Discontinued Trial|0
2082197|NCT00706654|3666183|FG000|Conversion Phase|Met Withdrawal Criteria|2
2082198|NCT00706654|3666184|FG001|Conversion Phase|Met Withdrawal Criteria|0
2082199|NCT00706654|3666185|FG002|Conversion Phase|Met Withdrawal Criteria|0
2082200|NCT00706654|3666186|FG003|Conversion Phase|Met Withdrawal Criteria|0
2082201|NCT00706654|3666183|FG000|Conversion Phase|Withdrawn by Investigator|14
2082202|NCT00706654|3666184|FG001|Conversion Phase|Withdrawn by Investigator|0
2082203|NCT00706654|3666185|FG002|Conversion Phase|Withdrawn by Investigator|0
2082204|NCT00706654|3666186|FG003|Conversion Phase|Withdrawn by Investigator|0
2082205|NCT00706654|3666183|FG000|Conversion Phase|Withdrew Consent|38
2082206|NCT00706654|3666184|FG001|Conversion Phase|Withdrew Consent|0
2082207|NCT00706654|3666185|FG002|Conversion Phase|Withdrew Consent|0
2082208|NCT00706654|3666186|FG003|Conversion Phase|Withdrew Consent|0
2082209|NCT00706654|3666183|FG000|Conversion Phase|Adverse Event|18
2082210|NCT00706654|3666184|FG001|Conversion Phase|Adverse Event|0
2082211|NCT00706654|3666185|FG002|Conversion Phase|Adverse Event|0
2082212|NCT00706654|3666186|FG003|Conversion Phase|Adverse Event|0
2082213|NCT00706654|3666183|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9
2082214|NCT00706654|3666184|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
2082215|NCT00706654|3666185|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
2082216|NCT00706654|3666186|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0
2082217|NCT00706654|3666183|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2
2082218|NCT00706654|3666184|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
2082219|NCT00706654|3666185|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
2082220|NCT00706654|3666186|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0
2082221|NCT00706654|3666183|FG000|Oral Stabilization Phase|Lost to Follow-up|17
2082222|NCT00706654|3666184|FG001|Oral Stabilization Phase|Lost to Follow-up|0
2082223|NCT00706654|3666185|FG002|Oral Stabilization Phase|Lost to Follow-up|0
2305607|NCT02674334|4006869|FG000|Overall Study|NIRS not recording|1
2305608|NCT02674334|4006870|FG001|Overall Study|NIRS not recording|0
2305609|NCT02674386|4006879|FG000|Overall Study|Lost to Follow-up|0
2082224|NCT00706654|3666186|FG003|Oral Stabilization Phase|Lost to Follow-up|0
2082225|NCT00706654|3666183|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19
2082226|NCT00706654|3666184|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0
2082227|NCT00706654|3666185|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0
2082228|NCT00706654|3666186|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0
2082229|NCT00706654|3666183|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15
2082230|NCT00706654|3666184|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
2082231|NCT00706654|3666185|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
2082232|NCT00706654|3666186|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0
2082233|NCT00706654|3666183|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21
2082234|NCT00706654|3666184|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
2082235|NCT00706654|3666185|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
2082236|NCT00706654|3666186|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0
2082237|NCT00706654|3666183|FG000|Oral Stabilization Phase|Withdrew consent|55
2082238|NCT00706654|3666184|FG001|Oral Stabilization Phase|Withdrew consent|0
2082239|NCT00706654|3666185|FG002|Oral Stabilization Phase|Withdrew consent|0
2082240|NCT00706654|3666186|FG003|Oral Stabilization Phase|Withdrew consent|0
2082241|NCT00706654|3666183|FG000|Oral Stabilization Phase|Protocol Deviation|2
2082242|NCT00706654|3666184|FG001|Oral Stabilization Phase|Protocol Deviation|0
2082243|NCT00706654|3666185|FG002|Oral Stabilization Phase|Protocol Deviation|0
2082244|NCT00706654|3666186|FG003|Oral Stabilization Phase|Protocol Deviation|0
2082245|NCT00706654|3666183|FG000|Oral Stabilization Phase|Adverse Event|21
2082246|NCT00706654|3666184|FG001|Oral Stabilization Phase|Adverse Event|0
2082247|NCT00706654|3666185|FG002|Oral Stabilization Phase|Adverse Event|0
2082248|NCT00706654|3666186|FG003|Oral Stabilization Phase|Adverse Event|0
2082249|NCT00706654|3666183|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
2082250|NCT00706654|3666184|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
2082251|NCT00706654|3666185|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
2082252|NCT00706654|3666186|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
2082253|NCT00706654|3666183|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
2082254|NCT00706654|3666184|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
2082255|NCT00706654|3666185|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
2082256|NCT00706654|3666186|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
2082257|NCT00706654|3666183|FG000|Depot Maintenance Phase|Lost to Follow-up|0
2082258|NCT00706654|3666184|FG001|Depot Maintenance Phase|Lost to Follow-up|4
2082259|NCT00706654|3666185|FG002|Depot Maintenance Phase|Lost to Follow-up|10
2082260|NCT00706654|3666186|FG003|Depot Maintenance Phase|Lost to Follow-up|6
2082261|NCT00706654|3666183|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
2082262|NCT00706654|3666184|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4
2082263|NCT00706654|3666185|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6
2082264|NCT00706654|3666186|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5
2082265|NCT00706654|3666183|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
2082266|NCT00706654|3666184|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
2082267|NCT00706654|3666185|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12
2082268|NCT00706654|3666186|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8
2082269|NCT00706654|3666183|FG000|Depot Maintenance Phase|Withdrew Consent|0
2082270|NCT00706654|3666184|FG001|Depot Maintenance Phase|Withdrew Consent|21
2082271|NCT00706654|3666185|FG002|Depot Maintenance Phase|Withdrew Consent|29
2082272|NCT00706654|3666186|FG003|Depot Maintenance Phase|Withdrew Consent|14
2082273|NCT00706654|3666183|FG000|Depot Maintenance Phase|Protocol Deviation|0
2082274|NCT00706654|3666184|FG001|Depot Maintenance Phase|Protocol Deviation|2
2082275|NCT00706654|3666185|FG002|Depot Maintenance Phase|Protocol Deviation|3
2082276|NCT00706654|3666186|FG003|Depot Maintenance Phase|Protocol Deviation|1
2082277|NCT00706654|3666183|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
2082278|NCT00706654|3666184|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
2082279|NCT00706654|3666185|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
2082280|NCT00706654|3666186|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
2082281|NCT00706654|3666183|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
2082282|NCT00706654|3666184|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
2082283|NCT00706654|3666185|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
2082284|NCT00706654|3666186|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
2082285|NCT00706654|3666183|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
2082286|NCT00706654|3666184|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
2082287|NCT00706654|3666185|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
2082288|NCT00706654|3666186|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
2082289|NCT00706706|3666196|FG000|Overall Study|Death|53
2082290|NCT00706706|3666196|FG000|Overall Study|Lost to Follow-up|7
2082291|NCT00706706|3666196|FG000|Overall Study|Study endpoint had reached|45
2082292|NCT00706849|3666245|FG000|Treatment Period|Adverse Event|0
2082293|NCT00706849|3666246|FG001|Treatment Period|Adverse Event|9
2305610|NCT02674386|4006880|FG001|Overall Study|Lost to Follow-up|1
2082294|NCT00706849|3666245|FG000|Treatment Period|Other|0
2082295|NCT00706849|3666246|FG001|Treatment Period|Other|1
2082296|NCT00706849|3666245|FG000|Follow-up Period|Withdrawal by Subject|0
2082297|NCT00706849|3666246|FG001|Follow-up Period|Withdrawal by Subject|2
2082298|NCT00706849|3666245|FG000|Follow-up Period|Protocol non-compliance|0
2082299|NCT00706849|3666246|FG001|Follow-up Period|Protocol non-compliance|1
2082300|NCT00706901|3666255|FG000|Overall Study|Lost to Follow-up|2
2082301|NCT00706901|3666256|FG001|Overall Study|Lost to Follow-up|3
2082302|NCT00706901|3666257|FG002|Overall Study|Lost to Follow-up|2
2082303|NCT00706901|3666255|FG000|Overall Study|Withdrawal by Subject|4
2082304|NCT00706901|3666256|FG001|Overall Study|Withdrawal by Subject|2
2082305|NCT00706901|3666257|FG002|Overall Study|Withdrawal by Subject|5
2082306|NCT00706901|3666255|FG000|Overall Study|In Jail|1
2082307|NCT00706901|3666256|FG001|Overall Study|In Jail|0
2082308|NCT00706901|3666257|FG002|Overall Study|In Jail|1
2082309|NCT00706901|3666255|FG000|Overall Study|Death|1
2082310|NCT00706901|3666256|FG001|Overall Study|Death|0
2082311|NCT00706901|3666257|FG002|Overall Study|Death|0
2082312|NCT00706914|3666269|FG000|Overall Study|Lack of Efficacy|0
2082313|NCT00706914|3666270|FG001|Overall Study|Lack of Efficacy|1
2082314|NCT00706914|3666271|FG002|Overall Study|Lack of Efficacy|0
2082315|NCT00706914|3666269|FG000|Overall Study|Lost to Follow-up|1
2082316|NCT00706914|3666270|FG001|Overall Study|Lost to Follow-up|0
2082317|NCT00706914|3666271|FG002|Overall Study|Lost to Follow-up|0
2082318|NCT00706914|3666269|FG000|Overall Study|Adverse Event|2
2082319|NCT00706914|3666270|FG001|Overall Study|Adverse Event|2
2082320|NCT00706914|3666271|FG002|Overall Study|Adverse Event|0
2082321|NCT00706914|3666269|FG000|Overall Study|Protocol Violation|3
2082322|NCT00706914|3666270|FG001|Overall Study|Protocol Violation|1
2082323|NCT00706914|3666271|FG002|Overall Study|Protocol Violation|1
2082324|NCT00706966|3666279|FG000|Overall Study|Adverse Event|1
2082325|NCT00706992|3666327|FG000|Overall Study|Study termination|5
2082326|NCT00706992|3666328|FG001|Overall Study|Study termination|5
2082327|NCT00706992|3666329|FG002|Overall Study|Study termination|6
2082328|NCT00706992|3666330|FG003|Overall Study|Study termination|2
2082329|NCT00706992|3666331|FG004|Overall Study|Study termination|3
2082330|NCT00706992|3666332|FG005|Overall Study|Study termination|2
2082331|NCT00706992|3666333|FG006|Overall Study|Study termination|3
2082332|NCT00706992|3666327|FG000|Overall Study|Disease progression before treatment|0
2082333|NCT00706992|3666328|FG001|Overall Study|Disease progression before treatment|0
2082334|NCT00706992|3666329|FG002|Overall Study|Disease progression before treatment|0
2082335|NCT00706992|3666330|FG003|Overall Study|Disease progression before treatment|0
2082336|NCT00706992|3666331|FG004|Overall Study|Disease progression before treatment|1
2082337|NCT00706992|3666332|FG005|Overall Study|Disease progression before treatment|0
2082338|NCT00706992|3666333|FG006|Overall Study|Disease progression before treatment|0
2082339|NCT00707031|3666352|FG000|Overall Study|Adverse Event|45
2082340|NCT00707031|3666353|FG001|Overall Study|Adverse Event|45
2082341|NCT00707031|3666352|FG000|Overall Study|Lack of Efficacy|19
2082342|NCT00707031|3666353|FG001|Overall Study|Lack of Efficacy|6
2082343|NCT00707031|3666352|FG000|Overall Study|Lost to Follow-up|2
2082344|NCT00707031|3666353|FG001|Overall Study|Lost to Follow-up|1
2082345|NCT00707031|3666352|FG000|Overall Study|Protocol Violation|1
2082346|NCT00707031|3666353|FG001|Overall Study|Protocol Violation|0
2082347|NCT00707031|3666352|FG000|Overall Study|Withdrawal by Subject|7
2082348|NCT00707031|3666353|FG001|Overall Study|Withdrawal by Subject|8
2082349|NCT00707031|3666352|FG000|Overall Study|Poor Compliance to Protocol|7
2082350|NCT00707031|3666353|FG001|Overall Study|Poor Compliance to Protocol|13
2082351|NCT00707031|3666352|FG000|Overall Study|Familial or Personal Reasons|12
2082352|NCT00707031|3666353|FG001|Overall Study|Familial or Personal Reasons|15
2082353|NCT00707031|3666352|FG000|Overall Study|Serious Noncompliance|2
2082354|NCT00707031|3666353|FG001|Overall Study|Serious Noncompliance|3
2082355|NCT00707031|3666352|FG000|Overall Study|Sponsor Decision|9
2082356|NCT00707031|3666353|FG001|Overall Study|Sponsor Decision|8
2082357|NCT00707057|3666362|FG000|Overall Study|Withdrawal by Subject|8
2082358|NCT00707057|3666363|FG001|Overall Study|Withdrawal by Subject|3
2082359|NCT00707057|3666362|FG000|Overall Study|Dosed incorrectly|0
2082360|NCT00707057|3666363|FG001|Overall Study|Dosed incorrectly|1
2082361|NCT00707174|3666371|FG000|Overall Study|Adverse Event|1
2082362|NCT00707174|3666372|FG001|Overall Study|Adverse Event|6
2082363|NCT00707174|3666371|FG000|Overall Study|Withdrawal by Subject|4
2082364|NCT00707174|3666372|FG001|Overall Study|Withdrawal by Subject|1
2082365|NCT00707239|3666381|FG000|Overall Study|Adverse Event|5
2082366|NCT00707239|3666382|FG001|Overall Study|Adverse Event|3
2082367|NCT00707239|3666383|FG002|Overall Study|Adverse Event|2
2082368|NCT00707239|3666381|FG000|Overall Study|Death|3
2082369|NCT00707239|3666382|FG001|Overall Study|Death|1
2082370|NCT00707239|3666383|FG002|Overall Study|Death|3
2082371|NCT00707239|3666381|FG000|Overall Study|Physician Decision|1
2082372|NCT00707239|3666382|FG001|Overall Study|Physician Decision|1
2082373|NCT00707239|3666383|FG002|Overall Study|Physician Decision|2
2082374|NCT00707239|3666381|FG000|Overall Study|Protocol Violation|0
2082375|NCT00707239|3666382|FG001|Overall Study|Protocol Violation|0
2082376|NCT00707239|3666383|FG002|Overall Study|Protocol Violation|1
2082377|NCT00707239|3666381|FG000|Overall Study|Lack of Efficacy|1
2082378|NCT00707239|3666382|FG001|Overall Study|Lack of Efficacy|2
2082379|NCT00707239|3666383|FG002|Overall Study|Lack of Efficacy|0
2082380|NCT00707239|3666381|FG000|Overall Study|Randomized, but not treated|1
2082381|NCT00707239|3666382|FG001|Overall Study|Randomized, but not treated|1
2082382|NCT00707239|3666383|FG002|Overall Study|Randomized, but not treated|1
2082383|NCT00707239|3666381|FG000|Overall Study|Other|8
2211412|NCT01659853|3851568|FG001|Washout , 3 to 7 Days|Protocol Violation|0
2082384|NCT00707239|3666382|FG001|Overall Study|Other|3
2082385|NCT00707239|3666383|FG002|Overall Study|Other|5
2082386|NCT00707486|3666407|FG000|Overall Study|Withdrawal by Subject|1
2082387|NCT00707577|3666415|FG000|Overall Study|Withdrawal by Subject|3
2082388|NCT00707577|3666416|FG001|Overall Study|Withdrawal by Subject|2
2082389|NCT00707577|3666415|FG000|Overall Study|Lost to Follow-up|34
2082390|NCT00707577|3666416|FG001|Overall Study|Lost to Follow-up|25
2082391|NCT00707577|3666415|FG000|Overall Study|Left employment|13
2082392|NCT00707577|3666416|FG001|Overall Study|Left employment|10
2082393|NCT00707577|3666415|FG000|Overall Study|Pregnancy|4
2082394|NCT00707577|3666416|FG001|Overall Study|Pregnancy|1
2082395|NCT00707746|3666435|FG000|Treatment Period|Adverse Event|2
2082396|NCT00707746|3666436|FG001|Treatment Period|Adverse Event|4
2082397|NCT00707746|3666435|FG000|Treatment Period|Ineligibility|0
2082398|NCT00707746|3666436|FG001|Treatment Period|Ineligibility|1
2082399|NCT00707954|3666469|FG000|Overall Study|Physician Decision|0
2082400|NCT00707954|3666470|FG001|Overall Study|Physician Decision|0
2082401|NCT00707954|3666471|FG002|Overall Study|Physician Decision|0
2082402|NCT00707954|3666472|FG003|Overall Study|Physician Decision|0
2082403|NCT00707954|3666473|FG004|Overall Study|Physician Decision|1
2107008|NCT00869024|3700255|FG001|Overall Study|Lost to Follow-up|1
2107009|NCT00869024|3700254|FG000|Overall Study|Protocol Violation|0
2107010|NCT00869024|3700255|FG001|Overall Study|Protocol Violation|1
2107011|NCT00869050|3700261|FG000|Overall Study|Screen Failure|3
2107012|NCT00869089|3700265|FG000|Overall Study|Lost to Follow-up|1
2107013|NCT00869089|3700265|FG000|Overall Study|Withdrawal by Subject|1
2107014|NCT00869089|3700265|FG000|Overall Study|Screen Fail|1
2107015|NCT00869323|3700306|FG000|Maintenance Therapy|concurrent illness|1
2107016|NCT00869362|3700321|FG000|Overall Study|Death|0
2107017|NCT00869362|3700322|FG001|Overall Study|Death|2
2107018|NCT00869362|3700321|FG000|Overall Study|Lost to Follow-up|1
2107019|NCT00869362|3700322|FG001|Overall Study|Lost to Follow-up|3
2107020|NCT00869401|3700343|FG000|Overall Study|Withdrawal by Subject|0
2107021|NCT00869401|3700344|FG001|Overall Study|Withdrawal by Subject|0
2107022|NCT00869401|3700345|FG002|Overall Study|Withdrawal by Subject|0
2107023|NCT00869401|3700346|FG003|Overall Study|Withdrawal by Subject|5
2107024|NCT00869401|3700347|FG004|Overall Study|Withdrawal by Subject|3
2107025|NCT00869440|3700363|FG000|Overall Study|Withdrawal by Subject|1
2107026|NCT00869440|3700364|FG001|Overall Study|Withdrawal by Subject|0
2107027|NCT00869440|3700365|FG002|Overall Study|Withdrawal by Subject|0
2107028|NCT00869440|3700366|FG003|Overall Study|Withdrawal by Subject|0
2107029|NCT00869440|3700363|FG000|Overall Study|Physician Decision|1
2107030|NCT00869440|3700364|FG001|Overall Study|Physician Decision|1
2107031|NCT00869440|3700365|FG002|Overall Study|Physician Decision|0
2107032|NCT00869440|3700366|FG003|Overall Study|Physician Decision|0
2107033|NCT00869518|3700378|FG000|Overall Study|Lost to Follow-up|1
2107034|NCT00869518|3700379|FG001|Overall Study|Lost to Follow-up|1
2107035|NCT00869557|3700387|FG000|Randomized Phase|Lost to Follow-up|2
2107036|NCT00869557|3700388|FG001|Randomized Phase|Lost to Follow-up|1
2107037|NCT00869557|3700387|FG000|Randomized Phase|Investigator's Discretion|1
2107038|NCT00869557|3700388|FG001|Randomized Phase|Investigator's Discretion|0
2107039|NCT00869557|3700387|FG000|Randomized Phase|Withdrew Consent|0
2107040|NCT00869557|3700388|FG001|Randomized Phase|Withdrew Consent|1
2107041|NCT00869557|3700387|FG000|Extension Phase|Adverse Event|2
2107042|NCT00869557|3700388|FG001|Extension Phase|Adverse Event|2
2107043|NCT00869557|3700387|FG000|Extension Phase|Lack of Efficacy|1
2107044|NCT00869557|3700388|FG001|Extension Phase|Lack of Efficacy|0
2107045|NCT00869557|3700387|FG000|Extension Phase|Lost to Follow-up|3
2107046|NCT00869557|3700388|FG001|Extension Phase|Lost to Follow-up|1
2107047|NCT00869557|3700387|FG000|Extension Phase|Investigator's Discretion|2
2107048|NCT00869557|3700388|FG001|Extension Phase|Investigator's Discretion|0
2107049|NCT00869557|3700387|FG000|Extension Phase|Withdrew Consent|2
2107050|NCT00869557|3700388|FG001|Extension Phase|Withdrew Consent|0
2107051|NCT00869778|3700417|FG000|Overall Study|Adverse Event|2
2107052|NCT00869778|3700418|FG001|Overall Study|Adverse Event|0
2107053|NCT00869778|3700419|FG002|Overall Study|Adverse Event|0
2107054|NCT00869778|3700417|FG000|Overall Study|Withdrawal by Subject|3
2107055|NCT00869778|3700418|FG001|Overall Study|Withdrawal by Subject|4
2107056|NCT00869778|3700419|FG002|Overall Study|Withdrawal by Subject|5
2107057|NCT00869778|3700417|FG000|Overall Study|Pregnancy|1
2107058|NCT00869778|3700418|FG001|Overall Study|Pregnancy|0
2107059|NCT00869778|3700419|FG002|Overall Study|Pregnancy|0
2107060|NCT00869778|3700417|FG000|Overall Study|Protocol Violation|5
2107061|NCT00869778|3700418|FG001|Overall Study|Protocol Violation|3
2107062|NCT00869778|3700419|FG002|Overall Study|Protocol Violation|5
2107063|NCT00869778|3700417|FG000|Overall Study|Unblinding|1
2107064|NCT00869778|3700418|FG001|Overall Study|Unblinding|0
2107065|NCT00869778|3700419|FG002|Overall Study|Unblinding|0
2107066|NCT00869960|3700448|FG000|Overall Study|Lost to Follow-up|2
2107067|NCT00869999|3700452|FG000|Overall Study|Withdrawal by Subject|1
2107068|NCT00869999|3700452|FG000|Overall Study|removed prior to starting therapy|1
2107069|NCT00870103|3700456|FG000|Overall Study|Physician Decision|2
2211413|NCT01659996|3851588|FG000|Overall Study|Protocol Violation|3
2082404|NCT00707980|3666498|FG000|Overall Study|Adverse Event|49
2082405|NCT00707980|3666498|FG000|Overall Study|Lack of Efficacy|35
2082406|NCT00707980|3666498|FG000|Overall Study|Non-Compliance with Study Drug|28
2082407|NCT00707980|3666498|FG000|Overall Study|Protocol Deviations|19
2082408|NCT00707980|3666498|FG000|Overall Study|Withdrawal of Consent|81
2082409|NCT00707980|3666498|FG000|Overall Study|Lost to Follow-up|59
2082410|NCT00707980|3666498|FG000|Overall Study|Other|39
2082411|NCT00707993|3666504|FG000|Overall Study|Adverse Event|16
2082412|NCT00707993|3666505|FG001|Overall Study|Adverse Event|20
2082413|NCT00707993|3666504|FG000|Overall Study|Protocol Violation|4
2082414|NCT00707993|3666505|FG001|Overall Study|Protocol Violation|7
2082415|NCT00707993|3666504|FG000|Overall Study|Lost to Follow-up|0
2082416|NCT00707993|3666505|FG001|Overall Study|Lost to Follow-up|4
2082417|NCT00707993|3666504|FG000|Overall Study|Withdrawal by Subject|12
2082418|NCT00707993|3666505|FG001|Overall Study|Withdrawal by Subject|16
2082419|NCT00707993|3666504|FG000|Overall Study|Hyperglycemic Rescue|55
2082420|NCT00707993|3666505|FG001|Overall Study|Hyperglycemic Rescue|47
2082421|NCT00707993|3666504|FG000|Overall Study|Other|2
2082422|NCT00707993|3666505|FG001|Overall Study|Other|0
2082423|NCT00708032|3666522|FG000|Overall Study|Adverse Event|0
2082424|NCT00708032|3666523|FG001|Overall Study|Adverse Event|2
2082425|NCT00708032|3666522|FG000|Overall Study|Lost to Follow-up|1
2082426|NCT00708032|3666523|FG001|Overall Study|Lost to Follow-up|2
2082427|NCT00708032|3666522|FG000|Overall Study|Pregnancy|0
2082428|NCT00708032|3666523|FG001|Overall Study|Pregnancy|1
2082429|NCT00708032|3666522|FG000|Overall Study|Poor vision|0
2082430|NCT00708032|3666523|FG001|Overall Study|Poor vision|6
2082431|NCT00708032|3666522|FG000|Overall Study|Visit out of range at month 12|4
2082432|NCT00708032|3666523|FG001|Overall Study|Visit out of range at month 12|1
2082433|NCT00708032|3666522|FG000|Overall Study|Did not meet protocol criteria|1
2082434|NCT00708032|3666523|FG001|Overall Study|Did not meet protocol criteria|2
2082435|NCT00708032|3666522|FG000|Overall Study|Protocol Violation|4
2082436|NCT00708032|3666523|FG001|Overall Study|Protocol Violation|1
2082437|NCT00708032|3666522|FG000|Overall Study|Withdrawal by Subject|0
2082438|NCT00708032|3666523|FG001|Overall Study|Withdrawal by Subject|1
2082439|NCT00708097|3666563|FG000|Period 1|Protocol Violation|0
2082440|NCT00708097|3666564|FG001|Period 1|Protocol Violation|1
2082441|NCT00708097|3666565|FG002|Period 1|Protocol Violation|0
2082442|NCT00708097|3666566|FG003|Period 1|Protocol Violation|2
2082443|NCT00708097|3666567|FG004|Period 1|Protocol Violation|0
2082444|NCT00708097|3666563|FG000|Period 1|Other Reason|0
2082445|NCT00708097|3666564|FG001|Period 1|Other Reason|0
2082446|NCT00708097|3666565|FG002|Period 1|Other Reason|0
2082447|NCT00708097|3666566|FG003|Period 1|Other Reason|0
2082448|NCT00708097|3666567|FG004|Period 1|Other Reason|1
2082449|NCT00708097|3666563|FG000|Period 2|Protocol Violation|0
2082450|NCT00708097|3666564|FG001|Period 2|Protocol Violation|1
2082451|NCT00708097|3666565|FG002|Period 2|Protocol Violation|1
2082452|NCT00708097|3666566|FG003|Period 2|Protocol Violation|1
2082453|NCT00708097|3666567|FG004|Period 2|Protocol Violation|0
2082454|NCT00708123|3666601|FG000|Period 1|Protocol Violation|0
2082455|NCT00708123|3666602|FG001|Period 1|Protocol Violation|1
2082456|NCT00708123|3666603|FG002|Period 1|Protocol Violation|0
2082457|NCT00708123|3666604|FG003|Period 1|Protocol Violation|1
2082458|NCT00708123|3666605|FG004|Period 1|Protocol Violation|0
2082459|NCT00708123|3666601|FG000|Period 1|Adverse Event|0
2082460|NCT00708123|3666602|FG001|Period 1|Adverse Event|0
2082461|NCT00708123|3666603|FG002|Period 1|Adverse Event|1
2082462|NCT00708123|3666604|FG003|Period 1|Adverse Event|0
2082463|NCT00708123|3666605|FG004|Period 1|Adverse Event|0
2082464|NCT00708123|3666601|FG000|Period 2|Protocol Violation|0
2082465|NCT00708123|3666602|FG001|Period 2|Protocol Violation|0
2082466|NCT00708123|3666603|FG002|Period 2|Protocol Violation|0
2082467|NCT00708123|3666604|FG003|Period 2|Protocol Violation|1
2082468|NCT00708123|3666605|FG004|Period 2|Protocol Violation|0
2082469|NCT00708123|3666601|FG000|Period 2|Other Reason|1
2082470|NCT00708123|3666602|FG001|Period 2|Other Reason|0
2082471|NCT00708123|3666603|FG002|Period 2|Other Reason|0
2082472|NCT00708123|3666604|FG003|Period 2|Other Reason|0
2082473|NCT00708123|3666605|FG004|Period 2|Other Reason|0
2082474|NCT00708123|3666601|FG000|Period 3|Lost to Follow-up|0
2082475|NCT00708123|3666602|FG001|Period 3|Lost to Follow-up|0
2082476|NCT00708123|3666603|FG002|Period 3|Lost to Follow-up|1
2082477|NCT00708123|3666604|FG003|Period 3|Lost to Follow-up|1
2082478|NCT00708123|3666605|FG004|Period 3|Lost to Follow-up|0
2082479|NCT00708123|3666601|FG000|Period 4|Protocol Violation|0
2082480|NCT00708123|3666602|FG001|Period 4|Protocol Violation|1
2082481|NCT00708123|3666603|FG002|Period 4|Protocol Violation|0
2082482|NCT00708123|3666604|FG003|Period 4|Protocol Violation|0
2082483|NCT00708123|3666605|FG004|Period 4|Protocol Violation|0
2082484|NCT00708162|3666623|FG000|Randomized Phase|Randomized but Not Treated|7
2082485|NCT00708162|3666624|FG001|Randomized Phase|Randomized but Not Treated|5
2082486|NCT00708162|3666623|FG000|Randomized Phase|Participant Noncompliance|40
2082487|NCT00708162|3666624|FG001|Randomized Phase|Participant Noncompliance|32
2082488|NCT00708162|3666623|FG000|Randomized Phase|Lost to Follow-up|34
2082489|NCT00708162|3666624|FG001|Randomized Phase|Lost to Follow-up|34
2082490|NCT00708162|3666623|FG000|Randomized Phase|Withdrew Consent|31
2082491|NCT00708162|3666624|FG001|Randomized Phase|Withdrew Consent|22
2082492|NCT00708162|3666623|FG000|Randomized Phase|Lack of Efficacy|14
2082493|NCT00708162|3666624|FG001|Randomized Phase|Lack of Efficacy|19
2082494|NCT00708162|3666623|FG000|Randomized Phase|Protocol Violation|10
2082495|NCT00708162|3666624|FG001|Randomized Phase|Protocol Violation|11
2082496|NCT00708162|3666623|FG000|Randomized Phase|Adverse Event|8
2082497|NCT00708162|3666624|FG001|Randomized Phase|Adverse Event|12
2082498|NCT00708162|3666623|FG000|Randomized Phase|Investigator's Discretion|7
2082499|NCT00708162|3666624|FG001|Randomized Phase|Investigator's Discretion|10
2082500|NCT00708162|3666623|FG000|Randomized Phase|Death|2
2082501|NCT00708162|3666624|FG001|Randomized Phase|Death|9
2082502|NCT00708162|3666623|FG000|Randomized Phase|Pregnancy|3
2082503|NCT00708162|3666624|FG001|Randomized Phase|Pregnancy|0
2082504|NCT00708162|3666623|FG000|Open-Label Phase|Lost to Follow-up|10
2082505|NCT00708162|3666624|FG001|Open-Label Phase|Lost to Follow-up|8
2082506|NCT00708162|3666623|FG000|Open-Label Phase|Withdrew Consent|12
2082507|NCT00708162|3666624|FG001|Open-Label Phase|Withdrew Consent|6
2082508|NCT00708162|3666623|FG000|Open-Label Phase|Participant Noncompliance|7
2082509|NCT00708162|3666624|FG001|Open-Label Phase|Participant Noncompliance|7
2082510|NCT00708162|3666623|FG000|Open-Label Phase|Lack of Efficacy|7
2082511|NCT00708162|3666624|FG001|Open-Label Phase|Lack of Efficacy|4
2082512|NCT00708162|3666623|FG000|Open-Label Phase|Investigator's Discretion|3
2082513|NCT00708162|3666624|FG001|Open-Label Phase|Investigator's Discretion|2
2082514|NCT00708162|3666623|FG000|Open-Label Phase|Death|3
2082515|NCT00708162|3666624|FG001|Open-Label Phase|Death|1
2082516|NCT00708162|3666623|FG000|Open-Label Phase|Adverse Event|1
2082517|NCT00708162|3666624|FG001|Open-Label Phase|Adverse Event|2
2082518|NCT00708162|3666623|FG000|Open-Label Phase|Other|1
2082519|NCT00708162|3666624|FG001|Open-Label Phase|Other|0
2082520|NCT00708175|3666633|FG000|Overall Study|Adverse Event|4
2082521|NCT00708175|3666634|FG001|Overall Study|Adverse Event|5
2082522|NCT00708175|3666633|FG000|Overall Study|Protocol Violation|2
2082523|NCT00708175|3666634|FG001|Overall Study|Protocol Violation|3
2082524|NCT00708175|3666633|FG000|Overall Study|Lost to Follow-up|5
2082525|NCT00708175|3666634|FG001|Overall Study|Lost to Follow-up|3
2082526|NCT00708175|3666633|FG000|Overall Study|Withdrawal by Subject|5
2082527|NCT00708175|3666634|FG001|Overall Study|Withdrawal by Subject|7
2082528|NCT00708175|3666633|FG000|Overall Study|BMD loss >7%|2
2082529|NCT00708175|3666634|FG001|Overall Study|BMD loss >7%|3
2082530|NCT00708201|3666642|FG000|Overall Study|Adverse Event|4
2082531|NCT00708201|3666643|FG001|Overall Study|Adverse Event|4
2082532|NCT00708201|3666642|FG000|Overall Study|Withdrawal by Subject|1
2082533|NCT00708201|3666643|FG001|Overall Study|Withdrawal by Subject|1
2082534|NCT00708201|3666642|FG000|Overall Study|Lost to Follow-up|2
2082535|NCT00708201|3666643|FG001|Overall Study|Lost to Follow-up|0
2082536|NCT00708201|3666642|FG000|Overall Study|Protocol Violation|0
2082537|NCT00708201|3666643|FG001|Overall Study|Protocol Violation|1
2082538|NCT00708214|3666652|FG000|Overall Study|Other Adverse Event|3
2082539|NCT00708214|3666653|FG001|Overall Study|Other Adverse Event|6
2082540|NCT00708214|3666654|FG002|Overall Study|Other Adverse Event|2
2082541|NCT00708214|3666652|FG000|Overall Study|Other|0
2082542|NCT00708214|3666653|FG001|Overall Study|Other|1
2082543|NCT00708214|3666654|FG002|Overall Study|Other|1
2082544|NCT00708214|3666652|FG000|Overall Study|Progressive Disease|4
2082545|NCT00708214|3666653|FG001|Overall Study|Progressive Disease|6
2082546|NCT00708214|3666654|FG002|Overall Study|Progressive Disease|5
2082547|NCT00708227|3666671|FG000|Overall Study|Physician Decision|0
2082548|NCT00708227|3666672|FG001|Overall Study|Physician Decision|3
2082549|NCT00708227|3666673|FG002|Overall Study|Physician Decision|1
2082550|NCT00708227|3666674|FG003|Overall Study|Physician Decision|2
2082551|NCT00708227|3666671|FG000|Overall Study|Withdrawal by Subject|1
2082552|NCT00708227|3666672|FG001|Overall Study|Withdrawal by Subject|2
2082553|NCT00708227|3666673|FG002|Overall Study|Withdrawal by Subject|0
2082554|NCT00708227|3666674|FG003|Overall Study|Withdrawal by Subject|1
2082555|NCT00708305|3666704|FG000|Period 1|Protocol Violation|1
2082556|NCT00708305|3666705|FG001|Period 1|Protocol Violation|0
2082557|NCT00708305|3666706|FG002|Period 1|Protocol Violation|1
2082558|NCT00708305|3666707|FG003|Period 1|Protocol Violation|0
2082559|NCT00708305|3666704|FG000|Period 1|Other Reason|0
2082560|NCT00708305|3666705|FG001|Period 1|Other Reason|0
2082561|NCT00708305|3666706|FG002|Period 1|Other Reason|0
2082562|NCT00708305|3666707|FG003|Period 1|Other Reason|2
2082563|NCT00708305|3666704|FG000|Period 2|Lost to Follow-up|0
2082564|NCT00708305|3666705|FG001|Period 2|Lost to Follow-up|1
2082565|NCT00708305|3666706|FG002|Period 2|Lost to Follow-up|0
2082566|NCT00708305|3666707|FG003|Period 2|Lost to Follow-up|0
2082567|NCT00708305|3666704|FG000|Period 2|Protocol Violation|0
2082568|NCT00708305|3666705|FG001|Period 2|Protocol Violation|1
2082569|NCT00708305|3666706|FG002|Period 2|Protocol Violation|0
2082570|NCT00708305|3666707|FG003|Period 2|Protocol Violation|0
2082571|NCT00708305|3666704|FG000|Period 2|Other Reason|1
2082572|NCT00708305|3666705|FG001|Period 2|Other Reason|0
2082573|NCT00708305|3666706|FG002|Period 2|Other Reason|0
2082574|NCT00708305|3666707|FG003|Period 2|Other Reason|1
2082575|NCT00708305|3666704|FG000|Period 3|Protocol Violation|0
2082576|NCT00708305|3666705|FG001|Period 3|Protocol Violation|2
2082577|NCT00708305|3666706|FG002|Period 3|Protocol Violation|0
2082578|NCT00708305|3666707|FG003|Period 3|Protocol Violation|0
2082579|NCT00708305|3666704|FG000|Period 3|Other Reason|1
2082580|NCT00708305|3666705|FG001|Period 3|Other Reason|0
2082581|NCT00708305|3666706|FG002|Period 3|Other Reason|0
2082582|NCT00708305|3666707|FG003|Period 3|Other Reason|0
2082583|NCT00708422|3666722|FG000|Overall Study|Adverse Event|3
2082584|NCT00708422|3666723|FG001|Overall Study|Adverse Event|1
2082585|NCT00708422|3666722|FG000|Overall Study|Withdrawal by Subject|1
2082586|NCT00708422|3666723|FG001|Overall Study|Withdrawal by Subject|0
2082587|NCT00708435|3666731|FG000|Overall Study|Death / Serious Adverse Event|10
2082588|NCT00708435|3666732|FG001|Overall Study|Death / Serious Adverse Event|5
2082589|NCT00708435|3666731|FG000|Overall Study|Lost to Follow-up|9
2082590|NCT00708435|3666732|FG001|Overall Study|Lost to Follow-up|4
2082591|NCT00708435|3666731|FG000|Overall Study|Withdrawal by Subject|3
2082592|NCT00708435|3666732|FG001|Overall Study|Withdrawal by Subject|7
2082593|NCT00708435|3666731|FG000|Overall Study|Adverse Event|1
2082594|NCT00708435|3666732|FG001|Overall Study|Adverse Event|0
2082595|NCT00708435|3666731|FG000|Overall Study|Protocol Violation|0
2082596|NCT00708435|3666732|FG001|Overall Study|Protocol Violation|1
2082597|NCT00708435|3666731|FG000|Overall Study|Intervention by primary care physician|1
2082598|NCT00708435|3666732|FG001|Overall Study|Intervention by primary care physician|0
2082599|NCT00708435|3666731|FG000|Overall Study|Refused hospitalization|1
2082600|NCT00708435|3666732|FG001|Overall Study|Refused hospitalization|0
2082601|NCT00708461|3666742|FG000|Overall Study|Lost to Follow-up|18
2082602|NCT00708461|3666743|FG001|Overall Study|Lost to Follow-up|11
2082603|NCT00708461|3666742|FG000|Overall Study|Withdrawal by Subject|8
2082604|NCT00708461|3666743|FG001|Overall Study|Withdrawal by Subject|9
2082605|NCT00708461|3666742|FG000|Overall Study|left workforce|115
2082606|NCT00708461|3666743|FG001|Overall Study|left workforce|180
2082607|NCT00708500|3666752|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
2082608|NCT00708500|3666753|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
2082609|NCT00708500|3666754|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
2082610|NCT00708500|3666752|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
2082611|NCT00708500|3666753|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
2082612|NCT00708500|3666754|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
2082613|NCT00708500|3666752|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
2082614|NCT00708500|3666753|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
2082615|NCT00708500|3666754|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
2082616|NCT00708500|3666752|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
2082617|NCT00708500|3666753|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
2082618|NCT00708500|3666754|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
2082619|NCT00708500|3666752|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
2082620|NCT00708500|3666753|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
2082621|NCT00708500|3666754|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
2082622|NCT00708500|3666752|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
2082623|NCT00708500|3666753|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
2082624|NCT00708500|3666754|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
2082625|NCT00708500|3666752|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
2082626|NCT00708500|3666753|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
2082627|NCT00708500|3666754|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
2082628|NCT00708500|3666752|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
2082629|NCT00708500|3666753|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
2082630|NCT00708500|3666754|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
2082631|NCT00708500|3666752|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
2082632|NCT00708500|3666753|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
2082633|NCT00708500|3666754|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
2082634|NCT00708500|3666752|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
2082635|NCT00708500|3666753|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
2082636|NCT00708500|3666754|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
2082637|NCT00708500|3666752|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
2082638|NCT00708500|3666753|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
2082639|NCT00708500|3666754|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
2082640|NCT00708500|3666752|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
2082641|NCT00708500|3666753|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
2082642|NCT00708500|3666754|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
2082643|NCT00708500|3666752|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
2082644|NCT00708500|3666753|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
2082645|NCT00708500|3666754|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
2082646|NCT00708500|3666752|FG000|FOLLOWUP|Adverse Event|0
2082647|NCT00708500|3666753|FG001|FOLLOWUP|Adverse Event|1
2082648|NCT00708500|3666754|FG002|FOLLOWUP|Adverse Event|0
2082649|NCT00708500|3666752|FG000|FOLLOWUP|Lost to Follow-up|1
2082650|NCT00708500|3666753|FG001|FOLLOWUP|Lost to Follow-up|6
2082651|NCT00708500|3666754|FG002|FOLLOWUP|Lost to Follow-up|4
2082652|NCT00708500|3666752|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3
2082653|NCT00708500|3666753|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4
2082654|NCT00708500|3666754|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5
2082655|NCT00708500|3666752|FG000|FOLLOWUP|Subject withdrew consent|31
2082656|NCT00708500|3666753|FG001|FOLLOWUP|Subject withdrew consent|4
2082657|NCT00708500|3666754|FG002|FOLLOWUP|Subject withdrew consent|5
2082658|NCT00708500|3666752|FG000|FOLLOWUP|Non-compliance with protocol|5
2082659|NCT00708500|3666753|FG001|FOLLOWUP|Non-compliance with protocol|0
2082660|NCT00708500|3666754|FG002|FOLLOWUP|Non-compliance with protocol|1
2082661|NCT00708552|3666775|FG000|Overall Study|Adverse Event|10
2082662|NCT00708552|3666776|FG001|Overall Study|Adverse Event|3
2082663|NCT00708552|3666777|FG002|Overall Study|Adverse Event|4
2082664|NCT00708552|3666778|FG003|Overall Study|Adverse Event|6
2082665|NCT00708552|3666775|FG000|Overall Study|Lack of Efficacy|0
2177331|NCT01372410|3801372|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0
2177332|NCT01372410|3801373|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0
2177333|NCT01372410|3801374|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0
2177334|NCT01372410|3801375|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0
2177335|NCT01372410|3801376|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1
2177336|NCT01372410|3801377|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0
2082666|NCT00708552|3666776|FG001|Overall Study|Lack of Efficacy|4
2082667|NCT00708552|3666777|FG002|Overall Study|Lack of Efficacy|1
2082668|NCT00708552|3666778|FG003|Overall Study|Lack of Efficacy|0
2082669|NCT00708552|3666775|FG000|Overall Study|Protocol Violation|0
2082670|NCT00708552|3666776|FG001|Overall Study|Protocol Violation|0
2082671|NCT00708552|3666777|FG002|Overall Study|Protocol Violation|2
2082672|NCT00708552|3666778|FG003|Overall Study|Protocol Violation|4
2082673|NCT00708552|3666775|FG000|Overall Study|Lost to Follow-up|4
2082674|NCT00708552|3666776|FG001|Overall Study|Lost to Follow-up|2
2082675|NCT00708552|3666777|FG002|Overall Study|Lost to Follow-up|0
2082676|NCT00708552|3666778|FG003|Overall Study|Lost to Follow-up|1
2082677|NCT00708552|3666775|FG000|Overall Study|Physician Decision|1
2082678|NCT00708552|3666776|FG001|Overall Study|Physician Decision|2
2082679|NCT00708552|3666777|FG002|Overall Study|Physician Decision|0
2082680|NCT00708552|3666778|FG003|Overall Study|Physician Decision|0
2082681|NCT00708552|3666775|FG000|Overall Study|Withdrawal by Subject|12
2082682|NCT00708552|3666776|FG001|Overall Study|Withdrawal by Subject|7
2082683|NCT00708552|3666777|FG002|Overall Study|Withdrawal by Subject|8
2082684|NCT00708552|3666778|FG003|Overall Study|Withdrawal by Subject|10
2082685|NCT00708643|3666794|FG000|Overall Study|Adverse Event|0
2082686|NCT00708643|3666795|FG001|Overall Study|Adverse Event|1
2082687|NCT00708682|3666801|FG000|Infant Series|Adverse Event|1
2082688|NCT00708682|3666801|FG000|Infant Series|Lost to Follow-up|4
2082689|NCT00708682|3666801|FG000|Infant Series|Protocol Violation|1
2082690|NCT00708682|3666801|FG000|Infant Series|Parent/legal guardian request|6
2082691|NCT00708682|3666801|FG000|Infant Series|Failed to return|2
2082692|NCT00708682|3666801|FG000|Infant Series|Other|19
2082693|NCT00708682|3666801|FG000|After Infant Series|Parent/Legal Guardian Request|1
2082694|NCT00708682|3666801|FG000|Toddler Dose|Parent/Legal Guardian Request|1
2082695|NCT00708682|3666801|FG000|Toddler Dose|Lost to Follow-up|3
2082696|NCT00708682|3666801|FG000|Toddler Dose|Failed to Return|4
2082697|NCT00708708|3666807|FG000|Overall Study|Another therapy instead of Enbrel|141
2082698|NCT00708708|3666807|FG000|Overall Study|Lost to Follow-up|52
2082699|NCT00708708|3666807|FG000|Overall Study|Withdrawal by Subject|51
2082700|NCT00708708|3666807|FG000|Overall Study|Intolerance|42
2082701|NCT00708708|3666807|FG000|Overall Study|Another therapy along with Enbrel|15
2082702|NCT00708708|3666807|FG000|Overall Study|Other unspecified|11
2082703|NCT00708708|3666807|FG000|Overall Study|Good effectiveness|9
2082704|NCT00708708|3666807|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9
2082705|NCT00708708|3666807|FG000|Overall Study|Administrative reasons|7
2082706|NCT00708708|3666807|FG000|Overall Study|Lack of effectiveness|4
2082707|NCT00708708|3666807|FG000|Overall Study|Lack of compliance|3
2082708|NCT00708708|3666807|FG000|Overall Study|Pregnancy|3
2082709|NCT00708708|3666807|FG000|Overall Study|Adverse Event|3
2082710|NCT00708708|3666807|FG000|Overall Study|Missing values|392
2082711|NCT00709059|3666859|FG000|Overall Study|Lost to Follow-up|34
2082712|NCT00709059|3666859|FG000|Overall Study|Withdrawal by Subject|19
2082713|NCT00709059|3666859|FG000|Overall Study|Physician Decision|7
2082714|NCT00709059|3666859|FG000|Overall Study|Disease complication|3
2082715|NCT00709059|3666859|FG000|Overall Study|Side effects|20
2082716|NCT00709059|3666859|FG000|Overall Study|Serious side effects|11
2107070|NCT00870103|3700456|FG000|Overall Study|Lost to Follow-up|2
2107071|NCT00870194|3700462|FG000|Overall Study|Adverse Event|10
2107072|NCT00870194|3700463|FG001|Overall Study|Adverse Event|5
2107073|NCT00870194|3700462|FG000|Overall Study|Lack of Efficacy|0
2107074|NCT00870194|3700463|FG001|Overall Study|Lack of Efficacy|1
2107075|NCT00870194|3700462|FG000|Overall Study|Lost to Follow-up|2
2107076|NCT00870194|3700463|FG001|Overall Study|Lost to Follow-up|0
2107077|NCT00870194|3700462|FG000|Overall Study|Physician Decision|3
2107078|NCT00870194|3700463|FG001|Overall Study|Physician Decision|1
2107079|NCT00870194|3700462|FG000|Overall Study|Protocol Violation|3
2107080|NCT00870194|3700463|FG001|Overall Study|Protocol Violation|3
2107081|NCT00870194|3700462|FG000|Overall Study|Entry Criteria Not Met|1
2107082|NCT00870194|3700463|FG001|Overall Study|Entry Criteria Not Met|2
2107083|NCT00870194|3700462|FG000|Overall Study|Subject Decision|7
2107084|NCT00870194|3700463|FG001|Overall Study|Subject Decision|2
2082717|NCT00709098|3666866|FG000|Double-blind Period|Withdrawal of consent|3
2082718|NCT00709098|3666867|FG001|Double-blind Period|Withdrawal of consent|3
2082719|NCT00709098|3666868|FG002|Double-blind Period|Withdrawal of consent|0
2082720|NCT00709098|3666866|FG000|Double-blind Period|Administrative reason|1
2082721|NCT00709098|3666867|FG001|Double-blind Period|Administrative reason|3
2082722|NCT00709098|3666868|FG002|Double-blind Period|Administrative reason|0
2082723|NCT00709098|3666866|FG000|Double-blind Period|Death|1
2082724|NCT00709098|3666867|FG001|Double-blind Period|Death|1
2082725|NCT00709098|3666868|FG002|Double-blind Period|Death|0
2082726|NCT00709098|3666866|FG000|Double-blind Period|Lost to Follow-up|1
2082727|NCT00709098|3666867|FG001|Double-blind Period|Lost to Follow-up|1
2082728|NCT00709098|3666868|FG002|Double-blind Period|Lost to Follow-up|0
2082729|NCT00709098|3666866|FG000|Open-label Period|Withdrawal of consent|0
2082730|NCT00709098|3666867|FG001|Open-label Period|Withdrawal of consent|0
2082731|NCT00709098|3666868|FG002|Open-label Period|Withdrawal of consent|7
2082732|NCT00709098|3666866|FG000|Open-label Period|Administrative reason|0
2211414|NCT01659996|3851589|FG001|Overall Study|Protocol Violation|3
2211415|NCT01659996|3851590|FG002|Overall Study|Protocol Violation|3
2211416|NCT01659996|3851588|FG000|Overall Study|Lost to Follow-up|1
2211417|NCT01659996|3851589|FG001|Overall Study|Lost to Follow-up|3
2211418|NCT01659996|3851590|FG002|Overall Study|Lost to Follow-up|2
2211419|NCT01659996|3851588|FG000|Overall Study|Adverse Event|0
2211420|NCT01659996|3851589|FG001|Overall Study|Adverse Event|0
2211421|NCT01659996|3851590|FG002|Overall Study|Adverse Event|1
2211422|NCT01659996|3851588|FG000|Overall Study|Withdrawal by Subject|4
2211423|NCT01659996|3851589|FG001|Overall Study|Withdrawal by Subject|1
2211424|NCT01659996|3851590|FG002|Overall Study|Withdrawal by Subject|5
2211425|NCT01660022|3851606|FG000|First Sequence (7 Days)|Withdrawal by Subject|0
2211426|NCT01660022|3851607|FG001|First Sequence (7 Days)|Withdrawal by Subject|1
2211427|NCT01660022|3851608|FG002|First Sequence (7 Days)|Withdrawal by Subject|0
2211428|NCT01660022|3851609|FG003|First Sequence (7 Days)|Withdrawal by Subject|1
2211429|NCT01660022|3851610|FG004|First Sequence (7 Days)|Withdrawal by Subject|0
2211430|NCT01660022|3851611|FG005|First Sequence (7 Days)|Withdrawal by Subject|0
2211431|NCT01660022|3851606|FG000|First Sequence (7 Days)|Adverse Event|0
2211432|NCT01660022|3851607|FG001|First Sequence (7 Days)|Adverse Event|0
2211433|NCT01660022|3851608|FG002|First Sequence (7 Days)|Adverse Event|0
2211434|NCT01660022|3851609|FG003|First Sequence (7 Days)|Adverse Event|0
2211435|NCT01660022|3851610|FG004|First Sequence (7 Days)|Adverse Event|1
2211436|NCT01660022|3851611|FG005|First Sequence (7 Days)|Adverse Event|3
2211437|NCT01660022|3851606|FG000|First Sequence (7 Days)|Protocol Violation|0
2211438|NCT01660022|3851607|FG001|First Sequence (7 Days)|Protocol Violation|0
2211439|NCT01660022|3851608|FG002|First Sequence (7 Days)|Protocol Violation|0
2211440|NCT01660022|3851609|FG003|First Sequence (7 Days)|Protocol Violation|0
2211441|NCT01660022|3851610|FG004|First Sequence (7 Days)|Protocol Violation|0
2211442|NCT01660022|3851611|FG005|First Sequence (7 Days)|Protocol Violation|1
2211443|NCT01660256|3851703|FG000|Overall Study|Adverse Event|4
2211444|NCT01660256|3851704|FG001|Overall Study|Adverse Event|0
2211445|NCT01660256|3851705|FG002|Overall Study|Adverse Event|2
2211446|NCT01660256|3851703|FG000|Overall Study|Withdrawal by Subject|1
2211447|NCT01660256|3851704|FG001|Overall Study|Withdrawal by Subject|0
2211448|NCT01660256|3851705|FG002|Overall Study|Withdrawal by Subject|2
2211449|NCT01660334|3851717|FG000|Overall Study|Lost to Follow-up|1
2211450|NCT01660412|3851721|FG000|Overall Study|Protocol Violation|0
2211451|NCT01660412|3851722|FG001|Overall Study|Protocol Violation|3
2211452|NCT01660711|3851742|FG000|Overall Study|Adverse Event|7
2211453|NCT01660711|3851742|FG000|Overall Study|Withdrawal by Subject|1
2211454|NCT01660763|3851752|FG000|Overall Study|Lack of Efficacy|45
2211455|NCT01660763|3851753|FG001|Overall Study|Lack of Efficacy|50
2305611|NCT02674386|4006881|FG002|Overall Study|Lost to Follow-up|1
2305612|NCT02674386|4006879|FG000|Overall Study|Withdrawal by Subject|0
2082733|NCT00709098|3666867|FG001|Open-label Period|Administrative reason|0
2082734|NCT00709098|3666868|FG002|Open-label Period|Administrative reason|5
2082735|NCT00709098|3666866|FG000|Open-label Period|Death|0
2082736|NCT00709098|3666867|FG001|Open-label Period|Death|0
2082737|NCT00709098|3666868|FG002|Open-label Period|Death|1
2082738|NCT00709098|3666866|FG000|Open-label Period|Lost to Follow-up|0
2082739|NCT00709098|3666867|FG001|Open-label Period|Lost to Follow-up|0
2082740|NCT00709098|3666868|FG002|Open-label Period|Lost to Follow-up|1
2082741|NCT00709111|3666877|FG000|Overall Study|Withdrawal by Subject|1
2082742|NCT00709111|3666877|FG000|Overall Study|Unable to attend clinic visits|1
2082743|NCT00709124|3666883|FG000|Overall Study|Death|3
2082744|NCT00709124|3666884|FG001|Overall Study|Death|1
2082745|NCT00709124|3666883|FG000|Overall Study|encephalopathy; can't do assessment|1
2082746|NCT00709124|3666884|FG001|Overall Study|encephalopathy; can't do assessment|0
2082747|NCT00709202|3666896|FG000|Overall Study|Withdrawal by Subject|6
2082748|NCT00709202|3666897|FG001|Overall Study|Withdrawal by Subject|6
2082749|NCT00709228|3666904|FG000|Overall Study|Not treated|14
2082750|NCT00709228|3666904|FG000|Overall Study|Eligibility criteria not met|281
2082751|NCT00709228|3666904|FG000|Overall Study|Adverse events|2
2082752|NCT00709228|3666904|FG000|Overall Study|Discontinued treatment|14
2082753|NCT00709228|3666904|FG000|Overall Study|Did not enter follow-up|4
2211456|NCT01660763|3851752|FG000|Overall Study|Adverse Event|22
2211457|NCT01660763|3851753|FG001|Overall Study|Adverse Event|7
2082754|NCT00709228|3666904|FG000|Overall Study|Discontinued follow-up|5
2082755|NCT00709228|3666904|FG000|Overall Study|Disease progression|1
2082756|NCT00709228|3666904|FG000|Overall Study|Lost to Follow-up|6
2082757|NCT00709228|3666904|FG000|Overall Study|Non-compliance|5
2082758|NCT00709319|3666925|FG000|Overall Study|Death|4
2082759|NCT00709319|3666925|FG000|Overall Study|Withdrawal by Subject|2
2082760|NCT00709592|3666931|FG000|Overall Study|Unable to proceed to transplant|0
2082761|NCT00709592|3666932|FG001|Overall Study|Unable to proceed to transplant|1
2082762|NCT00709618|3666938|FG000|Overall Study|Withdrawal by Subject|4
2082763|NCT00709618|3666938|FG000|Overall Study|Lost to Follow-up|1
2082764|NCT00709618|3666938|FG000|Overall Study|Study Closed/Terminated|25
2082765|NCT00709722|3666951|FG000|Overall Study|Adverse Event|1
2082766|NCT00709735|3666957|FG000|Overall Study|Lost to Follow-up|1
2082767|NCT00709735|3666958|FG001|Overall Study|Lost to Follow-up|1
2082768|NCT00709735|3666957|FG000|Overall Study|Relapse into Opioid Abuse|0
2082769|NCT00709735|3666958|FG001|Overall Study|Relapse into Opioid Abuse|1
2082770|NCT00709735|3666957|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2
2082771|NCT00709735|3666958|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0
2082772|NCT00709761|3666964|FG000|Overall Study|Withdrawal by Subject|8
2082773|NCT00709761|3666964|FG000|Overall Study|study closed/terminated|17
2082774|NCT00709761|3666964|FG000|Overall Study|Lost to Follow-up|2
2082775|NCT00709852|3666977|FG000|Period 1|Adverse Event|2
2082776|NCT00709852|3666978|FG001|Period 1|Adverse Event|0
2082777|NCT00709852|3666977|FG000|Period 1|Withdrawal by Subject|4
2082778|NCT00709852|3666978|FG001|Period 1|Withdrawal by Subject|2
2082779|NCT00709852|3666977|FG000|Period 1|Protocol Violation|1
2082780|NCT00709852|3666978|FG001|Period 1|Protocol Violation|0
2082781|NCT00709852|3666977|FG000|Period 1|Defective scanner|0
2082782|NCT00709852|3666978|FG001|Period 1|Defective scanner|1
2082783|NCT00709852|3666977|FG000|Period 1|Lost to Follow-up|1
2082784|NCT00709852|3666978|FG001|Period 1|Lost to Follow-up|0
2082785|NCT00709852|3666977|FG000|Period 2|Protocol Violation|4
2082786|NCT00709852|3666978|FG001|Period 2|Protocol Violation|1
2082787|NCT00709852|3666977|FG000|Period 2|Adverse Event|1
2082788|NCT00709852|3666978|FG001|Period 2|Adverse Event|1
2082789|NCT00709852|3666977|FG000|Period 2|Lost to Follow-up|1
2082790|NCT00709852|3666978|FG001|Period 2|Lost to Follow-up|0
2082791|NCT00709852|3666977|FG000|Period 2|No 72-hour follow-up|3
2082792|NCT00709852|3666978|FG001|Period 2|No 72-hour follow-up|0
2082793|NCT00709956|3667016|FG000|Overall Study|Withdrawal by Subject|1
2082794|NCT00709956|3667017|FG001|Overall Study|Withdrawal by Subject|1
2082795|NCT00709956|3667016|FG000|Overall Study|Inclusion/exclusion criteria violation|2
2082796|NCT00709956|3667017|FG001|Overall Study|Inclusion/exclusion criteria violation|3
2082797|NCT00709995|3667027|FG000|Overall Study|Adverse Event|4
2082798|NCT00709995|3667028|FG001|Overall Study|Adverse Event|2
2082799|NCT00709995|3667027|FG000|Overall Study|Withdrawal by Subject|1
2082800|NCT00709995|3667028|FG001|Overall Study|Withdrawal by Subject|3
2082801|NCT00710021|3667040|FG000|Overall Study|Lost to Follow-up|1
2082802|NCT00710021|3667041|FG001|Overall Study|Lost to Follow-up|0
2082803|NCT00710021|3667042|FG002|Overall Study|Lost to Follow-up|0
2082804|NCT00710021|3667040|FG000|Overall Study|Subject's Decision|0
2082805|NCT00710021|3667041|FG001|Overall Study|Subject's Decision|1
2082806|NCT00710021|3667042|FG002|Overall Study|Subject's Decision|0
2082807|NCT00710021|3667040|FG000|Overall Study|Subject misrandomized|0
2082808|NCT00710021|3667041|FG001|Overall Study|Subject misrandomized|1
2082809|NCT00710021|3667042|FG002|Overall Study|Subject misrandomized|1
2082810|NCT00710021|3667040|FG000|Overall Study|Physician Decision|0
2082811|NCT00710021|3667041|FG001|Overall Study|Physician Decision|1
2082812|NCT00710021|3667042|FG002|Overall Study|Physician Decision|0
2082813|NCT00710034|3667053|FG000|Completed 6 Weeks of Treatment|Adverse Event|5
2082814|NCT00710034|3667054|FG001|Completed 6 Weeks of Treatment|Adverse Event|12
2082815|NCT00710034|3667053|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12
2082816|NCT00710034|3667054|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8
2082817|NCT00710034|3667053|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15
2082818|NCT00710034|3667054|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17
2082819|NCT00710034|3667053|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2
2082820|NCT00710034|3667054|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6
2082821|NCT00710034|3667053|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
2082822|NCT00710034|3667054|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
2082823|NCT00710034|3667053|FG000|Completed 6 Weeks of Treatment|Physician Decision|1
2082824|NCT00710034|3667054|FG001|Completed 6 Weeks of Treatment|Physician Decision|0
2082825|NCT00710034|3667053|FG000|Completed 12 Weeks of Treatment|Adverse Event|0
2082826|NCT00710034|3667054|FG001|Completed 12 Weeks of Treatment|Adverse Event|1
2082827|NCT00710034|3667053|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0
2082828|NCT00710034|3667054|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2
2082829|NCT00710034|3667053|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5
2082830|NCT00710034|3667054|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5
2082831|NCT00710034|3667053|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
2082832|NCT00710034|3667054|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
2082833|NCT00710034|3667053|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
2082834|NCT00710034|3667054|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
2082835|NCT00710385|3667070|FG000|Overall Study|Did not qualify|1
2082836|NCT00710385|3667070|FG000|Overall Study|Withdrawal by Subject|1
2082837|NCT00710385|3667070|FG000|Overall Study|Undisclosed back pain|1
2082838|NCT00710385|3667070|FG000|Overall Study|Physician Decision|1
2082839|NCT00710385|3667070|FG000|Overall Study|Undisclosed excessive methadone use|1
2082840|NCT00710424|3667082|FG000|Overall Study|Adverse Event|30
2082841|NCT00710424|3667083|FG001|Overall Study|Adverse Event|12
2082842|NCT00710424|3667082|FG000|Overall Study|Lack of Efficacy|4
2082843|NCT00710424|3667083|FG001|Overall Study|Lack of Efficacy|5
2082844|NCT00710424|3667082|FG000|Overall Study|Withdrawal by Subject|5
2082845|NCT00710424|3667083|FG001|Overall Study|Withdrawal by Subject|3
2082846|NCT00710424|3667082|FG000|Overall Study|Lost to Follow-up|0
2082847|NCT00710424|3667083|FG001|Overall Study|Lost to Follow-up|1
2082848|NCT00710424|3667082|FG000|Overall Study|Refused medication, no side effects|1
2082849|NCT00710424|3667083|FG001|Overall Study|Refused medication, no side effects|0
2082850|NCT00710424|3667082|FG000|Overall Study|Non-compliance with stable analgesia|1
2082851|NCT00710424|3667083|FG001|Overall Study|Non-compliance with stable analgesia|0
2082852|NCT00710424|3667082|FG000|Overall Study|Did not meet entry criteria at visit 1|1
2082853|NCT00710424|3667083|FG001|Overall Study|Did not meet entry criteria at visit 1|0
2082854|NCT00710424|3667082|FG000|Overall Study|Subject thought medication changed|1
2082855|NCT00710424|3667083|FG001|Overall Study|Subject thought medication changed|0
2082856|NCT00710424|3667082|FG000|Overall Study|Ceased treatment due to travel|1
2082857|NCT00710424|3667083|FG001|Overall Study|Ceased treatment due to travel|0
2082858|NCT00710424|3667082|FG000|Overall Study|Subject preferred paracetamol|0
2082859|NCT00710424|3667083|FG001|Overall Study|Subject preferred paracetamol|1
2082860|NCT00710424|3667082|FG000|Overall Study|Felt good so stopped treatment|0
2082861|NCT00710424|3667083|FG001|Overall Study|Felt good so stopped treatment|1
2082862|NCT00710554|3667091|FG000|Overall Study|Adverse Event|24
2082863|NCT00710554|3667092|FG001|Overall Study|Adverse Event|7
2082864|NCT00710554|3667091|FG000|Overall Study|Withdrawal by Subject|7
2082865|NCT00710554|3667092|FG001|Overall Study|Withdrawal by Subject|3
2082866|NCT00710554|3667091|FG000|Overall Study|Lost to Follow-up|7
2082867|NCT00710554|3667092|FG001|Overall Study|Lost to Follow-up|1
2082868|NCT00710554|3667091|FG000|Overall Study|Lack of Efficacy|11
2082869|NCT00710554|3667092|FG001|Overall Study|Lack of Efficacy|12
2082870|NCT00710554|3667091|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0
2082871|NCT00710554|3667092|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1
2082872|NCT00710593|3667100|FG000|Overall Study|Incarceration|1
2082873|NCT00710593|3667101|FG001|Overall Study|Incarceration|0
2082874|NCT00710593|3667100|FG000|Overall Study|Unable to complete Wk 48 within window|2
2082875|NCT00710593|3667101|FG001|Overall Study|Unable to complete Wk 48 within window|0
2082876|NCT00710593|3667100|FG000|Overall Study|Lost to Follow-up|3
2082877|NCT00710593|3667101|FG001|Overall Study|Lost to Follow-up|1
2082878|NCT00710593|3667100|FG000|Overall Study|Moved out of area|1
2082879|NCT00710593|3667101|FG001|Overall Study|Moved out of area|0
2082880|NCT00710593|3667100|FG000|Overall Study|Failure to adhere or complete study eval|1
2082881|NCT00710593|3667101|FG001|Overall Study|Failure to adhere or complete study eval|1
2082882|NCT00710593|3667100|FG000|Overall Study|Protocol Violation|1
2082883|NCT00710593|3667101|FG001|Overall Study|Protocol Violation|1
2082884|NCT00710593|3667100|FG000|Overall Study|Prem disc vaccine, completed all visits|6
2082885|NCT00710593|3667101|FG001|Overall Study|Prem disc vaccine, completed all visits|2
2082886|NCT00710606|3667125|FG000|Overall Study|Adverse Event|0
2082887|NCT00710606|3667126|FG001|Overall Study|Adverse Event|2
2082888|NCT00710684|3667137|FG000|Overall Study|Adverse Event|11
2082889|NCT00710684|3667138|FG001|Overall Study|Adverse Event|19
2082890|NCT00710684|3667139|FG002|Overall Study|Adverse Event|16
2082891|NCT00710684|3667137|FG000|Overall Study|Lack of Efficacy|4
2082892|NCT00710684|3667138|FG001|Overall Study|Lack of Efficacy|3
2082893|NCT00710684|3667139|FG002|Overall Study|Lack of Efficacy|5
2082894|NCT00710684|3667137|FG000|Overall Study|Protocol Violation|5
2082895|NCT00710684|3667138|FG001|Overall Study|Protocol Violation|5
2082896|NCT00710684|3667139|FG002|Overall Study|Protocol Violation|5
2082897|NCT00710684|3667137|FG000|Overall Study|Lost to Follow-up|4
2082898|NCT00710684|3667138|FG001|Overall Study|Lost to Follow-up|6
2082899|NCT00710684|3667139|FG002|Overall Study|Lost to Follow-up|7
2082900|NCT00710684|3667137|FG000|Overall Study|Physician Decision|0
2082901|NCT00710684|3667138|FG001|Overall Study|Physician Decision|2
2082902|NCT00710684|3667139|FG002|Overall Study|Physician Decision|4
2082903|NCT00710684|3667137|FG000|Overall Study|Withdrawal by Subject|24
2082904|NCT00710684|3667138|FG001|Overall Study|Withdrawal by Subject|18
2082905|NCT00710684|3667139|FG002|Overall Study|Withdrawal by Subject|11
2082906|NCT00710684|3667137|FG000|Overall Study|Missing|1
2082907|NCT00710684|3667138|FG001|Overall Study|Missing|0
2082908|NCT00710684|3667139|FG002|Overall Study|Missing|0
2082909|NCT00710684|3667137|FG000|Overall Study|Did not continue after week 24|25
2082910|NCT00710684|3667138|FG001|Overall Study|Did not continue after week 24|21
2082911|NCT00710684|3667139|FG002|Overall Study|Did not continue after week 24|16
2082912|NCT00710749|3667153|FG000|First Intervention|Withdrawal by Subject|1
2082913|NCT00710749|3667154|FG001|First Intervention|Withdrawal by Subject|0
2082914|NCT00710762|3667164|FG000|Overall Study|Progressive disease|27
2082915|NCT00710762|3667165|FG001|Overall Study|Progressive disease|30
2107085|NCT00870233|3700469|FG000|Overall Study|Withdrawal by Subject|18
2082916|NCT00710762|3667164|FG000|Overall Study|Adverse Event other disease worsening|2
2082917|NCT00710762|3667165|FG001|Overall Study|Adverse Event other disease worsening|1
2082918|NCT00710762|3667164|FG000|Overall Study|Other Adverse Event|7
2082919|NCT00710762|3667165|FG001|Overall Study|Other Adverse Event|7
2082920|NCT00710762|3667164|FG000|Overall Study|Lost to Follow-up|1
2082921|NCT00710762|3667165|FG001|Overall Study|Lost to Follow-up|0
2082922|NCT00710762|3667164|FG000|Overall Study|Reason other than listed above|2
2082923|NCT00710762|3667165|FG001|Overall Study|Reason other than listed above|2
2082924|NCT00710866|3667191|FG000|Overall Study|Protocol Violation|5
2082925|NCT00710866|3667192|FG001|Overall Study|Protocol Violation|4
2082926|NCT00710866|3667191|FG000|Overall Study|Withdrawal by Subject|2
2082927|NCT00710866|3667192|FG001|Overall Study|Withdrawal by Subject|1
2082928|NCT00710866|3667191|FG000|Overall Study|Lost to Follow-up|1
2082929|NCT00710866|3667192|FG001|Overall Study|Lost to Follow-up|0
2082930|NCT00710866|3667191|FG000|Overall Study|Failed to meet eligibility|1
2082931|NCT00710866|3667192|FG001|Overall Study|Failed to meet eligibility|1
2082932|NCT00710879|3667200|FG000|Overall Study|Lost to Follow-up|2
2082933|NCT00710879|3667201|FG001|Overall Study|Lost to Follow-up|1
2082934|NCT00710879|3667200|FG000|Overall Study|Protocol Violation|0
2082935|NCT00710879|3667201|FG001|Overall Study|Protocol Violation|3
2082936|NCT00711009|3667243|FG000|Overall Study|Adverse Event/HIV-Related Event|4
2082937|NCT00711009|3667244|FG001|Overall Study|Adverse Event/HIV-Related Event|5
2082938|NCT00711009|3667243|FG000|Overall Study|Withdrawal by Subject|4
2082939|NCT00711009|3667244|FG001|Overall Study|Withdrawal by Subject|2
2082940|NCT00711009|3667243|FG000|Overall Study|Lost to Follow-up|3
2082941|NCT00711009|3667244|FG001|Overall Study|Lost to Follow-up|9
2082942|NCT00711009|3667243|FG000|Overall Study|Participant Noncompliant|0
2082943|NCT00711009|3667244|FG001|Overall Study|Participant Noncompliant|1
2082944|NCT00711009|3667243|FG000|Overall Study|Virologic Failure|2
2082945|NCT00711009|3667244|FG001|Overall Study|Virologic Failure|1
2082946|NCT00711009|3667243|FG000|Overall Study|Pregnancy|1
2082947|NCT00711009|3667244|FG001|Overall Study|Pregnancy|0
2082948|NCT00711009|3667243|FG000|Overall Study|Site closing|0
2082949|NCT00711009|3667244|FG001|Overall Study|Site closing|1
2082950|NCT00711009|3667243|FG000|Overall Study|Dose adjustment|1
2082951|NCT00711009|3667244|FG001|Overall Study|Dose adjustment|0
2082952|NCT00711100|3667254|FG000|Overall Study|Lack of Efficacy|5
2082953|NCT00711100|3667254|FG000|Overall Study|Withdrawal by Subject|8
2082954|NCT00711113|3667270|FG000|Overall Study|Lost to Follow-up|9
2082955|NCT00711113|3667270|FG000|Overall Study|Implant lost|2
2082956|NCT00711191|3667277|FG000|Overall Study|Adverse Event|1
2082957|NCT00711191|3667278|FG001|Overall Study|Adverse Event|1
2082958|NCT00711191|3667279|FG002|Overall Study|Adverse Event|2
2082959|NCT00711191|3667277|FG000|Overall Study|Objective progression or relapse|2
2082960|NCT00711191|3667278|FG001|Overall Study|Objective progression or relapse|3
2082961|NCT00711191|3667279|FG002|Overall Study|Objective progression or relapse|7
2082962|NCT00711191|3667277|FG000|Overall Study|Withdrawal by Subject|0
2082963|NCT00711191|3667278|FG001|Overall Study|Withdrawal by Subject|1
2082964|NCT00711191|3667279|FG002|Overall Study|Withdrawal by Subject|3
2082965|NCT00711243|3667296|FG000|Registed and Started Treatment|Withdrawal by Subject|0
2082966|NCT00711243|3667297|FG001|Registed and Started Treatment|Withdrawal by Subject|0
2082967|NCT00711243|3667298|FG002|Registed and Started Treatment|Withdrawal by Subject|0
2082968|NCT00711243|3667299|FG003|Registed and Started Treatment|Withdrawal by Subject|0
2082969|NCT00711243|3667300|FG004|Registed and Started Treatment|Withdrawal by Subject|0
2082970|NCT00711243|3667301|FG005|Registed and Started Treatment|Withdrawal by Subject|1
2082971|NCT00711243|3667296|FG000|Reached First Response/4 Cycles|Death|0
2082972|NCT00711243|3667297|FG001|Reached First Response/4 Cycles|Death|0
2082973|NCT00711243|3667298|FG002|Reached First Response/4 Cycles|Death|0
2082974|NCT00711243|3667299|FG003|Reached First Response/4 Cycles|Death|0
2082975|NCT00711243|3667300|FG004|Reached First Response/4 Cycles|Death|0
2082976|NCT00711243|3667301|FG005|Reached First Response/4 Cycles|Death|2
2082977|NCT00711243|3667296|FG000|Reached First Response/4 Cycles|Progressive disease|0
2082978|NCT00711243|3667297|FG001|Reached First Response/4 Cycles|Progressive disease|0
2082979|NCT00711243|3667298|FG002|Reached First Response/4 Cycles|Progressive disease|0
2082980|NCT00711243|3667299|FG003|Reached First Response/4 Cycles|Progressive disease|1
2082981|NCT00711243|3667300|FG004|Reached First Response/4 Cycles|Progressive disease|0
2082982|NCT00711243|3667301|FG005|Reached First Response/4 Cycles|Progressive disease|0
2082983|NCT00711243|3667296|FG000|Treated Cycle 5 After First Response|Progressive disease|1
2082984|NCT00711243|3667297|FG001|Treated Cycle 5 After First Response|Progressive disease|2
2082985|NCT00711243|3667298|FG002|Treated Cycle 5 After First Response|Progressive disease|0
2082986|NCT00711243|3667299|FG003|Treated Cycle 5 After First Response|Progressive disease|0
2082987|NCT00711243|3667300|FG004|Treated Cycle 5 After First Response|Progressive disease|1
2082988|NCT00711243|3667301|FG005|Treated Cycle 5 After First Response|Progressive disease|1
2082989|NCT00711243|3667296|FG000|Treated Cycle 5 After First Response|Death|0
2082990|NCT00711243|3667297|FG001|Treated Cycle 5 After First Response|Death|0
2082991|NCT00711243|3667298|FG002|Treated Cycle 5 After First Response|Death|0
2082992|NCT00711243|3667299|FG003|Treated Cycle 5 After First Response|Death|0
2082993|NCT00711243|3667300|FG004|Treated Cycle 5 After First Response|Death|0
2082994|NCT00711243|3667301|FG005|Treated Cycle 5 After First Response|Death|2
2082995|NCT00711243|3667296|FG000|Treated Cycle 5 After First Response|Decline in performance status|0
2082996|NCT00711243|3667297|FG001|Treated Cycle 5 After First Response|Decline in performance status|0
2082997|NCT00711243|3667298|FG002|Treated Cycle 5 After First Response|Decline in performance status|0
2082998|NCT00711243|3667299|FG003|Treated Cycle 5 After First Response|Decline in performance status|0
2082999|NCT00711243|3667300|FG004|Treated Cycle 5 After First Response|Decline in performance status|0
2083000|NCT00711243|3667301|FG005|Treated Cycle 5 After First Response|Decline in performance status|1
2083001|NCT00711243|3667296|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0
2083002|NCT00711243|3667297|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0
2083003|NCT00711243|3667298|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0
2083004|NCT00711243|3667299|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0
2083005|NCT00711243|3667300|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0
2083006|NCT00711243|3667301|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2
2083007|NCT00711412|3667344|FG000|Induction Treatment|Death|2
2083008|NCT00711412|3667344|FG000|Induction Treatment|Adverse Event|1
2083009|NCT00711412|3667344|FG000|Induction Treatment|Other|1
2083010|NCT00711412|3667344|FG000|Evaluated for Combination Treatment|Adverse Event|2
2083011|NCT00711412|3667344|FG000|Evaluated for Combination Treatment|Death|1
2083012|NCT00711412|3667344|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1
2083013|NCT00711412|3667344|FG000|Evaluated for Combination Treatment|Progressive disease|2
2083014|NCT00711412|3667344|FG000|Combination Treatment|Progressive Disease|1
2083015|NCT00711412|3667344|FG000|Evaluation for Response and Surgery|Progressive Disease|2
2083016|NCT00711412|3667344|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2
2083017|NCT00711412|3667344|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1
2083018|NCT00711412|3667344|FG000|Evaluation for Response and Surgery|Death|1
2083019|NCT00711412|3667344|FG000|Survival Follow up Until Death|Other|12
2083020|NCT00711425|3667349|FG000|Overall Study|Protocol Violation|1
2083021|NCT00711425|3667349|FG000|Overall Study|Death|2
2083022|NCT00711425|3667349|FG000|Overall Study|Lost to Follow-up|1
2083023|NCT00711477|3667365|FG000|Overall Study|Adverse Event|3
2083024|NCT00711477|3667366|FG001|Overall Study|Adverse Event|1
2083025|NCT00711477|3667365|FG000|Overall Study|Lost to Follow-up|0
2083026|NCT00711477|3667366|FG001|Overall Study|Lost to Follow-up|1
2083027|NCT00711477|3667365|FG000|Overall Study|Noncompliance|0
2083028|NCT00711477|3667366|FG001|Overall Study|Noncompliance|1
2083029|NCT00711516|3667381|FG000|Overall Study|Adverse Event|1
2083030|NCT00711516|3667382|FG001|Overall Study|Adverse Event|1
2083031|NCT00711516|3667381|FG000|Overall Study|Withdrawal by Subject|0
2083032|NCT00711516|3667382|FG001|Overall Study|Withdrawal by Subject|1
2083033|NCT00711516|3667381|FG000|Overall Study|Protocol Violation|0
2083034|NCT00711516|3667382|FG001|Overall Study|Protocol Violation|1
2083035|NCT00711529|3667390|FG000|Overall Study|Protocol Violation|2
2083036|NCT00711529|3667391|FG001|Overall Study|Protocol Violation|0
2083037|NCT00711529|3667390|FG000|Overall Study|Withdrawal by Subject|2
2083038|NCT00711529|3667391|FG001|Overall Study|Withdrawal by Subject|6
2083039|NCT00711594|3667401|FG000|Overall Study|Progressive disease|2
2083040|NCT00711594|3667402|FG001|Overall Study|Progressive disease|2
2083041|NCT00711594|3667403|FG002|Overall Study|Progressive disease|6
2083042|NCT00711594|3667404|FG003|Overall Study|Progressive disease|44
2083043|NCT00711594|3667401|FG000|Overall Study|Other Adverse Event|1
2083044|NCT00711594|3667402|FG001|Overall Study|Other Adverse Event|0
2083045|NCT00711594|3667403|FG002|Overall Study|Other Adverse Event|0
2083046|NCT00711594|3667404|FG003|Overall Study|Other Adverse Event|16
2083047|NCT00711594|3667401|FG000|Overall Study|Withdrawal by Subject|0
2083048|NCT00711594|3667402|FG001|Overall Study|Withdrawal by Subject|1
2083049|NCT00711594|3667403|FG002|Overall Study|Withdrawal by Subject|0
2083050|NCT00711594|3667404|FG003|Overall Study|Withdrawal by Subject|2
2083051|NCT00711646|3667418|FG000|Overall Study|Adverse Event|6
2083052|NCT00711646|3667419|FG001|Overall Study|Adverse Event|1
2083053|NCT00711646|3667418|FG000|Overall Study|Withdrawal by Subject|4
2083054|NCT00711646|3667419|FG001|Overall Study|Withdrawal by Subject|0
2083055|NCT00711646|3667418|FG000|Overall Study|Protocol Violation|0
2083056|NCT00711646|3667419|FG001|Overall Study|Protocol Violation|1
2083057|NCT00711646|3667418|FG000|Overall Study|Lost to Follow-up|1
2083058|NCT00711646|3667419|FG001|Overall Study|Lost to Follow-up|0
2083059|NCT00711646|3667418|FG000|Overall Study|administrative decision|0
2083060|NCT00711646|3667419|FG001|Overall Study|administrative decision|1
2083061|NCT00711646|3667418|FG000|Overall Study|patient non-compliance|1
2083062|NCT00711646|3667419|FG001|Overall Study|patient non-compliance|0
2083063|NCT00711802|3667444|FG000|Overall Study|Not treated (no further detail)|2
2083064|NCT00711802|3667445|FG001|Overall Study|Not treated (no further detail)|1
2083065|NCT00711802|3667446|FG002|Overall Study|Not treated (no further detail)|2
2083066|NCT00711802|3667447|FG003|Overall Study|Not treated (no further detail)|0
2083067|NCT00711802|3667448|FG004|Overall Study|Not treated (no further detail)|2
2083068|NCT00711802|3667449|FG005|Overall Study|Not treated (no further detail)|0
2083069|NCT00711802|3667450|FG006|Overall Study|Not treated (no further detail)|0
2083070|NCT00711802|3667451|FG007|Overall Study|Not treated (no further detail)|0
2083071|NCT00711802|3667444|FG000|Overall Study|Adverse Event|0
2083072|NCT00711802|3667445|FG001|Overall Study|Adverse Event|0
2083073|NCT00711802|3667446|FG002|Overall Study|Adverse Event|0
2083074|NCT00711802|3667447|FG003|Overall Study|Adverse Event|0
2083075|NCT00711802|3667448|FG004|Overall Study|Adverse Event|1
2083076|NCT00711802|3667449|FG005|Overall Study|Adverse Event|1
2083077|NCT00711802|3667450|FG006|Overall Study|Adverse Event|0
2083078|NCT00711802|3667451|FG007|Overall Study|Adverse Event|0
2083079|NCT00711802|3667444|FG000|Overall Study|Microbiological failure|0
2083080|NCT00711802|3667445|FG001|Overall Study|Microbiological failure|1
2083081|NCT00711802|3667446|FG002|Overall Study|Microbiological failure|0
2083082|NCT00711802|3667447|FG003|Overall Study|Microbiological failure|0
2083083|NCT00711802|3667448|FG004|Overall Study|Microbiological failure|0
2083084|NCT00711802|3667449|FG005|Overall Study|Microbiological failure|1
2083085|NCT00711802|3667450|FG006|Overall Study|Microbiological failure|0
2083086|NCT00711802|3667451|FG007|Overall Study|Microbiological failure|0
2083087|NCT00711802|3667444|FG000|Overall Study|Protocol Violation|0
2083088|NCT00711802|3667445|FG001|Overall Study|Protocol Violation|0
2083089|NCT00711802|3667446|FG002|Overall Study|Protocol Violation|0
2083090|NCT00711802|3667447|FG003|Overall Study|Protocol Violation|1
2083091|NCT00711802|3667448|FG004|Overall Study|Protocol Violation|0
2083092|NCT00711802|3667449|FG005|Overall Study|Protocol Violation|0
2083093|NCT00711802|3667450|FG006|Overall Study|Protocol Violation|0
2083094|NCT00711802|3667451|FG007|Overall Study|Protocol Violation|0
2083095|NCT00711802|3667444|FG000|Overall Study|Physician Decision|0
2083096|NCT00711802|3667445|FG001|Overall Study|Physician Decision|2
2083097|NCT00711802|3667446|FG002|Overall Study|Physician Decision|0
2083098|NCT00711802|3667447|FG003|Overall Study|Physician Decision|0
2083099|NCT00711802|3667448|FG004|Overall Study|Physician Decision|0
2083100|NCT00711802|3667449|FG005|Overall Study|Physician Decision|0
2083101|NCT00711802|3667450|FG006|Overall Study|Physician Decision|0
2083102|NCT00711802|3667451|FG007|Overall Study|Physician Decision|0
2083103|NCT00711802|3667444|FG000|Overall Study|Withdrawal by Subject|0
2083104|NCT00711802|3667445|FG001|Overall Study|Withdrawal by Subject|1
2083105|NCT00711802|3667446|FG002|Overall Study|Withdrawal by Subject|0
2083106|NCT00711802|3667447|FG003|Overall Study|Withdrawal by Subject|1
2083107|NCT00711802|3667448|FG004|Overall Study|Withdrawal by Subject|0
2083108|NCT00711802|3667449|FG005|Overall Study|Withdrawal by Subject|0
2083109|NCT00711802|3667450|FG006|Overall Study|Withdrawal by Subject|0
2083110|NCT00711802|3667451|FG007|Overall Study|Withdrawal by Subject|0
2083111|NCT00711802|3667444|FG000|Overall Study|Lost to Follow-up|0
2083112|NCT00711802|3667445|FG001|Overall Study|Lost to Follow-up|0
2083113|NCT00711802|3667446|FG002|Overall Study|Lost to Follow-up|3
2083114|NCT00711802|3667447|FG003|Overall Study|Lost to Follow-up|1
2083115|NCT00711802|3667448|FG004|Overall Study|Lost to Follow-up|10
2083116|NCT00711802|3667449|FG005|Overall Study|Lost to Follow-up|6
2083117|NCT00711802|3667450|FG006|Overall Study|Lost to Follow-up|4
2083118|NCT00711802|3667451|FG007|Overall Study|Lost to Follow-up|2
2083119|NCT00711802|3667444|FG000|Overall Study|Reason not reported|0
2083120|NCT00711802|3667445|FG001|Overall Study|Reason not reported|1
2083121|NCT00711802|3667446|FG002|Overall Study|Reason not reported|1
2083122|NCT00711802|3667447|FG003|Overall Study|Reason not reported|0
2083123|NCT00711802|3667448|FG004|Overall Study|Reason not reported|1
2083124|NCT00711802|3667449|FG005|Overall Study|Reason not reported|0
2083125|NCT00711802|3667450|FG006|Overall Study|Reason not reported|1
2083126|NCT00711802|3667451|FG007|Overall Study|Reason not reported|0
2083127|NCT00711880|3667487|FG000|Overall Study|Adverse Event|11
2083128|NCT00711880|3667488|FG001|Overall Study|Adverse Event|2
2083129|NCT00711880|3667487|FG000|Overall Study|Patient non-compliance|1
2083130|NCT00711880|3667488|FG001|Overall Study|Patient non-compliance|0
2083131|NCT00711880|3667487|FG000|Overall Study|Lack of Efficacy|1
2083132|NCT00711880|3667488|FG001|Overall Study|Lack of Efficacy|5
2083133|NCT00711958|3667496|FG000|Overall Study|Withdrawal by Subject|6
2083134|NCT00711958|3667497|FG001|Overall Study|Withdrawal by Subject|8
2083135|NCT00711958|3667496|FG000|Overall Study|Lack of Efficacy|3
2083136|NCT00711958|3667497|FG001|Overall Study|Lack of Efficacy|1
2083137|NCT00711958|3667496|FG000|Overall Study|Clinical deterioration|1
2083138|NCT00711958|3667497|FG001|Overall Study|Clinical deterioration|0
2083139|NCT00711958|3667496|FG000|Overall Study|Adverse Event|9
2083140|NCT00711958|3667497|FG001|Overall Study|Adverse Event|7
2083141|NCT00711958|3667496|FG000|Overall Study|Protocol Violation|1
2083142|NCT00711958|3667497|FG001|Overall Study|Protocol Violation|0
2083143|NCT00711958|3667496|FG000|Overall Study|Lost to Follow-up|2
2083144|NCT00711958|3667497|FG001|Overall Study|Lost to Follow-up|2
2083145|NCT00711958|3667496|FG000|Overall Study|Death|10
2083146|NCT00711958|3667497|FG001|Overall Study|Death|5
2083147|NCT00711958|3667496|FG000|Overall Study|Progression of disease|1
2083148|NCT00711958|3667497|FG001|Overall Study|Progression of disease|0
2083149|NCT00711971|3667506|FG000|Overall Study|Lost to Follow-up|3
2083150|NCT00711971|3667507|FG001|Overall Study|Lost to Follow-up|4
2083151|NCT00711971|3667508|FG002|Overall Study|Lost to Follow-up|1
2083152|NCT00712010|3667531|FG000|Washout (7 Days)|Withdrawal by Subject|1
2083153|NCT00712166|3667562|FG000|Overall Study|Noncompliance|0
2083154|NCT00712166|3667563|FG001|Overall Study|Noncompliance|1
2083155|NCT00712270|3667595|FG000|Overall Study|Withdrawal by Subject|11
2083156|NCT00712270|3667595|FG000|Overall Study|Screen Failure|3
2083157|NCT00712335|3667649|FG000|Overall Study|Withdrawal by Subject|0
2083158|NCT00712335|3667650|FG001|Overall Study|Withdrawal by Subject|7
2083159|NCT00712335|3667651|FG002|Overall Study|Withdrawal by Subject|2
2083160|NCT00712335|3667652|FG003|Overall Study|Withdrawal by Subject|3
2083161|NCT00712335|3667653|FG004|Overall Study|Withdrawal by Subject|0
2083162|NCT00712335|3667649|FG000|Overall Study|Lost to Follow-up|2
2083163|NCT00712335|3667650|FG001|Overall Study|Lost to Follow-up|5
2083164|NCT00712335|3667651|FG002|Overall Study|Lost to Follow-up|0
2083165|NCT00712335|3667652|FG003|Overall Study|Lost to Follow-up|1
2083166|NCT00712335|3667653|FG004|Overall Study|Lost to Follow-up|0
2083167|NCT00712335|3667649|FG000|Overall Study|Protocol Violation|1
2083168|NCT00712335|3667650|FG001|Overall Study|Protocol Violation|2
2083169|NCT00712335|3667651|FG002|Overall Study|Protocol Violation|1
2083170|NCT00712335|3667652|FG003|Overall Study|Protocol Violation|0
2083171|NCT00712335|3667653|FG004|Overall Study|Protocol Violation|0
2083172|NCT00712335|3667649|FG000|Overall Study|Lack of Efficacy|0
2211458|NCT01660763|3851752|FG000|Overall Study|Protocol Violation|1
2211459|NCT01660763|3851753|FG001|Overall Study|Protocol Violation|0
2211460|NCT01660763|3851752|FG000|Overall Study|Withdrawal by Subject|4
2211461|NCT01660763|3851753|FG001|Overall Study|Withdrawal by Subject|0
2211462|NCT01660763|3851752|FG000|Overall Study|Patient ready for early discharge|28
2211463|NCT01660763|3851753|FG001|Overall Study|Patient ready for early discharge|4
2211464|NCT01660906|3851786|FG000|Overall Study|Discontinued due to study drug toxicity|3
2211465|NCT01661062|3851790|FG000|Overall Study|Completed Treatment Off Study|3
2211466|NCT01661062|3851790|FG000|Overall Study|Withdrawal by Subject|2
2211467|NCT01661140|3851802|FG000|Open-Label Period|Adverse Event|44
2211468|NCT01661140|3851803|FG001|Open-Label Period|Adverse Event|0
2211469|NCT01661140|3851804|FG002|Open-Label Period|Adverse Event|0
2083173|NCT00712335|3667650|FG001|Overall Study|Lack of Efficacy|0
2083174|NCT00712335|3667651|FG002|Overall Study|Lack of Efficacy|1
2083175|NCT00712335|3667652|FG003|Overall Study|Lack of Efficacy|1
2083176|NCT00712335|3667653|FG004|Overall Study|Lack of Efficacy|0
2083177|NCT00712335|3667649|FG000|Overall Study|Other Reason|0
2083178|NCT00712335|3667650|FG001|Overall Study|Other Reason|3
2083179|NCT00712335|3667651|FG002|Overall Study|Other Reason|1
2083180|NCT00712335|3667652|FG003|Overall Study|Other Reason|0
2083181|NCT00712335|3667653|FG004|Overall Study|Other Reason|0
2083182|NCT00712348|3667665|FG000|Overall Study|Withdrawal by Subject|1
2083183|NCT00712543|3667684|FG000|Day 8-14|Lost to Follow-up|0
2083184|NCT00712543|3667685|FG001|Day 8-14|Lost to Follow-up|2
2083185|NCT00712673|3667694|FG000|Overall Study|Adverse Event|3
2083186|NCT00712673|3667695|FG001|Overall Study|Adverse Event|3
2083187|NCT00712673|3667696|FG002|Overall Study|Adverse Event|21
2083188|NCT00712673|3667697|FG003|Overall Study|Adverse Event|26
2083189|NCT00712673|3667694|FG000|Overall Study|Lack of Efficacy|2
2083190|NCT00712673|3667695|FG001|Overall Study|Lack of Efficacy|8
2083191|NCT00712673|3667696|FG002|Overall Study|Lack of Efficacy|8
2083192|NCT00712673|3667697|FG003|Overall Study|Lack of Efficacy|6
2083193|NCT00712673|3667694|FG000|Overall Study|Poor Compliance to Protocol|3
2083194|NCT00712673|3667695|FG001|Overall Study|Poor Compliance to Protocol|3
2083195|NCT00712673|3667696|FG002|Overall Study|Poor Compliance to Protocol|4
2083196|NCT00712673|3667697|FG003|Overall Study|Poor Compliance to Protocol|16
2083197|NCT00712673|3667694|FG000|Overall Study|Lost to Follow-up|1
2083198|NCT00712673|3667695|FG001|Overall Study|Lost to Follow-up|0
2083199|NCT00712673|3667696|FG002|Overall Study|Lost to Follow-up|2
2083200|NCT00712673|3667697|FG003|Overall Study|Lost to Follow-up|0
2083201|NCT00712673|3667694|FG000|Overall Study|Withdrawal by Subject|6
2083202|NCT00712673|3667695|FG001|Overall Study|Withdrawal by Subject|7
2083203|NCT00712673|3667696|FG002|Overall Study|Withdrawal by Subject|15
2083204|NCT00712673|3667697|FG003|Overall Study|Withdrawal by Subject|20
2083205|NCT00712673|3667694|FG000|Overall Study|Familial and Personal Reasons|5
2083206|NCT00712673|3667695|FG001|Overall Study|Familial and Personal Reasons|0
2083207|NCT00712673|3667696|FG002|Overall Study|Familial and Personal Reasons|5
2083208|NCT00712673|3667697|FG003|Overall Study|Familial and Personal Reasons|2
2083209|NCT00712673|3667694|FG000|Overall Study|Investigator's Decision|1
2083210|NCT00712673|3667695|FG001|Overall Study|Investigator's Decision|0
2083211|NCT00712673|3667696|FG002|Overall Study|Investigator's Decision|0
2083212|NCT00712673|3667697|FG003|Overall Study|Investigator's Decision|0
2083213|NCT00712673|3667694|FG000|Overall Study|Protocol Violation|0
2083214|NCT00712673|3667695|FG001|Overall Study|Protocol Violation|0
2083215|NCT00712673|3667696|FG002|Overall Study|Protocol Violation|2
2083216|NCT00712673|3667697|FG003|Overall Study|Protocol Violation|0
2083217|NCT00712712|3667716|FG000|Overall Study|Protocol Violation|11
2083218|NCT00712712|3667716|FG000|Overall Study|Radiofrequency not done|3
2083219|NCT00712712|3667716|FG000|Overall Study|Death|8
2083220|NCT00712712|3667716|FG000|Overall Study|Withdrawal by Subject|1
2083221|NCT00712725|3667728|FG000|Overall Study|Adverse Event|1
2083222|NCT00712725|3667729|FG001|Overall Study|Adverse Event|0
2083223|NCT00712725|3667730|FG002|Overall Study|Adverse Event|0
2083224|NCT00712725|3667731|FG003|Overall Study|Adverse Event|1
2083225|NCT00712725|3667732|FG004|Overall Study|Adverse Event|0
2083226|NCT00712725|3667733|FG005|Overall Study|Adverse Event|0
2083227|NCT00712725|3667734|FG006|Overall Study|Adverse Event|0
2083228|NCT00712725|3667735|FG007|Overall Study|Adverse Event|0
2083229|NCT00712725|3667728|FG000|Overall Study|Lost to Follow-up|3
2083230|NCT00712725|3667729|FG001|Overall Study|Lost to Follow-up|2
2083231|NCT00712725|3667730|FG002|Overall Study|Lost to Follow-up|1
2083232|NCT00712725|3667731|FG003|Overall Study|Lost to Follow-up|1
2083233|NCT00712725|3667732|FG004|Overall Study|Lost to Follow-up|2
2083234|NCT00712725|3667733|FG005|Overall Study|Lost to Follow-up|2
2083235|NCT00712725|3667734|FG006|Overall Study|Lost to Follow-up|3
2083236|NCT00712725|3667735|FG007|Overall Study|Lost to Follow-up|1
2083237|NCT00712725|3667728|FG000|Overall Study|Physician Decision|2
2083238|NCT00712725|3667729|FG001|Overall Study|Physician Decision|0
2083239|NCT00712725|3667730|FG002|Overall Study|Physician Decision|0
2083240|NCT00712725|3667731|FG003|Overall Study|Physician Decision|0
2083241|NCT00712725|3667732|FG004|Overall Study|Physician Decision|1
2083242|NCT00712725|3667733|FG005|Overall Study|Physician Decision|0
2083243|NCT00712725|3667734|FG006|Overall Study|Physician Decision|2
2083244|NCT00712725|3667735|FG007|Overall Study|Physician Decision|0
2083245|NCT00712725|3667728|FG000|Overall Study|Pregnancy|0
2083246|NCT00712725|3667729|FG001|Overall Study|Pregnancy|1
2083247|NCT00712725|3667730|FG002|Overall Study|Pregnancy|0
2083248|NCT00712725|3667731|FG003|Overall Study|Pregnancy|0
2083249|NCT00712725|3667732|FG004|Overall Study|Pregnancy|1
2083250|NCT00712725|3667733|FG005|Overall Study|Pregnancy|0
2083251|NCT00712725|3667734|FG006|Overall Study|Pregnancy|2
2083252|NCT00712725|3667735|FG007|Overall Study|Pregnancy|0
2083253|NCT00712725|3667728|FG000|Overall Study|Protocol Violation|2
2083254|NCT00712725|3667729|FG001|Overall Study|Protocol Violation|0
2083255|NCT00712725|3667730|FG002|Overall Study|Protocol Violation|1
2083256|NCT00712725|3667731|FG003|Overall Study|Protocol Violation|3
2083257|NCT00712725|3667732|FG004|Overall Study|Protocol Violation|2
2083258|NCT00712725|3667733|FG005|Overall Study|Protocol Violation|0
2083259|NCT00712725|3667734|FG006|Overall Study|Protocol Violation|1
2083260|NCT00712725|3667735|FG007|Overall Study|Protocol Violation|1
2083261|NCT00712725|3667728|FG000|Overall Study|Withdrawal by Subject|2
2083262|NCT00712725|3667729|FG001|Overall Study|Withdrawal by Subject|1
2083263|NCT00712725|3667730|FG002|Overall Study|Withdrawal by Subject|1
2083264|NCT00712725|3667731|FG003|Overall Study|Withdrawal by Subject|2
2083265|NCT00712725|3667732|FG004|Overall Study|Withdrawal by Subject|1
2083266|NCT00712725|3667733|FG005|Overall Study|Withdrawal by Subject|1
2083267|NCT00712725|3667734|FG006|Overall Study|Withdrawal by Subject|1
2083268|NCT00712725|3667735|FG007|Overall Study|Withdrawal by Subject|2
2083269|NCT00712725|3667728|FG000|Overall Study|Lack of Qualifying Event|16
2083270|NCT00712725|3667729|FG001|Overall Study|Lack of Qualifying Event|2
2083271|NCT00712725|3667730|FG002|Overall Study|Lack of Qualifying Event|6
2083272|NCT00712725|3667731|FG003|Overall Study|Lack of Qualifying Event|8
2083273|NCT00712725|3667732|FG004|Overall Study|Lack of Qualifying Event|11
2083274|NCT00712725|3667733|FG005|Overall Study|Lack of Qualifying Event|13
2083275|NCT00712725|3667734|FG006|Overall Study|Lack of Qualifying Event|11
2083276|NCT00712725|3667735|FG007|Overall Study|Lack of Qualifying Event|6
2083277|NCT00712725|3667728|FG000|Overall Study|Protocol Specified Criteria|3
2083278|NCT00712725|3667729|FG001|Overall Study|Protocol Specified Criteria|0
2083279|NCT00712725|3667730|FG002|Overall Study|Protocol Specified Criteria|1
2083280|NCT00712725|3667731|FG003|Overall Study|Protocol Specified Criteria|2
2083281|NCT00712725|3667732|FG004|Overall Study|Protocol Specified Criteria|1
2083282|NCT00712725|3667733|FG005|Overall Study|Protocol Specified Criteria|0
2083283|NCT00712725|3667734|FG006|Overall Study|Protocol Specified Criteria|2
2083284|NCT00712725|3667735|FG007|Overall Study|Protocol Specified Criteria|1
2083285|NCT00712920|3667756|FG000|Overall Study|Adverse Event|3
2083286|NCT00712920|3667757|FG001|Overall Study|Adverse Event|4
2083287|NCT00712920|3667758|FG002|Overall Study|Adverse Event|7
2083288|NCT00712920|3667756|FG000|Overall Study|Withdrawal by Subject|4
2083289|NCT00712920|3667757|FG001|Overall Study|Withdrawal by Subject|2
2083290|NCT00712920|3667758|FG002|Overall Study|Withdrawal by Subject|1
2083291|NCT00712920|3667756|FG000|Overall Study|Lost to Follow-up|1
2083292|NCT00712920|3667757|FG001|Overall Study|Lost to Follow-up|4
2083293|NCT00712920|3667758|FG002|Overall Study|Lost to Follow-up|0
2083294|NCT00712920|3667756|FG000|Overall Study|Lack of Efficacy|1
2083295|NCT00712920|3667757|FG001|Overall Study|Lack of Efficacy|0
2083296|NCT00712920|3667758|FG002|Overall Study|Lack of Efficacy|1
2083297|NCT00712920|3667756|FG000|Overall Study|Other|5
2083298|NCT00712920|3667757|FG001|Overall Study|Other|7
2083299|NCT00712920|3667758|FG002|Overall Study|Other|3
2083300|NCT00712920|3667756|FG000|Overall Study|Non-compliance|3
2083301|NCT00712920|3667757|FG001|Overall Study|Non-compliance|0
2083302|NCT00712920|3667758|FG002|Overall Study|Non-compliance|0
2083303|NCT00712959|3667768|FG000|Overall Study|Protocol Violation|3
2083304|NCT00712959|3667769|FG001|Overall Study|Protocol Violation|1
2083305|NCT00712959|3667768|FG000|Overall Study|Lost to Follow-up|13
2083306|NCT00712959|3667769|FG001|Overall Study|Lost to Follow-up|2
2083307|NCT00712959|3667768|FG000|Overall Study|Withdrawal by Subject|3
2083308|NCT00712959|3667769|FG001|Overall Study|Withdrawal by Subject|0
2083309|NCT00712985|3667775|FG000|Overall Study|1 withdrew prior to start of drug|1
2083310|NCT00712985|3667775|FG000|Overall Study|1 patient moved out of state|1
2083311|NCT00712985|3667775|FG000|Overall Study|Lack of Efficacy|3
2083312|NCT00713206|3667781|FG000|Overall Study|Lost to Follow-up|4
2083313|NCT00713206|3667782|FG001|Overall Study|Lost to Follow-up|4
2083314|NCT00713206|3667781|FG000|Overall Study|Death|1
2083315|NCT00713206|3667782|FG001|Overall Study|Death|0
2083316|NCT00713219|3667788|FG000|Overall Study|Death|1
2083317|NCT00713219|3667788|FG000|Overall Study|Protocol Violation|1
2083318|NCT00713310|3667798|FG000|Overall Study|Adverse Event|5
2083319|NCT00713310|3667799|FG001|Overall Study|Adverse Event|2
2083320|NCT00713310|3667798|FG000|Overall Study|Lack of Efficacy|0
2083321|NCT00713310|3667799|FG001|Overall Study|Lack of Efficacy|2
2083322|NCT00713310|3667798|FG000|Overall Study|Withdrawal by Subject|0
2083323|NCT00713310|3667799|FG001|Overall Study|Withdrawal by Subject|2
2083324|NCT00713323|3667805|FG000|Overall Study|Adverse Event|75
2083325|NCT00713323|3667805|FG000|Overall Study|Withdrawal by Subject|15
2083326|NCT00713323|3667805|FG000|Overall Study|Lost to Follow-up|11
2211470|NCT01661140|3851802|FG000|Open-Label Period|Protocol Violation|3
2211471|NCT01661140|3851803|FG001|Open-Label Period|Protocol Violation|0
2211472|NCT01661140|3851804|FG002|Open-Label Period|Protocol Violation|0
2211473|NCT01661140|3851802|FG000|Open-Label Period|Withdrawal by Subject|5
2211474|NCT01661140|3851803|FG001|Open-Label Period|Withdrawal by Subject|0
2211475|NCT01661140|3851804|FG002|Open-Label Period|Withdrawal by Subject|0
2211476|NCT01661140|3851802|FG000|Open-Label Period|Investigator Decision|3
2211477|NCT01661140|3851803|FG001|Open-Label Period|Investigator Decision|0
2211478|NCT01661140|3851804|FG002|Open-Label Period|Investigator Decision|0
2211479|NCT01661140|3851802|FG000|Open-Label Period|Death|1
2211480|NCT01661140|3851803|FG001|Open-Label Period|Death|0
2211481|NCT01661140|3851804|FG002|Open-Label Period|Death|0
2211482|NCT01661140|3851802|FG000|Open-Label Period|Administrative/Other|1
2211483|NCT01661140|3851803|FG001|Open-Label Period|Administrative/Other|0
2211484|NCT01661140|3851804|FG002|Open-Label Period|Administrative/Other|0
2211485|NCT01661140|3851802|FG000|Open-Label Period|Sponsor termination|16
2083327|NCT00713323|3667805|FG000|Overall Study|Lack of Efficacy|36
2083328|NCT00713323|3667805|FG000|Overall Study|Low creatine clearance at screening|1
2083329|NCT00713323|3667805|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1
2083330|NCT00713323|3667805|FG000|Overall Study|Surgery cured allodynic pain|1
2083331|NCT00713323|3667805|FG000|Overall Study|Pain free|1
2083332|NCT00713323|3667805|FG000|Overall Study|Non-compliance|1
2083333|NCT00713323|3667805|FG000|Overall Study|Pain resolved|1
2083334|NCT00713323|3667805|FG000|Overall Study|Subject travelling to USA|1
2083335|NCT00713323|3667805|FG000|Overall Study|Subject travelling to Dominica Republic|1
2083336|NCT00713323|3667805|FG000|Overall Study|Treatment that may interact with Sativex|1
2083337|NCT00713349|3667809|FG000|Overall Study|Protocol Violation|1
2083338|NCT00713544|3667834|FG000|Overall Study|Adverse Event|5
2083339|NCT00713544|3667835|FG001|Overall Study|Adverse Event|3
2083340|NCT00713544|3667836|FG002|Overall Study|Adverse Event|7
2083341|NCT00713544|3667837|FG003|Overall Study|Adverse Event|7
2083342|NCT00713544|3667838|FG004|Overall Study|Adverse Event|3
2083343|NCT00713544|3667839|FG005|Overall Study|Adverse Event|5
2083344|NCT00713544|3667834|FG000|Overall Study|Withdrawal by Subject|2
2083345|NCT00713544|3667835|FG001|Overall Study|Withdrawal by Subject|0
2083346|NCT00713544|3667836|FG002|Overall Study|Withdrawal by Subject|3
2083347|NCT00713544|3667837|FG003|Overall Study|Withdrawal by Subject|2
2083348|NCT00713544|3667838|FG004|Overall Study|Withdrawal by Subject|3
2083349|NCT00713544|3667839|FG005|Overall Study|Withdrawal by Subject|1
2083350|NCT00713544|3667834|FG000|Overall Study|Protocol Violation|0
2083351|NCT00713544|3667835|FG001|Overall Study|Protocol Violation|0
2083352|NCT00713544|3667836|FG002|Overall Study|Protocol Violation|0
2083353|NCT00713544|3667837|FG003|Overall Study|Protocol Violation|0
2083354|NCT00713544|3667838|FG004|Overall Study|Protocol Violation|0
2083355|NCT00713544|3667839|FG005|Overall Study|Protocol Violation|1
2083356|NCT00713544|3667834|FG000|Overall Study|Physician Decision|0
2083357|NCT00713544|3667835|FG001|Overall Study|Physician Decision|0
2083358|NCT00713544|3667836|FG002|Overall Study|Physician Decision|0
2083359|NCT00713544|3667837|FG003|Overall Study|Physician Decision|0
2083360|NCT00713544|3667838|FG004|Overall Study|Physician Decision|0
2083361|NCT00713544|3667839|FG005|Overall Study|Physician Decision|2
2083362|NCT00713544|3667834|FG000|Overall Study|Lack of Efficacy|0
2083363|NCT00713544|3667835|FG001|Overall Study|Lack of Efficacy|1
2083364|NCT00713544|3667836|FG002|Overall Study|Lack of Efficacy|0
2083365|NCT00713544|3667837|FG003|Overall Study|Lack of Efficacy|1
2083366|NCT00713544|3667838|FG004|Overall Study|Lack of Efficacy|1
2083367|NCT00713544|3667839|FG005|Overall Study|Lack of Efficacy|0
2083368|NCT00713544|3667834|FG000|Overall Study|Lost to Follow-up|0
2083369|NCT00713544|3667835|FG001|Overall Study|Lost to Follow-up|0
2083370|NCT00713544|3667836|FG002|Overall Study|Lost to Follow-up|1
2083371|NCT00713544|3667837|FG003|Overall Study|Lost to Follow-up|0
2083372|NCT00713544|3667838|FG004|Overall Study|Lost to Follow-up|0
2083373|NCT00713544|3667839|FG005|Overall Study|Lost to Follow-up|0
2083374|NCT00713544|3667834|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0
2083375|NCT00713544|3667835|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1
2083376|NCT00713544|3667836|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0
2083377|NCT00713544|3667837|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0
2083378|NCT00713544|3667838|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0
2083379|NCT00713544|3667839|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0
2083380|NCT00713544|3667834|FG000|Overall Study|Incorrect enrollment|0
2083381|NCT00713544|3667835|FG001|Overall Study|Incorrect enrollment|1
2083382|NCT00713544|3667836|FG002|Overall Study|Incorrect enrollment|0
2083383|NCT00713544|3667837|FG003|Overall Study|Incorrect enrollment|0
2083384|NCT00713544|3667838|FG004|Overall Study|Incorrect enrollment|0
2083385|NCT00713544|3667839|FG005|Overall Study|Incorrect enrollment|0
2083386|NCT00713544|3667834|FG000|Overall Study|Hepatotoxicity - not an AE|0
2083387|NCT00713544|3667835|FG001|Overall Study|Hepatotoxicity - not an AE|0
2083388|NCT00713544|3667836|FG002|Overall Study|Hepatotoxicity - not an AE|0
2083389|NCT00713544|3667837|FG003|Overall Study|Hepatotoxicity - not an AE|0
2083390|NCT00713544|3667838|FG004|Overall Study|Hepatotoxicity - not an AE|1
2083391|NCT00713544|3667839|FG005|Overall Study|Hepatotoxicity - not an AE|0
2083392|NCT00713609|3667868|FG000|Overall Study|Adverse Event|2
2083393|NCT00713609|3667869|FG001|Overall Study|Adverse Event|0
2083394|NCT00713609|3667870|FG002|Overall Study|Adverse Event|2
2083395|NCT00713609|3667871|FG003|Overall Study|Adverse Event|2
2083396|NCT00713609|3667872|FG004|Overall Study|Adverse Event|3
2083397|NCT00713609|3667873|FG005|Overall Study|Adverse Event|1
2083398|NCT00713609|3667868|FG000|Overall Study|Lost to Follow-up|5
2083399|NCT00713609|3667869|FG001|Overall Study|Lost to Follow-up|7
2083400|NCT00713609|3667870|FG002|Overall Study|Lost to Follow-up|5
2083401|NCT00713609|3667871|FG003|Overall Study|Lost to Follow-up|5
2083402|NCT00713609|3667872|FG004|Overall Study|Lost to Follow-up|7
2083403|NCT00713609|3667873|FG005|Overall Study|Lost to Follow-up|0
2083404|NCT00713609|3667868|FG000|Overall Study|Lack of Efficacy|1
2083405|NCT00713609|3667869|FG001|Overall Study|Lack of Efficacy|3
2083406|NCT00713609|3667870|FG002|Overall Study|Lack of Efficacy|0
2083407|NCT00713609|3667871|FG003|Overall Study|Lack of Efficacy|0
2083408|NCT00713609|3667872|FG004|Overall Study|Lack of Efficacy|1
2083409|NCT00713609|3667873|FG005|Overall Study|Lack of Efficacy|0
2083410|NCT00713609|3667868|FG000|Overall Study|Non-Compliance with Study Treatment|1
2083411|NCT00713609|3667869|FG001|Overall Study|Non-Compliance with Study Treatment|1
2083412|NCT00713609|3667870|FG002|Overall Study|Non-Compliance with Study Treatment|2
2083413|NCT00713609|3667871|FG003|Overall Study|Non-Compliance with Study Treatment|0
2083414|NCT00713609|3667872|FG004|Overall Study|Non-Compliance with Study Treatment|1
2083415|NCT00713609|3667873|FG005|Overall Study|Non-Compliance with Study Treatment|0
2083416|NCT00713609|3667868|FG000|Overall Study|Withdrawal by Subject|6
2083417|NCT00713609|3667869|FG001|Overall Study|Withdrawal by Subject|1
2083418|NCT00713609|3667870|FG002|Overall Study|Withdrawal by Subject|5
2083419|NCT00713609|3667871|FG003|Overall Study|Withdrawal by Subject|1
2083420|NCT00713609|3667872|FG004|Overall Study|Withdrawal by Subject|5
2083421|NCT00713609|3667873|FG005|Overall Study|Withdrawal by Subject|7
2083422|NCT00713609|3667868|FG000|Overall Study|Protocol Violation|6
2083423|NCT00713609|3667869|FG001|Overall Study|Protocol Violation|3
2083424|NCT00713609|3667870|FG002|Overall Study|Protocol Violation|1
2083425|NCT00713609|3667871|FG003|Overall Study|Protocol Violation|1
2083426|NCT00713609|3667872|FG004|Overall Study|Protocol Violation|2
2083427|NCT00713609|3667873|FG005|Overall Study|Protocol Violation|0
2083428|NCT00713648|3667887|FG000|Overall Study|Adverse Event|1
2083429|NCT00713648|3667887|FG000|Overall Study|Unclassified|2
2083430|NCT00713648|3667887|FG000|Overall Study|According to Protocol|2
2083431|NCT00713648|3667887|FG000|Overall Study|Development of antibodies|3
2083432|NCT00713700|3667908|FG000|Overall Study|Lost to Follow-up|3
2083433|NCT00713700|3667908|FG000|Overall Study|Withdrawal by Subject|1
2083434|NCT00713830|3667923|FG000|Overall Study|Adverse Event|23
2083435|NCT00713830|3667924|FG001|Overall Study|Adverse Event|71
2305613|NCT02674386|4006880|FG001|Overall Study|Withdrawal by Subject|4
2305614|NCT02674386|4006881|FG002|Overall Study|Withdrawal by Subject|0
2305615|NCT02674386|4006879|FG000|Overall Study|Other|0
2305616|NCT02674386|4006880|FG001|Overall Study|Other|1
2083436|NCT00713830|3667923|FG000|Overall Study|Lack of Efficacy|24
2083437|NCT00713830|3667924|FG001|Overall Study|Lack of Efficacy|16
2083438|NCT00713830|3667923|FG000|Overall Study|Lost to Follow-up|2
2083439|NCT00713830|3667924|FG001|Overall Study|Lost to Follow-up|9
2083440|NCT00713830|3667923|FG000|Overall Study|Withdrawal by Subject|13
2083441|NCT00713830|3667924|FG001|Overall Study|Withdrawal by Subject|23
2083442|NCT00713830|3667923|FG000|Overall Study|Poor Compliance to Protocol|7
2083443|NCT00713830|3667924|FG001|Overall Study|Poor Compliance to Protocol|14
2083444|NCT00713830|3667923|FG000|Overall Study|Familial and Personal Reasons|9
2083445|NCT00713830|3667924|FG001|Overall Study|Familial and Personal Reasons|34
2083446|NCT00713830|3667923|FG000|Overall Study|Sponsor Decision|4
2083447|NCT00713830|3667924|FG001|Overall Study|Sponsor Decision|10
2083448|NCT00714051|3667932|FG000|Overall Study|Withdrawal by Subject|1
2083449|NCT00714051|3667933|FG001|Overall Study|Withdrawal by Subject|0
2083450|NCT00714051|3667932|FG000|Overall Study|Death|0
2083451|NCT00714051|3667933|FG001|Overall Study|Death|1
2083452|NCT00714168|3667941|FG000|Overall Study|Pregnancy|5
2083453|NCT00714168|3667942|FG001|Overall Study|Pregnancy|4
2083454|NCT00714168|3667941|FG000|Overall Study|Lost to Follow-up|32
2083455|NCT00714168|3667942|FG001|Overall Study|Lost to Follow-up|50
2083456|NCT00714168|3667941|FG000|Overall Study|Relocation|4
2083457|NCT00714168|3667942|FG001|Overall Study|Relocation|3
2083458|NCT00714168|3667941|FG000|Overall Study|Non-study medical condition|3
2083459|NCT00714168|3667942|FG001|Overall Study|Non-study medical condition|2
2083460|NCT00714259|3667970|FG000|Overall Study|Death|2
2107086|NCT00870233|3700469|FG000|Overall Study|Did not undergo laparotomy|3
2305617|NCT02674386|4006881|FG002|Overall Study|Other|0
2107087|NCT00870233|3700469|FG000|Overall Study|Incompatible internet browser|2
2107088|NCT00870233|3700469|FG000|Overall Study|Death|1
2107089|NCT00870584|3700516|FG000|Overall Study|Adverse Event|3
2107090|NCT00870584|3700517|FG001|Overall Study|Adverse Event|3
2107091|NCT00870584|3700516|FG000|Overall Study|Withdrawal by Subject|6
2083461|NCT00714285|3667987|FG000|Overall Study|Lost to Follow-up|0
2083462|NCT00714285|3667988|FG001|Overall Study|Lost to Follow-up|2
2083463|NCT00714285|3667989|FG002|Overall Study|Lost to Follow-up|0
2083464|NCT00714285|3667990|FG003|Overall Study|Lost to Follow-up|1
2083465|NCT00714285|3667987|FG000|Overall Study|Migrated/moved from study area|0
2083466|NCT00714285|3667988|FG001|Overall Study|Migrated/moved from study area|1
2083467|NCT00714285|3667989|FG002|Overall Study|Migrated/moved from study area|0
2083468|NCT00714285|3667990|FG003|Overall Study|Migrated/moved from study area|0
2083469|NCT00714415|3668017|FG000|Overall Study|Lack of Efficacy|1
2083470|NCT00714415|3668018|FG001|Overall Study|Lack of Efficacy|0
2083471|NCT00714415|3668017|FG000|Overall Study|Death|1
2083472|NCT00714415|3668018|FG001|Overall Study|Death|0
2083473|NCT00714493|3668024|FG000|Overall Study|Adverse Event|11
2083474|NCT00714493|3668024|FG000|Overall Study|Death|3
2083475|NCT00714493|3668024|FG000|Overall Study|Lack of Efficacy|10
2083476|NCT00714493|3668024|FG000|Overall Study|Lost to Follow-up|3
2083477|NCT00714493|3668024|FG000|Overall Study|Protocol Violation|12
2083478|NCT00714493|3668024|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
2083479|NCT00714493|3668024|FG000|Overall Study|OTHER|2
2083480|NCT00714688|3668056|FG000|Overall Study|Lack of Efficacy|14
2083481|NCT00714688|3668057|FG001|Overall Study|Lack of Efficacy|1
2083482|NCT00714688|3668058|FG002|Overall Study|Lack of Efficacy|4
2083483|NCT00714688|3668056|FG000|Overall Study|Withdrawal by Subject|4
2083484|NCT00714688|3668057|FG001|Overall Study|Withdrawal by Subject|3
2083485|NCT00714688|3668058|FG002|Overall Study|Withdrawal by Subject|3
2083486|NCT00714688|3668056|FG000|Overall Study|Lost to Follow-up|5
2083487|NCT00714688|3668057|FG001|Overall Study|Lost to Follow-up|2
2083488|NCT00714688|3668058|FG002|Overall Study|Lost to Follow-up|0
2083489|NCT00714688|3668056|FG000|Overall Study|Adverse Event|2
2083490|NCT00714688|3668057|FG001|Overall Study|Adverse Event|15
2083491|NCT00714688|3668058|FG002|Overall Study|Adverse Event|19
2083492|NCT00714688|3668056|FG000|Overall Study|Subject Non-compliant|3
2083493|NCT00714688|3668057|FG001|Overall Study|Subject Non-compliant|5
2083494|NCT00714688|3668058|FG002|Overall Study|Subject Non-compliant|5
2083495|NCT00714688|3668056|FG000|Overall Study|Ineligible to Continue the Study|0
2083496|NCT00714688|3668057|FG001|Overall Study|Ineligible to Continue the Study|1
2083497|NCT00714688|3668058|FG002|Overall Study|Ineligible to Continue the Study|1
2083498|NCT00714688|3668056|FG000|Overall Study|Sponsor's Decision|0
2083499|NCT00714688|3668057|FG001|Overall Study|Sponsor's Decision|2
2083500|NCT00714688|3668058|FG002|Overall Study|Sponsor's Decision|0
2083501|NCT00714688|3668056|FG000|Overall Study|Other|1
2083502|NCT00714688|3668057|FG001|Overall Study|Other|6
2083503|NCT00714688|3668058|FG002|Overall Study|Other|5
2083504|NCT00714714|3668066|FG000|Overall Study|Adverse Event|1
2083505|NCT00714870|3668087|FG000|Overall Study|Lost to Follow-up|22
2083506|NCT00714870|3668088|FG001|Overall Study|Lost to Follow-up|5
2083507|NCT00714870|3668087|FG000|Overall Study|patient unable to come b/c back pain|1
2083508|NCT00714870|3668088|FG001|Overall Study|patient unable to come b/c back pain|0
2083509|NCT00714870|3668087|FG000|Overall Study|did not attend minimum of 4 sessions|4
2083510|NCT00714870|3668088|FG001|Overall Study|did not attend minimum of 4 sessions|0
2083511|NCT00715026|3668094|FG000|Overall Study|Withdrawal by Subject|5
2083512|NCT00715026|3668094|FG000|Overall Study|Lost to Follow-up|3
2083513|NCT00715026|3668094|FG000|Overall Study|Protocol Violation|1
2083514|NCT00715026|3668094|FG000|Overall Study|Surgery done on non-study consented hip|1
2083515|NCT00715078|3668101|FG000|Overall Study|Death|29
2083516|NCT00715078|3668102|FG001|Overall Study|Death|36
2083517|NCT00715078|3668103|FG002|Overall Study|Death|36
2083518|NCT00715078|3668101|FG000|Overall Study|Withdrawal by Subject|1
2083519|NCT00715078|3668102|FG001|Overall Study|Withdrawal by Subject|0
2083520|NCT00715078|3668103|FG002|Overall Study|Withdrawal by Subject|1
2083521|NCT00715078|3668101|FG000|Overall Study|Unable to start due to disease prog.|0
2083522|NCT00715078|3668102|FG001|Overall Study|Unable to start due to disease prog.|0
2083523|NCT00715078|3668103|FG002|Overall Study|Unable to start due to disease prog.|1
2083524|NCT00715117|3668160|FG000|Overall Study|Crohn's flare and rescue with steroids|0
2083525|NCT00715117|3668161|FG001|Overall Study|Crohn's flare and rescue with steroids|1
2083526|NCT00715208|3668174|FG000|Overall Study|Withdrawal by Subject|1
2083527|NCT00715208|3668175|FG001|Overall Study|Withdrawal by Subject|1
2083528|NCT00715208|3668174|FG000|Overall Study|Adverse Event|0
2083529|NCT00715208|3668175|FG001|Overall Study|Adverse Event|6
2083530|NCT00715208|3668174|FG000|Overall Study|Lack of Efficacy|0
2083531|NCT00715208|3668175|FG001|Overall Study|Lack of Efficacy|2
2083532|NCT00715299|3668181|FG000|Overall Study|Withdrawal by Subject|1
2083533|NCT00715299|3668181|FG000|Overall Study|Adverse Event|3
2083534|NCT00715299|3668181|FG000|Overall Study|failed the pre-screen exercise test|2
2083535|NCT00715403|3668196|FG000|Overall Study|Progressive disease|0
2083536|NCT00715403|3668197|FG001|Overall Study|Progressive disease|1
2083537|NCT00715403|3668198|FG002|Overall Study|Progressive disease|3
2083538|NCT00715403|3668199|FG003|Overall Study|Progressive disease|9
2083539|NCT00715403|3668200|FG004|Overall Study|Progressive disease|5
2083540|NCT00715403|3668201|FG005|Overall Study|Progressive disease|14
2083541|NCT00715403|3668202|FG006|Overall Study|Progressive disease|1
2083542|NCT00715403|3668196|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
2083543|NCT00715403|3668197|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
2083544|NCT00715403|3668198|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
2083545|NCT00715403|3668199|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
2083546|NCT00715403|3668200|FG004|Overall Study|Dose limiting Toxicity (DLT)|0
2083547|NCT00715403|3668201|FG005|Overall Study|Dose limiting Toxicity (DLT)|1
2083548|NCT00715403|3668202|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
2083549|NCT00715403|3668196|FG000|Overall Study|Other Adverse Event than DLT|1
2083550|NCT00715403|3668197|FG001|Overall Study|Other Adverse Event than DLT|0
2083551|NCT00715403|3668198|FG002|Overall Study|Other Adverse Event than DLT|0
2083552|NCT00715403|3668199|FG003|Overall Study|Other Adverse Event than DLT|0
2083553|NCT00715403|3668200|FG004|Overall Study|Other Adverse Event than DLT|0
2083554|NCT00715403|3668201|FG005|Overall Study|Other Adverse Event than DLT|2
2083555|NCT00715403|3668202|FG006|Overall Study|Other Adverse Event than DLT|0
2083556|NCT00715403|3668196|FG000|Overall Study|Protocol Violation|0
2083557|NCT00715403|3668197|FG001|Overall Study|Protocol Violation|0
2083558|NCT00715403|3668198|FG002|Overall Study|Protocol Violation|0
2083559|NCT00715403|3668199|FG003|Overall Study|Protocol Violation|0
2083560|NCT00715403|3668200|FG004|Overall Study|Protocol Violation|0
2083561|NCT00715403|3668201|FG005|Overall Study|Protocol Violation|1
2083562|NCT00715403|3668202|FG006|Overall Study|Protocol Violation|0
2083563|NCT00715403|3668196|FG000|Overall Study|Other reason not defined above|0
2083564|NCT00715403|3668197|FG001|Overall Study|Other reason not defined above|0
2083565|NCT00715403|3668198|FG002|Overall Study|Other reason not defined above|1
2083566|NCT00715403|3668199|FG003|Overall Study|Other reason not defined above|0
2083567|NCT00715403|3668200|FG004|Overall Study|Other reason not defined above|1
2083568|NCT00715403|3668201|FG005|Overall Study|Other reason not defined above|1
2083569|NCT00715403|3668202|FG006|Overall Study|Other reason not defined above|0
2083570|NCT00715429|3668220|FG000|Overall Study|Did not complete the study diary|0
2083571|NCT00715429|3668221|FG001|Overall Study|Did not complete the study diary|1
2083572|NCT00715520|3668230|FG000|Overall Study|Screen failure|8
2083573|NCT00715520|3668231|FG001|Overall Study|Screen failure|1
2083574|NCT00715520|3668232|FG002|Overall Study|Screen failure|1
2083575|NCT00715520|3668230|FG000|Overall Study|Withdrawal by Subject|2
2083576|NCT00715520|3668231|FG001|Overall Study|Withdrawal by Subject|0
2083577|NCT00715520|3668232|FG002|Overall Study|Withdrawal by Subject|1
2083578|NCT00715559|3668240|FG000|Overall Study|medication not tolerated - nausea|1
2083579|NCT00715624|3668246|FG000|Overall Study|Adverse Event|12
2083580|NCT00715624|3668247|FG001|Overall Study|Adverse Event|37
2083581|NCT00715624|3668246|FG000|Overall Study|Lack of Efficacy|11
2083582|NCT00715624|3668247|FG001|Overall Study|Lack of Efficacy|11
2083583|NCT00715624|3668246|FG000|Overall Study|Lost to Follow-up|1
2083584|NCT00715624|3668247|FG001|Overall Study|Lost to Follow-up|2
2083585|NCT00715624|3668246|FG000|Overall Study|Protocol Violation|1
2083586|NCT00715624|3668247|FG001|Overall Study|Protocol Violation|0
2083587|NCT00715624|3668246|FG000|Overall Study|Withdrawal by Subject|11
2083588|NCT00715624|3668247|FG001|Overall Study|Withdrawal by Subject|25
2083589|NCT00715624|3668246|FG000|Overall Study|Familial and personal reasons|10
2083590|NCT00715624|3668247|FG001|Overall Study|Familial and personal reasons|22
2083591|NCT00715624|3668246|FG000|Overall Study|Poor compliance|6
2083592|NCT00715624|3668247|FG001|Overall Study|Poor compliance|13
2083593|NCT00715624|3668246|FG000|Overall Study|Sponsor decision|0
2083594|NCT00715624|3668247|FG001|Overall Study|Sponsor decision|4
2083595|NCT00715624|3668246|FG000|Overall Study|Incorrect randomization (not treated)|0
2083596|NCT00715624|3668247|FG001|Overall Study|Incorrect randomization (not treated)|1
2083597|NCT00715624|3668246|FG000|Overall Study|Other|0
2083598|NCT00715624|3668247|FG001|Overall Study|Other|1
2083599|NCT00715676|3668265|FG000|Overall Study|Adverse Event|3
2083600|NCT00715676|3668266|FG001|Overall Study|Adverse Event|5
2083601|NCT00715676|3668267|FG002|Overall Study|Adverse Event|21
2083602|NCT00715676|3668265|FG000|Overall Study|Withdrawal by Subject|1
2083603|NCT00715676|3668266|FG001|Overall Study|Withdrawal by Subject|3
2083604|NCT00715676|3668267|FG002|Overall Study|Withdrawal by Subject|8
2083605|NCT00715676|3668265|FG000|Overall Study|Lost to Follow-up|1
2083606|NCT00715676|3668266|FG001|Overall Study|Lost to Follow-up|2
2083607|NCT00715676|3668267|FG002|Overall Study|Lost to Follow-up|1
2083608|NCT00715676|3668265|FG000|Overall Study|Terminated by Sponsor|1
2083609|NCT00715676|3668266|FG001|Overall Study|Terminated by Sponsor|0
2083610|NCT00715676|3668267|FG002|Overall Study|Terminated by Sponsor|0
2083611|NCT00715676|3668265|FG000|Overall Study|Did Not Meet Entry Criteria|0
2083612|NCT00715676|3668266|FG001|Overall Study|Did Not Meet Entry Criteria|0
2083613|NCT00715676|3668267|FG002|Overall Study|Did Not Meet Entry Criteria|1
2083614|NCT00715676|3668265|FG000|Overall Study|Use of Exclusionary Medication|0
2083615|NCT00715676|3668266|FG001|Overall Study|Use of Exclusionary Medication|0
2083616|NCT00715676|3668267|FG002|Overall Study|Use of Exclusionary Medication|1
2083617|NCT00715676|3668265|FG000|Overall Study|Elevated Blood Glucose|0
2083618|NCT00715676|3668266|FG001|Overall Study|Elevated Blood Glucose|1
2083619|NCT00715676|3668267|FG002|Overall Study|Elevated Blood Glucose|0
2083620|NCT00715793|3668307|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
2083621|NCT00715793|3668308|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
2083622|NCT00715793|3668307|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
2083623|NCT00715793|3668308|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
2083624|NCT00715910|3668328|FG000|Booster and ESFU Phase|Lost to Follow-up|0
2083625|NCT00715910|3668329|FG001|Booster and ESFU Phase|Lost to Follow-up|0
2083626|NCT00715910|3668330|FG002|Booster and ESFU Phase|Lost to Follow-up|0
2083627|NCT00715910|3668331|FG003|Booster and ESFU Phase|Lost to Follow-up|6
2083628|NCT00715910|3668332|FG004|Booster and ESFU Phase|Lost to Follow-up|1
2083629|NCT00715910|3668333|FG005|Booster and ESFU Phase|Lost to Follow-up|13
2083630|NCT00715910|3668328|FG000|Booster and ESFU Phase|Other|0
2083631|NCT00715910|3668329|FG001|Booster and ESFU Phase|Other|0
2083632|NCT00715910|3668330|FG002|Booster and ESFU Phase|Other|0
2083633|NCT00715910|3668331|FG003|Booster and ESFU Phase|Other|5
2083634|NCT00715910|3668332|FG004|Booster and ESFU Phase|Other|1
2083635|NCT00715910|3668333|FG005|Booster and ESFU Phase|Other|0
2083636|NCT00715949|3668349|FG000|Overall Study|could not finish first test|4
2083637|NCT00716092|3668375|FG000|Overall Study|Other incl. Lack of Efficacy|2
2083638|NCT00716092|3668376|FG001|Overall Study|Other incl. Lack of Efficacy|1
2083639|NCT00716092|3668377|FG002|Overall Study|Other incl. Lack of Efficacy|0
2083640|NCT00716144|3668389|FG000|Overall Study|Withdrawal by Subject|4
2083641|NCT00716144|3668390|FG001|Overall Study|Withdrawal by Subject|2
2083642|NCT00716144|3668391|FG002|Overall Study|Withdrawal by Subject|6
2083643|NCT00716144|3668392|FG003|Overall Study|Withdrawal by Subject|6
2083644|NCT00716144|3668389|FG000|Overall Study|Lost to Follow-up|2
2083645|NCT00716144|3668390|FG001|Overall Study|Lost to Follow-up|2
2083646|NCT00716144|3668391|FG002|Overall Study|Lost to Follow-up|1
2083647|NCT00716144|3668392|FG003|Overall Study|Lost to Follow-up|2
2083648|NCT00716144|3668389|FG000|Overall Study|Adverse Event|0
2083649|NCT00716144|3668390|FG001|Overall Study|Adverse Event|0
2083650|NCT00716144|3668391|FG002|Overall Study|Adverse Event|0
2083651|NCT00716144|3668392|FG003|Overall Study|Adverse Event|2
2083652|NCT00716144|3668389|FG000|Overall Study|Non-compliance|1
2083653|NCT00716144|3668390|FG001|Overall Study|Non-compliance|0
2083654|NCT00716144|3668391|FG002|Overall Study|Non-compliance|0
2083655|NCT00716144|3668392|FG003|Overall Study|Non-compliance|0
2083656|NCT00716144|3668389|FG000|Overall Study|Protocol Violation|2
2083657|NCT00716144|3668390|FG001|Overall Study|Protocol Violation|0
2083658|NCT00716144|3668391|FG002|Overall Study|Protocol Violation|1
2083659|NCT00716144|3668392|FG003|Overall Study|Protocol Violation|0
2083660|NCT00716144|3668389|FG000|Overall Study|Physician Decision|0
2083661|NCT00716144|3668390|FG001|Overall Study|Physician Decision|1
2083662|NCT00716144|3668391|FG002|Overall Study|Physician Decision|2
2083663|NCT00716144|3668392|FG003|Overall Study|Physician Decision|2
2083664|NCT00716144|3668389|FG000|Overall Study|Intercurrent illness|0
2083665|NCT00716144|3668390|FG001|Overall Study|Intercurrent illness|0
2083666|NCT00716144|3668391|FG002|Overall Study|Intercurrent illness|1
2083667|NCT00716144|3668392|FG003|Overall Study|Intercurrent illness|0
2083668|NCT00716144|3668389|FG000|Overall Study|Withdrew consent, allowed use of data|0
2083669|NCT00716144|3668390|FG001|Overall Study|Withdrew consent, allowed use of data|0
2083670|NCT00716144|3668391|FG002|Overall Study|Withdrew consent, allowed use of data|1
2083671|NCT00716144|3668392|FG003|Overall Study|Withdrew consent, allowed use of data|0
2083672|NCT00716144|3668389|FG000|Overall Study|Adverse event: left foot pain|0
2083673|NCT00716144|3668390|FG001|Overall Study|Adverse event: left foot pain|1
2083674|NCT00716144|3668391|FG002|Overall Study|Adverse event: left foot pain|0
2083675|NCT00716144|3668392|FG003|Overall Study|Adverse event: left foot pain|0
2083676|NCT00716144|3668389|FG000|Overall Study|Clinical Depression|0
2083677|NCT00716144|3668390|FG001|Overall Study|Clinical Depression|1
2083678|NCT00716144|3668391|FG002|Overall Study|Clinical Depression|0
2083679|NCT00716144|3668392|FG003|Overall Study|Clinical Depression|0
2083680|NCT00716274|3668405|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2
2083681|NCT00716274|3668406|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0
2083682|NCT00716274|3668407|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0
2083683|NCT00716274|3668408|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0
2083684|NCT00716274|3668409|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0
2083685|NCT00716274|3668410|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0
2305618|NCT02674386|4006879|FG000|Overall Study|Enrolled but not evaluated|0
2305619|NCT02674386|4006880|FG001|Overall Study|Enrolled but not evaluated|4
2305620|NCT02674386|4006881|FG002|Overall Study|Enrolled but not evaluated|0
2305621|NCT02674399|4006896|FG000|Overall Study|Lost to Follow-up|2
2305622|NCT02674399|4006897|FG001|Overall Study|Lost to Follow-up|0
2305623|NCT02674477|4006913|FG000|Overall Study|Protocol Violation|8
2083686|NCT00716274|3668405|FG000|Study Period II (16-Weeks)|Protocol Violation|0
2083687|NCT00716274|3668406|FG001|Study Period II (16-Weeks)|Protocol Violation|3
2083688|NCT00716274|3668407|FG002|Study Period II (16-Weeks)|Protocol Violation|0
2083689|NCT00716274|3668408|FG003|Study Period II (16-Weeks)|Protocol Violation|0
2083690|NCT00716274|3668409|FG004|Study Period II (16-Weeks)|Protocol Violation|0
2083691|NCT00716274|3668410|FG005|Study Period II (16-Weeks)|Protocol Violation|1
2083692|NCT00716274|3668405|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1
2083693|NCT00716274|3668406|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0
2083694|NCT00716274|3668407|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0
2083695|NCT00716274|3668408|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0
2083696|NCT00716274|3668409|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0
2083697|NCT00716274|3668410|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0
2305624|NCT02674477|4006914|FG001|Overall Study|Protocol Violation|2
2083698|NCT00716274|3668405|FG000|Study Period II (16-Weeks)|Physician Decision|3
2083699|NCT00716274|3668406|FG001|Study Period II (16-Weeks)|Physician Decision|1
2083700|NCT00716274|3668407|FG002|Study Period II (16-Weeks)|Physician Decision|0
2083701|NCT00716274|3668408|FG003|Study Period II (16-Weeks)|Physician Decision|0
2083702|NCT00716274|3668409|FG004|Study Period II (16-Weeks)|Physician Decision|0
2083703|NCT00716274|3668410|FG005|Study Period II (16-Weeks)|Physician Decision|1
2083704|NCT00716274|3668405|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
2083705|NCT00716274|3668406|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
2083706|NCT00716274|3668407|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
2083707|NCT00716274|3668408|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
2083708|NCT00716274|3668409|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
2083709|NCT00716274|3668410|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
2083710|NCT00716274|3668405|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0
2211486|NCT01661140|3851803|FG001|Open-Label Period|Sponsor termination|0
2211487|NCT01661140|3851804|FG002|Open-Label Period|Sponsor termination|0
2211488|NCT01661140|3851802|FG000|Open-Label Period|Did not meet EULAR criteria|1
2211489|NCT01661140|3851803|FG001|Open-Label Period|Did not meet EULAR criteria|0
2211490|NCT01661140|3851804|FG002|Open-Label Period|Did not meet EULAR criteria|0
2211491|NCT01661140|3851802|FG000|Open-Label Period|Lost to Follow-up|2
2211492|NCT01661140|3851803|FG001|Open-Label Period|Lost to Follow-up|0
2211493|NCT01661140|3851804|FG002|Open-Label Period|Lost to Follow-up|0
2211494|NCT01661140|3851802|FG000|Double-Blind Period|Refused Treatment|0
2211495|NCT01661140|3851803|FG001|Double-Blind Period|Refused Treatment|0
2211496|NCT01661140|3851804|FG002|Double-Blind Period|Refused Treatment|1
2211497|NCT01661140|3851802|FG000|Double-Blind Period|Adverse Event|0
2211498|NCT01661140|3851803|FG001|Double-Blind Period|Adverse Event|16
2211499|NCT01661140|3851804|FG002|Double-Blind Period|Adverse Event|18
2211500|NCT01661140|3851802|FG000|Double-Blind Period|Protocol Violation|0
2305625|NCT02674568|4006920|FG000|Overall Study|Withdrawal by Subject|5
2083711|NCT00716274|3668406|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2
2083712|NCT00716274|3668407|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0
2083713|NCT00716274|3668408|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0
2083714|NCT00716274|3668409|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0
2083715|NCT00716274|3668410|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0
2083716|NCT00716274|3668405|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0
2083717|NCT00716274|3668406|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0
2083718|NCT00716274|3668407|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2
2083719|NCT00716274|3668408|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0
2083720|NCT00716274|3668409|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0
2083721|NCT00716274|3668410|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0
2083722|NCT00716274|3668405|FG000|Study Period III (16-Weeks)|Physician Decision|0
2083723|NCT00716274|3668406|FG001|Study Period III (16-Weeks)|Physician Decision|0
2083724|NCT00716274|3668407|FG002|Study Period III (16-Weeks)|Physician Decision|0
2083725|NCT00716274|3668408|FG003|Study Period III (16-Weeks)|Physician Decision|0
2083726|NCT00716274|3668409|FG004|Study Period III (16-Weeks)|Physician Decision|1
2083727|NCT00716274|3668410|FG005|Study Period III (16-Weeks)|Physician Decision|0
2083728|NCT00716274|3668405|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0
2083729|NCT00716274|3668406|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0
2083730|NCT00716274|3668407|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0
2083731|NCT00716274|3668408|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1
2083732|NCT00716274|3668409|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1
2083733|NCT00716274|3668410|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0
2083734|NCT00716274|3668405|FG000|Study Period III (16-Weeks)|Adverse Event|0
2083735|NCT00716274|3668406|FG001|Study Period III (16-Weeks)|Adverse Event|0
2083736|NCT00716274|3668407|FG002|Study Period III (16-Weeks)|Adverse Event|0
2083737|NCT00716274|3668408|FG003|Study Period III (16-Weeks)|Adverse Event|0
2083738|NCT00716274|3668409|FG004|Study Period III (16-Weeks)|Adverse Event|1
2083739|NCT00716274|3668410|FG005|Study Period III (16-Weeks)|Adverse Event|0
2083740|NCT00716417|3668437|FG000|Overall Study|Adverse Event|0
2083741|NCT00716417|3668438|FG001|Overall Study|Adverse Event|0
2305626|NCT02674568|4006920|FG000|Overall Study|Death|303
2305627|NCT02674568|4006920|FG000|Overall Study|Physician Decision|2
2305628|NCT02674568|4006920|FG000|Overall Study|Lost to Follow-up|9
2305629|NCT02674568|4006920|FG000|Overall Study|Other, Not Specified|20
2305630|NCT02674633|4006931|FG000|Overall Study|Lost to Follow-up|3
2305631|NCT02674633|4006932|FG001|Overall Study|Lost to Follow-up|2
2305632|NCT02674633|4006931|FG000|Overall Study|Physician Decision|1
2305633|NCT02674633|4006932|FG001|Overall Study|Physician Decision|0
2305634|NCT02674633|4006931|FG000|Overall Study|Withdrawal by Parent/Guardian|1
2305635|NCT02674633|4006932|FG001|Overall Study|Withdrawal by Parent/Guardian|2
2305636|NCT02674685|4006947|FG000|Overall Study|Protocol Violation|4
2305637|NCT02674854|4006954|FG000|Overall Study|Adverse Event|17
2305638|NCT02674854|4006955|FG001|Overall Study|Adverse Event|15
2305639|NCT02674854|4006956|FG002|Overall Study|Adverse Event|5
2305640|NCT02674854|4006954|FG000|Overall Study|Withdrawal by Subject|1
2305641|NCT02674854|4006955|FG001|Overall Study|Withdrawal by Subject|5
2305642|NCT02674854|4006956|FG002|Overall Study|Withdrawal by Subject|4
2305643|NCT02674854|4006954|FG000|Overall Study|No-compliant subject|1
2083742|NCT00716417|3668439|FG002|Overall Study|Adverse Event|2
2083743|NCT00716417|3668440|FG003|Overall Study|Adverse Event|1
2083744|NCT00716417|3668441|FG004|Overall Study|Adverse Event|0
2083745|NCT00716417|3668442|FG005|Overall Study|Adverse Event|0
2083746|NCT00716417|3668443|FG006|Overall Study|Adverse Event|3
2083747|NCT00716417|3668444|FG007|Overall Study|Adverse Event|1
2083748|NCT00716417|3668445|FG008|Overall Study|Adverse Event|0
2083749|NCT00716417|3668446|FG009|Overall Study|Adverse Event|3
2083750|NCT00716417|3668437|FG000|Overall Study|Withdrawal by Subject|0
2083751|NCT00716417|3668438|FG001|Overall Study|Withdrawal by Subject|1
2083752|NCT00716417|3668439|FG002|Overall Study|Withdrawal by Subject|0
2083753|NCT00716417|3668440|FG003|Overall Study|Withdrawal by Subject|2
2083754|NCT00716417|3668441|FG004|Overall Study|Withdrawal by Subject|0
2083755|NCT00716417|3668442|FG005|Overall Study|Withdrawal by Subject|0
2083756|NCT00716417|3668443|FG006|Overall Study|Withdrawal by Subject|1
2083757|NCT00716417|3668444|FG007|Overall Study|Withdrawal by Subject|0
2083758|NCT00716417|3668445|FG008|Overall Study|Withdrawal by Subject|0
2083759|NCT00716417|3668446|FG009|Overall Study|Withdrawal by Subject|0
2083760|NCT00716417|3668437|FG000|Overall Study|Progressive disease|3
2083761|NCT00716417|3668438|FG001|Overall Study|Progressive disease|5
2083762|NCT00716417|3668439|FG002|Overall Study|Progressive disease|3
2083763|NCT00716417|3668440|FG003|Overall Study|Progressive disease|8
2083764|NCT00716417|3668441|FG004|Overall Study|Progressive disease|0
2083765|NCT00716417|3668442|FG005|Overall Study|Progressive disease|3
2083766|NCT00716417|3668443|FG006|Overall Study|Progressive disease|3
2083767|NCT00716417|3668444|FG007|Overall Study|Progressive disease|1
2083768|NCT00716417|3668445|FG008|Overall Study|Progressive disease|5
2083769|NCT00716417|3668446|FG009|Overall Study|Progressive disease|0
2083770|NCT00716417|3668437|FG000|Overall Study|Dose limiting toxicity (DLT)|0
2083771|NCT00716417|3668438|FG001|Overall Study|Dose limiting toxicity (DLT)|0
2211501|NCT01661140|3851803|FG001|Double-Blind Period|Protocol Violation|2
2211502|NCT01661140|3851804|FG002|Double-Blind Period|Protocol Violation|3
2211503|NCT01661140|3851802|FG000|Double-Blind Period|Withdrawal by Subject|0
2211504|NCT01661140|3851803|FG001|Double-Blind Period|Withdrawal by Subject|1
2083772|NCT00716417|3668439|FG002|Overall Study|Dose limiting toxicity (DLT)|0
2083773|NCT00716417|3668440|FG003|Overall Study|Dose limiting toxicity (DLT)|0
2083774|NCT00716417|3668441|FG004|Overall Study|Dose limiting toxicity (DLT)|1
2083775|NCT00716417|3668442|FG005|Overall Study|Dose limiting toxicity (DLT)|0
2083776|NCT00716417|3668443|FG006|Overall Study|Dose limiting toxicity (DLT)|0
2083777|NCT00716417|3668444|FG007|Overall Study|Dose limiting toxicity (DLT)|0
2083778|NCT00716417|3668445|FG008|Overall Study|Dose limiting toxicity (DLT)|0
2083779|NCT00716417|3668446|FG009|Overall Study|Dose limiting toxicity (DLT)|0
2083780|NCT00716417|3668437|FG000|Overall Study|On patient request due to toxicities|0
2083781|NCT00716417|3668438|FG001|Overall Study|On patient request due to toxicities|0
2083782|NCT00716417|3668439|FG002|Overall Study|On patient request due to toxicities|0
2083783|NCT00716417|3668440|FG003|Overall Study|On patient request due to toxicities|0
2083784|NCT00716417|3668441|FG004|Overall Study|On patient request due to toxicities|0
2083785|NCT00716417|3668442|FG005|Overall Study|On patient request due to toxicities|0
2083786|NCT00716417|3668443|FG006|Overall Study|On patient request due to toxicities|0
2083787|NCT00716417|3668444|FG007|Overall Study|On patient request due to toxicities|1
2083788|NCT00716417|3668445|FG008|Overall Study|On patient request due to toxicities|0
2083789|NCT00716417|3668446|FG009|Overall Study|On patient request due to toxicities|0
2083790|NCT00716456|3668478|FG000|Overall Study|Adverse Event|0
2083791|NCT00716456|3668479|FG001|Overall Study|Adverse Event|2
2083792|NCT00716456|3668480|FG002|Overall Study|Adverse Event|0
2083793|NCT00716482|3668488|FG000|Overall Study|Lost to Follow-up|6
2083794|NCT00716482|3668488|FG000|Overall Study|Inadequate acquisition or analysis|50
2083795|NCT00716482|3668488|FG000|Overall Study|no pathology obtained|10
2083796|NCT00716482|3668488|FG000|Overall Study|technical/machine error|28
2083797|NCT00716482|3668488|FG000|Overall Study|inclusion/exclusion criteria not met|25
2083798|NCT00716625|3668503|FG000|Overall Study|Safety was not Assessable|1
2083799|NCT00716859|3668561|FG000|Overall Study|Adverse Event|4
2083800|NCT00716859|3668562|FG001|Overall Study|Adverse Event|1
2083801|NCT00716859|3668561|FG000|Overall Study|Lack of Efficacy|3
2083802|NCT00716859|3668562|FG001|Overall Study|Lack of Efficacy|0
2083803|NCT00716859|3668561|FG000|Overall Study|Withdrawal by Subject|1
2083804|NCT00716859|3668562|FG001|Overall Study|Withdrawal by Subject|3
2083805|NCT00716859|3668561|FG000|Overall Study|Not treated|1
2083806|NCT00716859|3668562|FG001|Overall Study|Not treated|1
2083807|NCT00716976|3668583|FG000|Overall Study|Adverse Event|2
2083808|NCT00716976|3668584|FG001|Overall Study|Adverse Event|0
2083809|NCT00716976|3668583|FG000|Overall Study|Death|1
2083810|NCT00716976|3668584|FG001|Overall Study|Death|0
2083811|NCT00716976|3668583|FG000|Overall Study|Physician Decision|2
2083812|NCT00716976|3668584|FG001|Overall Study|Physician Decision|2
2083813|NCT00716976|3668583|FG000|Overall Study|Withdrawal by Subject|5
2083814|NCT00716976|3668584|FG001|Overall Study|Withdrawal by Subject|1
2083815|NCT00716976|3668583|FG000|Overall Study|Premature discontinuation cisplatin|5
2083816|NCT00716976|3668584|FG001|Overall Study|Premature discontinuation cisplatin|4
2083817|NCT00716976|3668583|FG000|Overall Study|Radiation during protocol|1
2083818|NCT00716976|3668584|FG001|Overall Study|Radiation during protocol|0
2083819|NCT00716976|3668583|FG000|Overall Study|Ineligibles|4
2083820|NCT00716976|3668584|FG001|Overall Study|Ineligibles|2
2083821|NCT00717067|3668613|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
2083822|NCT00717067|3668614|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
2083823|NCT00717067|3668615|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
2083824|NCT00717067|3668616|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
2083825|NCT00717067|3668617|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
2083826|NCT00717093|3668641|FG000|Overall Study|Adverse Event|19
2083827|NCT00717093|3668642|FG001|Overall Study|Adverse Event|9
2083828|NCT00717093|3668641|FG000|Overall Study|Lack of Efficacy|3
2083829|NCT00717093|3668642|FG001|Overall Study|Lack of Efficacy|13
2083830|NCT00717093|3668641|FG000|Overall Study|Lost to Follow-up|9
2083831|NCT00717093|3668642|FG001|Overall Study|Lost to Follow-up|6
2083832|NCT00717093|3668641|FG000|Overall Study|Withdrawal by Subject|12
2083833|NCT00717093|3668642|FG001|Overall Study|Withdrawal by Subject|19
2083834|NCT00717093|3668641|FG000|Overall Study|Other|0
2083835|NCT00717093|3668642|FG001|Overall Study|Other|1
2083836|NCT00717093|3668641|FG000|Overall Study|Randomized but not treated|1
2083837|NCT00717093|3668642|FG001|Overall Study|Randomized but not treated|0
2083838|NCT00717197|3668648|FG000|Overall Study|Unable to purchase study drug|5
2083839|NCT00717197|3668648|FG000|Overall Study|Tumor Progression|1
2083840|NCT00717197|3668648|FG000|Overall Study|Physician Decision|1
2083841|NCT00717236|3668654|FG000|Double-Blind Period|Adverse Event|33
2083842|NCT00717236|3668655|FG001|Double-Blind Period|Adverse Event|6
2083843|NCT00717236|3668654|FG000|Double-Blind Period|Lack of Efficacy|6
2083844|NCT00717236|3668655|FG001|Double-Blind Period|Lack of Efficacy|6
2083845|NCT00717236|3668654|FG000|Double-Blind Period|Lost to Follow-up|3
2083846|NCT00717236|3668655|FG001|Double-Blind Period|Lost to Follow-up|5
2083847|NCT00717236|3668654|FG000|Double-Blind Period|Withdrawal by Subject|10
2083848|NCT00717236|3668655|FG001|Double-Blind Period|Withdrawal by Subject|2
2083849|NCT00717236|3668654|FG000|Double-Blind Period|Loss of efficacy|3
2083850|NCT00717236|3668655|FG001|Double-Blind Period|Loss of efficacy|0
2083851|NCT00717236|3668654|FG000|Double-Blind Period|Other: Death|1
2083852|NCT00717236|3668655|FG001|Double-Blind Period|Other: Death|0
2083853|NCT00717236|3668654|FG000|Double-Blind Period|Other: Pregnancy|1
2083854|NCT00717236|3668655|FG001|Double-Blind Period|Other: Pregnancy|0
2083855|NCT00717236|3668654|FG000|Double-Blind Period|Other: Protocol Violation|2
2083856|NCT00717236|3668655|FG001|Double-Blind Period|Other: Protocol Violation|0
2083857|NCT00717236|3668654|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
2083858|NCT00717236|3668655|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
2083859|NCT00717236|3668654|FG000|Double-Blind Period|Other: Site withdrew|2
2083860|NCT00717236|3668655|FG001|Double-Blind Period|Other: Site withdrew|0
2083861|NCT00717236|3668654|FG000|Double-Blind Period|Other: Screening failure|1
2083862|NCT00717236|3668655|FG001|Double-Blind Period|Other: Screening failure|0
2083863|NCT00717236|3668654|FG000|Double-Blind Period|Other: subject withdrew consent|1
2083864|NCT00717236|3668655|FG001|Double-Blind Period|Other: subject withdrew consent|1
2083865|NCT00717236|3668654|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2
2083866|NCT00717236|3668655|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1
2083867|NCT00717236|3668654|FG000|Double-Blind Period|Other: History of adenoid grown|1
2083868|NCT00717236|3668655|FG001|Double-Blind Period|Other: History of adenoid grown|0
2083869|NCT00717236|3668654|FG000|Double-Blind Period|Other: History of cancer|1
2083870|NCT00717236|3668655|FG001|Double-Blind Period|Other: History of cancer|0
2211505|NCT01661140|3851804|FG002|Double-Blind Period|Withdrawal by Subject|3
2083871|NCT00717236|3668654|FG000|Double-Blind Period|Other: Sponsor request|1
2083872|NCT00717236|3668655|FG001|Double-Blind Period|Other: Sponsor request|0
2083873|NCT00717236|3668654|FG000|Double-Blind Period|Other: Inappropriate randomization|1
2083874|NCT00717236|3668655|FG001|Double-Blind Period|Other: Inappropriate randomization|0
2083875|NCT00717236|3668654|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
2083876|NCT00717236|3668655|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
2083877|NCT00717236|3668654|FG000|Double-Blind Period|Other: Subject moved|1
2083878|NCT00717236|3668655|FG001|Double-Blind Period|Other: Subject moved|1
2083879|NCT00717236|3668654|FG000|Double-Blind Period|Other: Stopped taking DMARD|1
2083880|NCT00717236|3668655|FG001|Double-Blind Period|Other: Stopped taking DMARD|0
2083881|NCT00717236|3668654|FG000|Double-Blind Period|Other: Prohibited medication taken|2
2083882|NCT00717236|3668655|FG001|Double-Blind Period|Other: Prohibited medication taken|2
2083883|NCT00717236|3668654|FG000|Double-Blind Period|Other: Transportation problems|0
2083884|NCT00717236|3668655|FG001|Double-Blind Period|Other: Transportation problems|1
2083885|NCT00717236|3668654|FG000|Double-Blind Period|Other: Investigator Decision|0
2083886|NCT00717236|3668655|FG001|Double-Blind Period|Other: Investigator Decision|1
2083887|NCT00717236|3668654|FG000|Open-Label Period|Adverse Event|29
2211506|NCT01661140|3851802|FG000|Double-Blind Period|Investigator's Decision|0
2211507|NCT01661140|3851803|FG001|Double-Blind Period|Investigator's Decision|1
2083888|NCT00717236|3668655|FG001|Open-Label Period|Adverse Event|4
2083889|NCT00717236|3668654|FG000|Open-Label Period|Lack of Efficacy|30
2083890|NCT00717236|3668655|FG001|Open-Label Period|Lack of Efficacy|8
2083891|NCT00717236|3668654|FG000|Open-Label Period|Lost to Follow-up|28
2083892|NCT00717236|3668655|FG001|Open-Label Period|Lost to Follow-up|4
2083893|NCT00717236|3668654|FG000|Open-Label Period|Withdrawal by Subject|20
2083894|NCT00717236|3668655|FG001|Open-Label Period|Withdrawal by Subject|2
2083895|NCT00717236|3668654|FG000|Open-Label Period|Loss of Efficacy|6
2083896|NCT00717236|3668655|FG001|Open-Label Period|Loss of Efficacy|1
2083897|NCT00717236|3668654|FG000|Open-Label Period|Other: Peripheral Neuropathy|0
2083898|NCT00717236|3668655|FG001|Open-Label Period|Other: Peripheral Neuropathy|1
2083899|NCT00717236|3668654|FG000|Open-Label Period|Other: Lack of Compliance|1
2083900|NCT00717236|3668655|FG001|Open-Label Period|Other: Lack of Compliance|1
2083901|NCT00717236|3668654|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1
2083902|NCT00717236|3668655|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0
2083903|NCT00717236|3668654|FG000|Open-Label Period|Other: Moved|1
2083904|NCT00717236|3668655|FG001|Open-Label Period|Other: Moved|0
2083905|NCT00717236|3668654|FG000|Open-Label Period|Other: Investigator Decision|1
2083906|NCT00717236|3668655|FG001|Open-Label Period|Other: Investigator Decision|0
2083907|NCT00717236|3668654|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1
2083908|NCT00717236|3668655|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0
2083909|NCT00717236|3668654|FG000|Open-Label Period|Other: Sponsor Request|3
2083910|NCT00717236|3668655|FG001|Open-Label Period|Other: Sponsor Request|0
2083911|NCT00717236|3668654|FG000|Open-Label Period|Other: Cataract Surgery|1
2083912|NCT00717236|3668655|FG001|Open-Label Period|Other: Cataract Surgery|0
2083913|NCT00717236|3668654|FG000|Open-Label Period|Other: Administration of Golimumab|1
2083914|NCT00717236|3668655|FG001|Open-Label Period|Other: Administration of Golimumab|0
2083915|NCT00717236|3668654|FG000|Open-Label Period|Other: Completion Accidently Performed|1
2083916|NCT00717236|3668655|FG001|Open-Label Period|Other: Completion Accidently Performed|0
2083917|NCT00717236|3668654|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1
2083918|NCT00717236|3668655|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0
2083919|NCT00717249|3668665|FG000|Overall Study|Lens Discomfort|4
2083920|NCT00717249|3668666|FG001|Overall Study|Lens Discomfort|1
2083921|NCT00717249|3668665|FG000|Overall Study|Unsatisfactory visual Response|0
2083922|NCT00717249|3668666|FG001|Overall Study|Unsatisfactory visual Response|2
2083923|NCT00717249|3668665|FG000|Overall Study|Adverse Event|4
2083924|NCT00717249|3668666|FG001|Overall Study|Adverse Event|2
2083925|NCT00717249|3668665|FG000|Overall Study|Lost to Follow-up|2
2083926|NCT00717249|3668666|FG001|Overall Study|Lost to Follow-up|0
2083927|NCT00717249|3668665|FG000|Overall Study|Withdrawal by Subject|1
2083928|NCT00717249|3668666|FG001|Overall Study|Withdrawal by Subject|2
2083929|NCT00717249|3668665|FG000|Overall Study|Pregnancy|6
2083930|NCT00717249|3668666|FG001|Overall Study|Pregnancy|3
2083931|NCT00717249|3668665|FG000|Overall Study|Protocol Violation|0
2083932|NCT00717249|3668666|FG001|Overall Study|Protocol Violation|2
2083933|NCT00717249|3668665|FG000|Overall Study|Subject became Ineligible|1
2083934|NCT00717249|3668666|FG001|Overall Study|Subject became Ineligible|1
2083935|NCT00717249|3668665|FG000|Overall Study|Unsatisfactory Physiological Response|0
2083936|NCT00717249|3668666|FG001|Overall Study|Unsatisfactory Physiological Response|1
2083937|NCT00717249|3668665|FG000|Overall Study|Gastric Surgery|0
2083938|NCT00717249|3668666|FG001|Overall Study|Gastric Surgery|1
2083939|NCT00717249|3668665|FG000|Overall Study|Diagnosed with Diabetes|1
2083940|NCT00717249|3668666|FG001|Overall Study|Diagnosed with Diabetes|0
2083941|NCT00717249|3668665|FG000|Overall Study|Diagnosed with Multiple Scletosis|1
2083942|NCT00717249|3668666|FG001|Overall Study|Diagnosed with Multiple Scletosis|0
2083943|NCT00717249|3668665|FG000|Overall Study|Subject relocated|1
2083944|NCT00717249|3668666|FG001|Overall Study|Subject relocated|0
2083945|NCT00717249|3668665|FG000|Overall Study|Headaches|1
2083946|NCT00717249|3668666|FG001|Overall Study|Headaches|0
2083947|NCT00717314|3668693|FG000|Overall Study|Adverse Event|3
2083948|NCT00717314|3668694|FG001|Overall Study|Adverse Event|2
2083949|NCT00717314|3668693|FG000|Overall Study|Protocol Violation|1
2083950|NCT00717314|3668694|FG001|Overall Study|Protocol Violation|0
2083951|NCT00717314|3668693|FG000|Overall Study|Lost to Follow-up|1
2083952|NCT00717314|3668694|FG001|Overall Study|Lost to Follow-up|5
2083953|NCT00717314|3668693|FG000|Overall Study|Withdrawal by Subject|1
2083954|NCT00717314|3668694|FG001|Overall Study|Withdrawal by Subject|3
2083955|NCT00717366|3668702|FG000|Core Study Period (20 Weeks)|Renal transplant|4
2083956|NCT00717366|3668703|FG001|Core Study Period (20 Weeks)|Renal transplant|9
2083957|NCT00717366|3668702|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0
2083958|NCT00717366|3668703|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2
2083959|NCT00717366|3668702|FG000|Core Study Period (20 Weeks)|Death|0
2083960|NCT00717366|3668703|FG001|Core Study Period (20 Weeks)|Death|1
2083961|NCT00717366|3668702|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
2083962|NCT00717366|3668703|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
2083963|NCT00717366|3668702|FG000|Extension Period (52 Weeks)|Renal transplant|3
2083964|NCT00717366|3668703|FG001|Extension Period (52 Weeks)|Renal transplant|13
2083965|NCT00717366|3668702|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0
2083966|NCT00717366|3668703|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2
2083967|NCT00717366|3668702|FG000|Extension Period (52 Weeks)|Withdrew consent|1
2083968|NCT00717366|3668703|FG001|Extension Period (52 Weeks)|Withdrew consent|1
2083969|NCT00717522|3668724|FG000|Overall Study|Disease Progression|5
2083970|NCT00717522|3668724|FG000|Overall Study|Adverse Event|1
2083971|NCT00717522|3668724|FG000|Overall Study|Death|1
2083972|NCT00717756|3668741|FG000|Overall Study|Withdrawal by Subject|1
2083973|NCT00717769|3668748|FG000|Overall Study|Adverse Event|9
2083974|NCT00717769|3668749|FG001|Overall Study|Adverse Event|6
2083975|NCT00717769|3668750|FG002|Overall Study|Adverse Event|1
2083976|NCT00717769|3668748|FG000|Overall Study|Lack of compliance|0
2083977|NCT00717769|3668749|FG001|Overall Study|Lack of compliance|2
2083978|NCT00717769|3668750|FG002|Overall Study|Lack of compliance|0
2083979|NCT00717769|3668748|FG000|Overall Study|Lost to Follow-up|3
2083980|NCT00717769|3668749|FG001|Overall Study|Lost to Follow-up|4
2083981|NCT00717769|3668750|FG002|Overall Study|Lost to Follow-up|0
2083982|NCT00717769|3668748|FG000|Overall Study|Lack of Efficacy|1
2083983|NCT00717769|3668749|FG001|Overall Study|Lack of Efficacy|2
2083984|NCT00717769|3668750|FG002|Overall Study|Lack of Efficacy|0
2083985|NCT00717769|3668748|FG000|Overall Study|Protocol Violation|0
2083986|NCT00717769|3668749|FG001|Overall Study|Protocol Violation|2
2083987|NCT00717769|3668750|FG002|Overall Study|Protocol Violation|0
2083988|NCT00717769|3668748|FG000|Overall Study|Sponsor decision|1
2083989|NCT00717769|3668749|FG001|Overall Study|Sponsor decision|0
2083990|NCT00717769|3668750|FG002|Overall Study|Sponsor decision|10
2083991|NCT00717769|3668748|FG000|Overall Study|Withdrew consent|2
2083992|NCT00717769|3668749|FG001|Overall Study|Withdrew consent|2
2083993|NCT00717769|3668750|FG002|Overall Study|Withdrew consent|0
2083994|NCT00717860|3668762|FG000|Overall Study|Clinical adverse experience|5
2083995|NCT00717860|3668763|FG001|Overall Study|Clinical adverse experience|9
2083996|NCT00717860|3668762|FG000|Overall Study|Laboratory adverse experience|2
2083997|NCT00717860|3668763|FG001|Overall Study|Laboratory adverse experience|2
2083998|NCT00717860|3668762|FG000|Overall Study|Lack of Efficacy|7
2083999|NCT00717860|3668763|FG001|Overall Study|Lack of Efficacy|13
2084000|NCT00717860|3668762|FG000|Overall Study|Discontinued for other reason|6
2084001|NCT00717860|3668763|FG001|Overall Study|Discontinued for other reason|1
2084002|NCT00717860|3668762|FG000|Overall Study|Withdrew consent|7
2084003|NCT00717860|3668763|FG001|Overall Study|Withdrew consent|3
2084004|NCT00717886|3668778|FG000|Overall Study|Withdrawal by Subject|3
2084005|NCT00717886|3668778|FG000|Overall Study|Treatment Failure|1
2084006|NCT00718042|3668806|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
2084007|NCT00718042|3668807|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
2084008|NCT00718042|3668808|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
2084009|NCT00718042|3668809|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
2084010|NCT00718042|3668810|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
2084011|NCT00718042|3668811|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
2084012|NCT00718042|3668806|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64
2084013|NCT00718042|3668807|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0
2084014|NCT00718042|3668808|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0
2084015|NCT00718042|3668809|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0
2084016|NCT00718042|3668810|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36
2084017|NCT00718042|3668811|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0
2084018|NCT00718042|3668806|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0
2084019|NCT00718042|3668807|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1
2084020|NCT00718042|3668808|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1
2084021|NCT00718042|3668809|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0
2084022|NCT00718042|3668810|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0
2084023|NCT00718042|3668811|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0
2084024|NCT00718042|3668806|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
2084025|NCT00718042|3668807|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
2084026|NCT00718042|3668808|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
2084027|NCT00718042|3668809|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
2084028|NCT00718042|3668810|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
2084029|NCT00718042|3668811|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
2084030|NCT00718042|3668806|FG000|Donor Follow-up|Lost to Follow-up|13
2084031|NCT00718042|3668807|FG001|Donor Follow-up|Lost to Follow-up|0
2084032|NCT00718042|3668808|FG002|Donor Follow-up|Lost to Follow-up|0
2084033|NCT00718042|3668809|FG003|Donor Follow-up|Lost to Follow-up|0
2084034|NCT00718042|3668810|FG004|Donor Follow-up|Lost to Follow-up|19
2084035|NCT00718042|3668811|FG005|Donor Follow-up|Lost to Follow-up|0
2084036|NCT00718081|3668826|FG000|Overall Study|Adverse Event|0
2084037|NCT00718081|3668827|FG001|Overall Study|Adverse Event|1
2084038|NCT00718081|3668828|FG002|Overall Study|Adverse Event|0
2084039|NCT00718081|3668826|FG000|Overall Study|Lack of Efficacy|7
2084040|NCT00718081|3668827|FG001|Overall Study|Lack of Efficacy|3
2084041|NCT00718081|3668828|FG002|Overall Study|Lack of Efficacy|21
2084042|NCT00718159|3668861|FG000|Overall Study|Progressive Disease|3
2084043|NCT00718159|3668862|FG001|Overall Study|Progressive Disease|3
2084044|NCT00718159|3668863|FG002|Overall Study|Progressive Disease|2
2084045|NCT00718159|3668864|FG003|Overall Study|Progressive Disease|0
2084046|NCT00718159|3668865|FG004|Overall Study|Progressive Disease|6
2084047|NCT00718159|3668866|FG005|Overall Study|Progressive Disease|0
2084048|NCT00718159|3668867|FG006|Overall Study|Progressive Disease|0
2084049|NCT00718159|3668861|FG000|Overall Study|Death due to Adverse Event|0
2084050|NCT00718159|3668862|FG001|Overall Study|Death due to Adverse Event|0
2084051|NCT00718159|3668863|FG002|Overall Study|Death due to Adverse Event|0
2084052|NCT00718159|3668864|FG003|Overall Study|Death due to Adverse Event|2
2084053|NCT00718159|3668865|FG004|Overall Study|Death due to Adverse Event|2
2084054|NCT00718159|3668866|FG005|Overall Study|Death due to Adverse Event|0
2084055|NCT00718159|3668867|FG006|Overall Study|Death due to Adverse Event|0
2084056|NCT00718159|3668861|FG000|Overall Study|Death due to Study Drug Toxicity|0
2084057|NCT00718159|3668862|FG001|Overall Study|Death due to Study Drug Toxicity|0
2084058|NCT00718159|3668863|FG002|Overall Study|Death due to Study Drug Toxicity|1
2084059|NCT00718159|3668864|FG003|Overall Study|Death due to Study Drug Toxicity|2
2084060|NCT00718159|3668865|FG004|Overall Study|Death due to Study Drug Toxicity|0
2084061|NCT00718159|3668866|FG005|Overall Study|Death due to Study Drug Toxicity|0
2084062|NCT00718159|3668867|FG006|Overall Study|Death due to Study Drug Toxicity|0
2084063|NCT00718159|3668861|FG000|Overall Study|Investigator Decision|0
2084064|NCT00718159|3668862|FG001|Overall Study|Investigator Decision|0
2084065|NCT00718159|3668863|FG002|Overall Study|Investigator Decision|0
2084066|NCT00718159|3668864|FG003|Overall Study|Investigator Decision|0
2084067|NCT00718159|3668865|FG004|Overall Study|Investigator Decision|0
2084068|NCT00718159|3668866|FG005|Overall Study|Investigator Decision|1
2084069|NCT00718159|3668867|FG006|Overall Study|Investigator Decision|1
2084070|NCT00718237|3668885|FG000|Overall Study|Adverse Event|1
2084071|NCT00718237|3668886|FG001|Overall Study|Adverse Event|3
2084072|NCT00718237|3668885|FG000|Overall Study|Lost to Follow-up|2
2084073|NCT00718237|3668886|FG001|Overall Study|Lost to Follow-up|2
2084074|NCT00718237|3668885|FG000|Overall Study|Physician Decision|1
2084075|NCT00718237|3668886|FG001|Overall Study|Physician Decision|0
2084076|NCT00718237|3668885|FG000|Overall Study|Withdrawal by Subject|9
2084077|NCT00718237|3668886|FG001|Overall Study|Withdrawal by Subject|10
2084078|NCT00718315|3668908|FG000|Overall Study|Adverse Event|1
2084079|NCT00718315|3668909|FG001|Overall Study|Adverse Event|2
2084080|NCT00718315|3668910|FG002|Overall Study|Adverse Event|3
2084081|NCT00718315|3668908|FG000|Overall Study|Death|6
2084082|NCT00718315|3668909|FG001|Overall Study|Death|6
2084083|NCT00718315|3668910|FG002|Overall Study|Death|5
2084084|NCT00718315|3668908|FG000|Overall Study|Lost to Follow-up|2
2084085|NCT00718315|3668909|FG001|Overall Study|Lost to Follow-up|3
2084086|NCT00718315|3668910|FG002|Overall Study|Lost to Follow-up|4
2084087|NCT00718315|3668908|FG000|Overall Study|Protocol Violation|5
2084088|NCT00718315|3668909|FG001|Overall Study|Protocol Violation|5
2084089|NCT00718315|3668910|FG002|Overall Study|Protocol Violation|3
2084090|NCT00718315|3668908|FG000|Overall Study|Erlotinib dose decreased|4
2084091|NCT00718315|3668909|FG001|Overall Study|Erlotinib dose decreased|3
2084092|NCT00718315|3668910|FG002|Overall Study|Erlotinib dose decreased|1
2084093|NCT00718315|3668908|FG000|Overall Study|Use of Minocyclin|1
2084094|NCT00718315|3668909|FG001|Overall Study|Use of Minocyclin|1
2084095|NCT00718315|3668910|FG002|Overall Study|Use of Minocyclin|1
2084096|NCT00718315|3668908|FG000|Overall Study|Disease progression|0
2084097|NCT00718315|3668909|FG001|Overall Study|Disease progression|1
2084098|NCT00718315|3668910|FG002|Overall Study|Disease progression|1
2084099|NCT00718315|3668908|FG000|Overall Study|Other|0
2084100|NCT00718315|3668909|FG001|Overall Study|Other|0
2084101|NCT00718315|3668910|FG002|Overall Study|Other|1
2084102|NCT00718315|3668908|FG000|Overall Study|Use of ATB and Corticoids|0
2084103|NCT00718315|3668909|FG001|Overall Study|Use of ATB and Corticoids|1
2084104|NCT00718315|3668910|FG002|Overall Study|Use of ATB and Corticoids|2
2084105|NCT00718328|3668920|FG000|Overall Study|Lost to Follow-up|1
2084106|NCT00718328|3668921|FG001|Overall Study|Lost to Follow-up|0
2084107|NCT00718419|3668929|FG000|Overall Study|Adverse Event|2
2084108|NCT00718419|3668930|FG001|Overall Study|Adverse Event|1
2084109|NCT00718419|3668929|FG000|Overall Study|Physician Decision|1
2084110|NCT00718419|3668930|FG001|Overall Study|Physician Decision|6
2084111|NCT00718419|3668929|FG000|Overall Study|Sponsor decision|0
2084112|NCT00718419|3668930|FG001|Overall Study|Sponsor decision|1
2084113|NCT00718419|3668929|FG000|Overall Study|Withdrawal by Subject|0
2084114|NCT00718419|3668930|FG001|Overall Study|Withdrawal by Subject|5
2084115|NCT00718419|3668929|FG000|Overall Study|Progressive Disease|7
2084116|NCT00718419|3668930|FG001|Overall Study|Progressive Disease|25
2084117|NCT00718419|3668929|FG000|Overall Study|Death Due to Progressive Disease|2
2084118|NCT00718419|3668930|FG001|Overall Study|Death Due to Progressive Disease|0
2084119|NCT00718419|3668929|FG000|Overall Study|Death Due to Study Drug Related|0
2084120|NCT00718419|3668930|FG001|Overall Study|Death Due to Study Drug Related|1
2084121|NCT00718419|3668929|FG000|Overall Study|Death Due to Adverse Events|1
2084122|NCT00718419|3668930|FG001|Overall Study|Death Due to Adverse Events|0
2084123|NCT00718510|3668938|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
2084124|NCT00718510|3668939|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
2084125|NCT00718510|3668938|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
2084126|NCT00718510|3668939|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
2084127|NCT00718523|3668947|FG000|Overall Study|Withdrawal by Subject|5
2084128|NCT00718523|3668948|FG001|Overall Study|Withdrawal by Subject|7
2084129|NCT00718523|3668947|FG000|Overall Study|Death|13
2084130|NCT00718523|3668948|FG001|Overall Study|Death|17
2084131|NCT00718549|3668954|FG000|Induction Phase|Disease Progression|1
2084132|NCT00718549|3668955|FG001|Induction Phase|Disease Progression|0
2084133|NCT00718549|3668956|FG002|Induction Phase|Disease Progression|0
2084134|NCT00718549|3668954|FG000|Induction Phase|Eligibility Criteria Violation|2
2084135|NCT00718549|3668955|FG001|Induction Phase|Eligibility Criteria Violation|0
2084136|NCT00718549|3668956|FG002|Induction Phase|Eligibility Criteria Violation|0
2084137|NCT00718549|3668954|FG000|Induction Phase|Early Termination - No Additional Info|59
2084138|NCT00718549|3668955|FG001|Induction Phase|Early Termination - No Additional Info|0
2084139|NCT00718549|3668956|FG002|Induction Phase|Early Termination - No Additional Info|0
2084140|NCT00718549|3668954|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
2084141|NCT00718549|3668955|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
2084142|NCT00718549|3668956|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
2084143|NCT00718549|3668954|FG000|Maintenance/ Observation Phase|Death|0
2084144|NCT00718549|3668955|FG001|Maintenance/ Observation Phase|Death|1
2084145|NCT00718549|3668956|FG002|Maintenance/ Observation Phase|Death|2
2084146|NCT00718549|3668954|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0
2084147|NCT00718549|3668955|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4
2084148|NCT00718549|3668956|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4
2084149|NCT00718549|3668954|FG000|Maintenance/ Observation Phase|Progression|0
2084150|NCT00718549|3668955|FG001|Maintenance/ Observation Phase|Progression|5
2084151|NCT00718549|3668956|FG002|Maintenance/ Observation Phase|Progression|14
2084152|NCT00718549|3668954|FG000|Maintenance/ Observation Phase|Relapse|0
2084153|NCT00718549|3668955|FG001|Maintenance/ Observation Phase|Relapse|3
2084154|NCT00718549|3668956|FG002|Maintenance/ Observation Phase|Relapse|2
2084155|NCT00718666|3668972|FG000|Booster Phase Year 5|No active participation request|0
2084156|NCT00718666|3668973|FG001|Booster Phase Year 5|No active participation request|0
2084157|NCT00718666|3668974|FG002|Booster Phase Year 5|No active participation request|1
2084158|NCT00718666|3668972|FG000|Booster Phase Year 5|Declined v-4 serology|1
2084159|NCT00718666|3668973|FG001|Booster Phase Year 5|Declined v-4 serology|0
2084160|NCT00718666|3668974|FG002|Booster Phase Year 5|Declined v-4 serology|0
2084161|NCT00718666|3668972|FG000|Booster Phase Year 5|Withdrawal by Subject|0
2084162|NCT00718666|3668973|FG001|Booster Phase Year 5|Withdrawal by Subject|0
2084163|NCT00718666|3668974|FG002|Booster Phase Year 5|Withdrawal by Subject|1
2084164|NCT00718666|3668972|FG000|Booster Phase Year 5|Lost to Follow-up|1
2084165|NCT00718666|3668973|FG001|Booster Phase Year 5|Lost to Follow-up|0
2084166|NCT00718666|3668974|FG002|Booster Phase Year 5|Lost to Follow-up|4
2084167|NCT00718718|3668999|FG000|Prior to Week 12|Adverse Event|0
2084168|NCT00718718|3669000|FG001|Prior to Week 12|Adverse Event|0
2084169|NCT00718718|3669001|FG002|Prior to Week 12|Adverse Event|0
2084170|NCT00718718|3669002|FG003|Prior to Week 12|Adverse Event|0
2084171|NCT00718718|3669003|FG004|Prior to Week 12|Adverse Event|0
2084172|NCT00718718|3669004|FG005|Prior to Week 12|Adverse Event|0
2084173|NCT00718718|3669005|FG006|Prior to Week 12|Adverse Event|0
2084174|NCT00718718|3669006|FG007|Prior to Week 12|Adverse Event|1
2084175|NCT00718718|3669007|FG008|Prior to Week 12|Adverse Event|1
2084176|NCT00718718|3669008|FG009|Prior to Week 12|Adverse Event|0
2084177|NCT00718718|3668999|FG000|Prior to Week 12|Withdrawal by Subject|0
2084178|NCT00718718|3669000|FG001|Prior to Week 12|Withdrawal by Subject|0
2084179|NCT00718718|3669001|FG002|Prior to Week 12|Withdrawal by Subject|0
2084180|NCT00718718|3669002|FG003|Prior to Week 12|Withdrawal by Subject|0
2084181|NCT00718718|3669003|FG004|Prior to Week 12|Withdrawal by Subject|3
2084182|NCT00718718|3669004|FG005|Prior to Week 12|Withdrawal by Subject|0
2084183|NCT00718718|3669005|FG006|Prior to Week 12|Withdrawal by Subject|1
2084184|NCT00718718|3669006|FG007|Prior to Week 12|Withdrawal by Subject|1
2084185|NCT00718718|3669007|FG008|Prior to Week 12|Withdrawal by Subject|1
2084186|NCT00718718|3669008|FG009|Prior to Week 12|Withdrawal by Subject|0
2084187|NCT00718718|3668999|FG000|Prior to Week 12|Other|1
2084188|NCT00718718|3669000|FG001|Prior to Week 12|Other|0
2084189|NCT00718718|3669001|FG002|Prior to Week 12|Other|1
2084190|NCT00718718|3669002|FG003|Prior to Week 12|Other|0
2084191|NCT00718718|3669003|FG004|Prior to Week 12|Other|0
2084192|NCT00718718|3669004|FG005|Prior to Week 12|Other|0
2084193|NCT00718718|3669005|FG006|Prior to Week 12|Other|0
2084194|NCT00718718|3669006|FG007|Prior to Week 12|Other|0
2084195|NCT00718718|3669007|FG008|Prior to Week 12|Other|0
2084196|NCT00718718|3669008|FG009|Prior to Week 12|Other|0
2084197|NCT00718718|3668999|FG000|Week 12 to End of Study|Adverse Event|0
2084198|NCT00718718|3669000|FG001|Week 12 to End of Study|Adverse Event|0
2084199|NCT00718718|3669001|FG002|Week 12 to End of Study|Adverse Event|0
2084200|NCT00718718|3669002|FG003|Week 12 to End of Study|Adverse Event|0
2084201|NCT00718718|3669003|FG004|Week 12 to End of Study|Adverse Event|0
2084202|NCT00718718|3669004|FG005|Week 12 to End of Study|Adverse Event|0
2084203|NCT00718718|3669005|FG006|Week 12 to End of Study|Adverse Event|0
2084204|NCT00718718|3669006|FG007|Week 12 to End of Study|Adverse Event|1
2084205|NCT00718718|3669007|FG008|Week 12 to End of Study|Adverse Event|0
2084206|NCT00718718|3669008|FG009|Week 12 to End of Study|Adverse Event|0
2084207|NCT00718718|3668999|FG000|Week 12 to End of Study|Death|0
2084208|NCT00718718|3669000|FG001|Week 12 to End of Study|Death|0
2084209|NCT00718718|3669001|FG002|Week 12 to End of Study|Death|0
2084210|NCT00718718|3669002|FG003|Week 12 to End of Study|Death|0
2084211|NCT00718718|3669003|FG004|Week 12 to End of Study|Death|0
2084212|NCT00718718|3669004|FG005|Week 12 to End of Study|Death|1
2084213|NCT00718718|3669005|FG006|Week 12 to End of Study|Death|0
2084214|NCT00718718|3669006|FG007|Week 12 to End of Study|Death|0
2084215|NCT00718718|3669007|FG008|Week 12 to End of Study|Death|0
2084216|NCT00718718|3669008|FG009|Week 12 to End of Study|Death|0
2084217|NCT00718718|3668999|FG000|Week 12 to End of Study|Withdrawal by Subject|0
2084218|NCT00718718|3669000|FG001|Week 12 to End of Study|Withdrawal by Subject|0
2084219|NCT00718718|3669001|FG002|Week 12 to End of Study|Withdrawal by Subject|0
2084220|NCT00718718|3669002|FG003|Week 12 to End of Study|Withdrawal by Subject|0
2084221|NCT00718718|3669003|FG004|Week 12 to End of Study|Withdrawal by Subject|0
2084222|NCT00718718|3669004|FG005|Week 12 to End of Study|Withdrawal by Subject|2
2084223|NCT00718718|3669005|FG006|Week 12 to End of Study|Withdrawal by Subject|1
2084224|NCT00718718|3669006|FG007|Week 12 to End of Study|Withdrawal by Subject|0
2084225|NCT00718718|3669007|FG008|Week 12 to End of Study|Withdrawal by Subject|0
2084226|NCT00718718|3669008|FG009|Week 12 to End of Study|Withdrawal by Subject|0
2084227|NCT00718718|3668999|FG000|Week 12 to End of Study|Lost to Follow-up|0
2084228|NCT00718718|3669000|FG001|Week 12 to End of Study|Lost to Follow-up|0
2084229|NCT00718718|3669001|FG002|Week 12 to End of Study|Lost to Follow-up|0
2084230|NCT00718718|3669002|FG003|Week 12 to End of Study|Lost to Follow-up|0
2084231|NCT00718718|3669003|FG004|Week 12 to End of Study|Lost to Follow-up|0
2084232|NCT00718718|3669004|FG005|Week 12 to End of Study|Lost to Follow-up|0
2084233|NCT00718718|3669005|FG006|Week 12 to End of Study|Lost to Follow-up|0
2084234|NCT00718718|3669006|FG007|Week 12 to End of Study|Lost to Follow-up|0
2084235|NCT00718718|3669007|FG008|Week 12 to End of Study|Lost to Follow-up|1
2084236|NCT00718718|3669008|FG009|Week 12 to End of Study|Lost to Follow-up|0
2084237|NCT00718718|3668999|FG000|Week 12 to End of Study|Other|0
2084238|NCT00718718|3669000|FG001|Week 12 to End of Study|Other|1
2084239|NCT00718718|3669001|FG002|Week 12 to End of Study|Other|0
2084240|NCT00718718|3669002|FG003|Week 12 to End of Study|Other|1
2084241|NCT00718718|3669003|FG004|Week 12 to End of Study|Other|0
2084242|NCT00718718|3669004|FG005|Week 12 to End of Study|Other|0
2084243|NCT00718718|3669005|FG006|Week 12 to End of Study|Other|1
2084244|NCT00718718|3669006|FG007|Week 12 to End of Study|Other|0
2084245|NCT00718718|3669007|FG008|Week 12 to End of Study|Other|0
2084246|NCT00718718|3669008|FG009|Week 12 to End of Study|Other|0
2084247|NCT00718770|3669034|FG000|Overall Study|Adverse Event|1
2084248|NCT00718770|3669034|FG000|Overall Study|Lack of Efficacy|1
2084249|NCT00718770|3669034|FG000|Overall Study|Lack of Efficacy|1
2084250|NCT00718770|3669034|FG000|Overall Study|Adverse Event|1
2084251|NCT00718770|3669034|FG000|Overall Study|Lack of Efficacy|1
2084252|NCT00718770|3669034|FG000|Overall Study|Adverse Event|1
2084253|NCT00718770|3669034|FG000|Overall Study|Lack of Efficacy|1
2084254|NCT00718770|3669034|FG000|Overall Study|Adverse Event|1
2084255|NCT00718809|3669040|FG000|Overall Study|Disease progression|9
2084256|NCT00718809|3669041|FG001|Overall Study|Disease progression|7
2084257|NCT00718809|3669040|FG000|Overall Study|Adverse Event|1
2084258|NCT00718809|3669041|FG001|Overall Study|Adverse Event|1
2084259|NCT00718809|3669040|FG000|Overall Study|Withdrawal by Subject|0
2084260|NCT00718809|3669041|FG001|Overall Study|Withdrawal by Subject|1
2084261|NCT00718809|3669040|FG000|Overall Study|Lost to Follow-up|1
2084262|NCT00718809|3669041|FG001|Overall Study|Lost to Follow-up|0
2084263|NCT00718809|3669040|FG000|Overall Study|Noncompliance|1
2084264|NCT00718809|3669041|FG001|Overall Study|Noncompliance|0
2084265|NCT00718861|3669049|FG000|Overall Study|Withdrawal by Subject|15
2084266|NCT00718861|3669050|FG001|Overall Study|Withdrawal by Subject|10
2084267|NCT00718861|3669049|FG000|Overall Study|Adverse Event|2
2084268|NCT00718861|3669050|FG001|Overall Study|Adverse Event|1
2084269|NCT00718861|3669049|FG000|Overall Study|Lost to Follow-up|2
2084270|NCT00718861|3669050|FG001|Overall Study|Lost to Follow-up|1
2084271|NCT00718861|3669049|FG000|Overall Study|Administrative Problems|1
2084272|NCT00718861|3669050|FG001|Overall Study|Administrative Problems|1
2084273|NCT00718861|3669049|FG000|Overall Study|Death|1
2084274|NCT00718861|3669050|FG001|Overall Study|Death|5
2084275|NCT00718887|3669058|FG000|Overall Study|Withdrawal by Subject|3
2084276|NCT00718887|3669059|FG001|Overall Study|Withdrawal by Subject|2
2084277|NCT00718887|3669058|FG000|Overall Study|Not identified|2
2084278|NCT00718887|3669059|FG001|Overall Study|Not identified|7
2084279|NCT00719043|3669078|FG000|Overall Study|Adverse Event|5
2084280|NCT00719043|3669079|FG001|Overall Study|Adverse Event|1
2084281|NCT00719043|3669080|FG002|Overall Study|Adverse Event|2
2084282|NCT00719043|3669081|FG003|Overall Study|Adverse Event|2
2084283|NCT00719043|3669082|FG004|Overall Study|Adverse Event|1
2084284|NCT00719043|3669083|FG005|Overall Study|Adverse Event|4
2084285|NCT00719043|3669084|FG006|Overall Study|Adverse Event|4
2084286|NCT00719043|3669078|FG000|Overall Study|Lost to Follow-up|14
2084287|NCT00719043|3669079|FG001|Overall Study|Lost to Follow-up|10
2084288|NCT00719043|3669080|FG002|Overall Study|Lost to Follow-up|8
2305644|NCT02674854|4006955|FG001|Overall Study|No-compliant subject|0
2305645|NCT02674854|4006956|FG002|Overall Study|No-compliant subject|1
2305646|NCT02674854|4006954|FG000|Overall Study|Lost to Follow-up|1
2305647|NCT02674854|4006955|FG001|Overall Study|Lost to Follow-up|0
2305648|NCT02674854|4006956|FG002|Overall Study|Lost to Follow-up|2
2305649|NCT02674854|4006954|FG000|Overall Study|Lack of Efficacy|0
2305650|NCT02674854|4006955|FG001|Overall Study|Lack of Efficacy|3
2305651|NCT02674854|4006956|FG002|Overall Study|Lack of Efficacy|0
2305652|NCT02674854|4006954|FG000|Overall Study|Disallowed Concurrent Medication|2
2084289|NCT00719043|3669081|FG003|Overall Study|Lost to Follow-up|9
2084290|NCT00719043|3669082|FG004|Overall Study|Lost to Follow-up|10
2084291|NCT00719043|3669083|FG005|Overall Study|Lost to Follow-up|9
2084292|NCT00719043|3669084|FG006|Overall Study|Lost to Follow-up|9
2084293|NCT00719043|3669078|FG000|Overall Study|Protocol Violation|0
2084294|NCT00719043|3669079|FG001|Overall Study|Protocol Violation|0
2084295|NCT00719043|3669080|FG002|Overall Study|Protocol Violation|0
2084296|NCT00719043|3669081|FG003|Overall Study|Protocol Violation|0
2084297|NCT00719043|3669082|FG004|Overall Study|Protocol Violation|0
2084298|NCT00719043|3669083|FG005|Overall Study|Protocol Violation|1
2084299|NCT00719043|3669084|FG006|Overall Study|Protocol Violation|0
2084300|NCT00719043|3669078|FG000|Overall Study|Other|1
2084301|NCT00719043|3669079|FG001|Overall Study|Other|0
2084302|NCT00719043|3669080|FG002|Overall Study|Other|1
2084303|NCT00719043|3669081|FG003|Overall Study|Other|2
2084304|NCT00719043|3669082|FG004|Overall Study|Other|0
2084305|NCT00719043|3669083|FG005|Overall Study|Other|2
2084306|NCT00719043|3669084|FG006|Overall Study|Other|1
2084307|NCT00719043|3669078|FG000|Overall Study|Withdrawal by Subject|12
2084308|NCT00719043|3669079|FG001|Overall Study|Withdrawal by Subject|14
2084309|NCT00719043|3669080|FG002|Overall Study|Withdrawal by Subject|9
2084310|NCT00719043|3669081|FG003|Overall Study|Withdrawal by Subject|10
2084311|NCT00719043|3669082|FG004|Overall Study|Withdrawal by Subject|16
2084312|NCT00719043|3669083|FG005|Overall Study|Withdrawal by Subject|18
2084313|NCT00719043|3669084|FG006|Overall Study|Withdrawal by Subject|14
2084314|NCT00719212|3669134|FG000|Overall Study|Death|41
2084315|NCT00719212|3669134|FG000|Overall Study|Lost to Follow-up|2
2084316|NCT00719212|3669134|FG000|Overall Study|Withdrawal by Subject|1
2084317|NCT00719264|3669140|FG000|Overall Study|Adverse Event|41
2084318|NCT00719264|3669141|FG001|Overall Study|Adverse Event|49
2084319|NCT00719264|3669140|FG000|Overall Study|Death|13
2084320|NCT00719264|3669141|FG001|Overall Study|Death|10
2084321|NCT00719264|3669140|FG000|Overall Study|Administrative Problems|6
2084322|NCT00719264|3669141|FG001|Overall Study|Administrative Problems|4
2084323|NCT00719264|3669140|FG000|Overall Study|Lost to Follow-up|1
2084324|NCT00719264|3669141|FG001|Overall Study|Lost to Follow-up|1
2084325|NCT00719264|3669140|FG000|Overall Study|Withdrawal by Subject|12
2084326|NCT00719264|3669141|FG001|Overall Study|Withdrawal by Subject|7
2084327|NCT00719264|3669140|FG000|Overall Study|Protocol Deviation|1
2084328|NCT00719264|3669141|FG001|Overall Study|Protocol Deviation|3
2084329|NCT00719264|3669140|FG000|Overall Study|New Cancer Therapy|4
2084330|NCT00719264|3669141|FG001|Overall Study|New Cancer Therapy|2
2084331|NCT00719264|3669140|FG000|Overall Study|Disease Progression|104
2084332|NCT00719264|3669141|FG001|Overall Study|Disease Progression|107
2084333|NCT00719355|3669165|FG000|Overall Study|Death|0
2084334|NCT00719355|3669166|FG001|Overall Study|Death|1
2084335|NCT00719355|3669165|FG000|Overall Study|Medical|14
2084336|NCT00719355|3669166|FG001|Overall Study|Medical|5
2084337|NCT00719355|3669165|FG000|Overall Study|Compliance|4
2084338|NCT00719355|3669166|FG001|Overall Study|Compliance|6
2084339|NCT00719355|3669165|FG000|Overall Study|Moved|0
2084340|NCT00719355|3669166|FG001|Overall Study|Moved|1
2084341|NCT00719472|3669172|FG000|Enrolled in Study|Physician decision to withdraw patient|1
2084342|NCT00719472|3669172|FG000|Enrolled in Study|Subject decision to withdraw|8
2084343|NCT00719472|3669172|FG000|Enrolled in Study|Various Reasons|17
2084344|NCT00719472|3669172|FG000|Received Cycle 1 Treatment|Adverse Event|8
2084345|NCT00719472|3669172|FG000|Received Cycle 1 Treatment|Death|5
2084346|NCT00719472|3669172|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
2084347|NCT00719472|3669172|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
2084348|NCT00719472|3669172|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9
2084349|NCT00719472|3669172|FG000|Received Cycle 1 Treatment|Various Reasons|13
2084350|NCT00719472|3669172|FG000|Received Cycle 2 Treatment|Adverse Event|12
2084351|NCT00719472|3669172|FG000|Received Cycle 2 Treatment|Death|6
2084352|NCT00719472|3669172|FG000|Received Cycle 2 Treatment|Disease progression|3
2084353|NCT00719472|3669172|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3
2084354|NCT00719472|3669172|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
2084355|NCT00719472|3669172|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6
2084356|NCT00719472|3669172|FG000|Received Cycle 2 Treatment|Various Reasons|25
2084357|NCT00719537|3669178|FG000|Overall Study|Withdrawal by Subject|1
2084358|NCT00719537|3669179|FG001|Overall Study|Withdrawal by Subject|0
2084359|NCT00719537|3669178|FG000|Overall Study|Lost to Follow-up|0
2084360|NCT00719537|3669179|FG001|Overall Study|Lost to Follow-up|1
2107092|NCT00870584|3700517|FG001|Overall Study|Withdrawal by Subject|7
2107093|NCT00870584|3700516|FG000|Overall Study|Lost to Follow-up|5
2107094|NCT00870584|3700517|FG001|Overall Study|Lost to Follow-up|1
2107095|NCT00870584|3700516|FG000|Overall Study|Protocol Deviation|2
2107096|NCT00870584|3700517|FG001|Overall Study|Protocol Deviation|2
2107097|NCT00870727|3700525|FG000|Overall Study|Lost to Follow-up|0
2107098|NCT00870727|3700526|FG001|Overall Study|Lost to Follow-up|1
2107099|NCT00870727|3700525|FG000|Overall Study|Lack of Efficacy|1
2107100|NCT00870727|3700526|FG001|Overall Study|Lack of Efficacy|3
2107101|NCT00870727|3700525|FG000|Overall Study|Adverse Event|0
2107102|NCT00870727|3700526|FG001|Overall Study|Adverse Event|1
2107103|NCT00870740|3700538|FG000|Overall Study|Adverse Event|2
2107104|NCT00870740|3700539|FG001|Overall Study|Adverse Event|1
2107105|NCT00870740|3700540|FG002|Overall Study|Adverse Event|3
2107106|NCT00870740|3700541|FG003|Overall Study|Adverse Event|2
2107107|NCT00870740|3700542|FG004|Overall Study|Adverse Event|1
2107108|NCT00870740|3700543|FG005|Overall Study|Adverse Event|6
2107109|NCT00870740|3700538|FG000|Overall Study|Consent Withdrawn|6
2107110|NCT00870740|3700539|FG001|Overall Study|Consent Withdrawn|3
2107111|NCT00870740|3700540|FG002|Overall Study|Consent Withdrawn|4
2211508|NCT01661140|3851804|FG002|Double-Blind Period|Investigator's Decision|2
2211509|NCT01661140|3851802|FG000|Double-Blind Period|Sponsor Termination|0
2211510|NCT01661140|3851803|FG001|Double-Blind Period|Sponsor Termination|14
2211511|NCT01661140|3851804|FG002|Double-Blind Period|Sponsor Termination|17
2211512|NCT01661140|3851802|FG000|Double-Blind Period|Administrative/Other|0
2211513|NCT01661140|3851803|FG001|Double-Blind Period|Administrative/Other|7
2211514|NCT01661140|3851804|FG002|Double-Blind Period|Administrative/Other|6
2211515|NCT01661179|3851812|FG000|Overall Study|Death|1
2084361|NCT00719563|3669187|FG000|Overall Study|Adverse Event|16
2084362|NCT00719563|3669188|FG001|Overall Study|Adverse Event|13
2084363|NCT00719563|3669187|FG000|Overall Study|Medical condition changed|3
2084364|NCT00719563|3669188|FG001|Overall Study|Medical condition changed|5
2084365|NCT00719563|3669187|FG000|Overall Study|Lack of Efficacy|3
2084366|NCT00719563|3669188|FG001|Overall Study|Lack of Efficacy|7
2084367|NCT00719563|3669187|FG000|Overall Study|Personal reasons|6
2084368|NCT00719563|3669188|FG001|Overall Study|Personal reasons|7
2084369|NCT00719563|3669187|FG000|Overall Study|Unknown reasons|4
2084370|NCT00719563|3669188|FG001|Overall Study|Unknown reasons|6
2084371|NCT00719563|3669187|FG000|Overall Study|Noncompliant|1
2084372|NCT00719563|3669188|FG001|Overall Study|Noncompliant|1
2084373|NCT00719563|3669187|FG000|Overall Study|Lost to Follow-up|5
2084374|NCT00719563|3669188|FG001|Overall Study|Lost to Follow-up|3
2084375|NCT00719680|3669219|FG000|Overall Study|Adverse Event|1
2084376|NCT00719680|3669219|FG000|Overall Study|Lost to Follow-up|1
2084377|NCT00719680|3669219|FG000|Overall Study|Withdrawal by Subject|3
2084378|NCT00719706|3669225|FG000|Overall Study|Adverse Event|5
2084379|NCT00719706|3669226|FG001|Overall Study|Adverse Event|4
2084380|NCT00719706|3669225|FG000|Overall Study|Withdrawal by Subject|1
2084381|NCT00719706|3669226|FG001|Overall Study|Withdrawal by Subject|2
2084382|NCT00719706|3669225|FG000|Overall Study|Protocol Violation|3
2084383|NCT00719706|3669226|FG001|Overall Study|Protocol Violation|0
2084384|NCT00719732|3669232|FG000|Overall Study|Lost to Follow-up|20
2084385|NCT00719732|3669232|FG000|Overall Study|Unilateral (not bilateral) implantation|1
2084386|NCT00719732|3669232|FG000|Overall Study|Illness not associated with device|1
2084387|NCT00719810|3669239|FG000|Overall Study|Adverse Event|0
2084388|NCT00719810|3669240|FG001|Overall Study|Adverse Event|2
2084389|NCT00719810|3669241|FG002|Overall Study|Adverse Event|3
2084390|NCT00719810|3669239|FG000|Overall Study|Lost to Follow-up|2
2084391|NCT00719810|3669240|FG001|Overall Study|Lost to Follow-up|0
2084392|NCT00719810|3669241|FG002|Overall Study|Lost to Follow-up|3
2084393|NCT00719810|3669239|FG000|Overall Study|Physician Decision|0
2084394|NCT00719810|3669240|FG001|Overall Study|Physician Decision|1
2084395|NCT00719810|3669241|FG002|Overall Study|Physician Decision|0
2084396|NCT00719810|3669239|FG000|Overall Study|Withdrawal by Subject|1
2084397|NCT00719810|3669240|FG001|Overall Study|Withdrawal by Subject|1
2084398|NCT00719810|3669241|FG002|Overall Study|Withdrawal by Subject|2
2084399|NCT00719849|3669251|FG000|Overall Study|Death|0
2084400|NCT00719849|3669252|FG001|Overall Study|Death|1
2084401|NCT00719862|3669260|FG000|Overall Study|Adverse Event|1
2084402|NCT00719862|3669261|FG001|Overall Study|Adverse Event|2
2084403|NCT00719862|3669260|FG000|Overall Study|Lack of Efficacy|3
2084404|NCT00719862|3669261|FG001|Overall Study|Lack of Efficacy|0
2084405|NCT00719862|3669260|FG000|Overall Study|Non-Compliance|1
2084406|NCT00719862|3669261|FG001|Overall Study|Non-Compliance|0
2084407|NCT00719862|3669260|FG000|Overall Study|Withdrawal by Subject|1
2084408|NCT00719862|3669261|FG001|Overall Study|Withdrawal by Subject|0
2084409|NCT00719862|3669260|FG000|Overall Study|Lost to Follow-up|0
2084410|NCT00719862|3669261|FG001|Overall Study|Lost to Follow-up|1
2084411|NCT00719862|3669260|FG000|Overall Study|Other|2
2084412|NCT00719862|3669261|FG001|Overall Study|Other|3
2084413|NCT00719901|3669267|FG000|Overall Study|Adverse Event|5
2084414|NCT00719901|3669267|FG000|Overall Study|Withdrawal by Subject|1
2084415|NCT00719901|3669267|FG000|Overall Study|Alternate Treatment|1
2084416|NCT00719901|3669267|FG000|Overall Study|Disease Progression|3
2084417|NCT00719901|3669267|FG000|Overall Study|Availability of Study Drug|1
2084418|NCT00719953|3669271|FG000|Overall Study|Adverse Event|4
2084419|NCT00720057|3669277|FG000|Overall Study|Lost to Follow-up|0
2084420|NCT00720057|3669278|FG001|Overall Study|Lost to Follow-up|2
2084421|NCT00720057|3669277|FG000|Overall Study|Protocol Violation|1
2084422|NCT00720057|3669278|FG001|Overall Study|Protocol Violation|0
2084423|NCT00720057|3669277|FG000|Overall Study|Withdrawal by Subject|0
2084424|NCT00720057|3669278|FG001|Overall Study|Withdrawal by Subject|1
2084425|NCT00720096|3669286|FG000|Overall Study|Withdrawal by Subject|0
2084426|NCT00720096|3669287|FG001|Overall Study|Withdrawal by Subject|2
2084427|NCT00720109|3669293|FG000|Induction Period|Did not meet eligibility criteria|3
2084428|NCT00720109|3669294|FG001|Induction Period|Did not meet eligibility criteria|0
2084429|NCT00720109|3669295|FG002|Induction Period|Did not meet eligibility criteria|0
2084430|NCT00720109|3669293|FG000|Induction Period|Bone Marrow Transplant|2
2084431|NCT00720109|3669294|FG001|Induction Period|Bone Marrow Transplant|0
2084432|NCT00720109|3669295|FG002|Induction Period|Bone Marrow Transplant|0
2084433|NCT00720109|3669293|FG000|Induction Period|Physician Decision|1
2084434|NCT00720109|3669294|FG001|Induction Period|Physician Decision|0
2084435|NCT00720109|3669295|FG002|Induction Period|Physician Decision|0
2084436|NCT00720109|3669293|FG000|Risk Stratification Period|Adverse Event|0
2084437|NCT00720109|3669294|FG001|Risk Stratification Period|Adverse Event|1
2084438|NCT00720109|3669295|FG002|Risk Stratification Period|Adverse Event|0
2084439|NCT00720109|3669293|FG000|Risk Stratification Period|Physician Decision|0
2084440|NCT00720109|3669294|FG001|Risk Stratification Period|Physician Decision|2
2084441|NCT00720109|3669295|FG002|Risk Stratification Period|Physician Decision|1
2084442|NCT00720109|3669293|FG000|Risk Stratification Period|Bone marrow transplant|0
2084443|NCT00720109|3669294|FG001|Risk Stratification Period|Bone marrow transplant|9
2084444|NCT00720109|3669295|FG002|Risk Stratification Period|Bone marrow transplant|7
2084445|NCT00720109|3669293|FG000|Risk Stratification Period|Disease progression or relapse|0
2084446|NCT00720109|3669294|FG001|Risk Stratification Period|Disease progression or relapse|2
2084447|NCT00720109|3669295|FG002|Risk Stratification Period|Disease progression or relapse|0
2084448|NCT00720109|3669293|FG000|Risk Stratification Period|Development of second malignant neoplasm|0
2084449|NCT00720109|3669294|FG001|Risk Stratification Period|Development of second malignant neoplasm|1
2084450|NCT00720109|3669295|FG002|Risk Stratification Period|Development of second malignant neoplasm|0
2084451|NCT00720122|3669304|FG000|Overall Study|Lost to Follow-up|1
2084452|NCT00720122|3669304|FG000|Overall Study|Physician Decision|1
2084453|NCT00720122|3669304|FG000|Overall Study|Withdrawal by Subject|7
2084454|NCT00720213|3669308|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7
2084455|NCT00720213|3669309|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0
2084456|NCT00720213|3669310|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0
2084457|NCT00720226|3669320|FG000|Overall Study|Withdrawal by Subject|7
2084458|NCT00720226|3669321|FG001|Overall Study|Withdrawal by Subject|4
2084459|NCT00720278|3669330|FG000|Overall Study|Adverse Event|5
2084460|NCT00720278|3669331|FG001|Overall Study|Adverse Event|3
2084461|NCT00720278|3669332|FG002|Overall Study|Adverse Event|4
2084462|NCT00720278|3669330|FG000|Overall Study|Withdrawal by Subject|0
2084463|NCT00720278|3669331|FG001|Overall Study|Withdrawal by Subject|1
2084464|NCT00720278|3669332|FG002|Overall Study|Withdrawal by Subject|0
2084465|NCT00720278|3669330|FG000|Overall Study|Lost to Follow-up|0
2084466|NCT00720278|3669331|FG001|Overall Study|Lost to Follow-up|0
2084467|NCT00720278|3669332|FG002|Overall Study|Lost to Follow-up|1
2084468|NCT00720278|3669330|FG000|Overall Study|Non-compliance|1
2084469|NCT00720278|3669331|FG001|Overall Study|Non-compliance|0
2084470|NCT00720278|3669332|FG002|Overall Study|Non-compliance|0
2084471|NCT00720278|3669330|FG000|Overall Study|eligibility criteria violation|1
2084472|NCT00720278|3669331|FG001|Overall Study|eligibility criteria violation|0
2084473|NCT00720278|3669332|FG002|Overall Study|eligibility criteria violation|1
2084474|NCT00720356|3669353|FG000|Registration to Study|Determined to have methylated MGMT|67
2084475|NCT00720356|3669353|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1
2084476|NCT00720356|3669353|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
2084477|NCT00720356|3669353|FG000|Went on to be Treated Cycle 3|Adverse Event|1
2084478|NCT00720356|3669353|FG000|Went on to be Treated Cycle 3|Physician Decision|1
2084479|NCT00720356|3669353|FG000|Follow up Until Death|Withdrawal by Subject|1
2084480|NCT00720356|3669353|FG000|Follow up Until Death|Alive at last data collection|4
2084481|NCT00720382|3669370|FG000|Overall Study|Adverse Event|54
2084482|NCT00720382|3669371|FG001|Overall Study|Adverse Event|17
2084483|NCT00720382|3669370|FG000|Overall Study|Lack of Efficacy|18
2084484|NCT00720382|3669371|FG001|Overall Study|Lack of Efficacy|7
2084485|NCT00720382|3669370|FG000|Overall Study|Non-Compliance|15
2084486|NCT00720382|3669371|FG001|Overall Study|Non-Compliance|5
2084487|NCT00720382|3669370|FG000|Overall Study|Withdrawal by Subject|47
2084488|NCT00720382|3669371|FG001|Overall Study|Withdrawal by Subject|11
2084489|NCT00720382|3669370|FG000|Overall Study|Lost to Follow-up|28
2084490|NCT00720382|3669371|FG001|Overall Study|Lost to Follow-up|14
2084491|NCT00720382|3669370|FG000|Overall Study|administrative|14
2084492|NCT00720382|3669371|FG001|Overall Study|administrative|5
2084493|NCT00720434|3669381|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
2084494|NCT00720434|3669382|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
2084495|NCT00720434|3669383|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
2084496|NCT00720434|3669384|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
2084497|NCT00720434|3669381|FG000|Open-Label Period (Week 5-72)|Adverse Event|0
2084498|NCT00720434|3669382|FG001|Open-Label Period (Week 5-72)|Adverse Event|0
2084499|NCT00720434|3669383|FG002|Open-Label Period (Week 5-72)|Adverse Event|0
2084500|NCT00720434|3669384|FG003|Open-Label Period (Week 5-72)|Adverse Event|2
2084501|NCT00720434|3669381|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1
2084502|NCT00720434|3669382|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0
2084503|NCT00720434|3669383|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0
2084504|NCT00720434|3669384|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0
2084505|NCT00720434|3669381|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
2084506|NCT00720434|3669382|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
2084507|NCT00720434|3669383|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
2084508|NCT00720434|3669384|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
2084509|NCT00720434|3669381|FG000|Open-Label Period (Week 5-72)|Other|4
2084510|NCT00720434|3669382|FG001|Open-Label Period (Week 5-72)|Other|3
2084511|NCT00720434|3669383|FG002|Open-Label Period (Week 5-72)|Other|3
2084512|NCT00720434|3669384|FG003|Open-Label Period (Week 5-72)|Other|2
2084513|NCT00720499|3669404|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2
2084514|NCT00720499|3669405|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
2084515|NCT00720499|3669404|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1
2084516|NCT00720499|3669405|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2
2084517|NCT00720499|3669404|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2
2084518|NCT00720499|3669405|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3
2084519|NCT00720759|3669422|FG000|Overall Study|Lost to Follow-up|0
2084520|NCT00720759|3669423|FG001|Overall Study|Lost to Follow-up|1
2084521|NCT00720759|3669424|FG002|Overall Study|Lost to Follow-up|1
2084522|NCT00720759|3669425|FG003|Overall Study|Lost to Follow-up|0
2084523|NCT00720798|3669435|FG000|Overall Study|Adverse Event|304
2084524|NCT00720798|3669435|FG000|Overall Study|Death|39
2084525|NCT00720798|3669435|FG000|Overall Study|Insufficient Therapeutic Response|129
2084526|NCT00720798|3669435|FG000|Overall Study|Protocol Violation|4
2084527|NCT00720798|3669435|FG000|Overall Study|Refused Treatment|151
2084528|NCT00720798|3669435|FG000|Overall Study|Failure to Return|46
2084529|NCT00720798|3669435|FG000|Overall Study|Reason not Specified|83
2084530|NCT00720876|3669439|FG000|Overall Study|found to be ineligible after starting tx|2
2084531|NCT00720941|3669445|FG000|Overall Study|Death|334
2084532|NCT00720941|3669446|FG001|Overall Study|Death|335
2084533|NCT00720941|3669445|FG000|Overall Study|Protocol Violation|0
2084534|NCT00720941|3669446|FG001|Overall Study|Protocol Violation|2
2084535|NCT00720941|3669445|FG000|Overall Study|Lost to Follow-up|17
2084536|NCT00720941|3669446|FG001|Overall Study|Lost to Follow-up|15
2084537|NCT00720941|3669445|FG000|Overall Study|Physician Decision|1
2084538|NCT00720941|3669446|FG001|Overall Study|Physician Decision|5
2084539|NCT00720941|3669445|FG000|Overall Study|Withdrawal by Subject|27
2084540|NCT00720941|3669446|FG001|Overall Study|Withdrawal by Subject|35
2084541|NCT00720941|3669445|FG000|Overall Study|Ongoing|34
2084542|NCT00720941|3669446|FG001|Overall Study|Ongoing|23
2084543|NCT00721110|3669456|FG000|Overall Study|Ultram use|1
2084544|NCT00721110|3669457|FG001|Overall Study|Ultram use|0
2084545|NCT00721110|3669458|FG002|Overall Study|Ultram use|0
2084546|NCT00721110|3669459|FG003|Overall Study|Ultram use|0
2084547|NCT00721110|3669456|FG000|Overall Study|vertical incision|0
2084548|NCT00721110|3669457|FG001|Overall Study|vertical incision|0
2084549|NCT00721110|3669458|FG002|Overall Study|vertical incision|1
2084550|NCT00721110|3669459|FG003|Overall Study|vertical incision|0
2084551|NCT00721123|3669469|FG000|Overall Study|Adverse Event|96
2084552|NCT00721123|3669469|FG000|Overall Study|Death|10
2084553|NCT00721123|3669469|FG000|Overall Study|Insufficient Therapeutic Response|21
2084554|NCT00721123|3669469|FG000|Overall Study|Protocol Violation|1
2084555|NCT00721123|3669469|FG000|Overall Study|Refused Treatment|41
2084556|NCT00721123|3669469|FG000|Overall Study|Failure to Return|9
2084557|NCT00721123|3669469|FG000|Overall Study|Withdrawal by Subject|5
2084558|NCT00721149|3669510|FG000|Overall Study|Physician Decision|1
2084559|NCT00721214|3669531|FG000|Overall Study|Chose another center for transplant|1
2084560|NCT00721214|3669531|FG000|Overall Study|Death|3
2084561|NCT00721227|3669537|FG000|Overall Study|Lost to Follow-up|3
2084562|NCT00721227|3669538|FG001|Overall Study|Lost to Follow-up|0
2084563|NCT00721227|3669537|FG000|Overall Study|Noncompliance with scheduled visits.|1
2084564|NCT00721227|3669538|FG001|Overall Study|Noncompliance with scheduled visits.|0
2084565|NCT00721279|3669556|FG000|Overall Study|Lack of Efficacy|6
2084566|NCT00721279|3669557|FG001|Overall Study|Lack of Efficacy|3
2084567|NCT00721279|3669556|FG000|Overall Study|Tolerability insufficient|5
2084568|NCT00721279|3669557|FG001|Overall Study|Tolerability insufficient|2
2084569|NCT00721279|3669556|FG000|Overall Study|Withdrawal by Subject|13
2084570|NCT00721279|3669557|FG001|Overall Study|Withdrawal by Subject|3
2084571|NCT00721279|3669556|FG000|Overall Study|Other|12
2084572|NCT00721279|3669557|FG001|Overall Study|Other|16
2084573|NCT00721396|3669579|FG000|Overall Study|Adverse Event|4
2084574|NCT00721396|3669580|FG001|Overall Study|Adverse Event|7
2084575|NCT00721396|3669581|FG002|Overall Study|Adverse Event|2
2084576|NCT00721396|3669582|FG003|Overall Study|Adverse Event|0
2084577|NCT00721396|3669579|FG000|Overall Study|Withdrawal by Subject|12
2084578|NCT00721396|3669580|FG001|Overall Study|Withdrawal by Subject|15
2084579|NCT00721396|3669581|FG002|Overall Study|Withdrawal by Subject|3
2084580|NCT00721396|3669582|FG003|Overall Study|Withdrawal by Subject|7
2084581|NCT00721396|3669579|FG000|Overall Study|Lost to Follow-up|7
2084582|NCT00721396|3669580|FG001|Overall Study|Lost to Follow-up|9
2084583|NCT00721396|3669581|FG002|Overall Study|Lost to Follow-up|3
2084584|NCT00721396|3669582|FG003|Overall Study|Lost to Follow-up|3
2084585|NCT00721396|3669579|FG000|Overall Study|Protocol Violation|4
2084586|NCT00721396|3669580|FG001|Overall Study|Protocol Violation|3
2084587|NCT00721396|3669581|FG002|Overall Study|Protocol Violation|1
2211516|NCT01661179|3851812|FG000|Overall Study|Withdrawal by Subject|1
2084588|NCT00721396|3669582|FG003|Overall Study|Protocol Violation|0
2084589|NCT00721396|3669579|FG000|Overall Study|Inappropriate enrollment|0
2084590|NCT00721396|3669580|FG001|Overall Study|Inappropriate enrollment|2
2084591|NCT00721396|3669581|FG002|Overall Study|Inappropriate enrollment|0
2084592|NCT00721396|3669582|FG003|Overall Study|Inappropriate enrollment|0
2084593|NCT00721396|3669579|FG000|Overall Study|Administrative reason|3
2084594|NCT00721396|3669580|FG001|Overall Study|Administrative reason|0
2084595|NCT00721396|3669581|FG002|Overall Study|Administrative reason|1
2084596|NCT00721396|3669582|FG003|Overall Study|Administrative reason|0
2084597|NCT00721409|3669600|FG000|Overall Study|Global deterioration of health status|2
2084598|NCT00721409|3669601|FG001|Overall Study|Global deterioration of health status|6
2305653|NCT02674854|4006955|FG001|Overall Study|Disallowed Concurrent Medication|2
2305654|NCT02674854|4006956|FG002|Overall Study|Disallowed Concurrent Medication|0
2305655|NCT02674854|4006954|FG000|Overall Study|Protocol Violation|1
2305656|NCT02674854|4006955|FG001|Overall Study|Protocol Violation|1
2305657|NCT02674854|4006956|FG002|Overall Study|Protocol Violation|2
2305658|NCT02674854|4006954|FG000|Overall Study|Death|0
2305659|NCT02674854|4006955|FG001|Overall Study|Death|1
2305660|NCT02674854|4006956|FG002|Overall Study|Death|0
2305661|NCT02674854|4006954|FG000|Overall Study|Subject missed V6.2|1
2305662|NCT02674854|4006955|FG001|Overall Study|Subject missed V6.2|0
2305663|NCT02674854|4006956|FG002|Overall Study|Subject missed V6.2|0
2305664|NCT02675075|4006966|FG000|Overall Study|Lost to Follow-up|3
2305665|NCT02675075|4006967|FG001|Overall Study|Lost to Follow-up|0
2305666|NCT02675426|4006978|FG000|Overall Study|Adverse Event|6
2305667|NCT02675426|4006979|FG001|Overall Study|Adverse Event|2
2305668|NCT02675426|4006980|FG002|Overall Study|Adverse Event|9
2305669|NCT02675426|4006978|FG000|Overall Study|Withdrawal by Subject|3
2305670|NCT02675426|4006979|FG001|Overall Study|Withdrawal by Subject|5
2305671|NCT02675426|4006980|FG002|Overall Study|Withdrawal by Subject|5
2305672|NCT02675426|4006978|FG000|Overall Study|Lost to Follow-up|1
2305673|NCT02675426|4006979|FG001|Overall Study|Lost to Follow-up|0
2305674|NCT02675426|4006980|FG002|Overall Study|Lost to Follow-up|2
2305675|NCT02675426|4006978|FG000|Overall Study|Other|3
2305676|NCT02675426|4006979|FG001|Overall Study|Other|1
2305677|NCT02675426|4006980|FG002|Overall Study|Other|2
2305678|NCT02675517|4006988|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8
2305679|NCT02675517|4006988|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151
2305680|NCT02675634|4007001|FG000|Test Period 1|Adverse Event|0
2305681|NCT02675634|4007002|FG001|Test Period 1|Adverse Event|1
2305682|NCT02675634|4007003|FG002|Test Period 1|Adverse Event|0
2305683|NCT02675634|4007004|FG003|Test Period 1|Adverse Event|1
2305684|NCT02675634|4007005|FG004|Test Period 1|Adverse Event|0
2305685|NCT02675634|4007006|FG005|Test Period 1|Adverse Event|0
2305686|NCT02675634|4007001|FG000|Test Period 1|Device deficiency that did not lead to A|0
2305687|NCT02675634|4007002|FG001|Test Period 1|Device deficiency that did not lead to A|0
2305688|NCT02675634|4007003|FG002|Test Period 1|Device deficiency that did not lead to A|1
2305689|NCT02675634|4007004|FG003|Test Period 1|Device deficiency that did not lead to A|0
2305690|NCT02675634|4007005|FG004|Test Period 1|Device deficiency that did not lead to A|0
2305691|NCT02675634|4007006|FG005|Test Period 1|Device deficiency that did not lead to A|0
2305692|NCT02675634|4007001|FG000|Test Period 2|Lack of Efficacy|1
2305693|NCT02675634|4007002|FG001|Test Period 2|Lack of Efficacy|0
2305694|NCT02675634|4007003|FG002|Test Period 2|Lack of Efficacy|0
2305695|NCT02675634|4007004|FG003|Test Period 2|Lack of Efficacy|0
2305696|NCT02675634|4007005|FG004|Test Period 2|Lack of Efficacy|0
2305697|NCT02675634|4007006|FG005|Test Period 2|Lack of Efficacy|0
2305698|NCT02675634|4007001|FG000|Test Period 2|Adverse Event|0
2305699|NCT02675634|4007002|FG001|Test Period 2|Adverse Event|0
2305700|NCT02675634|4007003|FG002|Test Period 2|Adverse Event|0
2305701|NCT02675634|4007004|FG003|Test Period 2|Adverse Event|0
2305702|NCT02675634|4007005|FG004|Test Period 2|Adverse Event|0
2305703|NCT02675634|4007006|FG005|Test Period 2|Adverse Event|1
2305704|NCT02675907|4007025|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
2305705|NCT02675907|4007026|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
2305706|NCT02675907|4007025|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
2305707|NCT02675907|4007026|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
2305708|NCT02675907|4007025|FG000|Study Overall|Lack of Efficacy|1
2305709|NCT02675907|4007026|FG001|Study Overall|Lack of Efficacy|0
2305710|NCT02675907|4007025|FG000|Study Overall|Withdrawal by Subject|2
2305711|NCT02675907|4007026|FG001|Study Overall|Withdrawal by Subject|2
2305712|NCT02675907|4007025|FG000|Study Overall|Lost to Follow-up|0
2305713|NCT02675907|4007026|FG001|Study Overall|Lost to Follow-up|2
2305714|NCT02675998|4007036|FG000|8-Week Treatment Period|Adverse Event|6
2305715|NCT02675998|4007037|FG001|8-Week Treatment Period|Adverse Event|5
2305716|NCT02675998|4007038|FG002|8-Week Treatment Period|Adverse Event|6
2305717|NCT02675998|4007039|FG003|8-Week Treatment Period|Adverse Event|0
2305718|NCT02675998|4007036|FG000|8-Week Treatment Period|Withdrawal by Subject|3
2305719|NCT02675998|4007037|FG001|8-Week Treatment Period|Withdrawal by Subject|3
2305720|NCT02675998|4007038|FG002|8-Week Treatment Period|Withdrawal by Subject|3
2305721|NCT02675998|4007039|FG003|8-Week Treatment Period|Withdrawal by Subject|0
2305722|NCT02675998|4007036|FG000|8-Week Treatment Period|Lack of Efficacy|2
2305723|NCT02675998|4007037|FG001|8-Week Treatment Period|Lack of Efficacy|5
2305724|NCT02675998|4007038|FG002|8-Week Treatment Period|Lack of Efficacy|3
2305725|NCT02675998|4007039|FG003|8-Week Treatment Period|Lack of Efficacy|0
2305726|NCT02675998|4007036|FG000|8-Week Treatment Period|Physician Decision|1
2305727|NCT02675998|4007037|FG001|8-Week Treatment Period|Physician Decision|0
2305728|NCT02675998|4007038|FG002|8-Week Treatment Period|Physician Decision|2
2305729|NCT02675998|4007039|FG003|8-Week Treatment Period|Physician Decision|0
2305730|NCT02675998|4007036|FG000|8-Week Treatment Period|GI side Effects|1
2305731|NCT02675998|4007037|FG001|8-Week Treatment Period|GI side Effects|4
2305732|NCT02675998|4007038|FG002|8-Week Treatment Period|GI side Effects|2
2305733|NCT02675998|4007039|FG003|8-Week Treatment Period|GI side Effects|0
2321734|NCT02963506|4036373|FG002|Double-Blind Period|Withdrawal by Subject|1
2305734|NCT02675998|4007036|FG000|8-Week Treatment Period|Protocol Violation|1
2305735|NCT02675998|4007037|FG001|8-Week Treatment Period|Protocol Violation|1
2305736|NCT02675998|4007038|FG002|8-Week Treatment Period|Protocol Violation|1
2305737|NCT02675998|4007039|FG003|8-Week Treatment Period|Protocol Violation|0
2305738|NCT02675998|4007036|FG000|8-Week Treatment Period|Other|3
2305739|NCT02675998|4007037|FG001|8-Week Treatment Period|Other|1
2305740|NCT02675998|4007038|FG002|8-Week Treatment Period|Other|2
2305741|NCT02675998|4007039|FG003|8-Week Treatment Period|Other|0
2305742|NCT02675998|4007036|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0
2305743|NCT02675998|4007037|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
2305744|NCT02675998|4007038|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
2305745|NCT02675998|4007039|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3
2305746|NCT02675998|4007036|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0
2305747|NCT02675998|4007037|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0
2305748|NCT02675998|4007038|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1
2305749|NCT02675998|4007039|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3
2305750|NCT02675998|4007036|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0
2305751|NCT02675998|4007037|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0
2305752|NCT02675998|4007038|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0
2305753|NCT02675998|4007039|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1
2305754|NCT02675998|4007036|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1
2305755|NCT02675998|4007037|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0
2305756|NCT02675998|4007038|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0
2305757|NCT02675998|4007039|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0
2305758|NCT02675998|4007036|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
2305759|NCT02675998|4007037|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
2305760|NCT02675998|4007038|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
2305761|NCT02675998|4007039|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1
2305762|NCT02676466|4007070|FG000|Overall Study|Death|0
2305763|NCT02676466|4007071|FG001|Overall Study|Death|2
2305764|NCT02676466|4007072|FG002|Overall Study|Death|1
2305765|NCT02676466|4007073|FG003|Overall Study|Death|0
2305766|NCT02676466|4007074|FG004|Overall Study|Death|0
2305767|NCT02676466|4007075|FG005|Overall Study|Death|0
2305768|NCT02676466|4007076|FG006|Overall Study|Death|0
2305769|NCT02676466|4007077|FG007|Overall Study|Death|0
2305770|NCT02676466|4007070|FG000|Overall Study|Withdrawal by Subject|4
2305771|NCT02676466|4007071|FG001|Overall Study|Withdrawal by Subject|3
2305772|NCT02676466|4007072|FG002|Overall Study|Withdrawal by Subject|1
2305773|NCT02676466|4007073|FG003|Overall Study|Withdrawal by Subject|0
2305774|NCT02676466|4007074|FG004|Overall Study|Withdrawal by Subject|3
2305775|NCT02676466|4007075|FG005|Overall Study|Withdrawal by Subject|1
2305776|NCT02676466|4007076|FG006|Overall Study|Withdrawal by Subject|1
2305777|NCT02676466|4007077|FG007|Overall Study|Withdrawal by Subject|1
2305778|NCT02676778|4007102|FG000|Overall Study|Disease Progression|7
2305779|NCT02676778|4007103|FG001|Overall Study|Disease Progression|3
2305780|NCT02676778|4007104|FG002|Overall Study|Disease Progression|1
2305781|NCT02676778|4007102|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1
2305782|NCT02676778|4007103|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1
2305783|NCT02676778|4007104|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0
2305784|NCT02676778|4007102|FG000|Overall Study|Withdrawal by Subject|3
2305785|NCT02676778|4007103|FG001|Overall Study|Withdrawal by Subject|2
2305786|NCT02676778|4007104|FG002|Overall Study|Withdrawal by Subject|0
2305787|NCT02676778|4007102|FG000|Overall Study|Other|4
2305788|NCT02676778|4007103|FG001|Overall Study|Other|3
2305789|NCT02676778|4007104|FG002|Overall Study|Other|0
2305790|NCT02676778|4007102|FG000|Overall Study|Adverse Event|2
2305791|NCT02676778|4007103|FG001|Overall Study|Adverse Event|3
2305792|NCT02676778|4007104|FG002|Overall Study|Adverse Event|0
2305793|NCT02676882|4007120|FG000|Overall Study|Adverse Event|1
2305794|NCT02676882|4007121|FG001|Overall Study|Adverse Event|0
2305795|NCT02676882|4007120|FG000|Overall Study|Lost to Follow-up|1
2305796|NCT02676882|4007121|FG001|Overall Study|Lost to Follow-up|0
2305797|NCT02676882|4007120|FG000|Overall Study|Withdrawal by Subject|1
2305798|NCT02676882|4007121|FG001|Overall Study|Withdrawal by Subject|2
2305799|NCT02676895|4007130|FG000|Overall Study|Administrative reason|1
2305800|NCT02676895|4007131|FG001|Overall Study|Administrative reason|0
2305801|NCT02676895|4007132|FG002|Overall Study|Administrative reason|0
2305802|NCT02676895|4007130|FG000|Overall Study|Protocol Violation|1
2305803|NCT02676895|4007131|FG001|Overall Study|Protocol Violation|0
2305804|NCT02676895|4007132|FG002|Overall Study|Protocol Violation|0
2305805|NCT02676895|4007130|FG000|Overall Study|Adverse Event|0
2305806|NCT02676895|4007131|FG001|Overall Study|Adverse Event|3
2305807|NCT02676895|4007132|FG002|Overall Study|Adverse Event|1
2305808|NCT02676895|4007130|FG000|Overall Study|Lost to Follow-up|0
2305809|NCT02676895|4007131|FG001|Overall Study|Lost to Follow-up|0
2305810|NCT02676895|4007132|FG002|Overall Study|Lost to Follow-up|1
2305811|NCT02676895|4007130|FG000|Overall Study|Withdrawal by Subject|0
2305812|NCT02676895|4007131|FG001|Overall Study|Withdrawal by Subject|0
2305813|NCT02676895|4007132|FG002|Overall Study|Withdrawal by Subject|1
2305814|NCT02677116|4007150|FG000|Overall Study|Adverse Event|0
2305815|NCT02677116|4007151|FG001|Overall Study|Adverse Event|1
2305816|NCT02677116|4007152|FG002|Overall Study|Adverse Event|0
2305817|NCT02677116|4007153|FG003|Overall Study|Adverse Event|0
2305818|NCT02677116|4007154|FG004|Overall Study|Adverse Event|0
2305819|NCT02677116|4007155|FG005|Overall Study|Adverse Event|1
2305820|NCT02677116|4007156|FG006|Overall Study|Adverse Event|1
2305821|NCT02677116|4007157|FG007|Overall Study|Adverse Event|0
2305822|NCT02677116|4007158|FG008|Overall Study|Adverse Event|0
2305823|NCT02677116|4007150|FG000|Overall Study|Physician Decision|0
2305824|NCT02677116|4007151|FG001|Overall Study|Physician Decision|2
2305825|NCT02677116|4007152|FG002|Overall Study|Physician Decision|3
2305826|NCT02677116|4007153|FG003|Overall Study|Physician Decision|2
2305827|NCT02677116|4007154|FG004|Overall Study|Physician Decision|1
2305828|NCT02677116|4007155|FG005|Overall Study|Physician Decision|3
2305829|NCT02677116|4007156|FG006|Overall Study|Physician Decision|1
2305830|NCT02677116|4007157|FG007|Overall Study|Physician Decision|1
2305831|NCT02677116|4007158|FG008|Overall Study|Physician Decision|2
2305832|NCT02677116|4007150|FG000|Overall Study|Withdrawal by parent or guardian|2
2305833|NCT02677116|4007151|FG001|Overall Study|Withdrawal by parent or guardian|1
2084599|NCT00721409|3669602|FG002|Overall Study|Global deterioration of health status|3
2084600|NCT00721409|3669600|FG000|Overall Study|Death|0
2084601|NCT00721409|3669601|FG001|Overall Study|Death|1
2084602|NCT00721409|3669602|FG002|Overall Study|Death|0
2084603|NCT00721409|3669600|FG000|Overall Study|Randomized not Treated|0
2084604|NCT00721409|3669601|FG001|Overall Study|Randomized not Treated|1
2084605|NCT00721409|3669602|FG002|Overall Study|Randomized not Treated|4
2084606|NCT00721409|3669600|FG000|Overall Study|Reason not specified|1
2084607|NCT00721409|3669601|FG001|Overall Study|Reason not specified|0
2084608|NCT00721409|3669602|FG002|Overall Study|Reason not specified|2
2084609|NCT00721409|3669600|FG000|Overall Study|Adverse Event|0
2084610|NCT00721409|3669601|FG001|Overall Study|Adverse Event|13
2084611|NCT00721409|3669602|FG002|Overall Study|Adverse Event|2
2084612|NCT00721409|3669600|FG000|Overall Study|Lost to Follow-up|0
2084613|NCT00721409|3669601|FG001|Overall Study|Lost to Follow-up|0
2084614|NCT00721409|3669602|FG002|Overall Study|Lost to Follow-up|1
2084615|NCT00721409|3669600|FG000|Overall Study|Withdrawal by Subject|1
2084616|NCT00721409|3669601|FG001|Overall Study|Withdrawal by Subject|6
2084617|NCT00721409|3669602|FG002|Overall Study|Withdrawal by Subject|5
2084618|NCT00721409|3669600|FG000|Overall Study|Objective progression or relapse|8
2084619|NCT00721409|3669601|FG001|Overall Study|Objective progression or relapse|55
2084620|NCT00721409|3669602|FG002|Overall Study|Objective progression or relapse|62
2084621|NCT00721578|3669649|FG000|Overall Study|Death|1
2084622|NCT00721578|3669650|FG001|Overall Study|Death|1
2084623|NCT00721578|3669649|FG000|Overall Study|Withdrawal by Subject|1
2084624|NCT00721578|3669650|FG001|Overall Study|Withdrawal by Subject|1
2084625|NCT00721630|3669661|FG000|Overall Study|Participant found to be ineligible|1
2084626|NCT00721734|3669670|FG000|Overall Study|Progressive Disease|3
2084627|NCT00721734|3669671|FG001|Overall Study|Progressive Disease|10
2084628|NCT00721734|3669672|FG002|Overall Study|Progressive Disease|4
2084629|NCT00721734|3669673|FG003|Overall Study|Progressive Disease|5
2084630|NCT00721734|3669674|FG004|Overall Study|Progressive Disease|2
2084631|NCT00721734|3669670|FG000|Overall Study|Adverse Event|3
2084632|NCT00721734|3669671|FG001|Overall Study|Adverse Event|1
2084633|NCT00721734|3669672|FG002|Overall Study|Adverse Event|4
2084634|NCT00721734|3669673|FG003|Overall Study|Adverse Event|0
2084635|NCT00721734|3669674|FG004|Overall Study|Adverse Event|3
2084636|NCT00721734|3669670|FG000|Overall Study|Withdrawal by Subject|2
2084637|NCT00721734|3669671|FG001|Overall Study|Withdrawal by Subject|1
2084638|NCT00721734|3669672|FG002|Overall Study|Withdrawal by Subject|0
2084639|NCT00721734|3669673|FG003|Overall Study|Withdrawal by Subject|0
2084640|NCT00721734|3669674|FG004|Overall Study|Withdrawal by Subject|1
2084641|NCT00721734|3669670|FG000|Overall Study|Other|0
2084642|NCT00721734|3669671|FG001|Overall Study|Other|0
2084643|NCT00721734|3669672|FG002|Overall Study|Other|0
2084644|NCT00721734|3669673|FG003|Overall Study|Other|1
2084645|NCT00721734|3669674|FG004|Overall Study|Other|0
2084646|NCT00721799|3669686|FG000|Overall Study|Withdrawal by Subject|7
2084647|NCT00721799|3669686|FG000|Overall Study|withdraw by subject after scan 1|1
2084648|NCT00721955|3669693|FG000|Overall Study|Adverse Event|0
2084649|NCT00721955|3669694|FG001|Overall Study|Adverse Event|0
2084650|NCT00721955|3669695|FG002|Overall Study|Adverse Event|2
2084651|NCT00721968|3669705|FG000|Overall Study|Lost to Follow-up|2
2084652|NCT00721968|3669706|FG001|Overall Study|Lost to Follow-up|0
2084653|NCT00722137|3669756|FG000|Overall Study|Overt Disease Progression|5
2084654|NCT00722137|3669757|FG001|Overall Study|Overt Disease Progression|4
2084655|NCT00722137|3669756|FG000|Overall Study|Adverse Event|17
2084656|NCT00722137|3669757|FG001|Overall Study|Adverse Event|21
2084657|NCT00722137|3669756|FG000|Overall Study|Death|12
2084658|NCT00722137|3669757|FG001|Overall Study|Death|7
2084659|NCT00722137|3669756|FG000|Overall Study|Withdrawal by Subject|6
2084660|NCT00722137|3669757|FG001|Overall Study|Withdrawal by Subject|9
2084661|NCT00722137|3669756|FG000|Overall Study|Other Reason Unknown|3
2305834|NCT02677116|4007152|FG002|Overall Study|Withdrawal by parent or guardian|0
2305835|NCT02677116|4007153|FG003|Overall Study|Withdrawal by parent or guardian|1
2084662|NCT00722137|3669757|FG001|Overall Study|Other Reason Unknown|4
2084663|NCT00722137|3669756|FG000|Overall Study|Randomized But Not Treated|2
2084664|NCT00722137|3669757|FG001|Overall Study|Randomized But Not Treated|3
2084665|NCT00722371|3669770|FG000|Overall Study|Adverse Event|6
2084666|NCT00722371|3669771|FG001|Overall Study|Adverse Event|13
2084667|NCT00722371|3669772|FG002|Overall Study|Adverse Event|9
2084668|NCT00722371|3669773|FG003|Overall Study|Adverse Event|10
2084669|NCT00722371|3669774|FG004|Overall Study|Adverse Event|6
2084670|NCT00722371|3669775|FG005|Overall Study|Adverse Event|8
2084671|NCT00722371|3669776|FG006|Overall Study|Adverse Event|4
2084672|NCT00722371|3669770|FG000|Overall Study|Contraindication|0
2084673|NCT00722371|3669771|FG001|Overall Study|Contraindication|0
2084674|NCT00722371|3669772|FG002|Overall Study|Contraindication|1
2084675|NCT00722371|3669773|FG003|Overall Study|Contraindication|0
2084676|NCT00722371|3669774|FG004|Overall Study|Contraindication|0
2084677|NCT00722371|3669775|FG005|Overall Study|Contraindication|0
2084678|NCT00722371|3669776|FG006|Overall Study|Contraindication|0
2084679|NCT00722371|3669770|FG000|Overall Study|Creatinine / Creatinine clearance|2
2084680|NCT00722371|3669771|FG001|Overall Study|Creatinine / Creatinine clearance|1
2084681|NCT00722371|3669772|FG002|Overall Study|Creatinine / Creatinine clearance|2
2084682|NCT00722371|3669773|FG003|Overall Study|Creatinine / Creatinine clearance|3
2084683|NCT00722371|3669774|FG004|Overall Study|Creatinine / Creatinine clearance|2
2084684|NCT00722371|3669775|FG005|Overall Study|Creatinine / Creatinine clearance|1
2084685|NCT00722371|3669776|FG006|Overall Study|Creatinine / Creatinine clearance|1
2084686|NCT00722371|3669770|FG000|Overall Study|Excluded medication|0
2084687|NCT00722371|3669771|FG001|Overall Study|Excluded medication|1
2084688|NCT00722371|3669772|FG002|Overall Study|Excluded medication|1
2084689|NCT00722371|3669773|FG003|Overall Study|Excluded medication|0
2084690|NCT00722371|3669774|FG004|Overall Study|Excluded medication|0
2084691|NCT00722371|3669775|FG005|Overall Study|Excluded medication|0
2084692|NCT00722371|3669776|FG006|Overall Study|Excluded medication|1
2084693|NCT00722371|3669770|FG000|Overall Study|Hyperglycemia|2
2084694|NCT00722371|3669771|FG001|Overall Study|Hyperglycemia|6
2084695|NCT00722371|3669772|FG002|Overall Study|Hyperglycemia|4
2084696|NCT00722371|3669773|FG003|Overall Study|Hyperglycemia|2
2084697|NCT00722371|3669774|FG004|Overall Study|Hyperglycemia|5
2084698|NCT00722371|3669775|FG005|Overall Study|Hyperglycemia|1
2084699|NCT00722371|3669776|FG006|Overall Study|Hyperglycemia|1
2084700|NCT00722371|3669770|FG000|Overall Study|Hypoglycemia|1
2211517|NCT01661179|3851812|FG000|Overall Study|Other Eligibility criteria|4
2211518|NCT01661205|3851816|FG000|Overall Study|Physician Decision|2
2217514|NCT01708941|3860841|FG003|Overall Study|Ineligible and never started treatment|0
2217515|NCT01708941|3860838|FG000|Overall Study|Never started treatment|2
2084701|NCT00722371|3669771|FG001|Overall Study|Hypoglycemia|0
2084702|NCT00722371|3669772|FG002|Overall Study|Hypoglycemia|0
2084703|NCT00722371|3669773|FG003|Overall Study|Hypoglycemia|0
2084704|NCT00722371|3669774|FG004|Overall Study|Hypoglycemia|0
2084705|NCT00722371|3669775|FG005|Overall Study|Hypoglycemia|0
2084706|NCT00722371|3669776|FG006|Overall Study|Hypoglycemia|0
2084707|NCT00722371|3669770|FG000|Overall Study|Lack of Efficacy|4
2084708|NCT00722371|3669771|FG001|Overall Study|Lack of Efficacy|6
2084709|NCT00722371|3669772|FG002|Overall Study|Lack of Efficacy|6
2084710|NCT00722371|3669773|FG003|Overall Study|Lack of Efficacy|6
2084711|NCT00722371|3669774|FG004|Overall Study|Lack of Efficacy|2
2084712|NCT00722371|3669775|FG005|Overall Study|Lack of Efficacy|3
2084713|NCT00722371|3669776|FG006|Overall Study|Lack of Efficacy|0
2084714|NCT00722371|3669770|FG000|Overall Study|Lost to Follow-up|11
2084715|NCT00722371|3669771|FG001|Overall Study|Lost to Follow-up|14
2084716|NCT00722371|3669772|FG002|Overall Study|Lost to Follow-up|21
2084717|NCT00722371|3669773|FG003|Overall Study|Lost to Follow-up|13
2084718|NCT00722371|3669774|FG004|Overall Study|Lost to Follow-up|8
2084719|NCT00722371|3669775|FG005|Overall Study|Lost to Follow-up|16
2084720|NCT00722371|3669776|FG006|Overall Study|Lost to Follow-up|13
2084721|NCT00722371|3669770|FG000|Overall Study|Physician Decision|5
2084722|NCT00722371|3669771|FG001|Overall Study|Physician Decision|2
2084723|NCT00722371|3669772|FG002|Overall Study|Physician Decision|2
2084724|NCT00722371|3669773|FG003|Overall Study|Physician Decision|5
2084725|NCT00722371|3669774|FG004|Overall Study|Physician Decision|2
2084726|NCT00722371|3669775|FG005|Overall Study|Physician Decision|3
2084727|NCT00722371|3669776|FG006|Overall Study|Physician Decision|4
2084728|NCT00722371|3669770|FG000|Overall Study|Pregnancy|1
2084729|NCT00722371|3669771|FG001|Overall Study|Pregnancy|1
2084730|NCT00722371|3669772|FG002|Overall Study|Pregnancy|0
2084731|NCT00722371|3669773|FG003|Overall Study|Pregnancy|0
2084732|NCT00722371|3669774|FG004|Overall Study|Pregnancy|0
2084733|NCT00722371|3669775|FG005|Overall Study|Pregnancy|1
2084734|NCT00722371|3669776|FG006|Overall Study|Pregnancy|0
2084735|NCT00722371|3669770|FG000|Overall Study|Protocol Violation|6
2084736|NCT00722371|3669771|FG001|Overall Study|Protocol Violation|1
2084737|NCT00722371|3669772|FG002|Overall Study|Protocol Violation|0
2084738|NCT00722371|3669773|FG003|Overall Study|Protocol Violation|1
2084739|NCT00722371|3669774|FG004|Overall Study|Protocol Violation|4
2084740|NCT00722371|3669775|FG005|Overall Study|Protocol Violation|2
2084741|NCT00722371|3669776|FG006|Overall Study|Protocol Violation|1
2084742|NCT00722371|3669770|FG000|Overall Study|Withdrawal by Subject|18
2084743|NCT00722371|3669771|FG001|Overall Study|Withdrawal by Subject|27
2084744|NCT00722371|3669772|FG002|Overall Study|Withdrawal by Subject|19
2084745|NCT00722371|3669773|FG003|Overall Study|Withdrawal by Subject|23
2084746|NCT00722371|3669774|FG004|Overall Study|Withdrawal by Subject|19
2084747|NCT00722371|3669775|FG005|Overall Study|Withdrawal by Subject|18
2084748|NCT00722371|3669776|FG006|Overall Study|Withdrawal by Subject|26
2084749|NCT00722423|3669794|FG000|Overall Study|Protocol Violation|0
2084750|NCT00722423|3669795|FG001|Overall Study|Protocol Violation|1
2084751|NCT00722761|3669844|FG000|Overall Study|Lost to Follow-up|1
2084752|NCT00722761|3669845|FG001|Overall Study|Lost to Follow-up|4
2084753|NCT00722761|3669844|FG000|Overall Study|Withdrawal by Subject|5
2084754|NCT00722761|3669845|FG001|Overall Study|Withdrawal by Subject|2
2084755|NCT00722800|3669853|FG000|Overall Study|Withdrawal by Subject|1
2084756|NCT00722800|3669854|FG001|Overall Study|Withdrawal by Subject|0
2084757|NCT00722800|3669853|FG000|Overall Study|Physician Decision|1
2084758|NCT00722800|3669854|FG001|Overall Study|Physician Decision|0
2084759|NCT00723008|3669866|FG000|Enrollment|Lost to Follow-up|1
2084760|NCT00723008|3669867|FG001|Enrollment|Lost to Follow-up|0
2084761|NCT00723008|3669866|FG000|4-Week Double Blinded|Lack of Efficacy|0
2084762|NCT00723008|3669867|FG001|4-Week Double Blinded|Lack of Efficacy|1
2084763|NCT00723008|3669866|FG000|4-Week Double Blinded|Withdrawal by Subject|1
2084764|NCT00723008|3669867|FG001|4-Week Double Blinded|Withdrawal by Subject|1
2084765|NCT00723008|3669866|FG000|4-Week Double Blinded|Lost to Follow-up|4
2084766|NCT00723008|3669867|FG001|4-Week Double Blinded|Lost to Follow-up|3
2211519|NCT01661595|3851838|FG000|Phase 1: Week 0-4|Adverse Event|1
2211520|NCT01661595|3851839|FG001|Phase 1: Week 0-4|Adverse Event|0
2084767|NCT00723008|3669866|FG000|4-Week Unblinded Treatment|Adverse Event|1
2084768|NCT00723008|3669867|FG001|4-Week Unblinded Treatment|Adverse Event|0
2084769|NCT00723008|3669866|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0
2084770|NCT00723008|3669867|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1
2084771|NCT00723021|3669881|FG000|Intervention Period 4|Adverse Event|0
2084772|NCT00723021|3669882|FG001|Intervention Period 4|Adverse Event|0
2305836|NCT02677116|4007154|FG004|Overall Study|Withdrawal by parent or guardian|0
2305837|NCT02677116|4007155|FG005|Overall Study|Withdrawal by parent or guardian|0
2305838|NCT02677116|4007156|FG006|Overall Study|Withdrawal by parent or guardian|2
2305839|NCT02677116|4007157|FG007|Overall Study|Withdrawal by parent or guardian|1
2305840|NCT02677116|4007158|FG008|Overall Study|Withdrawal by parent or guardian|0
2305841|NCT02677116|4007150|FG000|Overall Study|Withdrawal by Subject|1
2305842|NCT02677116|4007151|FG001|Overall Study|Withdrawal by Subject|0
2305843|NCT02677116|4007152|FG002|Overall Study|Withdrawal by Subject|0
2305844|NCT02677116|4007153|FG003|Overall Study|Withdrawal by Subject|0
2305845|NCT02677116|4007154|FG004|Overall Study|Withdrawal by Subject|0
2305846|NCT02677116|4007155|FG005|Overall Study|Withdrawal by Subject|0
2305847|NCT02677116|4007156|FG006|Overall Study|Withdrawal by Subject|0
2305848|NCT02677116|4007157|FG007|Overall Study|Withdrawal by Subject|0
2305849|NCT02677116|4007158|FG008|Overall Study|Withdrawal by Subject|0
2305850|NCT02677220|4007201|FG000|Overall Study|Adverse Event|1
2305851|NCT02677324|4007206|FG000|Overall Study|Disease Progression|6
2305852|NCT02677324|4007206|FG000|Overall Study|Inability to Swallow pills|1
2305853|NCT02677324|4007206|FG000|Overall Study|Non-compliance|1
2305854|NCT02677324|4007206|FG000|Overall Study|Lack of Efficacy|1
2305855|NCT02677324|4007206|FG000|Overall Study|Medical insurance coverage|1
2305856|NCT02677324|4007206|FG000|Overall Study|Adverse Event|1
2305857|NCT02677324|4007206|FG000|Overall Study|IgM Myeloma diagnosis|1
2305858|NCT02677714|4007265|FG000|Overall Study|Withdrawal by Subject|2
2305859|NCT02677714|4007266|FG001|Overall Study|Withdrawal by Subject|0
2305860|NCT02677844|4007310|FG000|Period 3|Withdrawal by Subject|0
2305861|NCT02677844|4007311|FG001|Period 3|Withdrawal by Subject|0
2305862|NCT02677844|4007312|FG002|Period 3|Withdrawal by Subject|0
2305863|NCT02677844|4007313|FG003|Period 3|Withdrawal by Subject|1
2305864|NCT02677844|4007314|FG004|Period 3|Withdrawal by Subject|0
2305865|NCT02677844|4007315|FG005|Period 3|Withdrawal by Subject|0
2305866|NCT02677844|4007316|FG006|Period 3|Withdrawal by Subject|0
2305867|NCT02678000|4007340|FG000|PART 2|Adverse Event|0
2084773|NCT00723021|3669883|FG002|Intervention Period 4|Adverse Event|0
2084774|NCT00723021|3669884|FG003|Intervention Period 4|Adverse Event|0
2084775|NCT00723021|3669885|FG004|Intervention Period 4|Adverse Event|1
2084776|NCT00723125|3669920|FG000|Overall Study|Met Dx|1
2084777|NCT00723125|3669921|FG001|Overall Study|Met Dx|0
2084778|NCT00723125|3669920|FG000|Overall Study|Withdrawal by Subject|15
2084779|NCT00723125|3669921|FG001|Overall Study|Withdrawal by Subject|6
2084780|NCT00723125|3669920|FG000|Overall Study|Adverse Event|2
2084781|NCT00723125|3669921|FG001|Overall Study|Adverse Event|0
2084782|NCT00723190|3669946|FG000|Overall Study|Withdrawal by Subject|45
2084783|NCT00723190|3669946|FG000|Overall Study|Lost to Follow-up|37
2084784|NCT00723190|3669946|FG000|Overall Study|Adverse Event|18
2084785|NCT00723190|3669946|FG000|Overall Study|Lack of Efficacy|16
2084786|NCT00723190|3669946|FG000|Overall Study|Protocol Violation|15
2084787|NCT00723190|3669946|FG000|Overall Study|Other-Premature Discontinuation|9
2084788|NCT00723190|3669946|FG000|Overall Study|Other-Not included in safety population|2
2084789|NCT00723203|3669950|FG000|Overall Study|Withdrawal by Subject|3
2084790|NCT00723229|3669956|FG000|First Intervention|Lost to Follow-up|7
2084791|NCT00723229|3669957|FG001|First Intervention|Lost to Follow-up|3
2084792|NCT00723255|3669963|FG000|Overall Study|Ineligible: Inadequate pathology|1
2084793|NCT00723255|3669963|FG000|Overall Study|Ineligible: Second primary|1
2084794|NCT00723255|3669963|FG000|Overall Study|Ineligible: Wrong Primary|2
2084795|NCT00723294|3669979|FG000|Overall Study|Lobular histology|2
2084796|NCT00723294|3669979|FG000|Overall Study|>25% intraductal component|1
2084797|NCT00723294|3669979|FG000|Overall Study|No MRI tumor enhancement|1
2084798|NCT00723294|3669979|FG000|Overall Study|1.0-Tesla MRI|1
2084799|NCT00723294|3669979|FG000|Overall Study|No cryoabalation|2
2084800|NCT00723294|3669979|FG000|Overall Study|Did not undergo surgery|1
2084801|NCT00723294|3669979|FG000|Overall Study|Treated prior to registration|1
2305868|NCT02678000|4007341|FG001|PART 2|Adverse Event|0
2305869|NCT02678000|4007342|FG002|PART 2|Adverse Event|2
2305870|NCT02678000|4007343|FG003|PART 2|Adverse Event|1
2305871|NCT02678000|4007344|FG004|PART 2|Adverse Event|0
2305872|NCT02678000|4007340|FG000|PART 2|Withdrawal by Subject|0
2305873|NCT02678000|4007341|FG001|PART 2|Withdrawal by Subject|0
2305874|NCT02678000|4007342|FG002|PART 2|Withdrawal by Subject|1
2305875|NCT02678000|4007343|FG003|PART 2|Withdrawal by Subject|0
2305876|NCT02678000|4007344|FG004|PART 2|Withdrawal by Subject|0
2305877|NCT02678247|4007380|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0
2305878|NCT02678247|4007381|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2
2305879|NCT02678247|4007380|FG000|First Intervention (7 Weeks)|Adverse Event|1
2305880|NCT02678247|4007381|FG001|First Intervention (7 Weeks)|Adverse Event|2
2305881|NCT02678247|4007380|FG000|First Intervention (7 Weeks)|Physician Decision|1
2305882|NCT02678247|4007381|FG001|First Intervention (7 Weeks)|Physician Decision|0
2305883|NCT02678247|4007380|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1
2305884|NCT02678247|4007381|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1
2305885|NCT02678247|4007380|FG000|Second Intervention (7 Weeks)|Adverse Event|2
2305886|NCT02678247|4007381|FG001|Second Intervention (7 Weeks)|Adverse Event|1
2305887|NCT02678247|4007380|FG000|Second Intervention (7 Weeks)|Physician Decision|1
2305888|NCT02678247|4007381|FG001|Second Intervention (7 Weeks)|Physician Decision|0
2305889|NCT02678286|4007394|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
2305890|NCT02678286|4007395|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
2305891|NCT02678286|4007394|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
2305892|NCT02678286|4007395|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
2305893|NCT02678286|4007394|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
2305894|NCT02678286|4007395|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
2305895|NCT02678286|4007394|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
2305896|NCT02678286|4007395|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
2305897|NCT02678286|4007394|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
2305898|NCT02678286|4007395|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
2305899|NCT02678390|4007403|FG000|AE (1 Day)|Withdrawal by Subject|0
2305900|NCT02678390|4007404|FG001|AE (1 Day)|Withdrawal by Subject|1
2305901|NCT02678416|4007412|FG000|Part 1|Withdrawal by Subject|1
2305902|NCT02678416|4007412|FG000|Part 2|Adverse Event|2
2305903|NCT02678416|4007412|FG000|Part 2|Withdrawal by Subject|1
2305904|NCT02678676|4007441|FG000|Overall Study|Death|619
2305905|NCT02678676|4007442|FG001|Overall Study|Death|649
2305906|NCT02678676|4007441|FG000|Overall Study|Withdrawal by Subject|13
2305907|NCT02678676|4007442|FG001|Overall Study|Withdrawal by Subject|5
2305908|NCT02678676|4007441|FG000|Overall Study|Lost to Follow-up|171
2305909|NCT02678676|4007442|FG001|Overall Study|Lost to Follow-up|151
2305910|NCT02678676|4007441|FG000|Overall Study|Unconfirmed for lost to follow-up|85
2305911|NCT02678676|4007442|FG001|Overall Study|Unconfirmed for lost to follow-up|67
2305912|NCT02678923|4007450|FG000|Overall Study|Protocol Deviation (Not Dosed)|1
2305913|NCT02678923|4007451|FG001|Overall Study|Protocol Deviation (Not Dosed)|3
2305914|NCT02678923|4007450|FG000|Overall Study|Withdrawal by Subject|3
2305915|NCT02678923|4007451|FG001|Overall Study|Withdrawal by Subject|2
2305916|NCT02678923|4007450|FG000|Overall Study|Lost to Follow-up|1
2305917|NCT02678923|4007451|FG001|Overall Study|Lost to Follow-up|0
2305918|NCT02678923|4007450|FG000|Overall Study|Did Not Return for Study Visits|1
2305919|NCT02678923|4007451|FG001|Overall Study|Did Not Return for Study Visits|0
2305920|NCT02679079|4007460|FG000|Overall Study|Adverse Event|2
2305921|NCT02679079|4007461|FG001|Overall Study|Adverse Event|0
2305922|NCT02679079|4007462|FG002|Overall Study|Adverse Event|2
2305923|NCT02679079|4007460|FG000|Overall Study|Protocol Violation|0
2305924|NCT02679079|4007461|FG001|Overall Study|Protocol Violation|1
2305925|NCT02679079|4007462|FG002|Overall Study|Protocol Violation|0
2305926|NCT02679079|4007460|FG000|Overall Study|Withdrawal by Subject|2
2305927|NCT02679079|4007461|FG001|Overall Study|Withdrawal by Subject|1
2305928|NCT02679079|4007462|FG002|Overall Study|Withdrawal by Subject|0
2305929|NCT02679222|4007470|FG000|Overall Study|No time for project|1
2305930|NCT02679235|4007482|FG000|Overall Study|Withdrawal by Subject|3
2305931|NCT02679235|4007482|FG000|Overall Study|Adverse Event|1
2305932|NCT02679274|4007488|FG000|Overall Study|Withdrawal by Subject|1
2305933|NCT02679274|4007489|FG001|Overall Study|Withdrawal by Subject|0
2305934|NCT02679287|4007497|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2
2305935|NCT02679287|4007498|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1
2305936|NCT02679287|4007497|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2
2305937|NCT02679287|4007498|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3
2107112|NCT00870740|3700541|FG003|Overall Study|Consent Withdrawn|6
2084802|NCT00723294|3669979|FG000|Overall Study|Treated by non-credentialed surgeon|1
2084803|NCT00723294|3669979|FG000|Overall Study|Benign lesion|1
2084804|NCT00723294|3669979|FG000|Overall Study|Withdrawal by Subject|1
2084805|NCT00723294|3669979|FG000|Overall Study|No treatment due to probe failure|1
2084806|NCT00723398|3669988|FG000|Overall Study|Withdrawal by Subject|2
2084807|NCT00723398|3669989|FG001|Overall Study|Withdrawal by Subject|6
2084808|NCT00723398|3669990|FG002|Overall Study|Withdrawal by Subject|4
2084809|NCT00723398|3669991|FG003|Overall Study|Withdrawal by Subject|4
2084810|NCT00723398|3669992|FG004|Overall Study|Withdrawal by Subject|4
2084811|NCT00723398|3669988|FG000|Overall Study|Protocol Violation|2
2084812|NCT00723398|3669989|FG001|Overall Study|Protocol Violation|1
2084813|NCT00723398|3669990|FG002|Overall Study|Protocol Violation|5
2084814|NCT00723398|3669991|FG003|Overall Study|Protocol Violation|0
2084815|NCT00723398|3669992|FG004|Overall Study|Protocol Violation|0
2084816|NCT00723398|3669988|FG000|Overall Study|Physician Decision|2
2084817|NCT00723398|3669989|FG001|Overall Study|Physician Decision|2
2084818|NCT00723398|3669990|FG002|Overall Study|Physician Decision|5
2084819|NCT00723398|3669991|FG003|Overall Study|Physician Decision|0
2084820|NCT00723398|3669992|FG004|Overall Study|Physician Decision|1
2084821|NCT00723398|3669988|FG000|Overall Study|Adverse Event|0
2084822|NCT00723398|3669989|FG001|Overall Study|Adverse Event|5
2084823|NCT00723398|3669990|FG002|Overall Study|Adverse Event|3
2084824|NCT00723398|3669991|FG003|Overall Study|Adverse Event|1
2084825|NCT00723398|3669992|FG004|Overall Study|Adverse Event|4
2084826|NCT00723398|3669988|FG000|Overall Study|Lost to Follow-up|0
2084827|NCT00723398|3669989|FG001|Overall Study|Lost to Follow-up|1
2084828|NCT00723398|3669990|FG002|Overall Study|Lost to Follow-up|0
2084829|NCT00723398|3669991|FG003|Overall Study|Lost to Follow-up|0
2084830|NCT00723398|3669992|FG004|Overall Study|Lost to Follow-up|0
2084831|NCT00723450|3670006|FG000|Open-Label Phase|Adverse Event|26
2084832|NCT00723450|3670007|FG001|Open-Label Phase|Adverse Event|0
2084833|NCT00723450|3670008|FG002|Open-Label Phase|Adverse Event|0
2084834|NCT00723450|3670006|FG000|Open-Label Phase|Lack of Efficacy|18
2084835|NCT00723450|3670007|FG001|Open-Label Phase|Lack of Efficacy|0
2084836|NCT00723450|3670008|FG002|Open-Label Phase|Lack of Efficacy|0
2084837|NCT00723450|3670006|FG000|Open-Label Phase|Protocol Violation|35
2084838|NCT00723450|3670007|FG001|Open-Label Phase|Protocol Violation|0
2084839|NCT00723450|3670008|FG002|Open-Label Phase|Protocol Violation|0
2084840|NCT00723450|3670006|FG000|Open-Label Phase|Lost to Follow-up|7
2084841|NCT00723450|3670007|FG001|Open-Label Phase|Lost to Follow-up|0
2084842|NCT00723450|3670008|FG002|Open-Label Phase|Lost to Follow-up|0
2084843|NCT00723450|3670006|FG000|Open-Label Phase|Physician Decision|2
2084844|NCT00723450|3670007|FG001|Open-Label Phase|Physician Decision|0
2084845|NCT00723450|3670008|FG002|Open-Label Phase|Physician Decision|0
2084846|NCT00723450|3670006|FG000|Open-Label Phase|Withdrawal by Subject|37
2084847|NCT00723450|3670007|FG001|Open-Label Phase|Withdrawal by Subject|0
2084848|NCT00723450|3670008|FG002|Open-Label Phase|Withdrawal by Subject|0
2084849|NCT00723450|3670006|FG000|Randomized Phase|Adverse Event|0
2084850|NCT00723450|3670007|FG001|Randomized Phase|Adverse Event|26
2084851|NCT00723450|3670008|FG002|Randomized Phase|Adverse Event|17
2084852|NCT00723450|3670006|FG000|Randomized Phase|Lack of Efficacy|0
2084853|NCT00723450|3670007|FG001|Randomized Phase|Lack of Efficacy|11
2084854|NCT00723450|3670008|FG002|Randomized Phase|Lack of Efficacy|11
2084855|NCT00723450|3670006|FG000|Randomized Phase|Protocol Violation|0
2084856|NCT00723450|3670007|FG001|Randomized Phase|Protocol Violation|9
2084857|NCT00723450|3670008|FG002|Randomized Phase|Protocol Violation|13
2084858|NCT00723450|3670006|FG000|Randomized Phase|Lost to Follow-up|0
2084859|NCT00723450|3670007|FG001|Randomized Phase|Lost to Follow-up|2
2084860|NCT00723450|3670008|FG002|Randomized Phase|Lost to Follow-up|3
2084861|NCT00723450|3670006|FG000|Randomized Phase|Physician Decision|0
2084862|NCT00723450|3670007|FG001|Randomized Phase|Physician Decision|3
2084863|NCT00723450|3670008|FG002|Randomized Phase|Physician Decision|1
2084864|NCT00723450|3670006|FG000|Randomized Phase|Withdrawal by Subject|0
2084865|NCT00723450|3670007|FG001|Randomized Phase|Withdrawal by Subject|14
2084866|NCT00723450|3670008|FG002|Randomized Phase|Withdrawal by Subject|22
2084867|NCT00723489|3670021|FG000|Overall Study|Physician Decision|0
2084868|NCT00723489|3670022|FG001|Overall Study|Physician Decision|1
2084869|NCT00723489|3670023|FG002|Overall Study|Physician Decision|0
2084870|NCT00723489|3670024|FG003|Overall Study|Physician Decision|0
2084871|NCT00723489|3670021|FG000|Overall Study|Pregnancy|0
2084872|NCT00723489|3670022|FG001|Overall Study|Pregnancy|0
2084873|NCT00723489|3670023|FG002|Overall Study|Pregnancy|0
2084874|NCT00723489|3670024|FG003|Overall Study|Pregnancy|1
2084875|NCT00723489|3670021|FG000|Overall Study|Withdrawal by Subject|0
2084876|NCT00723489|3670022|FG001|Overall Study|Withdrawal by Subject|0
2084877|NCT00723489|3670023|FG002|Overall Study|Withdrawal by Subject|0
2084878|NCT00723489|3670024|FG003|Overall Study|Withdrawal by Subject|1
2084879|NCT00723489|3670021|FG000|Overall Study|Seropositive at baseline|1
2084880|NCT00723489|3670022|FG001|Overall Study|Seropositive at baseline|0
2084881|NCT00723489|3670023|FG002|Overall Study|Seropositive at baseline|0
2084882|NCT00723489|3670024|FG003|Overall Study|Seropositive at baseline|0
2084883|NCT00723489|3670021|FG000|Overall Study|Prohibited Medication|0
2084884|NCT00723489|3670022|FG001|Overall Study|Prohibited Medication|0
2084885|NCT00723489|3670023|FG002|Overall Study|Prohibited Medication|0
2084886|NCT00723489|3670024|FG003|Overall Study|Prohibited Medication|1
2084887|NCT00723489|3670021|FG000|Overall Study|Samples Collected Out of Window|0
2084888|NCT00723489|3670022|FG001|Overall Study|Samples Collected Out of Window|3
2084889|NCT00723489|3670023|FG002|Overall Study|Samples Collected Out of Window|0
2084890|NCT00723489|3670024|FG003|Overall Study|Samples Collected Out of Window|0
2084891|NCT00723528|3670037|FG000|Period 1: Controlled Period (CP)|Adverse Event|0
2084892|NCT00723528|3670038|FG001|Period 1: Controlled Period (CP)|Adverse Event|0
2084893|NCT00723528|3670039|FG002|Period 1: Controlled Period (CP)|Adverse Event|1
2084894|NCT00723528|3670040|FG003|Period 1: Controlled Period (CP)|Adverse Event|0
2084895|NCT00723528|3670041|FG004|Period 1: Controlled Period (CP)|Adverse Event|0
2084896|NCT00723528|3670042|FG005|Period 1: Controlled Period (CP)|Adverse Event|0
2084897|NCT00723528|3670043|FG006|Period 1: Controlled Period (CP)|Adverse Event|0
2084898|NCT00723528|3670037|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
2084899|NCT00723528|3670038|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2084900|NCT00723528|3670039|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2084901|NCT00723528|3670040|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2084902|NCT00723528|3670041|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2084903|NCT00723528|3670042|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2084904|NCT00723528|3670043|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2084905|NCT00723528|3670037|FG000|Period 1: Controlled Period (CP)|Physician Decision|0
2084906|NCT00723528|3670038|FG001|Period 1: Controlled Period (CP)|Physician Decision|0
2084907|NCT00723528|3670039|FG002|Period 1: Controlled Period (CP)|Physician Decision|1
2084908|NCT00723528|3670040|FG003|Period 1: Controlled Period (CP)|Physician Decision|0
2084909|NCT00723528|3670041|FG004|Period 1: Controlled Period (CP)|Physician Decision|0
2084910|NCT00723528|3670042|FG005|Period 1: Controlled Period (CP)|Physician Decision|0
2084911|NCT00723528|3670043|FG006|Period 1: Controlled Period (CP)|Physician Decision|0
2084912|NCT00723528|3670037|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2084913|NCT00723528|3670038|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2084914|NCT00723528|3670039|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
2084915|NCT00723528|3670040|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2084916|NCT00723528|3670041|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2084917|NCT00723528|3670042|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2084918|NCT00723528|3670043|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2084919|NCT00723528|3670037|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
2084920|NCT00723528|3670038|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
2084921|NCT00723528|3670039|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
2084922|NCT00723528|3670040|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
2084923|NCT00723528|3670041|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
2084924|NCT00723528|3670042|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
2084925|NCT00723528|3670043|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
2084926|NCT00723528|3670037|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0
2084927|NCT00723528|3670038|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0
2084928|NCT00723528|3670039|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0
2084929|NCT00723528|3670040|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1
2084930|NCT00723528|3670041|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0
2084931|NCT00723528|3670042|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1
2084932|NCT00723528|3670043|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1
2084933|NCT00723528|3670037|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2084934|NCT00723528|3670038|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2084935|NCT00723528|3670039|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2084936|NCT00723528|3670040|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2084937|NCT00723528|3670041|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2084938|NCT00723528|3670042|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1
2084939|NCT00723528|3670043|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2084940|NCT00723528|3670037|FG000|Period 2: After Controlled Period|Other|0
2084941|NCT00723528|3670038|FG001|Period 2: After Controlled Period|Other|0
2084942|NCT00723528|3670039|FG002|Period 2: After Controlled Period|Other|0
2084943|NCT00723528|3670040|FG003|Period 2: After Controlled Period|Other|0
2084944|NCT00723528|3670041|FG004|Period 2: After Controlled Period|Other|1
2084945|NCT00723528|3670042|FG005|Period 2: After Controlled Period|Other|4
2084946|NCT00723528|3670043|FG006|Period 2: After Controlled Period|Other|0
2084947|NCT00723528|3670037|FG000|Period 2: After Controlled Period|Adverse Event|0
2084948|NCT00723528|3670038|FG001|Period 2: After Controlled Period|Adverse Event|0
2084949|NCT00723528|3670039|FG002|Period 2: After Controlled Period|Adverse Event|0
2084950|NCT00723528|3670040|FG003|Period 2: After Controlled Period|Adverse Event|0
2084951|NCT00723528|3670041|FG004|Period 2: After Controlled Period|Adverse Event|1
2084952|NCT00723528|3670042|FG005|Period 2: After Controlled Period|Adverse Event|0
2084953|NCT00723528|3670043|FG006|Period 2: After Controlled Period|Adverse Event|1
2084954|NCT00723528|3670037|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2084955|NCT00723528|3670038|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2084956|NCT00723528|3670039|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2084957|NCT00723528|3670040|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2084958|NCT00723528|3670041|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2084959|NCT00723528|3670042|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2084960|NCT00723528|3670043|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
2084961|NCT00723528|3670037|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2084962|NCT00723528|3670038|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2084963|NCT00723528|3670039|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2084964|NCT00723528|3670040|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2084965|NCT00723528|3670041|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2084966|NCT00723528|3670042|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2084967|NCT00723528|3670043|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
2084968|NCT00723554|3670059|FG000|Overall Study|Adverse Event|12
2084969|NCT00723554|3670059|FG000|Overall Study|Investigator's judgement|5
2084970|NCT00723554|3670059|FG000|Overall Study|Inhaled medication other than iloprost|4
2084971|NCT00723554|3670059|FG000|Overall Study|Withdrawal of consent|3
2084972|NCT00723554|3670059|FG000|Overall Study|Other|3
2084973|NCT00723554|3670059|FG000|Overall Study|Lost to Follow-up|1
2084974|NCT00723554|3670059|FG000|Overall Study|Non-compliance|1
2084975|NCT00723606|3670071|FG000|Overall Study|Adverse Event|2
2084976|NCT00723606|3670072|FG001|Overall Study|Adverse Event|5
2084977|NCT00723606|3670071|FG000|Overall Study|Other|2
2084978|NCT00723606|3670072|FG001|Overall Study|Other|0
2084979|NCT00723606|3670071|FG000|Overall Study|Withdrawal by Subject|0
2084980|NCT00723606|3670072|FG001|Overall Study|Withdrawal by Subject|2
2084981|NCT00723697|3670086|FG000|Overall Study|Physician questionnaires not received|2
2084982|NCT00723697|3670086|FG000|Overall Study|Missing Informed Consent Form|10
2084983|NCT00723697|3670086|FG000|Overall Study|Other exclusion criteria applied|6
2084984|NCT00723710|3670093|FG000|Overall Study|Disease progression|48
2084985|NCT00723710|3670093|FG000|Overall Study|Adverse Event|88
2084986|NCT00723710|3670093|FG000|Overall Study|Withdrawal by Subject|36
2084987|NCT00723710|3670093|FG000|Overall Study|Physician Decision|2
2084988|NCT00723801|3670109|FG000|Overall Study|Lost to Follow-up|1
2084989|NCT00723801|3670110|FG001|Overall Study|Lost to Follow-up|2
2084990|NCT00723801|3670109|FG000|Overall Study|Protocol Violation|2
2084991|NCT00723801|3670110|FG001|Overall Study|Protocol Violation|1
2084992|NCT00723840|3670120|FG000|Overall Study|Lost to Follow-up|2
2084993|NCT00723840|3670120|FG000|Overall Study|Failure to return|18
2084994|NCT00723840|3670120|FG000|Overall Study|Withdrawal by Subject|55
2084995|NCT00723840|3670120|FG000|Overall Study|Serious Adverse Events|3
2084996|NCT00723840|3670120|FG000|Overall Study|Other Medical Event|2
2084997|NCT00723840|3670120|FG000|Overall Study|Unspecified reason|2
2084998|NCT00723892|3670133|FG000|Overall Study|Participant not tracked|33
2084999|NCT00723892|3670134|FG001|Overall Study|Participant not tracked|35
2085000|NCT00723892|3670133|FG000|Overall Study|Virological criterion|24
2085001|NCT00723892|3670134|FG001|Overall Study|Virological criterion|9
2085002|NCT00723892|3670133|FG000|Overall Study|Withdrawal by Subject|6
2085003|NCT00723892|3670134|FG001|Overall Study|Withdrawal by Subject|9
2085004|NCT00723892|3670133|FG000|Overall Study|End planned|11
2085005|NCT00723892|3670134|FG001|Overall Study|End planned|7
2085006|NCT00723892|3670133|FG000|Overall Study|Bad tolerance|5
2085007|NCT00723892|3670134|FG001|Overall Study|Bad tolerance|5
2085008|NCT00723892|3670133|FG000|Overall Study|Multiple reasons|17
2085009|NCT00723892|3670134|FG001|Overall Study|Multiple reasons|12
2085010|NCT00723892|3670133|FG000|Overall Study|Other|6
2085011|NCT00723892|3670134|FG001|Overall Study|Other|3
2085012|NCT00723892|3670133|FG000|Overall Study|Study end|1
2085013|NCT00723892|3670134|FG001|Overall Study|Study end|3
2085014|NCT00723892|3670133|FG000|Overall Study|Weight loss|1
2085015|NCT00723892|3670134|FG001|Overall Study|Weight loss|3
2085016|NCT00723892|3670133|FG000|Overall Study|Alcohol abuse|0
2085017|NCT00723892|3670134|FG001|Overall Study|Alcohol abuse|1
2085018|NCT00723892|3670133|FG000|Overall Study|Intercurrent infection|2
2085019|NCT00723892|3670134|FG001|Overall Study|Intercurrent infection|0
2085020|NCT00723892|3670133|FG000|Overall Study|Drug addiction|1
2085021|NCT00723892|3670134|FG001|Overall Study|Drug addiction|0
2085022|NCT00723944|3670146|FG000|Permanent Prosthesis Placement|Adverse Event|1
2085023|NCT00723944|3670147|FG001|Permanent Prosthesis Placement|Adverse Event|7
2085024|NCT00723944|3670146|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2
2085025|NCT00723944|3670147|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2
2085026|NCT00723944|3670146|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1
2085027|NCT00723944|3670147|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4
2085028|NCT00723957|3670155|FG000|Overall Study|Adverse event unrelated to study drug|1
2085029|NCT00723957|3670156|FG001|Overall Study|Adverse event unrelated to study drug|4
2085030|NCT00723957|3670155|FG000|Overall Study|Death|3
2085031|NCT00723957|3670156|FG001|Overall Study|Death|4
2085032|NCT00723957|3670155|FG000|Overall Study|Disease progression|27
2085033|NCT00723957|3670156|FG001|Overall Study|Disease progression|25
2085034|NCT00723957|3670155|FG000|Overall Study|Maximum clinical benefit|4
2085035|NCT00723957|3670156|FG001|Overall Study|Maximum clinical benefit|5
2085036|NCT00723957|3670155|FG000|Overall Study|Investigator decision|1
2085037|NCT00723957|3670156|FG001|Overall Study|Investigator decision|1
2085038|NCT00723957|3670155|FG000|Overall Study|Study drug toxicity|4
2085039|NCT00723957|3670156|FG001|Overall Study|Study drug toxicity|6
2085040|NCT00723957|3670155|FG000|Overall Study|Withdrawal by Subject|7
2085041|NCT00723957|3670156|FG001|Overall Study|Withdrawal by Subject|5
2085042|NCT00723957|3670155|FG000|Overall Study|Reason not analyzed|1
2085043|NCT00723957|3670156|FG001|Overall Study|Reason not analyzed|0
2085044|NCT00723957|3670155|FG000|Overall Study|Never received treatment|3
2085045|NCT00723957|3670156|FG001|Overall Study|Never received treatment|3
2107113|NCT00870740|3700542|FG004|Overall Study|Consent Withdrawn|6
2107114|NCT00870740|3700543|FG005|Overall Study|Consent Withdrawn|5
2107115|NCT00870740|3700538|FG000|Overall Study|Investigator Decision|2
2107116|NCT00870740|3700539|FG001|Overall Study|Investigator Decision|0
2107117|NCT00870740|3700540|FG002|Overall Study|Investigator Decision|1
2107118|NCT00870740|3700541|FG003|Overall Study|Investigator Decision|0
2107119|NCT00870740|3700542|FG004|Overall Study|Investigator Decision|0
2107120|NCT00870740|3700543|FG005|Overall Study|Investigator Decision|0
2107121|NCT00870740|3700538|FG000|Overall Study|Subject Non-compliance|0
2107122|NCT00870740|3700539|FG001|Overall Study|Subject Non-compliance|0
2107123|NCT00870740|3700540|FG002|Overall Study|Subject Non-compliance|0
2107124|NCT00870740|3700541|FG003|Overall Study|Subject Non-compliance|0
2107125|NCT00870740|3700542|FG004|Overall Study|Subject Non-compliance|0
2107126|NCT00870740|3700543|FG005|Overall Study|Subject Non-compliance|1
2107127|NCT00870740|3700538|FG000|Overall Study|Death|0
2107128|NCT00870740|3700539|FG001|Overall Study|Death|0
2107129|NCT00870740|3700540|FG002|Overall Study|Death|0
2107130|NCT00870740|3700541|FG003|Overall Study|Death|0
2107131|NCT00870740|3700542|FG004|Overall Study|Death|1
2107132|NCT00870740|3700543|FG005|Overall Study|Death|0
2107133|NCT00870740|3700538|FG000|Overall Study|Other|2
2107134|NCT00870740|3700539|FG001|Overall Study|Other|5
2107135|NCT00870740|3700540|FG002|Overall Study|Other|2
2107136|NCT00870740|3700541|FG003|Overall Study|Other|4
2107137|NCT00870740|3700542|FG004|Overall Study|Other|3
2107138|NCT00870740|3700543|FG005|Overall Study|Other|5
2107139|NCT00870870|3700572|FG000|Overall Study|Withdrawal by Subject|0
2107140|NCT00870870|3700573|FG001|Overall Study|Withdrawal by Subject|1
2107141|NCT00870870|3700574|FG002|Overall Study|Withdrawal by Subject|1
2107142|NCT00870870|3700575|FG003|Overall Study|Withdrawal by Subject|3
2107143|NCT00870870|3700572|FG000|Overall Study|Adverse Event|0
2107144|NCT00870870|3700573|FG001|Overall Study|Adverse Event|0
2107145|NCT00870870|3700574|FG002|Overall Study|Adverse Event|2
2107146|NCT00870870|3700575|FG003|Overall Study|Adverse Event|2
2107147|NCT00871000|3700598|FG000|Overall Study|Withdrawal by Subject|1
2107148|NCT00871000|3700599|FG001|Overall Study|Withdrawal by Subject|0
2107149|NCT00871117|3700607|FG000|Overall Study|Lost to Follow-up|5
2107150|NCT00871117|3700608|FG001|Overall Study|Lost to Follow-up|6
2107151|NCT00871117|3700607|FG000|Overall Study|Other|0
2107152|NCT00871117|3700608|FG001|Overall Study|Other|4
2107153|NCT00871169|3700624|FG000|Overall Study|Protocol Violation|1
2107154|NCT00871169|3700624|FG000|Overall Study|Patient did not receive study treatment|2
2107155|NCT00871234|3700628|FG000|Overall Study|Adverse Event|2
2107156|NCT00871234|3700628|FG000|Overall Study|Lost to Follow-up|3
2107157|NCT00871338|3700647|FG000|Prior to Booster|Withdrawal by Subject|1
2107158|NCT00871338|3700648|FG001|Prior to Booster|Withdrawal by Subject|3
2107159|NCT00871338|3700647|FG000|Prior to Booster|Lost to Follow-up|1
2107160|NCT00871338|3700648|FG001|Prior to Booster|Lost to Follow-up|0
2107161|NCT00871377|3700654|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0
2107162|NCT00871377|3700655|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0
2107163|NCT00871377|3700656|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1
2107164|NCT00871377|3700657|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0
2107165|NCT00871377|3700658|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0
2107166|NCT00871377|3700659|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0
2107167|NCT00871377|3700654|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0
2107168|NCT00871377|3700655|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0
2107169|NCT00871377|3700656|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0
2107170|NCT00871377|3700657|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0
2107171|NCT00871377|3700658|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0
2107172|NCT00871377|3700659|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1
2107173|NCT00871377|3700654|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
2107174|NCT00871377|3700655|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
2107175|NCT00871377|3700656|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
2107176|NCT00871377|3700657|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
2107177|NCT00871377|3700658|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
2107178|NCT00871377|3700659|FG005|Washout (6 Weeks)|Withdrawal by Subject|0
2107179|NCT00871377|3700654|FG000|Washout (6 Weeks)|Withdrawal by Subject|0
2107180|NCT00871377|3700655|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
2107181|NCT00871377|3700656|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
2107182|NCT00871377|3700657|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
2107183|NCT00871377|3700658|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
2107184|NCT00871377|3700659|FG005|Washout (6 Weeks)|Withdrawal by Subject|1
2305938|NCT02679287|4007497|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0
2305939|NCT02679287|4007498|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1
2305940|NCT02679287|4007497|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0
2305941|NCT02679287|4007498|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1
2305942|NCT02679287|4007497|FG000|Period 2|Work/Scheduling Conflict|1
2305943|NCT02679287|4007498|FG001|Period 2|Work/Scheduling Conflict|0
2305944|NCT02679287|4007497|FG000|Period 2|Disliked Mobile System|2
2305945|NCT02679287|4007498|FG001|Period 2|Disliked Mobile System|0
2305946|NCT02679287|4007497|FG000|Period 3|Work/Scheduling Conflict|0
2305947|NCT02679287|4007498|FG001|Period 3|Work/Scheduling Conflict|1
2305948|NCT02679573|4007516|FG000|Overall Study|Adverse Event|13
2305949|NCT02679573|4007517|FG001|Overall Study|Adverse Event|6
2305950|NCT02679573|4007516|FG000|Overall Study|Lack of Efficacy|12
2305951|NCT02679573|4007517|FG001|Overall Study|Lack of Efficacy|15
2305952|NCT02679573|4007516|FG000|Overall Study|Could not complete required study visits|6
2305953|NCT02679573|4007517|FG001|Overall Study|Could not complete required study visits|2
2305954|NCT02679573|4007516|FG000|Overall Study|Withdrawal by Subject|2
2305955|NCT02679573|4007517|FG001|Overall Study|Withdrawal by Subject|9
2305956|NCT02679573|4007516|FG000|Overall Study|Death|2
2305957|NCT02679573|4007517|FG001|Overall Study|Death|0
2305958|NCT02679573|4007516|FG000|Overall Study|Physician Decision|2
2305959|NCT02679573|4007517|FG001|Overall Study|Physician Decision|4
2305960|NCT02679573|4007516|FG000|Overall Study|Lost to Follow-up|0
2305961|NCT02679573|4007517|FG001|Overall Study|Lost to Follow-up|3
2305962|NCT02679729|4007538|FG000|Overall Study|Lost to Follow-up|0
2305963|NCT02679729|4007539|FG001|Overall Study|Lost to Follow-up|1
2305964|NCT02679729|4007540|FG002|Overall Study|Lost to Follow-up|0
2305965|NCT02679729|4007541|FG003|Overall Study|Lost to Follow-up|0
2305966|NCT02679729|4007542|FG004|Overall Study|Lost to Follow-up|1
2305967|NCT02679729|4007543|FG005|Overall Study|Lost to Follow-up|0
2305968|NCT02679729|4007544|FG006|Overall Study|Lost to Follow-up|0
2305969|NCT02679729|4007545|FG007|Overall Study|Lost to Follow-up|0
2305970|NCT02679729|4007546|FG008|Overall Study|Lost to Follow-up|0
2305971|NCT02679729|4007538|FG000|Overall Study|Participant decision|0
2305972|NCT02679729|4007539|FG001|Overall Study|Participant decision|1
2305973|NCT02679729|4007540|FG002|Overall Study|Participant decision|0
2305974|NCT02679729|4007541|FG003|Overall Study|Participant decision|0
2305975|NCT02679729|4007542|FG004|Overall Study|Participant decision|0
2305976|NCT02679729|4007543|FG005|Overall Study|Participant decision|0
2305977|NCT02679729|4007544|FG006|Overall Study|Participant decision|1
2305978|NCT02679729|4007545|FG007|Overall Study|Participant decision|0
2305979|NCT02679729|4007546|FG008|Overall Study|Participant decision|0
2305980|NCT02679755|4007580|FG000|Overall Study|Death|0
2305981|NCT02679755|4007581|FG001|Overall Study|Death|3
2305982|NCT02679755|4007580|FG000|Overall Study|Global deterioration of health status|1
2305983|NCT02679755|4007581|FG001|Overall Study|Global deterioration of health status|8
2305984|NCT02679755|4007580|FG000|Overall Study|Lost to Follow-up|1
2305985|NCT02679755|4007581|FG001|Overall Study|Lost to Follow-up|0
2305986|NCT02679755|4007580|FG000|Overall Study|Objective progression or relapse|24
2305987|NCT02679755|4007581|FG001|Overall Study|Objective progression or relapse|83
2305988|NCT02679755|4007580|FG000|Overall Study|Not defined|0
2305989|NCT02679755|4007581|FG001|Overall Study|Not defined|2
2305990|NCT02679755|4007580|FG000|Overall Study|Withdrawal by participant|6
2305991|NCT02679755|4007581|FG001|Overall Study|Withdrawal by participant|3
2305992|NCT02679755|4007580|FG000|Overall Study|Adverse Event|1
2305993|NCT02679755|4007581|FG001|Overall Study|Adverse Event|4
2305994|NCT02679755|4007580|FG000|Overall Study|Adverse events not related to study drug|1
2085046|NCT00724061|3670166|FG000|Dose Escalation Phase|Adverse Event|2
2085047|NCT00724061|3670166|FG000|Dose Escalation Phase|Disease Progression|3
2085048|NCT00724126|3670172|FG000|Overall Study|Adverse Event|2
2085049|NCT00724126|3670173|FG001|Overall Study|Adverse Event|0
2085050|NCT00724126|3670172|FG000|Overall Study|Withdrawal by Subject|8
2085051|NCT00724126|3670173|FG001|Overall Study|Withdrawal by Subject|6
2085052|NCT00724126|3670172|FG000|Overall Study|Lost to Follow-up|6
2085053|NCT00724126|3670173|FG001|Overall Study|Lost to Follow-up|6
2085054|NCT00724126|3670172|FG000|Overall Study|Noncompliance|2
2085055|NCT00724126|3670173|FG001|Overall Study|Noncompliance|1
2085056|NCT00724126|3670172|FG000|Overall Study|Subject randomized although ineligible|1
2085057|NCT00724126|3670173|FG001|Overall Study|Subject randomized although ineligible|1
2085058|NCT00724126|3670172|FG000|Overall Study|Subject had to leave vicinity of site|0
2085059|NCT00724126|3670173|FG001|Overall Study|Subject had to leave vicinity of site|1
2085060|NCT00724152|3670184|FG000|Two-arm Study Period|Withdrawal by Subject|3
2085061|NCT00724152|3670185|FG001|Two-arm Study Period|Withdrawal by Subject|2
2085062|NCT00724152|3670186|FG002|Two-arm Study Period|Withdrawal by Subject|0
2085063|NCT00724152|3670184|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
2085064|NCT00724152|3670185|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
2085065|NCT00724152|3670186|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
2085066|NCT00724243|3670196|FG000|Overall Study|Lack of Efficacy|10
2085067|NCT00724243|3670196|FG000|Overall Study|Adverse Event|5
2085068|NCT00724373|3670213|FG000|Overall Study|Adverse Event|41
2085069|NCT00724373|3670213|FG000|Overall Study|Lack of Efficacy|82
2085070|NCT00724373|3670213|FG000|Overall Study|Lost to Follow-up|7
2085071|NCT00724373|3670213|FG000|Overall Study|Non-compliance|2
2085072|NCT00724373|3670213|FG000|Overall Study|HCV RNA negative after 4 weeks|9
2085073|NCT00724373|3670213|FG000|Overall Study|Participant moved away|1
2085074|NCT00724373|3670213|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
2085075|NCT00724373|3670213|FG000|Overall Study|Only to have 24 week regimen|1
2085076|NCT00724373|3670213|FG000|Overall Study|Viral Relapse|1
2085077|NCT00724373|3670213|FG000|Overall Study|Acute HCV infection|1
2085078|NCT00724373|3670213|FG000|Overall Study|Drug Relapse|1
2085079|NCT00724373|3670213|FG000|Overall Study|Tolerability|23
2085080|NCT00724451|3670217|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7
2085081|NCT00724451|3670217|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3
2085082|NCT00724451|3670217|FG000|Overall Study|Not Eligible for Treatment|431
2085083|NCT00724451|3670217|FG000|Overall Study|Participant Refused Treatment|89
2085084|NCT00724451|3670217|FG000|Overall Study|Never Started Treatment|89
2085085|NCT00724451|3670217|FG000|Overall Study|Unknown; No Data Sources Available|9
2085086|NCT00724451|3670217|FG000|Overall Study|Physician Decision|116
2085087|NCT00724451|3670217|FG000|Overall Study|Withdrawal by Subject|45
2085088|NCT00724451|3670217|FG000|Overall Study|Investigator + Participant Decision|13
2085089|NCT00724503|3670228|FG000|Overall Study|Lost to Follow-up|4
2085090|NCT00724503|3670229|FG001|Overall Study|Lost to Follow-up|8
2085091|NCT00724503|3670228|FG000|Overall Study|Withdrawal by Subject|11
2085092|NCT00724503|3670229|FG001|Overall Study|Withdrawal by Subject|23
2085093|NCT00724503|3670228|FG000|Overall Study|Death|190
2085094|NCT00724503|3670229|FG001|Overall Study|Death|182
2085095|NCT00724503|3670228|FG000|Overall Study|Adverse Event|1
2085096|NCT00724503|3670229|FG001|Overall Study|Adverse Event|0
2085097|NCT00724503|3670228|FG000|Overall Study|Not otherwise specified|4
2085098|NCT00724503|3670229|FG001|Overall Study|Not otherwise specified|7
2085099|NCT00724711|3670276|FG000|Overall Study|Adverse Event|7
2085100|NCT00724711|3670277|FG001|Overall Study|Adverse Event|3
2085101|NCT00724711|3670276|FG000|Overall Study|Pregnancy|0
2085102|NCT00724711|3670277|FG001|Overall Study|Pregnancy|1
2085103|NCT00724711|3670276|FG000|Overall Study|Lack of Efficacy|0
2085104|NCT00724711|3670277|FG001|Overall Study|Lack of Efficacy|1
2085105|NCT00724711|3670276|FG000|Overall Study|Physician Decision|0
2085106|NCT00724711|3670277|FG001|Overall Study|Physician Decision|3
2085107|NCT00724711|3670276|FG000|Overall Study|Withdrawal by Subject|5
2085108|NCT00724711|3670277|FG001|Overall Study|Withdrawal by Subject|4
2085109|NCT00724711|3670276|FG000|Overall Study|Lost to Follow-up|4
2085110|NCT00724711|3670277|FG001|Overall Study|Lost to Follow-up|5
2085111|NCT00724711|3670276|FG000|Overall Study|Protocol Violation|1
2085112|NCT00724711|3670277|FG001|Overall Study|Protocol Violation|0
2085113|NCT00724815|3670294|FG000|Overall Study|Randomized, not treated|31
2085114|NCT00724815|3670295|FG001|Overall Study|Randomized, not treated|30
2085115|NCT00724815|3670294|FG000|Overall Study|Adverse Event|5
2085116|NCT00724815|3670295|FG001|Overall Study|Adverse Event|3
2085117|NCT00724815|3670294|FG000|Overall Study|Lost to Follow-up|4
2085118|NCT00724815|3670295|FG001|Overall Study|Lost to Follow-up|1
2085119|NCT00724815|3670294|FG000|Overall Study|Other Various|3
2085120|NCT00724815|3670295|FG001|Overall Study|Other Various|5
2085121|NCT00724854|3670303|FG000|Overall Study|Lack of Efficacy|187
2085122|NCT00724854|3670304|FG001|Overall Study|Lack of Efficacy|13
2085123|NCT00724854|3670303|FG000|Overall Study|Lost to Follow-up|87
2085124|NCT00724854|3670304|FG001|Overall Study|Lost to Follow-up|10
2085125|NCT00724854|3670303|FG000|Overall Study|Adverse Event|62
2085126|NCT00724854|3670304|FG001|Overall Study|Adverse Event|4
2085127|NCT00724854|3670303|FG000|Overall Study|Other|42
2085128|NCT00724854|3670304|FG001|Overall Study|Other|3
2085129|NCT00724854|3670303|FG000|Overall Study|Death|11
2085130|NCT00724854|3670304|FG001|Overall Study|Death|0
2085131|NCT00724854|3670303|FG000|Overall Study|Change of treatment|7
2085132|NCT00724854|3670304|FG001|Overall Study|Change of treatment|0
2085133|NCT00724854|3670303|FG000|Overall Study|Withdrawal by Subject|5
2085134|NCT00724854|3670304|FG001|Overall Study|Withdrawal by Subject|0
2085135|NCT00724854|3670303|FG000|Overall Study|Adverse event + lack of efficacy|2
2085136|NCT00724854|3670304|FG001|Overall Study|Adverse event + lack of efficacy|1
2085137|NCT00724867|3670311|FG000|Overall Study|Adverse Event|25
2085138|NCT00724867|3670311|FG000|Overall Study|Lack of Efficacy|14
2085139|NCT00724867|3670311|FG000|Overall Study|Lost to Follow-up|12
2085140|NCT00724867|3670311|FG000|Overall Study|Non-compliance with study drug|6
2085141|NCT00724867|3670311|FG000|Overall Study|Physician Decision|17
2085142|NCT00724867|3670311|FG000|Overall Study|Protocol Violation|1
2085143|NCT00724867|3670311|FG000|Overall Study|Withdrawal by Subject|31
2085144|NCT00724867|3670311|FG000|Overall Study|Sponsor decision to end study|14
2085145|NCT00724867|3670311|FG000|Overall Study|Subject incarcerated|1
2085146|NCT00724867|3670311|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4
2085147|NCT00724867|3670311|FG000|Overall Study|Subject moved out of state|1
2085148|NCT00724867|3670311|FG000|Overall Study|Elected to exit due to site closure|2
2085149|NCT00724893|3670320|FG000|Overall Study|Adverse Event|76
2085150|NCT00724893|3670321|FG001|Overall Study|Adverse Event|142
2085151|NCT00724893|3670320|FG000|Overall Study|Withdrawal by Subject|0
2085152|NCT00724893|3670321|FG001|Overall Study|Withdrawal by Subject|1
2085153|NCT00724893|3670320|FG000|Overall Study|Lack of virologic response|94
2085154|NCT00724893|3670321|FG001|Overall Study|Lack of virologic response|202
2085155|NCT00724893|3670320|FG000|Overall Study|Reason not specified|193
2085156|NCT00724893|3670321|FG001|Overall Study|Reason not specified|7
2085157|NCT00724893|3670320|FG000|Overall Study|Patient choice|0
2085158|NCT00724893|3670321|FG001|Overall Study|Patient choice|26
2085159|NCT00724893|3670320|FG000|Overall Study|Geographic reasons|0
2085160|NCT00724893|3670321|FG001|Overall Study|Geographic reasons|11
2085161|NCT00724893|3670320|FG000|Overall Study|Incarceration|0
2085162|NCT00724893|3670321|FG001|Overall Study|Incarceration|9
2085163|NCT00724893|3670320|FG000|Overall Study|Substance abuse|0
2085164|NCT00724893|3670321|FG001|Overall Study|Substance abuse|3
2085165|NCT00724893|3670320|FG000|Overall Study|Financial reasons|0
2085166|NCT00724893|3670321|FG001|Overall Study|Financial reasons|2
2085167|NCT00724893|3670320|FG000|Overall Study|Assigned shorter treatment|0
2085168|NCT00724893|3670321|FG001|Overall Study|Assigned shorter treatment|2
2085169|NCT00724893|3670320|FG000|Overall Study|Lost to Follow-up|0
2085170|NCT00724893|3670321|FG001|Overall Study|Lost to Follow-up|52
2085171|NCT00724893|3670320|FG000|Overall Study|Unknown, missing data|1
2085172|NCT00724893|3670321|FG001|Overall Study|Unknown, missing data|1
2085173|NCT00724932|3670344|FG000|Overall Study|Lost to Follow-up|1
2085174|NCT00724932|3670345|FG001|Overall Study|Lost to Follow-up|0
2085175|NCT00724932|3670344|FG000|Overall Study|Not treated|4
2085176|NCT00724932|3670345|FG001|Overall Study|Not treated|3
2085177|NCT00724945|3670353|FG000|Period 1|non-compliance|1
2085178|NCT00724945|3670354|FG001|Period 1|non-compliance|0
2085179|NCT00724945|3670353|FG000|Period 1|Adverse Event|1
2085180|NCT00724945|3670354|FG001|Period 1|Adverse Event|1
2085181|NCT00724945|3670353|FG000|Period 1|Lost to Follow-up|1
2085182|NCT00724945|3670354|FG001|Period 1|Lost to Follow-up|0
2085183|NCT00724945|3670353|FG000|Period 2|lens comfort issue|3
2085184|NCT00724945|3670354|FG001|Period 2|lens comfort issue|0
2085185|NCT00724945|3670353|FG000|Period 2|lens physiology issue|1
2085186|NCT00724945|3670354|FG001|Period 2|lens physiology issue|0
2085187|NCT00724958|3670360|FG000|Overall Study|Adverse Event|28
2085188|NCT00724958|3670360|FG000|Overall Study|Loss of Response|40
2085189|NCT00724958|3670360|FG000|Overall Study|No Response|18
2085190|NCT00724958|3670360|FG000|Overall Study|Remission|7
2085191|NCT00724958|3670360|FG000|Overall Study|Other Reason|76
2085192|NCT00724958|3670360|FG000|Overall Study|No documentation for end of therapy|13
2085193|NCT00724971|3670364|FG000|Overall Study|Adverse Event|5
2085194|NCT00724971|3670364|FG000|Overall Study|Withdrawal by Subject|1
2085195|NCT00725010|3670393|FG000|Overall Study|Toxicity|9
2085196|NCT00725010|3670393|FG000|Overall Study|Tumor Progression|7
2085197|NCT00725010|3670393|FG000|Overall Study|Withdrawal by Subject|2
2085198|NCT00725010|3670393|FG000|Overall Study|Death|1
2085199|NCT00725010|3670393|FG000|Overall Study|Lost to Follow-up|1
2085200|NCT00725010|3670393|FG000|Overall Study|Hepatopathy probably not Temodal-related|1
2085201|NCT00725010|3670393|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1
2085202|NCT00725010|3670393|FG000|Overall Study|No further documentation|1
2085203|NCT00725010|3670393|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2
2085204|NCT00725075|3670411|FG000|Overall Study|Use of Excluded Medication|0
2085205|NCT00725075|3670412|FG001|Overall Study|Use of Excluded Medication|1
2085206|NCT00725075|3670413|FG002|Overall Study|Use of Excluded Medication|0
2085207|NCT00725075|3670411|FG000|Overall Study|Protocol Violation|0
2085208|NCT00725075|3670412|FG001|Overall Study|Protocol Violation|0
2085209|NCT00725075|3670413|FG002|Overall Study|Protocol Violation|1
2085210|NCT00725075|3670411|FG000|Overall Study|Lost to Follow-up|1
2085211|NCT00725075|3670412|FG001|Overall Study|Lost to Follow-up|0
2085212|NCT00725075|3670413|FG002|Overall Study|Lost to Follow-up|0
2085213|NCT00725075|3670411|FG000|Overall Study|Withdrawal by Subject|4
2085214|NCT00725075|3670412|FG001|Overall Study|Withdrawal by Subject|5
2085215|NCT00725075|3670413|FG002|Overall Study|Withdrawal by Subject|4
2085216|NCT00725075|3670411|FG000|Overall Study|Adverse Event|2
2085217|NCT00725075|3670412|FG001|Overall Study|Adverse Event|1
2085218|NCT00725075|3670413|FG002|Overall Study|Adverse Event|1
2085219|NCT00725075|3670411|FG000|Overall Study|Worsening of Disease|2
2085220|NCT00725075|3670412|FG001|Overall Study|Worsening of Disease|1
2085221|NCT00725075|3670413|FG002|Overall Study|Worsening of Disease|2
2085222|NCT00725075|3670411|FG000|Overall Study|Inclusion/Exclusion Criteria|1
2085223|NCT00725075|3670412|FG001|Overall Study|Inclusion/Exclusion Criteria|0
2085224|NCT00725075|3670413|FG002|Overall Study|Inclusion/Exclusion Criteria|1
2085225|NCT00725075|3670411|FG000|Overall Study|Other|1
2085226|NCT00725075|3670412|FG001|Overall Study|Other|0
2085227|NCT00725075|3670413|FG002|Overall Study|Other|0
2085228|NCT00725101|3670421|FG000|Overall Study|Death|3
2085229|NCT00725101|3670421|FG000|Overall Study|Lost to Follow-up|353
2085230|NCT00725101|3670421|FG000|Overall Study|Protocol Violation|1
2085231|NCT00725101|3670421|FG000|Overall Study|Withdrawal by Subject|127
2085232|NCT00725101|3670421|FG000|Overall Study|not specified/no reason given|11
2085233|NCT00725205|3670432|FG000|Overall Study|Adverse Event|22
2085234|NCT00725205|3670432|FG000|Overall Study|Investigator Discontinued|1
2085235|NCT00725205|3670432|FG000|Overall Study|Non-compliance With Protocol|14
2085236|NCT00725205|3670432|FG000|Overall Study|Other|8
2085237|NCT00725205|3670432|FG000|Overall Study|Protocol Defined Clinical Event|1
2085238|NCT00725205|3670432|FG000|Overall Study|Treatment Failure|41
2085239|NCT00725283|3670445|FG000|Overall Study|Missing Code|3
2085240|NCT00725283|3670445|FG000|Overall Study|Death|5
2085241|NCT00725283|3670445|FG000|Overall Study|Other|6
2085242|NCT00725283|3670445|FG000|Overall Study|Withdrawal by Subject|10
2085243|NCT00725296|3670449|FG000|Overall Study|Adverse Event|11
2085244|NCT00725296|3670449|FG000|Overall Study|Lack of Efficacy|7
2085245|NCT00725296|3670449|FG000|Overall Study|Withdrawal by Subject|3
2085246|NCT00725296|3670449|FG000|Overall Study|Non-Compliance|2
2085247|NCT00725296|3670449|FG000|Overall Study|Lost to Follow-up|1
2085248|NCT00725296|3670449|FG000|Overall Study|Other|38
2085249|NCT00725322|3670456|FG000|Washout (28 Days)|Withdrawal by Subject|2
2085250|NCT00725322|3670457|FG001|Washout (28 Days)|Withdrawal by Subject|0
2085251|NCT00725322|3670456|FG000|Washout (28 Days)|Protocol Violation|0
2085252|NCT00725322|3670457|FG001|Washout (28 Days)|Protocol Violation|1
2085253|NCT00725452|3670467|FG000|Overall Study|Adverse Event|3
2085254|NCT00725452|3670467|FG000|Overall Study|Lack of Efficacy|2
2085255|NCT00725452|3670467|FG000|Overall Study|Reason not specified|1
2085256|NCT00725452|3670467|FG000|Overall Study|Physician Decision|1
2085257|NCT00725452|3670467|FG000|Overall Study|Withdrawal by Subject|3
2085258|NCT00725452|3670467|FG000|Overall Study|Lost to Follow-up|1
2085259|NCT00725543|3670485|FG000|Overall Study|Adverse Event|10
2085260|NCT00725543|3670485|FG000|Overall Study|Lack of Efficacy|3
2085261|NCT00725543|3670485|FG000|Overall Study|Withdrawal by Subject|10
2085262|NCT00725543|3670485|FG000|Overall Study|Physician Decision|5
2085263|NCT00725543|3670485|FG000|Overall Study|Lost to Follow-up|4
2085264|NCT00725543|3670485|FG000|Overall Study|Non-compliance|2
2085265|NCT00725543|3670485|FG000|Overall Study|Other|119
2085266|NCT00725608|3670489|FG000|Overall Study|Lost to Follow-up|60
2085267|NCT00725608|3670489|FG000|Overall Study|Adverse Event|14
2085268|NCT00725608|3670489|FG000|Overall Study|Individual reasons|86
2085269|NCT00725608|3670489|FG000|Overall Study|Other|7
2085270|NCT00725621|3670493|FG000|Overall Study|Adverse Event|25
2085271|NCT00725621|3670493|FG000|Overall Study|Lack of Efficacy|46
2085272|NCT00725621|3670493|FG000|Overall Study|Withdrawal by Subject|57
2085273|NCT00725621|3670493|FG000|Overall Study|Physician Decision|19
2085274|NCT00725621|3670493|FG000|Overall Study|Lost to Follow-up|52
2085275|NCT00725621|3670493|FG000|Overall Study|Non-compliance|8
2085276|NCT00725621|3670493|FG000|Overall Study|Continued treatment by other physician|6
2085277|NCT00725621|3670493|FG000|Overall Study|Switched to other study|1
2085278|NCT00725621|3670493|FG000|Overall Study|Switched to other drug|1
2085279|NCT00725621|3670493|FG000|Overall Study|Prepared for elective surgery|1
2085280|NCT00725621|3670493|FG000|Overall Study|Reason not specified|55
2085281|NCT00725712|3670503|FG000|Overall Study|Withdrawal by Subject|2
2085282|NCT00725712|3670504|FG001|Overall Study|Withdrawal by Subject|1
2085283|NCT00725712|3670503|FG000|Overall Study|Protocol Violation|1
2085284|NCT00725712|3670504|FG001|Overall Study|Protocol Violation|0
2085285|NCT00725712|3670503|FG000|Overall Study|Progressive disease|37
2085286|NCT00725712|3670504|FG001|Overall Study|Progressive disease|16
2085287|NCT00725712|3670503|FG000|Overall Study|Clinical progression not based on RECIST|0
2085288|NCT00725712|3670504|FG001|Overall Study|Clinical progression not based on RECIST|3
2085289|NCT00725712|3670503|FG000|Overall Study|Adverse Event|5
2085290|NCT00725712|3670504|FG001|Overall Study|Adverse Event|5
2085291|NCT00725712|3670503|FG000|Overall Study|Death|2
2085292|NCT00725712|3670504|FG001|Overall Study|Death|0
2085293|NCT00725712|3670503|FG000|Overall Study|Other: Death|1
2085294|NCT00725712|3670504|FG001|Overall Study|Other: Death|0
2085295|NCT00725712|3670503|FG000|Overall Study|Hospitalized, unable to continue|0
2085296|NCT00725712|3670504|FG001|Overall Study|Hospitalized, unable to continue|1
2085297|NCT00725725|3670517|FG000|Overall Study|Adverse Event|1
2085298|NCT00725725|3670518|FG001|Overall Study|Adverse Event|3
2085299|NCT00725725|3670519|FG002|Overall Study|Adverse Event|2
2085300|NCT00725725|3670517|FG000|Overall Study|Lost to Follow-up|2
2085301|NCT00725725|3670518|FG001|Overall Study|Lost to Follow-up|0
2085302|NCT00725725|3670519|FG002|Overall Study|Lost to Follow-up|2
2085303|NCT00725725|3670517|FG000|Overall Study|Withdrawal by Subject|1
2085304|NCT00725725|3670518|FG001|Overall Study|Withdrawal by Subject|0
2085305|NCT00725725|3670519|FG002|Overall Study|Withdrawal by Subject|1
2085306|NCT00725725|3670517|FG000|Overall Study|Protocol Violation|0
2085307|NCT00725725|3670518|FG001|Overall Study|Protocol Violation|1
2085308|NCT00725725|3670519|FG002|Overall Study|Protocol Violation|0
2085309|NCT00725764|3670537|FG000|Overall Study|Withdrawal by Subject|2
2085310|NCT00725764|3670537|FG000|Overall Study|Physician Decision|1
2085311|NCT00725764|3670537|FG000|Overall Study|Progressive Disease|7
2085312|NCT00725764|3670537|FG000|Overall Study|Lost to Follow-up|1
2085313|NCT00725764|3670537|FG000|Overall Study|Death|1
2085314|NCT00725764|3670537|FG000|Overall Study|Participant non compliant with protocol|1
2085315|NCT00725764|3670537|FG000|Overall Study|Decline in performance status|1
2085316|NCT00725842|3670542|FG000|Overall Study|Lost to Follow-up|19
2085317|NCT00725842|3670542|FG000|Overall Study|Death|1
2085318|NCT00725842|3670542|FG000|Overall Study|Positive HCV-RNA at Visit 2|13
2177337|NCT01372410|3801378|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0
2177338|NCT01372410|3801379|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0
2177339|NCT01372410|3801372|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2177340|NCT01372410|3801373|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2177341|NCT01372410|3801374|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2085319|NCT00725842|3670542|FG000|Overall Study|Consent date prior to study start date|5
2085320|NCT00725842|3670542|FG000|Overall Study|Inclusion criterion not met|1
2085321|NCT00725842|3670542|FG000|Overall Study|No Visit 1 data|1
2085322|NCT00725920|3670548|FG000|Overall Study|Lack of Efficacy|3
2085323|NCT00725920|3670549|FG001|Overall Study|Lack of Efficacy|6
2085324|NCT00726063|3670566|FG000|Overall Study|Adverse Event|9
2085325|NCT00726063|3670567|FG001|Overall Study|Adverse Event|7
2085326|NCT00726232|3670579|FG000|Initial Phase (Dose-finding)|Death|0
2085327|NCT00726232|3670580|FG001|Initial Phase (Dose-finding)|Death|0
2085328|NCT00726232|3670581|FG002|Initial Phase (Dose-finding)|Death|0
2085329|NCT00726232|3670582|FG003|Initial Phase (Dose-finding)|Death|0
2085330|NCT00726232|3670583|FG004|Initial Phase (Dose-finding)|Death|1
2085331|NCT00726232|3670584|FG005|Initial Phase (Dose-finding)|Death|0
2085332|NCT00726232|3670585|FG006|Initial Phase (Dose-finding)|Death|0
2085333|NCT00726232|3670586|FG007|Initial Phase (Dose-finding)|Death|0
2085334|NCT00726232|3670579|FG000|Initial Phase (Dose-finding)|Adverse Event|2
2085335|NCT00726232|3670580|FG001|Initial Phase (Dose-finding)|Adverse Event|2
2085336|NCT00726232|3670581|FG002|Initial Phase (Dose-finding)|Adverse Event|2
2085337|NCT00726232|3670582|FG003|Initial Phase (Dose-finding)|Adverse Event|1
2085338|NCT00726232|3670583|FG004|Initial Phase (Dose-finding)|Adverse Event|7
2085339|NCT00726232|3670584|FG005|Initial Phase (Dose-finding)|Adverse Event|3
2085340|NCT00726232|3670585|FG006|Initial Phase (Dose-finding)|Adverse Event|0
2085341|NCT00726232|3670586|FG007|Initial Phase (Dose-finding)|Adverse Event|0
2085342|NCT00726232|3670579|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2
2085343|NCT00726232|3670580|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0
2085344|NCT00726232|3670581|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0
2085345|NCT00726232|3670582|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1
2085346|NCT00726232|3670583|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0
2085347|NCT00726232|3670584|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2
2085348|NCT00726232|3670585|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0
2085349|NCT00726232|3670586|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0
2085350|NCT00726232|3670579|FG000|Initial Phase (Dose-finding)|Disease progression|3
2085351|NCT00726232|3670580|FG001|Initial Phase (Dose-finding)|Disease progression|1
2085352|NCT00726232|3670581|FG002|Initial Phase (Dose-finding)|Disease progression|0
2085353|NCT00726232|3670582|FG003|Initial Phase (Dose-finding)|Disease progression|0
2085354|NCT00726232|3670583|FG004|Initial Phase (Dose-finding)|Disease progression|0
2085355|NCT00726232|3670584|FG005|Initial Phase (Dose-finding)|Disease progression|0
2085356|NCT00726232|3670585|FG006|Initial Phase (Dose-finding)|Disease progression|0
2085357|NCT00726232|3670586|FG007|Initial Phase (Dose-finding)|Disease progression|0
2085358|NCT00726232|3670579|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
2085359|NCT00726232|3670580|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
2085360|NCT00726232|3670581|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
2085361|NCT00726232|3670582|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
2085362|NCT00726232|3670583|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
2085363|NCT00726232|3670584|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
2085364|NCT00726232|3670585|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
2085365|NCT00726232|3670586|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
2085366|NCT00726232|3670579|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
2085367|NCT00726232|3670580|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
2085368|NCT00726232|3670581|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
2085369|NCT00726232|3670582|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
2085370|NCT00726232|3670583|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
2085371|NCT00726232|3670584|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
2085372|NCT00726232|3670585|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
2085373|NCT00726232|3670586|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
2085374|NCT00726232|3670579|FG000|Initial Phase (Dose-finding)|Unspecified reason|1
2085375|NCT00726232|3670580|FG001|Initial Phase (Dose-finding)|Unspecified reason|0
2085376|NCT00726232|3670581|FG002|Initial Phase (Dose-finding)|Unspecified reason|0
2085377|NCT00726232|3670582|FG003|Initial Phase (Dose-finding)|Unspecified reason|0
2085378|NCT00726232|3670583|FG004|Initial Phase (Dose-finding)|Unspecified reason|0
2085379|NCT00726232|3670584|FG005|Initial Phase (Dose-finding)|Unspecified reason|0
2085380|NCT00726232|3670585|FG006|Initial Phase (Dose-finding)|Unspecified reason|0
2085381|NCT00726232|3670586|FG007|Initial Phase (Dose-finding)|Unspecified reason|0
2085382|NCT00726232|3670579|FG000|Expansion Phase|Death|0
2085383|NCT00726232|3670580|FG001|Expansion Phase|Death|0
2085384|NCT00726232|3670581|FG002|Expansion Phase|Death|0
2085385|NCT00726232|3670582|FG003|Expansion Phase|Death|0
2085386|NCT00726232|3670583|FG004|Expansion Phase|Death|0
2085387|NCT00726232|3670584|FG005|Expansion Phase|Death|0
2085388|NCT00726232|3670585|FG006|Expansion Phase|Death|0
2085389|NCT00726232|3670586|FG007|Expansion Phase|Death|1
2085390|NCT00726232|3670579|FG000|Expansion Phase|Adverse Event|0
2085391|NCT00726232|3670580|FG001|Expansion Phase|Adverse Event|0
2085392|NCT00726232|3670581|FG002|Expansion Phase|Adverse Event|0
2085393|NCT00726232|3670582|FG003|Expansion Phase|Adverse Event|0
2085394|NCT00726232|3670583|FG004|Expansion Phase|Adverse Event|0
2085395|NCT00726232|3670584|FG005|Expansion Phase|Adverse Event|0
2085396|NCT00726232|3670585|FG006|Expansion Phase|Adverse Event|6
2085397|NCT00726232|3670586|FG007|Expansion Phase|Adverse Event|11
2085398|NCT00726232|3670579|FG000|Expansion Phase|Withdrawal by Subject|0
2085399|NCT00726232|3670580|FG001|Expansion Phase|Withdrawal by Subject|0
2085400|NCT00726232|3670581|FG002|Expansion Phase|Withdrawal by Subject|0
2085401|NCT00726232|3670582|FG003|Expansion Phase|Withdrawal by Subject|0
2085402|NCT00726232|3670583|FG004|Expansion Phase|Withdrawal by Subject|0
2085403|NCT00726232|3670584|FG005|Expansion Phase|Withdrawal by Subject|0
2085404|NCT00726232|3670585|FG006|Expansion Phase|Withdrawal by Subject|2
2085405|NCT00726232|3670586|FG007|Expansion Phase|Withdrawal by Subject|3
2085406|NCT00726232|3670579|FG000|Expansion Phase|Disease progression|0
2085407|NCT00726232|3670580|FG001|Expansion Phase|Disease progression|0
2085408|NCT00726232|3670581|FG002|Expansion Phase|Disease progression|0
2085409|NCT00726232|3670582|FG003|Expansion Phase|Disease progression|0
2085410|NCT00726232|3670583|FG004|Expansion Phase|Disease progression|0
2085411|NCT00726232|3670584|FG005|Expansion Phase|Disease progression|0
2085412|NCT00726232|3670585|FG006|Expansion Phase|Disease progression|4
2085413|NCT00726232|3670586|FG007|Expansion Phase|Disease progression|0
2085414|NCT00726232|3670579|FG000|Expansion Phase|Termination of the trial by sponsor|0
2085415|NCT00726232|3670580|FG001|Expansion Phase|Termination of the trial by sponsor|0
2085416|NCT00726232|3670581|FG002|Expansion Phase|Termination of the trial by sponsor|0
2085417|NCT00726232|3670582|FG003|Expansion Phase|Termination of the trial by sponsor|0
2085418|NCT00726232|3670583|FG004|Expansion Phase|Termination of the trial by sponsor|0
2085419|NCT00726232|3670584|FG005|Expansion Phase|Termination of the trial by sponsor|0
2085420|NCT00726232|3670585|FG006|Expansion Phase|Termination of the trial by sponsor|10
2085421|NCT00726232|3670586|FG007|Expansion Phase|Termination of the trial by sponsor|16
2085422|NCT00726232|3670579|FG000|Expansion Phase|Per Investigator: lack of response|0
2085423|NCT00726232|3670580|FG001|Expansion Phase|Per Investigator: lack of response|0
2085424|NCT00726232|3670581|FG002|Expansion Phase|Per Investigator: lack of response|0
2085425|NCT00726232|3670582|FG003|Expansion Phase|Per Investigator: lack of response|0
2085426|NCT00726232|3670583|FG004|Expansion Phase|Per Investigator: lack of response|0
2085427|NCT00726232|3670584|FG005|Expansion Phase|Per Investigator: lack of response|0
2085428|NCT00726232|3670585|FG006|Expansion Phase|Per Investigator: lack of response|1
2085429|NCT00726232|3670586|FG007|Expansion Phase|Per Investigator: lack of response|7
2085430|NCT00726232|3670579|FG000|Expansion Phase|Unspecified reason|0
2085431|NCT00726232|3670580|FG001|Expansion Phase|Unspecified reason|0
2085432|NCT00726232|3670581|FG002|Expansion Phase|Unspecified reason|0
2085433|NCT00726232|3670582|FG003|Expansion Phase|Unspecified reason|0
2085434|NCT00726232|3670583|FG004|Expansion Phase|Unspecified reason|0
2085435|NCT00726232|3670584|FG005|Expansion Phase|Unspecified reason|0
2085436|NCT00726232|3670585|FG006|Expansion Phase|Unspecified reason|1
2085437|NCT00726232|3670586|FG007|Expansion Phase|Unspecified reason|0
2085438|NCT00726323|3670607|FG000|Overall Study|Withdrawal by Subject|3
2085439|NCT00726323|3670608|FG001|Overall Study|Withdrawal by Subject|1
2085440|NCT00726323|3670607|FG000|Overall Study|Physician Decision|1
2085441|NCT00726323|3670608|FG001|Overall Study|Physician Decision|0
2085442|NCT00726323|3670607|FG000|Overall Study|Progressive disease|23
2085443|NCT00726323|3670608|FG001|Overall Study|Progressive disease|16
2085444|NCT00726323|3670607|FG000|Overall Study|Clinical progression|0
2085445|NCT00726323|3670608|FG001|Overall Study|Clinical progression|3
2085446|NCT00726323|3670607|FG000|Overall Study|Adverse Event|9
2085447|NCT00726323|3670608|FG001|Overall Study|Adverse Event|9
2085448|NCT00726323|3670607|FG000|Overall Study|Death|1
2085449|NCT00726323|3670608|FG001|Overall Study|Death|0
2085450|NCT00726323|3670607|FG000|Overall Study|Participant wished to discontinue|0
2085451|NCT00726323|3670608|FG001|Overall Study|Participant wished to discontinue|1
2085452|NCT00726323|3670607|FG000|Overall Study|Metastatic lesions inferred cyst|0
2085453|NCT00726323|3670608|FG001|Overall Study|Metastatic lesions inferred cyst|1
2085454|NCT00726388|3670618|FG000|Overall Study|Withdrawal by Subject|5
2085455|NCT00726388|3670618|FG000|Overall Study|Adverse Event|3
2085456|NCT00726388|3670618|FG000|Overall Study|Lost to Follow-up|10
2085457|NCT00726388|3670618|FG000|Overall Study|Participants Non-compliant With Study Procedures|5
2085458|NCT00726388|3670618|FG000|Overall Study|Other|5
2085459|NCT00726388|3670618|FG000|Overall Study|Enrolled, Not Treated|79
2085460|NCT00726453|3670631|FG000|Primary Enrollment Group|Death|18
2085461|NCT00726453|3670632|FG001|Primary Enrollment Group|Death|0
2085462|NCT00726453|3670631|FG000|Primary Enrollment Group|Withdrawal by Subject|13
2085463|NCT00726453|3670632|FG001|Primary Enrollment Group|Withdrawal by Subject|0
2085464|NCT00726453|3670631|FG000|38 mm Length Group|Death|0
2085465|NCT00726453|3670632|FG001|38 mm Length Group|Death|3
2085466|NCT00726557|3670637|FG000|Overall Study|Screening failure|4
2085467|NCT00726557|3670637|FG000|Overall Study|No end of treatment documentation|37
2085468|NCT00726557|3670637|FG000|Overall Study|No follow-up documentation available|55
2085469|NCT00726557|3670637|FG000|Overall Study|Treatment less than 3 months|17
2085470|NCT00726557|3670637|FG000|Overall Study|Inclusion criteria not met|15
2085471|NCT00726609|3670642|FG000|Overall Study|Adverse Event|10
2085472|NCT00726609|3670642|FG000|Overall Study|Withdrawal by Subject|2
2085473|NCT00726609|3670642|FG000|Overall Study|Lack of Efficacy|25
2085474|NCT00726609|3670642|FG000|Overall Study|Other|16
2085475|NCT00726609|3670642|FG000|Overall Study|Missing|42
2085476|NCT00726609|3670642|FG000|Overall Study|Other|3
2085477|NCT00726622|3670648|FG000|Overall Study|Withdrawal by Subject|16
2085478|NCT00726622|3670649|FG001|Overall Study|Withdrawal by Subject|2
2085479|NCT00726622|3670648|FG000|Overall Study|Physician Decision|0
2085480|NCT00726622|3670649|FG001|Overall Study|Physician Decision|1
2085481|NCT00726622|3670648|FG000|Overall Study|Metastasis|2
2085482|NCT00726622|3670649|FG001|Overall Study|Metastasis|0
2085483|NCT00726661|3670657|FG000|Overall Study|Lost to Follow-up|36
2085484|NCT00726661|3670658|FG001|Overall Study|Lost to Follow-up|11
2085485|NCT00726661|3670657|FG000|Overall Study|Withdrawal by Subject|17
2085486|NCT00726661|3670658|FG001|Overall Study|Withdrawal by Subject|13
2085487|NCT00726661|3670657|FG000|Overall Study|Trial terminated by sponsor|214
2085488|NCT00726661|3670658|FG001|Overall Study|Trial terminated by sponsor|187
2085489|NCT00726661|3670657|FG000|Overall Study|Death|475
2085490|NCT00726661|3670658|FG001|Overall Study|Death|159
2085491|NCT00726661|3670657|FG000|Overall Study|Physician Decision|25
2085492|NCT00726661|3670658|FG001|Overall Study|Physician Decision|13
2085493|NCT00726661|3670657|FG000|Overall Study|Other|47
2085494|NCT00726661|3670658|FG001|Overall Study|Other|35
2085495|NCT00726752|3670685|FG000|Overall Study|Lack of Efficacy|6
2085496|NCT00726882|3670689|FG000|Overall Study|Withdrawal by Subject|5
2085497|NCT00726882|3670689|FG000|Overall Study|Lost to Follow-up|7
2085498|NCT00726882|3670689|FG000|Overall Study|Other|10
2085499|NCT00726895|3670695|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
2085500|NCT00726895|3670696|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
2085501|NCT00726986|3670703|FG000|Induction Phase|Adverse Event|4
2085502|NCT00726986|3670703|FG000|Induction Phase|Withdrawal by Subject|2
2085503|NCT00726986|3670703|FG000|Induction Phase|Death|2
2085504|NCT00726986|3670703|FG000|Induction Phase|Lack of Efficacy|5
2085505|NCT00726986|3670703|FG000|Induction Phase|Secondary Disease|2
2085506|NCT00726986|3670703|FG000|Maintenance Phase|Adverse Event|1
2085507|NCT00726986|3670703|FG000|Maintenance Phase|Lack of Efficacy|2
2085508|NCT00726999|3670709|FG000|Overall Study|Physician Decision|0
2085509|NCT00726999|3670710|FG001|Overall Study|Physician Decision|1
2085510|NCT00726999|3670709|FG000|Overall Study|Withdrawal by Subject|2
2085511|NCT00726999|3670710|FG001|Overall Study|Withdrawal by Subject|0
2085512|NCT00726999|3670709|FG000|Overall Study|Protocol Violation|1
2085513|NCT00726999|3670710|FG001|Overall Study|Protocol Violation|0
2085514|NCT00727025|3670718|FG000|Overall Study|Physician Decision|23
2085515|NCT00727194|3670744|FG000|Screening Period|Low QMG scores|0
2085516|NCT00727194|3670745|FG001|Screening Period|Low QMG scores|0
2085517|NCT00727194|3670746|FG002|Screening Period|Low QMG scores|6
2085518|NCT00727194|3670744|FG000|Screening Period|Lacked AChR antibodies|0
2085519|NCT00727194|3670745|FG001|Screening Period|Lacked AChR antibodies|0
2085520|NCT00727194|3670746|FG002|Screening Period|Lacked AChR antibodies|5
2085521|NCT00727194|3670744|FG000|Screening Period|Not stable on concomitant MG therapy|0
2085522|NCT00727194|3670745|FG001|Screening Period|Not stable on concomitant MG therapy|0
2085523|NCT00727194|3670746|FG002|Screening Period|Not stable on concomitant MG therapy|2
2085524|NCT00727194|3670744|FG000|Screening Period|Severe infections|0
2085525|NCT00727194|3670745|FG001|Screening Period|Severe infections|0
2085526|NCT00727194|3670746|FG002|Screening Period|Severe infections|2
2085527|NCT00727194|3670744|FG000|Screening Period|History of thymoma|0
2085528|NCT00727194|3670745|FG001|Screening Period|History of thymoma|0
2085529|NCT00727194|3670746|FG002|Screening Period|History of thymoma|1
2085530|NCT00727194|3670744|FG000|Treatment Period 2|Lack of Efficacy|0
2085531|NCT00727194|3670745|FG001|Treatment Period 2|Lack of Efficacy|1
2085532|NCT00727194|3670746|FG002|Treatment Period 2|Lack of Efficacy|0
2085533|NCT00727246|3670773|FG000|Overall Study|could not complete MRI|0
2085534|NCT00727246|3670774|FG001|Overall Study|could not complete MRI|1
2085535|NCT00727246|3670775|FG002|Overall Study|could not complete MRI|0
2085536|NCT00727246|3670776|FG003|Overall Study|could not complete MRI|1
2085537|NCT00727246|3670773|FG000|Overall Study|incidental finding|0
2085538|NCT00727246|3670774|FG001|Overall Study|incidental finding|0
2085539|NCT00727246|3670775|FG002|Overall Study|incidental finding|0
2085540|NCT00727246|3670776|FG003|Overall Study|incidental finding|1
2085541|NCT00727246|3670773|FG000|Overall Study|withdrawn|0
2085542|NCT00727246|3670774|FG001|Overall Study|withdrawn|0
2085543|NCT00727246|3670775|FG002|Overall Study|withdrawn|1
2085544|NCT00727246|3670776|FG003|Overall Study|withdrawn|0
2085545|NCT00727259|3670786|FG000|Overall Study|Not all questionnaires completed|1055
2085546|NCT00727272|3670791|FG000|Washout Period A|Adverse Event|0
2085547|NCT00727272|3670792|FG001|Washout Period A|Adverse Event|0
2085548|NCT00727272|3670793|FG002|Washout Period A|Adverse Event|1
2085549|NCT00727272|3670791|FG000|Washout Period B|Withdrawal by Subject|0
2085550|NCT00727272|3670792|FG001|Washout Period B|Withdrawal by Subject|0
2085551|NCT00727272|3670793|FG002|Washout Period B|Withdrawal by Subject|1
2085552|NCT00727311|3670807|FG000|Overall Study|Did not receive drug|316
2085553|NCT00727311|3670807|FG000|Overall Study|Missing end of therapy data|205
2085554|NCT00727311|3670807|FG000|Overall Study|Adverse Event|58
2085555|NCT00727311|3670807|FG000|Overall Study|Lack of Efficacy|242
2085556|NCT00727311|3670807|FG000|Overall Study|Lost to Follow-up|73
2085557|NCT00727311|3670807|FG000|Overall Study|Withdrawal by Subject|77
2085558|NCT00727311|3670807|FG000|Overall Study|Other|97
2085559|NCT00727311|3670807|FG000|Overall Study|Multiple reasons|39
2085560|NCT00727402|3670833|FG000|Overall Study|Physician Decision|116
2085561|NCT00727415|3670837|FG000|Phase I|Dose Limiting Toxicity|2
2085562|NCT00727441|3670844|FG000|Overall Study|Disease Progression|11
2085563|NCT00727441|3670845|FG001|Overall Study|Disease Progression|14
2085564|NCT00727441|3670846|FG002|Overall Study|Disease Progression|17
2085565|NCT00727441|3670844|FG000|Overall Study|Eligibility|7
2085566|NCT00727441|3670845|FG001|Overall Study|Eligibility|5
2085567|NCT00727441|3670846|FG002|Overall Study|Eligibility|7
2085568|NCT00727441|3670844|FG000|Overall Study|Death|0
2085569|NCT00727441|3670845|FG001|Overall Study|Death|1
2085570|NCT00727441|3670846|FG002|Overall Study|Death|1
2085571|NCT00727441|3670844|FG000|Overall Study|Physician Decision|0
2085572|NCT00727441|3670845|FG001|Overall Study|Physician Decision|1
2085573|NCT00727441|3670846|FG002|Overall Study|Physician Decision|0
2085574|NCT00727441|3670844|FG000|Overall Study|Withdrawal by Subject|0
2085575|NCT00727441|3670845|FG001|Overall Study|Withdrawal by Subject|1
2085576|NCT00727441|3670846|FG002|Overall Study|Withdrawal by Subject|0
2085577|NCT00727506|3670863|FG000|Overall Study|Adverse Event|0
2085578|NCT00727506|3670864|FG001|Overall Study|Adverse Event|0
2085579|NCT00727506|3670865|FG002|Overall Study|Adverse Event|4
2085580|NCT00727506|3670866|FG003|Overall Study|Adverse Event|4
2085581|NCT00727506|3670867|FG004|Overall Study|Adverse Event|1
2085582|NCT00727506|3670868|FG005|Overall Study|Adverse Event|8
2085583|NCT00727506|3670863|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
2085584|NCT00727506|3670864|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
2085585|NCT00727506|3670865|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
2085586|NCT00727506|3670866|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
2085587|NCT00727506|3670867|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
2085588|NCT00727506|3670868|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0
2085589|NCT00727506|3670863|FG000|Overall Study|Progressive disease|4
2085590|NCT00727506|3670864|FG001|Overall Study|Progressive disease|7
2085591|NCT00727506|3670865|FG002|Overall Study|Progressive disease|9
2085592|NCT00727506|3670866|FG003|Overall Study|Progressive disease|28
2085593|NCT00727506|3670867|FG004|Overall Study|Progressive disease|38
2085594|NCT00727506|3670868|FG005|Overall Study|Progressive disease|28
2085595|NCT00727506|3670863|FG000|Overall Study|Refused to continue medication|0
2085596|NCT00727506|3670864|FG001|Overall Study|Refused to continue medication|1
2085597|NCT00727506|3670865|FG002|Overall Study|Refused to continue medication|2
2085598|NCT00727506|3670866|FG003|Overall Study|Refused to continue medication|3
2085599|NCT00727506|3670867|FG004|Overall Study|Refused to continue medication|1
2085600|NCT00727506|3670868|FG005|Overall Study|Refused to continue medication|2
2085601|NCT00727506|3670863|FG000|Overall Study|Other reason not described above|0
2085602|NCT00727506|3670864|FG001|Overall Study|Other reason not described above|0
2085603|NCT00727506|3670865|FG002|Overall Study|Other reason not described above|1
2085604|NCT00727506|3670866|FG003|Overall Study|Other reason not described above|4
2085605|NCT00727506|3670867|FG004|Overall Study|Other reason not described above|1
2085606|NCT00727506|3670868|FG005|Overall Study|Other reason not described above|1
2085607|NCT00727532|3670888|FG000|Overall Study|Adverse Event|1
2085608|NCT00727532|3670888|FG000|Overall Study|Withdrawal by Subject|1
2085609|NCT00727558|3670894|FG000|Overall Study|Lens issue|0
2085610|NCT00727558|3670895|FG001|Overall Study|Lens issue|1
2085611|NCT00727558|3670894|FG000|Overall Study|Adverse Event|0
2085612|NCT00727558|3670895|FG001|Overall Study|Adverse Event|1
2085613|NCT00727558|3670894|FG000|Overall Study|Subject unable to return for follow-up|1
2085614|NCT00727558|3670895|FG001|Overall Study|Subject unable to return for follow-up|1
2085615|NCT00727558|3670894|FG000|Overall Study|Lost to Follow-up|1
2085616|NCT00727558|3670895|FG001|Overall Study|Lost to Follow-up|0
2085617|NCT00727571|3670905|FG000|Overall Study|Ineligibility determined|1
2085618|NCT00727571|3670906|FG001|Overall Study|Ineligibility determined|1
2085619|NCT00727571|3670907|FG002|Overall Study|Ineligibility determined|1
2085620|NCT00727571|3670908|FG003|Overall Study|Ineligibility determined|0
2085621|NCT00727571|3670905|FG000|Overall Study|Death|0
2085622|NCT00727571|3670906|FG001|Overall Study|Death|19
2085623|NCT00727571|3670907|FG002|Overall Study|Death|5
2085624|NCT00727571|3670908|FG003|Overall Study|Death|1
2085625|NCT00727571|3670905|FG000|Overall Study|Physician Decision|0
2085626|NCT00727571|3670906|FG001|Overall Study|Physician Decision|5
2085627|NCT00727571|3670907|FG002|Overall Study|Physician Decision|0
2085628|NCT00727571|3670908|FG003|Overall Study|Physician Decision|0
2085629|NCT00727571|3670905|FG000|Overall Study|Withdrawal by Subject|0
2085630|NCT00727571|3670906|FG001|Overall Study|Withdrawal by Subject|10
2085631|NCT00727571|3670907|FG002|Overall Study|Withdrawal by Subject|11
2085632|NCT00727571|3670908|FG003|Overall Study|Withdrawal by Subject|0
2085633|NCT00727571|3670905|FG000|Overall Study|Subject Non Compliance|0
2085634|NCT00727571|3670906|FG001|Overall Study|Subject Non Compliance|6
2085635|NCT00727571|3670907|FG002|Overall Study|Subject Non Compliance|0
2085636|NCT00727571|3670908|FG003|Overall Study|Subject Non Compliance|4
2085637|NCT00727571|3670905|FG000|Overall Study|Dismissed from nursing home|0
2085638|NCT00727571|3670906|FG001|Overall Study|Dismissed from nursing home|9
2085639|NCT00727571|3670907|FG002|Overall Study|Dismissed from nursing home|5
2085640|NCT00727571|3670908|FG003|Overall Study|Dismissed from nursing home|0
2085641|NCT00727571|3670905|FG000|Overall Study|Hospitalization|0
2085642|NCT00727571|3670906|FG001|Overall Study|Hospitalization|1
2085643|NCT00727571|3670907|FG002|Overall Study|Hospitalization|0
2085644|NCT00727571|3670908|FG003|Overall Study|Hospitalization|1
2085645|NCT00727571|3670905|FG000|Overall Study|AE not leading to hospitalization|0
2085646|NCT00727571|3670906|FG001|Overall Study|AE not leading to hospitalization|0
2085647|NCT00727571|3670907|FG002|Overall Study|AE not leading to hospitalization|2
2085648|NCT00727571|3670908|FG003|Overall Study|AE not leading to hospitalization|0
2085649|NCT00727571|3670905|FG000|Overall Study|Other|0
2085650|NCT00727571|3670906|FG001|Overall Study|Other|4
2085651|NCT00727571|3670907|FG002|Overall Study|Other|6
2085652|NCT00727571|3670908|FG003|Overall Study|Other|0
2085653|NCT00727649|3670938|FG000|First Intervention (4-weeks)|Lost to Follow-up|1
2085654|NCT00727649|3670939|FG001|First Intervention (4-weeks)|Lost to Follow-up|2
2085655|NCT00727649|3670938|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2
2085656|NCT00727649|3670939|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1
2085657|NCT00727649|3670938|FG000|Wash-out (2-weeks)|Lost to Follow-up|3
2085658|NCT00727649|3670939|FG001|Wash-out (2-weeks)|Lost to Follow-up|1
2085659|NCT00727649|3670938|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1
2085660|NCT00727649|3670939|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2
2085661|NCT00727649|3670938|FG000|Second Intervention (4-weeks)|Death|1
2085662|NCT00727649|3670939|FG001|Second Intervention (4-weeks)|Death|0
2085663|NCT00727649|3670938|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0
2085664|NCT00727649|3670939|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1
2085665|NCT00727649|3670938|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0
2085666|NCT00727649|3670939|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2
2085667|NCT00727714|3670947|FG000|Overall Study|Lost to Follow-up|2
2085668|NCT00727844|3670962|FG000|Initial Randomization|Physician Decision|2
2085669|NCT00727844|3670963|FG001|Initial Randomization|Physician Decision|0
2085670|NCT00727844|3670964|FG002|Initial Randomization|Physician Decision|0
2085671|NCT00727844|3670965|FG003|Initial Randomization|Physician Decision|0
2085672|NCT00727909|3670984|FG000|Overall Study|Withdrawal by Subject|5
2085673|NCT00727909|3670985|FG001|Overall Study|Withdrawal by Subject|11
2085674|NCT00727909|3670986|FG002|Overall Study|Withdrawal by Subject|8
2085675|NCT00727909|3670987|FG003|Overall Study|Withdrawal by Subject|5
2085676|NCT00727909|3670984|FG000|Overall Study|Death|0
2085677|NCT00727909|3670985|FG001|Overall Study|Death|0
2085678|NCT00727909|3670986|FG002|Overall Study|Death|1
2085679|NCT00727909|3670987|FG003|Overall Study|Death|0
2085680|NCT00727961|3670991|FG000|Overall Study|Lost to Follow-up|1
2085681|NCT00727961|3670991|FG000|Overall Study|Adverse Event|4
2085682|NCT00727961|3670991|FG000|Overall Study|Patient's refusal|2
2085683|NCT00727961|3670991|FG000|Overall Study|Progression|30
2085684|NCT00728130|3670995|FG000|Overall Study|Withdrawal by Subject|1
2085685|NCT00728130|3670995|FG000|Overall Study|Paperwork not completed in time|1
2085686|NCT00728130|3670995|FG000|Overall Study|Physician Decision|1
2085687|NCT00728182|3671001|FG000|Overall Study|Adverse Event|1
2085688|NCT00728182|3671002|FG001|Overall Study|Adverse Event|0
2085689|NCT00728182|3671001|FG000|Overall Study|Lost to Follow-up|2
2085690|NCT00728182|3671002|FG001|Overall Study|Lost to Follow-up|0
2085691|NCT00728182|3671001|FG000|Overall Study|Death|0
2085692|NCT00728182|3671002|FG001|Overall Study|Death|2
2085693|NCT00728182|3671001|FG000|Overall Study|Protocol Noncompliance|0
2085694|NCT00728182|3671002|FG001|Overall Study|Protocol Noncompliance|1
2085695|NCT00728468|3671014|FG000|Overall Study|Enrolled but not treated|1
2085696|NCT00728468|3671014|FG000|Overall Study|Death|1
2085697|NCT00728468|3671014|FG000|Overall Study|Protocol Violation|4
2085698|NCT00728468|3671014|FG000|Overall Study|Objective progression or relapse|9
2085699|NCT00728468|3671014|FG000|Overall Study|Study terminated by sponsor|1
2085700|NCT00728481|3671020|FG000|Overall Study|Withdrawal by Subject|0
2085701|NCT00728481|3671021|FG001|Overall Study|Withdrawal by Subject|1
2085702|NCT00728481|3671020|FG000|Overall Study|Adverse Event|0
2085703|NCT00728481|3671021|FG001|Overall Study|Adverse Event|1
2085704|NCT00728481|3671020|FG000|Overall Study|Study medication non-compliance|0
2085705|NCT00728481|3671021|FG001|Overall Study|Study medication non-compliance|2
2085706|NCT00728481|3671020|FG000|Overall Study|Incorrectly assigned to opposite arm|1
2085707|NCT00728481|3671021|FG001|Overall Study|Incorrectly assigned to opposite arm|0
2085708|NCT00728494|3671029|FG000|Overall Study|Adverse Event|7
2085709|NCT00728494|3671030|FG001|Overall Study|Adverse Event|0
2085710|NCT00728494|3671029|FG000|Overall Study|Withdrawal by Subject|0
2085711|NCT00728494|3671030|FG001|Overall Study|Withdrawal by Subject|2
2085712|NCT00728494|3671029|FG000|Overall Study|Lack of Efficacy|2
2085713|NCT00728494|3671030|FG001|Overall Study|Lack of Efficacy|4
2085714|NCT00728494|3671029|FG000|Overall Study|No data available|0
2085715|NCT00728494|3671030|FG001|Overall Study|No data available|1
2107185|NCT00871377|3700654|FG000|Third Intervention (10 Weeks)|Death|0
2107186|NCT00871377|3700655|FG001|Third Intervention (10 Weeks)|Death|0
2107187|NCT00871377|3700656|FG002|Third Intervention (10 Weeks)|Death|0
2107188|NCT00871377|3700657|FG003|Third Intervention (10 Weeks)|Death|1
2107189|NCT00871377|3700658|FG004|Third Intervention (10 Weeks)|Death|0
2107190|NCT00871377|3700659|FG005|Third Intervention (10 Weeks)|Death|0
2107191|NCT00871403|3700670|FG000|Combination Treatment Phase|Randomized but Not Treated|1
2107192|NCT00871403|3700671|FG001|Combination Treatment Phase|Randomized but Not Treated|1
2107193|NCT00871403|3700672|FG002|Combination Treatment Phase|Randomized but Not Treated|1
2107194|NCT00871403|3700670|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
2085716|NCT00728689|3671047|FG000|Washout Period (Days 4 - 10)|Death in family|1
2085717|NCT00728689|3671048|FG001|Washout Period (Days 4 - 10)|Death in family|0
2085718|NCT00728754|3671068|FG000|Permanent Prosthesis Placement|Adverse Event|1
2085719|NCT00728754|3671069|FG001|Permanent Prosthesis Placement|Adverse Event|1
2085720|NCT00728754|3671068|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3
2085721|NCT00728754|3671069|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3
2085722|NCT00728754|3671068|FG000|One Year Post Placement Follow-up|Adverse Event|1
2085723|NCT00728754|3671069|FG001|One Year Post Placement Follow-up|Adverse Event|0
2085724|NCT00728884|3671084|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13
2085725|NCT00728884|3671084|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4
2085726|NCT00728936|3671108|FG000|Overall Study|Withdrawal by Subject|0
2085727|NCT00728936|3671109|FG001|Overall Study|Withdrawal by Subject|0
2085728|NCT00728936|3671110|FG002|Overall Study|Withdrawal by Subject|0
2085729|NCT00728936|3671111|FG003|Overall Study|Withdrawal by Subject|0
2085730|NCT00728936|3671112|FG004|Overall Study|Withdrawal by Subject|0
2085731|NCT00728936|3671113|FG005|Overall Study|Withdrawal by Subject|1
2085732|NCT00728936|3671114|FG006|Overall Study|Withdrawal by Subject|0
2085733|NCT00728949|3671132|FG000|Overall Study|Adverse Event|8
2085734|NCT00728949|3671133|FG001|Overall Study|Adverse Event|0
2085735|NCT00728949|3671132|FG000|Overall Study|Withdrawal by Subject|2
2085736|NCT00728949|3671133|FG001|Overall Study|Withdrawal by Subject|2
2085737|NCT00728949|3671132|FG000|Overall Study|Abnormal Lab Results|0
2085738|NCT00728949|3671133|FG001|Overall Study|Abnormal Lab Results|2
2085739|NCT00728949|3671132|FG000|Overall Study|On treatment at cutoff date|1
2085740|NCT00728949|3671133|FG001|Overall Study|On treatment at cutoff date|0
2085741|NCT00728962|3671139|FG000|Implant Placement Surgery|Adverse Event|8
2085742|NCT00728962|3671139|FG000|Implant Placement Surgery|Lost to Follow-up|1
2085743|NCT00728962|3671139|FG000|Implant Placement Surgery|Protocol Violation|1
2085744|NCT00728962|3671139|FG000|Permanent Prosthesis Placement|Adverse Event|3
2085745|NCT00728962|3671139|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3
2085746|NCT00728988|3671145|FG000|Overall Study|Not Treated|2
2085747|NCT00728988|3671146|FG001|Overall Study|Not Treated|2
2085748|NCT00728988|3671145|FG000|Overall Study|Death|1
2085749|NCT00728988|3671146|FG001|Overall Study|Death|1
2085750|NCT00728988|3671145|FG000|Overall Study|Adverse Event|3
2085751|NCT00728988|3671146|FG001|Overall Study|Adverse Event|2
2085752|NCT00728988|3671145|FG000|Overall Study|Other|85
2085753|NCT00728988|3671146|FG001|Overall Study|Other|77
2085754|NCT00728988|3671145|FG000|Overall Study|Withdrawal by Subject|2
2085755|NCT00728988|3671146|FG001|Overall Study|Withdrawal by Subject|6
2085756|NCT00729157|3671170|FG000|Overall Study|Withdrawal by Subject|1
2085757|NCT00729183|3671176|FG000|Overall Study|Adverse Event|11
2085758|NCT00729183|3671177|FG001|Overall Study|Adverse Event|5
2085759|NCT00729183|3671176|FG000|Overall Study|Lack of Efficacy|0
2085760|NCT00729183|3671177|FG001|Overall Study|Lack of Efficacy|1
2085761|NCT00729183|3671176|FG000|Overall Study|Lost to Follow-up|3
2085762|NCT00729183|3671177|FG001|Overall Study|Lost to Follow-up|1
2085763|NCT00729183|3671176|FG000|Overall Study|Physician Decision|1
2085764|NCT00729183|3671177|FG001|Overall Study|Physician Decision|1
2085765|NCT00729183|3671176|FG000|Overall Study|Protocol Violation|1
2085766|NCT00729183|3671177|FG001|Overall Study|Protocol Violation|0
2085767|NCT00729183|3671176|FG000|Overall Study|Withdrawal by Subject|9
2085768|NCT00729183|3671177|FG001|Overall Study|Withdrawal by Subject|7
2085769|NCT00729248|3671183|FG000|Overall Study|Physician Decision|2
2085770|NCT00729326|3671190|FG000|Overall Study|Lost to Follow-up|2
2085771|NCT00729326|3671191|FG001|Overall Study|Lost to Follow-up|0
2085772|NCT00729326|3671190|FG000|Overall Study|Physician Decision|0
2085773|NCT00729326|3671191|FG001|Overall Study|Physician Decision|1
2085774|NCT00729326|3671190|FG000|Overall Study|Protocol Violation|3
2085775|NCT00729326|3671191|FG001|Overall Study|Protocol Violation|2
2085776|NCT00729326|3671190|FG000|Overall Study|Subject Decision|4
2085777|NCT00729326|3671191|FG001|Overall Study|Subject Decision|4
2085778|NCT00729326|3671190|FG000|Overall Study|Sponsor Decision|1
2085779|NCT00729326|3671191|FG001|Overall Study|Sponsor Decision|2
2085780|NCT00729378|3671199|FG000|Baseline|Did not complete study measurements|72
2085781|NCT00729378|3671200|FG001|Baseline|Did not complete study measurements|33
2085782|NCT00729378|3671199|FG000|Baseline|Withdrawal by Subject|66
2085783|NCT00729378|3671200|FG001|Baseline|Withdrawal by Subject|59
2085784|NCT00729378|3671199|FG000|12-months|Lost to Follow-up|100
2085785|NCT00729378|3671200|FG001|12-months|Lost to Follow-up|65
2085786|NCT00729378|3671199|FG000|24-months|Lost to Follow-up|72
2085787|NCT00729378|3671200|FG001|24-months|Lost to Follow-up|51
2085788|NCT00729378|3671199|FG000|36-months|Lost to Follow-up|15
2085789|NCT00729378|3671200|FG001|36-months|Lost to Follow-up|6
2085790|NCT00729469|3671221|FG000|Overall Study|Adverse Event|14
2085791|NCT00729469|3671222|FG001|Overall Study|Adverse Event|25
2085792|NCT00729469|3671221|FG000|Overall Study|Lost to Follow-up|9
2085793|NCT00729469|3671222|FG001|Overall Study|Lost to Follow-up|9
2085794|NCT00729469|3671221|FG000|Overall Study|Protocol Violation|2
2085795|NCT00729469|3671222|FG001|Overall Study|Protocol Violation|1
2085796|NCT00729469|3671221|FG000|Overall Study|Withdrawal by Subject|19
2085797|NCT00729469|3671222|FG001|Overall Study|Withdrawal by Subject|8
2085798|NCT00729469|3671221|FG000|Overall Study|Other-Not mentioned|9
2085799|NCT00729469|3671222|FG001|Overall Study|Other-Not mentioned|4
2085800|NCT00729586|3671247|FG000|Overall Study|Ineligible|0
2085801|NCT00729586|3671248|FG001|Overall Study|Ineligible|1
2085802|NCT00729586|3671247|FG000|Overall Study|never treated|1
2085803|NCT00729586|3671248|FG001|Overall Study|never treated|0
2085804|NCT00729612|3671255|FG000|Overall Study|Non evaluable for response|10
2085805|NCT00729690|3671273|FG000|Overall Study|IT Catheter Malfunction|0
2085806|NCT00729690|3671274|FG001|Overall Study|IT Catheter Malfunction|2
2085807|NCT00729690|3671275|FG002|Overall Study|IT Catheter Malfunction|2
2085808|NCT00729833|3671291|FG000|Overall Study|Death|5
2085809|NCT00729833|3671292|FG001|Overall Study|Death|1
2085810|NCT00729833|3671293|FG002|Overall Study|Death|3
2085811|NCT00729833|3671294|FG003|Overall Study|Death|5
2085812|NCT00729833|3671291|FG000|Overall Study|Study Terminated by Sponsor|0
2085813|NCT00729833|3671292|FG001|Overall Study|Study Terminated by Sponsor|0
2085814|NCT00729833|3671293|FG002|Overall Study|Study Terminated by Sponsor|1
2085815|NCT00729833|3671294|FG003|Overall Study|Study Terminated by Sponsor|0
2085816|NCT00729833|3671291|FG000|Overall Study|Lost to Follow-up|1
2085817|NCT00729833|3671292|FG001|Overall Study|Lost to Follow-up|0
2085818|NCT00729833|3671293|FG002|Overall Study|Lost to Follow-up|0
2085819|NCT00729833|3671294|FG003|Overall Study|Lost to Follow-up|0
2085820|NCT00729833|3671291|FG000|Overall Study|Withdrawal by Subject|3
2085821|NCT00729833|3671292|FG001|Overall Study|Withdrawal by Subject|1
2085822|NCT00729833|3671293|FG002|Overall Study|Withdrawal by Subject|3
2085823|NCT00729833|3671294|FG003|Overall Study|Withdrawal by Subject|0
2085824|NCT00729833|3671291|FG000|Overall Study|Unspecified Reasons|11
2085825|NCT00729833|3671292|FG001|Overall Study|Unspecified Reasons|5
2085826|NCT00729833|3671293|FG002|Overall Study|Unspecified Reasons|5
2085827|NCT00729833|3671294|FG003|Overall Study|Unspecified Reasons|1
2085828|NCT00729859|3671317|FG000|Overall Study|Adverse Event|0
2085829|NCT00729859|3671318|FG001|Overall Study|Adverse Event|1
2085830|NCT00729859|3671319|FG002|Overall Study|Adverse Event|0
2085831|NCT00729859|3671317|FG000|Overall Study|Withdrawal by Subject|0
2085832|NCT00729859|3671318|FG001|Overall Study|Withdrawal by Subject|1
2085833|NCT00729859|3671319|FG002|Overall Study|Withdrawal by Subject|0
2085834|NCT00729937|3671348|FG000|Overall Study|Lost to Follow-up|49
2085835|NCT00729937|3671349|FG001|Overall Study|Lost to Follow-up|58
2085836|NCT00729937|3671350|FG002|Overall Study|Lost to Follow-up|18
2085837|NCT00729937|3671351|FG003|Overall Study|Lost to Follow-up|33
2085838|NCT00729937|3671352|FG004|Overall Study|Lost to Follow-up|18
2085839|NCT00729937|3671353|FG005|Overall Study|Lost to Follow-up|23
2085840|NCT00729937|3671348|FG000|Overall Study|Physician Decision|7
2085841|NCT00729937|3671349|FG001|Overall Study|Physician Decision|16
2085842|NCT00729937|3671350|FG002|Overall Study|Physician Decision|2
2085843|NCT00729937|3671351|FG003|Overall Study|Physician Decision|0
2085844|NCT00729937|3671352|FG004|Overall Study|Physician Decision|5
2085845|NCT00729937|3671353|FG005|Overall Study|Physician Decision|8
2085846|NCT00729937|3671348|FG000|Overall Study|Death|1
2085847|NCT00729937|3671349|FG001|Overall Study|Death|0
2085848|NCT00729937|3671350|FG002|Overall Study|Death|1
2085849|NCT00729937|3671351|FG003|Overall Study|Death|0
2085850|NCT00729937|3671352|FG004|Overall Study|Death|0
2085851|NCT00729937|3671353|FG005|Overall Study|Death|1
2085852|NCT00729937|3671348|FG000|Overall Study|Withdrawal by Subject|3
2085853|NCT00729937|3671349|FG001|Overall Study|Withdrawal by Subject|5
2085854|NCT00729937|3671350|FG002|Overall Study|Withdrawal by Subject|6
2085855|NCT00729937|3671351|FG003|Overall Study|Withdrawal by Subject|0
2085856|NCT00729937|3671352|FG004|Overall Study|Withdrawal by Subject|4
2085857|NCT00729937|3671353|FG005|Overall Study|Withdrawal by Subject|2
2085858|NCT00729937|3671348|FG000|Overall Study|Randomized but not treated|12
2085859|NCT00729937|3671349|FG001|Overall Study|Randomized but not treated|6
2085860|NCT00729937|3671350|FG002|Overall Study|Randomized but not treated|1
2085861|NCT00729937|3671351|FG003|Overall Study|Randomized but not treated|0
2085862|NCT00729937|3671352|FG004|Overall Study|Randomized but not treated|1
2085863|NCT00729937|3671353|FG005|Overall Study|Randomized but not treated|3
2085864|NCT00729937|3671348|FG000|Overall Study|Did not meet eligibility criteria|2
2085865|NCT00729937|3671349|FG001|Overall Study|Did not meet eligibility criteria|1
2085866|NCT00729937|3671350|FG002|Overall Study|Did not meet eligibility criteria|0
2085867|NCT00729937|3671351|FG003|Overall Study|Did not meet eligibility criteria|0
2085868|NCT00729937|3671352|FG004|Overall Study|Did not meet eligibility criteria|0
2085869|NCT00729937|3671353|FG005|Overall Study|Did not meet eligibility criteria|0
2085870|NCT00729937|3671348|FG000|Overall Study|Incarcerated|0
2085871|NCT00729937|3671349|FG001|Overall Study|Incarcerated|2
2085872|NCT00729937|3671350|FG002|Overall Study|Incarcerated|1
2085873|NCT00729937|3671351|FG003|Overall Study|Incarcerated|1
2085874|NCT00729937|3671352|FG004|Overall Study|Incarcerated|0
2085875|NCT00729937|3671353|FG005|Overall Study|Incarcerated|0
2085876|NCT00730015|3671370|FG000|Overall Study|Adverse Event|11
2085877|NCT00730015|3671371|FG001|Overall Study|Adverse Event|10
2085878|NCT00730015|3671372|FG002|Overall Study|Adverse Event|8
2085879|NCT00730015|3671370|FG000|Overall Study|Protocol Violation|2
2085880|NCT00730015|3671371|FG001|Overall Study|Protocol Violation|6
2085881|NCT00730015|3671372|FG002|Overall Study|Protocol Violation|4
2085882|NCT00730015|3671370|FG000|Overall Study|Withdrawal by Subject|12
2085883|NCT00730015|3671371|FG001|Overall Study|Withdrawal by Subject|12
2085884|NCT00730015|3671372|FG002|Overall Study|Withdrawal by Subject|8
2085885|NCT00730015|3671370|FG000|Overall Study|Lost to Follow-up|4
2085886|NCT00730015|3671371|FG001|Overall Study|Lost to Follow-up|10
2085887|NCT00730015|3671372|FG002|Overall Study|Lost to Follow-up|3
2085888|NCT00730015|3671370|FG000|Overall Study|Lack of Efficacy|1
2085889|NCT00730015|3671371|FG001|Overall Study|Lack of Efficacy|2
2085890|NCT00730015|3671372|FG002|Overall Study|Lack of Efficacy|8
2085891|NCT00730015|3671370|FG000|Overall Study|Other Reason|1
2085892|NCT00730015|3671371|FG001|Overall Study|Other Reason|0
2085893|NCT00730015|3671372|FG002|Overall Study|Other Reason|1
2085894|NCT00730028|3671390|FG000|Overall Study|Adverse Event|23
2085895|NCT00730028|3671391|FG001|Overall Study|Adverse Event|26
2085896|NCT00730028|3671392|FG002|Overall Study|Adverse Event|16
2085897|NCT00730028|3671393|FG003|Overall Study|Adverse Event|20
2085898|NCT00730028|3671394|FG004|Overall Study|Adverse Event|43
2085899|NCT00730028|3671390|FG000|Overall Study|Lost to Follow-up|13
2085900|NCT00730028|3671391|FG001|Overall Study|Lost to Follow-up|26
2085901|NCT00730028|3671392|FG002|Overall Study|Lost to Follow-up|22
2085902|NCT00730028|3671393|FG003|Overall Study|Lost to Follow-up|26
2085903|NCT00730028|3671394|FG004|Overall Study|Lost to Follow-up|25
2085904|NCT00730028|3671390|FG000|Overall Study|Protocol Violation|6
2085905|NCT00730028|3671391|FG001|Overall Study|Protocol Violation|1
2085906|NCT00730028|3671392|FG002|Overall Study|Protocol Violation|1
2085907|NCT00730028|3671393|FG003|Overall Study|Protocol Violation|2
2085908|NCT00730028|3671394|FG004|Overall Study|Protocol Violation|0
2085909|NCT00730028|3671390|FG000|Overall Study|Withdrawal by Subject|9
2085910|NCT00730028|3671391|FG001|Overall Study|Withdrawal by Subject|5
2085911|NCT00730028|3671392|FG002|Overall Study|Withdrawal by Subject|4
2085912|NCT00730028|3671393|FG003|Overall Study|Withdrawal by Subject|5
2085913|NCT00730028|3671394|FG004|Overall Study|Withdrawal by Subject|9
2085914|NCT00730028|3671390|FG000|Overall Study|Physician Decision|3
2085915|NCT00730028|3671391|FG001|Overall Study|Physician Decision|3
2085916|NCT00730028|3671392|FG002|Overall Study|Physician Decision|2
2085917|NCT00730028|3671393|FG003|Overall Study|Physician Decision|3
2085918|NCT00730028|3671394|FG004|Overall Study|Physician Decision|2
2085919|NCT00730028|3671390|FG000|Overall Study|Treatment Failure|5
2085920|NCT00730028|3671391|FG001|Overall Study|Treatment Failure|5
2085921|NCT00730028|3671392|FG002|Overall Study|Treatment Failure|0
2085922|NCT00730028|3671393|FG003|Overall Study|Treatment Failure|0
2085923|NCT00730028|3671394|FG004|Overall Study|Treatment Failure|1
2085924|NCT00730028|3671390|FG000|Overall Study|Randomization Error|1
2085925|NCT00730028|3671391|FG001|Overall Study|Randomization Error|0
2085926|NCT00730028|3671392|FG002|Overall Study|Randomization Error|0
2085927|NCT00730028|3671393|FG003|Overall Study|Randomization Error|0
2085928|NCT00730028|3671394|FG004|Overall Study|Randomization Error|2
2085929|NCT00730041|3671408|FG000|Overall Study|Lost to Follow-up|0
2085930|NCT00730041|3671409|FG001|Overall Study|Lost to Follow-up|2
2085931|NCT00730158|3671417|FG000|Overall Study|Withdrawal by Subject|1
2085932|NCT00730158|3671418|FG001|Overall Study|Withdrawal by Subject|1
2085933|NCT00730171|3671428|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
2085934|NCT00730171|3671428|FG000|Overall Study|Adverse Event|193
2085935|NCT00730171|3671428|FG000|Overall Study|Protocol Violation|48
2085936|NCT00730171|3671428|FG000|Overall Study|Withdrawal by Subject|202
2085937|NCT00730171|3671428|FG000|Overall Study|Lost to Follow-up|121
2085938|NCT00730171|3671428|FG000|Overall Study|Insufficient Therapeutic Response|141
2085939|NCT00730171|3671428|FG000|Overall Study|Other|61
2085940|NCT00730236|3671436|FG000|Overall Study|Adverse Event|4
2085941|NCT00730236|3671436|FG000|Overall Study|Withdrawal by Subject|1
2085942|NCT00730236|3671436|FG000|Overall Study|Non-compliance|1
2085943|NCT00730275|3671444|FG000|Overall Study|Withdrawal by Subject|0
2085944|NCT00730275|3671445|FG001|Overall Study|Withdrawal by Subject|0
2085945|NCT00730275|3671446|FG002|Overall Study|Withdrawal by Subject|0
2085946|NCT00730275|3671447|FG003|Overall Study|Withdrawal by Subject|1
2085947|NCT00730327|3671460|FG000|Overall Study|Lost to Follow-up|14
2085948|NCT00730327|3671461|FG001|Overall Study|Lost to Follow-up|16
2211521|NCT01661595|3851840|FG002|Phase 1: Week 0-4|Adverse Event|0
2211522|NCT01661595|3851841|FG003|Phase 1: Week 0-4|Adverse Event|0
2211523|NCT01661595|3851838|FG000|Phase 2: Week 5-8.|Protocol Violation|0
2211524|NCT01661595|3851839|FG001|Phase 2: Week 5-8.|Protocol Violation|0
2211525|NCT01661595|3851840|FG002|Phase 2: Week 5-8.|Protocol Violation|1
2211526|NCT01661595|3851841|FG003|Phase 2: Week 5-8.|Protocol Violation|0
2211527|NCT01661686|3851869|FG000|Overall Study|Lost to Follow-up|2
2211528|NCT01661686|3851870|FG001|Overall Study|Lost to Follow-up|1
2211529|NCT01661686|3851869|FG000|Overall Study|did not receive allocated intervention|0
2211530|NCT01661686|3851870|FG001|Overall Study|did not receive allocated intervention|1
2211531|NCT01661790|3851918|FG000|Overall Study|Lost to Follow-up|0
2085949|NCT00730327|3671460|FG000|Overall Study|Adverse Event|8
2085950|NCT00730327|3671461|FG001|Overall Study|Adverse Event|1
2085951|NCT00730327|3671460|FG000|Overall Study|Withdrawal by Subject|3
2085952|NCT00730327|3671461|FG001|Overall Study|Withdrawal by Subject|13
2085953|NCT00730327|3671460|FG000|Overall Study|Subject withdrew (reason not specified)|2
2085954|NCT00730327|3671461|FG001|Overall Study|Subject withdrew (reason not specified)|7
2085955|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Adverse Event|5
2211532|NCT01661790|3851919|FG001|Overall Study|Lost to Follow-up|2
2211533|NCT01661881|3851925|FG000|Overall Study|Disease Progression|1
2085956|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Adverse Event|10
2085957|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Adverse Event|4
2085958|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Adverse Event|8
2085959|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Adverse Event|4
2305995|NCT02679755|4007581|FG001|Overall Study|Adverse events not related to study drug|2
2305996|NCT02680002|4007615|FG000|Overall Study|Lost to Follow-up|5
2305997|NCT02680002|4007616|FG001|Overall Study|Lost to Follow-up|1
2305998|NCT02680002|4007617|FG002|Overall Study|Lost to Follow-up|4
2305999|NCT02680002|4007618|FG003|Overall Study|Lost to Follow-up|2
2306000|NCT02680002|4007619|FG004|Overall Study|Lost to Follow-up|0
2306001|NCT02680002|4007620|FG005|Overall Study|Lost to Follow-up|2
2306002|NCT02680002|4007615|FG000|Overall Study|Physician Decision|5
2306003|NCT02680002|4007616|FG001|Overall Study|Physician Decision|1
2306004|NCT02680002|4007617|FG002|Overall Study|Physician Decision|1
2306005|NCT02680002|4007618|FG003|Overall Study|Physician Decision|1
2306006|NCT02680002|4007619|FG004|Overall Study|Physician Decision|1
2306007|NCT02680002|4007620|FG005|Overall Study|Physician Decision|1
2306008|NCT02680002|4007615|FG000|Overall Study|Protocol Violation|1
2306009|NCT02680002|4007616|FG001|Overall Study|Protocol Violation|0
2306010|NCT02680002|4007617|FG002|Overall Study|Protocol Violation|1
2306011|NCT02680002|4007618|FG003|Overall Study|Protocol Violation|0
2211534|NCT01661933|3851929|FG000|Low-dose Gluten Challenge|Physician Decision|2
2211535|NCT01661933|3851929|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2
2211536|NCT01661972|3851946|FG000|Overall Study|Adverse Event|1
2211537|NCT01661972|3851947|FG001|Overall Study|Adverse Event|2
2211538|NCT01661972|3851946|FG000|Overall Study|Death during Treatment period|1
2211539|NCT01661972|3851947|FG001|Overall Study|Death during Treatment period|1
2211540|NCT01661972|3851946|FG000|Overall Study|Withdrawal by Subject|0
2211541|NCT01661972|3851947|FG001|Overall Study|Withdrawal by Subject|1
2211542|NCT01662024|3851955|FG000|Overall Study|Pregnancy|2
2211543|NCT01662024|3851955|FG000|Overall Study|Withdrawal by Subject|3
2211544|NCT01662063|3851964|FG000|Overall Study|Adverse Event or Intercurrent Illness|1
2211545|NCT01662063|3851965|FG001|Overall Study|Adverse Event or Intercurrent Illness|12
2211546|NCT01662063|3851966|FG002|Overall Study|Adverse Event or Intercurrent Illness|0
2211547|NCT01662063|3851964|FG000|Overall Study|Lack of Efficacy|1
2306012|NCT02680002|4007619|FG004|Overall Study|Protocol Violation|1
2306013|NCT02680002|4007620|FG005|Overall Study|Protocol Violation|2
2085960|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4
2085961|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5
2085962|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6
2085963|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4
2085964|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4
2085965|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
2085966|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
2085967|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
2085968|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
2085969|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
2085970|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7
2085971|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1
2085972|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2
2085973|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5
2085974|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8
2085975|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Did not met eligibility|0
2085976|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Did not met eligibility|0
2085977|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Did not met eligibility|1
2085978|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Did not met eligibility|0
2085979|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Did not met eligibility|0
2085980|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0
2085981|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0
2085982|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1
2085983|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0
2085984|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0
2085985|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1
2085986|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0
2085987|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0
2085988|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0
2085989|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0
2085990|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0
2085991|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1
2085992|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0
2085993|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0
2085994|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0
2085995|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0
2085996|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1
2108197|NCT00878722|3702050|FG001|Overall Study|Adverse Event|0
2306014|NCT02680002|4007615|FG000|Overall Study|Withdrawal by Subject|0
2085997|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0
2085998|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0
2085999|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2
2086000|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
2086001|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
2086002|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
2086003|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
2086004|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
2086005|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Misrandomized|0
2086006|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Misrandomized|1
2086007|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Misrandomized|0
2086008|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Misrandomized|0
2086009|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Misrandomized|0
2086010|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Study drug interrupted|0
2086011|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Study drug interrupted|1
2086012|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Study drug interrupted|0
2086013|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Study drug interrupted|0
2086014|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Study drug interrupted|0
2086015|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
2086016|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
2086017|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
2086018|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
2086019|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
2086020|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
2086021|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
2086022|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
2086023|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
2086024|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
2086025|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Change of location|0
2086026|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Change of location|0
2086027|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Change of location|0
2086028|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Change of location|1
2086029|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Change of location|0
2086030|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Pregnancy|0
2086031|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Pregnancy|1
2086032|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Pregnancy|0
2086033|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Pregnancy|0
2086034|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Pregnancy|0
2086035|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
2086036|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
2086037|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
2086038|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
2086039|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
2086040|NCT00730405|3671476|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1
2086041|NCT00730405|3671477|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0
2086042|NCT00730405|3671478|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0
2086043|NCT00730405|3671479|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0
2086044|NCT00730405|3671480|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0
2086045|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Adverse Event|2
2086046|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Adverse Event|6
2086047|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Adverse Event|2
2086048|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Adverse Event|3
2086049|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Adverse Event|4
2086050|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7
2086051|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6
2086052|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8
2086053|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4
2086054|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6
2086055|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7
2086056|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3
2086057|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3
2086058|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6
2086059|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10
2211548|NCT01662063|3851965|FG001|Overall Study|Lack of Efficacy|6
2211549|NCT01662063|3851966|FG002|Overall Study|Lack of Efficacy|0
2086060|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Death|0
2086061|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Death|1
2086062|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Death|0
2086063|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Death|1
2211550|NCT01662063|3851964|FG000|Overall Study|Lost to Follow-up|0
2086064|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Death|0
2086065|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Change of location|1
2086066|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Change of location|1
2086067|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Change of location|0
2086068|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Change of location|1
2086069|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Change of location|0
2086070|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Did not met eligibility|0
2086071|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Did not met eligibility|0
2086072|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Did not met eligibility|1
2086073|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Did not met eligibility|0
2086074|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Did not met eligibility|0
2086075|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0
2086076|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0
2086077|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1
2086078|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0
2086079|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0
2086080|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
2086081|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
2086082|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
2086083|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
2086084|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
2086085|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
2086086|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
2086087|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
2086088|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
2086089|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
2086090|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1
2086091|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0
2086092|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0
2086093|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0
2086094|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0
2086095|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0
2086096|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0
2086097|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0
2086098|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1
2086099|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0
2086100|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
2086101|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
2086102|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
2086103|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
2086104|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
2086105|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1
2086106|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1
2086107|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0
2086108|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0
2086109|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0
2086110|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Use of restricted medication|0
2086111|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Use of restricted medication|1
2086112|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Use of restricted medication|0
2086113|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Use of restricted medication|0
2086114|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Use of restricted medication|0
2086115|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Non-compliance|1
2086116|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Non-compliance|0
2086117|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Non-compliance|2
2086118|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Non-compliance|0
2086119|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Non-compliance|0
2086120|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Missing|0
2086121|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Missing|0
2086122|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Missing|2
2086123|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Missing|0
2086124|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Missing|0
2086125|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0
2086126|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0
2086127|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0
2086128|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0
2086129|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1
2086130|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
2086131|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
2086132|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
2086133|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
2086134|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
2086135|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Mis-randomized|0
2086136|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Mis-randomized|1
2086137|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Mis-randomized|0
2086138|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Mis-randomized|0
2086139|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Mis-randomized|0
2086140|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Other Protocol violation|0
2086141|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Other Protocol violation|0
2086142|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Other Protocol violation|1
2086143|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Other Protocol violation|0
2086144|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Other Protocol violation|0
2086145|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
2086146|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
2086147|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
2086148|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
2086149|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
2086150|NCT00730405|3671476|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1
2086151|NCT00730405|3671477|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0
2086152|NCT00730405|3671478|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0
2086153|NCT00730405|3671479|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0
2086154|NCT00730405|3671480|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0
2086155|NCT00730691|3671515|FG000|Overall Study|Adverse Event|4
2086156|NCT00730691|3671516|FG001|Overall Study|Adverse Event|8
2086157|NCT00730691|3671517|FG002|Overall Study|Adverse Event|11
2086158|NCT00730691|3671518|FG003|Overall Study|Adverse Event|11
2086159|NCT00730691|3671519|FG004|Overall Study|Adverse Event|23
2086160|NCT00730691|3671515|FG000|Overall Study|Lack of Efficacy|4
2086161|NCT00730691|3671516|FG001|Overall Study|Lack of Efficacy|4
2086162|NCT00730691|3671517|FG002|Overall Study|Lack of Efficacy|2
2086163|NCT00730691|3671518|FG003|Overall Study|Lack of Efficacy|1
2086164|NCT00730691|3671519|FG004|Overall Study|Lack of Efficacy|1
2086165|NCT00730691|3671515|FG000|Overall Study|Non-compliance with Study Drug|6
2086166|NCT00730691|3671516|FG001|Overall Study|Non-compliance with Study Drug|1
2086167|NCT00730691|3671517|FG002|Overall Study|Non-compliance with Study Drug|6
2086168|NCT00730691|3671518|FG003|Overall Study|Non-compliance with Study Drug|3
2086169|NCT00730691|3671519|FG004|Overall Study|Non-compliance with Study Drug|3
2086170|NCT00730691|3671515|FG000|Overall Study|Protocol Deviations|3
2086171|NCT00730691|3671516|FG001|Overall Study|Protocol Deviations|5
2086172|NCT00730691|3671517|FG002|Overall Study|Protocol Deviations|3
2306015|NCT02680002|4007616|FG001|Overall Study|Withdrawal by Subject|0
2306016|NCT02680002|4007617|FG002|Overall Study|Withdrawal by Subject|1
2306017|NCT02680002|4007618|FG003|Overall Study|Withdrawal by Subject|0
2306018|NCT02680002|4007619|FG004|Overall Study|Withdrawal by Subject|2
2306019|NCT02680002|4007620|FG005|Overall Study|Withdrawal by Subject|2
2306020|NCT02680002|4007615|FG000|Overall Study|Missed Visit 8 (Day 201)|2
2306021|NCT02680002|4007616|FG001|Overall Study|Missed Visit 8 (Day 201)|1
2306022|NCT02680002|4007617|FG002|Overall Study|Missed Visit 8 (Day 201)|3
2306023|NCT02680002|4007618|FG003|Overall Study|Missed Visit 8 (Day 201)|1
2306024|NCT02680002|4007619|FG004|Overall Study|Missed Visit 8 (Day 201)|5
2306025|NCT02680002|4007620|FG005|Overall Study|Missed Visit 8 (Day 201)|0
2306026|NCT02680002|4007615|FG000|Overall Study|Other|0
2306027|NCT02680002|4007616|FG001|Overall Study|Other|1
2306028|NCT02680002|4007617|FG002|Overall Study|Other|0
2306029|NCT02680002|4007618|FG003|Overall Study|Other|0
2306030|NCT02680002|4007619|FG004|Overall Study|Other|1
2306031|NCT02680002|4007620|FG005|Overall Study|Other|0
2306032|NCT02680002|4007615|FG000|Overall Study|Adverse Event|0
2306033|NCT02680002|4007616|FG001|Overall Study|Adverse Event|0
2306034|NCT02680002|4007617|FG002|Overall Study|Adverse Event|0
2306035|NCT02680002|4007618|FG003|Overall Study|Adverse Event|0
2306036|NCT02680002|4007619|FG004|Overall Study|Adverse Event|1
2306037|NCT02680002|4007620|FG005|Overall Study|Adverse Event|2
2306038|NCT02680041|4007637|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
2306039|NCT02680041|4007637|FG000|Overall Study|Lost to Follow-up|2
2306040|NCT02680639|4007694|FG000|Screening Period|Screen Failure|7
2306041|NCT02680639|4007695|FG001|Screening Period|Screen Failure|0
2306042|NCT02680639|4007696|FG002|Screening Period|Screen Failure|0
2306043|NCT02680665|4007706|FG000|Overall Study|No visit after the first prescription|5
2306044|NCT02680756|4007712|FG000|Overall Study|Adverse Event|10
2306045|NCT02680756|4007713|FG001|Overall Study|Adverse Event|2
2306046|NCT02680756|4007712|FG000|Overall Study|Lost to Follow-up|7
2306047|NCT02680756|4007713|FG001|Overall Study|Lost to Follow-up|6
2306048|NCT02680756|4007712|FG000|Overall Study|Withdrawal by Subject|5
2306049|NCT02680756|4007713|FG001|Overall Study|Withdrawal by Subject|5
2306050|NCT02680756|4007712|FG000|Overall Study|Physician Decision|4
2306051|NCT02680756|4007713|FG001|Overall Study|Physician Decision|1
2086173|NCT00730691|3671518|FG003|Overall Study|Protocol Deviations|7
2086174|NCT00730691|3671519|FG004|Overall Study|Protocol Deviations|5
2086175|NCT00730691|3671515|FG000|Overall Study|Withdrawal of Consent|7
2086176|NCT00730691|3671516|FG001|Overall Study|Withdrawal of Consent|9
2086177|NCT00730691|3671517|FG002|Overall Study|Withdrawal of Consent|3
2086178|NCT00730691|3671518|FG003|Overall Study|Withdrawal of Consent|6
2086179|NCT00730691|3671519|FG004|Overall Study|Withdrawal of Consent|3
2086180|NCT00730691|3671515|FG000|Overall Study|Lost to Follow-up|11
2086181|NCT00730691|3671516|FG001|Overall Study|Lost to Follow-up|8
2086182|NCT00730691|3671517|FG002|Overall Study|Lost to Follow-up|13
2086183|NCT00730691|3671518|FG003|Overall Study|Lost to Follow-up|15
2086184|NCT00730691|3671519|FG004|Overall Study|Lost to Follow-up|13
2086185|NCT00730691|3671515|FG000|Overall Study|Other|1
2086186|NCT00730691|3671516|FG001|Overall Study|Other|1
2086187|NCT00730691|3671517|FG002|Overall Study|Other|1
2086188|NCT00730691|3671518|FG003|Overall Study|Other|2
2086189|NCT00730691|3671519|FG004|Overall Study|Other|2
2086190|NCT00730756|3671537|FG000|Overall Study|Adverse Event|2
2086191|NCT00730756|3671538|FG001|Overall Study|Adverse Event|0
2086192|NCT00730756|3671537|FG000|Overall Study|Lack of Efficacy|1
2086193|NCT00730756|3671538|FG001|Overall Study|Lack of Efficacy|1
2086194|NCT00730756|3671537|FG000|Overall Study|Protocol Deviation|1
2086195|NCT00730756|3671538|FG001|Overall Study|Protocol Deviation|2
2086196|NCT00730756|3671537|FG000|Overall Study|Lost to Follow-up|0
2086197|NCT00730756|3671538|FG001|Overall Study|Lost to Follow-up|1
2086198|NCT00730756|3671537|FG000|Overall Study|Withdrew Consent|0
2086199|NCT00730756|3671538|FG001|Overall Study|Withdrew Consent|1
2086200|NCT00730847|3671544|FG000|Overall Study|Adverse Event|1
2086201|NCT00730847|3671544|FG000|Overall Study|Protocol Violation|2
2211551|NCT01662063|3851965|FG001|Overall Study|Lost to Follow-up|4
2211552|NCT01662063|3851966|FG002|Overall Study|Lost to Follow-up|0
2211553|NCT01662063|3851964|FG000|Overall Study|Protocol Violation|1
2211554|NCT01662063|3851965|FG001|Overall Study|Protocol Violation|0
2211555|NCT01662063|3851966|FG002|Overall Study|Protocol Violation|0
2211556|NCT01662063|3851964|FG000|Overall Study|Withdrawal by Subject|2
2086202|NCT00730847|3671544|FG000|Overall Study|Withdrawal by Subject|16
2086203|NCT00730847|3671544|FG000|Overall Study|Lost to Follow-up|67
2086204|NCT00730847|3671544|FG000|Overall Study|Unknown completion status|21
2086205|NCT00730847|3671544|FG000|Overall Study|Other|24
2086206|NCT00730912|3671551|FG000|Overall Study|Discontinued|0
2086207|NCT00730912|3671552|FG001|Overall Study|Discontinued|0
2086208|NCT00730912|3671553|FG002|Overall Study|Discontinued|1
2086209|NCT00730925|3671561|FG000|Overall Study|Progressive Disease|21
2086210|NCT00730925|3671561|FG000|Overall Study|Dose reducing Event|2
2086211|NCT00730925|3671561|FG000|Overall Study|Other Averse Event|7
2086212|NCT00730925|3671561|FG000|Overall Study|Protocol Violation|1
2086213|NCT00730925|3671561|FG000|Overall Study|Withdrawal by Subject|1
2086214|NCT00730925|3671561|FG000|Overall Study|Switch to combination therapy|8
2086215|NCT00730925|3671561|FG000|Overall Study|Other|1
2086216|NCT00731042|3671572|FG000|Second Intervention|Did not meet inclusion criteria|0
2086217|NCT00731042|3671573|FG001|Second Intervention|Did not meet inclusion criteria|2
2086218|NCT00731120|3671598|FG000|Overall Study|Adverse Event|7
2086219|NCT00731120|3671599|FG001|Overall Study|Adverse Event|6
2086220|NCT00731120|3671600|FG002|Overall Study|Adverse Event|8
2086221|NCT00731120|3671598|FG000|Overall Study|Lack of Efficacy|4
2086222|NCT00731120|3671599|FG001|Overall Study|Lack of Efficacy|5
2086223|NCT00731120|3671600|FG002|Overall Study|Lack of Efficacy|4
2086224|NCT00731120|3671598|FG000|Overall Study|Noncompliance with Study Drug|3
2086225|NCT00731120|3671599|FG001|Overall Study|Noncompliance with Study Drug|3
2086226|NCT00731120|3671600|FG002|Overall Study|Noncompliance with Study Drug|1
2086227|NCT00731120|3671598|FG000|Overall Study|Protocol Deviations|1
2086228|NCT00731120|3671599|FG001|Overall Study|Protocol Deviations|6
2086229|NCT00731120|3671600|FG002|Overall Study|Protocol Deviations|1
2086230|NCT00731120|3671598|FG000|Overall Study|Withdrawal of Consent|13
2086231|NCT00731120|3671599|FG001|Overall Study|Withdrawal of Consent|8
2086232|NCT00731120|3671600|FG002|Overall Study|Withdrawal of Consent|4
2086233|NCT00731120|3671598|FG000|Overall Study|Lost to Follow-up|10
2211557|NCT01662063|3851965|FG001|Overall Study|Withdrawal by Subject|4
2211558|NCT01662063|3851966|FG002|Overall Study|Withdrawal by Subject|1
2211559|NCT01662063|3851964|FG000|Overall Study|Physician Decision|0
2086234|NCT00731120|3671599|FG001|Overall Study|Lost to Follow-up|15
2086235|NCT00731120|3671600|FG002|Overall Study|Lost to Follow-up|17
2086236|NCT00731120|3671598|FG000|Overall Study|Other|4
2086237|NCT00731120|3671599|FG001|Overall Study|Other|0
2086238|NCT00731120|3671600|FG002|Overall Study|Other|1
2086239|NCT00731133|3671608|FG000|Overall Study|Withdrawal by Subject|10
2086240|NCT00731549|3671633|FG000|Overall Study|Lost to Follow-up|19
2086241|NCT00731549|3671633|FG000|Overall Study|Met withdrawal criteria|24
2086242|NCT00731549|3671633|FG000|Overall Study|Physician Decision|16
2086243|NCT00731549|3671633|FG000|Overall Study|Withdrawal by Subject|89
2086244|NCT00731549|3671633|FG000|Overall Study|Protocol deviation|1
2086245|NCT00731549|3671633|FG000|Overall Study|Adverse Event|31
2086246|NCT00731549|3671633|FG000|Overall Study|Lack of efficacy with AE|37
2211560|NCT01662063|3851965|FG001|Overall Study|Physician Decision|2
2211561|NCT01662063|3851966|FG002|Overall Study|Physician Decision|0
2086247|NCT00731549|3671633|FG000|Overall Study|Lack of efficacy without AE|6
2086248|NCT00731666|3671669|FG000|Overall Study|Adverse Event|2
2086249|NCT00731666|3671669|FG000|Overall Study|Lost to Follow-up|8
2086250|NCT00731666|3671669|FG000|Overall Study|Withdrawal by Subject|2
2086251|NCT00731679|3671675|FG000|Overall Study|Adverse Event|7
2086252|NCT00731679|3671676|FG001|Overall Study|Adverse Event|8
2086253|NCT00731679|3671675|FG000|Overall Study|Withdrawal by Subject|8
2086254|NCT00731679|3671676|FG001|Overall Study|Withdrawal by Subject|8
2086255|NCT00731679|3671675|FG000|Overall Study|Lost to Follow-up|7
2086256|NCT00731679|3671676|FG001|Overall Study|Lost to Follow-up|8
2086257|NCT00731679|3671675|FG000|Overall Study|Noncompliance|0
2086258|NCT00731679|3671676|FG001|Overall Study|Noncompliance|1
2086259|NCT00731679|3671675|FG000|Overall Study|Pregnancy|0
2086260|NCT00731679|3671676|FG001|Overall Study|Pregnancy|1
2086261|NCT00731692|3671685|FG000|Core Study (36 Months)|Lack of Efficacy|11
2086262|NCT00731692|3671686|FG001|Core Study (36 Months)|Lack of Efficacy|23
2086263|NCT00731692|3671687|FG002|Core Study (36 Months)|Lack of Efficacy|64
2086264|NCT00731692|3671685|FG000|Core Study (36 Months)|Physician Decision|1
2086265|NCT00731692|3671686|FG001|Core Study (36 Months)|Physician Decision|0
2086266|NCT00731692|3671687|FG002|Core Study (36 Months)|Physician Decision|2
2086267|NCT00731692|3671685|FG000|Core Study (36 Months)|Death|2
2086268|NCT00731692|3671686|FG001|Core Study (36 Months)|Death|1
2086269|NCT00731692|3671687|FG002|Core Study (36 Months)|Death|2
2086270|NCT00731692|3671685|FG000|Core Study (36 Months)|Lost to Follow-up|1
2086271|NCT00731692|3671686|FG001|Core Study (36 Months)|Lost to Follow-up|3
2086272|NCT00731692|3671687|FG002|Core Study (36 Months)|Lost to Follow-up|3
2086273|NCT00731692|3671685|FG000|Core Study (36 Months)|Administrative|2
2086274|NCT00731692|3671686|FG001|Core Study (36 Months)|Administrative|2
2086275|NCT00731692|3671687|FG002|Core Study (36 Months)|Administrative|6
2086276|NCT00731692|3671685|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4
2086277|NCT00731692|3671686|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3
2086278|NCT00731692|3671687|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5
2086279|NCT00731692|3671685|FG000|Core Study (36 Months)|Protocol Violation|4
2086280|NCT00731692|3671686|FG001|Core Study (36 Months)|Protocol Violation|5
2086281|NCT00731692|3671687|FG002|Core Study (36 Months)|Protocol Violation|8
2086282|NCT00731692|3671685|FG000|Core Study (36 Months)|Abnormal Lab values|6
2086283|NCT00731692|3671686|FG001|Core Study (36 Months)|Abnormal Lab values|19
2086284|NCT00731692|3671687|FG002|Core Study (36 Months)|Abnormal Lab values|5
2086285|NCT00731692|3671685|FG000|Core Study (36 Months)|Adverse Event|25
2086286|NCT00731692|3671686|FG001|Core Study (36 Months)|Adverse Event|28
2086287|NCT00731692|3671687|FG002|Core Study (36 Months)|Adverse Event|29
2086288|NCT00731692|3671685|FG000|Core Study (36 Months)|Withdrawal by Subject|12
2086289|NCT00731692|3671686|FG001|Core Study (36 Months)|Withdrawal by Subject|32
2086290|NCT00731692|3671687|FG002|Core Study (36 Months)|Withdrawal by Subject|46
2086291|NCT00731692|3671685|FG000|Extension Phase|Admin Problems: Terminated # patients|69
2086292|NCT00731692|3671686|FG001|Extension Phase|Admin Problems: Terminated # patients|189
2086293|NCT00731692|3671687|FG002|Extension Phase|Admin Problems: Terminated # patients|277
2086294|NCT00731692|3671685|FG000|Extension Phase|Abnormal test procedure|0
2086295|NCT00731692|3671686|FG001|Extension Phase|Abnormal test procedure|0
2086296|NCT00731692|3671687|FG002|Extension Phase|Abnormal test procedure|1
2086297|NCT00731692|3671685|FG000|Extension Phase|Abnormal lab values|0
2086298|NCT00731692|3671686|FG001|Extension Phase|Abnormal lab values|0
2086299|NCT00731692|3671687|FG002|Extension Phase|Abnormal lab values|1
2086300|NCT00731692|3671685|FG000|Extension Phase|Lost to Follow-up|0
2086301|NCT00731692|3671686|FG001|Extension Phase|Lost to Follow-up|1
2086302|NCT00731692|3671687|FG002|Extension Phase|Lost to Follow-up|4
2086303|NCT00731692|3671685|FG000|Extension Phase|Withdrawal by Subject|4
2086304|NCT00731692|3671686|FG001|Extension Phase|Withdrawal by Subject|5
2086305|NCT00731692|3671687|FG002|Extension Phase|Withdrawal by Subject|3
2086306|NCT00731692|3671685|FG000|Extension Phase|Adverse Event|1
2086307|NCT00731692|3671686|FG001|Extension Phase|Adverse Event|1
2086308|NCT00731692|3671687|FG002|Extension Phase|Adverse Event|15
2086309|NCT00731783|3671705|FG000|One Month Follow-Up Visit|Lost to Follow-up|14
2086310|NCT00731783|3671706|FG001|One Month Follow-Up Visit|Lost to Follow-up|22
2086311|NCT00731783|3671705|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7
2086312|NCT00731783|3671706|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16
2086313|NCT00731783|3671705|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6
2086314|NCT00731783|3671706|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3
2086315|NCT00731783|3671705|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6
2086316|NCT00731783|3671706|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7
2086317|NCT00731822|3671714|FG000|Overall Study|Adverse Event|2
2086318|NCT00731822|3671715|FG001|Overall Study|Adverse Event|1
2086319|NCT00731822|3671714|FG000|Overall Study|Protocol Violation|1
2086320|NCT00731822|3671715|FG001|Overall Study|Protocol Violation|0
2086321|NCT00731822|3671714|FG000|Overall Study|Lost to Follow-up|1
2086322|NCT00731822|3671715|FG001|Overall Study|Lost to Follow-up|0
2086323|NCT00731939|3671730|FG000|Overall Study|Adverse Event|6
2086324|NCT00731939|3671730|FG000|Overall Study|Lost to Follow-up|15
2086325|NCT00731939|3671730|FG000|Overall Study|Not implanted with study device|9
2086326|NCT00731939|3671730|FG000|Overall Study|Withdrawal by Subject|2
2086327|NCT00731939|3671730|FG000|Overall Study|Did not meet enrollment criteria|2
2086328|NCT00732069|3671738|FG000|Washout After First Study Drug|Adverse Event|1
2086329|NCT00732069|3671739|FG001|Washout After First Study Drug|Adverse Event|0
2086330|NCT00732069|3671740|FG002|Washout After First Study Drug|Adverse Event|0
2086331|NCT00732069|3671741|FG003|Washout After First Study Drug|Adverse Event|0
2086332|NCT00732069|3671742|FG004|Washout After First Study Drug|Adverse Event|0
2086333|NCT00732069|3671743|FG005|Washout After First Study Drug|Adverse Event|0
2086334|NCT00732160|3671755|FG000|Overall Study|Adverse Event|1
2086335|NCT00732160|3671756|FG001|Overall Study|Adverse Event|0
2086336|NCT00732160|3671757|FG002|Overall Study|Adverse Event|1
2086337|NCT00732160|3671758|FG003|Overall Study|Adverse Event|1
2086338|NCT00732160|3671755|FG000|Overall Study|scheduling|4
2086339|NCT00732160|3671756|FG001|Overall Study|scheduling|4
2086340|NCT00732160|3671757|FG002|Overall Study|scheduling|2
2086341|NCT00732160|3671758|FG003|Overall Study|scheduling|1
2086342|NCT00732199|3671770|FG000|Overall Study|Withdrawal by Subject|25
2086343|NCT00732199|3671771|FG001|Overall Study|Withdrawal by Subject|18
2086344|NCT00732199|3671770|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9
2086345|NCT00732199|3671771|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8
2086346|NCT00732238|3671838|FG000|Overall Study|Bacteremia|4
2086347|NCT00732238|3671839|FG001|Overall Study|Bacteremia|1
2086348|NCT00732238|3671838|FG000|Overall Study|Asymptomatic bacteriuria|1
2086349|NCT00732238|3671839|FG001|Overall Study|Asymptomatic bacteriuria|0
2086350|NCT00732251|3671847|FG000|Overall Study|Lost to Follow-up|3
2086351|NCT00732251|3671847|FG000|Overall Study|Withdrawal by Subject|3
2086352|NCT00732251|3671847|FG000|Overall Study|Early Term due to Site Closure|1
2086353|NCT00732303|3671851|FG000|Overall Study|Study Terminated|2
2086354|NCT00732472|3671859|FG000|Overall Study|Adverse Event|0
2086355|NCT00732472|3671860|FG001|Overall Study|Adverse Event|1
2086356|NCT00732472|3671861|FG002|Overall Study|Adverse Event|1
2086357|NCT00732472|3671862|FG003|Overall Study|Adverse Event|1
2086358|NCT00732472|3671859|FG000|Overall Study|Protocol Violation|0
2086359|NCT00732472|3671860|FG001|Overall Study|Protocol Violation|0
2086360|NCT00732472|3671861|FG002|Overall Study|Protocol Violation|0
2086361|NCT00732472|3671862|FG003|Overall Study|Protocol Violation|1
2086362|NCT00732472|3671859|FG000|Overall Study|Withdrawal by Subject|0
2086363|NCT00732472|3671860|FG001|Overall Study|Withdrawal by Subject|2
2086364|NCT00732472|3671861|FG002|Overall Study|Withdrawal by Subject|0
2086365|NCT00732472|3671862|FG003|Overall Study|Withdrawal by Subject|1
2086366|NCT00732498|3671873|FG000|Overall Study|Ineligible|1
2086367|NCT00732498|3671873|FG000|Overall Study|Adverse Event|2
2086368|NCT00732498|3671873|FG000|Overall Study|Physician Decision|3
2086369|NCT00732615|3671879|FG000|Overall Study|Withdrawal by Subject|3
2086370|NCT00732615|3671880|FG001|Overall Study|Withdrawal by Subject|1
2086371|NCT00732615|3671879|FG000|Overall Study|Lost to Follow-up|0
2086372|NCT00732615|3671880|FG001|Overall Study|Lost to Follow-up|1
2086373|NCT00732615|3671879|FG000|Overall Study|Adverse Event|0
2086374|NCT00732615|3671880|FG001|Overall Study|Adverse Event|2
2086375|NCT00732615|3671879|FG000|Overall Study|Physician Decision|3
2086376|NCT00732615|3671880|FG001|Overall Study|Physician Decision|0
2086377|NCT00732615|3671879|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1
2086378|NCT00732615|3671880|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1
2086379|NCT00732641|3671889|FG000|Overall Study|Relapse or Progressive Disease|65
2086380|NCT00732641|3671890|FG001|Overall Study|Relapse or Progressive Disease|101
2086381|NCT00732641|3671889|FG000|Overall Study|Serious Adverse Events|12
2086382|NCT00732641|3671890|FG001|Overall Study|Serious Adverse Events|3
2086383|NCT00732641|3671889|FG000|Overall Study|Physician Decision|6
2086384|NCT00732641|3671890|FG001|Overall Study|Physician Decision|0
2086385|NCT00732641|3671889|FG000|Overall Study|Withdrawal by Subject|4
2086386|NCT00732641|3671890|FG001|Overall Study|Withdrawal by Subject|2
2086387|NCT00732641|3671889|FG000|Overall Study|Unable to Complete|1
2086388|NCT00732641|3671890|FG001|Overall Study|Unable to Complete|1
2086389|NCT00732641|3671889|FG000|Overall Study|Other|18
2086390|NCT00732641|3671890|FG001|Overall Study|Other|5
2086391|NCT00732758|3671911|FG000|Overall Study|Lost to Follow-up|8
2086392|NCT00732758|3671912|FG001|Overall Study|Lost to Follow-up|16
2086393|NCT00732875|3671918|FG000|Overall Study|Adverse Event|16
2086394|NCT00732875|3671918|FG000|Overall Study|Withdrawal by Subject|6
2086395|NCT00732875|3671918|FG000|Overall Study|Lack of Efficacy|13
2086396|NCT00732940|3671933|FG000|Overall Study|Withdrawal by Subject|1
2086397|NCT00732940|3671934|FG001|Overall Study|Withdrawal by Subject|2
2086398|NCT00732940|3671933|FG000|Overall Study|Adverse Event|0
2086399|NCT00732940|3671934|FG001|Overall Study|Adverse Event|1
2086400|NCT00732940|3671933|FG000|Overall Study|Lost to Follow-up|1
2086401|NCT00732940|3671934|FG001|Overall Study|Lost to Follow-up|0
2086402|NCT00732992|3671942|FG000|Overall Study|Adverse Event|1
2086403|NCT00732992|3671943|FG001|Overall Study|Adverse Event|1
2086404|NCT00732992|3671942|FG000|Overall Study|Objective Progression or Relapse|3
2086405|NCT00732992|3671943|FG001|Overall Study|Objective Progression or Relapse|5
2086406|NCT00732992|3671942|FG000|Overall Study|Global Deterioration of Health Status|1
2086407|NCT00732992|3671943|FG001|Overall Study|Global Deterioration of Health Status|0
2086408|NCT00732992|3671942|FG000|Overall Study|Withdrawal by Subject|1
2086409|NCT00732992|3671943|FG001|Overall Study|Withdrawal by Subject|0
2086410|NCT00733226|3671971|FG000|Overall Study|Withdrawal by Subject|1
2086411|NCT00733226|3671972|FG001|Overall Study|Withdrawal by Subject|0
2086412|NCT00733226|3671971|FG000|Overall Study|Lost to Follow-up|2
2086413|NCT00733226|3671972|FG001|Overall Study|Lost to Follow-up|0
2086414|NCT00733226|3671971|FG000|Overall Study|moved to another place|2
2086415|NCT00733226|3671972|FG001|Overall Study|moved to another place|0
2086416|NCT00733291|3671985|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
2086417|NCT00733291|3671986|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
2086418|NCT00733291|3671987|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
2086419|NCT00733291|3671988|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
2086420|NCT00733304|3672002|FG000|Overall Study|Adverse Event|3
2086421|NCT00733304|3672003|FG001|Overall Study|Adverse Event|0
2086422|NCT00733304|3672004|FG002|Overall Study|Adverse Event|0
2086423|NCT00733304|3672002|FG000|Overall Study|Lack of Efficacy|0
2086424|NCT00733304|3672003|FG001|Overall Study|Lack of Efficacy|0
2086425|NCT00733304|3672004|FG002|Overall Study|Lack of Efficacy|2
2086426|NCT00733304|3672002|FG000|Overall Study|Lost to Follow-up|0
2086427|NCT00733304|3672003|FG001|Overall Study|Lost to Follow-up|1
2086428|NCT00733304|3672004|FG002|Overall Study|Lost to Follow-up|0
2086429|NCT00733304|3672002|FG000|Overall Study|Physician Decision|3
2086430|NCT00733304|3672003|FG001|Overall Study|Physician Decision|1
2086431|NCT00733304|3672004|FG002|Overall Study|Physician Decision|3
2086432|NCT00733304|3672002|FG000|Overall Study|Withdrawal by Subject|1
2086433|NCT00733304|3672003|FG001|Overall Study|Withdrawal by Subject|1
2086434|NCT00733304|3672004|FG002|Overall Study|Withdrawal by Subject|0
2107195|NCT00871403|3700671|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
2107196|NCT00871403|3700672|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
2107197|NCT00871403|3700670|FG000|Combination Treatment Phase|Adverse Event|0
2107198|NCT00871403|3700671|FG001|Combination Treatment Phase|Adverse Event|17
2107199|NCT00871403|3700672|FG002|Combination Treatment Phase|Adverse Event|2
2107200|NCT00871403|3700670|FG000|Combination Treatment Phase|Disease Progression|0
2107201|NCT00871403|3700671|FG001|Combination Treatment Phase|Disease Progression|8
2107202|NCT00871403|3700672|FG002|Combination Treatment Phase|Disease Progression|5
2107203|NCT00871403|3700670|FG000|Combination Treatment Phase|Withdrawal by Subject|0
2107204|NCT00871403|3700671|FG001|Combination Treatment Phase|Withdrawal by Subject|3
2107205|NCT00871403|3700672|FG002|Combination Treatment Phase|Withdrawal by Subject|1
2107206|NCT00871403|3700670|FG000|Combination Treatment Phase|Physician Decision|0
2107207|NCT00871403|3700671|FG001|Combination Treatment Phase|Physician Decision|1
2107208|NCT00871403|3700672|FG002|Combination Treatment Phase|Physician Decision|3
2107209|NCT00871403|3700670|FG000|Monotherapy Treatment Phase|Disease Progression|0
2107210|NCT00871403|3700671|FG001|Monotherapy Treatment Phase|Disease Progression|9
2107211|NCT00871403|3700672|FG002|Monotherapy Treatment Phase|Disease Progression|1
2107212|NCT00871403|3700670|FG000|Monotherapy Treatment Phase|Adverse Event|0
2107213|NCT00871403|3700671|FG001|Monotherapy Treatment Phase|Adverse Event|4
2107214|NCT00871403|3700672|FG002|Monotherapy Treatment Phase|Adverse Event|0
2107215|NCT00871429|3700679|FG000|Overall Study|Lost to Follow-up|6
2107216|NCT00871429|3700679|FG000|Overall Study|Withdrawal by Subject|17
2107217|NCT00871429|3700679|FG000|Overall Study|Questionnaire not completed|1
2107218|NCT00871494|3700687|FG000|Overall Study|Protocol Violation|5
2107219|NCT00871494|3700687|FG000|Overall Study|Lack of Efficacy|4
2107220|NCT00871494|3700687|FG000|Overall Study|Adverse Event|4
2107221|NCT00871494|3700687|FG000|Overall Study|Lost to Follow-up|1
2107222|NCT00871572|3700695|FG000|Overall Study|Adverse Event|0
2107223|NCT00871572|3700696|FG001|Overall Study|Adverse Event|2
2107224|NCT00871572|3700697|FG002|Overall Study|Adverse Event|0
2107225|NCT00871572|3700698|FG003|Overall Study|Adverse Event|3
2107226|NCT00871572|3700695|FG000|Overall Study|Investigator Decision|0
2107227|NCT00871572|3700696|FG001|Overall Study|Investigator Decision|1
2107228|NCT00871572|3700697|FG002|Overall Study|Investigator Decision|0
2107229|NCT00871572|3700698|FG003|Overall Study|Investigator Decision|1
2107230|NCT00871572|3700695|FG000|Overall Study|Lost to Follow-up|0
2107231|NCT00871572|3700696|FG001|Overall Study|Lost to Follow-up|1
2107232|NCT00871572|3700697|FG002|Overall Study|Lost to Follow-up|0
2107233|NCT00871572|3700698|FG003|Overall Study|Lost to Follow-up|1
2107234|NCT00871572|3700695|FG000|Overall Study|Protocol Violation|0
2107235|NCT00871572|3700696|FG001|Overall Study|Protocol Violation|0
2107236|NCT00871572|3700697|FG002|Overall Study|Protocol Violation|1
2107237|NCT00871572|3700698|FG003|Overall Study|Protocol Violation|1
2107238|NCT00871572|3700695|FG000|Overall Study|Sponsor Decision|1
2107239|NCT00871572|3700696|FG001|Overall Study|Sponsor Decision|0
2107240|NCT00871572|3700697|FG002|Overall Study|Sponsor Decision|0
2107241|NCT00871572|3700698|FG003|Overall Study|Sponsor Decision|0
2107242|NCT00871572|3700695|FG000|Overall Study|Withdrawal by Subject|1
2107243|NCT00871572|3700696|FG001|Overall Study|Withdrawal by Subject|2
2107244|NCT00871572|3700697|FG002|Overall Study|Withdrawal by Subject|3
2107245|NCT00871572|3700698|FG003|Overall Study|Withdrawal by Subject|1
2108198|NCT00878722|3702051|FG002|Overall Study|Adverse Event|0
2108199|NCT00878722|3702052|FG003|Overall Study|Adverse Event|0
2108200|NCT00878722|3702053|FG004|Overall Study|Adverse Event|0
2108201|NCT00878722|3702054|FG005|Overall Study|Adverse Event|0
2108202|NCT00878722|3702055|FG006|Overall Study|Adverse Event|2
2108203|NCT00878722|3702056|FG007|Overall Study|Adverse Event|0
2108204|NCT00878722|3702049|FG000|Overall Study|Withdrawal by Subject|0
2108205|NCT00878722|3702050|FG001|Overall Study|Withdrawal by Subject|0
2086435|NCT00733369|3672039|FG000|Overall Study|Lost to Follow-up|2
2086436|NCT00733369|3672040|FG001|Overall Study|Lost to Follow-up|1
2086437|NCT00733369|3672039|FG000|Overall Study|Adverse Event|4
2086438|NCT00733369|3672040|FG001|Overall Study|Adverse Event|4
2086439|NCT00733369|3672039|FG000|Overall Study|Protocol Violation|4
2086440|NCT00733369|3672040|FG001|Overall Study|Protocol Violation|4
2086441|NCT00733408|3672046|FG000|Overall Study|Adverse Event|4
2086442|NCT00733421|3672052|FG000|Overall Study|Withdrawal by Subject|1
2086443|NCT00733421|3672053|FG001|Overall Study|Withdrawal by Subject|1
2086444|NCT00733499|3672061|FG000|Pre-operative|Protocol Violation|0
2086445|NCT00733499|3672062|FG001|Pre-operative|Protocol Violation|1
2086446|NCT00733499|3672061|FG000|3 Months Follow-up|Death|1
2086447|NCT00733499|3672062|FG001|3 Months Follow-up|Death|2
2086448|NCT00733499|3672061|FG000|6 Months Follow-up|Death|0
2086449|NCT00733499|3672062|FG001|6 Months Follow-up|Death|2
2086450|NCT00733499|3672061|FG000|6 Months Follow-up|Adverse Event|0
2086451|NCT00733499|3672062|FG001|6 Months Follow-up|Adverse Event|1
2086452|NCT00733499|3672061|FG000|12 Months Follow-up|Death|2
2086453|NCT00733499|3672062|FG001|12 Months Follow-up|Death|1
2086454|NCT00733499|3672061|FG000|24 Months Follow-up|Death|0
2086455|NCT00733499|3672062|FG001|24 Months Follow-up|Death|1
2086456|NCT00733499|3672061|FG000|5 Year Followup|Adverse Event|2
2086457|NCT00733499|3672062|FG001|5 Year Followup|Adverse Event|2
2086458|NCT00733499|3672061|FG000|5 Year Followup|Non device related AE|0
2086459|NCT00733499|3672062|FG001|5 Year Followup|Non device related AE|1
2086460|NCT00733499|3672061|FG000|5 Year Followup|Revision of Study Implant|0
2086461|NCT00733499|3672062|FG001|5 Year Followup|Revision of Study Implant|1
2086462|NCT00733499|3672061|FG000|5 Year Followup|Lost to Follow-up|2
2086463|NCT00733499|3672062|FG001|5 Year Followup|Lost to Follow-up|0
2086464|NCT00733499|3672061|FG000|5 Year Followup|Death|13
2086465|NCT00733499|3672062|FG001|5 Year Followup|Death|19
2086466|NCT00733499|3672061|FG000|5 Year Followup|missing, unable to locate|0
2086467|NCT00733499|3672062|FG001|5 Year Followup|missing, unable to locate|1
2086468|NCT00733499|3672061|FG000|5 Year Followup|Withdrawal by Subject|4
2086469|NCT00733499|3672062|FG001|5 Year Followup|Withdrawal by Subject|1
2086470|NCT00733499|3672061|FG000|10 Year Followup|Death|9
2086471|NCT00733499|3672062|FG001|10 Year Followup|Death|7
2086472|NCT00733499|3672061|FG000|10 Year Followup|Adverse Event|3
2086473|NCT00733499|3672062|FG001|10 Year Followup|Adverse Event|3
2086474|NCT00733499|3672061|FG000|10 Year Followup|Lost to Follow-up|3
2086475|NCT00733499|3672062|FG001|10 Year Followup|Lost to Follow-up|2
2086476|NCT00733499|3672061|FG000|10 Year Followup|Withdrawal by Subject|5
2086477|NCT00733499|3672062|FG001|10 Year Followup|Withdrawal by Subject|5
2086478|NCT00733499|3672061|FG000|10 Year Followup|missing, unable to locate|0
2086479|NCT00733499|3672062|FG001|10 Year Followup|missing, unable to locate|2
2086480|NCT00733746|3672072|FG000|Overall Study|Ineligible|5
2086481|NCT00733824|3672081|FG000|Phase I|Withdrawal by Subject|1
2086482|NCT00733824|3672082|FG001|Phase I|Withdrawal by Subject|0
2086483|NCT00733824|3672083|FG002|Phase I|Withdrawal by Subject|0
2086484|NCT00733824|3672084|FG003|Phase I|Withdrawal by Subject|0
2086485|NCT00733824|3672085|FG004|Phase I|Withdrawal by Subject|0
2086486|NCT00733902|3672103|FG000|Overall Study|Death|0
2086487|NCT00733902|3672104|FG001|Overall Study|Death|0
2086488|NCT00733902|3672105|FG002|Overall Study|Death|0
2086489|NCT00733902|3672106|FG003|Overall Study|Death|1
2086490|NCT00733902|3672103|FG000|Overall Study|Adverse Event|3
2086491|NCT00733902|3672104|FG001|Overall Study|Adverse Event|4
2086492|NCT00733902|3672105|FG002|Overall Study|Adverse Event|7
2086493|NCT00733902|3672106|FG003|Overall Study|Adverse Event|11
2086494|NCT00733902|3672103|FG000|Overall Study|Lack of Efficacy|56
2086495|NCT00733902|3672104|FG001|Overall Study|Lack of Efficacy|21
2086496|NCT00733902|3672105|FG002|Overall Study|Lack of Efficacy|34
2086497|NCT00733902|3672106|FG003|Overall Study|Lack of Efficacy|23
2086498|NCT00733902|3672103|FG000|Overall Study|Protocol Violation|4
2086499|NCT00733902|3672104|FG001|Overall Study|Protocol Violation|6
2086500|NCT00733902|3672105|FG002|Overall Study|Protocol Violation|3
2086501|NCT00733902|3672106|FG003|Overall Study|Protocol Violation|3
2086502|NCT00733902|3672103|FG000|Overall Study|Withdrawal by Subject|10
2086503|NCT00733902|3672104|FG001|Overall Study|Withdrawal by Subject|5
2086504|NCT00733902|3672105|FG002|Overall Study|Withdrawal by Subject|4
2086505|NCT00733902|3672106|FG003|Overall Study|Withdrawal by Subject|16
2086506|NCT00733902|3672103|FG000|Overall Study|Entered extension study|89
2086507|NCT00733902|3672104|FG001|Overall Study|Entered extension study|124
2086508|NCT00733902|3672105|FG002|Overall Study|Entered extension study|111
2086509|NCT00733902|3672106|FG003|Overall Study|Entered extension study|109
2086510|NCT00733902|3672103|FG000|Overall Study|Randomized but not treated|2
2086511|NCT00733902|3672104|FG001|Overall Study|Randomized but not treated|2
2086512|NCT00733902|3672105|FG002|Overall Study|Randomized but not treated|2
2086513|NCT00733902|3672106|FG003|Overall Study|Randomized but not treated|1
2086514|NCT00733954|3672118|FG000|Overall Study|Lost to Follow-up|5
2086515|NCT00733954|3672119|FG001|Overall Study|Lost to Follow-up|2
2086516|NCT00733954|3672118|FG000|Overall Study|Protocol Violation|1
2086517|NCT00733954|3672119|FG001|Overall Study|Protocol Violation|0
2086518|NCT00733954|3672118|FG000|Overall Study|Withdrawal by Subject|2
2086519|NCT00733954|3672119|FG001|Overall Study|Withdrawal by Subject|0
2086520|NCT00733980|3672127|FG000|Overall Study|Adverse Event|5
2086521|NCT00733980|3672128|FG001|Overall Study|Adverse Event|2
2086522|NCT00733980|3672127|FG000|Overall Study|Lack of Efficacy|0
2086523|NCT00733980|3672128|FG001|Overall Study|Lack of Efficacy|1
2086524|NCT00733980|3672127|FG000|Overall Study|Protocol Violation|2
2086525|NCT00733980|3672128|FG001|Overall Study|Protocol Violation|1
2086526|NCT00733980|3672127|FG000|Overall Study|Protocol defined stopping criteria reach|1
2086527|NCT00733980|3672128|FG001|Overall Study|Protocol defined stopping criteria reach|1
2086528|NCT00733980|3672127|FG000|Overall Study|Lost to Follow-up|6
2086529|NCT00733980|3672128|FG001|Overall Study|Lost to Follow-up|11
2086530|NCT00733980|3672127|FG000|Overall Study|Physician Decision|2
2086531|NCT00733980|3672128|FG001|Overall Study|Physician Decision|3
2086532|NCT00733980|3672127|FG000|Overall Study|Withdrawal by Subject|6
2086533|NCT00733980|3672128|FG001|Overall Study|Withdrawal by Subject|2
2086534|NCT00734032|3672153|FG000|Overall Study|Adverse Event|0
2086535|NCT00734032|3672154|FG001|Overall Study|Adverse Event|1
2086536|NCT00734032|3672155|FG002|Overall Study|Adverse Event|0
2086537|NCT00734032|3672156|FG003|Overall Study|Adverse Event|0
2086538|NCT00734071|3672168|FG000|Overall Study|Adverse Event|4
2086539|NCT00734071|3672169|FG001|Overall Study|Adverse Event|3
2086540|NCT00734071|3672168|FG000|Overall Study|Lack of Efficacy|3
2086541|NCT00734071|3672169|FG001|Overall Study|Lack of Efficacy|1
2086542|NCT00734071|3672168|FG000|Overall Study|Noncompliance|2
2086543|NCT00734071|3672169|FG001|Overall Study|Noncompliance|2
2086544|NCT00734071|3672168|FG000|Overall Study|Protocol Deviations|3
2086545|NCT00734071|3672169|FG001|Overall Study|Protocol Deviations|4
2086546|NCT00734071|3672168|FG000|Overall Study|Voluntary Withdrawal|9
2086547|NCT00734071|3672169|FG001|Overall Study|Voluntary Withdrawal|7
2086548|NCT00734071|3672168|FG000|Overall Study|Lost to Follow-up|16
2086549|NCT00734071|3672169|FG001|Overall Study|Lost to Follow-up|8
2086550|NCT00734071|3672168|FG000|Overall Study|Other|1
2086551|NCT00734071|3672169|FG001|Overall Study|Other|2
2086552|NCT00734097|3672175|FG000|Screening|Protocol Violation|12
2086553|NCT00734097|3672175|FG000|Screening|Withdrawal by Subject|5
2086554|NCT00734097|3672175|FG000|Screening|Lost to Follow-up|2
2086555|NCT00734097|3672175|FG000|Screening|Unconfirmed pregnancy|1
2086556|NCT00734097|3672175|FG000|Open Label|Lost to Follow-up|7
2086557|NCT00734097|3672175|FG000|Open Label|Withdrawal by Subject|5
2086558|NCT00734097|3672175|FG000|Open Label|Protocol Violation|4
2086559|NCT00734149|3672179|FG000|Overall Study|Withdrawal by Subject|1
2086560|NCT00734162|3672189|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0
2086561|NCT00734162|3672190|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1
2086562|NCT00734162|3672191|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0
2086563|NCT00734162|3672192|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2
2086564|NCT00734162|3672189|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
2086565|NCT00734162|3672190|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
2086566|NCT00734162|3672191|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
2086567|NCT00734162|3672192|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
2086568|NCT00734162|3672189|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
2086569|NCT00734162|3672190|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
2086570|NCT00734162|3672191|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
2086571|NCT00734162|3672192|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
2086572|NCT00734162|3672189|FG000|Open-Label Phase|Withdrew Consent|1
2086573|NCT00734162|3672190|FG001|Open-Label Phase|Withdrew Consent|0
2086574|NCT00734162|3672191|FG002|Open-Label Phase|Withdrew Consent|1
2086575|NCT00734162|3672192|FG003|Open-Label Phase|Withdrew Consent|1
2086576|NCT00734162|3672189|FG000|Open-Label Phase|Lost to Follow-up|1
2086577|NCT00734162|3672190|FG001|Open-Label Phase|Lost to Follow-up|2
2086578|NCT00734162|3672191|FG002|Open-Label Phase|Lost to Follow-up|0
2086579|NCT00734162|3672192|FG003|Open-Label Phase|Lost to Follow-up|1
2086580|NCT00734162|3672189|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0
2086581|NCT00734162|3672190|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
2086582|NCT00734162|3672191|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
2086583|NCT00734162|3672192|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1
2086584|NCT00734214|3672208|FG000|Overall Study|Withdrawal by Subject|3
2086585|NCT00734214|3672209|FG001|Overall Study|Withdrawal by Subject|4
2086586|NCT00734214|3672208|FG000|Overall Study|MD withdrawal|1
2086587|NCT00734214|3672209|FG001|Overall Study|MD withdrawal|0
2086588|NCT00734474|3672270|FG000|Overall Study|Entry Criteria Not Met|0
2086589|NCT00734474|3672271|FG001|Overall Study|Entry Criteria Not Met|0
2086590|NCT00734474|3672272|FG002|Overall Study|Entry Criteria Not Met|5
2086591|NCT00734474|3672273|FG003|Overall Study|Entry Criteria Not Met|0
2086592|NCT00734474|3672274|FG004|Overall Study|Entry Criteria Not Met|3
2086593|NCT00734474|3672275|FG005|Overall Study|Entry Criteria Not Met|1
2086594|NCT00734474|3672276|FG006|Overall Study|Entry Criteria Not Met|0
2086595|NCT00734474|3672277|FG007|Overall Study|Entry Criteria Not Met|1
2086596|NCT00734474|3672278|FG008|Overall Study|Entry Criteria Not Met|1
2086597|NCT00734474|3672270|FG000|Overall Study|Lost to Follow-up|1
2086598|NCT00734474|3672271|FG001|Overall Study|Lost to Follow-up|0
2086599|NCT00734474|3672272|FG002|Overall Study|Lost to Follow-up|13
2086600|NCT00734474|3672273|FG003|Overall Study|Lost to Follow-up|0
2086601|NCT00734474|3672274|FG004|Overall Study|Lost to Follow-up|11
2086602|NCT00734474|3672275|FG005|Overall Study|Lost to Follow-up|1
2086603|NCT00734474|3672276|FG006|Overall Study|Lost to Follow-up|0
2306052|NCT02680756|4007712|FG000|Overall Study|Hb ≤7.5 g/dL|0
2306053|NCT02680756|4007713|FG001|Overall Study|Hb ≤7.5 g/dL|2
2306054|NCT02680756|4007712|FG000|Overall Study|Blood transfusion for any reason|0
2306055|NCT02680756|4007713|FG001|Overall Study|Blood transfusion for any reason|1
2306056|NCT02680756|4007712|FG000|Overall Study|Death|1
2306057|NCT02680756|4007713|FG001|Overall Study|Death|0
2306058|NCT02680756|4007712|FG000|Overall Study|Protocol Violation|1
2306059|NCT02680756|4007713|FG001|Overall Study|Protocol Violation|0
2306060|NCT02680756|4007712|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1
2306061|NCT02680756|4007713|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0
2306062|NCT02680756|4007712|FG000|Overall Study|None of above or not recorded|3
2306063|NCT02680756|4007713|FG001|Overall Study|None of above or not recorded|2
2306064|NCT02680834|4007721|FG000|Overall Study|Physician Decision|5
2306065|NCT02680834|4007722|FG001|Overall Study|Physician Decision|2
2306066|NCT02680834|4007721|FG000|Overall Study|Withdrawal by Subject|6
2306067|NCT02680834|4007722|FG001|Overall Study|Withdrawal by Subject|0
2306068|NCT02680834|4007721|FG000|Overall Study|Lost to Follow-up|0
2306069|NCT02680834|4007722|FG001|Overall Study|Lost to Follow-up|1
2306070|NCT02680847|4007731|FG000|Overall Study|Other|2
2306071|NCT02680847|4007732|FG001|Overall Study|Other|0
2086604|NCT00734474|3672277|FG007|Overall Study|Lost to Follow-up|9
2086605|NCT00734474|3672278|FG008|Overall Study|Lost to Follow-up|4
2086606|NCT00734474|3672270|FG000|Overall Study|Withdrawal by Subject|2
2086607|NCT00734474|3672271|FG001|Overall Study|Withdrawal by Subject|1
2086608|NCT00734474|3672272|FG002|Overall Study|Withdrawal by Subject|18
2086609|NCT00734474|3672273|FG003|Overall Study|Withdrawal by Subject|0
2086610|NCT00734474|3672274|FG004|Overall Study|Withdrawal by Subject|24
2086611|NCT00734474|3672275|FG005|Overall Study|Withdrawal by Subject|2
2086612|NCT00734474|3672276|FG006|Overall Study|Withdrawal by Subject|0
2086613|NCT00734474|3672277|FG007|Overall Study|Withdrawal by Subject|36
2086614|NCT00734474|3672278|FG008|Overall Study|Withdrawal by Subject|21
2086615|NCT00734474|3672270|FG000|Overall Study|Physician Decision|0
2086616|NCT00734474|3672271|FG001|Overall Study|Physician Decision|0
2086617|NCT00734474|3672272|FG002|Overall Study|Physician Decision|4
2086618|NCT00734474|3672273|FG003|Overall Study|Physician Decision|1
2086619|NCT00734474|3672274|FG004|Overall Study|Physician Decision|11
2086620|NCT00734474|3672275|FG005|Overall Study|Physician Decision|0
2086621|NCT00734474|3672276|FG006|Overall Study|Physician Decision|0
2086622|NCT00734474|3672277|FG007|Overall Study|Physician Decision|9
2086623|NCT00734474|3672278|FG008|Overall Study|Physician Decision|9
2086624|NCT00734474|3672270|FG000|Overall Study|Adverse Event|4
2086625|NCT00734474|3672271|FG001|Overall Study|Adverse Event|4
2086626|NCT00734474|3672272|FG002|Overall Study|Adverse Event|63
2086627|NCT00734474|3672273|FG003|Overall Study|Adverse Event|1
2086628|NCT00734474|3672274|FG004|Overall Study|Adverse Event|64
2086629|NCT00734474|3672275|FG005|Overall Study|Adverse Event|0
2086630|NCT00734474|3672276|FG006|Overall Study|Adverse Event|1
2086631|NCT00734474|3672277|FG007|Overall Study|Adverse Event|65
2086632|NCT00734474|3672278|FG008|Overall Study|Adverse Event|39
2086633|NCT00734474|3672270|FG000|Overall Study|Protocol Violation|0
2086634|NCT00734474|3672271|FG001|Overall Study|Protocol Violation|0
2086635|NCT00734474|3672272|FG002|Overall Study|Protocol Violation|4
2086636|NCT00734474|3672273|FG003|Overall Study|Protocol Violation|0
2086637|NCT00734474|3672274|FG004|Overall Study|Protocol Violation|3
2086638|NCT00734474|3672275|FG005|Overall Study|Protocol Violation|0
2086639|NCT00734474|3672276|FG006|Overall Study|Protocol Violation|0
2086640|NCT00734474|3672277|FG007|Overall Study|Protocol Violation|3
2086641|NCT00734474|3672278|FG008|Overall Study|Protocol Violation|1
2086642|NCT00734474|3672270|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8
2086643|NCT00734474|3672271|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25
2086644|NCT00734474|3672272|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0
2086645|NCT00734474|3672273|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8
2086646|NCT00734474|3672274|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0
2086647|NCT00734474|3672275|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21
2086648|NCT00734474|3672276|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23
2086649|NCT00734474|3672277|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0
2086650|NCT00734474|3672278|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0
2086651|NCT00734474|3672270|FG000|Overall Study|Sponsor Decision|0
2086652|NCT00734474|3672271|FG001|Overall Study|Sponsor Decision|0
2086653|NCT00734474|3672272|FG002|Overall Study|Sponsor Decision|0
2086654|NCT00734474|3672273|FG003|Overall Study|Sponsor Decision|0
2086655|NCT00734474|3672274|FG004|Overall Study|Sponsor Decision|2
2086656|NCT00734474|3672275|FG005|Overall Study|Sponsor Decision|0
2086657|NCT00734474|3672276|FG006|Overall Study|Sponsor Decision|0
2086658|NCT00734474|3672277|FG007|Overall Study|Sponsor Decision|0
2086659|NCT00734474|3672278|FG008|Overall Study|Sponsor Decision|0
2086660|NCT00734474|3672270|FG000|Overall Study|Death|0
2086661|NCT00734474|3672271|FG001|Overall Study|Death|0
2086662|NCT00734474|3672272|FG002|Overall Study|Death|1
2086663|NCT00734474|3672273|FG003|Overall Study|Death|0
2086664|NCT00734474|3672274|FG004|Overall Study|Death|0
2086665|NCT00734474|3672275|FG005|Overall Study|Death|0
2306072|NCT02680847|4007733|FG002|Overall Study|Other|0
2306073|NCT02680847|4007731|FG000|Overall Study|No longer met eligibility criteria|2
2086666|NCT00734474|3672276|FG006|Overall Study|Death|0
2086667|NCT00734474|3672277|FG007|Overall Study|Death|2
2086668|NCT00734474|3672278|FG008|Overall Study|Death|1
2086669|NCT00734474|3672270|FG000|Overall Study|Lack of Efficacy|0
2086670|NCT00734474|3672271|FG001|Overall Study|Lack of Efficacy|0
2086671|NCT00734474|3672272|FG002|Overall Study|Lack of Efficacy|4
2086672|NCT00734474|3672273|FG003|Overall Study|Lack of Efficacy|0
2086673|NCT00734474|3672274|FG004|Overall Study|Lack of Efficacy|0
2086674|NCT00734474|3672275|FG005|Overall Study|Lack of Efficacy|0
2086675|NCT00734474|3672276|FG006|Overall Study|Lack of Efficacy|0
2086676|NCT00734474|3672277|FG007|Overall Study|Lack of Efficacy|4
2086677|NCT00734474|3672278|FG008|Overall Study|Lack of Efficacy|6
2086678|NCT00734539|3672310|FG000|Main Study|Death|33
2086679|NCT00734539|3672311|FG001|Main Study|Death|32
2086680|NCT00734539|3672310|FG000|Main Study|Physician Decision|2
2086681|NCT00734539|3672311|FG001|Main Study|Physician Decision|0
2086682|NCT00734539|3672310|FG000|Main Study|Withdrawal by Subject|1
2086683|NCT00734539|3672311|FG001|Main Study|Withdrawal by Subject|3
2086684|NCT00734539|3672310|FG000|Main Study|Enrolled in error; ineligible|1
2086685|NCT00734539|3672311|FG001|Main Study|Enrolled in error; ineligible|0
2086686|NCT00734578|3672323|FG000|Overall Study|Adverse Event|4
2086687|NCT00734578|3672324|FG001|Overall Study|Adverse Event|6
2086688|NCT00734578|3672325|FG002|Overall Study|Adverse Event|1
2086689|NCT00734578|3672323|FG000|Overall Study|Protocol Violation|8
2086690|NCT00734578|3672324|FG001|Overall Study|Protocol Violation|6
2086691|NCT00734578|3672325|FG002|Overall Study|Protocol Violation|3
2086692|NCT00734578|3672323|FG000|Overall Study|Withdrawal by Subject|7
2086693|NCT00734578|3672324|FG001|Overall Study|Withdrawal by Subject|8
2086694|NCT00734578|3672325|FG002|Overall Study|Withdrawal by Subject|11
2086695|NCT00734578|3672323|FG000|Overall Study|Lost to Follow-up|9
2086696|NCT00734578|3672324|FG001|Overall Study|Lost to Follow-up|3
2086697|NCT00734578|3672325|FG002|Overall Study|Lost to Follow-up|5
2086698|NCT00734578|3672323|FG000|Overall Study|Lack of Efficacy|3
2086699|NCT00734578|3672324|FG001|Overall Study|Lack of Efficacy|2
2086700|NCT00734578|3672325|FG002|Overall Study|Lack of Efficacy|5
2086701|NCT00734578|3672323|FG000|Overall Study|Randomized in error|1
2086702|NCT00734578|3672324|FG001|Overall Study|Randomized in error|0
2086703|NCT00734578|3672325|FG002|Overall Study|Randomized in error|0
2086704|NCT00734578|3672323|FG000|Overall Study|Exclusion criteria|1
2086705|NCT00734578|3672324|FG001|Overall Study|Exclusion criteria|0
2086706|NCT00734578|3672325|FG002|Overall Study|Exclusion criteria|0
2086707|NCT00734591|3672335|FG000|Screening for Prospective Period|Site did not participate|1604
2086708|NCT00734591|3672336|FG001|Screening for Prospective Period|Site did not participate|1488
2086709|NCT00734591|3672335|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913
2086710|NCT00734591|3672336|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803
2086711|NCT00734591|3672335|FG000|Prospective Period|Withdrawal by Subject|11
2086712|NCT00734591|3672336|FG001|Prospective Period|Withdrawal by Subject|9
2086713|NCT00734591|3672335|FG000|Prospective Period|Lost to Follow-up|37
2086714|NCT00734591|3672336|FG001|Prospective Period|Lost to Follow-up|33
2086715|NCT00734591|3672335|FG000|Prospective Period|Study Terminated|1
2086716|NCT00734591|3672336|FG001|Prospective Period|Study Terminated|0
2086717|NCT00734591|3672335|FG000|Prospective Period|Other|2
2086718|NCT00734591|3672336|FG001|Prospective Period|Other|2
2086719|NCT00734604|3672348|FG000|Overall Study|Adverse Event|0
2086720|NCT00734604|3672349|FG001|Overall Study|Adverse Event|2
2086721|NCT00734604|3672350|FG002|Overall Study|Adverse Event|0
2086722|NCT00734604|3672351|FG003|Overall Study|Adverse Event|2
2086723|NCT00734604|3672352|FG004|Overall Study|Adverse Event|1
2086724|NCT00734604|3672353|FG005|Overall Study|Adverse Event|1
2086725|NCT00734604|3672348|FG000|Overall Study|Serious Adverse Event|1
2086726|NCT00734604|3672349|FG001|Overall Study|Serious Adverse Event|0
2086727|NCT00734604|3672350|FG002|Overall Study|Serious Adverse Event|1
2086728|NCT00734604|3672351|FG003|Overall Study|Serious Adverse Event|2
2086729|NCT00734604|3672352|FG004|Overall Study|Serious Adverse Event|0
2086730|NCT00734604|3672353|FG005|Overall Study|Serious Adverse Event|1
2086731|NCT00734604|3672348|FG000|Overall Study|Lost to Follow-up|1
2086732|NCT00734604|3672349|FG001|Overall Study|Lost to Follow-up|2
2086733|NCT00734604|3672350|FG002|Overall Study|Lost to Follow-up|2
2086734|NCT00734604|3672351|FG003|Overall Study|Lost to Follow-up|4
2086735|NCT00734604|3672352|FG004|Overall Study|Lost to Follow-up|2
2086736|NCT00734604|3672353|FG005|Overall Study|Lost to Follow-up|3
2086737|NCT00734604|3672348|FG000|Overall Study|Physician Decision|0
2086738|NCT00734604|3672349|FG001|Overall Study|Physician Decision|1
2086739|NCT00734604|3672350|FG002|Overall Study|Physician Decision|1
2086740|NCT00734604|3672351|FG003|Overall Study|Physician Decision|0
2086741|NCT00734604|3672352|FG004|Overall Study|Physician Decision|0
2086742|NCT00734604|3672353|FG005|Overall Study|Physician Decision|0
2086743|NCT00734604|3672348|FG000|Overall Study|Protocol Violation|0
2086744|NCT00734604|3672349|FG001|Overall Study|Protocol Violation|2
2086745|NCT00734604|3672350|FG002|Overall Study|Protocol Violation|0
2086746|NCT00734604|3672351|FG003|Overall Study|Protocol Violation|0
2086747|NCT00734604|3672352|FG004|Overall Study|Protocol Violation|1
2086748|NCT00734604|3672353|FG005|Overall Study|Protocol Violation|0
2086749|NCT00734604|3672348|FG000|Overall Study|Sponsor Decision|1
2086750|NCT00734604|3672349|FG001|Overall Study|Sponsor Decision|2
2086751|NCT00734604|3672350|FG002|Overall Study|Sponsor Decision|1
2086752|NCT00734604|3672351|FG003|Overall Study|Sponsor Decision|0
2086753|NCT00734604|3672352|FG004|Overall Study|Sponsor Decision|2
2086754|NCT00734604|3672353|FG005|Overall Study|Sponsor Decision|0
2086755|NCT00734604|3672348|FG000|Overall Study|Withdrawal by Subject|0
2086756|NCT00734604|3672349|FG001|Overall Study|Withdrawal by Subject|2
2086757|NCT00734604|3672350|FG002|Overall Study|Withdrawal by Subject|0
2086758|NCT00734604|3672351|FG003|Overall Study|Withdrawal by Subject|1
2086759|NCT00734604|3672352|FG004|Overall Study|Withdrawal by Subject|2
2086760|NCT00734604|3672353|FG005|Overall Study|Withdrawal by Subject|1
2086761|NCT00734604|3672348|FG000|Overall Study|Lack of Efficacy|0
2086762|NCT00734604|3672349|FG001|Overall Study|Lack of Efficacy|1
2086763|NCT00734604|3672350|FG002|Overall Study|Lack of Efficacy|1
2086764|NCT00734604|3672351|FG003|Overall Study|Lack of Efficacy|0
2086765|NCT00734604|3672352|FG004|Overall Study|Lack of Efficacy|0
2086766|NCT00734604|3672353|FG005|Overall Study|Lack of Efficacy|0
2086767|NCT00734617|3672366|FG000|Overall Study|Adverse Event|4
2086768|NCT00734617|3672367|FG001|Overall Study|Adverse Event|7
2086769|NCT00734617|3672366|FG000|Overall Study|Withdrawal by Subject|103
2086770|NCT00734617|3672367|FG001|Overall Study|Withdrawal by Subject|95
2086771|NCT00734630|3672375|FG000|Overall Study|Lack of Efficacy|4
2086772|NCT00734630|3672376|FG001|Overall Study|Lack of Efficacy|4
2086773|NCT00734630|3672375|FG000|Overall Study|Withdrawal by Subject|7
2086774|NCT00734630|3672376|FG001|Overall Study|Withdrawal by Subject|9
2086775|NCT00734630|3672375|FG000|Overall Study|Lost to Follow-up|13
2086776|NCT00734630|3672376|FG001|Overall Study|Lost to Follow-up|7
2086777|NCT00734630|3672375|FG000|Overall Study|Protocol Violation|0
2086778|NCT00734630|3672376|FG001|Overall Study|Protocol Violation|3
2086779|NCT00734630|3672375|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
2086780|NCT00734630|3672376|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
2086781|NCT00734630|3672375|FG000|Overall Study|Adverse Event|3
2086782|NCT00734630|3672376|FG001|Overall Study|Adverse Event|6
2086783|NCT00734630|3672375|FG000|Overall Study|Randomized in Error|0
2086784|NCT00734630|3672376|FG001|Overall Study|Randomized in Error|1
2086785|NCT00734630|3672375|FG000|Overall Study|Tested Positive for Illegal Drug Use|1
2086786|NCT00734630|3672376|FG001|Overall Study|Tested Positive for Illegal Drug Use|1
2086787|NCT00734630|3672375|FG000|Overall Study|Poor Compliance|1
2086788|NCT00734630|3672376|FG001|Overall Study|Poor Compliance|1
2086789|NCT00734656|3672382|FG000|Lab Session 1|Withdrawal by Subject|2
2086790|NCT00734656|3672383|FG001|Lab Session 1|Withdrawal by Subject|0
2086791|NCT00734656|3672384|FG002|Lab Session 1|Withdrawal by Subject|0
2086792|NCT00734656|3672385|FG003|Lab Session 1|Withdrawal by Subject|0
2086793|NCT00734656|3672382|FG000|Washout 1|Withdrawal by Subject|1
2086794|NCT00734656|3672383|FG001|Washout 1|Withdrawal by Subject|5
2086795|NCT00734656|3672384|FG002|Washout 1|Withdrawal by Subject|2
2086796|NCT00734656|3672385|FG003|Washout 1|Withdrawal by Subject|3
2086797|NCT00734656|3672382|FG000|Lab Session 2|Withdrawal by Subject|1
2086798|NCT00734656|3672383|FG001|Lab Session 2|Withdrawal by Subject|0
2086799|NCT00734656|3672384|FG002|Lab Session 2|Withdrawal by Subject|0
2086800|NCT00734656|3672385|FG003|Lab Session 2|Withdrawal by Subject|1
2086801|NCT00734656|3672382|FG000|Washout 2|Withdrawal by Subject|1
2086802|NCT00734656|3672383|FG001|Washout 2|Withdrawal by Subject|1
2086803|NCT00734656|3672384|FG002|Washout 2|Withdrawal by Subject|1
2086804|NCT00734656|3672385|FG003|Washout 2|Withdrawal by Subject|0
2086805|NCT00734656|3672382|FG000|Washout 3|Withdrawal by Subject|1
2086806|NCT00734656|3672383|FG001|Washout 3|Withdrawal by Subject|0
2086807|NCT00734656|3672384|FG002|Washout 3|Withdrawal by Subject|0
2086808|NCT00734656|3672385|FG003|Washout 3|Withdrawal by Subject|1
2086809|NCT00734656|3672382|FG000|Lab Session 4|Withdrawal by Subject|0
2086810|NCT00734656|3672383|FG001|Lab Session 4|Withdrawal by Subject|0
2086811|NCT00734656|3672384|FG002|Lab Session 4|Withdrawal by Subject|0
2086812|NCT00734656|3672385|FG003|Lab Session 4|Withdrawal by Subject|1
2086813|NCT00734747|3672400|FG000|SRS Procedure|No staples placed|3
2086814|NCT00734747|3672400|FG000|6 Month Follow-up|Did not meet inclusion criteria|3
2086815|NCT00734851|3672413|FG000|Overall Study|Withdrawal by Subject|2
2086816|NCT00734851|3672413|FG000|Overall Study|Lost to Follow-up|1
2086817|NCT00734851|3672413|FG000|Overall Study|Physician Decision|18
2086818|NCT00734929|3672428|FG000|Overall Study|Lost to Follow-up|1
2086819|NCT00734929|3672429|FG001|Overall Study|Lost to Follow-up|2
2086820|NCT00734929|3672428|FG000|Overall Study|No intervention/ screen fail|5
2086821|NCT00734929|3672429|FG001|Overall Study|No intervention/ screen fail|3
2086822|NCT00734994|3672446|FG000|Overall Study|Withdrawal by Subject|1
2086823|NCT00735007|3672451|FG000|Overall Study|Adverse Event|4
2086824|NCT00735007|3672451|FG000|Overall Study|Protocol Violation|1
2086825|NCT00735072|3672457|FG000|Overall Study|interrupted study med during ARV change|1
2086826|NCT00735072|3672458|FG001|Overall Study|interrupted study med during ARV change|0
2086827|NCT00735072|3672457|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0
2086828|NCT00735072|3672458|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1
2086829|NCT00735371|3672475|FG000|Overall Study|Adverse Event|3
2086830|NCT00735371|3672476|FG001|Overall Study|Adverse Event|3
2086831|NCT00735371|3672477|FG002|Overall Study|Adverse Event|4
2086832|NCT00735371|3672478|FG003|Overall Study|Adverse Event|1
2086833|NCT00735371|3672475|FG000|Overall Study|Protocol Violation|2
2086834|NCT00735371|3672476|FG001|Overall Study|Protocol Violation|2
2086835|NCT00735371|3672477|FG002|Overall Study|Protocol Violation|0
2086836|NCT00735371|3672478|FG003|Overall Study|Protocol Violation|3
2086837|NCT00735371|3672475|FG000|Overall Study|Withdrawal by Subject|0
2086838|NCT00735371|3672476|FG001|Overall Study|Withdrawal by Subject|2
2086839|NCT00735371|3672477|FG002|Overall Study|Withdrawal by Subject|2
2086840|NCT00735371|3672478|FG003|Overall Study|Withdrawal by Subject|0
2086841|NCT00735371|3672475|FG000|Overall Study|Lost to Follow-up|1
2086842|NCT00735371|3672476|FG001|Overall Study|Lost to Follow-up|1
2086843|NCT00735371|3672477|FG002|Overall Study|Lost to Follow-up|3
2086844|NCT00735371|3672478|FG003|Overall Study|Lost to Follow-up|1
2086845|NCT00735371|3672475|FG000|Overall Study|Lack of Efficacy|4
2086846|NCT00735371|3672476|FG001|Overall Study|Lack of Efficacy|2
2086847|NCT00735371|3672477|FG002|Overall Study|Lack of Efficacy|0
2086848|NCT00735371|3672478|FG003|Overall Study|Lack of Efficacy|4
2086849|NCT00735371|3672475|FG000|Overall Study|Sponsor Decision|3
2086850|NCT00735371|3672476|FG001|Overall Study|Sponsor Decision|1
2086851|NCT00735371|3672477|FG002|Overall Study|Sponsor Decision|0
2086852|NCT00735371|3672478|FG003|Overall Study|Sponsor Decision|1
2086853|NCT00735371|3672475|FG000|Overall Study|Protocol Violation|0
2086854|NCT00735371|3672476|FG001|Overall Study|Protocol Violation|1
2086855|NCT00735371|3672477|FG002|Overall Study|Protocol Violation|2
2086856|NCT00735371|3672478|FG003|Overall Study|Protocol Violation|0
2086857|NCT00735371|3672475|FG000|Overall Study|Prior Vyvanse Exposure|1
2086858|NCT00735371|3672476|FG001|Overall Study|Prior Vyvanse Exposure|1
2086859|NCT00735371|3672477|FG002|Overall Study|Prior Vyvanse Exposure|0
2086860|NCT00735371|3672478|FG003|Overall Study|Prior Vyvanse Exposure|0
2086861|NCT00735371|3672475|FG000|Overall Study|Exclusion criteria|1
2086862|NCT00735371|3672476|FG001|Overall Study|Exclusion criteria|0
2086863|NCT00735371|3672477|FG002|Overall Study|Exclusion criteria|0
2086864|NCT00735371|3672478|FG003|Overall Study|Exclusion criteria|0
2086865|NCT00735397|3672488|FG000|Overall Study|Adverse Event|194
2086866|NCT00735397|3672488|FG000|Overall Study|Lost to Follow-up|33
2086867|NCT00735397|3672488|FG000|Overall Study|Participant choice|252
2086868|NCT00735397|3672488|FG000|Overall Study|Inadequate therapeutic effect|202
2086869|NCT00735397|3672488|FG000|Overall Study|Administrative/Other|502
2086870|NCT00735475|3672524|FG000|Overall Study|Adverse Event|0
2086871|NCT00735475|3672525|FG001|Overall Study|Adverse Event|1
2086872|NCT00735475|3672524|FG000|Overall Study|Death|1
2086873|NCT00735475|3672525|FG001|Overall Study|Death|1
2086874|NCT00735475|3672524|FG000|Overall Study|Lost to Follow-up|3
2086875|NCT00735475|3672525|FG001|Overall Study|Lost to Follow-up|3
2086876|NCT00735475|3672524|FG000|Overall Study|Physician Decision|0
2086877|NCT00735475|3672525|FG001|Overall Study|Physician Decision|1
2086878|NCT00735475|3672524|FG000|Overall Study|Withdrawal by Subject|4
2086879|NCT00735475|3672525|FG001|Overall Study|Withdrawal by Subject|5
2086880|NCT00735644|3672540|FG000|Overall Study|Did not receive study vaccine|0
2086881|NCT00735644|3672541|FG001|Overall Study|Did not receive study vaccine|1
2086882|NCT00735644|3672542|FG002|Overall Study|Did not receive study vaccine|0
2086883|NCT00735644|3672543|FG003|Overall Study|Did not receive study vaccine|0
2086884|NCT00735644|3672544|FG004|Overall Study|Did not receive study vaccine|0
2211562|NCT01662063|3851964|FG000|Overall Study|Other|0
2211563|NCT01662063|3851965|FG001|Overall Study|Other|1
2211564|NCT01662063|3851966|FG002|Overall Study|Other|0
2211565|NCT01662310|3851996|FG000|Run-In or Stabilization Phase|Adverse Event|11
2211566|NCT01662310|3851997|FG001|Run-In or Stabilization Phase|Adverse Event|0
2211567|NCT01662310|3851998|FG002|Run-In or Stabilization Phase|Adverse Event|0
2211568|NCT01662310|3851999|FG003|Run-In or Stabilization Phase|Adverse Event|0
2211569|NCT01662310|3852000|FG004|Run-In or Stabilization Phase|Adverse Event|0
2211570|NCT01662310|3851996|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9
2211571|NCT01662310|3851997|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0
2086885|NCT00735644|3672540|FG000|Overall Study|Withdrawal by Subject|0
2086886|NCT00735644|3672541|FG001|Overall Study|Withdrawal by Subject|1
2086887|NCT00735644|3672542|FG002|Overall Study|Withdrawal by Subject|1
2086888|NCT00735644|3672543|FG003|Overall Study|Withdrawal by Subject|1
2086889|NCT00735644|3672544|FG004|Overall Study|Withdrawal by Subject|0
2086890|NCT00735696|3672572|FG000|Overall Study|Withdrawal by Subject|1
2086891|NCT00735696|3672572|FG000|Overall Study|Enrolled but never Treated|1
2086892|NCT00735709|3672580|FG000|Overall Study|Adverse Event|2
2086893|NCT00735709|3672581|FG001|Overall Study|Adverse Event|3
2086894|NCT00735709|3672582|FG002|Overall Study|Adverse Event|1
2086895|NCT00735709|3672583|FG003|Overall Study|Adverse Event|5
2086896|NCT00735709|3672580|FG000|Overall Study|Lack of Efficacy|8
2086897|NCT00735709|3672581|FG001|Overall Study|Lack of Efficacy|4
2086898|NCT00735709|3672582|FG002|Overall Study|Lack of Efficacy|2
2086899|NCT00735709|3672583|FG003|Overall Study|Lack of Efficacy|3
2086900|NCT00735709|3672580|FG000|Overall Study|Noncompliance|0
2086901|NCT00735709|3672581|FG001|Overall Study|Noncompliance|0
2086902|NCT00735709|3672582|FG002|Overall Study|Noncompliance|1
2086903|NCT00735709|3672583|FG003|Overall Study|Noncompliance|0
2086904|NCT00735709|3672580|FG000|Overall Study|Protocol deviations|1
2086905|NCT00735709|3672581|FG001|Overall Study|Protocol deviations|2
2086906|NCT00735709|3672582|FG002|Overall Study|Protocol deviations|1
2086907|NCT00735709|3672583|FG003|Overall Study|Protocol deviations|1
2086908|NCT00735709|3672580|FG000|Overall Study|Voluntary Withdrawal|1
2086909|NCT00735709|3672581|FG001|Overall Study|Voluntary Withdrawal|3
2086910|NCT00735709|3672582|FG002|Overall Study|Voluntary Withdrawal|5
2086911|NCT00735709|3672583|FG003|Overall Study|Voluntary Withdrawal|7
2086912|NCT00735709|3672580|FG000|Overall Study|Lost to Follow-up|0
2086913|NCT00735709|3672581|FG001|Overall Study|Lost to Follow-up|1
2086914|NCT00735709|3672582|FG002|Overall Study|Lost to Follow-up|1
2086915|NCT00735709|3672583|FG003|Overall Study|Lost to Follow-up|1
2086916|NCT00735709|3672580|FG000|Overall Study|Excluded medication|1
2086917|NCT00735709|3672581|FG001|Overall Study|Excluded medication|0
2086918|NCT00735709|3672582|FG002|Overall Study|Excluded medication|0
2086919|NCT00735709|3672583|FG003|Overall Study|Excluded medication|1
2086920|NCT00735878|3672620|FG000|Phase I- Dose Determination|Withdrawal by Subject|0
2086921|NCT00735878|3672621|FG001|Phase I- Dose Determination|Withdrawal by Subject|0
2086922|NCT00735878|3672622|FG002|Phase I- Dose Determination|Withdrawal by Subject|1
2086923|NCT00735904|3672633|FG000|Overall Study|Adverse Event|3
2086924|NCT00735904|3672633|FG000|Overall Study|Death|20
2086925|NCT00735904|3672633|FG000|Overall Study|Protocol Violation|1
2086926|NCT00735904|3672633|FG000|Overall Study|Withdrawal by Subject|1
2086927|NCT00735904|3672633|FG000|Overall Study|Study Terminated by Sponsor|5
2086928|NCT00735904|3672633|FG000|Overall Study|Other|8
2086929|NCT00735943|3672641|FG000|Overall Study|Lost to Follow-up|1
2086930|NCT00735943|3672641|FG000|Overall Study|Adverse Event|1
2086931|NCT00736034|3672649|FG000|Overall Study|Adverse Event|2
2086932|NCT00736099|3672665|FG000|Overall Study|Adverse Event|61
2086933|NCT00736099|3672666|FG001|Overall Study|Adverse Event|18
2086934|NCT00736099|3672665|FG000|Overall Study|Protocol Violation|10
2086935|NCT00736099|3672666|FG001|Overall Study|Protocol Violation|4
2086936|NCT00736099|3672665|FG000|Overall Study|Lost to Follow-up|12
2086937|NCT00736099|3672666|FG001|Overall Study|Lost to Follow-up|5
2086938|NCT00736099|3672665|FG000|Overall Study|Withdrawal by Subject|42
2086939|NCT00736099|3672666|FG001|Overall Study|Withdrawal by Subject|13
2086940|NCT00736099|3672665|FG000|Overall Study|Lack of Efficacy|15
2086941|NCT00736099|3672666|FG001|Overall Study|Lack of Efficacy|8
2086942|NCT00736099|3672665|FG000|Overall Study|Other reason|43
2086943|NCT00736099|3672666|FG001|Overall Study|Other reason|10
2086944|NCT00736190|3672681|FG000|Overall Study|Pregnancy|1
2086945|NCT00736190|3672681|FG000|Overall Study|Withdrawal by Subject|1
2086946|NCT00736190|3672681|FG000|Overall Study|Adverse Event|1
2086947|NCT00736255|3672705|FG000|Overall Study|Adverse Event|1
2086948|NCT00736255|3672706|FG001|Overall Study|Adverse Event|0
2086949|NCT00736255|3672705|FG000|Overall Study|Physician Decision|1
2086950|NCT00736255|3672706|FG001|Overall Study|Physician Decision|0
2086951|NCT00736255|3672705|FG000|Overall Study|Non-compliance|1
2086952|NCT00736255|3672706|FG001|Overall Study|Non-compliance|1
2086953|NCT00736333|3672712|FG000|Overall Study|Did Not Receive Drug or Not Documented|7
2086954|NCT00736333|3672712|FG000|Overall Study|Data Missing|2
2086955|NCT00736333|3672712|FG000|Overall Study|Tumor Progression|75
2086956|NCT00736333|3672712|FG000|Overall Study|Toxicity|6
2086957|NCT00736333|3672712|FG000|Overall Study|Withdrawal by Subject|10
2086958|NCT00736333|3672712|FG000|Overall Study|Death|7
2086959|NCT00736333|3672712|FG000|Overall Study|Other|4
2086960|NCT00736450|3672716|FG000|Overall Study|Not ABC gene eligible|19
2086961|NCT00736450|3672716|FG000|Overall Study|Withdrawal by Subject|5
2086962|NCT00736450|3672716|FG000|Overall Study|Physician Decision|1
2086963|NCT00736476|3672722|FG000|Overall Study|Adverse Event|1
2086964|NCT00736476|3672723|FG001|Overall Study|Adverse Event|0
2086965|NCT00736489|3672735|FG000|Period 1|Lost to Follow-up|1
2086966|NCT00736489|3672736|FG001|Period 1|Lost to Follow-up|0
2086967|NCT00736489|3672737|FG002|Period 1|Lost to Follow-up|0
2086968|NCT00736489|3672738|FG003|Period 1|Lost to Follow-up|0
2086969|NCT00736489|3672739|FG004|Period 1|Lost to Follow-up|0
2086970|NCT00736489|3672740|FG005|Period 1|Lost to Follow-up|0
2086971|NCT00736489|3672735|FG000|Period 1|Withdrawal by Subject|0
2086972|NCT00736489|3672736|FG001|Period 1|Withdrawal by Subject|0
2086973|NCT00736489|3672737|FG002|Period 1|Withdrawal by Subject|0
2086974|NCT00736489|3672738|FG003|Period 1|Withdrawal by Subject|0
2086975|NCT00736489|3672739|FG004|Period 1|Withdrawal by Subject|0
2086976|NCT00736489|3672740|FG005|Period 1|Withdrawal by Subject|1
2086977|NCT00736502|3672754|FG000|Overall Study|Adverse Event|22
2086978|NCT00736502|3672754|FG000|Overall Study|Lack of Efficacy|16
2086979|NCT00736502|3672754|FG000|Overall Study|Lost to Follow-up|27
2086980|NCT00736645|3672782|FG000|Overall Study|Adverse Event|0
2086981|NCT00736645|3672783|FG001|Overall Study|Adverse Event|2
2086982|NCT00736645|3672784|FG002|Overall Study|Adverse Event|0
2086983|NCT00736645|3672785|FG003|Overall Study|Adverse Event|0
2086984|NCT00736723|3672797|FG000|Overall Study|Withdrawal by Subject|4
2086985|NCT00736723|3672798|FG001|Overall Study|Withdrawal by Subject|3
2086986|NCT00736840|3672804|FG000|Overall Study|Lost to Follow-up|13
2086987|NCT00736853|3672808|FG000|Open-Label Period|Physician Decision|2
2086988|NCT00736853|3672809|FG001|Open-Label Period|Physician Decision|0
2086989|NCT00736853|3672810|FG002|Open-Label Period|Physician Decision|0
2086990|NCT00736853|3672808|FG000|Open-Label Period|Adverse Event|31
2086991|NCT00736853|3672809|FG001|Open-Label Period|Adverse Event|0
2086992|NCT00736853|3672810|FG002|Open-Label Period|Adverse Event|0
2086993|NCT00736853|3672808|FG000|Open-Label Period|Withdrawal by Subject|16
2086994|NCT00736853|3672809|FG001|Open-Label Period|Withdrawal by Subject|0
2086995|NCT00736853|3672810|FG002|Open-Label Period|Withdrawal by Subject|0
2306074|NCT02680847|4007732|FG001|Overall Study|No longer met eligibility criteria|2
2306075|NCT02680847|4007733|FG002|Overall Study|No longer met eligibility criteria|0
2306076|NCT02680847|4007731|FG000|Overall Study|Unwilling to participate in study|1
2306077|NCT02680847|4007732|FG001|Overall Study|Unwilling to participate in study|1
2306078|NCT02680847|4007733|FG002|Overall Study|Unwilling to participate in study|0
2306079|NCT02680847|4007731|FG000|Overall Study|Lack of Efficacy|0
2306080|NCT02680847|4007732|FG001|Overall Study|Lack of Efficacy|0
2306081|NCT02680847|4007733|FG002|Overall Study|Lack of Efficacy|2
2306082|NCT02680847|4007731|FG000|Overall Study|Adverse Event|0
2306083|NCT02680847|4007732|FG001|Overall Study|Adverse Event|0
2306084|NCT02680847|4007733|FG002|Overall Study|Adverse Event|1
2306085|NCT02681094|4007744|FG000|1 -Modified Enrolled Participants Set|Participant decision|7
2306086|NCT02681094|4007745|FG001|1 -Modified Enrolled Participants Set|Participant decision|10
2306087|NCT02681094|4007746|FG002|1 -Modified Enrolled Participants Set|Participant decision|9
2306088|NCT02681094|4007744|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10
2306089|NCT02681094|4007745|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4
2306090|NCT02681094|4007746|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1
2306091|NCT02681094|4007744|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
2306092|NCT02681094|4007745|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
2306093|NCT02681094|4007746|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
2306094|NCT02681094|4007744|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
2306095|NCT02681094|4007745|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
2306096|NCT02681094|4007746|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
2306097|NCT02681094|4007744|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
2306098|NCT02681094|4007745|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
2306099|NCT02681094|4007746|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
2306100|NCT02681094|4007744|FG000|1 -Modified Enrolled Participants Set|Other|6
2306101|NCT02681094|4007745|FG001|1 -Modified Enrolled Participants Set|Other|6
2306102|NCT02681094|4007746|FG002|1 -Modified Enrolled Participants Set|Other|7
2306103|NCT02681094|4007744|FG000|1 -Modified Enrolled Participants Set|No treatment given|0
2306104|NCT02681094|4007745|FG001|1 -Modified Enrolled Participants Set|No treatment given|1
2306105|NCT02681094|4007746|FG002|1 -Modified Enrolled Participants Set|No treatment given|1
2306106|NCT02681094|4007744|FG000|2 - Enrolled Participants Set|Participant decision|7
2306107|NCT02681094|4007745|FG001|2 - Enrolled Participants Set|Participant decision|10
2306108|NCT02681094|4007746|FG002|2 - Enrolled Participants Set|Participant decision|9
2306109|NCT02681094|4007744|FG000|2 - Enrolled Participants Set|Adverse Event|10
2306110|NCT02681094|4007745|FG001|2 - Enrolled Participants Set|Adverse Event|4
2306111|NCT02681094|4007746|FG002|2 - Enrolled Participants Set|Adverse Event|1
2306112|NCT02681094|4007744|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
2306113|NCT02681094|4007745|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
2306114|NCT02681094|4007746|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
2306115|NCT02681094|4007744|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1
2306116|NCT02681094|4007745|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5
2306117|NCT02681094|4007746|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14
2306118|NCT02681094|4007744|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
2306119|NCT02681094|4007745|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
2306120|NCT02681094|4007746|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
2306121|NCT02681094|4007744|FG000|2 - Enrolled Participants Set|Other|6
2306122|NCT02681094|4007745|FG001|2 - Enrolled Participants Set|Other|6
2306123|NCT02681094|4007746|FG002|2 - Enrolled Participants Set|Other|7
2306124|NCT02681094|4007744|FG000|2 - Enrolled Participants Set|No treatment given|0
2306125|NCT02681094|4007745|FG001|2 - Enrolled Participants Set|No treatment given|1
2306126|NCT02681094|4007746|FG002|2 - Enrolled Participants Set|No treatment given|1
2306127|NCT02681510|4007768|FG000|Overall Study|Withdrawal by Subject|1
2306128|NCT02681510|4007768|FG000|Overall Study|Lost to Follow-up|9
2306129|NCT02681523|4007772|FG000|Overall Study|Adverse Event|1
2306130|NCT02681523|4007772|FG000|Overall Study|Patient Non-compliance|1
2306131|NCT02682264|4007827|FG000|Overall Study|Withdrawal by Subject|56
2306132|NCT02682264|4007828|FG001|Overall Study|Withdrawal by Subject|45
2306133|NCT02682264|4007827|FG000|Overall Study|Lost to Follow-up|49
2306134|NCT02682264|4007828|FG001|Overall Study|Lost to Follow-up|41
2306135|NCT02682264|4007827|FG000|Overall Study|Lack of Efficacy|14
2306136|NCT02682264|4007828|FG001|Overall Study|Lack of Efficacy|16
2306137|NCT02682264|4007827|FG000|Overall Study|Withdrawal by Parent|6
2306138|NCT02682264|4007828|FG001|Overall Study|Withdrawal by Parent|7
2306139|NCT02682264|4007827|FG000|Overall Study|Adverse Event|9
2306140|NCT02682264|4007828|FG001|Overall Study|Adverse Event|0
2306141|NCT02682264|4007827|FG000|Overall Study|Noncompliance with study drug|1
2306142|NCT02682264|4007828|FG001|Overall Study|Noncompliance with study drug|4
2306143|NCT02682264|4007827|FG000|Overall Study|Pregnancy|1
2306144|NCT02682264|4007828|FG001|Overall Study|Pregnancy|2
2306145|NCT02682264|4007827|FG000|Overall Study|Recovery|1
2306146|NCT02682264|4007828|FG001|Overall Study|Recovery|2
2306147|NCT02682264|4007827|FG000|Overall Study|Progressive Disease|1
2306148|NCT02682264|4007828|FG001|Overall Study|Progressive Disease|0
2306149|NCT02682264|4007827|FG000|Overall Study|Technical Problems|0
2306150|NCT02682264|4007828|FG001|Overall Study|Technical Problems|1
2306151|NCT02682264|4007827|FG000|Overall Study|Moved abroad and unable to continue|0
2306152|NCT02682264|4007828|FG001|Overall Study|Moved abroad and unable to continue|3
2306153|NCT02682264|4007827|FG000|Overall Study|Stopped test article application|0
2306154|NCT02682264|4007828|FG001|Overall Study|Stopped test article application|1
2306155|NCT02682602|4007879|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1
2306156|NCT02682602|4007880|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0
2306157|NCT02682602|4007879|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
2086996|NCT00736853|3672808|FG000|Open-Label Period|Started but not treated|42
2086997|NCT00736853|3672809|FG001|Open-Label Period|Started but not treated|0
2086998|NCT00736853|3672810|FG002|Open-Label Period|Started but not treated|0
2086999|NCT00736853|3672808|FG000|Open-Label Period|Failed to meet the transfer criteria|40
2087000|NCT00736853|3672809|FG001|Open-Label Period|Failed to meet the transfer criteria|0
2087001|NCT00736853|3672810|FG002|Open-Label Period|Failed to meet the transfer criteria|0
2087002|NCT00736853|3672808|FG000|Open-Label Period|Unable to attend hospital appointments|1
2087003|NCT00736853|3672809|FG001|Open-Label Period|Unable to attend hospital appointments|0
2087004|NCT00736853|3672810|FG002|Open-Label Period|Unable to attend hospital appointments|0
2087005|NCT00736853|3672808|FG000|Double-Blind Period|Lack of Efficacy|0
2087006|NCT00736853|3672809|FG001|Double-Blind Period|Lack of Efficacy|19
2087007|NCT00736853|3672810|FG002|Double-Blind Period|Lack of Efficacy|42
2087008|NCT00736853|3672808|FG000|Double-Blind Period|Adverse Event|0
2087009|NCT00736853|3672809|FG001|Double-Blind Period|Adverse Event|3
2087010|NCT00736853|3672810|FG002|Double-Blind Period|Adverse Event|2
2087011|NCT00736853|3672808|FG000|Double-Blind Period|Withdrawal by Subject|0
2087012|NCT00736853|3672809|FG001|Double-Blind Period|Withdrawal by Subject|1
2087013|NCT00736853|3672810|FG002|Double-Blind Period|Withdrawal by Subject|4
2087014|NCT00736853|3672808|FG000|Double-Blind Period|Ineligible to participate the study|0
2087015|NCT00736853|3672809|FG001|Double-Blind Period|Ineligible to participate the study|1
2087016|NCT00736853|3672810|FG002|Double-Blind Period|Ineligible to participate the study|0
2087017|NCT00736879|3672823|FG000|Double Blind Treatment Period|Lack of Efficacy|1
2087018|NCT00736879|3672824|FG001|Double Blind Treatment Period|Lack of Efficacy|0
2087019|NCT00736879|3672825|FG002|Double Blind Treatment Period|Lack of Efficacy|0
2087020|NCT00736879|3672826|FG003|Double Blind Treatment Period|Lack of Efficacy|0
2087021|NCT00736879|3672823|FG000|Double Blind Treatment Period|Adverse Event|0
2087022|NCT00736879|3672824|FG001|Double Blind Treatment Period|Adverse Event|1
2087023|NCT00736879|3672825|FG002|Double Blind Treatment Period|Adverse Event|1
2087024|NCT00736879|3672826|FG003|Double Blind Treatment Period|Adverse Event|0
2087025|NCT00736879|3672823|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
2087026|NCT00736879|3672824|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
2087027|NCT00736879|3672825|FG002|Double Blind Treatment Period|Withdrawal by Subject|3
2087028|NCT00736879|3672826|FG003|Double Blind Treatment Period|Withdrawal by Subject|3
2087029|NCT00736879|3672823|FG000|Double Blind Treatment Period|Lost to Follow-up|0
2087030|NCT00736879|3672824|FG001|Double Blind Treatment Period|Lost to Follow-up|0
2087031|NCT00736879|3672825|FG002|Double Blind Treatment Period|Lost to Follow-up|2
2087032|NCT00736879|3672826|FG003|Double Blind Treatment Period|Lost to Follow-up|1
2087033|NCT00736879|3672823|FG000|Double Blind Treatment Period|Poor non-compliance|0
2087034|NCT00736879|3672824|FG001|Double Blind Treatment Period|Poor non-compliance|0
2087035|NCT00736879|3672825|FG002|Double Blind Treatment Period|Poor non-compliance|1
2087036|NCT00736879|3672826|FG003|Double Blind Treatment Period|Poor non-compliance|1
2087037|NCT00736879|3672823|FG000|Double Blind Treatment Period|No longer met criteria|0
2087038|NCT00736879|3672824|FG001|Double Blind Treatment Period|No longer met criteria|1
2211572|NCT01662310|3851998|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0
2211573|NCT01662310|3851999|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0
2211574|NCT01662310|3852000|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0
2211575|NCT01662310|3851996|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4
2211576|NCT01662310|3851997|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0
2211577|NCT01662310|3851998|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0
2211578|NCT01662310|3851999|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0
2211579|NCT01662310|3852000|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0
2211580|NCT01662310|3851996|FG000|Run-In or Stabilization Phase|Protocol Violation|15
2211581|NCT01662310|3851997|FG001|Run-In or Stabilization Phase|Protocol Violation|0
2211582|NCT01662310|3851998|FG002|Run-In or Stabilization Phase|Protocol Violation|0
2211583|NCT01662310|3851999|FG003|Run-In or Stabilization Phase|Protocol Violation|0
2211584|NCT01662310|3852000|FG004|Run-In or Stabilization Phase|Protocol Violation|0
2211585|NCT01662310|3851996|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25
2211586|NCT01662310|3851997|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0
2211587|NCT01662310|3851998|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0
2211588|NCT01662310|3851999|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0
2211589|NCT01662310|3852000|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0
2211590|NCT01662310|3851996|FG000|Run-In or Stabilization Phase|Other|1
2306158|NCT02682602|4007880|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
2306159|NCT02682784|4007894|FG000|Overall Study|Withdrawal by Subject|0
2306160|NCT02682784|4007895|FG001|Overall Study|Withdrawal by Subject|2
2211591|NCT01662310|3851997|FG001|Run-In or Stabilization Phase|Other|0
2211592|NCT01662310|3851998|FG002|Run-In or Stabilization Phase|Other|0
2087039|NCT00736879|3672825|FG002|Double Blind Treatment Period|No longer met criteria|0
2087040|NCT00736879|3672826|FG003|Double Blind Treatment Period|No longer met criteria|0
2087041|NCT00736879|3672823|FG000|Double Blind Treatment Period|non-specified|0
2087042|NCT00736879|3672824|FG001|Double Blind Treatment Period|non-specified|1
2087043|NCT00736879|3672825|FG002|Double Blind Treatment Period|non-specified|0
2087044|NCT00736879|3672826|FG003|Double Blind Treatment Period|non-specified|0
2087045|NCT00736879|3672823|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
2087046|NCT00736879|3672824|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
2087047|NCT00736879|3672825|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
2087048|NCT00736879|3672826|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
2087049|NCT00736879|3672823|FG000|Follow up Period - No Drug Treatment|non-specified|1
2087050|NCT00736879|3672824|FG001|Follow up Period - No Drug Treatment|non-specified|2
2087051|NCT00736879|3672825|FG002|Follow up Period - No Drug Treatment|non-specified|0
2087052|NCT00736879|3672826|FG003|Follow up Period - No Drug Treatment|non-specified|0
2087053|NCT00736944|3672839|FG000|Induction|Death|1
2087054|NCT00736944|3672839|FG000|Definitive Treatment|Physician Decision|1
2087055|NCT00736957|3672846|FG000|Overall Study|Adverse Event|43
2087056|NCT00736957|3672846|FG000|Overall Study|Withdrawal by Subject|49
2087057|NCT00736957|3672846|FG000|Overall Study|violation of eligibility criteria|2
2087058|NCT00736957|3672846|FG000|Overall Study|did not attend hospital appointments|1
2087059|NCT00736957|3672846|FG000|Overall Study|not eligible for Treatment Period I|22
2087060|NCT00736957|3672846|FG000|Overall Study|Physician Decision|5
2087061|NCT00736996|3672853|FG000|Overall Study|Lost to Follow-up|1
2087062|NCT00736996|3672854|FG001|Overall Study|Lost to Follow-up|9
2087063|NCT00736996|3672855|FG002|Overall Study|Lost to Follow-up|2
2087064|NCT00737048|3672866|FG000|Overall Study|Physician Decision|0
2087065|NCT00737048|3672867|FG001|Overall Study|Physician Decision|0
2087066|NCT00737048|3672868|FG002|Overall Study|Physician Decision|1
2087067|NCT00737048|3672866|FG000|Overall Study|Adverse Event|0
2087068|NCT00737048|3672867|FG001|Overall Study|Adverse Event|1
2087069|NCT00737048|3672868|FG002|Overall Study|Adverse Event|0
2087070|NCT00737048|3672866|FG000|Overall Study|Worsening of the symptoms|3
2087071|NCT00737048|3672867|FG001|Overall Study|Worsening of the symptoms|5
2087072|NCT00737048|3672868|FG002|Overall Study|Worsening of the symptoms|3
2087073|NCT00737061|3672876|FG000|Waiting Period|Lost to Follow-up|6
2087074|NCT00737061|3672876|FG000|Waiting Period|Withdrawal by Subject|1
2087075|NCT00737061|3672876|FG000|Waiting Period|Bilateral placement failure|34
2087076|NCT00737061|3672876|FG000|Waiting Period|Deemed patent following HSG|26
2087077|NCT00737061|3672876|FG000|Waiting Period|Alternative contraception failure|3
2087078|NCT00737061|3672876|FG000|Waiting Period|Elected surgical tubal ligation|5
2087079|NCT00737061|3672876|FG000|1 Year Wearing Period|Lost to Follow-up|11
2087080|NCT00737061|3672876|FG000|1 Year Wearing Period|Withdrawal by Subject|2
2087081|NCT00737061|3672876|FG000|1 Year Wearing Period|Discontinued reilance|3
2087082|NCT00737061|3672876|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1
2087083|NCT00737100|3672883|FG000|Overall Study|Adverse Event|6
2087084|NCT00737100|3672884|FG001|Overall Study|Adverse Event|5
2087085|NCT00737100|3672885|FG002|Overall Study|Adverse Event|3
2087086|NCT00737100|3672883|FG000|Overall Study|Lost to Follow-up|0
2087087|NCT00737100|3672884|FG001|Overall Study|Lost to Follow-up|1
2087088|NCT00737100|3672885|FG002|Overall Study|Lost to Follow-up|0
2087089|NCT00737100|3672883|FG000|Overall Study|Withdrawal by Subject|0
2087090|NCT00737100|3672884|FG001|Overall Study|Withdrawal by Subject|0
2087091|NCT00737100|3672885|FG002|Overall Study|Withdrawal by Subject|3
2087092|NCT00737100|3672883|FG000|Overall Study|Reason discontinued not explained above|1
2087093|NCT00737100|3672884|FG001|Overall Study|Reason discontinued not explained above|1
2087094|NCT00737100|3672885|FG002|Overall Study|Reason discontinued not explained above|1
2087095|NCT00737438|3672923|FG000|Overall Study|Withdrawal by Subject|2
2087096|NCT00737438|3672923|FG000|Overall Study|Patient ineligible|1
2087097|NCT00737464|3672927|FG000|Overall Study|Adverse Event|1
2087098|NCT00737464|3672927|FG000|Overall Study|Death|6
2087099|NCT00737464|3672927|FG000|Overall Study|Other - Failure to Return|1
2087100|NCT00737464|3672927|FG000|Overall Study|Refused Treatment / Withdrew Consent|6
2087101|NCT00737464|3672927|FG000|Overall Study|Other reasons|4
2087102|NCT00737477|3672931|FG000|Overall Study|Adverse Event|9
2087103|NCT00737477|3672931|FG000|Overall Study|Death|9
2087104|NCT00737477|3672931|FG000|Overall Study|Treatment Refusal|1
2087105|NCT00737477|3672931|FG000|Overall Study|Withdrawal by Subject|1
2087106|NCT00737477|3672931|FG000|Overall Study|Renal Transplantation|10
2087107|NCT00737477|3672931|FG000|Overall Study|Other|4
2087108|NCT00737529|3672935|FG000|Overall Study|Disease Progression|95
2087109|NCT00737529|3672935|FG000|Overall Study|Adverse Event|24
2087110|NCT00737529|3672935|FG000|Overall Study|Withdrawal by Subject|5
2087111|NCT00737529|3672935|FG000|Overall Study|Death|4
2087112|NCT00737529|3672935|FG000|Overall Study|Protocol Violation|1
2087113|NCT00737529|3672935|FG000|Overall Study|Other|4
2087114|NCT00737568|3672941|FG000|Treatment Period Through Week 240|Investigator's Discretion|6
2087115|NCT00737568|3672942|FG001|Treatment Period Through Week 240|Investigator's Discretion|5
2107246|NCT00871715|3700726|FG000|Overall Study|Withdrawal by Subject|6
2087116|NCT00737568|3672941|FG000|Treatment Period Through Week 240|Withdrew Consent|5
2087117|NCT00737568|3672942|FG001|Treatment Period Through Week 240|Withdrew Consent|6
2087118|NCT00737568|3672941|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
2087119|NCT00737568|3672942|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
2087120|NCT00737568|3672941|FG000|Treatment Period Through Week 240|Lost to Follow-up|3
2087121|NCT00737568|3672942|FG001|Treatment Period Through Week 240|Lost to Follow-up|3
2087122|NCT00737568|3672941|FG000|Treatment Period Through Week 240|Protocol Violation|2
2087123|NCT00737568|3672942|FG001|Treatment Period Through Week 240|Protocol Violation|3
2087124|NCT00737568|3672941|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
2087125|NCT00737568|3672942|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
2087126|NCT00737568|3672941|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
2087127|NCT00737568|3672942|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
2087128|NCT00737568|3672941|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0
2087129|NCT00737568|3672942|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1
2087130|NCT00737568|3672941|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
2087131|NCT00737568|3672942|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
2087132|NCT00737633|3672950|FG000|Overall Study|Study terminated by sponsor|44
2087133|NCT00737633|3672951|FG001|Overall Study|Study terminated by sponsor|55
2087134|NCT00737633|3672950|FG000|Overall Study|Lost to Follow-up|0
2087135|NCT00737633|3672951|FG001|Overall Study|Lost to Follow-up|1
2087136|NCT00737633|3672950|FG000|Overall Study|protocol non-compliance|0
2087137|NCT00737633|3672951|FG001|Overall Study|protocol non-compliance|1
2087138|NCT00737672|3672959|FG000|Overall Study|Graft Abandonment|48
2087139|NCT00737672|3672960|FG001|Overall Study|Graft Abandonment|56
2087140|NCT00737672|3672959|FG000|Overall Study|Death|23
2087141|NCT00737672|3672960|FG001|Overall Study|Death|22
2087142|NCT00737672|3672959|FG000|Overall Study|Withdrawal by Subject|1
2087143|NCT00737672|3672960|FG001|Overall Study|Withdrawal by Subject|2
2087144|NCT00737672|3672959|FG000|Overall Study|Lost to Follow-up|1
2087145|NCT00737672|3672960|FG001|Overall Study|Lost to Follow-up|0
2087146|NCT00737672|3672959|FG000|Overall Study|Miscellaneous|7
2087147|NCT00737672|3672960|FG001|Overall Study|Miscellaneous|1
2087148|NCT00737672|3672959|FG000|Overall Study|Physician Decision|0
2087149|NCT00737672|3672960|FG001|Overall Study|Physician Decision|2
2087150|NCT00737698|3672969|FG000|Overall Study|Withdrawal by Subject|6
2087151|NCT00737698|3672970|FG001|Overall Study|Withdrawal by Subject|5
2087152|NCT00737698|3672971|FG002|Overall Study|Withdrawal by Subject|3
2087153|NCT00737698|3672969|FG000|Overall Study|Death|0
2087154|NCT00737698|3672970|FG001|Overall Study|Death|0
2087155|NCT00737698|3672971|FG002|Overall Study|Death|1
2087156|NCT00737711|3672979|FG000|Overall Study|Adverse Event|2
2087157|NCT00737711|3672979|FG000|Overall Study|Death|8
2087158|NCT00737711|3672979|FG000|Overall Study|Failure to return|4
2087159|NCT00737711|3672979|FG000|Overall Study|Protocol Violation|1
2087160|NCT00737711|3672979|FG000|Overall Study|Withdrawal by Subject|5
2087161|NCT00737711|3672979|FG000|Overall Study|Blood transfusion|6
2087162|NCT00737711|3672979|FG000|Overall Study|Other|5
2107247|NCT00871715|3700727|FG001|Overall Study|Withdrawal by Subject|10
2107248|NCT00871715|3700728|FG002|Overall Study|Withdrawal by Subject|15
2107249|NCT00871715|3700726|FG000|Overall Study|Physician Decision|6
2107250|NCT00871715|3700727|FG001|Overall Study|Physician Decision|0
2107251|NCT00871715|3700728|FG002|Overall Study|Physician Decision|2
2107252|NCT00871715|3700726|FG000|Overall Study|Lost to Follow-up|3
2107253|NCT00871715|3700727|FG001|Overall Study|Lost to Follow-up|6
2107254|NCT00871715|3700728|FG002|Overall Study|Lost to Follow-up|9
2107255|NCT00871728|3700737|FG000|Overall Study|Adverse Event|1
2107256|NCT00871728|3700737|FG000|Overall Study|Protocol Violation|7
2107257|NCT00871728|3700737|FG000|Overall Study|Lost to Follow-up|2
2107258|NCT00871728|3700737|FG000|Overall Study|Failed to Visit Hospital|4
2107259|NCT00871728|3700737|FG000|Overall Study|Participant Non-compliance|1
2107260|NCT00871728|3700737|FG000|Overall Study|Withdrawal of Informed Consent|5
2107261|NCT00871741|3700743|FG000|Overall Study|Premature study termination|9
2107262|NCT00871741|3700744|FG001|Overall Study|Premature study termination|7
2107263|NCT00871780|3700750|FG000|Overall Study|Enrolled But Not Treated|6
2107264|NCT00871780|3700750|FG000|Overall Study|Withdrawal by Subject|9
2107265|NCT00871780|3700750|FG000|Overall Study|Adverse Event|6
2107266|NCT00871780|3700750|FG000|Overall Study|Voluntary Discontinuation|4
2107267|NCT00871780|3700750|FG000|Overall Study|Death|1
2107268|NCT00871780|3700750|FG000|Overall Study|Physician Decision|1
2107269|NCT00871858|3700776|FG000|Overall Study|Protocol Violation|3
2107270|NCT00871858|3700777|FG001|Overall Study|Protocol Violation|4
2107271|NCT00871858|3700776|FG000|Overall Study|Adverse Event|1
2107272|NCT00871858|3700777|FG001|Overall Study|Adverse Event|1
2107273|NCT00871858|3700776|FG000|Overall Study|Withdrawal by Subject|1
2107274|NCT00871858|3700777|FG001|Overall Study|Withdrawal by Subject|1
2107275|NCT00871858|3700776|FG000|Overall Study|Lost to Follow-up|0
2107276|NCT00871858|3700777|FG001|Overall Study|Lost to Follow-up|1
2107277|NCT00871871|3700785|FG000|Part I|Adverse Event|0
2107278|NCT00871871|3700786|FG001|Part I|Adverse Event|2
2107279|NCT00871871|3700787|FG002|Part I|Adverse Event|0
2107280|NCT00871871|3700788|FG003|Part I|Adverse Event|0
2107281|NCT00871871|3700785|FG000|Part I|Withdrawal by Subject|3
2087163|NCT00738062|3673029|FG000|Open Label Treatment|Lack of Efficacy|5
2087164|NCT00738062|3673030|FG001|Open Label Treatment|Lack of Efficacy|0
2087165|NCT00738062|3673031|FG002|Open Label Treatment|Lack of Efficacy|0
2087166|NCT00738062|3673029|FG000|Open Label Treatment|Adverse Event|11
2087167|NCT00738062|3673030|FG001|Open Label Treatment|Adverse Event|0
2087168|NCT00738062|3673031|FG002|Open Label Treatment|Adverse Event|0
2087169|NCT00738062|3673029|FG000|Open Label Treatment|Protocol Violation|2
2087170|NCT00738062|3673030|FG001|Open Label Treatment|Protocol Violation|0
2087171|NCT00738062|3673031|FG002|Open Label Treatment|Protocol Violation|0
2087172|NCT00738062|3673029|FG000|Open Label Treatment|Withdrawal by Subject|9
2087173|NCT00738062|3673030|FG001|Open Label Treatment|Withdrawal by Subject|0
2087174|NCT00738062|3673031|FG002|Open Label Treatment|Withdrawal by Subject|0
2087175|NCT00738062|3673029|FG000|Open Label Treatment|Investigator Decision|1
2087176|NCT00738062|3673030|FG001|Open Label Treatment|Investigator Decision|0
2087177|NCT00738062|3673031|FG002|Open Label Treatment|Investigator Decision|0
2087178|NCT00738062|3673029|FG000|Open-Label Extension|Adverse Event|5
2087179|NCT00738062|3673030|FG001|Open-Label Extension|Adverse Event|0
2087180|NCT00738062|3673031|FG002|Open-Label Extension|Adverse Event|0
2087181|NCT00738062|3673029|FG000|Open-Label Extension|Physician Decision|1
2087182|NCT00738062|3673030|FG001|Open-Label Extension|Physician Decision|0
2087183|NCT00738062|3673031|FG002|Open-Label Extension|Physician Decision|0
2087184|NCT00738062|3673029|FG000|Open-Label Extension|Lack of Efficacy|2
2087185|NCT00738062|3673030|FG001|Open-Label Extension|Lack of Efficacy|0
2087186|NCT00738062|3673031|FG002|Open-Label Extension|Lack of Efficacy|0
2087187|NCT00738062|3673029|FG000|Open-Label Extension|Withdrawal by Subject|6
2087188|NCT00738062|3673030|FG001|Open-Label Extension|Withdrawal by Subject|0
2087189|NCT00738062|3673031|FG002|Open-Label Extension|Withdrawal by Subject|0
2087190|NCT00738062|3673029|FG000|Open-Label Extension|Protocol Violation|1
2087191|NCT00738062|3673030|FG001|Open-Label Extension|Protocol Violation|0
2087192|NCT00738062|3673031|FG002|Open-Label Extension|Protocol Violation|0
2087193|NCT00738062|3673029|FG000|Open-Label Extension|Study Terminated|2
2087194|NCT00738062|3673030|FG001|Open-Label Extension|Study Terminated|0
2087195|NCT00738062|3673031|FG002|Open-Label Extension|Study Terminated|0
2087196|NCT00738101|3673040|FG000|Overall Study|Physician Decision|5
2087197|NCT00738101|3673040|FG000|Overall Study|Death|1
2087198|NCT00738101|3673040|FG000|Overall Study|Repeat enrollment|1
2087199|NCT00738283|3673044|FG000|Overall Study|Death|1
2087200|NCT00738283|3673044|FG000|Overall Study|Transfer to another facility|2
2087201|NCT00738283|3673044|FG000|Overall Study|Discharge home prior to end of study|1
2087202|NCT00738374|3673056|FG000|Induction Treatment Phase|Adverse Event|14
2087203|NCT00738374|3673057|FG001|Induction Treatment Phase|Adverse Event|0
2087204|NCT00738374|3673058|FG002|Induction Treatment Phase|Adverse Event|0
2211593|NCT01662310|3851999|FG003|Run-In or Stabilization Phase|Other|0
2211594|NCT01662310|3852000|FG004|Run-In or Stabilization Phase|Other|0
2087205|NCT00738374|3673059|FG003|Induction Treatment Phase|Adverse Event|0
2087206|NCT00738374|3673056|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4
2087207|NCT00738374|3673057|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0
2087208|NCT00738374|3673058|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0
2087209|NCT00738374|3673059|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0
2087210|NCT00738374|3673056|FG000|Induction Treatment Phase|Physician Decision|2
2087211|NCT00738374|3673057|FG001|Induction Treatment Phase|Physician Decision|0
2087212|NCT00738374|3673058|FG002|Induction Treatment Phase|Physician Decision|0
2087213|NCT00738374|3673059|FG003|Induction Treatment Phase|Physician Decision|0
2087214|NCT00738374|3673056|FG000|Induction Treatment Phase|Protocol Violation|2
2087215|NCT00738374|3673057|FG001|Induction Treatment Phase|Protocol Violation|0
2087216|NCT00738374|3673058|FG002|Induction Treatment Phase|Protocol Violation|0
2087217|NCT00738374|3673059|FG003|Induction Treatment Phase|Protocol Violation|0
2087218|NCT00738374|3673056|FG000|Induction Treatment Phase|Non-compliance|1
2087219|NCT00738374|3673057|FG001|Induction Treatment Phase|Non-compliance|0
2087220|NCT00738374|3673058|FG002|Induction Treatment Phase|Non-compliance|0
2087221|NCT00738374|3673059|FG003|Induction Treatment Phase|Non-compliance|0
2087222|NCT00738374|3673056|FG000|Induction Treatment Phase|Withdrawal by Subject|1
2087223|NCT00738374|3673057|FG001|Induction Treatment Phase|Withdrawal by Subject|0
2087224|NCT00738374|3673058|FG002|Induction Treatment Phase|Withdrawal by Subject|0
2087225|NCT00738374|3673059|FG003|Induction Treatment Phase|Withdrawal by Subject|0
2087226|NCT00738374|3673056|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0
2087227|NCT00738374|3673057|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1
2087228|NCT00738374|3673058|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2
2087229|NCT00738374|3673059|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0
2087230|NCT00738374|3673056|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
2087231|NCT00738374|3673057|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
2087232|NCT00738374|3673058|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
2087233|NCT00738374|3673059|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
2087234|NCT00738374|3673056|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
2087235|NCT00738374|3673057|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
2211595|NCT01662310|3851996|FG000|Double-Blind Phase|Adverse Event|0
2087236|NCT00738374|3673058|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
2087237|NCT00738374|3673059|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
2087238|NCT00738374|3673056|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0
2087239|NCT00738374|3673057|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1
2087240|NCT00738374|3673058|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0
2087241|NCT00738374|3673059|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0
2087242|NCT00738374|3673056|FG000|Maintenance Treatment/Observation Phase|Other|0
2087243|NCT00738374|3673057|FG001|Maintenance Treatment/Observation Phase|Other|1
2087244|NCT00738374|3673058|FG002|Maintenance Treatment/Observation Phase|Other|0
2087245|NCT00738374|3673059|FG003|Maintenance Treatment/Observation Phase|Other|0
2087246|NCT00738400|3673070|FG000|Overall Study|Adverse Event|3
2087247|NCT00738400|3673071|FG001|Overall Study|Adverse Event|1
2087248|NCT00738400|3673070|FG000|Overall Study|Withdrawal by Subject|0
2087249|NCT00738400|3673071|FG001|Overall Study|Withdrawal by Subject|1
2087250|NCT00738400|3673070|FG000|Overall Study|Lack of Efficacy|0
2087251|NCT00738400|3673071|FG001|Overall Study|Lack of Efficacy|1
2087252|NCT00738400|3673070|FG000|Overall Study|Lost to Follow-up|0
2087253|NCT00738400|3673071|FG001|Overall Study|Lost to Follow-up|3
2087254|NCT00738400|3673070|FG000|Overall Study|Protocol Violation|1
2087255|NCT00738400|3673071|FG001|Overall Study|Protocol Violation|0
2087256|NCT00738400|3673070|FG000|Overall Study|Non-compliant with study medication|0
2087257|NCT00738400|3673071|FG001|Overall Study|Non-compliant with study medication|1
2087258|NCT00738530|3673088|FG000|Overall Study|Death|220
2087259|NCT00738530|3673089|FG001|Overall Study|Death|224
2087260|NCT00738530|3673088|FG000|Overall Study|Lost to Follow-up|8
2087261|NCT00738530|3673089|FG001|Overall Study|Lost to Follow-up|6
2087262|NCT00738530|3673088|FG000|Overall Study|Withdrawal by Subject|6
2087263|NCT00738530|3673089|FG001|Overall Study|Withdrawal by Subject|8
2087264|NCT00738673|3673101|FG000|Overall Study|Adverse Event|1
2087265|NCT00738673|3673102|FG001|Overall Study|Adverse Event|0
2087266|NCT00738673|3673101|FG000|Overall Study|Lack of Efficacy|19
2087267|NCT00738673|3673102|FG001|Overall Study|Lack of Efficacy|8
2087268|NCT00738673|3673101|FG000|Overall Study|Protocol Violation|1
2087269|NCT00738673|3673102|FG001|Overall Study|Protocol Violation|2
2087270|NCT00738673|3673101|FG000|Overall Study|Withdrawal by Subject|3
2087271|NCT00738673|3673102|FG001|Overall Study|Withdrawal by Subject|1
2087272|NCT00738699|3673110|FG000|Overall Study|Withdrawal by Subject|5
2087273|NCT00738699|3673111|FG001|Overall Study|Withdrawal by Subject|0
2087274|NCT00738699|3673110|FG000|Overall Study|Lost to Follow-up|1
2087275|NCT00738699|3673111|FG001|Overall Study|Lost to Follow-up|0
2087276|NCT00738699|3673110|FG000|Overall Study|Death|144
2087277|NCT00738699|3673111|FG001|Overall Study|Death|68
2087278|NCT00738699|3673110|FG000|Overall Study|Discontinuation of study by Sponsor|123
2087279|NCT00738699|3673111|FG001|Overall Study|Discontinuation of study by Sponsor|72
2087280|NCT00738699|3673110|FG000|Overall Study|Other|2
2087281|NCT00738699|3673111|FG001|Overall Study|Other|0
2087282|NCT00738881|3673119|FG000|Overall Study|Withdrawal by Subject|0
2087283|NCT00738881|3673120|FG001|Overall Study|Withdrawal by Subject|2
2087284|NCT00738894|3673128|FG000|Overall Study|Lost to Follow-up|23
2087285|NCT00738894|3673129|FG001|Overall Study|Lost to Follow-up|13
2087286|NCT00738894|3673128|FG000|Overall Study|Withdrawal by Subject|10
2087287|NCT00738894|3673129|FG001|Overall Study|Withdrawal by Subject|15
2087288|NCT00738894|3673128|FG000|Overall Study|Physician Decision|4
2087289|NCT00738894|3673129|FG001|Overall Study|Physician Decision|5
2087290|NCT00738894|3673128|FG000|Overall Study|Death|2
2087291|NCT00738894|3673129|FG001|Overall Study|Death|0
2087292|NCT00739102|3673135|FG000|Overall Study|Death|5
2087293|NCT00739102|3673135|FG000|Overall Study|Withdrawal by Subject|10
2087294|NCT00739297|3673139|FG000|First Washout Period of 4-7 Days|Adverse Event|0
2087295|NCT00739297|3673140|FG001|First Washout Period of 4-7 Days|Adverse Event|0
2087296|NCT00739297|3673141|FG002|First Washout Period of 4-7 Days|Adverse Event|0
2087297|NCT00739297|3673142|FG003|First Washout Period of 4-7 Days|Adverse Event|2
2087298|NCT00739297|3673143|FG004|First Washout Period of 4-7 Days|Adverse Event|0
2087299|NCT00739297|3673144|FG005|First Washout Period of 4-7 Days|Adverse Event|0
2087300|NCT00739297|3673145|FG006|First Washout Period of 4-7 Days|Adverse Event|2
2087301|NCT00739297|3673139|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
2087302|NCT00739297|3673140|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
2087303|NCT00739297|3673141|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
2087304|NCT00739297|3673142|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
2087305|NCT00739297|3673143|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
2087306|NCT00739297|3673144|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
2087307|NCT00739297|3673145|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
2087308|NCT00739310|3673161|FG000|Overall Study|Poor adherance to prescribed therapy|4
2087309|NCT00739310|3673161|FG000|Overall Study|Withdrawal by Subject|1
2087310|NCT00739310|3673161|FG000|Overall Study|Lost to Follow-up|2
2087311|NCT00739596|3673186|FG000|Overall Study|Adverse Event|12
2087312|NCT00739596|3673187|FG001|Overall Study|Adverse Event|6
2087313|NCT00739596|3673186|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
2107282|NCT00871871|3700786|FG001|Part I|Withdrawal by Subject|0
2087314|NCT00739596|3673187|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
2087315|NCT00739596|3673186|FG000|Overall Study|Patient Withdrew Consent|8
2087316|NCT00739596|3673187|FG001|Overall Study|Patient Withdrew Consent|8
2087317|NCT00739596|3673186|FG000|Overall Study|Lost to Follow-up|0
2087318|NCT00739596|3673187|FG001|Overall Study|Lost to Follow-up|2
2087319|NCT00739596|3673186|FG000|Overall Study|Protocol Deviation|1
2087320|NCT00739596|3673187|FG001|Overall Study|Protocol Deviation|1
2087321|NCT00739648|3673195|FG000|Overall Study|Adverse Event|3
2087322|NCT00739648|3673196|FG001|Overall Study|Adverse Event|15
2087323|NCT00739648|3673195|FG000|Overall Study|Withdrawal by Subject|13
2087324|NCT00739648|3673196|FG001|Overall Study|Withdrawal by Subject|25
2087325|NCT00739648|3673195|FG000|Overall Study|Lost to Follow-up|4
2087326|NCT00739648|3673196|FG001|Overall Study|Lost to Follow-up|7
2087327|NCT00739648|3673195|FG000|Overall Study|Death|2
2087328|NCT00739648|3673196|FG001|Overall Study|Death|0
2087329|NCT00739648|3673195|FG000|Overall Study|Do not know|4
2087330|NCT00739648|3673196|FG001|Overall Study|Do not know|6
2087331|NCT00739661|3673208|FG000|Overall Study|Adverse Event|2
2087332|NCT00739661|3673209|FG001|Overall Study|Adverse Event|0
2087333|NCT00739661|3673208|FG000|Overall Study|Physician decision to withdraw patient|1
2087334|NCT00739661|3673209|FG001|Overall Study|Physician decision to withdraw patient|0
2087335|NCT00739661|3673208|FG000|Overall Study|Patient decision to withdraw|9
2087336|NCT00739661|3673209|FG001|Overall Study|Patient decision to withdraw|4
2087337|NCT00739661|3673208|FG000|Overall Study|Disease progression, radiographic|33
2087338|NCT00739661|3673209|FG001|Overall Study|Disease progression, radiographic|37
2087339|NCT00739661|3673208|FG000|Overall Study|Reason for discontinuation not available|1
2087340|NCT00739661|3673209|FG001|Overall Study|Reason for discontinuation not available|1
2087341|NCT00739908|3673255|FG000|Overall Study|Adverse Event|5
2087342|NCT00739908|3673256|FG001|Overall Study|Adverse Event|6
2087343|NCT00739908|3673255|FG000|Overall Study|Withdrawal by Subject|4
2087344|NCT00739908|3673256|FG001|Overall Study|Withdrawal by Subject|2
2087345|NCT00739908|3673255|FG000|Overall Study|Lost to Follow-up|14
2087346|NCT00739908|3673256|FG001|Overall Study|Lost to Follow-up|9
2087347|NCT00739908|3673255|FG000|Overall Study|Non-Compliance With Study Procedures|2
2087348|NCT00739908|3673256|FG001|Overall Study|Non-Compliance With Study Procedures|3
2087349|NCT00739908|3673255|FG000|Overall Study|Non-Compliance With Study Medication|0
2087350|NCT00739908|3673256|FG001|Overall Study|Non-Compliance With Study Medication|3
2087351|NCT00739908|3673255|FG000|Overall Study|Lack of Efficacy|0
2087352|NCT00739908|3673256|FG001|Overall Study|Lack of Efficacy|1
2211596|NCT01662310|3851997|FG001|Double-Blind Phase|Adverse Event|0
2211597|NCT01662310|3851998|FG002|Double-Blind Phase|Adverse Event|1
2211598|NCT01662310|3851999|FG003|Double-Blind Phase|Adverse Event|0
2087353|NCT00739908|3673255|FG000|Overall Study|Relocation|0
2087354|NCT00739908|3673256|FG001|Overall Study|Relocation|1
2087355|NCT00739934|3673264|FG000|Voriconazole IV|Adverse Event|6
2087356|NCT00739934|3673264|FG000|Voriconazole Oral|Other|3
2087357|NCT00739973|3673286|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
2087358|NCT00739973|3673287|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2087359|NCT00739973|3673288|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2087360|NCT00739973|3673289|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2087361|NCT00739973|3673290|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2087362|NCT00739973|3673291|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2087363|NCT00739973|3673292|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2087364|NCT00739973|3673293|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2087365|NCT00739973|3673294|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2087366|NCT00739973|3673286|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
2087367|NCT00739973|3673287|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2087368|NCT00739973|3673288|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2087369|NCT00739973|3673289|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2087370|NCT00739973|3673290|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2087371|NCT00739973|3673291|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2087372|NCT00739973|3673292|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2087373|NCT00739973|3673293|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2087374|NCT00739973|3673294|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2087375|NCT00739973|3673286|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
2087376|NCT00739973|3673287|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2087377|NCT00739973|3673288|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2087378|NCT00739973|3673289|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2087379|NCT00739973|3673290|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2087380|NCT00739973|3673291|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2087381|NCT00739973|3673292|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2087382|NCT00739973|3673293|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2087383|NCT00739973|3673294|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2087384|NCT00739973|3673286|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
2087385|NCT00739973|3673287|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2107283|NCT00871871|3700787|FG002|Part I|Withdrawal by Subject|0
2087386|NCT00739973|3673288|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2087387|NCT00739973|3673289|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2087388|NCT00739973|3673290|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2087389|NCT00739973|3673291|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2087390|NCT00739973|3673292|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2087391|NCT00739973|3673293|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2087392|NCT00739973|3673294|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2087393|NCT00739973|3673286|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
2087394|NCT00739973|3673287|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2087395|NCT00739973|3673288|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2087396|NCT00739973|3673289|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2087397|NCT00739973|3673290|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2087398|NCT00739973|3673291|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2087399|NCT00739973|3673292|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2087400|NCT00739973|3673293|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2087401|NCT00739973|3673294|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2087402|NCT00739973|3673286|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
2087403|NCT00739973|3673287|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2087404|NCT00739973|3673288|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2087405|NCT00739973|3673289|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2087406|NCT00739973|3673290|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2087407|NCT00739973|3673291|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2087408|NCT00739973|3673292|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2087409|NCT00739973|3673293|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2087410|NCT00739973|3673294|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2087411|NCT00739973|3673286|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
2087412|NCT00739973|3673287|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2087413|NCT00739973|3673288|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2087414|NCT00739973|3673289|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2087415|NCT00739973|3673290|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2087416|NCT00739973|3673291|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2087417|NCT00739973|3673292|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2087418|NCT00739973|3673293|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2087419|NCT00739973|3673294|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2087420|NCT00739973|3673286|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
2087421|NCT00739973|3673287|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
2087422|NCT00739973|3673288|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
2087423|NCT00739973|3673289|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
2087424|NCT00739973|3673290|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
2087425|NCT00739973|3673291|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
2087426|NCT00739973|3673292|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
2087427|NCT00739973|3673293|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
2087428|NCT00739973|3673294|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
2087429|NCT00739973|3673286|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2087430|NCT00739973|3673287|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2087431|NCT00739973|3673288|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2087432|NCT00739973|3673289|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2087433|NCT00739973|3673290|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
2087434|NCT00739973|3673291|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2087435|NCT00739973|3673292|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2087436|NCT00739973|3673293|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
2087437|NCT00739973|3673294|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2087438|NCT00739973|3673286|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
2087439|NCT00739973|3673287|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
2306161|NCT02682784|4007896|FG002|Overall Study|Withdrawal by Subject|1
2306162|NCT02682784|4007897|FG003|Overall Study|Withdrawal by Subject|2
2306163|NCT02682784|4007894|FG000|Overall Study|Physician Decision|1
2306164|NCT02682784|4007895|FG001|Overall Study|Physician Decision|0
2306165|NCT02682784|4007896|FG002|Overall Study|Physician Decision|1
2306166|NCT02682784|4007897|FG003|Overall Study|Physician Decision|1
2306167|NCT02682823|4007912|FG000|Overall Study|Withdrawal by Subject|0
2306168|NCT02682823|4007913|FG001|Overall Study|Withdrawal by Subject|0
2306169|NCT02682823|4007914|FG002|Overall Study|Withdrawal by Subject|1
2306170|NCT02682823|4007915|FG003|Overall Study|Withdrawal by Subject|0
2306171|NCT02682823|4007916|FG004|Overall Study|Withdrawal by Subject|1
2306172|NCT02682823|4007912|FG000|Overall Study|Protocol Deviation|0
2306173|NCT02682823|4007913|FG001|Overall Study|Protocol Deviation|1
2306174|NCT02682823|4007914|FG002|Overall Study|Protocol Deviation|0
2306175|NCT02682823|4007915|FG003|Overall Study|Protocol Deviation|0
2306176|NCT02682823|4007916|FG004|Overall Study|Protocol Deviation|0
2087440|NCT00739973|3673288|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2087441|NCT00739973|3673289|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2087442|NCT00739973|3673290|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2087443|NCT00739973|3673291|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2087444|NCT00739973|3673292|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2087445|NCT00739973|3673293|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2087446|NCT00739973|3673294|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2087447|NCT00739973|3673286|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
2087448|NCT00739973|3673287|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
2087449|NCT00739973|3673288|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
2087450|NCT00739973|3673289|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
2087451|NCT00739973|3673290|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
2087452|NCT00739973|3673291|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
2087453|NCT00739973|3673292|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
2087454|NCT00739973|3673293|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
2087455|NCT00739973|3673294|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
2087456|NCT00739973|3673286|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2087457|NCT00739973|3673287|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2087458|NCT00739973|3673288|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
2087459|NCT00739973|3673289|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2087460|NCT00739973|3673290|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2087461|NCT00739973|3673291|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2087462|NCT00739973|3673292|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2087463|NCT00739973|3673293|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2087464|NCT00739973|3673294|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2087465|NCT00739973|3673286|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
2087466|NCT00739973|3673287|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
2087467|NCT00739973|3673288|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
2087468|NCT00739973|3673289|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
2087469|NCT00739973|3673290|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
2087470|NCT00739973|3673291|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
2087471|NCT00739973|3673292|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
2087472|NCT00739973|3673293|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
2087473|NCT00739973|3673294|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
2087474|NCT00739973|3673286|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
2087475|NCT00739973|3673287|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
2087476|NCT00739973|3673288|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
2087477|NCT00739973|3673289|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
2087478|NCT00739973|3673290|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
2087479|NCT00739973|3673291|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
2087480|NCT00739973|3673292|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
2087481|NCT00739973|3673293|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
2087482|NCT00739973|3673294|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
2087483|NCT00739973|3673286|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2087484|NCT00739973|3673287|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2087485|NCT00739973|3673288|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2087486|NCT00739973|3673289|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2087487|NCT00739973|3673290|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2087488|NCT00739973|3673291|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2087489|NCT00739973|3673292|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
2087490|NCT00739973|3673293|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2087491|NCT00739973|3673294|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2087492|NCT00739973|3673286|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
2087493|NCT00739973|3673287|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
2087494|NCT00739973|3673288|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
2087495|NCT00739973|3673289|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
2087496|NCT00739973|3673290|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
2087497|NCT00739973|3673291|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
2087498|NCT00739973|3673292|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
2087499|NCT00739973|3673293|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
2087500|NCT00739973|3673294|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
2087501|NCT00739973|3673286|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2087502|NCT00739973|3673287|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
2087503|NCT00739973|3673288|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2087504|NCT00739973|3673289|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2087505|NCT00739973|3673290|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2087506|NCT00739973|3673291|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2087507|NCT00739973|3673292|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
2087508|NCT00739973|3673293|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2087509|NCT00739973|3673294|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2087510|NCT00740051|3673338|FG000|Overall Study|Lack of Efficacy|2
2087511|NCT00740051|3673339|FG001|Overall Study|Lack of Efficacy|5
2087512|NCT00740051|3673338|FG000|Overall Study|Adverse Event|1
2087513|NCT00740051|3673339|FG001|Overall Study|Adverse Event|4
2087514|NCT00740051|3673338|FG000|Overall Study|Protocol Violation|2
2211599|NCT01662310|3852000|FG004|Double-Blind Phase|Adverse Event|0
2211600|NCT01662310|3851996|FG000|Double-Blind Phase|Lost to Follow-up|0
2211601|NCT01662310|3851997|FG001|Double-Blind Phase|Lost to Follow-up|3
2211602|NCT01662310|3851998|FG002|Double-Blind Phase|Lost to Follow-up|0
2211603|NCT01662310|3851999|FG003|Double-Blind Phase|Lost to Follow-up|0
2211604|NCT01662310|3852000|FG004|Double-Blind Phase|Lost to Follow-up|0
2211605|NCT01662310|3851996|FG000|Double-Blind Phase|Pregnancy|0
2211606|NCT01662310|3851997|FG001|Double-Blind Phase|Pregnancy|2
2211607|NCT01662310|3851998|FG002|Double-Blind Phase|Pregnancy|0
2211608|NCT01662310|3851999|FG003|Double-Blind Phase|Pregnancy|0
2087515|NCT00740051|3673339|FG001|Overall Study|Protocol Violation|6
2087516|NCT00740051|3673338|FG000|Overall Study|Lost to Follow-up|3
2087517|NCT00740051|3673339|FG001|Overall Study|Lost to Follow-up|8
2087518|NCT00740051|3673338|FG000|Overall Study|Withdrawal by Subject|6
2087519|NCT00740051|3673339|FG001|Overall Study|Withdrawal by Subject|8
2087520|NCT00740051|3673338|FG000|Overall Study|Other reason (not specified)|4
2087521|NCT00740051|3673339|FG001|Overall Study|Other reason (not specified)|1
2087522|NCT00740220|3673364|FG000|Overall Study|screen failures (non-COPD patients)|9
2087523|NCT00740584|3673377|FG000|Overall Study|Withdrawal by Subject|1
2087524|NCT00740636|3673384|FG000|Overall Study|Adverse Event|0
2087525|NCT00740636|3673385|FG001|Overall Study|Adverse Event|2
2087526|NCT00740636|3673384|FG000|Overall Study|Patient Ineligible|0
2087527|NCT00740636|3673385|FG001|Overall Study|Patient Ineligible|1
2087528|NCT00740636|3673384|FG000|Overall Study|Patient Not Treated|0
2087529|NCT00740636|3673385|FG001|Overall Study|Patient Not Treated|1
2087530|NCT00740636|3673384|FG000|Overall Study|Progressive Disease|1
2087531|NCT00740636|3673385|FG001|Overall Study|Progressive Disease|0
2087532|NCT00740636|3673384|FG000|Overall Study|Death|1
2087533|NCT00740636|3673385|FG001|Overall Study|Death|0
2087534|NCT00740714|3673394|FG000|Overall Study|Withdrawal by Subject|17
2087535|NCT00740714|3673395|FG001|Overall Study|Withdrawal by Subject|19
2087536|NCT00740714|3673396|FG002|Overall Study|Withdrawal by Subject|29
2087537|NCT00740779|3673407|FG000|Overall Study|Adverse Event|4
2087538|NCT00740779|3673408|FG001|Overall Study|Adverse Event|6
2087539|NCT00740779|3673409|FG002|Overall Study|Adverse Event|3
2087540|NCT00740779|3673407|FG000|Overall Study|Protocol Violation|1
2087541|NCT00740779|3673408|FG001|Overall Study|Protocol Violation|1
2087542|NCT00740779|3673409|FG002|Overall Study|Protocol Violation|1
2087543|NCT00740779|3673407|FG000|Overall Study|Lack of Efficacy|0
2087544|NCT00740779|3673408|FG001|Overall Study|Lack of Efficacy|0
2087545|NCT00740779|3673409|FG002|Overall Study|Lack of Efficacy|2
2087546|NCT00740779|3673407|FG000|Overall Study|Withdrawal by Subject|2
2087547|NCT00740779|3673408|FG001|Overall Study|Withdrawal by Subject|4
2087548|NCT00740779|3673409|FG002|Overall Study|Withdrawal by Subject|2
2087549|NCT00740779|3673407|FG000|Overall Study|Lost to Follow-up|2
2087550|NCT00740779|3673408|FG001|Overall Study|Lost to Follow-up|3
2087551|NCT00740779|3673409|FG002|Overall Study|Lost to Follow-up|5
2087552|NCT00740792|3673421|FG000|Overall Study|Adverse Event|3
2087553|NCT00740792|3673422|FG001|Overall Study|Adverse Event|1
2087554|NCT00740792|3673423|FG002|Overall Study|Adverse Event|1
2087555|NCT00740792|3673424|FG003|Overall Study|Adverse Event|3
2087556|NCT00740792|3673421|FG000|Overall Study|Lack of Efficacy|1
2087557|NCT00740792|3673422|FG001|Overall Study|Lack of Efficacy|1
2087558|NCT00740792|3673423|FG002|Overall Study|Lack of Efficacy|0
2087559|NCT00740792|3673424|FG003|Overall Study|Lack of Efficacy|3
2087560|NCT00740792|3673421|FG000|Overall Study|Lost to Follow-up|2
2087561|NCT00740792|3673422|FG001|Overall Study|Lost to Follow-up|1
2087562|NCT00740792|3673423|FG002|Overall Study|Lost to Follow-up|0
2087563|NCT00740792|3673424|FG003|Overall Study|Lost to Follow-up|0
2087564|NCT00740792|3673421|FG000|Overall Study|Protocol Violation|0
2087565|NCT00740792|3673422|FG001|Overall Study|Protocol Violation|1
2087566|NCT00740792|3673423|FG002|Overall Study|Protocol Violation|0
2087567|NCT00740792|3673424|FG003|Overall Study|Protocol Violation|2
2087568|NCT00740792|3673421|FG000|Overall Study|Withdrawal by Subject|1
2087569|NCT00740792|3673422|FG001|Overall Study|Withdrawal by Subject|1
2087570|NCT00740792|3673423|FG002|Overall Study|Withdrawal by Subject|0
2087571|NCT00740792|3673424|FG003|Overall Study|Withdrawal by Subject|0
2211609|NCT01662310|3852000|FG004|Double-Blind Phase|Pregnancy|0
2087572|NCT00740792|3673421|FG000|Overall Study|administrative|3
2087573|NCT00740792|3673422|FG001|Overall Study|administrative|3
2087574|NCT00740792|3673423|FG002|Overall Study|administrative|8
2087575|NCT00740792|3673424|FG003|Overall Study|administrative|2
2087576|NCT00740857|3673450|FG000|Overall Study|Withdrawal by Subject|1
2087577|NCT00740857|3673451|FG001|Overall Study|Withdrawal by Subject|0
2087578|NCT00740857|3673452|FG002|Overall Study|Withdrawal by Subject|0
2087579|NCT00740870|3673460|FG000|Overall Study|Not Catheterized|4
2087580|NCT00740870|3673460|FG000|Overall Study|Further testing contraindicated implant|17
2087581|NCT00741013|3673470|FG000|Overall Study|Adverse Event|1
2087582|NCT00741013|3673471|FG001|Overall Study|Adverse Event|0
2087583|NCT00741013|3673472|FG002|Overall Study|Adverse Event|0
2087584|NCT00741013|3673470|FG000|Overall Study|Withdrawal by Subject|0
2087585|NCT00741013|3673471|FG001|Overall Study|Withdrawal by Subject|0
2087586|NCT00741013|3673472|FG002|Overall Study|Withdrawal by Subject|1
2087587|NCT00741013|3673470|FG000|Overall Study|Discovered failed screen after enrolled|0
2087588|NCT00741013|3673471|FG001|Overall Study|Discovered failed screen after enrolled|2
2087589|NCT00741013|3673472|FG002|Overall Study|Discovered failed screen after enrolled|0
2087590|NCT00741039|3673488|FG000|Overall Study|Patient non-compliance|2
2087591|NCT00741039|3673489|FG001|Overall Study|Patient non-compliance|0
2087592|NCT00741091|3673495|FG000|Overall Study|Death|13
2087593|NCT00741091|3673495|FG000|Overall Study|Lost to Follow-up|16
2087594|NCT00741091|3673495|FG000|Overall Study|Withdrawal by Subject|6
2087595|NCT00741091|3673495|FG000|Overall Study|Missed Visit|22
2087596|NCT00741260|3673525|FG000|Overall Study|Disease Progression|3
2087597|NCT00741260|3673526|FG001|Overall Study|Disease Progression|5
2087598|NCT00741260|3673527|FG002|Overall Study|Disease Progression|3
2087599|NCT00741260|3673528|FG003|Overall Study|Disease Progression|3
2087600|NCT00741260|3673529|FG004|Overall Study|Disease Progression|5
2087601|NCT00741260|3673530|FG005|Overall Study|Disease Progression|37
2087602|NCT00741260|3673531|FG006|Overall Study|Disease Progression|4
2087603|NCT00741260|3673525|FG000|Overall Study|Death|0
2087604|NCT00741260|3673526|FG001|Overall Study|Death|1
2087605|NCT00741260|3673527|FG002|Overall Study|Death|0
2087606|NCT00741260|3673528|FG003|Overall Study|Death|1
2087607|NCT00741260|3673529|FG004|Overall Study|Death|2
2087608|NCT00741260|3673530|FG005|Overall Study|Death|2
2087609|NCT00741260|3673531|FG006|Overall Study|Death|1
2087610|NCT00741260|3673525|FG000|Overall Study|Withdrawal by Subject|0
2087611|NCT00741260|3673526|FG001|Overall Study|Withdrawal by Subject|0
2087612|NCT00741260|3673527|FG002|Overall Study|Withdrawal by Subject|0
2087613|NCT00741260|3673528|FG003|Overall Study|Withdrawal by Subject|0
2087614|NCT00741260|3673529|FG004|Overall Study|Withdrawal by Subject|1
2087615|NCT00741260|3673530|FG005|Overall Study|Withdrawal by Subject|3
2087616|NCT00741260|3673531|FG006|Overall Study|Withdrawal by Subject|1
2087617|NCT00741260|3673525|FG000|Overall Study|Physician Decision|1
2087618|NCT00741260|3673526|FG001|Overall Study|Physician Decision|1
2087619|NCT00741260|3673527|FG002|Overall Study|Physician Decision|0
2087620|NCT00741260|3673528|FG003|Overall Study|Physician Decision|0
2087621|NCT00741260|3673529|FG004|Overall Study|Physician Decision|0
2087622|NCT00741260|3673530|FG005|Overall Study|Physician Decision|0
2087623|NCT00741260|3673531|FG006|Overall Study|Physician Decision|0
2087624|NCT00741260|3673525|FG000|Overall Study|Other|2
2087625|NCT00741260|3673526|FG001|Overall Study|Other|1
2087626|NCT00741260|3673527|FG002|Overall Study|Other|1
2087627|NCT00741260|3673528|FG003|Overall Study|Other|2
2087628|NCT00741260|3673529|FG004|Overall Study|Other|1
2087629|NCT00741260|3673530|FG005|Overall Study|Other|3
2087630|NCT00741260|3673531|FG006|Overall Study|Other|1
2087631|NCT00741286|3673567|FG000|Overall Study|Lost to Follow-up|15
2087632|NCT00741286|3673568|FG001|Overall Study|Lost to Follow-up|10
2087633|NCT00741286|3673567|FG000|Overall Study|Adverse Event|1
2087634|NCT00741286|3673568|FG001|Overall Study|Adverse Event|6
2087635|NCT00741286|3673567|FG000|Overall Study|Protocol Violation|3
2087636|NCT00741286|3673568|FG001|Overall Study|Protocol Violation|2
2087637|NCT00741286|3673567|FG000|Overall Study|Primary Outcome|1
2087638|NCT00741286|3673568|FG001|Overall Study|Primary Outcome|1
2087639|NCT00741338|3673576|FG000|Overall Study|Adverse Event|0
2087640|NCT00741338|3673577|FG001|Overall Study|Adverse Event|1
2087641|NCT00741598|3673619|FG000|Overall Study|Lost to Follow-up|3
2087642|NCT00741598|3673620|FG001|Overall Study|Lost to Follow-up|4
2087643|NCT00741598|3673619|FG000|Overall Study|Lack of Efficacy|1
2087644|NCT00741598|3673620|FG001|Overall Study|Lack of Efficacy|2
2087645|NCT00741598|3673619|FG000|Overall Study|Physician Decision|1
2087646|NCT00741598|3673620|FG001|Overall Study|Physician Decision|1
2087647|NCT00741598|3673619|FG000|Overall Study|Pregnancy|1
2087648|NCT00741598|3673620|FG001|Overall Study|Pregnancy|0
2087649|NCT00741598|3673619|FG000|Overall Study|Withdrawal by Subject|3
2087650|NCT00741598|3673620|FG001|Overall Study|Withdrawal by Subject|2
2087651|NCT00741611|3673630|FG000|Overall Study|Death|0
2087652|NCT00741611|3673631|FG001|Overall Study|Death|0
2087653|NCT00741611|3673632|FG002|Overall Study|Death|1
2087654|NCT00741611|3673630|FG000|Overall Study|Withdrawal by Subject|0
2087655|NCT00741611|3673631|FG001|Overall Study|Withdrawal by Subject|2
2087656|NCT00741611|3673632|FG002|Overall Study|Withdrawal by Subject|2
2087657|NCT00741819|3673641|FG000|Overall Study|Adverse Event|3
2087658|NCT00741819|3673641|FG000|Overall Study|Withdrawal by Subject|3
2087659|NCT00741819|3673641|FG000|Overall Study|Death|1
2087660|NCT00741819|3673641|FG000|Overall Study|Disease progression|1
2087661|NCT00741936|3673658|FG000|Overall Study|Lost to Follow-up|1
2087662|NCT00741936|3673659|FG001|Overall Study|Lost to Follow-up|1
2087663|NCT00741936|3673658|FG000|Overall Study|Adverse Event|3
2087664|NCT00741936|3673659|FG001|Overall Study|Adverse Event|4
2087665|NCT00741936|3673658|FG000|Overall Study|Pregnancy|0
2087666|NCT00741936|3673659|FG001|Overall Study|Pregnancy|1
2087667|NCT00741936|3673658|FG000|Overall Study|Protocol Violation|2
2087668|NCT00741936|3673659|FG001|Overall Study|Protocol Violation|0
2087669|NCT00741936|3673658|FG000|Overall Study|Lack of Efficacy|0
2087670|NCT00741936|3673659|FG001|Overall Study|Lack of Efficacy|2
2087671|NCT00741936|3673658|FG000|Overall Study|Low compliance|3
2087672|NCT00741936|3673659|FG001|Overall Study|Low compliance|0
2087673|NCT00742001|3673668|FG000|Overall Study|Withdrawn; health exclusion (flu)|0
2087674|NCT00742001|3673669|FG001|Overall Study|Withdrawn; health exclusion (flu)|0
2087675|NCT00742001|3673670|FG002|Overall Study|Withdrawn; health exclusion (flu)|1
2087676|NCT00742027|3673681|FG000|Overall Study|Disease Progression|76
2087677|NCT00742027|3673681|FG000|Overall Study|New Cancer Therapy|19
2087678|NCT00742027|3673681|FG000|Overall Study|Withdrawal by Subject|18
2087679|NCT00742027|3673681|FG000|Overall Study|Death|7
2087680|NCT00742027|3673681|FG000|Overall Study|Lost to Follow-up|4
2087681|NCT00742027|3673681|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2
2087682|NCT00742027|3673681|FG000|Overall Study|Missing|2
2087683|NCT00742027|3673681|FG000|Overall Study|Administrative Problems|1
2087684|NCT00742079|3673691|FG000|Overall Study|Lost to Follow-up|0
2087685|NCT00742079|3673692|FG001|Overall Study|Lost to Follow-up|1
2087686|NCT00742183|3673709|FG000|Overall Study|Adverse Event|2
2087687|NCT00742183|3673710|FG001|Overall Study|Adverse Event|2
2087688|NCT00742183|3673709|FG000|Overall Study|Death|1
2087689|NCT00742183|3673710|FG001|Overall Study|Death|0
2087690|NCT00742183|3673709|FG000|Overall Study|Physician Decision|0
2087691|NCT00742183|3673710|FG001|Overall Study|Physician Decision|2
2087692|NCT00742183|3673709|FG000|Overall Study|Lost to Follow-up|4
2087693|NCT00742183|3673710|FG001|Overall Study|Lost to Follow-up|4
2087694|NCT00742183|3673709|FG000|Overall Study|Required skin-graft|1
2087695|NCT00742183|3673710|FG001|Overall Study|Required skin-graft|1
2087696|NCT00742183|3673709|FG000|Overall Study|Withdrawal by Subject|1
2087697|NCT00742183|3673710|FG001|Overall Study|Withdrawal by Subject|0
2087698|NCT00742183|3673709|FG000|Overall Study|Lack of Efficacy|0
2087699|NCT00742183|3673710|FG001|Overall Study|Lack of Efficacy|3
2087700|NCT00742209|3673721|FG000|Overall Study|Adverse Event|11
2087701|NCT00742209|3673722|FG001|Overall Study|Adverse Event|4
2087702|NCT00742209|3673723|FG002|Overall Study|Adverse Event|17
2087703|NCT00742209|3673724|FG003|Overall Study|Adverse Event|16
2087704|NCT00742209|3673725|FG004|Overall Study|Adverse Event|13
2087705|NCT00742209|3673721|FG000|Overall Study|Participant Withdrew Consent|8
2087706|NCT00742209|3673722|FG001|Overall Study|Participant Withdrew Consent|4
2087707|NCT00742209|3673723|FG002|Overall Study|Participant Withdrew Consent|14
2087708|NCT00742209|3673724|FG003|Overall Study|Participant Withdrew Consent|7
2087709|NCT00742209|3673725|FG004|Overall Study|Participant Withdrew Consent|4
2087710|NCT00742209|3673721|FG000|Overall Study|Protocol Violation|6
2087711|NCT00742209|3673722|FG001|Overall Study|Protocol Violation|5
2087712|NCT00742209|3673723|FG002|Overall Study|Protocol Violation|4
2087713|NCT00742209|3673724|FG003|Overall Study|Protocol Violation|5
2087714|NCT00742209|3673725|FG004|Overall Study|Protocol Violation|3
2087715|NCT00742209|3673721|FG000|Overall Study|Lost to Follow-up|3
2087716|NCT00742209|3673722|FG001|Overall Study|Lost to Follow-up|4
2087717|NCT00742209|3673723|FG002|Overall Study|Lost to Follow-up|5
2087718|NCT00742209|3673724|FG003|Overall Study|Lost to Follow-up|5
2087719|NCT00742209|3673725|FG004|Overall Study|Lost to Follow-up|3
2087720|NCT00742209|3673721|FG000|Overall Study|Lack of Efficacy|6
2087721|NCT00742209|3673722|FG001|Overall Study|Lack of Efficacy|1
2087722|NCT00742209|3673723|FG002|Overall Study|Lack of Efficacy|1
2087723|NCT00742209|3673724|FG003|Overall Study|Lack of Efficacy|3
2087724|NCT00742209|3673725|FG004|Overall Study|Lack of Efficacy|1
2087725|NCT00742209|3673721|FG000|Overall Study|Investigator Discretion|0
2087726|NCT00742209|3673722|FG001|Overall Study|Investigator Discretion|0
2087727|NCT00742209|3673723|FG002|Overall Study|Investigator Discretion|5
2087728|NCT00742209|3673724|FG003|Overall Study|Investigator Discretion|1
2087729|NCT00742209|3673725|FG004|Overall Study|Investigator Discretion|1
2087730|NCT00742235|3673740|FG000|Overall Study|Lost to Follow-up|0
2087731|NCT00742235|3673741|FG001|Overall Study|Lost to Follow-up|31
2087732|NCT00742274|3673749|FG000|Overall Study|Death|1
2087733|NCT00742274|3673750|FG001|Overall Study|Death|0
2087734|NCT00742274|3673749|FG000|Overall Study|Withdrawal by Subject|1
2087735|NCT00742274|3673750|FG001|Overall Study|Withdrawal by Subject|2
2087736|NCT00742274|3673749|FG000|Overall Study|Removed for medical reasons|1
2087737|NCT00742274|3673750|FG001|Overall Study|Removed for medical reasons|1
2087738|NCT00742326|3673767|FG000|Overall Study|Physician Decision|0
2087739|NCT00742326|3673768|FG001|Overall Study|Physician Decision|1
2087740|NCT00742391|3673776|FG000|Overall Study|Adverse Event|2
2087741|NCT00742391|3673777|FG001|Overall Study|Adverse Event|1
2087742|NCT00742391|3673776|FG000|Overall Study|Lost to Follow-up|1
2087743|NCT00742391|3673777|FG001|Overall Study|Lost to Follow-up|0
2087744|NCT00742391|3673776|FG000|Overall Study|Protocol Violation|1
2087745|NCT00742391|3673777|FG001|Overall Study|Protocol Violation|0
2087746|NCT00742417|3673785|FG000|Randomized|Withdrawal by legal representative|0
2087747|NCT00742417|3673786|FG001|Randomized|Withdrawal by legal representative|1
2087748|NCT00742417|3673785|FG000|Randomized|Withdrawal by Subject|1
2087749|NCT00742417|3673786|FG001|Randomized|Withdrawal by Subject|0
2087750|NCT00742417|3673785|FG000|Randomized|Physician Decision|1
2087751|NCT00742417|3673786|FG001|Randomized|Physician Decision|0
2087752|NCT00742417|3673785|FG000|Intensive Period|Withdrawal by Subject|1
2087753|NCT00742417|3673786|FG001|Intensive Period|Withdrawal by Subject|1
2087754|NCT00742417|3673785|FG000|Intensive Period|Adverse Event|2
2087755|NCT00742417|3673786|FG001|Intensive Period|Adverse Event|0
2087756|NCT00742508|3673805|FG000|8-Week Primary Evaluation Period|Adverse Event|2
2087757|NCT00742508|3673806|FG001|8-Week Primary Evaluation Period|Adverse Event|4
2087758|NCT00742508|3673805|FG000|8-Week Primary Evaluation Period|Protocol Violation|1
2087759|NCT00742508|3673806|FG001|8-Week Primary Evaluation Period|Protocol Violation|0
2087760|NCT00742508|3673805|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
2087761|NCT00742508|3673806|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
2087762|NCT00742508|3673805|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0
2087763|NCT00742508|3673806|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2
2087764|NCT00742508|3673805|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
2087765|NCT00742508|3673806|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
2087766|NCT00742560|3673817|FG000|Overall Study|Adverse Event|0
2087767|NCT00742560|3673818|FG001|Overall Study|Adverse Event|0
2087768|NCT00742560|3673819|FG002|Overall Study|Adverse Event|1
2087769|NCT00742560|3673820|FG003|Overall Study|Adverse Event|1
2087770|NCT00742560|3673821|FG004|Overall Study|Adverse Event|1
2087771|NCT00742560|3673817|FG000|Overall Study|Death|0
2087772|NCT00742560|3673818|FG001|Overall Study|Death|2
2087773|NCT00742560|3673819|FG002|Overall Study|Death|0
2087774|NCT00742560|3673820|FG003|Overall Study|Death|2
2087775|NCT00742560|3673821|FG004|Overall Study|Death|3
2087776|NCT00742560|3673817|FG000|Overall Study|Subject's Decision|1
2087777|NCT00742560|3673818|FG001|Overall Study|Subject's Decision|0
2087778|NCT00742560|3673819|FG002|Overall Study|Subject's Decision|2
2087779|NCT00742560|3673820|FG003|Overall Study|Subject's Decision|3
2087780|NCT00742560|3673821|FG004|Overall Study|Subject's Decision|3
2087781|NCT00742560|3673817|FG000|Overall Study|Investigator's Decision|0
2087782|NCT00742560|3673818|FG001|Overall Study|Investigator's Decision|0
2087783|NCT00742560|3673819|FG002|Overall Study|Investigator's Decision|4
2087784|NCT00742560|3673820|FG003|Overall Study|Investigator's Decision|1
2087785|NCT00742560|3673821|FG004|Overall Study|Investigator's Decision|0
2087786|NCT00742560|3673817|FG000|Overall Study|Disease Progression|1
2087787|NCT00742560|3673818|FG001|Overall Study|Disease Progression|0
2087788|NCT00742560|3673819|FG002|Overall Study|Disease Progression|5
2087789|NCT00742560|3673820|FG003|Overall Study|Disease Progression|17
2087790|NCT00742560|3673821|FG004|Overall Study|Disease Progression|16
2087791|NCT00742560|3673817|FG000|Overall Study|New Multiple Myeloma Therapy|1
2087792|NCT00742560|3673818|FG001|Overall Study|New Multiple Myeloma Therapy|0
2087793|NCT00742560|3673819|FG002|Overall Study|New Multiple Myeloma Therapy|2
2087794|NCT00742560|3673820|FG003|Overall Study|New Multiple Myeloma Therapy|3
2087795|NCT00742560|3673821|FG004|Overall Study|New Multiple Myeloma Therapy|4
2087796|NCT00742560|3673817|FG000|Overall Study|Other|0
2087797|NCT00742560|3673818|FG001|Overall Study|Other|1
2087798|NCT00742560|3673819|FG002|Overall Study|Other|8
2087799|NCT00742560|3673820|FG003|Overall Study|Other|9
2087800|NCT00742560|3673821|FG004|Overall Study|Other|9
2087801|NCT00742560|3673817|FG000|Overall Study|MIssing|0
2087802|NCT00742560|3673818|FG001|Overall Study|MIssing|0
2087803|NCT00742560|3673819|FG002|Overall Study|MIssing|0
2087804|NCT00742560|3673820|FG003|Overall Study|MIssing|0
2087805|NCT00742560|3673821|FG004|Overall Study|MIssing|1
2087806|NCT00742625|3673861|FG000|Remission Induction|Progression|6
2087807|NCT00742625|3673861|FG000|Remission Induction|Failed induction|8
2087808|NCT00742625|3673861|FG000|Remission Induction|Adverse Event|3
2087809|NCT00742625|3673861|FG000|Remission Induction|Death|10
2087810|NCT00742625|3673861|FG000|Remission Induction|Refusal|5
2087811|NCT00742625|3673861|FG000|Remission Induction|Non protocol treatment|17
2087812|NCT00742625|3673861|FG000|Remission Induction|Other, not specified|5
2087813|NCT00742625|3673861|FG000|Consolidation|Progression|5
2087814|NCT00742625|3673861|FG000|Consolidation|Adverse Event|1
2087815|NCT00742625|3673861|FG000|Consolidation|Death|1
2087816|NCT00742625|3673861|FG000|Consolidation|Refused|1
2087817|NCT00742625|3673861|FG000|Consolidation|Non protocol therapy|13
2087818|NCT00742781|3673868|FG000|Overall Study|Withdrawal by Subject|3
2087819|NCT00742859|3673877|FG000|Overall Study|Adverse Event|5
2087820|NCT00742859|3673878|FG001|Overall Study|Adverse Event|6
2087821|NCT00742859|3673879|FG002|Overall Study|Adverse Event|3
2087822|NCT00742859|3673880|FG003|Overall Study|Adverse Event|1
2087823|NCT00742859|3673877|FG000|Overall Study|Death|1
2087824|NCT00742859|3673878|FG001|Overall Study|Death|0
2087825|NCT00742859|3673879|FG002|Overall Study|Death|0
2087826|NCT00742859|3673880|FG003|Overall Study|Death|1
2087827|NCT00742859|3673877|FG000|Overall Study|Physician Decision|1
2087828|NCT00742859|3673878|FG001|Overall Study|Physician Decision|2
2087829|NCT00742859|3673879|FG002|Overall Study|Physician Decision|0
2087830|NCT00742859|3673880|FG003|Overall Study|Physician Decision|0
2087831|NCT00742859|3673877|FG000|Overall Study|Withdrawal by Subject|4
2087832|NCT00742859|3673878|FG001|Overall Study|Withdrawal by Subject|2
2087833|NCT00742859|3673879|FG002|Overall Study|Withdrawal by Subject|4
2087834|NCT00742859|3673880|FG003|Overall Study|Withdrawal by Subject|1
2087835|NCT00742859|3673877|FG000|Overall Study|Endpoint|0
2087836|NCT00742859|3673878|FG001|Overall Study|Endpoint|1
2087837|NCT00742859|3673879|FG002|Overall Study|Endpoint|1
2087838|NCT00742859|3673880|FG003|Overall Study|Endpoint|2
2087839|NCT00742859|3673877|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0
2087840|NCT00742859|3673878|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1
2087841|NCT00742859|3673879|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1
2087842|NCT00742859|3673880|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0
2087843|NCT00742859|3673877|FG000|Overall Study|Sponsor req visit schedule noncompliance|0
2087844|NCT00742859|3673878|FG001|Overall Study|Sponsor req visit schedule noncompliance|0
2087845|NCT00742859|3673879|FG002|Overall Study|Sponsor req visit schedule noncompliance|0
2087846|NCT00742859|3673880|FG003|Overall Study|Sponsor req visit schedule noncompliance|1
2087847|NCT00742859|3673877|FG000|Overall Study|Sponsor request patient out of town|0
2087848|NCT00742859|3673878|FG001|Overall Study|Sponsor request patient out of town|0
2087849|NCT00742859|3673879|FG002|Overall Study|Sponsor request patient out of town|1
2087850|NCT00742859|3673880|FG003|Overall Study|Sponsor request patient out of town|1
2087851|NCT00742859|3673877|FG000|Overall Study|Site error|0
2087852|NCT00742859|3673878|FG001|Overall Study|Site error|0
2087853|NCT00742859|3673879|FG002|Overall Study|Site error|1
2087854|NCT00742859|3673880|FG003|Overall Study|Site error|1
2087855|NCT00742885|3673901|FG000|Overall Study|Lost to Follow-up|1
2087856|NCT00742885|3673902|FG001|Overall Study|Lost to Follow-up|0
2087857|NCT00742924|3673915|FG000|Overall Study|Adverse Event|0
2087858|NCT00742924|3673916|FG001|Overall Study|Adverse Event|0
2087859|NCT00742924|3673917|FG002|Overall Study|Adverse Event|1
2087860|NCT00742924|3673918|FG003|Overall Study|Adverse Event|1
2087861|NCT00742924|3673915|FG000|Overall Study|Lack of Efficacy|5
2087862|NCT00742924|3673916|FG001|Overall Study|Lack of Efficacy|1
2087863|NCT00742924|3673917|FG002|Overall Study|Lack of Efficacy|2
2087864|NCT00742924|3673918|FG003|Overall Study|Lack of Efficacy|4
2087865|NCT00742924|3673915|FG000|Overall Study|Physician Decision|0
2087866|NCT00742924|3673916|FG001|Overall Study|Physician Decision|0
2087867|NCT00742924|3673917|FG002|Overall Study|Physician Decision|0
2087868|NCT00742924|3673918|FG003|Overall Study|Physician Decision|1
2087869|NCT00742924|3673915|FG000|Overall Study|Withdrawal by Subject|0
2087870|NCT00742924|3673916|FG001|Overall Study|Withdrawal by Subject|1
2087871|NCT00742924|3673917|FG002|Overall Study|Withdrawal by Subject|1
2087872|NCT00742924|3673918|FG003|Overall Study|Withdrawal by Subject|0
2087873|NCT00743106|3673943|FG000|Overall Study|Met intraoperative exclusion criterion|8
2087874|NCT00743106|3673944|FG001|Overall Study|Met intraoperative exclusion criterion|5
2087875|NCT00743119|3673950|FG000|Overall Study|unreliable|3
2087876|NCT00743119|3673950|FG000|Overall Study|Withdrawal by Subject|1
2087877|NCT00743145|3673962|FG000|Overall Study|Withdrawal by Subject|1
2087878|NCT00743145|3673962|FG000|Overall Study|Adverse Event|2
2087879|NCT00743145|3673962|FG000|Overall Study|Pregnancy|1
2087880|NCT00743249|3673978|FG000|Overall Study|Adverse Event|0
2087881|NCT00743249|3673979|FG001|Overall Study|Adverse Event|4
2087882|NCT00743249|3673978|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0
2087883|NCT00743249|3673979|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1
2087884|NCT00743249|3673978|FG000|Overall Study|Unsuccessful insertion of stent|2
2087885|NCT00743249|3673979|FG001|Overall Study|Unsuccessful insertion of stent|1
2087886|NCT00743275|3673991|FG000|Overall Study|Protocol Violation|0
2087887|NCT00743275|3673992|FG001|Overall Study|Protocol Violation|1
2087888|NCT00743288|3673998|FG000|Overall Study|Adverse Event|1
2087889|NCT00743288|3673999|FG001|Overall Study|Adverse Event|1
2087890|NCT00743288|3674000|FG002|Overall Study|Adverse Event|2
2087891|NCT00743288|3674001|FG003|Overall Study|Adverse Event|2
2087892|NCT00743288|3674002|FG004|Overall Study|Adverse Event|1
2087893|NCT00743288|3674003|FG005|Overall Study|Adverse Event|1
2087894|NCT00743288|3674004|FG006|Overall Study|Adverse Event|2
2087895|NCT00743288|3673998|FG000|Overall Study|Withdrawal by Subject|0
2087896|NCT00743288|3673999|FG001|Overall Study|Withdrawal by Subject|0
2087897|NCT00743288|3674000|FG002|Overall Study|Withdrawal by Subject|1
2087898|NCT00743288|3674001|FG003|Overall Study|Withdrawal by Subject|0
2087899|NCT00743288|3674002|FG004|Overall Study|Withdrawal by Subject|0
2087900|NCT00743288|3674003|FG005|Overall Study|Withdrawal by Subject|1
2087901|NCT00743288|3674004|FG006|Overall Study|Withdrawal by Subject|1
2087902|NCT00743288|3673998|FG000|Overall Study|Progressive disease (PD)|2
2087903|NCT00743288|3673999|FG001|Overall Study|Progressive disease (PD)|0
2087904|NCT00743288|3674000|FG002|Overall Study|Progressive disease (PD)|1
2087905|NCT00743288|3674001|FG003|Overall Study|Progressive disease (PD)|4
2087906|NCT00743288|3674002|FG004|Overall Study|Progressive disease (PD)|5
2087907|NCT00743288|3674003|FG005|Overall Study|Progressive disease (PD)|3
2087908|NCT00743288|3674004|FG006|Overall Study|Progressive disease (PD)|6
2087909|NCT00743288|3673998|FG000|Overall Study|Worsening of condition (Not PD)|0
2087910|NCT00743288|3673999|FG001|Overall Study|Worsening of condition (Not PD)|2
2087911|NCT00743288|3674000|FG002|Overall Study|Worsening of condition (Not PD)|1
2087912|NCT00743288|3674001|FG003|Overall Study|Worsening of condition (Not PD)|1
2087913|NCT00743288|3674002|FG004|Overall Study|Worsening of condition (Not PD)|0
2087914|NCT00743288|3674003|FG005|Overall Study|Worsening of condition (Not PD)|0
2087915|NCT00743288|3674004|FG006|Overall Study|Worsening of condition (Not PD)|0
2087916|NCT00743340|3674015|FG000|Overall Study|Study medication non-compliance|1
2087917|NCT00743340|3674015|FG000|Overall Study|Lost to Follow-up|1
2087918|NCT00743340|3674015|FG000|Overall Study|Withdrawal from the Study|5
2087919|NCT00743340|3674015|FG000|Overall Study|Protocol Violation|1
2087920|NCT00743340|3674015|FG000|Overall Study|Virologic failure|8
2087921|NCT00743340|3674015|FG000|Overall Study|Pregnancy|1
2087922|NCT00743340|3674015|FG000|Overall Study|Rolled over to other Gilead Study|23
2087923|NCT00743340|3674015|FG000|Overall Study|Participant Relocated|1
2087924|NCT00743366|3674019|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3
2087925|NCT00743366|3674020|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3
2087926|NCT00743431|3674026|FG000|Overall Study|Toxicity|6
2087927|NCT00743431|3674026|FG000|Overall Study|Tumor progression|56
2087928|NCT00743431|3674026|FG000|Overall Study|Withdrawal by Subject|13
2087929|NCT00743431|3674026|FG000|Overall Study|Death|9
2087930|NCT00743431|3674026|FG000|Overall Study|Reason for discontinuation not specified|29
2087931|NCT00743431|3674026|FG000|Overall Study|No documentation available|13
2087932|NCT00743444|3674030|FG000|First Intervention|Catheter placement problems|0
2087933|NCT00743444|3674031|FG001|First Intervention|Catheter placement problems|1
2087934|NCT00743444|3674030|FG000|Washout Period|Adverse Event|0
2087935|NCT00743444|3674031|FG001|Washout Period|Adverse Event|1
2087936|NCT00743483|3674037|FG000|Baseline Period|Physician Decision|1
2087937|NCT00743483|3674037|FG000|Treatment Period|Adverse Event|1
2087938|NCT00743509|3674041|FG000|Overall Study|Withdrawal by Subject|2
2107284|NCT00871871|3700788|FG003|Part I|Withdrawal by Subject|0
2107285|NCT00871871|3700785|FG000|Part I|Laboratory abnormality|0
2107286|NCT00871871|3700786|FG001|Part I|Laboratory abnormality|1
2107287|NCT00871871|3700787|FG002|Part I|Laboratory abnormality|0
2107288|NCT00871871|3700788|FG003|Part I|Laboratory abnormality|0
2107289|NCT00871871|3700785|FG000|Part II|Lack of Efficacy|0
2107290|NCT00871871|3700786|FG001|Part II|Lack of Efficacy|0
2107291|NCT00871871|3700787|FG002|Part II|Lack of Efficacy|1
2107292|NCT00871871|3700788|FG003|Part II|Lack of Efficacy|0
2107293|NCT00871871|3700785|FG000|Part II|Withdrawal by Subject|0
2107294|NCT00871871|3700786|FG001|Part II|Withdrawal by Subject|0
2107295|NCT00871871|3700787|FG002|Part II|Withdrawal by Subject|2
2107296|NCT00871871|3700788|FG003|Part II|Withdrawal by Subject|1
2107297|NCT00871871|3700785|FG000|Part II|Adverse Event|0
2107298|NCT00871871|3700786|FG001|Part II|Adverse Event|0
2107299|NCT00871871|3700787|FG002|Part II|Adverse Event|1
2107300|NCT00871871|3700788|FG003|Part II|Adverse Event|2
2107301|NCT00871871|3700785|FG000|Part II|Protocol Violation|0
2107302|NCT00871871|3700786|FG001|Part II|Protocol Violation|0
2107303|NCT00871871|3700787|FG002|Part II|Protocol Violation|0
2107304|NCT00871871|3700788|FG003|Part II|Protocol Violation|1
2107305|NCT00871923|3700798|FG000|Overall Study|Death|1
2107306|NCT00871923|3700798|FG000|Overall Study|Withdrawal by Subject|1
2107307|NCT00871975|3700802|FG000|Overall Study|Technical difficulty w155-1ith equipment|3
2107308|NCT00871975|3700802|FG000|Overall Study|Catheters could not be inserted|1
2107309|NCT00871975|3700802|FG000|Overall Study|Patient unable to void/insufficient vol|13
2107310|NCT00871975|3700802|FG000|Overall Study|Motion artifact, tracing uninterpretable|5
2107311|NCT00872001|3700808|FG000|Overall Study|Adverse Event|34
2107312|NCT00872001|3700809|FG001|Overall Study|Adverse Event|23
2107313|NCT00872001|3700808|FG000|Overall Study|Protocol Defined Clinical Event|5
2107314|NCT00872001|3700809|FG001|Overall Study|Protocol Defined Clinical Event|7
2107315|NCT00872001|3700808|FG000|Overall Study|Lost to Follow-up|13
2107316|NCT00872001|3700809|FG001|Overall Study|Lost to Follow-up|12
2107317|NCT00872001|3700808|FG000|Overall Study|Withdrawal by Subject|18
2107318|NCT00872001|3700809|FG001|Overall Study|Withdrawal by Subject|30
2107319|NCT00872001|3700808|FG000|Overall Study|Protocol Violation|5
2107320|NCT00872001|3700809|FG001|Overall Study|Protocol Violation|8
2107321|NCT00872001|3700808|FG000|Overall Study|Did Not Meet Protocol Eligibility|38
2107322|NCT00872001|3700809|FG001|Overall Study|Did Not Meet Protocol Eligibility|36
2107323|NCT00872001|3700808|FG000|Overall Study|Administrative|23
2107324|NCT00872001|3700809|FG001|Overall Study|Administrative|15
2107325|NCT00872170|3700832|FG000|Overall Study|Adverse Event|1
2107326|NCT00872170|3700833|FG001|Overall Study|Adverse Event|0
2107327|NCT00872521|3700854|FG000|Completed PAD Induction|Patient choice|0
2107328|NCT00872521|3700855|FG001|Completed PAD Induction|Patient choice|1
2107329|NCT00872521|3700856|FG002|Completed PAD Induction|Patient choice|0
2107330|NCT00872521|3700854|FG000|Completed PAD Induction|Disease progression|0
2107331|NCT00872521|3700855|FG001|Completed PAD Induction|Disease progression|2
2107332|NCT00872521|3700856|FG002|Completed PAD Induction|Disease progression|0
2107333|NCT00872521|3700854|FG000|Completed PAD Induction|Adverse Event|4
2107334|NCT00872521|3700855|FG001|Completed PAD Induction|Adverse Event|0
2107335|NCT00872521|3700856|FG002|Completed PAD Induction|Adverse Event|0
2107336|NCT00872521|3700854|FG000|Completed PAD Induction|Death|1
2107337|NCT00872521|3700855|FG001|Completed PAD Induction|Death|1
2107338|NCT00872521|3700856|FG002|Completed PAD Induction|Death|0
2107339|NCT00872521|3700854|FG000|Primary Endpoint Analysis|Other|1
2107340|NCT00872521|3700855|FG001|Primary Endpoint Analysis|Other|2
2087939|NCT00743652|3674054|FG000|Overall Study|Parent/Legal Guardian Request|3
2087940|NCT00743652|3674055|FG001|Overall Study|Parent/Legal Guardian Request|2
2087941|NCT00743652|3674056|FG002|Overall Study|Parent/Legal Guardian Request|2
2087942|NCT00743652|3674057|FG003|Overall Study|Parent/Legal Guardian Request|2
2087943|NCT00743652|3674058|FG004|Overall Study|Parent/Legal Guardian Request|0
2087944|NCT00743652|3674054|FG000|Overall Study|Adverse Event|3
2087945|NCT00743652|3674055|FG001|Overall Study|Adverse Event|0
2087946|NCT00743652|3674056|FG002|Overall Study|Adverse Event|0
2087947|NCT00743652|3674057|FG003|Overall Study|Adverse Event|0
2087948|NCT00743652|3674058|FG004|Overall Study|Adverse Event|0
2087949|NCT00743652|3674054|FG000|Overall Study|Death|2
2087950|NCT00743652|3674055|FG001|Overall Study|Death|0
2087951|NCT00743652|3674056|FG002|Overall Study|Death|0
2087952|NCT00743652|3674057|FG003|Overall Study|Death|0
2087953|NCT00743652|3674058|FG004|Overall Study|Death|0
2087954|NCT00743652|3674054|FG000|Overall Study|Investigator Request|0
2087955|NCT00743652|3674055|FG001|Overall Study|Investigator Request|0
2087956|NCT00743652|3674056|FG002|Overall Study|Investigator Request|0
2087957|NCT00743652|3674057|FG003|Overall Study|Investigator Request|2
2087958|NCT00743652|3674058|FG004|Overall Study|Investigator Request|0
2087959|NCT00743652|3674054|FG000|Overall Study|Other|1
2087960|NCT00743652|3674055|FG001|Overall Study|Other|1
2087961|NCT00743652|3674056|FG002|Overall Study|Other|0
2087962|NCT00743652|3674057|FG003|Overall Study|Other|0
2087963|NCT00743652|3674058|FG004|Overall Study|Other|0
2087964|NCT00743652|3674054|FG000|Overall Study|Lost to Follow-up|1
2087965|NCT00743652|3674055|FG001|Overall Study|Lost to Follow-up|0
2087966|NCT00743652|3674056|FG002|Overall Study|Lost to Follow-up|0
2087967|NCT00743652|3674057|FG003|Overall Study|Lost to Follow-up|0
2087968|NCT00743652|3674058|FG004|Overall Study|Lost to Follow-up|0
2087969|NCT00744042|3674100|FG000|Overall Study|Withdrawal by Subject|1
2087970|NCT00744055|3674112|FG000|Overall Study|Withdrawal by Subject|6
2087971|NCT00744055|3674113|FG001|Overall Study|Withdrawal by Subject|9
2087972|NCT00744055|3674112|FG000|Overall Study|Lack of Efficacy|0
2087973|NCT00744055|3674113|FG001|Overall Study|Lack of Efficacy|1
2087974|NCT00744055|3674112|FG000|Overall Study|Physician Decision|0
2087975|NCT00744055|3674113|FG001|Overall Study|Physician Decision|2
2087976|NCT00744055|3674112|FG000|Overall Study|Protocol Violation|1
2211610|NCT01662310|3851996|FG000|Double-Blind Phase|Withdrawal by Subject|0
2211611|NCT01662310|3851997|FG001|Double-Blind Phase|Withdrawal by Subject|9
2087977|NCT00744055|3674113|FG001|Overall Study|Protocol Violation|1
2087978|NCT00744055|3674112|FG000|Overall Study|Lost to Follow-up|0
2087979|NCT00744055|3674113|FG001|Overall Study|Lost to Follow-up|1
2087980|NCT00744237|3674138|FG000|Overall Study|Lack of Efficacy|1
2087981|NCT00744237|3674139|FG001|Overall Study|Lack of Efficacy|1
2087982|NCT00744237|3674140|FG002|Overall Study|Lack of Efficacy|0
2087983|NCT00744237|3674138|FG000|Overall Study|Withdrawal by Subject|9
2087984|NCT00744237|3674139|FG001|Overall Study|Withdrawal by Subject|5
2087985|NCT00744237|3674140|FG002|Overall Study|Withdrawal by Subject|3
2087986|NCT00744237|3674138|FG000|Overall Study|Lost to Follow-up|1
2087987|NCT00744237|3674139|FG001|Overall Study|Lost to Follow-up|1
2087988|NCT00744237|3674140|FG002|Overall Study|Lost to Follow-up|1
2087989|NCT00744237|3674138|FG000|Overall Study|Protocol Violation|3
2087990|NCT00744237|3674139|FG001|Overall Study|Protocol Violation|4
2087991|NCT00744237|3674140|FG002|Overall Study|Protocol Violation|3
2087992|NCT00744237|3674138|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
2087993|NCT00744237|3674139|FG001|Overall Study|Inclusion/Exclusion criteria not met|0
2087994|NCT00744237|3674140|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
2087995|NCT00744237|3674138|FG000|Overall Study|Dosing Error|1
2087996|NCT00744237|3674139|FG001|Overall Study|Dosing Error|0
2087997|NCT00744237|3674140|FG002|Overall Study|Dosing Error|1
2087998|NCT00744237|3674138|FG000|Overall Study|Study Drug Error|1
2087999|NCT00744237|3674139|FG001|Overall Study|Study Drug Error|0
2088000|NCT00744237|3674140|FG002|Overall Study|Study Drug Error|0
2088001|NCT00744237|3674138|FG000|Overall Study|Prohibited Concomitant Medication|0
2088002|NCT00744237|3674139|FG001|Overall Study|Prohibited Concomitant Medication|0
2088003|NCT00744237|3674140|FG002|Overall Study|Prohibited Concomitant Medication|1
2088004|NCT00744237|3674138|FG000|Overall Study|Poor Compliance|0
2088005|NCT00744237|3674139|FG001|Overall Study|Poor Compliance|2
2088006|NCT00744237|3674140|FG002|Overall Study|Poor Compliance|0
2088007|NCT00744237|3674138|FG000|Overall Study|Administrative. Site Closed|1
2088008|NCT00744237|3674139|FG001|Overall Study|Administrative. Site Closed|1
2211612|NCT01662310|3851998|FG002|Double-Blind Phase|Withdrawal by Subject|3
2211613|NCT01662310|3851999|FG003|Double-Blind Phase|Withdrawal by Subject|0
2211614|NCT01662310|3852000|FG004|Double-Blind Phase|Withdrawal by Subject|0
2211615|NCT01662310|3851996|FG000|Double-Blind Phase|Other|0
2211616|NCT01662310|3851997|FG001|Double-Blind Phase|Other|0
2088009|NCT00744237|3674140|FG002|Overall Study|Administrative. Site Closed|1
2088010|NCT00744237|3674138|FG000|Overall Study|Adverse Event|9
2088011|NCT00744237|3674139|FG001|Overall Study|Adverse Event|13
2088012|NCT00744237|3674140|FG002|Overall Study|Adverse Event|5
2088013|NCT00744263|3674150|FG000|Overall Study|Death|3006
2088014|NCT00744263|3674151|FG001|Overall Study|Death|3005
2088015|NCT00744263|3674150|FG000|Overall Study|Lost to Follow-up|2038
2211617|NCT01662310|3851998|FG002|Double-Blind Phase|Other|1
2211618|NCT01662310|3851999|FG003|Double-Blind Phase|Other|0
2088016|NCT00744263|3674151|FG001|Overall Study|Lost to Follow-up|2135
2088017|NCT00744263|3674150|FG000|Overall Study|Withdrawal by Subject|166
2088018|NCT00744263|3674151|FG001|Overall Study|Withdrawal by Subject|150
2088019|NCT00744263|3674150|FG000|Overall Study|Physician Decision|20
2088020|NCT00744263|3674151|FG001|Overall Study|Physician Decision|23
2088021|NCT00744263|3674150|FG000|Overall Study|Protocol Violation|3
2088022|NCT00744263|3674151|FG001|Overall Study|Protocol Violation|5
2088023|NCT00744263|3674150|FG000|Overall Study|Adverse Event|1
2088024|NCT00744263|3674151|FG001|Overall Study|Adverse Event|0
2088025|NCT00744263|3674150|FG000|Overall Study|Other|2
2088026|NCT00744263|3674151|FG001|Overall Study|Other|2
2088027|NCT00744328|3674162|FG000|Overall Study|Lost to Follow-up|2
2088028|NCT00744328|3674163|FG001|Overall Study|Lost to Follow-up|5
2088029|NCT00744328|3674164|FG002|Overall Study|Lost to Follow-up|3
2088030|NCT00744328|3674162|FG000|Overall Study|Withdrawal by Subject|5
2088031|NCT00744328|3674163|FG001|Overall Study|Withdrawal by Subject|3
2088032|NCT00744328|3674164|FG002|Overall Study|Withdrawal by Subject|4
2088033|NCT00744328|3674162|FG000|Overall Study|Found ineligible after randomization|0
2088034|NCT00744328|3674163|FG001|Overall Study|Found ineligible after randomization|0
2088035|NCT00744328|3674164|FG002|Overall Study|Found ineligible after randomization|1
2088036|NCT00744471|3674186|FG000|Overall Study|Randomized but not treated|1
2088037|NCT00744471|3674187|FG001|Overall Study|Randomized but not treated|1
2088038|NCT00744471|3674188|FG002|Overall Study|Randomized but not treated|4
2088039|NCT00744471|3674189|FG003|Overall Study|Randomized but not treated|0
2088040|NCT00744471|3674186|FG000|Overall Study|Death|0
2088041|NCT00744471|3674187|FG001|Overall Study|Death|0
2088042|NCT00744471|3674188|FG002|Overall Study|Death|0
2088043|NCT00744471|3674189|FG003|Overall Study|Death|1
2088044|NCT00744471|3674186|FG000|Overall Study|Adverse Event|6
2088045|NCT00744471|3674187|FG001|Overall Study|Adverse Event|7
2088046|NCT00744471|3674188|FG002|Overall Study|Adverse Event|5
2088047|NCT00744471|3674189|FG003|Overall Study|Adverse Event|9
2088048|NCT00744471|3674186|FG000|Overall Study|Withdrawal by Subject|9
2088049|NCT00744471|3674187|FG001|Overall Study|Withdrawal by Subject|9
2088050|NCT00744471|3674188|FG002|Overall Study|Withdrawal by Subject|15
2088051|NCT00744471|3674189|FG003|Overall Study|Withdrawal by Subject|12
2088052|NCT00744471|3674186|FG000|Overall Study|Protocol Violation|1
2088053|NCT00744471|3674187|FG001|Overall Study|Protocol Violation|4
2088054|NCT00744471|3674188|FG002|Overall Study|Protocol Violation|1
2088055|NCT00744471|3674189|FG003|Overall Study|Protocol Violation|2
2088056|NCT00744471|3674186|FG000|Overall Study|Entered extension study|41
2088057|NCT00744471|3674187|FG001|Overall Study|Entered extension study|84
2088058|NCT00744471|3674188|FG002|Overall Study|Entered extension study|100
2088059|NCT00744471|3674189|FG003|Overall Study|Entered extension study|91
2088060|NCT00744471|3674186|FG000|Overall Study|Other|2
2088061|NCT00744471|3674187|FG001|Overall Study|Other|3
2088062|NCT00744471|3674188|FG002|Overall Study|Other|6
2088063|NCT00744471|3674189|FG003|Overall Study|Other|2
2088064|NCT00744471|3674186|FG000|Overall Study|Lack of Efficacy|83
2088065|NCT00744471|3674187|FG001|Overall Study|Lack of Efficacy|37
2088066|NCT00744471|3674188|FG002|Overall Study|Lack of Efficacy|19
2088067|NCT00744471|3674189|FG003|Overall Study|Lack of Efficacy|31
2088068|NCT00744471|3674186|FG000|Overall Study|Lost to Follow-up|0
2088069|NCT00744471|3674187|FG001|Overall Study|Lost to Follow-up|0
2088070|NCT00744471|3674188|FG002|Overall Study|Lost to Follow-up|2
2088071|NCT00744471|3674189|FG003|Overall Study|Lost to Follow-up|0
2088072|NCT00744497|3674201|FG000|Overall Study|Withdrawal by Subject|21
2088073|NCT00744497|3674202|FG001|Overall Study|Withdrawal by Subject|18
2088074|NCT00744497|3674201|FG000|Overall Study|Death|11
2088075|NCT00744497|3674202|FG001|Overall Study|Death|9
2088076|NCT00744497|3674201|FG000|Overall Study|Lost to Follow-up|4
2088077|NCT00744497|3674202|FG001|Overall Study|Lost to Follow-up|2
2088078|NCT00744497|3674201|FG000|Overall Study|Poor compliance/noncompliance|9
2088079|NCT00744497|3674202|FG001|Overall Study|Poor compliance/noncompliance|5
2088080|NCT00744497|3674201|FG000|Overall Study|No longer meets study criteria|7
2088081|NCT00744497|3674202|FG001|Overall Study|No longer meets study criteria|3
2088082|NCT00744497|3674201|FG000|Overall Study|Administrative Reason By Sponsor|25
2088083|NCT00744497|3674202|FG001|Overall Study|Administrative Reason By Sponsor|8
2088084|NCT00744497|3674201|FG000|Overall Study|Disease progression|312
2088085|NCT00744497|3674202|FG001|Overall Study|Disease progression|219
2088086|NCT00744497|3674201|FG000|Overall Study|Study drug toxicity|68
2088087|NCT00744497|3674202|FG001|Overall Study|Study drug toxicity|141
2088088|NCT00744497|3674201|FG000|Overall Study|Adverse event unrelated to study drug|78
2088089|NCT00744497|3674202|FG001|Overall Study|Adverse event unrelated to study drug|122
2088090|NCT00744497|3674201|FG000|Overall Study|Patient requested to stop study drug|65
2088091|NCT00744497|3674202|FG001|Overall Study|Patient requested to stop study drug|80
2088092|NCT00744497|3674201|FG000|Overall Study|Maximum clinical benefit|141
2088093|NCT00744497|3674202|FG001|Overall Study|Maximum clinical benefit|142
2088094|NCT00744497|3674201|FG000|Overall Study|Not defined|19
2088095|NCT00744497|3674202|FG001|Overall Study|Not defined|13
2088096|NCT00744523|3674210|FG000|30 Days After the Procedure|Insufficient follow-up|0
2088097|NCT00744523|3674211|FG001|30 Days After the Procedure|Insufficient follow-up|5
2088098|NCT00744627|3674221|FG000|Overall Study|Adverse Event|6
2088099|NCT00744627|3674222|FG001|Overall Study|Adverse Event|9
2088100|NCT00744627|3674221|FG000|Overall Study|Lack of Efficacy|7
2088101|NCT00744627|3674222|FG001|Overall Study|Lack of Efficacy|3
2088102|NCT00744627|3674221|FG000|Overall Study|Noncompliance|0
2088103|NCT00744627|3674222|FG001|Overall Study|Noncompliance|1
2088104|NCT00744627|3674221|FG000|Overall Study|Protocol Deviations|0
2088105|NCT00744627|3674222|FG001|Overall Study|Protocol Deviations|2
2088106|NCT00744627|3674221|FG000|Overall Study|Voluntary Withdrawal|9
2088107|NCT00744627|3674222|FG001|Overall Study|Voluntary Withdrawal|6
2088108|NCT00744627|3674221|FG000|Overall Study|Lost to Follow-up|2
2088109|NCT00744627|3674222|FG001|Overall Study|Lost to Follow-up|1
2088110|NCT00744627|3674221|FG000|Overall Study|Other|1
2088111|NCT00744627|3674222|FG001|Overall Study|Other|0
2088112|NCT00744653|3674228|FG000|Overall Study|antineoplastic treatment|11
2088113|NCT00744653|3674228|FG000|Overall Study|Death|1
2088114|NCT00744653|3674228|FG000|Overall Study|Lost to Follow-up|1
2088115|NCT00744653|3674228|FG000|Overall Study|Physician Decision|3
2088116|NCT00744757|3674237|FG000|Overall Study|Objective disease progression|7
2088117|NCT00744757|3674237|FG000|Overall Study|Physician Decision|5
2088118|NCT00744757|3674237|FG000|Overall Study|Withdrawal by Subject|1
2088119|NCT00744757|3674237|FG000|Overall Study|Death|6
2088120|NCT00744757|3674237|FG000|Overall Study|Adverse Event|2
2088121|NCT00744796|3674241|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12
2088122|NCT00744861|3674258|FG000|Feasibility Stage 1|Withdrawal by Subject|1
2088123|NCT00744861|3674259|FG001|Feasibility Stage 1|Withdrawal by Subject|1
2088124|NCT00744861|3674260|FG002|Feasibility Stage 1|Withdrawal by Subject|0
2088125|NCT00744861|3674261|FG003|Feasibility Stage 1|Withdrawal by Subject|0
2088126|NCT00744861|3674258|FG000|Feasibility Stage 1|Pregnancy|0
2088127|NCT00744861|3674259|FG001|Feasibility Stage 1|Pregnancy|1
2088128|NCT00744861|3674260|FG002|Feasibility Stage 1|Pregnancy|0
2088129|NCT00744861|3674261|FG003|Feasibility Stage 1|Pregnancy|0
2088130|NCT00744861|3674258|FG000|Pivotal Stage 2|Adverse Event|0
2088131|NCT00744861|3674259|FG001|Pivotal Stage 2|Adverse Event|0
2088132|NCT00744861|3674260|FG002|Pivotal Stage 2|Adverse Event|6
2088133|NCT00744861|3674261|FG003|Pivotal Stage 2|Adverse Event|11
2088134|NCT00744861|3674258|FG000|Pivotal Stage 2|Death|0
2088135|NCT00744861|3674259|FG001|Pivotal Stage 2|Death|0
2088136|NCT00744861|3674260|FG002|Pivotal Stage 2|Death|0
2088137|NCT00744861|3674261|FG003|Pivotal Stage 2|Death|1
2088138|NCT00744861|3674258|FG000|Pivotal Stage 2|Lost to Follow-up|0
2088139|NCT00744861|3674259|FG001|Pivotal Stage 2|Lost to Follow-up|0
2088140|NCT00744861|3674260|FG002|Pivotal Stage 2|Lost to Follow-up|13
2088141|NCT00744861|3674261|FG003|Pivotal Stage 2|Lost to Follow-up|14
2088142|NCT00744861|3674258|FG000|Pivotal Stage 2|Physician Decision|0
2088143|NCT00744861|3674259|FG001|Pivotal Stage 2|Physician Decision|0
2088144|NCT00744861|3674260|FG002|Pivotal Stage 2|Physician Decision|3
2088145|NCT00744861|3674261|FG003|Pivotal Stage 2|Physician Decision|1
2088146|NCT00744861|3674258|FG000|Pivotal Stage 2|Protocol Violation|0
2088147|NCT00744861|3674259|FG001|Pivotal Stage 2|Protocol Violation|0
2088148|NCT00744861|3674260|FG002|Pivotal Stage 2|Protocol Violation|0
2088149|NCT00744861|3674261|FG003|Pivotal Stage 2|Protocol Violation|1
2088150|NCT00744861|3674258|FG000|Pivotal Stage 2|Withdrawal by Subject|0
2088151|NCT00744861|3674259|FG001|Pivotal Stage 2|Withdrawal by Subject|0
2088152|NCT00744861|3674260|FG002|Pivotal Stage 2|Withdrawal by Subject|20
2088153|NCT00744861|3674261|FG003|Pivotal Stage 2|Withdrawal by Subject|14
2088154|NCT00744861|3674258|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0
2088155|NCT00744861|3674259|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0
2088156|NCT00744861|3674260|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60
2088157|NCT00744861|3674261|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63
2088158|NCT00744874|3674269|FG000|Overall Study|Lost to Follow-up|1
2088159|NCT00744874|3674269|FG000|Overall Study|Withdrawal by Subject|1
2088160|NCT00744874|3674269|FG000|Overall Study|Study Device not available at procedure|1
2088161|NCT00744874|3674269|FG000|Overall Study|Unable to accomodate schedule|1
2088162|NCT00744939|3674284|FG000|Overall Study|Withdrawal by Subject|9
2088163|NCT00744939|3674284|FG000|Overall Study|Protocol Violation|13
2088164|NCT00744939|3674284|FG000|Overall Study|Death|24
2088165|NCT00744939|3674284|FG000|Overall Study|distance|4
2088166|NCT00744939|3674284|FG000|Overall Study|Lost to Follow-up|12
2088167|NCT00744939|3674284|FG000|Overall Study|Medical history exclusionary|1
2088168|NCT00744939|3674284|FG000|Overall Study|Did not receive Magnevist|7
2088169|NCT00744939|3674284|FG000|Overall Study|Failed inclusion/exclusion criteria|19
2088170|NCT00744939|3674284|FG000|Overall Study|coma|1
2088171|NCT00744939|3674284|FG000|Overall Study|incorrect race|1
2088172|NCT00744978|3674307|FG000|Period 1|Lost to Follow-up|1
2088173|NCT00744978|3674308|FG001|Period 1|Lost to Follow-up|0
2088174|NCT00744978|3674307|FG000|Period 1|Withdrawal by Subject|0
2088175|NCT00744978|3674308|FG001|Period 1|Withdrawal by Subject|2
2088176|NCT00744978|3674307|FG000|Period 1|Other|0
2088177|NCT00744978|3674308|FG001|Period 1|Other|2
2088178|NCT00744978|3674307|FG000|Period 1|Adverse Event|4
2088179|NCT00744978|3674308|FG001|Period 1|Adverse Event|0
2088180|NCT00744978|3674307|FG000|Period 1|Randomized but not Treated|1
2088181|NCT00744978|3674308|FG001|Period 1|Randomized but not Treated|1
2088182|NCT00744978|3674307|FG000|Period 2|Adverse Event|0
2088183|NCT00744978|3674308|FG001|Period 2|Adverse Event|1
2088184|NCT00744991|3674314|FG000|Overall Study|Progressive Disease|11
2088185|NCT00744991|3674314|FG000|Overall Study|Withdrawal by Subject|8
2088186|NCT00744991|3674314|FG000|Overall Study|Physician Decision|3
2088187|NCT00744991|3674314|FG000|Overall Study|Adverse Event|2
2088188|NCT00744991|3674314|FG000|Overall Study|Protocol Entry Criteria Unmet|1
2088189|NCT00745095|3674327|FG000|Overall Study|Declined to participate|1
2088190|NCT00745095|3674328|FG001|Overall Study|Declined to participate|0
2088191|NCT00745095|3674329|FG002|Overall Study|Declined to participate|0
2088192|NCT00745095|3674330|FG003|Overall Study|Declined to participate|0
2088193|NCT00745095|3674331|FG004|Overall Study|Declined to participate|92
2088194|NCT00745095|3674332|FG005|Overall Study|Declined to participate|95
2088195|NCT00745095|3674327|FG000|Overall Study|Ineligible due to GFR criteria|0
2088196|NCT00745095|3674328|FG001|Overall Study|Ineligible due to GFR criteria|2
2088197|NCT00745095|3674329|FG002|Overall Study|Ineligible due to GFR criteria|3
2088198|NCT00745095|3674330|FG003|Overall Study|Ineligible due to GFR criteria|3
2088199|NCT00745095|3674331|FG004|Overall Study|Ineligible due to GFR criteria|30
2088200|NCT00745095|3674332|FG005|Overall Study|Ineligible due to GFR criteria|28
2088201|NCT00745121|3674351|FG000|Overall Study|Death|3
2088202|NCT00745121|3674352|FG001|Overall Study|Death|0
2088203|NCT00745121|3674351|FG000|Overall Study|Adverse Event|1
2088204|NCT00745121|3674352|FG001|Overall Study|Adverse Event|0
2088205|NCT00745121|3674351|FG000|Overall Study|Lost to Follow-up|1
2088206|NCT00745121|3674352|FG001|Overall Study|Lost to Follow-up|0
2088207|NCT00745121|3674351|FG000|Overall Study|Withdrawal by Subject|4
2088208|NCT00745121|3674352|FG001|Overall Study|Withdrawal by Subject|2
2088209|NCT00745251|3674360|FG000|Overall Study|Adverse Event|1
2088210|NCT00745251|3674361|FG001|Overall Study|Adverse Event|2
2088211|NCT00745251|3674360|FG000|Overall Study|Withdrawal by Subject|1
2088212|NCT00745251|3674361|FG001|Overall Study|Withdrawal by Subject|1
2088213|NCT00745368|3674376|FG000|Overall Study|Unable to provide sample|3
2088214|NCT00745420|3674380|FG000|Overall Study|Ineligible|1
2088215|NCT00745498|3674387|FG000|Overall Study|Lost to Follow-up|1
2088216|NCT00745498|3674388|FG001|Overall Study|Lost to Follow-up|1
2088217|NCT00745498|3674389|FG002|Overall Study|Lost to Follow-up|3
2088218|NCT00745498|3674387|FG000|Overall Study|Injection of intravitreal silicone oil o|3
2088219|NCT00745498|3674388|FG001|Overall Study|Injection of intravitreal silicone oil o|4
2088220|NCT00745498|3674389|FG002|Overall Study|Injection of intravitreal silicone oil o|4
2088221|NCT00745498|3674387|FG000|Overall Study|Non-PDR related VH|0
2088222|NCT00745498|3674388|FG001|Overall Study|Non-PDR related VH|1
2088223|NCT00745498|3674389|FG002|Overall Study|Non-PDR related VH|1
2088224|NCT00745498|3674387|FG000|Overall Study|Edophthalmitis after preoperative IVB|1
2088225|NCT00745498|3674388|FG001|Overall Study|Edophthalmitis after preoperative IVB|0
2088226|NCT00745498|3674389|FG002|Overall Study|Edophthalmitis after preoperative IVB|0
2088227|NCT00745615|3674401|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
2088228|NCT00745615|3674402|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
2088229|NCT00745615|3674403|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
2088230|NCT00745615|3674404|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
2088231|NCT00745615|3674405|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
2088232|NCT00745615|3674406|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
2088233|NCT00745615|3674401|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0
2088234|NCT00745615|3674402|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1
2088235|NCT00745615|3674403|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0
2088236|NCT00745615|3674404|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0
2088237|NCT00745615|3674405|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0
2088238|NCT00745615|3674406|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0
2088239|NCT00745615|3674401|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2
2088240|NCT00745615|3674402|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3
2088241|NCT00745615|3674403|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1
2088242|NCT00745615|3674404|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1
2088243|NCT00745615|3674405|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0
2088244|NCT00745615|3674406|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0
2088245|NCT00745615|3674401|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0
2088246|NCT00745615|3674402|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1
2088247|NCT00745615|3674403|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0
2088248|NCT00745615|3674404|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0
2088249|NCT00745615|3674405|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0
2088250|NCT00745615|3674406|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0
2088251|NCT00745615|3674401|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0
2088252|NCT00745615|3674402|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1
2088253|NCT00745615|3674403|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0
2088254|NCT00745615|3674404|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0
2088255|NCT00745615|3674405|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0
2088256|NCT00745615|3674406|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0
2088257|NCT00745615|3674401|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
2088258|NCT00745615|3674402|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
2088259|NCT00745615|3674403|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
2088260|NCT00745615|3674404|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
2088261|NCT00745615|3674405|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
2088262|NCT00745615|3674406|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
2088263|NCT00745615|3674401|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
2088264|NCT00745615|3674402|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
2088265|NCT00745615|3674403|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
2088266|NCT00745615|3674404|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
2088267|NCT00745615|3674405|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
2088268|NCT00745615|3674406|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
2088269|NCT00745615|3674401|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
2088270|NCT00745615|3674402|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
2088271|NCT00745615|3674403|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
2088272|NCT00745615|3674404|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
2088273|NCT00745615|3674405|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
2088274|NCT00745615|3674406|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
2088275|NCT00745615|3674401|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
2088276|NCT00745615|3674402|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
2088277|NCT00745615|3674403|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
2088278|NCT00745615|3674404|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
2088279|NCT00745615|3674405|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
2088280|NCT00745615|3674406|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
2088281|NCT00745615|3674401|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
2088282|NCT00745615|3674402|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
2088283|NCT00745615|3674403|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
2088284|NCT00745615|3674404|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
2088285|NCT00745615|3674405|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
2088286|NCT00745615|3674406|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
2088287|NCT00745615|3674401|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
2088288|NCT00745615|3674402|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
2088289|NCT00745615|3674403|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
2088290|NCT00745615|3674404|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
2088291|NCT00745615|3674405|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
2088292|NCT00745615|3674406|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
2088293|NCT00745615|3674401|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
2088294|NCT00745615|3674402|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
2088295|NCT00745615|3674403|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
2088296|NCT00745615|3674404|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
2088297|NCT00745615|3674405|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
2088298|NCT00745615|3674406|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
2088299|NCT00745615|3674401|FG000|Open-Label (up to Approx 10.5 Years)|Death|0
2088300|NCT00745615|3674402|FG001|Open-Label (up to Approx 10.5 Years)|Death|0
2088301|NCT00745615|3674403|FG002|Open-Label (up to Approx 10.5 Years)|Death|0
2088302|NCT00745615|3674404|FG003|Open-Label (up to Approx 10.5 Years)|Death|0
2088303|NCT00745615|3674405|FG004|Open-Label (up to Approx 10.5 Years)|Death|0
2088304|NCT00745615|3674406|FG005|Open-Label (up to Approx 10.5 Years)|Death|1
2088305|NCT00745615|3674401|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
2088306|NCT00745615|3674402|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
2088307|NCT00745615|3674403|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
2088308|NCT00745615|3674404|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
2088309|NCT00745615|3674405|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
2088310|NCT00745615|3674406|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
2088311|NCT00745823|3674420|FG000|Overall Study|Adverse Event|5
2088312|NCT00745823|3674421|FG001|Overall Study|Adverse Event|3
2088313|NCT00745823|3674420|FG000|Overall Study|Lack of Efficacy|20
2088314|NCT00745823|3674421|FG001|Overall Study|Lack of Efficacy|6
2088315|NCT00745823|3674420|FG000|Overall Study|Lost to Follow-up|10
2088316|NCT00745823|3674421|FG001|Overall Study|Lost to Follow-up|11
2088317|NCT00745823|3674420|FG000|Overall Study|Physician Decision|10
2088318|NCT00745823|3674421|FG001|Overall Study|Physician Decision|5
2088319|NCT00745823|3674420|FG000|Overall Study|Pregnancy|0
2088320|NCT00745823|3674421|FG001|Overall Study|Pregnancy|4
2088321|NCT00745823|3674420|FG000|Overall Study|Withdrawal by Subject|14
2088322|NCT00745823|3674421|FG001|Overall Study|Withdrawal by Subject|8
2088323|NCT00745823|3674420|FG000|Overall Study|Study Terminated by Sponsor|326
2088324|NCT00745823|3674421|FG001|Overall Study|Study Terminated by Sponsor|349
2088325|NCT00745849|3674429|FG000|First Intervention|Withdrawal by Subject|0
2088326|NCT00745849|3674430|FG001|First Intervention|Withdrawal by Subject|1
2088327|NCT00745849|3674429|FG000|First Intervention|Lost to Follow-up|1
2088328|NCT00745849|3674430|FG001|First Intervention|Lost to Follow-up|1
2088329|NCT00745849|3674429|FG000|Second Intervention|Lost to Follow-up|2
2088330|NCT00745849|3674430|FG001|Second Intervention|Lost to Follow-up|1
2088331|NCT00745875|3674438|FG000|Overall Study|Continuing study treatment|4
2088332|NCT00745875|3674439|FG001|Overall Study|Continuing study treatment|4
2088333|NCT00745901|3674447|FG000|Overall Study|Adverse Event|3
2088334|NCT00745901|3674448|FG001|Overall Study|Adverse Event|4
2088335|NCT00745901|3674447|FG000|Overall Study|Protocol Violation|0
2088336|NCT00745901|3674448|FG001|Overall Study|Protocol Violation|1
2088337|NCT00745901|3674447|FG000|Overall Study|Withdrawal by Subject|1
2088338|NCT00745901|3674448|FG001|Overall Study|Withdrawal by Subject|0
2088339|NCT00745901|3674447|FG000|Overall Study|Lost to Follow-up|7
2088340|NCT00745901|3674448|FG001|Overall Study|Lost to Follow-up|4
2088341|NCT00745901|3674447|FG000|Overall Study|Pregnancy|2
2088342|NCT00745901|3674448|FG001|Overall Study|Pregnancy|4
2088343|NCT00745901|3674447|FG000|Overall Study|Lack of compliance|2
2088344|NCT00745901|3674448|FG001|Overall Study|Lack of compliance|2
2088345|NCT00745901|3674447|FG000|Overall Study|Patient's next menses did not start with|1
2088346|NCT00745901|3674448|FG001|Overall Study|Patient's next menses did not start with|0
2088347|NCT00745901|3674447|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0
2088348|NCT00745901|3674448|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2
2088349|NCT00745901|3674447|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1
2088350|NCT00745901|3674448|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1
2088351|NCT00745901|3674447|FG000|Overall Study|Patient didn't take any study medication|7
2088352|NCT00745901|3674448|FG001|Overall Study|Patient didn't take any study medication|3
2088353|NCT00746096|3674465|FG000|Overall Study|Adverse Event|1
2088354|NCT00746096|3674466|FG001|Overall Study|Adverse Event|0
2088355|NCT00746096|3674465|FG000|Overall Study|Withdrawal by Subject|5
2088356|NCT00746096|3674466|FG001|Overall Study|Withdrawal by Subject|1
2088357|NCT00746096|3674465|FG000|Overall Study|Lost to Follow-up|2
2088358|NCT00746096|3674466|FG001|Overall Study|Lost to Follow-up|1
2088359|NCT00746096|3674465|FG000|Overall Study|Protocol Violation|1
2211619|NCT01662310|3852000|FG004|Double-Blind Phase|Other|0
2211620|NCT01662310|3851996|FG000|Double-Blind Phase|Randomized but not treated|0
2211621|NCT01662310|3851997|FG001|Double-Blind Phase|Randomized but not treated|1
2211622|NCT01662310|3851998|FG002|Double-Blind Phase|Randomized but not treated|0
2211623|NCT01662310|3851999|FG003|Double-Blind Phase|Randomized but not treated|0
2211624|NCT01662310|3852000|FG004|Double-Blind Phase|Randomized but not treated|0
2211625|NCT01662310|3851996|FG000|Open-Label Extension Phase|Adverse Event|0
2211626|NCT01662310|3851997|FG001|Open-Label Extension Phase|Adverse Event|0
2211627|NCT01662310|3851998|FG002|Open-Label Extension Phase|Adverse Event|0
2211628|NCT01662310|3851999|FG003|Open-Label Extension Phase|Adverse Event|3
2088360|NCT00746096|3674466|FG001|Overall Study|Protocol Violation|0
2088361|NCT00746096|3674465|FG000|Overall Study|No study drug treatment|1
2088362|NCT00746096|3674466|FG001|Overall Study|No study drug treatment|1
2088363|NCT00746252|3674492|FG000|Overall Study|weight gain >7.5 %|1
2211629|NCT01662310|3852000|FG004|Open-Label Extension Phase|Adverse Event|0
2088364|NCT00746252|3674493|FG001|Overall Study|weight gain >7.5 %|2
2088365|NCT00746330|3674503|FG000|Period 1|Abnormal test procedure result|0
2088366|NCT00746330|3674504|FG001|Period 1|Abnormal test procedure result|0
2088367|NCT00746330|3674505|FG002|Period 1|Abnormal test procedure result|1
2088368|NCT00746330|3674506|FG003|Period 1|Abnormal test procedure result|0
2088369|NCT00746356|3674517|FG000|Overall Study|Withdrawal by Subject|2
2088370|NCT00746356|3674518|FG001|Overall Study|Withdrawal by Subject|3
2088371|NCT00746356|3674517|FG000|Overall Study|Death|7
2088372|NCT00746356|3674518|FG001|Overall Study|Death|3
2088373|NCT00746356|3674517|FG000|Overall Study|Lost to Follow-up|1
2088374|NCT00746356|3674518|FG001|Overall Study|Lost to Follow-up|0
2088375|NCT00746356|3674517|FG000|Overall Study|Removal of Device|0
2088376|NCT00746356|3674518|FG001|Overall Study|Removal of Device|1
2088377|NCT00746356|3674517|FG000|Overall Study|Patient relocated|1
2088378|NCT00746356|3674518|FG001|Overall Study|Patient relocated|0
2088379|NCT00746551|3674563|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2
2088380|NCT00746551|3674564|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4
2088381|NCT00746551|3674563|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
2088382|NCT00746551|3674564|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
2088383|NCT00746551|3674563|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
2088384|NCT00746551|3674564|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
2088385|NCT00746564|3674570|FG000|Overall Study|Required Pacemaker/ICD Implant|2
2088386|NCT00746733|3674599|FG000|Second Intervention|Adverse Event|1
2088387|NCT00746733|3674600|FG001|Second Intervention|Adverse Event|0
2088388|NCT00746733|3674599|FG000|Third Intervention|Withdrawal by Subject|1
2088389|NCT00746733|3674600|FG001|Third Intervention|Withdrawal by Subject|1
2088390|NCT00746785|3674616|FG000|Overall Study|Lost to Follow-up|29
2088391|NCT00746785|3674617|FG001|Overall Study|Lost to Follow-up|25
2088392|NCT00746785|3674618|FG002|Overall Study|Lost to Follow-up|27
2088393|NCT00746798|3674630|FG000|Overall Study|Protocol Violation|0
2088394|NCT00746798|3674631|FG001|Overall Study|Protocol Violation|1
2088395|NCT00746798|3674632|FG002|Overall Study|Protocol Violation|0
2088396|NCT00746798|3674633|FG003|Overall Study|Protocol Violation|0
2088397|NCT00746798|3674630|FG000|Overall Study|Withdrawal by Subject|0
2088398|NCT00746798|3674631|FG001|Overall Study|Withdrawal by Subject|1
2088399|NCT00746798|3674632|FG002|Overall Study|Withdrawal by Subject|1
2088400|NCT00746798|3674633|FG003|Overall Study|Withdrawal by Subject|0
2088401|NCT00746798|3674630|FG000|Overall Study|Death|0
2088402|NCT00746798|3674631|FG001|Overall Study|Death|0
2088403|NCT00746798|3674632|FG002|Overall Study|Death|2
2088404|NCT00746798|3674633|FG003|Overall Study|Death|0
2088405|NCT00746798|3674630|FG000|Overall Study|Participant unable to return for visit|1
2107341|NCT00872521|3700856|FG002|Primary Endpoint Analysis|Other|0
2211630|NCT01662310|3851996|FG000|Open-Label Extension Phase|Death|0
2088406|NCT00746798|3674631|FG001|Overall Study|Participant unable to return for visit|0
2088407|NCT00746798|3674632|FG002|Overall Study|Participant unable to return for visit|0
2088408|NCT00746798|3674633|FG003|Overall Study|Participant unable to return for visit|0
2088409|NCT00746941|3674667|FG000|Overall Study|Death|2
2088410|NCT00746941|3674668|FG001|Overall Study|Death|0
2088411|NCT00746941|3674669|FG002|Overall Study|Death|0
2088412|NCT00746941|3674670|FG003|Overall Study|Death|6
2088413|NCT00746941|3674667|FG000|Overall Study|Physician Decision|0
2088414|NCT00746941|3674668|FG001|Overall Study|Physician Decision|0
2088415|NCT00746941|3674669|FG002|Overall Study|Physician Decision|2
2088416|NCT00746941|3674670|FG003|Overall Study|Physician Decision|0
2088417|NCT00746941|3674667|FG000|Overall Study|Withdrawal by Subject|3
2088418|NCT00746941|3674668|FG001|Overall Study|Withdrawal by Subject|0
2088419|NCT00746941|3674669|FG002|Overall Study|Withdrawal by Subject|0
2088420|NCT00746941|3674670|FG003|Overall Study|Withdrawal by Subject|2
2088421|NCT00746941|3674667|FG000|Overall Study|Other, reason not provided|2
2088422|NCT00746941|3674668|FG001|Overall Study|Other, reason not provided|4
2088423|NCT00746941|3674669|FG002|Overall Study|Other, reason not provided|0
2088424|NCT00746941|3674670|FG003|Overall Study|Other, reason not provided|4
2088425|NCT00746941|3674667|FG000|Overall Study|Adverse Event|0
2088426|NCT00746941|3674668|FG001|Overall Study|Adverse Event|0
2088427|NCT00746941|3674669|FG002|Overall Study|Adverse Event|0
2088428|NCT00746941|3674670|FG003|Overall Study|Adverse Event|1
2088429|NCT00747006|3674690|FG000|Overall Study|Adverse Event|1
2088430|NCT00747006|3674691|FG001|Overall Study|Adverse Event|0
2088431|NCT00747006|3674692|FG002|Overall Study|Adverse Event|0
2088432|NCT00747006|3674690|FG000|Overall Study|Lost to Follow-up|0
2088433|NCT00747006|3674691|FG001|Overall Study|Lost to Follow-up|1
2088434|NCT00747006|3674692|FG002|Overall Study|Lost to Follow-up|0
2088435|NCT00747006|3674690|FG000|Overall Study|Physician Decision|2
2088436|NCT00747006|3674691|FG001|Overall Study|Physician Decision|0
2088437|NCT00747006|3674692|FG002|Overall Study|Physician Decision|1
2088438|NCT00747149|3674705|FG000|Overall Study|Adverse Event|0
2088439|NCT00747149|3674706|FG001|Overall Study|Adverse Event|15
2088440|NCT00747149|3674705|FG000|Overall Study|Lost to Follow-up|0
2088441|NCT00747149|3674706|FG001|Overall Study|Lost to Follow-up|10
2088442|NCT00747149|3674705|FG000|Overall Study|Withdrawal by Subject|0
2088443|NCT00747149|3674706|FG001|Overall Study|Withdrawal by Subject|6
2088444|NCT00747149|3674705|FG000|Overall Study|Did not receive treatment|0
2088445|NCT00747149|3674706|FG001|Overall Study|Did not receive treatment|1
2088446|NCT00747149|3674705|FG000|Overall Study|Incorrect enrollment|0
2088447|NCT00747149|3674706|FG001|Overall Study|Incorrect enrollment|6
2088448|NCT00747149|3674705|FG000|Overall Study|Severe non-compliance to protocol|0
2088449|NCT00747149|3674706|FG001|Overall Study|Severe non-compliance to protocol|1
2088450|NCT00747149|3674705|FG000|Overall Study|Not reported|1
2088451|NCT00747149|3674706|FG001|Overall Study|Not reported|4
2088452|NCT00747227|3674729|FG000|Overall Study|Death|3
2088453|NCT00747227|3674730|FG001|Overall Study|Death|1
2088454|NCT00747227|3674729|FG000|Overall Study|Withdrawal by Subject|1
2088455|NCT00747227|3674730|FG001|Overall Study|Withdrawal by Subject|0
2088456|NCT00747227|3674729|FG000|Overall Study|Lost to Follow-up|1
2088457|NCT00747227|3674730|FG001|Overall Study|Lost to Follow-up|2
2088458|NCT00747227|3674729|FG000|Overall Study|Illness|1
2088459|NCT00747227|3674730|FG001|Overall Study|Illness|1
2088460|NCT00747344|3674738|FG000|Controlled Period|Adverse Event|3
2088461|NCT00747344|3674739|FG001|Controlled Period|Adverse Event|0
2088462|NCT00747344|3674740|FG002|Controlled Period|Adverse Event|0
2088463|NCT00747344|3674741|FG003|Controlled Period|Adverse Event|0
2088464|NCT00747344|3674738|FG000|Controlled Period|Lack of Efficacy|2
2088465|NCT00747344|3674739|FG001|Controlled Period|Lack of Efficacy|1
2088466|NCT00747344|3674740|FG002|Controlled Period|Lack of Efficacy|0
2088467|NCT00747344|3674741|FG003|Controlled Period|Lack of Efficacy|0
2088468|NCT00747344|3674738|FG000|Controlled Period|Other|0
2088469|NCT00747344|3674739|FG001|Controlled Period|Other|3
2088470|NCT00747344|3674740|FG002|Controlled Period|Other|0
2088471|NCT00747344|3674741|FG003|Controlled Period|Other|0
2088472|NCT00747344|3674738|FG000|After Controlled Period|Adverse Event|0
2088473|NCT00747344|3674739|FG001|After Controlled Period|Adverse Event|0
2088474|NCT00747344|3674740|FG002|After Controlled Period|Adverse Event|0
2088475|NCT00747344|3674741|FG003|After Controlled Period|Adverse Event|1
2088476|NCT00747435|3674749|FG000|Overall Study|Lost to Follow-up|2
2088477|NCT00747435|3674749|FG000|Overall Study|Withdrawal by Subject|3
2088478|NCT00747435|3674749|FG000|Overall Study|Still undergoing follow up|1
2088479|NCT00747474|3674753|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2088480|NCT00747474|3674754|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2088481|NCT00747474|3674755|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2088482|NCT00747474|3674756|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2088483|NCT00747474|3674757|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2088484|NCT00747474|3674758|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2088485|NCT00747474|3674759|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2088486|NCT00747474|3674760|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
2088487|NCT00747474|3674761|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2107342|NCT00872521|3700854|FG000|Primary Endpoint Analysis|Patient choice|0
2088488|NCT00747474|3674762|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2088489|NCT00747474|3674763|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2088490|NCT00747474|3674764|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2088491|NCT00747565|3674775|FG000|Overall Study|Withdrawal by Subject|10
2088492|NCT00747565|3674776|FG001|Overall Study|Withdrawal by Subject|6
2088493|NCT00747565|3674775|FG000|Overall Study|Lost to Follow-up|4
2088494|NCT00747565|3674776|FG001|Overall Study|Lost to Follow-up|1
2088495|NCT00747617|3674784|FG000|Overall Study|Lost to Follow-up|3
2088496|NCT00747617|3674785|FG001|Overall Study|Lost to Follow-up|1
2088497|NCT00747643|3674793|FG000|Overall Study|Withdrawal by Subject|36
2088498|NCT00747643|3674794|FG001|Overall Study|Withdrawal by Subject|27
2088499|NCT00747812|3674815|FG000|Overall Study|Research Site Staff Relocation|5
2088500|NCT00747812|3674816|FG001|Overall Study|Research Site Staff Relocation|3
2088501|NCT00748033|3674824|FG000|Overall Study|Adverse Event|0
2088502|NCT00748033|3674825|FG001|Overall Study|Adverse Event|1
2088503|NCT00748098|3674848|FG000|First Treatment Intervention Period|Adverse Event|1
2088504|NCT00748098|3674849|FG001|First Treatment Intervention Period|Adverse Event|1
2088505|NCT00748098|3674848|FG000|First Treatment Intervention Period|Protocol Violation|1
2088506|NCT00748098|3674849|FG001|First Treatment Intervention Period|Protocol Violation|0
2088507|NCT00748098|3674848|FG000|First Treatment Intervention Period|Lost to Follow-up|1
2088508|NCT00748098|3674849|FG001|First Treatment Intervention Period|Lost to Follow-up|0
2088509|NCT00748098|3674848|FG000|First Treatment Intervention Period|Withdrawal by Subject|2
2088510|NCT00748098|3674849|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
2088511|NCT00748098|3674848|FG000|First Taper Period|Protocol Violation|1
2088512|NCT00748098|3674849|FG001|First Taper Period|Protocol Violation|0
2088513|NCT00748098|3674848|FG000|First Taper Period|Withdrawal by Subject|2
2088514|NCT00748098|3674849|FG001|First Taper Period|Withdrawal by Subject|0
2088515|NCT00748098|3674848|FG000|First Taper Period|Protocol Stopping Criteria Met|0
2088516|NCT00748098|3674849|FG001|First Taper Period|Protocol Stopping Criteria Met|1
2088517|NCT00748098|3674848|FG000|1-Week Washout Period|Adverse Event|0
2088518|NCT00748098|3674849|FG001|1-Week Washout Period|Adverse Event|1
2088519|NCT00748098|3674848|FG000|1-Week Washout Period|Withdrawal by Subject|2
2088520|NCT00748098|3674849|FG001|1-Week Washout Period|Withdrawal by Subject|0
2088521|NCT00748098|3674848|FG000|Second Treatment Intervention Period|Adverse Event|4
2088522|NCT00748098|3674849|FG001|Second Treatment Intervention Period|Adverse Event|1
2088523|NCT00748098|3674848|FG000|Second Treatment Intervention Period|Lost to Follow-up|1
2088524|NCT00748098|3674849|FG001|Second Treatment Intervention Period|Lost to Follow-up|1
2088525|NCT00748098|3674848|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1
2088526|NCT00748098|3674849|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1
2088527|NCT00748189|3674858|FG000|Overall Study|Death|99
2088528|NCT00748189|3674859|FG001|Overall Study|Death|84
2088529|NCT00748189|3674858|FG000|Overall Study|Withdrawal by Subject|23
2088530|NCT00748189|3674859|FG001|Overall Study|Withdrawal by Subject|29
2088531|NCT00748189|3674858|FG000|Overall Study|Physician Decision|16
2088532|NCT00748189|3674859|FG001|Overall Study|Physician Decision|5
2088533|NCT00748189|3674858|FG000|Overall Study|Lost to Follow-up|8
2088534|NCT00748189|3674859|FG001|Overall Study|Lost to Follow-up|15
2088535|NCT00748189|3674858|FG000|Overall Study|Study terminated by Sponsor|70
2088536|NCT00748189|3674859|FG001|Overall Study|Study terminated by Sponsor|79
2088537|NCT00748215|3674872|FG000|Overall Study|Withdrawal by Subject|7
2088538|NCT00748215|3674873|FG001|Overall Study|Withdrawal by Subject|7
2088539|NCT00748215|3674872|FG000|Overall Study|Treatment change|2
2088540|NCT00748215|3674873|FG001|Overall Study|Treatment change|1
2088541|NCT00748215|3674872|FG000|Overall Study|Change in patient condition|0
2088542|NCT00748215|3674873|FG001|Overall Study|Change in patient condition|3
2088543|NCT00748215|3674872|FG000|Overall Study|Non-compliant|0
2088544|NCT00748215|3674873|FG001|Overall Study|Non-compliant|2
2088545|NCT00748215|3674872|FG000|Overall Study|Adverse Event|0
2088546|NCT00748215|3674873|FG001|Overall Study|Adverse Event|5
2088547|NCT00748241|3674879|FG000|Overall Study|Implant failure|1
2088548|NCT00748241|3674879|FG000|Overall Study|Lost to Follow-up|5
2088549|NCT00748241|3674879|FG000|Overall Study|Death|2
2088550|NCT00748540|3674892|FG000|Overall Study|Physician Decision|1
2088551|NCT00748553|3674898|FG000|Overall Study|Adverse Event|0
2088552|NCT00748553|3674899|FG001|Overall Study|Adverse Event|1
2088553|NCT00748553|3674898|FG000|Overall Study|disease progression|2
2088554|NCT00748553|3674899|FG001|Overall Study|disease progression|0
2088555|NCT00748553|3674898|FG000|Overall Study|noncompliance|1
2088556|NCT00748553|3674899|FG001|Overall Study|noncompliance|0
2088557|NCT00748566|3674904|FG000|Overall Study|Adverse Event|49
2088558|NCT00748566|3674904|FG000|Overall Study|Death|1
2088559|NCT00748566|3674904|FG000|Overall Study|Lack of Efficacy|12
2088560|NCT00748566|3674904|FG000|Overall Study|Lost to Follow-up|1
2088561|NCT00748566|3674904|FG000|Overall Study|Protocol Violation|13
2088562|NCT00748566|3674904|FG000|Overall Study|Withdrawal by Subject|22
2088563|NCT00748566|3674904|FG000|Overall Study|Study terminated by sponsor|5
2088564|NCT00748566|3674904|FG000|Overall Study|Other|9
2088565|NCT00748709|3674918|FG000|Overall Study|Progressive disease|15
2088566|NCT00748709|3674918|FG000|Overall Study|Drug reducing Toxity|2
2088567|NCT00748709|3674918|FG000|Overall Study|Other Adverse Event|1
2088568|NCT00748709|3674918|FG000|Overall Study|Withdrawal by Subject|1
2088569|NCT00748709|3674918|FG000|Overall Study|Other Reasons|1
2088570|NCT00748969|3674948|FG000|Overall Study|Withdrawal by Subject|1
2088571|NCT00748969|3674949|FG001|Overall Study|Withdrawal by Subject|0
2088572|NCT00748969|3674948|FG000|Overall Study|Withdrawal by Subject|0
2088573|NCT00748969|3674949|FG001|Overall Study|Withdrawal by Subject|1
2088574|NCT00749190|3674985|FG000|Overall Study|Adverse Event|0
2088575|NCT00749190|3674986|FG001|Overall Study|Adverse Event|2
2088576|NCT00749190|3674987|FG002|Overall Study|Adverse Event|0
2088577|NCT00749190|3674988|FG003|Overall Study|Adverse Event|4
2211631|NCT01662310|3851997|FG001|Open-Label Extension Phase|Death|0
2088578|NCT00749190|3674989|FG004|Overall Study|Adverse Event|0
2088579|NCT00749190|3674990|FG005|Overall Study|Adverse Event|3
2088580|NCT00749190|3674991|FG006|Overall Study|Adverse Event|0
2088581|NCT00749190|3674985|FG000|Overall Study|Lack of Efficacy|3
2088582|NCT00749190|3674986|FG001|Overall Study|Lack of Efficacy|1
2088583|NCT00749190|3674987|FG002|Overall Study|Lack of Efficacy|1
2088584|NCT00749190|3674988|FG003|Overall Study|Lack of Efficacy|0
2088585|NCT00749190|3674989|FG004|Overall Study|Lack of Efficacy|0
2088586|NCT00749190|3674990|FG005|Overall Study|Lack of Efficacy|1
2088587|NCT00749190|3674991|FG006|Overall Study|Lack of Efficacy|0
2088588|NCT00749190|3674985|FG000|Overall Study|Withdrawal by Subject|2
2088589|NCT00749190|3674986|FG001|Overall Study|Withdrawal by Subject|1
2088590|NCT00749190|3674987|FG002|Overall Study|Withdrawal by Subject|0
2088591|NCT00749190|3674988|FG003|Overall Study|Withdrawal by Subject|0
2088592|NCT00749190|3674989|FG004|Overall Study|Withdrawal by Subject|0
2088593|NCT00749190|3674990|FG005|Overall Study|Withdrawal by Subject|1
2088594|NCT00749190|3674991|FG006|Overall Study|Withdrawal by Subject|0
2088595|NCT00749190|3674985|FG000|Overall Study|Protocol Violation|0
2088596|NCT00749190|3674986|FG001|Overall Study|Protocol Violation|1
2088597|NCT00749190|3674987|FG002|Overall Study|Protocol Violation|0
2088598|NCT00749190|3674988|FG003|Overall Study|Protocol Violation|0
2088599|NCT00749190|3674989|FG004|Overall Study|Protocol Violation|0
2088600|NCT00749190|3674990|FG005|Overall Study|Protocol Violation|0
2088601|NCT00749190|3674991|FG006|Overall Study|Protocol Violation|1
2088602|NCT00749190|3674985|FG000|Overall Study|Other reason not defined above|0
2088603|NCT00749190|3674986|FG001|Overall Study|Other reason not defined above|0
2088604|NCT00749190|3674987|FG002|Overall Study|Other reason not defined above|0
2088605|NCT00749190|3674988|FG003|Overall Study|Other reason not defined above|1
2088606|NCT00749190|3674989|FG004|Overall Study|Other reason not defined above|0
2088607|NCT00749190|3674990|FG005|Overall Study|Other reason not defined above|0
2088608|NCT00749190|3674991|FG006|Overall Study|Other reason not defined above|0
2088609|NCT00749203|3675014|FG000|no Infusion at Week 1|Lost to Follow-up|0
2088610|NCT00749203|3675015|FG001|no Infusion at Week 1|Lost to Follow-up|1
2088611|NCT00749203|3675014|FG000|no Infusion at Week 1|Withdrawal by Subject|0
2088612|NCT00749203|3675015|FG001|no Infusion at Week 1|Withdrawal by Subject|1
2088613|NCT00749203|3675014|FG000|no Infusion at Week 1|delayed-onset sedation|0
2088614|NCT00749203|3675015|FG001|no Infusion at Week 1|delayed-onset sedation|1
2088615|NCT00749203|3675014|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0
2211632|NCT01662310|3851998|FG002|Open-Label Extension Phase|Death|0
2211633|NCT01662310|3851999|FG003|Open-Label Extension Phase|Death|1
2211634|NCT01662310|3852000|FG004|Open-Label Extension Phase|Death|0
2088616|NCT00749203|3675015|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1
2088617|NCT00749203|3675014|FG000|Second Infusion at 2 Weeks|Protocol Violation|0
2088618|NCT00749203|3675015|FG001|Second Infusion at 2 Weeks|Protocol Violation|1
2088619|NCT00749203|3675014|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
2088620|NCT00749203|3675015|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
2088621|NCT00749398|3675036|FG000|Overall Study|Lack of Efficacy|7
2088622|NCT00749398|3675036|FG000|Overall Study|Adverse Event|4
2088623|NCT00749398|3675036|FG000|Overall Study|Serious adverse event|11
2088624|NCT00749398|3675036|FG000|Overall Study|Withdrawal by Subject|17
2088625|NCT00749398|3675036|FG000|Overall Study|Lost to Follow-up|11
2088626|NCT00749398|3675036|FG000|Overall Study|Reason not specified|2
2088627|NCT00749398|3675036|FG000|Overall Study|Unknown reason|1
2088628|NCT00749411|3675042|FG000|Overall Study|Adverse Event|0
2088629|NCT00749411|3675043|FG001|Overall Study|Adverse Event|2
2088630|NCT00749411|3675042|FG000|Overall Study|Lack of Efficacy|0
2088631|NCT00749411|3675043|FG001|Overall Study|Lack of Efficacy|1
2088632|NCT00749411|3675042|FG000|Overall Study|Protocol Violation|1
2088633|NCT00749411|3675043|FG001|Overall Study|Protocol Violation|1
2088634|NCT00749411|3675042|FG000|Overall Study|Protocol-defined stopping criteria|0
2088635|NCT00749411|3675043|FG001|Overall Study|Protocol-defined stopping criteria|1
2088636|NCT00749463|3675052|FG000|Overall Study|Adverse Event|0
2088637|NCT00749463|3675053|FG001|Overall Study|Adverse Event|4
2088638|NCT00749463|3675054|FG002|Overall Study|Adverse Event|1
2088639|NCT00749463|3675052|FG000|Overall Study|Withdrawal by Subject|1
2088640|NCT00749463|3675053|FG001|Overall Study|Withdrawal by Subject|0
2088641|NCT00749463|3675054|FG002|Overall Study|Withdrawal by Subject|0
2088642|NCT00749580|3675073|FG000|Overall Study|Lost to Follow-up|4
2088643|NCT00749580|3675074|FG001|Overall Study|Lost to Follow-up|8
2088644|NCT00749580|3675073|FG000|Overall Study|Adverse Event|0
2088645|NCT00749580|3675074|FG001|Overall Study|Adverse Event|1
2107343|NCT00872521|3700855|FG001|Primary Endpoint Analysis|Patient choice|1
2217516|NCT01708941|3860839|FG001|Overall Study|Never started treatment|1
2088646|NCT00749684|3675102|FG000|Overall Study|Death|1
2088647|NCT00749684|3675102|FG000|Overall Study|Adverse Event|27
2088648|NCT00749684|3675102|FG000|Overall Study|Participant's Wish|10
2088649|NCT00749684|3675102|FG000|Overall Study|Not Documented|1
2088650|NCT00749684|3675102|FG000|Overall Study|Progressive Desease|31
2088651|NCT00749684|3675102|FG000|Overall Study|Therapy according to protocol + AE|2
2088652|NCT00749684|3675102|FG000|Overall Study|AE+discontinuation on participants wish|1
2088653|NCT00749684|3675102|FG000|Overall Study|Missing|9
2088654|NCT00749775|3675115|FG000|Overall Study|Protocol Violation|24
2088655|NCT00749775|3675115|FG000|Overall Study|Lost to Follow-up|36
2088656|NCT00749775|3675115|FG000|Overall Study|No visit after first day of treatment|44
2088657|NCT00749775|3675115|FG000|Overall Study|No drug administration|3
2088658|NCT00749892|3675141|FG000|Overall Study|Withdrawal by Subject|3
2088659|NCT00749944|3675158|FG000|Overall Study|Lost to Follow-up|2
2088660|NCT00749944|3675159|FG001|Overall Study|Lost to Follow-up|1
2088661|NCT00749944|3675158|FG000|Overall Study|Other|1
2088662|NCT00749944|3675159|FG001|Overall Study|Other|0
2088663|NCT00749944|3675158|FG000|Overall Study|Withdrawal by Subject|2
2088664|NCT00749944|3675159|FG001|Overall Study|Withdrawal by Subject|0
2088665|NCT00749996|3675178|FG000|Overall Study|Lost to Follow-up|7
2088666|NCT00749996|3675179|FG001|Overall Study|Lost to Follow-up|4
2088667|NCT00749996|3675178|FG000|Overall Study|Withdrawal by Subject|5
2088668|NCT00749996|3675179|FG001|Overall Study|Withdrawal by Subject|4
2088669|NCT00749996|3675178|FG000|Overall Study|Protocol Violation|2
2088670|NCT00749996|3675179|FG001|Overall Study|Protocol Violation|3
2088671|NCT00749996|3675178|FG000|Overall Study|Physician Decision|2
2088672|NCT00749996|3675179|FG001|Overall Study|Physician Decision|0
2088673|NCT00749996|3675178|FG000|Overall Study|Pregnancy|0
2088674|NCT00749996|3675179|FG001|Overall Study|Pregnancy|2
2088675|NCT00749996|3675178|FG000|Overall Study|Adverse Event|1
2088676|NCT00749996|3675179|FG001|Overall Study|Adverse Event|0
2088677|NCT00749996|3675178|FG000|Overall Study|Death|1
2088678|NCT00749996|3675179|FG001|Overall Study|Death|0
2088679|NCT00750061|3675187|FG000|Overall Study|Adverse Event|2
2088680|NCT00750061|3675188|FG001|Overall Study|Adverse Event|0
2088681|NCT00750061|3675187|FG000|Overall Study|Withdrawal by Subject|0
2088682|NCT00750061|3675188|FG001|Overall Study|Withdrawal by Subject|1
2088683|NCT00750061|3675187|FG000|Overall Study|Physician Decision|0
2088684|NCT00750061|3675188|FG001|Overall Study|Physician Decision|1
2088685|NCT00750139|3675198|FG000|Overall Study|Adverse Event|1
2088686|NCT00750139|3675199|FG001|Overall Study|Adverse Event|2
2088687|NCT00750139|3675200|FG002|Overall Study|Adverse Event|0
2088688|NCT00750139|3675201|FG003|Overall Study|Adverse Event|1
2088689|NCT00750139|3675198|FG000|Overall Study|Lost to Follow-up|17
2088690|NCT00750139|3675199|FG001|Overall Study|Lost to Follow-up|12
2088691|NCT00750139|3675200|FG002|Overall Study|Lost to Follow-up|15
2088692|NCT00750139|3675201|FG003|Overall Study|Lost to Follow-up|6
2088693|NCT00750139|3675198|FG000|Overall Study|Withdrawal by Subject|3
2088694|NCT00750139|3675199|FG001|Overall Study|Withdrawal by Subject|2
2088695|NCT00750139|3675200|FG002|Overall Study|Withdrawal by Subject|6
2088696|NCT00750139|3675201|FG003|Overall Study|Withdrawal by Subject|2
2088697|NCT00750139|3675198|FG000|Overall Study|Physician Decision|1
2088698|NCT00750139|3675199|FG001|Overall Study|Physician Decision|1
2088699|NCT00750139|3675200|FG002|Overall Study|Physician Decision|0
2088700|NCT00750139|3675201|FG003|Overall Study|Physician Decision|0
2088701|NCT00750139|3675198|FG000|Overall Study|Non-compliance|1
2088702|NCT00750139|3675199|FG001|Overall Study|Non-compliance|0
2088703|NCT00750139|3675200|FG002|Overall Study|Non-compliance|1
2088704|NCT00750139|3675201|FG003|Overall Study|Non-compliance|3
2088705|NCT00750139|3675198|FG000|Overall Study|Termination by sponsor|4
2088706|NCT00750139|3675199|FG001|Overall Study|Termination by sponsor|0
2088707|NCT00750139|3675200|FG002|Overall Study|Termination by sponsor|0
2088708|NCT00750139|3675201|FG003|Overall Study|Termination by sponsor|1
2088709|NCT00750139|3675198|FG000|Overall Study|Non-specific|62
2088710|NCT00750139|3675199|FG001|Overall Study|Non-specific|42
2088711|NCT00750139|3675200|FG002|Overall Study|Non-specific|79
2088712|NCT00750139|3675201|FG003|Overall Study|Non-specific|33
2088713|NCT00750152|3675215|FG000|Overall Study|Adverse Event|2
2088714|NCT00750152|3675216|FG001|Overall Study|Adverse Event|1
2088715|NCT00750152|3675215|FG000|Overall Study|Lost to Follow-up|8
2088716|NCT00750152|3675216|FG001|Overall Study|Lost to Follow-up|13
2088717|NCT00750152|3675215|FG000|Overall Study|Withdrawal by Subject|3
2088718|NCT00750152|3675216|FG001|Overall Study|Withdrawal by Subject|3
2088719|NCT00750152|3675215|FG000|Overall Study|Physician Decision|1
2088720|NCT00750152|3675216|FG001|Overall Study|Physician Decision|1
2088721|NCT00750152|3675215|FG000|Overall Study|Non-compliance|0
2088722|NCT00750152|3675216|FG001|Overall Study|Non-compliance|1
2088723|NCT00750152|3675215|FG000|Overall Study|Termination by sponsor|1
2088724|NCT00750152|3675216|FG001|Overall Study|Termination by sponsor|0
2088725|NCT00750152|3675215|FG000|Overall Study|Other|7
2088726|NCT00750152|3675216|FG001|Overall Study|Other|8
2088727|NCT00750269|3675240|FG000|Overall Study|Protocol Violation|0
2088728|NCT00750269|3675241|FG001|Overall Study|Protocol Violation|1
2088729|NCT00750269|3675242|FG002|Overall Study|Protocol Violation|1
2088730|NCT00750269|3675243|FG003|Overall Study|Protocol Violation|2
2088731|NCT00750269|3675244|FG004|Overall Study|Protocol Violation|4
2088732|NCT00750269|3675240|FG000|Overall Study|Withdrawal by Subject|0
2088733|NCT00750269|3675241|FG001|Overall Study|Withdrawal by Subject|0
2088734|NCT00750269|3675242|FG002|Overall Study|Withdrawal by Subject|2
2088735|NCT00750269|3675243|FG003|Overall Study|Withdrawal by Subject|2
2088736|NCT00750269|3675244|FG004|Overall Study|Withdrawal by Subject|2
2088737|NCT00750269|3675240|FG000|Overall Study|Physician Decision|0
2088738|NCT00750269|3675241|FG001|Overall Study|Physician Decision|0
2088739|NCT00750269|3675242|FG002|Overall Study|Physician Decision|0
2088740|NCT00750269|3675243|FG003|Overall Study|Physician Decision|0
2088741|NCT00750269|3675244|FG004|Overall Study|Physician Decision|2
2088742|NCT00750269|3675240|FG000|Overall Study|Patient too large for positioning|0
2088743|NCT00750269|3675241|FG001|Overall Study|Patient too large for positioning|0
2088744|NCT00750269|3675242|FG002|Overall Study|Patient too large for positioning|1
2088745|NCT00750269|3675243|FG003|Overall Study|Patient too large for positioning|0
2088746|NCT00750269|3675244|FG004|Overall Study|Patient too large for positioning|0
2088747|NCT00750269|3675240|FG000|Overall Study|Site error|0
2088748|NCT00750269|3675241|FG001|Overall Study|Site error|0
2088749|NCT00750269|3675242|FG002|Overall Study|Site error|0
2088750|NCT00750269|3675243|FG003|Overall Study|Site error|1
2088751|NCT00750269|3675244|FG004|Overall Study|Site error|0
2088752|NCT00750269|3675240|FG000|Overall Study|SBRT plan could not be drawn|0
2088753|NCT00750269|3675241|FG001|Overall Study|SBRT plan could not be drawn|0
2088754|NCT00750269|3675242|FG002|Overall Study|SBRT plan could not be drawn|0
2088755|NCT00750269|3675243|FG003|Overall Study|SBRT plan could not be drawn|0
2088756|NCT00750269|3675244|FG004|Overall Study|SBRT plan could not be drawn|1
2088757|NCT00750269|3675240|FG000|Overall Study|Fiducials could not be placed|0
2088758|NCT00750269|3675241|FG001|Overall Study|Fiducials could not be placed|0
2088759|NCT00750269|3675242|FG002|Overall Study|Fiducials could not be placed|0
2088760|NCT00750269|3675243|FG003|Overall Study|Fiducials could not be placed|0
2088761|NCT00750269|3675244|FG004|Overall Study|Fiducials could not be placed|1
2088762|NCT00750308|3675294|FG000|First Treatment|Adverse Event|0
2088763|NCT00750308|3675295|FG001|First Treatment|Adverse Event|1
2088764|NCT00750308|3675296|FG002|First Treatment|Adverse Event|0
2088765|NCT00750308|3675297|FG003|First Treatment|Adverse Event|0
2088766|NCT00750308|3675298|FG004|First Treatment|Adverse Event|0
2088767|NCT00750308|3675299|FG005|First Treatment|Adverse Event|0
2088768|NCT00750308|3675300|FG006|First Treatment|Adverse Event|0
2088769|NCT00750308|3675301|FG007|First Treatment|Adverse Event|0
2088770|NCT00750308|3675302|FG008|First Treatment|Adverse Event|0
2088771|NCT00750308|3675303|FG009|First Treatment|Adverse Event|0
2088772|NCT00750308|3675304|FG010|First Treatment|Adverse Event|1
2088773|NCT00750308|3675305|FG011|First Treatment|Adverse Event|1
2088774|NCT00750308|3675294|FG000|First Treatment|Withdrawal by Subject|0
2088775|NCT00750308|3675295|FG001|First Treatment|Withdrawal by Subject|0
2088776|NCT00750308|3675296|FG002|First Treatment|Withdrawal by Subject|0
2088777|NCT00750308|3675297|FG003|First Treatment|Withdrawal by Subject|1
2088778|NCT00750308|3675298|FG004|First Treatment|Withdrawal by Subject|0
2088779|NCT00750308|3675299|FG005|First Treatment|Withdrawal by Subject|0
2088780|NCT00750308|3675300|FG006|First Treatment|Withdrawal by Subject|0
2088781|NCT00750308|3675301|FG007|First Treatment|Withdrawal by Subject|1
2088782|NCT00750308|3675302|FG008|First Treatment|Withdrawal by Subject|0
2088783|NCT00750308|3675303|FG009|First Treatment|Withdrawal by Subject|0
2088784|NCT00750308|3675304|FG010|First Treatment|Withdrawal by Subject|0
2088785|NCT00750308|3675305|FG011|First Treatment|Withdrawal by Subject|0
2088786|NCT00750308|3675294|FG000|Second Treatment|Adverse Event|0
2088787|NCT00750308|3675295|FG001|Second Treatment|Adverse Event|0
2088788|NCT00750308|3675296|FG002|Second Treatment|Adverse Event|0
2088789|NCT00750308|3675297|FG003|Second Treatment|Adverse Event|0
2088790|NCT00750308|3675298|FG004|Second Treatment|Adverse Event|0
2088791|NCT00750308|3675299|FG005|Second Treatment|Adverse Event|1
2088792|NCT00750308|3675300|FG006|Second Treatment|Adverse Event|0
2088793|NCT00750308|3675301|FG007|Second Treatment|Adverse Event|0
2088794|NCT00750308|3675302|FG008|Second Treatment|Adverse Event|1
2088795|NCT00750308|3675303|FG009|Second Treatment|Adverse Event|0
2088796|NCT00750308|3675304|FG010|Second Treatment|Adverse Event|0
2088797|NCT00750308|3675305|FG011|Second Treatment|Adverse Event|0
2088798|NCT00750308|3675294|FG000|Second Treatment|Withdrawal by Subject|0
2088799|NCT00750308|3675295|FG001|Second Treatment|Withdrawal by Subject|0
2088800|NCT00750308|3675296|FG002|Second Treatment|Withdrawal by Subject|0
2088801|NCT00750308|3675297|FG003|Second Treatment|Withdrawal by Subject|0
2088802|NCT00750308|3675298|FG004|Second Treatment|Withdrawal by Subject|1
2088803|NCT00750308|3675299|FG005|Second Treatment|Withdrawal by Subject|0
2088804|NCT00750308|3675300|FG006|Second Treatment|Withdrawal by Subject|0
2088805|NCT00750308|3675301|FG007|Second Treatment|Withdrawal by Subject|0
2088806|NCT00750308|3675302|FG008|Second Treatment|Withdrawal by Subject|0
2088807|NCT00750308|3675303|FG009|Second Treatment|Withdrawal by Subject|0
2088808|NCT00750308|3675304|FG010|Second Treatment|Withdrawal by Subject|0
2088809|NCT00750308|3675305|FG011|Second Treatment|Withdrawal by Subject|0
2088810|NCT00750308|3675294|FG000|Third Treatment|Withdrawal by Subject|0
2088811|NCT00750308|3675295|FG001|Third Treatment|Withdrawal by Subject|1
2088812|NCT00750308|3675296|FG002|Third Treatment|Withdrawal by Subject|0
2088813|NCT00750308|3675297|FG003|Third Treatment|Withdrawal by Subject|0
2088814|NCT00750308|3675298|FG004|Third Treatment|Withdrawal by Subject|0
2088815|NCT00750308|3675299|FG005|Third Treatment|Withdrawal by Subject|0
2088816|NCT00750308|3675300|FG006|Third Treatment|Withdrawal by Subject|0
2088817|NCT00750308|3675301|FG007|Third Treatment|Withdrawal by Subject|0
2088818|NCT00750308|3675302|FG008|Third Treatment|Withdrawal by Subject|0
2088819|NCT00750308|3675303|FG009|Third Treatment|Withdrawal by Subject|0
2088820|NCT00750308|3675304|FG010|Third Treatment|Withdrawal by Subject|0
2088821|NCT00750308|3675305|FG011|Third Treatment|Withdrawal by Subject|0
2088822|NCT00750438|3675361|FG000|Overall Study|Protocol Violation|4
2088823|NCT00750438|3675362|FG001|Overall Study|Protocol Violation|1
2088824|NCT00750438|3675361|FG000|Overall Study|Physician Decision|2
2088825|NCT00750438|3675362|FG001|Overall Study|Physician Decision|2
2088826|NCT00750438|3675361|FG000|Overall Study|Withdrawal by Subject|1
2088827|NCT00750438|3675362|FG001|Overall Study|Withdrawal by Subject|1
2088828|NCT00750737|3675370|FG000|Overall Study|Withdrawal by Subject|3
2088829|NCT00750737|3675371|FG001|Overall Study|Withdrawal by Subject|3
2088830|NCT00750867|3675390|FG000|Overall Study|Adverse Event|2
2088831|NCT00750880|3675394|FG000|Overall Study|Adverse Event|76
2088832|NCT00750880|3675394|FG000|Overall Study|Death|4
2088833|NCT00750880|3675394|FG000|Overall Study|Lack of Efficacy|46
2088834|NCT00750880|3675394|FG000|Overall Study|Lost to Follow-up|10
2088835|NCT00750880|3675394|FG000|Overall Study|Protocol Violation|15
2088836|NCT00750880|3675394|FG000|Overall Study|Withdrawal by Subject|33
2088837|NCT00750880|3675394|FG000|Overall Study|Physician Decision|20
2088838|NCT00750880|3675394|FG000|Overall Study|Administrative|11
2088839|NCT00750893|3675399|FG000|Overall Study|Adverse Event|5
2088840|NCT00750893|3675399|FG000|Overall Study|Withdrawal by Subject|10
2088841|NCT00750893|3675399|FG000|Overall Study|Lost to Follow-up|510
2088842|NCT00750893|3675399|FG000|Overall Study|Other|17
2088843|NCT00750919|3675403|FG000|Overall Study|Adverse Event|9
2088844|NCT00750919|3675403|FG000|Overall Study|Withdrawal by Subject|1
2088845|NCT00750919|3675403|FG000|Overall Study|Lack of Efficacy|8
2088846|NCT00750919|3675403|FG000|Overall Study|Could not cooperate, unrelated to trial|4
2088847|NCT00750919|3675403|FG000|Overall Study|Other|36
2088848|NCT00751023|3675409|FG000|Overall Study|Lost to Follow-up|11
2088849|NCT00751023|3675410|FG001|Overall Study|Lost to Follow-up|7
2088850|NCT00751036|3675418|FG000|Overall Study|Disease Progression|28
2088851|NCT00751036|3675419|FG001|Overall Study|Disease Progression|29
2088852|NCT00751036|3675418|FG000|Overall Study|Adverse Event|6
2088853|NCT00751036|3675419|FG001|Overall Study|Adverse Event|4
2088854|NCT00751036|3675418|FG000|Overall Study|Administrative Problems|3
2088855|NCT00751036|3675419|FG001|Overall Study|Administrative Problems|4
2088856|NCT00751036|3675418|FG000|Overall Study|Withdrawal by Subject|5
2088857|NCT00751036|3675419|FG001|Overall Study|Withdrawal by Subject|2
2088858|NCT00751036|3675418|FG000|Overall Study|Death|3
2088859|NCT00751036|3675419|FG001|Overall Study|Death|3
2088860|NCT00751036|3675418|FG000|Overall Study|Lost to Follow-up|0
2088861|NCT00751036|3675419|FG001|Overall Study|Lost to Follow-up|1
2088862|NCT00751036|3675418|FG000|Overall Study|Protocol Violation|1
2088863|NCT00751036|3675419|FG001|Overall Study|Protocol Violation|0
2088864|NCT00751036|3675418|FG000|Overall Study|Missing end of Treatment Page|2
2088865|NCT00751036|3675419|FG001|Overall Study|Missing end of Treatment Page|3
2088866|NCT00751101|3675427|FG000|Overall Study|Withdrawal by Subject|1
2088867|NCT00751101|3675428|FG001|Overall Study|Withdrawal by Subject|0
2088868|NCT00751101|3675427|FG000|Overall Study|No HFS / Never Started Patch/|0
2088869|NCT00751101|3675428|FG001|Overall Study|No HFS / Never Started Patch/|4
2088870|NCT00751101|3675427|FG000|Overall Study|Never began capecitabine|1
2088871|NCT00751101|3675428|FG001|Overall Study|Never began capecitabine|0
2088872|NCT00751101|3675427|FG000|Overall Study|Physician Decision|0
2088873|NCT00751101|3675428|FG001|Overall Study|Physician Decision|1
2088874|NCT00751114|3675440|FG000|Overall Study|Adverse Event|2
2211635|NCT01662310|3851996|FG000|Open-Label Extension Phase|Lack of Efficacy|0
2211636|NCT01662310|3851997|FG001|Open-Label Extension Phase|Lack of Efficacy|0
2211637|NCT01662310|3851998|FG002|Open-Label Extension Phase|Lack of Efficacy|0
2211638|NCT01662310|3851999|FG003|Open-Label Extension Phase|Lack of Efficacy|2
2211639|NCT01662310|3852000|FG004|Open-Label Extension Phase|Lack of Efficacy|2
2211640|NCT01662310|3851996|FG000|Open-Label Extension Phase|Lost to Follow-up|0
2211641|NCT01662310|3851997|FG001|Open-Label Extension Phase|Lost to Follow-up|0
2211642|NCT01662310|3851998|FG002|Open-Label Extension Phase|Lost to Follow-up|0
2211643|NCT01662310|3851999|FG003|Open-Label Extension Phase|Lost to Follow-up|2
2211644|NCT01662310|3852000|FG004|Open-Label Extension Phase|Lost to Follow-up|1
2211645|NCT01662310|3851996|FG000|Open-Label Extension Phase|Pregnancy|0
2211646|NCT01662310|3851997|FG001|Open-Label Extension Phase|Pregnancy|0
2211647|NCT01662310|3851998|FG002|Open-Label Extension Phase|Pregnancy|0
2211648|NCT01662310|3851999|FG003|Open-Label Extension Phase|Pregnancy|1
2211649|NCT01662310|3852000|FG004|Open-Label Extension Phase|Pregnancy|0
2088875|NCT00751114|3675441|FG001|Overall Study|Adverse Event|4
2088876|NCT00751114|3675440|FG000|Overall Study|Protocol Violation|8
2088877|NCT00751114|3675441|FG001|Overall Study|Protocol Violation|9
2088878|NCT00751114|3675440|FG000|Overall Study|Withdrawal by Subject|9
2088879|NCT00751114|3675441|FG001|Overall Study|Withdrawal by Subject|4
2088880|NCT00751114|3675440|FG000|Overall Study|Lost to Follow-up|4
2088881|NCT00751114|3675441|FG001|Overall Study|Lost to Follow-up|7
2088882|NCT00751114|3675440|FG000|Overall Study|Lack of Efficacy|0
2211650|NCT01662310|3851996|FG000|Open-Label Extension Phase|Withdrawal by Subject|0
2088883|NCT00751114|3675441|FG001|Overall Study|Lack of Efficacy|7
2088884|NCT00751114|3675440|FG000|Overall Study|Not Treated|13
2088885|NCT00751114|3675441|FG001|Overall Study|Not Treated|1
2088886|NCT00751114|3675440|FG000|Overall Study|Out of country for 2 months|1
2088887|NCT00751114|3675441|FG001|Overall Study|Out of country for 2 months|0
2088888|NCT00751114|3675440|FG000|Overall Study|Move to another city|1
2088889|NCT00751114|3675441|FG001|Overall Study|Move to another city|0
2088890|NCT00751140|3675447|FG000|Overall Study|benign angioma excluded from analysis|1
2088891|NCT00751296|3675465|FG000|Overall Study|Adverse Event|2
2088892|NCT00751348|3675471|FG000|Overall Study|Withdrawal by Subject|5
2088893|NCT00751348|3675472|FG001|Overall Study|Withdrawal by Subject|2
2088894|NCT00751348|3675471|FG000|Overall Study|Migration from study area|1
2088895|NCT00751348|3675472|FG001|Overall Study|Migration from study area|0
2088896|NCT00751400|3675478|FG000|Overall Study|Lost to Follow-up|10
2088897|NCT00751621|3675491|FG000|Overall Study|Adverse Event|1
2088898|NCT00751621|3675491|FG000|Overall Study|Withdrawal by Subject|1
2088899|NCT00751621|3675491|FG000|Overall Study|Subject moved to another country|1
2088900|NCT00751621|3675491|FG000|Overall Study|Poor adherence to asthma treatment|1
2088901|NCT00751790|3675511|FG000|Overall Study|Lost to Follow-up|1
2088902|NCT00751790|3675511|FG000|Overall Study|Death|3
2088903|NCT00751790|3675511|FG000|Overall Study|Withdrawal by Subject|1
2088904|NCT00751881|3675518|FG000|Core Treatment Period|Not treated|1
2088905|NCT00751881|3675519|FG001|Core Treatment Period|Not treated|1
2088906|NCT00751881|3675520|FG002|Core Treatment Period|Not treated|2
2088907|NCT00751881|3675518|FG000|Core Treatment Period|Adverse Event|26
2088908|NCT00751881|3675519|FG001|Core Treatment Period|Adverse Event|54
2088909|NCT00751881|3675520|FG002|Core Treatment Period|Adverse Event|58
2088910|NCT00751881|3675518|FG000|Core Treatment Period|Lack of Efficacy|37
2088911|NCT00751881|3675519|FG001|Core Treatment Period|Lack of Efficacy|30
2088912|NCT00751881|3675520|FG002|Core Treatment Period|Lack of Efficacy|20
2088913|NCT00751881|3675518|FG000|Core Treatment Period|Poor compliance to protocol|15
2088914|NCT00751881|3675519|FG001|Core Treatment Period|Poor compliance to protocol|3
2088915|NCT00751881|3675520|FG002|Core Treatment Period|Poor compliance to protocol|4
2088916|NCT00751881|3675518|FG000|Core Treatment Period|Lost to Follow-up|6
2088917|NCT00751881|3675519|FG001|Core Treatment Period|Lost to Follow-up|4
2088918|NCT00751881|3675520|FG002|Core Treatment Period|Lost to Follow-up|3
2088919|NCT00751881|3675518|FG000|Core Treatment Period|Other: protocol deviation|3
2088920|NCT00751881|3675519|FG001|Core Treatment Period|Other: protocol deviation|3
2088921|NCT00751881|3675520|FG002|Core Treatment Period|Other: protocol deviation|7
2088922|NCT00751881|3675518|FG000|Core Treatment Period|Other: wish to parent|5
2088923|NCT00751881|3675519|FG001|Core Treatment Period|Other: wish to parent|7
2088924|NCT00751881|3675520|FG002|Core Treatment Period|Other: wish to parent|4
2088925|NCT00751881|3675518|FG000|Core Treatment Period|Other: personal/family constraints|6
2088926|NCT00751881|3675519|FG001|Core Treatment Period|Other: personal/family constraints|7
2088927|NCT00751881|3675520|FG002|Core Treatment Period|Other: personal/family constraints|10
2088928|NCT00751881|3675518|FG000|Core Treatment Period|Other: MS treatment change|6
2088929|NCT00751881|3675519|FG001|Core Treatment Period|Other: MS treatment change|4
2088930|NCT00751881|3675520|FG002|Core Treatment Period|Other: MS treatment change|4
2088931|NCT00751881|3675518|FG000|Core Treatment Period|Other: tolerability complaints|2
2088932|NCT00751881|3675519|FG001|Core Treatment Period|Other: tolerability complaints|0
2088933|NCT00751881|3675520|FG002|Core Treatment Period|Other: tolerability complaints|0
2088934|NCT00751881|3675518|FG000|Core Treatment Period|Other:participant's decision/unspecified|19
2088935|NCT00751881|3675519|FG001|Core Treatment Period|Other:participant's decision/unspecified|22
2088936|NCT00751881|3675520|FG002|Core Treatment Period|Other:participant's decision/unspecified|16
2088937|NCT00751881|3675518|FG000|Extension Study Period|Adverse Event|18
2088938|NCT00751881|3675519|FG001|Extension Study Period|Adverse Event|20
2088939|NCT00751881|3675520|FG002|Extension Study Period|Adverse Event|21
2088940|NCT00751881|3675518|FG000|Extension Study Period|Lack of Efficacy|14
2088941|NCT00751881|3675519|FG001|Extension Study Period|Lack of Efficacy|10
2088942|NCT00751881|3675520|FG002|Extension Study Period|Lack of Efficacy|20
2088943|NCT00751881|3675518|FG000|Extension Study Period|Lost to Follow-up|4
2088944|NCT00751881|3675519|FG001|Extension Study Period|Lost to Follow-up|9
2088945|NCT00751881|3675520|FG002|Extension Study Period|Lost to Follow-up|6
2088946|NCT00751881|3675518|FG000|Extension Study Period|Poor Compliance to Protocol|3
2088947|NCT00751881|3675519|FG001|Extension Study Period|Poor Compliance to Protocol|2
2088948|NCT00751881|3675520|FG002|Extension Study Period|Poor Compliance to Protocol|1
2088949|NCT00751881|3675518|FG000|Extension Study Period|Other than specified above|26
2088950|NCT00751881|3675519|FG001|Extension Study Period|Other than specified above|30
2088951|NCT00751881|3675520|FG002|Extension Study Period|Other than specified above|18
2088952|NCT00751998|3675542|FG000|Overall Study|Lost to Follow-up|7
2088953|NCT00751998|3675542|FG000|Overall Study|Death|11
2088954|NCT00751998|3675542|FG000|Overall Study|Withdrawal by Subject|2
2088955|NCT00752089|3675546|FG000|Overall Study|Adverse Event|1
2088956|NCT00752089|3675546|FG000|Overall Study|Protocol Deviation|2
2088957|NCT00752089|3675546|FG000|Overall Study|Could not attend visit 9|1
2088958|NCT00752089|3675546|FG000|Overall Study|Not capable of wearing partial denture|1
2088959|NCT00752089|3675546|FG000|Overall Study|Cannot continue the study|1
2088960|NCT00752128|3675566|FG000|Overall Study|Withdrawal by Subject|4
2088961|NCT00752206|3675573|FG000|Overall Study|Disease progression|8
2088962|NCT00752206|3675574|FG001|Overall Study|Disease progression|11
2088963|NCT00752206|3675573|FG000|Overall Study|Pregnancy|1
2088964|NCT00752206|3675574|FG001|Overall Study|Pregnancy|0
2088965|NCT00752219|3675582|FG000|Overall Study|Clinical failure|0
2088966|NCT00752219|3675583|FG001|Overall Study|Clinical failure|1
2088967|NCT00752219|3675582|FG000|Overall Study|Adverse Event|5
2088968|NCT00752219|3675583|FG001|Overall Study|Adverse Event|3
2088969|NCT00752219|3675582|FG000|Overall Study|Protocol deviation|1
2088970|NCT00752219|3675583|FG001|Overall Study|Protocol deviation|0
2088971|NCT00752219|3675582|FG000|Overall Study|Lost to Follow-up|1
2088972|NCT00752219|3675583|FG001|Overall Study|Lost to Follow-up|2
2088973|NCT00752219|3675582|FG000|Overall Study|Randomized but not treated|1
2088974|NCT00752219|3675583|FG001|Overall Study|Randomized but not treated|0
2088975|NCT00752219|3675582|FG000|Overall Study|Other|3
2088976|NCT00752219|3675583|FG001|Overall Study|Other|0
2088977|NCT00752232|3675596|FG000|Overall Study|Protocol Violation|0
2088978|NCT00752232|3675597|FG001|Overall Study|Protocol Violation|0
2088979|NCT00752232|3675598|FG002|Overall Study|Protocol Violation|0
2088980|NCT00752232|3675599|FG003|Overall Study|Protocol Violation|0
2088981|NCT00752232|3675600|FG004|Overall Study|Protocol Violation|0
2088982|NCT00752232|3675601|FG005|Overall Study|Protocol Violation|1
2088983|NCT00752232|3675602|FG006|Overall Study|Protocol Violation|0
2088984|NCT00752232|3675596|FG000|Overall Study|Caregiver request|2
2088985|NCT00752232|3675597|FG001|Overall Study|Caregiver request|0
2088986|NCT00752232|3675598|FG002|Overall Study|Caregiver request|0
2088987|NCT00752232|3675599|FG003|Overall Study|Caregiver request|0
2088988|NCT00752232|3675600|FG004|Overall Study|Caregiver request|1
2088989|NCT00752232|3675601|FG005|Overall Study|Caregiver request|0
2088990|NCT00752232|3675602|FG006|Overall Study|Caregiver request|0
2088991|NCT00752232|3675596|FG000|Overall Study|Investigator request|0
2088992|NCT00752232|3675597|FG001|Overall Study|Investigator request|0
2088993|NCT00752232|3675598|FG002|Overall Study|Investigator request|0
2088994|NCT00752232|3675599|FG003|Overall Study|Investigator request|0
2088995|NCT00752232|3675600|FG004|Overall Study|Investigator request|1
2088996|NCT00752232|3675601|FG005|Overall Study|Investigator request|0
2088997|NCT00752232|3675602|FG006|Overall Study|Investigator request|0
2088998|NCT00752232|3675596|FG000|Overall Study|Subject request|0
2088999|NCT00752232|3675597|FG001|Overall Study|Subject request|0
2089000|NCT00752232|3675598|FG002|Overall Study|Subject request|1
2089001|NCT00752232|3675599|FG003|Overall Study|Subject request|0
2089002|NCT00752232|3675600|FG004|Overall Study|Subject request|0
2089003|NCT00752232|3675601|FG005|Overall Study|Subject request|0
2089004|NCT00752232|3675602|FG006|Overall Study|Subject request|0
2089005|NCT00752232|3675596|FG000|Overall Study|Group home admission|0
2089006|NCT00752232|3675597|FG001|Overall Study|Group home admission|0
2089007|NCT00752232|3675598|FG002|Overall Study|Group home admission|0
2089008|NCT00752232|3675599|FG003|Overall Study|Group home admission|1
2089009|NCT00752232|3675600|FG004|Overall Study|Group home admission|0
2089010|NCT00752232|3675601|FG005|Overall Study|Group home admission|0
2089011|NCT00752232|3675602|FG006|Overall Study|Group home admission|0
2089012|NCT00752232|3675596|FG000|Overall Study|Caregiver could not attend the subject|0
2089013|NCT00752232|3675597|FG001|Overall Study|Caregiver could not attend the subject|0
2089014|NCT00752232|3675598|FG002|Overall Study|Caregiver could not attend the subject|0
2089015|NCT00752232|3675599|FG003|Overall Study|Caregiver could not attend the subject|0
2089016|NCT00752232|3675600|FG004|Overall Study|Caregiver could not attend the subject|1
2089017|NCT00752232|3675601|FG005|Overall Study|Caregiver could not attend the subject|0
2089018|NCT00752232|3675602|FG006|Overall Study|Caregiver could not attend the subject|0
2211651|NCT01662310|3851997|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
2211652|NCT01662310|3851998|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
2211653|NCT01662310|3851999|FG003|Open-Label Extension Phase|Withdrawal by Subject|2
2211654|NCT01662310|3852000|FG004|Open-Label Extension Phase|Withdrawal by Subject|7
2211655|NCT01662336|3852012|FG000|Overall Study|Adverse Event|1
2211656|NCT01662336|3852012|FG000|Overall Study|No longer on LPV/r|30
2211657|NCT01662336|3852012|FG000|Overall Study|Other|29
2211658|NCT01662336|3852012|FG000|Overall Study|Withdrawal by Subject|6
2211659|NCT01662362|3852021|FG000|Overall Study|Lost to Follow-up|38
2211660|NCT01662440|3852030|FG000|Overall Study|Adverse Event|1
2211661|NCT01662440|3852031|FG001|Overall Study|Adverse Event|0
2211662|NCT01662440|3852032|FG002|Overall Study|Adverse Event|0
2211663|NCT01662440|3852033|FG003|Overall Study|Adverse Event|1
2211664|NCT01662440|3852030|FG000|Overall Study|Death|0
2211665|NCT01662440|3852031|FG001|Overall Study|Death|1
2211666|NCT01662440|3852032|FG002|Overall Study|Death|0
2211667|NCT01662440|3852033|FG003|Overall Study|Death|0
2211668|NCT01662440|3852030|FG000|Overall Study|Lost to Follow-up|2
2211669|NCT01662440|3852031|FG001|Overall Study|Lost to Follow-up|2
2211670|NCT01662440|3852032|FG002|Overall Study|Lost to Follow-up|4
2211671|NCT01662440|3852033|FG003|Overall Study|Lost to Follow-up|1
2211672|NCT01662440|3852030|FG000|Overall Study|Subject moved to another country.|0
2089019|NCT00752557|3675622|FG000|Overall Study|Withdrawal by Subject|4
2211673|NCT01662440|3852031|FG001|Overall Study|Subject moved to another country.|1
2211674|NCT01662440|3852032|FG002|Overall Study|Subject moved to another country.|0
2211675|NCT01662440|3852033|FG003|Overall Study|Subject moved to another country.|0
2211676|NCT01662440|3852030|FG000|Overall Study|Protocol Violation|1
2211677|NCT01662440|3852031|FG001|Overall Study|Protocol Violation|0
2211678|NCT01662440|3852032|FG002|Overall Study|Protocol Violation|0
2211679|NCT01662440|3852033|FG003|Overall Study|Protocol Violation|0
2211680|NCT01662440|3852030|FG000|Overall Study|Withdrawal by Subject|5
2211681|NCT01662440|3852031|FG001|Overall Study|Withdrawal by Subject|2
2211682|NCT01662440|3852032|FG002|Overall Study|Withdrawal by Subject|2
2211683|NCT01662440|3852033|FG003|Overall Study|Withdrawal by Subject|2
2211684|NCT01662492|3852056|FG000|Overall Study|Other miscellaneous reasons.|1
2211685|NCT01662492|3852057|FG001|Overall Study|Other miscellaneous reasons.|0
2211686|NCT01662492|3852058|FG002|Overall Study|Other miscellaneous reasons.|1
2211687|NCT01662492|3852056|FG000|Overall Study|Withdrawal by Subject|0
2211688|NCT01662492|3852057|FG001|Overall Study|Withdrawal by Subject|0
2211689|NCT01662492|3852058|FG002|Overall Study|Withdrawal by Subject|1
2211690|NCT01662492|3852056|FG000|Overall Study|Protocol Violation|1
2211691|NCT01662492|3852057|FG001|Overall Study|Protocol Violation|0
2211692|NCT01662492|3852058|FG002|Overall Study|Protocol Violation|0
2211693|NCT01662492|3852056|FG000|Overall Study|Lost to Follow-up|0
2211694|NCT01662492|3852057|FG001|Overall Study|Lost to Follow-up|0
2211695|NCT01662492|3852058|FG002|Overall Study|Lost to Follow-up|2
2211696|NCT01662492|3852056|FG000|Overall Study|Lack of Efficacy|1
2211697|NCT01662492|3852057|FG001|Overall Study|Lack of Efficacy|1
2211698|NCT01662492|3852058|FG002|Overall Study|Lack of Efficacy|2
2211699|NCT01662505|3852069|FG000|Overall Study|Progressive disease|6
2211700|NCT01662505|3852070|FG001|Overall Study|Progressive disease|1
2211701|NCT01662505|3852071|FG002|Overall Study|Progressive disease|5
2211702|NCT01662505|3852069|FG000|Overall Study|Refused cont. medication|0
2211703|NCT01662505|3852070|FG001|Overall Study|Refused cont. medication|0
2211704|NCT01662505|3852071|FG002|Overall Study|Refused cont. medication|1
2211705|NCT01662505|3852069|FG000|Overall Study|Not specified above|1
2211706|NCT01662505|3852070|FG001|Overall Study|Not specified above|3
2211707|NCT01662505|3852071|FG002|Overall Study|Not specified above|2
2211708|NCT01662635|3852101|FG000|Overall Study|scarce samples for evaluation|30
2211709|NCT01662648|3852109|FG000|Overall Study|Death|1
2211710|NCT01662648|3852110|FG001|Overall Study|Death|3
2089020|NCT00752557|3675623|FG001|Overall Study|Withdrawal by Subject|3
2089021|NCT00752557|3675624|FG002|Overall Study|Withdrawal by Subject|3
2089022|NCT00752557|3675622|FG000|Overall Study|Unspecified resaons|0
2089023|NCT00752557|3675623|FG001|Overall Study|Unspecified resaons|2
2089024|NCT00752557|3675624|FG002|Overall Study|Unspecified resaons|2
2089025|NCT00752557|3675622|FG000|Overall Study|Lost to Follow-up|1
2089026|NCT00752557|3675623|FG001|Overall Study|Lost to Follow-up|0
2089027|NCT00752557|3675624|FG002|Overall Study|Lost to Follow-up|1
2089028|NCT00752609|3675636|FG000|Overall Study|Adverse Event|2
2089029|NCT00752609|3675637|FG001|Overall Study|Adverse Event|2
2089030|NCT00752609|3675636|FG000|Overall Study|Withdrawal by Subject|3
2089031|NCT00752609|3675637|FG001|Overall Study|Withdrawal by Subject|0
2089032|NCT00752609|3675636|FG000|Overall Study|Physician Decision|1
2089033|NCT00752609|3675637|FG001|Overall Study|Physician Decision|0
2089034|NCT00752609|3675636|FG000|Overall Study|Death|1
2089035|NCT00752609|3675637|FG001|Overall Study|Death|0
2089036|NCT00752609|3675636|FG000|Overall Study|Met exclusion criteria|1
2089037|NCT00752609|3675637|FG001|Overall Study|Met exclusion criteria|0
2089038|NCT00752609|3675636|FG000|Overall Study|Received Aranesp in error|1
2089039|NCT00752609|3675637|FG001|Overall Study|Received Aranesp in error|0
2089040|NCT00752622|3675646|FG000|Induction Phase|Adverse Event|3
2089041|NCT00752622|3675646|FG000|Induction Phase|Other|3
2089042|NCT00752622|3675646|FG000|Induction Phase|Non-responder|14
2089043|NCT00752622|3675646|FG000|Induction Phase|Withdrawal by Subject|1
2089044|NCT00752622|3675646|FG000|Induction Phase|Premature study termination|14
2089045|NCT00752622|3675646|FG000|Observational Phase|Premature Study Termination|36
2089046|NCT00752622|3675646|FG000|Observational Phase|Non-responder|2
2089047|NCT00752622|3675646|FG000|Observational Phase|Withdrawal by Subject|2
2089048|NCT00752622|3675646|FG000|Observational Phase|Adverse Event|1
2089049|NCT00752622|3675646|FG000|Observational Phase|Other|2
2089050|NCT00752622|3675646|FG000|Interventional Phase|Non-responder|2
2089051|NCT00752622|3675646|FG000|Interventional Phase|Physician Decision|1
2089052|NCT00752622|3675646|FG000|Interventional Phase|Premature Study Termination|5
2089053|NCT00752726|3675653|FG000|Overall Study|Lost to Follow-up|2
2089054|NCT00752726|3675654|FG001|Overall Study|Lost to Follow-up|1
2089055|NCT00752726|3675653|FG000|Overall Study|Adverse Event|3
2089056|NCT00752726|3675654|FG001|Overall Study|Adverse Event|0
2089057|NCT00752726|3675653|FG000|Overall Study|Withdrawal by Subject|5
2089058|NCT00752726|3675654|FG001|Overall Study|Withdrawal by Subject|10
2089059|NCT00752726|3675653|FG000|Overall Study|Other Reason|1
2089060|NCT00752726|3675654|FG001|Overall Study|Other Reason|2
2089061|NCT00752791|3675660|FG000|Overall Study|Adverse Event|7
2211711|NCT01662648|3852109|FG000|Overall Study|Adverse Event|40
2211712|NCT01662648|3852110|FG001|Overall Study|Adverse Event|37
2211713|NCT01662648|3852109|FG000|Overall Study|Lack of Efficacy|17
2211714|NCT01662648|3852110|FG001|Overall Study|Lack of Efficacy|16
2211715|NCT01662648|3852109|FG000|Overall Study|Participant ineligible to continue trial|1
2211716|NCT01662648|3852110|FG001|Overall Study|Participant ineligible to continue trial|1
2211717|NCT01662648|3852109|FG000|Overall Study|Lost to Follow-up|24
2211718|NCT01662648|3852110|FG001|Overall Study|Lost to Follow-up|36
2211719|NCT01662648|3852109|FG000|Overall Study|Withdrawal by Subject|36
2089062|NCT00752791|3675660|FG000|Overall Study|Withdrawal by Subject|1
2089063|NCT00752791|3675660|FG000|Overall Study|Physician Decision|1
2089064|NCT00752791|3675660|FG000|Overall Study|Death|1
2089065|NCT00752791|3675660|FG000|Overall Study|Renal transplant|3
2089066|NCT00752791|3675660|FG000|Overall Study|Switched to hemodialysis|2
2089067|NCT00752791|3675660|FG000|Overall Study|Protocol deviation|1
2089068|NCT00752856|3675666|FG000|Overall Study|randomized but did not do viral kinetics|0
2089069|NCT00752856|3675667|FG001|Overall Study|randomized but did not do viral kinetics|1
2089070|NCT00752895|3675675|FG000|Overall Study|Withdrawal by Subject|8
2089071|NCT00752895|3675676|FG001|Overall Study|Withdrawal by Subject|3
2089072|NCT00753012|3675699|FG000|Overall Study|Ineligible, abnormal cardiac histo|1
2089073|NCT00753012|3675700|FG001|Overall Study|Ineligible, abnormal cardiac histo|0
2089074|NCT00753012|3675699|FG000|Overall Study|Adverse Event|2
2089075|NCT00753012|3675700|FG001|Overall Study|Adverse Event|0
2089076|NCT00753012|3675699|FG000|Overall Study|Withdrawal by Subject|0
2089077|NCT00753012|3675700|FG001|Overall Study|Withdrawal by Subject|1
2089078|NCT00753012|3675699|FG000|Overall Study|Lost to Follow-up|4
2089079|NCT00753012|3675700|FG001|Overall Study|Lost to Follow-up|0
2089080|NCT00753012|3675699|FG000|Overall Study|Confounded endpoint data|1
2089081|NCT00753012|3675700|FG001|Overall Study|Confounded endpoint data|0
2089082|NCT00753272|3675726|FG000|Overall Study|Adverse Event|878
2089083|NCT00753272|3675727|FG001|Overall Study|Adverse Event|869
2089084|NCT00753272|3675726|FG000|Overall Study|Protocol Violation|28
2089085|NCT00753272|3675727|FG001|Overall Study|Protocol Violation|46
2089086|NCT00753272|3675726|FG000|Overall Study|Withdrawal by Subject|2481
2089087|NCT00753272|3675727|FG001|Overall Study|Withdrawal by Subject|2407
2089088|NCT00753272|3675726|FG000|Overall Study|Lost to Follow-up|491
2089089|NCT00753272|3675727|FG001|Overall Study|Lost to Follow-up|497
2089090|NCT00753272|3675726|FG000|Overall Study|Other|1104
2089091|NCT00753272|3675727|FG001|Overall Study|Other|1088
2089092|NCT00753415|3675764|FG000|Part A|Disease progression|1
2089093|NCT00753415|3675765|FG001|Part A|Disease progression|0
2089094|NCT00753415|3675766|FG002|Part A|Disease progression|1
2089095|NCT00753415|3675767|FG003|Part A|Disease progression|2
2089096|NCT00753415|3675768|FG004|Part A|Disease progression|0
2089097|NCT00753415|3675769|FG005|Part A|Disease progression|0
2089098|NCT00753415|3675770|FG006|Part A|Disease progression|0
2089099|NCT00753415|3675771|FG007|Part A|Disease progression|0
2089100|NCT00753415|3675772|FG008|Part A|Disease progression|0
2089101|NCT00753415|3675773|FG009|Part A|Disease progression|0
2089102|NCT00753415|3675764|FG000|Part A|Withdrawal by Subject|0
2089103|NCT00753415|3675765|FG001|Part A|Withdrawal by Subject|0
2089104|NCT00753415|3675766|FG002|Part A|Withdrawal by Subject|1
2089105|NCT00753415|3675767|FG003|Part A|Withdrawal by Subject|0
2089106|NCT00753415|3675768|FG004|Part A|Withdrawal by Subject|0
2089107|NCT00753415|3675769|FG005|Part A|Withdrawal by Subject|0
2089108|NCT00753415|3675770|FG006|Part A|Withdrawal by Subject|0
2089109|NCT00753415|3675771|FG007|Part A|Withdrawal by Subject|0
2089110|NCT00753415|3675772|FG008|Part A|Withdrawal by Subject|0
2089111|NCT00753415|3675773|FG009|Part A|Withdrawal by Subject|0
2089112|NCT00753415|3675764|FG000|Part B|Lost to Follow-up|0
2089113|NCT00753415|3675765|FG001|Part B|Lost to Follow-up|0
2089114|NCT00753415|3675766|FG002|Part B|Lost to Follow-up|0
2211720|NCT01662648|3852110|FG001|Overall Study|Withdrawal by Subject|53
2089115|NCT00753415|3675767|FG003|Part B|Lost to Follow-up|0
2089116|NCT00753415|3675768|FG004|Part B|Lost to Follow-up|0
2089117|NCT00753415|3675769|FG005|Part B|Lost to Follow-up|0
2089118|NCT00753415|3675770|FG006|Part B|Lost to Follow-up|0
2089119|NCT00753415|3675771|FG007|Part B|Lost to Follow-up|1
2089120|NCT00753415|3675772|FG008|Part B|Lost to Follow-up|1
2089121|NCT00753415|3675773|FG009|Part B|Lost to Follow-up|0
2089122|NCT00753415|3675764|FG000|Part B|Disease progression|0
2089123|NCT00753415|3675765|FG001|Part B|Disease progression|0
2089124|NCT00753415|3675766|FG002|Part B|Disease progression|0
2089125|NCT00753415|3675767|FG003|Part B|Disease progression|0
2089126|NCT00753415|3675768|FG004|Part B|Disease progression|0
2089127|NCT00753415|3675769|FG005|Part B|Disease progression|0
2089128|NCT00753415|3675770|FG006|Part B|Disease progression|0
2089129|NCT00753415|3675771|FG007|Part B|Disease progression|0
2089130|NCT00753415|3675772|FG008|Part B|Disease progression|2
2089131|NCT00753415|3675773|FG009|Part B|Disease progression|1
2089132|NCT00753454|3675797|FG000|Overall Study|Adverse Event|4
2089133|NCT00753454|3675797|FG000|Overall Study|Lack of Efficacy|1
2089134|NCT00753454|3675797|FG000|Overall Study|Lost to Follow-up|3
2089135|NCT00753454|3675797|FG000|Overall Study|Withdrawal by Subject|5
2089136|NCT00753454|3675797|FG000|Overall Study|Investigator Decision|1
2089137|NCT00753506|3675803|FG000|Overall Study|Withdrawal by Subject|4
2089138|NCT00753506|3675804|FG001|Overall Study|Withdrawal by Subject|1
2089139|NCT00753506|3675803|FG000|Overall Study|Lost to Follow-up|2
2089140|NCT00753506|3675804|FG001|Overall Study|Lost to Follow-up|0
2089141|NCT00753506|3675803|FG000|Overall Study|Other reason|1
2089142|NCT00753506|3675804|FG001|Overall Study|Other reason|1
2089143|NCT00753519|3675812|FG000|Overall Study|Withdrawal by Subject|0
2089144|NCT00753519|3675813|FG001|Overall Study|Withdrawal by Subject|2
2089145|NCT00753545|3675823|FG000|Overall Study|Death|98
2089146|NCT00753545|3675824|FG001|Overall Study|Death|112
2089147|NCT00753545|3675823|FG000|Overall Study|Lost to Follow-up|2
2089148|NCT00753545|3675824|FG001|Overall Study|Lost to Follow-up|3
2089149|NCT00753545|3675823|FG000|Overall Study|Protocol Violation|1
2089150|NCT00753545|3675824|FG001|Overall Study|Protocol Violation|0
2089151|NCT00753545|3675823|FG000|Overall Study|Voluntary Discontinuation of Patient|7
2089152|NCT00753545|3675824|FG001|Overall Study|Voluntary Discontinuation of Patient|3
2089153|NCT00753623|3675832|FG000|Phase I (14 Days)|Withdrawal by Subject|1
2089154|NCT00753623|3675833|FG001|Phase I (14 Days)|Withdrawal by Subject|1
2089155|NCT00753623|3675832|FG000|Phase I (14 Days)|Physician Decision|1
2089156|NCT00753623|3675833|FG001|Phase I (14 Days)|Physician Decision|2
2089157|NCT00753623|3675832|FG000|Phase I (14 Days)|Adverse Event|0
2089158|NCT00753623|3675833|FG001|Phase I (14 Days)|Adverse Event|1
2089159|NCT00753623|3675832|FG000|Washout (7 Days)|Physician Decision|1
2089160|NCT00753623|3675833|FG001|Washout (7 Days)|Physician Decision|0
2089161|NCT00753623|3675832|FG000|Phase II (14 Days)|Physician Decision|0
2089162|NCT00753623|3675833|FG001|Phase II (14 Days)|Physician Decision|1
2089163|NCT00753649|3675845|FG000|Overall Study|Migrated/moved from study area|1
2089164|NCT00753649|3675846|FG001|Overall Study|Migrated/moved from study area|0
2089165|NCT00753649|3675845|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3
2089166|NCT00753649|3675846|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0
2089167|NCT00753649|3675845|FG000|Overall Study|Lost to follow-up-complete vaccination|1
2089168|NCT00753649|3675846|FG001|Overall Study|Lost to follow-up-complete vaccination|0
2089169|NCT00753649|3675845|FG000|Overall Study|Protocol Violation|2
2089170|NCT00753649|3675846|FG001|Overall Study|Protocol Violation|0
2089171|NCT00753675|3675855|FG000|Overall Study|other reason|11
2089172|NCT00753675|3675856|FG001|Overall Study|other reason|12
2089173|NCT00753675|3675857|FG002|Overall Study|other reason|13
2089174|NCT00753675|3675855|FG000|Overall Study|Death|1
2089175|NCT00753675|3675856|FG001|Overall Study|Death|2
2089176|NCT00753675|3675857|FG002|Overall Study|Death|4
2089177|NCT00753675|3675855|FG000|Overall Study|Adverse Event|11
2089178|NCT00753675|3675856|FG001|Overall Study|Adverse Event|9
2089179|NCT00753675|3675857|FG002|Overall Study|Adverse Event|4
2089180|NCT00753675|3675855|FG000|Overall Study|Objective progression of disease|35
2089181|NCT00753675|3675856|FG001|Overall Study|Objective progression of disease|35
2089182|NCT00753675|3675857|FG002|Overall Study|Objective progression of disease|35
2089183|NCT00753675|3675855|FG000|Overall Study|Withdrawal by Subject|0
2089184|NCT00753675|3675856|FG001|Overall Study|Withdrawal by Subject|1
2089185|NCT00753675|3675857|FG002|Overall Study|Withdrawal by Subject|0
2089186|NCT00753675|3675855|FG000|Overall Study|Lost to Follow-up|1
2089187|NCT00753675|3675856|FG001|Overall Study|Lost to Follow-up|0
2089188|NCT00753675|3675857|FG002|Overall Study|Lost to Follow-up|0
2089189|NCT00753688|3675867|FG000|Overall Study|Death|102
2089190|NCT00753688|3675868|FG001|Overall Study|Death|203
2089191|NCT00753688|3675867|FG000|Overall Study|Missing|4
2089192|NCT00753688|3675868|FG001|Overall Study|Missing|9
2089193|NCT00753688|3675867|FG000|Overall Study|Participant Withdrew Consent|2
2089194|NCT00753688|3675868|FG001|Overall Study|Participant Withdrew Consent|2
2089195|NCT00753688|3675867|FG000|Overall Study|Ongoing - in Follow-up|15
2089196|NCT00753688|3675868|FG001|Overall Study|Ongoing - in Follow-up|31
2089197|NCT00753688|3675867|FG000|Overall Study|Adverse Event|0
2089198|NCT00753688|3675868|FG001|Overall Study|Adverse Event|1
2089199|NCT00753714|3675876|FG000|Overall Study|Lack of Efficacy|21
2089200|NCT00753714|3675877|FG001|Overall Study|Lack of Efficacy|34
2089201|NCT00753714|3675876|FG000|Overall Study|Adverse Event|26
2089202|NCT00753714|3675877|FG001|Overall Study|Adverse Event|18
2089203|NCT00753714|3675876|FG000|Overall Study|Protocol Violation|1
2089204|NCT00753714|3675877|FG001|Overall Study|Protocol Violation|0
2089205|NCT00753714|3675876|FG000|Overall Study|Lost to Follow-up|0
2089206|NCT00753714|3675877|FG001|Overall Study|Lost to Follow-up|1
2089207|NCT00753714|3675876|FG000|Overall Study|Withdrawal by Subject|2
2089208|NCT00753714|3675877|FG001|Overall Study|Withdrawal by Subject|1
2089209|NCT00753714|3675876|FG000|Overall Study|Death|3
2089210|NCT00753714|3675877|FG001|Overall Study|Death|3
2089211|NCT00753714|3675876|FG000|Overall Study|Other|7
2089212|NCT00753714|3675877|FG001|Overall Study|Other|5
2089213|NCT00753766|3675888|FG000|Overall Study|Physician Decision|1
2089214|NCT00753766|3675889|FG001|Overall Study|Physician Decision|0
2089215|NCT00753896|3675896|FG000|Overall Study|Adverse Event|4
2089216|NCT00753896|3675896|FG000|Overall Study|Death|1
2089217|NCT00753896|3675896|FG000|Overall Study|Lost to Follow-up|2
2089218|NCT00753896|3675896|FG000|Overall Study|Protocol Violation|1
2089219|NCT00753896|3675896|FG000|Overall Study|Withdrawal by Subject|4
2089220|NCT00753896|3675896|FG000|Overall Study|Entry Criteria Not Met|4
2089221|NCT00753922|3675904|FG000|Overall Study|Lost to Follow-up|155
2089222|NCT00753922|3675905|FG001|Overall Study|Lost to Follow-up|24
2089223|NCT00753922|3675906|FG002|Overall Study|Lost to Follow-up|28
2089224|NCT00753922|3675907|FG003|Overall Study|Lost to Follow-up|5
2089225|NCT00753922|3675904|FG000|Overall Study|Withdrawal by Subject|9
2089226|NCT00753922|3675905|FG001|Overall Study|Withdrawal by Subject|11
2089227|NCT00753922|3675906|FG002|Overall Study|Withdrawal by Subject|4
2089228|NCT00753922|3675907|FG003|Overall Study|Withdrawal by Subject|2
2089229|NCT00753922|3675904|FG000|Overall Study|Patient Non-compliance|55
2089230|NCT00753922|3675905|FG001|Overall Study|Patient Non-compliance|22
2089231|NCT00753922|3675906|FG002|Overall Study|Patient Non-compliance|14
2089232|NCT00753922|3675907|FG003|Overall Study|Patient Non-compliance|11
2089233|NCT00753922|3675904|FG000|Overall Study|Patients Not Completing Visit|11
2089234|NCT00753922|3675905|FG001|Overall Study|Patients Not Completing Visit|0
2089235|NCT00753922|3675906|FG002|Overall Study|Patients Not Completing Visit|1
2089236|NCT00753922|3675907|FG003|Overall Study|Patients Not Completing Visit|0
2089237|NCT00753922|3675904|FG000|Overall Study|Death|2
2089238|NCT00753922|3675905|FG001|Overall Study|Death|23
2089239|NCT00753922|3675906|FG002|Overall Study|Death|2
2089240|NCT00753922|3675907|FG003|Overall Study|Death|1
2089241|NCT00753922|3675904|FG000|Overall Study|Discontinuation Due to Explantation|14
2089242|NCT00753922|3675905|FG001|Overall Study|Discontinuation Due to Explantation|14
2089243|NCT00753922|3675906|FG002|Overall Study|Discontinuation Due to Explantation|14
2089244|NCT00753922|3675907|FG003|Overall Study|Discontinuation Due to Explantation|4
2089245|NCT00754065|3675941|FG000|Overall Study|Never received treatment|12
2089246|NCT00754065|3675942|FG001|Overall Study|Never received treatment|2
2089247|NCT00754065|3675941|FG000|Overall Study|Adverse Event|19
2089248|NCT00754065|3675942|FG001|Overall Study|Adverse Event|25
2089249|NCT00754065|3675941|FG000|Overall Study|Lost to Follow-up|7
2089250|NCT00754065|3675942|FG001|Overall Study|Lost to Follow-up|11
2089251|NCT00754065|3675941|FG000|Overall Study|Protocol Violation|12
2089252|NCT00754065|3675942|FG001|Overall Study|Protocol Violation|10
2089253|NCT00754065|3675941|FG000|Overall Study|Withdrawal by Subject|4
2089254|NCT00754065|3675942|FG001|Overall Study|Withdrawal by Subject|5
2089255|NCT00754065|3675941|FG000|Overall Study|Pregnancy|6
2089256|NCT00754065|3675942|FG001|Overall Study|Pregnancy|0
2089257|NCT00754065|3675941|FG000|Overall Study|Reason not specified or unknown, etc.|21
2089258|NCT00754065|3675942|FG001|Overall Study|Reason not specified or unknown, etc.|27
2089259|NCT00754234|3675995|FG000|Overall Study|Withdrawal by Subject|3
2089260|NCT00754325|3676014|FG000|Initial Treatment|Continuing Active Treatment|4
2089261|NCT00754325|3676015|FG001|Initial Treatment|Continuing Active Treatment|5
2089262|NCT00754325|3676014|FG000|Initial Treatment|Adverse Event|7
2089263|NCT00754325|3676015|FG001|Initial Treatment|Adverse Event|6
2089264|NCT00754325|3676014|FG000|Initial Treatment|Withdrawal by Subject|2
2089265|NCT00754325|3676015|FG001|Initial Treatment|Withdrawal by Subject|2
2089266|NCT00754325|3676014|FG000|Initial Treatment|Physician Decision|2
2089267|NCT00754325|3676015|FG001|Initial Treatment|Physician Decision|0
2089268|NCT00754325|3676014|FG000|Initial Treatment|Sponsor Request|0
2089269|NCT00754325|3676015|FG001|Initial Treatment|Sponsor Request|1
2089270|NCT00754325|3676014|FG000|Initial Treatment|Disease Progression|35
2089271|NCT00754325|3676015|FG001|Initial Treatment|Disease Progression|35
2089272|NCT00754338|3676026|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
2089273|NCT00754338|3676027|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
2089274|NCT00754338|3676028|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
2089275|NCT00754338|3676029|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
2089276|NCT00754338|3676026|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
2089277|NCT00754338|3676027|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
2089278|NCT00754338|3676028|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
2089279|NCT00754338|3676029|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
2089280|NCT00754390|3676052|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
2089281|NCT00754390|3676052|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
2089282|NCT00754390|3676052|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
2089283|NCT00754390|3676052|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
2089284|NCT00754442|3676061|FG000|Overall Study|Withdrawal by Subject|5
2089285|NCT00754442|3676062|FG001|Overall Study|Withdrawal by Subject|3
2089286|NCT00754559|3676103|FG000|Overall Study|Adverse Event|15
2089287|NCT00754559|3676103|FG000|Overall Study|Protocol Violation|11
2089288|NCT00754559|3676103|FG000|Overall Study|Lack of Efficacy|10
2089289|NCT00754559|3676103|FG000|Overall Study|Lost to Follow-up|2
2089290|NCT00754559|3676103|FG000|Overall Study|Administrative reason|1
2089291|NCT00754559|3676103|FG000|Overall Study|Other|5
2089292|NCT00754559|3676103|FG000|Overall Study|Withdrawal by Subject|3
2089293|NCT00754572|3676110|FG000|Overall Study|Adverse Event|19
2089294|NCT00754572|3676110|FG000|Overall Study|Other|39
2089295|NCT00754572|3676110|FG000|Overall Study|Protocol Violation|3
2089296|NCT00754572|3676110|FG000|Overall Study|Withdrawal by Subject|3
2089297|NCT00754572|3676110|FG000|Overall Study|Lack of Efficacy|2
2089298|NCT00754572|3676110|FG000|Overall Study|Death|1
2089299|NCT00754572|3676110|FG000|Overall Study|Administrative Reason|3
2089300|NCT00754572|3676110|FG000|Overall Study|Lost to Follow-up|1
2089301|NCT00754624|3676114|FG000|Overall Study|Adverse Event|16
2089302|NCT00754624|3676114|FG000|Overall Study|Death|1
2089303|NCT00754624|3676114|FG000|Overall Study|Physician Decision|8
2089304|NCT00754624|3676114|FG000|Overall Study|Protocol Violation|1
2089305|NCT00754624|3676114|FG000|Overall Study|Withdrawal by Subject|28
2089306|NCT00754624|3676114|FG000|Overall Study|Various|12
2089307|NCT00754624|3676114|FG000|Overall Study|Lost to Follow-up|3
2089308|NCT00754650|3676118|FG000|Overall Study|Disease Progression|2
2089309|NCT00754741|3676125|FG000|Overall Study|Died or disenrolled|57
2089310|NCT00754741|3676126|FG001|Overall Study|Died or disenrolled|69
2089311|NCT00754741|3676127|FG002|Overall Study|Died or disenrolled|54
2107344|NCT00872521|3700856|FG002|Primary Endpoint Analysis|Patient choice|0
2089312|NCT00754936|3676157|FG000|Overall Study|Lost to Follow-up|3
2089313|NCT00754936|3676157|FG000|Overall Study|Physician Decision|1
2089314|NCT00754936|3676157|FG000|Overall Study|Withdrawal by Subject|2
2089315|NCT00754936|3676157|FG000|Overall Study|Side Effects|3
2089316|NCT00754936|3676157|FG000|Overall Study|Inter-current medical events|3
2089317|NCT00755079|3676172|FG000|Overall Study|Lost to Follow-up|1
2089318|NCT00755079|3676173|FG001|Overall Study|Lost to Follow-up|3
2089319|NCT00755079|3676172|FG000|Overall Study|Adverse Event|0
2089320|NCT00755079|3676173|FG001|Overall Study|Adverse Event|1
2089321|NCT00755079|3676172|FG000|Overall Study|Withdrawal by Subject|0
2089322|NCT00755079|3676173|FG001|Overall Study|Withdrawal by Subject|2
2089323|NCT00755105|3676182|FG000|Overall Study|Withdrawal by Subject|9
2089324|NCT00755105|3676183|FG001|Overall Study|Withdrawal by Subject|11
2089325|NCT00755105|3676184|FG002|Overall Study|Withdrawal by Subject|4
2089326|NCT00755183|3676203|FG000|Overall Study|Adverse Event|5
2089327|NCT00755183|3676204|FG001|Overall Study|Adverse Event|2
2089328|NCT00755183|3676203|FG000|Overall Study|Protocol Violation|0
2089329|NCT00755183|3676204|FG001|Overall Study|Protocol Violation|1
2089330|NCT00755183|3676203|FG000|Overall Study|Withdrawal by Subject|0
2089331|NCT00755183|3676204|FG001|Overall Study|Withdrawal by Subject|2
2089332|NCT00755183|3676203|FG000|Overall Study|Administrative|2
2089333|NCT00755183|3676204|FG001|Overall Study|Administrative|1
2089334|NCT00755196|3676212|FG000|Overall Study|Lost to Follow-up|1
2089335|NCT00755196|3676212|FG000|Overall Study|Lack of Efficiency|1
2089336|NCT00755222|3676219|FG000|Overall Study|Withdrawal by Subject|4
2089337|NCT00755222|3676220|FG001|Overall Study|Withdrawal by Subject|2
2089338|NCT00755222|3676219|FG000|Overall Study|Adverse Event|2
2089339|NCT00755222|3676220|FG001|Overall Study|Adverse Event|0
2089340|NCT00755222|3676219|FG000|Overall Study|Protocol Violation|2
2089341|NCT00755222|3676220|FG001|Overall Study|Protocol Violation|0
2089342|NCT00755326|3676246|FG000|Overall Study|Lost to Follow-up|2
2089343|NCT00755326|3676247|FG001|Overall Study|Lost to Follow-up|3
2089344|NCT00755417|3676257|FG000|Overall Study|Adverse Event|28
2089345|NCT00755417|3676258|FG001|Overall Study|Adverse Event|20
2089346|NCT00755417|3676259|FG002|Overall Study|Adverse Event|7
2089347|NCT00755417|3676257|FG000|Overall Study|Lack of Efficacy|8
2089348|NCT00755417|3676258|FG001|Overall Study|Lack of Efficacy|4
2089349|NCT00755417|3676259|FG002|Overall Study|Lack of Efficacy|9
2089350|NCT00755417|3676257|FG000|Overall Study|Protocol Violation|2
2089351|NCT00755417|3676258|FG001|Overall Study|Protocol Violation|1
2089352|NCT00755417|3676259|FG002|Overall Study|Protocol Violation|1
2089353|NCT00755417|3676257|FG000|Overall Study|Lost to Follow-up|3
2089354|NCT00755417|3676258|FG001|Overall Study|Lost to Follow-up|0
2089355|NCT00755417|3676259|FG002|Overall Study|Lost to Follow-up|1
2089356|NCT00755417|3676257|FG000|Overall Study|Withdrawal by Subject|12
2089357|NCT00755417|3676258|FG001|Overall Study|Withdrawal by Subject|12
2089358|NCT00755417|3676259|FG002|Overall Study|Withdrawal by Subject|12
2089359|NCT00755417|3676257|FG000|Overall Study|Not specified or missing data|9
2089360|NCT00755417|3676258|FG001|Overall Study|Not specified or missing data|18
2089361|NCT00755417|3676259|FG002|Overall Study|Not specified or missing data|12
2089362|NCT00755716|3676270|FG000|Overall Study|Adverse Event|1
2089363|NCT00755716|3676271|FG001|Overall Study|Adverse Event|4
2089364|NCT00755716|3676272|FG002|Overall Study|Adverse Event|1
2089365|NCT00755716|3676270|FG000|Overall Study|Lack of Efficacy|2
2089366|NCT00755716|3676271|FG001|Overall Study|Lack of Efficacy|0
2089367|NCT00755716|3676272|FG002|Overall Study|Lack of Efficacy|0
2089368|NCT00755716|3676270|FG000|Overall Study|Lost to Follow-up|5
2089369|NCT00755716|3676271|FG001|Overall Study|Lost to Follow-up|3
2089370|NCT00755716|3676272|FG002|Overall Study|Lost to Follow-up|1
2089371|NCT00755716|3676270|FG000|Overall Study|work schedule issues|0
2089372|NCT00755716|3676271|FG001|Overall Study|work schedule issues|1
2089373|NCT00755716|3676272|FG002|Overall Study|work schedule issues|1
2089374|NCT00755807|3676295|FG000|Acute Phase|Adverse Event|16
2089375|NCT00755807|3676296|FG001|Acute Phase|Adverse Event|5
2089376|NCT00755807|3676295|FG000|Acute Phase|Protocol Violation|1
2089377|NCT00755807|3676296|FG001|Acute Phase|Protocol Violation|3
2089378|NCT00755807|3676295|FG000|Acute Phase|Withdrawal by Subject|1
2089379|NCT00755807|3676296|FG001|Acute Phase|Withdrawal by Subject|2
2089380|NCT00755807|3676295|FG000|Acute Phase|Lack of Efficacy|0
2089381|NCT00755807|3676296|FG001|Acute Phase|Lack of Efficacy|1
2089382|NCT00755807|3676295|FG000|Acute Phase|Physician Decision|0
2089383|NCT00755807|3676296|FG001|Acute Phase|Physician Decision|1
2089384|NCT00755807|3676295|FG000|Open-label Extension Phase|Adverse Event|7
2089385|NCT00755807|3676296|FG001|Open-label Extension Phase|Adverse Event|7
2089386|NCT00755807|3676295|FG000|Open-label Extension Phase|Protocol Violation|5
2089387|NCT00755807|3676296|FG001|Open-label Extension Phase|Protocol Violation|2
2089388|NCT00755807|3676295|FG000|Open-label Extension Phase|Lack of Efficacy|3
2089389|NCT00755807|3676296|FG001|Open-label Extension Phase|Lack of Efficacy|3
2089390|NCT00755807|3676295|FG000|Open-label Extension Phase|Withdrawal by Subject|1
2089391|NCT00755807|3676296|FG001|Open-label Extension Phase|Withdrawal by Subject|3
2089392|NCT00755807|3676295|FG000|Open-label Extension Phase|Lost to Follow-up|2
2089393|NCT00755807|3676296|FG001|Open-label Extension Phase|Lost to Follow-up|0
2089394|NCT00755807|3676295|FG000|Open-label Extension Phase|Sponsor Decision|0
2089395|NCT00755807|3676296|FG001|Open-label Extension Phase|Sponsor Decision|1
2089396|NCT00755846|3676312|FG000|Overall Study|Adverse Event|0
2089397|NCT00755846|3676313|FG001|Overall Study|Adverse Event|0
2089398|NCT00755846|3676314|FG002|Overall Study|Adverse Event|0
2089399|NCT00755846|3676315|FG003|Overall Study|Adverse Event|1
2089400|NCT00755846|3676316|FG004|Overall Study|Adverse Event|3
2089401|NCT00755846|3676317|FG005|Overall Study|Adverse Event|2
2089402|NCT00755846|3676312|FG000|Overall Study|Protocol Violation|1
2089403|NCT00755846|3676313|FG001|Overall Study|Protocol Violation|1
2089404|NCT00755846|3676314|FG002|Overall Study|Protocol Violation|1
2089405|NCT00755846|3676315|FG003|Overall Study|Protocol Violation|1
2089406|NCT00755846|3676316|FG004|Overall Study|Protocol Violation|1
2089407|NCT00755846|3676317|FG005|Overall Study|Protocol Violation|1
2089408|NCT00755846|3676312|FG000|Overall Study|Lost to Follow-up|0
2089409|NCT00755846|3676313|FG001|Overall Study|Lost to Follow-up|2
2089410|NCT00755846|3676314|FG002|Overall Study|Lost to Follow-up|1
2089411|NCT00755846|3676315|FG003|Overall Study|Lost to Follow-up|0
2089412|NCT00755846|3676316|FG004|Overall Study|Lost to Follow-up|4
2089413|NCT00755846|3676317|FG005|Overall Study|Lost to Follow-up|2
2089414|NCT00755846|3676312|FG000|Overall Study|Withdrawal by Subject|2
2089415|NCT00755846|3676313|FG001|Overall Study|Withdrawal by Subject|3
2089416|NCT00755846|3676314|FG002|Overall Study|Withdrawal by Subject|5
2089417|NCT00755846|3676315|FG003|Overall Study|Withdrawal by Subject|2
2089418|NCT00755846|3676316|FG004|Overall Study|Withdrawal by Subject|0
2089419|NCT00755846|3676317|FG005|Overall Study|Withdrawal by Subject|1
2089420|NCT00755846|3676312|FG000|Overall Study|Hyperglycemic Rescue|21
2089421|NCT00755846|3676313|FG001|Overall Study|Hyperglycemic Rescue|7
2089422|NCT00755846|3676314|FG002|Overall Study|Hyperglycemic Rescue|5
2089423|NCT00755846|3676315|FG003|Overall Study|Hyperglycemic Rescue|8
2089424|NCT00755846|3676316|FG004|Overall Study|Hyperglycemic Rescue|8
2089425|NCT00755846|3676317|FG005|Overall Study|Hyperglycemic Rescue|7
2089426|NCT00755846|3676312|FG000|Overall Study|Physician Decision|1
2089427|NCT00755846|3676313|FG001|Overall Study|Physician Decision|3
2089428|NCT00755846|3676314|FG002|Overall Study|Physician Decision|0
2089429|NCT00755846|3676315|FG003|Overall Study|Physician Decision|1
2089430|NCT00755846|3676316|FG004|Overall Study|Physician Decision|0
2089431|NCT00755846|3676317|FG005|Overall Study|Physician Decision|1
2089432|NCT00755846|3676312|FG000|Overall Study|Administrative Error|0
2089433|NCT00755846|3676313|FG001|Overall Study|Administrative Error|1
2089434|NCT00755846|3676314|FG002|Overall Study|Administrative Error|0
2089435|NCT00755846|3676315|FG003|Overall Study|Administrative Error|0
2089436|NCT00755846|3676316|FG004|Overall Study|Administrative Error|0
2089437|NCT00755846|3676317|FG005|Overall Study|Administrative Error|0
2211721|NCT01662648|3852109|FG000|Overall Study|Participant non-compliant|16
2306177|NCT02682823|4007912|FG000|Overall Study|Adverse Event|0
2306178|NCT02682823|4007913|FG001|Overall Study|Adverse Event|0
2306179|NCT02682823|4007914|FG002|Overall Study|Adverse Event|0
2306180|NCT02682823|4007915|FG003|Overall Study|Adverse Event|1
2306181|NCT02682823|4007916|FG004|Overall Study|Adverse Event|0
2306182|NCT02683109|4007934|FG000|Overall Study|Adverse Event|1
2306183|NCT02683109|4007935|FG001|Overall Study|Adverse Event|0
2306184|NCT02683187|4007951|FG000|Overall Study|Failed IV access|3
2306185|NCT02683187|4007951|FG000|Overall Study|Withdrawal by Subject|5
2306186|NCT02683525|4007976|FG000|Overall Study|Lost to Follow-up|1
2306187|NCT02683525|4007976|FG000|Overall Study|Physician Decision|1
2306188|NCT02683525|4007976|FG000|Overall Study|Disease Progression|6
2306189|NCT02683668|4007995|FG000|Period 2|Withdrawal by Subject|0
2306190|NCT02683668|4007996|FG001|Period 2|Withdrawal by Subject|1
2306191|NCT02683668|4007997|FG002|Period 2|Withdrawal by Subject|0
2306192|NCT02683746|4008014|FG000|Overall Study|Adverse Event|3
2306193|NCT02683746|4008015|FG001|Overall Study|Adverse Event|2
2306194|NCT02683746|4008014|FG000|Overall Study|Lost to Follow-up|5
2306195|NCT02683746|4008015|FG001|Overall Study|Lost to Follow-up|6
2306196|NCT02683746|4008014|FG000|Overall Study|Withdrawal by Subject|6
2306197|NCT02683746|4008015|FG001|Overall Study|Withdrawal by Subject|5
2306198|NCT02683746|4008014|FG000|Overall Study|Physician Decision|2
2306199|NCT02683746|4008015|FG001|Overall Study|Physician Decision|1
2306200|NCT02683785|4008034|FG000|Overall Study|Withdrawal by Subject|1
2306201|NCT02683785|4008035|FG001|Overall Study|Withdrawal by Subject|1
2306202|NCT02683785|4008034|FG000|Overall Study|Lost to Follow-up|0
2306203|NCT02683785|4008035|FG001|Overall Study|Lost to Follow-up|1
2306204|NCT02683785|4008034|FG000|Overall Study|Adverse Event|0
2306205|NCT02683785|4008035|FG001|Overall Study|Adverse Event|2
2306206|NCT02683876|4008045|FG000|Overall Study|samples damaged during shipping|2
2306207|NCT02683876|4008046|FG001|Overall Study|samples damaged during shipping|0
2321735|NCT02963506|4036374|FG003|Double-Blind Period|Withdrawal by Subject|1
2321736|NCT02963506|4036375|FG004|Double-Blind Period|Withdrawal by Subject|0
2321737|NCT02963506|4036376|FG005|Double-Blind Period|Withdrawal by Subject|0
2089438|NCT00755846|3676312|FG000|Overall Study|Participant Non-compliance|0
2089439|NCT00755846|3676313|FG001|Overall Study|Participant Non-compliance|0
2089440|NCT00755846|3676314|FG002|Overall Study|Participant Non-compliance|0
2089441|NCT00755846|3676315|FG003|Overall Study|Participant Non-compliance|0
2089442|NCT00755846|3676316|FG004|Overall Study|Participant Non-compliance|1
2321738|NCT02963506|4036377|FG006|Double-Blind Period|Withdrawal by Subject|0
2321739|NCT02963506|4036378|FG007|Double-Blind Period|Withdrawal by Subject|0
2321740|NCT02963506|4036379|FG008|Double-Blind Period|Withdrawal by Subject|0
2089443|NCT00755846|3676317|FG005|Overall Study|Participant Non-compliance|0
2089444|NCT00755937|3676340|FG000|Recruitment|Unknown if infliximab received|164
2089445|NCT00755937|3676340|FG000|Observational Follow-up|Lost to Follow-up|148
2089446|NCT00756002|3676346|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
2089447|NCT00756002|3676347|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
2089448|NCT00756002|3676346|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
2089449|NCT00756002|3676347|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
2089450|NCT00756002|3676346|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6
2089451|NCT00756002|3676347|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6
2089452|NCT00756002|3676346|FG000|Double-Blind Treatment Period|Protocol Violation|6
2089453|NCT00756002|3676347|FG001|Double-Blind Treatment Period|Protocol Violation|5
2089454|NCT00756002|3676346|FG000|Double-Blind Treatment Period|Other|2
2089455|NCT00756002|3676347|FG001|Double-Blind Treatment Period|Other|2
2089456|NCT00756275|3676385|FG000|Overall Study|Lost to Follow-up|25
2089457|NCT00756275|3676386|FG001|Overall Study|Lost to Follow-up|21
2089458|NCT00756275|3676385|FG000|Overall Study|Withdrawal by Subject|4
2089459|NCT00756275|3676386|FG001|Overall Study|Withdrawal by Subject|7
2089460|NCT00756314|3676394|FG000|Overall Study|Lost to Follow-up|2
2089461|NCT00756314|3676395|FG001|Overall Study|Lost to Follow-up|59
2089462|NCT00756444|3676403|FG000|Overall Study|Adverse Event|1
2089463|NCT00756444|3676404|FG001|Overall Study|Adverse Event|1
2089464|NCT00756444|3676403|FG000|Overall Study|Withdrawal by Subject|6
2089465|NCT00756444|3676404|FG001|Overall Study|Withdrawal by Subject|8
2089466|NCT00756444|3676403|FG000|Overall Study|Lost to Follow-up|0
2089467|NCT00756444|3676404|FG001|Overall Study|Lost to Follow-up|1
2089468|NCT00756444|3676403|FG000|Overall Study|Death|5
2089469|NCT00756444|3676404|FG001|Overall Study|Death|4
2089470|NCT00756444|3676403|FG000|Overall Study|Disease Progression|2
2089471|NCT00756444|3676404|FG001|Overall Study|Disease Progression|7
2089472|NCT00756444|3676403|FG000|Overall Study|Ineligibility Determined|1
2089473|NCT00756444|3676404|FG001|Overall Study|Ineligibility Determined|0
2089474|NCT00756457|3676413|FG000|Overall Study|Lost to Follow-up|1
2089475|NCT00756457|3676414|FG001|Overall Study|Lost to Follow-up|2
2089476|NCT00756470|3676436|FG000|Overall Study|Withdrawal by Subject|1
2089477|NCT00756470|3676436|FG000|Overall Study|Adverse Event|4
2089478|NCT00756652|3676483|FG000|Original Phase|Withdrawal by Subject|864
2089479|NCT00756652|3676484|FG001|Original Phase|Withdrawal by Subject|23
2089480|NCT00756652|3676483|FG000|Original Phase|Lost to Follow-up|601
2089481|NCT00756652|3676484|FG001|Original Phase|Lost to Follow-up|0
2089482|NCT00756652|3676483|FG000|Original Phase|Other Discontinuation|797
2089483|NCT00756652|3676484|FG001|Original Phase|Other Discontinuation|5
2089484|NCT00756652|3676483|FG000|Original Phase|Participant Noncompliance|18622
2089485|NCT00756652|3676484|FG001|Original Phase|Participant Noncompliance|424
2089486|NCT00756652|3676483|FG000|Original Phase|Unknown Discontinuation Reason|2
2089487|NCT00756652|3676484|FG001|Original Phase|Unknown Discontinuation Reason|0
2089488|NCT00756652|3676483|FG000|Original Phase|Participants without data|3259
2089489|NCT00756652|3676484|FG001|Original Phase|Participants without data|466
2089490|NCT00756652|3676483|FG000|Original Phase|Death|168
2089491|NCT00756652|3676484|FG001|Original Phase|Death|1
2089492|NCT00756652|3676483|FG000|Original Phase|Not due for F/U at Phase One closure|11076
2089493|NCT00756652|3676484|FG001|Original Phase|Not due for F/U at Phase One closure|2
2089494|NCT00756652|3676483|FG000|Re-Op Phase|Withdrawal by Subject|62
2089495|NCT00756652|3676484|FG001|Re-Op Phase|Withdrawal by Subject|0
2089496|NCT00756652|3676483|FG000|Re-Op Phase|Death|6
2089497|NCT00756652|3676484|FG001|Re-Op Phase|Death|0
2089498|NCT00756652|3676483|FG000|Re-Op Phase|Lost to Follow-up|340
2089499|NCT00756652|3676484|FG001|Re-Op Phase|Lost to Follow-up|0
2089500|NCT00756652|3676483|FG000|Re-Op Phase|Site Closed|2454
2089501|NCT00756652|3676484|FG001|Re-Op Phase|Site Closed|0
2089502|NCT00756652|3676483|FG000|Re-Op Phase|Withdrawn after explant|14
2089503|NCT00756652|3676484|FG001|Re-Op Phase|Withdrawn after explant|0
2089504|NCT00756717|3676493|FG000|Overall Study|Withdrawal by Subject|2
2089505|NCT00756730|3676499|FG000|Overall Study|discontinued due to rash prior to week 4|0
2089506|NCT00756730|3676500|FG001|Overall Study|discontinued due to rash prior to week 4|1
2089507|NCT00756730|3676499|FG000|Overall Study|persistent low-level viremmia|0
2089508|NCT00756730|3676500|FG001|Overall Study|persistent low-level viremmia|1
2089509|NCT00756886|3676508|FG000|Overall Study|Lost to Follow-up|1
2089510|NCT00756886|3676509|FG001|Overall Study|Lost to Follow-up|0
2089511|NCT00756886|3676508|FG000|Overall Study|Adverse Event|0
2089512|NCT00756886|3676509|FG001|Overall Study|Adverse Event|3
2089513|NCT00756886|3676508|FG000|Overall Study|Lack of Efficacy|1
2089514|NCT00756886|3676509|FG001|Overall Study|Lack of Efficacy|0
2306208|NCT02683941|4008065|FG000|Double-blind Phase|Adverse Event|0
2306209|NCT02683941|4008066|FG001|Double-blind Phase|Adverse Event|1
2306210|NCT02683941|4008065|FG000|Double-blind Phase|Withdrawal by Subject|4
2089515|NCT00756886|3676508|FG000|Overall Study|Ineligible|9
2089516|NCT00756886|3676509|FG001|Overall Study|Ineligible|4
2089517|NCT00757003|3676533|FG000|Overall Study|Death|33
2089518|NCT00757003|3676533|FG000|Overall Study|Lost to Follow-up|9
2089519|NCT00757003|3676533|FG000|Overall Study|Withdrawal by Subject|4
2089520|NCT00757003|3676533|FG000|Overall Study|Surgically explanted|2
2089521|NCT00757003|3676533|FG000|Overall Study|Not implanted|1
2089522|NCT00757172|3676538|FG000|Overall Study|Withdrawal by Subject|4
2089523|NCT00757172|3676538|FG000|Overall Study|Physician Decision|3
2089524|NCT00757172|3676538|FG000|Overall Study|Progression|4
2089525|NCT00757237|3676544|FG000|Overall Study|Lost to Follow-up|0
2089526|NCT00757237|3676545|FG001|Overall Study|Lost to Follow-up|1
2089527|NCT00757237|3676544|FG000|Overall Study|Protocol Violation|0
2089528|NCT00757237|3676545|FG001|Overall Study|Protocol Violation|2
2089529|NCT00757237|3676544|FG000|Overall Study|Physician Decision|2
2089530|NCT00757237|3676545|FG001|Overall Study|Physician Decision|3
2089531|NCT00757237|3676544|FG000|Overall Study|Withdrawal by Subject|8
2089532|NCT00757237|3676545|FG001|Overall Study|Withdrawal by Subject|12
2089533|NCT00757237|3676544|FG000|Overall Study|Safety or Tolerability|3
2089534|NCT00757237|3676545|FG001|Overall Study|Safety or Tolerability|5
2089535|NCT00757237|3676544|FG000|Overall Study|Other|0
2089536|NCT00757237|3676545|FG001|Overall Study|Other|2
2089537|NCT00757588|3676559|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
2089538|NCT00757588|3676560|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
2089539|NCT00757588|3676559|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6
2089540|NCT00757588|3676560|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3
2089541|NCT00757588|3676559|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
2089542|NCT00757588|3676560|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
2089543|NCT00757588|3676559|FG000|Period 1: Short-term (24-week) Phase|Death|1
2089544|NCT00757588|3676560|FG001|Period 1: Short-term (24-week) Phase|Death|0
2089545|NCT00757588|3676559|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
2089546|NCT00757588|3676560|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
2089547|NCT00757588|3676559|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
2089548|NCT00757588|3676560|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
2089549|NCT00757588|3676559|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
2089550|NCT00757588|3676560|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
2089551|NCT00757588|3676559|FG000|Period 1: Short-term (24-week) Phase|Other|0
2089552|NCT00757588|3676560|FG001|Period 1: Short-term (24-week) Phase|Other|1
2089553|NCT00757588|3676559|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
2089554|NCT00757588|3676560|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
2089555|NCT00757588|3676559|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4
2089556|NCT00757588|3676560|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0
2089557|NCT00757588|3676559|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
2089558|NCT00757588|3676560|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
2089559|NCT00757588|3676559|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
2089560|NCT00757588|3676560|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
2089561|NCT00757588|3676559|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
2089562|NCT00757588|3676560|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
2089563|NCT00757588|3676559|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1
2089564|NCT00757588|3676560|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0
2089565|NCT00757588|3676559|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
2089566|NCT00757588|3676560|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
2089567|NCT00757588|3676559|FG000|Period 2: Long-term (52-week) Phase|Other|1
2089568|NCT00757588|3676560|FG001|Period 2: Long-term (52-week) Phase|Other|0
2089569|NCT00757705|3676620|FG000|Overall Study|Adverse Event|19
2089570|NCT00757705|3676620|FG000|Overall Study|Lost to Follow-up|16
2089571|NCT00757705|3676620|FG000|Overall Study|Withdrawal by Subject|25
2089572|NCT00757705|3676620|FG000|Overall Study|Insufficient Response|26
2089573|NCT00757705|3676620|FG000|Overall Study|Ineligible to continue|8
2089574|NCT00757705|3676620|FG000|Overall Study|Non-compliant|9
2089575|NCT00757705|3676620|FG000|Overall Study|Other|18
2089576|NCT00757783|3676626|FG000|Overall Study|Adverse Event|0
2089577|NCT00757783|3676627|FG001|Overall Study|Adverse Event|2
2089578|NCT00757783|3676626|FG000|Overall Study|Lost to Follow-up|1
2089579|NCT00757783|3676627|FG001|Overall Study|Lost to Follow-up|1
2089580|NCT00757783|3676626|FG000|Overall Study|Protocol Violation|1
2089581|NCT00757783|3676627|FG001|Overall Study|Protocol Violation|0
2089582|NCT00757783|3676626|FG000|Overall Study|Withdrawal by Subject|2
2089583|NCT00757783|3676627|FG001|Overall Study|Withdrawal by Subject|1
2089584|NCT00757783|3676626|FG000|Overall Study|Other|1
2177342|NCT01372410|3801375|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2177343|NCT01372410|3801376|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
2177344|NCT01372410|3801377|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2177345|NCT01372410|3801378|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
2177346|NCT01372410|3801379|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
2177347|NCT01372410|3801372|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2177348|NCT01372410|3801373|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2177349|NCT01372410|3801374|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2177350|NCT01372410|3801375|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2177351|NCT01372410|3801376|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2177352|NCT01372410|3801377|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2089585|NCT00757783|3676627|FG001|Overall Study|Other|2
2089586|NCT00757848|3676647|FG000|Overall Study|Voluntary discontinuation|1
2089587|NCT00757848|3676648|FG001|Overall Study|Voluntary discontinuation|0
2089588|NCT00757848|3676647|FG000|Overall Study|Adverse Event|1
2089589|NCT00757848|3676648|FG001|Overall Study|Adverse Event|2
2089590|NCT00757848|3676647|FG000|Overall Study|Incorrect enrolment|1
2089591|NCT00757848|3676648|FG001|Overall Study|Incorrect enrolment|0
2089592|NCT00758043|3676658|FG000|Overall Study|Adverse Event|1
2089593|NCT00758043|3676659|FG001|Overall Study|Adverse Event|20
2089594|NCT00758043|3676660|FG002|Overall Study|Adverse Event|12
2089595|NCT00758043|3676661|FG003|Overall Study|Adverse Event|62
2089596|NCT00758043|3676658|FG000|Overall Study|Lack of Efficacy|0
2089597|NCT00758043|3676659|FG001|Overall Study|Lack of Efficacy|6
2089598|NCT00758043|3676660|FG002|Overall Study|Lack of Efficacy|18
2089599|NCT00758043|3676661|FG003|Overall Study|Lack of Efficacy|12
2089600|NCT00758043|3676658|FG000|Overall Study|Refused Further Treatment|0
2089601|NCT00758043|3676659|FG001|Overall Study|Refused Further Treatment|11
2089602|NCT00758043|3676660|FG002|Overall Study|Refused Further Treatment|5
2089603|NCT00758043|3676661|FG003|Overall Study|Refused Further Treatment|8
2089604|NCT00758043|3676658|FG000|Overall Study|Lost to Follow-up|0
2089605|NCT00758043|3676659|FG001|Overall Study|Lost to Follow-up|2
2089606|NCT00758043|3676660|FG002|Overall Study|Lost to Follow-up|2
2089607|NCT00758043|3676661|FG003|Overall Study|Lost to Follow-up|5
2089608|NCT00758043|3676658|FG000|Overall Study|Withdrawal by Subject|0
2089609|NCT00758043|3676659|FG001|Overall Study|Withdrawal by Subject|1
2089610|NCT00758043|3676660|FG002|Overall Study|Withdrawal by Subject|1
2089611|NCT00758043|3676661|FG003|Overall Study|Withdrawal by Subject|4
2089612|NCT00758043|3676658|FG000|Overall Study|Required Prohibited Medication|0
2089613|NCT00758043|3676659|FG001|Overall Study|Required Prohibited Medication|0
2089614|NCT00758043|3676660|FG002|Overall Study|Required Prohibited Medication|1
2089615|NCT00758043|3676661|FG003|Overall Study|Required Prohibited Medication|3
2089616|NCT00758043|3676658|FG000|Overall Study|Non-Compliant With study Drug|0
2089617|NCT00758043|3676659|FG001|Overall Study|Non-Compliant With study Drug|0
2089618|NCT00758043|3676660|FG002|Overall Study|Non-Compliant With study Drug|0
2089619|NCT00758043|3676661|FG003|Overall Study|Non-Compliant With study Drug|1
2089620|NCT00758043|3676658|FG000|Overall Study|Other Reasons|0
2089621|NCT00758043|3676659|FG001|Overall Study|Other Reasons|1
2089622|NCT00758043|3676660|FG002|Overall Study|Other Reasons|0
2089623|NCT00758043|3676661|FG003|Overall Study|Other Reasons|5
2089624|NCT00758069|3676680|FG000|Overall Study|Lack of Efficacy|0
2089625|NCT00758069|3676681|FG001|Overall Study|Lack of Efficacy|0
2089626|NCT00758069|3676682|FG002|Overall Study|Lack of Efficacy|1
2089627|NCT00758069|3676680|FG000|Overall Study|Incorrect Study Drug|1
2089628|NCT00758069|3676681|FG001|Overall Study|Incorrect Study Drug|0
2089629|NCT00758069|3676682|FG002|Overall Study|Incorrect Study Drug|0
2089630|NCT00758160|3676690|FG000|Overall Study|No Longer Requires Study Medication|4
2089631|NCT00758160|3676690|FG000|Overall Study|Administration Problems|3
2089632|NCT00758160|3676690|FG000|Overall Study|Adverse Event|15
2089633|NCT00758160|3676690|FG000|Overall Study|Lack of Efficacy|10
2089634|NCT00758160|3676690|FG000|Overall Study|Lost to Follow-up|14
2089635|NCT00758160|3676690|FG000|Overall Study|Protocol Violation|12
2089636|NCT00758160|3676690|FG000|Overall Study|Withdrawal by Subject|8
2089637|NCT00758264|3676701|FG000|Active Phase|Withdrawal by Subject|0
2089638|NCT00758264|3676702|FG001|Active Phase|Withdrawal by Subject|0
2089639|NCT00758264|3676703|FG002|Active Phase|Withdrawal by Subject|1
2089640|NCT00758264|3676701|FG000|Active Phase|Lost to Follow-up|1
2089641|NCT00758264|3676702|FG001|Active Phase|Lost to Follow-up|0
2089642|NCT00758264|3676703|FG002|Active Phase|Lost to Follow-up|0
2089643|NCT00758264|3676701|FG000|Active Phase|Other|0
2089644|NCT00758264|3676702|FG001|Active Phase|Other|0
2089645|NCT00758264|3676703|FG002|Active Phase|Other|4
2089646|NCT00758394|3676724|FG000|2nd Intervention Order|Lost to Follow-up|0
2089647|NCT00758394|3676725|FG001|2nd Intervention Order|Lost to Follow-up|1
2089648|NCT00758394|3676726|FG002|2nd Intervention Order|Lost to Follow-up|0
2089649|NCT00758394|3676727|FG003|2nd Intervention Order|Lost to Follow-up|0
2089650|NCT00758394|3676724|FG000|3rd Intervention|Lost to Follow-up|1
2089651|NCT00758394|3676725|FG001|3rd Intervention|Lost to Follow-up|0
2089652|NCT00758394|3676726|FG002|3rd Intervention|Lost to Follow-up|0
2089653|NCT00758394|3676727|FG003|3rd Intervention|Lost to Follow-up|1
2089654|NCT00758459|3676748|FG000|Overall Study|Adverse Event|3
2089655|NCT00758459|3676749|FG001|Overall Study|Adverse Event|2
2089656|NCT00758459|3676748|FG000|Overall Study|Protocol Violation|0
2089657|NCT00758459|3676749|FG001|Overall Study|Protocol Violation|1
2089658|NCT00758459|3676748|FG000|Overall Study|Withdrawal by Subject|0
2089659|NCT00758459|3676749|FG001|Overall Study|Withdrawal by Subject|1
2089660|NCT00758485|3676757|FG000|Overall Study|Lost to Follow-up|0
2089661|NCT00758485|3676758|FG001|Overall Study|Lost to Follow-up|1
2089662|NCT00758485|3676757|FG000|Overall Study|Not Treated|1
2089663|NCT00758485|3676758|FG001|Overall Study|Not Treated|2
2089664|NCT00758498|3676768|FG000|Overall Study|Adverse Event|2
2089665|NCT00758498|3676769|FG001|Overall Study|Adverse Event|2
2089666|NCT00758498|3676770|FG002|Overall Study|Adverse Event|3
2089667|NCT00758498|3676768|FG000|Overall Study|Subject legally detained out of state|1
2089668|NCT00758498|3676769|FG001|Overall Study|Subject legally detained out of state|0
2089669|NCT00758498|3676770|FG002|Overall Study|Subject legally detained out of state|0
2089670|NCT00758498|3676768|FG000|Overall Study|Withdrawal by Subject|0
2089671|NCT00758498|3676769|FG001|Overall Study|Withdrawal by Subject|0
2089672|NCT00758498|3676770|FG002|Overall Study|Withdrawal by Subject|1
2089673|NCT00758498|3676768|FG000|Overall Study|Noncompliance to study procedures|0
2089674|NCT00758498|3676769|FG001|Overall Study|Noncompliance to study procedures|0
2089675|NCT00758498|3676770|FG002|Overall Study|Noncompliance to study procedures|1
2089676|NCT00758524|3676784|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
2089677|NCT00758524|3676785|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2
2089678|NCT00758524|3676786|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4
2211722|NCT01662648|3852110|FG001|Overall Study|Participant non-compliant|20
2211723|NCT01662648|3852109|FG000|Overall Study|Other|8
2211724|NCT01662648|3852110|FG001|Overall Study|Other|11
2306211|NCT02683941|4008066|FG001|Double-blind Phase|Withdrawal by Subject|2
2089679|NCT00758524|3676787|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089680|NCT00758524|3676788|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
2089681|NCT00758524|3676789|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5
2089682|NCT00758524|3676790|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089683|NCT00758524|3676791|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089684|NCT00758524|3676792|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089685|NCT00758524|3676793|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089686|NCT00758524|3676794|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089687|NCT00758524|3676795|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089688|NCT00758524|3676796|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089689|NCT00758524|3676797|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089690|NCT00758524|3676798|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089691|NCT00758524|3676799|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089692|NCT00758524|3676800|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
2089693|NCT00758524|3676784|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
2089694|NCT00758524|3676785|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089695|NCT00758524|3676786|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2
2089696|NCT00758524|3676787|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
2089697|NCT00758524|3676788|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1
2089698|NCT00758524|3676789|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
2089699|NCT00758524|3676790|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089700|NCT00758524|3676791|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089701|NCT00758524|3676792|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089702|NCT00758524|3676793|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089703|NCT00758524|3676794|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089704|NCT00758524|3676795|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089705|NCT00758524|3676796|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089706|NCT00758524|3676797|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089707|NCT00758524|3676798|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089708|NCT00758524|3676799|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089709|NCT00758524|3676800|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
2089710|NCT00758524|3676784|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2
2089711|NCT00758524|3676785|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1
2089712|NCT00758524|3676786|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1
2089713|NCT00758524|3676787|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3
2089714|NCT00758524|3676788|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2
2089715|NCT00758524|3676789|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1
2089716|NCT00758524|3676790|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0
2089717|NCT00758524|3676791|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0
2089718|NCT00758524|3676792|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0
2089719|NCT00758524|3676793|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0
2089720|NCT00758524|3676794|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0
2089721|NCT00758524|3676795|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0
2089722|NCT00758524|3676796|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0
2089723|NCT00758524|3676797|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0
2089724|NCT00758524|3676798|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0
2089725|NCT00758524|3676799|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0
2089726|NCT00758524|3676800|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0
2089727|NCT00758524|3676784|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089728|NCT00758524|3676785|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
2089729|NCT00758524|3676786|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
2089730|NCT00758524|3676787|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089731|NCT00758524|3676788|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
2089732|NCT00758524|3676789|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
2306212|NCT02683941|4008065|FG000|Double-blind Phase|Lost to Follow-up|1
2306213|NCT02683941|4008066|FG001|Double-blind Phase|Lost to Follow-up|0
2306214|NCT02683941|4008065|FG000|Double-blind Phase|Disease Progression|5
2306215|NCT02683941|4008066|FG001|Double-blind Phase|Disease Progression|2
2306216|NCT02683941|4008065|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
2306217|NCT02683941|4008066|FG001|Open-label Treatment Phase|Withdrawal by Subject|2
2306218|NCT02683941|4008065|FG000|Open-label Treatment Phase|Disease Progression|1
2306219|NCT02683941|4008066|FG001|Open-label Treatment Phase|Disease Progression|2
2321741|NCT02963506|4036380|FG009|Double-Blind Period|Withdrawal by Subject|0
2089733|NCT00758524|3676790|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089734|NCT00758524|3676791|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089735|NCT00758524|3676792|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089736|NCT00758524|3676793|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089737|NCT00758524|3676794|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089738|NCT00758524|3676795|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089739|NCT00758524|3676796|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089740|NCT00758524|3676797|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089741|NCT00758524|3676798|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089742|NCT00758524|3676799|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089743|NCT00758524|3676800|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
2089744|NCT00758524|3676784|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089745|NCT00758524|3676785|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089746|NCT00758524|3676786|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1
2089747|NCT00758524|3676787|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1
2089748|NCT00758524|3676788|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089749|NCT00758524|3676789|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089750|NCT00758524|3676790|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089751|NCT00758524|3676791|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089752|NCT00758524|3676792|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089753|NCT00758524|3676793|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089754|NCT00758524|3676794|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089755|NCT00758524|3676795|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089756|NCT00758524|3676796|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089757|NCT00758524|3676797|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089758|NCT00758524|3676798|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089759|NCT00758524|3676799|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089760|NCT00758524|3676800|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0
2089761|NCT00758524|3676784|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089762|NCT00758524|3676785|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089763|NCT00758524|3676786|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089764|NCT00758524|3676787|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089765|NCT00758524|3676788|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1
2089766|NCT00758524|3676789|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089767|NCT00758524|3676790|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089768|NCT00758524|3676791|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089769|NCT00758524|3676792|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2306220|NCT02683941|4008065|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18
2306221|NCT02683941|4008066|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9
2089770|NCT00758524|3676793|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089771|NCT00758524|3676794|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089772|NCT00758524|3676795|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089773|NCT00758524|3676796|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089774|NCT00758524|3676797|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089775|NCT00758524|3676798|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089776|NCT00758524|3676799|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089777|NCT00758524|3676800|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
2089778|NCT00758524|3676784|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089779|NCT00758524|3676785|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1
2089780|NCT00758524|3676786|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089781|NCT00758524|3676787|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089782|NCT00758524|3676788|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089783|NCT00758524|3676789|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089784|NCT00758524|3676790|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089785|NCT00758524|3676791|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089786|NCT00758524|3676792|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089787|NCT00758524|3676793|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089788|NCT00758524|3676794|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089789|NCT00758524|3676795|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089790|NCT00758524|3676796|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089791|NCT00758524|3676797|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089792|NCT00758524|3676798|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089793|NCT00758524|3676799|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089794|NCT00758524|3676800|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
2089795|NCT00758524|3676784|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089796|NCT00758524|3676785|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1
2089797|NCT00758524|3676786|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089798|NCT00758524|3676787|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089799|NCT00758524|3676788|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089800|NCT00758524|3676789|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089801|NCT00758524|3676790|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089802|NCT00758524|3676791|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089803|NCT00758524|3676792|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089804|NCT00758524|3676793|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089805|NCT00758524|3676794|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089806|NCT00758524|3676795|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089807|NCT00758524|3676796|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089808|NCT00758524|3676797|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089809|NCT00758524|3676798|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089810|NCT00758524|3676799|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089811|NCT00758524|3676800|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0
2089812|NCT00758524|3676784|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089813|NCT00758524|3676785|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089814|NCT00758524|3676786|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089815|NCT00758524|3676787|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089816|NCT00758524|3676788|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089817|NCT00758524|3676789|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089818|NCT00758524|3676790|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089819|NCT00758524|3676791|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089820|NCT00758524|3676792|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2
2089821|NCT00758524|3676793|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089822|NCT00758524|3676794|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089823|NCT00758524|3676795|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089824|NCT00758524|3676796|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089825|NCT00758524|3676797|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089826|NCT00758524|3676798|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089827|NCT00758524|3676799|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089828|NCT00758524|3676800|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
2089829|NCT00758524|3676784|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089830|NCT00758524|3676785|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089831|NCT00758524|3676786|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089832|NCT00758524|3676787|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089833|NCT00758524|3676788|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089834|NCT00758524|3676789|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089835|NCT00758524|3676790|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1
2089836|NCT00758524|3676791|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089837|NCT00758524|3676792|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089838|NCT00758524|3676793|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089839|NCT00758524|3676794|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089840|NCT00758524|3676795|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089841|NCT00758524|3676796|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089842|NCT00758524|3676797|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089843|NCT00758524|3676798|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089844|NCT00758524|3676799|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089845|NCT00758524|3676800|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
2089846|NCT00758589|3676855|FG000|Overall Study|Adverse Event|3
2089847|NCT00758589|3676856|FG001|Overall Study|Adverse Event|2
2089848|NCT00758589|3676857|FG002|Overall Study|Adverse Event|5
2089849|NCT00758589|3676858|FG003|Overall Study|Adverse Event|4
2089850|NCT00758589|3676855|FG000|Overall Study|Withdrawal by Subject|0
2089851|NCT00758589|3676856|FG001|Overall Study|Withdrawal by Subject|1
2089852|NCT00758589|3676857|FG002|Overall Study|Withdrawal by Subject|1
2089853|NCT00758589|3676858|FG003|Overall Study|Withdrawal by Subject|1
2089854|NCT00758589|3676855|FG000|Overall Study|Palm stopped to work|0
2089855|NCT00758589|3676856|FG001|Overall Study|Palm stopped to work|0
2089856|NCT00758589|3676857|FG002|Overall Study|Palm stopped to work|0
2089857|NCT00758589|3676858|FG003|Overall Study|Palm stopped to work|1
2089858|NCT00758602|3676870|FG000|Overall Study|Adverse Event|11
2089859|NCT00758602|3676871|FG001|Overall Study|Adverse Event|10
2089860|NCT00758602|3676870|FG000|Overall Study|Lost to Follow-up|4
2089861|NCT00758602|3676871|FG001|Overall Study|Lost to Follow-up|3
2089862|NCT00758602|3676870|FG000|Overall Study|Withdrawal by Subject|1
2089863|NCT00758602|3676871|FG001|Overall Study|Withdrawal by Subject|3
2089864|NCT00758602|3676870|FG000|Overall Study|Protocol Violation|0
2089865|NCT00758602|3676871|FG001|Overall Study|Protocol Violation|2
2089866|NCT00758602|3676870|FG000|Overall Study|Death|0
2089867|NCT00758602|3676871|FG001|Overall Study|Death|1
2089868|NCT00758602|3676870|FG000|Overall Study|Reason not specified|3
2089869|NCT00758602|3676871|FG001|Overall Study|Reason not specified|3
2089870|NCT00758680|3676888|FG000|Overall Study|Adverse Event|0
2089871|NCT00758680|3676889|FG001|Overall Study|Adverse Event|0
2089872|NCT00758680|3676890|FG002|Overall Study|Adverse Event|0
2089873|NCT00758680|3676891|FG003|Overall Study|Adverse Event|0
2089874|NCT00758680|3676892|FG004|Overall Study|Adverse Event|0
2089875|NCT00758680|3676893|FG005|Overall Study|Adverse Event|0
2089876|NCT00758680|3676894|FG006|Overall Study|Adverse Event|0
2089877|NCT00758680|3676895|FG007|Overall Study|Adverse Event|1
2089878|NCT00758680|3676896|FG008|Overall Study|Adverse Event|0
2089879|NCT00758680|3676897|FG009|Overall Study|Adverse Event|1
2089880|NCT00758680|3676888|FG000|Overall Study|Laboratory Adverse Event|0
2089881|NCT00758680|3676889|FG001|Overall Study|Laboratory Adverse Event|0
2089882|NCT00758680|3676890|FG002|Overall Study|Laboratory Adverse Event|0
2089883|NCT00758680|3676891|FG003|Overall Study|Laboratory Adverse Event|0
2089884|NCT00758680|3676892|FG004|Overall Study|Laboratory Adverse Event|0
2089885|NCT00758680|3676893|FG005|Overall Study|Laboratory Adverse Event|0
2089886|NCT00758680|3676894|FG006|Overall Study|Laboratory Adverse Event|0
2089887|NCT00758680|3676895|FG007|Overall Study|Laboratory Adverse Event|0
2089888|NCT00758680|3676896|FG008|Overall Study|Laboratory Adverse Event|1
2089889|NCT00758680|3676897|FG009|Overall Study|Laboratory Adverse Event|0
2089890|NCT00758680|3676888|FG000|Overall Study|Withdrawal by Subject|0
2089891|NCT00758680|3676889|FG001|Overall Study|Withdrawal by Subject|0
2089892|NCT00758680|3676890|FG002|Overall Study|Withdrawal by Subject|0
2089893|NCT00758680|3676891|FG003|Overall Study|Withdrawal by Subject|0
2089894|NCT00758680|3676892|FG004|Overall Study|Withdrawal by Subject|0
2089895|NCT00758680|3676893|FG005|Overall Study|Withdrawal by Subject|0
2089896|NCT00758680|3676894|FG006|Overall Study|Withdrawal by Subject|1
2089897|NCT00758680|3676895|FG007|Overall Study|Withdrawal by Subject|0
2089898|NCT00758680|3676896|FG008|Overall Study|Withdrawal by Subject|1
2089899|NCT00758680|3676897|FG009|Overall Study|Withdrawal by Subject|0
2089900|NCT00758706|3676922|FG000|Overall Study|Adverse Event|4
2089901|NCT00758706|3676923|FG001|Overall Study|Adverse Event|4
2089902|NCT00758771|3676981|FG000|Overall Study|Withdrawal by Subject|1
2089903|NCT00758771|3676982|FG001|Overall Study|Withdrawal by Subject|1
2089904|NCT00758771|3676981|FG000|Overall Study|Did not meet eligibility criteria|2
2089905|NCT00758771|3676982|FG001|Overall Study|Did not meet eligibility criteria|4
2089906|NCT00759031|3677015|FG000|First Intervention (1 Day)|Physician Decision|1
2089907|NCT00759031|3677016|FG001|First Intervention (1 Day)|Physician Decision|0
2089908|NCT00759031|3677015|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
2089909|NCT00759031|3677016|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
2089910|NCT00759031|3677015|FG000|First Intervention (1 Day)|Screening failure|1
2089911|NCT00759031|3677016|FG001|First Intervention (1 Day)|Screening failure|0
2089912|NCT00759109|3677028|FG000|Overall Study|Adverse Event|17
2089913|NCT00759109|3677029|FG001|Overall Study|Adverse Event|12
2089914|NCT00759109|3677028|FG000|Overall Study|Inability to comply|1
2089915|NCT00759109|3677029|FG001|Overall Study|Inability to comply|1
2089916|NCT00759109|3677028|FG000|Overall Study|Withdrawal by Subject|9
2089917|NCT00759109|3677029|FG001|Overall Study|Withdrawal by Subject|5
2089918|NCT00759109|3677028|FG000|Overall Study|Death|4
2089919|NCT00759109|3677029|FG001|Overall Study|Death|3
2089920|NCT00759109|3677028|FG000|Overall Study|Lost to Follow-up|4
2089921|NCT00759109|3677029|FG001|Overall Study|Lost to Follow-up|6
2089922|NCT00759109|3677028|FG000|Overall Study|Started new therapy|2
2089923|NCT00759109|3677029|FG001|Overall Study|Started new therapy|6
2089924|NCT00759109|3677028|FG000|Overall Study|HCV RNA negative|1
2089925|NCT00759109|3677029|FG001|Overall Study|HCV RNA negative|0
2089926|NCT00759109|3677028|FG000|Overall Study|Participant moved to a different city|0
2089927|NCT00759109|3677029|FG001|Overall Study|Participant moved to a different city|1
2089928|NCT00759109|3677028|FG000|Overall Study|Participant had a liver transplant|0
2089929|NCT00759109|3677029|FG001|Overall Study|Participant had a liver transplant|1
2306222|NCT02683941|4008065|FG000|Open-label Treatment Phase|Other|1
2306223|NCT02683941|4008066|FG001|Open-label Treatment Phase|Other|0
2306224|NCT02683941|4008065|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3
2306225|NCT02683941|4008066|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3
2306226|NCT02683941|4008065|FG000|Open-label Follow-up Phase|Lost to Follow-up|1
2306227|NCT02683941|4008066|FG001|Open-label Follow-up Phase|Lost to Follow-up|0
2306228|NCT02683941|4008065|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6
2306229|NCT02683941|4008066|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4
2306230|NCT02683941|4008065|FG000|Open-label Follow-up Phase|Other|8
2306231|NCT02683941|4008066|FG001|Open-label Follow-up Phase|Other|1
2306232|NCT02684097|4008087|FG000|Overall Study|Lack of Efficacy|13
2306233|NCT02684097|4008088|FG001|Overall Study|Lack of Efficacy|6
2306234|NCT02684279|4008113|FG000|Overall Study|Adverse Event|87
2306235|NCT02684279|4008113|FG000|Overall Study|Lack of Efficacy|4
2306236|NCT02684279|4008113|FG000|Overall Study|Lost to Follow-up|61
2306237|NCT02684279|4008113|FG000|Overall Study|Protocol Violation|6
2306238|NCT02684279|4008113|FG000|Overall Study|Pregnancy|8
2306239|NCT02684279|4008113|FG000|Overall Study|Withdrawal by Subject|92
2306240|NCT02684279|4008113|FG000|Overall Study|non-compliance with study drug|9
2306241|NCT02684279|4008113|FG000|Overall Study|non compliance with study visits|2
2089930|NCT00759109|3677028|FG000|Overall Study|Lost during study|1
2089931|NCT00759109|3677029|FG001|Overall Study|Lost during study|0
2089932|NCT00759148|3677037|FG000|Overall Study|Adverse Event|1
2306242|NCT02684279|4008113|FG000|Overall Study|subject to have surgery|1
2089933|NCT00759148|3677038|FG001|Overall Study|Adverse Event|6
2089934|NCT00759148|3677037|FG000|Overall Study|Withdrawal by Subject|3
2089935|NCT00759148|3677038|FG001|Overall Study|Withdrawal by Subject|7
2089936|NCT00759148|3677037|FG000|Overall Study|Lost to Follow-up|3
2089937|NCT00759148|3677038|FG001|Overall Study|Lost to Follow-up|9
2089938|NCT00759148|3677037|FG000|Overall Study|Treatment Failure|6
2089939|NCT00759148|3677038|FG001|Overall Study|Treatment Failure|10
2089940|NCT00759148|3677037|FG000|Overall Study|Reason not given|1
2089941|NCT00759148|3677038|FG001|Overall Study|Reason not given|0
2089942|NCT00759174|3677053|FG000|Overall Study|Other|0
2089943|NCT00759174|3677054|FG001|Overall Study|Other|2
2089944|NCT00759356|3677094|FG000|Overall Study|Adverse Event|0
2089945|NCT00759356|3677095|FG001|Overall Study|Adverse Event|1
2089946|NCT00759356|3677094|FG000|Overall Study|Withdrawal by Subject|0
2089947|NCT00759356|3677095|FG001|Overall Study|Withdrawal by Subject|2
2089948|NCT00759356|3677094|FG000|Overall Study|Subject was unable to return|1
2089949|NCT00759356|3677095|FG001|Overall Study|Subject was unable to return|0
2089950|NCT00759395|3677103|FG000|Overall Study|Adverse Event|1
2089951|NCT00759395|3677104|FG001|Overall Study|Adverse Event|0
2089952|NCT00759395|3677103|FG000|Overall Study|Withdrawal by Subject|1
2089953|NCT00759395|3677104|FG001|Overall Study|Withdrawal by Subject|0
2089954|NCT00759395|3677103|FG000|Overall Study|Lack of Efficacy|0
2089955|NCT00759395|3677104|FG001|Overall Study|Lack of Efficacy|2
2089956|NCT00759564|3677147|FG000|Washout Period (at Least 14 Days)|Adverse Event|0
2089957|NCT00759564|3677148|FG001|Washout Period (at Least 14 Days)|Adverse Event|0
2089958|NCT00759564|3677149|FG002|Washout Period (at Least 14 Days)|Adverse Event|0
2089959|NCT00759564|3677150|FG003|Washout Period (at Least 14 Days)|Adverse Event|0
2089960|NCT00759564|3677151|FG004|Washout Period (at Least 14 Days)|Adverse Event|1
2089961|NCT00759655|3677191|FG000|Overall Study|Termination of the study by sponsor|1
2306243|NCT02684279|4008113|FG000|Overall Study|family emergency|1
2306244|NCT02684279|4008113|FG000|Overall Study|Site closures|7
2306245|NCT02684279|4008113|FG000|Overall Study|Physician Decision|1
2306246|NCT02684344|4008119|FG000|Overall Study|Withdrawal by Subject|0
2306247|NCT02684344|4008120|FG001|Overall Study|Withdrawal by Subject|1
2306248|NCT02684357|4008129|FG000|Part A|Adverse Event (Worsening of Disease)|1
2306249|NCT02684357|4008130|FG001|Part A|Adverse Event (Worsening of Disease)|0
2306250|NCT02684357|4008131|FG002|Part A|Adverse Event (Worsening of Disease)|0
2306251|NCT02684357|4008132|FG003|Part A|Adverse Event (Worsening of Disease)|0
2306252|NCT02684357|4008133|FG004|Part A|Adverse Event (Worsening of Disease)|0
2306253|NCT02684357|4008134|FG005|Part A|Adverse Event (Worsening of Disease)|0
2306254|NCT02684357|4008129|FG000|Part A|Lost to Follow-up|0
2306255|NCT02684357|4008130|FG001|Part A|Lost to Follow-up|2
2306256|NCT02684357|4008131|FG002|Part A|Lost to Follow-up|2
2306257|NCT02684357|4008132|FG003|Part A|Lost to Follow-up|0
2306258|NCT02684357|4008133|FG004|Part A|Lost to Follow-up|0
2306259|NCT02684357|4008134|FG005|Part A|Lost to Follow-up|0
2306260|NCT02684357|4008129|FG000|Part A|Withdrawal by Subject|3
2306261|NCT02684357|4008130|FG001|Part A|Withdrawal by Subject|0
2306262|NCT02684357|4008131|FG002|Part A|Withdrawal by Subject|0
2306263|NCT02684357|4008132|FG003|Part A|Withdrawal by Subject|0
2306264|NCT02684357|4008133|FG004|Part A|Withdrawal by Subject|0
2306265|NCT02684357|4008134|FG005|Part A|Withdrawal by Subject|0
2306266|NCT02684357|4008129|FG000|Part A|Other|0
2306267|NCT02684357|4008130|FG001|Part A|Other|1
2306268|NCT02684357|4008131|FG002|Part A|Other|0
2306269|NCT02684357|4008132|FG003|Part A|Other|0
2306270|NCT02684357|4008133|FG004|Part A|Other|0
2306271|NCT02684357|4008134|FG005|Part A|Other|0
2306272|NCT02684357|4008129|FG000|Part B|Adverse Event (Other)|0
2306273|NCT02684357|4008130|FG001|Part B|Adverse Event (Other)|0
2306274|NCT02684357|4008131|FG002|Part B|Adverse Event (Other)|0
2306275|NCT02684357|4008132|FG003|Part B|Adverse Event (Other)|1
2306276|NCT02684357|4008133|FG004|Part B|Adverse Event (Other)|1
2306277|NCT02684357|4008134|FG005|Part B|Adverse Event (Other)|1
2306278|NCT02684357|4008129|FG000|Part B|Lost to Follow-up|0
2306279|NCT02684357|4008130|FG001|Part B|Lost to Follow-up|0
2306280|NCT02684357|4008131|FG002|Part B|Lost to Follow-up|0
2306281|NCT02684357|4008132|FG003|Part B|Lost to Follow-up|1
2306282|NCT02684357|4008133|FG004|Part B|Lost to Follow-up|1
2306283|NCT02684357|4008134|FG005|Part B|Lost to Follow-up|7
2306284|NCT02684357|4008129|FG000|Part B|Withdrawal by Subject|0
2306285|NCT02684357|4008130|FG001|Part B|Withdrawal by Subject|0
2306286|NCT02684357|4008131|FG002|Part B|Withdrawal by Subject|0
2306287|NCT02684357|4008132|FG003|Part B|Withdrawal by Subject|0
2306288|NCT02684357|4008133|FG004|Part B|Withdrawal by Subject|2
2306289|NCT02684357|4008134|FG005|Part B|Withdrawal by Subject|4
2306290|NCT02684357|4008129|FG000|Part B|Other|0
2306291|NCT02684357|4008130|FG001|Part B|Other|0
2306292|NCT02684357|4008131|FG002|Part B|Other|0
2306293|NCT02684357|4008132|FG003|Part B|Other|1
2306294|NCT02684357|4008133|FG004|Part B|Other|0
2306295|NCT02684357|4008134|FG005|Part B|Other|1
2306296|NCT02684370|4008150|FG000|Part A|Adverse Event|2
2306297|NCT02684370|4008151|FG001|Part A|Adverse Event|0
2306298|NCT02684370|4008152|FG002|Part A|Adverse Event|1
2306299|NCT02684370|4008153|FG003|Part A|Adverse Event|0
2306300|NCT02684370|4008154|FG004|Part A|Adverse Event|0
2306301|NCT02684370|4008155|FG005|Part A|Adverse Event|0
2306302|NCT02684370|4008150|FG000|Part A|Lost to Follow-up|1
2089962|NCT00759681|3677206|FG000|Overall Study|Death|2
2089963|NCT00759681|3677207|FG001|Overall Study|Death|5
2089964|NCT00759681|3677206|FG000|Overall Study|Lost to Follow-up|8
2089965|NCT00759681|3677207|FG001|Overall Study|Lost to Follow-up|5
2089966|NCT00759759|3677220|FG000|Overall Study|didn't return for period 2|1
2089967|NCT00759759|3677221|FG001|Overall Study|didn't return for period 2|0
2089968|NCT00759759|3677220|FG000|Overall Study|Didn't receive drug in period 2|1
2089969|NCT00759759|3677221|FG001|Overall Study|Didn't receive drug in period 2|0
2089970|NCT00759759|3677220|FG000|Overall Study|Withdrawal by Subject|2
2089971|NCT00759759|3677221|FG001|Overall Study|Withdrawal by Subject|1
2089972|NCT00759785|3677238|FG000|Overall Study|Participant sample not evaluable|11
2089973|NCT00759785|3677239|FG001|Overall Study|Participant sample not evaluable|2
2089974|NCT00759785|3677238|FG000|Overall Study|Participant sample lost|0
2089975|NCT00759785|3677239|FG001|Overall Study|Participant sample lost|1
2211725|NCT01662648|3852109|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3
2211726|NCT01662648|3852110|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0
2089976|NCT00759785|3677238|FG000|Overall Study|Protocol Violation|1
2089977|NCT00759785|3677239|FG001|Overall Study|Protocol Violation|0
2089978|NCT00759785|3677238|FG000|Overall Study|Physician Decision|0
2089979|NCT00759785|3677239|FG001|Overall Study|Physician Decision|1
2089980|NCT00759785|3677238|FG000|Overall Study|Withdrawal by Subject|0
2089981|NCT00759785|3677239|FG001|Overall Study|Withdrawal by Subject|1
2107345|NCT00872521|3700854|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0
2107346|NCT00872521|3700855|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2
2107347|NCT00872521|3700856|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0
2107348|NCT00872521|3700854|FG000|Primary Endpoint Analysis|Patient response missing|0
2107349|NCT00872521|3700855|FG001|Primary Endpoint Analysis|Patient response missing|0
2107350|NCT00872521|3700856|FG002|Primary Endpoint Analysis|Patient response missing|1
2107351|NCT00872521|3700854|FG000|Completed 3-month Follow up|Other|0
2107352|NCT00872521|3700855|FG001|Completed 3-month Follow up|Other|2
2107353|NCT00872521|3700856|FG002|Completed 3-month Follow up|Other|0
2107354|NCT00872521|3700854|FG000|Completed 3-month Follow up|Physician Decision|0
2107355|NCT00872521|3700855|FG001|Completed 3-month Follow up|Physician Decision|1
2107356|NCT00872521|3700856|FG002|Completed 3-month Follow up|Physician Decision|0
2211727|NCT01662648|3852109|FG000|Overall Study|LOE and other reason unspecified|1
2211728|NCT01662648|3852110|FG001|Overall Study|LOE and other reason unspecified|0
2211729|NCT01662648|3852109|FG000|Overall Study|LOE and Participant non-compliant|0
2211730|NCT01662648|3852110|FG001|Overall Study|LOE and Participant non-compliant|1
2211731|NCT01662895|3852184|FG000|Overall Study|Lost to Follow-up|0
2211732|NCT01662895|3852185|FG001|Overall Study|Lost to Follow-up|1
2211733|NCT01662986|3852219|FG000|Overall Study|Adverse Event|5
2306303|NCT02684370|4008151|FG001|Part A|Lost to Follow-up|1
2306304|NCT02684370|4008152|FG002|Part A|Lost to Follow-up|0
2107357|NCT00872521|3700854|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0
2107358|NCT00872521|3700855|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2
2107359|NCT00872521|3700856|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1
2107360|NCT00872599|3700884|FG000|Second Washout Period|Adverse Event|1
2107361|NCT00872599|3700885|FG001|Second Washout Period|Adverse Event|1
2107362|NCT00872898|3700930|FG000|Part Two - Double Blind|Adverse Event|4
2107363|NCT00872898|3700931|FG001|Part Two - Double Blind|Adverse Event|3
2107364|NCT00872898|3700930|FG000|Part Two - Double Blind|Lack of Efficacy|1
2107365|NCT00872898|3700931|FG001|Part Two - Double Blind|Lack of Efficacy|0
2107366|NCT00872898|3700930|FG000|Part Two - Double Blind|Protocol Violation|1
2107367|NCT00872898|3700931|FG001|Part Two - Double Blind|Protocol Violation|0
2107368|NCT00872898|3700930|FG000|Part Two - Double Blind|Withdrawal by Subject|3
2211734|NCT01662986|3852220|FG001|Overall Study|Adverse Event|4
2306305|NCT02684370|4008153|FG003|Part A|Lost to Follow-up|0
2306306|NCT02684370|4008154|FG004|Part A|Lost to Follow-up|0
2306307|NCT02684370|4008155|FG005|Part A|Lost to Follow-up|0
2306308|NCT02684370|4008150|FG000|Part A|Subject Withdrawal|1
2306309|NCT02684370|4008151|FG001|Part A|Subject Withdrawal|0
2306310|NCT02684370|4008152|FG002|Part A|Subject Withdrawal|3
2306311|NCT02684370|4008153|FG003|Part A|Subject Withdrawal|0
2306312|NCT02684370|4008154|FG004|Part A|Subject Withdrawal|0
2306313|NCT02684370|4008155|FG005|Part A|Subject Withdrawal|0
2306314|NCT02684370|4008150|FG000|Part A|Other|0
2306315|NCT02684370|4008151|FG001|Part A|Other|0
2306316|NCT02684370|4008152|FG002|Part A|Other|1
2306317|NCT02684370|4008153|FG003|Part A|Other|0
2306318|NCT02684370|4008154|FG004|Part A|Other|0
2306319|NCT02684370|4008155|FG005|Part A|Other|0
2306320|NCT02684370|4008150|FG000|Part B|Adverse Event|0
2306321|NCT02684370|4008151|FG001|Part B|Adverse Event|0
2306322|NCT02684370|4008152|FG002|Part B|Adverse Event|0
2306323|NCT02684370|4008153|FG003|Part B|Adverse Event|0
2306324|NCT02684370|4008154|FG004|Part B|Adverse Event|2
2306325|NCT02684370|4008155|FG005|Part B|Adverse Event|1
2306326|NCT02684370|4008150|FG000|Part B|Lost to Follow-up|0
2306327|NCT02684370|4008151|FG001|Part B|Lost to Follow-up|0
2306328|NCT02684370|4008152|FG002|Part B|Lost to Follow-up|0
2306329|NCT02684370|4008153|FG003|Part B|Lost to Follow-up|1
2306330|NCT02684370|4008154|FG004|Part B|Lost to Follow-up|2
2306331|NCT02684370|4008155|FG005|Part B|Lost to Follow-up|5
2306332|NCT02684370|4008150|FG000|Part B|Subject Withdrawal|0
2306333|NCT02684370|4008151|FG001|Part B|Subject Withdrawal|0
2089982|NCT00759863|3677260|FG000|Overall Study|Death, moved, or lost contact|20
2089983|NCT00759863|3677261|FG001|Overall Study|Death, moved, or lost contact|18
2089984|NCT00759876|3677267|FG000|Overall Study|Sponsor terminated study early|36
2089985|NCT00759902|3677273|FG000|Overall Study|Adverse Event|0
2089986|NCT00759902|3677274|FG001|Overall Study|Adverse Event|1
2089987|NCT00759915|3677282|FG000|Overall Study|Withdrawal by Subject|1
2089988|NCT00759915|3677283|FG001|Overall Study|Withdrawal by Subject|0
2089989|NCT00759915|3677282|FG000|Overall Study|Adverse Event|0
2089990|NCT00759915|3677283|FG001|Overall Study|Adverse Event|1
2089991|NCT00759941|3677291|FG000|Overall Study|Use of medication|1
2089992|NCT00759941|3677292|FG001|Overall Study|Use of medication|0
2089993|NCT00759941|3677291|FG000|Overall Study|Adverse Event|1
2089994|NCT00759941|3677292|FG001|Overall Study|Adverse Event|0
2089995|NCT00759941|3677291|FG000|Overall Study|Exited in error by site|1
2089996|NCT00759941|3677292|FG001|Overall Study|Exited in error by site|1
2089997|NCT00759954|3677300|FG000|Overall Study|Personal reason|1
2089998|NCT00759954|3677301|FG001|Overall Study|Personal reason|0
2089999|NCT00759954|3677300|FG000|Overall Study|Adverse Event|1
2090000|NCT00759954|3677301|FG001|Overall Study|Adverse Event|2
2090001|NCT00760084|3677338|FG000|Overall Study|Physician Decision|5
2090002|NCT00760084|3677338|FG000|Overall Study|Withdrawal by Subject|2
2090003|NCT00760084|3677338|FG000|Overall Study|Progressive Disease|3
2090004|NCT00760214|3677345|FG000|Overall Study|Adverse Event|8
2090005|NCT00760214|3677346|FG001|Overall Study|Adverse Event|9
2090006|NCT00760214|3677347|FG002|Overall Study|Adverse Event|12
2090007|NCT00760214|3677345|FG000|Overall Study|Protocol Violation|3
2090008|NCT00760214|3677346|FG001|Overall Study|Protocol Violation|0
2090009|NCT00760214|3677347|FG002|Overall Study|Protocol Violation|3
2090010|NCT00760214|3677345|FG000|Overall Study|Lost to Follow-up|0
2090011|NCT00760214|3677346|FG001|Overall Study|Lost to Follow-up|0
2090012|NCT00760214|3677347|FG002|Overall Study|Lost to Follow-up|1
2090013|NCT00760214|3677345|FG000|Overall Study|Withdrawal by Subject|12
2090014|NCT00760214|3677346|FG001|Overall Study|Withdrawal by Subject|14
2090015|NCT00760214|3677347|FG002|Overall Study|Withdrawal by Subject|13
2090016|NCT00760214|3677345|FG000|Overall Study|Lack of Efficacy|3
2090017|NCT00760214|3677346|FG001|Overall Study|Lack of Efficacy|2
2090018|NCT00760214|3677347|FG002|Overall Study|Lack of Efficacy|4
2090019|NCT00760214|3677345|FG000|Overall Study|Pregnancy|0
2090020|NCT00760214|3677346|FG001|Overall Study|Pregnancy|0
2090021|NCT00760214|3677347|FG002|Overall Study|Pregnancy|1
2090022|NCT00760214|3677345|FG000|Overall Study|Physician Decision|1
2090023|NCT00760214|3677346|FG001|Overall Study|Physician Decision|1
2090024|NCT00760214|3677347|FG002|Overall Study|Physician Decision|1
2090025|NCT00760214|3677345|FG000|Overall Study|Other|3
2090026|NCT00760214|3677346|FG001|Overall Study|Other|4
2090027|NCT00760214|3677347|FG002|Overall Study|Other|6
2090028|NCT00760266|3677357|FG000|Overall Study|Adverse Event|13
2090029|NCT00760266|3677358|FG001|Overall Study|Adverse Event|7
2090030|NCT00760266|3677357|FG000|Overall Study|Abnormal laboratory value(s)|1
2090031|NCT00760266|3677358|FG001|Overall Study|Abnormal laboratory value(s)|0
2090032|NCT00760266|3677357|FG000|Overall Study|Abnormal test procedure result(s)|1
2090033|NCT00760266|3677358|FG001|Overall Study|Abnormal test procedure result(s)|0
2090034|NCT00760266|3677357|FG000|Overall Study|Lack of Efficacy|2
2090035|NCT00760266|3677358|FG001|Overall Study|Lack of Efficacy|2
2090036|NCT00760266|3677357|FG000|Overall Study|Protocol deviation|2
2090037|NCT00760266|3677358|FG001|Overall Study|Protocol deviation|4
2090038|NCT00760266|3677357|FG000|Overall Study|Patient withdrew consent|3
2090039|NCT00760266|3677358|FG001|Overall Study|Patient withdrew consent|3
2090040|NCT00760266|3677357|FG000|Overall Study|Lost to Follow-up|2
2090041|NCT00760266|3677358|FG001|Overall Study|Lost to Follow-up|1
2090042|NCT00760266|3677357|FG000|Overall Study|Administrative Problems|0
2090043|NCT00760266|3677358|FG001|Overall Study|Administrative Problems|1
2090044|NCT00760383|3677366|FG000|Overall Study|moved away; withdrew; medical reasons|5
2090045|NCT00760383|3677367|FG001|Overall Study|moved away; withdrew; medical reasons|7
2090046|NCT00760474|3677382|FG000|Period 1 (P1)|Discontinued then re-entered|1
2090047|NCT00760474|3677383|FG001|Period 1 (P1)|Discontinued then re-entered|1
2090048|NCT00760474|3677382|FG000|Placebo Washout Period|Other|0
2090049|NCT00760474|3677383|FG001|Placebo Washout Period|Other|1
2090050|NCT00760474|3677382|FG000|Period 2 (P2)|Lost to Follow-up|1
2090051|NCT00760474|3677383|FG001|Period 2 (P2)|Lost to Follow-up|0
2090052|NCT00760474|3677382|FG000|Period 2 (P2)|Adverse Event|0
2090053|NCT00760474|3677383|FG001|Period 2 (P2)|Adverse Event|1
2090054|NCT00760487|3677390|FG000|Overall Study|Unilateral implantation|3
2090055|NCT00760513|3677396|FG000|Overall Study|Withdrawal by Subject|5
2090056|NCT00760513|3677397|FG001|Overall Study|Withdrawal by Subject|7
2090057|NCT00760552|3677423|FG000|Overall Study|Death|2
2090058|NCT00760552|3677424|FG001|Overall Study|Death|0
2090059|NCT00760552|3677423|FG000|Overall Study|Lost to Follow-up|11
2090060|NCT00760552|3677424|FG001|Overall Study|Lost to Follow-up|10
2090061|NCT00760617|3677455|FG000|Overall Study|Adverse Event|5
2090062|NCT00760617|3677456|FG001|Overall Study|Adverse Event|2
2090063|NCT00760617|3677457|FG002|Overall Study|Adverse Event|0
2090064|NCT00760617|3677455|FG000|Overall Study|Lost to Follow-up|0
2090065|NCT00760617|3677456|FG001|Overall Study|Lost to Follow-up|0
2090066|NCT00760617|3677457|FG002|Overall Study|Lost to Follow-up|5
2108206|NCT00878722|3702051|FG002|Overall Study|Withdrawal by Subject|0
2090067|NCT00760669|3677465|FG000|Overall Study|Not assessed for overall improvement|18
2090068|NCT00760669|3677465|FG000|Overall Study|Participants missing efficacy assessment|6
2090069|NCT00760669|3677465|FG000|Overall Study|Participants with overlapping cases|1
2090070|NCT00760669|3677465|FG000|Overall Study|Took drug before entering in contract|5
2090071|NCT00760747|3677471|FG000|Study Period II|Adverse Event|3
2090072|NCT00760747|3677472|FG001|Study Period II|Adverse Event|4
2090073|NCT00760747|3677471|FG000|Study Period II|Lack of Efficacy|0
2090074|NCT00760747|3677472|FG001|Study Period II|Lack of Efficacy|6
2211735|NCT01662986|3852219|FG000|Overall Study|Protocol Violation|2
2090075|NCT00760747|3677471|FG000|Study Period II|Parent/Caregiver Decision|3
2090076|NCT00760747|3677472|FG001|Study Period II|Parent/Caregiver Decision|0
2090077|NCT00760747|3677471|FG000|Study Period II|Protocol Violation|6
2090078|NCT00760747|3677472|FG001|Study Period II|Protocol Violation|3
2090079|NCT00760747|3677471|FG000|Study Period II|Withdrawal by Subject|1
2090080|NCT00760747|3677472|FG001|Study Period II|Withdrawal by Subject|0
2090081|NCT00760747|3677471|FG000|Study Period II|No drug administered|0
2090082|NCT00760747|3677472|FG001|Study Period II|No drug administered|1
2090083|NCT00760747|3677471|FG000|Study Period III|Adverse Event|1
2090084|NCT00760747|3677472|FG001|Study Period III|Adverse Event|0
2090085|NCT00760747|3677471|FG000|Study Period III|Lack of Efficacy|1
2090086|NCT00760747|3677472|FG001|Study Period III|Lack of Efficacy|0
2090087|NCT00760747|3677471|FG000|Study Period III|Parent/Caregiver Decision|0
2090088|NCT00760747|3677472|FG001|Study Period III|Parent/Caregiver Decision|1
2090089|NCT00760747|3677471|FG000|Study Period III|Protocol Violation|1
2090090|NCT00760747|3677472|FG001|Study Period III|Protocol Violation|1
2090091|NCT00760747|3677471|FG000|Study Period III|Physician Decision|0
2090092|NCT00760747|3677472|FG001|Study Period III|Physician Decision|1
2090093|NCT00760838|3677480|FG000|Overall Study|Adverse Event|1
2090094|NCT00760838|3677481|FG001|Overall Study|Adverse Event|1
2090095|NCT00760838|3677480|FG000|Overall Study|Lack of Efficacy|1
2090096|NCT00760838|3677481|FG001|Overall Study|Lack of Efficacy|0
2090097|NCT00760838|3677480|FG000|Overall Study|Lost to Follow-up|2
2090098|NCT00760838|3677481|FG001|Overall Study|Lost to Follow-up|0
2090099|NCT00760838|3677480|FG000|Overall Study|Withdrawal by Subject|1
2090100|NCT00760838|3677481|FG001|Overall Study|Withdrawal by Subject|1
2090101|NCT00760877|3677489|FG000|Overall Study|Protocol Violation|1
2090102|NCT00760877|3677490|FG001|Overall Study|Protocol Violation|0
2090103|NCT00760877|3677489|FG000|Overall Study|Non-compliance with protocol treatment|2
2090104|NCT00760877|3677490|FG001|Overall Study|Non-compliance with protocol treatment|1
2090105|NCT00760877|3677489|FG000|Overall Study|Pregnancy|1
2090106|NCT00760877|3677490|FG001|Overall Study|Pregnancy|4
2090107|NCT00760877|3677489|FG000|Overall Study|Death|2
2090108|NCT00760877|3677490|FG001|Overall Study|Death|1
2090109|NCT00760877|3677489|FG000|Overall Study|Withdrawal by Subject|7
2090110|NCT00760877|3677490|FG001|Overall Study|Withdrawal by Subject|3
2090111|NCT00760877|3677489|FG000|Overall Study|Adverse Event|19
2090112|NCT00760877|3677490|FG001|Overall Study|Adverse Event|12
2090113|NCT00760877|3677489|FG000|Overall Study|Participant diagnosed with AML|0
2090114|NCT00760877|3677490|FG001|Overall Study|Participant diagnosed with AML|1
2090115|NCT00760877|3677489|FG000|Overall Study|Participant not eligible to cross-over|0
2090116|NCT00760877|3677490|FG001|Overall Study|Participant not eligible to cross-over|1
2090117|NCT00760877|3677489|FG000|Overall Study|Physician Decision|1
2090118|NCT00760877|3677490|FG001|Overall Study|Physician Decision|2
2090119|NCT00760877|3677489|FG000|Overall Study|Participants transferred to AMN107A2408|11
2090120|NCT00760877|3677490|FG001|Overall Study|Participants transferred to AMN107A2408|1
2090121|NCT00760877|3677489|FG000|Overall Study|Treatment failure|1
2090122|NCT00760877|3677490|FG001|Overall Study|Treatment failure|0
2090123|NCT00760929|3677501|FG000|Overall Study|Adverse Event|2
2090124|NCT00760929|3677502|FG001|Overall Study|Adverse Event|0
2090125|NCT00760929|3677503|FG002|Overall Study|Adverse Event|6
2090126|NCT00760929|3677504|FG003|Overall Study|Adverse Event|10
2090127|NCT00760929|3677501|FG000|Overall Study|Lack of Efficacy|0
2090128|NCT00760929|3677502|FG001|Overall Study|Lack of Efficacy|2
2090129|NCT00760929|3677503|FG002|Overall Study|Lack of Efficacy|1
2090130|NCT00760929|3677504|FG003|Overall Study|Lack of Efficacy|0
2090131|NCT00760929|3677501|FG000|Overall Study|Withdrawal by Subject|1
2306334|NCT02684370|4008152|FG002|Part B|Subject Withdrawal|0
2306335|NCT02684370|4008153|FG003|Part B|Subject Withdrawal|1
2306336|NCT02684370|4008154|FG004|Part B|Subject Withdrawal|1
2306337|NCT02684370|4008155|FG005|Part B|Subject Withdrawal|2
2306338|NCT02684617|4008219|FG000|Overall Study|Adverse Event|1
2306339|NCT02684617|4008220|FG001|Overall Study|Adverse Event|0
2090132|NCT00760929|3677502|FG001|Overall Study|Withdrawal by Subject|0
2090133|NCT00760929|3677503|FG002|Overall Study|Withdrawal by Subject|9
2090134|NCT00760929|3677504|FG003|Overall Study|Withdrawal by Subject|1
2090135|NCT00760929|3677501|FG000|Overall Study|Lost to Follow-up|0
2090136|NCT00760929|3677502|FG001|Overall Study|Lost to Follow-up|0
2090137|NCT00760929|3677503|FG002|Overall Study|Lost to Follow-up|1
2090138|NCT00760929|3677504|FG003|Overall Study|Lost to Follow-up|0
2090139|NCT00760929|3677501|FG000|Overall Study|Progression of Disease|21
2211736|NCT01662986|3852220|FG001|Overall Study|Protocol Violation|3
2306340|NCT02684617|4008221|FG002|Overall Study|Adverse Event|1
2306341|NCT02684617|4008219|FG000|Overall Study|Death|8
2306342|NCT02684617|4008220|FG001|Overall Study|Death|16
2090140|NCT00760929|3677502|FG001|Overall Study|Progression of Disease|26
2090141|NCT00760929|3677503|FG002|Overall Study|Progression of Disease|38
2090142|NCT00760929|3677504|FG003|Overall Study|Progression of Disease|42
2090143|NCT00760929|3677501|FG000|Overall Study|Other|2
2090144|NCT00760929|3677502|FG001|Overall Study|Other|0
2090145|NCT00760929|3677503|FG002|Overall Study|Other|2
2090146|NCT00760929|3677504|FG003|Overall Study|Other|1
2090147|NCT00760929|3677501|FG000|Overall Study|Death|0
2090148|NCT00760929|3677502|FG001|Overall Study|Death|0
2090149|NCT00760929|3677503|FG002|Overall Study|Death|1
2090150|NCT00760929|3677504|FG003|Overall Study|Death|0
2090151|NCT00760929|3677501|FG000|Overall Study|Violation of Selection Criteria at Entry|0
2090152|NCT00760929|3677502|FG001|Overall Study|Violation of Selection Criteria at Entry|0
2090153|NCT00760929|3677503|FG002|Overall Study|Violation of Selection Criteria at Entry|0
2090154|NCT00760929|3677504|FG003|Overall Study|Violation of Selection Criteria at Entry|1
2090155|NCT00760994|3677516|FG000|Overall Study|Lost to Follow-up|4
2090156|NCT00760994|3677517|FG001|Overall Study|Lost to Follow-up|4
2090157|NCT00760994|3677518|FG002|Overall Study|Lost to Follow-up|3
2090158|NCT00761150|3677572|FG000|Open-label Period|Adverse Event|36
2090159|NCT00761150|3677573|FG001|Open-label Period|Adverse Event|0
2090160|NCT00761150|3677574|FG002|Open-label Period|Adverse Event|0
2090161|NCT00761150|3677572|FG000|Open-label Period|Did not meet DB randomization criteria|11
2090162|NCT00761150|3677573|FG001|Open-label Period|Did not meet DB randomization criteria|0
2090163|NCT00761150|3677574|FG002|Open-label Period|Did not meet DB randomization criteria|0
2090164|NCT00761150|3677572|FG000|Open-label Period|Lost to Follow-up|7
2090165|NCT00761150|3677573|FG001|Open-label Period|Lost to Follow-up|0
2090166|NCT00761150|3677574|FG002|Open-label Period|Lost to Follow-up|0
2090167|NCT00761150|3677572|FG000|Open-label Period|Lack of Efficacy|4
2090168|NCT00761150|3677573|FG001|Open-label Period|Lack of Efficacy|0
2090169|NCT00761150|3677574|FG002|Open-label Period|Lack of Efficacy|0
2090170|NCT00761150|3677572|FG000|Open-label Period|Withdrawal by Subject|5
2090171|NCT00761150|3677573|FG001|Open-label Period|Withdrawal by Subject|0
2090172|NCT00761150|3677574|FG002|Open-label Period|Withdrawal by Subject|0
2090173|NCT00761150|3677572|FG000|Open-label Period|Noncompliance|2
2090174|NCT00761150|3677573|FG001|Open-label Period|Noncompliance|0
2090175|NCT00761150|3677574|FG002|Open-label Period|Noncompliance|0
2090176|NCT00761150|3677572|FG000|Open-label Period|Other|5
2090177|NCT00761150|3677573|FG001|Open-label Period|Other|0
2090178|NCT00761150|3677574|FG002|Open-label Period|Other|0
2090179|NCT00761150|3677572|FG000|Double-blind Period|Lack of Efficacy|0
2090180|NCT00761150|3677573|FG001|Double-blind Period|Lack of Efficacy|2
2090181|NCT00761150|3677574|FG002|Double-blind Period|Lack of Efficacy|19
2090182|NCT00761150|3677572|FG000|Double-blind Period|Adverse Event|0
2090183|NCT00761150|3677573|FG001|Double-blind Period|Adverse Event|3
2306343|NCT02684617|4008221|FG002|Overall Study|Death|28
2306344|NCT02684617|4008219|FG000|Overall Study|Withdrawal by Subject|2
2306345|NCT02684617|4008220|FG001|Overall Study|Withdrawal by Subject|0
2306346|NCT02684617|4008221|FG002|Overall Study|Withdrawal by Subject|4
2306347|NCT02684617|4008219|FG000|Overall Study|Screen Failure|1
2306348|NCT02684617|4008220|FG001|Overall Study|Screen Failure|0
2306349|NCT02684617|4008221|FG002|Overall Study|Screen Failure|2
2306350|NCT02684617|4008219|FG000|Overall Study|Study Terminated by Sponsor|6
2306351|NCT02684617|4008220|FG001|Overall Study|Study Terminated by Sponsor|1
2306352|NCT02684617|4008221|FG002|Overall Study|Study Terminated by Sponsor|5
2306353|NCT02684981|4008270|FG000|Overall Study|Permanently discontinued the treatment|157
2306354|NCT02684981|4008271|FG001|Overall Study|Permanently discontinued the treatment|161
2306355|NCT02684981|4008272|FG002|Overall Study|Permanently discontinued the treatment|110
2306356|NCT02684981|4008270|FG000|Overall Study|Other|83
2306357|NCT02684981|4008271|FG001|Overall Study|Other|49
2306358|NCT02684981|4008272|FG002|Overall Study|Other|17
2306359|NCT02685033|4008292|FG000|Overall Study|Withdrawal of Consent|0
2306360|NCT02685033|4008293|FG001|Overall Study|Withdrawal of Consent|1
2306361|NCT02685033|4008292|FG000|Overall Study|Lost to Follow-up|2
2306362|NCT02685033|4008293|FG001|Overall Study|Lost to Follow-up|1
2306363|NCT02685033|4008292|FG000|Overall Study|Adverse Event|1
2306364|NCT02685033|4008293|FG001|Overall Study|Adverse Event|0
2306365|NCT02685072|4008301|FG000|Treatment Period|Lost to Follow-up|12
2306366|NCT02685072|4008302|FG001|Treatment Period|Lost to Follow-up|6
2306367|NCT02685072|4008301|FG000|Treatment Period|Withdrawal by Subject|1
2306368|NCT02685072|4008302|FG001|Treatment Period|Withdrawal by Subject|3
2306369|NCT02685072|4008301|FG000|1-Month Follow-Up|Withdrawal by Subject|1
2306370|NCT02685072|4008302|FG001|1-Month Follow-Up|Withdrawal by Subject|0
2306371|NCT02685488|4008331|FG000|Overall Study|Withdrawal by Subject|0
2090184|NCT00761150|3677574|FG002|Double-blind Period|Adverse Event|3
2306372|NCT02685488|4008332|FG001|Overall Study|Withdrawal by Subject|1
2306373|NCT02685826|4008350|FG000|Overall Study|Adverse Event|2
2306374|NCT02685826|4008351|FG001|Overall Study|Adverse Event|0
2306375|NCT02685826|4008352|FG002|Overall Study|Adverse Event|1
2306376|NCT02685826|4008350|FG000|Overall Study|Progressive Disease|2
2306377|NCT02685826|4008351|FG001|Overall Study|Progressive Disease|1
2306378|NCT02685826|4008352|FG002|Overall Study|Progressive Disease|0
2306379|NCT02685826|4008350|FG000|Overall Study|Withdrawal by Subject|2
2306380|NCT02685826|4008351|FG001|Overall Study|Withdrawal by Subject|0
2306381|NCT02685826|4008352|FG002|Overall Study|Withdrawal by Subject|0
2090185|NCT00761150|3677572|FG000|Double-blind Period|Withdrawal by Subject|0
2090186|NCT00761150|3677573|FG001|Double-blind Period|Withdrawal by Subject|3
2090187|NCT00761150|3677574|FG002|Double-blind Period|Withdrawal by Subject|2
2090188|NCT00761150|3677572|FG000|Double-blind Period|Lost to Follow-up|0
2090189|NCT00761150|3677573|FG001|Double-blind Period|Lost to Follow-up|2
2090190|NCT00761150|3677574|FG002|Double-blind Period|Lost to Follow-up|1
2090191|NCT00761150|3677572|FG000|Double-blind Period|Did not meet DB randomization criteria|0
2090192|NCT00761150|3677573|FG001|Double-blind Period|Did not meet DB randomization criteria|0
2090193|NCT00761150|3677574|FG002|Double-blind Period|Did not meet DB randomization criteria|1
2090194|NCT00761150|3677572|FG000|Double-blind Period|Noncompliance|0
2090195|NCT00761150|3677573|FG001|Double-blind Period|Noncompliance|1
2090196|NCT00761150|3677574|FG002|Double-blind Period|Noncompliance|0
2090197|NCT00761150|3677572|FG000|Double-blind Period|Other|0
2090198|NCT00761150|3677573|FG001|Double-blind Period|Other|3
2090199|NCT00761150|3677574|FG002|Double-blind Period|Other|3
2090200|NCT00761189|3677581|FG000|Overall Study|Adverse Event|42
2090201|NCT00761189|3677581|FG000|Overall Study|Lack of Efficacy|45
2090202|NCT00761189|3677581|FG000|Overall Study|Lost to Follow-up|36
2090203|NCT00761189|3677581|FG000|Overall Study|Withdrawal by Subject|49
2090204|NCT00761189|3677581|FG000|Overall Study|Other|13
2090205|NCT00761215|3677597|FG000|Overall Study|Randomized but didn't receive drug|1
2090206|NCT00761215|3677598|FG001|Overall Study|Randomized but didn't receive drug|1
2090207|NCT00761215|3677599|FG002|Overall Study|Randomized but didn't receive drug|2
2090208|NCT00761215|3677597|FG000|Overall Study|Lost to Follow-up|6
2090209|NCT00761215|3677598|FG001|Overall Study|Lost to Follow-up|3
2090210|NCT00761215|3677599|FG002|Overall Study|Lost to Follow-up|6
2090211|NCT00761215|3677597|FG000|Overall Study|Withdrawal by Subject|1
2090212|NCT00761215|3677598|FG001|Overall Study|Withdrawal by Subject|0
2090213|NCT00761215|3677599|FG002|Overall Study|Withdrawal by Subject|0
2090214|NCT00761215|3677597|FG000|Overall Study|Bacteremia|1
2090215|NCT00761215|3677598|FG001|Overall Study|Bacteremia|0
2090216|NCT00761215|3677599|FG002|Overall Study|Bacteremia|0
2090217|NCT00761267|3677613|FG000|Overall Study|Death|1
2090218|NCT00761267|3677614|FG001|Overall Study|Death|2
2090219|NCT00761267|3677615|FG002|Overall Study|Death|5
2090220|NCT00761267|3677613|FG000|Overall Study|Lost to Follow-up|0
2090221|NCT00761267|3677614|FG001|Overall Study|Lost to Follow-up|0
2090222|NCT00761267|3677615|FG002|Overall Study|Lost to Follow-up|1
2090223|NCT00761267|3677613|FG000|Overall Study|Randomized but not treated|1
2090224|NCT00761267|3677614|FG001|Overall Study|Randomized but not treated|1
2090225|NCT00761267|3677615|FG002|Overall Study|Randomized but not treated|0
2090226|NCT00761267|3677613|FG000|Overall Study|Withdrawal by Subject|0
2090227|NCT00761267|3677614|FG001|Overall Study|Withdrawal by Subject|1
2090228|NCT00761267|3677615|FG002|Overall Study|Withdrawal by Subject|0
2090229|NCT00761280|3677636|FG000|Randomization to First Dose|Withdrawal by Subject|0
2090230|NCT00761280|3677637|FG001|Randomization to First Dose|Withdrawal by Subject|2
2090231|NCT00761280|3677636|FG000|Randomization to First Dose|Sponsor decision|1
2090232|NCT00761280|3677637|FG001|Randomization to First Dose|Sponsor decision|0
2090233|NCT00761280|3677636|FG000|Randomization to First Dose|Other|1
2090234|NCT00761280|3677637|FG001|Randomization to First Dose|Other|0
2090235|NCT00761280|3677636|FG000|First Dose to End of Study|End of trial|5
2090236|NCT00761280|3677637|FG001|First Dose to End of Study|End of trial|5
2090237|NCT00761280|3677636|FG000|First Dose to End of Study|Progressive disease|5
2090238|NCT00761280|3677637|FG001|First Dose to End of Study|Progressive disease|3
2090239|NCT00761280|3677636|FG000|First Dose to End of Study|Sponsor decision|1
2090240|NCT00761280|3677637|FG001|First Dose to End of Study|Sponsor decision|2
2090241|NCT00761280|3677636|FG000|First Dose to End of Study|Death|1
2090242|NCT00761280|3677637|FG001|First Dose to End of Study|Death|0
2090243|NCT00761280|3677636|FG000|First Dose to End of Study|Lost to Follow-up|0
2090244|NCT00761280|3677637|FG001|First Dose to End of Study|Lost to Follow-up|1
2090245|NCT00761306|3677643|FG000|Overall Study|Adverse Event|5
2090246|NCT00761306|3677643|FG000|Overall Study|Lack of Efficacy|4
2090247|NCT00761306|3677643|FG000|Overall Study|Protocol Violation|2
2090248|NCT00761306|3677643|FG000|Overall Study|Withdrawal of Consent|3
2090249|NCT00761306|3677643|FG000|Overall Study|Lost to Follow-up|1
2090250|NCT00761306|3677643|FG000|Overall Study|Administrative or Other Reasons|5
2090251|NCT00761319|3677649|FG000|Overall Study|Protocol Violation|21
2090252|NCT00761319|3677650|FG001|Overall Study|Protocol Violation|14
2090253|NCT00761319|3677649|FG000|Overall Study|Adverse Event|11
2090254|NCT00761319|3677650|FG001|Overall Study|Adverse Event|7
2090255|NCT00761319|3677649|FG000|Overall Study|Withdrawal by Subject|8
2090256|NCT00761319|3677650|FG001|Overall Study|Withdrawal by Subject|7
2090257|NCT00761319|3677649|FG000|Overall Study|Noncompliance|4
2090258|NCT00761319|3677650|FG001|Overall Study|Noncompliance|3
2090259|NCT00761319|3677649|FG000|Overall Study|Lost to Follow-up|1
2090260|NCT00761319|3677650|FG001|Overall Study|Lost to Follow-up|1
2090261|NCT00761319|3677649|FG000|Overall Study|Nonspecified|2
2090262|NCT00761319|3677650|FG001|Overall Study|Nonspecified|2
2090263|NCT00761319|3677649|FG000|Overall Study|Missing|1
2090264|NCT00761319|3677650|FG001|Overall Study|Missing|0
2090265|NCT00761462|3677662|FG000|Treatment|Subjects never received study medication|23
2090266|NCT00761462|3677663|FG001|Treatment|Subjects never received study medication|12
2090267|NCT00761462|3677662|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4
2090268|NCT00761462|3677663|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0
2090269|NCT00761462|3677662|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
2090270|NCT00761462|3677663|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
2090271|NCT00761462|3677662|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
2090272|NCT00761462|3677663|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
2090273|NCT00761514|3677669|FG000|Overall Study|Adverse Event|1
2090274|NCT00761514|3677669|FG000|Overall Study|Withdrawal by Subject|2
2090275|NCT00761514|3677669|FG000|Overall Study|Lost to Follow-up|1
2090276|NCT00761514|3677669|FG000|Overall Study|Health insurance didn't cover study drug|1
2090277|NCT00761514|3677669|FG000|Overall Study|Problem complying with study visit|1
2090278|NCT00761514|3677669|FG000|Overall Study|Unable to pay for medications|1
2090279|NCT00761579|3677673|FG000|Overall Study|Adverse Event|10
2090280|NCT00761579|3677673|FG000|Overall Study|Death|2
2090281|NCT00761579|3677673|FG000|Overall Study|Lack of Efficacy|21
2306382|NCT02685826|4008350|FG000|Overall Study|Full Clinical Hold by FDA|19
2306383|NCT02685826|4008351|FG001|Overall Study|Full Clinical Hold by FDA|9
2306384|NCT02685826|4008352|FG002|Overall Study|Full Clinical Hold by FDA|20
2306385|NCT02685995|4008373|FG000|Overall Study|Insertion of immediately puncturable graft.|1
2306386|NCT02685995|4008374|FG001|Overall Study|Insertion of immediately puncturable graft.|1
2306387|NCT02686034|4008382|FG000|Run-In Period 1|Eligibility|12
2306388|NCT02686034|4008383|FG001|Run-In Period 1|Eligibility|10
2306389|NCT02686034|4008382|FG000|Run-In Period 1|Withdrawal by Subject|4
2306390|NCT02686034|4008383|FG001|Run-In Period 1|Withdrawal by Subject|3
2306391|NCT02686034|4008382|FG000|Run-In Period 1|Lost to Follow-up|4
2306392|NCT02686034|4008383|FG001|Run-In Period 1|Lost to Follow-up|4
2306393|NCT02686034|4008382|FG000|Randomized Controlled Period 2|Lost to Follow-up|1
2306394|NCT02686034|4008383|FG001|Randomized Controlled Period 2|Lost to Follow-up|2
2306395|NCT02686034|4008382|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3
2306396|NCT02686034|4008383|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0
2306397|NCT02686034|4008382|FG000|Randomized Controlled Period 2|Adverse Event|0
2306398|NCT02686034|4008383|FG001|Randomized Controlled Period 2|Adverse Event|2
2306399|NCT02686034|4008382|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
2306400|NCT02686034|4008383|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
2306401|NCT02686034|4008382|FG000|Open Label Period 3|Lost to Follow-up|0
2306402|NCT02686034|4008383|FG001|Open Label Period 3|Lost to Follow-up|1
2306403|NCT02686164|4008398|FG000|Overall Study|Adverse Event|1
2306404|NCT02686164|4008398|FG000|Overall Study|Withdrawal of consent|1
2306405|NCT02686164|4008398|FG000|Overall Study|Clinical progression|1
2306406|NCT02687035|4008414|FG000|Overall Study|Withdrawal by Subject|1
2306407|NCT02687035|4008414|FG000|Overall Study|Death|87
2306408|NCT02687035|4008414|FG000|Overall Study|Lost to Follow-up|1
2306409|NCT02687035|4008414|FG000|Overall Study|Missed Visit|87
2306410|NCT02687035|4008414|FG000|Overall Study|Did not receive Study Device|8
2306411|NCT02687191|4008435|FG000|Overall Study|Death|0
2306412|NCT02687191|4008436|FG001|Overall Study|Death|1
2306413|NCT02687191|4008437|FG002|Overall Study|Death|1
2306414|NCT02687191|4008438|FG003|Overall Study|Death|0
2306415|NCT02687191|4008439|FG004|Overall Study|Death|1
2306416|NCT02687191|4008440|FG005|Overall Study|Death|1
2306417|NCT02687191|4008435|FG000|Overall Study|Withdrawal by Subject|0
2306418|NCT02687191|4008436|FG001|Overall Study|Withdrawal by Subject|0
2306419|NCT02687191|4008437|FG002|Overall Study|Withdrawal by Subject|0
2306420|NCT02687191|4008438|FG003|Overall Study|Withdrawal by Subject|1
2306421|NCT02687191|4008439|FG004|Overall Study|Withdrawal by Subject|0
2306422|NCT02687191|4008440|FG005|Overall Study|Withdrawal by Subject|0
2306423|NCT02687451|4008478|FG000|Overall Study|Withdrawal by Subject|1
2306424|NCT02687451|4008479|FG001|Overall Study|Withdrawal by Subject|0
2306425|NCT02687451|4008480|FG002|Overall Study|Withdrawal by Subject|0
2306426|NCT02687451|4008481|FG003|Overall Study|Withdrawal by Subject|0
2306427|NCT02687451|4008482|FG004|Overall Study|Withdrawal by Subject|0
2306428|NCT02687451|4008483|FG005|Overall Study|Withdrawal by Subject|1
2306429|NCT02687542|4008513|FG000|Overall Study|Medication error without associated AEs|0
2306430|NCT02687542|4008514|FG001|Overall Study|Medication error without associated AEs|0
2306431|NCT02687542|4008515|FG002|Overall Study|Medication error without associated AEs|0
2306432|NCT02687542|4008516|FG003|Overall Study|Medication error without associated AEs|0
2306433|NCT02687542|4008517|FG004|Overall Study|Medication error without associated AEs|1
2306434|NCT02687542|4008513|FG000|Overall Study|Lost to Follow-up|0
2306435|NCT02687542|4008514|FG001|Overall Study|Lost to Follow-up|0
2306436|NCT02687542|4008515|FG002|Overall Study|Lost to Follow-up|0
2306437|NCT02687542|4008516|FG003|Overall Study|Lost to Follow-up|0
2306438|NCT02687542|4008517|FG004|Overall Study|Lost to Follow-up|1
2306439|NCT02687542|4008513|FG000|Overall Study|Protocol Violation|0
2306440|NCT02687542|4008514|FG001|Overall Study|Protocol Violation|1
2306441|NCT02687542|4008515|FG002|Overall Study|Protocol Violation|0
2306442|NCT02687542|4008516|FG003|Overall Study|Protocol Violation|0
2306443|NCT02687542|4008517|FG004|Overall Study|Protocol Violation|0
2306444|NCT02687542|4008513|FG000|Overall Study|Other|5
2306445|NCT02687542|4008514|FG001|Overall Study|Other|9
2306446|NCT02687542|4008515|FG002|Overall Study|Other|10
2306447|NCT02687542|4008516|FG003|Overall Study|Other|6
2306448|NCT02687542|4008517|FG004|Overall Study|Other|5
2090282|NCT00761579|3677673|FG000|Overall Study|Lost to Follow-up|16
2090283|NCT00761579|3677673|FG000|Overall Study|Pregnancy|1
2090284|NCT00761579|3677673|FG000|Overall Study|Withdrawal by Subject|34
2090285|NCT00761579|3677673|FG000|Overall Study|Lack of compliance|2
2090286|NCT00761579|3677673|FG000|Overall Study|Protocol deviation|1
2090287|NCT00761579|3677673|FG000|Overall Study|Drug overdose|1
2090288|NCT00761579|3677673|FG000|Overall Study|Aggravation of depression|1
2090289|NCT00761579|3677673|FG000|Overall Study|Aggravation of symptoms by changing drug|1
2090290|NCT00761579|3677673|FG000|Overall Study|Lost survey form|1
2090291|NCT00761579|3677673|FG000|Overall Study|Intake of prohibited concomitant drug|1
2090292|NCT00761605|3677688|FG000|Overall Study|Adverse Event|26
2090293|NCT00761605|3677688|FG000|Overall Study|Death|2
2090294|NCT00761605|3677688|FG000|Overall Study|Lack of Efficacy|26
2090295|NCT00761605|3677688|FG000|Overall Study|Lost to Follow-up|29
2090296|NCT00761605|3677688|FG000|Overall Study|Withdrawal by Subject|37
2090297|NCT00761605|3677688|FG000|Overall Study|Other|21
2090298|NCT00761631|3677700|FG000|Overall Study|Parent/legal guardian request|8
2090299|NCT00761631|3677701|FG001|Overall Study|Parent/legal guardian request|3
2090300|NCT00761631|3677702|FG002|Overall Study|Parent/legal guardian request|8
2090301|NCT00761631|3677703|FG003|Overall Study|Parent/legal guardian request|0
2090302|NCT00761631|3677704|FG004|Overall Study|Parent/legal guardian request|5
2090303|NCT00761631|3677705|FG005|Overall Study|Parent/legal guardian request|0
2090304|NCT00761631|3677700|FG000|Overall Study|Lost to Follow-up|2
2090305|NCT00761631|3677701|FG001|Overall Study|Lost to Follow-up|4
2090306|NCT00761631|3677702|FG002|Overall Study|Lost to Follow-up|7
2090307|NCT00761631|3677703|FG003|Overall Study|Lost to Follow-up|1
2090308|NCT00761631|3677704|FG004|Overall Study|Lost to Follow-up|6
2090309|NCT00761631|3677705|FG005|Overall Study|Lost to Follow-up|1
2090310|NCT00761631|3677700|FG000|Overall Study|Protocol Violation|2
2090311|NCT00761631|3677701|FG001|Overall Study|Protocol Violation|0
2090312|NCT00761631|3677702|FG002|Overall Study|Protocol Violation|0
2090313|NCT00761631|3677703|FG003|Overall Study|Protocol Violation|1
2090314|NCT00761631|3677704|FG004|Overall Study|Protocol Violation|5
2090315|NCT00761631|3677705|FG005|Overall Study|Protocol Violation|1
2090316|NCT00761631|3677700|FG000|Overall Study|Randomized, not treated|1
2090317|NCT00761631|3677701|FG001|Overall Study|Randomized, not treated|0
2090318|NCT00761631|3677702|FG002|Overall Study|Randomized, not treated|0
2090319|NCT00761631|3677703|FG003|Overall Study|Randomized, not treated|0
2306449|NCT02687542|4008513|FG000|Overall Study|Adverse Event|3
2306450|NCT02687542|4008514|FG001|Overall Study|Adverse Event|1
2306451|NCT02687542|4008515|FG002|Overall Study|Adverse Event|3
2306452|NCT02687542|4008516|FG003|Overall Study|Adverse Event|2
2306453|NCT02687542|4008517|FG004|Overall Study|Adverse Event|9
2306454|NCT02687542|4008513|FG000|Overall Study|Withdrawal by Subject|0
2306455|NCT02687542|4008514|FG001|Overall Study|Withdrawal by Subject|1
2306456|NCT02687542|4008515|FG002|Overall Study|Withdrawal by Subject|1
2306457|NCT02687542|4008516|FG003|Overall Study|Withdrawal by Subject|2
2306458|NCT02687542|4008517|FG004|Overall Study|Withdrawal by Subject|4
2306459|NCT02687711|4008529|FG000|Overall Study|Adverse Event|89
2306460|NCT02687711|4008529|FG000|Overall Study|Lack of Efficacy|70
2306461|NCT02687711|4008529|FG000|Overall Study|Lost to Follow-up|20
2306462|NCT02687711|4008529|FG000|Overall Study|Consent withdrawn|15
2306463|NCT02687711|4008529|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1
2306464|NCT02687711|4008529|FG000|Overall Study|Too expensive|4
2306465|NCT02687711|4008529|FG000|Overall Study|Participant moved abroad|1
2306466|NCT02687711|4008529|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1
2306467|NCT02687711|4008529|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1
2306468|NCT02687711|4008529|FG000|Overall Study|Disliked taste|1
2306469|NCT02687711|4008529|FG000|Overall Study|Low mood|1
2306470|NCT02687711|4008529|FG000|Overall Study|Side effects|1
2306471|NCT02687711|4008529|FG000|Overall Study|Change of Hospital|1
2306472|NCT02687711|4008529|FG000|Overall Study|Liver Encephalopathy|1
2306473|NCT02687711|4008529|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1
2306474|NCT02687711|4008529|FG000|Overall Study|Withdrawn due to intake interruption|1
2306475|NCT02687711|4008529|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1
2306476|NCT02687711|4008529|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1
2306477|NCT02687711|4008529|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1
2306478|NCT02687815|4008535|FG000|Overall Study|Lost to Follow-up|2
2306479|NCT02687815|4008536|FG001|Overall Study|Lost to Follow-up|4
2306480|NCT02687815|4008535|FG000|Overall Study|Withdrawal by Subject|2
2306481|NCT02687815|4008536|FG001|Overall Study|Withdrawal by Subject|4
2306482|NCT02687919|4008544|FG000|Overall Study|Withdrawal by Subject|6
2090320|NCT00761631|3677704|FG004|Overall Study|Randomized, not treated|0
2090321|NCT00761631|3677705|FG005|Overall Study|Randomized, not treated|0
2090322|NCT00761631|3677700|FG000|Overall Study|Failed to return|1
2090323|NCT00761631|3677701|FG001|Overall Study|Failed to return|0
2090324|NCT00761631|3677702|FG002|Overall Study|Failed to return|1
2090325|NCT00761631|3677703|FG003|Overall Study|Failed to return|1
2090326|NCT00761631|3677704|FG004|Overall Study|Failed to return|5
2090327|NCT00761631|3677705|FG005|Overall Study|Failed to return|2
2090328|NCT00761631|3677700|FG000|Overall Study|Physician Decision|1
2090329|NCT00761631|3677701|FG001|Overall Study|Physician Decision|0
2090330|NCT00761631|3677702|FG002|Overall Study|Physician Decision|0
2090331|NCT00761631|3677703|FG003|Overall Study|Physician Decision|0
2090332|NCT00761631|3677704|FG004|Overall Study|Physician Decision|0
2090333|NCT00761631|3677705|FG005|Overall Study|Physician Decision|0
2090334|NCT00761631|3677700|FG000|Overall Study|Other|0
2090335|NCT00761631|3677701|FG001|Overall Study|Other|0
2090336|NCT00761631|3677702|FG002|Overall Study|Other|0
2090337|NCT00761631|3677703|FG003|Overall Study|Other|0
2090338|NCT00761631|3677704|FG004|Overall Study|Other|1
2090339|NCT00761631|3677705|FG005|Overall Study|Other|1
2090340|NCT00761657|3677737|FG000|Part 1 (up to Day 57)|Adverse Event|0
2090341|NCT00761657|3677738|FG001|Part 1 (up to Day 57)|Adverse Event|0
2090342|NCT00761657|3677739|FG002|Part 1 (up to Day 57)|Adverse Event|0
2090343|NCT00761657|3677740|FG003|Part 1 (up to Day 57)|Adverse Event|1
2090344|NCT00761657|3677741|FG004|Part 1 (up to Day 57)|Adverse Event|0
2090345|NCT00761657|3677742|FG005|Part 1 (up to Day 57)|Adverse Event|0
2090346|NCT00761657|3677743|FG006|Part 1 (up to Day 57)|Adverse Event|0
2090347|NCT00761657|3677744|FG007|Part 1 (up to Day 57)|Adverse Event|0
2090348|NCT00761657|3677745|FG008|Part 1 (up to Day 57)|Adverse Event|0
2090349|NCT00761657|3677737|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0
2090350|NCT00761657|3677738|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0
2090351|NCT00761657|3677739|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1
2090352|NCT00761657|3677740|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1
2090353|NCT00761657|3677741|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0
2090354|NCT00761657|3677742|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0
2090355|NCT00761657|3677743|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0
2090356|NCT00761657|3677744|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0
2090357|NCT00761657|3677745|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0
2090358|NCT00761657|3677737|FG000|Part 1 (up to Day 57)|Sponsor Decision|0
2090359|NCT00761657|3677738|FG001|Part 1 (up to Day 57)|Sponsor Decision|0
2090360|NCT00761657|3677739|FG002|Part 1 (up to Day 57)|Sponsor Decision|3
2090361|NCT00761657|3677740|FG003|Part 1 (up to Day 57)|Sponsor Decision|4
2090362|NCT00761657|3677741|FG004|Part 1 (up to Day 57)|Sponsor Decision|0
2090363|NCT00761657|3677742|FG005|Part 1 (up to Day 57)|Sponsor Decision|0
2090364|NCT00761657|3677743|FG006|Part 1 (up to Day 57)|Sponsor Decision|1
2090365|NCT00761657|3677744|FG007|Part 1 (up to Day 57)|Sponsor Decision|1
2090366|NCT00761657|3677745|FG008|Part 1 (up to Day 57)|Sponsor Decision|1
2090367|NCT00761657|3677737|FG000|Part 2 (up to Day 114)|Adverse Event|0
2090368|NCT00761657|3677738|FG001|Part 2 (up to Day 114)|Adverse Event|0
2090369|NCT00761657|3677739|FG002|Part 2 (up to Day 114)|Adverse Event|0
2090370|NCT00761657|3677740|FG003|Part 2 (up to Day 114)|Adverse Event|0
2090371|NCT00761657|3677741|FG004|Part 2 (up to Day 114)|Adverse Event|0
2090372|NCT00761657|3677742|FG005|Part 2 (up to Day 114)|Adverse Event|0
2090373|NCT00761657|3677743|FG006|Part 2 (up to Day 114)|Adverse Event|0
2090374|NCT00761657|3677744|FG007|Part 2 (up to Day 114)|Adverse Event|0
2090375|NCT00761657|3677745|FG008|Part 2 (up to Day 114)|Adverse Event|1
2090376|NCT00761735|3677775|FG000|Overall Study|Lost to Follow-up|6
2090377|NCT00761735|3677775|FG000|Overall Study|Withdrawal by Subject|6
2090378|NCT00761735|3677775|FG000|Overall Study|Non-compliance with protocol|1
2090379|NCT00761735|3677775|FG000|Overall Study|Administrative|1
2090380|NCT00761748|3677783|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3
2090381|NCT00761748|3677784|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0
2090382|NCT00761748|3677783|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
2090383|NCT00761748|3677784|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
2090384|NCT00761761|3677792|FG000|Overall Study|Lost to Follow-up|3
2090385|NCT00761761|3677793|FG001|Overall Study|Lost to Follow-up|1
2090386|NCT00761761|3677792|FG000|Overall Study|Withdrawal by Subject|3
2090387|NCT00761761|3677793|FG001|Overall Study|Withdrawal by Subject|0
2090388|NCT00761774|3677801|FG000|Overall Study|Adverse Event|17
2090389|NCT00761774|3677801|FG000|Overall Study|Lack of Efficacy|37
2090390|NCT00761774|3677801|FG000|Overall Study|Lost to Follow-up|2
2090391|NCT00761774|3677801|FG000|Overall Study|Withdrawal by Subject|9
2090392|NCT00761774|3677801|FG000|Overall Study|Non-compliance|4
2090393|NCT00761774|3677801|FG000|Overall Study|End of study|2
2090394|NCT00761774|3677801|FG000|Overall Study|Reclassification of seizures|1
2090395|NCT00761774|3677801|FG000|Overall Study|Medical decision to read SUSAR reports|1
2090396|NCT00761774|3677801|FG000|Overall Study|Sponsor decision|1
2090397|NCT00761774|3677801|FG000|Overall Study|Investigator clinical judgement|1
2090398|NCT00761774|3677801|FG000|Overall Study|Patient moved out of study area|1
2090399|NCT00761774|3677801|FG000|Overall Study|Coordinator leaving site|1
2090400|NCT00761774|3677801|FG000|Overall Study|Subject IP non-compliance|1
2090401|NCT00761774|3677801|FG000|Overall Study|IP stopped by hospital physician|1
2090402|NCT00761865|3677818|FG000|Overall Study|Lost to Follow-up|8
2090403|NCT00761865|3677819|FG001|Overall Study|Lost to Follow-up|7
2090404|NCT00761891|3677825|FG000|Overall Study|Withdrawal by Subject|10
2090405|NCT00761956|3677845|FG000|Overall Study|Lost to Follow-up|6
2090406|NCT00761956|3677846|FG001|Overall Study|Lost to Follow-up|11
2090407|NCT00761956|3677845|FG000|Overall Study|Withdrawal by Subject|3
2090408|NCT00761956|3677846|FG001|Overall Study|Withdrawal by Subject|8
2090409|NCT00761956|3677845|FG000|Overall Study|Death|0
2090410|NCT00761956|3677846|FG001|Overall Study|Death|1
2090411|NCT00761956|3677845|FG000|Overall Study|Adverse Event|26
2211737|NCT01662986|3852219|FG000|Overall Study|Lost to Follow-up|5
2211738|NCT01662986|3852220|FG001|Overall Study|Lost to Follow-up|4
2211739|NCT01662986|3852219|FG000|Overall Study|Withdrawal by Subject|2
2211740|NCT01662986|3852220|FG001|Overall Study|Withdrawal by Subject|2
2090412|NCT00761956|3677846|FG001|Overall Study|Adverse Event|34
2090413|NCT00761969|3677854|FG000|Overall Study|Death|112
2090414|NCT00761969|3677855|FG001|Overall Study|Death|47
2090415|NCT00761969|3677854|FG000|Overall Study|Lost to Follow-up|88
2090416|NCT00761969|3677855|FG001|Overall Study|Lost to Follow-up|93
2090417|NCT00762034|3677872|FG000|Induction Period|Protocol Violation|1
2090418|NCT00762034|3677873|FG001|Induction Period|Protocol Violation|2
2090419|NCT00762034|3677872|FG000|Induction Period|Entry Criterion Not Met|12
2090420|NCT00762034|3677873|FG001|Induction Period|Entry Criterion Not Met|11
2090421|NCT00762034|3677872|FG000|Induction Period|Adverse Event|27
2090422|NCT00762034|3677873|FG001|Induction Period|Adverse Event|38
2090423|NCT00762034|3677872|FG000|Induction Period|Lost to Follow-up|1
2090424|NCT00762034|3677873|FG001|Induction Period|Lost to Follow-up|1
2090425|NCT00762034|3677872|FG000|Induction Period|Progressive Disease|73
2090426|NCT00762034|3677873|FG001|Induction Period|Progressive Disease|55
2090427|NCT00762034|3677872|FG000|Induction Period|Physician Decision|21
2090428|NCT00762034|3677873|FG001|Induction Period|Physician Decision|20
2090429|NCT00762034|3677872|FG000|Induction Period|Withdrawal by Subject|15
2090430|NCT00762034|3677873|FG001|Induction Period|Withdrawal by Subject|19
2090431|NCT00762034|3677872|FG000|Induction Period|Deaths Not Due to Study Disease|19
2090432|NCT00762034|3677873|FG001|Induction Period|Deaths Not Due to Study Disease|14
2090433|NCT00762034|3677872|FG000|Induction Period|Deaths Due to Study Disease|9
2090434|NCT00762034|3677873|FG001|Induction Period|Deaths Due to Study Disease|9
2090435|NCT00762034|3677872|FG000|Maintenance Period|Protocol Violation|1
2090436|NCT00762034|3677873|FG001|Maintenance Period|Protocol Violation|3
2090437|NCT00762034|3677872|FG000|Maintenance Period|Entry Criterion Not Met|0
2090438|NCT00762034|3677873|FG001|Maintenance Period|Entry Criterion Not Met|2
2090439|NCT00762034|3677872|FG000|Maintenance Period|Adverse Event|42
2090440|NCT00762034|3677873|FG001|Maintenance Period|Adverse Event|26
2090441|NCT00762034|3677872|FG000|Maintenance Period|Progressive Disease|186
2090442|NCT00762034|3677873|FG001|Maintenance Period|Progressive Disease|224
2090443|NCT00762034|3677872|FG000|Maintenance Period|Physician Decision|25
2090444|NCT00762034|3677873|FG001|Maintenance Period|Physician Decision|20
2306483|NCT02687919|4008545|FG001|Overall Study|Withdrawal by Subject|6
2306484|NCT02687919|4008544|FG000|Overall Study|Protocol Violation|2
2306485|NCT02687919|4008545|FG001|Overall Study|Protocol Violation|0
2306486|NCT02688153|4008553|FG000|Overall Study|Death|7
2306487|NCT02688153|4008554|FG001|Overall Study|Death|5
2306488|NCT02688153|4008553|FG000|Overall Study|Withdrawal by Subject|4
2306489|NCT02688153|4008554|FG001|Overall Study|Withdrawal by Subject|2
2306490|NCT02688153|4008553|FG000|Overall Study|Valve Explant|1
2306491|NCT02688153|4008554|FG001|Overall Study|Valve Explant|0
2306492|NCT02688153|4008553|FG000|Overall Study|Conversion to Commercial Valve|3
2306493|NCT02688153|4008554|FG001|Overall Study|Conversion to Commercial Valve|0
2306494|NCT02688192|4008563|FG000|Overall Study|Lost to Follow-up|11
2306495|NCT02688192|4008564|FG001|Overall Study|Lost to Follow-up|5
2306496|NCT02688192|4008563|FG000|Overall Study|Physician Decision|1
2306497|NCT02688192|4008564|FG001|Overall Study|Physician Decision|0
2306498|NCT02688387|4008584|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306499|NCT02688387|4008585|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306500|NCT02688387|4008586|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
2306501|NCT02688387|4008587|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306502|NCT02688387|4008588|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306503|NCT02688387|4008589|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306504|NCT02688387|4008590|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306505|NCT02688387|4008591|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306506|NCT02688387|4008592|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306507|NCT02688387|4008593|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306508|NCT02688387|4008594|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306509|NCT02688387|4008595|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306510|NCT02688387|4008596|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306511|NCT02688387|4008597|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306512|NCT02688387|4008598|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306513|NCT02688387|4008599|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306514|NCT02688387|4008600|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306515|NCT02688387|4008601|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306516|NCT02688387|4008602|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306517|NCT02688387|4008603|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306518|NCT02688387|4008604|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306519|NCT02688387|4008605|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2306520|NCT02688387|4008584|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306521|NCT02688387|4008585|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306522|NCT02688387|4008586|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2090445|NCT00762034|3677872|FG000|Maintenance Period|Withdrawal by Subject|34
2090446|NCT00762034|3677873|FG001|Maintenance Period|Withdrawal by Subject|14
2090447|NCT00762034|3677872|FG000|Maintenance Period|Death not due to study disease|2
2090448|NCT00762034|3677873|FG001|Maintenance Period|Death not due to study disease|5
2090449|NCT00762034|3677872|FG000|Maintenance Period|Death due to study disease|3
2090450|NCT00762034|3677873|FG001|Maintenance Period|Death due to study disease|3
2090451|NCT00762034|3677872|FG000|Maintenance Period|Other|1
2090452|NCT00762034|3677873|FG001|Maintenance Period|Other|1
2090453|NCT00762073|3677891|FG000|Overall Study|Lack of Efficacy|1
2090454|NCT00762073|3677892|FG001|Overall Study|Lack of Efficacy|1
2090455|NCT00762073|3677893|FG002|Overall Study|Lack of Efficacy|0
2090456|NCT00762073|3677894|FG003|Overall Study|Lack of Efficacy|0
2090457|NCT00762073|3677891|FG000|Overall Study|Adverse Event|1
2090458|NCT00762073|3677892|FG001|Overall Study|Adverse Event|0
2090459|NCT00762073|3677893|FG002|Overall Study|Adverse Event|1
2090460|NCT00762073|3677894|FG003|Overall Study|Adverse Event|1
2090461|NCT00762073|3677891|FG000|Overall Study|Significant Subject Noncompliance|0
2090462|NCT00762073|3677892|FG001|Overall Study|Significant Subject Noncompliance|1
2090463|NCT00762073|3677893|FG002|Overall Study|Significant Subject Noncompliance|0
2090464|NCT00762073|3677894|FG003|Overall Study|Significant Subject Noncompliance|1
2090465|NCT00762073|3677891|FG000|Overall Study|Withdrawal by Subject|1
2090466|NCT00762073|3677892|FG001|Overall Study|Withdrawal by Subject|2
2090467|NCT00762073|3677893|FG002|Overall Study|Withdrawal by Subject|1
2090468|NCT00762073|3677894|FG003|Overall Study|Withdrawal by Subject|1
2090469|NCT00762073|3677891|FG000|Overall Study|Not on treatment for >/= 77 days|1
2090470|NCT00762073|3677892|FG001|Overall Study|Not on treatment for >/= 77 days|0
2090471|NCT00762073|3677893|FG002|Overall Study|Not on treatment for >/= 77 days|0
2090472|NCT00762073|3677894|FG003|Overall Study|Not on treatment for >/= 77 days|0
2090473|NCT00762086|3677913|FG000|Overall Study|Adverse Event|2
2306523|NCT02688387|4008587|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
2306524|NCT02688387|4008588|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306525|NCT02688387|4008589|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306526|NCT02688387|4008590|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306527|NCT02688387|4008591|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306528|NCT02688387|4008592|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306529|NCT02688387|4008593|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306530|NCT02688387|4008594|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306531|NCT02688387|4008595|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306532|NCT02688387|4008596|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306533|NCT02688387|4008597|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306534|NCT02688387|4008598|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306535|NCT02688387|4008599|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306536|NCT02688387|4008600|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306537|NCT02688387|4008601|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306538|NCT02688387|4008602|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306539|NCT02688387|4008603|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306540|NCT02688387|4008604|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306541|NCT02688387|4008605|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306542|NCT02688387|4008584|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306543|NCT02688387|4008585|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
2306544|NCT02688387|4008586|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306545|NCT02688387|4008587|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306546|NCT02688387|4008588|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2090474|NCT00762086|3677914|FG001|Overall Study|Adverse Event|0
2090475|NCT00762086|3677913|FG000|Overall Study|Lost to Follow-up|0
2090476|NCT00762086|3677914|FG001|Overall Study|Lost to Follow-up|2
2090477|NCT00762086|3677913|FG000|Overall Study|Non compliance|1
2090478|NCT00762086|3677914|FG001|Overall Study|Non compliance|0
2090479|NCT00762086|3677913|FG000|Overall Study|Withdrawal by Subject|2
2306547|NCT02688387|4008589|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306548|NCT02688387|4008590|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306549|NCT02688387|4008591|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306550|NCT02688387|4008592|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306551|NCT02688387|4008593|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306552|NCT02688387|4008594|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306553|NCT02688387|4008595|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306554|NCT02688387|4008596|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306555|NCT02688387|4008597|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306556|NCT02688387|4008598|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306557|NCT02688387|4008599|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2321742|NCT02963506|4036381|FG010|Double-Blind Period|Withdrawal by Subject|0
2090480|NCT00762086|3677914|FG001|Overall Study|Withdrawal by Subject|2
2090481|NCT00762086|3677913|FG000|Overall Study|Ineligible to participate in the study|1
2090482|NCT00762086|3677914|FG001|Overall Study|Ineligible to participate in the study|0
2090483|NCT00762164|3677922|FG000|Overall Study|Lost to Follow-up|1
2090484|NCT00762164|3677923|FG001|Overall Study|Lost to Follow-up|1
2090485|NCT00762164|3677922|FG000|Overall Study|Discontinued medication|2
2090486|NCT00762164|3677923|FG001|Overall Study|Discontinued medication|0
2090487|NCT00762164|3677922|FG000|Overall Study|Withdrawal by Subject|0
2090488|NCT00762164|3677923|FG001|Overall Study|Withdrawal by Subject|1
2090489|NCT00762229|3677951|FG000|Overall Study|Lost to Follow-up|1
2090490|NCT00762229|3677952|FG001|Overall Study|Lost to Follow-up|1
2090491|NCT00762229|3677951|FG000|Overall Study|did not recveive intervention|0
2090492|NCT00762229|3677952|FG001|Overall Study|did not recveive intervention|1
2090493|NCT00762268|3677960|FG000|Overall Study|Withdrawal by Subject|3
2090494|NCT00762268|3677961|FG001|Overall Study|Withdrawal by Subject|3
2090495|NCT00762359|3678006|FG000|Overall Study|Adverse Event|20
2090496|NCT00762359|3678007|FG001|Overall Study|Adverse Event|23
2090497|NCT00762359|3678006|FG000|Overall Study|Protocol Violation|21
2090498|NCT00762359|3678007|FG001|Overall Study|Protocol Violation|13
2090499|NCT00762359|3678006|FG000|Overall Study|Withdrawal by Subject|13
2090500|NCT00762359|3678007|FG001|Overall Study|Withdrawal by Subject|10
2090501|NCT00762359|3678006|FG000|Overall Study|Lack of Efficacy|0
2090502|NCT00762359|3678007|FG001|Overall Study|Lack of Efficacy|4
2090503|NCT00762359|3678006|FG000|Overall Study|Institution closed|2
2090504|NCT00762359|3678007|FG001|Overall Study|Institution closed|3
2090505|NCT00762359|3678006|FG000|Overall Study|Physician Decision|2
2090506|NCT00762359|3678007|FG001|Overall Study|Physician Decision|3
2090507|NCT00762359|3678006|FG000|Overall Study|Removal|0
2090508|NCT00762359|3678007|FG001|Overall Study|Removal|1
2090509|NCT00762359|3678006|FG000|Overall Study|Withdrew consent|1
2090510|NCT00762359|3678007|FG001|Overall Study|Withdrew consent|0
2090511|NCT00762372|3678016|FG000|Overall Study|Adverse Event|1
2090512|NCT00762372|3678017|FG001|Overall Study|Adverse Event|0
2090513|NCT00762372|3678018|FG002|Overall Study|Adverse Event|0
2090514|NCT00762385|3678032|FG000|First Intervention|Lens Issue|1
2090515|NCT00762385|3678033|FG001|First Intervention|Lens Issue|1
2090516|NCT00762385|3678032|FG000|First Intervention|Lost to Follow-up|0
2090517|NCT00762385|3678033|FG001|First Intervention|Lost to Follow-up|2
2090518|NCT00762385|3678032|FG000|First Intervention|Ineligible|1
2090519|NCT00762385|3678033|FG001|First Intervention|Ineligible|0
2090520|NCT00762385|3678032|FG000|First Intervention|Protocol Violation|0
2090521|NCT00762385|3678033|FG001|First Intervention|Protocol Violation|1
2090522|NCT00762385|3678032|FG000|Second Intervention|Protocol Violation|3
2090523|NCT00762385|3678033|FG001|Second Intervention|Protocol Violation|3
2090524|NCT00762411|3678044|FG000|Initial Treatment|Death|7
2090525|NCT00762411|3678045|FG001|Initial Treatment|Death|6
2090526|NCT00762411|3678044|FG000|Initial Treatment|Adverse Event|132
2090527|NCT00762411|3678045|FG001|Initial Treatment|Adverse Event|40
2090528|NCT00762411|3678044|FG000|Initial Treatment|Protocol Violation|4
2090529|NCT00762411|3678045|FG001|Initial Treatment|Protocol Violation|1
2090530|NCT00762411|3678044|FG000|Initial Treatment|Withdrawal by Subject|65
2090531|NCT00762411|3678045|FG001|Initial Treatment|Withdrawal by Subject|52
2090532|NCT00762411|3678044|FG000|Initial Treatment|Physician Decision|1
2090533|NCT00762411|3678045|FG001|Initial Treatment|Physician Decision|0
2090534|NCT00762411|3678044|FG000|Initial Treatment|Sponsor Decision|293
2090535|NCT00762411|3678045|FG001|Initial Treatment|Sponsor Decision|401
2090536|NCT00762411|3678044|FG000|Initial Treatment|Lost to Follow-up|5
2090537|NCT00762411|3678045|FG001|Initial Treatment|Lost to Follow-up|0
2090538|NCT00762411|3678044|FG000|Initial Treatment|Caregiver Decision|21
2090539|NCT00762411|3678045|FG001|Initial Treatment|Caregiver Decision|16
2090540|NCT00762411|3678044|FG000|Initial Treatment|Abnormal Lab/ECG Result|6
2090541|NCT00762411|3678045|FG001|Initial Treatment|Abnormal Lab/ECG Result|4
2090542|NCT00762411|3678044|FG000|Initial Treatment|Entry Criteria Exclusion|0
2090543|NCT00762411|3678045|FG001|Initial Treatment|Entry Criteria Exclusion|1
2211741|NCT01662986|3852219|FG000|Overall Study|Not Treated|1
2211742|NCT01662986|3852220|FG001|Overall Study|Not Treated|0
2211743|NCT01662986|3852219|FG000|Overall Study|Other than stated above|3
2211744|NCT01662986|3852220|FG001|Overall Study|Other than stated above|0
2211745|NCT01662999|3852232|FG000|Period 3|Withdrawal by Subject|0
2211746|NCT01662999|3852233|FG001|Period 3|Withdrawal by Subject|1
2211747|NCT01662999|3852234|FG002|Period 3|Withdrawal by Subject|0
2211748|NCT01662999|3852235|FG003|Period 3|Withdrawal by Subject|0
2211749|NCT01662999|3852236|FG004|Period 3|Withdrawal by Subject|0
2211750|NCT01662999|3852237|FG005|Period 3|Withdrawal by Subject|0
2211751|NCT01663103|3852273|FG000|Overall Study|Withdrawal by Subject|1
2211752|NCT01663103|3852274|FG001|Overall Study|Withdrawal by Subject|2
2211753|NCT01663103|3852273|FG000|Overall Study|Adverse Event|1
2211754|NCT01663103|3852274|FG001|Overall Study|Adverse Event|0
2211755|NCT01663103|3852273|FG000|Overall Study|dog bite|1
2211756|NCT01663103|3852274|FG001|Overall Study|dog bite|0
2211757|NCT01663233|3852286|FG000|Overall Study|Withdrawal by Subject|3
2211758|NCT01663233|3852287|FG001|Overall Study|Withdrawal by Subject|2
2211759|NCT01663233|3852286|FG000|Overall Study|Protocol Deviation|1
2090544|NCT00762411|3678044|FG000|Delayed Start|Adverse Event|0
2090545|NCT00762411|3678045|FG001|Delayed Start|Adverse Event|4
2090546|NCT00762411|3678044|FG000|Delayed Start|Protocol Violation|0
2090547|NCT00762411|3678045|FG001|Delayed Start|Protocol Violation|1
2211760|NCT01663233|3852287|FG001|Overall Study|Protocol Deviation|4
2090548|NCT00762411|3678044|FG000|Delayed Start|Sponsor Decision|16
2090549|NCT00762411|3678045|FG001|Delayed Start|Sponsor Decision|20
2090550|NCT00762411|3678044|FG000|Delayed Start|Caregiver Decision|1
2090551|NCT00762411|3678045|FG001|Delayed Start|Caregiver Decision|1
2090552|NCT00762411|3678044|FG000|Safety Follow Up (SFU)-Optional|Death|1
2090553|NCT00762411|3678045|FG001|Safety Follow Up (SFU)-Optional|Death|8
2090554|NCT00762411|3678044|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0
2090555|NCT00762411|3678045|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1
2090556|NCT00762411|3678044|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
2090557|NCT00762411|3678045|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
2090558|NCT00762411|3678044|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
2090559|NCT00762411|3678045|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
2090560|NCT00762411|3678044|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
2090561|NCT00762411|3678045|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
2090562|NCT00762411|3678044|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
2090563|NCT00762411|3678045|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
2090564|NCT00762463|3678079|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
2090565|NCT00762463|3678080|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
2090566|NCT00762463|3678081|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
2090567|NCT00762463|3678082|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
2090568|NCT00762463|3678079|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
2090569|NCT00762463|3678080|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
2090570|NCT00762463|3678081|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
2090571|NCT00762463|3678082|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
2090572|NCT00762463|3678079|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
2090573|NCT00762463|3678080|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
2090574|NCT00762463|3678081|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
2090575|NCT00762463|3678082|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
2090576|NCT00762463|3678079|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
2090577|NCT00762463|3678080|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
2090578|NCT00762463|3678081|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
2090579|NCT00762463|3678082|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
2090580|NCT00762463|3678079|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
2090581|NCT00762463|3678080|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
2090582|NCT00762463|3678081|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
2090583|NCT00762463|3678082|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
2090584|NCT00762463|3678079|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
2090585|NCT00762463|3678080|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
2090586|NCT00762463|3678081|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
2090587|NCT00762463|3678082|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
2090588|NCT00762463|3678079|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
2090589|NCT00762463|3678080|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
2090590|NCT00762463|3678081|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
2090591|NCT00762463|3678082|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
2090592|NCT00762463|3678079|FG000|Extension Phase (Week 6 to Week 12)|Other|0
2090593|NCT00762463|3678080|FG001|Extension Phase (Week 6 to Week 12)|Other|0
2090594|NCT00762463|3678081|FG002|Extension Phase (Week 6 to Week 12)|Other|0
2090595|NCT00762463|3678082|FG003|Extension Phase (Week 6 to Week 12)|Other|1
2090596|NCT00762476|3678097|FG000|Overall Study|Adverse Event|7
2090597|NCT00762476|3678098|FG001|Overall Study|Adverse Event|1
2090598|NCT00762476|3678097|FG000|Overall Study|Lost to Follow-up|2
2090599|NCT00762476|3678098|FG001|Overall Study|Lost to Follow-up|0
2090600|NCT00762476|3678097|FG000|Overall Study|Protocol Violation|5
2090601|NCT00762476|3678098|FG001|Overall Study|Protocol Violation|6
2090602|NCT00762476|3678097|FG000|Overall Study|Physician Decision|2
2090603|NCT00762476|3678098|FG001|Overall Study|Physician Decision|14
2090604|NCT00762476|3678097|FG000|Overall Study|Withdrawal by Subject|6
2090605|NCT00762476|3678098|FG001|Overall Study|Withdrawal by Subject|12
2090606|NCT00762476|3678097|FG000|Overall Study|antibiotic use|0
2090607|NCT00762476|3678098|FG001|Overall Study|antibiotic use|1
2090608|NCT00762476|3678097|FG000|Overall Study|non-compliance with study visits|0
2090609|NCT00762476|3678098|FG001|Overall Study|non-compliance with study visits|2
2090610|NCT00762476|3678097|FG000|Overall Study|Seasonal allergies|1
2090611|NCT00762476|3678098|FG001|Overall Study|Seasonal allergies|0
2090612|NCT00762502|3678108|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4
2090613|NCT00762502|3678109|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3
2090614|NCT00762502|3678110|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6
2090615|NCT00762502|3678108|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
2090616|NCT00762502|3678109|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
2090617|NCT00762502|3678110|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
2090618|NCT00762502|3678108|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0
2090619|NCT00762502|3678109|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1
2090620|NCT00762502|3678110|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0
2090621|NCT00762606|3678136|FG000|Overall Study|Lost to Follow-up|18
2090622|NCT00762606|3678137|FG001|Overall Study|Lost to Follow-up|13
2090623|NCT00762762|3678174|FG000|Overall Study|Did not report for appointments|8
2090624|NCT00762762|3678175|FG001|Overall Study|Did not report for appointments|10
2090625|NCT00762788|3678187|FG000|Overall Study|Lost to Follow-up|26
2090626|NCT00762788|3678188|FG001|Overall Study|Lost to Follow-up|37
2090627|NCT00762788|3678189|FG002|Overall Study|Lost to Follow-up|21
2090628|NCT00762788|3678190|FG003|Overall Study|Lost to Follow-up|26
2090629|NCT00762788|3678191|FG004|Overall Study|Lost to Follow-up|13
2090630|NCT00762788|3678192|FG005|Overall Study|Lost to Follow-up|21
2090631|NCT00762892|3678217|FG000|Overall Study|Lost to Follow-up|2
2090632|NCT00762892|3678218|FG001|Overall Study|Lost to Follow-up|5
2090633|NCT00762892|3678217|FG000|Overall Study|Withdrawal by Subject|0
2090634|NCT00762892|3678218|FG001|Overall Study|Withdrawal by Subject|1
2090635|NCT00762892|3678217|FG000|Overall Study|Death|1
2090636|NCT00762892|3678218|FG001|Overall Study|Death|0
2090637|NCT00762892|3678217|FG000|Overall Study|Pregnancy|1
2090638|NCT00762892|3678218|FG001|Overall Study|Pregnancy|0
2090639|NCT00762892|3678217|FG000|Overall Study|Incarceration|1
2090640|NCT00762892|3678218|FG001|Overall Study|Incarceration|0
2090641|NCT00762970|3678231|FG000|Overall Study|Withdrawal by Subject|7
2090642|NCT00762970|3678232|FG001|Overall Study|Withdrawal by Subject|4
2090643|NCT00762970|3678233|FG002|Overall Study|Withdrawal by Subject|0
2090644|NCT00762970|3678231|FG000|Overall Study|Protocol Violation|3
2090645|NCT00762970|3678232|FG001|Overall Study|Protocol Violation|1
2090646|NCT00762970|3678233|FG002|Overall Study|Protocol Violation|1
2090647|NCT00762970|3678231|FG000|Overall Study|Lost to Follow-up|1
2090648|NCT00762970|3678232|FG001|Overall Study|Lost to Follow-up|2
2090649|NCT00762970|3678233|FG002|Overall Study|Lost to Follow-up|0
2090650|NCT00762970|3678231|FG000|Overall Study|Difficulty of handling lens|1
2090651|NCT00762970|3678232|FG001|Overall Study|Difficulty of handling lens|2
2090652|NCT00762970|3678233|FG002|Overall Study|Difficulty of handling lens|0
2090653|NCT00762996|3678241|FG000|Period One|Protocol Violation|0
2090654|NCT00762996|3678242|FG001|Period One|Protocol Violation|0
2090655|NCT00762996|3678243|FG002|Period One|Protocol Violation|1
2090656|NCT00762996|3678244|FG003|Period One|Protocol Violation|0
2090657|NCT00762996|3678241|FG000|Period One|ineligible|0
2090658|NCT00762996|3678242|FG001|Period One|ineligible|0
2090659|NCT00762996|3678243|FG002|Period One|ineligible|1
2090660|NCT00762996|3678244|FG003|Period One|ineligible|1
2090661|NCT00762996|3678241|FG000|Period One|Adverse Event|0
2090662|NCT00762996|3678242|FG001|Period One|Adverse Event|0
2090663|NCT00762996|3678243|FG002|Period One|Adverse Event|1
2090664|NCT00762996|3678244|FG003|Period One|Adverse Event|0
2090665|NCT00762996|3678241|FG000|Period One|Withdrawal by Subject|0
2090666|NCT00762996|3678242|FG001|Period One|Withdrawal by Subject|0
2090667|NCT00762996|3678243|FG002|Period One|Withdrawal by Subject|1
2090668|NCT00762996|3678244|FG003|Period One|Withdrawal by Subject|0
2090669|NCT00763035|3678252|FG000|First Intervention|Did not meeting inclusion/exclusion|1
2090670|NCT00763035|3678253|FG001|First Intervention|Did not meeting inclusion/exclusion|0
2090671|NCT00763035|3678252|FG000|First Intervention|Adverse Event|0
2090672|NCT00763035|3678253|FG001|First Intervention|Adverse Event|1
2090673|NCT00763035|3678252|FG000|Second Intervention|Adverse Event|1
2090674|NCT00763035|3678253|FG001|Second Intervention|Adverse Event|0
2090675|NCT00763035|3678252|FG000|Second Intervention|Physician Decision|2
2090676|NCT00763035|3678253|FG001|Second Intervention|Physician Decision|0
2090677|NCT00763139|3678277|FG000|Overall Study|Adverse Event|4
2090678|NCT00763139|3678278|FG001|Overall Study|Adverse Event|2
2090679|NCT00763139|3678277|FG000|Overall Study|Withdrawal by Subject|0
2211761|NCT01663233|3852286|FG000|Overall Study|Lost to Follow-up|0
2211762|NCT01663233|3852287|FG001|Overall Study|Lost to Follow-up|1
2211763|NCT01663402|3852309|FG000|Overall Study|Randomized but not treated|19
2211764|NCT01663402|3852310|FG001|Overall Study|Randomized but not treated|11
2211765|NCT01663402|3852309|FG000|Overall Study|Adverse Event|347
2211766|NCT01663402|3852310|FG001|Overall Study|Adverse Event|362
2211767|NCT01663402|3852309|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0
2211768|NCT01663402|3852310|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730
2211769|NCT01663402|3852309|FG000|Overall Study|Poor compliance to protocol|529
2211770|NCT01663402|3852310|FG001|Overall Study|Poor compliance to protocol|454
2090680|NCT00763139|3678278|FG001|Overall Study|Withdrawal by Subject|1
2090681|NCT00763139|3678277|FG000|Overall Study|med change not allowed by protocol|1
2090682|NCT00763139|3678278|FG001|Overall Study|med change not allowed by protocol|0
2090683|NCT00763256|3678303|FG000|Overall Study|Didn't return for appointments|7
2090684|NCT00763256|3678304|FG001|Overall Study|Didn't return for appointments|10
2090685|NCT00763269|3678312|FG000|Overall Study|Lost to Follow-up|12
2090686|NCT00763269|3678313|FG001|Overall Study|Lost to Follow-up|13
2090687|NCT00763282|3678321|FG000|Overall Study|Withdrawal by Subject|6
2090688|NCT00763282|3678322|FG001|Overall Study|Withdrawal by Subject|5
2090689|NCT00763282|3678321|FG000|Overall Study|Death|4
2090690|NCT00763282|3678322|FG001|Overall Study|Death|3
2306558|NCT02688387|4008600|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306559|NCT02688387|4008601|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306560|NCT02688387|4008602|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2090691|NCT00763282|3678321|FG000|Overall Study|Lost to Follow-up|22
2090692|NCT00763282|3678322|FG001|Overall Study|Lost to Follow-up|26
2090693|NCT00763321|3678333|FG000|Open-label Period|Adverse Event|24
2090694|NCT00763321|3678334|FG001|Open-label Period|Adverse Event|0
2090695|NCT00763321|3678335|FG002|Open-label Period|Adverse Event|0
2090696|NCT00763321|3678333|FG000|Open-label Period|Lost to Follow-up|14
2090697|NCT00763321|3678334|FG001|Open-label Period|Lost to Follow-up|0
2090698|NCT00763321|3678335|FG002|Open-label Period|Lost to Follow-up|0
2090699|NCT00763321|3678333|FG000|Open-label Period|Withdrawal by Subject|7
2090700|NCT00763321|3678334|FG001|Open-label Period|Withdrawal by Subject|0
2090701|NCT00763321|3678335|FG002|Open-label Period|Withdrawal by Subject|0
2090702|NCT00763321|3678333|FG000|Open-label Period|Subject noncompliant|7
2090703|NCT00763321|3678334|FG001|Open-label Period|Subject noncompliant|0
2090704|NCT00763321|3678335|FG002|Open-label Period|Subject noncompliant|0
2090705|NCT00763321|3678333|FG000|Open-label Period|Did not meet DB randomization criteria|5
2090706|NCT00763321|3678334|FG001|Open-label Period|Did not meet DB randomization criteria|0
2090707|NCT00763321|3678335|FG002|Open-label Period|Did not meet DB randomization criteria|0
2306561|NCT02688387|4008603|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306562|NCT02688387|4008604|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2306563|NCT02688387|4008605|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2090708|NCT00763321|3678333|FG000|Open-label Period|Lack of Efficacy|2
2090709|NCT00763321|3678334|FG001|Open-label Period|Lack of Efficacy|0
2090710|NCT00763321|3678335|FG002|Open-label Period|Lack of Efficacy|0
2090711|NCT00763321|3678333|FG000|Open-label Period|Other|4
2211771|NCT01663402|3852309|FG000|Overall Study|Physician Decision|77
2211772|NCT01663402|3852310|FG001|Overall Study|Physician Decision|62
2211773|NCT01663402|3852309|FG000|Overall Study|Site terminated by sponsor|1
2211774|NCT01663402|3852310|FG001|Overall Study|Site terminated by sponsor|3
2211775|NCT01663402|3852309|FG000|Overall Study|Participant moved|139
2211776|NCT01663402|3852310|FG001|Overall Study|Participant moved|104
2211777|NCT01663402|3852309|FG000|Overall Study|Withdrawal by Subject|118
2211778|NCT01663402|3852310|FG001|Overall Study|Withdrawal by Subject|91
2211779|NCT01663402|3852309|FG000|Overall Study|Related to study drug administration|96
2211780|NCT01663402|3852310|FG001|Overall Study|Related to study drug administration|105
2306564|NCT02688387|4008584|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306565|NCT02688387|4008585|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306566|NCT02688387|4008586|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
2306567|NCT02688387|4008587|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306568|NCT02688387|4008588|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
2306569|NCT02688387|4008589|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306570|NCT02688387|4008590|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306571|NCT02688387|4008591|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306572|NCT02688387|4008592|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306573|NCT02688387|4008593|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306574|NCT02688387|4008594|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306575|NCT02688387|4008595|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306576|NCT02688387|4008596|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306577|NCT02688387|4008597|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306578|NCT02688387|4008598|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306579|NCT02688387|4008599|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306580|NCT02688387|4008600|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306581|NCT02688387|4008601|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306582|NCT02688387|4008602|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306583|NCT02688387|4008603|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306584|NCT02688387|4008604|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306585|NCT02688387|4008605|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2306586|NCT02688387|4008584|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
2306587|NCT02688387|4008585|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306588|NCT02688387|4008586|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306589|NCT02688387|4008587|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306590|NCT02688387|4008588|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306591|NCT02688387|4008589|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306592|NCT02688387|4008590|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306593|NCT02688387|4008591|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306594|NCT02688387|4008592|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306595|NCT02688387|4008593|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306596|NCT02688387|4008594|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306597|NCT02688387|4008595|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306598|NCT02688387|4008596|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306599|NCT02688387|4008597|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2211781|NCT01663402|3852309|FG000|Overall Study|Lost to Follow-up|17
2211782|NCT01663402|3852310|FG001|Overall Study|Lost to Follow-up|15
2211783|NCT01663402|3852309|FG000|Overall Study|Other than specified above|172
2211784|NCT01663402|3852310|FG001|Overall Study|Other than specified above|147
2211785|NCT01663506|3852316|FG000|Overall Study|Lack of Efficacy|3
2211786|NCT01663506|3852316|FG000|Overall Study|Consent Withdrawal by Subject|1
2090712|NCT00763321|3678334|FG001|Open-label Period|Other|0
2090713|NCT00763321|3678335|FG002|Open-label Period|Other|0
2090714|NCT00763321|3678333|FG000|Double-blind Period|Lack of Efficacy|0
2090715|NCT00763321|3678334|FG001|Double-blind Period|Lack of Efficacy|9
2090716|NCT00763321|3678335|FG002|Double-blind Period|Lack of Efficacy|17
2090717|NCT00763321|3678333|FG000|Double-blind Period|Adverse Event|0
2090718|NCT00763321|3678334|FG001|Double-blind Period|Adverse Event|4
2090719|NCT00763321|3678335|FG002|Double-blind Period|Adverse Event|4
2090720|NCT00763321|3678333|FG000|Double-blind Period|Lost to Follow-up|0
2090721|NCT00763321|3678334|FG001|Double-blind Period|Lost to Follow-up|4
2090722|NCT00763321|3678335|FG002|Double-blind Period|Lost to Follow-up|2
2090723|NCT00763321|3678333|FG000|Double-blind Period|Withdrawal by Subject|0
2090724|NCT00763321|3678334|FG001|Double-blind Period|Withdrawal by Subject|2
2090725|NCT00763321|3678335|FG002|Double-blind Period|Withdrawal by Subject|3
2090726|NCT00763321|3678333|FG000|Double-blind Period|Other|0
2090727|NCT00763321|3678334|FG001|Double-blind Period|Other|2
2090728|NCT00763321|3678335|FG002|Double-blind Period|Other|3
2107369|NCT00872898|3700931|FG001|Part Two - Double Blind|Withdrawal by Subject|1
2107370|NCT00872898|3700930|FG000|Part Two - Double Blind|Lost to Follow-up|0
2107371|NCT00872898|3700931|FG001|Part Two - Double Blind|Lost to Follow-up|2
2107372|NCT00872898|3700930|FG000|Part Two - Double Blind|Other reasons|2
2107373|NCT00872898|3700931|FG001|Part Two - Double Blind|Other reasons|0
2107374|NCT00872989|3700942|FG000|Overall Study|Adverse Event|7
2107375|NCT00872989|3700943|FG001|Overall Study|Adverse Event|15
2107376|NCT00872989|3700942|FG000|Overall Study|Withdrawal by Subject|8
2107377|NCT00872989|3700943|FG001|Overall Study|Withdrawal by Subject|5
2107378|NCT00872989|3700942|FG000|Overall Study|Progression/relapse|47
2107379|NCT00872989|3700943|FG001|Overall Study|Progression/relapse|35
2107380|NCT00872989|3700942|FG000|Overall Study|Not protocol specified|3
2107381|NCT00872989|3700943|FG001|Overall Study|Not protocol specified|8
2107382|NCT00873015|3700959|FG000|Overall Study|Withdrawal by Subject|0
2107383|NCT00873015|3700960|FG001|Overall Study|Withdrawal by Subject|1
2107384|NCT00873015|3700961|FG002|Overall Study|Withdrawal by Subject|0
2107385|NCT00873015|3700962|FG003|Overall Study|Withdrawal by Subject|0
2107386|NCT00873041|3700974|FG000|Core Study|Adverse Event|2
2107387|NCT00873041|3700975|FG001|Core Study|Adverse Event|3
2107388|NCT00873041|3700976|FG002|Core Study|Adverse Event|1
2107389|NCT00873041|3700974|FG000|Core Study|Withdrawal by Subject|1
2107390|NCT00873041|3700975|FG001|Core Study|Withdrawal by Subject|2
2107391|NCT00873041|3700976|FG002|Core Study|Withdrawal by Subject|2
2107392|NCT00873041|3700974|FG000|Core Study|Lost to Follow-up|3
2107393|NCT00873041|3700975|FG001|Core Study|Lost to Follow-up|1
2107394|NCT00873041|3700976|FG002|Core Study|Lost to Follow-up|0
2107395|NCT00873041|3700974|FG000|Core Study|Abnormal laboratory value|0
2211787|NCT01663506|3852316|FG000|Overall Study|Lost to Follow-up|1
2211788|NCT01663506|3852316|FG000|Overall Study|Adverse Event|1
2211789|NCT01663506|3852316|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2
2211790|NCT01663532|3852322|FG000|Overall Study|Lost to Follow-up|9
2306600|NCT02688387|4008598|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306601|NCT02688387|4008599|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306602|NCT02688387|4008600|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306603|NCT02688387|4008601|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306604|NCT02688387|4008602|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2211791|NCT01663532|3852323|FG001|Overall Study|Lost to Follow-up|10
2306605|NCT02688387|4008603|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306606|NCT02688387|4008604|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306607|NCT02688387|4008605|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2306608|NCT02688387|4008584|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306609|NCT02688387|4008585|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306610|NCT02688387|4008586|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306611|NCT02688387|4008587|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306612|NCT02688387|4008588|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306613|NCT02688387|4008589|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306614|NCT02688387|4008590|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306615|NCT02688387|4008591|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306616|NCT02688387|4008592|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306617|NCT02688387|4008593|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306618|NCT02688387|4008594|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
2306619|NCT02688387|4008595|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306620|NCT02688387|4008596|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306621|NCT02688387|4008597|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306622|NCT02688387|4008598|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306623|NCT02688387|4008599|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2107396|NCT00873041|3700975|FG001|Core Study|Abnormal laboratory value|0
2211792|NCT01663532|3852322|FG000|Overall Study|Adverse Event|7
2090729|NCT00763386|3678357|FG000|Overall Study|Adverse Event|43
2090730|NCT00763386|3678358|FG001|Overall Study|Adverse Event|33
2090731|NCT00763386|3678357|FG000|Overall Study|Death|1
2090732|NCT00763386|3678358|FG001|Overall Study|Death|2
2090733|NCT00763386|3678357|FG000|Overall Study|Lost to Follow-up|3
2090734|NCT00763386|3678358|FG001|Overall Study|Lost to Follow-up|3
2090735|NCT00763386|3678357|FG000|Overall Study|Withdrawal by Subject|0
2090736|NCT00763386|3678358|FG001|Overall Study|Withdrawal by Subject|1
2090737|NCT00763386|3678357|FG000|Overall Study|CRF missing|0
2090738|NCT00763386|3678358|FG001|Overall Study|CRF missing|1
2090739|NCT00763386|3678357|FG000|Overall Study|Study Prosthesis Removed|1
2090740|NCT00763386|3678358|FG001|Overall Study|Study Prosthesis Removed|0
2090741|NCT00763451|3678377|FG000|Overall Study|Adverse Event|4
2090742|NCT00763451|3678378|FG001|Overall Study|Adverse Event|6
2090743|NCT00763451|3678379|FG002|Overall Study|Adverse Event|19
2090744|NCT00763451|3678380|FG003|Overall Study|Adverse Event|14
2090745|NCT00763451|3678377|FG000|Overall Study|Lack of Efficacy|1
2090746|NCT00763451|3678378|FG001|Overall Study|Lack of Efficacy|4
2090747|NCT00763451|3678379|FG002|Overall Study|Lack of Efficacy|3
2090748|NCT00763451|3678380|FG003|Overall Study|Lack of Efficacy|2
2090749|NCT00763451|3678377|FG000|Overall Study|Withdrawal by Subject|1
2090750|NCT00763451|3678378|FG001|Overall Study|Withdrawal by Subject|6
2090751|NCT00763451|3678379|FG002|Overall Study|Withdrawal by Subject|9
2090752|NCT00763451|3678380|FG003|Overall Study|Withdrawal by Subject|7
2090753|NCT00763451|3678377|FG000|Overall Study|Protocol Violation|0
2090754|NCT00763451|3678378|FG001|Overall Study|Protocol Violation|0
2090755|NCT00763451|3678379|FG002|Overall Study|Protocol Violation|1
2090756|NCT00763451|3678380|FG003|Overall Study|Protocol Violation|0
2090757|NCT00763451|3678377|FG000|Overall Study|Poor Compliance to Protocol|1
2090758|NCT00763451|3678378|FG001|Overall Study|Poor Compliance to Protocol|1
2090759|NCT00763451|3678379|FG002|Overall Study|Poor Compliance to Protocol|2
2090760|NCT00763451|3678380|FG003|Overall Study|Poor Compliance to Protocol|2
2090761|NCT00763451|3678377|FG000|Overall Study|Familial and Personal Reasons|5
2090762|NCT00763451|3678378|FG001|Overall Study|Familial and Personal Reasons|3
2090763|NCT00763451|3678379|FG002|Overall Study|Familial and Personal Reasons|5
2090764|NCT00763451|3678380|FG003|Overall Study|Familial and Personal Reasons|4
2090765|NCT00763451|3678377|FG000|Overall Study|Randomized but not Treated|1
2090766|NCT00763451|3678378|FG001|Overall Study|Randomized but not Treated|1
2090767|NCT00763451|3678379|FG002|Overall Study|Randomized but not Treated|0
2090768|NCT00763451|3678380|FG003|Overall Study|Randomized but not Treated|0
2090769|NCT00763451|3678377|FG000|Overall Study|Study Site Reason|0
2090770|NCT00763451|3678378|FG001|Overall Study|Study Site Reason|1
2090771|NCT00763451|3678379|FG002|Overall Study|Study Site Reason|1
2090772|NCT00763451|3678380|FG003|Overall Study|Study Site Reason|1
2090773|NCT00763698|3678395|FG000|Overall Study|Unsuccessful Implant|5
2090774|NCT00763698|3678395|FG000|Overall Study|Death|4
2090775|NCT00763698|3678395|FG000|Overall Study|Withdrawal by Subject|1
2090776|NCT00763815|3678406|FG000|Overall Study|Adverse Event|14
2090777|NCT00763815|3678407|FG001|Overall Study|Adverse Event|29
2090778|NCT00763815|3678406|FG000|Overall Study|Lack of Efficacy|10
2090779|NCT00763815|3678407|FG001|Overall Study|Lack of Efficacy|11
2090780|NCT00763815|3678406|FG000|Overall Study|Poor Compliance to Protocol|6
2090781|NCT00763815|3678407|FG001|Overall Study|Poor Compliance to Protocol|6
2090782|NCT00763815|3678406|FG000|Overall Study|Lost to Follow-up|2
2090783|NCT00763815|3678407|FG001|Overall Study|Lost to Follow-up|4
2090784|NCT00763815|3678406|FG000|Overall Study|Early Termination|1
2090785|NCT00763815|3678407|FG001|Overall Study|Early Termination|0
2090786|NCT00763815|3678406|FG000|Overall Study|Familial and Personal Reasons|9
2090787|NCT00763815|3678407|FG001|Overall Study|Familial and Personal Reasons|16
2090788|NCT00763815|3678406|FG000|Overall Study|Physician Decision|1
2090789|NCT00763815|3678407|FG001|Overall Study|Physician Decision|0
2090790|NCT00763815|3678406|FG000|Overall Study|Withdrawal by Subject|7
2090791|NCT00763815|3678407|FG001|Overall Study|Withdrawal by Subject|12
2090792|NCT00763815|3678406|FG000|Overall Study|Protocol Violation|2
2090793|NCT00763815|3678407|FG001|Overall Study|Protocol Violation|5
2090794|NCT00763815|3678406|FG000|Overall Study|Sponsor's Decision|0
2090795|NCT00763815|3678407|FG001|Overall Study|Sponsor's Decision|1
2090796|NCT00763958|3678428|FG000|Overall Study|did not meet final criteria|4
2090797|NCT00763958|3678429|FG001|Overall Study|did not meet final criteria|4
2090798|NCT00763958|3678428|FG000|Overall Study|Lost to Follow-up|10
2090799|NCT00763958|3678429|FG001|Overall Study|Lost to Follow-up|2
2090800|NCT00763958|3678428|FG000|Overall Study|Believed they were receiving placebo|0
2090801|NCT00763958|3678429|FG001|Overall Study|Believed they were receiving placebo|5
2090802|NCT00763971|3678439|FG000|Overall Study|Adverse Event|5
2090803|NCT00763971|3678440|FG001|Overall Study|Adverse Event|2
2090804|NCT00763971|3678441|FG002|Overall Study|Adverse Event|4
2090805|NCT00763971|3678439|FG000|Overall Study|Protocol Violation|3
2090806|NCT00763971|3678440|FG001|Overall Study|Protocol Violation|3
2090807|NCT00763971|3678441|FG002|Overall Study|Protocol Violation|2
2090808|NCT00763971|3678439|FG000|Overall Study|Withdrawal by Subject|4
2090809|NCT00763971|3678440|FG001|Overall Study|Withdrawal by Subject|5
2090810|NCT00763971|3678441|FG002|Overall Study|Withdrawal by Subject|5
2090811|NCT00763971|3678439|FG000|Overall Study|Lost to Follow-up|0
2090812|NCT00763971|3678440|FG001|Overall Study|Lost to Follow-up|1
2090813|NCT00763971|3678441|FG002|Overall Study|Lost to Follow-up|0
2090814|NCT00763971|3678439|FG000|Overall Study|Lack of Efficacy|11
2090815|NCT00763971|3678440|FG001|Overall Study|Lack of Efficacy|22
2090816|NCT00763971|3678441|FG002|Overall Study|Lack of Efficacy|54
2090817|NCT00763971|3678439|FG000|Overall Study|Unable to swallow capsule|2
2090818|NCT00763971|3678440|FG001|Overall Study|Unable to swallow capsule|1
2090819|NCT00763971|3678441|FG002|Overall Study|Unable to swallow capsule|1
2090820|NCT00763971|3678439|FG000|Overall Study|Personal reason|3
2090821|NCT00763971|3678440|FG001|Overall Study|Personal reason|0
2090822|NCT00763971|3678441|FG002|Overall Study|Personal reason|0
2090823|NCT00763971|3678439|FG000|Overall Study|Exclusion criteria met|1
2090824|NCT00763971|3678440|FG001|Overall Study|Exclusion criteria met|0
2090825|NCT00763971|3678441|FG002|Overall Study|Exclusion criteria met|0
2090826|NCT00763971|3678439|FG000|Overall Study|Sponsor decision|1
2090827|NCT00763971|3678440|FG001|Overall Study|Sponsor decision|0
2090828|NCT00763971|3678441|FG002|Overall Study|Sponsor decision|0
2090829|NCT00763971|3678439|FG000|Overall Study|Due to holiday season|2
2090830|NCT00763971|3678440|FG001|Overall Study|Due to holiday season|0
2090831|NCT00763971|3678441|FG002|Overall Study|Due to holiday season|1
2090832|NCT00763971|3678439|FG000|Overall Study|Randomization error|0
2090833|NCT00763971|3678440|FG001|Overall Study|Randomization error|0
2090834|NCT00763971|3678441|FG002|Overall Study|Randomization error|1
2090835|NCT00763971|3678439|FG000|Overall Study|Medical monitor decision|0
2090836|NCT00763971|3678440|FG001|Overall Study|Medical monitor decision|0
2090837|NCT00763971|3678441|FG002|Overall Study|Medical monitor decision|1
2090838|NCT00763971|3678439|FG000|Overall Study|Moved to another country|0
2090839|NCT00763971|3678440|FG001|Overall Study|Moved to another country|1
2090840|NCT00763971|3678441|FG002|Overall Study|Moved to another country|0
2090841|NCT00763971|3678439|FG000|Overall Study|Subject wanted dose reduction|0
2090842|NCT00763971|3678440|FG001|Overall Study|Subject wanted dose reduction|1
2090843|NCT00763971|3678441|FG002|Overall Study|Subject wanted dose reduction|0
2090844|NCT00763971|3678439|FG000|Overall Study|Lack of availability|0
2090845|NCT00763971|3678440|FG001|Overall Study|Lack of availability|1
2090846|NCT00763971|3678441|FG002|Overall Study|Lack of availability|0
2090847|NCT00763971|3678439|FG000|Overall Study|Performed final visit on phone|0
2090848|NCT00763971|3678440|FG001|Overall Study|Performed final visit on phone|1
2090849|NCT00763971|3678441|FG002|Overall Study|Performed final visit on phone|0
2090850|NCT00763971|3678439|FG000|Overall Study|Participation in 489-326 required|1
2090851|NCT00763971|3678440|FG001|Overall Study|Participation in 489-326 required|0
2090852|NCT00763971|3678441|FG002|Overall Study|Participation in 489-326 required|0
2090853|NCT00764322|3678455|FG000|Overall Study|Withdrawal by Subject|11
2090854|NCT00764322|3678455|FG000|Overall Study|No CYP2D6 genotyping|9
2090855|NCT00764361|3678474|FG000|Overall Study|Withdrawal by Subject|2
2090856|NCT00764361|3678475|FG001|Overall Study|Withdrawal by Subject|3
2090857|NCT00764361|3678474|FG000|Overall Study|Adverse Event|0
2090858|NCT00764361|3678475|FG001|Overall Study|Adverse Event|1
2090859|NCT00764465|3678487|FG000|Overall Study|Adverse Event|2
2090860|NCT00764465|3678488|FG001|Overall Study|Adverse Event|0
2090861|NCT00764465|3678489|FG002|Overall Study|Adverse Event|0
2090862|NCT00764465|3678490|FG003|Overall Study|Adverse Event|1
2090863|NCT00764465|3678491|FG004|Overall Study|Adverse Event|1
2090864|NCT00764465|3678492|FG005|Overall Study|Adverse Event|1
2090865|NCT00764465|3678487|FG000|Overall Study|Withdrawal by Subject|0
2090866|NCT00764465|3678488|FG001|Overall Study|Withdrawal by Subject|1
2090867|NCT00764465|3678489|FG002|Overall Study|Withdrawal by Subject|1
2090868|NCT00764465|3678490|FG003|Overall Study|Withdrawal by Subject|0
2090869|NCT00764465|3678491|FG004|Overall Study|Withdrawal by Subject|0
2090870|NCT00764465|3678492|FG005|Overall Study|Withdrawal by Subject|0
2090871|NCT00764491|3678511|FG000|Overall Study|Lost to Follow-up|35
2090872|NCT00764491|3678512|FG001|Overall Study|Lost to Follow-up|17
2090873|NCT00764504|3678521|FG000|Overall Study|Death|12
2090874|NCT00764504|3678522|FG001|Overall Study|Death|6
2090875|NCT00764504|3678523|FG002|Overall Study|Death|13
2090876|NCT00764504|3678521|FG000|Overall Study|Revision of Device|12
2090877|NCT00764504|3678522|FG001|Overall Study|Revision of Device|23
2090878|NCT00764504|3678523|FG002|Overall Study|Revision of Device|14
2090879|NCT00764504|3678521|FG000|Overall Study|Physician Decision|1
2090880|NCT00764504|3678522|FG001|Overall Study|Physician Decision|0
2090881|NCT00764504|3678523|FG002|Overall Study|Physician Decision|0
2090882|NCT00764504|3678521|FG000|Overall Study|Withdrawal by Subject|1
2090883|NCT00764504|3678522|FG001|Overall Study|Withdrawal by Subject|7
2090884|NCT00764504|3678523|FG002|Overall Study|Withdrawal by Subject|4
2090885|NCT00764504|3678521|FG000|Overall Study|Lost to Follow-up|40
2090886|NCT00764504|3678522|FG001|Overall Study|Lost to Follow-up|34
2090887|NCT00764504|3678523|FG002|Overall Study|Lost to Follow-up|72
2090888|NCT00764517|3678533|FG000|Overall Study|Adverse Event|9
2090889|NCT00764517|3678534|FG001|Overall Study|Adverse Event|3
2090890|NCT00764517|3678533|FG000|Overall Study|Death|3
2090891|NCT00764517|3678534|FG001|Overall Study|Death|11
2090892|NCT00764517|3678533|FG000|Overall Study|Physician Decision|3
2090893|NCT00764517|3678534|FG001|Overall Study|Physician Decision|0
2090894|NCT00764660|3678542|FG000|Overall Study|Adverse Event|6
2090895|NCT00764660|3678543|FG001|Overall Study|Adverse Event|3
2090896|NCT00764660|3678542|FG000|Overall Study|Lost to Follow-up|3
2090897|NCT00764660|3678543|FG001|Overall Study|Lost to Follow-up|4
2090898|NCT00764660|3678542|FG000|Overall Study|Withdrawal by Subject|7
2090899|NCT00764660|3678543|FG001|Overall Study|Withdrawal by Subject|3
2090900|NCT00764660|3678542|FG000|Overall Study|Noncompliance With Protocol|5
2090901|NCT00764660|3678543|FG001|Overall Study|Noncompliance With Protocol|1
2090902|NCT00764660|3678542|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
2090903|NCT00764660|3678543|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
2090904|NCT00764673|3678549|FG000|Overall Study|Death|1
2090905|NCT00764673|3678549|FG000|Overall Study|Lost to Follow-up|3
2090906|NCT00764673|3678549|FG000|Overall Study|Withdrawal by Subject|6
2090907|NCT00764673|3678549|FG000|Overall Study|Revision of Device|2
2090908|NCT00764751|3678572|FG000|Overall Study|Adverse Event|1
2090909|NCT00764751|3678573|FG001|Overall Study|Adverse Event|1
2090910|NCT00764751|3678572|FG000|Overall Study|Psoriasis flare up on the scalp|1
2090911|NCT00764751|3678573|FG001|Overall Study|Psoriasis flare up on the scalp|0
2090912|NCT00764790|3678587|FG000|Overall Study|Protocol Violation|0
2090913|NCT00764790|3678588|FG001|Overall Study|Protocol Violation|0
2090914|NCT00764790|3678589|FG002|Overall Study|Protocol Violation|1
2090915|NCT00764790|3678587|FG000|Overall Study|Withdrawal by Subject|10
2090916|NCT00764790|3678588|FG001|Overall Study|Withdrawal by Subject|12
2090917|NCT00764790|3678589|FG002|Overall Study|Withdrawal by Subject|6
2090918|NCT00764790|3678587|FG000|Overall Study|Lost to Follow-up|28
2090919|NCT00764790|3678588|FG001|Overall Study|Lost to Follow-up|29
2090920|NCT00764790|3678589|FG002|Overall Study|Lost to Follow-up|23
2090921|NCT00764868|3678597|FG000|Overall Study|Adverse Event|18
2090922|NCT00764868|3678597|FG000|Overall Study|Withdrawal by Subject|31
2306624|NCT02688387|4008600|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306625|NCT02688387|4008601|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306626|NCT02688387|4008602|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306627|NCT02688387|4008603|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306628|NCT02688387|4008604|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306629|NCT02688387|4008605|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2306630|NCT02688387|4008584|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306631|NCT02688387|4008585|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306632|NCT02688387|4008586|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306633|NCT02688387|4008587|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306634|NCT02688387|4008588|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306635|NCT02688387|4008589|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306636|NCT02688387|4008590|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306637|NCT02688387|4008591|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306638|NCT02688387|4008592|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306639|NCT02688387|4008593|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306640|NCT02688387|4008594|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306641|NCT02688387|4008595|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306642|NCT02688387|4008596|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306643|NCT02688387|4008597|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306644|NCT02688387|4008598|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
2306645|NCT02688387|4008599|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306646|NCT02688387|4008600|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306647|NCT02688387|4008601|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306648|NCT02688387|4008602|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306649|NCT02688387|4008603|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306650|NCT02688387|4008604|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306651|NCT02688387|4008605|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2306652|NCT02688387|4008584|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306653|NCT02688387|4008585|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306654|NCT02688387|4008586|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306655|NCT02688387|4008587|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306656|NCT02688387|4008588|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306657|NCT02688387|4008589|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306658|NCT02688387|4008590|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306659|NCT02688387|4008591|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306660|NCT02688387|4008592|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306661|NCT02688387|4008593|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306662|NCT02688387|4008594|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306663|NCT02688387|4008595|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306664|NCT02688387|4008596|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306665|NCT02688387|4008597|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306666|NCT02688387|4008598|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306667|NCT02688387|4008599|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306668|NCT02688387|4008600|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306669|NCT02688387|4008601|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306670|NCT02688387|4008602|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2090923|NCT00764868|3678597|FG000|Overall Study|Non-compliance|16
2090924|NCT00764868|3678597|FG000|Overall Study|Lost to Follow-up|25
2090925|NCT00764868|3678597|FG000|Overall Study|Lack of Efficacy|5
2090926|NCT00764868|3678597|FG000|Overall Study|Subject moved|7
2090927|NCT00764868|3678597|FG000|Overall Study|Pregnancy|3
2090928|NCT00764868|3678597|FG000|Overall Study|Prohibited medication|1
2090929|NCT00764868|3678597|FG000|Overall Study|Out of town|1
2306671|NCT02688387|4008603|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306672|NCT02688387|4008604|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
2306673|NCT02688387|4008605|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2306674|NCT02688387|4008584|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306675|NCT02688387|4008585|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306676|NCT02688387|4008586|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306677|NCT02688387|4008587|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306678|NCT02688387|4008588|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306679|NCT02688387|4008589|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306680|NCT02688387|4008590|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306681|NCT02688387|4008591|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306682|NCT02688387|4008592|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306683|NCT02688387|4008593|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306684|NCT02688387|4008594|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306685|NCT02688387|4008595|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306686|NCT02688387|4008596|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306687|NCT02688387|4008597|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306688|NCT02688387|4008598|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306689|NCT02688387|4008599|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306690|NCT02688387|4008600|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306691|NCT02688387|4008601|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306692|NCT02688387|4008602|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
2306693|NCT02688387|4008603|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306694|NCT02688387|4008604|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
2306695|NCT02688387|4008605|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2306696|NCT02688387|4008584|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306697|NCT02688387|4008585|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306698|NCT02688387|4008586|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306699|NCT02688387|4008587|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306700|NCT02688387|4008588|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306701|NCT02688387|4008589|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306702|NCT02688387|4008590|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306703|NCT02688387|4008591|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306704|NCT02688387|4008592|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306705|NCT02688387|4008593|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306706|NCT02688387|4008594|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306707|NCT02688387|4008595|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306708|NCT02688387|4008596|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306709|NCT02688387|4008597|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306710|NCT02688387|4008598|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306711|NCT02688387|4008599|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306712|NCT02688387|4008600|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306713|NCT02688387|4008601|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306714|NCT02688387|4008602|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306715|NCT02688387|4008603|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
2306716|NCT02688387|4008604|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306717|NCT02688387|4008605|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2306718|NCT02688621|4008662|FG000|Overall Study|Pregnancy|1
2306719|NCT02688621|4008663|FG001|Overall Study|Pregnancy|3
2306720|NCT02688621|4008662|FG000|Overall Study|Lost to Follow-up|38
2306721|NCT02688621|4008663|FG001|Overall Study|Lost to Follow-up|15
2306722|NCT02688621|4008662|FG000|Overall Study|Withdrawal by Subject|1
2306723|NCT02688621|4008663|FG001|Overall Study|Withdrawal by Subject|0
2306724|NCT02688764|4008674|FG000|Overall Study|Adverse Event|3
2306725|NCT02688764|4008675|FG001|Overall Study|Adverse Event|3
2306726|NCT02688764|4008674|FG000|Overall Study|AE/Kidney transplant|1
2306727|NCT02688764|4008675|FG001|Overall Study|AE/Kidney transplant|0
2306728|NCT02688764|4008674|FG000|Overall Study|AE/Lack of efficacy|1
2306729|NCT02688764|4008675|FG001|Overall Study|AE/Lack of efficacy|0
2306730|NCT02688764|4008674|FG000|Overall Study|AE/Non-compl.|1
2306731|NCT02688764|4008675|FG001|Overall Study|AE/Non-compl.|0
2306732|NCT02688764|4008674|FG000|Overall Study|AE/Non-compl./Withd. parent|0
2306733|NCT02688764|4008675|FG001|Overall Study|AE/Non-compl./Withd. parent|1
2306734|NCT02688764|4008674|FG000|Overall Study|AE/Other|0
2306735|NCT02688764|4008675|FG001|Overall Study|AE/Other|1
2306736|NCT02688764|4008674|FG000|Overall Study|AE/Physician decision|1
2306737|NCT02688764|4008675|FG001|Overall Study|AE/Physician decision|0
2306738|NCT02688764|4008674|FG000|Overall Study|AE/Withd. parent|3
2306739|NCT02688764|4008675|FG001|Overall Study|AE/Withd. parent|0
2306740|NCT02688764|4008674|FG000|Overall Study|AE/Withd. parent/Withd. subject|1
2306741|NCT02688764|4008675|FG001|Overall Study|AE/Withd. parent/Withd. subject|1
2306742|NCT02688764|4008674|FG000|Overall Study|AE/Withd. subject|1
2306743|NCT02688764|4008675|FG001|Overall Study|AE/Withd. subject|0
2090930|NCT00764868|3678597|FG000|Overall Study|Misuse and compliance of study drug|1
2090931|NCT00764868|3678597|FG000|Overall Study|Subject sent to boarding school|1
2090932|NCT00764868|3678597|FG000|Overall Study|Met an exclusion criteria|1
2090933|NCT00764868|3678597|FG000|Overall Study|Positive drug screen|2
2090934|NCT00764868|3678597|FG000|Overall Study|Sponsor requested withdrawal|1
2090935|NCT00764881|3678603|FG000|Overall Study|Adverse Event|5
2090936|NCT00764881|3678604|FG001|Overall Study|Adverse Event|1
2211793|NCT01663532|3852323|FG001|Overall Study|Adverse Event|13
2090937|NCT00764881|3678603|FG000|Overall Study|Withdrawal by Subject|1
2090938|NCT00764881|3678604|FG001|Overall Study|Withdrawal by Subject|3
2090939|NCT00764881|3678603|FG000|Overall Study|Protocol Violation|2
2090940|NCT00764881|3678604|FG001|Overall Study|Protocol Violation|2
2090941|NCT00764881|3678603|FG000|Overall Study|Lost to Follow-up|2
2090942|NCT00764881|3678604|FG001|Overall Study|Lost to Follow-up|0
2090943|NCT00764881|3678603|FG000|Overall Study|Noncompliant|1
2090944|NCT00764881|3678604|FG001|Overall Study|Noncompliant|0
2090945|NCT00764881|3678603|FG000|Overall Study|Accidentally discontinued study drug|1
2090946|NCT00764881|3678604|FG001|Overall Study|Accidentally discontinued study drug|0
2090947|NCT00764881|3678603|FG000|Overall Study|Wished to become pregnant|1
2090948|NCT00764881|3678604|FG001|Overall Study|Wished to become pregnant|0
2090949|NCT00764881|3678603|FG000|Overall Study|Carcinoma detected|1
2090950|NCT00764881|3678604|FG001|Overall Study|Carcinoma detected|0
2090951|NCT00764881|3678603|FG000|Overall Study|Possibly noncompliant (study drug)|0
2090952|NCT00764881|3678604|FG001|Overall Study|Possibly noncompliant (study drug)|2
2090953|NCT00764881|3678603|FG000|Overall Study|no treatment or no observation|2
2090954|NCT00764881|3678604|FG001|Overall Study|no treatment or no observation|2
2090955|NCT00764946|3678613|FG000|Overall Study|Lack of Efficacy|1
2090956|NCT00764946|3678614|FG001|Overall Study|Lack of Efficacy|0
2090957|NCT00764946|3678615|FG002|Overall Study|Lack of Efficacy|0
2090958|NCT00764946|3678613|FG000|Overall Study|Lost to Follow-up|3
2090959|NCT00764946|3678614|FG001|Overall Study|Lost to Follow-up|4
2090960|NCT00764946|3678615|FG002|Overall Study|Lost to Follow-up|0
2090961|NCT00764946|3678613|FG000|Overall Study|Physician Decision|2
2090962|NCT00764946|3678614|FG001|Overall Study|Physician Decision|4
2090963|NCT00764946|3678615|FG002|Overall Study|Physician Decision|0
2090964|NCT00764946|3678613|FG000|Overall Study|Adverse Event|3
2090965|NCT00764946|3678614|FG001|Overall Study|Adverse Event|2
2090966|NCT00764946|3678615|FG002|Overall Study|Adverse Event|1
2090967|NCT00764946|3678613|FG000|Overall Study|Withdrawal by Subject|3
2090968|NCT00764946|3678614|FG001|Overall Study|Withdrawal by Subject|6
2090969|NCT00764946|3678615|FG002|Overall Study|Withdrawal by Subject|2
2090970|NCT00764946|3678613|FG000|Overall Study|Never Treated|1
2090971|NCT00764946|3678614|FG001|Overall Study|Never Treated|1
2090972|NCT00764946|3678615|FG002|Overall Study|Never Treated|1
2090973|NCT00765037|3678629|FG000|Overall Study|Lost to Follow-up|5
2090974|NCT00765037|3678629|FG000|Overall Study|Adverse Event|1
2090975|NCT00765063|3678633|FG000|Overall Study|Lack of Efficacy|5
2090976|NCT00765063|3678633|FG000|Overall Study|Withdrawal by Subject|1
2090977|NCT00765063|3678633|FG000|Overall Study|Other|16
2090978|NCT00765063|3678633|FG000|Overall Study|Protocol Violation|6
2090979|NCT00765063|3678633|FG000|Overall Study|Adverse Event|4
2090980|NCT00765076|3678640|FG000|Overall Study|Adverse Event|1
2090981|NCT00765076|3678641|FG001|Overall Study|Adverse Event|0
2090982|NCT00765076|3678642|FG002|Overall Study|Adverse Event|0
2090983|NCT00765076|3678640|FG000|Overall Study|Withdrawal by Subject|0
2090984|NCT00765076|3678641|FG001|Overall Study|Withdrawal by Subject|0
2090985|NCT00765076|3678642|FG002|Overall Study|Withdrawal by Subject|1
2090986|NCT00765102|3678650|FG000|Overall Study|Progressive disease|18
2090987|NCT00765102|3678650|FG000|Overall Study|Adverse Event|6
2090988|NCT00765102|3678650|FG000|Overall Study|Physician Decision|4
2090989|NCT00765102|3678650|FG000|Overall Study|Withdrawal by Subject|2
2090990|NCT00765102|3678650|FG000|Overall Study|Protocol Violation|1
2090991|NCT00765245|3678690|FG000|Overall Study|disease progression|3
2090992|NCT00765245|3678691|FG001|Overall Study|disease progression|2
2090993|NCT00765245|3678690|FG000|Overall Study|Withdrawal by Subject|3
2090994|NCT00765245|3678691|FG001|Overall Study|Withdrawal by Subject|0
2090995|NCT00765245|3678690|FG000|Overall Study|Adverse Event|5
2090996|NCT00765245|3678691|FG001|Overall Study|Adverse Event|0
2090997|NCT00765245|3678690|FG000|Overall Study|Physician Decision|1
2090998|NCT00765245|3678691|FG001|Overall Study|Physician Decision|0
2090999|NCT00765245|3678690|FG000|Overall Study|Death|1
2091000|NCT00765245|3678691|FG001|Overall Study|Death|0
2091001|NCT00765336|3678699|FG000|Overall Study|Protocol Violation|4
2091002|NCT00765336|3678700|FG001|Overall Study|Protocol Violation|2
2091003|NCT00765336|3678699|FG000|Overall Study|Withdrawal by Subject|6
2091004|NCT00765336|3678700|FG001|Overall Study|Withdrawal by Subject|4
2091005|NCT00765336|3678699|FG000|Overall Study|Lost to Follow-up|7
2091006|NCT00765336|3678700|FG001|Overall Study|Lost to Follow-up|9
2091007|NCT00765336|3678699|FG000|Overall Study|Adverse Event|2
2091008|NCT00765336|3678700|FG001|Overall Study|Adverse Event|1
2091009|NCT00765362|3678706|FG000|Overall Study|Death|9
2091010|NCT00765362|3678706|FG000|Overall Study|Adverse Event|2
2091011|NCT00765362|3678706|FG000|Overall Study|Protocol Violation|18
2091012|NCT00765362|3678706|FG000|Overall Study|Withdrawal by Subject|13
2091013|NCT00765362|3678706|FG000|Overall Study|Lost to Follow-up|95
2091014|NCT00765388|3678716|FG000|Period 1|Lack of Efficacy|1
2091015|NCT00765388|3678717|FG001|Period 1|Lack of Efficacy|2
2091016|NCT00765388|3678716|FG000|Period 1|Lost to Follow-up|0
2091017|NCT00765388|3678717|FG001|Period 1|Lost to Follow-up|1
2091018|NCT00765388|3678716|FG000|Period 1|Herpes Zoster|0
2091019|NCT00765388|3678717|FG001|Period 1|Herpes Zoster|1
2091020|NCT00765388|3678716|FG000|Period 1|Hip operation|0
2091021|NCT00765388|3678717|FG001|Period 1|Hip operation|1
2091022|NCT00765674|3678754|FG000|Overall Study|Adverse Event|7
2091023|NCT00765674|3678755|FG001|Overall Study|Adverse Event|2
2091024|NCT00765674|3678756|FG002|Overall Study|Adverse Event|8
2091025|NCT00765674|3678757|FG003|Overall Study|Adverse Event|11
2091026|NCT00765674|3678754|FG000|Overall Study|Abnormal Laboratory Value(s)|0
2091027|NCT00765674|3678755|FG001|Overall Study|Abnormal Laboratory Value(s)|0
2091028|NCT00765674|3678756|FG002|Overall Study|Abnormal Laboratory Value(s)|1
2091029|NCT00765674|3678757|FG003|Overall Study|Abnormal Laboratory Value(s)|0
2091030|NCT00765674|3678754|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
2091031|NCT00765674|3678755|FG001|Overall Study|Abnormal Test Procedure Result(s)|3
2091032|NCT00765674|3678756|FG002|Overall Study|Abnormal Test Procedure Result(s)|1
2091033|NCT00765674|3678757|FG003|Overall Study|Abnormal Test Procedure Result(s)|2
2091034|NCT00765674|3678754|FG000|Overall Study|Lack of Efficacy|2
2091035|NCT00765674|3678755|FG001|Overall Study|Lack of Efficacy|3
2091036|NCT00765674|3678756|FG002|Overall Study|Lack of Efficacy|1
2091037|NCT00765674|3678757|FG003|Overall Study|Lack of Efficacy|2
2091038|NCT00765674|3678754|FG000|Overall Study|Protocol Violation|2
2091039|NCT00765674|3678755|FG001|Overall Study|Protocol Violation|0
2091040|NCT00765674|3678756|FG002|Overall Study|Protocol Violation|1
2091041|NCT00765674|3678757|FG003|Overall Study|Protocol Violation|0
2091042|NCT00765674|3678754|FG000|Overall Study|Withdrawal by Subject|5
2091043|NCT00765674|3678755|FG001|Overall Study|Withdrawal by Subject|7
2091044|NCT00765674|3678756|FG002|Overall Study|Withdrawal by Subject|3
2091045|NCT00765674|3678757|FG003|Overall Study|Withdrawal by Subject|8
2306744|NCT02688764|4008674|FG000|Overall Study|Kidney transplant|10
2306745|NCT02688764|4008675|FG001|Overall Study|Kidney transplant|4
2306746|NCT02688764|4008674|FG000|Overall Study|Lack of Efficacy|3
2306747|NCT02688764|4008675|FG001|Overall Study|Lack of Efficacy|2
2306748|NCT02688764|4008674|FG000|Overall Study|Lack of efficacy/Physician decision|0
2306749|NCT02688764|4008675|FG001|Overall Study|Lack of efficacy/Physician decision|1
2306750|NCT02688764|4008674|FG000|Overall Study|Non-compliance with study drug|4
2306751|NCT02688764|4008675|FG001|Overall Study|Non-compliance with study drug|0
2306752|NCT02688764|4008674|FG000|Overall Study|Non-compl./Physician decision|2
2306753|NCT02688764|4008675|FG001|Overall Study|Non-compl./Physician decision|0
2306754|NCT02688764|4008674|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1
2306755|NCT02688764|4008675|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1
2306756|NCT02688764|4008674|FG000|Overall Study|Non-compl./Withd. subject|0
2306757|NCT02688764|4008675|FG001|Overall Study|Non-compl./Withd. subject|2
2306758|NCT02688764|4008674|FG000|Overall Study|Phosphorus level outside safe range|0
2306759|NCT02688764|4008675|FG001|Overall Study|Phosphorus level outside safe range|1
2306760|NCT02688764|4008674|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
2306761|NCT02688764|4008675|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
2306762|NCT02688764|4008674|FG000|Overall Study|Study drug taste/Withd. parent|1
2306763|NCT02688764|4008675|FG001|Overall Study|Study drug taste/Withd. parent|0
2306764|NCT02688764|4008674|FG000|Overall Study|Subject moving out|2
2306765|NCT02688764|4008675|FG001|Overall Study|Subject moving out|0
2306766|NCT02688764|4008674|FG000|Overall Study|Subject taken off dialysis|1
2306767|NCT02688764|4008675|FG001|Overall Study|Subject taken off dialysis|0
2306768|NCT02688764|4008674|FG000|Overall Study|Withdrawal by parent|3
2306769|NCT02688764|4008675|FG001|Overall Study|Withdrawal by parent|0
2306770|NCT02688933|4008698|FG000|Overall Study|Adverse Event|3
2306771|NCT02688933|4008699|FG001|Overall Study|Adverse Event|1
2306772|NCT02688933|4008698|FG000|Overall Study|Lack of Efficacy|2
2306773|NCT02688933|4008699|FG001|Overall Study|Lack of Efficacy|2
2306774|NCT02688933|4008698|FG000|Overall Study|Poor compliance to protocol|7
2306775|NCT02688933|4008699|FG001|Overall Study|Poor compliance to protocol|4
2306776|NCT02688933|4008698|FG000|Overall Study|Hypoglycemia|2
2306777|NCT02688933|4008699|FG001|Overall Study|Hypoglycemia|0
2306778|NCT02688933|4008698|FG000|Overall Study|Other than Specified|14
2306779|NCT02688933|4008699|FG001|Overall Study|Other than Specified|25
2306780|NCT02688933|4008698|FG000|Overall Study|Lost to Follow-up|1
2306781|NCT02688933|4008699|FG001|Overall Study|Lost to Follow-up|5
2306782|NCT02689076|4008725|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172
2306783|NCT02689076|4008726|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213
2091046|NCT00765674|3678754|FG000|Overall Study|Lost to Follow-up|4
2091047|NCT00765674|3678755|FG001|Overall Study|Lost to Follow-up|6
2091048|NCT00765674|3678756|FG002|Overall Study|Lost to Follow-up|2
2091049|NCT00765674|3678757|FG003|Overall Study|Lost to Follow-up|1
2091050|NCT00765674|3678754|FG000|Overall Study|Randomized in Error - No Study Drug|0
2091051|NCT00765674|3678755|FG001|Overall Study|Randomized in Error - No Study Drug|1
2091052|NCT00765674|3678756|FG002|Overall Study|Randomized in Error - No Study Drug|0
2091053|NCT00765674|3678757|FG003|Overall Study|Randomized in Error - No Study Drug|1
2091054|NCT00765726|3678767|FG000|Overall Study|Withdrawal by Subject|1
2091055|NCT00765726|3678767|FG000|Overall Study|Discontinuation of study by sponsor|8
2091056|NCT00765817|3678773|FG000|Overall Study|Adverse Event|13
2306784|NCT02689076|4008727|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0
2306785|NCT02689076|4008725|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3
2306786|NCT02689076|4008726|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1
2306787|NCT02689076|4008727|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0
2306788|NCT02689076|4008725|FG000|Overall Study|Did not have an HIE match|2
2306789|NCT02689076|4008726|FG001|Overall Study|Did not have an HIE match|0
2306790|NCT02689076|4008727|FG002|Overall Study|Did not have an HIE match|0
2306791|NCT02689076|4008725|FG000|Overall Study|Death during non-VA encounter|2
2306792|NCT02689076|4008726|FG001|Overall Study|Death during non-VA encounter|5
2306793|NCT02689076|4008727|FG002|Overall Study|Death during non-VA encounter|0
2306794|NCT02689076|4008725|FG000|Overall Study|Provider declined to participate after participant assignment|1
2306795|NCT02689076|4008726|FG001|Overall Study|Provider declined to participate after participant assignment|1
2306796|NCT02689076|4008727|FG002|Overall Study|Provider declined to participate after participant assignment|0
2306797|NCT02689076|4008725|FG000|Overall Study|Participant no longer active in VA system|1
2306798|NCT02689076|4008726|FG001|Overall Study|Participant no longer active in VA system|0
2306799|NCT02689076|4008727|FG002|Overall Study|Participant no longer active in VA system|0
2306800|NCT02689076|4008725|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
2306801|NCT02689076|4008726|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2
2306802|NCT02689076|4008727|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
2306803|NCT02689206|4008744|FG000|Overall Study|Adverse Event|0
2306804|NCT02689206|4008745|FG001|Overall Study|Adverse Event|0
2306805|NCT02689206|4008746|FG002|Overall Study|Adverse Event|1
2306806|NCT02689206|4008747|FG003|Overall Study|Adverse Event|0
2306807|NCT02689206|4008748|FG004|Overall Study|Adverse Event|2
2306808|NCT02689206|4008744|FG000|Overall Study|Protocol Violation|1
2306809|NCT02689206|4008745|FG001|Overall Study|Protocol Violation|0
2306810|NCT02689206|4008746|FG002|Overall Study|Protocol Violation|0
2306811|NCT02689206|4008747|FG003|Overall Study|Protocol Violation|1
2306812|NCT02689206|4008748|FG004|Overall Study|Protocol Violation|2
2306813|NCT02689206|4008744|FG000|Overall Study|Other: Reached stopping criteria|0
2306814|NCT02689206|4008745|FG001|Overall Study|Other: Reached stopping criteria|1
2306815|NCT02689206|4008746|FG002|Overall Study|Other: Reached stopping criteria|2
2306816|NCT02689206|4008747|FG003|Overall Study|Other: Reached stopping criteria|3
2306817|NCT02689206|4008748|FG004|Overall Study|Other: Reached stopping criteria|4
2306818|NCT02689206|4008744|FG000|Overall Study|Physician Decision|1
2306819|NCT02689206|4008745|FG001|Overall Study|Physician Decision|0
2306820|NCT02689206|4008746|FG002|Overall Study|Physician Decision|0
2306821|NCT02689206|4008747|FG003|Overall Study|Physician Decision|0
2306822|NCT02689206|4008748|FG004|Overall Study|Physician Decision|0
2306823|NCT02689206|4008744|FG000|Overall Study|Withdrawal by Subject|1
2306824|NCT02689206|4008745|FG001|Overall Study|Withdrawal by Subject|0
2306825|NCT02689206|4008746|FG002|Overall Study|Withdrawal by Subject|1
2306826|NCT02689206|4008747|FG003|Overall Study|Withdrawal by Subject|0
2306827|NCT02689206|4008748|FG004|Overall Study|Withdrawal by Subject|0
2306828|NCT02689219|4008766|FG000|Overall Study|Death|1
2306829|NCT02689219|4008767|FG001|Overall Study|Death|1
2306830|NCT02689219|4008766|FG000|Overall Study|Disease Progression|10
2306831|NCT02689219|4008767|FG001|Overall Study|Disease Progression|6
2306832|NCT02689492|4008773|FG000|Overall Study|Lost to Follow-up|61
2306833|NCT02689492|4008773|FG000|Overall Study|Withdrawal by Subject|11
2306834|NCT02689492|4008773|FG000|Overall Study|Death|9
2306835|NCT02689492|4008773|FG000|Overall Study|Physician Decision|2
2306836|NCT02689492|4008773|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1
2306837|NCT02689492|4008773|FG000|Overall Study|Withdrawal/ Physician's Decision|1
2306838|NCT02689492|4008773|FG000|Overall Study|Other than listed|1
2306839|NCT02689804|4008782|FG000|Overall Study|Withdrawal by Subject|2
2306840|NCT02689804|4008783|FG001|Overall Study|Withdrawal by Subject|0
2306841|NCT02690194|4008843|FG000|Overall Study|Withdrawal by Subject|1
2306842|NCT02690194|4008844|FG001|Overall Study|Withdrawal by Subject|4
2306843|NCT02690194|4008845|FG002|Overall Study|Withdrawal by Subject|0
2306844|NCT02690207|4008853|FG000|Overall Study|Lost to Follow-up|48
2306845|NCT02690207|4008853|FG000|Overall Study|Withdrawal by Subject|46
2306846|NCT02690207|4008853|FG000|Overall Study|Protocol Violation|2
2306847|NCT02690207|4008853|FG000|Overall Study|Serious adverse event|110
2306848|NCT02690207|4008853|FG000|Overall Study|Non-serious Adverse Event|18
2306849|NCT02690207|4008853|FG000|Overall Study|Migrated/moved from study area|5
2306850|NCT02690207|4008853|FG000|Overall Study|Suspected HZ Episode|1
2306851|NCT02690207|4008853|FG000|Overall Study|Other reasons for withdrawal|23
2306852|NCT02690649|4008863|FG000|Overall Study|Withdrawal by Subject|1
2306853|NCT02690649|4008864|FG001|Overall Study|Withdrawal by Subject|1
2306854|NCT02690649|4008863|FG000|Overall Study|Protocol Violation|0
2306855|NCT02690649|4008864|FG001|Overall Study|Protocol Violation|3
2306856|NCT02690701|4008874|FG000|Treatment Period 1|Adverse Event|2
2306857|NCT02690701|4008875|FG001|Treatment Period 1|Adverse Event|2
2091057|NCT00765817|3678774|FG001|Overall Study|Adverse Event|1
2091058|NCT00765817|3678773|FG000|Overall Study|Death|0
2091059|NCT00765817|3678774|FG001|Overall Study|Death|1
2091060|NCT00765817|3678773|FG000|Overall Study|Entry criteria not met|2
2091061|NCT00765817|3678774|FG001|Overall Study|Entry criteria not met|2
2091062|NCT00765817|3678773|FG000|Overall Study|Loss of glucose control|0
2091063|NCT00765817|3678774|FG001|Overall Study|Loss of glucose control|2
2091064|NCT00765817|3678773|FG000|Overall Study|Lost to Follow-up|1
2091065|NCT00765817|3678774|FG001|Overall Study|Lost to Follow-up|3
2091066|NCT00765817|3678773|FG000|Overall Study|Physician Decision|2
2091067|NCT00765817|3678774|FG001|Overall Study|Physician Decision|1
2091068|NCT00765817|3678773|FG000|Overall Study|Protocol Violation|1
2091069|NCT00765817|3678774|FG001|Overall Study|Protocol Violation|1
2091070|NCT00765817|3678773|FG000|Overall Study|Subject decision|7
2091071|NCT00765817|3678774|FG001|Overall Study|Subject decision|11
2091072|NCT00765843|3678783|FG000|Overall Study|Lost to Follow-up|1
2091073|NCT00765843|3678784|FG001|Overall Study|Lost to Follow-up|3
2091074|NCT00765843|3678785|FG002|Overall Study|Lost to Follow-up|2
2091075|NCT00765843|3678783|FG000|Overall Study|did not return to receive intervention|0
2091076|NCT00765843|3678784|FG001|Overall Study|did not return to receive intervention|1
2091077|NCT00765843|3678785|FG002|Overall Study|did not return to receive intervention|0
2091078|NCT00765843|3678783|FG000|Overall Study|Adverse Event|0
2091079|NCT00765843|3678784|FG001|Overall Study|Adverse Event|0
2091080|NCT00765843|3678785|FG002|Overall Study|Adverse Event|1
2091081|NCT00765882|3678803|FG000|Overall Study|Adverse Event|10
2091082|NCT00765882|3678804|FG001|Overall Study|Adverse Event|21
2091083|NCT00765882|3678805|FG002|Overall Study|Adverse Event|20
2306858|NCT02690701|4008874|FG000|Treatment Period 1|Withdrawal by Subject|0
2306859|NCT02690701|4008875|FG001|Treatment Period 1|Withdrawal by Subject|1
2306860|NCT02690701|4008874|FG000|Treatment Period 2|Adverse Event|2
2306861|NCT02690701|4008875|FG001|Treatment Period 2|Adverse Event|0
2306862|NCT02690701|4008874|FG000|Treatment Period 2|Lack of Efficacy|1
2306863|NCT02690701|4008875|FG001|Treatment Period 2|Lack of Efficacy|0
2306864|NCT02690701|4008874|FG000|Treatment Period 2|Lost to Follow-up|0
2306865|NCT02690701|4008875|FG001|Treatment Period 2|Lost to Follow-up|2
2306866|NCT02690701|4008874|FG000|Treatment Period 2|Withdrawal by Subject|0
2306867|NCT02690701|4008875|FG001|Treatment Period 2|Withdrawal by Subject|2
2306868|NCT02690701|4008874|FG000|Treatment Period 2|Protocol Violation|0
2306869|NCT02690701|4008875|FG001|Treatment Period 2|Protocol Violation|1
2306870|NCT02690714|4008882|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1
2306871|NCT02690714|4008882|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1
2306872|NCT02690727|4008890|FG000|Overall Study|Adverse Event|2
2306873|NCT02690727|4008891|FG001|Overall Study|Adverse Event|2
2306874|NCT02690974|4008917|FG000|Overall Study|Adverse Event|16
2306875|NCT02690974|4008917|FG000|Overall Study|Death|9
2306876|NCT02690974|4008917|FG000|Overall Study|Subject/guardian decision|4
2306877|NCT02690974|4008917|FG000|Overall Study|Lost to Follow-up|3
2306878|NCT02690974|4008917|FG000|Overall Study|Withdrawal of Informed Consent|3
2306879|NCT02690974|4008917|FG000|Overall Study|Physician Decision|2
2306880|NCT02690974|4008917|FG000|Overall Study|Non-compliance with study treatment|1
2306881|NCT02690974|4008917|FG000|Overall Study|Protocol-defined stopping criteria|1
2306882|NCT02690974|4008917|FG000|Overall Study|Protocol Deviation|1
2306883|NCT02691247|4008933|FG000|Overall Study|Withdrawal by Subject|1
2306884|NCT02691247|4008934|FG001|Overall Study|Withdrawal by Subject|2
2306885|NCT02691247|4008935|FG002|Overall Study|Withdrawal by Subject|2
2306886|NCT02691247|4008933|FG000|Overall Study|Lost to Follow-up|2
2306887|NCT02691247|4008934|FG001|Overall Study|Lost to Follow-up|0
2306888|NCT02691247|4008935|FG002|Overall Study|Lost to Follow-up|1
2306889|NCT02691455|4008975|FG000|Overall Study|Withdrawal by Subject|1
2306890|NCT02691455|4008976|FG001|Overall Study|Withdrawal by Subject|2
2306891|NCT02691455|4008975|FG000|Overall Study|Lost to Follow-up|15
2306892|NCT02691455|4008976|FG001|Overall Study|Lost to Follow-up|15
2306893|NCT02691468|4008984|FG000|Overall Study|Bronchial blocker use|2
2306894|NCT02691468|4008985|FG001|Overall Study|Bronchial blocker use|1
2306895|NCT02691468|4008984|FG000|Overall Study|Lost to Follow-up|2
2306896|NCT02691468|4008985|FG001|Overall Study|Lost to Follow-up|1
2306897|NCT02691468|4008984|FG000|Overall Study|Failure to advance FOB|2
2306898|NCT02691468|4008985|FG001|Overall Study|Failure to advance FOB|0
2306899|NCT02691494|4008994|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
2306900|NCT02691494|4008995|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
2306901|NCT02691494|4008996|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
2306902|NCT02691494|4008994|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2
2306903|NCT02691494|4008995|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3
2306904|NCT02691494|4008996|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
2306905|NCT02691494|4008994|FG000|Post-Treatment Follow-Up Period|Other|2
2306906|NCT02691494|4008995|FG001|Post-Treatment Follow-Up Period|Other|1
2306907|NCT02691494|4008996|FG002|Post-Treatment Follow-Up Period|Other|1
2306908|NCT02691494|4008994|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
2306909|NCT02691494|4008995|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
2306910|NCT02691494|4008996|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3
2306911|NCT02691494|4008994|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
2091084|NCT00765882|3678803|FG000|Overall Study|Lack of Efficacy|4
2091085|NCT00765882|3678804|FG001|Overall Study|Lack of Efficacy|0
2091086|NCT00765882|3678805|FG002|Overall Study|Lack of Efficacy|1
2091087|NCT00765882|3678803|FG000|Overall Study|Protocol Violation|4
2091088|NCT00765882|3678804|FG001|Overall Study|Protocol Violation|3
2091089|NCT00765882|3678805|FG002|Overall Study|Protocol Violation|1
2091090|NCT00765882|3678803|FG000|Overall Study|Withdrawal by Subject|2
2091091|NCT00765882|3678804|FG001|Overall Study|Withdrawal by Subject|6
2091092|NCT00765882|3678805|FG002|Overall Study|Withdrawal by Subject|6
2091093|NCT00765882|3678803|FG000|Overall Study|Lost to Follow-up|1
2091094|NCT00765882|3678804|FG001|Overall Study|Lost to Follow-up|9
2091095|NCT00765882|3678805|FG002|Overall Study|Lost to Follow-up|6
2091096|NCT00765882|3678803|FG000|Overall Study|Other Reason|3
2091097|NCT00765882|3678804|FG001|Overall Study|Other Reason|1
2091098|NCT00765882|3678805|FG002|Overall Study|Other Reason|2
2091099|NCT00765999|3678828|FG000|Overall Study|Adverse Event|203
2091100|NCT00765999|3678828|FG000|Overall Study|Insufficient Therapeutic Response|100
2091101|NCT00765999|3678828|FG000|Overall Study|Protocol Violation|95
2091102|NCT00765999|3678828|FG000|Overall Study|Consent Withdrawn|202
2091103|NCT00765999|3678828|FG000|Overall Study|Lost to Follow-up|131
2306912|NCT02691494|4008995|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1
2306913|NCT02691494|4008996|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
2306914|NCT02691507|4009006|FG000|Overall Study|Missed Visit 3|0
2306915|NCT02691507|4009007|FG001|Overall Study|Missed Visit 3|1
2306916|NCT02691572|4009015|FG000|Overall Study|Withdrawal by Subject|1
2306917|NCT02691572|4009016|FG001|Overall Study|Withdrawal by Subject|0
2306918|NCT02691572|4009015|FG000|Overall Study|Protocol Violation|0
2306919|NCT02691572|4009016|FG001|Overall Study|Protocol Violation|1
2306920|NCT02691702|4009033|FG000|Overall Study|Adverse Event|1
2306921|NCT02691702|4009034|FG001|Overall Study|Adverse Event|0
2306922|NCT02691702|4009035|FG002|Overall Study|Adverse Event|0
2306923|NCT02691702|4009036|FG003|Overall Study|Adverse Event|0
2306924|NCT02691702|4009037|FG004|Overall Study|Adverse Event|0
2306925|NCT02691702|4009038|FG005|Overall Study|Adverse Event|0
2306926|NCT02691702|4009039|FG006|Overall Study|Adverse Event|0
2306927|NCT02691702|4009040|FG007|Overall Study|Adverse Event|0
2306928|NCT02691702|4009041|FG008|Overall Study|Adverse Event|1
2306929|NCT02691702|4009042|FG009|Overall Study|Adverse Event|0
2306930|NCT02691702|4009043|FG010|Overall Study|Adverse Event|1
2306931|NCT02691702|4009033|FG000|Overall Study|Lost to Follow-up|0
2306932|NCT02691702|4009034|FG001|Overall Study|Lost to Follow-up|0
2306933|NCT02691702|4009035|FG002|Overall Study|Lost to Follow-up|1
2306934|NCT02691702|4009036|FG003|Overall Study|Lost to Follow-up|0
2306935|NCT02691702|4009037|FG004|Overall Study|Lost to Follow-up|0
2306936|NCT02691702|4009038|FG005|Overall Study|Lost to Follow-up|2
2306937|NCT02691702|4009039|FG006|Overall Study|Lost to Follow-up|0
2306938|NCT02691702|4009040|FG007|Overall Study|Lost to Follow-up|0
2306939|NCT02691702|4009041|FG008|Overall Study|Lost to Follow-up|0
2306940|NCT02691702|4009042|FG009|Overall Study|Lost to Follow-up|0
2306941|NCT02691702|4009043|FG010|Overall Study|Lost to Follow-up|1
2306942|NCT02691702|4009033|FG000|Overall Study|Withdrawal by Subject|1
2306943|NCT02691702|4009034|FG001|Overall Study|Withdrawal by Subject|1
2306944|NCT02691702|4009035|FG002|Overall Study|Withdrawal by Subject|0
2306945|NCT02691702|4009036|FG003|Overall Study|Withdrawal by Subject|0
2306946|NCT02691702|4009037|FG004|Overall Study|Withdrawal by Subject|0
2306947|NCT02691702|4009038|FG005|Overall Study|Withdrawal by Subject|1
2306948|NCT02691702|4009039|FG006|Overall Study|Withdrawal by Subject|2
2306949|NCT02691702|4009040|FG007|Overall Study|Withdrawal by Subject|0
2306950|NCT02691702|4009041|FG008|Overall Study|Withdrawal by Subject|0
2306951|NCT02691702|4009042|FG009|Overall Study|Withdrawal by Subject|0
2306952|NCT02691702|4009043|FG010|Overall Study|Withdrawal by Subject|0
2306953|NCT02691702|4009033|FG000|Overall Study|Other|0
2306954|NCT02691702|4009034|FG001|Overall Study|Other|0
2306955|NCT02691702|4009035|FG002|Overall Study|Other|0
2306956|NCT02691702|4009036|FG003|Overall Study|Other|0
2306957|NCT02691702|4009037|FG004|Overall Study|Other|0
2306958|NCT02691702|4009038|FG005|Overall Study|Other|0
2306959|NCT02691702|4009039|FG006|Overall Study|Other|1
2306960|NCT02691702|4009040|FG007|Overall Study|Other|0
2306961|NCT02691702|4009041|FG008|Overall Study|Other|1
2306962|NCT02691702|4009042|FG009|Overall Study|Other|0
2306963|NCT02691702|4009043|FG010|Overall Study|Other|0
2306964|NCT02691702|4009033|FG000|Overall Study|Protocol Violation|0
2306965|NCT02691702|4009034|FG001|Overall Study|Protocol Violation|0
2306966|NCT02691702|4009035|FG002|Overall Study|Protocol Violation|0
2306967|NCT02691702|4009036|FG003|Overall Study|Protocol Violation|0
2306968|NCT02691702|4009037|FG004|Overall Study|Protocol Violation|0
2306969|NCT02691702|4009038|FG005|Overall Study|Protocol Violation|0
2306970|NCT02691702|4009039|FG006|Overall Study|Protocol Violation|0
2091104|NCT00765999|3678828|FG000|Overall Study|Study Terminated by Sponsor|2
2091105|NCT00765999|3678828|FG000|Overall Study|Other Miscellaneous Reasons|51
2091106|NCT00766038|3678836|FG000|Overall Study|Lost to Follow-up|15
2306971|NCT02691702|4009040|FG007|Overall Study|Protocol Violation|0
2306972|NCT02691702|4009041|FG008|Overall Study|Protocol Violation|0
2306973|NCT02691702|4009042|FG009|Overall Study|Protocol Violation|2
2306974|NCT02691702|4009043|FG010|Overall Study|Protocol Violation|0
2306975|NCT02691741|4009077|FG000|Overall Study|Adverse Event|0
2091107|NCT00766038|3678837|FG001|Overall Study|Lost to Follow-up|14
2091108|NCT00766051|3678847|FG000|Overall Study|Withdrawal by Subject|2
2091109|NCT00766051|3678848|FG001|Overall Study|Withdrawal by Subject|0
2091110|NCT00766090|3678858|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2091111|NCT00766090|3678859|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2091112|NCT00766090|3678860|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2091113|NCT00766090|3678861|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2091114|NCT00766090|3678862|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2211794|NCT01663532|3852322|FG000|Overall Study|Met Withdrawal Criteria|7
2211795|NCT01663532|3852323|FG001|Overall Study|Met Withdrawal Criteria|6
2211796|NCT01663532|3852322|FG000|Overall Study|Physician Decision|1
2306976|NCT02691741|4009078|FG001|Overall Study|Adverse Event|2
2306977|NCT02691741|4009077|FG000|Overall Study|Lost to Follow-up|1
2306978|NCT02691741|4009078|FG001|Overall Study|Lost to Follow-up|0
2306979|NCT02691741|4009077|FG000|Overall Study|Physician Decision|0
2306980|NCT02691741|4009078|FG001|Overall Study|Physician Decision|1
2306981|NCT02691741|4009077|FG000|Overall Study|Withdrawal by Subject|0
2306982|NCT02691741|4009078|FG001|Overall Study|Withdrawal by Subject|4
2306983|NCT02691936|4009091|FG000|Overall Study|Withdrawal by Subject|2
2306984|NCT02691936|4009092|FG001|Overall Study|Withdrawal by Subject|5
2306985|NCT02692040|4009120|FG000|Overall Study|Protocol Violation|0
2306986|NCT02692040|4009121|FG001|Overall Study|Protocol Violation|0
2306987|NCT02692040|4009122|FG002|Overall Study|Protocol Violation|0
2306988|NCT02692040|4009123|FG003|Overall Study|Protocol Violation|0
2306989|NCT02692040|4009124|FG004|Overall Study|Protocol Violation|0
2306990|NCT02692040|4009125|FG005|Overall Study|Protocol Violation|0
2306991|NCT02692040|4009126|FG006|Overall Study|Protocol Violation|0
2306992|NCT02692040|4009127|FG007|Overall Study|Protocol Violation|0
2306993|NCT02692040|4009128|FG008|Overall Study|Protocol Violation|0
2306994|NCT02692040|4009129|FG009|Overall Study|Protocol Violation|0
2306995|NCT02692040|4009130|FG010|Overall Study|Protocol Violation|0
2306996|NCT02692040|4009131|FG011|Overall Study|Protocol Violation|0
2306997|NCT02692040|4009132|FG012|Overall Study|Protocol Violation|1
2306998|NCT02692040|4009133|FG013|Overall Study|Protocol Violation|0
2306999|NCT02692040|4009134|FG014|Overall Study|Protocol Violation|0
2307000|NCT02692040|4009135|FG015|Overall Study|Protocol Violation|0
2307001|NCT02692040|4009136|FG016|Overall Study|Protocol Violation|0
2307002|NCT02692040|4009120|FG000|Overall Study|Adverse Event|0
2307003|NCT02692040|4009121|FG001|Overall Study|Adverse Event|0
2307004|NCT02692040|4009122|FG002|Overall Study|Adverse Event|0
2307005|NCT02692040|4009123|FG003|Overall Study|Adverse Event|0
2307006|NCT02692040|4009124|FG004|Overall Study|Adverse Event|0
2307007|NCT02692040|4009125|FG005|Overall Study|Adverse Event|0
2307008|NCT02692040|4009126|FG006|Overall Study|Adverse Event|0
2307009|NCT02692040|4009127|FG007|Overall Study|Adverse Event|0
2307010|NCT02692040|4009128|FG008|Overall Study|Adverse Event|0
2307011|NCT02692040|4009129|FG009|Overall Study|Adverse Event|0
2307012|NCT02692040|4009130|FG010|Overall Study|Adverse Event|0
2307013|NCT02692040|4009131|FG011|Overall Study|Adverse Event|0
2307014|NCT02692040|4009132|FG012|Overall Study|Adverse Event|0
2307015|NCT02692040|4009133|FG013|Overall Study|Adverse Event|3
2307016|NCT02692040|4009134|FG014|Overall Study|Adverse Event|1
2307017|NCT02692040|4009135|FG015|Overall Study|Adverse Event|1
2307018|NCT02692040|4009136|FG016|Overall Study|Adverse Event|0
2307019|NCT02692235|4009221|FG000|Overall Study|Withdrawal by Subject|2
2307020|NCT02692235|4009222|FG001|Overall Study|Withdrawal by Subject|1
2307021|NCT02692235|4009221|FG000|Overall Study|Adverse Event|1
2307022|NCT02692235|4009222|FG001|Overall Study|Adverse Event|2
2307023|NCT02692417|4009239|FG000|Overall Study|Withdrawal by Subject|5
2307024|NCT02692417|4009240|FG001|Overall Study|Withdrawal by Subject|1
2307025|NCT02692417|4009239|FG000|Overall Study|Adverse Event|1
2307026|NCT02692417|4009240|FG001|Overall Study|Adverse Event|0
2307027|NCT02692482|4009248|FG000|Overall Study|Death|2
2307028|NCT02692482|4009249|FG001|Overall Study|Death|2
2307029|NCT02692482|4009248|FG000|Overall Study|Withdrawal by Subject|1
2307030|NCT02692482|4009249|FG001|Overall Study|Withdrawal by Subject|2
2307031|NCT02692560|4009271|FG000|Overall Study|Withdrawal by Subject|0
2307032|NCT02692560|4009272|FG001|Overall Study|Withdrawal by Subject|6
2307033|NCT02692586|4009278|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1
2307034|NCT02692586|4009278|FG000|Overall Study|Received adjunctive thrombolytics|2
2307035|NCT02692703|4009282|FG000|Overall Study|Lost to Follow-up|1
2307036|NCT02692703|4009282|FG000|Overall Study|Other|1
2321743|NCT02963506|4036382|FG011|Double-Blind Period|Withdrawal by Subject|0
2321744|NCT02963506|4036383|FG012|Double-Blind Period|Withdrawal by Subject|0
2321745|NCT02963506|4036371|FG000|Double-Blind Period|No compliance|0
2211797|NCT01663532|3852323|FG001|Overall Study|Physician Decision|1
2321746|NCT02963506|4036372|FG001|Double-Blind Period|No compliance|1
2321747|NCT02963506|4036373|FG002|Double-Blind Period|No compliance|0
2321748|NCT02963506|4036374|FG003|Double-Blind Period|No compliance|0
2321749|NCT02963506|4036375|FG004|Double-Blind Period|No compliance|0
2321750|NCT02963506|4036376|FG005|Double-Blind Period|No compliance|0
2321751|NCT02963506|4036377|FG006|Double-Blind Period|No compliance|0
2321752|NCT02963506|4036378|FG007|Double-Blind Period|No compliance|0
2321753|NCT02963506|4036379|FG008|Double-Blind Period|No compliance|0
2321754|NCT02963506|4036380|FG009|Double-Blind Period|No compliance|0
2321755|NCT02963506|4036381|FG010|Double-Blind Period|No compliance|0
2321756|NCT02963506|4036382|FG011|Double-Blind Period|No compliance|0
2321757|NCT02963506|4036383|FG012|Double-Blind Period|No compliance|0
2091115|NCT00766090|3678863|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2091116|NCT00766090|3678864|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2091117|NCT00766090|3678865|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2091118|NCT00766090|3678866|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1
2091119|NCT00766090|3678867|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2091120|NCT00766090|3678868|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2091121|NCT00766090|3678869|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2091122|NCT00766090|3678858|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2
2091123|NCT00766090|3678859|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2091124|NCT00766090|3678860|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2091125|NCT00766090|3678861|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2091126|NCT00766090|3678862|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2091127|NCT00766090|3678863|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2091128|NCT00766090|3678864|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2091129|NCT00766090|3678865|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2091130|NCT00766090|3678866|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2091131|NCT00766090|3678867|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2091132|NCT00766090|3678868|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2091133|NCT00766090|3678869|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2091134|NCT00766090|3678858|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2091135|NCT00766090|3678859|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2091136|NCT00766090|3678860|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2091137|NCT00766090|3678861|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2091138|NCT00766090|3678862|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2091139|NCT00766090|3678863|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2091140|NCT00766090|3678864|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2091141|NCT00766090|3678865|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2091142|NCT00766090|3678866|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2091143|NCT00766090|3678867|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2091144|NCT00766090|3678868|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2091145|NCT00766090|3678869|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2091146|NCT00766090|3678858|FG000|Washout Period 1 (14 Days)|Protocol Violation|0
2091147|NCT00766090|3678859|FG001|Washout Period 1 (14 Days)|Protocol Violation|0
2091148|NCT00766090|3678860|FG002|Washout Period 1 (14 Days)|Protocol Violation|1
2091149|NCT00766090|3678861|FG003|Washout Period 1 (14 Days)|Protocol Violation|0
2091150|NCT00766090|3678862|FG004|Washout Period 1 (14 Days)|Protocol Violation|0
2091151|NCT00766090|3678863|FG005|Washout Period 1 (14 Days)|Protocol Violation|0
2091152|NCT00766090|3678864|FG006|Washout Period 1 (14 Days)|Protocol Violation|0
2091153|NCT00766090|3678865|FG007|Washout Period 1 (14 Days)|Protocol Violation|0
2091154|NCT00766090|3678866|FG008|Washout Period 1 (14 Days)|Protocol Violation|0
2091155|NCT00766090|3678867|FG009|Washout Period 1 (14 Days)|Protocol Violation|0
2091156|NCT00766090|3678868|FG010|Washout Period 1 (14 Days)|Protocol Violation|0
2091157|NCT00766090|3678869|FG011|Washout Period 1 (14 Days)|Protocol Violation|0
2091158|NCT00766090|3678858|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2091159|NCT00766090|3678859|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2091160|NCT00766090|3678860|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2091161|NCT00766090|3678861|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2091162|NCT00766090|3678862|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2
2091163|NCT00766090|3678863|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2091164|NCT00766090|3678864|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2091165|NCT00766090|3678865|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2091166|NCT00766090|3678866|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2091167|NCT00766090|3678867|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2091168|NCT00766090|3678868|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2091169|NCT00766090|3678869|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2091170|NCT00766090|3678858|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2091171|NCT00766090|3678859|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2091172|NCT00766090|3678860|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1
2091173|NCT00766090|3678861|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2307037|NCT02692716|4009288|FG000|Overall Study|Lost to Follow-up|2
2307038|NCT02692716|4009289|FG001|Overall Study|Lost to Follow-up|5
2307039|NCT02692716|4009288|FG000|Overall Study|Withdrawal by Subject|3
2307040|NCT02692716|4009289|FG001|Overall Study|Withdrawal by Subject|1
2307041|NCT02693106|4009309|FG000|Overall Study|No time|3
2307042|NCT02693119|4009321|FG000|Open-Label Period|Withdrawal by Subject|0
2307043|NCT02693119|4009322|FG001|Open-Label Period|Withdrawal by Subject|1
2307044|NCT02693418|4009383|FG000|Overall Study|Lost to Follow-up|1
2307045|NCT02693418|4009384|FG001|Overall Study|Lost to Follow-up|2
2307046|NCT02693418|4009385|FG002|Overall Study|Lost to Follow-up|0
2307047|NCT02693418|4009386|FG003|Overall Study|Lost to Follow-up|0
2307048|NCT02693418|4009387|FG004|Overall Study|Lost to Follow-up|0
2307049|NCT02693418|4009383|FG000|Overall Study|Menses during study period|0
2307050|NCT02693418|4009384|FG001|Overall Study|Menses during study period|0
2307051|NCT02693418|4009385|FG002|Overall Study|Menses during study period|2
2307052|NCT02693418|4009386|FG003|Overall Study|Menses during study period|0
2307053|NCT02693418|4009387|FG004|Overall Study|Menses during study period|0
2091174|NCT00766090|3678862|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2091175|NCT00766090|3678863|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2091176|NCT00766090|3678864|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2091177|NCT00766090|3678865|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2091178|NCT00766090|3678866|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2091179|NCT00766090|3678867|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2091180|NCT00766090|3678868|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2091181|NCT00766090|3678869|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2091182|NCT00766090|3678858|FG000|Washout Period 2 (14 Days)|Physician Decision|0
2091183|NCT00766090|3678859|FG001|Washout Period 2 (14 Days)|Physician Decision|0
2091184|NCT00766090|3678860|FG002|Washout Period 2 (14 Days)|Physician Decision|1
2091185|NCT00766090|3678861|FG003|Washout Period 2 (14 Days)|Physician Decision|0
2091186|NCT00766090|3678862|FG004|Washout Period 2 (14 Days)|Physician Decision|0
2091187|NCT00766090|3678863|FG005|Washout Period 2 (14 Days)|Physician Decision|0
2091188|NCT00766090|3678864|FG006|Washout Period 2 (14 Days)|Physician Decision|0
2091189|NCT00766090|3678865|FG007|Washout Period 2 (14 Days)|Physician Decision|0
2091190|NCT00766090|3678866|FG008|Washout Period 2 (14 Days)|Physician Decision|0
2091191|NCT00766090|3678867|FG009|Washout Period 2 (14 Days)|Physician Decision|0
2091192|NCT00766090|3678868|FG010|Washout Period 2 (14 Days)|Physician Decision|0
2091193|NCT00766090|3678869|FG011|Washout Period 2 (14 Days)|Physician Decision|0
2091194|NCT00766090|3678858|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0
2091195|NCT00766090|3678859|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0
2091196|NCT00766090|3678860|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0
2091197|NCT00766090|3678861|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0
2091198|NCT00766090|3678862|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0
2091199|NCT00766090|3678863|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1
2091200|NCT00766090|3678864|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0
2091201|NCT00766090|3678865|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0
2091202|NCT00766090|3678866|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0
2091203|NCT00766090|3678867|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0
2091204|NCT00766090|3678868|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0
2091205|NCT00766090|3678869|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0
2091206|NCT00766090|3678858|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2091207|NCT00766090|3678859|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1
2091208|NCT00766090|3678860|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2091209|NCT00766090|3678861|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1
2091210|NCT00766090|3678862|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2091211|NCT00766090|3678863|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2091212|NCT00766090|3678864|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2091213|NCT00766090|3678865|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2091214|NCT00766090|3678866|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2091215|NCT00766090|3678867|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2091216|NCT00766090|3678868|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2091217|NCT00766090|3678869|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1
2091218|NCT00766090|3678858|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2091219|NCT00766090|3678859|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2091220|NCT00766090|3678860|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2091221|NCT00766090|3678861|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2091222|NCT00766090|3678862|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1
2091223|NCT00766090|3678863|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2091224|NCT00766090|3678864|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2091225|NCT00766090|3678865|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2307054|NCT02693691|4009399|FG000|Primary Endpoint Analysis (First 12M)|Death|30
2307055|NCT02693691|4009399|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12
2307056|NCT02693691|4009399|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7
2307057|NCT02693691|4009399|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1
2307058|NCT02693691|4009399|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12
2307059|NCT02693691|4009399|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11
2307060|NCT02693691|4009399|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1
2307061|NCT02693834|4009420|FG000|Baseline Measurement|Withdrawal by Subject|1
2307062|NCT02693834|4009421|FG001|Baseline Measurement|Withdrawal by Subject|0
2307063|NCT02693834|4009420|FG000|Baseline Measurement|Adverse Event|1
2307064|NCT02693834|4009421|FG001|Baseline Measurement|Adverse Event|0
2307065|NCT02693834|4009420|FG000|Week 2 Practice|Adverse Event|0
2307066|NCT02693834|4009421|FG001|Week 2 Practice|Adverse Event|1
2307067|NCT02694185|4009442|FG000|Overall Study|Withdrawal by Subject|45
2307068|NCT02694185|4009443|FG001|Overall Study|Withdrawal by Subject|0
2307069|NCT02694328|4009459|FG000|Overall Study|Adverse Event|27
2307070|NCT02694328|4009460|FG001|Overall Study|Adverse Event|33
2307071|NCT02694328|4009459|FG000|Overall Study|Withdrawal by Subject|27
2307072|NCT02694328|4009460|FG001|Overall Study|Withdrawal by Subject|23
2307073|NCT02694328|4009459|FG000|Overall Study|Lost to Follow-up|26
2307074|NCT02694328|4009460|FG001|Overall Study|Lost to Follow-up|22
2307075|NCT02694328|4009459|FG000|Overall Study|Noncompliant with study drug|11
2307076|NCT02694328|4009460|FG001|Overall Study|Noncompliant with study drug|8
2307077|NCT02694328|4009459|FG000|Overall Study|Incarceration|1
2091226|NCT00766090|3678866|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2091227|NCT00766090|3678867|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2091228|NCT00766090|3678868|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2091229|NCT00766090|3678869|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2091230|NCT00766142|3678890|FG000|Overall Study|Protocol Violation|4
2091231|NCT00766363|3678898|FG000|Overall Study|Withdrawal by Subject|1
2091232|NCT00766363|3678899|FG001|Overall Study|Withdrawal by Subject|0
2091233|NCT00766363|3678900|FG002|Overall Study|Withdrawal by Subject|0
2091234|NCT00766363|3678901|FG003|Overall Study|Withdrawal by Subject|0
2091235|NCT00766363|3678898|FG000|Overall Study|Adverse Event Prior to Randomization|0
2091236|NCT00766363|3678899|FG001|Overall Study|Adverse Event Prior to Randomization|1
2091237|NCT00766363|3678900|FG002|Overall Study|Adverse Event Prior to Randomization|0
2091238|NCT00766363|3678901|FG003|Overall Study|Adverse Event Prior to Randomization|0
2091239|NCT00766376|3678912|FG000|Overall Study|Withdrawal by Subject|27
2091240|NCT00766415|3678918|FG000|Overall Study|Withdrawal by Subject|0
2091241|NCT00766415|3678919|FG001|Overall Study|Withdrawal by Subject|1
2091242|NCT00766467|3678927|FG000|Overall Study|Withdrawal by Subject|7
2091243|NCT00766467|3678928|FG001|Overall Study|Withdrawal by Subject|2
2091244|NCT00766467|3678927|FG000|Overall Study|Adverse Event|1
2091245|NCT00766467|3678928|FG001|Overall Study|Adverse Event|1
2091246|NCT00766467|3678927|FG000|Overall Study|Protocol Violation|2
2091247|NCT00766467|3678928|FG001|Overall Study|Protocol Violation|4
2091248|NCT00766467|3678927|FG000|Overall Study|Tumor Progression on Study|0
2091249|NCT00766467|3678928|FG001|Overall Study|Tumor Progression on Study|1
2091250|NCT00766467|3678927|FG000|Overall Study|Physician Decision|1
2091251|NCT00766467|3678928|FG001|Overall Study|Physician Decision|0
2091252|NCT00766493|3678934|FG000|30 Days Post-Procedure|Discontinued|7
2091253|NCT00766493|3678934|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
2091254|NCT00766493|3678934|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
2091255|NCT00766506|3678940|FG000|Overall Study|Use rescue medication after 3 hours|3
2091256|NCT00766506|3678941|FG001|Overall Study|Use rescue medication after 3 hours|0
2091257|NCT00766506|3678940|FG000|Overall Study|Other|2
2091258|NCT00766506|3678941|FG001|Overall Study|Other|2
2091259|NCT00766532|3678947|FG000|Overall Study|Protocol Violation|2
2091260|NCT00766597|3678951|FG000|Overall Study|Unexpected closure of study|4
2307078|NCT02694328|4009460|FG001|Overall Study|Incarceration|1
2307079|NCT02694328|4009459|FG000|Overall Study|Lack of Efficacy|1
2307080|NCT02694328|4009460|FG001|Overall Study|Lack of Efficacy|2
2307081|NCT02694328|4009459|FG000|Overall Study|Pregnancy|1
2307082|NCT02694328|4009460|FG001|Overall Study|Pregnancy|1
2307083|NCT02694328|4009459|FG000|Overall Study|Protocol Violation|6
2307084|NCT02694328|4009460|FG001|Overall Study|Protocol Violation|5
2307085|NCT02694328|4009459|FG000|Overall Study|Abnormal Laboratory Value|0
2307086|NCT02694328|4009460|FG001|Overall Study|Abnormal Laboratory Value|3
2307087|NCT02694523|4009472|FG000|Part A|Adverse Event|7
2307088|NCT02694523|4009473|FG001|Part A|Adverse Event|3
2307089|NCT02694523|4009474|FG002|Part A|Adverse Event|0
2307090|NCT02694523|4009475|FG003|Part A|Adverse Event|0
2307091|NCT02694523|4009476|FG004|Part A|Adverse Event|0
2307092|NCT02694523|4009477|FG005|Part A|Adverse Event|0
2307093|NCT02694523|4009478|FG006|Part A|Adverse Event|0
2307094|NCT02694523|4009472|FG000|Part A|Protocol Violation|1
2307095|NCT02694523|4009473|FG001|Part A|Protocol Violation|0
2307096|NCT02694523|4009474|FG002|Part A|Protocol Violation|0
2307097|NCT02694523|4009475|FG003|Part A|Protocol Violation|0
2307098|NCT02694523|4009476|FG004|Part A|Protocol Violation|0
2307099|NCT02694523|4009477|FG005|Part A|Protocol Violation|0
2307100|NCT02694523|4009478|FG006|Part A|Protocol Violation|0
2307101|NCT02694523|4009472|FG000|Part A|Lost to Follow-up|1
2307102|NCT02694523|4009473|FG001|Part A|Lost to Follow-up|2
2307103|NCT02694523|4009474|FG002|Part A|Lost to Follow-up|0
2307104|NCT02694523|4009475|FG003|Part A|Lost to Follow-up|0
2307105|NCT02694523|4009476|FG004|Part A|Lost to Follow-up|0
2307106|NCT02694523|4009477|FG005|Part A|Lost to Follow-up|0
2307107|NCT02694523|4009478|FG006|Part A|Lost to Follow-up|0
2307108|NCT02694523|4009472|FG000|Part A|Withdrawal by Subject|3
2307109|NCT02694523|4009473|FG001|Part A|Withdrawal by Subject|1
2307110|NCT02694523|4009474|FG002|Part A|Withdrawal by Subject|0
2307111|NCT02694523|4009475|FG003|Part A|Withdrawal by Subject|0
2307112|NCT02694523|4009476|FG004|Part A|Withdrawal by Subject|0
2307113|NCT02694523|4009477|FG005|Part A|Withdrawal by Subject|0
2307114|NCT02694523|4009478|FG006|Part A|Withdrawal by Subject|0
2307115|NCT02694523|4009472|FG000|Part A|Other|1
2307116|NCT02694523|4009473|FG001|Part A|Other|1
2307117|NCT02694523|4009474|FG002|Part A|Other|0
2307118|NCT02694523|4009475|FG003|Part A|Other|0
2307119|NCT02694523|4009476|FG004|Part A|Other|0
2091261|NCT00766597|3678951|FG000|Overall Study|Without CCR5-tropic virus|5
2091262|NCT00766675|3678961|FG000|Overall Study|Adverse Event|16
2091263|NCT00766675|3678961|FG000|Overall Study|Lost to Follow-up|2
2091264|NCT00766675|3678961|FG000|Overall Study|Withdrawal by Subject|11
2307120|NCT02694523|4009477|FG005|Part A|Other|0
2307121|NCT02694523|4009478|FG006|Part A|Other|0
2307122|NCT02694523|4009472|FG000|Part B|Adverse Event|0
2307123|NCT02694523|4009473|FG001|Part B|Adverse Event|0
2307124|NCT02694523|4009474|FG002|Part B|Adverse Event|7
2307125|NCT02694523|4009475|FG003|Part B|Adverse Event|1
2307126|NCT02694523|4009476|FG004|Part B|Adverse Event|1
2091265|NCT00766675|3678961|FG000|Overall Study|Protocol Violation|8
2091266|NCT00766675|3678961|FG000|Overall Study|Participant took prohibited medication|1
2091267|NCT00766675|3678961|FG000|Overall Study|Receive other anti-neoplastic treatment|1
2091268|NCT00766675|3678961|FG000|Overall Study|Insufficient therapy|1
2091269|NCT00766831|3678981|FG000|Overall Study|Withdrawal by Subject|4
2091270|NCT00766831|3678981|FG000|Overall Study|Lost to Follow-up|3
2091271|NCT00766831|3678981|FG000|Overall Study|Adverse Event|20
2091272|NCT00766831|3678981|FG000|Overall Study|Protocol Violation|15
2091273|NCT00766831|3678981|FG000|Overall Study|Physician Decision|5
2091274|NCT00766831|3678981|FG000|Overall Study|Withdrawal of consent|26
2091275|NCT00766831|3678981|FG000|Overall Study|Non cooperation by participants|14
2091276|NCT00766831|3678981|FG000|Overall Study|Other|28
2091277|NCT00767000|3678990|FG000|54-week Study|Adverse Event|4
2091278|NCT00767000|3678991|FG001|54-week Study|Adverse Event|6
2091279|NCT00767000|3678992|FG002|54-week Study|Adverse Event|6
2091280|NCT00767000|3678993|FG003|54-week Study|Adverse Event|8
2091281|NCT00767000|3678994|FG004|54-week Study|Adverse Event|4
2091282|NCT00767000|3678990|FG000|54-week Study|Creaninine/creatinine clearance|2
2091283|NCT00767000|3678991|FG001|54-week Study|Creaninine/creatinine clearance|1
2091284|NCT00767000|3678992|FG002|54-week Study|Creaninine/creatinine clearance|2
2091285|NCT00767000|3678993|FG003|54-week Study|Creaninine/creatinine clearance|2
2091286|NCT00767000|3678994|FG004|54-week Study|Creaninine/creatinine clearance|4
2091287|NCT00767000|3678990|FG000|54-week Study|Hyperglycemia|0
2091288|NCT00767000|3678991|FG001|54-week Study|Hyperglycemia|0
2091289|NCT00767000|3678992|FG002|54-week Study|Hyperglycemia|1
2091290|NCT00767000|3678993|FG003|54-week Study|Hyperglycemia|0
2091291|NCT00767000|3678994|FG004|54-week Study|Hyperglycemia|1
2091292|NCT00767000|3678990|FG000|54-week Study|Hypoglycemia|0
2091293|NCT00767000|3678991|FG001|54-week Study|Hypoglycemia|1
2091294|NCT00767000|3678992|FG002|54-week Study|Hypoglycemia|0
2091295|NCT00767000|3678993|FG003|54-week Study|Hypoglycemia|0
2091296|NCT00767000|3678994|FG004|54-week Study|Hypoglycemia|0
2091297|NCT00767000|3678990|FG000|54-week Study|Interruption of study medication|0
2091298|NCT00767000|3678991|FG001|54-week Study|Interruption of study medication|0
2091299|NCT00767000|3678992|FG002|54-week Study|Interruption of study medication|1
2091300|NCT00767000|3678993|FG003|54-week Study|Interruption of study medication|0
2091301|NCT00767000|3678994|FG004|54-week Study|Interruption of study medication|0
2091302|NCT00767000|3678990|FG000|54-week Study|Lack of Efficacy|2
2091303|NCT00767000|3678991|FG001|54-week Study|Lack of Efficacy|0
2091304|NCT00767000|3678992|FG002|54-week Study|Lack of Efficacy|1
2091305|NCT00767000|3678993|FG003|54-week Study|Lack of Efficacy|0
2091306|NCT00767000|3678994|FG004|54-week Study|Lack of Efficacy|5
2091307|NCT00767000|3678990|FG000|54-week Study|Lost to Follow-up|4
2091308|NCT00767000|3678991|FG001|54-week Study|Lost to Follow-up|0
2091309|NCT00767000|3678992|FG002|54-week Study|Lost to Follow-up|1
2091310|NCT00767000|3678993|FG003|54-week Study|Lost to Follow-up|4
2091311|NCT00767000|3678994|FG004|54-week Study|Lost to Follow-up|2
2091312|NCT00767000|3678990|FG000|54-week Study|Physician Decision|4
2091313|NCT00767000|3678991|FG001|54-week Study|Physician Decision|0
2091314|NCT00767000|3678992|FG002|54-week Study|Physician Decision|1
2091315|NCT00767000|3678993|FG003|54-week Study|Physician Decision|1
2091316|NCT00767000|3678994|FG004|54-week Study|Physician Decision|1
2091317|NCT00767000|3678990|FG000|54-week Study|Progressive disease|0
2091318|NCT00767000|3678991|FG001|54-week Study|Progressive disease|0
2091319|NCT00767000|3678992|FG002|54-week Study|Progressive disease|1
2091320|NCT00767000|3678993|FG003|54-week Study|Progressive disease|0
2091321|NCT00767000|3678994|FG004|54-week Study|Progressive disease|0
2091322|NCT00767000|3678990|FG000|54-week Study|Protocol Violation|0
2091323|NCT00767000|3678991|FG001|54-week Study|Protocol Violation|0
2091324|NCT00767000|3678992|FG002|54-week Study|Protocol Violation|1
2091325|NCT00767000|3678993|FG003|54-week Study|Protocol Violation|2
2091326|NCT00767000|3678994|FG004|54-week Study|Protocol Violation|0
2307127|NCT02694523|4009477|FG005|Part B|Adverse Event|2
2307128|NCT02694523|4009478|FG006|Part B|Adverse Event|0
2307129|NCT02694523|4009472|FG000|Part B|Protocol Violation|0
2307130|NCT02694523|4009473|FG001|Part B|Protocol Violation|0
2307131|NCT02694523|4009474|FG002|Part B|Protocol Violation|1
2307132|NCT02694523|4009475|FG003|Part B|Protocol Violation|0
2307133|NCT02694523|4009476|FG004|Part B|Protocol Violation|0
2307134|NCT02694523|4009477|FG005|Part B|Protocol Violation|0
2307135|NCT02694523|4009478|FG006|Part B|Protocol Violation|0
2307136|NCT02694523|4009472|FG000|Part B|Lost to Follow-up|0
2307137|NCT02694523|4009473|FG001|Part B|Lost to Follow-up|0
2307138|NCT02694523|4009474|FG002|Part B|Lost to Follow-up|2
2307139|NCT02694523|4009475|FG003|Part B|Lost to Follow-up|3
2307140|NCT02694523|4009476|FG004|Part B|Lost to Follow-up|2
2307141|NCT02694523|4009477|FG005|Part B|Lost to Follow-up|0
2307142|NCT02694523|4009478|FG006|Part B|Lost to Follow-up|1
2307143|NCT02694523|4009472|FG000|Part B|Withdrawal by Subject|0
2307144|NCT02694523|4009473|FG001|Part B|Withdrawal by Subject|0
2307145|NCT02694523|4009474|FG002|Part B|Withdrawal by Subject|9
2307146|NCT02694523|4009475|FG003|Part B|Withdrawal by Subject|0
2307147|NCT02694523|4009476|FG004|Part B|Withdrawal by Subject|1
2307148|NCT02694523|4009477|FG005|Part B|Withdrawal by Subject|3
2307149|NCT02694523|4009478|FG006|Part B|Withdrawal by Subject|0
2307150|NCT02694523|4009472|FG000|Part B|Other|0
2307151|NCT02694523|4009473|FG001|Part B|Other|0
2307152|NCT02694523|4009474|FG002|Part B|Other|1
2091327|NCT00767000|3678990|FG000|54-week Study|Withdrawal by Subject|2
2091328|NCT00767000|3678991|FG001|54-week Study|Withdrawal by Subject|3
2091329|NCT00767000|3678992|FG002|54-week Study|Withdrawal by Subject|5
2091330|NCT00767000|3678993|FG003|54-week Study|Withdrawal by Subject|11
2091331|NCT00767000|3678994|FG004|54-week Study|Withdrawal by Subject|13
2091332|NCT00767000|3678990|FG000|54-week Study|Study terminated by sponsor|90
2091333|NCT00767000|3678991|FG001|54-week Study|Study terminated by sponsor|102
2091334|NCT00767000|3678992|FG002|54-week Study|Study terminated by sponsor|89
2307153|NCT02694523|4009475|FG003|Part B|Other|0
2307154|NCT02694523|4009476|FG004|Part B|Other|0
2307155|NCT02694523|4009477|FG005|Part B|Other|0
2307156|NCT02694523|4009478|FG006|Part B|Other|1
2307157|NCT02694536|4009490|FG000|Overall Study|Progressive Disease|40
2307158|NCT02694536|4009490|FG000|Overall Study|Lost to Follow-up|1
2307159|NCT02694536|4009490|FG000|Overall Study|Study Drug-Related Adverse Event|1
2307160|NCT02694536|4009490|FG000|Overall Study|Withdrawal by Subject|8
2307161|NCT02694536|4009490|FG000|Overall Study|Death|8
2307162|NCT02694536|4009490|FG000|Overall Study|Other|22
2307163|NCT02694549|4009494|FG000|Overall Study|screen failures|2
2307164|NCT02694562|4009498|FG000|Overall Study|Death|8
2307165|NCT02694562|4009498|FG000|Overall Study|Protocol Violation|4
2307166|NCT02694562|4009498|FG000|Overall Study|Lost to Follow-up|3
2307167|NCT02694562|4009498|FG000|Overall Study|Screen Failure|2
2307168|NCT02694562|4009498|FG000|Overall Study|Physician Decision|1
2307169|NCT02694718|4009506|FG000|Overall Study|Death|1
2307170|NCT02694718|4009506|FG000|Overall Study|Withdrawal by Subject|1
2307171|NCT02694744|4009512|FG000|Overall Study|Adverse Event|2
2307172|NCT02694744|4009513|FG001|Overall Study|Adverse Event|1
2307173|NCT02694744|4009512|FG000|Overall Study|Withdrawal by Subject|2
2307174|NCT02694744|4009513|FG001|Overall Study|Withdrawal by Subject|1
2307175|NCT02694744|4009512|FG000|Overall Study|Physician Decision|1
2307176|NCT02694744|4009513|FG001|Overall Study|Physician Decision|2
2307177|NCT02694744|4009512|FG000|Overall Study|Lost to Follow-up|1
2307178|NCT02694744|4009513|FG001|Overall Study|Lost to Follow-up|0
2307179|NCT02694744|4009512|FG000|Overall Study|Taking potassium supplement: exclusion 6|0
2307180|NCT02694744|4009513|FG001|Overall Study|Taking potassium supplement: exclusion 6|1
2307181|NCT02694978|4009532|FG000|Overall Study|Adverse Event|10
2307182|NCT02694978|4009533|FG001|Overall Study|Adverse Event|9
2307183|NCT02694978|4009532|FG000|Overall Study|Withdrawal by Subject|22
2307184|NCT02694978|4009533|FG001|Overall Study|Withdrawal by Subject|19
2307185|NCT02694978|4009532|FG000|Overall Study|Lost to Follow-up|14
2307186|NCT02694978|4009533|FG001|Overall Study|Lost to Follow-up|17
2307187|NCT02694978|4009532|FG000|Overall Study|Death|4
2307188|NCT02694978|4009533|FG001|Overall Study|Death|1
2307189|NCT02694978|4009532|FG000|Overall Study|Other-Decision of Participant|6
2307190|NCT02694978|4009533|FG001|Overall Study|Other-Decision of Participant|1
2307191|NCT02694978|4009532|FG000|Overall Study|Other-Investigator's decision|1
2307192|NCT02694978|4009533|FG001|Overall Study|Other-Investigator's decision|0
2307193|NCT02694978|4009532|FG000|Overall Study|Other-Unable to be reached|0
2307194|NCT02694978|4009533|FG001|Overall Study|Other-Unable to be reached|1
2307195|NCT02694978|4009532|FG000|Overall Study|Other-Protocol noncompliant|2
2307196|NCT02694978|4009533|FG001|Overall Study|Other-Protocol noncompliant|1
2307197|NCT02694978|4009532|FG000|Overall Study|Other-Personal reasons|3
2307198|NCT02694978|4009533|FG001|Overall Study|Other-Personal reasons|3
2307199|NCT02694978|4009532|FG000|Overall Study|Other-Withdrew prior to dosing|9
2307200|NCT02694978|4009533|FG001|Overall Study|Other-Withdrew prior to dosing|8
2307201|NCT02695329|4009545|FG000|Overall Study|Adverse Event|1
2307202|NCT02695329|4009546|FG001|Overall Study|Adverse Event|0
2307203|NCT02695329|4009545|FG000|Overall Study|Poor X-ray quality for measurement|4
2307204|NCT02695329|4009546|FG001|Overall Study|Poor X-ray quality for measurement|5
2307205|NCT02695420|4009556|FG000|Overall Study|Death|0
2307206|NCT02695420|4009557|FG001|Overall Study|Death|1
2307207|NCT02695420|4009558|FG002|Overall Study|Death|0
2307208|NCT02695420|4009559|FG003|Overall Study|Death|0
2307209|NCT02695524|4009578|FG000|Overall Study|Lost to Follow-up|3
2307210|NCT02695524|4009579|FG001|Overall Study|Lost to Follow-up|2
2307211|NCT02695524|4009578|FG000|Overall Study|Death|0
2307212|NCT02695524|4009579|FG001|Overall Study|Death|1
2307213|NCT02695537|4009585|FG000|Overall Study|Adverse Event|3
2307214|NCT02695537|4009585|FG000|Overall Study|Lack of Efficacy|28
2307215|NCT02695537|4009585|FG000|Overall Study|Withdrawal by Subject|4
2307216|NCT02695537|4009585|FG000|Overall Study|Protocol Violation|3
2307217|NCT02695628|4009589|FG000|Overall Study|Withdrawal by Subject|1
2307218|NCT02695719|4009595|FG000|Overall Study|Pretreatment Event/Adverse Event|2
2307219|NCT02695719|4009596|FG001|Overall Study|Pretreatment Event/Adverse Event|9
2307220|NCT02695719|4009595|FG000|Overall Study|Significant Protocol Deviation|0
2307221|NCT02695719|4009596|FG001|Overall Study|Significant Protocol Deviation|1
2307222|NCT02695719|4009595|FG000|Overall Study|Voluntary Withdrawal|1
2307223|NCT02695719|4009596|FG001|Overall Study|Voluntary Withdrawal|0
2307224|NCT02696031|4009605|FG000|Week 24|Adverse Event|2
2307225|NCT02696031|4009606|FG001|Week 24|Adverse Event|4
2307226|NCT02696031|4009607|FG002|Week 24|Adverse Event|2
2307227|NCT02696031|4009605|FG000|Week 24|Lack of Efficacy|2
2307228|NCT02696031|4009606|FG001|Week 24|Lack of Efficacy|1
2307229|NCT02696031|4009607|FG002|Week 24|Lack of Efficacy|2
2307230|NCT02696031|4009605|FG000|Week 24|Lost to Follow-up|0
2091335|NCT00767000|3678993|FG003|54-week Study|Study terminated by sponsor|196
2091336|NCT00767000|3678994|FG004|54-week Study|Study terminated by sponsor|194
2091337|NCT00767000|3678990|FG000|54-week Study|Reason not reported|0
2091338|NCT00767000|3678991|FG001|54-week Study|Reason not reported|0
2091339|NCT00767000|3678992|FG002|54-week Study|Reason not reported|0
2091340|NCT00767000|3678993|FG003|54-week Study|Reason not reported|1
2091341|NCT00767000|3678994|FG004|54-week Study|Reason not reported|0
2091342|NCT00767000|3678990|FG000|Optional 104-week Extension|Study terminated by sponsor|7
2091343|NCT00767000|3678991|FG001|Optional 104-week Extension|Study terminated by sponsor|3
2091344|NCT00767000|3678992|FG002|Optional 104-week Extension|Study terminated by sponsor|7
2091345|NCT00767000|3678993|FG003|Optional 104-week Extension|Study terminated by sponsor|2
2091346|NCT00767000|3678994|FG004|Optional 104-week Extension|Study terminated by sponsor|4
2091347|NCT00767039|3679008|FG000|Overall Study|Death|5
2091348|NCT00767039|3679009|FG001|Overall Study|Death|2
2091349|NCT00767104|3679017|FG000|Overall Study|Lost to Follow-up|1
2091350|NCT00767104|3679018|FG001|Overall Study|Lost to Follow-up|2
2091351|NCT00767325|3679026|FG000|Overall Study|Lack of Efficacy|2
2091352|NCT00767325|3679026|FG000|Overall Study|Adverse Event|7
2091353|NCT00767325|3679026|FG000|Overall Study|Lost to Follow-up|3
2091354|NCT00767325|3679026|FG000|Overall Study|No longer met study criteria|2
2091355|NCT00767325|3679026|FG000|Overall Study|Missed visit due to family reasons|1
2091356|NCT00767455|3679056|FG000|Overall Study|Investigator error|19
2091357|NCT00767520|3679088|FG000|Overall Study|Participants still on treatment|11
2091358|NCT00767520|3679089|FG001|Overall Study|Participants still on treatment|15
2091359|NCT00767520|3679088|FG000|Overall Study|Randomized in error and Never treated|0
2091360|NCT00767520|3679089|FG001|Overall Study|Randomized in error and Never treated|2
2091361|NCT00767676|3679110|FG000|Overall Study|Investigator error|54
2091362|NCT00767806|3679137|FG000|Overall Study|Adverse Event|30
2091363|NCT00767806|3679138|FG001|Overall Study|Adverse Event|11
2091364|NCT00767806|3679137|FG000|Overall Study|Withdrawal by Subject|8
2091365|NCT00767806|3679138|FG001|Overall Study|Withdrawal by Subject|13
2091366|NCT00767806|3679137|FG000|Overall Study|Protocol Violation|6
2091367|NCT00767806|3679138|FG001|Overall Study|Protocol Violation|5
2091368|NCT00767806|3679137|FG000|Overall Study|Lack of Efficacy|1
2091369|NCT00767806|3679138|FG001|Overall Study|Lack of Efficacy|9
2091370|NCT00767806|3679137|FG000|Overall Study|Physician Decision|4
2091371|NCT00767806|3679138|FG001|Overall Study|Physician Decision|3
2091372|NCT00767806|3679137|FG000|Overall Study|Lost to Follow-up|1
2091373|NCT00767806|3679138|FG001|Overall Study|Lost to Follow-up|4
2091374|NCT00767806|3679137|FG000|Overall Study|Entry Criteria Not Met|1
2091375|NCT00767806|3679138|FG001|Overall Study|Entry Criteria Not Met|1
2091376|NCT00767806|3679137|FG000|Overall Study|Sponsor Decision|0
2091377|NCT00767806|3679138|FG001|Overall Study|Sponsor Decision|1
2091378|NCT00767819|3679147|FG000|Overall Study|Unsatisfactory therapeutic effect|18
2091379|NCT00767819|3679148|FG001|Overall Study|Unsatisfactory therapeutic effect|14
2091380|NCT00767819|3679149|FG002|Overall Study|Unsatisfactory therapeutic effect|0
2091381|NCT00767819|3679147|FG000|Overall Study|Withdrawal by Subject|1
2091382|NCT00767819|3679148|FG001|Overall Study|Withdrawal by Subject|1
2091383|NCT00767819|3679149|FG002|Overall Study|Withdrawal by Subject|0
2091384|NCT00767819|3679147|FG000|Overall Study|Administrative problems|0
2091385|NCT00767819|3679148|FG001|Overall Study|Administrative problems|1
2091386|NCT00767819|3679149|FG002|Overall Study|Administrative problems|0
2091387|NCT00767819|3679147|FG000|Overall Study|Death|2
2091388|NCT00767819|3679148|FG001|Overall Study|Death|3
2091389|NCT00767819|3679149|FG002|Overall Study|Death|0
2091390|NCT00767819|3679147|FG000|Overall Study|Adverse Event|2
2091391|NCT00767819|3679148|FG001|Overall Study|Adverse Event|0
2091392|NCT00767819|3679149|FG002|Overall Study|Adverse Event|0
2091393|NCT00767819|3679147|FG000|Overall Study|Abnormal lab values|1
2091394|NCT00767819|3679148|FG001|Overall Study|Abnormal lab values|0
2091395|NCT00767819|3679149|FG002|Overall Study|Abnormal lab values|0
2091396|NCT00767819|3679147|FG000|Overall Study|Lost to Follow-up|1
2091397|NCT00767819|3679148|FG001|Overall Study|Lost to Follow-up|0
2091398|NCT00767819|3679149|FG002|Overall Study|Lost to Follow-up|0
2091399|NCT00768053|3679157|FG000|Overall Study|Adverse Event|10
2091400|NCT00768053|3679157|FG000|Overall Study|Lost to Follow-up|1
2091401|NCT00768066|3679164|FG000|Overall Study|Did not receive study product injection.|3
2091402|NCT00768066|3679165|FG001|Overall Study|Did not receive study product injection.|3
2091403|NCT00768066|3679166|FG002|Overall Study|Did not receive study product injection.|0
2091404|NCT00768079|3679177|FG000|Overall Study|Lost to Follow-up|2
2091405|NCT00768079|3679178|FG001|Overall Study|Lost to Follow-up|0
2091406|NCT00768079|3679179|FG002|Overall Study|Lost to Follow-up|4
2091407|NCT00768079|3679177|FG000|Overall Study|Participant incarcerated|0
2091408|NCT00768079|3679178|FG001|Overall Study|Participant incarcerated|1
2091409|NCT00768079|3679179|FG002|Overall Study|Participant incarcerated|0
2091410|NCT00768144|3679193|FG000|Overall Study|Adverse Event|13
2091411|NCT00768144|3679193|FG000|Overall Study|Progressive Disease|21
2091412|NCT00768144|3679193|FG000|Overall Study|Patient or MD Decision to End Treatment|1
2091413|NCT00768144|3679193|FG000|Overall Study|Pt Withdrew Consent|1
2091414|NCT00768222|3679199|FG000|Overall Study|Lost to Follow-up|1
2091415|NCT00768222|3679200|FG001|Overall Study|Lost to Follow-up|1
2091416|NCT00768222|3679199|FG000|Overall Study|Withdrawal by Subject|3
2091417|NCT00768222|3679200|FG001|Overall Study|Withdrawal by Subject|1
2091418|NCT00768222|3679199|FG000|Overall Study|Protocol Violation|0
2091419|NCT00768222|3679200|FG001|Overall Study|Protocol Violation|2
2091420|NCT00768300|3679245|FG000|Overall Study|Randomized but not treated|1
2091421|NCT00768300|3679246|FG001|Overall Study|Randomized but not treated|1
2091422|NCT00768300|3679245|FG000|Overall Study|Adverse Event|10
2091423|NCT00768300|3679246|FG001|Overall Study|Adverse Event|2
2091424|NCT00768300|3679245|FG000|Overall Study|Protocol Violation|6
2091425|NCT00768300|3679246|FG001|Overall Study|Protocol Violation|1
2091426|NCT00768300|3679245|FG000|Overall Study|Withdrawal by Subject|13
2091427|NCT00768300|3679246|FG001|Overall Study|Withdrawal by Subject|7
2091428|NCT00768300|3679245|FG000|Overall Study|Physician Decision|2
2091429|NCT00768300|3679246|FG001|Overall Study|Physician Decision|3
2091430|NCT00768300|3679245|FG000|Overall Study|Study discontinued by Sponsor|271
2091431|NCT00768300|3679246|FG001|Overall Study|Study discontinued by Sponsor|140
2091432|NCT00768300|3679245|FG000|Overall Study|Death|21
2091433|NCT00768300|3679246|FG001|Overall Study|Death|5
2091434|NCT00768300|3679245|FG000|Overall Study|Subject moved to pursue lung transplant|1
2091435|NCT00768300|3679246|FG001|Overall Study|Subject moved to pursue lung transplant|1
2091436|NCT00768300|3679245|FG000|Overall Study|Screen failure following randomization|1
2307231|NCT02696031|4009606|FG001|Week 24|Lost to Follow-up|1
2307232|NCT02696031|4009607|FG002|Week 24|Lost to Follow-up|1
2307233|NCT02696031|4009605|FG000|Week 24|Physician Decision|1
2307234|NCT02696031|4009606|FG001|Week 24|Physician Decision|0
2307235|NCT02696031|4009607|FG002|Week 24|Physician Decision|1
2307236|NCT02696031|4009605|FG000|Week 24|Protocol Violation|1
2307237|NCT02696031|4009606|FG001|Week 24|Protocol Violation|0
2307238|NCT02696031|4009607|FG002|Week 24|Protocol Violation|0
2307239|NCT02696031|4009605|FG000|Week 24|Withdrawal by Subject|4
2307240|NCT02696031|4009606|FG001|Week 24|Withdrawal by Subject|1
2307241|NCT02696031|4009607|FG002|Week 24|Withdrawal by Subject|5
2307242|NCT02696031|4009605|FG000|Week 52|Adverse Event|4
2307243|NCT02696031|4009606|FG001|Week 52|Adverse Event|5
2307244|NCT02696031|4009607|FG002|Week 52|Adverse Event|3
2307245|NCT02696031|4009605|FG000|Week 52|Lack of Efficacy|10
2307246|NCT02696031|4009606|FG001|Week 52|Lack of Efficacy|7
2307247|NCT02696031|4009607|FG002|Week 52|Lack of Efficacy|11
2307248|NCT02696031|4009605|FG000|Week 52|Lost to Follow-up|1
2307249|NCT02696031|4009606|FG001|Week 52|Lost to Follow-up|1
2307250|NCT02696031|4009607|FG002|Week 52|Lost to Follow-up|1
2307251|NCT02696031|4009605|FG000|Week 52|Physician Decision|1
2307252|NCT02696031|4009606|FG001|Week 52|Physician Decision|1
2307253|NCT02696031|4009607|FG002|Week 52|Physician Decision|2
2307254|NCT02696031|4009605|FG000|Week 52|Pregnancy|0
2307255|NCT02696031|4009606|FG001|Week 52|Pregnancy|2
2307256|NCT02696031|4009607|FG002|Week 52|Pregnancy|0
2307257|NCT02696031|4009605|FG000|Week 52|Protocol Violation|1
2307258|NCT02696031|4009606|FG001|Week 52|Protocol Violation|0
2307259|NCT02696031|4009607|FG002|Week 52|Protocol Violation|0
2307260|NCT02696031|4009605|FG000|Week 52|Withdrawal by Subject|12
2307261|NCT02696031|4009606|FG001|Week 52|Withdrawal by Subject|3
2307262|NCT02696031|4009607|FG002|Week 52|Withdrawal by Subject|9
2307263|NCT02696317|4009652|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2
2307264|NCT02696317|4009653|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4
2307265|NCT02696317|4009652|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1
2307266|NCT02696317|4009653|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0
2307267|NCT02696434|4009663|FG000|Overall Study|Adverse Event|3
2307268|NCT02696434|4009664|FG001|Overall Study|Adverse Event|1
2307269|NCT02696434|4009663|FG000|Overall Study|Lost to Follow-up|5
2307270|NCT02696434|4009664|FG001|Overall Study|Lost to Follow-up|4
2307271|NCT02696434|4009663|FG000|Overall Study|Withdrawal by Subject|14
2307272|NCT02696434|4009664|FG001|Overall Study|Withdrawal by Subject|12
2307273|NCT02696434|4009663|FG000|Overall Study|Physician Decision|0
2307274|NCT02696434|4009664|FG001|Overall Study|Physician Decision|1
2307275|NCT02696785|4009678|FG000|Blinded Treatment Period|Adverse Event|0
2307276|NCT02696785|4009679|FG001|Blinded Treatment Period|Adverse Event|1
2307277|NCT02696785|4009680|FG002|Blinded Treatment Period|Adverse Event|3
2307278|NCT02696785|4009681|FG003|Blinded Treatment Period|Adverse Event|0
2307279|NCT02696785|4009678|FG000|Blinded Treatment Period|Withdrawal by Subject|0
2307280|NCT02696785|4009679|FG001|Blinded Treatment Period|Withdrawal by Subject|1
2307281|NCT02696785|4009680|FG002|Blinded Treatment Period|Withdrawal by Subject|1
2307282|NCT02696785|4009681|FG003|Blinded Treatment Period|Withdrawal by Subject|2
2307283|NCT02696785|4009678|FG000|Blinded Treatment Period|Lack of Efficacy|0
2307284|NCT02696785|4009679|FG001|Blinded Treatment Period|Lack of Efficacy|0
2307285|NCT02696785|4009680|FG002|Blinded Treatment Period|Lack of Efficacy|0
2307286|NCT02696785|4009681|FG003|Blinded Treatment Period|Lack of Efficacy|1
2307287|NCT02696785|4009678|FG000|Blinded Treatment Period|Screen Failure|1
2307288|NCT02696785|4009679|FG001|Blinded Treatment Period|Screen Failure|0
2091437|NCT00768300|3679246|FG001|Overall Study|Screen failure following randomization|0
2091438|NCT00768300|3679245|FG000|Overall Study|Received lung transplant|1
2307289|NCT02696785|4009680|FG002|Blinded Treatment Period|Screen Failure|0
2307290|NCT02696785|4009681|FG003|Blinded Treatment Period|Screen Failure|0
2307291|NCT02696785|4009678|FG000|Washout Period|Withdrawal by Subject|0
2307292|NCT02696785|4009679|FG001|Washout Period|Withdrawal by Subject|1
2307293|NCT02696785|4009680|FG002|Washout Period|Withdrawal by Subject|0
2307294|NCT02696785|4009681|FG003|Washout Period|Withdrawal by Subject|0
2091439|NCT00768300|3679246|FG001|Overall Study|Received lung transplant|1
2091440|NCT00768300|3679245|FG000|Overall Study|Lost to Follow-up|0
2091441|NCT00768300|3679246|FG001|Overall Study|Lost to Follow-up|1
2211798|NCT01663532|3852322|FG000|Overall Study|Withdrawal by Subject|35
2307295|NCT02696785|4009678|FG000|Washout Period|Lack of Efficacy|0
2307296|NCT02696785|4009679|FG001|Washout Period|Lack of Efficacy|1
2307297|NCT02696785|4009680|FG002|Washout Period|Lack of Efficacy|0
2307298|NCT02696785|4009681|FG003|Washout Period|Lack of Efficacy|0
2307299|NCT02696785|4009678|FG000|Extended Treatment Period|Adverse Event|2
2307300|NCT02696785|4009679|FG001|Extended Treatment Period|Adverse Event|3
2307301|NCT02696785|4009680|FG002|Extended Treatment Period|Adverse Event|2
2307302|NCT02696785|4009681|FG003|Extended Treatment Period|Adverse Event|1
2307303|NCT02696785|4009678|FG000|Extended Treatment Period|Lack of Efficacy|0
2307304|NCT02696785|4009679|FG001|Extended Treatment Period|Lack of Efficacy|1
2307305|NCT02696785|4009680|FG002|Extended Treatment Period|Lack of Efficacy|0
2307306|NCT02696785|4009681|FG003|Extended Treatment Period|Lack of Efficacy|0
2307307|NCT02696785|4009678|FG000|Extended Treatment Period|Withdrawal by Subject|1
2307308|NCT02696785|4009679|FG001|Extended Treatment Period|Withdrawal by Subject|2
2307309|NCT02696785|4009680|FG002|Extended Treatment Period|Withdrawal by Subject|3
2307310|NCT02696785|4009681|FG003|Extended Treatment Period|Withdrawal by Subject|5
2307311|NCT02696785|4009678|FG000|Follow-up Period|Adverse Event|0
2307312|NCT02696785|4009679|FG001|Follow-up Period|Adverse Event|0
2307313|NCT02696785|4009680|FG002|Follow-up Period|Adverse Event|8
2307314|NCT02696785|4009681|FG003|Follow-up Period|Adverse Event|2
2307315|NCT02696785|4009678|FG000|Follow-up Period|Lost to Follow-up|0
2307316|NCT02696785|4009679|FG001|Follow-up Period|Lost to Follow-up|0
2307317|NCT02696785|4009680|FG002|Follow-up Period|Lost to Follow-up|0
2307318|NCT02696785|4009681|FG003|Follow-up Period|Lost to Follow-up|1
2307319|NCT02696785|4009678|FG000|Follow-up Period|Lack of Efficacy|0
2307320|NCT02696785|4009679|FG001|Follow-up Period|Lack of Efficacy|0
2307321|NCT02696785|4009680|FG002|Follow-up Period|Lack of Efficacy|0
2307322|NCT02696785|4009681|FG003|Follow-up Period|Lack of Efficacy|1
2307323|NCT02696785|4009678|FG000|Follow-up Period|Withdrawal by Subject|1
2307324|NCT02696785|4009679|FG001|Follow-up Period|Withdrawal by Subject|0
2307325|NCT02696785|4009680|FG002|Follow-up Period|Withdrawal by Subject|5
2307326|NCT02696785|4009681|FG003|Follow-up Period|Withdrawal by Subject|4
2307327|NCT02696798|4009712|FG000|Blinded Treatment Dosing Period|Adverse Event|2
2307328|NCT02696798|4009713|FG001|Blinded Treatment Dosing Period|Adverse Event|9
2307329|NCT02696798|4009714|FG002|Blinded Treatment Dosing Period|Adverse Event|2
2307330|NCT02696798|4009712|FG000|Blinded Treatment Dosing Period|Death|0
2307331|NCT02696798|4009713|FG001|Blinded Treatment Dosing Period|Death|0
2307332|NCT02696798|4009714|FG002|Blinded Treatment Dosing Period|Death|1
2307333|NCT02696798|4009712|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2
2307334|NCT02696798|4009713|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1
2307335|NCT02696798|4009714|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1
2307336|NCT02696798|4009712|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0
2307337|NCT02696798|4009713|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1
2307338|NCT02696798|4009714|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0
2307339|NCT02696798|4009712|FG000|Blinded Treatment Dosing Period|Physician Decision|0
2307340|NCT02696798|4009713|FG001|Blinded Treatment Dosing Period|Physician Decision|1
2307341|NCT02696798|4009714|FG002|Blinded Treatment Dosing Period|Physician Decision|0
2307342|NCT02696798|4009712|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7
2307343|NCT02696798|4009713|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3
2307344|NCT02696798|4009714|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4
2307345|NCT02696798|4009712|FG000|Extended Treatment Period|Adverse Event|1
2307346|NCT02696798|4009713|FG001|Extended Treatment Period|Adverse Event|4
2307347|NCT02696798|4009714|FG002|Extended Treatment Period|Adverse Event|5
2307348|NCT02696798|4009712|FG000|Extended Treatment Period|Lack of Efficacy|7
2307349|NCT02696798|4009713|FG001|Extended Treatment Period|Lack of Efficacy|2
2307350|NCT02696798|4009714|FG002|Extended Treatment Period|Lack of Efficacy|2
2307351|NCT02696798|4009712|FG000|Extended Treatment Period|Lost to Follow-up|1
2307352|NCT02696798|4009713|FG001|Extended Treatment Period|Lost to Follow-up|0
2307353|NCT02696798|4009714|FG002|Extended Treatment Period|Lost to Follow-up|0
2307354|NCT02696798|4009712|FG000|Extended Treatment Period|Physician Decision|0
2307355|NCT02696798|4009713|FG001|Extended Treatment Period|Physician Decision|1
2307356|NCT02696798|4009714|FG002|Extended Treatment Period|Physician Decision|0
2307357|NCT02696798|4009712|FG000|Extended Treatment Period|Withdrawal by Subject|3
2307358|NCT02696798|4009713|FG001|Extended Treatment Period|Withdrawal by Subject|2
2307359|NCT02696798|4009714|FG002|Extended Treatment Period|Withdrawal by Subject|3
2307360|NCT02696798|4009712|FG000|Post-treatment Follow-up Period|Adverse Event|2
2307361|NCT02696798|4009713|FG001|Post-treatment Follow-up Period|Adverse Event|12
2307362|NCT02696798|4009714|FG002|Post-treatment Follow-up Period|Adverse Event|6
2307363|NCT02696798|4009712|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0
2307364|NCT02696798|4009713|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1
2307365|NCT02696798|4009714|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1
2307366|NCT02696798|4009712|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1
2307367|NCT02696798|4009713|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2
2107397|NCT00873041|3700976|FG002|Core Study|Abnormal laboratory value|1
2091442|NCT00768300|3679245|FG000|Overall Study|Began prohibited concomitant medication|0
2091443|NCT00768300|3679246|FG001|Overall Study|Began prohibited concomitant medication|1
2307368|NCT02696798|4009714|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0
2307369|NCT02696798|4009712|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2
2307370|NCT02696798|4009713|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8
2307371|NCT02696798|4009714|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12
2307372|NCT02696798|4009712|FG000|Post-treatment Follow-up Period|Physician Decision|0
2307373|NCT02696798|4009713|FG001|Post-treatment Follow-up Period|Physician Decision|2
2307374|NCT02696798|4009714|FG002|Post-treatment Follow-up Period|Physician Decision|0
2307375|NCT02696798|4009712|FG000|Post-treatment Follow-up Period|No progressive improvement|0
2307376|NCT02696798|4009713|FG001|Post-treatment Follow-up Period|No progressive improvement|1
2307377|NCT02696798|4009714|FG002|Post-treatment Follow-up Period|No progressive improvement|0
2307378|NCT02696850|4009738|FG000|Overall Study|Withdrawal by Subject|3
2307379|NCT02696850|4009739|FG001|Overall Study|Withdrawal by Subject|3
2307380|NCT02696850|4009738|FG000|Overall Study|Lost to Follow-up|8
2307381|NCT02696850|4009739|FG001|Overall Study|Lost to Follow-up|5
2307382|NCT02696902|4009748|FG000|Overall Study|Lost to Follow-up|0
2307383|NCT02696902|4009749|FG001|Overall Study|Lost to Follow-up|1
2307384|NCT02696902|4009750|FG002|Overall Study|Lost to Follow-up|1
2307385|NCT02696902|4009748|FG000|Overall Study|Withdrawal by Subject|0
2307386|NCT02696902|4009749|FG001|Overall Study|Withdrawal by Subject|0
2307387|NCT02696902|4009750|FG002|Overall Study|Withdrawal by Subject|1
2307388|NCT02696902|4009748|FG000|Overall Study|Death|19
2307389|NCT02696902|4009749|FG001|Overall Study|Death|3
2307390|NCT02696902|4009750|FG002|Overall Study|Death|24
2307391|NCT02696902|4009748|FG000|Overall Study|Participant not fit post-randomization|0
2307392|NCT02696902|4009749|FG001|Overall Study|Participant not fit post-randomization|0
2307393|NCT02696902|4009750|FG002|Overall Study|Participant not fit post-randomization|1
2307394|NCT02696902|4009748|FG000|Overall Study|Participant not eligible (negative PCR)|0
2307395|NCT02696902|4009749|FG001|Overall Study|Participant not eligible (negative PCR)|0
2307396|NCT02696902|4009750|FG002|Overall Study|Participant not eligible (negative PCR)|1
2307397|NCT02696902|4009748|FG000|Overall Study|Principal investigator's decision|1
2307398|NCT02696902|4009749|FG001|Overall Study|Principal investigator's decision|0
2307399|NCT02696902|4009750|FG002|Overall Study|Principal investigator's decision|0
2307400|NCT02696902|4009748|FG000|Overall Study|Sponsor's decision|1
2307401|NCT02696902|4009749|FG001|Overall Study|Sponsor's decision|0
2307402|NCT02696902|4009750|FG002|Overall Study|Sponsor's decision|0
2307403|NCT02696902|4009748|FG000|Overall Study|Transferred to other hospital|1
2307404|NCT02696902|4009749|FG001|Overall Study|Transferred to other hospital|0
2307405|NCT02696902|4009750|FG002|Overall Study|Transferred to other hospital|0
2307406|NCT02697435|4009829|FG000|Overall Study|Withdrawal by Subject|1
2307407|NCT02697435|4009830|FG001|Overall Study|Withdrawal by Subject|0
2307408|NCT02697435|4009829|FG000|Overall Study|Physician Decision|0
2307409|NCT02697435|4009830|FG001|Overall Study|Physician Decision|4
2307410|NCT02697591|4009847|FG000|Overall Study|Lost to Follow-up|0
2307411|NCT02697591|4009848|FG001|Overall Study|Lost to Follow-up|0
2307412|NCT02697591|4009849|FG002|Overall Study|Lost to Follow-up|0
2307413|NCT02697591|4009850|FG003|Overall Study|Lost to Follow-up|0
2307414|NCT02697591|4009851|FG004|Overall Study|Lost to Follow-up|0
2307415|NCT02697591|4009852|FG005|Overall Study|Lost to Follow-up|1
2307416|NCT02697591|4009853|FG006|Overall Study|Lost to Follow-up|1
2307417|NCT02697591|4009854|FG007|Overall Study|Lost to Follow-up|0
2307418|NCT02697591|4009855|FG008|Overall Study|Lost to Follow-up|0
2307419|NCT02697591|4009856|FG009|Overall Study|Lost to Follow-up|1
2307420|NCT02697591|4009847|FG000|Overall Study|Withdrawal by Subject|1
2307421|NCT02697591|4009848|FG001|Overall Study|Withdrawal by Subject|1
2307422|NCT02697591|4009849|FG002|Overall Study|Withdrawal by Subject|2
2307423|NCT02697591|4009850|FG003|Overall Study|Withdrawal by Subject|1
2307424|NCT02697591|4009851|FG004|Overall Study|Withdrawal by Subject|7
2307425|NCT02697591|4009852|FG005|Overall Study|Withdrawal by Subject|6
2307426|NCT02697591|4009853|FG006|Overall Study|Withdrawal by Subject|9
2307427|NCT02697591|4009854|FG007|Overall Study|Withdrawal by Subject|1
2307428|NCT02697591|4009855|FG008|Overall Study|Withdrawal by Subject|6
2307429|NCT02697591|4009856|FG009|Overall Study|Withdrawal by Subject|10
2307430|NCT02697591|4009847|FG000|Overall Study|Physician Decision|1
2307431|NCT02697591|4009848|FG001|Overall Study|Physician Decision|0
2307432|NCT02697591|4009849|FG002|Overall Study|Physician Decision|0
2307433|NCT02697591|4009850|FG003|Overall Study|Physician Decision|0
2307434|NCT02697591|4009851|FG004|Overall Study|Physician Decision|1
2307435|NCT02697591|4009852|FG005|Overall Study|Physician Decision|2
2307436|NCT02697591|4009853|FG006|Overall Study|Physician Decision|0
2307437|NCT02697591|4009854|FG007|Overall Study|Physician Decision|0
2307438|NCT02697591|4009855|FG008|Overall Study|Physician Decision|1
2307439|NCT02697591|4009856|FG009|Overall Study|Physician Decision|1
2307440|NCT02697591|4009847|FG000|Overall Study|Death|2
2307441|NCT02697591|4009848|FG001|Overall Study|Death|3
2307442|NCT02697591|4009849|FG002|Overall Study|Death|1
2307443|NCT02697591|4009850|FG003|Overall Study|Death|1
2307444|NCT02697591|4009851|FG004|Overall Study|Death|4
2307445|NCT02697591|4009852|FG005|Overall Study|Death|5
2307446|NCT02697591|4009853|FG006|Overall Study|Death|3
2307447|NCT02697591|4009854|FG007|Overall Study|Death|1
2091444|NCT00768300|3679245|FG000|Overall Study|Treated but never dosed with Study drug|1
2091445|NCT00768300|3679246|FG001|Overall Study|Treated but never dosed with Study drug|0
2091446|NCT00768300|3679245|FG000|Overall Study|Missing data|1
2091447|NCT00768300|3679246|FG001|Overall Study|Missing data|0
2091448|NCT00768430|3679254|FG000|7 Day Endpoint|Withdrawal by Subject|2
2091449|NCT00768430|3679255|FG001|7 Day Endpoint|Withdrawal by Subject|3
2091450|NCT00768469|3679263|FG000|Overall Study|Adverse Event|0
2091451|NCT00768469|3679264|FG001|Overall Study|Adverse Event|2
2091452|NCT00768469|3679263|FG000|Overall Study|Disease Progression|3
2091453|NCT00768469|3679264|FG001|Overall Study|Disease Progression|4
2091454|NCT00768469|3679263|FG000|Overall Study|Withdrawal by Subject|0
2091455|NCT00768469|3679264|FG001|Overall Study|Withdrawal by Subject|1
2091456|NCT00768560|3679284|FG000|Intervention Set 1|Adverse Event|0
2091457|NCT00768560|3679285|FG001|Intervention Set 1|Adverse Event|1
2091458|NCT00768560|3679286|FG002|Intervention Set 1|Adverse Event|0
2091459|NCT00768560|3679287|FG003|Intervention Set 1|Adverse Event|0
2091460|NCT00768560|3679288|FG004|Intervention Set 1|Adverse Event|0
2091461|NCT00768560|3679289|FG005|Intervention Set 1|Adverse Event|0
2091462|NCT00768651|3679310|FG000|Overall Study|Withdrawal by Subject|1
2107398|NCT00873041|3700974|FG000|Core Study|Protocol deviation|1
2107399|NCT00873041|3700975|FG001|Core Study|Protocol deviation|0
2107400|NCT00873041|3700976|FG002|Core Study|Protocol deviation|1
2107401|NCT00873041|3700974|FG000|Extension Study|Adverse Event|1
2107402|NCT00873041|3700975|FG001|Extension Study|Adverse Event|0
2107403|NCT00873041|3700976|FG002|Extension Study|Adverse Event|1
2107404|NCT00873041|3700974|FG000|Extension Study|Administrative reasons|0
2107405|NCT00873041|3700975|FG001|Extension Study|Administrative reasons|0
2107406|NCT00873041|3700976|FG002|Extension Study|Administrative reasons|1
2107407|NCT00873093|3700996|FG000|Overall Study|Adverse Event|0
2107408|NCT00873093|3700997|FG001|Overall Study|Adverse Event|2
2107409|NCT00873093|3700998|FG002|Overall Study|Adverse Event|0
2107410|NCT00873093|3700999|FG003|Overall Study|Adverse Event|0
2107411|NCT00873093|3701000|FG004|Overall Study|Adverse Event|0
2107412|NCT00873093|3700996|FG000|Overall Study|Death|0
2107413|NCT00873093|3700997|FG001|Overall Study|Death|3
2107414|NCT00873093|3700998|FG002|Overall Study|Death|2
2107415|NCT00873093|3700999|FG003|Overall Study|Death|0
2107416|NCT00873093|3701000|FG004|Overall Study|Death|0
2107417|NCT00873093|3700996|FG000|Overall Study|Physician Decision|0
2107418|NCT00873093|3700997|FG001|Overall Study|Physician Decision|17
2107419|NCT00873093|3700998|FG002|Overall Study|Physician Decision|10
2107420|NCT00873093|3700999|FG003|Overall Study|Physician Decision|10
2107421|NCT00873093|3701000|FG004|Overall Study|Physician Decision|2
2107422|NCT00873093|3700996|FG000|Overall Study|Withdrawal by Subject|1
2107423|NCT00873093|3700997|FG001|Overall Study|Withdrawal by Subject|4
2107424|NCT00873093|3700998|FG002|Overall Study|Withdrawal by Subject|4
2107425|NCT00873093|3700999|FG003|Overall Study|Withdrawal by Subject|0
2107426|NCT00873093|3701000|FG004|Overall Study|Withdrawal by Subject|0
2107427|NCT00873093|3700996|FG000|Overall Study|Ineligible|0
2107428|NCT00873093|3700997|FG001|Overall Study|Ineligible|1
2107429|NCT00873093|3700998|FG002|Overall Study|Ineligible|0
2107430|NCT00873093|3700999|FG003|Overall Study|Ineligible|1
2107431|NCT00873093|3701000|FG004|Overall Study|Ineligible|0
2107432|NCT00873119|3701024|FG000|Overall Study|Patient request|4
2107433|NCT00873119|3701025|FG001|Overall Study|Patient request|2
2107434|NCT00873119|3701024|FG000|Overall Study|Adverse Event|8
2107435|NCT00873119|3701025|FG001|Overall Study|Adverse Event|0
2107436|NCT00873119|3701024|FG000|Overall Study|Progressive disease|26
2107437|NCT00873119|3701025|FG001|Overall Study|Progressive disease|18
2107438|NCT00873119|3701024|FG000|Overall Study|Death|2
2107439|NCT00873119|3701025|FG001|Overall Study|Death|1
2107440|NCT00873119|3701024|FG000|Overall Study|Other|2
2107441|NCT00873119|3701025|FG001|Overall Study|Other|5
2107442|NCT00873119|3701024|FG000|Overall Study|Not treated|2
2107443|NCT00873119|3701025|FG001|Overall Study|Not treated|0
2107444|NCT00873730|3701041|FG000|Overall Study|Protocol Deviation|5
2107445|NCT00873730|3701042|FG001|Overall Study|Protocol Deviation|2
2107446|NCT00873730|3701041|FG000|Overall Study|Adverse Event|0
2107447|NCT00873730|3701042|FG001|Overall Study|Adverse Event|2
2107448|NCT00873730|3701041|FG000|Overall Study|Withdrawal by Subject|0
2107449|NCT00873730|3701042|FG001|Overall Study|Withdrawal by Subject|1
2107450|NCT00873730|3701041|FG000|Overall Study|Sponsor decision|1
2107451|NCT00873730|3701042|FG001|Overall Study|Sponsor decision|0
2107452|NCT00873860|3701065|FG000|Overall Study|Lost to Follow-up|1
2107453|NCT00873860|3701066|FG001|Overall Study|Lost to Follow-up|0
2107454|NCT00873860|3701067|FG002|Overall Study|Lost to Follow-up|0
2107455|NCT00873860|3701068|FG003|Overall Study|Lost to Follow-up|1
2107456|NCT00873860|3701065|FG000|Overall Study|Withdrawal by Subject|1
2107457|NCT00873860|3701066|FG001|Overall Study|Withdrawal by Subject|0
2107458|NCT00873860|3701067|FG002|Overall Study|Withdrawal by Subject|2
2107459|NCT00873860|3701068|FG003|Overall Study|Withdrawal by Subject|0
2107460|NCT00873860|3701065|FG000|Overall Study|Death|1
2107461|NCT00873860|3701066|FG001|Overall Study|Death|0
2107462|NCT00873860|3701067|FG002|Overall Study|Death|0
2107463|NCT00873860|3701068|FG003|Overall Study|Death|0
2107464|NCT00873860|3701065|FG000|Overall Study|Other|1
2107465|NCT00873860|3701066|FG001|Overall Study|Other|0
2107466|NCT00873860|3701067|FG002|Overall Study|Other|1
2091463|NCT00768664|3679315|FG000|Overall Study|Death|57
2091464|NCT00768664|3679315|FG000|Overall Study|Lost to Follow-up|2
2091465|NCT00768664|3679315|FG000|Overall Study|Other|9
2091466|NCT00768664|3679315|FG000|Overall Study|Participant refused|1
2091467|NCT00768755|3679335|FG000|Phase 1|Death|6
2091468|NCT00768755|3679336|FG001|Phase 1|Death|0
2091469|NCT00768755|3679337|FG002|Phase 1|Death|0
2091470|NCT00768755|3679338|FG003|Phase 1|Death|0
2091471|NCT00768755|3679335|FG000|Phase 1|Other|4
2091472|NCT00768755|3679336|FG001|Phase 1|Other|0
2091473|NCT00768755|3679337|FG002|Phase 1|Other|0
2091474|NCT00768755|3679338|FG003|Phase 1|Other|0
2091475|NCT00768755|3679335|FG000|Phase 2|Death|0
2091476|NCT00768755|3679336|FG001|Phase 2|Death|37
2091477|NCT00768755|3679337|FG002|Phase 2|Death|48
2091478|NCT00768755|3679338|FG003|Phase 2|Death|31
2091479|NCT00768755|3679335|FG000|Phase 2|Protocol Violation|0
2091480|NCT00768755|3679336|FG001|Phase 2|Protocol Violation|2
2091481|NCT00768755|3679337|FG002|Phase 2|Protocol Violation|0
2091482|NCT00768755|3679338|FG003|Phase 2|Protocol Violation|1
2091483|NCT00768755|3679335|FG000|Phase 2|Lost to Follow-up|0
2091484|NCT00768755|3679336|FG001|Phase 2|Lost to Follow-up|1
2091485|NCT00768755|3679337|FG002|Phase 2|Lost to Follow-up|1
2091486|NCT00768755|3679338|FG003|Phase 2|Lost to Follow-up|4
2091487|NCT00768755|3679335|FG000|Phase 2|Withdrawal by Subject|0
2091488|NCT00768755|3679336|FG001|Phase 2|Withdrawal by Subject|1
2091489|NCT00768755|3679337|FG002|Phase 2|Withdrawal by Subject|0
2091490|NCT00768755|3679338|FG003|Phase 2|Withdrawal by Subject|1
2091491|NCT00768755|3679335|FG000|Phase 2|Other|0
2091492|NCT00768755|3679336|FG001|Phase 2|Other|1
2091493|NCT00768755|3679337|FG002|Phase 2|Other|2
2091494|NCT00768755|3679338|FG003|Phase 2|Other|4
2091495|NCT00768755|3679335|FG000|Phase 2|Study Terminated by Sponsor|0
2091496|NCT00768755|3679336|FG001|Phase 2|Study Terminated by Sponsor|13
2091497|NCT00768755|3679337|FG002|Phase 2|Study Terminated by Sponsor|7
2091498|NCT00768755|3679338|FG003|Phase 2|Study Terminated by Sponsor|14
2091499|NCT00768755|3679335|FG000|Phase 2|Randomized but not treated|0
2091500|NCT00768755|3679336|FG001|Phase 2|Randomized but not treated|0
2091501|NCT00768755|3679337|FG002|Phase 2|Randomized but not treated|0
2091502|NCT00768755|3679338|FG003|Phase 2|Randomized but not treated|2
2091503|NCT00768898|3679347|FG000|Overall Study|Unrelated injury|1
2091504|NCT00768898|3679347|FG000|Overall Study|Headache|1
2091505|NCT00768989|3679358|FG000|Prior to Week 24|Withdrawal by Subject|1
2091506|NCT00768989|3679359|FG001|Prior to Week 24|Withdrawal by Subject|0
2091507|NCT00768989|3679358|FG000|Prior to Week 24|Adverse Event|3
2091508|NCT00768989|3679359|FG001|Prior to Week 24|Adverse Event|0
2091509|NCT00768989|3679358|FG000|Prior to Week 24|Lost to Follow-up|0
2091510|NCT00768989|3679359|FG001|Prior to Week 24|Lost to Follow-up|1
2091511|NCT00768989|3679358|FG000|Prior to Week 24|Protocol Violation|0
2091512|NCT00768989|3679359|FG001|Prior to Week 24|Protocol Violation|2
2091513|NCT00768989|3679358|FG000|Week 24 to Prior to Week 36|Adverse Event|1
2091514|NCT00768989|3679359|FG001|Week 24 to Prior to Week 36|Adverse Event|0
2091515|NCT00768989|3679358|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6
2091516|NCT00768989|3679359|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0
2091517|NCT00768989|3679358|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1
2091518|NCT00768989|3679359|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0
2091519|NCT00768989|3679358|FG000|On or After Week 36|Lack of Efficacy|1
2091520|NCT00768989|3679359|FG001|On or After Week 36|Lack of Efficacy|0
2091521|NCT00768989|3679358|FG000|On or After Week 36|Adverse Event|0
2091522|NCT00768989|3679359|FG001|On or After Week 36|Adverse Event|1
2091523|NCT00768989|3679358|FG000|On or After Week 36|Lost to Follow-up|1
2211799|NCT01663532|3852323|FG001|Overall Study|Withdrawal by Subject|17
2211800|NCT01663532|3852322|FG000|Overall Study|Lack of Efficacy|15
2211801|NCT01663532|3852323|FG001|Overall Study|Lack of Efficacy|60
2211802|NCT01663623|3852331|FG000|Overall Study|Adverse Event|3
2211803|NCT01663623|3852332|FG001|Overall Study|Adverse Event|7
2211804|NCT01663623|3852331|FG000|Overall Study|Lack of Efficacy|5
2211805|NCT01663623|3852332|FG001|Overall Study|Lack of Efficacy|6
2211806|NCT01663623|3852331|FG000|Overall Study|Protocol Violation|0
2091524|NCT00768989|3679359|FG001|On or After Week 36|Lost to Follow-up|0
2091525|NCT00768989|3679358|FG000|On or After Week 36|Poor Compliance|1
2091526|NCT00768989|3679359|FG001|On or After Week 36|Poor Compliance|0
2091527|NCT00768989|3679358|FG000|On or After Week 36|Protocol Violation|1
2091528|NCT00768989|3679359|FG001|On or After Week 36|Protocol Violation|0
2091529|NCT00768989|3679358|FG000|On or After Week 36|Did not attend termination visit|2
2091530|NCT00768989|3679359|FG001|On or After Week 36|Did not attend termination visit|0
2091531|NCT00768989|3679358|FG000|On or After Week 36|Sponsor Termination|45
2091532|NCT00768989|3679359|FG001|On or After Week 36|Sponsor Termination|26
2091533|NCT00769067|3679378|FG000|Overall Study|Death|89
2091534|NCT00769067|3679379|FG001|Overall Study|Death|86
2091535|NCT00769067|3679378|FG000|Overall Study|Lost to Follow-up|3
2091536|NCT00769067|3679379|FG001|Overall Study|Lost to Follow-up|1
2091537|NCT00769067|3679378|FG000|Overall Study|Study terminated by sponsor|1
2091538|NCT00769067|3679379|FG001|Overall Study|Study terminated by sponsor|3
2091539|NCT00769067|3679378|FG000|Overall Study|Other|1
2091540|NCT00769067|3679379|FG001|Overall Study|Other|3
2091541|NCT00769067|3679378|FG000|Overall Study|Withdrawal by Subject|0
2211807|NCT01663623|3852332|FG001|Overall Study|Protocol Violation|1
2091542|NCT00769067|3679379|FG001|Overall Study|Withdrawal by Subject|1
2091543|NCT00769119|3679388|FG000|Overall Study|Voluntary discontinuation|0
2091544|NCT00769119|3679389|FG001|Overall Study|Voluntary discontinuation|2
2091545|NCT00769119|3679388|FG000|Overall Study|Adverse Event|1
2091546|NCT00769119|3679389|FG001|Overall Study|Adverse Event|1
2091547|NCT00769119|3679388|FG000|Overall Study|Disallowed medication|1
2091548|NCT00769119|3679389|FG001|Overall Study|Disallowed medication|0
2091549|NCT00769132|3679395|FG000|Period 1|Adverse Event|1
2091550|NCT00769132|3679396|FG001|Period 1|Adverse Event|0
2091551|NCT00769132|3679397|FG002|Period 1|Adverse Event|0
2091552|NCT00769132|3679398|FG003|Period 1|Adverse Event|1
2091553|NCT00769132|3679395|FG000|Period 2|Withdrawal by Subject|0
2091554|NCT00769132|3679396|FG001|Period 2|Withdrawal by Subject|0
2091555|NCT00769132|3679397|FG002|Period 2|Withdrawal by Subject|0
2091556|NCT00769132|3679398|FG003|Period 2|Withdrawal by Subject|1
2091557|NCT00769132|3679395|FG000|Period 3|Withdrawal by Subject|1
2091558|NCT00769132|3679396|FG001|Period 3|Withdrawal by Subject|0
2091559|NCT00769132|3679397|FG002|Period 3|Withdrawal by Subject|0
2091560|NCT00769132|3679398|FG003|Period 3|Withdrawal by Subject|0
2091561|NCT00769132|3679395|FG000|Period 4|Withdrawal by Subject|0
2091562|NCT00769132|3679396|FG001|Period 4|Withdrawal by Subject|1
2091563|NCT00769132|3679397|FG002|Period 4|Withdrawal by Subject|0
2091564|NCT00769132|3679398|FG003|Period 4|Withdrawal by Subject|0
2091565|NCT00769184|3679408|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
2091566|NCT00769184|3679409|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
2091567|NCT00769184|3679408|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
2091568|NCT00769184|3679409|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
2091569|NCT00769184|3679408|FG000|No Treatment (6 Weeks)|Adverse Event|1
2091570|NCT00769184|3679409|FG001|No Treatment (6 Weeks)|Adverse Event|1
2091571|NCT00769483|3679436|FG000|Overall Study|Withdrawal by Subject|0
2091572|NCT00769483|3679437|FG001|Overall Study|Withdrawal by Subject|1
2091573|NCT00769483|3679438|FG002|Overall Study|Withdrawal by Subject|0
2091574|NCT00769483|3679439|FG003|Overall Study|Withdrawal by Subject|0
2091575|NCT00769483|3679440|FG004|Overall Study|Withdrawal by Subject|1
2091576|NCT00769483|3679441|FG005|Overall Study|Withdrawal by Subject|0
2091577|NCT00769561|3679459|FG000|Overall Study|Withdrawal by Subject|2
2091578|NCT00769561|3679460|FG001|Overall Study|Withdrawal by Subject|2
2091579|NCT00769561|3679459|FG000|Overall Study|Lost to Follow-up|1
2091580|NCT00769561|3679460|FG001|Overall Study|Lost to Follow-up|3
2091581|NCT00769704|3679480|FG000|Overall Study|Lost to Follow-up|3
2091582|NCT00769704|3679481|FG001|Overall Study|Lost to Follow-up|2
2091583|NCT00769704|3679480|FG000|Overall Study|Death|95
2091584|NCT00769704|3679481|FG001|Overall Study|Death|190
2091585|NCT00769704|3679480|FG000|Overall Study|Withdrawal by Subject|12
2091586|NCT00769704|3679481|FG001|Overall Study|Withdrawal by Subject|5
2091587|NCT00769704|3679480|FG000|Overall Study|Other|1
2091588|NCT00769704|3679481|FG001|Overall Study|Other|2
2091589|NCT00769860|3679494|FG000|Overall Study|Withdrawal by Subject|2
2091590|NCT00769860|3679495|FG001|Overall Study|Withdrawal by Subject|0
2091591|NCT00770029|3679520|FG000|Overall Study|Lost to Follow-up|2
2091592|NCT00770029|3679521|FG001|Overall Study|Lost to Follow-up|0
2091593|NCT00770029|3679520|FG000|Overall Study|Withdrawal by Subject|3
2091594|NCT00770029|3679521|FG001|Overall Study|Withdrawal by Subject|3
2091595|NCT00770029|3679520|FG000|Overall Study|Adverse Event|1
2091596|NCT00770029|3679521|FG001|Overall Study|Adverse Event|0
2091597|NCT00770120|3679527|FG000|Overall Study|Progression|31
2091598|NCT00770120|3679527|FG000|Overall Study|Adverse Event|11
2091599|NCT00770120|3679527|FG000|Overall Study|Not Protocol Specified|11
2091600|NCT00770120|3679527|FG000|Overall Study|Death|3
2091601|NCT00770120|3679527|FG000|Overall Study|Withdrawal by Subject|2
2091602|NCT00770120|3679527|FG000|Overall Study|Ineligible|1
2091603|NCT00770120|3679527|FG000|Overall Study|Never Received Treatment/Not Analyzable|1
2091604|NCT00770120|3679527|FG000|Overall Study|Reason under Review|1
2091605|NCT00770146|3679551|FG000|Treatment Period|Withdrawal by Subject|6
2091606|NCT00770146|3679552|FG001|Treatment Period|Withdrawal by Subject|13
2091607|NCT00770146|3679551|FG000|Treatment Period|Adverse Event|2
2091608|NCT00770146|3679552|FG001|Treatment Period|Adverse Event|26
2091609|NCT00770146|3679551|FG000|Treatment Period|Other|1
2091610|NCT00770146|3679552|FG001|Treatment Period|Other|5
2091611|NCT00770146|3679551|FG000|Treatment Period|Protocol non-compliance|0
2091612|NCT00770146|3679552|FG001|Treatment Period|Protocol non-compliance|1
2091613|NCT00770146|3679551|FG000|Follow-up Period|Withdrawal by Subject|7
2091614|NCT00770146|3679552|FG001|Follow-up Period|Withdrawal by Subject|13
2091615|NCT00770146|3679551|FG000|Follow-up Period|Adverse Event|0
2091616|NCT00770146|3679552|FG001|Follow-up Period|Adverse Event|2
2091617|NCT00770146|3679551|FG000|Follow-up Period|Other|4
2091618|NCT00770146|3679552|FG001|Follow-up Period|Other|5
2091619|NCT00770211|3679560|FG000|Overall Study|Lost to Follow-up|1
2211808|NCT01663623|3852331|FG000|Overall Study|Other-Study closed/terminated|1
2091620|NCT00770211|3679561|FG001|Overall Study|Lost to Follow-up|0
2091621|NCT00770211|3679560|FG000|Overall Study|Withdrawal by Subject|0
2091622|NCT00770211|3679561|FG001|Overall Study|Withdrawal by Subject|2
2091623|NCT00770224|3679567|FG000|Step 1: Induction|Adverse Event|3
2091624|NCT00770224|3679568|FG001|Step 1: Induction|Adverse Event|0
2091625|NCT00770224|3679567|FG000|Step 1: Induction|Refusal unrelated to adverse event|6
2091626|NCT00770224|3679568|FG001|Step 1: Induction|Refusal unrelated to adverse event|0
2091627|NCT00770224|3679567|FG000|Step 1: Induction|Other reason not protocol specified|2
2091628|NCT00770224|3679568|FG001|Step 1: Induction|Other reason not protocol specified|0
2091629|NCT00770224|3679567|FG000|Step 1: Induction|Ineligible|2
2091630|NCT00770224|3679568|FG001|Step 1: Induction|Ineligible|0
2091631|NCT00770224|3679567|FG000|Step 1: Induction|No protocol treatment given|1
2091632|NCT00770224|3679568|FG001|Step 1: Induction|No protocol treatment given|0
2091633|NCT00770224|3679567|FG000|Step 2: Maintenance|Adverse Event|0
2091634|NCT00770224|3679568|FG001|Step 2: Maintenance|Adverse Event|10
2091635|NCT00770224|3679567|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0
2091636|NCT00770224|3679568|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8
2091637|NCT00770224|3679567|FG000|Step 2: Maintenance|Progression/relapse|0
2091638|NCT00770224|3679568|FG001|Step 2: Maintenance|Progression/relapse|1
2091639|NCT00770224|3679567|FG000|Step 2: Maintenance|Death|0
2091640|NCT00770224|3679568|FG001|Step 2: Maintenance|Death|2
2091641|NCT00770224|3679567|FG000|Step 2: Maintenance|Other reason not protocol specified|0
2091642|NCT00770224|3679568|FG001|Step 2: Maintenance|Other reason not protocol specified|7
2091643|NCT00770224|3679567|FG000|Step 2: Maintenance|Ineligible|0
2091644|NCT00770224|3679568|FG001|Step 2: Maintenance|Ineligible|2
2091645|NCT00770289|3679575|FG000|Overall Study|Other|6
2091646|NCT00770315|3679588|FG000|Overall Study|Adverse Event|11
2091647|NCT00770315|3679589|FG001|Overall Study|Adverse Event|17
2091648|NCT00770315|3679590|FG002|Overall Study|Adverse Event|16
2091649|NCT00770315|3679591|FG003|Overall Study|Adverse Event|6
2091650|NCT00770315|3679588|FG000|Overall Study|Lost to Follow-up|9
2091651|NCT00770315|3679589|FG001|Overall Study|Lost to Follow-up|5
2091652|NCT00770315|3679590|FG002|Overall Study|Lost to Follow-up|10
2091653|NCT00770315|3679591|FG003|Overall Study|Lost to Follow-up|3
2091654|NCT00770315|3679588|FG000|Overall Study|Withdrawal by Subject|13
2091655|NCT00770315|3679589|FG001|Overall Study|Withdrawal by Subject|17
2091656|NCT00770315|3679590|FG002|Overall Study|Withdrawal by Subject|24
2091657|NCT00770315|3679591|FG003|Overall Study|Withdrawal by Subject|20
2091658|NCT00770315|3679588|FG000|Overall Study|Noncompliance with Protocol|7
2091659|NCT00770315|3679589|FG001|Overall Study|Noncompliance with Protocol|4
2091660|NCT00770315|3679590|FG002|Overall Study|Noncompliance with Protocol|7
2091661|NCT00770315|3679591|FG003|Overall Study|Noncompliance with Protocol|9
2091662|NCT00770328|3679603|FG000|Overall Study|Adverse Event|11
2091663|NCT00770328|3679604|FG001|Overall Study|Adverse Event|2
2091664|NCT00770328|3679603|FG000|Overall Study|Lost to Follow-up|2
2091665|NCT00770328|3679604|FG001|Overall Study|Lost to Follow-up|2
2091666|NCT00770341|3679613|FG000|Overall Study|Did not meet eligibility criteria|1
2091667|NCT00770341|3679614|FG001|Overall Study|Did not meet eligibility criteria|0
2091668|NCT00770341|3679615|FG002|Overall Study|Did not meet eligibility criteria|0
2091669|NCT00770341|3679613|FG000|Overall Study|Withdrawal by Subject|0
2091670|NCT00770341|3679614|FG001|Overall Study|Withdrawal by Subject|1
2091671|NCT00770341|3679615|FG002|Overall Study|Withdrawal by Subject|0
2091672|NCT00770341|3679613|FG000|Overall Study|Clinical Adverse Event|3
2091673|NCT00770341|3679614|FG001|Overall Study|Clinical Adverse Event|1
2091674|NCT00770341|3679615|FG002|Overall Study|Clinical Adverse Event|2
2091675|NCT00770341|3679613|FG000|Overall Study|Laboratory adverse event|3
2091676|NCT00770341|3679614|FG001|Overall Study|Laboratory adverse event|3
2091677|NCT00770341|3679615|FG002|Overall Study|Laboratory adverse event|0
2091678|NCT00770341|3679613|FG000|Overall Study|Lack of Efficacy|3
2091679|NCT00770341|3679614|FG001|Overall Study|Lack of Efficacy|0
2091680|NCT00770341|3679615|FG002|Overall Study|Lack of Efficacy|1
2091681|NCT00770341|3679613|FG000|Overall Study|Other|1
2091682|NCT00770341|3679614|FG001|Overall Study|Other|0
2091683|NCT00770341|3679615|FG002|Overall Study|Other|0
2091684|NCT00770341|3679613|FG000|Overall Study|Not treated|1
2091685|NCT00770341|3679614|FG001|Overall Study|Not treated|0
2091686|NCT00770341|3679615|FG002|Overall Study|Not treated|0
2091687|NCT00770367|3679626|FG000|First Intervention|Withdrawal by Subject|0
2091688|NCT00770367|3679627|FG001|First Intervention|Withdrawal by Subject|2
2091689|NCT00770367|3679626|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0
2091690|NCT00770367|3679627|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1
2091691|NCT00770367|3679626|FG000|Second Intervention|Lost to Follow-up|2
2091692|NCT00770367|3679627|FG001|Second Intervention|Lost to Follow-up|0
2091693|NCT00770432|3679637|FG000|Overall Study|Other|4
2091694|NCT00770432|3679638|FG001|Overall Study|Other|6
2091695|NCT00770432|3679637|FG000|Overall Study|Non-compliance|0
2091696|NCT00770432|3679638|FG001|Overall Study|Non-compliance|1
2091697|NCT00770484|3679646|FG000|Overall Study|Withdrawal by Subject|1
2091698|NCT00770484|3679647|FG001|Overall Study|Withdrawal by Subject|0
2091699|NCT00770510|3679653|FG000|Overall Study|Lost to Follow-up|2
2091700|NCT00770510|3679653|FG000|Overall Study|Pregnancy|1
2091701|NCT00770510|3679653|FG000|Overall Study|Withdrawal by Subject|2
2091702|NCT00770562|3679667|FG000|Overall Study|Did not take treatment|1
2091703|NCT00770562|3679668|FG001|Overall Study|Did not take treatment|1
2091704|NCT00770588|3679677|FG000|Overall Study|Adverse Event|9
2091705|NCT00770588|3679678|FG001|Overall Study|Adverse Event|2
2091706|NCT00770588|3679677|FG000|Overall Study|Death caused by progression of disease|70
2091707|NCT00770588|3679678|FG001|Overall Study|Death caused by progression of disease|91
2091708|NCT00770588|3679677|FG000|Overall Study|Lost to Follow-up|1
2091709|NCT00770588|3679678|FG001|Overall Study|Lost to Follow-up|1
2091710|NCT00770588|3679677|FG000|Overall Study|Withdrawal by Subject|1
2211809|NCT01663623|3852332|FG001|Overall Study|Other-Study closed/terminated|1
2211810|NCT01663623|3852331|FG000|Overall Study|Physician Decision|1
2091711|NCT00770588|3679678|FG001|Overall Study|Withdrawal by Subject|1
2091712|NCT00770601|3679685|FG000|Overall Study|Withdrawal by Subject|1
2091713|NCT00770653|3679691|FG000|Overall Study|Adverse Event|13
2091714|NCT00770653|3679692|FG001|Overall Study|Adverse Event|5
2091715|NCT00770653|3679691|FG000|Overall Study|Protocol Violation|8
2091716|NCT00770653|3679692|FG001|Overall Study|Protocol Violation|6
2091717|NCT00770653|3679691|FG000|Overall Study|Withdrawal by Subject|4
2091718|NCT00770653|3679692|FG001|Overall Study|Withdrawal by Subject|7
2091719|NCT00770653|3679691|FG000|Overall Study|Lack of Compliance|1
2091720|NCT00770653|3679692|FG001|Overall Study|Lack of Compliance|4
2091721|NCT00770653|3679691|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2
2091722|NCT00770653|3679692|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2
2091723|NCT00770653|3679691|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2
2091724|NCT00770653|3679692|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1
2091725|NCT00770653|3679691|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0
2091726|NCT00770653|3679692|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2
2091727|NCT00770653|3679691|FG000|Overall Study|Lost to Follow-up|1
2091728|NCT00770653|3679692|FG001|Overall Study|Lost to Follow-up|2
2091729|NCT00770653|3679691|FG000|Overall Study|Physician Decision|1
2091730|NCT00770653|3679692|FG001|Overall Study|Physician Decision|0
2091731|NCT00770679|3679698|FG000|Overall Study|Lost to Follow-up|3
2091732|NCT00770679|3679698|FG000|Overall Study|Follow-up LDL measurement not collected|3
2091733|NCT00770692|3679706|FG000|Overall Study|Withdrawal by Subject|7
2091734|NCT00770692|3679707|FG001|Overall Study|Withdrawal by Subject|9
2091735|NCT00770692|3679708|FG002|Overall Study|Withdrawal by Subject|9
2091736|NCT00770692|3679709|FG003|Overall Study|Withdrawal by Subject|6
2091737|NCT00770692|3679706|FG000|Overall Study|Adverse Event|3
2091738|NCT00770692|3679707|FG001|Overall Study|Adverse Event|0
2091739|NCT00770692|3679708|FG002|Overall Study|Adverse Event|4
2091740|NCT00770692|3679709|FG003|Overall Study|Adverse Event|4
2091741|NCT00770692|3679706|FG000|Overall Study|Investigator judgment|2
2091742|NCT00770692|3679707|FG001|Overall Study|Investigator judgment|0
2091743|NCT00770692|3679708|FG002|Overall Study|Investigator judgment|1
2091744|NCT00770692|3679709|FG003|Overall Study|Investigator judgment|1
2091745|NCT00770770|3679725|FG000|Overall Study|Lost to Follow-up|1
2091746|NCT00770770|3679726|FG001|Overall Study|Lost to Follow-up|0
2091747|NCT00770770|3679725|FG000|Overall Study|Withdrawal by Subject|1
2091748|NCT00770770|3679726|FG001|Overall Study|Withdrawal by Subject|0
2091749|NCT00770770|3679725|FG000|Overall Study|Death|0
2091750|NCT00770770|3679726|FG001|Overall Study|Death|1
2091751|NCT00770770|3679725|FG000|Overall Study|Study Terminated|8
2091752|NCT00770770|3679726|FG001|Overall Study|Study Terminated|0
2091753|NCT00770809|3679735|FG000|Overall Study|Adverse Event|9
2091754|NCT00770809|3679736|FG001|Overall Study|Adverse Event|1
2091755|NCT00770809|3679737|FG002|Overall Study|Adverse Event|12
2091756|NCT00770809|3679735|FG000|Overall Study|Death|1
2091757|NCT00770809|3679736|FG001|Overall Study|Death|0
2091758|NCT00770809|3679737|FG002|Overall Study|Death|0
2091759|NCT00770809|3679735|FG000|Overall Study|Withdrawal by Subject|3
2091760|NCT00770809|3679736|FG001|Overall Study|Withdrawal by Subject|3
2091761|NCT00770809|3679737|FG002|Overall Study|Withdrawal by Subject|7
2091762|NCT00770809|3679735|FG000|Overall Study|Progression|2
2091763|NCT00770809|3679736|FG001|Overall Study|Progression|2
2091764|NCT00770809|3679737|FG002|Overall Study|Progression|0
2091765|NCT00770809|3679735|FG000|Overall Study|Complicating illness|0
2091766|NCT00770809|3679736|FG001|Overall Study|Complicating illness|0
2091767|NCT00770809|3679737|FG002|Overall Study|Complicating illness|1
2091768|NCT00770809|3679735|FG000|Overall Study|Other Medical Reasons|2
2091769|NCT00770809|3679736|FG001|Overall Study|Other Medical Reasons|4
2091770|NCT00770809|3679737|FG002|Overall Study|Other Medical Reasons|3
2091771|NCT00770913|3679766|FG000|Overall Study|Adverse Event|1
2091772|NCT00770913|3679767|FG001|Overall Study|Adverse Event|3
2091773|NCT00770913|3679768|FG002|Overall Study|Adverse Event|6
2091774|NCT00770913|3679766|FG000|Overall Study|Refusal to continue participation|6
2091775|NCT00770913|3679767|FG001|Overall Study|Refusal to continue participation|4
2091776|NCT00770913|3679768|FG002|Overall Study|Refusal to continue participation|5
2091777|NCT00770913|3679766|FG000|Overall Study|Physician Decision|0
2091778|NCT00770913|3679767|FG001|Overall Study|Physician Decision|1
2091779|NCT00770913|3679768|FG002|Overall Study|Physician Decision|1
2091780|NCT00770913|3679766|FG000|Overall Study|Protocol Violation|3
2091781|NCT00770913|3679767|FG001|Overall Study|Protocol Violation|0
2091782|NCT00770913|3679768|FG002|Overall Study|Protocol Violation|1
2091783|NCT00770913|3679766|FG000|Overall Study|Incorrect drug was allocated|1
2091784|NCT00770913|3679767|FG001|Overall Study|Incorrect drug was allocated|0
2091785|NCT00770913|3679768|FG002|Overall Study|Incorrect drug was allocated|0
2091786|NCT00770991|3679778|FG000|Overall Study|Physician Decision|2
2091787|NCT00770991|3679779|FG001|Overall Study|Physician Decision|0
2091788|NCT00770991|3679778|FG000|Overall Study|Withdrawal by Subject|1
2091789|NCT00770991|3679779|FG001|Overall Study|Withdrawal by Subject|0
2091790|NCT00770991|3679778|FG000|Overall Study|Adverse Event|1
2091791|NCT00770991|3679779|FG001|Overall Study|Adverse Event|5
2091792|NCT00770991|3679778|FG000|Overall Study|Pregnancy|1
2091793|NCT00770991|3679779|FG001|Overall Study|Pregnancy|0
2091794|NCT00771030|3679797|FG000|Overall Study|Adverse Event|0
2091795|NCT00771030|3679798|FG001|Overall Study|Adverse Event|1
2091796|NCT00771030|3679799|FG002|Overall Study|Adverse Event|0
2091797|NCT00771030|3679800|FG003|Overall Study|Adverse Event|0
2091798|NCT00771030|3679801|FG004|Overall Study|Adverse Event|0
2091799|NCT00771030|3679802|FG005|Overall Study|Adverse Event|0
2091800|NCT00771030|3679803|FG006|Overall Study|Adverse Event|0
2091801|NCT00771472|3679868|FG000|Overall Study|Physician Decision|2
2091802|NCT00771472|3679869|FG001|Overall Study|Physician Decision|3
2091803|NCT00771472|3679868|FG000|Overall Study|Progressive Disease|3
2091804|NCT00771472|3679869|FG001|Overall Study|Progressive Disease|1
2091805|NCT00771472|3679868|FG000|Overall Study|Protocol Violation|1
2091806|NCT00771472|3679869|FG001|Overall Study|Protocol Violation|0
2091807|NCT00771615|3679940|FG000|Overall Study|Withdrawal by Subject|0
2091808|NCT00771615|3679941|FG001|Overall Study|Withdrawal by Subject|1
2091809|NCT00771615|3679942|FG002|Overall Study|Withdrawal by Subject|0
2091810|NCT00771615|3679943|FG003|Overall Study|Withdrawal by Subject|0
2091811|NCT00771615|3679944|FG004|Overall Study|Withdrawal by Subject|0
2091812|NCT00771615|3679945|FG005|Overall Study|Withdrawal by Subject|0
2091813|NCT00771615|3679946|FG006|Overall Study|Withdrawal by Subject|0
2091814|NCT00771615|3679947|FG007|Overall Study|Withdrawal by Subject|1
2091815|NCT00771615|3679948|FG008|Overall Study|Withdrawal by Subject|0
2091816|NCT00771615|3679940|FG000|Overall Study|Lost to Follow-up|1
2091817|NCT00771615|3679941|FG001|Overall Study|Lost to Follow-up|1
2091818|NCT00771615|3679942|FG002|Overall Study|Lost to Follow-up|1
2091819|NCT00771615|3679943|FG003|Overall Study|Lost to Follow-up|1
2091820|NCT00771615|3679944|FG004|Overall Study|Lost to Follow-up|0
2091821|NCT00771615|3679945|FG005|Overall Study|Lost to Follow-up|1
2091822|NCT00771615|3679946|FG006|Overall Study|Lost to Follow-up|1
2091823|NCT00771615|3679947|FG007|Overall Study|Lost to Follow-up|0
2091824|NCT00771615|3679948|FG008|Overall Study|Lost to Follow-up|0
2091825|NCT00771667|3679981|FG000|Induction Phase|Adverse Event|5
2091826|NCT00771667|3679982|FG001|Induction Phase|Adverse Event|2
2091827|NCT00771667|3679983|FG002|Induction Phase|Adverse Event|4
2091828|NCT00771667|3679984|FG003|Induction Phase|Adverse Event|1
2091829|NCT00771667|3679985|FG004|Induction Phase|Adverse Event|0
2091830|NCT00771667|3679986|FG005|Induction Phase|Adverse Event|0
2091831|NCT00771667|3679987|FG006|Induction Phase|Adverse Event|0
2091832|NCT00771667|3679988|FG007|Induction Phase|Adverse Event|0
2091833|NCT00771667|3679989|FG008|Induction Phase|Adverse Event|0
2091834|NCT00771667|3679990|FG009|Induction Phase|Adverse Event|0
2091835|NCT00771667|3679981|FG000|Induction Phase|Lack of Efficacy|9
2091836|NCT00771667|3679982|FG001|Induction Phase|Lack of Efficacy|2
2091837|NCT00771667|3679983|FG002|Induction Phase|Lack of Efficacy|4
2091838|NCT00771667|3679984|FG003|Induction Phase|Lack of Efficacy|3
2091839|NCT00771667|3679985|FG004|Induction Phase|Lack of Efficacy|0
2091840|NCT00771667|3679986|FG005|Induction Phase|Lack of Efficacy|0
2091841|NCT00771667|3679987|FG006|Induction Phase|Lack of Efficacy|0
2091842|NCT00771667|3679988|FG007|Induction Phase|Lack of Efficacy|0
2091843|NCT00771667|3679989|FG008|Induction Phase|Lack of Efficacy|0
2091844|NCT00771667|3679990|FG009|Induction Phase|Lack of Efficacy|0
2091845|NCT00771667|3679981|FG000|Induction Phase|Lost to Follow-up|1
2091846|NCT00771667|3679982|FG001|Induction Phase|Lost to Follow-up|0
2091847|NCT00771667|3679983|FG002|Induction Phase|Lost to Follow-up|1
2091848|NCT00771667|3679984|FG003|Induction Phase|Lost to Follow-up|0
2091849|NCT00771667|3679985|FG004|Induction Phase|Lost to Follow-up|0
2091850|NCT00771667|3679986|FG005|Induction Phase|Lost to Follow-up|0
2091851|NCT00771667|3679987|FG006|Induction Phase|Lost to Follow-up|0
2091852|NCT00771667|3679988|FG007|Induction Phase|Lost to Follow-up|0
2091853|NCT00771667|3679989|FG008|Induction Phase|Lost to Follow-up|0
2091854|NCT00771667|3679990|FG009|Induction Phase|Lost to Follow-up|0
2091855|NCT00771667|3679981|FG000|Induction Phase|Other|4
2091856|NCT00771667|3679982|FG001|Induction Phase|Other|6
2091857|NCT00771667|3679983|FG002|Induction Phase|Other|3
2091858|NCT00771667|3679984|FG003|Induction Phase|Other|4
2091859|NCT00771667|3679985|FG004|Induction Phase|Other|0
2091860|NCT00771667|3679986|FG005|Induction Phase|Other|0
2091861|NCT00771667|3679987|FG006|Induction Phase|Other|0
2091862|NCT00771667|3679988|FG007|Induction Phase|Other|0
2091863|NCT00771667|3679989|FG008|Induction Phase|Other|0
2091864|NCT00771667|3679990|FG009|Induction Phase|Other|0
2091865|NCT00771667|3679981|FG000|Maintenance Phase|Adverse Event|0
2091866|NCT00771667|3679982|FG001|Maintenance Phase|Adverse Event|0
2091867|NCT00771667|3679983|FG002|Maintenance Phase|Adverse Event|0
2091868|NCT00771667|3679984|FG003|Maintenance Phase|Adverse Event|0
2091869|NCT00771667|3679985|FG004|Maintenance Phase|Adverse Event|1
2091870|NCT00771667|3679986|FG005|Maintenance Phase|Adverse Event|3
2091871|NCT00771667|3679987|FG006|Maintenance Phase|Adverse Event|5
2091872|NCT00771667|3679988|FG007|Maintenance Phase|Adverse Event|1
2091873|NCT00771667|3679989|FG008|Maintenance Phase|Adverse Event|8
2091874|NCT00771667|3679990|FG009|Maintenance Phase|Adverse Event|7
2091875|NCT00771667|3679981|FG000|Maintenance Phase|Lack of Efficacy|0
2091876|NCT00771667|3679982|FG001|Maintenance Phase|Lack of Efficacy|0
2091877|NCT00771667|3679983|FG002|Maintenance Phase|Lack of Efficacy|0
2091878|NCT00771667|3679984|FG003|Maintenance Phase|Lack of Efficacy|0
2091879|NCT00771667|3679985|FG004|Maintenance Phase|Lack of Efficacy|1
2091880|NCT00771667|3679986|FG005|Maintenance Phase|Lack of Efficacy|3
2091881|NCT00771667|3679987|FG006|Maintenance Phase|Lack of Efficacy|3
2091882|NCT00771667|3679988|FG007|Maintenance Phase|Lack of Efficacy|2
2091883|NCT00771667|3679989|FG008|Maintenance Phase|Lack of Efficacy|11
2091884|NCT00771667|3679990|FG009|Maintenance Phase|Lack of Efficacy|7
2091885|NCT00771667|3679981|FG000|Maintenance Phase|Other|0
2091886|NCT00771667|3679982|FG001|Maintenance Phase|Other|0
2091887|NCT00771667|3679983|FG002|Maintenance Phase|Other|0
2091888|NCT00771667|3679984|FG003|Maintenance Phase|Other|0
2091889|NCT00771667|3679985|FG004|Maintenance Phase|Other|0
2091890|NCT00771667|3679986|FG005|Maintenance Phase|Other|1
2091891|NCT00771667|3679987|FG006|Maintenance Phase|Other|2
2091892|NCT00771667|3679988|FG007|Maintenance Phase|Other|2
2091893|NCT00771667|3679989|FG008|Maintenance Phase|Other|3
2091894|NCT00771667|3679990|FG009|Maintenance Phase|Other|3
2091895|NCT00771758|3680020|FG000|Overall Study|Adverse Event|2
2091896|NCT00771758|3680021|FG001|Overall Study|Adverse Event|8
2091897|NCT00771758|3680022|FG002|Overall Study|Adverse Event|1
2091898|NCT00771758|3680020|FG000|Overall Study|Lack of Efficacy|0
2091899|NCT00771758|3680021|FG001|Overall Study|Lack of Efficacy|2
2091900|NCT00771758|3680022|FG002|Overall Study|Lack of Efficacy|1
2091901|NCT00771758|3680020|FG000|Overall Study|Lost to Follow-up|1
2091902|NCT00771758|3680021|FG001|Overall Study|Lost to Follow-up|0
2091903|NCT00771758|3680022|FG002|Overall Study|Lost to Follow-up|0
2091904|NCT00771758|3680020|FG000|Overall Study|Protocol Violation|1
2091905|NCT00771758|3680021|FG001|Overall Study|Protocol Violation|0
2091906|NCT00771758|3680022|FG002|Overall Study|Protocol Violation|0
2091907|NCT00771758|3680020|FG000|Overall Study|Withdrawal by Subject|1
2091908|NCT00771758|3680021|FG001|Overall Study|Withdrawal by Subject|0
2091909|NCT00771758|3680022|FG002|Overall Study|Withdrawal by Subject|0
2091910|NCT00771758|3680020|FG000|Overall Study|Other|3
2091911|NCT00771758|3680021|FG001|Overall Study|Other|2
2091912|NCT00771758|3680022|FG002|Overall Study|Other|0
2091913|NCT00771810|3680050|FG000|Overall Study|Adverse Event|3
2091914|NCT00771810|3680051|FG001|Overall Study|Adverse Event|0
2091915|NCT00771810|3680052|FG002|Overall Study|Adverse Event|2
2091916|NCT00771810|3680050|FG000|Overall Study|Lost to Follow-up|0
2091917|NCT00771810|3680051|FG001|Overall Study|Lost to Follow-up|0
2091918|NCT00771810|3680052|FG002|Overall Study|Lost to Follow-up|1
2091919|NCT00771810|3680050|FG000|Overall Study|Physician Decision|1
2091920|NCT00771810|3680051|FG001|Overall Study|Physician Decision|2
2091921|NCT00771810|3680052|FG002|Overall Study|Physician Decision|2
2091922|NCT00771810|3680050|FG000|Overall Study|Protocol Violation|0
2091923|NCT00771810|3680051|FG001|Overall Study|Protocol Violation|1
2091924|NCT00771810|3680052|FG002|Overall Study|Protocol Violation|1
2091925|NCT00771810|3680050|FG000|Overall Study|Withdrawal by Subject|1
2091926|NCT00771810|3680051|FG001|Overall Study|Withdrawal by Subject|2
2091927|NCT00771810|3680052|FG002|Overall Study|Withdrawal by Subject|0
2091928|NCT00771810|3680050|FG000|Overall Study|Other|0
2091929|NCT00771810|3680051|FG001|Overall Study|Other|0
2091930|NCT00771810|3680052|FG002|Overall Study|Other|1
2091931|NCT00771849|3680063|FG000|Overall Study|Lost to Follow-up|1
2091932|NCT00771849|3680064|FG001|Overall Study|Lost to Follow-up|2
2091933|NCT00771849|3680063|FG000|Overall Study|Withdrawal by Subject|1
2091934|NCT00771849|3680064|FG001|Overall Study|Withdrawal by Subject|1
2091935|NCT00771849|3680063|FG000|Overall Study|Not vaccinated|0
2091936|NCT00771849|3680064|FG001|Overall Study|Not vaccinated|1
2091937|NCT00771901|3680086|FG000|Overall Study|Dissat w/# of study medication (40/day)|0
2091938|NCT00771901|3680087|FG001|Overall Study|Dissat w/# of study medication (40/day)|0
2091939|NCT00771901|3680088|FG002|Overall Study|Dissat w/# of study medication (40/day)|4
2211811|NCT01663623|3852332|FG001|Overall Study|Physician Decision|4
2211812|NCT01663623|3852331|FG000|Overall Study|Withdrawal by Subject|2
2211813|NCT01663623|3852332|FG001|Overall Study|Withdrawal by Subject|1
2211814|NCT01663636|3852340|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
2211815|NCT01663636|3852341|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
2211816|NCT01663714|3852347|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
2211817|NCT01663714|3852347|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11
2211818|NCT01663714|3852347|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
2211819|NCT01663714|3852347|FG000|Long-Term Follow-Up|Lost to Follow-up|1
2211820|NCT01663714|3852347|FG000|Long-Term Follow-Up|Death|4
2211821|NCT01663714|3852347|FG000|Long-Term Follow-Up|Non-compliance|1
2211822|NCT01663727|3852355|FG000|Overall Study|Death|161
2211823|NCT01663727|3852356|FG001|Overall Study|Death|155
2211824|NCT01663727|3852355|FG000|Overall Study|Lost to Follow-up|10
2211825|NCT01663727|3852356|FG001|Overall Study|Lost to Follow-up|8
2091940|NCT00771914|3680100|FG000|Overall Study|Physician Decision|0
2091941|NCT00771914|3680101|FG001|Overall Study|Physician Decision|0
2091942|NCT00771914|3680102|FG002|Overall Study|Physician Decision|0
2211826|NCT01663727|3852355|FG000|Overall Study|Withdrawal by Subject|18
2211827|NCT01663727|3852356|FG001|Overall Study|Withdrawal by Subject|25
2091943|NCT00771914|3680103|FG003|Overall Study|Physician Decision|1
2091944|NCT00771914|3680100|FG000|Overall Study|Lost to Follow-up|0
2091945|NCT00771914|3680101|FG001|Overall Study|Lost to Follow-up|0
2091946|NCT00771914|3680102|FG002|Overall Study|Lost to Follow-up|0
2091947|NCT00771914|3680103|FG003|Overall Study|Lost to Follow-up|1
2091948|NCT00771927|3680115|FG000|Overall Study|Adverse Event|100
2091949|NCT00771927|3680116|FG001|Overall Study|Adverse Event|105
2091950|NCT00771927|3680115|FG000|Overall Study|Lack of Efficacy|70
2091951|NCT00771927|3680116|FG001|Overall Study|Lack of Efficacy|42
2091952|NCT00771927|3680115|FG000|Overall Study|Lost to Follow-up|46
2091953|NCT00771927|3680116|FG001|Overall Study|Lost to Follow-up|46
2091954|NCT00771927|3680115|FG000|Overall Study|Withdrawal by Subject|16
2091955|NCT00771927|3680116|FG001|Overall Study|Withdrawal by Subject|17
2091956|NCT00771927|3680115|FG000|Overall Study|Other reason|23
2091957|NCT00771927|3680116|FG001|Overall Study|Other reason|27
2091958|NCT00771953|3680124|FG000|Overall Study|Adverse Event|5
2091959|NCT00771953|3680125|FG001|Overall Study|Adverse Event|3
2091960|NCT00771953|3680124|FG000|Overall Study|Death|2
2091961|NCT00771953|3680125|FG001|Overall Study|Death|2
2091962|NCT00771953|3680124|FG000|Overall Study|Progression before active Tx|1
2091963|NCT00771953|3680125|FG001|Overall Study|Progression before active Tx|2
2091964|NCT00771953|3680124|FG000|Overall Study|Sponsor decision|1
2091965|NCT00771953|3680125|FG001|Overall Study|Sponsor decision|0
2091966|NCT00771953|3680124|FG000|Overall Study|Other complicating disease|1
2091967|NCT00771953|3680125|FG001|Overall Study|Other complicating disease|0
2091968|NCT00771953|3680124|FG000|Overall Study|Withdrawal by Subject|0
2091969|NCT00771953|3680125|FG001|Overall Study|Withdrawal by Subject|3
2091970|NCT00772005|3680137|FG000|Overall Study|Adverse Event|9
2091971|NCT00772005|3680138|FG001|Overall Study|Adverse Event|14
2091972|NCT00772005|3680139|FG002|Overall Study|Adverse Event|10
2091973|NCT00772005|3680140|FG003|Overall Study|Adverse Event|13
2091974|NCT00772005|3680137|FG000|Overall Study|Lack of Efficacy|0
2091975|NCT00772005|3680138|FG001|Overall Study|Lack of Efficacy|1
2091976|NCT00772005|3680139|FG002|Overall Study|Lack of Efficacy|0
2091977|NCT00772005|3680140|FG003|Overall Study|Lack of Efficacy|0
2091978|NCT00772005|3680137|FG000|Overall Study|Withdrawal by Subject|3
2091979|NCT00772005|3680138|FG001|Overall Study|Withdrawal by Subject|7
2091980|NCT00772005|3680139|FG002|Overall Study|Withdrawal by Subject|10
2091981|NCT00772005|3680140|FG003|Overall Study|Withdrawal by Subject|2
2091982|NCT00772005|3680137|FG000|Overall Study|Protocol Violation|2
2091983|NCT00772005|3680138|FG001|Overall Study|Protocol Violation|4
2091984|NCT00772005|3680139|FG002|Overall Study|Protocol Violation|1
2091985|NCT00772005|3680140|FG003|Overall Study|Protocol Violation|6
2091986|NCT00772005|3680137|FG000|Overall Study|Lost to Follow-up|7
2091987|NCT00772005|3680138|FG001|Overall Study|Lost to Follow-up|3
2091988|NCT00772005|3680139|FG002|Overall Study|Lost to Follow-up|6
2091989|NCT00772005|3680140|FG003|Overall Study|Lost to Follow-up|3
2091990|NCT00772005|3680137|FG000|Overall Study|Non-compliance with study procedures|1
2091991|NCT00772005|3680138|FG001|Overall Study|Non-compliance with study procedures|1
2091992|NCT00772005|3680139|FG002|Overall Study|Non-compliance with study procedures|0
2091993|NCT00772005|3680140|FG003|Overall Study|Non-compliance with study procedures|1
2091994|NCT00772005|3680137|FG000|Overall Study|Non-compliance with drug administration|3
2091995|NCT00772005|3680138|FG001|Overall Study|Non-compliance with drug administration|0
2211828|NCT01663727|3852355|FG000|Overall Study|Study Terminated|51
2211829|NCT01663727|3852356|FG001|Overall Study|Study Terminated|50
2091996|NCT00772005|3680139|FG002|Overall Study|Non-compliance with drug administration|1
2091997|NCT00772005|3680140|FG003|Overall Study|Non-compliance with drug administration|1
2091998|NCT00772031|3680152|FG000|Overall Study|Early termination of trial|12
2091999|NCT00772031|3680153|FG001|Overall Study|Early termination of trial|10
2092000|NCT00772031|3680152|FG000|Overall Study|Lost to Follow-up|20
2092001|NCT00772031|3680153|FG001|Overall Study|Lost to Follow-up|33
2092002|NCT00772070|3680167|FG000|Overall Study|Lost to Follow-up|0
2092003|NCT00772070|3680168|FG001|Overall Study|Lost to Follow-up|8
2092004|NCT00772070|3680167|FG000|Overall Study|Withdrawal by Subject|0
2092005|NCT00772070|3680168|FG001|Overall Study|Withdrawal by Subject|2
2092006|NCT00772070|3680167|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2
2092007|NCT00772070|3680168|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0
2092008|NCT00772109|3680178|FG000|Overall Study|Serious adverse event|1
2092009|NCT00772109|3680179|FG001|Overall Study|Serious adverse event|0
2092010|NCT00772109|3680180|FG002|Overall Study|Serious adverse event|1
2092011|NCT00772109|3680181|FG003|Overall Study|Serious adverse event|0
2092012|NCT00772109|3680178|FG000|Overall Study|Protocol Violation|5
2092013|NCT00772109|3680179|FG001|Overall Study|Protocol Violation|8
2092014|NCT00772109|3680180|FG002|Overall Study|Protocol Violation|7
2092015|NCT00772109|3680181|FG003|Overall Study|Protocol Violation|6
2092016|NCT00772109|3680178|FG000|Overall Study|Lost to Follow-up|7
2092017|NCT00772109|3680179|FG001|Overall Study|Lost to Follow-up|3
2092018|NCT00772109|3680180|FG002|Overall Study|Lost to Follow-up|5
2092019|NCT00772109|3680181|FG003|Overall Study|Lost to Follow-up|9
2092020|NCT00772109|3680178|FG000|Overall Study|Withdrawal by Subject|8
2092021|NCT00772109|3680179|FG001|Overall Study|Withdrawal by Subject|8
2092022|NCT00772109|3680180|FG002|Overall Study|Withdrawal by Subject|6
2092023|NCT00772109|3680181|FG003|Overall Study|Withdrawal by Subject|16
2092024|NCT00772148|3680193|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3
2092025|NCT00772148|3680194|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1
2092026|NCT00772148|3680193|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
2092027|NCT00772148|3680194|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
2092028|NCT00772148|3680193|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2
2092029|NCT00772148|3680194|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0
2092030|NCT00772148|3680193|FG000|Maintenance Phase (Week 52)|Death|2
2092031|NCT00772148|3680194|FG001|Maintenance Phase (Week 52)|Death|2
2092032|NCT00772148|3680193|FG000|Maintenance Phase (Week 52)|Adverse Event|1
2092033|NCT00772148|3680194|FG001|Maintenance Phase (Week 52)|Adverse Event|0
2092034|NCT00772148|3680193|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0
2092035|NCT00772148|3680194|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1
2092036|NCT00772148|3680193|FG000|Maintenance Phase (Week 52)|Administrative/other|1
2092037|NCT00772148|3680194|FG001|Maintenance Phase (Week 52)|Administrative/other|2
2092038|NCT00772330|3680204|FG000|Overall Study|Lost to Follow-up|3
2092039|NCT00772369|3680211|FG000|Overall Study|Did not return record release form|1
2092040|NCT00772382|3680215|FG000|Overall Study|Adverse Event|19
2092041|NCT00772382|3680215|FG000|Overall Study|Death|6
2092042|NCT00772382|3680215|FG000|Overall Study|Lack of Efficacy|4
2092043|NCT00772382|3680215|FG000|Overall Study|Physician Decision|5
2092044|NCT00772382|3680215|FG000|Overall Study|Protocol Violation|1
2092045|NCT00772382|3680215|FG000|Overall Study|Withdrawal by Subject|10
2092046|NCT00772382|3680215|FG000|Overall Study|Other Reasons|10
2092047|NCT00772447|3680221|FG000|Overall Study|Withdrawal by Subject|9
2092048|NCT00772447|3680222|FG001|Overall Study|Withdrawal by Subject|5
2092049|NCT00772447|3680221|FG000|Overall Study|Physician Decision|4
2092050|NCT00772447|3680222|FG001|Overall Study|Physician Decision|8
2092051|NCT00772447|3680221|FG000|Overall Study|Lost to Follow-up|2
2092052|NCT00772447|3680222|FG001|Overall Study|Lost to Follow-up|4
2092053|NCT00772447|3680221|FG000|Overall Study|incorrect enrolment|3
2092054|NCT00772447|3680222|FG001|Overall Study|incorrect enrolment|4
2092055|NCT00772447|3680221|FG000|Overall Study|Protocol Violation|0
2092056|NCT00772447|3680222|FG001|Overall Study|Protocol Violation|1
2092057|NCT00772447|3680221|FG000|Overall Study|all others|2
2092058|NCT00772447|3680222|FG001|Overall Study|all others|2
2092059|NCT00772538|3680231|FG000|Overall Study|Adverse Event|6
2092060|NCT00772538|3680232|FG001|Overall Study|Adverse Event|6
2092061|NCT00772538|3680231|FG000|Overall Study|Protocol Violation|3
2092062|NCT00772538|3680232|FG001|Overall Study|Protocol Violation|3
2092063|NCT00772538|3680231|FG000|Overall Study|Lost to Follow-up|1
2092064|NCT00772538|3680232|FG001|Overall Study|Lost to Follow-up|1
2092065|NCT00772538|3680231|FG000|Overall Study|Withdrawal by Subject|3
2092066|NCT00772538|3680232|FG001|Overall Study|Withdrawal by Subject|8
2092067|NCT00772538|3680231|FG000|Overall Study|Lack of Efficacy|0
2092068|NCT00772538|3680232|FG001|Overall Study|Lack of Efficacy|1
2092069|NCT00772538|3680231|FG000|Overall Study|Other|7
2092070|NCT00772538|3680232|FG001|Overall Study|Other|7
2092071|NCT00772577|3680240|FG000|Overall Study|Adverse Event|6
2092072|NCT00772577|3680241|FG001|Overall Study|Adverse Event|3
2092073|NCT00772577|3680240|FG000|Overall Study|Abnormal laboratory values|0
2092074|NCT00772577|3680241|FG001|Overall Study|Abnormal laboratory values|1
2092075|NCT00772577|3680240|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2092076|NCT00772577|3680241|FG001|Overall Study|Unsatisfactory therapeutic effect|8
2092077|NCT00772577|3680240|FG000|Overall Study|Patient withdrew consent|8
2092078|NCT00772577|3680241|FG001|Overall Study|Patient withdrew consent|5
2092079|NCT00772577|3680240|FG000|Overall Study|Lost to Follow-up|4
2092080|NCT00772577|3680241|FG001|Overall Study|Lost to Follow-up|3
2092081|NCT00772577|3680240|FG000|Overall Study|Administrative problems|2
2092082|NCT00772577|3680241|FG001|Overall Study|Administrative problems|1
2092083|NCT00772577|3680240|FG000|Overall Study|Protocol Deviation|3
2092084|NCT00772577|3680241|FG001|Overall Study|Protocol Deviation|2
2092085|NCT00772603|3680267|FG000|Overall Study|Withdrawal by Subject|11
2092086|NCT00772603|3680268|FG001|Overall Study|Withdrawal by Subject|10
2092087|NCT00772603|3680269|FG002|Overall Study|Withdrawal by Subject|6
2092088|NCT00772603|3680267|FG000|Overall Study|Adverse Event|37
2092089|NCT00772603|3680268|FG001|Overall Study|Adverse Event|18
2092090|NCT00772603|3680269|FG002|Overall Study|Adverse Event|10
2092091|NCT00772603|3680267|FG000|Overall Study|Subject Non-compliance|1
2092092|NCT00772603|3680268|FG001|Overall Study|Subject Non-compliance|6
2092093|NCT00772603|3680269|FG002|Overall Study|Subject Non-compliance|4
2092094|NCT00772603|3680267|FG000|Overall Study|Protocol Violation|0
2092095|NCT00772603|3680268|FG001|Overall Study|Protocol Violation|1
2092096|NCT00772603|3680269|FG002|Overall Study|Protocol Violation|1
2092097|NCT00772603|3680267|FG000|Overall Study|Lost to Follow-up|1
2092098|NCT00772603|3680268|FG001|Overall Study|Lost to Follow-up|5
2092099|NCT00772603|3680269|FG002|Overall Study|Lost to Follow-up|2
2092100|NCT00772603|3680267|FG000|Overall Study|Physician Decision|0
2092101|NCT00772603|3680268|FG001|Overall Study|Physician Decision|0
2092102|NCT00772603|3680269|FG002|Overall Study|Physician Decision|1
2092103|NCT00772603|3680267|FG000|Overall Study|Other|2
2092104|NCT00772603|3680268|FG001|Overall Study|Other|0
2092105|NCT00772603|3680269|FG002|Overall Study|Other|2
2092106|NCT00772629|3680282|FG000|Overall Study|Subject was not vaccinated|1
2092107|NCT00772629|3680283|FG001|Overall Study|Subject was not vaccinated|0
2092108|NCT00772668|3680289|FG000|Overall Study|Physician Decision|3
2092109|NCT00772707|3680294|FG000|Overall Study|Withdrawn|3
2092110|NCT00772889|3680306|FG000|Overall Study|Adverse Event|7
2092111|NCT00772889|3680307|FG001|Overall Study|Adverse Event|4
2092112|NCT00772889|3680308|FG002|Overall Study|Adverse Event|0
2092113|NCT00772889|3680306|FG000|Overall Study|Withdrawal by Subject|9
2092114|NCT00772889|3680307|FG001|Overall Study|Withdrawal by Subject|8
2092115|NCT00772889|3680308|FG002|Overall Study|Withdrawal by Subject|9
2092116|NCT00772889|3680306|FG000|Overall Study|Lost to Follow-up|6
2092117|NCT00772889|3680307|FG001|Overall Study|Lost to Follow-up|6
2092118|NCT00772889|3680308|FG002|Overall Study|Lost to Follow-up|7
2092119|NCT00772928|3680322|FG000|Overall Study|Lost to Follow-up|9
2092120|NCT00772928|3680323|FG001|Overall Study|Lost to Follow-up|6
2092121|NCT00772928|3680322|FG000|Overall Study|Protocol Violation|10
2092122|NCT00772928|3680323|FG001|Overall Study|Protocol Violation|12
2092123|NCT00772928|3680322|FG000|Overall Study|Withdrawal by Subject|25
2092124|NCT00772928|3680323|FG001|Overall Study|Withdrawal by Subject|22
2092125|NCT00772928|3680322|FG000|Overall Study|Did not receive vaccine|0
2092126|NCT00772928|3680323|FG001|Overall Study|Did not receive vaccine|1
2092127|NCT00772941|3680329|FG000|Overall Study|CRFs not available|195
2092128|NCT00772941|3680329|FG000|Overall Study|Study not completed|16
2092129|NCT00772941|3680329|FG000|Overall Study|Missed Visits|374
2092130|NCT00772941|3680329|FG000|Overall Study|Poor Compliance|7
2092131|NCT00772941|3680329|FG000|Overall Study|GPSP Violation|90
2092132|NCT00772954|3680359|FG000|Overall Study|Adverse Event|0
2092133|NCT00772954|3680360|FG001|Overall Study|Adverse Event|0
2092134|NCT00772954|3680361|FG002|Overall Study|Adverse Event|1
2092135|NCT00772967|3680369|FG000|Crossover Treatment 1|Adverse Event (Pain)|0
2092136|NCT00772967|3680370|FG001|Crossover Treatment 1|Adverse Event (Pain)|0
2092137|NCT00772967|3680371|FG002|Crossover Treatment 1|Adverse Event (Pain)|0
2092138|NCT00772967|3680372|FG003|Crossover Treatment 1|Adverse Event (Pain)|1
2092139|NCT00772967|3680373|FG004|Crossover Treatment 1|Adverse Event (Pain)|0
2092140|NCT00772967|3680374|FG005|Crossover Treatment 1|Adverse Event (Pain)|0
2092141|NCT00772967|3680369|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0
2092142|NCT00772967|3680370|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1
2092143|NCT00772967|3680371|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0
2092144|NCT00772967|3680372|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0
2092145|NCT00772967|3680373|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0
2092146|NCT00772967|3680374|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0
2092147|NCT00772967|3680369|FG000|Crossover Treatment 3|Adverse Event|0
2092148|NCT00772967|3680370|FG001|Crossover Treatment 3|Adverse Event|0
2092149|NCT00772967|3680371|FG002|Crossover Treatment 3|Adverse Event|0
2092150|NCT00772967|3680372|FG003|Crossover Treatment 3|Adverse Event|0
2092151|NCT00772967|3680373|FG004|Crossover Treatment 3|Adverse Event|1
2092152|NCT00772967|3680374|FG005|Crossover Treatment 3|Adverse Event|0
2092153|NCT00773097|3680382|FG000|Overall Study|Withdrawal by Subject|1
2092154|NCT00773097|3680382|FG000|Overall Study|Physician Decision|6
2092155|NCT00773136|3680386|FG000|Overall Study|Physician Decision|2
2092156|NCT00773175|3680393|FG000|Overall Study|Adverse Event|2
2092157|NCT00773175|3680394|FG001|Overall Study|Adverse Event|0
2092158|NCT00773175|3680393|FG000|Overall Study|Consent Withdrawn|0
2092159|NCT00773175|3680394|FG001|Overall Study|Consent Withdrawn|2
2092160|NCT00773253|3680407|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0
2092161|NCT00773253|3680408|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1
2092162|NCT00773279|3680416|FG000|Period 1|Adverse Event|2
2092163|NCT00773279|3680417|FG001|Period 1|Adverse Event|1
2092164|NCT00773279|3680416|FG000|Period 1|Lack of Efficacy|0
2092165|NCT00773279|3680417|FG001|Period 1|Lack of Efficacy|2
2092166|NCT00773279|3680416|FG000|Period 1|Unclassified|5
2092167|NCT00773279|3680417|FG001|Period 1|Unclassified|1
2092168|NCT00773279|3680416|FG000|Period 2|Adverse Event|0
2092169|NCT00773279|3680417|FG001|Period 2|Adverse Event|1
2092170|NCT00773279|3680416|FG000|Period 2|Lack of Efficacy|1
2092171|NCT00773279|3680417|FG001|Period 2|Lack of Efficacy|0
2092172|NCT00773279|3680416|FG000|Period 2|Protocol Violation|0
2092173|NCT00773279|3680417|FG001|Period 2|Protocol Violation|3
2092174|NCT00773279|3680416|FG000|Period 2|Unclassified|2
2092175|NCT00773279|3680417|FG001|Period 2|Unclassified|2
2092176|NCT00773292|3680424|FG000|Treatment 48 Weeks|Adverse Event|1
2092177|NCT00773292|3680424|FG000|Treatment 48 Weeks|Lack of Efficacy|1
2092178|NCT00773383|3680437|FG000|Overall Study|Adverse Event|4
2092179|NCT00773383|3680437|FG000|Overall Study|Death|1
2092180|NCT00773383|3680437|FG000|Overall Study|Progression of Disease|23
2092181|NCT00773383|3680437|FG000|Overall Study|Other|2
2092182|NCT00773383|3680437|FG000|Overall Study|No study dose received|1
2092183|NCT00773461|3680460|FG000|Overall Study|Adverse Event|1
2092184|NCT00773461|3680461|FG001|Overall Study|Adverse Event|3
2092185|NCT00773461|3680460|FG000|Overall Study|Withdrawal by Subject|4
2092186|NCT00773461|3680461|FG001|Overall Study|Withdrawal by Subject|1
2107467|NCT00873860|3701068|FG003|Overall Study|Other|0
2107468|NCT00873912|3701100|FG000|Overall Study|Withdrawal by Subject|1
2107469|NCT00873912|3701101|FG001|Overall Study|Withdrawal by Subject|0
2107470|NCT00873912|3701100|FG000|Overall Study|Lost to Follow-up|2
2107471|NCT00873912|3701101|FG001|Overall Study|Lost to Follow-up|0
2107472|NCT00874029|3701107|FG000|Overall Study|Withdrawal by Subject|10
2107473|NCT00874029|3701107|FG000|Overall Study|Pregnancy|4
2107474|NCT00874029|3701107|FG000|Overall Study|Physician Decision|1
2107475|NCT00874029|3701107|FG000|Overall Study|Adverse Event|1
2107476|NCT00874029|3701107|FG000|Overall Study|Lost to Follow-up|5
2107477|NCT00874120|3701127|FG000|First Intervention|Adverse Event|0
2107478|NCT00874120|3701128|FG001|First Intervention|Adverse Event|1
2092187|NCT00773513|3680474|FG000|Overall Study|Renal Transplant|254
2092188|NCT00773513|3680475|FG001|Overall Study|Renal Transplant|263
2092189|NCT00773513|3680474|FG000|Overall Study|Adverse Event / Intercurrent Illness|40
2092190|NCT00773513|3680475|FG001|Overall Study|Adverse Event / Intercurrent Illness|48
2092191|NCT00773513|3680474|FG000|Overall Study|Withdrew Consent|68
2092192|NCT00773513|3680475|FG001|Overall Study|Withdrew Consent|69
2092193|NCT00773513|3680474|FG000|Overall Study|Refused Treatment / Did not Cooperate|26
2092194|NCT00773513|3680475|FG001|Overall Study|Refused Treatment / Did not Cooperate|32
2092195|NCT00773513|3680474|FG000|Overall Study|Failure to Return|22
2092196|NCT00773513|3680475|FG001|Overall Study|Failure to Return|8
2092197|NCT00773513|3680474|FG000|Overall Study|Insufficient Therapeutic Response|1
2092198|NCT00773513|3680475|FG001|Overall Study|Insufficient Therapeutic Response|18
2092199|NCT00773513|3680474|FG000|Overall Study|Reason Not Specified|159
2092200|NCT00773513|3680475|FG001|Overall Study|Reason Not Specified|126
2092201|NCT00773513|3680474|FG000|Overall Study|Death|531
2092202|NCT00773513|3680475|FG001|Overall Study|Death|545
2092203|NCT00773734|3680489|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
2092204|NCT00773734|3680490|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
2092205|NCT00773734|3680491|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
2092206|NCT00773734|3680492|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
2092207|NCT00773734|3680493|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
2092208|NCT00773734|3680494|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
2092209|NCT00773734|3680489|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
2092210|NCT00773734|3680490|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
2092211|NCT00773734|3680491|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
2092212|NCT00773734|3680492|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
2092213|NCT00773734|3680493|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
2092214|NCT00773734|3680494|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
2092215|NCT00773734|3680489|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
2092216|NCT00773734|3680490|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
2092217|NCT00773734|3680491|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
2092218|NCT00773734|3680492|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
2092219|NCT00773734|3680493|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
2092220|NCT00773734|3680494|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
2092221|NCT00773734|3680489|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1
2092222|NCT00773734|3680490|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0
2092223|NCT00773734|3680491|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0
2092224|NCT00773734|3680492|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0
2092225|NCT00773734|3680493|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0
2092226|NCT00773734|3680494|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0
2092227|NCT00773734|3680489|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
2092228|NCT00773734|3680490|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
2092229|NCT00773734|3680491|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
2092230|NCT00773734|3680492|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
2092231|NCT00773734|3680493|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
2092232|NCT00773734|3680494|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
2092233|NCT00773734|3680489|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
2092234|NCT00773734|3680490|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
2092235|NCT00773734|3680491|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
2092236|NCT00773734|3680492|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
2092237|NCT00773734|3680493|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
2092238|NCT00773734|3680494|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
2092239|NCT00773734|3680489|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1
2092240|NCT00773734|3680490|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1
2092241|NCT00773734|3680491|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1
2092242|NCT00773734|3680492|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1
2092243|NCT00773734|3680493|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0
2092244|NCT00773734|3680494|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0
2092245|NCT00773734|3680489|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0
2092246|NCT00773734|3680490|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4
2092247|NCT00773734|3680491|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0
2092248|NCT00773734|3680492|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0
2092249|NCT00773734|3680493|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1
2092250|NCT00773734|3680494|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2
2092251|NCT00773734|3680489|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
2092252|NCT00773734|3680490|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
2092253|NCT00773734|3680491|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
2092254|NCT00773734|3680492|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
2092255|NCT00773734|3680493|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
2092256|NCT00773734|3680494|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
2092257|NCT00773734|3680489|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
2092258|NCT00773734|3680490|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
2092259|NCT00773734|3680491|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
2092260|NCT00773734|3680492|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
2092261|NCT00773734|3680493|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
2092262|NCT00773734|3680494|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
2092263|NCT00773734|3680489|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
2092264|NCT00773734|3680490|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
2092265|NCT00773734|3680491|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
2092266|NCT00773734|3680492|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
2092267|NCT00773734|3680493|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
2092268|NCT00773734|3680494|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
2092269|NCT00773734|3680489|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
2092270|NCT00773734|3680490|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
2092271|NCT00773734|3680491|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
2092272|NCT00773734|3680492|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
2092273|NCT00773734|3680493|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
2092274|NCT00773734|3680494|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
2092275|NCT00773734|3680489|FG000|Core: Active Treatment Phase Week 16-24|Other|0
2092276|NCT00773734|3680490|FG001|Core: Active Treatment Phase Week 16-24|Other|1
2092277|NCT00773734|3680491|FG002|Core: Active Treatment Phase Week 16-24|Other|0
2092278|NCT00773734|3680492|FG003|Core: Active Treatment Phase Week 16-24|Other|0
2092279|NCT00773734|3680493|FG004|Core: Active Treatment Phase Week 16-24|Other|0
2092280|NCT00773734|3680494|FG005|Core: Active Treatment Phase Week 16-24|Other|0
2092281|NCT00773734|3680489|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0
2092282|NCT00773734|3680490|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0
2092283|NCT00773734|3680491|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0
2092284|NCT00773734|3680492|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0
2092285|NCT00773734|3680493|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2
2092286|NCT00773734|3680494|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1
2092287|NCT00773734|3680489|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
2092288|NCT00773734|3680490|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
2092289|NCT00773734|3680491|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
2092290|NCT00773734|3680492|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
2092291|NCT00773734|3680493|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
2092292|NCT00773734|3680494|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
2092293|NCT00773734|3680489|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
2092294|NCT00773734|3680490|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
2092295|NCT00773734|3680491|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
2092296|NCT00773734|3680492|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
2092297|NCT00773734|3680493|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
2092298|NCT00773734|3680494|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
2092299|NCT00773734|3680489|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
2092300|NCT00773734|3680490|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
2092301|NCT00773734|3680491|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
2092302|NCT00773734|3680492|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
2092303|NCT00773734|3680493|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
2092304|NCT00773734|3680494|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
2092305|NCT00773734|3680489|FG000|Extension: Active Treatment Week 24-52|Other|0
2092306|NCT00773734|3680490|FG001|Extension: Active Treatment Week 24-52|Other|0
2092307|NCT00773734|3680491|FG002|Extension: Active Treatment Week 24-52|Other|1
2092308|NCT00773734|3680492|FG003|Extension: Active Treatment Week 24-52|Other|2
2092309|NCT00773734|3680493|FG004|Extension: Active Treatment Week 24-52|Other|0
2092310|NCT00773734|3680494|FG005|Extension: Active Treatment Week 24-52|Other|1
2092311|NCT00773734|3680489|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0
2092312|NCT00773734|3680490|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0
2092313|NCT00773734|3680491|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0
2092314|NCT00773734|3680492|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1
2092315|NCT00773734|3680493|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0
2092316|NCT00773734|3680494|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0
2092317|NCT00773734|3680489|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
2092318|NCT00773734|3680490|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
2092319|NCT00773734|3680491|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
2092320|NCT00773734|3680492|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
2092321|NCT00773734|3680493|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
2092322|NCT00773734|3680494|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
2092323|NCT00773734|3680489|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
2092324|NCT00773734|3680490|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
2092325|NCT00773734|3680491|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
2092326|NCT00773734|3680492|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
2092327|NCT00773734|3680493|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
2092328|NCT00773734|3680494|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
2092329|NCT00773734|3680489|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
2092330|NCT00773734|3680490|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
2092331|NCT00773734|3680491|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
2092332|NCT00773734|3680492|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
2092333|NCT00773734|3680493|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
2092334|NCT00773734|3680494|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
2092335|NCT00773747|3680553|FG000|Overall Study|Lack of Efficacy|112
2092336|NCT00773747|3680554|FG001|Overall Study|Lack of Efficacy|144
2092337|NCT00773747|3680553|FG000|Overall Study|Physician Decision|26
2092338|NCT00773747|3680554|FG001|Overall Study|Physician Decision|18
2092339|NCT00773747|3680553|FG000|Overall Study|Lost to Follow-up|0
2092340|NCT00773747|3680554|FG001|Overall Study|Lost to Follow-up|1
2092341|NCT00773747|3680553|FG000|Overall Study|Protocol Violation|2
2092342|NCT00773747|3680554|FG001|Overall Study|Protocol Violation|2
2092343|NCT00773747|3680553|FG000|Overall Study|Withdrawal by Subject|89
2092344|NCT00773747|3680554|FG001|Overall Study|Withdrawal by Subject|61
2092345|NCT00773747|3680553|FG000|Overall Study|Adverse Event|61
2092346|NCT00773747|3680554|FG001|Overall Study|Adverse Event|62
2092347|NCT00773747|3680553|FG000|Overall Study|Death|5
2092348|NCT00773747|3680554|FG001|Overall Study|Death|8
2092349|NCT00773747|3680553|FG000|Overall Study|Not Treated|2
2092350|NCT00773747|3680554|FG001|Overall Study|Not Treated|0
2092351|NCT00773838|3680568|FG000|Overall Study|Adverse Event|29
2092352|NCT00773838|3680568|FG000|Overall Study|Lost to Follow-up|1
2092353|NCT00773838|3680568|FG000|Overall Study|Physician Decision|8
2092354|NCT00773838|3680568|FG000|Overall Study|Progressive Disease|82
2092355|NCT00773838|3680568|FG000|Overall Study|Protocol Violation|2
2092356|NCT00773838|3680568|FG000|Overall Study|Withdrawal by Subject|21
2092357|NCT00773968|3680576|FG000|Overall Study|Adverse Event|2
2092358|NCT00773968|3680576|FG000|Overall Study|Death|1
2092359|NCT00773968|3680576|FG000|Overall Study|Failure to Return|2
2092360|NCT00773968|3680576|FG000|Overall Study|Lack of Efficacy|3
2092361|NCT00773968|3680576|FG000|Overall Study|Protocol Violation|1
2092362|NCT00773968|3680576|FG000|Overall Study|Withdrawal by Subject|11
2092363|NCT00773968|3680576|FG000|Overall Study|Screen Failure|17
2092364|NCT00773968|3680576|FG000|Overall Study|Other|8
2092365|NCT00774046|3680580|FG000|Screening|Not eligible|56
2092366|NCT00774046|3680580|FG000|Enrollment|Desired other therapy/refused|28
2092367|NCT00774046|3680580|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
2092368|NCT00774397|3680630|FG000|Overall Study|Adverse Event|1
2092369|NCT00774397|3680631|FG001|Overall Study|Adverse Event|3
2092370|NCT00774397|3680632|FG002|Overall Study|Adverse Event|16
2092371|NCT00774397|3680633|FG003|Overall Study|Adverse Event|8
2092372|NCT00774397|3680634|FG004|Overall Study|Adverse Event|8
2092373|NCT00774397|3680635|FG005|Overall Study|Adverse Event|3
2092374|NCT00774397|3680636|FG006|Overall Study|Adverse Event|16
2092375|NCT00774397|3680630|FG000|Overall Study|Lack of Efficacy|11
2092376|NCT00774397|3680631|FG001|Overall Study|Lack of Efficacy|4
2092377|NCT00774397|3680632|FG002|Overall Study|Lack of Efficacy|5
2092378|NCT00774397|3680633|FG003|Overall Study|Lack of Efficacy|3
2092379|NCT00774397|3680634|FG004|Overall Study|Lack of Efficacy|27
2092380|NCT00774397|3680635|FG005|Overall Study|Lack of Efficacy|15
2092381|NCT00774397|3680636|FG006|Overall Study|Lack of Efficacy|9
2092382|NCT00774397|3680630|FG000|Overall Study|Protocol Violation|0
2092383|NCT00774397|3680631|FG001|Overall Study|Protocol Violation|1
2092384|NCT00774397|3680632|FG002|Overall Study|Protocol Violation|3
2092385|NCT00774397|3680633|FG003|Overall Study|Protocol Violation|1
2092386|NCT00774397|3680634|FG004|Overall Study|Protocol Violation|2
2092387|NCT00774397|3680635|FG005|Overall Study|Protocol Violation|1
2092388|NCT00774397|3680636|FG006|Overall Study|Protocol Violation|0
2092389|NCT00774397|3680630|FG000|Overall Study|Lost to Follow-up|0
2092390|NCT00774397|3680631|FG001|Overall Study|Lost to Follow-up|1
2092391|NCT00774397|3680632|FG002|Overall Study|Lost to Follow-up|1
2092392|NCT00774397|3680633|FG003|Overall Study|Lost to Follow-up|1
2092393|NCT00774397|3680634|FG004|Overall Study|Lost to Follow-up|0
2092394|NCT00774397|3680635|FG005|Overall Study|Lost to Follow-up|1
2092395|NCT00774397|3680636|FG006|Overall Study|Lost to Follow-up|0
2092396|NCT00774397|3680630|FG000|Overall Study|Refused to continue trial medication|1
2092397|NCT00774397|3680631|FG001|Overall Study|Refused to continue trial medication|3
2092398|NCT00774397|3680632|FG002|Overall Study|Refused to continue trial medication|2
2092399|NCT00774397|3680633|FG003|Overall Study|Refused to continue trial medication|2
2092400|NCT00774397|3680634|FG004|Overall Study|Refused to continue trial medication|6
2092401|NCT00774397|3680635|FG005|Overall Study|Refused to continue trial medication|2
2092402|NCT00774397|3680636|FG006|Overall Study|Refused to continue trial medication|3
2092403|NCT00774397|3680630|FG000|Overall Study|Not treated|0
2092404|NCT00774397|3680631|FG001|Overall Study|Not treated|0
2092405|NCT00774397|3680632|FG002|Overall Study|Not treated|0
2092406|NCT00774397|3680633|FG003|Overall Study|Not treated|0
2092407|NCT00774397|3680634|FG004|Overall Study|Not treated|1
2092408|NCT00774397|3680635|FG005|Overall Study|Not treated|0
2092409|NCT00774397|3680636|FG006|Overall Study|Not treated|1
2092410|NCT00774397|3680630|FG000|Overall Study|Other than those stated above|1
2092411|NCT00774397|3680631|FG001|Overall Study|Other than those stated above|1
2092412|NCT00774397|3680632|FG002|Overall Study|Other than those stated above|3
2092413|NCT00774397|3680633|FG003|Overall Study|Other than those stated above|2
2092414|NCT00774397|3680634|FG004|Overall Study|Other than those stated above|2
2092415|NCT00774397|3680635|FG005|Overall Study|Other than those stated above|0
2092416|NCT00774397|3680636|FG006|Overall Study|Other than those stated above|1
2092417|NCT00774566|3680661|FG000|Overall Study|Protocol Violation|18
2092418|NCT00774566|3680662|FG001|Overall Study|Protocol Violation|15
2092419|NCT00774748|3680677|FG000|Overall Study|Lost to Follow-up|3
2092420|NCT00774787|3680685|FG000|Overall Study|Lost to Follow-up|1
2092421|NCT00774800|3680689|FG000|Intervention 4|Withdrawal by Subject|1
2092422|NCT00774852|3680701|FG000|Overall Study|Adverse Event|9
2092423|NCT00774852|3680702|FG001|Overall Study|Adverse Event|6
2092424|NCT00774852|3680701|FG000|Overall Study|Death|2
2092425|NCT00774852|3680702|FG001|Overall Study|Death|1
2092426|NCT00774852|3680701|FG000|Overall Study|Lack of Efficacy|3
2092427|NCT00774852|3680702|FG001|Overall Study|Lack of Efficacy|7
2092428|NCT00774852|3680701|FG000|Overall Study|Lost to Follow-up|9
2092429|NCT00774852|3680702|FG001|Overall Study|Lost to Follow-up|5
2092430|NCT00774852|3680701|FG000|Overall Study|Physician Decision|2
2092431|NCT00774852|3680702|FG001|Overall Study|Physician Decision|6
2092432|NCT00774852|3680701|FG000|Overall Study|Pregnancy|1
2092433|NCT00774852|3680702|FG001|Overall Study|Pregnancy|2
2092434|NCT00774852|3680701|FG000|Overall Study|Withdrawal by Subject|2
2092435|NCT00774852|3680702|FG001|Overall Study|Withdrawal by Subject|2
2092436|NCT00774852|3680701|FG000|Overall Study|Non-responder|15
2092437|NCT00774852|3680702|FG001|Overall Study|Non-responder|11
2092438|NCT00774852|3680701|FG000|Overall Study|Subject non-compliance|0
2092439|NCT00774852|3680702|FG001|Overall Study|Subject non-compliance|1
2092440|NCT00774852|3680701|FG000|Overall Study|Protocol Violation|1
2092441|NCT00774852|3680702|FG001|Overall Study|Protocol Violation|0
2092442|NCT00774852|3680701|FG000|Overall Study|Subject received prohibited medication|1
2092443|NCT00774852|3680702|FG001|Overall Study|Subject received prohibited medication|0
2092444|NCT00774930|3680720|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11
2092445|NCT00774930|3680721|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12
2092446|NCT00774930|3680720|FG000|DB Phase|Adverse Event|1
2092447|NCT00774930|3680721|FG001|DB Phase|Adverse Event|2
2092448|NCT00774930|3680720|FG000|DB Phase|Subject Decision|1
2092449|NCT00774930|3680721|FG001|DB Phase|Subject Decision|5
2092450|NCT00774930|3680720|FG000|DB Phase|Sponsor Decision|0
2092451|NCT00774930|3680721|FG001|DB Phase|Sponsor Decision|1
2092452|NCT00774930|3680720|FG000|DB Phase|Disease Progression|1
2092453|NCT00774930|3680721|FG001|DB Phase|Disease Progression|1
2092454|NCT00774930|3680720|FG000|DB Phase|Started Nonprotocol Radiation therapy|0
2092455|NCT00774930|3680721|FG001|DB Phase|Started Nonprotocol Radiation therapy|1
2092456|NCT00774930|3680720|FG000|IOL Phase|Adverse Event|1
2092457|NCT00774930|3680721|FG001|IOL Phase|Adverse Event|1
2092458|NCT00774930|3680720|FG000|IOL Phase|Subject Decision|4
2092459|NCT00774930|3680721|FG001|IOL Phase|Subject Decision|3
2092460|NCT00774930|3680720|FG000|IOL Phase|Physician Decision|3
2092461|NCT00774930|3680721|FG001|IOL Phase|Physician Decision|2
2092462|NCT00774930|3680720|FG000|IOL Phase|Sponsor Decision|1
2092463|NCT00774930|3680721|FG001|IOL Phase|Sponsor Decision|0
2092464|NCT00774930|3680720|FG000|IOL Phase|Disease Progression|2
2092465|NCT00774930|3680721|FG001|IOL Phase|Disease Progression|1
2092466|NCT00774930|3680720|FG000|IOL Phase|Subject Consumed Prohibited Medication|1
2092467|NCT00774930|3680721|FG001|IOL Phase|Subject Consumed Prohibited Medication|0
2092468|NCT00774930|3680720|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0
2092469|NCT00774930|3680721|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1
2092470|NCT00774930|3680720|FG000|IOL Phase|Other|1
2092471|NCT00774930|3680721|FG001|IOL Phase|Other|0
2092472|NCT00774930|3680720|FG000|IOL Phase|Brain radiation|0
2092473|NCT00774930|3680721|FG001|IOL Phase|Brain radiation|1
2092474|NCT00774930|3680720|FG000|LTOLE Phase|Adverse Event|7
2092475|NCT00774930|3680721|FG001|LTOLE Phase|Adverse Event|3
2092476|NCT00774930|3680720|FG000|LTOLE Phase|Subject decision|0
2092477|NCT00774930|3680721|FG001|LTOLE Phase|Subject decision|5
2092478|NCT00774930|3680720|FG000|LTOLE Phase|Physician Decision|4
2092479|NCT00774930|3680721|FG001|LTOLE Phase|Physician Decision|1
2092480|NCT00774930|3680720|FG000|LTOLE Phase|Sponsor decision|2
2092481|NCT00774930|3680721|FG001|LTOLE Phase|Sponsor decision|1
2092482|NCT00774930|3680720|FG000|LTOLE Phase|Disease Progression|2
2092483|NCT00774930|3680721|FG001|LTOLE Phase|Disease Progression|5
2092484|NCT00774930|3680720|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
2092485|NCT00774930|3680721|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
2092486|NCT00774930|3680720|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
2092487|NCT00774930|3680721|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
2092488|NCT00774995|3680733|FG000|Overall Study|Protocol Violation|0
2092489|NCT00774995|3680734|FG001|Overall Study|Protocol Violation|0
2092490|NCT00774995|3680735|FG002|Overall Study|Protocol Violation|1
2092491|NCT00774995|3680736|FG003|Overall Study|Protocol Violation|0
2092492|NCT00775021|3680746|FG000|First Intervention|Lost to Follow-up|1
2092493|NCT00775021|3680747|FG001|First Intervention|Lost to Follow-up|0
2092494|NCT00775021|3680746|FG000|Second Intervention|Adverse Event|0
2092495|NCT00775021|3680747|FG001|Second Intervention|Adverse Event|1
2092496|NCT00775138|3680757|FG000|Overall Study|Withdrawal by Subject|0
2092497|NCT00775138|3680758|FG001|Overall Study|Withdrawal by Subject|0
2092498|NCT00775138|3680759|FG002|Overall Study|Withdrawal by Subject|2
2092499|NCT00775138|3680760|FG003|Overall Study|Withdrawal by Subject|2
2092500|NCT00775138|3680757|FG000|Overall Study|Adverse Event|0
2092501|NCT00775138|3680758|FG001|Overall Study|Adverse Event|0
2092502|NCT00775138|3680759|FG002|Overall Study|Adverse Event|1
2092503|NCT00775138|3680760|FG003|Overall Study|Adverse Event|0
2092504|NCT00775203|3680774|FG000|Overall Study|Adverse Event|25
2092505|NCT00775203|3680775|FG001|Overall Study|Adverse Event|6
2092506|NCT00775203|3680774|FG000|Overall Study|Lack of Efficacy|8
2092507|NCT00775203|3680775|FG001|Overall Study|Lack of Efficacy|9
2092508|NCT00775203|3680774|FG000|Overall Study|Withdrawal by Subject|11
2092509|NCT00775203|3680775|FG001|Overall Study|Withdrawal by Subject|9
2092510|NCT00775203|3680774|FG000|Overall Study|Lost to Follow-up|11
2092511|NCT00775203|3680775|FG001|Overall Study|Lost to Follow-up|15
2092512|NCT00775203|3680774|FG000|Overall Study|Administrative reason|2
2092513|NCT00775203|3680775|FG001|Overall Study|Administrative reason|0
2092514|NCT00775203|3680774|FG000|Overall Study|Noncompliance|4
2092515|NCT00775203|3680775|FG001|Overall Study|Noncompliance|2
2092516|NCT00775203|3680774|FG000|Overall Study|Protocol Violation|0
2092517|NCT00775203|3680775|FG001|Overall Study|Protocol Violation|1
2092518|NCT00775203|3680774|FG000|Overall Study|Entered other study|1
2092519|NCT00775203|3680775|FG001|Overall Study|Entered other study|0
2092520|NCT00775203|3680774|FG000|Overall Study|Physician Decision|0
2092521|NCT00775203|3680775|FG001|Overall Study|Physician Decision|1
2092522|NCT00775268|3680792|FG000|Baseline|Drug not synthesize dose|1
2092523|NCT00775268|3680793|FG001|Baseline|Drug not synthesize dose|0
2092524|NCT00775268|3680792|FG000|Baseline|Not treated-ineligible per CT|0
2092525|NCT00775268|3680793|FG001|Baseline|Not treated-ineligible per CT|1
2092526|NCT00775268|3680792|FG000|After 2 Cycles|Participant refused to be scanned further|1
2092527|NCT00775268|3680793|FG001|After 2 Cycles|Participant refused to be scanned further|0
2092528|NCT00775268|3680792|FG000|After Completion|Participant missed scan appointment|1
2092529|NCT00775268|3680793|FG001|After Completion|Participant missed scan appointment|0
2092530|NCT00775437|3680818|FG000|Overall Study|Loss of efficacy|2
2092531|NCT00775437|3680818|FG000|Overall Study|Withdrawal by Subject|3
2092532|NCT00775437|3680818|FG000|Overall Study|Lost to Follow-up|1
2092533|NCT00775450|3680827|FG000|Overall Study|Serious Adverse Event|2
2092534|NCT00775450|3680828|FG001|Overall Study|Serious Adverse Event|0
2092535|NCT00775450|3680829|FG002|Overall Study|Serious Adverse Event|0
2092536|NCT00775450|3680830|FG003|Overall Study|Serious Adverse Event|0
2092537|NCT00775450|3680831|FG004|Overall Study|Serious Adverse Event|0
2092538|NCT00775450|3680827|FG000|Overall Study|Protocol Violation|0
2092539|NCT00775450|3680828|FG001|Overall Study|Protocol Violation|0
2092540|NCT00775450|3680829|FG002|Overall Study|Protocol Violation|0
2092541|NCT00775450|3680830|FG003|Overall Study|Protocol Violation|0
2092542|NCT00775450|3680831|FG004|Overall Study|Protocol Violation|1
2092543|NCT00775450|3680827|FG000|Overall Study|Withdrawal by Subject|1
2092544|NCT00775450|3680828|FG001|Overall Study|Withdrawal by Subject|0
2092545|NCT00775450|3680829|FG002|Overall Study|Withdrawal by Subject|0
2092546|NCT00775450|3680830|FG003|Overall Study|Withdrawal by Subject|0
2092547|NCT00775450|3680831|FG004|Overall Study|Withdrawal by Subject|1
2092548|NCT00775463|3680845|FG000|Overall Study|Withdrawal by Subject|0
2092549|NCT00775463|3680846|FG001|Overall Study|Withdrawal by Subject|1
2092550|NCT00775463|3680845|FG000|Overall Study|Adverse Event|7
2092551|NCT00775463|3680846|FG001|Overall Study|Adverse Event|9
2092552|NCT00775463|3680845|FG000|Overall Study|Protocol Violation|2
2092553|NCT00775463|3680846|FG001|Overall Study|Protocol Violation|2
2092554|NCT00775463|3680845|FG000|Overall Study|Lost to Follow-up|1
2092555|NCT00775463|3680846|FG001|Overall Study|Lost to Follow-up|0
2092556|NCT00775463|3680845|FG000|Overall Study|Lack of Efficacy|1
2092557|NCT00775463|3680846|FG001|Overall Study|Lack of Efficacy|1
2092558|NCT00775528|3680859|FG000|Overall Study|Protocol Violation|1
2092559|NCT00775593|3680863|FG000|Overall Study|Unmet eligibility criteria|6
2092560|NCT00775593|3680863|FG000|Overall Study|Death|1
2092561|NCT00775606|3680869|FG000|Overall Study|Study sponsor terminated funding|3
2092562|NCT00775606|3680870|FG001|Overall Study|Study sponsor terminated funding|0
2092563|NCT00775983|3680953|FG000|Overall Study|Protocol Violation|1
2092564|NCT00775983|3680954|FG001|Overall Study|Protocol Violation|2
2092565|NCT00776009|3680966|FG000|Period 1: First Intervention|Withdrawal by Subject|0
2092566|NCT00776009|3680967|FG001|Period 1: First Intervention|Withdrawal by Subject|0
2092567|NCT00776009|3680968|FG002|Period 1: First Intervention|Withdrawal by Subject|1
2092568|NCT00776009|3680969|FG003|Period 1: First Intervention|Withdrawal by Subject|0
2092569|NCT00776009|3680970|FG004|Period 1: First Intervention|Withdrawal by Subject|1
2092570|NCT00776009|3680971|FG005|Period 1: First Intervention|Withdrawal by Subject|0
2092571|NCT00776009|3680966|FG000|Period 1: First Intervention|Protocol Violation|0
2092572|NCT00776009|3680967|FG001|Period 1: First Intervention|Protocol Violation|1
2092573|NCT00776009|3680968|FG002|Period 1: First Intervention|Protocol Violation|0
2092574|NCT00776009|3680969|FG003|Period 1: First Intervention|Protocol Violation|0
2092575|NCT00776009|3680970|FG004|Period 1: First Intervention|Protocol Violation|1
2092576|NCT00776009|3680971|FG005|Period 1: First Intervention|Protocol Violation|0
2092577|NCT00776009|3680966|FG000|Period 2: Second Intervention|Withdrawal by Subject|0
2092578|NCT00776009|3680967|FG001|Period 2: Second Intervention|Withdrawal by Subject|0
2092579|NCT00776009|3680968|FG002|Period 2: Second Intervention|Withdrawal by Subject|0
2092580|NCT00776009|3680969|FG003|Period 2: Second Intervention|Withdrawal by Subject|0
2092581|NCT00776009|3680970|FG004|Period 2: Second Intervention|Withdrawal by Subject|0
2092582|NCT00776009|3680971|FG005|Period 2: Second Intervention|Withdrawal by Subject|1
2092583|NCT00776009|3680966|FG000|Period 2: Second Intervention|Protocol Violation|1
2092584|NCT00776009|3680967|FG001|Period 2: Second Intervention|Protocol Violation|0
2092585|NCT00776009|3680968|FG002|Period 2: Second Intervention|Protocol Violation|1
2092586|NCT00776009|3680969|FG003|Period 2: Second Intervention|Protocol Violation|0
2092587|NCT00776009|3680970|FG004|Period 2: Second Intervention|Protocol Violation|0
2092588|NCT00776009|3680971|FG005|Period 2: Second Intervention|Protocol Violation|0
2092589|NCT00776009|3680966|FG000|Period 3: Third Intervention|Withdrawal by Subject|1
2092590|NCT00776009|3680967|FG001|Period 3: Third Intervention|Withdrawal by Subject|0
2092591|NCT00776009|3680968|FG002|Period 3: Third Intervention|Withdrawal by Subject|0
2092592|NCT00776009|3680969|FG003|Period 3: Third Intervention|Withdrawal by Subject|0
2092593|NCT00776009|3680970|FG004|Period 3: Third Intervention|Withdrawal by Subject|0
2092594|NCT00776009|3680971|FG005|Period 3: Third Intervention|Withdrawal by Subject|0
2092595|NCT00776230|3680982|FG000|Overall Study|Lost to Follow-up|2
2092596|NCT00776230|3680983|FG001|Overall Study|Lost to Follow-up|1
2092597|NCT00776230|3680984|FG002|Overall Study|Lost to Follow-up|5
2092598|NCT00776230|3680982|FG000|Overall Study|Not vaccinated at Day 0|1
2092599|NCT00776230|3680983|FG001|Overall Study|Not vaccinated at Day 0|0
2092600|NCT00776230|3680984|FG002|Overall Study|Not vaccinated at Day 0|0
2092601|NCT00776230|3680982|FG000|Overall Study|Withdrawal by Subject|0
2092602|NCT00776230|3680983|FG001|Overall Study|Withdrawal by Subject|1
2092603|NCT00776230|3680984|FG002|Overall Study|Withdrawal by Subject|0
2092604|NCT00776230|3680982|FG000|Overall Study|Subject missed Visit 4|0
2092605|NCT00776230|3680983|FG001|Overall Study|Subject missed Visit 4|1
2092606|NCT00776230|3680984|FG002|Overall Study|Subject missed Visit 4|0
2092607|NCT00776659|3681007|FG000|Overall Study|Lost to Follow-up|15
2092608|NCT00776659|3681007|FG000|Overall Study|Withdrawal by Subject|10
2092609|NCT00776659|3681007|FG000|Overall Study|Study Terminated by Sponsor|1
2092610|NCT00776789|3681013|FG000|Overall Study|Consent refusal|2
2092611|NCT00776789|3681014|FG001|Overall Study|Consent refusal|2
2092612|NCT00776789|3681013|FG000|Overall Study|Poor quality video|1
2092613|NCT00776789|3681014|FG001|Overall Study|Poor quality video|1
2092614|NCT00776919|3681026|FG000|Overall Study|Withdrawal by Subject|16
2092615|NCT00776919|3681027|FG001|Overall Study|Withdrawal by Subject|14
2092616|NCT00776919|3681028|FG002|Overall Study|Withdrawal by Subject|15
2092617|NCT00776919|3681029|FG003|Overall Study|Withdrawal by Subject|26
2092618|NCT00776919|3681026|FG000|Overall Study|Lost to Follow-up|8
2092619|NCT00776919|3681027|FG001|Overall Study|Lost to Follow-up|12
2092620|NCT00776919|3681028|FG002|Overall Study|Lost to Follow-up|11
2092621|NCT00776919|3681029|FG003|Overall Study|Lost to Follow-up|8
2092622|NCT00776919|3681026|FG000|Overall Study|Adverse Event|1
2092623|NCT00776919|3681027|FG001|Overall Study|Adverse Event|0
2092624|NCT00776919|3681028|FG002|Overall Study|Adverse Event|2
2092625|NCT00776919|3681029|FG003|Overall Study|Adverse Event|2
2092626|NCT00776919|3681026|FG000|Overall Study|Protocol Violation|1
2092627|NCT00776919|3681027|FG001|Overall Study|Protocol Violation|2
2092628|NCT00776919|3681028|FG002|Overall Study|Protocol Violation|0
2092629|NCT00776919|3681029|FG003|Overall Study|Protocol Violation|1
2092630|NCT00776919|3681026|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1
2092631|NCT00776919|3681027|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5
2092632|NCT00776919|3681028|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4
2092633|NCT00776919|3681029|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2
2092634|NCT00776984|3681041|FG000|Overall Study|Adverse Event|8
2092635|NCT00776984|3681042|FG001|Overall Study|Adverse Event|2
2092636|NCT00776984|3681041|FG000|Overall Study|Protocol Violation|4
2092637|NCT00776984|3681042|FG001|Overall Study|Protocol Violation|2
2092638|NCT00776984|3681041|FG000|Overall Study|Lost to Follow-up|2
2092639|NCT00776984|3681042|FG001|Overall Study|Lost to Follow-up|0
2092640|NCT00776984|3681041|FG000|Overall Study|Withdrawal by Subject|12
2092641|NCT00776984|3681042|FG001|Overall Study|Withdrawal by Subject|7
2092642|NCT00776984|3681041|FG000|Overall Study|Lack of Efficacy|0
2092643|NCT00776984|3681042|FG001|Overall Study|Lack of Efficacy|1
2092644|NCT00776984|3681041|FG000|Overall Study|Other|5
2092645|NCT00776984|3681042|FG001|Overall Study|Other|9
2092646|NCT00776997|3681048|FG000|Overall Study|Adverse Event|2
2092647|NCT00777023|3681055|FG000|Overall Study|Adverse Event|15
2092648|NCT00777023|3681056|FG001|Overall Study|Adverse Event|21
2092649|NCT00777023|3681057|FG002|Overall Study|Adverse Event|8
2092650|NCT00777023|3681055|FG000|Overall Study|Lack of Efficacy|1
2092651|NCT00777023|3681056|FG001|Overall Study|Lack of Efficacy|0
2092652|NCT00777023|3681057|FG002|Overall Study|Lack of Efficacy|14
2092653|NCT00777023|3681055|FG000|Overall Study|Protocol Violation|2
2092654|NCT00777023|3681056|FG001|Overall Study|Protocol Violation|1
2092655|NCT00777023|3681057|FG002|Overall Study|Protocol Violation|1
2092656|NCT00777023|3681055|FG000|Overall Study|Lost to Follow-up|2
2092657|NCT00777023|3681056|FG001|Overall Study|Lost to Follow-up|3
2092658|NCT00777023|3681057|FG002|Overall Study|Lost to Follow-up|3
2092659|NCT00777023|3681055|FG000|Overall Study|Death|0
2092660|NCT00777023|3681056|FG001|Overall Study|Death|1
2092661|NCT00777023|3681057|FG002|Overall Study|Death|0
2092662|NCT00777023|3681055|FG000|Overall Study|Withdrawal by Subject|7
2092663|NCT00777023|3681056|FG001|Overall Study|Withdrawal by Subject|7
2092664|NCT00777023|3681057|FG002|Overall Study|Withdrawal by Subject|8
2092665|NCT00777023|3681055|FG000|Overall Study|Missing data|1
2092666|NCT00777023|3681056|FG001|Overall Study|Missing data|1
2092667|NCT00777023|3681057|FG002|Overall Study|Missing data|0
2092668|NCT00777023|3681055|FG000|Overall Study|Reasons not specified|4
2092669|NCT00777023|3681056|FG001|Overall Study|Reasons not specified|4
2092670|NCT00777023|3681057|FG002|Overall Study|Reasons not specified|2
2092671|NCT00777023|3681055|FG000|Overall Study|Last dose date unknown|3
2092672|NCT00777023|3681056|FG001|Overall Study|Last dose date unknown|3
2092673|NCT00777023|3681057|FG002|Overall Study|Last dose date unknown|1
2092674|NCT00777049|3681067|FG000|Overall Study|Withdrawal by Subject|1
2092675|NCT00777049|3681068|FG001|Overall Study|Withdrawal by Subject|0
2092676|NCT00777049|3681067|FG000|Overall Study|No treatment (elevated liver enzymes)|0
2092677|NCT00777049|3681068|FG001|Overall Study|No treatment (elevated liver enzymes)|1
2092678|NCT00777088|3681083|FG000|Overall Study|PED Treatment not attempted|1
2092679|NCT00777101|3681090|FG000|Overall Study|Death|48
2092680|NCT00777101|3681091|FG001|Overall Study|Death|43
2092681|NCT00777101|3681090|FG000|Overall Study|Withdrawal by Subject|11
2092682|NCT00777101|3681091|FG001|Overall Study|Withdrawal by Subject|6
2092683|NCT00777101|3681090|FG000|Overall Study|Lost to Follow-up|2
2092684|NCT00777101|3681091|FG001|Overall Study|Lost to Follow-up|1
2092685|NCT00777101|3681090|FG000|Overall Study|Discontinuation of Study by Sponsor|1
2092686|NCT00777101|3681091|FG001|Overall Study|Discontinuation of Study by Sponsor|0
2092687|NCT00777101|3681090|FG000|Overall Study|Failed to Return|0
2092688|NCT00777101|3681091|FG001|Overall Study|Failed to Return|1
2092689|NCT00777153|3681101|FG000|Overall Study|Lost to Follow-up|1
2092690|NCT00777153|3681102|FG001|Overall Study|Lost to Follow-up|1
2092691|NCT00777153|3681103|FG002|Overall Study|Lost to Follow-up|0
2092692|NCT00777153|3681101|FG000|Overall Study|Death|85
2092693|NCT00777153|3681102|FG001|Overall Study|Death|73
2092694|NCT00777153|3681103|FG002|Overall Study|Death|33
2092695|NCT00777153|3681101|FG000|Overall Study|Withdrawal by Subject|3
2092696|NCT00777153|3681102|FG001|Overall Study|Withdrawal by Subject|4
2092697|NCT00777153|3681103|FG002|Overall Study|Withdrawal by Subject|3
2092698|NCT00777153|3681101|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1
2092699|NCT00777153|3681102|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5
2092700|NCT00777153|3681103|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1
2092701|NCT00777205|3681126|FG000|Overall Study|Lost to Follow-up|25
2092702|NCT00777205|3681127|FG001|Overall Study|Lost to Follow-up|9
2092703|NCT00777205|3681126|FG000|Overall Study|Withdrawal by Subject|6
2092704|NCT00777205|3681127|FG001|Overall Study|Withdrawal by Subject|4
2092705|NCT00777205|3681126|FG000|Overall Study|Death|0
2092706|NCT00777205|3681127|FG001|Overall Study|Death|2
2092707|NCT00777205|3681126|FG000|Overall Study|Protocol Violation|0
2092708|NCT00777205|3681127|FG001|Overall Study|Protocol Violation|56
2092709|NCT00777257|3681138|FG000|Overall Study|Adverse Event|3
2092710|NCT00777257|3681139|FG001|Overall Study|Adverse Event|1
2092711|NCT00777257|3681140|FG002|Overall Study|Adverse Event|0
2092712|NCT00777257|3681138|FG000|Overall Study|Lost to Follow-up|3
2092713|NCT00777257|3681139|FG001|Overall Study|Lost to Follow-up|3
2092714|NCT00777257|3681140|FG002|Overall Study|Lost to Follow-up|2
2092715|NCT00777257|3681138|FG000|Overall Study|Protocol Violation|2
2092716|NCT00777257|3681139|FG001|Overall Study|Protocol Violation|2
2092717|NCT00777257|3681140|FG002|Overall Study|Protocol Violation|2
2092718|NCT00777257|3681138|FG000|Overall Study|Withdrawal by Subject|3
2092719|NCT00777257|3681139|FG001|Overall Study|Withdrawal by Subject|6
2092720|NCT00777257|3681140|FG002|Overall Study|Withdrawal by Subject|5
2092721|NCT00777296|3681152|FG000|Overall Study|Adverse Event|0
2092722|NCT00777296|3681153|FG001|Overall Study|Adverse Event|1
2092723|NCT00777296|3681154|FG002|Overall Study|Adverse Event|0
2092724|NCT00777296|3681155|FG003|Overall Study|Adverse Event|1
2092725|NCT00777296|3681152|FG000|Overall Study|Withdrawal by Subject|1
2092726|NCT00777296|3681153|FG001|Overall Study|Withdrawal by Subject|0
2092727|NCT00777296|3681154|FG002|Overall Study|Withdrawal by Subject|0
2092728|NCT00777296|3681155|FG003|Overall Study|Withdrawal by Subject|0
2092729|NCT00777296|3681152|FG000|Overall Study|CRF form not completed|0
2092730|NCT00777296|3681153|FG001|Overall Study|CRF form not completed|0
2092731|NCT00777296|3681154|FG002|Overall Study|CRF form not completed|2
2092732|NCT00777296|3681155|FG003|Overall Study|CRF form not completed|0
2092733|NCT00777491|3681188|FG000|Overall Study|Protocol Violation|0
2092734|NCT00777491|3681189|FG001|Overall Study|Protocol Violation|2
2092735|NCT00777491|3681188|FG000|Overall Study|Did not receive any protocol treatment|2
2092736|NCT00777491|3681189|FG001|Overall Study|Did not receive any protocol treatment|0
2092737|NCT00777556|3681195|FG000|Overall Study|Inappropriate self-selection|34
2092738|NCT00777556|3681195|FG000|Overall Study|Dispensed but did not use product|12
2092739|NCT00777556|3681195|FG000|Overall Study|Did not complete all 3 follow-up visits|20
2092740|NCT00777608|3681201|FG000|Overall Study|Lost to Follow-up|1
2092741|NCT00777608|3681202|FG001|Overall Study|Lost to Follow-up|1
2092742|NCT00777608|3681201|FG000|Overall Study|Withdrawal by Subject|1
2092743|NCT00777608|3681202|FG001|Overall Study|Withdrawal by Subject|3
2092744|NCT00777608|3681201|FG000|Overall Study|Protocol Violation|1
2092745|NCT00777608|3681202|FG001|Overall Study|Protocol Violation|0
2092746|NCT00777608|3681201|FG000|Overall Study|Investigator Decision|1
2092747|NCT00777608|3681202|FG001|Overall Study|Investigator Decision|2
2092748|NCT00777803|3681243|FG000|Overall Study|Lost to Follow-up|12
2092749|NCT00777803|3681244|FG001|Overall Study|Lost to Follow-up|5
2092750|NCT00777803|3681243|FG000|Overall Study|Adverse Event|1
2092751|NCT00777803|3681244|FG001|Overall Study|Adverse Event|0
2092752|NCT00777803|3681243|FG000|Overall Study|Non-compliance|2
2092753|NCT00777803|3681244|FG001|Overall Study|Non-compliance|2
2092754|NCT00777829|3681250|FG000|Overall Study|Withdrawal by Subject|0
2092755|NCT00777829|3681251|FG001|Overall Study|Withdrawal by Subject|2
2092756|NCT00777920|3681265|FG000|Overall Study|Adverse Event|39
2092757|NCT00777920|3681265|FG000|Overall Study|Withdrawal of Consent|4
2092758|NCT00777920|3681265|FG000|Overall Study|Lost to Follow-up|1
2092759|NCT00777920|3681265|FG000|Overall Study|Investigator's discretion|1
2092760|NCT00777920|3681265|FG000|Overall Study|Clinical status did not improve|1
2092761|NCT00777920|3681265|FG000|Overall Study|Other, not specified|4
2092762|NCT00777946|3681272|FG000|Overall Study|Adverse Event|11
2092763|NCT00777946|3681273|FG001|Overall Study|Adverse Event|1
2092764|NCT00777946|3681274|FG002|Overall Study|Adverse Event|3
2092765|NCT00777946|3681272|FG000|Overall Study|Lack of Efficacy|0
2092766|NCT00777946|3681273|FG001|Overall Study|Lack of Efficacy|0
2092767|NCT00777946|3681274|FG002|Overall Study|Lack of Efficacy|9
2092768|NCT00777946|3681272|FG000|Overall Study|Condition no longer required study drug|1
2092769|NCT00777946|3681273|FG001|Overall Study|Condition no longer required study drug|0
2092770|NCT00777946|3681274|FG002|Overall Study|Condition no longer required study drug|0
2092771|NCT00777946|3681272|FG000|Overall Study|Patient withdrew consent|3
2092772|NCT00777946|3681273|FG001|Overall Study|Patient withdrew consent|2
2092773|NCT00777946|3681274|FG002|Overall Study|Patient withdrew consent|3
2092774|NCT00777946|3681272|FG000|Overall Study|Lost to Follow-up|3
2092775|NCT00777946|3681273|FG001|Overall Study|Lost to Follow-up|1
2092776|NCT00777946|3681274|FG002|Overall Study|Lost to Follow-up|0
2092777|NCT00777946|3681272|FG000|Overall Study|Protocol deviation|2
2092778|NCT00777946|3681273|FG001|Overall Study|Protocol deviation|1
2092779|NCT00777946|3681274|FG002|Overall Study|Protocol deviation|1
2092780|NCT00777946|3681272|FG000|Overall Study|Randomized in error|1
2092781|NCT00777946|3681273|FG001|Overall Study|Randomized in error|1
2092782|NCT00777946|3681274|FG002|Overall Study|Randomized in error|0
2092783|NCT00778102|3681284|FG000|Overall Study|Adverse Event|8
2092784|NCT00778102|3681285|FG001|Overall Study|Adverse Event|5
2092785|NCT00778102|3681284|FG000|Overall Study|Death|1
2092786|NCT00778102|3681285|FG001|Overall Study|Death|1
2092787|NCT00778102|3681284|FG000|Overall Study|Lost to Follow-up|1
2092788|NCT00778102|3681285|FG001|Overall Study|Lost to Follow-up|0
2092789|NCT00778102|3681284|FG000|Overall Study|Violation of Selection Criteria|1
2092790|NCT00778102|3681285|FG001|Overall Study|Violation of Selection Criteria|1
2092791|NCT00778102|3681284|FG000|Overall Study|Protocol Violation|0
2092792|NCT00778102|3681285|FG001|Overall Study|Protocol Violation|1
2092793|NCT00778102|3681284|FG000|Overall Study|Refused Treatment|2
2092794|NCT00778102|3681285|FG001|Overall Study|Refused Treatment|3
2092795|NCT00778102|3681284|FG000|Overall Study|Withdrawal by Subject|1
2092796|NCT00778102|3681285|FG001|Overall Study|Withdrawal by Subject|1
2092797|NCT00778102|3681284|FG000|Overall Study|Administrative Reason|7
2092798|NCT00778102|3681285|FG001|Overall Study|Administrative Reason|10
2092799|NCT00778258|3681313|FG000|Overall Study|Adverse Event|1
2092800|NCT00778258|3681314|FG001|Overall Study|Adverse Event|0
2092801|NCT00778258|3681315|FG002|Overall Study|Adverse Event|0
2092802|NCT00778258|3681316|FG003|Overall Study|Adverse Event|0
2092803|NCT00778258|3681317|FG004|Overall Study|Adverse Event|0
2092804|NCT00778258|3681318|FG005|Overall Study|Adverse Event|1
2092805|NCT00778258|3681319|FG006|Overall Study|Adverse Event|0
2092806|NCT00778258|3681320|FG007|Overall Study|Adverse Event|0
2092807|NCT00778258|3681321|FG008|Overall Study|Adverse Event|0
2092808|NCT00778258|3681313|FG000|Overall Study|Lost to Follow-up|0
2092809|NCT00778258|3681314|FG001|Overall Study|Lost to Follow-up|0
2092810|NCT00778258|3681315|FG002|Overall Study|Lost to Follow-up|2
2092811|NCT00778258|3681316|FG003|Overall Study|Lost to Follow-up|0
2092812|NCT00778258|3681317|FG004|Overall Study|Lost to Follow-up|0
2092813|NCT00778258|3681318|FG005|Overall Study|Lost to Follow-up|3
2092814|NCT00778258|3681319|FG006|Overall Study|Lost to Follow-up|2
2092815|NCT00778258|3681320|FG007|Overall Study|Lost to Follow-up|2
2092816|NCT00778258|3681321|FG008|Overall Study|Lost to Follow-up|0
2092817|NCT00778258|3681313|FG000|Overall Study|Withdrawal by Subject|6
2092818|NCT00778258|3681314|FG001|Overall Study|Withdrawal by Subject|2
2092819|NCT00778258|3681315|FG002|Overall Study|Withdrawal by Subject|8
2092820|NCT00778258|3681316|FG003|Overall Study|Withdrawal by Subject|2
2092821|NCT00778258|3681317|FG004|Overall Study|Withdrawal by Subject|0
2092822|NCT00778258|3681318|FG005|Overall Study|Withdrawal by Subject|6
2092823|NCT00778258|3681319|FG006|Overall Study|Withdrawal by Subject|12
2092824|NCT00778258|3681320|FG007|Overall Study|Withdrawal by Subject|12
2092825|NCT00778258|3681321|FG008|Overall Study|Withdrawal by Subject|4
2092826|NCT00778258|3681313|FG000|Overall Study|New Contraindication|0
2092827|NCT00778258|3681314|FG001|Overall Study|New Contraindication|0
2092828|NCT00778258|3681315|FG002|Overall Study|New Contraindication|0
2092829|NCT00778258|3681316|FG003|Overall Study|New Contraindication|0
2092830|NCT00778258|3681317|FG004|Overall Study|New Contraindication|0
2092831|NCT00778258|3681318|FG005|Overall Study|New Contraindication|0
2092832|NCT00778258|3681319|FG006|Overall Study|New Contraindication|0
2092833|NCT00778258|3681320|FG007|Overall Study|New Contraindication|1
2092834|NCT00778258|3681321|FG008|Overall Study|New Contraindication|0
2092835|NCT00778258|3681313|FG000|Overall Study|Non-compliance|0
2092836|NCT00778258|3681314|FG001|Overall Study|Non-compliance|0
2092837|NCT00778258|3681315|FG002|Overall Study|Non-compliance|0
2092838|NCT00778258|3681316|FG003|Overall Study|Non-compliance|1
2092839|NCT00778258|3681317|FG004|Overall Study|Non-compliance|0
2092840|NCT00778258|3681318|FG005|Overall Study|Non-compliance|0
2092841|NCT00778258|3681319|FG006|Overall Study|Non-compliance|0
2092842|NCT00778258|3681320|FG007|Overall Study|Non-compliance|0
2092843|NCT00778258|3681321|FG008|Overall Study|Non-compliance|0
2092844|NCT00778258|3681313|FG000|Overall Study|Other|0
2092845|NCT00778258|3681314|FG001|Overall Study|Other|0
2092846|NCT00778258|3681315|FG002|Overall Study|Other|0
2092847|NCT00778258|3681316|FG003|Overall Study|Other|0
2092848|NCT00778258|3681317|FG004|Overall Study|Other|0
2092849|NCT00778258|3681318|FG005|Overall Study|Other|0
2092850|NCT00778258|3681319|FG006|Overall Study|Other|1
2092851|NCT00778258|3681320|FG007|Overall Study|Other|0
2092852|NCT00778258|3681321|FG008|Overall Study|Other|0
2092853|NCT00778336|3681362|FG000|Index Procedure-Discharge|Death|6
2092854|NCT00778336|3681363|FG001|Index Procedure-Discharge|Death|3
2092855|NCT00778336|3681364|FG002|Index Procedure-Discharge|Death|2
2092856|NCT00778336|3681365|FG003|Index Procedure-Discharge|Death|0
2092857|NCT00778336|3681362|FG000|3 Month Follow Up|Lost to Follow-up|15
2092858|NCT00778336|3681363|FG001|3 Month Follow Up|Lost to Follow-up|20
2092859|NCT00778336|3681364|FG002|3 Month Follow Up|Lost to Follow-up|3
2092860|NCT00778336|3681365|FG003|3 Month Follow Up|Lost to Follow-up|0
2092861|NCT00778336|3681362|FG000|3 Month Follow Up|Death|8
2092862|NCT00778336|3681363|FG001|3 Month Follow Up|Death|3
2092863|NCT00778336|3681364|FG002|3 Month Follow Up|Death|2
2092864|NCT00778336|3681365|FG003|3 Month Follow Up|Death|0
2092865|NCT00778375|3681375|FG000|Overall Study|Ineligible|3
2092866|NCT00778622|3681384|FG000|Overall Study|Adverse Event|5
2092867|NCT00778622|3681385|FG001|Overall Study|Adverse Event|4
2092868|NCT00778622|3681386|FG002|Overall Study|Adverse Event|7
2092869|NCT00778622|3681384|FG000|Overall Study|Withdrawal by Subject|4
2092870|NCT00778622|3681385|FG001|Overall Study|Withdrawal by Subject|5
2092871|NCT00778622|3681386|FG002|Overall Study|Withdrawal by Subject|5
2092872|NCT00778622|3681384|FG000|Overall Study|Lost to Follow-up|3
2092873|NCT00778622|3681385|FG001|Overall Study|Lost to Follow-up|3
2092874|NCT00778622|3681386|FG002|Overall Study|Lost to Follow-up|2
2092875|NCT00778622|3681384|FG000|Overall Study|Protocol Violation|0
2092876|NCT00778622|3681385|FG001|Overall Study|Protocol Violation|3
2092877|NCT00778622|3681386|FG002|Overall Study|Protocol Violation|0
2092878|NCT00778622|3681384|FG000|Overall Study|Lack of Efficacy|2
2092879|NCT00778622|3681385|FG001|Overall Study|Lack of Efficacy|0
2092880|NCT00778622|3681386|FG002|Overall Study|Lack of Efficacy|0
2092881|NCT00778622|3681384|FG000|Overall Study|immigration|1
2092882|NCT00778622|3681385|FG001|Overall Study|immigration|0
2092883|NCT00778622|3681386|FG002|Overall Study|immigration|0
2092884|NCT00778622|3681384|FG000|Overall Study|Other|1
2092885|NCT00778622|3681385|FG001|Overall Study|Other|0
2092886|NCT00778622|3681386|FG002|Overall Study|Other|1
2092887|NCT00778817|3681407|FG000|Overall Study|Adverse Event|2
2092888|NCT00778817|3681407|FG000|Overall Study|Withdrawal by Subject|2
2092889|NCT00778830|3681413|FG000|Overall Study|Ongoing at data cut-off|0
2092890|NCT00778830|3681414|FG001|Overall Study|Ongoing at data cut-off|1
2092891|NCT00778895|3681427|FG000|Active Phase|Adverse Event|3
2092892|NCT00778895|3681428|FG001|Active Phase|Adverse Event|1
2092893|NCT00778895|3681429|FG002|Active Phase|Adverse Event|0
2092894|NCT00778895|3681427|FG000|Active Phase|Withdrawal by Subject|1
2092895|NCT00778895|3681428|FG001|Active Phase|Withdrawal by Subject|4
2092896|NCT00778895|3681429|FG002|Active Phase|Withdrawal by Subject|0
2092897|NCT00778895|3681427|FG000|Active Phase|Lost to Follow-up|1
2092898|NCT00778895|3681428|FG001|Active Phase|Lost to Follow-up|1
2092899|NCT00778895|3681429|FG002|Active Phase|Lost to Follow-up|0
2092900|NCT00778895|3681427|FG000|Active Phase|Other|2
2092901|NCT00778895|3681428|FG001|Active Phase|Other|0
2092902|NCT00778895|3681429|FG002|Active Phase|Other|0
2092903|NCT00778895|3681427|FG000|ESFU Phase|Adverse Event|2
2092904|NCT00778895|3681428|FG001|ESFU Phase|Adverse Event|1
2092905|NCT00778895|3681429|FG002|ESFU Phase|Adverse Event|0
2092906|NCT00778895|3681427|FG000|ESFU Phase|Withdrawal by Subject|1
2092907|NCT00778895|3681428|FG001|ESFU Phase|Withdrawal by Subject|4
2092908|NCT00778895|3681429|FG002|ESFU Phase|Withdrawal by Subject|0
2092909|NCT00778895|3681427|FG000|ESFU Phase|Lost to Follow-up|6
2092910|NCT00778895|3681428|FG001|ESFU Phase|Lost to Follow-up|7
2092911|NCT00778895|3681429|FG002|ESFU Phase|Lost to Follow-up|2
2092912|NCT00778895|3681427|FG000|ESFU Phase|Other|2
2092913|NCT00778895|3681428|FG001|ESFU Phase|Other|0
2092914|NCT00778895|3681429|FG002|ESFU Phase|Other|0
2092915|NCT00778921|3681441|FG000|Overall Study|Adverse Event|9
2092916|NCT00778921|3681442|FG001|Overall Study|Adverse Event|10
2092917|NCT00778921|3681443|FG002|Overall Study|Adverse Event|14
2092918|NCT00778921|3681441|FG000|Overall Study|Abnormal Laboratory Value(s)|1
2092919|NCT00778921|3681442|FG001|Overall Study|Abnormal Laboratory Value(s)|0
2092920|NCT00778921|3681443|FG002|Overall Study|Abnormal Laboratory Value(s)|0
2092921|NCT00778921|3681441|FG000|Overall Study|Abnormal Test Procedure Result(s)|0
2092922|NCT00778921|3681442|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
2092923|NCT00778921|3681443|FG002|Overall Study|Abnormal Test Procedure Result(s)|2
2092924|NCT00778921|3681441|FG000|Overall Study|Unsatisfactory therapeutic response|1
2092925|NCT00778921|3681442|FG001|Overall Study|Unsatisfactory therapeutic response|1
2092926|NCT00778921|3681443|FG002|Overall Study|Unsatisfactory therapeutic response|1
2092927|NCT00778921|3681441|FG000|Overall Study|Patient No Longer Requires Study Drug|0
2092928|NCT00778921|3681442|FG001|Overall Study|Patient No Longer Requires Study Drug|1
2092929|NCT00778921|3681443|FG002|Overall Study|Patient No Longer Requires Study Drug|0
2092930|NCT00778921|3681441|FG000|Overall Study|Patient withdrew request|3
2092931|NCT00778921|3681442|FG001|Overall Study|Patient withdrew request|1
2092932|NCT00778921|3681443|FG002|Overall Study|Patient withdrew request|6
2092933|NCT00778921|3681441|FG000|Overall Study|Lost to Follow-up|0
2092934|NCT00778921|3681442|FG001|Overall Study|Lost to Follow-up|2
2092935|NCT00778921|3681443|FG002|Overall Study|Lost to Follow-up|1
2092936|NCT00778921|3681441|FG000|Overall Study|Administrative Problems|1
2092937|NCT00778921|3681442|FG001|Overall Study|Administrative Problems|2
2092938|NCT00778921|3681443|FG002|Overall Study|Administrative Problems|0
2092939|NCT00778921|3681441|FG000|Overall Study|Protocol Violation|3
2092940|NCT00778921|3681442|FG001|Overall Study|Protocol Violation|0
2092941|NCT00778921|3681443|FG002|Overall Study|Protocol Violation|2
2092942|NCT00778921|3681441|FG000|Overall Study|Not treated|0
2092943|NCT00778921|3681442|FG001|Overall Study|Not treated|2
2092944|NCT00778921|3681443|FG002|Overall Study|Not treated|2
2092945|NCT00779025|3681451|FG000|Overall Study|Withdrawal by Subject|1
2092946|NCT00779142|3681464|FG000|Overall Study|Screen Failures|3
2092947|NCT00779246|3681480|FG000|Overall Study|Missing sufficient data for analysis|33
2092948|NCT00779246|3681481|FG001|Overall Study|Missing sufficient data for analysis|53
2092949|NCT00779259|3681487|FG000|Quinine Alone|Adverse Event|2
2092950|NCT00779324|3681532|FG000|Overall Study|Lost to Follow-up|2
2092951|NCT00779324|3681533|FG001|Overall Study|Lost to Follow-up|1
2092952|NCT00779324|3681532|FG000|Overall Study|Withdrawal by Subject|4
2092953|NCT00779324|3681533|FG001|Overall Study|Withdrawal by Subject|2
2092954|NCT00779324|3681532|FG000|Overall Study|Missed visit|1
2092955|NCT00779324|3681533|FG001|Overall Study|Missed visit|1
2092956|NCT00779402|3681541|FG000|Treatment Phase 1|Disease Progression|1
2092957|NCT00779402|3681542|FG001|Treatment Phase 1|Disease Progression|0
2092958|NCT00779402|3681541|FG000|Treatment Phase 1|Adverse Event|2
2092959|NCT00779402|3681542|FG001|Treatment Phase 1|Adverse Event|0
2092960|NCT00779402|3681541|FG000|Treatment Phase 1|Protocol Violation|1
2092961|NCT00779402|3681542|FG001|Treatment Phase 1|Protocol Violation|0
2092962|NCT00779402|3681541|FG000|Treatment Phase 1|Patient Refused to Continue|17
2092963|NCT00779402|3681542|FG001|Treatment Phase 1|Patient Refused to Continue|2
2092964|NCT00779402|3681541|FG000|Treatment Phase 1|Lost to Follow-up|0
2092965|NCT00779402|3681542|FG001|Treatment Phase 1|Lost to Follow-up|1
2092966|NCT00779402|3681541|FG000|Treatment Phase 1|Death|0
2092967|NCT00779402|3681542|FG001|Treatment Phase 1|Death|1
2092968|NCT00779402|3681541|FG000|Treatment Phase 1|Intercurrent Illness|1
2092969|NCT00779402|3681542|FG001|Treatment Phase 1|Intercurrent Illness|1
2092970|NCT00779402|3681541|FG000|Treatment Phase 1|Withdrawal by Subject|1
2092971|NCT00779402|3681542|FG001|Treatment Phase 1|Withdrawal by Subject|0
2092972|NCT00779402|3681541|FG000|Treatment Phase 1|Other|4
2092973|NCT00779402|3681542|FG001|Treatment Phase 1|Other|2
2092974|NCT00779402|3681541|FG000|Treatment Phase 1|Closure of Study|3
2092975|NCT00779402|3681542|FG001|Treatment Phase 1|Closure of Study|2
2092976|NCT00779402|3681541|FG000|Treatment Phase 1|Completed Protocol Visits|3
2092977|NCT00779402|3681542|FG001|Treatment Phase 1|Completed Protocol Visits|6
2092978|NCT00779402|3681541|FG000|Surveillance Phase|Protocol Violation|0
2092979|NCT00779402|3681542|FG001|Surveillance Phase|Protocol Violation|1
2092980|NCT00779402|3681541|FG000|Surveillance Phase|Patient refused to continue|22
2092981|NCT00779402|3681542|FG001|Surveillance Phase|Patient refused to continue|14
2092982|NCT00779402|3681541|FG000|Surveillance Phase|Lost to Follow-up|2
2092983|NCT00779402|3681542|FG001|Surveillance Phase|Lost to Follow-up|1
2092984|NCT00779402|3681541|FG000|Surveillance Phase|Death|0
2092985|NCT00779402|3681542|FG001|Surveillance Phase|Death|1
2092986|NCT00779402|3681541|FG000|Surveillance Phase|Intercurrent Illness|2
2092987|NCT00779402|3681542|FG001|Surveillance Phase|Intercurrent Illness|0
2092988|NCT00779402|3681541|FG000|Surveillance Phase|Other|5
2092989|NCT00779402|3681542|FG001|Surveillance Phase|Other|5
2092990|NCT00779402|3681541|FG000|Surveillance Phase|Withdrawal by Subject|4
2092991|NCT00779402|3681542|FG001|Surveillance Phase|Withdrawal by Subject|1
2092992|NCT00779402|3681541|FG000|Surveillance Phase|Closure of study|5
2092993|NCT00779402|3681542|FG001|Surveillance Phase|Closure of study|6
2092994|NCT00779402|3681541|FG000|Surveillance Phase|Completed Protocol Visits|3
2092995|NCT00779402|3681542|FG001|Surveillance Phase|Completed Protocol Visits|2
2092996|NCT00779402|3681541|FG000|Long-term Follow-up|Patient refused to continue|2
2092997|NCT00779402|3681542|FG001|Long-term Follow-up|Patient refused to continue|0
2092998|NCT00779402|3681541|FG000|Long-term Follow-up|Other|5
2092999|NCT00779402|3681542|FG001|Long-term Follow-up|Other|0
2093000|NCT00779402|3681541|FG000|Long-term Follow-up|Closure of Study|8
2093001|NCT00779402|3681542|FG001|Long-term Follow-up|Closure of Study|4
2093002|NCT00779402|3681541|FG000|Long-term Follow-up|Completed Protocol Visits|6
2093003|NCT00779402|3681542|FG001|Long-term Follow-up|Completed Protocol Visits|2
2093004|NCT00779467|3681552|FG000|Overall Study|Lack of Efficacy|11
2093005|NCT00779467|3681553|FG001|Overall Study|Lack of Efficacy|2
2093006|NCT00779467|3681554|FG002|Overall Study|Lack of Efficacy|6
2093007|NCT00779467|3681555|FG003|Overall Study|Lack of Efficacy|11
2093008|NCT00779467|3681552|FG000|Overall Study|failed inclusion criteria|3
2093009|NCT00779467|3681553|FG001|Overall Study|failed inclusion criteria|3
2093010|NCT00779467|3681554|FG002|Overall Study|failed inclusion criteria|1
2093011|NCT00779467|3681555|FG003|Overall Study|failed inclusion criteria|2
2093012|NCT00779467|3681552|FG000|Overall Study|missing data|1
2211830|NCT01663727|3852355|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1
2211831|NCT01663727|3852356|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0
2211832|NCT01663727|3852355|FG000|Overall Study|Withdrawal prior to dosing.|1
2211833|NCT01663727|3852356|FG001|Overall Study|Withdrawal prior to dosing.|0
2093013|NCT00779467|3681553|FG001|Overall Study|missing data|0
2093014|NCT00779467|3681554|FG002|Overall Study|missing data|1
2093015|NCT00779467|3681555|FG003|Overall Study|missing data|4
2093016|NCT00779467|3681552|FG000|Overall Study|technical issue|0
2093017|NCT00779467|3681553|FG001|Overall Study|technical issue|0
2093018|NCT00779467|3681554|FG002|Overall Study|technical issue|2
2093019|NCT00779467|3681555|FG003|Overall Study|technical issue|1
2093020|NCT00779467|3681552|FG000|Overall Study|unavailable research staff|0
2093021|NCT00779467|3681553|FG001|Overall Study|unavailable research staff|0
2093022|NCT00779467|3681554|FG002|Overall Study|unavailable research staff|0
2093023|NCT00779467|3681555|FG003|Overall Study|unavailable research staff|1
2093024|NCT00779506|3681565|FG000|Overall Study|Screening Failed|2
2093025|NCT00779506|3681565|FG000|Overall Study|Adverse Event|4
2093026|NCT00779506|3681565|FG000|Overall Study|Lack of Efficacy|11
2093027|NCT00779506|3681565|FG000|Overall Study|Protocol Violation|5
2093028|NCT00779506|3681565|FG000|Overall Study|Withdrawal by Subject|6
2093029|NCT00779506|3681565|FG000|Overall Study|Lost to Follow-up|1
2093030|NCT00779584|3681587|FG000|Overall Study|Protocol Violation|0
2093031|NCT00779584|3681588|FG001|Overall Study|Protocol Violation|0
2093032|NCT00779584|3681589|FG002|Overall Study|Protocol Violation|0
2093033|NCT00779584|3681590|FG003|Overall Study|Protocol Violation|0
2093034|NCT00779584|3681591|FG004|Overall Study|Protocol Violation|0
2093035|NCT00779584|3681592|FG005|Overall Study|Protocol Violation|1
2093036|NCT00779584|3681593|FG006|Overall Study|Protocol Violation|0
2093037|NCT00779584|3681594|FG007|Overall Study|Protocol Violation|0
2093038|NCT00779584|3681595|FG008|Overall Study|Protocol Violation|0
2093039|NCT00779584|3681587|FG000|Overall Study|Withdrawal by Subject|1
2093040|NCT00779584|3681588|FG001|Overall Study|Withdrawal by Subject|1
2093041|NCT00779584|3681589|FG002|Overall Study|Withdrawal by Subject|2
2093042|NCT00779584|3681590|FG003|Overall Study|Withdrawal by Subject|0
2093043|NCT00779584|3681591|FG004|Overall Study|Withdrawal by Subject|0
2093044|NCT00779584|3681592|FG005|Overall Study|Withdrawal by Subject|2
2093045|NCT00779584|3681593|FG006|Overall Study|Withdrawal by Subject|1
2093046|NCT00779584|3681594|FG007|Overall Study|Withdrawal by Subject|0
2093047|NCT00779584|3681595|FG008|Overall Study|Withdrawal by Subject|0
2093048|NCT00779584|3681587|FG000|Overall Study|Lost to Follow-up|0
2093049|NCT00779584|3681588|FG001|Overall Study|Lost to Follow-up|0
2093050|NCT00779584|3681589|FG002|Overall Study|Lost to Follow-up|0
2093051|NCT00779584|3681590|FG003|Overall Study|Lost to Follow-up|0
2093052|NCT00779584|3681591|FG004|Overall Study|Lost to Follow-up|1
2093053|NCT00779584|3681592|FG005|Overall Study|Lost to Follow-up|0
2093054|NCT00779584|3681593|FG006|Overall Study|Lost to Follow-up|0
2093055|NCT00779584|3681594|FG007|Overall Study|Lost to Follow-up|0
2093056|NCT00779584|3681595|FG008|Overall Study|Lost to Follow-up|0
2093057|NCT00779584|3681587|FG000|Overall Study|Progression of Disease|0
2093058|NCT00779584|3681588|FG001|Overall Study|Progression of Disease|1
2093059|NCT00779584|3681589|FG002|Overall Study|Progression of Disease|2
2093060|NCT00779584|3681590|FG003|Overall Study|Progression of Disease|6
2093061|NCT00779584|3681591|FG004|Overall Study|Progression of Disease|5
2093062|NCT00779584|3681592|FG005|Overall Study|Progression of Disease|1
2093063|NCT00779584|3681593|FG006|Overall Study|Progression of Disease|4
2093064|NCT00779584|3681594|FG007|Overall Study|Progression of Disease|2
2093065|NCT00779584|3681595|FG008|Overall Study|Progression of Disease|1
2093066|NCT00779584|3681587|FG000|Overall Study|Adverse Event|1
2093067|NCT00779584|3681588|FG001|Overall Study|Adverse Event|0
2093068|NCT00779584|3681589|FG002|Overall Study|Adverse Event|2
2093069|NCT00779584|3681590|FG003|Overall Study|Adverse Event|0
2093070|NCT00779584|3681591|FG004|Overall Study|Adverse Event|0
2093071|NCT00779584|3681592|FG005|Overall Study|Adverse Event|0
2093072|NCT00779584|3681593|FG006|Overall Study|Adverse Event|2
2093073|NCT00779584|3681594|FG007|Overall Study|Adverse Event|1
2093074|NCT00779584|3681595|FG008|Overall Study|Adverse Event|1
2093075|NCT00779584|3681587|FG000|Overall Study|Symptomatic Deterioration|1
2093076|NCT00779584|3681588|FG001|Overall Study|Symptomatic Deterioration|1
2093077|NCT00779584|3681589|FG002|Overall Study|Symptomatic Deterioration|1
2093078|NCT00779584|3681590|FG003|Overall Study|Symptomatic Deterioration|0
2093079|NCT00779584|3681591|FG004|Overall Study|Symptomatic Deterioration|0
2093080|NCT00779584|3681592|FG005|Overall Study|Symptomatic Deterioration|1
2093081|NCT00779584|3681593|FG006|Overall Study|Symptomatic Deterioration|1
2093082|NCT00779584|3681594|FG007|Overall Study|Symptomatic Deterioration|0
2093083|NCT00779584|3681595|FG008|Overall Study|Symptomatic Deterioration|0
2093084|NCT00779584|3681587|FG000|Overall Study|Ongoing in Study|0
2093085|NCT00779584|3681588|FG001|Overall Study|Ongoing in Study|0
2093086|NCT00779584|3681589|FG002|Overall Study|Ongoing in Study|0
2093087|NCT00779584|3681590|FG003|Overall Study|Ongoing in Study|0
2093088|NCT00779584|3681591|FG004|Overall Study|Ongoing in Study|1
2093089|NCT00779584|3681592|FG005|Overall Study|Ongoing in Study|1
2093090|NCT00779584|3681593|FG006|Overall Study|Ongoing in Study|0
2093091|NCT00779584|3681594|FG007|Overall Study|Ongoing in Study|0
2093092|NCT00779584|3681595|FG008|Overall Study|Ongoing in Study|0
2211834|NCT01663740|3852364|FG000|Overall Study|Lost to Follow-up|1
2211835|NCT01663740|3852365|FG001|Overall Study|Lost to Follow-up|4
2211836|NCT01663740|3852364|FG000|Overall Study|Other|9
2211837|NCT01663740|3852365|FG001|Overall Study|Other|2
2211838|NCT01663740|3852364|FG000|Overall Study|Inclusion/Exclusion not met|1
2211839|NCT01663740|3852365|FG001|Overall Study|Inclusion/Exclusion not met|0
2211840|NCT01663740|3852364|FG000|Overall Study|Death|0
2211841|NCT01663740|3852365|FG001|Overall Study|Death|1
2211842|NCT01663740|3852364|FG000|Overall Study|Withdrawal by Subject|2
2211843|NCT01663740|3852365|FG001|Overall Study|Withdrawal by Subject|1
2211844|NCT01663740|3852364|FG000|Overall Study|No end of study status|3
2211845|NCT01663740|3852365|FG001|Overall Study|No end of study status|0
2211846|NCT01663857|3852384|FG000|Overall Study|Withdrew Consent to Study Participation|0
2211847|NCT01663857|3852385|FG001|Overall Study|Withdrew Consent to Study Participation|1
2211848|NCT01663857|3852386|FG002|Overall Study|Withdrew Consent to Study Participation|7
2211849|NCT01663857|3852387|FG003|Overall Study|Withdrew Consent to Study Participation|3
2211850|NCT01663857|3852384|FG000|Overall Study|Lost to Follow-up|0
2211851|NCT01663857|3852385|FG001|Overall Study|Lost to Follow-up|0
2211852|NCT01663857|3852386|FG002|Overall Study|Lost to Follow-up|3
2211853|NCT01663857|3852387|FG003|Overall Study|Lost to Follow-up|1
2211854|NCT01663896|3852403|FG000|Overall Study|Various reasons|43
2211855|NCT01663987|3852420|FG000|Overall Study|Adverse Event|7
2211856|NCT01663987|3852421|FG001|Overall Study|Adverse Event|2
2107479|NCT00874120|3701127|FG000|First Intervention|Withdrawal by Subject|2
2107480|NCT00874120|3701128|FG001|First Intervention|Withdrawal by Subject|0
2107481|NCT00874120|3701127|FG000|First Intervention|Lost to Follow-up|0
2107482|NCT00874120|3701128|FG001|First Intervention|Lost to Follow-up|1
2107483|NCT00874120|3701127|FG000|First Intervention|Protocol Violation|3
2107484|NCT00874120|3701128|FG001|First Intervention|Protocol Violation|0
2107485|NCT00874120|3701127|FG000|First Intervention|positive drug test|1
2107486|NCT00874120|3701128|FG001|First Intervention|positive drug test|0
2107487|NCT00874120|3701127|FG000|Second Intervention|Withdrawal by Subject|1
2107488|NCT00874120|3701128|FG001|Second Intervention|Withdrawal by Subject|0
2107489|NCT00874120|3701127|FG000|Second Intervention|Protocol Violation|1
2107490|NCT00874120|3701128|FG001|Second Intervention|Protocol Violation|0
2107491|NCT00874237|3701134|FG000|Overall Study|Physician Decision|0
2107492|NCT00874237|3701135|FG001|Overall Study|Physician Decision|1
2107493|NCT00874237|3701136|FG002|Overall Study|Physician Decision|0
2107494|NCT00874237|3701137|FG003|Overall Study|Physician Decision|0
2107495|NCT00874237|3701138|FG004|Overall Study|Physician Decision|0
2107496|NCT00874237|3701139|FG005|Overall Study|Physician Decision|0
2107497|NCT00874237|3701134|FG000|Overall Study|Withdrawal by Subject|0
2107498|NCT00874237|3701135|FG001|Overall Study|Withdrawal by Subject|0
2107499|NCT00874237|3701136|FG002|Overall Study|Withdrawal by Subject|1
2107500|NCT00874237|3701137|FG003|Overall Study|Withdrawal by Subject|0
2107501|NCT00874237|3701138|FG004|Overall Study|Withdrawal by Subject|0
2107502|NCT00874237|3701139|FG005|Overall Study|Withdrawal by Subject|0
2107503|NCT00874276|3701156|FG000|Overall Study|Withdrawal by Subject|1
2107504|NCT00874276|3701157|FG001|Overall Study|Withdrawal by Subject|1
2107505|NCT00874432|3701169|FG000|Overall Study|Withdrawal by Subject|1
2107506|NCT00874432|3701170|FG001|Overall Study|Withdrawal by Subject|0
2107507|NCT00874432|3701171|FG002|Overall Study|Withdrawal by Subject|0
2107508|NCT00874432|3701172|FG003|Overall Study|Withdrawal by Subject|0
2107509|NCT00874432|3701169|FG000|Overall Study|Physician Decision|1
2107510|NCT00874432|3701170|FG001|Overall Study|Physician Decision|0
2107511|NCT00874432|3701171|FG002|Overall Study|Physician Decision|0
2107512|NCT00874432|3701172|FG003|Overall Study|Physician Decision|0
2107513|NCT00874432|3701169|FG000|Overall Study|Other|1
2107514|NCT00874432|3701170|FG001|Overall Study|Other|2
2107515|NCT00874432|3701171|FG002|Overall Study|Other|8
2107516|NCT00874432|3701172|FG003|Overall Study|Other|3
2107517|NCT00874497|3701186|FG000|Overall Study|Lost to Follow-up|2
2107518|NCT00874497|3701187|FG001|Overall Study|Lost to Follow-up|4
2211857|NCT01663987|3852420|FG000|Overall Study|Lost to Follow-up|1
2211858|NCT01663987|3852421|FG001|Overall Study|Lost to Follow-up|1
2211859|NCT01663987|3852420|FG000|Overall Study|Withdrawal by Subject|2
2211860|NCT01663987|3852421|FG001|Overall Study|Withdrawal by Subject|3
2107519|NCT00874497|3701186|FG000|Overall Study|Adverse Event|9
2107520|NCT00874497|3701187|FG001|Overall Study|Adverse Event|4
2107521|NCT00874497|3701186|FG000|Overall Study|Sponsor Discontinued Trial|7
2107522|NCT00874497|3701187|FG001|Overall Study|Sponsor Discontinued Trial|3
2107523|NCT00874497|3701186|FG000|Overall Study|Met Withdrawal Criteria|4
2107524|NCT00874497|3701187|FG001|Overall Study|Met Withdrawal Criteria|2
2093093|NCT00779675|3681615|FG000|Treatment Period|Adverse Event|87
2093094|NCT00779675|3681615|FG000|Treatment Period|Treatment Failure|80
2093095|NCT00779675|3681615|FG000|Treatment Period|Transferred to Another Study|38
2093096|NCT00779675|3681615|FG000|Treatment Period|Lost to Follow-up|23
2093097|NCT00779675|3681615|FG000|Treatment Period|Withdrawal by Subject|46
2093098|NCT00779675|3681615|FG000|Treatment Period|Protocol Violation|54
2093099|NCT00779675|3681615|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1
2093100|NCT00779675|3681615|FG000|Treatment Period|Administrative|3
2093101|NCT00779675|3681615|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9
2093102|NCT00779675|3681615|FG000|Extended Treatment Period|Protocol Violation|13
2093103|NCT00779675|3681615|FG000|Extended Treatment Period|Adverse Event|6
2093104|NCT00779675|3681615|FG000|Extended Treatment Period|Treatment Failure|11
2093105|NCT00779675|3681615|FG000|Extended Treatment Period|Protocol defined clinical event|1
2093106|NCT00779675|3681615|FG000|Extended Treatment Period|Lost to Follow-up|6
2093107|NCT00779766|3681629|FG000|Month 24|Serious Adverse Event|2
2093108|NCT00779766|3681630|FG001|Month 24|Serious Adverse Event|3
2093109|NCT00779766|3681629|FG000|Month 24|Adverse Event|3
2093110|NCT00779766|3681630|FG001|Month 24|Adverse Event|3
2093111|NCT00779766|3681629|FG000|Month 24|Protocol Violation|3
2093112|NCT00779766|3681630|FG001|Month 24|Protocol Violation|1
2093113|NCT00779766|3681629|FG000|Month 24|Withdrawal by Subject|159
2093114|NCT00779766|3681630|FG001|Month 24|Withdrawal by Subject|127
2093115|NCT00779766|3681629|FG000|Month 24|Migrated/moved from study area|138
2093116|NCT00779766|3681630|FG001|Month 24|Migrated/moved from study area|162
2093117|NCT00779766|3681629|FG000|Month 24|Lost to Follow-up|9
2093118|NCT00779766|3681630|FG001|Month 24|Lost to Follow-up|9
2093119|NCT00779766|3681629|FG000|Month 24|Other|18
2093120|NCT00779766|3681630|FG001|Month 24|Other|27
2093121|NCT00779766|3681629|FG000|Month 48|Withdrawal by Subject|68
2093122|NCT00779766|3681630|FG001|Month 48|Withdrawal by Subject|63
2093123|NCT00779766|3681629|FG000|Month 48|Migrated/moved from study area|76
2093124|NCT00779766|3681630|FG001|Month 48|Migrated/moved from study area|75
2093125|NCT00779766|3681629|FG000|Month 48|Lost to Follow-up|29
2093126|NCT00779766|3681630|FG001|Month 48|Lost to Follow-up|30
2093127|NCT00779766|3681629|FG000|Month 48|Other|1
2093128|NCT00779766|3681630|FG001|Month 48|Other|0
2093129|NCT00779766|3681629|FG000|Month 72|Withdrawal by Subject|55
2093130|NCT00779766|3681630|FG001|Month 72|Withdrawal by Subject|71
2093131|NCT00779766|3681629|FG000|Month 72|Migrated/moved from study area|124
2093132|NCT00779766|3681630|FG001|Month 72|Migrated/moved from study area|109
2093133|NCT00779766|3681629|FG000|Month 72|Lost to Follow-up|6
2093134|NCT00779766|3681630|FG001|Month 72|Lost to Follow-up|8
2093135|NCT00779766|3681629|FG000|Month 72|Other|0
2093136|NCT00779766|3681630|FG001|Month 72|Other|1
2093137|NCT00779779|3681637|FG000|Overall Study|Adverse Event|1
2093138|NCT00779779|3681637|FG000|Overall Study|Protocol Violation|14
2093139|NCT00779779|3681637|FG000|Overall Study|Withdrawal by Subject|4
2093140|NCT00779779|3681637|FG000|Overall Study|Lost to Follow-up|5
2093141|NCT00779857|3681641|FG000|Overall Study|Death|1
2093142|NCT00779857|3681641|FG000|Overall Study|Withdrawal by Subject|3
2093143|NCT00779857|3681641|FG000|Overall Study|Missed Visit|2
2093144|NCT00779909|3681662|FG000|Overall Study|Lost to Follow-up|1
2093145|NCT00779909|3681663|FG001|Overall Study|Lost to Follow-up|0
2093146|NCT00779909|3681664|FG002|Overall Study|Lost to Follow-up|0
2093147|NCT00779909|3681665|FG003|Overall Study|Lost to Follow-up|1
2093148|NCT00779909|3681662|FG000|Overall Study|Withdrawal by Subject|0
2093149|NCT00779909|3681663|FG001|Overall Study|Withdrawal by Subject|1
2093150|NCT00779909|3681664|FG002|Overall Study|Withdrawal by Subject|0
2093151|NCT00779909|3681665|FG003|Overall Study|Withdrawal by Subject|0
2093152|NCT00780143|3681691|FG000|Overall Study|Progressive disease|1
2093153|NCT00780143|3681691|FG000|Overall Study|Toxicity|1
2093154|NCT00780143|3681691|FG000|Overall Study|Adverse Event|1
2093155|NCT00780273|3681708|FG000|Overall Study|Death|1
2093156|NCT00780273|3681708|FG000|Overall Study|Lost to Follow-up|1
2093157|NCT00780416|3681728|FG000|Overall Study|Physician Decision|3
2093158|NCT00780416|3681729|FG001|Overall Study|Physician Decision|3
2093159|NCT00780416|3681728|FG000|Overall Study|Protocol Violation|1
2093160|NCT00780416|3681729|FG001|Overall Study|Protocol Violation|0
2093161|NCT00780416|3681728|FG000|Overall Study|Withdrawal by Subject|8
2093162|NCT00780416|3681729|FG001|Overall Study|Withdrawal by Subject|6
2093163|NCT00780559|3681750|FG000|Overall Study|Lost to Follow-up|2
2093164|NCT00780559|3681751|FG001|Overall Study|Lost to Follow-up|7
2093165|NCT00780559|3681750|FG000|Overall Study|Death|1
2093166|NCT00780559|3681751|FG001|Overall Study|Death|0
2093167|NCT00780910|3681810|FG000|Overall Study|Adverse Event|2
2093168|NCT00780975|3681823|FG000|Overall Study|Progressive disease|3
2093169|NCT00780975|3681823|FG000|Overall Study|Toxicity|5
2093170|NCT00781274|3681836|FG000|Overall Study|Withdrawal by Subject|2
2093171|NCT00781326|3681840|FG000|Phase I|Adverse Event|1
2093172|NCT00781326|3681840|FG000|Phase I|Withdrawal by Subject|1
2093173|NCT00781326|3681840|FG000|Phase I|Physician Decision|2
2093174|NCT00781365|3681846|FG000|Overall Study|Withdrawal by Subject|13
2093175|NCT00781365|3681847|FG001|Overall Study|Withdrawal by Subject|8
2093176|NCT00781365|3681846|FG000|Overall Study|Did Not Attend Visit|20
2093177|NCT00781365|3681847|FG001|Overall Study|Did Not Attend Visit|28
2093178|NCT00781365|3681846|FG000|Overall Study|Language barrier|1
2093179|NCT00781365|3681847|FG001|Overall Study|Language barrier|0
2093180|NCT00781391|3681856|FG000|Overall Study|never received study drug|24
2093181|NCT00781391|3681857|FG001|Overall Study|never received study drug|23
2093182|NCT00781391|3681858|FG002|Overall Study|never received study drug|32
2093183|NCT00781391|3681856|FG000|Overall Study|Protocol Violation|19
2093184|NCT00781391|3681857|FG001|Overall Study|Protocol Violation|17
2093185|NCT00781391|3681858|FG002|Overall Study|Protocol Violation|20
2093186|NCT00781391|3681856|FG000|Overall Study|Death|789
2093187|NCT00781391|3681857|FG001|Overall Study|Death|730
2093188|NCT00781391|3681858|FG002|Overall Study|Death|706
2093189|NCT00781391|3681856|FG000|Overall Study|Withdrawal by Subject|47
2093190|NCT00781391|3681857|FG001|Overall Study|Withdrawal by Subject|37
2093191|NCT00781391|3681858|FG002|Overall Study|Withdrawal by Subject|25
2093192|NCT00781391|3681856|FG000|Overall Study|Lost to Follow-up|0
2093193|NCT00781391|3681857|FG001|Overall Study|Lost to Follow-up|0
2093194|NCT00781391|3681858|FG002|Overall Study|Lost to Follow-up|1
2093195|NCT00781456|3681868|FG000|Overall Study|Adverse Event|3
2093196|NCT00781456|3681869|FG001|Overall Study|Adverse Event|3
2093197|NCT00781456|3681868|FG000|Overall Study|Withdrawal by Subject|3
2093198|NCT00781456|3681869|FG001|Overall Study|Withdrawal by Subject|5
2093199|NCT00781456|3681868|FG000|Overall Study|Protocol Violation|4
2093200|NCT00781456|3681869|FG001|Overall Study|Protocol Violation|1
2093201|NCT00781456|3681868|FG000|Overall Study|Noncompliance With Protocol|1
2093202|NCT00781456|3681869|FG001|Overall Study|Noncompliance With Protocol|1
2093203|NCT00781456|3681868|FG000|Overall Study|Lost to Follow-up|10
2093204|NCT00781456|3681869|FG001|Overall Study|Lost to Follow-up|5
2093205|NCT00781456|3681868|FG000|Overall Study|Other Reason, Unknown|0
2093206|NCT00781456|3681869|FG001|Overall Study|Other Reason, Unknown|1
2093207|NCT00781599|3681888|FG000|Overall Study|Lost to Follow-up|7
2093208|NCT00781599|3681889|FG001|Overall Study|Lost to Follow-up|4
2093209|NCT00781768|3681897|FG000|Overall Study|Not transplanted.|0
2093210|NCT00781768|3681898|FG001|Overall Study|Not transplanted.|2
2093211|NCT00781859|3681906|FG000|Overall Study|Adverse Event|2
2093212|NCT00781859|3681907|FG001|Overall Study|Adverse Event|2
2093213|NCT00781859|3681906|FG000|Overall Study|Withdrawal by Subject|8
2093214|NCT00781859|3681907|FG001|Overall Study|Withdrawal by Subject|4
2093215|NCT00781859|3681906|FG000|Overall Study|Lost to Follow-up|6
2093216|NCT00781859|3681907|FG001|Overall Study|Lost to Follow-up|3
2093217|NCT00781859|3681906|FG000|Overall Study|Death|3
2093218|NCT00781859|3681907|FG001|Overall Study|Death|0
2093219|NCT00781885|3681913|FG000|Overall Study|Physician Decision|1
2093220|NCT00781911|3681928|FG000|Overall Study|Adverse Event|4
2093221|NCT00781911|3681929|FG001|Overall Study|Adverse Event|4
2093222|NCT00781911|3681928|FG000|Overall Study|Withdrawal by Subject|1
2093223|NCT00781911|3681929|FG001|Overall Study|Withdrawal by Subject|2
2093224|NCT00781911|3681928|FG000|Overall Study|Physician Decision|0
2093225|NCT00781911|3681929|FG001|Overall Study|Physician Decision|2
2093226|NCT00781911|3681928|FG000|Overall Study|Sponsor Decision|1
2093227|NCT00781911|3681929|FG001|Overall Study|Sponsor Decision|0
2093228|NCT00781937|3681939|FG000|Main Trial Period Through Week 56|Adverse Event|18
2093229|NCT00781937|3681940|FG001|Main Trial Period Through Week 56|Adverse Event|18
2093230|NCT00781937|3681939|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0
2093231|NCT00781937|3681940|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2
2093232|NCT00781937|3681939|FG000|Main Trial Period Through Week 56|Protocol Violation|8
2093233|NCT00781937|3681940|FG001|Main Trial Period Through Week 56|Protocol Violation|5
2093234|NCT00781937|3681939|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17
2093235|NCT00781937|3681940|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24
2093236|NCT00781937|3681939|FG000|Main Trial Period Through Week 56|Unclassified|10
2093237|NCT00781937|3681940|FG001|Main Trial Period Through Week 56|Unclassified|15
2093238|NCT00781937|3681939|FG000|Follow up Period (Week 56-68)|Protocol Violation|1
2093239|NCT00781937|3681940|FG001|Follow up Period (Week 56-68)|Protocol Violation|1
2093240|NCT00781937|3681939|FG000|Follow up Period (Week 56-68)|Unclassified|5
2093241|NCT00781937|3681940|FG001|Follow up Period (Week 56-68)|Unclassified|4
2093242|NCT00781963|3681958|FG000|Overall Study|Death|3
2093243|NCT00781963|3681959|FG001|Overall Study|Death|0
2093244|NCT00781963|3681958|FG000|Overall Study|Lost to Follow-up|2
2093245|NCT00781963|3681959|FG001|Overall Study|Lost to Follow-up|1
2093246|NCT00781963|3681958|FG000|Overall Study|Withdrawal by Subject|3
2093247|NCT00781963|3681959|FG001|Overall Study|Withdrawal by Subject|1
2093248|NCT00781963|3681958|FG000|Overall Study|Refused follow-up|9
2093249|NCT00781963|3681959|FG001|Overall Study|Refused follow-up|0
2093250|NCT00782067|3681965|FG000|Overall Study|Adverse Event|35
2093251|NCT00782067|3681965|FG000|Overall Study|Subject withdrew consent|11
2093252|NCT00782067|3681965|FG000|Overall Study|Lost to Follow-up|2
2093253|NCT00782067|3681965|FG000|Overall Study|Administrative problems|14
2093254|NCT00782067|3681965|FG000|Overall Study|Death|9
2093255|NCT00782067|3681965|FG000|Overall Study|Disease progression|43
2093256|NCT00782067|3681965|FG000|Overall Study|Protocol deviation|2
2093257|NCT00782171|3681971|FG000|Overall Study|Lost to Follow-up|2
2093258|NCT00782171|3681972|FG001|Overall Study|Lost to Follow-up|2
2093259|NCT00782171|3681971|FG000|Overall Study|Withdrawal by Subject|2
2093260|NCT00782171|3681972|FG001|Overall Study|Withdrawal by Subject|1
2093261|NCT00782171|3681971|FG000|Overall Study|complications|3
2093262|NCT00782171|3681972|FG001|Overall Study|complications|1
2093263|NCT00782171|3681971|FG000|Overall Study|others|7
2093264|NCT00782171|3681972|FG001|Overall Study|others|9
2093265|NCT00782171|3681971|FG000|Overall Study|not eligible|8
2093266|NCT00782171|3681972|FG001|Overall Study|not eligible|6
2093267|NCT00782210|3681981|FG000|Overall Study|Adverse Event|21
2093268|NCT00782210|3681982|FG001|Overall Study|Adverse Event|17
2093269|NCT00782210|3681983|FG002|Overall Study|Adverse Event|16
2093270|NCT00782210|3681981|FG000|Overall Study|Lost to Follow-up|2
2093271|NCT00782210|3681982|FG001|Overall Study|Lost to Follow-up|1
2093272|NCT00782210|3681983|FG002|Overall Study|Lost to Follow-up|2
2093273|NCT00782210|3681981|FG000|Overall Study|Withdrawal by Subject|11
2093274|NCT00782210|3681982|FG001|Overall Study|Withdrawal by Subject|8
2093275|NCT00782210|3681983|FG002|Overall Study|Withdrawal by Subject|11
2093276|NCT00782210|3681981|FG000|Overall Study|Non compliance with protocol|0
2093277|NCT00782210|3681982|FG001|Overall Study|Non compliance with protocol|3
2093278|NCT00782210|3681983|FG002|Overall Study|Non compliance with protocol|2
2093279|NCT00782210|3681981|FG000|Overall Study|Lack of Efficacy|13
2093280|NCT00782210|3681982|FG001|Overall Study|Lack of Efficacy|4
2093281|NCT00782210|3681983|FG002|Overall Study|Lack of Efficacy|1
2093282|NCT00782210|3681981|FG000|Overall Study|Other reason not described above|3
2093283|NCT00782210|3681982|FG001|Overall Study|Other reason not described above|2
2093284|NCT00782210|3681983|FG002|Overall Study|Other reason not described above|3
2093285|NCT00782275|3682000|FG000|Overall Study|Adverse Event|11
2093286|NCT00782275|3682000|FG000|Overall Study|Withdrawal by Subject|1
2093287|NCT00782275|3682000|FG000|Overall Study|Progressive Disease|21
2093288|NCT00782275|3682000|FG000|Overall Study|Physician Decision|4
2093289|NCT00782275|3682000|FG000|Overall Study|Not started treatment|1
2093290|NCT00782275|3682000|FG000|Overall Study|Other|3
2093291|NCT00782340|3682022|FG000|Open Label Titration|Adverse Event|12
2093292|NCT00782340|3682023|FG001|Open Label Titration|Adverse Event|0
2093293|NCT00782340|3682024|FG002|Open Label Titration|Adverse Event|0
2093294|NCT00782340|3682022|FG000|Open Label Titration|Treatment failure|50
2093295|NCT00782340|3682023|FG001|Open Label Titration|Treatment failure|0
2093296|NCT00782340|3682024|FG002|Open Label Titration|Treatment failure|0
2093297|NCT00782340|3682022|FG000|Open Label Titration|Protocol Violation|5
2093298|NCT00782340|3682023|FG001|Open Label Titration|Protocol Violation|0
2093299|NCT00782340|3682024|FG002|Open Label Titration|Protocol Violation|0
2093300|NCT00782340|3682022|FG000|Open Label Titration|Withdrawal by Subject|5
2093301|NCT00782340|3682023|FG001|Open Label Titration|Withdrawal by Subject|0
2093302|NCT00782340|3682024|FG002|Open Label Titration|Withdrawal by Subject|0
2093303|NCT00782340|3682022|FG000|Open Label Titration|Enrollment capped|16
2093304|NCT00782340|3682023|FG001|Open Label Titration|Enrollment capped|0
2093305|NCT00782340|3682024|FG002|Open Label Titration|Enrollment capped|0
2093306|NCT00782340|3682022|FG000|Open Label Titration|Did not meet responder criteria|2
2093307|NCT00782340|3682023|FG001|Open Label Titration|Did not meet responder criteria|0
2093308|NCT00782340|3682024|FG002|Open Label Titration|Did not meet responder criteria|0
2093309|NCT00782340|3682022|FG000|Open Label Titration|Lost to Follow-up|5
2093310|NCT00782340|3682023|FG001|Open Label Titration|Lost to Follow-up|0
2093311|NCT00782340|3682024|FG002|Open Label Titration|Lost to Follow-up|0
2093312|NCT00782340|3682022|FG000|Open Label Titration|Randomized in error|6
2093313|NCT00782340|3682023|FG001|Open Label Titration|Randomized in error|0
2093314|NCT00782340|3682024|FG002|Open Label Titration|Randomized in error|0
2093315|NCT00782418|3682035|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1
2093316|NCT00782418|3682036|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0
2093317|NCT00782418|3682037|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0
2093318|NCT00782418|3682038|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0
2093319|NCT00782418|3682039|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0
2093320|NCT00782418|3682040|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0
2093321|NCT00782418|3682041|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0
2093322|NCT00782418|3682035|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
2093323|NCT00782418|3682036|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
2093324|NCT00782418|3682037|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
2093325|NCT00782418|3682038|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
2093326|NCT00782418|3682039|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
2093327|NCT00782418|3682040|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
2093328|NCT00782418|3682041|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
2093329|NCT00782496|3682057|FG000|Overall Study|Lost to Follow-up|14
2093330|NCT00782496|3682058|FG001|Overall Study|Lost to Follow-up|15
2093331|NCT00782509|3682068|FG000|Overall Study|Adverse Event|20
2093332|NCT00782509|3682069|FG001|Overall Study|Adverse Event|10
2093333|NCT00782509|3682070|FG002|Overall Study|Adverse Event|20
2093334|NCT00782509|3682068|FG000|Overall Study|Lost to Follow-up|1
2093335|NCT00782509|3682069|FG001|Overall Study|Lost to Follow-up|2
2093336|NCT00782509|3682070|FG002|Overall Study|Lost to Follow-up|3
2093337|NCT00782509|3682068|FG000|Overall Study|Withdrawal by Subject|3
2093338|NCT00782509|3682069|FG001|Overall Study|Withdrawal by Subject|5
2093339|NCT00782509|3682070|FG002|Overall Study|Withdrawal by Subject|8
2093340|NCT00782509|3682068|FG000|Overall Study|Non compliance with protocol|2
2093341|NCT00782509|3682069|FG001|Overall Study|Non compliance with protocol|0
2093342|NCT00782509|3682070|FG002|Overall Study|Non compliance with protocol|0
2093343|NCT00782509|3682068|FG000|Overall Study|Other reasons not stated above|5
2093344|NCT00782509|3682069|FG001|Overall Study|Other reasons not stated above|2
2093345|NCT00782509|3682070|FG002|Overall Study|Other reasons not stated above|3
2093346|NCT00782509|3682068|FG000|Overall Study|Lack of Efficacy|10
2093347|NCT00782509|3682069|FG001|Overall Study|Lack of Efficacy|5
2093348|NCT00782509|3682070|FG002|Overall Study|Lack of Efficacy|2
2093349|NCT00782626|3682085|FG000|Overall Study|Adverse Event|1
2093350|NCT00782626|3682085|FG000|Overall Study|Progressive Disease|5
2093351|NCT00782626|3682085|FG000|Overall Study|Other Complicating Disease|1
2093352|NCT00782717|3682102|FG000|Overall Study|Adverse Event|2
2093353|NCT00782717|3682103|FG001|Overall Study|Adverse Event|5
2093354|NCT00782717|3682102|FG000|Overall Study|Patient decision unrelated to AE|6
2093355|NCT00782717|3682103|FG001|Overall Study|Patient decision unrelated to AE|3
2093356|NCT00782717|3682102|FG000|Overall Study|Noncompliance|2
2093357|NCT00782717|3682103|FG001|Overall Study|Noncompliance|1
2093358|NCT00782717|3682102|FG000|Overall Study|Treatment failure|3
2093359|NCT00782717|3682103|FG001|Overall Study|Treatment failure|14
2093360|NCT00782717|3682102|FG000|Overall Study|Enrollment close prior to surgery|1
2093361|NCT00782717|3682103|FG001|Overall Study|Enrollment close prior to surgery|0
2093362|NCT00782717|3682102|FG000|Overall Study|Did not meet entrance criteria|1
2093363|NCT00782717|3682103|FG001|Overall Study|Did not meet entrance criteria|3
2093364|NCT00782717|3682102|FG000|Overall Study|Exited in error|0
2093365|NCT00782717|3682103|FG001|Overall Study|Exited in error|2
2093366|NCT00782795|3682115|FG000|Overall Study|Withdrawal by Subject|1
2093367|NCT00782795|3682116|FG001|Overall Study|Withdrawal by Subject|2
2093368|NCT00782834|3682146|FG000|Treatment Phase|fibrous tumor not GIST|1
2093369|NCT00783094|3682153|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4
2093370|NCT00783094|3682154|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5
2093371|NCT00783094|3682155|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5
2093372|NCT00783094|3682153|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
2093373|NCT00783094|3682154|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
2093374|NCT00783094|3682155|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
2093375|NCT00783094|3682153|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0
2093376|NCT00783094|3682154|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2
2093377|NCT00783094|3682155|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0
2093378|NCT00783094|3682153|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1
2093379|NCT00783094|3682154|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2
2093380|NCT00783094|3682155|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1
2093381|NCT00783094|3682153|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
2093382|NCT00783094|3682154|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
2093383|NCT00783094|3682155|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
2093384|NCT00783094|3682153|FG000|Open-Label Extension Period|Adverse Event|12
2093385|NCT00783094|3682154|FG001|Open-Label Extension Period|Adverse Event|7
2093386|NCT00783094|3682155|FG002|Open-Label Extension Period|Adverse Event|16
2093387|NCT00783094|3682153|FG000|Open-Label Extension Period|Death|0
2093388|NCT00783094|3682154|FG001|Open-Label Extension Period|Death|0
2093389|NCT00783094|3682155|FG002|Open-Label Extension Period|Death|1
2093390|NCT00783094|3682153|FG000|Open-Label Extension Period|Protocol Violation|4
2093391|NCT00783094|3682154|FG001|Open-Label Extension Period|Protocol Violation|5
2093392|NCT00783094|3682155|FG002|Open-Label Extension Period|Protocol Violation|7
2093393|NCT00783094|3682153|FG000|Open-Label Extension Period|Withdrawal by Subject|1
2093394|NCT00783094|3682154|FG001|Open-Label Extension Period|Withdrawal by Subject|1
2093395|NCT00783094|3682155|FG002|Open-Label Extension Period|Withdrawal by Subject|3
2093396|NCT00783094|3682153|FG000|Open-Label Extension Period|Physician Decision|4
2093397|NCT00783094|3682154|FG001|Open-Label Extension Period|Physician Decision|2
2093398|NCT00783094|3682155|FG002|Open-Label Extension Period|Physician Decision|3
2093399|NCT00783094|3682153|FG000|Open-Label Extension Period|Lack of Efficacy|1
2093400|NCT00783094|3682154|FG001|Open-Label Extension Period|Lack of Efficacy|4
2093401|NCT00783094|3682155|FG002|Open-Label Extension Period|Lack of Efficacy|0
2093402|NCT00783198|3682169|FG000|Overall Study|Adverse Event|15
2093403|NCT00783198|3682170|FG001|Overall Study|Adverse Event|19
2093404|NCT00783198|3682171|FG002|Overall Study|Adverse Event|3
2093405|NCT00783198|3682169|FG000|Overall Study|Lost to Follow-up|11
2093406|NCT00783198|3682170|FG001|Overall Study|Lost to Follow-up|1
2093407|NCT00783198|3682171|FG002|Overall Study|Lost to Follow-up|7
2093408|NCT00783198|3682169|FG000|Overall Study|Withdrawal by Subject|22
2093409|NCT00783198|3682170|FG001|Overall Study|Withdrawal by Subject|14
2093410|NCT00783198|3682171|FG002|Overall Study|Withdrawal by Subject|20
2093411|NCT00783198|3682169|FG000|Overall Study|Noncompliance with protocol|7
2093412|NCT00783198|3682170|FG001|Overall Study|Noncompliance with protocol|7
2093413|NCT00783198|3682171|FG002|Overall Study|Noncompliance with protocol|10
2093414|NCT00783198|3682169|FG000|Overall Study|Did not meet protocol eligibility|0
2093415|NCT00783198|3682170|FG001|Overall Study|Did not meet protocol eligibility|1
2093416|NCT00783198|3682171|FG002|Overall Study|Did not meet protocol eligibility|0
2307448|NCT02697591|4009855|FG008|Overall Study|Death|1
2307449|NCT02697591|4009856|FG009|Overall Study|Death|5
2307450|NCT02697591|4009847|FG000|Overall Study|Reason not Specified|0
2093417|NCT00783198|3682169|FG000|Overall Study|Administrative|2
2093418|NCT00783198|3682170|FG001|Overall Study|Administrative|1
2093419|NCT00783198|3682171|FG002|Overall Study|Administrative|2
2093420|NCT00783289|3682183|FG000|Overall Study|Protocol Violation|0
2093421|NCT00783289|3682184|FG001|Overall Study|Protocol Violation|1
2093422|NCT00783289|3682185|FG002|Overall Study|Protocol Violation|0
2093423|NCT00783289|3682186|FG003|Overall Study|Protocol Violation|0
2093424|NCT00783302|3682199|FG000|Overall Study|Lost to Follow-up|17
2093425|NCT00783302|3682199|FG000|Overall Study|Technical Problems|11
2093426|NCT00783302|3682199|FG000|Overall Study|Protocol Violation|3
2093427|NCT00783302|3682199|FG000|Overall Study|Physician Decision|1
2093428|NCT00783302|3682199|FG000|Overall Study|Withdrawal by Subject|3
2093429|NCT00783432|3682228|FG000|Overall Study|Adverse Event|22
2093430|NCT00783432|3682229|FG001|Overall Study|Adverse Event|17
2093431|NCT00783432|3682228|FG000|Overall Study|Lack of Efficacy|20
2093432|NCT00783432|3682229|FG001|Overall Study|Lack of Efficacy|21
2093433|NCT00783432|3682228|FG000|Overall Study|Lost to Follow-up|11
2093434|NCT00783432|3682229|FG001|Overall Study|Lost to Follow-up|6
2093435|NCT00783432|3682228|FG000|Overall Study|Withdrawal by Subject|23
2093436|NCT00783432|3682229|FG001|Overall Study|Withdrawal by Subject|20
2093437|NCT00783432|3682228|FG000|Overall Study|subject moved|3
2093438|NCT00783432|3682229|FG001|Overall Study|subject moved|5
2093439|NCT00783432|3682228|FG000|Overall Study|Protocol Violation|6
2093440|NCT00783432|3682229|FG001|Overall Study|Protocol Violation|9
2093441|NCT00783692|3682255|FG000|Induction Phase|Adverse Event|7
2093442|NCT00783692|3682256|FG001|Induction Phase|Adverse Event|9
2093443|NCT00783692|3682257|FG002|Induction Phase|Adverse Event|24
2093444|NCT00783692|3682258|FG003|Induction Phase|Adverse Event|0
2093445|NCT00783692|3682259|FG004|Induction Phase|Adverse Event|0
2093446|NCT00783692|3682260|FG005|Induction Phase|Adverse Event|0
2093447|NCT00783692|3682261|FG006|Induction Phase|Adverse Event|0
2093448|NCT00783692|3682255|FG000|Induction Phase|Protocol Violation|0
2093449|NCT00783692|3682256|FG001|Induction Phase|Protocol Violation|0
2093450|NCT00783692|3682257|FG002|Induction Phase|Protocol Violation|1
2093451|NCT00783692|3682258|FG003|Induction Phase|Protocol Violation|0
2093452|NCT00783692|3682259|FG004|Induction Phase|Protocol Violation|0
2093453|NCT00783692|3682260|FG005|Induction Phase|Protocol Violation|0
2093454|NCT00783692|3682261|FG006|Induction Phase|Protocol Violation|0
2093455|NCT00783692|3682255|FG000|Induction Phase|Lack of Efficacy|1
2093456|NCT00783692|3682256|FG001|Induction Phase|Lack of Efficacy|3
2093457|NCT00783692|3682257|FG002|Induction Phase|Lack of Efficacy|28
2093458|NCT00783692|3682258|FG003|Induction Phase|Lack of Efficacy|0
2093459|NCT00783692|3682259|FG004|Induction Phase|Lack of Efficacy|0
2093460|NCT00783692|3682260|FG005|Induction Phase|Lack of Efficacy|0
2093461|NCT00783692|3682261|FG006|Induction Phase|Lack of Efficacy|0
2093462|NCT00783692|3682255|FG000|Induction Phase|Withdrawal by Subject|3
2093463|NCT00783692|3682256|FG001|Induction Phase|Withdrawal by Subject|9
2093464|NCT00783692|3682257|FG002|Induction Phase|Withdrawal by Subject|16
2093465|NCT00783692|3682258|FG003|Induction Phase|Withdrawal by Subject|0
2093466|NCT00783692|3682259|FG004|Induction Phase|Withdrawal by Subject|0
2093467|NCT00783692|3682260|FG005|Induction Phase|Withdrawal by Subject|0
2093468|NCT00783692|3682261|FG006|Induction Phase|Withdrawal by Subject|0
2093469|NCT00783692|3682255|FG000|Induction Phase|Lost to Follow-up|0
2093470|NCT00783692|3682256|FG001|Induction Phase|Lost to Follow-up|0
2093471|NCT00783692|3682257|FG002|Induction Phase|Lost to Follow-up|3
2093472|NCT00783692|3682258|FG003|Induction Phase|Lost to Follow-up|0
2093473|NCT00783692|3682259|FG004|Induction Phase|Lost to Follow-up|0
2093474|NCT00783692|3682260|FG005|Induction Phase|Lost to Follow-up|0
2093475|NCT00783692|3682261|FG006|Induction Phase|Lost to Follow-up|0
2093476|NCT00783692|3682255|FG000|Induction Phase|Other|0
2093477|NCT00783692|3682256|FG001|Induction Phase|Other|0
2093478|NCT00783692|3682257|FG002|Induction Phase|Other|2
2093479|NCT00783692|3682258|FG003|Induction Phase|Other|0
2093480|NCT00783692|3682259|FG004|Induction Phase|Other|0
2093481|NCT00783692|3682260|FG005|Induction Phase|Other|0
2093482|NCT00783692|3682261|FG006|Induction Phase|Other|0
2093483|NCT00783692|3682255|FG000|Maintenance Phase|Adverse Event|7
2093484|NCT00783692|3682256|FG001|Maintenance Phase|Adverse Event|0
2093485|NCT00783692|3682257|FG002|Maintenance Phase|Adverse Event|0
2093486|NCT00783692|3682258|FG003|Maintenance Phase|Adverse Event|15
2093487|NCT00783692|3682259|FG004|Maintenance Phase|Adverse Event|12
2093488|NCT00783692|3682260|FG005|Maintenance Phase|Adverse Event|9
2093489|NCT00783692|3682261|FG006|Maintenance Phase|Adverse Event|38
2093490|NCT00783692|3682255|FG000|Maintenance Phase|Protocol Violation|0
2093491|NCT00783692|3682256|FG001|Maintenance Phase|Protocol Violation|0
2093492|NCT00783692|3682257|FG002|Maintenance Phase|Protocol Violation|0
2093493|NCT00783692|3682258|FG003|Maintenance Phase|Protocol Violation|1
2093494|NCT00783692|3682259|FG004|Maintenance Phase|Protocol Violation|2
2093495|NCT00783692|3682260|FG005|Maintenance Phase|Protocol Violation|3
2093496|NCT00783692|3682261|FG006|Maintenance Phase|Protocol Violation|4
2093497|NCT00783692|3682255|FG000|Maintenance Phase|Lack of Efficacy|79
2093498|NCT00783692|3682256|FG001|Maintenance Phase|Lack of Efficacy|0
2093499|NCT00783692|3682257|FG002|Maintenance Phase|Lack of Efficacy|0
2093500|NCT00783692|3682258|FG003|Maintenance Phase|Lack of Efficacy|64
2093501|NCT00783692|3682259|FG004|Maintenance Phase|Lack of Efficacy|58
2093502|NCT00783692|3682260|FG005|Maintenance Phase|Lack of Efficacy|48
2093503|NCT00783692|3682261|FG006|Maintenance Phase|Lack of Efficacy|177
2093504|NCT00783692|3682255|FG000|Maintenance Phase|Withdrawal by Subject|7
2093505|NCT00783692|3682256|FG001|Maintenance Phase|Withdrawal by Subject|0
2093506|NCT00783692|3682257|FG002|Maintenance Phase|Withdrawal by Subject|0
2093507|NCT00783692|3682258|FG003|Maintenance Phase|Withdrawal by Subject|7
2093508|NCT00783692|3682259|FG004|Maintenance Phase|Withdrawal by Subject|6
2093509|NCT00783692|3682260|FG005|Maintenance Phase|Withdrawal by Subject|9
2093510|NCT00783692|3682261|FG006|Maintenance Phase|Withdrawal by Subject|24
2093511|NCT00783692|3682255|FG000|Maintenance Phase|Lost to Follow-up|2
2093512|NCT00783692|3682256|FG001|Maintenance Phase|Lost to Follow-up|0
2093513|NCT00783692|3682257|FG002|Maintenance Phase|Lost to Follow-up|0
2093514|NCT00783692|3682258|FG003|Maintenance Phase|Lost to Follow-up|1
2093515|NCT00783692|3682259|FG004|Maintenance Phase|Lost to Follow-up|3
2093516|NCT00783692|3682260|FG005|Maintenance Phase|Lost to Follow-up|2
2093517|NCT00783692|3682261|FG006|Maintenance Phase|Lost to Follow-up|5
2093518|NCT00783692|3682255|FG000|Maintenance Phase|Other|0
2093519|NCT00783692|3682256|FG001|Maintenance Phase|Other|0
2093520|NCT00783692|3682257|FG002|Maintenance Phase|Other|0
2093521|NCT00783692|3682258|FG003|Maintenance Phase|Other|1
2093522|NCT00783692|3682259|FG004|Maintenance Phase|Other|0
2093523|NCT00783692|3682260|FG005|Maintenance Phase|Other|1
2093524|NCT00783692|3682261|FG006|Maintenance Phase|Other|1
2093525|NCT00783705|3682276|FG000|Overall Study|Adverse Event|2
2093526|NCT00783705|3682277|FG001|Overall Study|Adverse Event|0
2093527|NCT00783705|3682276|FG000|Overall Study|Withdrawal by Subject|3
2093528|NCT00783705|3682277|FG001|Overall Study|Withdrawal by Subject|2
2093529|NCT00783705|3682276|FG000|Overall Study|Lost to Follow-up|1
2093530|NCT00783705|3682277|FG001|Overall Study|Lost to Follow-up|3
2093531|NCT00783718|3682286|FG000|Induction Phase|Adverse Event|4
2093532|NCT00783718|3682287|FG001|Induction Phase|Adverse Event|0
2093533|NCT00783718|3682288|FG002|Induction Phase|Adverse Event|7
2093534|NCT00783718|3682289|FG003|Induction Phase|Adverse Event|0
2093535|NCT00783718|3682290|FG004|Induction Phase|Adverse Event|0
2093536|NCT00783718|3682291|FG005|Induction Phase|Adverse Event|0
2093537|NCT00783718|3682292|FG006|Induction Phase|Adverse Event|0
2093538|NCT00783718|3682286|FG000|Induction Phase|Protocol Violation|1
2093539|NCT00783718|3682287|FG001|Induction Phase|Protocol Violation|1
2093540|NCT00783718|3682288|FG002|Induction Phase|Protocol Violation|6
2093541|NCT00783718|3682289|FG003|Induction Phase|Protocol Violation|0
2093542|NCT00783718|3682290|FG004|Induction Phase|Protocol Violation|0
2093543|NCT00783718|3682291|FG005|Induction Phase|Protocol Violation|0
2093544|NCT00783718|3682292|FG006|Induction Phase|Protocol Violation|0
2093545|NCT00783718|3682286|FG000|Induction Phase|Lack of Efficacy|5
2093546|NCT00783718|3682287|FG001|Induction Phase|Lack of Efficacy|2
2093547|NCT00783718|3682288|FG002|Induction Phase|Lack of Efficacy|14
2093548|NCT00783718|3682289|FG003|Induction Phase|Lack of Efficacy|0
2093549|NCT00783718|3682290|FG004|Induction Phase|Lack of Efficacy|0
2093550|NCT00783718|3682291|FG005|Induction Phase|Lack of Efficacy|0
2093551|NCT00783718|3682292|FG006|Induction Phase|Lack of Efficacy|0
2093552|NCT00783718|3682286|FG000|Induction Phase|Withdrawal by Subject|3
2093553|NCT00783718|3682287|FG001|Induction Phase|Withdrawal by Subject|4
2093554|NCT00783718|3682288|FG002|Induction Phase|Withdrawal by Subject|8
2093555|NCT00783718|3682289|FG003|Induction Phase|Withdrawal by Subject|0
2093556|NCT00783718|3682290|FG004|Induction Phase|Withdrawal by Subject|0
2093557|NCT00783718|3682291|FG005|Induction Phase|Withdrawal by Subject|0
2093558|NCT00783718|3682292|FG006|Induction Phase|Withdrawal by Subject|0
2093559|NCT00783718|3682286|FG000|Induction Phase|Lost to Follow-up|1
2093560|NCT00783718|3682287|FG001|Induction Phase|Lost to Follow-up|0
2093561|NCT00783718|3682288|FG002|Induction Phase|Lost to Follow-up|1
2093562|NCT00783718|3682289|FG003|Induction Phase|Lost to Follow-up|0
2093563|NCT00783718|3682290|FG004|Induction Phase|Lost to Follow-up|0
2093564|NCT00783718|3682291|FG005|Induction Phase|Lost to Follow-up|0
2093565|NCT00783718|3682292|FG006|Induction Phase|Lost to Follow-up|0
2093566|NCT00783718|3682286|FG000|Maintenance Phase|Adverse Event|12
2093567|NCT00783718|3682287|FG001|Maintenance Phase|Adverse Event|0
2093568|NCT00783718|3682288|FG002|Maintenance Phase|Adverse Event|0
2307451|NCT02697591|4009848|FG001|Overall Study|Reason not Specified|0
2307452|NCT02697591|4009849|FG002|Overall Study|Reason not Specified|0
2307453|NCT02697591|4009850|FG003|Overall Study|Reason not Specified|1
2307454|NCT02697591|4009851|FG004|Overall Study|Reason not Specified|1
2307455|NCT02697591|4009852|FG005|Overall Study|Reason not Specified|2
2307456|NCT02697591|4009853|FG006|Overall Study|Reason not Specified|3
2307457|NCT02697591|4009854|FG007|Overall Study|Reason not Specified|1
2307458|NCT02697591|4009855|FG008|Overall Study|Reason not Specified|1
2307459|NCT02697591|4009856|FG009|Overall Study|Reason not Specified|3
2307460|NCT02697617|4009879|FG000|Overall Study|Withdrawal by Subject|0
2307461|NCT02697617|4009880|FG001|Overall Study|Withdrawal by Subject|2
2307462|NCT02697617|4009879|FG000|Overall Study|Pregnancy|1
2307463|NCT02697617|4009880|FG001|Overall Study|Pregnancy|0
2307464|NCT02697734|4009892|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4
2307465|NCT02697734|4009893|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0
2307466|NCT02697734|4009892|FG000|Core Phase - up to Week 48|Adverse Event|1
2093569|NCT00783718|3682289|FG003|Maintenance Phase|Adverse Event|15
2093570|NCT00783718|3682290|FG004|Maintenance Phase|Adverse Event|7
2093571|NCT00783718|3682291|FG005|Maintenance Phase|Adverse Event|6
2093572|NCT00783718|3682292|FG006|Maintenance Phase|Adverse Event|16
2093573|NCT00783718|3682286|FG000|Maintenance Phase|Protocol Violation|1
2093574|NCT00783718|3682287|FG001|Maintenance Phase|Protocol Violation|0
2093575|NCT00783718|3682288|FG002|Maintenance Phase|Protocol Violation|0
2093576|NCT00783718|3682289|FG003|Maintenance Phase|Protocol Violation|0
2093577|NCT00783718|3682290|FG004|Maintenance Phase|Protocol Violation|0
2093578|NCT00783718|3682291|FG005|Maintenance Phase|Protocol Violation|0
2093579|NCT00783718|3682292|FG006|Maintenance Phase|Protocol Violation|2
2093580|NCT00783718|3682286|FG000|Maintenance Phase|Lack of Efficacy|83
2093581|NCT00783718|3682287|FG001|Maintenance Phase|Lack of Efficacy|0
2093582|NCT00783718|3682288|FG002|Maintenance Phase|Lack of Efficacy|0
2093583|NCT00783718|3682289|FG003|Maintenance Phase|Lack of Efficacy|61
2093584|NCT00783718|3682290|FG004|Maintenance Phase|Lack of Efficacy|31
2093585|NCT00783718|3682291|FG005|Maintenance Phase|Lack of Efficacy|33
2093586|NCT00783718|3682292|FG006|Maintenance Phase|Lack of Efficacy|155
2093587|NCT00783718|3682286|FG000|Maintenance Phase|Withdrawal by Subject|6
2093588|NCT00783718|3682287|FG001|Maintenance Phase|Withdrawal by Subject|0
2093589|NCT00783718|3682288|FG002|Maintenance Phase|Withdrawal by Subject|0
2093590|NCT00783718|3682289|FG003|Maintenance Phase|Withdrawal by Subject|2
2093591|NCT00783718|3682290|FG004|Maintenance Phase|Withdrawal by Subject|5
2093592|NCT00783718|3682291|FG005|Maintenance Phase|Withdrawal by Subject|2
2093593|NCT00783718|3682292|FG006|Maintenance Phase|Withdrawal by Subject|20
2093594|NCT00783718|3682286|FG000|Maintenance Phase|Lost to Follow-up|3
2093595|NCT00783718|3682287|FG001|Maintenance Phase|Lost to Follow-up|0
2093596|NCT00783718|3682288|FG002|Maintenance Phase|Lost to Follow-up|0
2093597|NCT00783718|3682289|FG003|Maintenance Phase|Lost to Follow-up|0
2093598|NCT00783718|3682290|FG004|Maintenance Phase|Lost to Follow-up|2
2093599|NCT00783718|3682291|FG005|Maintenance Phase|Lost to Follow-up|0
2093600|NCT00783718|3682292|FG006|Maintenance Phase|Lost to Follow-up|2
2093601|NCT00783796|3682302|FG000|Overall Study|Did not receive any stent|4
2093602|NCT00783796|3682302|FG000|Overall Study|Received non-XIENCE V stent|1
2093603|NCT00783796|3682302|FG000|Overall Study|Received commercial XIENCE V stent|1
2093604|NCT00783835|3682308|FG000|Overall Study|Adverse Event|3
2093605|NCT00783835|3682308|FG000|Overall Study|Medical Criteria|1
2093606|NCT00783835|3682308|FG000|Overall Study|Withdrawal by Subject|2
2093607|NCT00783835|3682308|FG000|Overall Study|Lost to Follow-up|1
2093608|NCT00783835|3682308|FG000|Overall Study|Participant not Adherent|3
2093609|NCT00784134|3682353|FG000|Overall Study|Lost to Follow-up|3
2093610|NCT00784134|3682354|FG001|Overall Study|Lost to Follow-up|6
2093611|NCT00784147|3682362|FG000|Overall Study|Lost to Follow-up|2
2093612|NCT00784147|3682363|FG001|Overall Study|Lost to Follow-up|4
2093613|NCT00784147|3682362|FG000|Overall Study|Withdrawal by Subject|1
2093614|NCT00784147|3682363|FG001|Overall Study|Withdrawal by Subject|3
2093615|NCT00784147|3682362|FG000|Overall Study|Physician Decision|2
2093616|NCT00784147|3682363|FG001|Overall Study|Physician Decision|1
2093617|NCT00784147|3682362|FG000|Overall Study|Protocol Violation|1
2093618|NCT00784147|3682363|FG001|Overall Study|Protocol Violation|1
2093619|NCT00784147|3682362|FG000|Overall Study|Death|2
2093620|NCT00784147|3682363|FG001|Overall Study|Death|0
2093621|NCT00784238|3682390|FG000|Overall Study|Adverse Event|14
2093622|NCT00784238|3682390|FG000|Overall Study|Death|2
2093623|NCT00784238|3682390|FG000|Overall Study|Lack of Efficacy|33
2093624|NCT00784238|3682390|FG000|Overall Study|Lost to Follow-up|29
2093625|NCT00784238|3682390|FG000|Overall Study|Pregnancy|1
2093626|NCT00784238|3682390|FG000|Overall Study|Withdrawal by Subject|26
2093627|NCT00784238|3682390|FG000|Overall Study|Other|14
2093628|NCT00784277|3682401|FG000|IR Treatment|Adverse Event|4
2093629|NCT00784277|3682402|FG001|IR Treatment|Adverse Event|8
2093630|NCT00784277|3682403|FG002|IR Treatment|Adverse Event|19
2093631|NCT00784277|3682404|FG003|IR Treatment|Adverse Event|35
2093632|NCT00784277|3682405|FG004|IR Treatment|Adverse Event|0
2093633|NCT00784277|3682406|FG005|IR Treatment|Adverse Event|0
2093634|NCT00784277|3682407|FG006|IR Treatment|Adverse Event|0
2093635|NCT00784277|3682401|FG000|IR Treatment|Lack of Efficacy|4
2093636|NCT00784277|3682402|FG001|IR Treatment|Lack of Efficacy|4
2093637|NCT00784277|3682403|FG002|IR Treatment|Lack of Efficacy|1
2093638|NCT00784277|3682404|FG003|IR Treatment|Lack of Efficacy|0
2093639|NCT00784277|3682405|FG004|IR Treatment|Lack of Efficacy|0
2093640|NCT00784277|3682406|FG005|IR Treatment|Lack of Efficacy|0
2093641|NCT00784277|3682407|FG006|IR Treatment|Lack of Efficacy|0
2093642|NCT00784277|3682401|FG000|IR Treatment|Lost to Follow-up|1
2093643|NCT00784277|3682402|FG001|IR Treatment|Lost to Follow-up|0
2093644|NCT00784277|3682403|FG002|IR Treatment|Lost to Follow-up|1
2093645|NCT00784277|3682404|FG003|IR Treatment|Lost to Follow-up|0
2093646|NCT00784277|3682405|FG004|IR Treatment|Lost to Follow-up|0
2093647|NCT00784277|3682406|FG005|IR Treatment|Lost to Follow-up|0
2093648|NCT00784277|3682407|FG006|IR Treatment|Lost to Follow-up|0
2093649|NCT00784277|3682401|FG000|IR Treatment|Withdrawal by Subject|5
2093650|NCT00784277|3682402|FG001|IR Treatment|Withdrawal by Subject|1
2093651|NCT00784277|3682403|FG002|IR Treatment|Withdrawal by Subject|4
2093652|NCT00784277|3682404|FG003|IR Treatment|Withdrawal by Subject|6
2093653|NCT00784277|3682405|FG004|IR Treatment|Withdrawal by Subject|0
2093654|NCT00784277|3682406|FG005|IR Treatment|Withdrawal by Subject|0
2093655|NCT00784277|3682407|FG006|IR Treatment|Withdrawal by Subject|0
2093656|NCT00784277|3682401|FG000|IR Treatment|Resolution Of Pain|0
2093657|NCT00784277|3682402|FG001|IR Treatment|Resolution Of Pain|1
2093658|NCT00784277|3682403|FG002|IR Treatment|Resolution Of Pain|0
2093659|NCT00784277|3682404|FG003|IR Treatment|Resolution Of Pain|0
2093660|NCT00784277|3682405|FG004|IR Treatment|Resolution Of Pain|0
2093661|NCT00784277|3682406|FG005|IR Treatment|Resolution Of Pain|0
2093662|NCT00784277|3682407|FG006|IR Treatment|Resolution Of Pain|0
2093663|NCT00784277|3682401|FG000|IR Treatment|Other|2
2093664|NCT00784277|3682402|FG001|IR Treatment|Other|3
2093665|NCT00784277|3682403|FG002|IR Treatment|Other|3
2093666|NCT00784277|3682404|FG003|IR Treatment|Other|2
2093667|NCT00784277|3682405|FG004|IR Treatment|Other|0
2093668|NCT00784277|3682406|FG005|IR Treatment|Other|0
2093669|NCT00784277|3682407|FG006|IR Treatment|Other|0
2093670|NCT00784277|3682401|FG000|ER Treatment|Adverse Event|0
2093671|NCT00784277|3682402|FG001|ER Treatment|Adverse Event|0
2093672|NCT00784277|3682403|FG002|ER Treatment|Adverse Event|0
2093673|NCT00784277|3682404|FG003|ER Treatment|Adverse Event|0
2093674|NCT00784277|3682405|FG004|ER Treatment|Adverse Event|1
2093675|NCT00784277|3682406|FG005|ER Treatment|Adverse Event|7
2093676|NCT00784277|3682407|FG006|ER Treatment|Adverse Event|7
2093677|NCT00784277|3682401|FG000|ER Treatment|Lack of Efficacy|0
2093678|NCT00784277|3682402|FG001|ER Treatment|Lack of Efficacy|0
2093679|NCT00784277|3682403|FG002|ER Treatment|Lack of Efficacy|0
2093680|NCT00784277|3682404|FG003|ER Treatment|Lack of Efficacy|0
2093681|NCT00784277|3682405|FG004|ER Treatment|Lack of Efficacy|3
2093682|NCT00784277|3682406|FG005|ER Treatment|Lack of Efficacy|4
2093683|NCT00784277|3682407|FG006|ER Treatment|Lack of Efficacy|0
2093684|NCT00784277|3682401|FG000|ER Treatment|Lost to Follow-up|0
2093685|NCT00784277|3682402|FG001|ER Treatment|Lost to Follow-up|0
2093686|NCT00784277|3682403|FG002|ER Treatment|Lost to Follow-up|0
2093687|NCT00784277|3682404|FG003|ER Treatment|Lost to Follow-up|0
2093688|NCT00784277|3682405|FG004|ER Treatment|Lost to Follow-up|0
2211861|NCT01663987|3852420|FG000|Overall Study|Other reason not defined above|3
2211862|NCT01663987|3852421|FG001|Overall Study|Other reason not defined above|0
2093689|NCT00784277|3682406|FG005|ER Treatment|Lost to Follow-up|2
2093690|NCT00784277|3682407|FG006|ER Treatment|Lost to Follow-up|0
2093691|NCT00784277|3682401|FG000|ER Treatment|Withdrawal by Subject|0
2093692|NCT00784277|3682402|FG001|ER Treatment|Withdrawal by Subject|0
2093693|NCT00784277|3682403|FG002|ER Treatment|Withdrawal by Subject|0
2093694|NCT00784277|3682404|FG003|ER Treatment|Withdrawal by Subject|0
2093695|NCT00784277|3682405|FG004|ER Treatment|Withdrawal by Subject|2
2093696|NCT00784277|3682406|FG005|ER Treatment|Withdrawal by Subject|5
2093697|NCT00784277|3682407|FG006|ER Treatment|Withdrawal by Subject|3
2093698|NCT00784277|3682401|FG000|ER Treatment|Study Medication Non-Compliant|0
2093699|NCT00784277|3682402|FG001|ER Treatment|Study Medication Non-Compliant|0
2093700|NCT00784277|3682403|FG002|ER Treatment|Study Medication Non-Compliant|0
2093701|NCT00784277|3682404|FG003|ER Treatment|Study Medication Non-Compliant|0
2093702|NCT00784277|3682405|FG004|ER Treatment|Study Medication Non-Compliant|2
2093703|NCT00784277|3682406|FG005|ER Treatment|Study Medication Non-Compliant|3
2093704|NCT00784277|3682407|FG006|ER Treatment|Study Medication Non-Compliant|3
2093705|NCT00784277|3682401|FG000|ER Treatment|Other|0
2093706|NCT00784277|3682402|FG001|ER Treatment|Other|0
2093707|NCT00784277|3682403|FG002|ER Treatment|Other|0
2093708|NCT00784277|3682404|FG003|ER Treatment|Other|0
2093709|NCT00784277|3682405|FG004|ER Treatment|Other|1
2093710|NCT00784277|3682406|FG005|ER Treatment|Other|3
2093711|NCT00784277|3682407|FG006|ER Treatment|Other|2
2093712|NCT00784368|3682433|FG000|Overall Study|Physician Decision|0
2093713|NCT00784368|3682434|FG001|Overall Study|Physician Decision|0
2093714|NCT00784368|3682435|FG002|Overall Study|Physician Decision|6
2093715|NCT00784368|3682433|FG000|Overall Study|Lack of Efficacy|2
2093716|NCT00784368|3682434|FG001|Overall Study|Lack of Efficacy|0
2093717|NCT00784368|3682435|FG002|Overall Study|Lack of Efficacy|1
2093718|NCT00784368|3682433|FG000|Overall Study|Adverse Event|6
2093719|NCT00784368|3682434|FG001|Overall Study|Adverse Event|9
2093720|NCT00784368|3682435|FG002|Overall Study|Adverse Event|2
2093721|NCT00784368|3682433|FG000|Overall Study|Diagnosis of fever|0
2093722|NCT00784368|3682434|FG001|Overall Study|Diagnosis of fever|0
2093723|NCT00784368|3682435|FG002|Overall Study|Diagnosis of fever|1
2093724|NCT00784368|3682433|FG000|Overall Study|Worsening of complications|0
2093725|NCT00784368|3682434|FG001|Overall Study|Worsening of complications|0
2093726|NCT00784368|3682435|FG002|Overall Study|Worsening of complications|1
2093727|NCT00784368|3682433|FG000|Overall Study|Worsening of symptoms|0
2093728|NCT00784368|3682434|FG001|Overall Study|Worsening of symptoms|1
2093729|NCT00784368|3682435|FG002|Overall Study|Worsening of symptoms|0
2093730|NCT00784368|3682433|FG000|Overall Study|Withdrawal of informed consent|0
2093731|NCT00784368|3682434|FG001|Overall Study|Withdrawal of informed consent|1
2093732|NCT00784368|3682435|FG002|Overall Study|Withdrawal of informed consent|0
2093733|NCT00784459|3682448|FG000|Overall Study|Adverse Event|0
2093734|NCT00784459|3682449|FG001|Overall Study|Adverse Event|2
2093735|NCT00784550|3682461|FG000|Overall Study|Adverse Event|12
2093736|NCT00784550|3682462|FG001|Overall Study|Adverse Event|10
2093737|NCT00784550|3682461|FG000|Overall Study|Lack of Efficacy|0
2093738|NCT00784550|3682462|FG001|Overall Study|Lack of Efficacy|1
2093739|NCT00784550|3682461|FG000|Overall Study|Protocol Violation|10
2093740|NCT00784550|3682462|FG001|Overall Study|Protocol Violation|10
2093741|NCT00784550|3682461|FG000|Overall Study|Lost to Follow-up|8
2093742|NCT00784550|3682462|FG001|Overall Study|Lost to Follow-up|5
2093743|NCT00784550|3682461|FG000|Overall Study|Physician Decision|2
2093744|NCT00784550|3682462|FG001|Overall Study|Physician Decision|3
2093745|NCT00784550|3682461|FG000|Overall Study|Withdrawal by Subject|4
2093746|NCT00784550|3682462|FG001|Overall Study|Withdrawal by Subject|13
2093747|NCT00784563|3682471|FG000|Years 1 & 2|Withdrawal by Subject|3
2093748|NCT00784563|3682472|FG001|Years 1 & 2|Withdrawal by Subject|2
2093749|NCT00784563|3682473|FG002|Years 1 & 2|Withdrawal by Subject|0
2093750|NCT00784563|3682471|FG000|Years 1 & 2|Adverse Event|0
2093751|NCT00784563|3682472|FG001|Years 1 & 2|Adverse Event|3
2093752|NCT00784563|3682473|FG002|Years 1 & 2|Adverse Event|0
2093753|NCT00784563|3682471|FG000|Year 3|Withdrawal by Subject|0
2093754|NCT00784563|3682472|FG001|Year 3|Withdrawal by Subject|0
2093755|NCT00784563|3682473|FG002|Year 3|Withdrawal by Subject|2
2093756|NCT00784563|3682471|FG000|Year 3|Adverse Event|0
2093757|NCT00784563|3682472|FG001|Year 3|Adverse Event|0
2093758|NCT00784563|3682473|FG002|Year 3|Adverse Event|1
2093759|NCT00784654|3682492|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44
2093760|NCT00784654|3682493|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0
2093761|NCT00784654|3682494|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0
2093762|NCT00784654|3682492|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
2093763|NCT00784654|3682493|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
2093764|NCT00784654|3682494|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
2093765|NCT00784654|3682492|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
2211863|NCT01664039|3852429|FG000|Overall Study|Adverse Event|3
2211864|NCT01664039|3852430|FG001|Overall Study|Adverse Event|4
2211865|NCT01664039|3852429|FG000|Overall Study|Lost to Follow-up|1
2211866|NCT01664039|3852430|FG001|Overall Study|Lost to Follow-up|1
2211867|NCT01664039|3852429|FG000|Overall Study|Withdrawal by Subject|1
2211868|NCT01664039|3852430|FG001|Overall Study|Withdrawal by Subject|3
2211869|NCT01664039|3852429|FG000|Overall Study|Noncompliance|1
2093766|NCT00784654|3682493|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
2093767|NCT00784654|3682494|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
2093768|NCT00784654|3682492|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
2093769|NCT00784654|3682493|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
2093770|NCT00784654|3682494|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
2093771|NCT00784654|3682492|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7
2093772|NCT00784654|3682493|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0
2093773|NCT00784654|3682494|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0
2093774|NCT00784654|3682492|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
2093775|NCT00784654|3682493|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
2093776|NCT00784654|3682494|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
2093777|NCT00784654|3682492|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
2093778|NCT00784654|3682493|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
2093779|NCT00784654|3682494|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
2093780|NCT00784654|3682492|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1
2093781|NCT00784654|3682493|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0
2093782|NCT00784654|3682494|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0
2093783|NCT00784654|3682492|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
2093784|NCT00784654|3682493|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
2093785|NCT00784654|3682494|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
2093786|NCT00784654|3682492|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
2093787|NCT00784654|3682493|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
2093788|NCT00784654|3682494|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
2093789|NCT00784654|3682492|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
2093790|NCT00784654|3682493|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
2093791|NCT00784654|3682494|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
2093792|NCT00784654|3682492|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0
2093793|NCT00784654|3682493|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8
2093794|NCT00784654|3682494|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35
2093795|NCT00784654|3682492|FG000|Randomized Withdrawal Period|Lack of Efficacy|0
2093796|NCT00784654|3682493|FG001|Randomized Withdrawal Period|Lack of Efficacy|5
2093797|NCT00784654|3682494|FG002|Randomized Withdrawal Period|Lack of Efficacy|18
2093798|NCT00784654|3682492|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
2093799|NCT00784654|3682493|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1
2093800|NCT00784654|3682494|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7
2093801|NCT00784654|3682492|FG000|Randomized Withdrawal Period|Protocol Violation|0
2093802|NCT00784654|3682493|FG001|Randomized Withdrawal Period|Protocol Violation|2
2093803|NCT00784654|3682494|FG002|Randomized Withdrawal Period|Protocol Violation|1
2093804|NCT00784654|3682492|FG000|Randomized Withdrawal Period|Adverse Event|0
2093805|NCT00784654|3682493|FG001|Randomized Withdrawal Period|Adverse Event|1
2093806|NCT00784654|3682494|FG002|Randomized Withdrawal Period|Adverse Event|1
2093807|NCT00784654|3682492|FG000|Randomized Withdrawal Period|Did not complete a visit|0
2093808|NCT00784654|3682493|FG001|Randomized Withdrawal Period|Did not complete a visit|1
2093809|NCT00784654|3682494|FG002|Randomized Withdrawal Period|Did not complete a visit|0
2093810|NCT00784654|3682492|FG000|Randomized Withdrawal Period|Family reasons|0
2093811|NCT00784654|3682493|FG001|Randomized Withdrawal Period|Family reasons|0
2093812|NCT00784654|3682494|FG002|Randomized Withdrawal Period|Family reasons|1
2093813|NCT00784693|3682507|FG000|Overall Study|Lost to Follow-up|0
2093814|NCT00784693|3682508|FG001|Overall Study|Lost to Follow-up|1
2093815|NCT00784693|3682507|FG000|Overall Study|Lack of Efficacy|1
2093816|NCT00784693|3682508|FG001|Overall Study|Lack of Efficacy|1
2093817|NCT00784693|3682507|FG000|Overall Study|Withdrawal by Subject|0
2093818|NCT00784693|3682508|FG001|Overall Study|Withdrawal by Subject|4
2093819|NCT00784693|3682507|FG000|Overall Study|Randomized but not Treated|1
2093820|NCT00784693|3682508|FG001|Overall Study|Randomized but not Treated|0
2093821|NCT00784693|3682507|FG000|Overall Study|Other|1
2093822|NCT00784693|3682508|FG001|Overall Study|Other|0
2093823|NCT00784719|3682521|FG000|Overall Study|Adverse Event|0
2093824|NCT00784719|3682522|FG001|Overall Study|Adverse Event|2
2093825|NCT00784719|3682523|FG002|Overall Study|Adverse Event|0
2093826|NCT00784719|3682524|FG003|Overall Study|Adverse Event|0
2093827|NCT00784719|3682525|FG004|Overall Study|Adverse Event|1
2093828|NCT00784719|3682526|FG005|Overall Study|Adverse Event|1
2093829|NCT00784719|3682527|FG006|Overall Study|Adverse Event|1
2093830|NCT00784719|3682521|FG000|Overall Study|Lost to Follow-up|0
2093831|NCT00784719|3682522|FG001|Overall Study|Lost to Follow-up|0
2093832|NCT00784719|3682523|FG002|Overall Study|Lost to Follow-up|0
2093833|NCT00784719|3682524|FG003|Overall Study|Lost to Follow-up|0
2093834|NCT00784719|3682525|FG004|Overall Study|Lost to Follow-up|1
2093835|NCT00784719|3682526|FG005|Overall Study|Lost to Follow-up|1
2093836|NCT00784719|3682527|FG006|Overall Study|Lost to Follow-up|0
2093837|NCT00784719|3682521|FG000|Overall Study|Other|2
2093838|NCT00784719|3682522|FG001|Overall Study|Other|1
2093839|NCT00784719|3682523|FG002|Overall Study|Other|1
2093840|NCT00784719|3682524|FG003|Overall Study|Other|0
2093841|NCT00784719|3682525|FG004|Overall Study|Other|2
2093842|NCT00784719|3682526|FG005|Overall Study|Other|1
2093843|NCT00784719|3682527|FG006|Overall Study|Other|3
2093844|NCT00784719|3682521|FG000|Overall Study|Withdrawal by Subject|1
2093845|NCT00784719|3682522|FG001|Overall Study|Withdrawal by Subject|0
2093846|NCT00784719|3682523|FG002|Overall Study|Withdrawal by Subject|0
2093847|NCT00784719|3682524|FG003|Overall Study|Withdrawal by Subject|0
2093848|NCT00784719|3682525|FG004|Overall Study|Withdrawal by Subject|2
2093849|NCT00784719|3682526|FG005|Overall Study|Withdrawal by Subject|0
2093850|NCT00784719|3682527|FG006|Overall Study|Withdrawal by Subject|1
2093851|NCT00784758|3682545|FG000|Overall Study|Withdrawal by Subject|3
2093852|NCT00784758|3682546|FG001|Overall Study|Withdrawal by Subject|0
2093853|NCT00784758|3682545|FG000|Overall Study|Adverse Event|1
2093854|NCT00784758|3682546|FG001|Overall Study|Adverse Event|0
2093855|NCT00784784|3682556|FG000|Overall Study|Withdrawal by Subject|2
2093856|NCT00784784|3682557|FG001|Overall Study|Withdrawal by Subject|2
2093857|NCT00784810|3682565|FG000|Overall Study|Adverse Event|32
2093858|NCT00784810|3682566|FG001|Overall Study|Adverse Event|20
2093859|NCT00784810|3682565|FG000|Overall Study|Lack of Efficacy|14
2093860|NCT00784810|3682566|FG001|Overall Study|Lack of Efficacy|11
2093861|NCT00784810|3682565|FG000|Overall Study|Withdrawal by Subject|11
2093862|NCT00784810|3682566|FG001|Overall Study|Withdrawal by Subject|9
2093863|NCT00784810|3682565|FG000|Overall Study|Administrative|5
2093864|NCT00784810|3682566|FG001|Overall Study|Administrative|8
2093865|NCT00784810|3682565|FG000|Overall Study|Lost to Follow-up|1
2093866|NCT00784810|3682566|FG001|Overall Study|Lost to Follow-up|1
2093867|NCT00784836|3682572|FG000|Overall Study|Early Study Termination|3
2093868|NCT00784875|3682584|FG000|Period A - Baseline|Entry Criteria Not Met|0
2093869|NCT00784875|3682585|FG001|Period A - Baseline|Entry Criteria Not Met|0
2093870|NCT00784875|3682586|FG002|Period A - Baseline|Entry Criteria Not Met|0
2093871|NCT00784875|3682587|FG003|Period A - Baseline|Entry Criteria Not Met|5
2093872|NCT00784875|3682584|FG000|Period A - Baseline|Adverse Event|0
2093873|NCT00784875|3682585|FG001|Period A - Baseline|Adverse Event|0
2093874|NCT00784875|3682586|FG002|Period A - Baseline|Adverse Event|0
2093875|NCT00784875|3682587|FG003|Period A - Baseline|Adverse Event|8
2093876|NCT00784875|3682584|FG000|Period A - Baseline|Protocol Violation|0
2093877|NCT00784875|3682585|FG001|Period A - Baseline|Protocol Violation|0
2093878|NCT00784875|3682586|FG002|Period A - Baseline|Protocol Violation|0
2093879|NCT00784875|3682587|FG003|Period A - Baseline|Protocol Violation|25
2093880|NCT00784875|3682584|FG000|Period A - Baseline|Withdrawal by Subject|0
2093881|NCT00784875|3682585|FG001|Period A - Baseline|Withdrawal by Subject|0
2093882|NCT00784875|3682586|FG002|Period A - Baseline|Withdrawal by Subject|0
2093883|NCT00784875|3682587|FG003|Period A - Baseline|Withdrawal by Subject|27
2093884|NCT00784875|3682584|FG000|Period A - Baseline|Physician Decision|0
2093885|NCT00784875|3682585|FG001|Period A - Baseline|Physician Decision|0
2093886|NCT00784875|3682586|FG002|Period A - Baseline|Physician Decision|0
2093887|NCT00784875|3682587|FG003|Period A - Baseline|Physician Decision|2
2093888|NCT00784875|3682584|FG000|Period A - Baseline|Sponsor Decision|0
2093889|NCT00784875|3682585|FG001|Period A - Baseline|Sponsor Decision|0
2093890|NCT00784875|3682586|FG002|Period A - Baseline|Sponsor Decision|0
2093891|NCT00784875|3682587|FG003|Period A - Baseline|Sponsor Decision|113
2093892|NCT00784875|3682584|FG000|Period A - Baseline|Lost to Follow-up|0
2093893|NCT00784875|3682585|FG001|Period A - Baseline|Lost to Follow-up|0
2093894|NCT00784875|3682586|FG002|Period A - Baseline|Lost to Follow-up|0
2093895|NCT00784875|3682587|FG003|Period A - Baseline|Lost to Follow-up|2
2093896|NCT00784875|3682584|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
2093897|NCT00784875|3682585|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
2093898|NCT00784875|3682586|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
2093899|NCT00784875|3682587|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
2093900|NCT00784875|3682584|FG000|Period B - Efficacy Endpoint|Adverse Event|0
2093901|NCT00784875|3682585|FG001|Period B - Efficacy Endpoint|Adverse Event|3
2093902|NCT00784875|3682586|FG002|Period B - Efficacy Endpoint|Adverse Event|2
2093903|NCT00784875|3682587|FG003|Period B - Efficacy Endpoint|Adverse Event|1
2093904|NCT00784875|3682584|FG000|Period B - Efficacy Endpoint|Protocol Violation|1
2093905|NCT00784875|3682585|FG001|Period B - Efficacy Endpoint|Protocol Violation|1
2093906|NCT00784875|3682586|FG002|Period B - Efficacy Endpoint|Protocol Violation|2
2093907|NCT00784875|3682587|FG003|Period B - Efficacy Endpoint|Protocol Violation|3
2093908|NCT00784875|3682584|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0
2093909|NCT00784875|3682585|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1
2093910|NCT00784875|3682586|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0
2093911|NCT00784875|3682587|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0
2093912|NCT00784875|3682584|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4
2093913|NCT00784875|3682585|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1
2093914|NCT00784875|3682586|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1
2093915|NCT00784875|3682587|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2
2093916|NCT00784875|3682584|FG000|Period B - Efficacy Endpoint|Physician Decision|0
2093917|NCT00784875|3682585|FG001|Period B - Efficacy Endpoint|Physician Decision|0
2093918|NCT00784875|3682586|FG002|Period B - Efficacy Endpoint|Physician Decision|1
2093919|NCT00784875|3682587|FG003|Period B - Efficacy Endpoint|Physician Decision|0
2093920|NCT00784875|3682584|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9
2093921|NCT00784875|3682585|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6
2093922|NCT00784875|3682586|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12
2093923|NCT00784875|3682587|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12
2093924|NCT00784875|3682584|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0
2093925|NCT00784875|3682585|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0
2093926|NCT00784875|3682586|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1
2093927|NCT00784875|3682587|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0
2093928|NCT00784875|3682584|FG000|Period C|Adverse Event|1
2093929|NCT00784875|3682585|FG001|Period C|Adverse Event|0
2093930|NCT00784875|3682586|FG002|Period C|Adverse Event|4
2093931|NCT00784875|3682587|FG003|Period C|Adverse Event|2
2093932|NCT00784875|3682584|FG000|Period C|Protocol Violation|0
2093933|NCT00784875|3682585|FG001|Period C|Protocol Violation|0
2093934|NCT00784875|3682586|FG002|Period C|Protocol Violation|1
2093935|NCT00784875|3682587|FG003|Period C|Protocol Violation|2
2093936|NCT00784875|3682584|FG000|Period C|Lack of Efficacy|0
2093937|NCT00784875|3682585|FG001|Period C|Lack of Efficacy|0
2093938|NCT00784875|3682586|FG002|Period C|Lack of Efficacy|1
2093939|NCT00784875|3682587|FG003|Period C|Lack of Efficacy|0
2093940|NCT00784875|3682584|FG000|Period C|Withdrawal by Subject|1
2093941|NCT00784875|3682585|FG001|Period C|Withdrawal by Subject|1
2093942|NCT00784875|3682586|FG002|Period C|Withdrawal by Subject|2
2093943|NCT00784875|3682587|FG003|Period C|Withdrawal by Subject|0
2093944|NCT00784875|3682584|FG000|Period C|Physician Decision|0
2093945|NCT00784875|3682585|FG001|Period C|Physician Decision|0
2093946|NCT00784875|3682586|FG002|Period C|Physician Decision|1
2093947|NCT00784875|3682587|FG003|Period C|Physician Decision|1
2093948|NCT00784875|3682584|FG000|Period C|Sponsor Decision|5
2093949|NCT00784875|3682585|FG001|Period C|Sponsor Decision|5
2093950|NCT00784875|3682586|FG002|Period C|Sponsor Decision|4
2093951|NCT00784875|3682587|FG003|Period C|Sponsor Decision|2
2093952|NCT00784875|3682584|FG000|Period D|Adverse Event|0
2093953|NCT00784875|3682585|FG001|Period D|Adverse Event|2
2093954|NCT00784875|3682586|FG002|Period D|Adverse Event|2
2093955|NCT00784875|3682587|FG003|Period D|Adverse Event|0
2093956|NCT00784875|3682584|FG000|Period D|Protocol Violation|1
2093957|NCT00784875|3682585|FG001|Period D|Protocol Violation|0
2093958|NCT00784875|3682586|FG002|Period D|Protocol Violation|0
2093959|NCT00784875|3682587|FG003|Period D|Protocol Violation|0
2093960|NCT00784875|3682584|FG000|Period D|Withdrawal by Subject|2
2093961|NCT00784875|3682585|FG001|Period D|Withdrawal by Subject|0
2093962|NCT00784875|3682586|FG002|Period D|Withdrawal by Subject|2
2093963|NCT00784875|3682587|FG003|Period D|Withdrawal by Subject|0
2093964|NCT00784875|3682584|FG000|Period D|Physician Decision|0
2093965|NCT00784875|3682585|FG001|Period D|Physician Decision|1
2093966|NCT00784875|3682586|FG002|Period D|Physician Decision|0
2093967|NCT00784875|3682587|FG003|Period D|Physician Decision|0
2093968|NCT00784875|3682584|FG000|Period D|Sponsor Decision|1
2093969|NCT00784875|3682585|FG001|Period D|Sponsor Decision|1
2093970|NCT00784875|3682586|FG002|Period D|Sponsor Decision|1
2093971|NCT00784875|3682587|FG003|Period D|Sponsor Decision|0
2093972|NCT00784875|3682584|FG000|Period D|Lost to Follow-up|1
2093973|NCT00784875|3682585|FG001|Period D|Lost to Follow-up|0
2093974|NCT00784875|3682586|FG002|Period D|Lost to Follow-up|1
2093975|NCT00784875|3682587|FG003|Period D|Lost to Follow-up|1
2093976|NCT00784927|3682610|FG000|Overall Study|Cancel Prior to Initiating Treatment|1
2093977|NCT00784927|3682610|FG000|Overall Study|Protocol Violation|1
2093978|NCT00784927|3682610|FG000|Overall Study|Ineligible|1
2093979|NCT00784979|3682615|FG000|Overall Study|incomplete data|6
2093980|NCT00785044|3682619|FG000|Overall Study|Dosed at non-participating sites|152
2093981|NCT00785044|3682619|FG000|Overall Study|Death|77
2093982|NCT00785044|3682619|FG000|Overall Study|Lost to Follow-up|266
2093983|NCT00785044|3682619|FG000|Overall Study|Withdrawal by Subject|1
2093984|NCT00785213|3682624|FG000|Quinine Sulfate Alone|Adverse Event|4
2093985|NCT00785213|3682624|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1
2093986|NCT00785486|3682631|FG000|Midazolam Alone|Withdrawal by Subject|1
2093987|NCT00785512|3682654|FG000|Overall Study|Inclusion/Exclusion not meet|0
2093988|NCT00785512|3682655|FG001|Overall Study|Inclusion/Exclusion not meet|0
2093989|NCT00785512|3682654|FG000|Overall Study|Adverse Event|0
2093990|NCT00785512|3682655|FG001|Overall Study|Adverse Event|0
2093991|NCT00785512|3682654|FG000|Overall Study|Lack of Efficacy|0
2093992|NCT00785512|3682655|FG001|Overall Study|Lack of Efficacy|2
2093993|NCT00785512|3682654|FG000|Overall Study|Withdrawal by Subject|0
2093994|NCT00785512|3682655|FG001|Overall Study|Withdrawal by Subject|1
2093995|NCT00785512|3682654|FG000|Overall Study|Lost to Follow-up|3
2093996|NCT00785512|3682655|FG001|Overall Study|Lost to Follow-up|0
2093997|NCT00785512|3682654|FG000|Overall Study|Precedure Refused|0
2093998|NCT00785512|3682655|FG001|Overall Study|Precedure Refused|0
2093999|NCT00785512|3682654|FG000|Overall Study|IVRS Programing Error|0
2094000|NCT00785512|3682655|FG001|Overall Study|IVRS Programing Error|0
2094001|NCT00785512|3682654|FG000|Overall Study|Physician Decision|0
2094002|NCT00785512|3682655|FG001|Overall Study|Physician Decision|0
2211870|NCT01664039|3852430|FG001|Overall Study|Noncompliance|1
2211871|NCT01664052|3852438|FG000|Phase 1|No device placement|6
2211872|NCT01664052|3852439|FG001|Phase 1|No device placement|0
2211873|NCT01664052|3852438|FG000|Phase 1|No HSG 1 hr post placement|1
2211874|NCT01664052|3852439|FG001|Phase 1|No HSG 1 hr post placement|0
2211875|NCT01664052|3852438|FG000|Phase 2|No device placement|0
2211876|NCT01664052|3852439|FG001|Phase 2|No device placement|4
2211877|NCT01664078|3852446|FG000|Overall Study|Death|9
2094003|NCT00785512|3682654|FG000|Overall Study|Lack of compliance|0
2094004|NCT00785512|3682655|FG001|Overall Study|Lack of compliance|1
2107525|NCT00874497|3701186|FG000|Overall Study|Physician Decision|1
2107526|NCT00874497|3701187|FG001|Overall Study|Physician Decision|1
2107527|NCT00874497|3701186|FG000|Overall Study|Withdrawal by Subject|5
2107528|NCT00874497|3701187|FG001|Overall Study|Withdrawal by Subject|4
2107529|NCT00874549|3701206|FG000|Overall Study|Adverse Event|0
2107530|NCT00874549|3701207|FG001|Overall Study|Adverse Event|0
2107531|NCT00874549|3701208|FG002|Overall Study|Adverse Event|1
2107532|NCT00874549|3701209|FG003|Overall Study|Adverse Event|0
2107533|NCT00874549|3701206|FG000|Overall Study|Protocol Violation|1
2107534|NCT00874549|3701207|FG001|Overall Study|Protocol Violation|0
2107535|NCT00874549|3701208|FG002|Overall Study|Protocol Violation|2
2107536|NCT00874549|3701209|FG003|Overall Study|Protocol Violation|1
2107537|NCT00874549|3701206|FG000|Overall Study|Lost to Follow-up|0
2107538|NCT00874549|3701207|FG001|Overall Study|Lost to Follow-up|0
2107539|NCT00874549|3701208|FG002|Overall Study|Lost to Follow-up|1
2107540|NCT00874549|3701209|FG003|Overall Study|Lost to Follow-up|0
2107541|NCT00874549|3701206|FG000|Overall Study|Withdrawal by Subject|0
2107542|NCT00874549|3701207|FG001|Overall Study|Withdrawal by Subject|1
2107543|NCT00874549|3701208|FG002|Overall Study|Withdrawal by Subject|0
2107544|NCT00874549|3701209|FG003|Overall Study|Withdrawal by Subject|1
2107545|NCT00874731|3701225|FG000|Part 1, Day 1: Placebo|Disease Progression|1
2107546|NCT00874731|3701226|FG001|Part 1, Day 1: Placebo|Disease Progression|0
2107547|NCT00874731|3701227|FG002|Part 1, Day 1: Placebo|Disease Progression|0
2107548|NCT00874731|3701225|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0
2107549|NCT00874731|3701226|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0
2107550|NCT00874731|3701227|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3
2107551|NCT00874731|3701225|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0
2107552|NCT00874731|3701226|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0
2107553|NCT00874731|3701227|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19
2107554|NCT00874770|3701239|FG000|Overall Study|Lack of Efficacy|2
2107555|NCT00874770|3701240|FG001|Overall Study|Lack of Efficacy|0
2107556|NCT00874770|3701241|FG002|Overall Study|Lack of Efficacy|0
2107557|NCT00874770|3701242|FG003|Overall Study|Lack of Efficacy|2
2107558|NCT00874770|3701239|FG000|Overall Study|Adverse Event|1
2107559|NCT00874770|3701240|FG001|Overall Study|Adverse Event|1
2107560|NCT00874770|3701241|FG002|Overall Study|Adverse Event|4
2107561|NCT00874770|3701242|FG003|Overall Study|Adverse Event|2
2107562|NCT00874770|3701239|FG000|Overall Study|Lost to Follow-up|1
2107563|NCT00874770|3701240|FG001|Overall Study|Lost to Follow-up|0
2107564|NCT00874770|3701241|FG002|Overall Study|Lost to Follow-up|0
2107565|NCT00874770|3701242|FG003|Overall Study|Lost to Follow-up|1
2107566|NCT00874770|3701239|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
2211878|NCT01664078|3852446|FG000|Overall Study|Withdrawal by Subject|4
2107567|NCT00874770|3701240|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
2211879|NCT01664078|3852446|FG000|Overall Study|Lost to Follow-up|2
2211880|NCT01664078|3852446|FG000|Overall Study|missed 5 year visit|1
2211881|NCT01664078|3852446|FG000|Overall Study|Other|53
2211882|NCT01664091|3852496|FG000|Overall Study|Death|1
2211883|NCT01664091|3852496|FG000|Overall Study|Disease Progression|2
2211884|NCT01664091|3852496|FG000|Overall Study|Lost to Follow-up|2
2211885|NCT01664091|3852496|FG000|Overall Study|Withdrawal by Subject|1
2211886|NCT01664104|3852501|FG000|Overall Study|Adverse Event|6
2211887|NCT01664104|3852501|FG000|Overall Study|Lack of Efficacy|2
2211888|NCT01664104|3852501|FG000|Overall Study|Withdrawal by Subject|1
2211889|NCT01664104|3852501|FG000|Overall Study|Lost to Follow-up|4
2211890|NCT01664104|3852501|FG000|Overall Study|Other|1
2211891|NCT01664104|3852501|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2
2211892|NCT01664130|3852514|FG000|Overall Study|competing secondary disease|2
2211893|NCT01664247|3852523|FG000|Overall Study|Adverse Event|5
2211894|NCT01664247|3852524|FG001|Overall Study|Adverse Event|3
2211895|NCT01664247|3852523|FG000|Overall Study|Protocol Violation|3
2211896|NCT01664247|3852524|FG001|Overall Study|Protocol Violation|5
2211897|NCT01664247|3852523|FG000|Overall Study|Withdrawal Criteria|1
2211898|NCT01664247|3852524|FG001|Overall Study|Withdrawal Criteria|4
2211899|NCT01664247|3852523|FG000|Overall Study|Unclassified|5
2211900|NCT01664247|3852524|FG001|Overall Study|Unclassified|29
2211901|NCT01664494|3852530|FG000|Overall Study|Withdrawal by Subject|27
2211902|NCT01664494|3852530|FG000|Overall Study|Death|18
2211903|NCT01664494|3852530|FG000|Overall Study|Other|49
2211904|NCT01664494|3852530|FG000|Overall Study|Lost to Follow-up|99
2211905|NCT01664533|3852534|FG000|Overall Study|Death|42
2211906|NCT01664533|3852534|FG000|Overall Study|Lost to Follow-up|3
2211907|NCT01664533|3852534|FG000|Overall Study|Study termination|9
2211908|NCT01664533|3852534|FG000|Overall Study|Protocol Violation|3
2211909|NCT01664624|3852552|FG000|Overall Study|Adverse Event|0
2094005|NCT00785538|3682666|FG000|Treatment Period|Adverse Event|1
2094006|NCT00785538|3682667|FG001|Treatment Period|Adverse Event|2
2094007|NCT00785538|3682668|FG002|Treatment Period|Adverse Event|2
2094008|NCT00785538|3682669|FG003|Treatment Period|Adverse Event|0
2094009|NCT00785538|3682666|FG000|Treatment Period|Withdrawal by Subject|0
2094010|NCT00785538|3682667|FG001|Treatment Period|Withdrawal by Subject|0
2094011|NCT00785538|3682668|FG002|Treatment Period|Withdrawal by Subject|0
2094012|NCT00785538|3682669|FG003|Treatment Period|Withdrawal by Subject|1
2094013|NCT00785577|3682685|FG000|Study Period 2: Therapy Phase|Adverse Event|5
2094014|NCT00785577|3682686|FG001|Study Period 2: Therapy Phase|Adverse Event|7
2094015|NCT00785577|3682687|FG002|Study Period 2: Therapy Phase|Adverse Event|14
2094016|NCT00785577|3682688|FG003|Study Period 2: Therapy Phase|Adverse Event|10
2094017|NCT00785577|3682689|FG004|Study Period 2: Therapy Phase|Adverse Event|17
2094018|NCT00785577|3682685|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0
2094019|NCT00785577|3682686|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
2094020|NCT00785577|3682687|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0
2094021|NCT00785577|3682688|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0
2094022|NCT00785577|3682689|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1
2094023|NCT00785577|3682685|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0
2094024|NCT00785577|3682686|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0
2094025|NCT00785577|3682687|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0
2094026|NCT00785577|3682688|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1
2094027|NCT00785577|3682689|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0
2094028|NCT00785577|3682685|FG000|Study Period 2: Therapy Phase|Physician Decision|1
2211910|NCT01664624|3852553|FG001|Overall Study|Adverse Event|1
2211911|NCT01664624|3852554|FG002|Overall Study|Adverse Event|0
2211912|NCT01664624|3852555|FG003|Overall Study|Adverse Event|0
2211913|NCT01664923|3852619|FG000|Period1:Double Blind Phase-29 Months|Death|8
2211914|NCT01664923|3852620|FG001|Period1:Double Blind Phase-29 Months|Death|6
2211915|NCT01664923|3852619|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
2211916|NCT01664923|3852620|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
2211917|NCT01664923|3852619|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2
2211918|NCT01664923|3852620|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0
2211919|NCT01664923|3852619|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
2094029|NCT00785577|3682686|FG001|Study Period 2: Therapy Phase|Physician Decision|0
2094030|NCT00785577|3682687|FG002|Study Period 2: Therapy Phase|Physician Decision|0
2094031|NCT00785577|3682688|FG003|Study Period 2: Therapy Phase|Physician Decision|0
2094032|NCT00785577|3682689|FG004|Study Period 2: Therapy Phase|Physician Decision|0
2094033|NCT00785577|3682685|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
2094034|NCT00785577|3682686|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
2094035|NCT00785577|3682687|FG002|Study Period 2: Therapy Phase|Protocol Violation|1
2094036|NCT00785577|3682688|FG003|Study Period 2: Therapy Phase|Protocol Violation|0
2094037|NCT00785577|3682689|FG004|Study Period 2: Therapy Phase|Protocol Violation|1
2094038|NCT00785577|3682685|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2
2094039|NCT00785577|3682686|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1
2211920|NCT01664923|3852620|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
2211921|NCT01664923|3852619|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65
2211922|NCT01664923|3852620|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132
2211923|NCT01664923|3852619|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14
2211924|NCT01664923|3852620|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9
2094040|NCT00785577|3682687|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1
2094041|NCT00785577|3682688|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0
2094042|NCT00785577|3682689|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1
2094043|NCT00785577|3682685|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
2094044|NCT00785577|3682686|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
2094045|NCT00785577|3682687|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
2094046|NCT00785577|3682688|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
2094047|NCT00785577|3682689|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
2094048|NCT00785577|3682685|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1
2094049|NCT00785577|3682686|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0
2094050|NCT00785577|3682687|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1
2094051|NCT00785577|3682688|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1
2094052|NCT00785577|3682689|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0
2094053|NCT00785577|3682685|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0
2094054|NCT00785577|3682686|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0
2094055|NCT00785577|3682687|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0
2094056|NCT00785577|3682688|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1
2094057|NCT00785577|3682689|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0
2094058|NCT00785577|3682685|FG000|Study Period 3: 1-Week Washout Phase|Death|0
2094059|NCT00785577|3682686|FG001|Study Period 3: 1-Week Washout Phase|Death|0
2094060|NCT00785577|3682687|FG002|Study Period 3: 1-Week Washout Phase|Death|0
2094061|NCT00785577|3682688|FG003|Study Period 3: 1-Week Washout Phase|Death|0
2094062|NCT00785577|3682689|FG004|Study Period 3: 1-Week Washout Phase|Death|1
2094063|NCT00785629|3682715|FG000|Overall Study|Adverse Event|2
2094064|NCT00785629|3682716|FG001|Overall Study|Adverse Event|1
2094065|NCT00785629|3682717|FG002|Overall Study|Adverse Event|1
2094066|NCT00785629|3682718|FG003|Overall Study|Adverse Event|5
2094067|NCT00785629|3682715|FG000|Overall Study|Protocol Violation|1
2094068|NCT00785629|3682716|FG001|Overall Study|Protocol Violation|2
2094069|NCT00785629|3682717|FG002|Overall Study|Protocol Violation|4
2094070|NCT00785629|3682718|FG003|Overall Study|Protocol Violation|5
2094071|NCT00785629|3682715|FG000|Overall Study|administrative decision|5
2094072|NCT00785629|3682716|FG001|Overall Study|administrative decision|1
2094073|NCT00785629|3682717|FG002|Overall Study|administrative decision|3
2094074|NCT00785629|3682718|FG003|Overall Study|administrative decision|4
2094075|NCT00785629|3682715|FG000|Overall Study|Withdrawal by Subject|0
2094076|NCT00785629|3682716|FG001|Overall Study|Withdrawal by Subject|1
2094077|NCT00785629|3682717|FG002|Overall Study|Withdrawal by Subject|2
2094078|NCT00785629|3682718|FG003|Overall Study|Withdrawal by Subject|2
2094079|NCT00785707|3682726|FG000|Overall Study|Lost to Follow-up|7
2094080|NCT00785785|3682736|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
2094081|NCT00785785|3682737|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
2094082|NCT00785785|3682736|FG000|Core Phase up to 36 Months|Adverse Event|31
2094083|NCT00785785|3682737|FG001|Core Phase up to 36 Months|Adverse Event|21
2094084|NCT00785785|3682736|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1
2094085|NCT00785785|3682737|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0
2094086|NCT00785785|3682736|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2
2094087|NCT00785785|3682737|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2
2094088|NCT00785785|3682736|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16
2094089|NCT00785785|3682737|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17
2094090|NCT00785785|3682736|FG000|Core Phase up to 36 Months|Lost to Follow-up|3
2094091|NCT00785785|3682737|FG001|Core Phase up to 36 Months|Lost to Follow-up|7
2094092|NCT00785785|3682736|FG000|Core Phase up to 36 Months|Administrative problems|3
2094093|NCT00785785|3682737|FG001|Core Phase up to 36 Months|Administrative problems|3
2094094|NCT00785785|3682736|FG000|Core Phase up to 36 Months|Death|5
2094095|NCT00785785|3682737|FG001|Core Phase up to 36 Months|Death|8
2094096|NCT00785785|3682736|FG000|Core Phase up to 36 Months|Disease progression|139
2094097|NCT00785785|3682737|FG001|Core Phase up to 36 Months|Disease progression|119
2094098|NCT00785785|3682736|FG000|Core Phase up to 36 Months|Protocol deviation|5
2094099|NCT00785785|3682737|FG001|Core Phase up to 36 Months|Protocol deviation|6
2094100|NCT00785785|3682736|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116
2094101|NCT00785785|3682737|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133
2094102|NCT00785785|3682736|FG000|Optional Extension Phase|Adverse Event|4
2094103|NCT00785785|3682737|FG001|Optional Extension Phase|Adverse Event|5
2094104|NCT00785785|3682736|FG000|Optional Extension Phase|Withdrawal by Subject|6
2094105|NCT00785785|3682737|FG001|Optional Extension Phase|Withdrawal by Subject|6
2094106|NCT00785785|3682736|FG000|Optional Extension Phase|Lost to Follow-up|1
2094107|NCT00785785|3682737|FG001|Optional Extension Phase|Lost to Follow-up|0
2094108|NCT00785785|3682736|FG000|Optional Extension Phase|Administrative problems|2
2094109|NCT00785785|3682737|FG001|Optional Extension Phase|Administrative problems|0
2094110|NCT00785785|3682736|FG000|Optional Extension Phase|Death|1
2094111|NCT00785785|3682737|FG001|Optional Extension Phase|Death|5
2094112|NCT00785785|3682736|FG000|Optional Extension Phase|Disease progression|22
2094113|NCT00785785|3682737|FG001|Optional Extension Phase|Disease progression|70
2094114|NCT00785785|3682736|FG000|Optional Extension Phase|Protocol deviation|0
2094115|NCT00785785|3682737|FG001|Optional Extension Phase|Protocol deviation|2
2094116|NCT00785785|3682736|FG000|Optional Extension Phase|Study terminated by sponsor|3
2094117|NCT00785785|3682737|FG001|Optional Extension Phase|Study terminated by sponsor|37
2094118|NCT00785928|3682756|FG000|Treatment Phase|Adverse Event|1
2094119|NCT00785928|3682757|FG001|Treatment Phase|Adverse Event|1
2094120|NCT00785928|3682758|FG002|Treatment Phase|Adverse Event|2
2094121|NCT00785928|3682759|FG003|Treatment Phase|Adverse Event|0
2094122|NCT00785928|3682760|FG004|Treatment Phase|Adverse Event|0
2094123|NCT00785928|3682761|FG005|Treatment Phase|Adverse Event|0
2094124|NCT00785928|3682762|FG006|Treatment Phase|Adverse Event|2
2094125|NCT00785928|3682756|FG000|Treatment Phase|Inadequate Response|0
2094126|NCT00785928|3682757|FG001|Treatment Phase|Inadequate Response|1
2094127|NCT00785928|3682758|FG002|Treatment Phase|Inadequate Response|0
2094128|NCT00785928|3682759|FG003|Treatment Phase|Inadequate Response|0
2094129|NCT00785928|3682760|FG004|Treatment Phase|Inadequate Response|0
2094130|NCT00785928|3682761|FG005|Treatment Phase|Inadequate Response|0
2094131|NCT00785928|3682762|FG006|Treatment Phase|Inadequate Response|0
2094132|NCT00785928|3682756|FG000|Treatment Phase|Lack of Efficacy|0
2094133|NCT00785928|3682757|FG001|Treatment Phase|Lack of Efficacy|1
2094134|NCT00785928|3682758|FG002|Treatment Phase|Lack of Efficacy|1
2094135|NCT00785928|3682759|FG003|Treatment Phase|Lack of Efficacy|0
2094136|NCT00785928|3682760|FG004|Treatment Phase|Lack of Efficacy|0
2094137|NCT00785928|3682761|FG005|Treatment Phase|Lack of Efficacy|0
2094138|NCT00785928|3682762|FG006|Treatment Phase|Lack of Efficacy|0
2094139|NCT00785928|3682756|FG000|Treatment Phase|Physician Decision|0
2094140|NCT00785928|3682757|FG001|Treatment Phase|Physician Decision|0
2094141|NCT00785928|3682758|FG002|Treatment Phase|Physician Decision|0
2094142|NCT00785928|3682759|FG003|Treatment Phase|Physician Decision|0
2094143|NCT00785928|3682760|FG004|Treatment Phase|Physician Decision|1
2094144|NCT00785928|3682761|FG005|Treatment Phase|Physician Decision|0
2094145|NCT00785928|3682762|FG006|Treatment Phase|Physician Decision|0
2094146|NCT00785928|3682756|FG000|Treatment Phase|Sponsor Decision|1
2094147|NCT00785928|3682757|FG001|Treatment Phase|Sponsor Decision|0
2094148|NCT00785928|3682758|FG002|Treatment Phase|Sponsor Decision|0
2094149|NCT00785928|3682759|FG003|Treatment Phase|Sponsor Decision|0
2094150|NCT00785928|3682760|FG004|Treatment Phase|Sponsor Decision|0
2094151|NCT00785928|3682761|FG005|Treatment Phase|Sponsor Decision|0
2094152|NCT00785928|3682762|FG006|Treatment Phase|Sponsor Decision|1
2094153|NCT00785928|3682756|FG000|Treatment Phase|Withdrawal by Subject|1
2094154|NCT00785928|3682757|FG001|Treatment Phase|Withdrawal by Subject|2
2094155|NCT00785928|3682758|FG002|Treatment Phase|Withdrawal by Subject|0
2094156|NCT00785928|3682759|FG003|Treatment Phase|Withdrawal by Subject|0
2094157|NCT00785928|3682760|FG004|Treatment Phase|Withdrawal by Subject|1
2094158|NCT00785928|3682761|FG005|Treatment Phase|Withdrawal by Subject|0
2094159|NCT00785928|3682762|FG006|Treatment Phase|Withdrawal by Subject|0
2094160|NCT00785980|3682800|FG000|7 Day Washout Period|Protocol Violation|3
2094161|NCT00786032|3682818|FG000|Overall Study|Death|4
2094162|NCT00786032|3682818|FG000|Overall Study|Withdrawal by Subject|14
2094163|NCT00786032|3682818|FG000|Overall Study|Did not complete in the timeframe|6
2094164|NCT00786188|3682826|FG000|Overall Study|Adverse Event|3
2094165|NCT00786188|3682827|FG001|Overall Study|Adverse Event|1
2094166|NCT00786188|3682826|FG000|Overall Study|Withdrawal by Subject|2
2094167|NCT00786188|3682827|FG001|Overall Study|Withdrawal by Subject|0
2094168|NCT00786409|3682835|FG000|Overall Study|Withdrawal by Subject|2
2094169|NCT00786409|3682835|FG000|Overall Study|Adverse Event|2
2094170|NCT00786409|3682835|FG000|Overall Study|Pregnancy|2
2094171|NCT00786409|3682835|FG000|Overall Study|Lost to Follow-up|1
2094172|NCT00786422|3682839|FG000|Rivaroxaban Treatment|Death|2
2094173|NCT00786422|3682839|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3
2094174|NCT00786422|3682839|FG000|Rivaroxaban Treatment|Lack of Efficacy|1
2094175|NCT00786422|3682839|FG000|Rivaroxaban Treatment|Physician Decision|1
2094176|NCT00786422|3682839|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1
2094177|NCT00786422|3682839|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
2094178|NCT00786422|3682839|FG000|Rivaroxaban Treatment|Adverse Event|2
2094179|NCT00786422|3682839|FG000|Follow-up Period|Death|1
2094180|NCT00786422|3682839|FG000|Follow-up Period|End-of-study done up to 4 days early|2
2094181|NCT00786474|3682847|FG000|Overall Study|Death|5
2094182|NCT00786474|3682848|FG001|Overall Study|Death|4
2094183|NCT00786474|3682847|FG000|Overall Study|Withdrawal by Subject|23
2094184|NCT00786474|3682848|FG001|Overall Study|Withdrawal by Subject|31
2094185|NCT00786474|3682847|FG000|Overall Study|Lost to Follow-up|3
2094186|NCT00786474|3682848|FG001|Overall Study|Lost to Follow-up|3
2094187|NCT00786474|3682847|FG000|Overall Study|Physician Decision|2
2094188|NCT00786474|3682848|FG001|Overall Study|Physician Decision|1
2094189|NCT00786474|3682847|FG000|Overall Study|Other|4
2094190|NCT00786474|3682848|FG001|Overall Study|Other|4
2094191|NCT00786565|3682871|FG000|Enrollment Prior to Surgery|Site Closed|3
2094192|NCT00786565|3682871|FG000|Enrollment Prior to Surgery|Protocol Violation|3
2094193|NCT00786565|3682871|FG000|Post Surgery|Abnormal macular pucker|1
2094194|NCT00786565|3682871|FG000|Post Surgery|Adapt AO implanted posterior side up|1
2094195|NCT00786799|3682888|FG000|Overall Study|Lost to Follow-up|1
2094196|NCT00786799|3682889|FG001|Overall Study|Lost to Follow-up|1
2094197|NCT00786838|3682909|FG000|Overall Study|Physician Decision|4
2094198|NCT00786838|3682909|FG000|Overall Study|Death|4
2094199|NCT00786838|3682909|FG000|Overall Study|Adverse Event|6
2094200|NCT00786838|3682909|FG000|Overall Study|Progressive disease|31
2094201|NCT00786838|3682909|FG000|Overall Study|Withdrawal by Subject|4
2094202|NCT00786864|3682920|FG000|Overall Study|Lost to Follow-up|0
2094203|NCT00786864|3682921|FG001|Overall Study|Lost to Follow-up|1
2094204|NCT00786864|3682920|FG000|Overall Study|Sustained serious back injury|1
2094205|NCT00786864|3682921|FG001|Overall Study|Sustained serious back injury|0
2094206|NCT00787137|3682968|FG000|Overall Study|Study Termination|0
2094207|NCT00787137|3682969|FG001|Overall Study|Study Termination|0
2094208|NCT00787137|3682970|FG002|Overall Study|Study Termination|1
2094209|NCT00787150|3682981|FG000|Overall Study|Adverse Event|4
2094210|NCT00787150|3682982|FG001|Overall Study|Adverse Event|4
2094211|NCT00787150|3682983|FG002|Overall Study|Adverse Event|4
2094212|NCT00787150|3682981|FG000|Overall Study|Physician Decision|1
2094213|NCT00787150|3682982|FG001|Overall Study|Physician Decision|2
2094214|NCT00787150|3682983|FG002|Overall Study|Physician Decision|1
2094215|NCT00787150|3682981|FG000|Overall Study|Withdrawal by Subject|2
2094216|NCT00787150|3682982|FG001|Overall Study|Withdrawal by Subject|1
2094217|NCT00787150|3682983|FG002|Overall Study|Withdrawal by Subject|0
2094218|NCT00787150|3682981|FG000|Overall Study|Dosing incorrect study durg|2
2094219|NCT00787150|3682982|FG001|Overall Study|Dosing incorrect study durg|0
2094220|NCT00787150|3682983|FG002|Overall Study|Dosing incorrect study durg|0
2094221|NCT00787189|3682995|FG000|Overall Study|Lost to Follow-up|2
2094222|NCT00787189|3682996|FG001|Overall Study|Lost to Follow-up|2
2094223|NCT00787202|3683007|FG000|Overall Study|Adverse Event|3
2094224|NCT00787202|3683008|FG001|Overall Study|Adverse Event|2
2094225|NCT00787202|3683009|FG002|Overall Study|Adverse Event|0
2094226|NCT00787202|3683010|FG003|Overall Study|Adverse Event|0
2094227|NCT00787202|3683011|FG004|Overall Study|Adverse Event|2
2094228|NCT00787202|3683007|FG000|Overall Study|Lack of Efficacy|5
2094229|NCT00787202|3683008|FG001|Overall Study|Lack of Efficacy|6
2094230|NCT00787202|3683009|FG002|Overall Study|Lack of Efficacy|5
2094231|NCT00787202|3683010|FG003|Overall Study|Lack of Efficacy|2
2094232|NCT00787202|3683011|FG004|Overall Study|Lack of Efficacy|1
2094233|NCT00787202|3683007|FG000|Overall Study|Lost to Follow-up|1
2094234|NCT00787202|3683008|FG001|Overall Study|Lost to Follow-up|0
2094235|NCT00787202|3683009|FG002|Overall Study|Lost to Follow-up|0
2094236|NCT00787202|3683010|FG003|Overall Study|Lost to Follow-up|0
2094237|NCT00787202|3683011|FG004|Overall Study|Lost to Follow-up|0
2094238|NCT00787202|3683007|FG000|Overall Study|Withdrawal by Subject|2
2094239|NCT00787202|3683008|FG001|Overall Study|Withdrawal by Subject|2
2094240|NCT00787202|3683009|FG002|Overall Study|Withdrawal by Subject|2
2094241|NCT00787202|3683010|FG003|Overall Study|Withdrawal by Subject|0
2094242|NCT00787202|3683011|FG004|Overall Study|Withdrawal by Subject|0
2094243|NCT00787202|3683007|FG000|Overall Study|Protocol Violation|2
2094244|NCT00787202|3683008|FG001|Overall Study|Protocol Violation|1
2094245|NCT00787202|3683009|FG002|Overall Study|Protocol Violation|0
2094246|NCT00787202|3683010|FG003|Overall Study|Protocol Violation|0
2094247|NCT00787202|3683011|FG004|Overall Study|Protocol Violation|1
2094248|NCT00787202|3683007|FG000|Overall Study|Randomized, not treated|1
2094249|NCT00787202|3683008|FG001|Overall Study|Randomized, not treated|0
2094250|NCT00787202|3683009|FG002|Overall Study|Randomized, not treated|0
2094251|NCT00787202|3683010|FG003|Overall Study|Randomized, not treated|0
2094252|NCT00787202|3683011|FG004|Overall Study|Randomized, not treated|0
2094253|NCT00787254|3683042|FG000|Overall Study|Adverse Event|24
2094254|NCT00787254|3683043|FG001|Overall Study|Adverse Event|23
2094255|NCT00787254|3683042|FG000|Overall Study|Protocol Violation|26
2094256|NCT00787254|3683043|FG001|Overall Study|Protocol Violation|23
2094257|NCT00787254|3683042|FG000|Overall Study|Withdrawal by Subject|16
2094258|NCT00787254|3683043|FG001|Overall Study|Withdrawal by Subject|11
2094259|NCT00787254|3683042|FG000|Overall Study|Lack of Efficacy|4
2094260|NCT00787254|3683043|FG001|Overall Study|Lack of Efficacy|15
2094261|NCT00787254|3683042|FG000|Overall Study|NSAIDs discontinuation|1
2094262|NCT00787254|3683043|FG001|Overall Study|NSAIDs discontinuation|2
2094263|NCT00787254|3683042|FG000|Overall Study|Institution closed|1
2094264|NCT00787254|3683043|FG001|Overall Study|Institution closed|0
2094265|NCT00787254|3683042|FG000|Overall Study|Physician Decision|4
2094266|NCT00787254|3683043|FG001|Overall Study|Physician Decision|8
2094267|NCT00787267|3683049|FG000|Overall Study|Screen failure/Ineligible|10
2094268|NCT00787267|3683049|FG000|Overall Study|No Reason Provided|1
2094269|NCT00787267|3683049|FG000|Overall Study|Withdrawal by Subject|1
2094270|NCT00787319|3683053|FG000|Overall Study|Lost to Follow-up|2
2094271|NCT00787319|3683053|FG000|Overall Study|Withdrawal by Subject|15
2094272|NCT00787319|3683053|FG000|Overall Study|Adverse Event|3
2094273|NCT00787319|3683053|FG000|Overall Study|Objective progression or relapse|30
2094274|NCT00787319|3683053|FG000|Overall Study|Lack of Efficacy|1
2094275|NCT00787319|3683053|FG000|Overall Study|Budget exhausted/exceeded|1
2094276|NCT00787319|3683053|FG000|Overall Study|Unresponsiveness to visit invitation|1
2094277|NCT00787319|3683053|FG000|Overall Study|No health insurance reimbursement|2
2094278|NCT00787319|3683053|FG000|Overall Study|Stabilized disease findings|3
2094279|NCT00787319|3683053|FG000|Overall Study|Inactive disease|5
2094280|NCT00787527|3683066|FG000|Overall Study|Toxicity|3
2094281|NCT00787566|3683077|FG000|Overall Study|AE related to chemotherapy|0
2094282|NCT00787566|3683078|FG001|Overall Study|AE related to chemotherapy|1
2094283|NCT00787566|3683079|FG002|Overall Study|AE related to chemotherapy|0
2094284|NCT00787605|3683089|FG000|Overall Study|Administrative Problems|3
2094285|NCT00787605|3683090|FG001|Overall Study|Administrative Problems|0
2094286|NCT00787605|3683089|FG000|Overall Study|Adverse Event|14
2094287|NCT00787605|3683090|FG001|Overall Study|Adverse Event|25
2094288|NCT00787605|3683089|FG000|Overall Study|Lost to Follow-up|3
2094289|NCT00787605|3683090|FG001|Overall Study|Lost to Follow-up|6
2094290|NCT00787605|3683089|FG000|Overall Study|Protocol Violation|7
2094291|NCT00787605|3683090|FG001|Overall Study|Protocol Violation|3
2094292|NCT00787605|3683089|FG000|Overall Study|Withdrawal by Subject|6
2094293|NCT00787605|3683090|FG001|Overall Study|Withdrawal by Subject|13
2094294|NCT00787605|3683089|FG000|Overall Study|Lack of Efficacy|13
2094295|NCT00787605|3683090|FG001|Overall Study|Lack of Efficacy|9
2094296|NCT00787644|3683098|FG000|Overall Study|Lost to Follow-up|1
2094297|NCT00787644|3683099|FG001|Overall Study|Lost to Follow-up|1
2094298|NCT00787644|3683098|FG000|Overall Study|Withdrawal by Subject|1
2094299|NCT00787644|3683099|FG001|Overall Study|Withdrawal by Subject|1
2094300|NCT00787787|3683116|FG000|Overall Study|Lack of Efficacy|4
2094301|NCT00787787|3683116|FG000|Overall Study|Adverse Event|3
2094302|NCT00787800|3683122|FG000|Overall Study|Withdrawal by Subject|3
2094303|NCT00787800|3683123|FG001|Overall Study|Withdrawal by Subject|5
2094304|NCT00787800|3683122|FG000|Overall Study|Death|0
2094305|NCT00787800|3683123|FG001|Overall Study|Death|2
2094306|NCT00787839|3683130|FG000|Overall Study|Failure to have the OGTT was most common|404
2094307|NCT00787891|3683162|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1
2094308|NCT00787891|3683163|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2
2094309|NCT00787891|3683162|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
2094310|NCT00787891|3683163|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
2094311|NCT00787891|3683162|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
2094312|NCT00787891|3683163|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
2094313|NCT00787891|3683162|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1
2094314|NCT00787891|3683163|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0
2094315|NCT00787891|3683162|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
2094316|NCT00787891|3683163|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
2094317|NCT00787891|3683162|FG000|Short-term Double-blind Phase (Part 1)|Other|0
2094318|NCT00787891|3683163|FG001|Short-term Double-blind Phase (Part 1)|Other|2
2094319|NCT00787891|3683162|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
2094320|NCT00787891|3683163|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
2094321|NCT00787891|3683162|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
2094322|NCT00787891|3683163|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
2094323|NCT00787891|3683162|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
2211925|NCT01664923|3852619|FG000|Period1:Double Blind Phase-29 Months|Other|3
2211926|NCT01664923|3852620|FG001|Period1:Double Blind Phase-29 Months|Other|4
2211927|NCT01664923|3852619|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
2211928|NCT01664923|3852620|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
2211929|NCT01664923|3852619|FG000|Period 2: Open-label Phase-36 Months|Death|3
2094324|NCT00787891|3683163|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
2094325|NCT00787891|3683162|FG000|Maintenance Double-blind Phase (Part 2)|Other|5
2094326|NCT00787891|3683163|FG001|Maintenance Double-blind Phase (Part 2)|Other|2
2094327|NCT00787930|3683180|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
2094328|NCT00788073|3683209|FG000|STX209 Then Placebo|Adverse Event|1
2094329|NCT00788073|3683210|FG001|STX209 Then Placebo|Adverse Event|0
2094330|NCT00788073|3683209|FG000|STX209 Then Placebo|Lost to Follow-up|0
2094331|NCT00788073|3683210|FG001|STX209 Then Placebo|Lost to Follow-up|1
2094332|NCT00788073|3683209|FG000|STX209 Then Placebo|Withdrawal by Subject|0
2094333|NCT00788073|3683210|FG001|STX209 Then Placebo|Withdrawal by Subject|1
2094334|NCT00788073|3683209|FG000|STX209 Then Placebo|unable to return due to travel|0
2094335|NCT00788073|3683210|FG001|STX209 Then Placebo|unable to return due to travel|1
2094336|NCT00788073|3683209|FG000|Placebo Then STX209|Adverse Event|2
2094337|NCT00788073|3683210|FG001|Placebo Then STX209|Adverse Event|0
2094338|NCT00788073|3683209|FG000|Placebo Then STX209|Protocol Violation|0
2094339|NCT00788073|3683210|FG001|Placebo Then STX209|Protocol Violation|1
2094340|NCT00788151|3683218|FG000|Overall Study|Other adverse event|0
2094341|NCT00788151|3683219|FG001|Overall Study|Other adverse event|2
2094342|NCT00788151|3683218|FG000|Overall Study|Protocol Violation|0
2094343|NCT00788151|3683219|FG001|Overall Study|Protocol Violation|1
2094344|NCT00788151|3683218|FG000|Overall Study|Withdrawal by Subject|13
2094345|NCT00788151|3683219|FG001|Overall Study|Withdrawal by Subject|6
2094346|NCT00788151|3683218|FG000|Overall Study|Enrolled but not treated|1
2094347|NCT00788151|3683219|FG001|Overall Study|Enrolled but not treated|1
2094348|NCT00788372|3683232|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18
2094349|NCT00788372|3683232|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
2094350|NCT00788372|3683232|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
2094351|NCT00788372|3683232|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13
2094352|NCT00788372|3683232|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9
2094353|NCT00788372|3683232|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
2094354|NCT00788372|3683232|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
2094355|NCT00788593|3683236|FG000|Placebo Run-in Phase|Adverse Event|2
2094356|NCT00788593|3683237|FG001|Placebo Run-in Phase|Adverse Event|0
2094357|NCT00788593|3683238|FG002|Placebo Run-in Phase|Adverse Event|0
2094358|NCT00788593|3683236|FG000|Placebo Run-in Phase|Withdrawal by Subject|2
2094359|NCT00788593|3683237|FG001|Placebo Run-in Phase|Withdrawal by Subject|0
2094360|NCT00788593|3683238|FG002|Placebo Run-in Phase|Withdrawal by Subject|0
2094361|NCT00788593|3683236|FG000|Placebo Run-in Phase|Protocol Violation|2
2094362|NCT00788593|3683237|FG001|Placebo Run-in Phase|Protocol Violation|0
2094363|NCT00788593|3683238|FG002|Placebo Run-in Phase|Protocol Violation|0
2094364|NCT00788593|3683236|FG000|First Intervention Period|Adverse Event|0
2094365|NCT00788593|3683237|FG001|First Intervention Period|Adverse Event|1
2094366|NCT00788593|3683238|FG002|First Intervention Period|Adverse Event|0
2094367|NCT00788593|3683236|FG000|Second Intervention Period|Lost to Follow-up|0
2094368|NCT00788593|3683237|FG001|Second Intervention Period|Lost to Follow-up|1
2094369|NCT00788593|3683238|FG002|Second Intervention Period|Lost to Follow-up|0
2094370|NCT00788593|3683236|FG000|Second Intervention Period|Other|0
2094371|NCT00788593|3683237|FG001|Second Intervention Period|Other|0
2094372|NCT00788593|3683238|FG002|Second Intervention Period|Other|1
2094373|NCT00788697|3683248|FG000|Overall Study|No study drug administered|12
2094374|NCT00788697|3683248|FG000|Overall Study|Training Patients|74
2094375|NCT00788697|3683248|FG000|Overall Study|no truth standard procedure available|5
2094376|NCT00788697|3683248|FG000|Overall Study|Technically inadequate truth standard|1
2094377|NCT00788697|3683248|FG000|Overall Study|Indeterminate diagnosis from truth stand|17
2094378|NCT00788775|3683262|FG000|Overall Study|Progressive Disease|8
2094379|NCT00788775|3683263|FG001|Overall Study|Progressive Disease|6
2094380|NCT00788775|3683262|FG000|Overall Study|Withdrawal by Subject|0
2094381|NCT00788775|3683263|FG001|Overall Study|Withdrawal by Subject|2
2094382|NCT00788775|3683262|FG000|Overall Study|Patient Non-Compliance|1
2094383|NCT00788775|3683263|FG001|Overall Study|Patient Non-Compliance|0
2094384|NCT00788775|3683262|FG000|Overall Study|Patient's measurable disease resected.|1
2094385|NCT00788775|3683263|FG001|Overall Study|Patient's measurable disease resected.|0
2094386|NCT00788827|3683269|FG000|Overall Study|Lack of Efficacy|2
2094387|NCT00788957|3683288|FG000|Part 1|Death|8
2094388|NCT00788957|3683289|FG001|Part 1|Death|0
2094389|NCT00788957|3683290|FG002|Part 1|Death|0
2094390|NCT00788957|3683291|FG003|Part 1|Death|0
2094391|NCT00788957|3683292|FG004|Part 1|Death|0
2094392|NCT00788957|3683293|FG005|Part 1|Death|0
2094393|NCT00788957|3683288|FG000|Part 1|Lost to Follow-up|1
2094394|NCT00788957|3683289|FG001|Part 1|Lost to Follow-up|0
2094395|NCT00788957|3683290|FG002|Part 1|Lost to Follow-up|0
2094396|NCT00788957|3683291|FG003|Part 1|Lost to Follow-up|0
2094397|NCT00788957|3683292|FG004|Part 1|Lost to Follow-up|0
2094398|NCT00788957|3683293|FG005|Part 1|Lost to Follow-up|0
2094399|NCT00788957|3683288|FG000|Part 2|Withdrawal by Subject|0
2094400|NCT00788957|3683289|FG001|Part 2|Withdrawal by Subject|9
2094401|NCT00788957|3683290|FG002|Part 2|Withdrawal by Subject|5
2094402|NCT00788957|3683291|FG003|Part 2|Withdrawal by Subject|3
2094403|NCT00788957|3683292|FG004|Part 2|Withdrawal by Subject|0
2094404|NCT00788957|3683293|FG005|Part 2|Withdrawal by Subject|0
2094405|NCT00788957|3683288|FG000|Part 2|Death|0
2094406|NCT00788957|3683289|FG001|Part 2|Death|32
2217517|NCT01708941|3860840|FG002|Overall Study|Never started treatment|0
2094407|NCT00788957|3683290|FG002|Part 2|Death|35
2094408|NCT00788957|3683291|FG003|Part 2|Death|37
2094409|NCT00788957|3683292|FG004|Part 2|Death|0
2094410|NCT00788957|3683293|FG005|Part 2|Death|0
2094411|NCT00788957|3683288|FG000|Part 2|Lost to Follow-up|0
2094412|NCT00788957|3683289|FG001|Part 2|Lost to Follow-up|0
2094413|NCT00788957|3683290|FG002|Part 2|Lost to Follow-up|3
2094414|NCT00788957|3683291|FG003|Part 2|Lost to Follow-up|0
2094415|NCT00788957|3683292|FG004|Part 2|Lost to Follow-up|0
2094416|NCT00788957|3683293|FG005|Part 2|Lost to Follow-up|0
2094417|NCT00788957|3683288|FG000|Part 2|On-study at time of data cut-off|0
2094418|NCT00788957|3683289|FG001|Part 2|On-study at time of data cut-off|1
2094419|NCT00788957|3683290|FG002|Part 2|On-study at time of data cut-off|1
2094420|NCT00788957|3683291|FG003|Part 2|On-study at time of data cut-off|1
2094421|NCT00788957|3683292|FG004|Part 2|On-study at time of data cut-off|0
2094422|NCT00788957|3683293|FG005|Part 2|On-study at time of data cut-off|0
2094423|NCT00788957|3683288|FG000|Part 3|Withdrawal by Subject|0
2094424|NCT00788957|3683289|FG001|Part 3|Withdrawal by Subject|0
2094425|NCT00788957|3683290|FG002|Part 3|Withdrawal by Subject|0
2094426|NCT00788957|3683291|FG003|Part 3|Withdrawal by Subject|0
2094427|NCT00788957|3683292|FG004|Part 3|Withdrawal by Subject|0
2094428|NCT00788957|3683293|FG005|Part 3|Withdrawal by Subject|2
2094429|NCT00788957|3683288|FG000|Part 3|Death|0
2094430|NCT00788957|3683289|FG001|Part 3|Death|0
2094431|NCT00788957|3683290|FG002|Part 3|Death|0
2094432|NCT00788957|3683291|FG003|Part 3|Death|0
2094433|NCT00788957|3683292|FG004|Part 3|Death|8
2094434|NCT00788957|3683293|FG005|Part 3|Death|9
2094435|NCT00788957|3683288|FG000|Part 3|On-study at time of data cut-off|0
2094436|NCT00788957|3683289|FG001|Part 3|On-study at time of data cut-off|0
2094437|NCT00788957|3683290|FG002|Part 3|On-study at time of data cut-off|0
2094438|NCT00788957|3683291|FG003|Part 3|On-study at time of data cut-off|0
2094439|NCT00788957|3683292|FG004|Part 3|On-study at time of data cut-off|1
2094440|NCT00788957|3683293|FG005|Part 3|On-study at time of data cut-off|0
2094441|NCT00789035|3683315|FG000|Overall Study|Adverse Event|0
2094442|NCT00789035|3683316|FG001|Overall Study|Adverse Event|2
2094443|NCT00789035|3683317|FG002|Overall Study|Adverse Event|0
2094444|NCT00789035|3683318|FG003|Overall Study|Adverse Event|1
2094445|NCT00789035|3683319|FG004|Overall Study|Adverse Event|3
2094446|NCT00789035|3683315|FG000|Overall Study|Lack of Efficacy|3
2094447|NCT00789035|3683316|FG001|Overall Study|Lack of Efficacy|0
2094448|NCT00789035|3683317|FG002|Overall Study|Lack of Efficacy|0
2094449|NCT00789035|3683318|FG003|Overall Study|Lack of Efficacy|0
2094450|NCT00789035|3683319|FG004|Overall Study|Lack of Efficacy|2
2094451|NCT00789035|3683315|FG000|Overall Study|Protocol Violation|1
2094452|NCT00789035|3683316|FG001|Overall Study|Protocol Violation|0
2094453|NCT00789035|3683317|FG002|Overall Study|Protocol Violation|0
2094454|NCT00789035|3683318|FG003|Overall Study|Protocol Violation|0
2094455|NCT00789035|3683319|FG004|Overall Study|Protocol Violation|0
2094456|NCT00789035|3683315|FG000|Overall Study|Withdrawal by Subject|0
2094457|NCT00789035|3683316|FG001|Overall Study|Withdrawal by Subject|2
2094458|NCT00789035|3683317|FG002|Overall Study|Withdrawal by Subject|0
2094459|NCT00789035|3683318|FG003|Overall Study|Withdrawal by Subject|0
2094460|NCT00789035|3683319|FG004|Overall Study|Withdrawal by Subject|0
2094461|NCT00789035|3683315|FG000|Overall Study|Other reason not defined above|2
2094462|NCT00789035|3683316|FG001|Overall Study|Other reason not defined above|3
2094463|NCT00789035|3683317|FG002|Overall Study|Other reason not defined above|1
2094464|NCT00789035|3683318|FG003|Overall Study|Other reason not defined above|0
2094465|NCT00789035|3683319|FG004|Overall Study|Other reason not defined above|1
2094466|NCT00789191|3683353|FG000|Overall Study|Adverse Event|2
2094467|NCT00789191|3683354|FG001|Overall Study|Adverse Event|4
2094468|NCT00789191|3683353|FG000|Overall Study|Lack of Efficacy|0
2094469|NCT00789191|3683354|FG001|Overall Study|Lack of Efficacy|5
2094470|NCT00789191|3683353|FG000|Overall Study|Protocol Violation|5
2094471|NCT00789191|3683354|FG001|Overall Study|Protocol Violation|3
2094472|NCT00789191|3683353|FG000|Overall Study|Withdrawal Criteria|2
2094473|NCT00789191|3683354|FG001|Overall Study|Withdrawal Criteria|4
2094474|NCT00789191|3683353|FG000|Overall Study|Unclassified|5
2094475|NCT00789191|3683354|FG001|Overall Study|Unclassified|3
2094476|NCT00789321|3683374|FG000|Overall Study|Adverse Event|0
2094477|NCT00789321|3683375|FG001|Overall Study|Adverse Event|1
2094478|NCT00789360|3683383|FG000|Overall Study|Protocol Violation|3
2094479|NCT00789360|3683384|FG001|Overall Study|Protocol Violation|1
2094480|NCT00789373|3683391|FG000|Induction|Adverse Event|64
2094481|NCT00789373|3683392|FG001|Induction|Adverse Event|0
2094482|NCT00789373|3683393|FG002|Induction|Adverse Event|0
2094483|NCT00789373|3683391|FG000|Induction|Death Due to study disease|24
2094484|NCT00789373|3683392|FG001|Induction|Death Due to study disease|0
2094485|NCT00789373|3683393|FG002|Induction|Death Due to study disease|0
2094486|NCT00789373|3683391|FG000|Induction|Death due to adverse event|19
2094487|NCT00789373|3683392|FG001|Induction|Death due to adverse event|0
2094488|NCT00789373|3683393|FG002|Induction|Death due to adverse event|0
2094489|NCT00789373|3683391|FG000|Induction|Death due to toxicity|11
2094490|NCT00789373|3683392|FG001|Induction|Death due to toxicity|0
2094491|NCT00789373|3683393|FG002|Induction|Death due to toxicity|0
2094492|NCT00789373|3683391|FG000|Induction|Death due to procedure|1
2094493|NCT00789373|3683392|FG001|Induction|Death due to procedure|0
2094494|NCT00789373|3683393|FG002|Induction|Death due to procedure|0
2094495|NCT00789373|3683391|FG000|Induction|Investigator decision|7
2094496|NCT00789373|3683392|FG001|Induction|Investigator decision|0
2094497|NCT00789373|3683393|FG002|Induction|Investigator decision|0
2094498|NCT00789373|3683391|FG000|Induction|Protocol entry criteria not met|9
2094499|NCT00789373|3683392|FG001|Induction|Protocol entry criteria not met|0
2094500|NCT00789373|3683393|FG002|Induction|Protocol entry criteria not met|0
2094501|NCT00789373|3683391|FG000|Induction|Lost to Follow-up|6
2094502|NCT00789373|3683392|FG001|Induction|Lost to Follow-up|0
2094503|NCT00789373|3683393|FG002|Induction|Lost to Follow-up|0
2211930|NCT01664923|3852620|FG001|Period 2: Open-label Phase-36 Months|Death|1
2211931|NCT01664923|3852619|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1
2211932|NCT01664923|3852620|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1
2211933|NCT01664923|3852619|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28
2211934|NCT01664923|3852620|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9
2211935|NCT01664923|3852619|FG000|Period 2: Open-label Phase-36 Months|Other|3
2211936|NCT01664923|3852620|FG001|Period 2: Open-label Phase-36 Months|Other|1
2217518|NCT01708941|3860841|FG003|Overall Study|Never started treatment|0
2094504|NCT00789373|3683391|FG000|Induction|Protocol Violation|1
2094505|NCT00789373|3683392|FG001|Induction|Protocol Violation|0
2094506|NCT00789373|3683393|FG002|Induction|Protocol Violation|0
2094507|NCT00789373|3683391|FG000|Induction|Progressive Disease|220
2094508|NCT00789373|3683392|FG001|Induction|Progressive Disease|0
2094509|NCT00789373|3683393|FG002|Induction|Progressive Disease|0
2094510|NCT00789373|3683391|FG000|Induction|Withdrawal by Subject|37
2094511|NCT00789373|3683392|FG001|Induction|Withdrawal by Subject|0
2094512|NCT00789373|3683393|FG002|Induction|Withdrawal by Subject|0
2094513|NCT00789373|3683391|FG000|Maintenance|Adverse Event|0
2094514|NCT00789373|3683392|FG001|Maintenance|Adverse Event|65
2094515|NCT00789373|3683393|FG002|Maintenance|Adverse Event|12
2094516|NCT00789373|3683391|FG000|Maintenance|Death due to study disease|0
2094517|NCT00789373|3683392|FG001|Maintenance|Death due to study disease|3
2094518|NCT00789373|3683393|FG002|Maintenance|Death due to study disease|1
2094519|NCT00789373|3683391|FG000|Maintenance|Death due to adverse event|0
2094520|NCT00789373|3683392|FG001|Maintenance|Death due to adverse event|4
2094521|NCT00789373|3683393|FG002|Maintenance|Death due to adverse event|1
2094522|NCT00789373|3683391|FG000|Maintenance|Death due to toxicity|0
2094523|NCT00789373|3683392|FG001|Maintenance|Death due to toxicity|1
2094524|NCT00789373|3683393|FG002|Maintenance|Death due to toxicity|2
2094525|NCT00789373|3683391|FG000|Maintenance|Investigator Decision|0
2094526|NCT00789373|3683392|FG001|Maintenance|Investigator Decision|4
2094527|NCT00789373|3683393|FG002|Maintenance|Investigator Decision|2
2094528|NCT00789373|3683391|FG000|Maintenance|Protocol entry criteria not met|0
2094529|NCT00789373|3683392|FG001|Maintenance|Protocol entry criteria not met|2
2094530|NCT00789373|3683393|FG002|Maintenance|Protocol entry criteria not met|0
2094531|NCT00789373|3683391|FG000|Maintenance|Lost to Follow-up|0
2094532|NCT00789373|3683392|FG001|Maintenance|Lost to Follow-up|2
2094533|NCT00789373|3683393|FG002|Maintenance|Lost to Follow-up|0
2094534|NCT00789373|3683391|FG000|Maintenance|Progressive Disease|0
2094535|NCT00789373|3683392|FG001|Maintenance|Progressive Disease|253
2094536|NCT00789373|3683393|FG002|Maintenance|Progressive Disease|152
2094537|NCT00789373|3683391|FG000|Maintenance|Withdrawal by Subject|0
2094538|NCT00789373|3683392|FG001|Maintenance|Withdrawal by Subject|21
2094539|NCT00789373|3683393|FG002|Maintenance|Withdrawal by Subject|8
2094540|NCT00789373|3683391|FG000|Maintenance|Sponsor Decision|0
2094541|NCT00789373|3683392|FG001|Maintenance|Sponsor Decision|0
2094542|NCT00789373|3683393|FG002|Maintenance|Sponsor Decision|2
2094543|NCT00789373|3683391|FG000|Maintenance|Participants On-Going at Data Cut-Off|0
2094544|NCT00789373|3683392|FG001|Maintenance|Participants On-Going at Data Cut-Off|4
2094545|NCT00789373|3683393|FG002|Maintenance|Participants On-Going at Data Cut-Off|0
2094546|NCT00789477|3683422|FG000|Overall Study|Withdrawal by Subject|2
2094547|NCT00789477|3683423|FG001|Overall Study|Withdrawal by Subject|1
2094548|NCT00789477|3683424|FG002|Overall Study|Withdrawal by Subject|3
2094549|NCT00789477|3683425|FG003|Overall Study|Withdrawal by Subject|2
2094550|NCT00789477|3683426|FG004|Overall Study|Withdrawal by Subject|3
2094551|NCT00789477|3683422|FG000|Overall Study|Protocol Violation|1
2094552|NCT00789477|3683423|FG001|Overall Study|Protocol Violation|0
2094553|NCT00789477|3683424|FG002|Overall Study|Protocol Violation|0
2094554|NCT00789477|3683425|FG003|Overall Study|Protocol Violation|1
2094555|NCT00789477|3683426|FG004|Overall Study|Protocol Violation|0
2094556|NCT00789477|3683422|FG000|Overall Study|Adverse Event|3
2094557|NCT00789477|3683423|FG001|Overall Study|Adverse Event|3
2094558|NCT00789477|3683424|FG002|Overall Study|Adverse Event|1
2094559|NCT00789477|3683425|FG003|Overall Study|Adverse Event|0
2094560|NCT00789477|3683426|FG004|Overall Study|Adverse Event|0
2094561|NCT00789477|3683422|FG000|Overall Study|Death|1
2094562|NCT00789477|3683423|FG001|Overall Study|Death|1
2094563|NCT00789477|3683424|FG002|Overall Study|Death|2
2094564|NCT00789477|3683425|FG003|Overall Study|Death|2
2094565|NCT00789477|3683426|FG004|Overall Study|Death|0
2094566|NCT00789477|3683422|FG000|Overall Study|Lost to Follow-up|0
2094567|NCT00789477|3683423|FG001|Overall Study|Lost to Follow-up|1
2094568|NCT00789477|3683424|FG002|Overall Study|Lost to Follow-up|4
2094569|NCT00789477|3683425|FG003|Overall Study|Lost to Follow-up|2
2094570|NCT00789477|3683426|FG004|Overall Study|Lost to Follow-up|4
2094571|NCT00789477|3683422|FG000|Overall Study|Lack of Efficacy|2
2094572|NCT00789477|3683423|FG001|Overall Study|Lack of Efficacy|0
2094573|NCT00789477|3683424|FG002|Overall Study|Lack of Efficacy|0
2094574|NCT00789477|3683425|FG003|Overall Study|Lack of Efficacy|0
2094575|NCT00789477|3683426|FG004|Overall Study|Lack of Efficacy|0
2094576|NCT00789477|3683422|FG000|Overall Study|Other|2
2094577|NCT00789477|3683423|FG001|Overall Study|Other|0
2094578|NCT00789477|3683424|FG002|Overall Study|Other|1
2094579|NCT00789477|3683425|FG003|Overall Study|Other|3
2094580|NCT00789477|3683426|FG004|Overall Study|Other|0
2094581|NCT00789529|3683442|FG000|Overall Study|Withdrawal by Subject|0
2094582|NCT00789529|3683443|FG001|Overall Study|Withdrawal by Subject|1
2094583|NCT00789529|3683442|FG000|Overall Study|Other Reason|1
2094584|NCT00789529|3683443|FG001|Overall Study|Other Reason|0
2094585|NCT00789555|3683452|FG000|Overall Study|Protocol Amendment|78
2094586|NCT00789555|3683453|FG001|Overall Study|Protocol Amendment|76
2094587|NCT00789555|3683454|FG002|Overall Study|Protocol Amendment|80
2094588|NCT00789555|3683452|FG000|Overall Study|Adverse Event|17
2094589|NCT00789555|3683453|FG001|Overall Study|Adverse Event|7
2094590|NCT00789555|3683454|FG002|Overall Study|Adverse Event|10
2094591|NCT00789555|3683452|FG000|Overall Study|Lost to Follow-up|9
2094592|NCT00789555|3683453|FG001|Overall Study|Lost to Follow-up|10
2094593|NCT00789555|3683454|FG002|Overall Study|Lost to Follow-up|18
2094594|NCT00789555|3683452|FG000|Overall Study|Patient decision unnrelated to adv event|38
2094595|NCT00789555|3683453|FG001|Overall Study|Patient decision unnrelated to adv event|29
2094596|NCT00789555|3683454|FG002|Overall Study|Patient decision unnrelated to adv event|26
2094597|NCT00789555|3683452|FG000|Overall Study|Treatment failure|11
2094598|NCT00789555|3683453|FG001|Overall Study|Treatment failure|8
2094599|NCT00789555|3683454|FG002|Overall Study|Treatment failure|12
2094600|NCT00789555|3683452|FG000|Overall Study|Protocol Violation|6
2094601|NCT00789555|3683453|FG001|Overall Study|Protocol Violation|9
2094602|NCT00789555|3683454|FG002|Overall Study|Protocol Violation|13
2094603|NCT00789581|3683464|FG000|AC Therapy|Adverse Event|2
2094604|NCT00789581|3683465|FG001|AC Therapy|Adverse Event|3
2094605|NCT00789581|3683464|FG000|AC Therapy|Withdrawal by Subject|4
2094606|NCT00789581|3683465|FG001|AC Therapy|Withdrawal by Subject|7
2094607|NCT00789581|3683464|FG000|AC Therapy|Disease recurrence|3
2094608|NCT00789581|3683465|FG001|AC Therapy|Disease recurrence|1
2094609|NCT00789581|3683464|FG000|AC Therapy|Intercurrent Illness|1
2094610|NCT00789581|3683465|FG001|AC Therapy|Intercurrent Illness|0
2094611|NCT00789581|3683464|FG000|AC Therapy|Never Treated|1
2094612|NCT00789581|3683465|FG001|AC Therapy|Never Treated|4
2094613|NCT00789581|3683464|FG000|AC Therapy|Other|0
2094614|NCT00789581|3683465|FG001|AC Therapy|Other|2
2094615|NCT00789581|3683464|FG000|Adjuvant Therapy|Never treated|2
2094616|NCT00789581|3683465|FG001|Adjuvant Therapy|Never treated|2
2094617|NCT00789581|3683464|FG000|Adjuvant Therapy|Adverse Event|20
2094618|NCT00789581|3683465|FG001|Adjuvant Therapy|Adverse Event|44
2094619|NCT00789581|3683464|FG000|Adjuvant Therapy|Withdrawal by Subject|14
2094620|NCT00789581|3683465|FG001|Adjuvant Therapy|Withdrawal by Subject|5
2094621|NCT00789581|3683464|FG000|Adjuvant Therapy|Disease recurrence|2
2094622|NCT00789581|3683465|FG001|Adjuvant Therapy|Disease recurrence|1
2094623|NCT00789581|3683464|FG000|Adjuvant Therapy|Intercurrent Illness|1
2094624|NCT00789581|3683465|FG001|Adjuvant Therapy|Intercurrent Illness|3
2094625|NCT00789581|3683464|FG000|Adjuvant Therapy|Protocol Violation|1
2094626|NCT00789581|3683465|FG001|Adjuvant Therapy|Protocol Violation|1
2094627|NCT00789581|3683464|FG000|Adjuvant Therapy|Other|0
2094628|NCT00789581|3683465|FG001|Adjuvant Therapy|Other|1
2094629|NCT00789698|3683489|FG000|Overall Study|Lack of Efficacy|10
2094630|NCT00789698|3683490|FG001|Overall Study|Lack of Efficacy|4
2094631|NCT00789698|3683491|FG002|Overall Study|Lack of Efficacy|5
2094632|NCT00789698|3683492|FG003|Overall Study|Lack of Efficacy|18
2094633|NCT00789698|3683489|FG000|Overall Study|Adverse Event|5
2094634|NCT00789698|3683490|FG001|Overall Study|Adverse Event|5
2094635|NCT00789698|3683491|FG002|Overall Study|Adverse Event|3
2094636|NCT00789698|3683492|FG003|Overall Study|Adverse Event|4
2094637|NCT00789698|3683489|FG000|Overall Study|Lost to Follow-up|5
2094638|NCT00789698|3683490|FG001|Overall Study|Lost to Follow-up|5
2094639|NCT00789698|3683491|FG002|Overall Study|Lost to Follow-up|2
2094640|NCT00789698|3683492|FG003|Overall Study|Lost to Follow-up|9
2094641|NCT00789698|3683489|FG000|Overall Study|Protocol Violation|6
2094642|NCT00789698|3683490|FG001|Overall Study|Protocol Violation|1
2094643|NCT00789698|3683491|FG002|Overall Study|Protocol Violation|2
2094644|NCT00789698|3683492|FG003|Overall Study|Protocol Violation|1
2094645|NCT00789698|3683489|FG000|Overall Study|Withdrawal by Subject|14
2094646|NCT00789698|3683490|FG001|Overall Study|Withdrawal by Subject|15
2094647|NCT00789698|3683491|FG002|Overall Study|Withdrawal by Subject|12
2094648|NCT00789698|3683492|FG003|Overall Study|Withdrawal by Subject|19
2094649|NCT00789698|3683489|FG000|Overall Study|Administrative|0
2094650|NCT00789698|3683490|FG001|Overall Study|Administrative|3
2094651|NCT00789698|3683491|FG002|Overall Study|Administrative|3
2094652|NCT00789698|3683492|FG003|Overall Study|Administrative|1
2094653|NCT00789737|3683512|FG000|Overall Study|Withdrawal by Subject|13
2094654|NCT00789737|3683513|FG001|Overall Study|Withdrawal by Subject|22
2094655|NCT00789737|3683512|FG000|Overall Study|Lost to Follow-up|10
2094656|NCT00789737|3683513|FG001|Overall Study|Lost to Follow-up|14
2094657|NCT00789737|3683512|FG000|Overall Study|Adverse Event|8
2094658|NCT00789737|3683513|FG001|Overall Study|Adverse Event|8
2094659|NCT00789737|3683512|FG000|Overall Study|Protocol Violation|3
2094660|NCT00789737|3683513|FG001|Overall Study|Protocol Violation|0
2094661|NCT00789737|3683512|FG000|Overall Study|Lack of Efficacy|3
2094662|NCT00789737|3683513|FG001|Overall Study|Lack of Efficacy|0
2094663|NCT00789737|3683512|FG000|Overall Study|hyperglycemia that met protocol-specifie|0
2094664|NCT00789737|3683513|FG001|Overall Study|hyperglycemia that met protocol-specifie|4
2094665|NCT00789737|3683512|FG000|Overall Study|Other|11
2094666|NCT00789737|3683513|FG001|Overall Study|Other|7
2094667|NCT00789815|3683555|FG000|Overall Study|Protocol Violation|6
2094668|NCT00789815|3683556|FG001|Overall Study|Protocol Violation|1
2094669|NCT00789815|3683555|FG000|Overall Study|Intubation due to massive bleeding|1
2094670|NCT00789815|3683556|FG001|Overall Study|Intubation due to massive bleeding|0
2094671|NCT00789828|3683564|FG000|Core Period (48 Weeks)|Administrative problems|0
2094672|NCT00789828|3683565|FG001|Core Period (48 Weeks)|Administrative problems|1
2094673|NCT00789828|3683564|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0
2094674|NCT00789828|3683565|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4
2094675|NCT00789828|3683564|FG000|Core Period (48 Weeks)|Lost to Follow-up|0
2094676|NCT00789828|3683565|FG001|Core Period (48 Weeks)|Lost to Follow-up|1
2094677|NCT00789828|3683564|FG000|Open-label Extension Period (4 Years)|Adverse Event|10
2094678|NCT00789828|3683565|FG001|Open-label Extension Period (4 Years)|Adverse Event|0
2094679|NCT00789828|3683564|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
2094680|NCT00789828|3683565|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
2094681|NCT00789828|3683564|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3
2094682|NCT00789828|3683565|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0
2094683|NCT00789828|3683564|FG000|Open-label Extension Period (4 Years)|Administrative problems|7
2094684|NCT00789828|3683565|FG001|Open-label Extension Period (4 Years)|Administrative problems|0
2094685|NCT00789828|3683564|FG000|Open-label Extension Period (4 Years)|Death|1
2094686|NCT00789828|3683565|FG001|Open-label Extension Period (4 Years)|Death|0
2094687|NCT00789828|3683564|FG000|Open-label Extension Period (4 Years)|Disease progression|1
2094688|NCT00789828|3683565|FG001|Open-label Extension Period (4 Years)|Disease progression|0
2108207|NCT00878722|3702052|FG003|Overall Study|Withdrawal by Subject|0
2094689|NCT00789828|3683564|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1
2094690|NCT00789828|3683565|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0
2094691|NCT00789854|3683577|FG000|Overall Study|Adverse Event|28
2094692|NCT00789854|3683578|FG001|Overall Study|Adverse Event|23
2094693|NCT00789854|3683579|FG002|Overall Study|Adverse Event|18
2094694|NCT00789854|3683577|FG000|Overall Study|Lost to Follow-up|1
2094695|NCT00789854|3683578|FG001|Overall Study|Lost to Follow-up|1
2094696|NCT00789854|3683579|FG002|Overall Study|Lost to Follow-up|4
2094697|NCT00789854|3683577|FG000|Overall Study|Withdrawal by Subject|9
2094698|NCT00789854|3683578|FG001|Overall Study|Withdrawal by Subject|6
2094699|NCT00789854|3683579|FG002|Overall Study|Withdrawal by Subject|17
2094700|NCT00789854|3683577|FG000|Overall Study|Eligibility criteria not fulfilled|2
2094701|NCT00789854|3683578|FG001|Overall Study|Eligibility criteria not fulfilled|5
2211937|NCT01664923|3852619|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4
2211938|NCT01664923|3852620|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7
2211939|NCT01664923|3852619|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
2094702|NCT00789854|3683579|FG002|Overall Study|Eligibility criteria not fulfilled|1
2094703|NCT00789854|3683577|FG000|Overall Study|Severe non-compliance to the protocol|3
2094704|NCT00789854|3683578|FG001|Overall Study|Severe non-compliance to the protocol|0
2094705|NCT00789854|3683579|FG002|Overall Study|Severe non-compliance to the protocol|0
2094706|NCT00789854|3683577|FG000|Overall Study|Safety reasons|0
2094707|NCT00789854|3683578|FG001|Overall Study|Safety reasons|0
2094708|NCT00789854|3683579|FG002|Overall Study|Safety reasons|2
2094709|NCT00789854|3683577|FG000|Overall Study|Other|6
2094710|NCT00789854|3683578|FG001|Overall Study|Other|0
2094711|NCT00789854|3683579|FG002|Overall Study|Other|5
2094712|NCT00789880|3683607|FG000|Overall Study|Adverse Event|0
2094713|NCT00789880|3683608|FG001|Overall Study|Adverse Event|0
2094714|NCT00789880|3683609|FG002|Overall Study|Adverse Event|0
2094715|NCT00789880|3683610|FG003|Overall Study|Adverse Event|0
2094716|NCT00789880|3683611|FG004|Overall Study|Adverse Event|1
2094717|NCT00789880|3683612|FG005|Overall Study|Adverse Event|0
2094718|NCT00789880|3683607|FG000|Overall Study|Protocol Violation|0
2094719|NCT00789880|3683608|FG001|Overall Study|Protocol Violation|1
2094720|NCT00789880|3683609|FG002|Overall Study|Protocol Violation|0
2094721|NCT00789880|3683610|FG003|Overall Study|Protocol Violation|1
2094722|NCT00789880|3683611|FG004|Overall Study|Protocol Violation|0
2094723|NCT00789880|3683612|FG005|Overall Study|Protocol Violation|0
2094724|NCT00789880|3683607|FG000|Overall Study|Withdrawal by Subject|1
2094725|NCT00789880|3683608|FG001|Overall Study|Withdrawal by Subject|0
2094726|NCT00789880|3683609|FG002|Overall Study|Withdrawal by Subject|0
2094727|NCT00789880|3683610|FG003|Overall Study|Withdrawal by Subject|0
2094728|NCT00789880|3683611|FG004|Overall Study|Withdrawal by Subject|2
2094729|NCT00789880|3683612|FG005|Overall Study|Withdrawal by Subject|0
2094730|NCT00789958|3683626|FG000|Overall Study|Adverse Event|3
2094731|NCT00789958|3683626|FG000|Overall Study|Withdrawal by Subject|4
2094732|NCT00789958|3683626|FG000|Overall Study|Progression|3
2094733|NCT00789958|3683626|FG000|Overall Study|not protocol specified|1
2094734|NCT00789958|3683626|FG000|Overall Study|Not eligible/not analyzable|26
2094735|NCT00790023|3683644|FG000|Overall Study|Adverse Event|2
2094736|NCT00790023|3683645|FG001|Overall Study|Adverse Event|1
2094737|NCT00790023|3683646|FG002|Overall Study|Adverse Event|4
2094738|NCT00790023|3683644|FG000|Overall Study|Protocol Violation|2
2094739|NCT00790023|3683645|FG001|Overall Study|Protocol Violation|4
2094740|NCT00790023|3683646|FG002|Overall Study|Protocol Violation|2
2094741|NCT00790023|3683644|FG000|Overall Study|Withdrawal by Subject|2
2094742|NCT00790023|3683645|FG001|Overall Study|Withdrawal by Subject|0
2094743|NCT00790023|3683646|FG002|Overall Study|Withdrawal by Subject|6
2094744|NCT00790023|3683644|FG000|Overall Study|Lost to Follow-up|0
2094745|NCT00790023|3683645|FG001|Overall Study|Lost to Follow-up|0
2094746|NCT00790023|3683646|FG002|Overall Study|Lost to Follow-up|1
2094747|NCT00790023|3683644|FG000|Overall Study|Other|5
2094748|NCT00790023|3683645|FG001|Overall Study|Other|5
2094749|NCT00790023|3683646|FG002|Overall Study|Other|8
2094750|NCT00790036|3683657|FG000|Overall Study|Abnormal lab values|3
2094751|NCT00790036|3683658|FG001|Overall Study|Abnormal lab values|2
2094752|NCT00790036|3683657|FG000|Overall Study|Administrative problems|5
2094753|NCT00790036|3683658|FG001|Overall Study|Administrative problems|9
2094754|NCT00790036|3683657|FG000|Overall Study|Adverse Event|113
2094755|NCT00790036|3683658|FG001|Overall Study|Adverse Event|44
2094756|NCT00790036|3683657|FG000|Overall Study|Death|1
2094757|NCT00790036|3683658|FG001|Overall Study|Death|0
2094758|NCT00790036|3683657|FG000|Overall Study|Disease progression|24
2094759|NCT00790036|3683658|FG001|Overall Study|Disease progression|48
2094760|NCT00790036|3683657|FG000|Overall Study|Lost to Follow-up|1
2094761|NCT00790036|3683658|FG001|Overall Study|Lost to Follow-up|2
2094762|NCT00790036|3683657|FG000|Overall Study|Protocol Violation|10
2094763|NCT00790036|3683658|FG001|Overall Study|Protocol Violation|2
2094764|NCT00790036|3683657|FG000|Overall Study|Withdrawal by Subject|18
2094765|NCT00790036|3683658|FG001|Overall Study|Withdrawal by Subject|7
2094766|NCT00790036|3683657|FG000|Overall Study|Subject/guardian decision|20
2094767|NCT00790036|3683658|FG001|Overall Study|Subject/guardian decision|7
2094768|NCT00790088|3683687|FG000|Overall Study|Protocol Violation|11
2094769|NCT00790088|3683687|FG000|Overall Study|Withdrawal by Subject|17
2094770|NCT00790088|3683687|FG000|Overall Study|Lost to Follow-up|7
2094771|NCT00790088|3683687|FG000|Overall Study|Physician Decision|4
2094772|NCT00790205|3683712|FG000|Overall Study|Lost to Follow-up|61
2094773|NCT00790205|3683713|FG001|Overall Study|Lost to Follow-up|71
2094774|NCT00790205|3683712|FG000|Overall Study|Withdrawal by Subject|299
2094775|NCT00790205|3683713|FG001|Overall Study|Withdrawal by Subject|363
2094776|NCT00790218|3683719|FG000|Overall Study|Death|1
2211940|NCT01664923|3852620|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
2211941|NCT01664949|3852632|FG000|Overall Study|Adverse Event|11
2211942|NCT01664949|3852633|FG001|Overall Study|Adverse Event|12
2211943|NCT01664949|3852632|FG000|Overall Study|Lack of Efficacy|1
2211944|NCT01664949|3852633|FG001|Overall Study|Lack of Efficacy|1
2211945|NCT01664949|3852632|FG000|Overall Study|Lost to Follow-up|1
2211946|NCT01664949|3852633|FG001|Overall Study|Lost to Follow-up|2
2211947|NCT01664949|3852632|FG000|Overall Study|Personal Reasons|3
2211948|NCT01664949|3852633|FG001|Overall Study|Personal Reasons|4
2211949|NCT01664949|3852632|FG000|Overall Study|Protocol Violation|5
2211950|NCT01664949|3852633|FG001|Overall Study|Protocol Violation|5
2211951|NCT01664949|3852632|FG000|Overall Study|Other Miscellaneous Reasons|3
2094777|NCT00790218|3683720|FG001|Overall Study|Death|0
2094778|NCT00790218|3683721|FG002|Overall Study|Death|0
2094779|NCT00790296|3683744|FG000|Overall Study|Did not meet study eligibility criteria|1
2094780|NCT00790296|3683745|FG001|Overall Study|Did not meet study eligibility criteria|1
2094781|NCT00790296|3683744|FG000|Overall Study|Adverse Event|0
2094782|NCT00790296|3683745|FG001|Overall Study|Adverse Event|1
2094783|NCT00790400|3683762|FG000|Double-blind Period (Core Phase)|Protocol Violation|1
2094784|NCT00790400|3683763|FG001|Double-blind Period (Core Phase)|Protocol Violation|0
2094785|NCT00790400|3683762|FG000|Double-blind Period (Core Phase)|Progressive disease|0
2094786|NCT00790400|3683763|FG001|Double-blind Period (Core Phase)|Progressive disease|9
2094787|NCT00790400|3683762|FG000|Double-blind Period (Core Phase)|Adverse Event|2
2094788|NCT00790400|3683763|FG001|Double-blind Period (Core Phase)|Adverse Event|4
2094789|NCT00790400|3683762|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
2094790|NCT00790400|3683763|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
2094791|NCT00790400|3683762|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1
2094792|NCT00790400|3683763|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0
2094793|NCT00790400|3683762|FG000|Double-blind Period (Core Phase)|Administrative problems|1
2094794|NCT00790400|3683763|FG001|Double-blind Period (Core Phase)|Administrative problems|0
2094795|NCT00790400|3683762|FG000|Double-blind Period (Core Phase)|Death|1
2094796|NCT00790400|3683763|FG001|Double-blind Period (Core Phase)|Death|0
2094797|NCT00790400|3683762|FG000|Everolimus Period (Core or Extension)|Adverse Event|9
2094798|NCT00790400|3683763|FG001|Everolimus Period (Core or Extension)|Adverse Event|0
2094799|NCT00790400|3683762|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
2094800|NCT00790400|3683763|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
2094801|NCT00790400|3683762|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
2094802|NCT00790400|3683763|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
2094803|NCT00790400|3683762|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1
2094804|NCT00790400|3683763|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0
2094805|NCT00790400|3683762|FG000|Everolimus Period (Core or Extension)|Administrative problems|2
2094806|NCT00790400|3683763|FG001|Everolimus Period (Core or Extension)|Administrative problems|0
2094807|NCT00790400|3683762|FG000|Everolimus Period (Core or Extension)|Death|1
2094808|NCT00790400|3683763|FG001|Everolimus Period (Core or Extension)|Death|0
2094809|NCT00790400|3683762|FG000|Everolimus Period (Core or Extension)|Disease progression|5
2094810|NCT00790400|3683763|FG001|Everolimus Period (Core or Extension)|Disease progression|0
2094811|NCT00790400|3683762|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1
2094812|NCT00790400|3683763|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0
2094813|NCT00790400|3683762|FG000|Everolimus Period (Core or Extension)|New treatment|2
2094814|NCT00790400|3683763|FG001|Everolimus Period (Core or Extension)|New treatment|0
2094815|NCT00790556|3683772|FG000|Treatment Period 1|Physician Decision|1
2094816|NCT00790556|3683773|FG001|Treatment Period 1|Physician Decision|0
2094817|NCT00790556|3683772|FG000|Treatment Period 1|Withdrawal by Subject|1
2094818|NCT00790556|3683773|FG001|Treatment Period 1|Withdrawal by Subject|0
2094819|NCT00790569|3683782|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20
2094820|NCT00790569|3683783|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8
2094821|NCT00790569|3683784|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20
2094822|NCT00790569|3683782|FG000|End of Treatment (6 Month Interview)|Death|0
2094823|NCT00790569|3683783|FG001|End of Treatment (6 Month Interview)|Death|2
2094824|NCT00790569|3683784|FG002|End of Treatment (6 Month Interview)|Death|1
2094825|NCT00790569|3683782|FG000|End of Treatment (6 Month Interview)|Hospitalized|2
2094826|NCT00790569|3683783|FG001|End of Treatment (6 Month Interview)|Hospitalized|0
2094827|NCT00790569|3683784|FG002|End of Treatment (6 Month Interview)|Hospitalized|0
2094828|NCT00790569|3683782|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0
2094829|NCT00790569|3683783|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0
2094830|NCT00790569|3683784|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2
2094831|NCT00790569|3683782|FG000|End of Treatment (6 Month Interview)|Incarcerated|0
2211952|NCT01664949|3852633|FG001|Overall Study|Other Miscellaneous Reasons|1
2094832|NCT00790569|3683783|FG001|End of Treatment (6 Month Interview)|Incarcerated|0
2094833|NCT00790569|3683784|FG002|End of Treatment (6 Month Interview)|Incarcerated|3
2094834|NCT00790569|3683782|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66
2094835|NCT00790569|3683783|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19
2094836|NCT00790569|3683784|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50
2107568|NCT00874770|3701241|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
2107569|NCT00874770|3701242|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
2107570|NCT00874822|3701262|FG000|Overall Study|excluded by criteria|8
2107571|NCT00874848|3701268|FG000|Overall Study|Adverse Event|13
2107572|NCT00874848|3701269|FG001|Overall Study|Adverse Event|2
2107573|NCT00874848|3701268|FG000|Overall Study|Progressive neoplastic disease|38
2107574|NCT00874848|3701269|FG001|Overall Study|Progressive neoplastic disease|18
2107575|NCT00874848|3701268|FG000|Overall Study|Withdrawal by Subject|7
2107576|NCT00874848|3701269|FG001|Overall Study|Withdrawal by Subject|4
2107577|NCT00874848|3701268|FG000|Overall Study|Noncompliance|1
2107578|NCT00874848|3701269|FG001|Overall Study|Noncompliance|1
2107579|NCT00874848|3701268|FG000|Overall Study|Failure to comply with protocol|0
2107580|NCT00874848|3701269|FG001|Overall Study|Failure to comply with protocol|1
2107581|NCT00874848|3701268|FG000|Overall Study|Physician Decision|0
2107582|NCT00874848|3701269|FG001|Overall Study|Physician Decision|2
2107583|NCT00875017|3701290|FG000|First Intervention|Withdrawal by Subject|1
2107584|NCT00875017|3701291|FG001|First Intervention|Withdrawal by Subject|0
2107585|NCT00875017|3701292|FG002|First Intervention|Withdrawal by Subject|1
2107586|NCT00875017|3701293|FG003|First Intervention|Withdrawal by Subject|0
2107587|NCT00875017|3701294|FG004|First Intervention|Withdrawal by Subject|0
2107588|NCT00875017|3701295|FG005|First Intervention|Withdrawal by Subject|0
2107589|NCT00875017|3701290|FG000|First Intervention|Adverse Event|0
2107590|NCT00875017|3701291|FG001|First Intervention|Adverse Event|0
2107591|NCT00875017|3701292|FG002|First Intervention|Adverse Event|0
2107592|NCT00875017|3701293|FG003|First Intervention|Adverse Event|1
2107593|NCT00875017|3701294|FG004|First Intervention|Adverse Event|0
2107594|NCT00875017|3701295|FG005|First Intervention|Adverse Event|0
2107595|NCT00875017|3701290|FG000|First Intervention|Problems collecting rectal effluent|1
2107596|NCT00875017|3701291|FG001|First Intervention|Problems collecting rectal effluent|0
2107597|NCT00875017|3701292|FG002|First Intervention|Problems collecting rectal effluent|0
2107598|NCT00875017|3701293|FG003|First Intervention|Problems collecting rectal effluent|0
2107599|NCT00875017|3701294|FG004|First Intervention|Problems collecting rectal effluent|0
2107600|NCT00875017|3701295|FG005|First Intervention|Problems collecting rectal effluent|0
2107601|NCT00875017|3701290|FG000|First Intervention|Intolerance to nasogastric tube|0
2107602|NCT00875017|3701291|FG001|First Intervention|Intolerance to nasogastric tube|0
2107603|NCT00875017|3701292|FG002|First Intervention|Intolerance to nasogastric tube|0
2107604|NCT00875017|3701293|FG003|First Intervention|Intolerance to nasogastric tube|0
2107605|NCT00875017|3701294|FG004|First Intervention|Intolerance to nasogastric tube|1
2107606|NCT00875017|3701295|FG005|First Intervention|Intolerance to nasogastric tube|0
2107607|NCT00875017|3701290|FG000|Washout|Problem collecting rectal effluent|0
2107608|NCT00875017|3701291|FG001|Washout|Problem collecting rectal effluent|0
2107609|NCT00875017|3701292|FG002|Washout|Problem collecting rectal effluent|1
2107610|NCT00875017|3701293|FG003|Washout|Problem collecting rectal effluent|0
2107611|NCT00875017|3701294|FG004|Washout|Problem collecting rectal effluent|0
2107612|NCT00875017|3701295|FG005|Washout|Problem collecting rectal effluent|0
2107613|NCT00875017|3701290|FG000|Second Intervention|Adverse Event|0
2107614|NCT00875017|3701291|FG001|Second Intervention|Adverse Event|0
2107615|NCT00875017|3701292|FG002|Second Intervention|Adverse Event|0
2107616|NCT00875017|3701293|FG003|Second Intervention|Adverse Event|1
2107617|NCT00875017|3701294|FG004|Second Intervention|Adverse Event|0
2107618|NCT00875017|3701295|FG005|Second Intervention|Adverse Event|0
2107619|NCT00875017|3701290|FG000|Washout|Problems collecting rectal effluent|0
2107620|NCT00875017|3701291|FG001|Washout|Problems collecting rectal effluent|1
2107621|NCT00875017|3701292|FG002|Washout|Problems collecting rectal effluent|0
2107622|NCT00875017|3701293|FG003|Washout|Problems collecting rectal effluent|0
2107623|NCT00875017|3701294|FG004|Washout|Problems collecting rectal effluent|0
2107624|NCT00875017|3701295|FG005|Washout|Problems collecting rectal effluent|0
2107625|NCT00875017|3701290|FG000|Third Intervention|Adverse Event|0
2107626|NCT00875017|3701291|FG001|Third Intervention|Adverse Event|1
2107627|NCT00875017|3701292|FG002|Third Intervention|Adverse Event|1
2107628|NCT00875017|3701293|FG003|Third Intervention|Adverse Event|0
2107629|NCT00875017|3701294|FG004|Third Intervention|Adverse Event|0
2107630|NCT00875017|3701295|FG005|Third Intervention|Adverse Event|0
2107631|NCT00875017|3701290|FG000|Washout|Withdrawal by Subject|0
2107632|NCT00875017|3701291|FG001|Washout|Withdrawal by Subject|0
2107633|NCT00875017|3701292|FG002|Washout|Withdrawal by Subject|0
2107634|NCT00875017|3701293|FG003|Washout|Withdrawal by Subject|0
2107635|NCT00875017|3701294|FG004|Washout|Withdrawal by Subject|1
2107636|NCT00875017|3701295|FG005|Washout|Withdrawal by Subject|0
2107637|NCT00875017|3701290|FG000|Fourth Intervention|Inability to comply with fasting|0
2107638|NCT00875017|3701291|FG001|Fourth Intervention|Inability to comply with fasting|0
2107639|NCT00875017|3701292|FG002|Fourth Intervention|Inability to comply with fasting|0
2107640|NCT00875017|3701293|FG003|Fourth Intervention|Inability to comply with fasting|0
2108208|NCT00878722|3702053|FG004|Overall Study|Withdrawal by Subject|0
2094837|NCT00790582|3683794|FG000|Overall Study|Death|14
2094838|NCT00790582|3683795|FG001|Overall Study|Death|32
2094839|NCT00790582|3683794|FG000|Overall Study|Physician Decision|7
2094840|NCT00790582|3683795|FG001|Overall Study|Physician Decision|1
2094841|NCT00790582|3683794|FG000|Overall Study|Lost to Follow-up|3
2094842|NCT00790582|3683795|FG001|Overall Study|Lost to Follow-up|3
2094843|NCT00790582|3683794|FG000|Overall Study|Withdrawal by Subject|7
2094844|NCT00790582|3683795|FG001|Overall Study|Withdrawal by Subject|51
2094845|NCT00790647|3683803|FG000|Overall Study|Adverse Event|1
2094846|NCT00790751|3683850|FG000|Overall Study|Protocol non-compliance|16
2094847|NCT00790751|3683851|FG001|Overall Study|Protocol non-compliance|16
2094848|NCT00790751|3683852|FG002|Overall Study|Protocol non-compliance|10
2094849|NCT00790751|3683853|FG003|Overall Study|Protocol non-compliance|11
2094850|NCT00790751|3683850|FG000|Overall Study|Lost to Follow-up|4
2094851|NCT00790751|3683851|FG001|Overall Study|Lost to Follow-up|9
2094852|NCT00790751|3683852|FG002|Overall Study|Lost to Follow-up|4
2094853|NCT00790751|3683853|FG003|Overall Study|Lost to Follow-up|5
2094854|NCT00790751|3683850|FG000|Overall Study|Adverse Event|5
2094855|NCT00790751|3683851|FG001|Overall Study|Adverse Event|3
2094856|NCT00790751|3683852|FG002|Overall Study|Adverse Event|5
2094857|NCT00790751|3683853|FG003|Overall Study|Adverse Event|4
2094858|NCT00790751|3683850|FG000|Overall Study|Requirement for restricted medication|0
2094859|NCT00790751|3683851|FG001|Overall Study|Requirement for restricted medication|2
2094860|NCT00790751|3683852|FG002|Overall Study|Requirement for restricted medication|0
2094861|NCT00790751|3683853|FG003|Overall Study|Requirement for restricted medication|0
2094862|NCT00790751|3683850|FG000|Overall Study|Death|0
2094863|NCT00790751|3683851|FG001|Overall Study|Death|0
2094864|NCT00790751|3683852|FG002|Overall Study|Death|1
2094865|NCT00790751|3683853|FG003|Overall Study|Death|0
2094866|NCT00790751|3683850|FG000|Overall Study|Physician Decision|0
2094867|NCT00790751|3683851|FG001|Overall Study|Physician Decision|0
2094868|NCT00790751|3683852|FG002|Overall Study|Physician Decision|0
2094869|NCT00790751|3683853|FG003|Overall Study|Physician Decision|1
2094870|NCT00790790|3683866|FG000|Study Period 2: Therapy Phase|Adverse Event|3
2094871|NCT00790790|3683867|FG001|Study Period 2: Therapy Phase|Adverse Event|16
2094872|NCT00790790|3683868|FG002|Study Period 2: Therapy Phase|Adverse Event|16
2094873|NCT00790790|3683866|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
2094874|NCT00790790|3683867|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
2094875|NCT00790790|3683868|FG002|Study Period 2: Therapy Phase|Protocol Violation|0
2094876|NCT00790790|3683866|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7
2094877|NCT00790790|3683867|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0
2094878|NCT00790790|3683868|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2
2094879|NCT00790790|3683866|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1
2094880|NCT00790790|3683867|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
2094881|NCT00790790|3683868|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3
2094882|NCT00790790|3683866|FG000|Study Period 2: Therapy Phase|Physician Decision|0
2094883|NCT00790790|3683867|FG001|Study Period 2: Therapy Phase|Physician Decision|1
2094884|NCT00790790|3683868|FG002|Study Period 2: Therapy Phase|Physician Decision|0
2094885|NCT00790842|3683888|FG000|Dose Level 1|Adverse Event|1
2094886|NCT00790842|3683889|FG001|Dose Level 1|Adverse Event|0
2094887|NCT00790842|3683890|FG002|Dose Level 1|Adverse Event|0
2094888|NCT00790842|3683891|FG003|Dose Level 1|Adverse Event|2
2094889|NCT00790842|3683892|FG004|Dose Level 1|Adverse Event|0
2094890|NCT00790842|3683893|FG005|Dose Level 1|Adverse Event|0
2094891|NCT00790842|3683894|FG006|Dose Level 1|Adverse Event|0
2094892|NCT00790842|3683895|FG007|Dose Level 1|Adverse Event|1
2094893|NCT00790842|3683896|FG008|Dose Level 1|Adverse Event|0
2094894|NCT00790842|3683897|FG009|Dose Level 1|Adverse Event|0
2094895|NCT00790842|3683898|FG010|Dose Level 1|Adverse Event|0
2094896|NCT00790842|3683888|FG000|Dose Level 1|Physician Decision|1
2094897|NCT00790842|3683889|FG001|Dose Level 1|Physician Decision|0
2094898|NCT00790842|3683890|FG002|Dose Level 1|Physician Decision|0
2094899|NCT00790842|3683891|FG003|Dose Level 1|Physician Decision|0
2094900|NCT00790842|3683892|FG004|Dose Level 1|Physician Decision|0
2094901|NCT00790842|3683893|FG005|Dose Level 1|Physician Decision|0
2094902|NCT00790842|3683894|FG006|Dose Level 1|Physician Decision|0
2094903|NCT00790842|3683895|FG007|Dose Level 1|Physician Decision|1
2094904|NCT00790842|3683896|FG008|Dose Level 1|Physician Decision|0
2094905|NCT00790842|3683897|FG009|Dose Level 1|Physician Decision|0
2094906|NCT00790842|3683898|FG010|Dose Level 1|Physician Decision|0
2094907|NCT00790842|3683888|FG000|Dose Level 1|Withdrawal by Subject|1
2094908|NCT00790842|3683889|FG001|Dose Level 1|Withdrawal by Subject|0
2094909|NCT00790842|3683890|FG002|Dose Level 1|Withdrawal by Subject|0
2094910|NCT00790842|3683891|FG003|Dose Level 1|Withdrawal by Subject|0
2094911|NCT00790842|3683892|FG004|Dose Level 1|Withdrawal by Subject|0
2094912|NCT00790842|3683893|FG005|Dose Level 1|Withdrawal by Subject|0
2094913|NCT00790842|3683894|FG006|Dose Level 1|Withdrawal by Subject|0
2094914|NCT00790842|3683895|FG007|Dose Level 1|Withdrawal by Subject|0
2094915|NCT00790842|3683896|FG008|Dose Level 1|Withdrawal by Subject|0
2094916|NCT00790842|3683897|FG009|Dose Level 1|Withdrawal by Subject|0
2094917|NCT00790842|3683898|FG010|Dose Level 1|Withdrawal by Subject|0
2094918|NCT00790842|3683888|FG000|Dose Level 2|Death|0
2094919|NCT00790842|3683889|FG001|Dose Level 2|Death|1
2094920|NCT00790842|3683890|FG002|Dose Level 2|Death|0
2094921|NCT00790842|3683891|FG003|Dose Level 2|Death|0
2094922|NCT00790842|3683892|FG004|Dose Level 2|Death|1
2094923|NCT00790842|3683893|FG005|Dose Level 2|Death|0
2094924|NCT00790842|3683894|FG006|Dose Level 2|Death|0
2094925|NCT00790842|3683895|FG007|Dose Level 2|Death|0
2094926|NCT00790842|3683896|FG008|Dose Level 2|Death|0
2094927|NCT00790842|3683897|FG009|Dose Level 2|Death|0
2094928|NCT00790842|3683898|FG010|Dose Level 2|Death|0
2094929|NCT00790842|3683888|FG000|Dose Level 2|Physician Decision|0
2094930|NCT00790842|3683889|FG001|Dose Level 2|Physician Decision|1
2094931|NCT00790842|3683890|FG002|Dose Level 2|Physician Decision|0
2094932|NCT00790842|3683891|FG003|Dose Level 2|Physician Decision|0
2094933|NCT00790842|3683892|FG004|Dose Level 2|Physician Decision|0
2094934|NCT00790842|3683893|FG005|Dose Level 2|Physician Decision|0
2094935|NCT00790842|3683894|FG006|Dose Level 2|Physician Decision|0
2094936|NCT00790842|3683895|FG007|Dose Level 2|Physician Decision|0
2094937|NCT00790842|3683896|FG008|Dose Level 2|Physician Decision|0
2094938|NCT00790842|3683897|FG009|Dose Level 2|Physician Decision|0
2094939|NCT00790842|3683898|FG010|Dose Level 2|Physician Decision|0
2094940|NCT00790842|3683888|FG000|Dose Level 2|Withdrawal by Subject|0
2094941|NCT00790842|3683889|FG001|Dose Level 2|Withdrawal by Subject|1
2094942|NCT00790842|3683890|FG002|Dose Level 2|Withdrawal by Subject|0
2094943|NCT00790842|3683891|FG003|Dose Level 2|Withdrawal by Subject|0
2094944|NCT00790842|3683892|FG004|Dose Level 2|Withdrawal by Subject|0
2094945|NCT00790842|3683893|FG005|Dose Level 2|Withdrawal by Subject|0
2094946|NCT00790842|3683894|FG006|Dose Level 2|Withdrawal by Subject|0
2094947|NCT00790842|3683895|FG007|Dose Level 2|Withdrawal by Subject|0
2094948|NCT00790842|3683896|FG008|Dose Level 2|Withdrawal by Subject|0
2094949|NCT00790842|3683897|FG009|Dose Level 2|Withdrawal by Subject|0
2094950|NCT00790842|3683898|FG010|Dose Level 2|Withdrawal by Subject|0
2094951|NCT00790842|3683888|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0
2094952|NCT00790842|3683889|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0
2094953|NCT00790842|3683890|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0
2094954|NCT00790842|3683891|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0
2094955|NCT00790842|3683892|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0
2094956|NCT00790842|3683893|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0
2094957|NCT00790842|3683894|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0
2211953|NCT01665430|3852707|FG000|Overall Study|Adverse Event|1
2211954|NCT01665430|3852707|FG000|Overall Study|Withdrawal by Subject|6
2211955|NCT01665430|3852707|FG000|Overall Study|Other Unspecified|2
2211956|NCT01665599|3852720|FG000|Overall Study|Adverse Event|1
2211957|NCT01665599|3852720|FG000|Overall Study|Consent Withdrawn|1
2211958|NCT01665599|3852720|FG000|Overall Study|Investigator/Sponsor decision|1
2094958|NCT00790842|3683895|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0
2094959|NCT00790842|3683896|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2
2094960|NCT00790842|3683897|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0
2094961|NCT00790842|3683898|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0
2094962|NCT00790842|3683888|FG000|Dose Level 3|Adverse Event|0
2094963|NCT00790842|3683889|FG001|Dose Level 3|Adverse Event|0
2094964|NCT00790842|3683890|FG002|Dose Level 3|Adverse Event|1
2094965|NCT00790842|3683891|FG003|Dose Level 3|Adverse Event|0
2094966|NCT00790842|3683892|FG004|Dose Level 3|Adverse Event|0
2094967|NCT00790842|3683893|FG005|Dose Level 3|Adverse Event|0
2094968|NCT00790842|3683894|FG006|Dose Level 3|Adverse Event|0
2094969|NCT00790842|3683895|FG007|Dose Level 3|Adverse Event|0
2094970|NCT00790842|3683896|FG008|Dose Level 3|Adverse Event|0
2094971|NCT00790842|3683897|FG009|Dose Level 3|Adverse Event|0
2094972|NCT00790842|3683898|FG010|Dose Level 3|Adverse Event|0
2094973|NCT00790842|3683888|FG000|Dose Level 3|Withdrawal by Subject|0
2094974|NCT00790842|3683889|FG001|Dose Level 3|Withdrawal by Subject|0
2094975|NCT00790842|3683890|FG002|Dose Level 3|Withdrawal by Subject|3
2094976|NCT00790842|3683891|FG003|Dose Level 3|Withdrawal by Subject|0
2094977|NCT00790842|3683892|FG004|Dose Level 3|Withdrawal by Subject|0
2094978|NCT00790842|3683893|FG005|Dose Level 3|Withdrawal by Subject|0
2094979|NCT00790842|3683894|FG006|Dose Level 3|Withdrawal by Subject|0
2094980|NCT00790842|3683895|FG007|Dose Level 3|Withdrawal by Subject|0
2094981|NCT00790842|3683896|FG008|Dose Level 3|Withdrawal by Subject|0
2094982|NCT00790842|3683897|FG009|Dose Level 3|Withdrawal by Subject|2
2094983|NCT00790842|3683898|FG010|Dose Level 3|Withdrawal by Subject|0
2094984|NCT00790842|3683888|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2094985|NCT00790842|3683889|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2094986|NCT00790842|3683890|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2094987|NCT00790842|3683891|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2094988|NCT00790842|3683892|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2094989|NCT00790842|3683893|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
2094990|NCT00790842|3683894|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2094991|NCT00790842|3683895|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2094992|NCT00790842|3683896|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2094993|NCT00790842|3683897|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2094994|NCT00790842|3683898|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2094995|NCT00790842|3683888|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0
2094996|NCT00790842|3683889|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0
2094997|NCT00790842|3683890|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1
2094998|NCT00790842|3683891|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0
2094999|NCT00790842|3683892|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0
2095000|NCT00790842|3683893|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0
2095001|NCT00790842|3683894|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0
2095002|NCT00790842|3683895|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0
2095003|NCT00790842|3683896|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0
2095004|NCT00790842|3683897|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0
2095005|NCT00790842|3683898|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0
2095006|NCT00790842|3683888|FG000|Dose Level 4|Adverse Event|0
2095007|NCT00790842|3683889|FG001|Dose Level 4|Adverse Event|0
2095008|NCT00790842|3683890|FG002|Dose Level 4|Adverse Event|0
2095009|NCT00790842|3683891|FG003|Dose Level 4|Adverse Event|0
2095010|NCT00790842|3683892|FG004|Dose Level 4|Adverse Event|0
2095011|NCT00790842|3683893|FG005|Dose Level 4|Adverse Event|0
2095012|NCT00790842|3683894|FG006|Dose Level 4|Adverse Event|1
2095013|NCT00790842|3683895|FG007|Dose Level 4|Adverse Event|0
2095014|NCT00790842|3683896|FG008|Dose Level 4|Adverse Event|0
2095015|NCT00790842|3683897|FG009|Dose Level 4|Adverse Event|0
2095016|NCT00790842|3683898|FG010|Dose Level 4|Adverse Event|0
2095017|NCT00790842|3683888|FG000|Dose Level 4|Physician Decision|0
2095018|NCT00790842|3683889|FG001|Dose Level 4|Physician Decision|0
2095019|NCT00790842|3683890|FG002|Dose Level 4|Physician Decision|0
2095020|NCT00790842|3683891|FG003|Dose Level 4|Physician Decision|0
2211959|NCT01665599|3852720|FG000|Overall Study|Death|1
2211960|NCT01665599|3852720|FG000|Overall Study|Lost to Follow-up|2
2211961|NCT01665599|3852720|FG000|Overall Study|Participant Left for More Than 3 Months|1
2211962|NCT01665599|3852720|FG000|Overall Study|Could Not Continue Due to Time Constrain|1
2095021|NCT00790842|3683892|FG004|Dose Level 4|Physician Decision|0
2095022|NCT00790842|3683893|FG005|Dose Level 4|Physician Decision|0
2095023|NCT00790842|3683894|FG006|Dose Level 4|Physician Decision|1
2095024|NCT00790842|3683895|FG007|Dose Level 4|Physician Decision|0
2095025|NCT00790842|3683896|FG008|Dose Level 4|Physician Decision|0
2095026|NCT00790842|3683897|FG009|Dose Level 4|Physician Decision|0
2095027|NCT00790842|3683898|FG010|Dose Level 4|Physician Decision|1
2095028|NCT00790842|3683888|FG000|Dose Level 4|Withdrawal by Subject|0
2095029|NCT00790842|3683889|FG001|Dose Level 4|Withdrawal by Subject|0
2095030|NCT00790842|3683890|FG002|Dose Level 4|Withdrawal by Subject|0
2095031|NCT00790842|3683891|FG003|Dose Level 4|Withdrawal by Subject|0
2095032|NCT00790842|3683892|FG004|Dose Level 4|Withdrawal by Subject|0
2095033|NCT00790842|3683893|FG005|Dose Level 4|Withdrawal by Subject|0
2095034|NCT00790842|3683894|FG006|Dose Level 4|Withdrawal by Subject|0
2095035|NCT00790842|3683895|FG007|Dose Level 4|Withdrawal by Subject|0
2095036|NCT00790842|3683896|FG008|Dose Level 4|Withdrawal by Subject|0
2095037|NCT00790842|3683897|FG009|Dose Level 4|Withdrawal by Subject|0
2095038|NCT00790842|3683898|FG010|Dose Level 4|Withdrawal by Subject|1
2095039|NCT00790842|3683888|FG000|Expansion Cohort|Adverse Event|0
2095040|NCT00790842|3683889|FG001|Expansion Cohort|Adverse Event|0
2095041|NCT00790842|3683890|FG002|Expansion Cohort|Adverse Event|0
2095042|NCT00790842|3683891|FG003|Expansion Cohort|Adverse Event|0
2095043|NCT00790842|3683892|FG004|Expansion Cohort|Adverse Event|0
2095044|NCT00790842|3683893|FG005|Expansion Cohort|Adverse Event|0
2095045|NCT00790842|3683894|FG006|Expansion Cohort|Adverse Event|1
2095046|NCT00790842|3683895|FG007|Expansion Cohort|Adverse Event|0
2095047|NCT00790842|3683896|FG008|Expansion Cohort|Adverse Event|0
2095048|NCT00790842|3683897|FG009|Expansion Cohort|Adverse Event|0
2095049|NCT00790842|3683898|FG010|Expansion Cohort|Adverse Event|0
2095050|NCT00790842|3683888|FG000|Expansion Cohort|Death|0
2095051|NCT00790842|3683889|FG001|Expansion Cohort|Death|0
2095052|NCT00790842|3683890|FG002|Expansion Cohort|Death|2
2095053|NCT00790842|3683891|FG003|Expansion Cohort|Death|0
2095054|NCT00790842|3683892|FG004|Expansion Cohort|Death|0
2095055|NCT00790842|3683893|FG005|Expansion Cohort|Death|0
2095056|NCT00790842|3683894|FG006|Expansion Cohort|Death|0
2095057|NCT00790842|3683895|FG007|Expansion Cohort|Death|0
2095058|NCT00790842|3683896|FG008|Expansion Cohort|Death|0
2095059|NCT00790842|3683897|FG009|Expansion Cohort|Death|0
2095060|NCT00790842|3683898|FG010|Expansion Cohort|Death|0
2211963|NCT01665768|3852724|FG000|Overall Study|Adverse Event|3
2211964|NCT01665768|3852724|FG000|Overall Study|Lack of Efficacy|19
2211965|NCT01665768|3852724|FG000|Overall Study|Withdrawal by Subject|1
2211966|NCT01665807|3852731|FG000|Overall Study|Withdrawal by Subject|2
2211967|NCT01665807|3852732|FG001|Overall Study|Withdrawal by Subject|0
2095061|NCT00790842|3683888|FG000|Expansion Cohort|Physician Decision|0
2095062|NCT00790842|3683889|FG001|Expansion Cohort|Physician Decision|0
2095063|NCT00790842|3683890|FG002|Expansion Cohort|Physician Decision|1
2095064|NCT00790842|3683891|FG003|Expansion Cohort|Physician Decision|0
2211968|NCT01665807|3852733|FG002|Overall Study|Withdrawal by Subject|1
2095065|NCT00790842|3683892|FG004|Expansion Cohort|Physician Decision|0
2095066|NCT00790842|3683893|FG005|Expansion Cohort|Physician Decision|0
2095067|NCT00790842|3683894|FG006|Expansion Cohort|Physician Decision|0
2095068|NCT00790842|3683895|FG007|Expansion Cohort|Physician Decision|0
2095069|NCT00790842|3683896|FG008|Expansion Cohort|Physician Decision|0
2095070|NCT00790842|3683897|FG009|Expansion Cohort|Physician Decision|0
2095071|NCT00790842|3683898|FG010|Expansion Cohort|Physician Decision|0
2095072|NCT00790842|3683888|FG000|Expansion Cohort|Withdrawal by Subject|0
2095073|NCT00790842|3683889|FG001|Expansion Cohort|Withdrawal by Subject|0
2095074|NCT00790842|3683890|FG002|Expansion Cohort|Withdrawal by Subject|3
2095075|NCT00790842|3683891|FG003|Expansion Cohort|Withdrawal by Subject|0
2095076|NCT00790842|3683892|FG004|Expansion Cohort|Withdrawal by Subject|0
2095077|NCT00790842|3683893|FG005|Expansion Cohort|Withdrawal by Subject|0
2095078|NCT00790842|3683894|FG006|Expansion Cohort|Withdrawal by Subject|0
2095079|NCT00790842|3683895|FG007|Expansion Cohort|Withdrawal by Subject|0
2095080|NCT00790842|3683896|FG008|Expansion Cohort|Withdrawal by Subject|0
2095081|NCT00790842|3683897|FG009|Expansion Cohort|Withdrawal by Subject|0
2095082|NCT00790842|3683898|FG010|Expansion Cohort|Withdrawal by Subject|0
2095083|NCT00790842|3683888|FG000|Expansion Cohort|Study Closure|0
2095084|NCT00790842|3683889|FG001|Expansion Cohort|Study Closure|0
2095085|NCT00790842|3683890|FG002|Expansion Cohort|Study Closure|1
2095086|NCT00790842|3683891|FG003|Expansion Cohort|Study Closure|0
2095087|NCT00790842|3683892|FG004|Expansion Cohort|Study Closure|0
2095088|NCT00790842|3683893|FG005|Expansion Cohort|Study Closure|0
2095089|NCT00790842|3683894|FG006|Expansion Cohort|Study Closure|0
2095090|NCT00790842|3683895|FG007|Expansion Cohort|Study Closure|0
2095091|NCT00790842|3683896|FG008|Expansion Cohort|Study Closure|0
2095092|NCT00790842|3683897|FG009|Expansion Cohort|Study Closure|0
2095093|NCT00790842|3683898|FG010|Expansion Cohort|Study Closure|0
2095094|NCT00790868|3683953|FG000|Overall Study|Withdrawal by Subject|4
2095095|NCT00790868|3683954|FG001|Overall Study|Withdrawal by Subject|5
2095096|NCT00790868|3683953|FG000|Overall Study|Lost to Follow-up|2
2095097|NCT00790868|3683954|FG001|Overall Study|Lost to Follow-up|12
2095098|NCT00790907|3683965|FG000|Overall Study|Adverse Event|9
2095099|NCT00790907|3683966|FG001|Overall Study|Adverse Event|7
2095100|NCT00790907|3683967|FG002|Overall Study|Adverse Event|6
2095101|NCT00790907|3683965|FG000|Overall Study|Physician Decision|304
2095102|NCT00790907|3683966|FG001|Overall Study|Physician Decision|271
2095103|NCT00790907|3683967|FG002|Overall Study|Physician Decision|255
2095104|NCT00790907|3683965|FG000|Overall Study|Withdrawal by Subject|1
2095105|NCT00790907|3683966|FG001|Overall Study|Withdrawal by Subject|7
2095106|NCT00790907|3683967|FG002|Overall Study|Withdrawal by Subject|5
2095107|NCT00790907|3683965|FG000|Overall Study|Bleeding Event|11
2095108|NCT00790907|3683966|FG001|Overall Study|Bleeding Event|16
2211969|NCT01665911|3852750|FG000|Overall Study|Protocol Violation|4
2211970|NCT01665911|3852750|FG000|Overall Study|Withdrawal by Subject|1
2211971|NCT01665911|3852750|FG000|Overall Study|Adverse Event|1
2211972|NCT01666002|3852770|FG000|Overall Study|Lost to Follow-up|5
2211973|NCT01666002|3852771|FG001|Overall Study|Lost to Follow-up|0
2211974|NCT01666119|3852778|FG000|Overall Study|Adverse Event|6
2211975|NCT01666119|3852778|FG000|Overall Study|Withdrawal by Subject|16
2211976|NCT01666119|3852778|FG000|Overall Study|Lost to Follow-up|7
2211977|NCT01666119|3852778|FG000|Overall Study|non compliance with study medication, pa|18
2211978|NCT01666119|3852778|FG000|Overall Study|Subject experiencing withdrawal symptoms|5
2211979|NCT01666314|3852812|FG000|Overall Study|Adverse Event|3
2211980|NCT01666314|3852813|FG001|Overall Study|Adverse Event|13
2211981|NCT01666314|3852814|FG002|Overall Study|Adverse Event|7
2211982|NCT01666314|3852815|FG003|Overall Study|Adverse Event|7
2211983|NCT01666314|3852812|FG000|Overall Study|Progressive Disease|11
2211984|NCT01666314|3852813|FG001|Overall Study|Progressive Disease|9
2211985|NCT01666314|3852814|FG002|Overall Study|Progressive Disease|19
2211986|NCT01666314|3852815|FG003|Overall Study|Progressive Disease|20
2211987|NCT01666314|3852812|FG000|Overall Study|Symptomatic Deterioration|1
2211988|NCT01666314|3852813|FG001|Overall Study|Symptomatic Deterioration|0
2211989|NCT01666314|3852814|FG002|Overall Study|Symptomatic Deterioration|2
2211990|NCT01666314|3852815|FG003|Overall Study|Symptomatic Deterioration|0
2211991|NCT01666314|3852812|FG000|Overall Study|Unsatisfactory Therapeutic Response|7
2211992|NCT01666314|3852813|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
2211993|NCT01666314|3852814|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
2211994|NCT01666314|3852815|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
2211995|NCT01666314|3852812|FG000|Overall Study|Withdrawal by Subject|1
2211996|NCT01666314|3852813|FG001|Overall Study|Withdrawal by Subject|1
2211997|NCT01666314|3852814|FG002|Overall Study|Withdrawal by Subject|2
2211998|NCT01666314|3852815|FG003|Overall Study|Withdrawal by Subject|3
2211999|NCT01666314|3852812|FG000|Overall Study|Reason not Specified|10
2212000|NCT01666314|3852813|FG001|Overall Study|Reason not Specified|7
2212001|NCT01666314|3852814|FG002|Overall Study|Reason not Specified|5
2212002|NCT01666314|3852815|FG003|Overall Study|Reason not Specified|5
2212003|NCT01666444|3852838|FG000|Overall Study|Did not initiate treatment|2
2212004|NCT01666444|3852839|FG001|Overall Study|Did not initiate treatment|1
2212005|NCT01666652|3852850|FG000|Overall Study|Serious Adverse Event|0
2212006|NCT01666652|3852851|FG001|Overall Study|Serious Adverse Event|0
2095109|NCT00790907|3683967|FG002|Overall Study|Bleeding Event|21
2095110|NCT00790907|3683965|FG000|Overall Study|Required Protocol-prohibited Therapy|17
2095111|NCT00790907|3683966|FG001|Overall Study|Required Protocol-prohibited Therapy|5
2212007|NCT01666652|3852852|FG002|Overall Study|Serious Adverse Event|0
2212008|NCT01666652|3852853|FG003|Overall Study|Serious Adverse Event|1
2212009|NCT01666652|3852854|FG004|Overall Study|Serious Adverse Event|0
2212010|NCT01666652|3852850|FG000|Overall Study|Withdrawal by Subject|0
2212011|NCT01666652|3852851|FG001|Overall Study|Withdrawal by Subject|0
2212012|NCT01666652|3852852|FG002|Overall Study|Withdrawal by Subject|0
2212013|NCT01666652|3852853|FG003|Overall Study|Withdrawal by Subject|0
2095112|NCT00790907|3683967|FG002|Overall Study|Required Protocol-prohibited Therapy|7
2095113|NCT00790907|3683965|FG000|Overall Study|Qualifying Condition Not Present|29
2095114|NCT00790907|3683966|FG001|Overall Study|Qualifying Condition Not Present|14
2095115|NCT00790907|3683967|FG002|Overall Study|Qualifying Condition Not Present|16
2095116|NCT00790907|3683965|FG000|Overall Study|Verbatim Reason on the Case Report Form|74
2095117|NCT00790907|3683966|FG001|Overall Study|Verbatim Reason on the Case Report Form|20
2095118|NCT00790907|3683967|FG002|Overall Study|Verbatim Reason on the Case Report Form|29
2095119|NCT00790907|3683965|FG000|Overall Study|Did Not Receive Study Drug|10
2095120|NCT00790907|3683966|FG001|Overall Study|Did Not Receive Study Drug|0
2095121|NCT00790907|3683967|FG002|Overall Study|Did Not Receive Study Drug|0
2095122|NCT00790933|3683979|FG000|Overall Study|Adverse Event|94
2095123|NCT00790933|3683980|FG001|Overall Study|Adverse Event|119
2095124|NCT00790933|3683981|FG002|Overall Study|Adverse Event|65
2095125|NCT00790933|3683982|FG003|Overall Study|Adverse Event|5
2095126|NCT00790933|3683983|FG004|Overall Study|Adverse Event|69
2095127|NCT00790933|3683979|FG000|Overall Study|Protocol Violation(s)|8
2095128|NCT00790933|3683980|FG001|Overall Study|Protocol Violation(s)|18
2095129|NCT00790933|3683981|FG002|Overall Study|Protocol Violation(s)|7
2095130|NCT00790933|3683982|FG003|Overall Study|Protocol Violation(s)|0
2095131|NCT00790933|3683983|FG004|Overall Study|Protocol Violation(s)|12
2095132|NCT00790933|3683979|FG000|Overall Study|Lack of Efficacy|192
2095133|NCT00790933|3683980|FG001|Overall Study|Lack of Efficacy|176
2095134|NCT00790933|3683981|FG002|Overall Study|Lack of Efficacy|130
2095135|NCT00790933|3683982|FG003|Overall Study|Lack of Efficacy|1
2095136|NCT00790933|3683983|FG004|Overall Study|Lack of Efficacy|121
2095137|NCT00790933|3683979|FG000|Overall Study|Study Terminated by Sponsor|0
2095138|NCT00790933|3683980|FG001|Overall Study|Study Terminated by Sponsor|0
2095139|NCT00790933|3683981|FG002|Overall Study|Study Terminated by Sponsor|1
2095140|NCT00790933|3683982|FG003|Overall Study|Study Terminated by Sponsor|0
2095141|NCT00790933|3683983|FG004|Overall Study|Study Terminated by Sponsor|0
2095142|NCT00790933|3683979|FG000|Overall Study|Withdrawal by Subject|123
2095143|NCT00790933|3683980|FG001|Overall Study|Withdrawal by Subject|120
2095144|NCT00790933|3683981|FG002|Overall Study|Withdrawal by Subject|52
2095145|NCT00790933|3683982|FG003|Overall Study|Withdrawal by Subject|6
2095146|NCT00790933|3683983|FG004|Overall Study|Withdrawal by Subject|50
2095147|NCT00790933|3683979|FG000|Overall Study|Lost to Follow-up|13
2095148|NCT00790933|3683980|FG001|Overall Study|Lost to Follow-up|31
2095149|NCT00790933|3683981|FG002|Overall Study|Lost to Follow-up|10
2095150|NCT00790933|3683982|FG003|Overall Study|Lost to Follow-up|1
2095151|NCT00790933|3683983|FG004|Overall Study|Lost to Follow-up|15
2095152|NCT00790933|3683979|FG000|Overall Study|Reason Not Specified|8
2095153|NCT00790933|3683980|FG001|Overall Study|Reason Not Specified|16
2095154|NCT00790933|3683981|FG002|Overall Study|Reason Not Specified|4
2095155|NCT00790933|3683982|FG003|Overall Study|Reason Not Specified|1
2095156|NCT00790933|3683983|FG004|Overall Study|Reason Not Specified|9
2095157|NCT00791128|3684021|FG000|Overall Study|Adverse Event|4
2095158|NCT00791128|3684021|FG000|Overall Study|Device migration|2
2095159|NCT00791128|3684021|FG000|Overall Study|non-compliance by subject|2
2095160|NCT00791128|3684021|FG000|Overall Study|abdominal tumor, unrelated to device|1
2095161|NCT00791258|3684038|FG000|Overall Study|Adverse Event|87
2095162|NCT00791258|3684038|FG000|Overall Study|Lost to Follow-up|18
2095163|NCT00791258|3684038|FG000|Overall Study|Protocol Violation|109
2095164|NCT00791258|3684038|FG000|Overall Study|Withdrawal by Subject|40
2095165|NCT00791258|3684038|FG000|Overall Study|Did not take medication for >3 days|1
2095166|NCT00791258|3684038|FG000|Overall Study|subject left area|2
2095167|NCT00791258|3684038|FG000|Overall Study|non-compliance|3
2095168|NCT00791258|3684038|FG000|Overall Study|Subject incarcerated|1
2095169|NCT00791258|3684038|FG000|Overall Study|Subject required restricted medication|1
2095170|NCT00791258|3684038|FG000|Overall Study|Lack of Efficacy|1
2095171|NCT00791388|3684056|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
2095172|NCT00791388|3684057|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
2095173|NCT00791388|3684058|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
2095174|NCT00791388|3684059|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
2095175|NCT00791388|3684060|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
2095176|NCT00791388|3684056|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
2095177|NCT00791388|3684057|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
2095178|NCT00791388|3684058|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
2095179|NCT00791388|3684059|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
2095180|NCT00791388|3684060|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
2095181|NCT00791388|3684056|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0
2095182|NCT00791388|3684057|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0
2095183|NCT00791388|3684058|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0
2095184|NCT00791388|3684059|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0
2095185|NCT00791388|3684060|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4
2095186|NCT00791479|3684078|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0
2095187|NCT00791479|3684079|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0
2095188|NCT00791479|3684080|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0
2095189|NCT00791479|3684081|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0
2095190|NCT00791479|3684082|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3
2095191|NCT00791479|3684083|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0
2095192|NCT00791479|3684078|FG000|Overall Study|Adverse Event|0
2095193|NCT00791479|3684079|FG001|Overall Study|Adverse Event|1
2095194|NCT00791479|3684080|FG002|Overall Study|Adverse Event|0
2095195|NCT00791479|3684081|FG003|Overall Study|Adverse Event|2
2095196|NCT00791479|3684082|FG004|Overall Study|Adverse Event|0
2095197|NCT00791479|3684083|FG005|Overall Study|Adverse Event|1
2095198|NCT00791479|3684078|FG000|Overall Study|Lost to Follow-up|0
2095199|NCT00791479|3684079|FG001|Overall Study|Lost to Follow-up|1
2095200|NCT00791479|3684080|FG002|Overall Study|Lost to Follow-up|0
2095201|NCT00791479|3684081|FG003|Overall Study|Lost to Follow-up|0
2095202|NCT00791479|3684082|FG004|Overall Study|Lost to Follow-up|0
2095203|NCT00791479|3684083|FG005|Overall Study|Lost to Follow-up|1
2095204|NCT00791479|3684078|FG000|Overall Study|Protocol Violation|2
2095205|NCT00791479|3684079|FG001|Overall Study|Protocol Violation|1
2095206|NCT00791479|3684080|FG002|Overall Study|Protocol Violation|0
2095207|NCT00791479|3684081|FG003|Overall Study|Protocol Violation|1
2095208|NCT00791479|3684082|FG004|Overall Study|Protocol Violation|0
2095209|NCT00791479|3684083|FG005|Overall Study|Protocol Violation|0
2095210|NCT00791479|3684078|FG000|Overall Study|Withdrawal by Subject|0
2095211|NCT00791479|3684079|FG001|Overall Study|Withdrawal by Subject|0
2095212|NCT00791479|3684080|FG002|Overall Study|Withdrawal by Subject|0
2212014|NCT01666652|3852854|FG004|Overall Study|Withdrawal by Subject|1
2212015|NCT01666652|3852850|FG000|Overall Study|Moved from study area|1
2212016|NCT01666652|3852851|FG001|Overall Study|Moved from study area|0
2212017|NCT01666652|3852852|FG002|Overall Study|Moved from study area|0
2212018|NCT01666652|3852853|FG003|Overall Study|Moved from study area|2
2212019|NCT01666652|3852854|FG004|Overall Study|Moved from study area|0
2212020|NCT01666652|3852850|FG000|Overall Study|Lost to Follow-up|1
2212021|NCT01666652|3852851|FG001|Overall Study|Lost to Follow-up|1
2212022|NCT01666652|3852852|FG002|Overall Study|Lost to Follow-up|1
2212023|NCT01666652|3852853|FG003|Overall Study|Lost to Follow-up|1
2212024|NCT01666652|3852854|FG004|Overall Study|Lost to Follow-up|0
2095213|NCT00791479|3684081|FG003|Overall Study|Withdrawal by Subject|1
2095214|NCT00791479|3684082|FG004|Overall Study|Withdrawal by Subject|0
2095215|NCT00791479|3684083|FG005|Overall Study|Withdrawal by Subject|1
2095216|NCT00791492|3684106|FG000|Overall Study|Withdrawal by Subject|1
2095217|NCT00791492|3684107|FG001|Overall Study|Withdrawal by Subject|2
2095218|NCT00791492|3684106|FG000|Overall Study|Liver transplantation|5
2095219|NCT00791492|3684107|FG001|Overall Study|Liver transplantation|1
2095220|NCT00791518|3684113|FG000|Overall Study|Protocol Violation|93
2095221|NCT00791557|3684132|FG000|Overall Study|Adverse Event|1
2095222|NCT00791648|3684138|FG000|Overall Study|Physician Decision|0
2095223|NCT00791648|3684139|FG001|Overall Study|Physician Decision|1
2095224|NCT00791648|3684138|FG000|Overall Study|Withdrawal by Subject|0
2095225|NCT00791648|3684139|FG001|Overall Study|Withdrawal by Subject|1
2095226|NCT00791661|3684148|FG000|7 Day Wash-out|Adverse Event|0
2095227|NCT00791661|3684149|FG001|7 Day Wash-out|Adverse Event|0
2095228|NCT00791661|3684150|FG002|7 Day Wash-out|Adverse Event|1
2095229|NCT00791661|3684148|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
2095230|NCT00791661|3684149|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
2095231|NCT00791661|3684150|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
2095232|NCT00791700|3684178|FG000|Overall Study|Insufficient clinical response|1
2095233|NCT00791700|3684179|FG001|Overall Study|Insufficient clinical response|4
2095234|NCT00791700|3684180|FG002|Overall Study|Insufficient clinical response|1
2095235|NCT00791700|3684181|FG003|Overall Study|Insufficient clinical response|8
2095236|NCT00791700|3684178|FG000|Overall Study|No longer willing to participate|1
2095237|NCT00791700|3684179|FG001|Overall Study|No longer willing to participate|1
2095238|NCT00791700|3684180|FG002|Overall Study|No longer willing to participate|0
2095239|NCT00791700|3684181|FG003|Overall Study|No longer willing to participate|8
2095240|NCT00791700|3684178|FG000|Overall Study|Non-compliance with study treatment|0
2095241|NCT00791700|3684179|FG001|Overall Study|Non-compliance with study treatment|2
2095242|NCT00791700|3684180|FG002|Overall Study|Non-compliance with study treatment|0
2095243|NCT00791700|3684181|FG003|Overall Study|Non-compliance with study treatment|4
2095244|NCT00791700|3684178|FG000|Overall Study|Withdrawn due to pregnancy|0
2095245|NCT00791700|3684179|FG001|Overall Study|Withdrawn due to pregnancy|0
2095246|NCT00791700|3684180|FG002|Overall Study|Withdrawn due to pregnancy|0
2095247|NCT00791700|3684181|FG003|Overall Study|Withdrawn due to pregnancy|1
2095248|NCT00791700|3684178|FG000|Overall Study|Other|0
2095249|NCT00791700|3684179|FG001|Overall Study|Other|1
2095250|NCT00791700|3684180|FG002|Overall Study|Other|0
2095251|NCT00791700|3684181|FG003|Overall Study|Other|1
2095252|NCT00791700|3684178|FG000|Overall Study|Death|0
2095253|NCT00791700|3684179|FG001|Overall Study|Death|0
2095254|NCT00791700|3684180|FG002|Overall Study|Death|0
2095255|NCT00791700|3684181|FG003|Overall Study|Death|1
2095256|NCT00791700|3684178|FG000|Overall Study|Lost to Follow-up|4
2095257|NCT00791700|3684179|FG001|Overall Study|Lost to Follow-up|3
2095258|NCT00791700|3684180|FG002|Overall Study|Lost to Follow-up|4
2095259|NCT00791700|3684181|FG003|Overall Study|Lost to Follow-up|6
2212025|NCT01666730|3852866|FG000|Overall Study|Adverse Event|16
2212026|NCT01666730|3852866|FG000|Overall Study|Death|2
2095260|NCT00791700|3684178|FG000|Overall Study|Adverse Event|0
2095261|NCT00791700|3684179|FG001|Overall Study|Adverse Event|0
2095262|NCT00791700|3684180|FG002|Overall Study|Adverse Event|1
2095263|NCT00791700|3684181|FG003|Overall Study|Adverse Event|1
2095264|NCT00791765|3684204|FG000|Weeks 1 to 12|Adverse Event|0
2095265|NCT00791765|3684205|FG001|Weeks 1 to 12|Adverse Event|1
2095266|NCT00791765|3684204|FG000|Weeks 1 to 12|Lost to Follow-up|1
2095267|NCT00791765|3684205|FG001|Weeks 1 to 12|Lost to Follow-up|0
2095268|NCT00791765|3684204|FG000|Weeks 1 to 12|Withdrawal by Subject|3
2095269|NCT00791765|3684205|FG001|Weeks 1 to 12|Withdrawal by Subject|0
2095270|NCT00791765|3684204|FG000|Weeks 1 to 12|Physician Decision|1
2095271|NCT00791765|3684205|FG001|Weeks 1 to 12|Physician Decision|0
2095272|NCT00791765|3684204|FG000|Weeks 1 to 12|Disease progression|3
2095273|NCT00791765|3684205|FG001|Weeks 1 to 12|Disease progression|0
2095274|NCT00791765|3684204|FG000|Weeks 1 to 12|Ineligibility determined|0
2095275|NCT00791765|3684205|FG001|Weeks 1 to 12|Ineligibility determined|3
2095276|NCT00791765|3684204|FG000|Weeks 13 to 24|Protocol deviation|2
2095277|NCT00791765|3684205|FG001|Weeks 13 to 24|Protocol deviation|0
2095278|NCT00791765|3684204|FG000|Weeks 13 to 24|Adverse Event|0
2095279|NCT00791765|3684205|FG001|Weeks 13 to 24|Adverse Event|3
2095280|NCT00791765|3684204|FG000|Weeks 13 to 24|Withdrawal by Subject|2
2095281|NCT00791765|3684205|FG001|Weeks 13 to 24|Withdrawal by Subject|1
2095282|NCT00791765|3684204|FG000|Weeks 13 to 24|Disease progression|0
2095283|NCT00791765|3684205|FG001|Weeks 13 to 24|Disease progression|1
2095284|NCT00791765|3684204|FG000|Weeks 13 to 24|Lost to Follow-up|1
2095285|NCT00791765|3684205|FG001|Weeks 13 to 24|Lost to Follow-up|2
2095286|NCT00791765|3684204|FG000|Weeks 13 to 24|Other|0
2095287|NCT00791765|3684205|FG001|Weeks 13 to 24|Other|1
2095288|NCT00791778|3684213|FG000|Double-blind Treatment|Adverse Event|49
2095289|NCT00791778|3684214|FG001|Double-blind Treatment|Adverse Event|9
2095290|NCT00791778|3684213|FG000|Double-blind Treatment|Physician Decision|6
2095291|NCT00791778|3684214|FG001|Double-blind Treatment|Physician Decision|26
2095292|NCT00791778|3684213|FG000|Double-blind Treatment|Protocol Violation|0
2095293|NCT00791778|3684214|FG001|Double-blind Treatment|Protocol Violation|4
2095294|NCT00791778|3684213|FG000|Double-blind Treatment|Withdrawal by Subject|20
2095295|NCT00791778|3684214|FG001|Double-blind Treatment|Withdrawal by Subject|9
2095296|NCT00791778|3684213|FG000|Double-blind Treatment|Non-compliant with study medication|2
2095297|NCT00791778|3684214|FG001|Double-blind Treatment|Non-compliant with study medication|0
2095298|NCT00791778|3684213|FG000|Follow-up|Withdrawal by Subject|3
2095299|NCT00791778|3684214|FG001|Follow-up|Withdrawal by Subject|0
2095300|NCT00791778|3684213|FG000|Follow-up|Lost to Follow-up|2
2095301|NCT00791778|3684214|FG001|Follow-up|Lost to Follow-up|1
2095302|NCT00791921|3684239|FG000|Overall Study|Protocol planed|24
2095303|NCT00791921|3684240|FG001|Overall Study|Protocol planed|88
2095304|NCT00791921|3684239|FG000|Overall Study|Withdrawal by Subject|1
2095305|NCT00791921|3684240|FG001|Overall Study|Withdrawal by Subject|2
2095306|NCT00791921|3684239|FG000|Overall Study|Adverse Event|8
2095307|NCT00791921|3684240|FG001|Overall Study|Adverse Event|2
2095308|NCT00791921|3684239|FG000|Overall Study|Lack of Efficacy|0
2095309|NCT00791921|3684240|FG001|Overall Study|Lack of Efficacy|2
2095310|NCT00791921|3684239|FG000|Overall Study|Lack of study drug administration|1
2095311|NCT00791921|3684240|FG001|Overall Study|Lack of study drug administration|1
2095312|NCT00791921|3684239|FG000|Overall Study|Reason other than those above|0
2095313|NCT00791921|3684240|FG001|Overall Study|Reason other than those above|1
2095314|NCT00791934|3684246|FG000|Overall Study|Withdrawal by Subject|2
2095315|NCT00791934|3684246|FG000|Overall Study|Did not consent for extended follow-up|13
2095316|NCT00791999|3684263|FG000|Overall Study|Protocol planed withdrawal|14
2095317|NCT00791999|3684264|FG001|Overall Study|Protocol planed withdrawal|11
2095318|NCT00791999|3684265|FG002|Overall Study|Protocol planed withdrawal|11
2095319|NCT00791999|3684266|FG003|Overall Study|Protocol planed withdrawal|45
2095320|NCT00791999|3684263|FG000|Overall Study|Withdrawal by Subject|0
2095321|NCT00791999|3684264|FG001|Overall Study|Withdrawal by Subject|1
2095322|NCT00791999|3684265|FG002|Overall Study|Withdrawal by Subject|0
2095323|NCT00791999|3684266|FG003|Overall Study|Withdrawal by Subject|2
2095324|NCT00791999|3684263|FG000|Overall Study|Protocol Violation|3
2095325|NCT00791999|3684264|FG001|Overall Study|Protocol Violation|0
2095326|NCT00791999|3684265|FG002|Overall Study|Protocol Violation|1
2095327|NCT00791999|3684266|FG003|Overall Study|Protocol Violation|0
2095328|NCT00791999|3684263|FG000|Overall Study|Adverse Event|3
2095329|NCT00791999|3684264|FG001|Overall Study|Adverse Event|3
2095330|NCT00791999|3684265|FG002|Overall Study|Adverse Event|7
2095331|NCT00791999|3684266|FG003|Overall Study|Adverse Event|3
2095332|NCT00791999|3684263|FG000|Overall Study|Lack of Efficacy|0
2095333|NCT00791999|3684264|FG001|Overall Study|Lack of Efficacy|1
2095334|NCT00791999|3684265|FG002|Overall Study|Lack of Efficacy|0
2095335|NCT00791999|3684266|FG003|Overall Study|Lack of Efficacy|2
2095336|NCT00791999|3684263|FG000|Overall Study|Reason other than those above|1
2095337|NCT00791999|3684264|FG001|Overall Study|Reason other than those above|0
2095338|NCT00791999|3684265|FG002|Overall Study|Reason other than those above|1
2095339|NCT00791999|3684266|FG003|Overall Study|Reason other than those above|0
2095340|NCT00792103|3684280|FG000|Overall Study|Enrolled, not treated|15
2095341|NCT00792103|3684280|FG000|Overall Study|Lost to Follow-up|17
2095342|NCT00792103|3684280|FG000|Overall Study|Adverse Event|25
2095343|NCT00792103|3684280|FG000|Overall Study|Withdrawal by Subject|52
2095344|NCT00792103|3684280|FG000|Overall Study|Protocol Violation|10
2095345|NCT00792103|3684280|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14
2095346|NCT00792298|3684288|FG000|Treatment Period 1|Adverse Event|0
2095347|NCT00792298|3684289|FG001|Treatment Period 1|Adverse Event|1
2095348|NCT00792298|3684290|FG002|Treatment Period 1|Adverse Event|0
2095349|NCT00792298|3684291|FG003|Treatment Period 1|Adverse Event|1
2095350|NCT00792298|3684292|FG004|Treatment Period 1|Adverse Event|0
2095351|NCT00792298|3684293|FG005|Treatment Period 1|Adverse Event|1
2095352|NCT00792298|3684294|FG006|Treatment Period 1|Adverse Event|1
2095353|NCT00792298|3684295|FG007|Treatment Period 1|Adverse Event|0
2095354|NCT00792298|3684288|FG000|Treatment Period 1|Lack of Efficacy|0
2095355|NCT00792298|3684289|FG001|Treatment Period 1|Lack of Efficacy|0
2095356|NCT00792298|3684290|FG002|Treatment Period 1|Lack of Efficacy|1
2095357|NCT00792298|3684291|FG003|Treatment Period 1|Lack of Efficacy|0
2095358|NCT00792298|3684292|FG004|Treatment Period 1|Lack of Efficacy|0
2095359|NCT00792298|3684293|FG005|Treatment Period 1|Lack of Efficacy|0
2095360|NCT00792298|3684294|FG006|Treatment Period 1|Lack of Efficacy|0
2095361|NCT00792298|3684295|FG007|Treatment Period 1|Lack of Efficacy|0
2095362|NCT00792298|3684288|FG000|Treatment Period 1|Withdrawal by Subject|1
2095363|NCT00792298|3684289|FG001|Treatment Period 1|Withdrawal by Subject|0
2095364|NCT00792298|3684290|FG002|Treatment Period 1|Withdrawal by Subject|1
2095365|NCT00792298|3684291|FG003|Treatment Period 1|Withdrawal by Subject|2
2095366|NCT00792298|3684292|FG004|Treatment Period 1|Withdrawal by Subject|0
2095367|NCT00792298|3684293|FG005|Treatment Period 1|Withdrawal by Subject|2
2095368|NCT00792298|3684294|FG006|Treatment Period 1|Withdrawal by Subject|1
2095369|NCT00792298|3684295|FG007|Treatment Period 1|Withdrawal by Subject|0
2095370|NCT00792298|3684288|FG000|Treatment Period 1|Lost to Follow-up|0
2095371|NCT00792298|3684289|FG001|Treatment Period 1|Lost to Follow-up|0
2095372|NCT00792298|3684290|FG002|Treatment Period 1|Lost to Follow-up|0
2095373|NCT00792298|3684291|FG003|Treatment Period 1|Lost to Follow-up|0
2095374|NCT00792298|3684292|FG004|Treatment Period 1|Lost to Follow-up|0
2095375|NCT00792298|3684293|FG005|Treatment Period 1|Lost to Follow-up|0
2095376|NCT00792298|3684294|FG006|Treatment Period 1|Lost to Follow-up|1
2095377|NCT00792298|3684295|FG007|Treatment Period 1|Lost to Follow-up|0
2095378|NCT00792298|3684288|FG000|Treatment Period 1|Physician Decision|0
2095379|NCT00792298|3684289|FG001|Treatment Period 1|Physician Decision|0
2095380|NCT00792298|3684290|FG002|Treatment Period 1|Physician Decision|0
2095381|NCT00792298|3684291|FG003|Treatment Period 1|Physician Decision|1
2095382|NCT00792298|3684292|FG004|Treatment Period 1|Physician Decision|0
2095383|NCT00792298|3684293|FG005|Treatment Period 1|Physician Decision|0
2095384|NCT00792298|3684294|FG006|Treatment Period 1|Physician Decision|1
2095385|NCT00792298|3684295|FG007|Treatment Period 1|Physician Decision|0
2095386|NCT00792298|3684288|FG000|Treatment Period 1|Protocol Violation|0
2095387|NCT00792298|3684289|FG001|Treatment Period 1|Protocol Violation|0
2095388|NCT00792298|3684290|FG002|Treatment Period 1|Protocol Violation|0
2095389|NCT00792298|3684291|FG003|Treatment Period 1|Protocol Violation|0
2095390|NCT00792298|3684292|FG004|Treatment Period 1|Protocol Violation|0
2095391|NCT00792298|3684293|FG005|Treatment Period 1|Protocol Violation|0
2095392|NCT00792298|3684294|FG006|Treatment Period 1|Protocol Violation|0
2095393|NCT00792298|3684295|FG007|Treatment Period 1|Protocol Violation|1
2095394|NCT00792298|3684288|FG000|Washout|Adverse Event|0
2095395|NCT00792298|3684289|FG001|Washout|Adverse Event|0
2095396|NCT00792298|3684290|FG002|Washout|Adverse Event|0
2095397|NCT00792298|3684291|FG003|Washout|Adverse Event|0
2095398|NCT00792298|3684292|FG004|Washout|Adverse Event|0
2095399|NCT00792298|3684293|FG005|Washout|Adverse Event|1
2095400|NCT00792298|3684294|FG006|Washout|Adverse Event|0
2095401|NCT00792298|3684295|FG007|Washout|Adverse Event|0
2095402|NCT00792298|3684288|FG000|Washout|Withdrawal by Subject|0
2095403|NCT00792298|3684289|FG001|Washout|Withdrawal by Subject|0
2095404|NCT00792298|3684290|FG002|Washout|Withdrawal by Subject|1
2095405|NCT00792298|3684291|FG003|Washout|Withdrawal by Subject|0
2095406|NCT00792298|3684292|FG004|Washout|Withdrawal by Subject|0
2095407|NCT00792298|3684293|FG005|Washout|Withdrawal by Subject|1
2095408|NCT00792298|3684294|FG006|Washout|Withdrawal by Subject|0
2095409|NCT00792298|3684295|FG007|Washout|Withdrawal by Subject|0
2095410|NCT00792298|3684288|FG000|Treatment Period 2|Lack of Efficacy|0
2095411|NCT00792298|3684289|FG001|Treatment Period 2|Lack of Efficacy|0
2095412|NCT00792298|3684290|FG002|Treatment Period 2|Lack of Efficacy|0
2095413|NCT00792298|3684291|FG003|Treatment Period 2|Lack of Efficacy|0
2212027|NCT01666730|3852866|FG000|Overall Study|Physician Decision|5
2212028|NCT01666730|3852866|FG000|Overall Study|Withdrawal by Subject|9
2212029|NCT01666730|3852866|FG000|Overall Study|Disease progression/relapse|18
2212030|NCT01666782|3852872|FG000|Overall Study|Received 2 doses of vaccine|0
2212031|NCT01666782|3852873|FG001|Overall Study|Received 2 doses of vaccine|1
2212032|NCT01666782|3852872|FG000|Overall Study|Enrolled both years; year 1 data used|4
2212033|NCT01666782|3852873|FG001|Overall Study|Enrolled both years; year 1 data used|0
2217519|NCT01708941|3860838|FG000|Overall Study|Ineligible|0
2217520|NCT01708941|3860839|FG001|Overall Study|Ineligible|0
2217521|NCT01708941|3860840|FG002|Overall Study|Ineligible|2
2095414|NCT00792298|3684292|FG004|Treatment Period 2|Lack of Efficacy|1
2095415|NCT00792298|3684293|FG005|Treatment Period 2|Lack of Efficacy|0
2217522|NCT01708941|3860841|FG003|Overall Study|Ineligible|0
2095416|NCT00792298|3684294|FG006|Treatment Period 2|Lack of Efficacy|0
2095417|NCT00792298|3684295|FG007|Treatment Period 2|Lack of Efficacy|0
2095418|NCT00792298|3684288|FG000|Treatment Period 2|Physician Decision|0
2095419|NCT00792298|3684289|FG001|Treatment Period 2|Physician Decision|0
2095420|NCT00792298|3684290|FG002|Treatment Period 2|Physician Decision|0
2095421|NCT00792298|3684291|FG003|Treatment Period 2|Physician Decision|0
2095422|NCT00792298|3684292|FG004|Treatment Period 2|Physician Decision|0
2095423|NCT00792298|3684293|FG005|Treatment Period 2|Physician Decision|0
2095424|NCT00792298|3684294|FG006|Treatment Period 2|Physician Decision|1
2095425|NCT00792298|3684295|FG007|Treatment Period 2|Physician Decision|0
2095426|NCT00792298|3684288|FG000|Treatment Period 2|Pregnancy|0
2095427|NCT00792298|3684289|FG001|Treatment Period 2|Pregnancy|0
2095428|NCT00792298|3684290|FG002|Treatment Period 2|Pregnancy|1
2095429|NCT00792298|3684291|FG003|Treatment Period 2|Pregnancy|0
2095430|NCT00792298|3684292|FG004|Treatment Period 2|Pregnancy|0
2095431|NCT00792298|3684293|FG005|Treatment Period 2|Pregnancy|0
2095432|NCT00792298|3684294|FG006|Treatment Period 2|Pregnancy|0
2095433|NCT00792298|3684295|FG007|Treatment Period 2|Pregnancy|0
2095434|NCT00792298|3684288|FG000|Treatment Period 2|Withdrawal by Subject|1
2095435|NCT00792298|3684289|FG001|Treatment Period 2|Withdrawal by Subject|1
2095436|NCT00792298|3684290|FG002|Treatment Period 2|Withdrawal by Subject|0
2095437|NCT00792298|3684291|FG003|Treatment Period 2|Withdrawal by Subject|2
2095438|NCT00792298|3684292|FG004|Treatment Period 2|Withdrawal by Subject|1
2095439|NCT00792298|3684293|FG005|Treatment Period 2|Withdrawal by Subject|0
2095440|NCT00792298|3684294|FG006|Treatment Period 2|Withdrawal by Subject|0
2095441|NCT00792298|3684295|FG007|Treatment Period 2|Withdrawal by Subject|2
2095442|NCT00792467|3684321|FG000|Overall Study|progression of disease|17
2095443|NCT00792467|3684321|FG000|Overall Study|Adverse Event|1
2095444|NCT00792467|3684321|FG000|Overall Study|patient request|1
2095445|NCT00792467|3684321|FG000|Overall Study|Lost to Follow-up|1
2095446|NCT00792467|3684321|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1
2095447|NCT00792467|3684321|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1
2095448|NCT00792571|3684326|FG000|Overall Study|Death|1
2095449|NCT00792571|3684326|FG000|Overall Study|Adverse Event|4
2095450|NCT00792571|3684326|FG000|Overall Study|Withdrawal by Subject|1
2095451|NCT00792571|3684326|FG000|Overall Study|Other|4
2095452|NCT00792623|3684334|FG000|Overall Study|Adverse Event|2
2095453|NCT00792623|3684334|FG000|Overall Study|Withdrawal by Subject|5
2095454|NCT00792636|3684342|FG000|Overall Study|Protocol Violation|17
2095455|NCT00792636|3684343|FG001|Overall Study|Protocol Violation|23
2095456|NCT00792636|3684344|FG002|Overall Study|Protocol Violation|20
2095457|NCT00792636|3684342|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19
2095458|NCT00792636|3684343|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20
2095459|NCT00792636|3684344|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20
2095460|NCT00792636|3684342|FG000|Overall Study|Lost to Follow-up|13
2095461|NCT00792636|3684343|FG001|Overall Study|Lost to Follow-up|19
2095462|NCT00792636|3684344|FG002|Overall Study|Lost to Follow-up|14
2095463|NCT00792636|3684342|FG000|Overall Study|Withdrew Consent|10
2095464|NCT00792636|3684343|FG001|Overall Study|Withdrew Consent|13
2095465|NCT00792636|3684344|FG002|Overall Study|Withdrew Consent|9
2095466|NCT00792636|3684342|FG000|Overall Study|Lack of Efficacy|3
2095467|NCT00792636|3684343|FG001|Overall Study|Lack of Efficacy|4
2095468|NCT00792636|3684344|FG002|Overall Study|Lack of Efficacy|13
2095469|NCT00792636|3684342|FG000|Overall Study|Adverse Event|4
2095470|NCT00792636|3684343|FG001|Overall Study|Adverse Event|2
2095471|NCT00792636|3684344|FG002|Overall Study|Adverse Event|3
2095472|NCT00792636|3684342|FG000|Overall Study|Investigator Discretion|2
2095473|NCT00792636|3684343|FG001|Overall Study|Investigator Discretion|0
2095474|NCT00792636|3684344|FG002|Overall Study|Investigator Discretion|2
2095475|NCT00792701|3684369|FG000|Overall Study|Adverse Event|0
2095476|NCT00792701|3684370|FG001|Overall Study|Adverse Event|22
2095477|NCT00792701|3684369|FG000|Overall Study|Ineligible|1
2095478|NCT00792701|3684370|FG001|Overall Study|Ineligible|3
2095479|NCT00792701|3684369|FG000|Overall Study|Withdrawal by Subject|1
2095480|NCT00792701|3684370|FG001|Overall Study|Withdrawal by Subject|19
2095481|NCT00792701|3684369|FG000|Overall Study|Not protocol specified|17
2095482|NCT00792701|3684370|FG001|Overall Study|Not protocol specified|0
2095483|NCT00792805|3684381|FG000|Overall Study|Adverse Event|12
2095484|NCT00792805|3684382|FG001|Overall Study|Adverse Event|10
2095485|NCT00792805|3684383|FG002|Overall Study|Adverse Event|10
2095486|NCT00792805|3684381|FG000|Overall Study|Subject withdrew consent|5
2095487|NCT00792805|3684382|FG001|Overall Study|Subject withdrew consent|6
2095488|NCT00792805|3684383|FG002|Overall Study|Subject withdrew consent|5
2095489|NCT00792805|3684381|FG000|Overall Study|Administrative problems|2
2095490|NCT00792805|3684382|FG001|Overall Study|Administrative problems|0
2095491|NCT00792805|3684383|FG002|Overall Study|Administrative problems|4
2095492|NCT00792805|3684381|FG000|Overall Study|Abnormal test procedure result(s)|1
2095493|NCT00792805|3684382|FG001|Overall Study|Abnormal test procedure result(s)|2
2095494|NCT00792805|3684383|FG002|Overall Study|Abnormal test procedure result(s)|0
2095495|NCT00792805|3684381|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2095496|NCT00792805|3684382|FG001|Overall Study|Unsatisfactory therapeutic effect|6
2095497|NCT00792805|3684383|FG002|Overall Study|Unsatisfactory therapeutic effect|6
2095498|NCT00792805|3684381|FG000|Overall Study|Lost to Follow-up|1
2095499|NCT00792805|3684382|FG001|Overall Study|Lost to Follow-up|1
2095500|NCT00792805|3684383|FG002|Overall Study|Lost to Follow-up|6
2095501|NCT00792805|3684381|FG000|Overall Study|Abnormal laboratory value(s)|0
2095502|NCT00792805|3684382|FG001|Overall Study|Abnormal laboratory value(s)|0
2212034|NCT01666951|3852890|FG000|Overall Study|Not dosed|1
2212035|NCT01666951|3852891|FG001|Overall Study|Not dosed|1
2212036|NCT01667107|3852906|FG000|Overall Study|Adverse Event|4
2212037|NCT01667107|3852907|FG001|Overall Study|Adverse Event|3
2212038|NCT01667107|3852906|FG000|Overall Study|Tolerability issues|0
2212039|NCT01667107|3852907|FG001|Overall Study|Tolerability issues|2
2212040|NCT01667107|3852906|FG000|Overall Study|Protocol Violation|0
2212041|NCT01667107|3852907|FG001|Overall Study|Protocol Violation|1
2212042|NCT01667107|3852906|FG000|Overall Study|Lack of Efficacy|0
2212043|NCT01667107|3852907|FG001|Overall Study|Lack of Efficacy|1
2212044|NCT01667224|3852915|FG000|Overall Study|Withdrawal by Subject|3
2212045|NCT01667224|3852916|FG001|Overall Study|Withdrawal by Subject|1
2212046|NCT01667224|3852915|FG000|Overall Study|Protocol Violation|1
2212047|NCT01667224|3852916|FG001|Overall Study|Protocol Violation|1
2212048|NCT01667419|3853010|FG000|Overall Study|Reason Not Specified|1
2212049|NCT01667419|3853011|FG001|Overall Study|Reason Not Specified|0
2095503|NCT00792805|3684383|FG002|Overall Study|Abnormal laboratory value(s)|1
2095504|NCT00792805|3684381|FG000|Overall Study|Protocol deviation|0
2095505|NCT00792805|3684382|FG001|Overall Study|Protocol deviation|1
2095506|NCT00792805|3684383|FG002|Overall Study|Protocol deviation|1
2095507|NCT00792909|3684394|FG000|Overall Study|Withdrawal by Subject|0
2095508|NCT00792909|3684395|FG001|Overall Study|Withdrawal by Subject|1
2095509|NCT00792909|3684396|FG002|Overall Study|Withdrawal by Subject|0
2095510|NCT00792935|3684428|FG000|Overall Study|Adverse Event|2
2095511|NCT00792935|3684429|FG001|Overall Study|Adverse Event|1
2095512|NCT00792935|3684428|FG000|Overall Study|Lost to Follow-up|0
2095513|NCT00792935|3684429|FG001|Overall Study|Lost to Follow-up|1
2095514|NCT00792935|3684428|FG000|Overall Study|Protocol Violation|2
2095515|NCT00792935|3684429|FG001|Overall Study|Protocol Violation|0
2095516|NCT00792935|3684428|FG000|Overall Study|Withdrawal by Subject|0
2095517|NCT00792935|3684429|FG001|Overall Study|Withdrawal by Subject|1
2095518|NCT00793104|3684435|FG000|Overall Study|Lost to Follow-up|1
2095519|NCT00793182|3684441|FG000|Overall Study|Adverse Event|0
2095520|NCT00793182|3684442|FG001|Overall Study|Adverse Event|1
2095521|NCT00793325|3684448|FG000|Overall Study|Protocol Violation|18
2095522|NCT00793325|3684448|FG000|Overall Study|Lost to Follow-up|1
2095523|NCT00793403|3684471|FG000|Overall Study|Other|73
2095524|NCT00793546|3684487|FG000|Overall Study|Death|3
2095525|NCT00793546|3684488|FG001|Overall Study|Death|0
2095526|NCT00793546|3684487|FG000|Overall Study|Lost to Follow-up|1
2095527|NCT00793546|3684488|FG001|Overall Study|Lost to Follow-up|0
2095528|NCT00793546|3684487|FG000|Overall Study|Withdrawal by Subject|1
2095529|NCT00793546|3684488|FG001|Overall Study|Withdrawal by Subject|1
2095530|NCT00793546|3684487|FG000|Overall Study|Study Terminated by Sponsor|8
2095531|NCT00793546|3684488|FG001|Overall Study|Study Terminated by Sponsor|27
2095532|NCT00793546|3684487|FG000|Overall Study|Other|1
2095533|NCT00793546|3684488|FG001|Overall Study|Other|0
2095534|NCT00793585|3684502|FG000|Overall Study|Adverse Event|1
2095535|NCT00793585|3684503|FG001|Overall Study|Adverse Event|1
2095536|NCT00793585|3684502|FG000|Overall Study|Protocol Violation|1
2095537|NCT00793585|3684503|FG001|Overall Study|Protocol Violation|2
2095538|NCT00793598|3684514|FG000|Overall Study|Patient Request|0
2095539|NCT00793598|3684515|FG001|Overall Study|Patient Request|1
2095540|NCT00793598|3684516|FG002|Overall Study|Patient Request|0
2095541|NCT00793598|3684517|FG003|Overall Study|Patient Request|0
2095542|NCT00793598|3684518|FG004|Overall Study|Patient Request|0
2095543|NCT00793598|3684519|FG005|Overall Study|Patient Request|0
2095544|NCT00793598|3684520|FG006|Overall Study|Patient Request|0
2095545|NCT00793598|3684521|FG007|Overall Study|Patient Request|0
2095546|NCT00793598|3684514|FG000|Overall Study|Protocol Violation|0
2095547|NCT00793598|3684515|FG001|Overall Study|Protocol Violation|0
2095548|NCT00793598|3684516|FG002|Overall Study|Protocol Violation|0
2095549|NCT00793598|3684517|FG003|Overall Study|Protocol Violation|0
2095550|NCT00793598|3684518|FG004|Overall Study|Protocol Violation|0
2095551|NCT00793598|3684519|FG005|Overall Study|Protocol Violation|0
2095552|NCT00793598|3684520|FG006|Overall Study|Protocol Violation|0
2095553|NCT00793598|3684521|FG007|Overall Study|Protocol Violation|1
2095554|NCT00793598|3684514|FG000|Overall Study|Subject not dosed|0
2095555|NCT00793598|3684515|FG001|Overall Study|Subject not dosed|0
2095556|NCT00793598|3684516|FG002|Overall Study|Subject not dosed|0
2095557|NCT00793598|3684517|FG003|Overall Study|Subject not dosed|0
2095558|NCT00793598|3684518|FG004|Overall Study|Subject not dosed|0
2095559|NCT00793598|3684519|FG005|Overall Study|Subject not dosed|1
2095560|NCT00793598|3684520|FG006|Overall Study|Subject not dosed|0
2095561|NCT00793598|3684521|FG007|Overall Study|Subject not dosed|0
2095562|NCT00793624|3684556|FG000|Overall Study|Adverse Event|18
2095563|NCT00793624|3684557|FG001|Overall Study|Adverse Event|16
2095564|NCT00793624|3684558|FG002|Overall Study|Adverse Event|15
2095565|NCT00793624|3684559|FG003|Overall Study|Adverse Event|20
2095566|NCT00793624|3684556|FG000|Overall Study|Lost to Follow-up|2
2212050|NCT01667419|3853012|FG002|Overall Study|Reason Not Specified|0
2212051|NCT01667419|3853013|FG003|Overall Study|Reason Not Specified|0
2095567|NCT00793624|3684557|FG001|Overall Study|Lost to Follow-up|2
2095568|NCT00793624|3684558|FG002|Overall Study|Lost to Follow-up|4
2095569|NCT00793624|3684559|FG003|Overall Study|Lost to Follow-up|0
2095570|NCT00793624|3684556|FG000|Overall Study|Withdrawal by Subject|20
2095571|NCT00793624|3684557|FG001|Overall Study|Withdrawal by Subject|9
2095572|NCT00793624|3684558|FG002|Overall Study|Withdrawal by Subject|11
2095573|NCT00793624|3684559|FG003|Overall Study|Withdrawal by Subject|14
2095574|NCT00793624|3684556|FG000|Overall Study|Lack of Efficacy|9
2095575|NCT00793624|3684557|FG001|Overall Study|Lack of Efficacy|2
2095576|NCT00793624|3684558|FG002|Overall Study|Lack of Efficacy|1
2095577|NCT00793624|3684559|FG003|Overall Study|Lack of Efficacy|3
2095578|NCT00793624|3684556|FG000|Overall Study|Non compliance with protocol|2
2095579|NCT00793624|3684557|FG001|Overall Study|Non compliance with protocol|3
2095580|NCT00793624|3684558|FG002|Overall Study|Non compliance with protocol|2
2095581|NCT00793624|3684559|FG003|Overall Study|Non compliance with protocol|3
2095582|NCT00793624|3684556|FG000|Overall Study|Other reason not described above|6
2095583|NCT00793624|3684557|FG001|Overall Study|Other reason not described above|4
2095584|NCT00793624|3684558|FG002|Overall Study|Other reason not described above|6
2095585|NCT00793624|3684559|FG003|Overall Study|Other reason not described above|3
2095586|NCT00793780|3684590|FG000|Overall Study|Withdrawal by Subject|2
2095587|NCT00793780|3684591|FG001|Overall Study|Withdrawal by Subject|1
2095588|NCT00793793|3684609|FG000|Overall Study|Adverse Event|0
2095589|NCT00793793|3684610|FG001|Overall Study|Adverse Event|0
2095590|NCT00793793|3684611|FG002|Overall Study|Adverse Event|1
2095591|NCT00793793|3684612|FG003|Overall Study|Adverse Event|1
2095592|NCT00793793|3684613|FG004|Overall Study|Adverse Event|0
2095593|NCT00793793|3684614|FG005|Overall Study|Adverse Event|1
2095594|NCT00793793|3684615|FG006|Overall Study|Adverse Event|2
2095595|NCT00793793|3684616|FG007|Overall Study|Adverse Event|0
2095596|NCT00793793|3684617|FG008|Overall Study|Adverse Event|0
2095597|NCT00793793|3684618|FG009|Overall Study|Adverse Event|0
2095598|NCT00793793|3684619|FG010|Overall Study|Adverse Event|0
2095599|NCT00793793|3684620|FG011|Overall Study|Adverse Event|2
2095600|NCT00793793|3684609|FG000|Overall Study|Protocol Violation|0
2095601|NCT00793793|3684610|FG001|Overall Study|Protocol Violation|0
2095602|NCT00793793|3684611|FG002|Overall Study|Protocol Violation|0
2095603|NCT00793793|3684612|FG003|Overall Study|Protocol Violation|1
2095604|NCT00793793|3684613|FG004|Overall Study|Protocol Violation|0
2095605|NCT00793793|3684614|FG005|Overall Study|Protocol Violation|0
2095606|NCT00793793|3684615|FG006|Overall Study|Protocol Violation|0
2095607|NCT00793793|3684616|FG007|Overall Study|Protocol Violation|0
2095608|NCT00793793|3684617|FG008|Overall Study|Protocol Violation|0
2095609|NCT00793793|3684618|FG009|Overall Study|Protocol Violation|0
2095610|NCT00793793|3684619|FG010|Overall Study|Protocol Violation|0
2095611|NCT00793793|3684620|FG011|Overall Study|Protocol Violation|0
2095612|NCT00793793|3684609|FG000|Overall Study|Lost to Follow-up|0
2095613|NCT00793793|3684610|FG001|Overall Study|Lost to Follow-up|0
2095614|NCT00793793|3684611|FG002|Overall Study|Lost to Follow-up|1
2095615|NCT00793793|3684612|FG003|Overall Study|Lost to Follow-up|0
2095616|NCT00793793|3684613|FG004|Overall Study|Lost to Follow-up|0
2095617|NCT00793793|3684614|FG005|Overall Study|Lost to Follow-up|0
2095618|NCT00793793|3684615|FG006|Overall Study|Lost to Follow-up|0
2095619|NCT00793793|3684616|FG007|Overall Study|Lost to Follow-up|0
2095620|NCT00793793|3684617|FG008|Overall Study|Lost to Follow-up|1
2095621|NCT00793793|3684618|FG009|Overall Study|Lost to Follow-up|3
2095622|NCT00793793|3684619|FG010|Overall Study|Lost to Follow-up|1
2095623|NCT00793793|3684620|FG011|Overall Study|Lost to Follow-up|0
2095624|NCT00793793|3684609|FG000|Overall Study|Withdrawal by Subject|0
2095625|NCT00793793|3684610|FG001|Overall Study|Withdrawal by Subject|0
2095626|NCT00793793|3684611|FG002|Overall Study|Withdrawal by Subject|0
2095627|NCT00793793|3684612|FG003|Overall Study|Withdrawal by Subject|0
2095628|NCT00793793|3684613|FG004|Overall Study|Withdrawal by Subject|1
2095629|NCT00793793|3684614|FG005|Overall Study|Withdrawal by Subject|0
2095630|NCT00793793|3684615|FG006|Overall Study|Withdrawal by Subject|0
2095631|NCT00793793|3684616|FG007|Overall Study|Withdrawal by Subject|0
2095632|NCT00793793|3684617|FG008|Overall Study|Withdrawal by Subject|1
2095633|NCT00793793|3684618|FG009|Overall Study|Withdrawal by Subject|0
2095634|NCT00793793|3684619|FG010|Overall Study|Withdrawal by Subject|0
2095635|NCT00793793|3684620|FG011|Overall Study|Withdrawal by Subject|0
2095636|NCT00793793|3684609|FG000|Overall Study|reason not specified|0
2095637|NCT00793793|3684610|FG001|Overall Study|reason not specified|1
2095638|NCT00793793|3684611|FG002|Overall Study|reason not specified|0
2095639|NCT00793793|3684612|FG003|Overall Study|reason not specified|1
2095640|NCT00793793|3684613|FG004|Overall Study|reason not specified|1
2095641|NCT00793793|3684614|FG005|Overall Study|reason not specified|1
2212052|NCT01667419|3853010|FG000|Overall Study|Withdrawal by Subject|16
2212053|NCT01667419|3853011|FG001|Overall Study|Withdrawal by Subject|8
2095642|NCT00793793|3684615|FG006|Overall Study|reason not specified|2
2095643|NCT00793793|3684616|FG007|Overall Study|reason not specified|0
2095644|NCT00793793|3684617|FG008|Overall Study|reason not specified|7
2095645|NCT00793793|3684618|FG009|Overall Study|reason not specified|6
2095646|NCT00793793|3684619|FG010|Overall Study|reason not specified|2
2095647|NCT00793793|3684620|FG011|Overall Study|reason not specified|4
2095648|NCT00793819|3684668|FG000|Overall Study|Adverse Event|8
2095649|NCT00793819|3684669|FG001|Overall Study|Adverse Event|4
2095650|NCT00793819|3684668|FG000|Overall Study|Lack of Efficacy|1
2095651|NCT00793819|3684669|FG001|Overall Study|Lack of Efficacy|1
2095652|NCT00793819|3684668|FG000|Overall Study|Withdrawal by Subject|4
2095653|NCT00793819|3684669|FG001|Overall Study|Withdrawal by Subject|3
2095654|NCT00793819|3684668|FG000|Overall Study|Lost to Follow-up|1
2095655|NCT00793819|3684669|FG001|Overall Study|Lost to Follow-up|1
2095656|NCT00793871|3684675|FG000|Overall Study|Death|50
2095657|NCT00793871|3684675|FG000|Overall Study|Lost to Follow-up|3
2095658|NCT00793871|3684675|FG000|Overall Study|Study terminated by the Sponsor|7
2095659|NCT00793910|3684681|FG000|Overall Study|discarded study pills|0
2095660|NCT00793910|3684682|FG001|Overall Study|discarded study pills|1
2095661|NCT00793910|3684681|FG000|Overall Study|did not pick up medications|1
2095662|NCT00793910|3684682|FG001|Overall Study|did not pick up medications|1
2095663|NCT00793910|3684681|FG000|Overall Study|ineligible based on entry criteria|2
2095664|NCT00793910|3684682|FG001|Overall Study|ineligible based on entry criteria|3
2095665|NCT00793910|3684681|FG000|Overall Study|decided to undergo LASIK instead of PRK|2
2095666|NCT00793910|3684682|FG001|Overall Study|decided to undergo LASIK instead of PRK|1
2095667|NCT00793910|3684681|FG000|Overall Study|Withdrawal by Subject|0
2095668|NCT00793910|3684682|FG001|Overall Study|Withdrawal by Subject|1
2095669|NCT00794040|3684690|FG000|Overall Study|Withdrawal by Subject|3
2095670|NCT00794040|3684691|FG001|Overall Study|Withdrawal by Subject|4
2095671|NCT00794040|3684690|FG000|Overall Study|Physician Decision|0
2095672|NCT00794040|3684691|FG001|Overall Study|Physician Decision|1
2095673|NCT00794118|3684697|FG000|Overall Study|Lost to Follow-up|16
2095674|NCT00794118|3684697|FG000|Overall Study|Withdrawal by Subject|9
2095675|NCT00794118|3684697|FG000|Overall Study|Changed hospital center|2
2095676|NCT00794157|3684713|FG000|Overall Study|Adverse Event|4
2095677|NCT00794157|3684714|FG001|Overall Study|Adverse Event|1
2095678|NCT00794157|3684715|FG002|Overall Study|Adverse Event|8
2095679|NCT00794157|3684713|FG000|Overall Study|Subject withdrew consent|2
2095680|NCT00794157|3684714|FG001|Overall Study|Subject withdrew consent|0
2095681|NCT00794157|3684715|FG002|Overall Study|Subject withdrew consent|3
2095682|NCT00794157|3684713|FG000|Overall Study|Lost to Follow-up|2
2095683|NCT00794157|3684714|FG001|Overall Study|Lost to Follow-up|0
2095684|NCT00794157|3684715|FG002|Overall Study|Lost to Follow-up|1
2095685|NCT00794157|3684713|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2095686|NCT00794157|3684714|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2095687|NCT00794157|3684715|FG002|Overall Study|Unsatisfactory therapeutic effect|2
2095688|NCT00794157|3684713|FG000|Overall Study|Administrative problems|1
2095689|NCT00794157|3684714|FG001|Overall Study|Administrative problems|7
2095690|NCT00794157|3684715|FG002|Overall Study|Administrative problems|4
2095691|NCT00794157|3684713|FG000|Overall Study|Abnormal test procedure result(s)|0
2095692|NCT00794157|3684714|FG001|Overall Study|Abnormal test procedure result(s)|1
2095693|NCT00794157|3684715|FG002|Overall Study|Abnormal test procedure result(s)|0
2095694|NCT00794157|3684713|FG000|Overall Study|Protocol deviation|0
2095695|NCT00794157|3684714|FG001|Overall Study|Protocol deviation|1
2095696|NCT00794157|3684715|FG002|Overall Study|Protocol deviation|1
2095697|NCT00794196|3684734|FG000|Overall Study|Lost to Follow-up|5
2095698|NCT00794196|3684735|FG001|Overall Study|Lost to Follow-up|23
2095699|NCT00794339|3684754|FG000|Overall Study|Withdrawal by Subject|3
2095700|NCT00794339|3684754|FG000|Overall Study|Ineligible|4
2095701|NCT00794339|3684754|FG000|Overall Study|Tx prior to ATSM|3
2095702|NCT00794339|3684754|FG000|Overall Study|ATSM imaging not complete or inadequate|3
2095703|NCT00794339|3684754|FG000|Overall Study|Tx not per protocol|1
2095704|NCT00794365|3684775|FG000|Overall Study|Lost to Follow-up|38
2095705|NCT00794365|3684775|FG000|Overall Study|Other|17
2095706|NCT00794365|3684775|FG000|Overall Study|Poor Compliance|11
2095707|NCT00794365|3684775|FG000|Overall Study|Adverse Event|10
2095708|NCT00794365|3684775|FG000|Overall Study|Lack of Efficacy|3
2095709|NCT00794417|3684783|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0
2095710|NCT00794417|3684784|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0
2095711|NCT00794417|3684785|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2
2095712|NCT00794417|3684786|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0
2095713|NCT00794417|3684783|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
2095714|NCT00794417|3684784|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
2095715|NCT00794417|3684785|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1
2095716|NCT00794417|3684786|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0
2095717|NCT00794417|3684783|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0
2095718|NCT00794417|3684784|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0
2095719|NCT00794417|3684785|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0
2095720|NCT00794417|3684786|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7
2095721|NCT00794417|3684783|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
2095722|NCT00794417|3684784|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
2095723|NCT00794417|3684785|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
2095724|NCT00794417|3684786|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11
2095725|NCT00794417|3684783|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
2095726|NCT00794417|3684784|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
2095727|NCT00794417|3684785|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
2095728|NCT00794417|3684786|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4
2095729|NCT00794417|3684783|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
2095730|NCT00794417|3684784|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
2095731|NCT00794417|3684785|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
2095732|NCT00794417|3684786|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13
2095733|NCT00794573|3684830|FG000|Overall Study|Death|3
2095734|NCT00794573|3684831|FG001|Overall Study|Death|0
2095735|NCT00794573|3684830|FG000|Overall Study|Withdrawal by Subject|9
2095736|NCT00794573|3684831|FG001|Overall Study|Withdrawal by Subject|12
2095737|NCT00794573|3684830|FG000|Overall Study|Lost to Follow-up|26
2095738|NCT00794573|3684831|FG001|Overall Study|Lost to Follow-up|33
2095739|NCT00794664|3684839|FG000|Treatment Period|Withdrawal by Subject|0
2095740|NCT00794664|3684840|FG001|Treatment Period|Withdrawal by Subject|2
2095741|NCT00794664|3684839|FG000|Treatment Period|Protocol non-compliance|0
2095742|NCT00794664|3684840|FG001|Treatment Period|Protocol non-compliance|1
2095743|NCT00794664|3684839|FG000|Treatment Period|Other|0
2095744|NCT00794664|3684840|FG001|Treatment Period|Other|1
2095745|NCT00794664|3684839|FG000|Treatment Period|Adverse Event|1
2095746|NCT00794664|3684840|FG001|Treatment Period|Adverse Event|8
2095747|NCT00794664|3684839|FG000|Follow-up Period|Other|1
2095748|NCT00794664|3684840|FG001|Follow-up Period|Other|2
2095749|NCT00794664|3684839|FG000|Follow-up Period|Withdrawal by Subject|0
2095750|NCT00794664|3684840|FG001|Follow-up Period|Withdrawal by Subject|2
2095751|NCT00794664|3684839|FG000|Follow-up Period|Protocol non-compliance|0
2095752|NCT00794664|3684840|FG001|Follow-up Period|Protocol non-compliance|1
2095753|NCT00794820|3684846|FG000|Overall Study|Adverse Event|11
2095754|NCT00794820|3684846|FG000|Overall Study|Secondary Malignancies|2
2095755|NCT00794820|3684846|FG000|Overall Study|Resistant Disease|2
2095756|NCT00794820|3684846|FG000|Overall Study|Ineligible/Screen Failure|1
2095757|NCT00794950|3684850|FG000|BCG Induction|Withdrawal by Subject|2
2095758|NCT00794950|3684850|FG000|BCG Induction|ineligible|3
2095759|NCT00794950|3684850|FG000|BCG Induction|noncompliant w. BCG|1
2095760|NCT00794950|3684850|FG000|BCG Induction|Adverse Event|1
2095761|NCT00794950|3684850|FG000|Beginning Sunitinib Treatment|cystectomy|5
2095762|NCT00794950|3684850|FG000|Beginning Sunitinib Treatment|Physician Decision|5
2095763|NCT00794950|3684850|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1
2095764|NCT00794950|3684850|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1
2095765|NCT00794963|3684857|FG000|Overall Study|Withdrawal by Subject|1
2095766|NCT00794963|3684858|FG001|Overall Study|Withdrawal by Subject|4
2095767|NCT00795132|3684873|FG000|Overall Study|Death|1
2095768|NCT00795132|3684873|FG000|Overall Study|Relapse|2
2095769|NCT00795184|3684920|FG000|Overall Study|Tissue sampling incomplete/conclusive|8
2095770|NCT00795184|3684921|FG001|Overall Study|Tissue sampling incomplete/conclusive|13
2095771|NCT00795509|3684983|FG000|Overall Study|Protocol Violation|31
2095772|NCT00795535|3684987|FG000|Overall Study|incomplete data and technical problems|20
2095773|NCT00795600|3684993|FG000|Overall Study|Adverse Event|1
2095774|NCT00795600|3684994|FG001|Overall Study|Adverse Event|1
2095775|NCT00795600|3684993|FG000|Overall Study|Protocol Violation|1
2095776|NCT00795600|3684994|FG001|Overall Study|Protocol Violation|2
2095777|NCT00795600|3684993|FG000|Overall Study|Withdrawal by Subject|1
2095778|NCT00795600|3684994|FG001|Overall Study|Withdrawal by Subject|0
2095779|NCT00795600|3684993|FG000|Overall Study|Unclassified|1
2095780|NCT00795600|3684994|FG001|Overall Study|Unclassified|1
2107641|NCT00875017|3701294|FG004|Fourth Intervention|Inability to comply with fasting|0
2107642|NCT00875017|3701295|FG005|Fourth Intervention|Inability to comply with fasting|1
2107643|NCT00875056|3701311|FG000|Overall Study|Adverse Event|6
2107644|NCT00875056|3701312|FG001|Overall Study|Adverse Event|1
2107645|NCT00875056|3701313|FG002|Overall Study|Adverse Event|2
2107646|NCT00875056|3701311|FG000|Overall Study|Progressive Disease|14
2107647|NCT00875056|3701312|FG001|Overall Study|Progressive Disease|8
2107648|NCT00875056|3701313|FG002|Overall Study|Progressive Disease|3
2107649|NCT00875056|3701311|FG000|Overall Study|Withdrawal by Subject|3
2107650|NCT00875056|3701312|FG001|Overall Study|Withdrawal by Subject|0
2107651|NCT00875056|3701313|FG002|Overall Study|Withdrawal by Subject|1
2107652|NCT00875420|3701361|FG000|Overall Study|Adverse Event|0
2107653|NCT00875420|3701362|FG001|Overall Study|Adverse Event|1
2107654|NCT00875420|3701363|FG002|Overall Study|Adverse Event|1
2107655|NCT00875420|3701364|FG003|Overall Study|Adverse Event|0
2107656|NCT00875420|3701365|FG004|Overall Study|Adverse Event|0
2107657|NCT00875420|3701361|FG000|Overall Study|Inability to complete study procedures|1
2107658|NCT00875420|3701362|FG001|Overall Study|Inability to complete study procedures|0
2107659|NCT00875420|3701363|FG002|Overall Study|Inability to complete study procedures|1
2107660|NCT00875420|3701364|FG003|Overall Study|Inability to complete study procedures|1
2107661|NCT00875420|3701365|FG004|Overall Study|Inability to complete study procedures|1
2107662|NCT00875420|3701361|FG000|Overall Study|Lost to Follow-up|1
2107663|NCT00875420|3701362|FG001|Overall Study|Lost to Follow-up|0
2107664|NCT00875420|3701363|FG002|Overall Study|Lost to Follow-up|0
2107665|NCT00875420|3701364|FG003|Overall Study|Lost to Follow-up|0
2107666|NCT00875420|3701365|FG004|Overall Study|Lost to Follow-up|0
2107667|NCT00875420|3701361|FG000|Overall Study|Personal reason|0
2107668|NCT00875420|3701362|FG001|Overall Study|Personal reason|0
2107669|NCT00875420|3701363|FG002|Overall Study|Personal reason|0
2095781|NCT00795639|3685002|FG000|Overall Study|Death|1
2095782|NCT00795639|3685003|FG001|Overall Study|Death|6
2095783|NCT00795639|3685002|FG000|Overall Study|Withdrawal by Subject|1
2095784|NCT00795639|3685003|FG001|Overall Study|Withdrawal by Subject|3
2095785|NCT00795639|3685002|FG000|Overall Study|Pregnancy|1
2095786|NCT00795639|3685003|FG001|Overall Study|Pregnancy|0
2095787|NCT00795639|3685002|FG000|Overall Study|Adverse Event|5
2095788|NCT00795639|3685003|FG001|Overall Study|Adverse Event|2
2095789|NCT00795639|3685002|FG000|Overall Study|Other|0
2095790|NCT00795639|3685003|FG001|Overall Study|Other|2
2095791|NCT00795639|3685002|FG000|Overall Study|Terminated by sponsor|13
2095792|NCT00795639|3685003|FG001|Overall Study|Terminated by sponsor|12
2095793|NCT00795639|3685002|FG000|Overall Study|Randomized and not treated|0
2095794|NCT00795639|3685003|FG001|Overall Study|Randomized and not treated|1
2095795|NCT00795704|3685011|FG000|Overall Study|Withdrawal by Subject|3
2095796|NCT00795704|3685012|FG001|Overall Study|Withdrawal by Subject|2
2095797|NCT00795704|3685011|FG000|Overall Study|Adverse Event|1
2095798|NCT00795704|3685012|FG001|Overall Study|Adverse Event|1
2095799|NCT00795717|3685020|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
2095800|NCT00795717|3685021|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
2095801|NCT00795717|3685020|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
2095802|NCT00795717|3685021|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
2095803|NCT00795717|3685020|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
2095804|NCT00795717|3685021|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
2095805|NCT00795717|3685020|FG000|Phase II|too busy|0
2095806|NCT00795717|3685021|FG001|Phase II|too busy|1
2095807|NCT00795821|3685034|FG000|Acute Treatment Phase|Adverse Event|23
2095808|NCT00795821|3685035|FG001|Acute Treatment Phase|Adverse Event|4
2095809|NCT00795821|3685034|FG000|Acute Treatment Phase|Death|1
2095810|NCT00795821|3685035|FG001|Acute Treatment Phase|Death|0
2095811|NCT00795821|3685034|FG000|Acute Treatment Phase|Lack of Efficacy|5
2095812|NCT00795821|3685035|FG001|Acute Treatment Phase|Lack of Efficacy|2
2095813|NCT00795821|3685034|FG000|Acute Treatment Phase|Lost to Follow-up|9
2095814|NCT00795821|3685035|FG001|Acute Treatment Phase|Lost to Follow-up|12
2095815|NCT00795821|3685034|FG000|Acute Treatment Phase|Physician Decision|1
2095816|NCT00795821|3685035|FG001|Acute Treatment Phase|Physician Decision|1
2095817|NCT00795821|3685034|FG000|Acute Treatment Phase|Protocol Violation|1
2095818|NCT00795821|3685035|FG001|Acute Treatment Phase|Protocol Violation|2
2095819|NCT00795821|3685034|FG000|Acute Treatment Phase|Withdrawal by Subject|16
2095820|NCT00795821|3685035|FG001|Acute Treatment Phase|Withdrawal by Subject|10
2095821|NCT00795821|3685034|FG000|Long-term Extension Phase|Adverse Event|25
2095822|NCT00795821|3685035|FG001|Long-term Extension Phase|Adverse Event|32
2095823|NCT00795821|3685034|FG000|Long-term Extension Phase|Lack of Efficacy|16
2095824|NCT00795821|3685035|FG001|Long-term Extension Phase|Lack of Efficacy|12
2095825|NCT00795821|3685034|FG000|Long-term Extension Phase|Lost to Follow-up|20
2095826|NCT00795821|3685035|FG001|Long-term Extension Phase|Lost to Follow-up|16
2095827|NCT00795821|3685034|FG000|Long-term Extension Phase|Physician Decision|1
2095828|NCT00795821|3685035|FG001|Long-term Extension Phase|Physician Decision|2
2095829|NCT00795821|3685034|FG000|Long-term Extension Phase|Protocol Violation|3
2095830|NCT00795821|3685035|FG001|Long-term Extension Phase|Protocol Violation|5
2095831|NCT00795821|3685034|FG000|Long-term Extension Phase|Withdrawal by Subject|25
2095832|NCT00795821|3685035|FG001|Long-term Extension Phase|Withdrawal by Subject|25
2095833|NCT00795821|3685034|FG000|Taper Phase|Adverse Event|2
2095834|NCT00795821|3685035|FG001|Taper Phase|Adverse Event|0
2095835|NCT00795821|3685034|FG000|Taper Phase|Lost to Follow-up|1
2095836|NCT00795821|3685035|FG001|Taper Phase|Lost to Follow-up|0
2095837|NCT00795821|3685034|FG000|Taper Phase|Physician Decision|2
2095838|NCT00795821|3685035|FG001|Taper Phase|Physician Decision|0
2095839|NCT00795821|3685034|FG000|Taper Phase|Withdrawal by Subject|4
2095840|NCT00795821|3685035|FG001|Taper Phase|Withdrawal by Subject|0
2095841|NCT00795886|3685051|FG000|Overall Study|Death|10
2095842|NCT00795951|3685056|FG000|Overall Study|Lost to Follow-up|1
2095843|NCT00795951|3685056|FG000|Overall Study|Withdrawal by Subject|1
2095844|NCT00796003|3685063|FG000|Overall Study|Disease Progression|2
2095845|NCT00796003|3685064|FG001|Overall Study|Disease Progression|13
2095846|NCT00796003|3685063|FG000|Overall Study|Adverse Event|1
2095847|NCT00796003|3685064|FG001|Overall Study|Adverse Event|7
2095848|NCT00796003|3685063|FG000|Overall Study|Specified organ function not met|0
2095849|NCT00796003|3685064|FG001|Overall Study|Specified organ function not met|1
2095850|NCT00796003|3685063|FG000|Overall Study|Physician Decision|0
2095851|NCT00796003|3685064|FG001|Overall Study|Physician Decision|4
2095852|NCT00796003|3685063|FG000|Overall Study|Withdrawal by Subject|0
2095853|NCT00796003|3685064|FG001|Overall Study|Withdrawal by Subject|1
2095854|NCT00796003|3685063|FG000|Overall Study|Other|0
2095855|NCT00796003|3685064|FG001|Overall Study|Other|1
2095856|NCT00796003|3685063|FG000|Overall Study|Participants Not treated|0
2095857|NCT00796003|3685064|FG001|Overall Study|Participants Not treated|2
2095858|NCT00796120|3685075|FG000|Overall Study|Death|3
2095859|NCT00796120|3685076|FG001|Overall Study|Death|0
2095860|NCT00796120|3685075|FG000|Overall Study|Adverse Event|11
2095861|NCT00796120|3685076|FG001|Overall Study|Adverse Event|6
2095862|NCT00796120|3685075|FG000|Overall Study|Progressive disease|22
2095863|NCT00796120|3685076|FG001|Overall Study|Progressive disease|13
2095864|NCT00796120|3685075|FG000|Overall Study|Participant refusal|3
2095865|NCT00796120|3685076|FG001|Overall Study|Participant refusal|4
2095866|NCT00796120|3685075|FG000|Overall Study|Other|6
2095867|NCT00796120|3685076|FG001|Overall Study|Other|17
2095868|NCT00796120|3685075|FG000|Overall Study|Physician Decision|16
2095869|NCT00796120|3685076|FG001|Overall Study|Physician Decision|17
2095870|NCT00796120|3685075|FG000|Overall Study|Randomized but not treated|0
2095871|NCT00796120|3685076|FG001|Overall Study|Randomized but not treated|3
2095872|NCT00796224|3685084|FG000|Overall Study|Adverse Event|1
2095873|NCT00796224|3685085|FG001|Overall Study|Adverse Event|0
2095874|NCT00796224|3685084|FG000|Overall Study|Protocol Violation|0
2095875|NCT00796224|3685085|FG001|Overall Study|Protocol Violation|1
2095876|NCT00796315|3685103|FG000|Overall Study|Protocol Violation|0
2095877|NCT00796315|3685104|FG001|Overall Study|Protocol Violation|1
2095878|NCT00796315|3685105|FG002|Overall Study|Protocol Violation|0
2095879|NCT00796328|3685116|FG000|Overall Study|experienced hypotension requiring tx|6
2095880|NCT00796367|3685123|FG000|Overall Study|Adverse Event|6
2095881|NCT00796367|3685124|FG001|Overall Study|Adverse Event|4
2095882|NCT00796367|3685125|FG002|Overall Study|Adverse Event|7
2095883|NCT00796367|3685123|FG000|Overall Study|Lost to Follow-up|5
2095884|NCT00796367|3685124|FG001|Overall Study|Lost to Follow-up|4
2095885|NCT00796367|3685125|FG002|Overall Study|Lost to Follow-up|21
2095886|NCT00796367|3685123|FG000|Overall Study|Withdrawal by Subject|9
2095887|NCT00796367|3685124|FG001|Overall Study|Withdrawal by Subject|11
2095888|NCT00796367|3685125|FG002|Overall Study|Withdrawal by Subject|12
2095889|NCT00796367|3685123|FG000|Overall Study|Lack of Efficacy|2
2095890|NCT00796367|3685124|FG001|Overall Study|Lack of Efficacy|1
2095891|NCT00796367|3685125|FG002|Overall Study|Lack of Efficacy|0
2095892|NCT00796367|3685123|FG000|Overall Study|non compliance|3
2095893|NCT00796367|3685124|FG001|Overall Study|non compliance|1
2095894|NCT00796367|3685125|FG002|Overall Study|non compliance|1
2095895|NCT00796367|3685123|FG000|Overall Study|Pregnancy|1
2095896|NCT00796367|3685124|FG001|Overall Study|Pregnancy|0
2095897|NCT00796367|3685125|FG002|Overall Study|Pregnancy|1
2095898|NCT00796367|3685123|FG000|Overall Study|Requirement for restricted medication|2
2095899|NCT00796367|3685124|FG001|Overall Study|Requirement for restricted medication|0
2095900|NCT00796367|3685125|FG002|Overall Study|Requirement for restricted medication|2
2095901|NCT00796367|3685123|FG000|Overall Study|other|2
2095902|NCT00796367|3685124|FG001|Overall Study|other|4
2095903|NCT00796367|3685125|FG002|Overall Study|other|3
2095904|NCT00796419|3685135|FG000|Overall Study|Death|0
2095905|NCT00796419|3685136|FG001|Overall Study|Death|1
2095906|NCT00796445|3685144|FG000|Overall Study|Protocol Violation|5
2095907|NCT00796445|3685145|FG001|Overall Study|Protocol Violation|3
2095908|NCT00796445|3685144|FG000|Overall Study|Adverse event, serious fatal|10
2095909|NCT00796445|3685145|FG001|Overall Study|Adverse event, serious fatal|5
2095910|NCT00796445|3685144|FG000|Overall Study|Adverse event, non-fatal|4
2095911|NCT00796445|3685145|FG001|Overall Study|Adverse event, non-fatal|0
2095912|NCT00796445|3685144|FG000|Overall Study|Disease progression/recurrence|537
2095913|NCT00796445|3685145|FG001|Overall Study|Disease progression/recurrence|268
2095914|NCT00796445|3685144|FG000|Overall Study|Other|10
2095915|NCT00796445|3685145|FG001|Overall Study|Other|7
2095916|NCT00796445|3685144|FG000|Overall Study|Withdrawal by Subject|18
2095917|NCT00796445|3685145|FG001|Overall Study|Withdrawal by Subject|9
2095918|NCT00796445|3685144|FG000|Overall Study|Invalid Informed Consent Form|1
2095919|NCT00796445|3685145|FG001|Overall Study|Invalid Informed Consent Form|0
2095920|NCT00796549|3685159|FG000|Overall Study|Adverse Event|11
2095921|NCT00796549|3685159|FG000|Overall Study|not entered|149
2095922|NCT00796549|3685159|FG000|Overall Study|Other|2
2095923|NCT00796549|3685159|FG000|Overall Study|Progressive disease|56
2095924|NCT00796562|3685165|FG000|Overall Study|Death|49
2095925|NCT00796614|3685173|FG000|Overall Study|Adverse Event|1
2095926|NCT00796614|3685174|FG001|Overall Study|Adverse Event|2
2095927|NCT00796614|3685175|FG002|Overall Study|Adverse Event|0
2095928|NCT00796614|3685176|FG003|Overall Study|Adverse Event|0
2095929|NCT00796614|3685173|FG000|Overall Study|Protocol Violation|0
2095930|NCT00796614|3685174|FG001|Overall Study|Protocol Violation|0
2095931|NCT00796614|3685175|FG002|Overall Study|Protocol Violation|2
2095932|NCT00796614|3685176|FG003|Overall Study|Protocol Violation|0
2095933|NCT00796614|3685173|FG000|Overall Study|Lost to Follow-up|2
2095934|NCT00796614|3685174|FG001|Overall Study|Lost to Follow-up|2
2095935|NCT00796614|3685175|FG002|Overall Study|Lost to Follow-up|1
2095936|NCT00796614|3685176|FG003|Overall Study|Lost to Follow-up|0
2095937|NCT00796614|3685173|FG000|Overall Study|Withdrawal by Subject|1
2095938|NCT00796614|3685174|FG001|Overall Study|Withdrawal by Subject|0
2095939|NCT00796614|3685175|FG002|Overall Study|Withdrawal by Subject|0
2095940|NCT00796614|3685176|FG003|Overall Study|Withdrawal by Subject|1
2095941|NCT00796614|3685173|FG000|Overall Study|Other than stated|1
2095942|NCT00796614|3685174|FG001|Overall Study|Other than stated|0
2095943|NCT00796614|3685175|FG002|Overall Study|Other than stated|0
2095944|NCT00796614|3685176|FG003|Overall Study|Other than stated|0
2095945|NCT00796653|3685199|FG000|Overall Study|Adverse Event|19
2095946|NCT00796653|3685200|FG001|Overall Study|Adverse Event|16
2095947|NCT00796653|3685201|FG002|Overall Study|Adverse Event|16
2095948|NCT00796653|3685202|FG003|Overall Study|Adverse Event|16
2095949|NCT00796653|3685199|FG000|Overall Study|Lost to Follow-up|2
2307467|NCT02697734|4009893|FG001|Core Phase - up to Week 48|Adverse Event|2
2307468|NCT02697734|4009892|FG000|Core Phase - up to Week 48|Physician Decision|1
2307469|NCT02697734|4009893|FG001|Core Phase - up to Week 48|Physician Decision|0
2307470|NCT02697734|4009892|FG000|Optional Extension Phase|Adverse Event|5
2307471|NCT02697734|4009893|FG001|Optional Extension Phase|Adverse Event|1
2307472|NCT02697734|4009892|FG000|Optional Extension Phase|Physician Decision|0
2307473|NCT02697734|4009893|FG001|Optional Extension Phase|Physician Decision|1
2307474|NCT02697773|4009910|FG000|Overall Study|Adverse Event|2
2307475|NCT02697773|4009911|FG001|Overall Study|Adverse Event|1
2307476|NCT02697773|4009912|FG002|Overall Study|Adverse Event|2
2307477|NCT02697773|4009910|FG000|Overall Study|Death|0
2307478|NCT02697773|4009911|FG001|Overall Study|Death|0
2307479|NCT02697773|4009912|FG002|Overall Study|Death|2
2307480|NCT02697773|4009910|FG000|Overall Study|Lack of Efficacy|4
2307481|NCT02697773|4009911|FG001|Overall Study|Lack of Efficacy|6
2307482|NCT02697773|4009912|FG002|Overall Study|Lack of Efficacy|6
2307483|NCT02697773|4009910|FG000|Overall Study|Lost to Follow-up|5
2307484|NCT02697773|4009911|FG001|Overall Study|Lost to Follow-up|5
2307485|NCT02697773|4009912|FG002|Overall Study|Lost to Follow-up|7
2307486|NCT02697773|4009910|FG000|Overall Study|Other|15
2307487|NCT02697773|4009911|FG001|Overall Study|Other|11
2307488|NCT02697773|4009912|FG002|Overall Study|Other|10
2307489|NCT02697773|4009910|FG000|Overall Study|Protocol Violation|1
2307490|NCT02697773|4009911|FG001|Overall Study|Protocol Violation|1
2307491|NCT02697773|4009912|FG002|Overall Study|Protocol Violation|0
2307492|NCT02697773|4009910|FG000|Overall Study|Withdrawal by Subject|10
2307493|NCT02697773|4009911|FG001|Overall Study|Withdrawal by Subject|13
2307494|NCT02697773|4009912|FG002|Overall Study|Withdrawal by Subject|13
2307495|NCT02697773|4009910|FG000|Overall Study|Randomized but not treated|1
2095950|NCT00796653|3685200|FG001|Overall Study|Lost to Follow-up|1
2095951|NCT00796653|3685201|FG002|Overall Study|Lost to Follow-up|2
2095952|NCT00796653|3685202|FG003|Overall Study|Lost to Follow-up|3
2095953|NCT00796653|3685199|FG000|Overall Study|Withdrawal by Subject|16
2095954|NCT00796653|3685200|FG001|Overall Study|Withdrawal by Subject|8
2095955|NCT00796653|3685201|FG002|Overall Study|Withdrawal by Subject|8
2095956|NCT00796653|3685202|FG003|Overall Study|Withdrawal by Subject|13
2212054|NCT01667419|3853012|FG002|Overall Study|Withdrawal by Subject|9
2212055|NCT01667419|3853013|FG003|Overall Study|Withdrawal by Subject|8
2095957|NCT00796653|3685199|FG000|Overall Study|Lack of Efficacy|8
2095958|NCT00796653|3685200|FG001|Overall Study|Lack of Efficacy|1
2095959|NCT00796653|3685201|FG002|Overall Study|Lack of Efficacy|3
2095960|NCT00796653|3685202|FG003|Overall Study|Lack of Efficacy|2
2095961|NCT00796653|3685199|FG000|Overall Study|Non compliance with protocol|2
2095962|NCT00796653|3685200|FG001|Overall Study|Non compliance with protocol|2
2095963|NCT00796653|3685201|FG002|Overall Study|Non compliance with protocol|0
2095964|NCT00796653|3685202|FG003|Overall Study|Non compliance with protocol|2
2095965|NCT00796653|3685199|FG000|Overall Study|Other reason not described above|4
2095966|NCT00796653|3685200|FG001|Overall Study|Other reason not described above|9
2095967|NCT00796653|3685201|FG002|Overall Study|Other reason not described above|7
2095968|NCT00796653|3685202|FG003|Overall Study|Other reason not described above|4
2095969|NCT00796666|3685222|FG000|Overall Study|Death|2
2095970|NCT00796666|3685223|FG001|Overall Study|Death|4
2095971|NCT00796666|3685222|FG000|Overall Study|Withdrawal by Subject|2
2095972|NCT00796666|3685223|FG001|Overall Study|Withdrawal by Subject|0
2095973|NCT00796666|3685222|FG000|Overall Study|Adverse Event|7
2095974|NCT00796666|3685223|FG001|Overall Study|Adverse Event|5
2212056|NCT01667419|3853010|FG000|Overall Study|Non-compliance|0
2095975|NCT00796666|3685222|FG000|Overall Study|Protocol Violation|1
2095976|NCT00796666|3685223|FG001|Overall Study|Protocol Violation|0
2095977|NCT00796666|3685222|FG000|Overall Study|Other|1
2095978|NCT00796666|3685223|FG001|Overall Study|Other|0
2095979|NCT00796666|3685222|FG000|Overall Study|Terminated by sponsor|53
2095980|NCT00796666|3685223|FG001|Overall Study|Terminated by sponsor|55
2095981|NCT00796666|3685222|FG000|Overall Study|Randomized and not treated|1
2095982|NCT00796666|3685223|FG001|Overall Study|Randomized and not treated|0
2095983|NCT00796718|3685248|FG000|Overall Study|Adverse Event|2
2095984|NCT00796718|3685248|FG000|Overall Study|Exclusion Criteria|1
2095985|NCT00796718|3685248|FG000|Overall Study|Lost to Follow-up|5
2095986|NCT00796718|3685248|FG000|Overall Study|Withdrawal by Informed Consent|1
2095987|NCT00796757|3685267|FG000|Overall Study|Withdrawal by Subject|14
2095988|NCT00796757|3685267|FG000|Overall Study|Death|61
2095989|NCT00796757|3685267|FG000|Overall Study|Protocol Violation|1
2095990|NCT00796757|3685267|FG000|Overall Study|Participant noncompliance|1
2095991|NCT00796757|3685267|FG000|Overall Study|Investigator's decision|2
2307496|NCT02697773|4009911|FG001|Overall Study|Randomized but not treated|1
2307497|NCT02697773|4009912|FG002|Overall Study|Randomized but not treated|0
2307498|NCT02697916|4009931|FG000|Overall Study|Death|357
2307499|NCT02697916|4009932|FG001|Overall Study|Death|315
2307500|NCT02697916|4009931|FG000|Overall Study|Withdrawal by Subject|221
2307501|NCT02697916|4009932|FG001|Overall Study|Withdrawal by Subject|393
2095992|NCT00796757|3685267|FG000|Overall Study|Other|7
2212057|NCT01667419|3853011|FG001|Overall Study|Non-compliance|0
2307502|NCT02698176|4009945|FG000|Overall Study|Progressive disease|4
2307503|NCT02698176|4009946|FG001|Overall Study|Progressive disease|3
2307504|NCT02698176|4009947|FG002|Overall Study|Progressive disease|1
2095993|NCT00796822|3685273|FG000|Overall Study|Lost to Follow-up|2
2095994|NCT00796822|3685274|FG001|Overall Study|Lost to Follow-up|0
2095995|NCT00796822|3685273|FG000|Overall Study|Adverse Event|1
2095996|NCT00796822|3685274|FG001|Overall Study|Adverse Event|0
2095997|NCT00796978|3685289|FG000|Overall Study|Cardiac adverse event|5
2095998|NCT00796978|3685289|FG000|Overall Study|Adverse Event|4
2095999|NCT00796978|3685289|FG000|Overall Study|Withdrawal by Subject|3
2096000|NCT00796991|3685296|FG000|Overall Study|Adverse Event|0
2096001|NCT00796991|3685297|FG001|Overall Study|Adverse Event|0
2096002|NCT00796991|3685298|FG002|Overall Study|Adverse Event|1
2096003|NCT00796991|3685296|FG000|Overall Study|Death|2
2096004|NCT00796991|3685297|FG001|Overall Study|Death|0
2096005|NCT00796991|3685298|FG002|Overall Study|Death|0
2096006|NCT00796991|3685296|FG000|Overall Study|Disease Progression|10
2096007|NCT00796991|3685297|FG001|Overall Study|Disease Progression|9
2096008|NCT00796991|3685298|FG002|Overall Study|Disease Progression|7
2096009|NCT00796991|3685296|FG000|Overall Study|Study Drug Toxicity|3
2096010|NCT00796991|3685297|FG001|Overall Study|Study Drug Toxicity|3
2096011|NCT00796991|3685298|FG002|Overall Study|Study Drug Toxicity|5
2096012|NCT00796991|3685296|FG000|Overall Study|Withdrawal by Subject|0
2096013|NCT00796991|3685297|FG001|Overall Study|Withdrawal by Subject|0
2096014|NCT00796991|3685298|FG002|Overall Study|Withdrawal by Subject|1
2096015|NCT00797108|3685309|FG000|Overall Study|Adverse Event|1
2096016|NCT00797108|3685310|FG001|Overall Study|Adverse Event|0
2096017|NCT00797108|3685311|FG002|Overall Study|Adverse Event|3
2096018|NCT00797108|3685309|FG000|Overall Study|Did Not Meet Entrance Criteria|0
2096019|NCT00797108|3685310|FG001|Overall Study|Did Not Meet Entrance Criteria|1
2096020|NCT00797108|3685311|FG002|Overall Study|Did Not Meet Entrance Criteria|0
2096021|NCT00797108|3685309|FG000|Overall Study|Global Deterioration of Health Status|0
2096022|NCT00797108|3685310|FG001|Overall Study|Global Deterioration of Health Status|1
2096023|NCT00797108|3685311|FG002|Overall Study|Global Deterioration of Health Status|0
2096024|NCT00797108|3685309|FG000|Overall Study|Lack of Efficacy|1
2096025|NCT00797108|3685310|FG001|Overall Study|Lack of Efficacy|0
2096026|NCT00797108|3685311|FG002|Overall Study|Lack of Efficacy|1
2096027|NCT00797108|3685309|FG000|Overall Study|Other|0
2096028|NCT00797108|3685310|FG001|Overall Study|Other|0
2096029|NCT00797108|3685311|FG002|Overall Study|Other|2
2096030|NCT00797108|3685309|FG000|Overall Study|Randomized but not Treated|2
2096031|NCT00797108|3685310|FG001|Overall Study|Randomized but not Treated|0
2096032|NCT00797108|3685311|FG002|Overall Study|Randomized but not Treated|0
2096033|NCT00797225|3685327|FG000|Weeks 1 to 12|Adverse Event|0
2096034|NCT00797225|3685328|FG001|Weeks 1 to 12|Adverse Event|0
2096035|NCT00797225|3685329|FG002|Weeks 1 to 12|Adverse Event|1
2096036|NCT00797225|3685330|FG003|Weeks 1 to 12|Adverse Event|0
2096037|NCT00797225|3685331|FG004|Weeks 1 to 12|Adverse Event|0
2096038|NCT00797225|3685332|FG005|Weeks 1 to 12|Adverse Event|0
2096039|NCT00797225|3685333|FG006|Weeks 1 to 12|Adverse Event|0
2096040|NCT00797225|3685334|FG007|Weeks 1 to 12|Adverse Event|0
2096041|NCT00797225|3685327|FG000|Weeks 1 to 12|Non-compliance|0
2096042|NCT00797225|3685328|FG001|Weeks 1 to 12|Non-compliance|1
2096043|NCT00797225|3685329|FG002|Weeks 1 to 12|Non-compliance|0
2096044|NCT00797225|3685330|FG003|Weeks 1 to 12|Non-compliance|0
2096045|NCT00797225|3685331|FG004|Weeks 1 to 12|Non-compliance|0
2096046|NCT00797225|3685332|FG005|Weeks 1 to 12|Non-compliance|0
2096047|NCT00797225|3685333|FG006|Weeks 1 to 12|Non-compliance|0
2096048|NCT00797225|3685334|FG007|Weeks 1 to 12|Non-compliance|0
2096049|NCT00797225|3685327|FG000|Weeks 1 to 12|Lack of Efficacy|1
2096050|NCT00797225|3685328|FG001|Weeks 1 to 12|Lack of Efficacy|0
2096051|NCT00797225|3685329|FG002|Weeks 1 to 12|Lack of Efficacy|0
2096052|NCT00797225|3685330|FG003|Weeks 1 to 12|Lack of Efficacy|0
2096053|NCT00797225|3685331|FG004|Weeks 1 to 12|Lack of Efficacy|0
2096054|NCT00797225|3685332|FG005|Weeks 1 to 12|Lack of Efficacy|0
2096055|NCT00797225|3685333|FG006|Weeks 1 to 12|Lack of Efficacy|0
2096056|NCT00797225|3685334|FG007|Weeks 1 to 12|Lack of Efficacy|0
2096057|NCT00797225|3685327|FG000|Weeks 1 to 12|Sponsor Decision|1
2096058|NCT00797225|3685328|FG001|Weeks 1 to 12|Sponsor Decision|0
2096059|NCT00797225|3685329|FG002|Weeks 1 to 12|Sponsor Decision|0
2096060|NCT00797225|3685330|FG003|Weeks 1 to 12|Sponsor Decision|0
2096061|NCT00797225|3685331|FG004|Weeks 1 to 12|Sponsor Decision|0
2096062|NCT00797225|3685332|FG005|Weeks 1 to 12|Sponsor Decision|0
2096063|NCT00797225|3685333|FG006|Weeks 1 to 12|Sponsor Decision|0
2096064|NCT00797225|3685334|FG007|Weeks 1 to 12|Sponsor Decision|0
2096065|NCT00797225|3685327|FG000|Weeks 13 to 24|Non-compliance|0
2096066|NCT00797225|3685328|FG001|Weeks 13 to 24|Non-compliance|2
2096067|NCT00797225|3685329|FG002|Weeks 13 to 24|Non-compliance|0
2096068|NCT00797225|3685330|FG003|Weeks 13 to 24|Non-compliance|0
2096069|NCT00797225|3685331|FG004|Weeks 13 to 24|Non-compliance|0
2096070|NCT00797225|3685332|FG005|Weeks 13 to 24|Non-compliance|0
2096071|NCT00797225|3685333|FG006|Weeks 13 to 24|Non-compliance|0
2096072|NCT00797225|3685334|FG007|Weeks 13 to 24|Non-compliance|0
2096073|NCT00797225|3685327|FG000|Weeks 13 to 24|Withdrawal by Subject|0
2096074|NCT00797225|3685328|FG001|Weeks 13 to 24|Withdrawal by Subject|1
2096075|NCT00797225|3685329|FG002|Weeks 13 to 24|Withdrawal by Subject|1
2096076|NCT00797225|3685330|FG003|Weeks 13 to 24|Withdrawal by Subject|0
2096077|NCT00797225|3685331|FG004|Weeks 13 to 24|Withdrawal by Subject|0
2096078|NCT00797225|3685332|FG005|Weeks 13 to 24|Withdrawal by Subject|0
2096079|NCT00797225|3685333|FG006|Weeks 13 to 24|Withdrawal by Subject|0
2096080|NCT00797225|3685334|FG007|Weeks 13 to 24|Withdrawal by Subject|0
2096081|NCT00797225|3685327|FG000|Weeks 13 to 24|Lost to Follow-up|0
2096082|NCT00797225|3685328|FG001|Weeks 13 to 24|Lost to Follow-up|0
2096083|NCT00797225|3685329|FG002|Weeks 13 to 24|Lost to Follow-up|1
2096084|NCT00797225|3685330|FG003|Weeks 13 to 24|Lost to Follow-up|0
2096085|NCT00797225|3685331|FG004|Weeks 13 to 24|Lost to Follow-up|1
2096086|NCT00797225|3685332|FG005|Weeks 13 to 24|Lost to Follow-up|0
2096087|NCT00797225|3685333|FG006|Weeks 13 to 24|Lost to Follow-up|0
2096088|NCT00797225|3685334|FG007|Weeks 13 to 24|Lost to Follow-up|0
2096089|NCT00797225|3685327|FG000|Weeks 13 to 24|Adverse Event|0
2096090|NCT00797225|3685328|FG001|Weeks 13 to 24|Adverse Event|1
2096091|NCT00797225|3685329|FG002|Weeks 13 to 24|Adverse Event|0
2096092|NCT00797225|3685330|FG003|Weeks 13 to 24|Adverse Event|0
2096093|NCT00797225|3685331|FG004|Weeks 13 to 24|Adverse Event|0
2096094|NCT00797225|3685332|FG005|Weeks 13 to 24|Adverse Event|0
2096095|NCT00797225|3685333|FG006|Weeks 13 to 24|Adverse Event|1
2096096|NCT00797225|3685334|FG007|Weeks 13 to 24|Adverse Event|0
2096097|NCT00797225|3685327|FG000|Weeks 13 to 24|Sponsor Decision|0
2096098|NCT00797225|3685328|FG001|Weeks 13 to 24|Sponsor Decision|0
2096099|NCT00797225|3685329|FG002|Weeks 13 to 24|Sponsor Decision|0
2096100|NCT00797225|3685330|FG003|Weeks 13 to 24|Sponsor Decision|0
2096101|NCT00797225|3685331|FG004|Weeks 13 to 24|Sponsor Decision|0
2096102|NCT00797225|3685332|FG005|Weeks 13 to 24|Sponsor Decision|0
2096103|NCT00797225|3685333|FG006|Weeks 13 to 24|Sponsor Decision|1
2096104|NCT00797225|3685334|FG007|Weeks 13 to 24|Sponsor Decision|0
2096105|NCT00797316|3685362|FG000|Overall Study|Administrative problems|1
2096106|NCT00797316|3685363|FG001|Overall Study|Administrative problems|0
2096107|NCT00797316|3685362|FG000|Overall Study|Adverse Event|5
2096108|NCT00797316|3685363|FG001|Overall Study|Adverse Event|3
2096109|NCT00797316|3685362|FG000|Overall Study|Lost to Follow-up|4
2096110|NCT00797316|3685363|FG001|Overall Study|Lost to Follow-up|8
2096111|NCT00797316|3685362|FG000|Overall Study|Protocol Deviation|1
2096112|NCT00797316|3685363|FG001|Overall Study|Protocol Deviation|2
2096113|NCT00797316|3685362|FG000|Overall Study|Patient withdrew consent|12
2096114|NCT00797316|3685363|FG001|Overall Study|Patient withdrew consent|6
2096115|NCT00797316|3685362|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2096116|NCT00797316|3685363|FG001|Overall Study|Unsatisfactory therapeutic effect|13
2096117|NCT00797511|3685377|FG000|Overall Study|Withdrawal by Subject|1
2096118|NCT00797563|3685382|FG000|Overall Study|Adverse Event|1
2096119|NCT00797667|3685389|FG000|Overall Study|Lack of Efficacy|0
2096120|NCT00797667|3685390|FG001|Overall Study|Lack of Efficacy|1
2096121|NCT00797667|3685391|FG002|Overall Study|Lack of Efficacy|0
2096122|NCT00797667|3685389|FG000|Overall Study|Lost to Follow-up|8
2096123|NCT00797667|3685390|FG001|Overall Study|Lost to Follow-up|12
2096124|NCT00797667|3685391|FG002|Overall Study|Lost to Follow-up|2
2096125|NCT00797667|3685389|FG000|Overall Study|Physician Decision|3
2096126|NCT00797667|3685390|FG001|Overall Study|Physician Decision|1
2096127|NCT00797667|3685391|FG002|Overall Study|Physician Decision|0
2096128|NCT00797667|3685389|FG000|Overall Study|Pregnancy|2
2096129|NCT00797667|3685390|FG001|Overall Study|Pregnancy|0
2096130|NCT00797667|3685391|FG002|Overall Study|Pregnancy|0
2096131|NCT00797667|3685389|FG000|Overall Study|Protocol Violation|2
2096132|NCT00797667|3685390|FG001|Overall Study|Protocol Violation|7
2096133|NCT00797667|3685391|FG002|Overall Study|Protocol Violation|0
2096134|NCT00797667|3685389|FG000|Overall Study|Study Terminated by Sponsor|217
2096135|NCT00797667|3685390|FG001|Overall Study|Study Terminated by Sponsor|216
2096136|NCT00797667|3685391|FG002|Overall Study|Study Terminated by Sponsor|115
2096137|NCT00797667|3685389|FG000|Overall Study|Withdrawal by Subject|9
2096138|NCT00797667|3685390|FG001|Overall Study|Withdrawal by Subject|14
2096139|NCT00797667|3685391|FG002|Overall Study|Withdrawal by Subject|2
2096140|NCT00797667|3685389|FG000|Overall Study|Adverse Event|19
2096141|NCT00797667|3685390|FG001|Overall Study|Adverse Event|8
2096142|NCT00797667|3685391|FG002|Overall Study|Adverse Event|8
2096143|NCT00797732|3685401|FG000|Overall Study|Withdrawal by Subject|3
2096144|NCT00797732|3685402|FG001|Overall Study|Withdrawal by Subject|3
2096145|NCT00797732|3685403|FG002|Overall Study|Withdrawal by Subject|0
2096146|NCT00797732|3685401|FG000|Overall Study|Lost to Follow-up|1
2096147|NCT00797732|3685402|FG001|Overall Study|Lost to Follow-up|0
2096148|NCT00797732|3685403|FG002|Overall Study|Lost to Follow-up|0
2096149|NCT00797732|3685401|FG000|Overall Study|Death|1
2096150|NCT00797732|3685402|FG001|Overall Study|Death|0
2096151|NCT00797732|3685403|FG002|Overall Study|Death|0
2096152|NCT00797732|3685401|FG000|Overall Study|Not meet inclusion criteria|0
2096153|NCT00797732|3685402|FG001|Overall Study|Not meet inclusion criteria|0
2096154|NCT00797732|3685403|FG002|Overall Study|Not meet inclusion criteria|7
2096155|NCT00797732|3685401|FG000|Overall Study|Excluded due to time constraints|0
2096156|NCT00797732|3685402|FG001|Overall Study|Excluded due to time constraints|0
2096157|NCT00797732|3685403|FG002|Overall Study|Excluded due to time constraints|24
2096158|NCT00797732|3685401|FG000|Overall Study|Refused to Participate|0
2096159|NCT00797732|3685402|FG001|Overall Study|Refused to Participate|0
2096160|NCT00797732|3685403|FG002|Overall Study|Refused to Participate|123
2096161|NCT00797823|3685421|FG000|First Period (Initial Randomization)|Physician Decision|1
2096162|NCT00797823|3685422|FG001|First Period (Initial Randomization)|Physician Decision|0
2096163|NCT00797823|3685423|FG002|First Period (Initial Randomization)|Physician Decision|0
2096164|NCT00797862|3685433|FG000|Overall Study|Adverse Event|86
2096165|NCT00797862|3685434|FG001|Overall Study|Adverse Event|44
2096166|NCT00797862|3685435|FG002|Overall Study|Adverse Event|58
2096167|NCT00797862|3685433|FG000|Overall Study|Abnormal Test Procedure Result|0
2096168|NCT00797862|3685434|FG001|Overall Study|Abnormal Test Procedure Result|1
2096169|NCT00797862|3685435|FG002|Overall Study|Abnormal Test Procedure Result|1
2096170|NCT00797862|3685433|FG000|Overall Study|Lack of Efficacy|1
2096171|NCT00797862|3685434|FG001|Overall Study|Lack of Efficacy|7
2096172|NCT00797862|3685435|FG002|Overall Study|Lack of Efficacy|6
2096173|NCT00797862|3685433|FG000|Overall Study|No longer required study medication|1
2096174|NCT00797862|3685434|FG001|Overall Study|No longer required study medication|0
2096175|NCT00797862|3685435|FG002|Overall Study|No longer required study medication|0
2096176|NCT00797862|3685433|FG000|Overall Study|Withdrawal by Subject|14
2096177|NCT00797862|3685434|FG001|Overall Study|Withdrawal by Subject|7
2096178|NCT00797862|3685435|FG002|Overall Study|Withdrawal by Subject|7
2096179|NCT00797862|3685433|FG000|Overall Study|Lost to Follow-up|11
2096180|NCT00797862|3685434|FG001|Overall Study|Lost to Follow-up|0
2096181|NCT00797862|3685435|FG002|Overall Study|Lost to Follow-up|5
2096182|NCT00797862|3685433|FG000|Overall Study|Administrative Problem|4
2096183|NCT00797862|3685434|FG001|Overall Study|Administrative Problem|0
2096184|NCT00797862|3685435|FG002|Overall Study|Administrative Problem|0
2096185|NCT00797862|3685433|FG000|Overall Study|Protocol Violation|4
2096186|NCT00797862|3685434|FG001|Overall Study|Protocol Violation|6
2096187|NCT00797862|3685435|FG002|Overall Study|Protocol Violation|8
2096188|NCT00797862|3685433|FG000|Overall Study|Mis-randomized|3
2096189|NCT00797862|3685434|FG001|Overall Study|Mis-randomized|3
2096190|NCT00797862|3685435|FG002|Overall Study|Mis-randomized|1
2096191|NCT00797966|3685447|FG000|Phase A|Lost to Follow-up|0
2096192|NCT00797966|3685448|FG001|Phase A|Lost to Follow-up|0
2096193|NCT00797966|3685449|FG002|Phase A|Lost to Follow-up|0
2096194|NCT00797966|3685450|FG003|Phase A|Lost to Follow-up|0
2096195|NCT00797966|3685451|FG004|Phase A|Lost to Follow-up|33
2096196|NCT00797966|3685452|FG005|Phase A|Lost to Follow-up|0
2096197|NCT00797966|3685447|FG000|Phase A|Adverse Event|0
2096198|NCT00797966|3685448|FG001|Phase A|Adverse Event|0
2096199|NCT00797966|3685449|FG002|Phase A|Adverse Event|0
2096200|NCT00797966|3685450|FG003|Phase A|Adverse Event|0
2096201|NCT00797966|3685451|FG004|Phase A|Adverse Event|46
2096202|NCT00797966|3685452|FG005|Phase A|Adverse Event|0
2096203|NCT00797966|3685447|FG000|Phase A|Met withdrawal criteria|0
2096204|NCT00797966|3685448|FG001|Phase A|Met withdrawal criteria|0
2096205|NCT00797966|3685449|FG002|Phase A|Met withdrawal criteria|0
2096206|NCT00797966|3685450|FG003|Phase A|Met withdrawal criteria|0
2096207|NCT00797966|3685451|FG004|Phase A|Met withdrawal criteria|4
2096208|NCT00797966|3685452|FG005|Phase A|Met withdrawal criteria|0
2096209|NCT00797966|3685447|FG000|Phase A|Physician Decision|0
2096210|NCT00797966|3685448|FG001|Phase A|Physician Decision|0
2096211|NCT00797966|3685449|FG002|Phase A|Physician Decision|0
2096212|NCT00797966|3685450|FG003|Phase A|Physician Decision|0
2096213|NCT00797966|3685451|FG004|Phase A|Physician Decision|13
2096214|NCT00797966|3685452|FG005|Phase A|Physician Decision|0
2096215|NCT00797966|3685447|FG000|Phase A|Withdrawal by Subject|0
2096216|NCT00797966|3685448|FG001|Phase A|Withdrawal by Subject|0
2212058|NCT01667419|3853012|FG002|Overall Study|Non-compliance|0
2212059|NCT01667419|3853013|FG003|Overall Study|Non-compliance|1
2212060|NCT01667419|3853010|FG000|Overall Study|Protocol Violation|1
2212061|NCT01667419|3853011|FG001|Overall Study|Protocol Violation|0
2096217|NCT00797966|3685449|FG002|Phase A|Withdrawal by Subject|0
2096218|NCT00797966|3685450|FG003|Phase A|Withdrawal by Subject|0
2096219|NCT00797966|3685451|FG004|Phase A|Withdrawal by Subject|33
2096220|NCT00797966|3685452|FG005|Phase A|Withdrawal by Subject|0
2096221|NCT00797966|3685447|FG000|Phase A|Protocol deviation|0
2096222|NCT00797966|3685448|FG001|Phase A|Protocol deviation|0
2096223|NCT00797966|3685449|FG002|Phase A|Protocol deviation|0
2096224|NCT00797966|3685450|FG003|Phase A|Protocol deviation|0
2096225|NCT00797966|3685451|FG004|Phase A|Protocol deviation|56
2096226|NCT00797966|3685452|FG005|Phase A|Protocol deviation|0
2096227|NCT00797966|3685447|FG000|Phase B|Lost to Follow-up|0
2096228|NCT00797966|3685448|FG001|Phase B|Lost to Follow-up|1
2096229|NCT00797966|3685449|FG002|Phase B|Lost to Follow-up|3
2096230|NCT00797966|3685450|FG003|Phase B|Lost to Follow-up|0
2096231|NCT00797966|3685451|FG004|Phase B|Lost to Follow-up|0
2096232|NCT00797966|3685452|FG005|Phase B|Lost to Follow-up|0
2096233|NCT00797966|3685447|FG000|Phase B|Adverse Event|2
2096234|NCT00797966|3685448|FG001|Phase B|Adverse Event|1
2096235|NCT00797966|3685449|FG002|Phase B|Adverse Event|3
2096236|NCT00797966|3685450|FG003|Phase B|Adverse Event|1
2096237|NCT00797966|3685451|FG004|Phase B|Adverse Event|0
2096238|NCT00797966|3685452|FG005|Phase B|Adverse Event|0
2096239|NCT00797966|3685447|FG000|Phase B|Met Withdrawal Criteria|3
2096240|NCT00797966|3685448|FG001|Phase B|Met Withdrawal Criteria|3
2096241|NCT00797966|3685449|FG002|Phase B|Met Withdrawal Criteria|6
2096242|NCT00797966|3685450|FG003|Phase B|Met Withdrawal Criteria|1
2096243|NCT00797966|3685451|FG004|Phase B|Met Withdrawal Criteria|0
2096244|NCT00797966|3685452|FG005|Phase B|Met Withdrawal Criteria|0
2096245|NCT00797966|3685447|FG000|Phase B|Physician Decision|1
2096246|NCT00797966|3685448|FG001|Phase B|Physician Decision|0
2096247|NCT00797966|3685449|FG002|Phase B|Physician Decision|3
2212062|NCT01667419|3853012|FG002|Overall Study|Protocol Violation|0
2096248|NCT00797966|3685450|FG003|Phase B|Physician Decision|1
2096249|NCT00797966|3685451|FG004|Phase B|Physician Decision|0
2096250|NCT00797966|3685452|FG005|Phase B|Physician Decision|0
2096251|NCT00797966|3685447|FG000|Phase B|Withdrawal by Subject|1
2096252|NCT00797966|3685448|FG001|Phase B|Withdrawal by Subject|4
2096253|NCT00797966|3685449|FG002|Phase B|Withdrawal by Subject|3
2096254|NCT00797966|3685450|FG003|Phase B|Withdrawal by Subject|3
2096255|NCT00797966|3685451|FG004|Phase B|Withdrawal by Subject|0
2096256|NCT00797966|3685452|FG005|Phase B|Withdrawal by Subject|0
2096257|NCT00797966|3685447|FG000|Phase B|Protocol Deviation|4
2096258|NCT00797966|3685448|FG001|Phase B|Protocol Deviation|8
2096259|NCT00797966|3685449|FG002|Phase B|Protocol Deviation|2
2096260|NCT00797966|3685450|FG003|Phase B|Protocol Deviation|6
2096261|NCT00797966|3685451|FG004|Phase B|Protocol Deviation|0
2096262|NCT00797966|3685452|FG005|Phase B|Protocol Deviation|0
2096263|NCT00797966|3685447|FG000|Phase B|Lack of Efficacy|0
2096264|NCT00797966|3685448|FG001|Phase B|Lack of Efficacy|1
2096265|NCT00797966|3685449|FG002|Phase B|Lack of Efficacy|1
2096266|NCT00797966|3685450|FG003|Phase B|Lack of Efficacy|4
2096267|NCT00797966|3685451|FG004|Phase B|Lack of Efficacy|0
2096268|NCT00797966|3685452|FG005|Phase B|Lack of Efficacy|0
2096269|NCT00797966|3685447|FG000|Phase A+|Lost to Follow-up|0
2096270|NCT00797966|3685448|FG001|Phase A+|Lost to Follow-up|0
2096271|NCT00797966|3685449|FG002|Phase A+|Lost to Follow-up|0
2096272|NCT00797966|3685450|FG003|Phase A+|Lost to Follow-up|0
2096273|NCT00797966|3685451|FG004|Phase A+|Lost to Follow-up|0
2096274|NCT00797966|3685452|FG005|Phase A+|Lost to Follow-up|9
2096275|NCT00797966|3685447|FG000|Phase A+|Met withdrawal criteria|0
2096276|NCT00797966|3685448|FG001|Phase A+|Met withdrawal criteria|0
2096277|NCT00797966|3685449|FG002|Phase A+|Met withdrawal criteria|0
2096278|NCT00797966|3685450|FG003|Phase A+|Met withdrawal criteria|0
2096279|NCT00797966|3685451|FG004|Phase A+|Met withdrawal criteria|0
2096280|NCT00797966|3685452|FG005|Phase A+|Met withdrawal criteria|5
2096281|NCT00797966|3685447|FG000|Phase A+|Withdrawal by Subject|0
2096282|NCT00797966|3685448|FG001|Phase A+|Withdrawal by Subject|0
2096283|NCT00797966|3685449|FG002|Phase A+|Withdrawal by Subject|0
2096284|NCT00797966|3685450|FG003|Phase A+|Withdrawal by Subject|0
2096285|NCT00797966|3685451|FG004|Phase A+|Withdrawal by Subject|0
2096286|NCT00797966|3685452|FG005|Phase A+|Withdrawal by Subject|6
2096287|NCT00797966|3685447|FG000|Phase A+|Adverse Event|0
2096288|NCT00797966|3685448|FG001|Phase A+|Adverse Event|0
2096289|NCT00797966|3685449|FG002|Phase A+|Adverse Event|0
2096290|NCT00797966|3685450|FG003|Phase A+|Adverse Event|0
2096291|NCT00797966|3685451|FG004|Phase A+|Adverse Event|0
2096292|NCT00797966|3685452|FG005|Phase A+|Adverse Event|4
2096293|NCT00797966|3685447|FG000|Phase A+|Protocol deviation|0
2096294|NCT00797966|3685448|FG001|Phase A+|Protocol deviation|0
2096295|NCT00797966|3685449|FG002|Phase A+|Protocol deviation|0
2096296|NCT00797966|3685450|FG003|Phase A+|Protocol deviation|0
2096297|NCT00797966|3685451|FG004|Phase A+|Protocol deviation|0
2096298|NCT00797966|3685452|FG005|Phase A+|Protocol deviation|4
2096299|NCT00798096|3685481|FG000|Overall Study|Ongoing|2
2096300|NCT00798135|3685485|FG000|Overall Study|Disease progression, relapse|11
2096301|NCT00798135|3685485|FG000|Overall Study|Disease progression, refractory|1
2096302|NCT00798135|3685485|FG000|Overall Study|Physician Decision|1
2096303|NCT00798161|3685496|FG000|Overall Study|Adverse Event|3
2096304|NCT00798161|3685497|FG001|Overall Study|Adverse Event|4
2096305|NCT00798161|3685498|FG002|Overall Study|Adverse Event|6
2096306|NCT00798161|3685499|FG003|Overall Study|Adverse Event|6
2096307|NCT00798161|3685500|FG004|Overall Study|Adverse Event|5
2096308|NCT00798161|3685501|FG005|Overall Study|Adverse Event|2
2096309|NCT00798161|3685502|FG006|Overall Study|Adverse Event|4
2096310|NCT00798161|3685496|FG000|Overall Study|Protocol Violation|2
2096311|NCT00798161|3685497|FG001|Overall Study|Protocol Violation|1
2096312|NCT00798161|3685498|FG002|Overall Study|Protocol Violation|3
2096313|NCT00798161|3685499|FG003|Overall Study|Protocol Violation|3
2096314|NCT00798161|3685500|FG004|Overall Study|Protocol Violation|3
2096315|NCT00798161|3685501|FG005|Overall Study|Protocol Violation|2
2096316|NCT00798161|3685502|FG006|Overall Study|Protocol Violation|0
2096317|NCT00798161|3685496|FG000|Overall Study|Lost to Follow-up|1
2096318|NCT00798161|3685497|FG001|Overall Study|Lost to Follow-up|3
2096319|NCT00798161|3685498|FG002|Overall Study|Lost to Follow-up|4
2096320|NCT00798161|3685499|FG003|Overall Study|Lost to Follow-up|3
2096321|NCT00798161|3685500|FG004|Overall Study|Lost to Follow-up|4
2096322|NCT00798161|3685501|FG005|Overall Study|Lost to Follow-up|0
2096323|NCT00798161|3685502|FG006|Overall Study|Lost to Follow-up|0
2096324|NCT00798161|3685496|FG000|Overall Study|Withdrawal by Subject|5
2096325|NCT00798161|3685497|FG001|Overall Study|Withdrawal by Subject|4
2096326|NCT00798161|3685498|FG002|Overall Study|Withdrawal by Subject|5
2096327|NCT00798161|3685499|FG003|Overall Study|Withdrawal by Subject|4
2096328|NCT00798161|3685500|FG004|Overall Study|Withdrawal by Subject|2
2096329|NCT00798161|3685501|FG005|Overall Study|Withdrawal by Subject|3
2096330|NCT00798161|3685502|FG006|Overall Study|Withdrawal by Subject|1
2096331|NCT00798161|3685496|FG000|Overall Study|Other reason (incl. lack of efficacy)|7
2096332|NCT00798161|3685497|FG001|Overall Study|Other reason (incl. lack of efficacy)|5
2096333|NCT00798161|3685498|FG002|Overall Study|Other reason (incl. lack of efficacy)|3
2096334|NCT00798161|3685499|FG003|Overall Study|Other reason (incl. lack of efficacy)|5
2096335|NCT00798161|3685500|FG004|Overall Study|Other reason (incl. lack of efficacy)|2
2096336|NCT00798161|3685501|FG005|Overall Study|Other reason (incl. lack of efficacy)|4
2096337|NCT00798161|3685502|FG006|Overall Study|Other reason (incl. lack of efficacy)|5
2096338|NCT00798174|3685518|FG000|Overall Study|inability to implant azygos coil|3
2096339|NCT00798174|3685519|FG001|Overall Study|inability to implant azygos coil|3
2096340|NCT00798174|3685518|FG000|Overall Study|Inability to sedate for DFT testing|1
2096341|NCT00798174|3685519|FG001|Overall Study|Inability to sedate for DFT testing|0
2096342|NCT00798304|3685526|FG000|Overall Study|Adverse Event|0
2096343|NCT00798304|3685527|FG001|Overall Study|Adverse Event|1
2096344|NCT00798304|3685528|FG002|Overall Study|Adverse Event|1
2096345|NCT00798304|3685526|FG000|Overall Study|Discontinuation by Sponsor|14
2096346|NCT00798304|3685527|FG001|Overall Study|Discontinuation by Sponsor|21
2096347|NCT00798304|3685528|FG002|Overall Study|Discontinuation by Sponsor|9
2096348|NCT00798317|3685538|FG000|Overall Study|Physician Decision|0
2096349|NCT00798317|3685539|FG001|Overall Study|Physician Decision|1
2096350|NCT00798317|3685538|FG000|Overall Study|Withdrawal by Subject|5
2096351|NCT00798317|3685539|FG001|Overall Study|Withdrawal by Subject|4
2096352|NCT00798317|3685538|FG000|Overall Study|Lost to Follow-up|2
2096353|NCT00798317|3685539|FG001|Overall Study|Lost to Follow-up|2
2096354|NCT00798317|3685538|FG000|Overall Study|Adverse Event|2
2096355|NCT00798317|3685539|FG001|Overall Study|Adverse Event|0
2096356|NCT00798317|3685538|FG000|Overall Study|Death|1
2096357|NCT00798317|3685539|FG001|Overall Study|Death|0
2096358|NCT00798369|3685551|FG000|Overall Study|Subject withdrew consent|0
2096359|NCT00798369|3685552|FG001|Overall Study|Subject withdrew consent|0
2096360|NCT00798369|3685553|FG002|Overall Study|Subject withdrew consent|1
2096361|NCT00798369|3685554|FG003|Overall Study|Subject withdrew consent|1
2096362|NCT00798369|3685555|FG004|Overall Study|Subject withdrew consent|0
2096363|NCT00798369|3685556|FG005|Overall Study|Subject withdrew consent|2
2096364|NCT00798369|3685551|FG000|Overall Study|Lost to Follow-up|1
2096365|NCT00798369|3685552|FG001|Overall Study|Lost to Follow-up|1
2096366|NCT00798369|3685553|FG002|Overall Study|Lost to Follow-up|1
2096367|NCT00798369|3685554|FG003|Overall Study|Lost to Follow-up|0
2096368|NCT00798369|3685555|FG004|Overall Study|Lost to Follow-up|1
2096369|NCT00798369|3685556|FG005|Overall Study|Lost to Follow-up|0
2096370|NCT00798369|3685551|FG000|Overall Study|Adminstrative problems|0
2096371|NCT00798369|3685552|FG001|Overall Study|Adminstrative problems|0
2096372|NCT00798369|3685553|FG002|Overall Study|Adminstrative problems|0
2096373|NCT00798369|3685554|FG003|Overall Study|Adminstrative problems|0
2096374|NCT00798369|3685555|FG004|Overall Study|Adminstrative problems|0
2096375|NCT00798369|3685556|FG005|Overall Study|Adminstrative problems|1
2096376|NCT00798434|3685573|FG000|Double-Blind|Adverse Event|22
2096377|NCT00798434|3685574|FG001|Double-Blind|Adverse Event|46
2096378|NCT00798434|3685573|FG000|Double-Blind|Death|0
2096379|NCT00798434|3685574|FG001|Double-Blind|Death|1
2096380|NCT00798434|3685573|FG000|Double-Blind|Lost to Follow-up|1
2096381|NCT00798434|3685574|FG001|Double-Blind|Lost to Follow-up|0
2096382|NCT00798434|3685573|FG000|Double-Blind|Lack of Efficacy|8
2096383|NCT00798434|3685574|FG001|Double-Blind|Lack of Efficacy|12
2096384|NCT00798434|3685573|FG000|Double-Blind|Withdrawal by Subject|17
2096385|NCT00798434|3685574|FG001|Double-Blind|Withdrawal by Subject|14
2096386|NCT00798434|3685573|FG000|Double-Blind|Protocol Violation|1
2096387|NCT00798434|3685574|FG001|Double-Blind|Protocol Violation|4
2096388|NCT00798434|3685573|FG000|Double-Blind|Did Not Meet Entrance Criteria|2
2096389|NCT00798434|3685574|FG001|Double-Blind|Did Not Meet Entrance Criteria|1
2096390|NCT00798434|3685573|FG000|Double-Blind|Other|1
2096391|NCT00798434|3685574|FG001|Double-Blind|Other|0
2212063|NCT01667419|3853013|FG003|Overall Study|Protocol Violation|0
2212064|NCT01667419|3853010|FG000|Overall Study|Lost to Follow-up|7
2212065|NCT01667419|3853011|FG001|Overall Study|Lost to Follow-up|6
2212066|NCT01667419|3853012|FG002|Overall Study|Lost to Follow-up|2
2212067|NCT01667419|3853013|FG003|Overall Study|Lost to Follow-up|4
2212068|NCT01667419|3853010|FG000|Overall Study|Death|18
2212069|NCT01667419|3853011|FG001|Overall Study|Death|33
2212070|NCT01667419|3853012|FG002|Overall Study|Death|25
2212071|NCT01667419|3853013|FG003|Overall Study|Death|26
2212072|NCT01667432|3853024|FG000|Overall Study|Premature Study Termination|26
2212073|NCT01667432|3853024|FG000|Overall Study|Failure to Return|10
2212074|NCT01667432|3853024|FG000|Overall Study|Moved to Another Center|3
2212075|NCT01667432|3853024|FG000|Overall Study|Lost to Follow-up|3
2212076|NCT01667432|3853024|FG000|Overall Study|Refused Treatment/Withdrew Consent|1
2212077|NCT01667432|3853024|FG000|Overall Study|Insufficient Therapeutic Response|4
2096392|NCT00798434|3685573|FG000|Double-Blind|Not Treated|3
2096393|NCT00798434|3685574|FG001|Double-Blind|Not Treated|6
2096394|NCT00798434|3685573|FG000|Open-Label|Adverse Event|33
2096395|NCT00798434|3685574|FG001|Open-Label|Adverse Event|11
2096396|NCT00798434|3685573|FG000|Open-Label|Lack of Efficacy|5
2096397|NCT00798434|3685574|FG001|Open-Label|Lack of Efficacy|11
2096398|NCT00798434|3685573|FG000|Open-Label|Withdrawal by Subject|2
2096399|NCT00798434|3685574|FG001|Open-Label|Withdrawal by Subject|7
2096400|NCT00798434|3685573|FG000|Open-Label|Protocol Violation|1
2096401|NCT00798434|3685574|FG001|Open-Label|Protocol Violation|0
2096402|NCT00798434|3685573|FG000|Open-Label|Other|1
2212078|NCT01667432|3853024|FG000|Overall Study|Adverse Event|1
2212079|NCT01667432|3853024|FG000|Overall Study|Protocol Deviation|2
2212080|NCT01667432|3853024|FG000|Overall Study|Principal Investigator Decision|1
2096403|NCT00798434|3685574|FG001|Open-Label|Other|2
2096404|NCT00798434|3685573|FG000|Open-Label|Not Treated|0
2096405|NCT00798434|3685574|FG001|Open-Label|Not Treated|1
2096406|NCT00798603|3685598|FG000|Overall Study|Still on treatment as of 11/6/2012|1
2096407|NCT00798603|3685598|FG000|Overall Study|Withdrawal by Subject|10
2096408|NCT00798603|3685598|FG000|Overall Study|Adverse Event|22
2096409|NCT00798603|3685598|FG000|Overall Study|Physician Decision|1
2096410|NCT00798603|3685598|FG000|Overall Study|Lack of insurance coverage|1
2096411|NCT00798655|3685602|FG000|Overall Study|Did not receive at least one dose of pan|2
2096412|NCT00798694|3685608|FG000|Overall Study|Lost to Follow-up|1
2096413|NCT00798694|3685609|FG001|Overall Study|Lost to Follow-up|1
2096414|NCT00798694|3685608|FG000|Overall Study|Physician Decision|1
2096415|NCT00798694|3685609|FG001|Overall Study|Physician Decision|0
2096416|NCT00798707|3685624|FG000|Overall Study|Adverse Event|6
2096417|NCT00798707|3685625|FG001|Overall Study|Adverse Event|8
2096418|NCT00798707|3685626|FG002|Overall Study|Adverse Event|8
2096419|NCT00798707|3685624|FG000|Overall Study|Failed to return|2
2096420|NCT00798707|3685625|FG001|Overall Study|Failed to return|2
2096421|NCT00798707|3685626|FG002|Overall Study|Failed to return|0
2096422|NCT00798707|3685624|FG000|Overall Study|Investigator|0
2096423|NCT00798707|3685625|FG001|Overall Study|Investigator|1
2096424|NCT00798707|3685626|FG002|Overall Study|Investigator|2
2212081|NCT01667432|3853024|FG000|Overall Study|Reason Not Specified|2
2212082|NCT01667432|3853024|FG000|Overall Study|Missing Information|4
2212083|NCT01667549|3853045|FG000|Overall Study|Withdrawal by Subject|3
2096425|NCT00798707|3685624|FG000|Overall Study|Lack of Efficacy|2
2096426|NCT00798707|3685625|FG001|Overall Study|Lack of Efficacy|2
2096427|NCT00798707|3685626|FG002|Overall Study|Lack of Efficacy|1
2096428|NCT00798707|3685624|FG000|Overall Study|Lost to Follow-up|5
2096429|NCT00798707|3685625|FG001|Overall Study|Lost to Follow-up|6
2096430|NCT00798707|3685626|FG002|Overall Study|Lost to Follow-up|6
2096431|NCT00798707|3685624|FG000|Overall Study|Other|0
2096432|NCT00798707|3685625|FG001|Overall Study|Other|1
2096433|NCT00798707|3685626|FG002|Overall Study|Other|0
2096434|NCT00798707|3685624|FG000|Overall Study|Protocol Violation|4
2096435|NCT00798707|3685625|FG001|Overall Study|Protocol Violation|0
2096436|NCT00798707|3685626|FG002|Overall Study|Protocol Violation|2
2096437|NCT00798707|3685624|FG000|Overall Study|Withdrawal by Subject|3
2096438|NCT00798707|3685625|FG001|Overall Study|Withdrawal by Subject|8
2096439|NCT00798707|3685626|FG002|Overall Study|Withdrawal by Subject|2
2096440|NCT00798707|3685624|FG000|Overall Study|Randomized not treated|4
2096441|NCT00798707|3685625|FG001|Overall Study|Randomized not treated|5
2096442|NCT00798707|3685626|FG002|Overall Study|Randomized not treated|1
2096443|NCT00798759|3685640|FG000|Overall Study|Adverse Event|3
2096444|NCT00798759|3685641|FG001|Overall Study|Adverse Event|3
2096445|NCT00798759|3685640|FG000|Overall Study|Lost to Follow-up|1
2096446|NCT00798759|3685641|FG001|Overall Study|Lost to Follow-up|1
2096447|NCT00798759|3685640|FG000|Overall Study|Protocol Violation|4
2096448|NCT00798759|3685641|FG001|Overall Study|Protocol Violation|8
2096449|NCT00798759|3685640|FG000|Overall Study|Other|0
2096450|NCT00798759|3685641|FG001|Overall Study|Other|1
2096451|NCT00798889|3685647|FG000|Overall Study|Adverse Event|53
2096452|NCT00798889|3685647|FG000|Overall Study|Protocol Violation|2
2096453|NCT00798889|3685647|FG000|Overall Study|Withdrawal by Subject|31
2096454|NCT00798889|3685647|FG000|Overall Study|Lost to Follow-up|1
2096455|NCT00798889|3685647|FG000|Overall Study|Lack of Efficacy|213
2096456|NCT00798889|3685647|FG000|Overall Study|Decision of Sponsor|11
2096457|NCT00798889|3685647|FG000|Overall Study|Enrolled, Not treated|3
2096458|NCT00798967|3685653|FG000|Overall Study|Adverse Event|2
2212084|NCT01667549|3853046|FG001|Overall Study|Withdrawal by Subject|5
2212085|NCT01667549|3853047|FG002|Overall Study|Withdrawal by Subject|7
2212086|NCT01667549|3853048|FG003|Overall Study|Withdrawal by Subject|6
2212087|NCT01667549|3853049|FG004|Overall Study|Withdrawal by Subject|1
2212088|NCT01667562|3853066|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30
2212089|NCT01667562|3853067|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0
2096459|NCT00798967|3685654|FG001|Overall Study|Adverse Event|3
2096460|NCT00798967|3685653|FG000|Overall Study|Withdrawal by Subject|0
2096461|NCT00798967|3685654|FG001|Overall Study|Withdrawal by Subject|1
2096462|NCT00798967|3685653|FG000|Overall Study|Physician Decision|1
2096463|NCT00798967|3685654|FG001|Overall Study|Physician Decision|0
2096464|NCT00798967|3685653|FG000|Overall Study|Randomized in error by site|1
2096465|NCT00798967|3685654|FG001|Overall Study|Randomized in error by site|0
2096466|NCT00799383|3685667|FG000|Overall Study|Protocol Violation|1
2096467|NCT00799383|3685668|FG001|Overall Study|Protocol Violation|1
2096468|NCT00799383|3685667|FG000|Overall Study|Adverse Event|0
2096469|NCT00799383|3685668|FG001|Overall Study|Adverse Event|1
2096470|NCT00799383|3685667|FG000|Overall Study|Lost to Follow-up|1
2096471|NCT00799383|3685668|FG001|Overall Study|Lost to Follow-up|2
2096472|NCT00799383|3685667|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1
2096473|NCT00799383|3685668|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1
2096474|NCT00799383|3685667|FG000|Overall Study|Withdrawal by Subject|0
2096475|NCT00799383|3685668|FG001|Overall Study|Withdrawal by Subject|1
2212090|NCT01667562|3853066|FG000|Erlotinib Phase|Lost to Follow-up|0
2096476|NCT00799409|3685677|FG000|Overall Study|Withdrawal by Subject|1
2096477|NCT00799409|3685678|FG001|Overall Study|Withdrawal by Subject|0
2212091|NCT01667562|3853067|FG001|Erlotinib Phase|Lost to Follow-up|1
2096478|NCT00799409|3685679|FG002|Overall Study|Withdrawal by Subject|0
2096479|NCT00799409|3685677|FG000|Overall Study|Lost to Follow-up|1
2096480|NCT00799409|3685678|FG001|Overall Study|Lost to Follow-up|0
2096481|NCT00799409|3685679|FG002|Overall Study|Lost to Follow-up|0
2096482|NCT00799409|3685677|FG000|Overall Study|Optimal Dose Not Achieved|2
2096483|NCT00799409|3685678|FG001|Overall Study|Optimal Dose Not Achieved|0
2096484|NCT00799409|3685679|FG002|Overall Study|Optimal Dose Not Achieved|0
2096485|NCT00799409|3685677|FG000|Overall Study|Failure to follow study protocol)|1
2096486|NCT00799409|3685678|FG001|Overall Study|Failure to follow study protocol)|0
2096487|NCT00799409|3685679|FG002|Overall Study|Failure to follow study protocol)|0
2096488|NCT00799409|3685677|FG000|Overall Study|Did not attend lab school day 1|1
2096489|NCT00799409|3685678|FG001|Overall Study|Did not attend lab school day 1|0
2096490|NCT00799409|3685679|FG002|Overall Study|Did not attend lab school day 1|0
2096491|NCT00799409|3685677|FG000|Overall Study|medication compliance|1
2096492|NCT00799409|3685678|FG001|Overall Study|medication compliance|0
2096493|NCT00799409|3685679|FG002|Overall Study|medication compliance|0
2096494|NCT00799422|3685687|FG000|First Week of Wear|Lost to Follow-up|0
2096495|NCT00799422|3685688|FG001|First Week of Wear|Lost to Follow-up|0
2096496|NCT00799422|3685689|FG002|First Week of Wear|Lost to Follow-up|1
2096497|NCT00799422|3685690|FG003|First Week of Wear|Lost to Follow-up|0
2096498|NCT00799422|3685691|FG004|First Week of Wear|Lost to Follow-up|0
2096499|NCT00799422|3685692|FG005|First Week of Wear|Lost to Follow-up|0
2096500|NCT00799422|3685687|FG000|First Week of Wear|Adverse Event|0
2096501|NCT00799422|3685688|FG001|First Week of Wear|Adverse Event|0
2096502|NCT00799422|3685689|FG002|First Week of Wear|Adverse Event|0
2096503|NCT00799422|3685690|FG003|First Week of Wear|Adverse Event|1
2096504|NCT00799422|3685691|FG004|First Week of Wear|Adverse Event|0
2096505|NCT00799422|3685692|FG005|First Week of Wear|Adverse Event|0
2096506|NCT00799487|3685716|FG000|Dose Adjustment Period|Lost to Follow-up|1
2096507|NCT00799487|3685717|FG001|Dose Adjustment Period|Lost to Follow-up|0
2096508|NCT00799487|3685718|FG002|Dose Adjustment Period|Lost to Follow-up|0
2096509|NCT00799487|3685716|FG000|Dose Adjustment Period|Adverse Event|2
2096510|NCT00799487|3685717|FG001|Dose Adjustment Period|Adverse Event|0
2096511|NCT00799487|3685718|FG002|Dose Adjustment Period|Adverse Event|0
2096512|NCT00799487|3685716|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8
2096513|NCT00799487|3685717|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0
2096514|NCT00799487|3685718|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0
2096515|NCT00799487|3685716|FG000|Dose Adjustment Period|Investigator Discretion|2
2096516|NCT00799487|3685717|FG001|Dose Adjustment Period|Investigator Discretion|0
2096517|NCT00799487|3685718|FG002|Dose Adjustment Period|Investigator Discretion|0
2096518|NCT00799487|3685716|FG000|Dose Adjustment Period|Withdrawal by Subject|3
2096519|NCT00799487|3685717|FG001|Dose Adjustment Period|Withdrawal by Subject|0
2096520|NCT00799487|3685718|FG002|Dose Adjustment Period|Withdrawal by Subject|0
2096521|NCT00799487|3685716|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1
2096522|NCT00799487|3685717|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0
2096523|NCT00799487|3685718|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0
2096524|NCT00799487|3685716|FG000|Dose Adjustment Period|Child too young (exclusion)|1
2096525|NCT00799487|3685717|FG001|Dose Adjustment Period|Child too young (exclusion)|0
2096526|NCT00799487|3685718|FG002|Dose Adjustment Period|Child too young (exclusion)|0
2096527|NCT00799487|3685716|FG000|Dose Adjustment Period|Missed laboratory day 1|1
2096528|NCT00799487|3685717|FG001|Dose Adjustment Period|Missed laboratory day 1|0
2096529|NCT00799487|3685718|FG002|Dose Adjustment Period|Missed laboratory day 1|0
2096530|NCT00799487|3685716|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
2096531|NCT00799487|3685717|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
2096532|NCT00799487|3685718|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
2096533|NCT00799487|3685716|FG000|Double-Blind Assessment Period|Lost to Follow-up|0
2096534|NCT00799487|3685717|FG001|Double-Blind Assessment Period|Lost to Follow-up|0
2096535|NCT00799487|3685718|FG002|Double-Blind Assessment Period|Lost to Follow-up|1
2096536|NCT00799487|3685716|FG000|Double-Blind Assessment Period|Subject was out of the state|0
2096537|NCT00799487|3685717|FG001|Double-Blind Assessment Period|Subject was out of the state|0
2096538|NCT00799487|3685718|FG002|Double-Blind Assessment Period|Subject was out of the state|1
2096539|NCT00799487|3685716|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0
2096540|NCT00799487|3685717|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1
2096541|NCT00799487|3685718|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0
2096542|NCT00799591|3685733|FG000|Overall Study|De-escalation of doses|20
2096543|NCT00799591|3685733|FG000|Overall Study|Death|14
2096544|NCT00799591|3685733|FG000|Overall Study|Technical failure|12
2096545|NCT00799591|3685733|FG000|Overall Study|Resistant germ|11
2096546|NCT00799591|3685733|FG000|Overall Study|New infection|4
2096547|NCT00799591|3685733|FG000|Overall Study|Resistance germ and technical failure|2
2096548|NCT00799591|3685733|FG000|Overall Study|Persistance of fever undetermined origin|1
2096549|NCT00799591|3685733|FG000|Overall Study|Antibiotic changed, no apparent reason|1
2096550|NCT00799591|3685733|FG000|Overall Study|Infectious origin not probable|1
2096551|NCT00799617|3685752|FG000|Main Testosterone Trial|Randomized in error|1
2096552|NCT00799617|3685753|FG001|Main Testosterone Trial|Randomized in error|1
2096553|NCT00799617|3685752|FG000|Main Testosterone Trial|Lost to Follow-up|18
2096554|NCT00799617|3685753|FG001|Main Testosterone Trial|Lost to Follow-up|20
2096555|NCT00799617|3685752|FG000|Sexual Funtion Trial|Lost to Follow-up|12
2096556|NCT00799617|3685753|FG001|Sexual Funtion Trial|Lost to Follow-up|14
2096557|NCT00799617|3685752|FG000|Sexual Funtion Trial|No Baseline Data|4
2096558|NCT00799617|3685753|FG001|Sexual Funtion Trial|No Baseline Data|7
2096559|NCT00799617|3685752|FG000|Physical Function Trial|Lost to Follow-up|6
2096560|NCT00799617|3685753|FG001|Physical Function Trial|Lost to Follow-up|11
2096561|NCT00799617|3685752|FG000|Vitality Trial|Lost to Follow-up|7
2096562|NCT00799617|3685753|FG001|Vitality Trial|Lost to Follow-up|22
2096563|NCT00799617|3685752|FG000|Cardiovascular Trial|Month 12 scan not available|15
2096564|NCT00799617|3685753|FG001|Cardiovascular Trial|Month 12 scan not available|15
2096565|NCT00799617|3685752|FG000|Cardiovascular Trial|Baseline scan not analyzable|0
2096566|NCT00799617|3685753|FG001|Cardiovascular Trial|Baseline scan not analyzable|2
2096567|NCT00799617|3685752|FG000|Bone Trial|Month 12 scan not available|6
2096568|NCT00799617|3685753|FG001|Bone Trial|Month 12 scan not available|16
2096569|NCT00799617|3685752|FG000|Cognitive Function Trial|Lost to Follow-up|0
2096570|NCT00799617|3685753|FG001|Cognitive Function Trial|Lost to Follow-up|1
2096571|NCT00799617|3685752|FG000|Anemia Trial|Withdrawal by Subject|3
2096572|NCT00799617|3685753|FG001|Anemia Trial|Withdrawal by Subject|3
2096573|NCT00799708|3685772|FG000|Overall Study|non-compliance|1
2096574|NCT00799708|3685773|FG001|Overall Study|non-compliance|0
2096575|NCT00799708|3685774|FG002|Overall Study|non-compliance|0
2096576|NCT00799825|3685796|FG000|Overall Study|Adverse Event|1
2096577|NCT00799825|3685796|FG000|Overall Study|Withdrawal by Subject|6
2096578|NCT00799825|3685796|FG000|Overall Study|Lost to Follow-up|38
2096579|NCT00799825|3685796|FG000|Overall Study|Pregnancy|3
2096580|NCT00799903|3685802|FG000|Overall Study|Investigator Site Closed|25
2096581|NCT00799903|3685803|FG001|Overall Study|Investigator Site Closed|23
2096582|NCT00799903|3685802|FG000|Overall Study|Withdrawal by Subject|179
2096583|NCT00799903|3685803|FG001|Overall Study|Withdrawal by Subject|175
2096584|NCT00799903|3685802|FG000|Overall Study|Lost to Follow-up|69
2096585|NCT00799903|3685803|FG001|Overall Study|Lost to Follow-up|80
2096586|NCT00800176|3685829|FG000|Overall Study|Adverse Event|2
2096587|NCT00800176|3685830|FG001|Overall Study|Adverse Event|1
2096588|NCT00800176|3685831|FG002|Overall Study|Adverse Event|0
2096589|NCT00800176|3685832|FG003|Overall Study|Adverse Event|2
2096590|NCT00800176|3685833|FG004|Overall Study|Adverse Event|1
2096591|NCT00800176|3685834|FG005|Overall Study|Adverse Event|1
2096592|NCT00800176|3685829|FG000|Overall Study|Refused treatment|3
2096593|NCT00800176|3685830|FG001|Overall Study|Refused treatment|2
2096594|NCT00800176|3685831|FG002|Overall Study|Refused treatment|0
2096595|NCT00800176|3685832|FG003|Overall Study|Refused treatment|0
2096596|NCT00800176|3685833|FG004|Overall Study|Refused treatment|1
2096597|NCT00800176|3685834|FG005|Overall Study|Refused treatment|4
2096598|NCT00800176|3685829|FG000|Overall Study|Failure to return|3
2096599|NCT00800176|3685830|FG001|Overall Study|Failure to return|3
2096600|NCT00800176|3685831|FG002|Overall Study|Failure to return|0
2096601|NCT00800176|3685832|FG003|Overall Study|Failure to return|2
2096602|NCT00800176|3685833|FG004|Overall Study|Failure to return|0
2096603|NCT00800176|3685834|FG005|Overall Study|Failure to return|0
2096604|NCT00800176|3685829|FG000|Overall Study|Other|1
2096605|NCT00800176|3685830|FG001|Overall Study|Other|0
2096606|NCT00800176|3685831|FG002|Overall Study|Other|0
2096607|NCT00800176|3685832|FG003|Overall Study|Other|0
2096608|NCT00800176|3685833|FG004|Overall Study|Other|2
2096609|NCT00800176|3685834|FG005|Overall Study|Other|0
2096610|NCT00800202|3685850|FG000|Overall Study|Adverse Event|7
2096611|NCT00800202|3685851|FG001|Overall Study|Adverse Event|6
2096612|NCT00800202|3685850|FG000|Overall Study|Death|1
2096613|NCT00800202|3685851|FG001|Overall Study|Death|0
2096614|NCT00800202|3685850|FG000|Overall Study|Other|5
2096615|NCT00800202|3685851|FG001|Overall Study|Other|0
2096616|NCT00800202|3685850|FG000|Overall Study|Disease Progression|54
2096617|NCT00800202|3685851|FG001|Overall Study|Disease Progression|18
2096618|NCT00800384|3685872|FG000|Overall Study|Withdrawal by Subject|24
2096619|NCT00800384|3685873|FG001|Overall Study|Withdrawal by Subject|17
2096620|NCT00800384|3685872|FG000|Overall Study|Lost to Follow-up|17
2096621|NCT00800384|3685873|FG001|Overall Study|Lost to Follow-up|26
2096622|NCT00800436|3685887|FG000|Overall Study|Withdrawal by Subject|0
2096623|NCT00800436|3685888|FG001|Overall Study|Withdrawal by Subject|0
2096624|NCT00800436|3685889|FG002|Overall Study|Withdrawal by Subject|1
2096625|NCT00800436|3685890|FG003|Overall Study|Withdrawal by Subject|1
2096626|NCT00800436|3685891|FG004|Overall Study|Withdrawal by Subject|0
2096627|NCT00800436|3685892|FG005|Overall Study|Withdrawal by Subject|0
2096628|NCT00800436|3685893|FG006|Overall Study|Withdrawal by Subject|0
2096629|NCT00800540|3685909|FG000|Period One: 6 Weeks|Noncompliance|1
2096630|NCT00800540|3685910|FG001|Period One: 6 Weeks|Noncompliance|0
2096631|NCT00800540|3685909|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
2096632|NCT00800540|3685910|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
2096633|NCT00800540|3685909|FG000|Period 2: 6 Weeks|Adverse Event|0
2096634|NCT00800540|3685910|FG001|Period 2: 6 Weeks|Adverse Event|1
2096635|NCT00800683|3685918|FG000|Overall Study|Adverse Event|11
2096636|NCT00800683|3685919|FG001|Overall Study|Adverse Event|8
2096637|NCT00800683|3685918|FG000|Overall Study|Lost to Follow-up|3
2096638|NCT00800683|3685919|FG001|Overall Study|Lost to Follow-up|1
2096639|NCT00800683|3685918|FG000|Overall Study|Withdrawal by Subject|1
2096640|NCT00800683|3685919|FG001|Overall Study|Withdrawal by Subject|7
2096641|NCT00800683|3685918|FG000|Overall Study|Lack of Efficacy|1
2096642|NCT00800683|3685919|FG001|Overall Study|Lack of Efficacy|1
2096643|NCT00800683|3685918|FG000|Overall Study|Other|1
2096644|NCT00800683|3685919|FG001|Overall Study|Other|2
2096645|NCT00800735|3685925|FG000|Overall Study|Administrative/Other|2
2096646|NCT00800735|3685925|FG000|Overall Study|Insufficient Therapeutic Response|2
2096647|NCT00800735|3685925|FG000|Overall Study|Violation of Selection Criteria at Entry|7
2096648|NCT00800735|3685925|FG000|Overall Study|Withdrew Consent|3
2096649|NCT00800982|3685944|FG000|Overall Study|Lost to Follow-up|1
2096650|NCT00800982|3685945|FG001|Overall Study|Lost to Follow-up|2
2096651|NCT00800982|3685944|FG000|Overall Study|Withdrawal by Subject|0
2096652|NCT00800982|3685945|FG001|Overall Study|Withdrawal by Subject|1
2096653|NCT00800982|3685944|FG000|Overall Study|Patient moved out of state|1
2096654|NCT00800982|3685945|FG001|Overall Study|Patient moved out of state|0
2096655|NCT00801099|3685951|FG000|Overall Study|Lost to Follow-up|101
2096656|NCT00801229|3685974|FG000|Signed Consent|Withdrawal by Subject|2
2096657|NCT00801229|3685975|FG001|Signed Consent|Withdrawal by Subject|2
2096658|NCT00801229|3685974|FG000|Signed Consent|Found Ineligible|1
2096659|NCT00801229|3685975|FG001|Signed Consent|Found Ineligible|1
2096660|NCT00801229|3685974|FG000|Received Study Drug/Placebo|Elevated SGOT level|1
2096661|NCT00801229|3685975|FG001|Received Study Drug/Placebo|Elevated SGOT level|0
2096662|NCT00801229|3685974|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0
2096663|NCT00801229|3685975|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1
2096664|NCT00801229|3685974|FG000|Received Study Drug/Placebo|Simulator sickness|1
2096665|NCT00801229|3685975|FG001|Received Study Drug/Placebo|Simulator sickness|1
2096666|NCT00801229|3685974|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1
2096667|NCT00801229|3685975|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0
2096668|NCT00801229|3685974|FG000|Received Study Drug/Placebo|Lost to Follow-up|0
2096669|NCT00801229|3685975|FG001|Received Study Drug/Placebo|Lost to Follow-up|1
2096670|NCT00801229|3685974|FG000|Received Study Drug/Placebo|Adverse Event|1
2096671|NCT00801229|3685975|FG001|Received Study Drug/Placebo|Adverse Event|1
2096672|NCT00801242|3685981|FG000|Overall Study|Adverse Event|10
2096673|NCT00801242|3685981|FG000|Overall Study|Withdrawal by Subject|13
2096674|NCT00801242|3685981|FG000|Overall Study|Protocol Violation|5
2096675|NCT00801242|3685981|FG000|Overall Study|Physician Decision|3
2096676|NCT00801242|3685981|FG000|Overall Study|Lost to Follow-up|1
2096677|NCT00801242|3685981|FG000|Overall Study|Miscellaneous reasons|20
2096678|NCT00801632|3686024|FG000|Overall Study|Re-transplant|1
2107670|NCT00875420|3701364|FG003|Overall Study|Personal reason|0
2107671|NCT00875420|3701365|FG004|Overall Study|Personal reason|1
2107672|NCT00875420|3701361|FG000|Overall Study|Prohibited medication|0
2107673|NCT00875420|3701362|FG001|Overall Study|Prohibited medication|0
2107674|NCT00875420|3701363|FG002|Overall Study|Prohibited medication|0
2107675|NCT00875420|3701364|FG003|Overall Study|Prohibited medication|1
2107676|NCT00875420|3701365|FG004|Overall Study|Prohibited medication|0
2107677|NCT00875420|3701361|FG000|Overall Study|Sponsor decision|0
2107678|NCT00875420|3701362|FG001|Overall Study|Sponsor decision|1
2107679|NCT00875420|3701363|FG002|Overall Study|Sponsor decision|0
2107680|NCT00875420|3701364|FG003|Overall Study|Sponsor decision|0
2107681|NCT00875420|3701365|FG004|Overall Study|Sponsor decision|0
2107682|NCT00875420|3701361|FG000|Overall Study|Withdrawal by Subject|0
2107683|NCT00875420|3701362|FG001|Overall Study|Withdrawal by Subject|0
2107684|NCT00875420|3701363|FG002|Overall Study|Withdrawal by Subject|1
2107685|NCT00875420|3701364|FG003|Overall Study|Withdrawal by Subject|0
2107686|NCT00875420|3701365|FG004|Overall Study|Withdrawal by Subject|0
2107687|NCT00875433|3701377|FG000|Overall Study|Progressive disease|41
2107688|NCT00875433|3701377|FG000|Overall Study|Other Adverse Event|14
2107689|NCT00875433|3701377|FG000|Overall Study|Withdrawal by Subject|2
2107690|NCT00875433|3701377|FG000|Overall Study|Other|3
2212092|NCT01667562|3853066|FG000|Erlotinib Phase|Adverse Event|0
2107691|NCT00875485|3701383|FG000|Challenge Dose Epoch|Pregnancy|1
2107692|NCT00875485|3701384|FG001|Challenge Dose Epoch|Pregnancy|0
2107693|NCT00875524|3701392|FG000|Overall Study|Serious adverse event|0
2107694|NCT00875524|3701393|FG001|Overall Study|Serious adverse event|1
2107695|NCT00875524|3701392|FG000|Overall Study|Protocol Violation|4
2107696|NCT00875524|3701393|FG001|Overall Study|Protocol Violation|0
2107697|NCT00875524|3701392|FG000|Overall Study|Lost to Follow-up|1
2107698|NCT00875524|3701393|FG001|Overall Study|Lost to Follow-up|0
2107699|NCT00875524|3701392|FG000|Overall Study|Withdrawal by Subject|3
2107700|NCT00875524|3701393|FG001|Overall Study|Withdrawal by Subject|5
2107701|NCT00875563|3701410|FG000|Overall Study|Death|4
2107702|NCT00875563|3701410|FG000|Overall Study|Withdrawal by Subject|7
2107703|NCT00875563|3701410|FG000|Overall Study|No long-term (3-5 year) consent|6
2107704|NCT00875563|3701410|FG000|Overall Study|Still be eligible for follow-up|7
2107705|NCT00875615|3701423|FG000|Overall Study|Withdrawal by Subject|1
2107706|NCT00875667|3701442|FG000|Overall Study|Adverse Event|29
2107707|NCT00875667|3701443|FG001|Overall Study|Adverse Event|10
2107708|NCT00875667|3701442|FG000|Overall Study|Withdrawal by Subject|17
2107709|NCT00875667|3701443|FG001|Overall Study|Withdrawal by Subject|5
2107710|NCT00875667|3701442|FG000|Overall Study|Death|7
2107711|NCT00875667|3701443|FG001|Overall Study|Death|2
2096679|NCT00801892|3686065|FG000|Main Study Period|Withdrawal by Subject|0
2096680|NCT00801892|3686066|FG001|Main Study Period|Withdrawal by Subject|1
2096681|NCT00801892|3686065|FG000|Sham Crossover Period|Lost to Follow-up|0
2096682|NCT00801892|3686066|FG001|Sham Crossover Period|Lost to Follow-up|2
2096683|NCT00801983|3686076|FG000|Period 1|Lost to Follow-up|2
2096684|NCT00801983|3686077|FG001|Period 1|Lost to Follow-up|0
2096685|NCT00801983|3686076|FG000|Period 1|Withdrawal by Subject|2
2096686|NCT00801983|3686077|FG001|Period 1|Withdrawal by Subject|8
2096687|NCT00801983|3686076|FG000|Period 2|Withdrawal by Subject|2
2096688|NCT00801983|3686077|FG001|Period 2|Withdrawal by Subject|1
2096689|NCT00802074|3686089|FG000|Overall Study|Adverse Event|1
2096690|NCT00802074|3686090|FG001|Overall Study|Adverse Event|1
2096691|NCT00802074|3686091|FG002|Overall Study|Adverse Event|1
2096692|NCT00802074|3686092|FG003|Overall Study|Adverse Event|0
2096693|NCT00802074|3686093|FG004|Overall Study|Adverse Event|0
2096694|NCT00802074|3686094|FG005|Overall Study|Adverse Event|0
2096695|NCT00802074|3686089|FG000|Overall Study|Withdrawal by Subject|1
2096696|NCT00802074|3686090|FG001|Overall Study|Withdrawal by Subject|0
2096697|NCT00802074|3686091|FG002|Overall Study|Withdrawal by Subject|0
2096698|NCT00802074|3686092|FG003|Overall Study|Withdrawal by Subject|0
2096699|NCT00802074|3686093|FG004|Overall Study|Withdrawal by Subject|0
2096700|NCT00802074|3686094|FG005|Overall Study|Withdrawal by Subject|0
2096701|NCT00802178|3686134|FG000|Overall Study|Lack of Efficacy|36
2096702|NCT00802178|3686134|FG000|Overall Study|Insufficient tolerability (IT)|17
2096703|NCT00802178|3686134|FG000|Overall Study|Withdrawal by Subject|18
2096704|NCT00802178|3686134|FG000|Overall Study|Other|32
2096705|NCT00802178|3686134|FG000|Overall Study|Lack of efficacy and patient wish|1
2096706|NCT00802178|3686134|FG000|Overall Study|IT and patient wish|8
2096707|NCT00802178|3686134|FG000|Overall Study|Patients wish and other reason|1
2096708|NCT00802360|3686154|FG000|Overall Study|Stimulation failure|4
2096709|NCT00802360|3686155|FG001|Overall Study|Stimulation failure|0
2096710|NCT00802360|3686156|FG002|Overall Study|Stimulation failure|3
2096711|NCT00802360|3686157|FG003|Overall Study|Stimulation failure|3
2096712|NCT00802360|3686154|FG000|Overall Study|Inadequate number of oocytes retrieved|0
2096713|NCT00802360|3686155|FG001|Overall Study|Inadequate number of oocytes retrieved|0
2096714|NCT00802360|3686156|FG002|Overall Study|Inadequate number of oocytes retrieved|0
2096715|NCT00802360|3686157|FG003|Overall Study|Inadequate number of oocytes retrieved|1
2212093|NCT01667562|3853067|FG001|Erlotinib Phase|Adverse Event|1
2212094|NCT01667562|3853066|FG000|Erlotinib Phase|Switch to Commercial Drug|0
2212095|NCT01667562|3853067|FG001|Erlotinib Phase|Switch to Commercial Drug|1
2212096|NCT01667679|3853074|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
2212097|NCT01667679|3853075|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
2212098|NCT01667679|3853074|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
2212099|NCT01667679|3853075|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
2212100|NCT01667679|3853074|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
2096716|NCT00802360|3686154|FG000|Overall Study|Cycle cancelled|0
2096717|NCT00802360|3686155|FG001|Overall Study|Cycle cancelled|1
2096718|NCT00802360|3686156|FG002|Overall Study|Cycle cancelled|1
2096719|NCT00802360|3686157|FG003|Overall Study|Cycle cancelled|1
2096720|NCT00802360|3686154|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0
2096721|NCT00802360|3686155|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0
2096722|NCT00802360|3686156|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0
2096723|NCT00802360|3686157|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1
2096724|NCT00802360|3686154|FG000|Overall Study|No positive serum pregnancy|17
2096725|NCT00802360|3686155|FG001|Overall Study|No positive serum pregnancy|20
2096726|NCT00802360|3686156|FG002|Overall Study|No positive serum pregnancy|14
2096727|NCT00802360|3686157|FG003|Overall Study|No positive serum pregnancy|10
2096728|NCT00802360|3686154|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1
2096729|NCT00802360|3686155|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
2096730|NCT00802360|3686156|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1
2096731|NCT00802360|3686157|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0
2096732|NCT00802360|3686154|FG000|Overall Study|Pregnancy loss/miscarriage|0
2096733|NCT00802360|3686155|FG001|Overall Study|Pregnancy loss/miscarriage|2
2096734|NCT00802360|3686156|FG002|Overall Study|Pregnancy loss/miscarriage|0
2096735|NCT00802360|3686157|FG003|Overall Study|Pregnancy loss/miscarriage|3
2096736|NCT00802360|3686154|FG000|Overall Study|Other|2
2096737|NCT00802360|3686155|FG001|Overall Study|Other|3
2096738|NCT00802360|3686156|FG002|Overall Study|Other|6
2096739|NCT00802360|3686157|FG003|Overall Study|Other|3
2096740|NCT00802438|3686178|FG000|Overall Study|Screen Failure|20
2096741|NCT00802438|3686178|FG000|Overall Study|Withdrawal by Subject|7
2096742|NCT00802438|3686178|FG000|Overall Study|Physician Decision|1
2096743|NCT00802464|3686186|FG000|Month 0 - Month 8|Adverse Event|0
2096744|NCT00802464|3686187|FG001|Month 0 - Month 8|Adverse Event|1
2096745|NCT00802464|3686188|FG002|Month 0 - Month 8|Adverse Event|1
2096746|NCT00802464|3686189|FG003|Month 0 - Month 8|Adverse Event|2
2096747|NCT00802464|3686186|FG000|Month 0 - Month 8|Protocol Violation|0
2096748|NCT00802464|3686187|FG001|Month 0 - Month 8|Protocol Violation|0
2096749|NCT00802464|3686188|FG002|Month 0 - Month 8|Protocol Violation|1
2096750|NCT00802464|3686189|FG003|Month 0 - Month 8|Protocol Violation|0
2096751|NCT00802464|3686186|FG000|Month 0 - Month 8|Withdrawal by Subject|0
2096752|NCT00802464|3686187|FG001|Month 0 - Month 8|Withdrawal by Subject|1
2096753|NCT00802464|3686188|FG002|Month 0 - Month 8|Withdrawal by Subject|2
2096754|NCT00802464|3686189|FG003|Month 0 - Month 8|Withdrawal by Subject|5
2096755|NCT00802464|3686186|FG000|Month 0 - Month 8|Lost to Follow-up|0
2096756|NCT00802464|3686187|FG001|Month 0 - Month 8|Lost to Follow-up|1
2096757|NCT00802464|3686188|FG002|Month 0 - Month 8|Lost to Follow-up|2
2096758|NCT00802464|3686189|FG003|Month 0 - Month 8|Lost to Follow-up|2
2096759|NCT00802464|3686186|FG000|Month 0 - Month 8|Other|0
2096760|NCT00802464|3686187|FG001|Month 0 - Month 8|Other|0
2096761|NCT00802464|3686188|FG002|Month 0 - Month 8|Other|1
2096762|NCT00802464|3686189|FG003|Month 0 - Month 8|Other|0
2096763|NCT00802464|3686186|FG000|Month 8 - Month 14|Adverse Event|0
2096764|NCT00802464|3686187|FG001|Month 8 - Month 14|Adverse Event|1
2096765|NCT00802464|3686188|FG002|Month 8 - Month 14|Adverse Event|0
2096766|NCT00802464|3686189|FG003|Month 8 - Month 14|Adverse Event|0
2096767|NCT00802464|3686186|FG000|Month 8 - Month 14|Withdrawal by Subject|1
2096768|NCT00802464|3686187|FG001|Month 8 - Month 14|Withdrawal by Subject|1
2096769|NCT00802464|3686188|FG002|Month 8 - Month 14|Withdrawal by Subject|0
2096770|NCT00802464|3686189|FG003|Month 8 - Month 14|Withdrawal by Subject|0
2096771|NCT00802464|3686186|FG000|Month 8 - Month 14|Lost to Follow-up|0
2096772|NCT00802464|3686187|FG001|Month 8 - Month 14|Lost to Follow-up|0
2096773|NCT00802464|3686188|FG002|Month 8 - Month 14|Lost to Follow-up|1
2096774|NCT00802464|3686189|FG003|Month 8 - Month 14|Lost to Follow-up|0
2096775|NCT00802529|3686216|FG000|Overall Study|Lost to Follow-up|0
2096776|NCT00802529|3686217|FG001|Overall Study|Lost to Follow-up|1
2096777|NCT00802672|3686235|FG000|Overall Study|Lack of fungal pathogen at baseline|56
2096778|NCT00802672|3686236|FG001|Overall Study|Lack of fungal pathogen at baseline|43
2096779|NCT00802672|3686237|FG002|Overall Study|Lack of fungal pathogen at baseline|25
2096780|NCT00802672|3686235|FG000|Overall Study|Adverse Event|1
2096781|NCT00802672|3686236|FG001|Overall Study|Adverse Event|1
2096782|NCT00802672|3686237|FG002|Overall Study|Adverse Event|1
2096783|NCT00802672|3686235|FG000|Overall Study|Protocol Violation|2
2096784|NCT00802672|3686236|FG001|Overall Study|Protocol Violation|1
2096785|NCT00802672|3686237|FG002|Overall Study|Protocol Violation|1
2096786|NCT00802672|3686235|FG000|Overall Study|Lost to Follow-up|5
2096787|NCT00802672|3686236|FG001|Overall Study|Lost to Follow-up|5
2096788|NCT00802672|3686237|FG002|Overall Study|Lost to Follow-up|3
2096789|NCT00802672|3686235|FG000|Overall Study|Withdrawal by Subject|1
2096790|NCT00802672|3686236|FG001|Overall Study|Withdrawal by Subject|1
2096791|NCT00802672|3686237|FG002|Overall Study|Withdrawal by Subject|2
2096792|NCT00802672|3686235|FG000|Overall Study|other|3
2096793|NCT00802672|3686236|FG001|Overall Study|other|1
2096794|NCT00802672|3686237|FG002|Overall Study|other|2
2096795|NCT00802737|3686257|FG000|Overall Study|Withdrawn due to Disease Progression|9
2096796|NCT00802737|3686258|FG001|Overall Study|Withdrawn due to Disease Progression|3
2096797|NCT00802737|3686259|FG002|Overall Study|Withdrawn due to Disease Progression|0
2096798|NCT00802737|3686257|FG000|Overall Study|Death|6
2096799|NCT00802737|3686258|FG001|Overall Study|Death|5
2096800|NCT00802737|3686259|FG002|Overall Study|Death|1
2096801|NCT00802737|3686257|FG000|Overall Study|Adverse Event|1
2096802|NCT00802737|3686258|FG001|Overall Study|Adverse Event|0
2096803|NCT00802737|3686259|FG002|Overall Study|Adverse Event|0
2096804|NCT00802737|3686257|FG000|Overall Study|Received Prohibited Therapy|1
2096805|NCT00802737|3686258|FG001|Overall Study|Received Prohibited Therapy|0
2096806|NCT00802737|3686259|FG002|Overall Study|Received Prohibited Therapy|0
2096807|NCT00802737|3686257|FG000|Overall Study|Ongoing CLL-Treatment|0
2096808|NCT00802737|3686258|FG001|Overall Study|Ongoing CLL-Treatment|1
2096809|NCT00802737|3686259|FG002|Overall Study|Ongoing CLL-Treatment|0
2096810|NCT00802737|3686257|FG000|Overall Study|Participant too Unwell|0
2096811|NCT00802737|3686258|FG001|Overall Study|Participant too Unwell|2
2096812|NCT00802737|3686259|FG002|Overall Study|Participant too Unwell|0
2096813|NCT00802841|3686270|FG000|Overall Study|Administrative problems|1
2096814|NCT00802841|3686271|FG001|Overall Study|Administrative problems|0
2096815|NCT00802841|3686270|FG000|Overall Study|Lost to Follow-up|2
2096816|NCT00802841|3686271|FG001|Overall Study|Lost to Follow-up|1
2096817|NCT00802841|3686270|FG000|Overall Study|Death|1
2096818|NCT00802841|3686271|FG001|Overall Study|Death|2
2096819|NCT00802841|3686270|FG000|Overall Study|Adverse Event|8
2096820|NCT00802841|3686271|FG001|Overall Study|Adverse Event|2
2096821|NCT00802841|3686270|FG000|Overall Study|Disease progression|7
2096822|NCT00802841|3686271|FG001|Overall Study|Disease progression|3
2096823|NCT00802841|3686270|FG000|Overall Study|Withdrawal by Subject|9
2096824|NCT00802841|3686271|FG001|Overall Study|Withdrawal by Subject|5
2096825|NCT00802841|3686270|FG000|Overall Study|Protocol deviation|2
2096826|NCT00802841|3686271|FG001|Overall Study|Protocol deviation|6
2096827|NCT00802841|3686270|FG000|Overall Study|Treatment duration completed|66
2096828|NCT00802841|3686271|FG001|Overall Study|Treatment duration completed|76
2096829|NCT00802867|3686283|FG000|Overall Study|Lost to Follow-up|6
2096830|NCT00802867|3686283|FG000|Overall Study|Protocol Violation|6
2096831|NCT00802867|3686283|FG000|Overall Study|Withdrawal by Subject|1
2096832|NCT00802945|3686307|FG000|Overall Study|Death|27
2096833|NCT00802945|3686308|FG001|Overall Study|Death|23
2096834|NCT00802945|3686307|FG000|Overall Study|Terminated by sponsor|8
2096835|NCT00802945|3686308|FG001|Overall Study|Terminated by sponsor|12
2096836|NCT00803023|3686338|FG000|Overall Study|Adverse Event|5
2096837|NCT00803023|3686339|FG001|Overall Study|Adverse Event|4
2096838|NCT00803023|3686340|FG002|Overall Study|Adverse Event|8
2096839|NCT00803023|3686341|FG003|Overall Study|Adverse Event|6
2096840|NCT00803023|3686338|FG000|Overall Study|Withdrawal by Subject|0
2096841|NCT00803023|3686339|FG001|Overall Study|Withdrawal by Subject|2
2096842|NCT00803023|3686340|FG002|Overall Study|Withdrawal by Subject|0
2096843|NCT00803023|3686341|FG003|Overall Study|Withdrawal by Subject|0
2096844|NCT00803023|3686338|FG000|Overall Study|Lost to Follow-up|0
2096845|NCT00803023|3686339|FG001|Overall Study|Lost to Follow-up|1
2096846|NCT00803023|3686340|FG002|Overall Study|Lost to Follow-up|2
2096847|NCT00803023|3686341|FG003|Overall Study|Lost to Follow-up|1
2096848|NCT00803023|3686338|FG000|Overall Study|Lack of Efficacy|0
2096849|NCT00803023|3686339|FG001|Overall Study|Lack of Efficacy|1
2096850|NCT00803023|3686340|FG002|Overall Study|Lack of Efficacy|1
2096851|NCT00803023|3686341|FG003|Overall Study|Lack of Efficacy|1
2096852|NCT00803049|3686355|FG000|Overall Study|Adverse Event|21
2096853|NCT00803049|3686356|FG001|Overall Study|Adverse Event|33
2096854|NCT00803049|3686357|FG002|Overall Study|Adverse Event|13
2096855|NCT00803049|3686358|FG003|Overall Study|Adverse Event|27
2096856|NCT00803049|3686355|FG000|Overall Study|Lack of Efficacy|10
2096857|NCT00803049|3686356|FG001|Overall Study|Lack of Efficacy|19
2096858|NCT00803049|3686357|FG002|Overall Study|Lack of Efficacy|6
2096859|NCT00803049|3686358|FG003|Overall Study|Lack of Efficacy|13
2096860|NCT00803049|3686355|FG000|Overall Study|Lost to Follow-up|0
2096861|NCT00803049|3686356|FG001|Overall Study|Lost to Follow-up|2
2096862|NCT00803049|3686357|FG002|Overall Study|Lost to Follow-up|0
2096863|NCT00803049|3686358|FG003|Overall Study|Lost to Follow-up|3
2096864|NCT00803049|3686355|FG000|Overall Study|Death|2
2096865|NCT00803049|3686356|FG001|Overall Study|Death|1
2096866|NCT00803049|3686357|FG002|Overall Study|Death|0
2096867|NCT00803049|3686358|FG003|Overall Study|Death|2
2096868|NCT00803049|3686355|FG000|Overall Study|Progressive Disease|6
2096869|NCT00803049|3686356|FG001|Overall Study|Progressive Disease|10
2096870|NCT00803049|3686357|FG002|Overall Study|Progressive Disease|6
2096871|NCT00803049|3686358|FG003|Overall Study|Progressive Disease|6
2096872|NCT00803049|3686355|FG000|Overall Study|Withdrawal by Subject|19
2096873|NCT00803049|3686356|FG001|Overall Study|Withdrawal by Subject|43
2096874|NCT00803049|3686357|FG002|Overall Study|Withdrawal by Subject|16
2096875|NCT00803049|3686358|FG003|Overall Study|Withdrawal by Subject|44
2096876|NCT00803049|3686355|FG000|Overall Study|Protocol Violation|0
2096877|NCT00803049|3686356|FG001|Overall Study|Protocol Violation|1
2096878|NCT00803049|3686357|FG002|Overall Study|Protocol Violation|1
2096879|NCT00803049|3686358|FG003|Overall Study|Protocol Violation|0
2096880|NCT00803049|3686355|FG000|Overall Study|Randomized and Not Treated|0
2096881|NCT00803049|3686356|FG001|Overall Study|Randomized and Not Treated|0
2096882|NCT00803049|3686357|FG002|Overall Study|Randomized and Not Treated|0
2096883|NCT00803049|3686358|FG003|Overall Study|Randomized and Not Treated|2
2096884|NCT00803049|3686355|FG000|Overall Study|Other than Specified Above|3
2096885|NCT00803049|3686356|FG001|Overall Study|Other than Specified Above|9
2096886|NCT00803049|3686357|FG002|Overall Study|Other than Specified Above|2
2096887|NCT00803049|3686358|FG003|Overall Study|Other than Specified Above|5
2096888|NCT00803101|3686387|FG000|Overall Study|Death / Serious Adverse Event|4
2096889|NCT00803101|3686388|FG001|Overall Study|Death / Serious Adverse Event|6
2096890|NCT00803101|3686387|FG000|Overall Study|Withdrawal by Subject|6
2096891|NCT00803101|3686388|FG001|Overall Study|Withdrawal by Subject|4
2096892|NCT00803101|3686387|FG000|Overall Study|Lost to Follow-up|2
2096893|NCT00803101|3686388|FG001|Overall Study|Lost to Follow-up|2
2096894|NCT00803101|3686387|FG000|Overall Study|Protocol Violation|1
2096895|NCT00803101|3686388|FG001|Overall Study|Protocol Violation|7
2096896|NCT00803101|3686387|FG000|Overall Study|Surgery finished outside protocol window|1
2096897|NCT00803101|3686388|FG001|Overall Study|Surgery finished outside protocol window|1
2096898|NCT00803101|3686387|FG000|Overall Study|Patient died outside SAE report period|1
2096899|NCT00803101|3686388|FG001|Overall Study|Patient died outside SAE report period|0
2096900|NCT00803101|3686387|FG000|Overall Study|Patient did not attend scheduled visit|2
2096901|NCT00803101|3686388|FG001|Overall Study|Patient did not attend scheduled visit|1
2096902|NCT00803101|3686387|FG000|Overall Study|Patient did not have surgery|1
2096903|NCT00803101|3686388|FG001|Overall Study|Patient did not have surgery|1
2096904|NCT00803205|3686396|FG000|Overall Study|Adverse Event|7
2096905|NCT00803205|3686397|FG001|Overall Study|Adverse Event|2
2096906|NCT00803205|3686396|FG000|Overall Study|Lost to Follow-up|1
2096907|NCT00803205|3686397|FG001|Overall Study|Lost to Follow-up|0
2096908|NCT00803205|3686396|FG000|Overall Study|Withdrawal by Subject|9
2096909|NCT00803205|3686397|FG001|Overall Study|Withdrawal by Subject|9
2096910|NCT00803205|3686396|FG000|Overall Study|Physician Decision|1
2096911|NCT00803205|3686397|FG001|Overall Study|Physician Decision|0
2096912|NCT00803205|3686396|FG000|Overall Study|Protocol Violation|1
2096913|NCT00803205|3686397|FG001|Overall Study|Protocol Violation|1
2096914|NCT00803205|3686396|FG000|Overall Study|Medical Monitor Decision|1
2096915|NCT00803205|3686397|FG001|Overall Study|Medical Monitor Decision|0
2096916|NCT00803205|3686396|FG000|Overall Study|Acquired a Lung Infection|0
2096917|NCT00803205|3686397|FG001|Overall Study|Acquired a Lung Infection|1
2096918|NCT00803205|3686396|FG000|Overall Study|Sponsor Decision|0
2096919|NCT00803205|3686397|FG001|Overall Study|Sponsor Decision|1
2096920|NCT00803244|3686405|FG000|Overall Study|Adverse Event|1
2096921|NCT00803244|3686406|FG001|Overall Study|Adverse Event|2
2096922|NCT00803244|3686405|FG000|Overall Study|Withdrawal by Subject|2
2096923|NCT00803244|3686406|FG001|Overall Study|Withdrawal by Subject|3
2096924|NCT00803244|3686405|FG000|Overall Study|Any other reason not above-mentioned|4
2096925|NCT00803244|3686406|FG001|Overall Study|Any other reason not above-mentioned|10
2096926|NCT00803270|3686414|FG000|Overall Study|Lost to Follow-up|1
2096927|NCT00803270|3686415|FG001|Overall Study|Lost to Follow-up|2
2096928|NCT00803361|3686423|FG000|Overall Study|Adverse Event|13
2096929|NCT00803361|3686424|FG001|Overall Study|Adverse Event|3
2096930|NCT00803361|3686423|FG000|Overall Study|Lack of Efficacy|4
2096931|NCT00803361|3686424|FG001|Overall Study|Lack of Efficacy|13
2096932|NCT00803361|3686423|FG000|Overall Study|Lost to Follow-up|1
2096933|NCT00803361|3686424|FG001|Overall Study|Lost to Follow-up|2
2096934|NCT00803361|3686423|FG000|Overall Study|Physician Decision|1
2096935|NCT00803361|3686424|FG001|Overall Study|Physician Decision|0
2096936|NCT00803361|3686423|FG000|Overall Study|Protocol Violation|2
2096937|NCT00803361|3686424|FG001|Overall Study|Protocol Violation|4
2096938|NCT00803361|3686423|FG000|Overall Study|Withdrawal by Subject|5
2096939|NCT00803361|3686424|FG001|Overall Study|Withdrawal by Subject|6
2096940|NCT00803452|3686442|FG000|Overall Study|Adverse Event|0
2096941|NCT00803452|3686443|FG001|Overall Study|Adverse Event|2
2096942|NCT00803452|3686442|FG000|Overall Study|Lost to Follow-up|0
2096943|NCT00803452|3686443|FG001|Overall Study|Lost to Follow-up|3
2096944|NCT00803569|3686458|FG000|Overall Study|Progressive Disease|3
2096945|NCT00803569|3686458|FG000|Overall Study|Noncompliance|1
2096946|NCT00803595|3686465|FG000|Overall Study|Adverse Event|3
2096947|NCT00803595|3686466|FG001|Overall Study|Adverse Event|4
2096948|NCT00803595|3686467|FG002|Overall Study|Adverse Event|1
2096949|NCT00803595|3686465|FG000|Overall Study|Protocol Violation|7
2096950|NCT00803595|3686466|FG001|Overall Study|Protocol Violation|2
2096951|NCT00803595|3686467|FG002|Overall Study|Protocol Violation|12
2096952|NCT00803595|3686465|FG000|Overall Study|Withdrawal by Subject|5
2096953|NCT00803595|3686466|FG001|Overall Study|Withdrawal by Subject|2
2096954|NCT00803595|3686467|FG002|Overall Study|Withdrawal by Subject|3
2096955|NCT00803634|3686477|FG000|Overall Study|Withdrew Consent|1
2096956|NCT00803634|3686478|FG001|Overall Study|Withdrew Consent|0
2096957|NCT00803634|3686477|FG000|Overall Study|Lost to Follow-up|2
2096958|NCT00803634|3686478|FG001|Overall Study|Lost to Follow-up|3
2096959|NCT00803634|3686477|FG000|Overall Study|Death|3
2096960|NCT00803634|3686478|FG001|Overall Study|Death|2
2096961|NCT00803712|3686510|FG000|Overall Study|Noncompliance|3
2096962|NCT00803712|3686511|FG001|Overall Study|Noncompliance|0
2096963|NCT00803712|3686510|FG000|Overall Study|Adverse Event|5
2096964|NCT00803712|3686511|FG001|Overall Study|Adverse Event|0
2096965|NCT00803712|3686510|FG000|Overall Study|Death|8
2096966|NCT00803712|3686511|FG001|Overall Study|Death|7
2096967|NCT00803712|3686510|FG000|Overall Study|Lost to Follow-up|3
2096968|NCT00803712|3686511|FG001|Overall Study|Lost to Follow-up|1
2096969|NCT00803712|3686510|FG000|Overall Study|Withdrawal by Subject|2
2096970|NCT00803712|3686511|FG001|Overall Study|Withdrawal by Subject|4
2096971|NCT00803712|3686510|FG000|Overall Study|"Other in electronic Case Report Form"|0
2096972|NCT00803712|3686511|FG001|Overall Study|"Other in electronic Case Report Form"|1
2096973|NCT00803712|3686510|FG000|Overall Study|Protocol criteria (other)|0
2096974|NCT00803712|3686511|FG001|Overall Study|Protocol criteria (other)|2
2096975|NCT00803712|3686510|FG000|Overall Study|Protocol criteria (renal transplant)|12
2096976|NCT00803712|3686511|FG001|Overall Study|Protocol criteria (renal transplant)|8
2096977|NCT00803712|3686510|FG000|Overall Study|Administrative decision|2
2096978|NCT00803712|3686511|FG001|Overall Study|Administrative decision|3
2096979|NCT00803712|3686510|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1
2096980|NCT00803712|3686511|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1
2096981|NCT00803738|3686519|FG000|Overall Study|Adverse Event|3
2096982|NCT00803738|3686520|FG001|Overall Study|Adverse Event|5
2096983|NCT00803738|3686519|FG000|Overall Study|Lost to Follow-up|4
2096984|NCT00803738|3686520|FG001|Overall Study|Lost to Follow-up|4
2096985|NCT00803738|3686519|FG000|Overall Study|Protocol Violation|18
2096986|NCT00803738|3686520|FG001|Overall Study|Protocol Violation|10
2096987|NCT00803738|3686519|FG000|Overall Study|Withdrawal by Subject|1
2096988|NCT00803738|3686520|FG001|Overall Study|Withdrawal by Subject|4
2096989|NCT00803738|3686519|FG000|Overall Study|Lack of Efficacy|10
2096990|NCT00803738|3686520|FG001|Overall Study|Lack of Efficacy|16
2096991|NCT00803738|3686519|FG000|Overall Study|Negative Baseline Culture of Candida|56
2096992|NCT00803738|3686520|FG001|Overall Study|Negative Baseline Culture of Candida|63
2096993|NCT00803738|3686519|FG000|Overall Study|Positive Results for STD or abnormal PAP|2
2096994|NCT00803738|3686520|FG001|Overall Study|Positive Results for STD or abnormal PAP|8
2096995|NCT00804141|3686548|FG000|Overall Study|Adverse Event|157
2096996|NCT00804141|3686548|FG000|Overall Study|Death|4
2096997|NCT00804141|3686548|FG000|Overall Study|Failed to return|96
2096998|NCT00804141|3686548|FG000|Overall Study|Investigator request|8
2096999|NCT00804141|3686548|FG000|Overall Study|Protocol Violation|85
2097000|NCT00804141|3686548|FG000|Overall Study|Withdrawal by Subject|131
2097001|NCT00804141|3686548|FG000|Overall Study|Lack of Efficacy|46
2097002|NCT00804141|3686548|FG000|Overall Study|Other than specified|30
2097003|NCT00804141|3686548|FG000|Overall Study|Enrolled but not treated|6
2097004|NCT00804193|3686555|FG000|Overall Study|Lack of baseline fungus|32
2097005|NCT00804193|3686556|FG001|Overall Study|Lack of baseline fungus|31
2097006|NCT00804193|3686557|FG002|Overall Study|Lack of baseline fungus|19
2097007|NCT00804193|3686555|FG000|Overall Study|Adverse Event|0
2097008|NCT00804193|3686556|FG001|Overall Study|Adverse Event|0
2097009|NCT00804193|3686557|FG002|Overall Study|Adverse Event|2
2097010|NCT00804193|3686555|FG000|Overall Study|Lack of Efficacy|1
2097011|NCT00804193|3686556|FG001|Overall Study|Lack of Efficacy|1
2097012|NCT00804193|3686557|FG002|Overall Study|Lack of Efficacy|3
2097013|NCT00804193|3686555|FG000|Overall Study|Protocol Violation|0
2097014|NCT00804193|3686556|FG001|Overall Study|Protocol Violation|8
2097015|NCT00804193|3686557|FG002|Overall Study|Protocol Violation|2
2097016|NCT00804193|3686555|FG000|Overall Study|Lost to Follow-up|3
2097017|NCT00804193|3686556|FG001|Overall Study|Lost to Follow-up|3
2097018|NCT00804193|3686557|FG002|Overall Study|Lost to Follow-up|4
2097019|NCT00804193|3686555|FG000|Overall Study|Withdrawal by Subject|3
2097020|NCT00804193|3686556|FG001|Overall Study|Withdrawal by Subject|1
2097021|NCT00804193|3686557|FG002|Overall Study|Withdrawal by Subject|2
2097022|NCT00804570|3686567|FG000|Overall Study|Adverse Event|14
2212101|NCT01667679|3853075|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
2212102|NCT01667679|3853074|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
2097023|NCT00804570|3686568|FG001|Overall Study|Adverse Event|7
2097024|NCT00804570|3686567|FG000|Overall Study|Lack of Efficacy|0
2097025|NCT00804570|3686568|FG001|Overall Study|Lack of Efficacy|1
2097026|NCT00804570|3686567|FG000|Overall Study|Lost to Follow-up|18
2097027|NCT00804570|3686568|FG001|Overall Study|Lost to Follow-up|21
2097028|NCT00804570|3686567|FG000|Overall Study|Entry criteria not met|5
2097029|NCT00804570|3686568|FG001|Overall Study|Entry criteria not met|5
2097030|NCT00804570|3686567|FG000|Overall Study|Protocol Violation|12
2097031|NCT00804570|3686568|FG001|Overall Study|Protocol Violation|16
2097032|NCT00804570|3686567|FG000|Overall Study|Physician Decision|1
2097033|NCT00804570|3686568|FG001|Overall Study|Physician Decision|2
2097034|NCT00804570|3686567|FG000|Overall Study|Sponsor decision|1
2097035|NCT00804570|3686568|FG001|Overall Study|Sponsor decision|4
2097036|NCT00804570|3686567|FG000|Overall Study|Withdrawal by Subject|21
2097037|NCT00804570|3686568|FG001|Overall Study|Withdrawal by Subject|38
2097038|NCT00804687|3686601|FG000|Period 3: Treatment Period|Positive Drug screen|0
2097039|NCT00804687|3686602|FG001|Period 3: Treatment Period|Positive Drug screen|0
2097040|NCT00804687|3686603|FG002|Period 3: Treatment Period|Positive Drug screen|0
2097041|NCT00804687|3686604|FG003|Period 3: Treatment Period|Positive Drug screen|1
2097042|NCT00804687|3686605|FG004|Period 3: Treatment Period|Positive Drug screen|0
2097043|NCT00804687|3686606|FG005|Period 3: Treatment Period|Positive Drug screen|0
2097044|NCT00804687|3686601|FG000|Period 5: Treatment Period|Withdrawal by Subject|0
2307505|NCT02698176|4009948|FG003|Overall Study|Progressive disease|0
2307506|NCT02698176|4009945|FG000|Overall Study|Adverse Event|2
2307507|NCT02698176|4009946|FG001|Overall Study|Adverse Event|0
2307508|NCT02698176|4009947|FG002|Overall Study|Adverse Event|0
2307509|NCT02698176|4009948|FG003|Overall Study|Adverse Event|0
2307510|NCT02698176|4009945|FG000|Overall Study|Clinical progression|3
2307511|NCT02698176|4009946|FG001|Overall Study|Clinical progression|0
2307512|NCT02698176|4009947|FG002|Overall Study|Clinical progression|0
2307513|NCT02698176|4009948|FG003|Overall Study|Clinical progression|0
2307514|NCT02698189|4009961|FG000|Overall Study|Progressive disease|3
2307515|NCT02698189|4009962|FG001|Overall Study|Progressive disease|5
2307516|NCT02698189|4009961|FG000|Overall Study|Still ongoing in the study|0
2097045|NCT00804687|3686602|FG001|Period 5: Treatment Period|Withdrawal by Subject|0
2097046|NCT00804687|3686603|FG002|Period 5: Treatment Period|Withdrawal by Subject|0
2097047|NCT00804687|3686604|FG003|Period 5: Treatment Period|Withdrawal by Subject|0
2097048|NCT00804687|3686605|FG004|Period 5: Treatment Period|Withdrawal by Subject|1
2097049|NCT00804687|3686606|FG005|Period 5: Treatment Period|Withdrawal by Subject|0
2097050|NCT00804687|3686601|FG000|Period 5: Treatment Period|Positive drugs of abuse|0
2097051|NCT00804687|3686602|FG001|Period 5: Treatment Period|Positive drugs of abuse|0
2097052|NCT00804687|3686603|FG002|Period 5: Treatment Period|Positive drugs of abuse|1
2097053|NCT00804687|3686604|FG003|Period 5: Treatment Period|Positive drugs of abuse|0
2097054|NCT00804687|3686605|FG004|Period 5: Treatment Period|Positive drugs of abuse|0
2097055|NCT00804687|3686606|FG005|Period 5: Treatment Period|Positive drugs of abuse|0
2097056|NCT00804687|3686601|FG000|Period 5: Treatment Period|Positive drug test|1
2097057|NCT00804687|3686602|FG001|Period 5: Treatment Period|Positive drug test|0
2097058|NCT00804687|3686603|FG002|Period 5: Treatment Period|Positive drug test|0
2097059|NCT00804687|3686604|FG003|Period 5: Treatment Period|Positive drug test|0
2097060|NCT00804687|3686605|FG004|Period 5: Treatment Period|Positive drug test|0
2097061|NCT00804687|3686606|FG005|Period 5: Treatment Period|Positive drug test|0
2097062|NCT00804843|3686616|FG000|Overall Study|Protocol Violation|1
2097063|NCT00804843|3686617|FG001|Overall Study|Protocol Violation|0
2097064|NCT00804843|3686616|FG000|Overall Study|Adverse Event|8
2097065|NCT00804843|3686617|FG001|Overall Study|Adverse Event|5
2097066|NCT00804843|3686616|FG000|Overall Study|Withdrawal by Subject|1
2307517|NCT02698189|4009962|FG001|Overall Study|Still ongoing in the study|1
2307518|NCT02698241|4009979|FG000|Overall Study|Inclusion/exclusion criteria not met|4
2307519|NCT02698241|4009979|FG000|Overall Study|Screening not met|7
2307520|NCT02698241|4009979|FG000|Overall Study|Withdrawal by Subject|7
2307521|NCT02698241|4009979|FG000|Overall Study|Physician Decision|2
2097067|NCT00804843|3686617|FG001|Overall Study|Withdrawal by Subject|2
2097068|NCT00804908|3686627|FG000|Overall Study|Other|115
2097069|NCT00804908|3686628|FG001|Overall Study|Other|116
2097070|NCT00804908|3686629|FG002|Overall Study|Other|114
2097071|NCT00804986|3686656|FG000|Overall Study|Adverse Event|0
2097072|NCT00804986|3686657|FG001|Overall Study|Adverse Event|1
2097073|NCT00804986|3686658|FG002|Overall Study|Adverse Event|2
2097074|NCT00804986|3686659|FG003|Overall Study|Adverse Event|1
2097075|NCT00804986|3686660|FG004|Overall Study|Adverse Event|3
2097076|NCT00804986|3686661|FG005|Overall Study|Adverse Event|0
2097077|NCT00804986|3686656|FG000|Overall Study|Lack of Efficacy|0
2097078|NCT00804986|3686657|FG001|Overall Study|Lack of Efficacy|0
2097079|NCT00804986|3686658|FG002|Overall Study|Lack of Efficacy|0
2097080|NCT00804986|3686659|FG003|Overall Study|Lack of Efficacy|1
2097081|NCT00804986|3686660|FG004|Overall Study|Lack of Efficacy|0
2097082|NCT00804986|3686661|FG005|Overall Study|Lack of Efficacy|3
2097083|NCT00804986|3686656|FG000|Overall Study|Lost to Follow-up|0
2097084|NCT00804986|3686657|FG001|Overall Study|Lost to Follow-up|0
2097085|NCT00804986|3686658|FG002|Overall Study|Lost to Follow-up|0
2097086|NCT00804986|3686659|FG003|Overall Study|Lost to Follow-up|1
2097087|NCT00804986|3686660|FG004|Overall Study|Lost to Follow-up|1
2097088|NCT00804986|3686661|FG005|Overall Study|Lost to Follow-up|3
2097089|NCT00804986|3686656|FG000|Overall Study|Protocol Violation|0
2097090|NCT00804986|3686657|FG001|Overall Study|Protocol Violation|1
2097091|NCT00804986|3686658|FG002|Overall Study|Protocol Violation|0
2097092|NCT00804986|3686659|FG003|Overall Study|Protocol Violation|1
2097093|NCT00804986|3686660|FG004|Overall Study|Protocol Violation|0
2097094|NCT00804986|3686661|FG005|Overall Study|Protocol Violation|0
2097095|NCT00804986|3686656|FG000|Overall Study|Withdrawal by Subject|0
2097096|NCT00804986|3686657|FG001|Overall Study|Withdrawal by Subject|3
2097097|NCT00804986|3686658|FG002|Overall Study|Withdrawal by Subject|0
2097098|NCT00804986|3686659|FG003|Overall Study|Withdrawal by Subject|3
2097099|NCT00804986|3686660|FG004|Overall Study|Withdrawal by Subject|5
2097100|NCT00804986|3686661|FG005|Overall Study|Withdrawal by Subject|3
2097101|NCT00804986|3686656|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
2097102|NCT00804986|3686657|FG001|Overall Study|Inclusion/Exclusion criteria not met|2
2097103|NCT00804986|3686658|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
2097104|NCT00804986|3686659|FG003|Overall Study|Inclusion/Exclusion criteria not met|1
2097105|NCT00804986|3686660|FG004|Overall Study|Inclusion/Exclusion criteria not met|0
2097106|NCT00804986|3686661|FG005|Overall Study|Inclusion/Exclusion criteria not met|1
2097107|NCT00804986|3686656|FG000|Overall Study|Sponsor Decision|0
2097108|NCT00804986|3686657|FG001|Overall Study|Sponsor Decision|1
2097109|NCT00804986|3686658|FG002|Overall Study|Sponsor Decision|0
2097110|NCT00804986|3686659|FG003|Overall Study|Sponsor Decision|0
2097111|NCT00804986|3686660|FG004|Overall Study|Sponsor Decision|0
2097112|NCT00804986|3686661|FG005|Overall Study|Sponsor Decision|0
2097113|NCT00804986|3686656|FG000|Overall Study|Physician Decision|1
2097114|NCT00804986|3686657|FG001|Overall Study|Physician Decision|0
2097115|NCT00804986|3686658|FG002|Overall Study|Physician Decision|0
2097116|NCT00804986|3686659|FG003|Overall Study|Physician Decision|0
2097117|NCT00804986|3686660|FG004|Overall Study|Physician Decision|0
2212103|NCT01667679|3853075|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
2212104|NCT01667679|3853074|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
2212105|NCT01667679|3853075|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
2097118|NCT00804986|3686661|FG005|Overall Study|Physician Decision|0
2097119|NCT00805025|3686692|FG000|Overall Study|Screened but not enrolled/treated|42
2097120|NCT00805025|3686692|FG000|Overall Study|Adverse Event|4
2097121|NCT00805025|3686692|FG000|Overall Study|Withdrawal by Subject|2
2097122|NCT00805025|3686692|FG000|Overall Study|Physician Decision|1
2097123|NCT00805142|3686707|FG000|Titration Period|Adverse Event|3
2097124|NCT00805142|3686708|FG001|Titration Period|Adverse Event|3
2097125|NCT00805142|3686707|FG000|Titration Period|Lack of Efficacy|1
2097126|NCT00805142|3686708|FG001|Titration Period|Lack of Efficacy|1
2097127|NCT00805142|3686707|FG000|Titration Period|Lost to Follow-up|0
2097128|NCT00805142|3686708|FG001|Titration Period|Lost to Follow-up|1
2097129|NCT00805142|3686707|FG000|Titration Period|Disease Progression|2
2097130|NCT00805142|3686708|FG001|Titration Period|Disease Progression|1
2097131|NCT00805142|3686707|FG000|Titration Period|Withdrawal of consent|0
2097132|NCT00805142|3686708|FG001|Titration Period|Withdrawal of consent|1
2097133|NCT00805142|3686707|FG000|Titration Period|Other|0
2097134|NCT00805142|3686708|FG001|Titration Period|Other|3
2097135|NCT00805142|3686707|FG000|Maintenance Period|Adverse Event|0
2097136|NCT00805142|3686708|FG001|Maintenance Period|Adverse Event|1
2097137|NCT00805142|3686707|FG000|Maintenance Period|Other|0
2097138|NCT00805142|3686708|FG001|Maintenance Period|Other|1
2097139|NCT00805194|3686723|FG000|Overall Study|Progressive disease (modified RECIST)|404
2097140|NCT00805194|3686724|FG001|Overall Study|Progressive disease (modified RECIST)|435
2097141|NCT00805194|3686723|FG000|Overall Study|Worsening or AE of underlying disease|64
2097142|NCT00805194|3686724|FG001|Overall Study|Worsening or AE of underlying disease|70
2097143|NCT00805194|3686723|FG000|Overall Study|Other AE|84
2097144|NCT00805194|3686724|FG001|Overall Study|Other AE|73
2097145|NCT00805194|3686723|FG000|Overall Study|Protocol Violation|9
2097146|NCT00805194|3686724|FG001|Overall Study|Protocol Violation|9
2097147|NCT00805194|3686723|FG000|Overall Study|Lost to Follow-up|5
2097148|NCT00805194|3686724|FG001|Overall Study|Lost to Follow-up|5
2097149|NCT00805194|3686723|FG000|Overall Study|Withdrawal by Subject|60
2097150|NCT00805194|3686724|FG001|Overall Study|Withdrawal by Subject|42
2097151|NCT00805194|3686723|FG000|Overall Study|Not treated|3
2097152|NCT00805194|3686724|FG001|Overall Study|Not treated|4
2097153|NCT00805194|3686723|FG000|Overall Study|Reasons other than stated above|20
2097154|NCT00805194|3686724|FG001|Overall Study|Reasons other than stated above|16
2097155|NCT00805207|3686744|FG000|Overall Study|Protocol Violation|0
2097156|NCT00805207|3686745|FG001|Overall Study|Protocol Violation|0
2097157|NCT00805207|3686746|FG002|Overall Study|Protocol Violation|1
2097158|NCT00805207|3686747|FG003|Overall Study|Protocol Violation|0
2097159|NCT00805207|3686748|FG004|Overall Study|Protocol Violation|0
2097160|NCT00805207|3686749|FG005|Overall Study|Protocol Violation|0
2097161|NCT00805207|3686750|FG006|Overall Study|Protocol Violation|0
2097162|NCT00805207|3686751|FG007|Overall Study|Protocol Violation|0
2097163|NCT00805207|3686752|FG008|Overall Study|Protocol Violation|0
2097164|NCT00805207|3686744|FG000|Overall Study|Physician Decision|0
2097165|NCT00805207|3686745|FG001|Overall Study|Physician Decision|1
2097166|NCT00805207|3686746|FG002|Overall Study|Physician Decision|0
2097167|NCT00805207|3686747|FG003|Overall Study|Physician Decision|0
2097168|NCT00805207|3686748|FG004|Overall Study|Physician Decision|0
2097169|NCT00805207|3686749|FG005|Overall Study|Physician Decision|1
2097170|NCT00805207|3686750|FG006|Overall Study|Physician Decision|0
2097171|NCT00805207|3686751|FG007|Overall Study|Physician Decision|0
2097172|NCT00805207|3686752|FG008|Overall Study|Physician Decision|0
2097173|NCT00805207|3686744|FG000|Overall Study|Withdrawal by Subject|0
2097174|NCT00805207|3686745|FG001|Overall Study|Withdrawal by Subject|1
2097175|NCT00805207|3686746|FG002|Overall Study|Withdrawal by Subject|0
2097176|NCT00805207|3686747|FG003|Overall Study|Withdrawal by Subject|0
2097177|NCT00805207|3686748|FG004|Overall Study|Withdrawal by Subject|1
2097178|NCT00805207|3686749|FG005|Overall Study|Withdrawal by Subject|2
2097179|NCT00805207|3686750|FG006|Overall Study|Withdrawal by Subject|0
2097180|NCT00805207|3686751|FG007|Overall Study|Withdrawal by Subject|0
2097181|NCT00805207|3686752|FG008|Overall Study|Withdrawal by Subject|0
2097182|NCT00805285|3686776|FG000|Overall Study|Lack of Efficacy|1
2097183|NCT00805389|3686785|FG000|Overall Study|Adverse Event|0
2307522|NCT02698241|4009979|FG000|Overall Study|Subject underwent system modification|2
2307523|NCT02698241|4009979|FG000|Overall Study|Lost to Follow-up|3
2307524|NCT02698241|4009979|FG000|Overall Study|Subject on inodrip not safe to continue|6
2307525|NCT02698241|4009979|FG000|Overall Study|geographic and licensing issue|1
2307526|NCT02698241|4009979|FG000|Overall Study|Death|2
2307527|NCT02698371|4009983|FG000|All Participants Flow|Lost to Follow-up|3
2097184|NCT00805389|3686786|FG001|Overall Study|Adverse Event|0
2097185|NCT00805389|3686787|FG002|Overall Study|Adverse Event|1
2097186|NCT00805389|3686788|FG003|Overall Study|Adverse Event|2
2097187|NCT00805389|3686789|FG004|Overall Study|Adverse Event|0
2097188|NCT00805389|3686785|FG000|Overall Study|Lost to Follow-up|4
2097189|NCT00805389|3686786|FG001|Overall Study|Lost to Follow-up|3
2097190|NCT00805389|3686787|FG002|Overall Study|Lost to Follow-up|6
2097191|NCT00805389|3686788|FG003|Overall Study|Lost to Follow-up|10
2097192|NCT00805389|3686789|FG004|Overall Study|Lost to Follow-up|9
2097193|NCT00805389|3686785|FG000|Overall Study|Protocol Violation|0
2097194|NCT00805389|3686786|FG001|Overall Study|Protocol Violation|0
2097195|NCT00805389|3686787|FG002|Overall Study|Protocol Violation|1
2097196|NCT00805389|3686788|FG003|Overall Study|Protocol Violation|0
2097197|NCT00805389|3686789|FG004|Overall Study|Protocol Violation|0
2097198|NCT00805389|3686785|FG000|Overall Study|Withdrawal by Subject|3
2097199|NCT00805389|3686786|FG001|Overall Study|Withdrawal by Subject|2
2097200|NCT00805389|3686787|FG002|Overall Study|Withdrawal by Subject|4
2097201|NCT00805389|3686788|FG003|Overall Study|Withdrawal by Subject|5
2097202|NCT00805389|3686789|FG004|Overall Study|Withdrawal by Subject|4
2097203|NCT00805441|3686813|FG000|Overall Study|Adverse Event|5
2097204|NCT00805441|3686814|FG001|Overall Study|Adverse Event|2
2097205|NCT00805441|3686813|FG000|Overall Study|Lack of Efficacy|0
2097206|NCT00805441|3686814|FG001|Overall Study|Lack of Efficacy|2
2097207|NCT00805441|3686813|FG000|Overall Study|Protocol Violation|4
2097208|NCT00805441|3686814|FG001|Overall Study|Protocol Violation|8
2097209|NCT00805441|3686813|FG000|Overall Study|Lost to Follow-up|10
2097210|NCT00805441|3686814|FG001|Overall Study|Lost to Follow-up|13
2097211|NCT00805441|3686813|FG000|Overall Study|Withdrawal by Subject|15
2097212|NCT00805441|3686814|FG001|Overall Study|Withdrawal by Subject|9
2097213|NCT00805441|3686813|FG000|Overall Study|Physician Decision|0
2097214|NCT00805441|3686814|FG001|Overall Study|Physician Decision|1
2097215|NCT00805441|3686813|FG000|Overall Study|Acute Alcohol Withdrawal|0
2097216|NCT00805441|3686814|FG001|Overall Study|Acute Alcohol Withdrawal|1
2097217|NCT00805467|3686824|FG000|Overall Study|Lack of Efficacy|0
2097218|NCT00805467|3686825|FG001|Overall Study|Lack of Efficacy|8
2097219|NCT00805467|3686826|FG002|Overall Study|Lack of Efficacy|13
2097220|NCT00805467|3686827|FG003|Overall Study|Lack of Efficacy|86
2097221|NCT00805467|3686824|FG000|Overall Study|Lost to Follow-up|0
2307528|NCT02698371|4009983|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
2097222|NCT00805467|3686825|FG001|Overall Study|Lost to Follow-up|1
2097223|NCT00805467|3686826|FG002|Overall Study|Lost to Follow-up|7
2097224|NCT00805467|3686827|FG003|Overall Study|Lost to Follow-up|21
2097225|NCT00805467|3686824|FG000|Overall Study|Withdrawal by Subject|0
2307529|NCT02698371|4009983|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
2307530|NCT02698371|4009983|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
2307531|NCT02698371|4009983|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
2307532|NCT02698371|4009983|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
2307533|NCT02698371|4009983|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
2307534|NCT02698410|4009999|FG000|Overall Study|Adverse Event|2
2307535|NCT02698410|4009999|FG000|Overall Study|Withdrawal by Subject|1
2307536|NCT02698410|4009999|FG000|Overall Study|Other|1
2307537|NCT02698423|4010005|FG000|Overall Study|Lost to Follow-up|19
2307538|NCT02698423|4010006|FG001|Overall Study|Lost to Follow-up|24
2307539|NCT02698436|4010016|FG000|Overall Study|Adverse Event|1
2307540|NCT02698436|4010017|FG001|Overall Study|Adverse Event|0
2307541|NCT02698436|4010016|FG000|Overall Study|Withdrawal by Subject|3
2307542|NCT02698436|4010017|FG001|Overall Study|Withdrawal by Subject|3
2307543|NCT02698436|4010016|FG000|Overall Study|Lost to Follow-up|2
2307544|NCT02698436|4010017|FG001|Overall Study|Lost to Follow-up|4
2307545|NCT02698436|4010016|FG000|Overall Study|Non-compliance with study regimen|1
2307546|NCT02698436|4010017|FG001|Overall Study|Non-compliance with study regimen|0
2307547|NCT02698475|4010023|FG000|Main Study Period|Lack of Efficacy|1
2307548|NCT02698475|4010023|FG000|Main Study Period|Protocol Violation|2
2307549|NCT02698475|4010023|FG000|Long-Term Extension Period|Lost to Follow-up|1
2353776|NCT02044848|4107121|FG000|Overall Study|Administrative Problems|2
2097226|NCT00805467|3686825|FG001|Overall Study|Withdrawal by Subject|6
2097227|NCT00805467|3686826|FG002|Overall Study|Withdrawal by Subject|45
2097228|NCT00805467|3686827|FG003|Overall Study|Withdrawal by Subject|50
2097229|NCT00805467|3686824|FG000|Overall Study|Protocol Violation|0
2097230|NCT00805467|3686825|FG001|Overall Study|Protocol Violation|3
2097231|NCT00805467|3686826|FG002|Overall Study|Protocol Violation|0
2097232|NCT00805467|3686827|FG003|Overall Study|Protocol Violation|5
2097233|NCT00805467|3686824|FG000|Overall Study|Adverse Event|0
2097234|NCT00805467|3686825|FG001|Overall Study|Adverse Event|13
2097235|NCT00805467|3686826|FG002|Overall Study|Adverse Event|26
2097236|NCT00805467|3686827|FG003|Overall Study|Adverse Event|57
2097237|NCT00805467|3686824|FG000|Overall Study|Death|0
2097238|NCT00805467|3686825|FG001|Overall Study|Death|2
2097239|NCT00805467|3686826|FG002|Overall Study|Death|7
2097240|NCT00805467|3686827|FG003|Overall Study|Death|5
2097241|NCT00805467|3686824|FG000|Overall Study|Physician Decision|0
2097242|NCT00805467|3686825|FG001|Overall Study|Physician Decision|1
2097243|NCT00805467|3686826|FG002|Overall Study|Physician Decision|2
2097244|NCT00805467|3686827|FG003|Overall Study|Physician Decision|6
2097245|NCT00805467|3686824|FG000|Overall Study|Not reported|0
2097246|NCT00805467|3686825|FG001|Overall Study|Not reported|0
2097247|NCT00805467|3686826|FG002|Overall Study|Not reported|3
2097248|NCT00805467|3686827|FG003|Overall Study|Not reported|7
2097249|NCT00805480|3686841|FG000|Overall Study|Withdrawal by Subject|13
2097250|NCT00805480|3686842|FG001|Overall Study|Withdrawal by Subject|5
2097251|NCT00805480|3686843|FG002|Overall Study|Withdrawal by Subject|11
2097252|NCT00805480|3686844|FG003|Overall Study|Withdrawal by Subject|5
2097253|NCT00805480|3686841|FG000|Overall Study|Lost to Follow-up|1
2097254|NCT00805480|3686842|FG001|Overall Study|Lost to Follow-up|2
2097255|NCT00805480|3686843|FG002|Overall Study|Lost to Follow-up|0
2097256|NCT00805480|3686844|FG003|Overall Study|Lost to Follow-up|0
2097257|NCT00805480|3686841|FG000|Overall Study|Adverse Event|0
2097258|NCT00805480|3686842|FG001|Overall Study|Adverse Event|0
2097259|NCT00805480|3686843|FG002|Overall Study|Adverse Event|1
2097260|NCT00805480|3686844|FG003|Overall Study|Adverse Event|0
2097261|NCT00805532|3686872|FG000|Overall Study|invalid data|0
2097262|NCT00805532|3686873|FG001|Overall Study|invalid data|1
2097263|NCT00805545|3686883|FG000|Overall Study|Protocol Violation|3
2097264|NCT00805545|3686884|FG001|Overall Study|Protocol Violation|2
2097265|NCT00805545|3686883|FG000|Overall Study|Protocol Violation|3
2097266|NCT00805545|3686884|FG001|Overall Study|Protocol Violation|1
2097267|NCT00805675|3686893|FG000|Overall Study|Adverse Event|0
2097268|NCT00805675|3686894|FG001|Overall Study|Adverse Event|0
2097269|NCT00805675|3686895|FG002|Overall Study|Adverse Event|1
2097270|NCT00805740|3686905|FG000|Overall Study|Death|7
2097271|NCT00805740|3686906|FG001|Overall Study|Death|4
2097272|NCT00805740|3686905|FG000|Overall Study|Withdrawal by Subject|1
2097273|NCT00805740|3686906|FG001|Overall Study|Withdrawal by Subject|0
2097274|NCT00805740|3686905|FG000|Overall Study|Lost to Follow-up|1
2097275|NCT00805740|3686906|FG001|Overall Study|Lost to Follow-up|0
2097276|NCT00805740|3686905|FG000|Overall Study|Randomized, but not treated|2
2097277|NCT00805740|3686906|FG001|Overall Study|Randomized, but not treated|0
2097278|NCT00805766|3686912|FG000|Screening Period|Adverse Event|1
2097279|NCT00805766|3686912|FG000|Screening Period|Lack of Efficacy|2
2097280|NCT00805766|3686912|FG000|Screening Period|Pregnancy|1
2097281|NCT00805766|3686912|FG000|Screening Period|Responder|2
2097282|NCT00805766|3686912|FG000|Increased Dose Period|Adverse Event|4
2097283|NCT00805766|3686912|FG000|Increased Dose Period|Lack of Efficacy|7
2097284|NCT00805766|3686912|FG000|Increased Dose Period|Pregnancy|1
2097285|NCT00805766|3686912|FG000|Increased Dose Period|Withdrawal by Subject|1
2097286|NCT00805792|3686920|FG000|Overall Study|Death|3
2097287|NCT00805792|3686920|FG000|Overall Study|Lost to Follow-up|2
2097288|NCT00805935|3686937|FG000|Overall Study|Stimulation Failure|1
2097289|NCT00805935|3686938|FG001|Overall Study|Stimulation Failure|5
2097290|NCT00805935|3686939|FG002|Overall Study|Stimulation Failure|2
2097291|NCT00805935|3686940|FG003|Overall Study|Stimulation Failure|2
2097292|NCT00805935|3686937|FG000|Overall Study|Cycle cancelled|0
2097293|NCT00805935|3686938|FG001|Overall Study|Cycle cancelled|0
2097294|NCT00805935|3686939|FG002|Overall Study|Cycle cancelled|2
2097295|NCT00805935|3686940|FG003|Overall Study|Cycle cancelled|0
2097296|NCT00805935|3686937|FG000|Overall Study|Cycle cancellation for risk of OHSS|1
2097297|NCT00805935|3686938|FG001|Overall Study|Cycle cancellation for risk of OHSS|0
2097298|NCT00805935|3686939|FG002|Overall Study|Cycle cancellation for risk of OHSS|1
2097299|NCT00805935|3686940|FG003|Overall Study|Cycle cancellation for risk of OHSS|0
2097300|NCT00805935|3686937|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
2097301|NCT00805935|3686938|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
2097302|NCT00805935|3686939|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
2097303|NCT00805935|3686940|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
2097304|NCT00805935|3686937|FG000|Overall Study|Lost to Follow-up|1
2097305|NCT00805935|3686938|FG001|Overall Study|Lost to Follow-up|0
2097306|NCT00805935|3686939|FG002|Overall Study|Lost to Follow-up|0
2097307|NCT00805935|3686940|FG003|Overall Study|Lost to Follow-up|0
2097308|NCT00805935|3686937|FG000|Overall Study|No positive serum pregnancy|8
2097309|NCT00805935|3686938|FG001|Overall Study|No positive serum pregnancy|7
2097310|NCT00805935|3686939|FG002|Overall Study|No positive serum pregnancy|6
2097311|NCT00805935|3686940|FG003|Overall Study|No positive serum pregnancy|5
2097312|NCT00805935|3686937|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0
2097313|NCT00805935|3686938|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
2097314|NCT00805935|3686939|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0
2097315|NCT00805935|3686940|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1
2097316|NCT00805935|3686937|FG000|Overall Study|Pregnancy loss/miscarriage|2
2097317|NCT00805935|3686938|FG001|Overall Study|Pregnancy loss/miscarriage|0
2097318|NCT00805935|3686939|FG002|Overall Study|Pregnancy loss/miscarriage|0
2097319|NCT00805935|3686940|FG003|Overall Study|Pregnancy loss/miscarriage|0
2097320|NCT00805935|3686937|FG000|Overall Study|Biochemical pregnancy|0
2097321|NCT00805935|3686938|FG001|Overall Study|Biochemical pregnancy|1
2097322|NCT00805935|3686939|FG002|Overall Study|Biochemical pregnancy|0
2097323|NCT00805935|3686940|FG003|Overall Study|Biochemical pregnancy|0
2097324|NCT00805935|3686937|FG000|Overall Study|Chemical pregnancy|0
2097325|NCT00805935|3686938|FG001|Overall Study|Chemical pregnancy|5
2097326|NCT00805935|3686939|FG002|Overall Study|Chemical pregnancy|3
2097327|NCT00805935|3686940|FG003|Overall Study|Chemical pregnancy|2
2097328|NCT00805935|3686937|FG000|Overall Study|Ectopic pregnancy|0
2097329|NCT00805935|3686938|FG001|Overall Study|Ectopic pregnancy|0
2097330|NCT00805935|3686939|FG002|Overall Study|Ectopic pregnancy|1
2097331|NCT00805935|3686940|FG003|Overall Study|Ectopic pregnancy|0
2097332|NCT00805935|3686937|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0
2097333|NCT00805935|3686938|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1
2097334|NCT00805935|3686939|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0
2097335|NCT00805935|3686940|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0
2097336|NCT00806026|3686968|FG000|Overall Study|Death|0
2097337|NCT00806026|3686969|FG001|Overall Study|Death|0
2097338|NCT00806026|3686970|FG002|Overall Study|Death|0
2097339|NCT00806026|3686971|FG003|Overall Study|Death|1
2097340|NCT00806026|3686972|FG004|Overall Study|Death|0
2097341|NCT00806026|3686973|FG005|Overall Study|Death|0
2307550|NCT02698475|4010023|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1
2307551|NCT02698475|4010023|FG000|Long-Term Extension Period|Withdrawal by Subject|3
2307552|NCT02698475|4010023|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22
2307553|NCT02698475|4010023|FG000|Long-Term Extension Period|Other|1
2307554|NCT02698787|4010047|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0
2307555|NCT02698787|4010048|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1
2307556|NCT02699099|4010065|FG000|Overall Study|Adverse Event|1
2307557|NCT02699099|4010066|FG001|Overall Study|Adverse Event|0
2307558|NCT02699099|4010067|FG002|Overall Study|Adverse Event|2
2307559|NCT02699099|4010065|FG000|Overall Study|Lost to Follow-up|0
2307560|NCT02699099|4010066|FG001|Overall Study|Lost to Follow-up|1
2307561|NCT02699099|4010067|FG002|Overall Study|Lost to Follow-up|0
2307562|NCT02699099|4010065|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7
2307563|NCT02699099|4010066|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
2307564|NCT02699099|4010067|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4
2097342|NCT00806026|3686968|FG000|Overall Study|Did not meet entrance criteria|4
2097343|NCT00806026|3686969|FG001|Overall Study|Did not meet entrance criteria|1
2097344|NCT00806026|3686970|FG002|Overall Study|Did not meet entrance criteria|2
2097345|NCT00806026|3686971|FG003|Overall Study|Did not meet entrance criteria|1
2097346|NCT00806026|3686972|FG004|Overall Study|Did not meet entrance criteria|0
2097347|NCT00806026|3686973|FG005|Overall Study|Did not meet entrance criteria|0
2097348|NCT00806026|3686968|FG000|Overall Study|Lack of Efficacy|5
2097349|NCT00806026|3686969|FG001|Overall Study|Lack of Efficacy|18
2097350|NCT00806026|3686970|FG002|Overall Study|Lack of Efficacy|13
2097351|NCT00806026|3686971|FG003|Overall Study|Lack of Efficacy|4
2097352|NCT00806026|3686972|FG004|Overall Study|Lack of Efficacy|8
2097353|NCT00806026|3686973|FG005|Overall Study|Lack of Efficacy|7
2097354|NCT00806026|3686968|FG000|Overall Study|Lost to Follow-up|8
2097355|NCT00806026|3686969|FG001|Overall Study|Lost to Follow-up|15
2097356|NCT00806026|3686970|FG002|Overall Study|Lost to Follow-up|8
2097357|NCT00806026|3686971|FG003|Overall Study|Lost to Follow-up|2
2097358|NCT00806026|3686972|FG004|Overall Study|Lost to Follow-up|6
2097359|NCT00806026|3686973|FG005|Overall Study|Lost to Follow-up|6
2212106|NCT01667679|3853074|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
2212107|NCT01667679|3853075|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
2212108|NCT01667679|3853074|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
2097360|NCT00806026|3686968|FG000|Overall Study|Withdrawal by Subject|14
2097361|NCT00806026|3686969|FG001|Overall Study|Withdrawal by Subject|17
2097362|NCT00806026|3686970|FG002|Overall Study|Withdrawal by Subject|9
2097363|NCT00806026|3686971|FG003|Overall Study|Withdrawal by Subject|2
2097364|NCT00806026|3686972|FG004|Overall Study|Withdrawal by Subject|5
2097365|NCT00806026|3686973|FG005|Overall Study|Withdrawal by Subject|3
2097366|NCT00806026|3686968|FG000|Overall Study|Other|3
2097367|NCT00806026|3686969|FG001|Overall Study|Other|6
2097368|NCT00806026|3686970|FG002|Overall Study|Other|8
2097369|NCT00806026|3686971|FG003|Overall Study|Other|2
2097370|NCT00806026|3686972|FG004|Overall Study|Other|0
2097371|NCT00806026|3686973|FG005|Overall Study|Other|4
2097372|NCT00806026|3686968|FG000|Overall Study|Protocol Violation|6
2097373|NCT00806026|3686969|FG001|Overall Study|Protocol Violation|9
2097374|NCT00806026|3686970|FG002|Overall Study|Protocol Violation|9
2097375|NCT00806026|3686971|FG003|Overall Study|Protocol Violation|0
2097376|NCT00806026|3686972|FG004|Overall Study|Protocol Violation|2
2097377|NCT00806026|3686973|FG005|Overall Study|Protocol Violation|3
2097378|NCT00806026|3686968|FG000|Overall Study|Adverse Event|52
2097379|NCT00806026|3686969|FG001|Overall Study|Adverse Event|35
2097380|NCT00806026|3686970|FG002|Overall Study|Adverse Event|44
2097381|NCT00806026|3686971|FG003|Overall Study|Adverse Event|17
2097382|NCT00806026|3686972|FG004|Overall Study|Adverse Event|9
2097383|NCT00806026|3686973|FG005|Overall Study|Adverse Event|9
2097384|NCT00806156|3686996|FG000|Overall Study|Death|35
2097385|NCT00806156|3686997|FG001|Overall Study|Death|95
2097386|NCT00806156|3686996|FG000|Overall Study|Did not meet eligibility criteria|1
2097387|NCT00806156|3686997|FG001|Overall Study|Did not meet eligibility criteria|0
2097388|NCT00806156|3686996|FG000|Overall Study|Study terminated by Sponsor|2
2097389|NCT00806156|3686997|FG001|Overall Study|Study terminated by Sponsor|40
2097390|NCT00806156|3686996|FG000|Overall Study|Consent withdrawn by subject|1
2097391|NCT00806156|3686997|FG001|Overall Study|Consent withdrawn by subject|3
2097392|NCT00806156|3686996|FG000|Overall Study|Lost to Follow-up|0
2097393|NCT00806156|3686997|FG001|Overall Study|Lost to Follow-up|1
2097394|NCT00806195|3687019|FG000|Overall Study|Death|6
2097395|NCT00806195|3687020|FG001|Overall Study|Death|0
2097396|NCT00806195|3687021|FG002|Overall Study|Death|1
2097397|NCT00806195|3687022|FG003|Overall Study|Death|0
2097398|NCT00806195|3687019|FG000|Overall Study|Adverse Event|25
2097399|NCT00806195|3687020|FG001|Overall Study|Adverse Event|5
2097400|NCT00806195|3687021|FG002|Overall Study|Adverse Event|11
2097401|NCT00806195|3687022|FG003|Overall Study|Adverse Event|2
2097402|NCT00806195|3687019|FG000|Overall Study|Withdrawal by Subject|119
2097403|NCT00806195|3687020|FG001|Overall Study|Withdrawal by Subject|31
2097404|NCT00806195|3687021|FG002|Overall Study|Withdrawal by Subject|76
2097405|NCT00806195|3687022|FG003|Overall Study|Withdrawal by Subject|35
2097406|NCT00806195|3687019|FG000|Overall Study|Lost to Follow-up|217
2097407|NCT00806195|3687020|FG001|Overall Study|Lost to Follow-up|66
2097408|NCT00806195|3687021|FG002|Overall Study|Lost to Follow-up|90
2097409|NCT00806195|3687022|FG003|Overall Study|Lost to Follow-up|34
2097410|NCT00806195|3687019|FG000|Overall Study|Inappropriate Enrollment|0
2097411|NCT00806195|3687020|FG001|Overall Study|Inappropriate Enrollment|1
2097412|NCT00806195|3687021|FG002|Overall Study|Inappropriate Enrollment|0
2097413|NCT00806195|3687022|FG003|Overall Study|Inappropriate Enrollment|0
2097414|NCT00806195|3687019|FG000|Overall Study|Administrative Reason|113
2097415|NCT00806195|3687020|FG001|Overall Study|Administrative Reason|35
2097416|NCT00806195|3687021|FG002|Overall Study|Administrative Reason|66
2097417|NCT00806195|3687022|FG003|Overall Study|Administrative Reason|26
2097418|NCT00806195|3687019|FG000|Overall Study|Protocol Violation|34
2097419|NCT00806195|3687020|FG001|Overall Study|Protocol Violation|24
2097420|NCT00806195|3687021|FG002|Overall Study|Protocol Violation|26
2097421|NCT00806195|3687022|FG003|Overall Study|Protocol Violation|9
2097422|NCT00806260|3687057|FG000|Period 1 (1 Day)|Adverse Event|0
2097423|NCT00806260|3687058|FG001|Period 1 (1 Day)|Adverse Event|0
2097424|NCT00806260|3687059|FG002|Period 1 (1 Day)|Adverse Event|0
2097425|NCT00806260|3687060|FG003|Period 1 (1 Day)|Adverse Event|0
2097426|NCT00806260|3687061|FG004|Period 1 (1 Day)|Adverse Event|3
2097427|NCT00806260|3687062|FG005|Period 1 (1 Day)|Adverse Event|0
2097428|NCT00806260|3687057|FG000|Period 2|Adverse Event|0
2097429|NCT00806260|3687058|FG001|Period 2|Adverse Event|0
2097430|NCT00806260|3687059|FG002|Period 2|Adverse Event|0
2097431|NCT00806260|3687060|FG003|Period 2|Adverse Event|1
2097432|NCT00806260|3687061|FG004|Period 2|Adverse Event|0
2097433|NCT00806260|3687062|FG005|Period 2|Adverse Event|0
2097434|NCT00806260|3687057|FG000|Period 2|Protocol Violation|1
2097435|NCT00806260|3687058|FG001|Period 2|Protocol Violation|0
2097436|NCT00806260|3687059|FG002|Period 2|Protocol Violation|1
2097437|NCT00806260|3687060|FG003|Period 2|Protocol Violation|0
2097438|NCT00806260|3687061|FG004|Period 2|Protocol Violation|0
2097439|NCT00806260|3687062|FG005|Period 2|Protocol Violation|0
2097440|NCT00806260|3687057|FG000|Period 2|Need to take concomitant medication|1
2097441|NCT00806260|3687058|FG001|Period 2|Need to take concomitant medication|0
2097442|NCT00806260|3687059|FG002|Period 2|Need to take concomitant medication|0
2097443|NCT00806260|3687060|FG003|Period 2|Need to take concomitant medication|0
2097444|NCT00806260|3687061|FG004|Period 2|Need to take concomitant medication|0
2097445|NCT00806260|3687062|FG005|Period 2|Need to take concomitant medication|0
2097446|NCT00806260|3687057|FG000|Period 2|sponsor request|0
2097447|NCT00806260|3687058|FG001|Period 2|sponsor request|0
2097448|NCT00806260|3687059|FG002|Period 2|sponsor request|1
2097449|NCT00806260|3687060|FG003|Period 2|sponsor request|1
2097450|NCT00806260|3687061|FG004|Period 2|sponsor request|0
2097451|NCT00806260|3687062|FG005|Period 2|sponsor request|0
2097452|NCT00806260|3687057|FG000|Period 3|Protocol Violation|0
2097453|NCT00806260|3687058|FG001|Period 3|Protocol Violation|1
2097454|NCT00806260|3687059|FG002|Period 3|Protocol Violation|1
2097455|NCT00806260|3687060|FG003|Period 3|Protocol Violation|0
2097456|NCT00806260|3687061|FG004|Period 3|Protocol Violation|0
2097457|NCT00806260|3687062|FG005|Period 3|Protocol Violation|0
2097458|NCT00806260|3687057|FG000|Period 3|Pregnancy|1
2097459|NCT00806260|3687058|FG001|Period 3|Pregnancy|0
2097460|NCT00806260|3687059|FG002|Period 3|Pregnancy|0
2097461|NCT00806260|3687060|FG003|Period 3|Pregnancy|0
2097462|NCT00806260|3687061|FG004|Period 3|Pregnancy|0
2097463|NCT00806260|3687062|FG005|Period 3|Pregnancy|0
2097464|NCT00806286|3687077|FG000|Overall Study|Adverse Event|5
2097465|NCT00806286|3687078|FG001|Overall Study|Adverse Event|2
2097466|NCT00806286|3687079|FG002|Overall Study|Adverse Event|0
2097467|NCT00806286|3687077|FG000|Overall Study|Disease progression|31
2097468|NCT00806286|3687078|FG001|Overall Study|Disease progression|38
2097469|NCT00806286|3687079|FG002|Overall Study|Disease progression|1
2097470|NCT00806286|3687077|FG000|Overall Study|Death|1
2097471|NCT00806286|3687078|FG001|Overall Study|Death|6
2097472|NCT00806286|3687079|FG002|Overall Study|Death|0
2097473|NCT00806286|3687077|FG000|Overall Study|Lost to Follow-up|0
2097474|NCT00806286|3687078|FG001|Overall Study|Lost to Follow-up|1
2097475|NCT00806286|3687079|FG002|Overall Study|Lost to Follow-up|0
2097476|NCT00806286|3687077|FG000|Overall Study|Withdrawal by Subject|8
2097477|NCT00806286|3687078|FG001|Overall Study|Withdrawal by Subject|3
2097478|NCT00806286|3687079|FG002|Overall Study|Withdrawal by Subject|1
2097479|NCT00806286|3687077|FG000|Overall Study|Physician Decision|2
2097480|NCT00806286|3687078|FG001|Overall Study|Physician Decision|2
2097481|NCT00806286|3687079|FG002|Overall Study|Physician Decision|0
2097482|NCT00806286|3687077|FG000|Overall Study|Due to a variety of reasons|7
2097483|NCT00806286|3687078|FG001|Overall Study|Due to a variety of reasons|2
2097484|NCT00806286|3687079|FG002|Overall Study|Due to a variety of reasons|1
2097485|NCT00806351|3687089|FG000|Overall Study|Death|5
2097486|NCT00806351|3687090|FG001|Overall Study|Death|4
2097487|NCT00806442|3687096|FG000|Overall Study|Lost to Follow-up|3
2097488|NCT00806442|3687097|FG001|Overall Study|Lost to Follow-up|2
2097489|NCT00806442|3687096|FG000|Overall Study|Withdrawal by Subject|1
2097490|NCT00806442|3687097|FG001|Overall Study|Withdrawal by Subject|5
2097491|NCT00806494|3687105|FG000|Overall Study|Adverse Event|29
2097492|NCT00806494|3687105|FG000|Overall Study|Lack of Efficacy|6
2097493|NCT00806494|3687105|FG000|Overall Study|Lost to Follow-up|10
2097494|NCT00806494|3687105|FG000|Overall Study|Other|30
2097495|NCT00806494|3687105|FG000|Overall Study|Withdrawal by Subject|5
2097496|NCT00806546|3687110|FG000|Overall Study|Enrolled, not treated|35
2097497|NCT00806546|3687110|FG000|Overall Study|Lost to Follow-up|32
2097498|NCT00806546|3687110|FG000|Overall Study|Adverse Event|74
2097499|NCT00806546|3687110|FG000|Overall Study|Withdrawal by Subject|75
2097500|NCT00806546|3687110|FG000|Overall Study|Protocol Violation|49
2097501|NCT00806546|3687110|FG000|Overall Study|Various|42
2097502|NCT00806585|3687119|FG000|Overall Study|Study terminated by Sponsor|0
2097503|NCT00806585|3687120|FG001|Overall Study|Study terminated by Sponsor|0
2097504|NCT00806585|3687121|FG002|Overall Study|Study terminated by Sponsor|1
2097505|NCT00806585|3687122|FG003|Overall Study|Study terminated by Sponsor|2
2097506|NCT00806585|3687123|FG004|Overall Study|Study terminated by Sponsor|0
2097507|NCT00806585|3687119|FG000|Overall Study|Protocol Violation|3
2097508|NCT00806585|3687120|FG001|Overall Study|Protocol Violation|1
2097509|NCT00806585|3687121|FG002|Overall Study|Protocol Violation|2
2097510|NCT00806585|3687122|FG003|Overall Study|Protocol Violation|0
2097511|NCT00806585|3687123|FG004|Overall Study|Protocol Violation|0
2097512|NCT00806585|3687119|FG000|Overall Study|Physician Decision|0
2097513|NCT00806585|3687120|FG001|Overall Study|Physician Decision|2
2097514|NCT00806585|3687121|FG002|Overall Study|Physician Decision|3
2097515|NCT00806585|3687122|FG003|Overall Study|Physician Decision|0
2097516|NCT00806585|3687123|FG004|Overall Study|Physician Decision|1
2097517|NCT00806585|3687119|FG000|Overall Study|Lost to Follow-up|2
2097518|NCT00806585|3687120|FG001|Overall Study|Lost to Follow-up|1
2097519|NCT00806585|3687121|FG002|Overall Study|Lost to Follow-up|2
2097520|NCT00806585|3687122|FG003|Overall Study|Lost to Follow-up|2
2097521|NCT00806585|3687123|FG004|Overall Study|Lost to Follow-up|5
2097522|NCT00806585|3687119|FG000|Overall Study|Lack of Efficacy|1
2097523|NCT00806585|3687120|FG001|Overall Study|Lack of Efficacy|0
2097524|NCT00806585|3687121|FG002|Overall Study|Lack of Efficacy|0
2097525|NCT00806585|3687122|FG003|Overall Study|Lack of Efficacy|0
2097526|NCT00806585|3687123|FG004|Overall Study|Lack of Efficacy|0
2097527|NCT00806585|3687119|FG000|Overall Study|Adverse Event|1
2097528|NCT00806585|3687120|FG001|Overall Study|Adverse Event|5
2097529|NCT00806585|3687121|FG002|Overall Study|Adverse Event|3
2097530|NCT00806585|3687122|FG003|Overall Study|Adverse Event|4
2097531|NCT00806585|3687123|FG004|Overall Study|Adverse Event|2
2097532|NCT00806585|3687119|FG000|Overall Study|Withdrawal by Subject|10
2097533|NCT00806585|3687120|FG001|Overall Study|Withdrawal by Subject|8
2097534|NCT00806585|3687121|FG002|Overall Study|Withdrawal by Subject|9
2097535|NCT00806585|3687122|FG003|Overall Study|Withdrawal by Subject|3
2097536|NCT00806585|3687123|FG004|Overall Study|Withdrawal by Subject|11
2097537|NCT00806585|3687119|FG000|Overall Study|Completion status unknown|15
2097538|NCT00806585|3687120|FG001|Overall Study|Completion status unknown|14
2097539|NCT00806585|3687121|FG002|Overall Study|Completion status unknown|12
2097540|NCT00806585|3687122|FG003|Overall Study|Completion status unknown|4
2097541|NCT00806585|3687123|FG004|Overall Study|Completion status unknown|12
2097542|NCT00806624|3687142|FG000|Overall Study|Adverse Event|2
2097543|NCT00806624|3687143|FG001|Overall Study|Adverse Event|8
2097544|NCT00806624|3687144|FG002|Overall Study|Adverse Event|0
2097545|NCT00806624|3687142|FG000|Overall Study|Death|0
2097546|NCT00806624|3687143|FG001|Overall Study|Death|1
2097547|NCT00806624|3687144|FG002|Overall Study|Death|1
2097548|NCT00806624|3687142|FG000|Overall Study|Lost to Follow-up|1
2097549|NCT00806624|3687143|FG001|Overall Study|Lost to Follow-up|0
2097550|NCT00806624|3687144|FG002|Overall Study|Lost to Follow-up|1
2097551|NCT00806624|3687142|FG000|Overall Study|Withdrawal by Subject|6
2097552|NCT00806624|3687143|FG001|Overall Study|Withdrawal by Subject|3
2097553|NCT00806624|3687144|FG002|Overall Study|Withdrawal by Subject|3
2097554|NCT00806624|3687142|FG000|Overall Study|discontinued before start of treatment|0
2097555|NCT00806624|3687143|FG001|Overall Study|discontinued before start of treatment|0
2097556|NCT00806624|3687144|FG002|Overall Study|discontinued before start of treatment|1
2097557|NCT00806819|3687168|FG000|Overall Study|progressive disease (modified RECIST )|217
2097558|NCT00806819|3687169|FG001|Overall Study|progressive disease (modified RECIST )|216
2097559|NCT00806819|3687168|FG000|Overall Study|Worsening or AE of underlying disease|18
2097560|NCT00806819|3687169|FG001|Overall Study|Worsening or AE of underlying disease|25
2097561|NCT00806819|3687168|FG000|Overall Study|Other AE|38
2097562|NCT00806819|3687169|FG001|Overall Study|Other AE|40
2097563|NCT00806819|3687168|FG000|Overall Study|Protocol Violation|9
2097564|NCT00806819|3687169|FG001|Overall Study|Protocol Violation|4
2097565|NCT00806819|3687168|FG000|Overall Study|Lost to Follow-up|1
2097566|NCT00806819|3687169|FG001|Overall Study|Lost to Follow-up|0
2097567|NCT00806819|3687168|FG000|Overall Study|Withdrawal by Subject|32
2097568|NCT00806819|3687169|FG001|Overall Study|Withdrawal by Subject|29
2097569|NCT00806819|3687168|FG000|Overall Study|Not treated|6
2097570|NCT00806819|3687169|FG001|Overall Study|Not treated|3
2097571|NCT00806819|3687168|FG000|Overall Study|Reasons other than stated above|25
2097572|NCT00806819|3687169|FG001|Overall Study|Reasons other than stated above|41
2097573|NCT00806988|3687178|FG000|Overall Study|Death|15
2097574|NCT00806988|3687179|FG001|Overall Study|Death|16
2097575|NCT00806988|3687178|FG000|Overall Study|Withdrawal by Subject|8
2097576|NCT00806988|3687179|FG001|Overall Study|Withdrawal by Subject|8
2097577|NCT00806988|3687178|FG000|Overall Study|Lost to Follow-up|4
2097578|NCT00806988|3687179|FG001|Overall Study|Lost to Follow-up|19
2097579|NCT00807001|3687190|FG000|Overall Study|Non-compliance|0
2097580|NCT00807001|3687191|FG001|Overall Study|Non-compliance|1
2097581|NCT00807001|3687192|FG002|Overall Study|Non-compliance|0
2097582|NCT00807001|3687193|FG003|Overall Study|Non-compliance|0
2097583|NCT00807001|3687194|FG004|Overall Study|Non-compliance|0
2097584|NCT00807014|3687208|FG000|Overall Study|Participant Considered Disease Cured|13
2097585|NCT00807014|3687209|FG001|Overall Study|Participant Considered Disease Cured|2
2097586|NCT00807014|3687208|FG000|Overall Study|Participant Considered Disease Not Cured|2
2097587|NCT00807014|3687209|FG001|Overall Study|Participant Considered Disease Not Cured|7
2097588|NCT00807014|3687208|FG000|Overall Study|Protocol Violation|2
2097589|NCT00807014|3687209|FG001|Overall Study|Protocol Violation|8
2097590|NCT00807014|3687208|FG000|Overall Study|Adverse Event|0
2097591|NCT00807014|3687209|FG001|Overall Study|Adverse Event|2
2097592|NCT00807014|3687208|FG000|Overall Study|Lost to Follow-up|9
2097593|NCT00807014|3687209|FG001|Overall Study|Lost to Follow-up|7
2097594|NCT00807014|3687208|FG000|Overall Study|Recovery|1
2097595|NCT00807014|3687209|FG001|Overall Study|Recovery|0
2097596|NCT00807014|3687208|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0
2097597|NCT00807014|3687209|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1
2107712|NCT00875667|3701442|FG000|Overall Study|Protocol Violation|2
2107713|NCT00875667|3701443|FG001|Overall Study|Protocol Violation|0
2107714|NCT00875667|3701442|FG000|Overall Study|Disease Progression|100
2107715|NCT00875667|3701443|FG001|Overall Study|Disease Progression|49
2107716|NCT00875667|3701442|FG000|Overall Study|Miscellaneous|12
2107717|NCT00875667|3701443|FG001|Overall Study|Miscellaneous|6
2107718|NCT00875667|3701442|FG000|Overall Study|Randomized but no Study Drug Given|3
2107719|NCT00875667|3701443|FG001|Overall Study|Randomized but no Study Drug Given|1
2107720|NCT00875706|3701452|FG000|Overall Study|Withdrawal by Subject|1
2107721|NCT00875706|3701453|FG001|Overall Study|Withdrawal by Subject|0
2107722|NCT00875706|3701454|FG002|Overall Study|Withdrawal by Subject|0
2107723|NCT00875797|3701464|FG000|Overall Study|Protocol Violation|6
2107724|NCT00875797|3701465|FG001|Overall Study|Protocol Violation|3
2107725|NCT00875810|3701474|FG000|Overall Study|Withdrawal by Subject|1
2107726|NCT00875810|3701474|FG000|Overall Study|Physician Decision|3
2107727|NCT00875810|3701474|FG000|Overall Study|Lost to Follow-up|39
2107728|NCT00875810|3701474|FG000|Overall Study|Patient enroled but not implanted|2
2107729|NCT00875810|3701474|FG000|Overall Study|Device explanted|1
2107730|NCT00875979|3701489|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
2107731|NCT00875979|3701490|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
2107732|NCT00875979|3701489|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
2107733|NCT00875979|3701490|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
2107734|NCT00875979|3701489|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
2107735|NCT00875979|3701490|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
2107736|NCT00875979|3701489|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
2107737|NCT00875979|3701490|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
2107738|NCT00875979|3701489|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
2107739|NCT00875979|3701490|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
2107740|NCT00875979|3701489|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
2107741|NCT00875979|3701490|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
2107742|NCT00875979|3701489|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
2107743|NCT00875979|3701490|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
2107744|NCT00875979|3701489|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
2107745|NCT00875979|3701490|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
2107746|NCT00875979|3701489|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0
2107747|NCT00875979|3701490|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1
2107748|NCT00876018|3701499|FG000|Overall Study|Lost to Follow-up|0
2107749|NCT00876018|3701500|FG001|Overall Study|Lost to Follow-up|1
2107750|NCT00876018|3701501|FG002|Overall Study|Lost to Follow-up|1
2107751|NCT00876018|3701499|FG000|Overall Study|Withdrew Consent due to Adverse Event|5
2107752|NCT00876018|3701500|FG001|Overall Study|Withdrew Consent due to Adverse Event|4
2107753|NCT00876018|3701501|FG002|Overall Study|Withdrew Consent due to Adverse Event|2
2107754|NCT00876187|3701516|FG000|Overall Study|Adverse Event|14
2107755|NCT00876187|3701517|FG001|Overall Study|Adverse Event|12
2107756|NCT00876187|3701518|FG002|Overall Study|Adverse Event|19
2107757|NCT00876187|3701519|FG003|Overall Study|Adverse Event|29
2107758|NCT00876187|3701520|FG004|Overall Study|Adverse Event|10
2107759|NCT00876187|3701516|FG000|Overall Study|Lack of Efficacy|59
2107760|NCT00876187|3701517|FG001|Overall Study|Lack of Efficacy|34
2107761|NCT00876187|3701518|FG002|Overall Study|Lack of Efficacy|45
2107762|NCT00876187|3701519|FG003|Overall Study|Lack of Efficacy|34
2107763|NCT00876187|3701520|FG004|Overall Study|Lack of Efficacy|59
2107764|NCT00876187|3701516|FG000|Overall Study|Lost to Follow-up|9
2107765|NCT00876187|3701517|FG001|Overall Study|Lost to Follow-up|10
2107766|NCT00876187|3701518|FG002|Overall Study|Lost to Follow-up|8
2107767|NCT00876187|3701519|FG003|Overall Study|Lost to Follow-up|8
2107768|NCT00876187|3701520|FG004|Overall Study|Lost to Follow-up|11
2107769|NCT00876187|3701516|FG000|Overall Study|Protocol Violation|6
2107770|NCT00876187|3701517|FG001|Overall Study|Protocol Violation|7
2107771|NCT00876187|3701518|FG002|Overall Study|Protocol Violation|7
2107772|NCT00876187|3701519|FG003|Overall Study|Protocol Violation|6
2107773|NCT00876187|3701520|FG004|Overall Study|Protocol Violation|3
2107774|NCT00876187|3701516|FG000|Overall Study|Withdrawal by Subject|16
2107775|NCT00876187|3701517|FG001|Overall Study|Withdrawal by Subject|26
2107776|NCT00876187|3701518|FG002|Overall Study|Withdrawal by Subject|32
2107777|NCT00876187|3701519|FG003|Overall Study|Withdrawal by Subject|38
2107778|NCT00876187|3701520|FG004|Overall Study|Withdrawal by Subject|37
2107779|NCT00876187|3701516|FG000|Overall Study|Entered extension study|101
2107780|NCT00876187|3701517|FG001|Overall Study|Entered extension study|120
2107781|NCT00876187|3701518|FG002|Overall Study|Entered extension study|156
2107782|NCT00876187|3701519|FG003|Overall Study|Entered extension study|151
2107783|NCT00876187|3701520|FG004|Overall Study|Entered extension study|144
2107784|NCT00876187|3701516|FG000|Overall Study|Randomized but not treated|3
2107785|NCT00876187|3701517|FG001|Overall Study|Randomized but not treated|1
2107786|NCT00876187|3701518|FG002|Overall Study|Randomized but not treated|3
2107787|NCT00876187|3701519|FG003|Overall Study|Randomized but not treated|2
2107788|NCT00876187|3701520|FG004|Overall Study|Randomized but not treated|3
2107789|NCT00876187|3701516|FG000|Overall Study|Other|2
2097598|NCT00807040|3687217|FG000|Overall Study|Death|24
2097599|NCT00807040|3687218|FG001|Overall Study|Death|29
2097600|NCT00807040|3687217|FG000|Overall Study|Withdrawal by Subject|8
2097601|NCT00807040|3687218|FG001|Overall Study|Withdrawal by Subject|6
2097602|NCT00807040|3687217|FG000|Overall Study|Lost to Follow-up|4
2097603|NCT00807040|3687218|FG001|Overall Study|Lost to Follow-up|6
2097604|NCT00807092|3687226|FG000|Overall Study|Adverse Event|0
2097605|NCT00807092|3687227|FG001|Overall Study|Adverse Event|1
2097606|NCT00807092|3687226|FG000|Overall Study|Protocol Violation|0
2097607|NCT00807092|3687227|FG001|Overall Study|Protocol Violation|2
2097608|NCT00807092|3687226|FG000|Overall Study|Withdrawal by Subject|1
2097609|NCT00807092|3687227|FG001|Overall Study|Withdrawal by Subject|0
2097610|NCT00807092|3687226|FG000|Overall Study|CGMS data collection failed|0
2097611|NCT00807092|3687227|FG001|Overall Study|CGMS data collection failed|1
2097612|NCT00807144|3687235|FG000|Overall Study|Lost to Follow-up|0
2097613|NCT00807144|3687236|FG001|Overall Study|Lost to Follow-up|1
2097614|NCT00807235|3687257|FG000|Overall Study|Adverse Event|1
2097615|NCT00807235|3687258|FG001|Overall Study|Adverse Event|0
2097616|NCT00807248|3687268|FG000|Overall Study|Adverse Event|1
2097617|NCT00807248|3687269|FG001|Overall Study|Adverse Event|2
2097618|NCT00807248|3687270|FG002|Overall Study|Adverse Event|2
2097619|NCT00807248|3687271|FG003|Overall Study|Adverse Event|6
2097620|NCT00807248|3687268|FG000|Overall Study|Lack of Efficacy|14
2097621|NCT00807248|3687269|FG001|Overall Study|Lack of Efficacy|4
2097622|NCT00807248|3687270|FG002|Overall Study|Lack of Efficacy|8
2097623|NCT00807248|3687271|FG003|Overall Study|Lack of Efficacy|3
2097624|NCT00807248|3687268|FG000|Overall Study|Protocol Violation|0
2097625|NCT00807248|3687269|FG001|Overall Study|Protocol Violation|1
2097626|NCT00807248|3687270|FG002|Overall Study|Protocol Violation|1
2097627|NCT00807248|3687271|FG003|Overall Study|Protocol Violation|0
2097628|NCT00807248|3687268|FG000|Overall Study|Withdrawal of Consent|5
2097629|NCT00807248|3687269|FG001|Overall Study|Withdrawal of Consent|5
2097630|NCT00807248|3687270|FG002|Overall Study|Withdrawal of Consent|5
2097631|NCT00807248|3687271|FG003|Overall Study|Withdrawal of Consent|5
2097632|NCT00807248|3687268|FG000|Overall Study|Lost to Follow-up|1
2097633|NCT00807248|3687269|FG001|Overall Study|Lost to Follow-up|0
2097634|NCT00807248|3687270|FG002|Overall Study|Lost to Follow-up|0
2097635|NCT00807248|3687271|FG003|Overall Study|Lost to Follow-up|0
2097636|NCT00807248|3687268|FG000|Overall Study|Other Reason|0
2097637|NCT00807248|3687269|FG001|Overall Study|Other Reason|0
2097638|NCT00807248|3687270|FG002|Overall Study|Other Reason|2
2097639|NCT00807248|3687271|FG003|Overall Study|Other Reason|0
2097640|NCT00807495|3687290|FG000|Overall Study|Adverse Event|6
2097641|NCT00807495|3687291|FG001|Overall Study|Adverse Event|3
2097642|NCT00807495|3687292|FG002|Overall Study|Adverse Event|1
2097643|NCT00807495|3687293|FG003|Overall Study|Adverse Event|1
2097644|NCT00807495|3687294|FG004|Overall Study|Adverse Event|2
2097645|NCT00807495|3687290|FG000|Overall Study|Withdrawal by Patient|2
2097646|NCT00807495|3687291|FG001|Overall Study|Withdrawal by Patient|0
2097647|NCT00807495|3687292|FG002|Overall Study|Withdrawal by Patient|1
2097648|NCT00807495|3687293|FG003|Overall Study|Withdrawal by Patient|0
2097649|NCT00807495|3687294|FG004|Overall Study|Withdrawal by Patient|0
2097650|NCT00807495|3687290|FG000|Overall Study|Reason Not Specified|0
2097651|NCT00807495|3687291|FG001|Overall Study|Reason Not Specified|3
2097652|NCT00807495|3687292|FG002|Overall Study|Reason Not Specified|2
2097653|NCT00807495|3687293|FG003|Overall Study|Reason Not Specified|0
2097654|NCT00807495|3687294|FG004|Overall Study|Reason Not Specified|3
2097655|NCT00807573|3687315|FG000|Overall Study|Withdrawal by Subject|1
2097656|NCT00807573|3687315|FG000|Overall Study|Adverse Event|1
2097657|NCT00807599|3687330|FG000|Overall Study|Not treated on protocol study|0
2097658|NCT00807599|3687331|FG001|Overall Study|Not treated on protocol study|0
2097659|NCT00807599|3687332|FG002|Overall Study|Not treated on protocol study|2
2097660|NCT00807599|3687330|FG000|Overall Study|Adverse Event|0
2097661|NCT00807599|3687331|FG001|Overall Study|Adverse Event|0
2097662|NCT00807599|3687332|FG002|Overall Study|Adverse Event|5
2097663|NCT00807599|3687330|FG000|Overall Study|Inadequate response to induction|0
2097664|NCT00807599|3687331|FG001|Overall Study|Inadequate response to induction|0
2097665|NCT00807599|3687332|FG002|Overall Study|Inadequate response to induction|9
2097666|NCT00807599|3687330|FG000|Overall Study|Withdrawal by Subject|0
2097667|NCT00807599|3687331|FG001|Overall Study|Withdrawal by Subject|0
2097668|NCT00807599|3687332|FG002|Overall Study|Withdrawal by Subject|1
2097669|NCT00807742|3687350|FG000|Overall Study|Death|9
2097670|NCT00807742|3687351|FG001|Overall Study|Death|2
2097671|NCT00807742|3687350|FG000|Overall Study|Withdrawal by Subject|2
2097672|NCT00807742|3687351|FG001|Overall Study|Withdrawal by Subject|1
2097673|NCT00807742|3687350|FG000|Overall Study|Lost to Follow-up|35
2097674|NCT00807742|3687351|FG001|Overall Study|Lost to Follow-up|51
2097675|NCT00807846|3687368|FG000|Overall Study|Adverse Event|5
2097676|NCT00807846|3687369|FG001|Overall Study|Adverse Event|0
2097677|NCT00807846|3687368|FG000|Overall Study|Lack of Efficacy|2
2097678|NCT00807846|3687369|FG001|Overall Study|Lack of Efficacy|0
2097679|NCT00807846|3687368|FG000|Overall Study|Protocol Violation|2
2097680|NCT00807846|3687369|FG001|Overall Study|Protocol Violation|1
2097681|NCT00807846|3687368|FG000|Overall Study|Withdrawal by Subject|2
2097682|NCT00807846|3687369|FG001|Overall Study|Withdrawal by Subject|1
2097683|NCT00807846|3687368|FG000|Overall Study|Other|1
2097684|NCT00807846|3687369|FG001|Overall Study|Other|2
2097685|NCT00807885|3687384|FG000|Overall Study|Lost to Follow-up|0
2097686|NCT00807885|3687385|FG001|Overall Study|Lost to Follow-up|0
2097687|NCT00807885|3687386|FG002|Overall Study|Lost to Follow-up|0
2097688|NCT00807885|3687387|FG003|Overall Study|Lost to Follow-up|0
2097689|NCT00807885|3687388|FG004|Overall Study|Lost to Follow-up|0
2097690|NCT00807885|3687389|FG005|Overall Study|Lost to Follow-up|1
2097691|NCT00807885|3687390|FG006|Overall Study|Lost to Follow-up|0
2097692|NCT00807885|3687391|FG007|Overall Study|Lost to Follow-up|0
2097693|NCT00807885|3687392|FG008|Overall Study|Lost to Follow-up|0
2097694|NCT00807937|3687416|FG000|Overall Study|Adverse Event|12
2097695|NCT00807937|3687417|FG001|Overall Study|Adverse Event|12
2097696|NCT00807937|3687418|FG002|Overall Study|Adverse Event|5
2097697|NCT00807937|3687419|FG003|Overall Study|Adverse Event|4
2097698|NCT00807937|3687416|FG000|Overall Study|Protocol Violation|4
2097699|NCT00807937|3687417|FG001|Overall Study|Protocol Violation|5
2097700|NCT00807937|3687418|FG002|Overall Study|Protocol Violation|3
2097701|NCT00807937|3687419|FG003|Overall Study|Protocol Violation|3
2097702|NCT00807937|3687416|FG000|Overall Study|Withdrawal by Subject|5
2097703|NCT00807937|3687417|FG001|Overall Study|Withdrawal by Subject|4
2097704|NCT00807937|3687418|FG002|Overall Study|Withdrawal by Subject|1
2097705|NCT00807937|3687419|FG003|Overall Study|Withdrawal by Subject|4
2097706|NCT00807937|3687416|FG000|Overall Study|Lost to Follow-up|4
2097707|NCT00807937|3687417|FG001|Overall Study|Lost to Follow-up|0
2097708|NCT00807937|3687418|FG002|Overall Study|Lost to Follow-up|2
2097709|NCT00807937|3687419|FG003|Overall Study|Lost to Follow-up|1
2097710|NCT00807937|3687416|FG000|Overall Study|Lack of Efficacy|0
2097711|NCT00807937|3687417|FG001|Overall Study|Lack of Efficacy|0
2097712|NCT00807937|3687418|FG002|Overall Study|Lack of Efficacy|1
2097713|NCT00807937|3687419|FG003|Overall Study|Lack of Efficacy|2
2097714|NCT00807937|3687416|FG000|Overall Study|Intake of prohibited medicine|0
2097715|NCT00807937|3687417|FG001|Overall Study|Intake of prohibited medicine|0
2097716|NCT00807937|3687418|FG002|Overall Study|Intake of prohibited medicine|2
2097717|NCT00807937|3687419|FG003|Overall Study|Intake of prohibited medicine|0
2097718|NCT00807937|3687416|FG000|Overall Study|All other reasons (not provided)|2
2097719|NCT00807937|3687417|FG001|Overall Study|All other reasons (not provided)|4
2097720|NCT00807937|3687418|FG002|Overall Study|All other reasons (not provided)|0
2097721|NCT00807937|3687419|FG003|Overall Study|All other reasons (not provided)|1
2097722|NCT00808015|3687438|FG000|Overall Study|Death|1
2097723|NCT00808015|3687438|FG000|Overall Study|Lack of Efficacy|58
2097724|NCT00808015|3687438|FG000|Overall Study|Lost to Follow-up|76
2097725|NCT00808015|3687438|FG000|Overall Study|Participants not willing to participate|158
2097726|NCT00808015|3687438|FG000|Overall Study|Adverse Event|22
2097727|NCT00808015|3687438|FG000|Overall Study|Other|25
2097728|NCT00808015|3687438|FG000|Overall Study|Enrolled but not treated|4
2097729|NCT00808028|3687446|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3
2097730|NCT00808028|3687447|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0
2097731|NCT00808028|3687448|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2
2097732|NCT00808028|3687449|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5
2097733|NCT00808028|3687446|FG000|Stage 1 (6 Months)|Other|1
2097734|NCT00808028|3687447|FG001|Stage 1 (6 Months)|Other|0
2097735|NCT00808028|3687448|FG002|Stage 1 (6 Months)|Other|2
2097736|NCT00808028|3687449|FG003|Stage 1 (6 Months)|Other|4
2097737|NCT00808028|3687446|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0
2097738|NCT00808028|3687447|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1
2097739|NCT00808028|3687448|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1
2097740|NCT00808028|3687449|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3
2097741|NCT00808028|3687446|FG000|Stage 1 (6 Months)|Adverse Event|0
2097742|NCT00808028|3687447|FG001|Stage 1 (6 Months)|Adverse Event|0
2097743|NCT00808028|3687448|FG002|Stage 1 (6 Months)|Adverse Event|1
2097744|NCT00808028|3687449|FG003|Stage 1 (6 Months)|Adverse Event|2
2097745|NCT00808028|3687446|FG000|Stage 1 (6 Months)|Lost to Follow-up|1
2097746|NCT00808028|3687447|FG001|Stage 1 (6 Months)|Lost to Follow-up|0
2097747|NCT00808028|3687448|FG002|Stage 1 (6 Months)|Lost to Follow-up|1
2097748|NCT00808028|3687449|FG003|Stage 1 (6 Months)|Lost to Follow-up|0
2097749|NCT00808028|3687446|FG000|Stage 1 (6 Months)|Protocol Violation|0
2097750|NCT00808028|3687447|FG001|Stage 1 (6 Months)|Protocol Violation|0
2097751|NCT00808028|3687448|FG002|Stage 1 (6 Months)|Protocol Violation|0
2097752|NCT00808028|3687449|FG003|Stage 1 (6 Months)|Protocol Violation|1
2097753|NCT00808028|3687446|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
2097754|NCT00808028|3687447|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
2097755|NCT00808028|3687448|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
2097756|NCT00808028|3687449|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
2097757|NCT00808028|3687446|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
2097758|NCT00808028|3687447|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
2097759|NCT00808028|3687448|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
2097760|NCT00808028|3687449|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
2097761|NCT00808028|3687446|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
2097762|NCT00808028|3687447|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
2097763|NCT00808028|3687448|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
2097764|NCT00808028|3687449|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
2097765|NCT00808028|3687446|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2
2097766|NCT00808028|3687447|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0
2097767|NCT00808028|3687448|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5
2097768|NCT00808028|3687449|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4
2097769|NCT00808028|3687446|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1
2097770|NCT00808028|3687447|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0
2097771|NCT00808028|3687448|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1
2097772|NCT00808028|3687449|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0
2097773|NCT00808028|3687446|FG000|Stage 2 (Followed up to 48 Months )|Other|0
2097774|NCT00808028|3687447|FG001|Stage 2 (Followed up to 48 Months )|Other|0
2097775|NCT00808028|3687448|FG002|Stage 2 (Followed up to 48 Months )|Other|1
2097776|NCT00808028|3687449|FG003|Stage 2 (Followed up to 48 Months )|Other|1
2097777|NCT00808028|3687446|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
2097778|NCT00808028|3687447|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
2097779|NCT00808028|3687448|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
2097780|NCT00808028|3687449|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
2097781|NCT00808028|3687446|FG000|Stage 2 (Followed up to 48 Months )|Death|0
2097782|NCT00808028|3687447|FG001|Stage 2 (Followed up to 48 Months )|Death|0
2097783|NCT00808028|3687448|FG002|Stage 2 (Followed up to 48 Months )|Death|1
2097784|NCT00808028|3687449|FG003|Stage 2 (Followed up to 48 Months )|Death|0
2097785|NCT00808028|3687446|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0
2097786|NCT00808028|3687447|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0
2097787|NCT00808028|3687448|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1
2097788|NCT00808028|3687449|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0
2097789|NCT00808067|3687471|FG000|Overall Study|Major/minor bleed|30
2097790|NCT00808067|3687472|FG001|Overall Study|Major/minor bleed|44
2097791|NCT00808067|3687471|FG000|Overall Study|Outcome event - other|33
2097792|NCT00808067|3687472|FG001|Overall Study|Outcome event - other|25
2097793|NCT00808067|3687471|FG000|Overall Study|Adverse Event|111
2097794|NCT00808067|3687472|FG001|Overall Study|Adverse Event|121
2097795|NCT00808067|3687471|FG000|Overall Study|Hospitalization (not including surgery)|18
2097796|NCT00808067|3687472|FG001|Overall Study|Hospitalization (not including surgery)|17
2097797|NCT00808067|3687471|FG000|Overall Study|Hospitalization due to surgery|37
2097798|NCT00808067|3687472|FG001|Overall Study|Hospitalization due to surgery|40
2097799|NCT00808067|3687471|FG000|Overall Study|Reduced creatinine clearance|53
2097800|NCT00808067|3687472|FG001|Overall Study|Reduced creatinine clearance|55
2097801|NCT00808067|3687471|FG000|Overall Study|Elevated LFT results|7
2097802|NCT00808067|3687472|FG001|Overall Study|Elevated LFT results|3
2097803|NCT00808067|3687471|FG000|Overall Study|Patient refused to take study medication|65
2097804|NCT00808067|3687472|FG001|Overall Study|Patient refused to take study medication|76
2097805|NCT00808067|3687471|FG000|Overall Study|Missing|1
2097806|NCT00808067|3687472|FG001|Overall Study|Missing|0
2097807|NCT00808067|3687471|FG000|Overall Study|Death|1
2097808|NCT00808067|3687472|FG001|Overall Study|Death|1
2097809|NCT00808067|3687471|FG000|Overall Study|Procedure|6
2097810|NCT00808067|3687472|FG001|Overall Study|Procedure|7
2097811|NCT00808067|3687471|FG000|Overall Study|Withdrawal by Subject|21
2097812|NCT00808067|3687472|FG001|Overall Study|Withdrawal by Subject|25
2097813|NCT00808067|3687471|FG000|Overall Study|Site closed|4
2097814|NCT00808067|3687472|FG001|Overall Study|Site closed|3
2097815|NCT00808067|3687471|FG000|Overall Study|Physician Decision|47
2097816|NCT00808067|3687472|FG001|Overall Study|Physician Decision|38
2097817|NCT00808067|3687471|FG000|Overall Study|Protocol Violation|3
2097818|NCT00808067|3687472|FG001|Overall Study|Protocol Violation|11
2097819|NCT00808067|3687471|FG000|Overall Study|Patient elected|7
2097820|NCT00808067|3687472|FG001|Overall Study|Patient elected|9
2097821|NCT00808067|3687471|FG000|Overall Study|Site closed for cause|19
2097822|NCT00808067|3687472|FG001|Overall Study|Site closed for cause|19
2097823|NCT00808067|3687471|FG000|Overall Study|Other reason not defined above|5
2097824|NCT00808067|3687472|FG001|Overall Study|Other reason not defined above|5
2097825|NCT00808067|3687471|FG000|Overall Study|Excluded from analysis|13
2097826|NCT00808067|3687472|FG001|Overall Study|Excluded from analysis|19
2097827|NCT00808132|3687483|FG000|Overall Study|Adverse Event|34
2097828|NCT00808132|3687484|FG001|Overall Study|Adverse Event|33
2097829|NCT00808132|3687485|FG002|Overall Study|Adverse Event|16
2097830|NCT00808132|3687486|FG003|Overall Study|Adverse Event|31
2097831|NCT00808132|3687487|FG004|Overall Study|Adverse Event|33
2097832|NCT00808132|3687483|FG000|Overall Study|Death|0
2097833|NCT00808132|3687484|FG001|Overall Study|Death|0
2097834|NCT00808132|3687485|FG002|Overall Study|Death|0
2097835|NCT00808132|3687486|FG003|Overall Study|Death|0
2097836|NCT00808132|3687487|FG004|Overall Study|Death|1
2097837|NCT00808132|3687483|FG000|Overall Study|Physician Decision|0
2097838|NCT00808132|3687484|FG001|Overall Study|Physician Decision|1
2097839|NCT00808132|3687485|FG002|Overall Study|Physician Decision|0
2097840|NCT00808132|3687486|FG003|Overall Study|Physician Decision|0
2097841|NCT00808132|3687487|FG004|Overall Study|Physician Decision|0
2097842|NCT00808132|3687483|FG000|Overall Study|Lost to Follow-up|8
2097843|NCT00808132|3687484|FG001|Overall Study|Lost to Follow-up|10
2097844|NCT00808132|3687485|FG002|Overall Study|Lost to Follow-up|11
2097845|NCT00808132|3687486|FG003|Overall Study|Lost to Follow-up|8
2097846|NCT00808132|3687487|FG004|Overall Study|Lost to Follow-up|9
2097847|NCT00808132|3687483|FG000|Overall Study|Protocol Violation|8
2097848|NCT00808132|3687484|FG001|Overall Study|Protocol Violation|9
2097849|NCT00808132|3687485|FG002|Overall Study|Protocol Violation|4
2097850|NCT00808132|3687486|FG003|Overall Study|Protocol Violation|9
2097851|NCT00808132|3687487|FG004|Overall Study|Protocol Violation|5
2097852|NCT00808132|3687483|FG000|Overall Study|Withdrawal by Subject|27
2097853|NCT00808132|3687484|FG001|Overall Study|Withdrawal by Subject|18
2097854|NCT00808132|3687485|FG002|Overall Study|Withdrawal by Subject|2
2097855|NCT00808132|3687486|FG003|Overall Study|Withdrawal by Subject|7
2097856|NCT00808132|3687487|FG004|Overall Study|Withdrawal by Subject|16
2097857|NCT00808132|3687483|FG000|Overall Study|Other|6
2097858|NCT00808132|3687484|FG001|Overall Study|Other|4
2097859|NCT00808132|3687485|FG002|Overall Study|Other|6
2097860|NCT00808132|3687486|FG003|Overall Study|Other|2
2097861|NCT00808132|3687487|FG004|Overall Study|Other|15
2097862|NCT00808132|3687483|FG000|Overall Study|Randomized, but not treated|10
2097863|NCT00808132|3687484|FG001|Overall Study|Randomized, but not treated|7
2097864|NCT00808132|3687485|FG002|Overall Study|Randomized, but not treated|9
2097865|NCT00808132|3687486|FG003|Overall Study|Randomized, but not treated|8
2097866|NCT00808132|3687487|FG004|Overall Study|Randomized, but not treated|9
2097867|NCT00808132|3687483|FG000|Overall Study|Unsatisfactory response|5
2097868|NCT00808132|3687484|FG001|Overall Study|Unsatisfactory response|6
2097869|NCT00808132|3687485|FG002|Overall Study|Unsatisfactory response|6
2097870|NCT00808132|3687486|FG003|Overall Study|Unsatisfactory response|4
2097871|NCT00808132|3687487|FG004|Overall Study|Unsatisfactory response|12
2097872|NCT00808210|3687501|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3
2097873|NCT00808210|3687502|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7
2097874|NCT00808210|3687501|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6
2097875|NCT00808210|3687502|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2
2097876|NCT00808210|3687501|FG000|Double-Blind TX Period|Adverse Event|0
2097877|NCT00808210|3687502|FG001|Double-Blind TX Period|Adverse Event|1
2097878|NCT00808210|3687501|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1
2097879|NCT00808210|3687502|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1
2097880|NCT00808210|3687501|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1
2097881|NCT00808210|3687502|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1
2097882|NCT00808210|3687501|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9
2097883|NCT00808210|3687502|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4
2097884|NCT00808236|3687510|FG000|Overall Study|Was not resuscitated|50
2097885|NCT00808236|3687511|FG001|Overall Study|Was not resuscitated|56
2097886|NCT00808236|3687510|FG000|Overall Study|Pre-defined exclusion|13
2097887|NCT00808236|3687511|FG001|Overall Study|Pre-defined exclusion|3
2097888|NCT00808236|3687510|FG000|Overall Study|Lost to Follow-up|1
2097889|NCT00808236|3687511|FG001|Overall Study|Lost to Follow-up|1
2097890|NCT00808236|3687510|FG000|Overall Study|Physician Decision|0
2097891|NCT00808236|3687511|FG001|Overall Study|Physician Decision|1
2097892|NCT00808236|3687510|FG000|Overall Study|Death|18
2097893|NCT00808236|3687511|FG001|Overall Study|Death|30
2097894|NCT00808249|3687521|FG000|Overall Study|Adverse Event|4
2097895|NCT00808249|3687522|FG001|Overall Study|Adverse Event|7
2097896|NCT00808249|3687523|FG002|Overall Study|Adverse Event|10
2097897|NCT00808249|3687524|FG003|Overall Study|Adverse Event|6
2097898|NCT00808249|3687521|FG000|Overall Study|Lost to Follow-up|2
2097899|NCT00808249|3687522|FG001|Overall Study|Lost to Follow-up|3
2097900|NCT00808249|3687523|FG002|Overall Study|Lost to Follow-up|3
2097901|NCT00808249|3687524|FG003|Overall Study|Lost to Follow-up|5
2097902|NCT00808249|3687521|FG000|Overall Study|Withdrawal by Subject|4
2097903|NCT00808249|3687522|FG001|Overall Study|Withdrawal by Subject|0
2097904|NCT00808249|3687523|FG002|Overall Study|Withdrawal by Subject|2
2097905|NCT00808249|3687524|FG003|Overall Study|Withdrawal by Subject|4
2097906|NCT00808249|3687521|FG000|Overall Study|Protocol Violation|3
2097907|NCT00808249|3687522|FG001|Overall Study|Protocol Violation|3
2097908|NCT00808249|3687523|FG002|Overall Study|Protocol Violation|3
2097909|NCT00808249|3687524|FG003|Overall Study|Protocol Violation|0
2097910|NCT00808249|3687521|FG000|Overall Study|Lack of Efficacy|1
2097911|NCT00808249|3687522|FG001|Overall Study|Lack of Efficacy|1
2097912|NCT00808249|3687523|FG002|Overall Study|Lack of Efficacy|0
2097913|NCT00808249|3687524|FG003|Overall Study|Lack of Efficacy|0
2097914|NCT00808249|3687521|FG000|Overall Study|study specific discontinuation criteria|1
2097915|NCT00808249|3687522|FG001|Overall Study|study specific discontinuation criteria|0
2097916|NCT00808249|3687523|FG002|Overall Study|study specific discontinuation criteria|1
2097917|NCT00808249|3687524|FG003|Overall Study|study specific discontinuation criteria|0
2097918|NCT00808249|3687521|FG000|Overall Study|All other reasons|2
2097919|NCT00808249|3687522|FG001|Overall Study|All other reasons|1
2097920|NCT00808249|3687523|FG002|Overall Study|All other reasons|3
2097921|NCT00808249|3687524|FG003|Overall Study|All other reasons|1
2097922|NCT00808444|3687558|FG000|Overall Study|Withdrawal by Subject|1
2097923|NCT00808444|3687559|FG001|Overall Study|Withdrawal by Subject|0
2097924|NCT00808444|3687558|FG000|Overall Study|Lost to Follow-up|0
2097925|NCT00808444|3687559|FG001|Overall Study|Lost to Follow-up|1
2097926|NCT00808483|3687580|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
2097927|NCT00808483|3687581|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
2097928|NCT00808483|3687580|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1
2097929|NCT00808483|3687581|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0
2097930|NCT00808483|3687580|FG000|From 5 Months to 12 Months|Lack of Efficacy|1
2097931|NCT00808483|3687581|FG001|From 5 Months to 12 Months|Lack of Efficacy|0
2097932|NCT00808509|3687596|FG000|Randomized Phase|Did not meet eligibility criteria|1
2097933|NCT00808509|3687597|FG001|Randomized Phase|Did not meet eligibility criteria|0
2097934|NCT00808509|3687596|FG000|Randomized Phase|Reduced methotrexate dose|1
2097935|NCT00808509|3687597|FG001|Randomized Phase|Reduced methotrexate dose|2
2097936|NCT00808509|3687596|FG000|Randomized Phase|Patient refused rescue therapy|0
2097937|NCT00808509|3687597|FG001|Randomized Phase|Patient refused rescue therapy|3
2097938|NCT00808639|3687605|FG000|Overall Study|Disease progression before surgery.|1
2097939|NCT00808665|3687611|FG000|Overall Study|Withdrawal by Subject|1
2097940|NCT00808665|3687612|FG001|Overall Study|Withdrawal by Subject|0
2097941|NCT00808665|3687611|FG000|Overall Study|only required minimally invasive surgery|1
2097942|NCT00808665|3687612|FG001|Overall Study|only required minimally invasive surgery|0
2097943|NCT00808665|3687611|FG000|Overall Study|surgery cancelled|1
2097944|NCT00808665|3687612|FG001|Overall Study|surgery cancelled|0
2097945|NCT00808665|3687611|FG000|Overall Study|required an additional procedure|0
2097946|NCT00808665|3687612|FG001|Overall Study|required an additional procedure|1
2097947|NCT00808665|3687611|FG000|Overall Study|Physician Decision|3
2097948|NCT00808665|3687612|FG001|Overall Study|Physician Decision|1
2097949|NCT00808665|3687611|FG000|Overall Study|Medication stopped by resident|0
2097950|NCT00808665|3687612|FG001|Overall Study|Medication stopped by resident|1
2097951|NCT00808808|3687621|FG000|Overall Study|Vaccinated; survey not completed|131
2097952|NCT00808808|3687622|FG001|Overall Study|Vaccinated; survey not completed|169
2097953|NCT00808808|3687623|FG002|Overall Study|Vaccinated; survey not completed|302
2097954|NCT00808808|3687621|FG000|Overall Study|Employee was not vaccinated.|2686
2097955|NCT00808808|3687622|FG001|Overall Study|Employee was not vaccinated.|2268
2097956|NCT00808808|3687623|FG002|Overall Study|Employee was not vaccinated.|2255
2097957|NCT00809094|3687655|FG000|Overall Study|Lost to Follow-up|0
2097958|NCT00809094|3687656|FG001|Overall Study|Lost to Follow-up|1
2097959|NCT00809133|3687676|FG000|Overall Study|Progressive disease|2
2097960|NCT00809133|3687677|FG001|Overall Study|Progressive disease|5
2097961|NCT00809133|3687678|FG002|Overall Study|Progressive disease|5
2097962|NCT00809133|3687679|FG003|Overall Study|Progressive disease|3
2097963|NCT00809133|3687680|FG004|Overall Study|Progressive disease|4
2097964|NCT00809133|3687681|FG005|Overall Study|Progressive disease|1
2097965|NCT00809133|3687682|FG006|Overall Study|Progressive disease|3
2097966|NCT00809133|3687683|FG007|Overall Study|Progressive disease|3
2097967|NCT00809133|3687684|FG008|Overall Study|Progressive disease|3
2097968|NCT00809133|3687685|FG009|Overall Study|Progressive disease|9
2097969|NCT00809133|3687686|FG010|Overall Study|Progressive disease|5
2097970|NCT00809133|3687687|FG011|Overall Study|Progressive disease|7
2097971|NCT00809133|3687688|FG012|Overall Study|Progressive disease|5
2097972|NCT00809133|3687689|FG013|Overall Study|Progressive disease|4
2097973|NCT00809133|3687676|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0
2097974|NCT00809133|3687677|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
2097975|NCT00809133|3687678|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
2097976|NCT00809133|3687679|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
2097977|NCT00809133|3687680|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
2097978|NCT00809133|3687681|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1
2212109|NCT01667679|3853075|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
2212110|NCT01667679|3853074|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
2097979|NCT00809133|3687682|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1
2097980|NCT00809133|3687683|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1
2097981|NCT00809133|3687684|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0
2097982|NCT00809133|3687685|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0
2097983|NCT00809133|3687686|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0
2097984|NCT00809133|3687687|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0
2097985|NCT00809133|3687688|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0
2097986|NCT00809133|3687689|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2
2097987|NCT00809133|3687676|FG000|Overall Study|Other adverse event|1
2097988|NCT00809133|3687677|FG001|Overall Study|Other adverse event|1
2097989|NCT00809133|3687678|FG002|Overall Study|Other adverse event|1
2097990|NCT00809133|3687679|FG003|Overall Study|Other adverse event|0
2097991|NCT00809133|3687680|FG004|Overall Study|Other adverse event|0
2097992|NCT00809133|3687681|FG005|Overall Study|Other adverse event|3
2097993|NCT00809133|3687682|FG006|Overall Study|Other adverse event|2
2097994|NCT00809133|3687683|FG007|Overall Study|Other adverse event|4
2097995|NCT00809133|3687684|FG008|Overall Study|Other adverse event|0
2097996|NCT00809133|3687685|FG009|Overall Study|Other adverse event|0
2097997|NCT00809133|3687686|FG010|Overall Study|Other adverse event|1
2097998|NCT00809133|3687687|FG011|Overall Study|Other adverse event|1
2097999|NCT00809133|3687688|FG012|Overall Study|Other adverse event|0
2098000|NCT00809133|3687689|FG013|Overall Study|Other adverse event|1
2098001|NCT00809133|3687676|FG000|Overall Study|Lost to Follow-up|0
2098002|NCT00809133|3687677|FG001|Overall Study|Lost to Follow-up|0
2098003|NCT00809133|3687678|FG002|Overall Study|Lost to Follow-up|0
2098004|NCT00809133|3687679|FG003|Overall Study|Lost to Follow-up|0
2098005|NCT00809133|3687680|FG004|Overall Study|Lost to Follow-up|0
2212111|NCT01667679|3853075|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
2212112|NCT01667679|3853074|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
2212113|NCT01667679|3853075|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
2212114|NCT01667679|3853074|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
2212115|NCT01667679|3853075|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
2212116|NCT01667679|3853074|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
2098006|NCT00809133|3687681|FG005|Overall Study|Lost to Follow-up|1
2098007|NCT00809133|3687682|FG006|Overall Study|Lost to Follow-up|0
2098008|NCT00809133|3687683|FG007|Overall Study|Lost to Follow-up|0
2098009|NCT00809133|3687684|FG008|Overall Study|Lost to Follow-up|0
2098010|NCT00809133|3687685|FG009|Overall Study|Lost to Follow-up|0
2098011|NCT00809133|3687686|FG010|Overall Study|Lost to Follow-up|0
2098012|NCT00809133|3687687|FG011|Overall Study|Lost to Follow-up|0
2098013|NCT00809133|3687688|FG012|Overall Study|Lost to Follow-up|0
2098014|NCT00809133|3687689|FG013|Overall Study|Lost to Follow-up|0
2098015|NCT00809133|3687676|FG000|Overall Study|Consent withdrawn|0
2098016|NCT00809133|3687677|FG001|Overall Study|Consent withdrawn|0
2098017|NCT00809133|3687678|FG002|Overall Study|Consent withdrawn|0
2098018|NCT00809133|3687679|FG003|Overall Study|Consent withdrawn|0
2098019|NCT00809133|3687680|FG004|Overall Study|Consent withdrawn|1
2098020|NCT00809133|3687681|FG005|Overall Study|Consent withdrawn|0
2098021|NCT00809133|3687682|FG006|Overall Study|Consent withdrawn|0
2098022|NCT00809133|3687683|FG007|Overall Study|Consent withdrawn|0
2098023|NCT00809133|3687684|FG008|Overall Study|Consent withdrawn|0
2098024|NCT00809133|3687685|FG009|Overall Study|Consent withdrawn|0
2098025|NCT00809133|3687686|FG010|Overall Study|Consent withdrawn|0
2098026|NCT00809133|3687687|FG011|Overall Study|Consent withdrawn|0
2098027|NCT00809133|3687688|FG012|Overall Study|Consent withdrawn|0
2098028|NCT00809133|3687689|FG013|Overall Study|Consent withdrawn|0
2098029|NCT00809133|3687676|FG000|Overall Study|Other not mentioned above|0
2098030|NCT00809133|3687677|FG001|Overall Study|Other not mentioned above|1
2098031|NCT00809133|3687678|FG002|Overall Study|Other not mentioned above|0
2098032|NCT00809133|3687679|FG003|Overall Study|Other not mentioned above|0
2098033|NCT00809133|3687680|FG004|Overall Study|Other not mentioned above|0
2098034|NCT00809133|3687681|FG005|Overall Study|Other not mentioned above|1
2098035|NCT00809133|3687682|FG006|Overall Study|Other not mentioned above|0
2098036|NCT00809133|3687683|FG007|Overall Study|Other not mentioned above|0
2098037|NCT00809133|3687684|FG008|Overall Study|Other not mentioned above|0
2098038|NCT00809133|3687685|FG009|Overall Study|Other not mentioned above|0
2098039|NCT00809133|3687686|FG010|Overall Study|Other not mentioned above|0
2098040|NCT00809133|3687687|FG011|Overall Study|Other not mentioned above|0
2098041|NCT00809133|3687688|FG012|Overall Study|Other not mentioned above|0
2098042|NCT00809133|3687689|FG013|Overall Study|Other not mentioned above|0
2098043|NCT00809159|3687745|FG000|Part 1|Adverse Event|1
2098044|NCT00809159|3687746|FG001|Part 1|Adverse Event|1
2098045|NCT00809159|3687747|FG002|Part 1|Adverse Event|0
2098046|NCT00809159|3687748|FG003|Part 1|Adverse Event|0
2098047|NCT00809159|3687749|FG004|Part 1|Adverse Event|0
2098048|NCT00809159|3687750|FG005|Part 1|Adverse Event|0
2212117|NCT01667679|3853075|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
2212118|NCT01667679|3853074|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
2212119|NCT01667679|3853075|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
2212120|NCT01667679|3853074|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
2212121|NCT01667679|3853075|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
2212122|NCT01667679|3853074|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
2212123|NCT01667679|3853075|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
2212124|NCT01667679|3853074|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
2212125|NCT01667679|3853075|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
2212126|NCT01667679|3853074|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
2212127|NCT01667679|3853075|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
2212128|NCT01667679|3853074|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
2212129|NCT01667679|3853075|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
2212130|NCT01667679|3853074|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
2212131|NCT01667679|3853075|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
2212132|NCT01667679|3853074|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
2212133|NCT01667679|3853075|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
2212134|NCT01667679|3853074|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
2212135|NCT01667679|3853075|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
2212136|NCT01667679|3853074|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
2212137|NCT01667679|3853075|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
2212138|NCT01667731|3853088|FG000|Overall Study|Enrolled but not treated|0
2212139|NCT01667731|3853089|FG001|Overall Study|Enrolled but not treated|0
2212140|NCT01667731|3853090|FG002|Overall Study|Enrolled but not treated|0
2098049|NCT00809159|3687745|FG000|Part 1|Lost to Follow-up|1
2098050|NCT00809159|3687746|FG001|Part 1|Lost to Follow-up|0
2098051|NCT00809159|3687747|FG002|Part 1|Lost to Follow-up|0
2098052|NCT00809159|3687748|FG003|Part 1|Lost to Follow-up|0
2098053|NCT00809159|3687749|FG004|Part 1|Lost to Follow-up|0
2098054|NCT00809159|3687750|FG005|Part 1|Lost to Follow-up|0
2212141|NCT01667731|3853091|FG003|Overall Study|Enrolled but not treated|0
2212142|NCT01667731|3853092|FG004|Overall Study|Enrolled but not treated|1
2212143|NCT01667731|3853088|FG000|Overall Study|Efficacy Failure|1
2212144|NCT01667731|3853089|FG001|Overall Study|Efficacy Failure|12
2212145|NCT01667731|3853090|FG002|Overall Study|Efficacy Failure|0
2212146|NCT01667731|3853091|FG003|Overall Study|Efficacy Failure|1
2212147|NCT01667731|3853092|FG004|Overall Study|Efficacy Failure|24
2212148|NCT01667731|3853088|FG000|Overall Study|Lost to Follow-up|2
2212149|NCT01667731|3853089|FG001|Overall Study|Lost to Follow-up|3
2212150|NCT01667731|3853090|FG002|Overall Study|Lost to Follow-up|1
2212151|NCT01667731|3853091|FG003|Overall Study|Lost to Follow-up|1
2212152|NCT01667731|3853092|FG004|Overall Study|Lost to Follow-up|2
2212153|NCT01667731|3853088|FG000|Overall Study|Subject Withdrew Consent|2
2212154|NCT01667731|3853089|FG001|Overall Study|Subject Withdrew Consent|0
2212155|NCT01667731|3853090|FG002|Overall Study|Subject Withdrew Consent|1
2212156|NCT01667731|3853091|FG003|Overall Study|Subject Withdrew Consent|0
2212157|NCT01667731|3853092|FG004|Overall Study|Subject Withdrew Consent|1
2212158|NCT01667731|3853088|FG000|Overall Study|Death|0
2212159|NCT01667731|3853089|FG001|Overall Study|Death|1
2212160|NCT01667731|3853090|FG002|Overall Study|Death|0
2212161|NCT01667731|3853091|FG003|Overall Study|Death|0
2212162|NCT01667731|3853092|FG004|Overall Study|Death|0
2098055|NCT00809159|3687745|FG000|Part 1|Withdrawal by Subject|3
2098056|NCT00809159|3687746|FG001|Part 1|Withdrawal by Subject|1
2098057|NCT00809159|3687747|FG002|Part 1|Withdrawal by Subject|0
2098058|NCT00809159|3687748|FG003|Part 1|Withdrawal by Subject|0
2098059|NCT00809159|3687749|FG004|Part 1|Withdrawal by Subject|0
2098060|NCT00809159|3687750|FG005|Part 1|Withdrawal by Subject|0
2098061|NCT00809159|3687745|FG000|Part 1|Unsatisfactory therapeutic effect|3
2098062|NCT00809159|3687746|FG001|Part 1|Unsatisfactory therapeutic effect|1
2098063|NCT00809159|3687747|FG002|Part 1|Unsatisfactory therapeutic effect|0
2098064|NCT00809159|3687748|FG003|Part 1|Unsatisfactory therapeutic effect|0
2098065|NCT00809159|3687749|FG004|Part 1|Unsatisfactory therapeutic effect|0
2098066|NCT00809159|3687750|FG005|Part 1|Unsatisfactory therapeutic effect|0
2098067|NCT00809159|3687745|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0
2098068|NCT00809159|3687746|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0
2098069|NCT00809159|3687747|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4
2098070|NCT00809159|3687748|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3
2098071|NCT00809159|3687749|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5
2098072|NCT00809159|3687750|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1
2098073|NCT00809159|3687745|FG000|Part 1 and 2|Administrative problems|0
2098074|NCT00809159|3687746|FG001|Part 1 and 2|Administrative problems|0
2098075|NCT00809159|3687747|FG002|Part 1 and 2|Administrative problems|0
2098076|NCT00809159|3687748|FG003|Part 1 and 2|Administrative problems|1
2098077|NCT00809159|3687749|FG004|Part 1 and 2|Administrative problems|0
2098078|NCT00809159|3687750|FG005|Part 1 and 2|Administrative problems|0
2098079|NCT00809159|3687745|FG000|Part 1 and 2|Adverse Event|0
2098080|NCT00809159|3687746|FG001|Part 1 and 2|Adverse Event|0
2098081|NCT00809159|3687747|FG002|Part 1 and 2|Adverse Event|1
2098082|NCT00809159|3687748|FG003|Part 1 and 2|Adverse Event|0
2098083|NCT00809159|3687749|FG004|Part 1 and 2|Adverse Event|1
2098084|NCT00809159|3687750|FG005|Part 1 and 2|Adverse Event|1
2098085|NCT00809159|3687745|FG000|Part 1 and 2|Lost to Follow-up|0
2098086|NCT00809159|3687746|FG001|Part 1 and 2|Lost to Follow-up|0
2098087|NCT00809159|3687747|FG002|Part 1 and 2|Lost to Follow-up|1
2098088|NCT00809159|3687748|FG003|Part 1 and 2|Lost to Follow-up|1
2098089|NCT00809159|3687749|FG004|Part 1 and 2|Lost to Follow-up|0
2098090|NCT00809159|3687750|FG005|Part 1 and 2|Lost to Follow-up|0
2098091|NCT00809159|3687745|FG000|Part 1 and 2|Withdrawal by Subject|0
2098092|NCT00809159|3687746|FG001|Part 1 and 2|Withdrawal by Subject|0
2098093|NCT00809159|3687747|FG002|Part 1 and 2|Withdrawal by Subject|4
2098094|NCT00809159|3687748|FG003|Part 1 and 2|Withdrawal by Subject|0
2098095|NCT00809159|3687749|FG004|Part 1 and 2|Withdrawal by Subject|0
2098096|NCT00809159|3687750|FG005|Part 1 and 2|Withdrawal by Subject|1
2098097|NCT00809328|3687773|FG000|Overall Study|Lack of Efficacy|18
2098098|NCT00809328|3687773|FG000|Overall Study|Adverse Event|6
2098099|NCT00809328|3687773|FG000|Overall Study|Protocol Violation|3
2098100|NCT00809328|3687773|FG000|Overall Study|Withdrawal by Subject|2
2098101|NCT00809354|3687787|FG000|Overall Study|Adverse Event|32
2098102|NCT00809354|3687788|FG001|Overall Study|Adverse Event|45
2098103|NCT00809354|3687789|FG002|Overall Study|Adverse Event|37
2098104|NCT00809354|3687790|FG003|Overall Study|Adverse Event|53
2098105|NCT00809354|3687791|FG004|Overall Study|Adverse Event|26
2098106|NCT00809354|3687792|FG005|Overall Study|Adverse Event|33
2098107|NCT00809354|3687793|FG006|Overall Study|Adverse Event|44
2098108|NCT00809354|3687794|FG007|Overall Study|Adverse Event|40
2098109|NCT00809354|3687795|FG008|Overall Study|Adverse Event|46
2212163|NCT01667900|3853132|FG000|Part B|Death|0
2098110|NCT00809354|3687796|FG009|Overall Study|Adverse Event|26
2098111|NCT00809354|3687787|FG000|Overall Study|Lack of Efficacy|23
2098112|NCT00809354|3687788|FG001|Overall Study|Lack of Efficacy|23
2098113|NCT00809354|3687789|FG002|Overall Study|Lack of Efficacy|22
2098114|NCT00809354|3687790|FG003|Overall Study|Lack of Efficacy|15
2098115|NCT00809354|3687791|FG004|Overall Study|Lack of Efficacy|40
2212164|NCT01667900|3853133|FG001|Part B|Death|0
2212165|NCT01667900|3853134|FG002|Part B|Death|0
2098116|NCT00809354|3687792|FG005|Overall Study|Lack of Efficacy|19
2098117|NCT00809354|3687793|FG006|Overall Study|Lack of Efficacy|21
2098118|NCT00809354|3687794|FG007|Overall Study|Lack of Efficacy|15
2098119|NCT00809354|3687795|FG008|Overall Study|Lack of Efficacy|18
2098120|NCT00809354|3687796|FG009|Overall Study|Lack of Efficacy|38
2098121|NCT00809354|3687787|FG000|Overall Study|Lost to Follow-up|10
2098122|NCT00809354|3687788|FG001|Overall Study|Lost to Follow-up|11
2098123|NCT00809354|3687789|FG002|Overall Study|Lost to Follow-up|8
2098124|NCT00809354|3687790|FG003|Overall Study|Lost to Follow-up|13
2098125|NCT00809354|3687791|FG004|Overall Study|Lost to Follow-up|6
2098126|NCT00809354|3687792|FG005|Overall Study|Lost to Follow-up|2
2098127|NCT00809354|3687793|FG006|Overall Study|Lost to Follow-up|0
2098128|NCT00809354|3687794|FG007|Overall Study|Lost to Follow-up|5
2098129|NCT00809354|3687795|FG008|Overall Study|Lost to Follow-up|4
2098130|NCT00809354|3687796|FG009|Overall Study|Lost to Follow-up|0
2098131|NCT00809354|3687787|FG000|Overall Study|Protocol Violation|7
2098132|NCT00809354|3687788|FG001|Overall Study|Protocol Violation|14
2098133|NCT00809354|3687789|FG002|Overall Study|Protocol Violation|14
2098134|NCT00809354|3687790|FG003|Overall Study|Protocol Violation|12
2098135|NCT00809354|3687791|FG004|Overall Study|Protocol Violation|14
2098136|NCT00809354|3687792|FG005|Overall Study|Protocol Violation|6
2098137|NCT00809354|3687793|FG006|Overall Study|Protocol Violation|4
2098138|NCT00809354|3687794|FG007|Overall Study|Protocol Violation|6
2098139|NCT00809354|3687795|FG008|Overall Study|Protocol Violation|9
2098140|NCT00809354|3687796|FG009|Overall Study|Protocol Violation|3
2098141|NCT00809354|3687787|FG000|Overall Study|Withdrawal by Subject|32
2098142|NCT00809354|3687788|FG001|Overall Study|Withdrawal by Subject|27
2098143|NCT00809354|3687789|FG002|Overall Study|Withdrawal by Subject|31
2098144|NCT00809354|3687790|FG003|Overall Study|Withdrawal by Subject|33
2098145|NCT00809354|3687791|FG004|Overall Study|Withdrawal by Subject|34
2098146|NCT00809354|3687792|FG005|Overall Study|Withdrawal by Subject|29
2098147|NCT00809354|3687793|FG006|Overall Study|Withdrawal by Subject|27
2098148|NCT00809354|3687794|FG007|Overall Study|Withdrawal by Subject|19
2098149|NCT00809354|3687795|FG008|Overall Study|Withdrawal by Subject|18
2098150|NCT00809354|3687796|FG009|Overall Study|Withdrawal by Subject|20
2098151|NCT00809354|3687787|FG000|Overall Study|Other|10
2098152|NCT00809354|3687788|FG001|Overall Study|Other|2
2098153|NCT00809354|3687789|FG002|Overall Study|Other|7
2098154|NCT00809354|3687790|FG003|Overall Study|Other|10
2098155|NCT00809354|3687791|FG004|Overall Study|Other|5
2098156|NCT00809354|3687792|FG005|Overall Study|Other|3
2098157|NCT00809354|3687793|FG006|Overall Study|Other|2
2098158|NCT00809354|3687794|FG007|Overall Study|Other|3
2098159|NCT00809354|3687795|FG008|Overall Study|Other|4
2098160|NCT00809354|3687796|FG009|Overall Study|Other|3
2098161|NCT00809354|3687787|FG000|Overall Study|Study terminated by sponsor|138
2098162|NCT00809354|3687788|FG001|Overall Study|Study terminated by sponsor|134
2098163|NCT00809354|3687789|FG002|Overall Study|Study terminated by sponsor|129
2098164|NCT00809354|3687790|FG003|Overall Study|Study terminated by sponsor|120
2098165|NCT00809354|3687791|FG004|Overall Study|Study terminated by sponsor|126
2098166|NCT00809354|3687792|FG005|Overall Study|Study terminated by sponsor|133
2098167|NCT00809354|3687793|FG006|Overall Study|Study terminated by sponsor|124
2098168|NCT00809354|3687794|FG007|Overall Study|Study terminated by sponsor|148
2098169|NCT00809354|3687795|FG008|Overall Study|Study terminated by sponsor|127
2098170|NCT00809354|3687796|FG009|Overall Study|Study terminated by sponsor|135
2098171|NCT00809354|3687787|FG000|Overall Study|Withdrawn due to pregnancy|0
2098172|NCT00809354|3687788|FG001|Overall Study|Withdrawn due to pregnancy|1
2098173|NCT00809354|3687789|FG002|Overall Study|Withdrawn due to pregnancy|0
2098174|NCT00809354|3687790|FG003|Overall Study|Withdrawn due to pregnancy|0
2098175|NCT00809354|3687791|FG004|Overall Study|Withdrawn due to pregnancy|0
2098176|NCT00809354|3687792|FG005|Overall Study|Withdrawn due to pregnancy|0
2098177|NCT00809354|3687793|FG006|Overall Study|Withdrawn due to pregnancy|0
2098178|NCT00809354|3687794|FG007|Overall Study|Withdrawn due to pregnancy|0
2098179|NCT00809354|3687795|FG008|Overall Study|Withdrawn due to pregnancy|0
2098180|NCT00809354|3687796|FG009|Overall Study|Withdrawn due to pregnancy|0
2098181|NCT00809354|3687787|FG000|Overall Study|Randomized but not Treated|3
2098182|NCT00809354|3687788|FG001|Overall Study|Randomized but not Treated|1
2098183|NCT00809354|3687789|FG002|Overall Study|Randomized but not Treated|6
2098184|NCT00809354|3687790|FG003|Overall Study|Randomized but not Treated|0
2098185|NCT00809354|3687791|FG004|Overall Study|Randomized but not Treated|5
2098186|NCT00809354|3687792|FG005|Overall Study|Randomized but not Treated|0
2098187|NCT00809354|3687793|FG006|Overall Study|Randomized but not Treated|1
2098188|NCT00809354|3687794|FG007|Overall Study|Randomized but not Treated|1
2098189|NCT00809354|3687795|FG008|Overall Study|Randomized but not Treated|2
2098190|NCT00809354|3687796|FG009|Overall Study|Randomized but not Treated|1
2098191|NCT00809354|3687787|FG000|Overall Study|Death|0
2098192|NCT00809354|3687788|FG001|Overall Study|Death|0
2098193|NCT00809354|3687789|FG002|Overall Study|Death|0
2098194|NCT00809354|3687790|FG003|Overall Study|Death|0
2098195|NCT00809354|3687791|FG004|Overall Study|Death|0
2098196|NCT00809354|3687792|FG005|Overall Study|Death|0
2098197|NCT00809354|3687793|FG006|Overall Study|Death|0
2098198|NCT00809354|3687794|FG007|Overall Study|Death|1
2098199|NCT00809354|3687795|FG008|Overall Study|Death|0
2098200|NCT00809354|3687796|FG009|Overall Study|Death|0
2098201|NCT00809445|3687826|FG000|1 Month Follow-up|Lost contact|1
2098202|NCT00809445|3687827|FG001|1 Month Follow-up|Lost contact|2
2098203|NCT00809445|3687828|FG002|1 Month Follow-up|Lost contact|1
2098204|NCT00809445|3687826|FG000|1 Month Follow-up|Withdrew consent|1
2098205|NCT00809445|3687827|FG001|1 Month Follow-up|Withdrew consent|1
2098206|NCT00809445|3687828|FG002|1 Month Follow-up|Withdrew consent|1
2098207|NCT00809445|3687826|FG000|1 Month Follow-up|Death|0
2098208|NCT00809445|3687827|FG001|1 Month Follow-up|Death|1
2098209|NCT00809445|3687828|FG002|1 Month Follow-up|Death|1
2098210|NCT00809445|3687826|FG000|1 Month Follow-up|Incarcerated|0
2098211|NCT00809445|3687827|FG001|1 Month Follow-up|Incarcerated|0
2098212|NCT00809445|3687828|FG002|1 Month Follow-up|Incarcerated|1
2098213|NCT00809445|3687826|FG000|6 Month Follow-up|Lost contact|16
2098214|NCT00809445|3687827|FG001|6 Month Follow-up|Lost contact|14
2098215|NCT00809445|3687828|FG002|6 Month Follow-up|Lost contact|14
2098216|NCT00809445|3687826|FG000|6 Month Follow-up|Death|2
2098217|NCT00809445|3687827|FG001|6 Month Follow-up|Death|1
2098218|NCT00809445|3687828|FG002|6 Month Follow-up|Death|1
2098219|NCT00809445|3687826|FG000|6 Month Follow-up|Incarcerated|6
2098220|NCT00809445|3687827|FG001|6 Month Follow-up|Incarcerated|8
2098221|NCT00809445|3687828|FG002|6 Month Follow-up|Incarcerated|8
2098222|NCT00809445|3687826|FG000|6 Month Follow-up|Withdrew consent|0
2098223|NCT00809445|3687827|FG001|6 Month Follow-up|Withdrew consent|0
2098224|NCT00809445|3687828|FG002|6 Month Follow-up|Withdrew consent|1
2098225|NCT00809471|3687839|FG000|Overall Study|Protocol non-compliance|15
2098226|NCT00809471|3687840|FG001|Overall Study|Protocol non-compliance|15
2098227|NCT00809471|3687841|FG002|Overall Study|Protocol non-compliance|6
2212166|NCT01667900|3853135|FG003|Part B|Death|0
2212167|NCT01667900|3853136|FG004|Part B|Death|0
2212168|NCT01667900|3853137|FG005|Part B|Death|0
2212169|NCT01667900|3853138|FG006|Part B|Death|0
2212170|NCT01667900|3853139|FG007|Part B|Death|0
2212171|NCT01667900|3853140|FG008|Part B|Death|0
2212172|NCT01667900|3853141|FG009|Part B|Death|0
2212173|NCT01667900|3853142|FG010|Part B|Death|0
2098228|NCT00809471|3687839|FG000|Overall Study|Lost to Follow-up|4
2098229|NCT00809471|3687840|FG001|Overall Study|Lost to Follow-up|2
2212174|NCT01667900|3853143|FG011|Part B|Death|0
2212175|NCT01667900|3853144|FG012|Part B|Death|0
2212176|NCT01667900|3853145|FG013|Part B|Death|0
2212177|NCT01667900|3853146|FG014|Part B|Death|0
2212178|NCT01667900|3853147|FG015|Part B|Death|0
2212179|NCT01667900|3853148|FG016|Part B|Death|1
2212180|NCT01667900|3853149|FG017|Part B|Death|0
2212181|NCT01667900|3853150|FG018|Part B|Death|0
2212182|NCT01667900|3853151|FG019|Part B|Death|0
2307565|NCT02699125|4010077|FG000|Placebo|Lost to Follow-up|2
2098230|NCT00809471|3687841|FG002|Overall Study|Lost to Follow-up|9
2098231|NCT00809471|3687839|FG000|Overall Study|Adverse Event|0
2098232|NCT00809471|3687840|FG001|Overall Study|Adverse Event|2
2098233|NCT00809471|3687841|FG002|Overall Study|Adverse Event|2
2098234|NCT00809471|3687839|FG000|Overall Study|Requirement for restricted medication|1
2098235|NCT00809471|3687840|FG001|Overall Study|Requirement for restricted medication|1
2098236|NCT00809471|3687841|FG002|Overall Study|Requirement for restricted medication|0
2098237|NCT00809614|3687860|FG000|Overall Study|Lack of Efficacy|2
2098238|NCT00809614|3687861|FG001|Overall Study|Lack of Efficacy|3
2098239|NCT00809614|3687860|FG000|Overall Study|Withdrawal by Subject|1
2098240|NCT00809614|3687861|FG001|Overall Study|Withdrawal by Subject|1
2098241|NCT00809757|3687870|FG000|Overall Study|Adverse Event|2
2098242|NCT00809757|3687871|FG001|Overall Study|Adverse Event|3
2098243|NCT00809757|3687872|FG002|Overall Study|Adverse Event|3
2098244|NCT00809757|3687870|FG000|Overall Study|Lost to Follow-up|0
2098245|NCT00809757|3687871|FG001|Overall Study|Lost to Follow-up|0
2098246|NCT00809757|3687872|FG002|Overall Study|Lost to Follow-up|1
2098247|NCT00809757|3687870|FG000|Overall Study|Protocol Violation|1
2098248|NCT00809757|3687871|FG001|Overall Study|Protocol Violation|1
2098249|NCT00809757|3687872|FG002|Overall Study|Protocol Violation|1
2098250|NCT00809757|3687870|FG000|Overall Study|Withdrawal by Subject|2
2098251|NCT00809757|3687871|FG001|Overall Study|Withdrawal by Subject|1
2098252|NCT00809757|3687872|FG002|Overall Study|Withdrawal by Subject|3
2098253|NCT00809757|3687870|FG000|Overall Study|Subject Uncooperative|1
2098254|NCT00809757|3687871|FG001|Overall Study|Subject Uncooperative|0
2098255|NCT00809757|3687872|FG002|Overall Study|Subject Uncooperative|2
2098256|NCT00809757|3687870|FG000|Overall Study|Noncompliance with Medication|0
2098257|NCT00809757|3687871|FG001|Overall Study|Noncompliance with Medication|0
2098258|NCT00809757|3687872|FG002|Overall Study|Noncompliance with Medication|1
2098259|NCT00809783|3687889|FG000|Overall Study|Death|1
2307566|NCT02699125|4010078|FG001|Placebo|Lost to Follow-up|0
2307567|NCT02699125|4010077|FG000|Placebo|Protocol Violation|1
2307568|NCT02699125|4010078|FG001|Placebo|Protocol Violation|0
2307569|NCT02699125|4010077|FG000|Placebo|Withdrawal by Subject|0
2307570|NCT02699125|4010078|FG001|Placebo|Withdrawal by Subject|4
2098260|NCT00809783|3687890|FG001|Overall Study|Death|0
2212183|NCT01667926|3853173|FG000|Overall Study|Withdrawal by Subject|1
2212184|NCT01667926|3853174|FG001|Overall Study|Withdrawal by Subject|2
2212185|NCT01667926|3853175|FG002|Overall Study|Withdrawal by Subject|2
2212186|NCT01667926|3853173|FG000|Overall Study|Physician Decision|0
2212187|NCT01667926|3853174|FG001|Overall Study|Physician Decision|0
2307571|NCT02699125|4010077|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7
2353777|NCT02044848|4107122|FG001|Overall Study|Administrative Problems|3
2098261|NCT00809783|3687891|FG002|Overall Study|Death|0
2098262|NCT00809783|3687889|FG000|Overall Study|Adverse Event|34
2098263|NCT00809783|3687890|FG001|Overall Study|Adverse Event|52
2098264|NCT00809783|3687891|FG002|Overall Study|Adverse Event|71
2098265|NCT00809783|3687889|FG000|Overall Study|Lack of Efficacy|39
2098266|NCT00809783|3687890|FG001|Overall Study|Lack of Efficacy|52
2098267|NCT00809783|3687891|FG002|Overall Study|Lack of Efficacy|63
2098268|NCT00809783|3687889|FG000|Overall Study|Lost to Follow-up|0
2098269|NCT00809783|3687890|FG001|Overall Study|Lost to Follow-up|3
2098270|NCT00809783|3687891|FG002|Overall Study|Lost to Follow-up|4
2098271|NCT00809783|3687889|FG000|Overall Study|Withdrawal by Subject|47
2098272|NCT00809783|3687890|FG001|Overall Study|Withdrawal by Subject|72
2098273|NCT00809783|3687891|FG002|Overall Study|Withdrawal by Subject|64
2098274|NCT00809783|3687889|FG000|Overall Study|Protocol Violation|2
2098275|NCT00809783|3687890|FG001|Overall Study|Protocol Violation|6
2098276|NCT00809783|3687891|FG002|Overall Study|Protocol Violation|5
2098277|NCT00809783|3687889|FG000|Overall Study|Randomized, but not treated|3
2098278|NCT00809783|3687890|FG001|Overall Study|Randomized, but not treated|0
2098279|NCT00809783|3687891|FG002|Overall Study|Randomized, but not treated|2
2098280|NCT00809783|3687889|FG000|Overall Study|Study Terminated by Sponsor|378
2098281|NCT00809783|3687890|FG001|Overall Study|Study Terminated by Sponsor|626
2098282|NCT00809783|3687891|FG002|Overall Study|Study Terminated by Sponsor|565
2098283|NCT00809783|3687889|FG000|Overall Study|Other|21
2098284|NCT00809783|3687890|FG001|Overall Study|Other|21
2098285|NCT00809783|3687891|FG002|Overall Study|Other|16
2098286|NCT00809835|3687912|FG000|Overall Study|Lost to Follow-up|7
2098287|NCT00809835|3687913|FG001|Overall Study|Lost to Follow-up|6
2098288|NCT00809835|3687914|FG002|Overall Study|Lost to Follow-up|10
2098289|NCT00809835|3687915|FG003|Overall Study|Lost to Follow-up|2
2098290|NCT00809835|3687912|FG000|Overall Study|Withdrawal by Subject|1
2098291|NCT00809835|3687913|FG001|Overall Study|Withdrawal by Subject|1
2098292|NCT00809835|3687914|FG002|Overall Study|Withdrawal by Subject|1
2098293|NCT00809835|3687915|FG003|Overall Study|Withdrawal by Subject|0
2098294|NCT00809926|3687949|FG000|Overall Study|Adverse Event|18
2098295|NCT00809926|3687950|FG001|Overall Study|Adverse Event|10
2098296|NCT00809926|3687949|FG000|Overall Study|Unsatisfactory therapeutic effect|3
2098297|NCT00809926|3687950|FG001|Overall Study|Unsatisfactory therapeutic effect|3
2098298|NCT00809926|3687949|FG000|Overall Study|Patient withdrew consent|8
2098299|NCT00809926|3687950|FG001|Overall Study|Patient withdrew consent|6
2098300|NCT00809926|3687949|FG000|Overall Study|Lost to Follow-up|2
2212188|NCT01667926|3853175|FG002|Overall Study|Physician Decision|1
2098301|NCT00809926|3687950|FG001|Overall Study|Lost to Follow-up|1
2098302|NCT00809926|3687949|FG000|Overall Study|Administrative Problems|0
2098303|NCT00809926|3687950|FG001|Overall Study|Administrative Problems|1
2098304|NCT00809926|3687949|FG000|Overall Study|Protocol deviation|0
2098305|NCT00809926|3687950|FG001|Overall Study|Protocol deviation|2
2098306|NCT00809965|3687959|FG000|Overall Study|Death|194
2098307|NCT00809965|3687960|FG001|Overall Study|Death|147
2098308|NCT00809965|3687961|FG002|Overall Study|Death|196
2098309|NCT00809965|3687959|FG000|Overall Study|Lost to Follow-up|17
2098310|NCT00809965|3687960|FG001|Overall Study|Lost to Follow-up|10
2098311|NCT00809965|3687961|FG002|Overall Study|Lost to Follow-up|18
2098312|NCT00809965|3687959|FG000|Overall Study|Withdrawal by Subject|405
2098313|NCT00809965|3687960|FG001|Overall Study|Withdrawal by Subject|448
2098314|NCT00809965|3687961|FG002|Overall Study|Withdrawal by Subject|441
2098315|NCT00809965|3687959|FG000|Overall Study|Other Reason|167
2098316|NCT00809965|3687960|FG001|Overall Study|Other Reason|170
2098317|NCT00809965|3687961|FG002|Overall Study|Other Reason|189
2098318|NCT00810043|3687971|FG000|Overall Study|Withdrawal by Subject|1
2098319|NCT00810043|3687972|FG001|Overall Study|Withdrawal by Subject|0
2098320|NCT00810043|3687973|FG002|Overall Study|Withdrawal by Subject|2
2098321|NCT00810043|3687971|FG000|Overall Study|Lost to Follow-up|1
2098322|NCT00810043|3687972|FG001|Overall Study|Lost to Follow-up|0
2098323|NCT00810043|3687973|FG002|Overall Study|Lost to Follow-up|0
2098324|NCT00810043|3687971|FG000|Overall Study|Physician Decision|0
2098325|NCT00810043|3687972|FG001|Overall Study|Physician Decision|0
2098326|NCT00810043|3687973|FG002|Overall Study|Physician Decision|2
2098327|NCT00810043|3687971|FG000|Overall Study|Death|2
2098328|NCT00810043|3687972|FG001|Overall Study|Death|0
2098329|NCT00810043|3687973|FG002|Overall Study|Death|0
2098330|NCT00810043|3687971|FG000|Overall Study|Unrelated medical problem|0
2098331|NCT00810043|3687972|FG001|Overall Study|Unrelated medical problem|1
2098332|NCT00810043|3687973|FG002|Overall Study|Unrelated medical problem|0
2098333|NCT00810043|3687971|FG000|Overall Study|Non-medical problem|0
2098334|NCT00810043|3687972|FG001|Overall Study|Non-medical problem|0
2098335|NCT00810043|3687973|FG002|Overall Study|Non-medical problem|1
2098336|NCT00810043|3687971|FG000|Overall Study|No longer met enrollment criteria|0
2098337|NCT00810043|3687972|FG001|Overall Study|No longer met enrollment criteria|0
2098338|NCT00810043|3687973|FG002|Overall Study|No longer met enrollment criteria|3
2307572|NCT02699125|4010078|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
2307573|NCT02699450|4010091|FG000|Overall Study|Death|2
2307574|NCT02699450|4010092|FG001|Overall Study|Death|1
2307575|NCT02699450|4010093|FG002|Overall Study|Death|2
2307576|NCT02699450|4010091|FG000|Overall Study|Met Criteria for Study Exit|0
2307577|NCT02699450|4010092|FG001|Overall Study|Met Criteria for Study Exit|0
2098339|NCT00810069|3687984|FG000|Lead-in Period I|Adverse Event|43
2098340|NCT00810069|3687985|FG001|Lead-in Period I|Adverse Event|0
2098341|NCT00810069|3687986|FG002|Lead-in Period I|Adverse Event|0
2098342|NCT00810069|3687984|FG000|Lead-in Period I|Lack of Efficacy|1
2098343|NCT00810069|3687985|FG001|Lead-in Period I|Lack of Efficacy|0
2098344|NCT00810069|3687986|FG002|Lead-in Period I|Lack of Efficacy|0
2098345|NCT00810069|3687984|FG000|Lead-in Period I|Lost to Follow-up|19
2098346|NCT00810069|3687985|FG001|Lead-in Period I|Lost to Follow-up|0
2098347|NCT00810069|3687986|FG002|Lead-in Period I|Lost to Follow-up|0
2212189|NCT01667926|3853173|FG000|Overall Study|Time committment|0
2212190|NCT01667926|3853174|FG001|Overall Study|Time committment|0
2212191|NCT01667926|3853175|FG002|Overall Study|Time committment|2
2212192|NCT01667926|3853173|FG000|Overall Study|Inclusion/Exclusion Criteria|0
2212193|NCT01667926|3853174|FG001|Overall Study|Inclusion/Exclusion Criteria|0
2212194|NCT01667926|3853175|FG002|Overall Study|Inclusion/Exclusion Criteria|5
2212195|NCT01667926|3853173|FG000|Overall Study|Lost to Follow-up|1
2212196|NCT01667926|3853174|FG001|Overall Study|Lost to Follow-up|2
2098348|NCT00810069|3687984|FG000|Lead-in Period I|Physician Decision|1
2098349|NCT00810069|3687985|FG001|Lead-in Period I|Physician Decision|0
2098350|NCT00810069|3687986|FG002|Lead-in Period I|Physician Decision|0
2098351|NCT00810069|3687984|FG000|Lead-in Period I|Protocol Violation|1
2098352|NCT00810069|3687985|FG001|Lead-in Period I|Protocol Violation|0
2098353|NCT00810069|3687986|FG002|Lead-in Period I|Protocol Violation|0
2098354|NCT00810069|3687984|FG000|Lead-in Period I|Withdrawal by Subject|46
2098355|NCT00810069|3687985|FG001|Lead-in Period I|Withdrawal by Subject|0
2098356|NCT00810069|3687986|FG002|Lead-in Period I|Withdrawal by Subject|0
2098357|NCT00810069|3687984|FG000|Lead-in Period I|Protocol entry criterion not met|5
2098358|NCT00810069|3687985|FG001|Lead-in Period I|Protocol entry criterion not met|0
2098359|NCT00810069|3687986|FG002|Lead-in Period I|Protocol entry criterion not met|0
2098360|NCT00810069|3687984|FG000|Lead-in Period I|Randomization criteria not met|158
2098361|NCT00810069|3687985|FG001|Lead-in Period I|Randomization criteria not met|0
2098362|NCT00810069|3687986|FG002|Lead-in Period I|Randomization criteria not met|0
2098363|NCT00810069|3687984|FG000|Double-Blind Period II|Adverse Event|0
2098364|NCT00810069|3687985|FG001|Double-Blind Period II|Adverse Event|9
2098365|NCT00810069|3687986|FG002|Double-Blind Period II|Adverse Event|8
2098366|NCT00810069|3687984|FG000|Double-Blind Period II|Lack of Efficacy|0
2098367|NCT00810069|3687985|FG001|Double-Blind Period II|Lack of Efficacy|7
2098368|NCT00810069|3687986|FG002|Double-Blind Period II|Lack of Efficacy|12
2098369|NCT00810069|3687984|FG000|Double-Blind Period II|Lost to Follow-up|0
2098370|NCT00810069|3687985|FG001|Double-Blind Period II|Lost to Follow-up|9
2098371|NCT00810069|3687986|FG002|Double-Blind Period II|Lost to Follow-up|9
2098372|NCT00810069|3687984|FG000|Double-Blind Period II|Physician Decision|0
2098373|NCT00810069|3687985|FG001|Double-Blind Period II|Physician Decision|0
2098374|NCT00810069|3687986|FG002|Double-Blind Period II|Physician Decision|1
2098375|NCT00810069|3687984|FG000|Double-Blind Period II|Withdrawal by Subject|0
2098376|NCT00810069|3687985|FG001|Double-Blind Period II|Withdrawal by Subject|21
2098377|NCT00810069|3687986|FG002|Double-Blind Period II|Withdrawal by Subject|35
2098378|NCT00810069|3687984|FG000|Double-Blind Period II|Protocol entry criterion not met|0
2098379|NCT00810069|3687985|FG001|Double-Blind Period II|Protocol entry criterion not met|0
2098380|NCT00810069|3687986|FG002|Double-Blind Period II|Protocol entry criterion not met|1
2098381|NCT00810069|3687984|FG000|Double-Blind Period II|Clinical relapse|0
2098382|NCT00810069|3687985|FG001|Double-Blind Period II|Clinical relapse|3
2098383|NCT00810069|3687986|FG002|Double-Blind Period II|Clinical relapse|0
2098384|NCT00810069|3687984|FG000|Double-Blind Period II|Protocol Violation|0
2098385|NCT00810069|3687985|FG001|Double-Blind Period II|Protocol Violation|7
2098386|NCT00810069|3687986|FG002|Double-Blind Period II|Protocol Violation|6
2098387|NCT00810082|3687997|FG000|Overall Study|Lost to Follow-up|0
2098388|NCT00810082|3687998|FG001|Overall Study|Lost to Follow-up|4
2098389|NCT00810108|3688010|FG000|Overall Study|Withdrawal by Subject|1
2098390|NCT00810108|3688011|FG001|Overall Study|Withdrawal by Subject|0
2098391|NCT00810199|3688018|FG000|Overall Study|Adverse Event|24
2098392|NCT00810199|3688019|FG001|Overall Study|Adverse Event|26
2098393|NCT00810199|3688018|FG000|Overall Study|Death|4
2098394|NCT00810199|3688019|FG001|Overall Study|Death|6
2098395|NCT00810199|3688018|FG000|Overall Study|Withdrew consent|9
2098396|NCT00810199|3688019|FG001|Overall Study|Withdrew consent|12
2098397|NCT00810199|3688018|FG000|Overall Study|Insufficient therapeutic response|5
2098398|NCT00810199|3688019|FG001|Overall Study|Insufficient therapeutic response|14
2098399|NCT00810199|3688018|FG000|Overall Study|Refused treatment/Did not cooperate|7
2098400|NCT00810199|3688019|FG001|Overall Study|Refused treatment/Did not cooperate|7
2098401|NCT00810199|3688018|FG000|Overall Study|Administrative/Other|5
2098402|NCT00810199|3688019|FG001|Overall Study|Administrative/Other|6
2098403|NCT00810199|3688018|FG000|Overall Study|Protocol Violation|2
2098404|NCT00810199|3688019|FG001|Overall Study|Protocol Violation|6
2098405|NCT00810199|3688018|FG000|Overall Study|Failure to return|1
2098406|NCT00810199|3688019|FG001|Overall Study|Failure to return|4
2098407|NCT00810199|3688018|FG000|Overall Study|Did not receive study drug|2
2098408|NCT00810199|3688019|FG001|Overall Study|Did not receive study drug|1
2098409|NCT00810264|3688031|FG000|Overall Study|Lost to Follow-up|191
2098410|NCT00810264|3688031|FG000|Overall Study|Withdrawal by subject or physician|721
2098411|NCT00810264|3688031|FG000|Overall Study|Death|641
2098412|NCT00810277|3688039|FG000|Overall Study|Adverse Event|1
2098413|NCT00810342|3688053|FG000|Month 1 Follow-up|Lost to Follow-up|4
2098414|NCT00810342|3688054|FG001|Month 1 Follow-up|Lost to Follow-up|2
2098415|NCT00810342|3688053|FG000|Month 1 Follow-up|Pregnancy|1
2098416|NCT00810342|3688054|FG001|Month 1 Follow-up|Pregnancy|0
2098417|NCT00810342|3688053|FG000|6-month Follow-up|Lost to Follow-up|18
2098418|NCT00810342|3688054|FG001|6-month Follow-up|Lost to Follow-up|6
2098419|NCT00810342|3688053|FG000|6-month Follow-up|Pregnancy|6
2098420|NCT00810342|3688054|FG001|6-month Follow-up|Pregnancy|2
2098421|NCT00810342|3688053|FG000|12-month Followup|Pregnancy|9
2098422|NCT00810342|3688054|FG001|12-month Followup|Pregnancy|10
2098423|NCT00810342|3688053|FG000|12-month Followup|Lost to Follow-up|3
2098424|NCT00810342|3688054|FG001|12-month Followup|Lost to Follow-up|1
2098425|NCT00810355|3688065|FG000|Overall Study|Lost to Follow-up|13
2098426|NCT00810355|3688066|FG001|Overall Study|Lost to Follow-up|17
2098427|NCT00810355|3688067|FG002|Overall Study|Lost to Follow-up|11
2098428|NCT00810355|3688065|FG000|Overall Study|Withdrawal by Subject|1
2098429|NCT00810355|3688066|FG001|Overall Study|Withdrawal by Subject|0
2098430|NCT00810355|3688067|FG002|Overall Study|Withdrawal by Subject|0
2098431|NCT00810368|3688077|FG000|Overall Study|Lost to Follow-up|4
2098432|NCT00810368|3688078|FG001|Overall Study|Lost to Follow-up|2
2098433|NCT00810368|3688077|FG000|Overall Study|Lack of Efficacy|2
2098434|NCT00810368|3688078|FG001|Overall Study|Lack of Efficacy|0
2098435|NCT00810394|3688086|FG000|Overall Study|Withdrawal by Subject|3
2098436|NCT00810407|3688090|FG000|Overall Study|Protocol Violation|3
2098437|NCT00810407|3688090|FG000|Overall Study|No Visit After First Day of Treatment|3
2098438|NCT00810511|3688111|FG000|Overall Study|Protocol Violation|0
2098439|NCT00810511|3688112|FG001|Overall Study|Protocol Violation|1
2098440|NCT00810511|3688111|FG000|Overall Study|Lack of Efficacy|9
2098441|NCT00810511|3688112|FG001|Overall Study|Lack of Efficacy|1
2098442|NCT00810511|3688111|FG000|Overall Study|death in the family|0
2098443|NCT00810511|3688112|FG001|Overall Study|death in the family|1
2098444|NCT00810511|3688111|FG000|Overall Study|Lost to Follow-up|1
2098445|NCT00810511|3688112|FG001|Overall Study|Lost to Follow-up|0
2098446|NCT00810511|3688111|FG000|Overall Study|deposits on contact lens|0
2098447|NCT00810511|3688112|FG001|Overall Study|deposits on contact lens|1
2098448|NCT00810602|3688122|FG000|Overall Study|Withdrawal by Subject|8
2098449|NCT00810602|3688123|FG001|Overall Study|Withdrawal by Subject|3
2098450|NCT00810615|3688129|FG000|Overall Study|Withdrawal by Subject|1
2098451|NCT00810615|3688130|FG001|Overall Study|Withdrawal by Subject|1
2098452|NCT00810641|3688151|FG000|Overall Study|Withdrawal by Subject|0
2098453|NCT00810641|3688152|FG001|Overall Study|Withdrawal by Subject|1
2098454|NCT00810641|3688153|FG002|Overall Study|Withdrawal by Subject|2
2098455|NCT00810693|3688164|FG000|Treatment Period|Adverse Event|8
2098456|NCT00810693|3688165|FG001|Treatment Period|Adverse Event|1
2098457|NCT00810693|3688166|FG002|Treatment Period|Adverse Event|7
2098458|NCT00810693|3688164|FG000|Treatment Period|Death|0
2098459|NCT00810693|3688165|FG001|Treatment Period|Death|1
2098460|NCT00810693|3688166|FG002|Treatment Period|Death|2
2098461|NCT00810693|3688164|FG000|Treatment Period|Lack of Efficacy|0
2098462|NCT00810693|3688165|FG001|Treatment Period|Lack of Efficacy|0
2098463|NCT00810693|3688166|FG002|Treatment Period|Lack of Efficacy|1
2098464|NCT00810693|3688164|FG000|Treatment Period|Lost to Follow-up|1
2098465|NCT00810693|3688165|FG001|Treatment Period|Lost to Follow-up|0
2098466|NCT00810693|3688166|FG002|Treatment Period|Lost to Follow-up|0
2098467|NCT00810693|3688164|FG000|Treatment Period|Non-compliance|1
2098468|NCT00810693|3688165|FG001|Treatment Period|Non-compliance|0
2098469|NCT00810693|3688166|FG002|Treatment Period|Non-compliance|0
2098470|NCT00810693|3688164|FG000|Treatment Period|Protocol Violation|1
2098471|NCT00810693|3688165|FG001|Treatment Period|Protocol Violation|2
2098472|NCT00810693|3688166|FG002|Treatment Period|Protocol Violation|2
2098473|NCT00810693|3688164|FG000|Treatment Period|Withdrawal by Subject|6
2098474|NCT00810693|3688165|FG001|Treatment Period|Withdrawal by Subject|2
2098475|NCT00810693|3688166|FG002|Treatment Period|Withdrawal by Subject|3
2098476|NCT00810693|3688164|FG000|Treatment Period|Not treated|0
2098477|NCT00810693|3688165|FG001|Treatment Period|Not treated|1
2098478|NCT00810693|3688166|FG002|Treatment Period|Not treated|1
2098479|NCT00810693|3688164|FG000|Follow-up Period (FUP)|Adverse Event|3
2098480|NCT00810693|3688165|FG001|Follow-up Period (FUP)|Adverse Event|1
2098481|NCT00810693|3688166|FG002|Follow-up Period (FUP)|Adverse Event|1
2098482|NCT00810693|3688164|FG000|Follow-up Period (FUP)|Death|2
2098483|NCT00810693|3688165|FG001|Follow-up Period (FUP)|Death|0
2098484|NCT00810693|3688166|FG002|Follow-up Period (FUP)|Death|1
2098485|NCT00810693|3688164|FG000|Follow-up Period (FUP)|Lost to Follow-up|1
2098486|NCT00810693|3688165|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
2098487|NCT00810693|3688166|FG002|Follow-up Period (FUP)|Lost to Follow-up|2
2098488|NCT00810693|3688164|FG000|Follow-up Period (FUP)|Protocol Violation|0
2098489|NCT00810693|3688165|FG001|Follow-up Period (FUP)|Protocol Violation|1
2098490|NCT00810693|3688166|FG002|Follow-up Period (FUP)|Protocol Violation|0
2098491|NCT00810693|3688164|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2
2098492|NCT00810693|3688165|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1
2098493|NCT00810693|3688166|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0
2098494|NCT00810810|3688201|FG000|Overall Study|Withdrawal by Subject|0
2098495|NCT00810810|3688202|FG001|Overall Study|Withdrawal by Subject|8
2098496|NCT00810810|3688203|FG002|Overall Study|Withdrawal by Subject|10
2098497|NCT00810810|3688204|FG003|Overall Study|Withdrawal by Subject|8
2098498|NCT00810810|3688201|FG000|Overall Study|Physician Decision|0
2098499|NCT00810810|3688202|FG001|Overall Study|Physician Decision|3
2098500|NCT00810810|3688203|FG002|Overall Study|Physician Decision|1
2098501|NCT00810810|3688204|FG003|Overall Study|Physician Decision|5
2098502|NCT00810901|3688229|FG000|Overall Study|Lost to Follow-up|88
2098503|NCT00810901|3688230|FG001|Overall Study|Lost to Follow-up|58
2098504|NCT00811018|3688236|FG000|Overall Study|Additional Chronic Treatment|31
2098505|NCT00811018|3688236|FG000|Overall Study|Adverse Event|79
2098506|NCT00811018|3688236|FG000|Overall Study|Death|147
2098507|NCT00811018|3688236|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
2098508|NCT00811018|3688236|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
2098509|NCT00811018|3688236|FG000|Overall Study|Investigator Decision|57
2098510|NCT00811018|3688236|FG000|Overall Study|Lost to Follow-up|19
2098511|NCT00811018|3688236|FG000|Overall Study|Pregnancy|6
2098512|NCT00811018|3688236|FG000|Overall Study|Sponsor Decision|450
2098513|NCT00811018|3688236|FG000|Overall Study|Withdrawal by Subject|70
2098514|NCT00811018|3688236|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9
2098515|NCT00811018|3688236|FG000|Overall Study|Other|26
2098516|NCT00811057|3688243|FG000|Overall Study|Protocol Violation|5
2098517|NCT00811057|3688244|FG001|Overall Study|Protocol Violation|10
2098518|NCT00811057|3688245|FG002|Overall Study|Protocol Violation|10
2098519|NCT00811070|3688259|FG000|Overall Study|Death|0
2098520|NCT00811070|3688260|FG001|Overall Study|Death|0
2098521|NCT00811070|3688261|FG002|Overall Study|Death|0
2098522|NCT00811070|3688262|FG003|Overall Study|Death|2
2098523|NCT00811070|3688263|FG004|Overall Study|Death|5
2098524|NCT00811070|3688264|FG005|Overall Study|Death|0
2098525|NCT00811070|3688259|FG000|Overall Study|Other|1
2098526|NCT00811070|3688260|FG001|Overall Study|Other|0
2098527|NCT00811070|3688261|FG002|Overall Study|Other|0
2098528|NCT00811070|3688262|FG003|Overall Study|Other|0
2098529|NCT00811070|3688263|FG004|Overall Study|Other|0
2098530|NCT00811070|3688264|FG005|Overall Study|Other|0
2098531|NCT00811070|3688259|FG000|Overall Study|Withdrawal by Subject|0
2098532|NCT00811070|3688260|FG001|Overall Study|Withdrawal by Subject|1
2098533|NCT00811070|3688261|FG002|Overall Study|Withdrawal by Subject|0
2098534|NCT00811070|3688262|FG003|Overall Study|Withdrawal by Subject|0
2098535|NCT00811070|3688263|FG004|Overall Study|Withdrawal by Subject|0
2098536|NCT00811070|3688264|FG005|Overall Study|Withdrawal by Subject|0
2098537|NCT00811070|3688259|FG000|Overall Study|Physician Decision|0
2098538|NCT00811070|3688260|FG001|Overall Study|Physician Decision|0
2098539|NCT00811070|3688261|FG002|Overall Study|Physician Decision|0
2098540|NCT00811070|3688262|FG003|Overall Study|Physician Decision|0
2098541|NCT00811070|3688263|FG004|Overall Study|Physician Decision|0
2098542|NCT00811070|3688264|FG005|Overall Study|Physician Decision|1
2098543|NCT00811135|3688280|FG000|Overall Study|Adverse Event/Intercurrent Illness|8
2098544|NCT00811135|3688280|FG000|Overall Study|Death|3
2098545|NCT00811135|3688280|FG000|Overall Study|Protocol Violation|2
2098546|NCT00811135|3688280|FG000|Overall Study|Violation of Selection Criteria|1
2098547|NCT00811135|3688280|FG000|Overall Study|Refused Treatment|1
2098548|NCT00811135|3688280|FG000|Overall Study|Withdrawal by Subject|3
2098549|NCT00811135|3688280|FG000|Overall Study|Administrative/Other Unspecified|11
2098550|NCT00811135|3688280|FG000|Overall Study|Ongoing|59
2098551|NCT00811174|3688284|FG000|Overall Study|Protocol Violation|2
2098552|NCT00811174|3688284|FG000|Overall Study|Sponsors Decision|1
2098553|NCT00811187|3688290|FG000|Overall Study|Unable to place device / procedure abort|3
2098554|NCT00811187|3688291|FG001|Overall Study|Unable to place device / procedure abort|3
2098555|NCT00811252|3688300|FG000|Overall Study|Adverse Event|6
2098556|NCT00811252|3688301|FG001|Overall Study|Adverse Event|10
2098557|NCT00811252|3688302|FG002|Overall Study|Adverse Event|15
2098558|NCT00811252|3688300|FG000|Overall Study|Lack of Efficacy|7
2098559|NCT00811252|3688301|FG001|Overall Study|Lack of Efficacy|2
2098560|NCT00811252|3688302|FG002|Overall Study|Lack of Efficacy|0
2098561|NCT00811252|3688300|FG000|Overall Study|Protocol Violation|3
2098562|NCT00811252|3688301|FG001|Overall Study|Protocol Violation|3
2098563|NCT00811252|3688302|FG002|Overall Study|Protocol Violation|2
2098564|NCT00811252|3688300|FG000|Overall Study|Withdrawal of Consent|1
2098565|NCT00811252|3688301|FG001|Overall Study|Withdrawal of Consent|2
2098566|NCT00811252|3688302|FG002|Overall Study|Withdrawal of Consent|2
2098567|NCT00811252|3688300|FG000|Overall Study|Lost to Follow-up|0
2098568|NCT00811252|3688301|FG001|Overall Study|Lost to Follow-up|0
2098569|NCT00811252|3688302|FG002|Overall Study|Lost to Follow-up|2
2098570|NCT00811252|3688300|FG000|Overall Study|Administrative or Other Reasons|0
2098571|NCT00811252|3688301|FG001|Overall Study|Administrative or Other Reasons|3
2098572|NCT00811252|3688302|FG002|Overall Study|Administrative or Other Reasons|2
2098573|NCT00811395|3688331|FG000|Extension Treatment|Adverse Event|1
2098574|NCT00811395|3688332|FG001|Extension Treatment|Adverse Event|2
2098575|NCT00811395|3688333|FG002|Extension Treatment|Adverse Event|2
2098576|NCT00811395|3688334|FG003|Extension Treatment|Adverse Event|2
2098577|NCT00811395|3688335|FG004|Extension Treatment|Adverse Event|0
2098578|NCT00811395|3688336|FG005|Extension Treatment|Adverse Event|1
2098579|NCT00811395|3688331|FG000|Extension Treatment|Progressive disease|1
2098580|NCT00811395|3688332|FG001|Extension Treatment|Progressive disease|1
2098581|NCT00811395|3688333|FG002|Extension Treatment|Progressive disease|0
2098582|NCT00811395|3688334|FG003|Extension Treatment|Progressive disease|0
2098583|NCT00811395|3688335|FG004|Extension Treatment|Progressive disease|0
2098584|NCT00811395|3688336|FG005|Extension Treatment|Progressive disease|0
2098585|NCT00811395|3688331|FG000|Extension Treatment|Participant did not wish to continue|0
2098586|NCT00811395|3688332|FG001|Extension Treatment|Participant did not wish to continue|3
2098587|NCT00811395|3688333|FG002|Extension Treatment|Participant did not wish to continue|0
2098588|NCT00811395|3688334|FG003|Extension Treatment|Participant did not wish to continue|1
2098589|NCT00811395|3688335|FG004|Extension Treatment|Participant did not wish to continue|0
2098590|NCT00811395|3688336|FG005|Extension Treatment|Participant did not wish to continue|1
2098591|NCT00811395|3688331|FG000|Extension Treatment|Other than above|0
2098592|NCT00811395|3688332|FG001|Extension Treatment|Other than above|0
2098593|NCT00811395|3688333|FG002|Extension Treatment|Other than above|1
2098594|NCT00811395|3688334|FG003|Extension Treatment|Other than above|0
2098595|NCT00811395|3688335|FG004|Extension Treatment|Other than above|0
2098596|NCT00811395|3688336|FG005|Extension Treatment|Other than above|0
2098597|NCT00811473|3688363|FG000|Overall Study|Adverse Event|3
2098598|NCT00811473|3688364|FG001|Overall Study|Adverse Event|12
2098599|NCT00811473|3688363|FG000|Overall Study|Lost to Follow-up|5
2098600|NCT00811473|3688364|FG001|Overall Study|Lost to Follow-up|1
2098601|NCT00811473|3688363|FG000|Overall Study|Withdrawal by Subject|2
2098602|NCT00811473|3688364|FG001|Overall Study|Withdrawal by Subject|4
2098603|NCT00811473|3688363|FG000|Overall Study|Severe non-compliance to protocol|2
2098604|NCT00811473|3688364|FG001|Overall Study|Severe non-compliance to protocol|4
2098605|NCT00811473|3688363|FG000|Overall Study|Lack of therapeutic response|4
2098606|NCT00811473|3688364|FG001|Overall Study|Lack of therapeutic response|1
2098607|NCT00811473|3688363|FG000|Overall Study|Condition under investigation worsened|1
2098608|NCT00811473|3688364|FG001|Overall Study|Condition under investigation worsened|3
2098609|NCT00811473|3688363|FG000|Overall Study|Other 2|4
2098610|NCT00811473|3688364|FG001|Overall Study|Other 2|1
2098611|NCT00811473|3688363|FG000|Overall Study|Incorrect Enrollment|1
2098612|NCT00811473|3688364|FG001|Overall Study|Incorrect Enrollment|0
2098613|NCT00811473|3688363|FG000|Overall Study|Safety Reasons|1
2098614|NCT00811473|3688364|FG001|Overall Study|Safety Reasons|0
2098615|NCT00811577|3688381|FG000|Overall Study|Lost to Follow-up|7
2098616|NCT00811577|3688382|FG001|Overall Study|Lost to Follow-up|1
2098617|NCT00811577|3688381|FG000|Overall Study|Withdrawal by Subject|3
2098618|NCT00811577|3688382|FG001|Overall Study|Withdrawal by Subject|0
2098619|NCT00811642|3688431|FG000|Overall Study|Adverse Event|3
2098620|NCT00811642|3688431|FG000|Overall Study|Protocol Violation|1
2098621|NCT00811642|3688431|FG000|Overall Study|Death|2
2098622|NCT00811642|3688431|FG000|Overall Study|Withdrawal by Subject|7
2098623|NCT00811642|3688431|FG000|Overall Study|Cumulative use of antifungal agent|2
2098624|NCT00811655|3688435|FG000|Overall Study|Physician Decision|1
2107790|NCT00876187|3701517|FG001|Overall Study|Other|5
2107791|NCT00876187|3701518|FG002|Overall Study|Other|9
2107792|NCT00876187|3701519|FG003|Overall Study|Other|7
2107793|NCT00876187|3701520|FG004|Overall Study|Other|4
2107794|NCT00876265|3701544|FG000|Overall Study|Miscellaneous reasons|4
2107795|NCT00876265|3701544|FG000|Overall Study|Lost to Follow-up|6
2107796|NCT00876265|3701544|FG000|Overall Study|Withdrawal by Subject|2
2107797|NCT00876343|3701553|FG000|Overall Study|Adverse Event|7
2107798|NCT00876343|3701554|FG001|Overall Study|Adverse Event|8
2107799|NCT00876343|3701555|FG002|Overall Study|Adverse Event|2
2107800|NCT00876343|3701553|FG000|Overall Study|Withdrawal by Subject|4
2107801|NCT00876343|3701554|FG001|Overall Study|Withdrawal by Subject|4
2107802|NCT00876343|3701555|FG002|Overall Study|Withdrawal by Subject|3
2107803|NCT00876343|3701553|FG000|Overall Study|Lack of Efficacy|0
2107804|NCT00876343|3701554|FG001|Overall Study|Lack of Efficacy|0
2107805|NCT00876343|3701555|FG002|Overall Study|Lack of Efficacy|1
2107806|NCT00876343|3701553|FG000|Overall Study|Protocol Violation|4
2107807|NCT00876343|3701554|FG001|Overall Study|Protocol Violation|1
2107808|NCT00876343|3701555|FG002|Overall Study|Protocol Violation|1
2107809|NCT00876343|3701553|FG000|Overall Study|Physician Decision|0
2107810|NCT00876343|3701554|FG001|Overall Study|Physician Decision|1
2107811|NCT00876343|3701555|FG002|Overall Study|Physician Decision|1
2107812|NCT00876343|3701553|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
2107813|NCT00876343|3701554|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
2107814|NCT00876343|3701555|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
2107815|NCT00876343|3701553|FG000|Overall Study|Change of residence or other commitments|2
2107816|NCT00876343|3701554|FG001|Overall Study|Change of residence or other commitments|2
2107817|NCT00876343|3701555|FG002|Overall Study|Change of residence or other commitments|3
2107818|NCT00876395|3701565|FG000|Overall Study|Untreated|8
2107819|NCT00876395|3701566|FG001|Overall Study|Untreated|1
2107820|NCT00876395|3701565|FG000|Overall Study|Adverse Event|63
2107821|NCT00876395|3701566|FG001|Overall Study|Adverse Event|11
2107822|NCT00876395|3701565|FG000|Overall Study|Abnormal test procedure result(s)|1
2107823|NCT00876395|3701566|FG001|Overall Study|Abnormal test procedure result(s)|0
2107824|NCT00876395|3701565|FG000|Overall Study|Disease progression|259
2107825|NCT00876395|3701566|FG001|Overall Study|Disease progression|162
2107826|NCT00876395|3701565|FG000|Overall Study|New cancer therapy|25
2107827|NCT00876395|3701566|FG001|Overall Study|New cancer therapy|7
2107828|NCT00876395|3701565|FG000|Overall Study|Protocol Violation|5
2107829|NCT00876395|3701566|FG001|Overall Study|Protocol Violation|2
2098625|NCT00811720|3688441|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
2098626|NCT00811720|3688442|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4
2098627|NCT00811720|3688441|FG000|All Treated Patients|Adverse Event|20
2098628|NCT00811720|3688442|FG001|All Treated Patients|Adverse Event|62
2098629|NCT00811720|3688441|FG000|All Treated Patients|Lack of Efficacy|22
2098630|NCT00811720|3688442|FG001|All Treated Patients|Lack of Efficacy|18
2098631|NCT00811720|3688441|FG000|All Treated Patients|Non-compliance|0
2098632|NCT00811720|3688442|FG001|All Treated Patients|Non-compliance|14
2098633|NCT00811720|3688441|FG000|All Treated Patients|Protocol Violation|9
2098634|NCT00811720|3688442|FG001|All Treated Patients|Protocol Violation|16
2098635|NCT00811720|3688441|FG000|All Treated Patients|Withdrawal by Subject|28
2098636|NCT00811720|3688442|FG001|All Treated Patients|Withdrawal by Subject|34
2098637|NCT00811720|3688441|FG000|All Treated Patients|Lost to Follow-up|10
2098638|NCT00811720|3688442|FG001|All Treated Patients|Lost to Follow-up|16
2098639|NCT00811720|3688441|FG000|All Treated Patients|Other Reason|7
2098640|NCT00811720|3688442|FG001|All Treated Patients|Other Reason|4
2098641|NCT00811733|3688450|FG000|Overall Study|Investigator Discretion|10
2098642|NCT00811733|3688451|FG001|Overall Study|Investigator Discretion|8
2098643|NCT00811733|3688450|FG000|Overall Study|Withdrawal by Subject|1
2098644|NCT00811733|3688451|FG001|Overall Study|Withdrawal by Subject|2
2098645|NCT00811928|3688469|FG000|Overall Study|AEs and SAEs Including Death|7
2098646|NCT00811928|3688470|FG001|Overall Study|AEs and SAEs Including Death|11
2098647|NCT00811928|3688469|FG000|Overall Study|Withdrawal by Subject|18
2098648|NCT00811928|3688470|FG001|Overall Study|Withdrawal by Subject|12
2098649|NCT00811928|3688469|FG000|Overall Study|Did Not Take Study Drug|3
2098650|NCT00811928|3688470|FG001|Overall Study|Did Not Take Study Drug|0
2098651|NCT00811928|3688469|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7
2098652|NCT00811928|3688470|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4
2098653|NCT00811928|3688469|FG000|Overall Study|Investigator Decision|2
2098654|NCT00811928|3688470|FG001|Overall Study|Investigator Decision|1
2098655|NCT00811928|3688469|FG000|Overall Study|Poor Compliance|2
2098656|NCT00811928|3688470|FG001|Overall Study|Poor Compliance|5
2098657|NCT00811941|3688478|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
2098658|NCT00811941|3688479|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8
2098659|NCT00811941|3688478|FG000|All Treated Patients|Adverse Event|2
2098660|NCT00811941|3688479|FG001|All Treated Patients|Adverse Event|43
2098661|NCT00811941|3688478|FG000|All Treated Patients|Lack of Efficacy|2
2098662|NCT00811941|3688479|FG001|All Treated Patients|Lack of Efficacy|3
2098663|NCT00811941|3688478|FG000|All Treated Patients|Non-compliance|1
2098664|NCT00811941|3688479|FG001|All Treated Patients|Non-compliance|8
2098665|NCT00811941|3688478|FG000|All Treated Patients|Protocol Violation|5
2098666|NCT00811941|3688479|FG001|All Treated Patients|Protocol Violation|17
2098667|NCT00811941|3688478|FG000|All Treated Patients|Withdrawal by Subject|35
2098668|NCT00811941|3688479|FG001|All Treated Patients|Withdrawal by Subject|94
2098669|NCT00811941|3688478|FG000|All Treated Patients|Lost to Follow-up|3
2098670|NCT00811941|3688479|FG001|All Treated Patients|Lost to Follow-up|12
2098671|NCT00811941|3688478|FG000|All Treated Patients|Other Reason|4
2098672|NCT00811941|3688479|FG001|All Treated Patients|Other Reason|14
2098673|NCT00811954|3688488|FG000|Overall Study|Death|10
2098674|NCT00811954|3688489|FG001|Overall Study|Death|6
2098675|NCT00811954|3688490|FG002|Overall Study|Death|13
2098676|NCT00811954|3688488|FG000|Overall Study|Lost to Follow-up|29
2098677|NCT00811954|3688489|FG001|Overall Study|Lost to Follow-up|23
2098678|NCT00811954|3688490|FG002|Overall Study|Lost to Follow-up|34
2098679|NCT00811954|3688488|FG000|Overall Study|Not able to get to clinic|28
2098680|NCT00811954|3688489|FG001|Overall Study|Not able to get to clinic|35
2098681|NCT00811954|3688490|FG002|Overall Study|Not able to get to clinic|30
2098682|NCT00811954|3688488|FG000|Overall Study|Not willing to adhere to requirements|12
2098683|NCT00811954|3688489|FG001|Overall Study|Not willing to adhere to requirements|2
2098684|NCT00811954|3688490|FG002|Overall Study|Not willing to adhere to requirements|16
2098685|NCT00811954|3688488|FG000|Overall Study|Withdraw consent prior study completion|4
2098686|NCT00811954|3688489|FG001|Overall Study|Withdraw consent prior study completion|6
2098687|NCT00811954|3688490|FG002|Overall Study|Withdraw consent prior study completion|5
2098688|NCT00811954|3688488|FG000|Overall Study|Site Closure|4
2098689|NCT00811954|3688489|FG001|Overall Study|Site Closure|0
2098690|NCT00811954|3688490|FG002|Overall Study|Site Closure|1
2098691|NCT00811954|3688488|FG000|Overall Study|Severe Debilitation|2
2098692|NCT00811954|3688489|FG001|Overall Study|Severe Debilitation|0
2098693|NCT00811954|3688490|FG002|Overall Study|Severe Debilitation|1
2098694|NCT00811954|3688488|FG000|Overall Study|Complete Protocol: No follow-up|0
2098695|NCT00811954|3688489|FG001|Overall Study|Complete Protocol: No follow-up|0
2098696|NCT00811954|3688490|FG002|Overall Study|Complete Protocol: No follow-up|1
2098697|NCT00812097|3688502|FG000|Overall Study|Death|3
2098698|NCT00812097|3688503|FG001|Overall Study|Death|10
2098699|NCT00812097|3688504|FG002|Overall Study|Death|3
2098700|NCT00812097|3688505|FG003|Overall Study|Death|3
2098701|NCT00812097|3688502|FG000|Overall Study|Withdrawal by Subject|14
2098702|NCT00812097|3688503|FG001|Overall Study|Withdrawal by Subject|12
2098703|NCT00812097|3688504|FG002|Overall Study|Withdrawal by Subject|8
2098704|NCT00812097|3688505|FG003|Overall Study|Withdrawal by Subject|2
2098705|NCT00812097|3688502|FG000|Overall Study|Lost to Follow-up|90
2098706|NCT00812097|3688503|FG001|Overall Study|Lost to Follow-up|14
2098707|NCT00812097|3688504|FG002|Overall Study|Lost to Follow-up|17
2098708|NCT00812097|3688505|FG003|Overall Study|Lost to Follow-up|5
2098709|NCT00812097|3688502|FG000|Overall Study|Explantation of study device(s)|27
2098710|NCT00812097|3688503|FG001|Overall Study|Explantation of study device(s)|29
2098711|NCT00812097|3688504|FG002|Overall Study|Explantation of study device(s)|14
2098712|NCT00812097|3688505|FG003|Overall Study|Explantation of study device(s)|20
2098713|NCT00812097|3688502|FG000|Overall Study|Unknown reasons and patient/doctor moves|111
2098714|NCT00812097|3688503|FG001|Overall Study|Unknown reasons and patient/doctor moves|24
2098715|NCT00812097|3688504|FG002|Overall Study|Unknown reasons and patient/doctor moves|15
2098716|NCT00812097|3688505|FG003|Overall Study|Unknown reasons and patient/doctor moves|5
2098717|NCT00812253|3688521|FG000|Overall Study|Withdrawal by Subject|3
2098718|NCT00812253|3688522|FG001|Overall Study|Withdrawal by Subject|2
2098719|NCT00812253|3688521|FG000|Overall Study|Protocol Violation|1
2098720|NCT00812253|3688522|FG001|Overall Study|Protocol Violation|1
2098721|NCT00812253|3688521|FG000|Overall Study|Lost to Follow-up|2
2098722|NCT00812253|3688522|FG001|Overall Study|Lost to Follow-up|0
2098723|NCT00812331|3688533|FG000|Overall Study|Adverse Event|1
2098724|NCT00812331|3688534|FG001|Overall Study|Adverse Event|0
2098725|NCT00812331|3688535|FG002|Overall Study|Adverse Event|0
2098726|NCT00812331|3688536|FG003|Overall Study|Adverse Event|0
2098727|NCT00812331|3688537|FG004|Overall Study|Adverse Event|0
2098728|NCT00812461|3688547|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23
2098729|NCT00812461|3688548|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17
2098730|NCT00812461|3688547|FG000|All Treated Patients|Adverse Event|8
2098731|NCT00812461|3688548|FG001|All Treated Patients|Adverse Event|15
2098732|NCT00812461|3688547|FG000|All Treated Patients|Lack of Efficacy|13
2098733|NCT00812461|3688548|FG001|All Treated Patients|Lack of Efficacy|7
2098734|NCT00812461|3688547|FG000|All Treated Patients|Non-compliance|6
2098735|NCT00812461|3688548|FG001|All Treated Patients|Non-compliance|9
2098736|NCT00812461|3688547|FG000|All Treated Patients|Protocol Violation|36
2098737|NCT00812461|3688548|FG001|All Treated Patients|Protocol Violation|27
2098738|NCT00812461|3688547|FG000|All Treated Patients|Withdrawal by Subject|45
2098739|NCT00812461|3688548|FG001|All Treated Patients|Withdrawal by Subject|54
2098740|NCT00812461|3688547|FG000|All Treated Patients|Lost to Follow-up|11
2098741|NCT00812461|3688548|FG001|All Treated Patients|Lost to Follow-up|14
2098742|NCT00812461|3688547|FG000|All Treated Patients|Other Reason|13
2098743|NCT00812461|3688548|FG001|All Treated Patients|Other Reason|21
2098744|NCT00812487|3688556|FG000|Overall Study|Lost to Follow-up|2
2098745|NCT00812487|3688557|FG001|Overall Study|Lost to Follow-up|0
2098746|NCT00812487|3688556|FG000|Overall Study|Withdrawal by Subject|3
2098747|NCT00812487|3688557|FG001|Overall Study|Withdrawal by Subject|2
2098748|NCT00812487|3688556|FG000|Overall Study|Transfer to ICU prior to intervention|1
2098749|NCT00812487|3688557|FG001|Overall Study|Transfer to ICU prior to intervention|0
2098750|NCT00812487|3688556|FG000|Overall Study|Protocol Violation|0
2098751|NCT00812487|3688557|FG001|Overall Study|Protocol Violation|1
2098752|NCT00812565|3688571|FG000|Overall Study|Did Not Receive Study Medication|1
2098753|NCT00812565|3688572|FG001|Overall Study|Did Not Receive Study Medication|1
2098754|NCT00812565|3688573|FG002|Overall Study|Did Not Receive Study Medication|0
2098755|NCT00812565|3688574|FG003|Overall Study|Did Not Receive Study Medication|0
2098756|NCT00812565|3688575|FG004|Overall Study|Did Not Receive Study Medication|0
2098757|NCT00812565|3688576|FG005|Overall Study|Did Not Receive Study Medication|0
2098758|NCT00812565|3688577|FG006|Overall Study|Did Not Receive Study Medication|0
2098759|NCT00812565|3688578|FG007|Overall Study|Did Not Receive Study Medication|0
2098760|NCT00812565|3688571|FG000|Overall Study|Adverse Event|0
2098761|NCT00812565|3688572|FG001|Overall Study|Adverse Event|0
2098762|NCT00812565|3688573|FG002|Overall Study|Adverse Event|0
2098763|NCT00812565|3688574|FG003|Overall Study|Adverse Event|2
2098764|NCT00812565|3688575|FG004|Overall Study|Adverse Event|0
2098765|NCT00812565|3688576|FG005|Overall Study|Adverse Event|0
2098766|NCT00812565|3688577|FG006|Overall Study|Adverse Event|0
2098767|NCT00812565|3688578|FG007|Overall Study|Adverse Event|1
2098768|NCT00812565|3688571|FG000|Overall Study|Did Not Come to Study Visit|1
2098769|NCT00812565|3688572|FG001|Overall Study|Did Not Come to Study Visit|0
2098770|NCT00812565|3688573|FG002|Overall Study|Did Not Come to Study Visit|0
2098771|NCT00812565|3688574|FG003|Overall Study|Did Not Come to Study Visit|0
2098772|NCT00812565|3688575|FG004|Overall Study|Did Not Come to Study Visit|0
2098773|NCT00812565|3688576|FG005|Overall Study|Did Not Come to Study Visit|0
2098774|NCT00812565|3688577|FG006|Overall Study|Did Not Come to Study Visit|0
2307578|NCT02699450|4010093|FG002|Overall Study|Met Criteria for Study Exit|1
2307579|NCT02699450|4010091|FG000|Overall Study|Protocol Violation|4
2307580|NCT02699450|4010092|FG001|Overall Study|Protocol Violation|3
2307581|NCT02699450|4010093|FG002|Overall Study|Protocol Violation|5
2307582|NCT02699450|4010091|FG000|Overall Study|Lost to Follow-up|3
2307583|NCT02699450|4010092|FG001|Overall Study|Lost to Follow-up|0
2307584|NCT02699450|4010093|FG002|Overall Study|Lost to Follow-up|5
2307585|NCT02699450|4010091|FG000|Overall Study|Physician Decision|2
2307586|NCT02699450|4010092|FG001|Overall Study|Physician Decision|0
2307587|NCT02699450|4010093|FG002|Overall Study|Physician Decision|0
2098775|NCT00812565|3688578|FG007|Overall Study|Did Not Come to Study Visit|0
2098776|NCT00812565|3688571|FG000|Overall Study|Withdrawal of Consent|1
2098777|NCT00812565|3688572|FG001|Overall Study|Withdrawal of Consent|0
2098778|NCT00812565|3688573|FG002|Overall Study|Withdrawal of Consent|0
2098779|NCT00812565|3688574|FG003|Overall Study|Withdrawal of Consent|0
2098780|NCT00812565|3688575|FG004|Overall Study|Withdrawal of Consent|1
2098781|NCT00812565|3688576|FG005|Overall Study|Withdrawal of Consent|0
2098782|NCT00812565|3688577|FG006|Overall Study|Withdrawal of Consent|0
2098783|NCT00812565|3688578|FG007|Overall Study|Withdrawal of Consent|0
2098784|NCT00812565|3688571|FG000|Overall Study|Reason Not Specified|0
2098785|NCT00812565|3688572|FG001|Overall Study|Reason Not Specified|0
2098786|NCT00812565|3688573|FG002|Overall Study|Reason Not Specified|0
2098787|NCT00812565|3688574|FG003|Overall Study|Reason Not Specified|0
2098788|NCT00812565|3688575|FG004|Overall Study|Reason Not Specified|0
2098789|NCT00812565|3688576|FG005|Overall Study|Reason Not Specified|1
2098790|NCT00812565|3688577|FG006|Overall Study|Reason Not Specified|0
2098791|NCT00812565|3688578|FG007|Overall Study|Reason Not Specified|0
2098792|NCT00812812|3688607|FG000|Overall Study|Adverse Event|2
2098793|NCT00812812|3688608|FG001|Overall Study|Adverse Event|1
2098794|NCT00812812|3688607|FG000|Overall Study|Lack of Efficacy|1
2098795|NCT00812812|3688608|FG001|Overall Study|Lack of Efficacy|0
2098796|NCT00812812|3688607|FG000|Overall Study|Lost to Follow-up|0
2098797|NCT00812812|3688608|FG001|Overall Study|Lost to Follow-up|1
2098798|NCT00812812|3688607|FG000|Overall Study|Withdrawal by Subject|0
2098799|NCT00812812|3688608|FG001|Overall Study|Withdrawal by Subject|2
2098800|NCT00812929|3688642|FG000|Washout Period 1 (7 Days)|Physician Decision|0
2098801|NCT00812929|3688643|FG001|Washout Period 1 (7 Days)|Physician Decision|0
2098802|NCT00812929|3688644|FG002|Washout Period 1 (7 Days)|Physician Decision|1
2098803|NCT00812929|3688645|FG003|Washout Period 1 (7 Days)|Physician Decision|0
2098804|NCT00812929|3688646|FG004|Washout Period 1 (7 Days)|Physician Decision|0
2098805|NCT00812929|3688647|FG005|Washout Period 1 (7 Days)|Physician Decision|0
2098806|NCT00812929|3688648|FG006|Washout Period 1 (7 Days)|Physician Decision|0
2098807|NCT00812929|3688649|FG007|Washout Period 1 (7 Days)|Physician Decision|0
2098808|NCT00812929|3688650|FG008|Washout Period 1 (7 Days)|Physician Decision|0
2098809|NCT00812929|3688651|FG009|Washout Period 1 (7 Days)|Physician Decision|0
2098810|NCT00812929|3688642|FG000|Washout Period 2 (7 Days)|Physician Decision|0
2098811|NCT00812929|3688643|FG001|Washout Period 2 (7 Days)|Physician Decision|0
2098812|NCT00812929|3688644|FG002|Washout Period 2 (7 Days)|Physician Decision|0
2098813|NCT00812929|3688645|FG003|Washout Period 2 (7 Days)|Physician Decision|0
2098814|NCT00812929|3688646|FG004|Washout Period 2 (7 Days)|Physician Decision|0
2098815|NCT00812929|3688647|FG005|Washout Period 2 (7 Days)|Physician Decision|0
2098816|NCT00812929|3688648|FG006|Washout Period 2 (7 Days)|Physician Decision|0
2098817|NCT00812929|3688649|FG007|Washout Period 2 (7 Days)|Physician Decision|0
2098818|NCT00812929|3688650|FG008|Washout Period 2 (7 Days)|Physician Decision|0
2098819|NCT00812929|3688651|FG009|Washout Period 2 (7 Days)|Physician Decision|1
2098820|NCT00812929|3688642|FG000|Washout Period 3 (7 Days)|Adverse Event|0
2098821|NCT00812929|3688643|FG001|Washout Period 3 (7 Days)|Adverse Event|0
2098822|NCT00812929|3688644|FG002|Washout Period 3 (7 Days)|Adverse Event|0
2098823|NCT00812929|3688645|FG003|Washout Period 3 (7 Days)|Adverse Event|0
2098824|NCT00812929|3688646|FG004|Washout Period 3 (7 Days)|Adverse Event|0
2098825|NCT00812929|3688647|FG005|Washout Period 3 (7 Days)|Adverse Event|1
2098826|NCT00812929|3688648|FG006|Washout Period 3 (7 Days)|Adverse Event|0
2307588|NCT02699450|4010091|FG000|Overall Study|Withdrawal by Subject|3
2307589|NCT02699450|4010092|FG001|Overall Study|Withdrawal by Subject|1
2307590|NCT02699450|4010093|FG002|Overall Study|Withdrawal by Subject|2
2307591|NCT02699450|4010091|FG000|Overall Study|Adverse Event|1
2307592|NCT02699450|4010092|FG001|Overall Study|Adverse Event|0
2307593|NCT02699450|4010093|FG002|Overall Study|Adverse Event|0
2307594|NCT02699463|4010104|FG000|Overall Study|Lost to Follow-up|11
2098827|NCT00812929|3688649|FG007|Washout Period 3 (7 Days)|Adverse Event|0
2098828|NCT00812929|3688650|FG008|Washout Period 3 (7 Days)|Adverse Event|0
2098829|NCT00812929|3688651|FG009|Washout Period 3 (7 Days)|Adverse Event|0
2098830|NCT00812955|3688672|FG000|Overall Study|Adverse Event|7
2098831|NCT00812955|3688673|FG001|Overall Study|Adverse Event|6
2098832|NCT00812955|3688674|FG002|Overall Study|Adverse Event|3
2098833|NCT00812955|3688675|FG003|Overall Study|Adverse Event|4
2098834|NCT00812955|3688672|FG000|Overall Study|Lost to Follow-up|2
2098835|NCT00812955|3688673|FG001|Overall Study|Lost to Follow-up|1
2098836|NCT00812955|3688674|FG002|Overall Study|Lost to Follow-up|1
2098837|NCT00812955|3688675|FG003|Overall Study|Lost to Follow-up|2
2098838|NCT00812955|3688672|FG000|Overall Study|Withdrawal by Subject|1
2098839|NCT00812955|3688673|FG001|Overall Study|Withdrawal by Subject|0
2098840|NCT00812955|3688674|FG002|Overall Study|Withdrawal by Subject|1
2098841|NCT00812955|3688675|FG003|Overall Study|Withdrawal by Subject|2
2098842|NCT00812955|3688672|FG000|Overall Study|randomized in error|0
2098843|NCT00812955|3688673|FG001|Overall Study|randomized in error|0
2098844|NCT00812955|3688674|FG002|Overall Study|randomized in error|1
2098845|NCT00812955|3688675|FG003|Overall Study|randomized in error|0
2098846|NCT00812968|3688689|FG000|Overall Study|Relapse after erythroid response|6
2098847|NCT00812968|3688689|FG000|Overall Study|Disease progression|1
2098848|NCT00812968|3688689|FG000|Overall Study|No further treatment required|1
2098849|NCT00812968|3688689|FG000|Overall Study|Study closed due to marketing approval|3
2098850|NCT00812981|3688697|FG000|Overall Study|Other|0
2098851|NCT00812981|3688698|FG001|Overall Study|Other|1
2098852|NCT00813098|3688707|FG000|Overall Study|Adverse Event|2
2098853|NCT00813098|3688708|FG001|Overall Study|Adverse Event|4
2098854|NCT00813098|3688709|FG002|Overall Study|Adverse Event|1
2098855|NCT00813098|3688707|FG000|Overall Study|Withdrawal by Subject|0
2098856|NCT00813098|3688708|FG001|Overall Study|Withdrawal by Subject|1
2098857|NCT00813098|3688709|FG002|Overall Study|Withdrawal by Subject|0
2098858|NCT00813098|3688707|FG000|Overall Study|Inability to complete study procedures|1
2098859|NCT00813098|3688708|FG001|Overall Study|Inability to complete study procedures|0
2098860|NCT00813098|3688709|FG002|Overall Study|Inability to complete study procedures|0
2098861|NCT00813098|3688707|FG000|Overall Study|Lost to Follow-up|0
2098862|NCT00813098|3688708|FG001|Overall Study|Lost to Follow-up|1
2098863|NCT00813098|3688709|FG002|Overall Study|Lost to Follow-up|0
2307595|NCT02699463|4010105|FG001|Overall Study|Lost to Follow-up|8
2307596|NCT02699463|4010104|FG000|Overall Study|Withdrawal by Subject|4
2098864|NCT00813098|3688707|FG000|Overall Study|Protocol Violation|0
2098865|NCT00813098|3688708|FG001|Overall Study|Protocol Violation|0
2098866|NCT00813098|3688709|FG002|Overall Study|Protocol Violation|1
2098867|NCT00813098|3688707|FG000|Overall Study|Principal Investigator decision|0
2098868|NCT00813098|3688708|FG001|Overall Study|Principal Investigator decision|1
2098869|NCT00813098|3688709|FG002|Overall Study|Principal Investigator decision|0
2098870|NCT00813098|3688707|FG000|Overall Study|Withdrew Consent|0
2098871|NCT00813098|3688708|FG001|Overall Study|Withdrew Consent|1
2098872|NCT00813098|3688709|FG002|Overall Study|Withdrew Consent|0
2098873|NCT00813124|3688726|FG000|Overall Study|Death|2
2098874|NCT00813124|3688726|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9
2098875|NCT00813124|3688726|FG000|Overall Study|Withdrawal by Subject|1
2098876|NCT00813150|3688732|FG000|Treatment Period|Adverse Event|16
2098877|NCT00813150|3688733|FG001|Treatment Period|Adverse Event|15
2098878|NCT00813150|3688732|FG000|Treatment Period|Death|2
2098879|NCT00813150|3688733|FG001|Treatment Period|Death|0
2098880|NCT00813150|3688732|FG000|Treatment Period|Progressive disease|1
2098881|NCT00813150|3688733|FG001|Treatment Period|Progressive disease|0
2098882|NCT00813150|3688732|FG000|Treatment Period|Complete response|0
2098883|NCT00813150|3688733|FG001|Treatment Period|Complete response|1
2098884|NCT00813150|3688732|FG000|Treatment Period|Stable disease|1
2098885|NCT00813150|3688733|FG001|Treatment Period|Stable disease|2
2098886|NCT00813150|3688732|FG000|Treatment Period|Protocol Violation|3
2098887|NCT00813150|3688733|FG001|Treatment Period|Protocol Violation|4
2098888|NCT00813150|3688732|FG000|Treatment Period|Withdrawal by Subject|5
2098889|NCT00813150|3688733|FG001|Treatment Period|Withdrawal by Subject|3
2098890|NCT00813150|3688732|FG000|Treatment Period|Non compliance|0
2098891|NCT00813150|3688733|FG001|Treatment Period|Non compliance|1
2098892|NCT00813150|3688732|FG000|Treatment Period|Reason not specified|3
2098893|NCT00813150|3688733|FG001|Treatment Period|Reason not specified|4
2098894|NCT00813150|3688732|FG000|Treatment Period|Data not available|1
2098895|NCT00813150|3688733|FG001|Treatment Period|Data not available|2
2098896|NCT00813150|3688732|FG000|Long Term Follow-up|Death|0
2098897|NCT00813150|3688733|FG001|Long Term Follow-up|Death|4
2098898|NCT00813150|3688732|FG000|Long Term Follow-up|Other|0
2098899|NCT00813150|3688733|FG001|Long Term Follow-up|Other|3
2177353|NCT01372410|3801378|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2177354|NCT01372410|3801379|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
2307597|NCT02699463|4010105|FG001|Overall Study|Withdrawal by Subject|1
2307598|NCT02699593|4010111|FG000|Period 1|Unsatisfactory Visual Response|0
2307599|NCT02699593|4010112|FG001|Period 1|Unsatisfactory Visual Response|1
2307600|NCT02699593|4010111|FG000|Period 1|Torn Contact Len|4
2307601|NCT02699593|4010112|FG001|Period 1|Torn Contact Len|3
2307602|NCT02699593|4010111|FG000|Period 1|Protocol Violation|0
2307603|NCT02699593|4010112|FG001|Period 1|Protocol Violation|1
2098900|NCT00813150|3688732|FG000|Long Term Follow-up|Lost to Follow-up|2
2098901|NCT00813150|3688733|FG001|Long Term Follow-up|Lost to Follow-up|0
2098902|NCT00813150|3688732|FG000|Long Term Follow-up|Progression/Relapse|22
2098903|NCT00813150|3688733|FG001|Long Term Follow-up|Progression/Relapse|24
2098904|NCT00813293|3688752|FG000|Overall Study|Intercurrent illness|1
2098905|NCT00813293|3688753|FG001|Overall Study|Intercurrent illness|0
2098906|NCT00813293|3688752|FG000|Overall Study|Adverse Event|0
2098907|NCT00813293|3688753|FG001|Overall Study|Adverse Event|1
2098908|NCT00813358|3688768|FG000|Overall Study|Death|32
2098909|NCT00813358|3688768|FG000|Overall Study|Lost to Follow-up|12
2098910|NCT00813358|3688768|FG000|Overall Study|other endpoints|5
2098911|NCT00813358|3688768|FG000|Overall Study|Withdrawal by Subject|20
2098912|NCT00813488|3688772|FG000|Titration Period 1|Adverse Event|6
2098913|NCT00813488|3688773|FG001|Titration Period 1|Adverse Event|1
2098914|NCT00813488|3688772|FG000|Titration Period 1|Lack of Efficacy|9
2098915|NCT00813488|3688773|FG001|Titration Period 1|Lack of Efficacy|7
2098916|NCT00813488|3688772|FG000|Titration Period 1|Withdrawal by Subject|2
2098917|NCT00813488|3688773|FG001|Titration Period 1|Withdrawal by Subject|2
2098918|NCT00813488|3688772|FG000|Titration Period 1|Protocol Violation|4
2098919|NCT00813488|3688773|FG001|Titration Period 1|Protocol Violation|3
2098920|NCT00813488|3688772|FG000|Titration Period 1|Non-compliance to study medication|4
2098921|NCT00813488|3688773|FG001|Titration Period 1|Non-compliance to study medication|1
2098922|NCT00813488|3688772|FG000|Titration Period 1|Non-compliance to study procedures|2
2098923|NCT00813488|3688773|FG001|Titration Period 1|Non-compliance to study procedures|2
2098924|NCT00813488|3688772|FG000|Titration Period 1|Technical Difficulties|0
2098925|NCT00813488|3688773|FG001|Titration Period 1|Technical Difficulties|1
2098926|NCT00813488|3688772|FG000|Titration Period 2|Adverse Event|2
2098927|NCT00813488|3688773|FG001|Titration Period 2|Adverse Event|3
2098928|NCT00813488|3688772|FG000|Titration Period 2|Lack of Efficacy|8
2098929|NCT00813488|3688773|FG001|Titration Period 2|Lack of Efficacy|4
2098930|NCT00813488|3688772|FG000|Titration Period 2|Protocol Violation|3
2098931|NCT00813488|3688773|FG001|Titration Period 2|Protocol Violation|2
2098932|NCT00813488|3688772|FG000|Titration Period 2|Lost to Follow-up|1
2098933|NCT00813488|3688773|FG001|Titration Period 2|Lost to Follow-up|0
2098934|NCT00813488|3688772|FG000|Titration Period 2|Non-compliance with study procedures|2
2098935|NCT00813488|3688773|FG001|Titration Period 2|Non-compliance with study procedures|1
2098936|NCT00813488|3688772|FG000|Double-blind Treatment Period 1|Adverse Event|1
2098937|NCT00813488|3688773|FG001|Double-blind Treatment Period 1|Adverse Event|1
2098938|NCT00813488|3688772|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0
2098939|NCT00813488|3688773|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1
2098940|NCT00813488|3688772|FG000|Double-blind Treatment Period 1|Protocol Violation|0
2098941|NCT00813488|3688773|FG001|Double-blind Treatment Period 1|Protocol Violation|2
2098942|NCT00813488|3688772|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0
2098943|NCT00813488|3688773|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1
2098944|NCT00813488|3688772|FG000|Double-blind Treatment Period 2|Adverse Event|1
2098945|NCT00813488|3688773|FG001|Double-blind Treatment Period 2|Adverse Event|0
2098946|NCT00813488|3688772|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1
2098947|NCT00813488|3688773|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1
2098948|NCT00813488|3688772|FG000|Double-blind Treatment Period 2|Protocol Violation|2
2098949|NCT00813488|3688773|FG001|Double-blind Treatment Period 2|Protocol Violation|0
2098950|NCT00813488|3688772|FG000|Double-blind Treatment Period 2|Other|1
2098951|NCT00813488|3688773|FG001|Double-blind Treatment Period 2|Other|0
2098952|NCT00813488|3688772|FG000|Open-label Extension|Adverse Event|1
2098953|NCT00813488|3688773|FG001|Open-label Extension|Adverse Event|2
2098954|NCT00813488|3688772|FG000|Open-label Extension|Lack of Efficacy|3
2098955|NCT00813488|3688773|FG001|Open-label Extension|Lack of Efficacy|0
2098956|NCT00813488|3688772|FG000|Open-label Extension|Withdrawal by Subject|0
2098957|NCT00813488|3688773|FG001|Open-label Extension|Withdrawal by Subject|2
2098958|NCT00813488|3688772|FG000|Open-label Extension|Protocol Violation|1
2098959|NCT00813488|3688773|FG001|Open-label Extension|Protocol Violation|2
2098960|NCT00813488|3688772|FG000|Open-label Extension|Non-compliance study medication|4
2098961|NCT00813488|3688773|FG001|Open-label Extension|Non-compliance study medication|0
2098962|NCT00813488|3688772|FG000|Open-label Extension|Non-compliance study procedures|2
2098963|NCT00813488|3688773|FG001|Open-label Extension|Non-compliance study procedures|1
2098964|NCT00813488|3688772|FG000|Open-label Extension|Other|1
2098965|NCT00813488|3688773|FG001|Open-label Extension|Other|0
2098966|NCT00813592|3688783|FG000|Overall Study|Disease assessment was not completed per|2
2098967|NCT00813709|3688791|FG000|Double Blind Period|Adverse Event|4
2098968|NCT00813709|3688792|FG001|Double Blind Period|Adverse Event|1
2098969|NCT00813709|3688793|FG002|Double Blind Period|Adverse Event|4
2098970|NCT00813709|3688794|FG003|Double Blind Period|Adverse Event|0
2098971|NCT00813709|3688795|FG004|Double Blind Period|Adverse Event|0
2098972|NCT00813709|3688796|FG005|Double Blind Period|Adverse Event|0
2098973|NCT00813709|3688791|FG000|Double Blind Period|Lost to Follow-up|3
2098974|NCT00813709|3688792|FG001|Double Blind Period|Lost to Follow-up|2
2098975|NCT00813709|3688793|FG002|Double Blind Period|Lost to Follow-up|2
2098976|NCT00813709|3688794|FG003|Double Blind Period|Lost to Follow-up|0
2098977|NCT00813709|3688795|FG004|Double Blind Period|Lost to Follow-up|0
2098978|NCT00813709|3688796|FG005|Double Blind Period|Lost to Follow-up|0
2098979|NCT00813709|3688791|FG000|Double Blind Period|Switched to open label phase|9
2098980|NCT00813709|3688792|FG001|Double Blind Period|Switched to open label phase|26
2098981|NCT00813709|3688793|FG002|Double Blind Period|Switched to open label phase|18
2098982|NCT00813709|3688794|FG003|Double Blind Period|Switched to open label phase|0
2098983|NCT00813709|3688795|FG004|Double Blind Period|Switched to open label phase|0
2098984|NCT00813709|3688796|FG005|Double Blind Period|Switched to open label phase|0
2098985|NCT00813709|3688791|FG000|Double Blind Period|Randomized but not treated|1
2098986|NCT00813709|3688792|FG001|Double Blind Period|Randomized but not treated|3
2098987|NCT00813709|3688793|FG002|Double Blind Period|Randomized but not treated|1
2098988|NCT00813709|3688794|FG003|Double Blind Period|Randomized but not treated|0
2098989|NCT00813709|3688795|FG004|Double Blind Period|Randomized but not treated|0
2098990|NCT00813709|3688796|FG005|Double Blind Period|Randomized but not treated|0
2098991|NCT00813709|3688791|FG000|Double Blind Period|Other|14
2098992|NCT00813709|3688792|FG001|Double Blind Period|Other|9
2098993|NCT00813709|3688793|FG002|Double Blind Period|Other|6
2098994|NCT00813709|3688794|FG003|Double Blind Period|Other|0
2098995|NCT00813709|3688795|FG004|Double Blind Period|Other|0
2212197|NCT01667926|3853175|FG002|Overall Study|Lost to Follow-up|1
2212198|NCT01667926|3853173|FG000|Overall Study|Side effects|3
2212199|NCT01667926|3853174|FG001|Overall Study|Side effects|0
2212200|NCT01667926|3853175|FG002|Overall Study|Side effects|0
2098996|NCT00813709|3688796|FG005|Double Blind Period|Other|0
2098997|NCT00813709|3688791|FG000|Open Label Period|Adverse Event|0
2098998|NCT00813709|3688792|FG001|Open Label Period|Adverse Event|0
2098999|NCT00813709|3688793|FG002|Open Label Period|Adverse Event|0
2099000|NCT00813709|3688794|FG003|Open Label Period|Adverse Event|5
2099001|NCT00813709|3688795|FG004|Open Label Period|Adverse Event|4
2099002|NCT00813709|3688796|FG005|Open Label Period|Adverse Event|3
2099003|NCT00813709|3688791|FG000|Open Label Period|Lack of Efficacy|0
2099004|NCT00813709|3688792|FG001|Open Label Period|Lack of Efficacy|0
2099005|NCT00813709|3688793|FG002|Open Label Period|Lack of Efficacy|0
2099006|NCT00813709|3688794|FG003|Open Label Period|Lack of Efficacy|3
2099007|NCT00813709|3688795|FG004|Open Label Period|Lack of Efficacy|1
2099008|NCT00813709|3688796|FG005|Open Label Period|Lack of Efficacy|1
2099009|NCT00813709|3688791|FG000|Open Label Period|Randomized but not treated|0
2099010|NCT00813709|3688792|FG001|Open Label Period|Randomized but not treated|0
2099011|NCT00813709|3688793|FG002|Open Label Period|Randomized but not treated|0
2099012|NCT00813709|3688794|FG003|Open Label Period|Randomized but not treated|1
2099013|NCT00813709|3688795|FG004|Open Label Period|Randomized but not treated|0
2099014|NCT00813709|3688796|FG005|Open Label Period|Randomized but not treated|1
2099015|NCT00813709|3688791|FG000|Open Label Period|Other|0
2099016|NCT00813709|3688792|FG001|Open Label Period|Other|0
2099017|NCT00813709|3688793|FG002|Open Label Period|Other|0
2099018|NCT00813709|3688794|FG003|Open Label Period|Other|11
2099019|NCT00813709|3688795|FG004|Open Label Period|Other|5
2099020|NCT00813709|3688796|FG005|Open Label Period|Other|6
2099021|NCT00813748|3688827|FG000|Skin Test Substudy|Physician Decision|0
2099022|NCT00813748|3688828|FG001|Skin Test Substudy|Physician Decision|1
2099023|NCT00813761|3688838|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
2099024|NCT00813761|3688839|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
2099025|NCT00813761|3688840|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
2099026|NCT00813761|3688841|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
2099027|NCT00813761|3688838|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
2099028|NCT00813761|3688839|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
2099029|NCT00813761|3688840|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
2099030|NCT00813761|3688841|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
2099031|NCT00813761|3688838|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
2099032|NCT00813761|3688839|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
2099033|NCT00813761|3688840|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
2099034|NCT00813761|3688841|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
2099035|NCT00813761|3688838|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0
2099036|NCT00813761|3688839|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0
2099037|NCT00813761|3688840|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3
2099038|NCT00813761|3688841|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0
2099039|NCT00813761|3688838|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
2099040|NCT00813761|3688839|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
2099041|NCT00813761|3688840|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
2099042|NCT00813761|3688841|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
2099043|NCT00813761|3688838|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
2099044|NCT00813761|3688839|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
2099045|NCT00813761|3688840|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
2099046|NCT00813761|3688841|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
2099047|NCT00813761|3688838|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
2099048|NCT00813761|3688839|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
2099049|NCT00813761|3688840|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
2099050|NCT00813761|3688841|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
2099051|NCT00813761|3688838|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
2099052|NCT00813761|3688839|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
2212201|NCT01668004|3853190|FG000|Overall Study|Adverse Event|7
2099053|NCT00813761|3688840|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
2099054|NCT00813761|3688841|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
2099055|NCT00813761|3688838|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
2099056|NCT00813761|3688839|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
2099057|NCT00813761|3688840|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
2099058|NCT00813761|3688841|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
2099059|NCT00813761|3688838|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
2099060|NCT00813761|3688839|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
2099061|NCT00813761|3688840|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
2099062|NCT00813761|3688841|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
2099063|NCT00813761|3688838|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
2099064|NCT00813761|3688839|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
2099065|NCT00813761|3688840|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
2099066|NCT00813761|3688841|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
2099067|NCT00813761|3688838|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
2099068|NCT00813761|3688839|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
2099069|NCT00813761|3688840|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
2099070|NCT00813761|3688841|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
2099071|NCT00813800|3688857|FG000|Overall Study|Screen Failure after Consent|2
2099072|NCT00813800|3688857|FG000|Overall Study|Adverse Event|1
2099073|NCT00813800|3688857|FG000|Overall Study|Worsening of depression|2
2099074|NCT00813800|3688857|FG000|Overall Study|Physician Decision|1
2099075|NCT00813813|3688863|FG000|Overall Study|Withdrawal by Subject|1
2099076|NCT00813813|3688864|FG001|Overall Study|Withdrawal by Subject|1
2099077|NCT00813813|3688863|FG000|Overall Study|Lost to Follow-up|2
2099078|NCT00813813|3688864|FG001|Overall Study|Lost to Follow-up|7
2099079|NCT00813813|3688863|FG000|Overall Study|Other|0
2099080|NCT00813813|3688864|FG001|Overall Study|Other|1
2099081|NCT00813865|3688870|FG000|Overall Study|Failure to Respond|3
2099082|NCT00813865|3688870|FG000|Overall Study|Lost to Follow-up|3
2099083|NCT00813865|3688870|FG000|Overall Study|Withdrawal by Subject|1
2099084|NCT00813904|3688874|FG000|Overall Study|Death|1
2099085|NCT00813917|3688880|FG000|Overall Study|Adverse Event|0
2099086|NCT00813917|3688881|FG001|Overall Study|Adverse Event|1
2099087|NCT00813917|3688880|FG000|Overall Study|Withdrawal by Subject|3
2099088|NCT00813917|3688881|FG001|Overall Study|Withdrawal by Subject|4
2099089|NCT00813917|3688880|FG000|Overall Study|Lost to Follow-up|3
2099090|NCT00813917|3688881|FG001|Overall Study|Lost to Follow-up|1
2099091|NCT00813943|3688890|FG000|Overall Study|Ongoing at cut-off date|5
2099092|NCT00813943|3688891|FG001|Overall Study|Ongoing at cut-off date|5
2099093|NCT00813943|3688892|FG002|Overall Study|Ongoing at cut-off date|3
2099094|NCT00813995|3688909|FG000|Overall Study|Clinical adverse event|9
2099095|NCT00813995|3688910|FG001|Overall Study|Clinical adverse event|3
2099096|NCT00813995|3688909|FG000|Overall Study|Laboratory adverse event|0
2099097|NCT00813995|3688910|FG001|Overall Study|Laboratory adverse event|2
2099098|NCT00813995|3688909|FG000|Overall Study|Lack of Efficacy|1
2099099|NCT00813995|3688910|FG001|Overall Study|Lack of Efficacy|0
2099100|NCT00813995|3688909|FG000|Overall Study|Lost to Follow-up|4
2099101|NCT00813995|3688910|FG001|Overall Study|Lost to Follow-up|2
2099102|NCT00813995|3688909|FG000|Overall Study|Other reason|2
2099103|NCT00813995|3688910|FG001|Overall Study|Other reason|2
2099104|NCT00813995|3688909|FG000|Overall Study|Protocol Violation|3
2099105|NCT00813995|3688910|FG001|Overall Study|Protocol Violation|2
2099106|NCT00813995|3688909|FG000|Overall Study|Subject moved|4
2099107|NCT00813995|3688910|FG001|Overall Study|Subject moved|0
2099108|NCT00813995|3688909|FG000|Overall Study|Withdrawal by Subject|0
2099109|NCT00813995|3688910|FG001|Overall Study|Withdrawal by Subject|5
2099110|NCT00814164|3688931|FG000|Overall Study|Progression|7
2099111|NCT00814164|3688931|FG000|Overall Study|not stated|7
2099112|NCT00814164|3688931|FG000|Overall Study|Death|5
2099113|NCT00814307|3688964|FG000|Overall Study|Randomized but not treated|1
2099114|NCT00814307|3688965|FG001|Overall Study|Randomized but not treated|0
2099115|NCT00814307|3688966|FG002|Overall Study|Randomized but not treated|0
2099116|NCT00814307|3688967|FG003|Overall Study|Randomized but not treated|0
2099117|NCT00814307|3688964|FG000|Overall Study|Adverse Event|3
2099118|NCT00814307|3688965|FG001|Overall Study|Adverse Event|9
2099119|NCT00814307|3688966|FG002|Overall Study|Adverse Event|3
2099120|NCT00814307|3688967|FG003|Overall Study|Adverse Event|2
2099121|NCT00814307|3688964|FG000|Overall Study|Lack of Efficacy|1
2099122|NCT00814307|3688965|FG001|Overall Study|Lack of Efficacy|1
2099123|NCT00814307|3688966|FG002|Overall Study|Lack of Efficacy|3
2099124|NCT00814307|3688967|FG003|Overall Study|Lack of Efficacy|4
2099125|NCT00814307|3688964|FG000|Overall Study|Other|1
2099126|NCT00814307|3688965|FG001|Overall Study|Other|2
2099127|NCT00814307|3688966|FG002|Overall Study|Other|0
2099128|NCT00814307|3688967|FG003|Overall Study|Other|1
2099129|NCT00814307|3688964|FG000|Overall Study|Protocol Violation|2
2099130|NCT00814307|3688965|FG001|Overall Study|Protocol Violation|8
2099131|NCT00814307|3688966|FG002|Overall Study|Protocol Violation|1
2099132|NCT00814307|3688967|FG003|Overall Study|Protocol Violation|1
2099133|NCT00814307|3688964|FG000|Overall Study|Withdrawal by Subject|4
2099134|NCT00814307|3688965|FG001|Overall Study|Withdrawal by Subject|6
2099135|NCT00814307|3688966|FG002|Overall Study|Withdrawal by Subject|0
2099136|NCT00814307|3688967|FG003|Overall Study|Withdrawal by Subject|2
2099137|NCT00814307|3688964|FG000|Overall Study|Death|0
2099138|NCT00814307|3688965|FG001|Overall Study|Death|1
2099139|NCT00814307|3688966|FG002|Overall Study|Death|0
2099140|NCT00814307|3688967|FG003|Overall Study|Death|0
2099141|NCT00814320|3688981|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
2099142|NCT00814320|3688982|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
2099143|NCT00814320|3688981|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
2099144|NCT00814320|3688982|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
2099145|NCT00814320|3688981|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
2099146|NCT00814320|3688982|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
2099147|NCT00814320|3688981|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
2099148|NCT00814320|3688982|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
2099149|NCT00814320|3688981|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
2099150|NCT00814320|3688982|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
2099151|NCT00814320|3688981|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
2099152|NCT00814320|3688982|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
2099153|NCT00814320|3688981|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
2099154|NCT00814320|3688982|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
2099155|NCT00814320|3688981|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
2099156|NCT00814320|3688982|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
2099157|NCT00814320|3688981|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
2099158|NCT00814320|3688982|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
2099159|NCT00814320|3688981|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
2099160|NCT00814320|3688982|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
2099161|NCT00814346|3689007|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0
2099162|NCT00814346|3689008|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1
2099163|NCT00814346|3689007|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0
2099164|NCT00814346|3689008|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2
2099165|NCT00814346|3689007|FG000|Open Phase (17 Months)|Adverse Event|5
2099166|NCT00814346|3689008|FG001|Open Phase (17 Months)|Adverse Event|0
2099167|NCT00814346|3689007|FG000|Open Phase (17 Months)|Consent|2
2099168|NCT00814346|3689008|FG001|Open Phase (17 Months)|Consent|0
2099169|NCT00814346|3689007|FG000|Open Phase (17 Months)|Lost to Follow-up|2
2099170|NCT00814346|3689008|FG001|Open Phase (17 Months)|Lost to Follow-up|0
2099171|NCT00814346|3689007|FG000|Open Phase (17 Months)|Not otherwise specified|1
2099172|NCT00814346|3689008|FG001|Open Phase (17 Months)|Not otherwise specified|0
2212202|NCT01668004|3853190|FG000|Overall Study|Withdrawal by Subject|2
2099173|NCT00814463|3689027|FG000|Overall Study|Lost to Follow-up|1
2099174|NCT00814489|3689035|FG000|Overall Study|Other|2
2099175|NCT00814489|3689036|FG001|Overall Study|Other|0
2099176|NCT00814489|3689037|FG002|Overall Study|Other|1
2099177|NCT00814502|3689049|FG000|Overall Study|Adverse Event|1
2099178|NCT00814502|3689050|FG001|Overall Study|Adverse Event|0
2099179|NCT00814502|3689049|FG000|Overall Study|Withdrawal by Subject|0
2099180|NCT00814502|3689050|FG001|Overall Study|Withdrawal by Subject|2
2099181|NCT00814580|3689060|FG000|Overall Study|Adverse Event|6
2099182|NCT00814580|3689061|FG001|Overall Study|Adverse Event|15
2099183|NCT00814580|3689060|FG000|Overall Study|Lack of Efficacy|18
2099184|NCT00814580|3689061|FG001|Overall Study|Lack of Efficacy|25
2099185|NCT00814580|3689060|FG000|Overall Study|Protocol Violation|2
2099186|NCT00814580|3689061|FG001|Overall Study|Protocol Violation|0
2099187|NCT00814580|3689060|FG000|Overall Study|Withdrawal by Subject|2
2099188|NCT00814580|3689061|FG001|Overall Study|Withdrawal by Subject|2
2099189|NCT00814580|3689060|FG000|Overall Study|Other|1
2099190|NCT00814580|3689061|FG001|Overall Study|Other|3
2099191|NCT00814580|3689060|FG000|Overall Study|Did Not Take Drug|2
2099192|NCT00814580|3689061|FG001|Overall Study|Did Not Take Drug|2
2099193|NCT00814632|3689079|FG000|Overall Study|Lack of Efficacy|2
2099194|NCT00814658|3689085|FG000|Overall Study|Lost to Follow-up|0
2099195|NCT00814658|3689086|FG001|Overall Study|Lost to Follow-up|1
2099196|NCT00814658|3689085|FG000|Overall Study|Physician Decision|1
2099197|NCT00814658|3689086|FG001|Overall Study|Physician Decision|0
2099198|NCT00814658|3689085|FG000|Overall Study|Adverse Event|3
2099199|NCT00814658|3689086|FG001|Overall Study|Adverse Event|3
2099200|NCT00814710|3689125|FG000|Overall Study|Adverse Event|1
2099201|NCT00814710|3689126|FG001|Overall Study|Adverse Event|0
2099202|NCT00814710|3689125|FG000|Overall Study|Lost to Follow-up|7
2099203|NCT00814710|3689126|FG001|Overall Study|Lost to Follow-up|3
2099204|NCT00814801|3689150|FG000|Overall Study|Adverse Event|15
2353778|NCT02042950|4107128|FG000|Overall Study|Progressive Disease|4
2353779|NCT02048904|4107132|FG000|Overall Study|Withdrawal by Subject|7
2353780|NCT02048904|4107132|FG000|Overall Study|Physician Decision|70
2353781|NCT02044822|4107136|FG000|Overall Study|Study Terminated by Sponsor|77
2353782|NCT02044822|4107136|FG000|Overall Study|Investigator's Discretion|10
2353783|NCT02044822|4107136|FG000|Overall Study|Withdrew Consent|3
2353784|NCT02044822|4107136|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2
2353785|NCT02044822|4107136|FG000|Overall Study|Lost to Follow-up|1
2353786|NCT02042924|4107140|FG000|Overall Study|Early Death|1
2099205|NCT00814801|3689151|FG001|Overall Study|Adverse Event|16
2099206|NCT00814801|3689152|FG002|Overall Study|Adverse Event|19
2099207|NCT00814801|3689150|FG000|Overall Study|Withdrawal by Subject|9
2099208|NCT00814801|3689151|FG001|Overall Study|Withdrawal by Subject|11
2099209|NCT00814801|3689152|FG002|Overall Study|Withdrawal by Subject|14
2099210|NCT00814801|3689150|FG000|Overall Study|Inappropriate as a subject|1
2099211|NCT00814801|3689151|FG001|Overall Study|Inappropriate as a subject|1
2099212|NCT00814801|3689152|FG002|Overall Study|Inappropriate as a subject|1
2099213|NCT00814801|3689150|FG000|Overall Study|Change of patients for CIBIC plus-J|1
2099214|NCT00814801|3689151|FG001|Overall Study|Change of patients for CIBIC plus-J|1
2099215|NCT00814801|3689152|FG002|Overall Study|Change of patients for CIBIC plus-J|0
2099216|NCT00814801|3689150|FG000|Overall Study|Missing or change of caregiver|6
2099217|NCT00814801|3689151|FG001|Overall Study|Missing or change of caregiver|2
2099218|NCT00814801|3689152|FG002|Overall Study|Missing or change of caregiver|4
2099219|NCT00814801|3689150|FG000|Overall Study|Non-compliance|0
2099220|NCT00814801|3689151|FG001|Overall Study|Non-compliance|1
2099221|NCT00814801|3689152|FG002|Overall Study|Non-compliance|1
2099222|NCT00814801|3689150|FG000|Overall Study|Other|2
2099223|NCT00814801|3689151|FG001|Overall Study|Other|6
2099224|NCT00814801|3689152|FG002|Overall Study|Other|4
2099225|NCT00814879|3689162|FG000|By Week 24|Cancer Diagnosis|1
2099226|NCT00814879|3689163|FG001|By Week 24|Cancer Diagnosis|0
2099227|NCT00814879|3689162|FG000|By Week 24|Incarceration|0
2099228|NCT00814879|3689163|FG001|By Week 24|Incarceration|1
2099229|NCT00814879|3689162|FG000|By Week 48|Lost to Follow-up|2
2099230|NCT00814879|3689163|FG001|By Week 48|Lost to Follow-up|2
2099231|NCT00814879|3689162|FG000|By Week 48|Death|0
2099232|NCT00814879|3689163|FG001|By Week 48|Death|1
2099233|NCT00815191|3689200|FG000|Overall Study|Protocol Violation|1
2099234|NCT00815191|3689201|FG001|Overall Study|Protocol Violation|1
2099235|NCT00815295|3689210|FG000|Overall Study|Cetuximab hypersensitivity reaction|0
2099236|NCT00815295|3689211|FG001|Overall Study|Cetuximab hypersensitivity reaction|1
2099237|NCT00815295|3689212|FG002|Overall Study|Cetuximab hypersensitivity reaction|3
2099238|NCT00815308|3689220|FG000|Overall Study|Adverse Event|4
2099239|NCT00815308|3689220|FG000|Overall Study|Withdrawal by Subject|0
2099240|NCT00815308|3689220|FG000|Overall Study|Protocol Violation|6
2099241|NCT00815516|3689250|FG000|Overall Study|Death|3
2099242|NCT00815516|3689251|FG001|Overall Study|Death|1
2099243|NCT00815516|3689250|FG000|Overall Study|Physician Decision|1
2099244|NCT00815516|3689251|FG001|Overall Study|Physician Decision|0
2099245|NCT00815659|3689257|FG000|Overall Study|Adverse Event|9
2099246|NCT00815659|3689257|FG000|Overall Study|Withdrawal by Subject|9
2099247|NCT00815659|3689257|FG000|Overall Study|Lost to Follow-up|4
2099248|NCT00815659|3689257|FG000|Overall Study|Protocol Violation|1
2099249|NCT00815919|3689290|FG000|Overall Study|Unrelated Fungal Infection|1
2099250|NCT00815919|3689290|FG000|Overall Study|AML Relapse|1
2099251|NCT00815919|3689290|FG000|Overall Study|Lack of Efficacy|2
2099252|NCT00816023|3689309|FG000|Overall Study|Lost to Follow-up|1
2099253|NCT00816023|3689310|FG001|Overall Study|Lost to Follow-up|1
2099254|NCT00816023|3689311|FG002|Overall Study|Lost to Follow-up|0
2099255|NCT00816023|3689312|FG003|Overall Study|Lost to Follow-up|0
2099256|NCT00816023|3689309|FG000|Overall Study|Withdrawal by Subject|1
2099257|NCT00816023|3689310|FG001|Overall Study|Withdrawal by Subject|0
2099258|NCT00816023|3689311|FG002|Overall Study|Withdrawal by Subject|0
2099259|NCT00816023|3689312|FG003|Overall Study|Withdrawal by Subject|0
2099260|NCT00816023|3689309|FG000|Overall Study|Physician Decision|0
2099261|NCT00816023|3689310|FG001|Overall Study|Physician Decision|0
2099262|NCT00816023|3689311|FG002|Overall Study|Physician Decision|1
2099263|NCT00816023|3689312|FG003|Overall Study|Physician Decision|0
2099264|NCT00816023|3689309|FG000|Overall Study|assessments complete prior to window|1
2099265|NCT00816023|3689310|FG001|Overall Study|assessments complete prior to window|1
2099266|NCT00816023|3689311|FG002|Overall Study|assessments complete prior to window|2
2099267|NCT00816023|3689312|FG003|Overall Study|assessments complete prior to window|1
2099268|NCT00816023|3689309|FG000|Overall Study|Randomized Not Treated|6
2099269|NCT00816023|3689310|FG001|Overall Study|Randomized Not Treated|4
2099270|NCT00816023|3689311|FG002|Overall Study|Randomized Not Treated|6
2099271|NCT00816023|3689312|FG003|Overall Study|Randomized Not Treated|11
2099272|NCT00816036|3689324|FG000|Overall Study|Death|47
2099273|NCT00816036|3689325|FG001|Overall Study|Death|28
2099274|NCT00816036|3689324|FG000|Overall Study|Lost to Follow-up|75
2099275|NCT00816036|3689325|FG001|Overall Study|Lost to Follow-up|57
2099276|NCT00816036|3689324|FG000|Overall Study|Withdrawal by Subject|54
2099277|NCT00816036|3689325|FG001|Overall Study|Withdrawal by Subject|23
2099278|NCT00816166|3689351|FG000|Overall Study|Lost to Follow-up|6
2099279|NCT00816166|3689352|FG001|Overall Study|Lost to Follow-up|10
2099280|NCT00816166|3689351|FG000|Overall Study|Death|4
2099281|NCT00816166|3689352|FG001|Overall Study|Death|2
2099282|NCT00816361|3689369|FG000|Overall Study|Withdrawal by Subject|0
2099283|NCT00816361|3689370|FG001|Overall Study|Withdrawal by Subject|0
2099284|NCT00816361|3689371|FG002|Overall Study|Withdrawal by Subject|0
2099285|NCT00816361|3689372|FG003|Overall Study|Withdrawal by Subject|0
2099286|NCT00816361|3689373|FG004|Overall Study|Withdrawal by Subject|1
2099287|NCT00816361|3689374|FG005|Overall Study|Withdrawal by Subject|2
2099288|NCT00816361|3689375|FG006|Overall Study|Withdrawal by Subject|0
2099289|NCT00816361|3689376|FG007|Overall Study|Withdrawal by Subject|2
2099290|NCT00816361|3689377|FG008|Overall Study|Withdrawal by Subject|1
2099291|NCT00816361|3689369|FG000|Overall Study|Death|4
2099292|NCT00816361|3689370|FG001|Overall Study|Death|3
2099293|NCT00816361|3689371|FG002|Overall Study|Death|3
2099294|NCT00816361|3689372|FG003|Overall Study|Death|3
2099295|NCT00816361|3689373|FG004|Overall Study|Death|1
2099296|NCT00816361|3689374|FG005|Overall Study|Death|1
2099297|NCT00816361|3689375|FG006|Overall Study|Death|3
2099298|NCT00816361|3689376|FG007|Overall Study|Death|7
2099299|NCT00816361|3689377|FG008|Overall Study|Death|8
2099300|NCT00816361|3689369|FG000|Overall Study|Other|0
2099301|NCT00816361|3689370|FG001|Overall Study|Other|0
2099302|NCT00816361|3689371|FG002|Overall Study|Other|0
2099303|NCT00816361|3689372|FG003|Overall Study|Other|0
2099304|NCT00816361|3689373|FG004|Overall Study|Other|0
2099305|NCT00816361|3689374|FG005|Overall Study|Other|0
2099306|NCT00816361|3689375|FG006|Overall Study|Other|0
2099307|NCT00816361|3689376|FG007|Overall Study|Other|0
2099308|NCT00816361|3689377|FG008|Overall Study|Other|1
2099309|NCT00816400|3689407|FG000|Overall Study|Death|2
2099310|NCT00816400|3689408|FG001|Overall Study|Death|3
2099311|NCT00816400|3689409|FG002|Overall Study|Death|3
2099312|NCT00816400|3689410|FG003|Overall Study|Death|3
2099313|NCT00816400|3689411|FG004|Overall Study|Death|2
2099314|NCT00816400|3689412|FG005|Overall Study|Death|3
2099315|NCT00816400|3689413|FG006|Overall Study|Death|2
2099316|NCT00816400|3689414|FG007|Overall Study|Death|5
2099317|NCT00816400|3689415|FG008|Overall Study|Death|6
2099318|NCT00816400|3689407|FG000|Overall Study|In hospice care at the end of the study|0
2099319|NCT00816400|3689408|FG001|Overall Study|In hospice care at the end of the study|0
2099320|NCT00816400|3689409|FG002|Overall Study|In hospice care at the end of the study|2
2099321|NCT00816400|3689410|FG003|Overall Study|In hospice care at the end of the study|0
2099322|NCT00816400|3689411|FG004|Overall Study|In hospice care at the end of the study|0
2099323|NCT00816400|3689412|FG005|Overall Study|In hospice care at the end of the study|0
2099324|NCT00816400|3689413|FG006|Overall Study|In hospice care at the end of the study|0
2099325|NCT00816400|3689414|FG007|Overall Study|In hospice care at the end of the study|0
2099326|NCT00816400|3689415|FG008|Overall Study|In hospice care at the end of the study|0
2099327|NCT00816556|3689439|FG000|Overall Study|Adverse Event|1
2099328|NCT00816556|3689440|FG001|Overall Study|Adverse Event|1
2099329|NCT00816556|3689441|FG002|Overall Study|Adverse Event|1
2099330|NCT00816556|3689439|FG000|Overall Study|Withdrawal by Subject|1
2099331|NCT00816556|3689440|FG001|Overall Study|Withdrawal by Subject|1
2099332|NCT00816556|3689441|FG002|Overall Study|Withdrawal by Subject|1
2099333|NCT00816556|3689439|FG000|Overall Study|Lost to Follow-up|0
2099334|NCT00816556|3689440|FG001|Overall Study|Lost to Follow-up|0
2099335|NCT00816556|3689441|FG002|Overall Study|Lost to Follow-up|1
2099336|NCT00816595|3689451|FG000|Overall Study|Withdrawal by Subject|2
2099337|NCT00816595|3689452|FG001|Overall Study|Withdrawal by Subject|0
2099338|NCT00817063|3689491|FG000|Overall Study|Adverse Event|32
2099339|NCT00817063|3689492|FG001|Overall Study|Adverse Event|13
2099340|NCT00817063|3689491|FG000|Overall Study|Death|1
2099341|NCT00817063|3689492|FG001|Overall Study|Death|1
2099342|NCT00817063|3689491|FG000|Overall Study|Lack of Efficacy|33
2099343|NCT00817063|3689492|FG001|Overall Study|Lack of Efficacy|86
2099344|NCT00817063|3689491|FG000|Overall Study|Failure to Return|13
2099345|NCT00817063|3689492|FG001|Overall Study|Failure to Return|12
2099346|NCT00817063|3689491|FG000|Overall Study|Violation of Selection at Entry|7
2099347|NCT00817063|3689492|FG001|Overall Study|Violation of Selection at Entry|4
2099348|NCT00817063|3689491|FG000|Overall Study|Protocol Violation|3
2099349|NCT00817063|3689492|FG001|Overall Study|Protocol Violation|8
2099350|NCT00817063|3689491|FG000|Overall Study|Withdrawal by Subject|17
2099351|NCT00817063|3689492|FG001|Overall Study|Withdrawal by Subject|37
2099352|NCT00817063|3689491|FG000|Overall Study|Early Improvement|19
2099353|NCT00817063|3689492|FG001|Overall Study|Early Improvement|4
2099354|NCT00817063|3689491|FG000|Overall Study|Administrative|10
2099355|NCT00817063|3689492|FG001|Overall Study|Administrative|4
2099356|NCT00817063|3689491|FG000|Overall Study|Abnormality of Laboratory Test|2
2099357|NCT00817063|3689492|FG001|Overall Study|Abnormality of Laboratory Test|1
2099358|NCT00817089|3689502|FG000|First Alcohol Challenge|Lost to Follow-up|0
2099359|NCT00817089|3689503|FG001|First Alcohol Challenge|Lost to Follow-up|0
2099360|NCT00817089|3689504|FG002|First Alcohol Challenge|Lost to Follow-up|0
2099361|NCT00817089|3689505|FG003|First Alcohol Challenge|Lost to Follow-up|1
2099362|NCT00817089|3689502|FG000|Second Alcohol Challenge|Lost to Follow-up|0
2099363|NCT00817089|3689503|FG001|Second Alcohol Challenge|Lost to Follow-up|1
2099364|NCT00817089|3689504|FG002|Second Alcohol Challenge|Lost to Follow-up|0
2099365|NCT00817089|3689505|FG003|Second Alcohol Challenge|Lost to Follow-up|0
2099366|NCT00817206|3689521|FG000|Overall Study|Adverse Event|10
2099367|NCT00817206|3689522|FG001|Overall Study|Adverse Event|3
2099368|NCT00817206|3689521|FG000|Overall Study|Protocol Violation|0
2099369|NCT00817206|3689522|FG001|Overall Study|Protocol Violation|2
2099370|NCT00817206|3689521|FG000|Overall Study|Lost to Follow-up|0
2099371|NCT00817206|3689522|FG001|Overall Study|Lost to Follow-up|1
2099372|NCT00817206|3689521|FG000|Overall Study|Death|2
2099373|NCT00817206|3689522|FG001|Overall Study|Death|0
2099374|NCT00817206|3689521|FG000|Overall Study|Withdrawal by Subject|7
2099375|NCT00817206|3689522|FG001|Overall Study|Withdrawal by Subject|3
2099376|NCT00817206|3689521|FG000|Overall Study|Physician Decision|2
2099377|NCT00817206|3689522|FG001|Overall Study|Physician Decision|0
2099378|NCT00817336|3689534|FG000|Overall Study|Withdrawal by Subject|1
2099379|NCT00817336|3689535|FG001|Overall Study|Withdrawal by Subject|1
2099380|NCT00817414|3689545|FG000|Overall Study|Adverse Event|1
2099381|NCT00817414|3689546|FG001|Overall Study|Adverse Event|1
2099382|NCT00817414|3689547|FG002|Overall Study|Adverse Event|1
2099383|NCT00817414|3689548|FG003|Overall Study|Adverse Event|0
2099384|NCT00817414|3689549|FG004|Overall Study|Adverse Event|0
2099385|NCT00817414|3689545|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
2099386|NCT00817414|3689546|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1
2099387|NCT00817414|3689547|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2
2099388|NCT00817414|3689548|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4
2099389|NCT00817414|3689549|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
2099390|NCT00817414|3689545|FG000|Overall Study|Withdrawal by Subject|1
2099391|NCT00817414|3689546|FG001|Overall Study|Withdrawal by Subject|1
2099392|NCT00817414|3689547|FG002|Overall Study|Withdrawal by Subject|0
2099393|NCT00817414|3689548|FG003|Overall Study|Withdrawal by Subject|0
2099394|NCT00817414|3689549|FG004|Overall Study|Withdrawal by Subject|0
2099395|NCT00817414|3689545|FG000|Overall Study|Lost to Follow-up|0
2099396|NCT00817414|3689546|FG001|Overall Study|Lost to Follow-up|0
2099397|NCT00817414|3689547|FG002|Overall Study|Lost to Follow-up|1
2099398|NCT00817414|3689548|FG003|Overall Study|Lost to Follow-up|1
2099399|NCT00817414|3689549|FG004|Overall Study|Lost to Follow-up|1
2099400|NCT00817414|3689545|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
2099401|NCT00817414|3689546|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
2099402|NCT00817414|3689547|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
2099403|NCT00817414|3689548|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7
2099404|NCT00817414|3689549|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
2099405|NCT00817414|3689545|FG000|Overall Study|Protocol Violation|0
2099406|NCT00817414|3689546|FG001|Overall Study|Protocol Violation|0
2099407|NCT00817414|3689547|FG002|Overall Study|Protocol Violation|0
2099408|NCT00817414|3689548|FG003|Overall Study|Protocol Violation|0
2099409|NCT00817414|3689549|FG004|Overall Study|Protocol Violation|1
2099410|NCT00817479|3689568|FG000|Overall Study|Physician Decision|1
2099411|NCT00817479|3689569|FG001|Overall Study|Physician Decision|1
2107830|NCT00876395|3701565|FG000|Overall Study|Withdrawal by Subject|66
2107831|NCT00876395|3701566|FG001|Overall Study|Withdrawal by Subject|33
2107832|NCT00876395|3701565|FG000|Overall Study|Lost to Follow-up|2
2107833|NCT00876395|3701566|FG001|Overall Study|Lost to Follow-up|0
2107834|NCT00876395|3701565|FG000|Overall Study|Administrative problems|39
2107835|NCT00876395|3701566|FG001|Overall Study|Administrative problems|23
2107836|NCT00876395|3701565|FG000|Overall Study|Death|12
2107837|NCT00876395|3701566|FG001|Overall Study|Death|0
2107838|NCT00876447|3701579|FG000|Overall Study|Other miscellaneous reasons|3
2107839|NCT00876447|3701580|FG001|Overall Study|Other miscellaneous reasons|8
2107840|NCT00876447|3701579|FG000|Overall Study|Site closure|19
2107841|NCT00876447|3701580|FG001|Overall Study|Site closure|14
2107842|NCT00876447|3701579|FG000|Overall Study|Protocol Violation|9
2107843|NCT00876447|3701580|FG001|Overall Study|Protocol Violation|3
2107844|NCT00876447|3701579|FG000|Overall Study|Personal reasons|30
2107845|NCT00876447|3701580|FG001|Overall Study|Personal reasons|28
2107846|NCT00876447|3701579|FG000|Overall Study|Lost to Follow-up|6
2107847|NCT00876447|3701580|FG001|Overall Study|Lost to Follow-up|15
2107848|NCT00876447|3701579|FG000|Overall Study|Pregnancy|4
2107849|NCT00876447|3701580|FG001|Overall Study|Pregnancy|2
2107850|NCT00876447|3701579|FG000|Overall Study|Lack of Efficacy|5
2107851|NCT00876447|3701580|FG001|Overall Study|Lack of Efficacy|3
2107852|NCT00876447|3701579|FG000|Overall Study|Adverse Event|4
2107853|NCT00876447|3701580|FG001|Overall Study|Adverse Event|8
2107854|NCT00876460|3701618|FG000|Combination Therapy Phase|Progressive disease|2
2107855|NCT00876460|3701619|FG001|Combination Therapy Phase|Progressive disease|3
2107856|NCT00876460|3701620|FG002|Combination Therapy Phase|Progressive disease|3
2107857|NCT00876460|3701621|FG003|Combination Therapy Phase|Progressive disease|3
2107858|NCT00876460|3701622|FG004|Combination Therapy Phase|Progressive disease|3
2107859|NCT00876460|3701623|FG005|Combination Therapy Phase|Progressive disease|1
2107860|NCT00876460|3701624|FG006|Combination Therapy Phase|Progressive disease|1
2107861|NCT00876460|3701625|FG007|Combination Therapy Phase|Progressive disease|1
2107862|NCT00876460|3701618|FG000|Combination Therapy Phase|Dose limiting toxicity|0
2107863|NCT00876460|3701619|FG001|Combination Therapy Phase|Dose limiting toxicity|1
2107864|NCT00876460|3701620|FG002|Combination Therapy Phase|Dose limiting toxicity|0
2107865|NCT00876460|3701621|FG003|Combination Therapy Phase|Dose limiting toxicity|1
2107866|NCT00876460|3701622|FG004|Combination Therapy Phase|Dose limiting toxicity|1
2107867|NCT00876460|3701623|FG005|Combination Therapy Phase|Dose limiting toxicity|2
2107868|NCT00876460|3701624|FG006|Combination Therapy Phase|Dose limiting toxicity|2
2107869|NCT00876460|3701625|FG007|Combination Therapy Phase|Dose limiting toxicity|1
2107870|NCT00876460|3701618|FG000|Combination Therapy Phase|Adverse Event|0
2107871|NCT00876460|3701619|FG001|Combination Therapy Phase|Adverse Event|2
2107872|NCT00876460|3701620|FG002|Combination Therapy Phase|Adverse Event|0
2107873|NCT00876460|3701621|FG003|Combination Therapy Phase|Adverse Event|2
2107874|NCT00876460|3701622|FG004|Combination Therapy Phase|Adverse Event|2
2107875|NCT00876460|3701623|FG005|Combination Therapy Phase|Adverse Event|0
2107876|NCT00876460|3701624|FG006|Combination Therapy Phase|Adverse Event|3
2099412|NCT00817531|3689575|FG000|Overall Study|Adverse Event|1
2099413|NCT00817531|3689575|FG000|Overall Study|Lack of Efficacy|1
2099414|NCT00817635|3689588|FG000|Overall Study|Adverse Event|1
2099415|NCT00817635|3689589|FG001|Overall Study|Adverse Event|0
2099416|NCT00817635|3689590|FG002|Overall Study|Adverse Event|0
2099417|NCT00817635|3689591|FG003|Overall Study|Adverse Event|1
2099418|NCT00817635|3689592|FG004|Overall Study|Adverse Event|1
2099419|NCT00817635|3689588|FG000|Overall Study|Abnormal Laboratory Value(s)|1
2099420|NCT00817635|3689589|FG001|Overall Study|Abnormal Laboratory Value(s)|1
2099421|NCT00817635|3689590|FG002|Overall Study|Abnormal Laboratory Value(s)|0
2099422|NCT00817635|3689591|FG003|Overall Study|Abnormal Laboratory Value(s)|0
2099423|NCT00817635|3689592|FG004|Overall Study|Abnormal Laboratory Value(s)|1
2099424|NCT00817635|3689588|FG000|Overall Study|Withdrawal by Subject|2
2099425|NCT00817635|3689589|FG001|Overall Study|Withdrawal by Subject|1
2099426|NCT00817635|3689590|FG002|Overall Study|Withdrawal by Subject|0
2099427|NCT00817635|3689591|FG003|Overall Study|Withdrawal by Subject|1
2099428|NCT00817635|3689592|FG004|Overall Study|Withdrawal by Subject|2
2099429|NCT00817635|3689588|FG000|Overall Study|Lost to Follow-up|0
2099430|NCT00817635|3689589|FG001|Overall Study|Lost to Follow-up|1
2099431|NCT00817635|3689590|FG002|Overall Study|Lost to Follow-up|0
2099432|NCT00817635|3689591|FG003|Overall Study|Lost to Follow-up|1
2099433|NCT00817635|3689592|FG004|Overall Study|Lost to Follow-up|0
2099434|NCT00817635|3689588|FG000|Overall Study|Administrative Problems|0
2099435|NCT00817635|3689589|FG001|Overall Study|Administrative Problems|0
2099436|NCT00817635|3689590|FG002|Overall Study|Administrative Problems|0
2099437|NCT00817635|3689591|FG003|Overall Study|Administrative Problems|0
2099438|NCT00817635|3689592|FG004|Overall Study|Administrative Problems|1
2099439|NCT00817635|3689588|FG000|Overall Study|Protocol Violation|5
2099440|NCT00817635|3689589|FG001|Overall Study|Protocol Violation|1
2099441|NCT00817635|3689590|FG002|Overall Study|Protocol Violation|3
2099442|NCT00817635|3689591|FG003|Overall Study|Protocol Violation|2
2099443|NCT00817635|3689592|FG004|Overall Study|Protocol Violation|3
2099444|NCT00817778|3689613|FG000|Overall Study|Adverse Event|1
2099445|NCT00817778|3689614|FG001|Overall Study|Adverse Event|0
2099446|NCT00817778|3689613|FG000|Overall Study|Withdrawal by Subject|1
2099447|NCT00817778|3689614|FG001|Overall Study|Withdrawal by Subject|1
2099448|NCT00817778|3689613|FG000|Overall Study|Protocol Violation|0
2099449|NCT00817778|3689614|FG001|Overall Study|Protocol Violation|1
2099450|NCT00817778|3689613|FG000|Overall Study|Study-specific discontinuation criteria|0
2099451|NCT00817778|3689614|FG001|Overall Study|Study-specific discontinuation criteria|1
2099452|NCT00817778|3689613|FG000|Overall Study|Poor venous access|1
2099453|NCT00817778|3689614|FG001|Overall Study|Poor venous access|0
2099454|NCT00818168|3689650|FG000|Overall Study|Lack of Efficacy|18
2099455|NCT00818168|3689650|FG000|Overall Study|Pregnancy|2
2099456|NCT00818168|3689650|FG000|Overall Study|Withdrawal by Subject|16
2099457|NCT00818168|3689650|FG000|Overall Study|Lost to Follow-up|7
2099458|NCT00818168|3689650|FG000|Overall Study|Adverse Event|19
2099459|NCT00818168|3689650|FG000|Overall Study|Reason for Non-completion Not reported|6
2099460|NCT00818168|3689650|FG000|Overall Study|Participant Moved|2
2099461|NCT00818207|3689656|FG000|Overall Study|Adverse Event|6
2099462|NCT00818207|3689657|FG001|Overall Study|Adverse Event|0
2099463|NCT00818207|3689656|FG000|Overall Study|Lost to Follow-up|160
2099464|NCT00818207|3689657|FG001|Overall Study|Lost to Follow-up|146
2099465|NCT00818207|3689656|FG000|Overall Study|Multiple reasons|11
2099466|NCT00818207|3689657|FG001|Overall Study|Multiple reasons|12
2099467|NCT00818207|3689656|FG000|Overall Study|Withdrawal by Subject|42
2099468|NCT00818207|3689657|FG001|Overall Study|Withdrawal by Subject|104
2099469|NCT00818207|3689656|FG000|Overall Study|Death|3
2099470|NCT00818207|3689657|FG001|Overall Study|Death|5
2099471|NCT00818246|3689663|FG000|Overall Study|Impossible to match pictures|5
2099472|NCT00818259|3689674|FG000|Part I|Withdrawal by Subject|1
2099473|NCT00818259|3689675|FG001|Part I|Withdrawal by Subject|0
2099474|NCT00818259|3689676|FG002|Part I|Withdrawal by Subject|0
2099475|NCT00818259|3689677|FG003|Part I|Withdrawal by Subject|0
2099476|NCT00818259|3689678|FG004|Part I|Withdrawal by Subject|0
2099477|NCT00818259|3689679|FG005|Part I|Withdrawal by Subject|0
2099478|NCT00818259|3689680|FG006|Part I|Withdrawal by Subject|0
2099479|NCT00818259|3689681|FG007|Part I|Withdrawal by Subject|0
2099480|NCT00818259|3689682|FG008|Part I|Withdrawal by Subject|0
2099481|NCT00818259|3689674|FG000|Part II|Physician Decision|0
2099482|NCT00818259|3689675|FG001|Part II|Physician Decision|0
2099483|NCT00818259|3689676|FG002|Part II|Physician Decision|1
2099484|NCT00818259|3689677|FG003|Part II|Physician Decision|0
2099485|NCT00818259|3689678|FG004|Part II|Physician Decision|0
2099486|NCT00818259|3689679|FG005|Part II|Physician Decision|0
2099487|NCT00818259|3689680|FG006|Part II|Physician Decision|0
2099488|NCT00818259|3689681|FG007|Part II|Physician Decision|0
2099489|NCT00818259|3689682|FG008|Part II|Physician Decision|0
2099490|NCT00818259|3689674|FG000|Part II|Lack of Efficacy|0
2099491|NCT00818259|3689675|FG001|Part II|Lack of Efficacy|0
2099492|NCT00818259|3689676|FG002|Part II|Lack of Efficacy|0
2099493|NCT00818259|3689677|FG003|Part II|Lack of Efficacy|1
2099494|NCT00818259|3689678|FG004|Part II|Lack of Efficacy|0
2099495|NCT00818259|3689679|FG005|Part II|Lack of Efficacy|0
2099496|NCT00818259|3689680|FG006|Part II|Lack of Efficacy|0
2099497|NCT00818259|3689681|FG007|Part II|Lack of Efficacy|0
2099498|NCT00818259|3689682|FG008|Part II|Lack of Efficacy|0
2099499|NCT00818259|3689674|FG000|Part II|Not Treated|0
2099500|NCT00818259|3689675|FG001|Part II|Not Treated|0
2099501|NCT00818259|3689676|FG002|Part II|Not Treated|0
2099502|NCT00818259|3689677|FG003|Part II|Not Treated|1
2099503|NCT00818259|3689678|FG004|Part II|Not Treated|0
2099504|NCT00818259|3689679|FG005|Part II|Not Treated|0
2099505|NCT00818259|3689680|FG006|Part II|Not Treated|0
2099506|NCT00818259|3689681|FG007|Part II|Not Treated|0
2099507|NCT00818259|3689682|FG008|Part II|Not Treated|0
2099508|NCT00818259|3689674|FG000|Part IV|Physician Decision|0
2099509|NCT00818259|3689675|FG001|Part IV|Physician Decision|0
2099510|NCT00818259|3689676|FG002|Part IV|Physician Decision|0
2099511|NCT00818259|3689677|FG003|Part IV|Physician Decision|0
2099512|NCT00818259|3689678|FG004|Part IV|Physician Decision|0
2099513|NCT00818259|3689679|FG005|Part IV|Physician Decision|1
2099514|NCT00818259|3689680|FG006|Part IV|Physician Decision|0
2099515|NCT00818259|3689681|FG007|Part IV|Physician Decision|0
2099516|NCT00818259|3689682|FG008|Part IV|Physician Decision|0
2099517|NCT00818259|3689674|FG000|Part V|Adverse Event|0
2099518|NCT00818259|3689675|FG001|Part V|Adverse Event|0
2099519|NCT00818259|3689676|FG002|Part V|Adverse Event|0
2099520|NCT00818259|3689677|FG003|Part V|Adverse Event|0
2099521|NCT00818259|3689678|FG004|Part V|Adverse Event|0
2099522|NCT00818259|3689679|FG005|Part V|Adverse Event|0
2099523|NCT00818259|3689680|FG006|Part V|Adverse Event|0
2099524|NCT00818259|3689681|FG007|Part V|Adverse Event|1
2099525|NCT00818259|3689682|FG008|Part V|Adverse Event|0
2099526|NCT00818389|3689722|FG000|Overall Study|Death|1
2099527|NCT00818389|3689723|FG001|Overall Study|Death|3
2099528|NCT00818389|3689722|FG000|Overall Study|ALS Disease Progression|1
2099529|NCT00818389|3689723|FG001|Overall Study|ALS Disease Progression|0
2099530|NCT00818389|3689722|FG000|Overall Study|Withdrawal by Subject|2
2099531|NCT00818389|3689723|FG001|Overall Study|Withdrawal by Subject|2
2099532|NCT00818389|3689722|FG000|Overall Study|Adverse Event|0
2099533|NCT00818389|3689723|FG001|Overall Study|Adverse Event|1
2099534|NCT00818441|3689731|FG000|Overall Study|Death|69
2099535|NCT00818441|3689732|FG001|Overall Study|Death|26
2099536|NCT00818441|3689731|FG000|Overall Study|Other|5
2099537|NCT00818441|3689732|FG001|Overall Study|Other|0
2099538|NCT00818441|3689731|FG000|Overall Study|Lost to Follow-up|2
2099539|NCT00818441|3689732|FG001|Overall Study|Lost to Follow-up|1
2099540|NCT00818441|3689731|FG000|Overall Study|Withdrawal by Subject|2
2099541|NCT00818441|3689732|FG001|Overall Study|Withdrawal by Subject|0
2099542|NCT00818441|3689731|FG000|Overall Study|Adverse Event|0
2099543|NCT00818441|3689732|FG001|Overall Study|Adverse Event|1
2099544|NCT00818441|3689731|FG000|Overall Study|Study terminated by sponsor|11
2099545|NCT00818441|3689732|FG001|Overall Study|Study terminated by sponsor|2
2099546|NCT00818454|3689739|FG000|Treatment Period 1|Adverse Event|0
2099547|NCT00818454|3689740|FG001|Treatment Period 1|Adverse Event|1
2099548|NCT00818454|3689741|FG002|Treatment Period 1|Adverse Event|0
2099549|NCT00818454|3689742|FG003|Treatment Period 1|Adverse Event|0
2099550|NCT00818454|3689739|FG000|Treatment Period 1|Other|3
2099551|NCT00818454|3689740|FG001|Treatment Period 1|Other|0
2099552|NCT00818454|3689741|FG002|Treatment Period 1|Other|0
2099553|NCT00818454|3689742|FG003|Treatment Period 1|Other|0
2099554|NCT00818454|3689739|FG000|Washout Period of 1 Week|Adverse Event|1
2099555|NCT00818454|3689740|FG001|Washout Period of 1 Week|Adverse Event|1
2099556|NCT00818454|3689741|FG002|Washout Period of 1 Week|Adverse Event|0
2099557|NCT00818454|3689742|FG003|Washout Period of 1 Week|Adverse Event|0
2099558|NCT00818454|3689739|FG000|Washout Period of 1 Week|Protocol Violation|2
2099559|NCT00818454|3689740|FG001|Washout Period of 1 Week|Protocol Violation|0
2099560|NCT00818454|3689741|FG002|Washout Period of 1 Week|Protocol Violation|0
2099561|NCT00818454|3689742|FG003|Washout Period of 1 Week|Protocol Violation|0
2099562|NCT00818454|3689739|FG000|Washout Period of 1 Week|Other|1
2099563|NCT00818454|3689740|FG001|Washout Period of 1 Week|Other|2
2099564|NCT00818454|3689741|FG002|Washout Period of 1 Week|Other|0
2099565|NCT00818454|3689742|FG003|Washout Period of 1 Week|Other|0
2099566|NCT00818454|3689739|FG000|Treatment Period 2|Other|2
2099567|NCT00818454|3689740|FG001|Treatment Period 2|Other|1
2099568|NCT00818454|3689741|FG002|Treatment Period 2|Other|0
2099569|NCT00818454|3689742|FG003|Treatment Period 2|Other|0
2099570|NCT00818454|3689739|FG000|Treatment Period 3|Adverse Event|0
2099571|NCT00818454|3689740|FG001|Treatment Period 3|Adverse Event|0
2099572|NCT00818454|3689741|FG002|Treatment Period 3|Adverse Event|0
2099573|NCT00818454|3689742|FG003|Treatment Period 3|Adverse Event|1
2099574|NCT00818519|3689754|FG000|Overall Study|Adverse Event|2
2099575|NCT00818519|3689755|FG001|Overall Study|Adverse Event|2
2099576|NCT00818519|3689754|FG000|Overall Study|Lost to Follow-up|4
2099577|NCT00818519|3689755|FG001|Overall Study|Lost to Follow-up|6
2099578|NCT00818519|3689754|FG000|Overall Study|Protocol Violation|2
2099579|NCT00818519|3689755|FG001|Overall Study|Protocol Violation|1
2099580|NCT00818519|3689754|FG000|Overall Study|Pregnancy|0
2099581|NCT00818519|3689755|FG001|Overall Study|Pregnancy|1
2099582|NCT00818519|3689754|FG000|Overall Study|Withdrawal by Subject|4
2099583|NCT00818519|3689755|FG001|Overall Study|Withdrawal by Subject|9
2099584|NCT00818519|3689754|FG000|Overall Study|participant recovered completely|1
2099585|NCT00818519|3689755|FG001|Overall Study|participant recovered completely|0
2099586|NCT00818519|3689754|FG000|Overall Study|participant will leave for long tme|1
2099587|NCT00818519|3689755|FG001|Overall Study|participant will leave for long tme|0
2099588|NCT00818623|3689769|FG000|Overall Study|Adverse Event|1
2099589|NCT00818623|3689770|FG001|Overall Study|Adverse Event|0
2099590|NCT00818623|3689771|FG002|Overall Study|Adverse Event|1
2099591|NCT00818623|3689772|FG003|Overall Study|Adverse Event|0
2099592|NCT00818623|3689773|FG004|Overall Study|Adverse Event|0
2099593|NCT00818623|3689774|FG005|Overall Study|Adverse Event|1
2099594|NCT00818623|3689775|FG006|Overall Study|Adverse Event|0
2099595|NCT00818623|3689776|FG007|Overall Study|Adverse Event|0
2099596|NCT00818623|3689769|FG000|Overall Study|Bad prostate specific antigen response|0
2099597|NCT00818623|3689770|FG001|Overall Study|Bad prostate specific antigen response|3
2099598|NCT00818623|3689771|FG002|Overall Study|Bad prostate specific antigen response|2
2099599|NCT00818623|3689772|FG003|Overall Study|Bad prostate specific antigen response|5
2099600|NCT00818623|3689773|FG004|Overall Study|Bad prostate specific antigen response|0
2099601|NCT00818623|3689774|FG005|Overall Study|Bad prostate specific antigen response|1
2099602|NCT00818623|3689775|FG006|Overall Study|Bad prostate specific antigen response|0
2099603|NCT00818623|3689776|FG007|Overall Study|Bad prostate specific antigen response|0
2099604|NCT00818623|3689769|FG000|Overall Study|Withdrawal by Subject|0
2099605|NCT00818623|3689770|FG001|Overall Study|Withdrawal by Subject|1
2099606|NCT00818623|3689771|FG002|Overall Study|Withdrawal by Subject|1
2099607|NCT00818623|3689772|FG003|Overall Study|Withdrawal by Subject|0
2099608|NCT00818623|3689773|FG004|Overall Study|Withdrawal by Subject|0
2099609|NCT00818623|3689774|FG005|Overall Study|Withdrawal by Subject|1
2099610|NCT00818623|3689775|FG006|Overall Study|Withdrawal by Subject|1
2099611|NCT00818623|3689776|FG007|Overall Study|Withdrawal by Subject|1
2099612|NCT00818623|3689769|FG000|Overall Study|Protocol Violation|1
2099613|NCT00818623|3689770|FG001|Overall Study|Protocol Violation|0
2099614|NCT00818623|3689771|FG002|Overall Study|Protocol Violation|0
2099615|NCT00818623|3689772|FG003|Overall Study|Protocol Violation|0
2099616|NCT00818623|3689773|FG004|Overall Study|Protocol Violation|1
2099617|NCT00818623|3689774|FG005|Overall Study|Protocol Violation|0
2099618|NCT00818623|3689775|FG006|Overall Study|Protocol Violation|1
2099619|NCT00818623|3689776|FG007|Overall Study|Protocol Violation|0
2099620|NCT00818623|3689769|FG000|Overall Study|Need of additional treatment|0
2099621|NCT00818623|3689770|FG001|Overall Study|Need of additional treatment|0
2099622|NCT00818623|3689771|FG002|Overall Study|Need of additional treatment|0
2099623|NCT00818623|3689772|FG003|Overall Study|Need of additional treatment|0
2099624|NCT00818623|3689773|FG004|Overall Study|Need of additional treatment|1
2099625|NCT00818623|3689774|FG005|Overall Study|Need of additional treatment|0
2099626|NCT00818623|3689775|FG006|Overall Study|Need of additional treatment|0
2099627|NCT00818623|3689776|FG007|Overall Study|Need of additional treatment|0
2099628|NCT00818623|3689769|FG000|Overall Study|Lack of trial drug at site|0
2099629|NCT00818623|3689770|FG001|Overall Study|Lack of trial drug at site|0
2099630|NCT00818623|3689771|FG002|Overall Study|Lack of trial drug at site|0
2099631|NCT00818623|3689772|FG003|Overall Study|Lack of trial drug at site|0
2099632|NCT00818623|3689773|FG004|Overall Study|Lack of trial drug at site|2
2099633|NCT00818623|3689774|FG005|Overall Study|Lack of trial drug at site|0
2099634|NCT00818623|3689775|FG006|Overall Study|Lack of trial drug at site|1
2099635|NCT00818623|3689776|FG007|Overall Study|Lack of trial drug at site|0
2099636|NCT00818623|3689769|FG000|Overall Study|Disease progression|0
2099637|NCT00818623|3689770|FG001|Overall Study|Disease progression|0
2099638|NCT00818623|3689771|FG002|Overall Study|Disease progression|0
2099639|NCT00818623|3689772|FG003|Overall Study|Disease progression|0
2099640|NCT00818623|3689773|FG004|Overall Study|Disease progression|0
2099641|NCT00818623|3689774|FG005|Overall Study|Disease progression|0
2099642|NCT00818623|3689775|FG006|Overall Study|Disease progression|1
2099643|NCT00818623|3689776|FG007|Overall Study|Disease progression|0
2099644|NCT00818649|3689794|FG000|Overall Study|Declining performance status|2
2099645|NCT00818649|3689794|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1
2099646|NCT00818649|3689794|FG000|Overall Study|Adverse Event|1
2099647|NCT00818662|3689803|FG000|Overall Study|Adverse Event|5
2099648|NCT00818662|3689804|FG001|Overall Study|Adverse Event|14
2099649|NCT00818662|3689805|FG002|Overall Study|Adverse Event|4
2099650|NCT00818662|3689806|FG003|Overall Study|Adverse Event|3
2099651|NCT00818662|3689803|FG000|Overall Study|Withdrawal by Subject|5
2099652|NCT00818662|3689804|FG001|Overall Study|Withdrawal by Subject|4
2099653|NCT00818662|3689805|FG002|Overall Study|Withdrawal by Subject|2
2099654|NCT00818662|3689806|FG003|Overall Study|Withdrawal by Subject|2
2099655|NCT00818662|3689803|FG000|Overall Study|Death|1
2099656|NCT00818662|3689804|FG001|Overall Study|Death|3
2099657|NCT00818662|3689805|FG002|Overall Study|Death|0
2099658|NCT00818662|3689806|FG003|Overall Study|Death|0
2099659|NCT00818662|3689803|FG000|Overall Study|Physician Decision|1
2099660|NCT00818662|3689804|FG001|Overall Study|Physician Decision|0
2099661|NCT00818662|3689805|FG002|Overall Study|Physician Decision|0
2099662|NCT00818662|3689806|FG003|Overall Study|Physician Decision|0
2099663|NCT00818662|3689803|FG000|Overall Study|Lost to Follow-up|0
2099664|NCT00818662|3689804|FG001|Overall Study|Lost to Follow-up|0
2099665|NCT00818662|3689805|FG002|Overall Study|Lost to Follow-up|0
2099666|NCT00818662|3689806|FG003|Overall Study|Lost to Follow-up|1
2099667|NCT00818662|3689803|FG000|Overall Study|Unwilling or Unable to Participate|4
2099668|NCT00818662|3689804|FG001|Overall Study|Unwilling or Unable to Participate|6
2099669|NCT00818662|3689805|FG002|Overall Study|Unwilling or Unable to Participate|2
2099670|NCT00818662|3689806|FG003|Overall Study|Unwilling or Unable to Participate|4
2099671|NCT00818662|3689803|FG000|Overall Study|Protocol Violation|1
2099672|NCT00818662|3689804|FG001|Overall Study|Protocol Violation|1
2099673|NCT00818662|3689805|FG002|Overall Study|Protocol Violation|0
2099674|NCT00818662|3689806|FG003|Overall Study|Protocol Violation|0
2099675|NCT00818662|3689803|FG000|Overall Study|Requires a Prohibited Medication|1
2099676|NCT00818662|3689804|FG001|Overall Study|Requires a Prohibited Medication|0
2099677|NCT00818662|3689805|FG002|Overall Study|Requires a Prohibited Medication|0
2099678|NCT00818662|3689806|FG003|Overall Study|Requires a Prohibited Medication|0
2099679|NCT00818662|3689803|FG000|Overall Study|Safety Risk|1
2099680|NCT00818662|3689804|FG001|Overall Study|Safety Risk|1
2099681|NCT00818662|3689805|FG002|Overall Study|Safety Risk|0
2099682|NCT00818662|3689806|FG003|Overall Study|Safety Risk|1
2099683|NCT00818662|3689803|FG000|Overall Study|Study Partner Unwilling or Unable|3
2099684|NCT00818662|3689804|FG001|Overall Study|Study Partner Unwilling or Unable|2
2099685|NCT00818662|3689805|FG002|Overall Study|Study Partner Unwilling or Unable|1
2099686|NCT00818662|3689806|FG003|Overall Study|Study Partner Unwilling or Unable|1
2099687|NCT00818662|3689803|FG000|Overall Study|Participant's health declined|0
2099688|NCT00818662|3689804|FG001|Overall Study|Participant's health declined|0
2099689|NCT00818662|3689805|FG002|Overall Study|Participant's health declined|0
2099690|NCT00818662|3689806|FG003|Overall Study|Participant's health declined|1
2099691|NCT00818662|3689803|FG000|Overall Study|Caregiver to pursue other treatment|0
2099692|NCT00818662|3689804|FG001|Overall Study|Caregiver to pursue other treatment|1
2099693|NCT00818662|3689805|FG002|Overall Study|Caregiver to pursue other treatment|0
2099694|NCT00818662|3689806|FG003|Overall Study|Caregiver to pursue other treatment|0
2099695|NCT00818662|3689803|FG000|Overall Study|Moving out of state|0
2099696|NCT00818662|3689804|FG001|Overall Study|Moving out of state|0
2099697|NCT00818662|3689805|FG002|Overall Study|Moving out of state|0
2099698|NCT00818662|3689806|FG003|Overall Study|Moving out of state|1
2099699|NCT00818662|3689803|FG000|Overall Study|Declined move to another study site|1
2099700|NCT00818662|3689804|FG001|Overall Study|Declined move to another study site|0
2099701|NCT00818662|3689805|FG002|Overall Study|Declined move to another study site|0
2099702|NCT00818662|3689806|FG003|Overall Study|Declined move to another study site|0
2099703|NCT00818662|3689803|FG000|Overall Study|Change in living situation|0
2099704|NCT00818662|3689804|FG001|Overall Study|Change in living situation|0
2099705|NCT00818662|3689805|FG002|Overall Study|Change in living situation|0
2099706|NCT00818662|3689806|FG003|Overall Study|Change in living situation|1
2099707|NCT00818662|3689803|FG000|Overall Study|Study partner decision|0
2099708|NCT00818662|3689804|FG001|Overall Study|Study partner decision|0
2099709|NCT00818662|3689805|FG002|Overall Study|Study partner decision|0
2099710|NCT00818662|3689806|FG003|Overall Study|Study partner decision|1
2099711|NCT00818662|3689803|FG000|Overall Study|Admitted to long term nursing care|0
2099712|NCT00818662|3689804|FG001|Overall Study|Admitted to long term nursing care|1
2099713|NCT00818662|3689805|FG002|Overall Study|Admitted to long term nursing care|0
2099714|NCT00818662|3689806|FG003|Overall Study|Admitted to long term nursing care|0
2099715|NCT00818753|3689820|FG000|Overall Study|Protocol Violation|1
2099716|NCT00818753|3689821|FG001|Overall Study|Protocol Violation|0
2099717|NCT00818753|3689822|FG002|Overall Study|Protocol Violation|0
2099718|NCT00818753|3689820|FG000|Overall Study|Other reason (not specified)|0
2099719|NCT00818753|3689821|FG001|Overall Study|Other reason (not specified)|0
2099720|NCT00818753|3689822|FG002|Overall Study|Other reason (not specified)|1
2099721|NCT00818753|3689820|FG000|Overall Study|Randomised and not treated|2
2099722|NCT00818753|3689821|FG001|Overall Study|Randomised and not treated|0
2099723|NCT00818753|3689822|FG002|Overall Study|Randomised and not treated|0
2099724|NCT00818766|3689832|FG000|Overall Study|Could not be Contacted on Day 28|11
2099725|NCT00818766|3689833|FG001|Overall Study|Could not be Contacted on Day 28|10
2099726|NCT00818766|3689832|FG000|Overall Study|Death|1
2099727|NCT00818766|3689833|FG001|Overall Study|Death|0
2099728|NCT00818766|3689832|FG000|Overall Study|Did not Receive Allocated Intervention|3
2099729|NCT00818766|3689833|FG001|Overall Study|Did not Receive Allocated Intervention|0
2099730|NCT00818779|3689841|FG000|Overall Study|Protocol Violation|1
2099731|NCT00818779|3689842|FG001|Overall Study|Protocol Violation|0
2099732|NCT00818779|3689841|FG000|Overall Study|Lost to Follow-up|1
2099733|NCT00818779|3689842|FG001|Overall Study|Lost to Follow-up|0
2099734|NCT00818779|3689841|FG000|Overall Study|Adverse Event|4
2099735|NCT00818779|3689842|FG001|Overall Study|Adverse Event|1
2099736|NCT00818883|3689861|FG000|Overall Study|Adverse Event|28
2099737|NCT00818883|3689862|FG001|Overall Study|Adverse Event|19
2099738|NCT00818883|3689861|FG000|Overall Study|Protocol Violation|2
2099739|NCT00818883|3689862|FG001|Overall Study|Protocol Violation|2
2099740|NCT00818883|3689861|FG000|Overall Study|Lost to Follow-up|3
2099741|NCT00818883|3689862|FG001|Overall Study|Lost to Follow-up|2
2177355|NCT01372410|3801372|FG000|Treatment Period 3 (7 Days)|Adverse Event|0
2099742|NCT00818883|3689861|FG000|Overall Study|Withdrawal by Subject|16
2099743|NCT00818883|3689862|FG001|Overall Study|Withdrawal by Subject|14
2099744|NCT00818883|3689861|FG000|Overall Study|Lack of Efficacy|0
2099745|NCT00818883|3689862|FG001|Overall Study|Lack of Efficacy|2
2099746|NCT00818883|3689861|FG000|Overall Study|Other|2
2099747|NCT00818883|3689862|FG001|Overall Study|Other|7
2099748|NCT00819013|3689876|FG000|Overall Study|Not meeting continuing study eligibility|2
2099749|NCT00819013|3689877|FG001|Overall Study|Not meeting continuing study eligibility|1
2099750|NCT00819013|3689878|FG002|Overall Study|Not meeting continuing study eligibility|2
2099751|NCT00819013|3689879|FG003|Overall Study|Not meeting continuing study eligibility|1
2099752|NCT00819013|3689876|FG000|Overall Study|Adverse Event|0
2099753|NCT00819013|3689877|FG001|Overall Study|Adverse Event|0
2099754|NCT00819013|3689878|FG002|Overall Study|Adverse Event|1
2099755|NCT00819013|3689879|FG003|Overall Study|Adverse Event|0
2099756|NCT00819013|3689876|FG000|Overall Study|Withdrawal by Subject|1
2099757|NCT00819013|3689877|FG001|Overall Study|Withdrawal by Subject|0
2099758|NCT00819013|3689878|FG002|Overall Study|Withdrawal by Subject|1
2099759|NCT00819013|3689879|FG003|Overall Study|Withdrawal by Subject|0
2099760|NCT00819013|3689876|FG000|Overall Study|Lost to Follow-up|0
2099761|NCT00819013|3689877|FG001|Overall Study|Lost to Follow-up|0
2099762|NCT00819013|3689878|FG002|Overall Study|Lost to Follow-up|1
2099763|NCT00819013|3689879|FG003|Overall Study|Lost to Follow-up|2
2099764|NCT00819013|3689876|FG000|Overall Study|Death|0
2099765|NCT00819013|3689877|FG001|Overall Study|Death|0
2099766|NCT00819013|3689878|FG002|Overall Study|Death|0
2099767|NCT00819013|3689879|FG003|Overall Study|Death|1
2099768|NCT00819039|3689892|FG000|Overall Study|Physician Decision|1
2099769|NCT00819039|3689893|FG001|Overall Study|Physician Decision|0
2099770|NCT00819039|3689894|FG002|Overall Study|Physician Decision|1
2099771|NCT00819039|3689892|FG000|Overall Study|Protocol Violation|1
2099772|NCT00819039|3689893|FG001|Overall Study|Protocol Violation|0
2099773|NCT00819039|3689894|FG002|Overall Study|Protocol Violation|0
2099774|NCT00819052|3689906|FG000|Overall Study|Adverse Event|0
2099775|NCT00819052|3689907|FG001|Overall Study|Adverse Event|5
2099776|NCT00819052|3689906|FG000|Overall Study|Protocol Violation|1
2099777|NCT00819052|3689907|FG001|Overall Study|Protocol Violation|2
2099778|NCT00819052|3689906|FG000|Overall Study|Lost to Follow-up|1
2099779|NCT00819052|3689907|FG001|Overall Study|Lost to Follow-up|2
2099780|NCT00819052|3689906|FG000|Overall Study|Withdrawal by Subject|1
2099781|NCT00819052|3689907|FG001|Overall Study|Withdrawal by Subject|2
2099782|NCT00819052|3689906|FG000|Overall Study|Lack of Efficacy|1
2099783|NCT00819052|3689907|FG001|Overall Study|Lack of Efficacy|1
2099784|NCT00819052|3689906|FG000|Overall Study|Pregnancy|1
2099785|NCT00819052|3689907|FG001|Overall Study|Pregnancy|2
2099786|NCT00819052|3689906|FG000|Overall Study|Death or events leading to death|1
2099787|NCT00819052|3689907|FG001|Overall Study|Death or events leading to death|0
2099788|NCT00819091|3689918|FG000|Overall Study|Adverse Event|3
2099789|NCT00819091|3689919|FG001|Overall Study|Adverse Event|5
2099790|NCT00819091|3689918|FG000|Overall Study|Protocol Violation|0
2099791|NCT00819091|3689919|FG001|Overall Study|Protocol Violation|1
2099792|NCT00819091|3689918|FG000|Overall Study|Lost to Follow-up|2
2099793|NCT00819091|3689919|FG001|Overall Study|Lost to Follow-up|0
2099794|NCT00819091|3689918|FG000|Overall Study|Withdrawal by Subject|1
2099795|NCT00819091|3689919|FG001|Overall Study|Withdrawal by Subject|2
2099796|NCT00819091|3689918|FG000|Overall Study|Other|1
2099797|NCT00819091|3689919|FG001|Overall Study|Other|2
2099798|NCT00819156|3689931|FG000|Overall Study|Adverse Event|1
2099799|NCT00819156|3689932|FG001|Overall Study|Adverse Event|4
2099800|NCT00819156|3689933|FG002|Overall Study|Adverse Event|2
2099801|NCT00819156|3689934|FG003|Overall Study|Adverse Event|1
2099802|NCT00819156|3689935|FG004|Overall Study|Adverse Event|2
2099803|NCT00819156|3689936|FG005|Overall Study|Adverse Event|3
2099804|NCT00819156|3689931|FG000|Overall Study|Withdrawal by Subject|0
2099805|NCT00819156|3689932|FG001|Overall Study|Withdrawal by Subject|3
2099806|NCT00819156|3689933|FG002|Overall Study|Withdrawal by Subject|2
2099807|NCT00819156|3689934|FG003|Overall Study|Withdrawal by Subject|0
2099808|NCT00819156|3689935|FG004|Overall Study|Withdrawal by Subject|1
2099809|NCT00819156|3689936|FG005|Overall Study|Withdrawal by Subject|0
2099810|NCT00819156|3689931|FG000|Overall Study|Protocol Violation|1
2099811|NCT00819156|3689932|FG001|Overall Study|Protocol Violation|0
2099812|NCT00819156|3689933|FG002|Overall Study|Protocol Violation|1
2099813|NCT00819156|3689934|FG003|Overall Study|Protocol Violation|0
2099814|NCT00819156|3689935|FG004|Overall Study|Protocol Violation|0
2099815|NCT00819156|3689936|FG005|Overall Study|Protocol Violation|1
2099816|NCT00819156|3689931|FG000|Overall Study|Lost to Follow-up|0
2099817|NCT00819156|3689932|FG001|Overall Study|Lost to Follow-up|1
2099818|NCT00819156|3689933|FG002|Overall Study|Lost to Follow-up|0
2099819|NCT00819156|3689934|FG003|Overall Study|Lost to Follow-up|0
2099820|NCT00819156|3689935|FG004|Overall Study|Lost to Follow-up|0
2099821|NCT00819156|3689936|FG005|Overall Study|Lost to Follow-up|2
2099822|NCT00819156|3689931|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5
2099823|NCT00819156|3689932|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2
2099824|NCT00819156|3689933|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1
2099825|NCT00819156|3689934|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1
2099826|NCT00819156|3689935|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1
2099827|NCT00819156|3689936|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2
2099828|NCT00819156|3689931|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3
2099829|NCT00819156|3689932|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0
2099830|NCT00819156|3689933|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0
2099831|NCT00819156|3689934|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0
2099832|NCT00819156|3689935|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1
2099833|NCT00819156|3689936|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0
2099834|NCT00819156|3689931|FG000|Overall Study|Prostate-specific antigen progression|0
2099835|NCT00819156|3689932|FG001|Overall Study|Prostate-specific antigen progression|0
2099836|NCT00819156|3689933|FG002|Overall Study|Prostate-specific antigen progression|0
2099837|NCT00819156|3689934|FG003|Overall Study|Prostate-specific antigen progression|0
2099838|NCT00819156|3689935|FG004|Overall Study|Prostate-specific antigen progression|1
2099839|NCT00819156|3689936|FG005|Overall Study|Prostate-specific antigen progression|0
2099840|NCT00819234|3689971|FG000|Overall Study|Withdrawal by Subject|8
2099841|NCT00819234|3689972|FG001|Overall Study|Withdrawal by Subject|13
2099842|NCT00819234|3689973|FG002|Overall Study|Withdrawal by Subject|6
2099843|NCT00819234|3689974|FG003|Overall Study|Withdrawal by Subject|3
2099844|NCT00819234|3689975|FG004|Overall Study|Withdrawal by Subject|0
2099845|NCT00819234|3689976|FG005|Overall Study|Withdrawal by Subject|4
2099846|NCT00819234|3689977|FG006|Overall Study|Withdrawal by Subject|4
2099847|NCT00819234|3689978|FG007|Overall Study|Withdrawal by Subject|8
2099848|NCT00819234|3689979|FG008|Overall Study|Withdrawal by Subject|5
2099849|NCT00819234|3689980|FG009|Overall Study|Withdrawal by Subject|3
2099850|NCT00819234|3689971|FG000|Overall Study|Adverse Event|0
2099851|NCT00819234|3689972|FG001|Overall Study|Adverse Event|0
2099852|NCT00819234|3689973|FG002|Overall Study|Adverse Event|1
2099853|NCT00819234|3689974|FG003|Overall Study|Adverse Event|0
2099854|NCT00819234|3689975|FG004|Overall Study|Adverse Event|0
2099855|NCT00819234|3689976|FG005|Overall Study|Adverse Event|2
2099856|NCT00819234|3689977|FG006|Overall Study|Adverse Event|0
2099857|NCT00819234|3689978|FG007|Overall Study|Adverse Event|0
2099858|NCT00819234|3689979|FG008|Overall Study|Adverse Event|0
2099859|NCT00819234|3689980|FG009|Overall Study|Adverse Event|0
2099860|NCT00819234|3689971|FG000|Overall Study|Physician Decision|0
2099861|NCT00819234|3689972|FG001|Overall Study|Physician Decision|0
2099862|NCT00819234|3689973|FG002|Overall Study|Physician Decision|0
2099863|NCT00819234|3689974|FG003|Overall Study|Physician Decision|1
2099864|NCT00819234|3689975|FG004|Overall Study|Physician Decision|0
2099865|NCT00819234|3689976|FG005|Overall Study|Physician Decision|0
2099866|NCT00819234|3689977|FG006|Overall Study|Physician Decision|0
2099867|NCT00819234|3689978|FG007|Overall Study|Physician Decision|0
2099868|NCT00819234|3689979|FG008|Overall Study|Physician Decision|0
2099869|NCT00819234|3689980|FG009|Overall Study|Physician Decision|2
2099870|NCT00819234|3689971|FG000|Overall Study|Protocol Violation|0
2099871|NCT00819234|3689972|FG001|Overall Study|Protocol Violation|0
2099872|NCT00819234|3689973|FG002|Overall Study|Protocol Violation|1
2099873|NCT00819234|3689974|FG003|Overall Study|Protocol Violation|0
2099874|NCT00819234|3689975|FG004|Overall Study|Protocol Violation|0
2099875|NCT00819234|3689976|FG005|Overall Study|Protocol Violation|0
2099876|NCT00819234|3689977|FG006|Overall Study|Protocol Violation|0
2099877|NCT00819234|3689978|FG007|Overall Study|Protocol Violation|0
2099878|NCT00819234|3689979|FG008|Overall Study|Protocol Violation|0
2099879|NCT00819234|3689980|FG009|Overall Study|Protocol Violation|0
2099880|NCT00819234|3689971|FG000|Overall Study|Lost to Follow-up|2
2099881|NCT00819234|3689972|FG001|Overall Study|Lost to Follow-up|2
2099882|NCT00819234|3689973|FG002|Overall Study|Lost to Follow-up|0
2099883|NCT00819234|3689974|FG003|Overall Study|Lost to Follow-up|2
2099884|NCT00819234|3689975|FG004|Overall Study|Lost to Follow-up|1
2099885|NCT00819234|3689976|FG005|Overall Study|Lost to Follow-up|1
2099886|NCT00819234|3689977|FG006|Overall Study|Lost to Follow-up|1
2099887|NCT00819234|3689978|FG007|Overall Study|Lost to Follow-up|1
2099888|NCT00819234|3689979|FG008|Overall Study|Lost to Follow-up|1
2099889|NCT00819234|3689980|FG009|Overall Study|Lost to Follow-up|2
2099890|NCT00819247|3690038|FG000|Overall Study|Adverse Event|0
2099891|NCT00819247|3690039|FG001|Overall Study|Adverse Event|5
2099892|NCT00819247|3690040|FG002|Overall Study|Adverse Event|3
2099893|NCT00819247|3690038|FG000|Overall Study|Insufficient testosterone response|5
2099894|NCT00819247|3690039|FG001|Overall Study|Insufficient testosterone response|8
2099895|NCT00819247|3690040|FG002|Overall Study|Insufficient testosterone response|10
2099896|NCT00819247|3690038|FG000|Overall Study|Withdrawal by Subject|1
2099897|NCT00819247|3690039|FG001|Overall Study|Withdrawal by Subject|0
2099898|NCT00819247|3690040|FG002|Overall Study|Withdrawal by Subject|0
2099899|NCT00819247|3690038|FG000|Overall Study|Protocol Violation|1
2099900|NCT00819247|3690039|FG001|Overall Study|Protocol Violation|0
2099901|NCT00819247|3690040|FG002|Overall Study|Protocol Violation|1
2099902|NCT00819247|3690038|FG000|Overall Study|Mistakenly withdrawn|0
2099903|NCT00819247|3690039|FG001|Overall Study|Mistakenly withdrawn|1
2099904|NCT00819247|3690040|FG002|Overall Study|Mistakenly withdrawn|0
2099905|NCT00819247|3690038|FG000|Overall Study|Bad prostate-specific antigen response|3
2099906|NCT00819247|3690039|FG001|Overall Study|Bad prostate-specific antigen response|2
2099907|NCT00819247|3690040|FG002|Overall Study|Bad prostate-specific antigen response|0
2099908|NCT00819247|3690038|FG000|Overall Study|Other|1
2099909|NCT00819247|3690039|FG001|Overall Study|Other|0
2099910|NCT00819247|3690040|FG002|Overall Study|Other|0
2099911|NCT00819390|3690067|FG000|Overall Study|Lost to Follow-up|1
2099912|NCT00819390|3690068|FG001|Overall Study|Lost to Follow-up|1
2099913|NCT00819390|3690069|FG002|Overall Study|Lost to Follow-up|0
2099914|NCT00819390|3690070|FG003|Overall Study|Lost to Follow-up|0
2099915|NCT00819390|3690067|FG000|Overall Study|Withdrawal by Subject|2
2099916|NCT00819390|3690068|FG001|Overall Study|Withdrawal by Subject|0
2099917|NCT00819390|3690069|FG002|Overall Study|Withdrawal by Subject|0
2099918|NCT00819390|3690070|FG003|Overall Study|Withdrawal by Subject|0
2099919|NCT00819390|3690067|FG000|Overall Study|Adverse Event|0
2099920|NCT00819390|3690068|FG001|Overall Study|Adverse Event|0
2099921|NCT00819390|3690069|FG002|Overall Study|Adverse Event|1
2099922|NCT00819390|3690070|FG003|Overall Study|Adverse Event|0
2099923|NCT00819585|3690104|FG000|Core Study|Adverse Event|2
2099924|NCT00819585|3690105|FG001|Core Study|Adverse Event|1
2099925|NCT00819585|3690106|FG002|Core Study|Adverse Event|1
2099926|NCT00819585|3690107|FG003|Core Study|Adverse Event|4
2099927|NCT00819585|3690108|FG004|Core Study|Adverse Event|1
2099928|NCT00819585|3690109|FG005|Core Study|Adverse Event|0
2099929|NCT00819585|3690110|FG006|Core Study|Adverse Event|2
2099930|NCT00819585|3690111|FG007|Core Study|Adverse Event|0
2099931|NCT00819585|3690112|FG008|Core Study|Adverse Event|0
2099932|NCT00819585|3690113|FG009|Core Study|Adverse Event|0
2099933|NCT00819585|3690114|FG010|Core Study|Adverse Event|0
2099934|NCT00819585|3690104|FG000|Core Study|Abnormal Laboratory Value(s)|2
2099935|NCT00819585|3690105|FG001|Core Study|Abnormal Laboratory Value(s)|0
2099936|NCT00819585|3690106|FG002|Core Study|Abnormal Laboratory Value(s)|0
2212203|NCT01668004|3853190|FG000|Overall Study|Lost to Follow-up|5
2212204|NCT01668004|3853190|FG000|Overall Study|Lack of Efficacy|9
2212205|NCT01668004|3853190|FG000|Overall Study|Non-compliance with treatment|2
2212206|NCT01668173|3853238|FG000|Overall Study|Adverse Event|3
2212207|NCT01668173|3853238|FG000|Overall Study|Trial suspension|4
2212208|NCT01668355|3853244|FG000|Overall Study|Death|3
2212209|NCT01668355|3853245|FG001|Overall Study|Death|1
2212210|NCT01668355|3853244|FG000|Overall Study|Withdrawal by Subject|6
2212211|NCT01668355|3853245|FG001|Overall Study|Withdrawal by Subject|1
2212212|NCT01668537|3853254|FG000|Overall Study|Request to Discontinue Prematurely|1
2212213|NCT01668537|3853255|FG001|Overall Study|Request to Discontinue Prematurely|1
2212214|NCT01668537|3853254|FG000|Overall Study|Subject unwilling/unable to comply|5
2212215|NCT01668537|3853255|FG001|Overall Study|Subject unwilling/unable to comply|0
2212216|NCT01668537|3853254|FG000|Overall Study|Reason Precludes Participation|1
2212217|NCT01668537|3853255|FG001|Overall Study|Reason Precludes Participation|0
2212218|NCT01668537|3853254|FG000|Overall Study|Lost to Follow-up|13
2212219|NCT01668537|3853255|FG001|Overall Study|Lost to Follow-up|6
2212220|NCT01668537|3853254|FG000|Overall Study|Other|2
2212221|NCT01668537|3853255|FG001|Overall Study|Other|3
2212222|NCT01668589|3853265|FG000|Overall Study|Lost to Follow-up|29
2212223|NCT01668589|3853266|FG001|Overall Study|Lost to Follow-up|37
2212224|NCT01668589|3853267|FG002|Overall Study|Lost to Follow-up|15
2099937|NCT00819585|3690107|FG003|Core Study|Abnormal Laboratory Value(s)|0
2099938|NCT00819585|3690108|FG004|Core Study|Abnormal Laboratory Value(s)|0
2099939|NCT00819585|3690109|FG005|Core Study|Abnormal Laboratory Value(s)|0
2099940|NCT00819585|3690110|FG006|Core Study|Abnormal Laboratory Value(s)|0
2099941|NCT00819585|3690111|FG007|Core Study|Abnormal Laboratory Value(s)|0
2099942|NCT00819585|3690112|FG008|Core Study|Abnormal Laboratory Value(s)|0
2099943|NCT00819585|3690113|FG009|Core Study|Abnormal Laboratory Value(s)|0
2099944|NCT00819585|3690114|FG010|Core Study|Abnormal Laboratory Value(s)|0
2099945|NCT00819585|3690104|FG000|Core Study|Unsatisfactory Therapeutic Effect|0
2099946|NCT00819585|3690105|FG001|Core Study|Unsatisfactory Therapeutic Effect|1
2099947|NCT00819585|3690106|FG002|Core Study|Unsatisfactory Therapeutic Effect|0
2099948|NCT00819585|3690107|FG003|Core Study|Unsatisfactory Therapeutic Effect|0
2099949|NCT00819585|3690108|FG004|Core Study|Unsatisfactory Therapeutic Effect|0
2212225|NCT01668589|3853268|FG003|Overall Study|Lost to Follow-up|5
2212226|NCT01668589|3853265|FG000|Overall Study|Full Consent/Agreement Withdrawn|54
2212227|NCT01668589|3853266|FG001|Overall Study|Full Consent/Agreement Withdrawn|8
2212228|NCT01668589|3853267|FG002|Overall Study|Full Consent/Agreement Withdrawn|11
2212229|NCT01668589|3853268|FG003|Overall Study|Full Consent/Agreement Withdrawn|4
2212230|NCT01668589|3853265|FG000|Overall Study|Death|12
2212231|NCT01668589|3853266|FG001|Overall Study|Death|3
2212232|NCT01668589|3853267|FG002|Overall Study|Death|2
2212233|NCT01668589|3853268|FG003|Overall Study|Death|11
2212234|NCT01668589|3853265|FG000|Overall Study|Other|44
2212235|NCT01668589|3853266|FG001|Overall Study|Other|10
2212236|NCT01668589|3853267|FG002|Overall Study|Other|7
2212237|NCT01668589|3853268|FG003|Overall Study|Other|15
2212238|NCT01668654|3853306|FG000|Overall Study|Study Closed/Terminated|3
2099950|NCT00819585|3690109|FG005|Core Study|Unsatisfactory Therapeutic Effect|0
2099951|NCT00819585|3690110|FG006|Core Study|Unsatisfactory Therapeutic Effect|1
2099952|NCT00819585|3690111|FG007|Core Study|Unsatisfactory Therapeutic Effect|0
2099953|NCT00819585|3690112|FG008|Core Study|Unsatisfactory Therapeutic Effect|0
2099954|NCT00819585|3690113|FG009|Core Study|Unsatisfactory Therapeutic Effect|0
2099955|NCT00819585|3690114|FG010|Core Study|Unsatisfactory Therapeutic Effect|0
2099956|NCT00819585|3690104|FG000|Core Study|Subject No Longer Requires Study Drug|0
2099957|NCT00819585|3690105|FG001|Core Study|Subject No Longer Requires Study Drug|0
2099958|NCT00819585|3690106|FG002|Core Study|Subject No Longer Requires Study Drug|0
2099959|NCT00819585|3690107|FG003|Core Study|Subject No Longer Requires Study Drug|0
2099960|NCT00819585|3690108|FG004|Core Study|Subject No Longer Requires Study Drug|1
2099961|NCT00819585|3690109|FG005|Core Study|Subject No Longer Requires Study Drug|0
2099962|NCT00819585|3690110|FG006|Core Study|Subject No Longer Requires Study Drug|0
2099963|NCT00819585|3690111|FG007|Core Study|Subject No Longer Requires Study Drug|0
2099964|NCT00819585|3690112|FG008|Core Study|Subject No Longer Requires Study Drug|0
2099965|NCT00819585|3690113|FG009|Core Study|Subject No Longer Requires Study Drug|0
2099966|NCT00819585|3690114|FG010|Core Study|Subject No Longer Requires Study Drug|0
2099967|NCT00819585|3690104|FG000|Core Study|Subject Withdrew Consent|0
2099968|NCT00819585|3690105|FG001|Core Study|Subject Withdrew Consent|3
2099969|NCT00819585|3690106|FG002|Core Study|Subject Withdrew Consent|2
2099970|NCT00819585|3690107|FG003|Core Study|Subject Withdrew Consent|1
2099971|NCT00819585|3690108|FG004|Core Study|Subject Withdrew Consent|0
2099972|NCT00819585|3690109|FG005|Core Study|Subject Withdrew Consent|0
2099973|NCT00819585|3690110|FG006|Core Study|Subject Withdrew Consent|3
2099974|NCT00819585|3690111|FG007|Core Study|Subject Withdrew Consent|0
2099975|NCT00819585|3690112|FG008|Core Study|Subject Withdrew Consent|0
2099976|NCT00819585|3690113|FG009|Core Study|Subject Withdrew Consent|0
2099977|NCT00819585|3690114|FG010|Core Study|Subject Withdrew Consent|0
2099978|NCT00819585|3690104|FG000|Core Study|Lost to Follow-up|2
2099979|NCT00819585|3690105|FG001|Core Study|Lost to Follow-up|1
2099980|NCT00819585|3690106|FG002|Core Study|Lost to Follow-up|2
2099981|NCT00819585|3690107|FG003|Core Study|Lost to Follow-up|0
2099982|NCT00819585|3690108|FG004|Core Study|Lost to Follow-up|1
2099983|NCT00819585|3690109|FG005|Core Study|Lost to Follow-up|1
2099984|NCT00819585|3690110|FG006|Core Study|Lost to Follow-up|1
2099985|NCT00819585|3690111|FG007|Core Study|Lost to Follow-up|0
2099986|NCT00819585|3690112|FG008|Core Study|Lost to Follow-up|0
2099987|NCT00819585|3690113|FG009|Core Study|Lost to Follow-up|0
2099988|NCT00819585|3690114|FG010|Core Study|Lost to Follow-up|0
2099989|NCT00819585|3690104|FG000|Core Study|Administrative Problems|0
2099990|NCT00819585|3690105|FG001|Core Study|Administrative Problems|0
2099991|NCT00819585|3690106|FG002|Core Study|Administrative Problems|0
2099992|NCT00819585|3690107|FG003|Core Study|Administrative Problems|0
2099993|NCT00819585|3690108|FG004|Core Study|Administrative Problems|0
2099994|NCT00819585|3690109|FG005|Core Study|Administrative Problems|0
2099995|NCT00819585|3690110|FG006|Core Study|Administrative Problems|2
2099996|NCT00819585|3690111|FG007|Core Study|Administrative Problems|0
2099997|NCT00819585|3690112|FG008|Core Study|Administrative Problems|0
2099998|NCT00819585|3690113|FG009|Core Study|Administrative Problems|0
2099999|NCT00819585|3690114|FG010|Core Study|Administrative Problems|0
2100000|NCT00819585|3690104|FG000|Core Study|Death|0
2100001|NCT00819585|3690105|FG001|Core Study|Death|0
2100002|NCT00819585|3690106|FG002|Core Study|Death|0
2212239|NCT01668654|3853306|FG000|Overall Study|Withdrawal by Subject|1
2212240|NCT01668667|3853314|FG000|Overall Study|Adverse Event|3
2212241|NCT01668667|3853315|FG001|Overall Study|Adverse Event|6
2212242|NCT01668667|3853316|FG002|Overall Study|Adverse Event|4
2353787|NCT02017522|4107148|FG000|Overall Study|Withdrawal by Subject|1
2353788|NCT02030015|4107153|FG000|Overall Study|Withdrawal by Subject|3
2353789|NCT02030015|4107153|FG000|Overall Study|Death|13
2353790|NCT02015663|4107159|FG000|Overall Study|unsatisfactory therapeutic effect|1
2353791|NCT02015663|4107160|FG001|Overall Study|unsatisfactory therapeutic effect|0
2353792|NCT02015663|4107159|FG000|Overall Study|Withdrawal by Subject|1
2353793|NCT02015663|4107160|FG001|Overall Study|Withdrawal by Subject|0
2353794|NCT02015663|4107159|FG000|Overall Study|Protocol Violation|0
2353795|NCT02015663|4107160|FG001|Overall Study|Protocol Violation|1
2353796|NCT02015663|4107159|FG000|Overall Study|Adverse Event|3
2212243|NCT01668667|3853317|FG003|Overall Study|Adverse Event|4
2212244|NCT01668667|3853314|FG000|Overall Study|Lack of Efficacy|3
2212245|NCT01668667|3853315|FG001|Overall Study|Lack of Efficacy|2
2212246|NCT01668667|3853316|FG002|Overall Study|Lack of Efficacy|2
2307604|NCT02699593|4010111|FG000|Period 1|Withdrawal by Subject|0
2307605|NCT02699593|4010112|FG001|Period 1|Withdrawal by Subject|1
2353797|NCT02015663|4107160|FG001|Overall Study|Adverse Event|0
2353798|NCT02015663|4107159|FG000|Overall Study|Administrative problems|10
2353799|NCT02015663|4107160|FG001|Overall Study|Administrative problems|11
2353800|NCT02029846|4107169|FG000|Overall Study|n=1 each arm|1
2353801|NCT02029846|4107170|FG001|Overall Study|n=1 each arm|1
2353802|NCT02011542|4107207|FG000|Overall Study|Physician Decision|1
2307606|NCT02699593|4010111|FG000|Period 1|Adverse Event|1
2307607|NCT02699593|4010112|FG001|Period 1|Adverse Event|1
2307608|NCT02699593|4010111|FG000|Period 2|Adverse Event|1
2307609|NCT02699593|4010112|FG001|Period 2|Adverse Event|1
2307610|NCT02699593|4010111|FG000|Period 2|Lost Contact Lens|0
2307611|NCT02699593|4010112|FG001|Period 2|Lost Contact Lens|1
2307612|NCT02699593|4010111|FG000|Period 2|Torn Contact Lens|1
2307613|NCT02699593|4010112|FG001|Period 2|Torn Contact Lens|0
2307614|NCT02699684|4010125|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
2307615|NCT02699684|4010126|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0
2353803|NCT02008370|4107211|FG000|Overall Study|Lost to Follow-up|7
2353804|NCT02005445|4107232|FG000|Overall Study|Dual study enrollment|0
2353805|NCT02005445|4107233|FG001|Overall Study|Dual study enrollment|1
2353806|NCT02006927|4107252|FG000|Overall Study|Adverse Event|2
2353807|NCT02006927|4107252|FG000|Overall Study|Withdrawal by Subject|1
2353808|NCT01996982|4107256|FG000|Overall Study|PI/team left institution|7
2353809|NCT01986751|4107266|FG000|Overall Study|improperly consented|10
2353810|NCT01986751|4107267|FG001|Overall Study|improperly consented|2
2353811|NCT01977729|4107326|FG000|Overall Study|Study terminated|1
2100003|NCT00819585|3690107|FG003|Core Study|Death|0
2307616|NCT02699749|4010147|FG000|Overall Study|Other|0
2100004|NCT00819585|3690108|FG004|Core Study|Death|0
2100005|NCT00819585|3690109|FG005|Core Study|Death|0
2100006|NCT00819585|3690110|FG006|Core Study|Death|1
2100007|NCT00819585|3690111|FG007|Core Study|Death|0
2100008|NCT00819585|3690112|FG008|Core Study|Death|0
2100009|NCT00819585|3690113|FG009|Core Study|Death|0
2100010|NCT00819585|3690114|FG010|Core Study|Death|0
2100011|NCT00819585|3690104|FG000|Core Study|Protocol Violation|0
2100012|NCT00819585|3690105|FG001|Core Study|Protocol Violation|0
2100013|NCT00819585|3690106|FG002|Core Study|Protocol Violation|1
2100014|NCT00819585|3690107|FG003|Core Study|Protocol Violation|0
2100015|NCT00819585|3690108|FG004|Core Study|Protocol Violation|0
2100016|NCT00819585|3690109|FG005|Core Study|Protocol Violation|1
2100017|NCT00819585|3690110|FG006|Core Study|Protocol Violation|3
2100018|NCT00819585|3690111|FG007|Core Study|Protocol Violation|0
2100019|NCT00819585|3690112|FG008|Core Study|Protocol Violation|0
2100020|NCT00819585|3690113|FG009|Core Study|Protocol Violation|0
2100021|NCT00819585|3690114|FG010|Core Study|Protocol Violation|0
2100022|NCT00819585|3690104|FG000|Extension Study|Abnormal Laboratory Value(s)|0
2100023|NCT00819585|3690105|FG001|Extension Study|Abnormal Laboratory Value(s)|0
2100024|NCT00819585|3690106|FG002|Extension Study|Abnormal Laboratory Value(s)|0
2100025|NCT00819585|3690107|FG003|Extension Study|Abnormal Laboratory Value(s)|0
2100026|NCT00819585|3690108|FG004|Extension Study|Abnormal Laboratory Value(s)|0
2100027|NCT00819585|3690109|FG005|Extension Study|Abnormal Laboratory Value(s)|0
2100028|NCT00819585|3690110|FG006|Extension Study|Abnormal Laboratory Value(s)|0
2100029|NCT00819585|3690111|FG007|Extension Study|Abnormal Laboratory Value(s)|0
2100030|NCT00819585|3690112|FG008|Extension Study|Abnormal Laboratory Value(s)|1
2100031|NCT00819585|3690113|FG009|Extension Study|Abnormal Laboratory Value(s)|0
2100032|NCT00819585|3690114|FG010|Extension Study|Abnormal Laboratory Value(s)|0
2100033|NCT00819585|3690104|FG000|Extension Study|Subject Withdrew Consent|0
2100034|NCT00819585|3690105|FG001|Extension Study|Subject Withdrew Consent|0
2100035|NCT00819585|3690106|FG002|Extension Study|Subject Withdrew Consent|0
2100036|NCT00819585|3690107|FG003|Extension Study|Subject Withdrew Consent|0
2100037|NCT00819585|3690108|FG004|Extension Study|Subject Withdrew Consent|0
2100038|NCT00819585|3690109|FG005|Extension Study|Subject Withdrew Consent|0
2100039|NCT00819585|3690110|FG006|Extension Study|Subject Withdrew Consent|0
2100040|NCT00819585|3690111|FG007|Extension Study|Subject Withdrew Consent|0
2100041|NCT00819585|3690112|FG008|Extension Study|Subject Withdrew Consent|3
2100042|NCT00819585|3690113|FG009|Extension Study|Subject Withdrew Consent|0
2100043|NCT00819585|3690114|FG010|Extension Study|Subject Withdrew Consent|1
2100044|NCT00819585|3690104|FG000|Extension Study|Lost to Follow-up|0
2100045|NCT00819585|3690105|FG001|Extension Study|Lost to Follow-up|0
2100046|NCT00819585|3690106|FG002|Extension Study|Lost to Follow-up|0
2100047|NCT00819585|3690107|FG003|Extension Study|Lost to Follow-up|0
2100048|NCT00819585|3690108|FG004|Extension Study|Lost to Follow-up|0
2100049|NCT00819585|3690109|FG005|Extension Study|Lost to Follow-up|0
2100050|NCT00819585|3690110|FG006|Extension Study|Lost to Follow-up|0
2100051|NCT00819585|3690111|FG007|Extension Study|Lost to Follow-up|0
2100052|NCT00819585|3690112|FG008|Extension Study|Lost to Follow-up|2
2100053|NCT00819585|3690113|FG009|Extension Study|Lost to Follow-up|1
2100054|NCT00819585|3690114|FG010|Extension Study|Lost to Follow-up|1
2100055|NCT00819585|3690104|FG000|Extension Study|Death|0
2100056|NCT00819585|3690105|FG001|Extension Study|Death|0
2100057|NCT00819585|3690106|FG002|Extension Study|Death|0
2100058|NCT00819585|3690107|FG003|Extension Study|Death|0
2100059|NCT00819585|3690108|FG004|Extension Study|Death|0
2100060|NCT00819585|3690109|FG005|Extension Study|Death|0
2100061|NCT00819585|3690110|FG006|Extension Study|Death|0
2100062|NCT00819585|3690111|FG007|Extension Study|Death|0
2100063|NCT00819585|3690112|FG008|Extension Study|Death|2
2100064|NCT00819585|3690113|FG009|Extension Study|Death|0
2100065|NCT00819585|3690114|FG010|Extension Study|Death|0
2100066|NCT00819741|3690157|FG000|Overall Study|Adverse Event|5
2100067|NCT00819741|3690158|FG001|Overall Study|Adverse Event|2
2100068|NCT00819741|3690157|FG000|Overall Study|Lack of Efficacy|0
2100069|NCT00819741|3690158|FG001|Overall Study|Lack of Efficacy|2
2100070|NCT00819741|3690157|FG000|Overall Study|Lost to Follow-up|3
2100071|NCT00819741|3690158|FG001|Overall Study|Lost to Follow-up|1
2100072|NCT00819741|3690157|FG000|Overall Study|Protocol Violation|3
2100073|NCT00819741|3690158|FG001|Overall Study|Protocol Violation|4
2100074|NCT00819741|3690157|FG000|Overall Study|Withdrawal by Subject|2
2100075|NCT00819741|3690158|FG001|Overall Study|Withdrawal by Subject|2
2100076|NCT00819741|3690157|FG000|Overall Study|Unclassified|6
2100077|NCT00819741|3690158|FG001|Overall Study|Unclassified|0
2100078|NCT00819741|3690157|FG000|Overall Study|Reasons unknown|3
2100079|NCT00819741|3690158|FG001|Overall Study|Reasons unknown|3
2100080|NCT00819767|3690166|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2100081|NCT00819767|3690167|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2100082|NCT00819780|3690175|FG000|Overall Study|Did not receive study drug|3
2100083|NCT00819780|3690176|FG001|Overall Study|Did not receive study drug|4
2100084|NCT00819780|3690175|FG000|Overall Study|Still in treatment|25
2100085|NCT00819780|3690176|FG001|Overall Study|Still in treatment|17
2100086|NCT00819910|3690191|FG000|Overall Study|Adverse Event|0
2100087|NCT00819910|3690192|FG001|Overall Study|Adverse Event|0
2100088|NCT00819910|3690193|FG002|Overall Study|Adverse Event|2
2100089|NCT00819910|3690194|FG003|Overall Study|Adverse Event|1
2100090|NCT00819910|3690191|FG000|Overall Study|Withdrawal by Subject|1
2100091|NCT00819910|3690192|FG001|Overall Study|Withdrawal by Subject|1
2100092|NCT00819910|3690193|FG002|Overall Study|Withdrawal by Subject|1
2307617|NCT02699749|4010148|FG001|Overall Study|Other|0
2307618|NCT02699749|4010149|FG002|Overall Study|Other|2
2307619|NCT02699749|4010150|FG003|Overall Study|Other|0
2307620|NCT02699749|4010151|FG004|Overall Study|Other|0
2307621|NCT02699749|4010152|FG005|Overall Study|Other|1
2307622|NCT02699749|4010153|FG006|Overall Study|Other|1
2100093|NCT00819910|3690194|FG003|Overall Study|Withdrawal by Subject|0
2100094|NCT00819910|3690191|FG000|Overall Study|Lost to Follow-up|1
2100095|NCT00819910|3690192|FG001|Overall Study|Lost to Follow-up|0
2100096|NCT00819910|3690193|FG002|Overall Study|Lost to Follow-up|0
2100097|NCT00819910|3690194|FG003|Overall Study|Lost to Follow-up|0
2100098|NCT00820040|3690206|FG000|Overall Study|Death|1
2100099|NCT00820040|3690206|FG000|Overall Study|Sponsor terminated study|1
2100100|NCT00820040|3690206|FG000|Overall Study|Screen failure|1
2100101|NCT00820170|3690215|FG000|Overall Study|Adverse Event|0
2100102|NCT00820170|3690216|FG001|Overall Study|Adverse Event|0
2100103|NCT00820170|3690217|FG002|Overall Study|Adverse Event|0
2100104|NCT00820170|3690218|FG003|Overall Study|Adverse Event|0
2100105|NCT00820170|3690219|FG004|Overall Study|Adverse Event|2
2100106|NCT00820170|3690215|FG000|Overall Study|Progressive Disease|0
2100107|NCT00820170|3690216|FG001|Overall Study|Progressive Disease|0
2100108|NCT00820170|3690217|FG002|Overall Study|Progressive Disease|0
2100109|NCT00820170|3690218|FG003|Overall Study|Progressive Disease|0
2100110|NCT00820170|3690219|FG004|Overall Study|Progressive Disease|2
2100111|NCT00820222|3690238|FG000|Overall Study|Lost to Follow-up|10
2100112|NCT00820222|3690239|FG001|Overall Study|Lost to Follow-up|9
2100113|NCT00820222|3690238|FG000|Overall Study|Withdrawal by Subject|19
2100114|NCT00820222|3690239|FG001|Overall Study|Withdrawal by Subject|21
2100115|NCT00820222|3690238|FG000|Overall Study|Physician Decision|93
2100116|NCT00820222|3690239|FG001|Overall Study|Physician Decision|88
2100117|NCT00820222|3690238|FG000|Overall Study|Sponsor Terminated Study|43
2100118|NCT00820222|3690239|FG001|Overall Study|Sponsor Terminated Study|65
2100119|NCT00820222|3690238|FG000|Overall Study|Unkown|11
2100120|NCT00820222|3690239|FG001|Overall Study|Unkown|7
2100121|NCT00820248|3690260|FG000|Overall Study|No treated|4
2100122|NCT00820248|3690261|FG001|Overall Study|No treated|1
2100123|NCT00820599|3690307|FG000|Overall Study|Death|129
2100124|NCT00820599|3690307|FG000|Overall Study|Withdrawal by Subject|2
2100125|NCT00820755|3690333|FG000|Period 1: Combination Therapy Phase|Adverse Event|77
2100126|NCT00820755|3690334|FG001|Period 1: Combination Therapy Phase|Adverse Event|0
2100127|NCT00820755|3690335|FG002|Period 1: Combination Therapy Phase|Adverse Event|0
2100128|NCT00820755|3690333|FG000|Period 1: Combination Therapy Phase|Death|28
2100129|NCT00820755|3690334|FG001|Period 1: Combination Therapy Phase|Death|0
2100130|NCT00820755|3690335|FG002|Period 1: Combination Therapy Phase|Death|0
2100131|NCT00820755|3690333|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4
2100132|NCT00820755|3690334|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0
2100133|NCT00820755|3690335|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0
2100134|NCT00820755|3690333|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1
2100135|NCT00820755|3690334|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0
2100136|NCT00820755|3690335|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0
2100137|NCT00820755|3690333|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
2100138|NCT00820755|3690334|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
2100139|NCT00820755|3690335|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
2100140|NCT00820755|3690333|FG000|Period 1: Combination Therapy Phase|Progressive disease|114
2100141|NCT00820755|3690334|FG001|Period 1: Combination Therapy Phase|Progressive disease|0
2100142|NCT00820755|3690335|FG002|Period 1: Combination Therapy Phase|Progressive disease|0
2353812|NCT01982253|4107339|FG000|Overall Study|Withdrawal by Subject|1
2353813|NCT01982253|4107340|FG001|Overall Study|Withdrawal by Subject|0
2353814|NCT01982253|4107341|FG002|Overall Study|Withdrawal by Subject|0
2353815|NCT01982253|4107339|FG000|Overall Study|Study terminated by sponsor|1
2100143|NCT00820755|3690333|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
2100144|NCT00820755|3690334|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
2307623|NCT02699749|4010154|FG007|Overall Study|Other|0
2307624|NCT02699749|4010155|FG008|Overall Study|Other|0
2307625|NCT02699749|4010156|FG009|Overall Study|Other|0
2307626|NCT02699749|4010157|FG010|Overall Study|Other|1
2100145|NCT00820755|3690335|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
2100146|NCT00820755|3690333|FG000|Period 1: Combination Therapy Phase|Other|11
2100147|NCT00820755|3690334|FG001|Period 1: Combination Therapy Phase|Other|0
2100148|NCT00820755|3690335|FG002|Period 1: Combination Therapy Phase|Other|0
2212247|NCT01668667|3853317|FG003|Overall Study|Lack of Efficacy|3
2100149|NCT00820755|3690333|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
2100150|NCT00820755|3690334|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
2100151|NCT00820755|3690335|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
2100152|NCT00820898|3690347|FG000|Overall Study|Inelgible - wrong primary site|1
2100153|NCT00821015|3690357|FG000|Overall Study|Lost to Follow-up|12
2100154|NCT00821093|3690372|FG000|Overall Study|Adverse Event|20
2100155|NCT00821093|3690373|FG001|Overall Study|Adverse Event|12
2100156|NCT00821093|3690372|FG000|Overall Study|Withdrawal by Subject|9
2100157|NCT00821093|3690373|FG001|Overall Study|Withdrawal by Subject|13
2100158|NCT00821093|3690372|FG000|Overall Study|Lost to Follow-up|9
2100159|NCT00821093|3690373|FG001|Overall Study|Lost to Follow-up|3
2100160|NCT00821093|3690372|FG000|Overall Study|Protocol deviation|3
2100161|NCT00821093|3690373|FG001|Overall Study|Protocol deviation|6
2100162|NCT00821093|3690372|FG000|Overall Study|Abnormal laboratory value(s)|2
2100163|NCT00821093|3690373|FG001|Overall Study|Abnormal laboratory value(s)|0
2100164|NCT00821093|3690372|FG000|Overall Study|Lack of Efficacy|2
2100165|NCT00821093|3690373|FG001|Overall Study|Lack of Efficacy|2
2100166|NCT00821093|3690372|FG000|Overall Study|Death|2
2100167|NCT00821093|3690373|FG001|Overall Study|Death|1
2100168|NCT00821093|3690372|FG000|Overall Study|Abnormal test procedure result(s)|1
2100169|NCT00821093|3690373|FG001|Overall Study|Abnormal test procedure result(s)|1
2100170|NCT00821093|3690372|FG000|Overall Study|Administrative problems|1
2100171|NCT00821093|3690373|FG001|Overall Study|Administrative problems|2
2107877|NCT00876460|3701625|FG007|Combination Therapy Phase|Adverse Event|2
2107878|NCT00876460|3701618|FG000|Combination Therapy Phase|Withdrawal by Subject|1
2107879|NCT00876460|3701619|FG001|Combination Therapy Phase|Withdrawal by Subject|1
2107880|NCT00876460|3701620|FG002|Combination Therapy Phase|Withdrawal by Subject|0
2107881|NCT00876460|3701621|FG003|Combination Therapy Phase|Withdrawal by Subject|0
2107882|NCT00876460|3701622|FG004|Combination Therapy Phase|Withdrawal by Subject|1
2107883|NCT00876460|3701623|FG005|Combination Therapy Phase|Withdrawal by Subject|0
2107884|NCT00876460|3701624|FG006|Combination Therapy Phase|Withdrawal by Subject|0
2107885|NCT00876460|3701625|FG007|Combination Therapy Phase|Withdrawal by Subject|0
2107886|NCT00876460|3701618|FG000|Combination Therapy Phase|Other reason not defined above|0
2107887|NCT00876460|3701619|FG001|Combination Therapy Phase|Other reason not defined above|0
2107888|NCT00876460|3701620|FG002|Combination Therapy Phase|Other reason not defined above|0
2107889|NCT00876460|3701621|FG003|Combination Therapy Phase|Other reason not defined above|0
2107890|NCT00876460|3701622|FG004|Combination Therapy Phase|Other reason not defined above|0
2107891|NCT00876460|3701623|FG005|Combination Therapy Phase|Other reason not defined above|0
2107892|NCT00876460|3701624|FG006|Combination Therapy Phase|Other reason not defined above|1
2107893|NCT00876460|3701625|FG007|Combination Therapy Phase|Other reason not defined above|2
2107894|NCT00876460|3701618|FG000|Combination Therapy Phase|Not treated|0
2107895|NCT00876460|3701619|FG001|Combination Therapy Phase|Not treated|0
2107896|NCT00876460|3701620|FG002|Combination Therapy Phase|Not treated|0
2107897|NCT00876460|3701621|FG003|Combination Therapy Phase|Not treated|0
2107898|NCT00876460|3701622|FG004|Combination Therapy Phase|Not treated|0
2107899|NCT00876460|3701623|FG005|Combination Therapy Phase|Not treated|0
2107900|NCT00876460|3701624|FG006|Combination Therapy Phase|Not treated|1
2107901|NCT00876460|3701625|FG007|Combination Therapy Phase|Not treated|0
2107902|NCT00876460|3701618|FG000|Mono Therapy Phase|Progressive disease|0
2107903|NCT00876460|3701619|FG001|Mono Therapy Phase|Progressive disease|0
2107904|NCT00876460|3701620|FG002|Mono Therapy Phase|Progressive disease|0
2107905|NCT00876460|3701621|FG003|Mono Therapy Phase|Progressive disease|0
2107906|NCT00876460|3701622|FG004|Mono Therapy Phase|Progressive disease|2
2107907|NCT00876460|3701623|FG005|Mono Therapy Phase|Progressive disease|0
2107908|NCT00876460|3701624|FG006|Mono Therapy Phase|Progressive disease|1
2107909|NCT00876460|3701625|FG007|Mono Therapy Phase|Progressive disease|3
2107910|NCT00876460|3701618|FG000|Mono Therapy Phase|Withdrawal by Subject|0
2107911|NCT00876460|3701619|FG001|Mono Therapy Phase|Withdrawal by Subject|1
2107912|NCT00876460|3701620|FG002|Mono Therapy Phase|Withdrawal by Subject|0
2107913|NCT00876460|3701621|FG003|Mono Therapy Phase|Withdrawal by Subject|0
2107914|NCT00876460|3701622|FG004|Mono Therapy Phase|Withdrawal by Subject|0
2107915|NCT00876460|3701623|FG005|Mono Therapy Phase|Withdrawal by Subject|0
2107916|NCT00876460|3701624|FG006|Mono Therapy Phase|Withdrawal by Subject|0
2107917|NCT00876460|3701625|FG007|Mono Therapy Phase|Withdrawal by Subject|0
2107918|NCT00876460|3701618|FG000|Mono Therapy Phase|Adverse Event|0
2107919|NCT00876460|3701619|FG001|Mono Therapy Phase|Adverse Event|0
2107920|NCT00876460|3701620|FG002|Mono Therapy Phase|Adverse Event|0
2107921|NCT00876460|3701621|FG003|Mono Therapy Phase|Adverse Event|1
2107922|NCT00876460|3701622|FG004|Mono Therapy Phase|Adverse Event|0
2107923|NCT00876460|3701623|FG005|Mono Therapy Phase|Adverse Event|0
2107924|NCT00876460|3701624|FG006|Mono Therapy Phase|Adverse Event|0
2107925|NCT00876460|3701625|FG007|Mono Therapy Phase|Adverse Event|0
2107926|NCT00876694|3701657|FG000|Overall Study|Adverse Event|10
2107927|NCT00876694|3701658|FG001|Overall Study|Adverse Event|7
2100172|NCT04187989|3690408|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6
2100173|NCT04187989|3690409|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8
2100174|NCT04187989|3690408|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8
2100175|NCT04187989|3690409|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8
2100176|NCT04109118|3690415|FG000|Overall Study|Lost to Follow-up|3
2100177|NCT04045132|3690422|FG000|Overall Study|Lost to Follow-up|3
2100178|NCT04045132|3690423|FG001|Overall Study|Lost to Follow-up|7
2100179|NCT03846219|3690434|FG000|Overall Study|Withdrawal by Subject|3
2100180|NCT03846219|3690435|FG001|Overall Study|Withdrawal by Subject|2
2100181|NCT03846219|3690436|FG002|Overall Study|Withdrawal by Subject|2
2100182|NCT03846219|3690434|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0
2100183|NCT03846219|3690435|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2
2100184|NCT03846219|3690436|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1
2100185|NCT03846219|3690434|FG000|Overall Study|Physician Decision|0
2100186|NCT03846219|3690435|FG001|Overall Study|Physician Decision|0
2100187|NCT03846219|3690436|FG002|Overall Study|Physician Decision|2
2100188|NCT03606668|3690478|FG000|Overall Study|Screen Failure|1
2100189|NCT03606668|3690478|FG000|Overall Study|Lost to Follow-up|1
2100190|NCT03575897|3690484|FG000|Overall Study|Lost to Follow-up|12
2100191|NCT03575897|3690485|FG001|Overall Study|Lost to Follow-up|13
2100192|NCT03343626|3690504|FG000|Overall Study|Lost to Follow-up|4
2100193|NCT03343626|3690505|FG001|Overall Study|Lost to Follow-up|3
2100194|NCT03343626|3690506|FG002|Overall Study|Lost to Follow-up|2
2100195|NCT03343626|3690507|FG003|Overall Study|Lost to Follow-up|5
2100196|NCT03343626|3690508|FG004|Overall Study|Lost to Follow-up|4
2100197|NCT03343626|3690509|FG005|Overall Study|Lost to Follow-up|4
2100198|NCT03343626|3690510|FG006|Overall Study|Lost to Follow-up|4
2100199|NCT03343626|3690511|FG007|Overall Study|Lost to Follow-up|7
2100200|NCT03343626|3690504|FG000|Overall Study|Withdrawal of Consent|2
2100201|NCT03343626|3690505|FG001|Overall Study|Withdrawal of Consent|1
2100202|NCT03343626|3690506|FG002|Overall Study|Withdrawal of Consent|0
2100203|NCT03343626|3690507|FG003|Overall Study|Withdrawal of Consent|3
2100204|NCT03343626|3690508|FG004|Overall Study|Withdrawal of Consent|3
2100205|NCT03343626|3690509|FG005|Overall Study|Withdrawal of Consent|1
2100206|NCT03343626|3690510|FG006|Overall Study|Withdrawal of Consent|1
2100207|NCT03343626|3690511|FG007|Overall Study|Withdrawal of Consent|2
2100208|NCT03343626|3690504|FG000|Overall Study|Reason not Specified|0
2100209|NCT03343626|3690505|FG001|Overall Study|Reason not Specified|1
2212248|NCT01668667|3853314|FG000|Overall Study|Protocol Violation|6
2212249|NCT01668667|3853315|FG001|Overall Study|Protocol Violation|10
2212250|NCT01668667|3853316|FG002|Overall Study|Protocol Violation|12
2100210|NCT03343626|3690506|FG002|Overall Study|Reason not Specified|0
2100211|NCT03343626|3690507|FG003|Overall Study|Reason not Specified|0
2100212|NCT03343626|3690508|FG004|Overall Study|Reason not Specified|0
2100213|NCT03343626|3690509|FG005|Overall Study|Reason not Specified|0
2100214|NCT03343626|3690510|FG006|Overall Study|Reason not Specified|0
2100215|NCT03343626|3690511|FG007|Overall Study|Reason not Specified|1
2100216|NCT03343626|3690504|FG000|Overall Study|Data Entry Error|0
2100217|NCT03343626|3690505|FG001|Overall Study|Data Entry Error|0
2100218|NCT03343626|3690506|FG002|Overall Study|Data Entry Error|0
2100219|NCT03343626|3690507|FG003|Overall Study|Data Entry Error|0
2100220|NCT03343626|3690508|FG004|Overall Study|Data Entry Error|0
2100221|NCT03343626|3690509|FG005|Overall Study|Data Entry Error|0
2100222|NCT03343626|3690510|FG006|Overall Study|Data Entry Error|0
2100223|NCT03343626|3690511|FG007|Overall Study|Data Entry Error|1
2100224|NCT02807363|3690566|FG000|Dosing Period|Adverse Event|0
2100225|NCT02807363|3690567|FG001|Dosing Period|Adverse Event|1
2100226|NCT02807363|3690568|FG002|Dosing Period|Adverse Event|0
2100227|NCT02807363|3690569|FG003|Dosing Period|Adverse Event|0
2100228|NCT02756403|3690585|FG000|Overall Study|Unable to swallow medication|0
2100229|NCT02756403|3690586|FG001|Overall Study|Unable to swallow medication|1
2100230|NCT02756403|3690587|FG002|Overall Study|Unable to swallow medication|1
2100231|NCT02756403|3690588|FG003|Overall Study|Unable to swallow medication|1
2100232|NCT02756403|3690585|FG000|Overall Study|Did not complete Procedure|0
2100233|NCT02756403|3690586|FG001|Overall Study|Did not complete Procedure|1
2100234|NCT02756403|3690587|FG002|Overall Study|Did not complete Procedure|0
2100235|NCT02756403|3690588|FG003|Overall Study|Did not complete Procedure|0
2100236|NCT02756403|3690585|FG000|Overall Study|Changed Mind About Procedure|0
2100237|NCT02756403|3690586|FG001|Overall Study|Changed Mind About Procedure|0
2100238|NCT02756403|3690587|FG002|Overall Study|Changed Mind About Procedure|1
2100239|NCT02756403|3690588|FG003|Overall Study|Changed Mind About Procedure|0
2100240|NCT02756403|3690585|FG000|Overall Study|Protocol Violation|0
2100241|NCT02756403|3690586|FG001|Overall Study|Protocol Violation|1
2100242|NCT02756403|3690587|FG002|Overall Study|Protocol Violation|0
2100243|NCT02756403|3690588|FG003|Overall Study|Protocol Violation|1
2100244|NCT02751502|3690598|FG000|Overall Study|Lack of funding|4
2100245|NCT02285062|3690637|FG000|Overall Study|Withdrawal by Subject|12
2100246|NCT02285062|3690638|FG001|Overall Study|Withdrawal by Subject|17
2100247|NCT02285062|3690637|FG000|Overall Study|Death|58
2100248|NCT02285062|3690638|FG001|Overall Study|Death|62
2100249|NCT02285062|3690637|FG000|Overall Study|Lost to Follow-up|8
2212251|NCT01668667|3853317|FG003|Overall Study|Protocol Violation|5
2212252|NCT01668667|3853314|FG000|Overall Study|Lost to Follow-up|9
2100250|NCT02285062|3690638|FG001|Overall Study|Lost to Follow-up|5
2100251|NCT02264977|3690644|FG000|Overall Study|Death|3
2100252|NCT02264977|3690644|FG000|Overall Study|Withdrawal by Subject|1
2100253|NCT02264977|3690644|FG000|Overall Study|Physician Decision|1
2107928|NCT00876694|3701657|FG000|Overall Study|Subject withdrew consent|6
2107929|NCT00876694|3701658|FG001|Overall Study|Subject withdrew consent|4
2107930|NCT00876694|3701657|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2107931|NCT00876694|3701658|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2107932|NCT00876694|3701657|FG000|Overall Study|Abnormal test procedure result(s)|1
2107933|NCT00876694|3701658|FG001|Overall Study|Abnormal test procedure result(s)|0
2107934|NCT00876694|3701657|FG000|Overall Study|Administrative problems|1
2107935|NCT00876694|3701658|FG001|Overall Study|Administrative problems|1
2107936|NCT00876694|3701657|FG000|Overall Study|Death|1
2107937|NCT00876694|3701658|FG001|Overall Study|Death|0
2107938|NCT00876733|3701668|FG000|Overall Study|Adverse Event|34
2107939|NCT00876733|3701669|FG001|Overall Study|Adverse Event|20
2107940|NCT00876733|3701670|FG002|Overall Study|Adverse Event|10
2107941|NCT00876733|3701671|FG003|Overall Study|Adverse Event|3
2107942|NCT00876733|3701668|FG000|Overall Study|Lack of Efficacy|17
2107943|NCT00876733|3701669|FG001|Overall Study|Lack of Efficacy|9
2107944|NCT00876733|3701670|FG002|Overall Study|Lack of Efficacy|10
2107945|NCT00876733|3701671|FG003|Overall Study|Lack of Efficacy|1
2107946|NCT00876733|3701668|FG000|Overall Study|Lost to Follow-up|26
2107947|NCT00876733|3701669|FG001|Overall Study|Lost to Follow-up|10
2107948|NCT00876733|3701670|FG002|Overall Study|Lost to Follow-up|3
2107949|NCT00876733|3701671|FG003|Overall Study|Lost to Follow-up|2
2107950|NCT00876733|3701668|FG000|Overall Study|Data not available|14
2107951|NCT00876733|3701669|FG001|Overall Study|Data not available|3
2107952|NCT00876733|3701670|FG002|Overall Study|Data not available|7
2107953|NCT00876733|3701671|FG003|Overall Study|Data not available|1
2107954|NCT00876928|3701696|FG000|Overall Study|Lost to Follow-up|2
2107955|NCT00876928|3701697|FG001|Overall Study|Lost to Follow-up|5
2107956|NCT00876928|3701696|FG000|Overall Study|Hypokalemia-affects insulin secretion|1
2107957|NCT00876928|3701697|FG001|Overall Study|Hypokalemia-affects insulin secretion|0
2107958|NCT00877006|3701728|FG000|Treatment Period|Death|2
2107959|NCT00877006|3701729|FG001|Treatment Period|Death|1
2107960|NCT00877006|3701728|FG000|Treatment Period|Adverse Event|10
2107961|NCT00877006|3701729|FG001|Treatment Period|Adverse Event|3
2107962|NCT00877006|3701728|FG000|Treatment Period|Withdrawal by Subject|2
2107963|NCT00877006|3701729|FG001|Treatment Period|Withdrawal by Subject|3
2107964|NCT00877006|3701728|FG000|Treatment Period|Protocol Violation|1
2107965|NCT00877006|3701729|FG001|Treatment Period|Protocol Violation|0
2107966|NCT00877006|3701728|FG000|Treatment Period|Lost to Follow-up|0
2107967|NCT00877006|3701729|FG001|Treatment Period|Lost to Follow-up|1
2107968|NCT00877006|3701728|FG000|Treatment Period|Disease Progression|1
2107969|NCT00877006|3701729|FG001|Treatment Period|Disease Progression|2
2107970|NCT00877006|3701728|FG000|Treatment Period|Started New Treatment Regimen|2
2107971|NCT00877006|3701729|FG001|Treatment Period|Started New Treatment Regimen|5
2107972|NCT00877006|3701728|FG000|Treatment Period|Other|4
2107973|NCT00877006|3701729|FG001|Treatment Period|Other|4
2107974|NCT00877006|3701728|FG000|Treatment Period|Randomized but Not Treated|3
2107975|NCT00877006|3701729|FG001|Treatment Period|Randomized but Not Treated|8
2107976|NCT00877006|3701728|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12
2107977|NCT00877006|3701729|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19
2107978|NCT00877006|3701728|FG000|Long-Term Follow-up Period|Lost to Follow-up|8
2107979|NCT00877006|3701729|FG001|Long-Term Follow-up Period|Lost to Follow-up|9
2107980|NCT00877006|3701728|FG000|Long-Term Follow-up Period|Death|26
2107981|NCT00877006|3701729|FG001|Long-Term Follow-up Period|Death|18
2107982|NCT00877006|3701728|FG000|Long-Term Follow-up Period|Other|7
2107983|NCT00877006|3701729|FG001|Long-Term Follow-up Period|Other|9
2107984|NCT00877032|3701744|FG000|Overall Study|Did not meet entrance criteria|0
2107985|NCT00877032|3701745|FG001|Overall Study|Did not meet entrance criteria|0
2107986|NCT00877032|3701746|FG002|Overall Study|Did not meet entrance criteria|0
2107987|NCT00877032|3701747|FG003|Overall Study|Did not meet entrance criteria|1
2107988|NCT00877032|3701748|FG004|Overall Study|Did not meet entrance criteria|0
2107989|NCT00877032|3701749|FG005|Overall Study|Did not meet entrance criteria|0
2107990|NCT00877032|3701750|FG006|Overall Study|Did not meet entrance criteria|2
2107991|NCT00877383|3701785|FG000|Overall Study|Adverse Event|13
2107992|NCT00877383|3701786|FG001|Overall Study|Adverse Event|14
2107993|NCT00877383|3701785|FG000|Overall Study|Lost to Follow-up|5
2107994|NCT00877383|3701786|FG001|Overall Study|Lost to Follow-up|3
2107995|NCT00877383|3701785|FG000|Overall Study|Subject withdrew consent|3
2353816|NCT01982253|4107340|FG001|Overall Study|Study terminated by sponsor|4
2353817|NCT01982253|4107341|FG002|Overall Study|Study terminated by sponsor|4
2353818|NCT01984268|4107349|FG000|Overall Study|Study Terminated|15
2353819|NCT01980875|4107369|FG000|Overall Study|Withdrew Consent|1
2353820|NCT01980875|4107370|FG001|Overall Study|Withdrew Consent|1
2353821|NCT01980875|4107371|FG002|Overall Study|Withdrew Consent|1
2353822|NCT01980875|4107369|FG000|Overall Study|Study Terminated by Sponsor|7
2353823|NCT01980875|4107370|FG001|Overall Study|Study Terminated by Sponsor|24
2107996|NCT00877383|3701786|FG001|Overall Study|Subject withdrew consent|12
2107997|NCT00877383|3701785|FG000|Overall Study|Subject no longer requires study drug|2
2108209|NCT00878722|3702054|FG005|Overall Study|Withdrawal by Subject|0
2100254|NCT01981096|3690650|FG000|Overall Study|Parent illness|1
2100255|NCT01981096|3690651|FG001|Overall Study|Parent illness|0
2100256|NCT01981096|3690650|FG000|Overall Study|Withdrawal by Subject|0
2100257|NCT01981096|3690651|FG001|Overall Study|Withdrawal by Subject|1
2100258|NCT01981096|3690650|FG000|Overall Study|Lost to Follow-up|2
2100259|NCT01981096|3690651|FG001|Overall Study|Lost to Follow-up|0
2100260|NCT01935336|3690661|FG000|Overall Study|Adverse Event|1
2100261|NCT01935336|3690662|FG001|Overall Study|Adverse Event|0
2100262|NCT01935336|3690663|FG002|Overall Study|Adverse Event|0
2100263|NCT01935336|3690664|FG003|Overall Study|Adverse Event|0
2100264|NCT01935336|3690661|FG000|Overall Study|Progressive disease|5
2100265|NCT01935336|3690662|FG001|Overall Study|Progressive disease|3
2100266|NCT01935336|3690663|FG002|Overall Study|Progressive disease|47
2100267|NCT01935336|3690664|FG003|Overall Study|Progressive disease|66
2100268|NCT01712490|3690682|FG000|Overall Study|Ongoing|601
2100269|NCT01712490|3690683|FG001|Overall Study|Ongoing|586
2100270|NCT01712490|3690682|FG000|Overall Study|Other|11
2100271|NCT01712490|3690683|FG001|Overall Study|Other|11
2100272|NCT01712490|3690682|FG000|Overall Study|Withdrawal by Subject|36
2100273|NCT01712490|3690683|FG001|Overall Study|Withdrawal by Subject|44
2100274|NCT01712490|3690682|FG000|Overall Study|Lost to Follow-up|16
2100275|NCT01712490|3690683|FG001|Overall Study|Lost to Follow-up|29
2100276|NCT01702805|3690691|FG000|Overall Study|Data withdrawn prior to hospital discharge|3
2100277|NCT01702805|3690692|FG001|Overall Study|Data withdrawn prior to hospital discharge|7
2100278|NCT01702805|3690691|FG000|Overall Study|Incomplete Follow-up|18
2100279|NCT01702805|3690692|FG001|Overall Study|Incomplete Follow-up|15
2100280|NCT01702805|3690691|FG000|Overall Study|Vital Status Assessment Only|40
2100281|NCT01702805|3690692|FG001|Overall Study|Vital Status Assessment Only|39
2100282|NCT01702805|3690691|FG000|Overall Study|Lost to Follow-up|5
2100283|NCT01702805|3690692|FG001|Overall Study|Lost to Follow-up|5
2100284|NCT01499160|3690698|FG000|Overall Study|Adverse Event|1
2100285|NCT01499160|3690698|FG000|Overall Study|Withdrawal by Subject|1
2100286|NCT01061151|3690740|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
2100287|NCT01061151|3690741|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
2100288|NCT01061151|3690742|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
2100289|NCT01061151|3690743|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
2100290|NCT01061151|3690740|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6
2100291|NCT01061151|3690741|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9
2100292|NCT01061151|3690742|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1
2100293|NCT01061151|3690743|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2
2100294|NCT01061151|3690740|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
2100295|NCT01061151|3690741|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
2100296|NCT01061151|3690742|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
2100297|NCT01061151|3690743|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
2100298|NCT01061151|3690740|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
2100299|NCT01061151|3690741|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
2100300|NCT01061151|3690742|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
2100301|NCT01061151|3690743|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
2100302|NCT01061151|3690740|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
2100303|NCT01061151|3690741|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
2100304|NCT01061151|3690742|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
2100305|NCT01061151|3690743|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
2100306|NCT01061151|3690740|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
2100307|NCT01061151|3690741|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
2100308|NCT01061151|3690742|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
2100309|NCT01061151|3690743|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
2100310|NCT01061151|3690740|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
2100311|NCT01061151|3690741|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
2100312|NCT01061151|3690742|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
2100313|NCT01061151|3690743|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
2100314|NCT01061151|3690740|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
2100315|NCT01061151|3690741|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
2100316|NCT01061151|3690742|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
2100317|NCT01061151|3690743|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
2100318|NCT01061151|3690740|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
2100319|NCT01061151|3690741|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
2100320|NCT01061151|3690742|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
2100321|NCT01061151|3690743|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
2100322|NCT01061151|3690740|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3
2100323|NCT01061151|3690741|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5
2100324|NCT01061151|3690742|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1
2100325|NCT01061151|3690743|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1
2100326|NCT01061151|3690740|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
2100327|NCT01061151|3690741|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
2100328|NCT01061151|3690742|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
2100329|NCT01061151|3690743|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
2100330|NCT01061151|3690740|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
2100331|NCT01061151|3690741|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
2100332|NCT01061151|3690742|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
2100333|NCT01061151|3690743|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
2100334|NCT01061151|3690740|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
2100335|NCT01061151|3690741|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
2100336|NCT01061151|3690742|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
2100337|NCT01061151|3690743|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
2100338|NCT01061151|3690740|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
2100339|NCT01061151|3690741|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
2100340|NCT01061151|3690742|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
2100341|NCT01061151|3690743|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
2100342|NCT01061151|3690740|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
2100343|NCT01061151|3690741|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
2100344|NCT01061151|3690742|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
2100345|NCT01061151|3690743|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
2100346|NCT00981058|3690765|FG000|Overall Study|Adverse Event|1
2100347|NCT00981058|3690766|FG001|Overall Study|Adverse Event|1
2100348|NCT00981058|3690765|FG000|Overall Study|Progressive Disease|61
2100349|NCT00981058|3690766|FG001|Overall Study|Progressive Disease|49
2100350|NCT00981058|3690765|FG000|Overall Study|Lost to Follow-up|16
2100351|NCT00981058|3690766|FG001|Overall Study|Lost to Follow-up|15
2100352|NCT00981058|3690765|FG000|Overall Study|New Anticancer Therapy|6
2100353|NCT00981058|3690766|FG001|Overall Study|New Anticancer Therapy|6
2100354|NCT00981058|3690765|FG000|Overall Study|Noncompliance|1
2100355|NCT00981058|3690766|FG001|Overall Study|Noncompliance|0
2100356|NCT00981058|3690765|FG000|Overall Study|Radiologist Error|0
2100357|NCT00981058|3690766|FG001|Overall Study|Radiologist Error|1
2100358|NCT00981058|3690765|FG000|Overall Study|Randomization Error|1
2100359|NCT00981058|3690766|FG001|Overall Study|Randomization Error|2
2100360|NCT00981058|3690765|FG000|Overall Study|Withdrawal by Subject|25
2100361|NCT00981058|3690766|FG001|Overall Study|Withdrawal by Subject|23
2100362|NCT00981058|3690765|FG000|Overall Study|On study treatment at conclusion|9
2100363|NCT00981058|3690766|FG001|Overall Study|On study treatment at conclusion|0
2100364|NCT00885495|3690774|FG000|Overall Study|Adverse Event|1
2100365|NCT00885495|3690775|FG001|Overall Study|Adverse Event|2
2100366|NCT00885495|3690774|FG000|Overall Study|Protocol Violation|0
2100367|NCT00885495|3690775|FG001|Overall Study|Protocol Violation|1
2100368|NCT00885495|3690774|FG000|Overall Study|Withdrawal by Subject|1
2100369|NCT00885495|3690775|FG001|Overall Study|Withdrawal by Subject|0
2100370|NCT00084799|3690788|FG000|Overall Study|Disease Progression|1
2100371|NCT00084799|3690789|FG001|Overall Study|Disease Progression|0
2100372|NCT00821236|3690798|FG000|Overall Study|Lost to Follow-up|3
2100373|NCT00821327|3690806|FG000|Overall Study|Adverse Event|13
2100374|NCT00821327|3690806|FG000|Overall Study|Patient Request|1
2100375|NCT00821327|3690806|FG000|Overall Study|Investigator Request|2
2100376|NCT00821327|3690806|FG000|Overall Study|Sponsor Request|1
2100377|NCT00821327|3690806|FG000|Overall Study|Disease Progression|13
2100378|NCT00821327|3690806|FG000|Overall Study|Other/Unknown|5
2100379|NCT00821431|3690812|FG000|Overall Study|Adverse Event|6
2100380|NCT00821431|3690813|FG001|Overall Study|Adverse Event|3
2100381|NCT00821431|3690812|FG000|Overall Study|Withdrawal by Subject|5
2100382|NCT00821431|3690813|FG001|Overall Study|Withdrawal by Subject|0
2100383|NCT00821431|3690812|FG000|Overall Study|Lost to Follow-up|1
2100384|NCT00821431|3690813|FG001|Overall Study|Lost to Follow-up|0
2100385|NCT00821431|3690812|FG000|Overall Study|Protocol Violation|3
2100386|NCT00821431|3690813|FG001|Overall Study|Protocol Violation|1
2100387|NCT00821431|3690812|FG000|Overall Study|Physician Decision|0
2100388|NCT00821431|3690813|FG001|Overall Study|Physician Decision|1
2100389|NCT00821509|3690822|FG000|Overall Study|Withdrawal by Subject|12
2100390|NCT00821509|3690823|FG001|Overall Study|Withdrawal by Subject|11
2100391|NCT00821509|3690824|FG002|Overall Study|Withdrawal by Subject|34
2100392|NCT00821678|3690845|FG000|Overall Study|Withdrawal by Subject|8
2100393|NCT00821678|3690846|FG001|Overall Study|Withdrawal by Subject|0
2100394|NCT00821678|3690845|FG000|Overall Study|Lost to Follow-up|13
2100395|NCT00821678|3690846|FG001|Overall Study|Lost to Follow-up|12
2100396|NCT00821678|3690845|FG000|Overall Study|Death|0
2100397|NCT00821678|3690846|FG001|Overall Study|Death|2
2100398|NCT00821873|3690878|FG000|Overall Study|Lost to Follow-up|4
2100399|NCT00822172|3690912|FG000|Overall Study|Adverse Event|10
2100400|NCT00822172|3690913|FG001|Overall Study|Adverse Event|12
2100401|NCT00822172|3690912|FG000|Overall Study|Death|1
2100402|NCT00822172|3690913|FG001|Overall Study|Death|0
2100403|NCT00822172|3690912|FG000|Overall Study|Lost to Follow-up|3
2100404|NCT00822172|3690913|FG001|Overall Study|Lost to Follow-up|1
2100405|NCT00822172|3690912|FG000|Overall Study|Withdrawal by Subject|1
2100406|NCT00822172|3690913|FG001|Overall Study|Withdrawal by Subject|4
2100407|NCT00822172|3690912|FG000|Overall Study|site closed|0
2100408|NCT00822172|3690913|FG001|Overall Study|site closed|1
2100409|NCT00822172|3690912|FG000|Overall Study|Other|0
2100410|NCT00822172|3690913|FG001|Overall Study|Other|1
2100411|NCT00822237|3690942|FG000|Dose 1 Vaccination|Not vaccinated|3
2100412|NCT00822237|3690943|FG001|Dose 1 Vaccination|Not vaccinated|0
2100413|NCT00822237|3690942|FG000|Dose 1 Vaccination|Withdrawal by Subject|13
2100414|NCT00822237|3690943|FG001|Dose 1 Vaccination|Withdrawal by Subject|14
2100415|NCT00822237|3690942|FG000|Dose 1 Vaccination|Lost to Follow-up|9
2100416|NCT00822237|3690943|FG001|Dose 1 Vaccination|Lost to Follow-up|12
2100417|NCT00822237|3690942|FG000|Dose 2 Vaccination|Withdrawal by Subject|2
2100418|NCT00822237|3690943|FG001|Dose 2 Vaccination|Withdrawal by Subject|2
2100419|NCT00822237|3690942|FG000|Dose 2 Vaccination|Lost to Follow-up|2
2100420|NCT00822237|3690943|FG001|Dose 2 Vaccination|Lost to Follow-up|9
2100421|NCT00822692|3691011|FG000|Overall Study|Lost to Follow-up|17
2100422|NCT00822692|3691012|FG001|Overall Study|Lost to Follow-up|25
2100423|NCT00822770|3691029|FG000|Overall Study|Not treated|1
2100424|NCT00822770|3691030|FG001|Overall Study|Not treated|0
2100425|NCT00822770|3691029|FG000|Overall Study|Complication/Incomplete treatment|1
2100426|NCT00822770|3691030|FG001|Overall Study|Complication/Incomplete treatment|0
2100427|NCT00822770|3691029|FG000|Overall Study|Death|1
2100428|NCT00822770|3691030|FG001|Overall Study|Death|1
2100429|NCT00822900|3691038|FG000|Overall Study|Withdrawal by Subject|14
2100430|NCT00822900|3691039|FG001|Overall Study|Withdrawal by Subject|14
2100431|NCT00822900|3691038|FG000|Overall Study|Lost to Follow-up|9
2100432|NCT00822900|3691039|FG001|Overall Study|Lost to Follow-up|9
2100433|NCT00822900|3691038|FG000|Overall Study|Death|83
2100434|NCT00822900|3691039|FG001|Overall Study|Death|69
2100435|NCT00822900|3691038|FG000|Overall Study|Became a ward of the state|2
2100436|NCT00822900|3691039|FG001|Overall Study|Became a ward of the state|1
2100437|NCT00822926|3691047|FG000|Second Injection Visit|Lost to Follow-up|1
2100438|NCT00822926|3691048|FG001|Second Injection Visit|Lost to Follow-up|0
2100439|NCT00822926|3691047|FG000|Second Injection Visit|Withdrawal by Subject|0
2100440|NCT00822926|3691048|FG001|Second Injection Visit|Withdrawal by Subject|1
2100441|NCT00823134|3691079|FG000|Overall Study|Invalid measurement|1
2100442|NCT00823199|3691084|FG000|Overall Study|Withdrawal by Subject|2
2100443|NCT00823212|3691091|FG000|Overall Study|Death|8
2100444|NCT00823212|3691092|FG001|Overall Study|Death|10
2100445|NCT00823212|3691091|FG000|Overall Study|Withdrawal by Subject|6
2307627|NCT02699749|4010158|FG011|Overall Study|Other|0
2307628|NCT02699749|4010159|FG012|Overall Study|Other|0
2307629|NCT02699749|4010160|FG013|Overall Study|Other|0
2307630|NCT02699749|4010147|FG000|Overall Study|Progressive Disease|3
2307631|NCT02699749|4010148|FG001|Overall Study|Progressive Disease|3
2307632|NCT02699749|4010149|FG002|Overall Study|Progressive Disease|14
2353824|NCT01980875|4107371|FG002|Overall Study|Study Terminated by Sponsor|22
2353825|NCT01980875|4107369|FG000|Overall Study|Lost to Follow-up|0
2353826|NCT01980875|4107370|FG001|Overall Study|Lost to Follow-up|0
2353827|NCT01980875|4107371|FG002|Overall Study|Lost to Follow-up|1
2353828|NCT01970462|4107417|FG000|Overall Study|Lost to Follow-up|0
2353829|NCT01970462|4107418|FG001|Overall Study|Lost to Follow-up|2
2353830|NCT01969565|4107424|FG000|Overall Study|Withdrawal by Subject|1
2353831|NCT01968226|4107429|FG000|Overall Study|[F-18] RDG-K5 was not available|2
2353832|NCT01962974|4107448|FG000|Overall Study|Study termination|7
2353833|NCT01951378|4107465|FG000|Overall Study|Study Terminated-Not completed|23
2353834|NCT01951378|4107466|FG001|Overall Study|Study Terminated-Not completed|17
2353835|NCT01944059|4107489|FG000|Overall Study|Lost to Follow-up|1
2353836|NCT01944059|4107489|FG000|Overall Study|Physician Decision|3
2353837|NCT01944059|4107489|FG000|Overall Study|Withdrawal by Subject|1
2353838|NCT01944059|4107489|FG000|Overall Study|Adverse Event|2
2353839|NCT01935947|4107497|FG000|Overall Study|Adverse Event|0
2353840|NCT01935947|4107498|FG001|Overall Study|Adverse Event|2
2353841|NCT01935947|4107499|FG002|Overall Study|Adverse Event|0
2100446|NCT00823212|3691092|FG001|Overall Study|Withdrawal by Subject|1
2100447|NCT00823212|3691091|FG000|Overall Study|Incarcerated|0
2100448|NCT00823212|3691092|FG001|Overall Study|Incarcerated|1
2100449|NCT00823212|3691091|FG000|Overall Study|Missed 12-month visit|21
2307633|NCT02699749|4010150|FG003|Overall Study|Progressive Disease|3
2307634|NCT02699749|4010151|FG004|Overall Study|Progressive Disease|3
2307635|NCT02699749|4010152|FG005|Overall Study|Progressive Disease|7
2307636|NCT02699749|4010153|FG006|Overall Study|Progressive Disease|5
2307637|NCT02699749|4010154|FG007|Overall Study|Progressive Disease|5
2307638|NCT02699749|4010155|FG008|Overall Study|Progressive Disease|6
2307639|NCT02699749|4010156|FG009|Overall Study|Progressive Disease|6
2307640|NCT02699749|4010157|FG010|Overall Study|Progressive Disease|5
2353842|NCT01935947|4107497|FG000|Overall Study|Diease Progression|2
2353843|NCT01935947|4107498|FG001|Overall Study|Diease Progression|2
2353844|NCT01935947|4107499|FG002|Overall Study|Diease Progression|2
2353845|NCT01935947|4107497|FG000|Overall Study|Death|1
2100450|NCT00823212|3691092|FG001|Overall Study|Missed 12-month visit|21
2100451|NCT00823264|3691102|FG000|Overall Study|Protocol Violation|2
2100452|NCT00823264|3691103|FG001|Overall Study|Protocol Violation|0
2100453|NCT00823472|3691125|FG000|Overall Study|Physician Decision|24
2100454|NCT00823472|3691126|FG001|Overall Study|Physician Decision|28
2100455|NCT00823615|3691132|FG000|Period 2|Lost to Follow-up|2
2100456|NCT00823615|3691133|FG001|Period 2|Lost to Follow-up|0
2100457|NCT00823615|3691132|FG000|Period 2|Time/Job Conflict|1
2100458|NCT00823615|3691133|FG001|Period 2|Time/Job Conflict|2
2100459|NCT00823719|3691141|FG000|Overall Study|Adverse Event|1
2100460|NCT00823719|3691142|FG001|Overall Study|Adverse Event|2
2100461|NCT00823719|3691141|FG000|Overall Study|Physician Decision|1
2100462|NCT00823719|3691142|FG001|Overall Study|Physician Decision|4
2100463|NCT00823719|3691141|FG000|Overall Study|Withdrawal by Subject|0
2100464|NCT00823719|3691142|FG001|Overall Study|Withdrawal by Subject|1
2100465|NCT00823719|3691141|FG000|Overall Study|Disease Progression|4
2100466|NCT00823719|3691142|FG001|Overall Study|Disease Progression|4
2100467|NCT00823823|3691160|FG000|Overall Study|Lost to Follow-up|3
2100468|NCT00823823|3691161|FG001|Overall Study|Lost to Follow-up|1
2100469|NCT00823823|3691160|FG000|Overall Study|Protocol Violation|5
2100470|NCT00823823|3691161|FG001|Overall Study|Protocol Violation|5
2100471|NCT00823836|3691169|FG000|NV and PR/XR Switching Phases|Adverse Event|22
2100472|NCT00823836|3691170|FG001|NV and PR/XR Switching Phases|Adverse Event|21
2100473|NCT00823836|3691169|FG000|NV and PR/XR Switching Phases|Protocol Violation|1
2100474|NCT00823836|3691170|FG001|NV and PR/XR Switching Phases|Protocol Violation|1
2100475|NCT00823836|3691169|FG000|NV and PR/XR Switching Phases|Physician Decision|5
2100476|NCT00823836|3691170|FG001|NV and PR/XR Switching Phases|Physician Decision|2
2100477|NCT00823836|3691169|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4
2100478|NCT00823836|3691170|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5
2100479|NCT00823836|3691169|FG000|Long-term Phase|Adverse Event|3
2100480|NCT00823836|3691170|FG001|Long-term Phase|Adverse Event|2
2100481|NCT00823836|3691169|FG000|Long-term Phase|Physician Decision|1
2100482|NCT00823836|3691170|FG001|Long-term Phase|Physician Decision|2
2100483|NCT00823836|3691169|FG000|Long-term Phase|Withdrawal by Subject|1
2100484|NCT00823836|3691170|FG001|Long-term Phase|Withdrawal by Subject|1
2100485|NCT00823901|3691181|FG000|Overall Study|Adverse Event|1
2100486|NCT00823901|3691182|FG001|Overall Study|Adverse Event|1
2100487|NCT00823901|3691181|FG000|Overall Study|Lack of Efficacy|1
2100488|NCT00823901|3691182|FG001|Overall Study|Lack of Efficacy|0
2100489|NCT00823901|3691181|FG000|Overall Study|Lost to Follow-up|2
2100490|NCT00823901|3691182|FG001|Overall Study|Lost to Follow-up|1
2100491|NCT00823979|3691195|FG000|Overall Study|Lack of Efficacy|13
2100492|NCT00823979|3691196|FG001|Overall Study|Lack of Efficacy|16
2100493|NCT00823979|3691197|FG002|Overall Study|Lack of Efficacy|9
2100494|NCT00823979|3691195|FG000|Overall Study|Lost to Follow-up|2
2100495|NCT00823979|3691196|FG001|Overall Study|Lost to Follow-up|1
2100496|NCT00823979|3691197|FG002|Overall Study|Lost to Follow-up|0
2100497|NCT00823979|3691195|FG000|Overall Study|Withdrawal by Subject|2
2100498|NCT00823979|3691196|FG001|Overall Study|Withdrawal by Subject|3
2100499|NCT00823979|3691197|FG002|Overall Study|Withdrawal by Subject|2
2100500|NCT00823979|3691195|FG000|Overall Study|Protocol Violation|1
2100501|NCT00823979|3691196|FG001|Overall Study|Protocol Violation|1
2100502|NCT00823979|3691197|FG002|Overall Study|Protocol Violation|0
2100503|NCT00823979|3691195|FG000|Overall Study|Pregnancy|0
2100504|NCT00823979|3691196|FG001|Overall Study|Pregnancy|1
2100505|NCT00823979|3691197|FG002|Overall Study|Pregnancy|0
2100506|NCT00823979|3691195|FG000|Overall Study|Adverse Event|0
2100507|NCT00823979|3691196|FG001|Overall Study|Adverse Event|2
2100508|NCT00823979|3691197|FG002|Overall Study|Adverse Event|4
2100509|NCT00823979|3691195|FG000|Overall Study|Other|2
2100510|NCT00823979|3691196|FG001|Overall Study|Other|0
2100511|NCT00823979|3691197|FG002|Overall Study|Other|1
2100512|NCT00823979|3691195|FG000|Overall Study|Randomized but not Treated|4
2100513|NCT00823979|3691196|FG001|Overall Study|Randomized but not Treated|3
2100514|NCT00823979|3691197|FG002|Overall Study|Randomized but not Treated|1
2100515|NCT00823979|3691195|FG000|Overall Study|Study Terminated by Sponsor|5
2100516|NCT00823979|3691196|FG001|Overall Study|Study Terminated by Sponsor|5
2100517|NCT00823979|3691197|FG002|Overall Study|Study Terminated by Sponsor|7
2100518|NCT00824005|3691207|FG000|Overall Study|Death|0
2100519|NCT00824005|3691208|FG001|Overall Study|Death|1
2100520|NCT00824005|3691207|FG000|Overall Study|Lost to Follow-up|0
2100521|NCT00824005|3691208|FG001|Overall Study|Lost to Follow-up|1
2100522|NCT00824161|3691240|FG000|Overall Study|Withdrawal by Subject|1
2100523|NCT00824161|3691240|FG000|Overall Study|Screen Failure|1
2107998|NCT00877383|3701786|FG001|Overall Study|Subject no longer requires study drug|0
2107999|NCT00877383|3701785|FG000|Overall Study|Administrative problems|2
2108000|NCT00877383|3701786|FG001|Overall Study|Administrative problems|0
2108001|NCT00877383|3701785|FG000|Overall Study|Protocol deviation|2
2108002|NCT00877383|3701786|FG001|Overall Study|Protocol deviation|6
2108003|NCT00877383|3701785|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2108004|NCT00877383|3701786|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2108005|NCT00877383|3701785|FG000|Overall Study|Death|1
2108006|NCT00877383|3701786|FG001|Overall Study|Death|2
2108007|NCT00877487|3701821|FG000|Open-label Treatment Phase|Adverse Event|1
2108008|NCT00877487|3701822|FG001|Open-label Treatment Phase|Adverse Event|0
2100524|NCT00824265|3691247|FG000|Treatment Phase|Adverse Event,non-fatal|50
2100525|NCT00824265|3691248|FG001|Treatment Phase|Adverse Event,non-fatal|52
2100526|NCT00824265|3691247|FG000|Treatment Phase|Protocol Violation|1
2100527|NCT00824265|3691248|FG001|Treatment Phase|Protocol Violation|0
2100528|NCT00824265|3691247|FG000|Treatment Phase|Lost to Follow-up|1
2100529|NCT00824265|3691248|FG001|Treatment Phase|Lost to Follow-up|1
2100530|NCT00824265|3691247|FG000|Treatment Phase|Physician Decision|6
2100531|NCT00824265|3691248|FG001|Treatment Phase|Physician Decision|12
2100532|NCT00824265|3691247|FG000|Treatment Phase|Withdrawal by Subject|6
2100533|NCT00824265|3691248|FG001|Treatment Phase|Withdrawal by Subject|15
2100534|NCT00824265|3691247|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
2100535|NCT00824265|3691248|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
2100536|NCT00824265|3691247|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
2100537|NCT00824265|3691248|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
2100538|NCT00824291|3691260|FG000|Overall Study|Adverse Event|15
2100539|NCT00824291|3691261|FG001|Overall Study|Adverse Event|6
2100540|NCT00824291|3691260|FG000|Overall Study|Discontinuation of Study by Sponsor|1
2100541|NCT00824291|3691261|FG001|Overall Study|Discontinuation of Study by Sponsor|2
2100542|NCT00824291|3691260|FG000|Overall Study|Lost to Follow-up|11
2100543|NCT00824291|3691261|FG001|Overall Study|Lost to Follow-up|9
2100544|NCT00824291|3691260|FG000|Overall Study|Non-compliance|1
2100545|NCT00824291|3691261|FG001|Overall Study|Non-compliance|1
2100546|NCT00824291|3691260|FG000|Overall Study|Protocol Violation|4
2100547|NCT00824291|3691261|FG001|Overall Study|Protocol Violation|1
2100548|NCT00824291|3691260|FG000|Overall Study|Withdrawal by Subject|14
2100549|NCT00824291|3691261|FG001|Overall Study|Withdrawal by Subject|8
2100550|NCT00824291|3691260|FG000|Overall Study|Lack of Efficacy|7
2100551|NCT00824291|3691261|FG001|Overall Study|Lack of Efficacy|8
2100552|NCT00824291|3691260|FG000|Overall Study|Participant on prohibited medication|1
2100553|NCT00824291|3691261|FG001|Overall Study|Participant on prohibited medication|0
2100554|NCT00824369|3691273|FG000|Overall Study|Nolonger willing to participate in study|1
2100555|NCT00824369|3691274|FG001|Overall Study|Nolonger willing to participate in study|0
2100556|NCT00824369|3691275|FG002|Overall Study|Nolonger willing to participate in study|1
2100557|NCT00824369|3691276|FG003|Overall Study|Nolonger willing to participate in study|2
2100558|NCT00824369|3691277|FG004|Overall Study|Nolonger willing to participate in study|0
2100559|NCT00824369|3691278|FG005|Overall Study|Nolonger willing to participate in study|1
2100560|NCT00824369|3691273|FG000|Overall Study|Lost to Follow-up|0
2100561|NCT00824369|3691274|FG001|Overall Study|Lost to Follow-up|0
2100562|NCT00824369|3691275|FG002|Overall Study|Lost to Follow-up|0
2100563|NCT00824369|3691276|FG003|Overall Study|Lost to Follow-up|0
2100564|NCT00824369|3691277|FG004|Overall Study|Lost to Follow-up|1
2100565|NCT00824369|3691278|FG005|Overall Study|Lost to Follow-up|0
2100566|NCT00824382|3691296|FG000|Overall Study|Adverse Event|4
2100567|NCT00824382|3691297|FG001|Overall Study|Adverse Event|1
2100568|NCT00824382|3691298|FG002|Overall Study|Adverse Event|1
2100569|NCT00824382|3691299|FG003|Overall Study|Adverse Event|4
2100570|NCT00824382|3691296|FG000|Overall Study|Protocol Violation|1
2100571|NCT00824382|3691297|FG001|Overall Study|Protocol Violation|0
2100572|NCT00824382|3691298|FG002|Overall Study|Protocol Violation|0
2100573|NCT00824382|3691299|FG003|Overall Study|Protocol Violation|1
2100574|NCT00824382|3691296|FG000|Overall Study|Investigator's decision|0
2100575|NCT00824382|3691297|FG001|Overall Study|Investigator's decision|1
2100576|NCT00824382|3691298|FG002|Overall Study|Investigator's decision|2
2100577|NCT00824382|3691299|FG003|Overall Study|Investigator's decision|0
2100578|NCT00824408|3691316|FG000|Run-in Phase|Progressive disease|4
2100579|NCT00824408|3691317|FG001|Run-in Phase|Progressive disease|4
2100580|NCT00824408|3691318|FG002|Run-in Phase|Progressive disease|0
2100581|NCT00824408|3691319|FG003|Run-in Phase|Progressive disease|0
2100582|NCT00824408|3691320|FG004|Run-in Phase|Progressive disease|0
2100583|NCT00824408|3691316|FG000|Run-in Phase|Adverse Event|1
2100584|NCT00824408|3691317|FG001|Run-in Phase|Adverse Event|1
2100585|NCT00824408|3691318|FG002|Run-in Phase|Adverse Event|0
2100586|NCT00824408|3691319|FG003|Run-in Phase|Adverse Event|0
2100587|NCT00824408|3691320|FG004|Run-in Phase|Adverse Event|0
2100588|NCT00824408|3691316|FG000|Run-in Phase|Refused to continue medication|1
2100589|NCT00824408|3691317|FG001|Run-in Phase|Refused to continue medication|0
2100590|NCT00824408|3691318|FG002|Run-in Phase|Refused to continue medication|0
2100591|NCT00824408|3691319|FG003|Run-in Phase|Refused to continue medication|0
2100592|NCT00824408|3691320|FG004|Run-in Phase|Refused to continue medication|0
2100593|NCT00824408|3691316|FG000|Run-in Phase|Other reason not defined above|0
2100594|NCT00824408|3691317|FG001|Run-in Phase|Other reason not defined above|1
2100595|NCT00824408|3691318|FG002|Run-in Phase|Other reason not defined above|0
2100596|NCT00824408|3691319|FG003|Run-in Phase|Other reason not defined above|0
2100597|NCT00824408|3691320|FG004|Run-in Phase|Other reason not defined above|0
2100598|NCT00824408|3691316|FG000|Randomized Phase|Not treated|0
2100599|NCT00824408|3691317|FG001|Randomized Phase|Not treated|0
2100600|NCT00824408|3691318|FG002|Randomized Phase|Not treated|1
2100601|NCT00824408|3691319|FG003|Randomized Phase|Not treated|1
2100602|NCT00824408|3691320|FG004|Randomized Phase|Not treated|1
2100603|NCT00824408|3691316|FG000|Randomized Phase|Progressive disease|0
2100604|NCT00824408|3691317|FG001|Randomized Phase|Progressive disease|0
2100605|NCT00824408|3691318|FG002|Randomized Phase|Progressive disease|25
2100606|NCT00824408|3691319|FG003|Randomized Phase|Progressive disease|36
2100607|NCT00824408|3691320|FG004|Randomized Phase|Progressive disease|34
2100608|NCT00824408|3691316|FG000|Randomized Phase|Adverse Event|0
2100609|NCT00824408|3691317|FG001|Randomized Phase|Adverse Event|0
2100610|NCT00824408|3691318|FG002|Randomized Phase|Adverse Event|4
2100611|NCT00824408|3691319|FG003|Randomized Phase|Adverse Event|5
2100612|NCT00824408|3691320|FG004|Randomized Phase|Adverse Event|5
2100613|NCT00824408|3691316|FG000|Randomized Phase|Refused to continue medication|0
2100614|NCT00824408|3691317|FG001|Randomized Phase|Refused to continue medication|0
2100615|NCT00824408|3691318|FG002|Randomized Phase|Refused to continue medication|2
2100616|NCT00824408|3691319|FG003|Randomized Phase|Refused to continue medication|2
2100617|NCT00824408|3691320|FG004|Randomized Phase|Refused to continue medication|2
2100618|NCT00824408|3691316|FG000|Randomized Phase|Other reason not defined above|0
2100619|NCT00824408|3691317|FG001|Randomized Phase|Other reason not defined above|0
2100620|NCT00824408|3691318|FG002|Randomized Phase|Other reason not defined above|4
2100621|NCT00824408|3691319|FG003|Randomized Phase|Other reason not defined above|2
2100622|NCT00824408|3691320|FG004|Randomized Phase|Other reason not defined above|4
2100623|NCT00824421|3691341|FG000|Overall Study|Adverse Event|6
2100624|NCT00824421|3691342|FG001|Overall Study|Adverse Event|6
2100625|NCT00824421|3691343|FG002|Overall Study|Adverse Event|6
2100626|NCT00824421|3691341|FG000|Overall Study|Death|0
2100627|NCT00824421|3691342|FG001|Overall Study|Death|1
2100628|NCT00824421|3691343|FG002|Overall Study|Death|0
2100629|NCT00824421|3691341|FG000|Overall Study|Lack of Efficacy|5
2100630|NCT00824421|3691342|FG001|Overall Study|Lack of Efficacy|7
2100631|NCT00824421|3691343|FG002|Overall Study|Lack of Efficacy|4
2100632|NCT00824421|3691341|FG000|Overall Study|Lost to Follow-up|2
2100633|NCT00824421|3691342|FG001|Overall Study|Lost to Follow-up|3
2100634|NCT00824421|3691343|FG002|Overall Study|Lost to Follow-up|0
2100635|NCT00824421|3691341|FG000|Overall Study|Pregnancy|1
2100636|NCT00824421|3691342|FG001|Overall Study|Pregnancy|0
2100637|NCT00824421|3691343|FG002|Overall Study|Pregnancy|1
2100638|NCT00824421|3691341|FG000|Overall Study|Withdrawal by Subject|2
2100639|NCT00824421|3691342|FG001|Overall Study|Withdrawal by Subject|3
2100640|NCT00824421|3691343|FG002|Overall Study|Withdrawal by Subject|3
2100641|NCT00824421|3691341|FG000|Overall Study|Randomized but not Treated|1
2100642|NCT00824421|3691342|FG001|Overall Study|Randomized but not Treated|1
2100643|NCT00824421|3691343|FG002|Overall Study|Randomized but not Treated|0
2100644|NCT00824421|3691341|FG000|Overall Study|Other|0
2100645|NCT00824421|3691342|FG001|Overall Study|Other|1
2100646|NCT00824421|3691343|FG002|Overall Study|Other|0
2212253|NCT01668667|3853315|FG001|Overall Study|Lost to Follow-up|4
2212254|NCT01668667|3853316|FG002|Overall Study|Lost to Follow-up|7
2212255|NCT01668667|3853317|FG003|Overall Study|Lost to Follow-up|6
2212256|NCT01668667|3853314|FG000|Overall Study|Physician Decision|3
2212257|NCT01668667|3853315|FG001|Overall Study|Physician Decision|0
2212258|NCT01668667|3853316|FG002|Overall Study|Physician Decision|1
2212259|NCT01668667|3853317|FG003|Overall Study|Physician Decision|0
2212260|NCT01668667|3853314|FG000|Overall Study|Withdrawal by Subject|7
2212261|NCT01668667|3853315|FG001|Overall Study|Withdrawal by Subject|4
2212262|NCT01668667|3853316|FG002|Overall Study|Withdrawal by Subject|5
2212263|NCT01668667|3853317|FG003|Overall Study|Withdrawal by Subject|5
2212264|NCT01668719|3853330|FG000|Phase I|On treatment|1
2212265|NCT01668719|3853331|FG001|Phase I|On treatment|0
2212266|NCT01668719|3853332|FG002|Phase I|On treatment|0
2212267|NCT01668719|3853330|FG000|Phase I|Adverse Event|2
2212268|NCT01668719|3853331|FG001|Phase I|Adverse Event|0
2307641|NCT02699749|4010158|FG011|Overall Study|Progressive Disease|4
2100647|NCT00824473|3691392|FG000|Overall Study|Adverse Event|4
2100648|NCT00824473|3691393|FG001|Overall Study|Adverse Event|5
2100649|NCT00824473|3691392|FG000|Overall Study|Lack of Efficacy|2
2100650|NCT00824473|3691393|FG001|Overall Study|Lack of Efficacy|2
2100651|NCT00824473|3691392|FG000|Overall Study|Protocol Violation|2
2100652|NCT00824473|3691393|FG001|Overall Study|Protocol Violation|0
2100653|NCT00824473|3691392|FG000|Overall Study|Non-Compliance|4
2100654|NCT00824473|3691393|FG001|Overall Study|Non-Compliance|2
2100655|NCT00824473|3691392|FG000|Overall Study|Withdrawal by Subject|2
2100656|NCT00824473|3691393|FG001|Overall Study|Withdrawal by Subject|3
2100657|NCT00824473|3691392|FG000|Overall Study|Other|1
2100658|NCT00824473|3691393|FG001|Overall Study|Other|1
2100659|NCT00824564|3691415|FG000|Overall Study|Lost to Follow-up|5
2212269|NCT01668719|3853332|FG002|Phase I|Adverse Event|0
2212270|NCT01668719|3853330|FG000|Phase I|Progression/relapse|1
2307642|NCT02699749|4010159|FG012|Overall Study|Progressive Disease|3
2307643|NCT02699749|4010160|FG013|Overall Study|Progressive Disease|5
2307644|NCT02699749|4010147|FG000|Overall Study|Death|0
2307645|NCT02699749|4010148|FG001|Overall Study|Death|0
2307646|NCT02699749|4010149|FG002|Overall Study|Death|0
2307647|NCT02699749|4010150|FG003|Overall Study|Death|0
2307648|NCT02699749|4010151|FG004|Overall Study|Death|0
2307649|NCT02699749|4010152|FG005|Overall Study|Death|0
2307650|NCT02699749|4010153|FG006|Overall Study|Death|0
2307651|NCT02699749|4010154|FG007|Overall Study|Death|0
2307652|NCT02699749|4010155|FG008|Overall Study|Death|0
2307653|NCT02699749|4010156|FG009|Overall Study|Death|0
2307654|NCT02699749|4010157|FG010|Overall Study|Death|0
2100660|NCT00824564|3691416|FG001|Overall Study|Lost to Follow-up|7
2100661|NCT00824564|3691415|FG000|Overall Study|Withdrawal by Subject|1
2100662|NCT00824564|3691416|FG001|Overall Study|Withdrawal by Subject|1
2100663|NCT00824564|3691415|FG000|Overall Study|Other|1
2100664|NCT00824564|3691416|FG001|Overall Study|Other|2
2100665|NCT00824564|3691415|FG000|Overall Study|Randomized, but not treated|1
2100666|NCT00824564|3691416|FG001|Overall Study|Randomized, but not treated|0
2100667|NCT00824616|3691424|FG000|Overall Study|Adverse Event|2
2100668|NCT00824616|3691425|FG001|Overall Study|Adverse Event|1
2100669|NCT00824616|3691424|FG000|Overall Study|Creatinine/Creatinine Clearance|0
2100670|NCT00824616|3691425|FG001|Overall Study|Creatinine/Creatinine Clearance|2
2100671|NCT00824616|3691424|FG000|Overall Study|Hyperglycemia|1
2100672|NCT00824616|3691425|FG001|Overall Study|Hyperglycemia|1
2100673|NCT00824616|3691424|FG000|Overall Study|Lack of Efficacy|2
2100674|NCT00824616|3691425|FG001|Overall Study|Lack of Efficacy|1
2100675|NCT00824616|3691424|FG000|Overall Study|Lost to Follow-up|0
2100676|NCT00824616|3691425|FG001|Overall Study|Lost to Follow-up|1
2100677|NCT00824616|3691424|FG000|Overall Study|Withdrawal by Subject|1
2100678|NCT00824616|3691425|FG001|Overall Study|Withdrawal by Subject|1
2100679|NCT00824655|3691433|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1
2100680|NCT00824655|3691434|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0
2100681|NCT00824655|3691433|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
2100682|NCT00824655|3691434|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
2100683|NCT00824720|3691445|FG000|Overall Study|failed plug insertion|3
2100684|NCT00824720|3691446|FG001|Overall Study|failed plug insertion|1
2100685|NCT00824720|3691447|FG002|Overall Study|failed plug insertion|0
2100686|NCT00824720|3691445|FG000|Overall Study|Protocol Violation|0
2100687|NCT00824720|3691446|FG001|Overall Study|Protocol Violation|0
2100688|NCT00824720|3691447|FG002|Overall Study|Protocol Violation|1
2100689|NCT00824772|3691465|FG000|Overall Study|Withdrawal by Subject|8
2100690|NCT00824850|3691480|FG000|Overall Study|Withdrawal by Subject|0
2100691|NCT00824850|3691481|FG001|Overall Study|Withdrawal by Subject|1
2100692|NCT00824993|3691495|FG000|Overall Study|Withdrawal by Subject|1
2100693|NCT00824993|3691496|FG001|Overall Study|Withdrawal by Subject|1
2100694|NCT00824993|3691495|FG000|Overall Study|Malignancy Relapse|9
2100695|NCT00824993|3691496|FG001|Overall Study|Malignancy Relapse|10
2100696|NCT00824993|3691495|FG000|Overall Study|Rapid Bone Loss|0
2100697|NCT00824993|3691496|FG001|Overall Study|Rapid Bone Loss|1
2100698|NCT00824993|3691495|FG000|Overall Study|Non-Compliant|2
2100699|NCT00824993|3691496|FG001|Overall Study|Non-Compliant|1
2100700|NCT00824993|3691495|FG000|Overall Study|Insurance Issue|2
2100701|NCT00824993|3691496|FG001|Overall Study|Insurance Issue|1
2100702|NCT00824993|3691495|FG000|Overall Study|Death|0
2100703|NCT00824993|3691496|FG001|Overall Study|Death|3
2100704|NCT00825162|3691505|FG000|Overall Study|Withdrawal by Subject|11
2100705|NCT00825162|3691506|FG001|Overall Study|Withdrawal by Subject|13
2100706|NCT00825162|3691507|FG002|Overall Study|Withdrawal by Subject|3
2100707|NCT00825162|3691505|FG000|Overall Study|Lost to Follow-up|9
2100708|NCT00825162|3691506|FG001|Overall Study|Lost to Follow-up|6
2100709|NCT00825162|3691507|FG002|Overall Study|Lost to Follow-up|3
2100710|NCT00825162|3691505|FG000|Overall Study|Physician Decision|2
2100711|NCT00825162|3691506|FG001|Overall Study|Physician Decision|0
2100712|NCT00825162|3691507|FG002|Overall Study|Physician Decision|0
2100713|NCT00825162|3691505|FG000|Overall Study|Move away from the study area|1
2100714|NCT00825162|3691506|FG001|Overall Study|Move away from the study area|0
2100715|NCT00825162|3691507|FG002|Overall Study|Move away from the study area|0
2100716|NCT00825162|3691505|FG000|Overall Study|Unable to attend the study visit|5
2100717|NCT00825162|3691506|FG001|Overall Study|Unable to attend the study visit|2
2100718|NCT00825162|3691507|FG002|Overall Study|Unable to attend the study visit|0
2100719|NCT00825175|3691522|FG000|Overall Study|Withdrawal by Subject|0
2100720|NCT00825175|3691523|FG001|Overall Study|Withdrawal by Subject|5
2100721|NCT00825305|3691540|FG000|Overall Study|Adverse Event|1
2100722|NCT00825305|3691541|FG001|Overall Study|Adverse Event|1
2100723|NCT00825305|3691540|FG000|Overall Study|Withdrawal by Subject|6
2100724|NCT00825305|3691541|FG001|Overall Study|Withdrawal by Subject|12
2100725|NCT00825305|3691540|FG000|Overall Study|Inappropriate inclusion|1
2100726|NCT00825305|3691541|FG001|Overall Study|Inappropriate inclusion|0
2100727|NCT00825305|3691540|FG000|Overall Study|Protocol Violation|9
2100728|NCT00825305|3691541|FG001|Overall Study|Protocol Violation|9
2100729|NCT00825305|3691540|FG000|Overall Study|Can not be classified|0
2100730|NCT00825305|3691541|FG001|Overall Study|Can not be classified|1
2100731|NCT00825682|3691615|FG000|Overall Study|personal reasons/ inconvenience|13
2100732|NCT00825682|3691616|FG001|Overall Study|personal reasons/ inconvenience|5
2100733|NCT00825812|3691643|FG000|Overall Study|Never entered follow up|0
2100734|NCT00825812|3691644|FG001|Overall Study|Never entered follow up|0
2100735|NCT00825812|3691645|FG002|Overall Study|Never entered follow up|0
2100736|NCT00825812|3691646|FG003|Overall Study|Never entered follow up|1
2100737|NCT00825812|3691643|FG000|Overall Study|Adverse Event|0
2100738|NCT00825812|3691644|FG001|Overall Study|Adverse Event|0
2100739|NCT00825812|3691645|FG002|Overall Study|Adverse Event|0
2100740|NCT00825812|3691646|FG003|Overall Study|Adverse Event|1
2100741|NCT00825812|3691643|FG000|Overall Study|Subject withdrew consent|0
2100742|NCT00825812|3691644|FG001|Overall Study|Subject withdrew consent|0
2100743|NCT00825812|3691645|FG002|Overall Study|Subject withdrew consent|3
2100744|NCT00825812|3691646|FG003|Overall Study|Subject withdrew consent|2
2100745|NCT00825812|3691643|FG000|Overall Study|Non-compliance with protocol|0
2100746|NCT00825812|3691644|FG001|Overall Study|Non-compliance with protocol|0
2100747|NCT00825812|3691645|FG002|Overall Study|Non-compliance with protocol|0
2100748|NCT00825812|3691646|FG003|Overall Study|Non-compliance with protocol|1
2100749|NCT00825812|3691643|FG000|Overall Study|Administrative|0
2100750|NCT00825812|3691644|FG001|Overall Study|Administrative|1
2100751|NCT00825812|3691645|FG002|Overall Study|Administrative|3
2100752|NCT00825812|3691646|FG003|Overall Study|Administrative|5
2100753|NCT00825825|3691656|FG000|First Medication Period (14 Days)|Adverse Event|1
2100754|NCT00825825|3691657|FG001|First Medication Period (14 Days)|Adverse Event|0
2100755|NCT00825825|3691658|FG002|First Medication Period (14 Days)|Adverse Event|0
2100756|NCT00825825|3691659|FG003|First Medication Period (14 Days)|Adverse Event|0
2100757|NCT00825825|3691660|FG004|First Medication Period (14 Days)|Adverse Event|0
2100758|NCT00825825|3691661|FG005|First Medication Period (14 Days)|Adverse Event|1
2100759|NCT00825825|3691656|FG000|First Medication Period (14 Days)|Physician Decision|2
2100760|NCT00825825|3691657|FG001|First Medication Period (14 Days)|Physician Decision|0
2100761|NCT00825825|3691658|FG002|First Medication Period (14 Days)|Physician Decision|1
2100762|NCT00825825|3691659|FG003|First Medication Period (14 Days)|Physician Decision|0
2100763|NCT00825825|3691660|FG004|First Medication Period (14 Days)|Physician Decision|0
2100764|NCT00825825|3691661|FG005|First Medication Period (14 Days)|Physician Decision|1
2100765|NCT00825825|3691656|FG000|Second Medication Period (14 Days)|Physician Decision|1
2100766|NCT00825825|3691657|FG001|Second Medication Period (14 Days)|Physician Decision|0
2100767|NCT00825825|3691658|FG002|Second Medication Period (14 Days)|Physician Decision|0
2100768|NCT00825825|3691659|FG003|Second Medication Period (14 Days)|Physician Decision|2
2100769|NCT00825825|3691660|FG004|Second Medication Period (14 Days)|Physician Decision|0
2100770|NCT00825825|3691661|FG005|Second Medication Period (14 Days)|Physician Decision|0
2100771|NCT00825825|3691656|FG000|Second Medication Period (14 Days)|Protocol Violation|1
2100772|NCT00825825|3691657|FG001|Second Medication Period (14 Days)|Protocol Violation|0
2100773|NCT00825825|3691658|FG002|Second Medication Period (14 Days)|Protocol Violation|0
2100774|NCT00825825|3691659|FG003|Second Medication Period (14 Days)|Protocol Violation|0
2100775|NCT00825825|3691660|FG004|Second Medication Period (14 Days)|Protocol Violation|1
2100776|NCT00825825|3691661|FG005|Second Medication Period (14 Days)|Protocol Violation|0
2100777|NCT00825825|3691656|FG000|Third Medication Period (14 Days)|Adverse Event|0
2100778|NCT00825825|3691657|FG001|Third Medication Period (14 Days)|Adverse Event|1
2100779|NCT00825825|3691658|FG002|Third Medication Period (14 Days)|Adverse Event|0
2100780|NCT00825825|3691659|FG003|Third Medication Period (14 Days)|Adverse Event|0
2100781|NCT00825825|3691660|FG004|Third Medication Period (14 Days)|Adverse Event|0
2100782|NCT00825825|3691661|FG005|Third Medication Period (14 Days)|Adverse Event|0
2100783|NCT00825825|3691656|FG000|Third Medication Period (14 Days)|Protocol Violation|0
2100784|NCT00825825|3691657|FG001|Third Medication Period (14 Days)|Protocol Violation|0
2100785|NCT00825825|3691658|FG002|Third Medication Period (14 Days)|Protocol Violation|0
2100786|NCT00825825|3691659|FG003|Third Medication Period (14 Days)|Protocol Violation|0
2100787|NCT00825825|3691660|FG004|Third Medication Period (14 Days)|Protocol Violation|0
2100788|NCT00825825|3691661|FG005|Third Medication Period (14 Days)|Protocol Violation|2
2100789|NCT00825825|3691656|FG000|Third Medication Period (14 Days)|poor data quality|0
2100790|NCT00825825|3691657|FG001|Third Medication Period (14 Days)|poor data quality|1
2100791|NCT00825825|3691658|FG002|Third Medication Period (14 Days)|poor data quality|0
2100792|NCT00825825|3691659|FG003|Third Medication Period (14 Days)|poor data quality|0
2100793|NCT00825825|3691660|FG004|Third Medication Period (14 Days)|poor data quality|0
2100794|NCT00825825|3691661|FG005|Third Medication Period (14 Days)|poor data quality|0
2100795|NCT00825916|3691671|FG000|Overall Study|Lost to Follow-up|4
2100796|NCT00825916|3691672|FG001|Overall Study|Lost to Follow-up|2
2100797|NCT00825916|3691673|FG002|Overall Study|Lost to Follow-up|1
2100798|NCT00825994|3691714|FG000|Overall Study|Withdrawal by Subject|2
2100799|NCT00825994|3691714|FG000|Overall Study|Lost to Follow-up|1
2100800|NCT00825994|3691714|FG000|Overall Study|Protocol Violation|1
2100801|NCT00825994|3691714|FG000|Overall Study|Placebo Responder at V2|1
2100802|NCT00826111|3691732|FG000|Overall Study|Lost to Follow-up|0
2100803|NCT00826111|3691733|FG001|Overall Study|Lost to Follow-up|1
2100804|NCT00826111|3691732|FG000|Overall Study|Protocol Violation|1
2100805|NCT00826111|3691733|FG001|Overall Study|Protocol Violation|0
2100806|NCT00826111|3691732|FG000|Overall Study|Withdrawal by Subject|5
2100807|NCT00826111|3691733|FG001|Overall Study|Withdrawal by Subject|0
2100808|NCT00826111|3691732|FG000|Overall Study|Physician Decision|1
2100809|NCT00826111|3691733|FG001|Overall Study|Physician Decision|1
2100810|NCT00826176|3691759|FG000|Overall Study|Lost to Follow-up|1
2100811|NCT00826176|3691760|FG001|Overall Study|Lost to Follow-up|0
2100812|NCT00826176|3691759|FG000|Overall Study|Subject Withdrew Consent|3
2100813|NCT00826176|3691760|FG001|Overall Study|Subject Withdrew Consent|0
2100814|NCT00826176|3691759|FG000|Overall Study|Administrative|9
2100815|NCT00826176|3691760|FG001|Overall Study|Administrative|0
2100816|NCT00826228|3691775|FG000|Overall Study|Withdrawal by Subject|1
2100817|NCT00826241|3691780|FG000|Overall Study|Withdrawal from Follow-up|1
2100818|NCT00826241|3691780|FG000|Overall Study|Withdrew consent|2
2100819|NCT00826241|3691780|FG000|Overall Study|Death|4
2100820|NCT00826241|3691780|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
2100821|NCT00826241|3691780|FG000|Overall Study|Non-compliance|1
2100822|NCT00826241|3691780|FG000|Overall Study|Progression of disease|1
2100823|NCT00826241|3691780|FG000|Overall Study|Patient refused follow-up|3
2100824|NCT00826241|3691780|FG000|Overall Study|Lost to Follow-up|9
2100825|NCT00826241|3691780|FG000|Overall Study|Could not obtain records|1
2100826|NCT00826241|3691780|FG000|Overall Study|Screen failure|2
2100827|NCT00826241|3691780|FG000|Overall Study|Pt unable to proceed to registration|1
2100828|NCT00826241|3691780|FG000|Overall Study|Pt opt not to proceed w/trmt|1
2100829|NCT00826267|3691787|FG000|Overall Study|Other Adverse Event|1
2100830|NCT00826267|3691788|FG001|Overall Study|Other Adverse Event|0
2100831|NCT00826267|3691789|FG002|Overall Study|Other Adverse Event|0
2100832|NCT00826280|3691801|FG000|Overall Study|Randomized but drug not received|1
2100833|NCT00826280|3691802|FG001|Overall Study|Randomized but drug not received|0
2100834|NCT00826280|3691803|FG002|Overall Study|Randomized but drug not received|1
2100835|NCT00826280|3691801|FG000|Overall Study|Adverse Event|1
2100836|NCT00826280|3691802|FG001|Overall Study|Adverse Event|3
2100837|NCT00826280|3691803|FG002|Overall Study|Adverse Event|0
2100838|NCT00826280|3691801|FG000|Overall Study|Lost to Follow-up|0
2100839|NCT00826280|3691802|FG001|Overall Study|Lost to Follow-up|1
2100840|NCT00826280|3691803|FG002|Overall Study|Lost to Follow-up|0
2100841|NCT00826280|3691801|FG000|Overall Study|Sponsor discontinued subject or study|1
2100842|NCT00826280|3691802|FG001|Overall Study|Sponsor discontinued subject or study|0
2100843|NCT00826280|3691803|FG002|Overall Study|Sponsor discontinued subject or study|0
2100844|NCT00826280|3691801|FG000|Overall Study|Reversible ischemic defect not present|43
2100845|NCT00826280|3691802|FG001|Overall Study|Reversible ischemic defect not present|40
2100846|NCT00826280|3691803|FG002|Overall Study|Reversible ischemic defect not present|44
2100847|NCT00826280|3691801|FG000|Overall Study|Interpretation Failure|1
2100848|NCT00826280|3691802|FG001|Overall Study|Interpretation Failure|0
2100849|NCT00826280|3691803|FG002|Overall Study|Interpretation Failure|0
2100850|NCT00826280|3691801|FG000|Overall Study|Machine Failure|1
2100851|NCT00826280|3691802|FG001|Overall Study|Machine Failure|1
2100852|NCT00826280|3691803|FG002|Overall Study|Machine Failure|0
2100853|NCT00826280|3691801|FG000|Overall Study|One or more non-interpretable scan|0
2100854|NCT00826280|3691802|FG001|Overall Study|One or more non-interpretable scan|1
2100855|NCT00826280|3691803|FG002|Overall Study|One or more non-interpretable scan|1
2100856|NCT00826449|3691813|FG000|Overall Study|Disease Progression|4
2100857|NCT00826449|3691813|FG000|Overall Study|Withdrawal by Subject|1
2100858|NCT00826514|3691820|FG000|Overall Study|Adverse Event|1
2100859|NCT00826514|3691821|FG001|Overall Study|Adverse Event|1
2100860|NCT00826514|3691820|FG000|Overall Study|Lack of Efficacy|0
2100861|NCT00826514|3691821|FG001|Overall Study|Lack of Efficacy|1
2100862|NCT00826514|3691820|FG000|Overall Study|Withdrawal by Subject|2
2100863|NCT00826514|3691821|FG001|Overall Study|Withdrawal by Subject|3
2100864|NCT00826540|3691827|FG000|Overall Study|ineligible|3
2100865|NCT00826540|3691827|FG000|Overall Study|Withdrawal by Subject|1
2100866|NCT00826618|3691831|FG000|Overall Study|Withdrawal by Subject|1
2100867|NCT00826748|3691838|FG000|Overall Study|Withdrawal by Subject|0
2100868|NCT00826748|3691839|FG001|Overall Study|Withdrawal by Subject|0
2100869|NCT00826748|3691840|FG002|Overall Study|Withdrawal by Subject|2
2100870|NCT00826748|3691838|FG000|Overall Study|Physician Decision|0
2100871|NCT00826748|3691839|FG001|Overall Study|Physician Decision|0
2100872|NCT00826748|3691840|FG002|Overall Study|Physician Decision|1
2100873|NCT00826748|3691838|FG000|Overall Study|Samples Did Not pass QC|0
2100874|NCT00826748|3691839|FG001|Overall Study|Samples Did Not pass QC|0
2100875|NCT00826748|3691840|FG002|Overall Study|Samples Did Not pass QC|1
2100876|NCT00826943|3691852|FG000|Overall Study|Withdrawal by Subject|0
2100877|NCT00826943|3691853|FG001|Overall Study|Withdrawal by Subject|0
2100878|NCT00826943|3691854|FG002|Overall Study|Withdrawal by Subject|0
2100879|NCT00826943|3691855|FG003|Overall Study|Withdrawal by Subject|0
2100880|NCT00826943|3691856|FG004|Overall Study|Withdrawal by Subject|1
2100881|NCT00826943|3691857|FG005|Overall Study|Withdrawal by Subject|0
2100882|NCT00827112|3691880|FG000|Overall Study|Adverse Event|2
2100883|NCT00827112|3691881|FG001|Overall Study|Adverse Event|0
2100884|NCT00827112|3691880|FG000|Overall Study|Lack of Efficacy|2
2100885|NCT00827112|3691881|FG001|Overall Study|Lack of Efficacy|0
2100886|NCT00827112|3691880|FG000|Overall Study|Lost to Follow-up|3
2100887|NCT00827112|3691881|FG001|Overall Study|Lost to Follow-up|2
2100888|NCT00827112|3691880|FG000|Overall Study|Pregnancy|0
2100889|NCT00827112|3691881|FG001|Overall Study|Pregnancy|1
2100890|NCT00827112|3691880|FG000|Overall Study|Protocol Violation|0
2100891|NCT00827112|3691881|FG001|Overall Study|Protocol Violation|2
2100892|NCT00827112|3691880|FG000|Overall Study|Withdrawal by Subject|2
2100893|NCT00827112|3691881|FG001|Overall Study|Withdrawal by Subject|1
2100894|NCT00827112|3691880|FG000|Overall Study|Randomized but not treated|5
2100895|NCT00827112|3691881|FG001|Overall Study|Randomized but not treated|3
2100896|NCT00827112|3691880|FG000|Overall Study|Other|1
2100897|NCT00827112|3691881|FG001|Overall Study|Other|3
2100898|NCT00827242|3691889|FG000|Overall Study|Withdrawal by Subject|2
2100899|NCT00827242|3691890|FG001|Overall Study|Withdrawal by Subject|4
2100900|NCT00827242|3691889|FG000|Overall Study|Protocol Violation|1
2100901|NCT00827242|3691890|FG001|Overall Study|Protocol Violation|3
2100902|NCT00827242|3691889|FG000|Overall Study|Lost to Follow-up|0
2100903|NCT00827242|3691890|FG001|Overall Study|Lost to Follow-up|3
2100904|NCT00827242|3691889|FG000|Overall Study|Adverse Event Excluding Death|2
2100905|NCT00827242|3691890|FG001|Overall Study|Adverse Event Excluding Death|1
2100906|NCT00827242|3691889|FG000|Overall Study|Entry Criteria Not Met|4
2100907|NCT00827242|3691890|FG001|Overall Study|Entry Criteria Not Met|1
2100908|NCT00827242|3691889|FG000|Overall Study|Physician Decision|2
2100909|NCT00827242|3691890|FG001|Overall Study|Physician Decision|0
2100910|NCT00827242|3691889|FG000|Overall Study|Death|1
2100911|NCT00827242|3691890|FG001|Overall Study|Death|0
2100912|NCT00827242|3691889|FG000|Overall Study|Lack of Efficacy|1
2100913|NCT00827242|3691890|FG001|Overall Study|Lack of Efficacy|0
2100914|NCT00827359|3691900|FG000|Overall Study|Progressive Diseas|19
2100915|NCT00827359|3691900|FG000|Overall Study|Unacceptable Toxicity|5
2100916|NCT00827359|3691900|FG000|Overall Study|Ineligible|1
2100917|NCT00827372|3691904|FG000|Overall Study|Adverse Event|5
2100918|NCT00827372|3691904|FG000|Overall Study|Lack of Efficacy|3
2100919|NCT00827502|3691909|FG000|Overall Study|randomized but not treated|11
2100920|NCT00827502|3691909|FG000|Overall Study|Adverse Event|1
2100921|NCT00827502|3691909|FG000|Overall Study|Lost to Follow-up|4
2100922|NCT00827502|3691909|FG000|Overall Study|Withdrawal by Subject|5
2100923|NCT00827541|3691915|FG000|Overall Study|Exitus|1
2100924|NCT00827541|3691916|FG001|Overall Study|Exitus|8
2100925|NCT00827541|3691915|FG000|Overall Study|Other|1
2100926|NCT00827541|3691916|FG001|Overall Study|Other|3
2100927|NCT00827541|3691915|FG000|Overall Study|Pathogen not susceptible|1
2100928|NCT00827541|3691916|FG001|Overall Study|Pathogen not susceptible|0
2100929|NCT00827541|3691915|FG000|Overall Study|Lack of effectiveness|1
2100930|NCT00827541|3691916|FG001|Overall Study|Lack of effectiveness|0
2100931|NCT00827606|3691924|FG000|Overall Study|Protocol Violation|4
2100932|NCT00827606|3691925|FG001|Overall Study|Protocol Violation|3
2100933|NCT00827606|3691924|FG000|Overall Study|Lost to Follow-up|3
2100934|NCT00827606|3691925|FG001|Overall Study|Lost to Follow-up|1
2100935|NCT00827606|3691924|FG000|Overall Study|Withdrawal by Subject|7
2100936|NCT00827606|3691925|FG001|Overall Study|Withdrawal by Subject|6
2100937|NCT00827606|3691924|FG000|Overall Study|Pregnancy|0
2100938|NCT00827606|3691925|FG001|Overall Study|Pregnancy|1
2100939|NCT00827606|3691924|FG000|Overall Study|Other|5
2100940|NCT00827606|3691925|FG001|Overall Study|Other|13
2100941|NCT00827606|3691924|FG000|Overall Study|LDL below 2.59 mmol/L|4
2100942|NCT00827606|3691925|FG001|Overall Study|LDL below 2.59 mmol/L|12
2100943|NCT00827606|3691924|FG000|Overall Study|Adverse Event|4
2100944|NCT00827606|3691925|FG001|Overall Study|Adverse Event|2
2212271|NCT01668719|3853331|FG001|Phase I|Progression/relapse|0
2212272|NCT01668719|3853332|FG002|Phase I|Progression/relapse|0
2212273|NCT01668719|3853330|FG000|Phase I|not protocol specified|2
2212274|NCT01668719|3853331|FG001|Phase I|not protocol specified|0
2212275|NCT01668719|3853332|FG002|Phase I|not protocol specified|0
2212276|NCT01668719|3853330|FG000|Phase II|On treatment|0
2212277|NCT01668719|3853331|FG001|Phase II|On treatment|4
2212278|NCT01668719|3853332|FG002|Phase II|On treatment|3
2212279|NCT01668719|3853330|FG000|Phase II|Adverse Event|0
2212280|NCT01668719|3853331|FG001|Phase II|Adverse Event|18
2212281|NCT01668719|3853332|FG002|Phase II|Adverse Event|18
2212282|NCT01668719|3853330|FG000|Phase II|Refusal unrelated to adverse event|0
2212283|NCT01668719|3853331|FG001|Phase II|Refusal unrelated to adverse event|4
2212284|NCT01668719|3853332|FG002|Phase II|Refusal unrelated to adverse event|1
2212285|NCT01668719|3853330|FG000|Phase II|Progression/relapse|0
2212286|NCT01668719|3853331|FG001|Phase II|Progression/relapse|13
2212287|NCT01668719|3853332|FG002|Phase II|Progression/relapse|17
2353846|NCT01935947|4107498|FG001|Overall Study|Death|0
2353847|NCT01935947|4107499|FG002|Overall Study|Death|0
2353848|NCT01939223|4107512|FG000|Overall Study|AE not assoc. with disease recurrence|1
2353849|NCT01939223|4107513|FG001|Overall Study|AE not assoc. with disease recurrence|1
2353850|NCT01939223|4107512|FG000|Overall Study|Disease recurrence (radiological)|1
2353851|NCT01939223|4107513|FG001|Overall Study|Disease recurrence (radiological)|3
2353852|NCT01939223|4107512|FG000|Overall Study|Study stopped by Sponsor|5
2353853|NCT01939223|4107513|FG001|Overall Study|Study stopped by Sponsor|7
2353854|NCT01939223|4107512|FG000|Overall Study|Withdrawal by Subject|6
2353855|NCT01939223|4107513|FG001|Overall Study|Withdrawal by Subject|0
2353856|NCT01938716|4107519|FG000|Overall Study|Physician Decision|2
2353857|NCT01938716|4107519|FG000|Overall Study|Withdrawal by Subject|2
2353858|NCT01936974|4107525|FG000|Overall Study|Physician Decision|2
2353859|NCT01936974|4107526|FG001|Overall Study|Physician Decision|5
2353860|NCT01934504|4107553|FG000|Overall Study|Protocol Deviation|0
2353861|NCT01934504|4107554|FG001|Overall Study|Protocol Deviation|0
2353862|NCT01934504|4107555|FG002|Overall Study|Protocol Deviation|0
2353863|NCT01934504|4107556|FG003|Overall Study|Protocol Deviation|2
2353864|NCT01934504|4107553|FG000|Overall Study|Study Terminated by Sponsor|1
2353865|NCT01934504|4107554|FG001|Overall Study|Study Terminated by Sponsor|0
2100945|NCT00827632|3691939|FG000|Overall Study|Lost to Follow-up|8
2100946|NCT00827632|3691940|FG001|Overall Study|Lost to Follow-up|12
2100947|NCT00827632|3691939|FG000|Overall Study|Early withdrawal|14
2100948|NCT00827632|3691940|FG001|Overall Study|Early withdrawal|11
2100949|NCT00827775|3691948|FG000|Overall Study|Withdrawal by Subject|0
2100950|NCT00827775|3691949|FG001|Overall Study|Withdrawal by Subject|5
2100951|NCT00827827|3691957|FG000|Overall Study|Lost to Follow-up|3
2212288|NCT01668719|3853330|FG000|Phase II|Death|0
2212289|NCT01668719|3853331|FG001|Phase II|Death|0
2212290|NCT01668719|3853332|FG002|Phase II|Death|2
2212291|NCT01668719|3853330|FG000|Phase II|not protocol specified|0
2212292|NCT01668719|3853331|FG001|Phase II|not protocol specified|13
2212293|NCT01668719|3853332|FG002|Phase II|not protocol specified|7
2212294|NCT01668784|3853344|FG000|Randomized (Pre-treatment)|Disease Progression|0
2100952|NCT00827827|3691958|FG001|Overall Study|Lost to Follow-up|0
2100953|NCT00827827|3691957|FG000|Overall Study|Fall at home- hospitalization|1
2100954|NCT00827827|3691958|FG001|Overall Study|Fall at home- hospitalization|0
2100955|NCT00827827|3691957|FG000|Overall Study|Another cerebrovascular accident (CVA)|1
2100956|NCT00827827|3691958|FG001|Overall Study|Another cerebrovascular accident (CVA)|0
2100957|NCT00827827|3691957|FG000|Overall Study|Gout|1
2100958|NCT00827827|3691958|FG001|Overall Study|Gout|0
2100959|NCT00827827|3691957|FG000|Overall Study|Transportation issues|1
2100960|NCT00827827|3691958|FG001|Overall Study|Transportation issues|0
2100961|NCT00827827|3691957|FG000|Overall Study|Burned with water at home|1
2100962|NCT00827827|3691958|FG001|Overall Study|Burned with water at home|0
2100963|NCT00827918|3691968|FG000|Overall Study|Adverse Event|4
2100964|NCT00827918|3691969|FG001|Overall Study|Adverse Event|0
2100965|NCT00827918|3691970|FG002|Overall Study|Adverse Event|0
2100966|NCT00827918|3691968|FG000|Overall Study|Lack of Efficacy|16
2100967|NCT00827918|3691969|FG001|Overall Study|Lack of Efficacy|4
2100968|NCT00827918|3691970|FG002|Overall Study|Lack of Efficacy|15
2100969|NCT00827918|3691968|FG000|Overall Study|Physician Decision|1
2100970|NCT00827918|3691969|FG001|Overall Study|Physician Decision|0
2100971|NCT00827918|3691970|FG002|Overall Study|Physician Decision|0
2100972|NCT00827918|3691968|FG000|Overall Study|Pregnancy|0
2100973|NCT00827918|3691969|FG001|Overall Study|Pregnancy|1
2100974|NCT00827918|3691970|FG002|Overall Study|Pregnancy|0
2100975|NCT00827918|3691968|FG000|Overall Study|Progressive Disease|1
2100976|NCT00827918|3691969|FG001|Overall Study|Progressive Disease|1
2100977|NCT00827918|3691970|FG002|Overall Study|Progressive Disease|0
2100978|NCT00827918|3691968|FG000|Overall Study|Protocol Violation|0
2100979|NCT00827918|3691969|FG001|Overall Study|Protocol Violation|1
2100980|NCT00827918|3691970|FG002|Overall Study|Protocol Violation|0
2100981|NCT00827918|3691968|FG000|Overall Study|Withdrawal by Subject|6
2100982|NCT00827918|3691969|FG001|Overall Study|Withdrawal by Subject|2
2100983|NCT00827918|3691970|FG002|Overall Study|Withdrawal by Subject|6
2100984|NCT00827931|3691980|FG000|Overall Study|Death|3
2100985|NCT00827931|3691981|FG001|Overall Study|Death|5
2100986|NCT00827931|3691980|FG000|Overall Study|Adverse Event|1
2100987|NCT00827931|3691981|FG001|Overall Study|Adverse Event|0
2100988|NCT00827931|3691980|FG000|Overall Study|Lost to Follow-up|1
2100989|NCT00827931|3691981|FG001|Overall Study|Lost to Follow-up|0
2100990|NCT00827931|3691980|FG000|Overall Study|Withdrawal by Subject|0
2100991|NCT00827931|3691981|FG001|Overall Study|Withdrawal by Subject|1
2100992|NCT00827931|3691980|FG000|Overall Study|Other|1
2100993|NCT00827931|3691981|FG001|Overall Study|Other|0
2100994|NCT00828009|3692005|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
2100995|NCT00828009|3692005|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2
2100996|NCT00828009|3692005|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
2100997|NCT00828009|3692005|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
2100998|NCT00828009|3692005|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
2100999|NCT00828009|3692005|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
2101000|NCT00828009|3692005|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
2101001|NCT00828009|3692005|FG000|Step 2 - Maintenance Therapy|Progressive disease|12
2101002|NCT00828009|3692005|FG000|Step 2 - Maintenance Therapy|Adverse Event|13
2101003|NCT00828009|3692005|FG000|Step 2 - Maintenance Therapy|Death|1
2101004|NCT00828009|3692005|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
2101005|NCT00828009|3692005|FG000|Step 2 - Maintenance Therapy|Complicating disease|2
2101006|NCT00828009|3692005|FG000|Step 2 - Maintenance Therapy|Other|1
2101007|NCT00828113|3692039|FG000|Overall Study|Withdrawal by Subject|27
2101008|NCT00828113|3692040|FG001|Overall Study|Withdrawal by Subject|26
2101009|NCT00828113|3692039|FG000|Overall Study|Lost to Follow-up|3
2101010|NCT00828113|3692040|FG001|Overall Study|Lost to Follow-up|5
2101011|NCT00828139|3692050|FG000|Overall Study|Adverse Event|8
2101012|NCT00828139|3692051|FG001|Overall Study|Adverse Event|1
2101013|NCT00828139|3692052|FG002|Overall Study|Adverse Event|10
2101014|NCT00828139|3692053|FG003|Overall Study|Adverse Event|5
2101015|NCT00828139|3692050|FG000|Overall Study|Death|2
2101016|NCT00828139|3692051|FG001|Overall Study|Death|1
2101017|NCT00828139|3692052|FG002|Overall Study|Death|0
2101018|NCT00828139|3692053|FG003|Overall Study|Death|2
2101019|NCT00828139|3692050|FG000|Overall Study|Refusal unrelated to toxicity|3
2101020|NCT00828139|3692051|FG001|Overall Study|Refusal unrelated to toxicity|4
2101021|NCT00828139|3692052|FG002|Overall Study|Refusal unrelated to toxicity|5
2101022|NCT00828139|3692053|FG003|Overall Study|Refusal unrelated to toxicity|3
2101023|NCT00828139|3692050|FG000|Overall Study|Disease Progression|24
2101024|NCT00828139|3692051|FG001|Overall Study|Disease Progression|33
2101025|NCT00828139|3692052|FG002|Overall Study|Disease Progression|35
2101026|NCT00828139|3692053|FG003|Overall Study|Disease Progression|39
2101027|NCT00828139|3692050|FG000|Overall Study|Other|4
2212295|NCT01668784|3853345|FG001|Randomized (Pre-treatment)|Disease Progression|1
2101028|NCT00828139|3692051|FG001|Overall Study|Other|2
2101029|NCT00828139|3692052|FG002|Overall Study|Other|5
2101030|NCT00828139|3692053|FG003|Overall Study|Other|2
2101031|NCT00828204|3692085|FG000|Main Study: Prior to Study Suspension|Adverse Event|1
2212296|NCT01668784|3853344|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
2212297|NCT01668784|3853345|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
2212298|NCT01668784|3853344|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1
2212299|NCT01668784|3853345|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8
2212300|NCT01668784|3853344|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1
2212301|NCT01668784|3853345|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0
2212302|NCT01668784|3853344|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
2212303|NCT01668784|3853345|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
2212304|NCT01668784|3853344|FG000|Randomized (Pre-treatment)|Other|0
2212305|NCT01668784|3853345|FG001|Randomized (Pre-treatment)|Other|1
2212306|NCT01668784|3853344|FG000|Treated (Overall)|Disease Progression|285
2101032|NCT00828204|3692086|FG001|Main Study: Prior to Study Suspension|Adverse Event|0
2101033|NCT00828204|3692085|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
2101034|NCT00828204|3692086|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
2101035|NCT00828204|3692085|FG000|Main Study: Prior to Study Suspension|Study Suspension|11
2101036|NCT00828204|3692086|FG001|Main Study: Prior to Study Suspension|Study Suspension|0
2101037|NCT00828204|3692085|FG000|Main Study: After Study Restart|Adverse Event|0
2101038|NCT00828204|3692086|FG001|Main Study: After Study Restart|Adverse Event|2
2101039|NCT00828204|3692085|FG000|Main Study: After Study Restart|Noncompliance|0
2101040|NCT00828204|3692086|FG001|Main Study: After Study Restart|Noncompliance|1
2101041|NCT00828204|3692085|FG000|Extension Study|Lost to Follow-up|0
2101042|NCT00828204|3692086|FG001|Extension Study|Lost to Follow-up|1
2101043|NCT00828204|3692085|FG000|Extension Study|Physician Decision|0
2101044|NCT00828204|3692086|FG001|Extension Study|Physician Decision|2
2101045|NCT00828451|3692124|FG000|Overall Study|Death|2
2101046|NCT00828451|3692124|FG000|Overall Study|Lack of intravenous line|7
2101047|NCT00828451|3692124|FG000|Overall Study|Withdrawal by Subject|1
2101048|NCT00828451|3692124|FG000|Overall Study|Deterioration in clinical status|1
2101049|NCT00828464|3692128|FG000|Overall Study|Withdrawal by Subject|1
2101050|NCT00828516|3692132|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2
2101051|NCT00828568|3692148|FG000|Randomized|Withdrawal by Subject|1
2101052|NCT00828568|3692149|FG001|Randomized|Withdrawal by Subject|0
2101053|NCT00828568|3692150|FG002|Randomized|Withdrawal by Subject|2
2101054|NCT00828568|3692148|FG000|Treated - Received at Least One Dose|Adverse Event|11
2101055|NCT00828568|3692149|FG001|Treated - Received at Least One Dose|Adverse Event|8
2101056|NCT00828568|3692150|FG002|Treated - Received at Least One Dose|Adverse Event|1
2101057|NCT00828568|3692148|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9
2101058|NCT00828568|3692149|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11
2101059|NCT00828568|3692150|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0
2101060|NCT00828568|3692148|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1
2101061|NCT00828568|3692149|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5
2101062|NCT00828568|3692150|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1
2101063|NCT00828568|3692148|FG000|Treated - Received at Least One Dose|Protocol Violation|9
2101064|NCT00828568|3692149|FG001|Treated - Received at Least One Dose|Protocol Violation|5
2101065|NCT00828568|3692150|FG002|Treated - Received at Least One Dose|Protocol Violation|3
2101066|NCT00828672|3692161|FG000|Study Treatment|Lost to Follow-up|1
2101067|NCT00828672|3692162|FG001|Study Treatment|Lost to Follow-up|0
2101068|NCT00828672|3692161|FG000|Study Treatment|Adverse Event|0
2101069|NCT00828672|3692162|FG001|Study Treatment|Adverse Event|1
2101070|NCT00828672|3692161|FG000|Study Treatment|Complete response, no surgery|1
2101071|NCT00828672|3692162|FG001|Study Treatment|Complete response, no surgery|1
2101072|NCT00828672|3692161|FG000|Post-surgery (<30 Days)|No central review materials|0
2101073|NCT00828672|3692162|FG001|Post-surgery (<30 Days)|No central review materials|1
2101074|NCT00828711|3692171|FG000|Overall Study|Lost to Follow-up|1
2101075|NCT00828711|3692172|FG001|Overall Study|Lost to Follow-up|0
2101076|NCT00828711|3692173|FG002|Overall Study|Lost to Follow-up|0
2101077|NCT00828750|3692181|FG000|Overall Study|Lack of Efficacy|3
2101078|NCT00828750|3692181|FG000|Overall Study|Normal PC Remained While No Treatment|1
2101079|NCT00828945|3692201|FG000|Overall Study|Death|4
2101080|NCT00828945|3692201|FG000|Overall Study|Participant was missing|1
2101081|NCT00828945|3692201|FG000|Overall Study|Other|36
2101082|NCT00828984|3692208|FG000|Overall Study|Adverse Event|2
2101083|NCT00828984|3692209|FG001|Overall Study|Adverse Event|3
2101084|NCT00828984|3692210|FG002|Overall Study|Adverse Event|0
2101085|NCT00828984|3692208|FG000|Overall Study|Lost to Follow-up|5
2101086|NCT00828984|3692209|FG001|Overall Study|Lost to Follow-up|3
2101087|NCT00828984|3692210|FG002|Overall Study|Lost to Follow-up|1
2101088|NCT00828984|3692208|FG000|Overall Study|Withdrawal by Subject|4
2101089|NCT00828984|3692209|FG001|Overall Study|Withdrawal by Subject|4
2101090|NCT00828984|3692210|FG002|Overall Study|Withdrawal by Subject|4
2101091|NCT00828984|3692208|FG000|Overall Study|Ineligable|1
2101092|NCT00828984|3692209|FG001|Overall Study|Ineligable|2
2101093|NCT00828984|3692210|FG002|Overall Study|Ineligable|0
2101094|NCT00828984|3692208|FG000|Overall Study|Medical Contraindication|0
2101095|NCT00828984|3692209|FG001|Overall Study|Medical Contraindication|1
2101096|NCT00828984|3692210|FG002|Overall Study|Medical Contraindication|0
2101097|NCT00828984|3692208|FG000|Overall Study|Noncompliant|1
2101098|NCT00828984|3692209|FG001|Overall Study|Noncompliant|2
2101099|NCT00828984|3692210|FG002|Overall Study|Noncompliant|3
2101100|NCT00828984|3692208|FG000|Overall Study|ConMed|1
2101101|NCT00828984|3692209|FG001|Overall Study|ConMed|1
2101102|NCT00828984|3692210|FG002|Overall Study|ConMed|1
2101103|NCT00829010|3692223|FG000|Overall Study|Adverse Event|1
2101104|NCT00829010|3692224|FG001|Overall Study|Adverse Event|0
2101105|NCT00829010|3692225|FG002|Overall Study|Adverse Event|0
2101106|NCT00829010|3692226|FG003|Overall Study|Adverse Event|0
2101107|NCT00829010|3692227|FG004|Overall Study|Adverse Event|0
2101108|NCT00829010|3692223|FG000|Overall Study|Withdrawal by Subject|0
2101109|NCT00829010|3692224|FG001|Overall Study|Withdrawal by Subject|1
2101110|NCT00829010|3692225|FG002|Overall Study|Withdrawal by Subject|1
2101111|NCT00829010|3692226|FG003|Overall Study|Withdrawal by Subject|0
2101112|NCT00829010|3692227|FG004|Overall Study|Withdrawal by Subject|2
2101113|NCT00829010|3692223|FG000|Overall Study|Lost to Follow-up|1
2101114|NCT00829010|3692224|FG001|Overall Study|Lost to Follow-up|0
2101115|NCT00829010|3692225|FG002|Overall Study|Lost to Follow-up|2
2101116|NCT00829010|3692226|FG003|Overall Study|Lost to Follow-up|0
2101117|NCT00829010|3692227|FG004|Overall Study|Lost to Follow-up|0
2101118|NCT00829010|3692223|FG000|Overall Study|Fatality|5
2101119|NCT00829010|3692224|FG001|Overall Study|Fatality|4
2101120|NCT00829010|3692225|FG002|Overall Study|Fatality|0
2101121|NCT00829010|3692226|FG003|Overall Study|Fatality|3
2101122|NCT00829010|3692227|FG004|Overall Study|Fatality|0
2101123|NCT00829010|3692223|FG000|Overall Study|Migrated/Moved from study area|3
2101124|NCT00829010|3692224|FG001|Overall Study|Migrated/Moved from study area|4
2101125|NCT00829010|3692225|FG002|Overall Study|Migrated/Moved from study area|0
2101126|NCT00829010|3692226|FG003|Overall Study|Migrated/Moved from study area|5
2101127|NCT00829010|3692227|FG004|Overall Study|Migrated/Moved from study area|0
2101128|NCT00829166|3692254|FG000|Overall Study|Death|305
2101129|NCT00829166|3692255|FG001|Overall Study|Death|333
2212307|NCT01668784|3853345|FG001|Treated (Overall)|Disease Progression|273
2212308|NCT01668784|3853344|FG000|Treated (Overall)|Study Drug Toxicity|35
2212309|NCT01668784|3853345|FG001|Treated (Overall)|Study Drug Toxicity|53
2212310|NCT01668784|3853344|FG000|Treated (Overall)|Death|1
2101130|NCT00829166|3692254|FG000|Overall Study|Lost to Follow-up|5
2101131|NCT00829166|3692255|FG001|Overall Study|Lost to Follow-up|4
2101132|NCT00829166|3692254|FG000|Overall Study|Physician's Decision|4
2101133|NCT00829166|3692255|FG001|Overall Study|Physician's Decision|3
2101134|NCT00829166|3692254|FG000|Overall Study|Subject's Decision|41
2101135|NCT00829166|3692255|FG001|Overall Study|Subject's Decision|55
2101136|NCT00829166|3692254|FG000|Overall Study|Sponsor's Decision|137
2101137|NCT00829166|3692255|FG001|Overall Study|Sponsor's Decision|98
2101138|NCT00829166|3692254|FG000|Overall Study|Reason Not Specified|3
2101139|NCT00829166|3692255|FG001|Overall Study|Reason Not Specified|3
2101140|NCT00829179|3692262|FG000|Overall Study|Withdrawal by Subject|1
2108009|NCT00877487|3701821|FG000|Open-label Treatment Phase|Protocol Violation|3
2108010|NCT00877487|3701822|FG001|Open-label Treatment Phase|Protocol Violation|0
2108011|NCT00877487|3701821|FG000|Open-label Treatment Phase|Withdrawal by Subject|1
2108012|NCT00877487|3701822|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
2108013|NCT00877487|3701821|FG000|Open-label Treatment Phase|Lost to Follow-up|1
2108014|NCT00877487|3701822|FG001|Open-label Treatment Phase|Lost to Follow-up|0
2108015|NCT00877487|3701821|FG000|Open-label Treatment Phase|Out of country for business|1
2108016|NCT00877487|3701822|FG001|Open-label Treatment Phase|Out of country for business|0
2108017|NCT00877487|3701821|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
2108018|NCT00877487|3701822|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
2108019|NCT00877487|3701821|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0
2108020|NCT00877487|3701822|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1
2108021|NCT00877487|3701821|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
2353866|NCT01934504|4107555|FG002|Overall Study|Study Terminated by Sponsor|5
2353867|NCT01934504|4107556|FG003|Overall Study|Study Terminated by Sponsor|5
2353868|NCT01928082|4107566|FG000|Overall Study|Study terminated.|1
2353869|NCT01928615|4107570|FG000|Overall Study|Study Terminated by Sponsor|2
2353870|NCT01911793|4107577|FG000|Overall Study|Physician Decision|1
2353871|NCT01911793|4107578|FG001|Overall Study|Physician Decision|5
2353872|NCT01912404|4107586|FG000|Overall Study|Due to personal reasons|1
2353873|NCT01912404|4107587|FG001|Overall Study|Due to personal reasons|0
2353874|NCT01910389|4107595|FG000|Overall Study|Withdrawal by Subject|2
2353875|NCT01910389|4107596|FG001|Overall Study|Withdrawal by Subject|0
2353876|NCT01910389|4107595|FG000|Overall Study|Study Closed|13
2353877|NCT01910389|4107596|FG001|Overall Study|Study Closed|8
2353878|NCT01913327|4107622|FG000|Overall Study|Withdrawal by Subject|0
2108022|NCT00877487|3701822|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
2108023|NCT00877487|3701821|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1
2108024|NCT00877487|3701822|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0
2108025|NCT00877773|3701837|FG000|Overall Study|Disease Progression|44
2108026|NCT00877799|3701846|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
2353879|NCT01913327|4107623|FG001|Overall Study|Withdrawal by Subject|1
2353880|NCT01902888|4107629|FG000|Overall Study|Study Terminated|3
2101141|NCT00829244|3692268|FG000|Overall Study|Adverse Event|1
2101142|NCT00829244|3692269|FG001|Overall Study|Adverse Event|3
2101143|NCT00829244|3692268|FG000|Overall Study|Protocol Violation|1
2101144|NCT00829244|3692269|FG001|Overall Study|Protocol Violation|0
2101145|NCT00829244|3692268|FG000|Overall Study|Lack of ovarian response to stimulation|9
2101146|NCT00829244|3692269|FG001|Overall Study|Lack of ovarian response to stimulation|5
2101147|NCT00829244|3692268|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
2101148|NCT00829244|3692269|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
2101149|NCT00829244|3692268|FG000|Overall Study|No fertilization|2
2101150|NCT00829244|3692269|FG001|Overall Study|No fertilization|2
2101151|NCT00829244|3692268|FG000|Overall Study|All embryos discarded|0
2101152|NCT00829244|3692269|FG001|Overall Study|All embryos discarded|3
2101153|NCT00829244|3692268|FG000|Overall Study|No embryo cleavage|0
2101154|NCT00829244|3692269|FG001|Overall Study|No embryo cleavage|2
2101155|NCT00829283|3692277|FG000|Overall Study|Lost to Follow-up|7
2101156|NCT00829283|3692278|FG001|Overall Study|Lost to Follow-up|25
2101157|NCT00829296|3692286|FG000|Overall Study|Adverse Event|5
2101158|NCT00829296|3692287|FG001|Overall Study|Adverse Event|4
2101159|NCT00829387|3692295|FG000|Overall Study|Withdrawal by Subject|2
2101160|NCT00829387|3692296|FG001|Overall Study|Withdrawal by Subject|3
2101161|NCT00829387|3692295|FG000|Overall Study|Disqualified by PI|1
2101162|NCT00829387|3692296|FG001|Overall Study|Disqualified by PI|0
2101163|NCT00829413|3692302|FG000|Overall Study|No study drug admimnistered|13
2101164|NCT00829413|3692302|FG000|Overall Study|Training Patients|67
2101165|NCT00829413|3692302|FG000|Overall Study|No truth standard procedure available|9
2101166|NCT00829413|3692302|FG000|Overall Study|Technically inadequate truth standard|2
2101167|NCT00829413|3692302|FG000|Overall Study|Indeterminate diagnosis from truth stand|3
2101168|NCT00829439|3692313|FG000|Overall Study|Adverse Event|0
2101169|NCT00829439|3692314|FG001|Overall Study|Adverse Event|0
2101170|NCT00829439|3692315|FG002|Overall Study|Adverse Event|1
2101171|NCT00829439|3692316|FG003|Overall Study|Adverse Event|0
2101172|NCT00829621|3692322|FG000|Overall Study|Death|1
2101173|NCT00829621|3692323|FG001|Overall Study|Death|0
2101174|NCT00829621|3692322|FG000|Overall Study|Lost to Follow-up|3
2101175|NCT00829621|3692323|FG001|Overall Study|Lost to Follow-up|4
2101176|NCT00829829|3692337|FG000|Overall Study|Protocol Violation|0
2101177|NCT00829829|3692338|FG001|Overall Study|Protocol Violation|3
2101178|NCT00829829|3692339|FG002|Overall Study|Protocol Violation|0
2101179|NCT00829829|3692337|FG000|Overall Study|Adverse Event|4
2101180|NCT00829829|3692338|FG001|Overall Study|Adverse Event|4
2101181|NCT00829829|3692339|FG002|Overall Study|Adverse Event|3
2101182|NCT00829829|3692337|FG000|Overall Study|Withdrawal by Subject|8
2101183|NCT00829829|3692338|FG001|Overall Study|Withdrawal by Subject|4
2101184|NCT00829829|3692339|FG002|Overall Study|Withdrawal by Subject|2
2101185|NCT00829829|3692337|FG000|Overall Study|Decision by the Sponsor|1
2101186|NCT00829829|3692338|FG001|Overall Study|Decision by the Sponsor|0
2101187|NCT00829829|3692339|FG002|Overall Study|Decision by the Sponsor|2
2101188|NCT00829829|3692337|FG000|Overall Study|Lost to Follow-up|7
2101189|NCT00829829|3692338|FG001|Overall Study|Lost to Follow-up|3
2101190|NCT00829829|3692339|FG002|Overall Study|Lost to Follow-up|3
2101191|NCT00829829|3692337|FG000|Overall Study|Other than specified above|2
2101192|NCT00829829|3692338|FG001|Overall Study|Other than specified above|2
2353881|NCT01901224|4107633|FG000|Overall Study|study was not funded and terminated|2
2353882|NCT01910441|4107639|FG000|Overall Study|Sponsor decision|0
2353883|NCT01910441|4107640|FG001|Overall Study|Sponsor decision|2
2353884|NCT01910441|4107639|FG000|Overall Study|Lost to Follow-up|6
2353885|NCT01910441|4107640|FG001|Overall Study|Lost to Follow-up|5
2353886|NCT01910441|4107639|FG000|Overall Study|Withdrawal by Subject|0
2353887|NCT01910441|4107640|FG001|Overall Study|Withdrawal by Subject|1
2353888|NCT01910441|4107639|FG000|Overall Study|Non-compliance|0
2353889|NCT01910441|4107640|FG001|Overall Study|Non-compliance|1
2353890|NCT01910441|4107639|FG000|Overall Study|Adverse Event|1
2353891|NCT01910441|4107640|FG001|Overall Study|Adverse Event|0
2353892|NCT01910441|4107639|FG000|Overall Study|Physician Decision|0
2353893|NCT01910441|4107640|FG001|Overall Study|Physician Decision|1
2353894|NCT01902966|4107646|FG000|Overall Study|Death|1
2353895|NCT01902966|4107646|FG000|Overall Study|Physician Decision|1
2353896|NCT01902966|4107646|FG000|Overall Study|Withdrawal by Subject|1
2353897|NCT01900730|4107661|FG000|Overall Study|Withdrawal by Subject|1
2353898|NCT01900730|4107662|FG001|Overall Study|Withdrawal by Subject|0
2353899|NCT01900730|4107661|FG000|Overall Study|Screen Failure|1
2353900|NCT01900730|4107662|FG001|Overall Study|Screen Failure|0
2353901|NCT01900626|4107690|FG000|Overall Study|study was closed due to low enrollment|1
2353902|NCT01900626|4107691|FG001|Overall Study|study was closed due to low enrollment|1
2353903|NCT01884077|4107713|FG000|Overall Study|screen fail|0
2353904|NCT01884077|4107714|FG001|Overall Study|screen fail|2
2101193|NCT00829829|3692339|FG002|Overall Study|Other than specified above|1
2101194|NCT00829933|3692352|FG000|Overall Study|Adverse Event|2
2101195|NCT00829933|3692353|FG001|Overall Study|Adverse Event|3
2101196|NCT00829933|3692354|FG002|Overall Study|Adverse Event|2
2101197|NCT00829933|3692355|FG003|Overall Study|Adverse Event|1
2101198|NCT00829933|3692352|FG000|Overall Study|Death|0
2353905|NCT01884077|4107713|FG000|Overall Study|canceled surgery|2
2353906|NCT01884077|4107714|FG001|Overall Study|canceled surgery|0
2353907|NCT01884077|4107713|FG000|Overall Study|Lost to Follow-up|0
2101199|NCT00829933|3692353|FG001|Overall Study|Death|0
2101200|NCT00829933|3692354|FG002|Overall Study|Death|1
2101201|NCT00829933|3692355|FG003|Overall Study|Death|1
2101202|NCT00829933|3692352|FG000|Overall Study|Lack of Efficacy|0
2101203|NCT00829933|3692353|FG001|Overall Study|Lack of Efficacy|1
2101204|NCT00829933|3692354|FG002|Overall Study|Lack of Efficacy|0
2101205|NCT00829933|3692355|FG003|Overall Study|Lack of Efficacy|0
2101206|NCT00829933|3692352|FG000|Overall Study|Physician Decision|5
2101207|NCT00829933|3692353|FG001|Overall Study|Physician Decision|7
2101208|NCT00829933|3692354|FG002|Overall Study|Physician Decision|8
2101209|NCT00829933|3692355|FG003|Overall Study|Physician Decision|1
2101210|NCT00829933|3692352|FG000|Overall Study|Pregnancy|0
2101211|NCT00829933|3692353|FG001|Overall Study|Pregnancy|0
2101212|NCT00829933|3692354|FG002|Overall Study|Pregnancy|0
2101213|NCT00829933|3692355|FG003|Overall Study|Pregnancy|2
2101214|NCT00829933|3692352|FG000|Overall Study|Protocol Violation|2
2101215|NCT00829933|3692353|FG001|Overall Study|Protocol Violation|1
2101216|NCT00829933|3692354|FG002|Overall Study|Protocol Violation|0
2101217|NCT00829933|3692355|FG003|Overall Study|Protocol Violation|0
2101218|NCT00829933|3692352|FG000|Overall Study|withdrew before treatment started|5
2101219|NCT00829933|3692353|FG001|Overall Study|withdrew before treatment started|1
2101220|NCT00829933|3692354|FG002|Overall Study|withdrew before treatment started|2
2101221|NCT00829933|3692355|FG003|Overall Study|withdrew before treatment started|9
2101222|NCT00830037|3692376|FG000|Overall Study|Withdrawal by Subject|2
2101223|NCT00830037|3692377|FG001|Overall Study|Withdrawal by Subject|3
2101224|NCT00830037|3692376|FG000|Overall Study|Lost to Follow-up|1
2101225|NCT00830037|3692377|FG001|Overall Study|Lost to Follow-up|2
2101226|NCT00830037|3692376|FG000|Overall Study|Active when terminated by DSMB|15
2101227|NCT00830037|3692377|FG001|Overall Study|Active when terminated by DSMB|14
2101228|NCT00830063|3692387|FG000|Overall Study|Adverse Event|7
2212311|NCT01668784|3853345|FG001|Treated (Overall)|Death|1
2212312|NCT01668784|3853344|FG000|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
2353908|NCT01884077|4107714|FG001|Overall Study|Lost to Follow-up|4
2353909|NCT01884077|4107713|FG000|Overall Study|study closed|6
2353910|NCT01884077|4107714|FG001|Overall Study|study closed|4
2353911|NCT01887288|4107746|FG000|Overall Study|The study was terminated and the PI has|16
2353912|NCT01861717|4107794|FG000|Overall Study|Lost to Follow-up|1
2353913|NCT01861717|4107794|FG000|Overall Study|Withdrawal by Subject|1
2353914|NCT01866709|4107801|FG000|Overall Study|Adverse Event|1
2353915|NCT01866709|4107802|FG001|Overall Study|Adverse Event|0
2353916|NCT01860040|4107810|FG000|Overall Study|Withdrawal by Subject|1
2353917|NCT01860040|4107811|FG001|Overall Study|Withdrawal by Subject|0
2353918|NCT01856322|4107856|FG000|Overall Study|off study due to lack of accrual|0
2353919|NCT01856322|4107857|FG001|Overall Study|off study due to lack of accrual|0
2353920|NCT01856322|4107858|FG002|Overall Study|off study due to lack of accrual|3
2101229|NCT00830063|3692388|FG001|Overall Study|Adverse Event|13
2101230|NCT00830063|3692389|FG002|Overall Study|Adverse Event|16
2101231|NCT00830063|3692390|FG003|Overall Study|Adverse Event|13
2101232|NCT00830063|3692387|FG000|Overall Study|Death|1
2101233|NCT00830063|3692388|FG001|Overall Study|Death|0
2101234|NCT00830063|3692389|FG002|Overall Study|Death|0
2101235|NCT00830063|3692390|FG003|Overall Study|Death|0
2101236|NCT00830063|3692387|FG000|Overall Study|Lost to Follow-up|0
2101237|NCT00830063|3692388|FG001|Overall Study|Lost to Follow-up|0
2101238|NCT00830063|3692389|FG002|Overall Study|Lost to Follow-up|3
2101239|NCT00830063|3692390|FG003|Overall Study|Lost to Follow-up|1
2101240|NCT00830063|3692387|FG000|Overall Study|Preferred Time Entry in Extension Study|119
2101241|NCT00830063|3692388|FG001|Overall Study|Preferred Time Entry in Extension Study|139
2101242|NCT00830063|3692389|FG002|Overall Study|Preferred Time Entry in Extension Study|127
2101243|NCT00830063|3692390|FG003|Overall Study|Preferred Time Entry in Extension Study|126
2101244|NCT00830063|3692387|FG000|Overall Study|Lack of Efficacy|51
2101245|NCT00830063|3692388|FG001|Overall Study|Lack of Efficacy|23
2101246|NCT00830063|3692389|FG002|Overall Study|Lack of Efficacy|25
2101247|NCT00830063|3692390|FG003|Overall Study|Lack of Efficacy|32
2101248|NCT00830063|3692387|FG000|Overall Study|Other|5
2101249|NCT00830063|3692388|FG001|Overall Study|Other|5
2101250|NCT00830063|3692389|FG002|Overall Study|Other|8
2101251|NCT00830063|3692390|FG003|Overall Study|Other|6
2101252|NCT00830063|3692387|FG000|Overall Study|Withdrawal by Subject|16
2101253|NCT00830063|3692388|FG001|Overall Study|Withdrawal by Subject|10
2101254|NCT00830063|3692389|FG002|Overall Study|Withdrawal by Subject|16
2101255|NCT00830063|3692390|FG003|Overall Study|Withdrawal by Subject|13
2101256|NCT00830063|3692387|FG000|Overall Study|Protocol Violation|1
2101257|NCT00830063|3692388|FG001|Overall Study|Protocol Violation|0
2101258|NCT00830063|3692389|FG002|Overall Study|Protocol Violation|3
2101259|NCT00830063|3692390|FG003|Overall Study|Protocol Violation|2
2101260|NCT00830063|3692387|FG000|Overall Study|Randomized But Not Treated|0
2101261|NCT00830063|3692388|FG001|Overall Study|Randomized But Not Treated|2
2101262|NCT00830063|3692389|FG002|Overall Study|Randomized But Not Treated|0
2101263|NCT00830063|3692390|FG003|Overall Study|Randomized But Not Treated|2
2101264|NCT00830115|3692409|FG000|Overall Study|Adverse Event|2
2101265|NCT00830115|3692409|FG000|Overall Study|Improvement/recovery|1
2101266|NCT00830128|3692415|FG000|Overall Study|Adverse Event|5
2101267|NCT00830128|3692415|FG000|Overall Study|Lack of Efficacy|7
2101268|NCT00830128|3692415|FG000|Overall Study|Protocol Violation|1
2101269|NCT00830128|3692415|FG000|Overall Study|Withdrawal by Subject|2
2101270|NCT00830128|3692415|FG000|Overall Study|Family obligation|1
2101271|NCT00830128|3692415|FG000|Overall Study|Relocation|1
2101272|NCT00830128|3692415|FG000|Overall Study|Work obligation|1
2101273|NCT00830128|3692415|FG000|Overall Study|Operating a vehicle|1
2101274|NCT00830167|3692421|FG000|Overall Study|Lack of Efficacy|26
2101275|NCT00830167|3692422|FG001|Overall Study|Lack of Efficacy|10
2101276|NCT00830167|3692421|FG000|Overall Study|Adverse Event|8
2101277|NCT00830167|3692422|FG001|Overall Study|Adverse Event|24
2101278|NCT00830167|3692421|FG000|Overall Study|Not meeting entrance criteria|2
2101279|NCT00830167|3692422|FG001|Overall Study|Not meeting entrance criteria|5
2353921|NCT01853176|4107867|FG000|Overall Study|Study terminated|4
2353922|NCT01853176|4107868|FG001|Overall Study|Study terminated|0
2353923|NCT01857271|4107874|FG000|Overall Study|Lost to Follow-up|1
2353924|NCT01853982|4107889|FG000|Overall Study|Withdrawal by Subject|1
2353925|NCT01853982|4107890|FG001|Overall Study|Withdrawal by Subject|0
2353926|NCT01853982|4107889|FG000|Overall Study|Death|1
2353927|NCT01853982|4107890|FG001|Overall Study|Death|0
2353928|NCT01853982|4107889|FG000|Overall Study|Lost to Follow-up|0
2353929|NCT01853982|4107890|FG001|Overall Study|Lost to Follow-up|1
2353930|NCT01831596|4107921|FG000|Overall Study|Other|8
2353931|NCT01821963|4107934|FG000|Overall Study|Adverse Event|1
2353932|NCT01821898|4107940|FG000|Overall Study|Withdrawal by Subject|2
2353933|NCT01821898|4107941|FG001|Overall Study|Withdrawal by Subject|1
2353934|NCT01829477|4107972|FG000|Overall Study|Study Terminated by Sponsor|15
2353935|NCT01829477|4107973|FG001|Overall Study|Study Terminated by Sponsor|15
2353936|NCT01829477|4107972|FG000|Overall Study|Withdrawal by Subject|1
2353937|NCT01829477|4107973|FG001|Overall Study|Withdrawal by Subject|0
2353938|NCT01803711|4107981|FG000|Overall Study|Adverse Event|1
2353939|NCT01803711|4107982|FG001|Overall Study|Adverse Event|1
2353940|NCT01806051|4108010|FG000|Overall Study|Withdrawal by Subject|6
2353941|NCT01810302|4108037|FG000|Overall Study|Death|1
2353942|NCT01810302|4108038|FG001|Overall Study|Death|0
2353943|NCT01810302|4108037|FG000|Overall Study|Physician Decision|0
2353944|NCT01810302|4108038|FG001|Overall Study|Physician Decision|1
2353945|NCT01806961|4108044|FG000|Overall Study|sponsor decision|16
2353946|NCT01783015|4108054|FG000|Blinded Treatment|Adverse Event|0
2353947|NCT01783015|4108055|FG001|Blinded Treatment|Adverse Event|1
2353948|NCT01783015|4108056|FG002|Blinded Treatment|Adverse Event|0
2353949|NCT01783015|4108054|FG000|Blinded Treatment|Protocol Violation|0
2353950|NCT01783015|4108055|FG001|Blinded Treatment|Protocol Violation|1
2353951|NCT01783015|4108056|FG002|Blinded Treatment|Protocol Violation|0
2353952|NCT01783015|4108054|FG000|Blinded Treatment|Withdrawal by Subject|0
2353953|NCT01783015|4108055|FG001|Blinded Treatment|Withdrawal by Subject|1
2353954|NCT01783015|4108056|FG002|Blinded Treatment|Withdrawal by Subject|0
2353955|NCT01783015|4108054|FG000|Blinded Treatment|Study Terminated by Sponsor|2
2353956|NCT01783015|4108055|FG001|Blinded Treatment|Study Terminated by Sponsor|0
2353957|NCT01783015|4108056|FG002|Blinded Treatment|Study Terminated by Sponsor|0
2353958|NCT01783015|4108054|FG000|Open Label Treatment|Study Terminated by Sponsor|0
2101280|NCT00830167|3692421|FG000|Overall Study|Withdrawal by Subject|2
2101281|NCT00830167|3692422|FG001|Overall Study|Withdrawal by Subject|0
2101282|NCT00830167|3692421|FG000|Overall Study|Lost to Follow-up|0
2101283|NCT00830167|3692422|FG001|Overall Study|Lost to Follow-up|1
2101284|NCT00830167|3692421|FG000|Overall Study|Protocol Violation|0
2101285|NCT00830167|3692422|FG001|Overall Study|Protocol Violation|1
2101286|NCT00830167|3692421|FG000|Overall Study|Other|2
2101287|NCT00830167|3692422|FG001|Overall Study|Other|2
2101288|NCT00830180|3692428|FG000|Overall Study|Adverse Event|6
2101289|NCT00830180|3692428|FG000|Overall Study|Death|11
2307655|NCT02699749|4010158|FG011|Overall Study|Death|0
2307656|NCT02699749|4010159|FG012|Overall Study|Death|0
2353959|NCT01783015|4108055|FG001|Open Label Treatment|Study Terminated by Sponsor|0
2353960|NCT01783015|4108056|FG002|Open Label Treatment|Study Terminated by Sponsor|6
2353961|NCT01781026|4108090|FG000|Overall Study|Lack of Efficacy|2
2353962|NCT01777854|4108116|FG000|Overall Study|Physician Decision|3
2353963|NCT01777854|4108117|FG001|Overall Study|Physician Decision|3
2353964|NCT01772719|4108125|FG000|Overall Study|Withdrawal by Subject|3
2353965|NCT01772719|4108125|FG000|Overall Study|Adverse Event|2
2353966|NCT01772719|4108125|FG000|Overall Study|Protocol Violation|1
2353967|NCT01772719|4108125|FG000|Overall Study|Lost to Follow-up|1
2353968|NCT01764997|4108137|FG000|Run-in Period|Adverse Event|15
2353969|NCT01764997|4108138|FG001|Run-in Period|Adverse Event|0
2353970|NCT01764997|4108139|FG002|Run-in Period|Adverse Event|0
2353971|NCT01764997|4108140|FG003|Run-in Period|Adverse Event|0
2353972|NCT01764997|4108141|FG004|Run-in Period|Adverse Event|0
2353973|NCT01764997|4108137|FG000|Run-in Period|Lack of Efficacy|5
2353974|NCT01764997|4108138|FG001|Run-in Period|Lack of Efficacy|0
2353975|NCT01764997|4108139|FG002|Run-in Period|Lack of Efficacy|0
2353976|NCT01764997|4108140|FG003|Run-in Period|Lack of Efficacy|0
2353977|NCT01764997|4108141|FG004|Run-in Period|Lack of Efficacy|0
2353978|NCT01764997|4108137|FG000|Run-in Period|Poor compliance to protocol|1
2353979|NCT01764997|4108138|FG001|Run-in Period|Poor compliance to protocol|0
2307657|NCT02699749|4010160|FG013|Overall Study|Death|1
2307658|NCT02699749|4010147|FG000|Overall Study|Lost to Follow-up|0
2307659|NCT02699749|4010148|FG001|Overall Study|Lost to Follow-up|0
2307660|NCT02699749|4010149|FG002|Overall Study|Lost to Follow-up|0
2307661|NCT02699749|4010150|FG003|Overall Study|Lost to Follow-up|0
2307662|NCT02699749|4010151|FG004|Overall Study|Lost to Follow-up|0
2307663|NCT02699749|4010152|FG005|Overall Study|Lost to Follow-up|1
2307664|NCT02699749|4010153|FG006|Overall Study|Lost to Follow-up|0
2307665|NCT02699749|4010154|FG007|Overall Study|Lost to Follow-up|1
2307666|NCT02699749|4010155|FG008|Overall Study|Lost to Follow-up|0
2307667|NCT02699749|4010156|FG009|Overall Study|Lost to Follow-up|0
2307668|NCT02699749|4010157|FG010|Overall Study|Lost to Follow-up|0
2307669|NCT02699749|4010158|FG011|Overall Study|Lost to Follow-up|0
2307670|NCT02699749|4010159|FG012|Overall Study|Lost to Follow-up|0
2307671|NCT02699749|4010160|FG013|Overall Study|Lost to Follow-up|0
2307672|NCT02699866|4010190|FG000|Overall Study|Withdrawal by Subject|3
2307673|NCT02699866|4010190|FG000|Overall Study|Physician Decision|2
2307674|NCT02699866|4010190|FG000|Overall Study|Adverse Event|3
2307675|NCT02699892|4010194|FG000|Overall Study|Other|36
2307676|NCT02699983|4010205|FG000|Overall Study|Withdrawal by Subject|1
2307677|NCT02699983|4010206|FG001|Overall Study|Withdrawal by Subject|0
2307678|NCT02699996|4010218|FG000|Overall Study|Withdrawal by Subject|5
2307679|NCT02699996|4010219|FG001|Overall Study|Withdrawal by Subject|2
2307680|NCT02700412|4010240|FG000|Overall Study|Adverse Event|6
2307681|NCT02700412|4010240|FG000|Overall Study|Death|1
2307682|NCT02700412|4010240|FG000|Overall Study|Lack of Efficacy|19
2307683|NCT02700412|4010240|FG000|Overall Study|Protocol Violation|5
2307684|NCT02700412|4010240|FG000|Overall Study|Withdrawal by Subject|2
2307685|NCT02700815|4010257|FG000|Overall Study|Adverse Event|0
2307686|NCT02700815|4010258|FG001|Overall Study|Adverse Event|6
2307687|NCT02700815|4010259|FG002|Overall Study|Adverse Event|2
2307688|NCT02700815|4010260|FG003|Overall Study|Adverse Event|3
2307689|NCT02700815|4010257|FG000|Overall Study|Lack of Efficacy|0
2307690|NCT02700815|4010258|FG001|Overall Study|Lack of Efficacy|0
2307691|NCT02700815|4010259|FG002|Overall Study|Lack of Efficacy|1
2019762|NCT00300885|3587199|FG000|Treatment|Protocol Violation|11
2019763|NCT00300885|3587200|FG001|Treatment|Protocol Violation|11
2019764|NCT00300885|3587199|FG000|Treatment|Withdrawal by Subject|26
2101290|NCT00830180|3692428|FG000|Overall Study|Insufficient clinical response|1
2307692|NCT02700815|4010260|FG003|Overall Study|Lack of Efficacy|2
2307693|NCT02700815|4010257|FG000|Overall Study|Lost to Follow-up|1
2353980|NCT01764997|4108139|FG002|Run-in Period|Poor compliance to protocol|0
2353981|NCT01764997|4108140|FG003|Run-in Period|Poor compliance to protocol|0
2101291|NCT00830180|3692428|FG000|Overall Study|Withdrawal by Subject|5
2101292|NCT00830180|3692428|FG000|Overall Study|Progressive disease|2
2101293|NCT00830180|3692428|FG000|Overall Study|Other - Unspecified|1
2101294|NCT00830375|3692460|FG000|Overall Study|Lost to Follow-up|1
2101295|NCT00830440|3692470|FG000|Overall Study|Protocol Violation|1
2101296|NCT00830440|3692471|FG001|Overall Study|Protocol Violation|0
2101297|NCT00830440|3692470|FG000|Overall Study|Withdrawal by Subject|1
2101298|NCT00830440|3692471|FG001|Overall Study|Withdrawal by Subject|0
2101299|NCT00830440|3692470|FG000|Overall Study|unsuccessful procedure|4
2101300|NCT00830440|3692471|FG001|Overall Study|unsuccessful procedure|0
2101301|NCT00830440|3692470|FG000|Overall Study|Adverse Event|2
2101302|NCT00830440|3692471|FG001|Overall Study|Adverse Event|0
2101303|NCT00830518|3692480|FG000|Overall Study|Progressive Disease|18
2101304|NCT00830518|3692481|FG001|Overall Study|Progressive Disease|8
2101305|NCT00830518|3692480|FG000|Overall Study|Symptomatic Deterioration|4
2101306|NCT00830518|3692481|FG001|Overall Study|Symptomatic Deterioration|1
2101307|NCT00830518|3692480|FG000|Overall Study|Adverse Event|14
2101308|NCT00830518|3692481|FG001|Overall Study|Adverse Event|1
2101309|NCT00830518|3692480|FG000|Overall Study|Withdrawal by Patient|2
2101310|NCT00830518|3692481|FG001|Overall Study|Withdrawal by Patient|0
2101311|NCT00830518|3692480|FG000|Overall Study|Reason not Specified|8
2101312|NCT00830518|3692481|FG001|Overall Study|Reason not Specified|1
2101313|NCT00830765|3692503|FG000|Overall Study|Protocol Violation|3
2101314|NCT00830765|3692504|FG001|Overall Study|Protocol Violation|2
2101315|NCT00830804|3692534|FG000|Overall Study|Lost to Follow-up|4
2101316|NCT00830804|3692534|FG000|Overall Study|Death|1
2101317|NCT00830804|3692534|FG000|Overall Study|Unable to get to clinic|7
2101318|NCT00830804|3692534|FG000|Overall Study|Consent withdrawn|2
2101319|NCT00830804|3692534|FG000|Overall Study|Unwilling to adhere to study requirement|1
2101320|NCT00830869|3692551|FG000|Period 1: Part 1|Symptomatic deterioration|0
2101321|NCT00830869|3692552|FG001|Period 1: Part 1|Symptomatic deterioration|0
2101322|NCT00830869|3692553|FG002|Period 1: Part 1|Symptomatic deterioration|0
2101323|NCT00830869|3692554|FG003|Period 1: Part 1|Symptomatic deterioration|1
2101324|NCT00830869|3692555|FG004|Period 1: Part 1|Symptomatic deterioration|0
2101325|NCT00830869|3692556|FG005|Period 1: Part 1|Symptomatic deterioration|1
2101326|NCT00830869|3692557|FG006|Period 1: Part 1|Symptomatic deterioration|1
2101327|NCT00830869|3692558|FG007|Period 1: Part 1|Symptomatic deterioration|0
2353982|NCT01764997|4108141|FG004|Run-in Period|Poor compliance to protocol|0
2353983|NCT01764997|4108137|FG000|Run-in Period|Other than specified above|17
2353984|NCT01764997|4108138|FG001|Run-in Period|Other than specified above|0
2353985|NCT01764997|4108139|FG002|Run-in Period|Other than specified above|0
2353986|NCT01764997|4108140|FG003|Run-in Period|Other than specified above|0
2353987|NCT01764997|4108141|FG004|Run-in Period|Other than specified above|0
2353988|NCT01764997|4108137|FG000|Study Drug Treatment Period|Adverse Event|0
2353989|NCT01764997|4108138|FG001|Study Drug Treatment Period|Adverse Event|1
2353990|NCT01764997|4108139|FG002|Study Drug Treatment Period|Adverse Event|0
2353991|NCT01764997|4108140|FG003|Study Drug Treatment Period|Adverse Event|0
2353992|NCT01764997|4108141|FG004|Study Drug Treatment Period|Adverse Event|24
2353993|NCT01764997|4108137|FG000|Study Drug Treatment Period|Lack of Efficacy|0
2353994|NCT01764997|4108138|FG001|Study Drug Treatment Period|Lack of Efficacy|0
2353995|NCT01764997|4108139|FG002|Study Drug Treatment Period|Lack of Efficacy|0
2353996|NCT01764997|4108140|FG003|Study Drug Treatment Period|Lack of Efficacy|0
2353997|NCT01764997|4108141|FG004|Study Drug Treatment Period|Lack of Efficacy|2
2353998|NCT01764997|4108137|FG000|Study Drug Treatment Period|Other than specified above|0
2353999|NCT01764997|4108138|FG001|Study Drug Treatment Period|Other than specified above|0
2354000|NCT01764997|4108139|FG002|Study Drug Treatment Period|Other than specified above|0
2354001|NCT01764997|4108140|FG003|Study Drug Treatment Period|Other than specified above|0
2354002|NCT01764997|4108141|FG004|Study Drug Treatment Period|Other than specified above|10
2354003|NCT01769443|4108157|FG000|Overall Study|Study closure|1
2354004|NCT01769443|4108158|FG001|Overall Study|Study closure|0
2354005|NCT01749826|4108180|FG000|Overall Study|Study Terminated|20
2101328|NCT00830869|3692559|FG008|Period 1: Part 1|Symptomatic deterioration|0
2101329|NCT00830869|3692560|FG009|Period 1: Part 1|Symptomatic deterioration|0
2101330|NCT00830869|3692561|FG010|Period 1: Part 1|Symptomatic deterioration|0
2101331|NCT00830869|3692562|FG011|Period 1: Part 1|Symptomatic deterioration|0
2101332|NCT00830869|3692551|FG000|Period 1: Part 1|Withdrawal by Subject|0
2212313|NCT01668784|3853345|FG001|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
2212314|NCT01668784|3853344|FG000|Treated (Overall)|Request to Discontinue Study Treatment|5
2212315|NCT01668784|3853345|FG001|Treated (Overall)|Request to Discontinue Study Treatment|18
2212316|NCT01668784|3853344|FG000|Treated (Overall)|Withdrawal by Subject|2
2212317|NCT01668784|3853345|FG001|Treated (Overall)|Withdrawal by Subject|3
2354006|NCT01749826|4108181|FG001|Overall Study|Study Terminated|0
2101333|NCT00830869|3692552|FG001|Period 1: Part 1|Withdrawal by Subject|1
2101334|NCT00830869|3692553|FG002|Period 1: Part 1|Withdrawal by Subject|0
2101335|NCT00830869|3692554|FG003|Period 1: Part 1|Withdrawal by Subject|0
2101336|NCT00830869|3692555|FG004|Period 1: Part 1|Withdrawal by Subject|0
2101337|NCT00830869|3692556|FG005|Period 1: Part 1|Withdrawal by Subject|0
2101338|NCT00830869|3692557|FG006|Period 1: Part 1|Withdrawal by Subject|0
2101339|NCT00830869|3692558|FG007|Period 1: Part 1|Withdrawal by Subject|0
2101340|NCT00830869|3692559|FG008|Period 1: Part 1|Withdrawal by Subject|0
2101341|NCT00830869|3692560|FG009|Period 1: Part 1|Withdrawal by Subject|0
2101342|NCT00830869|3692561|FG010|Period 1: Part 1|Withdrawal by Subject|0
2101343|NCT00830869|3692562|FG011|Period 1: Part 1|Withdrawal by Subject|0
2101344|NCT00830869|3692551|FG000|Period 1: Part 1|Adverse Event|0
2101345|NCT00830869|3692552|FG001|Period 1: Part 1|Adverse Event|0
2101346|NCT00830869|3692553|FG002|Period 1: Part 1|Adverse Event|0
2101347|NCT00830869|3692554|FG003|Period 1: Part 1|Adverse Event|0
2101348|NCT00830869|3692555|FG004|Period 1: Part 1|Adverse Event|0
2101349|NCT00830869|3692556|FG005|Period 1: Part 1|Adverse Event|1
2101350|NCT00830869|3692557|FG006|Period 1: Part 1|Adverse Event|1
2101351|NCT00830869|3692558|FG007|Period 1: Part 1|Adverse Event|0
2101352|NCT00830869|3692559|FG008|Period 1: Part 1|Adverse Event|0
2101353|NCT00830869|3692560|FG009|Period 1: Part 1|Adverse Event|0
2101354|NCT00830869|3692561|FG010|Period 1: Part 1|Adverse Event|0
2101355|NCT00830869|3692562|FG011|Period 1: Part 1|Adverse Event|0
2101356|NCT00830869|3692551|FG000|Period 1: Part 1|Progressive disease|1
2101357|NCT00830869|3692552|FG001|Period 1: Part 1|Progressive disease|0
2101358|NCT00830869|3692553|FG002|Period 1: Part 1|Progressive disease|1
2101359|NCT00830869|3692554|FG003|Period 1: Part 1|Progressive disease|6
2101360|NCT00830869|3692555|FG004|Period 1: Part 1|Progressive disease|4
2101361|NCT00830869|3692556|FG005|Period 1: Part 1|Progressive disease|4
2101362|NCT00830869|3692557|FG006|Period 1: Part 1|Progressive disease|1
2101363|NCT00830869|3692558|FG007|Period 1: Part 1|Progressive disease|0
2101364|NCT00830869|3692559|FG008|Period 1: Part 1|Progressive disease|0
2101365|NCT00830869|3692560|FG009|Period 1: Part 1|Progressive disease|0
2101366|NCT00830869|3692561|FG010|Period 1: Part 1|Progressive disease|0
2101367|NCT00830869|3692562|FG011|Period 1: Part 1|Progressive disease|0
2101368|NCT00830869|3692551|FG000|Period 2: Part 2|Protocol Violation|0
2101369|NCT00830869|3692552|FG001|Period 2: Part 2|Protocol Violation|0
2101370|NCT00830869|3692553|FG002|Period 2: Part 2|Protocol Violation|0
2101371|NCT00830869|3692554|FG003|Period 2: Part 2|Protocol Violation|0
2101372|NCT00830869|3692555|FG004|Period 2: Part 2|Protocol Violation|0
2101373|NCT00830869|3692556|FG005|Period 2: Part 2|Protocol Violation|0
2101374|NCT00830869|3692557|FG006|Period 2: Part 2|Protocol Violation|0
2101375|NCT00830869|3692558|FG007|Period 2: Part 2|Protocol Violation|1
2101376|NCT00830869|3692559|FG008|Period 2: Part 2|Protocol Violation|0
2101377|NCT00830869|3692560|FG009|Period 2: Part 2|Protocol Violation|1
2101378|NCT00830869|3692561|FG010|Period 2: Part 2|Protocol Violation|0
2101379|NCT00830869|3692562|FG011|Period 2: Part 2|Protocol Violation|0
2101380|NCT00830869|3692551|FG000|Period 2: Part 2|Withdrawal by Subject|0
2101381|NCT00830869|3692552|FG001|Period 2: Part 2|Withdrawal by Subject|0
2101382|NCT00830869|3692553|FG002|Period 2: Part 2|Withdrawal by Subject|0
2101383|NCT00830869|3692554|FG003|Period 2: Part 2|Withdrawal by Subject|0
2101384|NCT00830869|3692555|FG004|Period 2: Part 2|Withdrawal by Subject|0
2101385|NCT00830869|3692556|FG005|Period 2: Part 2|Withdrawal by Subject|0
2101386|NCT00830869|3692557|FG006|Period 2: Part 2|Withdrawal by Subject|0
2101387|NCT00830869|3692558|FG007|Period 2: Part 2|Withdrawal by Subject|1
2354007|NCT01752023|4108242|FG000|Overall Study|Physician Decision|2
2354008|NCT01752023|4108243|FG001|Overall Study|Physician Decision|1
2354009|NCT01740154|4108253|FG000|Overall Study|Adverse Event|1
2354010|NCT01748890|4108257|FG000|Overall Study|Insufficient recruitment for analysis|4
2354011|NCT01748162|4108263|FG000|Overall Study|no additional croup episodes to evaluate|2
2354012|NCT01748162|4108264|FG001|Overall Study|no additional croup episodes to evaluate|2
2354013|NCT01748162|4108263|FG000|Overall Study|participant consented but did not begin|0
2354014|NCT01748162|4108264|FG001|Overall Study|participant consented but did not begin|1
2354015|NCT01748162|4108263|FG000|Overall Study|reasons not available|3
2101388|NCT00830869|3692559|FG008|Period 2: Part 2|Withdrawal by Subject|2
2101389|NCT00830869|3692560|FG009|Period 2: Part 2|Withdrawal by Subject|1
2101390|NCT00830869|3692561|FG010|Period 2: Part 2|Withdrawal by Subject|0
2101391|NCT00830869|3692562|FG011|Period 2: Part 2|Withdrawal by Subject|1
2101392|NCT00830869|3692551|FG000|Period 2: Part 2|Adverse Event|0
2101393|NCT00830869|3692552|FG001|Period 2: Part 2|Adverse Event|0
2101394|NCT00830869|3692553|FG002|Period 2: Part 2|Adverse Event|0
2101395|NCT00830869|3692554|FG003|Period 2: Part 2|Adverse Event|0
2101396|NCT00830869|3692555|FG004|Period 2: Part 2|Adverse Event|0
2101397|NCT00830869|3692556|FG005|Period 2: Part 2|Adverse Event|0
2101398|NCT00830869|3692557|FG006|Period 2: Part 2|Adverse Event|0
2101399|NCT00830869|3692558|FG007|Period 2: Part 2|Adverse Event|4
2101400|NCT00830869|3692559|FG008|Period 2: Part 2|Adverse Event|3
2101401|NCT00830869|3692560|FG009|Period 2: Part 2|Adverse Event|2
2101402|NCT00830869|3692561|FG010|Period 2: Part 2|Adverse Event|2
2101403|NCT00830869|3692562|FG011|Period 2: Part 2|Adverse Event|0
2101404|NCT00830869|3692551|FG000|Period 2: Part 2|Symptomatic Deterioration|0
2101405|NCT00830869|3692552|FG001|Period 2: Part 2|Symptomatic Deterioration|0
2101406|NCT00830869|3692553|FG002|Period 2: Part 2|Symptomatic Deterioration|0
2101407|NCT00830869|3692554|FG003|Period 2: Part 2|Symptomatic Deterioration|0
2101408|NCT00830869|3692555|FG004|Period 2: Part 2|Symptomatic Deterioration|0
2101409|NCT00830869|3692556|FG005|Period 2: Part 2|Symptomatic Deterioration|0
2101410|NCT00830869|3692557|FG006|Period 2: Part 2|Symptomatic Deterioration|0
2101411|NCT00830869|3692558|FG007|Period 2: Part 2|Symptomatic Deterioration|0
2101412|NCT00830869|3692559|FG008|Period 2: Part 2|Symptomatic Deterioration|6
2101413|NCT00830869|3692560|FG009|Period 2: Part 2|Symptomatic Deterioration|3
2101414|NCT00830869|3692561|FG010|Period 2: Part 2|Symptomatic Deterioration|1
2101415|NCT00830869|3692562|FG011|Period 2: Part 2|Symptomatic Deterioration|4
2101416|NCT00830869|3692551|FG000|Period 2: Part 2|Progressive disease|0
2101417|NCT00830869|3692552|FG001|Period 2: Part 2|Progressive disease|0
2101418|NCT00830869|3692553|FG002|Period 2: Part 2|Progressive disease|0
2101419|NCT00830869|3692554|FG003|Period 2: Part 2|Progressive disease|0
2101420|NCT00830869|3692555|FG004|Period 2: Part 2|Progressive disease|0
2101421|NCT00830869|3692556|FG005|Period 2: Part 2|Progressive disease|0
2101422|NCT00830869|3692557|FG006|Period 2: Part 2|Progressive disease|0
2101423|NCT00830869|3692558|FG007|Period 2: Part 2|Progressive disease|14
2101424|NCT00830869|3692559|FG008|Period 2: Part 2|Progressive disease|11
2101425|NCT00830869|3692560|FG009|Period 2: Part 2|Progressive disease|12
2101426|NCT00830869|3692561|FG010|Period 2: Part 2|Progressive disease|8
2101427|NCT00830869|3692562|FG011|Period 2: Part 2|Progressive disease|15
2101428|NCT00830869|3692551|FG000|Period 2: Part 2|Other|0
2101429|NCT00830869|3692552|FG001|Period 2: Part 2|Other|0
2101430|NCT00830869|3692553|FG002|Period 2: Part 2|Other|0
2101431|NCT00830869|3692554|FG003|Period 2: Part 2|Other|0
2101432|NCT00830869|3692555|FG004|Period 2: Part 2|Other|0
2101433|NCT00830869|3692556|FG005|Period 2: Part 2|Other|0
2101434|NCT00830869|3692557|FG006|Period 2: Part 2|Other|0
2101435|NCT00830869|3692558|FG007|Period 2: Part 2|Other|0
2101436|NCT00830869|3692559|FG008|Period 2: Part 2|Other|0
2101437|NCT00830869|3692560|FG009|Period 2: Part 2|Other|1
2101438|NCT00830869|3692561|FG010|Period 2: Part 2|Other|0
2101439|NCT00830869|3692562|FG011|Period 2: Part 2|Other|0
2101440|NCT00830947|3692591|FG000|Overall Study|Lost to Follow-up|4
2101441|NCT00830947|3692592|FG001|Overall Study|Lost to Follow-up|4
2101442|NCT00830960|3692604|FG000|Overall Study|Death|5
2101443|NCT00830960|3692605|FG001|Overall Study|Death|4
2101444|NCT00830960|3692606|FG002|Overall Study|Death|3
2101445|NCT00830960|3692607|FG003|Overall Study|Death|2
2101446|NCT00830960|3692608|FG004|Overall Study|Death|6
2101447|NCT00830960|3692609|FG005|Overall Study|Death|1
2101448|NCT00830960|3692604|FG000|Overall Study|Lost to Follow-up|1
2101449|NCT00830960|3692605|FG001|Overall Study|Lost to Follow-up|1
2101450|NCT00830960|3692606|FG002|Overall Study|Lost to Follow-up|1
2101451|NCT00830960|3692607|FG003|Overall Study|Lost to Follow-up|0
2101452|NCT00830960|3692608|FG004|Overall Study|Lost to Follow-up|0
2101453|NCT00830960|3692609|FG005|Overall Study|Lost to Follow-up|1
2101454|NCT00830960|3692604|FG000|Overall Study|Withdrawal by Subject|19
2101455|NCT00830960|3692605|FG001|Overall Study|Withdrawal by Subject|19
2101456|NCT00830960|3692606|FG002|Overall Study|Withdrawal by Subject|18
2101457|NCT00830960|3692607|FG003|Overall Study|Withdrawal by Subject|23
2101458|NCT00830960|3692608|FG004|Overall Study|Withdrawal by Subject|16
2101459|NCT00830960|3692609|FG005|Overall Study|Withdrawal by Subject|21
2101460|NCT00830960|3692604|FG000|Overall Study|Sponsor Decision|1
2101461|NCT00830960|3692605|FG001|Overall Study|Sponsor Decision|2
2101462|NCT00830960|3692606|FG002|Overall Study|Sponsor Decision|3
2101463|NCT00830960|3692607|FG003|Overall Study|Sponsor Decision|4
2101464|NCT00830960|3692608|FG004|Overall Study|Sponsor Decision|5
2101465|NCT00830960|3692609|FG005|Overall Study|Sponsor Decision|7
2101466|NCT00830960|3692604|FG000|Overall Study|No study drug received|7
2101467|NCT00830960|3692605|FG001|Overall Study|No study drug received|2
2101468|NCT00830960|3692606|FG002|Overall Study|No study drug received|4
2101469|NCT00830960|3692607|FG003|Overall Study|No study drug received|3
2101470|NCT00830960|3692608|FG004|Overall Study|No study drug received|5
2101471|NCT00830960|3692609|FG005|Overall Study|No study drug received|7
2101472|NCT00831129|3692648|FG000|Overall Study|Adverse Event|0
2101473|NCT00831129|3692649|FG001|Overall Study|Adverse Event|1
2101474|NCT00831129|3692648|FG000|Overall Study|9 lost to follow-up reasons uknown|0
2101475|NCT00831129|3692649|FG001|Overall Study|9 lost to follow-up reasons uknown|9
2101476|NCT00831181|3692655|FG000|Overall Study|Adverse Event|12
2101477|NCT00831233|3692662|FG000|Overall Study|Adverse Event|0
2101478|NCT00831233|3692663|FG001|Overall Study|Adverse Event|1
2101479|NCT00831233|3692662|FG000|Overall Study|Protocol Violation|1
2101480|NCT00831233|3692663|FG001|Overall Study|Protocol Violation|0
2101481|NCT00831233|3692662|FG000|Overall Study|Selection Criteria Not Met|2
2101482|NCT00831233|3692663|FG001|Overall Study|Selection Criteria Not Met|0
2101483|NCT00831311|3692688|FG000|Overall Study|Definitive Contraindication|3
2101484|NCT00831311|3692689|FG001|Overall Study|Definitive Contraindication|3
2101485|NCT00831311|3692688|FG000|Overall Study|Lost to Follow-up|3
2101486|NCT00831311|3692689|FG001|Overall Study|Lost to Follow-up|0
2101487|NCT00831311|3692688|FG000|Overall Study|Physician Decision|0
2101488|NCT00831311|3692689|FG001|Overall Study|Physician Decision|1
2101489|NCT00831311|3692688|FG000|Overall Study|Withdrawal by Subject|6
2101490|NCT00831311|3692689|FG001|Overall Study|Withdrawal by Subject|4
2101491|NCT00831389|3692698|FG000|Overall Study|Withdrawal by Subject|0
2101492|NCT00831389|3692699|FG001|Overall Study|Withdrawal by Subject|1
2101493|NCT00831415|3692705|FG000|Overall Study|Adverse Event|14
2101494|NCT00831415|3692705|FG000|Overall Study|Failed to return|3
2101495|NCT00831415|3692705|FG000|Overall Study|Physician Decision|6
2101496|NCT00831415|3692705|FG000|Overall Study|Lost to Follow-up|9
2101497|NCT00831415|3692705|FG000|Overall Study|Protocol Violation|3
2101498|NCT00831415|3692705|FG000|Overall Study|Withdrawal by Subject|35
2101499|NCT00831415|3692705|FG000|Overall Study|Unsatisfactory response - Efficacy|4
2101500|NCT00831415|3692705|FG000|Overall Study|Death|1
2354016|NCT01748162|4108264|FG001|Overall Study|reasons not available|2
2354017|NCT01732926|4108289|FG000|Overall Study|Study Terminated by Sponsor|168
2354018|NCT01732926|4108290|FG001|Overall Study|Study Terminated by Sponsor|80
2354019|NCT01732926|4108289|FG000|Overall Study|Withdrawal by Subject|46
2354020|NCT01732926|4108290|FG001|Overall Study|Withdrawal by Subject|8
2354021|NCT01732926|4108289|FG000|Overall Study|Physician Decision|24
2354022|NCT01732926|4108290|FG001|Overall Study|Physician Decision|11
2354023|NCT01732926|4108289|FG000|Overall Study|Other Reason|21
2354024|NCT01732926|4108290|FG001|Overall Study|Other Reason|4
2354025|NCT01732926|4108289|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7
2354026|NCT01732926|4108290|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6
2354027|NCT01732926|4108289|FG000|Overall Study|Blind Broken by Subject or Study Site|1
2354028|NCT01732926|4108290|FG001|Overall Study|Blind Broken by Subject or Study Site|1
2354029|NCT01732913|4108307|FG000|Overall Study|Study Terminated by Sponsor|105
2354030|NCT01732913|4108308|FG001|Overall Study|Study Terminated by Sponsor|55
2354031|NCT01732913|4108307|FG000|Overall Study|Withdrawal by Subject|27
2354032|NCT01732913|4108308|FG001|Overall Study|Withdrawal by Subject|4
2354033|NCT01732913|4108307|FG000|Overall Study|Physician Decision|14
2354034|NCT01732913|4108308|FG001|Overall Study|Physician Decision|7
2354035|NCT01732913|4108307|FG000|Overall Study|Other|7
2354036|NCT01732913|4108308|FG001|Overall Study|Other|1
2354037|NCT01732913|4108307|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3
2354038|NCT01732913|4108308|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2
2354039|NCT01716052|4108320|FG000|Overall Study|Withdrawal of funding|1
2354040|NCT01716052|4108321|FG001|Overall Study|Withdrawal of funding|1
2354041|NCT01712854|4108336|FG000|Overall Study|Physician Decision|1
2354042|NCT01708057|4108363|FG000|Overall Study|Withdrawal due to study termination.|1
2354043|NCT01708057|4108364|FG001|Overall Study|Withdrawal due to study termination.|1
2101501|NCT00831441|3692715|FG000|Randomized|Death|82
2101502|NCT00831441|3692716|FG001|Randomized|Death|81
2101503|NCT00831441|3692715|FG000|Randomized|Adverse Event|248
2101504|NCT00831441|3692716|FG001|Randomized|Adverse Event|321
2101505|NCT00831441|3692715|FG000|Randomized|Emergency procedure|2
2101506|NCT00831441|3692716|FG001|Randomized|Emergency procedure|2
2101507|NCT00831441|3692715|FG000|Randomized|Elective procedure|26
2101508|NCT00831441|3692716|FG001|Randomized|Elective procedure|25
2101509|NCT00831441|3692715|FG000|Randomized|Physician Decision|26
2101510|NCT00831441|3692716|FG001|Randomized|Physician Decision|35
2101511|NCT00831441|3692715|FG000|Randomized|No longer met criteria|13
2101512|NCT00831441|3692716|FG001|Randomized|No longer met criteria|19
2101513|NCT00831441|3692715|FG000|Randomized|Withdrawal by Subject|178
2101514|NCT00831441|3692716|FG001|Randomized|Withdrawal by Subject|212
2101515|NCT00831441|3692715|FG000|Randomized|Lost to Follow-up|26
2101516|NCT00831441|3692716|FG001|Randomized|Lost to Follow-up|35
2101517|NCT00831441|3692715|FG000|Randomized|Administrative reason by sponsor|2780
2101518|NCT00831441|3692716|FG001|Randomized|Administrative reason by sponsor|2671
2101519|NCT00831441|3692715|FG000|Randomized|poor/non-compliance|30
2101520|NCT00831441|3692716|FG001|Randomized|poor/non-compliance|38
2101521|NCT00831441|3692715|FG000|Randomized|non-specified|276
2101522|NCT00831441|3692716|FG001|Randomized|non-specified|266
2101523|NCT00831441|3692715|FG000|Follow Up (30 Days)|Withdrawal by Subject|41
2101524|NCT00831441|3692716|FG001|Follow Up (30 Days)|Withdrawal by Subject|34
2101525|NCT00831441|3692715|FG000|Follow Up (30 Days)|Lost to Follow-up|13
2101526|NCT00831441|3692716|FG001|Follow Up (30 Days)|Lost to Follow-up|27
2101527|NCT00831441|3692715|FG000|Follow Up (30 Days)|Death|63
2101528|NCT00831441|3692716|FG001|Follow Up (30 Days)|Death|86
2101529|NCT00831441|3692715|FG000|Follow Up (30 Days)|non-specified|16
2101530|NCT00831441|3692716|FG001|Follow Up (30 Days)|non-specified|26
2101531|NCT00831441|3692715|FG000|Follow Up (30 Days)|missing end of study status|0
2101532|NCT00831441|3692716|FG001|Follow Up (30 Days)|missing end of study status|1
2101533|NCT00831493|3692727|FG000|Overall Study|Intractable nausea and vomiting|1
2101534|NCT00831701|3692742|FG000|Overall Study|Withdrawal by Subject|2
2101535|NCT00831701|3692743|FG001|Overall Study|Withdrawal by Subject|0
2101536|NCT00831701|3692742|FG000|Overall Study|Stone expulsion before first medication|2
2101537|NCT00831701|3692743|FG001|Overall Study|Stone expulsion before first medication|2
2101538|NCT00831701|3692742|FG000|Overall Study|Lost to Follow-up|1
2101539|NCT00831701|3692743|FG001|Overall Study|Lost to Follow-up|3
2101540|NCT00831779|3692770|FG000|Overall Study|Lost to Follow-up|1
2101541|NCT00831779|3692771|FG001|Overall Study|Lost to Follow-up|0
2101542|NCT00831779|3692770|FG000|Overall Study|No longer met criteria|0
2101543|NCT00831779|3692771|FG001|Overall Study|No longer met criteria|1
2101544|NCT00831792|3692777|FG000|Overall Study|Not Eligible|3
2101545|NCT00831792|3692777|FG000|Overall Study|Adverse Event|1
2101546|NCT00831792|3692777|FG000|Overall Study|Death|1
2101547|NCT00831792|3692777|FG000|Overall Study|Lack of Efficacy|1
2101548|NCT00831844|3692791|FG000|Overall Study|Adverse Event|2
2101549|NCT00831844|3692792|FG001|Overall Study|Adverse Event|0
2101550|NCT00831844|3692793|FG002|Overall Study|Adverse Event|0
2101551|NCT00831844|3692794|FG003|Overall Study|Adverse Event|0
2101552|NCT00831844|3692795|FG004|Overall Study|Adverse Event|1
2101553|NCT00831844|3692796|FG005|Overall Study|Adverse Event|1
2101554|NCT00831844|3692797|FG006|Overall Study|Adverse Event|2
2101555|NCT00831844|3692798|FG007|Overall Study|Adverse Event|0
2101556|NCT00831844|3692799|FG008|Overall Study|Adverse Event|0
2101557|NCT00831844|3692800|FG009|Overall Study|Adverse Event|0
2101558|NCT00831844|3692791|FG000|Overall Study|Death|0
2101559|NCT00831844|3692792|FG001|Overall Study|Death|0
2101560|NCT00831844|3692793|FG002|Overall Study|Death|0
2101561|NCT00831844|3692794|FG003|Overall Study|Death|1
2101562|NCT00831844|3692795|FG004|Overall Study|Death|0
2101563|NCT00831844|3692796|FG005|Overall Study|Death|0
2101564|NCT00831844|3692797|FG006|Overall Study|Death|0
2101565|NCT00831844|3692798|FG007|Overall Study|Death|0
2101566|NCT00831844|3692799|FG008|Overall Study|Death|0
2101567|NCT00831844|3692800|FG009|Overall Study|Death|0
2101568|NCT00831844|3692791|FG000|Overall Study|Lack of Efficacy|8
2101569|NCT00831844|3692792|FG001|Overall Study|Lack of Efficacy|10
2101570|NCT00831844|3692793|FG002|Overall Study|Lack of Efficacy|15
2101571|NCT00831844|3692794|FG003|Overall Study|Lack of Efficacy|8
2101572|NCT00831844|3692795|FG004|Overall Study|Lack of Efficacy|11
2101573|NCT00831844|3692796|FG005|Overall Study|Lack of Efficacy|17
2101574|NCT00831844|3692797|FG006|Overall Study|Lack of Efficacy|8
2101575|NCT00831844|3692798|FG007|Overall Study|Lack of Efficacy|9
2101576|NCT00831844|3692799|FG008|Overall Study|Lack of Efficacy|7
2101577|NCT00831844|3692800|FG009|Overall Study|Lack of Efficacy|0
2101578|NCT00831844|3692791|FG000|Overall Study|Physician Decision|0
2101579|NCT00831844|3692792|FG001|Overall Study|Physician Decision|1
2101580|NCT00831844|3692793|FG002|Overall Study|Physician Decision|3
2101581|NCT00831844|3692794|FG003|Overall Study|Physician Decision|1
2101582|NCT00831844|3692795|FG004|Overall Study|Physician Decision|1
2101583|NCT00831844|3692796|FG005|Overall Study|Physician Decision|1
2101584|NCT00831844|3692797|FG006|Overall Study|Physician Decision|0
2101585|NCT00831844|3692798|FG007|Overall Study|Physician Decision|0
2101586|NCT00831844|3692799|FG008|Overall Study|Physician Decision|1
2101587|NCT00831844|3692800|FG009|Overall Study|Physician Decision|0
2101588|NCT00831844|3692791|FG000|Overall Study|Withdrawal by Subject|0
2101589|NCT00831844|3692792|FG001|Overall Study|Withdrawal by Subject|0
2101590|NCT00831844|3692793|FG002|Overall Study|Withdrawal by Subject|1
2101591|NCT00831844|3692794|FG003|Overall Study|Withdrawal by Subject|0
2101592|NCT00831844|3692795|FG004|Overall Study|Withdrawal by Subject|0
2101593|NCT00831844|3692796|FG005|Overall Study|Withdrawal by Subject|0
2101594|NCT00831844|3692797|FG006|Overall Study|Withdrawal by Subject|0
2101595|NCT00831844|3692798|FG007|Overall Study|Withdrawal by Subject|1
2101596|NCT00831844|3692799|FG008|Overall Study|Withdrawal by Subject|1
2101597|NCT00831844|3692800|FG009|Overall Study|Withdrawal by Subject|0
2101598|NCT00831844|3692791|FG000|Overall Study|Ineligible|0
2101599|NCT00831844|3692792|FG001|Overall Study|Ineligible|1
2101600|NCT00831844|3692793|FG002|Overall Study|Ineligible|1
2101601|NCT00831844|3692794|FG003|Overall Study|Ineligible|0
2101602|NCT00831844|3692795|FG004|Overall Study|Ineligible|1
2101603|NCT00831844|3692796|FG005|Overall Study|Ineligible|0
2101604|NCT00831844|3692797|FG006|Overall Study|Ineligible|0
2101605|NCT00831844|3692798|FG007|Overall Study|Ineligible|0
2101606|NCT00831844|3692799|FG008|Overall Study|Ineligible|0
2101607|NCT00831844|3692800|FG009|Overall Study|Ineligible|0
2101608|NCT00832000|3692831|FG000|Overall Study|Adverse Event|2
2101609|NCT00832000|3692832|FG001|Overall Study|Adverse Event|0
2101610|NCT00832000|3692831|FG000|Overall Study|Withdrawal by Subject|1
2101611|NCT00832000|3692832|FG001|Overall Study|Withdrawal by Subject|0
2101612|NCT00832000|3692831|FG000|Overall Study|No calls to IVR in either period|1
2101613|NCT00832000|3692832|FG001|Overall Study|No calls to IVR in either period|1
2101614|NCT00832000|3692831|FG000|Overall Study|No calls to IVR in period 2|2
2101615|NCT00832000|3692832|FG001|Overall Study|No calls to IVR in period 2|0
2101616|NCT00832078|3692867|FG000|Test Day 1-2 Period|Lack of Efficacy|0
2101617|NCT00832078|3692868|FG001|Test Day 1-2 Period|Lack of Efficacy|2
2101618|NCT00832078|3692867|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1
2101619|NCT00832078|3692868|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0
2101620|NCT00832091|3692876|FG000|Overall Study|Adverse Event|1
2101621|NCT00832091|3692877|FG001|Overall Study|Adverse Event|1
2101622|NCT00832091|3692876|FG000|Overall Study|Protocol Violation|1
2101623|NCT00832091|3692877|FG001|Overall Study|Protocol Violation|0
2101624|NCT00832091|3692876|FG000|Overall Study|Withdrawal by Subject|2
2101625|NCT00832091|3692877|FG001|Overall Study|Withdrawal by Subject|1
2101626|NCT00832091|3692876|FG000|Overall Study|Prohibited Medication|1
2101627|NCT00832091|3692877|FG001|Overall Study|Prohibited Medication|0
2101628|NCT00832117|3692885|FG000|Overall Study|Death|1
2101629|NCT00832117|3692885|FG000|Overall Study|Disease Progression|11
2101630|NCT00832377|3692909|FG000|Overall Study|Protocol Violation|1
2101631|NCT00832416|3692930|FG000|Overall Study|Lack of Efficacy|17
2101632|NCT00832416|3692931|FG001|Overall Study|Lack of Efficacy|15
2101633|NCT00832416|3692932|FG002|Overall Study|Lack of Efficacy|13
2101634|NCT00832416|3692933|FG003|Overall Study|Lack of Efficacy|52
2101635|NCT00832416|3692930|FG000|Overall Study|Withdrawal by Subject|5
2101636|NCT00832416|3692931|FG001|Overall Study|Withdrawal by Subject|7
2101637|NCT00832416|3692932|FG002|Overall Study|Withdrawal by Subject|2
2101638|NCT00832416|3692933|FG003|Overall Study|Withdrawal by Subject|10
2101639|NCT00832416|3692930|FG000|Overall Study|Physician Decision|2
2101640|NCT00832416|3692931|FG001|Overall Study|Physician Decision|12
2101641|NCT00832416|3692932|FG002|Overall Study|Physician Decision|5
2101642|NCT00832416|3692933|FG003|Overall Study|Physician Decision|10
2101643|NCT00832416|3692930|FG000|Overall Study|Administrative|0
2101644|NCT00832416|3692931|FG001|Overall Study|Administrative|0
2101645|NCT00832416|3692932|FG002|Overall Study|Administrative|0
2101646|NCT00832416|3692933|FG003|Overall Study|Administrative|1
2101647|NCT00832416|3692930|FG000|Overall Study|Adverse Event|21
2101648|NCT00832416|3692931|FG001|Overall Study|Adverse Event|19
2101649|NCT00832416|3692932|FG002|Overall Study|Adverse Event|41
2101650|NCT00832416|3692933|FG003|Overall Study|Adverse Event|10
2101651|NCT00832416|3692930|FG000|Overall Study|Death|1
2101652|NCT00832416|3692931|FG001|Overall Study|Death|0
2101653|NCT00832416|3692932|FG002|Overall Study|Death|0
2101654|NCT00832416|3692933|FG003|Overall Study|Death|0
2101655|NCT00832585|3692943|FG000|Overall Study|Withdrawal by Subject|1
2101656|NCT00832585|3692943|FG000|Overall Study|Lost to Follow-up|1
2101657|NCT00832650|3692954|FG000|Overall Study|Randomized but not treated|0
2101658|NCT00832650|3692955|FG001|Overall Study|Randomized but not treated|0
2101659|NCT00832650|3692956|FG002|Overall Study|Randomized but not treated|1
2101660|NCT00832780|3692975|FG000|Overall Study|Death|16
2101661|NCT00832780|3692975|FG000|Overall Study|Lost to Follow-up|4
2101662|NCT00832780|3692975|FG000|Overall Study|no reason given|2
2101663|NCT00832780|3692975|FG000|Overall Study|other complicating condition|2
2101664|NCT00832780|3692975|FG000|Overall Study|Physician Decision|1
2101665|NCT00832819|3692982|FG000|Overall Study|Adverse Event|0
2101666|NCT00832819|3692983|FG001|Overall Study|Adverse Event|1
2101667|NCT00832819|3692984|FG002|Overall Study|Adverse Event|0
2101668|NCT00832819|3692982|FG000|Overall Study|Protocol Violation|0
2101669|NCT00832819|3692983|FG001|Overall Study|Protocol Violation|0
2101670|NCT00832819|3692984|FG002|Overall Study|Protocol Violation|1
2101671|NCT00832975|3692994|FG000|Overall Study|Lost to Follow-up|7
2101672|NCT00832975|3692994|FG000|Overall Study|Protocol Violation|6
2101673|NCT00832975|3692994|FG000|Overall Study|Death|5
2101674|NCT00832975|3692994|FG000|Overall Study|Physician Decision|4
2101675|NCT00832975|3692994|FG000|Overall Study|Withdrawal by Subject|3
2101676|NCT00832975|3692994|FG000|Overall Study|Other reasons|14
2101677|NCT00833027|3692998|FG000|Overall Study|Adverse Event|33
2101678|NCT00833027|3692998|FG000|Overall Study|Death|1
2101679|NCT00833027|3692998|FG000|Overall Study|Lack of Efficacy|12
2101680|NCT00833027|3692998|FG000|Overall Study|Lost to Follow-up|24
2101681|NCT00833027|3692998|FG000|Overall Study|Protocol Violation|115
2101682|NCT00833027|3692998|FG000|Overall Study|Withdrawal by Subject|16
2101683|NCT00833027|3692998|FG000|Overall Study|Missing|10
2101684|NCT00833040|3693002|FG000|Overall Study|Adverse Event|0
2101685|NCT00833040|3693003|FG001|Overall Study|Adverse Event|0
2101686|NCT00833040|3693004|FG002|Overall Study|Adverse Event|0
2101687|NCT00833040|3693005|FG003|Overall Study|Adverse Event|0
2101688|NCT00833040|3693006|FG004|Overall Study|Adverse Event|0
2101689|NCT00833040|3693007|FG005|Overall Study|Adverse Event|1
2101690|NCT00833053|3693014|FG000|Overall Study|Adverse Event|4
2101691|NCT00833053|3693015|FG001|Overall Study|Adverse Event|0
2101692|NCT00833053|3693014|FG000|Overall Study|Treatment Failure|3
2101693|NCT00833053|3693015|FG001|Overall Study|Treatment Failure|1
2101694|NCT00833053|3693014|FG000|Overall Study|Withdrawal by Subject|0
2101695|NCT00833053|3693015|FG001|Overall Study|Withdrawal by Subject|1
2101696|NCT00833053|3693014|FG000|Overall Study|Protocol Violation|2
2101697|NCT00833053|3693015|FG001|Overall Study|Protocol Violation|1
2101698|NCT00833092|3693023|FG000|Overall Study|Withdrawal by Subject|2
2101699|NCT00833092|3693024|FG001|Overall Study|Withdrawal by Subject|3
2101700|NCT00833092|3693023|FG000|Overall Study|Protocol Violation|2
2101701|NCT00833092|3693024|FG001|Overall Study|Protocol Violation|1
2101702|NCT00833092|3693023|FG000|Overall Study|Diarrhea|0
2101703|NCT00833092|3693024|FG001|Overall Study|Diarrhea|2
2101704|NCT00833092|3693023|FG000|Overall Study|constipation|0
2101705|NCT00833092|3693024|FG001|Overall Study|constipation|1
2101706|NCT00833105|3693030|FG000|Overall Study|Withdrawal by Subject|1
2101707|NCT00833105|3693030|FG000|Overall Study|Adverse Event|2
2101708|NCT00833248|3693038|FG000|Overall Study|Adverse Event|3
2101709|NCT00833248|3693039|FG001|Overall Study|Adverse Event|0
2101710|NCT00833248|3693038|FG000|Overall Study|Protocol Violation|1
2101711|NCT00833248|3693039|FG001|Overall Study|Protocol Violation|2
2101712|NCT00833248|3693038|FG000|Overall Study|Withdrawal by Subject|0
2101713|NCT00833248|3693039|FG001|Overall Study|Withdrawal by Subject|1
2101714|NCT00833261|3693045|FG000|Overall Study|Withdrawal by Subject|4
2101715|NCT00833417|3693060|FG000|Overall Study|Adverse Event|5
2101716|NCT00833417|3693061|FG001|Overall Study|Adverse Event|16
2101717|NCT00833417|3693060|FG000|Overall Study|Death|1
2101718|NCT00833417|3693061|FG001|Overall Study|Death|3
2101719|NCT00833417|3693060|FG000|Overall Study|Lost to Follow-up|1
2101720|NCT00833417|3693061|FG001|Overall Study|Lost to Follow-up|2
2101721|NCT00833417|3693060|FG000|Overall Study|Physician Decision to Withdraw Patient|3
2101722|NCT00833417|3693061|FG001|Overall Study|Physician Decision to Withdraw Patient|7
2101723|NCT00833417|3693060|FG000|Overall Study|Patient Decision to Withdraw|4
2101724|NCT00833417|3693061|FG001|Overall Study|Patient Decision to Withdraw|23
2101725|NCT00833417|3693060|FG000|Overall Study|Sponsor Decision to Terminate Study|1
2101726|NCT00833417|3693061|FG001|Overall Study|Sponsor Decision to Terminate Study|2
2101727|NCT00833417|3693060|FG000|Overall Study|Disease Progression|18
2101728|NCT00833417|3693061|FG001|Overall Study|Disease Progression|17
2101729|NCT00833417|3693060|FG000|Overall Study|Reason Not Specified|0
2101730|NCT00833417|3693061|FG001|Overall Study|Reason Not Specified|1
2354044|NCT01708057|4108365|FG002|Overall Study|Withdrawal due to study termination.|1
2354045|NCT01693367|4108385|FG000|Overall Study|Withdrawal by Subject|1
2354046|NCT01693367|4108386|FG001|Overall Study|Withdrawal by Subject|1
2354047|NCT01693367|4108385|FG000|Overall Study|Physician Decision|0
2354048|NCT01693367|4108386|FG001|Overall Study|Physician Decision|1
2354049|NCT01697800|4108407|FG000|Overall Study|Death|0
2354050|NCT01697800|4108408|FG001|Overall Study|Death|1
2354051|NCT01700348|4108414|FG000|Overall Study|Withdrawal by Subject|22
2354052|NCT01700348|4108414|FG000|Overall Study|Lost to Follow-up|1
2354053|NCT01689974|4108459|FG000|Overall Study|Termination of Study|5
2354054|NCT01689974|4108460|FG001|Overall Study|Termination of Study|5
2354055|NCT01676961|4108466|FG000|Overall Study|Death|3
2354056|NCT01676961|4108466|FG000|Overall Study|Lost to Follow-up|1
2354057|NCT01676961|4108466|FG000|Overall Study|Withdrawal by Subject|1
2354058|NCT01675011|4108534|FG000|Overall Study|Trial terminated by Sponsor|3
2354059|NCT01675011|4108535|FG001|Overall Study|Trial terminated by Sponsor|1
2354060|NCT01668147|4108563|FG000|Overall Study|Withdrawal by Subject|6
2354061|NCT01676701|4108573|FG000|Overall Study|Protocol Violation|1
2354062|NCT01676701|4108574|FG001|Overall Study|Protocol Violation|0
2101731|NCT00833469|3693079|FG000|Overall Study|Withdrawal by Subject|1
2101732|NCT00833469|3693079|FG000|Overall Study|Lost to Follow-up|1
2354063|NCT01676701|4108573|FG000|Overall Study|Sponsor Decision|3
2354064|NCT01676701|4108574|FG001|Overall Study|Sponsor Decision|4
2354065|NCT01662102|4108589|FG000|Overall Study|Sponsor's decision|1
2354066|NCT01662102|4108590|FG001|Overall Study|Sponsor's decision|0
2354067|NCT01659554|4108597|FG000|Overall Study|Study Termination|4
2101733|NCT00833482|3693085|FG000|Days 11-20|Adverse Event|0
2101734|NCT00833482|3693086|FG001|Days 11-20|Adverse Event|2
2354068|NCT01658813|4108601|FG000|Overall Study|Disease progression|3
2101735|NCT00833482|3693087|FG002|Days 11-20|Adverse Event|0
2101736|NCT00833482|3693088|FG003|Days 11-20|Adverse Event|0
2101737|NCT00833482|3693089|FG004|Days 11-20|Adverse Event|0
2101738|NCT00833482|3693090|FG005|Days 11-20|Adverse Event|0
2101739|NCT00833482|3693085|FG000|Days 11-20|Withdrawal by Subject|0
2101740|NCT00833482|3693086|FG001|Days 11-20|Withdrawal by Subject|1
2101741|NCT00833482|3693087|FG002|Days 11-20|Withdrawal by Subject|0
2101742|NCT00833482|3693088|FG003|Days 11-20|Withdrawal by Subject|0
2101743|NCT00833482|3693089|FG004|Days 11-20|Withdrawal by Subject|0
2101744|NCT00833482|3693090|FG005|Days 11-20|Withdrawal by Subject|0
2101745|NCT00833482|3693085|FG000|Days 21-30|Adverse Event|0
2101746|NCT00833482|3693086|FG001|Days 21-30|Adverse Event|0
2101747|NCT00833482|3693087|FG002|Days 21-30|Adverse Event|1
2101748|NCT00833482|3693088|FG003|Days 21-30|Adverse Event|0
2101749|NCT00833482|3693089|FG004|Days 21-30|Adverse Event|0
2101750|NCT00833482|3693090|FG005|Days 21-30|Adverse Event|0
2101751|NCT00833482|3693085|FG000|Days 21-30|Withdrawal by Subject|0
2101752|NCT00833482|3693086|FG001|Days 21-30|Withdrawal by Subject|0
2212318|NCT01668784|3853344|FG000|Treated (Overall)|Maximal Clinical Benefit|2
2212319|NCT01668784|3853345|FG001|Treated (Overall)|Maximal Clinical Benefit|3
2354069|NCT01642732|4108629|FG000|Overall Study|Withdrawal by Subject|1
2354070|NCT01648270|4108642|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12
2354071|NCT01641601|4108658|FG000|Overall Study|Study discontinued.|3
2354072|NCT01641601|4108659|FG001|Overall Study|Study discontinued.|5
2354073|NCT01627899|4108687|FG000|Overall Study|Study terminated early by sponsor.|5
2354074|NCT01632020|4108693|FG000|Overall Study|Withdrawal by Subject|1
2354075|NCT01632020|4108694|FG001|Overall Study|Withdrawal by Subject|0
2354076|NCT01632020|4108693|FG000|Overall Study|Adverse Event|1
2354077|NCT01632020|4108694|FG001|Overall Study|Adverse Event|0
2212320|NCT01668784|3853344|FG000|Treated (Overall)|Other|0
2212321|NCT01668784|3853345|FG001|Treated (Overall)|Other|4
2212322|NCT01668797|3853353|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3
2212323|NCT01668797|3853354|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0
2212324|NCT01668797|3853355|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0
2307694|NCT02700815|4010258|FG001|Overall Study|Lost to Follow-up|0
2307695|NCT02700815|4010259|FG002|Overall Study|Lost to Follow-up|0
2307696|NCT02700815|4010260|FG003|Overall Study|Lost to Follow-up|1
2307697|NCT02700815|4010257|FG000|Overall Study|Refusal to continue medication|0
2307698|NCT02700815|4010258|FG001|Overall Study|Refusal to continue medication|1
2307699|NCT02700815|4010259|FG002|Overall Study|Refusal to continue medication|0
2307700|NCT02700815|4010260|FG003|Overall Study|Refusal to continue medication|1
2307701|NCT02700815|4010257|FG000|Overall Study|Withdrawal by Subject|0
2307702|NCT02700815|4010258|FG001|Overall Study|Withdrawal by Subject|0
2307703|NCT02700815|4010259|FG002|Overall Study|Withdrawal by Subject|1
2307704|NCT02700815|4010260|FG003|Overall Study|Withdrawal by Subject|0
2307705|NCT02700919|4010273|FG000|Overall Study|Physician Decision|1
2307706|NCT02700919|4010274|FG001|Overall Study|Physician Decision|0
2307707|NCT02700919|4010275|FG002|Overall Study|Physician Decision|0
2307708|NCT02700919|4010273|FG000|Overall Study|Protocol Violation|1
2307709|NCT02700919|4010274|FG001|Overall Study|Protocol Violation|0
2307710|NCT02700919|4010275|FG002|Overall Study|Protocol Violation|0
2307711|NCT02700919|4010273|FG000|Overall Study|Adverse Event|1
2307712|NCT02700919|4010274|FG001|Overall Study|Adverse Event|3
2307713|NCT02700919|4010275|FG002|Overall Study|Adverse Event|1
2307714|NCT02700919|4010273|FG000|Overall Study|Withdrawal by Subject|5
2307715|NCT02700919|4010274|FG001|Overall Study|Withdrawal by Subject|8
2307716|NCT02700919|4010275|FG002|Overall Study|Withdrawal by Subject|2
2307717|NCT02700919|4010273|FG000|Overall Study|Lost to Follow-up|2
2307718|NCT02700919|4010274|FG001|Overall Study|Lost to Follow-up|0
2307719|NCT02700919|4010275|FG002|Overall Study|Lost to Follow-up|0
2307720|NCT02700919|4010273|FG000|Overall Study|Other|2
2307721|NCT02700919|4010274|FG001|Overall Study|Other|1
2307722|NCT02700919|4010275|FG002|Overall Study|Other|1
2307723|NCT02700984|4010294|FG000|Overall Study|Death|2
2307724|NCT02700984|4010295|FG001|Overall Study|Death|1
2307725|NCT02700984|4010294|FG000|Overall Study|Lost to Follow-up|2
2307726|NCT02700984|4010295|FG001|Overall Study|Lost to Follow-up|1
2307727|NCT02700984|4010294|FG000|Overall Study|Physician Decision|0
2307728|NCT02700984|4010295|FG001|Overall Study|Physician Decision|1
2307729|NCT02700984|4010294|FG000|Overall Study|Withdrawal by Subject|8
2307730|NCT02700984|4010295|FG001|Overall Study|Withdrawal by Subject|9
2307731|NCT02700984|4010294|FG000|Overall Study|Reason not specified|3
2307732|NCT02700984|4010295|FG001|Overall Study|Reason not specified|2
2307733|NCT02700997|4010311|FG000|Overall Study|Did not undergo CT imaging|1
2307734|NCT02700997|4010311|FG000|Overall Study|No CT measurement - pelvic calcification|1
2307735|NCT02701192|4010354|FG000|Overall Study|Protocol Violation|2
2307736|NCT02701192|4010354|FG000|Overall Study|Lost to Follow-up|4
2321758|NCT02963506|4036371|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321759|NCT02963506|4036372|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1
2101753|NCT00833482|3693087|FG002|Days 21-30|Withdrawal by Subject|0
2101754|NCT00833482|3693088|FG003|Days 21-30|Withdrawal by Subject|0
2101755|NCT00833482|3693089|FG004|Days 21-30|Withdrawal by Subject|1
2101756|NCT00833482|3693090|FG005|Days 21-30|Withdrawal by Subject|0
2101757|NCT00833547|3693114|FG000|Overall Study|Withdrawal by Subject|2
2101758|NCT00833547|3693115|FG001|Overall Study|Withdrawal by Subject|2
2101759|NCT00833560|3693121|FG000|Overall Study|Toxicity|13
2101760|NCT00833560|3693121|FG000|Overall Study|Adverse Event|11
2101761|NCT00833560|3693121|FG000|Overall Study|Protocol Violation|6
2101762|NCT00833560|3693121|FG000|Overall Study|Lack of Efficacy|4
2101763|NCT00833560|3693121|FG000|Overall Study|Death|2
2101764|NCT00833560|3693121|FG000|Overall Study|Pregression of other disease|1
2101765|NCT00833560|3693121|FG000|Overall Study|Other|5
2101766|NCT00833638|3693128|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1
2101767|NCT00833638|3693129|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2
2101768|NCT00833638|3693130|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0
2101769|NCT00833638|3693128|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
2101770|NCT00833638|3693129|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
2212325|NCT01668797|3853356|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0
2212326|NCT01668797|3853353|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
2212327|NCT01668797|3853354|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
2212328|NCT01668797|3853355|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
2212329|NCT01668797|3853356|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
2101771|NCT00833638|3693130|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
2101772|NCT00833638|3693128|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
2101773|NCT00833638|3693129|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
2101774|NCT00833638|3693130|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
2101775|NCT00833638|3693128|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1
2101776|NCT00833638|3693129|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0
2101777|NCT00833638|3693130|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0
2101778|NCT00833638|3693128|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
2101779|NCT00833638|3693129|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
2101780|NCT00833638|3693130|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
2101781|NCT00833638|3693128|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
2101782|NCT00833638|3693129|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
2101783|NCT00833638|3693130|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
2101784|NCT00833638|3693128|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
2101785|NCT00833638|3693129|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
2101786|NCT00833638|3693130|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
2101787|NCT00833638|3693128|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
2101788|NCT00833638|3693129|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
2101789|NCT00833638|3693130|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
2101790|NCT00833638|3693128|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0
2101791|NCT00833638|3693129|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1
2101792|NCT00833638|3693130|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2
2101793|NCT00833690|3693149|FG000|Overall Study|Withdrawal by Subject|1
2101794|NCT00833690|3693150|FG001|Overall Study|Withdrawal by Subject|0
2101795|NCT00833690|3693151|FG002|Overall Study|Withdrawal by Subject|0
2101796|NCT00833690|3693149|FG000|Overall Study|Discontinued study drug|3
2101797|NCT00833690|3693150|FG001|Overall Study|Discontinued study drug|2
2101798|NCT00833690|3693151|FG002|Overall Study|Discontinued study drug|0
2101799|NCT00833703|3693161|FG000|Overall Study|Parent(s)/guardian(s)'s request|0
2101800|NCT00833703|3693162|FG001|Overall Study|Parent(s)/guardian(s)'s request|1
2101801|NCT00833755|3693172|FG000|Overall Study|Physician Decision|4
2101802|NCT00833755|3693173|FG001|Overall Study|Physician Decision|4
2101803|NCT00833755|3693174|FG002|Overall Study|Physician Decision|2
2101804|NCT00833755|3693175|FG003|Overall Study|Physician Decision|6
2101805|NCT00833755|3693172|FG000|Overall Study|Subject had scheduling issues|0
2101806|NCT00833755|3693173|FG001|Overall Study|Subject had scheduling issues|1
2101807|NCT00833755|3693174|FG002|Overall Study|Subject had scheduling issues|0
2101808|NCT00833755|3693175|FG003|Overall Study|Subject had scheduling issues|0
2101809|NCT00833794|3693196|FG000|Open-label Phase|Adverse Event|225
2101810|NCT00833794|3693197|FG001|Open-label Phase|Adverse Event|0
2101811|NCT00833794|3693196|FG000|Open-label Phase|Lack of Efficacy|28
2101812|NCT00833794|3693197|FG001|Open-label Phase|Lack of Efficacy|0
2101813|NCT00833794|3693196|FG000|Open-label Phase|Withdrawal by Subject|48
2101814|NCT00833794|3693197|FG001|Open-label Phase|Withdrawal by Subject|0
2101815|NCT00833794|3693196|FG000|Open-label Phase|Physician Decision|20
2101816|NCT00833794|3693197|FG001|Open-label Phase|Physician Decision|0
2101817|NCT00833794|3693196|FG000|Open-label Phase|Administrative reason|1
2101818|NCT00833794|3693197|FG001|Open-label Phase|Administrative reason|0
2101819|NCT00833794|3693196|FG000|Open-label Phase|Protocol Violation|47
2101820|NCT00833794|3693197|FG001|Open-label Phase|Protocol Violation|0
2101821|NCT00833794|3693196|FG000|Open-label Phase|Did not complete wash-out period|12
2101822|NCT00833794|3693197|FG001|Open-label Phase|Did not complete wash-out period|0
2101823|NCT00833794|3693196|FG000|Open-label Phase|enrolled in error (immediately D/C)|1
2101824|NCT00833794|3693197|FG001|Open-label Phase|enrolled in error (immediately D/C)|0
2101825|NCT00833794|3693196|FG000|Double-blind Phase|Adverse Event|44
2101826|NCT00833794|3693197|FG001|Double-blind Phase|Adverse Event|11
2101827|NCT00833794|3693196|FG000|Double-blind Phase|Lack of Efficacy|34
2101828|NCT00833794|3693197|FG001|Double-blind Phase|Lack of Efficacy|22
2101829|NCT00833794|3693196|FG000|Double-blind Phase|Withdrawal by Subject|23
2101830|NCT00833794|3693197|FG001|Double-blind Phase|Withdrawal by Subject|6
2101831|NCT00833794|3693196|FG000|Double-blind Phase|Physician Decision|4
2101832|NCT00833794|3693197|FG001|Double-blind Phase|Physician Decision|7
2354078|NCT01619800|4108706|FG000|Overall Study|study terminated|2
2354079|NCT01619800|4108707|FG001|Overall Study|study terminated|0
2354080|NCT01614067|4108724|FG000|Overall Study|Pregnancy|1
2354081|NCT01614067|4108725|FG001|Overall Study|Pregnancy|0
2354082|NCT01614067|4108724|FG000|Overall Study|Physician Decision|6
2354083|NCT01614067|4108725|FG001|Overall Study|Physician Decision|5
2354084|NCT01614067|4108724|FG000|Overall Study|Withdrawal by Subject|0
2354085|NCT01614067|4108725|FG001|Overall Study|Withdrawal by Subject|1
2354086|NCT01614067|4108724|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8
2354087|NCT01614067|4108725|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9
2354088|NCT01605019|4108738|FG000|Overall Study|pt did not meet transplant endpoint|3
2354089|NCT01605019|4108739|FG001|Overall Study|pt did not meet transplant endpoint|0
2354090|NCT01609231|4108747|FG000|Overall Study|Adverse Event|1
2354091|NCT01609231|4108748|FG001|Overall Study|Adverse Event|3
2354092|NCT01609231|4108747|FG000|Overall Study|Physician Decision|1
2354093|NCT01609231|4108748|FG001|Overall Study|Physician Decision|0
2354094|NCT01609231|4108747|FG000|Overall Study|Withdrawal by Subject|1
2354095|NCT01609231|4108748|FG001|Overall Study|Withdrawal by Subject|0
2354096|NCT01603043|4108774|FG000|Overall Study|Study Futility|7
2354097|NCT01603043|4108775|FG001|Overall Study|Study Futility|3
2354098|NCT01605370|4108783|FG000|Overall Study|Adverse Event|1
2354099|NCT01605370|4108784|FG001|Overall Study|Adverse Event|0
2354100|NCT01605617|4108792|FG000|First Intervention|Adverse Event|0
2354101|NCT01605617|4108793|FG001|First Intervention|Adverse Event|1
2354102|NCT01605617|4108792|FG000|Washout Period of 4 Weeks|Study Terminated|2
2354103|NCT01605617|4108793|FG001|Washout Period of 4 Weeks|Study Terminated|1
2354104|NCT01603121|4108810|FG000|Second Intervention, 10 Hours|Adverse Event|1
2019765|NCT00300885|3587200|FG001|Treatment|Withdrawal by Subject|23
2019766|NCT00300885|3587199|FG000|Treatment|Disease progression|171
2019767|NCT00300885|3587200|FG001|Treatment|Disease progression|238
2019768|NCT00300885|3587199|FG000|Treatment|Random code broken (subject died)|0
2019769|NCT00300885|3587200|FG001|Treatment|Random code broken (subject died)|1
2019770|NCT00300885|3587199|FG000|Treatment|Non-compliant with study medication|3
2019771|NCT00300885|3587200|FG001|Treatment|Non-compliant with study medication|4
2019772|NCT00300885|3587199|FG000|Follow-up|Death|141
2019773|NCT00300885|3587200|FG001|Follow-up|Death|163
2019774|NCT00300885|3587199|FG000|Follow-up|Lost to Follow-up|11
2019775|NCT00300885|3587200|FG001|Follow-up|Lost to Follow-up|7
2019776|NCT00300885|3587199|FG000|Follow-up|Withdrawal by Subject|26
2019777|NCT00300885|3587200|FG001|Follow-up|Withdrawal by Subject|25
2019778|NCT00301067|3587210|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1
2019779|NCT00301067|3587211|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0
2019780|NCT00301067|3587212|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0
2019781|NCT00301067|3587213|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1
2019782|NCT00301067|3587210|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2
2019783|NCT00301067|3587211|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1
2019784|NCT00301067|3587212|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1
2019785|NCT00301067|3587213|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2
2019786|NCT00301067|3587210|FG000|Completed 4 Cycles of Treatment|Progressive disease|1
2019787|NCT00301067|3587211|FG001|Completed 4 Cycles of Treatment|Progressive disease|1
2019788|NCT00301067|3587212|FG002|Completed 4 Cycles of Treatment|Progressive disease|2
2019789|NCT00301067|3587213|FG003|Completed 4 Cycles of Treatment|Progressive disease|5
2019790|NCT00301067|3587210|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0
2019791|NCT00301067|3587211|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1
2019792|NCT00301067|3587212|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0
2019793|NCT00301067|3587213|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1
2019794|NCT00301067|3587210|FG000|Completed 12 Cycles of Treatment|Adverse Event|0
2019795|NCT00301067|3587211|FG001|Completed 12 Cycles of Treatment|Adverse Event|0
2019796|NCT00301067|3587212|FG002|Completed 12 Cycles of Treatment|Adverse Event|0
2019797|NCT00301067|3587213|FG003|Completed 12 Cycles of Treatment|Adverse Event|1
2019798|NCT00301067|3587210|FG000|Follow up Until Death|Alive at last data cut point|1
2019799|NCT00301067|3587211|FG001|Follow up Until Death|Alive at last data cut point|0
2019800|NCT00301067|3587212|FG002|Follow up Until Death|Alive at last data cut point|0
2019801|NCT00301067|3587213|FG003|Follow up Until Death|Alive at last data cut point|1
2101833|NCT00833794|3693196|FG000|Double-blind Phase|Administrative reason|1
2354105|NCT01603121|4108811|FG001|Second Intervention, 10 Hours|Adverse Event|0
2354106|NCT01603394|4108824|FG000|Overall Study|Adverse Event|1
2019802|NCT00301366|3587224|FG000|Overall Study|Adverse Event|1
2019803|NCT00301808|3587238|FG000|Overall Study|Adverse Event|5
2101834|NCT00833794|3693197|FG001|Double-blind Phase|Administrative reason|3
2101835|NCT00833833|3693211|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0
2101836|NCT00833833|3693212|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0
2101837|NCT00833833|3693213|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2
2101838|NCT00833833|3693214|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2
2101839|NCT00833833|3693215|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0
2101840|NCT00833833|3693216|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0
2101841|NCT00833833|3693211|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
2101842|NCT00833833|3693212|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
2101843|NCT00833833|3693213|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
2101844|NCT00833833|3693214|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
2101845|NCT00833833|3693215|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
2101846|NCT00833833|3693216|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
2101847|NCT00833833|3693211|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1
2101848|NCT00833833|3693212|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0
2101849|NCT00833833|3693213|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2
2101850|NCT00833833|3693214|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1
2101851|NCT00833833|3693215|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0
2354107|NCT01592383|4108828|FG000|Overall Study|Adverse Event|1
2354108|NCT01591096|4108850|FG000|Overall Study|Adverse Event|1
2354109|NCT01576575|4108867|FG000|Buprenorphine Control|Withdrawal by Subject|3
2354110|NCT01576575|4108867|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3
2354111|NCT01576575|4108867|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1
2354112|NCT01582100|4108891|FG000|Overall Study|Adverse Event|1
2354113|NCT01582100|4108891|FG000|Overall Study|Withdrawal by Subject|1
2354114|NCT01575028|4108904|FG000|Overall Study|Physician Decision|0
2354115|NCT01575028|4108905|FG001|Overall Study|Physician Decision|1
2354116|NCT01578785|4108913|FG000|Overall Study|Withdrawal by Subject|0
2354117|NCT01578785|4108914|FG001|Overall Study|Withdrawal by Subject|1
2354118|NCT01578785|4108913|FG000|Overall Study|Study terminated by sponsor|59
2354119|NCT01578785|4108914|FG001|Overall Study|Study terminated by sponsor|118
2354120|NCT01576549|4108920|FG000|Overall Study|Sponsor Decision|2
2354121|NCT01561989|4108940|FG000|Overall Study|accural target not met.|5
2354122|NCT01561989|4108941|FG001|Overall Study|accural target not met.|6
2354123|NCT01564732|4108949|FG000|Overall Study|Early termination by the study sponsor|6
2354124|NCT01564732|4108950|FG001|Overall Study|Early termination by the study sponsor|5
2354125|NCT01560507|4108959|FG000|Overall Study|Lost to Follow-up|3
2354126|NCT01560507|4108960|FG001|Overall Study|Lost to Follow-up|1
2354127|NCT01560507|4108961|FG002|Overall Study|Lost to Follow-up|2
2354128|NCT01560507|4108959|FG000|Overall Study|Withdrawal by Subject|1
2354129|NCT01560507|4108960|FG001|Overall Study|Withdrawal by Subject|1
2354130|NCT01560507|4108961|FG002|Overall Study|Withdrawal by Subject|0
2354131|NCT01555073|4109005|FG000|Overall Study|Lost to Follow-up|1
2354132|NCT01555073|4109006|FG001|Overall Study|Lost to Follow-up|2
2354133|NCT01555073|4109007|FG002|Overall Study|Lost to Follow-up|0
2354134|NCT01555073|4109008|FG003|Overall Study|Lost to Follow-up|5
2354135|NCT01541397|4109043|FG000|Overall Study|Study ended prior to data collection|4
2354136|NCT01541397|4109044|FG001|Overall Study|Study ended prior to data collection|2
2354137|NCT01546207|4109050|FG000|Overall Study|Death|1
2354138|NCT01547728|4109058|FG000|Overall Study|Change in procedure and equipment|1
2354139|NCT01547728|4109058|FG000|Overall Study|Drug not ready for subject|1
2354140|NCT01547728|4109058|FG000|Overall Study|Screen failure|39
2354141|NCT01546883|4109075|FG000|Overall Study|Withdrawal by Subject|3
2354142|NCT01546883|4109075|FG000|Overall Study|Adverse Event|4
2354143|NCT01546883|4109075|FG000|Overall Study|Lost to Follow-up|2
2354144|NCT01546883|4109075|FG000|Overall Study|early closure of study|2
2354145|NCT01546883|4109075|FG000|Overall Study|other unrelated illness|1
2354146|NCT01536015|4109085|FG000|Overall Study|Adverse Event|1
2354147|NCT01536015|4109086|FG001|Overall Study|Adverse Event|4
2354148|NCT01536015|4109085|FG000|Overall Study|Lost to Follow-up|0
2354149|NCT01536015|4109086|FG001|Overall Study|Lost to Follow-up|1
2354150|NCT01536015|4109085|FG000|Overall Study|Inclusion Criterion not met|2
2354151|NCT01536015|4109086|FG001|Overall Study|Inclusion Criterion not met|0
2354152|NCT01536015|4109085|FG000|Overall Study|Study closure|5
2354153|NCT01536015|4109086|FG001|Overall Study|Study closure|5
2354154|NCT01534676|4109112|FG000|Overall Study|Study closed due to poor enrollment|2
2354155|NCT01534676|4109113|FG001|Overall Study|Study closed due to poor enrollment|1
2354156|NCT01530087|4109137|FG000|Overall Study|Physician Decision|2
2354157|NCT01531387|4109174|FG000|Overall Study|Early termination of study|11
2354158|NCT01531387|4109175|FG001|Overall Study|Early termination of study|11
2354159|NCT01527292|4109194|FG000|Overall Study|Physician Decision|0
2354160|NCT01527292|4109195|FG001|Overall Study|Physician Decision|3
2354161|NCT01528696|4109214|FG000|Overall Study|See detailed description|18
2354162|NCT01528696|4109215|FG001|Overall Study|See detailed description|19
2354163|NCT01520714|4109249|FG000|Overall Study|Protocol Violation|0
2354164|NCT01520714|4109250|FG001|Overall Study|Protocol Violation|3
2101852|NCT00833833|3693216|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0
2101853|NCT00833833|3693211|FG000|Phase 1 (as of 01 April 2011)|Death|0
2101854|NCT00833833|3693212|FG001|Phase 1 (as of 01 April 2011)|Death|1
2354165|NCT01520714|4109249|FG000|Overall Study|Adverse Event|0
2354166|NCT01520714|4109250|FG001|Overall Study|Adverse Event|2
2354167|NCT01520714|4109249|FG000|Overall Study|Lack of Efficacy|0
2354168|NCT01520714|4109250|FG001|Overall Study|Lack of Efficacy|1
2354169|NCT01516034|4109265|FG000|Overall Study|Physician Decision|1
2354170|NCT01516034|4109265|FG000|Overall Study|Lack of Efficacy|7
2354171|NCT01510756|4109290|FG000|Overall Study|Death|1
2354172|NCT01510756|4109290|FG000|Overall Study|Lack of Efficacy|2
2354173|NCT01510756|4109290|FG000|Overall Study|Physician Decision|1
2212330|NCT01668797|3853353|FG000|Phase A (Conversion Phase)|Physician Decision|2
2212331|NCT01668797|3853354|FG001|Phase A (Conversion Phase)|Physician Decision|0
2212332|NCT01668797|3853355|FG002|Phase A (Conversion Phase)|Physician Decision|0
2019804|NCT00301808|3587238|FG000|Overall Study|Death|3
2019805|NCT00301808|3587238|FG000|Overall Study|Lack of Efficacy|4
2025886|NCT00347360|3594612|FG009|Overall Study|Subject refuse to sign updated consent|0
2025887|NCT00347360|3594613|FG010|Overall Study|Subject refuse to sign updated consent|0
2025888|NCT00347360|3594614|FG011|Overall Study|Subject refuse to sign updated consent|0
2025889|NCT00347360|3594615|FG012|Overall Study|Subject refuse to sign updated consent|0
2025890|NCT00347360|3594616|FG013|Overall Study|Subject refuse to sign updated consent|0
2025891|NCT00347360|3594617|FG014|Overall Study|Subject refuse to sign updated consent|1
2025892|NCT00347360|3594603|FG000|Overall Study|Visits conflicted with new job|0
2025893|NCT00347360|3594604|FG001|Overall Study|Visits conflicted with new job|0
2025894|NCT00347360|3594605|FG002|Overall Study|Visits conflicted with new job|0
2025895|NCT00347360|3594606|FG003|Overall Study|Visits conflicted with new job|0
2025896|NCT00347360|3594607|FG004|Overall Study|Visits conflicted with new job|0
2025897|NCT00347360|3594608|FG005|Overall Study|Visits conflicted with new job|0
2025898|NCT00347360|3594609|FG006|Overall Study|Visits conflicted with new job|1
2025899|NCT00347360|3594610|FG007|Overall Study|Visits conflicted with new job|0
2025900|NCT00347360|3594611|FG008|Overall Study|Visits conflicted with new job|0
2025901|NCT00347360|3594612|FG009|Overall Study|Visits conflicted with new job|0
2025902|NCT00347360|3594613|FG010|Overall Study|Visits conflicted with new job|0
2025903|NCT00347360|3594614|FG011|Overall Study|Visits conflicted with new job|0
2212333|NCT01668797|3853356|FG003|Phase A (Conversion Phase)|Physician Decision|0
2354174|NCT01509053|4109316|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
2025904|NCT00347360|3594615|FG012|Overall Study|Visits conflicted with new job|0
2025905|NCT00347360|3594616|FG013|Overall Study|Visits conflicted with new job|0
2025906|NCT00347360|3594617|FG014|Overall Study|Visits conflicted with new job|0
2025907|NCT00347438|3594649|FG000|Overall Study|Withdrawal by Subject|1
2025908|NCT00347438|3594649|FG000|Overall Study|Physician Decision|1
2025909|NCT00347776|3594656|FG000|1.5 Month Follow-up|Death|2
2025910|NCT00347776|3594657|FG001|1.5 Month Follow-up|Death|0
2025911|NCT00347776|3594658|FG002|1.5 Month Follow-up|Death|0
2025912|NCT00347776|3594656|FG000|1.5 Month Follow-up|reached the endpoint|12
2101855|NCT00833833|3693213|FG002|Phase 1 (as of 01 April 2011)|Death|2
2101856|NCT00833833|3693214|FG003|Phase 1 (as of 01 April 2011)|Death|0
2101857|NCT00833833|3693215|FG004|Phase 1 (as of 01 April 2011)|Death|0
2101858|NCT00833833|3693216|FG005|Phase 1 (as of 01 April 2011)|Death|0
2101859|NCT00833833|3693211|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
2101860|NCT00833833|3693212|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
2212334|NCT01668797|3853353|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16
2307737|NCT02701296|4010399|FG000|Overall Study|Incomplete Data|0
2354175|NCT01509053|4109316|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
2354176|NCT01509053|4109316|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
2354177|NCT01509053|4109316|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
2354178|NCT01509053|4109316|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
2354179|NCT01509053|4109316|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
2354180|NCT01478113|4109365|FG000|Overall Study|Withdrawal by Subject|0
2354181|NCT01478113|4109366|FG001|Overall Study|Withdrawal by Subject|1
2354182|NCT01478113|4109365|FG000|Overall Study|Physician Decision|1
2354183|NCT01478113|4109366|FG001|Overall Study|Physician Decision|0
2354184|NCT01482598|4109384|FG000|Overall Study|Death|7
2354185|NCT01482598|4109385|FG001|Overall Study|Death|10
2354186|NCT01482598|4109384|FG000|Overall Study|Physician Decision|0
2354187|NCT01482598|4109385|FG001|Overall Study|Physician Decision|3
2354188|NCT01482598|4109384|FG000|Overall Study|Withdrawal by Subject|4
2354189|NCT01482598|4109385|FG001|Overall Study|Withdrawal by Subject|5
2354190|NCT01482598|4109384|FG000|Overall Study|Lost to Follow-up|5
2354191|NCT01482598|4109385|FG001|Overall Study|Lost to Follow-up|4
2354192|NCT01473732|4109405|FG000|Overall Study|Adverse Event|1
2354193|NCT01473732|4109406|FG001|Overall Study|Adverse Event|0
2354194|NCT01473732|4109405|FG000|Overall Study|Death|1
2354195|NCT01473732|4109406|FG001|Overall Study|Death|0
2354196|NCT01465230|4109421|FG000|Overall Study|Withdrawal by Subject|2
2307738|NCT02701296|4010400|FG001|Overall Study|Incomplete Data|2
2307739|NCT02701361|4010409|FG000|Overall Study|Lost to Follow-up|5
2307740|NCT02701361|4010410|FG001|Overall Study|Lost to Follow-up|2
2307741|NCT02701361|4010411|FG002|Overall Study|Lost to Follow-up|1
2307742|NCT02701361|4010409|FG000|Overall Study|Withdrawal by Subject|4
2307743|NCT02701361|4010410|FG001|Overall Study|Withdrawal by Subject|0
2307744|NCT02701361|4010411|FG002|Overall Study|Withdrawal by Subject|0
2307745|NCT02701361|4010409|FG000|Overall Study|timed out in rehab center|0
2307746|NCT02701361|4010410|FG001|Overall Study|timed out in rehab center|1
2307747|NCT02701361|4010411|FG002|Overall Study|timed out in rehab center|0
2307748|NCT02701361|4010409|FG000|Overall Study|incarceration|0
2307749|NCT02701361|4010410|FG001|Overall Study|incarceration|0
2307750|NCT02701361|4010411|FG002|Overall Study|incarceration|1
2307751|NCT02701413|4010438|FG000|Overall Study|Withdrawal by Subject|7
2307752|NCT02701413|4010439|FG001|Overall Study|Withdrawal by Subject|11
2307753|NCT02701634|4010458|FG000|Overall Study|Adverse Event|2
2307754|NCT02701634|4010459|FG001|Overall Study|Adverse Event|3
2307755|NCT02701634|4010458|FG000|Overall Study|Death|1
2307756|NCT02701634|4010459|FG001|Overall Study|Death|0
2307757|NCT02701634|4010458|FG000|Overall Study|Investigator's Discretion|7
2307758|NCT02701634|4010459|FG001|Overall Study|Investigator's Discretion|4
2307759|NCT02701634|4010458|FG000|Overall Study|Study terminated by Sponsor|15
2307760|NCT02701634|4010459|FG001|Overall Study|Study terminated by Sponsor|17
2101861|NCT00833833|3693213|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
2101862|NCT00833833|3693214|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
2101863|NCT00833833|3693215|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
2101864|NCT00833833|3693216|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
2101865|NCT00833833|3693211|FG000|Phase 1 (as of 01 April 2011)|Other|1
2101866|NCT00833833|3693212|FG001|Phase 1 (as of 01 April 2011)|Other|3
2101867|NCT00833833|3693213|FG002|Phase 1 (as of 01 April 2011)|Other|0
2101868|NCT00833833|3693214|FG003|Phase 1 (as of 01 April 2011)|Other|1
2101869|NCT00833833|3693215|FG004|Phase 1 (as of 01 April 2011)|Other|0
2101870|NCT00833833|3693216|FG005|Phase 1 (as of 01 April 2011)|Other|0
2101871|NCT00833833|3693211|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0
2101872|NCT00833833|3693212|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0
2101873|NCT00833833|3693213|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0
2101874|NCT00833833|3693214|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0
2101875|NCT00833833|3693215|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23
2101876|NCT00833833|3693216|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22
2101877|NCT00833833|3693211|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0
2101878|NCT00833833|3693212|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0
2101879|NCT00833833|3693213|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0
2101880|NCT00833833|3693214|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0
2354197|NCT01463293|4109443|FG000|Overall Study|Lost to Follow-up|1
2354198|NCT01463293|4109444|FG001|Overall Study|Lost to Follow-up|4
2354199|NCT01463293|4109445|FG002|Overall Study|Lost to Follow-up|5
2354200|NCT01463293|4109443|FG000|Overall Study|Adverse Event|1
2354201|NCT01463293|4109444|FG001|Overall Study|Adverse Event|2
2354202|NCT01463293|4109445|FG002|Overall Study|Adverse Event|0
2354203|NCT01463293|4109443|FG000|Overall Study|Withdrawal by Subject|4
2354204|NCT01463293|4109444|FG001|Overall Study|Withdrawal by Subject|10
2354205|NCT01463293|4109445|FG002|Overall Study|Withdrawal by Subject|5
2354206|NCT01463293|4109443|FG000|Overall Study|Other|0
2354207|NCT01463293|4109444|FG001|Overall Study|Other|0
2354208|NCT01463293|4109445|FG002|Overall Study|Other|2
2354209|NCT01457053|4109453|FG000|Overall Study|Unable to undergo selected treatment|1
2354210|NCT01457053|4109454|FG001|Overall Study|Unable to undergo selected treatment|1
2354211|NCT01451723|4109462|FG000|Overall Study|study halted|6
2354212|NCT01451723|4109463|FG001|Overall Study|study halted|5
2354213|NCT01440517|4109473|FG000|Overall Study|Subject withdrawn prior to dosing|1
2354214|NCT01440595|4109479|FG000|Overall Study|Lost to Follow-up|0
2354215|NCT01440595|4109480|FG001|Overall Study|Lost to Follow-up|1
2354216|NCT01440595|4109481|FG002|Overall Study|Lost to Follow-up|0
2354217|NCT01440595|4109479|FG000|Overall Study|Study terminated by sponsor.|1
2354218|NCT01440595|4109480|FG001|Overall Study|Study terminated by sponsor.|2
2354219|NCT01440595|4109481|FG002|Overall Study|Study terminated by sponsor.|1
2101881|NCT00833833|3693215|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8
2101882|NCT00833833|3693216|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13
2101883|NCT00833833|3693211|FG000|Phase 2 (as of 01 April 2011)|Death|0
2101884|NCT00833833|3693212|FG001|Phase 2 (as of 01 April 2011)|Death|0
2101885|NCT00833833|3693213|FG002|Phase 2 (as of 01 April 2011)|Death|0
2101886|NCT00833833|3693214|FG003|Phase 2 (as of 01 April 2011)|Death|0
2101887|NCT00833833|3693215|FG004|Phase 2 (as of 01 April 2011)|Death|8
2101888|NCT00833833|3693216|FG005|Phase 2 (as of 01 April 2011)|Death|9
2101889|NCT00833833|3693211|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
2101890|NCT00833833|3693212|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
2101891|NCT00833833|3693213|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
2101892|NCT00833833|3693214|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
2101893|NCT00833833|3693215|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
2101894|NCT00833833|3693216|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
2101895|NCT00833833|3693211|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
2101896|NCT00833833|3693212|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
2101897|NCT00833833|3693213|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
2101898|NCT00833833|3693214|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
2101899|NCT00833833|3693215|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
2101900|NCT00833833|3693216|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
2101901|NCT00833833|3693211|FG000|Phase 2 (as of 01 April 2011)|Other|0
2101902|NCT00833833|3693212|FG001|Phase 2 (as of 01 April 2011)|Other|0
2101903|NCT00833833|3693213|FG002|Phase 2 (as of 01 April 2011)|Other|0
2101904|NCT00833833|3693214|FG003|Phase 2 (as of 01 April 2011)|Other|0
2101905|NCT00833833|3693215|FG004|Phase 2 (as of 01 April 2011)|Other|4
2101906|NCT00833833|3693216|FG005|Phase 2 (as of 01 April 2011)|Other|3
2101907|NCT00833833|3693211|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
2101908|NCT00833833|3693212|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
2101909|NCT00833833|3693213|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
2101910|NCT00833833|3693214|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
2101911|NCT00833833|3693215|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
2101912|NCT00833833|3693216|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
2101913|NCT00833898|3693238|FG000|Overall Study|Withdrawal by Subject|33
2101914|NCT00833898|3693239|FG001|Overall Study|Withdrawal by Subject|27
2101915|NCT00833898|3693238|FG000|Overall Study|Lost to Follow-up|7
2101916|NCT00833898|3693239|FG001|Overall Study|Lost to Follow-up|7
2101917|NCT00833898|3693238|FG000|Overall Study|Patient did not receive transplant|0
2101918|NCT00833898|3693239|FG001|Overall Study|Patient did not receive transplant|2
2101919|NCT00833911|3693245|FG000|Titration|Adverse Event|18
2101920|NCT00833911|3693245|FG000|Titration|Withdrawal by Subject|3
2101921|NCT00833911|3693245|FG000|Maintenance Phase I|Adverse Event|73
2101922|NCT00833911|3693245|FG000|Maintenance Phase I|Withdrawal by Subject|11
2101923|NCT00833911|3693245|FG000|Maintenance Phase I|Physician Decision|10
2101924|NCT00833911|3693245|FG000|Maintenance Phase I|Lack of Efficacy|4
2101925|NCT00833911|3693245|FG000|Maintenance Phase II|Adverse Event|6
2101926|NCT00833911|3693245|FG000|Maintenance Phase II|Physician Decision|2
2101927|NCT00833911|3693245|FG000|Maintenance Phase II|Withdrawal by Subject|1
2101928|NCT00833911|3693245|FG000|Maintenance Phase II|Lack of Efficacy|1
2101929|NCT00833924|3693253|FG000|Overall Study|Death|21
2101930|NCT00833924|3693253|FG000|Overall Study|Conversion|2
2101931|NCT00833924|3693253|FG000|Overall Study|Lost to Follow-up|2
2101932|NCT00833924|3693253|FG000|Overall Study|Withdrawal by Subject|13
2101933|NCT00833924|3693253|FG000|Overall Study|In study follow-up|71
2101934|NCT00833976|3693257|FG000|Overall Study|Withdrawal by Subject|5
2101935|NCT00833976|3693257|FG000|Overall Study|Lost to Follow-up|4
2101936|NCT00833976|3693257|FG000|Overall Study|Did not meet eligibility criteria|41
2101937|NCT00833976|3693257|FG000|Overall Study|Physician Decision|1
2101938|NCT00833989|3693265|FG000|Overall Study|Physician Decision|0
2101939|NCT00833989|3693266|FG001|Overall Study|Physician Decision|0
2101940|NCT00833989|3693267|FG002|Overall Study|Physician Decision|0
2101941|NCT00833989|3693268|FG003|Overall Study|Physician Decision|1
2101942|NCT00833989|3693265|FG000|Overall Study|Withdrawal by Subject|3
2101943|NCT00833989|3693266|FG001|Overall Study|Withdrawal by Subject|0
2101944|NCT00833989|3693267|FG002|Overall Study|Withdrawal by Subject|1
2101945|NCT00833989|3693268|FG003|Overall Study|Withdrawal by Subject|1
2101946|NCT00834041|3693283|FG000|Overall Study|Withdrawal by Subject|1
2101947|NCT00834041|3693284|FG001|Overall Study|Withdrawal by Subject|0
2101948|NCT00834041|3693283|FG000|Overall Study|Lost to Follow-up|0
2101949|NCT00834041|3693284|FG001|Overall Study|Lost to Follow-up|1
2101950|NCT00834080|3693290|FG000|Overall Study|Adverse Event|7
2101951|NCT00834080|3693290|FG000|Overall Study|Lost to Follow-up|7
2101952|NCT00834080|3693290|FG000|Overall Study|Withdrawal by Subject|5
2101953|NCT00834080|3693290|FG000|Overall Study|Other - Pregnancy|1
2101954|NCT00834080|3693290|FG000|Overall Study|Other - False positive tests of the UDS|1
2101955|NCT00834080|3693290|FG000|Overall Study|Physician Decision|1
2101956|NCT00834080|3693290|FG000|Overall Study|Subject Relocated|1
2108027|NCT00877799|3701847|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
2108028|NCT00877799|3701848|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
2108029|NCT00877799|3701849|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
2101957|NCT00834366|3693341|FG000|Treatment Period 1|Adverse Event|1
2101958|NCT00834366|3693342|FG001|Treatment Period 1|Adverse Event|1
2101959|NCT00834834|3693392|FG000|Overall Study|Withdrawal by Subject|4
2101960|NCT00834834|3693393|FG001|Overall Study|Withdrawal by Subject|3
2101961|NCT00834899|3693418|FG000|Overall Study|Withdrawal by Subject|1
2101962|NCT00834899|3693419|FG001|Overall Study|Withdrawal by Subject|1
2101963|NCT00834912|3693431|FG000|Treatment Period 1|Adverse Event|0
2101964|NCT00834912|3693432|FG001|Treatment Period 1|Adverse Event|1
2101965|NCT00834912|3693433|FG002|Treatment Period 1|Adverse Event|0
2101966|NCT00834912|3693434|FG003|Treatment Period 1|Adverse Event|1
2101967|NCT00834912|3693435|FG004|Treatment Period 1|Adverse Event|0
2101968|NCT00834912|3693436|FG005|Treatment Period 1|Adverse Event|0
2101969|NCT00834912|3693431|FG000|Treatment Period 2|Withdrawal by Subject|0
2101970|NCT00834912|3693432|FG001|Treatment Period 2|Withdrawal by Subject|0
2101971|NCT00834912|3693433|FG002|Treatment Period 2|Withdrawal by Subject|1
2101972|NCT00834912|3693434|FG003|Treatment Period 2|Withdrawal by Subject|0
2101973|NCT00834912|3693435|FG004|Treatment Period 2|Withdrawal by Subject|1
2101974|NCT00834912|3693436|FG005|Treatment Period 2|Withdrawal by Subject|0
2101975|NCT00835068|3693455|FG000|Overall Study|Death|1
2101976|NCT00835068|3693456|FG001|Overall Study|Death|0
2101977|NCT00835068|3693455|FG000|Overall Study|Adverse Event|0
2101978|NCT00835068|3693456|FG001|Overall Study|Adverse Event|1
2101979|NCT00835068|3693455|FG000|Overall Study|Other|8
2101980|NCT00835068|3693456|FG001|Overall Study|Other|0
2101981|NCT00835068|3693455|FG000|Overall Study|Withdrawal by Subject|1
2101982|NCT00835068|3693456|FG001|Overall Study|Withdrawal by Subject|0
2101983|NCT00835120|3693462|FG000|Overall Study|Lack of Efficacy|1
2101984|NCT00835120|3693462|FG000|Overall Study|Lost to Follow-up|3
2101985|NCT00835120|3693462|FG000|Overall Study|Adverse Event|2
2101986|NCT00835120|3693462|FG000|Overall Study|Withdrawal by Subject|2
2101987|NCT00835237|3693505|FG000|Overall Study|Lost to Follow-up|4
2101988|NCT00835237|3693506|FG001|Overall Study|Lost to Follow-up|0
2101989|NCT00835237|3693505|FG000|Overall Study|Withdrawal by Subject|2
2101990|NCT00835237|3693506|FG001|Overall Study|Withdrawal by Subject|0
2101991|NCT00835341|3693514|FG000|Overall Study|Lost to Follow-up|3
2101992|NCT00835341|3693515|FG001|Overall Study|Lost to Follow-up|12
2101993|NCT00835380|3693521|FG000|Overall Study|Withdrawal by Subject|2
2101994|NCT00835731|3693540|FG000|Overall Study|Withdrawal by Subject|1
2101995|NCT00835731|3693541|FG001|Overall Study|Withdrawal by Subject|0
2101996|NCT00835731|3693540|FG000|Overall Study|Physician Decision|1
2101997|NCT00835731|3693541|FG001|Overall Study|Physician Decision|1
2101998|NCT00835770|3693549|FG000|Overall Study|MS Relapse|17
2101999|NCT00835770|3693550|FG001|Overall Study|MS Relapse|23
2102000|NCT00835770|3693549|FG000|Overall Study|MS Progression|14
2102001|NCT00835770|3693550|FG001|Overall Study|MS Progression|9
2102002|NCT00835770|3693549|FG000|Overall Study|Adverse Event|113
2102003|NCT00835770|3693550|FG001|Overall Study|Adverse Event|124
2102004|NCT00835770|3693549|FG000|Overall Study|Lost to Follow-up|22
2102005|NCT00835770|3693550|FG001|Overall Study|Lost to Follow-up|19
2102006|NCT00835770|3693549|FG000|Overall Study|Consent Withdrawn|144
2102007|NCT00835770|3693550|FG001|Overall Study|Consent Withdrawn|156
2102008|NCT00835770|3693549|FG000|Overall Study|Investigator Decision|42
2102009|NCT00835770|3693550|FG001|Overall Study|Investigator Decision|42
2102010|NCT00835770|3693549|FG000|Overall Study|Participant Non-Compliance|11
2102011|NCT00835770|3693550|FG001|Overall Study|Participant Non-Compliance|9
2102012|NCT00835770|3693549|FG000|Overall Study|Death|4
2354220|NCT01446796|4109487|FG000|Overall Study|Withdrawal by Subject|1
2354221|NCT01446796|4109488|FG001|Overall Study|Withdrawal by Subject|0
2354222|NCT01443923|4109498|FG000|Overall Study|Adverse Event|1
2354223|NCT01443923|4109499|FG001|Overall Study|Adverse Event|0
2354224|NCT01439347|4109507|FG000|Overall Study|Death|10
2354225|NCT01439347|4109508|FG001|Overall Study|Death|9
2354226|NCT01439347|4109507|FG000|Overall Study|Withdrawal by Subject|0
2354227|NCT01439347|4109508|FG001|Overall Study|Withdrawal by Subject|1
2354228|NCT01439347|4109507|FG000|Overall Study|Physician Decision|1
2354229|NCT01439347|4109508|FG001|Overall Study|Physician Decision|0
2354230|NCT01439347|4109507|FG000|Overall Study|Sponsor Terminated Study|2
2354231|NCT01439347|4109508|FG001|Overall Study|Sponsor Terminated Study|3
2354232|NCT01433471|4109533|FG000|Overall Study|Withdrawal by Subject|0
2354233|NCT01433471|4109534|FG001|Overall Study|Withdrawal by Subject|1
2354234|NCT01436084|4109542|FG000|Overall Study|Disease Progression|2
2354235|NCT01436084|4109542|FG000|Overall Study|Withdrawal by Subject|1
2354236|NCT01436084|4109542|FG000|Overall Study|Early Closure of Study|1
2354237|NCT01415986|4109570|FG000|Overall Study|Lost to Follow-up|1
2102013|NCT00835770|3693550|FG001|Overall Study|Death|6
2102014|NCT00835770|3693549|FG000|Overall Study|Other|115
2102015|NCT00835770|3693550|FG001|Overall Study|Other|104
2102016|NCT00835770|3693549|FG000|Overall Study|Other|2
2102017|NCT00835770|3693550|FG001|Overall Study|Other|1
2102018|NCT00835978|3693593|FG000|Overall Study|Death|33
2102019|NCT00835978|3693594|FG001|Overall Study|Death|40
2102020|NCT00835978|3693595|FG002|Overall Study|Death|49
2102021|NCT00835978|3693596|FG003|Overall Study|Death|4
2102022|NCT00835978|3693593|FG000|Overall Study|Lost to Follow-up|3
2102023|NCT00835978|3693594|FG001|Overall Study|Lost to Follow-up|4
2354238|NCT01410799|4109575|FG000|Overall Study|PI decision|13
2354239|NCT01426113|4109581|FG000|Overall Study|Study Discontinued|1
2102024|NCT00835978|3693595|FG002|Overall Study|Lost to Follow-up|2
2102025|NCT00835978|3693596|FG003|Overall Study|Lost to Follow-up|1
2102026|NCT00835978|3693593|FG000|Overall Study|Other|5
2102027|NCT00835978|3693594|FG001|Overall Study|Other|1
2354240|NCT01426113|4109582|FG001|Overall Study|Study Discontinued|1
2354241|NCT01426113|4109581|FG000|Overall Study|Adverse Event|0
2354242|NCT01426113|4109582|FG001|Overall Study|Adverse Event|1
2354243|NCT01420965|4109600|FG000|Overall Study|Withdrawal by Subject|1
2354244|NCT01420965|4109601|FG001|Overall Study|Withdrawal by Subject|0
2354245|NCT01420965|4109602|FG002|Overall Study|Withdrawal by Subject|0
2354246|NCT01420965|4109600|FG000|Overall Study|Adverse Event|0
2354247|NCT01420965|4109601|FG001|Overall Study|Adverse Event|1
2354248|NCT01420965|4109602|FG002|Overall Study|Adverse Event|0
2354249|NCT01417377|4109610|FG000|Overall Study|Lost to Follow-up|12
2354250|NCT01417377|4109610|FG000|Overall Study|Enrolled, but not treated|1
2354251|NCT01416272|4109614|FG000|Overall Study|Unacceptable distance visual acuity|2
2354252|NCT01416272|4109614|FG000|Overall Study|Lost to Follow-up|1
2354253|NCT01416272|4109614|FG000|Overall Study|Study related complaints|1
2354254|NCT01414166|4109620|FG000|Overall Study|Adverse Event|10
2354255|NCT01414166|4109621|FG001|Overall Study|Adverse Event|2
2354256|NCT01414166|4109620|FG000|Overall Study|Lost to Follow-up|4
2354257|NCT01414166|4109621|FG001|Overall Study|Lost to Follow-up|1
2354258|NCT01414166|4109620|FG000|Overall Study|Non-compliance with study drug|2
2354259|NCT01414166|4109621|FG001|Overall Study|Non-compliance with study drug|0
2354260|NCT01414166|4109620|FG000|Overall Study|Physician Decision|2
2354261|NCT01414166|4109621|FG001|Overall Study|Physician Decision|0
2354262|NCT01414166|4109620|FG000|Overall Study|Protocol Violation|2
2354263|NCT01414166|4109621|FG001|Overall Study|Protocol Violation|0
2354264|NCT01414166|4109620|FG000|Overall Study|Study terminated by Sponsor|68
2354265|NCT01414166|4109621|FG001|Overall Study|Study terminated by Sponsor|75
2354266|NCT01414166|4109620|FG000|Overall Study|Withdrawal by Subject|3
2354267|NCT01414166|4109621|FG001|Overall Study|Withdrawal by Subject|5
2354268|NCT01408641|4109648|FG000|Overall Study|Physician Decision|1
2354269|NCT01408641|4109649|FG001|Overall Study|Physician Decision|0
2354270|NCT01409031|4109657|FG000|Overall Study|transferred to other hosp|1
2354271|NCT01409031|4109658|FG001|Overall Study|transferred to other hosp|0
2354272|NCT01403194|4109681|FG000|Overall Study|Screen Failure|2
2354273|NCT01403194|4109681|FG000|Overall Study|Lost to Follow-up|8
2354274|NCT01397552|4109687|FG000|Overall Study|Adverse Event|1
2354275|NCT01397552|4109688|FG001|Overall Study|Adverse Event|0
2354276|NCT01397552|4109687|FG000|Overall Study|Withdrawal by Subject|2
2354277|NCT01397552|4109688|FG001|Overall Study|Withdrawal by Subject|1
2354278|NCT01392170|4109694|FG000|Overall Study|Withdrawal by Subject|1
2354279|NCT01392170|4109694|FG000|Overall Study|Ineligible|1
2354280|NCT01389817|4109700|FG000|Overall Study|Physician Decision|1
2354281|NCT01389817|4109701|FG001|Overall Study|Physician Decision|0
2354282|NCT01389817|4109700|FG000|Overall Study|Lost to Follow-up|1
2354283|NCT01389817|4109701|FG001|Overall Study|Lost to Follow-up|0
2354284|NCT01389817|4109700|FG000|Overall Study|Withdrawal by Subject|2
2354285|NCT01389817|4109701|FG001|Overall Study|Withdrawal by Subject|0
2354286|NCT01390181|4109711|FG000|Overall Study|Lost to Follow-up|1
2354287|NCT01390181|4109711|FG000|Overall Study|Study Terminated due to Low Accrual|3
2354288|NCT01372618|4109759|FG000|Overall Study|PI Died. Study Terminated|9
2354289|NCT01379274|4109767|FG000|Overall Study|funding withdrawn|1
2354290|NCT01369641|4109780|FG000|Overall Study|Withdrawal by Subject|1
2354291|NCT01359254|4109795|FG000|Overall Study|Death|1
2354292|NCT01359254|4109796|FG001|Overall Study|Death|0
2354293|NCT01352416|4109833|FG000|Overall Study|Physician Decision|1
2212335|NCT01668797|3853354|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0
2212336|NCT01668797|3853355|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0
2212337|NCT01668797|3853356|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0
2354294|NCT01352416|4109834|FG001|Overall Study|Physician Decision|2
2354295|NCT01352416|4109835|FG002|Overall Study|Physician Decision|2
2354296|NCT01352416|4109836|FG003|Overall Study|Physician Decision|1
2019806|NCT00301821|3587242|FG000|Overall Study|Ineligible|25
2354297|NCT01349595|4109852|FG000|Overall Study|Lack of funding|2
2354298|NCT01349595|4109853|FG001|Overall Study|Lack of funding|2
2102028|NCT00835978|3693595|FG002|Overall Study|Other|8
2102029|NCT00835978|3693596|FG003|Overall Study|Other|0
2102030|NCT00835978|3693593|FG000|Overall Study|Objective progression or relapse|2
2102031|NCT00835978|3693594|FG001|Overall Study|Objective progression or relapse|0
2102032|NCT00835978|3693595|FG002|Overall Study|Objective progression or relapse|1
2102033|NCT00835978|3693596|FG003|Overall Study|Objective progression or relapse|0
2102034|NCT00835978|3693593|FG000|Overall Study|Adverse Event|1
2102035|NCT00835978|3693594|FG001|Overall Study|Adverse Event|0
2102036|NCT00835978|3693595|FG002|Overall Study|Adverse Event|1
2102037|NCT00835978|3693596|FG003|Overall Study|Adverse Event|0
2102038|NCT00835978|3693593|FG000|Overall Study|Withdrawal by Subject|0
2102039|NCT00835978|3693594|FG001|Overall Study|Withdrawal by Subject|3
2102040|NCT00835978|3693595|FG002|Overall Study|Withdrawal by Subject|0
2354299|NCT01347840|4109872|FG000|Overall Study|Withdrawal by Subject|1
2354300|NCT01335997|4109883|FG000|Period I and II|Adverse Event|63
2354301|NCT01335997|4109884|FG001|Period I and II|Adverse Event|43
2354302|NCT01335997|4109883|FG000|Period I and II|Noncompliance with Study Drug|1
2354303|NCT01335997|4109884|FG001|Period I and II|Noncompliance with Study Drug|1
2354304|NCT01335997|4109883|FG000|Period I and II|Lost to Follow-up|3
2354305|NCT01335997|4109884|FG001|Period I and II|Lost to Follow-up|5
2354306|NCT01335997|4109883|FG000|Period I and II|Withdrawal by Subject|9
2354307|NCT01335997|4109884|FG001|Period I and II|Withdrawal by Subject|4
2354308|NCT01335997|4109883|FG000|Period I and II|Study Terminated by Sponsor|406
2354309|NCT01335997|4109884|FG001|Period I and II|Study Terminated by Sponsor|415
2354310|NCT01335997|4109883|FG000|Period I and II|Protocol Violation|9
2354311|NCT01335997|4109884|FG001|Period I and II|Protocol Violation|10
2354312|NCT01335997|4109883|FG000|Period I and II|Physician Decision|2
2354313|NCT01335997|4109884|FG001|Period I and II|Physician Decision|1
2354314|NCT01335997|4109883|FG000|Period III|Adverse Event|0
2102041|NCT00835978|3693596|FG003|Overall Study|Withdrawal by Subject|5
2102042|NCT00835978|3693593|FG000|Overall Study|Study terminated by sponsor|12
2102043|NCT00835978|3693594|FG001|Overall Study|Study terminated by sponsor|8
2102044|NCT00835978|3693595|FG002|Overall Study|Study terminated by sponsor|30
2102045|NCT00835978|3693596|FG003|Overall Study|Study terminated by sponsor|0
2307761|NCT02701634|4010458|FG000|Overall Study|Withdrew Consent|6
2354315|NCT01335997|4109884|FG001|Period III|Adverse Event|2
2354316|NCT01335997|4109883|FG000|Period III|Study Terminated by Sponsor|77
2354317|NCT01335997|4109884|FG001|Period III|Study Terminated by Sponsor|76
2354318|NCT01335997|4109883|FG000|Period III|Protocol Violation|0
2354319|NCT01335997|4109884|FG001|Period III|Protocol Violation|1
2354320|NCT01335997|4109883|FG000|Period III|Lost to Follow-up|1
2354321|NCT01335997|4109884|FG001|Period III|Lost to Follow-up|0
2354322|NCT01341587|4109907|FG000|Overall Study|Lost to Follow-up|2
2354323|NCT01341587|4109908|FG001|Overall Study|Lost to Follow-up|0
2354324|NCT01341587|4109907|FG000|Overall Study|stopped using the meters|2
2354325|NCT01341587|4109908|FG001|Overall Study|stopped using the meters|10
2354326|NCT01334606|4109914|FG000|Overall Study|Study Terminated due to slow enrolment|18
2354327|NCT01332799|4109926|FG000|Overall Study|Insufficient funding|10
2354328|NCT01332799|4109927|FG001|Overall Study|Insufficient funding|10
2354329|NCT01329549|4109933|FG000|Overall Study|Withdrawal by Subject|1
2354330|NCT01329549|4109933|FG000|Overall Study|Adverse Event|1
2354331|NCT01326845|4109939|FG000|Overall Study|Administrative Problems|5
2354332|NCT01326845|4109940|FG001|Overall Study|Administrative Problems|2
2354333|NCT01326845|4109939|FG000|Overall Study|Adverse Event|1
2354334|NCT01326845|4109940|FG001|Overall Study|Adverse Event|0
2354335|NCT01326845|4109939|FG000|Overall Study|Misisng|1
2354336|NCT01326845|4109940|FG001|Overall Study|Misisng|3
2354337|NCT01329341|4109946|FG000|Overall Study|Withdrawal by Subject|44
2354338|NCT01320683|4109959|FG000|Overall Study|Positive antibody response|1
2354339|NCT01313273|4109965|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
2354340|NCT01313273|4109966|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
2354341|NCT01313273|4109965|FG000|Overall Study|Withdrawal by Subject|1
2354342|NCT01313273|4109966|FG001|Overall Study|Withdrawal by Subject|0
2354343|NCT01313273|4109965|FG000|Overall Study|Screening Chromogranin A-in normal range|0
2354344|NCT01313273|4109966|FG001|Overall Study|Screening Chromogranin A-in normal range|1
2354345|NCT01321008|4109972|FG000|Overall Study|Early Study Termination|1
2354346|NCT01310803|4109978|FG000|Overall Study|Subject terminated by Sponsor|1
2354347|NCT01310803|4109979|FG001|Overall Study|Subject terminated by Sponsor|0
2354348|NCT01313923|4109998|FG000|Overall Study|Physician Decision|3
2354349|NCT01321697|4110002|FG000|Overall Study|Study Terminated|7
2354350|NCT01312428|4110008|FG000|Overall Study|Study Termination|3
2354351|NCT01312428|4110009|FG001|Overall Study|Study Termination|4
2354352|NCT01290822|4110067|FG000|Overall Study|Withdrawal by Subject|1
2354353|NCT01290822|4110067|FG000|Overall Study|Physician Decision|10
2354354|NCT01290718|4110071|FG000|Overall Study|Early termination of the study|4
2354355|NCT01293123|4110077|FG000|Overall Study|Lost to Follow-up|0
2307762|NCT02701634|4010459|FG001|Overall Study|Withdrew Consent|7
2307763|NCT02701634|4010458|FG000|Overall Study|Randomized but not treated|1
2307764|NCT02701634|4010459|FG001|Overall Study|Randomized but not treated|0
2307765|NCT02701764|4010487|FG000|Overall Study|Lost to Follow-up|0
2307766|NCT02701764|4010488|FG001|Overall Study|Lost to Follow-up|1
2307767|NCT02701985|4010510|FG000|Overall Study|Withdrawal by Subject|1
2307768|NCT02701985|4010511|FG001|Overall Study|Withdrawal by Subject|1
2307769|NCT02701985|4010510|FG000|Overall Study|Lost to Follow-up|1
2307770|NCT02701985|4010511|FG001|Overall Study|Lost to Follow-up|0
2307771|NCT02701985|4010510|FG000|Overall Study|Death|1
2307772|NCT02701985|4010511|FG001|Overall Study|Death|0
2307773|NCT02701985|4010510|FG000|Overall Study|Adverse Event|0
2307774|NCT02701985|4010511|FG001|Overall Study|Adverse Event|5
2307775|NCT02702011|4010522|FG000|Overall Study|Withdrawal by Subject|0
2307776|NCT02702011|4010523|FG001|Overall Study|Withdrawal by Subject|1
2307777|NCT02702011|4010524|FG002|Overall Study|Withdrawal by Subject|0
2307778|NCT02702011|4010525|FG003|Overall Study|Withdrawal by Subject|0
2307779|NCT02702193|4010537|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1
2307780|NCT02702193|4010538|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0
2307781|NCT02702193|4010537|FG000|4 Month Follow up|Withdrawal by Subject|1
2307782|NCT02702193|4010538|FG001|4 Month Follow up|Withdrawal by Subject|0
2307783|NCT02702193|4010537|FG000|4 Month Follow up|Lost to Follow-up|17
2307784|NCT02702193|4010538|FG001|4 Month Follow up|Lost to Follow-up|18
2307785|NCT02702193|4010537|FG000|8 Month Follow up|Withdrawal by Subject|1
2307786|NCT02702193|4010538|FG001|8 Month Follow up|Withdrawal by Subject|0
2307787|NCT02702193|4010537|FG000|8 Month Follow up|Lost to Follow-up|14
2307788|NCT02702193|4010538|FG001|8 Month Follow up|Lost to Follow-up|18
2307789|NCT02702193|4010537|FG000|12 Month Follow up|Withdrawal by Subject|1
2307790|NCT02702193|4010538|FG001|12 Month Follow up|Withdrawal by Subject|0
2307791|NCT02702193|4010537|FG000|12 Month Follow up|Lost to Follow-up|16
2307792|NCT02702193|4010538|FG001|12 Month Follow up|Lost to Follow-up|18
2307793|NCT02702388|4010546|FG000|Overall Study|Disease Progression|18
2307794|NCT02702388|4010547|FG001|Overall Study|Disease Progression|25
2102046|NCT00836095|3693617|FG000|Overall Study|Physician Decision|0
2102047|NCT00836095|3693618|FG001|Overall Study|Physician Decision|3
2307795|NCT02702388|4010546|FG000|Overall Study|Withdrawal by Subject|9
2354356|NCT01293123|4110078|FG001|Overall Study|Lost to Follow-up|1
2354357|NCT01294046|4110084|FG000|Overall Study|Infection and surgical explant|1
2354358|NCT01294046|4110084|FG000|Overall Study|Eligibility criteria expanded|1
2354359|NCT01294046|4110084|FG000|Overall Study|Stimulation response inadqequate|1
2354360|NCT01281124|4110128|FG000|Overall Study|Death|1
2354361|NCT01282216|4110140|FG000|Overall Study|Graft failure|0
2354362|NCT01282216|4110141|FG001|Overall Study|Graft failure|0
2354363|NCT01282216|4110142|FG002|Overall Study|Graft failure|3
2354364|NCT01282216|4110143|FG003|Overall Study|Graft failure|2
2354365|NCT01282216|4110140|FG000|Overall Study|Physician Decision|0
2354366|NCT01282216|4110141|FG001|Overall Study|Physician Decision|0
2354367|NCT01282216|4110142|FG002|Overall Study|Physician Decision|11
2354368|NCT01282216|4110143|FG003|Overall Study|Physician Decision|0
2354369|NCT01282216|4110140|FG000|Overall Study|Relapse|0
2354370|NCT01282216|4110141|FG001|Overall Study|Relapse|0
2354371|NCT01282216|4110142|FG002|Overall Study|Relapse|17
2354372|NCT01282216|4110143|FG003|Overall Study|Relapse|6
2354373|NCT01282216|4110140|FG000|Overall Study|Death|0
2354374|NCT01282216|4110141|FG001|Overall Study|Death|0
2354375|NCT01282216|4110142|FG002|Overall Study|Death|2
2354376|NCT01282216|4110143|FG003|Overall Study|Death|0
2354377|NCT01284491|4110149|FG000|Overall Study|Study termination|13
2354378|NCT01274533|4110181|FG000|Overall Study|Withdrawal by Subject|1
2354379|NCT01274533|4110181|FG000|Overall Study|Non-compliance|1
2354380|NCT01274533|4110181|FG000|Overall Study|Disease progression|2
2354381|NCT01279616|4110185|FG000|Overall Study|donor could not be located|5
2354382|NCT01279616|4110185|FG000|Overall Study|no signs of sickle cell disease|2
2354383|NCT01276054|4110191|FG000|Overall Study|No one to oversee trial after P.I. left|2
2354384|NCT01276054|4110192|FG001|Overall Study|No one to oversee trial after P.I. left|2
2307796|NCT02702388|4010547|FG001|Overall Study|Withdrawal by Subject|7
2307797|NCT02702388|4010546|FG000|Overall Study|Adverse Event|11
2307798|NCT02702388|4010547|FG001|Overall Study|Adverse Event|15
2307799|NCT02702388|4010546|FG000|Overall Study|Other|2
2307800|NCT02702388|4010547|FG001|Overall Study|Other|4
2307801|NCT02702401|4010564|FG000|Overall Study|Death|180
2307802|NCT02702401|4010565|FG001|Overall Study|Death|101
2307803|NCT02702401|4010564|FG000|Overall Study|Withdrawal by Subject|4
2307804|NCT02702401|4010565|FG001|Overall Study|Withdrawal by Subject|0
2307805|NCT02702401|4010564|FG000|Overall Study|Ongoing in study|94
2307806|NCT02702401|4010565|FG001|Overall Study|Ongoing in study|34
2307807|NCT02702518|4010573|FG000|Overall Study|Lost to Follow-up|3
2307808|NCT02702518|4010574|FG001|Overall Study|Lost to Follow-up|4
2307809|NCT02702609|4010582|FG000|Overall Study|Lost to Follow-up|8
2307810|NCT02702609|4010583|FG001|Overall Study|Lost to Follow-up|4
2354385|NCT01264965|4110198|FG000|Overall Study|Withdrawal by Subject|10
2354386|NCT01266824|4110204|FG000|Overall Study|Study terminated prior to completion|2
2354387|NCT01266824|4110205|FG001|Overall Study|Study terminated prior to completion|3
2354388|NCT01264835|4110211|FG000|Overall Study|Lost to Follow-up|1
2354389|NCT01274429|4110215|FG000|Overall Study|Study closed do to lack of funding|5
2354390|NCT01273064|4110224|FG000|Overall Study|Adverse Event|5
2354391|NCT01273064|4110225|FG001|Overall Study|Adverse Event|1
2354392|NCT01273064|4110226|FG002|Overall Study|Adverse Event|3
2354393|NCT01273064|4110227|FG003|Overall Study|Adverse Event|2
2354394|NCT01273064|4110228|FG004|Overall Study|Adverse Event|1
2354395|NCT01273064|4110224|FG000|Overall Study|Withdrawal by Subject|4
2354396|NCT01273064|4110225|FG001|Overall Study|Withdrawal by Subject|2
2354397|NCT01273064|4110226|FG002|Overall Study|Withdrawal by Subject|2
2354398|NCT01273064|4110227|FG003|Overall Study|Withdrawal by Subject|2
2354399|NCT01273064|4110228|FG004|Overall Study|Withdrawal by Subject|0
2354400|NCT01273064|4110224|FG000|Overall Study|Study Termination|13
2354401|NCT01273064|4110225|FG001|Overall Study|Study Termination|27
2354402|NCT01273064|4110226|FG002|Overall Study|Study Termination|26
2354403|NCT01273064|4110227|FG003|Overall Study|Study Termination|16
2354404|NCT01273064|4110228|FG004|Overall Study|Study Termination|8
2354405|NCT01273064|4110224|FG000|Overall Study|Lost to Follow-up|1
2354406|NCT01273064|4110225|FG001|Overall Study|Lost to Follow-up|0
2354407|NCT01273064|4110226|FG002|Overall Study|Lost to Follow-up|0
2354408|NCT01273064|4110227|FG003|Overall Study|Lost to Follow-up|0
2354409|NCT01273064|4110228|FG004|Overall Study|Lost to Follow-up|0
2354410|NCT01273064|4110224|FG000|Overall Study|Physician Decision|0
2354411|NCT01273064|4110225|FG001|Overall Study|Physician Decision|0
2354412|NCT01273064|4110226|FG002|Overall Study|Physician Decision|0
2354413|NCT01273064|4110227|FG003|Overall Study|Physician Decision|0
2354414|NCT01273064|4110228|FG004|Overall Study|Physician Decision|1
2354415|NCT01274559|4110242|FG000|Overall Study|Adverse Event|57
2354416|NCT01274559|4110243|FG001|Overall Study|Adverse Event|13
2354417|NCT01274559|4110242|FG000|Overall Study|Death|1
2354418|NCT01274559|4110243|FG001|Overall Study|Death|1
2354419|NCT01274559|4110242|FG000|Overall Study|Lost to Follow-up|3
2354420|NCT01274559|4110243|FG001|Overall Study|Lost to Follow-up|3
2354421|NCT01274559|4110242|FG000|Overall Study|Non-compliance with Study Drug|2
2354422|NCT01274559|4110243|FG001|Overall Study|Non-compliance with Study Drug|4
2354423|NCT01274559|4110242|FG000|Overall Study|Physician Decision|2
2354424|NCT01274559|4110243|FG001|Overall Study|Physician Decision|1
2354425|NCT01274559|4110242|FG000|Overall Study|Protocol Violation|28
2354426|NCT01274559|4110243|FG001|Overall Study|Protocol Violation|23
2354427|NCT01274559|4110242|FG000|Overall Study|Study Terminated by Sponsor|79
2354428|NCT01274559|4110243|FG001|Overall Study|Study Terminated by Sponsor|87
2354429|NCT01274559|4110242|FG000|Overall Study|Withdrawal by Subject|25
2354430|NCT01274559|4110243|FG001|Overall Study|Withdrawal by Subject|13
2354431|NCT01267825|4110277|FG000|Overall Study|study terminated. no data collected.|1
2354432|NCT01267825|4110278|FG001|Overall Study|study terminated. no data collected.|0
2354433|NCT01264679|4110284|FG000|Overall Study|Participation in Another Clinical Trial|1
2354434|NCT01264679|4110284|FG000|Overall Study|Physician Decision|1
2354435|NCT01264679|4110284|FG000|Overall Study|Sponsor's Suspension of Dosing|2
2354436|NCT01264679|4110284|FG000|Overall Study|Withdrawal by Subject|1
2354437|NCT01259284|4110292|FG000|Overall Study|Study Termination|2
2354438|NCT01259284|4110293|FG001|Overall Study|Study Termination|0
2354439|NCT01259284|4110294|FG002|Overall Study|Study Termination|0
2307811|NCT02702609|4010582|FG000|Overall Study|Physician Decision|1
2307812|NCT02702609|4010583|FG001|Overall Study|Physician Decision|0
2307813|NCT02703259|4010609|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1
2307814|NCT02703259|4010610|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4
2307815|NCT02703259|4010609|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
2307816|NCT02703259|4010610|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
2307817|NCT02703259|4010609|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10
2307818|NCT02703259|4010610|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10
2307819|NCT02703311|4010616|FG000|Overall Study|Death|5
2307820|NCT02703311|4010616|FG000|Overall Study|Withdrawal by Subject|3
2307821|NCT02703324|4010620|FG000|Period Two|Withdrawal by Subject|0
2307822|NCT02703324|4010621|FG001|Period Two|Withdrawal by Subject|0
2307823|NCT02703324|4010622|FG002|Period Two|Withdrawal by Subject|1
2307824|NCT02703324|4010623|FG003|Period Two|Withdrawal by Subject|0
2307825|NCT02703324|4010624|FG004|Period Two|Withdrawal by Subject|0
2307826|NCT02703324|4010625|FG005|Period Two|Withdrawal by Subject|0
2307827|NCT02703337|4010634|FG000|Period One (Part A)|Withdrawal by Subject|0
2307828|NCT02703337|4010635|FG001|Period One (Part A)|Withdrawal by Subject|0
2307829|NCT02703337|4010636|FG002|Period One (Part A)|Withdrawal by Subject|0
2307830|NCT02703337|4010637|FG003|Period One (Part A)|Withdrawal by Subject|0
2307831|NCT02703337|4010638|FG004|Period One (Part A)|Withdrawal by Subject|1
2307832|NCT02703337|4010639|FG005|Period One (Part A)|Withdrawal by Subject|0
2307833|NCT02703337|4010640|FG006|Period One (Part A)|Withdrawal by Subject|0
2307834|NCT02703337|4010641|FG007|Period One (Part A)|Withdrawal by Subject|0
2307835|NCT02703454|4010686|FG000|Overall Study|Not treated|1
2307836|NCT02703454|4010687|FG001|Overall Study|Not treated|3
2307837|NCT02703454|4010686|FG000|Overall Study|Withdrawal by Subject|4
2307838|NCT02703454|4010687|FG001|Overall Study|Withdrawal by Subject|3
2354440|NCT01249157|4110302|FG000|Overall Study|Withdrawal by Subject|1
2354441|NCT01263028|4110306|FG000|Overall Study|Withdrawal by Subject|1
2354442|NCT01263028|4110306|FG000|Overall Study|Adverse Event|1
2354443|NCT01263028|4110306|FG000|Overall Study|Study terminated due to low enrollment.|4
2354444|NCT01259024|4110318|FG000|Overall Study|Physician Decision|1
2354445|NCT01251952|4110322|FG000|Overall Study|Adverse Event|1
2354446|NCT01251120|4110328|FG000|Overall Study|Lack of Efficacy|0
2354447|NCT01251120|4110329|FG001|Overall Study|Lack of Efficacy|1
2354448|NCT01248130|4110337|FG000|Overall Study|Protocol Violation|1
2354449|NCT01248130|4110338|FG001|Overall Study|Protocol Violation|0
2354450|NCT01248130|4110337|FG000|Overall Study|Ineligible|1
2354451|NCT01248130|4110338|FG001|Overall Study|Ineligible|0
2354452|NCT01243892|4110346|FG000|Overall Study|Did not meet eligibility criteria|2
2354453|NCT01243892|4110347|FG001|Overall Study|Did not meet eligibility criteria|0
2354454|NCT01246011|4110356|FG000|Overall Study|If needed warfarin clinically, withdrawn|0
2354455|NCT01246011|4110357|FG001|Overall Study|If needed warfarin clinically, withdrawn|0
2354456|NCT01246011|4110358|FG002|Overall Study|If needed warfarin clinically, withdrawn|3
2354457|NCT01246011|4110356|FG000|Overall Study|Withdrawal by Subject|0
2354458|NCT01246011|4110357|FG001|Overall Study|Withdrawal by Subject|0
2354459|NCT01246011|4110358|FG002|Overall Study|Withdrawal by Subject|1
2354460|NCT01242020|4110369|FG000|Overall Study|Withdrawal by Subject|2
2354461|NCT01242020|4110370|FG001|Overall Study|Withdrawal by Subject|0
2354462|NCT01242020|4110369|FG000|Overall Study|Failed screening|1
2354463|NCT01242020|4110370|FG001|Overall Study|Failed screening|0
2354464|NCT01244620|4110376|FG000|Overall Study|Study terminated|4
2354465|NCT01244620|4110377|FG001|Overall Study|Study terminated|4
2354466|NCT01244620|4110378|FG002|Overall Study|Study terminated|4
2354467|NCT01244620|4110379|FG003|Overall Study|Study terminated|4
2354468|NCT01241279|4110395|FG000|Overall Study|Lost to Follow-up|0
2354469|NCT01241279|4110396|FG001|Overall Study|Lost to Follow-up|1
2354470|NCT01230788|4110402|FG000|Overall Study|Prescribed exclusion drug|1
2354471|NCT01239680|4110408|FG000|Overall Study|Withdrawal by Subject|2
2354472|NCT01239680|4110409|FG001|Overall Study|Withdrawal by Subject|0
2354473|NCT01230307|4110440|FG000|Overall Study|LVAD Placement|0
2354474|NCT01230307|4110441|FG001|Overall Study|LVAD Placement|2
2354475|NCT01230489|4110447|FG000|Overall Study|Death|2
2354476|NCT01230489|4110447|FG000|Overall Study|Adverse Event|2
2354477|NCT01230489|4110447|FG000|Overall Study|Treatment modality changed|1
2354478|NCT01217060|4110503|FG000|Overall Study|Withdrawal by Subject|1
2354479|NCT01217047|4110511|FG000|Overall Study|Lost to Follow-up|0
2354480|NCT01217047|4110512|FG001|Overall Study|Lost to Follow-up|1
2354481|NCT01217047|4110513|FG002|Overall Study|Lost to Follow-up|0
2354482|NCT01206101|4110524|FG000|Overall Study|Adverse Event|1
2354483|NCT01206101|4110525|FG001|Overall Study|Adverse Event|0
2354484|NCT01206101|4110524|FG000|Overall Study|Physician Decision|0
2354485|NCT01206101|4110525|FG001|Overall Study|Physician Decision|1
2354486|NCT01206101|4110524|FG000|Overall Study|Unclassified|1
2354487|NCT01206101|4110525|FG001|Overall Study|Unclassified|0
2354488|NCT01209520|4110548|FG000|Overall Study|Withdrawal by Subject|3
2354489|NCT01207102|4110569|FG000|Overall Study|Withdrawal by Subject|5
2354490|NCT01207102|4110569|FG000|Overall Study|Adverse Event|2
2354491|NCT01207102|4110569|FG000|Overall Study|progression|2
2354492|NCT01207102|4110569|FG000|Overall Study|Withdrawal by Treating Physician|1
2354493|NCT01206439|4110587|FG000|Overall Study|subject did not meet inclusion criteria|1
2354494|NCT01198548|4110609|FG000|Overall Study|Disease Progression|9
2354495|NCT01198548|4110609|FG000|Overall Study|Administrative Decision|1
2354496|NCT01193556|4110632|FG000|Overall Study|Study termination|26
2354497|NCT01193556|4110633|FG001|Overall Study|Study termination|25
2354498|NCT01189435|4110639|FG000|Overall Study|Withdrawal by Subject|1
2354499|NCT01189435|4110639|FG000|Overall Study|Physician Decision|1
2354500|NCT01193530|4110645|FG000|Overall Study|Withdrawal by Subject|2
2354501|NCT01193530|4110646|FG001|Overall Study|Withdrawal by Subject|2
2354502|NCT01193530|4110645|FG000|Overall Study|Began Contraindicated Therapy|1
2354503|NCT01193530|4110646|FG001|Overall Study|Began Contraindicated Therapy|0
2354504|NCT01193530|4110645|FG000|Overall Study|Lost Light Box|0
2354505|NCT01193530|4110646|FG001|Overall Study|Lost Light Box|1
2354506|NCT01193530|4110645|FG000|Overall Study|Returned home - out of state|0
2354507|NCT01193530|4110646|FG001|Overall Study|Returned home - out of state|1
2354508|NCT01193530|4110645|FG000|Overall Study|Non-Compliance|0
2354509|NCT01193530|4110646|FG001|Overall Study|Non-Compliance|1
2354510|NCT01183221|4110680|FG000|3 Weeks Wash Out|Lost to Follow-up|1
2354511|NCT01183221|4110681|FG001|3 Weeks Wash Out|Lost to Follow-up|1
2354512|NCT01189227|4110689|FG000|Overall Study|Study terminated due to low accrual|6
2354513|NCT01189227|4110690|FG001|Overall Study|Study terminated due to low accrual|3
2354514|NCT01179737|4110709|FG000|Cohort 1 & Cohort 2|Adverse Event|3
2354515|NCT01179737|4110710|FG001|Cohort 1 & Cohort 2|Adverse Event|1
2354516|NCT01179737|4110711|FG002|Cohort 1 & Cohort 2|Adverse Event|1
2354517|NCT01179737|4110712|FG003|Cohort 1 & Cohort 2|Adverse Event|0
2354518|NCT01179737|4110709|FG000|Cohort 1 & Cohort 2|Withdrew consent|2
2354519|NCT01179737|4110710|FG001|Cohort 1 & Cohort 2|Withdrew consent|0
2354520|NCT01179737|4110711|FG002|Cohort 1 & Cohort 2|Withdrew consent|0
2354521|NCT01179737|4110712|FG003|Cohort 1 & Cohort 2|Withdrew consent|0
2354522|NCT01179737|4110709|FG000|Cohort 1 & Cohort 2|Administrative problems|0
2354523|NCT01179737|4110710|FG001|Cohort 1 & Cohort 2|Administrative problems|0
2354524|NCT01179737|4110711|FG002|Cohort 1 & Cohort 2|Administrative problems|2
2354525|NCT01179737|4110712|FG003|Cohort 1 & Cohort 2|Administrative problems|4
2354526|NCT01179737|4110709|FG000|Cohort 1 & Cohort 2|Death|0
2354527|NCT01179737|4110710|FG001|Cohort 1 & Cohort 2|Death|0
2354528|NCT01179737|4110711|FG002|Cohort 1 & Cohort 2|Death|1
2354529|NCT01179737|4110712|FG003|Cohort 1 & Cohort 2|Death|0
2354530|NCT01179737|4110709|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
2354531|NCT01179737|4110710|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
2354532|NCT01179737|4110711|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
2354533|NCT01179737|4110712|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
2354534|NCT01179737|4110709|FG000|Cohort 1 & Cohort 2 Expansion|Death|1
2354535|NCT01179737|4110710|FG001|Cohort 1 & Cohort 2 Expansion|Death|0
2354536|NCT01179737|4110711|FG002|Cohort 1 & Cohort 2 Expansion|Death|0
2354537|NCT01179737|4110712|FG003|Cohort 1 & Cohort 2 Expansion|Death|0
2354538|NCT01179737|4110709|FG000|Extension|The study was terminated|3
2354539|NCT01179737|4110710|FG001|Extension|The study was terminated|0
2354540|NCT01179737|4110711|FG002|Extension|The study was terminated|0
2354541|NCT01179737|4110712|FG003|Extension|The study was terminated|0
2354542|NCT01183468|4110725|FG000|Overall Study|Lost to Follow-up|2
2354543|NCT01183468|4110726|FG001|Overall Study|Lost to Follow-up|1
2354544|NCT01183468|4110727|FG002|Overall Study|Lost to Follow-up|0
2354545|NCT01183468|4110728|FG003|Overall Study|Lost to Follow-up|0
2354546|NCT01183468|4110725|FG000|Overall Study|Physician Decision|1
2354547|NCT01183468|4110726|FG001|Overall Study|Physician Decision|0
2354548|NCT01183468|4110727|FG002|Overall Study|Physician Decision|0
2354549|NCT01183468|4110728|FG003|Overall Study|Physician Decision|0
2354550|NCT01183468|4110725|FG000|Overall Study|Withdrawal by Subject|0
2354551|NCT01183468|4110726|FG001|Overall Study|Withdrawal by Subject|1
2354552|NCT01183468|4110727|FG002|Overall Study|Withdrawal by Subject|0
2354553|NCT01183468|4110728|FG003|Overall Study|Withdrawal by Subject|0
2354554|NCT01181921|4110736|FG000|Overall Study|Lost to Follow-up|1
2354555|NCT01188798|4110742|FG000|Overall Study|Death|0
2354556|NCT01188798|4110743|FG001|Overall Study|Death|1
2354557|NCT01188798|4110742|FG000|Overall Study|Required additional transplant|1
2354558|NCT01188798|4110743|FG001|Overall Study|Required additional transplant|1
2354559|NCT01188798|4110742|FG000|Overall Study|Protocol closure|1
2354560|NCT01188798|4110743|FG001|Overall Study|Protocol closure|1
2354561|NCT01174368|4110750|FG000|Overall Study|Withdrawal by Subject|1
2354562|NCT01183884|4110758|FG000|Overall Study|Progressive Disease|26
2354563|NCT01183884|4110758|FG000|Overall Study|Adverse Event|3
2354564|NCT01183884|4110758|FG000|Overall Study|Withdrawal by Subject|1
2354565|NCT01183884|4110758|FG000|Overall Study|Other Complicating Disease|3
2354566|NCT01183884|4110758|FG000|Overall Study|Not Treated|1
2354567|NCT01183884|4110758|FG000|Overall Study|Other|4
2354568|NCT01166178|4110768|FG000|Overall Study|Withdrawal by Subject|1
2354569|NCT01166178|4110769|FG001|Overall Study|Withdrawal by Subject|0
2354570|NCT01166178|4110768|FG000|Overall Study|Study was terminated|20
2354571|NCT01166178|4110769|FG001|Overall Study|Study was terminated|8
2354572|NCT01176513|4110775|FG000|Overall Study|Withdrew subjects prior to dosing|3
2354573|NCT01179399|4110783|FG000|Overall Study|Adverse Event|1
2354574|NCT01179399|4110783|FG000|Overall Study|Lack of Efficacy|30
2354575|NCT01179399|4110783|FG000|Overall Study|Withdrawal by Subject|1
2354576|NCT01171534|4110798|FG000|Overall Study|Lost to Follow-up|0
2354577|NCT01171534|4110799|FG001|Overall Study|Lost to Follow-up|2
2354578|NCT01171534|4110798|FG000|Overall Study|screen failure|0
2354579|NCT01171534|4110799|FG001|Overall Study|screen failure|1
2354580|NCT01155388|4110811|FG000|Overall Study|Adverse Event|1
2354581|NCT01155388|4110812|FG001|Overall Study|Adverse Event|0
2354582|NCT01155375|4110839|FG000|Overall Study|Adverse Event|1
2354583|NCT01155375|4110840|FG001|Overall Study|Adverse Event|0
2354584|NCT01162304|4110855|FG000|Overall Study|Beck scale to high|11
2354585|NCT01147393|4110907|FG000|Dose Level 1|Dose limiting Toxicity|2
2354586|NCT01147393|4110907|FG000|Dose Level -1|Dose Limited Toxicity|1
2354587|NCT01147536|4110920|FG000|Overall Study|Administrative study close|2
2354588|NCT01147536|4110920|FG000|Overall Study|Death|1
2354589|NCT01133288|4110933|FG000|Eligibility Assessment|met exclusion criteria|5
2354590|NCT01133288|4110933|FG000|Intervention Allocation|study terminated|2
2354591|NCT01142128|4110941|FG000|Overall Study|Physician Decision|1
2354592|NCT01142128|4110941|FG000|Overall Study|Lost to Follow-up|1
2354593|NCT01142128|4110941|FG000|Overall Study|Withdrawal by Subject|2
2354594|NCT01128114|4110960|FG000|Overall Study|Treatment Withdrawn|6
2354595|NCT01128114|4110960|FG000|Overall Study|Screening Failed|2
2354596|NCT01126879|4110966|FG000|Overall Study|Progressive Disease|3
2354597|NCT01126879|4110967|FG001|Overall Study|Progressive Disease|1
2354598|NCT01126879|4110966|FG000|Overall Study|Withdrawal by Subject|1
2354599|NCT01126879|4110967|FG001|Overall Study|Withdrawal by Subject|0
2354600|NCT01126879|4110966|FG000|Overall Study|Adverse Event|0
2354601|NCT01126879|4110967|FG001|Overall Study|Adverse Event|1
2354602|NCT01126879|4110966|FG000|Overall Study|Physician Decision|1
2354603|NCT01126879|4110967|FG001|Overall Study|Physician Decision|0
2307839|NCT02703454|4010686|FG000|Overall Study|Lost to Follow-up|1
2307840|NCT02703454|4010687|FG001|Overall Study|Lost to Follow-up|2
2307841|NCT02703454|4010686|FG000|Overall Study|Study discontinuation|5
2307842|NCT02703454|4010687|FG001|Overall Study|Study discontinuation|8
2307843|NCT02703532|4010714|FG000|Overall Study|Withdrawal by Subject|0
2307844|NCT02703532|4010715|FG001|Overall Study|Withdrawal by Subject|1
2307845|NCT02703532|4010716|FG002|Overall Study|Withdrawal by Subject|0
2307846|NCT02703532|4010717|FG003|Overall Study|Withdrawal by Subject|1
2307847|NCT02703532|4010714|FG000|Overall Study|Lost to Follow-up|2
2307848|NCT02703532|4010715|FG001|Overall Study|Lost to Follow-up|0
2307849|NCT02703532|4010716|FG002|Overall Study|Lost to Follow-up|2
2307850|NCT02703532|4010717|FG003|Overall Study|Lost to Follow-up|0
2307851|NCT02703636|4010727|FG000|Overall Study|Adverse Event|14
2307852|NCT02703636|4010727|FG000|Overall Study|Study stopped by sponsor|1
2307853|NCT02703636|4010727|FG000|Overall Study|Withdrawal by Subject|1
2307854|NCT02704091|4010774|FG000|Overall Study|Adverse Event|4
2307855|NCT02704091|4010775|FG001|Overall Study|Adverse Event|3
2307856|NCT02704091|4010774|FG000|Overall Study|Protocol Violation|5
2307857|NCT02704091|4010775|FG001|Overall Study|Protocol Violation|3
2307858|NCT02704091|4010774|FG000|Overall Study|Consent withdrawn|4
2307859|NCT02704091|4010775|FG001|Overall Study|Consent withdrawn|4
2307860|NCT02704091|4010774|FG000|Overall Study|Lost to Follow-up|13
2307861|NCT02704091|4010775|FG001|Overall Study|Lost to Follow-up|5
2307862|NCT02704091|4010774|FG000|Overall Study|Other|2
2307863|NCT02704091|4010775|FG001|Overall Study|Other|8
2307864|NCT02704143|4010789|FG000|Overall Study|disease progression|10
2307865|NCT02704689|4010802|FG000|Overall Study|Physician Decision|1
2307866|NCT02704689|4010802|FG000|Overall Study|Study device not implanted|2
2307867|NCT02705105|4010843|FG000|Treatment|Objective Disease Progression|1
2307868|NCT02705105|4010844|FG001|Treatment|Objective Disease Progression|50
2307869|NCT02705105|4010843|FG000|Treatment|Withdrawal by Subject|3
2307870|NCT02705105|4010844|FG001|Treatment|Withdrawal by Subject|5
2307871|NCT02705105|4010843|FG000|Treatment|Adverse Event|0
2307872|NCT02705105|4010844|FG001|Treatment|Adverse Event|17
2307873|NCT02705105|4010843|FG000|Treatment|Clinical Disease Progression|0
2307874|NCT02705105|4010844|FG001|Treatment|Clinical Disease Progression|32
2354604|NCT01136811|4110973|FG000|Overall Study|Physician Decision|11
2354605|NCT01139125|4110986|FG000|Overall Study|Withdrawal by Subject|1
2354606|NCT01131455|4111010|FG000|Overall Study|Death of PI|6
2354607|NCT01131455|4111011|FG001|Overall Study|Death of PI|4
2354608|NCT01131455|4111012|FG002|Overall Study|Death of PI|0
2354609|NCT01123850|4111029|FG000|Overall Study|Slow enrollment|45
2354610|NCT01122381|4111062|FG000|Overall Study|study terminated early|0
2354611|NCT01122381|4111063|FG001|Overall Study|study terminated early|1
2354612|NCT01116232|4111069|FG000|Overall Study|Progressive diease|4
2354613|NCT01108523|4111097|FG000|Overall Study|Protocol Violation|4
2354614|NCT01106534|4111105|FG000|Overall Study|Withdrawal by Subject|18
2354615|NCT01106534|4111105|FG000|Overall Study|Lost to Follow-up|2
2354616|NCT01106534|4111105|FG000|Overall Study|Death|16
2354617|NCT01106534|4111105|FG000|Overall Study|Physician Decision|1
2354618|NCT01100658|4111114|FG000|Overall Study|Withdrawal by Subject|1
2354619|NCT01103180|4111120|FG000|Overall Study|Withdrawal by Subject|8
2354620|NCT01103180|4111121|FG001|Overall Study|Withdrawal by Subject|13
2354621|NCT01103180|4111120|FG000|Overall Study|Lost to Follow-up|13
2354622|NCT01103180|4111121|FG001|Overall Study|Lost to Follow-up|7
2354623|NCT01103180|4111120|FG000|Overall Study|Physician Decision|1
2354624|NCT01103180|4111121|FG001|Overall Study|Physician Decision|0
2354625|NCT01103180|4111120|FG000|Overall Study|Protocol Violation|0
2354626|NCT01103180|4111121|FG001|Overall Study|Protocol Violation|1
2354627|NCT01102140|4111138|FG000|Overall Study|Lost to Follow-up|1
2354628|NCT01102140|4111139|FG001|Overall Study|Lost to Follow-up|0
2354629|NCT01102140|4111138|FG000|Overall Study|Investigator terminated study|2
2354630|NCT01102140|4111139|FG001|Overall Study|Investigator terminated study|2
2354631|NCT01095250|4111151|FG000|Overall Study|administrative reasons|8
2212338|NCT01668797|3853353|FG000|Phase A (Conversion Phase)|Protocol Violation|2
2212339|NCT01668797|3853354|FG001|Phase A (Conversion Phase)|Protocol Violation|0
2212340|NCT01668797|3853355|FG002|Phase A (Conversion Phase)|Protocol Violation|0
2212341|NCT01668797|3853356|FG003|Phase A (Conversion Phase)|Protocol Violation|0
2354632|NCT01095250|4111152|FG001|Overall Study|administrative reasons|10
2354633|NCT01095250|4111153|FG002|Overall Study|administrative reasons|7
2354634|NCT01095250|4111154|FG003|Overall Study|administrative reasons|5
2354635|NCT01095250|4111151|FG000|Overall Study|Withdrawal by Subject|0
2354636|NCT01095250|4111152|FG001|Overall Study|Withdrawal by Subject|0
2354637|NCT01095250|4111153|FG002|Overall Study|Withdrawal by Subject|1
2354638|NCT01095250|4111154|FG003|Overall Study|Withdrawal by Subject|0
2354639|NCT01093846|4111171|FG000|Overall Study|Adverse Event|0
2354640|NCT01093846|4111172|FG001|Overall Study|Adverse Event|0
2354641|NCT01093846|4111173|FG002|Overall Study|Adverse Event|1
2354642|NCT01093846|4111171|FG000|Overall Study|Lack of Efficacy|0
2354643|NCT01093846|4111172|FG001|Overall Study|Lack of Efficacy|0
2354644|NCT01093846|4111173|FG002|Overall Study|Lack of Efficacy|4
2354645|NCT01093846|4111171|FG000|Overall Study|Condition no longer required study drug|1
2354646|NCT01093846|4111172|FG001|Overall Study|Condition no longer required study drug|1
2354647|NCT01093846|4111173|FG002|Overall Study|Condition no longer required study drug|1
2354648|NCT01093846|4111171|FG000|Overall Study|Administrative Problems|18
2354649|NCT01093846|4111172|FG001|Overall Study|Administrative Problems|17
2354650|NCT01093846|4111173|FG002|Overall Study|Administrative Problems|15
2354651|NCT01081886|4111186|FG000|Overall Study|Study termination|11
2354652|NCT01081886|4111187|FG001|Overall Study|Study termination|13
2354653|NCT01080768|4111208|FG000|Overall Study|Protocol Deviation|2
2354654|NCT01080768|4111209|FG001|Overall Study|Protocol Deviation|1
2019807|NCT00301821|3587242|FG000|Overall Study|Cancel|1
2019808|NCT00301834|3587246|FG000|Overall Study|Death|1
2019809|NCT00301964|3587257|FG000|Overall Study|Second primary|2
2019810|NCT00301964|3587257|FG000|Overall Study|Wrong primary|1
2019811|NCT00301964|3587257|FG000|Overall Study|Inadequate pathology|1
2019812|NCT00302003|3587267|FG000|Overall Study|Lack of Efficacy|62
2019813|NCT00302003|3587267|FG000|Overall Study|Lost to Follow-up|1
2019814|NCT00302003|3587267|FG000|Overall Study|Physician Decision|2
2019815|NCT00302003|3587267|FG000|Overall Study|Withdrawal by Subject|5
2019816|NCT00302003|3587267|FG000|Overall Study|Ineligible|9
2019817|NCT00302003|3587267|FG000|Overall Study|Protocol Violation|1
2019818|NCT00302081|3587306|FG000|Overall Study|Adverse Event|6
2019819|NCT00302081|3587307|FG001|Overall Study|Adverse Event|5
2019820|NCT00302081|3587308|FG002|Overall Study|Adverse Event|4
2019821|NCT00302081|3587306|FG000|Overall Study|Lost to Follow-up|21
2019822|NCT00302081|3587307|FG001|Overall Study|Lost to Follow-up|18
2019823|NCT00302081|3587308|FG002|Overall Study|Lost to Follow-up|28
2019824|NCT00302081|3587306|FG000|Overall Study|Withdrawal by Subject|8
2019825|NCT00302081|3587307|FG001|Overall Study|Withdrawal by Subject|12
2019826|NCT00302081|3587308|FG002|Overall Study|Withdrawal by Subject|8
2019827|NCT00302081|3587306|FG000|Overall Study|Protocol Violation|5
2019828|NCT00302081|3587307|FG001|Overall Study|Protocol Violation|1
2019829|NCT00302081|3587308|FG002|Overall Study|Protocol Violation|2
2019830|NCT00302081|3587306|FG000|Overall Study|Lack of Efficacy|1
2019831|NCT00302081|3587307|FG001|Overall Study|Lack of Efficacy|0
2019832|NCT00302081|3587308|FG002|Overall Study|Lack of Efficacy|5
2019833|NCT00302081|3587306|FG000|Overall Study|Death|2
2019834|NCT00302081|3587307|FG001|Overall Study|Death|1
2307875|NCT02705105|4010843|FG000|Treatment|Physician Decision|0
2307876|NCT02705105|4010844|FG001|Treatment|Physician Decision|3
2307877|NCT02705105|4010843|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0
2307878|NCT02705105|4010844|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2
2307879|NCT02705105|4010843|FG000|Follow-Up|Death|3
2307880|NCT02705105|4010844|FG001|Follow-Up|Death|68
2307881|NCT02705105|4010843|FG000|Follow-Up|Withdrawal by Subject|1
2307882|NCT02705105|4010844|FG001|Follow-Up|Withdrawal by Subject|14
2307883|NCT02705105|4010843|FG000|Follow-Up|Study Terminated|0
2307884|NCT02705105|4010844|FG001|Follow-Up|Study Terminated|26
2307885|NCT02705105|4010843|FG000|Follow-Up|Discontinued per Amendment 3|0
2307886|NCT02705105|4010844|FG001|Follow-Up|Discontinued per Amendment 3|2
2307887|NCT02705586|4010880|FG000|Overall Study|Health Issues|2
2307888|NCT02705586|4010880|FG000|Overall Study|Transportation Difficulties|5
2307889|NCT02705586|4010880|FG000|Overall Study|Vacation/Planned Absence|1
2307890|NCT02705625|4010887|FG000|Overall Study|Protocol Violation|1
2307891|NCT02705625|4010888|FG001|Overall Study|Protocol Violation|0
2307892|NCT02705625|4010889|FG002|Overall Study|Protocol Violation|0
2307893|NCT02705625|4010887|FG000|Overall Study|Adverse Event|6
2019835|NCT00302081|3587308|FG002|Overall Study|Death|0
2019836|NCT00302081|3587306|FG000|Overall Study|Other|13
2019837|NCT00302081|3587307|FG001|Overall Study|Other|6
2019838|NCT00302081|3587308|FG002|Overall Study|Other|5
2019839|NCT00302107|3587318|FG000|Overall Study|Lost to Follow-up|6
2019840|NCT00302107|3587319|FG001|Overall Study|Lost to Follow-up|5
2019841|NCT00302107|3587318|FG000|Overall Study|Protocol Violation|1
2019842|NCT00302107|3587319|FG001|Overall Study|Protocol Violation|0
2019843|NCT00302107|3587318|FG000|Overall Study|Relocation|0
2307894|NCT02705625|4010888|FG001|Overall Study|Adverse Event|5
2307895|NCT02705625|4010889|FG002|Overall Study|Adverse Event|2
2354655|NCT01074502|4111219|FG000|Overall Study|Withdrawal by Subject|1
2354656|NCT01069861|4111232|FG000|Overall Study|Death|1
2354657|NCT01069861|4111232|FG000|Overall Study|Adverse Event|1
2354658|NCT01069861|4111232|FG000|Overall Study|Did not meet entrance criteria|1
2354659|NCT01069120|4111265|FG000|Overall Study|Study prematurely terminated|27
2354660|NCT01058642|4111284|FG000|Treatment Period 1|Adverse Event|0
2354661|NCT01058642|4111285|FG001|Treatment Period 1|Adverse Event|1
2354662|NCT01058642|4111286|FG002|Treatment Period 1|Adverse Event|1
2354663|NCT01058642|4111287|FG003|Treatment Period 1|Adverse Event|0
2354664|NCT01058642|4111284|FG000|Treatment Period 1|Physician Decision|0
2354665|NCT01058642|4111285|FG001|Treatment Period 1|Physician Decision|0
2354666|NCT01058642|4111286|FG002|Treatment Period 1|Physician Decision|1
2354667|NCT01058642|4111287|FG003|Treatment Period 1|Physician Decision|0
2354668|NCT01058642|4111284|FG000|Treatment Period 1|Withdrawal by Subject|1
2354669|NCT01058642|4111285|FG001|Treatment Period 1|Withdrawal by Subject|0
2354670|NCT01058642|4111286|FG002|Treatment Period 1|Withdrawal by Subject|0
2354671|NCT01058642|4111287|FG003|Treatment Period 1|Withdrawal by Subject|0
2354672|NCT01058642|4111284|FG000|Treatment Period 1|Lack of Efficacy|0
2354673|NCT01058642|4111285|FG001|Treatment Period 1|Lack of Efficacy|0
2354674|NCT01058642|4111286|FG002|Treatment Period 1|Lack of Efficacy|0
2354675|NCT01058642|4111287|FG003|Treatment Period 1|Lack of Efficacy|1
2307896|NCT02705625|4010887|FG000|Overall Study|Death|0
2307897|NCT02705625|4010888|FG001|Overall Study|Death|0
2307898|NCT02705625|4010889|FG002|Overall Study|Death|1
2307899|NCT02705625|4010887|FG000|Overall Study|Withdrawal by Subject|1
2307900|NCT02705625|4010888|FG001|Overall Study|Withdrawal by Subject|4
2307901|NCT02705625|4010889|FG002|Overall Study|Withdrawal by Subject|5
2307902|NCT02705625|4010887|FG000|Overall Study|Lost to Follow-up|0
2307903|NCT02705625|4010888|FG001|Overall Study|Lost to Follow-up|0
2307904|NCT02705625|4010889|FG002|Overall Study|Lost to Follow-up|1
2307905|NCT02705625|4010887|FG000|Overall Study|Non-compliance|0
2307906|NCT02705625|4010888|FG001|Overall Study|Non-compliance|1
2307907|NCT02705625|4010889|FG002|Overall Study|Non-compliance|1
2307908|NCT02705625|4010887|FG000|Overall Study|Overdosing|0
2307909|NCT02705625|4010888|FG001|Overall Study|Overdosing|0
2307910|NCT02705625|4010889|FG002|Overall Study|Overdosing|1
2307911|NCT02705716|4010899|FG000|Overall Study|Adverse Event|0
2307912|NCT02705716|4010900|FG001|Overall Study|Adverse Event|1
2307913|NCT02705716|4010899|FG000|Overall Study|Protocol Violation|3
2307914|NCT02705716|4010900|FG001|Overall Study|Protocol Violation|0
2307915|NCT02705716|4010899|FG000|Overall Study|Withdrawal of Consent|1
2307916|NCT02705716|4010900|FG001|Overall Study|Withdrawal of Consent|1
2307917|NCT02706327|4010933|FG000|Overall Study|Lost to Follow-up|1
2307918|NCT02706327|4010934|FG001|Overall Study|Lost to Follow-up|1
2307919|NCT02706327|4010935|FG002|Overall Study|Lost to Follow-up|2
2307920|NCT02706483|4010943|FG000|Overall Study|Adverse Event|97
2307921|NCT02706483|4010943|FG000|Overall Study|Death|1
2307922|NCT02706483|4010943|FG000|Overall Study|Lack of Efficacy|39
2307923|NCT02706483|4010943|FG000|Overall Study|Lost to Follow-up|101
2307924|NCT02706483|4010943|FG000|Overall Study|Non-compliance with study drug|15
2307925|NCT02706483|4010943|FG000|Overall Study|Physician Decision|6
2307926|NCT02706483|4010943|FG000|Overall Study|Pregnancy|6
2307927|NCT02706483|4010943|FG000|Overall Study|Protocol Violation|18
2307928|NCT02706483|4010943|FG000|Overall Study|Withdrawal by Subject|136
2307929|NCT02706483|4010943|FG000|Overall Study|Non-compliance with visits|6
2307930|NCT02706483|4010943|FG000|Overall Study|Site closure|4
2307931|NCT02706483|4010943|FG000|Overall Study|Subject moved|1
2307932|NCT02706717|4010949|FG000|Overall Study|Withdrawal by Subject|1
2307933|NCT02706717|4010950|FG001|Overall Study|Withdrawal by Subject|8
2307934|NCT02706717|4010949|FG000|Overall Study|Lost to Follow-up|0
2307935|NCT02706717|4010950|FG001|Overall Study|Lost to Follow-up|1
2307936|NCT02706717|4010949|FG000|Overall Study|Physician Decision|0
2307937|NCT02706717|4010950|FG001|Overall Study|Physician Decision|1
2307938|NCT02706717|4010949|FG000|Overall Study|Death|0
2307939|NCT02706717|4010950|FG001|Overall Study|Death|1
2307940|NCT02706834|4010967|FG000|Overall Study|Pretreatment Event/Adverse Event|0
2307941|NCT02706834|4010968|FG001|Overall Study|Pretreatment Event/Adverse Event|1
2307942|NCT02706834|4010969|FG002|Overall Study|Pretreatment Event/Adverse Event|0
2307943|NCT02706834|4010970|FG003|Overall Study|Pretreatment Event/Adverse Event|0
2307944|NCT02706834|4010971|FG004|Overall Study|Pretreatment Event/Adverse Event|0
2307945|NCT02706834|4010972|FG005|Overall Study|Pretreatment Event/Adverse Event|0
2307946|NCT02706834|4010973|FG006|Overall Study|Pretreatment Event/Adverse Event|0
2307947|NCT02706834|4010974|FG007|Overall Study|Pretreatment Event/Adverse Event|0
2307948|NCT02706834|4010975|FG008|Overall Study|Pretreatment Event/Adverse Event|0
2307949|NCT02706834|4010976|FG009|Overall Study|Pretreatment Event/Adverse Event|0
2307950|NCT02706834|4010977|FG010|Overall Study|Pretreatment Event/Adverse Event|1
2307951|NCT02706834|4010967|FG000|Overall Study|Lost to Follow-up|0
2307952|NCT02706834|4010968|FG001|Overall Study|Lost to Follow-up|0
2307953|NCT02706834|4010969|FG002|Overall Study|Lost to Follow-up|1
2307954|NCT02706834|4010970|FG003|Overall Study|Lost to Follow-up|0
2307955|NCT02706834|4010971|FG004|Overall Study|Lost to Follow-up|0
2307956|NCT02706834|4010972|FG005|Overall Study|Lost to Follow-up|0
2354676|NCT01058642|4111284|FG000|Treatment Period 1|Protocol Violation|0
2354677|NCT01058642|4111285|FG001|Treatment Period 1|Protocol Violation|0
2354678|NCT01058642|4111286|FG002|Treatment Period 1|Protocol Violation|0
2307957|NCT02706834|4010973|FG006|Overall Study|Lost to Follow-up|0
2354679|NCT01058642|4111287|FG003|Treatment Period 1|Protocol Violation|1
2354680|NCT01058642|4111284|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1
2354681|NCT01058642|4111285|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0
2354682|NCT01058642|4111286|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0
2354683|NCT01058642|4111287|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0
2354684|NCT01065818|4111295|FG000|Overall Study|Withdrawal by Subject|1
2354685|NCT01065818|4111295|FG000|Overall Study|Not a candidate for surgery|1
2354686|NCT01051921|4111299|FG000|Overall Study|Physician Decision|9
2354687|NCT01051921|4111299|FG000|Overall Study|Adverse Event|8
2354688|NCT01051921|4111299|FG000|Overall Study|Withdrawal by Subject|7
2354689|NCT01051921|4111299|FG000|Overall Study|Lost to Follow-up|4
2354690|NCT01051921|4111299|FG000|Overall Study|virological failure|1
2354691|NCT01051921|4111299|FG000|Overall Study|patient moved|1
2354692|NCT01058369|4111321|FG000|Overall Study|Adverse Event|1
2354693|NCT01058369|4111321|FG000|Overall Study|Early termination study|1
2354694|NCT01053221|4111331|FG000|Overall Study|The study was closed prematurely|5
2354695|NCT01053221|4111332|FG001|Overall Study|The study was closed prematurely|9
2354696|NCT01038752|4111340|FG000|Overall Study|Tumor Progression|2
2354697|NCT01038752|4111341|FG001|Overall Study|Tumor Progression|2
2354698|NCT01038752|4111340|FG000|Overall Study|Lost to Follow-up|3
2354699|NCT01038752|4111341|FG001|Overall Study|Lost to Follow-up|3
2354700|NCT01050218|4111347|FG000|Overall Study|Adverse Event|37
2354701|NCT01050218|4111347|FG000|Overall Study|Lack of Efficacy|8
2354702|NCT01050218|4111347|FG000|Overall Study|Protocol Violation|3
2354703|NCT01050218|4111347|FG000|Overall Study|Withdrawal by Subject|18
2354704|NCT01050218|4111347|FG000|Overall Study|Discontinued by sponsor|18
2354705|NCT01050218|4111347|FG000|Overall Study|Compliance|2
2354706|NCT01050218|4111347|FG000|Overall Study|Failed to return|7
2354707|NCT01050218|4111347|FG000|Overall Study|Serious Adverse Event|1
2354708|NCT01050218|4111347|FG000|Overall Study|Family emergency|1
2354709|NCT01045694|4111351|FG000|Overall Study|Withdrawal by Subject|2
2354710|NCT01031628|4111376|FG000|Overall Study|Study terminated early|0
2354711|NCT01031628|4111377|FG001|Overall Study|Study terminated early|1
2354712|NCT01031628|4111378|FG002|Overall Study|Study terminated early|3
2354713|NCT01031628|4111379|FG003|Overall Study|Study terminated early|0
2354714|NCT01030198|4111410|FG000|Overall Study|Could not measure efficacy accurately|0
2354715|NCT01030198|4111411|FG001|Overall Study|Could not measure efficacy accurately|7
2354716|NCT01028300|4111417|FG000|Overall Study|Study Terminated|4
2354717|NCT01022398|4111428|FG000|Overall Study|Study terminated|2
2354718|NCT01022398|4111429|FG001|Overall Study|Study terminated|2
2354719|NCT01019980|4111436|FG000|Overall Study|Drug not available.|2
2212342|NCT01668797|3853353|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7
2212343|NCT01668797|3853354|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0
2212344|NCT01668797|3853355|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0
2307958|NCT02706834|4010974|FG007|Overall Study|Lost to Follow-up|0
2307959|NCT02706834|4010975|FG008|Overall Study|Lost to Follow-up|0
2307960|NCT02706834|4010976|FG009|Overall Study|Lost to Follow-up|0
2307961|NCT02706834|4010977|FG010|Overall Study|Lost to Follow-up|0
2307962|NCT02706834|4010967|FG000|Overall Study|Voluntary Withdrawal|1
2307963|NCT02706834|4010968|FG001|Overall Study|Voluntary Withdrawal|0
2307964|NCT02706834|4010969|FG002|Overall Study|Voluntary Withdrawal|0
2307965|NCT02706834|4010970|FG003|Overall Study|Voluntary Withdrawal|0
2307966|NCT02706834|4010971|FG004|Overall Study|Voluntary Withdrawal|0
2307967|NCT02706834|4010972|FG005|Overall Study|Voluntary Withdrawal|0
2307968|NCT02706834|4010973|FG006|Overall Study|Voluntary Withdrawal|0
2307969|NCT02706834|4010974|FG007|Overall Study|Voluntary Withdrawal|0
2307970|NCT02706834|4010975|FG008|Overall Study|Voluntary Withdrawal|0
2307971|NCT02706834|4010976|FG009|Overall Study|Voluntary Withdrawal|1
2307972|NCT02706834|4010977|FG010|Overall Study|Voluntary Withdrawal|0
2307973|NCT02706834|4010967|FG000|Overall Study|Other Reason Not Specified|1
2307974|NCT02706834|4010968|FG001|Overall Study|Other Reason Not Specified|0
2307975|NCT02706834|4010969|FG002|Overall Study|Other Reason Not Specified|0
2307976|NCT02706834|4010970|FG003|Overall Study|Other Reason Not Specified|0
2307977|NCT02706834|4010971|FG004|Overall Study|Other Reason Not Specified|1
2307978|NCT02706834|4010972|FG005|Overall Study|Other Reason Not Specified|0
2307979|NCT02706834|4010973|FG006|Overall Study|Other Reason Not Specified|0
2307980|NCT02706834|4010974|FG007|Overall Study|Other Reason Not Specified|0
2307981|NCT02706834|4010975|FG008|Overall Study|Other Reason Not Specified|0
2307982|NCT02706834|4010976|FG009|Overall Study|Other Reason Not Specified|0
2307983|NCT02706834|4010977|FG010|Overall Study|Other Reason Not Specified|0
2307984|NCT02706873|4011026|FG000|Overall Study|Adverse Event|13
2307985|NCT02706873|4011027|FG001|Overall Study|Adverse Event|3
2354720|NCT01019980|4111437|FG001|Overall Study|Drug not available.|0
2354721|NCT01017263|4111447|FG000|Overall Study|not eligible|12
2354722|NCT01018810|4111474|FG000|Overall Study|Withdrawal by Subject|0
2354723|NCT01018810|4111475|FG001|Overall Study|Withdrawal by Subject|1
2354724|NCT01018810|4111476|FG002|Overall Study|Withdrawal by Subject|0
2354725|NCT01018810|4111477|FG003|Overall Study|Withdrawal by Subject|0
2354726|NCT01018810|4111478|FG004|Overall Study|Withdrawal by Subject|0
2354727|NCT01018810|4111474|FG000|Overall Study|Sponsor Decision|2
2354728|NCT01018810|4111475|FG001|Overall Study|Sponsor Decision|0
2354729|NCT01018810|4111476|FG002|Overall Study|Sponsor Decision|1
2354730|NCT01018810|4111477|FG003|Overall Study|Sponsor Decision|1
2354731|NCT01018810|4111478|FG004|Overall Study|Sponsor Decision|1
2354732|NCT01014767|4111507|FG000|Overall Study|PI left institution, data unavailable|12
2354733|NCT01014767|4111508|FG001|Overall Study|PI left institution, data unavailable|1
2354734|NCT01014767|4111509|FG002|Overall Study|PI left institution, data unavailable|4
2354735|NCT01014767|4111510|FG003|Overall Study|PI left institution, data unavailable|1
2354736|NCT01013701|4111520|FG000|Overall Study|study prematurely terminated|7
2354737|NCT01012414|4111525|FG000|Overall Study|Withdrawal by Subject|2
2354738|NCT01012414|4111525|FG000|Overall Study|Lost to Follow-up|1
2354739|NCT01012414|4111525|FG000|Overall Study|Trial was stopped before completed|7
2354740|NCT01001390|4111544|FG000|Overall Study|Failure to wear AFO device|2
2354741|NCT01001390|4111545|FG001|Overall Study|Failure to wear AFO device|0
2354742|NCT01004510|4111563|FG000|Overall Study|Adverse Event|1
2354743|NCT01005914|4111567|FG000|Overall Study|Adverse Event|4
2354744|NCT01005914|4111567|FG000|Overall Study|Death|4
2354745|NCT01005914|4111567|FG000|Overall Study|Lack of Efficacy|1
2354746|NCT01005914|4111567|FG000|Overall Study|Withdrawal by Subject|1
2354747|NCT00996333|4111571|FG000|Overall Study|Screen failure|1
2354748|NCT00996333|4111571|FG000|Overall Study|Withdrawal by Subject|1
2354749|NCT00996333|4111571|FG000|Overall Study|Death|4
2354750|NCT00996333|4111571|FG000|Overall Study|Adverse Event|1
2354751|NCT00996333|4111571|FG000|Overall Study|Physician Decision|1
2354752|NCT00996333|4111571|FG000|Overall Study|Other|5
2354753|NCT00998738|4111575|FG000|Overall Study|Uknown|1
2354754|NCT00997386|4111583|FG000|Overall Study|Death|7
2354755|NCT00985738|4111589|FG000|Overall Study|Study closed prematurely|8
2354756|NCT00985738|4111590|FG001|Overall Study|Study closed prematurely|8
2354757|NCT00975611|4111683|FG000|Overall Study|Screen Fail|16
2354758|NCT00975611|4111683|FG000|Overall Study|Physician Decision|1
2307986|NCT02706873|4011028|FG002|Overall Study|Adverse Event|13
2307987|NCT02706873|4011029|FG003|Overall Study|Adverse Event|12
2307988|NCT02706873|4011026|FG000|Overall Study|Withdrawal by Subject|15
2307989|NCT02706873|4011027|FG001|Overall Study|Withdrawal by Subject|0
2307990|NCT02706873|4011028|FG002|Overall Study|Withdrawal by Subject|8
2307991|NCT02706873|4011029|FG003|Overall Study|Withdrawal by Subject|11
2307992|NCT02706873|4011026|FG000|Overall Study|Lost to Follow-up|3
2307993|NCT02706873|4011027|FG001|Overall Study|Lost to Follow-up|0
2307994|NCT02706873|4011028|FG002|Overall Study|Lost to Follow-up|4
2307995|NCT02706873|4011029|FG003|Overall Study|Lost to Follow-up|2
2307996|NCT02706873|4011026|FG000|Overall Study|Lack of Efficacy|10
2307997|NCT02706873|4011027|FG001|Overall Study|Lack of Efficacy|0
2307998|NCT02706873|4011028|FG002|Overall Study|Lack of Efficacy|0
2354759|NCT00974922|4111708|FG000|Overall Study|study terminated|24
2354760|NCT00965146|4111723|FG000|Overall Study|Death|7
2354761|NCT00965146|4111723|FG000|Overall Study|Lost to Follow-up|22
2354762|NCT00965146|4111723|FG000|Overall Study|Withdrawal by Subject|17
2354763|NCT00965146|4111723|FG000|Overall Study|Unable to return|1
2354764|NCT00965146|4111723|FG000|Overall Study|Unwilling to return|11
2354765|NCT00965146|4111723|FG000|Overall Study|Intercurrent illness|1
2354766|NCT00965146|4111723|FG000|Overall Study|Revision / Removal of Study Implant|6
2354767|NCT00965146|4111723|FG000|Overall Study|Overall Study Termination|145
2354768|NCT00972023|4111727|FG000|Overall Study|Withdrawal by Subject|1
2354769|NCT00953329|4111746|FG000|Overall Study|Lack of Efficacy|1
2354770|NCT00958893|4111763|FG000|Overall Study|Study prematurely terminated|4
2354771|NCT00966654|4111767|FG000|Overall Study|Study was terminated,PI left institution|12
2354772|NCT00960154|4111775|FG000|Overall Study|Study termination|25
2354773|NCT00960154|4111776|FG001|Overall Study|Study termination|25
2354774|NCT00960752|4111785|FG000|Overall Study|Adverse Event|0
2354775|NCT00960752|4111786|FG001|Overall Study|Adverse Event|0
2354776|NCT00960752|4111787|FG002|Overall Study|Adverse Event|1
2354777|NCT00960752|4111785|FG000|Overall Study|Progression|0
2354778|NCT00960752|4111786|FG001|Overall Study|Progression|0
2354779|NCT00960752|4111787|FG002|Overall Study|Progression|1
2354780|NCT00958347|4111795|FG000|Overall Study|Death|43
2354781|NCT00958347|4111795|FG000|Overall Study|Withdrawal by Subject|23
2354782|NCT00958347|4111795|FG000|Overall Study|Lost to Follow-up|15
2354783|NCT00958347|4111795|FG000|Overall Study|revision/removal|10
2354784|NCT00958347|4111795|FG000|Overall Study|study termination|135
2354785|NCT00953615|4111808|FG000|Overall Study|Adverse Event|1
2354786|NCT00957034|4111820|FG000|Overall Study|Adverse Event|0
2354787|NCT00957034|4111821|FG001|Overall Study|Adverse Event|1
2354788|NCT00957034|4111822|FG002|Overall Study|Adverse Event|1
2354789|NCT00957034|4111820|FG000|Overall Study|Sponsor Terminated Study|6
2354790|NCT00957034|4111821|FG001|Overall Study|Sponsor Terminated Study|1
2354791|NCT00957034|4111822|FG002|Overall Study|Sponsor Terminated Study|5
2019844|NCT00302107|3587319|FG001|Overall Study|Relocation|1
2019845|NCT00302107|3587318|FG000|Overall Study|Withdrawal by Subject|0
2019846|NCT00302107|3587319|FG001|Overall Study|Withdrawal by Subject|3
2019847|NCT00302107|3587318|FG000|Overall Study|Adverse Event|1
2019848|NCT00302107|3587319|FG001|Overall Study|Adverse Event|0
2019849|NCT00302159|3587334|FG000|Overall Study|pt declined before treatment started|1
2019850|NCT00302159|3587334|FG000|Overall Study|pt started Avastin|1
2019851|NCT00302211|3587342|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2
2019852|NCT00302211|3587343|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1
2019853|NCT00302211|3587344|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0
2019854|NCT00302211|3587345|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0
2019855|NCT00302211|3587346|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0
2019856|NCT00302211|3587342|FG000|Double Blind Period (New Patients)|Adverse Event|0
2307999|NCT02706873|4011029|FG003|Overall Study|Lack of Efficacy|3
2308000|NCT02706873|4011026|FG000|Overall Study|Other|5
2308001|NCT02706873|4011027|FG001|Overall Study|Other|1
2308002|NCT02706873|4011028|FG002|Overall Study|Other|2
2308003|NCT02706873|4011029|FG003|Overall Study|Other|3
2308004|NCT02706873|4011026|FG000|Overall Study|Not Dosed|1
2308005|NCT02706873|4011027|FG001|Overall Study|Not Dosed|0
2308006|NCT02706873|4011028|FG002|Overall Study|Not Dosed|0
2308007|NCT02706873|4011029|FG003|Overall Study|Not Dosed|1
2308008|NCT02706873|4011026|FG000|Overall Study|Ongoing|0
2308009|NCT02706873|4011027|FG001|Overall Study|Ongoing|0
2308010|NCT02706873|4011028|FG002|Overall Study|Ongoing|0
2308011|NCT02706873|4011029|FG003|Overall Study|Ongoing|1
2308012|NCT02706886|4011050|FG000|Part A: SAD Period|Withdrawal by Subject|0
2308013|NCT02706886|4011051|FG001|Part A: SAD Period|Withdrawal by Subject|0
2308014|NCT02706886|4011052|FG002|Part A: SAD Period|Withdrawal by Subject|0
2308015|NCT02706886|4011053|FG003|Part A: SAD Period|Withdrawal by Subject|2
2308016|NCT02706886|4011054|FG004|Part A: SAD Period|Withdrawal by Subject|0
2308017|NCT02706886|4011055|FG005|Part A: SAD Period|Withdrawal by Subject|0
2308018|NCT02706886|4011056|FG006|Part A: SAD Period|Withdrawal by Subject|0
2308019|NCT02706886|4011057|FG007|Part A: SAD Period|Withdrawal by Subject|0
2308020|NCT02706886|4011058|FG008|Part A: SAD Period|Withdrawal by Subject|0
2308021|NCT02706899|4011103|FG000|Overall Study|Withdrawal by Subject|1
2308022|NCT02706899|4011104|FG001|Overall Study|Withdrawal by Subject|0
2308023|NCT02706899|4011103|FG000|Overall Study|Death|8
2308024|NCT02706899|4011104|FG001|Overall Study|Death|0
2308025|NCT02706899|4011103|FG000|Overall Study|Study Termination by Sponsor|4
2019857|NCT00302211|3587343|FG001|Double Blind Period (New Patients)|Adverse Event|0
2354792|NCT00957034|4111820|FG000|Overall Study|Withdrawal by Subject|0
2354793|NCT00957034|4111821|FG001|Overall Study|Withdrawal by Subject|2
2354794|NCT00957034|4111822|FG002|Overall Study|Withdrawal by Subject|0
2354795|NCT00949988|4111830|FG000|Overall Study|Withdrawal by Subject|3
2354796|NCT00948194|4111836|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1
2354797|NCT00948194|4111837|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0
2354798|NCT00946985|4111843|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4
2354799|NCT00946985|4111843|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
2354800|NCT00946985|4111843|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
2354801|NCT00946985|4111843|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
2354802|NCT00946985|4111843|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
2354803|NCT00946985|4111843|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
2354804|NCT00946985|4111843|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
2354805|NCT00946985|4111843|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2
2354806|NCT00946985|4111843|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
2354807|NCT00950690|4111851|FG000|Overall Study|Death|4
2354808|NCT00950690|4111851|FG000|Overall Study|Adverse Event|15
2354809|NCT00950690|4111851|FG000|Overall Study|Lack of Efficacy|22
2354810|NCT00950690|4111851|FG000|Overall Study|Lost to Follow-up|40
2354811|NCT00950690|4111851|FG000|Overall Study|Other|163
2354812|NCT00944229|4111855|FG000|Overall Study|Withdrawal by Subject|11
2354813|NCT00944229|4111855|FG000|Overall Study|Physician Decision|14
2354814|NCT00941928|4111859|FG000|Overall Study|Withdrawal by Subject|1
2354815|NCT00941928|4111859|FG000|Overall Study|Disease Progression|1
2354816|NCT00947011|4111876|FG000|Overall Study|Study was terminated,PI left institution|12
2354817|NCT00943605|4111884|FG000|Overall Study|Study termination|30
2354818|NCT00943605|4111885|FG001|Overall Study|Study termination|30
2354819|NCT00942409|4111891|FG000|Overall Study|Lack of Efficacy|1
2354820|NCT00942409|4111891|FG000|Overall Study|study drug unavailable|2
2354821|NCT00936598|4111901|FG000|Overall Study|Withdrawal by Subject|1
2354822|NCT00936598|4111902|FG001|Overall Study|Withdrawal by Subject|0
2354823|NCT00936598|4111901|FG000|Overall Study|Ineligible after consent|1
2354824|NCT00936598|4111902|FG001|Overall Study|Ineligible after consent|0
2354825|NCT00934791|4111926|FG000|Overall Study|Withdrawal by Subject|1
2354826|NCT00934791|4111927|FG001|Overall Study|Withdrawal by Subject|0
2354827|NCT00925548|4111975|FG000|Overall Study|Discontinuation of trial by sponsor|10
2354828|NCT00925548|4111976|FG001|Overall Study|Discontinuation of trial by sponsor|5
2354829|NCT00926575|4111985|FG000|Overall Study|Adverse Event|1
2354830|NCT00926575|4111986|FG001|Overall Study|Adverse Event|1
2354831|NCT00926575|4111985|FG000|Overall Study|Death|4
2354832|NCT00926575|4111986|FG001|Overall Study|Death|4
2354833|NCT00926575|4111985|FG000|Overall Study|Lost to Follow-up|1
2354834|NCT00926575|4111986|FG001|Overall Study|Lost to Follow-up|1
2354835|NCT00926575|4111985|FG000|Overall Study|Physician Decision|1
2354836|NCT00926575|4111986|FG001|Overall Study|Physician Decision|2
2354837|NCT00926575|4111985|FG000|Overall Study|Protocol Violation|1
2354838|NCT00926575|4111986|FG001|Overall Study|Protocol Violation|0
2354839|NCT00926575|4111985|FG000|Overall Study|Withdrawal by Subject|8
2354840|NCT00926575|4111986|FG001|Overall Study|Withdrawal by Subject|9
2354841|NCT00918463|4112013|FG000|Overall Study|Death|1
2354842|NCT00918463|4112013|FG000|Overall Study|Lack of Efficacy|1
2354843|NCT00913692|4112017|FG000|Screening (4 Months)|Physician Decision|3
2354844|NCT00913692|4112017|FG000|Screening (4 Months)|Not eligible after screening phase.|6
2354845|NCT00913692|4112017|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1
2354846|NCT00918645|4112024|FG000|Overall Study|Withdrawal by Subject|1
2354847|NCT00906035|4112057|FG000|Overall Study|Withdrawal by Subject|2
2354848|NCT00906035|4112058|FG001|Overall Study|Withdrawal by Subject|3
2354849|NCT00906035|4112059|FG002|Overall Study|Withdrawal by Subject|0
2354850|NCT00894790|4112090|FG000|Overall Study|Protocol Violation|0
2019858|NCT00302211|3587344|FG002|Double Blind Period (New Patients)|Adverse Event|3
2019859|NCT00302211|3587345|FG003|Double Blind Period (New Patients)|Adverse Event|0
2019860|NCT00302211|3587346|FG004|Double Blind Period (New Patients)|Adverse Event|0
2019861|NCT00302211|3587342|FG000|Double Blind Period (New Patients)|Investigator's judgement|1
2019862|NCT00302211|3587343|FG001|Double Blind Period (New Patients)|Investigator's judgement|0
2019863|NCT00302211|3587344|FG002|Double Blind Period (New Patients)|Investigator's judgement|0
2019864|NCT00302211|3587345|FG003|Double Blind Period (New Patients)|Investigator's judgement|0
2019865|NCT00302211|3587346|FG004|Double Blind Period (New Patients)|Investigator's judgement|0
2019866|NCT00302211|3587342|FG000|Double Blind Period (New Patients)|Disease progression|0
2019867|NCT00302211|3587343|FG001|Double Blind Period (New Patients)|Disease progression|1
2019868|NCT00302211|3587344|FG002|Double Blind Period (New Patients)|Disease progression|1
2019869|NCT00302211|3587345|FG003|Double Blind Period (New Patients)|Disease progression|0
2019870|NCT00302211|3587346|FG004|Double Blind Period (New Patients)|Disease progression|0
2019871|NCT00302211|3587342|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
2019872|NCT00302211|3587343|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
2019873|NCT00302211|3587344|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
2019874|NCT00302211|3587345|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
2019875|NCT00302211|3587346|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
2019876|NCT00302211|3587342|FG000|Open Label-Patients From Double-Blind|Adverse Event|0
2019877|NCT00302211|3587343|FG001|Open Label-Patients From Double-Blind|Adverse Event|0
2019878|NCT00302211|3587344|FG002|Open Label-Patients From Double-Blind|Adverse Event|0
2019879|NCT00302211|3587345|FG003|Open Label-Patients From Double-Blind|Adverse Event|1
2025913|NCT00347776|3594657|FG001|1.5 Month Follow-up|reached the endpoint|8
2354851|NCT00894790|4112091|FG001|Overall Study|Protocol Violation|1
2354852|NCT00894790|4112090|FG000|Overall Study|Lost to Follow-up|0
2354853|NCT00894790|4112091|FG001|Overall Study|Lost to Follow-up|1
2354854|NCT00894790|4112090|FG000|Overall Study|Did not meet entrance criteria|1
2354855|NCT00894790|4112091|FG001|Overall Study|Did not meet entrance criteria|0
2354856|NCT00902668|4112097|FG000|Overall Study|Protocol stopped due to slow accrual.|3
2354857|NCT00881205|4112103|FG000|Overall Study|Adverse Event|8
2354858|NCT00881205|4112104|FG001|Overall Study|Adverse Event|3
2354859|NCT00881205|4112103|FG000|Overall Study|Withdrawal by Subject|1
2354860|NCT00881205|4112104|FG001|Overall Study|Withdrawal by Subject|2
2354861|NCT00881205|4112103|FG000|Overall Study|Lost to Follow-up|0
2354862|NCT00881205|4112104|FG001|Overall Study|Lost to Follow-up|1
2354863|NCT00881205|4112103|FG000|Overall Study|Administrative problems|1
2354864|NCT00881205|4112104|FG001|Overall Study|Administrative problems|1
2354865|NCT00881205|4112103|FG000|Overall Study|Condition no longer requires drug|1
2354866|NCT00881205|4112104|FG001|Overall Study|Condition no longer requires drug|0
2354867|NCT00903006|4112121|FG000|Overall Study|Withdrawal by Subject|2
2354868|NCT00903006|4112122|FG001|Overall Study|Withdrawal by Subject|0
2354869|NCT00903006|4112123|FG002|Overall Study|Withdrawal by Subject|0
2354870|NCT00903006|4112124|FG003|Overall Study|Withdrawal by Subject|0
2354871|NCT00903006|4112121|FG000|Overall Study|Progressive Disease|0
2308026|NCT02706899|4011104|FG001|Overall Study|Study Termination by Sponsor|6
2308027|NCT02706938|4011157|FG000|First Period, 6 Weeks|Adverse Event|8
2308028|NCT02706938|4011158|FG001|First Period, 6 Weeks|Adverse Event|0
2308029|NCT02706938|4011157|FG000|First Period, 6 Weeks|Lost to Follow-up|2
2308030|NCT02706938|4011158|FG001|First Period, 6 Weeks|Lost to Follow-up|2
2308031|NCT02706938|4011157|FG000|First Period, 6 Weeks|Withdrawal by Subject|1
2308032|NCT02706938|4011158|FG001|First Period, 6 Weeks|Withdrawal by Subject|0
2308033|NCT02706938|4011157|FG000|Second Period, 6 Weeks|Adverse Event|0
2308034|NCT02706938|4011158|FG001|Second Period, 6 Weeks|Adverse Event|7
2308035|NCT02706938|4011157|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0
2308036|NCT02706938|4011158|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3
2308037|NCT02706951|4011168|FG000|Overall Study|Adverse Event|1
2308038|NCT02706951|4011169|FG001|Overall Study|Adverse Event|5
2308039|NCT02706951|4011170|FG002|Overall Study|Adverse Event|3
2308040|NCT02706951|4011168|FG000|Overall Study|Withdrawal by Subject|11
2308041|NCT02706951|4011169|FG001|Overall Study|Withdrawal by Subject|6
2308042|NCT02706951|4011170|FG002|Overall Study|Withdrawal by Subject|6
2308043|NCT02706951|4011168|FG000|Overall Study|Lost to Follow-up|0
2308044|NCT02706951|4011169|FG001|Overall Study|Lost to Follow-up|4
2308045|NCT02706951|4011170|FG002|Overall Study|Lost to Follow-up|1
2308046|NCT02706951|4011168|FG000|Overall Study|Other|2
2308047|NCT02706951|4011169|FG001|Overall Study|Other|1
2308048|NCT02706951|4011170|FG002|Overall Study|Other|0
2308049|NCT02707601|4011216|FG000|Overall Study|Death|0
2308050|NCT02707601|4011217|FG001|Overall Study|Death|1
2308051|NCT02707601|4011216|FG000|Overall Study|Lack of Efficacy|0
2308052|NCT02707601|4011217|FG001|Overall Study|Lack of Efficacy|1
2308053|NCT02707601|4011216|FG000|Overall Study|Investigator's Discretion|1
2308054|NCT02707601|4011217|FG001|Overall Study|Investigator's Discretion|0
2308055|NCT02707601|4011216|FG000|Overall Study|Withdrew Consent|0
2308056|NCT02707601|4011217|FG001|Overall Study|Withdrew Consent|1
2308057|NCT02707601|4011216|FG000|Overall Study|Lost to Follow-up|1
2308058|NCT02707601|4011217|FG001|Overall Study|Lost to Follow-up|1
2308059|NCT02707601|4011216|FG000|Overall Study|Participants Randomized but Not Treated|2
2308060|NCT02707601|4011217|FG001|Overall Study|Participants Randomized but Not Treated|0
2308061|NCT02707640|4011229|FG000|Overall Study|Adverse Event|4
2308062|NCT02707640|4011230|FG001|Overall Study|Adverse Event|2
2308063|NCT02707640|4011229|FG000|Overall Study|Death|1
2308064|NCT02707640|4011230|FG001|Overall Study|Death|2
2308065|NCT02707640|4011229|FG000|Overall Study|Physician Decision|2
2308066|NCT02707640|4011230|FG001|Overall Study|Physician Decision|0
2354872|NCT00903006|4112122|FG001|Overall Study|Progressive Disease|3
2354873|NCT00903006|4112123|FG002|Overall Study|Progressive Disease|1
2354874|NCT00903006|4112124|FG003|Overall Study|Progressive Disease|0
2354875|NCT00887315|4112141|FG000|Overall Study|Study termination|7
2354876|NCT00887315|4112142|FG001|Overall Study|Study termination|4
2354877|NCT00891904|4112148|FG000|Overall Study|Death|1
2354878|NCT00891904|4112148|FG000|Overall Study|Adverse Event|1
2354879|NCT00881608|4112157|FG000|Overall Study|Study prematurely terminated|11
2354880|NCT00889421|4112169|FG000|Overall Study|Lack of Efficacy|3
2354881|NCT00882310|4112186|FG000|Overall Study|Screen Failure|10
2354882|NCT00882310|4112186|FG000|Overall Study|Never received treatment|1
2354883|NCT00882310|4112186|FG000|Overall Study|Death|6
2354884|NCT00882310|4112186|FG000|Overall Study|Progression of disease|4
2354885|NCT00882310|4112186|FG000|Overall Study|Adverse Event|1
2354886|NCT00880542|4112190|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
2354887|NCT00880542|4112190|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
2354888|NCT00880542|4112190|FG000|REP: Surgical Resection|progressive disease|1
2354889|NCT00874939|4112198|FG000|Overall Study|Study terminated|4
2354890|NCT00877071|4112225|FG000|Overall Study|disease progression|2
2354891|NCT00878969|4112232|FG000|Overall Study|Physician Decision|5
2354892|NCT00878969|4112233|FG001|Overall Study|Physician Decision|3
2354893|NCT00878969|4112234|FG002|Overall Study|Physician Decision|2
2354894|NCT00878969|4112232|FG000|Overall Study|Withdrawal by Subject|1
2354895|NCT00878969|4112233|FG001|Overall Study|Withdrawal by Subject|6
2354896|NCT00878969|4112234|FG002|Overall Study|Withdrawal by Subject|3
2354897|NCT00878969|4112232|FG000|Overall Study|kidney transplant|2
2354898|NCT00878969|4112233|FG001|Overall Study|kidney transplant|3
2354899|NCT00878969|4112234|FG002|Overall Study|kidney transplant|2
2354900|NCT00878969|4112232|FG000|Overall Study|Adverse Event|3
2354901|NCT00878969|4112233|FG001|Overall Study|Adverse Event|1
2354902|NCT00878969|4112234|FG002|Overall Study|Adverse Event|2
2354903|NCT00878969|4112232|FG000|Overall Study|Lost to Follow-up|2
2354904|NCT00878969|4112233|FG001|Overall Study|Lost to Follow-up|1
2354905|NCT00878969|4112234|FG002|Overall Study|Lost to Follow-up|0
2354906|NCT00878969|4112232|FG000|Overall Study|Protocol Violation|2
2354907|NCT00878969|4112233|FG001|Overall Study|Protocol Violation|0
2354908|NCT00878969|4112234|FG002|Overall Study|Protocol Violation|0
2354909|NCT00878969|4112232|FG000|Overall Study|Death|0
2354910|NCT00878969|4112233|FG001|Overall Study|Death|0
2354911|NCT00878969|4112234|FG002|Overall Study|Death|2
2354912|NCT00878969|4112232|FG000|Overall Study|Pregnancy|0
2354913|NCT00878969|4112233|FG001|Overall Study|Pregnancy|1
2308067|NCT02707640|4011229|FG000|Overall Study|Withdrawal by Subject|0
2308068|NCT02707640|4011230|FG001|Overall Study|Withdrawal by Subject|1
2308069|NCT02707640|4011229|FG000|Overall Study|Participant's Personal Decision|1
2308070|NCT02707640|4011230|FG001|Overall Study|Participant's Personal Decision|2
2308071|NCT02707640|4011229|FG000|Overall Study|Sponsor Discretion|1
2308072|NCT02707640|4011230|FG001|Overall Study|Sponsor Discretion|0
2308073|NCT02707757|4011238|FG000|Overall Study|Protocol Violation|3
2308074|NCT02707757|4011239|FG001|Overall Study|Protocol Violation|2
2308075|NCT02707757|4011238|FG000|Overall Study|Withdrawal by Subject|2
2308076|NCT02707757|4011239|FG001|Overall Study|Withdrawal by Subject|0
2308077|NCT02707757|4011238|FG000|Overall Study|Death|0
2308078|NCT02707757|4011239|FG001|Overall Study|Death|1
2308079|NCT02707757|4011238|FG000|Overall Study|Adverse Event|6
2308080|NCT02707757|4011239|FG001|Overall Study|Adverse Event|4
2019880|NCT00302211|3587346|FG004|Open Label-Patients From Double-Blind|Adverse Event|0
2019881|NCT00302211|3587342|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0
2019882|NCT00302211|3587343|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0
2019883|NCT00302211|3587344|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0
2019884|NCT00302211|3587345|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1
2019885|NCT00302211|3587346|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0
2019886|NCT00302211|3587342|FG000|Open Label-Patients From Double-Blind|Disease progression|0
2019887|NCT00302211|3587343|FG001|Open Label-Patients From Double-Blind|Disease progression|0
2019888|NCT00302211|3587344|FG002|Open Label-Patients From Double-Blind|Disease progression|0
2308081|NCT02707757|4011238|FG000|Overall Study|Renal transplant/elective operation|1
2308082|NCT02707757|4011239|FG001|Overall Study|Renal transplant/elective operation|5
2308083|NCT02707861|4011258|FG000|Overall Study|Went onto commercial drug|30
2308084|NCT02707861|4011259|FG001|Overall Study|Went onto commercial drug|23
2308085|NCT02707861|4011258|FG000|Overall Study|Adverse Event|2
2308086|NCT02707861|4011259|FG001|Overall Study|Adverse Event|3
2354914|NCT00878969|4112234|FG002|Overall Study|Pregnancy|0
2354915|NCT00865514|4112242|FG000|Overall Study|Infusion cost exceeded funding|2
2354916|NCT00863512|4112259|FG000|Overall Study|Adverse Event|2
2354917|NCT00863512|4112260|FG001|Overall Study|Adverse Event|0
2354918|NCT00863512|4112259|FG000|Overall Study|Withdrawal by Subject|11
2354919|NCT00863512|4112260|FG001|Overall Study|Withdrawal by Subject|0
2354920|NCT00863512|4112259|FG000|Overall Study|Physician Decision|1
2354921|NCT00863512|4112260|FG001|Overall Study|Physician Decision|0
2354922|NCT00868998|4112266|FG000|Overall Study|Screen Failure|1
2354923|NCT00868998|4112266|FG000|Overall Study|Withdrawal by Subject|1
2354924|NCT00868998|4112266|FG000|Overall Study|Progression of disease|2
2354925|NCT00868998|4112266|FG000|Overall Study|Death|1
2354926|NCT00869258|4112270|FG000|Overall Study|Physician Decision|1
2354927|NCT00863330|4112274|FG000|Overall Study|study terminated early due to administra|6
2354928|NCT00853229|4112280|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
2354929|NCT00853229|4112281|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
2354930|NCT00860249|4112292|FG000|Overall Study|trial was terminated prior to completion|21
2354931|NCT00860249|4112293|FG001|Overall Study|trial was terminated prior to completion|18
2019889|NCT00302211|3587345|FG003|Open Label-Patients From Double-Blind|Disease progression|1
2019890|NCT00302211|3587346|FG004|Open Label-Patients From Double-Blind|Disease progression|2
2019891|NCT00302211|3587342|FG000|Open Label-Patients From Double-Blind|Death|0
2019892|NCT00302211|3587343|FG001|Open Label-Patients From Double-Blind|Death|0
2019893|NCT00302211|3587344|FG002|Open Label-Patients From Double-Blind|Death|0
2019894|NCT00302211|3587345|FG003|Open Label-Patients From Double-Blind|Death|1
2019895|NCT00302211|3587346|FG004|Open Label-Patients From Double-Blind|Death|1
2019896|NCT00302211|3587342|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0
2019897|NCT00302211|3587343|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0
2019898|NCT00302211|3587344|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0
2019899|NCT00302211|3587345|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0
2019900|NCT00302211|3587346|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1
2019901|NCT00302211|3587342|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
2019902|NCT00302211|3587343|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
2019903|NCT00302211|3587344|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
2019904|NCT00302211|3587345|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
2019905|NCT00302211|3587346|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
2019906|NCT00302211|3587342|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
2019907|NCT00302211|3587343|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
2019908|NCT00302211|3587344|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
2019909|NCT00302211|3587345|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
2019910|NCT00302211|3587346|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
2019911|NCT00302328|3587361|FG000|Overall Study|Physician Decision|0
2019912|NCT00302328|3587362|FG001|Overall Study|Physician Decision|1
2019913|NCT00302328|3587363|FG002|Overall Study|Physician Decision|0
2019914|NCT00302458|3587374|FG000|Overall Study|Lost to Follow-up|1
2019915|NCT00302458|3587374|FG000|Overall Study|Ineligible after screening|1
2019916|NCT00302458|3587374|FG000|Overall Study|Withdrawal by Subject|1
2019917|NCT00302718|3587386|FG000|Overall Study|Participant left the hospital|1
2019918|NCT00302718|3587387|FG001|Overall Study|Participant left the hospital|0
2019919|NCT00302718|3587388|FG002|Overall Study|Participant left the hospital|0
2019920|NCT00302718|3587389|FG003|Overall Study|Participant left the hospital|1
2019921|NCT00302718|3587386|FG000|Overall Study|Withdrawal by Subject|0
2019922|NCT00302718|3587387|FG001|Overall Study|Withdrawal by Subject|1
2019923|NCT00302718|3587388|FG002|Overall Study|Withdrawal by Subject|0
2019924|NCT00302718|3587389|FG003|Overall Study|Withdrawal by Subject|0
2019925|NCT00302718|3587386|FG000|Overall Study|Participant left primary care setting|0
2354932|NCT00860249|4112294|FG002|Overall Study|trial was terminated prior to completion|21
2354933|NCT00860158|4112302|FG000|Overall Study|Study Terminated|1
2354934|NCT00853567|4112309|FG000|Overall Study|Study prematurely terminated|71
2354935|NCT00849524|4112317|FG000|Overall Study|Lack of Efficacy|3
2308087|NCT02707861|4011258|FG000|Overall Study|Death|5
2308088|NCT02707861|4011259|FG001|Overall Study|Death|2
2308089|NCT02707861|4011258|FG000|Overall Study|Lack of Efficacy|0
2308090|NCT02707861|4011259|FG001|Overall Study|Lack of Efficacy|2
2308091|NCT02707861|4011258|FG000|Overall Study|Physician Decision|1
2308092|NCT02707861|4011259|FG001|Overall Study|Physician Decision|4
2308093|NCT02707861|4011258|FG000|Overall Study|Withdrawal by Subject|2
2308094|NCT02707861|4011259|FG001|Overall Study|Withdrawal by Subject|1
2308095|NCT02707861|4011258|FG000|Overall Study|Lost to Follow-up|1
2308096|NCT02707861|4011259|FG001|Overall Study|Lost to Follow-up|3
2308097|NCT02707952|4011269|FG000|Overall Study|Adverse Event|1
2308098|NCT02707952|4011270|FG001|Overall Study|Adverse Event|0
2308099|NCT02707952|4011271|FG002|Overall Study|Adverse Event|0
2308100|NCT02707952|4011272|FG003|Overall Study|Adverse Event|0
2308101|NCT02707952|4011269|FG000|Overall Study|Lost to Follow-up|1
2308102|NCT02707952|4011270|FG001|Overall Study|Lost to Follow-up|0
2308103|NCT02707952|4011271|FG002|Overall Study|Lost to Follow-up|0
2308104|NCT02707952|4011272|FG003|Overall Study|Lost to Follow-up|0
2308105|NCT02707952|4011269|FG000|Overall Study|Withdrawal by Subject|0
2308106|NCT02707952|4011270|FG001|Overall Study|Withdrawal by Subject|1
2308107|NCT02707952|4011271|FG002|Overall Study|Withdrawal by Subject|2
2308108|NCT02707952|4011272|FG003|Overall Study|Withdrawal by Subject|0
2308109|NCT02707965|4011293|FG000|Overall Study|Withdrawal by Subject|0
2308110|NCT02707965|4011294|FG001|Overall Study|Withdrawal by Subject|0
2308111|NCT02707965|4011295|FG002|Overall Study|Withdrawal by Subject|1
2308112|NCT02707965|4011296|FG003|Overall Study|Withdrawal by Subject|0
2308113|NCT02707965|4011297|FG004|Overall Study|Withdrawal by Subject|0
2308114|NCT02707965|4011298|FG005|Overall Study|Withdrawal by Subject|0
2308115|NCT02707965|4011299|FG006|Overall Study|Withdrawal by Subject|0
2308116|NCT02707965|4011300|FG007|Overall Study|Withdrawal by Subject|2
2308117|NCT02707965|4011301|FG008|Overall Study|Withdrawal by Subject|0
2308118|NCT02707965|4011302|FG009|Overall Study|Withdrawal by Subject|0
2308119|NCT02707965|4011303|FG010|Overall Study|Withdrawal by Subject|0
2308120|NCT02707965|4011304|FG011|Overall Study|Withdrawal by Subject|0
2308121|NCT02707965|4011305|FG012|Overall Study|Withdrawal by Subject|0
2308122|NCT02707965|4011306|FG013|Overall Study|Withdrawal by Subject|0
2308123|NCT02707965|4011307|FG014|Overall Study|Withdrawal by Subject|0
2308124|NCT02707965|4011308|FG015|Overall Study|Withdrawal by Subject|0
2308125|NCT02707965|4011293|FG000|Overall Study|PI decisions|0
2308126|NCT02707965|4011294|FG001|Overall Study|PI decisions|0
2308127|NCT02707965|4011295|FG002|Overall Study|PI decisions|0
2308128|NCT02707965|4011296|FG003|Overall Study|PI decisions|0
2308129|NCT02707965|4011297|FG004|Overall Study|PI decisions|0
2308130|NCT02707965|4011298|FG005|Overall Study|PI decisions|0
2308131|NCT02707965|4011299|FG006|Overall Study|PI decisions|0
2308132|NCT02707965|4011300|FG007|Overall Study|PI decisions|0
2308133|NCT02707965|4011301|FG008|Overall Study|PI decisions|0
2308134|NCT02707965|4011302|FG009|Overall Study|PI decisions|0
2308135|NCT02707965|4011303|FG010|Overall Study|PI decisions|0
2308136|NCT02707965|4011304|FG011|Overall Study|PI decisions|0
2308137|NCT02707965|4011305|FG012|Overall Study|PI decisions|0
2308138|NCT02707965|4011306|FG013|Overall Study|PI decisions|0
2308139|NCT02707965|4011307|FG014|Overall Study|PI decisions|2
2308140|NCT02707965|4011308|FG015|Overall Study|PI decisions|0
2308141|NCT02707965|4011293|FG000|Overall Study|Protocol deviation|1
2308142|NCT02707965|4011294|FG001|Overall Study|Protocol deviation|1
2308143|NCT02707965|4011295|FG002|Overall Study|Protocol deviation|0
2308144|NCT02707965|4011296|FG003|Overall Study|Protocol deviation|0
2308145|NCT02707965|4011297|FG004|Overall Study|Protocol deviation|0
2308146|NCT02707965|4011298|FG005|Overall Study|Protocol deviation|0
2308147|NCT02707965|4011299|FG006|Overall Study|Protocol deviation|0
2308148|NCT02707965|4011300|FG007|Overall Study|Protocol deviation|1
2308149|NCT02707965|4011301|FG008|Overall Study|Protocol deviation|0
2308150|NCT02707965|4011302|FG009|Overall Study|Protocol deviation|0
2308151|NCT02707965|4011303|FG010|Overall Study|Protocol deviation|0
2308152|NCT02707965|4011304|FG011|Overall Study|Protocol deviation|0
2308153|NCT02707965|4011305|FG012|Overall Study|Protocol deviation|0
2308154|NCT02707965|4011306|FG013|Overall Study|Protocol deviation|0
2308155|NCT02707965|4011307|FG014|Overall Study|Protocol deviation|0
2308156|NCT02707965|4011308|FG015|Overall Study|Protocol deviation|0
2308157|NCT02707991|4011343|FG000|Overall Study|Protocol Violation|1
2308158|NCT02707991|4011344|FG001|Overall Study|Protocol Violation|0
2308159|NCT02707991|4011343|FG000|Overall Study|Became ineligible|0
2308160|NCT02707991|4011344|FG001|Overall Study|Became ineligible|1
2308161|NCT02708095|4011353|FG000|Overall Study|Adverse Event|4
2308162|NCT02708095|4011354|FG001|Overall Study|Adverse Event|10
2308163|NCT02708095|4011355|FG002|Overall Study|Adverse Event|11
2308164|NCT02708095|4011353|FG000|Overall Study|Lack of Efficacy|9
2308165|NCT02708095|4011354|FG001|Overall Study|Lack of Efficacy|3
2354936|NCT00851682|4112332|FG000|Overall Study|screen failure|5
2308166|NCT02708095|4011355|FG002|Overall Study|Lack of Efficacy|0
2308167|NCT02708095|4011353|FG000|Overall Study|Lost to Follow-up|2
2354937|NCT00851682|4112333|FG001|Overall Study|screen failure|0
2354938|NCT00851747|4112355|FG000|Overall Study|Physician Decision|6
2354939|NCT00851747|4112356|FG001|Overall Study|Physician Decision|6
2354940|NCT00851747|4112357|FG002|Overall Study|Physician Decision|6
2354941|NCT00852241|4112364|FG000|Overall Study|Physician Decision|18
2354942|NCT00851552|4112368|FG000|Overall Study|Death|2
2354943|NCT00851552|4112368|FG000|Overall Study|Adverse Event|1
2354944|NCT00851552|4112368|FG000|Overall Study|Disease Progression|4
2354945|NCT00845845|4112378|FG000|Overall Study|Lost to Follow-up|0
2354946|NCT00845845|4112379|FG001|Overall Study|Lost to Follow-up|4
2354947|NCT00851591|4112387|FG000|Overall Study|Withdrawal by Subject|2
2354948|NCT00851591|4112388|FG001|Overall Study|Withdrawal by Subject|0
2019926|NCT00302718|3587387|FG001|Overall Study|Participant left primary care setting|0
2019927|NCT00302718|3587388|FG002|Overall Study|Participant left primary care setting|2
2019928|NCT00302718|3587389|FG003|Overall Study|Participant left primary care setting|1
2019929|NCT00302731|3587408|FG000|Overall Study|Lost to Follow-up|1
2019930|NCT00302731|3587409|FG001|Overall Study|Lost to Follow-up|2
2019931|NCT00302731|3587410|FG002|Overall Study|Lost to Follow-up|0
2019932|NCT00302731|3587411|FG003|Overall Study|Lost to Follow-up|0
2102048|NCT00836186|3693624|FG000|Overall Study|Blood could not be drawn|1
2019933|NCT00302731|3587408|FG000|Overall Study|Adverse Event|0
2019934|NCT00302731|3587409|FG001|Overall Study|Adverse Event|2
2019935|NCT00302731|3587410|FG002|Overall Study|Adverse Event|2
2019936|NCT00302731|3587411|FG003|Overall Study|Adverse Event|0
2019937|NCT00302731|3587408|FG000|Overall Study|Withdrawal by Subject|1
2019938|NCT00302731|3587409|FG001|Overall Study|Withdrawal by Subject|1
2019939|NCT00302731|3587410|FG002|Overall Study|Withdrawal by Subject|0
2019940|NCT00302731|3587411|FG003|Overall Study|Withdrawal by Subject|0
2019941|NCT00302731|3587408|FG000|Overall Study|Protocol Violation|1
2019942|NCT00302731|3587409|FG001|Overall Study|Protocol Violation|0
2019943|NCT00302731|3587410|FG002|Overall Study|Protocol Violation|0
2019944|NCT00302731|3587411|FG003|Overall Study|Protocol Violation|0
2019945|NCT00302731|3587408|FG000|Overall Study|cancer unrelated to study discovered|1
2019946|NCT00302731|3587409|FG001|Overall Study|cancer unrelated to study discovered|0
2019947|NCT00302731|3587410|FG002|Overall Study|cancer unrelated to study discovered|1
2354949|NCT00835679|4112425|FG000|Overall Study|Withdrawal by Subject|1
2308168|NCT02708095|4011354|FG001|Overall Study|Lost to Follow-up|0
2308169|NCT02708095|4011355|FG002|Overall Study|Lost to Follow-up|0
2308170|NCT02708095|4011353|FG000|Overall Study|Physician Decision|2
2308171|NCT02708095|4011354|FG001|Overall Study|Physician Decision|3
2308172|NCT02708095|4011355|FG002|Overall Study|Physician Decision|2
2308173|NCT02708095|4011353|FG000|Overall Study|Protocol Violation|0
2308174|NCT02708095|4011354|FG001|Overall Study|Protocol Violation|0
2308175|NCT02708095|4011355|FG002|Overall Study|Protocol Violation|1
2308176|NCT02708095|4011353|FG000|Overall Study|Withdrawal by Subject|5
2308177|NCT02708095|4011354|FG001|Overall Study|Withdrawal by Subject|3
2308178|NCT02708095|4011355|FG002|Overall Study|Withdrawal by Subject|4
2308179|NCT02708121|4011367|FG000|Overall Study|Withdrawn by Study Team|1
2308180|NCT02708121|4011368|FG001|Overall Study|Withdrawn by Study Team|1
2308181|NCT02708121|4011367|FG000|Overall Study|Withdrawal by Subject|0
2308182|NCT02708121|4011368|FG001|Overall Study|Withdrawal by Subject|4
2308183|NCT02708277|4011411|FG000|Overall Study|Lost to Follow-up|7
2308184|NCT02708277|4011412|FG001|Overall Study|Lost to Follow-up|4
2308185|NCT02708355|4011430|FG000|Overall Study|Adverse Event|1
2308186|NCT02708355|4011431|FG001|Overall Study|Adverse Event|0
2308187|NCT02708355|4011432|FG002|Overall Study|Adverse Event|0
2308188|NCT02708485|4011449|FG000|Overall Study|Withdrawal by Subject|3
2308189|NCT02708485|4011450|FG001|Overall Study|Withdrawal by Subject|2
2308190|NCT02708498|4011464|FG000|Overall Study|Death|20
2308191|NCT02708498|4011465|FG001|Overall Study|Death|19
2308192|NCT02708498|4011466|FG002|Overall Study|Death|0
2308193|NCT02708498|4011467|FG003|Overall Study|Death|0
2308194|NCT02708498|4011468|FG004|Overall Study|Death|1
2308195|NCT02708498|4011469|FG005|Overall Study|Death|0
2308196|NCT02708498|4011470|FG006|Overall Study|Death|0
2308197|NCT02708498|4011471|FG007|Overall Study|Death|0
2308198|NCT02708498|4011464|FG000|Overall Study|Unknown reason, missing data|0
2308199|NCT02708498|4011465|FG001|Overall Study|Unknown reason, missing data|0
2308200|NCT02708498|4011466|FG002|Overall Study|Unknown reason, missing data|62
2308201|NCT02708498|4011467|FG003|Overall Study|Unknown reason, missing data|51
2308202|NCT02708498|4011468|FG004|Overall Study|Unknown reason, missing data|195
2308203|NCT02708498|4011469|FG005|Overall Study|Unknown reason, missing data|132
2308204|NCT02708498|4011470|FG006|Overall Study|Unknown reason, missing data|0
2308205|NCT02708498|4011471|FG007|Overall Study|Unknown reason, missing data|0
2308206|NCT02708524|4011491|FG000|Overall Study|Adverse Event|0
2308207|NCT02708524|4011492|FG001|Overall Study|Adverse Event|1
2308208|NCT02708524|4011493|FG002|Overall Study|Adverse Event|0
2308209|NCT02708524|4011494|FG003|Overall Study|Adverse Event|0
2308210|NCT02708524|4011491|FG000|Overall Study|Lens Discomfort|1
2308211|NCT02708524|4011492|FG001|Overall Study|Lens Discomfort|0
2308212|NCT02708524|4011493|FG002|Overall Study|Lens Discomfort|1
2308213|NCT02708524|4011494|FG003|Overall Study|Lens Discomfort|0
2308214|NCT02708524|4011491|FG000|Overall Study|Lost to Follow-up|1
2308215|NCT02708524|4011492|FG001|Overall Study|Lost to Follow-up|1
2308216|NCT02708524|4011493|FG002|Overall Study|Lost to Follow-up|1
2308217|NCT02708524|4011494|FG003|Overall Study|Lost to Follow-up|0
2308218|NCT02708524|4011491|FG000|Overall Study|Protocol Violation|0
2308219|NCT02708524|4011492|FG001|Overall Study|Protocol Violation|1
2308220|NCT02708524|4011493|FG002|Overall Study|Protocol Violation|0
2308221|NCT02708524|4011494|FG003|Overall Study|Protocol Violation|0
2308222|NCT02708524|4011491|FG000|Overall Study|Withdrawal by Subject|1
2308223|NCT02708524|4011492|FG001|Overall Study|Withdrawal by Subject|1
2308224|NCT02708524|4011493|FG002|Overall Study|Withdrawal by Subject|0
2308225|NCT02708524|4011494|FG003|Overall Study|Withdrawal by Subject|0
2308226|NCT02708524|4011491|FG000|Overall Study|Dispensed incorrect study lens|0
2308227|NCT02708524|4011492|FG001|Overall Study|Dispensed incorrect study lens|1
2308228|NCT02708524|4011493|FG002|Overall Study|Dispensed incorrect study lens|1
2308229|NCT02708524|4011494|FG003|Overall Study|Dispensed incorrect study lens|0
2308230|NCT02708524|4011491|FG000|Overall Study|Did not wear lens at final visit|0
2308231|NCT02708524|4011492|FG001|Overall Study|Did not wear lens at final visit|1
2308232|NCT02708524|4011493|FG002|Overall Study|Did not wear lens at final visit|0
2308233|NCT02708524|4011494|FG003|Overall Study|Did not wear lens at final visit|0
2308234|NCT02708524|4011491|FG000|Overall Study|Subject lost study lens|1
2308235|NCT02708524|4011492|FG001|Overall Study|Subject lost study lens|0
2308236|NCT02708524|4011493|FG002|Overall Study|Subject lost study lens|0
2308237|NCT02708524|4011494|FG003|Overall Study|Subject lost study lens|0
2308238|NCT02708966|4011536|FG000|Overall Study|Lost to Follow-up|2
2308239|NCT02708966|4011537|FG001|Overall Study|Lost to Follow-up|2
2308240|NCT02709005|4011545|FG000|Overall Study|Lost to Follow-up|1
2308241|NCT02709005|4011546|FG001|Overall Study|Lost to Follow-up|1
2308242|NCT02709005|4011545|FG000|Overall Study|Withdrawal by Subject|3
2308243|NCT02709005|4011546|FG001|Overall Study|Withdrawal by Subject|0
2308244|NCT02709096|4011565|FG000|Overall Study|non-compliance|1
2308245|NCT02709096|4011566|FG001|Overall Study|non-compliance|1
2308246|NCT02709109|4011576|FG000|Treatment Period 1 (28 Days)|Adverse Event|3
2308247|NCT02709109|4011577|FG001|Treatment Period 1 (28 Days)|Adverse Event|3
2308248|NCT02709109|4011578|FG002|Treatment Period 1 (28 Days)|Adverse Event|1
2308249|NCT02709109|4011579|FG003|Treatment Period 1 (28 Days)|Adverse Event|0
2354950|NCT00835679|4112426|FG001|Overall Study|Withdrawal by Subject|0
2354951|NCT00835679|4112427|FG002|Overall Study|Withdrawal by Subject|0
2354952|NCT00835679|4112428|FG003|Overall Study|Withdrawal by Subject|0
2354953|NCT00841035|4112442|FG000|Phase 1 Overall Study|Physician Decision|13
2354954|NCT00840827|4112460|FG000|Overall Study|Adverse Event|1
2354955|NCT00840827|4112460|FG000|Overall Study|Lack of Efficacy|4
2354956|NCT00840827|4112460|FG000|Overall Study|Physician Decision|1
2354957|NCT00832624|4112494|FG000|Overall Study|Study Terminated|10
2354958|NCT00827567|4112537|FG000|Overall Study|Progression of Disease/Screen Failure|4
2354959|NCT00815633|4112541|FG000|Overall Study|study terminated|1
2354960|NCT00814983|4112547|FG000|Overall Study|Screen failure|1
2354961|NCT00814983|4112548|FG001|Overall Study|Screen failure|0
2354962|NCT00814983|4112547|FG000|Overall Study|Withdrawal by Subject|1
2354963|NCT00814983|4112548|FG001|Overall Study|Withdrawal by Subject|0
2354964|NCT00814983|4112547|FG000|Overall Study|Graft failure|1
2354965|NCT00814983|4112548|FG001|Overall Study|Graft failure|0
2354966|NCT00819832|4112571|FG000|Overall Study|Sponsor Termination of Study|3
2354967|NCT00819832|4112572|FG001|Overall Study|Sponsor Termination of Study|0
2354968|NCT00819832|4112573|FG002|Overall Study|Sponsor Termination of Study|0
2354969|NCT00819832|4112574|FG003|Overall Study|Sponsor Termination of Study|0
2354970|NCT00819832|4112575|FG004|Overall Study|Sponsor Termination of Study|0
2354971|NCT00819832|4112576|FG005|Overall Study|Sponsor Termination of Study|0
2354972|NCT00814892|4112599|FG000|Overall Study|Disease Progression|1
2354973|NCT00814892|4112599|FG000|Overall Study|Study Termination|1
2354974|NCT00802659|4112616|FG000|Overall Study|Physician Decision|0
2354975|NCT00802659|4112617|FG001|Overall Study|Physician Decision|1
2354976|NCT00802659|4112618|FG002|Overall Study|Physician Decision|0
2354977|NCT00802659|4112619|FG003|Overall Study|Physician Decision|0
2354978|NCT00807365|4112629|FG000|Overall Study|Study Terminated|5
2354979|NCT00814333|4112635|FG000|Enrollment|Lost to Follow-up|1
2354980|NCT00814333|4112636|FG001|Enrollment|Lost to Follow-up|0
2354981|NCT00808080|4112642|FG000|Overall Study|Patients Became Ineligible for infusion|6
2354982|NCT00802893|4112647|FG000|Overall Study|study terminated|3
2354983|NCT00809341|4112653|FG000|Overall Study|Physician Decision|0
2354984|NCT00809341|4112654|FG001|Overall Study|Physician Decision|1
2354985|NCT00808899|4112682|FG000|Overall Study|Death|1
2354986|NCT00808899|4112682|FG000|Overall Study|Physician Decision|3
2354987|NCT00803179|4112693|FG000|Overall Study|Lost to Follow-up|3
2308250|NCT02709109|4011576|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0
2308251|NCT02709109|4011577|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2
2308252|NCT02709109|4011578|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0
2308253|NCT02709109|4011579|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0
2308254|NCT02709109|4011576|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1
2308255|NCT02709109|4011577|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
2308256|NCT02709109|4011578|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
2308257|NCT02709109|4011579|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
2308258|NCT02709109|4011576|FG000|Washout Period (28 Days)|Other|2
2308259|NCT02709109|4011577|FG001|Washout Period (28 Days)|Other|2
2308260|NCT02709109|4011578|FG002|Washout Period (28 Days)|Other|3
2308261|NCT02709109|4011579|FG003|Washout Period (28 Days)|Other|0
2308262|NCT02709109|4011576|FG000|Treatment Period 2 (28 Days)|Adverse Event|2
2308263|NCT02709109|4011577|FG001|Treatment Period 2 (28 Days)|Adverse Event|3
2308264|NCT02709109|4011578|FG002|Treatment Period 2 (28 Days)|Adverse Event|0
2308265|NCT02709109|4011579|FG003|Treatment Period 2 (28 Days)|Adverse Event|0
2308266|NCT02709109|4011576|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0
2308267|NCT02709109|4011577|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1
2308268|NCT02709109|4011578|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1
2308269|NCT02709109|4011579|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0
2308270|NCT02709109|4011576|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0
2308271|NCT02709109|4011577|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0
2308272|NCT02709109|4011578|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1
2308273|NCT02709109|4011579|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0
2308274|NCT02709109|4011576|FG000|Treatment Period 2 (28 Days)|Other|0
2308275|NCT02709109|4011577|FG001|Treatment Period 2 (28 Days)|Other|0
2308276|NCT02709109|4011578|FG002|Treatment Period 2 (28 Days)|Other|1
2308277|NCT02709109|4011579|FG003|Treatment Period 2 (28 Days)|Other|0
2308278|NCT02709330|4011590|FG000|Overall Study|Death|5
2308279|NCT02709330|4011591|FG001|Overall Study|Death|0
2308280|NCT02709330|4011590|FG000|Overall Study|Lost to Follow-up|2
2308281|NCT02709330|4011591|FG001|Overall Study|Lost to Follow-up|0
2308282|NCT02709330|4011590|FG000|Overall Study|Physician Decision|2
2308283|NCT02709330|4011591|FG001|Overall Study|Physician Decision|0
2308284|NCT02709330|4011590|FG000|Overall Study|Withdrawal by Subject|4
2354988|NCT00790452|4112732|FG000|Overall Study|Drug supply issue|1
2354989|NCT00790452|4112733|FG001|Overall Study|Drug supply issue|0
2354990|NCT00787917|4112745|FG000|Blinded Treatment|Adverse Event|1
2354991|NCT00787917|4112746|FG001|Blinded Treatment|Adverse Event|0
2354992|NCT00787917|4112745|FG000|Blinded Treatment|Lack of Efficacy|1
2354993|NCT00787917|4112746|FG001|Blinded Treatment|Lack of Efficacy|0
2354994|NCT00787917|4112745|FG000|Blinded Treatment|Administrative problems|3
2354995|NCT00787917|4112746|FG001|Blinded Treatment|Administrative problems|2
2354996|NCT00787917|4112745|FG000|Open Label|Unsatisfactory therapeutic effect|1
2354997|NCT00787917|4112746|FG001|Open Label|Unsatisfactory therapeutic effect|0
2354998|NCT00787917|4112745|FG000|Open Label|Administrative problems|3
2354999|NCT00787917|4112746|FG001|Open Label|Administrative problems|0
2355000|NCT00798590|4112756|FG000|Overall Study|P.I, Left institution. Study terminated|11
2355001|NCT00798590|4112757|FG001|Overall Study|P.I, Left institution. Study terminated|8
2355002|NCT00796510|4112765|FG000|Overall Study|Death|1
2355003|NCT00796510|4112766|FG001|Overall Study|Death|0
2355004|NCT00796510|4112765|FG000|Overall Study|Study Terminated|2
2355005|NCT00796510|4112766|FG001|Overall Study|Study Terminated|0
2355006|NCT00796861|4112772|FG000|Overall Study|Withdrawal by Subject|2
2355007|NCT00796861|4112772|FG000|Overall Study|Death|2
2355008|NCT00791076|4112776|FG000|Overall Study|Study was terminated,PI left institution|8
2355009|NCT00796107|4112791|FG000|Overall Study|Lack of Efficacy|1
2355010|NCT00796107|4112791|FG000|Overall Study|Progressive Disease|5
2355011|NCT00785356|4112815|FG000|Overall Study|Study prematurely terminated|8
2355012|NCT00782483|4112823|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6
2355013|NCT00784043|4112833|FG000|Overall Study|Withdrawal by Subject|8
2355014|NCT00784043|4112834|FG001|Overall Study|Withdrawal by Subject|5
2355015|NCT00784043|4112833|FG000|Overall Study|Protocol Terminated|23
2355016|NCT00784043|4112834|FG001|Overall Study|Protocol Terminated|1
2355017|NCT00774306|4112857|FG000|Overall Study|Adverse Event|3
2355018|NCT00774306|4112858|FG001|Overall Study|Adverse Event|0
2355019|NCT00774306|4112859|FG002|Overall Study|Adverse Event|0
2308285|NCT02709330|4011591|FG001|Overall Study|Withdrawal by Subject|0
2308286|NCT02709369|4011597|FG000|Overall Study|Lost to Follow-up|15
2308287|NCT02709369|4011597|FG000|Overall Study|Withdrawal by Subject|10
2308288|NCT02709369|4011597|FG000|Overall Study|Did not received intervention|2
2308289|NCT02709486|4011604|FG000|Overall Study|Adverse Event|2
2308290|NCT02709486|4011605|FG001|Overall Study|Adverse Event|5
2308291|NCT02709486|4011606|FG002|Overall Study|Adverse Event|3
2308292|NCT02709486|4011604|FG000|Overall Study|Death|0
2308293|NCT02709486|4011605|FG001|Overall Study|Death|0
2308294|NCT02709486|4011606|FG002|Overall Study|Death|2
2308295|NCT02709486|4011604|FG000|Overall Study|Insufficient clinical response|7
2308296|NCT02709486|4011605|FG001|Overall Study|Insufficient clinical response|3
2308297|NCT02709486|4011606|FG002|Overall Study|Insufficient clinical response|3
2308298|NCT02709486|4011604|FG000|Overall Study|Lost to Follow-up|3
2308299|NCT02709486|4011605|FG001|Overall Study|Lost to Follow-up|2
2308300|NCT02709486|4011606|FG002|Overall Study|Lost to Follow-up|2
2308301|NCT02709486|4011604|FG000|Overall Study|Other|0
2308302|NCT02709486|4011605|FG001|Overall Study|Other|2
2308303|NCT02709486|4011606|FG002|Overall Study|Other|3
2308304|NCT02709486|4011604|FG000|Overall Study|Withdrawal by Subject|32
2308305|NCT02709486|4011605|FG001|Overall Study|Withdrawal by Subject|22
2308306|NCT02709486|4011606|FG002|Overall Study|Withdrawal by Subject|32
2308307|NCT02709538|4011617|FG000|Overall Study|Adverse Event|13
2308308|NCT02709538|4011618|FG001|Overall Study|Adverse Event|2
2308309|NCT02709538|4011619|FG002|Overall Study|Adverse Event|3
2308310|NCT02709538|4011617|FG000|Overall Study|Lack of Efficacy|1
2308311|NCT02709538|4011618|FG001|Overall Study|Lack of Efficacy|0
2308312|NCT02709538|4011619|FG002|Overall Study|Lack of Efficacy|0
2308313|NCT02709538|4011617|FG000|Overall Study|Lost to Follow-up|24
2308314|NCT02709538|4011618|FG001|Overall Study|Lost to Follow-up|8
2308315|NCT02709538|4011619|FG002|Overall Study|Lost to Follow-up|4
2308316|NCT02709538|4011617|FG000|Overall Study|Physician Decision|1
2308317|NCT02709538|4011618|FG001|Overall Study|Physician Decision|0
2308318|NCT02709538|4011619|FG002|Overall Study|Physician Decision|0
2308319|NCT02709538|4011617|FG000|Overall Study|Withdrawal by Subject|40
2308320|NCT02709538|4011618|FG001|Overall Study|Withdrawal by Subject|7
2308321|NCT02709538|4011619|FG002|Overall Study|Withdrawal by Subject|4
2308322|NCT02709538|4011617|FG000|Overall Study|Non-compliance with study procedures|5
2308323|NCT02709538|4011618|FG001|Overall Study|Non-compliance with study procedures|0
2308324|NCT02709538|4011619|FG002|Overall Study|Non-compliance with study procedures|0
2355020|NCT00774306|4112860|FG003|Overall Study|Adverse Event|0
2355021|NCT00774306|4112857|FG000|Overall Study|Protocol Violation|2
2355022|NCT00774306|4112858|FG001|Overall Study|Protocol Violation|0
2355023|NCT00774306|4112859|FG002|Overall Study|Protocol Violation|3
2355024|NCT00774306|4112860|FG003|Overall Study|Protocol Violation|0
2355025|NCT00774306|4112857|FG000|Overall Study|Withdrawal by Subject|6
2355026|NCT00774306|4112858|FG001|Overall Study|Withdrawal by Subject|1
2355027|NCT00774306|4112859|FG002|Overall Study|Withdrawal by Subject|1
2355028|NCT00774306|4112860|FG003|Overall Study|Withdrawal by Subject|0
2355029|NCT00774306|4112857|FG000|Overall Study|Lost to Follow-up|6
2355030|NCT00774306|4112858|FG001|Overall Study|Lost to Follow-up|0
2355031|NCT00774306|4112859|FG002|Overall Study|Lost to Follow-up|4
2355032|NCT00774306|4112860|FG003|Overall Study|Lost to Follow-up|5
2355033|NCT00774306|4112857|FG000|Overall Study|Death|1
2355034|NCT00774306|4112858|FG001|Overall Study|Death|1
2355035|NCT00774306|4112859|FG002|Overall Study|Death|0
2355036|NCT00774306|4112860|FG003|Overall Study|Death|0
2355037|NCT00779038|4112883|FG000|Overall Study|Study Prematurely Terminated|13
2355038|NCT00776100|4112898|FG000|Overall Study|Disease Progression|1
2355039|NCT00776100|4112899|FG001|Overall Study|Disease Progression|0
2355040|NCT00771316|4112907|FG000|Overall Study|Adverse Event|0
2355041|NCT00771316|4112908|FG001|Overall Study|Adverse Event|1
2355042|NCT00771316|4112907|FG000|Overall Study|Patient withdrew consent|1
2355043|NCT00771316|4112908|FG001|Overall Study|Patient withdrew consent|0
2355044|NCT00771316|4112907|FG000|Overall Study|Discontinued due to early termination|1
2355045|NCT00771316|4112908|FG001|Overall Study|Discontinued due to early termination|0
2355046|NCT00768040|4112929|FG000|Overall Study|Adverse Event|3
2355047|NCT00768040|4112930|FG001|Overall Study|Adverse Event|2
2355048|NCT00768040|4112929|FG000|Overall Study|Abnormal laboratory value|1
2355049|NCT00768040|4112930|FG001|Overall Study|Abnormal laboratory value|1
2355050|NCT00776555|4112938|FG000|Overall Study|Study terminated|3
2355051|NCT00776555|4112939|FG001|Overall Study|Study terminated|0
2355052|NCT00775190|4112947|FG000|Overall Study|Lost to Follow-up|2
2355053|NCT00775190|4112948|FG001|Overall Study|Lost to Follow-up|3
2308325|NCT02709538|4011617|FG000|Overall Study|Non-compliance with study drug|2
2308326|NCT02709538|4011618|FG001|Overall Study|Non-compliance with study drug|0
2308327|NCT02709538|4011619|FG002|Overall Study|Non-compliance with study drug|0
2308328|NCT02709538|4011617|FG000|Overall Study|Protocol deviation|10
2308329|NCT02709538|4011618|FG001|Overall Study|Protocol deviation|4
2308330|NCT02709538|4011619|FG002|Overall Study|Protocol deviation|4
2308331|NCT02709538|4011617|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1
2308332|NCT02709538|4011618|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0
2308333|NCT02709538|4011619|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0
2308334|NCT02709538|4011617|FG000|Overall Study|Other|16
2308335|NCT02709538|4011618|FG001|Overall Study|Other|7
2308336|NCT02709538|4011619|FG002|Overall Study|Other|5
2308337|NCT02709577|4011629|FG000|Overall Study|non-accommodating anatomy|0
2308338|NCT02709577|4011630|FG001|Overall Study|non-accommodating anatomy|1
2308339|NCT02709577|4011631|FG002|Overall Study|non-accommodating anatomy|0
2308340|NCT02709577|4011632|FG003|Overall Study|non-accommodating anatomy|0
2308341|NCT02709577|4011629|FG000|Overall Study|procedural complication|0
2308342|NCT02709577|4011630|FG001|Overall Study|procedural complication|1
2308343|NCT02709577|4011631|FG002|Overall Study|procedural complication|0
2308344|NCT02709577|4011632|FG003|Overall Study|procedural complication|0
2308345|NCT02709577|4011629|FG000|Overall Study|Withdrawal by Subject|2
2308346|NCT02709577|4011630|FG001|Overall Study|Withdrawal by Subject|3
2308347|NCT02709577|4011631|FG002|Overall Study|Withdrawal by Subject|2
2308348|NCT02709577|4011632|FG003|Overall Study|Withdrawal by Subject|0
2308349|NCT02709746|4011662|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4
2308350|NCT02709746|4011663|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0
2308351|NCT02709746|4011664|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0
2308352|NCT02709746|4011665|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0
2308353|NCT02709746|4011666|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0
2308354|NCT02709746|4011662|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14
2308355|NCT02709746|4011663|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0
2308356|NCT02709746|4011664|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0
2308357|NCT02709746|4011665|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0
2308358|NCT02709746|4011666|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0
2308359|NCT02709746|4011662|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12
2308360|NCT02709746|4011663|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
2308361|NCT02709746|4011664|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
2308362|NCT02709746|4011665|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
2308363|NCT02709746|4011666|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
2308364|NCT02709746|4011662|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7
2308365|NCT02709746|4011663|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
2308366|NCT02709746|4011664|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
2308367|NCT02709746|4011665|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
2308368|NCT02709746|4011666|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
2355054|NCT00775190|4112947|FG000|Overall Study|Withdrawal by Subject|1
2355055|NCT00775190|4112948|FG001|Overall Study|Withdrawal by Subject|2
2355056|NCT00775190|4112947|FG000|Overall Study|Protocol Violation|1
2355057|NCT00775190|4112948|FG001|Overall Study|Protocol Violation|0
2355058|NCT00762723|4112961|FG000|Overall Study|Study Terminated slow enrollement|5
2355059|NCT00762723|4112962|FG001|Overall Study|Study Terminated slow enrollement|5
2355060|NCT00762723|4112963|FG002|Overall Study|Study Terminated slow enrollement|3
2355061|NCT00770965|4112975|FG000|Safety Set|Withdrawal by Subject|0
2355062|NCT00770965|4112976|FG001|Safety Set|Withdrawal by Subject|0
2355063|NCT00770965|4112977|FG002|Safety Set|Withdrawal by Subject|0
2355064|NCT00770965|4112978|FG003|Safety Set|Withdrawal by Subject|1
2355065|NCT00770965|4112975|FG000|Safety Set|Protocol deviation|0
2355066|NCT00770965|4112976|FG001|Safety Set|Protocol deviation|0
2355067|NCT00770965|4112977|FG002|Safety Set|Protocol deviation|1
2355068|NCT00770965|4112978|FG003|Safety Set|Protocol deviation|0
2355069|NCT00770965|4112975|FG000|Excluded Set|Administrative problems|14
2355070|NCT00770965|4112976|FG001|Excluded Set|Administrative problems|12
2355071|NCT00770965|4112977|FG002|Excluded Set|Administrative problems|12
2355072|NCT00770965|4112978|FG003|Excluded Set|Administrative problems|10
2355073|NCT00770965|4112975|FG000|Excluded Set|Withdrawal by Subject|1
2355074|NCT00770965|4112976|FG001|Excluded Set|Withdrawal by Subject|1
2355075|NCT00770965|4112977|FG002|Excluded Set|Withdrawal by Subject|2
2355076|NCT00770965|4112978|FG003|Excluded Set|Withdrawal by Subject|3
2355077|NCT00769002|4112992|FG000|Overall Study|Study was not completed, no data|9
2355078|NCT00769002|4112993|FG001|Overall Study|Study was not completed, no data|9
2355079|NCT00766636|4113000|FG000|Overall Study|Withdrawal by Subject|1
2355080|NCT00766636|4113001|FG001|Overall Study|Withdrawal by Subject|1
2355081|NCT00766636|4113000|FG000|Overall Study|Incomplete Treatment|0
2355082|NCT00766636|4113001|FG001|Overall Study|Incomplete Treatment|1
2355083|NCT00766636|4113000|FG000|Overall Study|Adverse Event|1
2355084|NCT00766636|4113001|FG001|Overall Study|Adverse Event|0
2355085|NCT00766636|4113000|FG000|Overall Study|Disease Progression|1
2355086|NCT00766636|4113001|FG001|Overall Study|Disease Progression|0
2355087|NCT00768248|4113009|FG000|Overall Study|Research coordinator didn't collect data|1
2355088|NCT00768248|4113010|FG001|Overall Study|Research coordinator didn't collect data|1
2355089|NCT00764699|4113020|FG000|Overall Study|PI left and study terminated|3
2355090|NCT00763009|4113028|FG000|Overall Study|Coronary Anatomy unsuitable|1
2355091|NCT00761176|4113035|FG000|Overall Study|Death|1
2355092|NCT00761176|4113036|FG001|Overall Study|Death|0
2355093|NCT00761176|4113035|FG000|Overall Study|Withdrawal by Subject|1
2355094|NCT00761176|4113036|FG001|Overall Study|Withdrawal by Subject|1
2355095|NCT00754793|4113061|FG000|Overall Study|voluntary withdrawn from study|0
2355096|NCT00754793|4113062|FG001|Overall Study|voluntary withdrawn from study|1
2355097|NCT00754052|4113070|FG000|Overall Study|Study terminated by Sponsor|5
2355098|NCT00754052|4113071|FG001|Overall Study|Study terminated by Sponsor|3
2355099|NCT00750204|4113093|FG000|Overall Study|study halted prematurely|1
2355100|NCT00750204|4113094|FG001|Overall Study|study halted prematurely|1
2355101|NCT00752986|4113116|FG000|Overall Study|Withdrawal by Subject|2
2355102|NCT00752986|4113117|FG001|Overall Study|Withdrawal by Subject|1
2355103|NCT00752986|4113118|FG002|Overall Study|Withdrawal by Subject|2
2355104|NCT00752986|4113116|FG000|Overall Study|Protocol Violation|3
2355105|NCT00752986|4113117|FG001|Overall Study|Protocol Violation|0
2019948|NCT00302731|3587411|FG003|Overall Study|cancer unrelated to study discovered|0
2019949|NCT00302952|3587435|FG000|Overall Study|Physician Decision|1
2019950|NCT00302952|3587436|FG001|Overall Study|Physician Decision|1
2019951|NCT00302952|3587435|FG000|Overall Study|Withdrawal by Subject|2
2308369|NCT02709746|4011662|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2
2308370|NCT02709746|4011663|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0
2308371|NCT02709746|4011664|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0
2308372|NCT02709746|4011665|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0
2308373|NCT02709746|4011666|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0
2308374|NCT02709746|4011662|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12
2308375|NCT02709746|4011663|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
2308376|NCT02709746|4011664|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
2308377|NCT02709746|4011665|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
2308378|NCT02709746|4011666|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
2308379|NCT02709746|4011662|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7
2308380|NCT02709746|4011663|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
2308381|NCT02709746|4011664|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
2308382|NCT02709746|4011665|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
2308383|NCT02709746|4011666|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
2308384|NCT02709746|4011662|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7
2308385|NCT02709746|4011663|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
2308386|NCT02709746|4011664|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
2308387|NCT02709746|4011665|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
2308388|NCT02709746|4011666|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
2308389|NCT02709746|4011662|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103
2355106|NCT00752986|4113118|FG002|Overall Study|Protocol Violation|0
2019952|NCT00302952|3587436|FG001|Overall Study|Withdrawal by Subject|3
2019953|NCT00302952|3587435|FG000|Overall Study|Elevated SGOT (AST) lab value|0
2355107|NCT00754013|4113141|FG000|Overall Study|Lost to Follow-up|1
2355108|NCT00754013|4113142|FG001|Overall Study|Lost to Follow-up|1
2355109|NCT00754013|4113141|FG000|Overall Study|didn't return after study termed|3
2355110|NCT00754013|4113142|FG001|Overall Study|didn't return after study termed|4
2355111|NCT00735553|4113151|FG000|Overall Study|Study prematurely terminated|77
2355112|NCT00751933|4113159|FG000|Overall Study|Withdrawal by Subject|0
2355113|NCT00751933|4113160|FG001|Overall Study|Withdrawal by Subject|1
2355114|NCT00751933|4113161|FG002|Overall Study|Withdrawal by Subject|0
2355115|NCT00751933|4113162|FG003|Overall Study|Withdrawal by Subject|0
2355116|NCT00751933|4113159|FG000|Overall Study|Physician Decision|0
2355117|NCT00751933|4113160|FG001|Overall Study|Physician Decision|0
2355118|NCT00751933|4113161|FG002|Overall Study|Physician Decision|1
2355119|NCT00751933|4113162|FG003|Overall Study|Physician Decision|1
2355120|NCT00747461|4113179|FG000|Overall Study|study terminated by sponsor|5
2355121|NCT00736385|4113194|FG000|Overall Study|Withdrawal by Subject|2
2355122|NCT00736385|4113195|FG001|Overall Study|Withdrawal by Subject|2
2102049|NCT00836277|3693629|FG000|Overall Study|Not evaluable for response|6
2102050|NCT00836498|3693670|FG000|Overall Study|Adverse Event|1
2102051|NCT00836498|3693671|FG001|Overall Study|Adverse Event|0
2102052|NCT00836498|3693670|FG000|Overall Study|Lost to Follow-up|1
2102053|NCT00836498|3693671|FG001|Overall Study|Lost to Follow-up|0
2102054|NCT00836498|3693670|FG000|Overall Study|Withdrawal by Subject|2
2102055|NCT00836498|3693671|FG001|Overall Study|Withdrawal by Subject|1
2102056|NCT00836589|3693678|FG000|Overall Study|Lost to Follow-up|246
2102057|NCT00836589|3693678|FG000|Overall Study|Death|429
2102058|NCT00836589|3693678|FG000|Overall Study|Withdrawal by Subject or Physician|591
2102059|NCT00836693|3693700|FG000|Overall Study|Adverse Event|4
2102060|NCT00836693|3693701|FG001|Overall Study|Adverse Event|1
2102061|NCT00836693|3693700|FG000|Overall Study|Sponsor Decision|0
2102062|NCT00836693|3693701|FG001|Overall Study|Sponsor Decision|1
2102063|NCT00836693|3693700|FG000|Overall Study|Physician Decision|2
2102064|NCT00836693|3693701|FG001|Overall Study|Physician Decision|0
2102065|NCT00836693|3693700|FG000|Overall Study|Withdrawal by Subject|9
2102066|NCT00836693|3693701|FG001|Overall Study|Withdrawal by Subject|4
2102067|NCT00836693|3693700|FG000|Overall Study|Protocol Violation|1
2102068|NCT00836693|3693701|FG001|Overall Study|Protocol Violation|0
2102069|NCT00836693|3693700|FG000|Overall Study|Lost to Follow-up|1
2102070|NCT00836693|3693701|FG001|Overall Study|Lost to Follow-up|0
2102071|NCT00836745|3693711|FG000|Overall Study|Death|2
2102072|NCT00836745|3693711|FG000|Overall Study|Lost to Follow-up|10
2102073|NCT00836745|3693711|FG000|Overall Study|Adverse Event|3
2102074|NCT00836745|3693711|FG000|Overall Study|Objective progression or relapse|4
2102075|NCT00836745|3693711|FG000|Overall Study|Other|2
2102076|NCT00836810|3693723|FG000|Overall Study|New diagnosis|1
2102077|NCT00836810|3693724|FG001|Overall Study|New diagnosis|0
2102078|NCT00836875|3693732|FG000|Overall Study|Death|3
2102079|NCT00836875|3693733|FG001|Overall Study|Death|2
2102080|NCT00836875|3693732|FG000|Overall Study|Withdrawal by Subject|0
2102081|NCT00836875|3693733|FG001|Overall Study|Withdrawal by Subject|1
2102082|NCT00836927|3693761|FG000|Overall Study|Progressive disease|2
2102083|NCT00836927|3693762|FG001|Overall Study|Progressive disease|0
2102084|NCT00836927|3693763|FG002|Overall Study|Progressive disease|0
2102085|NCT00836927|3693764|FG003|Overall Study|Progressive disease|1
2102086|NCT00836927|3693765|FG004|Overall Study|Progressive disease|1
2102087|NCT00836927|3693761|FG000|Overall Study|Withdrawal by Subject|1
2102088|NCT00836927|3693762|FG001|Overall Study|Withdrawal by Subject|0
2102089|NCT00836927|3693763|FG002|Overall Study|Withdrawal by Subject|0
2102090|NCT00836927|3693764|FG003|Overall Study|Withdrawal by Subject|0
2102091|NCT00836927|3693765|FG004|Overall Study|Withdrawal by Subject|0
2102092|NCT00836953|3693779|FG000|Overall Study|Withdrawal by Subject|1
2102093|NCT00836953|3693779|FG000|Overall Study|Lost to Follow-up|1
2102094|NCT00837096|3693789|FG000|Overall Study|Physician Decision|1
2102095|NCT00837096|3693790|FG001|Overall Study|Physician Decision|1
2102096|NCT00837096|3693789|FG000|Overall Study|Not reported|9
2102097|NCT00837096|3693790|FG001|Overall Study|Not reported|8
2102098|NCT00837148|3693796|FG000|Overall Study|Adverse Event|1
2102099|NCT00837148|3693796|FG000|Overall Study|Death|1
2102100|NCT00837161|3693800|FG000|Overall Study|refused hysterectomy|2
2102101|NCT00837213|3693810|FG000|Overall Study|Lost to Follow-up|3
2102102|NCT00837213|3693811|FG001|Overall Study|Lost to Follow-up|2
2102103|NCT00837213|3693810|FG000|Overall Study|Withdrawal by Subject|2
2102104|NCT00837213|3693811|FG001|Overall Study|Withdrawal by Subject|2
2102105|NCT00837213|3693810|FG000|Overall Study|not stated|1
2102106|NCT00837213|3693811|FG001|Overall Study|not stated|1
2102107|NCT00837330|3693823|FG000|Overall Study|Lost to Follow-up|1
2102108|NCT00837330|3693824|FG001|Overall Study|Lost to Follow-up|3
2355123|NCT00736385|4113194|FG000|Overall Study|Adverse Event|0
2355124|NCT00736385|4113195|FG001|Overall Study|Adverse Event|1
2102109|NCT00837434|3693832|FG000|Overall Study|Physician Decision|3
2102110|NCT00837434|3693833|FG001|Overall Study|Physician Decision|0
2102111|NCT00837434|3693832|FG000|Overall Study|Lost to Follow-up|1
2102112|NCT00837434|3693833|FG001|Overall Study|Lost to Follow-up|1
2102113|NCT00837434|3693832|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1
2102114|NCT00837434|3693833|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0
2102115|NCT00837434|3693832|FG000|Overall Study|Noncompliant|2
2102116|NCT00837434|3693833|FG001|Overall Study|Noncompliant|0
2355125|NCT00743197|4113220|FG000|Overall Study|Study terminated due to departure of PI.|1
2355126|NCT00743197|4113221|FG001|Overall Study|Study terminated due to departure of PI.|2
2212345|NCT01668797|3853356|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0
2212346|NCT01668797|3853353|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
2355127|NCT00739063|4113227|FG000|Overall Study|Screen failures|8
2355128|NCT00740597|4113231|FG000|Overall Study|insurance would not cover treatment|1
2308390|NCT02709746|4011663|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
2308391|NCT02709746|4011664|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
2308392|NCT02709746|4011665|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
2308393|NCT02709746|4011666|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
2308394|NCT02709746|4011662|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0
2308395|NCT02709746|4011663|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1
2308396|NCT02709746|4011664|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0
2308397|NCT02709746|4011665|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0
2308398|NCT02709746|4011666|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2
2308399|NCT02709746|4011662|FG000|Phase B (Double-blind Treatment Period)|Other|0
2308400|NCT02709746|4011663|FG001|Phase B (Double-blind Treatment Period)|Other|6
2308401|NCT02709746|4011664|FG002|Phase B (Double-blind Treatment Period)|Other|5
2308402|NCT02709746|4011665|FG003|Phase B (Double-blind Treatment Period)|Other|6
2308403|NCT02709746|4011666|FG004|Phase B (Double-blind Treatment Period)|Other|7
2308404|NCT02709746|4011662|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
2308405|NCT02709746|4011663|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
2308406|NCT02709746|4011664|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4
2308407|NCT02709746|4011665|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
2308408|NCT02709746|4011666|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
2308409|NCT02709746|4011662|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
2308410|NCT02709746|4011663|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3
2308411|NCT02709746|4011664|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
2308412|NCT02709746|4011665|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1
2308413|NCT02709746|4011666|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2
2308414|NCT02709746|4011662|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0
2308415|NCT02709746|4011663|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4
2308416|NCT02709746|4011664|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8
2308417|NCT02709746|4011665|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5
2308418|NCT02709746|4011666|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2
2308419|NCT02709746|4011662|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0
2308420|NCT02709746|4011663|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
2308421|NCT02709746|4011664|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
2308422|NCT02709746|4011665|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
2308423|NCT02709746|4011666|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1
2308424|NCT02709746|4011662|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0
2308425|NCT02709746|4011663|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0
2308426|NCT02709746|4011664|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1
2308427|NCT02709746|4011665|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0
2308428|NCT02709746|4011666|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0
2308429|NCT02709746|4011662|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
2308430|NCT02709746|4011663|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4
2308431|NCT02709746|4011664|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
2308432|NCT02709746|4011665|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
2308433|NCT02709746|4011666|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
2308434|NCT02709785|4011681|FG000|Overall Study|Withdrawal by Subject|1
2308435|NCT02709785|4011682|FG001|Overall Study|Withdrawal by Subject|2
2308436|NCT02709785|4011683|FG002|Overall Study|Withdrawal by Subject|1
2308437|NCT02709889|4011699|FG000|Overall Study|Withdrawal by Subject|11
2308438|NCT02709889|4011700|FG001|Overall Study|Withdrawal by Subject|10
2308439|NCT02709889|4011701|FG002|Overall Study|Withdrawal by Subject|2
2308440|NCT02709889|4011702|FG003|Overall Study|Withdrawal by Subject|12
2308441|NCT02709889|4011699|FG000|Overall Study|Death|25
2308442|NCT02709889|4011700|FG001|Overall Study|Death|38
2308443|NCT02709889|4011701|FG002|Overall Study|Death|4
2308444|NCT02709889|4011702|FG003|Overall Study|Death|44
2308445|NCT02709889|4011699|FG000|Overall Study|Physician Decision|1
2308446|NCT02709889|4011700|FG001|Overall Study|Physician Decision|2
2308447|NCT02709889|4011701|FG002|Overall Study|Physician Decision|3
2308448|NCT02709889|4011702|FG003|Overall Study|Physician Decision|5
2308449|NCT02709889|4011699|FG000|Overall Study|Lost to Follow-up|2
2308450|NCT02709889|4011700|FG001|Overall Study|Lost to Follow-up|0
2308451|NCT02709889|4011701|FG002|Overall Study|Lost to Follow-up|0
2308452|NCT02709889|4011702|FG003|Overall Study|Lost to Follow-up|4
2308453|NCT02709889|4011699|FG000|Overall Study|Study Terminated by Sponsor|4
2308454|NCT02709889|4011700|FG001|Overall Study|Study Terminated by Sponsor|6
2308455|NCT02709889|4011701|FG002|Overall Study|Study Terminated by Sponsor|2
2355129|NCT00737282|4113250|FG000|Overall Study|Study prematurely terminated|175
2355130|NCT00739882|4113258|FG000|Double-blind Period|Adverse Event|1
2355131|NCT00739882|4113259|FG001|Double-blind Period|Adverse Event|2
2355132|NCT00739882|4113258|FG000|Double-blind Period|Protocol Violation|1
2355133|NCT00739882|4113259|FG001|Double-blind Period|Protocol Violation|0
2355134|NCT00739882|4113258|FG000|Double-blind Period|Lack of Efficacy|1
2355135|NCT00739882|4113259|FG001|Double-blind Period|Lack of Efficacy|1
2355136|NCT00739882|4113258|FG000|Double-blind Period|Other|16
2308456|NCT02709889|4011702|FG003|Overall Study|Study Terminated by Sponsor|17
2308457|NCT02709889|4011699|FG000|Overall Study|Other, Not Specified|0
2308458|NCT02709889|4011700|FG001|Overall Study|Other, Not Specified|1
2308459|NCT02709889|4011701|FG002|Overall Study|Other, Not Specified|1
2308460|NCT02709889|4011702|FG003|Overall Study|Other, Not Specified|6
2308461|NCT02710045|4011750|FG000|Overall Study|Death|1
2308462|NCT02710045|4011751|FG001|Overall Study|Death|2
2308463|NCT02710045|4011752|FG002|Overall Study|Death|0
2308464|NCT02710045|4011750|FG000|Overall Study|Withdrawal by Subject|6
2308465|NCT02710045|4011751|FG001|Overall Study|Withdrawal by Subject|6
2308466|NCT02710045|4011752|FG002|Overall Study|Withdrawal by Subject|2
2308467|NCT02710045|4011750|FG000|Overall Study|Protocol Violation|1
2308468|NCT02710045|4011751|FG001|Overall Study|Protocol Violation|2
2308469|NCT02710045|4011752|FG002|Overall Study|Protocol Violation|3
2308470|NCT02710045|4011750|FG000|Overall Study|Lost to Follow-up|3
2308471|NCT02710045|4011751|FG001|Overall Study|Lost to Follow-up|6
2308472|NCT02710045|4011752|FG002|Overall Study|Lost to Follow-up|7
2308473|NCT02710045|4011750|FG000|Overall Study|Physician Decision|0
2308474|NCT02710045|4011751|FG001|Overall Study|Physician Decision|0
2308475|NCT02710045|4011752|FG002|Overall Study|Physician Decision|1
2308476|NCT02710045|4011750|FG000|Overall Study|Poor Attendance|0
2308477|NCT02710045|4011751|FG001|Overall Study|Poor Attendance|1
2308478|NCT02710045|4011752|FG002|Overall Study|Poor Attendance|0
2321760|NCT02963506|4036373|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321761|NCT02963506|4036374|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321762|NCT02963506|4036375|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321763|NCT02963506|4036376|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321764|NCT02963506|4036377|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321765|NCT02963506|4036378|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321766|NCT02963506|4036379|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321767|NCT02963506|4036380|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321768|NCT02963506|4036381|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321769|NCT02963506|4036382|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321770|NCT02963506|4036383|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0
2321771|NCT02963506|4036371|FG000|Dose-Blind Period|Adverse Event|0
2321772|NCT02963506|4036372|FG001|Dose-Blind Period|Adverse Event|0
2321773|NCT02963506|4036373|FG002|Dose-Blind Period|Adverse Event|0
2321774|NCT02963506|4036374|FG003|Dose-Blind Period|Adverse Event|0
2321775|NCT02963506|4036375|FG004|Dose-Blind Period|Adverse Event|0
2321776|NCT02963506|4036376|FG005|Dose-Blind Period|Adverse Event|1
2321777|NCT02963506|4036377|FG006|Dose-Blind Period|Adverse Event|3
2321778|NCT02963506|4036378|FG007|Dose-Blind Period|Adverse Event|2
2321779|NCT02963506|4036379|FG008|Dose-Blind Period|Adverse Event|2
2321780|NCT02963506|4036380|FG009|Dose-Blind Period|Adverse Event|2
2321781|NCT02963506|4036381|FG010|Dose-Blind Period|Adverse Event|1
2321782|NCT02963506|4036382|FG011|Dose-Blind Period|Adverse Event|1
2321783|NCT02963506|4036383|FG012|Dose-Blind Period|Adverse Event|6
2321784|NCT02963506|4036371|FG000|Dose-Blind Period|Lack of Efficacy|0
2321785|NCT02963506|4036372|FG001|Dose-Blind Period|Lack of Efficacy|0
2321786|NCT02963506|4036373|FG002|Dose-Blind Period|Lack of Efficacy|0
2321787|NCT02963506|4036374|FG003|Dose-Blind Period|Lack of Efficacy|0
2321788|NCT02963506|4036375|FG004|Dose-Blind Period|Lack of Efficacy|0
2321789|NCT02963506|4036376|FG005|Dose-Blind Period|Lack of Efficacy|0
2321790|NCT02963506|4036377|FG006|Dose-Blind Period|Lack of Efficacy|0
2321791|NCT02963506|4036378|FG007|Dose-Blind Period|Lack of Efficacy|1
2321792|NCT02963506|4036379|FG008|Dose-Blind Period|Lack of Efficacy|0
2321793|NCT02963506|4036380|FG009|Dose-Blind Period|Lack of Efficacy|1
2321794|NCT02963506|4036381|FG010|Dose-Blind Period|Lack of Efficacy|0
2321795|NCT02963506|4036382|FG011|Dose-Blind Period|Lack of Efficacy|0
2321796|NCT02963506|4036383|FG012|Dose-Blind Period|Lack of Efficacy|0
2321797|NCT02963506|4036371|FG000|Dose-Blind Period|Lost to Follow-up|0
2321798|NCT02963506|4036372|FG001|Dose-Blind Period|Lost to Follow-up|0
2321799|NCT02963506|4036373|FG002|Dose-Blind Period|Lost to Follow-up|0
2321800|NCT02963506|4036374|FG003|Dose-Blind Period|Lost to Follow-up|0
2321801|NCT02963506|4036375|FG004|Dose-Blind Period|Lost to Follow-up|0
2321802|NCT02963506|4036376|FG005|Dose-Blind Period|Lost to Follow-up|1
2321803|NCT02963506|4036377|FG006|Dose-Blind Period|Lost to Follow-up|0
2321804|NCT02963506|4036378|FG007|Dose-Blind Period|Lost to Follow-up|0
2321805|NCT02963506|4036379|FG008|Dose-Blind Period|Lost to Follow-up|1
2321806|NCT02963506|4036380|FG009|Dose-Blind Period|Lost to Follow-up|0
2321807|NCT02963506|4036381|FG010|Dose-Blind Period|Lost to Follow-up|0
2321808|NCT02963506|4036382|FG011|Dose-Blind Period|Lost to Follow-up|1
2355137|NCT00739882|4113259|FG001|Double-blind Period|Other|8
2355138|NCT00739882|4113258|FG000|Open-label Period|Adverse Event|1
2355139|NCT00739882|4113259|FG001|Open-label Period|Adverse Event|0
2355140|NCT00739882|4113258|FG000|Open-label Period|Other|9
2355141|NCT00739882|4113259|FG001|Open-label Period|Other|5
2355142|NCT00735254|4113291|FG000|Overall Study|Protocol Violation|1
2355143|NCT00735254|4113292|FG001|Overall Study|Protocol Violation|1
2355144|NCT00735254|4113293|FG002|Overall Study|Protocol Violation|1
2355145|NCT00735254|4113294|FG003|Overall Study|Protocol Violation|0
2355146|NCT00729365|4113307|FG000|Overall Study|Physician Decision|33
2355147|NCT00729365|4113308|FG001|Overall Study|Physician Decision|6
2355148|NCT00729365|4113309|FG002|Overall Study|Physician Decision|7
2355149|NCT00724282|4113327|FG000|Overall Study|Withdrawal by Subject|3
2355150|NCT00724282|4113327|FG000|Overall Study|Physician Decision|1
2355151|NCT00730886|4113333|FG000|Overall Study|Lost to Follow-up|1
2355152|NCT00730886|4113334|FG001|Overall Study|Lost to Follow-up|0
2355153|NCT00730886|4113333|FG000|Overall Study|Physician Decision|1
2355154|NCT00730886|4113334|FG001|Overall Study|Physician Decision|0
2355155|NCT00729560|4113362|FG000|Overall Study|Withdrawal by Subject|3
2355156|NCT00714948|4113383|FG000|Overall Study|Adverse Event|2
2355157|NCT00720343|4113387|FG000|Overall Study|Physician Decision|3
2355158|NCT00720343|4113387|FG000|Overall Study|No data|3
2355159|NCT00718640|4113402|FG000|Overall Study|Adverse Event|4
2355160|NCT00718640|4113402|FG000|Overall Study|Death|1
2355161|NCT00718640|4113402|FG000|Overall Study|Unresolved toxicity after 2 weeks|2
2355162|NCT00720083|4113408|FG000|Overall Study|Ineligible|1
2355163|NCT00720083|4113409|FG001|Overall Study|Ineligible|2
2355164|NCT00717275|4113415|FG000|Overall Study|Premature study termination.|3
2355165|NCT00708734|4113419|FG000|Overall Study|scheduling conflict|2
2355166|NCT00708734|4113419|FG000|Overall Study|moved|1
2355167|NCT00708734|4113419|FG000|Overall Study|leg injury|1
2355168|NCT00708734|4113419|FG000|Overall Study|knee replacement|1
2355169|NCT00708734|4113419|FG000|Overall Study|vertigo|1
2355170|NCT00708734|4113419|FG000|Overall Study|leg fracture|1
2355171|NCT00711087|4113425|FG000|Overall Study|Lost to Follow-up|1
2212347|NCT01668797|3853354|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
2308479|NCT02710071|4011762|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3
2212348|NCT01668797|3853355|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
2212349|NCT01668797|3853356|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
2212350|NCT01668797|3853353|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
2212351|NCT01668797|3853354|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
2212352|NCT01668797|3853355|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
2212353|NCT01668797|3853356|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
2212354|NCT01668797|3853353|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0
2212355|NCT01668797|3853354|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16
2212356|NCT01668797|3853355|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0
2212357|NCT01668797|3853356|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0
2212358|NCT01668797|3853353|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
2212359|NCT01668797|3853354|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
2212360|NCT01668797|3853355|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
2212361|NCT01668797|3853356|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
2212362|NCT01668797|3853353|FG000|Phase B (Stabilization Phase)|Physician Decision|0
2212363|NCT01668797|3853354|FG001|Phase B (Stabilization Phase)|Physician Decision|11
2212364|NCT01668797|3853355|FG002|Phase B (Stabilization Phase)|Physician Decision|0
2212365|NCT01668797|3853356|FG003|Phase B (Stabilization Phase)|Physician Decision|0
2212366|NCT01668797|3853353|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0
2212367|NCT01668797|3853354|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60
2212368|NCT01668797|3853355|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0
2212369|NCT01668797|3853356|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0
2212370|NCT01668797|3853353|FG000|Phase B (Stabilization Phase)|Protocol Violation|0
2212371|NCT01668797|3853354|FG001|Phase B (Stabilization Phase)|Protocol Violation|3
2212372|NCT01668797|3853355|FG002|Phase B (Stabilization Phase)|Protocol Violation|0
2212373|NCT01668797|3853356|FG003|Phase B (Stabilization Phase)|Protocol Violation|0
2212374|NCT01668797|3853353|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0
2212375|NCT01668797|3853354|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21
2212376|NCT01668797|3853355|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0
2212377|NCT01668797|3853356|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0
2212378|NCT01668797|3853353|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
2212379|NCT01668797|3853354|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
2212380|NCT01668797|3853355|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
2212381|NCT01668797|3853356|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
2212382|NCT01668797|3853353|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
2212383|NCT01668797|3853354|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
2308480|NCT02710071|4011763|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4
2308481|NCT02710071|4011762|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1
2308482|NCT02710071|4011763|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
2355172|NCT00711087|4113426|FG001|Overall Study|Lost to Follow-up|0
2355173|NCT00706797|4113434|FG000|Overall Study|Lack of Efficacy|3
2355174|NCT00706797|4113435|FG001|Overall Study|Lack of Efficacy|0
2355175|NCT00706797|4113434|FG000|Overall Study|Adverse Event|0
2355176|NCT00706797|4113435|FG001|Overall Study|Adverse Event|3
2355177|NCT00706797|4113434|FG000|Overall Study|Withdrawal by Subject|8
2355178|NCT00706797|4113435|FG001|Overall Study|Withdrawal by Subject|1
2355179|NCT00706797|4113434|FG000|Overall Study|Death|1
2355180|NCT00706797|4113435|FG001|Overall Study|Death|0
2355181|NCT00706797|4113434|FG000|Overall Study|Discontinuation of study by sponsor|52
2355182|NCT00706797|4113435|FG001|Overall Study|Discontinuation of study by sponsor|63
2355183|NCT00706797|4113434|FG000|Overall Study|Protocol Violation|3
2355184|NCT00706797|4113435|FG001|Overall Study|Protocol Violation|2
2355185|NCT00706797|4113434|FG000|Overall Study|Lost to Follow-up|1
2355186|NCT00706797|4113435|FG001|Overall Study|Lost to Follow-up|2
2355187|NCT00706797|4113434|FG000|Overall Study|Other|1
2355188|NCT00706797|4113435|FG001|Overall Study|Other|0
2355189|NCT00713596|4113444|FG000|Overall Study|Study was terminated|2
2355190|NCT00713596|4113445|FG001|Overall Study|Study was terminated|3
2355191|NCT00713596|4113446|FG002|Overall Study|Study was terminated|2
2355192|NCT00703092|4113459|FG000|Overall Study|Withdrawal by Subject|2
2308483|NCT02710136|4011772|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
2308484|NCT02710136|4011773|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
2308485|NCT02710214|4011782|FG000|Overall Study|Lost to Follow-up|1
2308486|NCT02710214|4011783|FG001|Overall Study|Lost to Follow-up|0
2308487|NCT02710214|4011782|FG000|Overall Study|Lack of Efficacy|0
2308488|NCT02710214|4011783|FG001|Overall Study|Lack of Efficacy|1
2308489|NCT02710214|4011782|FG000|Overall Study|Death|0
2308490|NCT02710214|4011783|FG001|Overall Study|Death|1
2308491|NCT02710292|4011793|FG000|Period 1, First 10 Days of Wear|Adverse Event|0
2308492|NCT02710292|4011794|FG001|Period 1, First 10 Days of Wear|Adverse Event|1
2308493|NCT02710292|4011793|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
2308494|NCT02710292|4011794|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
2308495|NCT02710422|4011803|FG000|Overall Study|Termination of study|9
2308496|NCT02710422|4011804|FG001|Overall Study|Termination of study|9
2308497|NCT02710669|4011878|FG000|Overall Study|Physician Decision|2
2308498|NCT02710669|4011879|FG001|Overall Study|Physician Decision|1
2308499|NCT02710669|4011880|FG002|Overall Study|Physician Decision|0
2308500|NCT02710669|4011878|FG000|Overall Study|Institutional delays (including COVID)|2
2308501|NCT02710669|4011879|FG001|Overall Study|Institutional delays (including COVID)|2
2308502|NCT02710669|4011880|FG002|Overall Study|Institutional delays (including COVID)|0
2308503|NCT02710669|4011878|FG000|Overall Study|arrived in afib/aflutter|10
2308504|NCT02710669|4011879|FG001|Overall Study|arrived in afib/aflutter|8
2308505|NCT02710669|4011880|FG002|Overall Study|arrived in afib/aflutter|2
2308506|NCT02711306|4011908|FG000|Overall Study|Withdrawal by Subject|2
2308507|NCT02711306|4011909|FG001|Overall Study|Withdrawal by Subject|2
2308508|NCT02711345|4011925|FG000|Overall Study|Adverse Event|0
2308509|NCT02711345|4011926|FG001|Overall Study|Adverse Event|0
2308510|NCT02711345|4011927|FG002|Overall Study|Adverse Event|0
2355193|NCT00713258|4113465|FG000|Overall Study|Adverse Event|2
2355194|NCT00713258|4113466|FG001|Overall Study|Adverse Event|4
2355195|NCT00713258|4113465|FG000|Overall Study|Non-Compliance|2
2355196|NCT00713258|4113466|FG001|Overall Study|Non-Compliance|1
2355197|NCT00713258|4113465|FG000|Overall Study|Other|1
2308511|NCT02711345|4011928|FG003|Overall Study|Adverse Event|1
2308512|NCT02711345|4011929|FG004|Overall Study|Adverse Event|1
2308513|NCT02711345|4011930|FG005|Overall Study|Adverse Event|2
2308514|NCT02711345|4011931|FG006|Overall Study|Adverse Event|1
2308515|NCT02711345|4011932|FG007|Overall Study|Adverse Event|0
2308516|NCT02711345|4011933|FG008|Overall Study|Adverse Event|0
2308517|NCT02711345|4011934|FG009|Overall Study|Adverse Event|2
2308518|NCT02711345|4011925|FG000|Overall Study|Physician Decision|0
2308519|NCT02711345|4011926|FG001|Overall Study|Physician Decision|0
2308520|NCT02711345|4011927|FG002|Overall Study|Physician Decision|1
2308521|NCT02711345|4011928|FG003|Overall Study|Physician Decision|0
2308522|NCT02711345|4011929|FG004|Overall Study|Physician Decision|0
2308523|NCT02711345|4011930|FG005|Overall Study|Physician Decision|0
2308524|NCT02711345|4011931|FG006|Overall Study|Physician Decision|0
2308525|NCT02711345|4011932|FG007|Overall Study|Physician Decision|0
2308526|NCT02711345|4011933|FG008|Overall Study|Physician Decision|1
2308527|NCT02711345|4011934|FG009|Overall Study|Physician Decision|0
2308528|NCT02711345|4011925|FG000|Overall Study|Progressive disease|1
2308529|NCT02711345|4011926|FG001|Overall Study|Progressive disease|3
2308530|NCT02711345|4011927|FG002|Overall Study|Progressive disease|5
2308531|NCT02711345|4011928|FG003|Overall Study|Progressive disease|3
2212384|NCT01668797|3853355|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
2212385|NCT01668797|3853356|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
2212386|NCT01668797|3853353|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
2212387|NCT01668797|3853354|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
2308532|NCT02711345|4011929|FG004|Overall Study|Progressive disease|7
2308533|NCT02711345|4011930|FG005|Overall Study|Progressive disease|2
2308534|NCT02711345|4011931|FG006|Overall Study|Progressive disease|8
2308535|NCT02711345|4011932|FG007|Overall Study|Progressive disease|4
2308536|NCT02711345|4011933|FG008|Overall Study|Progressive disease|5
2308537|NCT02711345|4011934|FG009|Overall Study|Progressive disease|6
2308538|NCT02711345|4011925|FG000|Overall Study|Subject/guardian decision|0
2308539|NCT02711345|4011926|FG001|Overall Study|Subject/guardian decision|0
2308540|NCT02711345|4011927|FG002|Overall Study|Subject/guardian decision|0
2308541|NCT02711345|4011928|FG003|Overall Study|Subject/guardian decision|0
2308542|NCT02711345|4011929|FG004|Overall Study|Subject/guardian decision|0
2308543|NCT02711345|4011930|FG005|Overall Study|Subject/guardian decision|2
2308544|NCT02711345|4011931|FG006|Overall Study|Subject/guardian decision|3
2308545|NCT02711345|4011932|FG007|Overall Study|Subject/guardian decision|1
2308546|NCT02711345|4011933|FG008|Overall Study|Subject/guardian decision|0
2308547|NCT02711345|4011934|FG009|Overall Study|Subject/guardian decision|4
2308548|NCT02711345|4011925|FG000|Overall Study|Death|1
2308549|NCT02711345|4011926|FG001|Overall Study|Death|0
2308550|NCT02711345|4011927|FG002|Overall Study|Death|0
2308551|NCT02711345|4011928|FG003|Overall Study|Death|0
2308552|NCT02711345|4011929|FG004|Overall Study|Death|0
2308553|NCT02711345|4011930|FG005|Overall Study|Death|0
2308554|NCT02711345|4011931|FG006|Overall Study|Death|0
2308555|NCT02711345|4011932|FG007|Overall Study|Death|1
2308556|NCT02711345|4011933|FG008|Overall Study|Death|0
2308557|NCT02711345|4011934|FG009|Overall Study|Death|0
2308558|NCT02711553|4011965|FG000|Overall Study|Withdrawal by Subject|2
2308559|NCT02711553|4011966|FG001|Overall Study|Withdrawal by Subject|1
2308560|NCT02711553|4011967|FG002|Overall Study|Withdrawal by Subject|1
2308561|NCT02711553|4011968|FG003|Overall Study|Withdrawal by Subject|0
2308562|NCT02711553|4011965|FG000|Overall Study|Lost to Follow-up|3
2308563|NCT02711553|4011966|FG001|Overall Study|Lost to Follow-up|3
2308564|NCT02711553|4011967|FG002|Overall Study|Lost to Follow-up|6
2308565|NCT02711553|4011968|FG003|Overall Study|Lost to Follow-up|3
2308566|NCT02711553|4011965|FG000|Overall Study|On Study Treatment at Study Conclusion|1
2308567|NCT02711553|4011966|FG001|Overall Study|On Study Treatment at Study Conclusion|1
2308568|NCT02711553|4011967|FG002|Overall Study|On Study Treatment at Study Conclusion|3
2308569|NCT02711553|4011968|FG003|Overall Study|On Study Treatment at Study Conclusion|1
2308570|NCT02711800|4011980|FG000|Overall Study|Lost to Follow-up|1
2308571|NCT02711800|4011980|FG000|Overall Study|Withdrawal by Subject|1
2308572|NCT02711956|4012008|FG000|Overall Study|Adverse Event|0
2308573|NCT02711956|4012009|FG001|Overall Study|Adverse Event|0
2308574|NCT02711956|4012010|FG002|Overall Study|Adverse Event|0
2308575|NCT02711956|4012011|FG003|Overall Study|Adverse Event|1
2308576|NCT02711956|4012012|FG004|Overall Study|Adverse Event|2
2308577|NCT02711956|4012013|FG005|Overall Study|Adverse Event|0
2308578|NCT02711956|4012014|FG006|Overall Study|Adverse Event|0
2308579|NCT02711956|4012015|FG007|Overall Study|Adverse Event|1
2308580|NCT02711956|4012016|FG008|Overall Study|Adverse Event|1
2308581|NCT02711956|4012017|FG009|Overall Study|Adverse Event|1
2308582|NCT02711956|4012018|FG010|Overall Study|Adverse Event|1
2308583|NCT02711956|4012019|FG011|Overall Study|Adverse Event|0
2308584|NCT02711956|4012020|FG012|Overall Study|Adverse Event|0
2308585|NCT02711956|4012021|FG013|Overall Study|Adverse Event|0
2308586|NCT02711956|4012022|FG014|Overall Study|Adverse Event|2
2308587|NCT02711956|4012008|FG000|Overall Study|Physician Decision|0
2355198|NCT00713258|4113466|FG001|Overall Study|Other|1
2355199|NCT00707434|4113476|FG000|Overall Study|Adverse Event|1
2355200|NCT00707161|4113480|FG000|Overall Study|Physician Decision|6
2355201|NCT00708916|4113493|FG000|Overall Study|Subject Noncompliance|2
2355202|NCT00708916|4113493|FG000|Overall Study|Adverse Event|2
2355203|NCT00700778|4113498|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2
2355204|NCT00699842|4113505|FG000|Overall Study|Death|0
2355205|NCT00699842|4113506|FG001|Overall Study|Death|1
2355206|NCT00699842|4113507|FG002|Overall Study|Death|0
2355207|NCT00702962|4113517|FG000|Overall Study|Progressive disease|0
2355208|NCT00702962|4113518|FG001|Overall Study|Progressive disease|1
2355209|NCT00702962|4113517|FG000|Overall Study|Hospitalized for other health disorder|1
2355210|NCT00702962|4113518|FG001|Overall Study|Hospitalized for other health disorder|0
2355211|NCT00703534|4113528|FG000|Overall Study|Adverse Event|14
2355212|NCT00703534|4113529|FG001|Overall Study|Adverse Event|3
2355213|NCT00703534|4113528|FG000|Overall Study|Withdrawal by Subject|8
2355214|NCT00703534|4113529|FG001|Overall Study|Withdrawal by Subject|7
2355215|NCT00703534|4113528|FG000|Overall Study|Incorrect Enrollment|6
2308588|NCT02711956|4012009|FG001|Overall Study|Physician Decision|0
2308589|NCT02711956|4012010|FG002|Overall Study|Physician Decision|0
2308590|NCT02711956|4012011|FG003|Overall Study|Physician Decision|2
2308591|NCT02711956|4012012|FG004|Overall Study|Physician Decision|0
2308592|NCT02711956|4012013|FG005|Overall Study|Physician Decision|0
2308593|NCT02711956|4012014|FG006|Overall Study|Physician Decision|0
2308594|NCT02711956|4012015|FG007|Overall Study|Physician Decision|0
2308595|NCT02711956|4012016|FG008|Overall Study|Physician Decision|0
2308596|NCT02711956|4012017|FG009|Overall Study|Physician Decision|0
2308597|NCT02711956|4012018|FG010|Overall Study|Physician Decision|0
2308598|NCT02711956|4012019|FG011|Overall Study|Physician Decision|0
2308599|NCT02711956|4012020|FG012|Overall Study|Physician Decision|0
2308600|NCT02711956|4012021|FG013|Overall Study|Physician Decision|0
2308601|NCT02711956|4012022|FG014|Overall Study|Physician Decision|0
2308602|NCT02711956|4012008|FG000|Overall Study|Withdrawal by Subject|0
2308603|NCT02711956|4012009|FG001|Overall Study|Withdrawal by Subject|0
2308604|NCT02711956|4012010|FG002|Overall Study|Withdrawal by Subject|0
2308605|NCT02711956|4012011|FG003|Overall Study|Withdrawal by Subject|0
2308606|NCT02711956|4012012|FG004|Overall Study|Withdrawal by Subject|0
2308607|NCT02711956|4012013|FG005|Overall Study|Withdrawal by Subject|0
2308608|NCT02711956|4012014|FG006|Overall Study|Withdrawal by Subject|1
2308609|NCT02711956|4012015|FG007|Overall Study|Withdrawal by Subject|0
2308610|NCT02711956|4012016|FG008|Overall Study|Withdrawal by Subject|0
2308611|NCT02711956|4012017|FG009|Overall Study|Withdrawal by Subject|0
2308612|NCT02711956|4012018|FG010|Overall Study|Withdrawal by Subject|0
2308613|NCT02711956|4012019|FG011|Overall Study|Withdrawal by Subject|1
2308614|NCT02711956|4012020|FG012|Overall Study|Withdrawal by Subject|6
2308615|NCT02711956|4012021|FG013|Overall Study|Withdrawal by Subject|0
2308616|NCT02711956|4012022|FG014|Overall Study|Withdrawal by Subject|1
2308617|NCT02711956|4012008|FG000|Overall Study|Clinical progression|1
2308618|NCT02711956|4012009|FG001|Overall Study|Clinical progression|0
2308619|NCT02711956|4012010|FG002|Overall Study|Clinical progression|0
2308620|NCT02711956|4012011|FG003|Overall Study|Clinical progression|0
2308621|NCT02711956|4012012|FG004|Overall Study|Clinical progression|0
2308622|NCT02711956|4012013|FG005|Overall Study|Clinical progression|0
2308623|NCT02711956|4012014|FG006|Overall Study|Clinical progression|1
2308624|NCT02711956|4012015|FG007|Overall Study|Clinical progression|0
2308625|NCT02711956|4012016|FG008|Overall Study|Clinical progression|1
2308626|NCT02711956|4012017|FG009|Overall Study|Clinical progression|0
2308627|NCT02711956|4012018|FG010|Overall Study|Clinical progression|0
2308628|NCT02711956|4012019|FG011|Overall Study|Clinical progression|2
2308629|NCT02711956|4012020|FG012|Overall Study|Clinical progression|4
2308630|NCT02711956|4012021|FG013|Overall Study|Clinical progression|1
2308631|NCT02711956|4012022|FG014|Overall Study|Clinical progression|1
2308632|NCT02711956|4012008|FG000|Overall Study|Radiographic progression|1
2308633|NCT02711956|4012009|FG001|Overall Study|Radiographic progression|1
2308634|NCT02711956|4012010|FG002|Overall Study|Radiographic progression|2
2308635|NCT02711956|4012011|FG003|Overall Study|Radiographic progression|0
2308636|NCT02711956|4012012|FG004|Overall Study|Radiographic progression|1
2308637|NCT02711956|4012013|FG005|Overall Study|Radiographic progression|0
2308638|NCT02711956|4012014|FG006|Overall Study|Radiographic progression|0
2308639|NCT02711956|4012015|FG007|Overall Study|Radiographic progression|0
2308640|NCT02711956|4012016|FG008|Overall Study|Radiographic progression|2
2308641|NCT02711956|4012017|FG009|Overall Study|Radiographic progression|1
2308642|NCT02711956|4012018|FG010|Overall Study|Radiographic progression|0
2308643|NCT02711956|4012019|FG011|Overall Study|Radiographic progression|5
2308644|NCT02711956|4012020|FG012|Overall Study|Radiographic progression|3
2308645|NCT02711956|4012021|FG013|Overall Study|Radiographic progression|0
2308646|NCT02711956|4012022|FG014|Overall Study|Radiographic progression|1
2308647|NCT02711956|4012008|FG000|Overall Study|PSA progression with clinical progression|0
2308648|NCT02711956|4012009|FG001|Overall Study|PSA progression with clinical progression|0
2308649|NCT02711956|4012010|FG002|Overall Study|PSA progression with clinical progression|0
2308650|NCT02711956|4012011|FG003|Overall Study|PSA progression with clinical progression|0
2355216|NCT00703534|4113529|FG001|Overall Study|Incorrect Enrollment|6
2355217|NCT00703534|4113528|FG000|Overall Study|Lost to Follow-up|1
2355218|NCT00703534|4113529|FG001|Overall Study|Lost to Follow-up|4
2355219|NCT00703534|4113528|FG000|Overall Study|Severe Non Compliance|1
2355220|NCT00703534|4113529|FG001|Overall Study|Severe Non Compliance|5
2355221|NCT00698009|4113535|FG000|Overall Study|Withdrawal by Subject|1
2308651|NCT02711956|4012012|FG004|Overall Study|PSA progression with clinical progression|1
2308652|NCT02711956|4012013|FG005|Overall Study|PSA progression with clinical progression|0
2308653|NCT02711956|4012014|FG006|Overall Study|PSA progression with clinical progression|0
2308654|NCT02711956|4012015|FG007|Overall Study|PSA progression with clinical progression|0
2308655|NCT02711956|4012016|FG008|Overall Study|PSA progression with clinical progression|0
2308656|NCT02711956|4012017|FG009|Overall Study|PSA progression with clinical progression|0
2308657|NCT02711956|4012018|FG010|Overall Study|PSA progression with clinical progression|0
2308658|NCT02711956|4012019|FG011|Overall Study|PSA progression with clinical progression|0
2308659|NCT02711956|4012020|FG012|Overall Study|PSA progression with clinical progression|1
2308660|NCT02711956|4012021|FG013|Overall Study|PSA progression with clinical progression|1
2308661|NCT02711956|4012022|FG014|Overall Study|PSA progression with clinical progression|0
2308662|NCT02711956|4012008|FG000|Overall Study|PSA progression with radiographic progression|0
2308663|NCT02711956|4012009|FG001|Overall Study|PSA progression with radiographic progression|1
2308664|NCT02711956|4012010|FG002|Overall Study|PSA progression with radiographic progression|0
2308665|NCT02711956|4012011|FG003|Overall Study|PSA progression with radiographic progression|0
2308666|NCT02711956|4012012|FG004|Overall Study|PSA progression with radiographic progression|0
2308667|NCT02711956|4012013|FG005|Overall Study|PSA progression with radiographic progression|2
2308668|NCT02711956|4012014|FG006|Overall Study|PSA progression with radiographic progression|2
2308669|NCT02711956|4012015|FG007|Overall Study|PSA progression with radiographic progression|1
2308670|NCT02711956|4012016|FG008|Overall Study|PSA progression with radiographic progression|0
2308671|NCT02711956|4012017|FG009|Overall Study|PSA progression with radiographic progression|1
2308672|NCT02711956|4012018|FG010|Overall Study|PSA progression with radiographic progression|0
2308673|NCT02711956|4012019|FG011|Overall Study|PSA progression with radiographic progression|1
2308674|NCT02711956|4012020|FG012|Overall Study|PSA progression with radiographic progression|2
2308675|NCT02711956|4012021|FG013|Overall Study|PSA progression with radiographic progression|3
2308676|NCT02711956|4012022|FG014|Overall Study|PSA progression with radiographic progression|3
2308677|NCT02711995|4012063|FG000|Washout (90 Days)|Conflicting medication|1
2308678|NCT02712008|4012072|FG000|Baseline (Day 1) up to Week 12|Death|3
2308679|NCT02712008|4012073|FG001|Baseline (Day 1) up to Week 12|Death|0
2308680|NCT02712008|4012074|FG002|Baseline (Day 1) up to Week 12|Death|0
2308681|NCT02712008|4012075|FG003|Baseline (Day 1) up to Week 12|Death|0
2308682|NCT02712008|4012076|FG004|Baseline (Day 1) up to Week 12|Death|0
2308683|NCT02712008|4012077|FG005|Baseline (Day 1) up to Week 12|Death|0
2308684|NCT02712008|4012078|FG006|Baseline (Day 1) up to Week 12|Death|0
2308685|NCT02712008|4012079|FG007|Baseline (Day 1) up to Week 12|Death|0
2308686|NCT02712008|4012072|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308687|NCT02712008|4012073|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
2308688|NCT02712008|4012074|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
2308689|NCT02712008|4012075|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308690|NCT02712008|4012076|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308691|NCT02712008|4012077|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308692|NCT02712008|4012078|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308693|NCT02712008|4012079|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308694|NCT02712008|4012072|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
2308695|NCT02712008|4012073|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308696|NCT02712008|4012074|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
2308697|NCT02712008|4012075|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308698|NCT02712008|4012076|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308699|NCT02712008|4012077|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308700|NCT02712008|4012078|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308701|NCT02712008|4012079|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308702|NCT02712008|4012072|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0
2308703|NCT02712008|4012073|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0
2308704|NCT02712008|4012074|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1
2308705|NCT02712008|4012075|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0
2308706|NCT02712008|4012076|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0
2308707|NCT02712008|4012077|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0
2308708|NCT02712008|4012078|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0
2308709|NCT02712008|4012079|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0
2308710|NCT02712008|4012072|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0
2308711|NCT02712008|4012073|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1
2308712|NCT02712008|4012074|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0
2308713|NCT02712008|4012075|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0
2308714|NCT02712008|4012076|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0
2308715|NCT02712008|4012077|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0
2308716|NCT02712008|4012078|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0
2308717|NCT02712008|4012079|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0
2355222|NCT00702702|4113559|FG000|Overall Study|Study prematurely terminated|56
2355223|NCT00699413|4113578|FG000|Overall Study|Withdrawal by Subject|0
2355224|NCT00699413|4113579|FG001|Overall Study|Withdrawal by Subject|2
2355225|NCT00699413|4113578|FG000|Overall Study|Study terminated by sponsor|4
2355226|NCT00699413|4113579|FG001|Overall Study|Study terminated by sponsor|2
2355227|NCT00686972|4113589|FG000|Overall Study|P.I, Left institution. Study terminated|51
2355228|NCT00693017|4113595|FG000|Overall Study|Sponsor Decision|2
2355229|NCT00693017|4113596|FG001|Overall Study|Sponsor Decision|1
2355230|NCT00693017|4113595|FG000|Overall Study|Death|0
2355231|NCT00693017|4113596|FG001|Overall Study|Death|1
2355232|NCT00692003|4113635|FG000|Overall Study|Sponsor Decision|5
2355233|NCT00692003|4113636|FG001|Overall Study|Sponsor Decision|1
2355234|NCT00678288|4113644|FG000|Overall Study|Adverse Event|0
2355235|NCT00678288|4113645|FG001|Overall Study|Adverse Event|2
2355236|NCT00678288|4113644|FG000|Overall Study|Withdrawal by Subject|1
2355237|NCT00678288|4113645|FG001|Overall Study|Withdrawal by Subject|1
2355238|NCT00678288|4113644|FG000|Overall Study|Study terminated by the sponsor|2
2355239|NCT00678288|4113645|FG001|Overall Study|Study terminated by the sponsor|0
2355240|NCT00678288|4113644|FG000|Overall Study|Not compliant with study medication|0
2355241|NCT00678288|4113645|FG001|Overall Study|Not compliant with study medication|1
2355242|NCT00678288|4113644|FG000|Overall Study|Switch to commercial drug|0
2355243|NCT00678288|4113645|FG001|Overall Study|Switch to commercial drug|1
2355244|NCT00678288|4113644|FG000|Overall Study|Reason not reported|1
2355245|NCT00678288|4113645|FG001|Overall Study|Reason not reported|0
2355246|NCT00678288|4113644|FG000|Overall Study|Disease progression/recurrence/relapse|6
2355247|NCT00678288|4113645|FG001|Overall Study|Disease progression/recurrence/relapse|1
2355248|NCT00689052|4113657|FG000|Overall Study|Adverse Event|4
2308718|NCT02712008|4012072|FG000|From Week 12 up to Week 36|Adverse Event|0
2308719|NCT02712008|4012073|FG001|From Week 12 up to Week 36|Adverse Event|0
2308720|NCT02712008|4012074|FG002|From Week 12 up to Week 36|Adverse Event|0
2308721|NCT02712008|4012075|FG003|From Week 12 up to Week 36|Adverse Event|0
2308722|NCT02712008|4012076|FG004|From Week 12 up to Week 36|Adverse Event|1
2308723|NCT02712008|4012077|FG005|From Week 12 up to Week 36|Adverse Event|0
2308724|NCT02712008|4012078|FG006|From Week 12 up to Week 36|Adverse Event|0
2308725|NCT02712008|4012079|FG007|From Week 12 up to Week 36|Adverse Event|2
2308726|NCT02712008|4012072|FG000|From Week 12 up to Week 36|Death|1
2308727|NCT02712008|4012073|FG001|From Week 12 up to Week 36|Death|0
2308728|NCT02712008|4012074|FG002|From Week 12 up to Week 36|Death|0
2308729|NCT02712008|4012075|FG003|From Week 12 up to Week 36|Death|0
2308730|NCT02712008|4012076|FG004|From Week 12 up to Week 36|Death|0
2308731|NCT02712008|4012077|FG005|From Week 12 up to Week 36|Death|0
2308732|NCT02712008|4012078|FG006|From Week 12 up to Week 36|Death|1
2308733|NCT02712008|4012079|FG007|From Week 12 up to Week 36|Death|0
2308734|NCT02712008|4012072|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
2308735|NCT02712008|4012073|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
2308736|NCT02712008|4012074|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
2308737|NCT02712008|4012075|FG003|From Week 12 up to Week 36|Lost to Follow-up|1
2308738|NCT02712008|4012076|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
2308739|NCT02712008|4012077|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
2308740|NCT02712008|4012078|FG006|From Week 12 up to Week 36|Lost to Follow-up|1
2308741|NCT02712008|4012079|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
2308742|NCT02712008|4012072|FG000|From Week 12 up to Week 36|Physician Decision|0
2308743|NCT02712008|4012073|FG001|From Week 12 up to Week 36|Physician Decision|0
2308744|NCT02712008|4012074|FG002|From Week 12 up to Week 36|Physician Decision|0
2308745|NCT02712008|4012075|FG003|From Week 12 up to Week 36|Physician Decision|1
2308746|NCT02712008|4012076|FG004|From Week 12 up to Week 36|Physician Decision|1
2308747|NCT02712008|4012077|FG005|From Week 12 up to Week 36|Physician Decision|0
2308748|NCT02712008|4012078|FG006|From Week 12 up to Week 36|Physician Decision|0
2308749|NCT02712008|4012079|FG007|From Week 12 up to Week 36|Physician Decision|0
2308750|NCT02712008|4012072|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0
2308751|NCT02712008|4012073|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0
2308752|NCT02712008|4012074|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0
2308753|NCT02712008|4012075|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0
2308754|NCT02712008|4012076|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0
2308755|NCT02712008|4012077|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0
2308756|NCT02712008|4012078|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3
2308757|NCT02712008|4012079|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2
2308758|NCT02712320|4012109|FG000|Overall Study|Lost to Follow-up|1
2308759|NCT02712320|4012109|FG000|Overall Study|Withdrawal by Subject|1
2308760|NCT02712320|4012109|FG000|Overall Study|Transferred to another facility|1
2308761|NCT02712320|4012109|FG000|Overall Study|Treating with the prohibited medications|2
2308762|NCT02712333|4012115|FG000|First Period|Withdrawal by Subject|3
2308763|NCT02712333|4012116|FG001|First Period|Withdrawal by Subject|2
2308764|NCT02712398|4012144|FG000|Overall Study|Withdrawal by Subject|6
2308765|NCT02712398|4012144|FG000|Overall Study|Lost to Follow-up|6
2308766|NCT02712398|4012144|FG000|Overall Study|Sponsor Decision|1
2308767|NCT02712398|4012144|FG000|Overall Study|Physician Decision|1
2308768|NCT02712398|4012144|FG000|Overall Study|Death|2
2308769|NCT02712398|4012144|FG000|Overall Study|Re-operation|21
2308770|NCT02712424|4012150|FG000|Overall Study|Lost to Follow-up|34
2355249|NCT00689052|4113658|FG001|Overall Study|Adverse Event|6
2355250|NCT00689052|4113657|FG000|Overall Study|Protocol Violation|1
2355251|NCT00689052|4113658|FG001|Overall Study|Protocol Violation|0
2355252|NCT00689052|4113657|FG000|Overall Study|Lost to Follow-up|2
2355253|NCT00689052|4113658|FG001|Overall Study|Lost to Follow-up|0
2355254|NCT00689052|4113657|FG000|Overall Study|Withdrawal by Subject|2
2355255|NCT00689052|4113658|FG001|Overall Study|Withdrawal by Subject|0
2355256|NCT00689052|4113657|FG000|Overall Study|Early termination of the trial|22
2355257|NCT00689052|4113658|FG001|Overall Study|Early termination of the trial|24
2355258|NCT00683917|4113678|FG000|Overall Study|Study prematurely terminated|10
2355259|NCT00686036|4113701|FG000|Overall Study|Adverse Event|3
2355260|NCT00686036|4113702|FG001|Overall Study|Adverse Event|0
2355261|NCT00686036|4113701|FG000|Overall Study|Withdrawal by Subject|3
2355262|NCT00686036|4113702|FG001|Overall Study|Withdrawal by Subject|1
2355263|NCT00686036|4113701|FG000|Overall Study|Study terminated by AstraZeneca|2
2355264|NCT00686036|4113702|FG001|Overall Study|Study terminated by AstraZeneca|1
2355265|NCT00686036|4113701|FG000|Overall Study|PSA ≥ 10ng/mL|1
2355266|NCT00686036|4113702|FG001|Overall Study|PSA ≥ 10ng/mL|0
2355267|NCT00686036|4113701|FG000|Overall Study|Other reasons not identified|0
2355268|NCT00686036|4113702|FG001|Overall Study|Other reasons not identified|4
2355269|NCT00683787|4113724|FG000|Overall Study|Progression|3
2355270|NCT00683787|4113725|FG001|Overall Study|Progression|3
2355271|NCT00683787|4113726|FG002|Overall Study|Progression|0
2355272|NCT00683787|4113724|FG000|Overall Study|Adverse Event|0
2355273|NCT00683787|4113725|FG001|Overall Study|Adverse Event|0
2355274|NCT00683787|4113726|FG002|Overall Study|Adverse Event|2
2355275|NCT00678041|4113741|FG000|Overall Study|Physician Decision|5
2355276|NCT00678041|4113742|FG001|Overall Study|Physician Decision|5
2355277|NCT00681629|4113760|FG000|Overall Study|Study termination|4
2355278|NCT00681629|4113761|FG001|Overall Study|Study termination|2
2355279|NCT00681629|4113760|FG000|Overall Study|Adverse Event|1
2308771|NCT02712424|4012151|FG001|Overall Study|Lost to Follow-up|32
2308772|NCT02712554|4012159|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0
2308773|NCT02712554|4012160|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13
2308774|NCT02712554|4012159|FG000|Part B: Qualification Phase|Sponsor Decision|0
2308775|NCT02712554|4012160|FG001|Part B: Qualification Phase|Sponsor Decision|4
2308776|NCT02712554|4012159|FG000|Part B: Qualification Phase|Withdrawal by Subject|0
2308777|NCT02712554|4012160|FG001|Part B: Qualification Phase|Withdrawal by Subject|3
2308778|NCT02712554|4012159|FG000|Part B: Qualification Phase|Adverse Event|0
2308779|NCT02712554|4012160|FG001|Part B: Qualification Phase|Adverse Event|1
2308780|NCT02712554|4012159|FG000|Part B: Treatment Phase|Adverse Event|0
2308781|NCT02712554|4012160|FG001|Part B: Treatment Phase|Adverse Event|1
2308782|NCT02712554|4012159|FG000|Part B: Treatment Phase|Withdrawal by Subject|0
2308783|NCT02712554|4012160|FG001|Part B: Treatment Phase|Withdrawal by Subject|1
2308784|NCT02712554|4012159|FG000|Part B: Treatment Phase|Other|0
2308785|NCT02712554|4012160|FG001|Part B: Treatment Phase|Other|1
2308786|NCT02712788|4012185|FG000|Overall Study|Physician Decision|1
2308787|NCT02712788|4012186|FG001|Overall Study|Physician Decision|0
2308788|NCT02712788|4012185|FG000|Overall Study|Protocol Violation|1
2308789|NCT02712788|4012186|FG001|Overall Study|Protocol Violation|0
2308790|NCT02712983|4012201|FG000|Treatment Phase|Adverse Event|3
2308791|NCT02712983|4012202|FG001|Treatment Phase|Adverse Event|1
2308792|NCT02712983|4012203|FG002|Treatment Phase|Adverse Event|1
2308793|NCT02712983|4012204|FG003|Treatment Phase|Adverse Event|4
2308794|NCT02712983|4012205|FG004|Treatment Phase|Adverse Event|3
2308795|NCT02712983|4012206|FG005|Treatment Phase|Adverse Event|0
2308796|NCT02712983|4012207|FG006|Treatment Phase|Adverse Event|6
2308797|NCT02712983|4012208|FG007|Treatment Phase|Adverse Event|6
2308798|NCT02712983|4012209|FG008|Treatment Phase|Adverse Event|1
2308799|NCT02712983|4012201|FG000|Treatment Phase|Protocol Deviation|0
2308800|NCT02712983|4012202|FG001|Treatment Phase|Protocol Deviation|0
2308801|NCT02712983|4012203|FG002|Treatment Phase|Protocol Deviation|0
2308802|NCT02712983|4012204|FG003|Treatment Phase|Protocol Deviation|2
2308803|NCT02712983|4012205|FG004|Treatment Phase|Protocol Deviation|0
2308804|NCT02712983|4012206|FG005|Treatment Phase|Protocol Deviation|0
2308805|NCT02712983|4012207|FG006|Treatment Phase|Protocol Deviation|1
2308806|NCT02712983|4012208|FG007|Treatment Phase|Protocol Deviation|0
2308807|NCT02712983|4012209|FG008|Treatment Phase|Protocol Deviation|0
2308808|NCT02712983|4012201|FG000|Treatment Phase|Technical Problems|0
2308809|NCT02712983|4012202|FG001|Treatment Phase|Technical Problems|0
2355280|NCT00681629|4113761|FG001|Overall Study|Adverse Event|0
2308810|NCT02712983|4012203|FG002|Treatment Phase|Technical Problems|0
2308811|NCT02712983|4012204|FG003|Treatment Phase|Technical Problems|0
2308812|NCT02712983|4012205|FG004|Treatment Phase|Technical Problems|0
2308813|NCT02712983|4012206|FG005|Treatment Phase|Technical Problems|0
2308814|NCT02712983|4012207|FG006|Treatment Phase|Technical Problems|1
2308815|NCT02712983|4012208|FG007|Treatment Phase|Technical Problems|0
2308816|NCT02712983|4012209|FG008|Treatment Phase|Technical Problems|0
2308817|NCT02712983|4012201|FG000|Treatment Phase|Physician Decision|0
2308818|NCT02712983|4012202|FG001|Treatment Phase|Physician Decision|0
2308819|NCT02712983|4012203|FG002|Treatment Phase|Physician Decision|0
2355281|NCT00673361|4113821|FG000|Overall Study|Screen Failure|2
2355282|NCT00673179|4113838|FG000|Overall Study|Toxicity/Complications|3
2355283|NCT00673179|4113839|FG001|Overall Study|Toxicity/Complications|0
2355284|NCT00660348|4113858|FG000|Overall Study|Withdrawal by Subject|1
2355285|NCT00660348|4113859|FG001|Overall Study|Withdrawal by Subject|0
2355286|NCT00664066|4113865|FG000|Overall Study|Study terminated|3
2355287|NCT00667017|4113869|FG000|Overall Study|Withdrawal by Subject|1
2355288|NCT00665444|4113873|FG000|Overall Study|Physician Decision|1
2355289|NCT00665444|4113873|FG000|Overall Study|Study Terminated by Study Sponsor|1
2355290|NCT00660595|4113888|FG000|Overall Study|Lost to Follow-up|0
2355291|NCT00660595|4113889|FG001|Overall Study|Lost to Follow-up|1
2355292|NCT00660595|4113888|FG000|Overall Study|Did not consent to participate in study|12
2355293|NCT00660595|4113889|FG001|Overall Study|Did not consent to participate in study|8
2355294|NCT00660595|4113888|FG000|Overall Study|Participant left hospital|1
2355295|NCT00660595|4113889|FG001|Overall Study|Participant left hospital|0
2355296|NCT00660595|4113888|FG000|Overall Study|Non Specified reasons|5
2355297|NCT00660595|4113889|FG001|Overall Study|Non Specified reasons|0
2355298|NCT00646282|4113906|FG000|Overall Study|Protocol terminated|4
2355299|NCT00646282|4113907|FG001|Overall Study|Protocol terminated|4
2355300|NCT00657553|4113915|FG000|Overall Study|low accrual, no analysis run|5
2355301|NCT00657553|4113916|FG001|Overall Study|low accrual, no analysis run|5
2355302|NCT00648895|4113937|FG000|Overall Study|Lack of Efficacy|0
2355303|NCT00648895|4113938|FG001|Overall Study|Lack of Efficacy|1
2355304|NCT00647426|4113944|FG000|Overall Study|Withdrawal by Subject|2
2355305|NCT00645567|4113949|FG000|Overall Study|Adverse Event|1
2355306|NCT00637806|4113960|FG000|Double-blind Phase|Study Discontinued|2
2355307|NCT00637806|4113961|FG001|Double-blind Phase|Study Discontinued|0
2355308|NCT00637806|4113962|FG002|Double-blind Phase|Study Discontinued|1
2355309|NCT00637806|4113963|FG003|Double-blind Phase|Study Discontinued|0
2355310|NCT00637806|4113960|FG000|Extension Phase|Study Discontinued|0
2355311|NCT00637806|4113961|FG001|Extension Phase|Study Discontinued|0
2355312|NCT00637806|4113962|FG002|Extension Phase|Study Discontinued|0
2355313|NCT00637806|4113963|FG003|Extension Phase|Study Discontinued|1
2355314|NCT00629798|4113988|FG000|Overall Study|Not Treated|4
2355315|NCT00637728|4113998|FG000|Double-blind Phase|Adverse Event|1
2355316|NCT00637728|4113999|FG001|Double-blind Phase|Adverse Event|0
2355317|NCT00637728|4114000|FG002|Double-blind Phase|Adverse Event|0
2355318|NCT00637728|4113998|FG000|Double-blind Phase|Non-compliance|2
2355319|NCT00637728|4113999|FG001|Double-blind Phase|Non-compliance|0
2355320|NCT00637728|4114000|FG002|Double-blind Phase|Non-compliance|0
2355321|NCT00637728|4113998|FG000|Double-blind Phase|Study Discontinued|1
2355322|NCT00637728|4113999|FG001|Double-blind Phase|Study Discontinued|1
2308820|NCT02712983|4012204|FG003|Treatment Phase|Physician Decision|0
2308821|NCT02712983|4012205|FG004|Treatment Phase|Physician Decision|0
2308822|NCT02712983|4012206|FG005|Treatment Phase|Physician Decision|0
2308823|NCT02712983|4012207|FG006|Treatment Phase|Physician Decision|0
2308824|NCT02712983|4012208|FG007|Treatment Phase|Physician Decision|1
2308825|NCT02712983|4012209|FG008|Treatment Phase|Physician Decision|1
2308826|NCT02712983|4012201|FG000|Treatment Phase|Subject Decision|2
2308827|NCT02712983|4012202|FG001|Treatment Phase|Subject Decision|0
2308828|NCT02712983|4012203|FG002|Treatment Phase|Subject Decision|0
2308829|NCT02712983|4012204|FG003|Treatment Phase|Subject Decision|2
2308830|NCT02712983|4012205|FG004|Treatment Phase|Subject Decision|1
2308831|NCT02712983|4012206|FG005|Treatment Phase|Subject Decision|0
2308832|NCT02712983|4012207|FG006|Treatment Phase|Subject Decision|1
2308833|NCT02712983|4012208|FG007|Treatment Phase|Subject Decision|2
2308834|NCT02712983|4012209|FG008|Treatment Phase|Subject Decision|0
2308835|NCT02712983|4012201|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
2308836|NCT02712983|4012202|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
2308837|NCT02712983|4012203|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
2308838|NCT02712983|4012204|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
2308839|NCT02712983|4012205|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
2308840|NCT02712983|4012206|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
2308841|NCT02712983|4012207|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
2308842|NCT02712983|4012208|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
2308843|NCT02712983|4012209|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
2308844|NCT02712983|4012201|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
2308845|NCT02712983|4012202|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
2308846|NCT02712983|4012203|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
2308847|NCT02712983|4012204|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1
2308848|NCT02712983|4012205|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
2308849|NCT02712983|4012206|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
2308850|NCT02712983|4012207|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
2308851|NCT02712983|4012208|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
2308852|NCT02712983|4012209|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
2308853|NCT02712983|4012201|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
2308854|NCT02712983|4012202|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
2308855|NCT02712983|4012203|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
2308856|NCT02712983|4012204|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
2308857|NCT02712983|4012205|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
2355323|NCT00637728|4114000|FG002|Double-blind Phase|Study Discontinued|0
2355324|NCT00637416|4114035|FG000|Overall Study|Lost to Follow-up|1
2355325|NCT00637416|4114036|FG001|Overall Study|Lost to Follow-up|1
2355326|NCT00637416|4114035|FG000|Overall Study|Unable to take study drug|0
2355327|NCT00637416|4114036|FG001|Overall Study|Unable to take study drug|1
2308858|NCT02712983|4012206|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
2308859|NCT02712983|4012207|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
2308860|NCT02712983|4012208|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
2308861|NCT02712983|4012209|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
2308862|NCT02712996|4012231|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0
2308863|NCT02712996|4012232|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1
2308864|NCT02713204|4012256|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1
2308865|NCT02713204|4012257|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0
2308866|NCT02713204|4012258|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1
2308867|NCT02713204|4012259|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0
2308868|NCT02713204|4012260|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0
2308869|NCT02713204|4012261|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0
2308870|NCT02713204|4012262|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0
2308871|NCT02713204|4012263|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0
2308872|NCT02713204|4012256|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308873|NCT02713204|4012257|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308874|NCT02713204|4012258|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
2308875|NCT02713204|4012259|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308876|NCT02713204|4012260|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308877|NCT02713204|4012261|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308878|NCT02713204|4012262|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308879|NCT02713204|4012263|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2308880|NCT02713204|4012256|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308881|NCT02713204|4012257|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
2308882|NCT02713204|4012258|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308883|NCT02713204|4012259|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308884|NCT02713204|4012260|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308885|NCT02713204|4012261|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308886|NCT02713204|4012262|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308887|NCT02713204|4012263|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2308888|NCT02713204|4012256|FG000|From Week 12 up to Week 36|Adverse Event|1
2308889|NCT02713204|4012257|FG001|From Week 12 up to Week 36|Adverse Event|0
2308890|NCT02713204|4012258|FG002|From Week 12 up to Week 36|Adverse Event|0
2308891|NCT02713204|4012259|FG003|From Week 12 up to Week 36|Adverse Event|1
2308892|NCT02713204|4012260|FG004|From Week 12 up to Week 36|Adverse Event|1
2308893|NCT02713204|4012261|FG005|From Week 12 up to Week 36|Adverse Event|0
2308894|NCT02713204|4012262|FG006|From Week 12 up to Week 36|Adverse Event|2
2308895|NCT02713204|4012263|FG007|From Week 12 up to Week 36|Adverse Event|1
2308896|NCT02713204|4012256|FG000|From Week 12 up to Week 36|Death|0
2308897|NCT02713204|4012257|FG001|From Week 12 up to Week 36|Death|0
2308898|NCT02713204|4012258|FG002|From Week 12 up to Week 36|Death|0
2308899|NCT02713204|4012259|FG003|From Week 12 up to Week 36|Death|1
2308900|NCT02713204|4012260|FG004|From Week 12 up to Week 36|Death|0
2308901|NCT02713204|4012261|FG005|From Week 12 up to Week 36|Death|1
2308902|NCT02713204|4012262|FG006|From Week 12 up to Week 36|Death|0
2308903|NCT02713204|4012263|FG007|From Week 12 up to Week 36|Death|3
2308904|NCT02713204|4012256|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
2308905|NCT02713204|4012257|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
2308906|NCT02713204|4012258|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
2308907|NCT02713204|4012259|FG003|From Week 12 up to Week 36|Lost to Follow-up|2
2308908|NCT02713204|4012260|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
2308909|NCT02713204|4012261|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
2308910|NCT02713204|4012262|FG006|From Week 12 up to Week 36|Lost to Follow-up|0
2308911|NCT02713204|4012263|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
2308912|NCT02713204|4012256|FG000|From Week 12 up to Week 36|Participant Re-located|0
2308913|NCT02713204|4012257|FG001|From Week 12 up to Week 36|Participant Re-located|0
2308914|NCT02713204|4012258|FG002|From Week 12 up to Week 36|Participant Re-located|0
2308915|NCT02713204|4012259|FG003|From Week 12 up to Week 36|Participant Re-located|0
2308916|NCT02713204|4012260|FG004|From Week 12 up to Week 36|Participant Re-located|1
2308917|NCT02713204|4012261|FG005|From Week 12 up to Week 36|Participant Re-located|0
2308918|NCT02713204|4012262|FG006|From Week 12 up to Week 36|Participant Re-located|0
2308919|NCT02713204|4012263|FG007|From Week 12 up to Week 36|Participant Re-located|0
2308920|NCT02713243|4012294|FG000|Overall Study|Abnormal laboratory value(s)#|1
2308921|NCT02713243|4012295|FG001|Overall Study|Abnormal laboratory value(s)#|0
2308922|NCT02713243|4012294|FG000|Overall Study|Administrative problems|0
2308923|NCT02713243|4012295|FG001|Overall Study|Administrative problems|1
2308924|NCT02713243|4012294|FG000|Overall Study|Protocol deviation|0
2308925|NCT02713243|4012295|FG001|Overall Study|Protocol deviation|1
2308926|NCT02713490|4012311|FG000|Overall Study|Withdrawal by Subject|2
2308927|NCT02713490|4012312|FG001|Overall Study|Withdrawal by Subject|1
2308928|NCT02713490|4012311|FG000|Overall Study|Did not receive study drug|1
2308929|NCT02713490|4012312|FG001|Overall Study|Did not receive study drug|0
2355328|NCT00631137|4114086|FG000|Overall Study|Withdrawal by Subject|1
2355329|NCT00631137|4114087|FG001|Overall Study|Withdrawal by Subject|0
2355330|NCT00633061|4114104|FG000|Overall Study|Study closed|86
2355331|NCT00633061|4114105|FG001|Overall Study|Study closed|0
2355332|NCT00630292|4114117|FG000|Overall Study|Withdrawal by Subject|1
2355333|NCT00634010|4114123|FG000|Overall Study|Adverse Event|2
2355334|NCT00634010|4114124|FG001|Overall Study|Adverse Event|5
2355335|NCT00634010|4114123|FG000|Overall Study|Withdrawal by Subject|5
2355336|NCT00634010|4114124|FG001|Overall Study|Withdrawal by Subject|6
2355337|NCT00634010|4114123|FG000|Overall Study|Physician Decision|1
2355338|NCT00634010|4114124|FG001|Overall Study|Physician Decision|1
2355339|NCT00634010|4114123|FG000|Overall Study|Disease Progression|1
2355340|NCT00634010|4114124|FG001|Overall Study|Disease Progression|1
2355341|NCT00634010|4114123|FG000|Overall Study|Non-Compliant|1
2355342|NCT00634010|4114124|FG001|Overall Study|Non-Compliant|1
2355343|NCT00626561|4114174|FG000|Overall Study|Withdrawal by Subject|2
2355344|NCT00626561|4114174|FG000|Overall Study|Disease Progression|2
2355345|NCT00613730|4114178|FG000|Overall Study|Disease progression|2
2355346|NCT00613730|4114178|FG000|Overall Study|Administrative decision|1
2355347|NCT00625586|4114182|FG000|Overall Study|Adverse Event|1
2355348|NCT00625742|4114190|FG000|Overall Study|Disease Progression|2
2355349|NCT00625742|4114190|FG000|Overall Study|Withdrawal by Subject|1
2355350|NCT00625742|4114190|FG000|Overall Study|Adverse Event|4
2355351|NCT00625742|4114190|FG000|Overall Study|Lost to Follow-up|4
2355352|NCT00625742|4114190|FG000|Overall Study|Ineligible|1
2355353|NCT00619151|4114200|FG000|Overall Study|Study terminated prior to followup|1
2355354|NCT00619151|4114201|FG001|Overall Study|Study terminated prior to followup|0
2355355|NCT00622167|4114207|FG000|Overall Study|Did not meet angiographic criteria|20
2355356|NCT00616759|4114226|FG000|Overall Study|Physician Decision|2
2355357|NCT00616759|4114227|FG001|Overall Study|Physician Decision|0
2355358|NCT00616759|4114226|FG000|Overall Study|Withdrawal by Subject|1
2355359|NCT00616759|4114227|FG001|Overall Study|Withdrawal by Subject|2
2355360|NCT00616642|4114235|FG000|Overall Study|Withdrawal by Subject|0
2355361|NCT00616642|4114236|FG001|Overall Study|Withdrawal by Subject|1
2355362|NCT00619515|4114242|FG000|Overall Study|Study Termination by IRB|73
2355363|NCT00612677|4114250|FG000|Overall Study|study closed before treatment started|1
2355364|NCT00616603|4114257|FG000|Overall Study|Physician Decision|2
2355365|NCT00616603|4114258|FG001|Overall Study|Physician Decision|0
2355366|NCT00616603|4114259|FG002|Overall Study|Physician Decision|2
2355367|NCT00609765|4114300|FG000|Overall Study|Study ended prior to 12 months|1
2355368|NCT00595920|4114325|FG000|Overall Study|The OLTERMS study was discontinued by th|116
2355369|NCT00596947|4114331|FG000|Overall Study|study halted due to low enrollment|5
2355370|NCT00596947|4114332|FG001|Overall Study|study halted due to low enrollment|3
2355371|NCT00596947|4114331|FG000|Overall Study|Lost to Follow-up|1
2355372|NCT00596947|4114332|FG001|Overall Study|Lost to Follow-up|0
2355373|NCT00584012|4114338|FG000|Overall Study|Withdrawal by Subject|1
2355374|NCT00577772|4114374|FG000|Overall Study|Lost to Follow-up|0
2355375|NCT00577772|4114375|FG001|Overall Study|Lost to Follow-up|1
2355376|NCT00592007|4114381|FG000|Overall Study|Withdrawal by Subject|1
2355377|NCT00592007|4114381|FG000|Overall Study|patient ineligible (out of lab range)|1
2355378|NCT00595582|4114385|FG000|Overall Study|Pilot study that PI terminated|2
2355379|NCT00595582|4114385|FG000|Overall Study|Lost to Follow-up|1
2355380|NCT00595582|4114385|FG000|Overall Study|Adverse Event|2
2355381|NCT00595582|4114385|FG000|Overall Study|Physician Decision|5
2355382|NCT00588146|4114389|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4
2355383|NCT00588146|4114390|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3
2355384|NCT00590538|4114405|FG000|Overall Study|Study terminated before completed|2
2355385|NCT00583115|4114409|FG000|Overall Study|Death|1
2212388|NCT01668797|3853355|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
2212389|NCT01668797|3853356|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
2212390|NCT01668797|3853353|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
2212391|NCT01668797|3853354|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
2212392|NCT01668797|3853355|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
2212393|NCT01668797|3853356|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
2212394|NCT01668797|3853353|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
2212395|NCT01668797|3853354|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
2212396|NCT01668797|3853355|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
2212397|NCT01668797|3853356|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
2212398|NCT01668797|3853353|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
2212399|NCT01668797|3853354|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
2212400|NCT01668797|3853355|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
2212401|NCT01668797|3853356|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
2212402|NCT01668797|3853353|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
2212403|NCT01668797|3853354|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
2212404|NCT01668797|3853355|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
2212405|NCT01668797|3853356|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
2212406|NCT01668797|3853353|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
2212407|NCT01668797|3853354|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
2212408|NCT01668797|3853355|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
2212409|NCT01668797|3853356|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
2212410|NCT01668797|3853353|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
2212411|NCT01668797|3853354|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
2308930|NCT02713490|4012311|FG000|Overall Study|Met exclusion criteria|0
2308931|NCT02713490|4012312|FG001|Overall Study|Met exclusion criteria|1
2212412|NCT01668797|3853355|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
2212413|NCT01668797|3853356|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
2212414|NCT01668797|3853353|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
2212415|NCT01668797|3853354|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
2212416|NCT01668797|3853355|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
2212417|NCT01668797|3853356|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
2212418|NCT01668797|3853353|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
2212419|NCT01668797|3853354|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
2212420|NCT01668797|3853355|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
2212421|NCT01668797|3853356|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
2212422|NCT01668966|3853386|FG000|Overall Study|Withdrawal by Subject|1
2308932|NCT02713529|4012325|FG000|Overall Study|Withdrawal by Subject|3
2308933|NCT02713529|4012326|FG001|Overall Study|Withdrawal by Subject|1
2308934|NCT02713529|4012327|FG002|Overall Study|Withdrawal by Subject|4
2308935|NCT02713529|4012328|FG003|Overall Study|Withdrawal by Subject|2
2308936|NCT02713529|4012329|FG004|Overall Study|Withdrawal by Subject|0
2308937|NCT02713529|4012330|FG005|Overall Study|Withdrawal by Subject|1
2308938|NCT02713529|4012331|FG006|Overall Study|Withdrawal by Subject|1
2308939|NCT02713529|4012325|FG000|Overall Study|Lost to Follow-up|1
2308940|NCT02713529|4012326|FG001|Overall Study|Lost to Follow-up|0
2308941|NCT02713529|4012327|FG002|Overall Study|Lost to Follow-up|1
2308942|NCT02713529|4012328|FG003|Overall Study|Lost to Follow-up|0
2308943|NCT02713529|4012329|FG004|Overall Study|Lost to Follow-up|0
2308944|NCT02713529|4012330|FG005|Overall Study|Lost to Follow-up|0
2308945|NCT02713529|4012331|FG006|Overall Study|Lost to Follow-up|0
2308946|NCT02713529|4012325|FG000|Overall Study|Death|3
2308947|NCT02713529|4012326|FG001|Overall Study|Death|3
2308948|NCT02713529|4012327|FG002|Overall Study|Death|26
2308949|NCT02713529|4012328|FG003|Overall Study|Death|27
2308950|NCT02713529|4012329|FG004|Overall Study|Death|3
2308951|NCT02713529|4012330|FG005|Overall Study|Death|13
2212423|NCT01668966|3853386|FG000|Overall Study|Death|1
2212424|NCT01668966|3853386|FG000|Overall Study|Not treated|2
2212425|NCT01669122|3853394|FG000|Period I|Lost to Follow-up|1
2212426|NCT01669122|3853394|FG000|Washout Period II|Protocol Violation|2
2212427|NCT01669174|3853407|FG000|Overall Study|Subject withdrew consent|2
2212428|NCT01669174|3853408|FG001|Overall Study|Subject withdrew consent|2
2212429|NCT01669174|3853407|FG000|Overall Study|Lost to Follow-up|1
2355386|NCT00582712|4114413|FG000|Overall Study|Adverse Event|1
2355387|NCT00582712|4114413|FG000|Overall Study|Lack of Efficacy|1
2355388|NCT00582712|4114413|FG000|Overall Study|Withdrawal by Subject|1
2355389|NCT00582712|4114413|FG000|Overall Study|Complicating disease requiring treatment|1
2355390|NCT00587795|4114444|FG000|Overall Study|Withdrawal by Subject|1
2355391|NCT00587795|4114445|FG001|Overall Study|Withdrawal by Subject|0
2355392|NCT00590135|4114451|FG000|Overall Study|Primary endpoint measure not obtainable|59
2355393|NCT00582036|4114458|FG000|Overall Study|Withdrawal by Subject|0
2355394|NCT00582036|4114459|FG001|Overall Study|Withdrawal by Subject|1
2355395|NCT00585585|4114465|FG000|Overall Study|Adverse Event|1
2355396|NCT00585221|4114469|FG000|Overall Study|Protocol Violation|8
2355397|NCT00581113|4114475|FG000|Overall Study|Withdrawal by Subject|0
2355398|NCT00581113|4114476|FG001|Overall Study|Withdrawal by Subject|1
2355399|NCT00579254|4114482|FG000|Overall Study|Lost to Follow-up|39
2355400|NCT00579254|4114482|FG000|Overall Study|Discontinued when study terminated|73
2355401|NCT00587223|4114486|FG000|Overall Study|Adverse Event|1
2355402|NCT00577395|4114517|FG000|Overall Study|Study was terminated early by Sponsor|7
2355403|NCT00577395|4114518|FG001|Overall Study|Study was terminated early by Sponsor|6
2355404|NCT00573391|4114526|FG000|Overall Study|study stopped|2
2355405|NCT00573391|4114527|FG001|Overall Study|study stopped|2
2355406|NCT00573391|4114526|FG000|Overall Study|Death|1
2355407|NCT00573391|4114527|FG001|Overall Study|Death|0
2355408|NCT00574080|4114571|FG000|Overall Study|Death|10
2355409|NCT00574080|4114572|FG001|Overall Study|Death|10
2355410|NCT00558558|4114578|FG000|Overall Study|Unable to swallow|1
2355411|NCT00558558|4114578|FG000|Overall Study|Withdrawal by Subject|1
2355412|NCT00558558|4114578|FG000|Overall Study|Lack of Efficacy|4
2355413|NCT00573937|4114588|FG000|Overall Study|Study Terminated|0
2355414|NCT00573937|4114589|FG001|Overall Study|Study Terminated|1
2355415|NCT00577317|4114597|FG000|Overall Study|Study Terminated|0
2355416|NCT00577317|4114598|FG001|Overall Study|Study Terminated|2
2355417|NCT00571922|4114606|FG000|Overall Study|Completion unknown|36
2355418|NCT00571922|4114607|FG001|Overall Study|Completion unknown|36
2355419|NCT00573157|4114619|FG000|Overall Study|Adverse Event|3
2355420|NCT00573157|4114620|FG001|Overall Study|Adverse Event|1
2355421|NCT00573157|4114619|FG000|Overall Study|Other|1
2355422|NCT00573157|4114620|FG001|Overall Study|Other|1
2355423|NCT00561912|4114639|FG000|Overall Study|ineligible|1
2355424|NCT00561795|4114645|FG000|Overall Study|Adverse Event|3
2355425|NCT00561795|4114646|FG001|Overall Study|Adverse Event|3
2355426|NCT00561795|4114647|FG002|Overall Study|Adverse Event|0
2355427|NCT00561795|4114648|FG003|Overall Study|Adverse Event|0
2355428|NCT00561795|4114645|FG000|Overall Study|Study Closed/Terminated|0
2355429|NCT00561795|4114646|FG001|Overall Study|Study Closed/Terminated|3
2355430|NCT00561795|4114647|FG002|Overall Study|Study Closed/Terminated|0
2355431|NCT00561795|4114648|FG003|Overall Study|Study Closed/Terminated|0
2355432|NCT00561795|4114645|FG000|Overall Study|Physician Decision|1
2355433|NCT00561795|4114646|FG001|Overall Study|Physician Decision|0
2355434|NCT00561795|4114647|FG002|Overall Study|Physician Decision|0
2355435|NCT00561795|4114648|FG003|Overall Study|Physician Decision|0
2355436|NCT00556075|4114684|FG000|Overall Study|Lost to Follow-up|3
2355437|NCT00556075|4114685|FG001|Overall Study|Lost to Follow-up|0
2355438|NCT00556075|4114686|FG002|Overall Study|Lost to Follow-up|3
2212430|NCT01669174|3853408|FG001|Overall Study|Lost to Follow-up|0
2355439|NCT00556075|4114684|FG000|Overall Study|Withdrawal by Subject|3
2355440|NCT00556075|4114685|FG001|Overall Study|Withdrawal by Subject|3
2212431|NCT01669174|3853407|FG000|Overall Study|Adverse Event|2
2212432|NCT01669174|3853408|FG001|Overall Study|Adverse Event|2
2355441|NCT00556075|4114686|FG002|Overall Study|Withdrawal by Subject|0
2355442|NCT00556075|4114684|FG000|Overall Study|Protocol Violation|1
2355443|NCT00556075|4114685|FG001|Overall Study|Protocol Violation|1
2355444|NCT00556075|4114686|FG002|Overall Study|Protocol Violation|3
2355445|NCT00556075|4114684|FG000|Overall Study|Not eligible|1
2355446|NCT00556075|4114685|FG001|Overall Study|Not eligible|1
2355447|NCT00556075|4114686|FG002|Overall Study|Not eligible|2
2355448|NCT00556075|4114684|FG000|Overall Study|Adverse Event|1
2355449|NCT00556075|4114685|FG001|Overall Study|Adverse Event|2
2355450|NCT00556075|4114686|FG002|Overall Study|Adverse Event|0
2355451|NCT00556075|4114684|FG000|Overall Study|Personal issues|4
2355452|NCT00556075|4114685|FG001|Overall Study|Personal issues|1
2355453|NCT00556075|4114686|FG002|Overall Study|Personal issues|0
2355454|NCT00556075|4114684|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0
2355455|NCT00556075|4114685|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1
2355456|NCT00556075|4114686|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0
2355457|NCT00556166|4114698|FG000|Overall Study|Withdrawal by Subject|1
2212433|NCT01669174|3853407|FG000|Overall Study|Administrative problems|1
2212434|NCT01669174|3853408|FG001|Overall Study|Administrative problems|2
2355458|NCT00539838|4114722|FG000|Overall Study|Fail to return|2
2355459|NCT00539838|4114723|FG001|Overall Study|Fail to return|0
2355460|NCT00539838|4114724|FG002|Overall Study|Fail to return|0
2355461|NCT00539838|4114722|FG000|Overall Study|Withdrawal by Subject|0
2355462|NCT00539838|4114723|FG001|Overall Study|Withdrawal by Subject|4
2355463|NCT00539838|4114724|FG002|Overall Study|Withdrawal by Subject|0
2355464|NCT00539838|4114722|FG000|Overall Study|Death|0
2355465|NCT00539838|4114723|FG001|Overall Study|Death|2
2355466|NCT00539838|4114724|FG002|Overall Study|Death|0
2355467|NCT00539838|4114722|FG000|Overall Study|Did not cooperate|1
2355468|NCT00539838|4114723|FG001|Overall Study|Did not cooperate|0
2355469|NCT00539838|4114724|FG002|Overall Study|Did not cooperate|1
2355470|NCT00539838|4114722|FG000|Overall Study|Administrative|4
2355471|NCT00539838|4114723|FG001|Overall Study|Administrative|0
2355472|NCT00539838|4114724|FG002|Overall Study|Administrative|8
2355473|NCT00549328|4114734|FG000|Overall Study|Adverse Event|2
2355474|NCT00549328|4114734|FG000|Overall Study|Disease Progression|10
2308952|NCT02713529|4012331|FG006|Overall Study|Death|3
2308953|NCT02713542|4012353|FG000|Overall Study|Use of prohibited medication|14
2355475|NCT00549328|4114734|FG000|Overall Study|Death|1
2355476|NCT00549328|4114734|FG000|Overall Study|Use of Prohibited Medication|1
2355477|NCT00548327|4114740|FG000|Overall Study|Adverse Event|0
2355478|NCT00548327|4114741|FG001|Overall Study|Adverse Event|1
2355479|NCT00547300|4114772|FG000|Overall Study|Study was Administratively Terminated|25
2355480|NCT00547300|4114773|FG001|Overall Study|Study was Administratively Terminated|24
2355481|NCT00547300|4114772|FG000|Overall Study|Did not Meet Entry Criteria|0
2355482|NCT00547300|4114773|FG001|Overall Study|Did not Meet Entry Criteria|2
2355483|NCT00535262|4114805|FG000|Overall Study|No funding|3
2355484|NCT00537199|4114822|FG000|Overall Study|Study Terminated|1
2355485|NCT00536978|4114832|FG000|Overall Study|Not eligible for Adback Infusion|22
2355486|NCT00524485|4114836|FG000|Overall Study|Withdrawal by Subject|5
2355487|NCT00524134|4114858|FG000|Overall Study|Withdrawal by Subject|1
2355488|NCT00524134|4114858|FG000|Overall Study|Physician Decision|1
2355489|NCT00527748|4114862|FG000|Overall Study|Other|3
2355490|NCT00517699|4114866|FG000|Overall Study|Withdrawal by Subject|1
2355491|NCT00517699|4114866|FG000|Overall Study|Lack of Efficacy|1
2355492|NCT00517699|4114866|FG000|Overall Study|Administrative error|1
2355493|NCT00517699|4114866|FG000|Overall Study|Study terminated by Sponsor|2
2355494|NCT00528775|4114870|FG000|Overall Study|Other not specified|1
2355495|NCT00527982|4114906|FG000|Overall Study|Physician Decision|1
2355496|NCT00527982|4114907|FG001|Overall Study|Physician Decision|0
2355497|NCT00524459|4114913|FG000|Overall Study|Withdrawal by Subject|1
2355498|NCT00524459|4114913|FG000|Overall Study|Other|1
2355499|NCT00517361|4114917|FG000|Overall Study|Death|6
2355500|NCT00517361|4114917|FG000|Overall Study|The study was terminated|5
2355501|NCT00522457|4114929|FG000|Overall Study|Due to disease progression|16
2355502|NCT00522457|4114929|FG000|Overall Study|Adverse Event|2
2355503|NCT00526331|4114933|FG000|Overall Study|Sponsor Termination|55
2355504|NCT00522301|4114954|FG000|Overall Study|Withdrawal by Subject|1
2355505|NCT00522301|4114954|FG000|Overall Study|Adverse Event|5
2355506|NCT00517192|4114960|FG000|Overall Study|Adverse Event|1
2355507|NCT00517192|4114961|FG001|Overall Study|Adverse Event|1
2355508|NCT00517192|4114960|FG000|Overall Study|Lost to Follow-up|1
2355509|NCT00517192|4114961|FG001|Overall Study|Lost to Follow-up|1
2308954|NCT02713542|4012354|FG001|Overall Study|Use of prohibited medication|5
2308955|NCT02713542|4012353|FG000|Overall Study|Withdrawal by Subject|4
2308956|NCT02713542|4012354|FG001|Overall Study|Withdrawal by Subject|1
2308957|NCT02713594|4012362|FG000|Overall Study|Withdrawal by Subject|32
2308958|NCT02713594|4012363|FG001|Overall Study|Withdrawal by Subject|22
2308959|NCT02713594|4012362|FG000|Overall Study|Lost to Follow-up|358
2308960|NCT02713594|4012363|FG001|Overall Study|Lost to Follow-up|374
2308961|NCT02713789|4012412|FG000|Overall Study|Lost to Follow-up|0
2308962|NCT02713789|4012413|FG001|Overall Study|Lost to Follow-up|1
2355510|NCT00517192|4114960|FG000|Overall Study|Withdrawal by Subject|1
2355511|NCT00517192|4114961|FG001|Overall Study|Withdrawal by Subject|0
2355512|NCT00517192|4114960|FG000|Overall Study|Early termination of the trial|16
2355513|NCT00517192|4114961|FG001|Overall Study|Early termination of the trial|18
2355514|NCT00503581|4114974|FG000|Overall Study|Study closed|3
2355515|NCT00503581|4114975|FG001|Overall Study|Study closed|4
2355516|NCT00503581|4114976|FG002|Overall Study|Study closed|2
2355517|NCT00509600|4114984|FG000|Overall Study|Adverse Event|1
2355518|NCT00515112|4114990|FG000|Overall Study|Death|0
2355519|NCT00515112|4114991|FG001|Overall Study|Death|1
2355520|NCT00515112|4114990|FG000|Overall Study|The study was terminated|3
2355521|NCT00515112|4114991|FG001|Overall Study|The study was terminated|2
2355522|NCT00508872|4114997|FG000|Overall Study|Lost to Follow-up|1
2355523|NCT00508872|4114997|FG000|Overall Study|Physician Decision|1
2355524|NCT00514813|4115005|FG000|Overall Study|Study terminated|14
2355525|NCT00514813|4115006|FG001|Overall Study|Study terminated|74
2355526|NCT00514813|4115007|FG002|Overall Study|Study terminated|40
2355527|NCT00514813|4115008|FG003|Overall Study|Study terminated|2
2355528|NCT00514813|4115005|FG000|Overall Study|Adverse Event|0
2355529|NCT00514813|4115006|FG001|Overall Study|Adverse Event|2
2355530|NCT00514813|4115007|FG002|Overall Study|Adverse Event|2
2355531|NCT00514813|4115008|FG003|Overall Study|Adverse Event|0
2355532|NCT00514813|4115005|FG000|Overall Study|Protocol Violation|1
2355533|NCT00514813|4115006|FG001|Overall Study|Protocol Violation|0
2355534|NCT00514813|4115007|FG002|Overall Study|Protocol Violation|0
2355535|NCT00514813|4115008|FG003|Overall Study|Protocol Violation|0
2355536|NCT00514813|4115005|FG000|Overall Study|Withdrawal by Subject|0
2355537|NCT00514813|4115006|FG001|Overall Study|Withdrawal by Subject|1
2355538|NCT00514813|4115007|FG002|Overall Study|Withdrawal by Subject|0
2355539|NCT00514813|4115008|FG003|Overall Study|Withdrawal by Subject|0
2355540|NCT00514813|4115005|FG000|Overall Study|Lack of Efficacy|0
2355541|NCT00514813|4115006|FG001|Overall Study|Lack of Efficacy|1
2355542|NCT00514813|4115007|FG002|Overall Study|Lack of Efficacy|0
2355543|NCT00514813|4115008|FG003|Overall Study|Lack of Efficacy|0
2355544|NCT00514813|4115005|FG000|Overall Study|Kidney transplant|0
2355545|NCT00514813|4115006|FG001|Overall Study|Kidney transplant|6
2355546|NCT00514813|4115007|FG002|Overall Study|Kidney transplant|2
2355547|NCT00514813|4115008|FG003|Overall Study|Kidney transplant|0
2355548|NCT00514813|4115005|FG000|Overall Study|Death|0
2355549|NCT00514813|4115006|FG001|Overall Study|Death|2
2355550|NCT00514813|4115007|FG002|Overall Study|Death|3
2355551|NCT00514813|4115008|FG003|Overall Study|Death|2
2355552|NCT00501228|4115041|FG000|Overall Study|Withdrawal by Subject|1
2355553|NCT00496782|4115047|FG000|Overall Study|Protocol Violation|1
2355554|NCT00496782|4115048|FG001|Overall Study|Protocol Violation|2
2355555|NCT00487578|4115060|FG000|Overall Study|Adverse Event|1
2355556|NCT00487578|4115061|FG001|Overall Study|Adverse Event|2
2355557|NCT00487578|4115060|FG000|Overall Study|Lack of Efficacy|0
2355558|NCT00487578|4115061|FG001|Overall Study|Lack of Efficacy|1
2355559|NCT00487578|4115060|FG000|Overall Study|Lost to Follow-up|0
2355560|NCT00487578|4115061|FG001|Overall Study|Lost to Follow-up|1
2355561|NCT00503009|4115070|FG000|Overall Study|Protocol Violation|1
2355562|NCT00503009|4115071|FG001|Overall Study|Protocol Violation|0
2355563|NCT00503009|4115072|FG002|Overall Study|Protocol Violation|1
2355564|NCT00503009|4115070|FG000|Overall Study|Withdrawal by Subject|0
2355565|NCT00503009|4115071|FG001|Overall Study|Withdrawal by Subject|1
2355566|NCT00503009|4115072|FG002|Overall Study|Withdrawal by Subject|1
2355567|NCT00503009|4115070|FG000|Overall Study|Physician Decision|0
2355568|NCT00503009|4115071|FG001|Overall Study|Physician Decision|1
2355569|NCT00503009|4115072|FG002|Overall Study|Physician Decision|1
2355570|NCT00499590|4115087|FG000|Overall Study|Study Terminated|112
2355571|NCT00499590|4115088|FG001|Overall Study|Study Terminated|112
2355572|NCT00499590|4115089|FG002|Overall Study|Study Terminated|112
2355573|NCT00499590|4115087|FG000|Overall Study|Not treated|1
2355574|NCT00499590|4115088|FG001|Overall Study|Not treated|0
2355575|NCT00499590|4115089|FG002|Overall Study|Not treated|1
2355576|NCT00503841|4115124|FG000|Overall Study|All screen failures|44
2355577|NCT00493025|4115130|FG000|Overall Study|Physician Decision|19
2355578|NCT00491400|4115137|FG000|Overall Study|Withdrawal by Subject|5
2355579|NCT00491400|4115138|FG001|Overall Study|Withdrawal by Subject|4
2355580|NCT00490776|4115146|FG000|Overall Study|Withdrawal by Subject|1
2355581|NCT00490776|4115146|FG000|Overall Study|Administrative Problems|1
2355582|NCT00490776|4115146|FG000|Overall Study|Death|1
2355583|NCT00490776|4115146|FG000|Overall Study|New Cancer Therapy|1
2355584|NCT00490776|4115146|FG000|Overall Study|Disease Progression|5
2355585|NCT00487162|4115152|FG000|Overall Study|Adverse Event|0
2355586|NCT00487162|4115153|FG001|Overall Study|Adverse Event|1
2355587|NCT00487162|4115152|FG000|Overall Study|Physician Decision|0
2355588|NCT00487162|4115153|FG001|Overall Study|Physician Decision|1
2355589|NCT00487162|4115152|FG000|Overall Study|Withdrawal by Subject|2
2355590|NCT00487162|4115153|FG001|Overall Study|Withdrawal by Subject|3
2355591|NCT00487981|4115159|FG000|Overall Study|Hypothyroidism diagnosis|1
2355592|NCT00491387|4115163|FG000|Overall Study|study terminated|20
2355593|NCT00483119|4115174|FG000|Overall Study|Adverse Event|0
2355594|NCT00483119|4115175|FG001|Overall Study|Adverse Event|1
2355595|NCT00483119|4115174|FG000|Overall Study|Physician Decision|1
2355596|NCT00483119|4115175|FG001|Overall Study|Physician Decision|0
2355597|NCT00470067|4115216|FG000|Overall Study|Death|1
2355598|NCT00470067|4115216|FG000|Overall Study|Disease Progression|6
2355599|NCT00475657|4115243|FG000|Overall Study|Death|1
2355600|NCT00475657|4115243|FG000|Overall Study|Sponsor's Decision|3
2355601|NCT00472082|4115247|FG000|Overall Study|Study prematurely terminated|5
2355602|NCT00467753|4115261|FG000|Overall Study|Lost to Follow-up|1
2355603|NCT00467753|4115262|FG001|Overall Study|Lost to Follow-up|2
2355604|NCT00467753|4115261|FG000|Overall Study|Adverse Event|2
2355605|NCT00467753|4115262|FG001|Overall Study|Adverse Event|0
2355606|NCT00456612|4115272|FG000|Overall Study|Withdrawal by Subject|3
2355607|NCT00469612|4115279|FG000|Overall Study|Study terminated before data collected|2
2355608|NCT00469612|4115280|FG001|Overall Study|Study terminated before data collected|0
2355609|NCT00461812|4115286|FG000|Overall Study|study terminated|10
2355610|NCT00461682|4115296|FG000|Overall Study|Protocol Violation|1
2355611|NCT00462904|4115302|FG000|Overall Study|Lost to Follow-up|1
2355612|NCT00450333|4115310|FG000|Overall Study|Study terminated|47
2355613|NCT00450333|4115311|FG001|Overall Study|Study terminated|54
2355614|NCT00450333|4115312|FG002|Overall Study|Study terminated|16
2355615|NCT00450333|4115313|FG003|Overall Study|Study terminated|21
2355616|NCT00450333|4115310|FG000|Overall Study|Adverse Event|1
2355617|NCT00450333|4115311|FG001|Overall Study|Adverse Event|7
2355618|NCT00450333|4115312|FG002|Overall Study|Adverse Event|2
2355619|NCT00450333|4115313|FG003|Overall Study|Adverse Event|2
2355620|NCT00450333|4115310|FG000|Overall Study|Protocol Violation|1
2355621|NCT00450333|4115311|FG001|Overall Study|Protocol Violation|0
2355622|NCT00450333|4115312|FG002|Overall Study|Protocol Violation|1
2355623|NCT00450333|4115313|FG003|Overall Study|Protocol Violation|0
2355624|NCT00450333|4115310|FG000|Overall Study|Withdrawal by Subject|1
2355625|NCT00450333|4115311|FG001|Overall Study|Withdrawal by Subject|0
2355626|NCT00450333|4115312|FG002|Overall Study|Withdrawal by Subject|3
2355627|NCT00450333|4115313|FG003|Overall Study|Withdrawal by Subject|0
2355628|NCT00450333|4115310|FG000|Overall Study|Kidney transplant|1
2355629|NCT00450333|4115311|FG001|Overall Study|Kidney transplant|0
2355630|NCT00450333|4115312|FG002|Overall Study|Kidney transplant|1
2355631|NCT00450333|4115313|FG003|Overall Study|Kidney transplant|3
2355632|NCT00450333|4115310|FG000|Overall Study|Death|3
2355633|NCT00450333|4115311|FG001|Overall Study|Death|2
2355634|NCT00450333|4115312|FG002|Overall Study|Death|2
2102117|NCT00837434|3693832|FG000|Overall Study|Baseline assessments not done in time|1
2355635|NCT00450333|4115313|FG003|Overall Study|Death|2
2355636|NCT00455143|4115323|FG000|Overall Study|Physician Decision|1
2355637|NCT00455143|4115323|FG000|Overall Study|Withdrawal by Subject|1
2355638|NCT00455143|4115323|FG000|Overall Study|Staff was not avail to follow patient|2
2355639|NCT00455143|4115323|FG000|Overall Study|No longer met Inclusion Criteria|1
2355640|NCT00455143|4115323|FG000|Overall Study|Surgical time, staff not available|1
2355641|NCT00454571|4115339|FG000|Overall Study|Adverse Event|2
2355642|NCT00454571|4115340|FG001|Overall Study|Adverse Event|0
2355643|NCT00454571|4115339|FG000|Overall Study|Physician Decision|0
2355644|NCT00454571|4115340|FG001|Overall Study|Physician Decision|1
2355645|NCT00454571|4115339|FG000|Overall Study|Protocol Violation|1
2355646|NCT00454571|4115340|FG001|Overall Study|Protocol Violation|0
2355647|NCT00454571|4115339|FG000|Overall Study|Withdrawal by Subject|10
2355648|NCT00454571|4115340|FG001|Overall Study|Withdrawal by Subject|5
2355649|NCT00452361|4115348|FG000|Overall Study|Adverse Event|8
2355650|NCT00452361|4115349|FG001|Overall Study|Adverse Event|0
2355651|NCT00452361|4115348|FG000|Overall Study|Withdrawal by Subject|0
2355652|NCT00452361|4115349|FG001|Overall Study|Withdrawal by Subject|1
2355653|NCT00452361|4115348|FG000|Overall Study|Premature termination|13
2355654|NCT00452361|4115349|FG001|Overall Study|Premature termination|9
2355655|NCT00443040|4115358|FG000|Overall Study|Withdrawal by Subject|1
2355656|NCT00443040|4115359|FG001|Overall Study|Withdrawal by Subject|0
2355657|NCT00443040|4115360|FG002|Overall Study|Withdrawal by Subject|0
2355658|NCT00443040|4115358|FG000|Overall Study|Converted to an open laparotomy|3
2355659|NCT00443040|4115359|FG001|Overall Study|Converted to an open laparotomy|0
2355660|NCT00443040|4115360|FG002|Overall Study|Converted to an open laparotomy|1
2355661|NCT00447421|4115368|FG000|Overall Study|Lack of Efficacy|1
2355662|NCT00447421|4115368|FG000|Overall Study|Adverse Event|3
2355663|NCT00447421|4115368|FG000|Overall Study|Sponsor Decision|2
2355664|NCT00441272|4115374|FG000|Overall Study|Study terminated prior to enrollment|25
2355665|NCT00441272|4115375|FG001|Overall Study|Study terminated prior to enrollment|25
2355666|NCT00440271|4115387|FG000|Overall Study|Protocol Violation|1
2355667|NCT00440271|4115388|FG001|Overall Study|Protocol Violation|1
2355668|NCT00440271|4115387|FG000|Overall Study|Adverse Event|0
2355669|NCT00440271|4115388|FG001|Overall Study|Adverse Event|1
2355670|NCT00440271|4115387|FG000|Overall Study|Lost to Follow-up|1
2355671|NCT00440271|4115388|FG001|Overall Study|Lost to Follow-up|0
2355672|NCT00440271|4115387|FG000|Overall Study|Withdrawal by Subject|0
2355673|NCT00440271|4115388|FG001|Overall Study|Withdrawal by Subject|2
2355674|NCT00440271|4115387|FG000|Overall Study|Lack of Efficacy|0
2355675|NCT00440271|4115388|FG001|Overall Study|Lack of Efficacy|1
2355676|NCT00440271|4115387|FG000|Overall Study|Due to closure of trial|8
2355677|NCT00440271|4115388|FG001|Overall Study|Due to closure of trial|10
2355678|NCT00440271|4115387|FG000|Overall Study|Other|2
2355679|NCT00440271|4115388|FG001|Overall Study|Other|0
2355680|NCT00429026|4115398|FG000|Overall Study|Inevaluable for response.|40
2355681|NCT00439569|4115409|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
2355682|NCT00439569|4115409|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
2355683|NCT00439569|4115409|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
2355684|NCT00422669|4115416|FG000|Overall Study|The study was terminated early.|98
2355685|NCT00422669|4115417|FG001|Overall Study|The study was terminated early.|100
2355686|NCT00422669|4115418|FG002|Overall Study|The study was terminated early.|7
2355687|NCT00434590|4115430|FG000|Overall Study|Administrative problems|5
2355688|NCT00434590|4115431|FG001|Overall Study|Administrative problems|5
2355689|NCT00424645|4115439|FG000|Overall Study|Death|1
2355690|NCT00424645|4115440|FG001|Overall Study|Death|0
2355691|NCT00430027|4115446|FG000|Overall Study|Study terminated|8
2355692|NCT00429858|4115450|FG000|Overall Study|Withdrawal by Subject|1
2355693|NCT00429858|4115450|FG000|Overall Study|Study Termination|1
2355694|NCT00425438|4115457|FG000|Overall Study|Termination by Sponsor|25
2355695|NCT00425438|4115458|FG001|Overall Study|Termination by Sponsor|27
2355696|NCT00422942|4115468|FG000|Overall Study|Study terminated by Sponsor|3
2355697|NCT00409344|4115474|FG000|Overall Study|no enrollment|0
2355698|NCT00409344|4115475|FG001|Overall Study|no enrollment|0
2355699|NCT00414453|4115481|FG000|Overall Study|Abnormal lab work|16
2355700|NCT00417248|4115491|FG000|Overall Study|Study Terminated|6
2355701|NCT00417248|4115491|FG000|Overall Study|Death|1
2355702|NCT00417248|4115491|FG000|Overall Study|Lack of Efficacy|1
2355703|NCT00418145|4115496|FG000|Overall Study|study terminated|6
2355704|NCT00409331|4115506|FG000|Overall Study|Physician Decision|1
2355705|NCT00391430|4115523|FG000|Overall Study|Withdrawal by Subject|3
2355706|NCT00391430|4115524|FG001|Overall Study|Withdrawal by Subject|0
2355707|NCT00391430|4115525|FG002|Overall Study|Withdrawal by Subject|12
2355708|NCT00384293|4115558|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
2355709|NCT00384293|4115559|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
2355710|NCT00384293|4115560|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
2355711|NCT00384293|4115558|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
2355712|NCT00384293|4115559|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
2355713|NCT00384293|4115560|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
2355714|NCT00384293|4115558|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
2019954|NCT00302952|3587436|FG001|Overall Study|Elevated SGOT (AST) lab value|1
2019955|NCT00303069|3587446|FG000|Overall Study|Lost to Follow-up|1
2212435|NCT01669343|3853414|FG000|Part A: All Patients|Withdrawal by Subject|7
2212436|NCT01669343|3853414|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2
2212437|NCT01669343|3853414|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13
2212438|NCT01669343|3853414|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3
2355715|NCT00384293|4115559|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
2355716|NCT00384293|4115560|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
2019956|NCT00303069|3587447|FG001|Overall Study|Lost to Follow-up|0
2019957|NCT00303069|3587448|FG002|Overall Study|Lost to Follow-up|0
2019958|NCT00303069|3587449|FG003|Overall Study|Lost to Follow-up|2
2019959|NCT00303069|3587446|FG000|Overall Study|subject moved|1
2019960|NCT00303069|3587447|FG001|Overall Study|subject moved|0
2019961|NCT00303069|3587448|FG002|Overall Study|subject moved|0
2019962|NCT00303069|3587449|FG003|Overall Study|subject moved|0
2019963|NCT00303069|3587446|FG000|Overall Study|Recruitment into Army Reserves|0
2019964|NCT00303069|3587447|FG001|Overall Study|Recruitment into Army Reserves|0
2019965|NCT00303069|3587448|FG002|Overall Study|Recruitment into Army Reserves|1
2019966|NCT00303069|3587449|FG003|Overall Study|Recruitment into Army Reserves|0
2019967|NCT00303108|3587462|FG000|Overall Study|Adverse Event|5
2019968|NCT00303108|3587463|FG001|Overall Study|Adverse Event|6
2019969|NCT00303108|3587464|FG002|Overall Study|Adverse Event|7
2019970|NCT00303108|3587462|FG000|Overall Study|Patient Request|4
2019971|NCT00303108|3587463|FG001|Overall Study|Patient Request|2
2019972|NCT00303108|3587464|FG002|Overall Study|Patient Request|8
2019973|NCT00303108|3587462|FG000|Overall Study|Failed Entry|1
2019974|NCT00303108|3587463|FG001|Overall Study|Failed Entry|0
2019975|NCT00303108|3587464|FG002|Overall Study|Failed Entry|1
2019976|NCT00303108|3587462|FG000|Overall Study|ineligible|2
2019977|NCT00303108|3587463|FG001|Overall Study|ineligible|1
2019978|NCT00303108|3587464|FG002|Overall Study|ineligible|0
2019979|NCT00303186|3587471|FG000|Overall Study|Other|52
2019980|NCT00303316|3587477|FG000|Overall Study|Protocol Violation|1
2019981|NCT00303316|3587478|FG001|Overall Study|Protocol Violation|0
2019982|NCT00303316|3587477|FG000|Overall Study|Lost to Follow-up|0
2019983|NCT00303316|3587478|FG001|Overall Study|Lost to Follow-up|1
2019984|NCT00303316|3587477|FG000|Overall Study|Withdrawal by Subject|1
2019985|NCT00303316|3587478|FG001|Overall Study|Withdrawal by Subject|2
2019986|NCT00303329|3587486|FG000|Overall Study|Adverse Event|7
2019987|NCT00303329|3587487|FG001|Overall Study|Adverse Event|14
2019988|NCT00303329|3587486|FG000|Overall Study|Abnormal Laboratory Values|0
2019989|NCT00303329|3587487|FG001|Overall Study|Abnormal Laboratory Values|1
2019990|NCT00303329|3587486|FG000|Overall Study|Unsatisfactory therapeutic effect|9
2019991|NCT00303329|3587487|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2019992|NCT00303329|3587486|FG000|Overall Study|Condition no longer requires study drug|0
2019993|NCT00303329|3587487|FG001|Overall Study|Condition no longer requires study drug|8
2019994|NCT00303329|3587486|FG000|Overall Study|Protocol Violation|3
2019995|NCT00303329|3587487|FG001|Overall Study|Protocol Violation|0
2019996|NCT00303329|3587486|FG000|Overall Study|Withdrawal by Subject|9
2019997|NCT00303329|3587487|FG001|Overall Study|Withdrawal by Subject|15
2355717|NCT00384293|4115558|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
2355718|NCT00384293|4115559|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
2355719|NCT00384293|4115560|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
2355720|NCT00384293|4115558|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
2355721|NCT00384293|4115559|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
2355722|NCT00384293|4115560|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
2355723|NCT00384293|4115558|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
2355724|NCT00384293|4115559|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
2355725|NCT00384293|4115560|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
2355726|NCT00384293|4115558|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
2355727|NCT00384293|4115559|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
2355728|NCT00384293|4115560|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
2355729|NCT00384293|4115558|FG000|Post-randomization Period|Adverse Event|0
2355730|NCT00384293|4115559|FG001|Post-randomization Period|Adverse Event|23
2355731|NCT00384293|4115560|FG002|Post-randomization Period|Adverse Event|7
2355732|NCT00384293|4115558|FG000|Post-randomization Period|Lost to Follow-up|0
2355733|NCT00384293|4115559|FG001|Post-randomization Period|Lost to Follow-up|2
2355734|NCT00384293|4115560|FG002|Post-randomization Period|Lost to Follow-up|1
2355735|NCT00384293|4115558|FG000|Post-randomization Period|Protocol Violation|0
2355736|NCT00384293|4115559|FG001|Post-randomization Period|Protocol Violation|1
2355737|NCT00384293|4115560|FG002|Post-randomization Period|Protocol Violation|0
2355738|NCT00384293|4115558|FG000|Post-randomization Period|Withdrawal by Subject|0
2355739|NCT00384293|4115559|FG001|Post-randomization Period|Withdrawal by Subject|8
2355740|NCT00384293|4115560|FG002|Post-randomization Period|Withdrawal by Subject|6
2355741|NCT00384293|4115558|FG000|Post-randomization Period|Trial Termination|0
2355742|NCT00384293|4115559|FG001|Post-randomization Period|Trial Termination|180
2355743|NCT00384293|4115560|FG002|Post-randomization Period|Trial Termination|204
2355744|NCT00384293|4115558|FG000|Post-randomization Period|Patient Randomized in Error|0
2355745|NCT00384293|4115559|FG001|Post-randomization Period|Patient Randomized in Error|0
2355746|NCT00384293|4115560|FG002|Post-randomization Period|Patient Randomized in Error|1
2355747|NCT00377455|4115581|FG000|Overall Study|Withdrawal by Subject|1
2355748|NCT00371462|4115587|FG000|Overall Study|Withdrawal by Subject|1
2355749|NCT00371462|4115588|FG001|Overall Study|Withdrawal by Subject|0
2355750|NCT00371462|4115587|FG000|Overall Study|Other|7
2355751|NCT00371462|4115588|FG001|Overall Study|Other|8
2355752|NCT00369265|4115596|FG000|Overall Study|Study terminated|4
2355753|NCT00369265|4115597|FG001|Overall Study|Study terminated|7
2355754|NCT00364689|4115610|FG000|Overall Study|Lost to Follow-up|1
2355755|NCT00352118|4115616|FG000|Overall Study|Physician Decision|4
2355756|NCT00356421|4115639|FG000|Overall Study|Lack of Efficacy|3
2355757|NCT00356421|4115640|FG001|Overall Study|Lack of Efficacy|0
2355758|NCT00356421|4115639|FG000|Overall Study|Withdrawal by Subject|9
2355759|NCT00356421|4115640|FG001|Overall Study|Withdrawal by Subject|2
2355760|NCT00356421|4115639|FG000|Overall Study|Related to study drug|15
2355761|NCT00356421|4115640|FG001|Overall Study|Related to study drug|12
2355762|NCT00356421|4115639|FG000|Overall Study|Not related to study drug|5
2355763|NCT00356421|4115640|FG001|Overall Study|Not related to study drug|3
2355764|NCT00350623|4115649|FG000|Overall Study|Lost to Follow-up|8
2355765|NCT00350623|4115650|FG001|Overall Study|Lost to Follow-up|3
2355766|NCT00350623|4115651|FG002|Overall Study|Lost to Follow-up|4
2355767|NCT00350623|4115649|FG000|Overall Study|Withdrawal by Subject|0
2355768|NCT00350623|4115650|FG001|Overall Study|Withdrawal by Subject|1
2355769|NCT00350623|4115651|FG002|Overall Study|Withdrawal by Subject|1
2355770|NCT00350623|4115649|FG000|Overall Study|patient traveling outside the country|0
2355771|NCT00350623|4115650|FG001|Overall Study|patient traveling outside the country|0
2355772|NCT00350623|4115651|FG002|Overall Study|patient traveling outside the country|1
2355773|NCT00350844|4115679|FG000|Overall Study|Lost to Follow-up|1
2355774|NCT00348556|4115683|FG000|Overall Study|Adverse Event|1
2355775|NCT00319839|4115687|FG000|Overall Study|Adverse Event|5
2355776|NCT00319839|4115687|FG000|Overall Study|Withdrawal by Subject|1
2355777|NCT00344019|4115694|FG000|Overall Study|did not meet final inclusion criteria|0
2355778|NCT00344019|4115695|FG001|Overall Study|did not meet final inclusion criteria|0
2355779|NCT00344019|4115696|FG002|Overall Study|did not meet final inclusion criteria|74
2355780|NCT00338455|4115709|FG000|Overall Study|Death|2
2355781|NCT00338455|4115710|FG001|Overall Study|Death|1
2355782|NCT00338455|4115709|FG000|Overall Study|Physician Decision|1
2355783|NCT00338455|4115710|FG001|Overall Study|Physician Decision|0
2355784|NCT00329108|4115718|FG000|Overall Study|Adverse Event|2
2355785|NCT00329108|4115719|FG001|Overall Study|Adverse Event|2
2355786|NCT00329108|4115718|FG000|Overall Study|Lack of Efficacy|3
2355787|NCT00329108|4115719|FG001|Overall Study|Lack of Efficacy|3
2355788|NCT00329108|4115718|FG000|Overall Study|Withdrawal by Subject|0
2355789|NCT00329108|4115719|FG001|Overall Study|Withdrawal by Subject|2
2355790|NCT00329108|4115718|FG000|Overall Study|symptomatic deterioration|1
2355791|NCT00329108|4115719|FG001|Overall Study|symptomatic deterioration|1
2355792|NCT00329108|4115718|FG000|Overall Study|Subject no longer willing to participate|2
2355793|NCT00329108|4115719|FG001|Overall Study|Subject no longer willing to participate|2
2019998|NCT00303329|3587486|FG000|Overall Study|Lost to Follow-up|0
2019999|NCT00303329|3587487|FG001|Overall Study|Lost to Follow-up|1
2020000|NCT00303329|3587486|FG000|Overall Study|Administrative problems|1
2020001|NCT00303329|3587487|FG001|Overall Study|Administrative problems|0
2020002|NCT00303329|3587486|FG000|Overall Study|Death|2
2020003|NCT00303329|3587487|FG001|Overall Study|Death|12
2020004|NCT00303329|3587486|FG000|Overall Study|Stopped at end of core|3
2020005|NCT00303329|3587487|FG001|Overall Study|Stopped at end of core|9
2020006|NCT00303329|3587486|FG000|Overall Study|Stopped at end of extension 1|1
2020007|NCT00303329|3587487|FG001|Overall Study|Stopped at end of extension 1|0
2020008|NCT00303446|3587495|FG000|Overall Study|Withdrawal by Subject|2
2020009|NCT00303446|3587496|FG001|Overall Study|Withdrawal by Subject|2
2020010|NCT00303446|3587495|FG000|Overall Study|Death|0
2355794|NCT00329108|4115718|FG000|Overall Study|study terminated by sponsor|1
2355795|NCT00329108|4115719|FG001|Overall Study|study terminated by sponsor|0
2355796|NCT00329108|4115718|FG000|Overall Study|withdrew patient after SAE resolved|1
2355797|NCT00329108|4115719|FG001|Overall Study|withdrew patient after SAE resolved|0
2355798|NCT00329108|4115718|FG000|Overall Study|Protocol Violation|0
2355799|NCT00329108|4115719|FG001|Overall Study|Protocol Violation|2
2355800|NCT00333229|4115740|FG000|Overall Study|Lack of Efficacy|0
2355801|NCT00333229|4115741|FG001|Overall Study|Lack of Efficacy|1
2355802|NCT00314327|4115787|FG000|Overall Study|Withdrawal by Subject|1
2355803|NCT00308113|4115795|FG000|Overall Study|Protocol closure|0
2355804|NCT00308113|4115796|FG001|Overall Study|Protocol closure|0
2355805|NCT00308113|4115797|FG002|Overall Study|Protocol closure|0
2355806|NCT00308113|4115798|FG003|Overall Study|Protocol closure|1
2355807|NCT00298740|4115818|FG000|Overall Study|Lack of Efficacy|6
2355808|NCT00298740|4115818|FG000|Overall Study|Withdrawal by Subject|3
2355809|NCT00301080|4115822|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1
2355810|NCT00301080|4115823|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0
2355811|NCT00301080|4115824|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0
2355812|NCT00301080|4115825|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0
2355813|NCT00301080|4115826|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0
2355814|NCT00290407|4115844|FG000|Overall Study|Physician Decision|2
2355815|NCT00295490|4115852|FG000|Overall Study|Protocol Violation|0
2355816|NCT00295490|4115853|FG001|Overall Study|Protocol Violation|0
2355817|NCT00295490|4115854|FG002|Overall Study|Protocol Violation|3
2355818|NCT00295490|4115855|FG003|Overall Study|Protocol Violation|3
2355819|NCT00295490|4115852|FG000|Overall Study|Withdrawal by Subject|0
2355820|NCT00295490|4115853|FG001|Overall Study|Withdrawal by Subject|2
2355821|NCT00295490|4115854|FG002|Overall Study|Withdrawal by Subject|0
2355822|NCT00295490|4115855|FG003|Overall Study|Withdrawal by Subject|1
2355823|NCT00295490|4115852|FG000|Overall Study|Lost to Follow-up|0
2355824|NCT00295490|4115853|FG001|Overall Study|Lost to Follow-up|0
2355825|NCT00295490|4115854|FG002|Overall Study|Lost to Follow-up|1
2355826|NCT00295490|4115855|FG003|Overall Study|Lost to Follow-up|0
2355827|NCT00295490|4115852|FG000|Overall Study|Adverse Event|1
2355828|NCT00295490|4115853|FG001|Overall Study|Adverse Event|0
2355829|NCT00295490|4115854|FG002|Overall Study|Adverse Event|0
2355830|NCT00295490|4115855|FG003|Overall Study|Adverse Event|0
2355831|NCT00295490|4115852|FG000|Overall Study|Other|0
2355832|NCT00295490|4115853|FG001|Overall Study|Other|2
2355833|NCT00295490|4115854|FG002|Overall Study|Other|0
2355834|NCT00295490|4115855|FG003|Overall Study|Other|1
2355835|NCT00268463|4115867|FG000|Overall Study|study terminated due to low accrual|10
2355836|NCT00268463|4115868|FG001|Overall Study|study terminated due to low accrual|12
2355837|NCT00276419|4115885|FG000|First Intervention|Adverse Event|1
2355838|NCT00276419|4115886|FG001|First Intervention|Adverse Event|0
2355839|NCT00276419|4115885|FG000|First Intervention|Withdrawal by Subject|0
2355840|NCT00276419|4115886|FG001|First Intervention|Withdrawal by Subject|2
2355841|NCT00271947|4115934|FG000|Overall Study|Lost to Follow-up|1
2355842|NCT00252174|4115954|FG000|Overall Study|Withdrawal by Subject|0
2355843|NCT00252174|4115955|FG001|Overall Study|Withdrawal by Subject|1
2355844|NCT00252174|4115956|FG002|Overall Study|Withdrawal by Subject|0
2355845|NCT00256295|4115964|FG000|Overall Study|Withdrawal by Subject|3
2355846|NCT00256295|4115964|FG000|Overall Study|Death|1
2355847|NCT00239720|4115978|FG000|Overall Study|Adverse Event|1
2355848|NCT00239720|4115979|FG001|Overall Study|Adverse Event|0
2355849|NCT00239720|4115978|FG000|Overall Study|Lost to Follow-up|0
2355850|NCT00239720|4115979|FG001|Overall Study|Lost to Follow-up|1
2355851|NCT00250718|4115985|FG000|Overall Study|Death|1
2355852|NCT00250718|4115985|FG000|Overall Study|Adverse Event|1
2355853|NCT00250718|4115985|FG000|Overall Study|Withdrawal by Subject|1
2355854|NCT00206375|4116033|FG000|Overall Study|Lost to Follow-up|1
2355855|NCT00206375|4116034|FG001|Overall Study|Lost to Follow-up|0
2355856|NCT00206375|4116035|FG002|Overall Study|Lost to Follow-up|0
2355857|NCT00206375|4116033|FG000|Overall Study|Withdrawal by Subject|2
2355858|NCT00206375|4116034|FG001|Overall Study|Withdrawal by Subject|1
2355859|NCT00206375|4116035|FG002|Overall Study|Withdrawal by Subject|3
2355860|NCT00206375|4116033|FG000|Overall Study|Study terminated due to lack of funds|0
2355861|NCT00206375|4116034|FG001|Overall Study|Study terminated due to lack of funds|1
2355862|NCT00206375|4116035|FG002|Overall Study|Study terminated due to lack of funds|1
2355863|NCT00229931|4116045|FG000|Overall Study|Death|1
2355864|NCT00229931|4116046|FG001|Overall Study|Death|0
2355865|NCT00229931|4116045|FG000|Overall Study|Lost to Follow-up|3
2355866|NCT00229931|4116046|FG001|Overall Study|Lost to Follow-up|2
2355867|NCT00209131|4116054|FG000|Overall Study|Lack of personnel due to turnovers.|15
2355868|NCT00209131|4116055|FG001|Overall Study|Lack of personnel due to turnovers.|11
2355869|NCT00209027|4116085|FG000|Overall Study|study terminated|10
2020011|NCT00303446|3587496|FG001|Overall Study|Death|1
2020012|NCT00303446|3587495|FG000|Overall Study|Physician Decision|0
2020013|NCT00303446|3587496|FG001|Overall Study|Physician Decision|1
2020014|NCT00303459|3587504|FG000|Overall Study|Death|33
2020015|NCT00303459|3587505|FG001|Overall Study|Death|44
2020016|NCT00303459|3587504|FG000|Overall Study|Withdrawal of consent|32
2020017|NCT00303459|3587505|FG001|Overall Study|Withdrawal of consent|26
2020018|NCT00303459|3587504|FG000|Overall Study|Lost to Follow-up|5
2020019|NCT00303459|3587505|FG001|Overall Study|Lost to Follow-up|4
2020020|NCT00303459|3587504|FG000|Overall Study|Administrative reason|7
2020021|NCT00303459|3587505|FG001|Overall Study|Administrative reason|7
2020022|NCT00303459|3587504|FG000|Overall Study|Decision by the investigator|5
2020023|NCT00303459|3587505|FG001|Overall Study|Decision by the investigator|7
2020024|NCT00303459|3587504|FG000|Overall Study|Lung transplantation|1
2020025|NCT00303459|3587505|FG001|Overall Study|Lung transplantation|1
2020026|NCT00303472|3587519|FG000|Treatment Period|Adverse Event|0
2020027|NCT00303472|3587520|FG001|Treatment Period|Adverse Event|0
2020028|NCT00303472|3587521|FG002|Treatment Period|Adverse Event|0
2020029|NCT00303472|3587522|FG003|Treatment Period|Adverse Event|0
2020030|NCT00303472|3587523|FG004|Treatment Period|Adverse Event|1
2020031|NCT00303472|3587524|FG005|Treatment Period|Adverse Event|0
2020032|NCT00303472|3587525|FG006|Treatment Period|Adverse Event|0
2020033|NCT00303472|3587519|FG000|Treatment Period|Death|0
2020034|NCT00303472|3587520|FG001|Treatment Period|Death|0
2020035|NCT00303472|3587521|FG002|Treatment Period|Death|0
2020036|NCT00303472|3587522|FG003|Treatment Period|Death|1
2020037|NCT00303472|3587523|FG004|Treatment Period|Death|0
2020038|NCT00303472|3587524|FG005|Treatment Period|Death|0
2020039|NCT00303472|3587525|FG006|Treatment Period|Death|1
2020040|NCT00303472|3587519|FG000|Treatment Period|Withdrawal by Subject|0
2020041|NCT00303472|3587520|FG001|Treatment Period|Withdrawal by Subject|0
2020042|NCT00303472|3587521|FG002|Treatment Period|Withdrawal by Subject|0
2355870|NCT00209027|4116086|FG001|Overall Study|study terminated|0
2355871|NCT00182637|4116092|FG000|Overall Study|Adverse Event|2
2020043|NCT00303472|3587522|FG003|Treatment Period|Withdrawal by Subject|1
2020044|NCT00303472|3587523|FG004|Treatment Period|Withdrawal by Subject|0
2355872|NCT00182637|4116092|FG000|Overall Study|Disease Progression|1
2355873|NCT00176488|4116097|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1
2355874|NCT00162773|4116134|FG000|Overall Study|P.I, Left institution. Study terminated|22
2355875|NCT00147238|4116164|FG000|Overall Study|Inevaluable|8
2355876|NCT00165503|4116168|FG000|Overall Study|Death|1
2355877|NCT00165503|4116168|FG000|Overall Study|Lost to Follow-up|12
2355878|NCT00165503|4116168|FG000|Overall Study|Unresectable|3
2355879|NCT00160563|4116175|FG000|Overall Study|Adverse Event|1
2212439|NCT01669343|3853414|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1
2212440|NCT01669421|3853421|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
2355880|NCT00160563|4116176|FG001|Overall Study|Adverse Event|1
2355881|NCT00160563|4116177|FG002|Overall Study|Adverse Event|1
2355882|NCT00160563|4116175|FG000|Overall Study|Lost to Follow-up|1
2355883|NCT00160563|4116176|FG001|Overall Study|Lost to Follow-up|1
2355884|NCT00160563|4116177|FG002|Overall Study|Lost to Follow-up|2
2355885|NCT00160563|4116175|FG000|Overall Study|Protocol Violation|0
2355886|NCT00160563|4116176|FG001|Overall Study|Protocol Violation|0
2355887|NCT00160563|4116177|FG002|Overall Study|Protocol Violation|3
2355888|NCT00160563|4116175|FG000|Overall Study|Withdrawal by Subject|1
2355889|NCT00160563|4116176|FG001|Overall Study|Withdrawal by Subject|2
2355890|NCT00160563|4116177|FG002|Overall Study|Withdrawal by Subject|3
2355891|NCT00160563|4116175|FG000|Overall Study|Other (listed in the study report)|48
2355892|NCT00160563|4116176|FG001|Overall Study|Other (listed in the study report)|40
2355893|NCT00160563|4116177|FG002|Overall Study|Other (listed in the study report)|81
2355894|NCT00160563|4116175|FG000|Overall Study|Missing reason|0
2355895|NCT00160563|4116176|FG001|Overall Study|Missing reason|1
2355896|NCT00160563|4116177|FG002|Overall Study|Missing reason|0
2355897|NCT00142519|4116188|FG000|Overall Study|Not Treated|7
2355898|NCT00142519|4116189|FG001|Overall Study|Not Treated|9
2355899|NCT00142519|4116188|FG000|Overall Study|Protocol Violation|1
2355900|NCT00142519|4116189|FG001|Overall Study|Protocol Violation|0
2102118|NCT00837434|3693833|FG001|Overall Study|Baseline assessments not done in time|0
2355901|NCT00142519|4116188|FG000|Overall Study|Withdrawal by Subject|10
2355902|NCT00142519|4116189|FG001|Overall Study|Withdrawal by Subject|7
2355903|NCT00138073|4116204|FG000|Overall Study|lack of resources|55
2355904|NCT00113386|4116210|FG000|Overall Study|Withdrawal by Subject|1
2355905|NCT00113386|4116211|FG001|Overall Study|Withdrawal by Subject|0
2355906|NCT00113386|4116210|FG000|Overall Study|Physician Decision|0
2355907|NCT00113386|4116211|FG001|Overall Study|Physician Decision|1
2355908|NCT00113386|4116210|FG000|Overall Study|Toxicity|3
2355909|NCT00113386|4116211|FG001|Overall Study|Toxicity|0
2355910|NCT00113386|4116210|FG000|Overall Study|Ineligible|1
2355911|NCT00113386|4116211|FG001|Overall Study|Ineligible|2
2355912|NCT00113386|4116210|FG000|Overall Study|Unknown - Lost to Follow-Up|2
2355913|NCT00113386|4116211|FG001|Overall Study|Unknown - Lost to Follow-Up|1
2355914|NCT00138151|4116217|FG000|Overall Study|Withdrawal by Subject|3
2355915|NCT00138151|4116217|FG000|Overall Study|Physician Decision|1
2355916|NCT00129974|4116221|FG000|Overall Study|Other|1
2355917|NCT00126659|4116228|FG000|Overall Study|Adverse Event|0
2355918|NCT00126659|4116229|FG001|Overall Study|Adverse Event|0
2355919|NCT00126659|4116230|FG002|Overall Study|Adverse Event|2
2355920|NCT00125268|4116247|FG000|Overall Study|Withdrawal by Subject|1
2355921|NCT00125268|4116248|FG001|Overall Study|Withdrawal by Subject|1
2355922|NCT00113399|4116256|FG000|Overall Study|Death|1
2355923|NCT00113399|4116257|FG001|Overall Study|Death|1
2355924|NCT00113399|4116256|FG000|Overall Study|Withdrawal by Subject|1
2355925|NCT00113399|4116257|FG001|Overall Study|Withdrawal by Subject|2
2355926|NCT00113399|4116256|FG000|Overall Study|Complete Response|0
2355927|NCT00113399|4116257|FG001|Overall Study|Complete Response|1
2355928|NCT00113399|4116256|FG000|Overall Study|Other|0
2355929|NCT00113399|4116257|FG001|Overall Study|Other|1
2355930|NCT00107614|4116267|FG000|Overall Study|Physician Decision|10
2355931|NCT00107614|4116267|FG000|Overall Study|Death|2
2355932|NCT00107315|4116271|FG000|Overall Study|Disease Progression|9
2355933|NCT00107315|4116271|FG000|Overall Study|Adverse Event|4
2355934|NCT00107315|4116271|FG000|Overall Study|Withdrawal by Subject|2
2355935|NCT00108433|4116277|FG000|Overall Study|Lack of Efficacy|1
2355936|NCT00108433|4116278|FG001|Overall Study|Lack of Efficacy|2
2355937|NCT00108433|4116277|FG000|Overall Study|Death|3
2355938|NCT00108433|4116278|FG001|Overall Study|Death|0
2355939|NCT00108433|4116277|FG000|Overall Study|Adverse Event|3
2355940|NCT00108433|4116278|FG001|Overall Study|Adverse Event|1
2355941|NCT00108433|4116277|FG000|Overall Study|Other|14
2355942|NCT00108433|4116278|FG001|Overall Study|Other|14
2355943|NCT00113919|4116284|FG000|Overall Study|Physician Decision|8
2355944|NCT00113919|4116284|FG000|Overall Study|Death|6
2355945|NCT00100828|4116297|FG000|Overall Study|Physician Decision|6
2355946|NCT00104728|4116301|FG000|Overall Study|screen failures|19
2355947|NCT00083915|4116320|FG000|Overall Study|Death|6
2355948|NCT00083915|4116321|FG001|Overall Study|Death|3
2355949|NCT00083915|4116320|FG000|Overall Study|Physician Decision|11
2355950|NCT00083915|4116321|FG001|Overall Study|Physician Decision|6
2355951|NCT00083915|4116320|FG000|Overall Study|Withdrawal by Subject|8
2355952|NCT00083915|4116321|FG001|Overall Study|Withdrawal by Subject|3
2355953|NCT00083915|4116320|FG000|Overall Study|disease progression|18
2355954|NCT00083915|4116321|FG001|Overall Study|disease progression|23
2355955|NCT00083915|4116320|FG000|Overall Study|Failure to collect|3
2355956|NCT00083915|4116321|FG001|Overall Study|Failure to collect|0
2355957|NCT00083915|4116320|FG000|Overall Study|No response|3
2355958|NCT00083915|4116321|FG001|Overall Study|No response|1
2355959|NCT00083915|4116320|FG000|Overall Study|Insurance issues|1
2355960|NCT00083915|4116321|FG001|Overall Study|Insurance issues|1
2355961|NCT00088829|4116340|FG000|Overall Study|PI left institution and study was close|22
2355962|NCT00085631|4116363|FG000|Overall Study|Missing Data|4
2355963|NCT00085631|4116364|FG001|Overall Study|Missing Data|11
2355964|NCT00085631|4116365|FG002|Overall Study|Missing Data|7
2355965|NCT00062751|4116377|FG000|Overall Study|Disease progression|24
2355966|NCT00062751|4116378|FG001|Overall Study|Disease progression|17
2355967|NCT00062751|4116379|FG002|Overall Study|Disease progression|24
2355968|NCT00062751|4116380|FG003|Overall Study|Disease progression|2
2355969|NCT00062751|4116381|FG004|Overall Study|Disease progression|2
2355970|NCT00062751|4116377|FG000|Overall Study|Adverse Event|4
2355971|NCT00062751|4116378|FG001|Overall Study|Adverse Event|7
2355972|NCT00062751|4116379|FG002|Overall Study|Adverse Event|2
2355973|NCT00062751|4116380|FG003|Overall Study|Adverse Event|2
2355974|NCT00062751|4116381|FG004|Overall Study|Adverse Event|2
2355975|NCT00062751|4116377|FG000|Overall Study|Other|2
2355976|NCT00062751|4116378|FG001|Overall Study|Other|3
2355977|NCT00062751|4116379|FG002|Overall Study|Other|1
2355978|NCT00062751|4116380|FG003|Overall Study|Other|0
2355979|NCT00062751|4116381|FG004|Overall Study|Other|1
2355980|NCT00062751|4116377|FG000|Overall Study|Withdrawal by Subject|1
2355981|NCT00062751|4116378|FG001|Overall Study|Withdrawal by Subject|2
2355982|NCT00062751|4116379|FG002|Overall Study|Withdrawal by Subject|2
2355983|NCT00062751|4116380|FG003|Overall Study|Withdrawal by Subject|1
2355984|NCT00062751|4116381|FG004|Overall Study|Withdrawal by Subject|0
2355985|NCT00062751|4116377|FG000|Overall Study|Symptomatic deterioration|1
2355986|NCT00062751|4116378|FG001|Overall Study|Symptomatic deterioration|1
2355987|NCT00062751|4116379|FG002|Overall Study|Symptomatic deterioration|0
2355988|NCT00062751|4116380|FG003|Overall Study|Symptomatic deterioration|0
2355989|NCT00062751|4116381|FG004|Overall Study|Symptomatic deterioration|1
2355990|NCT00062751|4116377|FG000|Overall Study|Death|1
2355991|NCT00062751|4116378|FG001|Overall Study|Death|0
2355992|NCT00062751|4116379|FG002|Overall Study|Death|1
2355993|NCT00062751|4116380|FG003|Overall Study|Death|0
2355994|NCT00062751|4116381|FG004|Overall Study|Death|0
2355995|NCT00066807|4116396|FG000|Overall Study|Study was terminated early|14
2355996|NCT00066807|4116397|FG001|Overall Study|Study was terminated early|15
2355997|NCT00038142|4116418|FG000|Overall Study|Ineligible|1
2355998|NCT00038142|4116419|FG001|Overall Study|Ineligible|0
2355999|NCT00038142|4116418|FG000|Overall Study|Progressive Disease|11
2356000|NCT00038142|4116419|FG001|Overall Study|Progressive Disease|7
2356001|NCT00038142|4116418|FG000|Overall Study|Death|1
2356002|NCT00038142|4116419|FG001|Overall Study|Death|0
2356003|NCT00038142|4116418|FG000|Overall Study|Adverse Event|1
2356004|NCT00038142|4116419|FG001|Overall Study|Adverse Event|0
2356005|NCT00038142|4116418|FG000|Overall Study|Unknown Reason|8
2356006|NCT00038142|4116419|FG001|Overall Study|Unknown Reason|0
2356007|NCT00006478|4116434|FG000|Overall Study|Vaccine could not be produced|1
2356008|NCT00006478|4116434|FG000|Overall Study|Physician Decision|6
2356009|NCT00006916|4116447|FG000|Overall Study|Device not inserted|4
2356010|NCT00006916|4116447|FG000|Overall Study|Complication of device insertion|1
2356011|NCT02009384|4116521|FG000|Overall Study|Death|2
2356012|NCT04558125|4116525|FG000|Overall Study|Death|1
2356013|NCT02401308|4116531|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0
2356014|NCT02401308|4116532|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1
2356015|NCT04381988|4116540|FG000|Overall Study|The study was terminated|4
2102119|NCT00837434|3693832|FG000|Overall Study|Unable to obtain study drug|1
2356016|NCT04381988|4116541|FG001|Overall Study|The study was terminated|0
2356017|NCT00479167|4116569|FG000|Overall Study|Withdrawal by Subject|1
2356018|NCT03998189|4116576|FG000|Overall Study|Lack of Efficacy|0
2356019|NCT03998189|4116577|FG001|Overall Study|Lack of Efficacy|1
2356020|NCT02934503|4116691|FG000|Overall Study|progression of disease|3
2356021|NCT02934503|4116691|FG000|Overall Study|Withdrawal by Subject|1
2356022|NCT02137252|4116697|FG000|Overall Study|trial terminated early|2
2356023|NCT02137252|4116698|FG001|Overall Study|trial terminated early|1
2356024|NCT01294670|4116713|FG000|Overall Study|Not treated|1
2356025|NCT01294670|4116714|FG001|Overall Study|Not treated|0
2356026|NCT01294670|4116715|FG002|Overall Study|Not treated|0
2356027|NCT01294670|4116716|FG003|Overall Study|Not treated|0
2356028|NCT01294670|4116717|FG004|Overall Study|Not treated|0
2356029|NCT03095287|4116729|FG000|Overall Study|Treatment Failure|1
2356030|NCT03095287|4116729|FG000|Overall Study|Adverse Event|1
2356031|NCT02930122|4116739|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
2356032|NCT02930122|4116740|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
2356033|NCT04144166|4116767|FG000|Overall Study|Discharged before study start|1
2356034|NCT04144166|4116767|FG000|Overall Study|Pregnancy|1
2356035|NCT04144166|4116767|FG000|Overall Study|Nail polish could not be removed from finger|1
2356036|NCT04090164|4116778|FG000|Overall Study|incomplete data on file|245
2356037|NCT04090164|4116779|FG001|Overall Study|incomplete data on file|0
2356038|NCT03997825|4116872|FG000|Overall Study|Death|3
2356039|NCT03997825|4116872|FG000|Overall Study|Lost to Follow-up|10
2356040|NCT03997825|4116872|FG000|Overall Study|Withdrawal by Subject|3
2356041|NCT03997825|4116872|FG000|Overall Study|Refused participation|1
2356042|NCT03764813|4116909|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
2356043|NCT03764813|4116910|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
2356044|NCT03764813|4116911|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
2356045|NCT03764813|4116912|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
2356046|NCT00078806|4116928|FG000|Part 1A|Adverse Event|2
2356047|NCT00078806|4116929|FG001|Part 1A|Adverse Event|0
2356048|NCT00078806|4116930|FG002|Part 1A|Adverse Event|0
2356049|NCT00078806|4116931|FG003|Part 1A|Adverse Event|0
2356050|NCT00078806|4116928|FG000|Part 1A|Lack of Efficacy|7
2356051|NCT00078806|4116929|FG001|Part 1A|Lack of Efficacy|0
2356052|NCT00078806|4116930|FG002|Part 1A|Lack of Efficacy|0
2356053|NCT00078806|4116931|FG003|Part 1A|Lack of Efficacy|0
2356054|NCT00078806|4116928|FG000|Part 1A|Other|1
2356055|NCT00078806|4116929|FG001|Part 1A|Other|0
2356056|NCT00078806|4116930|FG002|Part 1A|Other|0
2356057|NCT00078806|4116931|FG003|Part 1A|Other|0
2356058|NCT00078806|4116928|FG000|Part 1B|Adverse Event|1
2356059|NCT00078806|4116929|FG001|Part 1B|Adverse Event|0
2356060|NCT00078806|4116930|FG002|Part 1B|Adverse Event|0
2356061|NCT00078806|4116931|FG003|Part 1B|Adverse Event|0
2356062|NCT00078806|4116928|FG000|Part 1B|Lack of Efficacy|7
2356063|NCT00078806|4116929|FG001|Part 1B|Lack of Efficacy|0
2356064|NCT00078806|4116930|FG002|Part 1B|Lack of Efficacy|0
2356065|NCT00078806|4116931|FG003|Part 1B|Lack of Efficacy|0
2356066|NCT00078806|4116928|FG000|Part 2|Adverse Event|0
2356067|NCT00078806|4116929|FG001|Part 2|Adverse Event|1
2356068|NCT00078806|4116930|FG002|Part 2|Adverse Event|0
2356069|NCT00078806|4116931|FG003|Part 2|Adverse Event|0
2356070|NCT00162370|4116946|FG000|Efficacy Population|Lost to Follow-up|51
2356071|NCT00214500|4116962|FG000|Treatment Period|Adverse Event|1
2356072|NCT00214500|4116962|FG000|Extension Period|Withdrawal by Subject|2
2356073|NCT00283959|4116974|FG000|Extension Period|Low Compliance|1
2356074|NCT00290758|4116980|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
2356075|NCT00290758|4116981|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
2356076|NCT00290758|4116980|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
2356077|NCT00290758|4116981|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
2356078|NCT00290758|4116980|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
2356079|NCT00290758|4116981|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
2356080|NCT00290758|4116980|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
2356081|NCT00290758|4116981|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
2356082|NCT00290758|4116980|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
2356083|NCT00290758|4116981|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
2356084|NCT00290758|4116980|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
2356085|NCT00290758|4116981|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
2356086|NCT00290758|4116980|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
2356087|NCT00290758|4116981|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
2356088|NCT00290758|4116980|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6
2356089|NCT00290758|4116981|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5
2308963|NCT02713789|4012414|FG002|Overall Study|Lost to Follow-up|1
2308964|NCT02713828|4012424|FG000|Overall Study|Death|2
2308965|NCT02713828|4012425|FG001|Overall Study|Death|0
2308966|NCT02713828|4012424|FG000|Overall Study|Withdrawal by Subject|1
2308967|NCT02713828|4012425|FG001|Overall Study|Withdrawal by Subject|0
2308968|NCT02713828|4012424|FG000|Overall Study|study terminated but patient allowed to|2
2308969|NCT02713828|4012425|FG001|Overall Study|study terminated but patient allowed to|0
2308970|NCT02713867|4012432|FG000|Randomization|Other Reason|2
2308971|NCT02713867|4012433|FG001|Randomization|Other Reason|1
2308972|NCT02713867|4012432|FG000|Randomization|Participant Withdrew consent|0
2308973|NCT02713867|4012433|FG001|Randomization|Participant Withdrew consent|2
2308974|NCT02713867|4012432|FG000|Treatment Period|Not Reported|1
2308975|NCT02713867|4012433|FG001|Treatment Period|Not Reported|0
2308976|NCT02713867|4012432|FG000|Treatment Period|Other Reasons|12
2308977|NCT02713867|4012433|FG001|Treatment Period|Other Reasons|18
2308978|NCT02713867|4012432|FG000|Treatment Period|Administrative reason by sponsor|9
2308979|NCT02713867|4012433|FG001|Treatment Period|Administrative reason by sponsor|4
2308980|NCT02713867|4012432|FG000|Treatment Period|No longer meets study criteria|2
2308981|NCT02713867|4012433|FG001|Treatment Period|No longer meets study criteria|1
2308982|NCT02713867|4012432|FG000|Treatment Period|Poor/Non Compliance|1
2308983|NCT02713867|4012433|FG001|Treatment Period|Poor/Non Compliance|0
2308984|NCT02713867|4012432|FG000|Treatment Period|Maximum Clinical Benefit|3
2308985|NCT02713867|4012433|FG001|Treatment Period|Maximum Clinical Benefit|4
2308986|NCT02713867|4012432|FG000|Treatment Period|Withdrew consent|1
2308987|NCT02713867|4012433|FG001|Treatment Period|Withdrew consent|6
2308988|NCT02713867|4012432|FG000|Treatment Period|Requested to Discontinue|8
2356090|NCT00310388|4116991|FG000|Primary Reporting Phase|Adverse Event|101
2356091|NCT00310388|4116992|FG001|Primary Reporting Phase|Adverse Event|0
2356092|NCT00310388|4116991|FG000|Primary Reporting Phase|Lack of Efficacy|56
2356093|NCT00310388|4116992|FG001|Primary Reporting Phase|Lack of Efficacy|0
2356094|NCT00310388|4116991|FG000|Primary Reporting Phase|Withdrawal by Subject|97
2356095|NCT00310388|4116992|FG001|Primary Reporting Phase|Withdrawal by Subject|0
2356096|NCT00310388|4116991|FG000|Primary Reporting Phase|Protocol Violation|10
2356097|NCT00310388|4116992|FG001|Primary Reporting Phase|Protocol Violation|0
2356098|NCT00310388|4116991|FG000|Primary Reporting Phase|Pregnancy|3
2356099|NCT00310388|4116992|FG001|Primary Reporting Phase|Pregnancy|0
2356100|NCT00310388|4116991|FG000|Primary Reporting Phase|Change in participant medical condition|3
2356101|NCT00310388|4116992|FG001|Primary Reporting Phase|Change in participant medical condition|0
2356102|NCT00310388|4116991|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
2356103|NCT00310388|4116992|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
2356104|NCT00310388|4116991|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
2356105|NCT00310388|4116992|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
2356106|NCT00310388|4116991|FG000|Primary Reporting Phase|Physician Decision|2
2356107|NCT00310388|4116992|FG001|Primary Reporting Phase|Physician Decision|0
2356108|NCT00310388|4116991|FG000|Primary Reporting Phase|Request of the sponsor|19
2356109|NCT00310388|4116992|FG001|Primary Reporting Phase|Request of the sponsor|0
2356110|NCT00310388|4116991|FG000|Primary Reporting Phase|Failed to return|8
2356111|NCT00310388|4116992|FG001|Primary Reporting Phase|Failed to return|0
2356112|NCT00310388|4116991|FG000|Primary Reporting Phase|Participant request unrelated to study|2
2356113|NCT00310388|4116992|FG001|Primary Reporting Phase|Participant request unrelated to study|0
2356114|NCT00310388|4116991|FG000|Primary Reporting Phase|Participant request|2
2356115|NCT00310388|4116992|FG001|Primary Reporting Phase|Participant request|0
2356116|NCT00310388|4116991|FG000|Primary Reporting Phase|Ministry of Health decision|25
2356117|NCT00310388|4116992|FG001|Primary Reporting Phase|Ministry of Health decision|0
2356118|NCT00310388|4116991|FG000|Primary Reporting Phase|Discontinuation of study|1
2356119|NCT00310388|4116992|FG001|Primary Reporting Phase|Discontinuation of study|0
2020045|NCT00303472|3587524|FG005|Treatment Period|Withdrawal by Subject|1
2212441|NCT01669421|3853421|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1
2212442|NCT01669577|3853453|FG000|Overall Study|Death|22
2020046|NCT00303472|3587525|FG006|Treatment Period|Withdrawal by Subject|0
2020047|NCT00303472|3587519|FG000|Treatment Period|Other|0
2020048|NCT00303472|3587520|FG001|Treatment Period|Other|0
2020049|NCT00303472|3587521|FG002|Treatment Period|Other|0
2020050|NCT00303472|3587522|FG003|Treatment Period|Other|0
2020051|NCT00303472|3587523|FG004|Treatment Period|Other|1
2020052|NCT00303472|3587524|FG005|Treatment Period|Other|0
2020053|NCT00303472|3587525|FG006|Treatment Period|Other|1
2020054|NCT00303472|3587519|FG000|Treatment Period|Disease Progression (to AML)|0
2020055|NCT00303472|3587520|FG001|Treatment Period|Disease Progression (to AML)|0
2020056|NCT00303472|3587521|FG002|Treatment Period|Disease Progression (to AML)|0
2020057|NCT00303472|3587522|FG003|Treatment Period|Disease Progression (to AML)|0
2020058|NCT00303472|3587523|FG004|Treatment Period|Disease Progression (to AML)|1
2020059|NCT00303472|3587524|FG005|Treatment Period|Disease Progression (to AML)|0
2020060|NCT00303472|3587525|FG006|Treatment Period|Disease Progression (to AML)|0
2020061|NCT00303472|3587519|FG000|Treatment Extension (Optional)|Adverse Event|1
2020062|NCT00303472|3587520|FG001|Treatment Extension (Optional)|Adverse Event|0
2020063|NCT00303472|3587521|FG002|Treatment Extension (Optional)|Adverse Event|1
2020064|NCT00303472|3587522|FG003|Treatment Extension (Optional)|Adverse Event|0
2020065|NCT00303472|3587523|FG004|Treatment Extension (Optional)|Adverse Event|0
2020066|NCT00303472|3587524|FG005|Treatment Extension (Optional)|Adverse Event|0
2020067|NCT00303472|3587525|FG006|Treatment Extension (Optional)|Adverse Event|0
2020068|NCT00303472|3587519|FG000|Treatment Extension (Optional)|Death|2
2020069|NCT00303472|3587520|FG001|Treatment Extension (Optional)|Death|0
2020070|NCT00303472|3587521|FG002|Treatment Extension (Optional)|Death|1
2020071|NCT00303472|3587522|FG003|Treatment Extension (Optional)|Death|0
2020072|NCT00303472|3587523|FG004|Treatment Extension (Optional)|Death|0
2020073|NCT00303472|3587524|FG005|Treatment Extension (Optional)|Death|0
2020074|NCT00303472|3587525|FG006|Treatment Extension (Optional)|Death|0
2212443|NCT01669577|3853453|FG000|Overall Study|Lost to Follow-up|78
2356120|NCT00310388|4116991|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1
2356121|NCT00310388|4116992|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0
2356122|NCT00310388|4116991|FG000|Primary Reporting Phase|Termination of study at sponsor request|3
2356123|NCT00310388|4116992|FG001|Primary Reporting Phase|Termination of study at sponsor request|0
2356124|NCT00310388|4116991|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1
2356125|NCT00310388|4116992|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0
2356126|NCT00310388|4116991|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2
2356127|NCT00310388|4116992|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0
2356128|NCT00310388|4116991|FG000|Primary Reporting Phase|Participant passed away|1
2356129|NCT00310388|4116992|FG001|Primary Reporting Phase|Participant passed away|0
2356130|NCT00310388|4116991|FG000|Primary Reporting Phase|Participant retired the informed consent|1
2356131|NCT00310388|4116992|FG001|Primary Reporting Phase|Participant retired the informed consent|0
2356132|NCT00310388|4116991|FG000|Primary Reporting Phase|Missing|1
2356133|NCT00310388|4116992|FG001|Primary Reporting Phase|Missing|0
2356134|NCT00310388|4116991|FG000|Primary Reporting Phase|Other|1
2356135|NCT00310388|4116992|FG001|Primary Reporting Phase|Other|0
2356136|NCT00310388|4116991|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
2356137|NCT00310388|4116992|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
2356138|NCT00310388|4116991|FG000|Safety Follow-up Continuation Phase|Adverse Event|0
2356139|NCT00310388|4116992|FG001|Safety Follow-up Continuation Phase|Adverse Event|1
2356140|NCT00310388|4116991|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
2356141|NCT00310388|4116992|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
2356142|NCT00310388|4116991|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
2356143|NCT00310388|4116992|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
2308989|NCT02713867|4012433|FG001|Treatment Period|Requested to Discontinue|7
2308990|NCT02713867|4012432|FG000|Treatment Period|AE unrelated to Study Drug|8
2308991|NCT02713867|4012433|FG001|Treatment Period|AE unrelated to Study Drug|9
2308992|NCT02713867|4012432|FG000|Treatment Period|Death|7
2308993|NCT02713867|4012433|FG001|Treatment Period|Death|3
2308994|NCT02713867|4012432|FG000|Treatment Period|Study Drug Toxicity|16
2308995|NCT02713867|4012433|FG001|Treatment Period|Study Drug Toxicity|20
2308996|NCT02713867|4012432|FG000|Treatment Period|Disease Progression|79
2308997|NCT02713867|4012433|FG001|Treatment Period|Disease Progression|78
2308998|NCT02714062|4012442|FG000|Overall Study|Adverse Event|0
2308999|NCT02714062|4012443|FG001|Overall Study|Adverse Event|0
2309000|NCT02714062|4012444|FG002|Overall Study|Adverse Event|2
2309001|NCT02714062|4012442|FG000|Overall Study|Withdrawal by Subject|1
2309002|NCT02714062|4012443|FG001|Overall Study|Withdrawal by Subject|0
2309003|NCT02714062|4012444|FG002|Overall Study|Withdrawal by Subject|1
2309004|NCT02714062|4012442|FG000|Overall Study|Protocol Violation|0
2309005|NCT02714062|4012443|FG001|Overall Study|Protocol Violation|1
2309006|NCT02714062|4012444|FG002|Overall Study|Protocol Violation|0
2309007|NCT02714153|4012454|FG000|Overall Study|Death|1
2356144|NCT00345358|4117001|FG000|Primary Vaccination Phase|Other|0
2356145|NCT00345358|4117002|FG001|Primary Vaccination Phase|Other|1
2356146|NCT00345358|4117003|FG002|Primary Vaccination Phase|Other|1
2356147|NCT00345358|4117004|FG003|Primary Vaccination Phase|Other|0
2356148|NCT00345358|4117001|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3
2356149|NCT00345358|4117002|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1
2356150|NCT00345358|4117003|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1
2356151|NCT00345358|4117004|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0
2356152|NCT00345358|4117001|FG000|Primary Vaccination Phase|Withdrawal by Subject|1
2356153|NCT00345358|4117002|FG001|Primary Vaccination Phase|Withdrawal by Subject|2
2356154|NCT00345358|4117003|FG002|Primary Vaccination Phase|Withdrawal by Subject|4
2356155|NCT00345358|4117004|FG003|Primary Vaccination Phase|Withdrawal by Subject|0
2356156|NCT00345358|4117001|FG000|Primary Vaccination Phase|Lost to Follow-up|1
2356157|NCT00345358|4117002|FG001|Primary Vaccination Phase|Lost to Follow-up|0
2356158|NCT00345358|4117003|FG002|Primary Vaccination Phase|Lost to Follow-up|2
2356159|NCT00345358|4117004|FG003|Primary Vaccination Phase|Lost to Follow-up|2
2356160|NCT00345358|4117001|FG000|Booster Vaccination Phase|Withdrawal by Subject|1
2356161|NCT00345358|4117002|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
2356162|NCT00345358|4117003|FG002|Booster Vaccination Phase|Withdrawal by Subject|0
2356163|NCT00345358|4117004|FG003|Booster Vaccination Phase|Withdrawal by Subject|0
2020075|NCT00303472|3587519|FG000|Treatment Extension (Optional)|Lost to Follow-up|0
2020076|NCT00303472|3587520|FG001|Treatment Extension (Optional)|Lost to Follow-up|0
2020077|NCT00303472|3587521|FG002|Treatment Extension (Optional)|Lost to Follow-up|0
2020078|NCT00303472|3587522|FG003|Treatment Extension (Optional)|Lost to Follow-up|1
2020079|NCT00303472|3587523|FG004|Treatment Extension (Optional)|Lost to Follow-up|0
2020080|NCT00303472|3587524|FG005|Treatment Extension (Optional)|Lost to Follow-up|0
2020081|NCT00303472|3587525|FG006|Treatment Extension (Optional)|Lost to Follow-up|0
2020082|NCT00303472|3587519|FG000|Treatment Extension (Optional)|Physician Decision|0
2020083|NCT00303472|3587520|FG001|Treatment Extension (Optional)|Physician Decision|4
2020084|NCT00303472|3587521|FG002|Treatment Extension (Optional)|Physician Decision|2
2020085|NCT00303472|3587522|FG003|Treatment Extension (Optional)|Physician Decision|3
2020086|NCT00303472|3587523|FG004|Treatment Extension (Optional)|Physician Decision|2
2020087|NCT00303472|3587524|FG005|Treatment Extension (Optional)|Physician Decision|0
2020088|NCT00303472|3587525|FG006|Treatment Extension (Optional)|Physician Decision|0
2020089|NCT00303472|3587519|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1
2020090|NCT00303472|3587520|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0
2020091|NCT00303472|3587521|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1
2020092|NCT00303472|3587522|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2
2020093|NCT00303472|3587523|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1
2020094|NCT00303472|3587524|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0
2020095|NCT00303472|3587525|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0
2020096|NCT00303472|3587519|FG000|Treatment Extension (Optional)|Other|0
2020097|NCT00303472|3587520|FG001|Treatment Extension (Optional)|Other|2
2020098|NCT00303472|3587521|FG002|Treatment Extension (Optional)|Other|4
2020099|NCT00303472|3587522|FG003|Treatment Extension (Optional)|Other|2
2020100|NCT00303472|3587523|FG004|Treatment Extension (Optional)|Other|1
2020101|NCT00303472|3587524|FG005|Treatment Extension (Optional)|Other|0
2020102|NCT00303472|3587525|FG006|Treatment Extension (Optional)|Other|0
2020103|NCT00303472|3587519|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1
2020104|NCT00303472|3587520|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0
2020105|NCT00303472|3587521|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0
2020106|NCT00303472|3587522|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0
2020107|NCT00303472|3587523|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0
2020108|NCT00303472|3587524|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1
2020109|NCT00303472|3587525|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0
2020110|NCT00303485|3587543|FG000|Overall Study|Adverse Event/Intercurrent Illness|0
2020111|NCT00303485|3587544|FG001|Overall Study|Adverse Event/Intercurrent Illness|1
2020112|NCT00303485|3587543|FG000|Overall Study|Failure to return|0
2020113|NCT00303485|3587544|FG001|Overall Study|Failure to return|1
2020114|NCT00303485|3587543|FG000|Overall Study|Withdrawal by Subject|1
2020115|NCT00303485|3587544|FG001|Overall Study|Withdrawal by Subject|0
2020116|NCT00303602|3587556|FG000|Overall Study|Adverse Event|2
2020117|NCT00303602|3587557|FG001|Overall Study|Adverse Event|2
2020118|NCT00303602|3587556|FG000|Overall Study|Withdrawal by Subject|5
2020119|NCT00303602|3587557|FG001|Overall Study|Withdrawal by Subject|6
2020120|NCT00303602|3587556|FG000|Overall Study|Lost to Follow-up|5
2020121|NCT00303602|3587557|FG001|Overall Study|Lost to Follow-up|2
2020122|NCT00303602|3587556|FG000|Overall Study|Protocol entry criteria not met|2
2020123|NCT00303602|3587557|FG001|Overall Study|Protocol entry criteria not met|2
2020124|NCT00303602|3587556|FG000|Overall Study|Physician Decision|2
2356164|NCT00345358|4117001|FG000|Booster Vaccination Phase|Lost to Follow-up|3
2356165|NCT00345358|4117002|FG001|Booster Vaccination Phase|Lost to Follow-up|0
2356166|NCT00345358|4117003|FG002|Booster Vaccination Phase|Lost to Follow-up|0
2356167|NCT00345358|4117004|FG003|Booster Vaccination Phase|Lost to Follow-up|0
2212444|NCT01669577|3853453|FG000|Overall Study|Physician Decision|34
2212445|NCT01669629|3853466|FG000|Period 1|protocol deviation|1
2212446|NCT01669629|3853467|FG001|Period 1|protocol deviation|2
2212447|NCT01669798|3853523|FG000|Overall Study|Physician Decision|5
2212448|NCT01669811|3853529|FG000|Overall Study|Investigator decision|0
2212449|NCT01669811|3853530|FG001|Overall Study|Investigator decision|1
2212450|NCT01669811|3853529|FG000|Overall Study|Withdrawal by Subject|1
2212451|NCT01669811|3853530|FG001|Overall Study|Withdrawal by Subject|2
2212452|NCT01669811|3853529|FG000|Overall Study|Adverse Event|2
2212453|NCT01669811|3853530|FG001|Overall Study|Adverse Event|6
2212454|NCT01669811|3853529|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
2212455|NCT01669811|3853530|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2
2212456|NCT01669902|3853541|FG000|Overall Study|Adverse Event|11
2212457|NCT01669902|3853541|FG000|Overall Study|Lack of Efficacy|10
2212458|NCT01669902|3853541|FG000|Overall Study|Other|8
2212459|NCT01669928|3853547|FG000|First Intervention|Withdrawal by Subject|3
2212460|NCT01669928|3853548|FG001|First Intervention|Withdrawal by Subject|5
2212461|NCT01670019|3853558|FG000|Overall Study|Adverse Event|3
2212462|NCT01670019|3853559|FG001|Overall Study|Adverse Event|0
2212463|NCT01670019|3853558|FG000|Overall Study|Withdrawal by Subject|6
2212464|NCT01670019|3853559|FG001|Overall Study|Withdrawal by Subject|0
2212465|NCT01670045|3853565|FG000|Overall Study|Withdrawal by Subject|3
2309008|NCT02714426|4012480|FG000|Overall Study|Withdrawal by Subject|2
2309009|NCT02714426|4012481|FG001|Overall Study|Withdrawal by Subject|2
2309010|NCT02714569|4012507|FG000|Part A Second Intervention|Withdrawal by Subject|0
2309011|NCT02714569|4012508|FG001|Part A Second Intervention|Withdrawal by Subject|1
2212466|NCT01670045|3853565|FG000|Overall Study|Adverse Event|1
2212467|NCT01670045|3853565|FG000|Overall Study|Death|1
2212468|NCT01670045|3853565|FG000|Overall Study|Lost to Follow-up|11
2212469|NCT01670097|3853571|FG000|Overall Study|Started Phase 1 cancer treatment|1
2212470|NCT01670097|3853572|FG001|Overall Study|Started Phase 1 cancer treatment|0
2356168|NCT00372229|4117016|FG000|Study Phase|Graft loss|0
2356169|NCT00372229|4117017|FG001|Study Phase|Graft loss|3
2356170|NCT00372229|4117016|FG000|Study Phase|Protocol Violation|3
2356171|NCT00372229|4117017|FG001|Study Phase|Protocol Violation|4
2356172|NCT00372229|4117016|FG000|Study Phase|Consent withdrawn|16
2356173|NCT00372229|4117017|FG001|Study Phase|Consent withdrawn|14
2356174|NCT00372229|4117016|FG000|Study Phase|Refused treatment/did not cooperate|3
2356175|NCT00372229|4117017|FG001|Study Phase|Refused treatment/did not cooperate|1
2356176|NCT00372229|4117016|FG000|Study Phase|Death|3
2356177|NCT00372229|4117017|FG001|Study Phase|Death|2
2356178|NCT00372229|4117016|FG000|Study Phase|Reason not specified|3
2356179|NCT00372229|4117017|FG001|Study Phase|Reason not specified|2
2356180|NCT00372229|4117016|FG000|Study Phase|Lost to Follow-up|3
2356181|NCT00372229|4117017|FG001|Study Phase|Lost to Follow-up|3
2356182|NCT00372229|4117016|FG000|Follow-Up Phase|Graft loss|8
2356183|NCT00372229|4117017|FG001|Follow-Up Phase|Graft loss|7
2356184|NCT00372229|4117016|FG000|Follow-Up Phase|Consent withdrawn|13
2356185|NCT00372229|4117017|FG001|Follow-Up Phase|Consent withdrawn|19
2356186|NCT00372229|4117016|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0
2356187|NCT00372229|4117017|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1
2356188|NCT00372229|4117016|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1
2356189|NCT00372229|4117017|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0
2356190|NCT00372229|4117016|FG000|Follow-Up Phase|Death|9
2356191|NCT00372229|4117017|FG001|Follow-Up Phase|Death|12
2356192|NCT00372229|4117016|FG000|Follow-Up Phase|Administrative|1
2356193|NCT00372229|4117017|FG001|Follow-Up Phase|Administrative|0
2356194|NCT00372229|4117016|FG000|Follow-Up Phase|Reason not specified|2
2356195|NCT00372229|4117017|FG001|Follow-Up Phase|Reason not specified|3
2356196|NCT00372229|4117016|FG000|Follow-Up Phase|Lost to Follow-up|12
2356197|NCT00372229|4117017|FG001|Follow-Up Phase|Lost to Follow-up|10
2356198|NCT00383708|4117027|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1
2356199|NCT00383708|4117027|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32
2356200|NCT00383708|4117027|FG000|Run-in Period|Protocol Violation|4
2356201|NCT00383708|4117027|FG000|Run-in Period|Adverse Event|2
2356202|NCT00383708|4117027|FG000|Run-in Period|Claustrophobia|1
2356203|NCT00383708|4117027|FG000|Co-administration Period|Adverse Event|5
2356204|NCT00413699|4117034|FG000|Initial Period|Death|25
2356205|NCT00413699|4117035|FG001|Initial Period|Death|30
2356206|NCT00413699|4117036|FG002|Initial Period|Death|0
2356207|NCT00413699|4117034|FG000|Initial Period|Lack of Efficacy|59
2356208|NCT00413699|4117035|FG001|Initial Period|Lack of Efficacy|115
2356209|NCT00413699|4117036|FG002|Initial Period|Lack of Efficacy|0
2356210|NCT00413699|4117034|FG000|Initial Period|Lost to Follow-up|31
2356211|NCT00413699|4117035|FG001|Initial Period|Lost to Follow-up|101
2356212|NCT00413699|4117036|FG002|Initial Period|Lost to Follow-up|0
2356213|NCT00413699|4117034|FG000|Initial Period|Protocol Violation|38
2356214|NCT00413699|4117035|FG001|Initial Period|Protocol Violation|89
2356215|NCT00413699|4117036|FG002|Initial Period|Protocol Violation|0
2356216|NCT00413699|4117034|FG000|Initial Period|Pregnancy|10
2356217|NCT00413699|4117035|FG001|Initial Period|Pregnancy|8
2356218|NCT00413699|4117036|FG002|Initial Period|Pregnancy|0
2356219|NCT00413699|4117034|FG000|Initial Period|Did not meet entrance criteria|2
2356220|NCT00413699|4117035|FG001|Initial Period|Did not meet entrance criteria|2
2356221|NCT00413699|4117036|FG002|Initial Period|Did not meet entrance criteria|0
2356222|NCT00413699|4117034|FG000|Initial Period|Medication error without adverse event|0
2356223|NCT00413699|4117035|FG001|Initial Period|Medication error without adverse event|1
2356224|NCT00413699|4117036|FG002|Initial Period|Medication error without adverse event|0
2356225|NCT00413699|4117034|FG000|Initial Period|Study terminated by Sponsor|0
2356226|NCT00413699|4117035|FG001|Initial Period|Study terminated by Sponsor|1
2356227|NCT00413699|4117036|FG002|Initial Period|Study terminated by Sponsor|0
2356228|NCT00413699|4117034|FG000|Initial Period|Other|67
2356229|NCT00413699|4117035|FG001|Initial Period|Other|211
2356230|NCT00413699|4117036|FG002|Initial Period|Other|0
2356231|NCT00413699|4117034|FG000|Initial Period|Adverse event related to study drug|178
2356232|NCT00413699|4117035|FG001|Initial Period|Adverse event related to study drug|527
2356233|NCT00413699|4117036|FG002|Initial Period|Adverse event related to study drug|0
2356234|NCT00413699|4117034|FG000|Initial Period|Adverse event not related to study drug|113
2356235|NCT00413699|4117035|FG001|Initial Period|Adverse event not related to study drug|248
2356236|NCT00413699|4117036|FG002|Initial Period|Adverse event not related to study drug|0
2356237|NCT00413699|4117034|FG000|Initial Period|Missing end of study page|0
2356238|NCT00413699|4117035|FG001|Initial Period|Missing end of study page|4
2356239|NCT00413699|4117036|FG002|Initial Period|Missing end of study page|0
2356240|NCT00413699|4117034|FG000|Initial Period|No longer willing to participate|116
2356241|NCT00413699|4117035|FG001|Initial Period|No longer willing to participate|368
2356242|NCT00413699|4117036|FG002|Initial Period|No longer willing to participate|0
2356243|NCT00413699|4117034|FG000|Extension Period|No Longer Willing to Participate|0
2356244|NCT00413699|4117035|FG001|Extension Period|No Longer Willing to Participate|0
2356245|NCT00413699|4117036|FG002|Extension Period|No Longer Willing to Participate|2
2356246|NCT00413699|4117034|FG000|Extension Period|Protocol Violation|0
2356247|NCT00413699|4117035|FG001|Extension Period|Protocol Violation|0
2356248|NCT00413699|4117036|FG002|Extension Period|Protocol Violation|1
2356249|NCT00413699|4117034|FG000|Extension Period|Adverse Event|0
2356250|NCT00413699|4117035|FG001|Extension Period|Adverse Event|0
2356251|NCT00413699|4117036|FG002|Extension Period|Adverse Event|2
2020125|NCT00303602|3587557|FG001|Overall Study|Physician Decision|1
2020126|NCT00303602|3587556|FG000|Overall Study|Noncompliance|2
2020127|NCT00303602|3587557|FG001|Overall Study|Noncompliance|2
2020128|NCT00303602|3587556|FG000|Overall Study|Protocol Violation|1
2020129|NCT00303602|3587557|FG001|Overall Study|Protocol Violation|0
2020130|NCT00303628|3587565|FG000|Overall Study|Disease progression|0
2020131|NCT00303628|3587566|FG001|Overall Study|Disease progression|1
2020132|NCT00303628|3587565|FG000|Overall Study|Adverse Event|26
2020133|NCT00303628|3587566|FG001|Overall Study|Adverse Event|36
2020134|NCT00303628|3587565|FG000|Overall Study|Death|0
2020135|NCT00303628|3587566|FG001|Overall Study|Death|1
2020136|NCT00303628|3587565|FG000|Overall Study|Withdrawal by Subject|11
2020137|NCT00303628|3587566|FG001|Overall Study|Withdrawal by Subject|20
2356252|NCT00436826|4117074|FG000|Double Blind Period (DBP)|Adverse Event|2
2356253|NCT00436826|4117075|FG001|Double Blind Period (DBP)|Adverse Event|0
2356254|NCT00436826|4117076|FG002|Double Blind Period (DBP)|Adverse Event|0
2356255|NCT00436826|4117077|FG003|Double Blind Period (DBP)|Adverse Event|0
2356256|NCT00436826|4117078|FG004|Double Blind Period (DBP)|Adverse Event|0
2356257|NCT00436826|4117079|FG005|Double Blind Period (DBP)|Adverse Event|0
2356258|NCT00436826|4117074|FG000|Double Blind Period (DBP)|Protocol Violation|1
2356259|NCT00436826|4117075|FG001|Double Blind Period (DBP)|Protocol Violation|0
2356260|NCT00436826|4117076|FG002|Double Blind Period (DBP)|Protocol Violation|0
2356261|NCT00436826|4117077|FG003|Double Blind Period (DBP)|Protocol Violation|0
2356262|NCT00436826|4117078|FG004|Double Blind Period (DBP)|Protocol Violation|0
2356263|NCT00436826|4117079|FG005|Double Blind Period (DBP)|Protocol Violation|0
2356264|NCT00436826|4117074|FG000|Double Blind Period (DBP)|Other|10
2356265|NCT00436826|4117075|FG001|Double Blind Period (DBP)|Other|11
2356266|NCT00436826|4117076|FG002|Double Blind Period (DBP)|Other|0
2356267|NCT00436826|4117077|FG003|Double Blind Period (DBP)|Other|0
2356268|NCT00436826|4117078|FG004|Double Blind Period (DBP)|Other|0
2356269|NCT00436826|4117079|FG005|Double Blind Period (DBP)|Other|0
2356270|NCT00436826|4117074|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
2356271|NCT00436826|4117075|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
2356272|NCT00436826|4117076|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
2356273|NCT00436826|4117077|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1
2356274|NCT00436826|4117078|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
2356275|NCT00436826|4117079|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
2356276|NCT00436826|4117074|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0
2356277|NCT00436826|4117075|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0
2356278|NCT00436826|4117076|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46
2356279|NCT00436826|4117077|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25
2356280|NCT00436826|4117078|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0
2356281|NCT00436826|4117079|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0
2356282|NCT00436826|4117074|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
2356283|NCT00436826|4117075|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
2356284|NCT00436826|4117076|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
2356285|NCT00436826|4117077|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
2356286|NCT00436826|4117078|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
2356287|NCT00436826|4117079|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
2020138|NCT00303628|3587565|FG000|Overall Study|Alternative therapy|2
2020139|NCT00303628|3587566|FG001|Overall Study|Alternative therapy|0
2020140|NCT00303628|3587565|FG000|Overall Study|Other complicating disease|0
2020141|NCT00303628|3587566|FG001|Overall Study|Other complicating disease|1
2020142|NCT00303628|3587565|FG000|Overall Study|Not start protocol therapy|3
2020143|NCT00303628|3587566|FG001|Overall Study|Not start protocol therapy|5
2020144|NCT00303628|3587565|FG000|Overall Study|Other|8
2020145|NCT00303628|3587566|FG001|Overall Study|Other|9
2020146|NCT00303667|3587574|FG000|Overall Study|Death|0
2020147|NCT00303667|3587575|FG001|Overall Study|Death|4
2020148|NCT00303719|3587583|FG000|Overall Study|Not evaluable, prior therapies|0
2020149|NCT00303719|3587584|FG001|Overall Study|Not evaluable, prior therapies|30
2020150|NCT00303719|3587583|FG000|Overall Study|Lost to Follow-up|0
2020151|NCT00303719|3587584|FG001|Overall Study|Lost to Follow-up|7
2020152|NCT00303953|3587608|FG000|Overall Study|Ineligible|1
2020153|NCT00303953|3587608|FG000|Overall Study|Death|1
2020154|NCT00303953|3587608|FG000|Overall Study|Adverse Event|4
2020155|NCT00303953|3587608|FG000|Overall Study|Lack of Efficacy|12
2020156|NCT00303953|3587608|FG000|Overall Study|Physician Decision|1
2020157|NCT00304031|3587641|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144
2020158|NCT00304031|3587642|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
2020159|NCT00304031|3587643|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
2020160|NCT00304031|3587641|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48
2020161|NCT00304031|3587642|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
2020162|NCT00304031|3587643|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
2020163|NCT00304031|3587641|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19
2020164|NCT00304031|3587642|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
2020165|NCT00304031|3587643|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
2356288|NCT00442546|4117098|FG000|Overall Study|Adverse Event|11
2356289|NCT00442546|4117099|FG001|Overall Study|Adverse Event|17
2356290|NCT00442546|4117100|FG002|Overall Study|Adverse Event|13
2356291|NCT00442546|4117098|FG000|Overall Study|Lost to Follow-up|1
2356292|NCT00442546|4117099|FG001|Overall Study|Lost to Follow-up|2
2356293|NCT00442546|4117100|FG002|Overall Study|Lost to Follow-up|1
2356294|NCT00442546|4117098|FG000|Overall Study|Other|4
2356295|NCT00442546|4117099|FG001|Overall Study|Other|9
2356296|NCT00442546|4117100|FG002|Overall Study|Other|6
2356297|NCT00442546|4117098|FG000|Overall Study|Withdrawal by Subject|5
2356298|NCT00442546|4117099|FG001|Overall Study|Withdrawal by Subject|5
2356299|NCT00442546|4117100|FG002|Overall Study|Withdrawal by Subject|7
2356300|NCT00442546|4117098|FG000|Overall Study|Randomized But Not Treated|5
2356301|NCT00442546|4117099|FG001|Overall Study|Randomized But Not Treated|4
2356302|NCT00442546|4117100|FG002|Overall Study|Randomized But Not Treated|6
2356303|NCT00545129|4117112|FG000|Overall Study|Lack of Efficacy|2
2356304|NCT00545129|4117113|FG001|Overall Study|Lack of Efficacy|5
2356305|NCT00545129|4117112|FG000|Overall Study|Death|2
2356306|NCT00545129|4117113|FG001|Overall Study|Death|1
2356307|NCT00545129|4117112|FG000|Overall Study|Adverse Event|1
2356308|NCT00545129|4117113|FG001|Overall Study|Adverse Event|1
2356309|NCT00545129|4117112|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9
2356310|NCT00545129|4117113|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14
2356311|NCT00545129|4117112|FG000|Overall Study|Other|3
2356312|NCT00545129|4117113|FG001|Overall Study|Other|3
2356325|NCT00554606|4117131|FG000|Overall Study|Adverse Event|3
2356326|NCT00554606|4117131|FG000|Overall Study|Abnormal laboratory values|1
2356327|NCT00554606|4117131|FG000|Overall Study|Unsatisfactory therapeutic effect|14
2356328|NCT00554606|4117131|FG000|Overall Study|Subject withdrew consent|2
2356329|NCT00554606|4117131|FG000|Overall Study|Lost to Follow-up|2
2356330|NCT00554606|4117131|FG000|Overall Study|Administrative problems|60
2356331|NCT00554606|4117131|FG000|Overall Study|Death|1
2356332|NCT00554606|4117131|FG000|Overall Study|Protocol deviation|2
2356337|NCT00566995|4117169|FG000|Overall Study|Toxicity|4
2356338|NCT00566995|4117169|FG000|Overall Study|Withdrew consent|3
2356339|NCT00586924|4117179|FG000|Overall Study|Adverse event/serious adverse event|0
2356313|NCT00548093|4117121|FG000|Overall Study|Death|33
2356314|NCT00548093|4117122|FG001|Overall Study|Death|13
2356315|NCT00548093|4117121|FG000|Overall Study|Lost to Follow-up|3
2356316|NCT00548093|4117122|FG001|Overall Study|Lost to Follow-up|1
2356317|NCT00548093|4117121|FG000|Overall Study|Objective progression or relapse|1
2356318|NCT00548093|4117122|FG001|Overall Study|Objective progression or relapse|1
2356319|NCT00548093|4117121|FG000|Overall Study|Other|11
2356320|NCT00548093|4117122|FG001|Overall Study|Other|1
2356321|NCT00548093|4117121|FG000|Overall Study|Withdrawal by Subject|1
2356322|NCT00548093|4117122|FG001|Overall Study|Withdrawal by Subject|0
2356323|NCT00548093|4117121|FG000|Overall Study|Completed post-treatment follow-up|1
2356324|NCT00548093|4117122|FG001|Overall Study|Completed post-treatment follow-up|0
2356333|NCT00555009|4117139|FG000|Overall Study|Withdrawal by Subject|0
2356334|NCT00555009|4117140|FG001|Overall Study|Withdrawal by Subject|1
2356335|NCT00555009|4117139|FG000|Overall Study|Terminated by Sponsor|2
2356336|NCT00555009|4117140|FG001|Overall Study|Terminated by Sponsor|5
2356340|NCT00586924|4117180|FG001|Overall Study|Adverse event/serious adverse event|0
2356341|NCT00586924|4117181|FG002|Overall Study|Adverse event/serious adverse event|0
2356342|NCT00586924|4117182|FG003|Overall Study|Adverse event/serious adverse event|1
2356343|NCT00586924|4117183|FG004|Overall Study|Adverse event/serious adverse event|0
2356344|NCT00586924|4117184|FG005|Overall Study|Adverse event/serious adverse event|2
2356345|NCT00586924|4117179|FG000|Overall Study|Initiation of alternative cancer therapy|0
2356346|NCT00586924|4117180|FG001|Overall Study|Initiation of alternative cancer therapy|0
2356347|NCT00586924|4117181|FG002|Overall Study|Initiation of alternative cancer therapy|0
2356348|NCT00586924|4117182|FG003|Overall Study|Initiation of alternative cancer therapy|0
2356349|NCT00586924|4117183|FG004|Overall Study|Initiation of alternative cancer therapy|0
2356350|NCT00586924|4117184|FG005|Overall Study|Initiation of alternative cancer therapy|1
2356351|NCT00586924|4117179|FG000|Overall Study|Disease progression|0
2356352|NCT00586924|4117180|FG001|Overall Study|Disease progression|0
2356353|NCT00586924|4117181|FG002|Overall Study|Disease progression|0
2356354|NCT00586924|4117182|FG003|Overall Study|Disease progression|1
2356355|NCT00586924|4117183|FG004|Overall Study|Disease progression|1
2356356|NCT00586924|4117184|FG005|Overall Study|Disease progression|0
2356357|NCT00586924|4117179|FG000|Overall Study|Development of neutralizing antibodies|2
2356358|NCT00586924|4117180|FG001|Overall Study|Development of neutralizing antibodies|2
2356359|NCT00586924|4117181|FG002|Overall Study|Development of neutralizing antibodies|2
2356360|NCT00586924|4117182|FG003|Overall Study|Development of neutralizing antibodies|0
2356361|NCT00586924|4117183|FG004|Overall Study|Development of neutralizing antibodies|0
2356362|NCT00586924|4117184|FG005|Overall Study|Development of neutralizing antibodies|22
2356363|NCT00586924|4117179|FG000|Overall Study|Complete response|0
2356364|NCT00586924|4117180|FG001|Overall Study|Complete response|1
2356365|NCT00586924|4117181|FG002|Overall Study|Complete response|0
2356366|NCT00586924|4117182|FG003|Overall Study|Complete response|0
2356367|NCT00586924|4117183|FG004|Overall Study|Complete response|2
2356368|NCT00586924|4117184|FG005|Overall Study|Complete response|2
2356369|NCT00586924|4117179|FG000|Overall Study|Other|1
2356370|NCT00586924|4117180|FG001|Overall Study|Other|0
2356371|NCT00586924|4117181|FG002|Overall Study|Other|1
2356372|NCT00586924|4117182|FG003|Overall Study|Other|1
2356373|NCT00586924|4117183|FG004|Overall Study|Other|1
2356374|NCT00586924|4117184|FG005|Overall Study|Other|6
2356375|NCT00588861|4117200|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95
2356376|NCT00588861|4117201|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86
2356377|NCT00588861|4117200|FG000|6 Months|Patients did not return for follow-up|98
2356378|NCT00588861|4117201|FG001|6 Months|Patients did not return for follow-up|73
2356379|NCT00588861|4117200|FG000|1 Year|Patients did not return for follow-up|89
2356380|NCT00588861|4117201|FG001|1 Year|Patients did not return for follow-up|82
2356381|NCT00588861|4117200|FG000|2 Years|Patients did not return for follow-up|92
2356382|NCT00588861|4117201|FG001|2 Years|Patients did not return for follow-up|87
2356383|NCT00588861|4117200|FG000|4 Years|Patients did not return for follow-up|91
2356384|NCT00588861|4117201|FG001|4 Years|Patients did not return for follow-up|103
2356385|NCT00588861|4117200|FG000|6 Years|Patients did not return for follow-up|104
2356386|NCT00588861|4117201|FG001|6 Years|Patients did not return for follow-up|109
2356387|NCT00588861|4117200|FG000|8 Years|Patients did not return for follow-up|105
2356388|NCT00588861|4117201|FG001|8 Years|Patients did not return for follow-up|114
2356389|NCT00588861|4117200|FG000|10 Years|Incomplete due to study termination|107
2356390|NCT00588861|4117201|FG001|10 Years|Incomplete due to study termination|114
2356391|NCT00641537|4117212|FG000|96-week Period|Adverse Event|0
2356392|NCT00641537|4117213|FG001|96-week Period|Adverse Event|1
2356393|NCT00641537|4117214|FG002|96-week Period|Adverse Event|3
2356394|NCT00641537|4117215|FG003|96-week Period|Adverse Event|0
2356395|NCT00641537|4117216|FG004|96-week Period|Adverse Event|2
2356396|NCT00641537|4117217|FG005|96-week Period|Adverse Event|0
2356397|NCT00641537|4117218|FG006|96-week Period|Adverse Event|0
2356398|NCT00641537|4117219|FG007|96-week Period|Adverse Event|0
2356399|NCT00641537|4117212|FG000|96-week Period|Lost to Follow-up|3
2356400|NCT00641537|4117213|FG001|96-week Period|Lost to Follow-up|1
2356401|NCT00641537|4117214|FG002|96-week Period|Lost to Follow-up|2
2356402|NCT00641537|4117215|FG003|96-week Period|Lost to Follow-up|2
2356403|NCT00641537|4117216|FG004|96-week Period|Lost to Follow-up|4
2356404|NCT00641537|4117217|FG005|96-week Period|Lost to Follow-up|0
2356405|NCT00641537|4117218|FG006|96-week Period|Lost to Follow-up|1
2356406|NCT00641537|4117219|FG007|96-week Period|Lost to Follow-up|0
2356407|NCT00641537|4117212|FG000|96-week Period|Protocol Violation|0
2356408|NCT00641537|4117213|FG001|96-week Period|Protocol Violation|1
2356409|NCT00641537|4117214|FG002|96-week Period|Protocol Violation|0
2356410|NCT00641537|4117215|FG003|96-week Period|Protocol Violation|1
2356411|NCT00641537|4117216|FG004|96-week Period|Protocol Violation|0
2356412|NCT00641537|4117217|FG005|96-week Period|Protocol Violation|1
2356413|NCT00641537|4117218|FG006|96-week Period|Protocol Violation|0
2356414|NCT00641537|4117219|FG007|96-week Period|Protocol Violation|0
2356415|NCT00641537|4117212|FG000|96-week Period|Death|2
2356416|NCT00641537|4117213|FG001|96-week Period|Death|0
2356417|NCT00641537|4117214|FG002|96-week Period|Death|1
2356418|NCT00641537|4117215|FG003|96-week Period|Death|0
2356419|NCT00641537|4117216|FG004|96-week Period|Death|0
2356420|NCT00641537|4117217|FG005|96-week Period|Death|0
2356421|NCT00641537|4117218|FG006|96-week Period|Death|0
2356422|NCT00641537|4117219|FG007|96-week Period|Death|0
2356423|NCT00641537|4117212|FG000|96-week Period|Other|4
2356424|NCT00641537|4117213|FG001|96-week Period|Other|7
2356425|NCT00641537|4117214|FG002|96-week Period|Other|14
2356426|NCT00641537|4117215|FG003|96-week Period|Other|9
2356427|NCT00641537|4117216|FG004|96-week Period|Other|11
2356428|NCT00641537|4117217|FG005|96-week Period|Other|6
2356429|NCT00641537|4117218|FG006|96-week Period|Other|4
2356430|NCT00641537|4117219|FG007|96-week Period|Other|6
2356431|NCT00641537|4117212|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
2356432|NCT00641537|4117213|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
2356433|NCT00641537|4117214|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
2356434|NCT00641537|4117215|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
2356435|NCT00641537|4117216|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
2356436|NCT00641537|4117217|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
2356437|NCT00641537|4117218|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
2356438|NCT00641537|4117219|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
2356439|NCT00641537|4117212|FG000|24-Week Supplemental Follow-up Period|Other|0
2356440|NCT00641537|4117213|FG001|24-Week Supplemental Follow-up Period|Other|2
2356441|NCT00641537|4117214|FG002|24-Week Supplemental Follow-up Period|Other|2
2356442|NCT00641537|4117215|FG003|24-Week Supplemental Follow-up Period|Other|1
2356443|NCT00641537|4117216|FG004|24-Week Supplemental Follow-up Period|Other|3
2356444|NCT00641537|4117217|FG005|24-Week Supplemental Follow-up Period|Other|0
2356445|NCT00641537|4117218|FG006|24-Week Supplemental Follow-up Period|Other|1
2356446|NCT00641537|4117219|FG007|24-Week Supplemental Follow-up Period|Other|1
2356447|NCT00655824|4117237|FG000|Overall Study|Adverse Event|3
2356448|NCT00655824|4117237|FG000|Overall Study|Early Termination of Study by Sponsor|74
2356449|NCT00655824|4117237|FG000|Overall Study|Protocol Violation|1
2356450|NCT00655824|4117237|FG000|Overall Study|Withdrawal by Subject|4
2356451|NCT00655824|4117237|FG000|Overall Study|Deterioration of Trial Disease|2
2356452|NCT00663052|4117243|FG000|Overall Study|Adverse Event|6
2356453|NCT00663052|4117244|FG001|Overall Study|Adverse Event|3
2356454|NCT00663052|4117243|FG000|Overall Study|Discontinuation of Study by Sponsor|2
2356455|NCT00663052|4117244|FG001|Overall Study|Discontinuation of Study by Sponsor|0
2356456|NCT00663052|4117243|FG000|Overall Study|Protocol Violation|1
2356457|NCT00663052|4117244|FG001|Overall Study|Protocol Violation|0
2356458|NCT00663052|4117243|FG000|Overall Study|Withdrawal by Subject|2
2356459|NCT00663052|4117244|FG001|Overall Study|Withdrawal by Subject|5
2356460|NCT00663052|4117243|FG000|Overall Study|Unsatisfactory Response - Efficacy|1
2356461|NCT00663052|4117244|FG001|Overall Study|Unsatisfactory Response - Efficacy|1
2356462|NCT00663052|4117243|FG000|Overall Study|Other|0
2356463|NCT00663052|4117244|FG001|Overall Study|Other|1
2356464|NCT00686374|4117250|FG000|Overall Study|Lack of Efficacy|10
2356465|NCT00686374|4117250|FG000|Overall Study|Adverse Event|8
2356466|NCT00686374|4117250|FG000|Overall Study|Withdrew consent|5
2356467|NCT00686374|4117250|FG000|Overall Study|Lost to Follow-up|1
2356468|NCT00686374|4117250|FG000|Overall Study|Missing reason|33
2356469|NCT00686374|4117250|FG000|Overall Study|Other, not specified|4
2356470|NCT00698828|4117257|FG000|Overall Study|Adverse Event|3
2356471|NCT00698828|4117258|FG001|Overall Study|Adverse Event|4
2356472|NCT00698828|4117259|FG002|Overall Study|Adverse Event|4
2356473|NCT00698828|4117257|FG000|Overall Study|Death|0
2356474|NCT00698828|4117258|FG001|Overall Study|Death|0
2356475|NCT00698828|4117259|FG002|Overall Study|Death|1
2356476|NCT00698828|4117257|FG000|Overall Study|Exacerbation of COPD|1
2356477|NCT00698828|4117258|FG001|Overall Study|Exacerbation of COPD|3
2356478|NCT00698828|4117259|FG002|Overall Study|Exacerbation of COPD|0
2356479|NCT00698828|4117257|FG000|Overall Study|Exacerbation of COPD (Not treated)|1
2356480|NCT00698828|4117258|FG001|Overall Study|Exacerbation of COPD (Not treated)|0
2356481|NCT00698828|4117259|FG002|Overall Study|Exacerbation of COPD (Not treated)|0
2356482|NCT00698828|4117257|FG000|Overall Study|Investigator/Sponsor decision|1
2356483|NCT00698828|4117258|FG001|Overall Study|Investigator/Sponsor decision|0
2356484|NCT00698828|4117259|FG002|Overall Study|Investigator/Sponsor decision|2
2356485|NCT00698828|4117257|FG000|Overall Study|Lost to Follow-up|1
2356486|NCT00698828|4117258|FG001|Overall Study|Lost to Follow-up|1
2356487|NCT00698828|4117259|FG002|Overall Study|Lost to Follow-up|0
2356488|NCT00698828|4117257|FG000|Overall Study|Withdrew consent|0
2356489|NCT00698828|4117258|FG001|Overall Study|Withdrew consent|7
2356490|NCT00698828|4117259|FG002|Overall Study|Withdrew consent|4
2356491|NCT00698828|4117257|FG000|Overall Study|Withdrew consent (not treated)|2
2356492|NCT00698828|4117258|FG001|Overall Study|Withdrew consent (not treated)|0
2356493|NCT00698828|4117259|FG002|Overall Study|Withdrew consent (not treated)|0
2212471|NCT01670097|3853571|FG000|Overall Study|Study burden|1
2020166|NCT00304031|3587641|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18
2020167|NCT00304031|3587642|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0
2020168|NCT00304031|3587643|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0
2020169|NCT00304031|3587641|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15
2020170|NCT00304031|3587642|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
2356494|NCT00712933|4117267|FG000|Overall Study|Adverse Event|69
2356495|NCT00712933|4117267|FG000|Overall Study|Lack of Efficacy|6
2356496|NCT00712933|4117267|FG000|Overall Study|Lost to Follow-up|22
2356497|NCT00712933|4117267|FG000|Overall Study|Non-compliance with study drug|13
2356498|NCT00712933|4117267|FG000|Overall Study|Other Pregnancy|37
2356499|NCT00712933|4117267|FG000|Overall Study|Sponsor decision|14
2356500|NCT00712933|4117267|FG000|Overall Study|Withdrew consent|4
2356501|NCT00712933|4117267|FG000|Overall Study|Hip replacement surgery|1
2356502|NCT00712933|4117267|FG000|Overall Study|Involved in Clinical research|3
2356503|NCT00712933|4117267|FG000|Overall Study|Participant hospitalized|1
2356504|NCT00712933|4117267|FG000|Overall Study|Participant travelled overseas|2
2356505|NCT00712933|4117267|FG000|Overall Study|Death of patient|1
2356506|NCT00712933|4117267|FG000|Overall Study|Other Physician decision|1
2356507|NCT00712933|4117267|FG000|Overall Study|Not committed to contraception|1
2356508|NCT00712933|4117267|FG000|Overall Study|Participant received medication|1
2356509|NCT00712933|4117267|FG000|Overall Study|Physician Decision|36
2356510|NCT00712933|4117267|FG000|Overall Study|Protocol Violation|4
2356511|NCT00712933|4117267|FG000|Overall Study|Withdrawal by Subject|151
2356512|NCT00725985|4117278|FG000|ITP- Treatment Disposition|Adverse Event|20
2356513|NCT00725985|4117279|FG001|ITP- Treatment Disposition|Adverse Event|10
2356514|NCT00725985|4117280|FG002|ITP- Treatment Disposition|Adverse Event|5
2356515|NCT00725985|4117281|FG003|ITP- Treatment Disposition|Adverse Event|0
2356516|NCT00725985|4117282|FG004|ITP- Treatment Disposition|Adverse Event|0
2356517|NCT00725985|4117283|FG005|ITP- Treatment Disposition|Adverse Event|0
2356518|NCT00725985|4117284|FG006|ITP- Treatment Disposition|Adverse Event|0
2356519|NCT00725985|4117285|FG007|ITP- Treatment Disposition|Adverse Event|0
2356520|NCT00725985|4117286|FG008|ITP- Treatment Disposition|Adverse Event|0
2356521|NCT00725985|4117287|FG009|ITP- Treatment Disposition|Adverse Event|0
2356522|NCT00725985|4117288|FG010|ITP- Treatment Disposition|Adverse Event|0
2356523|NCT00725985|4117289|FG011|ITP- Treatment Disposition|Adverse Event|0
2356524|NCT00725985|4117278|FG000|ITP- Treatment Disposition|Lost to Follow-up|0
2356525|NCT00725985|4117279|FG001|ITP- Treatment Disposition|Lost to Follow-up|0
2356526|NCT00725985|4117280|FG002|ITP- Treatment Disposition|Lost to Follow-up|2
2356527|NCT00725985|4117281|FG003|ITP- Treatment Disposition|Lost to Follow-up|0
2356528|NCT00725985|4117282|FG004|ITP- Treatment Disposition|Lost to Follow-up|0
2356529|NCT00725985|4117283|FG005|ITP- Treatment Disposition|Lost to Follow-up|0
2356530|NCT00725985|4117284|FG006|ITP- Treatment Disposition|Lost to Follow-up|0
2356531|NCT00725985|4117285|FG007|ITP- Treatment Disposition|Lost to Follow-up|0
2356532|NCT00725985|4117286|FG008|ITP- Treatment Disposition|Lost to Follow-up|0
2356533|NCT00725985|4117287|FG009|ITP- Treatment Disposition|Lost to Follow-up|0
2356534|NCT00725985|4117288|FG010|ITP- Treatment Disposition|Lost to Follow-up|0
2356535|NCT00725985|4117289|FG011|ITP- Treatment Disposition|Lost to Follow-up|0
2356536|NCT00725985|4117278|FG000|ITP- Treatment Disposition|Randomized but not treated|1
2356537|NCT00725985|4117279|FG001|ITP- Treatment Disposition|Randomized but not treated|0
2356538|NCT00725985|4117280|FG002|ITP- Treatment Disposition|Randomized but not treated|0
2356539|NCT00725985|4117281|FG003|ITP- Treatment Disposition|Randomized but not treated|0
2356540|NCT00725985|4117282|FG004|ITP- Treatment Disposition|Randomized but not treated|0
2356541|NCT00725985|4117283|FG005|ITP- Treatment Disposition|Randomized but not treated|0
2356542|NCT00725985|4117284|FG006|ITP- Treatment Disposition|Randomized but not treated|0
2356543|NCT00725985|4117285|FG007|ITP- Treatment Disposition|Randomized but not treated|0
2356544|NCT00725985|4117286|FG008|ITP- Treatment Disposition|Randomized but not treated|0
2356545|NCT00725985|4117287|FG009|ITP- Treatment Disposition|Randomized but not treated|0
2356546|NCT00725985|4117288|FG010|ITP- Treatment Disposition|Randomized but not treated|0
2356547|NCT00725985|4117289|FG011|ITP- Treatment Disposition|Randomized but not treated|0
2356548|NCT00725985|4117278|FG000|ITP- Treatment Disposition|Converted to CDMS|30
2356549|NCT00725985|4117279|FG001|ITP- Treatment Disposition|Converted to CDMS|27
2356550|NCT00725985|4117280|FG002|ITP- Treatment Disposition|Converted to CDMS|71
2356551|NCT00725985|4117281|FG003|ITP- Treatment Disposition|Converted to CDMS|0
2356552|NCT00725985|4117282|FG004|ITP- Treatment Disposition|Converted to CDMS|0
2356553|NCT00725985|4117283|FG005|ITP- Treatment Disposition|Converted to CDMS|0
2356554|NCT00725985|4117284|FG006|ITP- Treatment Disposition|Converted to CDMS|0
2356555|NCT00725985|4117285|FG007|ITP- Treatment Disposition|Converted to CDMS|0
2356556|NCT00725985|4117286|FG008|ITP- Treatment Disposition|Converted to CDMS|0
2356557|NCT00725985|4117287|FG009|ITP- Treatment Disposition|Converted to CDMS|0
2356558|NCT00725985|4117288|FG010|ITP- Treatment Disposition|Converted to CDMS|0
2356559|NCT00725985|4117289|FG011|ITP- Treatment Disposition|Converted to CDMS|0
2356560|NCT00725985|4117278|FG000|ITP- Treatment Disposition|Other|50
2356561|NCT00725985|4117279|FG001|ITP- Treatment Disposition|Other|38
2356562|NCT00725985|4117280|FG002|ITP- Treatment Disposition|Other|24
2356563|NCT00725985|4117281|FG003|ITP- Treatment Disposition|Other|0
2356564|NCT00725985|4117282|FG004|ITP- Treatment Disposition|Other|0
2356565|NCT00725985|4117283|FG005|ITP- Treatment Disposition|Other|0
2356566|NCT00725985|4117284|FG006|ITP- Treatment Disposition|Other|0
2356567|NCT00725985|4117285|FG007|ITP- Treatment Disposition|Other|0
2356568|NCT00725985|4117286|FG008|ITP- Treatment Disposition|Other|0
2356569|NCT00725985|4117287|FG009|ITP- Treatment Disposition|Other|0
2356570|NCT00725985|4117288|FG010|ITP- Treatment Disposition|Other|0
2356571|NCT00725985|4117289|FG011|ITP- Treatment Disposition|Other|0
2356572|NCT00725985|4117278|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0
2356573|NCT00725985|4117279|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0
2356574|NCT00725985|4117280|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0
2356575|NCT00725985|4117281|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2
2356576|NCT00725985|4117282|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2
2356577|NCT00725985|4117283|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5
2356578|NCT00725985|4117284|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0
2356579|NCT00725985|4117285|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0
2356580|NCT00725985|4117286|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0
2356581|NCT00725985|4117287|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0
2356582|NCT00725985|4117288|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0
2356583|NCT00725985|4117289|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0
2356584|NCT00725985|4117278|FG000|OLMP (Up to 96 Weeks)|Death|0
2356585|NCT00725985|4117279|FG001|OLMP (Up to 96 Weeks)|Death|0
2356586|NCT00725985|4117280|FG002|OLMP (Up to 96 Weeks)|Death|0
2356587|NCT00725985|4117281|FG003|OLMP (Up to 96 Weeks)|Death|0
2356588|NCT00725985|4117282|FG004|OLMP (Up to 96 Weeks)|Death|1
2356589|NCT00725985|4117283|FG005|OLMP (Up to 96 Weeks)|Death|0
2356590|NCT00725985|4117284|FG006|OLMP (Up to 96 Weeks)|Death|0
2356591|NCT00725985|4117285|FG007|OLMP (Up to 96 Weeks)|Death|0
2356592|NCT00725985|4117286|FG008|OLMP (Up to 96 Weeks)|Death|0
2356593|NCT00725985|4117287|FG009|OLMP (Up to 96 Weeks)|Death|0
2356594|NCT00725985|4117288|FG010|OLMP (Up to 96 Weeks)|Death|0
2356595|NCT00725985|4117289|FG011|OLMP (Up to 96 Weeks)|Death|0
2356596|NCT00725985|4117278|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
2356597|NCT00725985|4117279|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
2356598|NCT00725985|4117280|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
2356599|NCT00725985|4117281|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1
2356600|NCT00725985|4117282|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
2356601|NCT00725985|4117283|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
2020171|NCT00304031|3587643|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
2020172|NCT00304031|3587641|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10
2356602|NCT00725985|4117284|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
2309012|NCT02714569|4012509|FG002|Part A Second Intervention|Withdrawal by Subject|0
2309013|NCT02714569|4012510|FG003|Part A Second Intervention|Withdrawal by Subject|0
2309014|NCT02714569|4012511|FG004|Part A Second Intervention|Withdrawal by Subject|0
2309015|NCT02714569|4012512|FG005|Part A Second Intervention|Withdrawal by Subject|0
2309016|NCT02714569|4012513|FG006|Part A Second Intervention|Withdrawal by Subject|0
2309017|NCT02714569|4012514|FG007|Part A Second Intervention|Withdrawal by Subject|0
2309018|NCT02714569|4012515|FG008|Part A Second Intervention|Withdrawal by Subject|0
2309019|NCT02714569|4012516|FG009|Part A Second Intervention|Withdrawal by Subject|0
2309020|NCT02714569|4012517|FG010|Part A Second Intervention|Withdrawal by Subject|0
2309021|NCT02714569|4012507|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
2309022|NCT02714569|4012508|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
2309023|NCT02714569|4012509|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
2309024|NCT02714569|4012510|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1
2309025|NCT02714569|4012511|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
2309026|NCT02714569|4012512|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
2309027|NCT02714569|4012513|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
2356603|NCT00725985|4117285|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
2356604|NCT00725985|4117286|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
2356605|NCT00725985|4117287|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
2356606|NCT00725985|4117288|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
2356607|NCT00725985|4117289|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
2356608|NCT00725985|4117278|FG000|OLMP (Up to 96 Weeks)|Disease progression|0
2356609|NCT00725985|4117279|FG001|OLMP (Up to 96 Weeks)|Disease progression|0
2356610|NCT00725985|4117280|FG002|OLMP (Up to 96 Weeks)|Disease progression|0
2356611|NCT00725985|4117281|FG003|OLMP (Up to 96 Weeks)|Disease progression|0
2356612|NCT00725985|4117282|FG004|OLMP (Up to 96 Weeks)|Disease progression|0
2356613|NCT00725985|4117283|FG005|OLMP (Up to 96 Weeks)|Disease progression|4
2356614|NCT00725985|4117284|FG006|OLMP (Up to 96 Weeks)|Disease progression|0
2356615|NCT00725985|4117285|FG007|OLMP (Up to 96 Weeks)|Disease progression|0
2356616|NCT00725985|4117286|FG008|OLMP (Up to 96 Weeks)|Disease progression|0
2212472|NCT01670097|3853572|FG001|Overall Study|Study burden|0
2212473|NCT01670097|3853571|FG000|Overall Study|COPD exacerbation|0
2212474|NCT01670097|3853572|FG001|Overall Study|COPD exacerbation|1
2356617|NCT00725985|4117287|FG009|OLMP (Up to 96 Weeks)|Disease progression|0
2356618|NCT00725985|4117288|FG010|OLMP (Up to 96 Weeks)|Disease progression|0
2356619|NCT00725985|4117289|FG011|OLMP (Up to 96 Weeks)|Disease progression|0
2356620|NCT00725985|4117278|FG000|OLMP (Up to 96 Weeks)|Other|0
2356621|NCT00725985|4117279|FG001|OLMP (Up to 96 Weeks)|Other|0
2356622|NCT00725985|4117280|FG002|OLMP (Up to 96 Weeks)|Other|0
2356623|NCT00725985|4117281|FG003|OLMP (Up to 96 Weeks)|Other|15
2356624|NCT00725985|4117282|FG004|OLMP (Up to 96 Weeks)|Other|20
2356625|NCT00725985|4117283|FG005|OLMP (Up to 96 Weeks)|Other|44
2356626|NCT00725985|4117284|FG006|OLMP (Up to 96 Weeks)|Other|0
2356627|NCT00725985|4117285|FG007|OLMP (Up to 96 Weeks)|Other|0
2356628|NCT00725985|4117286|FG008|OLMP (Up to 96 Weeks)|Other|0
2356629|NCT00725985|4117287|FG009|OLMP (Up to 96 Weeks)|Other|0
2356630|NCT00725985|4117288|FG010|OLMP (Up to 96 Weeks)|Other|0
2356631|NCT00725985|4117289|FG011|OLMP (Up to 96 Weeks)|Other|0
2356632|NCT00725985|4117278|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
2356633|NCT00725985|4117279|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
2356634|NCT00725985|4117280|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
2356635|NCT00725985|4117281|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
2356636|NCT00725985|4117282|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
2356637|NCT00725985|4117283|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
2356638|NCT00725985|4117284|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
2356639|NCT00725985|4117285|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1
2356640|NCT00725985|4117286|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
2356641|NCT00725985|4117287|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
2356642|NCT00725985|4117288|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
2356643|NCT00725985|4117289|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
2356644|NCT00725985|4117278|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
2212475|NCT01670097|3853571|FG000|Overall Study|Neutropenia|0
2212476|NCT01670097|3853572|FG001|Overall Study|Neutropenia|1
2020173|NCT00304031|3587642|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
2020174|NCT00304031|3587643|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
2020175|NCT00304031|3587641|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1
2020176|NCT00304031|3587642|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
2020177|NCT00304031|3587643|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
2020178|NCT00304031|3587641|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37
2020179|NCT00304031|3587642|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
2020180|NCT00304031|3587643|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
2020181|NCT00304031|3587641|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
2356645|NCT00725985|4117279|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
2356646|NCT00725985|4117280|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
2356647|NCT00725985|4117281|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
2356648|NCT00725985|4117282|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
2356649|NCT00725985|4117283|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
2356650|NCT00725985|4117284|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
2356651|NCT00725985|4117285|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
2356652|NCT00725985|4117286|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1
2356653|NCT00725985|4117287|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
2356654|NCT00725985|4117288|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
2356655|NCT00725985|4117289|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
2356656|NCT00725985|4117278|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
2356657|NCT00725985|4117279|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
2356658|NCT00725985|4117280|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
2356659|NCT00725985|4117281|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
2356660|NCT00725985|4117282|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
2356661|NCT00725985|4117283|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
2356662|NCT00725985|4117284|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9
2356663|NCT00725985|4117285|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8
2356664|NCT00725985|4117286|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16
2356665|NCT00725985|4117287|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
2356666|NCT00725985|4117288|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
2356667|NCT00725985|4117289|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
2356668|NCT00725985|4117278|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0
2356669|NCT00725985|4117279|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0
2356670|NCT00725985|4117280|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0
2356671|NCT00725985|4117281|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0
2356672|NCT00725985|4117282|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0
2356673|NCT00725985|4117283|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0
2356674|NCT00725985|4117284|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0
2356675|NCT00725985|4117285|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0
2356676|NCT00725985|4117286|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0
2356677|NCT00725985|4117287|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34
2356678|NCT00725985|4117288|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36
2356679|NCT00725985|4117289|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14
2356680|NCT00799266|4117317|FG000|Overall Study|Adverse Event|0
2356681|NCT00799266|4117318|FG001|Overall Study|Adverse Event|1
2356682|NCT00799266|4117317|FG000|Overall Study|Subject withdrew consent|3
2356683|NCT00799266|4117318|FG001|Overall Study|Subject withdrew consent|0
2356684|NCT00844480|4117330|FG000|Overall Study|Withdrawal by Subject|2
2356685|NCT00844480|4117331|FG001|Overall Study|Withdrawal by Subject|3
2356686|NCT00873366|4117341|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1
2356687|NCT00873366|4117341|FG000|Overall Study|Off tamoxifen due to side effects|2
2356688|NCT00873366|4117341|FG000|Overall Study|Refused to continue DM-BT testing|3
2356689|NCT00930722|4117377|FG000|Overall Study|Lost to Follow-up|16
2356690|NCT00930722|4117377|FG000|Overall Study|No longer willing to participate|9
2356691|NCT00930722|4117377|FG000|Overall Study|Study terminated by sponsor|2
2356692|NCT00940498|4117389|FG000|Overall Study|Death|2
2356693|NCT00940498|4117390|FG001|Overall Study|Death|0
2356694|NCT00940498|4117391|FG002|Overall Study|Death|0
2356695|NCT00940498|4117392|FG003|Overall Study|Death|1
2356696|NCT00940498|4117393|FG004|Overall Study|Death|5
2356697|NCT00940498|4117394|FG005|Overall Study|Death|0
2356698|NCT00940498|4117395|FG006|Overall Study|Death|1
2356699|NCT00940498|4117396|FG007|Overall Study|Death|0
2356700|NCT00940498|4117389|FG000|Overall Study|Lost to Follow-up|1
2356701|NCT00940498|4117390|FG001|Overall Study|Lost to Follow-up|1
2356702|NCT00940498|4117391|FG002|Overall Study|Lost to Follow-up|2
2356703|NCT00940498|4117392|FG003|Overall Study|Lost to Follow-up|0
2356704|NCT00940498|4117393|FG004|Overall Study|Lost to Follow-up|1
2356705|NCT00940498|4117394|FG005|Overall Study|Lost to Follow-up|0
2356706|NCT00940498|4117395|FG006|Overall Study|Lost to Follow-up|0
2356707|NCT00940498|4117396|FG007|Overall Study|Lost to Follow-up|1
2356708|NCT00940498|4117389|FG000|Overall Study|Disease Progression|0
2356709|NCT00940498|4117390|FG001|Overall Study|Disease Progression|0
2356710|NCT00940498|4117391|FG002|Overall Study|Disease Progression|1
2356711|NCT00940498|4117392|FG003|Overall Study|Disease Progression|1
2356712|NCT00940498|4117393|FG004|Overall Study|Disease Progression|0
2356713|NCT00940498|4117394|FG005|Overall Study|Disease Progression|1
2356714|NCT00940498|4117395|FG006|Overall Study|Disease Progression|0
2356715|NCT00940498|4117396|FG007|Overall Study|Disease Progression|0
2356716|NCT00940498|4117389|FG000|Overall Study|Physician Decision|0
2356717|NCT00940498|4117390|FG001|Overall Study|Physician Decision|0
2025914|NCT00347776|3594658|FG002|1.5 Month Follow-up|reached the endpoint|12
2309028|NCT02714569|4012514|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
2309029|NCT02714569|4012515|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
2309030|NCT02714569|4012516|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
2309031|NCT02714569|4012517|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
2309032|NCT02714569|4012507|FG000|Part A Third Intervention|Adverse Event|0
2309033|NCT02714569|4012508|FG001|Part A Third Intervention|Adverse Event|0
2309034|NCT02714569|4012509|FG002|Part A Third Intervention|Adverse Event|1
2309035|NCT02714569|4012510|FG003|Part A Third Intervention|Adverse Event|0
2356718|NCT00940498|4117391|FG002|Overall Study|Physician Decision|0
2356719|NCT00940498|4117392|FG003|Overall Study|Physician Decision|0
2356720|NCT00940498|4117393|FG004|Overall Study|Physician Decision|2
2356721|NCT00940498|4117394|FG005|Overall Study|Physician Decision|0
2356722|NCT00940498|4117395|FG006|Overall Study|Physician Decision|0
2356723|NCT00940498|4117396|FG007|Overall Study|Physician Decision|0
2356724|NCT00940498|4117389|FG000|Overall Study|Not treated due to disease related pain|0
2356725|NCT00940498|4117390|FG001|Overall Study|Not treated due to disease related pain|0
2356726|NCT00940498|4117391|FG002|Overall Study|Not treated due to disease related pain|0
2356727|NCT00940498|4117392|FG003|Overall Study|Not treated due to disease related pain|0
2356728|NCT00940498|4117393|FG004|Overall Study|Not treated due to disease related pain|1
2356729|NCT00940498|4117394|FG005|Overall Study|Not treated due to disease related pain|0
2356730|NCT00940498|4117395|FG006|Overall Study|Not treated due to disease related pain|0
2356731|NCT00940498|4117396|FG007|Overall Study|Not treated due to disease related pain|0
2356732|NCT01009294|4117420|FG000|Overall Study|Study discontinued by Sponsor|6
2356733|NCT01049035|4117431|FG000|Overall Study|Serious adverse event|0
2356734|NCT01049035|4117432|FG001|Overall Study|Serious adverse event|1
2356735|NCT01049035|4117433|FG002|Overall Study|Serious adverse event|1
2356736|NCT01049035|4117434|FG003|Overall Study|Serious adverse event|2
2356737|NCT01049035|4117435|FG004|Overall Study|Serious adverse event|0
2356738|NCT01049035|4117436|FG005|Overall Study|Serious adverse event|0
2356739|NCT01049035|4117437|FG006|Overall Study|Serious adverse event|0
2356740|NCT01049035|4117431|FG000|Overall Study|Other adverse event (AE)|0
2356741|NCT01049035|4117432|FG001|Overall Study|Other adverse event (AE)|0
2356742|NCT01049035|4117433|FG002|Overall Study|Other adverse event (AE)|0
2356743|NCT01049035|4117434|FG003|Overall Study|Other adverse event (AE)|1
2356744|NCT01049035|4117435|FG004|Overall Study|Other adverse event (AE)|0
2356745|NCT01049035|4117436|FG005|Overall Study|Other adverse event (AE)|0
2356746|NCT01049035|4117437|FG006|Overall Study|Other adverse event (AE)|0
2356747|NCT01049035|4117431|FG000|Overall Study|Non-compliance with the protocol|12
2356748|NCT01049035|4117432|FG001|Overall Study|Non-compliance with the protocol|6
2356749|NCT01049035|4117433|FG002|Overall Study|Non-compliance with the protocol|14
2356750|NCT01049035|4117434|FG003|Overall Study|Non-compliance with the protocol|5
2356751|NCT01049035|4117435|FG004|Overall Study|Non-compliance with the protocol|3
2356752|NCT01049035|4117436|FG005|Overall Study|Non-compliance with the protocol|4
2356753|NCT01049035|4117437|FG006|Overall Study|Non-compliance with the protocol|10
2356754|NCT01049035|4117431|FG000|Overall Study|Lost to Follow-up|5
2356755|NCT01049035|4117432|FG001|Overall Study|Lost to Follow-up|4
2356756|NCT01049035|4117433|FG002|Overall Study|Lost to Follow-up|4
2356757|NCT01049035|4117434|FG003|Overall Study|Lost to Follow-up|1
2356758|NCT01049035|4117435|FG004|Overall Study|Lost to Follow-up|0
2356759|NCT01049035|4117436|FG005|Overall Study|Lost to Follow-up|3
2356760|NCT01049035|4117437|FG006|Overall Study|Lost to Follow-up|3
2356761|NCT01049035|4117431|FG000|Overall Study|Voluntary withdrawal not due to an AE|16
2356762|NCT01049035|4117432|FG001|Overall Study|Voluntary withdrawal not due to an AE|10
2356763|NCT01049035|4117433|FG002|Overall Study|Voluntary withdrawal not due to an AE|8
2356764|NCT01049035|4117434|FG003|Overall Study|Voluntary withdrawal not due to an AE|2
2356765|NCT01049035|4117435|FG004|Overall Study|Voluntary withdrawal not due to an AE|1
2356766|NCT01049035|4117436|FG005|Overall Study|Voluntary withdrawal not due to an AE|5
2356767|NCT01049035|4117437|FG006|Overall Study|Voluntary withdrawal not due to an AE|2
2356768|NCT01072175|4117484|FG000|Part A (Drug-Drug Interaction)|Death|1
2356769|NCT01072175|4117485|FG001|Part A (Drug-Drug Interaction)|Death|0
2356770|NCT01072175|4117486|FG002|Part A (Drug-Drug Interaction)|Death|0
2356771|NCT01072175|4117487|FG003|Part A (Drug-Drug Interaction)|Death|0
2356772|NCT01072175|4117488|FG004|Part A (Drug-Drug Interaction)|Death|0
2356773|NCT01072175|4117489|FG005|Part A (Drug-Drug Interaction)|Death|0
2356774|NCT01072175|4117490|FG006|Part A (Drug-Drug Interaction)|Death|0
2356775|NCT01072175|4117491|FG007|Part A (Drug-Drug Interaction)|Death|0
2356776|NCT01072175|4117492|FG008|Part A (Drug-Drug Interaction)|Death|0
2356777|NCT01072175|4117493|FG009|Part A (Drug-Drug Interaction)|Death|0
2356778|NCT01072175|4117494|FG010|Part A (Drug-Drug Interaction)|Death|0
2356779|NCT01072175|4117495|FG011|Part A (Drug-Drug Interaction)|Death|0
2356780|NCT01072175|4117496|FG012|Part A (Drug-Drug Interaction)|Death|0
2356781|NCT01072175|4117484|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6
2356782|NCT01072175|4117485|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0
2356783|NCT01072175|4117486|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0
2212477|NCT01670097|3853571|FG000|Overall Study|Clinical deterioration|0
2212478|NCT01670097|3853572|FG001|Overall Study|Clinical deterioration|1
2356784|NCT01072175|4117487|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0
2356785|NCT01072175|4117488|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0
2356786|NCT01072175|4117489|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0
2356787|NCT01072175|4117490|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0
2356788|NCT01072175|4117491|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0
2356789|NCT01072175|4117492|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0
2356790|NCT01072175|4117493|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0
2356791|NCT01072175|4117494|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0
2356792|NCT01072175|4117495|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0
2356793|NCT01072175|4117496|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0
2356794|NCT01072175|4117484|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
2356795|NCT01072175|4117485|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356796|NCT01072175|4117486|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356797|NCT01072175|4117487|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356798|NCT01072175|4117488|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356799|NCT01072175|4117489|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356800|NCT01072175|4117490|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356801|NCT01072175|4117491|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356802|NCT01072175|4117492|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356803|NCT01072175|4117493|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356804|NCT01072175|4117494|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356805|NCT01072175|4117495|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356806|NCT01072175|4117496|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2356807|NCT01072175|4117484|FG000|Part B (Dose Escalation and Expansion)|Death|0
2356808|NCT01072175|4117485|FG001|Part B (Dose Escalation and Expansion)|Death|4
2356809|NCT01072175|4117486|FG002|Part B (Dose Escalation and Expansion)|Death|18
2356810|NCT01072175|4117487|FG003|Part B (Dose Escalation and Expansion)|Death|21
2356811|NCT01072175|4117488|FG004|Part B (Dose Escalation and Expansion)|Death|68
2356812|NCT01072175|4117489|FG005|Part B (Dose Escalation and Expansion)|Death|0
2356813|NCT01072175|4117490|FG006|Part B (Dose Escalation and Expansion)|Death|0
2356814|NCT01072175|4117491|FG007|Part B (Dose Escalation and Expansion)|Death|0
2356815|NCT01072175|4117492|FG008|Part B (Dose Escalation and Expansion)|Death|0
2356816|NCT01072175|4117493|FG009|Part B (Dose Escalation and Expansion)|Death|0
2356817|NCT01072175|4117494|FG010|Part B (Dose Escalation and Expansion)|Death|0
2356818|NCT01072175|4117495|FG011|Part B (Dose Escalation and Expansion)|Death|0
2356819|NCT01072175|4117496|FG012|Part B (Dose Escalation and Expansion)|Death|0
2356820|NCT01072175|4117484|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0
2356821|NCT01072175|4117485|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0
2356822|NCT01072175|4117486|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2
2356823|NCT01072175|4117487|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0
2356824|NCT01072175|4117488|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4
2356825|NCT01072175|4117489|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0
2356826|NCT01072175|4117490|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0
2356827|NCT01072175|4117491|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0
2356828|NCT01072175|4117492|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0
2356829|NCT01072175|4117493|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0
2356830|NCT01072175|4117494|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0
2356831|NCT01072175|4117495|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0
2356832|NCT01072175|4117496|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0
2356833|NCT01072175|4117484|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2356834|NCT01072175|4117485|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
2356835|NCT01072175|4117486|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2356836|NCT01072175|4117487|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
2356837|NCT01072175|4117488|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
2356838|NCT01072175|4117489|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2356839|NCT01072175|4117490|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2356840|NCT01072175|4117491|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2356841|NCT01072175|4117492|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2356842|NCT01072175|4117493|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2356843|NCT01072175|4117494|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2356844|NCT01072175|4117495|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2356845|NCT01072175|4117496|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2356846|NCT01072175|4117484|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2356847|NCT01072175|4117485|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2356848|NCT01072175|4117486|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
2356849|NCT01072175|4117487|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
2356850|NCT01072175|4117488|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
2356851|NCT01072175|4117489|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2356852|NCT01072175|4117490|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2356853|NCT01072175|4117491|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2212479|NCT01670097|3853571|FG000|Overall Study|Disease progression|0
2212480|NCT01670097|3853572|FG001|Overall Study|Disease progression|1
2212481|NCT01670188|3853589|FG000|Overall Study|Death|0
2212482|NCT01670188|3853590|FG001|Overall Study|Death|1
2212483|NCT01670279|3853603|FG000|Overall Study|Adverse Event|0
2212484|NCT01670279|3853604|FG001|Overall Study|Adverse Event|1
2356854|NCT01072175|4117492|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2356855|NCT01072175|4117493|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2356856|NCT01072175|4117494|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2356857|NCT01072175|4117495|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2356858|NCT01072175|4117496|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2356859|NCT01072175|4117484|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2356860|NCT01072175|4117485|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
2356861|NCT01072175|4117486|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2356862|NCT01072175|4117487|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
2356863|NCT01072175|4117488|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
2356864|NCT01072175|4117489|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2356865|NCT01072175|4117490|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2356866|NCT01072175|4117491|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2356867|NCT01072175|4117492|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2356868|NCT01072175|4117493|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2356869|NCT01072175|4117494|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2356870|NCT01072175|4117495|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2356871|NCT01072175|4117496|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2356872|NCT01072175|4117484|FG000|Part C (Phase II: Randomized Phase)|Death|0
2356873|NCT01072175|4117485|FG001|Part C (Phase II: Randomized Phase)|Death|0
2356874|NCT01072175|4117486|FG002|Part C (Phase II: Randomized Phase)|Death|0
2356875|NCT01072175|4117487|FG003|Part C (Phase II: Randomized Phase)|Death|0
2356876|NCT01072175|4117488|FG004|Part C (Phase II: Randomized Phase)|Death|0
2356877|NCT01072175|4117489|FG005|Part C (Phase II: Randomized Phase)|Death|44
2356878|NCT01072175|4117490|FG006|Part C (Phase II: Randomized Phase)|Death|34
2356879|NCT01072175|4117491|FG007|Part C (Phase II: Randomized Phase)|Death|39
2356880|NCT01072175|4117492|FG008|Part C (Phase II: Randomized Phase)|Death|0
2356881|NCT01072175|4117493|FG009|Part C (Phase II: Randomized Phase)|Death|0
2356882|NCT01072175|4117494|FG010|Part C (Phase II: Randomized Phase)|Death|0
2356883|NCT01072175|4117495|FG011|Part C (Phase II: Randomized Phase)|Death|0
2356884|NCT01072175|4117496|FG012|Part C (Phase II: Randomized Phase)|Death|0
2356885|NCT01072175|4117484|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0
2356886|NCT01072175|4117485|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0
2356887|NCT01072175|4117486|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0
2356888|NCT01072175|4117487|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0
2356889|NCT01072175|4117488|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0
2356890|NCT01072175|4117489|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1
2356891|NCT01072175|4117490|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1
2356892|NCT01072175|4117491|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1
2356893|NCT01072175|4117492|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0
2356894|NCT01072175|4117493|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0
2356895|NCT01072175|4117494|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0
2356896|NCT01072175|4117495|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0
2356897|NCT01072175|4117496|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0
2356898|NCT01072175|4117484|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2356899|NCT01072175|4117485|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2356900|NCT01072175|4117486|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2356901|NCT01072175|4117487|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2309036|NCT02714569|4012511|FG004|Part A Third Intervention|Adverse Event|0
2309037|NCT02714569|4012512|FG005|Part A Third Intervention|Adverse Event|0
2309038|NCT02714569|4012513|FG006|Part A Third Intervention|Adverse Event|0
2309039|NCT02714569|4012514|FG007|Part A Third Intervention|Adverse Event|0
2309040|NCT02714569|4012515|FG008|Part A Third Intervention|Adverse Event|0
2212485|NCT01670279|3853605|FG002|Overall Study|Adverse Event|0
2212486|NCT01670279|3853606|FG003|Overall Study|Adverse Event|0
2309041|NCT02714569|4012516|FG009|Part A Third Intervention|Adverse Event|0
2309042|NCT02714569|4012517|FG010|Part A Third Intervention|Adverse Event|0
2309043|NCT02714569|4012507|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
2309044|NCT02714569|4012508|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
2309045|NCT02714569|4012509|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
2309046|NCT02714569|4012510|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
2309047|NCT02714569|4012511|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
2356902|NCT01072175|4117488|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2356903|NCT01072175|4117489|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2356904|NCT01072175|4117490|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
2356905|NCT01072175|4117491|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
2356906|NCT01072175|4117492|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2356907|NCT01072175|4117493|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2356908|NCT01072175|4117494|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2356909|NCT01072175|4117495|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2356910|NCT01072175|4117496|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2356911|NCT01072175|4117484|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2356912|NCT01072175|4117485|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2356913|NCT01072175|4117486|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2356914|NCT01072175|4117487|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2356915|NCT01072175|4117488|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2356916|NCT01072175|4117489|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
2356917|NCT01072175|4117490|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
2356918|NCT01072175|4117491|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
2356919|NCT01072175|4117492|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2356920|NCT01072175|4117493|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2356921|NCT01072175|4117494|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2356922|NCT01072175|4117495|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2212487|NCT01670279|3853603|FG000|Overall Study|Physician Decision|0
2212488|NCT01670279|3853604|FG001|Overall Study|Physician Decision|1
2212489|NCT01670279|3853605|FG002|Overall Study|Physician Decision|0
2212490|NCT01670279|3853606|FG003|Overall Study|Physician Decision|0
2212491|NCT01670279|3853603|FG000|Overall Study|Participant met withdrawal criteria|0
2212492|NCT01670279|3853604|FG001|Overall Study|Participant met withdrawal criteria|0
2212493|NCT01670279|3853605|FG002|Overall Study|Participant met withdrawal criteria|0
2212494|NCT01670279|3853606|FG003|Overall Study|Participant met withdrawal criteria|1
2212495|NCT01670292|3853614|FG000|Overall Study|Lost to Follow-up|14
2212496|NCT01670500|3853637|FG000|Overall Study|Withdrawal by Subject|1
2212497|NCT01670500|3853638|FG001|Overall Study|Withdrawal by Subject|0
2212498|NCT01670526|3853646|FG000|Overall Study|Withdrawal by Subject|3
2212499|NCT01670526|3853647|FG001|Overall Study|Withdrawal by Subject|1
2212500|NCT01670526|3853646|FG000|Overall Study|Lost to Follow-up|9
2212501|NCT01670526|3853647|FG001|Overall Study|Lost to Follow-up|5
2212502|NCT01670721|3853653|FG000|Overall Study|Participant's decision|15
2212503|NCT01670721|3853653|FG000|Overall Study|Other than specified above|38
2212504|NCT01671007|3853681|FG000|Overall Study|Other reasons than listed|166
2212505|NCT01671007|3853682|FG001|Overall Study|Other reasons than listed|373
2212506|NCT01671007|3853683|FG002|Overall Study|Other reasons than listed|197
2212507|NCT01671007|3853684|FG003|Overall Study|Other reasons than listed|228
2212508|NCT01671007|3853685|FG004|Overall Study|Other reasons than listed|14
2212509|NCT01671007|3853686|FG005|Overall Study|Other reasons than listed|71
2212510|NCT01671007|3853687|FG006|Overall Study|Other reasons than listed|17
2212511|NCT01671007|3853688|FG007|Overall Study|Other reasons than listed|66
2212512|NCT01671007|3853689|FG008|Overall Study|Other reasons than listed|0
2212513|NCT01671007|3853681|FG000|Overall Study|Withdrawal by Subject|36
2356923|NCT01072175|4117496|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2356924|NCT01072175|4117484|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2356925|NCT01072175|4117485|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2356926|NCT01072175|4117486|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2356927|NCT01072175|4117487|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2356928|NCT01072175|4117488|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2356929|NCT01072175|4117489|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
2356930|NCT01072175|4117490|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
2356931|NCT01072175|4117491|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2356932|NCT01072175|4117492|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2356933|NCT01072175|4117493|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2356934|NCT01072175|4117494|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2356935|NCT01072175|4117495|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2356936|NCT01072175|4117496|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2356937|NCT01072175|4117484|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0
2356938|NCT01072175|4117485|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0
2356939|NCT01072175|4117486|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0
2356940|NCT01072175|4117487|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0
2356941|NCT01072175|4117488|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0
2356942|NCT01072175|4117489|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0
2356943|NCT01072175|4117490|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0
2356944|NCT01072175|4117491|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0
2356945|NCT01072175|4117492|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37
2356946|NCT01072175|4117493|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0
2356947|NCT01072175|4117494|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0
2356948|NCT01072175|4117495|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0
2356949|NCT01072175|4117496|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0
2356950|NCT01072175|4117484|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2212514|NCT01671007|3853682|FG001|Overall Study|Withdrawal by Subject|59
2212515|NCT01671007|3853683|FG002|Overall Study|Withdrawal by Subject|53
2212516|NCT01671007|3853684|FG003|Overall Study|Withdrawal by Subject|58
2212517|NCT01671007|3853685|FG004|Overall Study|Withdrawal by Subject|4
2212518|NCT01671007|3853686|FG005|Overall Study|Withdrawal by Subject|15
2212519|NCT01671007|3853687|FG006|Overall Study|Withdrawal by Subject|1
2212520|NCT01671007|3853688|FG007|Overall Study|Withdrawal by Subject|19
2212521|NCT01671007|3853689|FG008|Overall Study|Withdrawal by Subject|0
2212522|NCT01671007|3853681|FG000|Overall Study|Lost to Follow-up|93
2212523|NCT01671007|3853682|FG001|Overall Study|Lost to Follow-up|142
2212524|NCT01671007|3853683|FG002|Overall Study|Lost to Follow-up|91
2212525|NCT01671007|3853684|FG003|Overall Study|Lost to Follow-up|63
2212526|NCT01671007|3853685|FG004|Overall Study|Lost to Follow-up|7
2212527|NCT01671007|3853686|FG005|Overall Study|Lost to Follow-up|20
2212528|NCT01671007|3853687|FG006|Overall Study|Lost to Follow-up|2
2212529|NCT01671007|3853688|FG007|Overall Study|Lost to Follow-up|28
2212530|NCT01671007|3853689|FG008|Overall Study|Lost to Follow-up|0
2212531|NCT01671007|3853681|FG000|Overall Study|No end of study case report form|3
2212532|NCT01671007|3853682|FG001|Overall Study|No end of study case report form|1
2212533|NCT01671007|3853683|FG002|Overall Study|No end of study case report form|0
2212534|NCT01671007|3853684|FG003|Overall Study|No end of study case report form|2
2212535|NCT01671007|3853685|FG004|Overall Study|No end of study case report form|0
2212536|NCT01671007|3853686|FG005|Overall Study|No end of study case report form|0
2212537|NCT01671007|3853687|FG006|Overall Study|No end of study case report form|0
2212538|NCT01671007|3853688|FG007|Overall Study|No end of study case report form|0
2212539|NCT01671007|3853689|FG008|Overall Study|No end of study case report form|0
2212540|NCT01671007|3853681|FG000|Overall Study|Not eligible|23
2212541|NCT01671007|3853682|FG001|Overall Study|Not eligible|76
2212542|NCT01671007|3853683|FG002|Overall Study|Not eligible|25
2212543|NCT01671007|3853684|FG003|Overall Study|Not eligible|17
2212544|NCT01671007|3853685|FG004|Overall Study|Not eligible|0
2356951|NCT01072175|4117485|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2356952|NCT01072175|4117486|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2356953|NCT01072175|4117487|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2356954|NCT01072175|4117488|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2356955|NCT01072175|4117489|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2356956|NCT01072175|4117490|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2356957|NCT01072175|4117491|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2356958|NCT01072175|4117492|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
2356959|NCT01072175|4117493|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2356960|NCT01072175|4117494|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2356961|NCT01072175|4117495|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2356962|NCT01072175|4117496|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2356963|NCT01072175|4117484|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356964|NCT01072175|4117485|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356965|NCT01072175|4117486|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356966|NCT01072175|4117487|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356967|NCT01072175|4117488|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356968|NCT01072175|4117489|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356969|NCT01072175|4117490|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356970|NCT01072175|4117491|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356971|NCT01072175|4117492|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
2356972|NCT01072175|4117493|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356973|NCT01072175|4117494|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356974|NCT01072175|4117495|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356975|NCT01072175|4117496|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2356976|NCT01072175|4117484|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356977|NCT01072175|4117485|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356978|NCT01072175|4117486|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356979|NCT01072175|4117487|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356980|NCT01072175|4117488|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356981|NCT01072175|4117489|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356982|NCT01072175|4117490|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356983|NCT01072175|4117491|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356984|NCT01072175|4117492|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
2356985|NCT01072175|4117493|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356986|NCT01072175|4117494|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356987|NCT01072175|4117495|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356988|NCT01072175|4117496|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2356989|NCT01072175|4117484|FG000|Part D (HPMC Capsules)|Death|0
2356990|NCT01072175|4117485|FG001|Part D (HPMC Capsules)|Death|0
2356991|NCT01072175|4117486|FG002|Part D (HPMC Capsules)|Death|0
2356992|NCT01072175|4117487|FG003|Part D (HPMC Capsules)|Death|0
2356993|NCT01072175|4117488|FG004|Part D (HPMC Capsules)|Death|0
2356994|NCT01072175|4117489|FG005|Part D (HPMC Capsules)|Death|0
2356995|NCT01072175|4117490|FG006|Part D (HPMC Capsules)|Death|0
2356996|NCT01072175|4117491|FG007|Part D (HPMC Capsules)|Death|0
2356997|NCT01072175|4117492|FG008|Part D (HPMC Capsules)|Death|0
2356998|NCT01072175|4117493|FG009|Part D (HPMC Capsules)|Death|10
2356999|NCT01072175|4117494|FG010|Part D (HPMC Capsules)|Death|12
2212545|NCT01671007|3853686|FG005|Overall Study|Not eligible|6
2212546|NCT01671007|3853687|FG006|Overall Study|Not eligible|1
2212547|NCT01671007|3853688|FG007|Overall Study|Not eligible|19
2212548|NCT01671007|3853689|FG008|Overall Study|Not eligible|0
2212549|NCT01671059|3853700|FG000|Overall Study|Adverse Event|4
2357000|NCT01072175|4117495|FG011|Part D (HPMC Capsules)|Death|28
2357001|NCT01072175|4117496|FG012|Part D (HPMC Capsules)|Death|26
2357002|NCT01072175|4117484|FG000|Part D (HPMC Capsules)|Physician Decision|0
2357003|NCT01072175|4117485|FG001|Part D (HPMC Capsules)|Physician Decision|0
2357004|NCT01072175|4117486|FG002|Part D (HPMC Capsules)|Physician Decision|0
2357005|NCT01072175|4117487|FG003|Part D (HPMC Capsules)|Physician Decision|0
2357006|NCT01072175|4117488|FG004|Part D (HPMC Capsules)|Physician Decision|0
2357007|NCT01072175|4117489|FG005|Part D (HPMC Capsules)|Physician Decision|0
2357008|NCT01072175|4117490|FG006|Part D (HPMC Capsules)|Physician Decision|0
2357009|NCT01072175|4117491|FG007|Part D (HPMC Capsules)|Physician Decision|0
2357010|NCT01072175|4117492|FG008|Part D (HPMC Capsules)|Physician Decision|0
2357011|NCT01072175|4117493|FG009|Part D (HPMC Capsules)|Physician Decision|0
2357012|NCT01072175|4117494|FG010|Part D (HPMC Capsules)|Physician Decision|1
2357013|NCT01072175|4117495|FG011|Part D (HPMC Capsules)|Physician Decision|1
2357014|NCT01072175|4117496|FG012|Part D (HPMC Capsules)|Physician Decision|1
2357015|NCT01072175|4117484|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0
2357016|NCT01072175|4117485|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0
2357017|NCT01072175|4117486|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0
2357018|NCT01072175|4117487|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0
2357019|NCT01072175|4117488|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0
2357020|NCT01072175|4117489|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0
2357021|NCT01072175|4117490|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0
2357022|NCT01072175|4117491|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0
2357023|NCT01072175|4117492|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0
2357024|NCT01072175|4117493|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0
2357025|NCT01072175|4117494|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1
2357026|NCT01072175|4117495|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1
2357027|NCT01072175|4117496|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3
2357028|NCT01072175|4117484|FG000|Part D (HPMC Capsules)|Study closed/terminated|0
2357029|NCT01072175|4117485|FG001|Part D (HPMC Capsules)|Study closed/terminated|0
2357030|NCT01072175|4117486|FG002|Part D (HPMC Capsules)|Study closed/terminated|0
2357031|NCT01072175|4117487|FG003|Part D (HPMC Capsules)|Study closed/terminated|0
2357032|NCT01072175|4117488|FG004|Part D (HPMC Capsules)|Study closed/terminated|0
2357033|NCT01072175|4117489|FG005|Part D (HPMC Capsules)|Study closed/terminated|0
2357034|NCT01072175|4117490|FG006|Part D (HPMC Capsules)|Study closed/terminated|0
2357035|NCT01072175|4117491|FG007|Part D (HPMC Capsules)|Study closed/terminated|0
2357036|NCT01072175|4117492|FG008|Part D (HPMC Capsules)|Study closed/terminated|0
2357037|NCT01072175|4117493|FG009|Part D (HPMC Capsules)|Study closed/terminated|2
2357038|NCT01072175|4117494|FG010|Part D (HPMC Capsules)|Study closed/terminated|1
2357039|NCT01072175|4117495|FG011|Part D (HPMC Capsules)|Study closed/terminated|10
2357040|NCT01072175|4117496|FG012|Part D (HPMC Capsules)|Study closed/terminated|9
2357041|NCT01072175|4117484|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0
2357042|NCT01072175|4117485|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0
2357043|NCT01072175|4117486|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0
2357044|NCT01072175|4117487|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0
2357045|NCT01072175|4117488|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0
2357046|NCT01072175|4117489|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0
2357047|NCT01072175|4117490|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0
2357048|NCT01072175|4117491|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0
2357049|NCT01072175|4117492|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0
2357050|NCT01072175|4117493|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0
2357051|NCT01072175|4117494|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1
2357052|NCT01072175|4117495|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3
2357053|NCT01072175|4117496|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0
2025915|NCT00347776|3594656|FG000|6 Month Follow-up|Death|2
2102120|NCT00837434|3693833|FG001|Overall Study|Unable to obtain study drug|0
2102121|NCT00837473|3693844|FG000|Overall Study|Lost to Follow-up|1
2357054|NCT01087203|4117530|FG000|Overall Study|Lost to Follow-up|2
2357055|NCT01087203|4117531|FG001|Overall Study|Lost to Follow-up|0
2357056|NCT01087203|4117530|FG000|Overall Study|Withdrawal by Subject|2
2357057|NCT01087203|4117531|FG001|Overall Study|Withdrawal by Subject|6
2357058|NCT01087203|4117530|FG000|Overall Study|Lack of Efficacy|1
2357059|NCT01087203|4117531|FG001|Overall Study|Lack of Efficacy|2
2357060|NCT01087203|4117530|FG000|Overall Study|Study terminated by sponsor|27
2357061|NCT01087203|4117531|FG001|Overall Study|Study terminated by sponsor|27
2357062|NCT01108055|4117542|FG000|Overall Study|Ineligible|11
2357063|NCT01108055|4117542|FG000|Overall Study|Not evaluable- didn't complete treatment|4
2357066|NCT01136967|4117552|FG000|Overall Study|Adverse Event|9
2357067|NCT01136967|4117553|FG001|Overall Study|Adverse Event|12
2357068|NCT01136967|4117552|FG000|Overall Study|Participant Choice|8
2357069|NCT01136967|4117553|FG001|Overall Study|Participant Choice|3
2357070|NCT01136967|4117552|FG000|Overall Study|Lost to Follow-up|0
2357071|NCT01136967|4117553|FG001|Overall Study|Lost to Follow-up|1
2357072|NCT01136967|4117552|FG000|Overall Study|Withdrawal by Subject|1
2357073|NCT01136967|4117553|FG001|Overall Study|Withdrawal by Subject|2
2357074|NCT01136967|4117552|FG000|Overall Study|Clinical Progression|3
2357075|NCT01136967|4117553|FG001|Overall Study|Clinical Progression|5
2357076|NCT01136967|4117552|FG000|Overall Study|Radiation|1
2357077|NCT01136967|4117553|FG001|Overall Study|Radiation|0
2357078|NCT01136967|4117552|FG000|Overall Study|Non-compliance|1
2357079|NCT01136967|4117553|FG001|Overall Study|Non-compliance|0
2357080|NCT01136967|4117552|FG000|Overall Study|Investigator's Choice|1
2357081|NCT01136967|4117553|FG001|Overall Study|Investigator's Choice|1
2357082|NCT01136967|4117552|FG000|Overall Study|Increase in Lesion Size|0
2357083|NCT01136967|4117553|FG001|Overall Study|Increase in Lesion Size|2
2357084|NCT01136967|4117552|FG000|Overall Study|Diagnosis of Second Primary Cancer|0
2357085|NCT01136967|4117553|FG001|Overall Study|Diagnosis of Second Primary Cancer|1
2309048|NCT02714569|4012512|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
2309049|NCT02714569|4012513|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
2309050|NCT02714569|4012514|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
2309051|NCT02714569|4012515|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
2357064|NCT01111019|4117546|FG000|Overall Study|Withdrew Prematurely|2
2357065|NCT01111019|4117546|FG000|Overall Study|Other|1
2357086|NCT01140451|4117570|FG000|Overall Study|Withdrawal by Subject|26
2357087|NCT01140451|4117571|FG001|Overall Study|Withdrawal by Subject|33
2357088|NCT01140451|4117570|FG000|Overall Study|Adverse Event|2
2357089|NCT01140451|4117571|FG001|Overall Study|Adverse Event|6
2357090|NCT01140451|4117570|FG000|Overall Study|Physician Decision|5
2357091|NCT01140451|4117571|FG001|Overall Study|Physician Decision|3
2357092|NCT01140451|4117570|FG000|Overall Study|Lost to Follow-up|2
2309052|NCT02714569|4012516|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
2309053|NCT02714569|4012517|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
2309054|NCT02714569|4012507|FG000|Part B (Overall)|Lost to Follow-up|0
2309055|NCT02714569|4012508|FG001|Part B (Overall)|Lost to Follow-up|0
2309056|NCT02714569|4012509|FG002|Part B (Overall)|Lost to Follow-up|0
2309057|NCT02714569|4012510|FG003|Part B (Overall)|Lost to Follow-up|0
2309058|NCT02714569|4012511|FG004|Part B (Overall)|Lost to Follow-up|0
2309059|NCT02714569|4012512|FG005|Part B (Overall)|Lost to Follow-up|0
2309060|NCT02714569|4012513|FG006|Part B (Overall)|Lost to Follow-up|1
2309061|NCT02714569|4012514|FG007|Part B (Overall)|Lost to Follow-up|0
2309062|NCT02714569|4012515|FG008|Part B (Overall)|Lost to Follow-up|0
2309063|NCT02714569|4012516|FG009|Part B (Overall)|Lost to Follow-up|0
2309064|NCT02714569|4012517|FG010|Part B (Overall)|Lost to Follow-up|0
2309065|NCT02714569|4012507|FG000|Part B (Overall)|Withdrawal by Subject|0
2309066|NCT02714569|4012508|FG001|Part B (Overall)|Withdrawal by Subject|0
2309067|NCT02714569|4012509|FG002|Part B (Overall)|Withdrawal by Subject|0
2309068|NCT02714569|4012510|FG003|Part B (Overall)|Withdrawal by Subject|0
2309069|NCT02714569|4012511|FG004|Part B (Overall)|Withdrawal by Subject|0
2309070|NCT02714569|4012512|FG005|Part B (Overall)|Withdrawal by Subject|0
2309071|NCT02714569|4012513|FG006|Part B (Overall)|Withdrawal by Subject|0
2309072|NCT02714569|4012514|FG007|Part B (Overall)|Withdrawal by Subject|1
2309073|NCT02714569|4012515|FG008|Part B (Overall)|Withdrawal by Subject|0
2309074|NCT02714569|4012516|FG009|Part B (Overall)|Withdrawal by Subject|1
2309075|NCT02714569|4012517|FG010|Part B (Overall)|Withdrawal by Subject|0
2309076|NCT02714569|4012507|FG000|Part B (Overall)|Adverse Event|0
2309077|NCT02714569|4012508|FG001|Part B (Overall)|Adverse Event|0
2309078|NCT02714569|4012509|FG002|Part B (Overall)|Adverse Event|0
2309079|NCT02714569|4012510|FG003|Part B (Overall)|Adverse Event|0
2309080|NCT02714569|4012511|FG004|Part B (Overall)|Adverse Event|0
2309081|NCT02714569|4012512|FG005|Part B (Overall)|Adverse Event|0
2309082|NCT02714569|4012513|FG006|Part B (Overall)|Adverse Event|0
2309083|NCT02714569|4012514|FG007|Part B (Overall)|Adverse Event|0
2309084|NCT02714569|4012515|FG008|Part B (Overall)|Adverse Event|0
2309085|NCT02714569|4012516|FG009|Part B (Overall)|Adverse Event|1
2309086|NCT02714569|4012517|FG010|Part B (Overall)|Adverse Event|0
2309087|NCT02714595|4012579|FG000|Overall Study|Lost to Follow-up|1
2309088|NCT02714595|4012580|FG001|Overall Study|Lost to Follow-up|0
2309089|NCT02714595|4012579|FG000|Overall Study|Withdrawal by Subject|1
2309090|NCT02714595|4012580|FG001|Overall Study|Withdrawal by Subject|2
2309091|NCT02714595|4012579|FG000|Overall Study|Lack of Efficacy|0
2309092|NCT02714595|4012580|FG001|Overall Study|Lack of Efficacy|1
2309093|NCT02714595|4012579|FG000|Overall Study|Death|30
2309094|NCT02714595|4012580|FG001|Overall Study|Death|9
2309095|NCT02714595|4012579|FG000|Overall Study|Other-Miscellaneous|0
2309096|NCT02714595|4012580|FG001|Overall Study|Other-Miscellaneous|1
2309097|NCT02714868|4012606|FG000|Overall Study|Withdrawal by Subject|3
2309098|NCT02714868|4012607|FG001|Overall Study|Withdrawal by Subject|0
2309099|NCT02714868|4012606|FG000|Overall Study|PI withdrawal safety risk self/others|1
2309100|NCT02714868|4012607|FG001|Overall Study|PI withdrawal safety risk self/others|0
2309101|NCT02714868|4012606|FG000|Overall Study|PI withdraw did not meet inclusion|1
2357093|NCT01140451|4117571|FG001|Overall Study|Lost to Follow-up|0
2357094|NCT01140451|4117570|FG000|Overall Study|Participants Planning Pregnancy|3
2357095|NCT01140451|4117571|FG001|Overall Study|Participants Planning Pregnancy|0
2309102|NCT02714868|4012607|FG001|Overall Study|PI withdraw did not meet inclusion|0
2309103|NCT02715258|4012641|FG000|Overall Study|Withdrawal by Subject|6
2309104|NCT02715258|4012642|FG001|Overall Study|Withdrawal by Subject|1
2309105|NCT02715258|4012641|FG000|Overall Study|Lost to Follow-up|7
2309106|NCT02715258|4012642|FG001|Overall Study|Lost to Follow-up|1
2309107|NCT02715258|4012641|FG000|Overall Study|Terminated by Sponsor|0
2309108|NCT02715258|4012642|FG001|Overall Study|Terminated by Sponsor|1
2309109|NCT02715258|4012641|FG000|Overall Study|Death|0
2309110|NCT02715258|4012642|FG001|Overall Study|Death|1
2309111|NCT02715258|4012641|FG000|Overall Study|Subject non-compliant|1
2309112|NCT02715258|4012642|FG001|Overall Study|Subject non-compliant|1
2309113|NCT02715258|4012641|FG000|Overall Study|GCP violation|2
2309114|NCT02715258|4012642|FG001|Overall Study|GCP violation|1
2309115|NCT02715726|4012658|FG000|Overall Study|Adverse Event|2
2309116|NCT02715726|4012659|FG001|Overall Study|Adverse Event|6
2357096|NCT01174563|4117578|FG000|Overall Study|Progressive Disease|45
2357097|NCT01174563|4117578|FG000|Overall Study|Death|5
2357098|NCT01174563|4117578|FG000|Overall Study|Investigator's Discretion|5
2357099|NCT01174563|4117578|FG000|Overall Study|Participant Withdrew Consent|3
2357100|NCT01174563|4117578|FG000|Overall Study|Rash Adverse Event|1
2357101|NCT01174563|4117578|FG000|Overall Study|Sponsor's decision|1
2357102|NCT01235962|4117658|FG000|Overall Study|Withdrawal by Subject|20
2357103|NCT01235962|4117659|FG001|Overall Study|Withdrawal by Subject|19
2357104|NCT01235962|4117660|FG002|Overall Study|Withdrawal by Subject|62
2357105|NCT01235962|4117661|FG003|Overall Study|Withdrawal by Subject|49
2357106|NCT01235962|4117658|FG000|Overall Study|Lost to Follow-up|21
2357107|NCT01235962|4117659|FG001|Overall Study|Lost to Follow-up|16
2357108|NCT01235962|4117660|FG002|Overall Study|Lost to Follow-up|47
2357109|NCT01235962|4117661|FG003|Overall Study|Lost to Follow-up|32
2357110|NCT01235962|4117658|FG000|Overall Study|Physician Decision|5
2357111|NCT01235962|4117659|FG001|Overall Study|Physician Decision|0
2357112|NCT01235962|4117660|FG002|Overall Study|Physician Decision|9
2357113|NCT01235962|4117661|FG003|Overall Study|Physician Decision|5
2357114|NCT01239368|4117689|FG000|Overall Study|Principal investigator discretion|1
2357115|NCT01239368|4117690|FG001|Overall Study|Principal investigator discretion|0
2357116|NCT01239368|4117691|FG002|Overall Study|Principal investigator discretion|0
2357117|NCT01239368|4117692|FG003|Overall Study|Principal investigator discretion|0
2020182|NCT00304031|3587642|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
2020183|NCT00304031|3587643|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
2020184|NCT00304070|3587661|FG000|Overall Study|Death|0
2020185|NCT00304070|3587662|FG001|Overall Study|Death|0
2020186|NCT00304070|3587663|FG002|Overall Study|Death|3
2020187|NCT00304070|3587661|FG000|Overall Study|Lost to Follow-up|0
2020188|NCT00304070|3587662|FG001|Overall Study|Lost to Follow-up|0
2020189|NCT00304070|3587663|FG002|Overall Study|Lost to Follow-up|1
2020190|NCT00304070|3587661|FG000|Overall Study|Physician Decision|0
2020191|NCT00304070|3587662|FG001|Overall Study|Physician Decision|0
2020192|NCT00304070|3587663|FG002|Overall Study|Physician Decision|3
2020193|NCT00304070|3587661|FG000|Overall Study|Withdrawal by Subject|0
2020194|NCT00304070|3587662|FG001|Overall Study|Withdrawal by Subject|0
2020195|NCT00304070|3587663|FG002|Overall Study|Withdrawal by Subject|1
2020196|NCT00304070|3587661|FG000|Overall Study|Progressive Disease|3
2020197|NCT00304070|3587662|FG001|Overall Study|Progressive Disease|7
2020198|NCT00304070|3587663|FG002|Overall Study|Progressive Disease|4
2020199|NCT00304083|3587677|FG000|Overall Study|Withdrawal by Subject|4
2020200|NCT00304083|3587678|FG001|Overall Study|Withdrawal by Subject|2
2020201|NCT00304083|3587677|FG000|Overall Study|Physician Decision|8
2020202|NCT00304083|3587678|FG001|Overall Study|Physician Decision|3
2020203|NCT00304083|3587677|FG000|Overall Study|Disease Progression|5
2020204|NCT00304083|3587678|FG001|Overall Study|Disease Progression|1
2020205|NCT00304083|3587677|FG000|Overall Study|Other|5
2020206|NCT00304083|3587678|FG001|Overall Study|Other|2
2357118|NCT01239368|4117693|FG004|Overall Study|Principal investigator discretion|1
2357119|NCT01239368|4117694|FG005|Overall Study|Principal investigator discretion|2
2357120|NCT01239368|4117695|FG006|Overall Study|Principal investigator discretion|0
2357121|NCT01239368|4117696|FG007|Overall Study|Principal investigator discretion|0
2357122|NCT01239368|4117697|FG008|Overall Study|Principal investigator discretion|0
2357123|NCT01239368|4117698|FG009|Overall Study|Principal investigator discretion|1
2357124|NCT01239368|4117689|FG000|Overall Study|Disease progression on study|1
2357125|NCT01239368|4117690|FG001|Overall Study|Disease progression on study|1
2357126|NCT01239368|4117691|FG002|Overall Study|Disease progression on study|1
2357127|NCT01239368|4117692|FG003|Overall Study|Disease progression on study|1
2357128|NCT01239368|4117693|FG004|Overall Study|Disease progression on study|4
2357129|NCT01239368|4117694|FG005|Overall Study|Disease progression on study|2
2357130|NCT01239368|4117695|FG006|Overall Study|Disease progression on study|5
2357131|NCT01239368|4117696|FG007|Overall Study|Disease progression on study|0
2357132|NCT01239368|4117697|FG008|Overall Study|Disease progression on study|0
2357133|NCT01239368|4117698|FG009|Overall Study|Disease progression on study|2
2357134|NCT01239368|4117689|FG000|Overall Study|Refused further treatment|0
2357135|NCT01239368|4117690|FG001|Overall Study|Refused further treatment|0
2357136|NCT01239368|4117691|FG002|Overall Study|Refused further treatment|0
2357137|NCT01239368|4117692|FG003|Overall Study|Refused further treatment|0
2357138|NCT01239368|4117693|FG004|Overall Study|Refused further treatment|0
2357139|NCT01239368|4117694|FG005|Overall Study|Refused further treatment|0
2357140|NCT01239368|4117695|FG006|Overall Study|Refused further treatment|0
2357141|NCT01239368|4117696|FG007|Overall Study|Refused further treatment|0
2357142|NCT01239368|4117697|FG008|Overall Study|Refused further treatment|0
2357143|NCT01239368|4117698|FG009|Overall Study|Refused further treatment|1
2357144|NCT01239368|4117689|FG000|Overall Study|Death|0
2357145|NCT01239368|4117690|FG001|Overall Study|Death|0
2357146|NCT01239368|4117691|FG002|Overall Study|Death|0
2357147|NCT01239368|4117692|FG003|Overall Study|Death|0
2357148|NCT01239368|4117693|FG004|Overall Study|Death|0
2357149|NCT01239368|4117694|FG005|Overall Study|Death|0
2357150|NCT01239368|4117695|FG006|Overall Study|Death|1
2357151|NCT01239368|4117696|FG007|Overall Study|Death|0
2357152|NCT01239368|4117697|FG008|Overall Study|Death|0
2357153|NCT01239368|4117698|FG009|Overall Study|Death|0
2357154|NCT01266031|4117734|FG000|Overall Study|Not treated|0
2357155|NCT01266031|4117735|FG001|Overall Study|Not treated|3
2357156|NCT01266031|4117736|FG002|Overall Study|Not treated|2
2357157|NCT01287741|4117757|FG000|Overall Study|Withdrawal by Subject|35
2357158|NCT01287741|4117758|FG001|Overall Study|Withdrawal by Subject|38
2357159|NCT01287741|4117757|FG000|Overall Study|Protocol Violation|2
2357160|NCT01287741|4117758|FG001|Overall Study|Protocol Violation|0
2357161|NCT01287741|4117757|FG000|Overall Study|Physician Decision|15
2357162|NCT01287741|4117758|FG001|Overall Study|Physician Decision|23
2357163|NCT01287741|4117757|FG000|Overall Study|Non-compliance|8
2357164|NCT01287741|4117758|FG001|Overall Study|Non-compliance|6
2357165|NCT01287741|4117757|FG000|Overall Study|Lost to Follow-up|10
2357166|NCT01287741|4117758|FG001|Overall Study|Lost to Follow-up|8
2357167|NCT01287741|4117757|FG000|Overall Study|Death|32
2357168|NCT01287741|4117758|FG001|Overall Study|Death|44
2357169|NCT01287741|4117757|FG000|Overall Study|Adverse Event|4
2357170|NCT01287741|4117758|FG001|Overall Study|Adverse Event|6
2357171|NCT01287741|4117757|FG000|Overall Study|Study terminated by Sponsor|307
2357172|NCT01287741|4117758|FG001|Overall Study|Study terminated by Sponsor|315
2357173|NCT01287741|4117757|FG000|Overall Study|Progressive disease|190
2357174|NCT01287741|4117758|FG001|Overall Study|Progressive disease|166
2357175|NCT01287741|4117757|FG000|Overall Study|Reason not specified|23
2357176|NCT01287741|4117758|FG001|Overall Study|Reason not specified|9
2357177|NCT01313689|4117775|FG000|24-Week Randomization 1|Adverse Event|10
2357178|NCT01313689|4117776|FG001|24-Week Randomization 1|Adverse Event|5
2357179|NCT01313689|4117777|FG002|24-Week Randomization 1|Adverse Event|0
2357180|NCT01313689|4117778|FG003|24-Week Randomization 1|Adverse Event|0
2357181|NCT01313689|4117779|FG004|24-Week Randomization 1|Adverse Event|0
2357182|NCT01313689|4117775|FG000|24-Week Randomization 1|Physician Decision|4
2357183|NCT01313689|4117776|FG001|24-Week Randomization 1|Physician Decision|5
2357184|NCT01313689|4117777|FG002|24-Week Randomization 1|Physician Decision|0
2357185|NCT01313689|4117778|FG003|24-Week Randomization 1|Physician Decision|0
2357186|NCT01313689|4117779|FG004|24-Week Randomization 1|Physician Decision|0
2357187|NCT01313689|4117775|FG000|24-Week Randomization 1|Withdrawal by Subject|5
2357188|NCT01313689|4117776|FG001|24-Week Randomization 1|Withdrawal by Subject|0
2357189|NCT01313689|4117777|FG002|24-Week Randomization 1|Withdrawal by Subject|0
2357190|NCT01313689|4117778|FG003|24-Week Randomization 1|Withdrawal by Subject|0
2357191|NCT01313689|4117779|FG004|24-Week Randomization 1|Withdrawal by Subject|0
2357192|NCT01313689|4117775|FG000|24-Week Randomization 2|Adverse Event|0
2357193|NCT01313689|4117776|FG001|24-Week Randomization 2|Adverse Event|0
2357194|NCT01313689|4117777|FG002|24-Week Randomization 2|Adverse Event|2
2357195|NCT01313689|4117778|FG003|24-Week Randomization 2|Adverse Event|0
2020207|NCT00304278|3587722|FG000|Overall Study|lack of insurance coverage for chemoRT|1
2020208|NCT00304278|3587722|FG000|Overall Study|PT had medical condition preventing TX|1
2020209|NCT00304356|3587726|FG000|Nitazoxanide|Physician Decision|5
2020210|NCT00304356|3587726|FG000|Nitazoxanide|Physician Decision|1
2020211|NCT00304356|3587726|FG000|Nitazoxanide|number is 0|1
2020212|NCT00304356|3587726|FG000|Nitazoxanide|Physician Decision|1
2020213|NCT00304356|3587726|FG000|Nitazoxanide|Physician Decision|1
2020214|NCT00304356|3587726|FG000|Nitazoxanide|Physician Decision|1
2020215|NCT00304915|3587763|FG000|Overall Study|Lost to Follow-up|11
2020216|NCT00304915|3587764|FG001|Overall Study|Lost to Follow-up|11
2020217|NCT00304915|3587763|FG000|Overall Study|Death|4
2020218|NCT00304915|3587764|FG001|Overall Study|Death|5
2020219|NCT00304915|3587763|FG000|Overall Study|Withdrawal by Subject|3
2020220|NCT00304915|3587764|FG001|Overall Study|Withdrawal by Subject|0
2020221|NCT00304954|3587774|FG000|Overall Study|Withdrawal by Subject|0
2020222|NCT00304954|3587775|FG001|Overall Study|Withdrawal by Subject|0
2020223|NCT00304954|3587776|FG002|Overall Study|Withdrawal by Subject|1
2020224|NCT00304954|3587777|FG003|Overall Study|Withdrawal by Subject|0
2020225|NCT00304954|3587774|FG000|Overall Study|Adverse Event|1
2020226|NCT00304954|3587775|FG001|Overall Study|Adverse Event|0
2020227|NCT00304954|3587776|FG002|Overall Study|Adverse Event|0
2020228|NCT00304954|3587777|FG003|Overall Study|Adverse Event|0
2102122|NCT00837473|3693844|FG000|Overall Study|Withdrawal by Subject|2
2020229|NCT00305006|3587797|FG000|Overall Study|Withdrawal by Subject|1
2020230|NCT00305006|3587798|FG001|Overall Study|Withdrawal by Subject|0
2020231|NCT00305006|3587797|FG000|Overall Study|Failure to complete pretest|0
2020232|NCT00305006|3587798|FG001|Overall Study|Failure to complete pretest|1
2020233|NCT00305058|3587806|FG000|Overall Study|Participant too young|1
2020234|NCT00305058|3587807|FG001|Overall Study|Participant too young|0
2357196|NCT01313689|4117779|FG004|24-Week Randomization 2|Adverse Event|8
2357197|NCT01313689|4117775|FG000|24-Week Randomization 2|Withdrawal by Subject|0
2357198|NCT01313689|4117776|FG001|24-Week Randomization 2|Withdrawal by Subject|0
2357199|NCT01313689|4117777|FG002|24-Week Randomization 2|Withdrawal by Subject|1
2357200|NCT01313689|4117778|FG003|24-Week Randomization 2|Withdrawal by Subject|1
2357201|NCT01313689|4117779|FG004|24-Week Randomization 2|Withdrawal by Subject|3
2357202|NCT01313689|4117775|FG000|24-Week Randomization 2|Physician Decision|0
2357203|NCT01313689|4117776|FG001|24-Week Randomization 2|Physician Decision|0
2357204|NCT01313689|4117777|FG002|24-Week Randomization 2|Physician Decision|0
2357205|NCT01313689|4117778|FG003|24-Week Randomization 2|Physician Decision|0
2357206|NCT01313689|4117779|FG004|24-Week Randomization 2|Physician Decision|4
2212550|NCT01671059|3853700|FG000|Overall Study|Lack of Efficacy|1
2212551|NCT01671085|3853707|FG000|Overall Study|Withdrawal by Subject|1
2357207|NCT01315353|4117801|FG000|Overall Study|Death|2
2357208|NCT01315353|4117802|FG001|Overall Study|Death|1
2357209|NCT01315353|4117803|FG002|Overall Study|Death|0
2357210|NCT01315353|4117801|FG000|Overall Study|Withdrawal by Subject|2
2357211|NCT01315353|4117802|FG001|Overall Study|Withdrawal by Subject|6
2357212|NCT01315353|4117803|FG002|Overall Study|Withdrawal by Subject|1
2357213|NCT01315353|4117801|FG000|Overall Study|Lost to Follow-up|13
2357214|NCT01315353|4117802|FG001|Overall Study|Lost to Follow-up|6
2357215|NCT01315353|4117803|FG002|Overall Study|Lost to Follow-up|6
2357216|NCT01315353|4117801|FG000|Overall Study|Unwilling to adhere to requirements|5
2357217|NCT01315353|4117802|FG001|Overall Study|Unwilling to adhere to requirements|5
2357218|NCT01315353|4117803|FG002|Overall Study|Unwilling to adhere to requirements|4
2357219|NCT01315353|4117801|FG000|Overall Study|Site closing|7
2357220|NCT01315353|4117802|FG001|Overall Study|Site closing|4
2357221|NCT01315353|4117803|FG002|Overall Study|Site closing|0
2357222|NCT01315353|4117801|FG000|Overall Study|Taken off study by site in error|0
2357223|NCT01315353|4117802|FG001|Overall Study|Taken off study by site in error|1
2357224|NCT01315353|4117803|FG002|Overall Study|Taken off study by site in error|0
2357225|NCT01315353|4117801|FG000|Overall Study|Inadvertent randomization/assignment|0
2357226|NCT01315353|4117802|FG001|Overall Study|Inadvertent randomization/assignment|0
2357227|NCT01315353|4117803|FG002|Overall Study|Inadvertent randomization/assignment|2
2357228|NCT01318993|4117811|FG000|Overall Study|Adverse Event|53
2357229|NCT01318993|4117811|FG000|Overall Study|Lack of Efficacy|121
2212552|NCT01671085|3853708|FG001|Overall Study|Withdrawal by Subject|0
2212553|NCT01671111|3853715|FG000|Overall Study|Adverse Event|2
2212554|NCT01671111|3853715|FG000|Overall Study|Lack of Efficacy|1
2212555|NCT01671111|3853715|FG000|Overall Study|Withdrawal by Subject|2
2212556|NCT01671111|3853715|FG000|Overall Study|Physician Decision|1
2212557|NCT01671111|3853715|FG000|Overall Study|Other|24
2357230|NCT01318993|4117811|FG000|Overall Study|Protocol Violation|3
2212558|NCT01671280|3853723|FG000|Overall Study|Withdrawal by Subject|2
2357231|NCT01318993|4117811|FG000|Overall Study|Protocol based stopping criteria|6
2357232|NCT01318993|4117811|FG000|Overall Study|Study closed or terminated|174
2357233|NCT01318993|4117811|FG000|Overall Study|Lost to Follow-up|4
2357234|NCT01318993|4117811|FG000|Overall Study|Physician Decision|13
2357235|NCT01318993|4117811|FG000|Overall Study|Withdrawal by Subject|24
2020235|NCT00305058|3587806|FG000|Overall Study|Missing data collection instrument|3
2020236|NCT00305058|3587807|FG001|Overall Study|Missing data collection instrument|2
2020237|NCT00305058|3587806|FG000|Overall Study|Missing outcome data|3
2020238|NCT00305058|3587807|FG001|Overall Study|Missing outcome data|2
2020239|NCT00305110|3587862|FG000|Overall Study|Missing data|29
2020240|NCT00305227|3587878|FG000|Overall Study|Lost to Follow-up|7
2020241|NCT00305227|3587879|FG001|Overall Study|Lost to Follow-up|6
2020242|NCT00305253|3587887|FG000|Overall Study|Withdrawal by Subject|0
2020243|NCT00305253|3587888|FG001|Overall Study|Withdrawal by Subject|1
2020244|NCT00305448|3587897|FG000|Overall Study|Protocol Violation|0
2020245|NCT00305448|3587898|FG001|Overall Study|Protocol Violation|1
2020246|NCT00305448|3587899|FG002|Overall Study|Protocol Violation|0
2020247|NCT00305448|3587897|FG000|Overall Study|Withdrawal by Subject|2
2020248|NCT00305448|3587898|FG001|Overall Study|Withdrawal by Subject|0
2020249|NCT00305448|3587899|FG002|Overall Study|Withdrawal by Subject|1
2020250|NCT00305448|3587897|FG000|Overall Study|Adverse Event|1
2020251|NCT00305448|3587898|FG001|Overall Study|Adverse Event|0
2020252|NCT00305448|3587899|FG002|Overall Study|Adverse Event|1
2020253|NCT00305448|3587897|FG000|Overall Study|Disease Progression|27
2020254|NCT00305448|3587898|FG001|Overall Study|Disease Progression|31
2020255|NCT00305448|3587899|FG002|Overall Study|Disease Progression|28
2020256|NCT00305448|3587897|FG000|Overall Study|Subjective Disease Progression|1
2020257|NCT00305448|3587898|FG001|Overall Study|Subjective Disease Progression|2
2020258|NCT00305448|3587899|FG002|Overall Study|Subjective Disease Progression|2
2357236|NCT01335685|4117819|FG000|Overall Study|Study Terminated by Sponsor|2
2357237|NCT01335685|4117820|FG001|Overall Study|Study Terminated by Sponsor|1
2357238|NCT01335685|4117821|FG002|Overall Study|Study Terminated by Sponsor|1
2357239|NCT01335685|4117822|FG003|Overall Study|Study Terminated by Sponsor|10
2357240|NCT01335685|4117823|FG004|Overall Study|Study Terminated by Sponsor|0
2357241|NCT01335685|4117824|FG005|Overall Study|Study Terminated by Sponsor|4
2357242|NCT01335685|4117825|FG006|Overall Study|Study Terminated by Sponsor|2
2357243|NCT01335685|4117826|FG007|Overall Study|Study Terminated by Sponsor|3
2357244|NCT01335685|4117819|FG000|Overall Study|Withdrawal by Subject|1
2357245|NCT01335685|4117820|FG001|Overall Study|Withdrawal by Subject|0
2357246|NCT01335685|4117821|FG002|Overall Study|Withdrawal by Subject|0
2357247|NCT01335685|4117822|FG003|Overall Study|Withdrawal by Subject|1
2357248|NCT01335685|4117823|FG004|Overall Study|Withdrawal by Subject|0
2357249|NCT01335685|4117824|FG005|Overall Study|Withdrawal by Subject|0
2357250|NCT01335685|4117825|FG006|Overall Study|Withdrawal by Subject|0
2357251|NCT01335685|4117826|FG007|Overall Study|Withdrawal by Subject|0
2357252|NCT01335685|4117819|FG000|Overall Study|Reason not Specified|0
2357253|NCT01335685|4117820|FG001|Overall Study|Reason not Specified|0
2357254|NCT01335685|4117821|FG002|Overall Study|Reason not Specified|1
2357255|NCT01335685|4117822|FG003|Overall Study|Reason not Specified|0
2357256|NCT01335685|4117823|FG004|Overall Study|Reason not Specified|0
2357257|NCT01335685|4117824|FG005|Overall Study|Reason not Specified|1
2357258|NCT01335685|4117825|FG006|Overall Study|Reason not Specified|0
2357259|NCT01335685|4117826|FG007|Overall Study|Reason not Specified|0
2357260|NCT01336621|4117849|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
2357261|NCT01336621|4117849|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
2357262|NCT01336621|4117849|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
2357263|NCT01336621|4117849|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
2020259|NCT00305448|3587897|FG000|Overall Study|Tumor Marker Elevation|0
2357264|NCT01336621|4117849|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
2357265|NCT01336621|4117849|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
2357266|NCT01336621|4117849|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
2357267|NCT01336621|4117849|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
2357268|NCT01336621|4117849|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
2357269|NCT01336621|4117849|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
2357270|NCT01336621|4117849|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1
2357271|NCT01336621|4117849|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
2357272|NCT01336621|4117849|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1
2357273|NCT01336621|4117849|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
2309117|NCT02715726|4012658|FG000|Overall Study|Protocol Violation|1
2309118|NCT02715726|4012659|FG001|Overall Study|Protocol Violation|0
2309119|NCT02715726|4012658|FG000|Overall Study|Death|2
2309120|NCT02715726|4012659|FG001|Overall Study|Death|1
2309121|NCT02715726|4012658|FG000|Overall Study|Participant moved|1
2309122|NCT02715726|4012659|FG001|Overall Study|Participant moved|3
2309123|NCT02715726|4012658|FG000|Overall Study|Other than specified above|11
2309124|NCT02715726|4012659|FG001|Overall Study|Other than specified above|15
2309125|NCT02715726|4012658|FG000|Overall Study|Randomized but not treated|1
2309126|NCT02715726|4012659|FG001|Overall Study|Randomized but not treated|2
2357274|NCT04170296|4117869|FG000|Overall Study|Adverse Event|1
2357275|NCT04170296|4117870|FG001|Overall Study|Adverse Event|0
2357276|NCT04170296|4117869|FG000|Overall Study|Withdrawal by Subject|3
2357277|NCT04170296|4117870|FG001|Overall Study|Withdrawal by Subject|2
2357278|NCT04170296|4117869|FG000|Overall Study|Lost to Follow-up|4
2357279|NCT04170296|4117870|FG001|Overall Study|Lost to Follow-up|2
2357280|NCT04039217|4117882|FG000|Overall Study|Lost to Follow-up|1
2357281|NCT03078192|4117936|FG000|Overall Study|Withdrawal by Subject|2
2357282|NCT03078192|4117937|FG001|Overall Study|Withdrawal by Subject|1
2357283|NCT03078192|4117936|FG000|Overall Study|screen failure|0
2357284|NCT03078192|4117937|FG001|Overall Study|screen failure|3
2357285|NCT02903823|4117952|FG000|Overall Study|Physician Decision|5
2357286|NCT02903823|4117952|FG000|Overall Study|Could not advance catheter|1
2357287|NCT02903823|4117952|FG000|Overall Study|Catheter dislodgement|1
2357288|NCT01547117|4117974|FG000|Overall Study|Physician Decision|0
2357289|NCT01547117|4117975|FG001|Overall Study|Physician Decision|1
2357290|NCT01547117|4117976|FG002|Overall Study|Physician Decision|1
2357291|NCT01547117|4117977|FG003|Overall Study|Physician Decision|3
2357292|NCT01547117|4117974|FG000|Overall Study|Withdrawal by Subject|1
2357293|NCT01547117|4117975|FG001|Overall Study|Withdrawal by Subject|2
2357294|NCT01547117|4117976|FG002|Overall Study|Withdrawal by Subject|1
2357295|NCT01547117|4117977|FG003|Overall Study|Withdrawal by Subject|2
2357296|NCT01431508|4118003|FG000|Overall Study|Lack of Efficacy|1
2357297|NCT01431508|4118003|FG000|Overall Study|Unable to Follow Protocol Procedures|1
2357298|NCT00871351|4118010|FG000|Overall Study|Withdrawal by Subject|1
2357299|NCT00871351|4118011|FG001|Overall Study|Withdrawal by Subject|0
2357300|NCT00871351|4118012|FG002|Overall Study|Withdrawal by Subject|0
2357301|NCT00871351|4118010|FG000|Overall Study|Adverse Event|3
2357302|NCT00871351|4118011|FG001|Overall Study|Adverse Event|1
2357303|NCT00871351|4118012|FG002|Overall Study|Adverse Event|0
2357304|NCT00832455|4118020|FG000|Overall Study|Adverse Event|13
2357305|NCT00832455|4118020|FG000|Overall Study|Lost to Follow-up|26
2357306|NCT00832455|4118020|FG000|Overall Study|Protocol Violation|4
2357307|NCT00832455|4118020|FG000|Overall Study|Withdrawal by Subject|17
2357308|NCT00832455|4118020|FG000|Overall Study|Screening Failure|2
2357309|NCT00832455|4118020|FG000|Overall Study|Stopped Medication|4
2357310|NCT00832455|4118020|FG000|Overall Study|Parent misunderstood study|1
2357311|NCT00832455|4118020|FG000|Overall Study|Parent dissatisfied|1
2357312|NCT00832455|4118020|FG000|Overall Study|No improvement|3
2357313|NCT00832455|4118020|FG000|Overall Study|Patient moved|1
2357314|NCT00812006|4118036|FG000|Overall Study|Lost to Follow-up|0
2357315|NCT00812006|4118037|FG001|Overall Study|Lost to Follow-up|0
2357316|NCT00812006|4118038|FG002|Overall Study|Lost to Follow-up|2
2357317|NCT00812006|4118036|FG000|Overall Study|Physician Decision|0
2357318|NCT00812006|4118037|FG001|Overall Study|Physician Decision|0
2357319|NCT00812006|4118038|FG002|Overall Study|Physician Decision|1
2357320|NCT00812006|4118036|FG000|Overall Study|Withdrawal by Subject|2
2357321|NCT00812006|4118037|FG001|Overall Study|Withdrawal by Subject|1
2357322|NCT00812006|4118038|FG002|Overall Study|Withdrawal by Subject|1
2357323|NCT00812006|4118036|FG000|Overall Study|Lack of Qualifying Event|4
2357324|NCT00812006|4118037|FG001|Overall Study|Lack of Qualifying Event|2
2357325|NCT00812006|4118038|FG002|Overall Study|Lack of Qualifying Event|2
2357326|NCT00687531|4118051|FG000|Overall Study|Did not meet protocol eligibility|104
2357327|NCT00687531|4118051|FG000|Overall Study|Adverse Event|5
2357328|NCT00687531|4118051|FG000|Overall Study|Lost to Follow-up|26
2357329|NCT00654628|4118055|FG000|6-week Active Treatment Period|Adverse Event|9
2357330|NCT00654628|4118055|FG000|6-week Active Treatment Period|Lost to Follow-up|10
2357331|NCT00654628|4118055|FG000|6-week Active Treatment Period|Transferred to branch hospital|1
2357332|NCT00654628|4118055|FG000|6-week Active Treatment Period|Out of window period|1
2357333|NCT00654628|4118055|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4
2357334|NCT00654628|4118055|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1
2357335|NCT00536380|4118081|FG000|Overall Study|Adverse Event|0
2357336|NCT00536380|4118082|FG001|Overall Study|Adverse Event|2
2357337|NCT00536380|4118083|FG002|Overall Study|Adverse Event|2
2357338|NCT00536380|4118081|FG000|Overall Study|Lost to Follow-up|0
2357339|NCT00536380|4118082|FG001|Overall Study|Lost to Follow-up|0
2357340|NCT00536380|4118083|FG002|Overall Study|Lost to Follow-up|1
2357341|NCT00536380|4118081|FG000|Overall Study|Withdrawal unrelated to study drug|2
2357342|NCT00536380|4118082|FG001|Overall Study|Withdrawal unrelated to study drug|0
2357343|NCT00536380|4118083|FG002|Overall Study|Withdrawal unrelated to study drug|1
2357344|NCT00536380|4118081|FG000|Overall Study|Withdrawal related to study drug|7
2357345|NCT00536380|4118082|FG001|Overall Study|Withdrawal related to study drug|5
2357346|NCT00536380|4118083|FG002|Overall Study|Withdrawal related to study drug|2
2357347|NCT00536380|4118081|FG000|Overall Study|Noncompliance with protocol|3
2357348|NCT00536380|4118082|FG001|Overall Study|Noncompliance with protocol|2
2357349|NCT00536380|4118083|FG002|Overall Study|Noncompliance with protocol|2
2357350|NCT00536380|4118081|FG000|Overall Study|Did not meet protocol eligibility|0
2357351|NCT00536380|4118082|FG001|Overall Study|Did not meet protocol eligibility|0
2357352|NCT00536380|4118083|FG002|Overall Study|Did not meet protocol eligibility|1
2357353|NCT00536380|4118081|FG000|Overall Study|Administrative|0
2357354|NCT00536380|4118082|FG001|Overall Study|Administrative|0
2357355|NCT00536380|4118083|FG002|Overall Study|Administrative|1
2357356|NCT00521599|4118094|FG000|Overall Study|Adverse Event|5
2357357|NCT00521599|4118095|FG001|Overall Study|Adverse Event|7
2357358|NCT00521599|4118096|FG002|Overall Study|Adverse Event|6
2357359|NCT00521599|4118094|FG000|Overall Study|Treatment Failure|8
2357360|NCT00521599|4118095|FG001|Overall Study|Treatment Failure|9
2357361|NCT00521599|4118096|FG002|Overall Study|Treatment Failure|22
2357362|NCT00521599|4118094|FG000|Overall Study|Lost to Follow-up|2
2357363|NCT00521599|4118095|FG001|Overall Study|Lost to Follow-up|1
2357364|NCT00521599|4118096|FG002|Overall Study|Lost to Follow-up|2
2357365|NCT00521599|4118094|FG000|Overall Study|Withdrawal by Subject|3
2357366|NCT00521599|4118095|FG001|Overall Study|Withdrawal by Subject|5
2357367|NCT00521599|4118096|FG002|Overall Study|Withdrawal by Subject|1
2357368|NCT00521599|4118094|FG000|Overall Study|Withdrawal by subject treatment related|3
2357369|NCT00521599|4118095|FG001|Overall Study|Withdrawal by subject treatment related|1
2357370|NCT00521599|4118096|FG002|Overall Study|Withdrawal by subject treatment related|2
2357371|NCT00521599|4118094|FG000|Overall Study|Protocol Violation|2
2357372|NCT00521599|4118095|FG001|Overall Study|Protocol Violation|4
2357373|NCT00521599|4118096|FG002|Overall Study|Protocol Violation|2
2357374|NCT00521599|4118094|FG000|Overall Study|Did not meet protocol eligibility|2
2357375|NCT00521599|4118095|FG001|Overall Study|Did not meet protocol eligibility|2
2357376|NCT00521599|4118096|FG002|Overall Study|Did not meet protocol eligibility|1
2357377|NCT00496834|4118107|FG000|Overall Study|Withdrawal by Subject|4
2357378|NCT00496834|4118108|FG001|Overall Study|Withdrawal by Subject|6
2357379|NCT00496834|4118107|FG000|Overall Study|Contraindicated medication administered|0
2020260|NCT00305448|3587898|FG001|Overall Study|Tumor Marker Elevation|0
2020261|NCT00305448|3587899|FG002|Overall Study|Tumor Marker Elevation|1
2020262|NCT00305604|3587933|FG000|Overall Study|Adverse Event|6
2020263|NCT00305604|3587934|FG001|Overall Study|Adverse Event|3
2020264|NCT00305604|3587933|FG000|Overall Study|Lack of Efficacy|11
2020265|NCT00305604|3587934|FG001|Overall Study|Lack of Efficacy|18
2020266|NCT00305604|3587933|FG000|Overall Study|Lost to Follow-up|0
2020267|NCT00305604|3587934|FG001|Overall Study|Lost to Follow-up|4
2020268|NCT00305604|3587933|FG000|Overall Study|Protocol Violation|2
2020269|NCT00305604|3587934|FG001|Overall Study|Protocol Violation|1
2020270|NCT00305604|3587933|FG000|Overall Study|Withdrawal by Subject|12
2020271|NCT00305604|3587934|FG001|Overall Study|Withdrawal by Subject|21
2020272|NCT00305604|3587933|FG000|Overall Study|Patient moved|1
2020273|NCT00305604|3587934|FG001|Overall Study|Patient moved|0
2020274|NCT00305695|3587967|FG000|Overall Study|Withdrawal by subject prior to 18 month|40
2020275|NCT00305695|3587968|FG001|Overall Study|Withdrawal by subject prior to 18 month|26
2020276|NCT00305695|3587967|FG000|Overall Study|Did not have baseline scan|1
2020277|NCT00305695|3587968|FG001|Overall Study|Did not have baseline scan|1
2020278|NCT00305773|3587980|FG000|Overall Study|Death|3
2020279|NCT00305773|3587981|FG001|Overall Study|Death|2
2020280|NCT00305773|3587980|FG000|Overall Study|Adverse Event|1
2020281|NCT00305773|3587981|FG001|Overall Study|Adverse Event|2
2309127|NCT02715804|4012667|FG000|Overall Study|Death|222
2357380|NCT00496834|4118108|FG001|Overall Study|Contraindicated medication administered|1
2357381|NCT00496834|4118107|FG000|Overall Study|Inclusion/exclusion criteria not met|3
2357382|NCT00496834|4118108|FG001|Overall Study|Inclusion/exclusion criteria not met|2
2357383|NCT00496834|4118107|FG000|Overall Study|Adverse Event|5
2357384|NCT00496834|4118108|FG001|Overall Study|Adverse Event|3
2357385|NCT00496834|4118107|FG000|Overall Study|IP administration violation|2
2357386|NCT00496834|4118108|FG001|Overall Study|IP administration violation|0
2357387|NCT00496834|4118107|FG000|Overall Study|Lost to Follow-up|2
2357388|NCT00496834|4118108|FG001|Overall Study|Lost to Follow-up|0
2357389|NCT00496834|4118107|FG000|Overall Study|Blood Pressure control failure|2
2357390|NCT00496834|4118108|FG001|Overall Study|Blood Pressure control failure|1
2357391|NCT00442897|4118118|FG000|Base Study (12 Week Follow-up)|Adverse Event|1
2357392|NCT00442897|4118119|FG001|Base Study (12 Week Follow-up)|Adverse Event|0
2357393|NCT00442897|4118118|FG000|Base Study (12 Week Follow-up)|Death|0
2357394|NCT00442897|4118119|FG001|Base Study (12 Week Follow-up)|Death|1
2357395|NCT00442897|4118118|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7
2357396|NCT00442897|4118119|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3
2357397|NCT00442897|4118118|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
2357398|NCT00442897|4118119|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
2357399|NCT00442897|4118118|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1
2309128|NCT02715804|4012668|FG001|Overall Study|Death|106
2309129|NCT02715804|4012667|FG000|Overall Study|Withdrawal by Subject|5
2309130|NCT02715804|4012668|FG001|Overall Study|Withdrawal by Subject|4
2309131|NCT02715804|4012667|FG000|Overall Study|Other than specified|2
2309132|NCT02715804|4012668|FG001|Overall Study|Other than specified|3
2309133|NCT02716194|4012677|FG000|Period 1 - ADVATE|Withdrawal by Subject|1
2309134|NCT02716194|4012678|FG001|Period 1 - ADVATE|Withdrawal by Subject|1
2309135|NCT02716194|4012679|FG002|Period 1 - ADVATE|Withdrawal by Subject|0
2357400|NCT00442897|4118119|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0
2357401|NCT00442897|4118118|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
2357402|NCT00442897|4118119|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
2357403|NCT00442897|4118118|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
2357404|NCT00442897|4118119|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
2357405|NCT00442897|4118118|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
2357406|NCT00442897|4118119|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
2357407|NCT00423579|4118127|FG000|Overall Study|Lost to Follow-up|3
2357408|NCT00423579|4118128|FG001|Overall Study|Lost to Follow-up|0
2357409|NCT00423579|4118127|FG000|Overall Study|Protocol Violation|1
2357410|NCT00423579|4118128|FG001|Overall Study|Protocol Violation|3
2357411|NCT00423579|4118127|FG000|Overall Study|Diagnosis of diabetes|0
2357412|NCT00423579|4118128|FG001|Overall Study|Diagnosis of diabetes|1
2357413|NCT00394355|4118138|FG000|Overall Study|Adverse Event|10
2357414|NCT00394355|4118139|FG001|Overall Study|Adverse Event|6
2357415|NCT00394355|4118140|FG002|Overall Study|Adverse Event|7
2357416|NCT00394355|4118141|FG003|Overall Study|Adverse Event|8
2357417|NCT00394355|4118138|FG000|Overall Study|Did not meet protocol eligibility|1
2357418|NCT00394355|4118139|FG001|Overall Study|Did not meet protocol eligibility|5
2357419|NCT00394355|4118140|FG002|Overall Study|Did not meet protocol eligibility|4
2357420|NCT00394355|4118141|FG003|Overall Study|Did not meet protocol eligibility|2
2357421|NCT00394355|4118138|FG000|Overall Study|Subject withdrawal - unrelated to drug|12
2357422|NCT00394355|4118139|FG001|Overall Study|Subject withdrawal - unrelated to drug|14
2357423|NCT00394355|4118140|FG002|Overall Study|Subject withdrawal - unrelated to drug|10
2357424|NCT00394355|4118141|FG003|Overall Study|Subject withdrawal - unrelated to drug|6
2357425|NCT00394355|4118138|FG000|Overall Study|Subject withdrawal - related to drug|1
2357426|NCT00394355|4118139|FG001|Overall Study|Subject withdrawal - related to drug|0
2357427|NCT00394355|4118140|FG002|Overall Study|Subject withdrawal - related to drug|0
2357428|NCT00394355|4118141|FG003|Overall Study|Subject withdrawal - related to drug|0
2357429|NCT00394355|4118138|FG000|Overall Study|Lost to Follow-up|7
2357430|NCT00394355|4118139|FG001|Overall Study|Lost to Follow-up|5
2357431|NCT00394355|4118140|FG002|Overall Study|Lost to Follow-up|4
2357432|NCT00394355|4118141|FG003|Overall Study|Lost to Follow-up|3
2357433|NCT00394355|4118138|FG000|Overall Study|Noncompliance with protocol|4
2357434|NCT00394355|4118139|FG001|Overall Study|Noncompliance with protocol|3
2357435|NCT00394355|4118140|FG002|Overall Study|Noncompliance with protocol|10
2357436|NCT00394355|4118141|FG003|Overall Study|Noncompliance with protocol|8
2357437|NCT00394355|4118138|FG000|Overall Study|Administrative|0
2357438|NCT00394355|4118139|FG001|Overall Study|Administrative|1
2357439|NCT00394355|4118140|FG002|Overall Study|Administrative|1
2357440|NCT00394355|4118141|FG003|Overall Study|Administrative|1
2212559|NCT01671319|3853736|FG000|Overall Study|Withdrawal by Subject|1
2212560|NCT01671332|3853742|FG000|Overall Study|Withdrawal by Subject|1
2212561|NCT01671332|3853743|FG001|Overall Study|Withdrawal by Subject|1
2212562|NCT01671345|3853751|FG000|Overall Study|Lost to Follow-up|10
2357441|NCT00394355|4118138|FG000|Overall Study|Lack of Efficacy|0
2357442|NCT00394355|4118139|FG001|Overall Study|Lack of Efficacy|0
2357443|NCT00394355|4118140|FG002|Overall Study|Lack of Efficacy|2
2357444|NCT00394355|4118141|FG003|Overall Study|Lack of Efficacy|3
2357445|NCT00166504|4118162|FG000|Overall Study|Adverse Event|3
2357446|NCT00166504|4118163|FG001|Overall Study|Adverse Event|3
2357447|NCT00166504|4118162|FG000|Overall Study|Lost to Follow-up|1
2357448|NCT00166504|4118163|FG001|Overall Study|Lost to Follow-up|1
2020282|NCT00305773|3587980|FG000|Overall Study|Alternative Treatment|4
2020283|NCT00305773|3587981|FG001|Overall Study|Alternative Treatment|4
2020284|NCT00305773|3587980|FG000|Overall Study|Physician Decision|1
2020285|NCT00305773|3587981|FG001|Overall Study|Physician Decision|1
2020286|NCT00305773|3587980|FG000|Overall Study|Withdrawal by Subject|1
2020287|NCT00305773|3587981|FG001|Overall Study|Withdrawal by Subject|4
2357449|NCT00166504|4118162|FG000|Overall Study|Withdrawal by Subject|1
2357450|NCT00166504|4118163|FG001|Overall Study|Withdrawal by Subject|0
2357451|NCT01345240|4118174|FG000|Overall Study|Adverse Event|3
2357452|NCT01345240|4118175|FG001|Overall Study|Adverse Event|5
2357453|NCT01345240|4118176|FG002|Overall Study|Adverse Event|4
2357454|NCT01345240|4118177|FG003|Overall Study|Adverse Event|2
2357455|NCT01345240|4118178|FG004|Overall Study|Adverse Event|1
2357456|NCT01345240|4118174|FG000|Overall Study|Lost to Follow-up|8
2357457|NCT01345240|4118175|FG001|Overall Study|Lost to Follow-up|9
2357458|NCT01345240|4118176|FG002|Overall Study|Lost to Follow-up|14
2357459|NCT01345240|4118177|FG003|Overall Study|Lost to Follow-up|7
2357460|NCT01345240|4118178|FG004|Overall Study|Lost to Follow-up|9
2020288|NCT00305773|3587980|FG000|Overall Study|Disease Progression|1
2020289|NCT00305773|3587981|FG001|Overall Study|Disease Progression|3
2020290|NCT00305773|3587980|FG000|Overall Study|All other reasons|3
2020291|NCT00305773|3587981|FG001|Overall Study|All other reasons|2
2020292|NCT00305864|3587991|FG000|Overall Study|Ineligible / No protocol treatment|0
2020293|NCT00305864|3587992|FG001|Overall Study|Ineligible / No protocol treatment|1
2020294|NCT00305864|3587993|FG002|Overall Study|Ineligible / No protocol treatment|1
2357461|NCT01371305|4118205|FG000|Overall Study|Adverse Event|0
2357462|NCT01371305|4118206|FG001|Overall Study|Adverse Event|0
2357463|NCT01371305|4118207|FG002|Overall Study|Adverse Event|0
2357464|NCT01371305|4118208|FG003|Overall Study|Adverse Event|2
2357465|NCT01371305|4118209|FG004|Overall Study|Adverse Event|1
2357466|NCT01371305|4118210|FG005|Overall Study|Adverse Event|0
2357467|NCT01371305|4118205|FG000|Overall Study|Study terminated by sponsor|0
2357468|NCT01371305|4118206|FG001|Overall Study|Study terminated by sponsor|0
2357469|NCT01371305|4118207|FG002|Overall Study|Study terminated by sponsor|0
2357470|NCT01371305|4118208|FG003|Overall Study|Study terminated by sponsor|0
2357471|NCT01371305|4118209|FG004|Overall Study|Study terminated by sponsor|3
2357472|NCT01371305|4118210|FG005|Overall Study|Study terminated by sponsor|1
2357473|NCT01371305|4118205|FG000|Overall Study|Subject request|0
2357474|NCT01371305|4118206|FG001|Overall Study|Subject request|0
2357475|NCT01371305|4118207|FG002|Overall Study|Subject request|0
2357476|NCT01371305|4118208|FG003|Overall Study|Subject request|0
2357477|NCT01371305|4118209|FG004|Overall Study|Subject request|0
2357478|NCT01371305|4118210|FG005|Overall Study|Subject request|1
2357479|NCT01376323|4118230|FG000|Overall Study|Adverse Event|1
2357480|NCT01376323|4118231|FG001|Overall Study|Adverse Event|0
2357481|NCT01376323|4118232|FG002|Overall Study|Adverse Event|0
2357482|NCT01376323|4118233|FG003|Overall Study|Adverse Event|2
2357483|NCT01376323|4118234|FG004|Overall Study|Adverse Event|0
2357484|NCT01376323|4118230|FG000|Overall Study|Lost to Follow-up|0
2357485|NCT01376323|4118231|FG001|Overall Study|Lost to Follow-up|0
2357486|NCT01376323|4118232|FG002|Overall Study|Lost to Follow-up|0
2357487|NCT01376323|4118233|FG003|Overall Study|Lost to Follow-up|2
2357488|NCT01376323|4118234|FG004|Overall Study|Lost to Follow-up|0
2357489|NCT01376323|4118230|FG000|Overall Study|Physician Decision|1
2357490|NCT01376323|4118231|FG001|Overall Study|Physician Decision|0
2357491|NCT01376323|4118232|FG002|Overall Study|Physician Decision|2
2357492|NCT01376323|4118233|FG003|Overall Study|Physician Decision|1
2357493|NCT01376323|4118234|FG004|Overall Study|Physician Decision|1
2357494|NCT01376323|4118230|FG000|Overall Study|Withdrawal by Subject|0
2357495|NCT01376323|4118231|FG001|Overall Study|Withdrawal by Subject|1
2357496|NCT01376323|4118232|FG002|Overall Study|Withdrawal by Subject|1
2357497|NCT01376323|4118233|FG003|Overall Study|Withdrawal by Subject|0
2357498|NCT01376323|4118234|FG004|Overall Study|Withdrawal by Subject|0
2357499|NCT01386658|4118258|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0
2357500|NCT01386658|4118259|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9
2357501|NCT01386658|4118258|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
2357502|NCT01386658|4118259|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
2357503|NCT01386684|4118269|FG000|Overall Study|Lost to Follow-up|51
2357504|NCT01386684|4118269|FG000|Overall Study|Other|51
2357505|NCT01386684|4118269|FG000|Overall Study|Death|47
2357506|NCT01386684|4118269|FG000|Overall Study|Withdrawal of Consent|44
2357507|NCT01386684|4118269|FG000|Overall Study|Alternative Therapy Required|37
2357508|NCT01386684|4118269|FG000|Overall Study|Disease Progression|28
2357509|NCT01386684|4118269|FG000|Overall Study|Adverse Event|20
2357510|NCT01386684|4118269|FG000|Overall Study|Noncompliance|8
2357511|NCT01386684|4118269|FG000|Overall Study|Protocol Violation|4
2357512|NCT01386684|4118269|FG000|Overall Study|Missing|3
2357513|NCT01403948|4118283|FG000|Overall Study|Progressive disease|0
2357514|NCT01403948|4118284|FG001|Overall Study|Progressive disease|2
2357515|NCT01403948|4118285|FG002|Overall Study|Progressive disease|2
2357516|NCT01403948|4118286|FG003|Overall Study|Progressive disease|4
2357517|NCT01403948|4118287|FG004|Overall Study|Progressive disease|2
2357518|NCT01403948|4118288|FG005|Overall Study|Progressive disease|6
2357519|NCT01403948|4118289|FG006|Overall Study|Progressive disease|2
2357520|NCT01403948|4118290|FG007|Overall Study|Progressive disease|4
2357521|NCT01403948|4118291|FG008|Overall Study|Progressive disease|5
2357522|NCT01403948|4118292|FG009|Overall Study|Progressive disease|5
2357523|NCT01403948|4118283|FG000|Overall Study|Other Adverse Event (Other than DLT)|0
2357524|NCT01403948|4118284|FG001|Overall Study|Other Adverse Event (Other than DLT)|0
2357525|NCT01403948|4118285|FG002|Overall Study|Other Adverse Event (Other than DLT)|0
2357526|NCT01403948|4118286|FG003|Overall Study|Other Adverse Event (Other than DLT)|0
2357527|NCT01403948|4118287|FG004|Overall Study|Other Adverse Event (Other than DLT)|2
2357528|NCT01403948|4118288|FG005|Overall Study|Other Adverse Event (Other than DLT)|0
2357529|NCT01403948|4118289|FG006|Overall Study|Other Adverse Event (Other than DLT)|2
2357530|NCT01403948|4118290|FG007|Overall Study|Other Adverse Event (Other than DLT)|0
2357531|NCT01403948|4118291|FG008|Overall Study|Other Adverse Event (Other than DLT)|1
2357532|NCT01403948|4118292|FG009|Overall Study|Other Adverse Event (Other than DLT)|0
2357533|NCT01403948|4118283|FG000|Overall Study|Lost to Follow-up|0
2357534|NCT01403948|4118284|FG001|Overall Study|Lost to Follow-up|0
2357535|NCT01403948|4118285|FG002|Overall Study|Lost to Follow-up|0
2357536|NCT01403948|4118286|FG003|Overall Study|Lost to Follow-up|0
2357537|NCT01403948|4118287|FG004|Overall Study|Lost to Follow-up|0
2357538|NCT01403948|4118288|FG005|Overall Study|Lost to Follow-up|0
2357539|NCT01403948|4118289|FG006|Overall Study|Lost to Follow-up|0
2357540|NCT01403948|4118290|FG007|Overall Study|Lost to Follow-up|0
2357541|NCT01403948|4118291|FG008|Overall Study|Lost to Follow-up|0
2357542|NCT01403948|4118292|FG009|Overall Study|Lost to Follow-up|1
2357543|NCT01403948|4118283|FG000|Overall Study|Refused cont. medication|0
2357544|NCT01403948|4118284|FG001|Overall Study|Refused cont. medication|0
2357545|NCT01403948|4118285|FG002|Overall Study|Refused cont. medication|0
2357546|NCT01403948|4118286|FG003|Overall Study|Refused cont. medication|0
2357547|NCT01403948|4118287|FG004|Overall Study|Refused cont. medication|1
2357548|NCT01403948|4118288|FG005|Overall Study|Refused cont. medication|0
2357549|NCT01403948|4118289|FG006|Overall Study|Refused cont. medication|0
2357550|NCT01403948|4118290|FG007|Overall Study|Refused cont. medication|0
2357551|NCT01403948|4118291|FG008|Overall Study|Refused cont. medication|0
2357552|NCT01403948|4118292|FG009|Overall Study|Refused cont. medication|1
2357553|NCT01403948|4118283|FG000|Overall Study|other than above|1
2357554|NCT01403948|4118284|FG001|Overall Study|other than above|2
2357555|NCT01403948|4118285|FG002|Overall Study|other than above|1
2357556|NCT01403948|4118286|FG003|Overall Study|other than above|0
2357557|NCT01403948|4118287|FG004|Overall Study|other than above|1
2102123|NCT00837486|3693850|FG000|Blinded-treatment Phase|Physician Decision|1
2102124|NCT00837486|3693851|FG001|Blinded-treatment Phase|Physician Decision|0
2357558|NCT01403948|4118288|FG005|Overall Study|other than above|1
2357559|NCT01403948|4118289|FG006|Overall Study|other than above|2
2357560|NCT01403948|4118290|FG007|Overall Study|other than above|0
2357561|NCT01403948|4118291|FG008|Overall Study|other than above|0
2357562|NCT01403948|4118292|FG009|Overall Study|other than above|0
2357563|NCT01404312|4118320|FG000|Overall Study|Death|21
2357564|NCT01404312|4118321|FG001|Overall Study|Death|27
2357565|NCT01404312|4118320|FG000|Overall Study|Withdrawal by Subject|15
2357566|NCT01404312|4118321|FG001|Overall Study|Withdrawal by Subject|18
2357567|NCT01404312|4118320|FG000|Overall Study|Participant Unable to get to clinic|93
2357568|NCT01404312|4118321|FG001|Overall Study|Participant Unable to get to clinic|103
2357569|NCT01404312|4118320|FG000|Overall Study|Lost to Follow-up|115
2357570|NCT01404312|4118321|FG001|Overall Study|Lost to Follow-up|111
2357571|NCT01404312|4118320|FG000|Overall Study|Site closed|22
2357572|NCT01404312|4118321|FG001|Overall Study|Site closed|21
2357573|NCT01404312|4118320|FG000|Overall Study|Participant not willing to adhere to req|31
2357574|NCT01404312|4118321|FG001|Overall Study|Participant not willing to adhere to req|29
2357575|NCT01404312|4118320|FG000|Overall Study|Severe debilitation, unable to continue|1
2357576|NCT01404312|4118321|FG001|Overall Study|Severe debilitation, unable to continue|2
2357577|NCT01425008|4118347|FG000|Dose Escalation Phase|Progressive Disease|2
2357578|NCT01425008|4118348|FG001|Dose Escalation Phase|Progressive Disease|3
2357579|NCT01425008|4118349|FG002|Dose Escalation Phase|Progressive Disease|2
2357580|NCT01425008|4118350|FG003|Dose Escalation Phase|Progressive Disease|3
2357581|NCT01425008|4118351|FG004|Dose Escalation Phase|Progressive Disease|5
2357582|NCT01425008|4118352|FG005|Dose Escalation Phase|Progressive Disease|4
2357583|NCT01425008|4118353|FG006|Dose Escalation Phase|Progressive Disease|0
2357584|NCT01425008|4118354|FG007|Dose Escalation Phase|Progressive Disease|2
2357585|NCT01425008|4118355|FG008|Dose Escalation Phase|Progressive Disease|6
2357586|NCT01425008|4118356|FG009|Dose Escalation Phase|Progressive Disease|2
2357587|NCT01425008|4118357|FG010|Dose Escalation Phase|Progressive Disease|0
2357588|NCT01425008|4118358|FG011|Dose Escalation Phase|Progressive Disease|0
2357589|NCT01425008|4118359|FG012|Dose Escalation Phase|Progressive Disease|0
2357590|NCT01425008|4118360|FG013|Dose Escalation Phase|Progressive Disease|0
2357591|NCT01425008|4118361|FG014|Dose Escalation Phase|Progressive Disease|0
2357592|NCT01425008|4118362|FG015|Dose Escalation Phase|Progressive Disease|0
2357593|NCT01425008|4118363|FG016|Dose Escalation Phase|Progressive Disease|0
2357594|NCT01425008|4118364|FG017|Dose Escalation Phase|Progressive Disease|0
2357595|NCT01425008|4118365|FG018|Dose Escalation Phase|Progressive Disease|0
2357596|NCT01425008|4118347|FG000|Dose Escalation Phase|Adverse Event|2
2357597|NCT01425008|4118348|FG001|Dose Escalation Phase|Adverse Event|0
2357598|NCT01425008|4118349|FG002|Dose Escalation Phase|Adverse Event|0
2020295|NCT00305864|3587994|FG003|Overall Study|Ineligible / No protocol treatment|13
2020296|NCT00305877|3588006|FG000|Overall Study|Lack of Efficacy|6
2020297|NCT00305877|3588007|FG001|Overall Study|Lack of Efficacy|9
2020298|NCT00305877|3588006|FG000|Overall Study|Adverse Event|9
2020299|NCT00305877|3588007|FG001|Overall Study|Adverse Event|14
2020300|NCT00305877|3588006|FG000|Overall Study|Death|0
2020301|NCT00305877|3588007|FG001|Overall Study|Death|1
2020302|NCT00305877|3588006|FG000|Overall Study|Withdrawal by Subject|4
2020303|NCT00305877|3588007|FG001|Overall Study|Withdrawal by Subject|2
2020304|NCT00305877|3588006|FG000|Overall Study|Physician Decision|1
2020305|NCT00305877|3588007|FG001|Overall Study|Physician Decision|1
2020306|NCT00305877|3588006|FG000|Overall Study|Never start treatment|2
2020307|NCT00305877|3588007|FG001|Overall Study|Never start treatment|5
2020308|NCT00305877|3588006|FG000|Overall Study|Ineligible|2
2020309|NCT00305877|3588007|FG001|Overall Study|Ineligible|1
2020310|NCT00305877|3588006|FG000|Overall Study|Transportation issue with daily RT|0
2020311|NCT00305877|3588007|FG001|Overall Study|Transportation issue with daily RT|1
2020312|NCT00306189|3588030|FG000|Overall Study|Physician Decision|0
2020313|NCT00306189|3588031|FG001|Overall Study|Physician Decision|0
2020314|NCT00306189|3588032|FG002|Overall Study|Physician Decision|0
2020315|NCT00306189|3588033|FG003|Overall Study|Physician Decision|1
2020316|NCT00306189|3588030|FG000|Overall Study|Adverse Event|3
2020317|NCT00306189|3588031|FG001|Overall Study|Adverse Event|3
2020318|NCT00306189|3588032|FG002|Overall Study|Adverse Event|2
2020319|NCT00306189|3588033|FG003|Overall Study|Adverse Event|2
2020320|NCT00306189|3588030|FG000|Overall Study|Withdrawal by Subject|4
2020321|NCT00306189|3588031|FG001|Overall Study|Withdrawal by Subject|2
2020322|NCT00306189|3588032|FG002|Overall Study|Withdrawal by Subject|8
2020323|NCT00306189|3588033|FG003|Overall Study|Withdrawal by Subject|1
2020324|NCT00306189|3588030|FG000|Overall Study|Ineligibility determined|1
2020325|NCT00306189|3588031|FG001|Overall Study|Ineligibility determined|1
2020326|NCT00306189|3588032|FG002|Overall Study|Ineligibility determined|1
2020327|NCT00306189|3588033|FG003|Overall Study|Ineligibility determined|1
2020328|NCT00306189|3588030|FG000|Overall Study|Other|1
2020329|NCT00306189|3588031|FG001|Overall Study|Other|0
2020330|NCT00306189|3588032|FG002|Overall Study|Other|0
2020331|NCT00306189|3588033|FG003|Overall Study|Other|0
2020332|NCT00306293|3588094|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1
2020333|NCT00306293|3588095|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0
2020334|NCT00306293|3588094|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
2020335|NCT00306293|3588095|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
2020336|NCT00306293|3588094|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
2020337|NCT00306293|3588095|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
2020338|NCT00306293|3588094|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
2020339|NCT00306293|3588095|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
2020340|NCT00306293|3588094|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1
2020341|NCT00306293|3588095|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0
2357599|NCT01425008|4118350|FG003|Dose Escalation Phase|Adverse Event|0
2357600|NCT01425008|4118351|FG004|Dose Escalation Phase|Adverse Event|0
2357601|NCT01425008|4118352|FG005|Dose Escalation Phase|Adverse Event|2
2357602|NCT01425008|4118353|FG006|Dose Escalation Phase|Adverse Event|0
2357603|NCT01425008|4118354|FG007|Dose Escalation Phase|Adverse Event|0
2357604|NCT01425008|4118355|FG008|Dose Escalation Phase|Adverse Event|2
2357605|NCT01425008|4118356|FG009|Dose Escalation Phase|Adverse Event|0
2357606|NCT01425008|4118357|FG010|Dose Escalation Phase|Adverse Event|0
2357607|NCT01425008|4118358|FG011|Dose Escalation Phase|Adverse Event|0
2357608|NCT01425008|4118359|FG012|Dose Escalation Phase|Adverse Event|0
2357609|NCT01425008|4118360|FG013|Dose Escalation Phase|Adverse Event|0
2357610|NCT01425008|4118361|FG014|Dose Escalation Phase|Adverse Event|0
2357611|NCT01425008|4118362|FG015|Dose Escalation Phase|Adverse Event|0
2357612|NCT01425008|4118363|FG016|Dose Escalation Phase|Adverse Event|0
2357613|NCT01425008|4118364|FG017|Dose Escalation Phase|Adverse Event|0
2357614|NCT01425008|4118365|FG018|Dose Escalation Phase|Adverse Event|0
2357615|NCT01425008|4118347|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357616|NCT01425008|4118348|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357617|NCT01425008|4118349|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357618|NCT01425008|4118350|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357619|NCT01425008|4118351|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
2357620|NCT01425008|4118352|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357621|NCT01425008|4118353|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2
2357622|NCT01425008|4118354|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
2357623|NCT01425008|4118355|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
2357624|NCT01425008|4118356|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357625|NCT01425008|4118357|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357626|NCT01425008|4118358|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357627|NCT01425008|4118359|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357628|NCT01425008|4118360|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357629|NCT01425008|4118361|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357630|NCT01425008|4118362|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357631|NCT01425008|4118363|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357632|NCT01425008|4118364|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357633|NCT01425008|4118365|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2357634|NCT01425008|4118347|FG000|Dose Escalation Phase|Withdrawal by Subject|0
2357635|NCT01425008|4118348|FG001|Dose Escalation Phase|Withdrawal by Subject|0
2357636|NCT01425008|4118349|FG002|Dose Escalation Phase|Withdrawal by Subject|0
2357637|NCT01425008|4118350|FG003|Dose Escalation Phase|Withdrawal by Subject|0
2357638|NCT01425008|4118351|FG004|Dose Escalation Phase|Withdrawal by Subject|1
2357639|NCT01425008|4118352|FG005|Dose Escalation Phase|Withdrawal by Subject|1
2357640|NCT01425008|4118353|FG006|Dose Escalation Phase|Withdrawal by Subject|1
2357641|NCT01425008|4118354|FG007|Dose Escalation Phase|Withdrawal by Subject|0
2357642|NCT01425008|4118355|FG008|Dose Escalation Phase|Withdrawal by Subject|1
2357643|NCT01425008|4118356|FG009|Dose Escalation Phase|Withdrawal by Subject|0
2357644|NCT01425008|4118357|FG010|Dose Escalation Phase|Withdrawal by Subject|0
2357645|NCT01425008|4118358|FG011|Dose Escalation Phase|Withdrawal by Subject|0
2357646|NCT01425008|4118359|FG012|Dose Escalation Phase|Withdrawal by Subject|0
2357647|NCT01425008|4118360|FG013|Dose Escalation Phase|Withdrawal by Subject|0
2357648|NCT01425008|4118361|FG014|Dose Escalation Phase|Withdrawal by Subject|0
2357649|NCT01425008|4118362|FG015|Dose Escalation Phase|Withdrawal by Subject|0
2357650|NCT01425008|4118363|FG016|Dose Escalation Phase|Withdrawal by Subject|0
2357651|NCT01425008|4118364|FG017|Dose Escalation Phase|Withdrawal by Subject|0
2357652|NCT01425008|4118365|FG018|Dose Escalation Phase|Withdrawal by Subject|0
2357653|NCT01425008|4118347|FG000|Dose Escalation Phase|Symptomatic Deterioration|0
2357654|NCT01425008|4118348|FG001|Dose Escalation Phase|Symptomatic Deterioration|0
2357655|NCT01425008|4118349|FG002|Dose Escalation Phase|Symptomatic Deterioration|1
2357656|NCT01425008|4118350|FG003|Dose Escalation Phase|Symptomatic Deterioration|0
2357657|NCT01425008|4118351|FG004|Dose Escalation Phase|Symptomatic Deterioration|0
2357658|NCT01425008|4118352|FG005|Dose Escalation Phase|Symptomatic Deterioration|0
2357659|NCT01425008|4118353|FG006|Dose Escalation Phase|Symptomatic Deterioration|0
2357660|NCT01425008|4118354|FG007|Dose Escalation Phase|Symptomatic Deterioration|0
2357661|NCT01425008|4118355|FG008|Dose Escalation Phase|Symptomatic Deterioration|2
2357662|NCT01425008|4118356|FG009|Dose Escalation Phase|Symptomatic Deterioration|2
2357663|NCT01425008|4118357|FG010|Dose Escalation Phase|Symptomatic Deterioration|0
2357664|NCT01425008|4118358|FG011|Dose Escalation Phase|Symptomatic Deterioration|0
2357665|NCT01425008|4118359|FG012|Dose Escalation Phase|Symptomatic Deterioration|0
2357666|NCT01425008|4118360|FG013|Dose Escalation Phase|Symptomatic Deterioration|0
2357667|NCT01425008|4118361|FG014|Dose Escalation Phase|Symptomatic Deterioration|0
2357668|NCT01425008|4118362|FG015|Dose Escalation Phase|Symptomatic Deterioration|0
2357669|NCT01425008|4118363|FG016|Dose Escalation Phase|Symptomatic Deterioration|0
2357670|NCT01425008|4118364|FG017|Dose Escalation Phase|Symptomatic Deterioration|0
2357671|NCT01425008|4118365|FG018|Dose Escalation Phase|Symptomatic Deterioration|0
2357672|NCT01425008|4118347|FG000|Dose Escalation Phase|Other|0
2357673|NCT01425008|4118348|FG001|Dose Escalation Phase|Other|0
2357674|NCT01425008|4118349|FG002|Dose Escalation Phase|Other|0
2357675|NCT01425008|4118350|FG003|Dose Escalation Phase|Other|0
2357676|NCT01425008|4118351|FG004|Dose Escalation Phase|Other|0
2357677|NCT01425008|4118352|FG005|Dose Escalation Phase|Other|0
2357678|NCT01425008|4118353|FG006|Dose Escalation Phase|Other|0
2357679|NCT01425008|4118354|FG007|Dose Escalation Phase|Other|0
2357680|NCT01425008|4118355|FG008|Dose Escalation Phase|Other|1
2357681|NCT01425008|4118356|FG009|Dose Escalation Phase|Other|0
2357682|NCT01425008|4118357|FG010|Dose Escalation Phase|Other|0
2357683|NCT01425008|4118358|FG011|Dose Escalation Phase|Other|0
2357684|NCT01425008|4118359|FG012|Dose Escalation Phase|Other|0
2357685|NCT01425008|4118360|FG013|Dose Escalation Phase|Other|0
2357686|NCT01425008|4118361|FG014|Dose Escalation Phase|Other|0
2357687|NCT01425008|4118362|FG015|Dose Escalation Phase|Other|0
2357688|NCT01425008|4118363|FG016|Dose Escalation Phase|Other|0
2357689|NCT01425008|4118364|FG017|Dose Escalation Phase|Other|0
2357690|NCT01425008|4118365|FG018|Dose Escalation Phase|Other|0
2357691|NCT01425008|4118347|FG000|Dose Expansion Phase|Progressive Disease|0
2357692|NCT01425008|4118348|FG001|Dose Expansion Phase|Progressive Disease|0
2357693|NCT01425008|4118349|FG002|Dose Expansion Phase|Progressive Disease|0
2357694|NCT01425008|4118350|FG003|Dose Expansion Phase|Progressive Disease|0
2357695|NCT01425008|4118351|FG004|Dose Expansion Phase|Progressive Disease|0
2357696|NCT01425008|4118352|FG005|Dose Expansion Phase|Progressive Disease|0
2357697|NCT01425008|4118353|FG006|Dose Expansion Phase|Progressive Disease|0
2357698|NCT01425008|4118354|FG007|Dose Expansion Phase|Progressive Disease|0
2357699|NCT01425008|4118355|FG008|Dose Expansion Phase|Progressive Disease|0
2357700|NCT01425008|4118356|FG009|Dose Expansion Phase|Progressive Disease|0
2357701|NCT01425008|4118357|FG010|Dose Expansion Phase|Progressive Disease|10
2357702|NCT01425008|4118358|FG011|Dose Expansion Phase|Progressive Disease|4
2357703|NCT01425008|4118359|FG012|Dose Expansion Phase|Progressive Disease|12
2357704|NCT01425008|4118360|FG013|Dose Expansion Phase|Progressive Disease|1
2357705|NCT01425008|4118361|FG014|Dose Expansion Phase|Progressive Disease|5
2357706|NCT01425008|4118362|FG015|Dose Expansion Phase|Progressive Disease|8
2357707|NCT01425008|4118363|FG016|Dose Expansion Phase|Progressive Disease|9
2357708|NCT01425008|4118364|FG017|Dose Expansion Phase|Progressive Disease|2
2357709|NCT01425008|4118365|FG018|Dose Expansion Phase|Progressive Disease|10
2357710|NCT01425008|4118347|FG000|Dose Expansion Phase|Withdrawal by Subject|0
2357711|NCT01425008|4118348|FG001|Dose Expansion Phase|Withdrawal by Subject|0
2357712|NCT01425008|4118349|FG002|Dose Expansion Phase|Withdrawal by Subject|0
2357713|NCT01425008|4118350|FG003|Dose Expansion Phase|Withdrawal by Subject|0
2357714|NCT01425008|4118351|FG004|Dose Expansion Phase|Withdrawal by Subject|0
2357715|NCT01425008|4118352|FG005|Dose Expansion Phase|Withdrawal by Subject|0
2357716|NCT01425008|4118353|FG006|Dose Expansion Phase|Withdrawal by Subject|0
2357717|NCT01425008|4118354|FG007|Dose Expansion Phase|Withdrawal by Subject|0
2357718|NCT01425008|4118355|FG008|Dose Expansion Phase|Withdrawal by Subject|0
2357719|NCT01425008|4118356|FG009|Dose Expansion Phase|Withdrawal by Subject|0
2357720|NCT01425008|4118357|FG010|Dose Expansion Phase|Withdrawal by Subject|1
2357721|NCT01425008|4118358|FG011|Dose Expansion Phase|Withdrawal by Subject|0
2357722|NCT01425008|4118359|FG012|Dose Expansion Phase|Withdrawal by Subject|0
2357723|NCT01425008|4118360|FG013|Dose Expansion Phase|Withdrawal by Subject|0
2357724|NCT01425008|4118361|FG014|Dose Expansion Phase|Withdrawal by Subject|0
2357725|NCT01425008|4118362|FG015|Dose Expansion Phase|Withdrawal by Subject|1
2357726|NCT01425008|4118363|FG016|Dose Expansion Phase|Withdrawal by Subject|1
2357727|NCT01425008|4118364|FG017|Dose Expansion Phase|Withdrawal by Subject|0
2357728|NCT01425008|4118365|FG018|Dose Expansion Phase|Withdrawal by Subject|0
2357729|NCT01425008|4118347|FG000|Dose Expansion Phase|Other|0
2357730|NCT01425008|4118348|FG001|Dose Expansion Phase|Other|0
2357731|NCT01425008|4118349|FG002|Dose Expansion Phase|Other|0
2357732|NCT01425008|4118350|FG003|Dose Expansion Phase|Other|0
2357733|NCT01425008|4118351|FG004|Dose Expansion Phase|Other|0
2357734|NCT01425008|4118352|FG005|Dose Expansion Phase|Other|0
2357735|NCT01425008|4118353|FG006|Dose Expansion Phase|Other|0
2357736|NCT01425008|4118354|FG007|Dose Expansion Phase|Other|0
2357737|NCT01425008|4118355|FG008|Dose Expansion Phase|Other|0
2357738|NCT01425008|4118356|FG009|Dose Expansion Phase|Other|0
2357739|NCT01425008|4118357|FG010|Dose Expansion Phase|Other|0
2357740|NCT01425008|4118358|FG011|Dose Expansion Phase|Other|0
2357741|NCT01425008|4118359|FG012|Dose Expansion Phase|Other|1
2357742|NCT01425008|4118360|FG013|Dose Expansion Phase|Other|0
2357743|NCT01425008|4118361|FG014|Dose Expansion Phase|Other|0
2357744|NCT01425008|4118362|FG015|Dose Expansion Phase|Other|0
2357745|NCT01425008|4118363|FG016|Dose Expansion Phase|Other|2
2357746|NCT01425008|4118364|FG017|Dose Expansion Phase|Other|0
2357747|NCT01425008|4118365|FG018|Dose Expansion Phase|Other|4
2357748|NCT01425008|4118347|FG000|Dose Expansion Phase|Symptomatic Deterioration|0
2357749|NCT01425008|4118348|FG001|Dose Expansion Phase|Symptomatic Deterioration|0
2357750|NCT01425008|4118349|FG002|Dose Expansion Phase|Symptomatic Deterioration|0
2357751|NCT01425008|4118350|FG003|Dose Expansion Phase|Symptomatic Deterioration|0
2357752|NCT01425008|4118351|FG004|Dose Expansion Phase|Symptomatic Deterioration|0
2357753|NCT01425008|4118352|FG005|Dose Expansion Phase|Symptomatic Deterioration|0
2357754|NCT01425008|4118353|FG006|Dose Expansion Phase|Symptomatic Deterioration|0
2357755|NCT01425008|4118354|FG007|Dose Expansion Phase|Symptomatic Deterioration|0
2357756|NCT01425008|4118355|FG008|Dose Expansion Phase|Symptomatic Deterioration|0
2357757|NCT01425008|4118356|FG009|Dose Expansion Phase|Symptomatic Deterioration|0
2357758|NCT01425008|4118357|FG010|Dose Expansion Phase|Symptomatic Deterioration|2
2357759|NCT01425008|4118358|FG011|Dose Expansion Phase|Symptomatic Deterioration|1
2357760|NCT01425008|4118359|FG012|Dose Expansion Phase|Symptomatic Deterioration|0
2357761|NCT01425008|4118360|FG013|Dose Expansion Phase|Symptomatic Deterioration|0
2357762|NCT01425008|4118361|FG014|Dose Expansion Phase|Symptomatic Deterioration|0
2357763|NCT01425008|4118362|FG015|Dose Expansion Phase|Symptomatic Deterioration|1
2357764|NCT01425008|4118363|FG016|Dose Expansion Phase|Symptomatic Deterioration|2
2357765|NCT01425008|4118364|FG017|Dose Expansion Phase|Symptomatic Deterioration|0
2357766|NCT01425008|4118365|FG018|Dose Expansion Phase|Symptomatic Deterioration|1
2357767|NCT01425008|4118347|FG000|Dose Expansion Phase|Adverse Event|0
2357768|NCT01425008|4118348|FG001|Dose Expansion Phase|Adverse Event|0
2357769|NCT01425008|4118349|FG002|Dose Expansion Phase|Adverse Event|0
2357770|NCT01425008|4118350|FG003|Dose Expansion Phase|Adverse Event|0
2357771|NCT01425008|4118351|FG004|Dose Expansion Phase|Adverse Event|0
2357772|NCT01425008|4118352|FG005|Dose Expansion Phase|Adverse Event|0
2357773|NCT01425008|4118353|FG006|Dose Expansion Phase|Adverse Event|0
2357774|NCT01425008|4118354|FG007|Dose Expansion Phase|Adverse Event|0
2357775|NCT01425008|4118355|FG008|Dose Expansion Phase|Adverse Event|0
2357776|NCT01425008|4118356|FG009|Dose Expansion Phase|Adverse Event|0
2357777|NCT01425008|4118357|FG010|Dose Expansion Phase|Adverse Event|2
2357778|NCT01425008|4118358|FG011|Dose Expansion Phase|Adverse Event|3
2357779|NCT01425008|4118359|FG012|Dose Expansion Phase|Adverse Event|3
2357780|NCT01425008|4118360|FG013|Dose Expansion Phase|Adverse Event|0
2357781|NCT01425008|4118361|FG014|Dose Expansion Phase|Adverse Event|1
2357782|NCT01425008|4118362|FG015|Dose Expansion Phase|Adverse Event|1
2357783|NCT01425008|4118363|FG016|Dose Expansion Phase|Adverse Event|5
2357784|NCT01425008|4118364|FG017|Dose Expansion Phase|Adverse Event|0
2357785|NCT01425008|4118365|FG018|Dose Expansion Phase|Adverse Event|3
2357786|NCT01425008|4118347|FG000|Dose Expansion Phase|Lost to Follow-up|0
2357787|NCT01425008|4118348|FG001|Dose Expansion Phase|Lost to Follow-up|0
2357788|NCT01425008|4118349|FG002|Dose Expansion Phase|Lost to Follow-up|0
2357789|NCT01425008|4118350|FG003|Dose Expansion Phase|Lost to Follow-up|0
2357790|NCT01425008|4118351|FG004|Dose Expansion Phase|Lost to Follow-up|0
2357791|NCT01425008|4118352|FG005|Dose Expansion Phase|Lost to Follow-up|0
2357792|NCT01425008|4118353|FG006|Dose Expansion Phase|Lost to Follow-up|0
2357793|NCT01425008|4118354|FG007|Dose Expansion Phase|Lost to Follow-up|0
2357794|NCT01425008|4118355|FG008|Dose Expansion Phase|Lost to Follow-up|0
2357795|NCT01425008|4118356|FG009|Dose Expansion Phase|Lost to Follow-up|0
2357796|NCT01425008|4118357|FG010|Dose Expansion Phase|Lost to Follow-up|0
2357797|NCT01425008|4118358|FG011|Dose Expansion Phase|Lost to Follow-up|0
2357798|NCT01425008|4118359|FG012|Dose Expansion Phase|Lost to Follow-up|0
2357799|NCT01425008|4118360|FG013|Dose Expansion Phase|Lost to Follow-up|0
2357800|NCT01425008|4118361|FG014|Dose Expansion Phase|Lost to Follow-up|0
2357801|NCT01425008|4118362|FG015|Dose Expansion Phase|Lost to Follow-up|0
2357802|NCT01425008|4118363|FG016|Dose Expansion Phase|Lost to Follow-up|1
2357803|NCT01425008|4118364|FG017|Dose Expansion Phase|Lost to Follow-up|0
2357804|NCT01425008|4118365|FG018|Dose Expansion Phase|Lost to Follow-up|0
2357805|NCT01425008|4118347|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357806|NCT01425008|4118348|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357807|NCT01425008|4118349|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357808|NCT01425008|4118350|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357809|NCT01425008|4118351|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2020342|NCT00306293|3588094|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
2020343|NCT00306293|3588095|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
2020344|NCT00306293|3588094|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
2020345|NCT00306293|3588095|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
2020346|NCT00306293|3588094|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1
2020347|NCT00306293|3588095|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0
2357810|NCT01425008|4118352|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357811|NCT01425008|4118353|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357812|NCT01425008|4118354|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357813|NCT01425008|4118355|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357814|NCT01425008|4118356|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357815|NCT01425008|4118357|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357816|NCT01425008|4118358|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357817|NCT01425008|4118359|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357818|NCT01425008|4118360|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357819|NCT01425008|4118361|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357820|NCT01425008|4118362|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357821|NCT01425008|4118363|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357822|NCT01425008|4118364|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
2357823|NCT01425008|4118365|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1
2357824|NCT01470326|4118418|FG000|Overall Study|Protocol Violation|32
2357825|NCT01470326|4118418|FG000|Overall Study|No Drug Administration Information|2
2357826|NCT01470326|4118418|FG000|Overall Study|No Visit After 1st Day of Treatment|119
2357827|NCT01480180|4118424|FG000|Main Phase|Withdrawal criteria|12
2357828|NCT01480180|4118425|FG001|Main Phase|Withdrawal criteria|1
2357829|NCT01480180|4118426|FG002|Main Phase|Withdrawal criteria|0
2357830|NCT01480180|4118427|FG003|Main Phase|Withdrawal criteria|0
2357831|NCT01480180|4118428|FG004|Main Phase|Withdrawal criteria|0
2357832|NCT01480180|4118429|FG005|Main Phase|Withdrawal criteria|0
2357833|NCT01480180|4118424|FG000|Main Phase|Lack of Efficacy|1
2357834|NCT01480180|4118425|FG001|Main Phase|Lack of Efficacy|0
2357835|NCT01480180|4118426|FG002|Main Phase|Lack of Efficacy|0
2357836|NCT01480180|4118427|FG003|Main Phase|Lack of Efficacy|0
2357837|NCT01480180|4118428|FG004|Main Phase|Lack of Efficacy|0
2357838|NCT01480180|4118429|FG005|Main Phase|Lack of Efficacy|0
2357839|NCT01480180|4118424|FG000|Main Phase|Non-compliance|3
2357840|NCT01480180|4118425|FG001|Main Phase|Non-compliance|0
2357841|NCT01480180|4118426|FG002|Main Phase|Non-compliance|0
2357842|NCT01480180|4118427|FG003|Main Phase|Non-compliance|0
2357843|NCT01480180|4118428|FG004|Main Phase|Non-compliance|0
2357844|NCT01480180|4118429|FG005|Main Phase|Non-compliance|0
2357845|NCT01480180|4118424|FG000|Main Phase|Unclassified|3
2357846|NCT01480180|4118425|FG001|Main Phase|Unclassified|0
2357847|NCT01480180|4118426|FG002|Main Phase|Unclassified|0
2357848|NCT01480180|4118427|FG003|Main Phase|Unclassified|0
2357849|NCT01480180|4118428|FG004|Main Phase|Unclassified|0
2357850|NCT01480180|4118429|FG005|Main Phase|Unclassified|0
2357851|NCT01480180|4118424|FG000|Extension Phase, Part 1|Withdrawal criteria|0
2357852|NCT01480180|4118425|FG001|Extension Phase, Part 1|Withdrawal criteria|0
2357853|NCT01480180|4118426|FG002|Extension Phase, Part 1|Withdrawal criteria|5
2357854|NCT01480180|4118427|FG003|Extension Phase, Part 1|Withdrawal criteria|0
2357855|NCT01480180|4118428|FG004|Extension Phase, Part 1|Withdrawal criteria|0
2357856|NCT01480180|4118429|FG005|Extension Phase, Part 1|Withdrawal criteria|0
2357857|NCT01480180|4118424|FG000|Extension Phase, Part 1|Unclassified|0
2357858|NCT01480180|4118425|FG001|Extension Phase, Part 1|Unclassified|0
2357859|NCT01480180|4118426|FG002|Extension Phase, Part 1|Unclassified|1
2357860|NCT01480180|4118427|FG003|Extension Phase, Part 1|Unclassified|0
2357861|NCT01480180|4118428|FG004|Extension Phase, Part 1|Unclassified|0
2357862|NCT01480180|4118429|FG005|Extension Phase, Part 1|Unclassified|0
2357863|NCT01480180|4118424|FG000|Extension Phase, Part 1|Adverse Event|0
2357864|NCT01480180|4118425|FG001|Extension Phase, Part 1|Adverse Event|0
2357865|NCT01480180|4118426|FG002|Extension Phase, Part 1|Adverse Event|4
2357866|NCT01480180|4118427|FG003|Extension Phase, Part 1|Adverse Event|1
2357867|NCT01480180|4118428|FG004|Extension Phase, Part 1|Adverse Event|0
2357868|NCT01480180|4118429|FG005|Extension Phase, Part 1|Adverse Event|0
2357869|NCT01480180|4118424|FG000|Extension Phase, Part 1|Change of treatment|0
2357870|NCT01480180|4118425|FG001|Extension Phase, Part 1|Change of treatment|0
2357871|NCT01480180|4118426|FG002|Extension Phase, Part 1|Change of treatment|0
2357872|NCT01480180|4118427|FG003|Extension Phase, Part 1|Change of treatment|9
2357873|NCT01480180|4118428|FG004|Extension Phase, Part 1|Change of treatment|0
2357874|NCT01480180|4118429|FG005|Extension Phase, Part 1|Change of treatment|0
2357875|NCT01480180|4118424|FG000|Extension Phase, Part 2|Withdrawal criteria|0
2357876|NCT01480180|4118425|FG001|Extension Phase, Part 2|Withdrawal criteria|0
2357877|NCT01480180|4118426|FG002|Extension Phase, Part 2|Withdrawal criteria|10
2357878|NCT01480180|4118427|FG003|Extension Phase, Part 2|Withdrawal criteria|6
2357879|NCT01480180|4118428|FG004|Extension Phase, Part 2|Withdrawal criteria|1
2357880|NCT01480180|4118429|FG005|Extension Phase, Part 2|Withdrawal criteria|0
2357881|NCT01480180|4118424|FG000|Extension Phase, Part 2|Lack of Efficacy|0
2357882|NCT01480180|4118425|FG001|Extension Phase, Part 2|Lack of Efficacy|0
2357883|NCT01480180|4118426|FG002|Extension Phase, Part 2|Lack of Efficacy|4
2357884|NCT01480180|4118427|FG003|Extension Phase, Part 2|Lack of Efficacy|0
2102125|NCT00837486|3693850|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2
2357885|NCT01480180|4118428|FG004|Extension Phase, Part 2|Lack of Efficacy|0
2357886|NCT01480180|4118429|FG005|Extension Phase, Part 2|Lack of Efficacy|0
2357887|NCT01480180|4118424|FG000|Extension Phase, Part 2|Unclassified|0
2357888|NCT01480180|4118425|FG001|Extension Phase, Part 2|Unclassified|0
2357889|NCT01480180|4118426|FG002|Extension Phase, Part 2|Unclassified|3
2357890|NCT01480180|4118427|FG003|Extension Phase, Part 2|Unclassified|1
2357891|NCT01480180|4118428|FG004|Extension Phase, Part 2|Unclassified|1
2357892|NCT01480180|4118429|FG005|Extension Phase, Part 2|Unclassified|0
2357893|NCT01545050|4118465|FG000|Overall Study|Lack of Efficacy|0
2357894|NCT01545050|4118466|FG001|Overall Study|Lack of Efficacy|0
2357895|NCT01545050|4118467|FG002|Overall Study|Lack of Efficacy|0
2357896|NCT01545050|4118468|FG003|Overall Study|Lack of Efficacy|3
2357897|NCT01545050|4118469|FG004|Overall Study|Lack of Efficacy|2
2357898|NCT01545050|4118465|FG000|Overall Study|Adverse Event|1
2357899|NCT01545050|4118466|FG001|Overall Study|Adverse Event|1
2357900|NCT01545050|4118467|FG002|Overall Study|Adverse Event|2
2357901|NCT01545050|4118468|FG003|Overall Study|Adverse Event|2
2357902|NCT01545050|4118469|FG004|Overall Study|Adverse Event|0
2357903|NCT01545050|4118465|FG000|Overall Study|Discontinued study treatment|1
2357904|NCT01545050|4118466|FG001|Overall Study|Discontinued study treatment|0
2357905|NCT01545050|4118467|FG002|Overall Study|Discontinued study treatment|0
2357906|NCT01545050|4118468|FG003|Overall Study|Discontinued study treatment|0
2357907|NCT01545050|4118469|FG004|Overall Study|Discontinued study treatment|0
2357908|NCT01545050|4118465|FG000|Overall Study|Withdrawal by Subject|1
2357909|NCT01545050|4118466|FG001|Overall Study|Withdrawal by Subject|0
2357910|NCT01545050|4118467|FG002|Overall Study|Withdrawal by Subject|0
2357911|NCT01545050|4118468|FG003|Overall Study|Withdrawal by Subject|2
2357912|NCT01545050|4118469|FG004|Overall Study|Withdrawal by Subject|1
2357913|NCT01545050|4118465|FG000|Overall Study|Participant no longer meets study criteria|0
2357914|NCT01545050|4118466|FG001|Overall Study|Participant no longer meets study criteria|2
2357915|NCT01545050|4118467|FG002|Overall Study|Participant no longer meets study criteria|0
2357916|NCT01545050|4118468|FG003|Overall Study|Participant no longer meets study criteria|0
2357917|NCT01545050|4118469|FG004|Overall Study|Participant no longer meets study criteria|1
2357918|NCT01545050|4118465|FG000|Overall Study|Administrative reason by sponsor|4
2357919|NCT01545050|4118466|FG001|Overall Study|Administrative reason by sponsor|2
2357920|NCT01545050|4118467|FG002|Overall Study|Administrative reason by sponsor|3
2357921|NCT01545050|4118468|FG003|Overall Study|Administrative reason by sponsor|5
2357922|NCT01545050|4118469|FG004|Overall Study|Administrative reason by sponsor|5
2357923|NCT01555021|4118496|FG000|Overall Study|Lost to Follow-up|1
2357924|NCT01555021|4118497|FG001|Overall Study|Lost to Follow-up|2
2357925|NCT01561430|4118513|FG000|Overall Study|Adverse Event|0
2357926|NCT01561430|4118514|FG001|Overall Study|Adverse Event|0
2357927|NCT01561430|4118515|FG002|Overall Study|Adverse Event|3
2357928|NCT01561430|4118516|FG003|Overall Study|Adverse Event|1
2357929|NCT01561430|4118513|FG000|Overall Study|Withdrawal by Subject|0
2357930|NCT01561430|4118514|FG001|Overall Study|Withdrawal by Subject|0
2357931|NCT01561430|4118515|FG002|Overall Study|Withdrawal by Subject|1
2357932|NCT01561430|4118516|FG003|Overall Study|Withdrawal by Subject|0
2309136|NCT02716298|4012700|FG000|First Intervention (1 Month)|Lens discomfort|1
2309137|NCT02716298|4012701|FG001|First Intervention (1 Month)|Lens discomfort|1
2309138|NCT02716584|4012727|FG000|Overall Study|Lost to Follow-up|8
2309139|NCT02716584|4012728|FG001|Overall Study|Lost to Follow-up|5
2309140|NCT02716779|4012759|FG000|Monotherapy|Adverse Event|0
2309141|NCT02716779|4012760|FG001|Monotherapy|Adverse Event|1
2309142|NCT02716779|4012761|FG002|Monotherapy|Adverse Event|1
2309143|NCT02716779|4012759|FG000|Combination Therapy|Adverse Event|0
2309144|NCT02716779|4012760|FG001|Combination Therapy|Adverse Event|2
2309145|NCT02716779|4012761|FG002|Combination Therapy|Adverse Event|1
2309146|NCT02716805|4012775|FG000|Overall Study|Progressive disease|2
2309147|NCT02716805|4012776|FG001|Overall Study|Progressive disease|0
2309148|NCT02716805|4012777|FG002|Overall Study|Progressive disease|0
2309149|NCT02716805|4012778|FG003|Overall Study|Progressive disease|0
2309150|NCT02716896|4012815|FG000|Overall Study|Physician Decision|0
2309151|NCT02716896|4012816|FG001|Overall Study|Physician Decision|1
2309152|NCT02716987|4012828|FG000|Overall Study|Ligand synthesis failure|0
2309153|NCT02716987|4012829|FG001|Overall Study|Ligand synthesis failure|0
2357933|NCT01561430|4118513|FG000|Overall Study|Physician Decision|0
2357934|NCT01561430|4118514|FG001|Overall Study|Physician Decision|1
2357935|NCT01561430|4118515|FG002|Overall Study|Physician Decision|0
2357936|NCT01561430|4118516|FG003|Overall Study|Physician Decision|0
2357937|NCT01561430|4118513|FG000|Overall Study|Sponsor Decision|1
2357938|NCT01561430|4118514|FG001|Overall Study|Sponsor Decision|14
2357939|NCT01561430|4118515|FG002|Overall Study|Sponsor Decision|13
2357940|NCT01561430|4118516|FG003|Overall Study|Sponsor Decision|12
2212563|NCT01671345|3853752|FG001|Overall Study|Lost to Follow-up|6
2212564|NCT01671345|3853751|FG000|Overall Study|visit with non-participating physician|3
2212565|NCT01671345|3853752|FG001|Overall Study|visit with non-participating physician|3
2212566|NCT01671488|3853770|FG000|Overall Study|Withdrawal by Subject|1
2309154|NCT02716987|4012830|FG002|Overall Study|Ligand synthesis failure|1
2309155|NCT02716987|4012831|FG003|Overall Study|Ligand synthesis failure|0
2309156|NCT02716987|4012832|FG004|Overall Study|Ligand synthesis failure|0
2309157|NCT02716987|4012833|FG005|Overall Study|Ligand synthesis failure|0
2309158|NCT02716987|4012828|FG000|Overall Study|Withdrawal by Subject|0
2309159|NCT02716987|4012829|FG001|Overall Study|Withdrawal by Subject|0
2309160|NCT02716987|4012830|FG002|Overall Study|Withdrawal by Subject|0
2309161|NCT02716987|4012831|FG003|Overall Study|Withdrawal by Subject|0
2309162|NCT02716987|4012832|FG004|Overall Study|Withdrawal by Subject|1
2309163|NCT02716987|4012833|FG005|Overall Study|Withdrawal by Subject|1
2309164|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Adverse Event|19
2309165|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Adverse Event|7
2309166|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
2309167|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
2309168|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Adverse Event|0
2309169|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2
2309170|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1
2309171|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2309172|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2309173|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2309174|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
2309175|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
2309176|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
2309177|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
2309178|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
2309179|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3
2309180|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1
2309181|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
2309182|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
2309183|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0
2309184|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
2309185|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
2309186|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2309187|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2321809|NCT02963506|4036383|FG012|Dose-Blind Period|Lost to Follow-up|0
2357941|NCT01595009|4118536|FG000|Core|Patients completed per protocol|85
2357942|NCT01595009|4118537|FG001|Core|Patients completed per protocol|44
2357943|NCT01595009|4118538|FG002|Core|Patients completed per protocol|0
2357944|NCT01595009|4118539|FG003|Core|Patients completed per protocol|0
2357945|NCT01595009|4118536|FG000|Core|Adverse Event|19
2357946|NCT01595009|4118537|FG001|Core|Adverse Event|23
2357947|NCT01595009|4118538|FG002|Core|Adverse Event|0
2357948|NCT01595009|4118539|FG003|Core|Adverse Event|0
2357949|NCT01595009|4118536|FG000|Core|Disease progression|14
2357950|NCT01595009|4118537|FG001|Core|Disease progression|26
2020348|NCT00306384|3588106|FG000|Overall Study|Adverse Event|103
2020349|NCT00306384|3588107|FG001|Overall Study|Adverse Event|87
2020350|NCT00306384|3588108|FG002|Overall Study|Adverse Event|40
2020351|NCT00306384|3588106|FG000|Overall Study|Major protocol deviation|43
2020352|NCT00306384|3588107|FG001|Overall Study|Major protocol deviation|51
2020353|NCT00306384|3588108|FG002|Overall Study|Major protocol deviation|18
2020354|NCT00306384|3588106|FG000|Overall Study|Lost to Follow-up|57
2020355|NCT00306384|3588107|FG001|Overall Study|Lost to Follow-up|41
2020356|NCT00306384|3588108|FG002|Overall Study|Lost to Follow-up|35
2020357|NCT00306384|3588106|FG000|Overall Study|Voluntary withdrawal|199
2020358|NCT00306384|3588107|FG001|Overall Study|Voluntary withdrawal|187
2020359|NCT00306384|3588108|FG002|Overall Study|Voluntary withdrawal|91
2020360|NCT00306384|3588106|FG000|Overall Study|Study termination|1
2020361|NCT00306384|3588107|FG001|Overall Study|Study termination|0
2020362|NCT00306384|3588108|FG002|Overall Study|Study termination|1
2020363|NCT00306384|3588106|FG000|Overall Study|Pregnancy|3
2020364|NCT00306384|3588107|FG001|Overall Study|Pregnancy|1
2020365|NCT00306384|3588108|FG002|Overall Study|Pregnancy|1
2020366|NCT00306384|3588106|FG000|Overall Study|Lack of Efficacy|26
2020367|NCT00306384|3588107|FG001|Overall Study|Lack of Efficacy|40
2020368|NCT00306384|3588108|FG002|Overall Study|Lack of Efficacy|38
2020369|NCT00306384|3588106|FG000|Overall Study|Investigator discretion|28
2020370|NCT00306384|3588107|FG001|Overall Study|Investigator discretion|31
2020371|NCT00306384|3588108|FG002|Overall Study|Investigator discretion|21
2020372|NCT00306384|3588106|FG000|Overall Study|Other|80
2020373|NCT00306384|3588107|FG001|Overall Study|Other|70
2020374|NCT00306384|3588108|FG002|Overall Study|Other|32
2020375|NCT00306384|3588106|FG000|Overall Study|Site closure|2
2020376|NCT00306384|3588107|FG001|Overall Study|Site closure|0
2020377|NCT00306384|3588108|FG002|Overall Study|Site closure|0
2020378|NCT00306527|3588125|FG000|Overall Study|Lost to Follow-up|3
2020379|NCT00306527|3588126|FG001|Overall Study|Lost to Follow-up|4
2020380|NCT00306527|3588127|FG002|Overall Study|Lost to Follow-up|3
2020381|NCT00306527|3588128|FG003|Overall Study|Lost to Follow-up|0
2020382|NCT00306527|3588125|FG000|Overall Study|Withdrawal by Subject|2
2020383|NCT00306527|3588126|FG001|Overall Study|Withdrawal by Subject|3
2020384|NCT00306527|3588127|FG002|Overall Study|Withdrawal by Subject|0
2020385|NCT00306527|3588128|FG003|Overall Study|Withdrawal by Subject|3
2020386|NCT00306527|3588125|FG000|Overall Study|Adverse Event|0
2020387|NCT00306527|3588126|FG001|Overall Study|Adverse Event|0
2020388|NCT00306527|3588127|FG002|Overall Study|Adverse Event|1
2020389|NCT00306527|3588128|FG003|Overall Study|Adverse Event|1
2020390|NCT00306527|3588125|FG000|Overall Study|Death|1
2020391|NCT00306527|3588126|FG001|Overall Study|Death|0
2020392|NCT00306527|3588127|FG002|Overall Study|Death|1
2020393|NCT00306527|3588128|FG003|Overall Study|Death|2
2020394|NCT00306592|3588142|FG000|Overall Study|Adverse Event|8
2020395|NCT00306592|3588143|FG001|Overall Study|Adverse Event|15
2020396|NCT00306592|3588142|FG000|Overall Study|Lost to Follow-up|1
2020397|NCT00306592|3588143|FG001|Overall Study|Lost to Follow-up|0
2020398|NCT00306592|3588142|FG000|Overall Study|Noncompliance|0
2020399|NCT00306592|3588143|FG001|Overall Study|Noncompliance|2
2020400|NCT00306592|3588142|FG000|Overall Study|Persistent Antibodies|6
2020401|NCT00306592|3588143|FG001|Overall Study|Persistent Antibodies|3
2020402|NCT00306592|3588142|FG000|Overall Study|Voluntary|10
2020403|NCT00306592|3588143|FG001|Overall Study|Voluntary|6
2020404|NCT00306592|3588142|FG000|Overall Study|Other|5
2020405|NCT00306592|3588143|FG001|Overall Study|Other|10
2020406|NCT00306592|3588142|FG000|Overall Study|Other|1
2020407|NCT00306592|3588143|FG001|Overall Study|Other|2
2020408|NCT00306592|3588142|FG000|Overall Study|48-week Treatment Period Ongoing|0
2020409|NCT00306592|3588143|FG001|Overall Study|48-week Treatment Period Ongoing|20
2020410|NCT00306670|3588149|FG000|Overall Study|patients recruited; Genentech, the st|0
2020411|NCT00306670|3588150|FG001|Overall Study|patients recruited; Genentech, the st|2
2020412|NCT00306787|3588158|FG000|Overall Study|Discontinued without taking study drug|208
2357951|NCT01595009|4118538|FG002|Core|Disease progression|0
2357952|NCT01595009|4118539|FG003|Core|Disease progression|0
2357953|NCT01595009|4118536|FG000|Core|Withdrawal by Subject|4
2357954|NCT01595009|4118537|FG001|Core|Withdrawal by Subject|17
2357955|NCT01595009|4118538|FG002|Core|Withdrawal by Subject|0
2357956|NCT01595009|4118539|FG003|Core|Withdrawal by Subject|0
2357957|NCT01595009|4118536|FG000|Core|Death|3
2357958|NCT01595009|4118537|FG001|Core|Death|6
2357959|NCT01595009|4118538|FG002|Core|Death|0
2357960|NCT01595009|4118539|FG003|Core|Death|0
2357961|NCT01595009|4118536|FG000|Core|Lost to Follow-up|1
2357962|NCT01595009|4118537|FG001|Core|Lost to Follow-up|2
2357963|NCT01595009|4118538|FG002|Core|Lost to Follow-up|0
2357964|NCT01595009|4118539|FG003|Core|Lost to Follow-up|0
2357965|NCT01595009|4118536|FG000|Core|Protocol deviation|0
2357966|NCT01595009|4118537|FG001|Core|Protocol deviation|1
2357967|NCT01595009|4118538|FG002|Core|Protocol deviation|0
2357968|NCT01595009|4118539|FG003|Core|Protocol deviation|0
2357969|NCT01595009|4118536|FG000|Core|Administrative problems|0
2357970|NCT01595009|4118537|FG001|Core|Administrative problems|1
2357971|NCT01595009|4118538|FG002|Core|Administrative problems|0
2357972|NCT01595009|4118539|FG003|Core|Administrative problems|0
2357973|NCT01595009|4118536|FG000|Extension|Administrative problems|0
2357974|NCT01595009|4118537|FG001|Extension|Administrative problems|0
2357975|NCT01595009|4118538|FG002|Extension|Administrative problems|0
2357976|NCT01595009|4118539|FG003|Extension|Administrative problems|1
2357977|NCT01595009|4118536|FG000|Extension|Patients completed per protocol|0
2357978|NCT01595009|4118537|FG001|Extension|Patients completed per protocol|0
2357979|NCT01595009|4118538|FG002|Extension|Patients completed per protocol|0
2357980|NCT01595009|4118539|FG003|Extension|Patients completed per protocol|2
2357981|NCT01595009|4118536|FG000|Extension|Disease progression|0
2357982|NCT01595009|4118537|FG001|Extension|Disease progression|0
2357983|NCT01595009|4118538|FG002|Extension|Disease progression|4
2357984|NCT01595009|4118539|FG003|Extension|Disease progression|7
2357985|NCT01595009|4118536|FG000|Extension|Adverse Event|0
2357986|NCT01595009|4118537|FG001|Extension|Adverse Event|0
2357987|NCT01595009|4118538|FG002|Extension|Adverse Event|0
2357988|NCT01595009|4118539|FG003|Extension|Adverse Event|1
2212567|NCT01671748|3853785|FG000|4 Week run-in Phase|Withdrawal by Subject|1
2212568|NCT01671748|3853786|FG001|4 Week run-in Phase|Withdrawal by Subject|0
2357989|NCT01620944|4118556|FG000|Overall Study|Early termination of Study|2
2357990|NCT01620944|4118557|FG001|Overall Study|Early termination of Study|1
2357991|NCT01627561|4118565|FG000|Overall Study|Lost to Follow-up|1
2357992|NCT01627561|4118566|FG001|Overall Study|Lost to Follow-up|0
2357993|NCT01627561|4118565|FG000|Overall Study|Withdrawal by Subject|0
2357994|NCT01627561|4118566|FG001|Overall Study|Withdrawal by Subject|1
2357995|NCT01627561|4118565|FG000|Overall Study|Migrated/moved from study area|0
2357996|NCT01627561|4118566|FG001|Overall Study|Migrated/moved from study area|2
2357997|NCT01652534|4118591|FG000|Overall Study|Lack of Efficacy|1
2357998|NCT01652534|4118592|FG001|Overall Study|Lack of Efficacy|0
2357999|NCT01701583|4118600|FG000|Overall Study|Withdrawal by Subject|2
2358000|NCT01701583|4118601|FG001|Overall Study|Withdrawal by Subject|0
2358001|NCT01714817|4118610|FG000|Year 1 Period|Lack of Efficacy|11
2358002|NCT01714817|4118611|FG001|Year 1 Period|Lack of Efficacy|9
2358003|NCT01714817|4118610|FG000|Year 1 Period|Adverse Event|20
2358004|NCT01714817|4118611|FG001|Year 1 Period|Adverse Event|17
2358005|NCT01714817|4118610|FG000|Year 1 Period|Withdrawal by Subject|6
2358006|NCT01714817|4118611|FG001|Year 1 Period|Withdrawal by Subject|7
2358007|NCT01714817|4118610|FG000|Year 1 Period|Death|1
2358008|NCT01714817|4118611|FG001|Year 1 Period|Death|1
2358009|NCT01714817|4118610|FG000|Year 1 Period|Lost to Follow-up|0
2358010|NCT01714817|4118611|FG001|Year 1 Period|Lost to Follow-up|2
2358011|NCT01714817|4118610|FG000|Year 1 Period|Poor / non-compliance|0
2358012|NCT01714817|4118611|FG001|Year 1 Period|Poor / non-compliance|1
2358013|NCT01714817|4118610|FG000|Year 1 Period|Pregnancy|2
2358014|NCT01714817|4118611|FG001|Year 1 Period|Pregnancy|0
2358015|NCT01714817|4118610|FG000|Year 1 Period|Participant no longer meets criteria|6
2358016|NCT01714817|4118611|FG001|Year 1 Period|Participant no longer meets criteria|2
2358017|NCT01714817|4118610|FG000|Year 1 Period|Not treated- received ACE inhibition|1
2358018|NCT01714817|4118611|FG001|Year 1 Period|Not treated- received ACE inhibition|0
2358019|NCT01714817|4118610|FG000|Year 1 Period|Change in Concomitant Medication|0
2358020|NCT01714817|4118611|FG001|Year 1 Period|Change in Concomitant Medication|1
2358021|NCT01714817|4118610|FG000|Year 1 Period|Need of use of Prohibited Medications|1
2358022|NCT01714817|4118611|FG001|Year 1 Period|Need of use of Prohibited Medications|0
2358023|NCT01714817|4118610|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0
2358024|NCT01714817|4118611|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1
2358025|NCT01714817|4118610|FG000|Year 1 Period|Hypersensitivity to the medication|0
2358026|NCT01714817|4118611|FG001|Year 1 Period|Hypersensitivity to the medication|1
2358027|NCT01714817|4118610|FG000|Year 2 Period|Lack of Efficacy|4
2358028|NCT01714817|4118611|FG001|Year 2 Period|Lack of Efficacy|12
2358029|NCT01714817|4118610|FG000|Year 2 Period|Adverse Event|7
2358030|NCT01714817|4118611|FG001|Year 2 Period|Adverse Event|6
2358031|NCT01714817|4118610|FG000|Year 2 Period|Participant request to stop treatment|4
2358032|NCT01714817|4118611|FG001|Year 2 Period|Participant request to stop treatment|4
2358033|NCT01714817|4118610|FG000|Year 2 Period|Administrative reason by Sponsor|4
2358034|NCT01714817|4118611|FG001|Year 2 Period|Administrative reason by Sponsor|3
2358035|NCT01714817|4118610|FG000|Year 2 Period|Participant withdrew consent|1
2358036|NCT01714817|4118611|FG001|Year 2 Period|Participant withdrew consent|5
2358037|NCT01714817|4118610|FG000|Year 2 Period|Participant no longer meets criteria|1
2358038|NCT01714817|4118611|FG001|Year 2 Period|Participant no longer meets criteria|4
2358039|NCT01714817|4118610|FG000|Year 2 Period|Lost to Follow-up|2
2358040|NCT01714817|4118611|FG001|Year 2 Period|Lost to Follow-up|0
2358041|NCT01714817|4118610|FG000|Year 2 Period|Participant went to US stopped treatment|0
2358042|NCT01714817|4118611|FG001|Year 2 Period|Participant went to US stopped treatment|1
2358043|NCT01714817|4118610|FG000|Year 2 Period|Pregnancy|1
2358044|NCT01714817|4118611|FG001|Year 2 Period|Pregnancy|1
2358045|NCT01714817|4118610|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2
2358046|NCT01714817|4118611|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1
2358047|NCT01714817|4118610|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0
2358048|NCT01714817|4118611|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1
2358049|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27
2358050|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21
2358051|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Disease progression|1
2358052|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Disease progression|4
2358053|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Not effective|0
2358054|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Not effective|1
2358055|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
2358056|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
2358057|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1
2358058|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1
2358059|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1
2358060|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0
2358061|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0
2358062|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1
2358063|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Pregnancy|1
2358064|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Pregnancy|0
2358065|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1
2358066|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0
2358067|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1
2358068|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0
2358069|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33
2358070|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38
2358071|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0
2358072|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1
2358073|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0
2358074|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1
2358075|NCT01714817|4118610|FG000|Long-Term Extension (LTE) Period|Study was terminated|0
2358076|NCT01714817|4118611|FG001|Long-Term Extension (LTE) Period|Study was terminated|1
2358077|NCT01755689|4118624|FG000|Overall Study|Withdrawal by Subject|1
2358078|NCT01755689|4118625|FG001|Overall Study|Withdrawal by Subject|3
2358079|NCT01755689|4118626|FG002|Overall Study|Withdrawal by Subject|2
2358080|NCT01755689|4118627|FG003|Overall Study|Withdrawal by Subject|1
2358081|NCT01755689|4118628|FG004|Overall Study|Withdrawal by Subject|1
2358082|NCT01755689|4118624|FG000|Overall Study|Migrated/moved from study area|0
2358083|NCT01755689|4118625|FG001|Overall Study|Migrated/moved from study area|1
2358084|NCT01755689|4118626|FG002|Overall Study|Migrated/moved from study area|1
2358085|NCT01755689|4118627|FG003|Overall Study|Migrated/moved from study area|1
2358086|NCT01755689|4118628|FG004|Overall Study|Migrated/moved from study area|1
2358087|NCT01755689|4118624|FG000|Overall Study|Lost to Follow-up|1
2358088|NCT01755689|4118625|FG001|Overall Study|Lost to Follow-up|0
2358089|NCT01755689|4118626|FG002|Overall Study|Lost to Follow-up|1
2358090|NCT01755689|4118627|FG003|Overall Study|Lost to Follow-up|0
2358091|NCT01755689|4118628|FG004|Overall Study|Lost to Follow-up|2
2358092|NCT01755689|4118624|FG000|Overall Study|Pregnancy|1
2358093|NCT01755689|4118625|FG001|Overall Study|Pregnancy|1
2358094|NCT01755689|4118626|FG002|Overall Study|Pregnancy|2
2358095|NCT01755689|4118627|FG003|Overall Study|Pregnancy|4
2358096|NCT01755689|4118628|FG004|Overall Study|Pregnancy|2
2358097|NCT01762761|4118650|FG000|Overall Study|Adverse Event|15
2358098|NCT01762761|4118651|FG001|Overall Study|Adverse Event|17
2358099|NCT01762761|4118650|FG000|Overall Study|Lack of Efficacy|9
2358100|NCT01762761|4118651|FG001|Overall Study|Lack of Efficacy|25
2358101|NCT01762761|4118650|FG000|Overall Study|Protocol Violation|1
2358102|NCT01762761|4118651|FG001|Overall Study|Protocol Violation|1
2358103|NCT01762761|4118650|FG000|Overall Study|Study closed/terminated|0
2358104|NCT01762761|4118651|FG001|Overall Study|Study closed/terminated|2
2358105|NCT01762761|4118650|FG000|Overall Study|Lost to Follow-up|3
2358106|NCT01762761|4118651|FG001|Overall Study|Lost to Follow-up|6
2358107|NCT01762761|4118650|FG000|Overall Study|Physician Decision|4
2358108|NCT01762761|4118651|FG001|Overall Study|Physician Decision|6
2358109|NCT01762761|4118650|FG000|Overall Study|Withdrawal by Subject|7
2358110|NCT01762761|4118651|FG001|Overall Study|Withdrawal by Subject|8
2358115|NCT01774370|4118675|FG000|Overall Study|Never taken the PRADAXA during the study|4
2358116|NCT01774370|4118675|FG000|Overall Study|Administered prior to the contract date|4
2358117|NCT01774370|4118675|FG000|Overall Study|Subjects of contraindications|34
2358118|NCT01774370|4118675|FG000|Overall Study|Violated inclusion/exclusion criteria|53
2358119|NCT01774370|4118675|FG000|Overall Study|Follow-up failure|34
2358120|NCT01777295|4118681|FG000|Overall Study|Withdrawal by Subject|2
2358121|NCT01777295|4118682|FG001|Overall Study|Withdrawal by Subject|2
2358122|NCT01777295|4118681|FG000|Overall Study|Pregnancy|0
2358123|NCT01777295|4118682|FG001|Overall Study|Pregnancy|1
2358124|NCT01777295|4118681|FG000|Overall Study|Personal problem|1
2358125|NCT01777295|4118682|FG001|Overall Study|Personal problem|0
2358126|NCT01777295|4118681|FG000|Overall Study|Investigator call for AEs check|1
2358127|NCT01777295|4118682|FG001|Overall Study|Investigator call for AEs check|0
2358128|NCT01787552|4118702|FG000|Overall Study|Withdrawal by Subject|2
2358129|NCT01787552|4118703|FG001|Overall Study|Withdrawal by Subject|0
2358130|NCT01787552|4118704|FG002|Overall Study|Withdrawal by Subject|0
2358131|NCT01787552|4118705|FG003|Overall Study|Withdrawal by Subject|4
2358132|NCT01787552|4118702|FG000|Overall Study|Physician Decision|2
2358133|NCT01787552|4118703|FG001|Overall Study|Physician Decision|2
2358134|NCT01787552|4118704|FG002|Overall Study|Physician Decision|1
2358135|NCT01787552|4118705|FG003|Overall Study|Physician Decision|2
2358136|NCT01787552|4118702|FG000|Overall Study|Death|0
2358137|NCT01787552|4118703|FG001|Overall Study|Death|0
2358138|NCT01787552|4118704|FG002|Overall Study|Death|0
2358139|NCT01787552|4118705|FG003|Overall Study|Death|1
2358140|NCT01787552|4118702|FG000|Overall Study|Adverse Event|2
2358141|NCT01787552|4118703|FG001|Overall Study|Adverse Event|5
2358142|NCT01787552|4118704|FG002|Overall Study|Adverse Event|2
2358143|NCT01787552|4118705|FG003|Overall Study|Adverse Event|16
2358144|NCT01787552|4118702|FG000|Overall Study|Study terminated by Sponsor|0
2212569|NCT01671748|3853785|FG000|4 Week run-in Phase|Adverse Event|1
2212570|NCT01671748|3853786|FG001|4 Week run-in Phase|Adverse Event|0
2212571|NCT01671748|3853785|FG000|4 Week run-in Phase|Not eligible|9
2212572|NCT01671748|3853786|FG001|4 Week run-in Phase|Not eligible|0
2212573|NCT01672294|3853810|FG000|Overall Study|Withdrawal by Subject|4
2212574|NCT01672294|3853811|FG001|Overall Study|Withdrawal by Subject|4
2212575|NCT01672294|3853812|FG002|Overall Study|Withdrawal by Subject|4
2212576|NCT01672294|3853813|FG003|Overall Study|Withdrawal by Subject|4
2358145|NCT01787552|4118703|FG001|Overall Study|Study terminated by Sponsor|0
2358146|NCT01787552|4118704|FG002|Overall Study|Study terminated by Sponsor|1
2358147|NCT01787552|4118705|FG003|Overall Study|Study terminated by Sponsor|3
2358148|NCT01787552|4118702|FG000|Overall Study|Progressive Disease|2
2358149|NCT01787552|4118703|FG001|Overall Study|Progressive Disease|2
2358150|NCT01787552|4118704|FG002|Overall Study|Progressive Disease|1
2358151|NCT01787552|4118705|FG003|Overall Study|Progressive Disease|1
2358152|NCT01807117|4118720|FG000|Overall Study|Physician Decision|2
2358153|NCT01807117|4118720|FG000|Overall Study|Disease diagnosis not a study disease|1
2212577|NCT01672294|3853810|FG000|Overall Study|Excluded by study|1
2212578|NCT01672294|3853811|FG001|Overall Study|Excluded by study|1
2358164|NCT01814826|4118748|FG000|Overall Study|Other|3
2358165|NCT01814826|4118749|FG001|Overall Study|Other|5
2358111|NCT01763788|4118662|FG000|Overall Study|Lost to Follow-up|0
2358112|NCT01763788|4118663|FG001|Overall Study|Lost to Follow-up|0
2358113|NCT01763788|4118664|FG002|Overall Study|Lost to Follow-up|1
2358114|NCT01763788|4118665|FG003|Overall Study|Lost to Follow-up|0
2358154|NCT01808261|4118728|FG000|Overall Study|Physician Decision|0
2358155|NCT01808261|4118729|FG001|Overall Study|Physician Decision|2
2358156|NCT01808261|4118728|FG000|Overall Study|Study Closed/Terminated|25
2358157|NCT01808261|4118729|FG001|Overall Study|Study Closed/Terminated|23
2358158|NCT01808261|4118728|FG000|Overall Study|Adverse event, non-fatal|2
2358159|NCT01808261|4118729|FG001|Overall Study|Adverse event, non-fatal|0
2358160|NCT01808261|4118728|FG000|Overall Study|Consent withdrawn by subject|6
2358161|NCT01808261|4118729|FG001|Overall Study|Consent withdrawn by subject|7
2358162|NCT01808261|4118728|FG000|Overall Study|Lost to Follow-up|3
2358163|NCT01808261|4118729|FG001|Overall Study|Lost to Follow-up|1
2358166|NCT01814826|4118750|FG002|Overall Study|Other|0
2358167|NCT01814826|4118748|FG000|Overall Study|Death|29
2358168|NCT01814826|4118749|FG001|Overall Study|Death|24
2358169|NCT01814826|4118750|FG002|Overall Study|Death|3
2020413|NCT00306787|3588159|FG001|Overall Study|Discontinued without taking study drug|215
2020414|NCT00306787|3588158|FG000|Overall Study|Adverse Event|1
2020415|NCT00306787|3588159|FG001|Overall Study|Adverse Event|1
2020416|NCT00306787|3588158|FG000|Overall Study|Lack of Efficacy|1
2020417|NCT00306787|3588159|FG001|Overall Study|Lack of Efficacy|0
2020418|NCT00306787|3588158|FG000|Overall Study|Protocol Violation|8
2020419|NCT00306787|3588159|FG001|Overall Study|Protocol Violation|10
2020420|NCT00306787|3588158|FG000|Overall Study|Withdrawal by Subject|2
2020421|NCT00306787|3588159|FG001|Overall Study|Withdrawal by Subject|9
2020422|NCT00306787|3588158|FG000|Overall Study|Lost to Follow-up|9
2020423|NCT00306787|3588159|FG001|Overall Study|Lost to Follow-up|6
2020424|NCT00306787|3588158|FG000|Overall Study|Administrative problems|4
2020425|NCT00306787|3588159|FG001|Overall Study|Administrative problems|0
2020426|NCT00306787|3588158|FG000|Overall Study|Abnormal laboratory value(s)|1
2108210|NCT00878722|3702055|FG006|Overall Study|Withdrawal by Subject|0
2358170|NCT01829711|4118759|FG000|Overall Study|Lost to Follow-up|2
2358171|NCT01829711|4118759|FG000|Overall Study|Withdrawal by Subject|3
2358172|NCT01829711|4118759|FG000|Overall Study|Death|4
2358173|NCT01829711|4118759|FG000|Overall Study|Started new therapies|17
2358174|NCT01829711|4118759|FG000|Overall Study|Adverse Event|3
2358175|NCT01829711|4118759|FG000|Overall Study|Due to progression of disease|13
2358176|NCT01829711|4118759|FG000|Overall Study|Due to lack of response|1
2358177|NCT01846273|4118766|FG000|Overall Study|Adverse Event|9
2358178|NCT01846273|4118767|FG001|Overall Study|Adverse Event|7
2358179|NCT01846273|4118768|FG002|Overall Study|Adverse Event|0
2358180|NCT01846273|4118766|FG000|Overall Study|Subject withdrew consent|5
2358181|NCT01846273|4118767|FG001|Overall Study|Subject withdrew consent|8
2358182|NCT01846273|4118768|FG002|Overall Study|Subject withdrew consent|0
2358183|NCT01846273|4118766|FG000|Overall Study|Lost to Follow-up|2
2358184|NCT01846273|4118767|FG001|Overall Study|Lost to Follow-up|1
2358185|NCT01846273|4118768|FG002|Overall Study|Lost to Follow-up|0
2358186|NCT01846273|4118766|FG000|Overall Study|Administrative problems|1
2358187|NCT01846273|4118767|FG001|Overall Study|Administrative problems|0
2358188|NCT01846273|4118768|FG002|Overall Study|Administrative problems|0
2358189|NCT01846273|4118766|FG000|Overall Study|Death|2
2358190|NCT01846273|4118767|FG001|Overall Study|Death|1
2358191|NCT01846273|4118768|FG002|Overall Study|Death|0
2358192|NCT01846273|4118766|FG000|Overall Study|Disease Progression|0
2358193|NCT01846273|4118767|FG001|Overall Study|Disease Progression|4
2358194|NCT01846273|4118768|FG002|Overall Study|Disease Progression|0
2358195|NCT01846273|4118766|FG000|Overall Study|Protocol Deviation|2
2358196|NCT01846273|4118767|FG001|Overall Study|Protocol Deviation|3
2358197|NCT01846273|4118768|FG002|Overall Study|Protocol Deviation|0
2358198|NCT01846273|4118766|FG000|Overall Study|Physician Decision|1
2358199|NCT01846273|4118767|FG001|Overall Study|Physician Decision|2
2358200|NCT01846273|4118768|FG002|Overall Study|Physician Decision|0
2358201|NCT01875185|4118778|FG000|Overall Study|study was terminated|52
2358202|NCT01875185|4118779|FG001|Overall Study|study was terminated|48
2358203|NCT01891643|4118805|FG000|Overall Study|Adverse event unrelated to study drug|2
2358204|NCT01891643|4118806|FG001|Overall Study|Adverse event unrelated to study drug|5
2358205|NCT01891643|4118805|FG000|Overall Study|Disease Progression|4
2358206|NCT01891643|4118806|FG001|Overall Study|Disease Progression|3
2358207|NCT01891643|4118805|FG000|Overall Study|Study Drug Toxicity|3
2358208|NCT01891643|4118806|FG001|Overall Study|Study Drug Toxicity|0
2358209|NCT01891643|4118805|FG000|Overall Study|Maximum Clinical Benefit|0
2358210|NCT01891643|4118806|FG001|Overall Study|Maximum Clinical Benefit|1
2358211|NCT01891643|4118805|FG000|Overall Study|Poor/Non-compliance|0
2358212|NCT01891643|4118806|FG001|Overall Study|Poor/Non-compliance|1
2358213|NCT01891643|4118805|FG000|Overall Study|Participant request to discontinue|1
2358214|NCT01891643|4118806|FG001|Overall Study|Participant request to discontinue|0
2212579|NCT01672294|3853812|FG002|Overall Study|Excluded by study|0
2212580|NCT01672294|3853813|FG003|Overall Study|Excluded by study|0
2212581|NCT01672294|3853810|FG000|Overall Study|Lost to Follow-up|1
2212582|NCT01672294|3853811|FG001|Overall Study|Lost to Follow-up|16
2212583|NCT01672294|3853812|FG002|Overall Study|Lost to Follow-up|7
2212584|NCT01672294|3853813|FG003|Overall Study|Lost to Follow-up|9
2212585|NCT01672710|3853834|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
2212586|NCT01672710|3853835|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
2212587|NCT01672710|3853834|FG000|3 Month Follow up|Lost to Follow-up|2
2212588|NCT01672710|3853835|FG001|3 Month Follow up|Lost to Follow-up|3
2212589|NCT01672710|3853834|FG000|3 Month Follow up|follow up due after termination date|4
2217523|NCT01708954|3860854|FG000|Step 1|Disease progression|26
2212590|NCT01672710|3853835|FG001|3 Month Follow up|follow up due after termination date|1
2212591|NCT01672723|3853841|FG000|First Intervention|Adverse Event|3
2212592|NCT01672723|3853842|FG001|First Intervention|Adverse Event|0
2212593|NCT01672736|3853848|FG000|Overall Study|Available drug expired on 31 May 16|3
2212594|NCT01672788|3853852|FG000|Washout Period 2 (7 Days)|Adverse Event|0
2212595|NCT01672788|3853853|FG001|Washout Period 2 (7 Days)|Adverse Event|0
2212596|NCT01672788|3853854|FG002|Washout Period 2 (7 Days)|Adverse Event|0
2212597|NCT01672788|3853855|FG003|Washout Period 2 (7 Days)|Adverse Event|1
2212598|NCT01672801|3853867|FG000|Overall Study|Screen Failure|0
2212599|NCT01672801|3853868|FG001|Overall Study|Screen Failure|1
2212600|NCT01672853|3853883|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0
2212601|NCT01672853|3853884|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4
2358215|NCT01900691|4118812|FG000|Overall Study|Death|7
2358216|NCT01900691|4118812|FG000|Overall Study|Lost to Follow-up|4
2358217|NCT01900691|4118812|FG000|Overall Study|Study Device Not Placed|3
2358218|NCT01900691|4118812|FG000|Overall Study|Non Study stent inside study stent|1
2358219|NCT01900691|4118812|FG000|Overall Study|Six month Follow up completed, stent not removed|2
2358220|NCT01900691|4118812|FG000|Overall Study|Miscellaneous|2
2358221|NCT01901432|4118822|FG000|Overall Study|Adverse Event|0
2358222|NCT01901432|4118823|FG001|Overall Study|Adverse Event|1
2358223|NCT01901432|4118824|FG002|Overall Study|Adverse Event|1
2358224|NCT01901432|4118825|FG003|Overall Study|Adverse Event|0
2358225|NCT01901432|4118826|FG004|Overall Study|Adverse Event|1
2358226|NCT01901432|4118822|FG000|Overall Study|Withdrawal by Subject|0
2358227|NCT01901432|4118823|FG001|Overall Study|Withdrawal by Subject|0
2358228|NCT01901432|4118824|FG002|Overall Study|Withdrawal by Subject|1
2358229|NCT01901432|4118825|FG003|Overall Study|Withdrawal by Subject|0
2358230|NCT01901432|4118826|FG004|Overall Study|Withdrawal by Subject|5
2358231|NCT01901432|4118822|FG000|Overall Study|Physician Decision|0
2358232|NCT01901432|4118823|FG001|Overall Study|Physician Decision|0
2358233|NCT01901432|4118824|FG002|Overall Study|Physician Decision|0
2358234|NCT01901432|4118825|FG003|Overall Study|Physician Decision|0
2358235|NCT01901432|4118826|FG004|Overall Study|Physician Decision|2
2358236|NCT01901432|4118822|FG000|Overall Study|Patient decision to stop study drug|0
2358237|NCT01901432|4118823|FG001|Overall Study|Patient decision to stop study drug|0
2358238|NCT01901432|4118824|FG002|Overall Study|Patient decision to stop study drug|0
2358239|NCT01901432|4118825|FG003|Overall Study|Patient decision to stop study drug|0
2358240|NCT01901432|4118826|FG004|Overall Study|Patient decision to stop study drug|1
2358241|NCT01904279|4118847|FG000|Overall Study|Lack of Efficacy|2
2358242|NCT01904279|4118848|FG001|Overall Study|Lack of Efficacy|3
2358243|NCT01904279|4118847|FG000|Overall Study|Withdrawal by Subject|1
2358244|NCT01904279|4118848|FG001|Overall Study|Withdrawal by Subject|0
2358245|NCT01915498|4118873|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
2358246|NCT01915498|4118874|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
2358247|NCT01915498|4118875|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
2358248|NCT01915498|4118876|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
2358249|NCT01915498|4118877|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
2358250|NCT01915498|4118878|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
2358251|NCT01915498|4118879|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
2358252|NCT01915498|4118880|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
2358253|NCT01915498|4118881|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
2358254|NCT01915498|4118882|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
2358255|NCT01915498|4118883|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
2358256|NCT01915498|4118884|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
2358257|NCT01915498|4118885|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
2358258|NCT01915498|4118886|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
2358259|NCT01915498|4118887|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
2358260|NCT01915498|4118888|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
2358261|NCT01915498|4118889|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
2358262|NCT01915498|4118890|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
2358263|NCT01915498|4118891|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
2358264|NCT01915498|4118873|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
2358265|NCT01915498|4118874|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
2358266|NCT01915498|4118875|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
2358267|NCT01915498|4118876|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
2358268|NCT01915498|4118877|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
2358269|NCT01915498|4118878|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
2358270|NCT01915498|4118879|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
2358271|NCT01915498|4118880|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
2358272|NCT01915498|4118881|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
2358273|NCT01915498|4118882|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
2358274|NCT01915498|4118883|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
2358275|NCT01915498|4118884|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
2108211|NCT00878722|3702056|FG007|Overall Study|Withdrawal by Subject|2
2358276|NCT01915498|4118885|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
2358277|NCT01915498|4118886|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
2358278|NCT01915498|4118887|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
2358279|NCT01915498|4118888|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
2358280|NCT01915498|4118889|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
2358281|NCT01915498|4118890|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16
2358282|NCT01915498|4118891|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
2358283|NCT01915498|4118873|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1
2358284|NCT01915498|4118874|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
2358285|NCT01915498|4118875|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
2358286|NCT01915498|4118876|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
2358287|NCT01915498|4118877|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
2358288|NCT01915498|4118878|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
2358289|NCT01915498|4118879|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
2358290|NCT01915498|4118880|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15
2358291|NCT01915498|4118881|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
2358292|NCT01915498|4118882|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7
2358293|NCT01915498|4118883|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
2358294|NCT01915498|4118884|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
2358295|NCT01915498|4118885|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
2358296|NCT01915498|4118886|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24
2358297|NCT01915498|4118887|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14
2358298|NCT01915498|4118888|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9
2358299|NCT01915498|4118889|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8
2358300|NCT01915498|4118890|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41
2358301|NCT01915498|4118891|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0
2358302|NCT01915498|4118873|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358303|NCT01915498|4118874|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358304|NCT01915498|4118875|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358305|NCT01915498|4118876|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358306|NCT01915498|4118877|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358307|NCT01915498|4118878|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358308|NCT01915498|4118879|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358309|NCT01915498|4118880|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358310|NCT01915498|4118881|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358311|NCT01915498|4118882|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358312|NCT01915498|4118883|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1
2358313|NCT01915498|4118884|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358314|NCT01915498|4118885|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358315|NCT01915498|4118886|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358316|NCT01915498|4118887|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358317|NCT01915498|4118888|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358318|NCT01915498|4118889|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358319|NCT01915498|4118890|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358320|NCT01915498|4118891|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
2358321|NCT01915498|4118873|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2
2358322|NCT01915498|4118874|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1
2358323|NCT01915498|4118875|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1
2358324|NCT01915498|4118876|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1
2358325|NCT01915498|4118877|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1
2358326|NCT01915498|4118878|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2
2358327|NCT01915498|4118879|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0
2358328|NCT01915498|4118880|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1
2358329|NCT01915498|4118881|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0
2358330|NCT01915498|4118882|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0
2358331|NCT01915498|4118883|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2
2358332|NCT01915498|4118884|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0
2358333|NCT01915498|4118885|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0
2358334|NCT01915498|4118886|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4
2309188|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2309189|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9
2309190|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4
2309191|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0
2309192|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0
2309193|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0
2309194|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
2309195|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
2309196|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
2309197|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
2358335|NCT01915498|4118887|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1
2020427|NCT00306787|3588159|FG001|Overall Study|Abnormal laboratory value(s)|0
2020428|NCT00306852|3588167|FG000|Overall Study|Death|14
2020429|NCT00306852|3588168|FG001|Overall Study|Death|14
2020430|NCT00306852|3588167|FG000|Overall Study|Lost to Follow-up|15
2020431|NCT00306852|3588168|FG001|Overall Study|Lost to Follow-up|24
2020432|NCT00306891|3588178|FG000|Part A|Withdrawal by Subject|1
2020433|NCT00306891|3588179|FG001|Part A|Withdrawal by Subject|1
2020434|NCT00306891|3588180|FG002|Part A|Withdrawal by Subject|0
2020435|NCT00306891|3588181|FG003|Part A|Withdrawal by Subject|0
2020436|NCT00306891|3588178|FG000|Part A|Condition under investigation worsened|2
2020437|NCT00306891|3588179|FG001|Part A|Condition under investigation worsened|2
2020438|NCT00306891|3588180|FG002|Part A|Condition under investigation worsened|0
2020439|NCT00306891|3588181|FG003|Part A|Condition under investigation worsened|0
2020440|NCT00306891|3588178|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0
2020441|NCT00306891|3588179|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1
2020442|NCT00306891|3588180|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0
2020443|NCT00306891|3588181|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0
2020444|NCT00306891|3588178|FG000|Part A|Partial bowel obstruction|1
2020445|NCT00306891|3588179|FG001|Part A|Partial bowel obstruction|0
2020446|NCT00306891|3588180|FG002|Part A|Partial bowel obstruction|0
2020447|NCT00306891|3588181|FG003|Part A|Partial bowel obstruction|0
2020448|NCT00306891|3588178|FG000|Part A|Reaccumul. of ascites following drainage|0
2020449|NCT00306891|3588179|FG001|Part A|Reaccumul. of ascites following drainage|1
2020450|NCT00306891|3588180|FG002|Part A|Reaccumul. of ascites following drainage|0
2020451|NCT00306891|3588181|FG003|Part A|Reaccumul. of ascites following drainage|0
2020452|NCT00306891|3588178|FG000|Part A|Suspicion of second malignancy|0
2020453|NCT00306891|3588179|FG001|Part A|Suspicion of second malignancy|1
2020454|NCT00306891|3588180|FG002|Part A|Suspicion of second malignancy|0
2020455|NCT00306891|3588181|FG003|Part A|Suspicion of second malignancy|0
2020456|NCT00306891|3588178|FG000|Part A|QTC interval outwith elig. criteria|1
2020457|NCT00306891|3588179|FG001|Part A|QTC interval outwith elig. criteria|0
2020458|NCT00306891|3588180|FG002|Part A|QTC interval outwith elig. criteria|0
2020459|NCT00306891|3588181|FG003|Part A|QTC interval outwith elig. criteria|0
2020460|NCT00306891|3588178|FG000|Part B|Death|0
2020461|NCT00306891|3588179|FG001|Part B|Death|0
2020462|NCT00306891|3588180|FG002|Part B|Death|1
2020463|NCT00306891|3588181|FG003|Part B|Death|2
2020464|NCT00306891|3588178|FG000|Part B|Adverse Event|0
2020465|NCT00306891|3588179|FG001|Part B|Adverse Event|0
2020466|NCT00306891|3588180|FG002|Part B|Adverse Event|5
2020467|NCT00306891|3588181|FG003|Part B|Adverse Event|5
2358336|NCT01915498|4118888|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4
2358337|NCT01915498|4118889|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3
2358338|NCT01915498|4118890|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16
2358339|NCT01915498|4118891|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0
2358340|NCT01915498|4118873|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358341|NCT01915498|4118874|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358342|NCT01915498|4118875|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358343|NCT01915498|4118876|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358344|NCT01915498|4118877|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
2358345|NCT01915498|4118878|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358346|NCT01915498|4118879|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358347|NCT01915498|4118880|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358348|NCT01915498|4118881|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358349|NCT01915498|4118882|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
2358350|NCT01915498|4118883|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358351|NCT01915498|4118884|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358352|NCT01915498|4118885|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358353|NCT01915498|4118886|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358354|NCT01915498|4118887|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358355|NCT01915498|4118888|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358356|NCT01915498|4118889|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358357|NCT01915498|4118890|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358358|NCT01915498|4118891|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
2358359|NCT01915498|4118873|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
2358360|NCT01915498|4118874|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
2358361|NCT01915498|4118875|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2
2358362|NCT01915498|4118876|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
2358363|NCT01915498|4118877|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
2358364|NCT01915498|4118878|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
2358365|NCT01915498|4118879|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
2358366|NCT01915498|4118880|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
2358367|NCT01915498|4118881|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
2358368|NCT01915498|4118882|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
2358369|NCT01915498|4118883|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
2358370|NCT01915498|4118884|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
2358371|NCT01915498|4118885|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
2358372|NCT01915498|4118886|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
2358373|NCT01915498|4118887|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
2358374|NCT01915498|4118888|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
2358375|NCT01915498|4118889|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4
2358376|NCT01915498|4118890|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8
2358377|NCT01915498|4118891|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
2358378|NCT01915498|4118873|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
2358379|NCT01915498|4118874|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
2358380|NCT01915498|4118875|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
2358381|NCT01915498|4118876|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
2358382|NCT01915498|4118877|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
2358383|NCT01915498|4118878|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
2358384|NCT01915498|4118879|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
2358385|NCT01915498|4118880|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
2020468|NCT00306891|3588178|FG000|Part B|Withdrawal by Subject|0
2020469|NCT00306891|3588179|FG001|Part B|Withdrawal by Subject|0
2020470|NCT00306891|3588180|FG002|Part B|Withdrawal by Subject|3
2020471|NCT00306891|3588181|FG003|Part B|Withdrawal by Subject|1
2020472|NCT00306891|3588178|FG000|Part B|Condition under investigation worsened|0
2020473|NCT00306891|3588179|FG001|Part B|Condition under investigation worsened|0
2020474|NCT00306891|3588180|FG002|Part B|Condition under investigation worsened|2
2020475|NCT00306891|3588181|FG003|Part B|Condition under investigation worsened|8
2020476|NCT00306891|3588178|FG000|Part B|Development of study specific disc crit.|0
2020477|NCT00306891|3588179|FG001|Part B|Development of study specific disc crit.|0
2020478|NCT00306891|3588180|FG002|Part B|Development of study specific disc crit.|0
2020479|NCT00306891|3588181|FG003|Part B|Development of study specific disc crit.|1
2020480|NCT00306995|3588208|FG000|Study Part I|Withdrawal by Subject|0
2020481|NCT00306995|3588209|FG001|Study Part I|Withdrawal by Subject|0
2020482|NCT00306995|3588210|FG002|Study Part I|Withdrawal by Subject|0
2020483|NCT00306995|3588211|FG003|Study Part I|Withdrawal by Subject|0
2020484|NCT00306995|3588212|FG004|Study Part I|Withdrawal by Subject|0
2020485|NCT00306995|3588213|FG005|Study Part I|Withdrawal by Subject|0
2020486|NCT00306995|3588214|FG006|Study Part I|Withdrawal by Subject|1
2020487|NCT00306995|3588208|FG000|Study Part II for Subset 2|Serious Adverse Event|0
2020488|NCT00306995|3588209|FG001|Study Part II for Subset 2|Serious Adverse Event|1
2020489|NCT00306995|3588210|FG002|Study Part II for Subset 2|Serious Adverse Event|0
2020490|NCT00306995|3588211|FG003|Study Part II for Subset 2|Serious Adverse Event|0
2020491|NCT00306995|3588212|FG004|Study Part II for Subset 2|Serious Adverse Event|0
2020492|NCT00306995|3588213|FG005|Study Part II for Subset 2|Serious Adverse Event|0
2020493|NCT00306995|3588214|FG006|Study Part II for Subset 2|Serious Adverse Event|0
2020494|NCT00307034|3588261|FG000|Overall Study|Adverse Event|1
2020495|NCT00307034|3588262|FG001|Overall Study|Adverse Event|2
2020496|NCT00307034|3588261|FG000|Overall Study|Withdrawal by Subject|1
2020497|NCT00307034|3588262|FG001|Overall Study|Withdrawal by Subject|2
2020498|NCT00307034|3588261|FG000|Overall Study|Lost to Follow-up|0
2020499|NCT00307034|3588262|FG001|Overall Study|Lost to Follow-up|3
2020500|NCT00307047|3588270|FG000|Overall Study|Lost to Follow-up|35
2020501|NCT00307047|3588271|FG001|Overall Study|Lost to Follow-up|24
2020502|NCT00307047|3588270|FG000|Overall Study|Withdrawal by Subject|6
2020503|NCT00307047|3588271|FG001|Overall Study|Withdrawal by Subject|6
2020504|NCT00307047|3588270|FG000|Overall Study|Physician Decision|1
2020505|NCT00307047|3588271|FG001|Overall Study|Physician Decision|2
2020506|NCT00307047|3588270|FG000|Overall Study|Lost to follow-up for other reasons|0
2020507|NCT00307047|3588271|FG001|Overall Study|Lost to follow-up for other reasons|1
2020508|NCT00307047|3588270|FG000|Overall Study|All death, all MI, all Revascularization|27
2020509|NCT00307047|3588271|FG001|Overall Study|All death, all MI, all Revascularization|16
2020510|NCT00307086|3588277|FG000|Overall Study|ineligible|5
2020511|NCT00307125|3588283|FG000|Screening Phase|Adverse Event|1
2020512|NCT00307125|3588284|FG001|Screening Phase|Adverse Event|0
2020513|NCT00307125|3588285|FG002|Screening Phase|Adverse Event|0
2020514|NCT00307125|3588283|FG000|Screening Phase|Protocol Violation|27
2020515|NCT00307125|3588284|FG001|Screening Phase|Protocol Violation|0
2020516|NCT00307125|3588285|FG002|Screening Phase|Protocol Violation|0
2020517|NCT00307125|3588283|FG000|Screening Phase|Lost to Follow-up|87
2020518|NCT00307125|3588284|FG001|Screening Phase|Lost to Follow-up|0
2108212|NCT00878722|3702049|FG000|Overall Study|Relapse|0
2020519|NCT00307125|3588285|FG002|Screening Phase|Lost to Follow-up|0
2020520|NCT00307125|3588283|FG000|Screening Phase|Death|10
2020521|NCT00307125|3588284|FG001|Screening Phase|Death|0
2020522|NCT00307125|3588285|FG002|Screening Phase|Death|0
2020523|NCT00307125|3588283|FG000|Screening Phase|Withdrawal by Subject|77
2020524|NCT00307125|3588284|FG001|Screening Phase|Withdrawal by Subject|0
2020525|NCT00307125|3588285|FG002|Screening Phase|Withdrawal by Subject|0
2020526|NCT00307125|3588283|FG000|Screening Phase|Physician Decision|26
2020527|NCT00307125|3588284|FG001|Screening Phase|Physician Decision|0
2020528|NCT00307125|3588285|FG002|Screening Phase|Physician Decision|0
2020529|NCT00307125|3588283|FG000|Screening Phase|Sponsor Decision|4
2020530|NCT00307125|3588284|FG001|Screening Phase|Sponsor Decision|0
2020531|NCT00307125|3588285|FG002|Screening Phase|Sponsor Decision|0
2020532|NCT00307125|3588283|FG000|Screening Phase|Study Terminated|17
2020533|NCT00307125|3588284|FG001|Screening Phase|Study Terminated|0
2020534|NCT00307125|3588285|FG002|Screening Phase|Study Terminated|0
2020535|NCT00307125|3588283|FG000|Screening Phase|Graft Loss|3
2020536|NCT00307125|3588284|FG001|Screening Phase|Graft Loss|0
2020537|NCT00307125|3588285|FG002|Screening Phase|Graft Loss|0
2020538|NCT00307125|3588283|FG000|Screening Phase|Graft Failure|8
2020539|NCT00307125|3588284|FG001|Screening Phase|Graft Failure|0
2020540|NCT00307125|3588285|FG002|Screening Phase|Graft Failure|0
2020541|NCT00307125|3588283|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83
2020542|NCT00307125|3588284|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0
2020543|NCT00307125|3588285|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0
2020544|NCT00307125|3588283|FG000|Screening Phase|Scheduling issues/Non-compliance|55
2020545|NCT00307125|3588284|FG001|Screening Phase|Scheduling issues/Non-compliance|0
2020546|NCT00307125|3588285|FG002|Screening Phase|Scheduling issues/Non-compliance|0
2020547|NCT00307125|3588283|FG000|Screening Phase|Moved or transferred facilities|34
2020548|NCT00307125|3588284|FG001|Screening Phase|Moved or transferred facilities|0
2020549|NCT00307125|3588285|FG002|Screening Phase|Moved or transferred facilities|0
2020550|NCT00307125|3588283|FG000|Screening Phase|Received Pancreas Transplant|8
2020551|NCT00307125|3588284|FG001|Screening Phase|Received Pancreas Transplant|0
2020552|NCT00307125|3588285|FG002|Screening Phase|Received Pancreas Transplant|0
2020553|NCT00307125|3588283|FG000|Screening Phase|Ineligible for pilot|4
2020554|NCT00307125|3588284|FG001|Screening Phase|Ineligible for pilot|0
2020555|NCT00307125|3588285|FG002|Screening Phase|Ineligible for pilot|0
2020556|NCT00307125|3588283|FG000|Screening Phase|Try to get pregnant|1
2020557|NCT00307125|3588284|FG001|Screening Phase|Try to get pregnant|0
2020558|NCT00307125|3588285|FG002|Screening Phase|Try to get pregnant|0
2020559|NCT00307125|3588283|FG000|Screening Phase|Developed acute leukemia|1
2020560|NCT00307125|3588284|FG001|Screening Phase|Developed acute leukemia|0
2020561|NCT00307125|3588285|FG002|Screening Phase|Developed acute leukemia|0
2020562|NCT00307125|3588283|FG000|Screening Phase|Metastatic colon cancer|1
2020563|NCT00307125|3588284|FG001|Screening Phase|Metastatic colon cancer|0
2020564|NCT00307125|3588285|FG002|Screening Phase|Metastatic colon cancer|0
2020565|NCT00307125|3588283|FG000|Screening Phase|Malignancy|1
2020566|NCT00307125|3588284|FG001|Screening Phase|Malignancy|0
2020567|NCT00307125|3588285|FG002|Screening Phase|Malignancy|0
2020568|NCT00307125|3588283|FG000|Screening Phase|PAK|1
2020569|NCT00307125|3588284|FG001|Screening Phase|PAK|0
2020570|NCT00307125|3588285|FG002|Screening Phase|PAK|0
2020571|NCT00307125|3588283|FG000|Screening Phase|Ineligible|1
2020572|NCT00307125|3588284|FG001|Screening Phase|Ineligible|0
2020573|NCT00307125|3588285|FG002|Screening Phase|Ineligible|0
2020574|NCT00307125|3588283|FG000|Screening Phase|Screen Error|1
2020575|NCT00307125|3588284|FG001|Screening Phase|Screen Error|0
2020576|NCT00307125|3588285|FG002|Screening Phase|Screen Error|0
2020577|NCT00307125|3588283|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
2020578|NCT00307125|3588284|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
2020579|NCT00307125|3588285|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
2020580|NCT00307125|3588283|FG000|Screening Phase|AMR and treated with rituximab|1
2108213|NCT00878722|3702050|FG001|Overall Study|Relapse|0
2020581|NCT00307125|3588284|FG001|Screening Phase|AMR and treated with rituximab|0
2020582|NCT00307125|3588285|FG002|Screening Phase|AMR and treated with rituximab|0
2020583|NCT00307125|3588283|FG000|Screening Phase|Coronary artery bypass|1
2020584|NCT00307125|3588284|FG001|Screening Phase|Coronary artery bypass|0
2020585|NCT00307125|3588285|FG002|Screening Phase|Coronary artery bypass|0
2020586|NCT00307125|3588283|FG000|Pilot Phase|Lost to Follow-up|0
2020587|NCT00307125|3588284|FG001|Pilot Phase|Lost to Follow-up|1
2020588|NCT00307125|3588285|FG002|Pilot Phase|Lost to Follow-up|0
2020589|NCT00307125|3588283|FG000|Pilot Phase|Withdrawal by Subject|0
2020590|NCT00307125|3588284|FG001|Pilot Phase|Withdrawal by Subject|1
2020591|NCT00307125|3588285|FG002|Pilot Phase|Withdrawal by Subject|1
2020592|NCT00307151|3588299|FG000|Overall Study|Death|4
2020593|NCT00307151|3588300|FG001|Overall Study|Death|3
2020594|NCT00307151|3588301|FG002|Overall Study|Death|10
2020595|NCT00307151|3588302|FG003|Overall Study|Death|3
2020596|NCT00307151|3588299|FG000|Overall Study|Severe debilitation, unable to continue|1
2020597|NCT00307151|3588300|FG001|Overall Study|Severe debilitation, unable to continue|0
2020598|NCT00307151|3588301|FG002|Overall Study|Severe debilitation, unable to continue|0
2020599|NCT00307151|3588302|FG003|Overall Study|Severe debilitation, unable to continue|0
2020600|NCT00307151|3588299|FG000|Overall Study|Subject unable to get to clinic|1
2020601|NCT00307151|3588300|FG001|Overall Study|Subject unable to get to clinic|0
2020602|NCT00307151|3588301|FG002|Overall Study|Subject unable to get to clinic|6
2020603|NCT00307151|3588302|FG003|Overall Study|Subject unable to get to clinic|2
2020604|NCT00307151|3588299|FG000|Overall Study|Withdrew consent|0
2020605|NCT00307151|3588300|FG001|Overall Study|Withdrew consent|1
2020606|NCT00307151|3588301|FG002|Overall Study|Withdrew consent|1
2020607|NCT00307151|3588302|FG003|Overall Study|Withdrew consent|3
2020608|NCT00307151|3588299|FG000|Overall Study|Not willing to adhere to study reqs|2
2020609|NCT00307151|3588300|FG001|Overall Study|Not willing to adhere to study reqs|0
2020610|NCT00307151|3588301|FG002|Overall Study|Not willing to adhere to study reqs|2
2020611|NCT00307151|3588302|FG003|Overall Study|Not willing to adhere to study reqs|2
2020612|NCT00307151|3588299|FG000|Overall Study|Clinic unable to contact subject|3
2020613|NCT00307151|3588300|FG001|Overall Study|Clinic unable to contact subject|3
2020614|NCT00307151|3588301|FG002|Overall Study|Clinic unable to contact subject|1
2020615|NCT00307151|3588302|FG003|Overall Study|Clinic unable to contact subject|1
2020616|NCT00307164|3588314|FG000|Overall Study|Death|1
2020617|NCT00307164|3588315|FG001|Overall Study|Death|0
2020618|NCT00307164|3588314|FG000|Overall Study|Severe debilitation, unable to continue|1
2020619|NCT00307164|3588315|FG001|Overall Study|Severe debilitation, unable to continue|0
2020620|NCT00307164|3588314|FG000|Overall Study|Subject/parent not able to get to clinic|2
2020621|NCT00307164|3588315|FG001|Overall Study|Subject/parent not able to get to clinic|1
2020622|NCT00307164|3588314|FG000|Overall Study|Withdrawal by Subject|1
2020623|NCT00307164|3588315|FG001|Overall Study|Withdrawal by Subject|8
2020624|NCT00307164|3588314|FG000|Overall Study|Not compliant with requirements|4
2020625|NCT00307164|3588315|FG001|Overall Study|Not compliant with requirements|4
2020626|NCT00307164|3588314|FG000|Overall Study|Lost to Follow-up|6
2020627|NCT00307164|3588315|FG001|Overall Study|Lost to Follow-up|1
2020628|NCT00307294|3588321|FG000|Overall Study|Withdrawal by Subject|1
2020629|NCT00307333|3588328|FG000|Overall Study|Lost to Follow-up|11
2020630|NCT00307333|3588329|FG001|Overall Study|Lost to Follow-up|3
2020631|NCT00307437|3588338|FG000|Controlled Period|Adverse Event|7
2020632|NCT00307437|3588339|FG001|Controlled Period|Adverse Event|2
2020633|NCT00307437|3588340|FG002|Controlled Period|Adverse Event|5
2020634|NCT00307437|3588341|FG003|Controlled Period|Adverse Event|0
2020635|NCT00307437|3588342|FG004|Controlled Period|Adverse Event|0
2020636|NCT00307437|3588343|FG005|Controlled Period|Adverse Event|0
2020637|NCT00307437|3588344|FG006|Controlled Period|Adverse Event|0
2020638|NCT00307437|3588338|FG000|Controlled Period|Death|0
2020639|NCT00307437|3588339|FG001|Controlled Period|Death|0
2020640|NCT00307437|3588340|FG002|Controlled Period|Death|1
2020641|NCT00307437|3588341|FG003|Controlled Period|Death|0
2020642|NCT00307437|3588342|FG004|Controlled Period|Death|0
2020643|NCT00307437|3588343|FG005|Controlled Period|Death|0
2020644|NCT00307437|3588344|FG006|Controlled Period|Death|0
2020645|NCT00307437|3588338|FG000|Controlled Period|Lack of Efficacy|2
2020646|NCT00307437|3588339|FG001|Controlled Period|Lack of Efficacy|0
2020647|NCT00307437|3588340|FG002|Controlled Period|Lack of Efficacy|0
2020648|NCT00307437|3588341|FG003|Controlled Period|Lack of Efficacy|0
2020649|NCT00307437|3588342|FG004|Controlled Period|Lack of Efficacy|0
2020650|NCT00307437|3588343|FG005|Controlled Period|Lack of Efficacy|0
2020651|NCT00307437|3588344|FG006|Controlled Period|Lack of Efficacy|0
2020652|NCT00307437|3588338|FG000|Controlled Period|Lost to Follow-up|2
2020653|NCT00307437|3588339|FG001|Controlled Period|Lost to Follow-up|3
2020654|NCT00307437|3588340|FG002|Controlled Period|Lost to Follow-up|0
2020655|NCT00307437|3588341|FG003|Controlled Period|Lost to Follow-up|0
2020656|NCT00307437|3588342|FG004|Controlled Period|Lost to Follow-up|0
2020657|NCT00307437|3588343|FG005|Controlled Period|Lost to Follow-up|0
2020658|NCT00307437|3588344|FG006|Controlled Period|Lost to Follow-up|0
2020659|NCT00307437|3588338|FG000|Controlled Period|Other|5
2020660|NCT00307437|3588339|FG001|Controlled Period|Other|1
2020661|NCT00307437|3588340|FG002|Controlled Period|Other|3
2020662|NCT00307437|3588341|FG003|Controlled Period|Other|0
2020663|NCT00307437|3588342|FG004|Controlled Period|Other|0
2020664|NCT00307437|3588343|FG005|Controlled Period|Other|0
2020665|NCT00307437|3588344|FG006|Controlled Period|Other|0
2020666|NCT00307437|3588338|FG000|After Controlled Period|Adverse Event|0
2020667|NCT00307437|3588339|FG001|After Controlled Period|Adverse Event|0
2020668|NCT00307437|3588340|FG002|After Controlled Period|Adverse Event|0
2020669|NCT00307437|3588341|FG003|After Controlled Period|Adverse Event|18
2020670|NCT00307437|3588342|FG004|After Controlled Period|Adverse Event|16
2020671|NCT00307437|3588343|FG005|After Controlled Period|Adverse Event|31
2020672|NCT00307437|3588344|FG006|After Controlled Period|Adverse Event|40
2020673|NCT00307437|3588338|FG000|After Controlled Period|Death|0
2020674|NCT00307437|3588339|FG001|After Controlled Period|Death|0
2020675|NCT00307437|3588340|FG002|After Controlled Period|Death|0
2020676|NCT00307437|3588341|FG003|After Controlled Period|Death|3
2020677|NCT00307437|3588342|FG004|After Controlled Period|Death|1
2020678|NCT00307437|3588343|FG005|After Controlled Period|Death|1
2020679|NCT00307437|3588344|FG006|After Controlled Period|Death|3
2020680|NCT00307437|3588338|FG000|After Controlled Period|Lack of Efficacy|0
2020681|NCT00307437|3588339|FG001|After Controlled Period|Lack of Efficacy|0
2020682|NCT00307437|3588340|FG002|After Controlled Period|Lack of Efficacy|0
2020683|NCT00307437|3588341|FG003|After Controlled Period|Lack of Efficacy|15
2020684|NCT00307437|3588342|FG004|After Controlled Period|Lack of Efficacy|17
2020685|NCT00307437|3588343|FG005|After Controlled Period|Lack of Efficacy|37
2020686|NCT00307437|3588344|FG006|After Controlled Period|Lack of Efficacy|24
2020687|NCT00307437|3588338|FG000|After Controlled Period|Lost to Follow-up|0
2020688|NCT00307437|3588339|FG001|After Controlled Period|Lost to Follow-up|0
2020689|NCT00307437|3588340|FG002|After Controlled Period|Lost to Follow-up|0
2020690|NCT00307437|3588341|FG003|After Controlled Period|Lost to Follow-up|7
2020691|NCT00307437|3588342|FG004|After Controlled Period|Lost to Follow-up|12
2020692|NCT00307437|3588343|FG005|After Controlled Period|Lost to Follow-up|13
2020693|NCT00307437|3588344|FG006|After Controlled Period|Lost to Follow-up|18
2020694|NCT00307437|3588338|FG000|After Controlled Period|Other|0
2020695|NCT00307437|3588339|FG001|After Controlled Period|Other|0
2020696|NCT00307437|3588340|FG002|After Controlled Period|Other|0
2020697|NCT00307437|3588341|FG003|After Controlled Period|Other|15
2020698|NCT00307437|3588342|FG004|After Controlled Period|Other|9
2020699|NCT00307437|3588343|FG005|After Controlled Period|Other|40
2020700|NCT00307437|3588344|FG006|After Controlled Period|Other|28
2020701|NCT00307489|3588368|FG000|Baseline Through Week 48|Lost to Follow-up|0
2020702|NCT00307489|3588369|FG001|Baseline Through Week 48|Lost to Follow-up|1
2020703|NCT00307489|3588368|FG000|Baseline Through Week 48|Physician Decision|1
2020704|NCT00307489|3588369|FG001|Baseline Through Week 48|Physician Decision|0
2020705|NCT00307489|3588368|FG000|Baseline Through Week 48|Withdrawal by Subject|0
2020706|NCT00307489|3588369|FG001|Baseline Through Week 48|Withdrawal by Subject|1
2020707|NCT00307489|3588368|FG000|Week 48 Through Week 168|Adverse Event|1
2020708|NCT00307489|3588369|FG001|Week 48 Through Week 168|Adverse Event|0
2020709|NCT00307489|3588368|FG000|Week 48 Through Week 168|Physician Decision|1
2020710|NCT00307489|3588369|FG001|Week 48 Through Week 168|Physician Decision|0
2020711|NCT00307489|3588368|FG000|Week 48 Through Week 168|Withdrawal by Subject|1
2020712|NCT00307489|3588369|FG001|Week 48 Through Week 168|Withdrawal by Subject|2
2020713|NCT00307489|3588368|FG000|Week 48 Through Week 168|Lack of Efficacy|2
2020714|NCT00307489|3588369|FG001|Week 48 Through Week 168|Lack of Efficacy|2
2020715|NCT00307489|3588368|FG000|Week 48 Through Week 168|Death|0
2020716|NCT00307489|3588369|FG001|Week 48 Through Week 168|Death|1
2020717|NCT00307489|3588368|FG000|Week 48 Through Week 168|Lost to Follow-up|0
2020718|NCT00307489|3588369|FG001|Week 48 Through Week 168|Lost to Follow-up|1
2020719|NCT00307489|3588368|FG000|Week 48 Through Week 168|Seroconversion|1
2020720|NCT00307489|3588369|FG001|Week 48 Through Week 168|Seroconversion|0
2020721|NCT00307684|3588375|FG000|Open Label Phase|Lack of Efficacy|0
2020722|NCT00307684|3588376|FG001|Open Label Phase|Lack of Efficacy|0
2020723|NCT00307684|3588377|FG002|Open Label Phase|Lack of Efficacy|3
2020724|NCT00307684|3588375|FG000|Open Label Phase|Adverse Event|0
2020725|NCT00307684|3588376|FG001|Open Label Phase|Adverse Event|0
2020726|NCT00307684|3588377|FG002|Open Label Phase|Adverse Event|16
2020727|NCT00307684|3588375|FG000|Open Label Phase|Withdrawal by Subject|0
2020728|NCT00307684|3588376|FG001|Open Label Phase|Withdrawal by Subject|0
2020729|NCT00307684|3588377|FG002|Open Label Phase|Withdrawal by Subject|15
2020730|NCT00307684|3588375|FG000|Open Label Phase|Lost to Follow-up|0
2020731|NCT00307684|3588376|FG001|Open Label Phase|Lost to Follow-up|0
2020732|NCT00307684|3588377|FG002|Open Label Phase|Lost to Follow-up|11
2212602|NCT01672853|3853885|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0
2212603|NCT01672853|3853883|FG000|Overall Study|Pregnancy|0
2212604|NCT01672853|3853884|FG001|Overall Study|Pregnancy|1
2212605|NCT01672853|3853885|FG002|Overall Study|Pregnancy|0
2212606|NCT01672853|3853883|FG000|Overall Study|Investigator's Discretion|1
2212607|NCT01672853|3853884|FG001|Overall Study|Investigator's Discretion|0
2212608|NCT01672853|3853885|FG002|Overall Study|Investigator's Discretion|0
2212609|NCT01672853|3853883|FG000|Overall Study|Withdrew Consent|5
2212610|NCT01672853|3853884|FG001|Overall Study|Withdrew Consent|5
2212611|NCT01672853|3853885|FG002|Overall Study|Withdrew Consent|5
2212612|NCT01672853|3853883|FG000|Overall Study|Adverse Event|4
2212613|NCT01672853|3853884|FG001|Overall Study|Adverse Event|6
2212614|NCT01672853|3853885|FG002|Overall Study|Adverse Event|8
2212615|NCT01672853|3853883|FG000|Overall Study|Lost to Follow-up|0
2212616|NCT01672853|3853884|FG001|Overall Study|Lost to Follow-up|1
2309198|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
2309199|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3
2309200|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3
2309201|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0
2309202|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0
2309203|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0
2309204|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
2309205|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2212617|NCT01672853|3853885|FG002|Overall Study|Lost to Follow-up|0
2212618|NCT01672853|3853883|FG000|Overall Study|Randomized but Never Treated|0
2020733|NCT00307684|3588375|FG000|Open Label Phase|non compliance|0
2020734|NCT00307684|3588376|FG001|Open Label Phase|non compliance|0
2020735|NCT00307684|3588377|FG002|Open Label Phase|non compliance|5
2020736|NCT00307684|3588375|FG000|Open Label Phase|other|0
2020737|NCT00307684|3588376|FG001|Open Label Phase|other|0
2020738|NCT00307684|3588377|FG002|Open Label Phase|other|6
2020739|NCT00307684|3588375|FG000|Double Blind Phase|Lack of Efficacy|2
2020740|NCT00307684|3588376|FG001|Double Blind Phase|Lack of Efficacy|5
2020741|NCT00307684|3588377|FG002|Double Blind Phase|Lack of Efficacy|0
2020742|NCT00307736|3588385|FG000|Overall Study|Adverse Event|0
2020743|NCT00307736|3588386|FG001|Overall Study|Adverse Event|0
2020744|NCT00307736|3588387|FG002|Overall Study|Adverse Event|1
2020745|NCT00307736|3588388|FG003|Overall Study|Adverse Event|3
2020746|NCT00307736|3588385|FG000|Overall Study|Withdrawal by Subject|0
2020747|NCT00307736|3588386|FG001|Overall Study|Withdrawal by Subject|0
2020748|NCT00307736|3588387|FG002|Overall Study|Withdrawal by Subject|2
2020749|NCT00307736|3588388|FG003|Overall Study|Withdrawal by Subject|0
2020750|NCT00307801|3588401|FG000|Overall Study|Adverse Event|12
2020751|NCT00307801|3588402|FG001|Overall Study|Adverse Event|4
2020752|NCT00307801|3588401|FG000|Overall Study|Withdrawal by Subject|9
2020753|NCT00307801|3588402|FG001|Overall Study|Withdrawal by Subject|4
2020754|NCT00307801|3588401|FG000|Overall Study|Non-compliance, not taken all tablets|1
2020755|NCT00307801|3588402|FG001|Overall Study|Non-compliance, not taken all tablets|2
2020756|NCT00307801|3588401|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2
2020757|NCT00307801|3588402|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0
2020758|NCT00307801|3588401|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0
2020759|NCT00307801|3588402|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1
2020760|NCT00307801|3588401|FG000|Overall Study|Wrong Randomization|1
2020761|NCT00307801|3588402|FG001|Overall Study|Wrong Randomization|0
2020762|NCT00307801|3588401|FG000|Overall Study|Lack of Efficacy|0
2020763|NCT00307801|3588402|FG001|Overall Study|Lack of Efficacy|2
2020764|NCT00307801|3588401|FG000|Overall Study|Lost to Follow-up, moved abroad|1
2020765|NCT00307801|3588402|FG001|Overall Study|Lost to Follow-up, moved abroad|1
2020766|NCT00307801|3588401|FG000|Overall Study|Frustration with e-diary|1
2020767|NCT00307801|3588402|FG001|Overall Study|Frustration with e-diary|0
2020768|NCT00307801|3588401|FG000|Overall Study|Protocol Violation|3
2020769|NCT00307801|3588402|FG001|Overall Study|Protocol Violation|2
2020770|NCT00307801|3588401|FG000|Overall Study|No reason specified|2
2020771|NCT00307801|3588402|FG001|Overall Study|No reason specified|0
2020772|NCT00307801|3588401|FG000|Overall Study|Pregnancy|0
2020773|NCT00307801|3588402|FG001|Overall Study|Pregnancy|1
2020774|NCT00307931|3588409|FG000|Overall Study|Adverse Event|1
2025916|NCT00347776|3594657|FG001|6 Month Follow-up|Death|1
2025917|NCT00347776|3594658|FG002|6 Month Follow-up|Death|3
2025918|NCT00347776|3594656|FG000|6 Month Follow-up|reached endpont|20
2025919|NCT00347776|3594657|FG001|6 Month Follow-up|reached endpont|12
2025920|NCT00347776|3594658|FG002|6 Month Follow-up|reached endpont|15
2025921|NCT00347776|3594656|FG000|12 Month Follow-up|Lost to Follow-up|7
2025922|NCT00347776|3594657|FG001|12 Month Follow-up|Lost to Follow-up|6
2025923|NCT00347776|3594658|FG002|12 Month Follow-up|Lost to Follow-up|6
2025924|NCT00347776|3594656|FG000|12 Month Follow-up|Death|3
2025925|NCT00347776|3594657|FG001|12 Month Follow-up|Death|4
2025926|NCT00347776|3594658|FG002|12 Month Follow-up|Death|4
2025927|NCT00347776|3594656|FG000|12 Month Follow-up|Reached endpoint|13
2309206|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2309207|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2309208|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2309209|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Technical error|1
2020775|NCT00308074|3588423|FG000|Overall Study|Withdrawal by Subject|1
2020776|NCT00308087|3588429|FG000|Overall Study|Progressive Disease|19
2212619|NCT01672853|3853884|FG001|Overall Study|Randomized but Never Treated|0
2212620|NCT01672853|3853885|FG002|Overall Study|Randomized but Never Treated|1
2212621|NCT01672866|3853896|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
2212622|NCT01672866|3853897|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
2212623|NCT01672866|3853898|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
2212624|NCT01672866|3853896|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
2212625|NCT01672866|3853897|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
2212626|NCT01672866|3853898|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
2212627|NCT01672866|3853896|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
2212628|NCT01672866|3853897|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
2212629|NCT01672866|3853898|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
2212630|NCT01672866|3853896|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3
2212631|NCT01672866|3853897|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3
2212632|NCT01672866|3853898|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3
2212633|NCT01672866|3853896|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
2212634|NCT01672866|3853897|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
2212635|NCT01672866|3853898|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
2212636|NCT01672866|3853896|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
2212637|NCT01672866|3853897|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
2212638|NCT01672866|3853898|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
2212639|NCT01672866|3853896|FG000|Blinded Phase (up to 240 Weeks)|Death|0
2212640|NCT01672866|3853897|FG001|Blinded Phase (up to 240 Weeks)|Death|0
2212641|NCT01672866|3853898|FG002|Blinded Phase (up to 240 Weeks)|Death|1
2212642|NCT01672866|3853896|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
2212643|NCT01672866|3853897|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
2212644|NCT01672866|3853898|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
2212645|NCT01672866|3853896|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
2212646|NCT01672866|3853897|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
2212647|NCT01672866|3853898|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
2212648|NCT01672866|3853896|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
2212649|NCT01672866|3853897|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
2020777|NCT00308087|3588430|FG001|Overall Study|Progressive Disease|21
2020778|NCT00308087|3588429|FG000|Overall Study|Study Closure|11
2020779|NCT00308087|3588430|FG001|Overall Study|Study Closure|12
2020780|NCT00308087|3588429|FG000|Overall Study|Withdrawal by Subject|2
2020781|NCT00308087|3588430|FG001|Overall Study|Withdrawal by Subject|1
2020782|NCT00308087|3588429|FG000|Overall Study|Other|4
2020783|NCT00308087|3588430|FG001|Overall Study|Other|3
2020784|NCT00308139|3588438|FG000|Overall Study|Adverse Event|20
2020785|NCT00308139|3588439|FG001|Overall Study|Adverse Event|14
2020786|NCT00308139|3588438|FG000|Overall Study|Lost to Follow-up|13
2309210|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Technical error|0
2020787|NCT00308139|3588439|FG001|Overall Study|Lost to Follow-up|8
2020788|NCT00308139|3588438|FG000|Overall Study|Protocol Violation|3
2020789|NCT00308139|3588439|FG001|Overall Study|Protocol Violation|2
2020790|NCT00308139|3588438|FG000|Overall Study|Withdrawal of Consent|40
2020791|NCT00308139|3588439|FG001|Overall Study|Withdrawal of Consent|42
2020792|NCT00308139|3588438|FG000|Overall Study|Investigator Decision|11
2020793|NCT00308139|3588439|FG001|Overall Study|Investigator Decision|10
2020794|NCT00308139|3588438|FG000|Overall Study|Loss of Glucose Control|5
2020795|NCT00308139|3588439|FG001|Overall Study|Loss of Glucose Control|7
2020796|NCT00308139|3588438|FG000|Overall Study|Administrative|1
2020797|NCT00308139|3588439|FG001|Overall Study|Administrative|4
2020798|NCT00308139|3588438|FG000|Overall Study|Other|1
2020799|NCT00308139|3588439|FG001|Overall Study|Other|0
2020800|NCT00308308|3588500|FG000|Overall Study|Adverse Event|17
2020801|NCT00308308|3588501|FG001|Overall Study|Adverse Event|2
2020802|NCT00308308|3588500|FG000|Overall Study|Lost to Follow-up|5
2020803|NCT00308308|3588501|FG001|Overall Study|Lost to Follow-up|5
2020804|NCT00308308|3588500|FG000|Overall Study|Physician Decision|15
2020805|NCT00308308|3588501|FG001|Overall Study|Physician Decision|7
2020806|NCT00308308|3588500|FG000|Overall Study|Protocol Violation|3
2020807|NCT00308308|3588501|FG001|Overall Study|Protocol Violation|14
2020808|NCT00308308|3588500|FG000|Overall Study|Withdrawal by Subject|47
2020809|NCT00308308|3588501|FG001|Overall Study|Withdrawal by Subject|19
2020810|NCT00308308|3588500|FG000|Overall Study|Various|7
2020811|NCT00308308|3588501|FG001|Overall Study|Various|5
2020812|NCT00308308|3588500|FG000|Overall Study|Randomized but not dosed|8
2020813|NCT00308308|3588501|FG001|Overall Study|Randomized but not dosed|16
2020814|NCT00308308|3588500|FG000|Overall Study|Other|1
2020815|NCT00308308|3588501|FG001|Overall Study|Other|0
2212650|NCT01672866|3853898|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
2212651|NCT01672866|3853896|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
2212652|NCT01672866|3853897|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
2212653|NCT01672866|3853898|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
2212654|NCT01672866|3853896|FG000|Open-Label Phase (up to 240 Weeks)|Death|1
2212655|NCT01672866|3853897|FG001|Open-Label Phase (up to 240 Weeks)|Death|0
2212656|NCT01672866|3853898|FG002|Open-Label Phase (up to 240 Weeks)|Death|0
2212657|NCT01672866|3853896|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
2212658|NCT01672866|3853897|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
2212659|NCT01672866|3853898|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
2212660|NCT01672879|3853911|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
2212661|NCT01672879|3853912|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
2212662|NCT01672879|3853913|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
2212663|NCT01672879|3853911|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
2212664|NCT01672879|3853912|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
2212665|NCT01672879|3853913|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
2212666|NCT01672879|3853911|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
2212667|NCT01672879|3853912|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
2212668|NCT01672879|3853913|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
2212669|NCT01672879|3853911|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
2212670|NCT01672879|3853912|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
2020816|NCT00308555|3588509|FG000|Overall Study|Withdrawal by Subject|1
2020817|NCT00308555|3588510|FG001|Overall Study|Withdrawal by Subject|0
2020818|NCT00308555|3588509|FG000|Overall Study|Physician Decision|2
2020819|NCT00308555|3588510|FG001|Overall Study|Physician Decision|0
2020820|NCT00308581|3588516|FG000|Induction Phase|Adverse Event|0
2020821|NCT00308581|3588517|FG001|Induction Phase|Adverse Event|0
2020822|NCT00308581|3588518|FG002|Induction Phase|Adverse Event|37
2020823|NCT00308581|3588516|FG000|Induction Phase|Lack of Efficacy|0
2020824|NCT00308581|3588517|FG001|Induction Phase|Lack of Efficacy|0
2020825|NCT00308581|3588518|FG002|Induction Phase|Lack of Efficacy|121
2020826|NCT00308581|3588516|FG000|Induction Phase|Withdrawal by Subject|0
2020827|NCT00308581|3588517|FG001|Induction Phase|Withdrawal by Subject|0
2020828|NCT00308581|3588518|FG002|Induction Phase|Withdrawal by Subject|5
2020829|NCT00308581|3588516|FG000|Induction Phase|Unknown reason|0
2020830|NCT00308581|3588517|FG001|Induction Phase|Unknown reason|0
2020831|NCT00308581|3588518|FG002|Induction Phase|Unknown reason|3
2020832|NCT00308581|3588516|FG000|Randomized Maintenance Phase|Adverse Event|10
2020833|NCT00308581|3588517|FG001|Randomized Maintenance Phase|Adverse Event|17
2020834|NCT00308581|3588518|FG002|Randomized Maintenance Phase|Adverse Event|0
2020835|NCT00308581|3588516|FG000|Randomized Maintenance Phase|Lack of Efficacy|9
2020836|NCT00308581|3588517|FG001|Randomized Maintenance Phase|Lack of Efficacy|21
2020837|NCT00308581|3588518|FG002|Randomized Maintenance Phase|Lack of Efficacy|0
2020838|NCT00308581|3588516|FG000|Randomized Maintenance Phase|Lost to Follow-up|0
2020839|NCT00308581|3588517|FG001|Randomized Maintenance Phase|Lost to Follow-up|2
2020840|NCT00308581|3588518|FG002|Randomized Maintenance Phase|Lost to Follow-up|0
2020841|NCT00308581|3588516|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1
2020842|NCT00308581|3588517|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4
2020843|NCT00308581|3588518|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0
2020844|NCT00308581|3588516|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
2020845|NCT00308581|3588517|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
2212671|NCT01672879|3853913|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
2025928|NCT00347776|3594657|FG001|12 Month Follow-up|Reached endpoint|6
2020846|NCT00308581|3588518|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
2020847|NCT00308581|3588516|FG000|Randomized Maintenance Phase|Unknown reason|3
2020848|NCT00308581|3588517|FG001|Randomized Maintenance Phase|Unknown reason|0
2020849|NCT00308581|3588518|FG002|Randomized Maintenance Phase|Unknown reason|0
2020850|NCT00308620|3588529|FG000|Overall Study|Death|1
2020851|NCT00308620|3588530|FG001|Overall Study|Death|1
2020852|NCT00308620|3588531|FG002|Overall Study|Death|0
2020853|NCT00308620|3588529|FG000|Overall Study|Lost to Follow-up|0
2020854|NCT00308620|3588530|FG001|Overall Study|Lost to Follow-up|0
2020855|NCT00308620|3588531|FG002|Overall Study|Lost to Follow-up|1
2020856|NCT00308711|3588542|FG000|Overall Study|Withdrawal by Subject|1
2020857|NCT00308711|3588543|FG001|Overall Study|Withdrawal by Subject|0
2020858|NCT00308711|3588544|FG002|Overall Study|Withdrawal by Subject|1
2020859|NCT00308711|3588542|FG000|Overall Study|Protocol Violation|0
2020860|NCT00308711|3588543|FG001|Overall Study|Protocol Violation|1
2020861|NCT00308711|3588544|FG002|Overall Study|Protocol Violation|1
2020862|NCT00308711|3588542|FG000|Overall Study|Lost to Follow-up|0
2020863|NCT00308711|3588543|FG001|Overall Study|Lost to Follow-up|1
2020864|NCT00308711|3588544|FG002|Overall Study|Lost to Follow-up|0
2020865|NCT00308711|3588542|FG000|Overall Study|Baby not born within 7 days of treatment|1
2020866|NCT00308711|3588543|FG001|Overall Study|Baby not born within 7 days of treatment|2
2020867|NCT00308711|3588544|FG002|Overall Study|Baby not born within 7 days of treatment|2
2020868|NCT00308711|3588542|FG000|Overall Study|Subject incarcerated, data not allowed|0
2020869|NCT00308711|3588543|FG001|Overall Study|Subject incarcerated, data not allowed|0
2020870|NCT00308711|3588544|FG002|Overall Study|Subject incarcerated, data not allowed|1
2020871|NCT00308737|3588555|FG000|Overall Study|Adverse Event|104
2020872|NCT00308737|3588556|FG001|Overall Study|Adverse Event|9
2020873|NCT00308737|3588557|FG002|Overall Study|Adverse Event|0
2020874|NCT00308737|3588555|FG000|Overall Study|Death|4
2020875|NCT00308737|3588556|FG001|Overall Study|Death|3
2020876|NCT00308737|3588557|FG002|Overall Study|Death|0
2020877|NCT00308737|3588555|FG000|Overall Study|Lost to Follow-up|56
2020878|NCT00308737|3588556|FG001|Overall Study|Lost to Follow-up|80
2020879|NCT00308737|3588557|FG002|Overall Study|Lost to Follow-up|5
2020880|NCT00308737|3588555|FG000|Overall Study|Physician Decision|15
2020881|NCT00308737|3588556|FG001|Overall Study|Physician Decision|2
1968101|NCT04446429|3528324|FG000|Overall Study|Lost to Follow-up|6
1968102|NCT04446429|3528325|FG001|Overall Study|Lost to Follow-up|0
1968104|NCT03116685|3528393|FG000|Overall Study|Physician Decision|0
1968105|NCT03116685|3528394|FG001|Overall Study|Physician Decision|1
1968106|NCT03099304|3528405|FG000|DB Period Day 1 to Week 24|Adverse Event|1
1968107|NCT03099304|3528406|FG001|DB Period Day 1 to Week 24|Adverse Event|1
1968108|NCT03099304|3528407|FG002|DB Period Day 1 to Week 24|Adverse Event|0
1968109|NCT03099304|3528408|FG003|DB Period Day 1 to Week 24|Adverse Event|0
1968110|NCT03099304|3528409|FG004|DB Period Day 1 to Week 24|Adverse Event|1
1968111|NCT03099304|3528405|FG000|DB Period Day 1 to Week 24|Lost to Follow-up|1
1968112|NCT03099304|3528406|FG001|DB Period Day 1 to Week 24|Lost to Follow-up|1
1968113|NCT03099304|3528407|FG002|DB Period Day 1 to Week 24|Lost to Follow-up|0
1968114|NCT03099304|3528408|FG003|DB Period Day 1 to Week 24|Lost to Follow-up|0
1968115|NCT03099304|3528409|FG004|DB Period Day 1 to Week 24|Lost to Follow-up|0
1968116|NCT03099304|3528405|FG000|DB Period Day 1 to Week 24|Reason not specified|0
1968117|NCT03099304|3528406|FG001|DB Period Day 1 to Week 24|Reason not specified|0
1968118|NCT03099304|3528407|FG002|DB Period Day 1 to Week 24|Reason not specified|0
1968119|NCT03099304|3528408|FG003|DB Period Day 1 to Week 24|Reason not specified|1
1968120|NCT03099304|3528409|FG004|DB Period Day 1 to Week 24|Reason not specified|0
1968121|NCT03099304|3528405|FG000|DB Period Day 1 to Week 24|Withdrawal by Subject|3
1968122|NCT03099304|3528406|FG001|DB Period Day 1 to Week 24|Withdrawal by Subject|3
1968123|NCT03099304|3528407|FG002|DB Period Day 1 to Week 24|Withdrawal by Subject|0
1968124|NCT03099304|3528408|FG003|DB Period Day 1 to Week 24|Withdrawal by Subject|2
1968125|NCT03099304|3528409|FG004|DB Period Day 1 to Week 24|Withdrawal by Subject|2
1968126|NCT03099304|3528405|FG000|DB Period Day 1 to Week 24|Protocol Violation|0
1968127|NCT03099304|3528406|FG001|DB Period Day 1 to Week 24|Protocol Violation|0
1968128|NCT03099304|3528407|FG002|DB Period Day 1 to Week 24|Protocol Violation|1
1968129|NCT03099304|3528408|FG003|DB Period Day 1 to Week 24|Protocol Violation|1
1968130|NCT03099304|3528409|FG004|DB Period Day 1 to Week 24|Protocol Violation|0
1968131|NCT03099304|3528405|FG000|DB Period Weeks 24 to 52|Protocol Violation|0
1968132|NCT03099304|3528406|FG001|DB Period Weeks 24 to 52|Protocol Violation|0
1968133|NCT03099304|3528407|FG002|DB Period Weeks 24 to 52|Protocol Violation|1
1968134|NCT03099304|3528408|FG003|DB Period Weeks 24 to 52|Protocol Violation|0
1968135|NCT03099304|3528409|FG004|DB Period Weeks 24 to 52|Protocol Violation|0
1968136|NCT03099304|3528405|FG000|DB Period Weeks 24 to 52|Lost to Follow-up|0
1968137|NCT03099304|3528406|FG001|DB Period Weeks 24 to 52|Lost to Follow-up|1
1968138|NCT03099304|3528407|FG002|DB Period Weeks 24 to 52|Lost to Follow-up|1
1968139|NCT03099304|3528408|FG003|DB Period Weeks 24 to 52|Lost to Follow-up|1
1968140|NCT03099304|3528409|FG004|DB Period Weeks 24 to 52|Lost to Follow-up|0
1968141|NCT03099304|3528405|FG000|DB Period Weeks 24 to 52|Adverse Event|0
1968142|NCT03099304|3528406|FG001|DB Period Weeks 24 to 52|Adverse Event|0
1968143|NCT03099304|3528407|FG002|DB Period Weeks 24 to 52|Adverse Event|0
1968144|NCT03099304|3528408|FG003|DB Period Weeks 24 to 52|Adverse Event|1
1968145|NCT03099304|3528409|FG004|DB Period Weeks 24 to 52|Adverse Event|1
1968146|NCT03099304|3528405|FG000|DB Period Weeks 24 to 52|Withdrawal by Subject|0
1968147|NCT03099304|3528406|FG001|DB Period Weeks 24 to 52|Withdrawal by Subject|0
1968148|NCT03099304|3528407|FG002|DB Period Weeks 24 to 52|Withdrawal by Subject|0
1968149|NCT03099304|3528408|FG003|DB Period Weeks 24 to 52|Withdrawal by Subject|4
1968150|NCT03099304|3528409|FG004|DB Period Weeks 24 to 52|Withdrawal by Subject|1
1968151|NCT03099304|3528405|FG000|DB Period Weeks 24 to 52|Reason not specified|0
1968152|NCT03099304|3528406|FG001|DB Period Weeks 24 to 52|Reason not specified|0
1968153|NCT03099304|3528407|FG002|DB Period Weeks 24 to 52|Reason not specified|0
1968154|NCT03099304|3528408|FG003|DB Period Weeks 24 to 52|Reason not specified|1
1968155|NCT03099304|3528409|FG004|DB Period Weeks 24 to 52|Reason not specified|0
1968156|NCT02682901|3528455|FG000|Overall Study|Adverse Event|10
1968157|NCT02682901|3528456|FG001|Overall Study|Adverse Event|3
1968158|NCT02682901|3528455|FG000|Overall Study|Lack of Efficacy|0
1968159|NCT02682901|3528456|FG001|Overall Study|Lack of Efficacy|1
2212672|NCT01672879|3853911|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
2217524|NCT01708954|3860855|FG001|Step 1|Disease progression|17
1968160|NCT02567825|3528464|FG000|Overall Study|No follow-up post-randomization|5
1968161|NCT02567825|3528465|FG001|Overall Study|No follow-up post-randomization|1
1968162|NCT02567825|3528464|FG000|Overall Study|Follow-up less than 23 months|16
1968163|NCT02567825|3528465|FG001|Overall Study|Follow-up less than 23 months|20
1968164|NCT02555657|3528473|FG000|Overall Study|Death|274
1968165|NCT02555657|3528474|FG001|Overall Study|Death|262
1968166|NCT02555657|3528473|FG000|Overall Study|Physician Decision|0
1968167|NCT02555657|3528474|FG001|Overall Study|Physician Decision|1
1968168|NCT02555657|3528473|FG000|Overall Study|Sponsor Decision|27
1968169|NCT02555657|3528474|FG001|Overall Study|Sponsor Decision|15
1968170|NCT02555657|3528473|FG000|Overall Study|Withdrawal by Subject|11
1968171|NCT02555657|3528474|FG001|Overall Study|Withdrawal by Subject|32
1968172|NCT02328014|3528485|FG000|Overall Study|Adverse Event|1
1968173|NCT02328014|3528486|FG001|Overall Study|Adverse Event|0
1968174|NCT02328014|3528487|FG002|Overall Study|Adverse Event|0
1968175|NCT02328014|3528488|FG003|Overall Study|Adverse Event|1
1968176|NCT02328014|3528485|FG000|Overall Study|Death|0
1968177|NCT02328014|3528486|FG001|Overall Study|Death|0
1968178|NCT02328014|3528487|FG002|Overall Study|Death|0
1968179|NCT02328014|3528488|FG003|Overall Study|Death|4
1968103|NCT04194528|3528348|FG000|Overall Study|Adverse Event|1
1968180|NCT02328014|3528485|FG000|Overall Study|Physician Decision|0
1968181|NCT02328014|3528486|FG001|Overall Study|Physician Decision|0
1968182|NCT02328014|3528487|FG002|Overall Study|Physician Decision|0
1968183|NCT02328014|3528488|FG003|Overall Study|Physician Decision|1
1968184|NCT02328014|3528485|FG000|Overall Study|Disease Progression|1
1968185|NCT02328014|3528486|FG001|Overall Study|Disease Progression|0
1968186|NCT02328014|3528487|FG002|Overall Study|Disease Progression|1
1968187|NCT02328014|3528488|FG003|Overall Study|Disease Progression|3
1968188|NCT02328014|3528485|FG000|Overall Study|Study Terminated by Sponsor|4
1968189|NCT02328014|3528486|FG001|Overall Study|Study Terminated by Sponsor|1
1968190|NCT02328014|3528487|FG002|Overall Study|Study Terminated by Sponsor|1
1968191|NCT02328014|3528488|FG003|Overall Study|Study Terminated by Sponsor|0
1968192|NCT02328014|3528485|FG000|Overall Study|Subject Started Another Cancer Therapy|0
1968193|NCT02328014|3528486|FG001|Overall Study|Subject Started Another Cancer Therapy|5
1968194|NCT02328014|3528487|FG002|Overall Study|Subject Started Another Cancer Therapy|4
1968195|NCT02328014|3528488|FG003|Overall Study|Subject Started Another Cancer Therapy|12
1968196|NCT02328014|3528485|FG000|Overall Study|Withdrawal by Subject|0
1968197|NCT02328014|3528486|FG001|Overall Study|Withdrawal by Subject|0
1968198|NCT02328014|3528487|FG002|Overall Study|Withdrawal by Subject|0
1968199|NCT02328014|3528488|FG003|Overall Study|Withdrawal by Subject|1
1968200|NCT02190721|3528501|FG000|Overall Study|Patient was out of the city|0
1968201|NCT02190721|3528502|FG001|Overall Study|Patient was out of the city|1
1968202|NCT02190721|3528503|FG002|Overall Study|Patient was out of the city|0
1968203|NCT00739401|3528536|FG000|Overall Study|patients were not due for the 2 year follow-up|34
1968204|NCT00739401|3528536|FG000|Overall Study|Death|3
1968205|NCT00739401|3528536|FG000|Overall Study|Withdrawal by Subject|4
2020882|NCT00308737|3588557|FG002|Overall Study|Physician Decision|1
2020883|NCT00308737|3588555|FG000|Overall Study|Protocol Violation|34
2020884|NCT00308737|3588556|FG001|Overall Study|Protocol Violation|9
2020885|NCT00308737|3588557|FG002|Overall Study|Protocol Violation|5
2020886|NCT00308737|3588555|FG000|Overall Study|Withdrawal by Subject|218
2020887|NCT00308737|3588556|FG001|Overall Study|Withdrawal by Subject|166
2020888|NCT00308737|3588557|FG002|Overall Study|Withdrawal by Subject|18
2020889|NCT00308737|3588555|FG000|Overall Study|Various|32
2020890|NCT00308737|3588556|FG001|Overall Study|Various|20
2020891|NCT00308737|3588557|FG002|Overall Study|Various|8
2020892|NCT00308750|3588568|FG000|Overall Study|Adverse Event|9
2020893|NCT00308750|3588569|FG001|Overall Study|Adverse Event|9
2020894|NCT00308750|3588570|FG002|Overall Study|Adverse Event|13
2020895|NCT00308750|3588568|FG000|Overall Study|Withdrawal by Subject|6
2020896|NCT00308750|3588569|FG001|Overall Study|Withdrawal by Subject|2
2020897|NCT00308750|3588570|FG002|Overall Study|Withdrawal by Subject|3
2020898|NCT00308750|3588568|FG000|Overall Study|Physician Decision|3
2020899|NCT00308750|3588569|FG001|Overall Study|Physician Decision|4
2020900|NCT00308750|3588570|FG002|Overall Study|Physician Decision|3
2020901|NCT00308750|3588568|FG000|Overall Study|Sponsor Decision|1
2020902|NCT00308750|3588569|FG001|Overall Study|Sponsor Decision|0
2020903|NCT00308750|3588570|FG002|Overall Study|Sponsor Decision|0
2020904|NCT00308750|3588568|FG000|Overall Study|Disease Progression|47
2020905|NCT00308750|3588569|FG001|Overall Study|Disease Progression|24
2020906|NCT00308750|3588570|FG002|Overall Study|Disease Progression|28
2020907|NCT00308750|3588568|FG000|Overall Study|Unrelated Complication|3
2020908|NCT00308750|3588569|FG001|Overall Study|Unrelated Complication|0
2020909|NCT00308750|3588570|FG002|Overall Study|Unrelated Complication|1
2020910|NCT00308750|3588568|FG000|Overall Study|Death|1
2020911|NCT00308750|3588569|FG001|Overall Study|Death|0
2020912|NCT00308750|3588570|FG002|Overall Study|Death|1
2020913|NCT00308750|3588568|FG000|Overall Study|Protocol Violation|1
2020914|NCT00308750|3588569|FG001|Overall Study|Protocol Violation|0
2020915|NCT00308750|3588570|FG002|Overall Study|Protocol Violation|0
2020916|NCT00308750|3588568|FG000|Overall Study|New Primary Disease Identified|1
2020917|NCT00308750|3588569|FG001|Overall Study|New Primary Disease Identified|1
2020918|NCT00308750|3588570|FG002|Overall Study|New Primary Disease Identified|0
2020919|NCT00308997|3588581|FG000|Overall Study|Subject feigned clinical data|0
2020920|NCT00308997|3588582|FG001|Overall Study|Subject feigned clinical data|1
2020921|NCT00308997|3588581|FG000|Overall Study|Unable to tolerate intervention|1
2020922|NCT00308997|3588582|FG001|Overall Study|Unable to tolerate intervention|0
2020923|NCT00309166|3588594|FG000|Overall Study|Adverse event, non-fatal|1
2020924|NCT00309166|3588595|FG001|Overall Study|Adverse event, non-fatal|0
2020925|NCT00309166|3588594|FG000|Overall Study|Withdrawal by Subject|4
2020926|NCT00309166|3588595|FG001|Overall Study|Withdrawal by Subject|3
2020927|NCT00309244|3588603|FG000|Overall Study|Adverse Event|29
2020928|NCT00309244|3588604|FG001|Overall Study|Adverse Event|12
2020929|NCT00309244|3588603|FG000|Overall Study|Lost to Follow-up|6
2020930|NCT00309244|3588604|FG001|Overall Study|Lost to Follow-up|22
2020931|NCT00309244|3588603|FG000|Overall Study|Physician Decision|5
2020932|NCT00309244|3588604|FG001|Overall Study|Physician Decision|8
2020933|NCT00309244|3588603|FG000|Overall Study|Protocol Violation|6
2020934|NCT00309244|3588604|FG001|Overall Study|Protocol Violation|3
2020935|NCT00309244|3588603|FG000|Overall Study|Withdrawal by Subject|50
2020936|NCT00309244|3588604|FG001|Overall Study|Withdrawal by Subject|32
2020937|NCT00309244|3588603|FG000|Overall Study|Various|7
2020938|NCT00309244|3588604|FG001|Overall Study|Various|7
1968206|NCT00651742|3528540|FG000|Overall Study|Objective Disease Progression|22
1968207|NCT00651742|3528540|FG000|Overall Study|Toxicity|3
1968208|NCT00651742|3528540|FG000|Overall Study|Investigator Judgment|1
1968209|NCT00651742|3528540|FG000|Overall Study|Withdrawal of Consent|1
2212673|NCT01672879|3853912|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
2212674|NCT01672879|3853913|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
2212675|NCT01672879|3853911|FG000|Blinded Phase (Up to 240 Weeks)|Death|0
2212676|NCT01672879|3853912|FG001|Blinded Phase (Up to 240 Weeks)|Death|2
2212677|NCT01672879|3853913|FG002|Blinded Phase (Up to 240 Weeks)|Death|0
2212678|NCT01672879|3853911|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1
2212679|NCT01672879|3853912|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0
2212680|NCT01672879|3853913|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0
2212681|NCT01672879|3853911|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
2212682|NCT01672879|3853912|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
2212683|NCT01672879|3853913|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
2212684|NCT01672879|3853911|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
2212685|NCT01672879|3853912|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
2212686|NCT01672879|3853913|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
2212687|NCT01672879|3853911|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
2212688|NCT01672879|3853912|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
2212689|NCT01672879|3853913|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
2212690|NCT01672879|3853911|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
2212691|NCT01672879|3853912|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
1968210|NCT00651742|3528540|FG000|Overall Study|Enrolled but not treated|1
1968211|NCT04930263|3528559|FG000|Overall Study|Withdrawal by Subject|3
1968212|NCT04930263|3528560|FG001|Overall Study|Withdrawal by Subject|5
1968213|NCT04524598|3528570|FG000|Phase I - Feasibility|Lost to Follow-up|2
1968214|NCT04524598|3528571|FG001|Phase I - Feasibility|Lost to Follow-up|4
1968215|NCT04524598|3528572|FG002|Phase I - Feasibility|Lost to Follow-up|0
1968216|NCT04524598|3528573|FG003|Phase I - Feasibility|Lost to Follow-up|0
1968217|NCT04524598|3528574|FG004|Phase I - Feasibility|Lost to Follow-up|0
1968218|NCT04524598|3528570|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2
1968219|NCT04524598|3528571|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1
1968220|NCT04524598|3528572|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
1968221|NCT04524598|3528573|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
1968222|NCT04524598|3528574|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
1968223|NCT04524598|3528570|FG000|Phase II - Outcomes|Lost to Follow-up|0
1968224|NCT04524598|3528571|FG001|Phase II - Outcomes|Lost to Follow-up|0
1968225|NCT04524598|3528572|FG002|Phase II - Outcomes|Lost to Follow-up|16
1968226|NCT04524598|3528573|FG003|Phase II - Outcomes|Lost to Follow-up|8
1968227|NCT04524598|3528574|FG004|Phase II - Outcomes|Lost to Follow-up|0
1968228|NCT04524598|3528570|FG000|Phase II - Outcomes|Withdrawal by Subject|0
1968229|NCT04524598|3528571|FG001|Phase II - Outcomes|Withdrawal by Subject|0
1968230|NCT04524598|3528572|FG002|Phase II - Outcomes|Withdrawal by Subject|2
1968231|NCT04524598|3528573|FG003|Phase II - Outcomes|Withdrawal by Subject|0
1968232|NCT04524598|3528574|FG004|Phase II - Outcomes|Withdrawal by Subject|0
1968233|NCT04524598|3528570|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
1968234|NCT04524598|3528571|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
1968235|NCT04524598|3528572|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8
1968236|NCT04524598|3528573|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5
1968237|NCT04524598|3528574|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
1968238|NCT04524598|3528570|FG000|Phase II - Control Extension|Lost to Follow-up|0
1968239|NCT04524598|3528571|FG001|Phase II - Control Extension|Lost to Follow-up|0
1968240|NCT04524598|3528572|FG002|Phase II - Control Extension|Lost to Follow-up|0
1968241|NCT04524598|3528573|FG003|Phase II - Control Extension|Lost to Follow-up|0
1968242|NCT04524598|3528574|FG004|Phase II - Control Extension|Lost to Follow-up|6
1968243|NCT04524598|3528570|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
1968244|NCT04524598|3528571|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
1968245|NCT04524598|3528572|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
1968246|NCT04524598|3528573|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
1968247|NCT04524598|3528574|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6
1968248|NCT04321252|3528597|FG000|Overall Study|Withdrawal by Subject|0
1968249|NCT04321252|3528598|FG001|Overall Study|Withdrawal by Subject|0
1968250|NCT04321252|3528599|FG002|Overall Study|Withdrawal by Subject|0
1968251|NCT04321252|3528600|FG003|Overall Study|Withdrawal by Subject|0
1968252|NCT04321252|3528601|FG004|Overall Study|Withdrawal by Subject|0
1968253|NCT04321252|3528602|FG005|Overall Study|Withdrawal by Subject|1
1968254|NCT04321252|3528603|FG006|Overall Study|Withdrawal by Subject|0
1968255|NCT04321252|3528604|FG007|Overall Study|Withdrawal by Subject|0
1968256|NCT04321252|3528605|FG008|Overall Study|Withdrawal by Subject|0
1968257|NCT04176445|3528635|FG000|Overall Study|Adverse Event|0
1968258|NCT04176445|3528636|FG001|Overall Study|Adverse Event|1
1968259|NCT04176445|3528635|FG000|Overall Study|change plans weaning after first intervention|0
1968260|NCT04176445|3528636|FG001|Overall Study|change plans weaning after first intervention|1
1968261|NCT04126213|3528648|FG000|Overall Study|Lost to Follow-up|9
1968262|NCT04126213|3528649|FG001|Overall Study|Lost to Follow-up|1
1968263|NCT04126213|3528650|FG002|Overall Study|Lost to Follow-up|5
1968264|NCT04126213|3528651|FG003|Overall Study|Lost to Follow-up|10
1968265|NCT04126213|3528652|FG004|Overall Study|Lost to Follow-up|4
1968266|NCT04126213|3528653|FG005|Overall Study|Lost to Follow-up|7
1968267|NCT04126213|3528648|FG000|Overall Study|Withdrawal by Subject|3
1968268|NCT04126213|3528649|FG001|Overall Study|Withdrawal by Subject|2
1968269|NCT04126213|3528650|FG002|Overall Study|Withdrawal by Subject|1
1968270|NCT04126213|3528651|FG003|Overall Study|Withdrawal by Subject|1
1968271|NCT04126213|3528652|FG004|Overall Study|Withdrawal by Subject|1
1968272|NCT04126213|3528653|FG005|Overall Study|Withdrawal by Subject|1
1968273|NCT04126213|3528648|FG000|Overall Study|Other|0
1968274|NCT04126213|3528649|FG001|Overall Study|Other|0
1968275|NCT04126213|3528650|FG002|Overall Study|Other|2
1968276|NCT04126213|3528651|FG003|Overall Study|Other|2
1968277|NCT04126213|3528652|FG004|Overall Study|Other|0
1968278|NCT04126213|3528653|FG005|Overall Study|Other|1
1968279|NCT04126213|3528648|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1968280|NCT04126213|3528649|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
1968281|NCT04126213|3528650|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
1968282|NCT04126213|3528651|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
1968283|NCT04126213|3528652|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
1968284|NCT04126213|3528653|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
1968285|NCT03672188|3528689|FG000|Overall Study|Withdrawal by Subject|0
1968286|NCT03672188|3528690|FG001|Overall Study|Withdrawal by Subject|0
1968287|NCT03672188|3528691|FG002|Overall Study|Withdrawal by Subject|0
1968288|NCT03672188|3528692|FG003|Overall Study|Withdrawal by Subject|3
1968289|NCT03672188|3528693|FG004|Overall Study|Withdrawal by Subject|0
1968290|NCT03672188|3528694|FG005|Overall Study|Withdrawal by Subject|0
1968291|NCT03672188|3528695|FG006|Overall Study|Withdrawal by Subject|0
1968292|NCT03672188|3528696|FG007|Overall Study|Withdrawal by Subject|0
1968293|NCT03672188|3528697|FG008|Overall Study|Withdrawal by Subject|0
1968294|NCT03672188|3528698|FG009|Overall Study|Withdrawal by Subject|0
1968295|NCT03672188|3528699|FG010|Overall Study|Withdrawal by Subject|0
1968296|NCT03672188|3528700|FG011|Overall Study|Withdrawal by Subject|0
1968297|NCT03672188|3528701|FG012|Overall Study|Withdrawal by Subject|0
1968298|NCT03672188|3528702|FG013|Overall Study|Withdrawal by Subject|0
1968299|NCT03672188|3528703|FG014|Overall Study|Withdrawal by Subject|0
1968300|NCT03672188|3528689|FG000|Overall Study|Death|0
1968301|NCT03672188|3528690|FG001|Overall Study|Death|0
1968302|NCT03672188|3528691|FG002|Overall Study|Death|0
1968303|NCT03672188|3528692|FG003|Overall Study|Death|0
1968304|NCT03672188|3528693|FG004|Overall Study|Death|0
1968305|NCT03672188|3528694|FG005|Overall Study|Death|0
1968306|NCT03672188|3528695|FG006|Overall Study|Death|0
1968307|NCT03672188|3528696|FG007|Overall Study|Death|0
1968308|NCT03672188|3528697|FG008|Overall Study|Death|0
1968309|NCT03672188|3528698|FG009|Overall Study|Death|0
1968310|NCT03672188|3528699|FG010|Overall Study|Death|0
1968311|NCT03672188|3528700|FG011|Overall Study|Death|0
1968312|NCT03672188|3528701|FG012|Overall Study|Death|1
1968313|NCT03672188|3528702|FG013|Overall Study|Death|0
1968314|NCT03672188|3528703|FG014|Overall Study|Death|0
1968315|NCT03672188|3528689|FG000|Overall Study|Lost to Follow-up|0
1968316|NCT03672188|3528690|FG001|Overall Study|Lost to Follow-up|0
1968317|NCT03672188|3528691|FG002|Overall Study|Lost to Follow-up|1
1968318|NCT03672188|3528692|FG003|Overall Study|Lost to Follow-up|0
1968319|NCT03672188|3528693|FG004|Overall Study|Lost to Follow-up|0
1968320|NCT03672188|3528694|FG005|Overall Study|Lost to Follow-up|0
1968321|NCT03672188|3528695|FG006|Overall Study|Lost to Follow-up|0
1968322|NCT03672188|3528696|FG007|Overall Study|Lost to Follow-up|0
1968323|NCT03672188|3528697|FG008|Overall Study|Lost to Follow-up|0
1968324|NCT03672188|3528698|FG009|Overall Study|Lost to Follow-up|0
1968325|NCT03672188|3528699|FG010|Overall Study|Lost to Follow-up|0
1968326|NCT03672188|3528700|FG011|Overall Study|Lost to Follow-up|0
1968327|NCT03672188|3528701|FG012|Overall Study|Lost to Follow-up|0
1968328|NCT03672188|3528702|FG013|Overall Study|Lost to Follow-up|0
1968329|NCT03672188|3528703|FG014|Overall Study|Lost to Follow-up|0
1968330|NCT03573336|3528776|FG000|Overall Study|Study terminated|2
1968331|NCT03573336|3528777|FG001|Overall Study|Study terminated|4
1968332|NCT03573336|3528778|FG002|Overall Study|Study terminated|2
2020939|NCT00309244|3588603|FG000|Overall Study|Randomized but not dosed|11
2020940|NCT00309244|3588604|FG001|Overall Study|Randomized but not dosed|12
2020941|NCT00309244|3588603|FG000|Overall Study|Death|4
2020942|NCT00309244|3588604|FG001|Overall Study|Death|1
2020943|NCT00309387|3588612|FG000|Overall Study|Death|72
2020944|NCT00309387|3588613|FG001|Overall Study|Death|73
2020945|NCT00309387|3588612|FG000|Overall Study|Lost to Follow-up|70
2020946|NCT00309387|3588613|FG001|Overall Study|Lost to Follow-up|86
2020947|NCT00309452|3588622|FG000|Overall Study|Withdrawal by Subject|3
2020948|NCT00309452|3588623|FG001|Overall Study|Withdrawal by Subject|0
2020949|NCT00309608|3588659|FG000|Overall Study|Adverse Event|1
1968333|NCT03230916|3528797|FG000|Overall Study|Withdrawal by Subject|0
1968334|NCT03230916|3528798|FG001|Overall Study|Withdrawal by Subject|0
1968335|NCT03230916|3528799|FG002|Overall Study|Withdrawal by Subject|0
1968336|NCT03230916|3528800|FG003|Overall Study|Withdrawal by Subject|0
1968337|NCT03230916|3528801|FG004|Overall Study|Withdrawal by Subject|0
1968338|NCT03230916|3528802|FG005|Overall Study|Withdrawal by Subject|1
1968339|NCT03230916|3528803|FG006|Overall Study|Withdrawal by Subject|0
1968340|NCT03230916|3528804|FG007|Overall Study|Withdrawal by Subject|0
1968341|NCT03230916|3528805|FG008|Overall Study|Withdrawal by Subject|0
1968342|NCT03230916|3528806|FG009|Overall Study|Withdrawal by Subject|0
1968343|NCT03230916|3528807|FG010|Overall Study|Withdrawal by Subject|0
1968344|NCT03195894|3528850|FG000|Overall Study|"An example is Started other treatment."|4
1968345|NCT03195894|3528851|FG001|Overall Study|"An example is Started other treatment."|5
1968346|NCT03195894|3528850|FG000|Overall Study|Withdrawal by Subject|15
1968347|NCT03195894|3528851|FG001|Overall Study|Withdrawal by Subject|4
1968348|NCT03195894|3528850|FG000|Overall Study|Lost to Follow-up|14
1968349|NCT03195894|3528851|FG001|Overall Study|Lost to Follow-up|19
1968350|NCT03032705|3528862|FG000|Overall Study|Lost to Follow-up|16
1968351|NCT03032705|3528863|FG001|Overall Study|Lost to Follow-up|17
1968352|NCT03032705|3528862|FG000|Overall Study|did not quality|6
1968353|NCT03032705|3528863|FG001|Overall Study|did not quality|6
1968354|NCT02573259|3528876|FG000|Overall Study|Death|1
1968355|NCT02573259|3528877|FG001|Overall Study|Death|6
1968356|NCT02573259|3528878|FG002|Overall Study|Death|5
1968357|NCT02573259|3528879|FG003|Overall Study|Death|6
1968358|NCT02573259|3528880|FG004|Overall Study|Death|9
1968359|NCT02573259|3528881|FG005|Overall Study|Death|32
1968360|NCT02573259|3528882|FG006|Overall Study|Death|21
1968361|NCT02573259|3528876|FG000|Overall Study|Lost to Follow-up|0
1968362|NCT02573259|3528877|FG001|Overall Study|Lost to Follow-up|0
1968363|NCT02573259|3528878|FG002|Overall Study|Lost to Follow-up|0
1968364|NCT02573259|3528879|FG003|Overall Study|Lost to Follow-up|0
1968365|NCT02573259|3528880|FG004|Overall Study|Lost to Follow-up|0
1968366|NCT02573259|3528881|FG005|Overall Study|Lost to Follow-up|2
1968367|NCT02573259|3528882|FG006|Overall Study|Lost to Follow-up|1
1968368|NCT02573259|3528876|FG000|Overall Study|Participant refused further follow-up|0
1968369|NCT02573259|3528877|FG001|Overall Study|Participant refused further follow-up|2
1968370|NCT02573259|3528878|FG002|Overall Study|Participant refused further follow-up|1
1968371|NCT02573259|3528879|FG003|Overall Study|Participant refused further follow-up|0
1968372|NCT02573259|3528880|FG004|Overall Study|Participant refused further follow-up|3
1968373|NCT02573259|3528881|FG005|Overall Study|Participant refused further follow-up|20
1968374|NCT02573259|3528882|FG006|Overall Study|Participant refused further follow-up|7
1968375|NCT02573259|3528876|FG000|Overall Study|Other|0
1968376|NCT02573259|3528877|FG001|Overall Study|Other|0
1968377|NCT02573259|3528878|FG002|Overall Study|Other|0
1968378|NCT02573259|3528879|FG003|Overall Study|Other|0
1968379|NCT02573259|3528880|FG004|Overall Study|Other|1
1968380|NCT02573259|3528881|FG005|Overall Study|Other|4
1968381|NCT02573259|3528882|FG006|Overall Study|Other|5
1968382|NCT02318329|3528924|FG000|Overall Study|Progressive Disease|2
1968383|NCT02318329|3528925|FG001|Overall Study|Progressive Disease|3
1968384|NCT02318329|3528926|FG002|Overall Study|Progressive Disease|2
1968385|NCT02318329|3528927|FG003|Overall Study|Progressive Disease|3
1968386|NCT02318329|3528928|FG004|Overall Study|Progressive Disease|3
1968387|NCT02318329|3528929|FG005|Overall Study|Progressive Disease|3
1968388|NCT02318329|3528930|FG006|Overall Study|Progressive Disease|1
1968389|NCT02318329|3528931|FG007|Overall Study|Progressive Disease|1
1968390|NCT02318329|3528932|FG008|Overall Study|Progressive Disease|5
1968391|NCT02318329|3528933|FG009|Overall Study|Progressive Disease|39
1968392|NCT02318329|3528924|FG000|Overall Study|Death|0
1968393|NCT02318329|3528925|FG001|Overall Study|Death|0
1968394|NCT02318329|3528926|FG002|Overall Study|Death|0
1968395|NCT02318329|3528927|FG003|Overall Study|Death|0
1968396|NCT02318329|3528928|FG004|Overall Study|Death|0
1968397|NCT02318329|3528929|FG005|Overall Study|Death|0
1968398|NCT02318329|3528930|FG006|Overall Study|Death|0
1968399|NCT02318329|3528931|FG007|Overall Study|Death|0
1968400|NCT02318329|3528932|FG008|Overall Study|Death|0
1968401|NCT02318329|3528933|FG009|Overall Study|Death|5
1968402|NCT02318329|3528924|FG000|Overall Study|Lost to Follow-up|0
1968403|NCT02318329|3528925|FG001|Overall Study|Lost to Follow-up|0
1968404|NCT02318329|3528926|FG002|Overall Study|Lost to Follow-up|0
1968405|NCT02318329|3528927|FG003|Overall Study|Lost to Follow-up|0
1968406|NCT02318329|3528928|FG004|Overall Study|Lost to Follow-up|0
1968407|NCT02318329|3528929|FG005|Overall Study|Lost to Follow-up|0
1968408|NCT02318329|3528930|FG006|Overall Study|Lost to Follow-up|0
1968409|NCT02318329|3528931|FG007|Overall Study|Lost to Follow-up|0
1968410|NCT02318329|3528932|FG008|Overall Study|Lost to Follow-up|0
1968411|NCT02318329|3528933|FG009|Overall Study|Lost to Follow-up|1
1968412|NCT02318329|3528924|FG000|Overall Study|Withdrawal by Subject|0
1968413|NCT02318329|3528925|FG001|Overall Study|Withdrawal by Subject|0
1968414|NCT02318329|3528926|FG002|Overall Study|Withdrawal by Subject|0
1968415|NCT02318329|3528927|FG003|Overall Study|Withdrawal by Subject|0
1968416|NCT02318329|3528928|FG004|Overall Study|Withdrawal by Subject|0
1968417|NCT02318329|3528929|FG005|Overall Study|Withdrawal by Subject|0
1968418|NCT02318329|3528930|FG006|Overall Study|Withdrawal by Subject|0
1968419|NCT02318329|3528931|FG007|Overall Study|Withdrawal by Subject|0
1968420|NCT02318329|3528932|FG008|Overall Study|Withdrawal by Subject|0
1968421|NCT02318329|3528933|FG009|Overall Study|Withdrawal by Subject|6
1968422|NCT02318329|3528924|FG000|Overall Study|Other|1
1968423|NCT02318329|3528925|FG001|Overall Study|Other|1
1968424|NCT02318329|3528926|FG002|Overall Study|Other|1
1968425|NCT02318329|3528927|FG003|Overall Study|Other|0
1968426|NCT02318329|3528928|FG004|Overall Study|Other|0
1968427|NCT02318329|3528929|FG005|Overall Study|Other|0
1968428|NCT02318329|3528930|FG006|Overall Study|Other|0
1968429|NCT02318329|3528931|FG007|Overall Study|Other|0
1968430|NCT02318329|3528932|FG008|Overall Study|Other|1
1968431|NCT02318329|3528933|FG009|Overall Study|Other|1
1968432|NCT02097420|3528974|FG000|Overall Study|Death|4
1968433|NCT02097420|3528974|FG000|Overall Study|Device explanted|3
1968434|NCT02097420|3528974|FG000|Overall Study|Not reached 12-month visit|7
1968435|NCT01602666|3528980|FG000|Induction Chemotherapy|Death|2
1968436|NCT01602666|3528981|FG001|Induction Chemotherapy|Death|1
1968437|NCT01602666|3528980|FG000|Induction Chemotherapy|Lack of Efficacy|16
1968438|NCT01602666|3528981|FG001|Induction Chemotherapy|Lack of Efficacy|7
1968439|NCT01602666|3528980|FG000|Induction Chemotherapy|Physician Decision|12
1968440|NCT01602666|3528981|FG001|Induction Chemotherapy|Physician Decision|5
1968441|NCT01602666|3528980|FG000|Induction Chemotherapy|Withdrawal by Subject|0
1968442|NCT01602666|3528981|FG001|Induction Chemotherapy|Withdrawal by Subject|2
1968443|NCT01602666|3528980|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5
1968444|NCT01602666|3528981|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6
1968445|NCT01602666|3528980|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2
1968446|NCT01602666|3528981|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3
1968447|NCT01602666|3528980|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4
1968448|NCT01602666|3528981|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5
1968449|NCT01602666|3528980|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2
1968450|NCT01602666|3528981|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3
1968451|NCT01602666|3528980|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4
1968452|NCT01602666|3528981|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0
1968453|NCT01602666|3528980|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0
1968454|NCT01602666|3528981|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14
1968455|NCT01602666|3528980|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0
1968456|NCT01602666|3528981|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9
1968457|NCT01375959|3528991|FG000|First Intervention (6 Weeks)|Adverse Event|2
1968458|NCT01375959|3528992|FG001|First Intervention (6 Weeks)|Adverse Event|3
1968459|NCT01375959|3528991|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0
1968460|NCT01375959|3528992|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1
1968461|NCT01375959|3528991|FG000|Second Intervention (6 Weeks)|Adverse Event|0
1968462|NCT01375959|3528992|FG001|Second Intervention (6 Weeks)|Adverse Event|2
1968463|NCT01224106|3529003|FG000|Double-Blind Treatment Phase|Death|3
1968464|NCT01224106|3529004|FG001|Double-Blind Treatment Phase|Death|0
1968465|NCT01224106|3529005|FG002|Double-Blind Treatment Phase|Death|0
1968466|NCT01224106|3529006|FG003|Double-Blind Treatment Phase|Death|0
1968467|NCT01224106|3529007|FG004|Double-Blind Treatment Phase|Death|0
1968468|NCT01224106|3529003|FG000|Double-Blind Treatment Phase|Physician Decision|6
1968469|NCT01224106|3529004|FG001|Double-Blind Treatment Phase|Physician Decision|5
1968470|NCT01224106|3529005|FG002|Double-Blind Treatment Phase|Physician Decision|4
1968471|NCT01224106|3529006|FG003|Double-Blind Treatment Phase|Physician Decision|0
1968472|NCT01224106|3529007|FG004|Double-Blind Treatment Phase|Physician Decision|0
1968473|NCT01224106|3529003|FG000|Double-Blind Treatment Phase|Adverse Event|0
1968474|NCT01224106|3529004|FG001|Double-Blind Treatment Phase|Adverse Event|5
1968475|NCT01224106|3529005|FG002|Double-Blind Treatment Phase|Adverse Event|3
1968476|NCT01224106|3529006|FG003|Double-Blind Treatment Phase|Adverse Event|0
1968477|NCT01224106|3529007|FG004|Double-Blind Treatment Phase|Adverse Event|0
1968478|NCT01224106|3529003|FG000|Double-Blind Treatment Phase|Other|0
1968479|NCT01224106|3529004|FG001|Double-Blind Treatment Phase|Other|0
1968480|NCT01224106|3529005|FG002|Double-Blind Treatment Phase|Other|1
1968481|NCT01224106|3529006|FG003|Double-Blind Treatment Phase|Other|0
1968482|NCT01224106|3529007|FG004|Double-Blind Treatment Phase|Other|0
1968483|NCT01224106|3529003|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7
1968484|NCT01224106|3529004|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8
1968485|NCT01224106|3529005|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8
1968486|NCT01224106|3529006|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0
1968487|NCT01224106|3529007|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0
1968488|NCT01224106|3529003|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62
1968489|NCT01224106|3529004|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68
1968490|NCT01224106|3529005|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63
1968491|NCT01224106|3529006|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
1968492|NCT01224106|3529007|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
1968493|NCT01224106|3529003|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1
1968494|NCT01224106|3529004|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
1968495|NCT01224106|3529005|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
1968496|NCT01224106|3529006|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
1968497|NCT01224106|3529007|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0
1968498|NCT01224106|3529003|FG000|Open-Label Extension (OLE) Phase|Death|0
1968499|NCT01224106|3529004|FG001|Open-Label Extension (OLE) Phase|Death|0
1968500|NCT01224106|3529005|FG002|Open-Label Extension (OLE) Phase|Death|0
1968501|NCT01224106|3529006|FG003|Open-Label Extension (OLE) Phase|Death|1
1968502|NCT01224106|3529007|FG004|Open-Label Extension (OLE) Phase|Death|3
1968503|NCT01224106|3529003|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0
1968504|NCT01224106|3529004|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
1968505|NCT01224106|3529005|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0
1968506|NCT01224106|3529006|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2
1968507|NCT01224106|3529007|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6
1968508|NCT01224106|3529003|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0
1968509|NCT01224106|3529004|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0
1968510|NCT01224106|3529005|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0
1968511|NCT01224106|3529006|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2
1968512|NCT01224106|3529007|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7
1968513|NCT01224106|3529003|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
1968514|NCT01224106|3529004|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
1968515|NCT01224106|3529005|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
1968516|NCT01224106|3529006|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6
1968517|NCT01224106|3529007|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15
1968518|NCT01224106|3529003|FG000|Open-Label Extension (OLE) Phase|Other|0
1968519|NCT01224106|3529004|FG001|Open-Label Extension (OLE) Phase|Other|0
1968520|NCT01224106|3529005|FG002|Open-Label Extension (OLE) Phase|Other|0
1968521|NCT01224106|3529006|FG003|Open-Label Extension (OLE) Phase|Other|5
1968522|NCT01224106|3529007|FG004|Open-Label Extension (OLE) Phase|Other|3
1968523|NCT00567567|3529037|FG000|Overall Study|Adverse Event|0
1968524|NCT00567567|3529038|FG001|Overall Study|Adverse Event|2
1968525|NCT00567567|3529039|FG002|Overall Study|Adverse Event|5
1968526|NCT00567567|3529037|FG000|Overall Study|Death|8
1968527|NCT00567567|3529038|FG001|Overall Study|Death|1
1968528|NCT00567567|3529039|FG002|Overall Study|Death|5
1968529|NCT00567567|3529037|FG000|Overall Study|Lack of Efficacy|16
1968530|NCT00567567|3529038|FG001|Overall Study|Lack of Efficacy|17
1968531|NCT00567567|3529039|FG002|Overall Study|Lack of Efficacy|48
1968532|NCT00567567|3529037|FG000|Overall Study|Lost to Follow-up|0
1968533|NCT00567567|3529038|FG001|Overall Study|Lost to Follow-up|0
1968534|NCT00567567|3529039|FG002|Overall Study|Lost to Follow-up|1
1968535|NCT00567567|3529037|FG000|Overall Study|Physician Decision|16
1968536|NCT00567567|3529038|FG001|Overall Study|Physician Decision|18
1968537|NCT00567567|3529039|FG002|Overall Study|Physician Decision|84
1968538|NCT00567567|3529037|FG000|Overall Study|Withdrawal by Subject|0
1968539|NCT00567567|3529038|FG001|Overall Study|Withdrawal by Subject|0
1968540|NCT00567567|3529039|FG002|Overall Study|Withdrawal by Subject|2
1968541|NCT00567567|3529037|FG000|Overall Study|Ineligible|4
1968542|NCT00567567|3529038|FG001|Overall Study|Ineligible|0
1968543|NCT00567567|3529039|FG002|Overall Study|Ineligible|9
1968544|NCT00567567|3529037|FG000|Overall Study|Refusal by patient/parent/guardian|9
1968545|NCT00567567|3529038|FG001|Overall Study|Refusal by patient/parent/guardian|16
1968546|NCT00567567|3529039|FG002|Overall Study|Refusal by patient/parent/guardian|122
1968547|NCT00567567|3529037|FG000|Overall Study|Enrolled another COG therapeutic study|99
1968548|NCT00567567|3529038|FG001|Overall Study|Enrolled another COG therapeutic study|80
1968549|NCT00567567|3529039|FG002|Overall Study|Enrolled another COG therapeutic study|0
1968550|NCT00567567|3529037|FG000|Overall Study|Unable adequate stem cell for transplant|0
1968551|NCT00567567|3529038|FG001|Overall Study|Unable adequate stem cell for transplant|0
1968552|NCT00567567|3529039|FG002|Overall Study|Unable adequate stem cell for transplant|2
1968553|NCT00354835|3529051|FG000|Overall Study|Death|1
1968554|NCT00354835|3529052|FG001|Overall Study|Death|1
1968555|NCT00354835|3529051|FG000|Overall Study|Physician Decision|8
1968556|NCT00354835|3529052|FG001|Overall Study|Physician Decision|13
1968557|NCT00354835|3529051|FG000|Overall Study|Withdrawal by Subject|2
1968558|NCT00354835|3529052|FG001|Overall Study|Withdrawal by Subject|1
1968559|NCT00354835|3529051|FG000|Overall Study|Ineligible|17
1968560|NCT00354835|3529052|FG001|Overall Study|Ineligible|16
1968561|NCT00354835|3529051|FG000|Overall Study|Disease progression or relapse|15
1968562|NCT00354835|3529052|FG001|Overall Study|Disease progression or relapse|22
1968563|NCT00354835|3529051|FG000|Overall Study|Adverse Event|6
1968564|NCT00354835|3529052|FG001|Overall Study|Adverse Event|0
1968565|NCT00354835|3529051|FG000|Overall Study|Refusal of further therapy|3
1968566|NCT00354835|3529052|FG001|Overall Study|Refusal of further therapy|8
2020950|NCT00309608|3588660|FG001|Overall Study|Adverse Event|5
2020951|NCT00309608|3588661|FG002|Overall Study|Adverse Event|3
2020952|NCT00309608|3588662|FG003|Overall Study|Adverse Event|2
2020953|NCT00309608|3588663|FG004|Overall Study|Adverse Event|3
2020954|NCT00309608|3588659|FG000|Overall Study|Protocol Violation|2
2020955|NCT00309608|3588660|FG001|Overall Study|Protocol Violation|0
2020956|NCT00309608|3588661|FG002|Overall Study|Protocol Violation|0
2020957|NCT00309608|3588662|FG003|Overall Study|Protocol Violation|0
1968567|NCT04531241|3529073|FG000|Period 1|Withdrawal by Subject|2
1968568|NCT04531241|3529074|FG001|Period 1|Withdrawal by Subject|0
1968569|NCT04531241|3529073|FG000|Period 1|Dispesed incorrect lens power|1
1968570|NCT04531241|3529074|FG001|Period 1|Dispesed incorrect lens power|0
1968571|NCT04531241|3529073|FG000|Period 1|Protocol Violation|1
1968572|NCT04531241|3529074|FG001|Period 1|Protocol Violation|0
1968573|NCT04531241|3529073|FG000|Period 1|No longer eligible|0
1968574|NCT04531241|3529074|FG001|Period 1|No longer eligible|1
1968575|NCT04531241|3529073|FG000|Period 1|Lens Discomfort|0
1968576|NCT04531241|3529074|FG001|Period 1|Lens Discomfort|1
1968577|NCT04531241|3529073|FG000|Period 2|Covid-19 Related|1
1968578|NCT04531241|3529074|FG001|Period 2|Covid-19 Related|1
1968579|NCT04185220|3529119|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0
1968580|NCT04185220|3529120|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1
1968581|NCT04185220|3529119|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0
1968582|NCT04185220|3529120|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1
1968583|NCT03815175|3529137|FG000|Overall Study|Subject Lost to Follow-up|6
1968584|NCT03815175|3529137|FG000|Overall Study|Subject Withdrew Consent|48
1968585|NCT03815175|3529137|FG000|Overall Study|Subject Withdrawn by Physician/Site|10
1968586|NCT03815175|3529137|FG000|Overall Study|Death|86
1968587|NCT03815175|3529137|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1
1968588|NCT03815175|3529137|FG000|Overall Study|Subject Discontinued by Sponsor|2
1968589|NCT03815175|3529137|FG000|Overall Study|Other Status Change Reason|1
1968590|NCT03815175|3529137|FG000|Overall Study|Missed Visit|12
1968591|NCT03600714|3529141|FG000|Overall Study|Out of country and could not return for post-treatment visits|1
1968592|NCT03470441|3529162|FG000|Overall Study|Death|0
1968593|NCT03470441|3529163|FG001|Overall Study|Death|1
1968594|NCT03470441|3529164|FG002|Overall Study|Death|1
1968595|NCT03470441|3529165|FG003|Overall Study|Death|0
1968596|NCT03470441|3529162|FG000|Overall Study|Adverse Event|0
1968597|NCT03470441|3529163|FG001|Overall Study|Adverse Event|0
1968598|NCT03470441|3529164|FG002|Overall Study|Adverse Event|0
1968599|NCT03470441|3529165|FG003|Overall Study|Adverse Event|1
1968600|NCT03470441|3529162|FG000|Overall Study|Withdrawal by Subject|1
1968601|NCT03470441|3529163|FG001|Overall Study|Withdrawal by Subject|4
1968602|NCT03470441|3529164|FG002|Overall Study|Withdrawal by Subject|1
1968603|NCT03470441|3529165|FG003|Overall Study|Withdrawal by Subject|3
1968604|NCT03452397|3529179|FG000|Overall Study|Adverse Event|1
1968605|NCT03452397|3529180|FG001|Overall Study|Adverse Event|0
1968606|NCT03452397|3529181|FG002|Overall Study|Adverse Event|0
1968607|NCT03452397|3529182|FG003|Overall Study|Adverse Event|0
1968608|NCT03452397|3529179|FG000|Overall Study|Administrative reason|0
1968609|NCT03452397|3529180|FG001|Overall Study|Administrative reason|0
1968610|NCT03452397|3529181|FG002|Overall Study|Administrative reason|1
1968611|NCT03452397|3529182|FG003|Overall Study|Administrative reason|1
1968612|NCT03452397|3529179|FG000|Overall Study|Withdrawal by Subject|0
1968613|NCT03452397|3529180|FG001|Overall Study|Withdrawal by Subject|0
1968614|NCT03452397|3529181|FG002|Overall Study|Withdrawal by Subject|1
1968615|NCT03452397|3529182|FG003|Overall Study|Withdrawal by Subject|0
1968616|NCT03448939|3529196|FG000|Overall Study|Adverse Event|5
1968617|NCT03448939|3529197|FG001|Overall Study|Adverse Event|1
1968618|NCT03448939|3529196|FG000|Overall Study|Lost to Follow-up|6
1968619|NCT03448939|3529197|FG001|Overall Study|Lost to Follow-up|6
1968620|NCT03448939|3529196|FG000|Overall Study|Pregnancy|1
1968621|NCT03448939|3529197|FG001|Overall Study|Pregnancy|1
1968622|NCT03448939|3529196|FG000|Overall Study|Withdrawal by Subject|9
1968623|NCT03448939|3529197|FG001|Overall Study|Withdrawal by Subject|3
1968624|NCT03410108|3529203|FG000|Overall Study|Ongoing|41
1968625|NCT03410108|3529203|FG000|Overall Study|Adverse Event|4
1968626|NCT03410108|3529203|FG000|Overall Study|Progressive Disease|58
1968627|NCT03410108|3529203|FG000|Overall Study|Withdrawal by Subject|1
1968628|NCT03283371|3529221|FG000|Placebo-controlled|Adverse Event|1
1968629|NCT03283371|3529222|FG001|Placebo-controlled|Adverse Event|1
1968630|NCT03283371|3529223|FG002|Placebo-controlled|Adverse Event|0
1968631|NCT03283371|3529224|FG003|Placebo-controlled|Adverse Event|0
1968632|NCT03283371|3529221|FG000|Placebo-controlled|Lack of Efficacy|1
1968633|NCT03283371|3529222|FG001|Placebo-controlled|Lack of Efficacy|0
2102126|NCT00837486|3693851|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0
1968634|NCT03283371|3529223|FG002|Placebo-controlled|Lack of Efficacy|0
1968635|NCT03283371|3529224|FG003|Placebo-controlled|Lack of Efficacy|0
1968636|NCT03283371|3529221|FG000|Placebo-controlled|Withdrawal by Subject|1
1968637|NCT03283371|3529222|FG001|Placebo-controlled|Withdrawal by Subject|1
1968638|NCT03283371|3529223|FG002|Placebo-controlled|Withdrawal by Subject|0
1968639|NCT03283371|3529224|FG003|Placebo-controlled|Withdrawal by Subject|0
1968640|NCT03283371|3529221|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0
1968641|NCT03283371|3529222|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1
1968642|NCT03283371|3529223|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0
1968643|NCT03283371|3529224|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0
1968644|NCT03283371|3529221|FG000|Open-label Phase|Adverse Event|0
1968645|NCT03283371|3529222|FG001|Open-label Phase|Adverse Event|0
1968646|NCT03283371|3529223|FG002|Open-label Phase|Adverse Event|2
1968647|NCT03283371|3529224|FG003|Open-label Phase|Adverse Event|0
1968648|NCT03283371|3529221|FG000|Open-label Phase|Withdrawal by Subject|0
1968649|NCT03283371|3529222|FG001|Open-label Phase|Withdrawal by Subject|0
1968650|NCT03283371|3529223|FG002|Open-label Phase|Withdrawal by Subject|1
1968651|NCT03283371|3529224|FG003|Open-label Phase|Withdrawal by Subject|0
1968652|NCT03283371|3529221|FG000|Open-label Phase|Other|0
1968653|NCT03283371|3529222|FG001|Open-label Phase|Other|0
1968654|NCT03283371|3529223|FG002|Open-label Phase|Other|1
1968655|NCT03283371|3529224|FG003|Open-label Phase|Other|1
1968656|NCT03257254|3529234|FG000|Overall Study|Withdrawal by Subject|7
1968657|NCT03257254|3529234|FG000|Overall Study|Lost to Follow-up|9
1968658|NCT03257254|3529234|FG000|Overall Study|Study discontinued by sponsor|5
1968659|NCT03084718|3529243|FG000|Overall Study|Withdrawal by Subject|4
1968660|NCT03084718|3529244|FG001|Overall Study|Withdrawal by Subject|3
1968661|NCT03084718|3529245|FG002|Overall Study|Withdrawal by Subject|4
1968662|NCT03084718|3529246|FG003|Overall Study|Withdrawal by Subject|0
1968663|NCT03084718|3529247|FG004|Overall Study|Withdrawal by Subject|0
1968664|NCT03084718|3529243|FG000|Overall Study|Physician Decision|1
1968665|NCT03084718|3529244|FG001|Overall Study|Physician Decision|0
1968666|NCT03084718|3529245|FG002|Overall Study|Physician Decision|0
1968667|NCT03084718|3529246|FG003|Overall Study|Physician Decision|0
1968668|NCT03084718|3529247|FG004|Overall Study|Physician Decision|0
1968669|NCT03084718|3529243|FG000|Overall Study|Adverse Event|3
1968670|NCT03084718|3529244|FG001|Overall Study|Adverse Event|5
1968671|NCT03084718|3529245|FG002|Overall Study|Adverse Event|5
1968672|NCT03084718|3529246|FG003|Overall Study|Adverse Event|8
1968673|NCT03084718|3529247|FG004|Overall Study|Adverse Event|2
1968674|NCT03084718|3529243|FG000|Overall Study|Lack of Efficacy|2
1968675|NCT03084718|3529244|FG001|Overall Study|Lack of Efficacy|0
1968676|NCT03084718|3529245|FG002|Overall Study|Lack of Efficacy|1
1968677|NCT03084718|3529246|FG003|Overall Study|Lack of Efficacy|4
1968678|NCT03084718|3529247|FG004|Overall Study|Lack of Efficacy|0
1968679|NCT03084718|3529243|FG000|Overall Study|Lost to Follow-up|0
1968680|NCT03084718|3529244|FG001|Overall Study|Lost to Follow-up|1
1968681|NCT03084718|3529245|FG002|Overall Study|Lost to Follow-up|0
1968682|NCT03084718|3529246|FG003|Overall Study|Lost to Follow-up|0
1968683|NCT03084718|3529247|FG004|Overall Study|Lost to Follow-up|2
1968684|NCT03084718|3529243|FG000|Overall Study|Protocol Violation|0
1968685|NCT03084718|3529244|FG001|Overall Study|Protocol Violation|0
1968686|NCT03084718|3529245|FG002|Overall Study|Protocol Violation|1
1968687|NCT03084718|3529246|FG003|Overall Study|Protocol Violation|0
1968688|NCT03084718|3529247|FG004|Overall Study|Protocol Violation|0
1968689|NCT03084718|3529243|FG000|Overall Study|Death|0
1968690|NCT03084718|3529244|FG001|Overall Study|Death|1
1968691|NCT03084718|3529245|FG002|Overall Study|Death|0
1968692|NCT03084718|3529246|FG003|Overall Study|Death|0
1968693|NCT03084718|3529247|FG004|Overall Study|Death|0
1968694|NCT03084718|3529243|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
1968695|NCT03084718|3529244|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
1968696|NCT03084718|3529245|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
1968697|NCT03084718|3529246|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2
1968698|NCT03084718|3529247|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
1968699|NCT03069417|3529264|FG000|Overall Study|Lost to Follow-up|2
1968700|NCT03069417|3529265|FG001|Overall Study|Lost to Follow-up|0
1968701|NCT03069417|3529264|FG000|Overall Study|Reason Unknown|4
1968702|NCT03069417|3529265|FG001|Overall Study|Reason Unknown|7
1968703|NCT02936323|3529294|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1968704|NCT02936323|3529295|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
1968705|NCT02936323|3529296|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1968706|NCT02936323|3529297|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
1968707|NCT02936323|3529298|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
1968708|NCT02936323|3529299|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
1968709|NCT02936323|3529300|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1968710|NCT02936323|3529301|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1968711|NCT02936323|3529302|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1968712|NCT02936323|3529303|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
1968713|NCT02936323|3529294|FG000|Phase 1 Dose Escalation|Death|2
1968714|NCT02936323|3529295|FG001|Phase 1 Dose Escalation|Death|1
1968715|NCT02936323|3529296|FG002|Phase 1 Dose Escalation|Death|3
1968716|NCT02936323|3529297|FG003|Phase 1 Dose Escalation|Death|1
1968717|NCT02936323|3529298|FG004|Phase 1 Dose Escalation|Death|2
1968718|NCT02936323|3529299|FG005|Phase 1 Dose Escalation|Death|3
1968719|NCT02936323|3529300|FG006|Phase 1 Dose Escalation|Death|3
1968720|NCT02936323|3529301|FG007|Phase 1 Dose Escalation|Death|0
1968721|NCT02936323|3529302|FG008|Phase 1 Dose Escalation|Death|0
1968722|NCT02936323|3529303|FG009|Phase 1 Dose Escalation|Death|0
1968723|NCT02936323|3529294|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0
1968724|NCT02936323|3529295|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0
1968725|NCT02936323|3529296|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0
1968726|NCT02936323|3529297|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0
1968727|NCT02936323|3529298|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0
1968728|NCT02936323|3529299|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1
1968729|NCT02936323|3529300|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0
1968730|NCT02936323|3529301|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0
1968731|NCT02936323|3529302|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0
1968732|NCT02936323|3529303|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0
1968733|NCT02936323|3529294|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1968734|NCT02936323|3529295|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1968735|NCT02936323|3529296|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1968736|NCT02936323|3529297|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1968737|NCT02936323|3529298|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1968738|NCT02936323|3529299|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1968739|NCT02936323|3529300|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
1968740|NCT02936323|3529301|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11
1968741|NCT02936323|3529302|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4
1968742|NCT02936323|3529303|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2
2212692|NCT01672879|3853913|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
2212693|NCT01672879|3853911|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
2212694|NCT01672879|3853912|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
2212695|NCT01672879|3853913|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
2212696|NCT01672879|3853911|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
2212697|NCT01672879|3853912|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
2212698|NCT01672879|3853913|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
2212699|NCT01672892|3853924|FG000|Overall Study|Protocol Violation|7
2212700|NCT01672892|3853925|FG001|Overall Study|Protocol Violation|3
2212701|NCT01672957|3853934|FG000|Overall Study|Protocol Violation|48
2212702|NCT01672957|3853934|FG000|Overall Study|Death|2
2212703|NCT01672957|3853934|FG000|Overall Study|ICF Signed After Transplantation|5
2212704|NCT01672970|3853938|FG000|Overall Study|Lack of Efficacy|12
2212705|NCT01672970|3853938|FG000|Overall Study|Adverse Event|18
2212706|NCT01672970|3853938|FG000|Overall Study|Withdrawal by Subject|2
2212707|NCT01672970|3853938|FG000|Overall Study|Lost to Follow-up|5
2212708|NCT01672970|3853938|FG000|Overall Study|Other|9
2212709|NCT01672970|3853938|FG000|Overall Study|Enrolled but not treated|1
2212710|NCT01673009|3854000|FG000|Overall Study|Physician Decision|5
2212711|NCT01673009|3854000|FG000|Overall Study|Withdrawal by Subject|8
2217525|NCT01708954|3860856|FG002|Step 1|Disease progression|14
2217526|NCT01708954|3860854|FG000|Step 1|Adverse Event|3
2217527|NCT01708954|3860855|FG001|Step 1|Adverse Event|11
2217528|NCT01708954|3860856|FG002|Step 1|Adverse Event|13
2217529|NCT01708954|3860854|FG000|Step 1|Death|3
2217530|NCT01708954|3860855|FG001|Step 1|Death|2
2217531|NCT01708954|3860856|FG002|Step 1|Death|3
2217532|NCT01708954|3860854|FG000|Step 1|Withdrawal by Subject|2
2217533|NCT01708954|3860855|FG001|Step 1|Withdrawal by Subject|5
2217534|NCT01708954|3860856|FG002|Step 1|Withdrawal by Subject|3
2217535|NCT01708954|3860854|FG000|Step 1|Other complicating disease|0
2217536|NCT01708954|3860855|FG001|Step 1|Other complicating disease|2
2217537|NCT01708954|3860856|FG002|Step 1|Other complicating disease|0
2217538|NCT01708954|3860854|FG000|Step 1|Crossed over to Step 2|2
2217539|NCT01708954|3860855|FG001|Step 1|Crossed over to Step 2|0
2217540|NCT01708954|3860856|FG002|Step 1|Crossed over to Step 2|0
2217541|NCT01708954|3860854|FG000|Step 1|Symptomatic deterioration|1
2217542|NCT01708954|3860855|FG001|Step 1|Symptomatic deterioration|0
2217543|NCT01708954|3860856|FG002|Step 1|Symptomatic deterioration|1
1968743|NCT02936323|3529294|FG000|Phase 2a Dose Expansion|Physician Decision|0
1968744|NCT02936323|3529295|FG001|Phase 2a Dose Expansion|Physician Decision|0
1968745|NCT02936323|3529296|FG002|Phase 2a Dose Expansion|Physician Decision|0
1968746|NCT02936323|3529297|FG003|Phase 2a Dose Expansion|Physician Decision|0
1968747|NCT02936323|3529298|FG004|Phase 2a Dose Expansion|Physician Decision|0
1968748|NCT02936323|3529299|FG005|Phase 2a Dose Expansion|Physician Decision|0
1968749|NCT02936323|3529300|FG006|Phase 2a Dose Expansion|Physician Decision|0
1968750|NCT02936323|3529301|FG007|Phase 2a Dose Expansion|Physician Decision|0
1968751|NCT02936323|3529302|FG008|Phase 2a Dose Expansion|Physician Decision|0
1968752|NCT02936323|3529303|FG009|Phase 2a Dose Expansion|Physician Decision|1
1968753|NCT02936323|3529294|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0
1968754|NCT02936323|3529295|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0
1968755|NCT02936323|3529296|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0
1968756|NCT02936323|3529297|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0
1968757|NCT02936323|3529298|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0
1968758|NCT02936323|3529299|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0
1968759|NCT02936323|3529300|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0
1968760|NCT02936323|3529301|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2
1968761|NCT02936323|3529302|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1
1968762|NCT02936323|3529303|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0
1968763|NCT02936323|3529294|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1968764|NCT02936323|3529295|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0
2217544|NCT01708954|3860854|FG000|Step 1|Off-treatment reason not submitted|1
2217545|NCT01708954|3860855|FG001|Step 1|Off-treatment reason not submitted|1
1968765|NCT02936323|3529296|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1968766|NCT02936323|3529297|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1968767|NCT02936323|3529298|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1968768|NCT02936323|3529299|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1968769|NCT02936323|3529300|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1968770|NCT02936323|3529301|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1968771|NCT02936323|3529302|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0
1968772|NCT02936323|3529303|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1
1968773|NCT02936323|3529294|FG000|Phase 2a Dose Expansion|Death|0
1968774|NCT02936323|3529295|FG001|Phase 2a Dose Expansion|Death|0
1968775|NCT02936323|3529296|FG002|Phase 2a Dose Expansion|Death|0
1968776|NCT02936323|3529297|FG003|Phase 2a Dose Expansion|Death|0
1968777|NCT02936323|3529298|FG004|Phase 2a Dose Expansion|Death|0
1968778|NCT02936323|3529299|FG005|Phase 2a Dose Expansion|Death|0
1968779|NCT02936323|3529300|FG006|Phase 2a Dose Expansion|Death|0
1968780|NCT02936323|3529301|FG007|Phase 2a Dose Expansion|Death|4
1968781|NCT02936323|3529302|FG008|Phase 2a Dose Expansion|Death|8
1968782|NCT02936323|3529303|FG009|Phase 2a Dose Expansion|Death|10
1968783|NCT02437318|3529346|FG000|Overall Study|Progressive disease|173
1968784|NCT02437318|3529347|FG001|Overall Study|Progressive disease|208
1968785|NCT02437318|3529346|FG000|Overall Study|Subject/guardian decision|22
1968786|NCT02437318|3529347|FG001|Overall Study|Subject/guardian decision|10
1968787|NCT02437318|3529346|FG000|Overall Study|Physician Decision|11
1968788|NCT02437318|3529347|FG001|Overall Study|Physician Decision|10
1968789|NCT02437318|3529346|FG000|Overall Study|Adverse Event|14
1968790|NCT02437318|3529347|FG001|Overall Study|Adverse Event|3
1968791|NCT02437318|3529346|FG000|Overall Study|Death|4
1968792|NCT02437318|3529347|FG001|Overall Study|Death|4
1968793|NCT02437318|3529346|FG000|Overall Study|Protocol Violation|5
1968794|NCT02437318|3529347|FG001|Overall Study|Protocol Violation|6
1968795|NCT02437318|3529346|FG000|Overall Study|Untreated|0
1968796|NCT02437318|3529347|FG001|Overall Study|Untreated|1
1968797|NCT02429791|3529355|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6
1968798|NCT02429791|3529356|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2
1968799|NCT02429791|3529355|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
1968800|NCT02429791|3529356|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2
1968801|NCT02429791|3529355|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
1968802|NCT02429791|3529356|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
1968803|NCT02429791|3529355|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
1968804|NCT02429791|3529356|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
1968805|NCT02429791|3529355|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1
1968806|NCT02429791|3529356|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4
1968807|NCT02429791|3529355|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
1968808|NCT02429791|3529356|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
1968809|NCT02429791|3529355|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
1968810|NCT02429791|3529356|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
1968811|NCT02429791|3529355|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
1968812|NCT02429791|3529356|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
1968813|NCT02429791|3529355|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
1968814|NCT02429791|3529356|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
1968815|NCT02429791|3529355|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
1968816|NCT02429791|3529356|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
1968817|NCT02429791|3529355|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
1968818|NCT02429791|3529356|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
1968819|NCT02429791|3529355|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
1968820|NCT02429791|3529356|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
1968821|NCT02422797|3529371|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11
1968822|NCT02422797|3529372|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1
1968823|NCT02422797|3529371|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
1968824|NCT02422797|3529372|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1
1968825|NCT02422797|3529371|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
1968826|NCT02422797|3529372|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
1968827|NCT02422797|3529371|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
1968828|NCT02422797|3529372|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
1968829|NCT02422797|3529371|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0
1968830|NCT02422797|3529372|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3
1968831|NCT02422797|3529371|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
1968832|NCT02422797|3529372|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
1968833|NCT02422797|3529371|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
1968834|NCT02422797|3529372|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
1968835|NCT02422797|3529371|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
1968836|NCT02422797|3529372|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
1968837|NCT02422797|3529371|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
1968838|NCT02422797|3529372|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
1968839|NCT02422797|3529371|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
1968840|NCT02422797|3529372|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
1968841|NCT02422797|3529371|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
1968842|NCT02422797|3529372|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
1968843|NCT02422797|3529371|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
1968844|NCT02422797|3529372|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
1968845|NCT02422797|3529371|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
1968846|NCT02422797|3529372|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
1968847|NCT02422797|3529371|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
1968848|NCT02422797|3529372|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
1968849|NCT02422615|3529390|FG000|Overall Study|Progressive disease|193
1968850|NCT02422615|3529391|FG001|Overall Study|Progressive disease|142
1968851|NCT02422615|3529390|FG000|Overall Study|Adverse Event|41
1968852|NCT02422615|3529391|FG001|Overall Study|Adverse Event|10
1968853|NCT02422615|3529390|FG000|Overall Study|Physician Decision|22
1968854|NCT02422615|3529391|FG001|Overall Study|Physician Decision|7
1968855|NCT02422615|3529390|FG000|Overall Study|Subject/guardian decision|21
1968856|NCT02422615|3529391|FG001|Overall Study|Subject/guardian decision|5
1968857|NCT02422615|3529390|FG000|Overall Study|Death|2
1968858|NCT02422615|3529391|FG001|Overall Study|Death|0
1968859|NCT02422615|3529390|FG000|Overall Study|Protocol Violation|1
1968860|NCT02422615|3529391|FG001|Overall Study|Protocol Violation|1
1968861|NCT02422615|3529390|FG000|Overall Study|Technical problems|0
1968862|NCT02422615|3529391|FG001|Overall Study|Technical problems|1
2020958|NCT00309608|3588663|FG004|Overall Study|Protocol Violation|0
2020959|NCT00309608|3588659|FG000|Overall Study|Lost to Follow-up|0
2020960|NCT00309608|3588660|FG001|Overall Study|Lost to Follow-up|0
2020961|NCT00309608|3588661|FG002|Overall Study|Lost to Follow-up|2
2020962|NCT00309608|3588662|FG003|Overall Study|Lost to Follow-up|0
2020963|NCT00309608|3588663|FG004|Overall Study|Lost to Follow-up|1
2020964|NCT00309608|3588659|FG000|Overall Study|Withdrawal by Subject|1
2020965|NCT00309608|3588660|FG001|Overall Study|Withdrawal by Subject|4
2020966|NCT00309608|3588661|FG002|Overall Study|Withdrawal by Subject|2
2020967|NCT00309608|3588662|FG003|Overall Study|Withdrawal by Subject|0
2020968|NCT00309608|3588663|FG004|Overall Study|Withdrawal by Subject|0
2020969|NCT00309608|3588659|FG000|Overall Study|Other incl. Lack of efficacy|10
2020970|NCT00309608|3588660|FG001|Overall Study|Other incl. Lack of efficacy|4
2020971|NCT00309608|3588661|FG002|Overall Study|Other incl. Lack of efficacy|3
2020972|NCT00309608|3588662|FG003|Overall Study|Other incl. Lack of efficacy|4
2020973|NCT00309608|3588663|FG004|Overall Study|Other incl. Lack of efficacy|0
2020974|NCT00309777|3588697|FG000|Overall Study|Adverse Event|13
2020975|NCT00309777|3588698|FG001|Overall Study|Adverse Event|2
2020976|NCT00309777|3588699|FG002|Overall Study|Adverse Event|8
2020977|NCT00309777|3588700|FG003|Overall Study|Adverse Event|1
2020978|NCT00309777|3588697|FG000|Overall Study|Protocol Violation|4
2020979|NCT00309777|3588698|FG001|Overall Study|Protocol Violation|1
2020980|NCT00309777|3588699|FG002|Overall Study|Protocol Violation|3
2020981|NCT00309777|3588700|FG003|Overall Study|Protocol Violation|1
2020982|NCT00309777|3588697|FG000|Overall Study|Withdrawal by Subject|6
2020983|NCT00309777|3588698|FG001|Overall Study|Withdrawal by Subject|5
2020984|NCT00309777|3588699|FG002|Overall Study|Withdrawal by Subject|7
2020985|NCT00309777|3588700|FG003|Overall Study|Withdrawal by Subject|2
2020986|NCT00309777|3588697|FG000|Overall Study|Lost to Follow-up|0
2020987|NCT00309777|3588698|FG001|Overall Study|Lost to Follow-up|0
2020988|NCT00309777|3588699|FG002|Overall Study|Lost to Follow-up|1
2020989|NCT00309777|3588700|FG003|Overall Study|Lost to Follow-up|0
2020990|NCT00309777|3588697|FG000|Overall Study|Death|0
2020991|NCT00309777|3588698|FG001|Overall Study|Death|1
2020992|NCT00309777|3588699|FG002|Overall Study|Death|0
2020993|NCT00309777|3588700|FG003|Overall Study|Death|0
2020994|NCT00309842|3588710|FG000|Overall Study|Lost to Follow-up|1
2020995|NCT00309907|3588714|FG000|Overall Study|Death|4
2020996|NCT00309907|3588714|FG000|Overall Study|Physician Decision|1
2020997|NCT00309907|3588714|FG000|Overall Study|Ineligible|11
2020998|NCT00309907|3588714|FG000|Overall Study|Major infectious event|4
2020999|NCT00309946|3588719|FG000|Overall Study|Withdrawal by Subject|1
2021000|NCT00309959|3588723|FG000|Overall Study|Ineligible - no prior chemotherapy|2
2021001|NCT00309985|3588734|FG000|Overall Study|Disease progression|12
2021002|NCT00309985|3588735|FG001|Overall Study|Disease progression|0
2021003|NCT00309985|3588734|FG000|Overall Study|Adverse Event|30
2021004|NCT00309985|3588735|FG001|Overall Study|Adverse Event|0
2021005|NCT00309985|3588734|FG000|Overall Study|Death|2
2021006|NCT00309985|3588735|FG001|Overall Study|Death|0
2021007|NCT00309985|3588734|FG000|Overall Study|Withdrawal by Subject|5
2021008|NCT00309985|3588735|FG001|Overall Study|Withdrawal by Subject|1
2021009|NCT00309985|3588734|FG000|Overall Study|Physician Decision|3
2021010|NCT00309985|3588735|FG001|Overall Study|Physician Decision|0
2021011|NCT00309985|3588734|FG000|Overall Study|Never started treatment|7
2021012|NCT00309985|3588735|FG001|Overall Study|Never started treatment|0
2021013|NCT00309985|3588734|FG000|Overall Study|Complicating disease|1
2021014|NCT00309985|3588735|FG001|Overall Study|Complicating disease|0
2021015|NCT00309985|3588734|FG000|Overall Study|Non-compliance|1
2021016|NCT00309985|3588735|FG001|Overall Study|Non-compliance|0
1968863|NCT02132611|3529410|FG000|Overall Study|Death|2
1968864|NCT01796197|3529414|FG000|Overall Study|Lost to Follow-up|1
1968865|NCT01796197|3529414|FG000|Overall Study|Lack of Efficacy|1
1968866|NCT01147822|3529420|FG000|Overall Study|Death|66
1968867|NCT01147822|3529421|FG001|Overall Study|Death|59
1968868|NCT01147822|3529420|FG000|Overall Study|Protocol Violation|0
1968869|NCT01147822|3529421|FG001|Overall Study|Protocol Violation|1
1968870|NCT01147822|3529420|FG000|Overall Study|Lost to Follow-up|3
1968871|NCT01147822|3529421|FG001|Overall Study|Lost to Follow-up|2
1968872|NCT01147822|3529420|FG000|Overall Study|Physician Decision|0
1968873|NCT01147822|3529421|FG001|Overall Study|Physician Decision|2
1968874|NCT01147822|3529420|FG000|Overall Study|Withdrawal by Subject|8
1968875|NCT01147822|3529421|FG001|Overall Study|Withdrawal by Subject|13
1968876|NCT01147822|3529420|FG000|Overall Study|Not Completed/Ongoing|111
1968877|NCT01147822|3529421|FG001|Overall Study|Not Completed/Ongoing|102
1968878|NCT04476251|3529442|FG000|Overall Study|Not treated|1
1968879|NCT03915860|3529450|FG000|Overall Study|Adverse Event|3
1968880|NCT03915860|3529450|FG000|Overall Study|Withdrawal by Subject|6
1968881|NCT03915860|3529450|FG000|Overall Study|Lost to Follow-up|2
1968882|NCT03915860|3529450|FG000|Overall Study|Other than specified|3
1968883|NCT03795233|3529469|FG000|Overall Study|Withdrawal by Subject|2
1968884|NCT03795233|3529470|FG001|Overall Study|Withdrawal by Subject|1
1968885|NCT03795233|3529469|FG000|Overall Study|Lost to Follow-up|1
1968886|NCT03795233|3529470|FG001|Overall Study|Lost to Follow-up|0
1968887|NCT03795233|3529469|FG000|Overall Study|Death|1
1968888|NCT03795233|3529470|FG001|Overall Study|Death|0
1968889|NCT03786380|3529481|FG000|Overall Study|Adverse Event|1
1968890|NCT03786380|3529482|FG001|Overall Study|Adverse Event|0
1968891|NCT03786380|3529483|FG002|Overall Study|Adverse Event|0
1968892|NCT03786380|3529484|FG003|Overall Study|Adverse Event|3
1968893|NCT03786380|3529485|FG004|Overall Study|Adverse Event|1
1968894|NCT03786380|3529481|FG000|Overall Study|Lack of Efficacy|0
1968895|NCT03786380|3529482|FG001|Overall Study|Lack of Efficacy|0
1968896|NCT03786380|3529483|FG002|Overall Study|Lack of Efficacy|0
1968897|NCT03786380|3529484|FG003|Overall Study|Lack of Efficacy|0
1968898|NCT03786380|3529485|FG004|Overall Study|Lack of Efficacy|1
1968899|NCT03786380|3529481|FG000|Overall Study|Withdrawal by Subject|1
1968900|NCT03786380|3529482|FG001|Overall Study|Withdrawal by Subject|2
1968901|NCT03786380|3529483|FG002|Overall Study|Withdrawal by Subject|2
1968902|NCT03786380|3529484|FG003|Overall Study|Withdrawal by Subject|1
1968903|NCT03786380|3529485|FG004|Overall Study|Withdrawal by Subject|2
1968904|NCT03786380|3529481|FG000|Overall Study|Lost to Follow-up|3
1968905|NCT03786380|3529482|FG001|Overall Study|Lost to Follow-up|0
1968906|NCT03786380|3529483|FG002|Overall Study|Lost to Follow-up|1
1968907|NCT03786380|3529484|FG003|Overall Study|Lost to Follow-up|2
1968908|NCT03786380|3529485|FG004|Overall Study|Lost to Follow-up|0
1968909|NCT03786380|3529481|FG000|Overall Study|Physician Decision|0
1968910|NCT03786380|3529482|FG001|Overall Study|Physician Decision|0
1968911|NCT03786380|3529483|FG002|Overall Study|Physician Decision|1
1968912|NCT03786380|3529484|FG003|Overall Study|Physician Decision|0
1968913|NCT03786380|3529485|FG004|Overall Study|Physician Decision|0
1968914|NCT03786380|3529481|FG000|Overall Study|Study Terminated by the Sponsor|30
1968915|NCT03786380|3529482|FG001|Overall Study|Study Terminated by the Sponsor|20
1968916|NCT03786380|3529483|FG002|Overall Study|Study Terminated by the Sponsor|50
1968917|NCT03786380|3529484|FG003|Overall Study|Study Terminated by the Sponsor|57
1968918|NCT03786380|3529485|FG004|Overall Study|Study Terminated by the Sponsor|23
1968919|NCT03786380|3529481|FG000|Overall Study|Reason Not Specified|0
1968920|NCT03786380|3529482|FG001|Overall Study|Reason Not Specified|0
1968921|NCT03786380|3529483|FG002|Overall Study|Reason Not Specified|0
1968922|NCT03786380|3529484|FG003|Overall Study|Reason Not Specified|0
1968923|NCT03786380|3529485|FG004|Overall Study|Reason Not Specified|1
1968924|NCT03645863|3529509|FG000|Overall Study|Withdrawal by Subject|1
1968925|NCT03645863|3529510|FG001|Overall Study|Withdrawal by Subject|0
1968926|NCT03645863|3529511|FG002|Overall Study|Withdrawal by Subject|0
1968927|NCT03564145|3529519|FG000|Overall Study|Adverse Event|4
1968928|NCT03564145|3529519|FG000|Overall Study|Lost to Follow-up|21
1968929|NCT03564145|3529519|FG000|Overall Study|Protocol Violation|2
1968930|NCT03564145|3529519|FG000|Overall Study|Withdrawal by Subject|48
1968931|NCT03564145|3529519|FG000|Overall Study|Study Terminated by Sponsor|146
1968932|NCT03564145|3529519|FG000|Overall Study|Physician Decision|1
1968933|NCT03564145|3529519|FG000|Overall Study|Other Than Specified|1
1968934|NCT03564145|3529519|FG000|Overall Study|Pregnancy|1
1968935|NCT03564119|3529525|FG000|Overall Study|Adverse Event|4
1968936|NCT03564119|3529526|FG001|Overall Study|Adverse Event|0
1968937|NCT03564119|3529525|FG000|Overall Study|Lost to Follow-up|1
1968938|NCT03564119|3529526|FG001|Overall Study|Lost to Follow-up|4
1968939|NCT03564119|3529525|FG000|Overall Study|Protocol Violation|1
1968940|NCT03564119|3529526|FG001|Overall Study|Protocol Violation|0
1968941|NCT03564119|3529525|FG000|Overall Study|Withdrawal by Subject|9
1968942|NCT03564119|3529526|FG001|Overall Study|Withdrawal by Subject|4
1968943|NCT03564119|3529525|FG000|Overall Study|Other Than Specified|0
1968944|NCT03564119|3529526|FG001|Overall Study|Other Than Specified|1
1968945|NCT03181529|3529581|FG000|Overall Study|Withdrawal by Subject|1
1968946|NCT03181529|3529582|FG001|Overall Study|Withdrawal by Subject|1
2021017|NCT00309985|3588734|FG000|Overall Study|Chemotherapy discontinued only|1
1968947|NCT03181529|3529581|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1
1968948|NCT03181529|3529582|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0
1968949|NCT02946931|3529651|FG000|Overall Study|Did not require collection of CRFs|573
2212712|NCT01673126|3854020|FG000|Overall Study|change of diagnosis|4
2212713|NCT01673126|3854021|FG001|Overall Study|change of diagnosis|3
1968950|NCT02946931|3529651|FG000|Overall Study|Other than listed|38
1968951|NCT02946931|3529651|FG000|Overall Study|Discharge from hospital|117
1968952|NCT02946931|3529651|FG000|Overall Study|Adverse Event|81
1968953|NCT02946931|3529651|FG000|Overall Study|CRFs not fixed|2
1968954|NCT02946931|3529651|FG000|Overall Study|CRFs not valid|1
1968955|NCT02946931|3529651|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6
1968956|NCT02779556|3529657|FG000|Baseline|Partial baseline interview completed|1
1968957|NCT02779556|3529658|FG001|Baseline|Partial baseline interview completed|0
1968958|NCT02779556|3529657|FG000|3 Months|Lost to Follow-up|40
1968959|NCT02779556|3529658|FG001|3 Months|Lost to Follow-up|29
1968960|NCT02779556|3529657|FG000|3 Months|Missed 3 month clinic visit|27
1968961|NCT02779556|3529658|FG001|3 Months|Missed 3 month clinic visit|19
1968962|NCT02779556|3529657|FG000|6 Month|Lost to Follow-up|33
1968963|NCT02779556|3529658|FG001|6 Month|Lost to Follow-up|39
1968964|NCT02779556|3529657|FG000|6 Month HbA1c|No value collected during window|69
1968965|NCT02779556|3529658|FG001|6 Month HbA1c|No value collected during window|50
1968966|NCT02779556|3529657|FG000|12 Month HbA1c|No value collected during window|138
1968967|NCT02779556|3529658|FG001|12 Month HbA1c|No value collected during window|102
1968968|NCT02675751|3529682|FG000|Overall Study|Lost to Follow-up|16
1968969|NCT02621424|3529697|FG000|Overall Study|Withdrawal by Subject|1
1968970|NCT02621424|3529698|FG001|Overall Study|Withdrawal by Subject|2
1968971|NCT02611960|3529706|FG000|Overall Study|COVID-19 Association Unspecified Adverse Event|7
1968972|NCT02611960|3529707|FG001|Overall Study|COVID-19 Association Unspecified Adverse Event|8
1968973|NCT02611960|3529706|FG000|Overall Study|Death|87
1968974|NCT02611960|3529707|FG001|Overall Study|Death|85
1968975|NCT02611960|3529706|FG000|Overall Study|Withdrawal by Subject|0
1968976|NCT02611960|3529707|FG001|Overall Study|Withdrawal by Subject|1
1968977|NCT02611960|3529706|FG000|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|1
1968978|NCT02611960|3529707|FG001|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|4
1968979|NCT02611960|3529706|FG000|Overall Study|Participants Ongoing|22
1968980|NCT02611960|3529707|FG001|Overall Study|Participants Ongoing|18
1968981|NCT02595372|3529714|FG000|Overall Study|Adverse Event|6
1968982|NCT02595372|3529714|FG000|Overall Study|Physician Decision|2
1968983|NCT02595372|3529714|FG000|Overall Study|Disease Progression|1
1968984|NCT02434354|3529724|FG000|Overall Study|screen fail|3
1968985|NCT02334722|3529730|FG000|Overall Study|Lost to Follow-up|4
1968986|NCT02334722|3529731|FG001|Overall Study|Lost to Follow-up|0
1968987|NCT02334722|3529730|FG000|Overall Study|6 week questionnaire not completed|2
1968988|NCT02334722|3529731|FG001|Overall Study|6 week questionnaire not completed|0
1968989|NCT02334722|3529730|FG000|Overall Study|Unable to obtain medication|1
1968990|NCT02334722|3529731|FG001|Overall Study|Unable to obtain medication|1
1968991|NCT02334722|3529730|FG000|Overall Study|Withdrawal by Subject|0
1968992|NCT02334722|3529731|FG001|Overall Study|Withdrawal by Subject|3
1968993|NCT02334722|3529730|FG000|Overall Study|Adverse Event|0
1968994|NCT02334722|3529731|FG001|Overall Study|Adverse Event|2
1968995|NCT02334722|3529730|FG000|Overall Study|Physician Decision|0
1968996|NCT02334722|3529731|FG001|Overall Study|Physician Decision|1
1968997|NCT01966731|3529741|FG000|Overall Study|Death|2
1968998|NCT01966731|3529741|FG000|Overall Study|Lost to Follow-up|1
1968999|NCT01966731|3529741|FG000|Overall Study|Physician Decision|2
1969000|NCT01966731|3529741|FG000|Overall Study|Follow up is not complete|600
1969001|NCT01966731|3529741|FG000|Overall Study|Screening Failure|29
1969002|NCT01966731|3529741|FG000|Overall Study|Found to be ineligible|1
1969003|NCT01844518|3529765|FG000|Overall Study|Adverse Event|7
1969004|NCT01844518|3529766|FG001|Overall Study|Adverse Event|1
1969005|NCT01844518|3529765|FG000|Overall Study|Lack of Efficacy|17
1969006|NCT01844518|3529766|FG001|Overall Study|Lack of Efficacy|5
1969007|NCT01844518|3529765|FG000|Overall Study|Participant's request to discontinue|4
1969008|NCT01844518|3529766|FG001|Overall Study|Participant's request to discontinue|1
1969009|NCT01844518|3529765|FG000|Overall Study|Poor/Non-compliance|1
1969010|NCT01844518|3529766|FG001|Overall Study|Poor/Non-compliance|0
1969011|NCT01844518|3529765|FG000|Overall Study|No Longer Met Study Criteria|2
1969012|NCT01844518|3529766|FG001|Overall Study|No Longer Met Study Criteria|0
1969013|NCT01844518|3529765|FG000|Overall Study|Withdrawal by Subject|9
1969014|NCT01844518|3529766|FG001|Overall Study|Withdrawal by Subject|0
1969015|NCT01844518|3529765|FG000|Overall Study|Pregnancy|1
1969016|NCT01844518|3529766|FG001|Overall Study|Pregnancy|0
1969017|NCT01675479|3529775|FG000|Overall Study|Lost to Follow-up|11
1969018|NCT01349959|3529788|FG000|Overall Study|Adverse Event|7
1969019|NCT01193842|3529797|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1969020|NCT01193842|3529798|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
1969021|NCT01193842|3529799|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1969022|NCT01193842|3529800|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1969023|NCT01193842|3529801|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1969024|NCT01193842|3529797|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
1969025|NCT01193842|3529798|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1969026|NCT01193842|3529799|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1969027|NCT01193842|3529800|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1969028|NCT01193842|3529801|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1969029|NCT01193842|3529797|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1969030|NCT01193842|3529798|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1969031|NCT01193842|3529799|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
1969032|NCT01193842|3529800|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1969033|NCT01193842|3529801|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1969034|NCT01193842|3529797|FG000|Phase II: Randomized Groups|Death|0
1969035|NCT01193842|3529798|FG001|Phase II: Randomized Groups|Death|0
1969036|NCT01193842|3529799|FG002|Phase II: Randomized Groups|Death|0
1969037|NCT01193842|3529800|FG003|Phase II: Randomized Groups|Death|1
1969038|NCT01193842|3529801|FG004|Phase II: Randomized Groups|Death|1
1969039|NCT01193842|3529797|FG000|Phase II: Randomized Groups|Adverse Event|0
1969040|NCT01193842|3529798|FG001|Phase II: Randomized Groups|Adverse Event|0
1969041|NCT01193842|3529799|FG002|Phase II: Randomized Groups|Adverse Event|0
1969042|NCT01193842|3529800|FG003|Phase II: Randomized Groups|Adverse Event|5
1969043|NCT01193842|3529801|FG004|Phase II: Randomized Groups|Adverse Event|3
1969044|NCT01193842|3529797|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0
1969045|NCT01193842|3529798|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0
1969046|NCT01193842|3529799|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0
1969047|NCT01193842|3529800|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1
1969048|NCT01193842|3529801|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2
1969049|NCT01193842|3529797|FG000|Phase II: Randomized Groups|Ineligible|0
1969050|NCT01193842|3529798|FG001|Phase II: Randomized Groups|Ineligible|0
1969051|NCT01193842|3529799|FG002|Phase II: Randomized Groups|Ineligible|0
1969052|NCT01193842|3529800|FG003|Phase II: Randomized Groups|Ineligible|0
1969053|NCT01193842|3529801|FG004|Phase II: Randomized Groups|Ineligible|1
1969054|NCT01193842|3529797|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1969055|NCT01193842|3529798|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1969056|NCT01193842|3529799|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1969057|NCT01193842|3529800|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
1969058|NCT01193842|3529801|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
1969059|NCT01168219|3529818|FG000|Overall Study|off study before starting treatment|2
1969060|NCT01168219|3529818|FG000|Overall Study|withdrew before transplant|1
1969061|NCT01168219|3529818|FG000|Overall Study|ineligible due to CML|2
2021018|NCT00309985|3588735|FG001|Overall Study|Chemotherapy discontinued only|0
2021019|NCT00310037|3588743|FG000|Overall Study|Adverse Event|7
2021020|NCT00310037|3588744|FG001|Overall Study|Adverse Event|14
2021021|NCT00310037|3588743|FG000|Overall Study|Withdrawal by Subject|4
2021022|NCT00310037|3588744|FG001|Overall Study|Withdrawal by Subject|3
2021023|NCT00310037|3588743|FG000|Overall Study|Progression|6
2021024|NCT00310037|3588744|FG001|Overall Study|Progression|0
2021025|NCT00310037|3588743|FG000|Overall Study|Non-protocol treatment|1
2021026|NCT00310037|3588744|FG001|Overall Study|Non-protocol treatment|0
2021027|NCT00310375|3588788|FG000|Primary Reporting Phase|Adverse Event|28
2021028|NCT00310375|3588789|FG001|Primary Reporting Phase|Adverse Event|22
2021029|NCT00310375|3588790|FG002|Primary Reporting Phase|Adverse Event|0
2021030|NCT00310375|3588788|FG000|Primary Reporting Phase|Lack of Efficacy|24
2021031|NCT00310375|3588789|FG001|Primary Reporting Phase|Lack of Efficacy|19
2021032|NCT00310375|3588790|FG002|Primary Reporting Phase|Lack of Efficacy|0
2021033|NCT00310375|3588788|FG000|Primary Reporting Phase|Pregnancy|2
2021034|NCT00310375|3588789|FG001|Primary Reporting Phase|Pregnancy|2
2021035|NCT00310375|3588790|FG002|Primary Reporting Phase|Pregnancy|0
2021036|NCT00310375|3588788|FG000|Primary Reporting Phase|Withdrawal by Subject|10
2021037|NCT00310375|3588789|FG001|Primary Reporting Phase|Withdrawal by Subject|7
2021038|NCT00310375|3588790|FG002|Primary Reporting Phase|Withdrawal by Subject|0
2021039|NCT00310375|3588788|FG000|Primary Reporting Phase|Protocol Violation|8
2021040|NCT00310375|3588789|FG001|Primary Reporting Phase|Protocol Violation|5
2021041|NCT00310375|3588790|FG002|Primary Reporting Phase|Protocol Violation|0
2021042|NCT00310375|3588788|FG000|Primary Reporting Phase|Change in Par medical condition|2
2021043|NCT00310375|3588789|FG001|Primary Reporting Phase|Change in Par medical condition|0
2021044|NCT00310375|3588790|FG002|Primary Reporting Phase|Change in Par medical condition|0
2021045|NCT00310375|3588788|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
2021046|NCT00310375|3588789|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
2021047|NCT00310375|3588790|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
2021048|NCT00310375|3588788|FG000|Primary Reporting Phase|Physician Decision|5
2021049|NCT00310375|3588789|FG001|Primary Reporting Phase|Physician Decision|3
2021050|NCT00310375|3588790|FG002|Primary Reporting Phase|Physician Decision|0
2021051|NCT00310375|3588788|FG000|Primary Reporting Phase|Request of the sponsor|2
2021052|NCT00310375|3588789|FG001|Primary Reporting Phase|Request of the sponsor|2
2021053|NCT00310375|3588790|FG002|Primary Reporting Phase|Request of the sponsor|0
2021054|NCT00310375|3588788|FG000|Primary Reporting Phase|Failed to return|1
2021055|NCT00310375|3588789|FG001|Primary Reporting Phase|Failed to return|3
2021056|NCT00310375|3588790|FG002|Primary Reporting Phase|Failed to return|0
1969062|NCT01062425|3529841|FG000|Overall Study|Protocol Violation|3
1969063|NCT01062425|3529842|FG001|Overall Study|Protocol Violation|6
1969064|NCT00812708|3529848|FG000|Overall Study|Device could not be implanted|2
1969065|NCT00812708|3529848|FG000|Overall Study|Lack of medical insurance|1
1969066|NCT00812708|3529848|FG000|Overall Study|Switched to another study|1
1969067|NCT00812708|3529848|FG000|Overall Study|Surgery cancelled due to uveitis|1
1969068|NCT00812708|3529848|FG000|Overall Study|Signed consent but later withdrew|3
1969069|NCT00792259|3529856|FG000|Overall Study|Poor Quality Scans|1
1969070|NCT00792259|3529857|FG001|Overall Study|Poor Quality Scans|0
1969071|NCT00792259|3529858|FG002|Overall Study|Poor Quality Scans|0
1969072|NCT00741988|3529868|FG000|Overall Study|Adverse Event|2
1969073|NCT00741988|3529869|FG001|Overall Study|Adverse Event|4
1969074|NCT00741988|3529868|FG000|Overall Study|Lack of Efficacy|2
1969075|NCT00741988|3529869|FG001|Overall Study|Lack of Efficacy|0
1969076|NCT00515671|3529886|FG000|Overall Study|Lost to Follow-up|13
1969077|NCT00515671|3529887|FG001|Overall Study|Lost to Follow-up|10
1969078|NCT00515671|3529886|FG000|Overall Study|Withdrawal by Subject|3
1969079|NCT00515671|3529887|FG001|Overall Study|Withdrawal by Subject|5
1969080|NCT00515671|3529886|FG000|Overall Study|incarcerated|1
1969081|NCT00515671|3529887|FG001|Overall Study|incarcerated|2
1969082|NCT00455403|3529895|FG000|Overall Study|Lost to Follow-up|2
1969083|NCT00455403|3529896|FG001|Overall Study|Lost to Follow-up|1
1969084|NCT00455403|3529895|FG000|Overall Study|Withdrawal by Subject|1
1969085|NCT00455403|3529896|FG001|Overall Study|Withdrawal by Subject|3
1969086|NCT00455403|3529895|FG000|Overall Study|Protocol Violation|0
1969087|NCT00455403|3529896|FG001|Overall Study|Protocol Violation|2
1969088|NCT00238420|3529904|FG000|Overall Study|Protocol Violation|1
1969089|NCT00238420|3529905|FG001|Overall Study|Protocol Violation|1
2021057|NCT00310375|3588788|FG000|Primary Reporting Phase|Participant request unrelated to study|1
2021058|NCT00310375|3588789|FG001|Primary Reporting Phase|Participant request unrelated to study|2
2021059|NCT00310375|3588790|FG002|Primary Reporting Phase|Participant request unrelated to study|0
2021060|NCT00310375|3588788|FG000|Primary Reporting Phase|Going for temporal lobectomy|1
2021061|NCT00310375|3588789|FG001|Primary Reporting Phase|Going for temporal lobectomy|0
2021062|NCT00310375|3588790|FG002|Primary Reporting Phase|Going for temporal lobectomy|0
2021063|NCT00310375|3588788|FG000|Primary Reporting Phase|Missed study drug >5 days|1
2021064|NCT00310375|3588789|FG001|Primary Reporting Phase|Missed study drug >5 days|0
2021065|NCT00310375|3588790|FG002|Primary Reporting Phase|Missed study drug >5 days|0
2021066|NCT00310375|3588788|FG000|Primary Reporting Phase|Site closure|3
2021067|NCT00310375|3588789|FG001|Primary Reporting Phase|Site closure|0
2021068|NCT00310375|3588790|FG002|Primary Reporting Phase|Site closure|0
2021069|NCT00310375|3588788|FG000|Primary Reporting Phase|Missed study drug for 2 months|1
2021070|NCT00310375|3588789|FG001|Primary Reporting Phase|Missed study drug for 2 months|0
2021071|NCT00310375|3588790|FG002|Primary Reporting Phase|Missed study drug for 2 months|0
2021072|NCT00310375|3588788|FG000|Primary Reporting Phase|Par. switched to commercial product|0
2021073|NCT00310375|3588789|FG001|Primary Reporting Phase|Par. switched to commercial product|1
2021074|NCT00310375|3588790|FG002|Primary Reporting Phase|Par. switched to commercial product|0
2021075|NCT00310375|3588788|FG000|Primary Reporting Phase|Request of Ethics Committee|0
2021076|NCT00310375|3588789|FG001|Primary Reporting Phase|Request of Ethics Committee|1
2021077|NCT00310375|3588790|FG002|Primary Reporting Phase|Request of Ethics Committee|0
2021078|NCT00310375|3588788|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0
2021079|NCT00310375|3588789|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0
2021080|NCT00310375|3588790|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1
2021081|NCT00310440|3588821|FG000|Overall Study|Lost to Follow-up|17
2021082|NCT00310440|3588822|FG001|Overall Study|Lost to Follow-up|8
2021083|NCT00310440|3588821|FG000|Overall Study|Withdrawal by Subject|2
2021084|NCT00310440|3588822|FG001|Overall Study|Withdrawal by Subject|1
2021085|NCT00310440|3588821|FG000|Overall Study|Missed 12 Month Visit|7
2021086|NCT00310440|3588822|FG001|Overall Study|Missed 12 Month Visit|4
2021087|NCT00310804|3588848|FG000|Overall Study|Lost to Follow-up|2
2021088|NCT00310804|3588849|FG001|Overall Study|Lost to Follow-up|0
2021089|NCT00310804|3588848|FG000|Overall Study|Withdrawal by Subject|3
2021090|NCT00310804|3588849|FG001|Overall Study|Withdrawal by Subject|0
2021091|NCT00310817|3588873|FG000|Overall Study|AE or Death|3
2021092|NCT00310817|3588874|FG001|Overall Study|AE or Death|1
2021093|NCT00310817|3588875|FG002|Overall Study|AE or Death|0
2021094|NCT00310817|3588876|FG003|Overall Study|AE or Death|0
2021095|NCT00310817|3588873|FG000|Overall Study|Withdrawal by Subject|1
2021096|NCT00310817|3588874|FG001|Overall Study|Withdrawal by Subject|4
2021097|NCT00310817|3588875|FG002|Overall Study|Withdrawal by Subject|6
2021098|NCT00310817|3588876|FG003|Overall Study|Withdrawal by Subject|7
2021099|NCT00310817|3588873|FG000|Overall Study|Lost to Follow-up|2
2021100|NCT00310817|3588874|FG001|Overall Study|Lost to Follow-up|1
2021101|NCT00310817|3588875|FG002|Overall Study|Lost to Follow-up|0
2021102|NCT00310817|3588876|FG003|Overall Study|Lost to Follow-up|0
2021103|NCT00310817|3588873|FG000|Overall Study|Inappropriate Enrollment|1
2021104|NCT00310817|3588874|FG001|Overall Study|Inappropriate Enrollment|0
2021105|NCT00310817|3588875|FG002|Overall Study|Inappropriate Enrollment|1
2021106|NCT00310817|3588876|FG003|Overall Study|Inappropriate Enrollment|0
2021107|NCT00310817|3588873|FG000|Overall Study|Protocol Violation|1
2021108|NCT00310817|3588874|FG001|Overall Study|Protocol Violation|1
1969090|NCT04128319|3529924|FG000|Overall Study|Death|3
1969091|NCT03761810|3529930|FG000|Overall Study|Adverse Event|12
1969092|NCT03761810|3529931|FG001|Overall Study|Adverse Event|0
1969093|NCT03761810|3529930|FG000|Overall Study|Lost to Follow-up|15
1969094|NCT03761810|3529931|FG001|Overall Study|Lost to Follow-up|7
1969095|NCT03761810|3529930|FG000|Overall Study|Pregnancy|1
1969096|NCT03761810|3529931|FG001|Overall Study|Pregnancy|0
1969097|NCT03761810|3529930|FG000|Overall Study|Withdrawal by Subject|14
1969098|NCT03761810|3529931|FG001|Overall Study|Withdrawal by Subject|5
1969099|NCT03761810|3529930|FG000|Overall Study|Physician Decision|1
1969100|NCT03761810|3529931|FG001|Overall Study|Physician Decision|0
1969101|NCT03761810|3529930|FG000|Overall Study|Withdrawal by Parent/Guardian|4
1969102|NCT03761810|3529931|FG001|Overall Study|Withdrawal by Parent/Guardian|0
1969103|NCT03761810|3529930|FG000|Overall Study|Other Than Specified|1
1969104|NCT03761810|3529931|FG001|Overall Study|Other Than Specified|0
1969105|NCT03761784|3529939|FG000|Overall Study|Adverse Event|4
1969106|NCT03761784|3529940|FG001|Overall Study|Adverse Event|0
1969107|NCT03761784|3529939|FG000|Overall Study|Lost to Follow-up|10
1969108|NCT03761784|3529940|FG001|Overall Study|Lost to Follow-up|7
1969109|NCT03761784|3529939|FG000|Overall Study|Pregnancy|1
1969110|NCT03761784|3529940|FG001|Overall Study|Pregnancy|0
1969111|NCT03761784|3529939|FG000|Overall Study|Protocol Violation|2
1969112|NCT03761784|3529940|FG001|Overall Study|Protocol Violation|0
1969113|NCT03761784|3529939|FG000|Overall Study|Withdrawal by Parent or Guardian|4
1969114|NCT03761784|3529940|FG001|Overall Study|Withdrawal by Parent or Guardian|1
1969115|NCT03761784|3529939|FG000|Overall Study|Withdrawal by Subject|9
1969116|NCT03761784|3529940|FG001|Overall Study|Withdrawal by Subject|4
1969117|NCT03761784|3529939|FG000|Overall Study|Physician Decision|1
1969118|NCT03761784|3529940|FG001|Overall Study|Physician Decision|0
1969119|NCT03761784|3529939|FG000|Overall Study|Other Than Specified|1
1969120|NCT03761784|3529940|FG001|Overall Study|Other Than Specified|0
1969121|NCT03541317|3529948|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1
1969122|NCT03541317|3529949|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0
1969123|NCT03541317|3529950|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0
1969124|NCT03541317|3529951|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0
1969125|NCT03541317|3529952|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0
1969126|NCT03541317|3529953|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0
1969127|NCT03361865|3529976|FG000|Overall Study|Death|17
1969128|NCT03361865|3529977|FG001|Overall Study|Death|18
1969129|NCT03361865|3529976|FG000|Overall Study|Physician Decision|1
1969130|NCT03361865|3529977|FG001|Overall Study|Physician Decision|9
1969131|NCT03361865|3529976|FG000|Overall Study|Withdrawal by Subject|1
1969132|NCT03361865|3529977|FG001|Overall Study|Withdrawal by Subject|0
1969133|NCT02929056|3530003|FG000|Overall Study|Lost to Follow-up|0
1969134|NCT02929056|3530004|FG001|Overall Study|Lost to Follow-up|1
1969135|NCT02896855|3530012|FG000|Overall Study|Death|50
1969136|NCT02896855|3530013|FG001|Overall Study|Death|40
2212714|NCT01673178|3854032|FG000|Overall Study|Lost to Follow-up|0
2212715|NCT01673178|3854033|FG001|Overall Study|Lost to Follow-up|1
1969137|NCT02896855|3530012|FG000|Overall Study|Lost to Follow-up|15
1969138|NCT02896855|3530013|FG001|Overall Study|Lost to Follow-up|9
1969139|NCT02896855|3530012|FG000|Overall Study|Withdrawal by Subject|7
1969140|NCT02896855|3530013|FG001|Overall Study|Withdrawal by Subject|4
1969141|NCT02871778|3530026|FG000|Part A: Treatment Period 1|Adverse Event|1
1969142|NCT02871778|3530027|FG001|Part A: Treatment Period 1|Adverse Event|1
1969143|NCT02871778|3530028|FG002|Part A: Treatment Period 1|Adverse Event|1
1969144|NCT02871778|3530029|FG003|Part A: Treatment Period 1|Adverse Event|0
1969145|NCT02871778|3530030|FG004|Part A: Treatment Period 1|Adverse Event|0
1969146|NCT02871778|3530031|FG005|Part A: Treatment Period 1|Adverse Event|0
1969147|NCT02871778|3530032|FG006|Part A: Treatment Period 1|Adverse Event|0
1969148|NCT02871778|3530033|FG007|Part A: Treatment Period 1|Adverse Event|0
1969149|NCT02871778|3530026|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
1969150|NCT02871778|3530027|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
1969151|NCT02871778|3530028|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
1969152|NCT02871778|3530029|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
1969153|NCT02871778|3530030|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
1969154|NCT02871778|3530031|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
1969155|NCT02871778|3530032|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
1969156|NCT02871778|3530033|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
1969157|NCT02871778|3530026|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0
1969158|NCT02871778|3530027|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0
1969159|NCT02871778|3530028|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1
1969160|NCT02871778|3530029|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0
1969161|NCT02871778|3530030|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0
1969162|NCT02871778|3530031|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0
1969163|NCT02871778|3530032|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0
1969164|NCT02871778|3530033|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0
1969165|NCT02871778|3530026|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0
2212716|NCT01673178|3854034|FG002|Overall Study|Lost to Follow-up|0
1969166|NCT02871778|3530027|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0
1969167|NCT02871778|3530028|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1
1969168|NCT02871778|3530029|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0
1969169|NCT02871778|3530030|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0
1969170|NCT02871778|3530031|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0
1969171|NCT02871778|3530032|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0
1969172|NCT02871778|3530033|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0
1969173|NCT02871778|3530026|FG000|Part A: Treatment Period 1|Wrong drug shipment|0
1969174|NCT02871778|3530027|FG001|Part A: Treatment Period 1|Wrong drug shipment|1
1969175|NCT02871778|3530028|FG002|Part A: Treatment Period 1|Wrong drug shipment|0
1969176|NCT02871778|3530029|FG003|Part A: Treatment Period 1|Wrong drug shipment|0
1969177|NCT02871778|3530030|FG004|Part A: Treatment Period 1|Wrong drug shipment|0
1969178|NCT02871778|3530031|FG005|Part A: Treatment Period 1|Wrong drug shipment|0
1969179|NCT02871778|3530032|FG006|Part A: Treatment Period 1|Wrong drug shipment|0
1969180|NCT02871778|3530033|FG007|Part A: Treatment Period 1|Wrong drug shipment|0
1969181|NCT02871778|3530026|FG000|Part A: Treatment Period 2|Adverse Event|2
1969182|NCT02871778|3530027|FG001|Part A: Treatment Period 2|Adverse Event|2
1969183|NCT02871778|3530028|FG002|Part A: Treatment Period 2|Adverse Event|0
1969184|NCT02871778|3530029|FG003|Part A: Treatment Period 2|Adverse Event|0
1969185|NCT02871778|3530030|FG004|Part A: Treatment Period 2|Adverse Event|0
1969186|NCT02871778|3530031|FG005|Part A: Treatment Period 2|Adverse Event|0
1969187|NCT02871778|3530032|FG006|Part A: Treatment Period 2|Adverse Event|0
1969188|NCT02871778|3530033|FG007|Part A: Treatment Period 2|Adverse Event|0
1969189|NCT02871778|3530026|FG000|Part A: Treatment Period 2|Lost to Follow-up|0
1969190|NCT02871778|3530027|FG001|Part A: Treatment Period 2|Lost to Follow-up|0
1969191|NCT02871778|3530028|FG002|Part A: Treatment Period 2|Lost to Follow-up|0
1969192|NCT02871778|3530029|FG003|Part A: Treatment Period 2|Lost to Follow-up|1
1969193|NCT02871778|3530030|FG004|Part A: Treatment Period 2|Lost to Follow-up|0
1969194|NCT02871778|3530031|FG005|Part A: Treatment Period 2|Lost to Follow-up|0
1969195|NCT02871778|3530032|FG006|Part A: Treatment Period 2|Lost to Follow-up|0
1969196|NCT02871778|3530033|FG007|Part A: Treatment Period 2|Lost to Follow-up|0
1969197|NCT02871778|3530026|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
1969198|NCT02871778|3530027|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1969199|NCT02871778|3530028|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
1969200|NCT02871778|3530029|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1969201|NCT02871778|3530030|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1969202|NCT02871778|3530031|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1969203|NCT02871778|3530032|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1969204|NCT02871778|3530033|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
1969205|NCT02871778|3530026|FG000|Part B: Treatment Period 3|Adverse Event|0
1969206|NCT02871778|3530027|FG001|Part B: Treatment Period 3|Adverse Event|0
1969207|NCT02871778|3530028|FG002|Part B: Treatment Period 3|Adverse Event|0
1969208|NCT02871778|3530029|FG003|Part B: Treatment Period 3|Adverse Event|0
1969209|NCT02871778|3530030|FG004|Part B: Treatment Period 3|Adverse Event|1
1969210|NCT02871778|3530031|FG005|Part B: Treatment Period 3|Adverse Event|1
1969211|NCT02871778|3530032|FG006|Part B: Treatment Period 3|Adverse Event|1
1969212|NCT02871778|3530033|FG007|Part B: Treatment Period 3|Adverse Event|0
1969213|NCT02756208|3530066|FG000|Overall Study|Withdrawal by Subject|1
1969214|NCT02756208|3530067|FG001|Overall Study|Withdrawal by Subject|0
1969215|NCT02756208|3530068|FG002|Overall Study|Withdrawal by Subject|1
1969216|NCT02756208|3530069|FG003|Overall Study|Withdrawal by Subject|3
1969217|NCT02756208|3530066|FG000|Overall Study|Lost to Follow-up|3
1969218|NCT02756208|3530067|FG001|Overall Study|Lost to Follow-up|1
1969219|NCT02756208|3530068|FG002|Overall Study|Lost to Follow-up|1
1969220|NCT02756208|3530069|FG003|Overall Study|Lost to Follow-up|1
1969221|NCT02756208|3530066|FG000|Overall Study|Physician Decision|1
1969222|NCT02756208|3530067|FG001|Overall Study|Physician Decision|0
1969223|NCT02756208|3530068|FG002|Overall Study|Physician Decision|0
1969224|NCT02756208|3530069|FG003|Overall Study|Physician Decision|0
1969225|NCT02756208|3530066|FG000|Overall Study|Protocol Violation|0
1969226|NCT02756208|3530067|FG001|Overall Study|Protocol Violation|1
1969227|NCT02756208|3530068|FG002|Overall Study|Protocol Violation|0
1969228|NCT02756208|3530069|FG003|Overall Study|Protocol Violation|0
1969229|NCT02714218|3530082|FG000|Overall Study|Disease Progression|56
1969230|NCT02714218|3530083|FG001|Overall Study|Disease Progression|51
1969231|NCT02714218|3530084|FG002|Overall Study|Disease Progression|14
1969232|NCT02714218|3530082|FG000|Overall Study|Adverse Event Unrelated to Study Drug|10
1969233|NCT02714218|3530083|FG001|Overall Study|Adverse Event Unrelated to Study Drug|6
1969234|NCT02714218|3530084|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0
1969235|NCT02714218|3530082|FG000|Overall Study|Study Drug Toxicity|46
1969236|NCT02714218|3530083|FG001|Overall Study|Study Drug Toxicity|69
1969237|NCT02714218|3530084|FG002|Overall Study|Study Drug Toxicity|4
1969238|NCT02714218|3530082|FG000|Overall Study|Request to Discontinue Treatment|1
1969239|NCT02714218|3530083|FG001|Overall Study|Request to Discontinue Treatment|5
1969240|NCT02714218|3530084|FG002|Overall Study|Request to Discontinue Treatment|1
2108214|NCT00878722|3702051|FG002|Overall Study|Relapse|0
1969241|NCT02714218|3530082|FG000|Overall Study|Participant Withdrew Consent|2
1969242|NCT02714218|3530083|FG001|Overall Study|Participant Withdrew Consent|3
1969243|NCT02714218|3530084|FG002|Overall Study|Participant Withdrew Consent|0
1969244|NCT02714218|3530082|FG000|Overall Study|Maximum Clinical Benefit|2
1969245|NCT02714218|3530083|FG001|Overall Study|Maximum Clinical Benefit|2
1969246|NCT02714218|3530084|FG002|Overall Study|Maximum Clinical Benefit|0
1969247|NCT02714218|3530082|FG000|Overall Study|Medical Decision|0
1969248|NCT02714218|3530083|FG001|Overall Study|Medical Decision|1
2309211|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Technical error|0
2309212|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Technical error|0
2309213|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Technical error|0
2309214|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Patient decision|5
2309215|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Patient decision|2
2309216|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Patient decision|0
2309217|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Patient decision|0
2309218|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Patient decision|0
2309219|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
1969249|NCT02714218|3530084|FG002|Overall Study|Medical Decision|0
1969250|NCT02714218|3530082|FG000|Overall Study|Not Reported|9
1969251|NCT02714218|3530083|FG001|Overall Study|Not Reported|5
1969252|NCT02714218|3530084|FG002|Overall Study|Not Reported|0
1969253|NCT02714218|3530082|FG000|Overall Study|Completed|2
1969254|NCT02714218|3530083|FG001|Overall Study|Completed|0
1969255|NCT02714218|3530084|FG002|Overall Study|Completed|0
1969256|NCT02714218|3530082|FG000|Overall Study|Dose Delayed > 6 weeks|1
1969257|NCT02714218|3530083|FG001|Overall Study|Dose Delayed > 6 weeks|0
1969258|NCT02714218|3530084|FG002|Overall Study|Dose Delayed > 6 weeks|0
1969259|NCT02714218|3530082|FG000|Overall Study|Complete Response|1
1969260|NCT02714218|3530083|FG001|Overall Study|Complete Response|0
1969261|NCT02714218|3530084|FG002|Overall Study|Complete Response|0
1969262|NCT02714218|3530082|FG000|Overall Study|Stop treatment, but will do follow up|0
1969263|NCT02714218|3530083|FG001|Overall Study|Stop treatment, but will do follow up|1
1969264|NCT02714218|3530084|FG002|Overall Study|Stop treatment, but will do follow up|0
1969265|NCT02564263|3530093|FG000|Overall Study|Adverse Event|31
1969266|NCT02564263|3530094|FG001|Overall Study|Adverse Event|29
1969267|NCT02564263|3530093|FG000|Overall Study|Death|236
1969268|NCT02564263|3530094|FG001|Overall Study|Death|242
1969269|NCT02564263|3530093|FG000|Overall Study|Withdrawal by Subject|5
1969270|NCT02564263|3530094|FG001|Overall Study|Withdrawal by Subject|18
1969271|NCT02564263|3530093|FG000|Overall Study|Ongoing in Study|42
1969272|NCT02564263|3530094|FG001|Overall Study|Ongoing in Study|25
2021109|NCT00310817|3588875|FG002|Overall Study|Protocol Violation|1
2021110|NCT00310817|3588876|FG003|Overall Study|Protocol Violation|1
2021111|NCT00310817|3588873|FG000|Overall Study|Unable to classify|3
2021112|NCT00310817|3588874|FG001|Overall Study|Unable to classify|1
2021113|NCT00310817|3588875|FG002|Overall Study|Unable to classify|0
2021114|NCT00310817|3588876|FG003|Overall Study|Unable to classify|0
2021115|NCT00310856|3588922|FG000|Overall Study|Withdrawal by Subject|2
2021116|NCT00310856|3588923|FG001|Overall Study|Withdrawal by Subject|2
2021117|NCT00310856|3588924|FG002|Overall Study|Withdrawal by Subject|2
2021118|NCT00310856|3588922|FG000|Overall Study|Lost to Follow-up|1
2021119|NCT00310856|3588923|FG001|Overall Study|Lost to Follow-up|2
2021120|NCT00310856|3588924|FG002|Overall Study|Lost to Follow-up|6
2021121|NCT00310856|3588922|FG000|Overall Study|Inappropriate enrollment|1
2021122|NCT00310856|3588923|FG001|Overall Study|Inappropriate enrollment|1
2021123|NCT00310856|3588924|FG002|Overall Study|Inappropriate enrollment|0
2021124|NCT00310856|3588922|FG000|Overall Study|Unable to classify|1
2021125|NCT00310856|3588923|FG001|Overall Study|Unable to classify|0
2021126|NCT00310856|3588924|FG002|Overall Study|Unable to classify|0
2021127|NCT00311155|3588933|FG000|Overall Study|Adverse Event|21
2021128|NCT00311155|3588933|FG000|Overall Study|Withdrawal by Subject|17
2021129|NCT00311155|3588933|FG000|Overall Study|Did not meet entry criteria|55
2021130|NCT00311168|3588939|FG000|First Intervention|Withdrawal by Subject|2
2021131|NCT00311168|3588940|FG001|First Intervention|Withdrawal by Subject|2
2021132|NCT00311168|3588939|FG000|First Intervention|Lost to Follow-up|1
2021133|NCT00311168|3588940|FG001|First Intervention|Lost to Follow-up|1
2021134|NCT00311168|3588939|FG000|First Intervention|Protocol Violation|1
2021135|NCT00311168|3588940|FG001|First Intervention|Protocol Violation|1
2021136|NCT00311168|3588939|FG000|First Intervention|Adverse Event|1
2021137|NCT00311168|3588940|FG001|First Intervention|Adverse Event|0
2021138|NCT00311168|3588939|FG000|First Intervention|Other|2
2021139|NCT00311168|3588940|FG001|First Intervention|Other|2
2021140|NCT00311168|3588939|FG000|Second Intervention|Lost to Follow-up|9
2021141|NCT00311168|3588940|FG001|Second Intervention|Lost to Follow-up|2
2021142|NCT00311168|3588939|FG000|Second Intervention|Withdrawal by Subject|0
2021143|NCT00311168|3588940|FG001|Second Intervention|Withdrawal by Subject|1
2021144|NCT00311168|3588939|FG000|Second Intervention|Other|1
2021145|NCT00311168|3588940|FG001|Second Intervention|Other|1
2021146|NCT00311181|3588948|FG000|Overall Study|Final DFTs were not obtained|96
2021147|NCT00311311|3588961|FG000|Overall Study|Adverse Event|3
2021148|NCT00311311|3588962|FG001|Overall Study|Adverse Event|2
2021149|NCT00311311|3588961|FG000|Overall Study|Withdrawal by Subject|1
2021150|NCT00311311|3588962|FG001|Overall Study|Withdrawal by Subject|1
1969273|NCT02450331|3530102|FG000|Overall Study|Death|120
1969274|NCT02450331|3530103|FG001|Overall Study|Death|114
1969275|NCT02450331|3530102|FG000|Overall Study|Lost to Follow-up|9
1969276|NCT02450331|3530103|FG001|Overall Study|Lost to Follow-up|7
1969277|NCT02450331|3530102|FG000|Overall Study|Withdrawal by Subject|50
1969278|NCT02450331|3530103|FG001|Overall Study|Withdrawal by Subject|39
1969279|NCT02450331|3530102|FG000|Overall Study|On-Study Status: In Disease recurrence follow-up|179
1969280|NCT02450331|3530103|FG001|Overall Study|On-Study Status: In Disease recurrence follow-up|208
1969281|NCT02450331|3530102|FG000|Overall Study|On-Study Status: In Survival follow-up|45
1969282|NCT02450331|3530103|FG001|Overall Study|On-Study Status: In Survival follow-up|38
1969283|NCT02149121|3530117|FG000|Main Study Period|Lack of Efficacy|2
1969284|NCT02149121|3530118|FG001|Main Study Period|Lack of Efficacy|2
1969285|NCT02149121|3530119|FG002|Main Study Period|Lack of Efficacy|1
1969286|NCT02149121|3530120|FG003|Main Study Period|Lack of Efficacy|0
1969287|NCT02149121|3530121|FG004|Main Study Period|Lack of Efficacy|0
1969288|NCT02149121|3530122|FG005|Main Study Period|Lack of Efficacy|0
1969289|NCT02149121|3530123|FG006|Main Study Period|Lack of Efficacy|0
1969290|NCT02149121|3530117|FG000|Main Study Period|Withdrawal by Subject|9
1969291|NCT02149121|3530118|FG001|Main Study Period|Withdrawal by Subject|5
1969292|NCT02149121|3530119|FG002|Main Study Period|Withdrawal by Subject|1
1969293|NCT02149121|3530120|FG003|Main Study Period|Withdrawal by Subject|0
1969294|NCT02149121|3530121|FG004|Main Study Period|Withdrawal by Subject|0
1969295|NCT02149121|3530122|FG005|Main Study Period|Withdrawal by Subject|0
1969296|NCT02149121|3530123|FG006|Main Study Period|Withdrawal by Subject|0
1969297|NCT02149121|3530117|FG000|Main Study Period|Adverse Event|2
1969298|NCT02149121|3530118|FG001|Main Study Period|Adverse Event|5
1969299|NCT02149121|3530119|FG002|Main Study Period|Adverse Event|1
1969300|NCT02149121|3530120|FG003|Main Study Period|Adverse Event|0
1969301|NCT02149121|3530121|FG004|Main Study Period|Adverse Event|0
1969302|NCT02149121|3530122|FG005|Main Study Period|Adverse Event|0
1969303|NCT02149121|3530123|FG006|Main Study Period|Adverse Event|0
1969304|NCT02149121|3530117|FG000|Main Study Period|Protocol Violation|2
1969305|NCT02149121|3530118|FG001|Main Study Period|Protocol Violation|0
1969306|NCT02149121|3530119|FG002|Main Study Period|Protocol Violation|0
1969307|NCT02149121|3530120|FG003|Main Study Period|Protocol Violation|0
1969308|NCT02149121|3530121|FG004|Main Study Period|Protocol Violation|0
1969309|NCT02149121|3530122|FG005|Main Study Period|Protocol Violation|0
1969310|NCT02149121|3530123|FG006|Main Study Period|Protocol Violation|0
1969311|NCT02149121|3530117|FG000|Main Study Period|Lost to Follow-up|2
1969312|NCT02149121|3530118|FG001|Main Study Period|Lost to Follow-up|1
1969313|NCT02149121|3530119|FG002|Main Study Period|Lost to Follow-up|0
1969314|NCT02149121|3530120|FG003|Main Study Period|Lost to Follow-up|0
1969315|NCT02149121|3530121|FG004|Main Study Period|Lost to Follow-up|0
1969316|NCT02149121|3530122|FG005|Main Study Period|Lost to Follow-up|0
1969317|NCT02149121|3530123|FG006|Main Study Period|Lost to Follow-up|0
1969318|NCT02149121|3530117|FG000|Main Study Period|Death|1
1969319|NCT02149121|3530118|FG001|Main Study Period|Death|0
1969320|NCT02149121|3530119|FG002|Main Study Period|Death|0
1969321|NCT02149121|3530120|FG003|Main Study Period|Death|0
1969322|NCT02149121|3530121|FG004|Main Study Period|Death|0
1969323|NCT02149121|3530122|FG005|Main Study Period|Death|0
1969324|NCT02149121|3530123|FG006|Main Study Period|Death|0
1969325|NCT02149121|3530117|FG000|Main Study Period|Physician Decision|1
1969326|NCT02149121|3530118|FG001|Main Study Period|Physician Decision|0
1969327|NCT02149121|3530119|FG002|Main Study Period|Physician Decision|0
1969328|NCT02149121|3530120|FG003|Main Study Period|Physician Decision|0
1969329|NCT02149121|3530121|FG004|Main Study Period|Physician Decision|0
1969330|NCT02149121|3530122|FG005|Main Study Period|Physician Decision|0
1969331|NCT02149121|3530123|FG006|Main Study Period|Physician Decision|0
1969332|NCT02149121|3530117|FG000|Main Study Period|Developed any malignancy|0
1969333|NCT02149121|3530118|FG001|Main Study Period|Developed any malignancy|1
1969334|NCT02149121|3530119|FG002|Main Study Period|Developed any malignancy|1
1969335|NCT02149121|3530120|FG003|Main Study Period|Developed any malignancy|0
1969336|NCT02149121|3530121|FG004|Main Study Period|Developed any malignancy|0
1969337|NCT02149121|3530122|FG005|Main Study Period|Developed any malignancy|0
1969338|NCT02149121|3530123|FG006|Main Study Period|Developed any malignancy|0
1969339|NCT02149121|3530117|FG000|Main Study Period|Unmet predefined eligibility criteria|2
1969340|NCT02149121|3530118|FG001|Main Study Period|Unmet predefined eligibility criteria|2
1969341|NCT02149121|3530119|FG002|Main Study Period|Unmet predefined eligibility criteria|0
1969342|NCT02149121|3530120|FG003|Main Study Period|Unmet predefined eligibility criteria|0
1969343|NCT02149121|3530121|FG004|Main Study Period|Unmet predefined eligibility criteria|0
1969344|NCT02149121|3530122|FG005|Main Study Period|Unmet predefined eligibility criteria|0
1969345|NCT02149121|3530123|FG006|Main Study Period|Unmet predefined eligibility criteria|0
1969346|NCT02149121|3530117|FG000|Main Study Period|Disease progression|0
1969347|NCT02149121|3530118|FG001|Main Study Period|Disease progression|1
1969348|NCT02149121|3530119|FG002|Main Study Period|Disease progression|0
1969349|NCT02149121|3530120|FG003|Main Study Period|Disease progression|0
1969350|NCT02149121|3530121|FG004|Main Study Period|Disease progression|0
1969351|NCT02149121|3530122|FG005|Main Study Period|Disease progression|0
1969352|NCT02149121|3530123|FG006|Main Study Period|Disease progression|0
2021151|NCT00311311|3588961|FG000|Overall Study|Noncompliance|0
1969353|NCT02149121|3530117|FG000|Extension Study Period|Withdrawal by Subject|0
1969354|NCT02149121|3530118|FG001|Extension Study Period|Withdrawal by Subject|0
1969355|NCT02149121|3530119|FG002|Extension Study Period|Withdrawal by Subject|0
1969356|NCT02149121|3530120|FG003|Extension Study Period|Withdrawal by Subject|1
1969357|NCT02149121|3530121|FG004|Extension Study Period|Withdrawal by Subject|0
1969358|NCT02149121|3530122|FG005|Extension Study Period|Withdrawal by Subject|2
1969359|NCT02149121|3530123|FG006|Extension Study Period|Withdrawal by Subject|0
1969360|NCT02066181|3530146|FG000|Overall Study|Withdrawal by Subject|1
1969361|NCT02066181|3530147|FG001|Overall Study|Withdrawal by Subject|1
1969362|NCT01933932|3530158|FG000|Overall Study|Death|173
1969363|NCT01933932|3530159|FG001|Overall Study|Death|163
1969364|NCT01933932|3530158|FG000|Overall Study|Withdrawal by Subject|11
1969365|NCT01933932|3530159|FG001|Overall Study|Withdrawal by Subject|14
1969366|NCT01933932|3530158|FG000|Overall Study|Eligibility criteria not fulfilled|0
1969367|NCT01933932|3530159|FG001|Overall Study|Eligibility criteria not fulfilled|1
1969368|NCT01927419|3530167|FG000|Overall Study|Disease progression|15
1969369|NCT01927419|3530168|FG001|Overall Study|Disease progression|17
1969370|NCT01927419|3530167|FG000|Overall Study|Study drug toxicity|43
1969371|NCT01927419|3530168|FG001|Overall Study|Study drug toxicity|7
1969372|NCT01927419|3530167|FG000|Overall Study|Death|0
1969373|NCT01927419|3530168|FG001|Overall Study|Death|1
1969374|NCT01927419|3530167|FG000|Overall Study|Adverse event unrelated to study drug|6
1969375|NCT01927419|3530168|FG001|Overall Study|Adverse event unrelated to study drug|1
1969376|NCT01927419|3530167|FG000|Overall Study|Withdrawal by Subject|3
1969377|NCT01927419|3530168|FG001|Overall Study|Withdrawal by Subject|1
1969378|NCT01927419|3530167|FG000|Overall Study|Other|2
1969379|NCT01927419|3530168|FG001|Overall Study|Other|1
1969380|NCT01927419|3530167|FG000|Overall Study|Not reported|1
1969381|NCT01927419|3530168|FG001|Overall Study|Not reported|0
1969382|NCT01889186|3530178|FG000|Overall Study|Adverse event- not related to progression|18
1969383|NCT01889186|3530179|FG001|Overall Study|Adverse event- not related to progression|5
1969384|NCT01889186|3530178|FG000|Overall Study|Adverse event- related to progression|7
1969385|NCT01889186|3530179|FG001|Overall Study|Adverse event- related to progression|2
1969386|NCT01889186|3530178|FG000|Overall Study|COVID-19 logistical restrictions|1
1969387|NCT01889186|3530179|FG001|Overall Study|COVID-19 logistical restrictions|0
1969388|NCT01889186|3530178|FG000|Overall Study|Investigator request|1
1969389|NCT01889186|3530179|FG001|Overall Study|Investigator request|1
1969390|NCT01889186|3530178|FG000|Overall Study|Progressive disease- Richter's|12
1969391|NCT01889186|3530179|FG001|Overall Study|Progressive disease- Richter's|7
1969392|NCT01889186|3530178|FG000|Overall Study|Progressive disease per protocol|46
1969393|NCT01889186|3530179|FG001|Overall Study|Progressive disease per protocol|17
1969394|NCT01889186|3530178|FG000|Overall Study|Stem cell transplant|2
1969395|NCT01889186|3530179|FG001|Overall Study|Stem cell transplant|1
1969396|NCT01889186|3530178|FG000|Overall Study|Withdrew consent|2
1969397|NCT01889186|3530179|FG001|Overall Study|Withdrew consent|3
1969398|NCT01889186|3530178|FG000|Overall Study|Other, not specified|18
1969399|NCT01889186|3530179|FG001|Overall Study|Other, not specified|15
1969400|NCT01850004|3530187|FG000|Overall Study|Subject Moved|1
1969401|NCT01850004|3530187|FG000|Overall Study|Poor/Non-compliance|1
1969402|NCT01850004|3530187|FG000|Overall Study|Subject Withdrew Consent|4
1969403|NCT01850004|3530187|FG000|Overall Study|Subject Request to Discontinue Treatment|1
1969404|NCT01850004|3530187|FG000|Overall Study|AE Unrelated to Study Drug|1
1969405|NCT01844505|3530199|FG000|Overall Study|Disease progression|170
1969406|NCT01844505|3530200|FG001|Overall Study|Disease progression|88
1969407|NCT01844505|3530201|FG002|Overall Study|Disease progression|224
1969408|NCT01844505|3530199|FG000|Overall Study|Study drug toxicity|40
1969409|NCT01844505|3530200|FG001|Overall Study|Study drug toxicity|131
1969410|NCT01844505|3530201|FG002|Overall Study|Study drug toxicity|50
1969411|NCT01844505|3530199|FG000|Overall Study|Death|1
1969412|NCT01844505|3530200|FG001|Overall Study|Death|3
1969413|NCT01844505|3530201|FG002|Overall Study|Death|1
1969414|NCT01844505|3530199|FG000|Overall Study|Adverse event unrelated to study drug|7
1969415|NCT01844505|3530200|FG001|Overall Study|Adverse event unrelated to study drug|15
1969416|NCT01844505|3530201|FG002|Overall Study|Adverse event unrelated to study drug|6
1969417|NCT01844505|3530199|FG000|Overall Study|Subject request discontinue treatment|17
1969418|NCT01844505|3530200|FG001|Overall Study|Subject request discontinue treatment|14
1969419|NCT01844505|3530201|FG002|Overall Study|Subject request discontinue treatment|8
1969420|NCT01844505|3530199|FG000|Overall Study|Withdrawal by Subject|0
1969421|NCT01844505|3530200|FG001|Overall Study|Withdrawal by Subject|3
1969422|NCT01844505|3530201|FG002|Overall Study|Withdrawal by Subject|0
1969423|NCT01844505|3530199|FG000|Overall Study|Lost to Follow-up|1
1969424|NCT01844505|3530200|FG001|Overall Study|Lost to Follow-up|0
1969425|NCT01844505|3530201|FG002|Overall Study|Lost to Follow-up|0
1969426|NCT01844505|3530199|FG000|Overall Study|Maximum clinical benefit|8
1969427|NCT01844505|3530200|FG001|Overall Study|Maximum clinical benefit|11
1969428|NCT01844505|3530201|FG002|Overall Study|Maximum clinical benefit|2
1969429|NCT01844505|3530199|FG000|Overall Study|Poor/non-compliance|1
1969430|NCT01844505|3530200|FG001|Overall Study|Poor/non-compliance|1
2212717|NCT01673178|3854035|FG003|Overall Study|Lost to Follow-up|0
1969431|NCT01844505|3530201|FG002|Overall Study|Poor/non-compliance|1
1969432|NCT01844505|3530199|FG000|Overall Study|Subject no longer meets criteria|0
1969433|NCT01844505|3530200|FG001|Overall Study|Subject no longer meets criteria|1
1969434|NCT01844505|3530201|FG002|Overall Study|Subject no longer meets criteria|0
1969435|NCT01844505|3530199|FG000|Overall Study|Other Reasons|4
1969436|NCT01844505|3530200|FG001|Overall Study|Other Reasons|2
1969437|NCT01844505|3530201|FG002|Overall Study|Other Reasons|2
1969438|NCT01844505|3530199|FG000|Overall Study|Not Reported|0
1969439|NCT01844505|3530200|FG001|Overall Study|Not Reported|0
1969440|NCT01844505|3530201|FG002|Overall Study|Not Reported|1
1969441|NCT01757535|3530211|FG000|Overall Study|Disease Relapse|143
1969442|NCT01757535|3530212|FG001|Overall Study|Disease Relapse|180
1969443|NCT01757535|3530211|FG000|Overall Study|Adverse Event|29
1969444|NCT01757535|3530212|FG001|Overall Study|Adverse Event|11
1969445|NCT01757535|3530211|FG000|Overall Study|Withdrawal by Subject|9
1969446|NCT01757535|3530212|FG001|Overall Study|Withdrawal by Subject|13
1969447|NCT01757535|3530211|FG000|Overall Study|Miscellaneous|5
1969448|NCT01757535|3530212|FG001|Overall Study|Miscellaneous|2
1969449|NCT01757535|3530211|FG000|Overall Study|Physician Decision|6
1969450|NCT01757535|3530212|FG001|Overall Study|Physician Decision|0
1969451|NCT01757535|3530211|FG000|Overall Study|Death|1
1969452|NCT01757535|3530212|FG001|Overall Study|Death|2
1969453|NCT01750281|3530221|FG000|Overall Study|Discontinued Selumetinib/Placebo|37
1969454|NCT01750281|3530222|FG001|Overall Study|Discontinued Selumetinib/Placebo|77
1969455|NCT01750281|3530223|FG002|Overall Study|Discontinued Selumetinib/Placebo|75
1969456|NCT01750281|3530221|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
1969457|NCT01750281|3530222|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
1969458|NCT01750281|3530223|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
1969459|NCT01750281|3530221|FG000|Overall Study|Did not receive treatment|0
1969460|NCT01750281|3530222|FG001|Overall Study|Did not receive treatment|1
1969461|NCT01750281|3530223|FG002|Overall Study|Did not receive treatment|0
1969462|NCT01510184|3530233|FG000|Overall Study|Sponsor discretion|28
1969463|NCT01510184|3530234|FG001|Overall Study|Sponsor discretion|28
1969464|NCT01510184|3530233|FG000|Overall Study|Death|1
1969465|NCT01510184|3530234|FG001|Overall Study|Death|2
1969466|NCT01510184|3530233|FG000|Overall Study|Withdrawal by Subject|1
1969467|NCT01510184|3530234|FG001|Overall Study|Withdrawal by Subject|4
1969468|NCT01510184|3530233|FG000|Overall Study|Other|0
1969469|NCT01510184|3530234|FG001|Overall Study|Other|1
1969470|NCT01471444|3530242|FG000|Overall Study|Physician Decision|3
1969471|NCT01471444|3530243|FG001|Overall Study|Physician Decision|2
1969472|NCT01471444|3530242|FG000|Overall Study|Withdrawal by Subject|0
1969473|NCT01471444|3530243|FG001|Overall Study|Withdrawal by Subject|1
1969474|NCT01238211|3530250|FG000|Overall Study|Continues active treatment|31
1969475|NCT01238211|3530250|FG000|Overall Study|Adverse Event|7
1969476|NCT01238211|3530250|FG000|Overall Study|Death|4
1969477|NCT01238211|3530250|FG000|Overall Study|Relapse/Progression|2
1969478|NCT01238211|3530250|FG000|Overall Study|Withdrawal by Subject|7
1969479|NCT01238211|3530250|FG000|Overall Study|Non-protocol treatment|4
1969480|NCT01238211|3530250|FG000|Overall Study|Investigator/Patient Decision|3
2021152|NCT00311311|3588962|FG001|Overall Study|Noncompliance|1
2021153|NCT00311311|3588961|FG000|Overall Study|Study Termination by Sponsor|3
2021154|NCT00311311|3588962|FG001|Overall Study|Study Termination by Sponsor|4
2021155|NCT00311311|3588961|FG000|Overall Study|Death|1
2021156|NCT00311311|3588962|FG001|Overall Study|Death|0
2021157|NCT00311311|3588961|FG000|Overall Study|Lack of ancillary assistance|0
2021158|NCT00311311|3588962|FG001|Overall Study|Lack of ancillary assistance|1
2021159|NCT00311363|3588971|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42
2021160|NCT00311363|3588972|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0
2021161|NCT00311363|3588973|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0
2021162|NCT00311363|3588971|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
2021163|NCT00311363|3588972|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
2021164|NCT00311363|3588973|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
2021165|NCT00311363|3588971|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
2021166|NCT00311363|3588972|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
2021167|NCT00311363|3588973|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
2021168|NCT00311363|3588971|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
2021169|NCT00311363|3588972|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
2021170|NCT00311363|3588973|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
2021171|NCT00311363|3588971|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8
2021172|NCT00311363|3588972|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0
2021173|NCT00311363|3588973|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0
2021174|NCT00311363|3588971|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1
2021175|NCT00311363|3588972|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0
2021176|NCT00311363|3588973|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0
2021177|NCT00311363|3588971|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
2021178|NCT00311363|3588972|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
2021179|NCT00311363|3588973|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
2021180|NCT00311363|3588971|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1
2021181|NCT00311363|3588972|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0
2025929|NCT00347776|3594658|FG002|12 Month Follow-up|Reached endpoint|9
1969481|NCT03745651|3530298|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
1969482|NCT03745651|3530299|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
1969483|NCT03745651|3530300|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1969484|NCT03745651|3530301|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1969485|NCT03745651|3530302|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1969486|NCT03745651|3530303|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1969487|NCT03745651|3530304|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1969488|NCT03745651|3530298|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3
1969489|NCT03745651|3530299|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13
1969490|NCT03745651|3530300|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4
1969491|NCT03745651|3530301|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1969492|NCT03745651|3530302|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1969493|NCT03745651|3530303|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1969494|NCT03745651|3530304|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1969495|NCT03745651|3530298|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3
1969496|NCT03745651|3530299|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1969497|NCT03745651|3530300|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
1969498|NCT03745651|3530301|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1969499|NCT03745651|3530302|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1969500|NCT03745651|3530303|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1969501|NCT03745651|3530304|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1969502|NCT03745651|3530298|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969503|NCT03745651|3530299|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2
1969504|NCT03745651|3530300|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969505|NCT03745651|3530301|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969506|NCT03745651|3530302|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969507|NCT03745651|3530303|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969508|NCT03745651|3530304|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969509|NCT03745651|3530298|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
1969510|NCT03745651|3530299|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21
1969511|NCT03745651|3530300|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15
1969512|NCT03745651|3530301|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1969513|NCT03745651|3530302|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1969514|NCT03745651|3530303|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1969515|NCT03745651|3530304|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1969516|NCT03745651|3530298|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1
1969517|NCT03745651|3530299|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
1969518|NCT03745651|3530300|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
1969519|NCT03745651|3530301|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
1969520|NCT03745651|3530302|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
1969521|NCT03745651|3530303|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
1969522|NCT03745651|3530304|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
1969523|NCT03745651|3530298|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1969524|NCT03745651|3530299|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1969525|NCT03745651|3530300|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1969526|NCT03745651|3530301|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1969527|NCT03745651|3530302|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1969528|NCT03745651|3530303|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4
1969529|NCT03745651|3530304|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1969530|NCT03745651|3530298|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1969531|NCT03745651|3530299|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1969532|NCT03745651|3530300|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1969533|NCT03745651|3530301|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
1969534|NCT03745651|3530302|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1969535|NCT03745651|3530303|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
1969536|NCT03745651|3530304|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
1969537|NCT03745651|3530298|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1969538|NCT03745651|3530299|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1969539|NCT03745651|3530300|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1969540|NCT03745651|3530301|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4
1969541|NCT03745651|3530302|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2
1969542|NCT03745651|3530303|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
1969543|NCT03745651|3530304|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10
1969544|NCT03745651|3530298|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1969545|NCT03745651|3530299|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1969546|NCT03745651|3530300|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1969547|NCT03745651|3530301|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
1969548|NCT03745651|3530302|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1969549|NCT03745651|3530303|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4
1969550|NCT03745651|3530304|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2
1969551|NCT03745651|3530298|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
1969552|NCT03745651|3530299|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
1969553|NCT03745651|3530300|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
1969554|NCT03745651|3530301|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
1969555|NCT03745651|3530302|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
1969556|NCT03745651|3530303|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
1969557|NCT03745651|3530304|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
1969558|NCT03745651|3530298|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969559|NCT03745651|3530299|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969560|NCT03745651|3530300|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969561|NCT03745651|3530301|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969562|NCT03745651|3530302|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969563|NCT03745651|3530303|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
1969564|NCT03745651|3530304|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969565|NCT03745651|3530298|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1969566|NCT03745651|3530299|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1969567|NCT03745651|3530300|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1969568|NCT03745651|3530301|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12
1969569|NCT03745651|3530302|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8
1969570|NCT03745651|3530303|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26
1969571|NCT03745651|3530304|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34
1969572|NCT03745651|3530298|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
1969573|NCT03745651|3530299|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
1969574|NCT03745651|3530300|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
1969575|NCT03745651|3530301|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
1969576|NCT03745651|3530302|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
1969577|NCT03745651|3530303|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
1969578|NCT03745651|3530304|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
1969579|NCT03745638|3530323|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4
1969580|NCT03745638|3530324|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2
1969581|NCT03745638|3530325|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
1969582|NCT03745638|3530326|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1969583|NCT03745638|3530327|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1969584|NCT03745638|3530328|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1969585|NCT03745638|3530329|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
1969586|NCT03745638|3530323|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1
1969587|NCT03745638|3530324|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1969588|NCT03745638|3530325|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1969589|NCT03745638|3530326|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1969590|NCT03745638|3530327|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1969591|NCT03745638|3530328|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1969592|NCT03745638|3530329|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
1969593|NCT03745638|3530323|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5
1969594|NCT03745638|3530324|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12
1969595|NCT03745638|3530325|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8
1969596|NCT03745638|3530326|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1969597|NCT03745638|3530327|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1969598|NCT03745638|3530328|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1969599|NCT03745638|3530329|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
1969600|NCT03745638|3530323|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
1969601|NCT03745638|3530324|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
1969602|NCT03745638|3530325|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1969603|NCT03745638|3530326|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1969604|NCT03745638|3530327|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1969605|NCT03745638|3530328|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1969606|NCT03745638|3530329|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
1969607|NCT03745638|3530323|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1
1969608|NCT03745638|3530324|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
1969609|NCT03745638|3530325|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
1969610|NCT03745638|3530326|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
1969611|NCT03745638|3530327|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
1969612|NCT03745638|3530328|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
1969613|NCT03745638|3530329|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
1969614|NCT03745638|3530323|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969615|NCT03745638|3530324|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3
1969616|NCT03745638|3530325|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969617|NCT03745638|3530326|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969618|NCT03745638|3530327|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969619|NCT03745638|3530328|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969620|NCT03745638|3530329|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
1969621|NCT03745638|3530323|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17
1969622|NCT03745638|3530324|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
1969623|NCT03745638|3530325|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19
1969624|NCT03745638|3530326|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1969625|NCT03745638|3530327|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1969626|NCT03745638|3530328|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1969627|NCT03745638|3530329|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
1969628|NCT03745638|3530323|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2
1969629|NCT03745638|3530324|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1
1969630|NCT03745638|3530325|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
1969631|NCT03745638|3530326|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
1969632|NCT03745638|3530327|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
1969633|NCT03745638|3530328|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
1969634|NCT03745638|3530329|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
1969635|NCT03745638|3530323|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1969636|NCT03745638|3530324|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1969637|NCT03745638|3530325|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1969638|NCT03745638|3530326|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1969639|NCT03745638|3530327|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
1969640|NCT03745638|3530328|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6
1969641|NCT03745638|3530329|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1
1969642|NCT03745638|3530323|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1969643|NCT03745638|3530324|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1969644|NCT03745638|3530325|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1969645|NCT03745638|3530326|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
1969646|NCT03745638|3530327|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
1969647|NCT03745638|3530328|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
1969648|NCT03745638|3530329|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
1969649|NCT03745638|3530323|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1969650|NCT03745638|3530324|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1969651|NCT03745638|3530325|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
1969652|NCT03745638|3530326|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3
1969653|NCT03745638|3530327|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5
1969654|NCT03745638|3530328|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
1969655|NCT03745638|3530329|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24
1969656|NCT03745638|3530323|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1969657|NCT03745638|3530324|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1969658|NCT03745638|3530325|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1969659|NCT03745638|3530326|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1969660|NCT03745638|3530327|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
1969661|NCT03745638|3530328|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3
1969662|NCT03745638|3530329|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
1969663|NCT03745638|3530323|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969664|NCT03745638|3530324|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969665|NCT03745638|3530325|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969666|NCT03745638|3530326|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969667|NCT03745638|3530327|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969668|NCT03745638|3530328|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
1969669|NCT03745638|3530329|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
1969670|NCT03745638|3530323|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1969671|NCT03745638|3530324|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1969672|NCT03745638|3530325|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
1969673|NCT03745638|3530326|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7
1969674|NCT03745638|3530327|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3
1969675|NCT03745638|3530328|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17
1969676|NCT03745638|3530329|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21
1969677|NCT03745638|3530323|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
1969678|NCT03745638|3530324|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
1969679|NCT03745638|3530325|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
1969680|NCT03745638|3530326|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
1969681|NCT03745638|3530327|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
1969682|NCT03745638|3530328|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4
1969683|NCT03745638|3530329|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3
1969684|NCT03715764|3530348|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2
1969685|NCT03715764|3530349|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3
1969686|NCT03715764|3530348|FG000|3 Month Follow-up|Lost to Follow-up|2
1969687|NCT03715764|3530349|FG001|3 Month Follow-up|Lost to Follow-up|2
1969688|NCT03715764|3530348|FG000|3 Month Follow-up|Withdrawal by Subject|1
1969689|NCT03715764|3530349|FG001|3 Month Follow-up|Withdrawal by Subject|1
1969690|NCT03715764|3530348|FG000|6 Month Follow-up|Lost to Follow-up|3
1969691|NCT03715764|3530349|FG001|6 Month Follow-up|Lost to Follow-up|0
1969692|NCT03715764|3530348|FG000|12 Month Follow-up|Lost to Follow-up|2
1969693|NCT03715764|3530349|FG001|12 Month Follow-up|Lost to Follow-up|3
1969694|NCT03715764|3530348|FG000|12 Month Follow-up|Pregnancy|0
1969695|NCT03715764|3530349|FG001|12 Month Follow-up|Pregnancy|1
1969696|NCT03715764|3530348|FG000|12 Month Follow-up|Surgery|2
1969697|NCT03715764|3530349|FG001|12 Month Follow-up|Surgery|0
1969698|NCT03715764|3530348|FG000|12 Month Follow-up|Wrong address|1
1969699|NCT03715764|3530349|FG001|12 Month Follow-up|Wrong address|0
1969700|NCT03715764|3530348|FG000|12 Month Follow-up|No symptoms|1
1969701|NCT03715764|3530349|FG001|12 Month Follow-up|No symptoms|0
1969702|NCT03715764|3530348|FG000|12 Month Follow-up|Changed primary care centre|0
1969703|NCT03715764|3530349|FG001|12 Month Follow-up|Changed primary care centre|1
1969704|NCT03654729|3530362|FG000|Overall Study|Death|9
1969705|NCT03654729|3530363|FG001|Overall Study|Death|9
1969706|NCT03654729|3530364|FG002|Overall Study|Death|16
1969707|NCT03654729|3530362|FG000|Overall Study|Withdrawal by Subject|8
1969708|NCT03654729|3530363|FG001|Overall Study|Withdrawal by Subject|6
1969709|NCT03654729|3530364|FG002|Overall Study|Withdrawal by Subject|4
1969710|NCT03654729|3530362|FG000|Overall Study|Study terminated by Sponsor|3
1969711|NCT03654729|3530363|FG001|Overall Study|Study terminated by Sponsor|5
1969712|NCT03654729|3530364|FG002|Overall Study|Study terminated by Sponsor|4
1969713|NCT03654729|3530362|FG000|Overall Study|Not reported|2
1969714|NCT03654729|3530363|FG001|Overall Study|Not reported|4
1969715|NCT03654729|3530364|FG002|Overall Study|Not reported|5
1969716|NCT03654729|3530362|FG000|Overall Study|Progressive disease|3
1969717|NCT03654729|3530363|FG001|Overall Study|Progressive disease|0
1969718|NCT03654729|3530364|FG002|Overall Study|Progressive disease|0
1969719|NCT03654729|3530362|FG000|Overall Study|Lost to Follow-up|2
1969720|NCT03654729|3530363|FG001|Overall Study|Lost to Follow-up|0
1969721|NCT03654729|3530364|FG002|Overall Study|Lost to Follow-up|0
1969722|NCT03654729|3530362|FG000|Overall Study|Physician Decision|2
1969723|NCT03654729|3530363|FG001|Overall Study|Physician Decision|0
1969724|NCT03654729|3530364|FG002|Overall Study|Physician Decision|0
1969725|NCT03654729|3530362|FG000|Overall Study|Protocol Violation|1
1969726|NCT03654729|3530363|FG001|Overall Study|Protocol Violation|1
1969727|NCT03654729|3530364|FG002|Overall Study|Protocol Violation|0
1969728|NCT03654729|3530362|FG000|Overall Study|Non-compliance with study drug|0
1969729|NCT03654729|3530363|FG001|Overall Study|Non-compliance with study drug|1
1969730|NCT03654729|3530364|FG002|Overall Study|Non-compliance with study drug|0
1969731|NCT03654729|3530362|FG000|Overall Study|Site terminated by Sponsor|1
1969732|NCT03654729|3530363|FG001|Overall Study|Site terminated by Sponsor|0
1969733|NCT03654729|3530364|FG002|Overall Study|Site terminated by Sponsor|0
2021182|NCT00311363|3588973|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0
2021183|NCT00311363|3588971|FG000|24-Week Single-Blind Treatment Period|Death|1
2021184|NCT00311363|3588972|FG001|24-Week Single-Blind Treatment Period|Death|0
2021185|NCT00311363|3588973|FG002|24-Week Single-Blind Treatment Period|Death|0
2021186|NCT00311363|3588971|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0
2021187|NCT00311363|3588972|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3
2021188|NCT00311363|3588973|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0
2021189|NCT00311363|3588971|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
2021190|NCT00311363|3588972|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
2021191|NCT00311363|3588973|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
2021192|NCT00311363|3588971|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
2021193|NCT00311363|3588972|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
2021194|NCT00311363|3588973|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
2021195|NCT00311363|3588971|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
2021196|NCT00311363|3588972|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
2021197|NCT00311363|3588973|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
2021198|NCT00311363|3588971|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0
2021199|NCT00311363|3588972|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1
2021200|NCT00311363|3588973|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2
2021201|NCT00311363|3588971|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
2021202|NCT00311363|3588972|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
2021203|NCT00311363|3588973|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
2021204|NCT00311402|3588998|FG000|Overall Study|Adverse Event|118
2021205|NCT00311402|3588999|FG001|Overall Study|Adverse Event|105
2021206|NCT00311402|3588998|FG000|Overall Study|Lost to Follow-up|0
2021207|NCT00311402|3588999|FG001|Overall Study|Lost to Follow-up|3
1969734|NCT02976038|3530416|FG000|Overall Study|Physician Decision|22
1969735|NCT02976038|3530416|FG000|Overall Study|Withdrawal by Subject|3
1969736|NCT02976038|3530416|FG000|Overall Study|Lost to Follow-up|2
1969737|NCT02976038|3530416|FG000|Overall Study|Adverse Event|1
1969738|NCT02951767|3530430|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54
1969739|NCT02951767|3530430|FG000|Overall Study|Withdrawal by Subject|5
1969740|NCT02951767|3530430|FG000|Overall Study|Death|59
1969741|NCT02951767|3530430|FG000|Overall Study|Lost to Follow-up|1
2102127|NCT00837486|3693850|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
2102128|NCT00837486|3693851|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
2102129|NCT00837486|3693850|FG000|Long-term Follow-up Phase - Open Label|Death|1
2102130|NCT00837486|3693851|FG001|Long-term Follow-up Phase - Open Label|Death|0
2102131|NCT00837577|3693868|FG000|Double-blind Period|Clinical Adverse Event|1
2102132|NCT00837577|3693869|FG001|Double-blind Period|Clinical Adverse Event|0
2102133|NCT00837577|3693868|FG000|Double-blind Period|Withdrawal by Subject|1
2102134|NCT00837577|3693869|FG001|Double-blind Period|Withdrawal by Subject|0
2102135|NCT00837577|3693868|FG000|Open-label Period|Clinical Adverse Event|2
2102136|NCT00837577|3693869|FG001|Open-label Period|Clinical Adverse Event|2
2212718|NCT01673178|3854036|FG004|Overall Study|Lost to Follow-up|0
1969754|NCT02631070|3530446|FG000|Overall Study|Withdrawal by Subject|35
1969755|NCT02631070|3530447|FG001|Overall Study|Withdrawal by Subject|13
1969756|NCT02631070|3530446|FG000|Overall Study|Death|45
1969757|NCT02631070|3530447|FG001|Overall Study|Death|24
1969758|NCT02631070|3530446|FG000|Overall Study|Lost to Follow-up|5
1969759|NCT02631070|3530447|FG001|Overall Study|Lost to Follow-up|1
1969760|NCT02631070|3530446|FG000|Overall Study|Transition to rollover protocol|52
1969761|NCT02631070|3530447|FG001|Overall Study|Transition to rollover protocol|21
1969762|NCT02631070|3530446|FG000|Overall Study|Other reasons|12
1969763|NCT02631070|3530447|FG001|Overall Study|Other reasons|5
1969764|NCT02557139|3530456|FG000|Overall Study|Significant liver elevation|1
1969765|NCT02557139|3530457|FG001|Overall Study|Significant liver elevation|0
1969766|NCT02557139|3530458|FG002|Overall Study|Significant liver elevation|1
1969767|NCT02557139|3530456|FG000|Overall Study|Withdrawal by Subject|1
1969768|NCT02557139|3530457|FG001|Overall Study|Withdrawal by Subject|0
1969769|NCT02557139|3530458|FG002|Overall Study|Withdrawal by Subject|0
1969770|NCT02557139|3530456|FG000|Overall Study|Illness of prohibited medication|0
1969771|NCT02557139|3530457|FG001|Overall Study|Illness of prohibited medication|0
1969772|NCT02557139|3530458|FG002|Overall Study|Illness of prohibited medication|1
1969773|NCT02513667|3530477|FG000|Overall Study|Withdrawal by Subject|0
1969774|NCT02513667|3530478|FG001|Overall Study|Withdrawal by Subject|1
1969775|NCT02281955|3530484|FG000|Overall Study|Death|1
1969776|NCT02202434|3530492|FG000|Overall Study|Death|70
1969777|NCT02202434|3530493|FG001|Overall Study|Death|39
1969778|NCT02202434|3530494|FG002|Overall Study|Death|13
1969779|NCT02202434|3530495|FG003|Overall Study|Death|27
1969780|NCT02202434|3530492|FG000|Overall Study|Lost to Follow-up|1
1969781|NCT02202434|3530493|FG001|Overall Study|Lost to Follow-up|1
1969782|NCT02202434|3530494|FG002|Overall Study|Lost to Follow-up|1
1969783|NCT02202434|3530495|FG003|Overall Study|Lost to Follow-up|0
1969784|NCT02202434|3530492|FG000|Overall Study|Physician Decision|2
1969785|NCT02202434|3530493|FG001|Overall Study|Physician Decision|3
1969786|NCT02202434|3530494|FG002|Overall Study|Physician Decision|0
1969787|NCT02202434|3530495|FG003|Overall Study|Physician Decision|0
1969788|NCT02202434|3530492|FG000|Overall Study|Withdrawal by Subject|13
1969789|NCT02202434|3530493|FG001|Overall Study|Withdrawal by Subject|14
1969790|NCT02202434|3530494|FG002|Overall Study|Withdrawal by Subject|1
1969791|NCT02202434|3530495|FG003|Overall Study|Withdrawal by Subject|4
1969792|NCT02202434|3530492|FG000|Overall Study|Completed Study|1
1969793|NCT02202434|3530493|FG001|Overall Study|Completed Study|0
1969794|NCT02202434|3530494|FG002|Overall Study|Completed Study|0
1969795|NCT02202434|3530495|FG003|Overall Study|Completed Study|0
1969796|NCT02202434|3530492|FG000|Overall Study|Visit Missed|21
1969797|NCT02202434|3530493|FG001|Overall Study|Visit Missed|12
1969798|NCT02202434|3530494|FG002|Overall Study|Visit Missed|0
1969799|NCT02202434|3530495|FG003|Overall Study|Visit Missed|5
1969800|NCT02202434|3530492|FG000|Overall Study|Other|1
1969801|NCT02202434|3530493|FG001|Overall Study|Other|0
1969802|NCT02202434|3530494|FG002|Overall Study|Other|0
1969803|NCT02202434|3530495|FG003|Overall Study|Other|1
1969804|NCT02108652|3530505|FG000|Overall Study|Death|226
1969805|NCT02108652|3530505|FG000|Overall Study|Lost to Follow-up|2
1969806|NCT02108652|3530505|FG000|Overall Study|Withdrawal by Subject|8
1969807|NCT02108652|3530505|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74
1969808|NCT02097134|3530509|FG000|Overall Study|Physician Decision|4
1969809|NCT02097134|3530509|FG000|Overall Study|Non-Protocol Therapy|1
1969810|NCT02097134|3530509|FG000|Overall Study|Progressive Disease|3
1969811|NCT02097134|3530509|FG000|Overall Study|Refusal of Further Protocol Therapy|1
1969812|NCT01564537|3530520|FG000|Overall Study|Withdrawal by Participant|4
1969813|NCT01564537|3530521|FG001|Overall Study|Withdrawal by Participant|4
1969814|NCT01564537|3530520|FG000|Overall Study|Lost to Follow-up|1
1969815|NCT01564537|3530521|FG001|Overall Study|Lost to Follow-up|0
1969816|NCT01564537|3530520|FG000|Overall Study|Other Miscellaneous Reasons|1
1969817|NCT01564537|3530521|FG001|Overall Study|Other Miscellaneous Reasons|2
1969818|NCT01230242|3530528|FG000|Overall Study|Physician Decision|2
1969819|NCT01230242|3530528|FG000|Overall Study|Withdrawal by Subject|1
1969820|NCT00983437|3530532|FG000|Overall Study|Adverse Event|9
1969821|NCT00983437|3530532|FG000|Overall Study|Lack of Efficacy|1
1969822|NCT00983437|3530532|FG000|Overall Study|Withdrawal by Subject|8
1969823|NCT00983437|3530532|FG000|Overall Study|Noncompliance to Study Procedures|1
1969824|NCT00983437|3530532|FG000|Overall Study|Lost to Follow-up|2
1969825|NCT00983437|3530532|FG000|Overall Study|Other Reason|26
1969826|NCT00965757|3530538|FG000|Double-blind Phase|Progression of concomitant disease|1
1969827|NCT00965757|3530539|FG001|Double-blind Phase|Progression of concomitant disease|2
1969828|NCT00965757|3530540|FG002|Double-blind Phase|Progression of concomitant disease|0
1969829|NCT00965757|3530541|FG003|Double-blind Phase|Progression of concomitant disease|0
1969830|NCT00965757|3530538|FG000|Double-blind Phase|Adverse drug reaction|2
1969831|NCT00965757|3530539|FG001|Double-blind Phase|Adverse drug reaction|1
1969832|NCT00965757|3530540|FG002|Double-blind Phase|Adverse drug reaction|0
1969833|NCT00965757|3530541|FG003|Double-blind Phase|Adverse drug reaction|0
1969834|NCT00965757|3530538|FG000|Double-blind Phase|Abnormal Laboratory Value|2
1969835|NCT00965757|3530539|FG001|Double-blind Phase|Abnormal Laboratory Value|0
1969836|NCT00965757|3530540|FG002|Double-blind Phase|Abnormal Laboratory Value|0
1969837|NCT00965757|3530541|FG003|Double-blind Phase|Abnormal Laboratory Value|0
1969838|NCT00965757|3530538|FG000|Double-blind Phase|Lack of Efficacy|7
1969839|NCT00965757|3530539|FG001|Double-blind Phase|Lack of Efficacy|11
1969840|NCT00965757|3530540|FG002|Double-blind Phase|Lack of Efficacy|0
1969841|NCT00965757|3530541|FG003|Double-blind Phase|Lack of Efficacy|0
1969842|NCT00965757|3530538|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2
1969843|NCT00965757|3530539|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1969844|NCT00965757|3530540|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1969845|NCT00965757|3530541|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1969846|NCT00965757|3530538|FG000|Double-blind Phase|Lost to Follow-up|0
1969847|NCT00965757|3530539|FG001|Double-blind Phase|Lost to Follow-up|1
1969848|NCT00965757|3530540|FG002|Double-blind Phase|Lost to Follow-up|0
1969849|NCT00965757|3530541|FG003|Double-blind Phase|Lost to Follow-up|0
1969850|NCT00965757|3530538|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2
1969851|NCT00965757|3530539|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3
1969852|NCT00965757|3530540|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0
1969853|NCT00965757|3530541|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0
1969854|NCT00965757|3530538|FG000|Double-blind Phase|Other|1
1969855|NCT00965757|3530539|FG001|Double-blind Phase|Other|0
1969856|NCT00965757|3530540|FG002|Double-blind Phase|Other|0
1969857|NCT00965757|3530541|FG003|Double-blind Phase|Other|0
1969858|NCT00965757|3530538|FG000|Extension Phase|Progression of concomitant disease|0
1969859|NCT00965757|3530539|FG001|Extension Phase|Progression of concomitant disease|0
1969860|NCT00965757|3530540|FG002|Extension Phase|Progression of concomitant disease|4
1969861|NCT00965757|3530541|FG003|Extension Phase|Progression of concomitant disease|2
1969862|NCT00965757|3530538|FG000|Extension Phase|Adverse drug reaction|0
1969863|NCT00965757|3530539|FG001|Extension Phase|Adverse drug reaction|0
1969864|NCT00965757|3530540|FG002|Extension Phase|Adverse drug reaction|6
1969865|NCT00965757|3530541|FG003|Extension Phase|Adverse drug reaction|3
1969866|NCT00965757|3530538|FG000|Extension Phase|Abnormal Laboratory Value|0
1969867|NCT00965757|3530539|FG001|Extension Phase|Abnormal Laboratory Value|0
1969868|NCT00965757|3530540|FG002|Extension Phase|Abnormal Laboratory Value|6
1969869|NCT00965757|3530541|FG003|Extension Phase|Abnormal Laboratory Value|1
1969870|NCT00965757|3530538|FG000|Extension Phase|Lack of Efficacy|0
1969871|NCT00965757|3530539|FG001|Extension Phase|Lack of Efficacy|0
1969872|NCT00965757|3530540|FG002|Extension Phase|Lack of Efficacy|8
1969873|NCT00965757|3530541|FG003|Extension Phase|Lack of Efficacy|12
1969874|NCT00965757|3530538|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0
1969875|NCT00965757|3530539|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0
1969876|NCT00965757|3530540|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4
1969877|NCT00965757|3530541|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0
1969878|NCT00965757|3530538|FG000|Extension Phase|Lost to Follow-up|0
1969879|NCT00965757|3530539|FG001|Extension Phase|Lost to Follow-up|0
1969880|NCT00965757|3530540|FG002|Extension Phase|Lost to Follow-up|0
1969881|NCT00965757|3530541|FG003|Extension Phase|Lost to Follow-up|1
1969882|NCT00965757|3530538|FG000|Extension Phase|Ineligible after Taking Study Drug|0
1969883|NCT00965757|3530539|FG001|Extension Phase|Ineligible after Taking Study Drug|0
1969884|NCT00965757|3530540|FG002|Extension Phase|Ineligible after Taking Study Drug|3
1969885|NCT00965757|3530541|FG003|Extension Phase|Ineligible after Taking Study Drug|3
1969886|NCT00965757|3530538|FG000|Extension Phase|Protocol Violation|0
1969887|NCT00965757|3530539|FG001|Extension Phase|Protocol Violation|0
1969888|NCT00965757|3530540|FG002|Extension Phase|Protocol Violation|0
1969889|NCT00965757|3530541|FG003|Extension Phase|Protocol Violation|1
1969890|NCT00965757|3530538|FG000|Extension Phase|Other|0
1969891|NCT00965757|3530539|FG001|Extension Phase|Other|0
1969892|NCT00965757|3530540|FG002|Extension Phase|Other|2
1969893|NCT00965757|3530541|FG003|Extension Phase|Other|1
1969894|NCT00928447|3530549|FG000|Overall Study|Withdrawal by Subject|1
1969895|NCT00928447|3530549|FG000|Overall Study|Investigator's decision|1
1969896|NCT00893789|3530557|FG000|Overall Study|Withdrawal by Subject|3
1969897|NCT00893789|3530558|FG001|Overall Study|Withdrawal by Subject|1
1969898|NCT00893789|3530559|FG002|Overall Study|Withdrawal by Subject|3
1969899|NCT00893789|3530560|FG003|Overall Study|Withdrawal by Subject|1
1969900|NCT00893789|3530557|FG000|Overall Study|Noncompliance With Study Drug|1
1969901|NCT00893789|3530558|FG001|Overall Study|Noncompliance With Study Drug|0
1969902|NCT00893789|3530559|FG002|Overall Study|Noncompliance With Study Drug|1
1969903|NCT00893789|3530560|FG003|Overall Study|Noncompliance With Study Drug|2
1969904|NCT00893789|3530557|FG000|Overall Study|Noncompliance With Study Procedures|1
1969905|NCT00893789|3530558|FG001|Overall Study|Noncompliance With Study Procedures|0
1969906|NCT00893789|3530559|FG002|Overall Study|Noncompliance With Study Procedures|0
1969907|NCT00893789|3530560|FG003|Overall Study|Noncompliance With Study Procedures|0
1969908|NCT00893789|3530557|FG000|Overall Study|Taking Excluded Concomitant Medication|1
1969909|NCT00893789|3530558|FG001|Overall Study|Taking Excluded Concomitant Medication|0
1969910|NCT00893789|3530559|FG002|Overall Study|Taking Excluded Concomitant Medication|1
1969911|NCT00893789|3530560|FG003|Overall Study|Taking Excluded Concomitant Medication|0
1969912|NCT00893789|3530557|FG000|Overall Study|Adverse Event|0
1969913|NCT00893789|3530558|FG001|Overall Study|Adverse Event|2
1969914|NCT00893789|3530559|FG002|Overall Study|Adverse Event|1
1969915|NCT00893789|3530560|FG003|Overall Study|Adverse Event|5
1969916|NCT00893789|3530557|FG000|Overall Study|Protocol Violation|0
1969917|NCT00893789|3530558|FG001|Overall Study|Protocol Violation|1
1969918|NCT00893789|3530559|FG002|Overall Study|Protocol Violation|1
1969919|NCT00893789|3530560|FG003|Overall Study|Protocol Violation|4
1969920|NCT00893789|3530557|FG000|Overall Study|Lost to Follow-up|0
1969921|NCT00893789|3530558|FG001|Overall Study|Lost to Follow-up|0
1969922|NCT00893789|3530559|FG002|Overall Study|Lost to Follow-up|0
1969923|NCT00893789|3530560|FG003|Overall Study|Lost to Follow-up|1
2021208|NCT00311402|3588998|FG000|Overall Study|Withdrawal by Subject|17
2021209|NCT00311402|3588999|FG001|Overall Study|Withdrawal by Subject|18
2021210|NCT00311402|3588998|FG000|Overall Study|Lack of Efficacy|58
2021211|NCT00311402|3588999|FG001|Overall Study|Lack of Efficacy|42
2021212|NCT00311402|3588998|FG000|Overall Study|Protocol Violation|7
2021213|NCT00311402|3588999|FG001|Overall Study|Protocol Violation|6
2021214|NCT00311402|3588998|FG000|Overall Study|IRB's rejection etc.|10
2021215|NCT00311402|3588999|FG001|Overall Study|IRB's rejection etc.|3
2021216|NCT00311584|3589007|FG000|Overall Study|Death|1
2021217|NCT00311584|3589008|FG001|Overall Study|Death|0
2021218|NCT00311584|3589007|FG000|Overall Study|Lack of Efficacy|12
2021219|NCT00311584|3589008|FG001|Overall Study|Lack of Efficacy|15
2021220|NCT00311584|3589007|FG000|Overall Study|Physician Decision|4
2021221|NCT00311584|3589008|FG001|Overall Study|Physician Decision|5
2021222|NCT00311584|3589007|FG000|Overall Study|Withdrawal by Subject|1
2021223|NCT00311584|3589008|FG001|Overall Study|Withdrawal by Subject|1
2021224|NCT00311584|3589007|FG000|Overall Study|ineligible|2
2021225|NCT00311584|3589008|FG001|Overall Study|ineligible|2
2021226|NCT00311623|3589017|FG000|Overall Study|Physician Decision|0
2021227|NCT00311623|3589018|FG001|Overall Study|Physician Decision|0
2021228|NCT00311623|3589019|FG002|Overall Study|Physician Decision|2
2021229|NCT00312195|3589039|FG000|Overall Study|Adverse Event|4
2021230|NCT00312195|3589040|FG001|Overall Study|Adverse Event|6
2021231|NCT00312195|3589039|FG000|Overall Study|Lost to Follow-up|1
2021232|NCT00312195|3589040|FG001|Overall Study|Lost to Follow-up|0
2021233|NCT00312195|3589039|FG000|Overall Study|Protocol Violation|1
2021234|NCT00312195|3589040|FG001|Overall Study|Protocol Violation|0
2021235|NCT00312208|3589050|FG000|Overall Study|Adverse Event|97
2021236|NCT00312208|3589051|FG001|Overall Study|Adverse Event|61
2021237|NCT00312208|3589050|FG000|Overall Study|Protocol Violation|5
2021238|NCT00312208|3589051|FG001|Overall Study|Protocol Violation|3
2021239|NCT00312208|3589050|FG000|Overall Study|Death|2
2021240|NCT00312208|3589051|FG001|Overall Study|Death|1
2021241|NCT00312208|3589050|FG000|Overall Study|Lack of Efficacy|7
2021242|NCT00312208|3589051|FG001|Overall Study|Lack of Efficacy|4
2021243|NCT00312208|3589050|FG000|Overall Study|Lost to Follow-up|3
2021244|NCT00312208|3589051|FG001|Overall Study|Lost to Follow-up|5
2021245|NCT00312208|3589050|FG000|Overall Study|Withdrawal by Subject|53
2021246|NCT00312208|3589051|FG001|Overall Study|Withdrawal by Subject|42
2021247|NCT00312208|3589050|FG000|Overall Study|Other|5
2021248|NCT00312208|3589051|FG001|Overall Study|Other|7
2021249|NCT00312221|3589060|FG000|Open-label Run-in Period|Withdrawal by Subject|6
2021250|NCT00312221|3589061|FG001|Open-label Run-in Period|Withdrawal by Subject|0
2021251|NCT00312221|3589062|FG002|Open-label Run-in Period|Withdrawal by Subject|0
2021252|NCT00312221|3589063|FG003|Open-label Run-in Period|Withdrawal by Subject|0
2021253|NCT00312221|3589060|FG000|Open-label Run-in Period|Adverse Event|74
2021254|NCT00312221|3589061|FG001|Open-label Run-in Period|Adverse Event|0
2021255|NCT00312221|3589062|FG002|Open-label Run-in Period|Adverse Event|0
2021256|NCT00312221|3589063|FG003|Open-label Run-in Period|Adverse Event|0
2021257|NCT00312221|3589060|FG000|Open-label Run-in Period|Lost to Follow-up|5
2021258|NCT00312221|3589061|FG001|Open-label Run-in Period|Lost to Follow-up|0
2021259|NCT00312221|3589062|FG002|Open-label Run-in Period|Lost to Follow-up|0
2021260|NCT00312221|3589063|FG003|Open-label Run-in Period|Lost to Follow-up|0
2021261|NCT00312221|3589060|FG000|Open-label Run-in Period|Administrative|42
2021262|NCT00312221|3589061|FG001|Open-label Run-in Period|Administrative|0
2021263|NCT00312221|3589062|FG002|Open-label Run-in Period|Administrative|0
2021264|NCT00312221|3589063|FG003|Open-label Run-in Period|Administrative|0
1969924|NCT03933449|3530580|FG000|Overall Study|Adverse Event|6
1969925|NCT03933449|3530581|FG001|Overall Study|Adverse Event|4
1969926|NCT03933449|3530580|FG000|Overall Study|Death|36
1969927|NCT03933449|3530581|FG001|Overall Study|Death|51
1969928|NCT03933449|3530580|FG000|Overall Study|Ongoing in Study|20
1969929|NCT03933449|3530581|FG001|Overall Study|Ongoing in Study|6
1969930|NCT03901144|3530587|FG000|Overall Study|Lost to Follow-up|1
1969931|NCT03901144|3530588|FG001|Overall Study|Lost to Follow-up|1
1969932|NCT03901144|3530589|FG002|Overall Study|Lost to Follow-up|1
1969933|NCT03901144|3530590|FG003|Overall Study|Lost to Follow-up|1
1969934|NCT03461211|3530615|FG000|Overall Study|Adverse Event|1
1969935|NCT03461211|3530616|FG001|Overall Study|Adverse Event|1
1969936|NCT03461211|3530615|FG000|Overall Study|Lack of Efficacy|0
1969937|NCT03461211|3530616|FG001|Overall Study|Lack of Efficacy|1
1969938|NCT03282123|3530624|FG000|Overall Study|Withdrawal by Subject|5
1969939|NCT03276780|3530631|FG000|Overall Study|Withdrawal by Subject|5
1969940|NCT03276780|3530632|FG001|Overall Study|Withdrawal by Subject|3
1969941|NCT03276780|3530631|FG000|Overall Study|Lost to Follow-up|3
1969942|NCT03276780|3530632|FG001|Overall Study|Lost to Follow-up|5
1969943|NCT03276780|3530631|FG000|Overall Study|Moved out of state|1
1969944|NCT03276780|3530632|FG001|Overall Study|Moved out of state|1
1969945|NCT03276780|3530631|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1
1969946|NCT03276780|3530632|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0
1969947|NCT03276780|3530631|FG000|Overall Study|No show to appointments after baseline through Week 5|8
1969948|NCT03276780|3530632|FG001|Overall Study|No show to appointments after baseline through Week 5|1
1969949|NCT03219333|3530642|FG000|Overall Study|Withdrawal by Subject|8
1969950|NCT03219333|3530643|FG001|Overall Study|Withdrawal by Subject|3
1969951|NCT03219333|3530642|FG000|Overall Study|Lost to Follow-up|1
1969952|NCT03219333|3530643|FG001|Overall Study|Lost to Follow-up|0
1969953|NCT03219333|3530642|FG000|Overall Study|Death|94
1969954|NCT03219333|3530643|FG001|Overall Study|Death|44
1969955|NCT03219333|3530642|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
1969956|NCT03219333|3530643|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
1969957|NCT03100149|3530665|FG000|Overall Study|Adverse Event|0
1969958|NCT03100149|3530666|FG001|Overall Study|Adverse Event|1
1969959|NCT03100149|3530667|FG002|Overall Study|Adverse Event|0
1969960|NCT03100149|3530665|FG000|Overall Study|Participant Moved out of Country|0
1969961|NCT03100149|3530666|FG001|Overall Study|Participant Moved out of Country|0
1969962|NCT03100149|3530667|FG002|Overall Study|Participant Moved out of Country|1
1969963|NCT03100149|3530665|FG000|Overall Study|Withdrawal by Subject|0
1969964|NCT03100149|3530666|FG001|Overall Study|Withdrawal by Subject|3
1969965|NCT03100149|3530667|FG002|Overall Study|Withdrawal by Subject|1
1969966|NCT03050814|3530678|FG000|Overall Study|Screen failures|0
1969967|NCT03050814|3530679|FG001|Overall Study|Screen failures|0
1969968|NCT03050814|3530680|FG002|Overall Study|Screen failures|4
1969969|NCT02797262|3530688|FG000|Overall Study|Withdrawal by Subject|5
1969970|NCT02797262|3530689|FG001|Overall Study|Withdrawal by Subject|1
1969971|NCT02797262|3530688|FG000|Overall Study|Lost to Follow-up|10
1969972|NCT02797262|3530689|FG001|Overall Study|Lost to Follow-up|7
1969973|NCT02797262|3530688|FG000|Overall Study|Death|1
1969974|NCT02797262|3530689|FG001|Overall Study|Death|2
1969975|NCT02797262|3530688|FG000|Overall Study|Adverse Event|1
1969976|NCT02797262|3530689|FG001|Overall Study|Adverse Event|0
1969977|NCT02797262|3530688|FG000|Overall Study|COVID-19|2
1969978|NCT02797262|3530689|FG001|Overall Study|COVID-19|1
1969979|NCT02797262|3530688|FG000|Overall Study|Out-of-country|1
1969980|NCT02797262|3530689|FG001|Overall Study|Out-of-country|0
1969981|NCT02409368|3530707|FG000|Overall Study|Adverse event unrelated to study drug|16
1969982|NCT02409368|3530708|FG001|Overall Study|Adverse event unrelated to study drug|42
1969983|NCT02409368|3530709|FG002|Overall Study|Adverse event unrelated to study drug|10
1969984|NCT02409368|3530707|FG000|Overall Study|Death|5
1969985|NCT02409368|3530708|FG001|Overall Study|Death|17
1969986|NCT02409368|3530709|FG002|Overall Study|Death|5
1969987|NCT02409368|3530707|FG000|Overall Study|Disease Progression|101
1969988|NCT02409368|3530708|FG001|Overall Study|Disease Progression|346
1969989|NCT02409368|3530709|FG002|Overall Study|Disease Progression|63
1969990|NCT02409368|3530707|FG000|Overall Study|Lost to Follow-up|1
1969991|NCT02409368|3530708|FG001|Overall Study|Lost to Follow-up|5
1969992|NCT02409368|3530709|FG002|Overall Study|Lost to Follow-up|0
1969993|NCT02409368|3530707|FG000|Overall Study|maximum clinical benefit|3
1969994|NCT02409368|3530708|FG001|Overall Study|maximum clinical benefit|8
1969995|NCT02409368|3530709|FG002|Overall Study|maximum clinical benefit|1
1969996|NCT02409368|3530707|FG000|Overall Study|poor/non compliant|0
1969997|NCT02409368|3530708|FG001|Overall Study|poor/non compliant|2
1969998|NCT02409368|3530709|FG002|Overall Study|poor/non compliant|2
1969999|NCT02409368|3530707|FG000|Overall Study|study drug toxicity|12
1970000|NCT02409368|3530708|FG001|Overall Study|study drug toxicity|35
1970001|NCT02409368|3530709|FG002|Overall Study|study drug toxicity|6
1970002|NCT02409368|3530707|FG000|Overall Study|no longer meets study criteria|3
1970003|NCT02409368|3530708|FG001|Overall Study|no longer meets study criteria|9
1970004|NCT02409368|3530709|FG002|Overall Study|no longer meets study criteria|3
1970005|NCT02409368|3530707|FG000|Overall Study|Participant request to discontinue|3
1970006|NCT02409368|3530708|FG001|Overall Study|Participant request to discontinue|3
1970007|NCT02409368|3530709|FG002|Overall Study|Participant request to discontinue|3
1970008|NCT02409368|3530707|FG000|Overall Study|Participant withdrew consent|2
1970009|NCT02409368|3530708|FG001|Overall Study|Participant withdrew consent|4
1970010|NCT02409368|3530709|FG002|Overall Study|Participant withdrew consent|3
1970011|NCT02409368|3530707|FG000|Overall Study|Other Reasons|2
1970012|NCT02409368|3530708|FG001|Overall Study|Other Reasons|17
1970013|NCT02409368|3530709|FG002|Overall Study|Other Reasons|3
1970014|NCT02409368|3530707|FG000|Overall Study|Not Reported|0
1970015|NCT02409368|3530708|FG001|Overall Study|Not Reported|1
1970016|NCT02409368|3530709|FG002|Overall Study|Not Reported|0
1970017|NCT02277119|3530730|FG000|Overall Study|Lack of Efficacy|1
1970018|NCT02277119|3530731|FG001|Overall Study|Lack of Efficacy|1
1970019|NCT02277119|3530732|FG002|Overall Study|Lack of Efficacy|1
1970020|NCT02277119|3530730|FG000|Overall Study|Protocol Violation|2
1970021|NCT02277119|3530731|FG001|Overall Study|Protocol Violation|3
1970022|NCT02277119|3530732|FG002|Overall Study|Protocol Violation|7
1970023|NCT02220894|3530742|FG000|Overall Study|Adverse Event|118
1970024|NCT02220894|3530743|FG001|Overall Study|Adverse Event|70
1970025|NCT02220894|3530742|FG000|Overall Study|Death|252
1970026|NCT02220894|3530743|FG001|Overall Study|Death|368
1970027|NCT02220894|3530742|FG000|Overall Study|Lost to Follow-up|0
1970028|NCT02220894|3530743|FG001|Overall Study|Lost to Follow-up|2
1970029|NCT02220894|3530742|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1970030|NCT02220894|3530743|FG001|Overall Study|Withdrawal by Parent/Guardian|1
1970031|NCT02220894|3530742|FG000|Overall Study|Withdrawal by Subject|2
1970032|NCT02220894|3530743|FG001|Overall Study|Withdrawal by Subject|13
1970033|NCT02220894|3530742|FG000|Overall Study|Ongoing in Study|265
1970034|NCT02220894|3530743|FG001|Overall Study|Ongoing in Study|183
1970035|NCT01721759|3530898|FG000|Overall Study|Disease progression|78
1970036|NCT01721759|3530898|FG000|Overall Study|Study drug toxicity|14
1970037|NCT01721759|3530898|FG000|Overall Study|Adverse event unrelated to study drug|9
1970038|NCT01721759|3530898|FG000|Overall Study|Withdrawal by Subject|1
1970039|NCT01285102|3530911|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4
1970040|NCT01026220|3530915|FG000|Induction|Death|1
2212719|NCT01673178|3854032|FG000|Overall Study|Withdrawal by Subject|0
2212720|NCT01673178|3854033|FG001|Overall Study|Withdrawal by Subject|0
2309220|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
1970041|NCT01026220|3530916|FG001|Induction|Death|0
1970042|NCT01026220|3530917|FG002|Induction|Death|0
1970043|NCT01026220|3530915|FG000|Induction|Lack of Efficacy|2
1970044|NCT01026220|3530916|FG001|Induction|Lack of Efficacy|0
1970045|NCT01026220|3530917|FG002|Induction|Lack of Efficacy|0
1970046|NCT01026220|3530915|FG000|Induction|Physician Decision|12
1970047|NCT01026220|3530916|FG001|Induction|Physician Decision|0
1970048|NCT01026220|3530917|FG002|Induction|Physician Decision|0
1970049|NCT01026220|3530915|FG000|Induction|Withdrawal by Subject|9
1970050|NCT01026220|3530916|FG001|Induction|Withdrawal by Subject|0
1970051|NCT01026220|3530917|FG002|Induction|Withdrawal by Subject|0
1970052|NCT01026220|3530915|FG000|Induction|Ineligible|1
1970053|NCT01026220|3530916|FG001|Induction|Ineligible|0
1970054|NCT01026220|3530917|FG002|Induction|Ineligible|0
1970055|NCT01026220|3530915|FG000|Consolidation Maintenance|Death|0
1970056|NCT01026220|3530916|FG001|Consolidation Maintenance|Death|1
1970057|NCT01026220|3530917|FG002|Consolidation Maintenance|Death|0
1970058|NCT01026220|3530915|FG000|Consolidation Maintenance|Lack of Efficacy|0
1970059|NCT01026220|3530916|FG001|Consolidation Maintenance|Lack of Efficacy|1
1970060|NCT01026220|3530917|FG002|Consolidation Maintenance|Lack of Efficacy|1
1970061|NCT01026220|3530915|FG000|Consolidation Maintenance|Physician Decision|0
2309221|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
2309222|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
2309223|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
2309224|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1
2309225|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0
2309226|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0
2309227|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0
2309228|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0
2309229|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
1970062|NCT01026220|3530916|FG001|Consolidation Maintenance|Physician Decision|2
1970063|NCT01026220|3530917|FG002|Consolidation Maintenance|Physician Decision|7
1970064|NCT01026220|3530915|FG000|Consolidation Maintenance|Withdrawal by Subject|0
1970065|NCT01026220|3530916|FG001|Consolidation Maintenance|Withdrawal by Subject|2
1970066|NCT01026220|3530917|FG002|Consolidation Maintenance|Withdrawal by Subject|6
2021265|NCT00312221|3589060|FG000|Open-label Run-in Period|Lack of Efficacy|102
2021266|NCT00312221|3589061|FG001|Open-label Run-in Period|Lack of Efficacy|0
2021267|NCT00312221|3589062|FG002|Open-label Run-in Period|Lack of Efficacy|0
2021268|NCT00312221|3589063|FG003|Open-label Run-in Period|Lack of Efficacy|0
2021269|NCT00312221|3589060|FG000|Open-label Run-in Period|Did not qualify|5
2021270|NCT00312221|3589061|FG001|Open-label Run-in Period|Did not qualify|0
2021271|NCT00312221|3589062|FG002|Open-label Run-in Period|Did not qualify|0
1970067|NCT03877926|3531013|FG000|Overall Study|Adverse Event|1
1970068|NCT03877926|3531014|FG001|Overall Study|Adverse Event|0
1970069|NCT03877926|3531015|FG002|Overall Study|Adverse Event|0
1970070|NCT03877926|3531016|FG003|Overall Study|Adverse Event|0
1970071|NCT03877926|3531013|FG000|Overall Study|Death|2
1970072|NCT03877926|3531014|FG001|Overall Study|Death|2
1970073|NCT03877926|3531015|FG002|Overall Study|Death|2
1970074|NCT03877926|3531016|FG003|Overall Study|Death|0
2212721|NCT01673178|3854034|FG002|Overall Study|Withdrawal by Subject|1
2212722|NCT01673178|3854035|FG003|Overall Study|Withdrawal by Subject|4
2212723|NCT01673178|3854036|FG004|Overall Study|Withdrawal by Subject|2
2212724|NCT01673178|3854032|FG000|Overall Study|Protocol Violation|1
2212725|NCT01673178|3854033|FG001|Overall Study|Protocol Violation|1
1970075|NCT03877926|3531013|FG000|Overall Study|Lost to Follow-up|41
1970076|NCT03877926|3531014|FG001|Overall Study|Lost to Follow-up|52
1970077|NCT03877926|3531015|FG002|Overall Study|Lost to Follow-up|45
1970078|NCT03877926|3531016|FG003|Overall Study|Lost to Follow-up|17
1970079|NCT03877926|3531013|FG000|Overall Study|Physician Decision|2
1970080|NCT03877926|3531014|FG001|Overall Study|Physician Decision|0
1970081|NCT03877926|3531015|FG002|Overall Study|Physician Decision|2
1970082|NCT03877926|3531016|FG003|Overall Study|Physician Decision|0
1970083|NCT03877926|3531013|FG000|Overall Study|Withdrawal by Subject|18
1970084|NCT03877926|3531014|FG001|Overall Study|Withdrawal by Subject|21
1970085|NCT03877926|3531015|FG002|Overall Study|Withdrawal by Subject|12
1970086|NCT03877926|3531016|FG003|Overall Study|Withdrawal by Subject|4
1970087|NCT03877926|3531013|FG000|Overall Study|Other - Various|4
1970088|NCT03877926|3531014|FG001|Overall Study|Other - Various|1
1970089|NCT03877926|3531015|FG002|Overall Study|Other - Various|1
1970090|NCT03877926|3531016|FG003|Overall Study|Other - Various|0
1970091|NCT03877926|3531013|FG000|Overall Study|Not Treated|3
1970092|NCT03877926|3531014|FG001|Overall Study|Not Treated|1
1970093|NCT03877926|3531015|FG002|Overall Study|Not Treated|1
1970094|NCT03877926|3531016|FG003|Overall Study|Not Treated|0
1970095|NCT03862807|3531039|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1
1970096|NCT03857867|3531043|FG000|Overall Study|Physician Decision|1
1970097|NCT03691571|3531050|FG000|Overall Study|Withdrawal by Subject|9
1970098|NCT03691571|3531051|FG001|Overall Study|Withdrawal by Subject|2
1970099|NCT03436199|3531061|FG000|Overall Study|Adverse Event|15
1970100|NCT03436199|3531062|FG001|Overall Study|Adverse Event|40
1970101|NCT03436199|3531063|FG002|Overall Study|Adverse Event|7
1970102|NCT03436199|3531061|FG000|Overall Study|Withdrawal by Subject|4
1970103|NCT03436199|3531062|FG001|Overall Study|Withdrawal by Subject|10
1970104|NCT03436199|3531063|FG002|Overall Study|Withdrawal by Subject|3
1970105|NCT03436199|3531061|FG000|Overall Study|Lost to Follow-up|1
1970106|NCT03436199|3531062|FG001|Overall Study|Lost to Follow-up|0
1970107|NCT03436199|3531063|FG002|Overall Study|Lost to Follow-up|2
1970108|NCT03436199|3531061|FG000|Overall Study|Protocol Violation|1
1970109|NCT03436199|3531062|FG001|Overall Study|Protocol Violation|1
1970110|NCT03436199|3531063|FG002|Overall Study|Protocol Violation|0
1970111|NCT03436199|3531061|FG000|Overall Study|Physician Decision|0
1970112|NCT03436199|3531062|FG001|Overall Study|Physician Decision|1
1970113|NCT03436199|3531063|FG002|Overall Study|Physician Decision|0
1970114|NCT03436199|3531061|FG000|Overall Study|Could not return to clinic|1
1970115|NCT03436199|3531062|FG001|Overall Study|Could not return to clinic|0
1970116|NCT03436199|3531063|FG002|Overall Study|Could not return to clinic|0
1970117|NCT03436199|3531061|FG000|Overall Study|Withdrawn per physician|0
1970118|NCT03436199|3531062|FG001|Overall Study|Withdrawn per physician|1
1970119|NCT03436199|3531063|FG002|Overall Study|Withdrawn per physician|0
1970120|NCT03417102|3531073|FG000|Overall Study|Adverse Event|0
1970121|NCT03417102|3531074|FG001|Overall Study|Adverse Event|1
1970122|NCT03417102|3531073|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0
1970123|NCT03417102|3531074|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3
1970124|NCT03417102|3531073|FG000|Overall Study|Other|0
1970125|NCT03417102|3531074|FG001|Overall Study|Other|1
1970126|NCT03250273|3531091|FG000|Overall Study|Disease Progression|2
1970127|NCT03250273|3531092|FG001|Overall Study|Disease Progression|9
1970128|NCT03250273|3531091|FG000|Overall Study|Adverse Event|0
1970129|NCT03250273|3531092|FG001|Overall Study|Adverse Event|1
1970130|NCT03250273|3531091|FG000|Overall Study|Death|0
1970131|NCT03250273|3531092|FG001|Overall Study|Death|1
1970132|NCT03250273|3531091|FG000|Overall Study|Failed to Maintain Eligibility|0
1970133|NCT03250273|3531092|FG001|Overall Study|Failed to Maintain Eligibility|1
1970134|NCT03217136|3531100|FG000|Overall Study|Lost to Follow-up|2
1970135|NCT03217136|3531101|FG001|Overall Study|Lost to Follow-up|1
1970136|NCT03217136|3531100|FG000|Overall Study|Site Randomized Participant in Error|0
1970137|NCT03217136|3531101|FG001|Overall Study|Site Randomized Participant in Error|1
1970138|NCT03217136|3531100|FG000|Overall Study|Did Not Meet Criteria after Randomization|0
1970139|NCT03217136|3531101|FG001|Overall Study|Did Not Meet Criteria after Randomization|1
1970140|NCT03217136|3531100|FG000|Overall Study|Dispensing Error|1
1970141|NCT03217136|3531101|FG001|Overall Study|Dispensing Error|0
1970142|NCT03217136|3531100|FG000|Overall Study|Withdrawal by Parent/Guardian|1
1970143|NCT03217136|3531101|FG001|Overall Study|Withdrawal by Parent/Guardian|0
1970144|NCT03181542|3531109|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1
2021272|NCT00312221|3589063|FG003|Open-label Run-in Period|Did not qualify|0
1970145|NCT03181542|3531110|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0
1970146|NCT02983617|3531118|FG000|Overall Study|Adverse Event|0
1970147|NCT02983617|3531119|FG001|Overall Study|Adverse Event|7
1970148|NCT02983617|3531118|FG000|Overall Study|Death|0
1970149|NCT02983617|3531119|FG001|Overall Study|Death|1
1970150|NCT02983617|3531118|FG000|Overall Study|Investigator's Discretion|0
1970151|NCT02983617|3531119|FG001|Overall Study|Investigator's Discretion|1
2021273|NCT00312221|3589060|FG000|Double-blind Phase|Withdrawal by Subject|0
2021274|NCT00312221|3589061|FG001|Double-blind Phase|Withdrawal by Subject|6
2212726|NCT01673178|3854034|FG002|Overall Study|Protocol Violation|0
2212727|NCT01673178|3854035|FG003|Overall Study|Protocol Violation|1
2212728|NCT01673178|3854036|FG004|Overall Study|Protocol Violation|0
2212729|NCT01673178|3854032|FG000|Overall Study|Adverse Event|1
2212730|NCT01673178|3854033|FG001|Overall Study|Adverse Event|0
2212731|NCT01673178|3854034|FG002|Overall Study|Adverse Event|0
2212732|NCT01673178|3854035|FG003|Overall Study|Adverse Event|2
2021275|NCT00312221|3589062|FG002|Double-blind Phase|Withdrawal by Subject|8
2021276|NCT00312221|3589063|FG003|Double-blind Phase|Withdrawal by Subject|7
2021277|NCT00312221|3589060|FG000|Double-blind Phase|Adverse Event|0
2021278|NCT00312221|3589061|FG001|Double-blind Phase|Adverse Event|10
2021279|NCT00312221|3589062|FG002|Double-blind Phase|Adverse Event|19
2021280|NCT00312221|3589063|FG003|Double-blind Phase|Adverse Event|18
2021281|NCT00312221|3589060|FG000|Double-blind Phase|Lost to Follow-up|0
2021282|NCT00312221|3589061|FG001|Double-blind Phase|Lost to Follow-up|0
2021283|NCT00312221|3589062|FG002|Double-blind Phase|Lost to Follow-up|2
2021284|NCT00312221|3589063|FG003|Double-blind Phase|Lost to Follow-up|2
2021285|NCT00312221|3589060|FG000|Double-blind Phase|Administrative|0
2021286|NCT00312221|3589061|FG001|Double-blind Phase|Administrative|26
2021287|NCT00312221|3589062|FG002|Double-blind Phase|Administrative|37
2021288|NCT00312221|3589063|FG003|Double-blind Phase|Administrative|33
2021289|NCT00312221|3589060|FG000|Double-blind Phase|Lack of Efficacy|0
2021290|NCT00312221|3589061|FG001|Double-blind Phase|Lack of Efficacy|17
2021291|NCT00312221|3589062|FG002|Double-blind Phase|Lack of Efficacy|6
2021292|NCT00312221|3589063|FG003|Double-blind Phase|Lack of Efficacy|10
2021293|NCT00312338|3589074|FG000|Overall Study|Adverse Event|7
2021294|NCT00312338|3589075|FG001|Overall Study|Adverse Event|2
2021295|NCT00312338|3589074|FG000|Overall Study|Lost to Follow-up|9
2021296|NCT00312338|3589075|FG001|Overall Study|Lost to Follow-up|1
2021297|NCT00312338|3589074|FG000|Overall Study|Withdrawal by Subject|4
2021298|NCT00312338|3589075|FG001|Overall Study|Withdrawal by Subject|0
2021299|NCT00312338|3589074|FG000|Overall Study|Subsequent infection|2
2021300|NCT00312338|3589075|FG001|Overall Study|Subsequent infection|0
2021301|NCT00312377|3589083|FG000|Overall Study|Death|403
2021302|NCT00312377|3589084|FG001|Overall Study|Death|418
2021303|NCT00312377|3589083|FG000|Overall Study|Withdrawal by Subject|23
2021304|NCT00312377|3589084|FG001|Overall Study|Withdrawal by Subject|30
2021305|NCT00312377|3589083|FG000|Overall Study|Lost to Follow-up|9
2021306|NCT00312377|3589084|FG001|Overall Study|Lost to Follow-up|12
2021307|NCT00312377|3589083|FG000|Overall Study|Non-compliance|0
2021308|NCT00312377|3589084|FG001|Overall Study|Non-compliance|2
2021309|NCT00312377|3589083|FG000|Overall Study|Randomised but never received treatment|6
2021310|NCT00312377|3589084|FG001|Overall Study|Randomised but never received treatment|6
2021311|NCT00312377|3589083|FG000|Overall Study|Discontinue treatment survival follow up|202
2021312|NCT00312377|3589084|FG001|Overall Study|Discontinue treatment survival follow up|200
2021313|NCT00312377|3589083|FG000|Overall Study|Site ended participation in study|1
2021314|NCT00312377|3589084|FG001|Overall Study|Site ended participation in study|0
2021315|NCT00312494|3589093|FG000|Overall Study|Randomized; not treated with study drug|9
2021316|NCT00312494|3589094|FG001|Overall Study|Randomized; not treated with study drug|10
2021317|NCT00312494|3589095|FG002|Overall Study|Randomized; not treated with study drug|5
2021318|NCT00312494|3589093|FG000|Overall Study|Adverse Event|33
2021319|NCT00312494|3589094|FG001|Overall Study|Adverse Event|15
2021320|NCT00312494|3589095|FG002|Overall Study|Adverse Event|11
2021321|NCT00312494|3589093|FG000|Overall Study|Lack of Efficacy|4
2021322|NCT00312494|3589094|FG001|Overall Study|Lack of Efficacy|6
2021323|NCT00312494|3589095|FG002|Overall Study|Lack of Efficacy|8
2021324|NCT00312494|3589093|FG000|Overall Study|Laboratory abnormality|1
2021325|NCT00312494|3589094|FG001|Overall Study|Laboratory abnormality|0
2021326|NCT00312494|3589095|FG002|Overall Study|Laboratory abnormality|0
2021327|NCT00312494|3589093|FG000|Overall Study|Lost to Follow-up|8
2021328|NCT00312494|3589094|FG001|Overall Study|Lost to Follow-up|8
2021329|NCT00312494|3589095|FG002|Overall Study|Lost to Follow-up|8
2021330|NCT00312494|3589093|FG000|Overall Study|Withdrawal by Subject|6
2021331|NCT00312494|3589094|FG001|Overall Study|Withdrawal by Subject|9
2021332|NCT00312494|3589095|FG002|Overall Study|Withdrawal by Subject|10
2021333|NCT00312494|3589093|FG000|Overall Study|Other|10
2021334|NCT00312494|3589094|FG001|Overall Study|Other|10
2021335|NCT00312494|3589095|FG002|Overall Study|Other|1
2021336|NCT00312572|3589105|FG000|Overall Study|Adverse Event|10
2021337|NCT00312572|3589106|FG001|Overall Study|Adverse Event|16
2021338|NCT00312572|3589105|FG000|Overall Study|Lost to Follow-up|1
2021339|NCT00312572|3589106|FG001|Overall Study|Lost to Follow-up|1
2021340|NCT00312572|3589105|FG000|Overall Study|Administrative|4
2021341|NCT00312572|3589106|FG001|Overall Study|Administrative|2
2021342|NCT00312572|3589105|FG000|Overall Study|Lack of Efficacy|1
1970152|NCT02649946|3531153|FG000|Overall Study|Withdrawal by Subject|1
1970153|NCT02649946|3531154|FG001|Overall Study|Withdrawal by Subject|1
1970154|NCT02649946|3531153|FG000|Overall Study|Death|7
1970155|NCT02649946|3531154|FG001|Overall Study|Death|9
1970156|NCT02649946|3531153|FG000|Overall Study|Physician Decision|1
1970157|NCT02649946|3531154|FG001|Overall Study|Physician Decision|0
1970158|NCT02649946|3531153|FG000|Overall Study|Lost to Follow-up|2
1970159|NCT02649946|3531154|FG001|Overall Study|Lost to Follow-up|1
1970160|NCT02649946|3531153|FG000|Overall Study|Erroneously enrolled|1
1970161|NCT02649946|3531154|FG001|Overall Study|Erroneously enrolled|0
1970162|NCT02649946|3531153|FG000|Overall Study|Missed 6-month follow-up visit|0
1970163|NCT02649946|3531154|FG001|Overall Study|Missed 6-month follow-up visit|4
1970164|NCT02431247|3531162|FG000|BL to EOE-Test and BL to Switch- Control|Other|11
1970165|NCT02431247|3531163|FG001|BL to EOE-Test and BL to Switch- Control|Other|2
1970166|NCT02431247|3531164|FG002|BL to EOE-Test and BL to Switch- Control|Other|0
1970167|NCT02431247|3531162|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17
1970168|NCT02431247|3531163|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8
1970169|NCT02431247|3531164|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0
1970170|NCT02431247|3531162|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9
1970171|NCT02431247|3531163|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4
1970172|NCT02431247|3531164|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0
1970173|NCT02431247|3531162|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
1970174|NCT02431247|3531163|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
1970175|NCT02431247|3531164|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0
1970176|NCT02431247|3531162|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12
1970177|NCT02431247|3531163|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16
1970178|NCT02431247|3531164|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0
1970179|NCT02431247|3531162|FG000|BL to EOE-Test and BL to Switch- Control|Death|0
1970180|NCT02431247|3531163|FG001|BL to EOE-Test and BL to Switch- Control|Death|1
1970181|NCT02431247|3531164|FG002|BL to EOE-Test and BL to Switch- Control|Death|0
1970182|NCT02431247|3531162|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14
1970183|NCT02431247|3531163|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9
1970184|NCT02431247|3531164|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0
1970185|NCT02431247|3531162|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2
1970186|NCT02431247|3531163|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
1970187|NCT02431247|3531164|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
1970188|NCT02431247|3531162|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
1970189|NCT02431247|3531163|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
1970190|NCT02431247|3531164|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4
1970191|NCT02431247|3531162|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
1970192|NCT02431247|3531163|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
1970193|NCT02431247|3531164|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12
1970194|NCT02431247|3531162|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
1970195|NCT02431247|3531163|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
1970196|NCT02431247|3531164|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
1970197|NCT02431247|3531162|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
1970198|NCT02431247|3531163|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
1970199|NCT02431247|3531164|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5
1970200|NCT02431247|3531162|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
1970201|NCT02431247|3531163|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
1970202|NCT02431247|3531164|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
1970203|NCT02431247|3531162|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
1970204|NCT02431247|3531163|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
1970205|NCT02431247|3531164|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10
1970206|NCT02395666|3531178|FG000|Overall Study|Physician Decision|3
1970207|NCT02395666|3531179|FG001|Overall Study|Physician Decision|0
1970208|NCT02395666|3531178|FG000|Overall Study|Lost to Follow-up|1
1970209|NCT02395666|3531179|FG001|Overall Study|Lost to Follow-up|0
1970210|NCT02395666|3531178|FG000|Overall Study|Withdrawal by Subject|2
1970211|NCT02395666|3531179|FG001|Overall Study|Withdrawal by Subject|1
1970212|NCT02345850|3531192|FG000|Overall Study|Not transplanted|10
1970213|NCT02345850|3531193|FG001|Overall Study|Not transplanted|5
1970214|NCT02345850|3531194|FG002|Overall Study|Not transplanted|4
1970215|NCT02345850|3531192|FG000|Overall Study|Lost to Follow-up|2
1970216|NCT02345850|3531193|FG001|Overall Study|Lost to Follow-up|3
1970217|NCT02345850|3531194|FG002|Overall Study|Lost to Follow-up|2
1970218|NCT02345850|3531192|FG000|Overall Study|Withdrawal by Subject|1
1970219|NCT02345850|3531193|FG001|Overall Study|Withdrawal by Subject|0
1970220|NCT02345850|3531194|FG002|Overall Study|Withdrawal by Subject|0
1970221|NCT02343302|3531204|FG000|Overall Study|Physician Decision|1
1970222|NCT02343302|3531205|FG001|Overall Study|Physician Decision|1
1970223|NCT02281084|3531215|FG000|Overall Study|Adverse Event|1
1970224|NCT02281084|3531216|FG001|Overall Study|Adverse Event|0
1970225|NCT02281084|3531217|FG002|Overall Study|Adverse Event|0
1970226|NCT02281084|3531218|FG003|Overall Study|Adverse Event|0
1970227|NCT02281084|3531215|FG000|Overall Study|Withdrawal by Subject|1
1970228|NCT02281084|3531216|FG001|Overall Study|Withdrawal by Subject|2
1970229|NCT02281084|3531217|FG002|Overall Study|Withdrawal by Subject|0
1970230|NCT02281084|3531218|FG003|Overall Study|Withdrawal by Subject|0
1970231|NCT02281084|3531215|FG000|Overall Study|Death|20
1970232|NCT02281084|3531216|FG001|Overall Study|Death|16
1970233|NCT02281084|3531217|FG002|Overall Study|Death|3
1970234|NCT02281084|3531218|FG003|Overall Study|Death|5
1970235|NCT02281084|3531215|FG000|Overall Study|Physician Decision|0
1970236|NCT02281084|3531216|FG001|Overall Study|Physician Decision|0
1970237|NCT02281084|3531217|FG002|Overall Study|Physician Decision|1
1970238|NCT02281084|3531218|FG003|Overall Study|Physician Decision|0
1970239|NCT01464164|3531264|FG000|Overall Study|Screen failure|0
1970240|NCT01464164|3531265|FG001|Overall Study|Screen failure|1
1970241|NCT01464164|3531266|FG002|Overall Study|Screen failure|2
1970242|NCT01464164|3531267|FG003|Overall Study|Screen failure|0
1970243|NCT01464164|3531268|FG004|Overall Study|Screen failure|0
1970244|NCT01464164|3531269|FG005|Overall Study|Screen failure|0
1970245|NCT01464164|3531270|FG006|Overall Study|Screen failure|0
1970246|NCT01464164|3531264|FG000|Overall Study|Physician Decision|0
1970247|NCT01464164|3531265|FG001|Overall Study|Physician Decision|0
1970248|NCT01464164|3531266|FG002|Overall Study|Physician Decision|0
1970249|NCT01464164|3531267|FG003|Overall Study|Physician Decision|0
1970250|NCT01464164|3531268|FG004|Overall Study|Physician Decision|0
1970251|NCT01464164|3531269|FG005|Overall Study|Physician Decision|0
1970252|NCT01464164|3531270|FG006|Overall Study|Physician Decision|2
1970253|NCT01111565|3531300|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3
1970254|NCT01111565|3531301|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
1970255|NCT01111565|3531302|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
1970256|NCT01111565|3531303|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
1970257|NCT01111565|3531304|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
1970258|NCT01111565|3531300|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1
1970259|NCT01111565|3531301|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0
1970260|NCT01111565|3531302|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0
1970261|NCT01111565|3531303|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0
1970262|NCT01111565|3531304|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0
1970263|NCT01111565|3531300|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58
1970264|NCT01111565|3531301|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
1970265|NCT01111565|3531302|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
1970266|NCT01111565|3531303|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
1970267|NCT01111565|3531304|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
1970268|NCT01111565|3531300|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1
1970269|NCT01111565|3531301|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
1970270|NCT01111565|3531302|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
1970271|NCT01111565|3531303|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
1970272|NCT01111565|3531304|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
1970273|NCT01111565|3531300|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1
1970274|NCT01111565|3531301|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
1970275|NCT01111565|3531302|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
1970276|NCT01111565|3531303|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
1970277|NCT01111565|3531304|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
1970278|NCT01111565|3531300|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1
1970279|NCT01111565|3531301|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0
1970280|NCT01111565|3531302|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0
1970281|NCT01111565|3531303|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0
1970282|NCT01111565|3531304|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0
1970283|NCT01111565|3531300|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1
1970284|NCT01111565|3531301|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
1970285|NCT01111565|3531302|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
1970286|NCT01111565|3531303|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
1970287|NCT01111565|3531304|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
1970288|NCT01111565|3531300|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
1970289|NCT01111565|3531301|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
1970290|NCT01111565|3531302|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
1970291|NCT01111565|3531303|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
1970292|NCT01111565|3531304|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
1970293|NCT01111565|3531300|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
1970294|NCT01111565|3531301|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
1970295|NCT01111565|3531302|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2
1970296|NCT01111565|3531303|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
1970297|NCT01111565|3531304|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
1970298|NCT01111565|3531300|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
1970299|NCT01111565|3531301|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
1970300|NCT01111565|3531302|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
1970301|NCT01111565|3531303|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2
1970302|NCT01111565|3531304|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
1970303|NCT01111565|3531300|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
1970304|NCT01111565|3531301|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
1970305|NCT01111565|3531302|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
1970306|NCT01111565|3531303|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1
1970307|NCT01111565|3531304|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
1970308|NCT01111565|3531300|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
1970309|NCT01111565|3531301|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
1970310|NCT01111565|3531302|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
1970311|NCT01111565|3531303|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
1970312|NCT01111565|3531304|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1
1970313|NCT01092117|3531314|FG000|Index Procedure to 1 Month|Death|1
1970314|NCT01092117|3531314|FG000|1 Month|Death|1
1970315|NCT01092117|3531314|FG000|1 Month|Withdrawal by Subject|1
1970316|NCT01092117|3531314|FG000|1 Month|Lost to Follow-up|1
1970317|NCT01092117|3531314|FG000|6 Months|Death|2
1970318|NCT01092117|3531314|FG000|6 Months|Withdrawal by Subject|3
1970319|NCT01092117|3531314|FG000|12 Month|Death|11
1970320|NCT01092117|3531314|FG000|12 Month|Withdrawal by Subject|2
1970321|NCT01092117|3531314|FG000|12 Month|Lost to Follow-up|1
1970322|NCT01092117|3531314|FG000|Year 2|Death|5
1970323|NCT01092117|3531314|FG000|Year 2|Withdrawal by Subject|4
1970324|NCT01092117|3531314|FG000|Year 2|Lost to Follow-up|1
1970325|NCT01092117|3531314|FG000|Year 3|Death|7
1970326|NCT01092117|3531314|FG000|Year 3|Withdrawal by Subject|9
1970327|NCT01092117|3531314|FG000|Year 3|Lost to Follow-up|3
1970328|NCT01092117|3531314|FG000|Year 4|Death|8
1970329|NCT01092117|3531314|FG000|Year 4|Withdrawal by Subject|4
1970330|NCT01092117|3531314|FG000|Year 4|Lost to Follow-up|4
1970331|NCT00950989|3531322|FG000|Overall Study|Death|0
1970332|NCT00950989|3531323|FG001|Overall Study|Death|0
1970333|NCT00950989|3531324|FG002|Overall Study|Death|1
1970334|NCT00950989|3531325|FG003|Overall Study|Death|0
1970335|NCT00950989|3531322|FG000|Overall Study|Administrative Decision|0
1970336|NCT00950989|3531323|FG001|Overall Study|Administrative Decision|1
1970337|NCT00950989|3531324|FG002|Overall Study|Administrative Decision|0
1970338|NCT00950989|3531325|FG003|Overall Study|Administrative Decision|0
1970339|NCT00950989|3531322|FG000|Overall Study|Disease Progression|0
1970340|NCT00950989|3531323|FG001|Overall Study|Disease Progression|0
1970341|NCT00950989|3531324|FG002|Overall Study|Disease Progression|1
1970342|NCT00950989|3531325|FG003|Overall Study|Disease Progression|0
1970343|NCT00950989|3531322|FG000|Overall Study|Withdrawal by Subject|2
1970344|NCT00950989|3531323|FG001|Overall Study|Withdrawal by Subject|1
1970345|NCT00950989|3531324|FG002|Overall Study|Withdrawal by Subject|0
1970346|NCT00950989|3531325|FG003|Overall Study|Withdrawal by Subject|0
1970347|NCT00950989|3531322|FG000|Overall Study|Adverse Event|2
1970348|NCT00950989|3531323|FG001|Overall Study|Adverse Event|1
1970349|NCT00950989|3531324|FG002|Overall Study|Adverse Event|1
1970350|NCT00950989|3531325|FG003|Overall Study|Adverse Event|0
1970351|NCT00601900|3531340|FG000|Overall Study|Withdrawal by Subject|0
1970352|NCT00601900|3531341|FG001|Overall Study|Withdrawal by Subject|3
1970353|NCT00489307|3531349|FG000|Overall Study|Death|1
1970354|NCT00489307|3531350|FG001|Overall Study|Death|1
1970355|NCT00489307|3531349|FG000|Overall Study|Lost to Follow-up|2
1970356|NCT00489307|3531350|FG001|Overall Study|Lost to Follow-up|2
1970357|NCT00489307|3531349|FG000|Overall Study|Physician Decision|1
1970358|NCT00489307|3531350|FG001|Overall Study|Physician Decision|0
1970359|NCT00489307|3531349|FG000|Overall Study|Withdrawal by Subject|2
1970360|NCT00489307|3531350|FG001|Overall Study|Withdrawal by Subject|4
1970361|NCT00489307|3531349|FG000|Overall Study|Hospitalization unrelated to treatment|10
1970362|NCT00489307|3531350|FG001|Overall Study|Hospitalization unrelated to treatment|7
1970363|NCT00489307|3531349|FG000|Overall Study|Surgery after assignment|1
1970364|NCT00489307|3531350|FG001|Overall Study|Surgery after assignment|0
1970365|NCT00489307|3531349|FG000|Overall Study|Did not fill up the forms|2
1970366|NCT00489307|3531350|FG001|Overall Study|Did not fill up the forms|1
1970367|NCT00489307|3531349|FG000|Overall Study|Patient or family refusal|5
1970368|NCT00489307|3531350|FG001|Overall Study|Patient or family refusal|9
1970369|NCT00072410|3531358|FG000|Overall Study|Progressive disease|0
1970370|NCT00072410|3531359|FG001|Overall Study|Progressive disease|3
2021343|NCT00312572|3589106|FG001|Overall Study|Lack of Efficacy|2
2021344|NCT00312663|3589117|FG000|Immunization Phase|Adverse Event|0
2021345|NCT00312663|3589118|FG001|Immunization Phase|Adverse Event|1
2021346|NCT00312663|3589119|FG002|Immunization Phase|Adverse Event|0
2021347|NCT00312702|3589131|FG000|Immunization Phase|Lost to Follow-up|0
2021348|NCT00312702|3589132|FG001|Immunization Phase|Lost to Follow-up|1
2021349|NCT00312702|3589133|FG002|Immunization Phase|Lost to Follow-up|0
2021350|NCT00312728|3589141|FG000|Overall Study|Progressive disease|53
2021351|NCT00312728|3589141|FG000|Overall Study|Adverse Event|32
2021352|NCT00312728|3589141|FG000|Overall Study|Withdrawal by Subject|10
2021353|NCT00312728|3589141|FG000|Overall Study|Required non-protocol cancer treatment|2
2021354|NCT00312728|3589141|FG000|Overall Study|Protocol Violation|2
2021355|NCT00312728|3589141|FG000|Overall Study|Other|10
2021356|NCT00312728|3589141|FG000|Overall Study|Other|1
2021357|NCT00312845|3589147|FG000|Overall Study|Adverse Event|19
2021358|NCT00312845|3589148|FG001|Overall Study|Adverse Event|5
2021359|NCT00312845|3589147|FG000|Overall Study|Death|2
2021360|NCT00312845|3589148|FG001|Overall Study|Death|2
1970371|NCT04498247|3531406|FG000|Overall Study|Lost to Follow-up|0
1970372|NCT04498247|3531407|FG001|Overall Study|Lost to Follow-up|0
1970373|NCT04498247|3531408|FG002|Overall Study|Lost to Follow-up|0
1970374|NCT04498247|3531409|FG003|Overall Study|Lost to Follow-up|1
1970375|NCT04498247|3531410|FG004|Overall Study|Lost to Follow-up|0
1970376|NCT04498247|3531411|FG005|Overall Study|Lost to Follow-up|0
1970377|NCT04498247|3531412|FG006|Overall Study|Lost to Follow-up|0
1970378|NCT04498247|3531413|FG007|Overall Study|Lost to Follow-up|0
1970379|NCT04498247|3531406|FG000|Overall Study|Mistakenly Randomized; Not Treated|1
1970380|NCT04498247|3531407|FG001|Overall Study|Mistakenly Randomized; Not Treated|0
1970381|NCT04498247|3531408|FG002|Overall Study|Mistakenly Randomized; Not Treated|0
1970382|NCT04498247|3531409|FG003|Overall Study|Mistakenly Randomized; Not Treated|0
1970383|NCT04498247|3531410|FG004|Overall Study|Mistakenly Randomized; Not Treated|0
1970384|NCT04498247|3531411|FG005|Overall Study|Mistakenly Randomized; Not Treated|0
1970385|NCT04498247|3531412|FG006|Overall Study|Mistakenly Randomized; Not Treated|0
1970386|NCT04498247|3531413|FG007|Overall Study|Mistakenly Randomized; Not Treated|0
1970387|NCT04498247|3531406|FG000|Overall Study|Withdrawal by Subject|0
1970388|NCT04498247|3531407|FG001|Overall Study|Withdrawal by Subject|8
1970389|NCT04498247|3531408|FG002|Overall Study|Withdrawal by Subject|0
1970390|NCT04498247|3531409|FG003|Overall Study|Withdrawal by Subject|7
1970391|NCT04498247|3531410|FG004|Overall Study|Withdrawal by Subject|0
1970392|NCT04498247|3531411|FG005|Overall Study|Withdrawal by Subject|0
1970393|NCT04498247|3531412|FG006|Overall Study|Withdrawal by Subject|1
1970394|NCT04498247|3531413|FG007|Overall Study|Withdrawal by Subject|0
1970395|NCT04498247|3531406|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0
1970396|NCT04498247|3531407|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4
1970397|NCT04498247|3531408|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0
1970398|NCT04498247|3531409|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3
1970399|NCT04498247|3531410|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0
1970400|NCT04498247|3531411|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0
1970401|NCT04498247|3531412|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7
1970402|NCT04498247|3531413|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0
1970403|NCT04472650|3531430|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1
1970404|NCT04472650|3531431|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0
1970405|NCT04151290|3531448|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286
1970454|NCT03819114|3531562|FG000|Overall Study|Protocol Violation|0
1970455|NCT03819114|3531563|FG001|Overall Study|Protocol Violation|1
1970456|NCT03819114|3531564|FG002|Overall Study|Protocol Violation|1
1970457|NCT03819114|3531565|FG003|Overall Study|Protocol Violation|0
1970458|NCT03819114|3531562|FG000|Overall Study|Lost to Follow-up|0
1970459|NCT03819114|3531563|FG001|Overall Study|Lost to Follow-up|0
1970460|NCT03819114|3531564|FG002|Overall Study|Lost to Follow-up|1
1970461|NCT03819114|3531565|FG003|Overall Study|Lost to Follow-up|0
1970462|NCT03804268|3531579|FG000|Overall Study|Adverse Event|2
1970463|NCT03804268|3531580|FG001|Overall Study|Adverse Event|2
1970464|NCT03804268|3531579|FG000|Overall Study|Withdrawal by Subject|2
1970465|NCT03804268|3531580|FG001|Overall Study|Withdrawal by Subject|0
1970466|NCT03804268|3531579|FG000|Overall Study|Lost to Follow-up|1
1970467|NCT03804268|3531580|FG001|Overall Study|Lost to Follow-up|0
1970468|NCT03804268|3531579|FG000|Overall Study|Physician Decision|2
1970469|NCT03804268|3531580|FG001|Overall Study|Physician Decision|0
1970470|NCT04435808|3531600|FG000|Overall Study|Study stopped by DSMB|0
1970471|NCT04435808|3531601|FG001|Overall Study|Study stopped by DSMB|1
1970472|NCT04409262|3531609|FG000|Overall Study|Adverse Event|0
1970473|NCT04409262|3531610|FG001|Overall Study|Adverse Event|2
1970474|NCT04409262|3531609|FG000|Overall Study|Death|55
1970475|NCT04409262|3531610|FG001|Overall Study|Death|97
1970476|NCT04409262|3531609|FG000|Overall Study|Lost to Follow-up|12
1970477|NCT04409262|3531610|FG001|Overall Study|Lost to Follow-up|23
1970478|NCT04409262|3531609|FG000|Overall Study|Lack of Staff|0
1970479|NCT04409262|3531610|FG001|Overall Study|Lack of Staff|1
1970480|NCT04409262|3531609|FG000|Overall Study|Protocol Violation|3
1970481|NCT04409262|3531610|FG001|Overall Study|Protocol Violation|1
1970482|NCT04409262|3531609|FG000|Overall Study|Withdrawal by Subject|5
1970483|NCT04409262|3531610|FG001|Overall Study|Withdrawal by Subject|10
1970484|NCT04305912|3531619|FG000|First Intervention|COVID-19 Suspension|2
1970485|NCT04305912|3531620|FG001|First Intervention|COVID-19 Suspension|0
1970486|NCT04305912|3531619|FG000|First Intervention|Withdrawal by Subject|0
1970487|NCT04305912|3531620|FG001|First Intervention|Withdrawal by Subject|1
1970488|NCT04305912|3531619|FG000|Second Intervention|Adverse Event|0
1970489|NCT04305912|3531620|FG001|Second Intervention|Adverse Event|1
1970490|NCT03987919|3531639|FG000|Overall Study|Adverse Event|1
1970491|NCT03987919|3531640|FG001|Overall Study|Adverse Event|4
1970492|NCT03987919|3531641|FG002|Overall Study|Adverse Event|1
1970493|NCT03987919|3531642|FG003|Overall Study|Adverse Event|3
1970494|NCT03987919|3531639|FG000|Overall Study|Death|4
1970495|NCT03987919|3531640|FG001|Overall Study|Death|4
1970496|NCT03987919|3531641|FG002|Overall Study|Death|4
1970497|NCT03987919|3531642|FG003|Overall Study|Death|1
1970498|NCT03987919|3531639|FG000|Overall Study|Lost to Follow-up|5
1970499|NCT03987919|3531640|FG001|Overall Study|Lost to Follow-up|6
1970500|NCT03987919|3531641|FG002|Overall Study|Lost to Follow-up|8
1970501|NCT03987919|3531642|FG003|Overall Study|Lost to Follow-up|12
1970422|NCT04038385|3531477|FG000|Overall Study|Completed baseline assessment only|7
1970423|NCT04038385|3531478|FG001|Overall Study|Completed baseline assessment only|4
1970424|NCT04038385|3531477|FG000|Overall Study|Moved out of area|4
1970425|NCT04038385|3531478|FG001|Overall Study|Moved out of area|2
1970426|NCT04038385|3531477|FG000|Overall Study|Discontinued study involvement|6
1970427|NCT04038385|3531478|FG001|Overall Study|Discontinued study involvement|1
1970428|NCT03978091|3531490|FG000|Overall Study|Lost to Follow-up|0
1970429|NCT03978091|3531491|FG001|Overall Study|Lost to Follow-up|0
1970430|NCT03978091|3531492|FG002|Overall Study|Lost to Follow-up|1
1970431|NCT03978091|3531493|FG003|Overall Study|Lost to Follow-up|0
1970432|NCT03978091|3531494|FG004|Overall Study|Lost to Follow-up|0
1970433|NCT03978091|3531495|FG005|Overall Study|Lost to Follow-up|0
1970434|NCT03978091|3531490|FG000|Overall Study|Withdrawal by Subject|0
1970435|NCT03978091|3531491|FG001|Overall Study|Withdrawal by Subject|0
1970436|NCT03978091|3531492|FG002|Overall Study|Withdrawal by Subject|0
1970437|NCT03978091|3531493|FG003|Overall Study|Withdrawal by Subject|1
1970438|NCT03978091|3531494|FG004|Overall Study|Withdrawal by Subject|1
1970439|NCT03978091|3531495|FG005|Overall Study|Withdrawal by Subject|0
1970440|NCT03923738|3531509|FG000|Period 1|Adverse Event|1
1970441|NCT03923738|3531509|FG000|Period 1|Withdrawal by Subject|1
1970442|NCT03887117|3531519|FG000|Overall Study|Discontinued prematurely|0
1970443|NCT03887117|3531520|FG001|Overall Study|Discontinued prematurely|1
1970444|NCT03887117|3531521|FG002|Overall Study|Discontinued prematurely|1
1970445|NCT03887117|3531522|FG003|Overall Study|Discontinued prematurely|2
1970446|NCT03858634|3531543|FG000|Overall Study|Withdrawal by Subject|1
1970447|NCT03858634|3531544|FG001|Overall Study|Withdrawal by Subject|0
1970448|NCT03858634|3531543|FG000|Overall Study|Adverse Event|1
1970449|NCT03858634|3531544|FG001|Overall Study|Adverse Event|0
1970450|NCT03858634|3531543|FG000|Overall Study|Lost to Follow-up|0
1970451|NCT03858634|3531544|FG001|Overall Study|Lost to Follow-up|1
1970452|NCT03858634|3531543|FG000|Overall Study|Other, Not Specified|1
1970453|NCT03858634|3531544|FG001|Overall Study|Other, Not Specified|1
1970502|NCT03987919|3531639|FG000|Overall Study|Physician Decision|0
1970503|NCT03987919|3531640|FG001|Overall Study|Physician Decision|2
1970504|NCT03987919|3531641|FG002|Overall Study|Physician Decision|0
1970505|NCT03987919|3531642|FG003|Overall Study|Physician Decision|4
1970506|NCT03987919|3531639|FG000|Overall Study|Pregnancy|1
1970507|NCT03987919|3531640|FG001|Overall Study|Pregnancy|0
1970508|NCT03987919|3531641|FG002|Overall Study|Pregnancy|1
1970509|NCT03987919|3531642|FG003|Overall Study|Pregnancy|1
1970510|NCT03987919|3531639|FG000|Overall Study|Protocol Violation|0
1970511|NCT03987919|3531640|FG001|Overall Study|Protocol Violation|1
1970512|NCT03987919|3531641|FG002|Overall Study|Protocol Violation|0
1970513|NCT03987919|3531642|FG003|Overall Study|Protocol Violation|0
1970514|NCT03987919|3531639|FG000|Overall Study|Site terminated by Sponsor|0
1970515|NCT03987919|3531640|FG001|Overall Study|Site terminated by Sponsor|0
1970516|NCT03987919|3531641|FG002|Overall Study|Site terminated by Sponsor|0
1970517|NCT03987919|3531642|FG003|Overall Study|Site terminated by Sponsor|1
1970518|NCT03987919|3531639|FG000|Overall Study|Withdrawal by Subject|7
1970519|NCT03987919|3531640|FG001|Overall Study|Withdrawal by Subject|7
1970520|NCT03987919|3531641|FG002|Overall Study|Withdrawal by Subject|8
1970521|NCT03987919|3531642|FG003|Overall Study|Withdrawal by Subject|4
1970522|NCT03987919|3531639|FG000|Overall Study|Other - as reported by the investigator|1
1970523|NCT03987919|3531640|FG001|Overall Study|Other - as reported by the investigator|3
1970524|NCT03987919|3531641|FG002|Overall Study|Other - as reported by the investigator|2
1970525|NCT03987919|3531642|FG003|Overall Study|Other - as reported by the investigator|0
1970526|NCT03905694|3531668|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18
1970527|NCT03861039|3531675|FG000|Overall Study|Adverse Event|2
1970528|NCT03861039|3531676|FG001|Overall Study|Adverse Event|5
1970529|NCT03861039|3531677|FG002|Overall Study|Adverse Event|11
1970530|NCT03861039|3531675|FG000|Overall Study|Withdrawal by Subject|1
1970531|NCT03861039|3531676|FG001|Overall Study|Withdrawal by Subject|3
1970532|NCT03861039|3531677|FG002|Overall Study|Withdrawal by Subject|4
1970533|NCT03759587|3531687|FG000|Overall Study|Ongoing|19
1970534|NCT03730662|3531695|FG000|Treatment Period (52 Weeks)|Adverse Event|3
1970535|NCT03730662|3531696|FG001|Treatment Period (52 Weeks)|Adverse Event|2
1970536|NCT03730662|3531697|FG002|Treatment Period (52 Weeks)|Adverse Event|0
1970537|NCT03730662|3531698|FG003|Treatment Period (52 Weeks)|Adverse Event|3
1970538|NCT03730662|3531695|FG000|Treatment Period (52 Weeks)|Screen Failure|0
1970539|NCT03730662|3531696|FG001|Treatment Period (52 Weeks)|Screen Failure|1
1970540|NCT03730662|3531697|FG002|Treatment Period (52 Weeks)|Screen Failure|0
1970541|NCT03730662|3531698|FG003|Treatment Period (52 Weeks)|Screen Failure|0
1970542|NCT03730662|3531695|FG000|Treatment Period (52 Weeks)|Death|6
1970543|NCT03730662|3531696|FG001|Treatment Period (52 Weeks)|Death|2
1970544|NCT03730662|3531697|FG002|Treatment Period (52 Weeks)|Death|2
1970545|NCT03730662|3531698|FG003|Treatment Period (52 Weeks)|Death|9
1970546|NCT03730662|3531695|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4
1970547|NCT03730662|3531696|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2
1970548|NCT03730662|3531697|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2
1970549|NCT03730662|3531698|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11
1970550|NCT03730662|3531695|FG000|Treatment Period (52 Weeks)|Physician Decision|1
1970551|NCT03730662|3531696|FG001|Treatment Period (52 Weeks)|Physician Decision|1
1970552|NCT03730662|3531697|FG002|Treatment Period (52 Weeks)|Physician Decision|0
1970553|NCT03730662|3531698|FG003|Treatment Period (52 Weeks)|Physician Decision|3
1970554|NCT03730662|3531695|FG000|Treatment Period (52 Weeks)|Protocol Violation|0
1970555|NCT03730662|3531696|FG001|Treatment Period (52 Weeks)|Protocol Violation|1
1970556|NCT03730662|3531697|FG002|Treatment Period (52 Weeks)|Protocol Violation|0
1970557|NCT03730662|3531698|FG003|Treatment Period (52 Weeks)|Protocol Violation|1
1970558|NCT03730662|3531695|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5
1970559|NCT03730662|3531696|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0
1970560|NCT03730662|3531697|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5
1970561|NCT03730662|3531698|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23
1970562|NCT03730662|3531695|FG000|Treatment Period (52 Weeks)|Personal Reason|2
1970563|NCT03730662|3531696|FG001|Treatment Period (52 Weeks)|Personal Reason|2
1970564|NCT03730662|3531697|FG002|Treatment Period (52 Weeks)|Personal Reason|0
1970565|NCT03730662|3531698|FG003|Treatment Period (52 Weeks)|Personal Reason|2
1970566|NCT03730662|3531695|FG000|Variable Treatment Period|Adverse Event|1
1970567|NCT03730662|3531696|FG001|Variable Treatment Period|Adverse Event|2
1970568|NCT03730662|3531697|FG002|Variable Treatment Period|Adverse Event|0
1970569|NCT03730662|3531698|FG003|Variable Treatment Period|Adverse Event|7
1970570|NCT03730662|3531695|FG000|Variable Treatment Period|Death|9
1970571|NCT03730662|3531696|FG001|Variable Treatment Period|Death|0
1970572|NCT03730662|3531697|FG002|Variable Treatment Period|Death|6
1970573|NCT03730662|3531698|FG003|Variable Treatment Period|Death|26
1970574|NCT03730662|3531695|FG000|Variable Treatment Period|Lost to Follow-up|2
1970575|NCT03730662|3531696|FG001|Variable Treatment Period|Lost to Follow-up|1
1970576|NCT03730662|3531697|FG002|Variable Treatment Period|Lost to Follow-up|4
1970577|NCT03730662|3531698|FG003|Variable Treatment Period|Lost to Follow-up|11
1970578|NCT03730662|3531695|FG000|Variable Treatment Period|Personal Reason|0
1970579|NCT03730662|3531696|FG001|Variable Treatment Period|Personal Reason|2
1970580|NCT03730662|3531697|FG002|Variable Treatment Period|Personal Reason|1
1970581|NCT03730662|3531698|FG003|Variable Treatment Period|Personal Reason|6
1970582|NCT03730662|3531695|FG000|Variable Treatment Period|Physician Decision|0
1970583|NCT03730662|3531696|FG001|Variable Treatment Period|Physician Decision|0
1970584|NCT03730662|3531697|FG002|Variable Treatment Period|Physician Decision|0
1970585|NCT03730662|3531698|FG003|Variable Treatment Period|Physician Decision|3
1970586|NCT03730662|3531695|FG000|Variable Treatment Period|Protocol Violation|0
1970587|NCT03730662|3531696|FG001|Variable Treatment Period|Protocol Violation|1
1970588|NCT03730662|3531697|FG002|Variable Treatment Period|Protocol Violation|1
1970589|NCT03730662|3531698|FG003|Variable Treatment Period|Protocol Violation|1
1970590|NCT03730662|3531695|FG000|Variable Treatment Period|Withdrawal by Subject|2
1970591|NCT03730662|3531696|FG001|Variable Treatment Period|Withdrawal by Subject|1
1970592|NCT03730662|3531697|FG002|Variable Treatment Period|Withdrawal by Subject|4
1970593|NCT03730662|3531698|FG003|Variable Treatment Period|Withdrawal by Subject|17
1970594|NCT03681184|3531714|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0
1970595|NCT03681184|3531715|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1
1970596|NCT03681184|3531714|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12
1970597|NCT03681184|3531715|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23
1970598|NCT03681184|3531714|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
1970599|NCT03681184|3531715|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
2021361|NCT00312845|3589147|FG000|Overall Study|Withdrawal by Subject|14
2021362|NCT00312845|3589148|FG001|Overall Study|Withdrawal by Subject|6
2021363|NCT00312845|3589147|FG000|Overall Study|Disease Progression|56
2021364|NCT00312845|3589148|FG001|Overall Study|Disease Progression|77
2021365|NCT00312845|3589147|FG000|Overall Study|Lost to Follow-up|2
2021366|NCT00312845|3589148|FG001|Overall Study|Lost to Follow-up|0
2021367|NCT00312845|3589147|FG000|Overall Study|Other|6
2021368|NCT00312845|3589148|FG001|Overall Study|Other|5
2021369|NCT00312858|3589156|FG000|Overall Study|Adverse Event|0
2021370|NCT00312858|3589157|FG001|Overall Study|Adverse Event|1
2021371|NCT00312858|3589156|FG000|Overall Study|Lost to Follow-up|25
2021372|NCT00312858|3589157|FG001|Overall Study|Lost to Follow-up|42
2021373|NCT00312858|3589156|FG000|Overall Study|Protocol Violation|3
1970600|NCT03538444|3531723|FG000|Overall Study|opioid withdrawal|1
1970601|NCT03538444|3531724|FG001|Overall Study|opioid withdrawal|0
1970602|NCT03410693|3531732|FG000|Overall Study|Disc trt: Withdrawal by participant|6
1970603|NCT03410693|3531733|FG001|Overall Study|Disc trt: Withdrawal by participant|4
1970604|NCT03410693|3531732|FG000|Overall Study|Disc trt: Lost to follow up|0
1970605|NCT03410693|3531733|FG001|Overall Study|Disc trt: Lost to follow up|1
1970606|NCT03410693|3531732|FG000|Overall Study|Disc trt: radiological progression|58
1970607|NCT03410693|3531733|FG001|Overall Study|Disc trt: radiological progression|50
1970608|NCT03410693|3531732|FG000|Overall Study|Disc trt: Other|1
1970609|NCT03410693|3531733|FG001|Overall Study|Disc trt: Other|0
1970610|NCT03410693|3531732|FG000|Overall Study|Study drug never administered|1
1970611|NCT03410693|3531733|FG001|Overall Study|Study drug never administered|6
1970612|NCT03410693|3531732|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6
1970613|NCT03410693|3531733|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4
1970614|NCT03410693|3531732|FG000|Overall Study|Disc trt: Adverse Event (AE)|13
1970615|NCT03410693|3531733|FG001|Overall Study|Disc trt: Adverse Event (AE)|9
1970616|NCT03410693|3531732|FG000|Overall Study|Disc trt: Physician decision|0
1970617|NCT03410693|3531733|FG001|Overall Study|Disc trt: Physician decision|5
1970618|NCT03410693|3531732|FG000|Overall Study|Disc trt: clinical progression|1
1970619|NCT03410693|3531733|FG001|Overall Study|Disc trt: clinical progression|5
1970620|NCT03410693|3531732|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1
1970621|NCT03410693|3531733|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4
1970622|NCT03369431|3531747|FG000|Overall Study|Lost to Follow-up|1
1970623|NCT03369431|3531748|FG001|Overall Study|Lost to Follow-up|3
1970624|NCT03369431|3531747|FG000|Overall Study|Withdrawal by Subject|2
1970625|NCT03369431|3531748|FG001|Overall Study|Withdrawal by Subject|3
1970626|NCT03369431|3531747|FG000|Overall Study|Protocol Violation|1
1970627|NCT03369431|3531748|FG001|Overall Study|Protocol Violation|1
1970628|NCT03252925|3531769|FG000|Overall Study|Withdrawal by Subject|1
1970629|NCT03252925|3531770|FG001|Overall Study|Withdrawal by Subject|0
1970630|NCT03252925|3531769|FG000|Overall Study|Protocol Violation|6
1970631|NCT03252925|3531770|FG001|Overall Study|Protocol Violation|0
1970632|NCT03252925|3531769|FG000|Overall Study|Adverse Event|1
1970633|NCT03252925|3531770|FG001|Overall Study|Adverse Event|0
1970634|NCT03252925|3531769|FG000|Overall Study|Lost to Follow-up|6
1970635|NCT03252925|3531770|FG001|Overall Study|Lost to Follow-up|6
1970636|NCT03185832|3531780|FG000|Overall Study|Death|9
1970637|NCT03185832|3531781|FG001|Overall Study|Death|14
1970638|NCT03185832|3531782|FG002|Overall Study|Death|9
1970639|NCT03185832|3531783|FG003|Overall Study|Death|7
1970640|NCT03185832|3531780|FG000|Overall Study|Withdrawn - vital status available|0
1970641|NCT03185832|3531781|FG001|Overall Study|Withdrawn - vital status available|1
1970642|NCT03185832|3531782|FG002|Overall Study|Withdrawn - vital status available|1
1970643|NCT03185832|3531783|FG003|Overall Study|Withdrawn - vital status available|4
1970644|NCT02959918|3531814|FG000|Overall Study|Adverse Event|1
1970645|NCT02959918|3531815|FG001|Overall Study|Adverse Event|1
1970646|NCT02959918|3531816|FG002|Overall Study|Adverse Event|2
1970647|NCT02959918|3531817|FG003|Overall Study|Adverse Event|0
1970648|NCT02959918|3531818|FG004|Overall Study|Adverse Event|0
1970649|NCT02959918|3531819|FG005|Overall Study|Adverse Event|2
1970650|NCT02959918|3531820|FG006|Overall Study|Adverse Event|2
1970651|NCT02959918|3531821|FG007|Overall Study|Adverse Event|1
1970652|NCT02959918|3531822|FG008|Overall Study|Adverse Event|2
1970653|NCT02959918|3531823|FG009|Overall Study|Adverse Event|1
1970654|NCT02959918|3531824|FG010|Overall Study|Adverse Event|1
1970655|NCT02959918|3531825|FG011|Overall Study|Adverse Event|3
1970656|NCT02959918|3531826|FG012|Overall Study|Adverse Event|2
1970657|NCT02959918|3531827|FG013|Overall Study|Adverse Event|4
1970658|NCT02959918|3531814|FG000|Overall Study|Lost to Follow-up|0
1970659|NCT02959918|3531815|FG001|Overall Study|Lost to Follow-up|0
1970660|NCT02959918|3531816|FG002|Overall Study|Lost to Follow-up|0
1970661|NCT02959918|3531817|FG003|Overall Study|Lost to Follow-up|0
1970662|NCT02959918|3531818|FG004|Overall Study|Lost to Follow-up|0
1970663|NCT02959918|3531819|FG005|Overall Study|Lost to Follow-up|0
1970664|NCT02959918|3531820|FG006|Overall Study|Lost to Follow-up|0
1970665|NCT02959918|3531821|FG007|Overall Study|Lost to Follow-up|0
1970666|NCT02959918|3531822|FG008|Overall Study|Lost to Follow-up|0
1970667|NCT02959918|3531823|FG009|Overall Study|Lost to Follow-up|1
1970668|NCT02959918|3531824|FG010|Overall Study|Lost to Follow-up|0
1970669|NCT02959918|3531825|FG011|Overall Study|Lost to Follow-up|0
1970670|NCT02959918|3531826|FG012|Overall Study|Lost to Follow-up|1
1970671|NCT02959918|3531827|FG013|Overall Study|Lost to Follow-up|0
1970672|NCT02959918|3531814|FG000|Overall Study|Withdrawal by Subject|0
1970673|NCT02959918|3531815|FG001|Overall Study|Withdrawal by Subject|0
1970674|NCT02959918|3531816|FG002|Overall Study|Withdrawal by Subject|1
1970675|NCT02959918|3531817|FG003|Overall Study|Withdrawal by Subject|2
1970676|NCT02959918|3531818|FG004|Overall Study|Withdrawal by Subject|0
1970677|NCT02959918|3531819|FG005|Overall Study|Withdrawal by Subject|0
1970678|NCT02959918|3531820|FG006|Overall Study|Withdrawal by Subject|1
1970679|NCT02959918|3531821|FG007|Overall Study|Withdrawal by Subject|0
1970680|NCT02959918|3531822|FG008|Overall Study|Withdrawal by Subject|1
1970681|NCT02959918|3531823|FG009|Overall Study|Withdrawal by Subject|1
1970682|NCT02959918|3531824|FG010|Overall Study|Withdrawal by Subject|2
1970683|NCT02959918|3531825|FG011|Overall Study|Withdrawal by Subject|3
1970684|NCT02959918|3531826|FG012|Overall Study|Withdrawal by Subject|1
1970685|NCT02959918|3531827|FG013|Overall Study|Withdrawal by Subject|1
1970686|NCT02959918|3531814|FG000|Overall Study|Protocol Violation|0
1970687|NCT02959918|3531815|FG001|Overall Study|Protocol Violation|0
1970688|NCT02959918|3531816|FG002|Overall Study|Protocol Violation|1
1970689|NCT02959918|3531817|FG003|Overall Study|Protocol Violation|0
1970690|NCT02959918|3531818|FG004|Overall Study|Protocol Violation|0
1970691|NCT02959918|3531819|FG005|Overall Study|Protocol Violation|1
1970692|NCT02959918|3531820|FG006|Overall Study|Protocol Violation|0
1970693|NCT02959918|3531821|FG007|Overall Study|Protocol Violation|0
1970694|NCT02959918|3531822|FG008|Overall Study|Protocol Violation|2
1970695|NCT02959918|3531823|FG009|Overall Study|Protocol Violation|1
1970696|NCT02959918|3531824|FG010|Overall Study|Protocol Violation|0
1970697|NCT02959918|3531825|FG011|Overall Study|Protocol Violation|1
1970698|NCT02959918|3531826|FG012|Overall Study|Protocol Violation|1
1970699|NCT02959918|3531827|FG013|Overall Study|Protocol Violation|0
1970700|NCT02959918|3531814|FG000|Overall Study|Stopping Rule Met|1
1970701|NCT02959918|3531815|FG001|Overall Study|Stopping Rule Met|0
1970702|NCT02959918|3531816|FG002|Overall Study|Stopping Rule Met|3
1970703|NCT02959918|3531817|FG003|Overall Study|Stopping Rule Met|4
1970704|NCT02959918|3531818|FG004|Overall Study|Stopping Rule Met|5
1970705|NCT02959918|3531819|FG005|Overall Study|Stopping Rule Met|3
1970706|NCT02959918|3531820|FG006|Overall Study|Stopping Rule Met|2
1970707|NCT02959918|3531821|FG007|Overall Study|Stopping Rule Met|4
1970708|NCT02959918|3531822|FG008|Overall Study|Stopping Rule Met|1
1970709|NCT02959918|3531823|FG009|Overall Study|Stopping Rule Met|1
1970710|NCT02959918|3531824|FG010|Overall Study|Stopping Rule Met|3
1970711|NCT02959918|3531825|FG011|Overall Study|Stopping Rule Met|5
1970712|NCT02959918|3531826|FG012|Overall Study|Stopping Rule Met|2
1970713|NCT02959918|3531827|FG013|Overall Study|Stopping Rule Met|1
1970714|NCT02959918|3531814|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1
1970715|NCT02959918|3531815|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2
1970716|NCT02959918|3531816|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1
1970717|NCT02959918|3531817|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3
1970718|NCT02959918|3531818|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
1970719|NCT02959918|3531819|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
1970720|NCT02959918|3531820|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
1970721|NCT02959918|3531821|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
1970722|NCT02959918|3531822|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
1970723|NCT02959918|3531823|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
1970724|NCT02959918|3531824|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
1970725|NCT02959918|3531825|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
1970726|NCT02959918|3531826|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
1970727|NCT02959918|3531827|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
1970728|NCT02959918|3531814|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970729|NCT02959918|3531815|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970730|NCT02959918|3531816|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970731|NCT02959918|3531817|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970732|NCT02959918|3531818|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970733|NCT02959918|3531819|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970734|NCT02959918|3531820|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970735|NCT02959918|3531821|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1
1970736|NCT02959918|3531822|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970737|NCT02959918|3531823|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970738|NCT02959918|3531824|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970739|NCT02959918|3531825|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970740|NCT02959918|3531826|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970741|NCT02959918|3531827|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0
1970742|NCT02959918|3531814|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0
1970743|NCT02959918|3531815|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0
1970744|NCT02959918|3531816|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0
1970745|NCT02959918|3531817|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0
1970746|NCT02959918|3531818|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0
1970747|NCT02959918|3531819|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0
1970748|NCT02959918|3531820|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0
1970749|NCT02959918|3531821|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0
1970750|NCT02959918|3531822|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1
1970751|NCT02959918|3531823|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0
1970752|NCT02959918|3531824|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0
1970753|NCT02959918|3531825|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0
1970754|NCT02959918|3531826|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0
1970755|NCT02959918|3531827|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0
1970756|NCT02959918|3531814|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970757|NCT02959918|3531815|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970758|NCT02959918|3531816|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970759|NCT02959918|3531817|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970760|NCT02959918|3531818|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
2309230|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
2309231|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
2309232|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
2309233|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
2309234|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Investigator decision|2
2309235|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Investigator decision|1
2309236|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Investigator decision|0
2309237|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Investigator decision|0
2309238|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Investigator decision|0
2309239|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2309240|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
2309241|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2309242|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2309243|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2309244|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
2309245|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2309246|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2309247|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2309248|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2309249|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
2309250|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
2309251|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
1970761|NCT02959918|3531819|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970762|NCT02959918|3531820|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970763|NCT02959918|3531821|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970764|NCT02959918|3531822|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970765|NCT02959918|3531823|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1
1970766|NCT02959918|3531824|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970767|NCT02959918|3531825|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970768|NCT02959918|3531826|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970769|NCT02959918|3531827|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
1970770|NCT02855944|3531862|FG000|Period 1: Treatment|Ongoing|44
1970771|NCT02855944|3531863|FG001|Period 1: Treatment|Ongoing|5
1970772|NCT02855944|3531862|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1
1970773|NCT02855944|3531863|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3
1970774|NCT02855944|3531862|FG000|Period 2: Crossover to Rucaparib|Ongoing|0
1970775|NCT02855944|3531863|FG001|Period 2: Crossover to Rucaparib|Ongoing|27
2021374|NCT00312858|3589157|FG001|Overall Study|Protocol Violation|8
2021375|NCT00312858|3589156|FG000|Overall Study|Withdraw by Participant|20
2021376|NCT00312858|3589157|FG001|Overall Study|Withdraw by Participant|20
2021377|NCT00312858|3589156|FG000|Overall Study|Participant Moved|11
2021378|NCT00312858|3589157|FG001|Overall Study|Participant Moved|10
2021379|NCT00312858|3589156|FG000|Overall Study|Other|9
2021380|NCT00312858|3589157|FG001|Overall Study|Other|12
2021381|NCT00312897|3589174|FG000|Overall Study|Adverse Event|1
2021382|NCT00312897|3589175|FG001|Overall Study|Adverse Event|0
2021383|NCT00312897|3589174|FG000|Overall Study|Lost to Follow-up|2
2021384|NCT00312897|3589175|FG001|Overall Study|Lost to Follow-up|0
2021385|NCT00312897|3589174|FG000|Overall Study|Physician Decision|1
2021386|NCT00312897|3589175|FG001|Overall Study|Physician Decision|0
2021387|NCT00312897|3589174|FG000|Overall Study|Withdrawal by Subject|1
2021388|NCT00312897|3589175|FG001|Overall Study|Withdrawal by Subject|3
2021389|NCT00312897|3589174|FG000|Overall Study|Pregnancy|1
2021390|NCT00312897|3589175|FG001|Overall Study|Pregnancy|0
2021391|NCT00312897|3589174|FG000|Overall Study|discontinued prior to getting treatment|0
2021392|NCT00312897|3589175|FG001|Overall Study|discontinued prior to getting treatment|3
2021393|NCT00313014|3589193|FG000|Overall Study|Withdrawal by Subject|11
2021394|NCT00313014|3589194|FG001|Overall Study|Withdrawal by Subject|7
2021395|NCT00313014|3589195|FG002|Overall Study|Withdrawal by Subject|5
2021396|NCT00313014|3589193|FG000|Overall Study|Adverse Event|14
2021397|NCT00313014|3589194|FG001|Overall Study|Adverse Event|29
2021398|NCT00313014|3589195|FG002|Overall Study|Adverse Event|16
2021399|NCT00313014|3589193|FG000|Overall Study|Lost to Follow-up|7
2021400|NCT00313014|3589194|FG001|Overall Study|Lost to Follow-up|6
2021401|NCT00313014|3589195|FG002|Overall Study|Lost to Follow-up|10
2021402|NCT00313014|3589193|FG000|Overall Study|Administrative|9
2021403|NCT00313014|3589194|FG001|Overall Study|Administrative|6
1970776|NCT02485691|3531872|FG000|Overall Study|Adverse Event|25
1970777|NCT02485691|3531873|FG001|Overall Study|Adverse Event|11
1970778|NCT02485691|3531872|FG000|Overall Study|Poor compliance to protocol|0
1970779|NCT02485691|3531873|FG001|Overall Study|Poor compliance to protocol|1
1970780|NCT02485691|3531872|FG000|Overall Study|Disease progression|57
1970781|NCT02485691|3531873|FG001|Overall Study|Disease progression|92
1970782|NCT02485691|3531872|FG000|Overall Study|Investigator's decision|23
1970783|NCT02485691|3531873|FG001|Overall Study|Investigator's decision|5
1970784|NCT02485691|3531872|FG000|Overall Study|Participant's request|13
1970785|NCT02485691|3531873|FG001|Overall Study|Participant's request|6
1970786|NCT02485691|3531872|FG000|Overall Study|Other reason|8
1970787|NCT02485691|3531873|FG001|Overall Study|Other reason|9
1970788|NCT02485691|3531872|FG000|Overall Study|Randomized and not treated|3
1970789|NCT02485691|3531873|FG001|Overall Study|Randomized and not treated|2
1970790|NCT02472964|3531882|FG000|Part 1 (up to Week 24)|Adverse Event|2
1970791|NCT02472964|3531883|FG001|Part 1 (up to Week 24)|Adverse Event|4
1970792|NCT02472964|3531882|FG000|Part 1 (up to Week 24)|disease progression|58
1970793|NCT02472964|3531883|FG001|Part 1 (up to Week 24)|disease progression|47
1970794|NCT02472964|3531882|FG000|Part 1 (up to Week 24)|Death|3
1970795|NCT02472964|3531883|FG001|Part 1 (up to Week 24)|Death|6
1970796|NCT02472964|3531882|FG000|Part 1 (up to Week 24)|Physician Decision|3
1970797|NCT02472964|3531883|FG001|Part 1 (up to Week 24)|Physician Decision|1
1970798|NCT02472964|3531882|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0
1970799|NCT02472964|3531883|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1
1970800|NCT02472964|3531882|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7
1970801|NCT02472964|3531883|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2
1970802|NCT02472964|3531882|FG000|Part 1 (up to Week 24)|Other|2
1970803|NCT02472964|3531883|FG001|Part 1 (up to Week 24)|Other|1
1970804|NCT02472964|3531882|FG000|Part 2 (Week 24-week 48)|Adverse Event|4
1970805|NCT02472964|3531883|FG001|Part 2 (Week 24-week 48)|Adverse Event|2
1970806|NCT02472964|3531882|FG000|Part 2 (Week 24-week 48)|Disease Progression|52
1970807|NCT02472964|3531883|FG001|Part 2 (Week 24-week 48)|Disease Progression|56
1970808|NCT02472964|3531882|FG000|Part 2 (Week 24-week 48)|Death|0
1970809|NCT02472964|3531883|FG001|Part 2 (Week 24-week 48)|Death|1
1970810|NCT02472964|3531882|FG000|Part 2 (Week 24-week 48)|Physician Decision|1
1970811|NCT02472964|3531883|FG001|Part 2 (Week 24-week 48)|Physician Decision|1
1970812|NCT02472964|3531882|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2
1970813|NCT02472964|3531883|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1
1970814|NCT02472964|3531882|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
1970815|NCT02472964|3531883|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
1970816|NCT02472964|3531882|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3
1970817|NCT02472964|3531883|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1
1970818|NCT02178722|3531894|FG000|Overall Study|Withdrawal by Subject|0
1970819|NCT02178722|3531895|FG001|Overall Study|Withdrawal by Subject|0
1970820|NCT02178722|3531896|FG002|Overall Study|Withdrawal by Subject|0
1970821|NCT02178722|3531897|FG003|Overall Study|Withdrawal by Subject|2
1970822|NCT02178722|3531898|FG004|Overall Study|Withdrawal by Subject|33
1970823|NCT02178722|3531894|FG000|Overall Study|Death|2
1970824|NCT02178722|3531895|FG001|Overall Study|Death|13
1970825|NCT02178722|3531896|FG002|Overall Study|Death|12
1970826|NCT02178722|3531897|FG003|Overall Study|Death|12
1970827|NCT02178722|3531898|FG004|Overall Study|Death|205
1970828|NCT02178722|3531894|FG000|Overall Study|Lost to Follow-up|0
1970829|NCT02178722|3531895|FG001|Overall Study|Lost to Follow-up|0
1970830|NCT02178722|3531896|FG002|Overall Study|Lost to Follow-up|0
1970831|NCT02178722|3531897|FG003|Overall Study|Lost to Follow-up|2
1970832|NCT02178722|3531898|FG004|Overall Study|Lost to Follow-up|11
1970833|NCT02178722|3531894|FG000|Overall Study|Study terminated by Sponsor|2
1970834|NCT02178722|3531895|FG001|Overall Study|Study terminated by Sponsor|7
1970835|NCT02178722|3531896|FG002|Overall Study|Study terminated by Sponsor|6
1970836|NCT02178722|3531897|FG003|Overall Study|Study terminated by Sponsor|4
1970837|NCT02178722|3531898|FG004|Overall Study|Study terminated by Sponsor|128
1970838|NCT02178722|3531894|FG000|Overall Study|Physician Decision|0
1970839|NCT02178722|3531895|FG001|Overall Study|Physician Decision|0
1970840|NCT02178722|3531896|FG002|Overall Study|Physician Decision|0
1970841|NCT02178722|3531897|FG003|Overall Study|Physician Decision|0
1970842|NCT02178722|3531898|FG004|Overall Study|Physician Decision|3
1970843|NCT02178722|3531894|FG000|Overall Study|Other|0
1970844|NCT02178722|3531895|FG001|Overall Study|Other|0
1970845|NCT02178722|3531896|FG002|Overall Study|Other|0
1970846|NCT02178722|3531897|FG003|Overall Study|Other|0
1970847|NCT02178722|3531898|FG004|Overall Study|Other|2
1970848|NCT01258803|3531913|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1
1970849|NCT01258803|3531914|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1
2309252|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
2309253|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
2309254|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1
2309255|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0
2309256|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0
2309257|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0
1970850|NCT01258803|3531915|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0
1970851|NCT01258803|3531916|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0
1970852|NCT01258803|3531917|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0
1970853|NCT01258803|3531918|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1
1970854|NCT01258803|3531913|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1970855|NCT01258803|3531914|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
1970856|NCT01258803|3531915|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1970857|NCT01258803|3531916|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1970858|NCT01258803|3531917|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1970859|NCT01258803|3531918|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1970860|NCT01258803|3531913|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0
1970861|NCT01258803|3531914|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0
1970862|NCT01258803|3531915|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1
1970863|NCT01258803|3531916|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0
1970864|NCT01258803|3531917|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0
1970865|NCT01258803|3531918|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0
1970866|NCT00862251|3531939|FG000|Overall Study|Adverse Event|8
1970867|NCT00862251|3531940|FG001|Overall Study|Adverse Event|3
1970868|NCT00862251|3531941|FG002|Overall Study|Adverse Event|1
1970869|NCT00862251|3531939|FG000|Overall Study|Lost to Follow-up|0
1970870|NCT00862251|3531940|FG001|Overall Study|Lost to Follow-up|0
1970871|NCT00862251|3531941|FG002|Overall Study|Lost to Follow-up|1
1970872|NCT00862251|3531939|FG000|Overall Study|Protocol Violation|2
1970873|NCT00862251|3531940|FG001|Overall Study|Protocol Violation|0
1970874|NCT00862251|3531941|FG002|Overall Study|Protocol Violation|1
1970875|NCT00862251|3531939|FG000|Overall Study|Withdrawal by Subject|9
1970876|NCT00862251|3531940|FG001|Overall Study|Withdrawal by Subject|2
1970877|NCT00862251|3531941|FG002|Overall Study|Withdrawal by Subject|6
1970878|NCT00783263|3531956|FG000|Overall Study|Adverse Event|3
1970879|NCT00783263|3531957|FG001|Overall Study|Adverse Event|0
1970880|NCT00783263|3531958|FG002|Overall Study|Adverse Event|2
1970881|NCT00783263|3531959|FG003|Overall Study|Adverse Event|1
1970882|NCT00783263|3531956|FG000|Overall Study|Lost to Follow-up|1
1970883|NCT00783263|3531957|FG001|Overall Study|Lost to Follow-up|1
1970884|NCT00783263|3531958|FG002|Overall Study|Lost to Follow-up|0
1970885|NCT00783263|3531959|FG003|Overall Study|Lost to Follow-up|0
1970886|NCT00783263|3531956|FG000|Overall Study|Withdrawal by Subject|0
1970887|NCT00783263|3531957|FG001|Overall Study|Withdrawal by Subject|1
1970888|NCT00783263|3531958|FG002|Overall Study|Withdrawal by Subject|1
1970889|NCT00783263|3531959|FG003|Overall Study|Withdrawal by Subject|2
1970890|NCT00782184|3531984|FG000|Overall Study|Adverse Event|1
1970891|NCT00782184|3531985|FG001|Overall Study|Adverse Event|2
1970892|NCT00782184|3531984|FG000|Overall Study|Protocol Violation|0
1970893|NCT00782184|3531985|FG001|Overall Study|Protocol Violation|1
1970894|NCT00782184|3531984|FG000|Overall Study|Withdrawal by Subject|3
1970895|NCT00782184|3531985|FG001|Overall Study|Withdrawal by Subject|2
1970896|NCT00635882|3531998|FG000|Overall Study|Protocol Violation|1
1970897|NCT00635882|3531999|FG001|Overall Study|Protocol Violation|0
1970898|NCT00635882|3532000|FG002|Overall Study|Protocol Violation|0
1970899|NCT00635882|3532001|FG003|Overall Study|Protocol Violation|0
1970900|NCT00635882|3532002|FG004|Overall Study|Protocol Violation|0
1970901|NCT00635882|3532003|FG005|Overall Study|Protocol Violation|0
1970902|NCT00535405|3532031|FG000|Overall Study|Adverse Event|6
1970903|NCT00535405|3532032|FG001|Overall Study|Adverse Event|8
1970904|NCT00535405|3532033|FG002|Overall Study|Adverse Event|3
1970905|NCT00535405|3532034|FG003|Overall Study|Adverse Event|8
1970906|NCT00535405|3532035|FG004|Overall Study|Adverse Event|6
1970907|NCT00535405|3532031|FG000|Overall Study|Lost to Follow-up|1
1970908|NCT00535405|3532032|FG001|Overall Study|Lost to Follow-up|3
1970909|NCT00535405|3532033|FG002|Overall Study|Lost to Follow-up|3
1970910|NCT00535405|3532034|FG003|Overall Study|Lost to Follow-up|2
1970911|NCT00535405|3532035|FG004|Overall Study|Lost to Follow-up|1
1970912|NCT00535405|3532031|FG000|Overall Study|Physician Decision|3
1970913|NCT00535405|3532032|FG001|Overall Study|Physician Decision|2
1970914|NCT00535405|3532033|FG002|Overall Study|Physician Decision|0
1970915|NCT00535405|3532034|FG003|Overall Study|Physician Decision|1
1970916|NCT00535405|3532035|FG004|Overall Study|Physician Decision|1
1970917|NCT00535405|3532031|FG000|Overall Study|Protocol Violation|2
1970918|NCT00535405|3532032|FG001|Overall Study|Protocol Violation|2
1970919|NCT00535405|3532033|FG002|Overall Study|Protocol Violation|2
1970920|NCT00535405|3532034|FG003|Overall Study|Protocol Violation|1
1970921|NCT00535405|3532035|FG004|Overall Study|Protocol Violation|0
1970922|NCT00535405|3532031|FG000|Overall Study|Withdrawal by Subject|5
1970923|NCT00535405|3532032|FG001|Overall Study|Withdrawal by Subject|11
1970924|NCT00535405|3532033|FG002|Overall Study|Withdrawal by Subject|10
1970925|NCT00535405|3532034|FG003|Overall Study|Withdrawal by Subject|10
1970926|NCT00535405|3532035|FG004|Overall Study|Withdrawal by Subject|8
1970927|NCT00496730|3532049|FG000|Overall Study|Lost to Follow-up|4
1970928|NCT00496730|3532050|FG001|Overall Study|Lost to Follow-up|3
1970929|NCT00496730|3532049|FG000|Overall Study|Withdrawal by Subject|2
1970930|NCT00496730|3532050|FG001|Overall Study|Withdrawal by Subject|2
1970931|NCT00462748|3532059|FG000|Overall Study|Adverse Event|7
1970932|NCT00462748|3532060|FG001|Overall Study|Adverse Event|5
1970933|NCT00462748|3532061|FG002|Overall Study|Adverse Event|9
1970934|NCT00462748|3532059|FG000|Overall Study|Protocol Violation|0
1970935|NCT00462748|3532060|FG001|Overall Study|Protocol Violation|2
1970936|NCT00462748|3532061|FG002|Overall Study|Protocol Violation|1
1970937|NCT00462748|3532059|FG000|Overall Study|Withdrew consent|3
1970938|NCT00462748|3532060|FG001|Overall Study|Withdrew consent|3
1970939|NCT00462748|3532061|FG002|Overall Study|Withdrew consent|0
1970940|NCT00462748|3532059|FG000|Overall Study|Lost to Follow-up|1
1970941|NCT00462748|3532060|FG001|Overall Study|Lost to Follow-up|1
1970942|NCT00462748|3532061|FG002|Overall Study|Lost to Follow-up|1
1970943|NCT00462748|3532059|FG000|Overall Study|Discontinued after 41 days Rx|1
1970944|NCT00462748|3532060|FG001|Overall Study|Discontinued after 41 days Rx|0
1970945|NCT00462748|3532061|FG002|Overall Study|Discontinued after 41 days Rx|0
1970946|NCT00418834|3532071|FG000|Overall Study|Adverse Event|16
1970947|NCT00418834|3532072|FG001|Overall Study|Adverse Event|9
1970948|NCT00418834|3532071|FG000|Overall Study|Lost to Follow-up|0
1970949|NCT00418834|3532072|FG001|Overall Study|Lost to Follow-up|1
1970950|NCT00418834|3532071|FG000|Overall Study|Protocol Violation|4
1970951|NCT00418834|3532072|FG001|Overall Study|Protocol Violation|3
1970952|NCT00418834|3532071|FG000|Overall Study|Withdrawal by Subject|3
1970953|NCT00418834|3532072|FG001|Overall Study|Withdrawal by Subject|7
1970954|NCT00409773|3532083|FG000|Overall Study|Adverse Event|3
1970955|NCT00409773|3532084|FG001|Overall Study|Adverse Event|4
1970956|NCT00409773|3532085|FG002|Overall Study|Adverse Event|4
1970957|NCT00409773|3532086|FG003|Overall Study|Adverse Event|2
1970958|NCT00409773|3532087|FG004|Overall Study|Adverse Event|6
1970959|NCT00409773|3532083|FG000|Overall Study|Lost to Follow-up|6
1970960|NCT00409773|3532084|FG001|Overall Study|Lost to Follow-up|1
1970961|NCT00409773|3532085|FG002|Overall Study|Lost to Follow-up|2
1970962|NCT00409773|3532086|FG003|Overall Study|Lost to Follow-up|3
1970963|NCT00409773|3532087|FG004|Overall Study|Lost to Follow-up|1
1970964|NCT00409773|3532083|FG000|Overall Study|Physician Decision|0
1970965|NCT00409773|3532084|FG001|Overall Study|Physician Decision|0
1970966|NCT00409773|3532085|FG002|Overall Study|Physician Decision|0
1970967|NCT00409773|3532086|FG003|Overall Study|Physician Decision|2
1970968|NCT00409773|3532087|FG004|Overall Study|Physician Decision|0
1970969|NCT00409773|3532083|FG000|Overall Study|Protocol Violation|0
1970970|NCT00409773|3532084|FG001|Overall Study|Protocol Violation|2
1970971|NCT00409773|3532085|FG002|Overall Study|Protocol Violation|3
1970972|NCT00409773|3532086|FG003|Overall Study|Protocol Violation|3
1970973|NCT00409773|3532087|FG004|Overall Study|Protocol Violation|1
1970974|NCT00409773|3532083|FG000|Overall Study|Withdrawal by Subject|0
1970975|NCT00409773|3532084|FG001|Overall Study|Withdrawal by Subject|0
1970976|NCT00409773|3532085|FG002|Overall Study|Withdrawal by Subject|0
1970977|NCT00409773|3532086|FG003|Overall Study|Withdrawal by Subject|2
1970978|NCT00409773|3532087|FG004|Overall Study|Withdrawal by Subject|1
1970979|NCT00409773|3532083|FG000|Overall Study|Lack of Eligibility|0
1970980|NCT00409773|3532084|FG001|Overall Study|Lack of Eligibility|0
1970981|NCT00409773|3532085|FG002|Overall Study|Lack of Eligibility|0
1970982|NCT00409773|3532086|FG003|Overall Study|Lack of Eligibility|0
1970983|NCT00409773|3532087|FG004|Overall Study|Lack of Eligibility|1
1970984|NCT00276484|3532101|FG000|Overall Study|Adverse Event|4
1970985|NCT00276484|3532102|FG001|Overall Study|Adverse Event|7
1970986|NCT00276484|3532101|FG000|Overall Study|Lost to Follow-up|1
1970987|NCT00276484|3532102|FG001|Overall Study|Lost to Follow-up|1
1970988|NCT00276484|3532101|FG000|Overall Study|Protocol Violation|0
1970989|NCT00276484|3532102|FG001|Overall Study|Protocol Violation|1
1970990|NCT00276484|3532101|FG000|Overall Study|Withdrawal by Subject|4
1970991|NCT00276484|3532102|FG001|Overall Study|Withdrawal by Subject|3
1970992|NCT00276484|3532101|FG000|Overall Study|Could not take time off work|0
1970993|NCT00276484|3532102|FG001|Overall Study|Could not take time off work|1
1970994|NCT00276458|3532110|FG000|Overall Study|Adverse Event|0
1970995|NCT00276458|3532111|FG001|Overall Study|Adverse Event|2
1970996|NCT00276458|3532110|FG000|Overall Study|Lost to Follow-up|2
1970997|NCT00276458|3532111|FG001|Overall Study|Lost to Follow-up|2
1970998|NCT00276458|3532110|FG000|Overall Study|Protocol Violation|4
1970999|NCT00276458|3532111|FG001|Overall Study|Protocol Violation|3
1971000|NCT00271817|3532120|FG000|Part 1|Adverse Event|68
1971001|NCT00271817|3532121|FG001|Part 1|Adverse Event|25
1971002|NCT00271817|3532122|FG002|Part 1|Adverse Event|156
1971003|NCT00271817|3532120|FG000|Part 1|Lost to Follow-up|6
1971004|NCT00271817|3532121|FG001|Part 1|Lost to Follow-up|8
1971005|NCT00271817|3532122|FG002|Part 1|Lost to Follow-up|24
1971006|NCT00271817|3532120|FG000|Part 1|Protocol Violation|5
1971007|NCT00271817|3532121|FG001|Part 1|Protocol Violation|4
1971008|NCT00271817|3532122|FG002|Part 1|Protocol Violation|7
1971009|NCT00271817|3532120|FG000|Part 1|Patient Moved|3
1971010|NCT00271817|3532121|FG001|Part 1|Patient Moved|1
1971011|NCT00271817|3532122|FG002|Part 1|Patient Moved|5
1971012|NCT00271817|3532120|FG000|Part 1|Withdrawal by Subject|23
1971013|NCT00271817|3532121|FG001|Part 1|Withdrawal by Subject|17
1971014|NCT00271817|3532122|FG002|Part 1|Withdrawal by Subject|45
1971015|NCT00271817|3532120|FG000|Part 1|LDL < 50 mg/dL|1
1971016|NCT00271817|3532121|FG001|Part 1|LDL < 50 mg/dL|4
1971017|NCT00271817|3532122|FG002|Part 1|LDL < 50 mg/dL|48
1971018|NCT00271817|3532120|FG000|Part 2|Adverse Event|0
1971019|NCT00271817|3532121|FG001|Part 2|Adverse Event|17
1971020|NCT00271817|3532122|FG002|Part 2|Adverse Event|33
1971021|NCT00271817|3532120|FG000|Part 2|Lack of Efficacy|0
1971022|NCT00271817|3532121|FG001|Part 2|Lack of Efficacy|1
1971023|NCT00271817|3532122|FG002|Part 2|Lack of Efficacy|6
1971024|NCT00271817|3532120|FG000|Part 2|Lost to Follow-up|0
1971025|NCT00271817|3532121|FG001|Part 2|Lost to Follow-up|6
1971026|NCT00271817|3532122|FG002|Part 2|Lost to Follow-up|18
1971027|NCT00271817|3532120|FG000|Part 2|Protocol Violation|0
1971028|NCT00271817|3532121|FG001|Part 2|Protocol Violation|3
1971029|NCT00271817|3532122|FG002|Part 2|Protocol Violation|5
1971030|NCT00271817|3532120|FG000|Part 2|Patient Moved|0
1971031|NCT00271817|3532121|FG001|Part 2|Patient Moved|0
1971032|NCT00271817|3532122|FG002|Part 2|Patient Moved|5
1971033|NCT00271817|3532120|FG000|Part 2|Withdrawal by Subject|0
1971034|NCT00271817|3532121|FG001|Part 2|Withdrawal by Subject|2
1971035|NCT00271817|3532122|FG002|Part 2|Withdrawal by Subject|13
1971036|NCT00271817|3532120|FG000|Part 2|LDL < 50 mg/dL|0
1971037|NCT00271817|3532121|FG001|Part 2|LDL < 50 mg/dL|3
1971038|NCT00271817|3532122|FG002|Part 2|LDL < 50 mg/dL|4
2021404|NCT00313014|3589195|FG002|Overall Study|Administrative|14
2021405|NCT00313014|3589193|FG000|Overall Study|Lack of Efficacy|52
2021406|NCT00313014|3589194|FG001|Overall Study|Lack of Efficacy|25
2021407|NCT00313014|3589195|FG002|Overall Study|Lack of Efficacy|16
2021408|NCT00313144|3589204|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
2021409|NCT00313144|3589204|FG000|Overall Study|Death|7
2021410|NCT00313144|3589204|FG000|Overall Study|Lost to Follow-up|5
2021411|NCT00313144|3589204|FG000|Overall Study|Withdrawal by Subject|4
2021412|NCT00313144|3589204|FG000|Overall Study|Terminated by sponsor/ homecare provider|4
2021413|NCT00313144|3589204|FG000|Overall Study|Physician Decision|4
2021414|NCT00313144|3589204|FG000|Overall Study|Adverse event - transient|5
2021415|NCT00313144|3589204|FG000|Overall Study|Liver transplant|1
2021416|NCT00313144|3589204|FG000|Overall Study|Insurance (homecare provider) change|1
2021417|NCT00313144|3589204|FG000|Overall Study|Change to different product|1
2021418|NCT00313144|3589204|FG000|Overall Study|Due to termination of the study|66
2021419|NCT00313170|3589220|FG000|Overall Study|Death|2
2021420|NCT00313170|3589221|FG001|Overall Study|Death|4
2021421|NCT00313170|3589222|FG002|Overall Study|Death|2
2021422|NCT00313170|3589220|FG000|Overall Study|Adverse Event|1
2021423|NCT00313170|3589221|FG001|Overall Study|Adverse Event|2
2021424|NCT00313170|3589222|FG002|Overall Study|Adverse Event|0
2021425|NCT00313170|3589220|FG000|Overall Study|Disease progression|31
2021426|NCT00313170|3589221|FG001|Overall Study|Disease progression|26
2021427|NCT00313170|3589222|FG002|Overall Study|Disease progression|27
2021428|NCT00313170|3589220|FG000|Overall Study|Withdrawal by Subject|1
2021429|NCT00313170|3589221|FG001|Overall Study|Withdrawal by Subject|0
2021430|NCT00313170|3589222|FG002|Overall Study|Withdrawal by Subject|1
2021431|NCT00313170|3589220|FG000|Overall Study|Incorrect enrollment|0
2021432|NCT00313170|3589221|FG001|Overall Study|Incorrect enrollment|2
2021433|NCT00313170|3589222|FG002|Overall Study|Incorrect enrollment|1
2021434|NCT00313170|3589220|FG000|Overall Study|Lost to Follow-up|0
2021435|NCT00313170|3589221|FG001|Overall Study|Lost to Follow-up|0
2021436|NCT00313170|3589222|FG002|Overall Study|Lost to Follow-up|1
2021437|NCT00313170|3589220|FG000|Overall Study|Progression (investigators opinion)|1
2021438|NCT00313170|3589221|FG001|Overall Study|Progression (investigators opinion)|0
2021439|NCT00313170|3589222|FG002|Overall Study|Progression (investigators opinion)|0
2021440|NCT00313300|3589245|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19
2021441|NCT00313300|3589246|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14
2021442|NCT00313300|3589247|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17
2021443|NCT00313300|3589248|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0
2021444|NCT00313300|3589249|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0
2021445|NCT00313300|3589245|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
2021446|NCT00313300|3589246|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
2021447|NCT00313300|3589247|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
2021448|NCT00313300|3589248|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
2021449|NCT00313300|3589249|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
2021450|NCT00313300|3589245|FG000|Randomized in Phase A (26 Weeks)|Death|3
2021451|NCT00313300|3589246|FG001|Randomized in Phase A (26 Weeks)|Death|4
2021452|NCT00313300|3589247|FG002|Randomized in Phase A (26 Weeks)|Death|0
2021453|NCT00313300|3589248|FG003|Randomized in Phase A (26 Weeks)|Death|0
2021454|NCT00313300|3589249|FG004|Randomized in Phase A (26 Weeks)|Death|0
2021455|NCT00313300|3589245|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
2021456|NCT00313300|3589246|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
2021457|NCT00313300|3589247|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
2021458|NCT00313300|3589248|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
2021459|NCT00313300|3589249|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
2021460|NCT00313300|3589245|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
2021461|NCT00313300|3589246|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
2021462|NCT00313300|3589247|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
2021463|NCT00313300|3589248|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
2021464|NCT00313300|3589249|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
2021465|NCT00313300|3589245|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
2021466|NCT00313300|3589246|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
2021467|NCT00313300|3589247|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
2021468|NCT00313300|3589248|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
2021469|NCT00313300|3589249|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
1971039|NCT03420781|3532154|FG000|Treatment Period (40 Weeks)|Adverse Event|1
1971040|NCT03420781|3532155|FG001|Treatment Period (40 Weeks)|Adverse Event|6
1971041|NCT03420781|3532156|FG002|Treatment Period (40 Weeks)|Adverse Event|0
1971042|NCT03420781|3532157|FG003|Treatment Period (40 Weeks)|Adverse Event|0
1971043|NCT03420781|3532158|FG004|Treatment Period (40 Weeks)|Adverse Event|0
1971044|NCT03420781|3532154|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1
1971045|NCT03420781|3532155|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1
1971046|NCT03420781|3532156|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0
1971047|NCT03420781|3532157|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0
1971048|NCT03420781|3532158|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0
1971049|NCT03420781|3532154|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22
1971050|NCT03420781|3532155|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16
1971051|NCT03420781|3532156|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0
1971052|NCT03420781|3532157|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0
1971053|NCT03420781|3532158|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0
1971054|NCT03420781|3532154|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10
1971055|NCT03420781|3532155|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6
1971056|NCT03420781|3532156|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0
1971057|NCT03420781|3532157|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0
1971058|NCT03420781|3532158|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0
1971059|NCT03420781|3532154|FG000|Treatment Period (40 Weeks)|Death|2
1971060|NCT03420781|3532155|FG001|Treatment Period (40 Weeks)|Death|2
1971061|NCT03420781|3532156|FG002|Treatment Period (40 Weeks)|Death|0
1971062|NCT03420781|3532157|FG003|Treatment Period (40 Weeks)|Death|0
1971063|NCT03420781|3532158|FG004|Treatment Period (40 Weeks)|Death|0
1971064|NCT03420781|3532154|FG000|Treatment Period (40 Weeks)|Physician Decision|3
1971065|NCT03420781|3532155|FG001|Treatment Period (40 Weeks)|Physician Decision|4
1971066|NCT03420781|3532156|FG002|Treatment Period (40 Weeks)|Physician Decision|0
1971067|NCT03420781|3532157|FG003|Treatment Period (40 Weeks)|Physician Decision|0
1971068|NCT03420781|3532158|FG004|Treatment Period (40 Weeks)|Physician Decision|0
1971069|NCT03420781|3532154|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0
1971070|NCT03420781|3532155|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2
1971071|NCT03420781|3532156|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0
1971072|NCT03420781|3532157|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0
1971073|NCT03420781|3532158|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0
1971074|NCT03420781|3532154|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101
1971075|NCT03420781|3532155|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89
1971076|NCT03420781|3532156|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
1971077|NCT03420781|3532157|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
1971078|NCT03420781|3532158|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
1971079|NCT03420781|3532154|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1
1971080|NCT03420781|3532155|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
1971081|NCT03420781|3532156|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
1971082|NCT03420781|3532157|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
1971083|NCT03420781|3532158|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
1971084|NCT03420781|3532154|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3
1971085|NCT03420781|3532155|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0
1971086|NCT03420781|3532156|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0
1971087|NCT03420781|3532157|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0
1971088|NCT03420781|3532158|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0
1971089|NCT03420781|3532154|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
1971090|NCT03420781|3532155|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
1971091|NCT03420781|3532156|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
1971092|NCT03420781|3532157|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2
1971093|NCT03420781|3532158|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
1971094|NCT03420781|3532154|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
1971095|NCT03420781|3532155|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
1971096|NCT03420781|3532156|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
1971097|NCT03420781|3532157|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
1971098|NCT03420781|3532158|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2
1971099|NCT03420781|3532154|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
1971100|NCT03420781|3532155|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
1971101|NCT03420781|3532156|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6
1971102|NCT03420781|3532157|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
1971103|NCT03420781|3532158|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
1971125|NCT02908685|3532302|FG000|Part 1 Exploratory|Withdrawal by Subject|0
1971126|NCT02908685|3532303|FG001|Part 1 Exploratory|Withdrawal by Subject|1
1971127|NCT02908685|3532304|FG002|Part 1 Exploratory|Withdrawal by Subject|0
1971128|NCT02908685|3532305|FG003|Part 1 Exploratory|Withdrawal by Subject|0
1971129|NCT02908685|3532306|FG004|Part 1 Exploratory|Withdrawal by Subject|0
1971130|NCT02908685|3532307|FG005|Part 1 Exploratory|Withdrawal by Subject|0
1971131|NCT02908685|3532308|FG006|Part 1 Exploratory|Withdrawal by Subject|0
1971132|NCT02908685|3532309|FG007|Part 1 Exploratory|Withdrawal by Subject|0
1971104|NCT03316586|3532174|FG000|Overall Study|Adverse Event|2
1971105|NCT03316586|3532174|FG000|Overall Study|Physician Decision|3
1971106|NCT03316586|3532174|FG000|Overall Study|Lack of Efficacy|10
1971107|NCT03316586|3532174|FG000|Overall Study|still on treatment|1
1971108|NCT03316586|3532174|FG000|Overall Study|Patient needed radiation therapy|1
1971109|NCT03316586|3532174|FG000|Overall Study|Physician Decision to send patient for breast surgery|1
1971110|NCT03269695|3532193|FG000|Overall Study|Adverse Event|2
1971111|NCT03269695|3532194|FG001|Overall Study|Adverse Event|1
1971112|NCT03269695|3532193|FG000|Overall Study|Lack of Efficacy|0
1971113|NCT03269695|3532194|FG001|Overall Study|Lack of Efficacy|1
1971114|NCT03269695|3532193|FG000|Overall Study|Withdrawal by Subject|0
1971115|NCT03269695|3532194|FG001|Overall Study|Withdrawal by Subject|1
1971116|NCT03227757|3532201|FG000|Overall Study|Death|7
1971117|NCT03227757|3532201|FG000|Overall Study|Withdrawal|5
1971118|NCT03227757|3532201|FG000|Overall Study|Missed visits|4
1971119|NCT03142334|3532211|FG000|Overall Study|Death|18
1971120|NCT03142334|3532212|FG001|Overall Study|Death|33
2212733|NCT01673178|3854036|FG004|Overall Study|Adverse Event|0
2212734|NCT01673178|3854032|FG000|Overall Study|Other|1
1971121|NCT03142334|3532211|FG000|Overall Study|Withdrawal by Subject|15
1971122|NCT03142334|3532212|FG001|Overall Study|Withdrawal by Subject|11
1971123|NCT03142334|3532211|FG000|Overall Study|Ongoing on trial follow up|463
1971124|NCT03142334|3532212|FG001|Overall Study|Ongoing on trial follow up|454
1971133|NCT02908685|3532310|FG008|Part 1 Exploratory|Withdrawal by Subject|0
1971134|NCT02908685|3532311|FG009|Part 1 Exploratory|Withdrawal by Subject|0
1971135|NCT02908685|3532312|FG010|Part 1 Exploratory|Withdrawal by Subject|0
1971136|NCT02908685|3532313|FG011|Part 1 Exploratory|Withdrawal by Subject|0
1971137|NCT02908685|3532302|FG000|Part 2 Confirmatory|Changed to Spinraza|0
1971138|NCT02908685|3532303|FG001|Part 2 Confirmatory|Changed to Spinraza|0
1971139|NCT02908685|3532304|FG002|Part 2 Confirmatory|Changed to Spinraza|0
1971140|NCT02908685|3532305|FG003|Part 2 Confirmatory|Changed to Spinraza|0
1971141|NCT02908685|3532306|FG004|Part 2 Confirmatory|Changed to Spinraza|0
1971142|NCT02908685|3532307|FG005|Part 2 Confirmatory|Changed to Spinraza|0
1971143|NCT02908685|3532308|FG006|Part 2 Confirmatory|Changed to Spinraza|0
1971144|NCT02908685|3532309|FG007|Part 2 Confirmatory|Changed to Spinraza|0
1971145|NCT02908685|3532310|FG008|Part 2 Confirmatory|Changed to Spinraza|0
1971146|NCT02908685|3532311|FG009|Part 2 Confirmatory|Changed to Spinraza|0
1971147|NCT02908685|3532312|FG010|Part 2 Confirmatory|Changed to Spinraza|2
1971148|NCT02908685|3532313|FG011|Part 2 Confirmatory|Changed to Spinraza|1
1971149|NCT02908685|3532302|FG000|Part 2 Confirmatory|Changed to other treatment|0
1971150|NCT02908685|3532303|FG001|Part 2 Confirmatory|Changed to other treatment|0
1971151|NCT02908685|3532304|FG002|Part 2 Confirmatory|Changed to other treatment|0
1971152|NCT02908685|3532305|FG003|Part 2 Confirmatory|Changed to other treatment|0
1971153|NCT02908685|3532306|FG004|Part 2 Confirmatory|Changed to other treatment|0
1971154|NCT02908685|3532307|FG005|Part 2 Confirmatory|Changed to other treatment|0
1971155|NCT02908685|3532308|FG006|Part 2 Confirmatory|Changed to other treatment|0
1971156|NCT02908685|3532309|FG007|Part 2 Confirmatory|Changed to other treatment|0
1971157|NCT02908685|3532310|FG008|Part 2 Confirmatory|Changed to other treatment|0
1971158|NCT02908685|3532311|FG009|Part 2 Confirmatory|Changed to other treatment|0
1971159|NCT02908685|3532312|FG010|Part 2 Confirmatory|Changed to other treatment|1
1971160|NCT02908685|3532313|FG011|Part 2 Confirmatory|Changed to other treatment|0
1971161|NCT02857426|3532332|FG000|Overall Study|Disease progression|34
2212735|NCT01673178|3854033|FG001|Overall Study|Other|0
2212736|NCT01673178|3854034|FG002|Overall Study|Other|2
2309258|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0
2309259|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0
2309260|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1
2309261|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0
2309262|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0
2309263|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0
2309264|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1
2309265|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2309266|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2309267|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2309268|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2309269|NCT02717195|4012862|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
2309270|NCT02717195|4012863|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
2309271|NCT02717195|4012864|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
2309272|NCT02717195|4012865|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
2309273|NCT02717195|4012866|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
1971162|NCT02857426|3532333|FG001|Overall Study|Disease progression|13
1971163|NCT02857426|3532332|FG000|Overall Study|Study drug toxicity|4
1971164|NCT02857426|3532333|FG001|Overall Study|Study drug toxicity|1
1971165|NCT02857426|3532332|FG000|Overall Study|Death|1
1971166|NCT02857426|3532333|FG001|Overall Study|Death|0
1971167|NCT02857426|3532332|FG000|Overall Study|Adverse event unrelated to study drug|6
1971168|NCT02857426|3532333|FG001|Overall Study|Adverse event unrelated to study drug|2
1971169|NCT02857426|3532332|FG000|Overall Study|Participant withdrew consent|1
2212737|NCT01673178|3854035|FG003|Overall Study|Other|1
1971170|NCT02857426|3532333|FG001|Overall Study|Participant withdrew consent|1
1971171|NCT02857426|3532332|FG000|Overall Study|Maximum clinical benefit|1
1971172|NCT02857426|3532333|FG001|Overall Study|Maximum clinical benefit|0
1971173|NCT02857426|3532332|FG000|Overall Study|Completed treatment|0
1971174|NCT02857426|3532333|FG001|Overall Study|Completed treatment|2
1971175|NCT02855125|3532341|FG000|Overall Study|Withdrawal by Subject|2
1971176|NCT02855125|3532342|FG001|Overall Study|Withdrawal by Subject|2
1971177|NCT02855125|3532341|FG000|Overall Study|Clinical Disease Progression|5
1971178|NCT02855125|3532342|FG001|Overall Study|Clinical Disease Progression|4
1971179|NCT02855125|3532341|FG000|Overall Study|Radiologic Disease Progression|36
1971180|NCT02855125|3532342|FG001|Overall Study|Radiologic Disease Progression|39
1971181|NCT02855125|3532341|FG000|Overall Study|Adverse Event|11
1971182|NCT02855125|3532342|FG001|Overall Study|Adverse Event|7
1971183|NCT02855125|3532341|FG000|Overall Study|Physician Decision|1
1971184|NCT02855125|3532342|FG001|Overall Study|Physician Decision|0
1971185|NCT02855125|3532341|FG000|Overall Study|On Treatment|9
1971186|NCT02855125|3532342|FG001|Overall Study|On Treatment|11
1971187|NCT02855125|3532341|FG000|Overall Study|Randomized but not treated|0
1971188|NCT02855125|3532342|FG001|Overall Study|Randomized but not treated|1
1971189|NCT02836236|3532350|FG000|Overall Study|Randomized but Never Treated|1
1971190|NCT02836236|3532351|FG001|Overall Study|Randomized but Never Treated|0
1971191|NCT02836236|3532350|FG000|Overall Study|Withdrew Consent|2
1971192|NCT02836236|3532351|FG001|Overall Study|Withdrew Consent|0
1971193|NCT02836236|3532350|FG000|Overall Study|Adverse Event|0
1971194|NCT02836236|3532351|FG001|Overall Study|Adverse Event|1
1971195|NCT02836236|3532350|FG000|Overall Study|Investigator's Discretion|1
1971196|NCT02836236|3532351|FG001|Overall Study|Investigator's Discretion|0
1971197|NCT02836236|3532350|FG000|Overall Study|Still on Study|101
1971198|NCT02836236|3532351|FG001|Overall Study|Still on Study|49
1971199|NCT02831764|3532359|FG000|Overall Study|Protocol specific withdrawal criteria|0
1971200|NCT02831764|3532360|FG001|Overall Study|Protocol specific withdrawal criteria|2
1971201|NCT02831764|3532359|FG000|Overall Study|Withdrawal by Subject|7
1971202|NCT02831764|3532360|FG001|Overall Study|Withdrawal by Subject|6
1971203|NCT02831764|3532359|FG000|Overall Study|Physician Decision|2
1971204|NCT02831764|3532360|FG001|Overall Study|Physician Decision|2
1971205|NCT02831764|3532359|FG000|Overall Study|Lost to Follow-up|6
1971206|NCT02831764|3532360|FG001|Overall Study|Lost to Follow-up|5
1971207|NCT02831764|3532359|FG000|Overall Study|Adverse Event|8
1971208|NCT02831764|3532360|FG001|Overall Study|Adverse Event|5
1971209|NCT02831764|3532359|FG000|Overall Study|Lack of Efficacy|2
1971210|NCT02831764|3532360|FG001|Overall Study|Lack of Efficacy|2
1971211|NCT02831764|3532359|FG000|Overall Study|Protocol Violation|5
1971212|NCT02831764|3532360|FG001|Overall Study|Protocol Violation|2
1971213|NCT02831764|3532359|FG000|Overall Study|Ongoing at the time of the analysis|330
1971214|NCT02831764|3532360|FG001|Overall Study|Ongoing at the time of the analysis|335
1971215|NCT02680587|3532378|FG000|Overall Study|Withdrawal by Subject|1
1971216|NCT02680587|3532379|FG001|Overall Study|Withdrawal by Subject|0
1971217|NCT02652949|3532400|FG000|30-Day Follow-up for Primary Endpoint|Death|1
1971218|NCT02652949|3532400|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
1971219|NCT02652949|3532400|FG000|6-Month Follow-up Secondary Endpoint|Death|5
1971220|NCT02652949|3532400|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
1971221|NCT02652949|3532400|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
1971222|NCT02652949|3532400|FG000|12-Month Follow-up Secondary Endpoint|Death|4
1971223|NCT02652949|3532400|FG000|24-Month Follow-up Secondary Endpoint|Death|2
1971224|NCT02652949|3532400|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
1971225|NCT02652949|3532400|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
1971226|NCT02652949|3532400|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28
1971227|NCT02574455|3532412|FG000|Overall Study|Death|197
1971228|NCT02574455|3532413|FG001|Overall Study|Death|210
1971229|NCT02574455|3532412|FG000|Overall Study|Withdrawal of Consent|11
1971230|NCT02574455|3532413|FG001|Overall Study|Withdrawal of Consent|28
1971231|NCT02574455|3532412|FG000|Overall Study|Lost to Follow-up|4
1971232|NCT02574455|3532413|FG001|Overall Study|Lost to Follow-up|4
1971233|NCT02574455|3532412|FG000|Overall Study|Sponsor's Decision|55
1971234|NCT02574455|3532413|FG001|Overall Study|Sponsor's Decision|20
1971235|NCT02527798|3532429|FG000|Overall Study|Physician Decision|1
1971236|NCT02527798|3532430|FG001|Overall Study|Physician Decision|0
1971237|NCT02527798|3532431|FG002|Overall Study|Physician Decision|1
1971238|NCT02527798|3532432|FG003|Overall Study|Physician Decision|1
1971239|NCT02527798|3532433|FG004|Overall Study|Physician Decision|0
1971240|NCT02527798|3532434|FG005|Overall Study|Physician Decision|0
1971241|NCT02527798|3532429|FG000|Overall Study|Death|0
1971242|NCT02527798|3532430|FG001|Overall Study|Death|0
1971243|NCT02527798|3532431|FG002|Overall Study|Death|1
1971244|NCT02527798|3532432|FG003|Overall Study|Death|0
1971245|NCT02527798|3532433|FG004|Overall Study|Death|0
1971246|NCT02527798|3532434|FG005|Overall Study|Death|0
1971247|NCT02527798|3532429|FG000|Overall Study|Withdrawal by Subject|0
1971248|NCT02527798|3532430|FG001|Overall Study|Withdrawal by Subject|1
1971249|NCT02527798|3532431|FG002|Overall Study|Withdrawal by Subject|2
1971250|NCT02527798|3532432|FG003|Overall Study|Withdrawal by Subject|0
1971251|NCT02527798|3532433|FG004|Overall Study|Withdrawal by Subject|0
1971252|NCT02527798|3532434|FG005|Overall Study|Withdrawal by Subject|0
1971253|NCT02527798|3532429|FG000|Overall Study|Reason undisclosed|1
1971254|NCT02527798|3532430|FG001|Overall Study|Reason undisclosed|0
1971255|NCT02527798|3532431|FG002|Overall Study|Reason undisclosed|1
1971256|NCT02527798|3532432|FG003|Overall Study|Reason undisclosed|0
1971257|NCT02527798|3532433|FG004|Overall Study|Reason undisclosed|0
1971258|NCT02527798|3532434|FG005|Overall Study|Reason undisclosed|0
1971259|NCT02527798|3532429|FG000|Overall Study|Did not receive intervention|1
1971260|NCT02527798|3532430|FG001|Overall Study|Did not receive intervention|1
1971261|NCT02527798|3532431|FG002|Overall Study|Did not receive intervention|0
1971262|NCT02527798|3532432|FG003|Overall Study|Did not receive intervention|0
1971263|NCT02527798|3532433|FG004|Overall Study|Did not receive intervention|0
1971264|NCT02527798|3532434|FG005|Overall Study|Did not receive intervention|0
1971265|NCT02279745|3532485|FG000|Overall Study|Adverse Event|7
1971266|NCT02279745|3532485|FG000|Overall Study|Death|6
1971267|NCT02279745|3532485|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2
1971268|NCT02279745|3532485|FG000|Overall Study|Withdrawal by Subject|2
1971269|NCT02279745|3532485|FG000|Overall Study|Pregnancy|1
1971270|NCT02279745|3532485|FG000|Overall Study|Study Non-compliance|1
1971271|NCT02279745|3532485|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1
1971272|NCT02030938|3532517|FG000|Overall Study|Lost to Follow-up|4
1971273|NCT02030938|3532517|FG000|Overall Study|Withdrawal by Subject|1
1971274|NCT02006147|3532529|FG000|Overall Study|Protocol Violation|1
1971275|NCT02006147|3532530|FG001|Overall Study|Protocol Violation|1
1971276|NCT02006147|3532531|FG002|Overall Study|Protocol Violation|0
1971277|NCT02006147|3532532|FG003|Overall Study|Protocol Violation|0
1971278|NCT02006147|3532529|FG000|Overall Study|Withdrawal by Subject|0
1971279|NCT02006147|3532530|FG001|Overall Study|Withdrawal by Subject|1
1971280|NCT02006147|3532531|FG002|Overall Study|Withdrawal by Subject|0
1971281|NCT02006147|3532532|FG003|Overall Study|Withdrawal by Subject|0
1971282|NCT02006147|3532529|FG000|Overall Study|Withdrawal by Sponsor|1
1971283|NCT02006147|3532530|FG001|Overall Study|Withdrawal by Sponsor|0
1971284|NCT02006147|3532531|FG002|Overall Study|Withdrawal by Sponsor|0
1971285|NCT02006147|3532532|FG003|Overall Study|Withdrawal by Sponsor|0
1971286|NCT01999179|3532538|FG000|Overall Study|Adverse Event|1
1971287|NCT01999179|3532538|FG000|Overall Study|Lost to Follow-up|1
2212738|NCT01673178|3854036|FG004|Overall Study|Other|0
2212739|NCT01673282|3854067|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9
2212740|NCT01673282|3854068|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5
2212741|NCT01673282|3854067|FG000|Overall Study|Lack of Efficacy|9
1971288|NCT01999179|3532538|FG000|Overall Study|Change in Therapy|3
1971289|NCT01999179|3532538|FG000|Overall Study|New catheter|2
2021470|NCT00313300|3589245|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
2021471|NCT00313300|3589246|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
2021472|NCT00313300|3589247|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
2021473|NCT00313300|3589248|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
2021474|NCT00313300|3589249|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
2021475|NCT00313300|3589245|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34
2021476|NCT00313300|3589246|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9
2021477|NCT00313300|3589247|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12
2309274|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0
2309275|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0
2309276|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10
2309277|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11
2309278|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8
2309279|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
2309280|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
2309281|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
2309282|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
2309283|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
2309284|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
2309285|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
2309286|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
2309287|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
2309288|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
2309289|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0
2309290|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0
2309291|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1
2309292|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0
2021478|NCT00313300|3589248|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23
2021479|NCT00313300|3589249|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19
2021480|NCT00313300|3589245|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
2021481|NCT00313300|3589246|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
2021482|NCT00313300|3589247|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
2021483|NCT00313300|3589248|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
2021484|NCT00313300|3589249|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
1971290|NCT01940341|3532544|FG000|Double-Blind Phase|Randomized but Never Treated|0
1971291|NCT01940341|3532545|FG001|Double-Blind Phase|Randomized but Never Treated|1
1971292|NCT01940341|3532544|FG000|Double-Blind Phase|Adverse Event|3
1971293|NCT01940341|3532545|FG001|Double-Blind Phase|Adverse Event|2
1971294|NCT01940341|3532544|FG000|Double-Blind Phase|Withdrew Consent|3
1971295|NCT01940341|3532545|FG001|Double-Blind Phase|Withdrew Consent|2
1971296|NCT01940341|3532544|FG000|Double-Blind Phase|Lost to Follow-up|4
1971297|NCT01940341|3532545|FG001|Double-Blind Phase|Lost to Follow-up|1
1971298|NCT01940341|3532544|FG000|Double-Blind Phase|Pregnancy|0
1971299|NCT01940341|3532545|FG001|Double-Blind Phase|Pregnancy|1
1971300|NCT01940341|3532544|FG000|Double-Blind Phase|Investigator's Discretion|1
1971301|NCT01940341|3532545|FG001|Double-Blind Phase|Investigator's Discretion|0
1971302|NCT01940341|3532544|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0
1971303|NCT01940341|3532545|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
1971304|NCT01940341|3532544|FG000|Double-Blind Phase|Protocol Specified Criteria|1
1971305|NCT01940341|3532545|FG001|Double-Blind Phase|Protocol Specified Criteria|0
1971306|NCT01940341|3532544|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269
1971307|NCT01940341|3532545|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132
1971308|NCT01940341|3532544|FG000|Open-label Extension Phase|Still on Study|4
1971309|NCT01940341|3532545|FG001|Open-label Extension Phase|Still on Study|1
1971310|NCT01925794|3532553|FG000|180 Days|Death|2
1971311|NCT01925794|3532553|FG000|180 Days|Withdrawal by Subject|2
1971312|NCT01925794|3532553|FG000|270 Days|Death|2
1971313|NCT01925794|3532553|FG000|270 Days|Protocol Violation|3
1971314|NCT01886872|3532573|FG000|Overall Study|Ineligible|7
1971315|NCT01886872|3532574|FG001|Overall Study|Ineligible|4
1971316|NCT01886872|3532575|FG002|Overall Study|Ineligible|12
1971317|NCT01849250|3532590|FG000|Overall Study|Withdrawal by Subject|1
1971318|NCT01849250|3532591|FG001|Overall Study|Withdrawal by Subject|0
1971319|NCT01849250|3532590|FG000|Overall Study|Not Evaluable|5
1971320|NCT01849250|3532591|FG001|Overall Study|Not Evaluable|3
1971321|NCT01849250|3532590|FG000|Overall Study|Screen Failure|1
1971322|NCT01849250|3532591|FG001|Overall Study|Screen Failure|0
1971323|NCT01609790|3532601|FG000|Overall Study|Protocol Violation|1
1971324|NCT01609790|3532602|FG001|Overall Study|Protocol Violation|7
1971325|NCT01609790|3532603|FG002|Overall Study|Protocol Violation|8
1971326|NCT01441115|3532615|FG000|Overall Study|Taken off study - Principal Investigator discretion|1
1971327|NCT01295944|3532622|FG000|Overall Study|Switched to alternative treatment|1
1971328|NCT01295944|3532622|FG000|Overall Study|Ineligible|9
1971329|NCT01295944|3532622|FG000|Overall Study|Withdrawal by Subject|4
1971330|NCT01295944|3532622|FG000|Overall Study|Participant chose to be treated in Peru|1
1971331|NCT01295944|3532622|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1
1971332|NCT01295944|3532622|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1
2309293|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1
2309294|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
2309295|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
2309296|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
2309297|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
2309298|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
2309299|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
2309300|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
2309301|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
2309302|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
2309303|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
2309304|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2309305|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2309306|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
2309307|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2309308|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2309309|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Patient decision|0
2309310|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Patient decision|0
2309311|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Patient decision|0
2309312|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Patient decision|2
2309313|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Patient decision|2
2309314|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0
2309315|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0
2309316|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0
2309317|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1
2309318|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1
2309319|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0
1971333|NCT01295944|3532622|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1
1971334|NCT01199302|3532630|FG000|Overall Study|Adverse Event|1
1971335|NCT01199302|3532631|FG001|Overall Study|Adverse Event|1
1971336|NCT01199302|3532632|FG002|Overall Study|Adverse Event|2
1971337|NCT01199302|3532633|FG003|Overall Study|Adverse Event|0
1971338|NCT01199302|3532630|FG000|Overall Study|Withdrawal by Subject|2
1971339|NCT01199302|3532631|FG001|Overall Study|Withdrawal by Subject|2
1971340|NCT01199302|3532632|FG002|Overall Study|Withdrawal by Subject|3
1971341|NCT01199302|3532633|FG003|Overall Study|Withdrawal by Subject|0
1971342|NCT01199302|3532630|FG000|Overall Study|Disease Progression|3
1971343|NCT01199302|3532631|FG001|Overall Study|Disease Progression|4
1971344|NCT01199302|3532632|FG002|Overall Study|Disease Progression|4
1971345|NCT01199302|3532633|FG003|Overall Study|Disease Progression|2
1971346|NCT01199302|3532630|FG000|Overall Study|Study Termination|13
1971347|NCT01199302|3532631|FG001|Overall Study|Study Termination|8
1971348|NCT01199302|3532632|FG002|Overall Study|Study Termination|11
1971349|NCT01199302|3532633|FG003|Overall Study|Study Termination|9
1971350|NCT01199302|3532630|FG000|Overall Study|Lost to Follow-up|0
1971351|NCT01199302|3532631|FG001|Overall Study|Lost to Follow-up|1
1971352|NCT01199302|3532632|FG002|Overall Study|Lost to Follow-up|0
1971353|NCT01199302|3532633|FG003|Overall Study|Lost to Follow-up|0
1971354|NCT01199302|3532630|FG000|Overall Study|Other|1
1971355|NCT01199302|3532631|FG001|Overall Study|Other|0
1971356|NCT01199302|3532632|FG002|Overall Study|Other|0
1971357|NCT01199302|3532633|FG003|Overall Study|Other|0
1971358|NCT01123707|3532644|FG000|Overall Study|Lost to Follow-up|3
1971359|NCT01123707|3532645|FG001|Overall Study|Lost to Follow-up|1
1971360|NCT01123707|3532646|FG002|Overall Study|Lost to Follow-up|3
1971361|NCT01123707|3532647|FG003|Overall Study|Lost to Follow-up|2
1971362|NCT01123707|3532644|FG000|Overall Study|Adverse Event|5
1971363|NCT01123707|3532645|FG001|Overall Study|Adverse Event|7
1971364|NCT01123707|3532646|FG002|Overall Study|Adverse Event|5
1971365|NCT01123707|3532647|FG003|Overall Study|Adverse Event|3
1971366|NCT01123707|3532644|FG000|Overall Study|Sponsor Discontinued Study|30
1971367|NCT01123707|3532645|FG001|Overall Study|Sponsor Discontinued Study|24
1971368|NCT01123707|3532646|FG002|Overall Study|Sponsor Discontinued Study|25
1971369|NCT01123707|3532647|FG003|Overall Study|Sponsor Discontinued Study|40
1971370|NCT01123707|3532644|FG000|Overall Study|Participant Met Withdrawal Criteria|1
1971371|NCT01123707|3532645|FG001|Overall Study|Participant Met Withdrawal Criteria|1
1971372|NCT01123707|3532646|FG002|Overall Study|Participant Met Withdrawal Criteria|0
1971373|NCT01123707|3532647|FG003|Overall Study|Participant Met Withdrawal Criteria|1
1971374|NCT01123707|3532644|FG000|Overall Study|Investigator Withdrew Participant|0
1971375|NCT01123707|3532645|FG001|Overall Study|Investigator Withdrew Participant|1
1971376|NCT01123707|3532646|FG002|Overall Study|Investigator Withdrew Participant|1
1971377|NCT01123707|3532647|FG003|Overall Study|Investigator Withdrew Participant|1
1971378|NCT01123707|3532644|FG000|Overall Study|Subject Withdrew Consent|4
1971379|NCT01123707|3532645|FG001|Overall Study|Subject Withdrew Consent|5
1971380|NCT01123707|3532646|FG002|Overall Study|Subject Withdrew Consent|1
1971381|NCT01123707|3532647|FG003|Overall Study|Subject Withdrew Consent|2
1971382|NCT01123707|3532644|FG000|Overall Study|Lack of Efficacy|1
1971383|NCT01123707|3532645|FG001|Overall Study|Lack of Efficacy|2
1971384|NCT01123707|3532646|FG002|Overall Study|Lack of Efficacy|1
1971385|NCT01123707|3532647|FG003|Overall Study|Lack of Efficacy|0
1971386|NCT01123707|3532644|FG000|Overall Study|Subject Met Exclusion Criteria|0
1971387|NCT01123707|3532645|FG001|Overall Study|Subject Met Exclusion Criteria|0
1971388|NCT01123707|3532646|FG002|Overall Study|Subject Met Exclusion Criteria|2
1971389|NCT01123707|3532647|FG003|Overall Study|Subject Met Exclusion Criteria|1
1971390|NCT00462943|3532664|FG000|Overall Study|Failure to achieve a response|5
1971391|NCT00462943|3532665|FG001|Overall Study|Failure to achieve a response|5
1971392|NCT00462943|3532666|FG002|Overall Study|Failure to achieve a response|1
1971393|NCT00462943|3532664|FG000|Overall Study|Adverse Event|6
1971394|NCT00462943|3532665|FG001|Overall Study|Adverse Event|4
2212742|NCT01673282|3854068|FG001|Overall Study|Lack of Efficacy|2
2212743|NCT01673282|3854067|FG000|Overall Study|Lost to Follow-up|11
2212744|NCT01673282|3854068|FG001|Overall Study|Lost to Follow-up|10
2212745|NCT01673282|3854067|FG000|Overall Study|Withdrawal by Subject|3
2309320|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0
2309321|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0
2309322|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0
2309323|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1
2309324|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Change of residence|0
2309325|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Change of residence|0
2309326|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Change of residence|0
2309327|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Change of residence|1
2309328|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Change of residence|1
2309329|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
1971395|NCT00462943|3532666|FG002|Overall Study|Adverse Event|1
1971396|NCT00462943|3532664|FG000|Overall Study|Protocol Violation|1
1971397|NCT00462943|3532665|FG001|Overall Study|Protocol Violation|0
1971398|NCT00462943|3532666|FG002|Overall Study|Protocol Violation|0
1971399|NCT00462943|3532664|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8
1971400|NCT00462943|3532665|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2
2212746|NCT01673282|3854068|FG001|Overall Study|Withdrawal by Subject|3
1971401|NCT00462943|3532666|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4
1971402|NCT00462943|3532664|FG000|Overall Study|Disease Progression|15
1971403|NCT00462943|3532665|FG001|Overall Study|Disease Progression|15
1971404|NCT00462943|3532666|FG002|Overall Study|Disease Progression|9
1971405|NCT00462943|3532664|FG000|Overall Study|Death|5
1971406|NCT00462943|3532665|FG001|Overall Study|Death|2
1971407|NCT00462943|3532666|FG002|Overall Study|Death|7
1971408|NCT00462943|3532664|FG000|Overall Study|Stem Cell Transplant|1
1971409|NCT00462943|3532665|FG001|Overall Study|Stem Cell Transplant|1
1971410|NCT00462943|3532666|FG002|Overall Study|Stem Cell Transplant|0
1971411|NCT00462943|3532664|FG000|Overall Study|Bone Marrow Transplant|1
1971412|NCT00462943|3532665|FG001|Overall Study|Bone Marrow Transplant|0
1971413|NCT00462943|3532666|FG002|Overall Study|Bone Marrow Transplant|0
1971414|NCT00462943|3532664|FG000|Overall Study|Required Lymphocyte Infusion|1
1971415|NCT00462943|3532665|FG001|Overall Study|Required Lymphocyte Infusion|0
1971416|NCT00462943|3532666|FG002|Overall Study|Required Lymphocyte Infusion|0
1971417|NCT00462943|3532664|FG000|Overall Study|Transplant - not specified|1
1971418|NCT00462943|3532665|FG001|Overall Study|Transplant - not specified|0
1971419|NCT00462943|3532666|FG002|Overall Study|Transplant - not specified|1
1971420|NCT00462943|3532664|FG000|Overall Study|Physician Decision|1
1971421|NCT00462943|3532665|FG001|Overall Study|Physician Decision|0
1971422|NCT00462943|3532666|FG002|Overall Study|Physician Decision|0
1971423|NCT00462943|3532664|FG000|Overall Study|Withdrawal by Subject|0
1971424|NCT00462943|3532665|FG001|Overall Study|Withdrawal by Subject|1
1971425|NCT00462943|3532666|FG002|Overall Study|Withdrawal by Subject|0
1971426|NCT00248287|3532676|FG000|Overall Study|Adverse Event|11
1971427|NCT00248287|3532677|FG001|Overall Study|Adverse Event|10
1971428|NCT00248287|3532676|FG000|Overall Study|Death|1
1971429|NCT00248287|3532677|FG001|Overall Study|Death|0
1971430|NCT00248287|3532676|FG000|Overall Study|Lost to Follow-up|0
1971431|NCT00248287|3532677|FG001|Overall Study|Lost to Follow-up|1
1971432|NCT00248287|3532676|FG000|Overall Study|Investigator Request|4
1971433|NCT00248287|3532677|FG001|Overall Study|Investigator Request|3
1971434|NCT00248287|3532676|FG000|Overall Study|Patient Request|5
1971435|NCT00248287|3532677|FG001|Overall Study|Patient Request|3
1971436|NCT00248287|3532676|FG000|Overall Study|Other|3
1971437|NCT00248287|3532677|FG001|Overall Study|Other|2
1971438|NCT00105560|3532687|FG000|Overall Study|Lost to Follow-up|1
2021485|NCT00313300|3589245|FG000|Randomized in Phase B (26 Weeks)|Death|5
2021486|NCT00313300|3589246|FG001|Randomized in Phase B (26 Weeks)|Death|3
2021487|NCT00313300|3589247|FG002|Randomized in Phase B (26 Weeks)|Death|1
2021488|NCT00313300|3589248|FG003|Randomized in Phase B (26 Weeks)|Death|0
2021489|NCT00313300|3589249|FG004|Randomized in Phase B (26 Weeks)|Death|1
2021490|NCT00313300|3589245|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
2021491|NCT00313300|3589246|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
2021492|NCT00313300|3589247|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
2021493|NCT00313300|3589248|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
2021494|NCT00313300|3589249|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
2021495|NCT00313300|3589245|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
2021496|NCT00313300|3589246|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
2021497|NCT00313300|3589247|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
2021498|NCT00313300|3589248|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
2021499|NCT00313300|3589249|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
2021500|NCT00313300|3589245|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
2021501|NCT00313300|3589246|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
2021502|NCT00313300|3589247|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
2021503|NCT00313300|3589248|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
2021504|NCT00313300|3589249|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
2021505|NCT00313300|3589245|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
2021506|NCT00313300|3589246|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
2021507|NCT00313300|3589247|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
2021508|NCT00313300|3589248|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
2021509|NCT00313300|3589249|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
2021510|NCT00313300|3589245|FG000|Randomized in Phase B (26 Weeks)|non-specified|1
2021511|NCT00313300|3589246|FG001|Randomized in Phase B (26 Weeks)|non-specified|0
2021512|NCT00313300|3589247|FG002|Randomized in Phase B (26 Weeks)|non-specified|0
2021513|NCT00313300|3589248|FG003|Randomized in Phase B (26 Weeks)|non-specified|0
2021514|NCT00313300|3589249|FG004|Randomized in Phase B (26 Weeks)|non-specified|0
2021515|NCT00313300|3589245|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
2021516|NCT00313300|3589246|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
2021517|NCT00313300|3589247|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
2021518|NCT00313300|3589248|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
2021519|NCT00313300|3589249|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
2021520|NCT00313300|3589245|FG000|Follow-Up(30days)-Randomized Phase A|Death|0
2021521|NCT00313300|3589246|FG001|Follow-Up(30days)-Randomized Phase A|Death|1
2021522|NCT00313300|3589247|FG002|Follow-Up(30days)-Randomized Phase A|Death|0
2021523|NCT00313300|3589248|FG003|Follow-Up(30days)-Randomized Phase A|Death|0
2021524|NCT00313300|3589249|FG004|Follow-Up(30days)-Randomized Phase A|Death|0
2212747|NCT01673282|3854067|FG000|Overall Study|Other|1
2212748|NCT01673282|3854068|FG001|Overall Study|Other|6
1971439|NCT04569786|3532721|FG000|Overall Study|Lost to Follow-up|1
1971440|NCT04569786|3532722|FG001|Overall Study|Lost to Follow-up|0
1971441|NCT04569786|3532723|FG002|Overall Study|Lost to Follow-up|4
1971442|NCT04569786|3532724|FG003|Overall Study|Lost to Follow-up|1
1971443|NCT04569786|3532725|FG004|Overall Study|Lost to Follow-up|0
1971444|NCT04569786|3532721|FG000|Overall Study|Withdrawal by Subject|0
1971445|NCT04569786|3532722|FG001|Overall Study|Withdrawal by Subject|0
1971446|NCT04569786|3532723|FG002|Overall Study|Withdrawal by Subject|0
1971447|NCT04569786|3532724|FG003|Overall Study|Withdrawal by Subject|5
1971448|NCT04569786|3532725|FG004|Overall Study|Withdrawal by Subject|1
1971449|NCT04569786|3532721|FG000|Overall Study|Physician Decision|0
1971450|NCT04569786|3532722|FG001|Overall Study|Physician Decision|0
1971451|NCT04569786|3532723|FG002|Overall Study|Physician Decision|0
1971452|NCT04569786|3532724|FG003|Overall Study|Physician Decision|1
1971453|NCT04569786|3532725|FG004|Overall Study|Physician Decision|0
1971454|NCT04129944|3532746|FG000|Overall Study|Death|0
1971455|NCT04129944|3532747|FG001|Overall Study|Death|0
1971456|NCT04129944|3532748|FG002|Overall Study|Death|0
1971457|NCT04129944|3532749|FG003|Overall Study|Death|1
1971458|NCT04129944|3532746|FG000|Overall Study|Lost to Follow-up|1
1971459|NCT04129944|3532747|FG001|Overall Study|Lost to Follow-up|0
1971460|NCT04129944|3532748|FG002|Overall Study|Lost to Follow-up|0
1971461|NCT04129944|3532749|FG003|Overall Study|Lost to Follow-up|0
1971462|NCT04129944|3532746|FG000|Overall Study|Withdrawal by Subject|1
1971463|NCT04129944|3532747|FG001|Overall Study|Withdrawal by Subject|0
1971464|NCT04129944|3532748|FG002|Overall Study|Withdrawal by Subject|1
1971465|NCT04129944|3532749|FG003|Overall Study|Withdrawal by Subject|2
1971546|NCT03370120|3532877|FG000|Overall Study|Lost to Follow-up|1
1971547|NCT03370120|3532877|FG000|Overall Study|Lack of Efficacy|37
1971548|NCT03370120|3532877|FG000|Overall Study|Per sponsor's instructions|1
1971549|NCT03370120|3532877|FG000|Overall Study|Study was terminated by parent company UCB|2
1971550|NCT03370120|3532877|FG000|Overall Study|The study was ended by the promoter|3
1971551|NCT03370120|3532877|FG000|Overall Study|Discontinuation of drug development|3
1971552|NCT03370120|3532877|FG000|Overall Study|End of project|2
1971553|NCT03370120|3532877|FG000|Overall Study|Premature study closure|2
1971554|NCT03370120|3532877|FG000|Overall Study|Premature program termination|1
1971555|NCT03370120|3532877|FG000|Overall Study|Premature study termination|7
1971556|NCT03370120|3532877|FG000|Overall Study|Trial terminated by sponsor|2
1971557|NCT03370120|3532877|FG000|Overall Study|Trial discontinued by sponsor|2
1971558|NCT03370120|3532877|FG000|Overall Study|Study ended|15
1971559|NCT03370120|3532877|FG000|Overall Study|Clinical trial has been cancelled|1
1971560|NCT03370120|3532877|FG000|Overall Study|End of study per sponsor decision|2
1971561|NCT03370120|3532877|FG000|Overall Study|Promoter's decision|2
1971562|NCT03370120|3532877|FG000|Overall Study|The trial has been suspended|3
1971563|NCT03370120|3532877|FG000|Overall Study|Sponsor stopped PSL development based on data|3
1971564|NCT03370120|3532877|FG000|Overall Study|Early termination by order of sponsor|2
1971565|NCT03370120|3532877|FG000|Overall Study|Discontinuation of the study|5
1971566|NCT03370120|3532877|FG000|Overall Study|End of clinical trial discontinuation|1
1971567|NCT03370120|3532877|FG000|Overall Study|Because the clinical trial ended halfway|4
1971568|NCT03370120|3532877|FG000|Overall Study|Development discontinued|5
1971569|NCT03370120|3532877|FG000|Overall Study|Padsenovil program closed|3
1971570|NCT03370120|3532877|FG000|Overall Study|End of project|2
1971571|NCT03370120|3532877|FG000|Overall Study|Termination of project|1
1971572|NCT03370120|3532877|FG000|Overall Study|The study was interrupted by sponsor|4
1971573|NCT03370120|3532877|FG000|Overall Study|The protocol was interrupted by sponsor|1
1971574|NCT03370120|3532877|FG000|Overall Study|End of sponsor decision|1
1971575|NCT03370120|3532877|FG000|Overall Study|The study was terminated prematurely by study lead|1
1971576|NCT03370120|3532877|FG000|Overall Study|Early termination of studies|5
1971577|NCT03370120|3532877|FG000|Overall Study|This study is ended early|1
1971578|NCT03370120|3532877|FG000|Overall Study|End of padsevonil program|2
1971579|NCT03370120|3532877|FG000|Overall Study|Decision of sponsor|6
1971580|NCT03370120|3532877|FG000|Overall Study|Asked by the sponsor|3
1971581|NCT03370120|3532877|FG000|Overall Study|Sponsor decision to stop the protocol|1
1971582|NCT03370120|3532877|FG000|Overall Study|PI decision poor compliance from participant|1
1971583|NCT03370120|3532877|FG000|Overall Study|Promoter ended the study|3
1971584|NCT03370120|3532877|FG000|Overall Study|Premature study close by sponsor's decision|4
1971585|NCT03370120|3532877|FG000|Overall Study|Study terminated by sponsor|33
1971586|NCT03370120|3532877|FG000|Overall Study|Sponsor prematurely terminated this study|2
1971587|NCT03370120|3532877|FG000|Overall Study|Sponsor decision to terminate study|63
1971588|NCT03370120|3532877|FG000|Overall Study|Program closure|3
1971589|NCT03370120|3532877|FG000|Overall Study|Study ended prematurely|1
1971590|NCT03370120|3532877|FG000|Overall Study|Study stopped by sponsor|2
1971591|NCT03370120|3532877|FG000|Overall Study|Program termination|55
1971592|NCT03370120|3532877|FG000|Overall Study|Sponsor decision|62
1971593|NCT03370120|3532877|FG000|Overall Study|Sponsor study closure|10
1971594|NCT03332498|3532901|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0
1971595|NCT03332498|3532902|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0
1971596|NCT03332498|3532903|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2
2021525|NCT00313300|3589245|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
2021526|NCT00313300|3589246|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
1971466|NCT03857542|3532770|FG000|Overall Study|Adverse Event|1
1971467|NCT03857542|3532771|FG001|Overall Study|Adverse Event|3
1971468|NCT03857542|3532770|FG000|Overall Study|Withdrawal by Subject|2
1971469|NCT03857542|3532771|FG001|Overall Study|Withdrawal by Subject|1
1971470|NCT03857542|3532770|FG000|Overall Study|Lost to Follow-up|2
1971471|NCT03857542|3532771|FG001|Overall Study|Lost to Follow-up|1
1971472|NCT03857542|3532770|FG000|Overall Study|Reason not Specified|1
1971473|NCT03857542|3532771|FG001|Overall Study|Reason not Specified|0
1971474|NCT03848832|3532781|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0
1971475|NCT03848832|3532782|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0
1971476|NCT03848832|3532783|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1
1971477|NCT03848832|3532781|FG000|Overall Study|Withdrawal by Subject|0
1971478|NCT03848832|3532782|FG001|Overall Study|Withdrawal by Subject|0
1971479|NCT03848832|3532783|FG002|Overall Study|Withdrawal by Subject|1
1971480|NCT03848832|3532781|FG000|Overall Study|Withdrawal (Covid-19)|0
1971481|NCT03848832|3532782|FG001|Overall Study|Withdrawal (Covid-19)|2
1971482|NCT03848832|3532783|FG002|Overall Study|Withdrawal (Covid-19)|0
1971483|NCT03848832|3532781|FG000|Overall Study|Physician Decision|2
1971484|NCT03848832|3532782|FG001|Overall Study|Physician Decision|1
1971485|NCT03848832|3532783|FG002|Overall Study|Physician Decision|3
1971486|NCT03848832|3532781|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0
1971487|NCT03848832|3532782|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0
1971488|NCT03848832|3532783|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1
1971489|NCT03848832|3532781|FG000|Overall Study|Adverse Event|1
1971490|NCT03848832|3532782|FG001|Overall Study|Adverse Event|0
1971491|NCT03848832|3532783|FG002|Overall Study|Adverse Event|0
1971492|NCT03656744|3532805|FG000|Overall Study|Adverse Event|1
1971493|NCT03656744|3532806|FG001|Overall Study|Adverse Event|4
1971494|NCT03656744|3532807|FG002|Overall Study|Adverse Event|1
1971495|NCT03656744|3532805|FG000|Overall Study|Protocol Violation|1
1971496|NCT03656744|3532806|FG001|Overall Study|Protocol Violation|0
1971497|NCT03656744|3532807|FG002|Overall Study|Protocol Violation|0
1971498|NCT03656744|3532805|FG000|Overall Study|Lost to Follow-up|2
1971499|NCT03656744|3532806|FG001|Overall Study|Lost to Follow-up|2
1971500|NCT03656744|3532807|FG002|Overall Study|Lost to Follow-up|0
1971501|NCT03656744|3532805|FG000|Overall Study|Withdrawal by Subject|0
1971502|NCT03656744|3532806|FG001|Overall Study|Withdrawal by Subject|1
1971503|NCT03656744|3532807|FG002|Overall Study|Withdrawal by Subject|0
1971504|NCT03656744|3532805|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1
1971505|NCT03656744|3532806|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
1971506|NCT03656744|3532807|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
1971507|NCT03510598|3532815|FG000|Overall Study|Withdrawal by Subject|1
1971508|NCT03487796|3532823|FG000|Overall Study|Lost to Follow-up|18
1971509|NCT03487796|3532824|FG001|Overall Study|Lost to Follow-up|6
1971510|NCT03446612|3532838|FG000|Overall Study|Protocol defined stopping criteria|0
1971511|NCT03446612|3532839|FG001|Overall Study|Protocol defined stopping criteria|1
1971512|NCT03434379|3532862|FG000|Global Period|Lost to Follow-up|3
1971513|NCT03434379|3532863|FG001|Global Period|Lost to Follow-up|1
1971514|NCT03434379|3532864|FG002|Global Period|Lost to Follow-up|0
1971515|NCT03434379|3532865|FG003|Global Period|Lost to Follow-up|0
1971516|NCT03434379|3532862|FG000|Global Period|Death|99
1971517|NCT03434379|3532863|FG001|Global Period|Death|179
1971518|NCT03434379|3532864|FG002|Global Period|Death|0
1971519|NCT03434379|3532865|FG003|Global Period|Death|0
1971520|NCT03434379|3532862|FG000|Global Period|Withdrawal by Subject|20
1971521|NCT03434379|3532863|FG001|Global Period|Withdrawal by Subject|20
1971522|NCT03434379|3532864|FG002|Global Period|Withdrawal by Subject|0
1971523|NCT03434379|3532865|FG003|Global Period|Withdrawal by Subject|0
1971524|NCT03434379|3532862|FG000|Global Period|On Study|43
1971525|NCT03434379|3532863|FG001|Global Period|On Study|136
1971526|NCT03434379|3532864|FG002|Global Period|On Study|0
1971527|NCT03434379|3532865|FG003|Global Period|On Study|0
1971528|NCT03434379|3532862|FG000|China Extension Period|Lost to Follow-up|0
1971529|NCT03434379|3532863|FG001|China Extension Period|Lost to Follow-up|0
1971530|NCT03434379|3532864|FG002|China Extension Period|Lost to Follow-up|1
1971531|NCT03434379|3532865|FG003|China Extension Period|Lost to Follow-up|0
1971532|NCT03434379|3532862|FG000|China Extension Period|Death|0
1971533|NCT03434379|3532863|FG001|China Extension Period|Death|0
1971534|NCT03434379|3532864|FG002|China Extension Period|Death|38
1971535|NCT03434379|3532865|FG003|China Extension Period|Death|61
1971536|NCT03434379|3532862|FG000|China Extension Period|Withdrawal by Subject|0
1971537|NCT03434379|3532863|FG001|China Extension Period|Withdrawal by Subject|0
1971538|NCT03434379|3532864|FG002|China Extension Period|Withdrawal by Subject|7
1971539|NCT03434379|3532865|FG003|China Extension Period|Withdrawal by Subject|6
1971540|NCT03434379|3532862|FG000|China Extension Period|On Study|0
2309330|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
2321810|NCT02963506|4036371|FG000|Dose-Blind Period|Withdrawal by Subject|0
1971541|NCT03434379|3532863|FG001|China Extension Period|On Study|0
1971542|NCT03434379|3532864|FG002|China Extension Period|On Study|15
1971543|NCT03434379|3532865|FG003|China Extension Period|On Study|66
1971544|NCT03370120|3532877|FG000|Overall Study|Adverse event, non-fatal|24
1971545|NCT03370120|3532877|FG000|Overall Study|Withdrawal by Subject|6
1971597|NCT03143829|3532912|FG000|Overall Study|Withdrawal by Subject|2
1971598|NCT03143829|3532913|FG001|Overall Study|Withdrawal by Subject|5
1971599|NCT03143829|3532912|FG000|Overall Study|Lost to Follow-up|0
1971600|NCT03143829|3532913|FG001|Overall Study|Lost to Follow-up|2
1971601|NCT03143829|3532912|FG000|Overall Study|Death|1
1971602|NCT03143829|3532913|FG001|Overall Study|Death|1
1971603|NCT03143829|3532912|FG000|Overall Study|changed treatment, no longer eligible|2
1971604|NCT03143829|3532913|FG001|Overall Study|changed treatment, no longer eligible|2
1971605|NCT02963610|3532928|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3
1971606|NCT02766335|3532935|FG000|Initial Registration|Adverse Event|6
1971607|NCT02766335|3532936|FG001|Initial Registration|Adverse Event|3
1971608|NCT02766335|3532937|FG002|Initial Registration|Adverse Event|0
1971609|NCT02766335|3532935|FG000|Initial Registration|Refusal unrelated to adverse event|1
1971610|NCT02766335|3532936|FG001|Initial Registration|Refusal unrelated to adverse event|0
1971611|NCT02766335|3532937|FG002|Initial Registration|Refusal unrelated to adverse event|0
1971612|NCT02766335|3532935|FG000|Initial Registration|Progression/relapse|49
1971613|NCT02766335|3532936|FG001|Initial Registration|Progression/relapse|15
1971614|NCT02766335|3532937|FG002|Initial Registration|Progression/relapse|0
1971615|NCT02766335|3532935|FG000|Initial Registration|Death|1
1971616|NCT02766335|3532936|FG001|Initial Registration|Death|3
1971617|NCT02766335|3532937|FG002|Initial Registration|Death|0
1971618|NCT02766335|3532935|FG000|Initial Registration|not protocol specified|1
1971619|NCT02766335|3532936|FG001|Initial Registration|not protocol specified|9
1971620|NCT02766335|3532937|FG002|Initial Registration|not protocol specified|0
1971621|NCT02766335|3532935|FG000|Re-registration of Arm I to MEDI4738|Death|0
1971622|NCT02766335|3532936|FG001|Re-registration of Arm I to MEDI4738|Death|0
1971623|NCT02766335|3532937|FG002|Re-registration of Arm I to MEDI4738|Death|1
1971624|NCT02766335|3532935|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0
1971625|NCT02766335|3532936|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0
1971626|NCT02766335|3532937|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1
1971627|NCT02606136|3532943|FG000|Overall Study|Participant/Legal Guardian Decision|5
1971628|NCT02606136|3532943|FG000|Overall Study|Withdrawal by Subject|1
1971629|NCT02228382|3532952|FG000|Overall Study|Death|5
1971630|NCT02228382|3532953|FG001|Overall Study|Death|7
1971631|NCT02228382|3532954|FG002|Overall Study|Death|5
1971632|NCT02228382|3532955|FG003|Overall Study|Death|0
1971633|NCT02228382|3532956|FG004|Overall Study|Death|2
1971634|NCT02228382|3532952|FG000|Overall Study|Participant refused further follow-up|0
1971635|NCT02228382|3532953|FG001|Overall Study|Participant refused further follow-up|0
1971636|NCT02228382|3532954|FG002|Overall Study|Participant refused further follow-up|1
1971637|NCT02228382|3532955|FG003|Overall Study|Participant refused further follow-up|0
1971638|NCT02228382|3532956|FG004|Overall Study|Participant refused further follow-up|0
1971639|NCT02228382|3532952|FG000|Overall Study|Study terminated by sponsor|3
1971640|NCT02228382|3532953|FG001|Overall Study|Study terminated by sponsor|5
1971641|NCT02228382|3532954|FG002|Overall Study|Study terminated by sponsor|7
1971642|NCT02228382|3532955|FG003|Overall Study|Study terminated by sponsor|0
1971643|NCT02228382|3532956|FG004|Overall Study|Study terminated by sponsor|0
1971644|NCT02228382|3532952|FG000|Overall Study|Lost to Follow-up|0
1971645|NCT02228382|3532953|FG001|Overall Study|Lost to Follow-up|0
1971646|NCT02228382|3532954|FG002|Overall Study|Lost to Follow-up|3
1971647|NCT02228382|3532955|FG003|Overall Study|Lost to Follow-up|1
1971648|NCT02228382|3532956|FG004|Overall Study|Lost to Follow-up|0
1971649|NCT02228382|3532952|FG000|Overall Study|Withdrawal by Subject|0
1971650|NCT02228382|3532953|FG001|Overall Study|Withdrawal by Subject|3
1971651|NCT02228382|3532954|FG002|Overall Study|Withdrawal by Subject|2
1971652|NCT02228382|3532955|FG003|Overall Study|Withdrawal by Subject|1
1971653|NCT02228382|3532956|FG004|Overall Study|Withdrawal by Subject|0
1971654|NCT02228382|3532952|FG000|Overall Study|Other|2
1971655|NCT02228382|3532953|FG001|Overall Study|Other|3
1971656|NCT02228382|3532954|FG002|Overall Study|Other|3
1971657|NCT02228382|3532955|FG003|Overall Study|Other|0
1971658|NCT02228382|3532956|FG004|Overall Study|Other|0
1971659|NCT02208024|3532973|FG000|Overall Study|Withdrawal by Subject|1
1971660|NCT02001623|3533019|FG000|Overall Study|Disease Progression|2
1971661|NCT02001623|3533020|FG001|Overall Study|Disease Progression|2
1971662|NCT02001623|3533021|FG002|Overall Study|Disease Progression|3
1971663|NCT02001623|3533022|FG003|Overall Study|Disease Progression|2
1971664|NCT02001623|3533023|FG004|Overall Study|Disease Progression|3
1971665|NCT02001623|3533024|FG005|Overall Study|Disease Progression|2
1971666|NCT02001623|3533025|FG006|Overall Study|Disease Progression|3
1971667|NCT02001623|3533026|FG007|Overall Study|Disease Progression|3
1971668|NCT02001623|3533027|FG008|Overall Study|Disease Progression|7
1971669|NCT02001623|3533028|FG009|Overall Study|Disease Progression|40
1971670|NCT02001623|3533029|FG010|Overall Study|Disease Progression|5
1971671|NCT02001623|3533030|FG011|Overall Study|Disease Progression|9
1971672|NCT02001623|3533031|FG012|Overall Study|Disease Progression|9
1971673|NCT02001623|3533032|FG013|Overall Study|Disease Progression|20
1971674|NCT02001623|3533033|FG014|Overall Study|Disease Progression|9
1971675|NCT02001623|3533019|FG000|Overall Study|Physician Decision|0
1971676|NCT02001623|3533020|FG001|Overall Study|Physician Decision|0
1971677|NCT02001623|3533021|FG002|Overall Study|Physician Decision|0
1971678|NCT02001623|3533022|FG003|Overall Study|Physician Decision|0
1971679|NCT02001623|3533023|FG004|Overall Study|Physician Decision|0
1971680|NCT02001623|3533024|FG005|Overall Study|Physician Decision|0
1971681|NCT02001623|3533025|FG006|Overall Study|Physician Decision|0
1971682|NCT02001623|3533026|FG007|Overall Study|Physician Decision|0
1971683|NCT02001623|3533027|FG008|Overall Study|Physician Decision|3
1971684|NCT02001623|3533028|FG009|Overall Study|Physician Decision|2
1971685|NCT02001623|3533029|FG010|Overall Study|Physician Decision|3
1971686|NCT02001623|3533030|FG011|Overall Study|Physician Decision|3
1971687|NCT02001623|3533031|FG012|Overall Study|Physician Decision|1
1971688|NCT02001623|3533032|FG013|Overall Study|Physician Decision|2
1971689|NCT02001623|3533033|FG014|Overall Study|Physician Decision|1
1971690|NCT02001623|3533019|FG000|Overall Study|Death|0
1971691|NCT02001623|3533020|FG001|Overall Study|Death|1
1971692|NCT02001623|3533021|FG002|Overall Study|Death|0
1971693|NCT02001623|3533022|FG003|Overall Study|Death|0
1971694|NCT02001623|3533023|FG004|Overall Study|Death|0
1971695|NCT02001623|3533024|FG005|Overall Study|Death|0
1971696|NCT02001623|3533025|FG006|Overall Study|Death|0
1971697|NCT02001623|3533026|FG007|Overall Study|Death|0
1971698|NCT02001623|3533027|FG008|Overall Study|Death|0
1971699|NCT02001623|3533028|FG009|Overall Study|Death|0
1971700|NCT02001623|3533029|FG010|Overall Study|Death|0
1971701|NCT02001623|3533030|FG011|Overall Study|Death|0
1971702|NCT02001623|3533031|FG012|Overall Study|Death|0
1971703|NCT02001623|3533032|FG013|Overall Study|Death|0
1971704|NCT02001623|3533033|FG014|Overall Study|Death|0
1971705|NCT02001623|3533019|FG000|Overall Study|Adverse Event|0
1971706|NCT02001623|3533020|FG001|Overall Study|Adverse Event|0
1971707|NCT02001623|3533021|FG002|Overall Study|Adverse Event|0
1971708|NCT02001623|3533022|FG003|Overall Study|Adverse Event|0
1971709|NCT02001623|3533023|FG004|Overall Study|Adverse Event|0
1971710|NCT02001623|3533024|FG005|Overall Study|Adverse Event|1
1971711|NCT02001623|3533025|FG006|Overall Study|Adverse Event|0
1971712|NCT02001623|3533026|FG007|Overall Study|Adverse Event|3
2309331|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
2309332|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
2309333|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
2309334|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2309335|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2309336|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1
2309337|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2309338|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2309339|NCT02717195|4012862|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0
2309340|NCT02717195|4012863|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0
2309341|NCT02717195|4012864|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0
2309342|NCT02717195|4012865|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1
2309343|NCT02717195|4012866|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1
2309344|NCT02717494|4012891|FG000|First Intervention (Step 1)|Lost to Follow-up|4
2309345|NCT02717494|4012892|FG001|First Intervention (Step 1)|Lost to Follow-up|7
2309346|NCT02717494|4012893|FG002|First Intervention (Step 1)|Lost to Follow-up|3
2309347|NCT02717494|4012891|FG000|First Intervention (Step 1)|Withdrawal by Subject|2
2309348|NCT02717494|4012892|FG001|First Intervention (Step 1)|Withdrawal by Subject|0
2309349|NCT02717494|4012893|FG002|First Intervention (Step 1)|Withdrawal by Subject|1
2309350|NCT02717494|4012891|FG000|First Intervention (Step 1)|Death|0
2309351|NCT02717494|4012892|FG001|First Intervention (Step 1)|Death|0
2309352|NCT02717494|4012893|FG002|First Intervention (Step 1)|Death|1
2309353|NCT02717494|4012891|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
2309354|NCT02717494|4012892|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
2309355|NCT02717494|4012893|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
2309356|NCT02717546|4012919|FG000|Overall Study|Lost to Follow-up|12
2309357|NCT02717754|4012929|FG000|Overall Study|Incorrect Infusion Duration|0
2309358|NCT02717754|4012930|FG001|Overall Study|Incorrect Infusion Duration|0
2309359|NCT02717754|4012931|FG002|Overall Study|Incorrect Infusion Duration|0
2309360|NCT02717754|4012932|FG003|Overall Study|Incorrect Infusion Duration|10
2309361|NCT02717754|4012933|FG004|Overall Study|Incorrect Infusion Duration|20
2309362|NCT02717754|4012934|FG005|Overall Study|Incorrect Infusion Duration|20
2309363|NCT02718131|4012959|FG000|Overall Study|Withdrawal by Subject|1
1971713|NCT02001623|3533027|FG008|Overall Study|Adverse Event|4
1971714|NCT02001623|3533028|FG009|Overall Study|Adverse Event|6
1971715|NCT02001623|3533029|FG010|Overall Study|Adverse Event|4
1971716|NCT02001623|3533030|FG011|Overall Study|Adverse Event|0
1971717|NCT02001623|3533031|FG012|Overall Study|Adverse Event|3
1971718|NCT02001623|3533032|FG013|Overall Study|Adverse Event|5
1971719|NCT02001623|3533033|FG014|Overall Study|Adverse Event|6
1971720|NCT02001623|3533019|FG000|Overall Study|Other - Miscellaneous|0
1971721|NCT02001623|3533020|FG001|Overall Study|Other - Miscellaneous|0
1971722|NCT02001623|3533021|FG002|Overall Study|Other - Miscellaneous|0
1971723|NCT02001623|3533022|FG003|Overall Study|Other - Miscellaneous|0
1971724|NCT02001623|3533023|FG004|Overall Study|Other - Miscellaneous|0
1971725|NCT02001623|3533024|FG005|Overall Study|Other - Miscellaneous|0
1971726|NCT02001623|3533025|FG006|Overall Study|Other - Miscellaneous|0
1971727|NCT02001623|3533026|FG007|Overall Study|Other - Miscellaneous|0
1971728|NCT02001623|3533027|FG008|Overall Study|Other - Miscellaneous|0
1971729|NCT02001623|3533028|FG009|Overall Study|Other - Miscellaneous|1
1971730|NCT02001623|3533029|FG010|Overall Study|Other - Miscellaneous|0
1971731|NCT02001623|3533030|FG011|Overall Study|Other - Miscellaneous|0
1971732|NCT02001623|3533031|FG012|Overall Study|Other - Miscellaneous|0
1971733|NCT02001623|3533032|FG013|Overall Study|Other - Miscellaneous|1
1971734|NCT02001623|3533033|FG014|Overall Study|Other - Miscellaneous|0
1971735|NCT02001623|3533019|FG000|Overall Study|Withdrawal by Subject|1
1971736|NCT02001623|3533020|FG001|Overall Study|Withdrawal by Subject|0
1971737|NCT02001623|3533021|FG002|Overall Study|Withdrawal by Subject|0
1971738|NCT02001623|3533022|FG003|Overall Study|Withdrawal by Subject|0
1971739|NCT02001623|3533023|FG004|Overall Study|Withdrawal by Subject|0
1971740|NCT02001623|3533024|FG005|Overall Study|Withdrawal by Subject|0
1971741|NCT02001623|3533025|FG006|Overall Study|Withdrawal by Subject|0
1971742|NCT02001623|3533026|FG007|Overall Study|Withdrawal by Subject|0
1971743|NCT02001623|3533027|FG008|Overall Study|Withdrawal by Subject|1
1971744|NCT02001623|3533028|FG009|Overall Study|Withdrawal by Subject|3
1971745|NCT02001623|3533029|FG010|Overall Study|Withdrawal by Subject|2
1971746|NCT02001623|3533030|FG011|Overall Study|Withdrawal by Subject|2
1971747|NCT02001623|3533031|FG012|Overall Study|Withdrawal by Subject|1
1971748|NCT02001623|3533032|FG013|Overall Study|Withdrawal by Subject|5
1971749|NCT02001623|3533033|FG014|Overall Study|Withdrawal by Subject|2
1971750|NCT02001623|3533019|FG000|Overall Study|Lost to Follow-up|0
1971751|NCT02001623|3533020|FG001|Overall Study|Lost to Follow-up|0
1971752|NCT02001623|3533021|FG002|Overall Study|Lost to Follow-up|0
1971753|NCT02001623|3533022|FG003|Overall Study|Lost to Follow-up|0
1971754|NCT02001623|3533023|FG004|Overall Study|Lost to Follow-up|0
1971755|NCT02001623|3533024|FG005|Overall Study|Lost to Follow-up|0
1971756|NCT02001623|3533025|FG006|Overall Study|Lost to Follow-up|0
2212749|NCT01673347|3854074|FG000|Overall Study|failure of allograft|7
2212750|NCT01673373|3854078|FG000|Overall Study|Death|2
2212751|NCT01673386|3854082|FG000|Overall Study|Study terminated by sponsor|16
2212752|NCT01673386|3854083|FG001|Overall Study|Study terminated by sponsor|22
2212753|NCT01673386|3854082|FG000|Overall Study|Adverse Event|5
2212754|NCT01673386|3854083|FG001|Overall Study|Adverse Event|2
1971757|NCT02001623|3533026|FG007|Overall Study|Lost to Follow-up|0
1971758|NCT02001623|3533027|FG008|Overall Study|Lost to Follow-up|0
1971759|NCT02001623|3533028|FG009|Overall Study|Lost to Follow-up|1
1971760|NCT02001623|3533029|FG010|Overall Study|Lost to Follow-up|0
1971761|NCT02001623|3533030|FG011|Overall Study|Lost to Follow-up|0
1971762|NCT02001623|3533031|FG012|Overall Study|Lost to Follow-up|0
1971763|NCT02001623|3533032|FG013|Overall Study|Lost to Follow-up|0
1971764|NCT02001623|3533033|FG014|Overall Study|Lost to Follow-up|0
1971765|NCT02001623|3533019|FG000|Overall Study|Start of New Anti-cancer Treatment|0
1971766|NCT02001623|3533020|FG001|Overall Study|Start of New Anti-cancer Treatment|0
1971767|NCT02001623|3533021|FG002|Overall Study|Start of New Anti-cancer Treatment|0
1971768|NCT02001623|3533022|FG003|Overall Study|Start of New Anti-cancer Treatment|0
1971769|NCT02001623|3533023|FG004|Overall Study|Start of New Anti-cancer Treatment|0
1971770|NCT02001623|3533024|FG005|Overall Study|Start of New Anti-cancer Treatment|0
1971771|NCT02001623|3533025|FG006|Overall Study|Start of New Anti-cancer Treatment|0
1971772|NCT02001623|3533026|FG007|Overall Study|Start of New Anti-cancer Treatment|0
1971773|NCT02001623|3533027|FG008|Overall Study|Start of New Anti-cancer Treatment|0
1971774|NCT02001623|3533028|FG009|Overall Study|Start of New Anti-cancer Treatment|0
1971775|NCT02001623|3533029|FG010|Overall Study|Start of New Anti-cancer Treatment|0
1971776|NCT02001623|3533030|FG011|Overall Study|Start of New Anti-cancer Treatment|1
1971777|NCT02001623|3533031|FG012|Overall Study|Start of New Anti-cancer Treatment|0
1971778|NCT02001623|3533032|FG013|Overall Study|Start of New Anti-cancer Treatment|1
1971779|NCT02001623|3533033|FG014|Overall Study|Start of New Anti-cancer Treatment|0
1971780|NCT02001623|3533019|FG000|Overall Study|Dose Delay Due to Toxicity|0
1971781|NCT02001623|3533020|FG001|Overall Study|Dose Delay Due to Toxicity|0
1971782|NCT02001623|3533021|FG002|Overall Study|Dose Delay Due to Toxicity|0
1971783|NCT02001623|3533022|FG003|Overall Study|Dose Delay Due to Toxicity|0
1971784|NCT02001623|3533023|FG004|Overall Study|Dose Delay Due to Toxicity|0
1971785|NCT02001623|3533024|FG005|Overall Study|Dose Delay Due to Toxicity|0
1971786|NCT02001623|3533025|FG006|Overall Study|Dose Delay Due to Toxicity|0
1971787|NCT02001623|3533026|FG007|Overall Study|Dose Delay Due to Toxicity|0
1971788|NCT02001623|3533027|FG008|Overall Study|Dose Delay Due to Toxicity|0
1971789|NCT02001623|3533028|FG009|Overall Study|Dose Delay Due to Toxicity|0
1971790|NCT02001623|3533029|FG010|Overall Study|Dose Delay Due to Toxicity|0
1971791|NCT02001623|3533030|FG011|Overall Study|Dose Delay Due to Toxicity|0
1971792|NCT02001623|3533031|FG012|Overall Study|Dose Delay Due to Toxicity|0
1971793|NCT02001623|3533032|FG013|Overall Study|Dose Delay Due to Toxicity|1
1971794|NCT02001623|3533033|FG014|Overall Study|Dose Delay Due to Toxicity|0
1971795|NCT01900002|3533082|FG000|Overall Study|Withdrawal by Subject|2
1971796|NCT01900002|3533082|FG000|Overall Study|ineligible for Y-90|4
1971797|NCT01595061|3533086|FG000|Overall Study|Never Treated|3
1971798|NCT01595061|3533086|FG000|Overall Study|Inadequate Pathology|1
2021527|NCT00313300|3589247|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
2021528|NCT00313300|3589248|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
2212755|NCT01673386|3854082|FG000|Overall Study|Progressive disease|4
1971799|NCT04126083|3533103|FG000|Overall Study|Withdrawal by Subject|1
1971800|NCT03444038|3533260|FG000|Overall Study|Adverse Event|12
1971801|NCT03444038|3533260|FG000|Overall Study|Withdrawal by Subject|7
1971802|NCT03444038|3533260|FG000|Overall Study|Lost to Follow-up|1
1971803|NCT03444038|3533260|FG000|Overall Study|Physician Decision|2
1971804|NCT03444038|3533260|FG000|Overall Study|Lack of Efficacy|7
1971805|NCT03265665|3533315|FG000|24-week Data Collection|Withdrawal by Subject|2
1971806|NCT03265665|3533316|FG001|24-week Data Collection|Withdrawal by Subject|2
1971807|NCT03265665|3533315|FG000|24-week Data Collection|Lost to Follow-up|4
1971808|NCT03265665|3533316|FG001|24-week Data Collection|Lost to Follow-up|5
1971809|NCT03265665|3533315|FG000|36-week Data Collection|Lost to Follow-up|6
1971810|NCT03265665|3533316|FG001|36-week Data Collection|Lost to Follow-up|8
1971811|NCT03248531|3533327|FG000|Overall Study|Adverse Event|0
1971812|NCT03248531|3533328|FG001|Overall Study|Adverse Event|0
1971813|NCT03248531|3533329|FG002|Overall Study|Adverse Event|1
1971814|NCT03248531|3533327|FG000|Overall Study|Lost to Follow-up|1
1971815|NCT03248531|3533328|FG001|Overall Study|Lost to Follow-up|0
1971816|NCT03248531|3533329|FG002|Overall Study|Lost to Follow-up|5
1971817|NCT03248531|3533327|FG000|Overall Study|Withdrawal by Subject|3
1971818|NCT03248531|3533328|FG001|Overall Study|Withdrawal by Subject|3
1971819|NCT03248531|3533329|FG002|Overall Study|Withdrawal by Subject|2
1971820|NCT03248531|3533327|FG000|Overall Study|Sponsor Request|0
1971821|NCT03248531|3533328|FG001|Overall Study|Sponsor Request|2
1971822|NCT03248531|3533329|FG002|Overall Study|Sponsor Request|0
1971823|NCT02741700|3533350|FG000|Overall Study|Lost to Follow-up|17
1971824|NCT02741700|3533351|FG001|Overall Study|Lost to Follow-up|8
1971825|NCT02741700|3533350|FG000|Overall Study|Withdrawal by Subject|2
1971826|NCT02741700|3533351|FG001|Overall Study|Withdrawal by Subject|5
1971827|NCT02741700|3533350|FG000|Overall Study|Physician Decision|3
1971828|NCT02741700|3533351|FG001|Overall Study|Physician Decision|0
1971829|NCT02741700|3533350|FG000|Overall Study|Moved out of State|0
1971830|NCT02741700|3533351|FG001|Overall Study|Moved out of State|1
1971831|NCT02741700|3533350|FG000|Overall Study|Death|4
1971832|NCT02741700|3533351|FG001|Overall Study|Death|5
1971833|NCT02725593|3533359|FG000|Blinded Treatment Period|Withdrawal by Subject|4
1971834|NCT02725593|3533360|FG001|Blinded Treatment Period|Withdrawal by Subject|3
1971835|NCT02725593|3533359|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0
1971836|NCT02725593|3533360|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2
1971837|NCT02725593|3533359|FG000|Blinded Treatment Period|Lost to Follow-up|1
1971838|NCT02725593|3533360|FG001|Blinded Treatment Period|Lost to Follow-up|1
1971839|NCT02725593|3533359|FG000|Long Term Extension|Withdrawal by Subject|1
1971840|NCT02725593|3533360|FG001|Long Term Extension|Withdrawal by Subject|3
1971841|NCT02716675|3533369|FG000|Overall Study|Death|2
1971842|NCT02716675|3533370|FG001|Overall Study|Death|3
1971843|NCT02716675|3533371|FG002|Overall Study|Death|0
1971844|NCT02716675|3533369|FG000|Overall Study|Physician Decision|2
1971845|NCT02716675|3533370|FG001|Overall Study|Physician Decision|1
1971846|NCT02716675|3533371|FG002|Overall Study|Physician Decision|1
1971847|NCT02716675|3533369|FG000|Overall Study|Lost to Follow-up|100
1971848|NCT02716675|3533370|FG001|Overall Study|Lost to Follow-up|87
1971849|NCT02716675|3533371|FG002|Overall Study|Lost to Follow-up|99
1971850|NCT02716675|3533369|FG000|Overall Study|Withdrawal by Subject|22
1971851|NCT02716675|3533370|FG001|Overall Study|Withdrawal by Subject|25
1971852|NCT02716675|3533371|FG002|Overall Study|Withdrawal by Subject|20
1971853|NCT02716675|3533369|FG000|Overall Study|Protocol Violation|0
1971854|NCT02716675|3533370|FG001|Overall Study|Protocol Violation|3
1971855|NCT02716675|3533371|FG002|Overall Study|Protocol Violation|1
1971856|NCT02716675|3533369|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36
1971857|NCT02716675|3533370|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31
1971858|NCT02716675|3533371|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42
1971859|NCT02716675|3533369|FG000|Overall Study|Other|38
1971860|NCT02716675|3533370|FG001|Overall Study|Other|47
1971861|NCT02716675|3533371|FG002|Overall Study|Other|48
1971862|NCT02636946|3533386|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0
1971863|NCT02636946|3533387|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1
1971864|NCT02636946|3533386|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1
1971865|NCT02636946|3533387|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0
1971866|NCT02636946|3533386|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0
1971867|NCT02636946|3533387|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1
1971868|NCT02636946|3533386|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0
1971869|NCT02636946|3533387|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1
1971870|NCT02636946|3533386|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0
1971871|NCT02636946|3533387|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2
1971872|NCT02636946|3533386|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2
1971873|NCT02636946|3533387|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1
1971874|NCT02631941|3533403|FG000|Overall Study|Physician Decision|0
1971875|NCT02631941|3533404|FG001|Overall Study|Physician Decision|1
1971876|NCT02631941|3533405|FG002|Overall Study|Physician Decision|0
1971877|NCT02631941|3533406|FG003|Overall Study|Physician Decision|0
1971878|NCT02631941|3533407|FG004|Overall Study|Physician Decision|0
1971879|NCT02631941|3533408|FG005|Overall Study|Physician Decision|0
1971880|NCT02631941|3533409|FG006|Overall Study|Physician Decision|0
1971881|NCT02631941|3533410|FG007|Overall Study|Physician Decision|0
1971882|NCT02631941|3533411|FG008|Overall Study|Physician Decision|0
1971883|NCT02631941|3533412|FG009|Overall Study|Physician Decision|0
1971884|NCT02631941|3533403|FG000|Overall Study|Adverse Event|0
1971885|NCT02631941|3533404|FG001|Overall Study|Adverse Event|1
2212756|NCT01673386|3854083|FG001|Overall Study|Progressive disease|1
2212757|NCT01673386|3854082|FG000|Overall Study|Withdrawal by Subject|0
2309364|NCT02718131|4012960|FG001|Overall Study|Withdrawal by Subject|0
2309365|NCT02718131|4012959|FG000|Overall Study|Adverse Event|1
2309366|NCT02718131|4012960|FG001|Overall Study|Adverse Event|0
2309367|NCT02718131|4012959|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1
2309368|NCT02718131|4012960|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0
2309369|NCT02718326|4012979|FG000|Overall Study|Adverse Event|4
2309370|NCT02718326|4012980|FG001|Overall Study|Adverse Event|9
2309371|NCT02718326|4012981|FG002|Overall Study|Adverse Event|0
2309372|NCT02718326|4012979|FG000|Overall Study|Death|8
2309373|NCT02718326|4012980|FG001|Overall Study|Death|1
2309374|NCT02718326|4012981|FG002|Overall Study|Death|2
2309375|NCT02718326|4012979|FG000|Overall Study|Withdrawal by Subject|4
2309376|NCT02718326|4012980|FG001|Overall Study|Withdrawal by Subject|9
2309377|NCT02718326|4012981|FG002|Overall Study|Withdrawal by Subject|6
2309378|NCT02718326|4012979|FG000|Overall Study|Lost to Follow-up|18
1971886|NCT02631941|3533405|FG002|Overall Study|Adverse Event|0
1971887|NCT02631941|3533406|FG003|Overall Study|Adverse Event|0
1971888|NCT02631941|3533407|FG004|Overall Study|Adverse Event|0
1971889|NCT02631941|3533408|FG005|Overall Study|Adverse Event|0
1971890|NCT02631941|3533409|FG006|Overall Study|Adverse Event|0
1971891|NCT02631941|3533410|FG007|Overall Study|Adverse Event|0
1971892|NCT02631941|3533411|FG008|Overall Study|Adverse Event|0
1971893|NCT02631941|3533412|FG009|Overall Study|Adverse Event|0
1971894|NCT02631941|3533403|FG000|Overall Study|Withdrawal by Subject|0
1971895|NCT02631941|3533404|FG001|Overall Study|Withdrawal by Subject|0
1971896|NCT02631941|3533405|FG002|Overall Study|Withdrawal by Subject|0
2309379|NCT02718326|4012980|FG001|Overall Study|Lost to Follow-up|5
2309380|NCT02718326|4012981|FG002|Overall Study|Lost to Follow-up|14
2309381|NCT02718326|4012979|FG000|Overall Study|Protocol Deviation|1
2309382|NCT02718326|4012980|FG001|Overall Study|Protocol Deviation|0
2309383|NCT02718326|4012981|FG002|Overall Study|Protocol Deviation|0
2309384|NCT02718326|4012979|FG000|Overall Study|Pregnancy|1
2309385|NCT02718326|4012980|FG001|Overall Study|Pregnancy|0
2309386|NCT02718326|4012981|FG002|Overall Study|Pregnancy|0
2309387|NCT02718417|4012994|FG000|Chemotherapy Phase (CP)|Adverse Event|9
2309388|NCT02718417|4012995|FG001|Chemotherapy Phase (CP)|Adverse Event|14
2309389|NCT02718417|4012996|FG002|Chemotherapy Phase (CP)|Adverse Event|13
2309390|NCT02718417|4012994|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5
2309391|NCT02718417|4012995|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4
2309392|NCT02718417|4012996|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1
2309393|NCT02718417|4012994|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3
2309394|NCT02718417|4012995|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2
2309395|NCT02718417|4012996|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1
2309396|NCT02718417|4012994|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4
2309397|NCT02718417|4012995|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2
2309398|NCT02718417|4012996|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1
2309399|NCT02718417|4012994|FG000|Chemotherapy Phase (CP)|Physician's decision|5
2309400|NCT02718417|4012995|FG001|Chemotherapy Phase (CP)|Physician's decision|0
2309401|NCT02718417|4012996|FG002|Chemotherapy Phase (CP)|Physician's decision|4
2309402|NCT02718417|4012994|FG000|Chemotherapy Phase (CP)|Progressive disease|11
2309403|NCT02718417|4012995|FG001|Chemotherapy Phase (CP)|Progressive disease|7
2309404|NCT02718417|4012996|FG002|Chemotherapy Phase (CP)|Progressive disease|10
2309405|NCT02718417|4012994|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13
2309406|NCT02718417|4012995|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8
2309407|NCT02718417|4012996|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15
2309408|NCT02718417|4012994|FG000|Chemotherapy Phase (CP)|Other|2
2309409|NCT02718417|4012995|FG001|Chemotherapy Phase (CP)|Other|0
2309410|NCT02718417|4012996|FG002|Chemotherapy Phase (CP)|Other|1
2309411|NCT02718417|4012994|FG000|Maintenance Phase (MP)|Adverse Event|21
2309412|NCT02718417|4012995|FG001|Maintenance Phase (MP)|Adverse Event|26
2309413|NCT02718417|4012996|FG002|Maintenance Phase (MP)|Adverse Event|0
2309414|NCT02718417|4012994|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1
2309415|NCT02718417|4012995|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1
2309416|NCT02718417|4012996|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0
2309417|NCT02718417|4012994|FG000|Maintenance Phase (MP)|Global deterioration of health status|5
2309418|NCT02718417|4012995|FG001|Maintenance Phase (MP)|Global deterioration of health status|3
2309419|NCT02718417|4012996|FG002|Maintenance Phase (MP)|Global deterioration of health status|0
2309420|NCT02718417|4012994|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0
2309421|NCT02718417|4012995|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1
2309422|NCT02718417|4012996|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0
1971897|NCT02631941|3533406|FG003|Overall Study|Withdrawal by Subject|0
1971898|NCT02631941|3533407|FG004|Overall Study|Withdrawal by Subject|1
1971899|NCT02631941|3533408|FG005|Overall Study|Withdrawal by Subject|0
1971900|NCT02631941|3533409|FG006|Overall Study|Withdrawal by Subject|0
1971901|NCT02631941|3533410|FG007|Overall Study|Withdrawal by Subject|1
1971902|NCT02631941|3533411|FG008|Overall Study|Withdrawal by Subject|0
1971903|NCT02631941|3533412|FG009|Overall Study|Withdrawal by Subject|0
1971904|NCT02631941|3533403|FG000|Overall Study|Lost to Follow-up|0
1971905|NCT02631941|3533404|FG001|Overall Study|Lost to Follow-up|0
1971906|NCT02631941|3533405|FG002|Overall Study|Lost to Follow-up|0
1971907|NCT02631941|3533406|FG003|Overall Study|Lost to Follow-up|0
1971908|NCT02631941|3533407|FG004|Overall Study|Lost to Follow-up|0
1971909|NCT02631941|3533408|FG005|Overall Study|Lost to Follow-up|0
1971910|NCT02631941|3533409|FG006|Overall Study|Lost to Follow-up|0
1971911|NCT02631941|3533410|FG007|Overall Study|Lost to Follow-up|0
1971912|NCT02631941|3533411|FG008|Overall Study|Lost to Follow-up|1
1971913|NCT02631941|3533412|FG009|Overall Study|Lost to Follow-up|0
1971914|NCT02568215|3533425|FG000|Overall Study|Death|1
1971915|NCT02568215|3533426|FG001|Overall Study|Death|2
1971916|NCT02568215|3533427|FG002|Overall Study|Death|0
1971917|NCT02568215|3533425|FG000|Overall Study|Physician Decision|2
1971918|NCT02568215|3533426|FG001|Overall Study|Physician Decision|2
2212758|NCT01673386|3854083|FG001|Overall Study|Withdrawal by Subject|2
2309423|NCT02718417|4012994|FG000|Maintenance Phase (MP)|Physician's decision|6
1971919|NCT02568215|3533427|FG002|Overall Study|Physician Decision|2
1971920|NCT02568215|3533425|FG000|Overall Study|Lost to Follow-up|29
1971921|NCT02568215|3533426|FG001|Overall Study|Lost to Follow-up|32
1971922|NCT02568215|3533427|FG002|Overall Study|Lost to Follow-up|41
1971923|NCT02568215|3533425|FG000|Overall Study|Withdrawal by Subject|21
1971924|NCT02568215|3533426|FG001|Overall Study|Withdrawal by Subject|19
1971925|NCT02568215|3533427|FG002|Overall Study|Withdrawal by Subject|22
1971926|NCT02568215|3533425|FG000|Overall Study|Protocol Violation|1
1971927|NCT02568215|3533426|FG001|Overall Study|Protocol Violation|1
1971928|NCT02568215|3533427|FG002|Overall Study|Protocol Violation|0
1971929|NCT02568215|3533425|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25
1971930|NCT02568215|3533426|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23
1971931|NCT02568215|3533427|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21
1971932|NCT02568215|3533425|FG000|Overall Study|Other|0
1971933|NCT02568215|3533426|FG001|Overall Study|Other|1
1971934|NCT02568215|3533427|FG002|Overall Study|Other|4
1971935|NCT02528643|3533455|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5
1971936|NCT02528643|3533456|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8
1971937|NCT02528643|3533455|FG000|DB (Median Duration up to 14.65 Months)|Death|1
1971938|NCT02528643|3533456|FG001|DB (Median Duration up to 14.65 Months)|Death|6
1971939|NCT02528643|3533455|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0
1971940|NCT02528643|3533456|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1
1971941|NCT02528643|3533455|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44
1971942|NCT02528643|3533456|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82
1971943|NCT02528643|3533455|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2
1971944|NCT02528643|3533456|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8
1971945|NCT02528643|3533455|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3
1971946|NCT02528643|3533456|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5
1971947|NCT02528643|3533455|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0
1971948|NCT02528643|3533456|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1
1971949|NCT02527434|3533467|FG000|Overall Study|Lost to Follow-up|2
1971950|NCT02527434|3533468|FG001|Overall Study|Lost to Follow-up|2
1971951|NCT02527434|3533469|FG002|Overall Study|Lost to Follow-up|0
1971952|NCT02527434|3533467|FG000|Overall Study|Death|19
1971953|NCT02527434|3533468|FG001|Overall Study|Death|6
1971954|NCT02527434|3533469|FG002|Overall Study|Death|17
1971955|NCT02527434|3533467|FG000|Overall Study|Withdrawal by Subject|5
1971956|NCT02527434|3533468|FG001|Overall Study|Withdrawal by Subject|3
1971957|NCT02527434|3533469|FG002|Overall Study|Withdrawal by Subject|3
1971958|NCT02527434|3533467|FG000|Overall Study|Reason Not Specified|1
1971959|NCT02527434|3533468|FG001|Overall Study|Reason Not Specified|0
1971960|NCT02527434|3533469|FG002|Overall Study|Reason Not Specified|0
1971961|NCT02527434|3533467|FG000|Overall Study|Site closure|1
1971962|NCT02527434|3533468|FG001|Overall Study|Site closure|0
1971963|NCT02527434|3533469|FG002|Overall Study|Site closure|0
1971964|NCT02294461|3533515|FG000|Double-blind Period (up to 29.4 Months)|Death|6
1971965|NCT02294461|3533516|FG001|Double-blind Period (up to 29.4 Months)|Death|4
1971966|NCT02294461|3533515|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30
1971967|NCT02294461|3533516|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66
1971968|NCT02294461|3533515|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27
1971969|NCT02294461|3533516|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54
2309424|NCT02718417|4012995|FG001|Maintenance Phase (MP)|Physician's decision|7
2309425|NCT02718417|4012996|FG002|Maintenance Phase (MP)|Physician's decision|0
2309426|NCT02718417|4012994|FG000|Maintenance Phase (MP)|Progressive disease|100
2309427|NCT02718417|4012995|FG001|Maintenance Phase (MP)|Progressive disease|88
2309428|NCT02718417|4012996|FG002|Maintenance Phase (MP)|Progressive disease|0
2309429|NCT02718417|4012994|FG000|Maintenance Phase (MP)|Other|2
2309430|NCT02718417|4012995|FG001|Maintenance Phase (MP)|Other|1
2309431|NCT02718417|4012996|FG002|Maintenance Phase (MP)|Other|0
1971970|NCT02294461|3533515|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0
1971971|NCT02294461|3533516|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2
1971972|NCT02294461|3533515|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1
1971973|NCT02294461|3533516|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0
1971974|NCT02294461|3533515|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38
1971975|NCT02294461|3533516|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51
1971976|NCT02294461|3533515|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16
1971977|NCT02294461|3533516|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15
1971978|NCT02294461|3533515|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19
1971979|NCT02294461|3533516|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9
1971980|NCT02294461|3533515|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16
1971981|NCT02294461|3533516|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12
1971982|NCT02294461|3533515|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18
1971983|NCT02294461|3533516|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9
1971984|NCT02294461|3533515|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2
1971985|NCT02294461|3533516|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0
1971986|NCT02294461|3533515|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3
1971987|NCT02294461|3533516|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1
1971988|NCT02294461|3533515|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15
1971989|NCT02294461|3533516|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9
1971990|NCT02294461|3533515|FG000|Open-label Period (up to 54.3 Months)|Death|6
1971991|NCT02294461|3533516|FG001|Open-label Period (up to 54.3 Months)|Death|5
1971992|NCT02294461|3533515|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6
1971993|NCT02294461|3533516|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6
1971994|NCT02258659|3533534|FG000|Overall Study|Withdrawal by Subject|1
1971995|NCT02237508|3533548|FG000|Overall Study|Withdrawal by Subject|0
1971996|NCT02237508|3533549|FG001|Overall Study|Withdrawal by Subject|2
2177356|NCT01372410|3801373|FG001|Treatment Period 3 (7 Days)|Adverse Event|0
2177357|NCT01372410|3801374|FG002|Treatment Period 3 (7 Days)|Adverse Event|1
2177358|NCT01372410|3801375|FG003|Treatment Period 3 (7 Days)|Adverse Event|0
2177359|NCT01372410|3801376|FG004|Treatment Period 3 (7 Days)|Adverse Event|0
2309432|NCT02718417|4012994|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17
2309433|NCT02718417|4012995|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20
2309434|NCT02718417|4012996|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0
2309435|NCT02718417|4012994|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114
2309436|NCT02718417|4012995|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140
2309437|NCT02718417|4012996|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0
2309438|NCT02718417|4012994|FG000|Observation Phase (OP)|Adverse Event|0
2309439|NCT02718417|4012995|FG001|Observation Phase (OP)|Adverse Event|0
2309440|NCT02718417|4012996|FG002|Observation Phase (OP)|Adverse Event|1
2309441|NCT02718417|4012994|FG000|Observation Phase (OP)|Death leading to discontinuation|0
2309442|NCT02718417|4012995|FG001|Observation Phase (OP)|Death leading to discontinuation|0
2309443|NCT02718417|4012996|FG002|Observation Phase (OP)|Death leading to discontinuation|2
2309444|NCT02718417|4012994|FG000|Observation Phase (OP)|Lost to Follow-up|0
2309445|NCT02718417|4012995|FG001|Observation Phase (OP)|Lost to Follow-up|0
2309446|NCT02718417|4012996|FG002|Observation Phase (OP)|Lost to Follow-up|1
2309447|NCT02718417|4012994|FG000|Observation Phase (OP)|Physician Decision|0
2309448|NCT02718417|4012995|FG001|Observation Phase (OP)|Physician Decision|0
2309449|NCT02718417|4012996|FG002|Observation Phase (OP)|Physician Decision|9
2309450|NCT02718417|4012994|FG000|Observation Phase (OP)|Progressive disease|0
2309451|NCT02718417|4012995|FG001|Observation Phase (OP)|Progressive disease|0
2309452|NCT02718417|4012996|FG002|Observation Phase (OP)|Progressive disease|92
2309453|NCT02718417|4012994|FG000|Observation Phase (OP)|Study terminated by sponsor|0
2309454|NCT02718417|4012995|FG001|Observation Phase (OP)|Study terminated by sponsor|0
2309455|NCT02718417|4012996|FG002|Observation Phase (OP)|Study terminated by sponsor|135
2309456|NCT02718417|4012994|FG000|Observation Phase (OP)|Withdrawal by Subject|0
2309457|NCT02718417|4012995|FG001|Observation Phase (OP)|Withdrawal by Subject|0
2309458|NCT02718417|4012996|FG002|Observation Phase (OP)|Withdrawal by Subject|34
2309459|NCT02718417|4012994|FG000|Observation Phase (OP)|Global deterioration of health status|0
2309460|NCT02718417|4012995|FG001|Observation Phase (OP)|Global deterioration of health status|0
2309461|NCT02718417|4012996|FG002|Observation Phase (OP)|Global deterioration of health status|1
2309462|NCT02718417|4012994|FG000|Observation Phase (OP)|Other|0
2309463|NCT02718417|4012995|FG001|Observation Phase (OP)|Other|0
2309464|NCT02718417|4012996|FG002|Observation Phase (OP)|Other|7
2309465|NCT02718417|4012994|FG000|Follow-up Phase|Adverse Event|3
2309466|NCT02718417|4012995|FG001|Follow-up Phase|Adverse Event|1
2309467|NCT02718417|4012996|FG002|Follow-up Phase|Adverse Event|1
2309468|NCT02718417|4012994|FG000|Follow-up Phase|Other|4
2309469|NCT02718417|4012995|FG001|Follow-up Phase|Other|6
2309470|NCT02718417|4012996|FG002|Follow-up Phase|Other|4
2309471|NCT02718417|4012994|FG000|Follow-up Phase|Withdrawal by Subject|19
2309472|NCT02718417|4012995|FG001|Follow-up Phase|Withdrawal by Subject|17
2309473|NCT02718417|4012996|FG002|Follow-up Phase|Withdrawal by Subject|5
2309474|NCT02718417|4012994|FG000|Follow-up Phase|Study terminated by sponsor|100
2309475|NCT02718417|4012995|FG001|Follow-up Phase|Study terminated by sponsor|138
1971997|NCT02237508|3533550|FG002|Overall Study|Withdrawal by Subject|0
1971998|NCT02237508|3533551|FG003|Overall Study|Withdrawal by Subject|1
1971999|NCT02237508|3533552|FG004|Overall Study|Withdrawal by Subject|0
1972000|NCT02237508|3533553|FG005|Overall Study|Withdrawal by Subject|1
1972001|NCT02237508|3533554|FG006|Overall Study|Withdrawal by Subject|1
1972002|NCT02237508|3533555|FG007|Overall Study|Withdrawal by Subject|0
1972003|NCT02237508|3533556|FG008|Overall Study|Withdrawal by Subject|1
1972004|NCT02237508|3533557|FG009|Overall Study|Withdrawal by Subject|0
1972005|NCT02237508|3533548|FG000|Overall Study|Physician Decision|0
1972006|NCT02237508|3533549|FG001|Overall Study|Physician Decision|1
1972007|NCT02237508|3533550|FG002|Overall Study|Physician Decision|0
1972008|NCT02237508|3533551|FG003|Overall Study|Physician Decision|0
1972009|NCT02237508|3533552|FG004|Overall Study|Physician Decision|0
1972010|NCT02237508|3533553|FG005|Overall Study|Physician Decision|0
1972011|NCT02237508|3533554|FG006|Overall Study|Physician Decision|0
1972012|NCT02237508|3533555|FG007|Overall Study|Physician Decision|0
1972013|NCT02237508|3533556|FG008|Overall Study|Physician Decision|0
1972014|NCT02237508|3533557|FG009|Overall Study|Physician Decision|0
1972015|NCT02237508|3533548|FG000|Overall Study|Protocol Violation|0
1972016|NCT02237508|3533549|FG001|Overall Study|Protocol Violation|0
1972017|NCT02237508|3533550|FG002|Overall Study|Protocol Violation|1
1972018|NCT02237508|3533551|FG003|Overall Study|Protocol Violation|0
1972019|NCT02237508|3533552|FG004|Overall Study|Protocol Violation|0
1972020|NCT02237508|3533553|FG005|Overall Study|Protocol Violation|0
1972021|NCT02237508|3533554|FG006|Overall Study|Protocol Violation|0
1972022|NCT02237508|3533555|FG007|Overall Study|Protocol Violation|0
1972023|NCT02237508|3533556|FG008|Overall Study|Protocol Violation|0
1972024|NCT02237508|3533557|FG009|Overall Study|Protocol Violation|0
1972025|NCT02197234|3533575|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
1972026|NCT02197234|3533575|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
1972027|NCT02197234|3533575|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
1972028|NCT02197234|3533575|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
1972029|NCT02197234|3533575|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
1972030|NCT02197234|3533575|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6
1972031|NCT02197234|3533575|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
1972032|NCT02163733|3533584|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0
1972033|NCT02163733|3533585|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0
1972034|NCT02163733|3533586|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5
1972035|NCT02163733|3533584|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
1972036|NCT02163733|3533585|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
1972037|NCT02163733|3533586|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
1972038|NCT02157883|3533593|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
1972039|NCT02157883|3533593|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
1972040|NCT02157883|3533593|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
1972041|NCT02157883|3533593|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
1972042|NCT02157883|3533593|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3
1972043|NCT01877655|3533611|FG000|Overall Study|Death|57
1972044|NCT01877655|3533612|FG001|Overall Study|Death|52
1972045|NCT01877655|3533611|FG000|Overall Study|Withdrawal by Subject|18
1972046|NCT01877655|3533612|FG001|Overall Study|Withdrawal by Subject|26
1972047|NCT01877655|3533611|FG000|Overall Study|Physician Decision|11
1972048|NCT01877655|3533612|FG001|Overall Study|Physician Decision|10
1972049|NCT01877655|3533611|FG000|Overall Study|Miscellaneous|4
1972050|NCT01877655|3533612|FG001|Overall Study|Miscellaneous|4
1972051|NCT01877655|3533611|FG000|Overall Study|Randomized but Never Received Drug|8
1972052|NCT01877655|3533612|FG001|Overall Study|Randomized but Never Received Drug|5
1972053|NCT01802632|3533624|FG000|Overall Study|Death|28
1972054|NCT01802632|3533625|FG001|Overall Study|Death|1
1972055|NCT01802632|3533626|FG002|Overall Study|Death|38
1972056|NCT01802632|3533627|FG003|Overall Study|Death|0
1972057|NCT01802632|3533628|FG004|Overall Study|Death|2
1972058|NCT01802632|3533629|FG005|Overall Study|Death|0
1972059|NCT01802632|3533624|FG000|Overall Study|Withdrawal by Subject|4
1972060|NCT01802632|3533625|FG001|Overall Study|Withdrawal by Subject|2
1972061|NCT01802632|3533626|FG002|Overall Study|Withdrawal by Subject|7
1972062|NCT01802632|3533627|FG003|Overall Study|Withdrawal by Subject|3
1972063|NCT01802632|3533628|FG004|Overall Study|Withdrawal by Subject|0
1972064|NCT01802632|3533629|FG005|Overall Study|Withdrawal by Subject|1
1972065|NCT01802632|3533624|FG000|Overall Study|Objective Disease Progression|1
1972066|NCT01802632|3533625|FG001|Overall Study|Objective Disease Progression|12
1972067|NCT01802632|3533626|FG002|Overall Study|Objective Disease Progression|104
1972068|NCT01802632|3533627|FG003|Overall Study|Objective Disease Progression|6
1972069|NCT01802632|3533628|FG004|Overall Study|Objective Disease Progression|4
1972070|NCT01802632|3533629|FG005|Overall Study|Objective Disease Progression|4
1972071|NCT01802632|3533624|FG000|Overall Study|Ongoing Study at Data Cut-off|168
1972072|NCT01802632|3533625|FG001|Overall Study|Ongoing Study at Data Cut-off|16
1972073|NCT01802632|3533626|FG002|Overall Study|Ongoing Study at Data Cut-off|115
1972074|NCT01802632|3533627|FG003|Overall Study|Ongoing Study at Data Cut-off|50
1972075|NCT01802632|3533628|FG004|Overall Study|Ongoing Study at Data Cut-off|6
1972076|NCT01802632|3533629|FG005|Overall Study|Ongoing Study at Data Cut-off|22
1972077|NCT01802632|3533624|FG000|Overall Study|Other (not specified)|0
1972078|NCT01802632|3533625|FG001|Overall Study|Other (not specified)|0
1972079|NCT01802632|3533626|FG002|Overall Study|Other (not specified)|7
1972080|NCT01802632|3533627|FG003|Overall Study|Other (not specified)|1
1972081|NCT01802632|3533628|FG004|Overall Study|Other (not specified)|0
1972082|NCT01802632|3533629|FG005|Overall Study|Other (not specified)|1
1972083|NCT01706705|3533641|FG000|Overall Study|Death|1
1972084|NCT01706705|3533641|FG000|Overall Study|Lack of Efficacy|13
1972085|NCT01706705|3533641|FG000|Overall Study|Non-clinical|6
1972086|NCT01625286|3533653|FG000|Overall Study|Adverse Event|0
1972087|NCT01625286|3533654|FG001|Overall Study|Adverse Event|0
1972088|NCT01625286|3533655|FG002|Overall Study|Adverse Event|0
1972089|NCT01625286|3533656|FG003|Overall Study|Adverse Event|0
1972090|NCT01625286|3533657|FG004|Overall Study|Adverse Event|1
1972091|NCT01625286|3533658|FG005|Overall Study|Adverse Event|2
1972092|NCT01625286|3533659|FG006|Overall Study|Adverse Event|1
1972093|NCT01625286|3533653|FG000|Overall Study|Death|0
1972094|NCT01625286|3533654|FG001|Overall Study|Death|0
1972095|NCT01625286|3533655|FG002|Overall Study|Death|1
1972096|NCT01625286|3533656|FG003|Overall Study|Death|1
1972097|NCT01625286|3533657|FG004|Overall Study|Death|0
1972098|NCT01625286|3533658|FG005|Overall Study|Death|11
1972099|NCT01625286|3533659|FG006|Overall Study|Death|16
1972100|NCT01625286|3533653|FG000|Overall Study|Withdrawal by Subject|0
1972101|NCT01625286|3533654|FG001|Overall Study|Withdrawal by Subject|1
1972102|NCT01625286|3533655|FG002|Overall Study|Withdrawal by Subject|0
1972103|NCT01625286|3533656|FG003|Overall Study|Withdrawal by Subject|1
1972104|NCT01625286|3533657|FG004|Overall Study|Withdrawal by Subject|0
1972105|NCT01625286|3533658|FG005|Overall Study|Withdrawal by Subject|0
1972106|NCT01625286|3533659|FG006|Overall Study|Withdrawal by Subject|1
1972107|NCT01625286|3533653|FG000|Overall Study|Any reason not specifically recorded|0
1972108|NCT01625286|3533654|FG001|Overall Study|Any reason not specifically recorded|0
1972109|NCT01625286|3533655|FG002|Overall Study|Any reason not specifically recorded|0
1972110|NCT01625286|3533656|FG003|Overall Study|Any reason not specifically recorded|0
1972111|NCT01625286|3533657|FG004|Overall Study|Any reason not specifically recorded|0
1972112|NCT01625286|3533658|FG005|Overall Study|Any reason not specifically recorded|1
1972113|NCT01625286|3533659|FG006|Overall Study|Any reason not specifically recorded|0
1972114|NCT01625286|3533653|FG000|Overall Study|Progressive disease|6
1972115|NCT01625286|3533654|FG001|Overall Study|Progressive disease|3
1972116|NCT01625286|3533655|FG002|Overall Study|Progressive disease|4
1972117|NCT01625286|3533656|FG003|Overall Study|Progressive disease|5
1972118|NCT01625286|3533657|FG004|Overall Study|Progressive disease|5
1972119|NCT01625286|3533658|FG005|Overall Study|Progressive disease|0
1972120|NCT01625286|3533659|FG006|Overall Study|Progressive disease|0
1972121|NCT01625286|3533653|FG000|Overall Study|Lost to Follow-up|0
1972122|NCT01625286|3533654|FG001|Overall Study|Lost to Follow-up|0
1972123|NCT01625286|3533655|FG002|Overall Study|Lost to Follow-up|0
1972124|NCT01625286|3533656|FG003|Overall Study|Lost to Follow-up|0
1972125|NCT01625286|3533657|FG004|Overall Study|Lost to Follow-up|0
1972126|NCT01625286|3533658|FG005|Overall Study|Lost to Follow-up|0
1972127|NCT01625286|3533659|FG006|Overall Study|Lost to Follow-up|1
1972128|NCT01625286|3533653|FG000|Overall Study|Ongoing off-treatment at DCO|0
1972129|NCT01625286|3533654|FG001|Overall Study|Ongoing off-treatment at DCO|0
1972130|NCT01625286|3533655|FG002|Overall Study|Ongoing off-treatment at DCO|0
1972131|NCT01625286|3533656|FG003|Overall Study|Ongoing off-treatment at DCO|0
1972132|NCT01625286|3533657|FG004|Overall Study|Ongoing off-treatment at DCO|0
1972133|NCT01625286|3533658|FG005|Overall Study|Ongoing off-treatment at DCO|32
1972134|NCT01625286|3533659|FG006|Overall Study|Ongoing off-treatment at DCO|31
1972135|NCT01625286|3533653|FG000|Overall Study|Ongoing on-treatment at DCO|6
1972136|NCT01625286|3533654|FG001|Overall Study|Ongoing on-treatment at DCO|4
1972137|NCT01625286|3533655|FG002|Overall Study|Ongoing on-treatment at DCO|0
1972138|NCT01625286|3533656|FG003|Overall Study|Ongoing on-treatment at DCO|0
1972139|NCT01625286|3533657|FG004|Overall Study|Ongoing on-treatment at DCO|0
1972140|NCT01625286|3533658|FG005|Overall Study|Ongoing on-treatment at DCO|8
1972141|NCT01625286|3533659|FG006|Overall Study|Ongoing on-treatment at DCO|6
1972142|NCT01609842|3533679|FG000|Concurrent Intervention Control|pharmacy data not available|2
1972143|NCT01609842|3533680|FG001|Concurrent Intervention Control|pharmacy data not available|0
1972144|NCT00769379|3533714|FG000|Overall Study|No follow up data mapped to Other.|3
1972145|NCT00769379|3533715|FG001|Overall Study|No follow up data mapped to Other.|13
1972146|NCT00288080|3533723|FG000|Overall Study|Withdrawal by Subject|1
1972147|NCT00288080|3533724|FG001|Overall Study|Withdrawal by Subject|3
1972148|NCT00288080|3533723|FG000|Overall Study|Protocol Violation|25
1972149|NCT00288080|3533724|FG001|Overall Study|Protocol Violation|20
1972150|NCT00099437|3533732|FG000|Overall Study|Lost to Follow-up|30
1972151|NCT00099437|3533733|FG001|Overall Study|Lost to Follow-up|33
1972152|NCT00099437|3533732|FG000|Overall Study|Death|293
1972153|NCT00099437|3533733|FG001|Overall Study|Death|261
1972154|NCT00099437|3533732|FG000|Overall Study|Withdrawal by Subject|6
1972155|NCT00099437|3533733|FG001|Overall Study|Withdrawal by Subject|10
1972156|NCT00099437|3533732|FG000|Overall Study|Ongoing in FU but not on treatment|37
1972157|NCT00099437|3533733|FG001|Overall Study|Ongoing in FU but not on treatment|45
1972158|NCT00003479|3533739|FG000|Overall Study|Not evaluable|3
1972159|NCT00003458|3533743|FG000|Overall Study|Not evaluable|4
1972160|NCT04160195|3533750|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1
1972161|NCT04160195|3533751|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0
1972162|NCT04152447|3533761|FG000|Overall Study|Lost to Follow-up|1
1972163|NCT04152447|3533762|FG001|Overall Study|Lost to Follow-up|0
1972164|NCT04152447|3533761|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1
1972165|NCT04152447|3533762|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1
1972166|NCT04152447|3533761|FG000|Overall Study|Withdrawal by Subject|0
1972167|NCT04152447|3533762|FG001|Overall Study|Withdrawal by Subject|1
1972168|NCT04152447|3533761|FG000|Overall Study|Found ineligible after enrolling|1
1972169|NCT04152447|3533762|FG001|Overall Study|Found ineligible after enrolling|1
1972170|NCT04152447|3533761|FG000|Overall Study|Did not receive VR headset in time.|0
1972171|NCT04152447|3533762|FG001|Overall Study|Did not receive VR headset in time.|2
1972172|NCT03794544|3533782|FG000|Overall Study|Withdrawal by Subject|1
1972173|NCT03794544|3533783|FG001|Overall Study|Withdrawal by Subject|1
1972174|NCT03794544|3533784|FG002|Overall Study|Withdrawal by Subject|0
1972175|NCT03794544|3533785|FG003|Overall Study|Withdrawal by Subject|0
1972176|NCT03794544|3533782|FG000|Overall Study|Death|0
1972177|NCT03794544|3533783|FG001|Overall Study|Death|0
1972178|NCT03794544|3533784|FG002|Overall Study|Death|0
1972179|NCT03794544|3533785|FG003|Overall Study|Death|1
1972180|NCT03794544|3533782|FG000|Overall Study|Lost to Follow-up|0
1972181|NCT03794544|3533783|FG001|Overall Study|Lost to Follow-up|1
1972182|NCT03794544|3533784|FG002|Overall Study|Lost to Follow-up|1
1972183|NCT03794544|3533785|FG003|Overall Study|Lost to Follow-up|0
1972184|NCT03794544|3533782|FG000|Overall Study|Other|0
1972185|NCT03794544|3533783|FG001|Overall Study|Other|1
1972186|NCT03794544|3533784|FG002|Overall Study|Other|0
1972187|NCT03794544|3533785|FG003|Overall Study|Other|0
1972188|NCT03732807|3533802|FG000|Treatment Period (up to Week 24)|Adverse Event|3
1972189|NCT03732807|3533803|FG001|Treatment Period (up to Week 24)|Adverse Event|0
1972190|NCT03732807|3533804|FG002|Treatment Period (up to Week 24)|Adverse Event|2
1972191|NCT03732807|3533805|FG003|Treatment Period (up to Week 24)|Adverse Event|4
1972192|NCT03732807|3533806|FG004|Treatment Period (up to Week 24)|Adverse Event|2
1972193|NCT03732807|3533807|FG005|Treatment Period (up to Week 24)|Adverse Event|0
1972194|NCT03732807|3533808|FG006|Treatment Period (up to Week 24)|Adverse Event|1
1972195|NCT03732807|3533802|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1
1972196|NCT03732807|3533803|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0
1972197|NCT03732807|3533804|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1
1972198|NCT03732807|3533805|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2
1972199|NCT03732807|3533806|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1
1972200|NCT03732807|3533807|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0
1972201|NCT03732807|3533808|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0
1972202|NCT03732807|3533802|FG000|Treatment Period (up to Week 24)|Physician Decision|0
1972203|NCT03732807|3533803|FG001|Treatment Period (up to Week 24)|Physician Decision|1
1972204|NCT03732807|3533804|FG002|Treatment Period (up to Week 24)|Physician Decision|2
1972205|NCT03732807|3533805|FG003|Treatment Period (up to Week 24)|Physician Decision|5
1972206|NCT03732807|3533806|FG004|Treatment Period (up to Week 24)|Physician Decision|0
1972207|NCT03732807|3533807|FG005|Treatment Period (up to Week 24)|Physician Decision|0
1972208|NCT03732807|3533808|FG006|Treatment Period (up to Week 24)|Physician Decision|1
2309476|NCT02718417|4012996|FG002|Follow-up Phase|Study terminated by sponsor|6
2309477|NCT02718417|4012994|FG000|Follow-up Phase|Lost to Follow-up|2
2309478|NCT02718417|4012995|FG001|Follow-up Phase|Lost to Follow-up|3
2309479|NCT02718417|4012996|FG002|Follow-up Phase|Lost to Follow-up|0
1972209|NCT03732807|3533802|FG000|Treatment Period (up to Week 24)|Pregnancy|1
1972210|NCT03732807|3533803|FG001|Treatment Period (up to Week 24)|Pregnancy|0
1972211|NCT03732807|3533804|FG002|Treatment Period (up to Week 24)|Pregnancy|0
1972212|NCT03732807|3533805|FG003|Treatment Period (up to Week 24)|Pregnancy|0
1972213|NCT03732807|3533806|FG004|Treatment Period (up to Week 24)|Pregnancy|1
1972214|NCT03732807|3533807|FG005|Treatment Period (up to Week 24)|Pregnancy|0
1972215|NCT03732807|3533808|FG006|Treatment Period (up to Week 24)|Pregnancy|1
1972216|NCT03732807|3533802|FG000|Treatment Period (up to Week 24)|Protocol Violation|1
1972217|NCT03732807|3533803|FG001|Treatment Period (up to Week 24)|Protocol Violation|1
1972218|NCT03732807|3533804|FG002|Treatment Period (up to Week 24)|Protocol Violation|0
1972219|NCT03732807|3533805|FG003|Treatment Period (up to Week 24)|Protocol Violation|0
1972220|NCT03732807|3533806|FG004|Treatment Period (up to Week 24)|Protocol Violation|0
1972221|NCT03732807|3533807|FG005|Treatment Period (up to Week 24)|Protocol Violation|0
1972222|NCT03732807|3533808|FG006|Treatment Period (up to Week 24)|Protocol Violation|0
1972223|NCT03732807|3533802|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4
1972224|NCT03732807|3533803|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4
2102137|NCT00837577|3693868|FG000|Open-label Period|Laboratory Adverse Event|0
1972225|NCT03732807|3533804|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4
1972226|NCT03732807|3533805|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4
1972227|NCT03732807|3533806|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1
1972228|NCT03732807|3533807|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1
1972229|NCT03732807|3533808|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2
2212759|NCT01673490|3854089|FG000|Overall Study|Lost to Follow-up|1
1972230|NCT03732807|3533802|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0
1972231|NCT03732807|3533803|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0
1972232|NCT03732807|3533804|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0
1972233|NCT03732807|3533805|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0
1972234|NCT03732807|3533806|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0
1972235|NCT03732807|3533807|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1
1972236|NCT03732807|3533808|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0
1972237|NCT03732807|3533802|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0
1972238|NCT03732807|3533803|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2
1972239|NCT03732807|3533804|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2
1972240|NCT03732807|3533805|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1
1972241|NCT03732807|3533806|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0
1972242|NCT03732807|3533807|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0
1972243|NCT03732807|3533808|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2
1972244|NCT03732807|3533802|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2
1972245|NCT03732807|3533803|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1
1972246|NCT03732807|3533804|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0
1972247|NCT03732807|3533805|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3
1972248|NCT03732807|3533806|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3
1972249|NCT03732807|3533807|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0
1972250|NCT03732807|3533808|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1
1972251|NCT03732807|3533802|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
1972252|NCT03732807|3533803|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
1972253|NCT03732807|3533804|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2
1972254|NCT03732807|3533805|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1
1972255|NCT03732807|3533806|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1
1972256|NCT03732807|3533807|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2
1972257|NCT03732807|3533808|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
1972258|NCT03732807|3533802|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
1972259|NCT03732807|3533803|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1
1972260|NCT03732807|3533804|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
1972261|NCT03732807|3533805|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
1972262|NCT03732807|3533806|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
1972263|NCT03732807|3533807|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
2309480|NCT02718417|4012994|FG000|Follow-up Phase|Death leading to discontinuation|7
2309481|NCT02718417|4012995|FG001|Follow-up Phase|Death leading to discontinuation|7
2309482|NCT02718417|4012996|FG002|Follow-up Phase|Death leading to discontinuation|3
2309483|NCT02718417|4012994|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20
2309484|NCT02718417|4012995|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17
2309485|NCT02718417|4012996|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11
2309486|NCT02718417|4012994|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
2309487|NCT02718417|4012995|FG001|Long-term Follow-up Phase|Lost to Follow-up|4
2309488|NCT02718417|4012996|FG002|Long-term Follow-up Phase|Lost to Follow-up|3
2309489|NCT02718417|4012994|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105
2309490|NCT02718417|4012995|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80
2309491|NCT02718417|4012996|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112
2309492|NCT02718417|4012994|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6
2309493|NCT02718417|4012995|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9
2309494|NCT02718417|4012996|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9
2309495|NCT02718417|4012994|FG000|Long-term Follow-up Phase|Other|0
2309496|NCT02718417|4012995|FG001|Long-term Follow-up Phase|Other|2
2309497|NCT02718417|4012996|FG002|Long-term Follow-up Phase|Other|0
2309498|NCT02718625|4013013|FG000|Overall Study|Adverse Event|0
2309499|NCT02718625|4013014|FG001|Overall Study|Adverse Event|1
2309500|NCT02718625|4013013|FG000|Overall Study|Termination of Study by Sponsor|0
2309501|NCT02718625|4013014|FG001|Overall Study|Termination of Study by Sponsor|1
2309502|NCT02718898|4013022|FG000|Blinded Treatment Period|Adverse Event|5
2309503|NCT02718898|4013023|FG001|Blinded Treatment Period|Adverse Event|1
2309504|NCT02718898|4013024|FG002|Blinded Treatment Period|Adverse Event|0
2309505|NCT02718898|4013025|FG003|Blinded Treatment Period|Adverse Event|0
2309506|NCT02718898|4013026|FG004|Blinded Treatment Period|Adverse Event|0
2309507|NCT02718898|4013027|FG005|Blinded Treatment Period|Adverse Event|0
2309508|NCT02718898|4013028|FG006|Blinded Treatment Period|Adverse Event|0
2309509|NCT02718898|4013022|FG000|Blinded Treatment Period|Physician Decision|1
2309510|NCT02718898|4013023|FG001|Blinded Treatment Period|Physician Decision|0
2309511|NCT02718898|4013024|FG002|Blinded Treatment Period|Physician Decision|0
2309512|NCT02718898|4013025|FG003|Blinded Treatment Period|Physician Decision|0
2309513|NCT02718898|4013026|FG004|Blinded Treatment Period|Physician Decision|0
2309514|NCT02718898|4013027|FG005|Blinded Treatment Period|Physician Decision|0
2309515|NCT02718898|4013028|FG006|Blinded Treatment Period|Physician Decision|0
2309516|NCT02718898|4013022|FG000|Blinded Treatment Period|Lack of Efficacy|1
2025930|NCT00347919|3594669|FG000|Overall Study|Lost to Follow-up|11
1972264|NCT03732807|3533808|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
1972265|NCT03732807|3533802|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0
1972266|NCT03732807|3533803|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1
1972267|NCT03732807|3533804|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0
1972268|NCT03732807|3533805|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1
1972269|NCT03732807|3533806|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1
1972270|NCT03732807|3533807|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0
1972271|NCT03732807|3533808|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0
1972272|NCT03732807|3533802|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3
1972273|NCT03732807|3533803|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2
1972274|NCT03732807|3533804|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
1972275|NCT03732807|3533805|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
1972276|NCT03732807|3533806|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0
1972277|NCT03732807|3533807|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
1972278|NCT03732807|3533808|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
1972279|NCT03732807|3533802|FG000|Treatment Extension (Week 25 up to 48)|Other|1
1972280|NCT03732807|3533803|FG001|Treatment Extension (Week 25 up to 48)|Other|4
1972281|NCT03732807|3533804|FG002|Treatment Extension (Week 25 up to 48)|Other|0
1972282|NCT03732807|3533805|FG003|Treatment Extension (Week 25 up to 48)|Other|2
2309517|NCT02718898|4013023|FG001|Blinded Treatment Period|Lack of Efficacy|0
2309518|NCT02718898|4013024|FG002|Blinded Treatment Period|Lack of Efficacy|0
2309519|NCT02718898|4013025|FG003|Blinded Treatment Period|Lack of Efficacy|0
2309520|NCT02718898|4013026|FG004|Blinded Treatment Period|Lack of Efficacy|0
2309521|NCT02718898|4013027|FG005|Blinded Treatment Period|Lack of Efficacy|0
2309522|NCT02718898|4013028|FG006|Blinded Treatment Period|Lack of Efficacy|0
2309523|NCT02718898|4013022|FG000|Blinded Treatment Period|Lost to Follow-up|2
2309524|NCT02718898|4013023|FG001|Blinded Treatment Period|Lost to Follow-up|0
2309525|NCT02718898|4013024|FG002|Blinded Treatment Period|Lost to Follow-up|0
2309526|NCT02718898|4013025|FG003|Blinded Treatment Period|Lost to Follow-up|0
2309527|NCT02718898|4013026|FG004|Blinded Treatment Period|Lost to Follow-up|0
2309528|NCT02718898|4013027|FG005|Blinded Treatment Period|Lost to Follow-up|0
2309529|NCT02718898|4013028|FG006|Blinded Treatment Period|Lost to Follow-up|0
2309530|NCT02718898|4013022|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0
2309531|NCT02718898|4013023|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0
2309532|NCT02718898|4013024|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1
2309533|NCT02718898|4013025|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1
2309534|NCT02718898|4013026|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0
2309535|NCT02718898|4013027|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0
2309536|NCT02718898|4013028|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0
2309537|NCT02718898|4013022|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2309538|NCT02718898|4013023|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2309539|NCT02718898|4013024|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2309540|NCT02718898|4013025|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
2309541|NCT02718898|4013026|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2309542|NCT02718898|4013027|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2309543|NCT02718898|4013028|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2309544|NCT02718898|4013022|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2309545|NCT02718898|4013023|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2309546|NCT02718898|4013024|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
2309547|NCT02718898|4013025|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
2309548|NCT02718898|4013026|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2309549|NCT02718898|4013027|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2309550|NCT02718898|4013028|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2309551|NCT02718898|4013022|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2309552|NCT02718898|4013023|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2309553|NCT02718898|4013024|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
2309554|NCT02718898|4013025|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
2309555|NCT02718898|4013026|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2309556|NCT02718898|4013027|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2309557|NCT02718898|4013028|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2309558|NCT02718898|4013022|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2309559|NCT02718898|4013023|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2309560|NCT02718898|4013024|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2309561|NCT02718898|4013025|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
2309562|NCT02718898|4013026|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2309563|NCT02718898|4013027|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2309564|NCT02718898|4013028|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2309565|NCT02718898|4013022|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2309566|NCT02718898|4013023|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
1972283|NCT03732807|3533806|FG004|Treatment Extension (Week 25 up to 48)|Other|0
1972284|NCT03732807|3533807|FG005|Treatment Extension (Week 25 up to 48)|Other|0
1972285|NCT03732807|3533808|FG006|Treatment Extension (Week 25 up to 48)|Other|0
2021529|NCT00313300|3589249|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
2021530|NCT00313300|3589245|FG000|Follow-Up(30days)-Randomized Phase B|Death|1
2021531|NCT00313300|3589246|FG001|Follow-Up(30days)-Randomized Phase B|Death|0
2021532|NCT00313300|3589247|FG002|Follow-Up(30days)-Randomized Phase B|Death|0
2021533|NCT00313300|3589248|FG003|Follow-Up(30days)-Randomized Phase B|Death|0
2021534|NCT00313300|3589249|FG004|Follow-Up(30days)-Randomized Phase B|Death|0
2021535|NCT00313300|3589245|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
2021536|NCT00313300|3589246|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
2021537|NCT00313300|3589247|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
2021538|NCT00313300|3589248|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
2021539|NCT00313300|3589249|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
2021540|NCT00313300|3589245|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
2021541|NCT00313300|3589246|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
2021542|NCT00313300|3589247|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
2021543|NCT00313300|3589248|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
2021544|NCT00313300|3589249|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
2021545|NCT00313313|3589270|FG000|Overall Study|Lack of Efficacy|14
2021546|NCT00313313|3589271|FG001|Overall Study|Lack of Efficacy|9
2021547|NCT00313313|3589272|FG002|Overall Study|Lack of Efficacy|20
2021548|NCT00313313|3589270|FG000|Overall Study|Withdrawal of consent by subject|18
2021549|NCT00313313|3589271|FG001|Overall Study|Withdrawal of consent by subject|17
2021550|NCT00313313|3589272|FG002|Overall Study|Withdrawal of consent by subject|31
2021551|NCT00313313|3589270|FG000|Overall Study|Lost to Follow-up|10
2021552|NCT00313313|3589271|FG001|Overall Study|Lost to Follow-up|7
2021553|NCT00313313|3589272|FG002|Overall Study|Lost to Follow-up|9
2021554|NCT00313313|3589270|FG000|Overall Study|Adverse Event|15
2021555|NCT00313313|3589271|FG001|Overall Study|Adverse Event|16
2021556|NCT00313313|3589272|FG002|Overall Study|Adverse Event|12
2021557|NCT00313313|3589270|FG000|Overall Study|Physician Decision|2
2309567|NCT02718898|4013024|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2309568|NCT02718898|4013025|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
2309569|NCT02718898|4013026|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2309570|NCT02718898|4013027|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2309571|NCT02718898|4013028|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2309572|NCT02718898|4013022|FG000|Post Treatment Follow-up Period|Adverse Event|0
2309573|NCT02718898|4013023|FG001|Post Treatment Follow-up Period|Adverse Event|0
2309574|NCT02718898|4013024|FG002|Post Treatment Follow-up Period|Adverse Event|0
2309575|NCT02718898|4013025|FG003|Post Treatment Follow-up Period|Adverse Event|0
2309576|NCT02718898|4013026|FG004|Post Treatment Follow-up Period|Adverse Event|0
2309577|NCT02718898|4013027|FG005|Post Treatment Follow-up Period|Adverse Event|1
2309578|NCT02718898|4013028|FG006|Post Treatment Follow-up Period|Adverse Event|1
2309579|NCT02718898|4013022|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0
2309580|NCT02718898|4013023|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0
2309581|NCT02718898|4013024|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0
2309582|NCT02718898|4013025|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0
2309583|NCT02718898|4013026|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1
2309584|NCT02718898|4013027|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5
2309585|NCT02718898|4013028|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1
2309586|NCT02718898|4013022|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0
2309587|NCT02718898|4013023|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0
2309588|NCT02718898|4013024|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0
2309589|NCT02718898|4013025|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0
2309590|NCT02718898|4013026|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0
2309591|NCT02718898|4013027|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5
2309592|NCT02718898|4013028|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3
2309593|NCT02719028|4013054|FG000|Overall Study|Adverse Event|2
2309594|NCT02719028|4013055|FG001|Overall Study|Adverse Event|1
2309595|NCT02719028|4013056|FG002|Overall Study|Adverse Event|4
2309596|NCT02719028|4013057|FG003|Overall Study|Adverse Event|8
2309597|NCT02719028|4013054|FG000|Overall Study|Physician Decision|0
2309598|NCT02719028|4013055|FG001|Overall Study|Physician Decision|1
2309599|NCT02719028|4013056|FG002|Overall Study|Physician Decision|1
2309600|NCT02719028|4013057|FG003|Overall Study|Physician Decision|1
2309601|NCT02719028|4013054|FG000|Overall Study|Use of prohibited medication|0
2309602|NCT02719028|4013055|FG001|Overall Study|Use of prohibited medication|0
2309603|NCT02719028|4013056|FG002|Overall Study|Use of prohibited medication|1
2309604|NCT02719028|4013057|FG003|Overall Study|Use of prohibited medication|0
2309605|NCT02719028|4013054|FG000|Overall Study|Protocol Violation|0
2309606|NCT02719028|4013055|FG001|Overall Study|Protocol Violation|0
2021558|NCT00313313|3589271|FG001|Overall Study|Physician Decision|6
2021559|NCT00313313|3589272|FG002|Overall Study|Physician Decision|4
2021560|NCT00313313|3589270|FG000|Overall Study|Poor/Noncompliance|3
2021561|NCT00313313|3589271|FG001|Overall Study|Poor/Noncompliance|6
1972286|NCT03731364|3533830|FG000|Overall Study|Adverse Event|0
1972287|NCT03731364|3533831|FG001|Overall Study|Adverse Event|0
1972288|NCT03731364|3533832|FG002|Overall Study|Adverse Event|1
1972289|NCT03731364|3533833|FG003|Overall Study|Adverse Event|2
1972290|NCT03731364|3533834|FG004|Overall Study|Adverse Event|1
2021562|NCT00313313|3589272|FG002|Overall Study|Poor/Noncompliance|2
2021563|NCT00313313|3589270|FG000|Overall Study|Pregnancy|1
2021564|NCT00313313|3589271|FG001|Overall Study|Pregnancy|2
2021565|NCT00313313|3589272|FG002|Overall Study|Pregnancy|0
2021566|NCT00313313|3589270|FG000|Overall Study|Death|0
2021567|NCT00313313|3589271|FG001|Overall Study|Death|0
2021568|NCT00313313|3589272|FG002|Overall Study|Death|2
2021569|NCT00313313|3589270|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
2021570|NCT00313313|3589271|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
2021571|NCT00313313|3589272|FG002|Overall Study|Subject No Longer Meets Study Criteria|2
2021572|NCT00313586|3589296|FG000|Overall Study|Disease progression|14
2021573|NCT00313586|3589297|FG001|Overall Study|Disease progression|19
2021574|NCT00313586|3589298|FG002|Overall Study|Disease progression|10
2021575|NCT00313586|3589299|FG003|Overall Study|Disease progression|3
2021576|NCT00313586|3589296|FG000|Overall Study|Adverse Event|12
2021577|NCT00313586|3589297|FG001|Overall Study|Adverse Event|18
2021578|NCT00313586|3589298|FG002|Overall Study|Adverse Event|3
2021579|NCT00313586|3589299|FG003|Overall Study|Adverse Event|10
2021580|NCT00313586|3589296|FG000|Overall Study|Death|11
2021581|NCT00313586|3589297|FG001|Overall Study|Death|8
2021582|NCT00313586|3589298|FG002|Overall Study|Death|1
2021583|NCT00313586|3589299|FG003|Overall Study|Death|7
2021584|NCT00313586|3589296|FG000|Overall Study|Withdrawal by Subject|13
2021585|NCT00313586|3589297|FG001|Overall Study|Withdrawal by Subject|6
2021586|NCT00313586|3589298|FG002|Overall Study|Withdrawal by Subject|6
2021587|NCT00313586|3589299|FG003|Overall Study|Withdrawal by Subject|2
2021588|NCT00313586|3589296|FG000|Overall Study|Alternative therapy|3
2021589|NCT00313586|3589297|FG001|Overall Study|Alternative therapy|6
2021590|NCT00313586|3589298|FG002|Overall Study|Alternative therapy|2
2021591|NCT00313586|3589299|FG003|Overall Study|Alternative therapy|0
2021592|NCT00313586|3589296|FG000|Overall Study|Other complicating disease|2
2021593|NCT00313586|3589297|FG001|Overall Study|Other complicating disease|2
2021594|NCT00313586|3589298|FG002|Overall Study|Other complicating disease|0
2021595|NCT00313586|3589299|FG003|Overall Study|Other complicating disease|0
2021596|NCT00313586|3589296|FG000|Overall Study|Did not achieve HI-major/better response|10
2021597|NCT00313586|3589297|FG001|Overall Study|Did not achieve HI-major/better response|7
2021598|NCT00313586|3589298|FG002|Overall Study|Did not achieve HI-major/better response|2
2021599|NCT00313586|3589299|FG003|Overall Study|Did not achieve HI-major/better response|1
2021600|NCT00313586|3589296|FG000|Overall Study|Physician Decision|2
2021601|NCT00313586|3589297|FG001|Overall Study|Physician Decision|1
2021602|NCT00313586|3589298|FG002|Overall Study|Physician Decision|0
2021603|NCT00313586|3589299|FG003|Overall Study|Physician Decision|0
2021604|NCT00313586|3589296|FG000|Overall Study|Absolute neutrophil count not recovered|2
2021605|NCT00313586|3589297|FG001|Overall Study|Absolute neutrophil count not recovered|1
2021606|NCT00313586|3589298|FG002|Overall Study|Absolute neutrophil count not recovered|0
2021607|NCT00313586|3589299|FG003|Overall Study|Absolute neutrophil count not recovered|0
2021608|NCT00313586|3589296|FG000|Overall Study|Lost insurance|0
2102138|NCT00837577|3693869|FG001|Open-label Period|Laboratory Adverse Event|1
2212760|NCT01673490|3854089|FG000|Overall Study|Adverse Event|3
2212761|NCT01673490|3854089|FG000|Overall Study|Withdrawal by Subject|3
2212762|NCT01673594|3854104|FG000|Overall Study|Adverse Event|3
2212763|NCT01673594|3854105|FG001|Overall Study|Adverse Event|1
2212764|NCT01673594|3854104|FG000|Overall Study|Lost to Follow-up|1
2212765|NCT01673594|3854105|FG001|Overall Study|Lost to Follow-up|0
2212766|NCT01673594|3854104|FG000|Overall Study|Physician Decision|2
2212767|NCT01673594|3854105|FG001|Overall Study|Physician Decision|4
2212768|NCT01673594|3854104|FG000|Overall Study|Withdrawal by Subject|0
2212769|NCT01673594|3854105|FG001|Overall Study|Withdrawal by Subject|1
2212770|NCT01673646|3854114|FG000|Overall Study|Adverse Event|2
2212771|NCT01673646|3854115|FG001|Overall Study|Adverse Event|1
2212772|NCT01673646|3854116|FG002|Overall Study|Adverse Event|1
2309607|NCT02719028|4013056|FG002|Overall Study|Protocol Violation|0
2102139|NCT00837577|3693868|FG000|Open-label Period|Lack of Efficacy|4
2309608|NCT02719028|4013057|FG003|Overall Study|Protocol Violation|1
2309609|NCT02719171|4013085|FG000|Overall Study|Adverse Event|1
2309610|NCT02719171|4013086|FG001|Overall Study|Adverse Event|2
2309611|NCT02719171|4013087|FG002|Overall Study|Adverse Event|0
2309612|NCT02719171|4013088|FG003|Overall Study|Adverse Event|0
2021609|NCT00313586|3589297|FG001|Overall Study|Lost insurance|1
2021610|NCT00313586|3589298|FG002|Overall Study|Lost insurance|0
2021611|NCT00313586|3589299|FG003|Overall Study|Lost insurance|0
2021612|NCT00313586|3589296|FG000|Overall Study|Moved|0
2021613|NCT00313586|3589297|FG001|Overall Study|Moved|1
2021614|NCT00313586|3589298|FG002|Overall Study|Moved|0
2021615|NCT00313586|3589299|FG003|Overall Study|Moved|0
2021616|NCT00313586|3589296|FG000|Overall Study|Death before starting treatment|1
2021617|NCT00313586|3589297|FG001|Overall Study|Death before starting treatment|0
2021618|NCT00313586|3589298|FG002|Overall Study|Death before starting treatment|0
2021619|NCT00313586|3589299|FG003|Overall Study|Death before starting treatment|0
1972291|NCT04598152|3533855|FG000|Overall Study|Lost to Follow-up|0
1972292|NCT04598152|3533856|FG001|Overall Study|Lost to Follow-up|1
1972293|NCT03945825|3533895|FG000|Overall Study|Enrolled but treatment not administered|0
1972294|NCT03945825|3533896|FG001|Overall Study|Enrolled but treatment not administered|0
1972295|NCT03945825|3533897|FG002|Overall Study|Enrolled but treatment not administered|0
1972296|NCT03945825|3533898|FG003|Overall Study|Enrolled but treatment not administered|0
1972297|NCT03945825|3533899|FG004|Overall Study|Enrolled but treatment not administered|1
1972298|NCT03945825|3533900|FG005|Overall Study|Enrolled but treatment not administered|0
1972299|NCT03945825|3533895|FG000|Overall Study|Lost to Follow-up|1
1972300|NCT03945825|3533896|FG001|Overall Study|Lost to Follow-up|5
1972301|NCT03945825|3533897|FG002|Overall Study|Lost to Follow-up|0
1972302|NCT03945825|3533898|FG003|Overall Study|Lost to Follow-up|1
1972303|NCT03945825|3533899|FG004|Overall Study|Lost to Follow-up|2
1972304|NCT03945825|3533900|FG005|Overall Study|Lost to Follow-up|2
1972305|NCT03945825|3533895|FG000|Overall Study|Withdrawal by Subject|1
1972306|NCT03945825|3533896|FG001|Overall Study|Withdrawal by Subject|0
1972307|NCT03945825|3533897|FG002|Overall Study|Withdrawal by Subject|1
1972308|NCT03945825|3533898|FG003|Overall Study|Withdrawal by Subject|1
1972309|NCT03945825|3533899|FG004|Overall Study|Withdrawal by Subject|0
1972310|NCT03945825|3533900|FG005|Overall Study|Withdrawal by Subject|1
1972311|NCT03562767|3533947|FG000|Overall Study|Physician Decision|2
1972312|NCT03562767|3533948|FG001|Overall Study|Physician Decision|0
1972313|NCT03562767|3533949|FG002|Overall Study|Physician Decision|0
1972314|NCT03562767|3533947|FG000|Overall Study|Logistic Reason|1
1972315|NCT03562767|3533948|FG001|Overall Study|Logistic Reason|3
1972316|NCT03562767|3533949|FG002|Overall Study|Logistic Reason|0
1972317|NCT03559699|3533961|FG000|Overall Study|Withdrawal by Subject|6
1972318|NCT03559699|3533961|FG000|Overall Study|Lost to Follow-up|1
1972319|NCT03305016|3533987|FG000|Overall Study|Withdrawal by Subject|2
1972320|NCT03291067|3534004|FG000|Overall Study|Adverse Event|0
1972321|NCT03291067|3534005|FG001|Overall Study|Adverse Event|2
1972322|NCT03291067|3534006|FG002|Overall Study|Adverse Event|17
1972323|NCT03291067|3534007|FG003|Overall Study|Adverse Event|3
1972324|NCT03291067|3534004|FG000|Overall Study|Lost to Follow-up|2
1972325|NCT03291067|3534005|FG001|Overall Study|Lost to Follow-up|1
1972326|NCT03291067|3534006|FG002|Overall Study|Lost to Follow-up|0
1972327|NCT03291067|3534007|FG003|Overall Study|Lost to Follow-up|1
1972328|NCT03291067|3534004|FG000|Overall Study|Physician Decision|0
1972329|NCT03291067|3534005|FG001|Overall Study|Physician Decision|0
1972330|NCT03291067|3534006|FG002|Overall Study|Physician Decision|1
1972331|NCT03291067|3534007|FG003|Overall Study|Physician Decision|0
1972332|NCT03291067|3534004|FG000|Overall Study|Protocol Violation|5
1972333|NCT03291067|3534005|FG001|Overall Study|Protocol Violation|3
1972334|NCT03291067|3534006|FG002|Overall Study|Protocol Violation|4
1972335|NCT03291067|3534007|FG003|Overall Study|Protocol Violation|2
1972336|NCT03291067|3534004|FG000|Overall Study|Withdrawal by Subject|3
1972337|NCT03291067|3534005|FG001|Overall Study|Withdrawal by Subject|4
1972338|NCT03291067|3534006|FG002|Overall Study|Withdrawal by Subject|7
1972339|NCT03291067|3534007|FG003|Overall Study|Withdrawal by Subject|5
1972340|NCT03291067|3534004|FG000|Overall Study|Other|0
2309613|NCT02719171|4013089|FG004|Overall Study|Adverse Event|2
2309614|NCT02719171|4013085|FG000|Overall Study|Lost to Follow-up|0
2309615|NCT02719171|4013086|FG001|Overall Study|Lost to Follow-up|0
2309616|NCT02719171|4013087|FG002|Overall Study|Lost to Follow-up|1
2309617|NCT02719171|4013088|FG003|Overall Study|Lost to Follow-up|0
2309618|NCT02719171|4013089|FG004|Overall Study|Lost to Follow-up|0
2309619|NCT02719171|4013085|FG000|Overall Study|Subject Withdrawal|0
2309620|NCT02719171|4013086|FG001|Overall Study|Subject Withdrawal|2
2309621|NCT02719171|4013087|FG002|Overall Study|Subject Withdrawal|2
2309622|NCT02719171|4013088|FG003|Overall Study|Subject Withdrawal|1
2309623|NCT02719171|4013089|FG004|Overall Study|Subject Withdrawal|0
2309624|NCT02719171|4013085|FG000|Overall Study|Other|0
2309625|NCT02719171|4013086|FG001|Overall Study|Other|0
2309626|NCT02719171|4013087|FG002|Overall Study|Other|0
2309627|NCT02719171|4013088|FG003|Overall Study|Other|1
2309628|NCT02719171|4013089|FG004|Overall Study|Other|0
2309629|NCT02719353|4013104|FG000|First Intervention|Physician Decision|0
2309630|NCT02719353|4013105|FG001|First Intervention|Physician Decision|1
2309631|NCT02719743|4013133|FG000|Overall Study|Consent withdrawal|0
2309632|NCT02719743|4013134|FG001|Overall Study|Consent withdrawal|2
1972341|NCT03291067|3534005|FG001|Overall Study|Other|4
1972342|NCT03291067|3534006|FG002|Overall Study|Other|4
1972343|NCT03291067|3534007|FG003|Overall Study|Other|6
1972344|NCT03271047|3534021|FG000|Phase 1b: Dose Finding Period|Death|8
1972345|NCT03271047|3534022|FG001|Phase 1b: Dose Finding Period|Death|8
1972346|NCT03271047|3534023|FG002|Phase 1b: Dose Finding Period|Death|0
1972347|NCT03271047|3534024|FG003|Phase 1b: Dose Finding Period|Death|0
1972348|NCT03271047|3534021|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1
1972349|NCT03271047|3534022|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0
1972350|NCT03271047|3534023|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0
1972351|NCT03271047|3534024|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0
1972352|NCT03271047|3534021|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
1972353|NCT03271047|3534022|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2
1972354|NCT03271047|3534023|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
1972355|NCT03271047|3534024|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
1972356|NCT03271047|3534021|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
1972357|NCT03271047|3534022|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
1972358|NCT03271047|3534023|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
1972359|NCT03271047|3534024|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
1972360|NCT03271047|3534021|FG000|Randomized Phase 2 Period|Other|0
1972361|NCT03271047|3534022|FG001|Randomized Phase 2 Period|Other|0
1972362|NCT03271047|3534023|FG002|Randomized Phase 2 Period|Other|0
1972363|NCT03271047|3534024|FG003|Randomized Phase 2 Period|Other|1
1972364|NCT03271047|3534021|FG000|Randomized Phase 2 Period|Death|0
1972365|NCT03271047|3534022|FG001|Randomized Phase 2 Period|Death|0
1972366|NCT03271047|3534023|FG002|Randomized Phase 2 Period|Death|20
1972367|NCT03271047|3534024|FG003|Randomized Phase 2 Period|Death|21
1972368|NCT03271047|3534021|FG000|Randomized Phase 2 Period|Lost to Follow-up|0
1972369|NCT03271047|3534022|FG001|Randomized Phase 2 Period|Lost to Follow-up|0
1972370|NCT03271047|3534023|FG002|Randomized Phase 2 Period|Lost to Follow-up|2
1972371|NCT03271047|3534024|FG003|Randomized Phase 2 Period|Lost to Follow-up|1
2309633|NCT02719743|4013135|FG002|Overall Study|Consent withdrawal|0
2309634|NCT02719743|4013136|FG003|Overall Study|Consent withdrawal|1
2309635|NCT02719743|4013137|FG004|Overall Study|Consent withdrawal|0
2309636|NCT02719743|4013133|FG000|Overall Study|Migrated/moved from study area|0
2309637|NCT02719743|4013134|FG001|Overall Study|Migrated/moved from study area|0
2309638|NCT02719743|4013135|FG002|Overall Study|Migrated/moved from study area|0
2309639|NCT02719743|4013136|FG003|Overall Study|Migrated/moved from study area|0
2309640|NCT02719743|4013137|FG004|Overall Study|Migrated/moved from study area|2
2309641|NCT02719743|4013133|FG000|Overall Study|Lost to Follow-up|1
2309642|NCT02719743|4013134|FG001|Overall Study|Lost to Follow-up|1
2309643|NCT02719743|4013135|FG002|Overall Study|Lost to Follow-up|0
2309644|NCT02719743|4013136|FG003|Overall Study|Lost to Follow-up|0
2309645|NCT02719743|4013137|FG004|Overall Study|Lost to Follow-up|0
2309646|NCT02720042|4013158|FG000|Overall Study|Death|3
2309647|NCT02720042|4013158|FG000|Overall Study|Lost to Follow-up|4
2309648|NCT02720042|4013158|FG000|Overall Study|Withdrawal by Subject|1
2309649|NCT02720042|4013158|FG000|Overall Study|Physician Decision|3
2309650|NCT02720042|4013158|FG000|Overall Study|Phasix Mesh explanted|1
2309651|NCT02720042|4013158|FG000|Overall Study|unable due to non-study-related illness|3
2309652|NCT02720081|4013164|FG000|Overall Study|Adverse Event|0
2309653|NCT02720081|4013165|FG001|Overall Study|Adverse Event|3
2309654|NCT02720081|4013164|FG000|Overall Study|Protocol Violation|4
2309655|NCT02720081|4013165|FG001|Overall Study|Protocol Violation|1
2321811|NCT02963506|4036372|FG001|Dose-Blind Period|Withdrawal by Subject|0
2321812|NCT02963506|4036373|FG002|Dose-Blind Period|Withdrawal by Subject|0
2321813|NCT02963506|4036374|FG003|Dose-Blind Period|Withdrawal by Subject|0
2321814|NCT02963506|4036375|FG004|Dose-Blind Period|Withdrawal by Subject|0
2321815|NCT02963506|4036376|FG005|Dose-Blind Period|Withdrawal by Subject|1
2321816|NCT02963506|4036377|FG006|Dose-Blind Period|Withdrawal by Subject|2
2321817|NCT02963506|4036378|FG007|Dose-Blind Period|Withdrawal by Subject|2
2321818|NCT02963506|4036379|FG008|Dose-Blind Period|Withdrawal by Subject|0
2321819|NCT02963506|4036380|FG009|Dose-Blind Period|Withdrawal by Subject|1
2321820|NCT02963506|4036381|FG010|Dose-Blind Period|Withdrawal by Subject|0
2321821|NCT02963506|4036382|FG011|Dose-Blind Period|Withdrawal by Subject|0
2321822|NCT02963506|4036383|FG012|Dose-Blind Period|Withdrawal by Subject|0
2321823|NCT02963506|4036371|FG000|Dose-Blind Period|Sponsor decision|0
2321824|NCT02963506|4036372|FG001|Dose-Blind Period|Sponsor decision|0
2321825|NCT02963506|4036373|FG002|Dose-Blind Period|Sponsor decision|0
2321826|NCT02963506|4036374|FG003|Dose-Blind Period|Sponsor decision|0
2321827|NCT02963506|4036375|FG004|Dose-Blind Period|Sponsor decision|0
2321828|NCT02963506|4036376|FG005|Dose-Blind Period|Sponsor decision|1
2321829|NCT02963506|4036377|FG006|Dose-Blind Period|Sponsor decision|0
2321830|NCT02963506|4036378|FG007|Dose-Blind Period|Sponsor decision|0
2321831|NCT02963506|4036379|FG008|Dose-Blind Period|Sponsor decision|0
2321832|NCT02963506|4036380|FG009|Dose-Blind Period|Sponsor decision|0
2321833|NCT02963506|4036381|FG010|Dose-Blind Period|Sponsor decision|0
2321834|NCT02963506|4036382|FG011|Dose-Blind Period|Sponsor decision|0
2321835|NCT02963506|4036383|FG012|Dose-Blind Period|Sponsor decision|0
2321836|NCT02963506|4036371|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0
2321837|NCT02963506|4036372|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0
2321838|NCT02963506|4036373|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0
2321839|NCT02963506|4036374|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0
2321840|NCT02963506|4036375|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0
2321841|NCT02963506|4036376|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0
2321842|NCT02963506|4036377|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0
2321843|NCT02963506|4036378|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0
2321844|NCT02963506|4036379|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0
2321845|NCT02963506|4036380|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0
2321846|NCT02963506|4036381|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0
2321847|NCT02963506|4036382|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0
1972372|NCT03271047|3534021|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0
1972373|NCT03271047|3534022|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0
1972374|NCT03271047|3534023|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5
1972375|NCT03271047|3534024|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0
1972376|NCT03271047|3534021|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0
1972377|NCT03271047|3534022|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0
1972378|NCT03271047|3534023|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0
1972379|NCT03271047|3534024|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4
1972380|NCT03257436|3534036|FG000|Overall Study|Withdrawal by Subject|76
1972381|NCT03257436|3534036|FG000|Overall Study|Death|19
1972382|NCT03158285|3534053|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4
1972383|NCT03158285|3534054|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2
1972384|NCT03158285|3534055|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6
1972385|NCT03158285|3534053|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0
1972386|NCT03158285|3534054|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
1972387|NCT03158285|3534055|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
1972388|NCT03158285|3534053|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
1972389|NCT03158285|3534054|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
1972390|NCT03158285|3534055|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0
1972391|NCT03158285|3534053|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
1972392|NCT03158285|3534054|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1
1972393|NCT03158285|3534055|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
1972394|NCT03158285|3534053|FG000|Placebo-controlled Period: Week 0 - 24|Other|1
1972395|NCT03158285|3534054|FG001|Placebo-controlled Period: Week 0 - 24|Other|1
1972396|NCT03158285|3534055|FG002|Placebo-controlled Period: Week 0 - 24|Other|0
1972397|NCT03158285|3534053|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
1972398|NCT03158285|3534054|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0
1972399|NCT03158285|3534055|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1
1972400|NCT03158285|3534053|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5
1972401|NCT03158285|3534054|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
1972402|NCT03158285|3534055|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
1972403|NCT03158285|3534053|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
1972404|NCT03158285|3534054|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
1972405|NCT03158285|3534055|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
1972406|NCT03158285|3534053|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0
1972407|NCT03158285|3534054|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0
1972408|NCT03158285|3534055|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1
1972409|NCT03158285|3534053|FG000|Active Treatment Period: Week 24 - 52|Other|1
1972410|NCT03158285|3534054|FG001|Active Treatment Period: Week 24 - 52|Other|1
1972411|NCT03158285|3534055|FG002|Active Treatment Period: Week 24 - 52|Other|0
1972412|NCT03158285|3534053|FG000|Active Treatment Period: Week 52-100|Adverse Event|7
1972413|NCT03158285|3534054|FG001|Active Treatment Period: Week 52-100|Adverse Event|5
2309656|NCT02720198|4013177|FG000|Overall Study|Withdrawal by Subject|0
2309657|NCT02720198|4013178|FG001|Overall Study|Withdrawal by Subject|1
2309658|NCT02720484|4013188|FG000|Treatment on Study|Adverse Event|1
2309659|NCT02720484|4013188|FG000|Treatment on Study|Withdrawal by Subject|1
2309660|NCT02720484|4013188|FG000|Treatment on Study|Progressive Disease|4
2309661|NCT02720484|4013188|FG000|Follow Up for 2 Years|Withdrawal by Subject|1
2309662|NCT02720484|4013188|FG000|Follow Up for 2 Years|Death|3
2309663|NCT02720484|4013188|FG000|Follow Up for 2 Years|Lost to Follow-up|2
2309664|NCT02720523|4013196|FG000|Period 1: Placebo-controlled Period|Adverse Event|0
2309665|NCT02720523|4013197|FG001|Period 1: Placebo-controlled Period|Adverse Event|0
2309666|NCT02720523|4013198|FG002|Period 1: Placebo-controlled Period|Adverse Event|1
2309667|NCT02720523|4013199|FG003|Period 1: Placebo-controlled Period|Adverse Event|5
2309668|NCT02720523|4013200|FG004|Period 1: Placebo-controlled Period|Adverse Event|0
2309669|NCT02720523|4013201|FG005|Period 1: Placebo-controlled Period|Adverse Event|0
2309670|NCT02720523|4013202|FG006|Period 1: Placebo-controlled Period|Adverse Event|0
2309671|NCT02720523|4013196|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
2309672|NCT02720523|4013197|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2309673|NCT02720523|4013198|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2309674|NCT02720523|4013199|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2309675|NCT02720523|4013200|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2309676|NCT02720523|4013201|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2309677|NCT02720523|4013202|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2309678|NCT02720523|4013196|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1
2309679|NCT02720523|4013197|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1972414|NCT03158285|3534055|FG002|Active Treatment Period: Week 52-100|Adverse Event|3
1972415|NCT03158285|3534053|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1
1972416|NCT03158285|3534054|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1
1972417|NCT03158285|3534055|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3
1972418|NCT03158285|3534053|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5
1972419|NCT03158285|3534054|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2
1972420|NCT03158285|3534055|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1
1972421|NCT03158285|3534053|FG000|Active Treatment Period: Week 52-100|Pregnancy|0
1972422|NCT03158285|3534054|FG001|Active Treatment Period: Week 52-100|Pregnancy|0
1972423|NCT03158285|3534055|FG002|Active Treatment Period: Week 52-100|Pregnancy|1
1972424|NCT03158285|3534053|FG000|Active Treatment Period: Week 52-100|Death|1
1972425|NCT03158285|3534054|FG001|Active Treatment Period: Week 52-100|Death|0
1972426|NCT03158285|3534055|FG002|Active Treatment Period: Week 52-100|Death|0
1972427|NCT03158285|3534053|FG000|Active Treatment Period: Week 52-100|Other|4
1972428|NCT03158285|3534054|FG001|Active Treatment Period: Week 52-100|Other|1
1972429|NCT03158285|3534055|FG002|Active Treatment Period: Week 52-100|Other|0
1972430|NCT03051217|3534071|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2
1972431|NCT03051217|3534072|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
1972432|NCT03051217|3534073|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
1972433|NCT03051217|3534074|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
1972434|NCT03051217|3534075|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
1972435|NCT03051217|3534076|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
1972436|NCT03051217|3534077|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
1972437|NCT03051217|3534071|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1972438|NCT03051217|3534072|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1
1972439|NCT03051217|3534073|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1972440|NCT03051217|3534074|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2309680|NCT02720523|4013198|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2309681|NCT02720523|4013199|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2309682|NCT02720523|4013200|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2309683|NCT02720523|4013201|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2309684|NCT02720523|4013202|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2309685|NCT02720523|4013196|FG000|Period 1: Placebo-controlled Period|Other|0
2309686|NCT02720523|4013197|FG001|Period 1: Placebo-controlled Period|Other|0
2309687|NCT02720523|4013198|FG002|Period 1: Placebo-controlled Period|Other|1
2309688|NCT02720523|4013199|FG003|Period 1: Placebo-controlled Period|Other|1
2309689|NCT02720523|4013200|FG004|Period 1: Placebo-controlled Period|Other|0
2309690|NCT02720523|4013201|FG005|Period 1: Placebo-controlled Period|Other|0
2309691|NCT02720523|4013202|FG006|Period 1: Placebo-controlled Period|Other|0
2309692|NCT02720523|4013196|FG000|Period 2: Long-term Extension Period|Ongoing|0
2309693|NCT02720523|4013197|FG001|Period 2: Long-term Extension Period|Ongoing|0
2309694|NCT02720523|4013198|FG002|Period 2: Long-term Extension Period|Ongoing|0
2309695|NCT02720523|4013199|FG003|Period 2: Long-term Extension Period|Ongoing|0
2309696|NCT02720523|4013200|FG004|Period 2: Long-term Extension Period|Ongoing|57
2309697|NCT02720523|4013201|FG005|Period 2: Long-term Extension Period|Ongoing|54
2309698|NCT02720523|4013202|FG006|Period 2: Long-term Extension Period|Ongoing|45
2309699|NCT02720523|4013196|FG000|Period 2: Long-term Extension Period|Adverse Event|0
2309700|NCT02720523|4013197|FG001|Period 2: Long-term Extension Period|Adverse Event|0
2309701|NCT02720523|4013198|FG002|Period 2: Long-term Extension Period|Adverse Event|0
2309702|NCT02720523|4013199|FG003|Period 2: Long-term Extension Period|Adverse Event|0
2309703|NCT02720523|4013200|FG004|Period 2: Long-term Extension Period|Adverse Event|4
2309704|NCT02720523|4013201|FG005|Period 2: Long-term Extension Period|Adverse Event|7
2309705|NCT02720523|4013202|FG006|Period 2: Long-term Extension Period|Adverse Event|11
2309706|NCT02720523|4013196|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2309707|NCT02720523|4013197|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2309708|NCT02720523|4013198|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2309709|NCT02720523|4013199|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2309710|NCT02720523|4013200|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2
2309711|NCT02720523|4013201|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1
2309712|NCT02720523|4013202|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1
2309713|NCT02720523|4013196|FG000|Period 2: Long-term Extension Period|Other|0
2309714|NCT02720523|4013197|FG001|Period 2: Long-term Extension Period|Other|0
2309715|NCT02720523|4013198|FG002|Period 2: Long-term Extension Period|Other|0
2309716|NCT02720523|4013199|FG003|Period 2: Long-term Extension Period|Other|0
2309717|NCT02720523|4013200|FG004|Period 2: Long-term Extension Period|Other|2
2309718|NCT02720523|4013201|FG005|Period 2: Long-term Extension Period|Other|0
2309719|NCT02720523|4013202|FG006|Period 2: Long-term Extension Period|Other|3
2309720|NCT02720536|4013215|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11
2309721|NCT02720536|4013215|FG000|Overall Study|PR - pregnancy|2
2309722|NCT02720536|4013215|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2
2309723|NCT02720536|4013215|FG000|Overall Study|PR - death|1
2309724|NCT02720536|4013215|FG000|Overall Study|PR - adverse event|1
2309725|NCT02720536|4013215|FG000|Overall Study|PR - abnormal lab value(s)|1
2309726|NCT02720536|4013215|FG000|Overall Study|PR- unwilling to comply with procedures|1
2309727|NCT02720757|4013229|FG000|Overall Study|Other reason|5
2309728|NCT02720757|4013229|FG000|Overall Study|Loss of contact|4
2309729|NCT02720757|4013229|FG000|Overall Study|Informed consent withdrawal|1
2309730|NCT02720757|4013229|FG000|Overall Study|Patients wish to withdraw|2
1972441|NCT03051217|3534075|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1972442|NCT03051217|3534076|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1972443|NCT03051217|3534077|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2025931|NCT00347919|3594670|FG001|Overall Study|Lost to Follow-up|13
1972444|NCT03051217|3534071|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1972445|NCT03051217|3534072|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1972446|NCT03051217|3534073|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1972447|NCT03051217|3534074|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1972448|NCT03051217|3534075|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1972449|NCT03051217|3534076|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1972450|NCT03051217|3534077|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1972451|NCT03051217|3534071|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
1972452|NCT03051217|3534072|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
1972453|NCT03051217|3534073|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
1972454|NCT03051217|3534074|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
1972455|NCT03051217|3534075|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
1972456|NCT03051217|3534076|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
1972457|NCT03051217|3534077|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
1972458|NCT03051217|3534071|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1972459|NCT03051217|3534072|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1972460|NCT03051217|3534073|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1972461|NCT03051217|3534074|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
1972462|NCT03051217|3534075|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1972463|NCT03051217|3534076|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1972464|NCT03051217|3534077|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1972465|NCT03051217|3534071|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2309731|NCT02720757|4013229|FG000|Overall Study|Missing|3
2309732|NCT02720757|4013229|FG000|Overall Study|General exclusion|3
2309733|NCT02721147|4013255|FG000|Overall Study|Lost to Follow-up|2
2309734|NCT02721147|4013256|FG001|Overall Study|Lost to Follow-up|0
2309735|NCT02721147|4013257|FG002|Overall Study|Lost to Follow-up|0
2309736|NCT02721251|4013268|FG000|Overall Study|Withdrawal by Subject|8
2309737|NCT02721251|4013269|FG001|Overall Study|Withdrawal by Subject|7
2309738|NCT02721251|4013270|FG002|Overall Study|Withdrawal by Subject|9
2309739|NCT02721251|4013268|FG000|Overall Study|poor adherence|2
2309740|NCT02721251|4013269|FG001|Overall Study|poor adherence|2
2309741|NCT02721251|4013270|FG002|Overall Study|poor adherence|2
2309742|NCT02721355|4013281|FG000|Overall Study|Lost to Follow-up|6
2309743|NCT02721355|4013282|FG001|Overall Study|Lost to Follow-up|1
2309744|NCT02721875|4013294|FG000|Overall Study|Progressive disease/relapse|1
2309745|NCT02721875|4013295|FG001|Overall Study|Progressive disease/relapse|0
2309746|NCT02721966|4013304|FG000|Overall Study|Protocol Violation|1
2309747|NCT02721966|4013305|FG001|Overall Study|Protocol Violation|0
2309748|NCT02721966|4013306|FG002|Overall Study|Protocol Violation|0
2309749|NCT02721966|4013307|FG003|Overall Study|Protocol Violation|0
2309750|NCT02721966|4013308|FG004|Overall Study|Protocol Violation|0
2309751|NCT02721966|4013304|FG000|Overall Study|Withdrawal by Subject|9
2309752|NCT02721966|4013305|FG001|Overall Study|Withdrawal by Subject|2
2309753|NCT02721966|4013306|FG002|Overall Study|Withdrawal by Subject|3
2309754|NCT02721966|4013307|FG003|Overall Study|Withdrawal by Subject|7
2309755|NCT02721966|4013308|FG004|Overall Study|Withdrawal by Subject|0
2309756|NCT02721966|4013304|FG000|Overall Study|Adverse Event|4
2309757|NCT02721966|4013305|FG001|Overall Study|Adverse Event|4
2309758|NCT02721966|4013306|FG002|Overall Study|Adverse Event|3
2309759|NCT02721966|4013307|FG003|Overall Study|Adverse Event|0
2309760|NCT02721966|4013308|FG004|Overall Study|Adverse Event|0
2309761|NCT02721966|4013304|FG000|Overall Study|Death|1
2309762|NCT02721966|4013305|FG001|Overall Study|Death|0
2309763|NCT02721966|4013306|FG002|Overall Study|Death|0
2309764|NCT02721966|4013307|FG003|Overall Study|Death|0
2309765|NCT02721966|4013308|FG004|Overall Study|Death|0
2309766|NCT02721966|4013304|FG000|Overall Study|Lack of Efficacy|7
2309767|NCT02721966|4013305|FG001|Overall Study|Lack of Efficacy|4
2309768|NCT02721966|4013306|FG002|Overall Study|Lack of Efficacy|0
2309769|NCT02721966|4013307|FG003|Overall Study|Lack of Efficacy|0
2309770|NCT02721966|4013308|FG004|Overall Study|Lack of Efficacy|0
2309771|NCT02721966|4013304|FG000|Overall Study|Lost to Follow-up|0
2309772|NCT02721966|4013305|FG001|Overall Study|Lost to Follow-up|0
2309773|NCT02721966|4013306|FG002|Overall Study|Lost to Follow-up|3
2309774|NCT02721966|4013307|FG003|Overall Study|Lost to Follow-up|0
2309775|NCT02721966|4013308|FG004|Overall Study|Lost to Follow-up|0
2309776|NCT02721966|4013304|FG000|Overall Study|Physician Decision|1
2309777|NCT02721966|4013305|FG001|Overall Study|Physician Decision|1
2309778|NCT02721966|4013306|FG002|Overall Study|Physician Decision|0
2309779|NCT02721966|4013307|FG003|Overall Study|Physician Decision|0
2309780|NCT02721966|4013308|FG004|Overall Study|Physician Decision|0
2309781|NCT02721966|4013304|FG000|Overall Study|Pregnancy|1
2309782|NCT02721966|4013305|FG001|Overall Study|Pregnancy|0
2309783|NCT02721966|4013306|FG002|Overall Study|Pregnancy|0
1972466|NCT03051217|3534072|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1972467|NCT03051217|3534073|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2309784|NCT02721966|4013307|FG003|Overall Study|Pregnancy|0
2309785|NCT02721966|4013308|FG004|Overall Study|Pregnancy|0
2309786|NCT02721966|4013304|FG000|Overall Study|Did not continue to period 2|5
2309787|NCT02721966|4013305|FG001|Overall Study|Did not continue to period 2|12
1972468|NCT03051217|3534074|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
1972469|NCT03051217|3534075|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1972470|NCT03051217|3534076|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1972471|NCT03051217|3534077|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1972472|NCT03051217|3534071|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1972473|NCT03051217|3534072|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1972474|NCT03051217|3534073|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1972475|NCT03051217|3534074|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1972476|NCT03051217|3534075|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
1972477|NCT03051217|3534076|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1972478|NCT03051217|3534077|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1972479|NCT03051217|3534071|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1972480|NCT03051217|3534072|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1972481|NCT03051217|3534073|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1972482|NCT03051217|3534074|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1972483|NCT03051217|3534075|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1972484|NCT03051217|3534076|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
1972485|NCT03051217|3534077|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1972486|NCT03025542|3534093|FG000|Overall Study|Adverse Event|0
1972487|NCT03025542|3534094|FG001|Overall Study|Adverse Event|2
1972488|NCT03025542|3534093|FG000|Overall Study|Lost to Follow-up|1
1972489|NCT03025542|3534094|FG001|Overall Study|Lost to Follow-up|0
1972490|NCT03025542|3534093|FG000|Overall Study|Withdrawal by Subject|1
1972491|NCT03025542|3534094|FG001|Overall Study|Withdrawal by Subject|0
1972492|NCT02889809|3534130|FG000|Overall Study|Withdrawal by Subject|30
1972493|NCT02889809|3534131|FG001|Overall Study|Withdrawal by Subject|21
1972494|NCT02889809|3534130|FG000|Overall Study|Lost to Follow-up|1
1972495|NCT02889809|3534131|FG001|Overall Study|Lost to Follow-up|1
1972496|NCT02889809|3534130|FG000|Overall Study|Site Closed|12
1972497|NCT02889809|3534131|FG001|Overall Study|Site Closed|11
1972498|NCT02849587|3534140|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
1972499|NCT02849587|3534141|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3
1972500|NCT02849587|3534142|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
1972501|NCT02849587|3534140|FG000|Overall Study|Withdrawal by Subject|0
1972502|NCT02849587|3534141|FG001|Overall Study|Withdrawal by Subject|1
1972503|NCT02849587|3534142|FG002|Overall Study|Withdrawal by Subject|0
1972504|NCT02815540|3534154|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2
1972505|NCT02781727|3534189|FG000|Pre-dosing Period|Withdrawal by Subject|1
1972506|NCT02781727|3534190|FG001|Pre-dosing Period|Withdrawal by Subject|0
1972507|NCT02781727|3534189|FG000|Treatment Period|Withdrawal by Subject|1
1972508|NCT02781727|3534190|FG001|Treatment Period|Withdrawal by Subject|0
1972509|NCT02781727|3534189|FG000|Treatment Period|Lost to Follow-up|0
1972510|NCT02781727|3534190|FG001|Treatment Period|Lost to Follow-up|1
1972511|NCT02778204|3534200|FG000|Overall Study|Adverse Event|1
1972512|NCT02778204|3534201|FG001|Overall Study|Adverse Event|0
1972513|NCT02778204|3534202|FG002|Overall Study|Adverse Event|0
1972514|NCT02778204|3534203|FG003|Overall Study|Adverse Event|0
1972515|NCT02778204|3534200|FG000|Overall Study|Withdrawal by Subject|0
1972516|NCT02778204|3534201|FG001|Overall Study|Withdrawal by Subject|0
1972517|NCT02778204|3534202|FG002|Overall Study|Withdrawal by Subject|1
1972518|NCT02778204|3534203|FG003|Overall Study|Withdrawal by Subject|2
1972519|NCT02778204|3534200|FG000|Overall Study|Lost to Follow-up|1
1972520|NCT02778204|3534201|FG001|Overall Study|Lost to Follow-up|0
1972521|NCT02778204|3534202|FG002|Overall Study|Lost to Follow-up|2
1972522|NCT02778204|3534203|FG003|Overall Study|Lost to Follow-up|1
1972523|NCT02778204|3534200|FG000|Overall Study|Protocol Violation|0
1972524|NCT02778204|3534201|FG001|Overall Study|Protocol Violation|0
1972525|NCT02778204|3534202|FG002|Overall Study|Protocol Violation|1
1972526|NCT02778204|3534203|FG003|Overall Study|Protocol Violation|0
1972527|NCT02778204|3534200|FG000|Overall Study|Eligibility Violation|0
1972528|NCT02778204|3534201|FG001|Overall Study|Eligibility Violation|0
1972529|NCT02778204|3534202|FG002|Overall Study|Eligibility Violation|0
1972530|NCT02778204|3534203|FG003|Overall Study|Eligibility Violation|1
2021620|NCT00313612|3589309|FG000|Overall Study|Patient never received treatment|0
2021621|NCT00313612|3589310|FG001|Overall Study|Patient never received treatment|1
2021622|NCT00313703|3589320|FG000|Overall Study|Lost to Follow-up|11
2021623|NCT00313703|3589321|FG001|Overall Study|Lost to Follow-up|2
2021624|NCT00313703|3589322|FG002|Overall Study|Lost to Follow-up|5
2021625|NCT00313703|3589323|FG003|Overall Study|Lost to Follow-up|12
2021626|NCT00313716|3589339|FG000|Overall Study|Death|3
2021627|NCT00313716|3589340|FG001|Overall Study|Death|2
2021628|NCT00313716|3589341|FG002|Overall Study|Death|9
2021629|NCT00313716|3589342|FG003|Overall Study|Death|3
2021630|NCT00313716|3589343|FG004|Overall Study|Death|5
2021631|NCT00313716|3589344|FG005|Overall Study|Death|9
2021632|NCT00313716|3589339|FG000|Overall Study|Lost to Follow-up|2
2021633|NCT00313716|3589340|FG001|Overall Study|Lost to Follow-up|5
1972531|NCT02496611|3534226|FG000|Overall Study|Lost to Follow-up|2
1972532|NCT02496611|3534227|FG001|Overall Study|Lost to Follow-up|1
1972533|NCT02496611|3534226|FG000|Overall Study|Withdrawal by Subject|5
1972534|NCT02496611|3534227|FG001|Overall Study|Withdrawal by Subject|2
1972535|NCT02227199|3534246|FG000|Overall Study|Physician Decision|0
1972536|NCT02227199|3534247|FG001|Overall Study|Physician Decision|0
1972537|NCT02227199|3534248|FG002|Overall Study|Physician Decision|1
1972538|NCT02227199|3534246|FG000|Overall Study|Adverse Event|0
1972539|NCT02227199|3534247|FG001|Overall Study|Adverse Event|0
1972540|NCT02227199|3534248|FG002|Overall Study|Adverse Event|3
1972541|NCT02198794|3534260|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79
1972542|NCT02198794|3534261|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
1972543|NCT02198794|3534262|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
1972544|NCT02198794|3534263|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
1972545|NCT02198794|3534260|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33
1972546|NCT02198794|3534261|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0
1972547|NCT02198794|3534262|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0
1972548|NCT02198794|3534263|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0
1972549|NCT02198794|3534260|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24
1972550|NCT02198794|3534261|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
1972551|NCT02198794|3534262|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
1972552|NCT02198794|3534263|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
1972553|NCT02198794|3534260|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9
1972554|NCT02198794|3534261|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
1972555|NCT02198794|3534262|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
1972556|NCT02198794|3534263|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
1972557|NCT02198794|3534260|FG000|Part A: Open-Label (158 Weeks)|Death|8
1972558|NCT02198794|3534261|FG001|Part A: Open-Label (158 Weeks)|Death|0
1972559|NCT02198794|3534262|FG002|Part A: Open-Label (158 Weeks)|Death|0
1972560|NCT02198794|3534263|FG003|Part A: Open-Label (158 Weeks)|Death|0
1972561|NCT02198794|3534260|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3
1972562|NCT02198794|3534261|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
1972563|NCT02198794|3534262|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
1972564|NCT02198794|3534263|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
1972565|NCT02198794|3534260|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5
1972566|NCT02198794|3534261|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0
1972567|NCT02198794|3534262|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0
1972568|NCT02198794|3534263|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0
1972569|NCT02198794|3534260|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1
1972570|NCT02198794|3534261|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0
1972571|NCT02198794|3534262|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0
1972572|NCT02198794|3534263|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0
1972573|NCT02198794|3534260|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1
1972574|NCT02198794|3534261|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0
1972575|NCT02198794|3534262|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0
1972576|NCT02198794|3534263|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0
1972577|NCT02198794|3534260|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142
1972578|NCT02198794|3534261|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
1972579|NCT02198794|3534262|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
1972580|NCT02198794|3534263|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
1972581|NCT02198794|3534260|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
1972582|NCT02198794|3534261|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3
1972583|NCT02198794|3534262|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1
1972584|NCT02198794|3534263|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
1972585|NCT02198794|3534260|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
1972586|NCT02198794|3534261|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
1972587|NCT02198794|3534262|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
1972588|NCT02198794|3534263|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
1972589|NCT02198794|3534260|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
1972590|NCT02198794|3534261|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
1972591|NCT02198794|3534262|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
1972592|NCT02198794|3534263|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3
1972593|NCT02198794|3534260|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
1972594|NCT02198794|3534261|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
1972595|NCT02198794|3534262|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
1972596|NCT02198794|3534263|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2
1972597|NCT02198794|3534260|FG000|Part C: Safety Assessment (52 Weeks)|Death|0
1972598|NCT02198794|3534261|FG001|Part C: Safety Assessment (52 Weeks)|Death|0
1972599|NCT02198794|3534262|FG002|Part C: Safety Assessment (52 Weeks)|Death|0
1972600|NCT02198794|3534263|FG003|Part C: Safety Assessment (52 Weeks)|Death|2
1972601|NCT02177695|3534274|FG000|ITT Analysis|Ineligible|5
1972602|NCT02177695|3534275|FG001|ITT Analysis|Ineligible|5
1972603|NCT02177695|3534274|FG000|Primary COXEN Analysis|inadequate tissue submitted|5
1972604|NCT02177695|3534275|FG001|Primary COXEN Analysis|inadequate tissue submitted|6
1972605|NCT02177695|3534274|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15
1972606|NCT02177695|3534275|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8
1972607|NCT02177695|3534274|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13
1972608|NCT02177695|3534275|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13
1972609|NCT02105636|3534305|FG000|Overall Study|Disease Progression|162
1972610|NCT02105636|3534306|FG001|Overall Study|Disease Progression|83
1972611|NCT02105636|3534305|FG000|Overall Study|Study Drug Toxicity|9
1972612|NCT02105636|3534306|FG001|Overall Study|Study Drug Toxicity|11
1972613|NCT02105636|3534305|FG000|Overall Study|Adverse Event Unrelated to Study Drug|12
1972614|NCT02105636|3534306|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
1972615|NCT02105636|3534305|FG000|Overall Study|Subject Request to Discontinue Treatment|4
1972616|NCT02105636|3534306|FG001|Overall Study|Subject Request to Discontinue Treatment|6
1972617|NCT02105636|3534305|FG000|Overall Study|Subject Withdrew Consent|4
1972618|NCT02105636|3534306|FG001|Overall Study|Subject Withdrew Consent|1
1972619|NCT02105636|3534305|FG000|Overall Study|Maximum Clinical Benefit|1
1972620|NCT02105636|3534306|FG001|Overall Study|Maximum Clinical Benefit|1
1972621|NCT02105636|3534305|FG000|Overall Study|Poor/Non-compliance|0
1972622|NCT02105636|3534306|FG001|Overall Study|Poor/Non-compliance|1
1972623|NCT02105636|3534305|FG000|Overall Study|Reason Not Specified|0
1972624|NCT02105636|3534306|FG001|Overall Study|Reason Not Specified|2
1972625|NCT02105636|3534305|FG000|Overall Study|Not Reported|3
1972626|NCT02105636|3534306|FG001|Overall Study|Not Reported|0
1972627|NCT02038946|3534313|FG000|Overall Study|Death|5
1972628|NCT02038946|3534313|FG000|Overall Study|Withdrawal by Subject|3
1972629|NCT02038946|3534313|FG000|Overall Study|Lost to Follow-up|2
1972630|NCT02038946|3534313|FG000|Overall Study|Other reasons|2
1972631|NCT01988571|3534319|FG000|Overall Study|Death|3
1972632|NCT01988571|3534320|FG001|Overall Study|Death|1
1972633|NCT01988571|3534319|FG000|Overall Study|Physician Decision|2
1972634|NCT01988571|3534320|FG001|Overall Study|Physician Decision|1
1972635|NCT01988571|3534319|FG000|Overall Study|Lost to Follow-up|3
1972636|NCT01988571|3534320|FG001|Overall Study|Lost to Follow-up|0
1972637|NCT01988571|3534319|FG000|Overall Study|Withdrawal by Subject|31
1972638|NCT01988571|3534320|FG001|Overall Study|Withdrawal by Subject|33
1972639|NCT01715285|3534338|FG000|Treatment Period|Adverse Event|60
1972640|NCT01715285|3534339|FG001|Treatment Period|Adverse Event|33
1972641|NCT01715285|3534340|FG002|Treatment Period|Adverse Event|0
1972642|NCT01715285|3534338|FG000|Treatment Period|Lost to Follow-up|3
1972643|NCT01715285|3534339|FG001|Treatment Period|Lost to Follow-up|2
1972644|NCT01715285|3534340|FG002|Treatment Period|Lost to Follow-up|0
1972645|NCT01715285|3534338|FG000|Treatment Period|Death|36
1972646|NCT01715285|3534339|FG001|Treatment Period|Death|23
1972647|NCT01715285|3534340|FG002|Treatment Period|Death|0
1972648|NCT01715285|3534338|FG000|Treatment Period|Noncompliance With Study Drug|4
1972649|NCT01715285|3534339|FG001|Treatment Period|Noncompliance With Study Drug|2
1972650|NCT01715285|3534340|FG002|Treatment Period|Noncompliance With Study Drug|0
1972651|NCT01715285|3534338|FG000|Treatment Period|Progressive Disease|254
1972652|NCT01715285|3534339|FG001|Treatment Period|Progressive Disease|388
1972653|NCT01715285|3534340|FG002|Treatment Period|Progressive Disease|0
1972654|NCT01715285|3534338|FG000|Treatment Period|Withdrawal Of Consent|52
1972655|NCT01715285|3534339|FG001|Treatment Period|Withdrawal Of Consent|47
1972656|NCT01715285|3534340|FG002|Treatment Period|Withdrawal Of Consent|0
1972657|NCT01715285|3534338|FG000|Treatment Period|Physician Decision|21
1972658|NCT01715285|3534339|FG001|Treatment Period|Physician Decision|23
1972659|NCT01715285|3534340|FG002|Treatment Period|Physician Decision|0
1972660|NCT01715285|3534338|FG000|Treatment Period|Ongoing|157
1972661|NCT01715285|3534339|FG001|Treatment Period|Ongoing|0
1972662|NCT01715285|3534340|FG002|Treatment Period|Ongoing|0
1972663|NCT01715285|3534338|FG000|Treatment Period|Other|10
1972664|NCT01715285|3534339|FG001|Treatment Period|Other|12
1972665|NCT01715285|3534340|FG002|Treatment Period|Other|0
1972666|NCT01715285|3534338|FG000|Treatment Period|Placebo Cross-over|0
1972667|NCT01715285|3534339|FG001|Treatment Period|Placebo Cross-over|72
1972668|NCT01715285|3534340|FG002|Treatment Period|Placebo Cross-over|0
1972669|NCT01715285|3534338|FG000|Open-label (OL) Extension Phase|Ongoing|157
1972670|NCT01715285|3534339|FG001|Open-label (OL) Extension Phase|Ongoing|0
2309788|NCT02721966|4013306|FG002|Overall Study|Did not continue to period 2|0
1972671|NCT01715285|3534340|FG002|Open-label (OL) Extension Phase|Ongoing|72
1972672|NCT01332266|3534356|FG000|Phase 1b|Death|3
1972673|NCT01332266|3534357|FG001|Phase 1b|Death|3
1972674|NCT01332266|3534358|FG002|Phase 1b|Death|2
1972675|NCT01332266|3534359|FG003|Phase 1b|Death|0
1972676|NCT01332266|3534360|FG004|Phase 1b|Death|0
1972677|NCT01332266|3534356|FG000|Phase 1b|Lost to Follow-up|0
1972678|NCT01332266|3534357|FG001|Phase 1b|Lost to Follow-up|1
1972679|NCT01332266|3534358|FG002|Phase 1b|Lost to Follow-up|0
1972680|NCT01332266|3534359|FG003|Phase 1b|Lost to Follow-up|0
1972681|NCT01332266|3534360|FG004|Phase 1b|Lost to Follow-up|0
1972682|NCT01332266|3534356|FG000|Phase 1b|Withdrawal by Subject|1
1972683|NCT01332266|3534357|FG001|Phase 1b|Withdrawal by Subject|1
1972684|NCT01332266|3534358|FG002|Phase 1b|Withdrawal by Subject|1
1972685|NCT01332266|3534359|FG003|Phase 1b|Withdrawal by Subject|0
1972686|NCT01332266|3534360|FG004|Phase 1b|Withdrawal by Subject|0
1972687|NCT01332266|3534356|FG000|Phase 2|Death|0
1972688|NCT01332266|3534357|FG001|Phase 2|Death|0
1972689|NCT01332266|3534358|FG002|Phase 2|Death|0
1972690|NCT01332266|3534359|FG003|Phase 2|Death|33
1972691|NCT01332266|3534360|FG004|Phase 2|Death|36
1972692|NCT01332266|3534356|FG000|Phase 2|Lost to Follow-up|0
1972693|NCT01332266|3534357|FG001|Phase 2|Lost to Follow-up|0
1972694|NCT01332266|3534358|FG002|Phase 2|Lost to Follow-up|0
1972695|NCT01332266|3534359|FG003|Phase 2|Lost to Follow-up|2
1972696|NCT01332266|3534360|FG004|Phase 2|Lost to Follow-up|0
1972697|NCT01332266|3534356|FG000|Phase 2|Physician Decision|0
1972698|NCT01332266|3534357|FG001|Phase 2|Physician Decision|0
1972699|NCT01332266|3534358|FG002|Phase 2|Physician Decision|0
1972700|NCT01332266|3534359|FG003|Phase 2|Physician Decision|3
1972701|NCT01332266|3534360|FG004|Phase 2|Physician Decision|1
1972702|NCT01332266|3534356|FG000|Phase 2|Symptomatic deterioration|0
1972703|NCT01332266|3534357|FG001|Phase 2|Symptomatic deterioration|0
1972704|NCT01332266|3534358|FG002|Phase 2|Symptomatic deterioration|0
1972705|NCT01332266|3534359|FG003|Phase 2|Symptomatic deterioration|0
1972706|NCT01332266|3534360|FG004|Phase 2|Symptomatic deterioration|1
1972707|NCT01332266|3534356|FG000|Phase 2|Progression Disease|0
1972708|NCT01332266|3534357|FG001|Phase 2|Progression Disease|0
1972709|NCT01332266|3534358|FG002|Phase 2|Progression Disease|0
1972710|NCT01332266|3534359|FG003|Phase 2|Progression Disease|2
1972711|NCT01332266|3534360|FG004|Phase 2|Progression Disease|1
1972712|NCT01332266|3534356|FG000|Phase 2|Withdrawal by Subject|0
1972713|NCT01332266|3534357|FG001|Phase 2|Withdrawal by Subject|0
1972714|NCT01332266|3534358|FG002|Phase 2|Withdrawal by Subject|0
1972715|NCT01332266|3534359|FG003|Phase 2|Withdrawal by Subject|2
1972716|NCT01332266|3534360|FG004|Phase 2|Withdrawal by Subject|2
1972717|NCT01150890|3534377|FG000|Overall Study|Other|0
1972718|NCT01150890|3534378|FG001|Overall Study|Other|1
1972719|NCT01150890|3534379|FG002|Overall Study|Other|0
1972720|NCT01150890|3534380|FG003|Overall Study|Other|2
1972721|NCT01150890|3534377|FG000|Overall Study|Pregnancy|0
1972722|NCT01150890|3534378|FG001|Overall Study|Pregnancy|0
1972723|NCT01150890|3534379|FG002|Overall Study|Pregnancy|0
1972724|NCT01150890|3534380|FG003|Overall Study|Pregnancy|1
1972725|NCT01150890|3534377|FG000|Overall Study|Administrative Decision|4
1972726|NCT01150890|3534378|FG001|Overall Study|Administrative Decision|4
1972727|NCT01150890|3534379|FG002|Overall Study|Administrative Decision|5
2309789|NCT02721966|4013307|FG003|Overall Study|Did not continue to period 2|0
2309790|NCT02721966|4013308|FG004|Overall Study|Did not continue to period 2|5
2309791|NCT02722044|4013316|FG000|Overall Study|Adverse Event|2
2309792|NCT02722044|4013316|FG000|Overall Study|Physician Decision|1
2309793|NCT02722044|4013316|FG000|Overall Study|Withdrawal by Subject|1
2309794|NCT02722044|4013316|FG000|Overall Study|Did Not Meet Criteria at Week 14|1
2309795|NCT02722148|4013321|FG000|Overall Study|Lost to Follow-up|2
2309796|NCT02722148|4013321|FG000|Overall Study|Non compliant with treatment regimen|3
2309797|NCT02722278|4013337|FG000|Overall Study|Withdrawal by Subject|5
2309798|NCT02722278|4013338|FG001|Overall Study|Withdrawal by Subject|3
2309799|NCT02722278|4013337|FG000|Overall Study|Adverse Event|4
2309800|NCT02722278|4013338|FG001|Overall Study|Adverse Event|1
2309801|NCT02722278|4013337|FG000|Overall Study|Lost to Follow-up|2
2309802|NCT02722278|4013338|FG001|Overall Study|Lost to Follow-up|0
2309803|NCT02722278|4013337|FG000|Overall Study|Protocol Violation|1
2309804|NCT02722278|4013338|FG001|Overall Study|Protocol Violation|0
2309805|NCT02722278|4013337|FG000|Overall Study|High PSA pre-study/ not eligible|0
2309806|NCT02722278|4013338|FG001|Overall Study|High PSA pre-study/ not eligible|1
2309807|NCT02722278|4013337|FG000|Overall Study|Subject declined after tx assignment|0
2309808|NCT02722278|4013338|FG001|Overall Study|Subject declined after tx assignment|1
2309809|NCT02722278|4013337|FG000|Overall Study|Site closure not study related|0
2309810|NCT02722278|4013338|FG001|Overall Study|Site closure not study related|1
2309811|NCT02722304|4013351|FG000|Overall Study|Study Terminated by Sponsor|1
2309812|NCT02722304|4013352|FG001|Overall Study|Study Terminated by Sponsor|0
2309813|NCT02722304|4013353|FG002|Overall Study|Study Terminated by Sponsor|2
2309814|NCT02722304|4013354|FG003|Overall Study|Study Terminated by Sponsor|1
2309815|NCT02722304|4013355|FG004|Overall Study|Study Terminated by Sponsor|1
2309816|NCT02722304|4013351|FG000|Overall Study|Other|0
2309817|NCT02722304|4013352|FG001|Overall Study|Other|0
2309818|NCT02722304|4013353|FG002|Overall Study|Other|0
2309819|NCT02722304|4013354|FG003|Overall Study|Other|1
2309820|NCT02722304|4013355|FG004|Overall Study|Other|1
1972728|NCT01150890|3534380|FG003|Overall Study|Administrative Decision|6
1972729|NCT01150890|3534377|FG000|Overall Study|Ineligibility determined|0
1972730|NCT01150890|3534378|FG001|Overall Study|Ineligibility determined|1
1972731|NCT01150890|3534379|FG002|Overall Study|Ineligibility determined|0
1972732|NCT01150890|3534380|FG003|Overall Study|Ineligibility determined|0
1972733|NCT01150890|3534377|FG000|Overall Study|Adverse Event|0
1972734|NCT01150890|3534378|FG001|Overall Study|Adverse Event|0
1972735|NCT01150890|3534379|FG002|Overall Study|Adverse Event|2
1972736|NCT01150890|3534380|FG003|Overall Study|Adverse Event|0
1972737|NCT01150890|3534377|FG000|Overall Study|Withdrawal by Subject|0
1972738|NCT01150890|3534378|FG001|Overall Study|Withdrawal by Subject|0
1972739|NCT01150890|3534379|FG002|Overall Study|Withdrawal by Subject|2
1972740|NCT01150890|3534380|FG003|Overall Study|Withdrawal by Subject|1
1972741|NCT01150890|3534377|FG000|Overall Study|Disease progression|0
1972742|NCT01150890|3534378|FG001|Overall Study|Disease progression|7
1972743|NCT01150890|3534379|FG002|Overall Study|Disease progression|3
1972744|NCT01150890|3534380|FG003|Overall Study|Disease progression|7
1972745|NCT01140867|3534393|FG000|Overall Study|Adverse Event|22
1972746|NCT01140867|3534393|FG000|Overall Study|Lack of Efficacy|3
1972747|NCT01140867|3534393|FG000|Overall Study|Lost to Follow-up|2
1972748|NCT01140867|3534393|FG000|Overall Study|Withdrawal by Subject|1
1972749|NCT01140867|3534393|FG000|Overall Study|Protocol Violation|1
1972750|NCT01140867|3534393|FG000|Overall Study|Uncooperative patient|2
1972751|NCT01140867|3534393|FG000|Overall Study|Medication Noncompliance|2
1972752|NCT01137773|3534399|FG000|Overall Study|Death|3
1972753|NCT01137773|3534400|FG001|Overall Study|Death|3
1972754|NCT01137773|3534399|FG000|Overall Study|Lost to Follow-up|6
1972755|NCT01137773|3534400|FG001|Overall Study|Lost to Follow-up|0
1972756|NCT01127256|3534410|FG000|Overall Study|Adverse Event|13
1972757|NCT01127256|3534411|FG001|Overall Study|Adverse Event|13
1972758|NCT01127256|3534410|FG000|Overall Study|Lack of Efficacy|4
1972759|NCT01127256|3534411|FG001|Overall Study|Lack of Efficacy|0
1972760|NCT01127256|3534410|FG000|Overall Study|Lost to Follow-up|16
1972761|NCT01127256|3534411|FG001|Overall Study|Lost to Follow-up|17
1972762|NCT01127256|3534410|FG000|Overall Study|Withdrawal by Subject|5
1972763|NCT01127256|3534411|FG001|Overall Study|Withdrawal by Subject|9
1972764|NCT01127256|3534410|FG000|Overall Study|Protocol Violation|1
1972765|NCT01127256|3534411|FG001|Overall Study|Protocol Violation|0
1972766|NCT01004861|3534430|FG000|Overall Study|Disease progression|3
1972767|NCT01004861|3534431|FG001|Overall Study|Disease progression|4
1972768|NCT01004861|3534432|FG002|Overall Study|Disease progression|5
1972769|NCT01004861|3534433|FG003|Overall Study|Disease progression|4
1972770|NCT01004861|3534434|FG004|Overall Study|Disease progression|4
1972771|NCT01004861|3534435|FG005|Overall Study|Disease progression|4
1972772|NCT01004861|3534436|FG006|Overall Study|Disease progression|5
1972773|NCT01004861|3534437|FG007|Overall Study|Disease progression|1
1972774|NCT01004861|3534438|FG008|Overall Study|Disease progression|4
1972775|NCT01004861|3534439|FG009|Overall Study|Disease progression|7
1972776|NCT01004861|3534440|FG010|Overall Study|Disease progression|6
2212773|NCT01673646|3854114|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2212774|NCT01673646|3854115|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2212775|NCT01673646|3854116|FG002|Overall Study|Unsatisfactory therapeutic effect|0
2212776|NCT01673646|3854114|FG000|Overall Study|Condition no longer requires study drug|0
2212777|NCT01673646|3854115|FG001|Overall Study|Condition no longer requires study drug|1
2212778|NCT01673646|3854116|FG002|Overall Study|Condition no longer requires study drug|0
2309821|NCT02722499|4013382|FG000|Overall Study|Lost to Follow-up|2
2309822|NCT02722499|4013383|FG001|Overall Study|Lost to Follow-up|0
2309823|NCT02722499|4013384|FG002|Overall Study|Lost to Follow-up|1
2309824|NCT02722928|4013411|FG000|Overall Study|Standard CT was not as required per prot|5
2309825|NCT02722928|4013412|FG001|Overall Study|Standard CT was not as required per prot|13
2309826|NCT02722928|4013411|FG000|Overall Study|Required Intraoperative MRI|5
2309827|NCT02722928|4013412|FG001|Overall Study|Required Intraoperative MRI|7
2309828|NCT02722967|4013425|FG000|Overall Study|Adverse Event|1
2309829|NCT02722967|4013426|FG001|Overall Study|Adverse Event|0
2309830|NCT02722967|4013427|FG002|Overall Study|Adverse Event|0
2309831|NCT02722967|4013425|FG000|Overall Study|Lost to Follow-up|0
2309832|NCT02722967|4013426|FG001|Overall Study|Lost to Follow-up|1
2309833|NCT02722967|4013427|FG002|Overall Study|Lost to Follow-up|0
2309834|NCT02722967|4013425|FG000|Overall Study|Non-compliance with patch wearing|2
2309835|NCT02722967|4013426|FG001|Overall Study|Non-compliance with patch wearing|1
2309836|NCT02722967|4013427|FG002|Overall Study|Non-compliance with patch wearing|1
2309837|NCT02722967|4013425|FG000|Overall Study|Withdrawal by Subject|1
2309838|NCT02722967|4013426|FG001|Overall Study|Withdrawal by Subject|0
2309839|NCT02722967|4013427|FG002|Overall Study|Withdrawal by Subject|1
2309840|NCT02722967|4013425|FG000|Overall Study|Physician Decision|1
2309841|NCT02722967|4013426|FG001|Overall Study|Physician Decision|0
2309842|NCT02722967|4013427|FG002|Overall Study|Physician Decision|0
2212779|NCT01673646|3854114|FG000|Overall Study|Withdrawal by Subject|0
2212780|NCT01673646|3854115|FG001|Overall Study|Withdrawal by Subject|2
2212781|NCT01673646|3854116|FG002|Overall Study|Withdrawal by Subject|2
2212782|NCT01673646|3854114|FG000|Overall Study|Completed Core/did not enter Ext.|2
2212783|NCT01673646|3854115|FG001|Overall Study|Completed Core/did not enter Ext.|1
2309843|NCT02722967|4013425|FG000|Overall Study|Non-adherence of the patch to the skin|0
2309844|NCT02722967|4013426|FG001|Overall Study|Non-adherence of the patch to the skin|0
2309845|NCT02722967|4013427|FG002|Overall Study|Non-adherence of the patch to the skin|2
2309846|NCT02723006|4013438|FG000|Overall Study|Withdrawal by Subject|0
2309847|NCT02723006|4013439|FG001|Overall Study|Withdrawal by Subject|1
2309848|NCT02723006|4013440|FG002|Overall Study|Withdrawal by Subject|1
1972777|NCT01004861|3534441|FG011|Overall Study|Disease progression|3
1972778|NCT01004861|3534442|FG012|Overall Study|Disease progression|8
1972779|NCT01004861|3534430|FG000|Overall Study|Physician Decision|0
1972780|NCT01004861|3534431|FG001|Overall Study|Physician Decision|2
1972781|NCT01004861|3534432|FG002|Overall Study|Physician Decision|1
1972782|NCT01004861|3534433|FG003|Overall Study|Physician Decision|1
1972783|NCT01004861|3534434|FG004|Overall Study|Physician Decision|1
1972784|NCT01004861|3534435|FG005|Overall Study|Physician Decision|0
1972785|NCT01004861|3534436|FG006|Overall Study|Physician Decision|0
1972786|NCT01004861|3534437|FG007|Overall Study|Physician Decision|1
2309849|NCT02723006|4013438|FG000|Overall Study|Study Terminated by Sponsor|1
1972787|NCT01004861|3534438|FG008|Overall Study|Physician Decision|0
1972788|NCT01004861|3534439|FG009|Overall Study|Physician Decision|0
1972789|NCT01004861|3534440|FG010|Overall Study|Physician Decision|0
1972790|NCT01004861|3534441|FG011|Overall Study|Physician Decision|0
1972791|NCT01004861|3534442|FG012|Overall Study|Physician Decision|3
1972792|NCT01004861|3534430|FG000|Overall Study|Adverse Event|0
1972793|NCT01004861|3534431|FG001|Overall Study|Adverse Event|0
1972794|NCT01004861|3534432|FG002|Overall Study|Adverse Event|0
1972795|NCT01004861|3534433|FG003|Overall Study|Adverse Event|1
1972796|NCT01004861|3534434|FG004|Overall Study|Adverse Event|0
1972797|NCT01004861|3534435|FG005|Overall Study|Adverse Event|2
1972798|NCT01004861|3534436|FG006|Overall Study|Adverse Event|1
1972799|NCT01004861|3534437|FG007|Overall Study|Adverse Event|1
1972800|NCT01004861|3534438|FG008|Overall Study|Adverse Event|13
1972801|NCT01004861|3534439|FG009|Overall Study|Adverse Event|1
1972802|NCT01004861|3534440|FG010|Overall Study|Adverse Event|1
1972803|NCT01004861|3534441|FG011|Overall Study|Adverse Event|0
1972804|NCT01004861|3534442|FG012|Overall Study|Adverse Event|2
1972805|NCT01004861|3534430|FG000|Overall Study|Protocol Violation|0
1972806|NCT01004861|3534431|FG001|Overall Study|Protocol Violation|0
1972807|NCT01004861|3534432|FG002|Overall Study|Protocol Violation|0
2309850|NCT02723006|4013439|FG001|Overall Study|Study Terminated by Sponsor|6
2309851|NCT02723006|4013440|FG002|Overall Study|Study Terminated by Sponsor|6
2309852|NCT02723084|4013450|FG000|Overall Study|Withdrawal by Subject|1
2309853|NCT02723084|4013451|FG001|Overall Study|Withdrawal by Subject|1
2309854|NCT02723084|4013450|FG000|Overall Study|Lost to Follow-up|3
2309855|NCT02723084|4013451|FG001|Overall Study|Lost to Follow-up|0
2309856|NCT02723175|4013459|FG000|Overall Study|Lost to 1 Month Follow Up|3
2309857|NCT02723175|4013460|FG001|Overall Study|Lost to 1 Month Follow Up|2
2309858|NCT02723175|4013459|FG000|Overall Study|Lost to 3 Month Follow Up|1
2309859|NCT02723175|4013460|FG001|Overall Study|Lost to 3 Month Follow Up|1
2309860|NCT02723188|4013469|FG000|Overall Study|Withdrawal by Subject|1
2309861|NCT02723188|4013470|FG001|Overall Study|Withdrawal by Subject|0
2309862|NCT02723188|4013471|FG002|Overall Study|Withdrawal by Subject|0
2309863|NCT02723201|4013482|FG000|Second Intervention Period|Protocol Violation|1
2309864|NCT02723201|4013483|FG001|Second Intervention Period|Protocol Violation|0
2309865|NCT02723201|4013484|FG002|Second Intervention Period|Protocol Violation|0
2309866|NCT02723201|4013482|FG000|Second Intervention Period|Adverse Event|1
2309867|NCT02723201|4013483|FG001|Second Intervention Period|Adverse Event|0
2309868|NCT02723201|4013484|FG002|Second Intervention Period|Adverse Event|0
2309869|NCT02723344|4013500|FG000|Overall Study|Lost to Follow-up|0
2309870|NCT02723344|4013501|FG001|Overall Study|Lost to Follow-up|4
2309871|NCT02723591|4013509|FG000|Overall Study|Adverse Event|48
2309872|NCT02723591|4013510|FG001|Overall Study|Adverse Event|40
2309873|NCT02723591|4013509|FG000|Overall Study|Death|2
2309874|NCT02723591|4013510|FG001|Overall Study|Death|2
2309875|NCT02723591|4013509|FG000|Overall Study|Lack of Efficacy|4
2309876|NCT02723591|4013510|FG001|Overall Study|Lack of Efficacy|3
2309877|NCT02723591|4013509|FG000|Overall Study|Lost to Follow-up|1
2309878|NCT02723591|4013510|FG001|Overall Study|Lost to Follow-up|7
2309879|NCT02723591|4013509|FG000|Overall Study|Protocol Violation|20
2309880|NCT02723591|4013510|FG001|Overall Study|Protocol Violation|23
2309881|NCT02723591|4013509|FG000|Overall Study|Withdrawal by Subject|4
2309882|NCT02723591|4013510|FG001|Overall Study|Withdrawal by Subject|8
2309883|NCT02723591|4013509|FG000|Overall Study|Randomized but Never Received StudyDrug|12
2309884|NCT02723591|4013510|FG001|Overall Study|Randomized but Never Received StudyDrug|12
2309885|NCT02723591|4013509|FG000|Overall Study|Miscellaneous|5
2309886|NCT02723591|4013510|FG001|Overall Study|Miscellaneous|6
2309887|NCT02723630|4013522|FG000|Intervention Period 1|Adverse Event|1
2309888|NCT02723630|4013523|FG001|Intervention Period 1|Adverse Event|0
2309889|NCT02723630|4013524|FG002|Intervention Period 1|Adverse Event|0
2309890|NCT02723630|4013525|FG003|Intervention Period 1|Adverse Event|0
2309891|NCT02723630|4013526|FG004|Intervention Period 1|Adverse Event|0
2309892|NCT02723630|4013527|FG005|Intervention Period 1|Adverse Event|0
2309893|NCT02723630|4013522|FG000|Intervention Period 3|consumption of restricted item|0
2309894|NCT02723630|4013523|FG001|Intervention Period 3|consumption of restricted item|1
2309895|NCT02723630|4013524|FG002|Intervention Period 3|consumption of restricted item|0
2309896|NCT02723630|4013525|FG003|Intervention Period 3|consumption of restricted item|0
2309897|NCT02723630|4013526|FG004|Intervention Period 3|consumption of restricted item|0
2309898|NCT02723630|4013527|FG005|Intervention Period 3|consumption of restricted item|0
2309899|NCT02723786|4013540|FG000|Overall Study|Lost to Follow-up|1
1972808|NCT01004861|3534433|FG003|Overall Study|Protocol Violation|0
1972809|NCT01004861|3534434|FG004|Overall Study|Protocol Violation|1
1972810|NCT01004861|3534435|FG005|Overall Study|Protocol Violation|0
1972811|NCT01004861|3534436|FG006|Overall Study|Protocol Violation|0
2309900|NCT02724020|4013567|FG000|Overall Study|Death|16
2309901|NCT02724020|4013568|FG001|Overall Study|Death|18
2309902|NCT02724020|4013569|FG002|Overall Study|Death|19
2309903|NCT02724020|4013567|FG000|Overall Study|Lost to Follow-up|0
2309904|NCT02724020|4013568|FG001|Overall Study|Lost to Follow-up|3
2309905|NCT02724020|4013569|FG002|Overall Study|Lost to Follow-up|0
2309906|NCT02724020|4013567|FG000|Overall Study|Site Terminated by Sponsor|15
2309907|NCT02724020|4013568|FG001|Overall Study|Site Terminated by Sponsor|8
1972812|NCT01004861|3534437|FG007|Overall Study|Protocol Violation|0
1972813|NCT01004861|3534438|FG008|Overall Study|Protocol Violation|0
1972814|NCT01004861|3534439|FG009|Overall Study|Protocol Violation|0
1972815|NCT01004861|3534440|FG010|Overall Study|Protocol Violation|0
1972816|NCT01004861|3534441|FG011|Overall Study|Protocol Violation|0
1972817|NCT01004861|3534442|FG012|Overall Study|Protocol Violation|0
1972818|NCT01004861|3534430|FG000|Overall Study|Lost to Follow-up|0
1972819|NCT01004861|3534431|FG001|Overall Study|Lost to Follow-up|0
1972820|NCT01004861|3534432|FG002|Overall Study|Lost to Follow-up|0
1972821|NCT01004861|3534433|FG003|Overall Study|Lost to Follow-up|0
1972822|NCT01004861|3534434|FG004|Overall Study|Lost to Follow-up|0
1972823|NCT01004861|3534435|FG005|Overall Study|Lost to Follow-up|0
1972824|NCT01004861|3534436|FG006|Overall Study|Lost to Follow-up|0
1972825|NCT01004861|3534437|FG007|Overall Study|Lost to Follow-up|1
1972826|NCT01004861|3534438|FG008|Overall Study|Lost to Follow-up|3
1972827|NCT01004861|3534439|FG009|Overall Study|Lost to Follow-up|0
1972828|NCT01004861|3534440|FG010|Overall Study|Lost to Follow-up|0
1972829|NCT01004861|3534441|FG011|Overall Study|Lost to Follow-up|1
1972830|NCT01004861|3534442|FG012|Overall Study|Lost to Follow-up|0
1972831|NCT01004861|3534430|FG000|Overall Study|Non-compliance|0
1972832|NCT01004861|3534431|FG001|Overall Study|Non-compliance|0
1972833|NCT01004861|3534432|FG002|Overall Study|Non-compliance|0
1972834|NCT01004861|3534433|FG003|Overall Study|Non-compliance|0
1972835|NCT01004861|3534434|FG004|Overall Study|Non-compliance|0
1972836|NCT01004861|3534435|FG005|Overall Study|Non-compliance|0
1972837|NCT01004861|3534436|FG006|Overall Study|Non-compliance|0
2102140|NCT00837577|3693869|FG001|Open-label Period|Lack of Efficacy|3
2309908|NCT02724020|4013569|FG002|Overall Study|Site Terminated by Sponsor|8
2309909|NCT02724020|4013567|FG000|Overall Study|Withdrawal by Subject|1
2309910|NCT02724020|4013568|FG001|Overall Study|Withdrawal by Subject|3
2309911|NCT02724020|4013569|FG002|Overall Study|Withdrawal by Subject|5
2309912|NCT02724111|4013592|FG000|Overall Study|Protocol Violation|2
2309913|NCT02724111|4013593|FG001|Overall Study|Protocol Violation|5
2309914|NCT02724462|4013610|FG000|3 Month Follow-up Survey|Lost to Follow-up|171
2309915|NCT02724462|4013611|FG001|3 Month Follow-up Survey|Lost to Follow-up|151
2309916|NCT02724462|4013610|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40
2309917|NCT02724462|4013611|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48
2309918|NCT02724462|4013610|FG000|6 Month Follow-up Survey|Lost to Follow-up|156
2309919|NCT02724462|4013611|FG001|6 Month Follow-up Survey|Lost to Follow-up|123
2309920|NCT02724462|4013610|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40
2309921|NCT02724462|4013611|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48
2309922|NCT02724462|4013610|FG000|12 Month Follow-up Survey|Lost to Follow-up|174
2309923|NCT02724462|4013611|FG001|12 Month Follow-up Survey|Lost to Follow-up|134
2309924|NCT02724462|4013610|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40
2309925|NCT02724462|4013611|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48
2309926|NCT02724592|4013619|FG000|Overall Study|Lost to Follow-up|4
2309927|NCT02724592|4013620|FG001|Overall Study|Lost to Follow-up|1
2309928|NCT02724644|4013628|FG000|Overall Study|Adverse Event|7
2309929|NCT02724644|4013629|FG001|Overall Study|Adverse Event|1
2309930|NCT02724644|4013628|FG000|Overall Study|Lost to Follow-up|6
2309931|NCT02724644|4013629|FG001|Overall Study|Lost to Follow-up|2
2309932|NCT02724644|4013628|FG000|Overall Study|Withdrawal by Subject|7
2309933|NCT02724644|4013629|FG001|Overall Study|Withdrawal by Subject|1
2309934|NCT02724644|4013628|FG000|Overall Study|Administrative|1
2309935|NCT02724644|4013629|FG001|Overall Study|Administrative|0
2309936|NCT02724839|4013651|FG000|Overall Study|Withdrawal by Subject|1
2309937|NCT02724839|4013652|FG001|Overall Study|Withdrawal by Subject|1
2309938|NCT02724839|4013653|FG002|Overall Study|Withdrawal by Subject|0
2309939|NCT02724839|4013651|FG000|Overall Study|Lost to Follow-up|0
2309940|NCT02724839|4013652|FG001|Overall Study|Lost to Follow-up|3
2309941|NCT02724839|4013653|FG002|Overall Study|Lost to Follow-up|2
2309942|NCT02724839|4013651|FG000|Overall Study|Physician Decision|0
2309943|NCT02724839|4013652|FG001|Overall Study|Physician Decision|0
2309944|NCT02724839|4013653|FG002|Overall Study|Physician Decision|3
2309945|NCT02724878|4013668|FG000|Overall Study|Still on Active Therapy|15
2309946|NCT02724878|4013668|FG000|Overall Study|Disease Progression|31
2309947|NCT02724878|4013668|FG000|Overall Study|Toxicity|5
2309948|NCT02724878|4013668|FG000|Overall Study|Death|1
2309949|NCT02724878|4013668|FG000|Overall Study|Withdrawal by Subject|4
2309950|NCT02724878|4013668|FG000|Overall Study|Lost to Follow-up|2
2309951|NCT02724878|4013668|FG000|Overall Study|Protocol Violation|1
2309952|NCT02724878|4013668|FG000|Overall Study|Ineligible for Study Drug|5
2309953|NCT02724878|4013668|FG000|Overall Study|Other|1
2309954|NCT02724956|4013674|FG000|Overall Study|Physician Decision|1
2309955|NCT02724956|4013675|FG001|Overall Study|Physician Decision|0
2309956|NCT02724956|4013674|FG000|Overall Study|Lack of Efficacy|0
2309957|NCT02724956|4013675|FG001|Overall Study|Lack of Efficacy|1
2309958|NCT02724956|4013674|FG000|Overall Study|Withdrawal by Subject|0
1972838|NCT01004861|3534437|FG007|Overall Study|Non-compliance|0
1972839|NCT01004861|3534438|FG008|Overall Study|Non-compliance|5
1972840|NCT01004861|3534439|FG009|Overall Study|Non-compliance|0
1972841|NCT01004861|3534440|FG010|Overall Study|Non-compliance|0
1972842|NCT01004861|3534441|FG011|Overall Study|Non-compliance|0
1972843|NCT01004861|3534442|FG012|Overall Study|Non-compliance|1
1972844|NCT01004861|3534430|FG000|Overall Study|Other|0
1972845|NCT01004861|3534431|FG001|Overall Study|Other|0
1972846|NCT01004861|3534432|FG002|Overall Study|Other|0
1972847|NCT01004861|3534433|FG003|Overall Study|Other|0
1972848|NCT01004861|3534434|FG004|Overall Study|Other|0
1972849|NCT01004861|3534435|FG005|Overall Study|Other|0
1972850|NCT01004861|3534436|FG006|Overall Study|Other|0
1972851|NCT01004861|3534437|FG007|Overall Study|Other|0
1972852|NCT01004861|3534438|FG008|Overall Study|Other|0
1972853|NCT01004861|3534439|FG009|Overall Study|Other|2
1972854|NCT01004861|3534440|FG010|Overall Study|Other|1
1972855|NCT01004861|3534441|FG011|Overall Study|Other|2
1972856|NCT01004861|3534442|FG012|Overall Study|Other|3
1972857|NCT01004861|3534430|FG000|Overall Study|Patient decision|0
1972858|NCT01004861|3534431|FG001|Overall Study|Patient decision|0
1972859|NCT01004861|3534432|FG002|Overall Study|Patient decision|0
1972860|NCT01004861|3534433|FG003|Overall Study|Patient decision|0
1972861|NCT01004861|3534434|FG004|Overall Study|Patient decision|1
1972862|NCT01004861|3534435|FG005|Overall Study|Patient decision|0
1972863|NCT01004861|3534436|FG006|Overall Study|Patient decision|1
1972864|NCT01004861|3534437|FG007|Overall Study|Patient decision|0
1972865|NCT01004861|3534438|FG008|Overall Study|Patient decision|7
1972866|NCT01004861|3534439|FG009|Overall Study|Patient decision|1
1972867|NCT01004861|3534440|FG010|Overall Study|Patient decision|1
1972868|NCT01004861|3534441|FG011|Overall Study|Patient decision|2
1972869|NCT01004861|3534442|FG012|Overall Study|Patient decision|3
1972870|NCT01004861|3534430|FG000|Overall Study|Transitioned to Phase 4 study|0
1972871|NCT01004861|3534431|FG001|Overall Study|Transitioned to Phase 4 study|0
1972872|NCT01004861|3534432|FG002|Overall Study|Transitioned to Phase 4 study|0
1972873|NCT01004861|3534433|FG003|Overall Study|Transitioned to Phase 4 study|0
1972874|NCT01004861|3534434|FG004|Overall Study|Transitioned to Phase 4 study|0
1972875|NCT01004861|3534435|FG005|Overall Study|Transitioned to Phase 4 study|0
2309959|NCT02724956|4013675|FG001|Overall Study|Withdrawal by Subject|1
2309960|NCT02725008|4013683|FG000|Overall Study|Lost to Follow-up|7
2309961|NCT02725008|4013684|FG001|Overall Study|Lost to Follow-up|9
2309962|NCT02725008|4013683|FG000|Overall Study|Withdrawal by Subject|2
2309963|NCT02725008|4013684|FG001|Overall Study|Withdrawal by Subject|2
2309964|NCT02725008|4013683|FG000|Overall Study|Admitted to hospital|0
2309965|NCT02725008|4013684|FG001|Overall Study|Admitted to hospital|1
2309966|NCT02725268|4013694|FG000|Overall Study|Death|58
2309967|NCT02725268|4013695|FG001|Overall Study|Death|59
2309968|NCT02725268|4013696|FG002|Overall Study|Death|30
2309969|NCT02725268|4013697|FG003|Overall Study|Death|16
2309970|NCT02725268|4013694|FG000|Overall Study|Lost to Follow-up|4
2309971|NCT02725268|4013695|FG001|Overall Study|Lost to Follow-up|3
2309972|NCT02725268|4013696|FG002|Overall Study|Lost to Follow-up|0
2309973|NCT02725268|4013697|FG003|Overall Study|Lost to Follow-up|1
2309974|NCT02725268|4013694|FG000|Overall Study|Site Terminated by Sponsor|0
2309975|NCT02725268|4013695|FG001|Overall Study|Site Terminated by Sponsor|1
2309976|NCT02725268|4013696|FG002|Overall Study|Site Terminated by Sponsor|0
2309977|NCT02725268|4013697|FG003|Overall Study|Site Terminated by Sponsor|0
2309978|NCT02725268|4013694|FG000|Overall Study|Withdrawal by Subject|8
2309979|NCT02725268|4013695|FG001|Overall Study|Withdrawal by Subject|6
2309980|NCT02725268|4013696|FG002|Overall Study|Withdrawal by Subject|8
2309981|NCT02725268|4013697|FG003|Overall Study|Withdrawal by Subject|1
2309982|NCT02725268|4013694|FG000|Overall Study|Reason not Specified|2
2309983|NCT02725268|4013695|FG001|Overall Study|Reason not Specified|1
2309984|NCT02725268|4013696|FG002|Overall Study|Reason not Specified|0
2309985|NCT02725268|4013697|FG003|Overall Study|Reason not Specified|0
2309986|NCT02725411|4013710|FG000|Treatment Period (56 Weeks)|Adverse Event|3
2309987|NCT02725411|4013711|FG001|Treatment Period (56 Weeks)|Adverse Event|5
2309988|NCT02725411|4013712|FG002|Treatment Period (56 Weeks)|Adverse Event|4
2309989|NCT02725411|4013710|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1
2309990|NCT02725411|4013711|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4
2309991|NCT02725411|4013712|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1
2309992|NCT02725411|4013710|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0
2309993|NCT02725411|4013711|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1
2309994|NCT02725411|4013712|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0
2309995|NCT02725411|4013710|FG000|Treatment Period (56 Weeks)|Other|1
2309996|NCT02725411|4013711|FG001|Treatment Period (56 Weeks)|Other|4
2309997|NCT02725411|4013712|FG002|Treatment Period (56 Weeks)|Other|5
2309998|NCT02725411|4013710|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0
2309999|NCT02725411|4013711|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1
1972876|NCT01004861|3534436|FG006|Overall Study|Transitioned to Phase 4 study|0
1972877|NCT01004861|3534437|FG007|Overall Study|Transitioned to Phase 4 study|0
1972878|NCT01004861|3534438|FG008|Overall Study|Transitioned to Phase 4 study|2
1972879|NCT01004861|3534439|FG009|Overall Study|Transitioned to Phase 4 study|0
2310000|NCT02725411|4013712|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4
2310001|NCT02725411|4013710|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25
2310002|NCT02725411|4013711|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
2310003|NCT02725411|4013712|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
2310004|NCT02725411|4013710|FG000|Follow-up Period (24 Weeks)|Adverse Event|1
1972880|NCT01004861|3534440|FG010|Overall Study|Transitioned to Phase 4 study|0
1972881|NCT01004861|3534441|FG011|Overall Study|Transitioned to Phase 4 study|0
1972882|NCT01004861|3534442|FG012|Overall Study|Transitioned to Phase 4 study|0
1972883|NCT01004861|3534430|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1972884|NCT01004861|3534431|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1972885|NCT01004861|3534432|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1972886|NCT01004861|3534433|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
2310005|NCT02725411|4013711|FG001|Follow-up Period (24 Weeks)|Adverse Event|1
2310006|NCT02725411|4013712|FG002|Follow-up Period (24 Weeks)|Adverse Event|0
2310007|NCT02725411|4013710|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0
2310008|NCT02725411|4013711|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2
2310009|NCT02725411|4013712|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0
2310010|NCT02725411|4013710|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1
2310011|NCT02725411|4013711|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1
2310012|NCT02725411|4013712|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0
2310013|NCT02725411|4013710|FG000|Follow-up Period (24 Weeks)|Other|1
2310014|NCT02725411|4013711|FG001|Follow-up Period (24 Weeks)|Other|4
2310015|NCT02725411|4013712|FG002|Follow-up Period (24 Weeks)|Other|2
2310016|NCT02725411|4013710|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
2310017|NCT02725411|4013711|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
2310018|NCT02725411|4013712|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
2310019|NCT02725476|4013722|FG000|Overall Study|Physician Decision|2
2310020|NCT02725476|4013723|FG001|Overall Study|Physician Decision|0
2310021|NCT02725476|4013722|FG000|Overall Study|Adverse Event|1
2310022|NCT02725476|4013723|FG001|Overall Study|Adverse Event|1
2310023|NCT02725515|4013731|FG000|Overall Study|Refused infusion (no study treatment)|1
2310024|NCT02725515|4013732|FG001|Overall Study|Refused infusion (no study treatment)|0
2310025|NCT02725515|4013731|FG000|Overall Study|Loss of Improvement per Protocol|14
2310026|NCT02725515|4013732|FG001|Overall Study|Loss of Improvement per Protocol|25
2310027|NCT02725515|4013731|FG000|Overall Study|Withdrawal by Subject|2
2310028|NCT02725515|4013732|FG001|Overall Study|Withdrawal by Subject|1
2310029|NCT02725515|4013731|FG000|Overall Study|Non-Compliance With Study Drug|0
2310030|NCT02725515|4013732|FG001|Overall Study|Non-Compliance With Study Drug|3
2310031|NCT02725515|4013731|FG000|Overall Study|Lost to Follow-up|1
2310032|NCT02725515|4013732|FG001|Overall Study|Lost to Follow-up|1
2310033|NCT02725515|4013731|FG000|Overall Study|Adverse Event|7
2310034|NCT02725515|4013732|FG001|Overall Study|Adverse Event|2
2310035|NCT02725515|4013731|FG000|Overall Study|No Documented Disease Improvement|0
2310036|NCT02725515|4013732|FG001|Overall Study|No Documented Disease Improvement|1
2310037|NCT02725515|4013731|FG000|Overall Study|Completed Study Under Original Protocol|0
2310038|NCT02725515|4013732|FG001|Overall Study|Completed Study Under Original Protocol|1
2310039|NCT02725515|4013731|FG000|Overall Study|Lack of Response|0
2310040|NCT02725515|4013732|FG001|Overall Study|Lack of Response|1
2310041|NCT02725710|4013744|FG000|Overall Study|Lost to Follow-up|1
2310042|NCT02725710|4013745|FG001|Overall Study|Lost to Follow-up|0
2310043|NCT02725788|4013753|FG000|Overall Study|Lost to Follow-up|1
2310044|NCT02725788|4013754|FG001|Overall Study|Lost to Follow-up|1
2310045|NCT02725788|4013753|FG000|Overall Study|Protocol Violation|0
2310046|NCT02725788|4013754|FG001|Overall Study|Protocol Violation|1
2310047|NCT02725866|4013769|FG000|Overall Study|Failure to return|6
2310048|NCT02725866|4013769|FG000|Overall Study|Withdrew consent|3
2310049|NCT02725866|4013769|FG000|Overall Study|Insufficient virological response|1
2310050|NCT02725866|4013769|FG000|Overall Study|Other, not specified|4
2310051|NCT02726022|4013773|FG000|Overall Study|Adverse Event|14
2310052|NCT02726022|4013773|FG000|Overall Study|Treatment Failure|8
2310053|NCT02726022|4013773|FG000|Overall Study|Poor Compliance|13
2310054|NCT02726022|4013773|FG000|Overall Study|Treatment Failure and Poor Compliance|1
2310055|NCT02726074|4013777|FG000|Overall Study|Withdrawal by Subject|4
2310056|NCT02726074|4013777|FG000|Overall Study|Adverse Event|14
2310057|NCT02726074|4013777|FG000|Overall Study|Protocol Violation|3
2310058|NCT02726074|4013777|FG000|Overall Study|Lost to Follow-up|2
2310059|NCT02726074|4013777|FG000|Overall Study|Others|3
2310060|NCT02726113|4013783|FG000|Total Enrollment|Physician Decision|0
2310061|NCT02726113|4013784|FG001|Total Enrollment|Physician Decision|1
2310062|NCT02726113|4013783|FG000|Total Enrollment|Protocol Violation|1
2310063|NCT02726113|4013784|FG001|Total Enrollment|Protocol Violation|0
2310064|NCT02726113|4013783|FG000|Total Enrollment|Withdrawal by Subject|2
2310065|NCT02726113|4013784|FG001|Total Enrollment|Withdrawal by Subject|1
2310066|NCT02726113|4013783|FG000|Total Enrollment|Insurance non-coverage for surgery|1
2310067|NCT02726113|4013784|FG001|Total Enrollment|Insurance non-coverage for surgery|1
2310068|NCT02726113|4013783|FG000|Genomic Analysis|Protocol Violation|1
2310069|NCT02726113|4013784|FG001|Genomic Analysis|Protocol Violation|0
2310070|NCT02726113|4013783|FG000|Genomic Analysis|Withdrawal by Subject|2
2310071|NCT02726113|4013784|FG001|Genomic Analysis|Withdrawal by Subject|1
2310072|NCT02726113|4013783|FG000|Genomic Analysis|Insurance non-coverage for surgery|1
2310073|NCT02726113|4013784|FG001|Genomic Analysis|Insurance non-coverage for surgery|1
2310074|NCT02726945|4013837|FG000|Overall Study|Withdrawal by Subject|0
2310075|NCT02726945|4013838|FG001|Overall Study|Withdrawal by Subject|0
1972887|NCT01004861|3534434|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1972888|NCT01004861|3534435|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1972889|NCT01004861|3534436|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1972890|NCT01004861|3534437|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1972891|NCT01004861|3534438|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1
1972892|NCT01004861|3534439|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1972893|NCT01004861|3534440|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1972894|NCT01004861|3534441|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1972895|NCT01004861|3534442|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
1972896|NCT01004861|3534430|FG000|Overall Study|Patient withdrew|0
1972897|NCT01004861|3534431|FG001|Overall Study|Patient withdrew|0
1972898|NCT01004861|3534432|FG002|Overall Study|Patient withdrew|0
1972899|NCT01004861|3534433|FG003|Overall Study|Patient withdrew|0
1972900|NCT01004861|3534434|FG004|Overall Study|Patient withdrew|0
1972901|NCT01004861|3534435|FG005|Overall Study|Patient withdrew|0
1972902|NCT01004861|3534436|FG006|Overall Study|Patient withdrew|0
1972903|NCT01004861|3534437|FG007|Overall Study|Patient withdrew|0
1972904|NCT01004861|3534438|FG008|Overall Study|Patient withdrew|1
1972905|NCT01004861|3534439|FG009|Overall Study|Patient withdrew|0
2212784|NCT01673646|3854116|FG002|Overall Study|Completed Core/did not enter Ext.|1
2310076|NCT02726945|4013839|FG002|Overall Study|Withdrawal by Subject|1
2310077|NCT02726945|4013837|FG000|Overall Study|Elected to have total knee replacement|0
2310078|NCT02726945|4013838|FG001|Overall Study|Elected to have total knee replacement|1
2310079|NCT02726945|4013839|FG002|Overall Study|Elected to have total knee replacement|0
2310080|NCT02727192|4013858|FG000|Overall Study|Lost to Follow-up|1
2310081|NCT02727192|4013859|FG001|Overall Study|Lost to Follow-up|0
2310082|NCT02727192|4013860|FG002|Overall Study|Lost to Follow-up|0
2310083|NCT02727322|4013869|FG000|Overall Study|Withdrawal by Subject|1
2310084|NCT02727322|4013870|FG001|Overall Study|Withdrawal by Subject|1
2310085|NCT02727322|4013869|FG000|Overall Study|Protocol Violation|1
2310086|NCT02727322|4013870|FG001|Overall Study|Protocol Violation|0
2310087|NCT02727660|4013883|FG000|Overall Study|Lack of Efficacy|40
2310088|NCT02727660|4013884|FG001|Overall Study|Lack of Efficacy|40
2310089|NCT02727660|4013885|FG002|Overall Study|Lack of Efficacy|70
2310090|NCT02727660|4013883|FG000|Overall Study|Adverse Event|28
2310091|NCT02727660|4013884|FG001|Overall Study|Adverse Event|21
2310092|NCT02727660|4013885|FG002|Overall Study|Adverse Event|32
2310093|NCT02727660|4013883|FG000|Overall Study|Withdrawal by Subject|26
2310094|NCT02727660|4013884|FG001|Overall Study|Withdrawal by Subject|25
2310095|NCT02727660|4013885|FG002|Overall Study|Withdrawal by Subject|30
2310096|NCT02727660|4013883|FG000|Overall Study|Physician Decision|3
2310097|NCT02727660|4013884|FG001|Overall Study|Physician Decision|8
2310098|NCT02727660|4013885|FG002|Overall Study|Physician Decision|14
2310099|NCT02727660|4013883|FG000|Overall Study|Lost to Follow-up|5
2310100|NCT02727660|4013884|FG001|Overall Study|Lost to Follow-up|9
2310101|NCT02727660|4013885|FG002|Overall Study|Lost to Follow-up|8
2310102|NCT02727660|4013883|FG000|Overall Study|Protocol Violation|7
2310103|NCT02727660|4013884|FG001|Overall Study|Protocol Violation|5
2310104|NCT02727660|4013885|FG002|Overall Study|Protocol Violation|5
2310105|NCT02727660|4013883|FG000|Overall Study|Protocol Specified Disc. Criteria|5
2310106|NCT02727660|4013884|FG001|Overall Study|Protocol Specified Disc. Criteria|5
2310107|NCT02727660|4013885|FG002|Overall Study|Protocol Specified Disc. Criteria|2
2310108|NCT02727660|4013883|FG000|Overall Study|Administrative Reasons|2
2310109|NCT02727660|4013884|FG001|Overall Study|Administrative Reasons|3
2310110|NCT02727660|4013885|FG002|Overall Study|Administrative Reasons|4
2310111|NCT02727699|4013895|FG000|Overall Study|Adverse Event|2
2310112|NCT02727699|4013896|FG001|Overall Study|Adverse Event|0
2310113|NCT02727699|4013895|FG000|Overall Study|Withdrawal by Subject|5
2310114|NCT02727699|4013896|FG001|Overall Study|Withdrawal by Subject|3
2310115|NCT02727699|4013895|FG000|Overall Study|Protocol Violation|0
2310116|NCT02727699|4013896|FG001|Overall Study|Protocol Violation|1
2310117|NCT02727699|4013895|FG000|Overall Study|Physician Decision|0
2310118|NCT02727699|4013896|FG001|Overall Study|Physician Decision|1
2310119|NCT02727699|4013895|FG000|Overall Study|Lost to Follow-up|1
2310120|NCT02727699|4013896|FG001|Overall Study|Lost to Follow-up|0
2310121|NCT02727699|4013895|FG000|Overall Study|Sponsor Decision|1
2310122|NCT02727699|4013896|FG001|Overall Study|Sponsor Decision|0
2310123|NCT02727777|4013909|FG000|Overall Study|Screen Failure|2
2310124|NCT02727777|4013910|FG001|Overall Study|Screen Failure|0
2310125|NCT02727777|4013911|FG002|Overall Study|Screen Failure|0
2310126|NCT02727777|4013909|FG000|Overall Study|Progressive disease|2
2310127|NCT02727777|4013910|FG001|Overall Study|Progressive disease|0
2310128|NCT02727777|4013911|FG002|Overall Study|Progressive disease|0
2310129|NCT02728089|4013955|FG000|Overall Study|Physician Decision|2
2310130|NCT02728089|4013955|FG000|Overall Study|Withdrawal by Subject|1
2310131|NCT02728102|4013962|FG000|Overall Study|Death|1
2310132|NCT02728102|4013963|FG001|Overall Study|Death|0
2310133|NCT02728102|4013964|FG002|Overall Study|Death|0
2310134|NCT02728102|4013962|FG000|Overall Study|Withdrawal by Subject|0
1972906|NCT01004861|3534440|FG010|Overall Study|Patient withdrew|0
1972907|NCT01004861|3534441|FG011|Overall Study|Patient withdrew|0
1972908|NCT01004861|3534442|FG012|Overall Study|Patient withdrew|0
1972909|NCT01004861|3534430|FG000|Overall Study|Surgical resection|0
1972910|NCT01004861|3534431|FG001|Overall Study|Surgical resection|0
1972911|NCT01004861|3534432|FG002|Overall Study|Surgical resection|0
1972912|NCT01004861|3534433|FG003|Overall Study|Surgical resection|0
1972913|NCT01004861|3534434|FG004|Overall Study|Surgical resection|0
1972914|NCT01004861|3534435|FG005|Overall Study|Surgical resection|0
1972915|NCT01004861|3534436|FG006|Overall Study|Surgical resection|0
1972916|NCT01004861|3534437|FG007|Overall Study|Surgical resection|0
1972917|NCT01004861|3534438|FG008|Overall Study|Surgical resection|1
1972918|NCT01004861|3534439|FG009|Overall Study|Surgical resection|0
1972919|NCT01004861|3534440|FG010|Overall Study|Surgical resection|0
1972920|NCT01004861|3534441|FG011|Overall Study|Surgical resection|0
1972921|NCT01004861|3534442|FG012|Overall Study|Surgical resection|0
1972922|NCT01004861|3534430|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0
1972923|NCT01004861|3534431|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0
1972924|NCT01004861|3534432|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0
1972925|NCT01004861|3534433|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0
1972926|NCT01004861|3534434|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0
2310135|NCT02728102|4013963|FG001|Overall Study|Withdrawal by Subject|2
2310136|NCT02728102|4013964|FG002|Overall Study|Withdrawal by Subject|2
2310137|NCT02728206|4013971|FG000|Overall Study|Death|1
2310138|NCT02728830|4013975|FG000|Overall Study|Exclusionary Surgery|9
2310139|NCT02728830|4013975|FG000|Overall Study|Exclusionary Pathology|6
2310140|NCT02728830|4013975|FG000|Overall Study|Physician Decision|3
2310141|NCT02728830|4013975|FG000|Overall Study|Withdrawal by Subject|2
2310142|NCT02728830|4013975|FG000|Overall Study|Lost to Follow-up|1
2310143|NCT02728830|4013975|FG000|Overall Study|Exclusionary Lab Values|1
2310144|NCT02728830|4013975|FG000|Overall Study|Contraindicated Illness|1
2310145|NCT02728830|4013975|FG000|Overall Study|Language Barrier|1
2310146|NCT02728895|4013981|FG000|Overall Study|Other|1
2310147|NCT02728895|4013982|FG001|Overall Study|Other|2
2310148|NCT02728895|4013981|FG000|Overall Study|Withdrawal by Subject|0
2310149|NCT02728895|4013982|FG001|Overall Study|Withdrawal by Subject|3
2310150|NCT02729025|4013990|FG000|Overall Study|Sponsor Decision|0
2310151|NCT02729025|4013991|FG001|Overall Study|Sponsor Decision|1
2310152|NCT02729051|4014023|FG000|Overall Study|Adverse Event|21
2310153|NCT02729051|4014024|FG001|Overall Study|Adverse Event|11
2310154|NCT02729051|4014023|FG000|Overall Study|Lack of Efficacy|1
2310155|NCT02729051|4014024|FG001|Overall Study|Lack of Efficacy|1
2310156|NCT02729051|4014023|FG000|Overall Study|Lost to Follow-up|1
2310157|NCT02729051|4014024|FG001|Overall Study|Lost to Follow-up|2
2310158|NCT02729051|4014023|FG000|Overall Study|Physician Decision|1
2310159|NCT02729051|4014024|FG001|Overall Study|Physician Decision|1
2310160|NCT02729051|4014023|FG000|Overall Study|Withdrawal by Subject|6
2310161|NCT02729051|4014024|FG001|Overall Study|Withdrawal by Subject|17
2310162|NCT02729194|4014030|FG000|Overall Study|Withdrawal by Subject|3
2310163|NCT02729545|4014036|FG000|Overall Study|Pregnancy|1
2310164|NCT02729545|4014037|FG001|Overall Study|Pregnancy|1
2310165|NCT02729545|4014036|FG000|Overall Study|Lost to Follow-up|0
2310166|NCT02729545|4014037|FG001|Overall Study|Lost to Follow-up|1
2310167|NCT02729545|4014036|FG000|Overall Study|Withdrawal by Subject|2
2310168|NCT02729545|4014037|FG001|Overall Study|Withdrawal by Subject|3
2310169|NCT02729740|4014043|FG000|Overall Study|Early Termination|130
2310170|NCT02729740|4014043|FG000|Overall Study|Other|1
2310171|NCT02729753|4014049|FG000|Overall Study|Device Malfunction. No units in stock.|0
2310172|NCT02729753|4014050|FG001|Overall Study|Device Malfunction. No units in stock.|1
2310173|NCT02729831|4014063|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
2310174|NCT02729831|4014064|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
2310175|NCT02729831|4014065|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
2310176|NCT02729831|4014066|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
2310177|NCT02729831|4014063|FG000|1 Week Post-visit|Lost to Follow-up|43
2310178|NCT02729831|4014064|FG001|1 Week Post-visit|Lost to Follow-up|40
2310179|NCT02729831|4014065|FG002|1 Week Post-visit|Lost to Follow-up|38
2310180|NCT02729831|4014066|FG003|1 Week Post-visit|Lost to Follow-up|36
2310181|NCT02729831|4014063|FG000|6 Month Follow-up|Lost to Follow-up|54
2310182|NCT02729831|4014064|FG001|6 Month Follow-up|Lost to Follow-up|51
2310183|NCT02729831|4014065|FG002|6 Month Follow-up|Lost to Follow-up|48
2310184|NCT02729831|4014066|FG003|6 Month Follow-up|Lost to Follow-up|42
2310185|NCT02729831|4014063|FG000|6 Month Follow-up|Death|1
2310186|NCT02729831|4014064|FG001|6 Month Follow-up|Death|3
2310187|NCT02729831|4014065|FG002|6 Month Follow-up|Death|0
2310188|NCT02729831|4014066|FG003|6 Month Follow-up|Death|1
2310189|NCT02729896|4014079|FG000|Overall Study|Death|0
2310190|NCT02729896|4014080|FG001|Overall Study|Death|2
2310191|NCT02729896|4014081|FG002|Overall Study|Death|13
2310192|NCT02729896|4014079|FG000|Overall Study|Lost to Follow-up|0
2310193|NCT02729896|4014080|FG001|Overall Study|Lost to Follow-up|2
2310194|NCT02729896|4014081|FG002|Overall Study|Lost to Follow-up|3
2310195|NCT02729896|4014079|FG000|Overall Study|Other|0
2310196|NCT02729896|4014080|FG001|Overall Study|Other|2
1972927|NCT01004861|3534435|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0
1972928|NCT01004861|3534436|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0
1972929|NCT01004861|3534437|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0
1972930|NCT01004861|3534438|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1
1972931|NCT01004861|3534439|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0
1972932|NCT01004861|3534440|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0
1972933|NCT01004861|3534441|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0
1972934|NCT01004861|3534442|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0
1972935|NCT01004861|3534430|FG000|Overall Study|Study termination by Sponsor|0
1972936|NCT01004861|3534431|FG001|Overall Study|Study termination by Sponsor|0
1972937|NCT01004861|3534432|FG002|Overall Study|Study termination by Sponsor|0
1972938|NCT01004861|3534433|FG003|Overall Study|Study termination by Sponsor|0
1972939|NCT01004861|3534434|FG004|Overall Study|Study termination by Sponsor|0
1972940|NCT01004861|3534435|FG005|Overall Study|Study termination by Sponsor|0
1972941|NCT01004861|3534436|FG006|Overall Study|Study termination by Sponsor|0
1972942|NCT01004861|3534437|FG007|Overall Study|Study termination by Sponsor|0
1972943|NCT01004861|3534438|FG008|Overall Study|Study termination by Sponsor|1
1972944|NCT01004861|3534439|FG009|Overall Study|Study termination by Sponsor|0
1972945|NCT01004861|3534440|FG010|Overall Study|Study termination by Sponsor|0
1972946|NCT01004861|3534441|FG011|Overall Study|Study termination by Sponsor|0
1972947|NCT01004861|3534442|FG012|Overall Study|Study termination by Sponsor|0
1972948|NCT00912223|3534474|FG000|Overall Study|Withdrawal by Subject|1
1972949|NCT00912223|3534474|FG000|Overall Study|Not transplanted|1
1972950|NCT00912223|3534474|FG000|Overall Study|Transformed disease|1
1972951|NCT00381381|3534478|FG000|Overall Study|Adverse Event|3
1972952|NCT00381381|3534478|FG000|Overall Study|Lost to Follow-up|52
1972953|NCT00381381|3534478|FG000|Overall Study|Withdrawal by Subject|9
2021634|NCT00313716|3589341|FG002|Overall Study|Lost to Follow-up|2
2021635|NCT00313716|3589342|FG003|Overall Study|Lost to Follow-up|1
2021636|NCT00313716|3589343|FG004|Overall Study|Lost to Follow-up|0
2021637|NCT00313716|3589344|FG005|Overall Study|Lost to Follow-up|4
2021638|NCT00313716|3589339|FG000|Overall Study|Withdrawal by Subject|0
2021639|NCT00313716|3589340|FG001|Overall Study|Withdrawal by Subject|1
2021640|NCT00313716|3589341|FG002|Overall Study|Withdrawal by Subject|1
2021641|NCT00313716|3589342|FG003|Overall Study|Withdrawal by Subject|0
2021642|NCT00313716|3589343|FG004|Overall Study|Withdrawal by Subject|1
2021643|NCT00313716|3589344|FG005|Overall Study|Withdrawal by Subject|0
2021644|NCT00313781|3589368|FG000|Before Crossover|Death|22
2021645|NCT00313781|3589369|FG001|Before Crossover|Death|8
2021646|NCT00313781|3589370|FG002|Before Crossover|Death|0
2021647|NCT00313781|3589368|FG000|Before Crossover|Lost to Follow-up|0
2021648|NCT00313781|3589369|FG001|Before Crossover|Lost to Follow-up|3
2021649|NCT00313781|3589370|FG002|Before Crossover|Lost to Follow-up|0
2021650|NCT00313781|3589368|FG000|Before Crossover|Withdrawal by Subject|3
2021651|NCT00313781|3589369|FG001|Before Crossover|Withdrawal by Subject|1
2021652|NCT00313781|3589370|FG002|Before Crossover|Withdrawal by Subject|0
2021653|NCT00313781|3589368|FG000|Before Crossover|Other|45
2021654|NCT00313781|3589369|FG001|Before Crossover|Other|30
2021655|NCT00313781|3589370|FG002|Before Crossover|Other|0
2021656|NCT00313781|3589368|FG000|Before Crossover|Crossover|0
2021657|NCT00313781|3589369|FG001|Before Crossover|Crossover|37
2021658|NCT00313781|3589370|FG002|Before Crossover|Crossover|0
2021659|NCT00313781|3589368|FG000|Before Crossover|Randomized, not treated|5
2021660|NCT00313781|3589369|FG001|Before Crossover|Randomized, not treated|0
2021661|NCT00313781|3589370|FG002|Before Crossover|Randomized, not treated|0
2021662|NCT00313781|3589368|FG000|After Crossover|Death|0
2021663|NCT00313781|3589369|FG001|After Crossover|Death|0
2021664|NCT00313781|3589370|FG002|After Crossover|Death|6
2021665|NCT00313781|3589368|FG000|After Crossover|Withdrawal by Subject|0
2021666|NCT00313781|3589369|FG001|After Crossover|Withdrawal by Subject|0
2021667|NCT00313781|3589370|FG002|After Crossover|Withdrawal by Subject|3
2021668|NCT00313781|3589368|FG000|After Crossover|Other|0
2021669|NCT00313781|3589369|FG001|After Crossover|Other|0
2021670|NCT00313781|3589370|FG002|After Crossover|Other|18
2021671|NCT00313820|3589381|FG000|Assigned to Treatment|Other|1
2021672|NCT00313820|3589382|FG001|Assigned to Treatment|Other|0
2021673|NCT00313820|3589381|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9
2021674|NCT00313820|3589382|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4
2021675|NCT00313820|3589381|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
2021676|NCT00313820|3589382|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
2021677|NCT00313820|3589381|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
2021678|NCT00313820|3589382|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
2021679|NCT00313820|3589381|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
2021680|NCT00313820|3589382|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
2021681|NCT00313820|3589381|FG000|Pregabalin or Placebo Treatment Period|Other|2
2021682|NCT00313820|3589382|FG001|Pregabalin or Placebo Treatment Period|Other|3
2021683|NCT00313846|3589390|FG000|Overall Study|Withdrawal by Subject|2
2021684|NCT00313846|3589391|FG001|Overall Study|Withdrawal by Subject|0
1972954|NCT04706403|3534502|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
1972955|NCT04706403|3534503|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
1972956|NCT04706403|3534504|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
1972957|NCT04706403|3534505|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
2310197|NCT02729896|4014081|FG002|Overall Study|Other|0
2310198|NCT02729896|4014079|FG000|Overall Study|Physician Decision|1
2310199|NCT02729896|4014080|FG001|Overall Study|Physician Decision|2
2310200|NCT02729896|4014081|FG002|Overall Study|Physician Decision|3
2310201|NCT02729896|4014079|FG000|Overall Study|Progressive Disease|0
2310202|NCT02729896|4014080|FG001|Overall Study|Progressive Disease|1
2310203|NCT02729896|4014081|FG002|Overall Study|Progressive Disease|0
2310204|NCT02729896|4014079|FG000|Overall Study|Withdrawal by Subject|1
2310205|NCT02729896|4014080|FG001|Overall Study|Withdrawal by Subject|0
2310206|NCT02729896|4014081|FG002|Overall Study|Withdrawal by Subject|3
2310207|NCT02729909|4014092|FG000|Overall Study|Lost to Follow-up|0
2310208|NCT02729909|4014093|FG001|Overall Study|Lost to Follow-up|1
2310209|NCT02729909|4014092|FG000|Overall Study|Lack of Efficacy|0
2310210|NCT02729909|4014093|FG001|Overall Study|Lack of Efficacy|2
2310211|NCT02729909|4014092|FG000|Overall Study|Significant Protocol Deviation|0
2310212|NCT02729909|4014093|FG001|Overall Study|Significant Protocol Deviation|2
2310213|NCT02729909|4014092|FG000|Overall Study|Voluntary Withdrawal|1
2310214|NCT02729909|4014093|FG001|Overall Study|Voluntary Withdrawal|0
2310215|NCT02730169|4014107|FG000|Overall Study|Protocol Violation|1
2310216|NCT02730169|4014108|FG001|Overall Study|Protocol Violation|0
2310217|NCT02730169|4014109|FG002|Overall Study|Protocol Violation|0
2310218|NCT02730169|4014110|FG003|Overall Study|Protocol Violation|1
2310219|NCT02730169|4014107|FG000|Overall Study|Adverse Event|2
2310220|NCT02730169|4014108|FG001|Overall Study|Adverse Event|3
2310221|NCT02730169|4014109|FG002|Overall Study|Adverse Event|3
2310222|NCT02730169|4014110|FG003|Overall Study|Adverse Event|0
2310223|NCT02730169|4014107|FG000|Overall Study|Adverse Event of Special Interest|0
2310224|NCT02730169|4014108|FG001|Overall Study|Adverse Event of Special Interest|1
2310225|NCT02730169|4014109|FG002|Overall Study|Adverse Event of Special Interest|2
2310226|NCT02730169|4014110|FG003|Overall Study|Adverse Event of Special Interest|0
2310227|NCT02730169|4014107|FG000|Overall Study|Withdrawal by Subject|6
2310228|NCT02730169|4014108|FG001|Overall Study|Withdrawal by Subject|11
2310229|NCT02730169|4014109|FG002|Overall Study|Withdrawal by Subject|6
2310230|NCT02730169|4014110|FG003|Overall Study|Withdrawal by Subject|8
2310231|NCT02730169|4014107|FG000|Overall Study|Lost to Follow-up|5
2310232|NCT02730169|4014108|FG001|Overall Study|Lost to Follow-up|6
2310233|NCT02730169|4014109|FG002|Overall Study|Lost to Follow-up|5
2310234|NCT02730169|4014110|FG003|Overall Study|Lost to Follow-up|6
2310235|NCT02730169|4014107|FG000|Overall Study|Other|0
2310236|NCT02730169|4014108|FG001|Overall Study|Other|0
2310237|NCT02730169|4014109|FG002|Overall Study|Other|1
2310238|NCT02730169|4014110|FG003|Overall Study|Other|1
2310239|NCT02730195|4014120|FG000|Overall Study|Withdrawal by Subject|1
2321848|NCT02963506|4036383|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1
2321849|NCT02963701|4036411|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
2321850|NCT02963701|4036412|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
2321851|NCT02963922|4036420|FG000|Overall Study|Adverse Event|15
2321852|NCT02963922|4036421|FG001|Overall Study|Adverse Event|6
2321853|NCT02963922|4036420|FG000|Overall Study|Protocol deviation|6
2321854|NCT02963922|4036421|FG001|Overall Study|Protocol deviation|6
2321855|NCT02963922|4036420|FG000|Overall Study|Lack of Efficacy|1
2321856|NCT02963922|4036421|FG001|Overall Study|Lack of Efficacy|1
2321857|NCT02963922|4036420|FG000|Overall Study|Lost to Follow-up|2
2321858|NCT02963922|4036421|FG001|Overall Study|Lost to Follow-up|3
2321859|NCT02963922|4036420|FG000|Overall Study|Other|8
2321860|NCT02963922|4036421|FG001|Overall Study|Other|14
2321861|NCT02963935|4036429|FG000|Overall Study|Adverse Event|12
2321862|NCT02963935|4036430|FG001|Overall Study|Adverse Event|6
2321863|NCT02963935|4036429|FG000|Overall Study|Protocol Violation|2
2321864|NCT02963935|4036430|FG001|Overall Study|Protocol Violation|1
2321865|NCT02963935|4036429|FG000|Overall Study|Lack of Efficacy|0
2321866|NCT02963935|4036430|FG001|Overall Study|Lack of Efficacy|2
2321867|NCT02963935|4036429|FG000|Overall Study|Lost to Follow-up|1
2321868|NCT02963935|4036430|FG001|Overall Study|Lost to Follow-up|6
2321869|NCT02963935|4036429|FG000|Overall Study|Unclassified|13
2321870|NCT02963935|4036430|FG001|Overall Study|Unclassified|22
2321871|NCT02964234|4036451|FG000|Overall Study|Lost to Follow-up|22
2321872|NCT02964234|4036452|FG001|Overall Study|Lost to Follow-up|13
2321873|NCT02964247|4036460|FG000|Overall Study|Lost to Follow-up|2
2321874|NCT02964247|4036461|FG001|Overall Study|Lost to Follow-up|0
2321875|NCT02964247|4036460|FG000|Overall Study|Withdrawal by Subject|1
2321876|NCT02964247|4036461|FG001|Overall Study|Withdrawal by Subject|2
2321877|NCT02964312|4036467|FG000|Overall Study|Lost to Follow-up|28
2321878|NCT02964312|4036467|FG000|Overall Study|Withdrawal by Subject|11
2321879|NCT02964312|4036467|FG000|Overall Study|Lack of Efficacy|10
2321880|NCT02964312|4036467|FG000|Overall Study|Did not consent to long-term FU|14
2321881|NCT02964312|4036467|FG000|Overall Study|Death|1
2321882|NCT02964325|4036476|FG000|Overall Study|Lost to Follow-up|3
2321883|NCT02964325|4036477|FG001|Overall Study|Lost to Follow-up|3
1972958|NCT04706403|3534506|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2
2021685|NCT00313846|3589390|FG000|Overall Study|Adverse Event|1
2021686|NCT00313846|3589391|FG001|Overall Study|Adverse Event|8
2021687|NCT00313846|3589390|FG000|Overall Study|Administrative|2
2021688|NCT00313846|3589391|FG001|Overall Study|Administrative|3
2021689|NCT00313911|3589400|FG000|Overall Study|Serious adverse event|6
2021690|NCT00313911|3589401|FG001|Overall Study|Serious adverse event|1
2021691|NCT00313911|3589400|FG000|Overall Study|Adverse Event|2
2021692|NCT00313911|3589401|FG001|Overall Study|Adverse Event|3
2021693|NCT00313911|3589400|FG000|Overall Study|Protocol Violation|19
2310240|NCT02730208|4014126|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
2310241|NCT02730208|4014127|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
2310242|NCT02730351|4014150|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1
2310243|NCT02730351|4014151|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0
2310244|NCT02730351|4014150|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0
2310245|NCT02730351|4014151|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1
2310246|NCT02730351|4014150|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
2310247|NCT02730351|4014151|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
2310248|NCT02730351|4014150|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1
2310249|NCT02730351|4014151|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0
2310250|NCT02730351|4014150|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
2310251|NCT02730351|4014151|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
2310252|NCT02730377|4014159|FG000|Overall Study|Other|5
2310253|NCT02730377|4014160|FG001|Overall Study|Other|4
2310254|NCT02730377|4014159|FG000|Overall Study|Death|1
2310255|NCT02730377|4014160|FG001|Overall Study|Death|8
2310256|NCT02730377|4014159|FG000|Overall Study|Inadequate glycaemic control|368
2310257|NCT02730377|4014160|FG001|Overall Study|Inadequate glycaemic control|473
2310258|NCT02730377|4014159|FG000|Overall Study|Adverse Event|79
2310259|NCT02730377|4014160|FG001|Overall Study|Adverse Event|41
2310260|NCT02730377|4014159|FG000|Overall Study|Protocol Violation|23
2310261|NCT02730377|4014160|FG001|Overall Study|Protocol Violation|30
2310262|NCT02730377|4014159|FG000|Overall Study|Lack of Efficacy|4
2310263|NCT02730377|4014160|FG001|Overall Study|Lack of Efficacy|13
2310264|NCT02730377|4014159|FG000|Overall Study|Pregnancy|0
2310265|NCT02730377|4014160|FG001|Overall Study|Pregnancy|1
2310266|NCT02730377|4014159|FG000|Overall Study|Withdrawal by Subject|45
2310267|NCT02730377|4014160|FG001|Overall Study|Withdrawal by Subject|42
2310268|NCT02730377|4014159|FG000|Overall Study|Lost to Follow-up|25
2310269|NCT02730377|4014160|FG001|Overall Study|Lost to Follow-up|21
2310270|NCT02730455|4014174|FG000|Overall Study|Death|5
2310271|NCT02730455|4014175|FG001|Overall Study|Death|6
2310272|NCT02730455|4014176|FG002|Overall Study|Death|4
2310273|NCT02730455|4014174|FG000|Overall Study|Consent withdrawn|2
2310274|NCT02730455|4014175|FG001|Overall Study|Consent withdrawn|4
2310275|NCT02730455|4014176|FG002|Overall Study|Consent withdrawn|1
2310276|NCT02730455|4014174|FG000|Overall Study|Lost to Follow-up|3
2310277|NCT02730455|4014175|FG001|Overall Study|Lost to Follow-up|1
2310278|NCT02730455|4014176|FG002|Overall Study|Lost to Follow-up|4
2310279|NCT02730455|4014174|FG000|Overall Study|Other|1
2310280|NCT02730455|4014175|FG001|Overall Study|Other|1
2310281|NCT02730455|4014176|FG002|Overall Study|Other|2
2310282|NCT02730455|4014174|FG000|Overall Study|Other|2
2310283|NCT02730455|4014175|FG001|Overall Study|Other|2
2310284|NCT02730455|4014176|FG002|Overall Study|Other|0
2310285|NCT02730598|4014186|FG000|Overall Study|Withdrawal by Subject|3
2310286|NCT02730598|4014187|FG001|Overall Study|Withdrawal by Subject|3
2310287|NCT02730598|4014186|FG000|Overall Study|Protocol Violation|0
2310288|NCT02730598|4014187|FG001|Overall Study|Protocol Violation|1
2310289|NCT02730598|4014186|FG000|Overall Study|Unrelated Injury affecting outcomes.|1
2310290|NCT02730598|4014187|FG001|Overall Study|Unrelated Injury affecting outcomes.|0
2310291|NCT02730728|4014200|FG000|Overall Study|Withdrawal by Subject|0
2310292|NCT02730728|4014201|FG001|Overall Study|Withdrawal by Subject|1
2310293|NCT02730728|4014202|FG002|Overall Study|Withdrawal by Subject|0
2310294|NCT02730728|4014200|FG000|Overall Study|Lack of Efficacy|0
2310295|NCT02730728|4014201|FG001|Overall Study|Lack of Efficacy|1
2310296|NCT02730728|4014202|FG002|Overall Study|Lack of Efficacy|1
2310297|NCT02730819|4014210|FG000|Overall Study|Lost to Follow-up|9
2310298|NCT02730871|4014216|FG000|Overall Study|Adverse Event|6
2310299|NCT02730871|4014217|FG001|Overall Study|Adverse Event|0
2310300|NCT02731131|4014247|FG000|Overall Study|Psychiatric Disorder|0
2310301|NCT02731131|4014248|FG001|Overall Study|Psychiatric Disorder|1
2310302|NCT02731131|4014247|FG000|Overall Study|Refused Therapy|0
2310303|NCT02731131|4014248|FG001|Overall Study|Refused Therapy|1
2310304|NCT02731157|4014254|FG000|First Rejuvenated RCE|Withdrawal by Subject|1
2310305|NCT02731638|4014320|FG000|Overall Study|Lost to Follow-up|6
2310306|NCT02731638|4014321|FG001|Overall Study|Lost to Follow-up|9
2310307|NCT02731690|4014327|FG000|Overall Study|Adverse Event|1
2310308|NCT02731690|4014327|FG000|Overall Study|Withdrawal by Subject|3
2310309|NCT02731690|4014327|FG000|Overall Study|Discontinuation of Study by Sponsor|26
2310310|NCT02731729|4014333|FG000|Overall Study|Death|2
2310311|NCT02731729|4014334|FG001|Overall Study|Death|2
2310312|NCT02731729|4014333|FG000|Overall Study|Study terminated by Sponsor|6
2310313|NCT02731729|4014334|FG001|Overall Study|Study terminated by Sponsor|6
1972959|NCT03712124|3534530|FG000|Overall Study|Protocol Violation|1
1972960|NCT03712124|3534531|FG001|Overall Study|Protocol Violation|0
1972961|NCT03535740|3534543|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55
1972962|NCT03535740|3534543|FG000|Overall Study|Death|34
1972963|NCT03535740|3534543|FG000|Overall Study|Lost to Follow-up|1
1972964|NCT03535740|3534543|FG000|Overall Study|Withdrawal by Subject|13
1973030|NCT02013167|3534639|FG000|Overall Study|Withdrawal by Subject|15
1973031|NCT02013167|3534640|FG001|Overall Study|Withdrawal by Subject|14
1973032|NCT02013167|3534639|FG000|Overall Study|Sponsor Decision|1
1973033|NCT02013167|3534640|FG001|Overall Study|Sponsor Decision|3
1973034|NCT02013167|3534639|FG000|Overall Study|Lost to Follow-up|0
1973035|NCT02013167|3534640|FG001|Overall Study|Lost to Follow-up|1
1973036|NCT02013167|3534639|FG000|Overall Study|Death|85
1973037|NCT02013167|3534640|FG001|Overall Study|Death|160
1973038|NCT02004522|3534649|FG000|Overall Study|Adverse Event|55
1973039|NCT02004522|3534650|FG001|Overall Study|Adverse Event|6
1973040|NCT02004522|3534649|FG000|Overall Study|Withdrawal by Subject|13
1973041|NCT02004522|3534650|FG001|Overall Study|Withdrawal by Subject|7
1973042|NCT02004522|3534649|FG000|Overall Study|Death|12
1973043|NCT02004522|3534650|FG001|Overall Study|Death|3
1973044|NCT02004522|3534649|FG000|Overall Study|Physician Decision|3
1973045|NCT02004522|3534650|FG001|Overall Study|Physician Decision|4
1973046|NCT02004522|3534649|FG000|Overall Study|Protocol Violation|1
1973047|NCT02004522|3534650|FG001|Overall Study|Protocol Violation|0
1973048|NCT02004522|3534649|FG000|Overall Study|Other is reason listed by PI.|4
1973049|NCT02004522|3534650|FG001|Overall Study|Other is reason listed by PI.|1
1973050|NCT02004522|3534649|FG000|Overall Study|Never Dosed|2
1973051|NCT02004522|3534650|FG001|Overall Study|Never Dosed|4
1973052|NCT02004522|3534649|FG000|Overall Study|Disease Progression|35
1973053|NCT02004522|3534650|FG001|Overall Study|Disease Progression|31
1973054|NCT02004522|3534649|FG000|Overall Study|Completed Treatrment Cycles Per Protocol|1
1973055|NCT02004522|3534650|FG001|Overall Study|Completed Treatrment Cycles Per Protocol|103
1973056|NCT02000427|3534656|FG000|Overall Study|Death|22
1973057|NCT01981850|3534667|FG000|Main Phase Stage 1|Death|2
1973058|NCT01981850|3534668|FG001|Main Phase Stage 1|Death|0
1973059|NCT01981850|3534669|FG002|Main Phase Stage 1|Death|0
1973060|NCT01981850|3534670|FG003|Main Phase Stage 1|Death|0
1973061|NCT01981850|3534671|FG004|Main Phase Stage 1|Death|0
1973062|NCT01981850|3534672|FG005|Main Phase Stage 1|Death|0
1973063|NCT01981850|3534673|FG006|Main Phase Stage 1|Death|0
1973064|NCT01981850|3534674|FG007|Main Phase Stage 1|Death|0
1973065|NCT01981850|3534675|FG008|Main Phase Stage 1|Death|0
1973066|NCT01981850|3534676|FG009|Main Phase Stage 1|Death|0
1973067|NCT01981850|3534667|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1
1973068|NCT01981850|3534668|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0
1973069|NCT01981850|3534669|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0
1973070|NCT01981850|3534670|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0
1973071|NCT01981850|3534671|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0
1973072|NCT01981850|3534672|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0
1973073|NCT01981850|3534673|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0
1973074|NCT01981850|3534674|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0
1973075|NCT01981850|3534675|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0
1973076|NCT01981850|3534676|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0
1973077|NCT01981850|3534667|FG000|Main Phase Stage 1|Lack of Efficacy|0
1973078|NCT01981850|3534668|FG001|Main Phase Stage 1|Lack of Efficacy|2
1973079|NCT01981850|3534669|FG002|Main Phase Stage 1|Lack of Efficacy|0
1973080|NCT01981850|3534670|FG003|Main Phase Stage 1|Lack of Efficacy|0
1973081|NCT01981850|3534671|FG004|Main Phase Stage 1|Lack of Efficacy|0
1973082|NCT01981850|3534672|FG005|Main Phase Stage 1|Lack of Efficacy|0
1973083|NCT01981850|3534673|FG006|Main Phase Stage 1|Lack of Efficacy|0
1973084|NCT01981850|3534674|FG007|Main Phase Stage 1|Lack of Efficacy|0
1973085|NCT01981850|3534675|FG008|Main Phase Stage 1|Lack of Efficacy|0
1973086|NCT01981850|3534676|FG009|Main Phase Stage 1|Lack of Efficacy|0
1973087|NCT01981850|3534667|FG000|Main Phase Stage 1|Various reasons|0
1973088|NCT01981850|3534668|FG001|Main Phase Stage 1|Various reasons|0
1973089|NCT01981850|3534669|FG002|Main Phase Stage 1|Various reasons|2
1973090|NCT01981850|3534670|FG003|Main Phase Stage 1|Various reasons|0
1973091|NCT01981850|3534671|FG004|Main Phase Stage 1|Various reasons|0
1973092|NCT01981850|3534672|FG005|Main Phase Stage 1|Various reasons|0
1973093|NCT01981850|3534673|FG006|Main Phase Stage 1|Various reasons|0
1973094|NCT01981850|3534674|FG007|Main Phase Stage 1|Various reasons|0
1973095|NCT01981850|3534675|FG008|Main Phase Stage 1|Various reasons|0
1973096|NCT01981850|3534676|FG009|Main Phase Stage 1|Various reasons|0
1973097|NCT01981850|3534667|FG000|Main Phase Stage 2|Adverse Event|0
1973098|NCT01981850|3534668|FG001|Main Phase Stage 2|Adverse Event|0
1973099|NCT01981850|3534669|FG002|Main Phase Stage 2|Adverse Event|0
1973100|NCT01981850|3534670|FG003|Main Phase Stage 2|Adverse Event|0
1973101|NCT01981850|3534671|FG004|Main Phase Stage 2|Adverse Event|6
1973102|NCT01981850|3534672|FG005|Main Phase Stage 2|Adverse Event|5
1973103|NCT01981850|3534673|FG006|Main Phase Stage 2|Adverse Event|7
1973104|NCT01981850|3534674|FG007|Main Phase Stage 2|Adverse Event|0
1973105|NCT01981850|3534675|FG008|Main Phase Stage 2|Adverse Event|0
1973106|NCT01981850|3534676|FG009|Main Phase Stage 2|Adverse Event|0
1973107|NCT01981850|3534667|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0
1972965|NCT03503318|3534551|FG000|Overall Study|Death|1
1972966|NCT03503318|3534552|FG001|Overall Study|Death|0
1972967|NCT03503318|3534553|FG002|Overall Study|Death|4
1972968|NCT03503318|3534551|FG000|Overall Study|Adverse Event|3
1972969|NCT03503318|3534552|FG001|Overall Study|Adverse Event|4
1972970|NCT03503318|3534553|FG002|Overall Study|Adverse Event|2
1972971|NCT03503318|3534551|FG000|Overall Study|Withdrawal by Subject|12
1972972|NCT03503318|3534552|FG001|Overall Study|Withdrawal by Subject|17
1972973|NCT03503318|3534553|FG002|Overall Study|Withdrawal by Subject|16
1972974|NCT03503318|3534551|FG000|Overall Study|Protocol Violation|5
1972975|NCT03503318|3534552|FG001|Overall Study|Protocol Violation|0
1972976|NCT03503318|3534553|FG002|Overall Study|Protocol Violation|3
1972977|NCT03503318|3534551|FG000|Overall Study|Lost to Follow-up|17
1972978|NCT03503318|3534552|FG001|Overall Study|Lost to Follow-up|15
1972979|NCT03503318|3534553|FG002|Overall Study|Lost to Follow-up|12
1972980|NCT03503318|3534551|FG000|Overall Study|Other than specified|1
1972981|NCT03503318|3534552|FG001|Overall Study|Other than specified|3
1972982|NCT03503318|3534553|FG002|Overall Study|Other than specified|3
1972983|NCT02921789|3534581|FG000|Overall Study|Adverse Event|0
1972984|NCT02921789|3534582|FG001|Overall Study|Adverse Event|1
1972985|NCT02921789|3534581|FG000|Overall Study|Lost to Follow-up|1
1972986|NCT02921789|3534582|FG001|Overall Study|Lost to Follow-up|0
1972987|NCT02921789|3534581|FG000|Overall Study|Protocol Deviation|2
1972988|NCT02921789|3534582|FG001|Overall Study|Protocol Deviation|0
1972989|NCT02921789|3534581|FG000|Overall Study|Withdrawal by Subject|2
1972990|NCT02921789|3534582|FG001|Overall Study|Withdrawal by Subject|1
1972991|NCT02921789|3534581|FG000|Overall Study|Miscellaneous|3
1972992|NCT02921789|3534582|FG001|Overall Study|Miscellaneous|2
1972993|NCT02896257|3534602|FG000|Providers|Without eligible patients|21
1972994|NCT02896257|3534603|FG001|Providers|Without eligible patients|28
1972995|NCT02896257|3534602|FG000|Patients|PFT entry criteria not met|43
1972996|NCT02896257|3534603|FG001|Patients|PFT entry criteria not met|50
1972997|NCT02896257|3534602|FG000|Patients|No capacity to review|8
1972998|NCT02896257|3534603|FG001|Patients|No capacity to review|11
1972999|NCT02896257|3534602|FG000|Patients|Appointment rescheduled/cancelled|5
1973000|NCT02896257|3534603|FG001|Patients|Appointment rescheduled/cancelled|7
1973001|NCT02896257|3534602|FG000|Patients|PCP not assigned a clinic|4
1973002|NCT02896257|3534603|FG001|Patients|PCP not assigned a clinic|0
1973003|NCT02896257|3534602|FG000|Patients|No history of COPD|0
1973004|NCT02896257|3534603|FG001|Patients|No history of COPD|1
1973005|NCT02896257|3534602|FG000|Patients|Deceased between review and index date|0
1973006|NCT02896257|3534603|FG001|Patients|Deceased between review and index date|1
1973007|NCT02896257|3534602|FG000|Patients|No ICS Rx upon review|1
1973008|NCT02896257|3534603|FG001|Patients|No ICS Rx upon review|1
1973009|NCT02896257|3534602|FG000|Patients|Protocol Violation|2
1973010|NCT02896257|3534603|FG001|Patients|Protocol Violation|1
1973011|NCT02896257|3534602|FG000|Patients|Hospice care|0
1973012|NCT02896257|3534603|FG001|Patients|Hospice care|1
1973013|NCT02736617|3534619|FG000|Treatment|Adverse Event|1
1973014|NCT02736617|3534619|FG000|Treatment|Lack of Efficacy|1
1973015|NCT02736617|3534619|FG000|Treatment|Withdrawal by Subject|1
1973016|NCT02736617|3534619|FG000|Maintenance|Lack of Efficacy|4
1973017|NCT02736617|3534619|FG000|Maintenance|Physician Decision|1
1973018|NCT02579265|3534630|FG000|Overall Study|Weaned off earlier than 28 days|44
1973019|NCT02579265|3534631|FG001|Overall Study|Weaned off earlier than 28 days|43
1973020|NCT02579265|3534630|FG000|Overall Study|Adverse Event|2
1973021|NCT02579265|3534631|FG001|Overall Study|Adverse Event|0
1973022|NCT02579265|3534630|FG000|Overall Study|Any other reason not specified|0
1973023|NCT02579265|3534631|FG001|Overall Study|Any other reason not specified|2
1973024|NCT02579265|3534630|FG000|Overall Study|Withdrawal by Subject|2
1973025|NCT02579265|3534631|FG001|Overall Study|Withdrawal by Subject|0
1973026|NCT02579265|3534630|FG000|Overall Study|Physician Decision|1
1973027|NCT02579265|3534631|FG001|Overall Study|Physician Decision|0
1973028|NCT02579265|3534630|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1
1973029|NCT02579265|3534631|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0
1973108|NCT01981850|3534668|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0
2212785|NCT01673698|3854130|FG000|Overall Study|Lost to Follow-up|51
2212786|NCT01673698|3854131|FG001|Overall Study|Lost to Follow-up|13
2212787|NCT01673854|3854151|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
2212788|NCT01673854|3854151|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
2212789|NCT01673854|3854151|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
2212790|NCT01673854|3854151|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
2212791|NCT01673854|3854151|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
2212792|NCT01673854|3854151|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
2212793|NCT01673854|3854151|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
2212794|NCT01673854|3854151|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
2212795|NCT01673854|3854151|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
1973109|NCT01981850|3534669|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0
1973110|NCT01981850|3534670|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0
1973111|NCT01981850|3534671|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4
1973112|NCT01981850|3534672|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3
2212796|NCT01673854|3854151|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
2212797|NCT01673854|3854151|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
2212798|NCT01673854|3854151|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
2212799|NCT01673867|3854157|FG000|Randomization|AE unrelated to study drug|1
2212800|NCT01673867|3854158|FG001|Randomization|AE unrelated to study drug|0
2212801|NCT01673867|3854157|FG000|Randomization|Requested treatment discontinuation|0
2212802|NCT01673867|3854158|FG001|Randomization|Requested treatment discontinuation|4
2212803|NCT01673867|3854157|FG000|Randomization|Withdrawal by Subject|0
2212804|NCT01673867|3854158|FG001|Randomization|Withdrawal by Subject|12
2212805|NCT01673867|3854157|FG000|Randomization|Lost to Follow-up|0
2212806|NCT01673867|3854158|FG001|Randomization|Lost to Follow-up|1
2212807|NCT01673867|3854157|FG000|Randomization|No longer meets criteria|4
2212808|NCT01673867|3854158|FG001|Randomization|No longer meets criteria|5
2212809|NCT01673867|3854157|FG000|Treatment|Disease Progression|194
2212810|NCT01673867|3854158|FG001|Treatment|Disease Progression|179
2212811|NCT01673867|3854157|FG000|Treatment|Study Drug Toxicity|17
2212812|NCT01673867|3854158|FG001|Treatment|Study Drug Toxicity|42
2212813|NCT01673867|3854157|FG000|Treatment|Death|1
2212814|NCT01673867|3854158|FG001|Treatment|Death|1
2212815|NCT01673867|3854157|FG000|Treatment|AE unrelated to study drug|19
2212816|NCT01673867|3854158|FG001|Treatment|AE unrelated to study drug|11
2212817|NCT01673867|3854157|FG000|Treatment|Requested treatment discontinuation|5
2212818|NCT01673867|3854158|FG001|Treatment|Requested treatment discontinuation|16
2212819|NCT01673867|3854157|FG000|Treatment|Withdrawal by Subject|4
2212820|NCT01673867|3854158|FG001|Treatment|Withdrawal by Subject|6
2212821|NCT01673867|3854157|FG000|Treatment|Maximum clinical benefit|0
2212822|NCT01673867|3854158|FG001|Treatment|Maximum clinical benefit|10
2212823|NCT01673867|3854157|FG000|Treatment|No longer meets criteria|2
2212824|NCT01673867|3854158|FG001|Treatment|No longer meets criteria|0
2212825|NCT01673867|3854157|FG000|Treatment|Required steroid therapy|1
2212826|NCT01673867|3854158|FG001|Treatment|Required steroid therapy|0
2212827|NCT01673867|3854157|FG000|Treatment|Health status not improved|1
2212828|NCT01673867|3854158|FG001|Treatment|Health status not improved|0
2212829|NCT01673867|3854157|FG000|Treatment|Required prolonged hospitalization|0
2212830|NCT01673867|3854158|FG001|Treatment|Required prolonged hospitalization|1
2212831|NCT01673867|3854157|FG000|Treatment|Symptomatic deterioration|0
2212832|NCT01673867|3854158|FG001|Treatment|Symptomatic deterioration|1
2212833|NCT01673867|3854157|FG000|Treatment|Physician Decision|0
2212834|NCT01673867|3854158|FG001|Treatment|Physician Decision|1
2212835|NCT01673984|3854178|FG000|Overall Study|Adverse Event|1
1973113|NCT01981850|3534673|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3
1973114|NCT01981850|3534674|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0
1973115|NCT01981850|3534675|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0
1973116|NCT01981850|3534676|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0
1973117|NCT01981850|3534667|FG000|Main Phase Stage 2|Lack of Efficacy|0
1973118|NCT01981850|3534668|FG001|Main Phase Stage 2|Lack of Efficacy|0
1973119|NCT01981850|3534669|FG002|Main Phase Stage 2|Lack of Efficacy|0
1973120|NCT01981850|3534670|FG003|Main Phase Stage 2|Lack of Efficacy|0
1973121|NCT01981850|3534671|FG004|Main Phase Stage 2|Lack of Efficacy|1
1973122|NCT01981850|3534672|FG005|Main Phase Stage 2|Lack of Efficacy|2
1973123|NCT01981850|3534673|FG006|Main Phase Stage 2|Lack of Efficacy|0
1973124|NCT01981850|3534674|FG007|Main Phase Stage 2|Lack of Efficacy|0
1973125|NCT01981850|3534675|FG008|Main Phase Stage 2|Lack of Efficacy|0
1973126|NCT01981850|3534676|FG009|Main Phase Stage 2|Lack of Efficacy|0
1973127|NCT01981850|3534667|FG000|Main Phase Stage 2|Various reasons|0
1973128|NCT01981850|3534668|FG001|Main Phase Stage 2|Various reasons|0
1973129|NCT01981850|3534669|FG002|Main Phase Stage 2|Various reasons|0
1973130|NCT01981850|3534670|FG003|Main Phase Stage 2|Various reasons|0
1973131|NCT01981850|3534671|FG004|Main Phase Stage 2|Various reasons|2
1973132|NCT01981850|3534672|FG005|Main Phase Stage 2|Various reasons|0
1973133|NCT01981850|3534673|FG006|Main Phase Stage 2|Various reasons|1
1973134|NCT01981850|3534674|FG007|Main Phase Stage 2|Various reasons|0
1973135|NCT01981850|3534675|FG008|Main Phase Stage 2|Various reasons|0
1973136|NCT01981850|3534676|FG009|Main Phase Stage 2|Various reasons|0
1973137|NCT01981850|3534667|FG000|Main Phase Stage 2|Progressive Disease|0
1973138|NCT01981850|3534668|FG001|Main Phase Stage 2|Progressive Disease|0
1973139|NCT01981850|3534669|FG002|Main Phase Stage 2|Progressive Disease|0
1973140|NCT01981850|3534670|FG003|Main Phase Stage 2|Progressive Disease|0
1973141|NCT01981850|3534671|FG004|Main Phase Stage 2|Progressive Disease|0
1973142|NCT01981850|3534672|FG005|Main Phase Stage 2|Progressive Disease|6
1973143|NCT01981850|3534673|FG006|Main Phase Stage 2|Progressive Disease|6
1973144|NCT01981850|3534674|FG007|Main Phase Stage 2|Progressive Disease|0
1973145|NCT01981850|3534675|FG008|Main Phase Stage 2|Progressive Disease|0
2212836|NCT01673984|3854179|FG001|Overall Study|Adverse Event|0
2212837|NCT01673984|3854178|FG000|Overall Study|Study termination|9
2212838|NCT01673984|3854179|FG001|Overall Study|Study termination|6
2212839|NCT01674010|3854185|FG000|Open Treatment Phase 1|Adverse Event|10
2212840|NCT01674010|3854186|FG001|Open Treatment Phase 1|Adverse Event|0
2212841|NCT01674010|3854187|FG002|Open Treatment Phase 1|Adverse Event|0
2212842|NCT01674010|3854185|FG000|Open Treatment Phase 1|Death|1
2212843|NCT01674010|3854186|FG001|Open Treatment Phase 1|Death|0
1973146|NCT01981850|3534676|FG009|Main Phase Stage 2|Progressive Disease|0
1973147|NCT01981850|3534667|FG000|Open Label Extension (OLE)|Adverse Event|0
1973148|NCT01981850|3534668|FG001|Open Label Extension (OLE)|Adverse Event|0
1973149|NCT01981850|3534669|FG002|Open Label Extension (OLE)|Adverse Event|0
1973150|NCT01981850|3534670|FG003|Open Label Extension (OLE)|Adverse Event|0
1973151|NCT01981850|3534671|FG004|Open Label Extension (OLE)|Adverse Event|0
1973152|NCT01981850|3534672|FG005|Open Label Extension (OLE)|Adverse Event|0
1973153|NCT01981850|3534673|FG006|Open Label Extension (OLE)|Adverse Event|0
1973154|NCT01981850|3534674|FG007|Open Label Extension (OLE)|Adverse Event|2
1973155|NCT01981850|3534675|FG008|Open Label Extension (OLE)|Adverse Event|1
1973156|NCT01981850|3534676|FG009|Open Label Extension (OLE)|Adverse Event|8
1973157|NCT01981850|3534667|FG000|Open Label Extension (OLE)|Lack of Efficacy|0
1973158|NCT01981850|3534668|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
1973159|NCT01981850|3534669|FG002|Open Label Extension (OLE)|Lack of Efficacy|0
1973160|NCT01981850|3534670|FG003|Open Label Extension (OLE)|Lack of Efficacy|0
1973161|NCT01981850|3534671|FG004|Open Label Extension (OLE)|Lack of Efficacy|0
1973162|NCT01981850|3534672|FG005|Open Label Extension (OLE)|Lack of Efficacy|0
1973163|NCT01981850|3534673|FG006|Open Label Extension (OLE)|Lack of Efficacy|0
1973164|NCT01981850|3534674|FG007|Open Label Extension (OLE)|Lack of Efficacy|4
1973165|NCT01981850|3534675|FG008|Open Label Extension (OLE)|Lack of Efficacy|1
1973166|NCT01981850|3534676|FG009|Open Label Extension (OLE)|Lack of Efficacy|19
1973167|NCT01981850|3534667|FG000|Open Label Extension (OLE)|Various reasons|0
1973168|NCT01981850|3534668|FG001|Open Label Extension (OLE)|Various reasons|0
1973169|NCT01981850|3534669|FG002|Open Label Extension (OLE)|Various reasons|0
1973170|NCT01981850|3534670|FG003|Open Label Extension (OLE)|Various reasons|0
1973171|NCT01981850|3534671|FG004|Open Label Extension (OLE)|Various reasons|0
1973172|NCT01981850|3534672|FG005|Open Label Extension (OLE)|Various reasons|0
1973173|NCT01981850|3534673|FG006|Open Label Extension (OLE)|Various reasons|0
1973174|NCT01981850|3534674|FG007|Open Label Extension (OLE)|Various reasons|3
1973175|NCT01981850|3534675|FG008|Open Label Extension (OLE)|Various reasons|1
1973176|NCT01981850|3534676|FG009|Open Label Extension (OLE)|Various reasons|3
1973177|NCT01981850|3534667|FG000|Open Label Extension (OLE)|Progressive Disease|0
1973178|NCT01981850|3534668|FG001|Open Label Extension (OLE)|Progressive Disease|0
1973179|NCT01981850|3534669|FG002|Open Label Extension (OLE)|Progressive Disease|0
1973180|NCT01981850|3534670|FG003|Open Label Extension (OLE)|Progressive Disease|0
1973181|NCT01981850|3534671|FG004|Open Label Extension (OLE)|Progressive Disease|0
1973182|NCT01981850|3534672|FG005|Open Label Extension (OLE)|Progressive Disease|0
1973183|NCT01981850|3534673|FG006|Open Label Extension (OLE)|Progressive Disease|0
1973184|NCT01981850|3534674|FG007|Open Label Extension (OLE)|Progressive Disease|3
1973185|NCT01981850|3534675|FG008|Open Label Extension (OLE)|Progressive Disease|2
1973186|NCT01981850|3534676|FG009|Open Label Extension (OLE)|Progressive Disease|9
1973187|NCT01981850|3534667|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1973188|NCT01981850|3534668|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1973189|NCT01981850|3534669|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1973190|NCT01981850|3534670|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1973191|NCT01981850|3534671|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1973192|NCT01981850|3534672|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1973193|NCT01981850|3534673|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1973194|NCT01981850|3534674|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1973195|NCT01981850|3534675|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0
1973196|NCT01981850|3534676|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8
1973197|NCT01981850|3534667|FG000|Open Label Extension (OLE)|Lost to Follow-up|0
1973198|NCT01981850|3534668|FG001|Open Label Extension (OLE)|Lost to Follow-up|0
1973199|NCT01981850|3534669|FG002|Open Label Extension (OLE)|Lost to Follow-up|0
1973200|NCT01981850|3534670|FG003|Open Label Extension (OLE)|Lost to Follow-up|0
1973201|NCT01981850|3534671|FG004|Open Label Extension (OLE)|Lost to Follow-up|0
1973202|NCT01981850|3534672|FG005|Open Label Extension (OLE)|Lost to Follow-up|0
1973203|NCT01981850|3534673|FG006|Open Label Extension (OLE)|Lost to Follow-up|0
1973204|NCT01981850|3534674|FG007|Open Label Extension (OLE)|Lost to Follow-up|0
1973205|NCT01981850|3534675|FG008|Open Label Extension (OLE)|Lost to Follow-up|0
1973206|NCT01981850|3534676|FG009|Open Label Extension (OLE)|Lost to Follow-up|1
1973207|NCT01804816|3534708|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
1973208|NCT01804816|3534708|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1
1973209|NCT01519960|3534742|FG000|Overall Study|Ongoing in Follow-Up|101
1973210|NCT01519960|3534743|FG001|Overall Study|Ongoing in Follow-Up|11
1973211|NCT01519960|3534744|FG002|Overall Study|Ongoing in Follow-Up|10
1973212|NCT01519960|3534742|FG000|Overall Study|Ongoing/Switched to PEG-IFN|0
1973213|NCT01519960|3534743|FG001|Overall Study|Ongoing/Switched to PEG-IFN|33
1973214|NCT01519960|3534744|FG002|Overall Study|Ongoing/Switched to PEG-IFN|0
1973215|NCT01519960|3534742|FG000|Overall Study|Adverse Event|0
1973216|NCT01519960|3534743|FG001|Overall Study|Adverse Event|1
1973217|NCT01519960|3534744|FG002|Overall Study|Adverse Event|0
1973218|NCT01519960|3534742|FG000|Overall Study|Withdrawal by Subject|0
1973219|NCT01519960|3534743|FG001|Overall Study|Withdrawal by Subject|4
1973220|NCT01519960|3534744|FG002|Overall Study|Withdrawal by Subject|0
1973221|NCT01519960|3534742|FG000|Overall Study|Lost to Follow-up|0
1973222|NCT01519960|3534743|FG001|Overall Study|Lost to Follow-up|1
1973223|NCT01519960|3534744|FG002|Overall Study|Lost to Follow-up|0
2310314|NCT02731729|4014333|FG000|Overall Study|Withdrawal by Subject|1
2310315|NCT02731729|4014334|FG001|Overall Study|Withdrawal by Subject|0
1973224|NCT00688376|3534757|FG000|Double-Blind Phase|Adverse Event|4
1973225|NCT00688376|3534758|FG001|Double-Blind Phase|Adverse Event|4
1973226|NCT00688376|3534757|FG000|Double-Blind Phase|Protocol Violation|1
1973227|NCT00688376|3534758|FG001|Double-Blind Phase|Protocol Violation|2
1973228|NCT00688376|3534757|FG000|Double-Blind Phase|Withdrawal by Subject|1
1973229|NCT00688376|3534758|FG001|Double-Blind Phase|Withdrawal by Subject|0
1973230|NCT00688376|3534757|FG000|Double-Blind Phase|Not treated|0
1973231|NCT00688376|3534758|FG001|Double-Blind Phase|Not treated|1
1973232|NCT00688376|3534757|FG000|Blinded Extension Phase|Adverse Event|3
1973233|NCT00688376|3534758|FG001|Blinded Extension Phase|Adverse Event|4
1973234|NCT00688376|3534757|FG000|Blinded Extension Phase|Withdrawal by Subject|0
1973235|NCT00688376|3534758|FG001|Blinded Extension Phase|Withdrawal by Subject|1
1973236|NCT00688376|3534757|FG000|Blinded Extension Phase|Physician Decision|1
1973237|NCT00688376|3534758|FG001|Blinded Extension Phase|Physician Decision|0
1973238|NCT00688376|3534757|FG000|Blinded Extension Phase|Other|1
1973239|NCT00688376|3534758|FG001|Blinded Extension Phase|Other|0
1973240|NCT00121108|3534785|FG000|Overall Study|Lost to Follow-up|10
1973241|NCT00121108|3534786|FG001|Overall Study|Lost to Follow-up|22
1973242|NCT00121108|3534785|FG000|Overall Study|Withdrawal by Subject|106
1973243|NCT00121108|3534786|FG001|Overall Study|Withdrawal by Subject|195
1973244|NCT00121108|3534785|FG000|Overall Study|Death|5
1973245|NCT00121108|3534786|FG001|Overall Study|Death|8
1973246|NCT00003102|3534796|FG000|Overall Study|Physician Decision|1
1973247|NCT00003102|3534797|FG001|Overall Study|Physician Decision|1
1973248|NCT00003102|3534798|FG002|Overall Study|Physician Decision|0
1973249|NCT00003102|3534796|FG000|Overall Study|Progressive Disease|0
1973250|NCT00003102|3534797|FG001|Overall Study|Progressive Disease|1
1973251|NCT00003102|3534798|FG002|Overall Study|Progressive Disease|0
1973252|NCT00003102|3534796|FG000|Overall Study|Adverse Event|0
1973253|NCT00003102|3534797|FG001|Overall Study|Adverse Event|1
1973254|NCT00003102|3534798|FG002|Overall Study|Adverse Event|1
1973255|NCT00003102|3534796|FG000|Overall Study|Death|0
1973256|NCT00003102|3534797|FG001|Overall Study|Death|0
1973257|NCT00003102|3534798|FG002|Overall Study|Death|1
2021694|NCT00313911|3589401|FG001|Overall Study|Protocol Violation|10
2021695|NCT00313911|3589400|FG000|Overall Study|Lost to Follow-up|27
2021696|NCT00313911|3589401|FG001|Overall Study|Lost to Follow-up|14
2021697|NCT00313911|3589400|FG000|Overall Study|Withdrawal by Subject|39
2021698|NCT00313911|3589401|FG001|Overall Study|Withdrawal by Subject|12
2021699|NCT00313911|3589400|FG000|Overall Study|Did not meet age criteria|1
2021700|NCT00313911|3589401|FG001|Overall Study|Did not meet age criteria|1
2021701|NCT00314132|3589418|FG000|Overall Study|Lost to Follow-up|3
2021702|NCT00314132|3589419|FG001|Overall Study|Lost to Follow-up|13
2021703|NCT00314132|3589418|FG000|Overall Study|Withdrawal by Subject|3
2021704|NCT00314132|3589419|FG001|Overall Study|Withdrawal by Subject|5
2021705|NCT00314132|3589418|FG000|Overall Study|Adverse Event|1
2021706|NCT00314132|3589419|FG001|Overall Study|Adverse Event|0
2021707|NCT00314132|3589418|FG000|Overall Study|Physician Decision|1
2021708|NCT00314132|3589419|FG001|Overall Study|Physician Decision|0
2021709|NCT00314145|3589429|FG000|Overall Study|Withdrawal by Subject|8
2021710|NCT00314145|3589430|FG001|Overall Study|Withdrawal by Subject|10
2021711|NCT00314145|3589429|FG000|Overall Study|Lost to Follow-up|5
2021712|NCT00314145|3589430|FG001|Overall Study|Lost to Follow-up|12
2021713|NCT00314145|3589429|FG000|Overall Study|Physician Decision|3
2021714|NCT00314145|3589430|FG001|Overall Study|Physician Decision|4
2021715|NCT00314145|3589429|FG000|Overall Study|Adverse Event|0
2021716|NCT00314145|3589430|FG001|Overall Study|Adverse Event|3
2021717|NCT00314145|3589429|FG000|Overall Study|Protocol Violation|3
2021718|NCT00314145|3589430|FG001|Overall Study|Protocol Violation|0
2021719|NCT00314145|3589429|FG000|Overall Study|Sponsor Decision|2
2021720|NCT00314145|3589430|FG001|Overall Study|Sponsor Decision|0
2021721|NCT00314249|3589448|FG000|Overall Study|Adverse Event|73
2021722|NCT00314249|3589449|FG001|Overall Study|Adverse Event|94
2021723|NCT00314249|3589448|FG000|Overall Study|Lack of Efficacy|33
2021724|NCT00314249|3589449|FG001|Overall Study|Lack of Efficacy|24
2021725|NCT00314249|3589448|FG000|Overall Study|Withdrawal by Subject|21
2021726|NCT00314249|3589449|FG001|Overall Study|Withdrawal by Subject|28
2310316|NCT02731742|4014344|FG000|Overall Study|Death|1
2021727|NCT00314249|3589448|FG000|Overall Study|Lost to Follow-up|15
2021728|NCT00314249|3589449|FG001|Overall Study|Lost to Follow-up|9
2021729|NCT00314249|3589448|FG000|Overall Study|Physician Decision|1
2021730|NCT00314249|3589449|FG001|Overall Study|Physician Decision|1
2021731|NCT00314249|3589448|FG000|Overall Study|Withdrawn for other reasons|4
2021732|NCT00314249|3589449|FG001|Overall Study|Withdrawn for other reasons|1
2021733|NCT00314249|3589448|FG000|Overall Study|Non-Compliant|5
2021734|NCT00314249|3589449|FG001|Overall Study|Non-Compliant|6
2021735|NCT00314262|3589455|FG000|Overall Study|Adverse Event|2
2021736|NCT00314262|3589455|FG000|Overall Study|Withdrawal by Subject|2
2021737|NCT00314262|3589455|FG000|Overall Study|Physician Decision|1
2021738|NCT00314340|3589459|FG000|Overall Study|lost interest|1
2021739|NCT00314366|3589467|FG000|Overall Study|not treated due to patient medical condi|1
2310317|NCT02731742|4014345|FG001|Overall Study|Death|2
1973258|NCT04633837|3534808|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5
1973259|NCT04633837|3534809|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0
1973260|NCT04057937|3534817|FG000|Placebo-controlled Phase|Adverse Event|3
1973261|NCT04057937|3534818|FG001|Placebo-controlled Phase|Adverse Event|0
1973262|NCT04057937|3534817|FG000|Active-treatment Phase|Withdrawal by Subject|1
1973263|NCT04057937|3534818|FG001|Active-treatment Phase|Withdrawal by Subject|0
1973264|NCT04057937|3534817|FG000|Active-treatment Phase|Pregnancy|0
1973265|NCT04057937|3534818|FG001|Active-treatment Phase|Pregnancy|1
1973266|NCT04057937|3534817|FG000|Active-treatment Phase|Physician Decision|0
1973267|NCT04057937|3534818|FG001|Active-treatment Phase|Physician Decision|1
1973268|NCT03674112|3534827|FG000|Overall Study|Adverse Event|1
1973269|NCT03674112|3534828|FG001|Overall Study|Adverse Event|0
1973270|NCT03674112|3534827|FG000|Overall Study|Ongoing in the Study|79
1973271|NCT03674112|3534828|FG001|Overall Study|Ongoing in the Study|80
1973272|NCT03032510|3534860|FG000|Overall Study|Adverse Event|5
1973273|NCT03032510|3534861|FG001|Overall Study|Adverse Event|2
1973274|NCT03032510|3534860|FG000|Overall Study|Lost to Follow-up|8
1973275|NCT03032510|3534861|FG001|Overall Study|Lost to Follow-up|7
1973276|NCT03032510|3534860|FG000|Overall Study|Withdrawal by Subject|8
1973277|NCT03032510|3534861|FG001|Overall Study|Withdrawal by Subject|7
1973278|NCT03032510|3534860|FG000|Overall Study|Subject noncompliance|4
1973279|NCT03032510|3534861|FG001|Overall Study|Subject noncompliance|2
1973280|NCT03032510|3534860|FG000|Overall Study|Physician Decision|2
1973281|NCT03032510|3534861|FG001|Overall Study|Physician Decision|0
1973282|NCT02946047|3534892|FG000|Overall Study|Adverse Event|1
1973283|NCT02946047|3534893|FG001|Overall Study|Adverse Event|0
1973284|NCT02946047|3534894|FG002|Overall Study|Adverse Event|0
1973285|NCT02946047|3534895|FG003|Overall Study|Adverse Event|0
1973286|NCT02784704|3534913|FG000|Overall Study|Adverse Event|4
1973287|NCT02784704|3534914|FG001|Overall Study|Adverse Event|2
1973288|NCT02784704|3534913|FG000|Overall Study|Lost to Follow-up|6
1973289|NCT02784704|3534914|FG001|Overall Study|Lost to Follow-up|4
1973290|NCT02784704|3534913|FG000|Overall Study|Withdrawal by Subject|1
1973291|NCT02784704|3534914|FG001|Overall Study|Withdrawal by Subject|3
1973292|NCT02784704|3534913|FG000|Overall Study|Subject Non Compliance|2
1973293|NCT02784704|3534914|FG001|Overall Study|Subject Non Compliance|0
1973294|NCT04876274|3534924|FG000|Overall Study|Lost to Follow-up|9
1973295|NCT04876274|3534925|FG001|Overall Study|Lost to Follow-up|12
1973296|NCT04831515|3534931|FG000|First Intervention|Adverse Event|0
1973297|NCT04831515|3534932|FG001|First Intervention|Adverse Event|1
1973298|NCT03881059|3534963|FG000|Treatment Period - Part A|Adverse Event|1
1973299|NCT03881059|3534964|FG001|Treatment Period - Part A|Adverse Event|3
1973300|NCT03881059|3534965|FG002|Treatment Period - Part A|Adverse Event|4
1973301|NCT03881059|3534963|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0
1973302|NCT03881059|3534964|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1
1973303|NCT03881059|3534965|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1
1973304|NCT03881059|3534963|FG000|Treatment Period - Part A|Withdrawal by Subject|5
1973305|NCT03881059|3534964|FG001|Treatment Period - Part A|Withdrawal by Subject|2
1973306|NCT03881059|3534965|FG002|Treatment Period - Part A|Withdrawal by Subject|3
1973307|NCT03881059|3534963|FG000|Treatment Period - Part A|Other reasons|2
1973308|NCT03881059|3534964|FG001|Treatment Period - Part A|Other reasons|1
1973309|NCT03881059|3534965|FG002|Treatment Period - Part A|Other reasons|0
1973310|NCT03881059|3534963|FG000|Treatment Period - Part B|Adverse Event|0
1973311|NCT03881059|3534964|FG001|Treatment Period - Part B|Adverse Event|0
1973312|NCT03881059|3534965|FG002|Treatment Period - Part B|Adverse Event|3
1973313|NCT03881059|3534963|FG000|Treatment Period - Part B|Death|0
1973314|NCT03881059|3534964|FG001|Treatment Period - Part B|Death|1
1973315|NCT03881059|3534965|FG002|Treatment Period - Part B|Death|1
1973316|NCT03881059|3534963|FG000|Treatment Period - Part B|Lack of Efficacy|1
1973317|NCT03881059|3534964|FG001|Treatment Period - Part B|Lack of Efficacy|1
1973318|NCT03881059|3534965|FG002|Treatment Period - Part B|Lack of Efficacy|0
1973319|NCT03881059|3534963|FG000|Treatment Period - Part B|Lost to Follow-up|1
1973320|NCT03881059|3534964|FG001|Treatment Period - Part B|Lost to Follow-up|1
1973321|NCT03881059|3534965|FG002|Treatment Period - Part B|Lost to Follow-up|0
1973322|NCT03881059|3534963|FG000|Treatment Period - Part B|Site terminated by sponsor|1
1973323|NCT03881059|3534964|FG001|Treatment Period - Part B|Site terminated by sponsor|0
1973324|NCT03881059|3534965|FG002|Treatment Period - Part B|Site terminated by sponsor|3
2212844|NCT01674010|3854187|FG002|Open Treatment Phase 1|Death|0
2212845|NCT01674010|3854185|FG000|Open Treatment Phase 1|Lost to Follow-up|19
1973325|NCT03881059|3534963|FG000|Treatment Period - Part B|Withdrawal by Subject|1
1973326|NCT03881059|3534964|FG001|Treatment Period - Part B|Withdrawal by Subject|0
1973327|NCT03881059|3534965|FG002|Treatment Period - Part B|Withdrawal by Subject|1
1973328|NCT03881059|3534963|FG000|Treatment Period - Part B|Other reasons|4
1973329|NCT03881059|3534964|FG001|Treatment Period - Part B|Other reasons|3
1973330|NCT03881059|3534965|FG002|Treatment Period - Part B|Other reasons|3
1973331|NCT03817853|3534982|FG000|Induction Phase|Adverse Event|5
1973332|NCT03817853|3534983|FG001|Induction Phase|Adverse Event|0
1973333|NCT03817853|3534984|FG002|Induction Phase|Adverse Event|0
1973334|NCT03817853|3534982|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3
2212846|NCT01674010|3854186|FG001|Open Treatment Phase 1|Lost to Follow-up|0
2212847|NCT01674010|3854187|FG002|Open Treatment Phase 1|Lost to Follow-up|0
2212848|NCT01674010|3854185|FG000|Open Treatment Phase 1|Physician Decision|9
2212849|NCT01674010|3854186|FG001|Open Treatment Phase 1|Physician Decision|0
2212850|NCT01674010|3854187|FG002|Open Treatment Phase 1|Physician Decision|0
1973335|NCT03817853|3534983|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
1973336|NCT03817853|3534984|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
1973337|NCT03817853|3534982|FG000|Induction Phase|Physician Decision|2
1973338|NCT03817853|3534983|FG001|Induction Phase|Physician Decision|0
1973339|NCT03817853|3534984|FG002|Induction Phase|Physician Decision|0
1973340|NCT03817853|3534982|FG000|Induction Phase|Progressive Disease|4
1973341|NCT03817853|3534983|FG001|Induction Phase|Progressive Disease|0
1973342|NCT03817853|3534984|FG002|Induction Phase|Progressive Disease|0
1973343|NCT03817853|3534982|FG000|Induction Phase|Withdrawal by Subject|3
1973344|NCT03817853|3534983|FG001|Induction Phase|Withdrawal by Subject|0
1973345|NCT03817853|3534984|FG002|Induction Phase|Withdrawal by Subject|0
1973346|NCT03817853|3534982|FG000|Induction Phase|Continuing on Study|34
1973347|NCT03817853|3534983|FG001|Induction Phase|Continuing on Study|0
1973348|NCT03817853|3534984|FG002|Induction Phase|Continuing on Study|0
1973349|NCT03817853|3534982|FG000|Maintenance/ Follow-up Phase|Adverse Event|0
1973350|NCT03817853|3534983|FG001|Maintenance/ Follow-up Phase|Adverse Event|1
1973351|NCT03817853|3534984|FG002|Maintenance/ Follow-up Phase|Adverse Event|0
1973352|NCT03817853|3534982|FG000|Maintenance/ Follow-up Phase|Death|0
1973353|NCT03817853|3534983|FG001|Maintenance/ Follow-up Phase|Death|1
1973354|NCT03817853|3534984|FG002|Maintenance/ Follow-up Phase|Death|1
1973355|NCT03817853|3534982|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0
1973356|NCT03817853|3534983|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1
1973357|NCT03817853|3534984|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3
1973358|NCT03817853|3534982|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
1973359|NCT03817853|3534983|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1
1973360|NCT03817853|3534984|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
1973361|NCT03817853|3534982|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0
1973362|NCT03817853|3534983|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52
1973363|NCT03817853|3534984|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2
2021740|NCT00314366|3589468|FG001|Overall Study|not treated due to patient medical condi|0
2021741|NCT00314574|3589479|FG000|Overall Study|Death|3
2021742|NCT00314574|3589480|FG001|Overall Study|Death|0
2021743|NCT00314574|3589479|FG000|Overall Study|Adverse Event|11
2021744|NCT00314574|3589480|FG001|Overall Study|Adverse Event|16
2021745|NCT00314574|3589479|FG000|Overall Study|Lost to Follow-up|19
2021746|NCT00314574|3589480|FG001|Overall Study|Lost to Follow-up|25
2021747|NCT00314574|3589479|FG000|Overall Study|Withdrawal by Subject|33
2021748|NCT00314574|3589480|FG001|Overall Study|Withdrawal by Subject|22
2021749|NCT00314574|3589479|FG000|Overall Study|Physician Decision|22
2021750|NCT00314574|3589480|FG001|Overall Study|Physician Decision|15
2021751|NCT00314574|3589479|FG000|Overall Study|Pregnancy|6
2021752|NCT00314574|3589480|FG001|Overall Study|Pregnancy|4
2021753|NCT00314574|3589479|FG000|Overall Study|Data unknown at database lock|0
2021754|NCT00314574|3589480|FG001|Overall Study|Data unknown at database lock|1
2021755|NCT00314795|3589486|FG000|Overall Study|Adverse Event|8
2021756|NCT00314795|3589486|FG000|Overall Study|Death|4
2021757|NCT00314795|3589486|FG000|Overall Study|Reason not Specified|3
2021758|NCT00314795|3589486|FG000|Overall Study|Renal Transplant|3
2021759|NCT00314795|3589486|FG000|Overall Study|Participants Withdrew Consent|2
2021760|NCT00314808|3589490|FG000|Overall Study|Disease Progression without AE|4
2021761|NCT00314808|3589490|FG000|Overall Study|Withdrawal by Subject/PI without AE|4
2021762|NCT00314951|3589496|FG000|Treatment|Didn't meet criteria for mITT population|16
2021763|NCT00314951|3589497|FG001|Treatment|Didn't meet criteria for mITT population|11
2021764|NCT00314951|3589496|FG000|Follow-up|mITT failure|44
2021765|NCT00314951|3589497|FG001|Follow-up|mITT failure|34
2021766|NCT00315055|3589505|FG000|Overall Study|Protocol Violation|2
2021767|NCT00315055|3589506|FG001|Overall Study|Protocol Violation|4
2021768|NCT00315055|3589505|FG000|Overall Study|Lost to Follow-up|1
2021769|NCT00315055|3589506|FG001|Overall Study|Lost to Follow-up|1
2025932|NCT00347919|3594671|FG002|Overall Study|Lost to Follow-up|0
2025933|NCT00347919|3594669|FG000|Overall Study|Withdrawal by Subject|6
2025934|NCT00347919|3594670|FG001|Overall Study|Withdrawal by Subject|8
2212851|NCT01674010|3854185|FG000|Open Treatment Phase 1|Protocol Violation|7
2212852|NCT01674010|3854186|FG001|Open Treatment Phase 1|Protocol Violation|0
2025935|NCT00347919|3594671|FG002|Overall Study|Withdrawal by Subject|0
2025936|NCT00347919|3594669|FG000|Overall Study|Physician Decision|1
2025937|NCT00347919|3594670|FG001|Overall Study|Physician Decision|1
2025938|NCT00347919|3594671|FG002|Overall Study|Physician Decision|0
2025939|NCT00347919|3594669|FG000|Overall Study|Sponsor terminated study|15
2025940|NCT00347919|3594670|FG001|Overall Study|Sponsor terminated study|10
2025941|NCT00347919|3594671|FG002|Overall Study|Sponsor terminated study|16
2025942|NCT00347919|3594669|FG000|Overall Study|Death|35
2025943|NCT00347919|3594670|FG001|Overall Study|Death|42
2025944|NCT00347919|3594671|FG002|Overall Study|Death|19
2025945|NCT00347919|3594669|FG000|Overall Study|Par. Started Other Treatment|1
1973364|NCT03450629|3534994|FG000|Overall Study|Adverse Event|15
1973365|NCT03450629|3534995|FG001|Overall Study|Adverse Event|14
1973366|NCT03450629|3534994|FG000|Overall Study|Physician Decision|2
1973367|NCT03450629|3534995|FG001|Overall Study|Physician Decision|2
1973368|NCT03450629|3534994|FG000|Overall Study|Lack of Efficacy|2
1973369|NCT03450629|3534995|FG001|Overall Study|Lack of Efficacy|0
1973370|NCT03450629|3534994|FG000|Overall Study|Lost to Follow-up|4
1973371|NCT03450629|3534995|FG001|Overall Study|Lost to Follow-up|2
1973372|NCT03450629|3534994|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
1973373|NCT03450629|3534995|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
1973374|NCT03450629|3534994|FG000|Overall Study|Non-Compliance With Study Drug|2
1973375|NCT03450629|3534995|FG001|Overall Study|Non-Compliance With Study Drug|1
1973376|NCT03450629|3534994|FG000|Overall Study|Protocol Violation|11
1973377|NCT03450629|3534995|FG001|Overall Study|Protocol Violation|8
1973378|NCT03450629|3534994|FG000|Overall Study|Withdrawal by Subject|12
1973379|NCT03450629|3534995|FG001|Overall Study|Withdrawal by Subject|6
1973380|NCT03367403|3535004|FG000|Overall Study|Adverse Event|20
1973381|NCT03367403|3535005|FG001|Overall Study|Adverse Event|6
1973382|NCT03367403|3535006|FG002|Overall Study|Adverse Event|2
1973383|NCT03367403|3535004|FG000|Overall Study|Withdrawal by Subject|12
1973384|NCT03367403|3535005|FG001|Overall Study|Withdrawal by Subject|12
1973385|NCT03367403|3535006|FG002|Overall Study|Withdrawal by Subject|1
1973386|NCT03367403|3535004|FG000|Overall Study|Death|1
1973387|NCT03367403|3535005|FG001|Overall Study|Death|2
1973388|NCT03367403|3535006|FG002|Overall Study|Death|0
1973389|NCT03367403|3535004|FG000|Overall Study|Physician Decision|0
1973390|NCT03367403|3535005|FG001|Overall Study|Physician Decision|1
1973391|NCT03367403|3535006|FG002|Overall Study|Physician Decision|0
1973392|NCT03367403|3535004|FG000|Overall Study|Protocol Violation|1
1973393|NCT03367403|3535005|FG001|Overall Study|Protocol Violation|1
1973394|NCT03367403|3535006|FG002|Overall Study|Protocol Violation|0
1973395|NCT03367403|3535004|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0
1973396|NCT03367403|3535005|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2
1973397|NCT03367403|3535006|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0
1973398|NCT03367403|3535004|FG000|Overall Study|COVID-19|3
1973399|NCT03367403|3535005|FG001|Overall Study|COVID-19|7
1973400|NCT03367403|3535006|FG002|Overall Study|COVID-19|0
1973401|NCT03367403|3535004|FG000|Overall Study|Abuse of Alcohol Intake|0
1973402|NCT03367403|3535005|FG001|Overall Study|Abuse of Alcohol Intake|1
1973403|NCT03367403|3535006|FG002|Overall Study|Abuse of Alcohol Intake|0
1973404|NCT03367403|3535004|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0
1973405|NCT03367403|3535005|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1
1973406|NCT03367403|3535006|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0
1973407|NCT03286426|3535014|FG000|Overall Study|Physician Decision|3
1973408|NCT03106779|3535033|FG000|Overall Study|Lack of Efficacy|33
1973409|NCT03106779|3535034|FG001|Overall Study|Lack of Efficacy|24
2310318|NCT02731742|4014346|FG002|Overall Study|Death|5
2310319|NCT02731742|4014347|FG003|Overall Study|Death|0
2310320|NCT02731742|4014344|FG000|Overall Study|Physician Decision|0
2310321|NCT02731742|4014345|FG001|Overall Study|Physician Decision|0
2310322|NCT02731742|4014346|FG002|Overall Study|Physician Decision|0
2310323|NCT02731742|4014347|FG003|Overall Study|Physician Decision|1
2310324|NCT02731742|4014344|FG000|Overall Study|Study Terminated by Sponsor|2
1973410|NCT03106779|3535033|FG000|Overall Study|Adverse Event|8
1973411|NCT03106779|3535034|FG001|Overall Study|Adverse Event|16
1973412|NCT03106779|3535033|FG000|Overall Study|Physician Decision|10
1973413|NCT03106779|3535034|FG001|Overall Study|Physician Decision|6
1973414|NCT03106779|3535033|FG000|Overall Study|Patient/guardian decision|4
1973415|NCT03106779|3535034|FG001|Overall Study|Patient/guardian decision|3
1973416|NCT03106779|3535033|FG000|Overall Study|Progressive disease|1
1973417|NCT03106779|3535034|FG001|Overall Study|Progressive disease|3
1973418|NCT03106779|3535033|FG000|Overall Study|Lost to Follow-up|1
1973419|NCT03106779|3535034|FG001|Overall Study|Lost to Follow-up|2
1973420|NCT03106779|3535033|FG000|Overall Study|Death|1
1973421|NCT03106779|3535034|FG001|Overall Study|Death|0
1973422|NCT03106779|3535033|FG000|Overall Study|Protocol Violation|1
1973423|NCT03106779|3535034|FG001|Overall Study|Protocol Violation|0
1973424|NCT03106779|3535033|FG000|Overall Study|Not treated|1
1973425|NCT03106779|3535034|FG001|Overall Study|Not treated|0
1973426|NCT02809677|3535049|FG000|Overall Study|Withdrawal by Subject|8
1973427|NCT02554253|3535060|FG000|Overall Study|ineligible after enrollment|1
1973428|NCT02554253|3535061|FG001|Overall Study|ineligible after enrollment|0
1973429|NCT02554253|3535060|FG000|Overall Study|converted to transcatheter procedure|0
1973430|NCT02554253|3535061|FG001|Overall Study|converted to transcatheter procedure|1
1973431|NCT02554253|3535060|FG000|Overall Study|received both drugs|0
1973432|NCT02554253|3535061|FG001|Overall Study|received both drugs|1
1973433|NCT02476916|3535079|FG000|Core Period|Adverse Event|2
1973434|NCT02476916|3535080|FG001|Core Period|Adverse Event|2
1973435|NCT02476916|3535079|FG000|Core Period|Investigator decision|1
1973436|NCT02476916|3535080|FG001|Core Period|Investigator decision|1
2310325|NCT02731742|4014345|FG001|Overall Study|Study Terminated by Sponsor|1
1973437|NCT02476916|3535079|FG000|Core Period|Withdrawal by Subject|3
1973438|NCT02476916|3535080|FG001|Core Period|Withdrawal by Subject|0
1973439|NCT02476916|3535079|FG000|Extension Period|Prematurely Discontinued Treatment|6
1973440|NCT02476916|3535080|FG001|Extension Period|Prematurely Discontinued Treatment|1
1973441|NCT02476916|3535079|FG000|Extension Period|On Treatment|12
1973442|NCT02476916|3535080|FG001|Extension Period|On Treatment|17
1973443|NCT02462876|3535087|FG000|Overall Study|Death|3
1973444|NCT02462876|3535087|FG000|Overall Study|Lost to Follow-up|7
1973445|NCT02462876|3535087|FG000|Overall Study|Surgical Bypass|9
1973446|NCT02462876|3535087|FG000|Overall Study|Amputation Above the Metatarsals|1
1973447|NCT02462876|3535087|FG000|Overall Study|36 months follow-up visit missed|1
1973448|NCT02462876|3535087|FG000|Overall Study|Patient did not come back since 4 months follow-up|1
1973449|NCT02462876|3535087|FG000|Overall Study|Patient did not come back to the vascular department|1
1973450|NCT02462876|3535087|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1
1973451|NCT02462876|3535087|FG000|Overall Study|Patient refused to come back|1
1973452|NCT02462876|3535087|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1
1973453|NCT02462876|3535087|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1
1973454|NCT02106195|3535091|FG000|Overall Study|Adverse Event|2
1973455|NCT02106195|3535091|FG000|Overall Study|Protocol Violation|1
2021770|NCT00315445|3589601|FG000|Overall Study|Adverse Event|7
2021771|NCT00315445|3589602|FG001|Overall Study|Adverse Event|12
2021772|NCT00315445|3589603|FG002|Overall Study|Adverse Event|15
2021773|NCT00315445|3589601|FG000|Overall Study|Lack of Efficacy|16
2021774|NCT00315445|3589602|FG001|Overall Study|Lack of Efficacy|1
2021775|NCT00315445|3589603|FG002|Overall Study|Lack of Efficacy|7
2021776|NCT00315445|3589601|FG000|Overall Study|Lost to Follow-up|1
2021777|NCT00315445|3589602|FG001|Overall Study|Lost to Follow-up|0
2021778|NCT00315445|3589603|FG002|Overall Study|Lost to Follow-up|1
2021779|NCT00315445|3589601|FG000|Overall Study|Protocol Violation|2
2021780|NCT00315445|3589602|FG001|Overall Study|Protocol Violation|0
2021781|NCT00315445|3589603|FG002|Overall Study|Protocol Violation|1
2021782|NCT00315445|3589601|FG000|Overall Study|Other|1
2021783|NCT00315445|3589602|FG001|Overall Study|Other|3
2021784|NCT00315445|3589603|FG002|Overall Study|Other|0
2021785|NCT00315458|3589613|FG000|Overall Study|Administrative|0
2021786|NCT00315458|3589614|FG001|Overall Study|Administrative|3
2021787|NCT00315458|3589615|FG002|Overall Study|Administrative|8
2021788|NCT00315458|3589616|FG003|Overall Study|Administrative|21
2021789|NCT00315458|3589613|FG000|Overall Study|Adverse Event|2
2021790|NCT00315458|3589614|FG001|Overall Study|Adverse Event|4
2021791|NCT00315458|3589615|FG002|Overall Study|Adverse Event|23
2021792|NCT00315458|3589616|FG003|Overall Study|Adverse Event|3
2021793|NCT00315458|3589613|FG000|Overall Study|Lost to Follow-up|1
2021794|NCT00315458|3589614|FG001|Overall Study|Lost to Follow-up|2
2021795|NCT00315458|3589615|FG002|Overall Study|Lost to Follow-up|0
2021796|NCT00315458|3589616|FG003|Overall Study|Lost to Follow-up|2
2021797|NCT00315458|3589613|FG000|Overall Study|Withdrawal by Subject|0
2021798|NCT00315458|3589614|FG001|Overall Study|Withdrawal by Subject|3
2021799|NCT00315458|3589615|FG002|Overall Study|Withdrawal by Subject|0
2021800|NCT00315458|3589616|FG003|Overall Study|Withdrawal by Subject|2
2021801|NCT00315458|3589613|FG000|Overall Study|Lack of Efficacy|0
2021802|NCT00315458|3589614|FG001|Overall Study|Lack of Efficacy|0
2021803|NCT00315458|3589615|FG002|Overall Study|Lack of Efficacy|20
2021804|NCT00315458|3589616|FG003|Overall Study|Lack of Efficacy|1
2021805|NCT00315458|3589613|FG000|Overall Study|Did not qualify|0
2021806|NCT00315458|3589614|FG001|Overall Study|Did not qualify|0
2021807|NCT00315458|3589615|FG002|Overall Study|Did not qualify|1
2021808|NCT00315458|3589616|FG003|Overall Study|Did not qualify|0
2021809|NCT00315705|3589645|FG000|Phase 1|Refused further treatment|1
2021810|NCT00315705|3589645|FG000|Phase 1|Failure to achieve response|8
2021811|NCT00315705|3589645|FG000|Phase 1|Disease relapse|4
2021812|NCT00315705|3589645|FG000|Phase 1|Scheduled for transplant|9
2021813|NCT00315705|3589645|FG000|Phase 1|Death|3
2021814|NCT00315705|3589645|FG000|Phase 2|Physician Decision|4
2021815|NCT00315705|3589645|FG000|Phase 2|Adverse Event|1
2021816|NCT00315705|3589645|FG000|Phase 2|Failure to achieve response|3
2021817|NCT00315705|3589645|FG000|Phase 2|Disease relapse|1
2021818|NCT00315705|3589645|FG000|Phase 2|Scheduled for transplant|8
2021819|NCT00315705|3589645|FG000|Phase 2|Other|1
2021820|NCT00315705|3589645|FG000|Phase 2|Death|7
2021821|NCT00315731|3589662|FG000|Overall Study|Lost to Follow-up|1
2021822|NCT00315731|3589662|FG000|Overall Study|Death|5
2021823|NCT00316004|3589688|FG000|Overall Study|Subject was not given study fluid.|14
2021824|NCT00316004|3589689|FG001|Overall Study|Subject was not given study fluid.|14
2021825|NCT00316004|3589690|FG002|Overall Study|Subject was not given study fluid.|21
2021826|NCT00316017|3589701|FG000|Overall Study|Protocol Violation|11
2021827|NCT00316017|3589702|FG001|Overall Study|Protocol Violation|13
2021828|NCT00316017|3589703|FG002|Overall Study|Protocol Violation|19
2021829|NCT00316082|3589716|FG000|Overall Study|Lack of Efficacy|2
2021830|NCT00316082|3589717|FG001|Overall Study|Lack of Efficacy|3
2021831|NCT00316082|3589718|FG002|Overall Study|Lack of Efficacy|3
2021832|NCT00316082|3589719|FG003|Overall Study|Lack of Efficacy|4
2021833|NCT00316082|3589720|FG004|Overall Study|Lack of Efficacy|6
2021834|NCT00316082|3589716|FG000|Overall Study|Withdrawal of Consent by Subject|10
2021835|NCT00316082|3589717|FG001|Overall Study|Withdrawal of Consent by Subject|8
2021836|NCT00316082|3589718|FG002|Overall Study|Withdrawal of Consent by Subject|2
1973456|NCT01307046|3535113|FG000|Overall Study|Adverse Event|3
1973457|NCT01307046|3535114|FG001|Overall Study|Adverse Event|3
1973458|NCT01307046|3535113|FG000|Overall Study|Lack of Efficacy|0
1973459|NCT01307046|3535114|FG001|Overall Study|Lack of Efficacy|2
1973460|NCT01307046|3535113|FG000|Overall Study|Physician Decision|2
1973461|NCT01307046|3535114|FG001|Overall Study|Physician Decision|0
2212853|NCT01674010|3854187|FG002|Open Treatment Phase 1|Protocol Violation|0
2212854|NCT01674010|3854185|FG000|Open Treatment Phase 1|Sponsor Decision|79
2212855|NCT01674010|3854186|FG001|Open Treatment Phase 1|Sponsor Decision|0
1973462|NCT01307046|3535113|FG000|Overall Study|Withdrawal by Subject|1
1973463|NCT01307046|3535114|FG001|Overall Study|Withdrawal by Subject|1
1973464|NCT01307046|3535113|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4
1973465|NCT01307046|3535114|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2
1973466|NCT01307046|3535113|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2
1973467|NCT01307046|3535114|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3
1973468|NCT01307033|3535122|FG000|8-week Double-blind Period|Adverse Event|2
1973469|NCT01307033|3535123|FG001|8-week Double-blind Period|Adverse Event|0
1973470|NCT01307033|3535124|FG002|8-week Double-blind Period|Adverse Event|0
1973471|NCT01307033|3535125|FG003|8-week Double-blind Period|Adverse Event|0
1973472|NCT01307033|3535122|FG000|8-week Double-blind Period|Withdrawal by Subject|4
1973473|NCT01307033|3535123|FG001|8-week Double-blind Period|Withdrawal by Subject|1
1973474|NCT01307033|3535124|FG002|8-week Double-blind Period|Withdrawal by Subject|0
1973475|NCT01307033|3535125|FG003|8-week Double-blind Period|Withdrawal by Subject|0
1973476|NCT01307033|3535122|FG000|8-week Double-blind Period|Lack of Efficacy|1
1973477|NCT01307033|3535123|FG001|8-week Double-blind Period|Lack of Efficacy|0
1973478|NCT01307033|3535124|FG002|8-week Double-blind Period|Lack of Efficacy|0
1973479|NCT01307033|3535125|FG003|8-week Double-blind Period|Lack of Efficacy|0
1973480|NCT01307033|3535122|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1973481|NCT01307033|3535123|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
1973482|NCT01307033|3535124|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1973483|NCT01307033|3535125|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1973484|NCT01307033|3535122|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
1973485|NCT01307033|3535123|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
1973486|NCT01307033|3535124|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
1973487|NCT01307033|3535125|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
1973488|NCT01307033|3535122|FG000|44-week Open-label Extension|Adverse Event|0
1973489|NCT01307033|3535123|FG001|44-week Open-label Extension|Adverse Event|0
1973490|NCT01307033|3535124|FG002|44-week Open-label Extension|Adverse Event|2
1973491|NCT01307033|3535125|FG003|44-week Open-label Extension|Adverse Event|1
1973492|NCT01307033|3535122|FG000|44-week Open-label Extension|Withdrawal by Subject|0
1973493|NCT01307033|3535123|FG001|44-week Open-label Extension|Withdrawal by Subject|0
1973494|NCT01307033|3535124|FG002|44-week Open-label Extension|Withdrawal by Subject|2
1973495|NCT01307033|3535125|FG003|44-week Open-label Extension|Withdrawal by Subject|1
1973496|NCT01307033|3535122|FG000|44-week Open-label Extension|Physician Decision|0
1973497|NCT01307033|3535123|FG001|44-week Open-label Extension|Physician Decision|0
1973498|NCT01307033|3535124|FG002|44-week Open-label Extension|Physician Decision|1
1973499|NCT01307033|3535125|FG003|44-week Open-label Extension|Physician Decision|0
1973500|NCT01307033|3535122|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1973501|NCT01307033|3535123|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1973502|NCT01307033|3535124|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1973503|NCT01307033|3535125|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
1973504|NCT01307033|3535122|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
1973505|NCT01307033|3535123|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
1973506|NCT01307033|3535124|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
1973507|NCT01307033|3535125|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
1973508|NCT01307033|3535122|FG000|44-week Open-label Extension|Death|0
1973509|NCT01307033|3535123|FG001|44-week Open-label Extension|Death|0
1973510|NCT01307033|3535124|FG002|44-week Open-label Extension|Death|0
1973511|NCT01307033|3535125|FG003|44-week Open-label Extension|Death|1
1973512|NCT00942331|3535139|FG000|Overall Study|Did not start treatment|15
1973513|NCT00942331|3535140|FG001|Overall Study|Did not start treatment|22
1973514|NCT00739674|3535148|FG000|Overall Study|Screening failures|19
1973515|NCT00739674|3535149|FG001|Overall Study|Screening failures|17
1973516|NCT00739674|3535148|FG000|Overall Study|Site 212 removal|19
1973517|NCT00739674|3535149|FG001|Overall Study|Site 212 removal|13
1973518|NCT00739674|3535148|FG000|Overall Study|No follow-up data|33
1973519|NCT00739674|3535149|FG001|Overall Study|No follow-up data|18
1973520|NCT00739674|3535148|FG000|Overall Study|Dietician consultation >30 days|1
1973521|NCT00739674|3535149|FG001|Overall Study|Dietician consultation >30 days|9
1973522|NCT00739674|3535148|FG000|Overall Study|Adverse Event|22
1973523|NCT00739674|3535149|FG001|Overall Study|Adverse Event|13
1973524|NCT00739674|3535148|FG000|Overall Study|Death|1
1973525|NCT00739674|3535149|FG001|Overall Study|Death|0
1973526|NCT00739674|3535148|FG000|Overall Study|Lack of Efficacy|1
1973527|NCT00739674|3535149|FG001|Overall Study|Lack of Efficacy|0
1973528|NCT00739674|3535148|FG000|Overall Study|Lost to Follow-up|52
1973529|NCT00739674|3535149|FG001|Overall Study|Lost to Follow-up|30
1973530|NCT00739674|3535148|FG000|Overall Study|Protocol Violation|5
1973531|NCT00739674|3535149|FG001|Overall Study|Protocol Violation|5
1973532|NCT00739674|3535148|FG000|Overall Study|Withdrawal by Subject|9
1973533|NCT00739674|3535149|FG001|Overall Study|Withdrawal by Subject|9
1973534|NCT00739674|3535148|FG000|Overall Study|Reason missing|2
1973535|NCT00739674|3535149|FG001|Overall Study|Reason missing|0
1973536|NCT00739674|3535148|FG000|Overall Study|Clinic closed|6
1973537|NCT00739674|3535149|FG001|Overall Study|Clinic closed|4
1973538|NCT00739674|3535148|FG000|Overall Study|Patient moved|3
1973539|NCT00739674|3535149|FG001|Overall Study|Patient moved|2
1973540|NCT00739674|3535148|FG000|Overall Study|Non compliant|4
1973541|NCT00739674|3535149|FG001|Overall Study|Non compliant|0
1973542|NCT00739674|3535148|FG000|Overall Study|Unable to attend visit|3
1973543|NCT00739674|3535149|FG001|Overall Study|Unable to attend visit|1
1973544|NCT00739674|3535148|FG000|Overall Study|Home monitoring off meds|1
1973545|NCT00739674|3535149|FG001|Overall Study|Home monitoring off meds|0
1973546|NCT00739674|3535148|FG000|Overall Study|Erectile dysfunction|0
1973547|NCT00739674|3535149|FG001|Overall Study|Erectile dysfunction|1
1973548|NCT00546754|3535157|FG000|Overall Study|Serious Adverse Event|1
1973549|NCT00546754|3535158|FG001|Overall Study|Serious Adverse Event|1
1973550|NCT00546754|3535157|FG000|Overall Study|Adverse Event|11
1973551|NCT00546754|3535158|FG001|Overall Study|Adverse Event|16
1973552|NCT00546754|3535157|FG000|Overall Study|Lack of Efficacy|1
1973553|NCT00546754|3535158|FG001|Overall Study|Lack of Efficacy|1
1973554|NCT00546754|3535157|FG000|Overall Study|Lost to Follow-up|9
1973555|NCT00546754|3535158|FG001|Overall Study|Lost to Follow-up|15
1973556|NCT00546754|3535157|FG000|Overall Study|Protocol Violation|3
1973557|NCT00546754|3535158|FG001|Overall Study|Protocol Violation|0
1973558|NCT00546754|3535157|FG000|Overall Study|Withdrawal by Subject|6
1973559|NCT00546754|3535158|FG001|Overall Study|Withdrawal by Subject|7
1973560|NCT00546754|3535157|FG000|Overall Study|Dyspnea|1
1973561|NCT00546754|3535158|FG001|Overall Study|Dyspnea|0
1973562|NCT00546754|3535157|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
1973563|NCT00546754|3535158|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
1973564|NCT00546754|3535157|FG000|Overall Study|Hip Replacement|1
1973565|NCT00546754|3535158|FG001|Overall Study|Hip Replacement|0
1973566|NCT00546754|3535157|FG000|Overall Study|Suicide|1
1973567|NCT00546754|3535158|FG001|Overall Study|Suicide|0
1973568|NCT00546754|3535157|FG000|Overall Study|Missing Cooperation|1
1973569|NCT00546754|3535158|FG001|Overall Study|Missing Cooperation|0
1973570|NCT00546754|3535157|FG000|Overall Study|Elevated Creatinine and Potassium levels|0
1973571|NCT00546754|3535158|FG001|Overall Study|Elevated Creatinine and Potassium levels|1
1973572|NCT00546754|3535157|FG000|Overall Study|Patient's Decision|0
1973573|NCT00546754|3535158|FG001|Overall Study|Patient's Decision|1
1973574|NCT00546754|3535157|FG000|Overall Study|Missing|14
1973575|NCT00546754|3535158|FG001|Overall Study|Missing|7
1973576|NCT00479713|3535166|FG000|Overall Study|Adverse Event|8
1973577|NCT00479713|3535167|FG001|Overall Study|Adverse Event|6
1973578|NCT00479713|3535166|FG000|Overall Study|Death|1
1973579|NCT00479713|3535167|FG001|Overall Study|Death|0
1973580|NCT00479713|3535166|FG000|Overall Study|Lost to Follow-up|0
1973581|NCT00479713|3535167|FG001|Overall Study|Lost to Follow-up|1
1973582|NCT00479713|3535166|FG000|Overall Study|Protocol Violation|0
1973583|NCT00479713|3535167|FG001|Overall Study|Protocol Violation|1
1973584|NCT00479713|3535166|FG000|Overall Study|Withdrawal by Subject|4
1973585|NCT00479713|3535167|FG001|Overall Study|Withdrawal by Subject|1
1973586|NCT00406783|3535175|FG000|Overall Study|Adverse Event|4
1973587|NCT00406783|3535176|FG001|Overall Study|Adverse Event|4
1973588|NCT00406783|3535175|FG000|Overall Study|Treatment Failure|2
1973589|NCT00406783|3535176|FG001|Overall Study|Treatment Failure|3
1973590|NCT00406783|3535175|FG000|Overall Study|Lost to Follow-up|3
1973591|NCT00406783|3535176|FG001|Overall Study|Lost to Follow-up|0
1973592|NCT00406783|3535175|FG000|Overall Study|Withdrawal by Subject|1
1973593|NCT00406783|3535176|FG001|Overall Study|Withdrawal by Subject|4
1973594|NCT00406783|3535175|FG000|Overall Study|Protocol Violation|4
1973595|NCT00406783|3535176|FG001|Overall Study|Protocol Violation|4
1973596|NCT00405964|3535184|FG000|Overall Study|Treatment Failure|17
1973597|NCT00405964|3535185|FG001|Overall Study|Treatment Failure|45
1973598|NCT00405964|3535184|FG000|Overall Study|Adverse Event|7
1973599|NCT00405964|3535185|FG001|Overall Study|Adverse Event|16
1973600|NCT00405964|3535184|FG000|Overall Study|Lost to Follow-up|5
1973601|NCT00405964|3535185|FG001|Overall Study|Lost to Follow-up|5
1973602|NCT00405964|3535184|FG000|Overall Study|Withdrawal by Subject|19
1973603|NCT00405964|3535185|FG001|Overall Study|Withdrawal by Subject|23
1973604|NCT00405964|3535184|FG000|Overall Study|Protocol Violation|11
1973605|NCT00405964|3535185|FG001|Overall Study|Protocol Violation|6
1973606|NCT00383721|3535196|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11
1973607|NCT00383721|3535197|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5
1973608|NCT00383721|3535198|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7
1973609|NCT00383721|3535199|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14
1973610|NCT00383721|3535200|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13
1973611|NCT00383721|3535196|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
1973612|NCT00383721|3535197|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1973613|NCT00383721|3535198|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1973614|NCT00383721|3535199|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
1973615|NCT00383721|3535200|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
1973616|NCT00383721|3535196|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
1973617|NCT00383721|3535197|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
1973618|NCT00383721|3535198|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1973619|NCT00383721|3535199|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
1973620|NCT00383721|3535200|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
1973621|NCT00383721|3535196|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
1973622|NCT00383721|3535197|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
1973623|NCT00383721|3535198|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
1973624|NCT00383721|3535199|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
1973625|NCT00383721|3535200|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
1973626|NCT00383721|3535196|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
1973627|NCT00383721|3535197|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1973628|NCT00383721|3535198|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
1973629|NCT00383721|3535199|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
1973630|NCT00383721|3535200|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
1973631|NCT00383721|3535196|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
1973632|NCT00383721|3535197|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1973633|NCT00383721|3535198|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
1973634|NCT00383721|3535199|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
1973635|NCT00383721|3535200|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
1973636|NCT00383721|3535196|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
1973637|NCT00383721|3535197|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
1973638|NCT00383721|3535198|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
1973639|NCT00383721|3535199|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
1973640|NCT00383721|3535200|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
1973641|NCT00383721|3535196|FG000|26-Week Double-Blind Treatment Period|Administrative|1
1973642|NCT00383721|3535197|FG001|26-Week Double-Blind Treatment Period|Administrative|3
1973643|NCT00383721|3535198|FG002|26-Week Double-Blind Treatment Period|Administrative|3
1973644|NCT00383721|3535199|FG003|26-Week Double-Blind Treatment Period|Administrative|3
1973645|NCT00383721|3535200|FG004|26-Week Double-Blind Treatment Period|Administrative|3
1973646|NCT00383721|3535196|FG000|26-Week Double-Blind Treatment Period|Ongoing|1
1973647|NCT00383721|3535197|FG001|26-Week Double-Blind Treatment Period|Ongoing|0
1973648|NCT00383721|3535198|FG002|26-Week Double-Blind Treatment Period|Ongoing|0
1973649|NCT00383721|3535199|FG003|26-Week Double-Blind Treatment Period|Ongoing|0
1973650|NCT00383721|3535200|FG004|26-Week Double-Blind Treatment Period|Ongoing|0
1973651|NCT00383721|3535196|FG000|26-Week Treatment Safety Extension|Adverse Event|6
1973652|NCT00383721|3535197|FG001|26-Week Treatment Safety Extension|Adverse Event|7
1973653|NCT00383721|3535198|FG002|26-Week Treatment Safety Extension|Adverse Event|10
1973654|NCT00383721|3535199|FG003|26-Week Treatment Safety Extension|Adverse Event|1
1973655|NCT00383721|3535200|FG004|26-Week Treatment Safety Extension|Adverse Event|0
1973656|NCT00383721|3535196|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0
1973657|NCT00383721|3535197|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2
1973658|NCT00383721|3535198|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4
1973659|NCT00383721|3535199|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
1973660|NCT00383721|3535200|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
1973661|NCT00383721|3535196|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2
1973662|NCT00383721|3535197|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0
1973663|NCT00383721|3535198|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
1973664|NCT00383721|3535199|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1
1973665|NCT00383721|3535200|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0
1973666|NCT00383721|3535196|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1973667|NCT00383721|3535197|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
1973668|NCT00383721|3535198|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1973669|NCT00383721|3535199|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
1973670|NCT00383721|3535200|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
1973671|NCT00383721|3535196|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
1973672|NCT00383721|3535197|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1
1973673|NCT00383721|3535198|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1
1973674|NCT00383721|3535199|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1
1973675|NCT00383721|3535200|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0
1973676|NCT00383721|3535196|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2
1973677|NCT00383721|3535197|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1973678|NCT00383721|3535198|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1973679|NCT00383721|3535199|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4
1973680|NCT00383721|3535200|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
1973681|NCT00383721|3535196|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1973682|NCT00383721|3535197|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1973683|NCT00383721|3535198|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1973684|NCT00383721|3535199|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
2212856|NCT01674010|3854187|FG002|Open Treatment Phase 1|Sponsor Decision|0
2212857|NCT01674010|3854185|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30
2212858|NCT01674010|3854186|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0
2212859|NCT01674010|3854187|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0
2212860|NCT01674010|3854185|FG000|Open Treatment Phase 1|Withdrawal by Subject|25
2212861|NCT01674010|3854186|FG001|Open Treatment Phase 1|Withdrawal by Subject|0
2212862|NCT01674010|3854187|FG002|Open Treatment Phase 1|Withdrawal by Subject|0
2212863|NCT01674010|3854185|FG000|Randomization Phase 2|Adverse Event|0
2212864|NCT01674010|3854186|FG001|Randomization Phase 2|Adverse Event|1
2212865|NCT01674010|3854187|FG002|Randomization Phase 2|Adverse Event|1
2212866|NCT01674010|3854185|FG000|Randomization Phase 2|Lost to Follow-up|0
2212867|NCT01674010|3854186|FG001|Randomization Phase 2|Lost to Follow-up|1
2212868|NCT01674010|3854187|FG002|Randomization Phase 2|Lost to Follow-up|2
2212869|NCT01674010|3854185|FG000|Randomization Phase 2|Mood episode recurrence|0
2212870|NCT01674010|3854186|FG001|Randomization Phase 2|Mood episode recurrence|8
2212871|NCT01674010|3854187|FG002|Randomization Phase 2|Mood episode recurrence|2
2212872|NCT01674010|3854185|FG000|Randomization Phase 2|Physician Decision|0
2212873|NCT01674010|3854186|FG001|Randomization Phase 2|Physician Decision|0
2212874|NCT01674010|3854187|FG002|Randomization Phase 2|Physician Decision|2
2212875|NCT01674010|3854185|FG000|Randomization Phase 2|Pregnancy|0
2212876|NCT01674010|3854186|FG001|Randomization Phase 2|Pregnancy|1
2212877|NCT01674010|3854187|FG002|Randomization Phase 2|Pregnancy|1
2212878|NCT01674010|3854185|FG000|Randomization Phase 2|Protocol Violation|0
2212879|NCT01674010|3854186|FG001|Randomization Phase 2|Protocol Violation|1
2212880|NCT01674010|3854187|FG002|Randomization Phase 2|Protocol Violation|1
2212881|NCT01674010|3854185|FG000|Randomization Phase 2|Sponsor Decision|0
1973685|NCT00383721|3535200|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1973686|NCT00383721|3535196|FG000|26-Week Treatment Safety Extension|Administrative|1
1973687|NCT00383721|3535197|FG001|26-Week Treatment Safety Extension|Administrative|2
1973688|NCT00383721|3535198|FG002|26-Week Treatment Safety Extension|Administrative|3
1973689|NCT00383721|3535199|FG003|26-Week Treatment Safety Extension|Administrative|1
1973690|NCT00383721|3535200|FG004|26-Week Treatment Safety Extension|Administrative|0
1973691|NCT00383552|3535216|FG000|Overall Study|Adverse Event|7
1973692|NCT00383552|3535217|FG001|Overall Study|Adverse Event|6
1973693|NCT00383552|3535218|FG002|Overall Study|Adverse Event|9
1973694|NCT00383552|3535219|FG003|Overall Study|Adverse Event|6
1973695|NCT00383552|3535216|FG000|Overall Study|Lack of Efficacy|4
1973696|NCT00383552|3535217|FG001|Overall Study|Lack of Efficacy|13
1973697|NCT00383552|3535218|FG002|Overall Study|Lack of Efficacy|29
1973698|NCT00383552|3535219|FG003|Overall Study|Lack of Efficacy|42
1973699|NCT00383552|3535216|FG000|Overall Study|Lost to Follow-up|0
1973700|NCT00383552|3535217|FG001|Overall Study|Lost to Follow-up|1
1973701|NCT00383552|3535218|FG002|Overall Study|Lost to Follow-up|5
1973702|NCT00383552|3535219|FG003|Overall Study|Lost to Follow-up|1
1973703|NCT00383552|3535216|FG000|Overall Study|Did not wish to continue (unrelated)|4
1973704|NCT00383552|3535217|FG001|Overall Study|Did not wish to continue (unrelated)|9
1973705|NCT00383552|3535218|FG002|Overall Study|Did not wish to continue (unrelated)|5
1973706|NCT00383552|3535219|FG003|Overall Study|Did not wish to continue (unrelated)|6
1973707|NCT00383552|3535216|FG000|Overall Study|Did not wish to continue (related)|1
1973708|NCT00383552|3535217|FG001|Overall Study|Did not wish to continue (related)|0
1973709|NCT00383552|3535218|FG002|Overall Study|Did not wish to continue (related)|2
1973710|NCT00383552|3535219|FG003|Overall Study|Did not wish to continue (related)|3
1973711|NCT00383552|3535216|FG000|Overall Study|Noncompliance with the protocol|11
1973712|NCT00383552|3535217|FG001|Overall Study|Noncompliance with the protocol|6
1973713|NCT00383552|3535218|FG002|Overall Study|Noncompliance with the protocol|8
1973714|NCT00383552|3535219|FG003|Overall Study|Noncompliance with the protocol|10
1973715|NCT00383552|3535216|FG000|Overall Study|Did not meet protocol eligibility|8
1973716|NCT00383552|3535217|FG001|Overall Study|Did not meet protocol eligibility|6
1973717|NCT00383552|3535218|FG002|Overall Study|Did not meet protocol eligibility|2
1973718|NCT00383552|3535219|FG003|Overall Study|Did not meet protocol eligibility|3
1973719|NCT00383552|3535216|FG000|Overall Study|Administrative|1
1973720|NCT00383552|3535217|FG001|Overall Study|Administrative|0
1973721|NCT00383552|3535218|FG002|Overall Study|Administrative|1
1973722|NCT00383552|3535219|FG003|Overall Study|Administrative|1
1973723|NCT00383435|3535239|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10
2212882|NCT01674010|3854186|FG001|Randomization Phase 2|Sponsor Decision|42
2212883|NCT01674010|3854187|FG002|Randomization Phase 2|Sponsor Decision|45
2212884|NCT01674010|3854185|FG000|Randomization Phase 2|Withdrawal by Subject|0
2212885|NCT01674010|3854186|FG001|Randomization Phase 2|Withdrawal by Subject|8
1973724|NCT00383435|3535240|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2
1973725|NCT00383435|3535241|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8
1973726|NCT00383435|3535242|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6
1973727|NCT00383435|3535243|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8
1973728|NCT00383435|3535239|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1973729|NCT00383435|3535240|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
1973730|NCT00383435|3535241|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1973731|NCT00383435|3535242|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
1973732|NCT00383435|3535243|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
1973733|NCT00383435|3535239|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
1973734|NCT00383435|3535240|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
1973735|NCT00383435|3535241|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
1973736|NCT00383435|3535242|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1973737|NCT00383435|3535243|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1973738|NCT00383435|3535239|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
1973739|NCT00383435|3535240|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
1973740|NCT00383435|3535241|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
1973741|NCT00383435|3535242|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
1973742|NCT00383435|3535243|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
1973743|NCT00383435|3535239|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
1973744|NCT00383435|3535240|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1973745|NCT00383435|3535241|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
1973746|NCT00383435|3535242|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1973747|NCT00383435|3535243|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
1973748|NCT00383435|3535239|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
1973749|NCT00383435|3535240|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1973750|NCT00383435|3535241|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
1973751|NCT00383435|3535242|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1973752|NCT00383435|3535243|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
1973753|NCT00383435|3535239|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
1973754|NCT00383435|3535240|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
1973755|NCT00383435|3535241|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
1973756|NCT00383435|3535242|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
1973757|NCT00383435|3535243|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
1973758|NCT00383435|3535239|FG000|26-Week Double-Blind Treatment Period|Administrative|5
1973759|NCT00383435|3535240|FG001|26-Week Double-Blind Treatment Period|Administrative|3
1973760|NCT00383435|3535241|FG002|26-Week Double-Blind Treatment Period|Administrative|1
1973761|NCT00383435|3535242|FG003|26-Week Double-Blind Treatment Period|Administrative|1
1973762|NCT00383435|3535243|FG004|26-Week Double-Blind Treatment Period|Administrative|1
1973763|NCT00383435|3535239|FG000|26-Week Treatment Safety Extension|Adverse Event|4
1973764|NCT00383435|3535240|FG001|26-Week Treatment Safety Extension|Adverse Event|2
1973765|NCT00383435|3535241|FG002|26-Week Treatment Safety Extension|Adverse Event|5
1973766|NCT00383435|3535242|FG003|26-Week Treatment Safety Extension|Adverse Event|5
1973767|NCT00383435|3535243|FG004|26-Week Treatment Safety Extension|Adverse Event|1
1973768|NCT00383435|3535239|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1
1973769|NCT00383435|3535240|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1
1973770|NCT00383435|3535241|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1
1973771|NCT00383435|3535242|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
1973772|NCT00383435|3535243|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
1973773|NCT00383435|3535239|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0
1973774|NCT00383435|3535240|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2
1973775|NCT00383435|3535241|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
1973776|NCT00383435|3535242|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0
1973777|NCT00383435|3535243|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1
1973778|NCT00383435|3535239|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1973779|NCT00383435|3535240|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1973780|NCT00383435|3535241|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1973781|NCT00383435|3535242|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1973782|NCT00383435|3535243|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
1973783|NCT00383435|3535239|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
1973784|NCT00383435|3535240|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0
1973785|NCT00383435|3535241|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2
1973786|NCT00383435|3535242|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0
1973787|NCT00383435|3535243|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1
1973788|NCT00383435|3535239|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4
1973789|NCT00383435|3535240|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1973790|NCT00383435|3535241|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1973791|NCT00383435|3535242|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1973792|NCT00383435|3535243|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
1973793|NCT00383435|3535239|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1973794|NCT00383435|3535240|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1973795|NCT00383435|3535241|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1973796|NCT00383435|3535242|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1973797|NCT00383435|3535243|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1973798|NCT00383435|3535239|FG000|26-Week Treatment Safety Extension|Administrative|1
1973799|NCT00383435|3535240|FG001|26-Week Treatment Safety Extension|Administrative|1
1973800|NCT00383435|3535241|FG002|26-Week Treatment Safety Extension|Administrative|0
1973801|NCT00383435|3535242|FG003|26-Week Treatment Safety Extension|Administrative|1
1973802|NCT00383435|3535243|FG004|26-Week Treatment Safety Extension|Administrative|0
1973803|NCT00381485|3535258|FG000|Open-Label Run-In Period|Adverse Event|9
1973804|NCT00381485|3535259|FG001|Open-Label Run-In Period|Adverse Event|0
1973805|NCT00381485|3535260|FG002|Open-Label Run-In Period|Adverse Event|0
1973806|NCT00381485|3535261|FG003|Open-Label Run-In Period|Adverse Event|0
1973807|NCT00381485|3535258|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76
1973808|NCT00381485|3535259|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0
1973809|NCT00381485|3535260|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0
1973810|NCT00381485|3535261|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0
1973811|NCT00381485|3535258|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
1973812|NCT00381485|3535259|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1973813|NCT00381485|3535260|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1973814|NCT00381485|3535261|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1973815|NCT00381485|3535258|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
1973816|NCT00381485|3535259|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1973817|NCT00381485|3535260|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1973818|NCT00381485|3535261|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1973819|NCT00381485|3535258|FG000|Open-Label Run-In Period|Lost to Follow-up|3
1973820|NCT00381485|3535259|FG001|Open-Label Run-In Period|Lost to Follow-up|0
1973821|NCT00381485|3535260|FG002|Open-Label Run-In Period|Lost to Follow-up|0
1973822|NCT00381485|3535261|FG003|Open-Label Run-In Period|Lost to Follow-up|0
1973823|NCT00381485|3535258|FG000|Open-Label Run-In Period|Treatment failure|1
1973824|NCT00381485|3535259|FG001|Open-Label Run-In Period|Treatment failure|0
1973825|NCT00381485|3535260|FG002|Open-Label Run-In Period|Treatment failure|0
1973826|NCT00381485|3535261|FG003|Open-Label Run-In Period|Treatment failure|0
1973827|NCT00381485|3535258|FG000|Double-Blind Treatment Period|Adverse Event|0
1973828|NCT00381485|3535259|FG001|Double-Blind Treatment Period|Adverse Event|2
1973829|NCT00381485|3535260|FG002|Double-Blind Treatment Period|Adverse Event|2
1973830|NCT00381485|3535261|FG003|Double-Blind Treatment Period|Adverse Event|5
1973831|NCT00381485|3535258|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
1973832|NCT00381485|3535259|FG001|Double-Blind Treatment Period|Lack of Efficacy|8
1973833|NCT00381485|3535260|FG002|Double-Blind Treatment Period|Lack of Efficacy|11
1973834|NCT00381485|3535261|FG003|Double-Blind Treatment Period|Lack of Efficacy|13
1973835|NCT00381485|3535258|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
1973836|NCT00381485|3535259|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
1973837|NCT00381485|3535260|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
1973838|NCT00381485|3535261|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
1973839|NCT00381485|3535258|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0
1973840|NCT00381485|3535259|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9
1973841|NCT00381485|3535260|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3
1973842|NCT00381485|3535261|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3
1973843|NCT00381485|3535258|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0
1973844|NCT00381485|3535259|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5
1973845|NCT00381485|3535260|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7
1973846|NCT00381485|3535261|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5
1973847|NCT00381485|3535258|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
1973848|NCT00381485|3535259|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
1973849|NCT00381485|3535260|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
1973850|NCT00381485|3535261|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
1973851|NCT00381485|3535258|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1973852|NCT00381485|3535259|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1973853|NCT00381485|3535260|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1973854|NCT00381485|3535261|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
1973855|NCT00381485|3535258|FG000|Double-Blind Treatment Period|Administrative|0
1973856|NCT00381485|3535259|FG001|Double-Blind Treatment Period|Administrative|1
1973857|NCT00381485|3535260|FG002|Double-Blind Treatment Period|Administrative|0
1973858|NCT00381485|3535261|FG003|Double-Blind Treatment Period|Administrative|1
1973859|NCT00379288|3535274|FG000|Overall Study|Adverse Event|5
1973860|NCT00379288|3535275|FG001|Overall Study|Adverse Event|6
1973861|NCT00379288|3535276|FG002|Overall Study|Adverse Event|2
1973862|NCT00379288|3535277|FG003|Overall Study|Adverse Event|0
1973863|NCT00379288|3535274|FG000|Overall Study|Treatment Failure|0
1973864|NCT00379288|3535275|FG001|Overall Study|Treatment Failure|1
1973865|NCT00379288|3535276|FG002|Overall Study|Treatment Failure|0
1973866|NCT00379288|3535277|FG003|Overall Study|Treatment Failure|1
1973867|NCT00379288|3535274|FG000|Overall Study|Lost to Follow-up|3
1973868|NCT00379288|3535275|FG001|Overall Study|Lost to Follow-up|3
1973869|NCT00379288|3535276|FG002|Overall Study|Lost to Follow-up|2
1973870|NCT00379288|3535277|FG003|Overall Study|Lost to Follow-up|0
1973871|NCT00379288|3535274|FG000|Overall Study|Subject withdrew-unrelated to study drug|0
1973872|NCT00379288|3535275|FG001|Overall Study|Subject withdrew-unrelated to study drug|3
1973873|NCT00379288|3535276|FG002|Overall Study|Subject withdrew-unrelated to study drug|4
1973874|NCT00379288|3535277|FG003|Overall Study|Subject withdrew-unrelated to study drug|2
1973875|NCT00379288|3535274|FG000|Overall Study|Subject withdrew-related to study drug|1
1973876|NCT00379288|3535275|FG001|Overall Study|Subject withdrew-related to study drug|0
1973877|NCT00379288|3535276|FG002|Overall Study|Subject withdrew-related to study drug|0
1973878|NCT00379288|3535277|FG003|Overall Study|Subject withdrew-related to study drug|1
1973879|NCT00379288|3535274|FG000|Overall Study|Noncompliance with protocol|8
1973880|NCT00379288|3535275|FG001|Overall Study|Noncompliance with protocol|6
1973881|NCT00379288|3535276|FG002|Overall Study|Noncompliance with protocol|2
1973882|NCT00379288|3535277|FG003|Overall Study|Noncompliance with protocol|1
1973883|NCT00379288|3535274|FG000|Overall Study|Did not meet protocol eligibility|0
1973884|NCT00379288|3535275|FG001|Overall Study|Did not meet protocol eligibility|1
1973885|NCT00379288|3535276|FG002|Overall Study|Did not meet protocol eligibility|0
1973886|NCT00379288|3535277|FG003|Overall Study|Did not meet protocol eligibility|2
1973887|NCT00379288|3535274|FG000|Overall Study|Administrative|2
1973888|NCT00379288|3535275|FG001|Overall Study|Administrative|2
1973889|NCT00379288|3535276|FG002|Overall Study|Administrative|0
1973890|NCT00379288|3535277|FG003|Overall Study|Administrative|1
1973891|NCT00378378|3535290|FG000|Overall Study|Withdrawal by Subject|0
1973892|NCT00378378|3535291|FG001|Overall Study|Withdrawal by Subject|1
1973893|NCT00378378|3535292|FG002|Overall Study|Withdrawal by Subject|0
1973894|NCT00378378|3535290|FG000|Overall Study|Treatment Failure|0
1973895|NCT00378378|3535291|FG001|Overall Study|Treatment Failure|0
1973896|NCT00378378|3535292|FG002|Overall Study|Treatment Failure|1
1973897|NCT00378378|3535290|FG000|Overall Study|Non-compliance with protocol|0
1973898|NCT00378378|3535291|FG001|Overall Study|Non-compliance with protocol|0
1973899|NCT00378378|3535292|FG002|Overall Study|Non-compliance with protocol|1
1973900|NCT00089895|3535302|FG000|Overall Study|Consent Withdrawn|11
1973901|NCT00089895|3535303|FG001|Overall Study|Consent Withdrawn|14
1973902|NCT00089895|3535302|FG000|Overall Study|Technical reason|7
1973903|NCT00089895|3535303|FG001|Overall Study|Technical reason|2
1973904|NCT00089895|3535302|FG000|Overall Study|Surgery|0
1973905|NCT00089895|3535303|FG001|Overall Study|Surgery|1
1973906|NCT00089895|3535302|FG000|Overall Study|Bleeding|0
1973907|NCT00089895|3535303|FG001|Overall Study|Bleeding|2
1973908|NCT00089895|3535302|FG000|Overall Study|Physician Decision|3
1973909|NCT00089895|3535303|FG001|Overall Study|Physician Decision|7
1973910|NCT00089895|3535302|FG000|Overall Study|Exclusion criteria met|6
1973911|NCT00089895|3535303|FG001|Overall Study|Exclusion criteria met|6
1973912|NCT00089895|3535302|FG000|Overall Study|Not otherwise specified|4
1973913|NCT00089895|3535303|FG001|Overall Study|Not otherwise specified|8
1973914|NCT00089895|3535302|FG000|Overall Study|Missing|4
1973915|NCT00089895|3535303|FG001|Overall Study|Missing|2
1973916|NCT02614066|3535313|FG000|Overall Study|Initiated KTE-X19 and Died|5
1973917|NCT02614066|3535314|FG001|Overall Study|Initiated KTE-X19 and Died|12
1973918|NCT02614066|3535315|FG002|Overall Study|Initiated KTE-X19 and Died|11
1973919|NCT02614066|3535316|FG003|Overall Study|Initiated KTE-X19 and Died|20
1973920|NCT02614066|3535313|FG000|Overall Study|Full Consent Withdrawn|0
1973921|NCT02614066|3535314|FG001|Overall Study|Full Consent Withdrawn|1
1973922|NCT02614066|3535315|FG002|Overall Study|Full Consent Withdrawn|0
1973923|NCT02614066|3535316|FG003|Overall Study|Full Consent Withdrawn|3
1973924|NCT02614066|3535313|FG000|Overall Study|Lost to Follow-up|0
1973925|NCT02614066|3535314|FG001|Overall Study|Lost to Follow-up|1
1973926|NCT02614066|3535315|FG002|Overall Study|Lost to Follow-up|0
1973927|NCT02614066|3535316|FG003|Overall Study|Lost to Follow-up|0
1973928|NCT02614066|3535313|FG000|Overall Study|Still on-study|1
1973929|NCT02614066|3535314|FG001|Overall Study|Still on-study|9
1973930|NCT02614066|3535315|FG002|Overall Study|Still on-study|5
1973931|NCT02614066|3535316|FG003|Overall Study|Still on-study|32
1973932|NCT02614066|3535313|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0
2102141|NCT00837577|3693868|FG000|Open-label Period|Withdrawal by Subject|1
1973933|NCT02614066|3535314|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5
1973934|NCT02614066|3535315|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4
1973935|NCT02614066|3535316|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16
1973936|NCT02577354|3535326|FG000|Overall Study|Lack of Efficacy|4
1973937|NCT02577354|3535327|FG001|Overall Study|Lack of Efficacy|4
1973938|NCT02577354|3535326|FG000|Overall Study|Lost to Follow-up|3
1973939|NCT02577354|3535327|FG001|Overall Study|Lost to Follow-up|1
1973940|NCT02577354|3535326|FG000|Overall Study|Missed Visit|4
1973941|NCT02577354|3535327|FG001|Overall Study|Missed Visit|3
1973942|NCT02577354|3535326|FG000|Overall Study|Adverse Event|4
1973943|NCT02577354|3535327|FG001|Overall Study|Adverse Event|5
1973944|NCT02471807|3535347|FG000|Overall Study|Death|14
1973945|NCT02471807|3535347|FG000|Overall Study|Withdrawal by Subject|1
1973946|NCT02471807|3535347|FG000|Overall Study|Explant|5
1973947|NCT02471807|3535347|FG000|Overall Study|Visits not yet due|2
1973948|NCT02471807|3535347|FG000|Overall Study|Missed Visit|1
1973949|NCT02321514|3535351|FG000|Overall Study|Death|15
1973950|NCT02321514|3535351|FG000|Overall Study|Missed Visit|7
1973951|NCT02321514|3535351|FG000|Overall Study|Study Exit|3
2021837|NCT00316082|3589719|FG003|Overall Study|Withdrawal of Consent by Subject|9
2021838|NCT00316082|3589720|FG004|Overall Study|Withdrawal of Consent by Subject|5
2021839|NCT00316082|3589716|FG000|Overall Study|Lost to Follow-up|7
2021840|NCT00316082|3589717|FG001|Overall Study|Lost to Follow-up|6
2021841|NCT00316082|3589718|FG002|Overall Study|Lost to Follow-up|7
2021842|NCT00316082|3589719|FG003|Overall Study|Lost to Follow-up|8
2021843|NCT00316082|3589720|FG004|Overall Study|Lost to Follow-up|6
2021844|NCT00316082|3589716|FG000|Overall Study|Poor/noncompliance|6
2021845|NCT00316082|3589717|FG001|Overall Study|Poor/noncompliance|1
2021846|NCT00316082|3589718|FG002|Overall Study|Poor/noncompliance|4
2021847|NCT00316082|3589719|FG003|Overall Study|Poor/noncompliance|1
2021848|NCT00316082|3589720|FG004|Overall Study|Poor/noncompliance|4
2021849|NCT00316082|3589716|FG000|Overall Study|Adverse Event|4
2021850|NCT00316082|3589717|FG001|Overall Study|Adverse Event|2
2021851|NCT00316082|3589718|FG002|Overall Study|Adverse Event|5
2021852|NCT00316082|3589719|FG003|Overall Study|Adverse Event|1
2021853|NCT00316082|3589720|FG004|Overall Study|Adverse Event|3
2021854|NCT00316082|3589716|FG000|Overall Study|Subject no longer meets study criteria|3
2021855|NCT00316082|3589717|FG001|Overall Study|Subject no longer meets study criteria|1
2021856|NCT00316082|3589718|FG002|Overall Study|Subject no longer meets study criteria|2
2021857|NCT00316082|3589719|FG003|Overall Study|Subject no longer meets study criteria|2
2021858|NCT00316082|3589720|FG004|Overall Study|Subject no longer meets study criteria|1
2021859|NCT00316082|3589716|FG000|Overall Study|Physician Decision|1
2021860|NCT00316082|3589717|FG001|Overall Study|Physician Decision|1
2021861|NCT00316082|3589718|FG002|Overall Study|Physician Decision|2
2021862|NCT00316082|3589719|FG003|Overall Study|Physician Decision|1
2021863|NCT00316082|3589720|FG004|Overall Study|Physician Decision|1
2021864|NCT00316082|3589716|FG000|Overall Study|Death|0
2021865|NCT00316082|3589717|FG001|Overall Study|Death|0
2021866|NCT00316082|3589718|FG002|Overall Study|Death|1
2021867|NCT00316082|3589719|FG003|Overall Study|Death|0
2021868|NCT00316082|3589720|FG004|Overall Study|Death|0
2021869|NCT00316082|3589716|FG000|Overall Study|Administrative reason by sponsor|0
2021870|NCT00316082|3589717|FG001|Overall Study|Administrative reason by sponsor|0
2021871|NCT00316082|3589718|FG002|Overall Study|Administrative reason by sponsor|1
2021872|NCT00316082|3589719|FG003|Overall Study|Administrative reason by sponsor|0
2021873|NCT00316082|3589720|FG004|Overall Study|Administrative reason by sponsor|0
2021874|NCT00316121|3589738|FG000|Overall Study|Death|1
2021875|NCT00316121|3589739|FG001|Overall Study|Death|0
2021876|NCT00316121|3589738|FG000|Overall Study|Lost to Follow-up|14
2021877|NCT00316121|3589739|FG001|Overall Study|Lost to Follow-up|8
2021878|NCT00316121|3589738|FG000|Overall Study|Withdrawal by Subject|2
2021879|NCT00316121|3589739|FG001|Overall Study|Withdrawal by Subject|0
2021880|NCT00316121|3589738|FG000|Overall Study|Reason is missing|1
2021881|NCT00316121|3589739|FG001|Overall Study|Reason is missing|0
2021882|NCT00316121|3589738|FG000|Overall Study|Subject relocated|1
2021883|NCT00316121|3589739|FG001|Overall Study|Subject relocated|1
2021884|NCT00316121|3589738|FG000|Overall Study|Subject refused to return|1
2021885|NCT00316121|3589739|FG001|Overall Study|Subject refused to return|0
2021886|NCT00316121|3589738|FG000|Overall Study|Subject no show for visit x 3|1
2021887|NCT00316121|3589739|FG001|Overall Study|Subject no show for visit x 3|0
2021888|NCT00316121|3589738|FG000|Overall Study|Subject did not have 24 month visit|1
2021889|NCT00316121|3589739|FG001|Overall Study|Subject did not have 24 month visit|0
2021890|NCT00316173|3589747|FG000|Run-in Phase|Adverse Event|1
2021891|NCT00316173|3589748|FG001|Run-in Phase|Adverse Event|0
2021892|NCT00316173|3589747|FG000|Run-in Phase|Protocol Violation|1
2021893|NCT00316173|3589748|FG001|Run-in Phase|Protocol Violation|0
2021894|NCT00316173|3589747|FG000|Run-in Phase|Study Follow-up Stopped|5
2021895|NCT00316173|3589748|FG001|Run-in Phase|Study Follow-up Stopped|0
2021896|NCT00316173|3589747|FG000|Treatment Phase|Adverse Event|0
2021897|NCT00316173|3589748|FG001|Treatment Phase|Adverse Event|1
2021898|NCT00316173|3589747|FG000|Treatment Phase|Lack of Efficacy|0
2021899|NCT00316173|3589748|FG001|Treatment Phase|Lack of Efficacy|3
2021900|NCT00316173|3589747|FG000|Treatment Phase|Lost to Follow-up|0
2021901|NCT00316173|3589748|FG001|Treatment Phase|Lost to Follow-up|3
2021902|NCT00316173|3589747|FG000|Treatment Phase|Withdrawal by Subject|0
2021903|NCT00316173|3589748|FG001|Treatment Phase|Withdrawal by Subject|1
2021904|NCT00316173|3589747|FG000|Treatment Phase|Study Follow-up Stopped|0
2021905|NCT00316173|3589748|FG001|Treatment Phase|Study Follow-up Stopped|34
2021906|NCT00316186|3589753|FG000|Overall Study|Adverse Event|6
2021907|NCT00316186|3589753|FG000|Overall Study|Disease Progression|4
2021908|NCT00316186|3589753|FG000|Overall Study|Lost to Follow-up|1
2021909|NCT00316186|3589753|FG000|Overall Study|Other|1
1973952|NCT01453946|3535373|FG000|Overall Study|Did not receive drug for the taper phase|1
1973953|NCT01453946|3535373|FG000|Overall Study|Protocol Violation|2
1973954|NCT01453946|3535373|FG000|Overall Study|Lack of Efficacy|3
1973955|NCT01453946|3535373|FG000|Overall Study|Adverse Event|3
1973956|NCT01444092|3535377|FG000|Overall Study|Adverse Event|8
1973957|NCT01444092|3535377|FG000|Overall Study|Protocol Violation|1
1973958|NCT01444092|3535377|FG000|Overall Study|Withdrawal by Subject|1
1973959|NCT01444092|3535377|FG000|Overall Study|Other Eligibility criteria|7
1973960|NCT01332968|3535383|FG000|Induction Period|Withdrawal by Subject|3
1973961|NCT01332968|3535384|FG001|Induction Period|Withdrawal by Subject|5
1973962|NCT01332968|3535385|FG002|Induction Period|Withdrawal by Subject|0
1973963|NCT01332968|3535386|FG003|Induction Period|Withdrawal by Subject|0
1973964|NCT01332968|3535387|FG004|Induction Period|Withdrawal by Subject|0
1973965|NCT01332968|3535388|FG005|Induction Period|Withdrawal by Subject|0
1973966|NCT01332968|3535389|FG006|Induction Period|Withdrawal by Subject|0
1973967|NCT01332968|3535390|FG007|Induction Period|Withdrawal by Subject|0
1973968|NCT01332968|3535383|FG000|Induction Period|Protocol Violation|3
1973969|NCT01332968|3535384|FG001|Induction Period|Protocol Violation|4
1973970|NCT01332968|3535385|FG002|Induction Period|Protocol Violation|0
1973971|NCT01332968|3535386|FG003|Induction Period|Protocol Violation|0
1973972|NCT01332968|3535387|FG004|Induction Period|Protocol Violation|0
1973973|NCT01332968|3535388|FG005|Induction Period|Protocol Violation|0
1973974|NCT01332968|3535389|FG006|Induction Period|Protocol Violation|0
1973975|NCT01332968|3535390|FG007|Induction Period|Protocol Violation|0
1973976|NCT01332968|3535383|FG000|Induction Period|Progressive disease|15
1973977|NCT01332968|3535384|FG001|Induction Period|Progressive disease|7
1973978|NCT01332968|3535385|FG002|Induction Period|Progressive disease|0
1973979|NCT01332968|3535386|FG003|Induction Period|Progressive disease|0
1973980|NCT01332968|3535387|FG004|Induction Period|Progressive disease|0
1973981|NCT01332968|3535388|FG005|Induction Period|Progressive disease|0
1973982|NCT01332968|3535389|FG006|Induction Period|Progressive disease|0
1973983|NCT01332968|3535390|FG007|Induction Period|Progressive disease|0
1973984|NCT01332968|3535383|FG000|Induction Period|Physician Decision|6
1973985|NCT01332968|3535384|FG001|Induction Period|Physician Decision|1
1973986|NCT01332968|3535385|FG002|Induction Period|Physician Decision|0
1973987|NCT01332968|3535386|FG003|Induction Period|Physician Decision|0
1973988|NCT01332968|3535387|FG004|Induction Period|Physician Decision|0
1973989|NCT01332968|3535388|FG005|Induction Period|Physician Decision|0
1973990|NCT01332968|3535389|FG006|Induction Period|Physician Decision|0
1973991|NCT01332968|3535390|FG007|Induction Period|Physician Decision|0
1973992|NCT01332968|3535383|FG000|Induction Period|Other|2
1973993|NCT01332968|3535384|FG001|Induction Period|Other|2
1973994|NCT01332968|3535385|FG002|Induction Period|Other|0
1973995|NCT01332968|3535386|FG003|Induction Period|Other|0
1973996|NCT01332968|3535387|FG004|Induction Period|Other|0
1973997|NCT01332968|3535388|FG005|Induction Period|Other|0
1973998|NCT01332968|3535389|FG006|Induction Period|Other|0
1973999|NCT01332968|3535390|FG007|Induction Period|Other|0
1974000|NCT01332968|3535383|FG000|Induction Period|Non-compliance|1
1974001|NCT01332968|3535384|FG001|Induction Period|Non-compliance|0
1974002|NCT01332968|3535385|FG002|Induction Period|Non-compliance|0
1974003|NCT01332968|3535386|FG003|Induction Period|Non-compliance|0
1974004|NCT01332968|3535387|FG004|Induction Period|Non-compliance|0
1974005|NCT01332968|3535388|FG005|Induction Period|Non-compliance|0
1974006|NCT01332968|3535389|FG006|Induction Period|Non-compliance|0
1974007|NCT01332968|3535390|FG007|Induction Period|Non-compliance|0
1974008|NCT01332968|3535383|FG000|Induction Period|Death|1
1974009|NCT01332968|3535384|FG001|Induction Period|Death|4
1974010|NCT01332968|3535385|FG002|Induction Period|Death|0
1974011|NCT01332968|3535386|FG003|Induction Period|Death|0
1974012|NCT01332968|3535387|FG004|Induction Period|Death|0
1974013|NCT01332968|3535388|FG005|Induction Period|Death|0
1974014|NCT01332968|3535389|FG006|Induction Period|Death|0
1974015|NCT01332968|3535390|FG007|Induction Period|Death|0
1974016|NCT01332968|3535383|FG000|Induction Period|Adverse Event|23
1974017|NCT01332968|3535384|FG001|Induction Period|Adverse Event|26
1974018|NCT01332968|3535385|FG002|Induction Period|Adverse Event|0
1974019|NCT01332968|3535386|FG003|Induction Period|Adverse Event|0
1974020|NCT01332968|3535387|FG004|Induction Period|Adverse Event|0
1974021|NCT01332968|3535388|FG005|Induction Period|Adverse Event|0
1974022|NCT01332968|3535389|FG006|Induction Period|Adverse Event|0
1974023|NCT01332968|3535390|FG007|Induction Period|Adverse Event|0
1974024|NCT01332968|3535383|FG000|Induction Period|Randomized, but not treated|4
1974025|NCT01332968|3535384|FG001|Induction Period|Randomized, but not treated|7
1974026|NCT01332968|3535385|FG002|Induction Period|Randomized, but not treated|0
1974027|NCT01332968|3535386|FG003|Induction Period|Randomized, but not treated|0
1974028|NCT01332968|3535387|FG004|Induction Period|Randomized, but not treated|0
1974029|NCT01332968|3535388|FG005|Induction Period|Randomized, but not treated|0
1974030|NCT01332968|3535389|FG006|Induction Period|Randomized, but not treated|0
1974031|NCT01332968|3535390|FG007|Induction Period|Randomized, but not treated|0
1974032|NCT01332968|3535383|FG000|Maintenance/Observation Period|Withdrawal by Subject|0
1974033|NCT01332968|3535384|FG001|Maintenance/Observation Period|Withdrawal by Subject|0
1974034|NCT01332968|3535385|FG002|Maintenance/Observation Period|Withdrawal by Subject|10
1974035|NCT01332968|3535386|FG003|Maintenance/Observation Period|Withdrawal by Subject|5
1974036|NCT01332968|3535387|FG004|Maintenance/Observation Period|Withdrawal by Subject|0
1974037|NCT01332968|3535388|FG005|Maintenance/Observation Period|Withdrawal by Subject|0
1974038|NCT01332968|3535389|FG006|Maintenance/Observation Period|Withdrawal by Subject|0
1974039|NCT01332968|3535390|FG007|Maintenance/Observation Period|Withdrawal by Subject|0
1974040|NCT01332968|3535383|FG000|Maintenance/Observation Period|Protocol Violation|0
1974041|NCT01332968|3535384|FG001|Maintenance/Observation Period|Protocol Violation|0
1974042|NCT01332968|3535385|FG002|Maintenance/Observation Period|Protocol Violation|1
1974043|NCT01332968|3535386|FG003|Maintenance/Observation Period|Protocol Violation|1
1974044|NCT01332968|3535387|FG004|Maintenance/Observation Period|Protocol Violation|0
1974045|NCT01332968|3535388|FG005|Maintenance/Observation Period|Protocol Violation|0
1974046|NCT01332968|3535389|FG006|Maintenance/Observation Period|Protocol Violation|0
1974047|NCT01332968|3535390|FG007|Maintenance/Observation Period|Protocol Violation|0
1974048|NCT01332968|3535383|FG000|Maintenance/Observation Period|Progressive disease|0
1974049|NCT01332968|3535384|FG001|Maintenance/Observation Period|Progressive disease|0
1974050|NCT01332968|3535385|FG002|Maintenance/Observation Period|Progressive disease|72
1974051|NCT01332968|3535386|FG003|Maintenance/Observation Period|Progressive disease|39
1974052|NCT01332968|3535387|FG004|Maintenance/Observation Period|Progressive disease|0
1974053|NCT01332968|3535388|FG005|Maintenance/Observation Period|Progressive disease|0
1974054|NCT01332968|3535389|FG006|Maintenance/Observation Period|Progressive disease|0
1974055|NCT01332968|3535390|FG007|Maintenance/Observation Period|Progressive disease|0
1974056|NCT01332968|3535383|FG000|Maintenance/Observation Period|Physician Decision|0
1974057|NCT01332968|3535384|FG001|Maintenance/Observation Period|Physician Decision|0
1974058|NCT01332968|3535385|FG002|Maintenance/Observation Period|Physician Decision|14
1974059|NCT01332968|3535386|FG003|Maintenance/Observation Period|Physician Decision|19
1974060|NCT01332968|3535387|FG004|Maintenance/Observation Period|Physician Decision|0
1974061|NCT01332968|3535388|FG005|Maintenance/Observation Period|Physician Decision|0
1974062|NCT01332968|3535389|FG006|Maintenance/Observation Period|Physician Decision|0
1974063|NCT01332968|3535390|FG007|Maintenance/Observation Period|Physician Decision|0
1974064|NCT01332968|3535383|FG000|Maintenance/Observation Period|Other|0
1974065|NCT01332968|3535384|FG001|Maintenance/Observation Period|Other|0
1974066|NCT01332968|3535385|FG002|Maintenance/Observation Period|Other|4
1974067|NCT01332968|3535386|FG003|Maintenance/Observation Period|Other|5
1974068|NCT01332968|3535387|FG004|Maintenance/Observation Period|Other|0
1974069|NCT01332968|3535388|FG005|Maintenance/Observation Period|Other|0
1974070|NCT01332968|3535389|FG006|Maintenance/Observation Period|Other|0
1974071|NCT01332968|3535390|FG007|Maintenance/Observation Period|Other|0
1974072|NCT01332968|3535383|FG000|Maintenance/Observation Period|Non-compliance|0
1974073|NCT01332968|3535384|FG001|Maintenance/Observation Period|Non-compliance|0
1974074|NCT01332968|3535385|FG002|Maintenance/Observation Period|Non-compliance|2
1974075|NCT01332968|3535386|FG003|Maintenance/Observation Period|Non-compliance|3
1974076|NCT01332968|3535387|FG004|Maintenance/Observation Period|Non-compliance|0
1974077|NCT01332968|3535388|FG005|Maintenance/Observation Period|Non-compliance|1
1974078|NCT01332968|3535389|FG006|Maintenance/Observation Period|Non-compliance|0
1974079|NCT01332968|3535390|FG007|Maintenance/Observation Period|Non-compliance|0
1974080|NCT01332968|3535383|FG000|Maintenance/Observation Period|Lost to Follow-up|0
1974081|NCT01332968|3535384|FG001|Maintenance/Observation Period|Lost to Follow-up|0
1974082|NCT01332968|3535385|FG002|Maintenance/Observation Period|Lost to Follow-up|1
1974083|NCT01332968|3535386|FG003|Maintenance/Observation Period|Lost to Follow-up|2
1974084|NCT01332968|3535387|FG004|Maintenance/Observation Period|Lost to Follow-up|0
1974085|NCT01332968|3535388|FG005|Maintenance/Observation Period|Lost to Follow-up|0
1974086|NCT01332968|3535389|FG006|Maintenance/Observation Period|Lost to Follow-up|0
1974087|NCT01332968|3535390|FG007|Maintenance/Observation Period|Lost to Follow-up|0
1974088|NCT01332968|3535383|FG000|Maintenance/Observation Period|Death|0
1974089|NCT01332968|3535384|FG001|Maintenance/Observation Period|Death|0
1974090|NCT01332968|3535385|FG002|Maintenance/Observation Period|Death|5
1974091|NCT01332968|3535386|FG003|Maintenance/Observation Period|Death|6
1974092|NCT01332968|3535387|FG004|Maintenance/Observation Period|Death|0
1974093|NCT01332968|3535388|FG005|Maintenance/Observation Period|Death|0
1974094|NCT01332968|3535389|FG006|Maintenance/Observation Period|Death|0
1974095|NCT01332968|3535390|FG007|Maintenance/Observation Period|Death|0
1974096|NCT01332968|3535383|FG000|Maintenance/Observation Period|Adverse Event|0
1974097|NCT01332968|3535384|FG001|Maintenance/Observation Period|Adverse Event|0
1974098|NCT01332968|3535385|FG002|Maintenance/Observation Period|Adverse Event|50
1974099|NCT01332968|3535386|FG003|Maintenance/Observation Period|Adverse Event|65
1974100|NCT01332968|3535387|FG004|Maintenance/Observation Period|Adverse Event|0
1974101|NCT01332968|3535388|FG005|Maintenance/Observation Period|Adverse Event|0
1974102|NCT01332968|3535389|FG006|Maintenance/Observation Period|Adverse Event|0
1974103|NCT01332968|3535390|FG007|Maintenance/Observation Period|Adverse Event|0
1974104|NCT01332968|3535383|FG000|Maintenance/Observation Period|Treatment ongoing|0
1974105|NCT01332968|3535384|FG001|Maintenance/Observation Period|Treatment ongoing|0
1974106|NCT01332968|3535385|FG002|Maintenance/Observation Period|Treatment ongoing|54
1974107|NCT01332968|3535386|FG003|Maintenance/Observation Period|Treatment ongoing|62
1974108|NCT01332968|3535387|FG004|Maintenance/Observation Period|Treatment ongoing|10
1974109|NCT01332968|3535388|FG005|Maintenance/Observation Period|Treatment ongoing|8
1974110|NCT01332968|3535389|FG006|Maintenance/Observation Period|Treatment ongoing|0
1974111|NCT01332968|3535390|FG007|Maintenance/Observation Period|Treatment ongoing|0
1974112|NCT01332968|3535383|FG000|Follow-Up Period|Death|0
1974113|NCT01332968|3535384|FG001|Follow-Up Period|Death|0
1974114|NCT01332968|3535385|FG002|Follow-Up Period|Death|0
1974115|NCT01332968|3535386|FG003|Follow-Up Period|Death|0
1974116|NCT01332968|3535387|FG004|Follow-Up Period|Death|0
1974117|NCT01332968|3535388|FG005|Follow-Up Period|Death|0
1974118|NCT01332968|3535389|FG006|Follow-Up Period|Death|38
1974119|NCT01332968|3535390|FG007|Follow-Up Period|Death|22
1974120|NCT01332968|3535383|FG000|Follow-Up Period|Follow-up ongoing|0
1974121|NCT01332968|3535384|FG001|Follow-Up Period|Follow-up ongoing|0
1974122|NCT01332968|3535385|FG002|Follow-Up Period|Follow-up ongoing|0
1974123|NCT01332968|3535386|FG003|Follow-Up Period|Follow-up ongoing|0
1974124|NCT01332968|3535387|FG004|Follow-Up Period|Follow-up ongoing|0
1974125|NCT01332968|3535388|FG005|Follow-Up Period|Follow-up ongoing|0
1974126|NCT01332968|3535389|FG006|Follow-Up Period|Follow-up ongoing|502
1974127|NCT01332968|3535390|FG007|Follow-Up Period|Follow-up ongoing|505
1974128|NCT01332968|3535383|FG000|Follow-Up Period|Withdrawal by Subject|0
2212886|NCT01674010|3854187|FG002|Randomization Phase 2|Withdrawal by Subject|7
1974129|NCT01332968|3535384|FG001|Follow-Up Period|Withdrawal by Subject|0
1974130|NCT01332968|3535385|FG002|Follow-Up Period|Withdrawal by Subject|0
1974131|NCT01332968|3535386|FG003|Follow-Up Period|Withdrawal by Subject|0
1974132|NCT01332968|3535387|FG004|Follow-Up Period|Withdrawal by Subject|0
1974133|NCT01332968|3535388|FG005|Follow-Up Period|Withdrawal by Subject|0
1974134|NCT01332968|3535389|FG006|Follow-Up Period|Withdrawal by Subject|1
1974135|NCT01332968|3535390|FG007|Follow-Up Period|Withdrawal by Subject|2
1974136|NCT01332968|3535383|FG000|Follow-Up Period|Lost to Follow-up|0
1974137|NCT01332968|3535384|FG001|Follow-Up Period|Lost to Follow-up|0
1974138|NCT01332968|3535385|FG002|Follow-Up Period|Lost to Follow-up|0
1974139|NCT01332968|3535386|FG003|Follow-Up Period|Lost to Follow-up|0
1974140|NCT01332968|3535387|FG004|Follow-Up Period|Lost to Follow-up|0
1974141|NCT01332968|3535388|FG005|Follow-Up Period|Lost to Follow-up|0
1974142|NCT01332968|3535389|FG006|Follow-Up Period|Lost to Follow-up|1
1974143|NCT01332968|3535390|FG007|Follow-Up Period|Lost to Follow-up|2
1974144|NCT01265784|3535401|FG000|Overall Study|Lost to Follow-up|5
1974145|NCT01265784|3535402|FG001|Overall Study|Lost to Follow-up|3
1974146|NCT01265784|3535403|FG002|Overall Study|Lost to Follow-up|2
1974147|NCT01265784|3535401|FG000|Overall Study|Withdrawal by Subject|0
1974148|NCT01265784|3535402|FG001|Overall Study|Withdrawal by Subject|5
1974149|NCT01265784|3535403|FG002|Overall Study|Withdrawal by Subject|0
1974150|NCT01265784|3535401|FG000|Overall Study|Physician Decision|1
1974151|NCT01265784|3535402|FG001|Overall Study|Physician Decision|0
1974152|NCT01265784|3535403|FG002|Overall Study|Physician Decision|1
1974153|NCT01265784|3535401|FG000|Overall Study|Adverse Event|1
1974154|NCT01265784|3535402|FG001|Overall Study|Adverse Event|0
1974155|NCT01265784|3535403|FG002|Overall Study|Adverse Event|0
1974156|NCT01265784|3535401|FG000|Overall Study|Death|3
1974157|NCT01265784|3535402|FG001|Overall Study|Death|0
1974158|NCT01265784|3535403|FG002|Overall Study|Death|0
1974159|NCT01265784|3535401|FG000|Overall Study|Protocol Violation|2
1974160|NCT01265784|3535402|FG001|Overall Study|Protocol Violation|0
1974161|NCT01265784|3535403|FG002|Overall Study|Protocol Violation|0
1974162|NCT01265784|3535401|FG000|Overall Study|Incorrectly Randomized|0
1974163|NCT01265784|3535402|FG001|Overall Study|Incorrectly Randomized|0
1974164|NCT01265784|3535403|FG002|Overall Study|Incorrectly Randomized|1
1974165|NCT00577577|3535413|FG000|Overall Study|Adverse Event|3
1974166|NCT00577577|3535414|FG001|Overall Study|Adverse Event|2
1974167|NCT00577577|3535413|FG000|Overall Study|Lost to Follow-up|1
1974168|NCT00577577|3535414|FG001|Overall Study|Lost to Follow-up|0
1974169|NCT00577577|3535413|FG000|Overall Study|Protocol Violation|0
1974170|NCT00577577|3535414|FG001|Overall Study|Protocol Violation|3
1974171|NCT00577577|3535413|FG000|Overall Study|Transportation|1
1974172|NCT00577577|3535414|FG001|Overall Study|Transportation|0
1974173|NCT00392327|3535428|FG000|Overall Study|Death|1
1974174|NCT00392327|3535429|FG001|Overall Study|Death|0
1974175|NCT00392327|3535430|FG002|Overall Study|Death|1
1974176|NCT00392327|3535431|FG003|Overall Study|Death|0
1974177|NCT00392327|3535432|FG004|Overall Study|Death|0
1974178|NCT00392327|3535433|FG005|Overall Study|Death|0
1974179|NCT00392327|3535434|FG006|Overall Study|Death|0
1974180|NCT00392327|3535435|FG007|Overall Study|Death|0
1974181|NCT00392327|3535428|FG000|Overall Study|Lack of Efficacy|8
1974182|NCT00392327|3535429|FG001|Overall Study|Lack of Efficacy|8
1974183|NCT00392327|3535430|FG002|Overall Study|Lack of Efficacy|9
1974184|NCT00392327|3535431|FG003|Overall Study|Lack of Efficacy|6
1974185|NCT00392327|3535432|FG004|Overall Study|Lack of Efficacy|3
1974186|NCT00392327|3535433|FG005|Overall Study|Lack of Efficacy|3
1974187|NCT00392327|3535434|FG006|Overall Study|Lack of Efficacy|3
1974188|NCT00392327|3535435|FG007|Overall Study|Lack of Efficacy|3
1974189|NCT00392327|3535428|FG000|Overall Study|Physician Decision|3
1974190|NCT00392327|3535429|FG001|Overall Study|Physician Decision|5
1974191|NCT00392327|3535430|FG002|Overall Study|Physician Decision|2
1974192|NCT00392327|3535431|FG003|Overall Study|Physician Decision|2
1974193|NCT00392327|3535432|FG004|Overall Study|Physician Decision|0
1974194|NCT00392327|3535433|FG005|Overall Study|Physician Decision|1
1974195|NCT00392327|3535434|FG006|Overall Study|Physician Decision|5
1974196|NCT00392327|3535435|FG007|Overall Study|Physician Decision|3
2310326|NCT02731742|4014346|FG002|Overall Study|Study Terminated by Sponsor|1
2310327|NCT02731742|4014347|FG003|Overall Study|Study Terminated by Sponsor|1
2310328|NCT02731755|4014357|FG000|First Intervention|Withdrawal by Subject|0
1974197|NCT00392327|3535428|FG000|Overall Study|Protocol Violation|0
1974198|NCT00392327|3535429|FG001|Overall Study|Protocol Violation|0
1974199|NCT00392327|3535430|FG002|Overall Study|Protocol Violation|1
1974200|NCT00392327|3535431|FG003|Overall Study|Protocol Violation|0
1974201|NCT00392327|3535432|FG004|Overall Study|Protocol Violation|0
1974202|NCT00392327|3535433|FG005|Overall Study|Protocol Violation|0
1974203|NCT00392327|3535434|FG006|Overall Study|Protocol Violation|0
1974204|NCT00392327|3535435|FG007|Overall Study|Protocol Violation|0
1974205|NCT00392327|3535428|FG000|Overall Study|Withdrawal by Subject|3
1974206|NCT00392327|3535429|FG001|Overall Study|Withdrawal by Subject|2
1974207|NCT00392327|3535430|FG002|Overall Study|Withdrawal by Subject|4
1974208|NCT00392327|3535431|FG003|Overall Study|Withdrawal by Subject|6
1974209|NCT00392327|3535432|FG004|Overall Study|Withdrawal by Subject|0
1974210|NCT00392327|3535433|FG005|Overall Study|Withdrawal by Subject|1
1974211|NCT00392327|3535434|FG006|Overall Study|Withdrawal by Subject|1
1974212|NCT00392327|3535435|FG007|Overall Study|Withdrawal by Subject|5
1974213|NCT00392327|3535428|FG000|Overall Study|Ineligible|0
1974214|NCT00392327|3535429|FG001|Overall Study|Ineligible|4
1974215|NCT00392327|3535430|FG002|Overall Study|Ineligible|3
1974216|NCT00392327|3535431|FG003|Overall Study|Ineligible|2
1974217|NCT00392327|3535432|FG004|Overall Study|Ineligible|0
1974218|NCT00392327|3535433|FG005|Overall Study|Ineligible|0
1974219|NCT00392327|3535434|FG006|Overall Study|Ineligible|0
1974220|NCT00392327|3535435|FG007|Overall Study|Ineligible|0
1974221|NCT00085202|3535455|FG000|Overall Study|Still on therapy|2
1974222|NCT00085202|3535456|FG001|Overall Study|Still on therapy|0
1974223|NCT00085202|3535455|FG000|Overall Study|Bone involvement confirmed by bone scan|0
1974224|NCT00085202|3535456|FG001|Overall Study|Bone involvement confirmed by bone scan|1
1974225|NCT00085202|3535455|FG000|Overall Study|Excessive toxicity|6
1974226|NCT00085202|3535456|FG001|Overall Study|Excessive toxicity|5
1974227|NCT00085202|3535455|FG000|Overall Study|Non-specified|3
1974228|NCT00085202|3535456|FG001|Overall Study|Non-specified|5
1974229|NCT00085202|3535455|FG000|Overall Study|Withdrawal by Subject|2
1974230|NCT00085202|3535456|FG001|Overall Study|Withdrawal by Subject|1
1974231|NCT00085202|3535455|FG000|Overall Study|Physician Decision|4
1974232|NCT00085202|3535456|FG001|Overall Study|Physician Decision|1
1974233|NCT00085202|3535455|FG000|Overall Study|Progressive disease|1
1974234|NCT00085202|3535456|FG001|Overall Study|Progressive disease|11
2021910|NCT00316199|3589757|FG000|Overall Study|Adverse Event|2
2021911|NCT00316199|3589757|FG000|Overall Study|Death|8
2021912|NCT00316199|3589757|FG000|Overall Study|Lost to Follow-up|2
2021913|NCT00316225|3589761|FG000|Overall Study|Adverse Event|2
2021914|NCT00316225|3589761|FG000|Overall Study|Physician Decision|3
2021915|NCT00316225|3589761|FG000|Overall Study|Progressive Disease|15
2021916|NCT00316225|3589761|FG000|Overall Study|Withdrawal by Subject|3
2021917|NCT00316225|3589761|FG000|Overall Study|Death|2
2021918|NCT00316264|3589768|FG000|Overall Study|Lost to Follow-up|0
2021919|NCT00316264|3589769|FG001|Overall Study|Lost to Follow-up|1
2021920|NCT00316264|3589770|FG002|Overall Study|Lost to Follow-up|0
2021921|NCT00316264|3589768|FG000|Overall Study|Withdrawal of Consent|3
2021922|NCT00316264|3589769|FG001|Overall Study|Withdrawal of Consent|5
2021923|NCT00316264|3589770|FG002|Overall Study|Withdrawal of Consent|6
2021924|NCT00316264|3589768|FG000|Overall Study|Death|2
2021925|NCT00316264|3589769|FG001|Overall Study|Death|0
2021926|NCT00316264|3589770|FG002|Overall Study|Death|0
2021927|NCT00316264|3589768|FG000|Overall Study|Other|1
2021928|NCT00316264|3589769|FG001|Overall Study|Other|1
2021929|NCT00316264|3589770|FG002|Overall Study|Other|0
2021930|NCT00316277|3589780|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88
2021931|NCT00316277|3589781|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75
2021932|NCT00316277|3589780|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2
2021933|NCT00316277|3589781|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0
2021934|NCT00316277|3589780|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220
2021935|NCT00316277|3589781|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225
2021936|NCT00316277|3589780|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
2021937|NCT00316277|3589781|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
2021938|NCT00316277|3589780|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
2021939|NCT00316277|3589781|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
2021940|NCT00316303|3589797|FG000|Overall Study|Lost to Follow-up|11
2021941|NCT00316303|3589798|FG001|Overall Study|Lost to Follow-up|16
2021942|NCT00316589|3589841|FG000|Overall Study|Withdrawal by Subject|0
2021943|NCT00316589|3589842|FG001|Overall Study|Withdrawal by Subject|5
2021944|NCT00316589|3589843|FG002|Overall Study|Withdrawal by Subject|0
2021945|NCT00316589|3589844|FG003|Overall Study|Withdrawal by Subject|1
2021946|NCT00316589|3589841|FG000|Overall Study|Subject unwilling/unable to comply|0
2021947|NCT00316589|3589842|FG001|Overall Study|Subject unwilling/unable to comply|6
2021948|NCT00316589|3589843|FG002|Overall Study|Subject unwilling/unable to comply|0
2021949|NCT00316589|3589844|FG003|Overall Study|Subject unwilling/unable to comply|2
2021950|NCT00316589|3589841|FG000|Overall Study|Adverse Event|1
2021951|NCT00316589|3589842|FG001|Overall Study|Adverse Event|0
2021952|NCT00316589|3589843|FG002|Overall Study|Adverse Event|0
1974235|NCT04386616|3535557|FG000|Overall Study|Death|22
1974236|NCT04386616|3535558|FG001|Overall Study|Death|22
1974237|NCT04386616|3535559|FG002|Overall Study|Death|21
1974238|NCT04386616|3535557|FG000|Overall Study|Lost to Follow-up|5
1974239|NCT04386616|3535558|FG001|Overall Study|Lost to Follow-up|8
1974240|NCT04386616|3535559|FG002|Overall Study|Lost to Follow-up|6
1974241|NCT04386616|3535557|FG000|Overall Study|Withdrawal by Subject|2
1974242|NCT04386616|3535558|FG001|Overall Study|Withdrawal by Subject|4
1974243|NCT04386616|3535559|FG002|Overall Study|Withdrawal by Subject|1
1974244|NCT04386616|3535557|FG000|Overall Study|Adverse Event|1
1974245|NCT04386616|3535558|FG001|Overall Study|Adverse Event|1
1974246|NCT04386616|3535559|FG002|Overall Study|Adverse Event|0
1974247|NCT04296942|3535592|FG000|Overall Study|Study closure by sponsor|1
1974248|NCT04296942|3535593|FG001|Overall Study|Study closure by sponsor|0
1974249|NCT04296942|3535594|FG002|Overall Study|Study closure by sponsor|0
1974250|NCT04278872|3535606|FG000|Overall Study|Adverse Event|1
1974251|NCT04278872|3535607|FG001|Overall Study|Adverse Event|0
1974252|NCT04278872|3535606|FG000|Overall Study|Protocol Violation|0
1974253|NCT04278872|3535607|FG001|Overall Study|Protocol Violation|1
1974254|NCT04278872|3535606|FG000|Overall Study|Study Termination|2
1974255|NCT04278872|3535607|FG001|Overall Study|Study Termination|0
1974256|NCT04213807|3535616|FG000|Overall Study|Physician Decision|0
1974257|NCT04213807|3535617|FG001|Overall Study|Physician Decision|0
1974258|NCT04213807|3535618|FG002|Overall Study|Physician Decision|1
1974259|NCT03833661|3535681|FG000|Overall Study|Treatment ongoing|9
1974260|NCT03721107|3535704|FG000|Overall Study|Adverse Event|1
1974261|NCT03721107|3535705|FG001|Overall Study|Adverse Event|1
1974262|NCT03721107|3535706|FG002|Overall Study|Adverse Event|6
1974263|NCT03721107|3535707|FG003|Overall Study|Adverse Event|5
1974264|NCT03721107|3535704|FG000|Overall Study|Lost to Follow-up|2
1974265|NCT03721107|3535705|FG001|Overall Study|Lost to Follow-up|0
1974266|NCT03721107|3535706|FG002|Overall Study|Lost to Follow-up|3
1974267|NCT03721107|3535707|FG003|Overall Study|Lost to Follow-up|0
1974268|NCT03721107|3535704|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0
1974269|NCT03721107|3535705|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0
1974270|NCT03721107|3535706|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0
1974271|NCT03721107|3535707|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1
1974272|NCT03721107|3535704|FG000|Overall Study|Physician Decision|0
1974273|NCT03721107|3535705|FG001|Overall Study|Physician Decision|1
1974274|NCT03721107|3535706|FG002|Overall Study|Physician Decision|0
1974275|NCT03721107|3535707|FG003|Overall Study|Physician Decision|0
1974276|NCT03721107|3535704|FG000|Overall Study|Pregnancy|0
1974277|NCT03721107|3535705|FG001|Overall Study|Pregnancy|0
1974278|NCT03721107|3535706|FG002|Overall Study|Pregnancy|1
1974279|NCT03721107|3535707|FG003|Overall Study|Pregnancy|0
1974280|NCT03721107|3535704|FG000|Overall Study|Withdrawal by Subject|1
1974281|NCT03721107|3535705|FG001|Overall Study|Withdrawal by Subject|1
1974282|NCT03721107|3535706|FG002|Overall Study|Withdrawal by Subject|5
1974283|NCT03721107|3535707|FG003|Overall Study|Withdrawal by Subject|5
1974284|NCT03721107|3535704|FG000|Overall Study|Other|1
1974285|NCT03721107|3535705|FG001|Overall Study|Other|0
1974286|NCT03721107|3535706|FG002|Overall Study|Other|0
1974287|NCT03721107|3535707|FG003|Overall Study|Other|1
1974288|NCT03644849|3535747|FG000|Overall Study|Lost to Follow-up|1
1974289|NCT03644849|3535748|FG001|Overall Study|Lost to Follow-up|3
1974290|NCT03604159|3535765|FG000|Overall Study|Lost to Follow-up|6
1974291|NCT03604159|3535766|FG001|Overall Study|Lost to Follow-up|7
1974292|NCT03602885|3535774|FG000|Overall Study|Lost to Follow-up|3
1974293|NCT03602885|3535775|FG001|Overall Study|Lost to Follow-up|0
1974294|NCT03539601|3535785|FG000|Overall Study|Withdraw by parent/guardian|1
1974295|NCT03539601|3535786|FG001|Overall Study|Withdraw by parent/guardian|0
1974296|NCT03539601|3535787|FG002|Overall Study|Withdraw by parent/guardian|1
1974297|NCT03539601|3535788|FG003|Overall Study|Withdraw by parent/guardian|0
1974298|NCT03539601|3535785|FG000|Overall Study|Adverse Event|0
1974299|NCT03539601|3535786|FG001|Overall Study|Adverse Event|2
1974300|NCT03539601|3535787|FG002|Overall Study|Adverse Event|0
1974301|NCT03539601|3535788|FG003|Overall Study|Adverse Event|0
1974302|NCT03539601|3535785|FG000|Overall Study|Lost to Follow-up|2
1974303|NCT03539601|3535786|FG001|Overall Study|Lost to Follow-up|4
1974304|NCT03539601|3535787|FG002|Overall Study|Lost to Follow-up|5
1974305|NCT03539601|3535788|FG003|Overall Study|Lost to Follow-up|0
1974306|NCT03539601|3535785|FG000|Overall Study|Withdrawal by Subject|2
1974307|NCT03539601|3535786|FG001|Overall Study|Withdrawal by Subject|0
1974308|NCT03539601|3535787|FG002|Overall Study|Withdrawal by Subject|0
1974309|NCT03539601|3535788|FG003|Overall Study|Withdrawal by Subject|1
1974310|NCT03539601|3535785|FG000|Overall Study|Randomized but not treated|1
1974311|NCT03539601|3535786|FG001|Overall Study|Randomized but not treated|1
1974312|NCT03539601|3535787|FG002|Overall Study|Randomized but not treated|0
1974313|NCT03539601|3535788|FG003|Overall Study|Randomized but not treated|0
1974314|NCT03539458|3535806|FG000|Overall Study|Death|1
1974315|NCT03532451|3535812|FG000|Overall Study|Withdrawal by Subject|0
1974316|NCT03532451|3535813|FG001|Overall Study|Withdrawal by Subject|1
1974317|NCT03532451|3535812|FG000|Overall Study|Progression prior to the surgery|1
1974318|NCT03532451|3535813|FG001|Overall Study|Progression prior to the surgery|0
1974319|NCT03478956|3535830|FG000|Overall Study|Adverse Event|1
1974320|NCT03478956|3535831|FG001|Overall Study|Adverse Event|0
1974321|NCT03478956|3535830|FG000|Overall Study|Withdrawal by Subject|0
1974322|NCT03478956|3535831|FG001|Overall Study|Withdrawal by Subject|1
1974323|NCT03478956|3535830|FG000|Overall Study|Ongoing in the Study|11
1974324|NCT03478956|3535831|FG001|Overall Study|Ongoing in the Study|11
1974325|NCT03464136|3535839|FG000|Overall Study|Lost to Follow-up|5
1974326|NCT03464136|3535840|FG001|Overall Study|Lost to Follow-up|8
1974327|NCT03464136|3535839|FG000|Overall Study|Withdrawal by Subject|16
1974328|NCT03464136|3535840|FG001|Overall Study|Withdrawal by Subject|13
1974329|NCT03464136|3535839|FG000|Overall Study|Death|1
1974330|NCT03464136|3535840|FG001|Overall Study|Death|0
1974331|NCT03464136|3535839|FG000|Overall Study|Other|8
1974332|NCT03464136|3535840|FG001|Overall Study|Other|4
1974333|NCT03439657|3535848|FG000|Overall Study|Adverse Event|2
1974334|NCT03439657|3535849|FG001|Overall Study|Adverse Event|3
1974335|NCT03439657|3535848|FG000|Overall Study|Lost to Follow-up|1
1974336|NCT03439657|3535849|FG001|Overall Study|Lost to Follow-up|0
1974337|NCT03439657|3535848|FG000|Overall Study|Protocol Violation|1
1974338|NCT03439657|3535849|FG001|Overall Study|Protocol Violation|1
1974339|NCT03439657|3535848|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3
1974340|NCT03439657|3535849|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0
1974341|NCT03377790|3535859|FG000|Overall Study|Withdrawal by Subject|1
1974342|NCT03377790|3535860|FG001|Overall Study|Withdrawal by Subject|0
1974343|NCT03377790|3535859|FG000|Overall Study|Adverse Event|1
1974344|NCT03377790|3535860|FG001|Overall Study|Adverse Event|0
1974345|NCT03377790|3535859|FG000|Overall Study|Lost to Follow-up|0
1974346|NCT03377790|3535860|FG001|Overall Study|Lost to Follow-up|2
1974347|NCT03377790|3535859|FG000|Overall Study|Randomized but not treated|1
1974348|NCT03377790|3535860|FG001|Overall Study|Randomized but not treated|0
1974349|NCT03377790|3535859|FG000|Overall Study|Withdrawn by Parent/Guardian|7
1974350|NCT03377790|3535860|FG001|Overall Study|Withdrawn by Parent/Guardian|4
1974351|NCT03353675|3535866|FG000|Overall Study|Adverse Event|4
1974352|NCT03294109|3535872|FG000|Overall Study|Withdrawal by Subject|6
1974353|NCT03294109|3535873|FG001|Overall Study|Withdrawal by Subject|5
1974354|NCT03268005|3535882|FG000|Overall Study|Death|2
1974355|NCT03268005|3535883|FG001|Overall Study|Death|1
1974356|NCT03268005|3535882|FG000|Overall Study|Lost to Follow-up|2
1974357|NCT03268005|3535883|FG001|Overall Study|Lost to Follow-up|2
1974358|NCT03268005|3535882|FG000|Overall Study|Withdrawal by Subject|11
1974359|NCT03268005|3535883|FG001|Overall Study|Withdrawal by Subject|11
2021953|NCT00316589|3589844|FG003|Overall Study|Adverse Event|1
2021954|NCT00316589|3589841|FG000|Overall Study|Physician Decision|0
2021955|NCT00316589|3589842|FG001|Overall Study|Physician Decision|1
2021956|NCT00316589|3589843|FG002|Overall Study|Physician Decision|0
2021957|NCT00316589|3589844|FG003|Overall Study|Physician Decision|0
2021958|NCT00316589|3589841|FG000|Overall Study|Other reason|0
2021959|NCT00316589|3589842|FG001|Overall Study|Other reason|12
2021960|NCT00316589|3589843|FG002|Overall Study|Other reason|1
2021961|NCT00316589|3589844|FG003|Overall Study|Other reason|1
2021962|NCT00316602|3589858|FG000|Overall Study|Withdrawal by Subject|3
2021963|NCT00316602|3589859|FG001|Overall Study|Withdrawal by Subject|2
2021964|NCT00316602|3589858|FG000|Overall Study|Subject unwilling/unable to comply with|3
2021965|NCT00316602|3589859|FG001|Overall Study|Subject unwilling/unable to comply with|17
2021966|NCT00316602|3589858|FG000|Overall Study|Adverse Event|1
2021967|NCT00316602|3589859|FG001|Overall Study|Adverse Event|0
2021968|NCT00316602|3589858|FG000|Overall Study|Other|3
2021969|NCT00316602|3589859|FG001|Overall Study|Other|6
2021970|NCT00316693|3589867|FG000|Overall Study|Adverse Event|6
2021971|NCT00316693|3589868|FG001|Overall Study|Adverse Event|1
2021972|NCT00316693|3589867|FG000|Overall Study|Protocol Violation|1
2021973|NCT00316693|3589868|FG001|Overall Study|Protocol Violation|0
2021974|NCT00316693|3589867|FG000|Overall Study|Withdrawal by Subject|6
2021975|NCT00316693|3589868|FG001|Overall Study|Withdrawal by Subject|6
2021976|NCT00316693|3589867|FG000|Overall Study|Lost to Follow-up|26
2021977|NCT00316693|3589868|FG001|Overall Study|Lost to Follow-up|34
2021978|NCT00316693|3589867|FG000|Overall Study|Other|38
2021979|NCT00316693|3589868|FG001|Overall Study|Other|44
2021980|NCT00316706|3589876|FG000|Overall Study|Lost to Follow-up|38
2021981|NCT00316706|3589877|FG001|Overall Study|Lost to Follow-up|48
2021982|NCT00316719|3589885|FG000|Overall Study|Adverse Event|0
2021983|NCT00316719|3589886|FG001|Overall Study|Adverse Event|6
2021984|NCT00316719|3589885|FG000|Overall Study|Consent withdrawn|2
2021985|NCT00316719|3589886|FG001|Overall Study|Consent withdrawn|0
2021986|NCT00316888|3589898|FG000|Overall Study|Adverse Event|4
2021987|NCT00316888|3589899|FG001|Overall Study|Adverse Event|5
2021988|NCT00316888|3589898|FG000|Overall Study|Withdrawal by Subject|2
2021989|NCT00316888|3589899|FG001|Overall Study|Withdrawal by Subject|2
2021990|NCT00316888|3589898|FG000|Overall Study|Not start protocol therapy|0
2021991|NCT00316888|3589899|FG001|Overall Study|Not start protocol therapy|1
2021992|NCT00316914|3589907|FG000|Overall Study|Withdrawal by Subject|5
2021993|NCT00316914|3589908|FG001|Overall Study|Withdrawal by Subject|3
2021994|NCT00316914|3589907|FG000|Overall Study|Adverse Event|8
2021995|NCT00316914|3589908|FG001|Overall Study|Adverse Event|7
2021996|NCT00316914|3589907|FG000|Overall Study|Other Problems|6
2021997|NCT00316914|3589908|FG001|Overall Study|Other Problems|11
2021998|NCT00316914|3589907|FG000|Overall Study|Missing end of treatment documentation|14
1974360|NCT03225170|3535892|FG000|Overall Study|Lost to Follow-up|4
1974361|NCT03225170|3535893|FG001|Overall Study|Lost to Follow-up|4
1974362|NCT03225170|3535894|FG002|Overall Study|Lost to Follow-up|0
1974363|NCT03225170|3535892|FG000|Overall Study|Did not complete intervention/control writing exercise|0
1974364|NCT03225170|3535893|FG001|Overall Study|Did not complete intervention/control writing exercise|1
1974365|NCT03225170|3535894|FG002|Overall Study|Did not complete intervention/control writing exercise|0
1974366|NCT03219034|3535918|FG000|Overall Study|Lost to Follow-up|9
1974367|NCT03219034|3535919|FG001|Overall Study|Lost to Follow-up|13
1974368|NCT03219034|3535918|FG000|Overall Study|Additional dental work needed|1
1974369|NCT03219034|3535919|FG001|Overall Study|Additional dental work needed|0
1974370|NCT03219034|3535918|FG000|Overall Study|UPPP Surgery|1
1974371|NCT03219034|3535919|FG001|Overall Study|UPPP Surgery|0
1974372|NCT03219034|3535918|FG000|Overall Study|Dental sensitivity|0
1974373|NCT03219034|3535919|FG001|Overall Study|Dental sensitivity|1
1974374|NCT03219034|3535918|FG000|Overall Study|Death in family|0
1974375|NCT03219034|3535919|FG001|Overall Study|Death in family|1
1974376|NCT03181789|3535931|FG000|Overall Study|Withdrawal by Subject|0
1974377|NCT03181789|3535932|FG001|Overall Study|Withdrawal by Subject|1
1974378|NCT03181789|3535933|FG002|Overall Study|Withdrawal by Subject|1
1974379|NCT03181789|3535934|FG003|Overall Study|Withdrawal by Subject|0
1974380|NCT03181789|3535931|FG000|Overall Study|Lost to Follow-up|7
1974381|NCT03181789|3535932|FG001|Overall Study|Lost to Follow-up|1
1974382|NCT03181789|3535933|FG002|Overall Study|Lost to Follow-up|0
1974383|NCT03181789|3535934|FG003|Overall Study|Lost to Follow-up|0
1974384|NCT03181789|3535931|FG000|Overall Study|Participant unable to adhere to visit|0
1974385|NCT03181789|3535932|FG001|Overall Study|Participant unable to adhere to visit|1
1974386|NCT03181789|3535933|FG002|Overall Study|Participant unable to adhere to visit|0
1974387|NCT03181789|3535934|FG003|Overall Study|Participant unable to adhere to visit|0
1974388|NCT03168438|3535946|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0
1974389|NCT03168438|3535947|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1
1974390|NCT03110380|3535956|FG000|Double-Blind Treatment Phase|Withdrew Consent|10
1974391|NCT03110380|3535957|FG001|Double-Blind Treatment Phase|Withdrew Consent|16
1974392|NCT03110380|3535958|FG002|Double-Blind Treatment Phase|Withdrew Consent|0
1974393|NCT03110380|3535959|FG003|Double-Blind Treatment Phase|Withdrew Consent|0
1974394|NCT03110380|3535956|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
1974395|NCT03110380|3535957|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3
1974396|NCT03110380|3535958|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0
1974397|NCT03110380|3535959|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
1974398|NCT03110380|3535956|FG000|Double-Blind Treatment Phase|Adverse Event|3
1974399|NCT03110380|3535957|FG001|Double-Blind Treatment Phase|Adverse Event|3
1974400|NCT03110380|3535958|FG002|Double-Blind Treatment Phase|Adverse Event|0
1974401|NCT03110380|3535959|FG003|Double-Blind Treatment Phase|Adverse Event|0
1974402|NCT03110380|3535956|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1
1974403|NCT03110380|3535957|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3
1974404|NCT03110380|3535958|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0
1974405|NCT03110380|3535959|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0
1974406|NCT03110380|3535956|FG000|Double-Blind Treatment Phase|Death|2
1974407|NCT03110380|3535957|FG001|Double-Blind Treatment Phase|Death|1
1974408|NCT03110380|3535958|FG002|Double-Blind Treatment Phase|Death|0
1974409|NCT03110380|3535959|FG003|Double-Blind Treatment Phase|Death|0
1974410|NCT03110380|3535956|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
1974411|NCT03110380|3535957|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
1974412|NCT03110380|3535958|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
1974413|NCT03110380|3535959|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
1974414|NCT03110380|3535956|FG000|Double-Blind Treatment Phase|Protocol Violation|0
1974415|NCT03110380|3535957|FG001|Double-Blind Treatment Phase|Protocol Violation|1
1974416|NCT03110380|3535958|FG002|Double-Blind Treatment Phase|Protocol Violation|0
1974417|NCT03110380|3535959|FG003|Double-Blind Treatment Phase|Protocol Violation|0
1974418|NCT03110380|3535956|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0
1974419|NCT03110380|3535957|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2
1974420|NCT03110380|3535958|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0
1974421|NCT03110380|3535959|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0
1974422|NCT03110380|3535956|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
1974423|NCT03110380|3535957|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
1974424|NCT03110380|3535958|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3
1974425|NCT03110380|3535959|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1
1974426|NCT03110380|3535956|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
1974427|NCT03110380|3535957|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
1974428|NCT03110380|3535958|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
1974429|NCT03110380|3535959|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
1974430|NCT03110380|3535956|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0
1974431|NCT03110380|3535957|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0
1974432|NCT03110380|3535958|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0
1974433|NCT03110380|3535959|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1
1974434|NCT03078478|3535975|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
1974435|NCT03078478|3535976|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
1974436|NCT03078478|3535975|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
1974437|NCT03078478|3535976|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
1974438|NCT03078478|3535975|FG000|Maintenance Period 1 (36 Weeks)|Death|3
1974439|NCT03078478|3535976|FG001|Maintenance Period 1 (36 Weeks)|Death|3
1974440|NCT03078478|3535975|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
2212887|NCT01674062|3854197|FG000|Overall Study|Insufficient Therapeutic Response|56
2212888|NCT01674062|3854198|FG001|Overall Study|Insufficient Therapeutic Response|26
2212889|NCT01674062|3854197|FG000|Overall Study|Other|8
1974441|NCT03078478|3535976|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
1974442|NCT03078478|3535975|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
1974443|NCT03078478|3535976|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
1974444|NCT03078478|3535975|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
1974445|NCT03078478|3535976|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
1974446|NCT03078478|3535975|FG000|Maintencance Period 2 (36 Weeks)|Death|4
1974447|NCT03078478|3535976|FG001|Maintencance Period 2 (36 Weeks)|Death|6
1974448|NCT03078478|3535975|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
1974449|NCT03078478|3535976|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
1974450|NCT02993263|3535991|FG000|Overall Study|Equipment Software failed and results were lost.|323
1974451|NCT02985684|3535995|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
1974452|NCT02985684|3535995|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
1974453|NCT02985684|3535995|FG000|6-Month Closure Success Evaluation|Device Removal|3
1974454|NCT02951052|3536010|FG000|Overall Study|Adverse Event|13
1974455|NCT02951052|3536011|FG001|Overall Study|Adverse Event|5
1974456|NCT02951052|3536010|FG000|Overall Study|Withdrawal by Subject|1
1974457|NCT02951052|3536011|FG001|Overall Study|Withdrawal by Subject|5
1974458|NCT02951052|3536010|FG000|Overall Study|Physician Decision|2
1974459|NCT02951052|3536011|FG001|Overall Study|Physician Decision|0
1974460|NCT02951052|3536010|FG000|Overall Study|Lost to Follow-up|1
1974461|NCT02951052|3536011|FG001|Overall Study|Lost to Follow-up|1
1974462|NCT02951052|3536010|FG000|Overall Study|Protocol-specified withdrawal criterion|1
1974463|NCT02951052|3536011|FG001|Overall Study|Protocol-specified withdrawal criterion|0
1974464|NCT02951052|3536010|FG000|Overall Study|Protocol Violation|5
1974465|NCT02951052|3536011|FG001|Overall Study|Protocol Violation|3
1974466|NCT02951052|3536010|FG000|Overall Study|Lack of Efficacy|3
1974467|NCT02951052|3536011|FG001|Overall Study|Lack of Efficacy|4
1974468|NCT02951052|3536010|FG000|Overall Study|Ongoing|1
1974469|NCT02951052|3536011|FG001|Overall Study|Ongoing|0
1974470|NCT02903914|3536029|FG000|Overall Study|Adverse Event|0
1974471|NCT02903914|3536030|FG001|Overall Study|Adverse Event|0
1974472|NCT02903914|3536031|FG002|Overall Study|Adverse Event|1
1974473|NCT02903914|3536032|FG003|Overall Study|Adverse Event|0
1974474|NCT02903914|3536033|FG004|Overall Study|Adverse Event|0
1974475|NCT02903914|3536034|FG005|Overall Study|Adverse Event|1
1974476|NCT02903914|3536035|FG006|Overall Study|Adverse Event|2
1974477|NCT02903914|3536036|FG007|Overall Study|Adverse Event|1
1974478|NCT02903914|3536029|FG000|Overall Study|Withdrawal by Subject|3
1974479|NCT02903914|3536030|FG001|Overall Study|Withdrawal by Subject|1
1974480|NCT02903914|3536031|FG002|Overall Study|Withdrawal by Subject|28
1974481|NCT02903914|3536032|FG003|Overall Study|Withdrawal by Subject|0
1974482|NCT02903914|3536033|FG004|Overall Study|Withdrawal by Subject|1
1974483|NCT02903914|3536034|FG005|Overall Study|Withdrawal by Subject|1
1974484|NCT02903914|3536035|FG006|Overall Study|Withdrawal by Subject|12
1974485|NCT02903914|3536036|FG007|Overall Study|Withdrawal by Subject|0
1974486|NCT02903914|3536029|FG000|Overall Study|Progressive Disease|1
1974487|NCT02903914|3536030|FG001|Overall Study|Progressive Disease|0
1974488|NCT02903914|3536031|FG002|Overall Study|Progressive Disease|4
1974489|NCT02903914|3536032|FG003|Overall Study|Progressive Disease|0
1974490|NCT02903914|3536033|FG004|Overall Study|Progressive Disease|0
1974491|NCT02903914|3536034|FG005|Overall Study|Progressive Disease|0
1974492|NCT02903914|3536035|FG006|Overall Study|Progressive Disease|2
1974493|NCT02903914|3536036|FG007|Overall Study|Progressive Disease|4
1974494|NCT02903914|3536029|FG000|Overall Study|Death|0
1974495|NCT02903914|3536030|FG001|Overall Study|Death|0
1974496|NCT02903914|3536031|FG002|Overall Study|Death|9
1974497|NCT02903914|3536032|FG003|Overall Study|Death|0
1974498|NCT02903914|3536033|FG004|Overall Study|Death|1
1974499|NCT02903914|3536034|FG005|Overall Study|Death|3
1974500|NCT02903914|3536035|FG006|Overall Study|Death|24
1974501|NCT02903914|3536036|FG007|Overall Study|Death|0
1974502|NCT02903914|3536029|FG000|Overall Study|Lost to Follow-up|0
1974503|NCT02903914|3536030|FG001|Overall Study|Lost to Follow-up|1
1974504|NCT02903914|3536031|FG002|Overall Study|Lost to Follow-up|0
1974505|NCT02903914|3536032|FG003|Overall Study|Lost to Follow-up|0
1974506|NCT02903914|3536033|FG004|Overall Study|Lost to Follow-up|2
1974507|NCT02903914|3536034|FG005|Overall Study|Lost to Follow-up|0
1974508|NCT02903914|3536035|FG006|Overall Study|Lost to Follow-up|1
1974509|NCT02903914|3536036|FG007|Overall Study|Lost to Follow-up|0
1974510|NCT02903914|3536029|FG000|Overall Study|Physician Decision|0
2212890|NCT01674062|3854198|FG001|Overall Study|Other|1
2212891|NCT01674062|3854197|FG000|Overall Study|Adverse Event|1
1974511|NCT02903914|3536030|FG001|Overall Study|Physician Decision|0
1974512|NCT02903914|3536031|FG002|Overall Study|Physician Decision|1
1974513|NCT02903914|3536032|FG003|Overall Study|Physician Decision|0
1974514|NCT02903914|3536033|FG004|Overall Study|Physician Decision|0
1974515|NCT02903914|3536034|FG005|Overall Study|Physician Decision|0
1974516|NCT02903914|3536035|FG006|Overall Study|Physician Decision|1
1974517|NCT02903914|3536036|FG007|Overall Study|Physician Decision|0
1974518|NCT02903914|3536029|FG000|Overall Study|Symptomatic Deterioration|0
1974519|NCT02903914|3536030|FG001|Overall Study|Symptomatic Deterioration|0
1974520|NCT02903914|3536031|FG002|Overall Study|Symptomatic Deterioration|1
1974521|NCT02903914|3536032|FG003|Overall Study|Symptomatic Deterioration|0
1974522|NCT02903914|3536033|FG004|Overall Study|Symptomatic Deterioration|0
1974523|NCT02903914|3536034|FG005|Overall Study|Symptomatic Deterioration|0
1974524|NCT02903914|3536035|FG006|Overall Study|Symptomatic Deterioration|0
1974525|NCT02903914|3536036|FG007|Overall Study|Symptomatic Deterioration|0
1974526|NCT02903914|3536029|FG000|Overall Study|New Cancer Therapy|2
1974527|NCT02903914|3536030|FG001|Overall Study|New Cancer Therapy|2
1974528|NCT02903914|3536031|FG002|Overall Study|New Cancer Therapy|21
1974529|NCT02903914|3536032|FG003|Overall Study|New Cancer Therapy|4
1974530|NCT02903914|3536033|FG004|Overall Study|New Cancer Therapy|3
1974531|NCT02903914|3536034|FG005|Overall Study|New Cancer Therapy|6
1974532|NCT02903914|3536035|FG006|Overall Study|New Cancer Therapy|55
1974533|NCT02903914|3536036|FG007|Overall Study|New Cancer Therapy|0
1974534|NCT02903914|3536029|FG000|Overall Study|Reasoning not specified|2
1974535|NCT02903914|3536030|FG001|Overall Study|Reasoning not specified|3
1974536|NCT02903914|3536031|FG002|Overall Study|Reasoning not specified|20
1974537|NCT02903914|3536032|FG003|Overall Study|Reasoning not specified|3
1974538|NCT02903914|3536033|FG004|Overall Study|Reasoning not specified|3
1974539|NCT02903914|3536034|FG005|Overall Study|Reasoning not specified|3
1974540|NCT02903914|3536035|FG006|Overall Study|Reasoning not specified|20
1974541|NCT02903914|3536036|FG007|Overall Study|Reasoning not specified|0
1974542|NCT02879448|3536058|FG000|Overall Study|No implant attempt|17
1974543|NCT02879448|3536059|FG001|Overall Study|No implant attempt|28
1974544|NCT02879448|3536058|FG000|Overall Study|Withdrawal by Subject|20
1974545|NCT02879448|3536059|FG001|Overall Study|Withdrawal by Subject|46
1974546|NCT02879448|3536058|FG000|Overall Study|Death|63
1974547|NCT02879448|3536059|FG001|Overall Study|Death|85
1974548|NCT02879448|3536058|FG000|Overall Study|Lost to Follow-up|3
1974549|NCT02879448|3536059|FG001|Overall Study|Lost to Follow-up|4
1974550|NCT02879448|3536058|FG000|Overall Study|Missing visit|34
1974551|NCT02879448|3536059|FG001|Overall Study|Missing visit|39
1974552|NCT02879448|3536058|FG000|Overall Study|Pending evaluation|1
1974553|NCT02879448|3536059|FG001|Overall Study|Pending evaluation|0
1974554|NCT02873195|3536067|FG000|Overall Study|Ineligible|5
1974555|NCT02873195|3536068|FG001|Overall Study|Ineligible|0
2021999|NCT00316914|3589908|FG001|Overall Study|Missing end of treatment documentation|15
2022000|NCT00317044|3589917|FG000|Overall Study|Protocol Violation|28
2022001|NCT00317044|3589918|FG001|Overall Study|Protocol Violation|22
2022002|NCT00317044|3589919|FG002|Overall Study|Protocol Violation|20
2022003|NCT00317044|3589917|FG000|Overall Study|Adverse Event|4
2022004|NCT00317044|3589918|FG001|Overall Study|Adverse Event|7
2022005|NCT00317044|3589919|FG002|Overall Study|Adverse Event|4
2022006|NCT00317044|3589917|FG000|Overall Study|Withdrawal by Subject|10
2022007|NCT00317044|3589918|FG001|Overall Study|Withdrawal by Subject|7
2022008|NCT00317044|3589919|FG002|Overall Study|Withdrawal by Subject|12
2022009|NCT00317044|3589917|FG000|Overall Study|Lost to Follow-up|0
2022010|NCT00317044|3589918|FG001|Overall Study|Lost to Follow-up|2
2022011|NCT00317044|3589919|FG002|Overall Study|Lost to Follow-up|3
2022012|NCT00317044|3589917|FG000|Overall Study|Multiple Reasons|6
2022013|NCT00317044|3589918|FG001|Overall Study|Multiple Reasons|2
2022014|NCT00317044|3589919|FG002|Overall Study|Multiple Reasons|6
2022015|NCT00317109|3589929|FG000|Overall Study|Withdrawal by Subject|2
2022016|NCT00317109|3589930|FG001|Overall Study|Withdrawal by Subject|0
2022017|NCT00317109|3589929|FG000|Overall Study|Migated/moved from study area|1
2022018|NCT00317109|3589930|FG001|Overall Study|Migated/moved from study area|0
2022019|NCT00317356|3589953|FG000|Overall Study|Adverse Event|0
2022020|NCT00317356|3589954|FG001|Overall Study|Adverse Event|0
2022021|NCT00317356|3589955|FG002|Overall Study|Adverse Event|1
2022022|NCT00317356|3589956|FG003|Overall Study|Adverse Event|0
2022023|NCT00317356|3589953|FG000|Overall Study|Lack of Efficacy|1
2022024|NCT00317356|3589954|FG001|Overall Study|Lack of Efficacy|1
2022025|NCT00317356|3589955|FG002|Overall Study|Lack of Efficacy|0
2022026|NCT00317356|3589956|FG003|Overall Study|Lack of Efficacy|3
2022027|NCT00317356|3589953|FG000|Overall Study|Physician Decision|0
2022028|NCT00317356|3589954|FG001|Overall Study|Physician Decision|1
2022029|NCT00317356|3589955|FG002|Overall Study|Physician Decision|0
2022030|NCT00317356|3589956|FG003|Overall Study|Physician Decision|0
2022031|NCT00317369|3589969|FG000|Overall Study|Adverse Event|2
2022032|NCT00317369|3589970|FG001|Overall Study|Adverse Event|1
2022033|NCT00317369|3589971|FG002|Overall Study|Adverse Event|0
2022034|NCT00317369|3589969|FG000|Overall Study|Lack of Efficacy|0
2022035|NCT00317369|3589970|FG001|Overall Study|Lack of Efficacy|1
2022036|NCT00317369|3589971|FG002|Overall Study|Lack of Efficacy|1
2022037|NCT00317369|3589969|FG000|Overall Study|Withdrawal by Subject|0
2022038|NCT00317369|3589970|FG001|Overall Study|Withdrawal by Subject|0
2022039|NCT00317369|3589971|FG002|Overall Study|Withdrawal by Subject|1
1974556|NCT02821000|3536074|FG000|Overall Study|Death|44
1974557|NCT02821000|3536074|FG000|Overall Study|Withdrawal by Subject|1
1974558|NCT02821000|3536074|FG000|Overall Study|Ongoing in Study|58
1974559|NCT02785952|3536080|FG000|Overall Study|Adverse Event|31
1974560|NCT02785952|3536081|FG001|Overall Study|Adverse Event|19
1974561|NCT02785952|3536080|FG000|Overall Study|Refusal unrelated to adverse events|10
1974562|NCT02785952|3536081|FG001|Overall Study|Refusal unrelated to adverse events|5
1974563|NCT02785952|3536080|FG000|Overall Study|Disease progression/relapse|61
1974564|NCT02785952|3536081|FG001|Overall Study|Disease progression/relapse|89
1974565|NCT02785952|3536080|FG000|Overall Study|Death|11
1974566|NCT02785952|3536081|FG001|Overall Study|Death|7
1974567|NCT02785952|3536080|FG000|Overall Study|Other- not protocol specified|6
1974568|NCT02785952|3536081|FG001|Overall Study|Other- not protocol specified|4
1974569|NCT02785952|3536080|FG000|Overall Study|On protocol treatment|6
1974570|NCT02785952|3536081|FG001|Overall Study|On protocol treatment|3
1974571|NCT02748616|3536093|FG000|Overall Study|Lost to Follow-up|1
1974572|NCT02748616|3536093|FG000|Overall Study|Withdrawal by Subject|2
1974573|NCT02748616|3536093|FG000|Overall Study|Physician Decision|2
1974574|NCT02748616|3536093|FG000|Overall Study|Did Not Complete Ursodial Course|2
1974575|NCT02719522|3536097|FG000|Overall Study|Implant Failure|4
1974576|NCT02719522|3536097|FG000|Overall Study|Death|2
1974577|NCT02719522|3536097|FG000|Overall Study|Lost to Follow-up|5
1974578|NCT02586025|3536118|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1
1974579|NCT02586025|3536119|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0
1974580|NCT02586025|3536118|FG000|Neoadjuvant Treatment|Death|1
1974581|NCT02586025|3536119|FG001|Neoadjuvant Treatment|Death|0
1974582|NCT02586025|3536118|FG000|Neoadjuvant Treatment|Adverse Event|1
1974583|NCT02586025|3536119|FG001|Neoadjuvant Treatment|Adverse Event|0
1974584|NCT02586025|3536118|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4
1974585|NCT02586025|3536119|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3
1974586|NCT02586025|3536118|FG000|Neoadjuvant Treatment|Physician Decision|2
1974587|NCT02586025|3536119|FG001|Neoadjuvant Treatment|Physician Decision|1
1974588|NCT02586025|3536118|FG000|Neoadjuvant Treatment|Progressive Disease|2
1974589|NCT02586025|3536119|FG001|Neoadjuvant Treatment|Progressive Disease|3
1974590|NCT02586025|3536118|FG000|Adjuvant Treatment|Remain in Adjuvant Treatment|133
1974591|NCT02586025|3536119|FG001|Adjuvant Treatment|Remain in Adjuvant Treatment|61
1974592|NCT02586025|3536118|FG000|Adjuvant Treatment|Withdrawal by Subject|5
1974593|NCT02586025|3536119|FG001|Adjuvant Treatment|Withdrawal by Subject|3
1974594|NCT02586025|3536118|FG000|Adjuvant Treatment|Physician Decision|0
1974595|NCT02586025|3536119|FG001|Adjuvant Treatment|Physician Decision|1
1974596|NCT02586025|3536118|FG000|Adjuvant Treatment|Recurrent Disease|1
1974597|NCT02586025|3536119|FG001|Adjuvant Treatment|Recurrent Disease|4
1974598|NCT02586025|3536118|FG000|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
1974599|NCT02586025|3536119|FG001|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
1974600|NCT02585232|3536127|FG000|Overall Study|Lost to Follow-up|8
1974601|NCT02585232|3536128|FG001|Overall Study|Lost to Follow-up|8
1974602|NCT02585232|3536127|FG000|Overall Study|Withdrawal by Subject|4
1974603|NCT02585232|3536128|FG001|Overall Study|Withdrawal by Subject|8
1974604|NCT02583269|3536139|FG000|Overall Study|Patient hospitalized prior to start|1
1974605|NCT02583269|3536140|FG001|Overall Study|Patient hospitalized prior to start|0
1974606|NCT02583269|3536141|FG002|Overall Study|Patient hospitalized prior to start|0
1974607|NCT02583269|3536142|FG003|Overall Study|Patient hospitalized prior to start|0
1974608|NCT02583269|3536143|FG004|Overall Study|Patient hospitalized prior to start|0
1974609|NCT02545283|3536179|FG000|Overall Study|Lost to Follow-up|2
1974610|NCT02545283|3536180|FG001|Overall Study|Lost to Follow-up|4
1974611|NCT02545283|3536179|FG000|Overall Study|Withdrawal by Subject|5
1974612|NCT02545283|3536180|FG001|Overall Study|Withdrawal by Subject|9
1974613|NCT02545283|3536179|FG000|Overall Study|Death|109
1974614|NCT02545283|3536180|FG001|Overall Study|Death|211
1974615|NCT02545283|3536179|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0
1974616|NCT02545283|3536180|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3
1974617|NCT02545283|3536179|FG000|Overall Study|Study Terminated By Sponsor|33
1974618|NCT02545283|3536180|FG001|Overall Study|Study Terminated By Sponsor|71
1974619|NCT02524171|3536190|FG000|6-month Follow-up|Lost to Follow-up|53
1974620|NCT02524171|3536191|FG001|6-month Follow-up|Lost to Follow-up|45
1974621|NCT02524171|3536190|FG000|12-month Follow-up Interview|Lost to Follow-up|45
1974622|NCT02524171|3536191|FG001|12-month Follow-up Interview|Lost to Follow-up|41
1974623|NCT02476968|3536227|FG000|Overall Study|Other|0
1974624|NCT02476968|3536228|FG001|Overall Study|Other|2
1974625|NCT02476968|3536229|FG002|Overall Study|Other|0
1974626|NCT02476968|3536227|FG000|Overall Study|Lost to Follow-up|10
1974627|NCT02476968|3536228|FG001|Overall Study|Lost to Follow-up|0
1974628|NCT02476968|3536229|FG002|Overall Study|Lost to Follow-up|1
1974629|NCT02476968|3536227|FG000|Overall Study|Death|34
1974630|NCT02476968|3536228|FG001|Overall Study|Death|6
1974631|NCT02476968|3536229|FG002|Overall Study|Death|0
1974632|NCT02476968|3536227|FG000|Overall Study|Eligibility criteria not fulfilled|0
1974633|NCT02476968|3536228|FG001|Overall Study|Eligibility criteria not fulfilled|0
1974634|NCT02476968|3536229|FG002|Overall Study|Eligibility criteria not fulfilled|1
1974635|NCT02476968|3536227|FG000|Overall Study|Patient decision|30
1974636|NCT02476968|3536228|FG001|Overall Study|Patient decision|7
1974637|NCT02476968|3536229|FG002|Overall Study|Patient decision|0
1974638|NCT02367040|3536241|FG000|Overall Study|Lost to Follow-up|1
1974639|NCT02367040|3536242|FG001|Overall Study|Lost to Follow-up|1
2212892|NCT01674062|3854198|FG001|Overall Study|Adverse Event|1
2212893|NCT01674062|3854197|FG000|Overall Study|Death|0
1974640|NCT02367040|3536241|FG000|Overall Study|Lack of Efficacy|1
1974641|NCT02367040|3536242|FG001|Overall Study|Lack of Efficacy|0
1974642|NCT02367040|3536241|FG000|Overall Study|Additional primary malignancy|0
1974643|NCT02367040|3536242|FG001|Overall Study|Additional primary malignancy|1
1974644|NCT02367040|3536241|FG000|Overall Study|AE not associated with clinical disease progression|104
1974645|NCT02367040|3536242|FG001|Overall Study|AE not associated with clinical disease progression|9
1974646|NCT02367040|3536241|FG000|Overall Study|AE associated with clinical disease progression|1
1974647|NCT02367040|3536242|FG001|Overall Study|AE associated with clinical disease progression|3
1974648|NCT02367040|3536241|FG000|Overall Study|Physician Decision|2
1974649|NCT02367040|3536242|FG001|Overall Study|Physician Decision|8
1974650|NCT02367040|3536241|FG000|Overall Study|Non-compliance with study drug|1
1974651|NCT02367040|3536242|FG001|Overall Study|Non-compliance with study drug|0
1974652|NCT02367040|3536241|FG000|Overall Study|Failure to meet continuation criteria|1
1974653|NCT02367040|3536242|FG001|Overall Study|Failure to meet continuation criteria|0
1974654|NCT02367040|3536241|FG000|Overall Study|Switching to other therapy|2
1974655|NCT02367040|3536242|FG001|Overall Study|Switching to other therapy|0
1974656|NCT02367040|3536241|FG000|Overall Study|Withdrawal by Subject|41
1974657|NCT02367040|3536242|FG001|Overall Study|Withdrawal by Subject|14
1974658|NCT02367040|3536241|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1
1974659|NCT02367040|3536242|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0
1974660|NCT02367040|3536241|FG000|Overall Study|Patient decision|35
1974661|NCT02367040|3536242|FG001|Overall Study|Patient decision|11
1974662|NCT02367040|3536241|FG000|Overall Study|Required procedure failed|1
1974663|NCT02367040|3536242|FG001|Overall Study|Required procedure failed|0
1974664|NCT02367040|3536241|FG000|Overall Study|Randomized by mistake with study treatment|1
1974665|NCT02367040|3536242|FG001|Overall Study|Randomized by mistake with study treatment|0
1974666|NCT02367040|3536241|FG000|Overall Study|Protocol Violation|1
1974667|NCT02367040|3536242|FG001|Overall Study|Protocol Violation|0
1974668|NCT02367040|3536241|FG000|Overall Study|Progressive disease - radiological progression|39
1974669|NCT02367040|3536242|FG001|Overall Study|Progressive disease - radiological progression|67
1974670|NCT02367040|3536241|FG000|Overall Study|Progressive disease - clinical progression|2
1974671|NCT02367040|3536242|FG001|Overall Study|Progressive disease - clinical progression|6
1974672|NCT02367040|3536241|FG000|Overall Study|Drug not administered|3
1974673|NCT02367040|3536242|FG001|Overall Study|Drug not administered|2
2022040|NCT00317473|3589985|FG000|Overall Study|Withdrawal by Subject|2
2022041|NCT00317473|3589986|FG001|Overall Study|Withdrawal by Subject|1
2022042|NCT00317473|3589987|FG002|Overall Study|Withdrawal by Subject|2
2022043|NCT00317473|3589988|FG003|Overall Study|Withdrawal by Subject|1
2022044|NCT00317473|3589989|FG004|Overall Study|Withdrawal by Subject|3
2022045|NCT00317473|3589990|FG005|Overall Study|Withdrawal by Subject|1
2022046|NCT00317473|3589985|FG000|Overall Study|Relocation|1
2022047|NCT00317473|3589986|FG001|Overall Study|Relocation|0
2022048|NCT00317473|3589987|FG002|Overall Study|Relocation|1
2022049|NCT00317473|3589988|FG003|Overall Study|Relocation|1
2022050|NCT00317473|3589989|FG004|Overall Study|Relocation|5
2022051|NCT00317473|3589990|FG005|Overall Study|Relocation|2
2022052|NCT00317473|3589985|FG000|Overall Study|Death|1
2022053|NCT00317473|3589986|FG001|Overall Study|Death|0
2022054|NCT00317473|3589987|FG002|Overall Study|Death|0
2022055|NCT00317473|3589988|FG003|Overall Study|Death|0
2022056|NCT00317473|3589989|FG004|Overall Study|Death|0
2022057|NCT00317473|3589990|FG005|Overall Study|Death|0
2022058|NCT00317473|3589985|FG000|Overall Study|Other|0
2022059|NCT00317473|3589986|FG001|Overall Study|Other|2
2022060|NCT00317473|3589987|FG002|Overall Study|Other|0
2022061|NCT00317473|3589988|FG003|Overall Study|Other|0
2022062|NCT00317473|3589989|FG004|Overall Study|Other|0
2022063|NCT00317473|3589990|FG005|Overall Study|Other|0
2022064|NCT00317603|3590014|FG000|Overall Study|Progressive Disease|3
2022065|NCT00317642|3590020|FG000|Overall Study|Not Received Either Study Drug|1
2022066|NCT00317642|3590021|FG001|Overall Study|Not Received Either Study Drug|3
2022067|NCT00317642|3590020|FG000|Overall Study|Physician Decision|15
2022068|NCT00317642|3590021|FG001|Overall Study|Physician Decision|7
2022069|NCT00317642|3590020|FG000|Overall Study|Participant declined treatment|14
2022070|NCT00317642|3590021|FG001|Overall Study|Participant declined treatment|3
2022071|NCT00317642|3590020|FG000|Overall Study|Adverse Event|17
2022072|NCT00317642|3590021|FG001|Overall Study|Adverse Event|5
2022073|NCT00317642|3590020|FG000|Overall Study|Treatment Failure|56
2022074|NCT00317642|3590021|FG001|Overall Study|Treatment Failure|102
2022075|NCT00317642|3590020|FG000|Overall Study|Disease Recurrence|1
2022076|NCT00317642|3590021|FG001|Overall Study|Disease Recurrence|2
2022077|NCT00317642|3590020|FG000|Overall Study|Death|14
2022078|NCT00317642|3590021|FG001|Overall Study|Death|7
2022079|NCT00317642|3590020|FG000|Overall Study|Not Continue to Consolidation|2
2022080|NCT00317642|3590021|FG001|Overall Study|Not Continue to Consolidation|0
2212894|NCT01674062|3854198|FG001|Overall Study|Death|1
2022081|NCT00317642|3590020|FG000|Overall Study|Withdrawal by Subject|0
2212895|NCT01674062|3854197|FG000|Overall Study|Programming Error|1
1974674|NCT02306122|3536255|FG000|Initial Physician Randomization|Physician Decision|0
1974675|NCT02306122|3536256|FG001|Initial Physician Randomization|Physician Decision|0
1974676|NCT02306122|3536257|FG002|Initial Physician Randomization|Physician Decision|0
1974677|NCT02306122|3536258|FG003|Initial Physician Randomization|Physician Decision|0
1974678|NCT02306122|3536259|FG004|Initial Physician Randomization|Physician Decision|0
1974679|NCT02306122|3536260|FG005|Initial Physician Randomization|Physician Decision|0
1974680|NCT02306122|3536261|FG006|Initial Physician Randomization|Physician Decision|0
1974681|NCT02306122|3536262|FG007|Initial Physician Randomization|Physician Decision|0
1974682|NCT02306122|3536263|FG008|Initial Physician Randomization|Physician Decision|1
1974683|NCT02306122|3536264|FG009|Initial Physician Randomization|Physician Decision|0
1974684|NCT02306122|3536265|FG010|Initial Physician Randomization|Physician Decision|0
1974685|NCT02178709|3536301|FG000|Overall Study|Adverse Event|5
1974686|NCT02178709|3536301|FG000|Overall Study|Death|2
1974687|NCT02178709|3536301|FG000|Overall Study|Withdrawal by Subject|2
1974688|NCT02178709|3536301|FG000|Overall Study|Physician Decision|2
1974689|NCT02178709|3536301|FG000|Overall Study|Disease Progression|5
1974690|NCT02147184|3536307|FG000|Overall Study|Lost to Follow-up|28
1974691|NCT02147184|3536308|FG001|Overall Study|Lost to Follow-up|15
1974692|NCT02147184|3536307|FG000|Overall Study|Study Burden|11
1974693|NCT02147184|3536308|FG001|Overall Study|Study Burden|7
1974694|NCT02147184|3536307|FG000|Overall Study|Pregnancy|6
1974695|NCT02147184|3536308|FG001|Overall Study|Pregnancy|0
1974696|NCT02147184|3536307|FG000|Overall Study|Moved out of state|3
1974697|NCT02147184|3536308|FG001|Overall Study|Moved out of state|3
1974698|NCT02147184|3536307|FG000|Overall Study|Physician Decision|0
1974699|NCT02147184|3536308|FG001|Overall Study|Physician Decision|2
1974700|NCT02147184|3536307|FG000|Overall Study|Other|1
1974701|NCT02147184|3536308|FG001|Overall Study|Other|0
1974702|NCT02075840|3536326|FG000|Overall Study|Withdrawal by Subject|13
1974703|NCT02075840|3536327|FG001|Overall Study|Withdrawal by Subject|22
1974704|NCT02075840|3536326|FG000|Overall Study|Reason not specified|1
1974705|NCT02075840|3536327|FG001|Overall Study|Reason not specified|0
1974706|NCT02075840|3536326|FG000|Overall Study|Adverse Event|0
1974707|NCT02075840|3536327|FG001|Overall Study|Adverse Event|2
1974708|NCT02075840|3536326|FG000|Overall Study|Death|35
1974709|NCT02075840|3536327|FG001|Overall Study|Death|40
1974710|NCT02075840|3536326|FG000|Overall Study|Lost to Follow-up|3
1974711|NCT02075840|3536327|FG001|Overall Study|Lost to Follow-up|2
1974712|NCT02075840|3536326|FG000|Overall Study|Physician Decision|1
1974713|NCT02075840|3536327|FG001|Overall Study|Physician Decision|3
1974714|NCT02075840|3536326|FG000|Overall Study|Ongoing at CCOD|99
1974715|NCT02075840|3536327|FG001|Overall Study|Ongoing at CCOD|82
1974716|NCT02000219|3536342|FG000|14-Week Study Period|Physician Decision|1
1974717|NCT02000219|3536342|FG000|14-Week Study Period|Adverse Event|1
1974718|NCT02000219|3536342|FG000|14-Week Study Period|Underwent transplantation|1
1974719|NCT02000219|3536342|FG000|Continuation Period|Withdrawal by Subject|1
1974720|NCT02000219|3536342|FG000|Continuation Period|Had liver transplant|2
1974721|NCT02000219|3536342|FG000|Continuation Period|Non-compliance with study drug|2
1974722|NCT01978938|3536348|FG000|Overall Study|Lost to Follow-up|12
1974723|NCT01978938|3536349|FG001|Overall Study|Lost to Follow-up|6
1974724|NCT01978938|3536348|FG000|Overall Study|Withdrawal by Subject|8
1974725|NCT01978938|3536349|FG001|Overall Study|Withdrawal by Subject|4
1974726|NCT01978938|3536348|FG000|Overall Study|Adverse Event, non-fatal|2
1974727|NCT01978938|3536349|FG001|Overall Study|Adverse Event, non-fatal|1
1974728|NCT01978938|3536348|FG000|Overall Study|Participant noncompliance|1
1974729|NCT01978938|3536349|FG001|Overall Study|Participant noncompliance|1
1974730|NCT01978938|3536348|FG000|Overall Study|Did not meet inclusion criteria|0
1974731|NCT01978938|3536349|FG001|Overall Study|Did not meet inclusion criteria|1
1974732|NCT01978938|3536348|FG000|Overall Study|Previously scheduled procedure|0
1974733|NCT01978938|3536349|FG001|Overall Study|Previously scheduled procedure|1
1974734|NCT01854385|3536355|FG000|Pre-Treatment|Withdrawal by Subject|4
1974735|NCT01854385|3536355|FG000|Pre-Treatment|Did not meet criteria based on headache number|15
1974736|NCT01854385|3536355|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3
1974737|NCT01854385|3536355|FG000|Pre-Treatment|Unable to come for study visits|1
1974738|NCT01854385|3536355|FG000|Treatment|Lost to Follow-up|1
1974739|NCT01844856|3536361|FG000|Overall Study|Lost to Follow-up|15
1974740|NCT01844856|3536362|FG001|Overall Study|Lost to Follow-up|3
1974741|NCT01844856|3536361|FG000|Overall Study|Adverse Event|3
1974742|NCT01844856|3536362|FG001|Overall Study|Adverse Event|6
1974743|NCT01844856|3536361|FG000|Overall Study|Withdrawal by Subject|3
1974744|NCT01844856|3536362|FG001|Overall Study|Withdrawal by Subject|2
1974745|NCT01844856|3536361|FG000|Overall Study|Noncompliance|2
1974746|NCT01844856|3536362|FG001|Overall Study|Noncompliance|3
1974747|NCT01844856|3536361|FG000|Overall Study|Enterococcus Resistant|0
1974748|NCT01844856|3536362|FG001|Overall Study|Enterococcus Resistant|1
1974749|NCT01844856|3536361|FG000|Overall Study|Inadvertently Not Scheduled|1
1974750|NCT01844856|3536362|FG001|Overall Study|Inadvertently Not Scheduled|0
1974751|NCT01844856|3536361|FG000|Overall Study|Randomized but was a Screen Failure|0
1974752|NCT01844856|3536362|FG001|Overall Study|Randomized but was a Screen Failure|1
1974753|NCT01712789|3536426|FG000|Overall Study|Lack of Efficacy|2
1974754|NCT01712789|3536426|FG000|Overall Study|Lost to Follow-up|1
1974755|NCT01712789|3536426|FG000|Overall Study|Progressive Disease|504
1974756|NCT01712789|3536426|FG000|Overall Study|Death|57
1974757|NCT01712789|3536426|FG000|Overall Study|Adverse Event|52
1974758|NCT01712789|3536426|FG000|Overall Study|Miscellaneous|31
1974759|NCT01712789|3536426|FG000|Overall Study|Withdrawal by Subject|21
1974760|NCT01712789|3536426|FG000|Overall Study|Transition to Commercial Treatment|8
1974761|NCT01712789|3536426|FG000|Overall Study|Participants Did Not Receive Study Drug|6
1974762|NCT01660451|3536433|FG000|Overall Study|Protocol Violation|0
1974763|NCT01660451|3536434|FG001|Overall Study|Protocol Violation|1
1974764|NCT01660451|3536435|FG002|Overall Study|Protocol Violation|1
1974765|NCT01660451|3536433|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11
1974766|NCT01660451|3536434|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8
1974767|NCT01660451|3536435|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26
1974768|NCT01660451|3536433|FG000|Overall Study|AE with Clinical PD|1
1974769|NCT01660451|3536434|FG001|Overall Study|AE with Clinical PD|3
1974770|NCT01660451|3536435|FG002|Overall Study|AE with Clinical PD|9
1974771|NCT01660451|3536433|FG000|Overall Study|Sponsor Decision|0
1974772|NCT01660451|3536434|FG001|Overall Study|Sponsor Decision|0
1974773|NCT01660451|3536435|FG002|Overall Study|Sponsor Decision|1
1974774|NCT01660451|3536433|FG000|Overall Study|Protocol Deviation|0
1974775|NCT01660451|3536434|FG001|Overall Study|Protocol Deviation|0
1974776|NCT01660451|3536435|FG002|Overall Study|Protocol Deviation|1
1974777|NCT01660451|3536433|FG000|Overall Study|Physician Decision|1
1974778|NCT01660451|3536434|FG001|Overall Study|Physician Decision|2
1974779|NCT01660451|3536435|FG002|Overall Study|Physician Decision|5
1974780|NCT01660451|3536433|FG000|Overall Study|Withdrawal by Subject|1
1974781|NCT01660451|3536434|FG001|Overall Study|Withdrawal by Subject|0
1974782|NCT01660451|3536435|FG002|Overall Study|Withdrawal by Subject|16
1974783|NCT01660451|3536433|FG000|Overall Study|Ongoing with treatment|3
1974784|NCT01660451|3536434|FG001|Overall Study|Ongoing with treatment|3
1974785|NCT01660451|3536435|FG002|Overall Study|Ongoing with treatment|46
1974786|NCT01651403|3536446|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
1974787|NCT01651403|3536447|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
1974788|NCT01651403|3536446|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
1974789|NCT01651403|3536447|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
1974790|NCT01651403|3536446|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0
1974791|NCT01651403|3536447|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1
1974792|NCT01651403|3536446|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13
1974793|NCT01651403|3536447|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9
1974794|NCT01651403|3536446|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2
1974795|NCT01651403|3536447|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1
1974796|NCT01651403|3536446|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6
1974797|NCT01651403|3536447|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4
1974798|NCT01542736|3536462|FG000|Overall Study|Death|1
2022082|NCT00317642|3590021|FG001|Overall Study|Withdrawal by Subject|1
2022083|NCT00317642|3590020|FG000|Overall Study|Referred For Transplantation|1
2022084|NCT00317642|3590021|FG001|Overall Study|Referred For Transplantation|0
2022085|NCT00317642|3590020|FG000|Overall Study|AML Not Centrally Confirmed|1
2022086|NCT00317642|3590021|FG001|Overall Study|AML Not Centrally Confirmed|5
2022087|NCT00318149|3590062|FG000|Overall Study|Adverse Event|0
2022088|NCT00318149|3590063|FG001|Overall Study|Adverse Event|0
2022089|NCT00318149|3590064|FG002|Overall Study|Adverse Event|0
2022090|NCT00318149|3590065|FG003|Overall Study|Adverse Event|0
2022091|NCT00318149|3590066|FG004|Overall Study|Adverse Event|0
2022092|NCT00318149|3590067|FG005|Overall Study|Adverse Event|2
2022093|NCT00318370|3590101|FG000|Period 1|Lack of Efficacy|5
2022094|NCT00318370|3590102|FG001|Period 1|Lack of Efficacy|0
2022095|NCT00318370|3590103|FG002|Period 1|Lack of Efficacy|0
2022096|NCT00318370|3590101|FG000|Period 1|Physician Decision|1
2022097|NCT00318370|3590102|FG001|Period 1|Physician Decision|0
2022098|NCT00318370|3590103|FG002|Period 1|Physician Decision|0
2022099|NCT00318370|3590101|FG000|Period 1|Withdrawal by Subject|1
2022100|NCT00318370|3590102|FG001|Period 1|Withdrawal by Subject|0
2022101|NCT00318370|3590103|FG002|Period 1|Withdrawal by Subject|0
2022102|NCT00318370|3590101|FG000|Period 2|Adverse Event|0
2022103|NCT00318370|3590102|FG001|Period 2|Adverse Event|3
2022104|NCT00318370|3590103|FG002|Period 2|Adverse Event|0
2022105|NCT00318370|3590101|FG000|Period 2|Lack of Efficacy|0
2022106|NCT00318370|3590102|FG001|Period 2|Lack of Efficacy|5
2022107|NCT00318370|3590103|FG002|Period 2|Lack of Efficacy|0
2022108|NCT00318370|3590101|FG000|Period 2|Physician Decision|0
2022109|NCT00318370|3590102|FG001|Period 2|Physician Decision|1
2310329|NCT02731755|4014358|FG001|First Intervention|Withdrawal by Subject|2
2310330|NCT02732015|4014384|FG000|Overall Study|Lost to Follow-up|0
2310331|NCT02732015|4014385|FG001|Overall Study|Lost to Follow-up|1
2310332|NCT02732119|4014396|FG000|Phase I|Adverse Event|1
2022110|NCT00318370|3590103|FG002|Period 2|Physician Decision|0
2022111|NCT00318370|3590101|FG000|Period 2|Withdrawal by Subject|0
2022112|NCT00318370|3590102|FG001|Period 2|Withdrawal by Subject|1
2022113|NCT00318370|3590103|FG002|Period 2|Withdrawal by Subject|0
2022114|NCT00318370|3590101|FG000|Period 2|Other|0
2022115|NCT00318370|3590102|FG001|Period 2|Other|1
2022116|NCT00318370|3590103|FG002|Period 2|Other|0
2022117|NCT00318370|3590101|FG000|Period 3|Adverse Event|0
1974799|NCT01535807|3536468|FG000|Overall Study|Withdrawal by Subject|1
1974800|NCT01535807|3536469|FG001|Overall Study|Withdrawal by Subject|1
1974801|NCT01535807|3536468|FG000|Overall Study|Data collection error|1
1974802|NCT01535807|3536469|FG001|Overall Study|Data collection error|1
1974803|NCT01147666|3536490|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1
1974804|NCT01147666|3536491|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1
1974805|NCT01147666|3536492|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1
1974806|NCT01147666|3536493|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1974807|NCT01147666|3536494|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1974808|NCT01147666|3536495|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1974809|NCT01147666|3536496|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1974810|NCT01147666|3536497|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1974811|NCT01147666|3536498|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1974812|NCT01147666|3536499|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1974813|NCT01147666|3536500|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1974814|NCT01147666|3536501|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1974815|NCT01147666|3536502|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1
1974816|NCT01147666|3536503|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1974817|NCT01147666|3536504|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0
1974818|NCT01147666|3536490|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1974819|NCT01147666|3536491|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
1974820|NCT01147666|3536492|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1974821|NCT01147666|3536493|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1974822|NCT01147666|3536494|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
1974823|NCT01147666|3536495|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
1974824|NCT01147666|3536496|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
1974825|NCT01147666|3536497|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
1974826|NCT01147666|3536498|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1974827|NCT01147666|3536499|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
1974828|NCT01147666|3536500|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1974829|NCT01147666|3536501|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1974830|NCT01147666|3536502|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
1974831|NCT01147666|3536503|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
1974832|NCT01147666|3536504|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
1974833|NCT01147666|3536490|FG000|Dosing Period 1: 6-Week Treatment|Death|0
1974834|NCT01147666|3536491|FG001|Dosing Period 1: 6-Week Treatment|Death|0
1974835|NCT01147666|3536492|FG002|Dosing Period 1: 6-Week Treatment|Death|0
1974836|NCT01147666|3536493|FG003|Dosing Period 1: 6-Week Treatment|Death|0
1974837|NCT01147666|3536494|FG004|Dosing Period 1: 6-Week Treatment|Death|1
1974838|NCT01147666|3536495|FG005|Dosing Period 1: 6-Week Treatment|Death|1
1974839|NCT01147666|3536496|FG006|Dosing Period 1: 6-Week Treatment|Death|1
1974840|NCT01147666|3536497|FG007|Dosing Period 1: 6-Week Treatment|Death|0
1974841|NCT01147666|3536498|FG008|Dosing Period 1: 6-Week Treatment|Death|0
1974842|NCT01147666|3536499|FG009|Dosing Period 1: 6-Week Treatment|Death|0
1974843|NCT01147666|3536500|FG010|Dosing Period 1: 6-Week Treatment|Death|0
1974844|NCT01147666|3536501|FG011|Dosing Period 1: 6-Week Treatment|Death|0
1974845|NCT01147666|3536502|FG012|Dosing Period 1: 6-Week Treatment|Death|1
1974846|NCT01147666|3536503|FG013|Dosing Period 1: 6-Week Treatment|Death|0
1974847|NCT01147666|3536504|FG014|Dosing Period 1: 6-Week Treatment|Death|0
1974848|NCT01147666|3536490|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
1974849|NCT01147666|3536491|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974850|NCT01147666|3536492|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974851|NCT01147666|3536493|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
1974852|NCT01147666|3536494|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974853|NCT01147666|3536495|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974854|NCT01147666|3536496|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974855|NCT01147666|3536497|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974856|NCT01147666|3536498|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974857|NCT01147666|3536499|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974858|NCT01147666|3536500|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
1974859|NCT01147666|3536501|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974860|NCT01147666|3536502|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974861|NCT01147666|3536503|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974862|NCT01147666|3536504|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
1974863|NCT01147666|3536490|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1974864|NCT01147666|3536491|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1974865|NCT01147666|3536492|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1974866|NCT01147666|3536493|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1974867|NCT01147666|3536494|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1974868|NCT01147666|3536495|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1974869|NCT01147666|3536496|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1974870|NCT01147666|3536497|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1974871|NCT01147666|3536498|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1974872|NCT01147666|3536499|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1974873|NCT01147666|3536500|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1974874|NCT01147666|3536501|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1974875|NCT01147666|3536502|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1974876|NCT01147666|3536503|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
1974877|NCT01147666|3536504|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
1974878|NCT01147666|3536490|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974879|NCT01147666|3536491|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974880|NCT01147666|3536492|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974881|NCT01147666|3536493|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1
1974882|NCT01147666|3536494|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974883|NCT01147666|3536495|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974884|NCT01147666|3536496|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974885|NCT01147666|3536497|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974886|NCT01147666|3536498|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974887|NCT01147666|3536499|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974888|NCT01147666|3536500|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2
1974889|NCT01147666|3536501|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974890|NCT01147666|3536502|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974891|NCT01147666|3536503|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974892|NCT01147666|3536504|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0
1974893|NCT01147666|3536490|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974894|NCT01147666|3536491|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974895|NCT01147666|3536492|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974896|NCT01147666|3536493|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974897|NCT01147666|3536494|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974898|NCT01147666|3536495|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974899|NCT01147666|3536496|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974900|NCT01147666|3536497|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974901|NCT01147666|3536498|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974902|NCT01147666|3536499|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974903|NCT01147666|3536500|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974904|NCT01147666|3536501|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
1974905|NCT01147666|3536502|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
1974906|NCT01147666|3536503|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
1974907|NCT01147666|3536504|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
1974908|NCT01147666|3536490|FG000|Dosing Period 2: 19-Week Treatment|Death|0
1974909|NCT01147666|3536491|FG001|Dosing Period 2: 19-Week Treatment|Death|0
1974910|NCT01147666|3536492|FG002|Dosing Period 2: 19-Week Treatment|Death|0
1974911|NCT01147666|3536493|FG003|Dosing Period 2: 19-Week Treatment|Death|0
1974912|NCT01147666|3536494|FG004|Dosing Period 2: 19-Week Treatment|Death|1
1974913|NCT01147666|3536495|FG005|Dosing Period 2: 19-Week Treatment|Death|1
1974914|NCT01147666|3536496|FG006|Dosing Period 2: 19-Week Treatment|Death|1
1974915|NCT01147666|3536497|FG007|Dosing Period 2: 19-Week Treatment|Death|0
1974916|NCT01147666|3536498|FG008|Dosing Period 2: 19-Week Treatment|Death|0
1974917|NCT01147666|3536499|FG009|Dosing Period 2: 19-Week Treatment|Death|0
1974918|NCT01147666|3536500|FG010|Dosing Period 2: 19-Week Treatment|Death|0
1974919|NCT01147666|3536501|FG011|Dosing Period 2: 19-Week Treatment|Death|0
1974920|NCT01147666|3536502|FG012|Dosing Period 2: 19-Week Treatment|Death|1
1974921|NCT01147666|3536503|FG013|Dosing Period 2: 19-Week Treatment|Death|0
1974922|NCT01147666|3536504|FG014|Dosing Period 2: 19-Week Treatment|Death|0
1974923|NCT01147666|3536490|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1974924|NCT01147666|3536491|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1974925|NCT01147666|3536492|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1974926|NCT01147666|3536493|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1974927|NCT01147666|3536494|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3
1974928|NCT01147666|3536495|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
1974929|NCT01147666|3536496|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
1974930|NCT01147666|3536497|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
1974931|NCT01147666|3536498|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1974932|NCT01147666|3536499|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
1974933|NCT01147666|3536500|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1974934|NCT01147666|3536501|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1974935|NCT01147666|3536502|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
1974936|NCT01147666|3536503|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
1974937|NCT01147666|3536504|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
1974938|NCT01147666|3536490|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974939|NCT01147666|3536491|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974940|NCT01147666|3536492|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974941|NCT01147666|3536493|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1
1974942|NCT01147666|3536494|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974943|NCT01147666|3536495|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974944|NCT01147666|3536496|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974945|NCT01147666|3536497|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974946|NCT01147666|3536498|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974947|NCT01147666|3536499|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974948|NCT01147666|3536500|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974949|NCT01147666|3536501|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974950|NCT01147666|3536502|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974951|NCT01147666|3536503|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974952|NCT01147666|3536504|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
1974953|NCT01147666|3536490|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1974954|NCT01147666|3536491|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1974955|NCT01147666|3536492|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1974956|NCT01147666|3536493|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1974957|NCT01147666|3536494|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
1974958|NCT01147666|3536495|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
1974959|NCT01147666|3536496|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1974960|NCT01147666|3536497|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
1974961|NCT01147666|3536498|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1974962|NCT01147666|3536499|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
1974963|NCT01147666|3536500|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1974964|NCT01147666|3536501|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1974965|NCT01147666|3536502|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1974966|NCT01147666|3536503|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
1974967|NCT01147666|3536504|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
1974968|NCT01147666|3536490|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974969|NCT01147666|3536491|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974970|NCT01147666|3536492|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974971|NCT01147666|3536493|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1
1974972|NCT01147666|3536494|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974973|NCT01147666|3536495|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974974|NCT01147666|3536496|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974975|NCT01147666|3536497|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974976|NCT01147666|3536498|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974977|NCT01147666|3536499|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974978|NCT01147666|3536500|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2
1974979|NCT01147666|3536501|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974980|NCT01147666|3536502|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974981|NCT01147666|3536503|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974982|NCT01147666|3536504|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0
1974983|NCT01147666|3536490|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974984|NCT01147666|3536491|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974985|NCT01147666|3536492|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974986|NCT01147666|3536493|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974987|NCT01147666|3536494|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974988|NCT01147666|3536495|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974989|NCT01147666|3536496|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974990|NCT01147666|3536497|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974991|NCT01147666|3536498|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974992|NCT01147666|3536499|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974993|NCT01147666|3536500|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974994|NCT01147666|3536501|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974995|NCT01147666|3536502|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1
1974996|NCT01147666|3536503|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974997|NCT01147666|3536504|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0
1974998|NCT01147666|3536490|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1974999|NCT01147666|3536491|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975000|NCT01147666|3536492|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975001|NCT01147666|3536493|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975002|NCT01147666|3536494|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975003|NCT01147666|3536495|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975004|NCT01147666|3536496|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975005|NCT01147666|3536497|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975006|NCT01147666|3536498|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975007|NCT01147666|3536499|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975008|NCT01147666|3536500|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975009|NCT01147666|3536501|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975010|NCT01147666|3536502|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
1975011|NCT01147666|3536503|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
1975012|NCT01147666|3536504|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
1975013|NCT01065454|3536570|FG000|Treatment|Adverse Event|7
1975014|NCT01065454|3536571|FG001|Treatment|Adverse Event|4
1975015|NCT01065454|3536572|FG002|Treatment|Adverse Event|3
1975016|NCT01065454|3536573|FG003|Treatment|Adverse Event|6
1975017|NCT01065454|3536570|FG000|Treatment|Death|1
1975018|NCT01065454|3536571|FG001|Treatment|Death|0
1975019|NCT01065454|3536572|FG002|Treatment|Death|0
1975020|NCT01065454|3536573|FG003|Treatment|Death|0
1975021|NCT01065454|3536570|FG000|Treatment|Non-compliance|1
1975022|NCT01065454|3536571|FG001|Treatment|Non-compliance|0
1975023|NCT01065454|3536572|FG002|Treatment|Non-compliance|0
1975024|NCT01065454|3536573|FG003|Treatment|Non-compliance|1
1975025|NCT01065454|3536570|FG000|Treatment|Protocol Decision|0
1975026|NCT01065454|3536571|FG001|Treatment|Protocol Decision|0
1975027|NCT01065454|3536572|FG002|Treatment|Protocol Decision|3
1975028|NCT01065454|3536573|FG003|Treatment|Protocol Decision|2
1975029|NCT01065454|3536570|FG000|Treatment|Protocol Violation|1
1975030|NCT01065454|3536571|FG001|Treatment|Protocol Violation|0
1975031|NCT01065454|3536572|FG002|Treatment|Protocol Violation|1
1975032|NCT01065454|3536573|FG003|Treatment|Protocol Violation|0
1975033|NCT01065454|3536570|FG000|Treatment|Withdrawal by Subject|3
1975034|NCT01065454|3536571|FG001|Treatment|Withdrawal by Subject|1
1975035|NCT01065454|3536572|FG002|Treatment|Withdrawal by Subject|2
1975036|NCT01065454|3536573|FG003|Treatment|Withdrawal by Subject|3
1975037|NCT01065454|3536570|FG000|Follow up|Adverse Event|1
1975038|NCT01065454|3536571|FG001|Follow up|Adverse Event|0
1975039|NCT01065454|3536572|FG002|Follow up|Adverse Event|0
1975040|NCT01065454|3536573|FG003|Follow up|Adverse Event|1
1975041|NCT01065454|3536570|FG000|Follow up|Death|0
1975042|NCT01065454|3536571|FG001|Follow up|Death|1
1975043|NCT01065454|3536572|FG002|Follow up|Death|1
1975044|NCT01065454|3536573|FG003|Follow up|Death|0
1975045|NCT01065454|3536570|FG000|Follow up|Lost to Follow-up|0
1975046|NCT01065454|3536571|FG001|Follow up|Lost to Follow-up|0
1975047|NCT01065454|3536572|FG002|Follow up|Lost to Follow-up|0
1975048|NCT01065454|3536573|FG003|Follow up|Lost to Follow-up|1
1975049|NCT01065454|3536570|FG000|Follow up|Progressive disease|0
1975050|NCT01065454|3536571|FG001|Follow up|Progressive disease|0
1975051|NCT01065454|3536572|FG002|Follow up|Progressive disease|0
1975052|NCT01065454|3536573|FG003|Follow up|Progressive disease|1
1975053|NCT01065454|3536570|FG000|Follow up|Withdrawal by Subject|1
1975054|NCT01065454|3536571|FG001|Follow up|Withdrawal by Subject|1
1975055|NCT01065454|3536572|FG002|Follow up|Withdrawal by Subject|1
1975056|NCT01065454|3536573|FG003|Follow up|Withdrawal by Subject|0
1975057|NCT01065454|3536570|FG000|Follow up|study ongoing|37
1975058|NCT01065454|3536571|FG001|Follow up|study ongoing|22
1975059|NCT01065454|3536572|FG002|Follow up|study ongoing|15
1975060|NCT01065454|3536573|FG003|Follow up|study ongoing|41
1975061|NCT00982111|3536585|FG000|Overall Study|Adverse Event|1
1975062|NCT00982111|3536586|FG001|Overall Study|Adverse Event|1
1975063|NCT00982111|3536585|FG000|Overall Study|Progressive Disease|46
1975064|NCT00982111|3536586|FG001|Overall Study|Progressive Disease|39
1975065|NCT00982111|3536585|FG000|Overall Study|Lost to Follow-up|9
1975066|NCT00982111|3536586|FG001|Overall Study|Lost to Follow-up|6
1975067|NCT00982111|3536585|FG000|Overall Study|New Anti-Cancer Therapy|5
1975068|NCT00982111|3536586|FG001|Overall Study|New Anti-Cancer Therapy|5
1975069|NCT00982111|3536585|FG000|Overall Study|Medical Decision|1
1975070|NCT00982111|3536586|FG001|Overall Study|Medical Decision|0
1975071|NCT00982111|3536585|FG000|Overall Study|Withdrawal by Subject|17
1975072|NCT00982111|3536586|FG001|Overall Study|Withdrawal by Subject|19
1975073|NCT00982111|3536585|FG000|Overall Study|Global Study End|0
1975074|NCT00982111|3536586|FG001|Overall Study|Global Study End|1
1975075|NCT00982111|3536585|FG000|Overall Study|Sponsor's Decision|0
1975076|NCT00982111|3536586|FG001|Overall Study|Sponsor's Decision|1
1975077|NCT00116142|3536600|FG000|Overall Study|Adverse Event|8
1975078|NCT00116142|3536601|FG001|Overall Study|Adverse Event|7
1975079|NCT00116142|3536600|FG000|Overall Study|Protocol Violation|2
1975080|NCT00116142|3536601|FG001|Overall Study|Protocol Violation|1
1975081|NCT00116142|3536600|FG000|Overall Study|Withdrawal by Subject|5
1975082|NCT00116142|3536601|FG001|Overall Study|Withdrawal by Subject|5
1975083|NCT00116142|3536600|FG000|Overall Study|Physician Decision|3
1975084|NCT00116142|3536601|FG001|Overall Study|Physician Decision|1
1975085|NCT00116142|3536600|FG000|Overall Study|Delayed Radiation Therapy|1
1975086|NCT00116142|3536601|FG001|Overall Study|Delayed Radiation Therapy|0
1975087|NCT00116142|3536600|FG000|Overall Study|Patient could not tolerate docetaxel|0
1975088|NCT00116142|3536601|FG001|Overall Study|Patient could not tolerate docetaxel|2
1975089|NCT00116142|3536600|FG000|Overall Study|Patient stopped due to depression|0
1975090|NCT00116142|3536601|FG001|Overall Study|Patient stopped due to depression|1
1975091|NCT00116142|3536600|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0
1975092|NCT00116142|3536601|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1
1975093|NCT00116142|3536600|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0
1975094|NCT00116142|3536601|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1
1975095|NCT00116142|3536600|FG000|Overall Study|Patient didn't start due to low platelet counts|0
1975096|NCT00116142|3536601|FG001|Overall Study|Patient didn't start due to low platelet counts|1
1975097|NCT00070018|3536610|FG000|Overall Study|Adverse Event|2
1975098|NCT00070018|3536610|FG000|Overall Study|Lack of Efficacy|1
1975099|NCT00070018|3536610|FG000|Overall Study|Withdrawal by Subject|1
2022118|NCT00318370|3590102|FG001|Period 3|Adverse Event|0
2212896|NCT01674062|3854198|FG001|Overall Study|Programming Error|0
2212897|NCT01674569|3854213|FG000|Overall Study|Adverse Event|0
2212898|NCT01674569|3854214|FG001|Overall Study|Adverse Event|2
2212899|NCT01674569|3854215|FG002|Overall Study|Adverse Event|0
2212900|NCT01674569|3854216|FG003|Overall Study|Adverse Event|1
2022119|NCT00318370|3590103|FG002|Period 3|Adverse Event|1
2022120|NCT00318370|3590101|FG000|Period 3|Lack of Efficacy|0
2022121|NCT00318370|3590102|FG001|Period 3|Lack of Efficacy|0
2022122|NCT00318370|3590103|FG002|Period 3|Lack of Efficacy|24
2022123|NCT00318370|3590101|FG000|Period 3|Death|0
2022124|NCT00318370|3590102|FG001|Period 3|Death|0
2022125|NCT00318370|3590103|FG002|Period 3|Death|1
2022126|NCT00318370|3590101|FG000|Period 3|Physician Decision|0
2022127|NCT00318370|3590102|FG001|Period 3|Physician Decision|0
2022128|NCT00318370|3590103|FG002|Period 3|Physician Decision|1
2022129|NCT00318370|3590101|FG000|Period 3|Withdrawal by Subject|0
2022130|NCT00318370|3590102|FG001|Period 3|Withdrawal by Subject|0
2022131|NCT00318370|3590103|FG002|Period 3|Withdrawal by Subject|3
2022132|NCT00318370|3590101|FG000|Period 3|Other|0
2022133|NCT00318370|3590102|FG001|Period 3|Other|0
2022134|NCT00318370|3590103|FG002|Period 3|Other|3
2022135|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Adverse Event|11
2022136|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Adverse Event|23
2022137|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Adverse Event|29
2022138|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Adverse Event|2
2022139|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Adverse Event|8
2022140|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Lack of Efficacy|19
2022141|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Lack of Efficacy|8
2022142|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Lack of Efficacy|13
2022143|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Lack of Efficacy|29
2022144|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Lack of Efficacy|9
2022145|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Protocol Violation|2
2022146|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Protocol Violation|4
2022147|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Protocol Violation|4
2022148|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Protocol Violation|4
2022149|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Protocol Violation|5
2022150|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Lost to follow up|0
2022151|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Lost to follow up|1
2022152|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Lost to follow up|0
2022153|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Lost to follow up|0
2022154|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Lost to follow up|0
2022155|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
2022156|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
2022157|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
2022158|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
2022159|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
2022160|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Consent withdrawn|0
2022161|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Consent withdrawn|3
2022162|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Consent withdrawn|4
2022163|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Consent withdrawn|10
2022164|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Consent withdrawn|4
2022165|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0
2022166|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2
2022167|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1
2022168|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0
2022169|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2
2022170|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Move|0
2022171|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Move|1
2022172|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Move|0
2022173|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Move|0
2022174|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Move|0
2022175|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
2022176|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
2022177|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
2022178|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
2022179|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
2022180|NCT00318461|3590124|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1
2022181|NCT00318461|3590125|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0
2022182|NCT00318461|3590126|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0
2022183|NCT00318461|3590127|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2
2212901|NCT01674569|3854217|FG004|Overall Study|Adverse Event|2
2022184|NCT00318461|3590128|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0
2022185|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Work commitment|0
2022186|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Work commitment|0
2022187|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Work commitment|0
2022188|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Work commitment|0
2022189|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Work commitment|1
1975100|NCT04447287|3536623|FG000|Period 1: Run-in Period|Adverse Event|3
1975101|NCT04447287|3536624|FG001|Period 1: Run-in Period|Adverse Event|0
1975102|NCT04447287|3536625|FG002|Period 1: Run-in Period|Adverse Event|0
1975103|NCT04447287|3536623|FG000|Period 1: Run-in Period|Withdrawal by Subject|1
1975104|NCT04447287|3536624|FG001|Period 1: Run-in Period|Withdrawal by Subject|0
1975105|NCT04447287|3536625|FG002|Period 1: Run-in Period|Withdrawal by Subject|0
1975106|NCT04447287|3536623|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1
1975107|NCT04447287|3536624|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
1975108|NCT04447287|3536625|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
1975109|NCT04039503|3536681|FG000|Overall Study|Adverse Event|3
1975110|NCT04039503|3536682|FG001|Overall Study|Adverse Event|0
1975111|NCT04039503|3536683|FG002|Overall Study|Adverse Event|2
1975112|NCT04039503|3536684|FG003|Overall Study|Adverse Event|0
1975113|NCT04039503|3536681|FG000|Overall Study|Lost to Follow-up|0
1975114|NCT04039503|3536682|FG001|Overall Study|Lost to Follow-up|0
1975115|NCT04039503|3536683|FG002|Overall Study|Lost to Follow-up|1
1975116|NCT04039503|3536684|FG003|Overall Study|Lost to Follow-up|0
1975117|NCT04039503|3536681|FG000|Overall Study|Protocol Violation|0
1975118|NCT04039503|3536682|FG001|Overall Study|Protocol Violation|1
1975119|NCT04039503|3536683|FG002|Overall Study|Protocol Violation|2
1975120|NCT04039503|3536684|FG003|Overall Study|Protocol Violation|1
1975121|NCT04039503|3536681|FG000|Overall Study|Withdrawal by Subject|4
1975122|NCT04039503|3536682|FG001|Overall Study|Withdrawal by Subject|3
1975123|NCT04039503|3536683|FG002|Overall Study|Withdrawal by Subject|5
1975124|NCT04039503|3536684|FG003|Overall Study|Withdrawal by Subject|2
1975125|NCT03695172|3536702|FG000|Overall Study|Withdrawal by Subject|1
1975126|NCT03695172|3536703|FG001|Overall Study|Withdrawal by Subject|1
1975127|NCT03695172|3536704|FG002|Overall Study|Withdrawal by Subject|0
1975128|NCT03394027|3536732|FG000|Overall Study|Ineligible|3
1975129|NCT03394027|3536733|FG001|Overall Study|Ineligible|1
1975130|NCT03394027|3536734|FG002|Overall Study|Ineligible|3
1975131|NCT03394027|3536732|FG000|Overall Study|Participant declined to participate before treatment started|0
1975132|NCT03394027|3536733|FG001|Overall Study|Participant declined to participate before treatment started|0
1975133|NCT03394027|3536734|FG002|Overall Study|Participant declined to participate before treatment started|1
1975134|NCT03357952|3536762|FG000|Overall Study|Withdrawal by Subject|0
1975135|NCT03357952|3536763|FG001|Overall Study|Withdrawal by Subject|1
1975136|NCT03357952|3536762|FG000|Overall Study|Sponsor Decision|9
1975137|NCT03357952|3536763|FG001|Overall Study|Sponsor Decision|0
1975138|NCT03170869|3536782|FG000|Overall Study|Protocol Violation|5
2212902|NCT01674569|3854218|FG005|Overall Study|Adverse Event|2
2212903|NCT01674569|3854213|FG000|Overall Study|Protocol Violation|0
2212904|NCT01674569|3854214|FG001|Overall Study|Protocol Violation|1
2212905|NCT01674569|3854215|FG002|Overall Study|Protocol Violation|1
2212906|NCT01674569|3854216|FG003|Overall Study|Protocol Violation|0
2212907|NCT01674569|3854217|FG004|Overall Study|Protocol Violation|0
2212908|NCT01674569|3854218|FG005|Overall Study|Protocol Violation|0
2212909|NCT01674569|3854213|FG000|Overall Study|Withdrawal by Subject|0
2212910|NCT01674569|3854214|FG001|Overall Study|Withdrawal by Subject|0
2212911|NCT01674569|3854215|FG002|Overall Study|Withdrawal by Subject|1
2212912|NCT01674569|3854216|FG003|Overall Study|Withdrawal by Subject|0
2212913|NCT01674569|3854217|FG004|Overall Study|Withdrawal by Subject|0
2212914|NCT01674569|3854218|FG005|Overall Study|Withdrawal by Subject|0
2212915|NCT01674621|3854227|FG000|Overall Study|Adverse Event|3
2212916|NCT01674621|3854228|FG001|Overall Study|Adverse Event|2
2212917|NCT01674621|3854229|FG002|Overall Study|Adverse Event|5
2212918|NCT01674621|3854230|FG003|Overall Study|Adverse Event|5
2212919|NCT01674621|3854231|FG004|Overall Study|Adverse Event|1
2212920|NCT01674621|3854227|FG000|Overall Study|Inability to Complete Study Procedures|0
2212921|NCT01674621|3854228|FG001|Overall Study|Inability to Complete Study Procedures|0
2212922|NCT01674621|3854229|FG002|Overall Study|Inability to Complete Study Procedures|0
2212923|NCT01674621|3854230|FG003|Overall Study|Inability to Complete Study Procedures|0
2212924|NCT01674621|3854231|FG004|Overall Study|Inability to Complete Study Procedures|2
2212925|NCT01674621|3854227|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
2212926|NCT01674621|3854228|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
2212927|NCT01674621|3854229|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
2212928|NCT01674621|3854230|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
2212929|NCT01674621|3854231|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
2212930|NCT01674621|3854227|FG000|Overall Study|Withdrawal by Subject|2
2212931|NCT01674621|3854228|FG001|Overall Study|Withdrawal by Subject|5
2212932|NCT01674621|3854229|FG002|Overall Study|Withdrawal by Subject|2
2212933|NCT01674621|3854230|FG003|Overall Study|Withdrawal by Subject|0
2212934|NCT01674621|3854231|FG004|Overall Study|Withdrawal by Subject|1
2212935|NCT01674621|3854227|FG000|Overall Study|Other than specified|0
2212936|NCT01674621|3854228|FG001|Overall Study|Other than specified|1
2212937|NCT01674621|3854229|FG002|Overall Study|Other than specified|0
2212938|NCT01674621|3854230|FG003|Overall Study|Other than specified|0
2212939|NCT01674621|3854231|FG004|Overall Study|Other than specified|2
2212940|NCT01674634|3854244|FG000|Overall Study|Withdrawal by Subject|3
2212941|NCT01674634|3854244|FG000|Overall Study|Lost to Follow-up|3
2212942|NCT01674647|3854254|FG000|Treatment Period|Death|4
2212943|NCT01674647|3854255|FG001|Treatment Period|Death|1
2212944|NCT01674647|3854254|FG000|Treatment Period|Efficacy outcome reached|0
2212945|NCT01674647|3854255|FG001|Treatment Period|Efficacy outcome reached|1
2212946|NCT01674647|3854254|FG000|Treatment Period|Physician Decision|3
2212947|NCT01674647|3854255|FG001|Treatment Period|Physician Decision|1
2212948|NCT01674647|3854254|FG000|Treatment Period|Adverse Event|60
2212949|NCT01674647|3854255|FG001|Treatment Period|Adverse Event|22
2212950|NCT01674647|3854254|FG000|Treatment Period|Non-compliance with study drug|3
2212951|NCT01674647|3854255|FG001|Treatment Period|Non-compliance with study drug|0
2212952|NCT01674647|3854254|FG000|Treatment Period|Lost to Follow-up|1
2212953|NCT01674647|3854255|FG001|Treatment Period|Lost to Follow-up|1
2212954|NCT01674647|3854254|FG000|Treatment Period|Withdrawal by Subject|19
2212955|NCT01674647|3854255|FG001|Treatment Period|Withdrawal by Subject|16
2212956|NCT01674647|3854254|FG000|Treatment Period|Switching to other therapy|5
2212957|NCT01674647|3854255|FG001|Treatment Period|Switching to other therapy|2
2212958|NCT01674647|3854254|FG000|Treatment Period|Logistical difficulties|5
2212959|NCT01674647|3854255|FG001|Treatment Period|Logistical difficulties|8
2212960|NCT01674647|3854254|FG000|Treatment Period|Treatment failure|0
2212961|NCT01674647|3854255|FG001|Treatment Period|Treatment failure|14
2212962|NCT01674647|3854254|FG000|Treatment Period|Protocol Violation|56
2212963|NCT01674647|3854255|FG001|Treatment Period|Protocol Violation|36
2212964|NCT01674647|3854254|FG000|30-day Safety Follow-up Period|Death|3
2212965|NCT01674647|3854255|FG001|30-day Safety Follow-up Period|Death|2
2212966|NCT01674647|3854254|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0
2212967|NCT01674647|3854255|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1
2212968|NCT01674647|3854254|FG000|30-day Safety Follow-up Period|Protocol Violation|39
2212969|NCT01674647|3854255|FG001|30-day Safety Follow-up Period|Protocol Violation|22
2212970|NCT01674647|3854254|FG000|30-day Safety Follow-up Period|Logistical difficulties|1
2212971|NCT01674647|3854255|FG001|30-day Safety Follow-up Period|Logistical difficulties|3
2212972|NCT01674647|3854254|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7
2212973|NCT01674647|3854255|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8
2212974|NCT01674647|3854254|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8
2212975|NCT01674647|3854255|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5
2212976|NCT01674712|3854266|FG000|Overall Study|Adverse Event|5
2212977|NCT01674712|3854267|FG001|Overall Study|Adverse Event|6
2212978|NCT01674712|3854268|FG002|Overall Study|Adverse Event|3
2212979|NCT01674712|3854269|FG003|Overall Study|Adverse Event|4
2212980|NCT01674712|3854270|FG004|Overall Study|Adverse Event|6
2212981|NCT01674712|3854266|FG000|Overall Study|Lost to Follow-up|1
2212982|NCT01674712|3854267|FG001|Overall Study|Lost to Follow-up|0
2177360|NCT01372410|3801377|FG005|Treatment Period 3 (7 Days)|Adverse Event|0
2177361|NCT01372410|3801378|FG006|Treatment Period 3 (7 Days)|Adverse Event|0
2177362|NCT01372410|3801379|FG007|Treatment Period 3 (7 Days)|Adverse Event|0
2177363|NCT01372410|3801372|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0
2177364|NCT01372410|3801373|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0
2212983|NCT01674712|3854268|FG002|Overall Study|Lost to Follow-up|0
2212984|NCT01674712|3854269|FG003|Overall Study|Lost to Follow-up|0
2212985|NCT01674712|3854270|FG004|Overall Study|Lost to Follow-up|0
2212986|NCT01674712|3854266|FG000|Overall Study|Protocol Violation|2
2212987|NCT01674712|3854267|FG001|Overall Study|Protocol Violation|0
2212988|NCT01674712|3854268|FG002|Overall Study|Protocol Violation|0
2212989|NCT01674712|3854269|FG003|Overall Study|Protocol Violation|0
2212990|NCT01674712|3854270|FG004|Overall Study|Protocol Violation|0
2212991|NCT01674712|3854266|FG000|Overall Study|Withdrawal by Subject|2
2212992|NCT01674712|3854267|FG001|Overall Study|Withdrawal by Subject|2
2212993|NCT01674712|3854268|FG002|Overall Study|Withdrawal by Subject|5
2212994|NCT01674712|3854269|FG003|Overall Study|Withdrawal by Subject|4
2212995|NCT01674712|3854270|FG004|Overall Study|Withdrawal by Subject|3
2212996|NCT01674712|3854266|FG000|Overall Study|Administrative|0
2212997|NCT01674712|3854267|FG001|Overall Study|Administrative|1
2212998|NCT01674712|3854268|FG002|Overall Study|Administrative|0
2212999|NCT01674712|3854269|FG003|Overall Study|Administrative|0
2213000|NCT01674712|3854270|FG004|Overall Study|Administrative|1
2213001|NCT01674712|3854266|FG000|Overall Study|Lack of Efficacy|0
2213002|NCT01674712|3854267|FG001|Overall Study|Lack of Efficacy|0
2213003|NCT01674712|3854268|FG002|Overall Study|Lack of Efficacy|1
2213004|NCT01674712|3854269|FG003|Overall Study|Lack of Efficacy|0
2213005|NCT01674712|3854270|FG004|Overall Study|Lack of Efficacy|1
2213006|NCT01674725|3854284|FG000|Overall Study|Adverse Event|1
2213007|NCT01674725|3854285|FG001|Overall Study|Adverse Event|0
2213008|NCT01674725|3854284|FG000|Overall Study|Did not receive study drug|1
2177365|NCT01372410|3801374|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0
2177366|NCT01372410|3801375|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0
2177367|NCT01372410|3801376|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0
2177368|NCT01372410|3801377|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1
2177369|NCT01372410|3801378|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0
2177370|NCT01372410|3801379|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0
2177371|NCT01372501|3801408|FG000|Overall Study|Adverse Event|4
2213009|NCT01674725|3854285|FG001|Overall Study|Did not receive study drug|0
2213010|NCT01674725|3854284|FG000|Overall Study|Withdrawal by Subject|1
2213011|NCT01674725|3854285|FG001|Overall Study|Withdrawal by Subject|0
2213012|NCT01674725|3854284|FG000|Overall Study|Lost to Follow-up|0
2213013|NCT01674725|3854285|FG001|Overall Study|Lost to Follow-up|1
2213014|NCT01675050|3854293|FG000|Period One Treatment|Withdrawal by Subject|1
2213015|NCT01675050|3854294|FG001|Period One Treatment|Withdrawal by Subject|0
2213016|NCT01675128|3854307|FG000|Overall Study|Disease progression on study|1
2213017|NCT01675128|3854308|FG001|Overall Study|Disease progression on study|1
2213018|NCT01675128|3854309|FG002|Overall Study|Disease progression on study|1
2213019|NCT01675128|3854307|FG000|Overall Study|Refused further treatment|1
2213020|NCT01675128|3854308|FG001|Overall Study|Refused further treatment|0
2213021|NCT01675128|3854309|FG002|Overall Study|Refused further treatment|0
2213022|NCT01675128|3854307|FG000|Overall Study|Pulmonary complication; off study|0
2213023|NCT01675128|3854308|FG001|Overall Study|Pulmonary complication; off study|1
2213024|NCT01675128|3854309|FG002|Overall Study|Pulmonary complication; off study|0
2213025|NCT01675141|3854324|FG000|Overall Study|Lenalidomide outside NIH|3
2213026|NCT01675141|3854324|FG000|Overall Study|Withdrawal by Subject|3
2213027|NCT01675141|3854324|FG000|Overall Study|Physician Decision|4
2213028|NCT01675141|3854324|FG000|Overall Study|No treatment, per protocol|1
2213029|NCT01675154|3854332|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
2213030|NCT01675154|3854333|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1
2213031|NCT01675154|3854334|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
2213032|NCT01675154|3854335|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
2213033|NCT01675167|3854359|FG000|Open-label Titration Phase|Adverse Event|81
2213034|NCT01675167|3854360|FG001|Open-label Titration Phase|Adverse Event|0
2213035|NCT01675167|3854361|FG002|Open-label Titration Phase|Adverse Event|0
2213036|NCT01675167|3854359|FG000|Open-label Titration Phase|Lack of Efficacy|63
2213037|NCT01675167|3854360|FG001|Open-label Titration Phase|Lack of Efficacy|0
2213038|NCT01675167|3854361|FG002|Open-label Titration Phase|Lack of Efficacy|0
2213039|NCT01675167|3854359|FG000|Open-label Titration Phase|Withdrawal by Subject|46
2213040|NCT01675167|3854360|FG001|Open-label Titration Phase|Withdrawal by Subject|0
2213041|NCT01675167|3854361|FG002|Open-label Titration Phase|Withdrawal by Subject|0
2213042|NCT01675167|3854359|FG000|Open-label Titration Phase|Protocol Violation|43
2213043|NCT01675167|3854360|FG001|Open-label Titration Phase|Protocol Violation|0
2213044|NCT01675167|3854361|FG002|Open-label Titration Phase|Protocol Violation|0
2213045|NCT01675167|3854359|FG000|Open-label Titration Phase|Lost to Follow-up|15
2213046|NCT01675167|3854360|FG001|Open-label Titration Phase|Lost to Follow-up|0
2213047|NCT01675167|3854361|FG002|Open-label Titration Phase|Lost to Follow-up|0
2213048|NCT01675167|3854359|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
2213049|NCT01675167|3854360|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
2213050|NCT01675167|3854361|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
2213051|NCT01675167|3854359|FG000|Open-label Titration Phase|Other|55
2213052|NCT01675167|3854360|FG001|Open-label Titration Phase|Other|0
2213053|NCT01675167|3854361|FG002|Open-label Titration Phase|Other|0
2213054|NCT01675167|3854359|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
2213055|NCT01675167|3854360|FG001|Double-blind Treatment Phase|Lack of Efficacy|19
2213056|NCT01675167|3854361|FG002|Double-blind Treatment Phase|Lack of Efficacy|61
2213057|NCT01675167|3854359|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
2213058|NCT01675167|3854360|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
2213059|NCT01675167|3854361|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6
2213060|NCT01675167|3854359|FG000|Double-blind Treatment Phase|Adverse Event|0
2213061|NCT01675167|3854360|FG001|Double-blind Treatment Phase|Adverse Event|5
2213062|NCT01675167|3854361|FG002|Double-blind Treatment Phase|Adverse Event|13
2213063|NCT01675167|3854359|FG000|Double-blind Treatment Phase|Protocol Violation|0
2213064|NCT01675167|3854360|FG001|Double-blind Treatment Phase|Protocol Violation|4
2213065|NCT01675167|3854361|FG002|Double-blind Treatment Phase|Protocol Violation|11
2213066|NCT01675167|3854359|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
2213067|NCT01675167|3854360|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
2213068|NCT01675167|3854361|FG002|Double-blind Treatment Phase|Lost to Follow-up|5
2213069|NCT01675167|3854359|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
2213070|NCT01675167|3854360|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
2213071|NCT01675167|3854361|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
2213072|NCT01675167|3854359|FG000|Double-blind Treatment Phase|Other|0
2213073|NCT01675167|3854360|FG001|Double-blind Treatment Phase|Other|7
2213074|NCT01675167|3854361|FG002|Double-blind Treatment Phase|Other|5
2213075|NCT01675427|3854378|FG000|Overall Study|Withdrawal by Subject|7
2213076|NCT01675427|3854378|FG000|Overall Study|Participant Refused Sample Collection|18
2213077|NCT01675427|3854378|FG000|Overall Study|Sample not Collected by Mistake|2
2213078|NCT01675427|3854378|FG000|Overall Study|Lost to Follow-up|5
2213079|NCT01675427|3854378|FG000|Overall Study|Other|2
2213080|NCT01675492|3854421|FG000|Overall Study|study completed early - product approval|42
2213081|NCT01675531|3854426|FG000|Overall Study|Adverse Event|9
2213082|NCT01675531|3854426|FG000|Overall Study|Withdrawal by Subject|7
2213083|NCT01675531|3854426|FG000|Overall Study|Lack of Efficacy|1
2213084|NCT01675531|3854426|FG000|Overall Study|Protocol Violation|8
2213085|NCT01675544|3854431|FG000|Overall Study|Withdrawal by Subject|2
2213086|NCT01675596|3854435|FG000|Overall Study|Death|6
2213087|NCT01675596|3854435|FG000|Overall Study|Exit with other reason|1
2213088|NCT01675596|3854435|FG000|Overall Study|Missed Visit|1
2213089|NCT01675622|3854441|FG000|Overall Study|Withdrawal by Subject|2
2213090|NCT01675622|3854442|FG001|Overall Study|Withdrawal by Subject|2
2213091|NCT01675622|3854441|FG000|Overall Study|Adverse Event|12
2213092|NCT01675622|3854442|FG001|Overall Study|Adverse Event|10
2213093|NCT01675622|3854441|FG000|Overall Study|Protocol Violation|4
1975139|NCT03170869|3536782|FG000|Overall Study|Early study termination|3
1975140|NCT03066622|3536789|FG000|Overall Study|Lost to Follow-up|24
1975141|NCT03066622|3536790|FG001|Overall Study|Lost to Follow-up|25
1975142|NCT03066622|3536789|FG000|Overall Study|Withdrawal by Subject|2
1975143|NCT03066622|3536790|FG001|Overall Study|Withdrawal by Subject|1
1975144|NCT03052920|3536796|FG000|Overall Study|Withdrawal by Subject|1
1975145|NCT03016312|3536815|FG000|Overall Study|Death|194
1975146|NCT03016312|3536816|FG001|Overall Study|Death|164
1975147|NCT03016312|3536815|FG000|Overall Study|Lost to Follow-up|11
1975148|NCT03016312|3536816|FG001|Overall Study|Lost to Follow-up|12
1975149|NCT03016312|3536815|FG000|Overall Study|Started new therapy, loss of contact|2
1975150|NCT03016312|3536816|FG001|Overall Study|Started new therapy, loss of contact|1
1975151|NCT03016312|3536815|FG000|Overall Study|Physician Decision|0
1975152|NCT03016312|3536816|FG001|Overall Study|Physician Decision|2
1975153|NCT03016312|3536815|FG000|Overall Study|Withdrawal by Subject|34
1975154|NCT03016312|3536816|FG001|Overall Study|Withdrawal by Subject|39
1975155|NCT02722434|3536834|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1
1975156|NCT02722434|3536835|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0
1975157|NCT02722434|3536834|FG000|Overall Study|Withdrawal After Beginning Treatment|0
1975158|NCT02722434|3536835|FG001|Overall Study|Withdrawal After Beginning Treatment|3
1975159|NCT02604511|3536845|FG000|Overall Study|Adverse Event|3
1975160|NCT02604511|3536845|FG000|Overall Study|Disease Progression|4
1975161|NCT02604511|3536845|FG000|Overall Study|Withdrawal by Subject|3
1975162|NCT02604511|3536845|FG000|Overall Study|Participant ineligible|1
1975163|NCT02604511|3536845|FG000|Overall Study|Intercurrent illness|1
1975174|NCT01963728|3536899|FG000|Overall Study|Study terminated early|0
1975175|NCT01963728|3536900|FG001|Overall Study|Study terminated early|1
1975176|NCT01248247|3536910|FG000|Overall Study|Adverse Event|2
1975177|NCT01248247|3536911|FG001|Overall Study|Adverse Event|4
1975178|NCT01248247|3536912|FG002|Overall Study|Adverse Event|4
1975179|NCT01248247|3536913|FG003|Overall Study|Adverse Event|2
1975180|NCT01248247|3536910|FG000|Overall Study|Death|0
1975181|NCT01248247|3536911|FG001|Overall Study|Death|1
1975182|NCT01248247|3536912|FG002|Overall Study|Death|4
1975183|NCT01248247|3536913|FG003|Overall Study|Death|7
1975184|NCT01248247|3536910|FG000|Overall Study|Lost to Follow-up|0
1975185|NCT01248247|3536911|FG001|Overall Study|Lost to Follow-up|1
1975186|NCT01248247|3536912|FG002|Overall Study|Lost to Follow-up|1
1975187|NCT01248247|3536913|FG003|Overall Study|Lost to Follow-up|0
1975188|NCT01248247|3536910|FG000|Overall Study|Alternative treatment|0
1975189|NCT01248247|3536911|FG001|Overall Study|Alternative treatment|1
1975190|NCT01248247|3536912|FG002|Overall Study|Alternative treatment|0
1975191|NCT01248247|3536913|FG003|Overall Study|Alternative treatment|0
1975192|NCT01248247|3536910|FG000|Overall Study|Other|2
1975193|NCT01248247|3536911|FG001|Overall Study|Other|8
1975194|NCT01248247|3536912|FG002|Overall Study|Other|8
1975195|NCT01248247|3536913|FG003|Overall Study|Other|5
1975196|NCT01248247|3536910|FG000|Overall Study|Progression|18
1975197|NCT01248247|3536911|FG001|Overall Study|Progression|27
1975198|NCT01248247|3536912|FG002|Overall Study|Progression|56
1975199|NCT01248247|3536913|FG003|Overall Study|Progression|44
1975200|NCT01248247|3536910|FG000|Overall Study|Refuse further treatment|0
1975201|NCT01248247|3536911|FG001|Overall Study|Refuse further treatment|0
1975202|NCT01248247|3536912|FG002|Overall Study|Refuse further treatment|1
1975203|NCT01248247|3536913|FG003|Overall Study|Refuse further treatment|2
1975204|NCT01248247|3536910|FG000|Overall Study|Complicating disease|0
1975205|NCT01248247|3536911|FG001|Overall Study|Complicating disease|0
1975206|NCT01248247|3536912|FG002|Overall Study|Complicating disease|1
1975207|NCT01248247|3536913|FG003|Overall Study|Complicating disease|1
1975208|NCT01164228|3536925|FG000|Overall Study|Progression|24
1975209|NCT01164228|3536926|FG001|Overall Study|Progression|25
1975210|NCT01164228|3536925|FG000|Overall Study|Adverse Event|13
1975211|NCT01164228|3536926|FG001|Overall Study|Adverse Event|7
1975212|NCT01164228|3536925|FG000|Overall Study|Death|1
1975213|NCT01164228|3536926|FG001|Overall Study|Death|1
1975214|NCT01164228|3536925|FG000|Overall Study|Withdrawal by Subject|2
1975215|NCT01164228|3536926|FG001|Overall Study|Withdrawal by Subject|0
1975216|NCT01164228|3536925|FG000|Overall Study|Physician Decision|1
1975217|NCT01164228|3536926|FG001|Overall Study|Physician Decision|2
1975218|NCT01164228|3536925|FG000|Overall Study|Symptomatic deterioration|1
1975219|NCT01164228|3536926|FG001|Overall Study|Symptomatic deterioration|0
1975220|NCT01164228|3536925|FG000|Overall Study|Never started treatment|1
1975221|NCT01164228|3536926|FG001|Overall Study|Never started treatment|3
1975222|NCT01164228|3536925|FG000|Overall Study|Ineligible|1
1975223|NCT01164228|3536926|FG001|Overall Study|Ineligible|0
1975224|NCT00591318|3536993|FG000|Overall Study|Lack of Efficacy|2
1975225|NCT00591318|3536994|FG001|Overall Study|Lack of Efficacy|0
1975226|NCT00591318|3536993|FG000|Overall Study|Adverse Event|2
1975227|NCT00591318|3536994|FG001|Overall Study|Adverse Event|0
2022190|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Investigator decision|0
2022191|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Investigator decision|0
2022192|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Investigator decision|0
2022193|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Investigator decision|0
2022194|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Investigator decision|1
2022195|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Lack of time|1
2022196|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Lack of time|0
2022197|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Lack of time|0
2022198|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Lack of time|0
2022199|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Lack of time|0
2022200|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
2022201|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
2022202|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
2022203|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
2022204|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
2022205|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Hyperglicaemia|0
2022206|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Hyperglicaemia|0
2022207|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Hyperglicaemia|0
2022208|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Hyperglicaemia|1
2022209|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Hyperglicaemia|0
2022210|NCT00318461|3590124|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
2022211|NCT00318461|3590125|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
2022212|NCT00318461|3590126|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
2022213|NCT00318461|3590127|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
2022214|NCT00318461|3590128|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
2022215|NCT00318461|3590124|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0
2022216|NCT00318461|3590125|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1
2022217|NCT00318461|3590126|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0
2022218|NCT00318461|3590127|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0
2022219|NCT00318461|3590128|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0
2022220|NCT00318461|3590124|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
2022221|NCT00318461|3590125|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
2022222|NCT00318461|3590126|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
2022223|NCT00318461|3590127|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
2022224|NCT00318461|3590128|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
2022225|NCT00318461|3590124|FG000|Open-Label Extension, 18 Months|Adverse Event|11
2022226|NCT00318461|3590125|FG001|Open-Label Extension, 18 Months|Adverse Event|8
2022227|NCT00318461|3590126|FG002|Open-Label Extension, 18 Months|Adverse Event|6
2022228|NCT00318461|3590127|FG003|Open-Label Extension, 18 Months|Adverse Event|1
2022229|NCT00318461|3590128|FG004|Open-Label Extension, 18 Months|Adverse Event|6
2022230|NCT00318461|3590124|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41
2022231|NCT00318461|3590125|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33
2022232|NCT00318461|3590126|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37
2022233|NCT00318461|3590127|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27
2022234|NCT00318461|3590128|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63
2022235|NCT00318461|3590124|FG000|Open-Label Extension, 18 Months|Protocol Violation|7
2022236|NCT00318461|3590125|FG001|Open-Label Extension, 18 Months|Protocol Violation|5
2022237|NCT00318461|3590126|FG002|Open-Label Extension, 18 Months|Protocol Violation|3
2022238|NCT00318461|3590127|FG003|Open-Label Extension, 18 Months|Protocol Violation|4
2022239|NCT00318461|3590128|FG004|Open-Label Extension, 18 Months|Protocol Violation|6
2022240|NCT00318474|3590142|FG000|Overall Study|Adverse Event|1
2022241|NCT00318474|3590143|FG001|Overall Study|Adverse Event|1
2022242|NCT00318474|3590142|FG000|Overall Study|Lost to Follow-up|0
2022243|NCT00318474|3590143|FG001|Overall Study|Lost to Follow-up|1
2022244|NCT00318474|3590142|FG000|Overall Study|Pregnancy|0
2022245|NCT00318474|3590143|FG001|Overall Study|Pregnancy|2
2022246|NCT00318474|3590142|FG000|Overall Study|Protocol Violation|1
2022247|NCT00318474|3590143|FG001|Overall Study|Protocol Violation|0
2022248|NCT00318474|3590142|FG000|Overall Study|Withdrawal by Subject|3
2022249|NCT00318474|3590143|FG001|Overall Study|Withdrawal by Subject|2
2213094|NCT01675622|3854442|FG001|Overall Study|Protocol Violation|1
2022250|NCT00318474|3590142|FG000|Overall Study|Fall in GFR|3
2022251|NCT00318474|3590143|FG001|Overall Study|Fall in GFR|3
1975228|NCT04534517|3537015|FG000|Overall Study|Adverse Event|1
1975229|NCT04534517|3537015|FG000|Overall Study|Withdrawal by Subject|1
1975230|NCT04534517|3537015|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1
1975231|NCT04534517|3537015|FG000|Overall Study|COVID-19 Related|1
1975232|NCT04494646|3537021|FG000|Overall Study|Adverse Event|0
1975233|NCT04494646|3537022|FG001|Overall Study|Adverse Event|1
1975234|NCT04494646|3537021|FG000|Overall Study|Withdrawal by Subject|0
1975235|NCT04494646|3537022|FG001|Overall Study|Withdrawal by Subject|1
1975236|NCT04258020|3537030|FG000|Overall Study|Withdrawal by Subject|1
1975237|NCT04258020|3537031|FG001|Overall Study|Withdrawal by Subject|0
1975238|NCT04234464|3537039|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1
1975239|NCT04234464|3537040|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0
1975240|NCT04126733|3537046|FG000|Treatment Period|Other Reason|1
1975241|NCT04126733|3537046|FG000|Treatment Period|Death|1
1975242|NCT04126733|3537046|FG000|Treatment Period|Physician Decision|3
1975243|NCT04126733|3537046|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7
1975244|NCT04126733|3537046|FG000|Treatment Period|Adverse Event|7
1975245|NCT04126733|3537046|FG000|Treatment Period|Progressive Disease - Radiological Progression|44
1975246|NCT04126733|3537046|FG000|Treatment Period|Ongoing with Study Treatment|7
1975247|NCT04126733|3537046|FG000|Active Follow-up Period|Death|13
1975248|NCT04126733|3537046|FG000|Active Follow-up Period|Other Reason|1
1975249|NCT04126733|3537046|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4
1975250|NCT04126733|3537046|FG000|Active Follow-up Period|Withdrawal by Subject|2
1975251|NCT04126733|3537046|FG000|Long-term Follow-up Period|Withdrawal by Subject|1
1975252|NCT04126733|3537046|FG000|Long-term Follow-up Period|Death|5
1975253|NCT03860259|3537052|FG000|Overall Study|Lost to Follow-up|5
1975254|NCT03860259|3537053|FG001|Overall Study|Lost to Follow-up|5
1975255|NCT03860259|3537052|FG000|Overall Study|Protocol Violation|1
1975256|NCT03860259|3537053|FG001|Overall Study|Protocol Violation|0
1975257|NCT03852316|3537059|FG000|Overall Study|Protocol Violation|1
1975258|NCT03852316|3537059|FG000|Overall Study|Withdrawal by Subject|2
1975259|NCT03852316|3537059|FG000|Overall Study|Enrolled but Device not Utilized|1
1975260|NCT03789318|3537068|FG000|Overall Study|Adverse Event|0
1975261|NCT03789318|3537069|FG001|Overall Study|Adverse Event|0
1975262|NCT03789318|3537070|FG002|Overall Study|Adverse Event|1
1975263|NCT03789318|3537071|FG003|Overall Study|Adverse Event|1
1975264|NCT03789318|3537072|FG004|Overall Study|Adverse Event|0
1975265|NCT03789318|3537068|FG000|Overall Study|Lost to Follow-up|0
1975266|NCT03789318|3537069|FG001|Overall Study|Lost to Follow-up|0
1975267|NCT03789318|3537070|FG002|Overall Study|Lost to Follow-up|1
1975268|NCT03789318|3537071|FG003|Overall Study|Lost to Follow-up|0
1975269|NCT03789318|3537072|FG004|Overall Study|Lost to Follow-up|0
1975270|NCT03789318|3537068|FG000|Overall Study|Withdrawal by Subject|0
1975271|NCT03789318|3537069|FG001|Overall Study|Withdrawal by Subject|0
1975272|NCT03789318|3537070|FG002|Overall Study|Withdrawal by Subject|1
1975273|NCT03789318|3537071|FG003|Overall Study|Withdrawal by Subject|0
1975274|NCT03789318|3537072|FG004|Overall Study|Withdrawal by Subject|0
1975275|NCT03774875|3537086|FG000|Overall Study|Adverse Event|8
1975276|NCT03774875|3537087|FG001|Overall Study|Adverse Event|16
1975277|NCT03774875|3537086|FG000|Overall Study|Lack of Efficacy|2
1975278|NCT03774875|3537087|FG001|Overall Study|Lack of Efficacy|4
1975279|NCT03774875|3537086|FG000|Overall Study|Withdrawal by Subject|12
1975280|NCT03774875|3537087|FG001|Overall Study|Withdrawal by Subject|10
1975281|NCT03774875|3537086|FG000|Overall Study|Lost to Follow-up|0
1975282|NCT03774875|3537087|FG001|Overall Study|Lost to Follow-up|2
1975283|NCT03774875|3537086|FG000|Overall Study|Protocol Deviation|0
1975284|NCT03774875|3537087|FG001|Overall Study|Protocol Deviation|1
1975285|NCT03774875|3537086|FG000|Overall Study|Reason Unknown|1
1975286|NCT03774875|3537087|FG001|Overall Study|Reason Unknown|0
1975287|NCT03158688|3537125|FG000|Overall Study|Continuing in study|107
1975288|NCT03158688|3537126|FG001|Overall Study|Continuing in study|233
1975289|NCT03158688|3537125|FG000|Overall Study|Death|36
1975290|NCT03158688|3537126|FG001|Overall Study|Death|59
1975291|NCT03158688|3537125|FG000|Overall Study|Withdrawal by Subject|9
1975292|NCT03158688|3537126|FG001|Overall Study|Withdrawal by Subject|14
1975293|NCT03158688|3537125|FG000|Overall Study|Decision by sponsor|2
1975294|NCT03158688|3537126|FG001|Overall Study|Decision by sponsor|3
1975295|NCT03158688|3537125|FG000|Overall Study|Lost to Follow-up|0
1975296|NCT03158688|3537126|FG001|Overall Study|Lost to Follow-up|3
1975297|NCT03103321|3537136|FG000|Overall Study|Protocol Violation|1
1975298|NCT03103321|3537137|FG001|Overall Study|Protocol Violation|1
1975299|NCT03103321|3537138|FG002|Overall Study|Protocol Violation|1
1975300|NCT03103321|3537139|FG003|Overall Study|Protocol Violation|0
1975301|NCT03079869|3537151|FG000|Overall Study|Adverse Event|6
1975302|NCT03079869|3537152|FG001|Overall Study|Adverse Event|8
1975303|NCT03079869|3537151|FG000|Overall Study|Withdrawal by Subject|4
1975304|NCT03079869|3537152|FG001|Overall Study|Withdrawal by Subject|1
1975305|NCT03079869|3537151|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3
1975306|NCT03079869|3537152|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2
1975307|NCT03033875|3537161|FG000|Overall Study|Withdrawal by Subject|5
1975308|NCT03033875|3537162|FG001|Overall Study|Withdrawal by Subject|9
1975309|NCT03033875|3537163|FG002|Overall Study|Withdrawal by Subject|4
1975310|NCT03033875|3537161|FG000|Overall Study|Other|14
1975311|NCT03033875|3537162|FG001|Overall Study|Other|15
1975312|NCT03033875|3537163|FG002|Overall Study|Other|8
1975313|NCT02887248|3537175|FG000|Overall Study|Withdrawal by Subject|1
1975314|NCT02887248|3537175|FG000|Overall Study|Adverse Event|1
1975315|NCT02887248|3537175|FG000|Overall Study|Progressive Disease|1
2022252|NCT00318474|3590142|FG000|Overall Study|Post-therapy hyperflycemia|0
2022253|NCT00318474|3590143|FG001|Overall Study|Post-therapy hyperflycemia|1
2022254|NCT00318474|3590142|FG000|Overall Study|Trial terminated|10
2022255|NCT00318474|3590143|FG001|Overall Study|Trial terminated|7
2022256|NCT00318565|3590149|FG000|Overall Study|Excluded per protocol|24
2022257|NCT00318643|3590169|FG000|Overall Study|Adverse Event|0
2022258|NCT00318643|3590170|FG001|Overall Study|Adverse Event|0
2022259|NCT00318643|3590171|FG002|Overall Study|Adverse Event|0
2022260|NCT00318643|3590172|FG003|Overall Study|Adverse Event|0
2022261|NCT00318643|3590173|FG004|Overall Study|Adverse Event|1
2022262|NCT00318643|3590169|FG000|Overall Study|Participant's Decision|0
2022263|NCT00318643|3590170|FG001|Overall Study|Participant's Decision|0
2022264|NCT00318643|3590171|FG002|Overall Study|Participant's Decision|0
2022265|NCT00318643|3590172|FG003|Overall Study|Participant's Decision|0
2022266|NCT00318643|3590173|FG004|Overall Study|Participant's Decision|1
2022267|NCT00318643|3590169|FG000|Overall Study|Investigator's Decision|0
2022268|NCT00318643|3590170|FG001|Overall Study|Investigator's Decision|0
2022269|NCT00318643|3590171|FG002|Overall Study|Investigator's Decision|0
2022270|NCT00318643|3590172|FG003|Overall Study|Investigator's Decision|0
2022271|NCT00318643|3590173|FG004|Overall Study|Investigator's Decision|1
2022272|NCT00319020|3590214|FG000|Overall Study|Death|2
2022273|NCT00319020|3590215|FG001|Overall Study|Death|2
2022274|NCT00319020|3590214|FG000|Overall Study|Withdrawal by Subject|4
2022275|NCT00319020|3590215|FG001|Overall Study|Withdrawal by Subject|1
2022276|NCT00319020|3590214|FG000|Overall Study|F-1 completed but not enrolled in F-2|1
2022277|NCT00319020|3590215|FG001|Overall Study|F-1 completed but not enrolled in F-2|0
2022278|NCT00319020|3590214|FG000|Overall Study|Administrative reason|0
2022279|NCT00319020|3590215|FG001|Overall Study|Administrative reason|5
2022280|NCT00319020|3590214|FG000|Overall Study|Disease progression|0
2022281|NCT00319020|3590215|FG001|Overall Study|Disease progression|2
2022282|NCT00319020|3590214|FG000|Overall Study|Transplant|0
2022283|NCT00319020|3590215|FG001|Overall Study|Transplant|1
2022284|NCT00319020|3590214|FG000|Overall Study|Treatment failure|0
2022285|NCT00319020|3590215|FG001|Overall Study|Treatment failure|1
2022286|NCT00319020|3590214|FG000|Overall Study|Adverse Event|0
2022287|NCT00319020|3590215|FG001|Overall Study|Adverse Event|1
2022288|NCT00319046|3590223|FG000|Overall Study|withdrawal of subject's consent|7
2022289|NCT00319046|3590223|FG000|Overall Study|administrative reason|1
2022290|NCT00319098|3590231|FG000|Overall Study|Serious adverse event|3
2022291|NCT00319098|3590232|FG001|Overall Study|Serious adverse event|0
2022292|NCT00319098|3590231|FG000|Overall Study|Adverse Event|20
2022293|NCT00319098|3590232|FG001|Overall Study|Adverse Event|1
2022294|NCT00319098|3590231|FG000|Overall Study|Withdrawal by Subject|37
2022295|NCT00319098|3590232|FG001|Overall Study|Withdrawal by Subject|8
2022296|NCT00319098|3590231|FG000|Overall Study|Migrated/moved from study area|2
2022297|NCT00319098|3590232|FG001|Overall Study|Migrated/moved from study area|1
2022298|NCT00319098|3590231|FG000|Overall Study|Lost to Follow-up|37
2022299|NCT00319098|3590232|FG001|Overall Study|Lost to Follow-up|13
2022300|NCT00319098|3590231|FG000|Overall Study|Others|33
2022301|NCT00319098|3590232|FG001|Overall Study|Others|8
2022302|NCT00319098|3590231|FG000|Overall Study|Protocol Violation|3
2022303|NCT00319098|3590232|FG001|Overall Study|Protocol Violation|1
2022304|NCT00319111|3590242|FG000|Overall Study|Adverse Event|20
2022305|NCT00319111|3590242|FG000|Overall Study|Withdrawal of consent|11
2022306|NCT00319111|3590242|FG000|Overall Study|Death|9
2022307|NCT00319111|3590242|FG000|Overall Study|Lack of clinical improvement|4
2022308|NCT00319111|3590242|FG000|Overall Study|Administrative|2
2022309|NCT00319111|3590242|FG000|Overall Study|Treatment failure|1
2022310|NCT00319254|3590246|FG000|Overall Study|Withdrawal by Subject|4
2022311|NCT00319254|3590246|FG000|Overall Study|Death|46
2022312|NCT00319254|3590246|FG000|Overall Study|Lost to Follow-up|2
2022313|NCT00319254|3590246|FG000|Overall Study|Enrolled, Not Treated|2
2022314|NCT00319436|3590252|FG000|Overall Study|Withdrawal by Subject|6
2022315|NCT00319436|3590253|FG001|Overall Study|Withdrawal by Subject|7
2022316|NCT00319501|3590261|FG000|Double-blind Period|Withdrawal by Subject|0
2022317|NCT00319501|3590262|FG001|Double-blind Period|Withdrawal by Subject|3
2022318|NCT00319501|3590261|FG000|Double-blind Period|Sponsor Request|1
2022319|NCT00319501|3590262|FG001|Double-blind Period|Sponsor Request|0
2022320|NCT00319501|3590261|FG000|Double-blind Period|Did not receive treatment|42
2022321|NCT00319501|3590262|FG001|Double-blind Period|Did not receive treatment|29
2022322|NCT00319501|3590261|FG000|Open-label Period|Adverse Event|5
2022323|NCT00319501|3590262|FG001|Open-label Period|Adverse Event|0
2022324|NCT00319501|3590261|FG000|Open-label Period|Protocol Violation|6
2022325|NCT00319501|3590262|FG001|Open-label Period|Protocol Violation|0
2022326|NCT00319501|3590261|FG000|Open-label Period|Withdrawal by Subject|38
2022327|NCT00319501|3590262|FG001|Open-label Period|Withdrawal by Subject|0
2022328|NCT00319501|3590261|FG000|Open-label Period|Principal Investigator decision|6
1975316|NCT02849990|3537179|FG000|Overall Study|Adverse Event|1
1975317|NCT02849990|3537179|FG000|Overall Study|Withdrawal by Subject|1
1975318|NCT02467270|3537212|FG000|Overall Study|Participants Never Treated|0
1975319|NCT02467270|3537213|FG001|Overall Study|Participants Never Treated|1
1975320|NCT02467270|3537214|FG002|Overall Study|Participants Never Treated|0
1975321|NCT02467270|3537212|FG000|Overall Study|Ongoing|50
1975322|NCT02467270|3537213|FG001|Overall Study|Ongoing|41
1975323|NCT02467270|3537214|FG002|Overall Study|Ongoing|43
1975324|NCT02467270|3537212|FG000|Overall Study|Adverse Event|16
1975325|NCT02467270|3537213|FG001|Overall Study|Adverse Event|15
1975326|NCT02467270|3537214|FG002|Overall Study|Adverse Event|14
1975327|NCT02467270|3537212|FG000|Overall Study|Progressive Disease|7
1975328|NCT02467270|3537213|FG001|Overall Study|Progressive Disease|7
1975329|NCT02467270|3537214|FG002|Overall Study|Progressive Disease|4
1975330|NCT02467270|3537212|FG000|Overall Study|Death|2
1975331|NCT02467270|3537213|FG001|Overall Study|Death|0
1975332|NCT02467270|3537214|FG002|Overall Study|Death|2
1975333|NCT02467270|3537212|FG000|Overall Study|Lack of Efficacy|12
1975334|NCT02467270|3537213|FG001|Overall Study|Lack of Efficacy|18
1975335|NCT02467270|3537214|FG002|Overall Study|Lack of Efficacy|23
1975336|NCT02467270|3537212|FG000|Overall Study|Non-compliance With Study Drug|0
1975337|NCT02467270|3537213|FG001|Overall Study|Non-compliance With Study Drug|2
1975338|NCT02467270|3537214|FG002|Overall Study|Non-compliance With Study Drug|1
1975339|NCT02467270|3537212|FG000|Overall Study|Lost to Follow-up|2
1975340|NCT02467270|3537213|FG001|Overall Study|Lost to Follow-up|1
1975341|NCT02467270|3537214|FG002|Overall Study|Lost to Follow-up|0
1975342|NCT02467270|3537212|FG000|Overall Study|Pregnancy|0
1975343|NCT02467270|3537213|FG001|Overall Study|Pregnancy|1
1975344|NCT02467270|3537214|FG002|Overall Study|Pregnancy|0
1975345|NCT02467270|3537212|FG000|Overall Study|Physician Decision|0
1975346|NCT02467270|3537213|FG001|Overall Study|Physician Decision|4
1975347|NCT02467270|3537214|FG002|Overall Study|Physician Decision|1
1975348|NCT02467270|3537212|FG000|Overall Study|Withdrawal by Subject|4
1975349|NCT02467270|3537213|FG001|Overall Study|Withdrawal by Subject|3
1975350|NCT02467270|3537214|FG002|Overall Study|Withdrawal by Subject|5
1975351|NCT02467270|3537212|FG000|Overall Study|Reason not Specified|1
1975352|NCT02467270|3537213|FG001|Overall Study|Reason not Specified|2
1975353|NCT02467270|3537214|FG002|Overall Study|Reason not Specified|1
1975354|NCT02452554|3537228|FG000|Overall Study|Death|2
1975355|NCT02452554|3537229|FG001|Overall Study|Death|1
1975356|NCT02452554|3537230|FG002|Overall Study|Death|0
1975357|NCT02452554|3537231|FG003|Overall Study|Death|0
1975358|NCT02452554|3537232|FG004|Overall Study|Death|0
1975359|NCT02452554|3537233|FG005|Overall Study|Death|0
1975360|NCT02452554|3537228|FG000|Overall Study|Lack of Efficacy|13
1975361|NCT02452554|3537229|FG001|Overall Study|Lack of Efficacy|14
1975362|NCT02452554|3537230|FG002|Overall Study|Lack of Efficacy|9
1975363|NCT02452554|3537231|FG003|Overall Study|Lack of Efficacy|1
1975364|NCT02452554|3537232|FG004|Overall Study|Lack of Efficacy|5
1975365|NCT02452554|3537233|FG005|Overall Study|Lack of Efficacy|8
1975366|NCT02452554|3537228|FG000|Overall Study|Physician Decision|0
1975367|NCT02452554|3537229|FG001|Overall Study|Physician Decision|1
1975368|NCT02452554|3537230|FG002|Overall Study|Physician Decision|0
1975369|NCT02452554|3537231|FG003|Overall Study|Physician Decision|0
1975370|NCT02452554|3537232|FG004|Overall Study|Physician Decision|0
1975371|NCT02452554|3537233|FG005|Overall Study|Physician Decision|0
1975372|NCT02452554|3537228|FG000|Overall Study|Withdrawal by Subject|1
1975373|NCT02452554|3537229|FG001|Overall Study|Withdrawal by Subject|0
1975374|NCT02452554|3537230|FG002|Overall Study|Withdrawal by Subject|2
1975375|NCT02452554|3537231|FG003|Overall Study|Withdrawal by Subject|0
1975376|NCT02452554|3537232|FG004|Overall Study|Withdrawal by Subject|0
1975377|NCT02452554|3537233|FG005|Overall Study|Withdrawal by Subject|1
1975378|NCT02452554|3537228|FG000|Overall Study|Ineligible|0
1975379|NCT02452554|3537229|FG001|Overall Study|Ineligible|1
1975380|NCT02452554|3537230|FG002|Overall Study|Ineligible|0
1975381|NCT02452554|3537231|FG003|Overall Study|Ineligible|0
1975382|NCT02452554|3537232|FG004|Overall Study|Ineligible|0
1975383|NCT02452554|3537233|FG005|Overall Study|Ineligible|0
1975384|NCT02452554|3537228|FG000|Overall Study|Never Received Treatment|1
1975385|NCT02452554|3537229|FG001|Overall Study|Never Received Treatment|0
1975386|NCT02452554|3537230|FG002|Overall Study|Never Received Treatment|0
1975387|NCT02452554|3537231|FG003|Overall Study|Never Received Treatment|0
1975388|NCT02452554|3537232|FG004|Overall Study|Never Received Treatment|0
1975389|NCT02452554|3537233|FG005|Overall Study|Never Received Treatment|0
1975390|NCT02335424|3537261|FG000|Overall Study|Withdrawal by Subject|12
1975391|NCT02335424|3537261|FG000|Overall Study|Ongoing In Study|89
1975392|NCT02335424|3537261|FG000|Overall Study|Adverse Event|25
1975393|NCT02335424|3537261|FG000|Overall Study|Death|239
1975394|NCT02335424|3537261|FG000|Overall Study|Lost to Follow-up|2
1975395|NCT02335424|3537261|FG000|Overall Study|Physician Decision|3
1975396|NCT02335424|3537261|FG000|Overall Study|Not treated|4
1975397|NCT02318277|3537273|FG000|Overall Study|Physician Decision|0
1975398|NCT02318277|3537274|FG001|Overall Study|Physician Decision|0
1975399|NCT02318277|3537275|FG002|Overall Study|Physician Decision|0
1975400|NCT02318277|3537276|FG003|Overall Study|Physician Decision|0
1975401|NCT02318277|3537277|FG004|Overall Study|Physician Decision|0
1975402|NCT02318277|3537278|FG005|Overall Study|Physician Decision|0
1975403|NCT02318277|3537279|FG006|Overall Study|Physician Decision|0
1975404|NCT02318277|3537280|FG007|Overall Study|Physician Decision|1
1975405|NCT02318277|3537273|FG000|Overall Study|Other|0
1975406|NCT02318277|3537274|FG001|Overall Study|Other|0
1975407|NCT02318277|3537275|FG002|Overall Study|Other|0
1975408|NCT02318277|3537276|FG003|Overall Study|Other|0
1975409|NCT02318277|3537277|FG004|Overall Study|Other|0
1975410|NCT02318277|3537278|FG005|Overall Study|Other|0
1975411|NCT02318277|3537279|FG006|Overall Study|Other|1
1975412|NCT02318277|3537280|FG007|Overall Study|Other|0
1975413|NCT02318277|3537273|FG000|Overall Study|Withdrawal by Subject|0
1975414|NCT02318277|3537274|FG001|Overall Study|Withdrawal by Subject|0
1975415|NCT02318277|3537275|FG002|Overall Study|Withdrawal by Subject|1
1975416|NCT02318277|3537276|FG003|Overall Study|Withdrawal by Subject|0
1975417|NCT02318277|3537277|FG004|Overall Study|Withdrawal by Subject|1
1975418|NCT02318277|3537278|FG005|Overall Study|Withdrawal by Subject|1
1975419|NCT02318277|3537279|FG006|Overall Study|Withdrawal by Subject|6
1975420|NCT02318277|3537280|FG007|Overall Study|Withdrawal by Subject|14
1975421|NCT02318277|3537273|FG000|Overall Study|Participant trial terminated by sponsor|0
1975422|NCT02318277|3537274|FG001|Overall Study|Participant trial terminated by sponsor|0
1975423|NCT02318277|3537275|FG002|Overall Study|Participant trial terminated by sponsor|1
1975424|NCT02318277|3537276|FG003|Overall Study|Participant trial terminated by sponsor|0
1975425|NCT02318277|3537277|FG004|Overall Study|Participant trial terminated by sponsor|1
1975426|NCT02318277|3537278|FG005|Overall Study|Participant trial terminated by sponsor|2
1975427|NCT02318277|3537279|FG006|Overall Study|Participant trial terminated by sponsor|5
1975428|NCT02318277|3537280|FG007|Overall Study|Participant trial terminated by sponsor|16
1975429|NCT02318277|3537273|FG000|Overall Study|Lost to Follow-up|1
1975430|NCT02318277|3537274|FG001|Overall Study|Lost to Follow-up|0
1975431|NCT02318277|3537275|FG002|Overall Study|Lost to Follow-up|1
1975432|NCT02318277|3537276|FG003|Overall Study|Lost to Follow-up|0
1975433|NCT02318277|3537277|FG004|Overall Study|Lost to Follow-up|0
1975434|NCT02318277|3537278|FG005|Overall Study|Lost to Follow-up|0
1975435|NCT02318277|3537279|FG006|Overall Study|Lost to Follow-up|3
1975436|NCT02318277|3537280|FG007|Overall Study|Lost to Follow-up|4
1975437|NCT02318277|3537273|FG000|Overall Study|Death|5
1975438|NCT02318277|3537274|FG001|Overall Study|Death|3
1975439|NCT02318277|3537275|FG002|Overall Study|Death|1
1975440|NCT02318277|3537276|FG003|Overall Study|Death|4
1975441|NCT02318277|3537277|FG004|Overall Study|Death|6
1975442|NCT02318277|3537278|FG005|Overall Study|Death|5
1975443|NCT02318277|3537279|FG006|Overall Study|Death|34
1975444|NCT02318277|3537280|FG007|Overall Study|Death|58
1975445|NCT02318277|3537273|FG000|Overall Study|Transitioned to Hospice|0
1975446|NCT02318277|3537274|FG001|Overall Study|Transitioned to Hospice|0
1975447|NCT02318277|3537275|FG002|Overall Study|Transitioned to Hospice|0
1975448|NCT02318277|3537276|FG003|Overall Study|Transitioned to Hospice|0
1975449|NCT02318277|3537277|FG004|Overall Study|Transitioned to Hospice|0
1975450|NCT02318277|3537278|FG005|Overall Study|Transitioned to Hospice|1
1975451|NCT02318277|3537279|FG006|Overall Study|Transitioned to Hospice|0
1975452|NCT02318277|3537280|FG007|Overall Study|Transitioned to Hospice|0
1975453|NCT02143063|3537336|FG000|Overall Study|Lost to Follow-up|16
1975454|NCT02143063|3537337|FG001|Overall Study|Lost to Follow-up|28
1975455|NCT02143063|3537338|FG002|Overall Study|Lost to Follow-up|29
1975456|NCT02143063|3537336|FG000|Overall Study|Withdrawal by Subject|0
1975457|NCT02143063|3537337|FG001|Overall Study|Withdrawal by Subject|1
1975458|NCT02143063|3537338|FG002|Overall Study|Withdrawal by Subject|0
1975459|NCT02143063|3537336|FG000|Overall Study|Death|0
1975460|NCT02143063|3537337|FG001|Overall Study|Death|1
1975461|NCT02143063|3537338|FG002|Overall Study|Death|1
1975462|NCT02017964|3537346|FG000|Overall Study|Patient deemed ineligible|1
1975463|NCT01968785|3537352|FG000|Overall Study|Withdrawal by Subject|1
1975464|NCT01968785|3537353|FG001|Overall Study|Withdrawal by Subject|0
1975465|NCT01956110|3537361|FG000|Overall Study|Protocol Violation|25
1975466|NCT01956110|3537362|FG001|Overall Study|Protocol Violation|11
1975467|NCT01956110|3537361|FG000|Overall Study|Adverse Event|9
1975468|NCT01956110|3537362|FG001|Overall Study|Adverse Event|10
1975469|NCT01956110|3537361|FG000|Overall Study|Personal reasons|1
1975470|NCT01956110|3537362|FG001|Overall Study|Personal reasons|1
1975471|NCT01648023|3537371|FG000|Overall Study|Screen Fail Post Randomization|1
1975472|NCT01648023|3537372|FG001|Overall Study|Screen Fail Post Randomization|2
1975473|NCT01083433|3537395|FG000|Overall Study|Lost to Follow-up|2
1975474|NCT01083433|3537396|FG001|Overall Study|Lost to Follow-up|1
1975475|NCT01083433|3537397|FG002|Overall Study|Lost to Follow-up|1
1975476|NCT01083433|3537395|FG000|Overall Study|Withdrawal by Subject|0
1975477|NCT01083433|3537396|FG001|Overall Study|Withdrawal by Subject|5
1975478|NCT01083433|3537397|FG002|Overall Study|Withdrawal by Subject|3
1975479|NCT01083433|3537395|FG000|Overall Study|Pregnancy|0
1975480|NCT01083433|3537396|FG001|Overall Study|Pregnancy|0
1975481|NCT01083433|3537397|FG002|Overall Study|Pregnancy|1
1975482|NCT00787176|3537423|FG000|Overall Study|Low quality fetal heart rate tracing|7
1975483|NCT00787176|3537424|FG001|Overall Study|Low quality fetal heart rate tracing|3
1975484|NCT00787176|3537425|FG002|Overall Study|Low quality fetal heart rate tracing|6
1975485|NCT00787176|3537426|FG003|Overall Study|Low quality fetal heart rate tracing|5
1975486|NCT00352534|3537439|FG000|Initial Staging|Ineligible|8
1975487|NCT00352534|3537440|FG001|Initial Staging|Ineligible|9
1975488|NCT00352534|3537441|FG002|Initial Staging|Ineligible|0
1975489|NCT00352534|3537442|FG003|Initial Staging|Ineligible|0
1975490|NCT00352534|3537443|FG004|Initial Staging|Ineligible|0
1975491|NCT00352534|3537444|FG005|Initial Staging|Ineligible|0
1975492|NCT00352534|3537445|FG006|Initial Staging|Ineligible|0
1975493|NCT00352534|3537439|FG000|Final Risk Group Assignment|Lack of Efficacy|0
1975494|NCT00352534|3537440|FG001|Final Risk Group Assignment|Lack of Efficacy|0
1975495|NCT00352534|3537441|FG002|Final Risk Group Assignment|Lack of Efficacy|0
1975496|NCT00352534|3537442|FG003|Final Risk Group Assignment|Lack of Efficacy|2
1975497|NCT00352534|3537443|FG004|Final Risk Group Assignment|Lack of Efficacy|1
1975498|NCT00352534|3537444|FG005|Final Risk Group Assignment|Lack of Efficacy|19
1975499|NCT00352534|3537445|FG006|Final Risk Group Assignment|Lack of Efficacy|0
1975500|NCT00352534|3537439|FG000|Final Risk Group Assignment|Physician Decision|0
1975501|NCT00352534|3537440|FG001|Final Risk Group Assignment|Physician Decision|0
1975502|NCT00352534|3537441|FG002|Final Risk Group Assignment|Physician Decision|0
1975503|NCT00352534|3537442|FG003|Final Risk Group Assignment|Physician Decision|0
1975504|NCT00352534|3537443|FG004|Final Risk Group Assignment|Physician Decision|0
1975505|NCT00352534|3537444|FG005|Final Risk Group Assignment|Physician Decision|8
1975506|NCT00352534|3537445|FG006|Final Risk Group Assignment|Physician Decision|0
1975507|NCT00352534|3537439|FG000|Final Risk Group Assignment|Withdrawal by Subject|0
1975508|NCT00352534|3537440|FG001|Final Risk Group Assignment|Withdrawal by Subject|0
1975509|NCT00352534|3537441|FG002|Final Risk Group Assignment|Withdrawal by Subject|0
1975510|NCT00352534|3537442|FG003|Final Risk Group Assignment|Withdrawal by Subject|0
1975511|NCT00352534|3537443|FG004|Final Risk Group Assignment|Withdrawal by Subject|0
1975512|NCT00352534|3537444|FG005|Final Risk Group Assignment|Withdrawal by Subject|3
1975513|NCT00352534|3537445|FG006|Final Risk Group Assignment|Withdrawal by Subject|0
1975514|NCT00352534|3537439|FG000|Final Risk Group Assignment|Ineligible|0
1975515|NCT00352534|3537440|FG001|Final Risk Group Assignment|Ineligible|0
1975516|NCT00352534|3537441|FG002|Final Risk Group Assignment|Ineligible|3
1975517|NCT00352534|3537442|FG003|Final Risk Group Assignment|Ineligible|1
1975518|NCT00352534|3537443|FG004|Final Risk Group Assignment|Ineligible|0
1975519|NCT00352534|3537444|FG005|Final Risk Group Assignment|Ineligible|13
1975520|NCT00352534|3537445|FG006|Final Risk Group Assignment|Ineligible|0
1975521|NCT00352534|3537439|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0
1975522|NCT00352534|3537440|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0
1975523|NCT00352534|3537441|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0
1975524|NCT00352534|3537442|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0
1975525|NCT00352534|3537443|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0
1975526|NCT00352534|3537444|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0
1975527|NCT00352534|3537445|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28
1975528|NCT00352534|3537439|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1975529|NCT00352534|3537440|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1975530|NCT00352534|3537441|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1975531|NCT00352534|3537442|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1975532|NCT00352534|3537443|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1975533|NCT00352534|3537444|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1975534|NCT00352534|3537445|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
1975535|NCT00352534|3537439|FG000|Final Risk Group Assignment|Death|0
1975536|NCT00352534|3537440|FG001|Final Risk Group Assignment|Death|0
1975537|NCT00352534|3537441|FG002|Final Risk Group Assignment|Death|0
1975538|NCT00352534|3537442|FG003|Final Risk Group Assignment|Death|0
1975539|NCT00352534|3537443|FG004|Final Risk Group Assignment|Death|0
1975540|NCT00352534|3537444|FG005|Final Risk Group Assignment|Death|2
1975541|NCT00352534|3537445|FG006|Final Risk Group Assignment|Death|0
1975542|NCT00033293|3537457|FG000|Overall Study|Death|0
1975543|NCT00033293|3537458|FG001|Overall Study|Death|1
1975544|NCT00033293|3537457|FG000|Overall Study|Lack of Efficacy|5
1975545|NCT00033293|3537458|FG001|Overall Study|Lack of Efficacy|8
1975546|NCT00033293|3537457|FG000|Overall Study|Lost to Follow-up|0
1975547|NCT00033293|3537458|FG001|Overall Study|Lost to Follow-up|1
1975548|NCT00033293|3537457|FG000|Overall Study|Physician Decision|3
1975549|NCT00033293|3537458|FG001|Overall Study|Physician Decision|1
1975550|NCT00033293|3537457|FG000|Overall Study|Withdrawal by Subject|1
1975551|NCT00033293|3537458|FG001|Overall Study|Withdrawal by Subject|0
1975552|NCT00033293|3537457|FG000|Overall Study|Could not be weaned from steroid therapy|1
1975553|NCT00033293|3537458|FG001|Overall Study|Could not be weaned from steroid therapy|1
1975554|NCT00033293|3537457|FG000|Overall Study|Treatment refused|0
1975555|NCT00033293|3537458|FG001|Overall Study|Treatment refused|6
2022329|NCT00319501|3590262|FG001|Open-label Period|Principal Investigator decision|0
2022330|NCT00319501|3590261|FG000|Open-label Period|Sponsor request|12
2022331|NCT00319501|3590262|FG001|Open-label Period|Sponsor request|0
2022332|NCT00319501|3590261|FG000|Open-label Period|Lost to Follow-up|5
2022333|NCT00319501|3590262|FG001|Open-label Period|Lost to Follow-up|0
2022334|NCT00319501|3590261|FG000|Open-label Period|Did not receive treatment|33
2022335|NCT00319501|3590262|FG001|Open-label Period|Did not receive treatment|0
2022336|NCT00319501|3590261|FG000|Open-label Period|Other|11
2022337|NCT00319501|3590262|FG001|Open-label Period|Other|0
2022338|NCT00319501|3590261|FG000|Open-label Extension Period|Adverse Event|2
1975556|NCT04497415|3537468|FG000|Overall Study|Lost to Follow-up|43
1975557|NCT04497415|3537469|FG001|Overall Study|Lost to Follow-up|27
1975558|NCT03894540|3537503|FG000|Overall Study|Adverse Event|0
1975559|NCT03894540|3537504|FG001|Overall Study|Adverse Event|0
1975560|NCT03894540|3537505|FG002|Overall Study|Adverse Event|0
1975561|NCT03894540|3537506|FG003|Overall Study|Adverse Event|0
1975562|NCT03894540|3537507|FG004|Overall Study|Adverse Event|1
1975563|NCT03894540|3537508|FG005|Overall Study|Adverse Event|0
1975564|NCT03894540|3537503|FG000|Overall Study|Withdrawal by Subject|0
1975565|NCT03894540|3537504|FG001|Overall Study|Withdrawal by Subject|0
1975566|NCT03894540|3537505|FG002|Overall Study|Withdrawal by Subject|0
1975567|NCT03894540|3537506|FG003|Overall Study|Withdrawal by Subject|0
1975568|NCT03894540|3537507|FG004|Overall Study|Withdrawal by Subject|1
1975569|NCT03894540|3537508|FG005|Overall Study|Withdrawal by Subject|0
1975570|NCT03894540|3537503|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
1975571|NCT03894540|3537504|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
1975572|NCT03894540|3537505|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1
1975573|NCT03894540|3537506|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
1975574|NCT03894540|3537507|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2
1975575|NCT03894540|3537508|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
1975576|NCT03894540|3537503|FG000|Overall Study|Progressive Disease Clinical|1
1975577|NCT03894540|3537504|FG001|Overall Study|Progressive Disease Clinical|1
1975578|NCT03894540|3537505|FG002|Overall Study|Progressive Disease Clinical|0
1975579|NCT03894540|3537506|FG003|Overall Study|Progressive Disease Clinical|1
1975580|NCT03894540|3537507|FG004|Overall Study|Progressive Disease Clinical|5
1975581|NCT03894540|3537508|FG005|Overall Study|Progressive Disease Clinical|1
1975582|NCT03894540|3537503|FG000|Overall Study|Study termination by sponsor|0
1975583|NCT03894540|3537504|FG001|Overall Study|Study termination by sponsor|0
1975584|NCT03894540|3537505|FG002|Overall Study|Study termination by sponsor|0
1975585|NCT03894540|3537506|FG003|Overall Study|Study termination by sponsor|0
1975586|NCT03894540|3537507|FG004|Overall Study|Study termination by sponsor|2
1975587|NCT03894540|3537508|FG005|Overall Study|Study termination by sponsor|0
2022339|NCT00319501|3590262|FG001|Open-label Extension Period|Adverse Event|0
2022340|NCT00319501|3590261|FG000|Open-label Extension Period|Did not receive treatment|18
2022341|NCT00319501|3590262|FG001|Open-label Extension Period|Did not receive treatment|0
2022342|NCT00319501|3590261|FG000|Open-label Extension Period|Other|1
2022343|NCT00319501|3590262|FG001|Open-label Extension Period|Other|0
2022344|NCT00319501|3590261|FG000|Open-label Extension Period|Principal investigator decision|2
2022345|NCT00319501|3590262|FG001|Open-label Extension Period|Principal investigator decision|0
2022346|NCT00319501|3590261|FG000|Open-label Extension Period|Sponsor request|26
2022347|NCT00319501|3590262|FG001|Open-label Extension Period|Sponsor request|0
2022348|NCT00319501|3590261|FG000|Open-label Extension Period|Withdrawal by Subject|2
2022349|NCT00319501|3590262|FG001|Open-label Extension Period|Withdrawal by Subject|0
2022350|NCT00319553|3590275|FG000|Overall Study|Protocol Violation|1
2022351|NCT00319553|3590276|FG001|Overall Study|Protocol Violation|2
2022352|NCT00319553|3590275|FG000|Overall Study|Lost to Follow-up|2
2022353|NCT00319553|3590276|FG001|Overall Study|Lost to Follow-up|1
2022354|NCT00319553|3590275|FG000|Overall Study|Withdrawal by Subject|1
2022355|NCT00319553|3590276|FG001|Overall Study|Withdrawal by Subject|1
2022356|NCT00319592|3590284|FG000|Overall Study|Protocol Violation|1
2022357|NCT00319592|3590285|FG001|Overall Study|Protocol Violation|0
2022358|NCT00319592|3590284|FG000|Overall Study|Physician Decision|0
2022359|NCT00319592|3590285|FG001|Overall Study|Physician Decision|1
2022360|NCT00319696|3590300|FG000|Overall Study|Adverse Event|36
2022361|NCT00319696|3590300|FG000|Overall Study|withdrawal of consent|14
2022362|NCT00319696|3590300|FG000|Overall Study|administrative|7
2022363|NCT00319696|3590300|FG000|Overall Study|Lost to Follow-up|3
2022364|NCT00319735|3590310|FG000|Overall Study|Death|2
2022365|NCT00319956|3590327|FG000|Overall Study|Death|20
2022366|NCT00319956|3590328|FG001|Overall Study|Death|24
2022367|NCT00319982|3590336|FG000|Overall Study|Withdrawal by Subject|1
2022368|NCT00319982|3590337|FG001|Overall Study|Withdrawal by Subject|0
2022369|NCT00320112|3590345|FG000|Overall Study|Lost to Follow-up|3
2022370|NCT00320112|3590346|FG001|Overall Study|Lost to Follow-up|4
2022371|NCT00320112|3590345|FG000|Overall Study|Withdrawal by Subject|3
2022372|NCT00320112|3590346|FG001|Overall Study|Withdrawal by Subject|0
2022373|NCT00320112|3590345|FG000|Overall Study|Death|2
2022374|NCT00320112|3590346|FG001|Overall Study|Death|1
2022375|NCT00320190|3590360|FG000|First 12 Months|Completed but did not enter extension|5
2022376|NCT00320190|3590361|FG001|First 12 Months|Completed but did not enter extension|3
2022377|NCT00320190|3590360|FG000|First 12 Months|Sponsor terminated study|2
2022378|NCT00320190|3590361|FG001|First 12 Months|Sponsor terminated study|2
2022379|NCT00320190|3590360|FG000|First 12 Months|Lost to Follow-up|0
2022380|NCT00320190|3590361|FG001|First 12 Months|Lost to Follow-up|1
2022381|NCT00320190|3590360|FG000|First 12 Months|Enrollment failure|0
2022382|NCT00320190|3590361|FG001|First 12 Months|Enrollment failure|1
2022383|NCT00320190|3590360|FG000|First 12 Months|Adverse event unrelated to study drug|1
2022384|NCT00320190|3590361|FG001|First 12 Months|Adverse event unrelated to study drug|0
1975588|NCT03725293|3537532|FG000|Overall Study|Physician Decision|9
1975589|NCT03725293|3537533|FG001|Overall Study|Physician Decision|6
1975590|NCT03725293|3537532|FG000|Overall Study|alternative vascular access needs|1
1975591|NCT03725293|3537533|FG001|Overall Study|alternative vascular access needs|2
1975592|NCT03725293|3537532|FG000|Overall Study|venous anatomy screen failures|2
1975593|NCT03725293|3537533|FG001|Overall Study|venous anatomy screen failures|1
1975594|NCT03702231|3537542|FG000|Overall Study|Withdrawal by Subject|1
1975595|NCT03702231|3537543|FG001|Overall Study|Withdrawal by Subject|0
1975596|NCT03702231|3537544|FG002|Overall Study|Withdrawal by Subject|0
1975597|NCT03702231|3537542|FG000|Overall Study|Protocol Violation|0
1975598|NCT03702231|3537543|FG001|Overall Study|Protocol Violation|0
1975599|NCT03702231|3537544|FG002|Overall Study|Protocol Violation|1
1975600|NCT03702231|3537542|FG000|Overall Study|COVID Pandemic|3
1975601|NCT03702231|3537543|FG001|Overall Study|COVID Pandemic|4
1975602|NCT03702231|3537544|FG002|Overall Study|COVID Pandemic|1
1975603|NCT03600805|3537577|FG000|Overall Study|Adverse Event|2
1975604|NCT03600805|3537578|FG001|Overall Study|Adverse Event|1
1975605|NCT03600805|3537579|FG002|Overall Study|Adverse Event|1
1975606|NCT03600805|3537580|FG003|Overall Study|Adverse Event|7
1975607|NCT03600805|3537577|FG000|Overall Study|Lack of Efficacy|2
1975608|NCT03600805|3537578|FG001|Overall Study|Lack of Efficacy|1
1975609|NCT03600805|3537579|FG002|Overall Study|Lack of Efficacy|0
1975610|NCT03600805|3537580|FG003|Overall Study|Lack of Efficacy|0
1975611|NCT03600805|3537577|FG000|Overall Study|Withdrawal by Subject|1
1975612|NCT03600805|3537578|FG001|Overall Study|Withdrawal by Subject|0
1975613|NCT03600805|3537579|FG002|Overall Study|Withdrawal by Subject|0
1975614|NCT03600805|3537580|FG003|Overall Study|Withdrawal by Subject|1
1975615|NCT03600805|3537577|FG000|Overall Study|Other unspecified|14
1975616|NCT03600805|3537578|FG001|Overall Study|Other unspecified|6
1975617|NCT03600805|3537579|FG002|Overall Study|Other unspecified|7
1975618|NCT03600805|3537580|FG003|Overall Study|Other unspecified|11
1975619|NCT03556358|3537594|FG000|Overall Study|Subjects Randomized that did not Treat|3
1975620|NCT03556358|3537595|FG001|Overall Study|Subjects Randomized that did not Treat|0
1975621|NCT03556358|3537594|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7
1975622|NCT03556358|3537595|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5
1975623|NCT03556358|3537594|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0
1975624|NCT03556358|3537595|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1
1975625|NCT03556358|3537594|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0
1975626|NCT03556358|3537595|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1
1975627|NCT03556358|3537594|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0
1975628|NCT03556358|3537595|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2
1975629|NCT03556358|3537594|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0
1975630|NCT03556358|3537595|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1
1975631|NCT03556358|3537594|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1
1975632|NCT03556358|3537595|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2
1975633|NCT03290781|3537608|FG000|Overall Study|Adverse Event|5
1975634|NCT03290781|3537609|FG001|Overall Study|Adverse Event|7
1975635|NCT03290781|3537610|FG002|Overall Study|Adverse Event|4
1975636|NCT03290781|3537611|FG003|Overall Study|Adverse Event|1
1975637|NCT03290781|3537612|FG004|Overall Study|Adverse Event|0
1975638|NCT03290781|3537613|FG005|Overall Study|Adverse Event|0
1975639|NCT03290781|3537614|FG006|Overall Study|Adverse Event|0
1975640|NCT03290781|3537608|FG000|Overall Study|Death|0
1975641|NCT03290781|3537609|FG001|Overall Study|Death|0
1975642|NCT03290781|3537610|FG002|Overall Study|Death|1
1975643|NCT03290781|3537611|FG003|Overall Study|Death|0
1975644|NCT03290781|3537612|FG004|Overall Study|Death|1
1975645|NCT03290781|3537613|FG005|Overall Study|Death|0
1975646|NCT03290781|3537614|FG006|Overall Study|Death|0
1975647|NCT03290781|3537608|FG000|Overall Study|Withdrawal by Subject|6
1975648|NCT03290781|3537609|FG001|Overall Study|Withdrawal by Subject|5
1975649|NCT03290781|3537610|FG002|Overall Study|Withdrawal by Subject|9
1975650|NCT03290781|3537611|FG003|Overall Study|Withdrawal by Subject|10
1975651|NCT03290781|3537612|FG004|Overall Study|Withdrawal by Subject|1
1975652|NCT03290781|3537613|FG005|Overall Study|Withdrawal by Subject|2
1975653|NCT03290781|3537614|FG006|Overall Study|Withdrawal by Subject|0
1975654|NCT03290781|3537608|FG000|Overall Study|Physician Decision|0
1975655|NCT03290781|3537609|FG001|Overall Study|Physician Decision|1
1975656|NCT03290781|3537610|FG002|Overall Study|Physician Decision|0
1975657|NCT03290781|3537611|FG003|Overall Study|Physician Decision|0
1975658|NCT03290781|3537612|FG004|Overall Study|Physician Decision|0
1975659|NCT03290781|3537613|FG005|Overall Study|Physician Decision|0
1975660|NCT03290781|3537614|FG006|Overall Study|Physician Decision|0
1975661|NCT03290781|3537608|FG000|Overall Study|Site Terminated by Sponsor|1
1975662|NCT03290781|3537609|FG001|Overall Study|Site Terminated by Sponsor|0
1975663|NCT03290781|3537610|FG002|Overall Study|Site Terminated by Sponsor|2
1975664|NCT03290781|3537611|FG003|Overall Study|Site Terminated by Sponsor|1
1975665|NCT03290781|3537612|FG004|Overall Study|Site Terminated by Sponsor|0
1975666|NCT03290781|3537613|FG005|Overall Study|Site Terminated by Sponsor|0
1975667|NCT03290781|3537614|FG006|Overall Study|Site Terminated by Sponsor|0
1975668|NCT03290781|3537608|FG000|Overall Study|Lost to Follow-up|0
1975669|NCT03290781|3537609|FG001|Overall Study|Lost to Follow-up|0
1975670|NCT03290781|3537610|FG002|Overall Study|Lost to Follow-up|0
1975671|NCT03290781|3537611|FG003|Overall Study|Lost to Follow-up|1
1975672|NCT03290781|3537612|FG004|Overall Study|Lost to Follow-up|0
1975673|NCT03290781|3537613|FG005|Overall Study|Lost to Follow-up|0
1975674|NCT03290781|3537614|FG006|Overall Study|Lost to Follow-up|0
1975675|NCT03290781|3537608|FG000|Overall Study|Protocol Deviation|2
1975676|NCT03290781|3537609|FG001|Overall Study|Protocol Deviation|0
1975677|NCT03290781|3537610|FG002|Overall Study|Protocol Deviation|0
1975678|NCT03290781|3537611|FG003|Overall Study|Protocol Deviation|1
1975679|NCT03290781|3537612|FG004|Overall Study|Protocol Deviation|0
1975680|NCT03290781|3537613|FG005|Overall Study|Protocol Deviation|0
1975681|NCT03290781|3537614|FG006|Overall Study|Protocol Deviation|0
1975682|NCT03290781|3537608|FG000|Overall Study|Disease Relapse|32
1975683|NCT03290781|3537609|FG001|Overall Study|Disease Relapse|5
1975684|NCT03290781|3537610|FG002|Overall Study|Disease Relapse|38
1975685|NCT03290781|3537611|FG003|Overall Study|Disease Relapse|7
1975686|NCT03290781|3537612|FG004|Overall Study|Disease Relapse|3
1975687|NCT03290781|3537613|FG005|Overall Study|Disease Relapse|1
1975688|NCT03290781|3537614|FG006|Overall Study|Disease Relapse|4
1975689|NCT03290781|3537608|FG000|Overall Study|Other|3
1975690|NCT03290781|3537609|FG001|Overall Study|Other|0
1975691|NCT03290781|3537610|FG002|Overall Study|Other|2
1975692|NCT03290781|3537611|FG003|Overall Study|Other|2
1975693|NCT03290781|3537612|FG004|Overall Study|Other|0
1975694|NCT03290781|3537613|FG005|Overall Study|Other|0
1975695|NCT03290781|3537614|FG006|Overall Study|Other|0
1975696|NCT03228680|3537673|FG000|Overall Study|Adverse Event|13
1975697|NCT03228680|3537674|FG001|Overall Study|Adverse Event|18
1975698|NCT03228680|3537673|FG000|Overall Study|Randomization failure|0
1975699|NCT03228680|3537674|FG001|Overall Study|Randomization failure|1
1975700|NCT03228680|3537673|FG000|Overall Study|Withdrawal by Subject|1
1975701|NCT03228680|3537674|FG001|Overall Study|Withdrawal by Subject|0
1975702|NCT03228680|3537673|FG000|Overall Study|Other|9
1975703|NCT03228680|3537674|FG001|Overall Study|Other|16
1975704|NCT03170882|3537696|FG000|Overall Study|Ongoing|10
1975705|NCT03170882|3537697|FG001|Overall Study|Ongoing|14
1975706|NCT03170882|3537696|FG000|Overall Study|Death|15
1975707|NCT03170882|3537697|FG001|Overall Study|Death|29
1975708|NCT03170882|3537696|FG000|Overall Study|Lost to Follow-up|0
1975709|NCT03170882|3537697|FG001|Overall Study|Lost to Follow-up|1
1975710|NCT03170882|3537696|FG000|Overall Study|Withdrawal by Subject|4
1975711|NCT03170882|3537697|FG001|Overall Study|Withdrawal by Subject|6
1975712|NCT03170882|3537696|FG000|Overall Study|Reason not Specified|0
1975713|NCT03170882|3537697|FG001|Overall Study|Reason not Specified|1
1975714|NCT03064126|3537712|FG000|Overall Study|Death|6
1975715|NCT03064126|3537713|FG001|Overall Study|Death|2
1975716|NCT03064126|3537714|FG002|Overall Study|Death|2
1975717|NCT03064126|3537715|FG003|Overall Study|Death|1
1975718|NCT03064126|3537712|FG000|Overall Study|Investigator Discretion|1
1975719|NCT03064126|3537713|FG001|Overall Study|Investigator Discretion|0
1975720|NCT03064126|3537714|FG002|Overall Study|Investigator Discretion|0
1975721|NCT03064126|3537715|FG003|Overall Study|Investigator Discretion|0
1975722|NCT03064126|3537712|FG000|Overall Study|Withdrawal by Subject|7
1975723|NCT03064126|3537713|FG001|Overall Study|Withdrawal by Subject|4
1975724|NCT03064126|3537714|FG002|Overall Study|Withdrawal by Subject|0
1975725|NCT03064126|3537715|FG003|Overall Study|Withdrawal by Subject|0
1975726|NCT03064126|3537712|FG000|Overall Study|Subject moved|1
1975727|NCT03064126|3537713|FG001|Overall Study|Subject moved|0
1975728|NCT03064126|3537714|FG002|Overall Study|Subject moved|0
1975729|NCT03064126|3537715|FG003|Overall Study|Subject moved|0
1975730|NCT03064126|3537712|FG000|Overall Study|Protocol Violation|11
1975731|NCT03064126|3537713|FG001|Overall Study|Protocol Violation|1
1975732|NCT03064126|3537714|FG002|Overall Study|Protocol Violation|1
1975733|NCT03064126|3537715|FG003|Overall Study|Protocol Violation|0
1975734|NCT02679781|3537741|FG000|Overall Study|Lost to Follow-up|1
1975735|NCT02679781|3537742|FG001|Overall Study|Lost to Follow-up|2
1975736|NCT02679781|3537741|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6
1975737|NCT02679781|3537742|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1
1975738|NCT02624869|3537751|FG000|Overall Study|Lost to Follow-up|0
1975739|NCT02624869|3537752|FG001|Overall Study|Lost to Follow-up|0
1975740|NCT02624869|3537753|FG002|Overall Study|Lost to Follow-up|1
1975741|NCT02624869|3537751|FG000|Overall Study|Withdrawal by Subject|1
1975742|NCT02624869|3537752|FG001|Overall Study|Withdrawal by Subject|3
1975743|NCT02624869|3537753|FG002|Overall Study|Withdrawal by Subject|1
1975744|NCT02569242|3537777|FG000|Overall Study|Death|1
1975745|NCT02569242|3537778|FG001|Overall Study|Death|0
1975746|NCT02569242|3537777|FG000|Overall Study|Withdrawal by Subject|0
1975747|NCT02569242|3537778|FG001|Overall Study|Withdrawal by Subject|1
2022385|NCT00320190|3590360|FG000|First 12 Months|Investigator request|0
2022386|NCT00320190|3590361|FG001|First 12 Months|Investigator request|1
2022387|NCT00320190|3590360|FG000|First 12 Months|Study drug toxicity|0
2022388|NCT00320190|3590361|FG001|First 12 Months|Study drug toxicity|1
2022389|NCT00320190|3590360|FG000|First 12 Months|Withdrawal by Subject|0
2022390|NCT00320190|3590361|FG001|First 12 Months|Withdrawal by Subject|1
1975748|NCT02435433|3537801|FG000|Overall Study|On Treatment|11
1975749|NCT02435433|3537802|FG001|Overall Study|On Treatment|0
1975750|NCT02435433|3537803|FG002|Overall Study|On Treatment|0
1975751|NCT02435433|3537804|FG003|Overall Study|On Treatment|0
1975752|NCT02435433|3537805|FG004|Overall Study|On Treatment|0
1975753|NCT02435433|3537801|FG000|Overall Study|Withdrawal by Subject|2
1975754|NCT02435433|3537802|FG001|Overall Study|Withdrawal by Subject|3
1975755|NCT02435433|3537803|FG002|Overall Study|Withdrawal by Subject|0
1975756|NCT02435433|3537804|FG003|Overall Study|Withdrawal by Subject|0
1975757|NCT02435433|3537805|FG004|Overall Study|Withdrawal by Subject|0
1975758|NCT02435433|3537801|FG000|Overall Study|Lost to Follow-up|2
1975759|NCT02435433|3537802|FG001|Overall Study|Lost to Follow-up|2
1975760|NCT02435433|3537803|FG002|Overall Study|Lost to Follow-up|0
1975761|NCT02435433|3537804|FG003|Overall Study|Lost to Follow-up|0
1975762|NCT02435433|3537805|FG004|Overall Study|Lost to Follow-up|0
1975763|NCT02426125|3537815|FG000|Overall Study|Lost to Follow-up|12
1975764|NCT02426125|3537816|FG001|Overall Study|Lost to Follow-up|10
1975765|NCT02426125|3537815|FG000|Overall Study|Protocol Violation|1
1975766|NCT02426125|3537816|FG001|Overall Study|Protocol Violation|0
1975767|NCT02426125|3537815|FG000|Overall Study|Withdrawal by Subject|16
1975768|NCT02426125|3537816|FG001|Overall Study|Withdrawal by Subject|16
1975769|NCT02368886|3537837|FG000|Overall Study|Cancel|1
1975770|NCT02368886|3537838|FG001|Overall Study|Cancel|1
1975771|NCT02368886|3537839|FG002|Overall Study|Cancel|1
1975772|NCT02368886|3537840|FG003|Overall Study|Cancel|3
1975773|NCT02368886|3537837|FG000|Overall Study|Ineligible|0
1975774|NCT02368886|3537838|FG001|Overall Study|Ineligible|0
1975775|NCT02368886|3537839|FG002|Overall Study|Ineligible|0
1975776|NCT02368886|3537840|FG003|Overall Study|Ineligible|1
1975777|NCT02354703|3537852|FG000|Overall Study|Withdrawal by Subject|1
1975778|NCT02354703|3537853|FG001|Overall Study|Withdrawal by Subject|1
1975779|NCT02354703|3537854|FG002|Overall Study|Withdrawal by Subject|1
1975780|NCT02354703|3537855|FG003|Overall Study|Withdrawal by Subject|1
1975781|NCT02354703|3537852|FG000|Overall Study|Lost to Follow-up|2
1975782|NCT02354703|3537853|FG001|Overall Study|Lost to Follow-up|7
1975783|NCT02354703|3537854|FG002|Overall Study|Lost to Follow-up|9
1975784|NCT02354703|3537855|FG003|Overall Study|Lost to Follow-up|2
1975785|NCT02354703|3537852|FG000|Overall Study|Adverse Event|0
1975786|NCT02354703|3537853|FG001|Overall Study|Adverse Event|0
1975787|NCT02354703|3537854|FG002|Overall Study|Adverse Event|1
1975788|NCT02354703|3537855|FG003|Overall Study|Adverse Event|0
1975789|NCT02312258|3537869|FG000|Overall Study|Adverse Event|15
1975790|NCT02312258|3537870|FG001|Overall Study|Adverse Event|47
1975791|NCT02312258|3537869|FG000|Overall Study|Lost to Follow-up|0
1975792|NCT02312258|3537870|FG001|Overall Study|Lost to Follow-up|1
1975793|NCT02312258|3537869|FG000|Overall Study|Progressive Disease|174
1975794|NCT02312258|3537870|FG001|Overall Study|Progressive Disease|188
1975795|NCT02312258|3537869|FG000|Overall Study|Withdrawal by Subject|8
1975796|NCT02312258|3537870|FG001|Overall Study|Withdrawal by Subject|9
1975797|NCT02312258|3537869|FG000|Overall Study|Reason not Specified|11
1975798|NCT02312258|3537870|FG001|Overall Study|Reason not Specified|31
1975799|NCT02312258|3537869|FG000|Overall Study|Participants Ongoing Treatment|43
1975800|NCT02312258|3537870|FG001|Overall Study|Participants Ongoing Treatment|83
1975801|NCT01981551|3537876|FG000|Overall Study|Refused further treatment|8
1975802|NCT01981551|3537876|FG000|Overall Study|Adverse Event|1
1975803|NCT01772472|3537882|FG000|Overall Study|Death|56
1975804|NCT01772472|3537883|FG001|Overall Study|Death|42
1975805|NCT01772472|3537882|FG000|Overall Study|Physician Decision|1
1975806|NCT01772472|3537883|FG001|Overall Study|Physician Decision|3
1975807|NCT01772472|3537882|FG000|Overall Study|Other|5
1975808|NCT01772472|3537883|FG001|Overall Study|Other|5
1975809|NCT01772472|3537882|FG000|Overall Study|Lost to Follow-up|12
1975810|NCT01772472|3537883|FG001|Overall Study|Lost to Follow-up|8
1975811|NCT01772472|3537882|FG000|Overall Study|Withdrawal by Subject|72
1975812|NCT01772472|3537883|FG001|Overall Study|Withdrawal by Subject|50
1975813|NCT01772472|3537882|FG000|Overall Study|Ongoing|597
1975814|NCT01772472|3537883|FG001|Overall Study|Ongoing|635
1975815|NCT00468130|3537895|FG000|Overall Study|Adverse Event|2
1975816|NCT00468130|3537896|FG001|Overall Study|Adverse Event|1
1975817|NCT00468130|3537895|FG000|Overall Study|Withdrawal by Subject|0
1975818|NCT00468130|3537896|FG001|Overall Study|Withdrawal by Subject|1
1975819|NCT00384111|3537904|FG000|Overall Study|Disease Progression|3
1975820|NCT00384111|3537904|FG000|Overall Study|Adverse Event|1
1975821|NCT00384111|3537904|FG000|Overall Study|Investigator Decision|3
1975822|NCT00384111|3537904|FG000|Overall Study|Study Terminated by the Sponsor|19
1975823|NCT04854642|3537908|FG000|Overall Study|Adverse Event|1
1975824|NCT04854642|3537909|FG001|Overall Study|Adverse Event|2
1975825|NCT04854642|3537908|FG000|Overall Study|Withdrawal by Subject|0
1975826|NCT04854642|3537909|FG001|Overall Study|Withdrawal by Subject|1
1975827|NCT04608344|3537919|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0
1975828|NCT04608344|3537920|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1
1975829|NCT04608344|3537919|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1
1975830|NCT04608344|3537920|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0
1975831|NCT04388787|3537947|FG000|Blinded Period|Patient could not follow instructions|1
1975832|NCT04388787|3537947|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9
1975833|NCT04377620|3537971|FG000|Overall Study|Death|42
1975834|NCT04377620|3537972|FG001|Overall Study|Death|48
1975835|NCT04377620|3537973|FG002|Overall Study|Death|36
1975836|NCT04377620|3537971|FG000|Overall Study|Withdrawal by Subject|0
1975837|NCT04377620|3537972|FG001|Overall Study|Withdrawal by Subject|2
1975838|NCT04377620|3537973|FG002|Overall Study|Withdrawal by Subject|0
1975839|NCT04310566|3538004|FG000|Period 1|Study Termination due to COVID-19|15
1975840|NCT04310566|3538005|FG001|Period 1|Study Termination due to COVID-19|17
1975841|NCT04310566|3538004|FG000|Period 1|Protocol Violation|0
1975842|NCT04310566|3538005|FG001|Period 1|Protocol Violation|1
1975843|NCT04310566|3538004|FG000|Period 1|Subject no longer meets eligbility criteria|0
1975844|NCT04310566|3538005|FG001|Period 1|Subject no longer meets eligbility criteria|1
1975845|NCT04310566|3538004|FG000|Period 1|Lost to Follow-up|1
1975846|NCT04310566|3538005|FG001|Period 1|Lost to Follow-up|0
1975847|NCT04310566|3538004|FG000|Period 1|Withdrawal by Subject|0
1975848|NCT04310566|3538005|FG001|Period 1|Withdrawal by Subject|1
1975849|NCT04310566|3538004|FG000|Period 2|Study Termination|7
1975850|NCT04310566|3538005|FG001|Period 2|Study Termination|5
1975851|NCT04206020|3538013|FG000|Overall Study|Adverse Event|1
1975852|NCT04206020|3538014|FG001|Overall Study|Adverse Event|4
1975853|NCT04206020|3538013|FG000|Overall Study|Protocol Violation|2
1975854|NCT04206020|3538014|FG001|Overall Study|Protocol Violation|0
1975855|NCT04206020|3538013|FG000|Overall Study|Withdrawal by Subject|2
1975856|NCT04206020|3538014|FG001|Overall Study|Withdrawal by Subject|0
1975857|NCT04206020|3538013|FG000|Overall Study|Lost to Follow-up|2
1975858|NCT04206020|3538014|FG001|Overall Study|Lost to Follow-up|0
1975859|NCT04206020|3538013|FG000|Overall Study|Pregnancy|0
1975860|NCT04206020|3538014|FG001|Overall Study|Pregnancy|1
1975861|NCT04206020|3538013|FG000|Overall Study|Unable to attend visits|1
1975862|NCT04206020|3538014|FG001|Overall Study|Unable to attend visits|2
2022391|NCT00320190|3590360|FG000|Long-term (12-month) Extension|Sponsor terminated study|7
2022392|NCT00320190|3590361|FG001|Long-term (12-month) Extension|Sponsor terminated study|0
2022393|NCT00320190|3590360|FG000|Long-term (12-month) Extension|Lack of major molecular response|1
2022394|NCT00320190|3590361|FG001|Long-term (12-month) Extension|Lack of major molecular response|2
2022395|NCT00320190|3590360|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1
2022396|NCT00320190|3590361|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0
2022397|NCT00320216|3590372|FG000|Overall Study|Adverse Event|0
2022398|NCT00320216|3590373|FG001|Overall Study|Adverse Event|6
2022399|NCT00320216|3590374|FG002|Overall Study|Adverse Event|0
2022400|NCT00320216|3590375|FG003|Overall Study|Adverse Event|2
2022401|NCT00320216|3590376|FG004|Overall Study|Adverse Event|2
2022402|NCT00320216|3590372|FG000|Overall Study|Lack of Efficacy|6
2022403|NCT00320216|3590373|FG001|Overall Study|Lack of Efficacy|2
2022404|NCT00320216|3590374|FG002|Overall Study|Lack of Efficacy|1
2022405|NCT00320216|3590375|FG003|Overall Study|Lack of Efficacy|0
2022406|NCT00320216|3590376|FG004|Overall Study|Lack of Efficacy|1
2022407|NCT00320216|3590372|FG000|Overall Study|Lost to Follow-up|3
2022408|NCT00320216|3590373|FG001|Overall Study|Lost to Follow-up|0
2022409|NCT00320216|3590374|FG002|Overall Study|Lost to Follow-up|0
2022410|NCT00320216|3590375|FG003|Overall Study|Lost to Follow-up|0
2022411|NCT00320216|3590376|FG004|Overall Study|Lost to Follow-up|0
2022412|NCT00320216|3590372|FG000|Overall Study|Other|7
2022413|NCT00320216|3590373|FG001|Overall Study|Other|2
2022414|NCT00320216|3590374|FG002|Overall Study|Other|5
2022415|NCT00320216|3590375|FG003|Overall Study|Other|1
2022416|NCT00320216|3590376|FG004|Overall Study|Other|3
2022417|NCT00320255|3590407|FG000|Overall Study|Lack of Efficacy|1
2022418|NCT00320255|3590408|FG001|Overall Study|Lack of Efficacy|0
2022419|NCT00320255|3590409|FG002|Overall Study|Lack of Efficacy|0
2213095|NCT01675622|3854441|FG000|Overall Study|Lack of Efficacy|2
2022420|NCT00320255|3590410|FG003|Overall Study|Lack of Efficacy|0
2022421|NCT00320255|3590411|FG004|Overall Study|Lack of Efficacy|0
2022422|NCT00320255|3590412|FG005|Overall Study|Lack of Efficacy|0
2022423|NCT00320255|3590407|FG000|Overall Study|Adverse Event|5
2022424|NCT00320255|3590408|FG001|Overall Study|Adverse Event|2
2022425|NCT00320255|3590409|FG002|Overall Study|Adverse Event|3
2022426|NCT00320255|3590410|FG003|Overall Study|Adverse Event|2
2022427|NCT00320255|3590411|FG004|Overall Study|Adverse Event|0
2022428|NCT00320255|3590412|FG005|Overall Study|Adverse Event|0
2022429|NCT00320255|3590407|FG000|Overall Study|Withdrawal by Subject|1
2022430|NCT00320255|3590408|FG001|Overall Study|Withdrawal by Subject|2
2022431|NCT00320255|3590409|FG002|Overall Study|Withdrawal by Subject|2
2022432|NCT00320255|3590410|FG003|Overall Study|Withdrawal by Subject|4
2022433|NCT00320255|3590411|FG004|Overall Study|Withdrawal by Subject|0
2022434|NCT00320255|3590412|FG005|Overall Study|Withdrawal by Subject|0
2022435|NCT00320255|3590407|FG000|Overall Study|Poor compliance/noncompliance|1
2022436|NCT00320255|3590408|FG001|Overall Study|Poor compliance/noncompliance|1
2022437|NCT00320255|3590409|FG002|Overall Study|Poor compliance/noncompliance|0
2022438|NCT00320255|3590410|FG003|Overall Study|Poor compliance/noncompliance|1
2022439|NCT00320255|3590411|FG004|Overall Study|Poor compliance/noncompliance|0
2022440|NCT00320255|3590412|FG005|Overall Study|Poor compliance/noncompliance|0
2022441|NCT00320255|3590407|FG000|Overall Study|No longer meets study criteria|0
2022442|NCT00320255|3590408|FG001|Overall Study|No longer meets study criteria|0
2022443|NCT00320255|3590409|FG002|Overall Study|No longer meets study criteria|0
1975863|NCT04097301|3538020|FG000|Overall Study|Death|1
1975864|NCT04097301|3538020|FG000|Overall Study|Withdrawal by Subject|1
1975865|NCT04097301|3538020|FG000|Overall Study|Screening Failure|5
1975866|NCT03953079|3538033|FG000|Core Study|Withdrawal by Subject|1
1975867|NCT03953079|3538034|FG001|Core Study|Withdrawal by Subject|2
1975868|NCT03953079|3538035|FG002|Core Study|Withdrawal by Subject|1
1975869|NCT03953079|3538033|FG000|Core Study|COVID-19|0
1975870|NCT03953079|3538034|FG001|Core Study|COVID-19|1
1975871|NCT03953079|3538035|FG002|Core Study|COVID-19|0
1975872|NCT03953079|3538033|FG000|Core Study|Difficulties leaving the house|0
1975873|NCT03953079|3538034|FG001|Core Study|Difficulties leaving the house|1
1975874|NCT03953079|3538035|FG002|Core Study|Difficulties leaving the house|0
1975875|NCT03953079|3538033|FG000|Extension Study|Withdrawal by Subject|1
1975876|NCT03953079|3538034|FG001|Extension Study|Withdrawal by Subject|0
1975877|NCT03953079|3538035|FG002|Extension Study|Withdrawal by Subject|0
1975878|NCT03953079|3538033|FG000|Extension Study|Received Rescue Treatment|5
1975879|NCT03953079|3538034|FG001|Extension Study|Received Rescue Treatment|6
1975880|NCT03953079|3538035|FG002|Extension Study|Received Rescue Treatment|5
1975881|NCT03922750|3538047|FG000|Overall Study|Unclassified|0
1975882|NCT03922750|3538048|FG001|Overall Study|Unclassified|0
1975883|NCT03922750|3538049|FG002|Overall Study|Unclassified|1
1975884|NCT03922750|3538047|FG000|Overall Study|Adverse Event|0
1975885|NCT03922750|3538048|FG001|Overall Study|Adverse Event|1
1975886|NCT03922750|3538049|FG002|Overall Study|Adverse Event|0
1975887|NCT03910673|3538062|FG000|Overall Study|Adverse Event|0
1975888|NCT03910673|3538063|FG001|Overall Study|Adverse Event|0
1975889|NCT03910673|3538064|FG002|Overall Study|Adverse Event|0
1975890|NCT03910673|3538065|FG003|Overall Study|Adverse Event|2
1975891|NCT03910673|3538066|FG004|Overall Study|Adverse Event|0
1975892|NCT03885999|3538070|FG000|Overall Study|Adverse Event|1
1975893|NCT03882970|3538078|FG000|Overall Study|Adverse Event|5
1975894|NCT03882970|3538079|FG001|Overall Study|Adverse Event|7
1975895|NCT03882970|3538080|FG002|Overall Study|Adverse Event|3
1975896|NCT03882970|3538081|FG003|Overall Study|Adverse Event|1
1975897|NCT03882970|3538078|FG000|Overall Study|Death|1
1975898|NCT03882970|3538079|FG001|Overall Study|Death|2
1975899|NCT03882970|3538080|FG002|Overall Study|Death|1
1975900|NCT03882970|3538081|FG003|Overall Study|Death|1
1975901|NCT03882970|3538078|FG000|Overall Study|Lost to Follow-up|8
1975902|NCT03882970|3538079|FG001|Overall Study|Lost to Follow-up|9
1975903|NCT03882970|3538080|FG002|Overall Study|Lost to Follow-up|5
1975904|NCT03882970|3538081|FG003|Overall Study|Lost to Follow-up|5
1975905|NCT03882970|3538078|FG000|Overall Study|Physician Decision|0
1975906|NCT03882970|3538079|FG001|Overall Study|Physician Decision|2
1975907|NCT03882970|3538080|FG002|Overall Study|Physician Decision|2
1975908|NCT03882970|3538081|FG003|Overall Study|Physician Decision|2
1975909|NCT03882970|3538078|FG000|Overall Study|Protocol Violation|2
1975910|NCT03882970|3538079|FG001|Overall Study|Protocol Violation|0
1975911|NCT03882970|3538080|FG002|Overall Study|Protocol Violation|0
1975912|NCT03882970|3538081|FG003|Overall Study|Protocol Violation|0
1975913|NCT03882970|3538078|FG000|Overall Study|Withdrawal by Subject|8
1975914|NCT03882970|3538079|FG001|Overall Study|Withdrawal by Subject|17
1975915|NCT03882970|3538080|FG002|Overall Study|Withdrawal by Subject|7
1975916|NCT03882970|3538081|FG003|Overall Study|Withdrawal by Subject|22
1975917|NCT03882970|3538078|FG000|Overall Study|Personal Reason|2
1975918|NCT03882970|3538079|FG001|Overall Study|Personal Reason|3
1975919|NCT03882970|3538080|FG002|Overall Study|Personal Reason|1
1975920|NCT03882970|3538081|FG003|Overall Study|Personal Reason|3
1975921|NCT03867734|3538105|FG000|Overall Study|Lost to Follow-up|2
1975922|NCT03781778|3538125|FG000|Overall Study|Withdrawal by Subject|2
1975923|NCT03781778|3538126|FG001|Overall Study|Withdrawal by Subject|2
1975924|NCT03730480|3538149|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1
1975925|NCT03713034|3538162|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5
1975926|NCT03713034|3538163|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4
1975927|NCT03654404|3538171|FG000|Overall Study|Death|1
1975928|NCT03654404|3538171|FG000|Overall Study|Lost to Follow-up|2
1975929|NCT03654404|3538171|FG000|Overall Study|Withdrawal by Subject|5
1975930|NCT03567057|3538178|FG000|Overall Study|Adverse Event|56
1975931|NCT03567057|3538179|FG001|Overall Study|Adverse Event|53
1975932|NCT03567057|3538180|FG002|Overall Study|Adverse Event|28
1975933|NCT03567057|3538178|FG000|Overall Study|Withdrawal by Subject|22
1975934|NCT03567057|3538179|FG001|Overall Study|Withdrawal by Subject|24
1975935|NCT03567057|3538180|FG002|Overall Study|Withdrawal by Subject|13
1975936|NCT03567057|3538178|FG000|Overall Study|Lost to Follow-up|3
1975937|NCT03567057|3538179|FG001|Overall Study|Lost to Follow-up|5
1975938|NCT03567057|3538180|FG002|Overall Study|Lost to Follow-up|2
1975939|NCT03567057|3538178|FG000|Overall Study|COVID-19 pandemic|4
1975940|NCT03567057|3538179|FG001|Overall Study|COVID-19 pandemic|3
1975941|NCT03567057|3538180|FG002|Overall Study|COVID-19 pandemic|0
1975942|NCT03567057|3538178|FG000|Overall Study|Non-compliance with study drug|4
1975943|NCT03567057|3538179|FG001|Overall Study|Non-compliance with study drug|2
1975944|NCT03567057|3538180|FG002|Overall Study|Non-compliance with study drug|0
1975945|NCT03567057|3538178|FG000|Overall Study|Lack of Efficacy|3
1975946|NCT03567057|3538179|FG001|Overall Study|Lack of Efficacy|0
1975947|NCT03567057|3538180|FG002|Overall Study|Lack of Efficacy|1
1975948|NCT03567057|3538178|FG000|Overall Study|Death|1
1975949|NCT03567057|3538179|FG001|Overall Study|Death|0
1975950|NCT03567057|3538180|FG002|Overall Study|Death|0
1975951|NCT03567057|3538178|FG000|Overall Study|Physician Decision|1
1975952|NCT03567057|3538179|FG001|Overall Study|Physician Decision|0
1975953|NCT03567057|3538180|FG002|Overall Study|Physician Decision|0
1975954|NCT03567057|3538178|FG000|Overall Study|Unstable medical condition|1
1975955|NCT03567057|3538179|FG001|Overall Study|Unstable medical condition|0
1975956|NCT03567057|3538180|FG002|Overall Study|Unstable medical condition|0
1975957|NCT03567057|3538178|FG000|Overall Study|Medical history event|0
1975958|NCT03567057|3538179|FG001|Overall Study|Medical history event|0
1975959|NCT03567057|3538180|FG002|Overall Study|Medical history event|1
1975960|NCT03567057|3538178|FG000|Overall Study|Other|0
1975961|NCT03567057|3538179|FG001|Overall Study|Other|0
1975962|NCT03567057|3538180|FG002|Overall Study|Other|1
1975963|NCT03548987|3538190|FG000|Run-in Period (Week 0 to Week 20)|Other|9
1975964|NCT03548987|3538191|FG001|Run-in Period (Week 0 to Week 20)|Other|0
1975965|NCT03548987|3538190|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8
1975966|NCT03548987|3538191|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0
1975967|NCT03548987|3538190|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11
1975968|NCT03548987|3538191|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0
1975969|NCT03548987|3538190|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2
1975970|NCT03548987|3538191|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0
1975971|NCT03548987|3538190|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19
1975972|NCT03548987|3538191|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0
1975973|NCT03548987|3538190|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1
1975974|NCT03548987|3538191|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0
1975975|NCT03548987|3538190|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1
1975976|NCT03548987|3538191|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0
1975977|NCT03548987|3538190|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48
1975978|NCT03548987|3538191|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0
1975979|NCT03548987|3538190|FG000|Maintenance Period (Week 20 to Week 68)|other|12
1975980|NCT03548987|3538191|FG001|Maintenance Period (Week 20 to Week 68)|other|23
1975981|NCT03548987|3538190|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2
2177372|NCT01372501|3801408|FG000|Overall Study|Device migration|1
1975982|NCT03548987|3538191|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1
1975983|NCT03548987|3538190|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
1975984|NCT03548987|3538191|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
1975985|NCT03548987|3538190|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2
1975986|NCT03548987|3538191|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0
1975987|NCT03548987|3538190|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1
1975988|NCT03548987|3538191|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0
1975989|NCT03548987|3538190|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13
1975990|NCT03548987|3538191|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6
2022444|NCT00320255|3590410|FG003|Overall Study|No longer meets study criteria|1
2022445|NCT00320255|3590411|FG004|Overall Study|No longer meets study criteria|0
2022446|NCT00320255|3590412|FG005|Overall Study|No longer meets study criteria|0
2022447|NCT00320255|3590407|FG000|Overall Study|Other|3
2022448|NCT00320255|3590408|FG001|Overall Study|Other|2
2022449|NCT00320255|3590409|FG002|Overall Study|Other|1
2022450|NCT00320255|3590410|FG003|Overall Study|Other|0
2022451|NCT00320255|3590411|FG004|Overall Study|Other|0
2022452|NCT00320255|3590412|FG005|Overall Study|Other|0
2022453|NCT00320372|3590441|FG000|Overall Study|Physician Decision|4
2022454|NCT00320372|3590442|FG001|Overall Study|Physician Decision|7
2022455|NCT00320372|3590441|FG000|Overall Study|Death|7
2022456|NCT00320372|3590442|FG001|Overall Study|Death|8
2022457|NCT00320372|3590441|FG000|Overall Study|Withdrawal by Subject|55
2022458|NCT00320372|3590442|FG001|Overall Study|Withdrawal by Subject|37
2022459|NCT00320372|3590441|FG000|Overall Study|Non-Compliance|40
2022460|NCT00320372|3590442|FG001|Overall Study|Non-Compliance|39
2022461|NCT00320372|3590441|FG000|Overall Study|Did not Meet (I/E)|3
2022462|NCT00320372|3590442|FG001|Overall Study|Did not Meet (I/E)|1
2022463|NCT00320372|3590441|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86
2022464|NCT00320372|3590442|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71
2022465|NCT00320385|3590458|FG000|Overall Study|Lost to Follow-up|7
2022466|NCT00320385|3590459|FG001|Overall Study|Lost to Follow-up|10
2022467|NCT00320385|3590458|FG000|Overall Study|Withdrawal by Subject|6
2022468|NCT00320385|3590459|FG001|Overall Study|Withdrawal by Subject|7
2022469|NCT00320385|3590458|FG000|Overall Study|Sponsor Terminated Study|2
2022470|NCT00320385|3590459|FG001|Overall Study|Sponsor Terminated Study|1
2022471|NCT00320385|3590458|FG000|Overall Study|Investigator Decision|0
2022472|NCT00320385|3590459|FG001|Overall Study|Investigator Decision|1
2022473|NCT00320385|3590458|FG000|Overall Study|Death|1
2022474|NCT00320385|3590459|FG001|Overall Study|Death|2
2022475|NCT00320385|3590458|FG000|Overall Study|Serious Adverse Event|1
2022476|NCT00320385|3590459|FG001|Overall Study|Serious Adverse Event|0
2022477|NCT00320385|3590458|FG000|Overall Study|Withdrew Consent|1
2022478|NCT00320385|3590459|FG001|Overall Study|Withdrew Consent|0
2022479|NCT00320385|3590458|FG000|Overall Study|Adverse Event|0
2022480|NCT00320385|3590459|FG001|Overall Study|Adverse Event|1
1975991|NCT03548064|3538206|FG000|Overall Study|Withdrawal by Subject|0
1975992|NCT03548064|3538207|FG001|Overall Study|Withdrawal by Subject|0
1975993|NCT03548064|3538208|FG002|Overall Study|Withdrawal by Subject|0
1975994|NCT03548064|3538209|FG003|Overall Study|Withdrawal by Subject|1
1975995|NCT03548064|3538210|FG004|Overall Study|Withdrawal by Subject|0
1975996|NCT03548064|3538211|FG005|Overall Study|Withdrawal by Subject|0
1975997|NCT03548064|3538212|FG006|Overall Study|Withdrawal by Subject|0
1975998|NCT03548064|3538213|FG007|Overall Study|Withdrawal by Subject|0
1975999|NCT03548064|3538206|FG000|Overall Study|Lost to Follow-up|0
1976000|NCT03548064|3538207|FG001|Overall Study|Lost to Follow-up|0
1976001|NCT03548064|3538208|FG002|Overall Study|Lost to Follow-up|0
1976002|NCT03548064|3538209|FG003|Overall Study|Lost to Follow-up|0
1976003|NCT03548064|3538210|FG004|Overall Study|Lost to Follow-up|2
1976004|NCT03548064|3538211|FG005|Overall Study|Lost to Follow-up|0
1976005|NCT03548064|3538212|FG006|Overall Study|Lost to Follow-up|0
1976006|NCT03548064|3538213|FG007|Overall Study|Lost to Follow-up|0
1976007|NCT03548064|3538206|FG000|Overall Study|Covid-19 Pandemic|0
1976008|NCT03548064|3538207|FG001|Overall Study|Covid-19 Pandemic|0
1976009|NCT03548064|3538208|FG002|Overall Study|Covid-19 Pandemic|0
1976010|NCT03548064|3538209|FG003|Overall Study|Covid-19 Pandemic|0
1976011|NCT03548064|3538210|FG004|Overall Study|Covid-19 Pandemic|10
1976012|NCT03548064|3538211|FG005|Overall Study|Covid-19 Pandemic|3
1976013|NCT03548064|3538212|FG006|Overall Study|Covid-19 Pandemic|0
1976014|NCT03548064|3538213|FG007|Overall Study|Covid-19 Pandemic|0
1976015|NCT03446456|3538239|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
1976016|NCT03446456|3538240|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
1976017|NCT03446456|3538239|FG000|Overall Study|Lost to Follow-up|1
1976018|NCT03446456|3538240|FG001|Overall Study|Lost to Follow-up|3
1976019|NCT03446456|3538239|FG000|Overall Study|Participant failed the toxicology test|1
1976020|NCT03446456|3538240|FG001|Overall Study|Participant failed the toxicology test|0
1976021|NCT03446456|3538239|FG000|Overall Study|Break down of the experimental equipment|1
1976022|NCT03446456|3538240|FG001|Overall Study|Break down of the experimental equipment|0
1976023|NCT03382834|3538248|FG000|Overall Study|Lost to Follow-up|1
1976024|NCT03382834|3538249|FG001|Overall Study|Lost to Follow-up|0
1976025|NCT03382834|3538248|FG000|Overall Study|Withdrawal by Subject|0
1976026|NCT03382834|3538249|FG001|Overall Study|Withdrawal by Subject|1
1976027|NCT03371823|3538257|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1
1976028|NCT03371823|3538258|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0
1976029|NCT03366337|3538268|FG000|Overall Study|Lost to Follow-up|1
1976030|NCT03366337|3538269|FG001|Overall Study|Lost to Follow-up|0
1976031|NCT03366337|3538270|FG002|Overall Study|Lost to Follow-up|1
1976032|NCT03366337|3538271|FG003|Overall Study|Lost to Follow-up|0
1976033|NCT03366337|3538268|FG000|Overall Study|Withdrawal by Subject|2
1976034|NCT03366337|3538269|FG001|Overall Study|Withdrawal by Subject|0
1976035|NCT03366337|3538270|FG002|Overall Study|Withdrawal by Subject|1
1976036|NCT03366337|3538271|FG003|Overall Study|Withdrawal by Subject|1
1976037|NCT03353350|3538285|FG000|30-week Core Treatment Period|Protocol Violation|1
1976038|NCT03353350|3538286|FG001|30-week Core Treatment Period|Protocol Violation|1
1976039|NCT03353350|3538287|FG002|30-week Core Treatment Period|Protocol Violation|1
1976040|NCT03353350|3538288|FG003|30-week Core Treatment Period|Protocol Violation|0
1976041|NCT03353350|3538285|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2
1976042|NCT03353350|3538286|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2
1976043|NCT03353350|3538287|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2
1976044|NCT03353350|3538288|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0
1976045|NCT03353350|3538285|FG000|30-week Core Treatment Period|Adverse Event|0
1976046|NCT03353350|3538286|FG001|30-week Core Treatment Period|Adverse Event|4
1976047|NCT03353350|3538287|FG002|30-week Core Treatment Period|Adverse Event|2
1976048|NCT03353350|3538288|FG003|30-week Core Treatment Period|Adverse Event|3
1976049|NCT03353350|3538285|FG000|30-week Core Treatment Period|Withdrawal by Subject|19
1976050|NCT03353350|3538286|FG001|30-week Core Treatment Period|Withdrawal by Subject|12
1976051|NCT03353350|3538287|FG002|30-week Core Treatment Period|Withdrawal by Subject|19
1976052|NCT03353350|3538288|FG003|30-week Core Treatment Period|Withdrawal by Subject|19
1976053|NCT03353350|3538285|FG000|26-week Treatment Extension Period|Protocol Violation|2
1976054|NCT03353350|3538286|FG001|26-week Treatment Extension Period|Protocol Violation|0
1976055|NCT03353350|3538287|FG002|26-week Treatment Extension Period|Protocol Violation|0
1976056|NCT03353350|3538288|FG003|26-week Treatment Extension Period|Protocol Violation|0
1976057|NCT03353350|3538285|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0
1976058|NCT03353350|3538286|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0
1976059|NCT03353350|3538287|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1
1976060|NCT03353350|3538288|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1
1976061|NCT03353350|3538285|FG000|26-week Treatment Extension Period|Adverse Event|1
1976062|NCT03353350|3538286|FG001|26-week Treatment Extension Period|Adverse Event|0
1976063|NCT03353350|3538287|FG002|26-week Treatment Extension Period|Adverse Event|0
1976064|NCT03353350|3538288|FG003|26-week Treatment Extension Period|Adverse Event|1
1976065|NCT03353350|3538285|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2
1976066|NCT03353350|3538286|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3
1976067|NCT03353350|3538287|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3
1976068|NCT03353350|3538288|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12
1976069|NCT03350503|3538298|FG000|Overall Study|Adverse Event|1
1976070|NCT03350503|3538298|FG000|Overall Study|Hospital Transfer or Removal|2
1976071|NCT03350503|3538298|FG000|Overall Study|Subject Wishes|2
1976072|NCT03326193|3538302|FG000|Overall Study|Treatment ongoing at the time of analysis|26
1976073|NCT03326193|3538302|FG000|Overall Study|Death|19
1976074|NCT03326193|3538302|FG000|Overall Study|Withdrawal by Subject|8
1976075|NCT03282565|3538318|FG000|Overall Study|COVID-19 Research Shutdown|0
1976076|NCT03282565|3538319|FG001|Overall Study|COVID-19 Research Shutdown|2
1976077|NCT03282565|3538320|FG002|Overall Study|COVID-19 Research Shutdown|2
1976078|NCT03276936|3538330|FG000|Overall Study|Adverse Event|4
1976079|NCT03276936|3538331|FG001|Overall Study|Adverse Event|2
1976080|NCT03276936|3538330|FG000|Overall Study|Lost to Follow-up|16
1976081|NCT03276936|3538331|FG001|Overall Study|Lost to Follow-up|13
1976082|NCT03276936|3538330|FG000|Overall Study|Withdrawal by Subject|30
1976083|NCT03276936|3538331|FG001|Overall Study|Withdrawal by Subject|20
1976084|NCT03276936|3538330|FG000|Overall Study|Not mentioned|6
1976085|NCT03276936|3538331|FG001|Overall Study|Not mentioned|3
1976086|NCT03271021|3538339|FG000|Overall Study|Adverse Event|3
1976087|NCT03271021|3538340|FG001|Overall Study|Adverse Event|2
1976088|NCT03271021|3538339|FG000|Overall Study|Withdrawal by Subject|36
1976089|NCT03271021|3538340|FG001|Overall Study|Withdrawal by Subject|53
1976090|NCT03271021|3538339|FG000|Overall Study|Lost to Follow-up|34
1976091|NCT03271021|3538340|FG001|Overall Study|Lost to Follow-up|39
1976092|NCT03271021|3538339|FG000|Overall Study|Protocol Violation|6
1976093|NCT03271021|3538340|FG001|Overall Study|Protocol Violation|4
1976094|NCT03271021|3538339|FG000|Overall Study|Abnormal Lab Results|1
1976095|NCT03271021|3538340|FG001|Overall Study|Abnormal Lab Results|0
1976096|NCT03271021|3538339|FG000|Overall Study|Miscellaneous|9
1976097|NCT03271021|3538340|FG001|Overall Study|Miscellaneous|8
1976098|NCT03255083|3538350|FG000|Overall Study|Clinical progression|1
1976099|NCT03255083|3538351|FG001|Overall Study|Clinical progression|0
1976100|NCT03255083|3538352|FG002|Overall Study|Clinical progression|0
1976101|NCT03255083|3538353|FG003|Overall Study|Clinical progression|0
1976102|NCT03255083|3538350|FG000|Overall Study|Adverse Event|0
1976103|NCT03255083|3538351|FG001|Overall Study|Adverse Event|1
1976104|NCT03255083|3538352|FG002|Overall Study|Adverse Event|0
1976105|NCT03255083|3538353|FG003|Overall Study|Adverse Event|0
1976106|NCT03255083|3538350|FG000|Overall Study|Progressive disease by RECIST version 1.1|4
1976107|NCT03255083|3538351|FG001|Overall Study|Progressive disease by RECIST version 1.1|1
1976108|NCT03255083|3538352|FG002|Overall Study|Progressive disease by RECIST version 1.1|2
1976109|NCT03255083|3538353|FG003|Overall Study|Progressive disease by RECIST version 1.1|1
1976110|NCT03255083|3538350|FG000|Overall Study|Withdrawal by Subject|1
1976111|NCT03255083|3538351|FG001|Overall Study|Withdrawal by Subject|1
1976112|NCT03255083|3538352|FG002|Overall Study|Withdrawal by Subject|1
1976113|NCT03255083|3538353|FG003|Overall Study|Withdrawal by Subject|0
1976114|NCT03227471|3538378|FG000|Overall Study|Withdrawal by Subject|0
1976115|NCT03227471|3538379|FG001|Overall Study|Withdrawal by Subject|0
1976116|NCT03227471|3538380|FG002|Overall Study|Withdrawal by Subject|0
1976117|NCT03227471|3538381|FG003|Overall Study|Withdrawal by Subject|0
1976118|NCT03227471|3538382|FG004|Overall Study|Withdrawal by Subject|1
1976119|NCT03227471|3538383|FG005|Overall Study|Withdrawal by Subject|0
1976120|NCT03227471|3538384|FG006|Overall Study|Withdrawal by Subject|0
1976121|NCT03227471|3538385|FG007|Overall Study|Withdrawal by Subject|0
1976122|NCT03227471|3538386|FG008|Overall Study|Withdrawal by Subject|0
1976123|NCT03227471|3538387|FG009|Overall Study|Withdrawal by Subject|0
1976124|NCT03227471|3538388|FG010|Overall Study|Withdrawal by Subject|0
1976125|NCT03227471|3538389|FG011|Overall Study|Withdrawal by Subject|0
1976126|NCT03227471|3538390|FG012|Overall Study|Withdrawal by Subject|1
1976127|NCT03227471|3538391|FG013|Overall Study|Withdrawal by Subject|0
1976128|NCT03227471|3538392|FG014|Overall Study|Withdrawal by Subject|0
1976129|NCT03227471|3538378|FG000|Overall Study|Randomized, Never Dosed|0
1976130|NCT03227471|3538379|FG001|Overall Study|Randomized, Never Dosed|0
1976131|NCT03227471|3538380|FG002|Overall Study|Randomized, Never Dosed|0
1976132|NCT03227471|3538381|FG003|Overall Study|Randomized, Never Dosed|0
1976133|NCT03227471|3538382|FG004|Overall Study|Randomized, Never Dosed|0
1976134|NCT03227471|3538383|FG005|Overall Study|Randomized, Never Dosed|0
1976135|NCT03227471|3538384|FG006|Overall Study|Randomized, Never Dosed|0
1976136|NCT03227471|3538385|FG007|Overall Study|Randomized, Never Dosed|0
1976137|NCT03227471|3538386|FG008|Overall Study|Randomized, Never Dosed|0
1976138|NCT03227471|3538387|FG009|Overall Study|Randomized, Never Dosed|0
1976139|NCT03227471|3538388|FG010|Overall Study|Randomized, Never Dosed|0
1976140|NCT03227471|3538389|FG011|Overall Study|Randomized, Never Dosed|0
1976141|NCT03227471|3538390|FG012|Overall Study|Randomized, Never Dosed|0
1976142|NCT03227471|3538391|FG013|Overall Study|Randomized, Never Dosed|0
1976143|NCT03227471|3538392|FG014|Overall Study|Randomized, Never Dosed|1
1976144|NCT03221842|3538453|FG000|Period 1 (Open-label)|Adverse Event|4
1976145|NCT03221842|3538454|FG001|Period 1 (Open-label)|Adverse Event|0
1976146|NCT03221842|3538453|FG000|Period 1 (Open-label)|Physician Decision|2
1976147|NCT03221842|3538454|FG001|Period 1 (Open-label)|Physician Decision|0
1976148|NCT03221842|3538453|FG000|Period 1 (Open-label)|Lost to Follow-up|1
1976149|NCT03221842|3538454|FG001|Period 1 (Open-label)|Lost to Follow-up|0
1976150|NCT03221842|3538453|FG000|Period 1 (Open-label)|Terminated by sponsor|1
1976151|NCT03221842|3538454|FG001|Period 1 (Open-label)|Terminated by sponsor|0
1976152|NCT03221842|3538453|FG000|Period 1 (Open-label)|Other|2
1976153|NCT03221842|3538454|FG001|Period 1 (Open-label)|Other|0
1976154|NCT03221842|3538453|FG000|Period 2 (Randomized, Blinded)|Death|0
1976155|NCT03221842|3538454|FG001|Period 2 (Randomized, Blinded)|Death|1
1976156|NCT03221842|3538453|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1
1976157|NCT03221842|3538454|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0
1976158|NCT03194321|3538464|FG000|Overall Study|Withdrawal by Subject|1
1976159|NCT03194321|3538464|FG000|Overall Study|Lost to Follow-up|1
1976160|NCT03194321|3538464|FG000|Overall Study|Travel for Follow-up|1
1976161|NCT03165721|3538471|FG000|Overall Study|Refused further treatment|3
1976162|NCT03165721|3538472|FG001|Overall Study|Refused further treatment|0
1976163|NCT03165721|3538473|FG002|Overall Study|Refused further treatment|0
1976164|NCT03165721|3538471|FG000|Overall Study|Physician Decision|1
1976165|NCT03165721|3538472|FG001|Overall Study|Physician Decision|0
1976166|NCT03165721|3538473|FG002|Overall Study|Physician Decision|0
2022481|NCT00320398|3590467|FG000|Overall Study|Adverse Event|1
2022482|NCT00320398|3590468|FG001|Overall Study|Adverse Event|4
2022483|NCT00320398|3590467|FG000|Overall Study|Other|1
2022484|NCT00320398|3590468|FG001|Overall Study|Other|0
2022485|NCT00320411|3590475|FG000|Overall Study|No investigational product admin.|4
2022486|NCT00320424|3590479|FG000|Overall Study|Adverse Event|3
2022487|NCT00320424|3590479|FG000|Overall Study|Other|3
2022488|NCT00320489|3590485|FG000|Overall Study|Adverse Event|26
2022489|NCT00320489|3590486|FG001|Overall Study|Adverse Event|25
2022490|NCT00320489|3590485|FG000|Overall Study|Clinical Relapse|26
2022491|NCT00320489|3590486|FG001|Overall Study|Clinical Relapse|20
2022492|NCT00320489|3590485|FG000|Overall Study|Death|0
2022493|NCT00320489|3590486|FG001|Overall Study|Death|2
2022494|NCT00320489|3590485|FG000|Overall Study|Entry Criteria Exclusion|2
2022495|NCT00320489|3590486|FG001|Overall Study|Entry Criteria Exclusion|4
2022496|NCT00320489|3590485|FG000|Overall Study|Lack of Efficacy|16
2022497|NCT00320489|3590486|FG001|Overall Study|Lack of Efficacy|7
2022498|NCT00320489|3590485|FG000|Overall Study|Lost to Follow-up|21
2022499|NCT00320489|3590486|FG001|Overall Study|Lost to Follow-up|22
2022500|NCT00320489|3590485|FG000|Overall Study|Physician Decision|8
2022501|NCT00320489|3590486|FG001|Overall Study|Physician Decision|8
2022502|NCT00320489|3590485|FG000|Overall Study|Protocol Violation|4
2022503|NCT00320489|3590486|FG001|Overall Study|Protocol Violation|4
2022504|NCT00320489|3590485|FG000|Overall Study|Sponsor Decision|3
2022505|NCT00320489|3590486|FG001|Overall Study|Sponsor Decision|3
2022506|NCT00320489|3590485|FG000|Overall Study|Withdrawal by Subject|39
2022507|NCT00320489|3590486|FG001|Overall Study|Withdrawal by Subject|41
2022508|NCT00320515|3590492|FG000|Overall Study|Death|33
2022509|NCT00320515|3590492|FG000|Overall Study|Lost to Follow-up|6
2022510|NCT00320515|3590492|FG000|Overall Study|Physician Decision|2
2022511|NCT00320515|3590492|FG000|Overall Study|Withdrawal by Subject|8
2022512|NCT00320528|3590499|FG000|Study Period II|Adverse Event|3
2022513|NCT00320528|3590500|FG001|Study Period II|Adverse Event|4
2022514|NCT00320528|3590501|FG002|Study Period II|Adverse Event|8
2022515|NCT00320528|3590499|FG000|Study Period II|Parent/Caregiver Decision|8
2022516|NCT00320528|3590500|FG001|Study Period II|Parent/Caregiver Decision|3
2022517|NCT00320528|3590501|FG002|Study Period II|Parent/Caregiver Decision|11
2022518|NCT00320528|3590499|FG000|Study Period II|Withdrawal by Subject|0
2022519|NCT00320528|3590500|FG001|Study Period II|Withdrawal by Subject|1
2022520|NCT00320528|3590501|FG002|Study Period II|Withdrawal by Subject|1
2022521|NCT00320528|3590499|FG000|Study Period II|Entry Criteria Exclusion|0
2022522|NCT00320528|3590500|FG001|Study Period II|Entry Criteria Exclusion|2
2022523|NCT00320528|3590501|FG002|Study Period II|Entry Criteria Exclusion|2
2022524|NCT00320528|3590499|FG000|Study Period III|Adverse Event|1
2022525|NCT00320528|3590500|FG001|Study Period III|Adverse Event|0
2022526|NCT00320528|3590501|FG002|Study Period III|Adverse Event|0
2022527|NCT00320528|3590499|FG000|Study Period III|Lost to Follow-up|1
2022528|NCT00320528|3590500|FG001|Study Period III|Lost to Follow-up|0
2022529|NCT00320528|3590501|FG002|Study Period III|Lost to Follow-up|0
2022530|NCT00320528|3590499|FG000|Study Period III|Withdrawal by Subject|1
2022531|NCT00320528|3590500|FG001|Study Period III|Withdrawal by Subject|1
2022532|NCT00320528|3590501|FG002|Study Period III|Withdrawal by Subject|2
2022533|NCT00320528|3590499|FG000|Study Period III|Lack of Efficacy|2
2022534|NCT00320528|3590500|FG001|Study Period III|Lack of Efficacy|0
2022535|NCT00320528|3590501|FG002|Study Period III|Lack of Efficacy|0
2022536|NCT00320528|3590499|FG000|Study Period III|Parent/Caregiver Decision|14
2022537|NCT00320528|3590500|FG001|Study Period III|Parent/Caregiver Decision|3
2022538|NCT00320528|3590501|FG002|Study Period III|Parent/Caregiver Decision|11
2022539|NCT00320528|3590499|FG000|Study Period III|Protocol Violation|0
2022540|NCT00320528|3590500|FG001|Study Period III|Protocol Violation|1
2022541|NCT00320528|3590501|FG002|Study Period III|Protocol Violation|0
2022542|NCT00320528|3590499|FG000|Study Period III|Physician Decision|0
2022543|NCT00320528|3590500|FG001|Study Period III|Physician Decision|1
2022544|NCT00320528|3590501|FG002|Study Period III|Physician Decision|2
2022545|NCT00320528|3590499|FG000|Study Period III|Sponsor Decision|0
2022546|NCT00320528|3590500|FG001|Study Period III|Sponsor Decision|0
1976167|NCT03085095|3538483|FG000|Overall Study|Adverse Event|23
1976168|NCT03085095|3538484|FG001|Overall Study|Adverse Event|8
1976169|NCT03085095|3538483|FG000|Overall Study|Protocol Violation|0
1976170|NCT03085095|3538484|FG001|Overall Study|Protocol Violation|1
1976171|NCT03085095|3538483|FG000|Overall Study|Lost to Follow-up|2
1976172|NCT03085095|3538484|FG001|Overall Study|Lost to Follow-up|1
1976173|NCT03085095|3538483|FG000|Overall Study|Withdrawal by Subject|17
1976174|NCT03085095|3538484|FG001|Overall Study|Withdrawal by Subject|6
1976175|NCT03085095|3538483|FG000|Overall Study|Physician Decision|9
1976176|NCT03085095|3538484|FG001|Overall Study|Physician Decision|3
1976177|NCT03085095|3538483|FG000|Overall Study|Testosterone Suppression Level Not Met|7
1976178|NCT03085095|3538484|FG001|Overall Study|Testosterone Suppression Level Not Met|13
1976179|NCT03085095|3538483|FG000|Overall Study|Did not Receive Study Drug|2
1976180|NCT03085095|3538484|FG001|Overall Study|Did not Receive Study Drug|2
1976181|NCT03085095|3538483|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1
1976182|NCT03085095|3538484|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0
1976183|NCT03048422|3538496|FG000|Overall Study|Death|1
1976184|NCT03048422|3538497|FG001|Overall Study|Death|0
1976185|NCT03048422|3538498|FG002|Overall Study|Death|0
1976186|NCT03048422|3538496|FG000|Overall Study|Lost to Follow-up|5
1976187|NCT03048422|3538497|FG001|Overall Study|Lost to Follow-up|0
1976188|NCT03048422|3538498|FG002|Overall Study|Lost to Follow-up|1
1976189|NCT03048422|3538496|FG000|Overall Study|Withdrawal by Subject|5
1976190|NCT03048422|3538497|FG001|Overall Study|Withdrawal by Subject|7
1976191|NCT03048422|3538498|FG002|Overall Study|Withdrawal by Subject|4
1976192|NCT03048422|3538496|FG000|Overall Study|Moved|3
1976193|NCT03048422|3538497|FG001|Overall Study|Moved|2
1976194|NCT03048422|3538498|FG002|Overall Study|Moved|2
1976195|NCT03048422|3538496|FG000|Overall Study|Noncompliant with Study Requirements|2
1976196|NCT03048422|3538497|FG001|Overall Study|Noncompliant with Study Requirements|1
1976197|NCT03048422|3538498|FG002|Overall Study|Noncompliant with Study Requirements|2
1976198|NCT03048422|3538496|FG000|Overall Study|Not Able to Get to Clinic|1
1976199|NCT03048422|3538497|FG001|Overall Study|Not Able to Get to Clinic|0
1976200|NCT03048422|3538498|FG002|Overall Study|Not Able to Get to Clinic|0
1976201|NCT03032068|3538516|FG000|Overall Study|Adverse Event|1
1976202|NCT02908672|3538535|FG000|Overall Study|Death|112
1976203|NCT02908672|3538536|FG001|Overall Study|Death|93
1976204|NCT02908672|3538535|FG000|Overall Study|Lost to Follow-up|3
1976205|NCT02908672|3538536|FG001|Overall Study|Lost to Follow-up|3
1976206|NCT02908672|3538535|FG000|Overall Study|Other|2
2102142|NCT00837577|3693869|FG001|Open-label Period|Withdrawal by Subject|2
2102143|NCT00837577|3693868|FG000|Open-label Period|Other Reason|1
2102144|NCT00837577|3693869|FG001|Open-label Period|Other Reason|1
2102145|NCT00837616|3693891|FG000|Overall Study|Withdrawal by Subject|0
2102146|NCT00837616|3693892|FG001|Overall Study|Withdrawal by Subject|1
2102147|NCT00837694|3693904|FG000|Overall Study|Lost to Follow-up|2
2102148|NCT00837694|3693905|FG001|Overall Study|Lost to Follow-up|0
2102149|NCT00837694|3693906|FG002|Overall Study|Lost to Follow-up|2
2102150|NCT00837694|3693907|FG003|Overall Study|Lost to Follow-up|1
2102151|NCT00837694|3693908|FG004|Overall Study|Lost to Follow-up|1
2102152|NCT00837694|3693909|FG005|Overall Study|Lost to Follow-up|1
2108030|NCT00877799|3701850|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
2108031|NCT00877799|3701846|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
2108032|NCT00877799|3701847|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
2108033|NCT00877799|3701848|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
2108034|NCT00877799|3701849|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
2108035|NCT00877799|3701850|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
2108036|NCT00877799|3701846|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
2108037|NCT00877799|3701847|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
2108038|NCT00877799|3701848|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
2108039|NCT00877799|3701849|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
2108040|NCT00877799|3701850|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
2213096|NCT01675622|3854442|FG001|Overall Study|Lack of Efficacy|4
2213097|NCT01675622|3854441|FG000|Overall Study|Lost to Follow-up|1
2213098|NCT01675622|3854442|FG001|Overall Study|Lost to Follow-up|3
2213099|NCT01675622|3854441|FG000|Overall Study|Other|5
2213100|NCT01675622|3854442|FG001|Overall Study|Other|4
2213101|NCT01675661|3854464|FG000|Overall Study|Lost to Follow-up|22
2213102|NCT01675661|3854465|FG001|Overall Study|Lost to Follow-up|23
2213103|NCT01675661|3854464|FG000|Overall Study|Practical problems|9
2213104|NCT01675661|3854465|FG001|Overall Study|Practical problems|5
2213105|NCT01675661|3854464|FG000|Overall Study|Moved away|5
2213106|NCT01675661|3854465|FG001|Overall Study|Moved away|6
2213107|NCT01675661|3854464|FG000|Overall Study|Withdrawal by Subject|3
2213108|NCT01675661|3854465|FG001|Overall Study|Withdrawal by Subject|7
2213109|NCT01675661|3854464|FG000|Overall Study|Physician Decision|0
2213110|NCT01675661|3854465|FG001|Overall Study|Physician Decision|2
2213111|NCT01675661|3854464|FG000|Overall Study|Death|0
2213112|NCT01675661|3854465|FG001|Overall Study|Death|1
2213113|NCT01675661|3854464|FG000|Overall Study|Other reason|1
2213114|NCT01675661|3854465|FG001|Overall Study|Other reason|2
2213115|NCT01675765|3854473|FG000|Overall Study|Progressive disease|4
1976207|NCT02908672|3538536|FG001|Overall Study|Other|0
1976208|NCT02908672|3538535|FG000|Overall Study|Protocol Violation|1
1976209|NCT02908672|3538536|FG001|Overall Study|Protocol Violation|1
1976210|NCT02908672|3538535|FG000|Overall Study|Withdrawal by Subject|13
1976211|NCT02908672|3538536|FG001|Overall Study|Withdrawal by Subject|18
1976212|NCT02908672|3538535|FG000|Overall Study|Study is ongoing|124
1976213|NCT02908672|3538536|FG001|Overall Study|Study is ongoing|141
1976214|NCT02908672|3538535|FG000|Overall Study|Discontinued the study during run-in|3
1976215|NCT02908672|3538536|FG001|Overall Study|Discontinued the study during run-in|0
1976216|NCT02864407|3538542|FG000|Overall Study|Protocol Violation|3
1976217|NCT02864407|3538542|FG000|Overall Study|Lost to Follow-up|115
1976218|NCT02864407|3538542|FG000|Overall Study|Not treated with Vahelva® Respimat®|1
1976219|NCT02864407|3538542|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3
1976220|NCT02864407|3538542|FG000|Overall Study|Consent prior to the contract date|1
1976221|NCT02835690|3538549|FG000|Overall Study|Death|4
1976222|NCT02835690|3538550|FG001|Overall Study|Death|6
1976223|NCT02835690|3538551|FG002|Overall Study|Death|6
1976224|NCT02835690|3538549|FG000|Overall Study|Ongoing in Study (Follow-up)|10
1976225|NCT02835690|3538550|FG001|Overall Study|Ongoing in Study (Follow-up)|7
1976226|NCT02835690|3538551|FG002|Overall Study|Ongoing in Study (Follow-up)|9
1976227|NCT02835690|3538549|FG000|Overall Study|Not Treated|0
1976228|NCT02835690|3538550|FG001|Overall Study|Not Treated|2
1976229|NCT02835690|3538551|FG002|Overall Study|Not Treated|0
1976230|NCT02828982|3538559|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
1976231|NCT02828982|3538560|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
1976232|NCT02815280|3538574|FG000|Double-Blind Phase|Adverse Event|1
1976233|NCT02815280|3538575|FG001|Double-Blind Phase|Adverse Event|1
1976234|NCT02815280|3538574|FG000|Double-Blind Phase|Lost to Follow-up|10
1976235|NCT02815280|3538575|FG001|Double-Blind Phase|Lost to Follow-up|9
1976236|NCT02815280|3538574|FG000|Double-Blind Phase|Withdrawal by Subject|20
1976237|NCT02815280|3538575|FG001|Double-Blind Phase|Withdrawal by Subject|11
1976238|NCT02815280|3538574|FG000|Double-Blind Phase|Protocol Violation|2
1976239|NCT02815280|3538575|FG001|Double-Blind Phase|Protocol Violation|2
1976240|NCT02815280|3538574|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3
1976241|NCT02815280|3538575|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2
1976242|NCT02815280|3538574|FG000|Open-Label Phase|Adverse Event|2
1976243|NCT02815280|3538575|FG001|Open-Label Phase|Adverse Event|3
1976244|NCT02815280|3538574|FG000|Open-Label Phase|Lost to Follow-up|18
1976245|NCT02815280|3538575|FG001|Open-Label Phase|Lost to Follow-up|9
1976246|NCT02815280|3538574|FG000|Open-Label Phase|Withdrawal by Subject|33
1976247|NCT02815280|3538575|FG001|Open-Label Phase|Withdrawal by Subject|18
1976248|NCT02815280|3538574|FG000|Open-Label Phase|Protocol Violation|3
1976249|NCT02815280|3538575|FG001|Open-Label Phase|Protocol Violation|0
1976250|NCT02815280|3538574|FG000|Open-Label Phase|Administrative|26
1976251|NCT02815280|3538575|FG001|Open-Label Phase|Administrative|12
1976252|NCT02815280|3538574|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5
1976253|NCT02815280|3538575|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2
1976254|NCT02815267|3538587|FG000|Double-Blind Phase|Adverse Event|0
1976255|NCT02815267|3538588|FG001|Double-Blind Phase|Adverse Event|3
1976256|NCT02815267|3538587|FG000|Double-Blind Phase|Lost to Follow-up|17
1976257|NCT02815267|3538588|FG001|Double-Blind Phase|Lost to Follow-up|9
1976258|NCT02815267|3538587|FG000|Double-Blind Phase|Withdrawal by Subject|11
1976259|NCT02815267|3538588|FG001|Double-Blind Phase|Withdrawal by Subject|10
1976260|NCT02815267|3538587|FG000|Double-Blind Phase|Protocol Violation|3
1976261|NCT02815267|3538588|FG001|Double-Blind Phase|Protocol Violation|2
1976262|NCT02815267|3538587|FG000|Double-Blind Phase|Site withdrawal|1
1976263|NCT02815267|3538588|FG001|Double-Blind Phase|Site withdrawal|6
1976264|NCT02815267|3538587|FG000|Double-Blind Phase|Received a disallowed medication|1
1976265|NCT02815267|3538588|FG001|Double-Blind Phase|Received a disallowed medication|1
1976266|NCT02815267|3538587|FG000|Open-Label Phase|Adverse Event|1
1976267|NCT02815267|3538588|FG001|Open-Label Phase|Adverse Event|1
1976268|NCT02815267|3538587|FG000|Open-Label Phase|Lost to Follow-up|23
1976269|NCT02815267|3538588|FG001|Open-Label Phase|Lost to Follow-up|9
1976270|NCT02815267|3538587|FG000|Open-Label Phase|Withdrawal by Subject|24
1976271|NCT02815267|3538588|FG001|Open-Label Phase|Withdrawal by Subject|13
1976272|NCT02815267|3538587|FG000|Open-Label Phase|Protocol Violation|0
1976273|NCT02815267|3538588|FG001|Open-Label Phase|Protocol Violation|1
1976274|NCT02815267|3538587|FG000|Open-Label Phase|Administrative|21
1976275|NCT02815267|3538588|FG001|Open-Label Phase|Administrative|12
1976276|NCT02815267|3538587|FG000|Open-Label Phase|Other|2
1976277|NCT02815267|3538588|FG001|Open-Label Phase|Other|5
1976278|NCT02802228|3538600|FG000|Overall Study|Withdrawal by Subject|2
1976279|NCT02802228|3538601|FG001|Overall Study|Withdrawal by Subject|0
1976280|NCT02802228|3538600|FG000|Overall Study|Lost to Follow-up|1
1976281|NCT02802228|3538601|FG001|Overall Study|Lost to Follow-up|0
1976282|NCT02802228|3538600|FG000|Overall Study|Adverse Event|1
1976283|NCT02802228|3538601|FG001|Overall Study|Adverse Event|0
1976284|NCT02802228|3538600|FG000|Overall Study|Physician Decision|1
1976285|NCT02802228|3538601|FG001|Overall Study|Physician Decision|0
1976286|NCT02701283|3538633|FG000|Overall Study|Death|25
1976287|NCT02701283|3538634|FG001|Overall Study|Death|29
1976288|NCT02701283|3538635|FG002|Overall Study|Death|19
1976289|NCT02701283|3538633|FG000|Overall Study|Lost to Follow-up|3
1976290|NCT02701283|3538634|FG001|Overall Study|Lost to Follow-up|8
1976291|NCT02701283|3538635|FG002|Overall Study|Lost to Follow-up|1
1976292|NCT02701283|3538633|FG000|Overall Study|Withdrawal by Subject|12
1976293|NCT02701283|3538634|FG001|Overall Study|Withdrawal by Subject|41
1976294|NCT02701283|3538635|FG002|Overall Study|Withdrawal by Subject|1
1976295|NCT02701283|3538633|FG000|Overall Study|Missed 2-year visit|22
1976296|NCT02701283|3538634|FG001|Overall Study|Missed 2-year visit|27
1976297|NCT02701283|3538635|FG002|Overall Study|Missed 2-year visit|0
1976298|NCT02701283|3538633|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7
1976299|NCT02701283|3538634|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57
1976300|NCT02701283|3538635|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0
1976301|NCT02674516|3538648|FG000|Overall Study|Lost to Follow-up|3
1976302|NCT02674516|3538649|FG001|Overall Study|Lost to Follow-up|0
1976303|NCT02674516|3538648|FG000|Overall Study|Protocol Violation|0
1976304|NCT02674516|3538649|FG001|Overall Study|Protocol Violation|4
1976305|NCT02674516|3538648|FG000|Overall Study|Knowledge of study hypothesis|1
1976306|NCT02674516|3538649|FG001|Overall Study|Knowledge of study hypothesis|0
1976307|NCT02655016|3538657|FG000|Overall Study|Disease progression|6
1976308|NCT02655016|3538658|FG001|Overall Study|Disease progression|4
1976309|NCT02655016|3538657|FG000|Overall Study|Site closed|0
1976310|NCT02655016|3538658|FG001|Overall Study|Site closed|1
1976311|NCT02655016|3538657|FG000|Overall Study|Death|30
1976312|NCT02655016|3538658|FG001|Overall Study|Death|48
1976313|NCT02655016|3538657|FG000|Overall Study|Lost to Follow-up|1
1976314|NCT02655016|3538658|FG001|Overall Study|Lost to Follow-up|1
1976315|NCT02655016|3538657|FG000|Overall Study|Withdrawal by Subject|18
1976316|NCT02655016|3538658|FG001|Overall Study|Withdrawal by Subject|36
1976317|NCT02505425|3538678|FG000|Overall Study|Lost to Follow-up|41
1976318|NCT02505425|3538679|FG001|Overall Study|Lost to Follow-up|61
1976319|NCT02505425|3538680|FG002|Overall Study|Lost to Follow-up|31
1976320|NCT02505425|3538681|FG003|Overall Study|Lost to Follow-up|19
1976321|NCT02505425|3538678|FG000|Overall Study|Withdrawal by Subject|39
1976322|NCT02505425|3538679|FG001|Overall Study|Withdrawal by Subject|9
1976323|NCT02505425|3538680|FG002|Overall Study|Withdrawal by Subject|19
1976324|NCT02505425|3538681|FG003|Overall Study|Withdrawal by Subject|7
1976325|NCT02505425|3538678|FG000|Overall Study|Death|8
1976326|NCT02505425|3538679|FG001|Overall Study|Death|12
1976327|NCT02505425|3538680|FG002|Overall Study|Death|0
1976328|NCT02505425|3538681|FG003|Overall Study|Death|0
1976329|NCT02487979|3538691|FG000|Overall Study|Physician Decision|2
1976330|NCT02487979|3538691|FG000|Overall Study|Withdrawal by Subject|2
1976331|NCT02487979|3538691|FG000|Overall Study|Progressive Disease|17
1976332|NCT02463448|3538695|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3
1976333|NCT02463448|3538695|FG000|6 Months Through 12 Months|Lost to Follow-up|1
1976334|NCT02463448|3538695|FG000|6 Months Through 12 Months|Withdrawal by Subject|1
1976335|NCT02463448|3538695|FG000|12 Months Through End of Study|Lost to Follow-up|1
2022547|NCT00320528|3590501|FG002|Study Period III|Sponsor Decision|1
2022548|NCT00320528|3590499|FG000|Study Period III|Atomoxetine Commercially Available|68
2022549|NCT00320528|3590500|FG001|Study Period III|Atomoxetine Commercially Available|25
2022550|NCT00320528|3590501|FG002|Study Period III|Atomoxetine Commercially Available|90
2022551|NCT00320541|3590511|FG000|Overall Study|Adverse Event|21
2022552|NCT00320541|3590512|FG001|Overall Study|Adverse Event|19
2022553|NCT00320541|3590511|FG000|Overall Study|Protocol Violation|0
2022554|NCT00320541|3590512|FG001|Overall Study|Protocol Violation|1
2022555|NCT00320541|3590511|FG000|Overall Study|Withdrawal by Subject|12
2022556|NCT00320541|3590512|FG001|Overall Study|Withdrawal by Subject|16
2022557|NCT00320541|3590511|FG000|Overall Study|Physician Decision|9
2022558|NCT00320541|3590512|FG001|Overall Study|Physician Decision|13
2022559|NCT00320541|3590511|FG000|Overall Study|Other|3
2022560|NCT00320541|3590512|FG001|Overall Study|Other|4
2022561|NCT00320541|3590511|FG000|Overall Study|Sponsor Decision|2
2022562|NCT00320541|3590512|FG001|Overall Study|Sponsor Decision|1
2022563|NCT00320541|3590511|FG000|Overall Study|Death due to Study Disease|1
2022564|NCT00320541|3590512|FG001|Overall Study|Death due to Study Disease|3
2022565|NCT00320541|3590511|FG000|Overall Study|Death due to Adverse Event(s)|1
2022566|NCT00320541|3590512|FG001|Overall Study|Death due to Adverse Event(s)|0
2022567|NCT00320541|3590511|FG000|Overall Study|Protocol Entry Criterion Not Met|1
2022568|NCT00320541|3590512|FG001|Overall Study|Protocol Entry Criterion Not Met|0
2022569|NCT00320593|3590520|FG000|Overall Study|Lost to Follow-up|3
2022570|NCT00320593|3590521|FG001|Overall Study|Lost to Follow-up|0
2213116|NCT01675765|3854474|FG001|Overall Study|Progressive disease|4
2213117|NCT01675765|3854473|FG000|Overall Study|Adverse Event|1
2022571|NCT00320593|3590520|FG000|Overall Study|Moved to another state|1
2022572|NCT00320593|3590521|FG001|Overall Study|Moved to another state|0
2022573|NCT00320593|3590520|FG000|Overall Study|Withdrawal by Subject|2
2022574|NCT00320593|3590521|FG001|Overall Study|Withdrawal by Subject|1
2022575|NCT00320593|3590520|FG000|Overall Study|Withdrawal by clinical center|1
2022576|NCT00320593|3590521|FG001|Overall Study|Withdrawal by clinical center|0
2022577|NCT00320606|3590527|FG000|Overall Study|Adverse Event|1
2022578|NCT00320606|3590527|FG000|Overall Study|Protocol Violation|1
1976336|NCT02276547|3538708|FG000|Overall Study|Death|2
1976337|NCT02276547|3538708|FG000|Overall Study|Explant|2
1976338|NCT02263885|3538712|FG000|Overall Study|Withdrawal by Subject|7
1976339|NCT02263885|3538712|FG000|Overall Study|Alternative Treatment|3
2102153|NCT00837759|3693923|FG000|Overall Study|Protocol Violation|3
2102154|NCT00837759|3693923|FG000|Overall Study|Lost to Follow-up|1
2102155|NCT00837811|3693930|FG000|Overall Study|Adverse Event|4
2102156|NCT00837811|3693931|FG001|Overall Study|Adverse Event|6
2102157|NCT00837811|3693932|FG002|Overall Study|Adverse Event|0
2102158|NCT00837811|3693930|FG000|Overall Study|Death|1
2102159|NCT00837811|3693931|FG001|Overall Study|Death|1
2102160|NCT00837811|3693932|FG002|Overall Study|Death|0
2102161|NCT00837811|3693930|FG000|Overall Study|Lack of Efficacy|0
2102162|NCT00837811|3693931|FG001|Overall Study|Lack of Efficacy|11
2102163|NCT00837811|3693932|FG002|Overall Study|Lack of Efficacy|0
2102164|NCT00837811|3693930|FG000|Overall Study|Lost to Follow-up|1
2102165|NCT00837811|3693931|FG001|Overall Study|Lost to Follow-up|3
2102166|NCT00837811|3693932|FG002|Overall Study|Lost to Follow-up|0
2102167|NCT00837811|3693930|FG000|Overall Study|Physician Decision|0
2102168|NCT00837811|3693931|FG001|Overall Study|Physician Decision|2
2102169|NCT00837811|3693932|FG002|Overall Study|Physician Decision|1
2102170|NCT00837811|3693930|FG000|Overall Study|Withdrawal by Subject|1
1976358|NCT02213926|3538726|FG000|Overall Study|Death|59
1976359|NCT02213926|3538726|FG000|Overall Study|Withdrawal by Subject|10
1976360|NCT02213926|3538726|FG000|Overall Study|study terminated by sponsor|51
1976361|NCT02213926|3538726|FG000|Overall Study|Lost to Follow-up|3
1976362|NCT02213926|3538726|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1
2102171|NCT00837811|3693931|FG001|Overall Study|Withdrawal by Subject|9
2102172|NCT00837811|3693932|FG002|Overall Study|Withdrawal by Subject|0
2102173|NCT00837811|3693930|FG000|Overall Study|Sponsor Decision|0
2102174|NCT00837811|3693931|FG001|Overall Study|Sponsor Decision|2
2102175|NCT00837811|3693932|FG002|Overall Study|Sponsor Decision|0
2102176|NCT00837876|3693959|FG000|Overall Study|Death|2
2102177|NCT00837876|3693959|FG000|Overall Study|Adverse Event|7
2102178|NCT00837876|3693959|FG000|Overall Study|Physician Decision|1
2102179|NCT00837876|3693959|FG000|Overall Study|Withdrawal by Subject|3
2102180|NCT00837876|3693959|FG000|Overall Study|disease progression|24
2102181|NCT00837967|3693973|FG000|Washout Period of 7 - 14 Days|Adverse Event|2
2102182|NCT00837967|3693974|FG001|Washout Period of 7 - 14 Days|Adverse Event|0
2102183|NCT00838097|3693995|FG000|Overall Study|Ineligibility determined|6
2102184|NCT00838097|3693995|FG000|Overall Study|Adverse Event|2
2102185|NCT00838097|3693995|FG000|Overall Study|Withdrawal by Subject|3
2102186|NCT00838097|3693995|FG000|Overall Study|Requirement for alternative therapy|2
2102187|NCT00838097|3693995|FG000|Overall Study|Physician Decision|4
2102188|NCT00838097|3693995|FG000|Overall Study|Lost to Follow-up|11
2102189|NCT00838097|3693995|FG000|Overall Study|Death|6
2102190|NCT00838097|3693995|FG000|Overall Study|Protocol-specified criteria|142
2102191|NCT00838110|3694001|FG000|Overall Study|Death|0
2102192|NCT00838110|3694002|FG001|Overall Study|Death|0
1976385|NCT02008396|3538744|FG000|Overall Study|Protocol Violation|0
1976386|NCT02008396|3538745|FG001|Overall Study|Protocol Violation|1
1976387|NCT01995175|3538752|FG000|Overall Study|Withdrawal by Subject|35
1976388|NCT01995175|3538752|FG000|Overall Study|Lost to Follow-up|102
1976389|NCT01995175|3538752|FG000|Overall Study|Other|67
1976390|NCT01995175|3538752|FG000|Overall Study|Migrated / moved from the study area|49
1976391|NCT01804270|3538766|FG000|Overall Study|Withdrawal by Subject|1
1976392|NCT01804270|3538767|FG001|Overall Study|Withdrawal by Subject|1
1976393|NCT01781390|3538776|FG000|Overall Study|Withdrawal of Consent|0
1976394|NCT01781390|3538777|FG001|Overall Study|Withdrawal of Consent|3
1976395|NCT01781390|3538778|FG002|Overall Study|Withdrawal of Consent|1
1976396|NCT01781390|3538776|FG000|Overall Study|Lost to Follow-up|1
1976397|NCT01781390|3538777|FG001|Overall Study|Lost to Follow-up|1
1976398|NCT01781390|3538778|FG002|Overall Study|Lost to Follow-up|1
1976399|NCT01781390|3538776|FG000|Overall Study|Adverse Event|1
1976400|NCT01781390|3538777|FG001|Overall Study|Adverse Event|2
1976401|NCT01781390|3538778|FG002|Overall Study|Adverse Event|1
1976402|NCT01781390|3538776|FG000|Overall Study|Participants who were Randomized and Not Treated|1
1976403|NCT01781390|3538777|FG001|Overall Study|Participants who were Randomized and Not Treated|1
1976404|NCT01781390|3538778|FG002|Overall Study|Participants who were Randomized and Not Treated|1
1976405|NCT01566695|3538788|FG000|Overall Study|Lack of Efficacy|18
1976406|NCT01566695|3538789|FG001|Overall Study|Lack of Efficacy|45
1976407|NCT01566695|3538788|FG000|Overall Study|Adverse Event|28
1976408|NCT01566695|3538789|FG001|Overall Study|Adverse Event|27
1976409|NCT01566695|3538788|FG000|Overall Study|Death|20
1976410|NCT01566695|3538789|FG001|Overall Study|Death|8
1976411|NCT01566695|3538788|FG000|Overall Study|Withdrawal by Subject|14
1976412|NCT01566695|3538789|FG001|Overall Study|Withdrawal by Subject|7
1976413|NCT01566695|3538788|FG000|Overall Study|Progressive Disease|11
1976414|NCT01566695|3538789|FG001|Overall Study|Progressive Disease|6
1976415|NCT01566695|3538788|FG000|Overall Study|Miscellaneous|4
1976416|NCT01566695|3538789|FG001|Overall Study|Miscellaneous|6
1976417|NCT01412333|3538797|FG000|Overall Study|Death|1
1976418|NCT01412333|3538798|FG001|Overall Study|Death|1
2102193|NCT00838110|3694003|FG002|Overall Study|Death|1
2102194|NCT00838110|3694004|FG003|Overall Study|Death|2
2102195|NCT00838110|3694001|FG000|Overall Study|Adverse Event|11
1976419|NCT01412333|3538797|FG000|Overall Study|Physician Decision|0
1976420|NCT01412333|3538798|FG001|Overall Study|Physician Decision|1
1976421|NCT01412333|3538797|FG000|Overall Study|Reason not specified|16
1976422|NCT01412333|3538798|FG001|Overall Study|Reason not specified|10
1976423|NCT01412333|3538797|FG000|Overall Study|Non-compliance with study drug|1
1976424|NCT01412333|3538798|FG001|Overall Study|Non-compliance with study drug|1
1976425|NCT01412333|3538797|FG000|Overall Study|Protocol Violation|1
1976426|NCT01412333|3538798|FG001|Overall Study|Protocol Violation|1
1976427|NCT01412333|3538797|FG000|Overall Study|Non-compliance|1
1976428|NCT01412333|3538798|FG001|Overall Study|Non-compliance|3
1976429|NCT01412333|3538797|FG000|Overall Study|Lack of Efficacy|15
1976430|NCT01412333|3538798|FG001|Overall Study|Lack of Efficacy|6
1976431|NCT01412333|3538797|FG000|Overall Study|Pregnancy|3
1976432|NCT01412333|3538798|FG001|Overall Study|Pregnancy|0
1976433|NCT01412333|3538797|FG000|Overall Study|Consent withdrawn by participant|25
1976434|NCT01412333|3538798|FG001|Overall Study|Consent withdrawn by participant|12
1976435|NCT01412333|3538797|FG000|Overall Study|Adverse Event|25
1976436|NCT01412333|3538798|FG001|Overall Study|Adverse Event|16
1976437|NCT01412333|3538797|FG000|Overall Study|Lost to Follow-up|10
1976438|NCT01412333|3538798|FG001|Overall Study|Lost to Follow-up|6
1976439|NCT01338636|3538805|FG000|Overall Study|Withdrawn due to lack of improvement|8
1976440|NCT01253161|3538809|FG000|Overall Study|Adverse Event|1
1976441|NCT01247324|3538815|FG000|Overall Study|Death|1
1976442|NCT01247324|3538816|FG001|Overall Study|Death|0
1976443|NCT01247324|3538815|FG000|Overall Study|Physician Decision|0
1976444|NCT01247324|3538816|FG001|Overall Study|Physician Decision|1
1976445|NCT01247324|3538815|FG000|Overall Study|Non-compliance with study drug|3
1976446|NCT01247324|3538816|FG001|Overall Study|Non-compliance with study drug|0
1976447|NCT01247324|3538815|FG000|Overall Study|Lack of Efficacy|12
1976448|NCT01247324|3538816|FG001|Overall Study|Lack of Efficacy|8
1976449|NCT01247324|3538815|FG000|Overall Study|Non-compliance|2
1976450|NCT01247324|3538816|FG001|Overall Study|Non-compliance|0
1976451|NCT01247324|3538815|FG000|Overall Study|Pregnancy|2
1976452|NCT01247324|3538816|FG001|Overall Study|Pregnancy|3
1976453|NCT01247324|3538815|FG000|Overall Study|Protocol Violation|1
1976454|NCT01247324|3538816|FG001|Overall Study|Protocol Violation|2
1976455|NCT01247324|3538815|FG000|Overall Study|Reason not specified|11
1976456|NCT01247324|3538816|FG001|Overall Study|Reason not specified|8
1976457|NCT01247324|3538815|FG000|Overall Study|Consent withdrawn by participant|13
1976458|NCT01247324|3538816|FG001|Overall Study|Consent withdrawn by participant|8
1976459|NCT01247324|3538815|FG000|Overall Study|Adverse Event|25
1976460|NCT01247324|3538816|FG001|Overall Study|Adverse Event|13
1976461|NCT01247324|3538815|FG000|Overall Study|Lost to Follow-up|1
1976462|NCT01247324|3538816|FG001|Overall Study|Lost to Follow-up|1
1976463|NCT01208974|3538823|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1
1976464|NCT01208974|3538824|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
1976465|NCT01208974|3538825|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
1976466|NCT01208974|3538826|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
1976467|NCT01208974|3538823|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1
1976468|NCT01208974|3538824|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
1976469|NCT01208974|3538825|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
1976470|NCT01208974|3538826|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
1976471|NCT01208974|3538823|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1
1976472|NCT01208974|3538824|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
1976473|NCT01208974|3538825|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
1976474|NCT01208974|3538826|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
1976475|NCT01063517|3538835|FG000|Overall Study|Consent withdrawal|1
1976476|NCT01063517|3538836|FG001|Overall Study|Consent withdrawal|0
1976477|NCT01063517|3538835|FG000|Overall Study|Study reached data cut-off|19
1976478|NCT01063517|3538836|FG001|Overall Study|Study reached data cut-off|7
1976479|NCT01063517|3538835|FG000|Overall Study|Lost to Follow-up|4
1976480|NCT01063517|3538836|FG001|Overall Study|Lost to Follow-up|3
1976481|NCT01063517|3538835|FG000|Overall Study|Withdrawal by Subject|1
1976482|NCT01063517|3538836|FG001|Overall Study|Withdrawal by Subject|2
1976483|NCT01063517|3538835|FG000|Overall Study|Death|33
1976484|NCT01063517|3538836|FG001|Overall Study|Death|48
1976485|NCT00938912|3538842|FG000|Overall Study|Withdrawal by Subject|28
1976486|NCT00938912|3538842|FG000|Overall Study|Lost to Follow-up|4
1976487|NCT00938912|3538842|FG000|Overall Study|Lack of Efficacy|43
1976488|NCT00938912|3538842|FG000|Overall Study|Adverse event, non-fatal|24
1976489|NCT00938912|3538842|FG000|Overall Study|Adverse event, fatal|1
1976490|NCT00938912|3538842|FG000|Overall Study|Participant self adjusted antiepileptic medication|1
1976491|NCT00938912|3538842|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1
1976492|NCT00938912|3538842|FG000|Overall Study|Participant needed prohibit medication|1
1976493|NCT00938912|3538842|FG000|Overall Study|Participant was scheduled for lobal resection|1
1976494|NCT00938912|3538842|FG000|Overall Study|Did not meet Eligibility criteria|1
1976495|NCT00938912|3538842|FG000|Overall Study|Participant relocated not related to AE|1
1976496|NCT00938912|3538842|FG000|Overall Study|Participant moved to another city|1
1976497|NCT00938912|3538842|FG000|Overall Study|Participant experienced break through seizures|1
1976498|NCT00938912|3538842|FG000|Overall Study|No longer wished to participate in the study|1
1976499|NCT00938912|3538842|FG000|Overall Study|Protocol Deviation|2
1976500|NCT00792948|3538874|FG000|Overall Study|Adverse Event|6
1976501|NCT00792948|3538874|FG000|Overall Study|Death|4
1976502|NCT00792948|3538874|FG000|Overall Study|Withdrawal by Subject|3
1976503|NCT00792948|3538874|FG000|Overall Study|Ineligible|2
1976504|NCT00792948|3538874|FG000|Overall Study|Insurance denial - not treated|1
1976505|NCT00792948|3538874|FG000|Overall Study|Physician Decision|11
1976506|NCT00792948|3538874|FG000|Overall Study|Protocol Violation|1
1976507|NCT00676715|3538885|FG000|Overall Study|Withdrawal by Subject|7
1976508|NCT00676715|3538886|FG001|Overall Study|Withdrawal by Subject|9
1976509|NCT00676715|3538887|FG002|Overall Study|Withdrawal by Subject|10
1976510|NCT00676715|3538888|FG003|Overall Study|Withdrawal by Subject|10
1976511|NCT00676715|3538885|FG000|Overall Study|Other|2
1976512|NCT00676715|3538886|FG001|Overall Study|Other|6
1976513|NCT00676715|3538887|FG002|Overall Study|Other|4
1976514|NCT00676715|3538888|FG003|Overall Study|Other|3
1976515|NCT00676715|3538885|FG000|Overall Study|Lost to Follow-up|1
1976516|NCT00676715|3538886|FG001|Overall Study|Lost to Follow-up|1
1976517|NCT00676715|3538887|FG002|Overall Study|Lost to Follow-up|7
1976518|NCT00676715|3538888|FG003|Overall Study|Lost to Follow-up|3
1976519|NCT00676715|3538885|FG000|Overall Study|Death|1
1976520|NCT00676715|3538886|FG001|Overall Study|Death|1
1976521|NCT00676715|3538887|FG002|Overall Study|Death|1
1976522|NCT00676715|3538888|FG003|Overall Study|Death|0
1976523|NCT00676715|3538885|FG000|Overall Study|Adverse Event|0
1976524|NCT00676715|3538886|FG001|Overall Study|Adverse Event|1
1976525|NCT00676715|3538887|FG002|Overall Study|Adverse Event|2
1976526|NCT00676715|3538888|FG003|Overall Study|Adverse Event|0
1976527|NCT00676715|3538885|FG000|Overall Study|Participants Ongoing|29
1976528|NCT00676715|3538886|FG001|Overall Study|Participants Ongoing|29
1976529|NCT00676715|3538887|FG002|Overall Study|Participants Ongoing|17
1976530|NCT00676715|3538888|FG003|Overall Study|Participants Ongoing|24
1976531|NCT00579826|3538900|FG000|Overall Study|Withdrawal by Subject|5
1976532|NCT00579826|3538901|FG001|Overall Study|Withdrawal by Subject|3
1976533|NCT00322218|3538909|FG000|Overall Study|Death|3
1976534|NCT00322218|3538910|FG001|Overall Study|Death|6
1976535|NCT00186888|3538919|FG000|Overall Study|Toxicity|0
1976536|NCT00186888|3538920|FG001|Overall Study|Toxicity|1
1976537|NCT00186888|3538921|FG002|Overall Study|Toxicity|0
1976538|NCT00186888|3538919|FG000|Overall Study|Relapse or progression of disease|4
1976539|NCT00186888|3538920|FG001|Overall Study|Relapse or progression of disease|2
1976540|NCT00186888|3538921|FG002|Overall Study|Relapse or progression of disease|0
2022579|NCT00320606|3590527|FG000|Overall Study|Withdrawal by Subject|1
2022580|NCT00320710|3590544|FG000|Overall Study|Disease progression|24
2022581|NCT00320710|3590545|FG001|Overall Study|Disease progression|19
2022582|NCT00320710|3590546|FG002|Overall Study|Disease progression|2
2022583|NCT00320710|3590544|FG000|Overall Study|Death|10
2022584|NCT00320710|3590545|FG001|Overall Study|Death|7
2022585|NCT00320710|3590546|FG002|Overall Study|Death|1
2022586|NCT00320710|3590544|FG000|Overall Study|Administrative problems|1
2022587|NCT00320710|3590545|FG001|Overall Study|Administrative problems|2
2022588|NCT00320710|3590546|FG002|Overall Study|Administrative problems|0
2022589|NCT00320710|3590544|FG000|Overall Study|Withdrawal by Subject|20
2022590|NCT00320710|3590545|FG001|Overall Study|Withdrawal by Subject|26
2022591|NCT00320710|3590546|FG002|Overall Study|Withdrawal by Subject|1
2022592|NCT00320710|3590544|FG000|Overall Study|Protocol Violation|6
2022593|NCT00320710|3590545|FG001|Overall Study|Protocol Violation|5
2022594|NCT00320710|3590546|FG002|Overall Study|Protocol Violation|0
2022595|NCT00320710|3590544|FG000|Overall Study|Abnormal test procedure result(s)|2
2022596|NCT00320710|3590545|FG001|Overall Study|Abnormal test procedure result(s)|0
2022597|NCT00320710|3590546|FG002|Overall Study|Abnormal test procedure result(s)|0
2022598|NCT00320710|3590544|FG000|Overall Study|Abnormal laboratory value(s)|12
2022599|NCT00320710|3590545|FG001|Overall Study|Abnormal laboratory value(s)|3
2022600|NCT00320710|3590546|FG002|Overall Study|Abnormal laboratory value(s)|0
2022601|NCT00320710|3590544|FG000|Overall Study|Adverse Event|18
2022602|NCT00320710|3590545|FG001|Overall Study|Adverse Event|14
2022603|NCT00320710|3590546|FG002|Overall Study|Adverse Event|1
2022604|NCT00320710|3590544|FG000|Overall Study|Lost to Follow-up|1
2022605|NCT00320710|3590545|FG001|Overall Study|Lost to Follow-up|0
2022606|NCT00320710|3590546|FG002|Overall Study|Lost to Follow-up|0
2022607|NCT00320788|3590565|FG000|Overall Study|Adverse Event|0
2022608|NCT00320788|3590566|FG001|Overall Study|Adverse Event|0
2022609|NCT00320788|3590567|FG002|Overall Study|Adverse Event|0
2022610|NCT00320788|3590568|FG003|Overall Study|Adverse Event|1
2022611|NCT00320788|3590569|FG004|Overall Study|Adverse Event|0
2022612|NCT00320788|3590565|FG000|Overall Study|Death|0
2022613|NCT00320788|3590566|FG001|Overall Study|Death|0
2022614|NCT00320788|3590567|FG002|Overall Study|Death|1
2022615|NCT00320788|3590568|FG003|Overall Study|Death|0
2022616|NCT00320788|3590569|FG004|Overall Study|Death|1
2022617|NCT00320788|3590565|FG000|Overall Study|Lost to Follow-up|0
2022618|NCT00320788|3590566|FG001|Overall Study|Lost to Follow-up|2
2022619|NCT00320788|3590567|FG002|Overall Study|Lost to Follow-up|1
2022620|NCT00320788|3590568|FG003|Overall Study|Lost to Follow-up|0
2022621|NCT00320788|3590569|FG004|Overall Study|Lost to Follow-up|0
2022622|NCT00320788|3590565|FG000|Overall Study|Decision by the Sponsor|1
2022623|NCT00320788|3590566|FG001|Overall Study|Decision by the Sponsor|1
1976541|NCT04311463|3539006|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
1976542|NCT04311463|3539007|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0
1976543|NCT04311463|3539006|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1
1976544|NCT04311463|3539007|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1
1976545|NCT04311463|3539006|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2
1976546|NCT04311463|3539007|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
1976547|NCT03930186|3539023|FG000|Weeks 0 to 16|Adverse Event|6
1976548|NCT03930186|3539023|FG000|Weeks 0 to 16|Withdrawal by Subject|6
1976549|NCT03930186|3539023|FG000|Weeks 16 to 32|Adverse Event|1
1976550|NCT03930186|3539023|FG000|Weeks 16 to 32|Withdrawal by Subject|3
1976551|NCT03740100|3539027|FG000|Overall Study|Adverse Event|1
1976552|NCT03740100|3539027|FG000|Overall Study|Death|1
1976553|NCT03597295|3539031|FG000|Overall Study|Death|37
1976554|NCT03597295|3539031|FG000|Overall Study|Lost to Follow-up|3
1976555|NCT03597295|3539031|FG000|Overall Study|Participants ongoing in the study|54
1976556|NCT03086369|3539041|FG000|Overall Study|Adverse Event|0
1976557|NCT03086369|3539042|FG001|Overall Study|Adverse Event|0
1976558|NCT03086369|3539043|FG002|Overall Study|Adverse Event|0
1976559|NCT03086369|3539044|FG003|Overall Study|Adverse Event|3
1976560|NCT03086369|3539045|FG004|Overall Study|Adverse Event|4
1976561|NCT03086369|3539041|FG000|Overall Study|Lost to Follow-up|1
1976562|NCT03086369|3539042|FG001|Overall Study|Lost to Follow-up|0
1976563|NCT03086369|3539043|FG002|Overall Study|Lost to Follow-up|0
1976564|NCT03086369|3539044|FG003|Overall Study|Lost to Follow-up|2
1976565|NCT03086369|3539045|FG004|Overall Study|Lost to Follow-up|1
1976566|NCT03086369|3539041|FG000|Overall Study|Physician Decision|0
1976567|NCT03086369|3539042|FG001|Overall Study|Physician Decision|0
1976568|NCT03086369|3539043|FG002|Overall Study|Physician Decision|0
1976569|NCT03086369|3539044|FG003|Overall Study|Physician Decision|2
1976570|NCT03086369|3539045|FG004|Overall Study|Physician Decision|5
1976571|NCT03086369|3539041|FG000|Overall Study|Withdrawal by Subject|0
1976572|NCT03086369|3539042|FG001|Overall Study|Withdrawal by Subject|0
1976573|NCT03086369|3539043|FG002|Overall Study|Withdrawal by Subject|0
1976574|NCT03086369|3539044|FG003|Overall Study|Withdrawal by Subject|5
1976575|NCT03086369|3539045|FG004|Overall Study|Withdrawal by Subject|5
1976576|NCT03086369|3539041|FG000|Overall Study|Progressive Disease|0
1976577|NCT03086369|3539042|FG001|Overall Study|Progressive Disease|0
1976578|NCT03086369|3539043|FG002|Overall Study|Progressive Disease|0
1976579|NCT03086369|3539044|FG003|Overall Study|Progressive Disease|14
1976580|NCT03086369|3539045|FG004|Overall Study|Progressive Disease|4
1976581|NCT03086369|3539041|FG000|Overall Study|On Treatment|0
1976582|NCT03086369|3539042|FG001|Overall Study|On Treatment|0
1976583|NCT03086369|3539043|FG002|Overall Study|On Treatment|0
1976584|NCT03086369|3539044|FG003|Overall Study|On Treatment|1
1976585|NCT03086369|3539045|FG004|Overall Study|On Treatment|2
1976586|NCT02849626|3539071|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11
1976587|NCT02849626|3539072|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3
1976588|NCT02849626|3539071|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
1976589|NCT02849626|3539072|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
1976590|NCT02849626|3539071|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
1976591|NCT02849626|3539072|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
1976592|NCT02849626|3539071|FG000|Core Phase (up to 23 Weeks)|Non-specified|3
1976593|NCT02849626|3539072|FG001|Core Phase (up to 23 Weeks)|Non-specified|0
1976594|NCT02849626|3539071|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3
1976595|NCT02849626|3539072|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2
1976596|NCT02849626|3539071|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
1976597|NCT02849626|3539072|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
1976598|NCT02849626|3539071|FG000|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
1976599|NCT02849626|3539072|FG001|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
1976600|NCT02849626|3539071|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1
1976601|NCT02849626|3539072|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0
1976602|NCT02810418|3539095|FG000|Arm A Dose Escalation|Adverse Event|2
1976603|NCT02810418|3539096|FG001|Arm A Dose Escalation|Adverse Event|1
1976604|NCT02810418|3539097|FG002|Arm A Dose Escalation|Adverse Event|0
1976605|NCT02810418|3539098|FG003|Arm A Dose Escalation|Adverse Event|0
1976606|NCT02810418|3539099|FG004|Arm A Dose Escalation|Adverse Event|0
1976607|NCT02810418|3539100|FG005|Arm A Dose Escalation|Adverse Event|0
1976608|NCT02810418|3539101|FG006|Arm A Dose Escalation|Adverse Event|0
1976609|NCT02810418|3539095|FG000|Dose Expansion|Adverse Event|0
1976610|NCT02810418|3539096|FG001|Dose Expansion|Adverse Event|1
1976611|NCT02810418|3539097|FG002|Dose Expansion|Adverse Event|1
1976612|NCT02810418|3539098|FG003|Dose Expansion|Adverse Event|0
1976613|NCT02810418|3539099|FG004|Dose Expansion|Adverse Event|0
1976614|NCT02810418|3539100|FG005|Dose Expansion|Adverse Event|0
1976615|NCT02810418|3539101|FG006|Dose Expansion|Adverse Event|0
1976616|NCT02810418|3539095|FG000|Dose Expansion|Physician Decision|0
1976617|NCT02810418|3539096|FG001|Dose Expansion|Physician Decision|0
2102196|NCT00838110|3694002|FG001|Overall Study|Adverse Event|10
1976618|NCT02810418|3539097|FG002|Dose Expansion|Physician Decision|2
1976619|NCT02810418|3539098|FG003|Dose Expansion|Physician Decision|0
1976620|NCT02810418|3539099|FG004|Dose Expansion|Physician Decision|0
1976621|NCT02810418|3539100|FG005|Dose Expansion|Physician Decision|0
1976622|NCT02810418|3539101|FG006|Dose Expansion|Physician Decision|0
1976623|NCT02810418|3539095|FG000|Arm B Dose Escalation|Adverse Event|0
1976624|NCT02810418|3539096|FG001|Arm B Dose Escalation|Adverse Event|0
1976625|NCT02810418|3539097|FG002|Arm B Dose Escalation|Adverse Event|0
1976626|NCT02810418|3539098|FG003|Arm B Dose Escalation|Adverse Event|0
1976627|NCT02810418|3539099|FG004|Arm B Dose Escalation|Adverse Event|1
1976628|NCT02810418|3539100|FG005|Arm B Dose Escalation|Adverse Event|2
1976629|NCT02810418|3539101|FG006|Arm B Dose Escalation|Adverse Event|0
1976630|NCT02779855|3539167|FG000|Overall Study|Withdrawal by patient prior to treatment|1
1976631|NCT02779855|3539168|FG001|Overall Study|Withdrawal by patient prior to treatment|0
1976632|NCT02779855|3539169|FG002|Overall Study|Withdrawal by patient prior to treatment|0
1976633|NCT02654132|3539180|FG000|Overall Study|Disease Progression|26
1976634|NCT02654132|3539181|FG001|Overall Study|Disease Progression|31
1976635|NCT02654132|3539180|FG000|Overall Study|Adverse Event Unrelated to Study Drug|5
1976636|NCT02654132|3539181|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5
1976637|NCT02654132|3539180|FG000|Overall Study|Switched to another tx|0
1976638|NCT02654132|3539181|FG001|Overall Study|Switched to another tx|1
1976639|NCT02654132|3539180|FG000|Overall Study|Study Drug Toxicity|1
1976640|NCT02654132|3539181|FG001|Overall Study|Study Drug Toxicity|2
1976641|NCT02654132|3539180|FG000|Overall Study|Maximum Clinical Benefit|0
1976642|NCT02654132|3539181|FG001|Overall Study|Maximum Clinical Benefit|2
1976643|NCT02654132|3539180|FG000|Overall Study|Subj Request to Discontinue Treatment|1
1976644|NCT02654132|3539181|FG001|Overall Study|Subj Request to Discontinue Treatment|0
1976645|NCT02654132|3539180|FG000|Overall Study|Not Reported|0
1976646|NCT02654132|3539181|FG001|Overall Study|Not Reported|1
1976647|NCT02654132|3539180|FG000|Overall Study|Subject Withdrew Consent|2
1976648|NCT02654132|3539181|FG001|Overall Study|Subject Withdrew Consent|1
1976649|NCT02654132|3539180|FG000|Overall Study|Inadequate response to therapy|1
1976650|NCT02654132|3539181|FG001|Overall Study|Inadequate response to therapy|0
1976651|NCT02654132|3539180|FG000|Overall Study|Clinical Progression (not protocol)|0
1976652|NCT02654132|3539181|FG001|Overall Study|Clinical Progression (not protocol)|1
1976653|NCT02654132|3539180|FG000|Overall Study|Never treated|0
1976654|NCT02654132|3539181|FG001|Overall Study|Never treated|2
1976655|NCT02603432|3539190|FG000|Overall Study|Ongoing|184
1976656|NCT02603432|3539191|FG001|Overall Study|Ongoing|144
1976657|NCT02603432|3539190|FG000|Overall Study|Adverse Event|1
1976658|NCT02603432|3539191|FG001|Overall Study|Adverse Event|0
1976659|NCT02603432|3539190|FG000|Overall Study|Death|144
1976660|NCT02603432|3539191|FG001|Overall Study|Death|177
1976661|NCT02603432|3539190|FG000|Overall Study|Lost to Follow-up|4
1976662|NCT02603432|3539191|FG001|Overall Study|Lost to Follow-up|6
1976663|NCT02603432|3539190|FG000|Overall Study|Progressive Disease|5
1976664|NCT02603432|3539191|FG001|Overall Study|Progressive Disease|5
1976665|NCT02603432|3539190|FG000|Overall Study|Withdrawal by Subject|9
1976666|NCT02603432|3539191|FG001|Overall Study|Withdrawal by Subject|17
1976667|NCT02603432|3539190|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
1976668|NCT02603432|3539191|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
1976669|NCT02603432|3539190|FG000|Overall Study|Other|0
1976670|NCT02603432|3539191|FG001|Overall Study|Other|1
1976671|NCT02600923|3539197|FG000|Overall Study|Death|10
1976672|NCT02600923|3539197|FG000|Overall Study|Adverse Event|3
1976673|NCT02600923|3539197|FG000|Overall Study|Global deterioration of health status|2
1976674|NCT02600923|3539197|FG000|Overall Study|Insufficient clinical response|6
1976675|NCT02600923|3539197|FG000|Overall Study|Lost to Follow-up|1
1976676|NCT02600923|3539197|FG000|Overall Study|Withdrawal by Subject|5
1976677|NCT02600923|3539197|FG000|Overall Study|Objective progression or relapse|50
1976678|NCT02600923|3539197|FG000|Overall Study|Study terminated by Sponsor|53
1976679|NCT02600923|3539197|FG000|Overall Study|Not treated|1
2022624|NCT00320788|3590567|FG002|Overall Study|Decision by the Sponsor|0
2022625|NCT00320788|3590568|FG003|Overall Study|Decision by the Sponsor|0
2022626|NCT00320788|3590569|FG004|Overall Study|Decision by the Sponsor|1
2022627|NCT00320788|3590565|FG000|Overall Study|Other|1
2022628|NCT00320788|3590566|FG001|Overall Study|Other|2
2022629|NCT00320788|3590567|FG002|Overall Study|Other|1
2022630|NCT00320788|3590568|FG003|Overall Study|Other|1
2022631|NCT00320788|3590569|FG004|Overall Study|Other|1
2022632|NCT00320788|3590565|FG000|Overall Study|Physician Decision|1
2022633|NCT00320788|3590566|FG001|Overall Study|Physician Decision|1
2022634|NCT00320788|3590567|FG002|Overall Study|Physician Decision|0
2022635|NCT00320788|3590568|FG003|Overall Study|Physician Decision|0
2022636|NCT00320788|3590569|FG004|Overall Study|Physician Decision|0
2022637|NCT00320788|3590565|FG000|Overall Study|Protocol Violation|0
2022638|NCT00320788|3590566|FG001|Overall Study|Protocol Violation|0
2022639|NCT00320788|3590567|FG002|Overall Study|Protocol Violation|0
2022640|NCT00320788|3590568|FG003|Overall Study|Protocol Violation|0
2022641|NCT00320788|3590569|FG004|Overall Study|Protocol Violation|1
2022642|NCT00320788|3590565|FG000|Overall Study|Withdrawal by Subject|3
2022643|NCT00320788|3590566|FG001|Overall Study|Withdrawal by Subject|0
2022644|NCT00320788|3590567|FG002|Overall Study|Withdrawal by Subject|0
2022645|NCT00320788|3590568|FG003|Overall Study|Withdrawal by Subject|3
2022646|NCT00320788|3590569|FG004|Overall Study|Withdrawal by Subject|1
2022647|NCT00320801|3590589|FG000|Open-label Run-in Period|Withdrawal by Subject|2
1976680|NCT02412735|3539222|FG000|Overall Study|Adverse Event|0
1976681|NCT02412735|3539223|FG001|Overall Study|Adverse Event|1
1976682|NCT02412735|3539224|FG002|Overall Study|Adverse Event|2
1976683|NCT02412735|3539222|FG000|Overall Study|Withdrawal by Subject|23
1976684|NCT02412735|3539223|FG001|Overall Study|Withdrawal by Subject|27
1976685|NCT02412735|3539224|FG002|Overall Study|Withdrawal by Subject|22
1976686|NCT02412735|3539222|FG000|Overall Study|Investigator Decision|3
1976687|NCT02412735|3539223|FG001|Overall Study|Investigator Decision|3
1976688|NCT02412735|3539224|FG002|Overall Study|Investigator Decision|2
1976689|NCT02412735|3539222|FG000|Overall Study|Lost to Follow-up|17
1976690|NCT02412735|3539223|FG001|Overall Study|Lost to Follow-up|11
1976691|NCT02412735|3539224|FG002|Overall Study|Lost to Follow-up|18
1976692|NCT02412735|3539222|FG000|Overall Study|Reason not Specified|3
1976693|NCT02412735|3539223|FG001|Overall Study|Reason not Specified|2
1976694|NCT02412735|3539224|FG002|Overall Study|Reason not Specified|2
1976695|NCT02371889|3539234|FG000|Overall Study|Adverse medication effect|11
1976696|NCT02371889|3539235|FG001|Overall Study|Adverse medication effect|2
1976697|NCT02371889|3539234|FG000|Overall Study|Lost to Follow-up|6
1976698|NCT02371889|3539235|FG001|Overall Study|Lost to Follow-up|5
1976699|NCT02371889|3539234|FG000|Overall Study|Personal time constraints|2
1976700|NCT02371889|3539235|FG001|Overall Study|Personal time constraints|4
1976701|NCT02371889|3539234|FG000|Overall Study|Lack of Efficacy|0
1976702|NCT02371889|3539235|FG001|Overall Study|Lack of Efficacy|2
1976703|NCT02371889|3539234|FG000|Overall Study|Relapse|0
1976704|NCT02371889|3539235|FG001|Overall Study|Relapse|1
1976705|NCT02337829|3539249|FG000|Overall Study|Death|0
1976706|NCT02337829|3539250|FG001|Overall Study|Death|1
1976707|NCT02337829|3539251|FG002|Overall Study|Death|0
1976708|NCT02337829|3539252|FG003|Overall Study|Death|0
1976709|NCT02337829|3539249|FG000|Overall Study|Study terminated by sponsor|12
1976710|NCT02337829|3539250|FG001|Overall Study|Study terminated by sponsor|10
1976711|NCT02337829|3539251|FG002|Overall Study|Study terminated by sponsor|5
1976712|NCT02337829|3539252|FG003|Overall Study|Study terminated by sponsor|6
1976713|NCT02337829|3539249|FG000|Overall Study|discontinued for other reasons|6
1976714|NCT02337829|3539250|FG001|Overall Study|discontinued for other reasons|3
1976715|NCT02337829|3539251|FG002|Overall Study|discontinued for other reasons|1
1976716|NCT02337829|3539252|FG003|Overall Study|discontinued for other reasons|4
1976717|NCT02272803|3539266|FG000|Overall Study|Disease progression|4
1976718|NCT02272803|3539267|FG001|Overall Study|Disease progression|2
1976719|NCT02272803|3539266|FG000|Overall Study|Adverse Event unrelated to study drug|1
1976720|NCT02272803|3539267|FG001|Overall Study|Adverse Event unrelated to study drug|4
1976721|NCT02272803|3539266|FG000|Overall Study|Study drug toxicity|1
1976722|NCT02272803|3539267|FG001|Overall Study|Study drug toxicity|4
1976723|NCT02272803|3539266|FG000|Overall Study|Subj request to discontinue study trt|1
1976724|NCT02272803|3539267|FG001|Overall Study|Subj request to discontinue study trt|4
1976725|NCT02272803|3539266|FG000|Overall Study|Maximum clinical benefit|1
1976726|NCT02272803|3539267|FG001|Overall Study|Maximum clinical benefit|1
1976727|NCT02272803|3539266|FG000|Overall Study|Subject moved to care facility|0
1976728|NCT02272803|3539267|FG001|Overall Study|Subject moved to care facility|1
1976729|NCT02272803|3539266|FG000|Overall Study|Poor/non-compliance|0
1976730|NCT02272803|3539267|FG001|Overall Study|Poor/non-compliance|1
1976731|NCT02272803|3539266|FG000|Overall Study|Withdrawal by Subject|1
1976732|NCT02272803|3539267|FG001|Overall Study|Withdrawal by Subject|0
1976733|NCT02186834|3539273|FG000|Dose Escalation|Death|0
1976734|NCT02186834|3539274|FG001|Dose Escalation|Death|0
1976735|NCT02186834|3539275|FG002|Dose Escalation|Death|0
1976736|NCT02186834|3539276|FG003|Dose Escalation|Death|1
1976737|NCT02186834|3539277|FG004|Dose Escalation|Death|0
1976738|NCT02186834|3539278|FG005|Dose Escalation|Death|0
1976739|NCT02186834|3539273|FG000|Treatment at RP2D|Died prior to treatment|0
1976740|NCT02186834|3539274|FG001|Treatment at RP2D|Died prior to treatment|0
1976741|NCT02186834|3539275|FG002|Treatment at RP2D|Died prior to treatment|0
1976742|NCT02186834|3539276|FG003|Treatment at RP2D|Died prior to treatment|0
1976743|NCT02186834|3539277|FG004|Treatment at RP2D|Died prior to treatment|0
1976744|NCT02186834|3539278|FG005|Treatment at RP2D|Died prior to treatment|1
1976745|NCT02100722|3539298|FG000|Overall Study|Withdrawal pre-procedure|4
1976746|NCT02100722|3539299|FG001|Overall Study|Withdrawal pre-procedure|9
1976747|NCT02100722|3539298|FG000|Overall Study|Withdrawal post-procedure|0
1976748|NCT02100722|3539299|FG001|Overall Study|Withdrawal post-procedure|3
1976749|NCT02100722|3539298|FG000|Overall Study|Lost to Follow-up|2
1976750|NCT02100722|3539299|FG001|Overall Study|Lost to Follow-up|2
1976751|NCT02100722|3539298|FG000|Overall Study|Continuing on study|751
1976752|NCT02100722|3539299|FG001|Overall Study|Continuing on study|729
1976753|NCT02059265|3539306|FG000|Overall Study|Ineligible|4
1976754|NCT02046096|3539312|FG000|Overall Study|Death|28
1976755|NCT02046096|3539313|FG001|Overall Study|Death|45
1976756|NCT02046096|3539312|FG000|Overall Study|Lost to Follow-up|9
1976757|NCT02046096|3539313|FG001|Overall Study|Lost to Follow-up|20
1976758|NCT02046096|3539312|FG000|Overall Study|Withdrawal by Subject|5
1976759|NCT02046096|3539313|FG001|Overall Study|Withdrawal by Subject|17
1976760|NCT02046096|3539312|FG000|Overall Study|Other endpoint|2
1976761|NCT02046096|3539313|FG001|Overall Study|Other endpoint|19
1976762|NCT01945775|3539323|FG000|Overall Study|Death|214
1976763|NCT01945775|3539324|FG001|Overall Study|Death|98
1976764|NCT01945775|3539323|FG000|Overall Study|Lost to Follow-up|12
1976765|NCT01945775|3539324|FG001|Overall Study|Lost to Follow-up|7
1976766|NCT01945775|3539323|FG000|Overall Study|Withdrawal by Subject|11
1976767|NCT01945775|3539324|FG001|Overall Study|Withdrawal by Subject|21
1976768|NCT01945775|3539323|FG000|Overall Study|Other|50
1976769|NCT01945775|3539324|FG001|Overall Study|Other|18
1976770|NCT01781637|3539332|FG000|Overall Study|Adverse Event|1
1976771|NCT01781637|3539333|FG001|Overall Study|Adverse Event|0
1976772|NCT01781637|3539332|FG000|Overall Study|Lack of Efficacy|2
1976773|NCT01781637|3539333|FG001|Overall Study|Lack of Efficacy|6
1976774|NCT01781637|3539332|FG000|Overall Study|Withdrawal by Subject|1
1976775|NCT01781637|3539333|FG001|Overall Study|Withdrawal by Subject|0
1976776|NCT01711541|3539344|FG000|Overall Study|Cancel prior to treatment|0
1976777|NCT01711541|3539345|FG001|Overall Study|Cancel prior to treatment|0
1976778|NCT01711541|3539346|FG002|Overall Study|Cancel prior to treatment|0
1976779|NCT01711541|3539347|FG003|Overall Study|Cancel prior to treatment|1
1976780|NCT01711541|3539348|FG004|Overall Study|Cancel prior to treatment|0
1976781|NCT01711541|3539344|FG000|Overall Study|Ineligible|0
1976782|NCT01711541|3539345|FG001|Overall Study|Ineligible|1
1976783|NCT01711541|3539346|FG002|Overall Study|Ineligible|0
1976784|NCT01711541|3539347|FG003|Overall Study|Ineligible|0
1976785|NCT01711541|3539348|FG004|Overall Study|Ineligible|0
1976786|NCT01670539|3539365|FG000|Overall Study|Death|3
1976787|NCT01670539|3539366|FG001|Overall Study|Death|5
1976788|NCT01670539|3539365|FG000|Overall Study|Withdrawal by Subject|3
1976789|NCT01670539|3539366|FG001|Overall Study|Withdrawal by Subject|0
1976790|NCT01371981|3539379|FG000|Overall Study|Adverse Event|12
1976791|NCT01371981|3539380|FG001|Overall Study|Adverse Event|17
1976792|NCT01371981|3539381|FG002|Overall Study|Adverse Event|0
1976793|NCT01371981|3539382|FG003|Overall Study|Adverse Event|4
1976794|NCT01371981|3539383|FG004|Overall Study|Adverse Event|1
1976795|NCT01371981|3539384|FG005|Overall Study|Adverse Event|0
1976796|NCT01371981|3539379|FG000|Overall Study|Death|22
1976797|NCT01371981|3539380|FG001|Overall Study|Death|16
1976798|NCT01371981|3539381|FG002|Overall Study|Death|0
1976799|NCT01371981|3539382|FG003|Overall Study|Death|0
1976800|NCT01371981|3539383|FG004|Overall Study|Death|2
1976801|NCT01371981|3539384|FG005|Overall Study|Death|2
1976802|NCT01371981|3539379|FG000|Overall Study|Lack of Efficacy|69
1976803|NCT01371981|3539380|FG001|Overall Study|Lack of Efficacy|61
1976804|NCT01371981|3539381|FG002|Overall Study|Lack of Efficacy|4
1976805|NCT01371981|3539382|FG003|Overall Study|Lack of Efficacy|8
1976806|NCT01371981|3539383|FG004|Overall Study|Lack of Efficacy|5
1976807|NCT01371981|3539384|FG005|Overall Study|Lack of Efficacy|0
1976808|NCT01371981|3539379|FG000|Overall Study|Physician Decision|48
1976809|NCT01371981|3539380|FG001|Overall Study|Physician Decision|63
1976810|NCT01371981|3539381|FG002|Overall Study|Physician Decision|1
1976811|NCT01371981|3539382|FG003|Overall Study|Physician Decision|7
1976812|NCT01371981|3539383|FG004|Overall Study|Physician Decision|14
1976813|NCT01371981|3539384|FG005|Overall Study|Physician Decision|3
1976814|NCT01371981|3539379|FG000|Overall Study|Withdrawal by Subject|12
1976815|NCT01371981|3539380|FG001|Overall Study|Withdrawal by Subject|19
1976816|NCT01371981|3539381|FG002|Overall Study|Withdrawal by Subject|1
1976817|NCT01371981|3539382|FG003|Overall Study|Withdrawal by Subject|2
1976818|NCT01371981|3539383|FG004|Overall Study|Withdrawal by Subject|10
1976819|NCT01371981|3539384|FG005|Overall Study|Withdrawal by Subject|3
1976820|NCT01371981|3539379|FG000|Overall Study|Ineligible|19
1976821|NCT01371981|3539380|FG001|Overall Study|Ineligible|13
1976822|NCT01371981|3539381|FG002|Overall Study|Ineligible|0
1976823|NCT01371981|3539382|FG003|Overall Study|Ineligible|0
1976824|NCT01371981|3539383|FG004|Overall Study|Ineligible|0
1976825|NCT01371981|3539384|FG005|Overall Study|Ineligible|4
1976826|NCT01371981|3539379|FG000|Overall Study|Did not start treatment|2
1976827|NCT01371981|3539380|FG001|Overall Study|Did not start treatment|3
1976828|NCT01371981|3539381|FG002|Overall Study|Did not start treatment|0
1976829|NCT01371981|3539382|FG003|Overall Study|Did not start treatment|0
1976830|NCT01371981|3539383|FG004|Overall Study|Did not start treatment|0
1976831|NCT01371981|3539384|FG005|Overall Study|Did not start treatment|2
1976832|NCT01196390|3539405|FG000|Overall Study|Protocol Violation|4
1976833|NCT01196390|3539406|FG001|Overall Study|Protocol Violation|5
1976834|NCT00980460|3539419|FG000|Overall Study|Death|0
1976835|NCT00980460|3539420|FG001|Overall Study|Death|0
1976836|NCT00980460|3539421|FG002|Overall Study|Death|1
1976837|NCT00980460|3539422|FG003|Overall Study|Death|2
1976838|NCT00980460|3539423|FG004|Overall Study|Death|1
1976839|NCT00980460|3539419|FG000|Overall Study|Lack of Efficacy|0
1976840|NCT00980460|3539420|FG001|Overall Study|Lack of Efficacy|0
1976841|NCT00980460|3539421|FG002|Overall Study|Lack of Efficacy|10
1976842|NCT00980460|3539422|FG003|Overall Study|Lack of Efficacy|6
1976843|NCT00980460|3539423|FG004|Overall Study|Lack of Efficacy|8
1976844|NCT00980460|3539419|FG000|Overall Study|Lost to Follow-up|0
1976845|NCT00980460|3539420|FG001|Overall Study|Lost to Follow-up|0
1976846|NCT00980460|3539421|FG002|Overall Study|Lost to Follow-up|0
1976847|NCT00980460|3539422|FG003|Overall Study|Lost to Follow-up|1
1976848|NCT00980460|3539423|FG004|Overall Study|Lost to Follow-up|0
1976849|NCT00980460|3539419|FG000|Overall Study|Physician Decision|0
1976850|NCT00980460|3539420|FG001|Overall Study|Physician Decision|0
1976851|NCT00980460|3539421|FG002|Overall Study|Physician Decision|11
1976852|NCT00980460|3539422|FG003|Overall Study|Physician Decision|5
1976853|NCT00980460|3539423|FG004|Overall Study|Physician Decision|3
1976854|NCT00980460|3539419|FG000|Overall Study|Withdrawal by Subject|0
1976855|NCT00980460|3539420|FG001|Overall Study|Withdrawal by Subject|0
1976856|NCT00980460|3539421|FG002|Overall Study|Withdrawal by Subject|1
1976857|NCT00980460|3539422|FG003|Overall Study|Withdrawal by Subject|0
1976858|NCT00980460|3539423|FG004|Overall Study|Withdrawal by Subject|0
1976859|NCT00980460|3539419|FG000|Overall Study|Ineligible|0
1976860|NCT00980460|3539420|FG001|Overall Study|Ineligible|2
1976861|NCT00980460|3539421|FG002|Overall Study|Ineligible|3
1976862|NCT00980460|3539422|FG003|Overall Study|Ineligible|1
1976863|NCT00980460|3539423|FG004|Overall Study|Ineligible|4
1976864|NCT00980460|3539419|FG000|Overall Study|Refusal of further therapy|0
1976865|NCT00980460|3539420|FG001|Overall Study|Refusal of further therapy|2
1976866|NCT00980460|3539421|FG002|Overall Study|Refusal of further therapy|3
1976867|NCT00980460|3539422|FG003|Overall Study|Refusal of further therapy|2
1976868|NCT00980460|3539423|FG004|Overall Study|Refusal of further therapy|0
1976869|NCT00980460|3539419|FG000|Overall Study|No therapy within 42 days of resection|0
1976870|NCT00980460|3539420|FG001|Overall Study|No therapy within 42 days of resection|0
1976871|NCT00980460|3539421|FG002|Overall Study|No therapy within 42 days of resection|3
1976872|NCT00980460|3539422|FG003|Overall Study|No therapy within 42 days of resection|1
1976873|NCT00980460|3539423|FG004|Overall Study|No therapy within 42 days of resection|0
1976874|NCT00980460|3539419|FG000|Overall Study|No transplant by protocol timepoints|0
1976875|NCT00980460|3539420|FG001|Overall Study|No transplant by protocol timepoints|0
1976876|NCT00980460|3539421|FG002|Overall Study|No transplant by protocol timepoints|3
1976877|NCT00980460|3539422|FG003|Overall Study|No transplant by protocol timepoints|0
1976878|NCT00980460|3539423|FG004|Overall Study|No transplant by protocol timepoints|0
1976879|NCT00407602|3539442|FG000|Overall Study|Death - unrelated to device|1
1976880|NCT00407602|3539442|FG000|Overall Study|Device explanted|5
1976881|NCT00407602|3539442|FG000|Overall Study|Withdrawal by Subject|1
2022648|NCT00320801|3590590|FG001|Open-label Run-in Period|Withdrawal by Subject|0
2022649|NCT00320801|3590591|FG002|Open-label Run-in Period|Withdrawal by Subject|0
2022650|NCT00320801|3590592|FG003|Open-label Run-in Period|Withdrawal by Subject|0
2022651|NCT00320801|3590589|FG000|Open-label Run-in Period|Adverse Event|33
2022652|NCT00320801|3590590|FG001|Open-label Run-in Period|Adverse Event|0
2022653|NCT00320801|3590591|FG002|Open-label Run-in Period|Adverse Event|0
2022654|NCT00320801|3590592|FG003|Open-label Run-in Period|Adverse Event|0
2022655|NCT00320801|3590589|FG000|Open-label Run-in Period|Administrative|10
2022656|NCT00320801|3590590|FG001|Open-label Run-in Period|Administrative|0
2022657|NCT00320801|3590591|FG002|Open-label Run-in Period|Administrative|0
2022658|NCT00320801|3590592|FG003|Open-label Run-in Period|Administrative|0
2022659|NCT00320801|3590589|FG000|Open-label Run-in Period|Lack of Efficacy|44
2022660|NCT00320801|3590590|FG001|Open-label Run-in Period|Lack of Efficacy|0
2022661|NCT00320801|3590591|FG002|Open-label Run-in Period|Lack of Efficacy|0
2022662|NCT00320801|3590592|FG003|Open-label Run-in Period|Lack of Efficacy|0
2022663|NCT00320801|3590589|FG000|Open-label Run-in Period|Lost to Follow-up|2
2022664|NCT00320801|3590590|FG001|Open-label Run-in Period|Lost to Follow-up|0
2022665|NCT00320801|3590591|FG002|Open-label Run-in Period|Lost to Follow-up|0
2022666|NCT00320801|3590592|FG003|Open-label Run-in Period|Lost to Follow-up|0
2022667|NCT00320801|3590589|FG000|Open-label Run-in Period|Did not qualify|1
2022668|NCT00320801|3590590|FG001|Open-label Run-in Period|Did not qualify|0
2022669|NCT00320801|3590591|FG002|Open-label Run-in Period|Did not qualify|0
2022670|NCT00320801|3590592|FG003|Open-label Run-in Period|Did not qualify|0
2022671|NCT00320801|3590589|FG000|Double-blind Phase|Withdrawal by Subject|0
2022672|NCT00320801|3590590|FG001|Double-blind Phase|Withdrawal by Subject|0
2022673|NCT00320801|3590591|FG002|Double-blind Phase|Withdrawal by Subject|1
2022674|NCT00320801|3590592|FG003|Double-blind Phase|Withdrawal by Subject|0
2022675|NCT00320801|3590589|FG000|Double-blind Phase|Adverse Event|0
2022676|NCT00320801|3590590|FG001|Double-blind Phase|Adverse Event|2
2022677|NCT00320801|3590591|FG002|Double-blind Phase|Adverse Event|8
2022678|NCT00320801|3590592|FG003|Double-blind Phase|Adverse Event|0
2022679|NCT00320801|3590589|FG000|Double-blind Phase|Administrative|0
2022680|NCT00320801|3590590|FG001|Double-blind Phase|Administrative|0
2022681|NCT00320801|3590591|FG002|Double-blind Phase|Administrative|4
2022682|NCT00320801|3590592|FG003|Double-blind Phase|Administrative|0
2022683|NCT00320801|3590589|FG000|Double-blind Phase|Lack of Efficacy|0
2022684|NCT00320801|3590590|FG001|Double-blind Phase|Lack of Efficacy|9
2022685|NCT00320801|3590591|FG002|Double-blind Phase|Lack of Efficacy|1
2022686|NCT00320801|3590592|FG003|Double-blind Phase|Lack of Efficacy|0
2022687|NCT00320801|3590589|FG000|Extension Phase|Withdrawal by Subject|0
2022688|NCT00320801|3590590|FG001|Extension Phase|Withdrawal by Subject|0
2022689|NCT00320801|3590591|FG002|Extension Phase|Withdrawal by Subject|0
2022690|NCT00320801|3590592|FG003|Extension Phase|Withdrawal by Subject|6
2022691|NCT00320801|3590589|FG000|Extension Phase|Adverse Event|0
2022692|NCT00320801|3590590|FG001|Extension Phase|Adverse Event|0
2022693|NCT00320801|3590591|FG002|Extension Phase|Adverse Event|0
2022694|NCT00320801|3590592|FG003|Extension Phase|Adverse Event|8
2022695|NCT00320801|3590589|FG000|Extension Phase|Administrative|0
2022696|NCT00320801|3590590|FG001|Extension Phase|Administrative|0
2022697|NCT00320801|3590591|FG002|Extension Phase|Administrative|0
2022698|NCT00320801|3590592|FG003|Extension Phase|Administrative|29
2022699|NCT00320801|3590589|FG000|Extension Phase|Lack of Efficacy|0
2022700|NCT00320801|3590590|FG001|Extension Phase|Lack of Efficacy|0
1976882|NCT04567186|3539466|FG000|Period 1|COVID-19 related|1
1976883|NCT04567186|3539467|FG001|Period 1|COVID-19 related|0
1976884|NCT04567186|3539466|FG000|Period 1|Protocol Violation|0
1976885|NCT04567186|3539467|FG001|Period 1|Protocol Violation|1
1976886|NCT04567186|3539466|FG000|Period 1|Adverse Event|0
1976887|NCT04567186|3539467|FG001|Period 1|Adverse Event|2
1976888|NCT04567186|3539466|FG000|Period 2|COVID-19 Related|0
1976889|NCT04567186|3539467|FG001|Period 2|COVID-19 Related|1
1976890|NCT04567186|3539466|FG000|Period 2|Protocol Violation|0
1976891|NCT04567186|3539467|FG001|Period 2|Protocol Violation|1
1976892|NCT04567186|3539466|FG000|Period 2|Lost to Follow-up|0
1976893|NCT04567186|3539467|FG001|Period 2|Lost to Follow-up|1
1976894|NCT04567186|3539466|FG000|Period 3|Subject no longer meets eligibilty criteria|1
1976895|NCT04567186|3539467|FG001|Period 3|Subject no longer meets eligibilty criteria|0
1976896|NCT04065074|3539490|FG000|Overall Study|Adverse Event|1
1976897|NCT04065074|3539490|FG000|Overall Study|Protocol Non-Compliance after injection|1
1976898|NCT03980730|3539496|FG000|Overall Study|Study Terminated by Sponsor|0
1976899|NCT03980730|3539497|FG001|Overall Study|Study Terminated by Sponsor|3
1976900|NCT03980730|3539496|FG000|Overall Study|Adverse Event|2
1976901|NCT03980730|3539497|FG001|Overall Study|Adverse Event|0
1976902|NCT03980730|3539496|FG000|Overall Study|Sponsor Request|0
1976903|NCT03980730|3539497|FG001|Overall Study|Sponsor Request|1
1976904|NCT03793010|3539505|FG000|Overall Study|Withdrawal by Subject|5
1976905|NCT03793010|3539506|FG001|Overall Study|Withdrawal by Subject|7
1976906|NCT03793010|3539505|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19
1976907|NCT03793010|3539506|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18
1976908|NCT03793010|3539505|FG000|Overall Study|Lost to Follow-up|1
1976909|NCT03793010|3539506|FG001|Overall Study|Lost to Follow-up|2
1976910|NCT03793010|3539505|FG000|Overall Study|Patient couldn't sit still for injection|1
1976911|NCT03793010|3539506|FG001|Overall Study|Patient couldn't sit still for injection|0
1976912|NCT03793010|3539505|FG000|Overall Study|Withdrew to pursue other treatment|1
1976913|NCT03793010|3539506|FG001|Overall Study|Withdrew to pursue other treatment|0
1976914|NCT03793010|3539505|FG000|Overall Study|Did not meet eligibility criteria|1
1976915|NCT03793010|3539506|FG001|Overall Study|Did not meet eligibility criteria|0
1976916|NCT03644017|3539512|FG000|Overall Study|Access Abandonment|5
1976917|NCT03644017|3539512|FG000|Overall Study|Kidney Transplant|2
1976918|NCT03592186|3539518|FG000|Overall Study|Withdrawal by Subject|1
1976919|NCT03592186|3539519|FG001|Overall Study|Withdrawal by Subject|0
1976920|NCT03592186|3539518|FG000|Overall Study|Lost to Follow-up|16
1976921|NCT03592186|3539519|FG001|Overall Study|Lost to Follow-up|11
1976922|NCT03529942|3539525|FG000|Overall Study|Withdrawal by Subject|13
1976923|NCT03529942|3539525|FG000|Overall Study|Physician Decision|1
1976924|NCT03529942|3539525|FG000|Overall Study|Lost to Follow-up|7
1976925|NCT03529942|3539525|FG000|Overall Study|Needle inserted but no drug administered|1
1976926|NCT03529942|3539525|FG000|Overall Study|Personal reasons|1
1976927|NCT03373760|3539534|FG000|Overall Study|Adverse Event|8
1976928|NCT03373760|3539534|FG000|Overall Study|Disease Progression|46
1976929|NCT03373760|3539534|FG000|Overall Study|Death|4
1976930|NCT03349775|3539543|FG000|Overall Study|Side Effects|1
1976931|NCT03349775|3539544|FG001|Overall Study|Side Effects|2
1976932|NCT03349775|3539543|FG000|Overall Study|Withdrawal by Subject|1
1976933|NCT03349775|3539544|FG001|Overall Study|Withdrawal by Subject|1
1976934|NCT03349775|3539543|FG000|Overall Study|No primary outcome measurements|0
1976935|NCT03349775|3539544|FG001|Overall Study|No primary outcome measurements|1
1976936|NCT03256344|3539561|FG000|Overall Study|Ongoing on study|3
1976937|NCT03256344|3539562|FG001|Overall Study|Ongoing on study|3
1976938|NCT03256344|3539561|FG000|Overall Study|Death|5
1976939|NCT03256344|3539562|FG001|Overall Study|Death|19
1976940|NCT03256344|3539561|FG000|Overall Study|Withdrawal by Subject|3
1976941|NCT03256344|3539562|FG001|Overall Study|Withdrawal by Subject|3
1976942|NCT03207815|3539570|FG000|Overall Study|Protocol Violation|3
1976943|NCT03207815|3539571|FG001|Overall Study|Protocol Violation|1
1976944|NCT03207815|3539570|FG000|Overall Study|Adverse Event|1
1976945|NCT03207815|3539571|FG001|Overall Study|Adverse Event|2
1976946|NCT03207815|3539570|FG000|Overall Study|Lost to Follow-up|1
1976947|NCT03207815|3539571|FG001|Overall Study|Lost to Follow-up|2
1976948|NCT03207815|3539570|FG000|Overall Study|Investigator's Discretion|1
1976949|NCT03207815|3539571|FG001|Overall Study|Investigator's Discretion|1
1976950|NCT03207815|3539570|FG000|Overall Study|Lack of Efficacy|0
1976951|NCT03207815|3539571|FG001|Overall Study|Lack of Efficacy|1
1976952|NCT03207815|3539570|FG000|Overall Study|Pregnancy/Partner Pregnancy|1
1976953|NCT03207815|3539571|FG001|Overall Study|Pregnancy/Partner Pregnancy|0
1976954|NCT03207815|3539570|FG000|Overall Study|Withdrew Consent|1
1976955|NCT03207815|3539571|FG001|Overall Study|Withdrew Consent|0
1976956|NCT03073733|3539589|FG000|Overall Study|Lost to Follow-up|1
1976957|NCT03073733|3539590|FG001|Overall Study|Lost to Follow-up|0
1976958|NCT03073733|3539591|FG002|Overall Study|Lost to Follow-up|0
1976959|NCT03073733|3539589|FG000|Overall Study|Physician Decision|0
2213118|NCT01675765|3854474|FG001|Overall Study|Adverse Event|2
2213119|NCT01675765|3854473|FG000|Overall Study|Withdrawal by Subject|2
2213120|NCT01675765|3854474|FG001|Overall Study|Withdrawal by Subject|0
2213121|NCT01675765|3854473|FG000|Overall Study|Death|1
1976960|NCT03073733|3539590|FG001|Overall Study|Physician Decision|1
1976961|NCT03073733|3539591|FG002|Overall Study|Physician Decision|0
2213122|NCT01675765|3854474|FG001|Overall Study|Death|0
2213123|NCT01675765|3854473|FG000|Overall Study|Clinical progression|3
2213124|NCT01675765|3854474|FG001|Overall Study|Clinical progression|2
2213125|NCT01675882|3854493|FG000|Overall Study|Adverse Event|0
2213126|NCT01675882|3854494|FG001|Overall Study|Adverse Event|2
2213127|NCT01675882|3854495|FG002|Overall Study|Adverse Event|1
1976962|NCT03073733|3539589|FG000|Overall Study|Withdrawal by Subject|0
1976963|NCT03073733|3539590|FG001|Overall Study|Withdrawal by Subject|0
1976964|NCT03073733|3539591|FG002|Overall Study|Withdrawal by Subject|1
1976965|NCT02968563|3539610|FG000|Overall Study|Adverse Event|0
1976966|NCT02968563|3539611|FG001|Overall Study|Adverse Event|6
1976967|NCT02968563|3539610|FG000|Overall Study|Death|1
1976968|NCT02968563|3539611|FG001|Overall Study|Death|1
1976969|NCT02968563|3539610|FG000|Overall Study|Lost to Follow-up|0
1976970|NCT02968563|3539611|FG001|Overall Study|Lost to Follow-up|1
1976971|NCT02915783|3539617|FG000|Overall Study|Ongoing: Receiving Treatment|6
1976972|NCT02915783|3539617|FG000|Overall Study|Ongoing: In Survival Follow Up|8
1976973|NCT02913482|3539624|FG000|Overall Study|Death|0
1976974|NCT02913482|3539625|FG001|Overall Study|Death|2
1976975|NCT02913482|3539626|FG002|Overall Study|Death|2
1976976|NCT02913482|3539624|FG000|Overall Study|Progressive Disease|1
1976977|NCT02913482|3539625|FG001|Overall Study|Progressive Disease|1
1976978|NCT02913482|3539626|FG002|Overall Study|Progressive Disease|1
1976979|NCT02787044|3539638|FG000|Overall Study|Lost to Follow-up|15
1976980|NCT02787044|3539639|FG001|Overall Study|Lost to Follow-up|19
1976981|NCT02698163|3539651|FG000|Overall Study|Lost to Follow-up|0
1976982|NCT02698163|3539652|FG001|Overall Study|Lost to Follow-up|1
1976983|NCT02352948|3539692|FG000|Overall Study|Death|47
1976984|NCT02352948|3539693|FG001|Overall Study|Death|48
1976985|NCT02352948|3539694|FG002|Overall Study|Death|114
1976986|NCT02352948|3539695|FG003|Overall Study|Death|74
1976987|NCT02352948|3539696|FG004|Overall Study|Death|77
1976988|NCT02352948|3539697|FG005|Overall Study|Death|44
1976989|NCT02352948|3539692|FG000|Overall Study|Lost to Follow-up|1
1976990|NCT02352948|3539693|FG001|Overall Study|Lost to Follow-up|0
1976991|NCT02352948|3539694|FG002|Overall Study|Lost to Follow-up|2
1976992|NCT02352948|3539695|FG003|Overall Study|Lost to Follow-up|1
1976993|NCT02352948|3539696|FG004|Overall Study|Lost to Follow-up|2
1976994|NCT02352948|3539697|FG005|Overall Study|Lost to Follow-up|1
1976995|NCT02352948|3539692|FG000|Overall Study|Withdrawal by Subject|1
1976996|NCT02352948|3539693|FG001|Overall Study|Withdrawal by Subject|10
1976997|NCT02352948|3539694|FG002|Overall Study|Withdrawal by Subject|11
1976998|NCT02352948|3539695|FG003|Overall Study|Withdrawal by Subject|23
1976999|NCT02352948|3539696|FG004|Overall Study|Withdrawal by Subject|9
1977000|NCT02352948|3539697|FG005|Overall Study|Withdrawal by Subject|4
1977001|NCT02352948|3539692|FG000|Overall Study|Eligibility criteria not fulfilled|0
1977002|NCT02352948|3539693|FG001|Overall Study|Eligibility criteria not fulfilled|1
1977003|NCT02352948|3539694|FG002|Overall Study|Eligibility criteria not fulfilled|0
1977004|NCT02352948|3539695|FG003|Overall Study|Eligibility criteria not fulfilled|1
1977005|NCT02352948|3539696|FG004|Overall Study|Eligibility criteria not fulfilled|0
1977006|NCT02352948|3539697|FG005|Overall Study|Eligibility criteria not fulfilled|0
1977007|NCT02352948|3539692|FG000|Overall Study|Other|0
1977008|NCT02352948|3539693|FG001|Overall Study|Other|0
1977009|NCT02352948|3539694|FG002|Overall Study|Other|2
1977010|NCT02352948|3539695|FG003|Overall Study|Other|0
1977011|NCT02352948|3539696|FG004|Overall Study|Other|0
1977012|NCT02352948|3539697|FG005|Overall Study|Other|0
1977013|NCT02332590|3539719|FG000|DB Period (up to 24 Weeks)|Adverse Event|15
1977014|NCT02332590|3539720|FG001|DB Period (up to 24 Weeks)|Adverse Event|11
1977015|NCT02332590|3539719|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4
1977016|NCT02332590|3539720|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2
1977017|NCT02332590|3539719|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3
1977018|NCT02332590|3539720|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1
1977019|NCT02332590|3539719|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1
1977020|NCT02332590|3539720|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0
1977021|NCT02332590|3539719|FG000|DB Period (up to 24 Weeks)|Other than specified above|6
1977022|NCT02332590|3539720|FG001|DB Period (up to 24 Weeks)|Other than specified above|5
1977023|NCT02332590|3539719|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20
1977024|NCT02332590|3539720|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23
1977025|NCT02332590|3539719|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2
1977026|NCT02332590|3539720|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6
1977027|NCT02332590|3539719|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5
1977028|NCT02332590|3539720|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1
1977029|NCT02332590|3539719|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20
1977030|NCT02332590|3539720|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15
1977031|NCT02256631|3539735|FG000|Overall Study|Lost to Follow-up|1
1977032|NCT02256631|3539736|FG001|Overall Study|Lost to Follow-up|1
1977033|NCT02256631|3539737|FG002|Overall Study|Lost to Follow-up|0
1977034|NCT02256631|3539738|FG003|Overall Study|Lost to Follow-up|2
2213128|NCT01675882|3854496|FG003|Overall Study|Adverse Event|0
2213129|NCT01675882|3854493|FG000|Overall Study|Participant unwilling to continue|2
1977035|NCT02256631|3539739|FG004|Overall Study|Lost to Follow-up|0
1977036|NCT02256631|3539740|FG005|Overall Study|Lost to Follow-up|1
1977037|NCT02256631|3539741|FG006|Overall Study|Lost to Follow-up|1
1977038|NCT02256631|3539735|FG000|Overall Study|Withdrawal by Subject|0
1977039|NCT02256631|3539736|FG001|Overall Study|Withdrawal by Subject|0
1977040|NCT02256631|3539737|FG002|Overall Study|Withdrawal by Subject|0
1977041|NCT02256631|3539738|FG003|Overall Study|Withdrawal by Subject|1
1977042|NCT02256631|3539739|FG004|Overall Study|Withdrawal by Subject|1
1977043|NCT02256631|3539740|FG005|Overall Study|Withdrawal by Subject|0
1977044|NCT02256631|3539741|FG006|Overall Study|Withdrawal by Subject|1
1977045|NCT02256631|3539735|FG000|Overall Study|Unable to get to clinic|0
1977046|NCT02256631|3539736|FG001|Overall Study|Unable to get to clinic|2
1977047|NCT02256631|3539737|FG002|Overall Study|Unable to get to clinic|0
1977048|NCT02256631|3539738|FG003|Overall Study|Unable to get to clinic|1
1977049|NCT02256631|3539739|FG004|Overall Study|Unable to get to clinic|0
1977050|NCT02256631|3539740|FG005|Overall Study|Unable to get to clinic|1
1977051|NCT02256631|3539741|FG006|Overall Study|Unable to get to clinic|2
1977052|NCT01972217|3539761|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1977053|NCT01972217|3539762|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
1977054|NCT01972217|3539763|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1977055|NCT01972217|3539764|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1977056|NCT01972217|3539761|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
1977057|NCT01972217|3539762|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
1977058|NCT01972217|3539763|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
1977059|NCT01972217|3539764|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
1977060|NCT01972217|3539761|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0
1977061|NCT01972217|3539762|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1
1977062|NCT01972217|3539763|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0
1977063|NCT01972217|3539764|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0
1977064|NCT01972217|3539761|FG000|Part A: Open-label Safety Run-in Period|Death|0
1977065|NCT01972217|3539762|FG001|Part A: Open-label Safety Run-in Period|Death|1
1977066|NCT01972217|3539763|FG002|Part A: Open-label Safety Run-in Period|Death|0
1977067|NCT01972217|3539764|FG003|Part A: Open-label Safety Run-in Period|Death|0
1977068|NCT01972217|3539761|FG000|Part B Double-blind, Randomised Period|Death|0
1977069|NCT01972217|3539762|FG001|Part B Double-blind, Randomised Period|Death|0
1977070|NCT01972217|3539763|FG002|Part B Double-blind, Randomised Period|Death|43
1977071|NCT01972217|3539764|FG003|Part B Double-blind, Randomised Period|Death|44
1977072|NCT01972217|3539761|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0
1977073|NCT01972217|3539762|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0
1977074|NCT01972217|3539763|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1
1977075|NCT01972217|3539764|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0
1977076|NCT01972217|3539761|FG000|Part B Double-blind, Randomised Period|Screen failure|0
1977077|NCT01972217|3539762|FG001|Part B Double-blind, Randomised Period|Screen failure|0
1977078|NCT01972217|3539763|FG002|Part B Double-blind, Randomised Period|Screen failure|0
1977079|NCT01972217|3539764|FG003|Part B Double-blind, Randomised Period|Screen failure|1
1977080|NCT01972217|3539761|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0
1977081|NCT01972217|3539762|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0
1977082|NCT01972217|3539763|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2
1977083|NCT01972217|3539764|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1
1977084|NCT01972217|3539761|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1977085|NCT01972217|3539762|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1977086|NCT01972217|3539763|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1977087|NCT01972217|3539764|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
1977088|NCT01816165|3539778|FG000|Overall Study|Adverse Event|1
1977089|NCT01816165|3539779|FG001|Overall Study|Adverse Event|0
1977090|NCT01816165|3539780|FG002|Overall Study|Adverse Event|0
1977091|NCT01816165|3539781|FG003|Overall Study|Adverse Event|0
1977092|NCT01813929|3539803|FG000|Overall Study|Withdrawal by Subject|0
1977093|NCT01813929|3539804|FG001|Overall Study|Withdrawal by Subject|1
2022701|NCT00320801|3590591|FG002|Extension Phase|Lack of Efficacy|0
2022702|NCT00320801|3590592|FG003|Extension Phase|Lack of Efficacy|2
2022703|NCT00320801|3590589|FG000|Extension Phase|Lost to Follow-up|0
2022704|NCT00320801|3590590|FG001|Extension Phase|Lost to Follow-up|0
2022705|NCT00320801|3590591|FG002|Extension Phase|Lost to Follow-up|0
2022706|NCT00320801|3590592|FG003|Extension Phase|Lost to Follow-up|3
2022707|NCT00321048|3590604|FG000|Overall Study|Withdrawal by Subject|6
2022708|NCT00321048|3590605|FG001|Overall Study|Withdrawal by Subject|8
2022709|NCT00321373|3590629|FG000|Overall Study|Adverse Event|0
2022710|NCT00321373|3590630|FG001|Overall Study|Adverse Event|0
2022711|NCT00321373|3590631|FG002|Overall Study|Adverse Event|1
2022712|NCT00321373|3590629|FG000|Overall Study|Lost to Follow-up|1
2022713|NCT00321373|3590630|FG001|Overall Study|Lost to Follow-up|0
2022714|NCT00321373|3590631|FG002|Overall Study|Lost to Follow-up|1
2022715|NCT00321373|3590629|FG000|Overall Study|Withdrawal by Subject|1
2022716|NCT00321373|3590630|FG001|Overall Study|Withdrawal by Subject|0
2022717|NCT00321373|3590631|FG002|Overall Study|Withdrawal by Subject|0
2022718|NCT00321373|3590629|FG000|Overall Study|Other|0
1977094|NCT00882050|3539825|FG000|Overall Study|Physician Decision|1
1977095|NCT00882050|3539826|FG001|Overall Study|Physician Decision|0
1977096|NCT00882050|3539827|FG002|Overall Study|Physician Decision|0
1977097|NCT00070564|3539841|FG000|Overall Study|Progression|2
1977098|NCT00070564|3539842|FG001|Overall Study|Progression|4
1977099|NCT00070564|3539843|FG002|Overall Study|Progression|7
1977100|NCT00070564|3539844|FG003|Overall Study|Progression|7
1977101|NCT00070564|3539845|FG004|Overall Study|Progression|1
1977102|NCT00070564|3539846|FG005|Overall Study|Progression|0
1977103|NCT00070564|3539841|FG000|Overall Study|Delinquent|1
1977104|NCT00070564|3539842|FG001|Overall Study|Delinquent|4
1977105|NCT00070564|3539843|FG002|Overall Study|Delinquent|2
1977106|NCT00070564|3539844|FG003|Overall Study|Delinquent|0
1977107|NCT00070564|3539845|FG004|Overall Study|Delinquent|0
1977108|NCT00070564|3539846|FG005|Overall Study|Delinquent|0
1977109|NCT00070564|3539841|FG000|Overall Study|Adverse Event|150
1977110|NCT00070564|3539842|FG001|Overall Study|Adverse Event|142
1977111|NCT00070564|3539843|FG002|Overall Study|Adverse Event|120
1977112|NCT00070564|3539844|FG003|Overall Study|Adverse Event|108
1977113|NCT00070564|3539845|FG004|Overall Study|Adverse Event|63
1977114|NCT00070564|3539846|FG005|Overall Study|Adverse Event|36
1977115|NCT00070564|3539841|FG000|Overall Study|Death|4
1977116|NCT00070564|3539842|FG001|Overall Study|Death|1
1977117|NCT00070564|3539843|FG002|Overall Study|Death|5
1977118|NCT00070564|3539844|FG003|Overall Study|Death|3
1977119|NCT00070564|3539845|FG004|Overall Study|Death|0
1977120|NCT00070564|3539846|FG005|Overall Study|Death|1
1977121|NCT00070564|3539841|FG000|Overall Study|Other, not protocol specified|17
1977122|NCT00070564|3539842|FG001|Overall Study|Other, not protocol specified|15
1977123|NCT00070564|3539843|FG002|Overall Study|Other, not protocol specified|14
1977124|NCT00070564|3539844|FG003|Overall Study|Other, not protocol specified|19
1977125|NCT00070564|3539845|FG004|Overall Study|Other, not protocol specified|6
1977126|NCT00070564|3539846|FG005|Overall Study|Other, not protocol specified|7
1977127|NCT00070564|3539841|FG000|Overall Study|Withdrawal by Subject|26
1977128|NCT00070564|3539842|FG001|Overall Study|Withdrawal by Subject|37
1977129|NCT00070564|3539843|FG002|Overall Study|Withdrawal by Subject|23
1977130|NCT00070564|3539844|FG003|Overall Study|Withdrawal by Subject|30
1977131|NCT00070564|3539845|FG004|Overall Study|Withdrawal by Subject|8
1977132|NCT00070564|3539846|FG005|Overall Study|Withdrawal by Subject|8
1977133|NCT00070564|3539841|FG000|Overall Study|Not reported|0
1977134|NCT00070564|3539842|FG001|Overall Study|Not reported|0
1977135|NCT00070564|3539843|FG002|Overall Study|Not reported|0
1977136|NCT00070564|3539844|FG003|Overall Study|Not reported|0
1977137|NCT00070564|3539845|FG004|Overall Study|Not reported|1
1977138|NCT00070564|3539846|FG005|Overall Study|Not reported|0
1977139|NCT04425720|3539886|FG000|Overall Study|Withdrawal by Subject|0
1977140|NCT04425720|3539887|FG001|Overall Study|Withdrawal by Subject|20
1977141|NCT04409509|3539896|FG000|Overall Study|Failure to meet randomization requirement|1
1977142|NCT04409509|3539897|FG001|Overall Study|Failure to meet randomization requirement|0
1977143|NCT04409509|3539896|FG000|Overall Study|Adverse Event|0
1977144|NCT04409509|3539897|FG001|Overall Study|Adverse Event|1
1977145|NCT04409509|3539896|FG000|Overall Study|Death|11
1977146|NCT04409509|3539897|FG001|Overall Study|Death|10
1977147|NCT04409509|3539896|FG000|Overall Study|Non-compliance with study drug|0
1977148|NCT04409509|3539897|FG001|Overall Study|Non-compliance with study drug|1
1977149|NCT04409509|3539896|FG000|Overall Study|Lost to Follow-up|0
1977150|NCT04409509|3539897|FG001|Overall Study|Lost to Follow-up|3
1977151|NCT04409509|3539896|FG000|Overall Study|Withdrawal by Subject|0
1977152|NCT04409509|3539897|FG001|Overall Study|Withdrawal by Subject|3
1977153|NCT04409509|3539896|FG000|Overall Study|Randomized by mistake|0
1977154|NCT04409509|3539897|FG001|Overall Study|Randomized by mistake|1
1977155|NCT04409509|3539896|FG000|Overall Study|Other|1
1977156|NCT04409509|3539897|FG001|Overall Study|Other|1
1977179|NCT03922321|3539978|FG000|Overall Study|Participant Moved|1
1977180|NCT03922321|3539978|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1
2022719|NCT00321373|3590630|FG001|Overall Study|Other|0
2022720|NCT00321373|3590631|FG002|Overall Study|Other|1
2022721|NCT00321464|3590641|FG000|Overall Study|Death|169
2022722|NCT00321464|3590642|FG001|Overall Study|Death|174
2022723|NCT00321464|3590641|FG000|Overall Study|Disease progression|124
2022724|NCT00321464|3590642|FG001|Overall Study|Disease progression|124
2022725|NCT00321464|3590641|FG000|Overall Study|Withdrawal by Subject|117
2022726|NCT00321464|3590642|FG001|Overall Study|Withdrawal by Subject|118
2022727|NCT00321464|3590641|FG000|Overall Study|Participant request|57
2022728|NCT00321464|3590642|FG001|Overall Study|Participant request|61
2022729|NCT00321464|3590641|FG000|Overall Study|Adverse Event|43
2022730|NCT00321464|3590642|FG001|Overall Study|Adverse Event|28
2022731|NCT00321464|3590641|FG000|Overall Study|Physician Decision|15
2022732|NCT00321464|3590642|FG001|Overall Study|Physician Decision|14
2022733|NCT00321464|3590641|FG000|Overall Study|Noncompliance|4
2022734|NCT00321464|3590642|FG001|Overall Study|Noncompliance|10
2022735|NCT00321464|3590641|FG000|Overall Study|Lost to Follow-up|7
2022736|NCT00321464|3590642|FG001|Overall Study|Lost to Follow-up|8
2022737|NCT00321464|3590641|FG000|Overall Study|Protocol deviation|0
2022738|NCT00321464|3590642|FG001|Overall Study|Protocol deviation|2
2022739|NCT00321464|3590641|FG000|Overall Study|Ineligibility determined|2
2022740|NCT00321464|3590642|FG001|Overall Study|Ineligibility determined|1
1977157|NCT04380519|3539907|FG000|Overall Study|Withdrawal by Subject|4
1977158|NCT04380519|3539908|FG001|Overall Study|Withdrawal by Subject|0
1977159|NCT04380519|3539909|FG002|Overall Study|Withdrawal by Subject|1
1977160|NCT04380519|3539907|FG000|Overall Study|Death|14
1977161|NCT04380519|3539908|FG001|Overall Study|Death|9
1977162|NCT04380519|3539909|FG002|Overall Study|Death|6
1977163|NCT04380519|3539907|FG000|Overall Study|Adverse Event|0
1977164|NCT04380519|3539908|FG001|Overall Study|Adverse Event|1
1977165|NCT04380519|3539909|FG002|Overall Study|Adverse Event|0
1977166|NCT04380519|3539907|FG000|Overall Study|relatives' decision|0
1977167|NCT04380519|3539908|FG001|Overall Study|relatives' decision|1
1977168|NCT04380519|3539909|FG002|Overall Study|relatives' decision|0
1977169|NCT04362813|3539919|FG000|Overall Study|Death|12
1977170|NCT04362813|3539920|FG001|Overall Study|Death|16
1977171|NCT04362813|3539919|FG000|Overall Study|Withdrawal by Subject|3
1977172|NCT04362813|3539920|FG001|Overall Study|Withdrawal by Subject|1
1977173|NCT04362813|3539919|FG000|Overall Study|Protocol Violation|0
1977174|NCT04362813|3539920|FG001|Overall Study|Protocol Violation|3
1977175|NCT04362813|3539919|FG000|Overall Study|Lost to Follow-up|1
1977176|NCT04362813|3539920|FG001|Overall Study|Lost to Follow-up|1
1977177|NCT04362813|3539919|FG000|Overall Study|Enrolled but did not receive treatment|2
1977178|NCT04362813|3539920|FG001|Overall Study|Enrolled but did not receive treatment|4
1977181|NCT03911713|3539987|FG000|Overall Study|Lost to Follow-up|0
1977182|NCT03911713|3539988|FG001|Overall Study|Lost to Follow-up|2
1977183|NCT03911713|3539989|FG002|Overall Study|Lost to Follow-up|0
1977184|NCT03911713|3539990|FG003|Overall Study|Lost to Follow-up|0
1977185|NCT03911713|3539991|FG004|Overall Study|Lost to Follow-up|0
1977186|NCT03911713|3539987|FG000|Overall Study|Other|0
1977187|NCT03911713|3539988|FG001|Overall Study|Other|0
1977188|NCT03911713|3539989|FG002|Overall Study|Other|0
1977189|NCT03911713|3539990|FG003|Overall Study|Other|1
1977190|NCT03911713|3539991|FG004|Overall Study|Other|0
1977191|NCT03911713|3539987|FG000|Overall Study|Randomized, Never Dosed|1
1977192|NCT03911713|3539988|FG001|Overall Study|Randomized, Never Dosed|0
1977193|NCT03911713|3539989|FG002|Overall Study|Randomized, Never Dosed|0
1977194|NCT03911713|3539990|FG003|Overall Study|Randomized, Never Dosed|1
1977195|NCT03911713|3539991|FG004|Overall Study|Randomized, Never Dosed|0
1977196|NCT03852459|3540016|FG000|Overall Study|Adverse Event|2
1977197|NCT03852459|3540017|FG001|Overall Study|Adverse Event|2
1977198|NCT03852459|3540016|FG000|Overall Study|Withdrawal by Subject|1
1977199|NCT03852459|3540017|FG001|Overall Study|Withdrawal by Subject|1
1977200|NCT03740919|3540026|FG000|Lead-in Period|Lost to Follow-up|1
1977201|NCT03740919|3540027|FG001|Lead-in Period|Lost to Follow-up|0
1977202|NCT03740919|3540028|FG002|Lead-in Period|Lost to Follow-up|0
1977203|NCT03740919|3540029|FG003|Lead-in Period|Lost to Follow-up|0
1977204|NCT03740919|3540026|FG000|Lead-in Period|Physician Decision|2
1977205|NCT03740919|3540027|FG001|Lead-in Period|Physician Decision|0
1977206|NCT03740919|3540028|FG002|Lead-in Period|Physician Decision|0
1977207|NCT03740919|3540029|FG003|Lead-in Period|Physician Decision|0
1977208|NCT03740919|3540026|FG000|Lead-in Period|Protocol Violation|1
1977209|NCT03740919|3540027|FG001|Lead-in Period|Protocol Violation|0
1977210|NCT03740919|3540028|FG002|Lead-in Period|Protocol Violation|0
1977211|NCT03740919|3540029|FG003|Lead-in Period|Protocol Violation|0
1977212|NCT03740919|3540026|FG000|Lead-in Period|Withdrawal by Subject|10
1977213|NCT03740919|3540027|FG001|Lead-in Period|Withdrawal by Subject|0
1977214|NCT03740919|3540028|FG002|Lead-in Period|Withdrawal by Subject|0
1977215|NCT03740919|3540029|FG003|Lead-in Period|Withdrawal by Subject|0
1977216|NCT03740919|3540026|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18
1977217|NCT03740919|3540027|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
1977218|NCT03740919|3540028|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
1977219|NCT03740919|3540029|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
1977220|NCT03740919|3540026|FG000|Lead-in Period|Study Task Too Burdensome|1
1977221|NCT03740919|3540027|FG001|Lead-in Period|Study Task Too Burdensome|0
1977222|NCT03740919|3540028|FG002|Lead-in Period|Study Task Too Burdensome|0
1977223|NCT03740919|3540029|FG003|Lead-in Period|Study Task Too Burdensome|0
1977224|NCT03740919|3540026|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1
1977225|NCT03740919|3540027|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
1977226|NCT03740919|3540028|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
1977227|NCT03740919|3540029|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
1977228|NCT03740919|3540026|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1
1977229|NCT03740919|3540027|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0
1977230|NCT03740919|3540028|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0
1977231|NCT03740919|3540029|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0
1977232|NCT03740919|3540026|FG000|Treatment Period|Adverse Event|0
1977233|NCT03740919|3540027|FG001|Treatment Period|Adverse Event|0
1977234|NCT03740919|3540028|FG002|Treatment Period|Adverse Event|2
1977235|NCT03740919|3540029|FG003|Treatment Period|Adverse Event|0
1977236|NCT03740919|3540026|FG000|Treatment Period|Protocol Violation|0
1977237|NCT03740919|3540027|FG001|Treatment Period|Protocol Violation|1
1977238|NCT03740919|3540028|FG002|Treatment Period|Protocol Violation|0
1977239|NCT03740919|3540029|FG003|Treatment Period|Protocol Violation|0
1977240|NCT03740919|3540026|FG000|Treatment Period|Withdrawal by Subject|0
1977241|NCT03740919|3540027|FG001|Treatment Period|Withdrawal by Subject|7
1977242|NCT03740919|3540028|FG002|Treatment Period|Withdrawal by Subject|6
1977243|NCT03740919|3540029|FG003|Treatment Period|Withdrawal by Subject|2
1977244|NCT03740919|3540026|FG000|Treatment Period|Terminated by Sponsor|0
1977245|NCT03740919|3540027|FG001|Treatment Period|Terminated by Sponsor|1
1977246|NCT03740919|3540028|FG002|Treatment Period|Terminated by Sponsor|0
1977247|NCT03740919|3540029|FG003|Treatment Period|Terminated by Sponsor|0
1977248|NCT03740919|3540026|FG000|Treatment Period|Issue with Insulin Pump|0
1977249|NCT03740919|3540027|FG001|Treatment Period|Issue with Insulin Pump|1
1977250|NCT03740919|3540028|FG002|Treatment Period|Issue with Insulin Pump|0
1977251|NCT03740919|3540029|FG003|Treatment Period|Issue with Insulin Pump|0
1977252|NCT03740919|3540026|FG000|Treatment Period|Due to COVID-19 Pandemic|0
1977253|NCT03740919|3540027|FG001|Treatment Period|Due to COVID-19 Pandemic|0
1977254|NCT03740919|3540028|FG002|Treatment Period|Due to COVID-19 Pandemic|3
1977255|NCT03740919|3540029|FG003|Treatment Period|Due to COVID-19 Pandemic|1
1977256|NCT03740919|3540026|FG000|Treatment Period|Failure of Inclusion Criteria|0
1977257|NCT03740919|3540027|FG001|Treatment Period|Failure of Inclusion Criteria|0
1977258|NCT03740919|3540028|FG002|Treatment Period|Failure of Inclusion Criteria|1
1977259|NCT03740919|3540029|FG003|Treatment Period|Failure of Inclusion Criteria|0
1977260|NCT03740919|3540026|FG000|Treatment Period|Not Completing Diary|0
1977261|NCT03740919|3540027|FG001|Treatment Period|Not Completing Diary|0
1977262|NCT03740919|3540028|FG002|Treatment Period|Not Completing Diary|1
1977263|NCT03740919|3540029|FG003|Treatment Period|Not Completing Diary|0
1977264|NCT03740919|3540026|FG000|Treatment Period|Insulin Painful to Participant|0
1977265|NCT03740919|3540027|FG001|Treatment Period|Insulin Painful to Participant|0
1977266|NCT03740919|3540028|FG002|Treatment Period|Insulin Painful to Participant|1
1977267|NCT03740919|3540029|FG003|Treatment Period|Insulin Painful to Participant|0
1977268|NCT03647488|3540063|FG000|Overall Study|Progressive disease|10
1977269|NCT03647488|3540064|FG001|Overall Study|Progressive disease|0
1977270|NCT03647488|3540065|FG002|Overall Study|Progressive disease|0
1977271|NCT03647488|3540063|FG000|Overall Study|Adverse Event|5
1977272|NCT03647488|3540064|FG001|Overall Study|Adverse Event|0
1977273|NCT03647488|3540065|FG002|Overall Study|Adverse Event|0
1977274|NCT03647488|3540063|FG000|Overall Study|Clinical progression|2
1977275|NCT03647488|3540064|FG001|Overall Study|Clinical progression|0
1977276|NCT03647488|3540065|FG002|Overall Study|Clinical progression|0
1977277|NCT03647488|3540063|FG000|Overall Study|Participant refused to take investigational product|1
1977278|NCT03647488|3540064|FG001|Overall Study|Participant refused to take investigational product|0
1977279|NCT03647488|3540065|FG002|Overall Study|Participant refused to take investigational product|0
1977280|NCT03614923|3540074|FG000|Overall Study|Withdrawal by Subject|2
1977281|NCT03614923|3540075|FG001|Overall Study|Withdrawal by Subject|1
1977282|NCT03614923|3540076|FG002|Overall Study|Withdrawal by Subject|1
1977283|NCT03614923|3540074|FG000|Overall Study|Adverse Event|0
1977284|NCT03614923|3540075|FG001|Overall Study|Adverse Event|2
1977285|NCT03614923|3540076|FG002|Overall Study|Adverse Event|1
1977286|NCT03614923|3540074|FG000|Overall Study|Lost to Follow-up|1
1977287|NCT03614923|3540075|FG001|Overall Study|Lost to Follow-up|0
1977288|NCT03614923|3540076|FG002|Overall Study|Lost to Follow-up|1
1977289|NCT03614923|3540074|FG000|Overall Study|Lack of Efficacy|2
1977290|NCT03614923|3540075|FG001|Overall Study|Lack of Efficacy|0
1977291|NCT03614923|3540076|FG002|Overall Study|Lack of Efficacy|1
1977292|NCT03614923|3540074|FG000|Overall Study|Non-compliance|0
1977293|NCT03614923|3540075|FG001|Overall Study|Non-compliance|1
1977294|NCT03614923|3540076|FG002|Overall Study|Non-compliance|0
1977295|NCT03614923|3540074|FG000|Overall Study|Other|0
1977296|NCT03614923|3540075|FG001|Overall Study|Other|1
1977297|NCT03614923|3540076|FG002|Overall Study|Other|1
2022741|NCT00321464|3590641|FG000|Overall Study|Other|21
2022742|NCT00321464|3590642|FG001|Overall Study|Other|18
2025946|NCT00347919|3594670|FG001|Overall Study|Par. Started Other Treatment|1
2025947|NCT00347919|3594671|FG002|Overall Study|Par. Started Other Treatment|1
2025948|NCT00347919|3594669|FG000|Overall Study|Missing|2
2025949|NCT00347919|3594670|FG001|Overall Study|Missing|1
2213130|NCT01675882|3854494|FG001|Overall Study|Participant unwilling to continue|4
2213131|NCT01675882|3854495|FG002|Overall Study|Participant unwilling to continue|2
2213132|NCT01675882|3854496|FG003|Overall Study|Participant unwilling to continue|1
2025950|NCT00347919|3594671|FG002|Overall Study|Missing|2
2025951|NCT00347932|3594683|FG000|Overall Study|Adverse Event|4
2025952|NCT00347932|3594684|FG001|Overall Study|Adverse Event|5
2025953|NCT00347932|3594683|FG000|Overall Study|Lack of Efficacy|3
2025954|NCT00347932|3594684|FG001|Overall Study|Lack of Efficacy|14
2025955|NCT00347932|3594683|FG000|Overall Study|Lost to Follow-up|10
2025956|NCT00347932|3594684|FG001|Overall Study|Lost to Follow-up|9
2025957|NCT00347932|3594683|FG000|Overall Study|Withdrawal by Subject|10
2025958|NCT00347932|3594684|FG001|Overall Study|Withdrawal by Subject|16
2025959|NCT00347932|3594683|FG000|Overall Study|Did not meet inclusion criteria|4
2025960|NCT00347932|3594684|FG001|Overall Study|Did not meet inclusion criteria|8
2025961|NCT00347958|3594690|FG000|Overall Study|Adverse Event|1
2025962|NCT00347958|3594690|FG000|Overall Study|Protocol Violation|2
2025963|NCT00347958|3594690|FG000|Overall Study|Withdrawal by Subject|1
2025964|NCT00348140|3594697|FG000|Overall Study|Adverse Event|46
2025965|NCT00348140|3594698|FG001|Overall Study|Adverse Event|49
2025966|NCT00348140|3594699|FG002|Overall Study|Adverse Event|78
2025967|NCT00348140|3594697|FG000|Overall Study|Lost to Follow-up|4
1977298|NCT03517540|3540088|FG000|Overall Study|Protocol Violation|2
1977299|NCT03517540|3540089|FG001|Overall Study|Protocol Violation|0
1977300|NCT03517540|3540090|FG002|Overall Study|Protocol Violation|0
1977301|NCT03517540|3540091|FG003|Overall Study|Protocol Violation|1
1977302|NCT03517540|3540088|FG000|Overall Study|Adverse Event|9
1977303|NCT03517540|3540089|FG001|Overall Study|Adverse Event|3
1977304|NCT03517540|3540090|FG002|Overall Study|Adverse Event|8
1977305|NCT03517540|3540091|FG003|Overall Study|Adverse Event|1
1977306|NCT03517540|3540088|FG000|Overall Study|Withdrawal by Subject|3
1977307|NCT03517540|3540089|FG001|Overall Study|Withdrawal by Subject|4
1977308|NCT03517540|3540090|FG002|Overall Study|Withdrawal by Subject|1
1977309|NCT03517540|3540091|FG003|Overall Study|Withdrawal by Subject|3
1977310|NCT03502187|3540104|FG000|Overall Study|Withdrawal by Subject|4
1977311|NCT03502187|3540105|FG001|Overall Study|Withdrawal by Subject|3
1977312|NCT03502187|3540106|FG002|Overall Study|Withdrawal by Subject|3
1977313|NCT03502187|3540104|FG000|Overall Study|Lost to Follow-up|5
1977314|NCT03502187|3540105|FG001|Overall Study|Lost to Follow-up|4
1977315|NCT03502187|3540106|FG002|Overall Study|Lost to Follow-up|5
1977316|NCT03447262|3540114|FG000|Overall Study|Adverse Event|7
1977317|NCT03447262|3540114|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
1977318|NCT03447262|3540114|FG000|Overall Study|Commercial Drug is Available for Participant|9
1977319|NCT03447262|3540114|FG000|Overall Study|Death|2
1977320|NCT03447262|3540114|FG000|Overall Study|Study Termination by Sponsor|455
1977321|NCT03447262|3540114|FG000|Overall Study|Other|4
1977322|NCT03432819|3540123|FG000|Overall Study|Lost to Follow-up|2
1977323|NCT03432819|3540124|FG001|Overall Study|Lost to Follow-up|2
1977324|NCT03432819|3540123|FG000|Overall Study|Withdrawal by Subject|5
1977325|NCT03432819|3540124|FG001|Overall Study|Withdrawal by Subject|3
1977326|NCT03365791|3540130|FG000|Overall Study|Adverse Event|5
1977327|NCT03365791|3540130|FG000|Overall Study|Death|1
1977328|NCT03365791|3540130|FG000|Overall Study|Lost to Follow-up|1
1977329|NCT03365791|3540130|FG000|Overall Study|Physician Decision|9
1977330|NCT03365791|3540130|FG000|Overall Study|Progressive disease|51
1977331|NCT03365791|3540130|FG000|Overall Study|Subject/guardian decision|5
1977332|NCT03323749|3540137|FG000|Double-blind Period|Lost to Follow-up|4
1977333|NCT03323749|3540138|FG001|Double-blind Period|Lost to Follow-up|5
1977334|NCT03323749|3540137|FG000|Double-blind Period|Adverse Event|3
1977335|NCT03323749|3540138|FG001|Double-blind Period|Adverse Event|1
1977336|NCT03323749|3540137|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83
1977337|NCT03323749|3540138|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88
1977338|NCT03323749|3540137|FG000|Open-Label Period|Adverse Event|3
1977339|NCT03323749|3540138|FG001|Open-Label Period|Adverse Event|10
1977340|NCT03323749|3540137|FG000|Open-Label Period|Withdrawal by Subject|7
1977341|NCT03323749|3540138|FG001|Open-Label Period|Withdrawal by Subject|5
1977342|NCT03322566|3540151|FG000|Overall Study|Death|34
1977343|NCT03322566|3540152|FG001|Overall Study|Death|35
1977344|NCT03322566|3540153|FG002|Overall Study|Death|23
1977345|NCT03322566|3540151|FG000|Overall Study|Physician Decision|6
1977346|NCT03322566|3540152|FG001|Overall Study|Physician Decision|7
1977347|NCT03322566|3540153|FG002|Overall Study|Physician Decision|2
1977348|NCT03322566|3540151|FG000|Overall Study|Withdrawal by Subject|4
1977349|NCT03322566|3540152|FG001|Overall Study|Withdrawal by Subject|3
1977350|NCT03322566|3540153|FG002|Overall Study|Withdrawal by Subject|6
1977351|NCT03322566|3540151|FG000|Overall Study|Lost to Follow-up|0
1977352|NCT03322566|3540152|FG001|Overall Study|Lost to Follow-up|0
1977353|NCT03322566|3540153|FG002|Overall Study|Lost to Follow-up|1
1977354|NCT03322566|3540151|FG000|Overall Study|Study terminated by sponsor|1
1977355|NCT03322566|3540152|FG001|Overall Study|Study terminated by sponsor|0
1977356|NCT03322566|3540153|FG002|Overall Study|Study terminated by sponsor|1
1977357|NCT03322540|3540163|FG000|Overall Study|Death|21
1977358|NCT03322540|3540164|FG001|Overall Study|Death|28
1977359|NCT03322540|3540163|FG000|Overall Study|Lost to Follow-up|0
1977360|NCT03322540|3540164|FG001|Overall Study|Lost to Follow-up|1
1977361|NCT03322540|3540163|FG000|Overall Study|Physician Decision|7
1977362|NCT03322540|3540164|FG001|Overall Study|Physician Decision|6
1977363|NCT03322540|3540163|FG000|Overall Study|Withdrawal by Subject|3
1977364|NCT03322540|3540164|FG001|Overall Study|Withdrawal by Subject|1
1977365|NCT03322540|3540163|FG000|Overall Study|Study terminated by sponsor|0
1977366|NCT03322540|3540164|FG001|Overall Study|Study terminated by sponsor|1
1977367|NCT03189719|3540183|FG000|Overall Study|Death|260
1977368|NCT03189719|3540184|FG001|Overall Study|Death|308
1977369|NCT03189719|3540183|FG000|Overall Study|Withdrawal by Subject|5
1977370|NCT03189719|3540184|FG001|Overall Study|Withdrawal by Subject|3
1977371|NCT03189719|3540183|FG000|Overall Study|Ongoing in Study|108
1977372|NCT03189719|3540184|FG001|Overall Study|Ongoing in Study|65
1977373|NCT03155997|3540192|FG000|Overall Study|Withdrawal by Subject|119
1977374|NCT03155997|3540193|FG001|Overall Study|Withdrawal by Subject|134
1977375|NCT03155997|3540192|FG000|Overall Study|Lost to Follow-up|12
1977376|NCT03155997|3540193|FG001|Overall Study|Lost to Follow-up|13
1977377|NCT03155997|3540192|FG000|Overall Study|Missing disposition data|0
1977378|NCT03155997|3540193|FG001|Overall Study|Missing disposition data|1
1977379|NCT03155997|3540192|FG000|Overall Study|On study treatment|2027
1977380|NCT03155997|3540193|FG001|Overall Study|On study treatment|2074
1977381|NCT03104400|3540203|FG000|Overall Study|Adverse Event|5
1977382|NCT03104400|3540204|FG001|Overall Study|Adverse Event|7
1977383|NCT03104400|3540205|FG002|Overall Study|Adverse Event|11
1977384|NCT03104400|3540206|FG003|Overall Study|Adverse Event|9
1977385|NCT03104400|3540207|FG004|Overall Study|Adverse Event|21
1977386|NCT03104400|3540203|FG000|Overall Study|Withdrawal by Subject|17
1977387|NCT03104400|3540204|FG001|Overall Study|Withdrawal by Subject|19
1977388|NCT03104400|3540205|FG002|Overall Study|Withdrawal by Subject|29
1977389|NCT03104400|3540206|FG003|Overall Study|Withdrawal by Subject|25
1977390|NCT03104400|3540207|FG004|Overall Study|Withdrawal by Subject|24
1977391|NCT03104400|3540203|FG000|Overall Study|Lost to Follow-up|4
1977392|NCT03104400|3540204|FG001|Overall Study|Lost to Follow-up|1
1977393|NCT03104400|3540205|FG002|Overall Study|Lost to Follow-up|4
1977394|NCT03104400|3540206|FG003|Overall Study|Lost to Follow-up|8
1977395|NCT03104400|3540207|FG004|Overall Study|Lost to Follow-up|7
1977396|NCT03104400|3540203|FG000|Overall Study|Lack of Efficacy|6
1977397|NCT03104400|3540204|FG001|Overall Study|Lack of Efficacy|3
1977398|NCT03104400|3540205|FG002|Overall Study|Lack of Efficacy|8
1977399|NCT03104400|3540206|FG003|Overall Study|Lack of Efficacy|2
1977400|NCT03104400|3540207|FG004|Overall Study|Lack of Efficacy|1
1977401|NCT03104400|3540203|FG000|Overall Study|COVID Logistical Restrictions|0
1977402|NCT03104400|3540204|FG001|Overall Study|COVID Logistical Restrictions|0
1977403|NCT03104400|3540205|FG002|Overall Study|COVID Logistical Restrictions|0
1977404|NCT03104400|3540206|FG003|Overall Study|COVID Logistical Restrictions|1
1977405|NCT03104400|3540207|FG004|Overall Study|COVID Logistical Restrictions|0
1977406|NCT03104400|3540203|FG000|Overall Study|Other|2
1977407|NCT03104400|3540204|FG001|Overall Study|Other|3
1977408|NCT03104400|3540205|FG002|Overall Study|Other|7
1977409|NCT03104400|3540206|FG003|Overall Study|Other|6
1977410|NCT03104400|3540207|FG004|Overall Study|Other|4
1977411|NCT03104400|3540203|FG000|Overall Study|Other|0
1977412|NCT03104400|3540204|FG001|Overall Study|Other|1
1977413|NCT03104400|3540205|FG002|Overall Study|Other|0
1977414|NCT03104400|3540206|FG003|Overall Study|Other|0
1977415|NCT03104400|3540207|FG004|Overall Study|Other|0
1977416|NCT03104374|3540224|FG000|Overall Study|Adverse Event|7
1977417|NCT03104374|3540225|FG001|Overall Study|Adverse Event|6
1977418|NCT03104374|3540226|FG002|Overall Study|Adverse Event|12
1977419|NCT03104374|3540227|FG003|Overall Study|Adverse Event|15
1977420|NCT03104374|3540224|FG000|Overall Study|Withdrawal by Subject|18
1977421|NCT03104374|3540225|FG001|Overall Study|Withdrawal by Subject|10
1977422|NCT03104374|3540226|FG002|Overall Study|Withdrawal by Subject|10
1977423|NCT03104374|3540227|FG003|Overall Study|Withdrawal by Subject|17
1977424|NCT03104374|3540224|FG000|Overall Study|Lost to Follow-up|4
1977425|NCT03104374|3540225|FG001|Overall Study|Lost to Follow-up|4
1977426|NCT03104374|3540226|FG002|Overall Study|Lost to Follow-up|6
1977427|NCT03104374|3540227|FG003|Overall Study|Lost to Follow-up|8
1977428|NCT03104374|3540224|FG000|Overall Study|Lack of Efficacy|6
1977429|NCT03104374|3540225|FG001|Overall Study|Lack of Efficacy|7
1977430|NCT03104374|3540226|FG002|Overall Study|Lack of Efficacy|12
1977431|NCT03104374|3540227|FG003|Overall Study|Lack of Efficacy|6
1977432|NCT03104374|3540224|FG000|Overall Study|Other|2
1977433|NCT03104374|3540225|FG001|Overall Study|Other|2
1977434|NCT03104374|3540226|FG002|Overall Study|Other|4
1977435|NCT03104374|3540227|FG003|Overall Study|Other|7
1977436|NCT03072043|3540240|FG000|Overall Study|Death|0
1977437|NCT03072043|3540241|FG001|Overall Study|Death|0
1977438|NCT03072043|3540242|FG002|Overall Study|Death|3
1977439|NCT03072043|3540240|FG000|Overall Study|Adverse Event|0
1977440|NCT03072043|3540241|FG001|Overall Study|Adverse Event|0
1977441|NCT03072043|3540242|FG002|Overall Study|Adverse Event|2
1977442|NCT03072043|3540240|FG000|Overall Study|Withdrawal by Subject|0
1977443|NCT03072043|3540241|FG001|Overall Study|Withdrawal by Subject|0
1977444|NCT03072043|3540242|FG002|Overall Study|Withdrawal by Subject|4
1977445|NCT02905032|3540270|FG000|Overall Study|Withdrawal by Subject|2
1977446|NCT02905032|3540271|FG001|Overall Study|Withdrawal by Subject|0
2213133|NCT01675882|3854493|FG000|Overall Study|Lost to Follow-up|0
1977447|NCT02905032|3540272|FG002|Overall Study|Withdrawal by Subject|0
1977448|NCT02905032|3540270|FG000|Overall Study|Protocol Violation|6
1977449|NCT02905032|3540271|FG001|Overall Study|Protocol Violation|12
1977450|NCT02905032|3540272|FG002|Overall Study|Protocol Violation|0
1977451|NCT02837029|3540282|FG000|Screening|Failed to meet screening requirements.|7
1977452|NCT02837029|3540283|FG001|Screening|Failed to meet screening requirements.|3
1977453|NCT02837029|3540284|FG002|Screening|Failed to meet screening requirements.|0
1977454|NCT02837029|3540282|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2
1977455|NCT02837029|3540283|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
1977456|NCT02837029|3540284|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
1977457|NCT02837029|3540282|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
1977458|NCT02837029|3540283|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2
2102197|NCT00838110|3694003|FG002|Overall Study|Adverse Event|8
1977459|NCT02837029|3540284|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
1977460|NCT02837029|3540282|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
1977461|NCT02837029|3540283|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1
1977462|NCT02837029|3540284|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
1977463|NCT02837029|3540282|FG000|Cycle 2 and Beyond|Adverse Event|1
1977464|NCT02837029|3540283|FG001|Cycle 2 and Beyond|Adverse Event|0
1977465|NCT02837029|3540284|FG002|Cycle 2 and Beyond|Adverse Event|0
1977466|NCT02837029|3540282|FG000|2 Year Follow-up|Death|6
1977467|NCT02837029|3540283|FG001|2 Year Follow-up|Death|7
1977468|NCT02837029|3540284|FG002|2 Year Follow-up|Death|0
1977469|NCT02737475|3540339|FG000|Overall Study|Other reasons|0
1977470|NCT02737475|3540340|FG001|Overall Study|Other reasons|0
1977471|NCT02737475|3540341|FG002|Overall Study|Other reasons|0
1977472|NCT02737475|3540342|FG003|Overall Study|Other reasons|0
1977473|NCT02737475|3540343|FG004|Overall Study|Other reasons|1
1977474|NCT02737475|3540344|FG005|Overall Study|Other reasons|1
1977475|NCT02737475|3540345|FG006|Overall Study|Other reasons|0
1977476|NCT02737475|3540346|FG007|Overall Study|Other reasons|0
1977477|NCT02737475|3540347|FG008|Overall Study|Other reasons|1
1977478|NCT02737475|3540348|FG009|Overall Study|Other reasons|0
1977479|NCT02737475|3540349|FG010|Overall Study|Other reasons|1
1977480|NCT02737475|3540350|FG011|Overall Study|Other reasons|0
1977481|NCT02737475|3540351|FG012|Overall Study|Other reasons|0
1977482|NCT02737475|3540352|FG013|Overall Study|Other reasons|0
1977483|NCT02737475|3540353|FG014|Overall Study|Other reasons|0
1977484|NCT02737475|3540354|FG015|Overall Study|Other reasons|0
1977485|NCT02737475|3540355|FG016|Overall Study|Other reasons|0
1977486|NCT02737475|3540356|FG017|Overall Study|Other reasons|0
1977487|NCT02737475|3540357|FG018|Overall Study|Other reasons|0
1977488|NCT02737475|3540358|FG019|Overall Study|Other reasons|0
1977489|NCT02737475|3540359|FG020|Overall Study|Other reasons|0
1977490|NCT02737475|3540360|FG021|Overall Study|Other reasons|1
1977491|NCT02737475|3540361|FG022|Overall Study|Other reasons|0
1977492|NCT02737475|3540362|FG023|Overall Study|Other reasons|1
1977493|NCT02737475|3540363|FG024|Overall Study|Other reasons|1
1977494|NCT02737475|3540364|FG025|Overall Study|Other reasons|1
1977495|NCT02737475|3540365|FG026|Overall Study|Other reasons|0
1977496|NCT02737475|3540339|FG000|Overall Study|Death|1
1977497|NCT02737475|3540340|FG001|Overall Study|Death|0
1977498|NCT02737475|3540341|FG002|Overall Study|Death|0
1977499|NCT02737475|3540342|FG003|Overall Study|Death|1
1977500|NCT02737475|3540343|FG004|Overall Study|Death|0
1977501|NCT02737475|3540344|FG005|Overall Study|Death|0
1977502|NCT02737475|3540345|FG006|Overall Study|Death|0
1977503|NCT02737475|3540346|FG007|Overall Study|Death|2
1977504|NCT02737475|3540347|FG008|Overall Study|Death|0
1977505|NCT02737475|3540348|FG009|Overall Study|Death|0
1977506|NCT02737475|3540349|FG010|Overall Study|Death|0
1977507|NCT02737475|3540350|FG011|Overall Study|Death|4
1977508|NCT02737475|3540351|FG012|Overall Study|Death|2
1977509|NCT02737475|3540352|FG013|Overall Study|Death|2
1977510|NCT02737475|3540353|FG014|Overall Study|Death|0
1977511|NCT02737475|3540354|FG015|Overall Study|Death|2
1977512|NCT02737475|3540355|FG016|Overall Study|Death|2
1977513|NCT02737475|3540356|FG017|Overall Study|Death|2
1977514|NCT02737475|3540357|FG018|Overall Study|Death|1
1977515|NCT02737475|3540358|FG019|Overall Study|Death|0
1977516|NCT02737475|3540359|FG020|Overall Study|Death|0
1977517|NCT02737475|3540360|FG021|Overall Study|Death|0
1977518|NCT02737475|3540361|FG022|Overall Study|Death|0
1977519|NCT02737475|3540362|FG023|Overall Study|Death|0
1977520|NCT02737475|3540363|FG024|Overall Study|Death|0
1977521|NCT02737475|3540364|FG025|Overall Study|Death|0
1977522|NCT02737475|3540365|FG026|Overall Study|Death|0
1977523|NCT02737475|3540339|FG000|Overall Study|Participant withdrew consent|0
1977524|NCT02737475|3540340|FG001|Overall Study|Participant withdrew consent|0
1977525|NCT02737475|3540341|FG002|Overall Study|Participant withdrew consent|0
1977526|NCT02737475|3540342|FG003|Overall Study|Participant withdrew consent|0
1977527|NCT02737475|3540343|FG004|Overall Study|Participant withdrew consent|0
1977528|NCT02737475|3540344|FG005|Overall Study|Participant withdrew consent|2
1977529|NCT02737475|3540345|FG006|Overall Study|Participant withdrew consent|0
1977530|NCT02737475|3540346|FG007|Overall Study|Participant withdrew consent|0
1977531|NCT02737475|3540347|FG008|Overall Study|Participant withdrew consent|0
1977532|NCT02737475|3540348|FG009|Overall Study|Participant withdrew consent|0
1977533|NCT02737475|3540349|FG010|Overall Study|Participant withdrew consent|0
1977534|NCT02737475|3540350|FG011|Overall Study|Participant withdrew consent|0
1977535|NCT02737475|3540351|FG012|Overall Study|Participant withdrew consent|0
1977536|NCT02737475|3540352|FG013|Overall Study|Participant withdrew consent|0
1977537|NCT02737475|3540353|FG014|Overall Study|Participant withdrew consent|1
1977538|NCT02737475|3540354|FG015|Overall Study|Participant withdrew consent|0
1977539|NCT02737475|3540355|FG016|Overall Study|Participant withdrew consent|0
1977540|NCT02737475|3540356|FG017|Overall Study|Participant withdrew consent|2
1977541|NCT02737475|3540357|FG018|Overall Study|Participant withdrew consent|1
1977542|NCT02737475|3540358|FG019|Overall Study|Participant withdrew consent|0
1977543|NCT02737475|3540359|FG020|Overall Study|Participant withdrew consent|2
1977544|NCT02737475|3540360|FG021|Overall Study|Participant withdrew consent|0
1977545|NCT02737475|3540361|FG022|Overall Study|Participant withdrew consent|0
1977546|NCT02737475|3540362|FG023|Overall Study|Participant withdrew consent|0
1977547|NCT02737475|3540363|FG024|Overall Study|Participant withdrew consent|0
1977548|NCT02737475|3540364|FG025|Overall Study|Participant withdrew consent|0
1977549|NCT02737475|3540365|FG026|Overall Study|Participant withdrew consent|0
1977550|NCT02737475|3540339|FG000|Overall Study|Lost to Follow-up|0
1977551|NCT02737475|3540340|FG001|Overall Study|Lost to Follow-up|0
1977552|NCT02737475|3540341|FG002|Overall Study|Lost to Follow-up|0
1977553|NCT02737475|3540342|FG003|Overall Study|Lost to Follow-up|0
1977554|NCT02737475|3540343|FG004|Overall Study|Lost to Follow-up|0
1977555|NCT02737475|3540344|FG005|Overall Study|Lost to Follow-up|0
1977556|NCT02737475|3540345|FG006|Overall Study|Lost to Follow-up|0
1977557|NCT02737475|3540346|FG007|Overall Study|Lost to Follow-up|0
1977558|NCT02737475|3540347|FG008|Overall Study|Lost to Follow-up|0
1977559|NCT02737475|3540348|FG009|Overall Study|Lost to Follow-up|0
1977560|NCT02737475|3540349|FG010|Overall Study|Lost to Follow-up|0
1977561|NCT02737475|3540350|FG011|Overall Study|Lost to Follow-up|0
1977562|NCT02737475|3540351|FG012|Overall Study|Lost to Follow-up|0
1977563|NCT02737475|3540352|FG013|Overall Study|Lost to Follow-up|0
1977564|NCT02737475|3540353|FG014|Overall Study|Lost to Follow-up|0
1977565|NCT02737475|3540354|FG015|Overall Study|Lost to Follow-up|1
1977566|NCT02737475|3540355|FG016|Overall Study|Lost to Follow-up|0
1977567|NCT02737475|3540356|FG017|Overall Study|Lost to Follow-up|0
1977568|NCT02737475|3540357|FG018|Overall Study|Lost to Follow-up|0
1977569|NCT02737475|3540358|FG019|Overall Study|Lost to Follow-up|0
1977570|NCT02737475|3540359|FG020|Overall Study|Lost to Follow-up|0
1977571|NCT02737475|3540360|FG021|Overall Study|Lost to Follow-up|0
1977572|NCT02737475|3540361|FG022|Overall Study|Lost to Follow-up|0
1977573|NCT02737475|3540362|FG023|Overall Study|Lost to Follow-up|0
1977574|NCT02737475|3540363|FG024|Overall Study|Lost to Follow-up|0
1977575|NCT02737475|3540364|FG025|Overall Study|Lost to Follow-up|0
1977576|NCT02737475|3540365|FG026|Overall Study|Lost to Follow-up|0
1977577|NCT02737475|3540339|FG000|Overall Study|Disease Progression|0
1977578|NCT02737475|3540340|FG001|Overall Study|Disease Progression|0
1977579|NCT02737475|3540341|FG002|Overall Study|Disease Progression|0
1977580|NCT02737475|3540342|FG003|Overall Study|Disease Progression|0
1977581|NCT02737475|3540343|FG004|Overall Study|Disease Progression|0
1977582|NCT02737475|3540344|FG005|Overall Study|Disease Progression|0
1977583|NCT02737475|3540345|FG006|Overall Study|Disease Progression|0
1977584|NCT02737475|3540346|FG007|Overall Study|Disease Progression|0
1977585|NCT02737475|3540347|FG008|Overall Study|Disease Progression|0
1977586|NCT02737475|3540348|FG009|Overall Study|Disease Progression|0
1977587|NCT02737475|3540349|FG010|Overall Study|Disease Progression|0
1977588|NCT02737475|3540350|FG011|Overall Study|Disease Progression|0
1977589|NCT02737475|3540351|FG012|Overall Study|Disease Progression|0
1977590|NCT02737475|3540352|FG013|Overall Study|Disease Progression|0
1977591|NCT02737475|3540353|FG014|Overall Study|Disease Progression|0
1977592|NCT02737475|3540354|FG015|Overall Study|Disease Progression|0
1977593|NCT02737475|3540355|FG016|Overall Study|Disease Progression|0
1977594|NCT02737475|3540356|FG017|Overall Study|Disease Progression|0
1977595|NCT02737475|3540357|FG018|Overall Study|Disease Progression|0
1977596|NCT02737475|3540358|FG019|Overall Study|Disease Progression|0
1977597|NCT02737475|3540359|FG020|Overall Study|Disease Progression|0
1977598|NCT02737475|3540360|FG021|Overall Study|Disease Progression|0
1977599|NCT02737475|3540361|FG022|Overall Study|Disease Progression|0
1977600|NCT02737475|3540362|FG023|Overall Study|Disease Progression|0
1977601|NCT02737475|3540363|FG024|Overall Study|Disease Progression|0
1977602|NCT02737475|3540364|FG025|Overall Study|Disease Progression|0
1977603|NCT02737475|3540365|FG026|Overall Study|Disease Progression|1
1977604|NCT02642965|3540457|FG000|Overall Study|Lack of Efficacy|4
1977605|NCT02642965|3540457|FG000|Overall Study|Physician Decision|9
1977606|NCT02629159|3540464|FG000|Overall Study|Adverse Event|17
1977607|NCT02629159|3540465|FG001|Overall Study|Adverse Event|20
1977608|NCT02629159|3540466|FG002|Overall Study|Adverse Event|22
1977609|NCT02629159|3540464|FG000|Overall Study|Withdrawal by Subject|22
1977610|NCT02629159|3540465|FG001|Overall Study|Withdrawal by Subject|11
1977611|NCT02629159|3540466|FG002|Overall Study|Withdrawal by Subject|15
1977612|NCT02629159|3540464|FG000|Overall Study|Lost to Follow-up|7
1977613|NCT02629159|3540465|FG001|Overall Study|Lost to Follow-up|4
1977614|NCT02629159|3540466|FG002|Overall Study|Lost to Follow-up|5
1977615|NCT02629159|3540464|FG000|Overall Study|Lack of Efficacy|4
1977616|NCT02629159|3540465|FG001|Overall Study|Lack of Efficacy|0
1977617|NCT02629159|3540466|FG002|Overall Study|Lack of Efficacy|1
1977618|NCT02629159|3540464|FG000|Overall Study|Other|6
1977619|NCT02629159|3540465|FG001|Overall Study|Other|4
1977620|NCT02629159|3540466|FG002|Overall Study|Other|8
1977621|NCT02604433|3540479|FG000|Overall Study|Withdrawal by Subject|37
1977622|NCT02604433|3540480|FG001|Overall Study|Withdrawal by Subject|16
1977623|NCT02604433|3540479|FG000|Overall Study|Adverse Event|4
1977624|NCT02604433|3540480|FG001|Overall Study|Adverse Event|0
1977625|NCT02604433|3540479|FG000|Overall Study|Other reasons|3
1977626|NCT02604433|3540480|FG001|Overall Study|Other reasons|5
1977627|NCT02604433|3540479|FG000|Overall Study|Death|4
1977628|NCT02604433|3540480|FG001|Overall Study|Death|1
1977629|NCT02604433|3540479|FG000|Overall Study|Transition to Rollover Protocol|169
1977630|NCT02604433|3540480|FG001|Overall Study|Transition to Rollover Protocol|82
1977631|NCT02604433|3540479|FG000|Overall Study|Physician Decision|1
1977632|NCT02604433|3540480|FG001|Overall Study|Physician Decision|1
1977633|NCT02604433|3540479|FG000|Overall Study|Lack of Efficacy|0
1977634|NCT02604433|3540480|FG001|Overall Study|Lack of Efficacy|1
1977635|NCT02550652|3540488|FG000|Overall Study|Death|1
1977636|NCT02550652|3540489|FG001|Overall Study|Death|4
1977637|NCT02550652|3540488|FG000|Overall Study|Lack of Efficacy|1
1977638|NCT02550652|3540489|FG001|Overall Study|Lack of Efficacy|0
1977639|NCT02550652|3540488|FG000|Overall Study|Withdrawal by Subject|3
1977640|NCT02550652|3540489|FG001|Overall Study|Withdrawal by Subject|7
1977641|NCT02550652|3540488|FG000|Overall Study|Post Trial Access|1
1977642|NCT02550652|3540489|FG001|Overall Study|Post Trial Access|0
1977643|NCT02550652|3540488|FG000|Overall Study|Lost to Follow-up|1
1977644|NCT02550652|3540489|FG001|Overall Study|Lost to Follow-up|3
1977645|NCT02550652|3540488|FG000|Overall Study|Physician Decision|0
1977646|NCT02550652|3540489|FG001|Overall Study|Physician Decision|2
1977647|NCT02550652|3540488|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14
1977648|NCT02550652|3540489|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5
2022743|NCT00321555|3590648|FG000|Overall Study|Developed antibodies|1
2022744|NCT00321555|3590648|FG000|Overall Study|Switched to alternative treatment|3
2022745|NCT00321555|3590648|FG000|Overall Study|Physician Decision|1
2022746|NCT00321555|3590648|FG000|Overall Study|Disease progression on study|1
2022747|NCT00321620|3590672|FG000|Overall Study|Death|269
2022748|NCT00321620|3590673|FG001|Overall Study|Death|294
2022749|NCT00321620|3590672|FG000|Overall Study|Withdrawal by Subject|164
2022750|NCT00321620|3590673|FG001|Overall Study|Withdrawal by Subject|147
2022751|NCT00321620|3590672|FG000|Overall Study|Disease progression|113
2022752|NCT00321620|3590673|FG001|Overall Study|Disease progression|117
2022753|NCT00321620|3590672|FG000|Overall Study|Adverse Event|43
2022754|NCT00321620|3590673|FG001|Overall Study|Adverse Event|56
2022755|NCT00321620|3590672|FG000|Overall Study|Lost to Follow-up|13
2022756|NCT00321620|3590673|FG001|Overall Study|Lost to Follow-up|9
2022757|NCT00321620|3590672|FG000|Overall Study|Physician Decision|4
2022758|NCT00321620|3590673|FG001|Overall Study|Physician Decision|1
2022759|NCT00321620|3590672|FG000|Overall Study|Noncompliance|14
2022760|NCT00321620|3590673|FG001|Overall Study|Noncompliance|7
2022761|NCT00321620|3590672|FG000|Overall Study|Protocol deviation|4
2022762|NCT00321620|3590673|FG001|Overall Study|Protocol deviation|3
2022763|NCT00321620|3590672|FG000|Overall Study|Ineligibility determined|2
2022764|NCT00321620|3590673|FG001|Overall Study|Ineligibility determined|3
2022765|NCT00321620|3590672|FG000|Overall Study|Participant request|75
2022766|NCT00321620|3590673|FG001|Overall Study|Participant request|52
2022767|NCT00321620|3590672|FG000|Overall Study|Other|42
2022768|NCT00321620|3590673|FG001|Overall Study|Other|33
2022769|NCT00321646|3590679|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
2022770|NCT00321646|3590679|FG000|Neoadjuvant Chemotherapy|Adverse Event|2
2022771|NCT00321646|3590679|FG000|Neoadjuvant Chemotherapy|Disease progression|1
2022772|NCT00321672|3590687|FG000|Overall Study|Withdrawal by Subject|5
2022773|NCT00321672|3590688|FG001|Overall Study|Withdrawal by Subject|1
2022774|NCT00321672|3590689|FG002|Overall Study|Withdrawal by Subject|2
2022775|NCT00321672|3590690|FG003|Overall Study|Withdrawal by Subject|0
2022776|NCT00321672|3590687|FG000|Overall Study|Noncompliance|1
2022777|NCT00321672|3590688|FG001|Overall Study|Noncompliance|2
2022778|NCT00321672|3590689|FG002|Overall Study|Noncompliance|1
2022779|NCT00321672|3590690|FG003|Overall Study|Noncompliance|0
2022780|NCT00321672|3590687|FG000|Overall Study|Adverse Event|1
2022781|NCT00321672|3590688|FG001|Overall Study|Adverse Event|1
2022782|NCT00321672|3590689|FG002|Overall Study|Adverse Event|0
2022783|NCT00321672|3590690|FG003|Overall Study|Adverse Event|0
2022784|NCT00321672|3590687|FG000|Overall Study|Lack of Efficacy|1
2022785|NCT00321672|3590688|FG001|Overall Study|Lack of Efficacy|1
2022786|NCT00321672|3590689|FG002|Overall Study|Lack of Efficacy|0
2022787|NCT00321672|3590690|FG003|Overall Study|Lack of Efficacy|0
2022788|NCT00321672|3590687|FG000|Overall Study|Lost to Follow-up|2
2022789|NCT00321672|3590688|FG001|Overall Study|Lost to Follow-up|0
2022790|NCT00321672|3590689|FG002|Overall Study|Lost to Follow-up|4
2022791|NCT00321672|3590690|FG003|Overall Study|Lost to Follow-up|2
2022792|NCT00321672|3590687|FG000|Overall Study|Death|1
2022793|NCT00321672|3590688|FG001|Overall Study|Death|0
2022794|NCT00321672|3590689|FG002|Overall Study|Death|0
2022795|NCT00321672|3590690|FG003|Overall Study|Death|0
2022796|NCT00321672|3590687|FG000|Overall Study|Too far to travel for visits|1
2022797|NCT00321672|3590688|FG001|Overall Study|Too far to travel for visits|0
2022798|NCT00321672|3590689|FG002|Overall Study|Too far to travel for visits|0
2022799|NCT00321672|3590690|FG003|Overall Study|Too far to travel for visits|0
2022800|NCT00321672|3590687|FG000|Overall Study|Incarcerated|0
2022801|NCT00321672|3590688|FG001|Overall Study|Incarcerated|0
2022802|NCT00321672|3590689|FG002|Overall Study|Incarcerated|2
2022803|NCT00321672|3590690|FG003|Overall Study|Incarcerated|0
2022804|NCT00321672|3590687|FG000|Overall Study|Moved out of state|0
2022805|NCT00321672|3590688|FG001|Overall Study|Moved out of state|1
2022806|NCT00321672|3590689|FG002|Overall Study|Moved out of state|1
2022807|NCT00321672|3590690|FG003|Overall Study|Moved out of state|0
2022808|NCT00321672|3590687|FG000|Overall Study|Protocol Violation|0
2022809|NCT00321672|3590688|FG001|Overall Study|Protocol Violation|0
2022810|NCT00321672|3590689|FG002|Overall Study|Protocol Violation|1
2022811|NCT00321672|3590690|FG003|Overall Study|Protocol Violation|0
2022812|NCT00321672|3590687|FG000|Overall Study|Diagnosis of testicular cancer|0
2022813|NCT00321672|3590688|FG001|Overall Study|Diagnosis of testicular cancer|1
2022814|NCT00321672|3590689|FG002|Overall Study|Diagnosis of testicular cancer|0
2022815|NCT00321672|3590690|FG003|Overall Study|Diagnosis of testicular cancer|0
2022816|NCT00321672|3590687|FG000|Overall Study|Extensive travel required for new job|0
2022817|NCT00321672|3590688|FG001|Overall Study|Extensive travel required for new job|1
1977649|NCT02420821|3540514|FG000|Overall Study|Lost to Follow-up|2
1977650|NCT02420821|3540515|FG001|Overall Study|Lost to Follow-up|0
1977651|NCT02420821|3540514|FG000|Overall Study|Non-compliance|1
1977652|NCT02420821|3540515|FG001|Overall Study|Non-compliance|2
1977653|NCT02420821|3540514|FG000|Overall Study|Physician Decision|5
1977654|NCT02420821|3540515|FG001|Overall Study|Physician Decision|2
1977655|NCT02420821|3540514|FG000|Overall Study|Withdrawal by Subject|31
1977656|NCT02420821|3540515|FG001|Overall Study|Withdrawal by Subject|17
1977657|NCT02420821|3540514|FG000|Overall Study|Death|129
1977658|NCT02420821|3540515|FG001|Overall Study|Death|116
1977659|NCT02412670|3540524|FG000|Overall Study|Adverse Event|4
1977660|NCT02412670|3540525|FG001|Overall Study|Adverse Event|1
1977661|NCT02412670|3540524|FG000|Overall Study|Physician Decision|1
1977662|NCT02412670|3540525|FG001|Overall Study|Physician Decision|0
2213134|NCT01675882|3854494|FG001|Overall Study|Lost to Follow-up|1
2213135|NCT01675882|3854495|FG002|Overall Study|Lost to Follow-up|0
2213136|NCT01675882|3854496|FG003|Overall Study|Lost to Follow-up|0
2213137|NCT01675882|3854493|FG000|Overall Study|Non-compliance|0
2213138|NCT01675882|3854494|FG001|Overall Study|Non-compliance|0
2213139|NCT01675882|3854495|FG002|Overall Study|Non-compliance|0
2213140|NCT01675882|3854496|FG003|Overall Study|Non-compliance|1
2213141|NCT01676012|3854506|FG000|Overall Study|Adverse Event|2
2213142|NCT01676012|3854506|FG000|Overall Study|incomplete set of videos|1
2213143|NCT01676116|3854512|FG000|Overall Study|Withdrawal criteria|2
2213144|NCT01676116|3854513|FG001|Overall Study|Withdrawal criteria|14
2213145|NCT01676116|3854512|FG000|Overall Study|Adverse Event|1
2213146|NCT01676116|3854513|FG001|Overall Study|Adverse Event|2
2213147|NCT01676116|3854512|FG000|Overall Study|Unclassified|4
2213148|NCT01676116|3854513|FG001|Overall Study|Unclassified|10
2213149|NCT01676116|3854512|FG000|Overall Study|Protocol Violation|9
2213150|NCT01676116|3854513|FG001|Overall Study|Protocol Violation|3
2213151|NCT01676220|3854521|FG000|Overall Study|Randomized But Not Treated|4
2213152|NCT01676220|3854522|FG001|Overall Study|Randomized But Not Treated|1
2213153|NCT01676220|3854521|FG000|Overall Study|Adverse Event|10
2213154|NCT01676220|3854522|FG001|Overall Study|Adverse Event|8
2213155|NCT01676220|3854521|FG000|Overall Study|Lack of Efficacy|2
2213156|NCT01676220|3854522|FG001|Overall Study|Lack of Efficacy|5
2213157|NCT01676220|3854521|FG000|Overall Study|Protocol Violation|11
2213158|NCT01676220|3854522|FG001|Overall Study|Protocol Violation|12
1977663|NCT02412670|3540524|FG000|Overall Study|Withdrawal by Subject|1
1977664|NCT02412670|3540525|FG001|Overall Study|Withdrawal by Subject|0
1977665|NCT02412670|3540524|FG000|Overall Study|Ineligible|1
1977666|NCT02412670|3540525|FG001|Overall Study|Ineligible|0
1977667|NCT02410343|3540533|FG000|Core Period (24 Weeks)|Adverse Event|1
1977668|NCT02410343|3540534|FG001|Core Period (24 Weeks)|Adverse Event|0
1977669|NCT02410343|3540533|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4
1977670|NCT02410343|3540534|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7
1977671|NCT02410343|3540533|FG000|Extension Period (12 Months)|Adverse Event|1
1977672|NCT02410343|3540534|FG001|Extension Period (12 Months)|Adverse Event|0
1977673|NCT02410343|3540533|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0
1977674|NCT02410343|3540534|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1
1977675|NCT02339740|3540547|FG000|Overall Study|Death|1
1977676|NCT02339740|3540548|FG001|Overall Study|Death|0
1977677|NCT02339740|3540547|FG000|Overall Study|Physician Decision|0
1977678|NCT02339740|3540548|FG001|Overall Study|Physician Decision|2
1977679|NCT02339740|3540547|FG000|Overall Study|Withdrawal by Subject|5
1977680|NCT02339740|3540548|FG001|Overall Study|Withdrawal by Subject|1
1977681|NCT02339740|3540547|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3
1977682|NCT02339740|3540548|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1
1977683|NCT02125461|3540571|FG000|Overall Study|Withdrawal by Subject|30
1977684|NCT02125461|3540572|FG001|Overall Study|Withdrawal by Subject|16
1977685|NCT02125461|3540571|FG000|Overall Study|Lost to Follow-up|8
1977686|NCT02125461|3540572|FG001|Overall Study|Lost to Follow-up|3
1977687|NCT02125461|3540571|FG000|Overall Study|Death|260
1977688|NCT02125461|3540572|FG001|Overall Study|Death|149
1977689|NCT02125461|3540571|FG000|Overall Study|Missing Termination Reason|0
1977690|NCT02125461|3540572|FG001|Overall Study|Missing Termination Reason|1
1977691|NCT02045303|3540580|FG000|Overall Study|Protocol Violation|2
1977692|NCT02045303|3540581|FG001|Overall Study|Protocol Violation|1
1977693|NCT02045303|3540582|FG002|Overall Study|Protocol Violation|0
1977694|NCT02045303|3540580|FG000|Overall Study|Withdrawal by Subject|0
1977695|NCT02045303|3540581|FG001|Overall Study|Withdrawal by Subject|2
1977696|NCT02045303|3540582|FG002|Overall Study|Withdrawal by Subject|0
1977697|NCT02025556|3540594|FG000|Overall Study|Adverse Event|0
1977698|NCT02025556|3540595|FG001|Overall Study|Adverse Event|4
1977699|NCT02025556|3540596|FG002|Overall Study|Adverse Event|2
1977700|NCT02025556|3540594|FG000|Overall Study|Lack of Efficacy|2
1977701|NCT02025556|3540595|FG001|Overall Study|Lack of Efficacy|1
1977702|NCT02025556|3540596|FG002|Overall Study|Lack of Efficacy|0
1977703|NCT02025556|3540594|FG000|Overall Study|Protocol Violation|2
1977704|NCT02025556|3540595|FG001|Overall Study|Protocol Violation|1
1977705|NCT02025556|3540596|FG002|Overall Study|Protocol Violation|0
2213159|NCT01676220|3854521|FG000|Overall Study|Received Rescue Therapy|14
2213160|NCT01676220|3854522|FG001|Overall Study|Received Rescue Therapy|22
2213161|NCT01676220|3854521|FG000|Overall Study|Personal Reason|34
2310333|NCT02732119|4014397|FG001|Phase I|Adverse Event|3
2310334|NCT02732119|4014398|FG002|Phase I|Adverse Event|1
2310335|NCT02732119|4014399|FG003|Phase I|Adverse Event|0
2310336|NCT02732119|4014400|FG004|Phase I|Adverse Event|0
2310337|NCT02732119|4014396|FG000|Phase I|Progressive disease|7
2310338|NCT02732119|4014397|FG001|Phase I|Progressive disease|3
2310339|NCT02732119|4014398|FG002|Phase I|Progressive disease|2
2310340|NCT02732119|4014399|FG003|Phase I|Progressive disease|0
2310341|NCT02732119|4014400|FG004|Phase I|Progressive disease|0
2310342|NCT02732119|4014396|FG000|Phase I|Protocol deviation|0
2310343|NCT02732119|4014397|FG001|Phase I|Protocol deviation|1
2310344|NCT02732119|4014398|FG002|Phase I|Protocol deviation|0
2310345|NCT02732119|4014399|FG003|Phase I|Protocol deviation|0
2310346|NCT02732119|4014400|FG004|Phase I|Protocol deviation|0
2310347|NCT02732119|4014396|FG000|Phase I|Physician Decision|0
2310348|NCT02732119|4014397|FG001|Phase I|Physician Decision|3
2310349|NCT02732119|4014398|FG002|Phase I|Physician Decision|4
2310350|NCT02732119|4014399|FG003|Phase I|Physician Decision|0
2310351|NCT02732119|4014400|FG004|Phase I|Physician Decision|0
2310352|NCT02732119|4014396|FG000|Phase II|Adverse Event|0
2310353|NCT02732119|4014397|FG001|Phase II|Adverse Event|0
2310354|NCT02732119|4014398|FG002|Phase II|Adverse Event|0
2310355|NCT02732119|4014399|FG003|Phase II|Adverse Event|3
2310356|NCT02732119|4014400|FG004|Phase II|Adverse Event|3
2310357|NCT02732119|4014396|FG000|Phase II|Death|0
2310358|NCT02732119|4014397|FG001|Phase II|Death|0
2310359|NCT02732119|4014398|FG002|Phase II|Death|0
2310360|NCT02732119|4014399|FG003|Phase II|Death|1
1977706|NCT02025556|3540594|FG000|Overall Study|Withdrawal by Subject|0
1977707|NCT02025556|3540595|FG001|Overall Study|Withdrawal by Subject|3
1977708|NCT02025556|3540596|FG002|Overall Study|Withdrawal by Subject|6
1977709|NCT02025556|3540594|FG000|Overall Study|Lost to Follow-up|2
1977710|NCT02025556|3540595|FG001|Overall Study|Lost to Follow-up|4
1977711|NCT02025556|3540596|FG002|Overall Study|Lost to Follow-up|0
1977712|NCT02025556|3540594|FG000|Overall Study|Reason not reported|0
1977713|NCT02025556|3540595|FG001|Overall Study|Reason not reported|0
1977714|NCT02025556|3540596|FG002|Overall Study|Reason not reported|1
1977715|NCT01986933|3540609|FG000|Placebo-controlled (Part A)|Adverse Event|1
1977716|NCT01986933|3540610|FG001|Placebo-controlled (Part A)|Adverse Event|5
1977717|NCT01986933|3540611|FG002|Placebo-controlled (Part A)|Adverse Event|2
1977718|NCT01986933|3540612|FG003|Placebo-controlled (Part A)|Adverse Event|2
1977719|NCT01986933|3540613|FG004|Placebo-controlled (Part A)|Adverse Event|4
1977720|NCT01986933|3540609|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3
1977721|NCT01986933|3540610|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1
1977722|NCT01986933|3540611|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1
1977723|NCT01986933|3540612|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2
1977724|NCT01986933|3540613|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1
1977725|NCT01986933|3540609|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5
1977726|NCT01986933|3540610|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2
1977727|NCT01986933|3540611|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6
1977728|NCT01986933|3540612|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2
1977729|NCT01986933|3540613|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7
1977730|NCT01986933|3540609|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0
1977731|NCT01986933|3540610|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1
1977732|NCT01986933|3540611|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0
1977733|NCT01986933|3540612|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1
1977734|NCT01986933|3540613|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0
1977735|NCT01986933|3540609|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0
1977736|NCT01986933|3540610|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0
1977737|NCT01986933|3540611|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0
1977738|NCT01986933|3540612|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0
1977739|NCT01986933|3540613|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2
1977740|NCT01986933|3540609|FG000|Active-to-active (Part B)|Adverse Event|0
1977741|NCT01986933|3540610|FG001|Active-to-active (Part B)|Adverse Event|2
1977742|NCT01986933|3540611|FG002|Active-to-active (Part B)|Adverse Event|0
1977743|NCT01986933|3540612|FG003|Active-to-active (Part B)|Adverse Event|1
1977744|NCT01986933|3540613|FG004|Active-to-active (Part B)|Adverse Event|3
1977745|NCT01986933|3540609|FG000|Active-to-active (Part B)|Lack of Efficacy|0
1977746|NCT01986933|3540610|FG001|Active-to-active (Part B)|Lack of Efficacy|3
1977747|NCT01986933|3540611|FG002|Active-to-active (Part B)|Lack of Efficacy|2
1977748|NCT01986933|3540612|FG003|Active-to-active (Part B)|Lack of Efficacy|0
1977749|NCT01986933|3540613|FG004|Active-to-active (Part B)|Lack of Efficacy|4
1977750|NCT01986933|3540609|FG000|Active-to-active (Part B)|Pregnancy|0
1977751|NCT01986933|3540610|FG001|Active-to-active (Part B)|Pregnancy|0
1977752|NCT01986933|3540611|FG002|Active-to-active (Part B)|Pregnancy|0
1977753|NCT01986933|3540612|FG003|Active-to-active (Part B)|Pregnancy|0
1977754|NCT01986933|3540613|FG004|Active-to-active (Part B)|Pregnancy|1
1977755|NCT01986933|3540609|FG000|Active-to-active (Part B)|Physician Decision|0
1977756|NCT01986933|3540610|FG001|Active-to-active (Part B)|Physician Decision|0
2310361|NCT02732119|4014400|FG004|Phase II|Death|0
2310362|NCT02732119|4014396|FG000|Phase II|Progressive dissease|0
2310363|NCT02732119|4014397|FG001|Phase II|Progressive dissease|0
2310364|NCT02732119|4014398|FG002|Phase II|Progressive dissease|0
1977757|NCT01986933|3540611|FG002|Active-to-active (Part B)|Physician Decision|1
1977758|NCT01986933|3540612|FG003|Active-to-active (Part B)|Physician Decision|1
1977759|NCT01986933|3540613|FG004|Active-to-active (Part B)|Physician Decision|0
1977760|NCT01986933|3540609|FG000|Active-to-active (Part B)|Withdrawal by Subject|0
1977761|NCT01986933|3540610|FG001|Active-to-active (Part B)|Withdrawal by Subject|4
1977762|NCT01986933|3540611|FG002|Active-to-active (Part B)|Withdrawal by Subject|7
1977763|NCT01986933|3540612|FG003|Active-to-active (Part B)|Withdrawal by Subject|6
1977764|NCT01986933|3540613|FG004|Active-to-active (Part B)|Withdrawal by Subject|6
1977765|NCT01986933|3540609|FG000|Active-to-active (Part B)|Lost to Follow-up|0
1977766|NCT01986933|3540610|FG001|Active-to-active (Part B)|Lost to Follow-up|0
1977767|NCT01986933|3540611|FG002|Active-to-active (Part B)|Lost to Follow-up|0
1977768|NCT01986933|3540612|FG003|Active-to-active (Part B)|Lost to Follow-up|0
1977769|NCT01986933|3540613|FG004|Active-to-active (Part B)|Lost to Follow-up|1
1977770|NCT01986933|3540609|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0
1977771|NCT01986933|3540610|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1
1977772|NCT01986933|3540611|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0
1977773|NCT01986933|3540612|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1
1977774|NCT01986933|3540613|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1
1977775|NCT01986933|3540609|FG000|Placebo-to-active (Part B)|Adverse Event|0
1977776|NCT01986933|3540610|FG001|Placebo-to-active (Part B)|Adverse Event|1
1977777|NCT01986933|3540611|FG002|Placebo-to-active (Part B)|Adverse Event|0
1977778|NCT01986933|3540612|FG003|Placebo-to-active (Part B)|Adverse Event|1
1977779|NCT01986933|3540613|FG004|Placebo-to-active (Part B)|Adverse Event|0
1977780|NCT01986933|3540609|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0
1977781|NCT01986933|3540610|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0
1977782|NCT01986933|3540611|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0
1977783|NCT01986933|3540612|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1
1977784|NCT01986933|3540613|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0
1977785|NCT01986933|3540609|FG000|Placebo-to-active (Part B)|Protocol Violation|0
1977786|NCT01986933|3540610|FG001|Placebo-to-active (Part B)|Protocol Violation|0
1977787|NCT01986933|3540611|FG002|Placebo-to-active (Part B)|Protocol Violation|1
1977788|NCT01986933|3540612|FG003|Placebo-to-active (Part B)|Protocol Violation|0
1977789|NCT01986933|3540613|FG004|Placebo-to-active (Part B)|Protocol Violation|0
1977790|NCT01986933|3540609|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0
1977791|NCT01986933|3540610|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3
1977792|NCT01986933|3540611|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4
1977793|NCT01986933|3540612|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3
1977794|NCT01986933|3540613|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0
1977795|NCT01986933|3540609|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0
1977796|NCT01986933|3540610|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1
1977797|NCT01986933|3540611|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0
1977798|NCT01986933|3540612|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0
1977799|NCT01986933|3540613|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0
1977800|NCT01835145|3540650|FG000|Overall Study|Ineligible prior to treatment|1
1977801|NCT01835145|3540651|FG001|Overall Study|Ineligible prior to treatment|0
1977802|NCT01701674|3540666|FG000|Overall Study|Unable to safely complete treatment|1
1977803|NCT01563107|3540728|FG000|Overall Study|Physician Decision|0
1977804|NCT01563107|3540729|FG001|Overall Study|Physician Decision|1
1977805|NCT01563107|3540730|FG002|Overall Study|Physician Decision|1
1977806|NCT01563107|3540731|FG003|Overall Study|Physician Decision|3
1977807|NCT01563107|3540728|FG000|Overall Study|Withdrawal by Subject|1
1977808|NCT01563107|3540729|FG001|Overall Study|Withdrawal by Subject|2
1977809|NCT01563107|3540730|FG002|Overall Study|Withdrawal by Subject|1
1977810|NCT01563107|3540731|FG003|Overall Study|Withdrawal by Subject|2
1977811|NCT01194570|3540803|FG000|Overall Study|Death|1
1977812|NCT01194570|3540804|FG001|Overall Study|Death|3
1977813|NCT01194570|3540803|FG000|Overall Study|Ongoing at CCOD|162
1977814|NCT01194570|3540804|FG001|Overall Study|Ongoing at CCOD|387
1977815|NCT01194570|3540803|FG000|Overall Study|Physician Decision|2
1977816|NCT01194570|3540804|FG001|Overall Study|Physician Decision|6
1977817|NCT01194570|3540803|FG000|Overall Study|Reason not specified|13
1977818|NCT01194570|3540804|FG001|Overall Study|Reason not specified|20
1977819|NCT01194570|3540803|FG000|Overall Study|Protocol Violation|0
1977820|NCT01194570|3540804|FG001|Overall Study|Protocol Violation|2
1977821|NCT01194570|3540803|FG000|Overall Study|Non-compliance with study drug|2
1977822|NCT01194570|3540804|FG001|Overall Study|Non-compliance with study drug|2
1977823|NCT01194570|3540803|FG000|Overall Study|Adverse Event|12
1977824|NCT01194570|3540804|FG001|Overall Study|Adverse Event|18
1977825|NCT01194570|3540803|FG000|Overall Study|Non-compliance|2
1977826|NCT01194570|3540804|FG001|Overall Study|Non-compliance|2
1977827|NCT01194570|3540803|FG000|Overall Study|Lack of Efficacy|27
1977828|NCT01194570|3540804|FG001|Overall Study|Lack of Efficacy|21
1977829|NCT01194570|3540803|FG000|Overall Study|Withdrawal by Subject|21
1977830|NCT01194570|3540804|FG001|Overall Study|Withdrawal by Subject|22
1977831|NCT01194570|3540803|FG000|Overall Study|Pregnancy|1
1977832|NCT01194570|3540804|FG001|Overall Study|Pregnancy|1
1977833|NCT01194570|3540803|FG000|Overall Study|Lost to Follow-up|1
1977834|NCT01194570|3540804|FG001|Overall Study|Lost to Follow-up|4
1977835|NCT01146652|3540812|FG000|Overall Study|Adverse Event|506
1977836|NCT01146652|3540813|FG001|Overall Study|Adverse Event|15
1977837|NCT01146652|3540812|FG000|Overall Study|Lack of Efficacy|91
1977838|NCT01146652|3540813|FG001|Overall Study|Lack of Efficacy|7
1977839|NCT01146652|3540812|FG000|Overall Study|Poor compliance to protocol|38
1977840|NCT01146652|3540813|FG001|Overall Study|Poor compliance to protocol|1
1977841|NCT01146652|3540812|FG000|Overall Study|Other unspecified reasons|314
1977842|NCT01146652|3540813|FG001|Overall Study|Other unspecified reasons|22
1977843|NCT01146652|3540812|FG000|Overall Study|Enrolled but not treated|2
1977844|NCT01146652|3540813|FG001|Overall Study|Enrolled but not treated|0
1977845|NCT01116648|3540841|FG000|Phase 1 Dose Level 3|Adverse Event|0
1977846|NCT01116648|3540842|FG001|Phase 1 Dose Level 3|Adverse Event|0
1977847|NCT01116648|3540843|FG002|Phase 1 Dose Level 3|Adverse Event|0
1977848|NCT01116648|3540844|FG003|Phase 1 Dose Level 3|Adverse Event|2
1977849|NCT01116648|3540845|FG004|Phase 1 Dose Level 3|Adverse Event|0
1977850|NCT01116648|3540846|FG005|Phase 1 Dose Level 3|Adverse Event|0
1977851|NCT01116648|3540847|FG006|Phase 1 Dose Level 3|Adverse Event|0
1977852|NCT01116648|3540848|FG007|Phase 1 Dose Level 3|Adverse Event|0
1977853|NCT01116648|3540849|FG008|Phase 1 Dose Level 3|Adverse Event|0
1977854|NCT01116648|3540850|FG009|Phase 1 Dose Level 3|Adverse Event|0
1977855|NCT01116648|3540851|FG010|Phase 1 Dose Level 3|Adverse Event|0
1977856|NCT01116648|3540852|FG011|Phase 1 Dose Level 3|Adverse Event|0
1977857|NCT01116648|3540853|FG012|Phase 1 Dose Level 3|Adverse Event|0
1977858|NCT01116648|3540854|FG013|Phase 1 Dose Level 3|Adverse Event|0
1977859|NCT01116648|3540855|FG014|Phase 1 Dose Level 3|Adverse Event|0
1977860|NCT01064648|3540883|FG000|Phase I Cohort1: Dose Level 1|Progression|5
1977861|NCT01064648|3540884|FG001|Phase I Cohort1: Dose Level 1|Progression|0
1977862|NCT01064648|3540885|FG002|Phase I Cohort1: Dose Level 1|Progression|0
1977863|NCT01064648|3540886|FG003|Phase I Cohort1: Dose Level 1|Progression|0
1977864|NCT01064648|3540883|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
1977865|NCT01064648|3540884|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
1977866|NCT01064648|3540885|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
1977867|NCT01064648|3540886|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
1977868|NCT01064648|3540883|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0
1977869|NCT01064648|3540884|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3
1977870|NCT01064648|3540885|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0
1977871|NCT01064648|3540886|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0
1977872|NCT01064648|3540883|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
1977873|NCT01064648|3540884|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
1977874|NCT01064648|3540885|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
1977875|NCT01064648|3540886|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
1977876|NCT01064648|3540883|FG000|Phase I Cohort 2: Dose Level 2|Progression|0
1977877|NCT01064648|3540884|FG001|Phase I Cohort 2: Dose Level 2|Progression|5
1977878|NCT01064648|3540885|FG002|Phase I Cohort 2: Dose Level 2|Progression|0
1977879|NCT01064648|3540886|FG003|Phase I Cohort 2: Dose Level 2|Progression|0
1977880|NCT01064648|3540883|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
1977881|NCT01064648|3540884|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
1977882|NCT01064648|3540885|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
1977883|NCT01064648|3540886|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
1977884|NCT01064648|3540883|FG000|Phase II|Adverse Event|0
1977885|NCT01064648|3540884|FG001|Phase II|Adverse Event|0
1977886|NCT01064648|3540885|FG002|Phase II|Adverse Event|15
1977887|NCT01064648|3540886|FG003|Phase II|Adverse Event|8
1977888|NCT01064648|3540883|FG000|Phase II|Death|0
1977889|NCT01064648|3540884|FG001|Phase II|Death|0
1977890|NCT01064648|3540885|FG002|Phase II|Death|4
1977891|NCT01064648|3540886|FG003|Phase II|Death|5
1977892|NCT01064648|3540883|FG000|Phase II|Withdrawal by Subject|0
1977893|NCT01064648|3540884|FG001|Phase II|Withdrawal by Subject|0
1977894|NCT01064648|3540885|FG002|Phase II|Withdrawal by Subject|2
1977895|NCT01064648|3540886|FG003|Phase II|Withdrawal by Subject|5
1977896|NCT01064648|3540883|FG000|Phase II|Progression|0
1977897|NCT01064648|3540884|FG001|Phase II|Progression|0
1977898|NCT01064648|3540885|FG002|Phase II|Progression|21
1977899|NCT01064648|3540886|FG003|Phase II|Progression|27
1977900|NCT01064648|3540883|FG000|Phase II|Non-protocol specified|0
1977901|NCT01064648|3540884|FG001|Phase II|Non-protocol specified|0
1977902|NCT01064648|3540885|FG002|Phase II|Non-protocol specified|5
1977903|NCT01064648|3540886|FG003|Phase II|Non-protocol specified|3
1977904|NCT01064648|3540883|FG000|Phase II|Under Review|0
1977905|NCT01064648|3540884|FG001|Phase II|Under Review|0
1977906|NCT01064648|3540885|FG002|Phase II|Under Review|2
1977907|NCT01064648|3540886|FG003|Phase II|Under Review|0
1977908|NCT01064479|3540901|FG000|Overall Study|Death|10
1977909|NCT01064479|3540902|FG001|Overall Study|Death|11
1977910|NCT01064479|3540901|FG000|Overall Study|Withdrawal by Subject|2
1977911|NCT01064479|3540902|FG001|Overall Study|Withdrawal by Subject|2
1977912|NCT01064479|3540901|FG000|Overall Study|Disease progression|1
1977913|NCT01064479|3540902|FG001|Overall Study|Disease progression|1
1977914|NCT01064479|3540901|FG000|Overall Study|Toxicity|1
1977915|NCT01064479|3540902|FG001|Overall Study|Toxicity|1
1977916|NCT01064479|3540901|FG000|Overall Study|Other|1
1977917|NCT01064479|3540902|FG001|Overall Study|Other|2
1977918|NCT01042522|3540910|FG000|Overall Study|Adverse Event|1
1977919|NCT01042522|3540911|FG001|Overall Study|Adverse Event|2
1977920|NCT01042522|3540910|FG000|Overall Study|Disease Progression|5
1977921|NCT01042522|3540911|FG001|Overall Study|Disease Progression|0
1977922|NCT01042522|3540910|FG000|Overall Study|Death|1
1977923|NCT01042522|3540911|FG001|Overall Study|Death|0
1977924|NCT01042522|3540910|FG000|Overall Study|Patient Refused|0
1977925|NCT01042522|3540911|FG001|Overall Study|Patient Refused|3
1977926|NCT01042522|3540910|FG000|Overall Study|Withdrawal by Subject|1
1977927|NCT01042522|3540911|FG001|Overall Study|Withdrawal by Subject|1
1977928|NCT00710970|3540950|FG000|Overall Study|Never took drug|3
1977929|NCT00685919|3540958|FG000|Overall Study|Withdrawal by Subject|0
1977930|NCT00685919|3540959|FG001|Overall Study|Withdrawal by Subject|0
1977931|NCT00685919|3540960|FG002|Overall Study|Withdrawal by Subject|1
1977932|NCT00685919|3540961|FG003|Overall Study|Withdrawal by Subject|0
1977933|NCT00685919|3540958|FG000|Overall Study|Physician Decision|1
1977934|NCT00685919|3540959|FG001|Overall Study|Physician Decision|0
1977935|NCT00685919|3540960|FG002|Overall Study|Physician Decision|0
1977936|NCT00685919|3540961|FG003|Overall Study|Physician Decision|0
2022818|NCT00321672|3590689|FG002|Overall Study|Extensive travel required for new job|0
2022819|NCT00321672|3590690|FG003|Overall Study|Extensive travel required for new job|0
2022820|NCT00321685|3590704|FG000|Overall Study|Adverse Event|18
2022821|NCT00321685|3590704|FG000|Overall Study|Death|2
2022822|NCT00321685|3590704|FG000|Overall Study|Withdrawal by Subject|8
2022823|NCT00321685|3590704|FG000|Overall Study|Alternative therapy|1
2022824|NCT00321685|3590704|FG000|Overall Study|Complicating disese|1
2022825|NCT00321685|3590704|FG000|Overall Study|Other|5
2022826|NCT00321685|3590704|FG000|Overall Study|Not start protocol therapy|2
2022827|NCT00321685|3590704|FG000|Overall Study|Ineligible|2
2022828|NCT00321711|3590734|FG000|Part A|Adverse Event|3
2022829|NCT00321711|3590735|FG001|Part A|Adverse Event|3
2022830|NCT00321711|3590736|FG002|Part A|Adverse Event|2
2022831|NCT00321711|3590737|FG003|Part A|Adverse Event|0
2022832|NCT00321711|3590738|FG004|Part A|Adverse Event|0
2022833|NCT00321711|3590734|FG000|Part A|Withdrawal by Subject|1
2022834|NCT00321711|3590735|FG001|Part A|Withdrawal by Subject|1
2022835|NCT00321711|3590736|FG002|Part A|Withdrawal by Subject|1
2022836|NCT00321711|3590737|FG003|Part A|Withdrawal by Subject|0
2022837|NCT00321711|3590738|FG004|Part A|Withdrawal by Subject|0
2022838|NCT00321711|3590734|FG000|Part A|Disease progression|0
2022839|NCT00321711|3590735|FG001|Part A|Disease progression|1
2022840|NCT00321711|3590736|FG002|Part A|Disease progression|0
2022841|NCT00321711|3590737|FG003|Part A|Disease progression|0
2022842|NCT00321711|3590738|FG004|Part A|Disease progression|0
2022843|NCT00321711|3590734|FG000|Part A|Requirement for alternative therapy|0
2022844|NCT00321711|3590735|FG001|Part A|Requirement for alternative therapy|2
2022845|NCT00321711|3590736|FG002|Part A|Requirement for alternative therapy|1
2022846|NCT00321711|3590737|FG003|Part A|Requirement for alternative therapy|0
2022847|NCT00321711|3590738|FG004|Part A|Requirement for alternative therapy|0
2022848|NCT00321711|3590734|FG000|Part A|Physician Decision|0
2022849|NCT00321711|3590735|FG001|Part A|Physician Decision|1
2022850|NCT00321711|3590736|FG002|Part A|Physician Decision|3
2022851|NCT00321711|3590737|FG003|Part A|Physician Decision|0
2022852|NCT00321711|3590738|FG004|Part A|Physician Decision|0
2022853|NCT00321711|3590734|FG000|Part A|Other|1
2022854|NCT00321711|3590735|FG001|Part A|Other|2
2022855|NCT00321711|3590736|FG002|Part A|Other|3
2022856|NCT00321711|3590737|FG003|Part A|Other|0
2022857|NCT00321711|3590738|FG004|Part A|Other|0
2022858|NCT00321711|3590734|FG000|Part A|Protocol deviation|0
2022859|NCT00321711|3590735|FG001|Part A|Protocol deviation|0
2022860|NCT00321711|3590736|FG002|Part A|Protocol deviation|1
2022861|NCT00321711|3590737|FG003|Part A|Protocol deviation|0
2022862|NCT00321711|3590738|FG004|Part A|Protocol deviation|0
2022863|NCT00321711|3590734|FG000|Part B|Noncompliance|0
2022864|NCT00321711|3590735|FG001|Part B|Noncompliance|0
2022865|NCT00321711|3590736|FG002|Part B|Noncompliance|0
2022866|NCT00321711|3590737|FG003|Part B|Noncompliance|0
2022867|NCT00321711|3590738|FG004|Part B|Noncompliance|1
2022868|NCT00321711|3590734|FG000|Part B|Adverse Event|0
2022869|NCT00321711|3590735|FG001|Part B|Adverse Event|0
2022870|NCT00321711|3590736|FG002|Part B|Adverse Event|0
2022871|NCT00321711|3590737|FG003|Part B|Adverse Event|2
2022872|NCT00321711|3590738|FG004|Part B|Adverse Event|1
2022873|NCT00321711|3590734|FG000|Part B|Disease progression|0
2022874|NCT00321711|3590735|FG001|Part B|Disease progression|0
2022875|NCT00321711|3590736|FG002|Part B|Disease progression|0
2022876|NCT00321711|3590737|FG003|Part B|Disease progression|1
2022877|NCT00321711|3590738|FG004|Part B|Disease progression|0
2022878|NCT00321711|3590734|FG000|Part B|Physician Decision|0
2022879|NCT00321711|3590735|FG001|Part B|Physician Decision|0
2022880|NCT00321711|3590736|FG002|Part B|Physician Decision|0
2022881|NCT00321711|3590737|FG003|Part B|Physician Decision|1
2022882|NCT00321711|3590738|FG004|Part B|Physician Decision|2
2022883|NCT00321711|3590734|FG000|Part B|Death|0
2022884|NCT00321711|3590735|FG001|Part B|Death|0
2022885|NCT00321711|3590736|FG002|Part B|Death|0
2022886|NCT00321711|3590737|FG003|Part B|Death|2
2022887|NCT00321711|3590738|FG004|Part B|Death|1
2022888|NCT00321737|3590753|FG000|Overall Study|Relapse of Erosive Esophagitis|76
2022889|NCT00321737|3590754|FG001|Overall Study|Relapse of Erosive Esophagitis|25
2025968|NCT00348140|3594698|FG001|Overall Study|Lost to Follow-up|4
1977937|NCT00344487|3540971|FG000|Overall Study|immunologic failure|1
1977938|NCT00281658|3540979|FG000|Double-blind, Randomized Phase|Death|120
1977939|NCT00281658|3540980|FG001|Double-blind, Randomized Phase|Death|46
1977940|NCT00281658|3540981|FG002|Double-blind, Randomized Phase|Death|0
1977941|NCT00281658|3540979|FG000|Double-blind, Randomized Phase|Lost to Follow-up|12
1977942|NCT00281658|3540980|FG001|Double-blind, Randomized Phase|Lost to Follow-up|5
1977943|NCT00281658|3540981|FG002|Double-blind, Randomized Phase|Lost to Follow-up|0
1977944|NCT00281658|3540979|FG000|Double-blind, Randomized Phase|Withdrawal by Subject|4
1977945|NCT00281658|3540980|FG001|Double-blind, Randomized Phase|Withdrawal by Subject|1
1977946|NCT00281658|3540981|FG002|Double-blind, Randomized Phase|Withdrawal by Subject|0
1977947|NCT00281658|3540979|FG000|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1977948|NCT00281658|3540980|FG001|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1977949|NCT00281658|3540981|FG002|Double-blind, Randomized Phase|Participant Entered New Protocol|0
1977950|NCT00281658|3540979|FG000|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1977951|NCT00281658|3540980|FG001|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
1977952|NCT00281658|3540981|FG002|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1977953|NCT00281658|3540979|FG000|Open-label Monotherapy Extension Phase|Death|0
1977954|NCT00281658|3540980|FG001|Open-label Monotherapy Extension Phase|Death|0
1977955|NCT00281658|3540981|FG002|Open-label Monotherapy Extension Phase|Death|97
1977956|NCT00281658|3540979|FG000|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1977957|NCT00281658|3540980|FG001|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1977958|NCT00281658|3540981|FG002|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
1977959|NCT00281658|3540979|FG000|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1977960|NCT00281658|3540980|FG001|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1977961|NCT00281658|3540981|FG002|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
1977962|NCT04034355|3541012|FG000|Overall Study|Study terminated by Sponsor|10
1977963|NCT04034355|3541013|FG001|Overall Study|Study terminated by Sponsor|17
1977964|NCT04034355|3541012|FG000|Overall Study|Withdrawal by Subject|12
1977965|NCT04034355|3541013|FG001|Overall Study|Withdrawal by Subject|11
1977966|NCT04034355|3541012|FG000|Overall Study|Site terminated by Sponsor|4
1977967|NCT04034355|3541013|FG001|Overall Study|Site terminated by Sponsor|5
1977968|NCT04034355|3541012|FG000|Overall Study|Adverse Event|2
1977969|NCT04034355|3541013|FG001|Overall Study|Adverse Event|0
1977970|NCT04034355|3541012|FG000|Overall Study|Death|1
1977971|NCT04034355|3541013|FG001|Overall Study|Death|1
1977972|NCT04034355|3541012|FG000|Overall Study|Not reported|2
1977973|NCT04034355|3541013|FG001|Overall Study|Not reported|0
1977974|NCT04034355|3541012|FG000|Overall Study|Lost to Follow-up|1
1977975|NCT04034355|3541013|FG001|Overall Study|Lost to Follow-up|0
1977976|NCT04034355|3541012|FG000|Overall Study|Physician Decision|1
1977977|NCT04034355|3541013|FG001|Overall Study|Physician Decision|0
1977978|NCT04034355|3541012|FG000|Overall Study|Protocol Violation|0
1977979|NCT04034355|3541013|FG001|Overall Study|Protocol Violation|1
1977980|NCT04034355|3541012|FG000|Overall Study|Progressive disease|1
1977981|NCT04034355|3541013|FG001|Overall Study|Progressive disease|0
1978018|NCT02660827|3541227|FG000|From Study to End of Continued Access|Withdrawal by Subject|21
1978019|NCT02660827|3541227|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2
1978020|NCT02660827|3541227|FG000|From Study to End of Continued Access|Adverse Event|3
1978021|NCT02660827|3541227|FG000|From Study to End of Continued Access|didn't participate continued access period|5
1978022|NCT02660827|3541227|FG000|Period 1: Study Period|Withdrawal by Subject|1
1978023|NCT02660827|3541227|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20
1978024|NCT02660827|3541227|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2
1978025|NCT02660827|3541227|FG000|Period 2: Continued Access Period|Adverse Event|3
1978026|NCT02581930|3541243|FG000|Overall Study|Withdrawal by Subject|1
1978027|NCT02581930|3541243|FG000|Overall Study|patient declined further treatment|1
1978028|NCT02496676|3541249|FG000|Phase 1 - Period 1|Adverse Event|0
1978029|NCT02496676|3541250|FG001|Phase 1 - Period 1|Adverse Event|1
1978030|NCT02496676|3541249|FG000|Phase 2 - IV MgSO4|Adverse Event|0
2213162|NCT01676220|3854522|FG001|Overall Study|Personal Reason|45
2213163|NCT01676220|3854521|FG000|Overall Study|Lost to Follow-up|11
2213164|NCT01676220|3854522|FG001|Overall Study|Lost to Follow-up|18
2213165|NCT01676220|3854521|FG000|Overall Study|Selection Criterion/Protocol Violation|9
2213166|NCT01676220|3854522|FG001|Overall Study|Selection Criterion/Protocol Violation|9
2213167|NCT01676220|3854521|FG000|Overall Study|Site Closure/Site Withdrawal|1
2213168|NCT01676220|3854522|FG001|Overall Study|Site Closure/Site Withdrawal|4
2213169|NCT01676220|3854521|FG000|Overall Study|Perceived Lack of Efficacy|3
2213170|NCT01676220|3854522|FG001|Overall Study|Perceived Lack of Efficacy|1
2213171|NCT01676220|3854521|FG000|Overall Study|Non Serious Hypoglycemia|2
2213172|NCT01676220|3854522|FG001|Overall Study|Non Serious Hypoglycemia|0
2213173|NCT01676220|3854521|FG000|Overall Study|No More Need of Insulin|1
2213174|NCT01676220|3854522|FG001|Overall Study|No More Need of Insulin|0
2213175|NCT01676727|3854595|FG000|Overall Study|Death|18
2213176|NCT01676727|3854595|FG000|Overall Study|Withdrawal by Subject|6
2213177|NCT01676727|3854595|FG000|Overall Study|Screening failure|5
2213178|NCT01676727|3854595|FG000|Overall Study|Not willing to attend 1-year visit|2
2213179|NCT01676727|3854595|FG000|Overall Study|Valve explanted|1
2213180|NCT01676896|3854612|FG000|Overall Study|Withdrawal by Subject|12
1977982|NCT03721276|3541025|FG000|Overall Study|Lost to Follow-up|5
1977983|NCT03721276|3541026|FG001|Overall Study|Lost to Follow-up|3
1977984|NCT03721276|3541025|FG000|Overall Study|Adverse Event|0
1977985|NCT03721276|3541026|FG001|Overall Study|Adverse Event|1
1977986|NCT03637491|3541049|FG000|Overall Study|Death|9
1977987|NCT03637491|3541050|FG001|Overall Study|Death|9
1977988|NCT03637491|3541051|FG002|Overall Study|Death|5
1977989|NCT03637491|3541052|FG003|Overall Study|Death|3
1977990|NCT03637491|3541049|FG000|Overall Study|Lost to Follow-up|0
1977991|NCT03637491|3541050|FG001|Overall Study|Lost to Follow-up|1
1977992|NCT03637491|3541051|FG002|Overall Study|Lost to Follow-up|0
1977993|NCT03637491|3541052|FG003|Overall Study|Lost to Follow-up|1
1977994|NCT03637491|3541049|FG000|Overall Study|Study Terminated By Sponsor|0
1977995|NCT03637491|3541050|FG001|Overall Study|Study Terminated By Sponsor|2
1977996|NCT03637491|3541051|FG002|Overall Study|Study Terminated By Sponsor|1
1977997|NCT03637491|3541052|FG003|Overall Study|Study Terminated By Sponsor|0
1977998|NCT03637491|3541049|FG000|Overall Study|Withdrawal by Subject|1
1977999|NCT03637491|3541050|FG001|Overall Study|Withdrawal by Subject|0
1978000|NCT03637491|3541051|FG002|Overall Study|Withdrawal by Subject|1
1978001|NCT03637491|3541052|FG003|Overall Study|Withdrawal by Subject|2
1978002|NCT03334539|3541147|FG000|Overall Study|Adverse Event|3
1978003|NCT03334539|3541148|FG001|Overall Study|Adverse Event|5
1978004|NCT03334539|3541149|FG002|Overall Study|Adverse Event|0
1978005|NCT03334539|3541147|FG000|Overall Study|Withdrawal by Subject|0
1978006|NCT03334539|3541148|FG001|Overall Study|Withdrawal by Subject|1
1978007|NCT03334539|3541149|FG002|Overall Study|Withdrawal by Subject|1
1978008|NCT03334539|3541147|FG000|Overall Study|Administrative Reasons|1
1978009|NCT03334539|3541148|FG001|Overall Study|Administrative Reasons|0
1978010|NCT03334539|3541149|FG002|Overall Study|Administrative Reasons|0
1978011|NCT03334539|3541147|FG000|Overall Study|Hypertension Not Controlled|0
1978012|NCT03334539|3541148|FG001|Overall Study|Hypertension Not Controlled|1
1978013|NCT03334539|3541149|FG002|Overall Study|Hypertension Not Controlled|0
1978014|NCT03269344|3541171|FG000|Overall Study|Protocol Violation|4
1978015|NCT03269344|3541172|FG001|Overall Study|Protocol Violation|3
1978016|NCT03076775|3541186|FG000|Overall Study|Lost to Follow-up|1
1978017|NCT03076775|3541187|FG001|Overall Study|Lost to Follow-up|0
1978031|NCT02496676|3541250|FG001|Phase 2 - IV MgSO4|Adverse Event|1
1978032|NCT02425644|3541266|FG000|Overall Study|Lost to Follow-up|2
1978033|NCT02425644|3541267|FG001|Overall Study|Lost to Follow-up|3
1978034|NCT02425644|3541266|FG000|Overall Study|Withdrawal by Subject|41
1978035|NCT02425644|3541267|FG001|Overall Study|Withdrawal by Subject|36
1978036|NCT02425644|3541266|FG000|Overall Study|Lack of Efficacy|3
1978037|NCT02425644|3541267|FG001|Overall Study|Lack of Efficacy|10
1978038|NCT02425644|3541266|FG000|Overall Study|Adverse Event|13
1978039|NCT02425644|3541267|FG001|Overall Study|Adverse Event|3
1978040|NCT02425644|3541266|FG000|Overall Study|Death|0
1978041|NCT02425644|3541267|FG001|Overall Study|Death|2
1978042|NCT02425644|3541266|FG000|Overall Study|Other|18
1978043|NCT02425644|3541267|FG001|Overall Study|Other|17
1978044|NCT02340221|3541280|FG000|Overall Study|Death|58
1978045|NCT02340221|3541281|FG001|Overall Study|Death|101
1978046|NCT02340221|3541280|FG000|Overall Study|Withdrawal by Participant|14
1978047|NCT02340221|3541281|FG001|Overall Study|Withdrawal by Participant|22
1978048|NCT02340221|3541280|FG000|Overall Study|Lost to Follow-up|2
1978049|NCT02340221|3541281|FG001|Overall Study|Lost to Follow-up|3
1978050|NCT02340221|3541280|FG000|Overall Study|Reason Not Specified|0
1978051|NCT02340221|3541281|FG001|Overall Study|Reason Not Specified|1
1978052|NCT02340221|3541280|FG000|Overall Study|Continued on study|140
1978053|NCT02340221|3541281|FG001|Overall Study|Continued on study|290
1978054|NCT02270957|3541290|FG000|Overall Study|Lack of Efficacy|2
1978055|NCT02270957|3541291|FG001|Overall Study|Lack of Efficacy|4
1978056|NCT02270957|3541290|FG000|Overall Study|Adverse Event|2
1978057|NCT02270957|3541291|FG001|Overall Study|Adverse Event|0
1978058|NCT02134925|3541300|FG000|Overall Study|Withdrawal by Subject|1
1978059|NCT02134925|3541301|FG001|Overall Study|Withdrawal by Subject|0
1978060|NCT02134925|3541300|FG000|Overall Study|Cancel|1
1978061|NCT02134925|3541301|FG001|Overall Study|Cancel|6
1978062|NCT02054104|3541309|FG000|Overall Study|Did not want to continue due to college classes|1
1978063|NCT02054104|3541310|FG001|Overall Study|Did not want to continue due to college classes|0
1978064|NCT02054104|3541309|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1
1978065|NCT02054104|3541310|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0
1978066|NCT02054104|3541309|FG000|Overall Study|No evidence of immunologic response|2
1978067|NCT02054104|3541310|FG001|Overall Study|No evidence of immunologic response|2
1978068|NCT02054104|3541309|FG000|Overall Study|Disease Progression On Study|4
1978069|NCT02054104|3541310|FG001|Overall Study|Disease Progression On Study|5
1978070|NCT02054104|3541309|FG000|Overall Study|Diagnosis of lymphoma|0
1978071|NCT02054104|3541310|FG001|Overall Study|Diagnosis of lymphoma|1
1978072|NCT02054104|3541309|FG000|Overall Study|Inconclusive response|0
1978073|NCT02054104|3541310|FG001|Overall Study|Inconclusive response|1
1978074|NCT01899144|3541316|FG000|Treatment Period 2|Other|1
1978075|NCT01899144|3541316|FG000|Treatment Period 3|Other|2
1978076|NCT01899144|3541316|FG000|Treatment Period 5|Other|1
1978077|NCT01793610|3541331|FG000|Overall Study|Withdrawal by Subject|1
1978078|NCT01793610|3541332|FG001|Overall Study|Withdrawal by Subject|0
1978079|NCT01793610|3541333|FG002|Overall Study|Withdrawal by Subject|1
1978080|NCT01757665|3541347|FG000|Overall Study|Still on Study - Visit Completed|240
1978081|NCT01757665|3541348|FG001|Overall Study|Still on Study - Visit Completed|30
1978082|NCT01757665|3541347|FG000|Overall Study|Still on Study - Visit Pending|398
1978083|NCT01757665|3541348|FG001|Overall Study|Still on Study - Visit Pending|40
1978084|NCT01757665|3541347|FG000|Overall Study|Still on Study - Missed Visit|14
1978085|NCT01757665|3541348|FG001|Overall Study|Still on Study - Missed Visit|1
1978086|NCT01757665|3541347|FG000|Overall Study|Death|25
1978087|NCT01757665|3541348|FG001|Overall Study|Death|8
1978088|NCT01757665|3541347|FG000|Overall Study|Explant|1
1978089|NCT01757665|3541348|FG001|Overall Study|Explant|2
1978090|NCT01757665|3541347|FG000|Overall Study|Withdrawal by Subject|10
1978091|NCT01757665|3541348|FG001|Overall Study|Withdrawal by Subject|0
1978092|NCT01757665|3541347|FG000|Overall Study|Lost to Follow-up|1
1978093|NCT01757665|3541348|FG001|Overall Study|Lost to Follow-up|1
1978094|NCT01757665|3541347|FG000|Overall Study|Not Implanted with Device|5
1978095|NCT01757665|3541348|FG001|Overall Study|Not Implanted with Device|1
1978096|NCT00822120|3541389|FG000|Initial Registration|Adverse Event|1
1978097|NCT00822120|3541390|FG001|Initial Registration|Adverse Event|0
1978098|NCT00822120|3541391|FG002|Initial Registration|Adverse Event|0
1978099|NCT00822120|3541392|FG003|Initial Registration|Adverse Event|0
1978100|NCT00822120|3541393|FG004|Initial Registration|Adverse Event|0
1978101|NCT00822120|3541394|FG005|Initial Registration|Adverse Event|0
1978102|NCT00822120|3541389|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1
1978103|NCT00822120|3541390|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
1978104|NCT00822120|3541391|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0
1978105|NCT00822120|3541392|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0
1978106|NCT00822120|3541393|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0
1978107|NCT00822120|3541394|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0
1978108|NCT00822120|3541389|FG000|Initial Registration|Reasons not Protocol Specified|2
1978109|NCT00822120|3541390|FG001|Initial Registration|Reasons not Protocol Specified|0
1978110|NCT00822120|3541391|FG002|Initial Registration|Reasons not Protocol Specified|0
1978111|NCT00822120|3541392|FG003|Initial Registration|Reasons not Protocol Specified|0
1978112|NCT00822120|3541393|FG004|Initial Registration|Reasons not Protocol Specified|0
1978113|NCT00822120|3541394|FG005|Initial Registration|Reasons not Protocol Specified|0
1978114|NCT00822120|3541389|FG000|Initial Registration|Ineligible|22
1978115|NCT00822120|3541390|FG001|Initial Registration|Ineligible|1
1978116|NCT00822120|3541391|FG002|Initial Registration|Ineligible|0
1978117|NCT00822120|3541392|FG003|Initial Registration|Ineligible|0
1978118|NCT00822120|3541393|FG004|Initial Registration|Ineligible|0
1978119|NCT00822120|3541394|FG005|Initial Registration|Ineligible|0
1978120|NCT00822120|3541389|FG000|PET-directed Therapy|Adverse Event|0
1978121|NCT00822120|3541390|FG001|PET-directed Therapy|Adverse Event|0
1978122|NCT00822120|3541391|FG002|PET-directed Therapy|Adverse Event|0
1978123|NCT00822120|3541392|FG003|PET-directed Therapy|Adverse Event|1
1978124|NCT00822120|3541393|FG004|PET-directed Therapy|Adverse Event|0
1978125|NCT00822120|3541394|FG005|PET-directed Therapy|Adverse Event|0
1978126|NCT00822120|3541389|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1978127|NCT00822120|3541390|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1978128|NCT00822120|3541391|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1978129|NCT00822120|3541392|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
1978130|NCT00822120|3541393|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1978131|NCT00822120|3541394|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1978132|NCT00822120|3541389|FG000|PET-directed Therapy|Death|0
1978133|NCT00822120|3541390|FG001|PET-directed Therapy|Death|0
1978134|NCT00822120|3541391|FG002|PET-directed Therapy|Death|0
1978135|NCT00822120|3541392|FG003|PET-directed Therapy|Death|2
1978136|NCT00822120|3541393|FG004|PET-directed Therapy|Death|0
1978137|NCT00822120|3541394|FG005|PET-directed Therapy|Death|0
1978138|NCT00822120|3541389|FG000|PET-directed Therapy|Protocol Violation|0
1978139|NCT00822120|3541390|FG001|PET-directed Therapy|Protocol Violation|0
1978140|NCT00822120|3541391|FG002|PET-directed Therapy|Protocol Violation|0
1978141|NCT00822120|3541392|FG003|PET-directed Therapy|Protocol Violation|6
1978142|NCT00822120|3541393|FG004|PET-directed Therapy|Protocol Violation|0
1978143|NCT00822120|3541394|FG005|PET-directed Therapy|Protocol Violation|0
2022890|NCT00321737|3590755|FG002|Overall Study|Relapse of Erosive Esophagitis|19
2022891|NCT00321737|3590753|FG000|Overall Study|Adverse Event|11
2022892|NCT00321737|3590754|FG001|Overall Study|Adverse Event|3
2022893|NCT00321737|3590755|FG002|Overall Study|Adverse Event|6
2022894|NCT00321737|3590753|FG000|Overall Study|Lost to Follow-up|5
2022895|NCT00321737|3590754|FG001|Overall Study|Lost to Follow-up|5
2022896|NCT00321737|3590755|FG002|Overall Study|Lost to Follow-up|6
2022897|NCT00321737|3590753|FG000|Overall Study|Withdrawal by Subject|19
2022898|NCT00321737|3590754|FG001|Overall Study|Withdrawal by Subject|12
2022899|NCT00321737|3590755|FG002|Overall Study|Withdrawal by Subject|17
2022900|NCT00321737|3590753|FG000|Overall Study|Protocol Violation|0
2022901|NCT00321737|3590754|FG001|Overall Study|Protocol Violation|0
2022902|NCT00321737|3590755|FG002|Overall Study|Protocol Violation|1
2022903|NCT00321737|3590753|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1
2022904|NCT00321737|3590754|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1978144|NCT00603954|3541417|FG000|Overall Study|Protocol Violation|1
1978145|NCT00603954|3541418|FG001|Overall Study|Protocol Violation|2
1978146|NCT04532294|3541432|FG000|Overall Study|Withdrawal by Subject|0
1978147|NCT04532294|3541433|FG001|Overall Study|Withdrawal by Subject|0
1978148|NCT04532294|3541434|FG002|Overall Study|Withdrawal by Subject|1
1978149|NCT04532294|3541432|FG000|Overall Study|Participants Not Dosed|0
1978150|NCT04532294|3541433|FG001|Overall Study|Participants Not Dosed|0
1978151|NCT04532294|3541434|FG002|Overall Study|Participants Not Dosed|2
1978152|NCT04250077|3541447|FG000|Overall Study|Withdrawal by Subject|0
1978153|NCT04250077|3541448|FG001|Overall Study|Withdrawal by Subject|1
1978154|NCT04250077|3541449|FG002|Overall Study|Withdrawal by Subject|0
1978155|NCT04250077|3541447|FG000|Overall Study|Lost to Follow-up|2
1978156|NCT04250077|3541448|FG001|Overall Study|Lost to Follow-up|3
1978157|NCT04250077|3541449|FG002|Overall Study|Lost to Follow-up|0
1978158|NCT03441360|3541503|FG000|Overall Study|Radiological disease progression|5
1978159|NCT03441360|3541504|FG001|Overall Study|Radiological disease progression|6
1978160|NCT03441360|3541505|FG002|Overall Study|Radiological disease progression|4
1978161|NCT03441360|3541503|FG000|Overall Study|Clinical disease progression|2
1978162|NCT03441360|3541504|FG001|Overall Study|Clinical disease progression|2
1978163|NCT03441360|3541505|FG002|Overall Study|Clinical disease progression|0
1978164|NCT03441360|3541503|FG000|Overall Study|Adverse Event|1
1978165|NCT03441360|3541504|FG001|Overall Study|Adverse Event|0
1978166|NCT03441360|3541505|FG002|Overall Study|Adverse Event|1
2022905|NCT00321737|3590755|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0
2022906|NCT00321737|3590753|FG000|Overall Study|Possible Barrett's Esophagus|2
2022907|NCT00321737|3590754|FG001|Overall Study|Possible Barrett's Esophagus|1
2022908|NCT00321737|3590755|FG002|Overall Study|Possible Barrett's Esophagus|1
2022909|NCT00321737|3590753|FG000|Overall Study|Therapeutic Failure|6
2022910|NCT00321737|3590754|FG001|Overall Study|Therapeutic Failure|0
2022911|NCT00321737|3590755|FG002|Overall Study|Therapeutic Failure|2
2022912|NCT00321737|3590753|FG000|Overall Study|Pregnancy|0
2022913|NCT00321737|3590754|FG001|Overall Study|Pregnancy|2
2022914|NCT00321737|3590755|FG002|Overall Study|Pregnancy|0
2022915|NCT00321737|3590753|FG000|Overall Study|Noncompliance|2
2022916|NCT00321737|3590754|FG001|Overall Study|Noncompliance|0
2022917|NCT00321737|3590755|FG002|Overall Study|Noncompliance|0
2022918|NCT00321737|3590753|FG000|Overall Study|Subject Request/ Subject Unavailable|0
2022919|NCT00321737|3590754|FG001|Overall Study|Subject Request/ Subject Unavailable|0
2022920|NCT00321737|3590755|FG002|Overall Study|Subject Request/ Subject Unavailable|2
2022921|NCT00321763|3590767|FG000|Overall Study|Adverse Event|1
2022922|NCT00321763|3590768|FG001|Overall Study|Adverse Event|1
2022923|NCT00321763|3590769|FG002|Overall Study|Adverse Event|0
2022924|NCT00321763|3590770|FG003|Overall Study|Adverse Event|1
2022925|NCT00321763|3590767|FG000|Overall Study|Withdrawal by Subject|2
2022926|NCT00321763|3590768|FG001|Overall Study|Withdrawal by Subject|0
2022927|NCT00321763|3590769|FG002|Overall Study|Withdrawal by Subject|1
2022928|NCT00321763|3590770|FG003|Overall Study|Withdrawal by Subject|0
2022929|NCT00321763|3590767|FG000|Overall Study|Lost to Follow-up|3
2022930|NCT00321763|3590768|FG001|Overall Study|Lost to Follow-up|1
2022931|NCT00321763|3590769|FG002|Overall Study|Lost to Follow-up|5
2022932|NCT00321763|3590770|FG003|Overall Study|Lost to Follow-up|4
2022933|NCT00321789|3590784|FG000|Overall Study|Lost to Follow-up|4
2022934|NCT00321789|3590785|FG001|Overall Study|Lost to Follow-up|7
2022935|NCT00321789|3590784|FG000|Overall Study|Withdrawal by Subject|6
2022936|NCT00321789|3590785|FG001|Overall Study|Withdrawal by Subject|6
2022937|NCT00321789|3590784|FG000|Overall Study|Protocol Violation|5
2022938|NCT00321789|3590785|FG001|Overall Study|Protocol Violation|3
2022939|NCT00321828|3590791|FG000|Overall Study|Ineligible|3
2022940|NCT00321828|3590791|FG000|Overall Study|No follow up data|1
2022941|NCT00321854|3590797|FG000|Overall Study|Adverse Event|41
2022942|NCT00321854|3590798|FG001|Overall Study|Adverse Event|43
2022943|NCT00321854|3590797|FG000|Overall Study|Lack of Efficacy|9
2022944|NCT00321854|3590798|FG001|Overall Study|Lack of Efficacy|14
2022945|NCT00321854|3590797|FG000|Overall Study|Protocol Violation|6
2022946|NCT00321854|3590798|FG001|Overall Study|Protocol Violation|5
2022947|NCT00321854|3590797|FG000|Overall Study|Lost to Follow-up|0
2022948|NCT00321854|3590798|FG001|Overall Study|Lost to Follow-up|2
2022949|NCT00321854|3590797|FG000|Overall Study|Withdrawal by Subject|6
2022950|NCT00321854|3590798|FG001|Overall Study|Withdrawal by Subject|17
2022951|NCT00321854|3590797|FG000|Overall Study|Other|1
2022952|NCT00321854|3590798|FG001|Overall Study|Other|1
2022953|NCT00321893|3590808|FG000|Overall Study|Non-Compliance/Refusal|16
2022954|NCT00321893|3590809|FG001|Overall Study|Non-Compliance/Refusal|10
2022955|NCT00321893|3590808|FG000|Overall Study|Lost to Follow-up|2
2022956|NCT00321893|3590809|FG001|Overall Study|Lost to Follow-up|1
2022957|NCT00321893|3590808|FG000|Overall Study|Adverse Event|6
2022958|NCT00321893|3590809|FG001|Overall Study|Adverse Event|3
2022959|NCT00321906|3590817|FG000|Overall Study|Adverse Event|36
2022960|NCT00321906|3590818|FG001|Overall Study|Adverse Event|44
2022961|NCT00321906|3590817|FG000|Overall Study|Death|9
2022962|NCT00321906|3590818|FG001|Overall Study|Death|6
2022963|NCT00321906|3590817|FG000|Overall Study|Lost to Follow-up|1
2022964|NCT00321906|3590818|FG001|Overall Study|Lost to Follow-up|2
2022965|NCT00321906|3590817|FG000|Overall Study|Withdrawal by Subject|0
2022966|NCT00321906|3590818|FG001|Overall Study|Withdrawal by Subject|4
1978167|NCT03412565|3541517|FG000|Overall Study|Other|0
1978168|NCT03412565|3541518|FG001|Overall Study|Other|0
1978169|NCT03412565|3541519|FG002|Overall Study|Other|0
1978170|NCT03412565|3541520|FG003|Overall Study|Other|3
1978171|NCT03412565|3541517|FG000|Overall Study|Withdrawal by Subject|0
1978172|NCT03412565|3541518|FG001|Overall Study|Withdrawal by Subject|0
1978173|NCT03412565|3541519|FG002|Overall Study|Withdrawal by Subject|1
1978174|NCT03412565|3541520|FG003|Overall Study|Withdrawal by Subject|5
1978175|NCT03412565|3541517|FG000|Overall Study|Physician Decision|0
1978176|NCT03412565|3541518|FG001|Overall Study|Physician Decision|1
1978177|NCT03412565|3541519|FG002|Overall Study|Physician Decision|0
1978178|NCT03412565|3541520|FG003|Overall Study|Physician Decision|1
1978179|NCT03412565|3541517|FG000|Overall Study|Death|1
1978180|NCT03412565|3541518|FG001|Overall Study|Death|2
1978181|NCT03412565|3541519|FG002|Overall Study|Death|2
1978182|NCT03412565|3541520|FG003|Overall Study|Death|4
1978183|NCT03412565|3541517|FG000|Overall Study|Still ongoing|0
1978184|NCT03412565|3541518|FG001|Overall Study|Still ongoing|62
1978185|NCT03412565|3541519|FG002|Overall Study|Still ongoing|59
1978186|NCT03412565|3541520|FG003|Overall Study|Still ongoing|41
1978187|NCT03296553|3541537|FG000|Overall Study|Withdrawal by Subject|1
1978188|NCT03296553|3541538|FG001|Overall Study|Withdrawal by Subject|1
1978189|NCT03296553|3541537|FG000|Overall Study|Death|1
1978190|NCT03296553|3541538|FG001|Overall Study|Death|0
2102198|NCT00838110|3694004|FG003|Overall Study|Adverse Event|7
2102199|NCT00838110|3694001|FG000|Overall Study|Withdrawal by Subject|5
2102200|NCT00838110|3694002|FG001|Overall Study|Withdrawal by Subject|6
2102201|NCT00838110|3694003|FG002|Overall Study|Withdrawal by Subject|3
2102202|NCT00838110|3694004|FG003|Overall Study|Withdrawal by Subject|4
2102203|NCT00838110|3694001|FG000|Overall Study|Other|3
2102204|NCT00838110|3694002|FG001|Overall Study|Other|3
2102205|NCT00838110|3694003|FG002|Overall Study|Other|3
2102206|NCT00838110|3694004|FG003|Overall Study|Other|2
2102207|NCT00838110|3694001|FG000|Overall Study|Protocol Violation|0
2102208|NCT00838110|3694002|FG001|Overall Study|Protocol Violation|2
2102209|NCT00838110|3694003|FG002|Overall Study|Protocol Violation|1
2102210|NCT00838110|3694004|FG003|Overall Study|Protocol Violation|1
2102211|NCT00838110|3694001|FG000|Overall Study|Lost to Follow-up|3
2102212|NCT00838110|3694002|FG001|Overall Study|Lost to Follow-up|0
2102213|NCT00838110|3694003|FG002|Overall Study|Lost to Follow-up|0
2102214|NCT00838110|3694004|FG003|Overall Study|Lost to Follow-up|0
2102215|NCT00838110|3694001|FG000|Overall Study|Did not meet eligibility criteria|0
2102216|NCT00838110|3694002|FG001|Overall Study|Did not meet eligibility criteria|0
2102217|NCT00838110|3694003|FG002|Overall Study|Did not meet eligibility criteria|1
2102218|NCT00838110|3694004|FG003|Overall Study|Did not meet eligibility criteria|2
1978213|NCT03194646|3541569|FG000|Overall Study|Adverse Event|24
1978214|NCT03194646|3541570|FG001|Overall Study|Adverse Event|25
1978215|NCT03194646|3541571|FG002|Overall Study|Adverse Event|14
1978216|NCT03194646|3541572|FG003|Overall Study|Adverse Event|17
1978217|NCT03194646|3541569|FG000|Overall Study|Lack of Efficacy|4
1978218|NCT03194646|3541570|FG001|Overall Study|Lack of Efficacy|2
1978219|NCT03194646|3541571|FG002|Overall Study|Lack of Efficacy|2
1978220|NCT03194646|3541572|FG003|Overall Study|Lack of Efficacy|12
1978221|NCT03194646|3541569|FG000|Overall Study|Lost to Follow-up|30
1978222|NCT03194646|3541570|FG001|Overall Study|Lost to Follow-up|22
1978223|NCT03194646|3541571|FG002|Overall Study|Lost to Follow-up|12
1978224|NCT03194646|3541572|FG003|Overall Study|Lost to Follow-up|35
1978225|NCT03194646|3541569|FG000|Overall Study|Non-compliance with study drug|4
1978226|NCT03194646|3541570|FG001|Overall Study|Non-compliance with study drug|0
1978227|NCT03194646|3541571|FG002|Overall Study|Non-compliance with study drug|1
1978228|NCT03194646|3541572|FG003|Overall Study|Non-compliance with study drug|1
1978229|NCT03194646|3541569|FG000|Overall Study|Other|87
1978230|NCT03194646|3541570|FG001|Overall Study|Other|67
1978231|NCT03194646|3541571|FG002|Overall Study|Other|34
1978232|NCT03194646|3541572|FG003|Overall Study|Other|31
1978233|NCT03194646|3541569|FG000|Overall Study|Physician Decision|7
1978234|NCT03194646|3541570|FG001|Overall Study|Physician Decision|9
1978235|NCT03194646|3541571|FG002|Overall Study|Physician Decision|5
1978236|NCT03194646|3541572|FG003|Overall Study|Physician Decision|4
1978237|NCT03194646|3541569|FG000|Overall Study|Pregnancy|4
1978238|NCT03194646|3541570|FG001|Overall Study|Pregnancy|5
1978239|NCT03194646|3541571|FG002|Overall Study|Pregnancy|1
1978240|NCT03194646|3541572|FG003|Overall Study|Pregnancy|2
1978241|NCT03194646|3541569|FG000|Overall Study|Protocol Violation|4
1978242|NCT03194646|3541570|FG001|Overall Study|Protocol Violation|2
1978243|NCT03194646|3541571|FG002|Overall Study|Protocol Violation|1
1978244|NCT03194646|3541572|FG003|Overall Study|Protocol Violation|1
1978245|NCT03194646|3541569|FG000|Overall Study|Site terminated by sponsor|0
1978246|NCT03194646|3541570|FG001|Overall Study|Site terminated by sponsor|0
1978247|NCT03194646|3541571|FG002|Overall Study|Site terminated by sponsor|2
1978248|NCT03194646|3541572|FG003|Overall Study|Site terminated by sponsor|0
1978249|NCT03194646|3541569|FG000|Overall Study|Study terminated by sponsor|60
1978250|NCT03194646|3541570|FG001|Overall Study|Study terminated by sponsor|61
1978251|NCT03194646|3541571|FG002|Overall Study|Study terminated by sponsor|30
1978252|NCT03194646|3541572|FG003|Overall Study|Study terminated by sponsor|34
1978253|NCT03194646|3541569|FG000|Overall Study|Withdrawal by Subject|74
1978254|NCT03194646|3541570|FG001|Overall Study|Withdrawal by Subject|75
1978255|NCT03194646|3541571|FG002|Overall Study|Withdrawal by Subject|36
1978256|NCT03194646|3541572|FG003|Overall Study|Withdrawal by Subject|131
1978257|NCT03194646|3541569|FG000|Overall Study|Missing|4
1978258|NCT03194646|3541570|FG001|Overall Study|Missing|0
1978259|NCT03194646|3541571|FG002|Overall Study|Missing|1
1978260|NCT03194646|3541572|FG003|Overall Study|Missing|12
1978261|NCT03148795|3541587|FG000|Overall Study|Death|6
1978262|NCT03148795|3541587|FG000|Overall Study|Adverse Event|5
1978263|NCT03148795|3541587|FG000|Overall Study|Other|15
1978264|NCT03148795|3541587|FG000|Overall Study|No Longer Clinically Benefitting|2
1978265|NCT03148795|3541587|FG000|Overall Study|Global Deterioration Of Health Status|6
1978266|NCT03148795|3541587|FG000|Overall Study|Withdrawal by Subject|2
1978267|NCT03148795|3541587|FG000|Overall Study|Progressive Disease|62
1978268|NCT03148795|3541587|FG000|Overall Study|Ongoing|30
1978269|NCT03052608|3541606|FG000|Treatment Phase|Adverse Event|10
1978270|NCT03052608|3541607|FG001|Treatment Phase|Adverse Event|12
1978271|NCT03052608|3541606|FG000|Treatment Phase|Death|6
1978272|NCT03052608|3541607|FG001|Treatment Phase|Death|4
1978273|NCT03052608|3541606|FG000|Treatment Phase|Withdrawal by Subject|4
1978274|NCT03052608|3541607|FG001|Treatment Phase|Withdrawal by Subject|12
1978275|NCT03052608|3541606|FG000|Treatment Phase|Global Deterioration of Health Status|0
1978276|NCT03052608|3541607|FG001|Treatment Phase|Global Deterioration of Health Status|3
1978277|NCT03052608|3541606|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0
1978278|NCT03052608|3541607|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1
1978279|NCT03052608|3541606|FG000|Treatment Phase|Subject didn't receive study treatment.|0
1978280|NCT03052608|3541607|FG001|Treatment Phase|Subject didn't receive study treatment.|1
1978281|NCT03052608|3541606|FG000|Treatment Phase|Ongoing|103
1978282|NCT03052608|3541607|FG001|Treatment Phase|Ongoing|31
1978283|NCT03052608|3541606|FG000|Long-Term Follow-up Phase|Death|23
1978284|NCT03052608|3541607|FG001|Long-Term Follow-up Phase|Death|28
1978285|NCT03052608|3541606|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0
1978286|NCT03052608|3541607|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2
1978287|NCT03052608|3541606|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4
1978288|NCT03052608|3541607|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18
1978289|NCT03052608|3541606|FG000|Long-Term Follow-up Phase|Ongoing|122
1978290|NCT03052608|3541607|FG001|Long-Term Follow-up Phase|Ongoing|99
1978291|NCT03038438|3541613|FG000|Overall Study|Death|2
1978292|NCT03038438|3541613|FG000|Overall Study|Lost to Follow-up|4
1978293|NCT03038438|3541613|FG000|Overall Study|Subject Incarceration|1
1978294|NCT03038438|3541613|FG000|Overall Study|Withdrawal by Subject|2
1978295|NCT03038438|3541613|FG000|Overall Study|No 24-Month Follow-Up|43
1978296|NCT03000569|3541619|FG000|Overall Study|Withdrawal by Subject|1
1978297|NCT03000569|3541620|FG001|Overall Study|Withdrawal by Subject|0
1978298|NCT03000530|3541637|FG000|Overall Study|Adverse Event|0
1978299|NCT03000530|3541638|FG001|Overall Study|Adverse Event|0
1978300|NCT03000530|3541639|FG002|Overall Study|Adverse Event|2
1978301|NCT03000530|3541637|FG000|Overall Study|Lost to Follow-up|0
1978302|NCT03000530|3541638|FG001|Overall Study|Lost to Follow-up|3
1978303|NCT03000530|3541639|FG002|Overall Study|Lost to Follow-up|1
1978304|NCT03000530|3541637|FG000|Overall Study|Withdrawal by Subject|0
1978305|NCT03000530|3541638|FG001|Overall Study|Withdrawal by Subject|2
1978306|NCT03000530|3541639|FG002|Overall Study|Withdrawal by Subject|1
1978307|NCT02978781|3541653|FG000|Part A|Adverse Event|1
1978308|NCT02978781|3541654|FG001|Part A|Adverse Event|1
1978309|NCT02978781|3541655|FG002|Part A|Adverse Event|0
1978310|NCT02978781|3541656|FG003|Part A|Adverse Event|0
1978311|NCT02978781|3541657|FG004|Part A|Adverse Event|0
1978312|NCT02978781|3541653|FG000|Part A|Withdrawal by Subject|0
1978313|NCT02978781|3541654|FG001|Part A|Withdrawal by Subject|1
1978314|NCT02978781|3541655|FG002|Part A|Withdrawal by Subject|0
1978315|NCT02978781|3541656|FG003|Part A|Withdrawal by Subject|0
1978316|NCT02978781|3541657|FG004|Part A|Withdrawal by Subject|0
1978317|NCT02978781|3541653|FG000|Part B|Withdrawal by Subject|0
1978318|NCT02978781|3541654|FG001|Part B|Withdrawal by Subject|0
1978319|NCT02978781|3541655|FG002|Part B|Withdrawal by Subject|0
1978320|NCT02978781|3541656|FG003|Part B|Withdrawal by Subject|1
1978321|NCT02978781|3541657|FG004|Part B|Withdrawal by Subject|0
1978322|NCT02978781|3541653|FG000|Part C|Adverse Event|0
1978323|NCT02978781|3541654|FG001|Part C|Adverse Event|0
1978324|NCT02978781|3541655|FG002|Part C|Adverse Event|0
1978325|NCT02978781|3541656|FG003|Part C|Adverse Event|0
1978326|NCT02978781|3541657|FG004|Part C|Adverse Event|2
1978327|NCT02978781|3541653|FG000|Part C|Withdrawal by Subject|0
1978328|NCT02978781|3541654|FG001|Part C|Withdrawal by Subject|0
1978329|NCT02978781|3541655|FG002|Part C|Withdrawal by Subject|0
1978330|NCT02978781|3541656|FG003|Part C|Withdrawal by Subject|0
1978331|NCT02978781|3541657|FG004|Part C|Withdrawal by Subject|1
1978332|NCT02978781|3541653|FG000|Part C|Tremor not improved due to Topamax discontinuation|0
1978333|NCT02978781|3541654|FG001|Part C|Tremor not improved due to Topamax discontinuation|0
1978334|NCT02978781|3541655|FG002|Part C|Tremor not improved due to Topamax discontinuation|0
1978335|NCT02978781|3541656|FG003|Part C|Tremor not improved due to Topamax discontinuation|0
1978336|NCT02978781|3541657|FG004|Part C|Tremor not improved due to Topamax discontinuation|1
1978337|NCT02964507|3541691|FG000|Overall Study|Protocol specified Withdrawal criteria met|0
2022967|NCT00321919|3590826|FG000|Overall Study|Adverse Event|17
1978338|NCT02964507|3541692|FG001|Overall Study|Protocol specified Withdrawal criteria met|1
1978339|NCT02964507|3541693|FG002|Overall Study|Protocol specified Withdrawal criteria met|0
1978340|NCT02964507|3541694|FG003|Overall Study|Protocol specified Withdrawal criteria met|0
1978341|NCT02964507|3541695|FG004|Overall Study|Protocol specified Withdrawal criteria met|1
1978342|NCT02964507|3541696|FG005|Overall Study|Protocol specified Withdrawal criteria met|0
1978343|NCT02964507|3541697|FG006|Overall Study|Protocol specified Withdrawal criteria met|0
1978344|NCT02964507|3541698|FG007|Overall Study|Protocol specified Withdrawal criteria met|0
1978345|NCT02964507|3541691|FG000|Overall Study|Ongoing at the time of analysis|1
1978346|NCT02964507|3541692|FG001|Overall Study|Ongoing at the time of analysis|0
1978347|NCT02964507|3541693|FG002|Overall Study|Ongoing at the time of analysis|2
1978348|NCT02964507|3541694|FG003|Overall Study|Ongoing at the time of analysis|0
1978349|NCT02964507|3541695|FG004|Overall Study|Ongoing at the time of analysis|0
1978350|NCT02964507|3541696|FG005|Overall Study|Ongoing at the time of analysis|0
1978351|NCT02964507|3541697|FG006|Overall Study|Ongoing at the time of analysis|0
1978352|NCT02964507|3541698|FG007|Overall Study|Ongoing at the time of analysis|0
1978353|NCT02964507|3541691|FG000|Overall Study|Study terminated by Sponsor|9
1978354|NCT02964507|3541692|FG001|Overall Study|Study terminated by Sponsor|1
1978355|NCT02964507|3541693|FG002|Overall Study|Study terminated by Sponsor|9
1978356|NCT02964507|3541694|FG003|Overall Study|Study terminated by Sponsor|3
1978357|NCT02964507|3541695|FG004|Overall Study|Study terminated by Sponsor|3
1978358|NCT02964507|3541696|FG005|Overall Study|Study terminated by Sponsor|2
1978359|NCT02964507|3541697|FG006|Overall Study|Study terminated by Sponsor|0
1978360|NCT02964507|3541698|FG007|Overall Study|Study terminated by Sponsor|0
1978361|NCT02964507|3541691|FG000|Overall Study|Other|3
1978362|NCT02964507|3541692|FG001|Overall Study|Other|0
1978363|NCT02964507|3541693|FG002|Overall Study|Other|0
1978364|NCT02964507|3541694|FG003|Overall Study|Other|0
1978365|NCT02964507|3541695|FG004|Overall Study|Other|1
1978366|NCT02964507|3541696|FG005|Overall Study|Other|0
1978367|NCT02964507|3541697|FG006|Overall Study|Other|0
1978368|NCT02964507|3541698|FG007|Overall Study|Other|0
1978369|NCT02964507|3541691|FG000|Overall Study|Death|11
1978370|NCT02964507|3541692|FG001|Overall Study|Death|9
1978371|NCT02964507|3541693|FG002|Overall Study|Death|12
1978372|NCT02964507|3541694|FG003|Overall Study|Death|2
1978373|NCT02964507|3541695|FG004|Overall Study|Death|10
1978374|NCT02964507|3541696|FG005|Overall Study|Death|5
1978375|NCT02964507|3541697|FG006|Overall Study|Death|0
1978376|NCT02964507|3541698|FG007|Overall Study|Death|0
1978377|NCT02964507|3541691|FG000|Overall Study|Withdrawal by Subject|1
1978378|NCT02964507|3541692|FG001|Overall Study|Withdrawal by Subject|0
1978379|NCT02964507|3541693|FG002|Overall Study|Withdrawal by Subject|1
1978380|NCT02964507|3541694|FG003|Overall Study|Withdrawal by Subject|1
1978381|NCT02964507|3541695|FG004|Overall Study|Withdrawal by Subject|0
1978382|NCT02964507|3541696|FG005|Overall Study|Withdrawal by Subject|1
1978383|NCT02964507|3541697|FG006|Overall Study|Withdrawal by Subject|0
1978384|NCT02964507|3541698|FG007|Overall Study|Withdrawal by Subject|0
1978385|NCT02964507|3541691|FG000|Overall Study|Physician Decision|1
1978386|NCT02964507|3541692|FG001|Overall Study|Physician Decision|0
1978387|NCT02964507|3541693|FG002|Overall Study|Physician Decision|1
1978388|NCT02964507|3541694|FG003|Overall Study|Physician Decision|0
1978389|NCT02964507|3541695|FG004|Overall Study|Physician Decision|1
1978390|NCT02964507|3541696|FG005|Overall Study|Physician Decision|0
1978391|NCT02964507|3541697|FG006|Overall Study|Physician Decision|0
1978392|NCT02964507|3541698|FG007|Overall Study|Physician Decision|0
1978393|NCT02942277|3541732|FG000|Year 1|Withdrawal by Subject|0
1978394|NCT02942277|3541733|FG001|Year 1|Withdrawal by Subject|0
1978395|NCT02942277|3541734|FG002|Year 1|Withdrawal by Subject|0
1978396|NCT02942277|3541735|FG003|Year 1|Withdrawal by Subject|0
1978397|NCT02942277|3541736|FG004|Year 1|Withdrawal by Subject|1
1978398|NCT02942277|3541737|FG005|Year 1|Withdrawal by Subject|3
1978399|NCT02942277|3541738|FG006|Year 1|Withdrawal by Subject|0
1978400|NCT02942277|3541739|FG007|Year 1|Withdrawal by Subject|1
1978401|NCT02942277|3541740|FG008|Year 1|Withdrawal by Subject|0
1978402|NCT02942277|3541741|FG009|Year 1|Withdrawal by Subject|0
1978403|NCT02942277|3541742|FG010|Year 1|Withdrawal by Subject|3
1978404|NCT02942277|3541732|FG000|Year 1|Travel|0
1978405|NCT02942277|3541733|FG001|Year 1|Travel|1
1978406|NCT02942277|3541734|FG002|Year 1|Travel|0
1978407|NCT02942277|3541735|FG003|Year 1|Travel|0
1978408|NCT02942277|3541736|FG004|Year 1|Travel|4
1978409|NCT02942277|3541737|FG005|Year 1|Travel|5
1978410|NCT02942277|3541738|FG006|Year 1|Travel|0
1978411|NCT02942277|3541739|FG007|Year 1|Travel|0
1978412|NCT02942277|3541740|FG008|Year 1|Travel|0
1978413|NCT02942277|3541741|FG009|Year 1|Travel|0
1978414|NCT02942277|3541742|FG010|Year 1|Travel|8
1978415|NCT02942277|3541732|FG000|Year 1|Joined Army|0
1978416|NCT02942277|3541733|FG001|Year 1|Joined Army|1
1978417|NCT02942277|3541734|FG002|Year 1|Joined Army|0
1978418|NCT02942277|3541735|FG003|Year 1|Joined Army|0
1978419|NCT02942277|3541736|FG004|Year 1|Joined Army|0
1978420|NCT02942277|3541737|FG005|Year 1|Joined Army|0
1978421|NCT02942277|3541738|FG006|Year 1|Joined Army|0
1978422|NCT02942277|3541739|FG007|Year 1|Joined Army|0
1978423|NCT02942277|3541740|FG008|Year 1|Joined Army|0
1978424|NCT02942277|3541741|FG009|Year 1|Joined Army|0
1978425|NCT02942277|3541742|FG010|Year 1|Joined Army|0
1978426|NCT02942277|3541732|FG000|Year 1|Subject met withdrawal criteria|0
1978427|NCT02942277|3541733|FG001|Year 1|Subject met withdrawal criteria|0
1978428|NCT02942277|3541734|FG002|Year 1|Subject met withdrawal criteria|0
1978429|NCT02942277|3541735|FG003|Year 1|Subject met withdrawal criteria|1
1978430|NCT02942277|3541736|FG004|Year 1|Subject met withdrawal criteria|0
1978431|NCT02942277|3541737|FG005|Year 1|Subject met withdrawal criteria|0
1978432|NCT02942277|3541738|FG006|Year 1|Subject met withdrawal criteria|0
1978433|NCT02942277|3541739|FG007|Year 1|Subject met withdrawal criteria|0
1978434|NCT02942277|3541740|FG008|Year 1|Subject met withdrawal criteria|0
1978435|NCT02942277|3541741|FG009|Year 1|Subject met withdrawal criteria|0
1978436|NCT02942277|3541742|FG010|Year 1|Subject met withdrawal criteria|0
1978437|NCT02942277|3541732|FG000|Year 1|Lost to Follow-up|0
1978438|NCT02942277|3541733|FG001|Year 1|Lost to Follow-up|0
1978439|NCT02942277|3541734|FG002|Year 1|Lost to Follow-up|0
1978440|NCT02942277|3541735|FG003|Year 1|Lost to Follow-up|0
1978441|NCT02942277|3541736|FG004|Year 1|Lost to Follow-up|1
1978442|NCT02942277|3541737|FG005|Year 1|Lost to Follow-up|0
1978443|NCT02942277|3541738|FG006|Year 1|Lost to Follow-up|0
1978444|NCT02942277|3541739|FG007|Year 1|Lost to Follow-up|0
1978445|NCT02942277|3541740|FG008|Year 1|Lost to Follow-up|0
1978446|NCT02942277|3541741|FG009|Year 1|Lost to Follow-up|0
1978447|NCT02942277|3541742|FG010|Year 1|Lost to Follow-up|2
1978448|NCT02942277|3541732|FG000|Year 1|Protocol Violation|0
1978449|NCT02942277|3541733|FG001|Year 1|Protocol Violation|0
1978450|NCT02942277|3541734|FG002|Year 1|Protocol Violation|0
1978451|NCT02942277|3541735|FG003|Year 1|Protocol Violation|0
1978452|NCT02942277|3541736|FG004|Year 1|Protocol Violation|1
1978453|NCT02942277|3541737|FG005|Year 1|Protocol Violation|1
1978454|NCT02942277|3541738|FG006|Year 1|Protocol Violation|0
1978455|NCT02942277|3541739|FG007|Year 1|Protocol Violation|0
1978456|NCT02942277|3541740|FG008|Year 1|Protocol Violation|0
1978457|NCT02942277|3541741|FG009|Year 1|Protocol Violation|0
1978458|NCT02942277|3541742|FG010|Year 1|Protocol Violation|2
1978459|NCT02942277|3541732|FG000|Year 1|Pregnancy|0
1978460|NCT02942277|3541733|FG001|Year 1|Pregnancy|0
1978461|NCT02942277|3541734|FG002|Year 1|Pregnancy|0
1978462|NCT02942277|3541735|FG003|Year 1|Pregnancy|0
1978463|NCT02942277|3541736|FG004|Year 1|Pregnancy|0
1978464|NCT02942277|3541737|FG005|Year 1|Pregnancy|1
1978465|NCT02942277|3541738|FG006|Year 1|Pregnancy|0
1978466|NCT02942277|3541739|FG007|Year 1|Pregnancy|0
1978467|NCT02942277|3541740|FG008|Year 1|Pregnancy|0
1978468|NCT02942277|3541741|FG009|Year 1|Pregnancy|0
1978469|NCT02942277|3541742|FG010|Year 1|Pregnancy|0
1978470|NCT02942277|3541732|FG000|Year 2|Lost to Follow-up|0
1978471|NCT02942277|3541733|FG001|Year 2|Lost to Follow-up|0
1978472|NCT02942277|3541734|FG002|Year 2|Lost to Follow-up|0
1978473|NCT02942277|3541735|FG003|Year 2|Lost to Follow-up|0
1978474|NCT02942277|3541736|FG004|Year 2|Lost to Follow-up|2
1978475|NCT02942277|3541737|FG005|Year 2|Lost to Follow-up|1
1978476|NCT02942277|3541738|FG006|Year 2|Lost to Follow-up|0
1978477|NCT02942277|3541739|FG007|Year 2|Lost to Follow-up|0
1978478|NCT02942277|3541740|FG008|Year 2|Lost to Follow-up|0
1978479|NCT02942277|3541741|FG009|Year 2|Lost to Follow-up|0
1978480|NCT02942277|3541742|FG010|Year 2|Lost to Follow-up|0
1978481|NCT02942277|3541732|FG000|Year 2|Did not rescreen|0
1978482|NCT02942277|3541733|FG001|Year 2|Did not rescreen|0
1978483|NCT02942277|3541734|FG002|Year 2|Did not rescreen|1
1978484|NCT02942277|3541735|FG003|Year 2|Did not rescreen|1
1978485|NCT02942277|3541736|FG004|Year 2|Did not rescreen|9
1978486|NCT02942277|3541737|FG005|Year 2|Did not rescreen|6
1978487|NCT02942277|3541738|FG006|Year 2|Did not rescreen|0
1978488|NCT02942277|3541739|FG007|Year 2|Did not rescreen|1
1978489|NCT02942277|3541740|FG008|Year 2|Did not rescreen|0
1978490|NCT02942277|3541741|FG009|Year 2|Did not rescreen|0
1978491|NCT02942277|3541742|FG010|Year 2|Did not rescreen|21
1978492|NCT02942277|3541732|FG000|Year 2|Met withdrawal criteria|0
1978493|NCT02942277|3541733|FG001|Year 2|Met withdrawal criteria|0
1978494|NCT02942277|3541734|FG002|Year 2|Met withdrawal criteria|0
1978495|NCT02942277|3541735|FG003|Year 2|Met withdrawal criteria|0
1978496|NCT02942277|3541736|FG004|Year 2|Met withdrawal criteria|1
1978497|NCT02942277|3541737|FG005|Year 2|Met withdrawal criteria|2
1978498|NCT02942277|3541738|FG006|Year 2|Met withdrawal criteria|0
1978499|NCT02942277|3541739|FG007|Year 2|Met withdrawal criteria|0
1978500|NCT02942277|3541740|FG008|Year 2|Met withdrawal criteria|0
1978501|NCT02942277|3541741|FG009|Year 2|Met withdrawal criteria|0
1978502|NCT02942277|3541742|FG010|Year 2|Met withdrawal criteria|1
1978503|NCT02942277|3541732|FG000|Year 2|Travel|0
1978504|NCT02942277|3541733|FG001|Year 2|Travel|1
1978505|NCT02942277|3541734|FG002|Year 2|Travel|0
1978506|NCT02942277|3541735|FG003|Year 2|Travel|0
1978507|NCT02942277|3541736|FG004|Year 2|Travel|0
1978508|NCT02942277|3541737|FG005|Year 2|Travel|1
1978509|NCT02942277|3541738|FG006|Year 2|Travel|0
1978510|NCT02942277|3541739|FG007|Year 2|Travel|0
1978511|NCT02942277|3541740|FG008|Year 2|Travel|0
1978512|NCT02942277|3541741|FG009|Year 2|Travel|1
1978513|NCT02942277|3541742|FG010|Year 2|Travel|3
1978514|NCT02942277|3541732|FG000|Year 2|Non-compliant|0
1978515|NCT02942277|3541733|FG001|Year 2|Non-compliant|0
1978516|NCT02942277|3541734|FG002|Year 2|Non-compliant|0
1978517|NCT02942277|3541735|FG003|Year 2|Non-compliant|0
1978518|NCT02942277|3541736|FG004|Year 2|Non-compliant|1
1978519|NCT02942277|3541737|FG005|Year 2|Non-compliant|1
1978520|NCT02942277|3541738|FG006|Year 2|Non-compliant|0
1978521|NCT02942277|3541739|FG007|Year 2|Non-compliant|0
1978522|NCT02942277|3541740|FG008|Year 2|Non-compliant|0
1978523|NCT02942277|3541741|FG009|Year 2|Non-compliant|0
1978524|NCT02942277|3541742|FG010|Year 2|Non-compliant|0
1978525|NCT02942277|3541732|FG000|Year 2|Withdrawal by Subject|0
1978526|NCT02942277|3541733|FG001|Year 2|Withdrawal by Subject|0
1978527|NCT02942277|3541734|FG002|Year 2|Withdrawal by Subject|0
1978528|NCT02942277|3541735|FG003|Year 2|Withdrawal by Subject|0
1978529|NCT02942277|3541736|FG004|Year 2|Withdrawal by Subject|0
1978530|NCT02942277|3541737|FG005|Year 2|Withdrawal by Subject|0
1978531|NCT02942277|3541738|FG006|Year 2|Withdrawal by Subject|1
1978532|NCT02942277|3541739|FG007|Year 2|Withdrawal by Subject|0
1978533|NCT02942277|3541740|FG008|Year 2|Withdrawal by Subject|0
1978534|NCT02942277|3541741|FG009|Year 2|Withdrawal by Subject|0
1978535|NCT02942277|3541742|FG010|Year 2|Withdrawal by Subject|0
1978536|NCT02942017|3541771|FG000|Overall Study|Adverse Event|0
1978537|NCT02942017|3541772|FG001|Overall Study|Adverse Event|1
1978538|NCT02942017|3541771|FG000|Overall Study|Withdrawal by Subject|0
1978539|NCT02942017|3541772|FG001|Overall Study|Withdrawal by Subject|1
1978540|NCT02942017|3541771|FG000|Overall Study|Lost to Follow-up|1
1978541|NCT02942017|3541772|FG001|Overall Study|Lost to Follow-up|1
1978542|NCT02942017|3541771|FG000|Overall Study|Randomized but not dosed|1
1978543|NCT02942017|3541772|FG001|Overall Study|Randomized but not dosed|3
1978544|NCT02942004|3541781|FG000|Overall Study|Withdrawal by Subject|0
1978545|NCT02942004|3541782|FG001|Overall Study|Withdrawal by Subject|2
1978546|NCT02942004|3541783|FG002|Overall Study|Withdrawal by Subject|3
1978547|NCT02942004|3541781|FG000|Overall Study|Lost to Follow-up|1
1978548|NCT02942004|3541782|FG001|Overall Study|Lost to Follow-up|1
1978549|NCT02942004|3541783|FG002|Overall Study|Lost to Follow-up|2
1978550|NCT02942004|3541781|FG000|Overall Study|Randomized but not dosed|3
1978551|NCT02942004|3541782|FG001|Overall Study|Randomized but not dosed|9
1978552|NCT02942004|3541783|FG002|Overall Study|Randomized but not dosed|4
2022968|NCT00321919|3590827|FG001|Overall Study|Adverse Event|10
2022969|NCT00321919|3590826|FG000|Overall Study|Death|21
2022970|NCT00321919|3590827|FG001|Overall Study|Death|17
2022971|NCT00321919|3590826|FG000|Overall Study|Insufficient Therapeutic Response|1
2022972|NCT00321919|3590827|FG001|Overall Study|Insufficient Therapeutic Response|0
2022973|NCT00321919|3590826|FG000|Overall Study|Violation of Selection Criteria at Entry|1
2022974|NCT00321919|3590827|FG001|Overall Study|Violation of Selection Criteria at Entry|1
2022975|NCT00321919|3590826|FG000|Overall Study|Refused Treatment|23
2022976|NCT00321919|3590827|FG001|Overall Study|Refused Treatment|14
2022977|NCT00321919|3590826|FG000|Overall Study|Other Protocol Violation|2
2022978|NCT00321919|3590827|FG001|Overall Study|Other Protocol Violation|3
2022979|NCT00321919|3590826|FG000|Overall Study|Failure to Return|3
2022980|NCT00321919|3590827|FG001|Overall Study|Failure to Return|1
2022981|NCT00321919|3590826|FG000|Overall Study|Other withdrawal reason|7
2022982|NCT00321919|3590827|FG001|Overall Study|Other withdrawal reason|6
2022983|NCT00321932|3590836|FG000|Overall Study|Death|3
2022984|NCT00321932|3590837|FG001|Overall Study|Death|6
2022985|NCT00321932|3590836|FG000|Overall Study|Withdrawal by Subject|3
2022986|NCT00321932|3590837|FG001|Overall Study|Withdrawal by Subject|6
2022987|NCT00321932|3590836|FG000|Overall Study|Early relapse|2
2022988|NCT00321932|3590837|FG001|Overall Study|Early relapse|8
2022989|NCT00321932|3590836|FG000|Overall Study|Missing data|2
2022990|NCT00321932|3590837|FG001|Overall Study|Missing data|1
2022991|NCT00321984|3590856|FG000|Overall Study|Adverse Event|9
2022992|NCT00321984|3590857|FG001|Overall Study|Adverse Event|6
2022993|NCT00321984|3590858|FG002|Overall Study|Adverse Event|8
2022994|NCT00321984|3590856|FG000|Overall Study|Protocol Violation|0
2022995|NCT00321984|3590857|FG001|Overall Study|Protocol Violation|1
2022996|NCT00321984|3590858|FG002|Overall Study|Protocol Violation|1
2022997|NCT00321984|3590856|FG000|Overall Study|Lost to Follow-up|2
2022998|NCT00321984|3590857|FG001|Overall Study|Lost to Follow-up|4
2022999|NCT00321984|3590858|FG002|Overall Study|Lost to Follow-up|2
2023000|NCT00321984|3590856|FG000|Overall Study|Withdrawal by Subject|8
2023001|NCT00321984|3590857|FG001|Overall Study|Withdrawal by Subject|6
2023002|NCT00321984|3590858|FG002|Overall Study|Withdrawal by Subject|5
2023003|NCT00321984|3590856|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3
2023004|NCT00321984|3590857|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1
2023005|NCT00321984|3590858|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
2023006|NCT00321984|3590856|FG000|Overall Study|Lack of Efficacy|3
2023007|NCT00321984|3590857|FG001|Overall Study|Lack of Efficacy|1
2023008|NCT00321984|3590858|FG002|Overall Study|Lack of Efficacy|3
2023009|NCT00321984|3590856|FG000|Overall Study|Noncompliant|0
2023010|NCT00321984|3590857|FG001|Overall Study|Noncompliant|0
2023011|NCT00321984|3590858|FG002|Overall Study|Noncompliant|2
2023012|NCT00321984|3590856|FG000|Overall Study|Pregnancy|0
2023013|NCT00321984|3590857|FG001|Overall Study|Pregnancy|1
2023014|NCT00321984|3590858|FG002|Overall Study|Pregnancy|0
2023015|NCT00321984|3590856|FG000|Overall Study|Per Subject Request|1
2023016|NCT00321984|3590857|FG001|Overall Study|Per Subject Request|0
2023017|NCT00321984|3590858|FG002|Overall Study|Per Subject Request|0
2023018|NCT00321984|3590856|FG000|Overall Study|Per Investigator Request|1
2023019|NCT00321984|3590857|FG001|Overall Study|Per Investigator Request|0
2023020|NCT00321984|3590858|FG002|Overall Study|Per Investigator Request|0
2023021|NCT00321984|3590856|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
2025969|NCT00348140|3594699|FG002|Overall Study|Lost to Follow-up|4
1978553|NCT02924064|3541793|FG000|Overall Study|Adverse Event|2
1978554|NCT02924064|3541794|FG001|Overall Study|Adverse Event|2
1978555|NCT02924064|3541793|FG000|Overall Study|Lost to Follow-up|0
1978556|NCT02924064|3541794|FG001|Overall Study|Lost to Follow-up|2
1978557|NCT02924064|3541793|FG000|Overall Study|Physician Decision|0
1978558|NCT02924064|3541794|FG001|Overall Study|Physician Decision|2
1978559|NCT02924064|3541793|FG000|Overall Study|Protocol Violation|1
1978560|NCT02924064|3541794|FG001|Overall Study|Protocol Violation|3
2213181|NCT01676896|3854613|FG001|Overall Study|Withdrawal by Subject|7
2213182|NCT01676896|3854614|FG002|Overall Study|Withdrawal by Subject|19
2213183|NCT01676909|3854624|FG000|Overall Study|Withdrawal by Subject|3
2213184|NCT01676909|3854625|FG001|Overall Study|Withdrawal by Subject|5
2213185|NCT01676909|3854624|FG000|Overall Study|Lost to Follow-up|15
2213186|NCT01676909|3854625|FG001|Overall Study|Lost to Follow-up|9
2213187|NCT01677182|3854636|FG000|Overall Study|Adverse Event|2
2213188|NCT01677182|3854637|FG001|Overall Study|Adverse Event|1
2213189|NCT01677182|3854638|FG002|Overall Study|Adverse Event|8
2213190|NCT01677182|3854636|FG000|Overall Study|Protocol Violation|5
1978561|NCT02924064|3541793|FG000|Overall Study|Withdrawal by Subject|4
1978562|NCT02924064|3541794|FG001|Overall Study|Withdrawal by Subject|5
1978563|NCT02924064|3541793|FG000|Overall Study|Other|17
1978564|NCT02924064|3541794|FG001|Overall Study|Other|29
1978565|NCT02916706|3541802|FG000|Overall Study|Adverse Event|0
1978566|NCT02916706|3541803|FG001|Overall Study|Adverse Event|1
1978567|NCT02916706|3541802|FG000|Overall Study|Lost to Follow-up|0
1978568|NCT02916706|3541803|FG001|Overall Study|Lost to Follow-up|1
1978569|NCT02916706|3541802|FG000|Overall Study|Physician Decision|1
1978570|NCT02916706|3541803|FG001|Overall Study|Physician Decision|0
1978571|NCT02916706|3541802|FG000|Overall Study|Protocol Violation|3
1978572|NCT02916706|3541803|FG001|Overall Study|Protocol Violation|1
1978573|NCT02916706|3541802|FG000|Overall Study|Withdrawal by Subject|6
1978574|NCT02916706|3541803|FG001|Overall Study|Withdrawal by Subject|9
1978575|NCT02916706|3541802|FG000|Overall Study|Other|5
1978576|NCT02916706|3541803|FG001|Overall Study|Other|19
1978577|NCT02890355|3541811|FG000|Overall Study|Adverse Event|5
1978578|NCT02890355|3541812|FG001|Overall Study|Adverse Event|5
1978579|NCT02890355|3541811|FG000|Overall Study|Refusal unrelated to adverse event|5
1978580|NCT02890355|3541812|FG001|Overall Study|Refusal unrelated to adverse event|10
1978581|NCT02890355|3541811|FG000|Overall Study|Progression/relapse|46
1978582|NCT02890355|3541812|FG001|Overall Study|Progression/relapse|39
1978583|NCT02890355|3541811|FG000|Overall Study|Not protocol specified|3
1978584|NCT02890355|3541812|FG001|Overall Study|Not protocol specified|4
2102219|NCT00838110|3694001|FG000|Overall Study|Randomized but not treated|0
2102220|NCT00838110|3694002|FG001|Overall Study|Randomized but not treated|1
2102221|NCT00838110|3694003|FG002|Overall Study|Randomized but not treated|0
2102222|NCT00838110|3694004|FG003|Overall Study|Randomized but not treated|0
2102223|NCT00838201|3694033|FG000|Overall Study|Investigator decision, or other reasons|2
2102224|NCT00838201|3694034|FG001|Overall Study|Investigator decision, or other reasons|3
2102225|NCT00838201|3694033|FG000|Overall Study|Noncompliance|0
2102226|NCT00838201|3694034|FG001|Overall Study|Noncompliance|1
2102227|NCT00838201|3694033|FG000|Overall Study|Administrative decision|1
2102228|NCT00838201|3694034|FG001|Overall Study|Administrative decision|2
2102229|NCT00838201|3694033|FG000|Overall Study|Disease progression|3
2102230|NCT00838201|3694034|FG001|Overall Study|Disease progression|3
2102231|NCT00838201|3694033|FG000|Overall Study|Consent withdrawn|16
2213191|NCT01677182|3854637|FG001|Overall Study|Protocol Violation|1
1978600|NCT02861014|3541833|FG000|Primary Analysis|Adverse Event|7
1978601|NCT02861014|3541833|FG000|Primary Analysis|Death|1
1978602|NCT02861014|3541833|FG000|Primary Analysis|Lack of Efficacy|3
1978603|NCT02861014|3541833|FG000|Primary Analysis|Physician Decision|2
1978604|NCT02861014|3541833|FG000|Primary Analysis|Pregnancy|4
1978605|NCT02861014|3541833|FG000|Primary Analysis|Protocol Violation|2
1978606|NCT02861014|3541833|FG000|Primary Analysis|Study Terminated By Sponsor|3
1978607|NCT02861014|3541833|FG000|Primary Analysis|Withdrawal by Subject|14
1978608|NCT02861014|3541833|FG000|Primary Analysis|Commercial ocrelizumab|3
1978609|NCT02861014|3541833|FG000|Safety Follow-up|Adverse Event|1
1978610|NCT02861014|3541833|FG000|Safety Follow-up|Pregnancy|1
1978611|NCT02861014|3541833|FG000|Safety Follow-up|Withdrawal by Subject|9
1978612|NCT02861014|3541833|FG000|Safety Follow-up|Study terminated by sponsor|1
1978613|NCT02861014|3541833|FG000|Safety Follow-up|Physician Decision|1
1978614|NCT02861014|3541833|FG000|Safety Follow-up|Roll-over to a long term extension study|1
1978615|NCT02861014|3541833|FG000|Safety Follow-up|Commercial ocrelizumab|36
1978616|NCT02775435|3541841|FG000|Overall Study|Adverse Event|48
1978617|NCT02775435|3541842|FG001|Overall Study|Adverse Event|25
1978618|NCT02775435|3541841|FG000|Overall Study|Lost to Follow-up|0
1978619|NCT02775435|3541842|FG001|Overall Study|Lost to Follow-up|2
1978620|NCT02775435|3541841|FG000|Overall Study|Physician Decision|5
1978621|NCT02775435|3541842|FG001|Overall Study|Physician Decision|6
1978622|NCT02775435|3541841|FG000|Overall Study|Withdrawal by Subject|5
1978623|NCT02775435|3541842|FG001|Overall Study|Withdrawal by Subject|9
1978624|NCT02775435|3541841|FG000|Overall Study|Progressive Disease|86
1978625|NCT02775435|3541842|FG001|Overall Study|Progressive Disease|140
1978626|NCT02775435|3541841|FG000|Overall Study|Clinical Progression|13
1978627|NCT02775435|3541842|FG001|Overall Study|Clinical Progression|26
1978628|NCT02775435|3541841|FG000|Overall Study|Ongoing in Study|121
1978629|NCT02775435|3541842|FG001|Overall Study|Ongoing in Study|72
1978630|NCT02775435|3541841|FG000|Overall Study|Not Treated|0
1978631|NCT02775435|3541842|FG001|Overall Study|Not Treated|1
1978632|NCT02726880|3541857|FG000|Overall Study|Withdrawal by Subject|2
1978633|NCT02726880|3541858|FG001|Overall Study|Withdrawal by Subject|0
1978634|NCT02726880|3541857|FG000|Overall Study|Lost to Follow-up|1
1978635|NCT02726880|3541858|FG001|Overall Study|Lost to Follow-up|3
2102232|NCT00838201|3694034|FG001|Overall Study|Consent withdrawn|19
2102233|NCT00838201|3694033|FG000|Overall Study|Lost to Follow-up|4
2102234|NCT00838201|3694034|FG001|Overall Study|Lost to Follow-up|3
2102235|NCT00838201|3694033|FG000|Overall Study|Adverse Event|5
2102236|NCT00838201|3694034|FG001|Overall Study|Adverse Event|9
2102237|NCT00838201|3694033|FG000|Overall Study|Death|11
2102238|NCT00838201|3694034|FG001|Overall Study|Death|13
2102239|NCT00838331|3694040|FG000|Aged Blood Transfusion|Withdrawal by Subject|9
2102240|NCT00838435|3694044|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1
2102241|NCT00838435|3694044|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2
2102242|NCT00838435|3694044|FG000|Part 2 (7 Years)|Adverse Event|2
2102243|NCT00838435|3694044|FG000|Part 2 (7 Years)|Lost to Follow-up|2
2102244|NCT00838435|3694044|FG000|Part 2 (7 Years)|Physician Decision|1
2102245|NCT00838435|3694044|FG000|Part 2 (7 Years)|Sponsor Decision|6
2102246|NCT00838435|3694044|FG000|Part 2 (7 Years)|Withdrawal by Subject|5
2102247|NCT00838513|3694051|FG000|Screening Period|Screen Failure|3
2102248|NCT00838513|3694051|FG000|Extension Treatment Period|Death|1
2102249|NCT00838513|3694051|FG000|Post Treatment Period (Patients Who Disc|Death|1
2102250|NCT00838526|3694057|FG000|Overall Study|Adverse Event|3
2102251|NCT00838526|3694058|FG001|Overall Study|Adverse Event|12
2102252|NCT00838526|3694057|FG000|Overall Study|Lost to Follow-up|4
2102253|NCT00838526|3694058|FG001|Overall Study|Lost to Follow-up|12
2102254|NCT00838526|3694057|FG000|Overall Study|Withdrawal by Subject|4
2102255|NCT00838526|3694058|FG001|Overall Study|Withdrawal by Subject|5
1978660|NCT02642042|3541895|FG000|Overall Study|Adverse Event|22
1978661|NCT02642042|3541895|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
1978662|NCT02642042|3541895|FG000|Overall Study|Progression/Relapse|28
1978663|NCT02642042|3541895|FG000|Overall Study|Death|1
1978664|NCT02642042|3541895|FG000|Overall Study|Not Protocol Specified|2
1978665|NCT02601209|3541918|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
1978666|NCT02601209|3541919|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
1978667|NCT02601209|3541920|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
1978668|NCT02601209|3541921|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1978669|NCT02601209|3541922|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1978670|NCT02601209|3541923|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1978671|NCT02601209|3541924|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1978672|NCT02601209|3541925|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1978673|NCT02601209|3541926|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
1978674|NCT02601209|3541918|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1978675|NCT02601209|3541919|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1978676|NCT02601209|3541920|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1978677|NCT02601209|3541921|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1978678|NCT02601209|3541922|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
1978679|NCT02601209|3541923|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
1978680|NCT02601209|3541924|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
1978681|NCT02601209|3541925|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1978682|NCT02601209|3541926|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
1978683|NCT02592551|3541943|FG000|Overall Study|Not evaluable|1
1978684|NCT02592551|3541944|FG001|Overall Study|Not evaluable|3
1978685|NCT02592551|3541945|FG002|Overall Study|Not evaluable|0
1978686|NCT02583048|3541957|FG000|Overall Study|Withdrawal by Subject|0
1978687|NCT02583048|3541958|FG001|Overall Study|Withdrawal by Subject|1
1978688|NCT02583048|3541959|FG002|Overall Study|Withdrawal by Subject|0
1978689|NCT02583048|3541957|FG000|Overall Study|Failed to meet eligibility criterion|0
1978690|NCT02583048|3541958|FG001|Overall Study|Failed to meet eligibility criterion|0
1978691|NCT02583048|3541959|FG002|Overall Study|Failed to meet eligibility criterion|1
1978692|NCT02574481|3541974|FG000|Overall Study|Withdrawal by Subject|6
1978693|NCT02574481|3541975|FG001|Overall Study|Withdrawal by Subject|4
1978694|NCT02574481|3541976|FG002|Overall Study|Withdrawal by Subject|1
1978695|NCT02574481|3541977|FG003|Overall Study|Withdrawal by Subject|0
1978696|NCT02574481|3541974|FG000|Overall Study|Adverse Event|2
1978697|NCT02574481|3541975|FG001|Overall Study|Adverse Event|0
1978698|NCT02574481|3541976|FG002|Overall Study|Adverse Event|0
1978699|NCT02574481|3541977|FG003|Overall Study|Adverse Event|0
1978700|NCT02574481|3541974|FG000|Overall Study|Visit Missed|12
1978701|NCT02574481|3541975|FG001|Overall Study|Visit Missed|4
1978702|NCT02574481|3541976|FG002|Overall Study|Visit Missed|2
1978703|NCT02574481|3541977|FG003|Overall Study|Visit Missed|0
2102256|NCT00838526|3694057|FG000|Overall Study|Lack of Efficacy|2
2102257|NCT00838526|3694058|FG001|Overall Study|Lack of Efficacy|3
1978704|NCT02574481|3541974|FG000|Overall Study|Other|1
1978705|NCT02574481|3541975|FG001|Overall Study|Other|0
1978706|NCT02574481|3541976|FG002|Overall Study|Other|0
1978707|NCT02574481|3541977|FG003|Overall Study|Other|0
1978708|NCT02574481|3541974|FG000|Overall Study|Death|6
1978709|NCT02574481|3541975|FG001|Overall Study|Death|6
1978710|NCT02574481|3541976|FG002|Overall Study|Death|0
1978711|NCT02574481|3541977|FG003|Overall Study|Death|0
1978712|NCT02546986|3541992|FG000|Treatment Period|Progressive Disease|20
1978713|NCT02546986|3541993|FG001|Treatment Period|Progressive Disease|22
1978714|NCT02546986|3541992|FG000|Treatment Period|Adverse Event|14
1978715|NCT02546986|3541993|FG001|Treatment Period|Adverse Event|6
1978716|NCT02546986|3541992|FG000|Treatment Period|Symptomatic Deterioration|4
1978717|NCT02546986|3541993|FG001|Treatment Period|Symptomatic Deterioration|3
1978718|NCT02546986|3541992|FG000|Treatment Period|Death|3
1978719|NCT02546986|3541993|FG001|Treatment Period|Death|4
1978720|NCT02546986|3541992|FG000|Treatment Period|Physician Decision|1
2213192|NCT01677182|3854638|FG002|Overall Study|Protocol Violation|4
2213193|NCT01677182|3854636|FG000|Overall Study|Lost to Follow-up|4
2213194|NCT01677182|3854637|FG001|Overall Study|Lost to Follow-up|0
2213195|NCT01677182|3854638|FG002|Overall Study|Lost to Follow-up|3
2213196|NCT01677182|3854636|FG000|Overall Study|Withdrawal by Subject|7
2213197|NCT01677182|3854637|FG001|Overall Study|Withdrawal by Subject|12
2213198|NCT01677182|3854638|FG002|Overall Study|Withdrawal by Subject|10
2213199|NCT01677182|3854636|FG000|Overall Study|Study termination|12
2213200|NCT01677182|3854637|FG001|Overall Study|Study termination|9
2213201|NCT01677182|3854638|FG002|Overall Study|Study termination|11
1978721|NCT02546986|3541993|FG001|Treatment Period|Physician Decision|2
1978722|NCT02546986|3541992|FG000|Treatment Period|Protocol Violation|1
1978723|NCT02546986|3541993|FG001|Treatment Period|Protocol Violation|0
1978724|NCT02546986|3541992|FG000|Treatment Period|Withdrawal by Subject|1
1978725|NCT02546986|3541993|FG001|Treatment Period|Withdrawal by Subject|1
1978726|NCT02546986|3541992|FG000|Treatment Period|Non-compliance with Study Drug|0
1978727|NCT02546986|3541993|FG001|Treatment Period|Non-compliance with Study Drug|1
1978728|NCT02546986|3541992|FG000|Treatment Period|Study Terminated by Sponsor|0
1978729|NCT02546986|3541993|FG001|Treatment Period|Study Terminated by Sponsor|1
1978730|NCT02546986|3541992|FG000|Treatment Period|Miscellaneous|7
1978731|NCT02546986|3541993|FG001|Treatment Period|Miscellaneous|9
1978732|NCT02546986|3541992|FG000|Survival Follow-Up Phase|Missing Status|3
1978733|NCT02546986|3541993|FG001|Survival Follow-Up Phase|Missing Status|5
1978734|NCT02546986|3541992|FG000|Survival Follow-Up Phase|Death|18
1978735|NCT02546986|3541993|FG001|Survival Follow-Up Phase|Death|12
1978736|NCT02546986|3541992|FG000|Survival Follow-Up Phase|Alive|13
1978737|NCT02546986|3541993|FG001|Survival Follow-Up Phase|Alive|16
1978738|NCT02546986|3541992|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
1978739|NCT02546986|3541993|FG001|Survival Follow-Up Phase|Lost to Follow-up|2
1978740|NCT02539160|3542001|FG000|Phase 1 Pre-crossover|Adverse Event|3
1978741|NCT02539160|3542002|FG001|Phase 1 Pre-crossover|Adverse Event|3
1978742|NCT02539160|3542003|FG002|Phase 1 Pre-crossover|Adverse Event|2
1978743|NCT02539160|3542004|FG003|Phase 1 Pre-crossover|Adverse Event|1
1978744|NCT02539160|3542001|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2
1978745|NCT02539160|3542002|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1
1978746|NCT02539160|3542003|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1
1978747|NCT02539160|3542004|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0
1978748|NCT02539160|3542001|FG000|Phase 1 Pre-crossover|Protocol Violation|0
1978749|NCT02539160|3542002|FG001|Phase 1 Pre-crossover|Protocol Violation|0
1978750|NCT02539160|3542003|FG002|Phase 1 Pre-crossover|Protocol Violation|0
1978751|NCT02539160|3542004|FG003|Phase 1 Pre-crossover|Protocol Violation|2
1978752|NCT02507973|3542014|FG000|Overall Study|Adverse Event|1
1978753|NCT02500797|3542028|FG000|Overall Study|Cancel (rapid disease progression)|0
1978754|NCT02500797|3542029|FG001|Overall Study|Cancel (rapid disease progression)|0
1978755|NCT02500797|3542030|FG002|Overall Study|Cancel (rapid disease progression)|0
1978756|NCT02500797|3542031|FG003|Overall Study|Cancel (rapid disease progression)|0
1978757|NCT02500797|3542032|FG004|Overall Study|Cancel (rapid disease progression)|1
1978758|NCT02500797|3542033|FG005|Overall Study|Cancel (rapid disease progression)|1
1978759|NCT02500797|3542034|FG006|Overall Study|Cancel (rapid disease progression)|0
1978760|NCT02500797|3542035|FG007|Overall Study|Cancel (rapid disease progression)|0
1978761|NCT02500797|3542028|FG000|Overall Study|Withdrawal by Subject|1
1978762|NCT02500797|3542029|FG001|Overall Study|Withdrawal by Subject|0
1978763|NCT02500797|3542030|FG002|Overall Study|Withdrawal by Subject|0
1978764|NCT02500797|3542031|FG003|Overall Study|Withdrawal by Subject|0
1978765|NCT02500797|3542032|FG004|Overall Study|Withdrawal by Subject|0
1978766|NCT02500797|3542033|FG005|Overall Study|Withdrawal by Subject|0
1978767|NCT02500797|3542034|FG006|Overall Study|Withdrawal by Subject|0
1978768|NCT02500797|3542035|FG007|Overall Study|Withdrawal by Subject|0
2102258|NCT00838526|3694057|FG000|Overall Study|Other|11
2102259|NCT00838526|3694058|FG001|Overall Study|Other|7
2102260|NCT00838539|3694076|FG000|Overall Study|Disease Progression|2
2102261|NCT00838539|3694077|FG001|Overall Study|Disease Progression|4
2102262|NCT00838539|3694078|FG002|Overall Study|Disease Progression|3
2102263|NCT00838539|3694079|FG003|Overall Study|Disease Progression|2
2102264|NCT00838539|3694080|FG004|Overall Study|Disease Progression|4
2213202|NCT01677182|3854636|FG000|Overall Study|Lack of Efficacy|3
2102265|NCT00838539|3694081|FG005|Overall Study|Disease Progression|2
2102266|NCT00838539|3694082|FG006|Overall Study|Disease Progression|3
2102267|NCT00838539|3694083|FG007|Overall Study|Disease Progression|4
2102268|NCT00838539|3694084|FG008|Overall Study|Disease Progression|4
2102269|NCT00838539|3694085|FG009|Overall Study|Disease Progression|5
2102270|NCT00838539|3694086|FG010|Overall Study|Disease Progression|1
2102271|NCT00838539|3694087|FG011|Overall Study|Disease Progression|4
2102272|NCT00838539|3694076|FG000|Overall Study|Adverse Event|1
2102273|NCT00838539|3694077|FG001|Overall Study|Adverse Event|1
1978787|NCT02477696|3542072|FG000|Overall Study|Adverse Event|40
1978788|NCT02477696|3542073|FG001|Overall Study|Adverse Event|59
1978789|NCT02477696|3542072|FG000|Overall Study|CLL Disease Progression|82
1978790|NCT02477696|3542073|FG001|Overall Study|CLL Disease Progression|68
1978791|NCT02477696|3542072|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2
1978792|NCT02477696|3542073|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10
1978793|NCT02477696|3542072|FG000|Overall Study|Death|5
1978794|NCT02477696|3542073|FG001|Overall Study|Death|6
1978795|NCT02477696|3542072|FG000|Overall Study|Withdrawal by Subject|7
1978796|NCT02477696|3542073|FG001|Overall Study|Withdrawal by Subject|7
1978797|NCT02477696|3542072|FG000|Overall Study|Physician Decision|5
1978798|NCT02477696|3542073|FG001|Overall Study|Physician Decision|5
1978799|NCT02477618|3542081|FG000|Overall Study|Completed Visits but Discontinued Drug|2
1978800|NCT02477618|3542082|FG001|Overall Study|Completed Visits but Discontinued Drug|1
1978801|NCT02477618|3542081|FG000|Overall Study|Died in Double-Blind Treatment Period|11
1978802|NCT02477618|3542082|FG001|Overall Study|Died in Double-Blind Treatment Period|11
1978803|NCT02477618|3542081|FG000|Overall Study|Adverse Event|1
1978804|NCT02477618|3542082|FG001|Overall Study|Adverse Event|1
1978805|NCT02477618|3542081|FG000|Overall Study|Transferred Away from Study Site|1
1978806|NCT02477618|3542082|FG001|Overall Study|Transferred Away from Study Site|0
1978807|NCT02477618|3542081|FG000|Overall Study|Left Study Site for Rehabilitation|0
1978808|NCT02477618|3542082|FG001|Overall Study|Left Study Site for Rehabilitation|1
2023022|NCT00321984|3590857|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
2023023|NCT00321984|3590858|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
2023024|NCT00322023|3590869|FG000|Overall Study|various|0
2023025|NCT00322023|3590870|FG001|Overall Study|various|2
2023026|NCT00322023|3590871|FG002|Overall Study|various|6
2023027|NCT00322049|3590883|FG000|Overall Study|Moved out of area|0
2023028|NCT00322049|3590884|FG001|Overall Study|Moved out of area|0
2023029|NCT00322049|3590885|FG002|Overall Study|Moved out of area|0
2023030|NCT00322049|3590886|FG003|Overall Study|Moved out of area|1
2023031|NCT00322049|3590883|FG000|Overall Study|Infected with Dengue during study|0
2023032|NCT00322049|3590884|FG001|Overall Study|Infected with Dengue during study|1
2023033|NCT00322049|3590885|FG002|Overall Study|Infected with Dengue during study|0
2023034|NCT00322049|3590886|FG003|Overall Study|Infected with Dengue during study|0
2023035|NCT00322153|3590916|FG000|Overall Study|Adverse Event|21
2023036|NCT00322153|3590917|FG001|Overall Study|Adverse Event|34
2023037|NCT00322153|3590916|FG000|Overall Study|Protocol Violation|6
2023038|NCT00322153|3590917|FG001|Overall Study|Protocol Violation|14
2023039|NCT00322153|3590916|FG000|Overall Study|Withdrawal by Subject|18
2023040|NCT00322153|3590917|FG001|Overall Study|Withdrawal by Subject|10
2023041|NCT00322153|3590916|FG000|Overall Study|Lack of Efficacy|8
2023042|NCT00322153|3590917|FG001|Overall Study|Lack of Efficacy|3
2023043|NCT00322153|3590916|FG000|Overall Study|Lost to Follow-up|5
2023044|NCT00322153|3590917|FG001|Overall Study|Lost to Follow-up|4
2023045|NCT00322153|3590916|FG000|Overall Study|Withdrawn for other reasons|5
2023046|NCT00322153|3590917|FG001|Overall Study|Withdrawn for other reasons|4
2023047|NCT00322348|3590963|FG000|Overall Study|Adverse Event|0
2023048|NCT00322348|3590964|FG001|Overall Study|Adverse Event|1
2023049|NCT00322348|3590963|FG000|Overall Study|Withdrawal by Subject|1
2023050|NCT00322348|3590964|FG001|Overall Study|Withdrawal by Subject|4
2023051|NCT00322348|3590963|FG000|Overall Study|Lost to Follow-up|1
2023052|NCT00322348|3590964|FG001|Overall Study|Lost to Follow-up|0
2023053|NCT00322348|3590963|FG000|Overall Study|Death|0
2023054|NCT00322348|3590964|FG001|Overall Study|Death|2
2023055|NCT00322348|3590963|FG000|Overall Study|Disease Progression|30
2023056|NCT00322348|3590964|FG001|Overall Study|Disease Progression|25
2023057|NCT00322348|3590963|FG000|Overall Study|Reasons not specified|5
2023058|NCT00322348|3590964|FG001|Overall Study|Reasons not specified|1
2023059|NCT00322374|3590973|FG000|Starting Dose|Physician Decision|2
2023060|NCT00322374|3590974|FG001|Starting Dose|Physician Decision|0
2023061|NCT00322374|3590975|FG002|Starting Dose|Physician Decision|0
2023062|NCT00322374|3590976|FG003|Starting Dose|Physician Decision|0
2023063|NCT00322374|3590973|FG000|Starting Dose|Study Drug Toxicity|4
2023064|NCT00322374|3590974|FG001|Starting Dose|Study Drug Toxicity|0
2023065|NCT00322374|3590975|FG002|Starting Dose|Study Drug Toxicity|0
2023066|NCT00322374|3590976|FG003|Starting Dose|Study Drug Toxicity|0
2023067|NCT00322374|3590973|FG000|First Escalation|Documented Disease Progression|0
2023068|NCT00322374|3590974|FG001|First Escalation|Documented Disease Progression|6
2023069|NCT00322374|3590975|FG002|First Escalation|Documented Disease Progression|0
2023070|NCT00322374|3590976|FG003|First Escalation|Documented Disease Progression|0
2023071|NCT00322374|3590973|FG000|First Escalation|Physician Decision|0
2023072|NCT00322374|3590974|FG001|First Escalation|Physician Decision|12
2102274|NCT00838539|3694078|FG002|Overall Study|Adverse Event|1
2102275|NCT00838539|3694079|FG003|Overall Study|Adverse Event|1
2102276|NCT00838539|3694080|FG004|Overall Study|Adverse Event|2
2102277|NCT00838539|3694081|FG005|Overall Study|Adverse Event|1
2102278|NCT00838539|3694082|FG006|Overall Study|Adverse Event|0
1978814|NCT02257528|3542105|FG000|Overall Study|Never received study treatment|1
2102279|NCT00838539|3694083|FG007|Overall Study|Adverse Event|2
2102280|NCT00838539|3694084|FG008|Overall Study|Adverse Event|0
2102281|NCT00838539|3694085|FG009|Overall Study|Adverse Event|1
2102282|NCT00838539|3694086|FG010|Overall Study|Adverse Event|2
2102283|NCT00838539|3694087|FG011|Overall Study|Adverse Event|0
2102284|NCT00838539|3694076|FG000|Overall Study|Withdrawal by Subject|0
2102285|NCT00838539|3694077|FG001|Overall Study|Withdrawal by Subject|1
2102286|NCT00838539|3694078|FG002|Overall Study|Withdrawal by Subject|0
2102287|NCT00838539|3694079|FG003|Overall Study|Withdrawal by Subject|0
2102288|NCT00838539|3694080|FG004|Overall Study|Withdrawal by Subject|0
2102289|NCT00838539|3694081|FG005|Overall Study|Withdrawal by Subject|0
2102290|NCT00838539|3694082|FG006|Overall Study|Withdrawal by Subject|0
2102291|NCT00838539|3694083|FG007|Overall Study|Withdrawal by Subject|0
2102292|NCT00838539|3694084|FG008|Overall Study|Withdrawal by Subject|0
2102293|NCT00838539|3694085|FG009|Overall Study|Withdrawal by Subject|1
2102294|NCT00838539|3694086|FG010|Overall Study|Withdrawal by Subject|2
2102295|NCT00838539|3694087|FG011|Overall Study|Withdrawal by Subject|0
2102296|NCT00838539|3694076|FG000|Overall Study|Death|0
2102297|NCT00838539|3694077|FG001|Overall Study|Death|0
2102298|NCT00838539|3694078|FG002|Overall Study|Death|0
2102299|NCT00838539|3694079|FG003|Overall Study|Death|0
2102300|NCT00838539|3694080|FG004|Overall Study|Death|0
2102301|NCT00838539|3694081|FG005|Overall Study|Death|0
2102302|NCT00838539|3694082|FG006|Overall Study|Death|1
2102303|NCT00838539|3694083|FG007|Overall Study|Death|0
2102304|NCT00838539|3694084|FG008|Overall Study|Death|0
2102305|NCT00838539|3694085|FG009|Overall Study|Death|0
2102306|NCT00838539|3694086|FG010|Overall Study|Death|0
2102307|NCT00838539|3694087|FG011|Overall Study|Death|0
2102308|NCT00838539|3694076|FG000|Overall Study|Physician Decision|0
2102309|NCT00838539|3694077|FG001|Overall Study|Physician Decision|0
2102310|NCT00838539|3694078|FG002|Overall Study|Physician Decision|0
2102311|NCT00838539|3694079|FG003|Overall Study|Physician Decision|0
2102312|NCT00838539|3694080|FG004|Overall Study|Physician Decision|0
2102313|NCT00838539|3694081|FG005|Overall Study|Physician Decision|0
2102314|NCT00838539|3694082|FG006|Overall Study|Physician Decision|0
2102315|NCT00838539|3694083|FG007|Overall Study|Physician Decision|0
2102316|NCT00838539|3694084|FG008|Overall Study|Physician Decision|1
1978853|NCT02003924|3542158|FG000|Double-blind Phase|Lost to Follow-up|2
1978854|NCT02003924|3542159|FG001|Double-blind Phase|Lost to Follow-up|1
1978855|NCT02003924|3542160|FG002|Double-blind Phase|Lost to Follow-up|0
1978856|NCT02003924|3542158|FG000|Double-blind Phase|Protocol Violation|1
1978857|NCT02003924|3542159|FG001|Double-blind Phase|Protocol Violation|2
1978858|NCT02003924|3542160|FG002|Double-blind Phase|Protocol Violation|0
1978859|NCT02003924|3542158|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71
1978860|NCT02003924|3542159|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47
1978861|NCT02003924|3542160|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0
1978862|NCT02003924|3542158|FG000|Double-blind Phase|Disease Progression|229
1978863|NCT02003924|3542159|FG001|Double-blind Phase|Disease Progression|247
1978864|NCT02003924|3542160|FG002|Double-blind Phase|Disease Progression|0
1978865|NCT02003924|3542158|FG000|Double-blind Phase|Adverse Event|120
1978866|NCT02003924|3542159|FG001|Double-blind Phase|Adverse Event|31
1978867|NCT02003924|3542160|FG002|Double-blind Phase|Adverse Event|0
1978868|NCT02003924|3542158|FG000|Double-blind Phase|Randomized But not Treated|3
1978869|NCT02003924|3542159|FG001|Double-blind Phase|Randomized But not Treated|3
1978870|NCT02003924|3542160|FG002|Double-blind Phase|Randomized But not Treated|0
1978871|NCT02003924|3542158|FG000|Double-blind Phase|Other|29
1978872|NCT02003924|3542159|FG001|Double-blind Phase|Other|50
1978873|NCT02003924|3542160|FG002|Double-blind Phase|Other|0
1978874|NCT02003924|3542158|FG000|Open-label Phase|Lost to Follow-up|0
1978875|NCT02003924|3542159|FG001|Open-label Phase|Lost to Follow-up|0
1978876|NCT02003924|3542160|FG002|Open-label Phase|Lost to Follow-up|1
1978877|NCT02003924|3542158|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9
1978878|NCT02003924|3542159|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0
1978879|NCT02003924|3542160|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1
1978880|NCT02003924|3542158|FG000|Open-label Phase|Disease Progression|59
1978881|NCT02003924|3542159|FG001|Open-label Phase|Disease Progression|0
1978882|NCT02003924|3542160|FG002|Open-label Phase|Disease Progression|5
1978883|NCT02003924|3542158|FG000|Open-label Phase|Adverse Event|25
1978884|NCT02003924|3542159|FG001|Open-label Phase|Adverse Event|0
1978885|NCT02003924|3542160|FG002|Open-label Phase|Adverse Event|10
2102317|NCT00838539|3694085|FG009|Overall Study|Physician Decision|0
1978886|NCT02003924|3542158|FG000|Open-label Phase|Other|7
1978887|NCT02003924|3542159|FG001|Open-label Phase|Other|0
1978888|NCT02003924|3542160|FG002|Open-label Phase|Other|0
1978889|NCT02003924|3542158|FG000|Long-term Follow-up Phase|Death|288
1978890|NCT02003924|3542159|FG001|Long-term Follow-up Phase|Death|174
1978891|NCT02003924|3542160|FG002|Long-term Follow-up Phase|Death|4
1978892|NCT02003924|3542158|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
1978893|NCT02003924|3542159|FG001|Long-term Follow-up Phase|Lost to Follow-up|6
1978894|NCT02003924|3542160|FG002|Long-term Follow-up Phase|Lost to Follow-up|1
1978895|NCT02003924|3542158|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66
1978896|NCT02003924|3542159|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55
1978897|NCT02003924|3542160|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1
1978898|NCT02003924|3542158|FG000|Long-term Follow-up Phase|Other|5
1978899|NCT02003924|3542159|FG001|Long-term Follow-up Phase|Other|2
1978900|NCT02003924|3542160|FG002|Long-term Follow-up Phase|Other|1
1978901|NCT01971970|3542169|FG000|Baseline Until Week 6|Stopped anti-TNF use|1
1978902|NCT01971970|3542170|FG001|Baseline Until Week 6|Stopped anti-TNF use|0
1978903|NCT01971970|3542169|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0
1978904|NCT01971970|3542170|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1
1978905|NCT01971970|3542169|FG000|Week 14 Until Week 22|Lost to Follow-up|0
1978906|NCT01971970|3542170|FG001|Week 14 Until Week 22|Lost to Follow-up|1
1978907|NCT01971970|3542169|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7
1978908|NCT01971970|3542170|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3
1978909|NCT01971970|3542169|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1
1978910|NCT01971970|3542170|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0
1978911|NCT01971970|3542169|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0
1978912|NCT01971970|3542170|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1
1978913|NCT01971970|3542169|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1
1978914|NCT01971970|3542170|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3
1978915|NCT01969409|3542183|FG000|Overall Study|Death|2
1978916|NCT01969409|3542184|FG001|Overall Study|Death|2
1978917|NCT01969409|3542183|FG000|Overall Study|Transplant|1
1978918|NCT01969409|3542184|FG001|Overall Study|Transplant|1
1978919|NCT01969409|3542183|FG000|Overall Study|Withdrawal by Subject|0
1978920|NCT01969409|3542184|FG001|Overall Study|Withdrawal by Subject|1
2213203|NCT01677182|3854637|FG001|Overall Study|Lack of Efficacy|0
2213204|NCT01677182|3854638|FG002|Overall Study|Lack of Efficacy|1
2213205|NCT01677182|3854636|FG000|Overall Study|Other reasons|1
2213206|NCT01677182|3854637|FG001|Overall Study|Other reasons|5
2102318|NCT00838539|3694086|FG010|Overall Study|Physician Decision|0
2102319|NCT00838539|3694087|FG011|Overall Study|Physician Decision|0
2102320|NCT00838539|3694076|FG000|Overall Study|Clinical Progression|0
2102321|NCT00838539|3694077|FG001|Overall Study|Clinical Progression|0
2102322|NCT00838539|3694078|FG002|Overall Study|Clinical Progression|0
2102323|NCT00838539|3694079|FG003|Overall Study|Clinical Progression|0
2102324|NCT00838539|3694080|FG004|Overall Study|Clinical Progression|0
2102325|NCT00838539|3694081|FG005|Overall Study|Clinical Progression|0
2102326|NCT00838539|3694082|FG006|Overall Study|Clinical Progression|1
2102327|NCT00838539|3694083|FG007|Overall Study|Clinical Progression|0
1978931|NCT01853748|3542201|FG000|Allocation|Withdrawal by Subject|1
1978932|NCT01853748|3542202|FG001|Allocation|Withdrawal by Subject|13
1978933|NCT01853748|3542201|FG000|Allocation|not sufficient to receive intervention|0
1978934|NCT01853748|3542202|FG001|Allocation|not sufficient to receive intervention|1
1978935|NCT01853748|3542201|FG000|Follow-Up|Withdrawal by Subject|7
1978936|NCT01853748|3542202|FG001|Follow-Up|Withdrawal by Subject|6
1978937|NCT01853748|3542201|FG000|Follow-Up|Adverse Event|67
1978938|NCT01853748|3542202|FG001|Follow-Up|Adverse Event|7
1978939|NCT01853748|3542201|FG000|Follow-Up|not available for data collection|16
1978940|NCT01853748|3542202|FG001|Follow-Up|not available for data collection|4
1978941|NCT01665144|3542219|FG000|Overall Study|New therapy for study indication|2
1978942|NCT01665144|3542220|FG001|Overall Study|New therapy for study indication|1
1978943|NCT01665144|3542219|FG000|Overall Study|Technical problems|2
1978944|NCT01665144|3542220|FG001|Overall Study|Technical problems|0
1978945|NCT01665144|3542219|FG000|Overall Study|Death|3
1978946|NCT01665144|3542220|FG001|Overall Study|Death|1
1978947|NCT01665144|3542219|FG000|Overall Study|Protocol deviation|3
1978948|NCT01665144|3542220|FG001|Overall Study|Protocol deviation|1
1978949|NCT01665144|3542219|FG000|Overall Study|Non-compliance w/study treatment|5
1978950|NCT01665144|3542220|FG001|Overall Study|Non-compliance w/study treatment|0
1978951|NCT01665144|3542219|FG000|Overall Study|Progressive disease|8
1978952|NCT01665144|3542220|FG001|Overall Study|Progressive disease|4
1978953|NCT01665144|3542219|FG000|Overall Study|Lost to Follow-up|9
1978954|NCT01665144|3542220|FG001|Overall Study|Lost to Follow-up|8
1978955|NCT01665144|3542219|FG000|Overall Study|Physician Decision|13
1978956|NCT01665144|3542220|FG001|Overall Study|Physician Decision|1
1978957|NCT01665144|3542219|FG000|Overall Study|Lack of Efficacy|16
1978958|NCT01665144|3542220|FG001|Overall Study|Lack of Efficacy|11
1978959|NCT01665144|3542219|FG000|Overall Study|Adverse Event|45
1978960|NCT01665144|3542220|FG001|Overall Study|Adverse Event|18
1978961|NCT01665144|3542219|FG000|Overall Study|Withdrawal by Subject|96
1978962|NCT01665144|3542220|FG001|Overall Study|Withdrawal by Subject|77
2102328|NCT00838539|3694084|FG008|Overall Study|Clinical Progression|0
2102329|NCT00838539|3694085|FG009|Overall Study|Clinical Progression|0
2102330|NCT00838539|3694086|FG010|Overall Study|Clinical Progression|0
2102331|NCT00838539|3694087|FG011|Overall Study|Clinical Progression|0
2102332|NCT00838539|3694076|FG000|Overall Study|Symptomatic Deterioration|0
2102333|NCT00838539|3694077|FG001|Overall Study|Symptomatic Deterioration|0
2102334|NCT00838539|3694078|FG002|Overall Study|Symptomatic Deterioration|1
2102335|NCT00838539|3694079|FG003|Overall Study|Symptomatic Deterioration|1
2102336|NCT00838539|3694080|FG004|Overall Study|Symptomatic Deterioration|0
2102337|NCT00838539|3694081|FG005|Overall Study|Symptomatic Deterioration|1
2102338|NCT00838539|3694082|FG006|Overall Study|Symptomatic Deterioration|0
2102339|NCT00838539|3694083|FG007|Overall Study|Symptomatic Deterioration|0
2102340|NCT00838539|3694084|FG008|Overall Study|Symptomatic Deterioration|0
2102341|NCT00838539|3694085|FG009|Overall Study|Symptomatic Deterioration|1
2102342|NCT00838539|3694086|FG010|Overall Study|Symptomatic Deterioration|0
2102343|NCT00838539|3694087|FG011|Overall Study|Symptomatic Deterioration|0
2102344|NCT00838565|3694133|FG000|Overall Study|Withdrawal by Subject|0
2102345|NCT00838565|3694134|FG001|Overall Study|Withdrawal by Subject|0
2102346|NCT00838565|3694135|FG002|Overall Study|Withdrawal by Subject|1
2102347|NCT00838565|3694136|FG003|Overall Study|Withdrawal by Subject|0
2102348|NCT00838565|3694137|FG004|Overall Study|Withdrawal by Subject|0
2102349|NCT00838565|3694138|FG005|Overall Study|Withdrawal by Subject|2
2102350|NCT00838565|3694133|FG000|Overall Study|Other|0
2102351|NCT00838565|3694134|FG001|Overall Study|Other|2
2102352|NCT00838565|3694135|FG002|Overall Study|Other|0
2102353|NCT00838565|3694136|FG003|Overall Study|Other|0
2213207|NCT01677182|3854638|FG002|Overall Study|Other reasons|2
1978993|NCT01385176|3542249|FG000|Randomization Phase|Death|1
1978994|NCT01385176|3542250|FG001|Randomization Phase|Death|2
1978995|NCT01385176|3542249|FG000|6-18 Month All VNS Active|Death|1
1978996|NCT01385176|3542250|FG001|6-18 Month All VNS Active|Death|2
1978997|NCT01385176|3542249|FG000|6-18 Month All VNS Active|Physician Decision|0
1978998|NCT01385176|3542250|FG001|6-18 Month All VNS Active|Physician Decision|1
1978999|NCT01385176|3542249|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2
1979000|NCT01385176|3542250|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0
1979001|NCT01385176|3542249|FG000|6-18 Month All VNS Active|Heart Transplant|1
1979002|NCT01385176|3542250|FG001|6-18 Month All VNS Active|Heart Transplant|0
2023073|NCT00322374|3590975|FG002|First Escalation|Physician Decision|0
2023074|NCT00322374|3590976|FG003|First Escalation|Physician Decision|0
2023075|NCT00322374|3590973|FG000|First Escalation|Study Drug Toxicity|0
2023076|NCT00322374|3590974|FG001|First Escalation|Study Drug Toxicity|11
2023077|NCT00322374|3590975|FG002|First Escalation|Study Drug Toxicity|0
2023078|NCT00322374|3590976|FG003|First Escalation|Study Drug Toxicity|0
2023079|NCT00322374|3590973|FG000|First Escalation|Participant Request|0
2023080|NCT00322374|3590974|FG001|First Escalation|Participant Request|1
2023081|NCT00322374|3590975|FG002|First Escalation|Participant Request|0
2023082|NCT00322374|3590976|FG003|First Escalation|Participant Request|0
2023083|NCT00322374|3590973|FG000|Second Escalation|Physician Decision|0
2023084|NCT00322374|3590974|FG001|Second Escalation|Physician Decision|0
2023085|NCT00322374|3590975|FG002|Second Escalation|Physician Decision|5
2023086|NCT00322374|3590976|FG003|Second Escalation|Physician Decision|0
2023087|NCT00322374|3590973|FG000|Second Escalation|Study Drug Toxicity|0
2023088|NCT00322374|3590974|FG001|Second Escalation|Study Drug Toxicity|0
2023089|NCT00322374|3590975|FG002|Second Escalation|Study Drug Toxicity|1
2023090|NCT00322374|3590976|FG003|Second Escalation|Study Drug Toxicity|0
2023091|NCT00322387|3590991|FG000|Treatment Period|Adverse Event|0
2023092|NCT00322387|3590992|FG001|Treatment Period|Adverse Event|1
2023093|NCT00322387|3590991|FG000|Follow-up Period|Final assessment not done|1
2023094|NCT00322387|3590992|FG001|Follow-up Period|Final assessment not done|3
2023095|NCT00322387|3590991|FG000|Follow-up Period|Death|1
2023096|NCT00322387|3590992|FG001|Follow-up Period|Death|0
2023097|NCT00322452|3591015|FG000|Overall Study|Eligibility criteria not fulfilled|0
2023098|NCT00322452|3591016|FG001|Overall Study|Eligibility criteria not fulfilled|1
2023099|NCT00322452|3591015|FG000|Overall Study|Lost to Follow-up|5
2023100|NCT00322452|3591016|FG001|Overall Study|Lost to Follow-up|2
2023101|NCT00322452|3591015|FG000|Overall Study|Withdrawal by Subject|19
2023102|NCT00322452|3591016|FG001|Overall Study|Withdrawal by Subject|46
2023103|NCT00322452|3591015|FG000|Overall Study|Death|223
2023104|NCT00322452|3591016|FG001|Overall Study|Death|227
2023105|NCT00322491|3591044|FG000|Overall Study|Adverse Event|1
2023106|NCT00322491|3591045|FG001|Overall Study|Adverse Event|0
2023107|NCT00322491|3591044|FG000|Overall Study|Death|1
2023108|NCT00322491|3591045|FG001|Overall Study|Death|2
2023109|NCT00322556|3591052|FG000|Overall Study|Adverse Event|1
2023110|NCT00322556|3591052|FG000|Overall Study|Withdrawal by Subject|1
2023111|NCT00322556|3591052|FG000|Overall Study|Lost to Follow-up|3
2023112|NCT00322556|3591052|FG000|Overall Study|Other Reason|7
2023113|NCT00322621|3591059|FG000|Period II - Acute Therapy Phase|Adverse Event|20
2023114|NCT00322621|3591060|FG001|Period II - Acute Therapy Phase|Adverse Event|0
2023115|NCT00322621|3591061|FG002|Period II - Acute Therapy Phase|Adverse Event|0
2023116|NCT00322621|3591059|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1
2023117|NCT00322621|3591060|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0
2023118|NCT00322621|3591061|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0
2023119|NCT00322621|3591059|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8
2023120|NCT00322621|3591060|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0
2023121|NCT00322621|3591061|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0
2023122|NCT00322621|3591059|FG000|Period II - Acute Therapy Phase|Protocol Violation|2
2025970|NCT00348140|3594697|FG000|Overall Study|Protocol Violation|12
2102354|NCT00838565|3694137|FG004|Overall Study|Other|0
2102355|NCT00838565|3694138|FG005|Overall Study|Other|0
2102356|NCT00838565|3694133|FG000|Overall Study|Randomized but not Treated|0
2102357|NCT00838565|3694134|FG001|Overall Study|Randomized but not Treated|1
2102358|NCT00838565|3694135|FG002|Overall Study|Randomized but not Treated|0
2102359|NCT00838565|3694136|FG003|Overall Study|Randomized but not Treated|0
2102360|NCT00838565|3694137|FG004|Overall Study|Randomized but not Treated|0
2102361|NCT00838565|3694138|FG005|Overall Study|Randomized but not Treated|0
1979011|NCT01307787|3542267|FG000|Overall Study|Withdrawal by Subject|2
1979012|NCT01307787|3542268|FG001|Overall Study|Withdrawal by Subject|0
1979013|NCT01275677|3542281|FG000|Overall Study|Not at risk for recurrence.|1
1979014|NCT01275677|3542282|FG001|Overall Study|Not at risk for recurrence.|1
1979015|NCT01275677|3542281|FG000|Overall Study|No follow-up|26
1979016|NCT01275677|3542282|FG001|Overall Study|No follow-up|37
1979017|NCT01275677|3542281|FG000|Overall Study|No clinical follow up.|1
1979018|NCT01275677|3542282|FG001|Overall Study|No clinical follow up.|4
1979019|NCT01250912|3542288|FG000|Overall Study|Lost to Follow-up|1
2102362|NCT00838578|3694157|FG000|Overall Study|Protocol Violation|2
2102363|NCT00838682|3694167|FG000|Overall Study|Lost to Follow-up|21
2102364|NCT00838682|3694168|FG001|Overall Study|Lost to Follow-up|14
2102365|NCT00838682|3694167|FG000|Overall Study|detection of exclusion criteria|4
2102366|NCT00838682|3694168|FG001|Overall Study|detection of exclusion criteria|3
2102367|NCT00838682|3694167|FG000|Overall Study|Protocol Violation|0
2102368|NCT00838682|3694168|FG001|Overall Study|Protocol Violation|1
2102369|NCT00838682|3694167|FG000|Overall Study|Withdrawal by Subject|0
2102370|NCT00838682|3694168|FG001|Overall Study|Withdrawal by Subject|1
2102371|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Adverse Event|5
2102372|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Adverse Event|13
2102373|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Adverse Event|17
2102374|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Adverse Event|25
2102375|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Protocol Violation|1
2102376|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Protocol Violation|6
2102377|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Protocol Violation|6
2102378|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Protocol Violation|5
2102379|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Noncompliance|9
2102380|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Noncompliance|13
2102381|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Noncompliance|12
2102382|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Noncompliance|6
1979044|NCT01141712|3542324|FG000|Overall Study|Disease progression|3
1979045|NCT00843882|3542342|FG000|Step 1|Lack of Efficacy|14
1979046|NCT00843882|3542343|FG001|Step 1|Lack of Efficacy|10
1979047|NCT00843882|3542344|FG002|Step 1|Lack of Efficacy|21
1979048|NCT00843882|3542342|FG000|Step 1|Adverse Event|8
1979049|NCT00843882|3542343|FG001|Step 1|Adverse Event|17
1979050|NCT00843882|3542344|FG002|Step 1|Adverse Event|20
1979051|NCT00843882|3542342|FG000|Step 1|Death|1
1979052|NCT00843882|3542343|FG001|Step 1|Death|2
1979053|NCT00843882|3542344|FG002|Step 1|Death|4
1979054|NCT00843882|3542342|FG000|Step 1|Withdrawal by Subject|6
1979055|NCT00843882|3542343|FG001|Step 1|Withdrawal by Subject|12
1979056|NCT00843882|3542344|FG002|Step 1|Withdrawal by Subject|9
1979057|NCT00843882|3542342|FG000|Step 1|Physician Decision|0
1979058|NCT00843882|3542343|FG001|Step 1|Physician Decision|5
1979059|NCT00843882|3542344|FG002|Step 1|Physician Decision|1
1979060|NCT00843882|3542342|FG000|Step 1|Patient and physician's decision|0
1979061|NCT00843882|3542343|FG001|Step 1|Patient and physician's decision|0
1979062|NCT00843882|3542344|FG002|Step 1|Patient and physician's decision|1
1979063|NCT00843882|3542342|FG000|Step 1|Other complicating disease|1
1979064|NCT00843882|3542343|FG001|Step 1|Other complicating disease|3
1979065|NCT00843882|3542344|FG002|Step 1|Other complicating disease|4
1979066|NCT00843882|3542342|FG000|Step 1|Alternative therapy|0
1979067|NCT00843882|3542343|FG001|Step 1|Alternative therapy|1
1979068|NCT00843882|3542344|FG002|Step 1|Alternative therapy|1
1979069|NCT00843882|3542342|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0
1979070|NCT00843882|3542343|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4
1979071|NCT00843882|3542344|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0
1979072|NCT00843882|3542342|FG000|Step 1|Off treatment reason unknown|0
1979073|NCT00843882|3542343|FG001|Step 1|Off treatment reason unknown|1
1979074|NCT00843882|3542344|FG002|Step 1|Off treatment reason unknown|4
1979075|NCT00843882|3542342|FG000|Step 1|Never started treatment|2
1979076|NCT00843882|3542343|FG001|Step 1|Never started treatment|0
1979077|NCT00843882|3542344|FG002|Step 1|Never started treatment|0
1979078|NCT00843882|3542342|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1
1979079|NCT00843882|3542343|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9
1979080|NCT00843882|3542344|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0
1979081|NCT00843882|3542342|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0
1979082|NCT00843882|3542343|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6
1979083|NCT00843882|3542344|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0
1979084|NCT00843882|3542342|FG000|Step 2 (Cross-over to Arm B)|Death|0
1979085|NCT00843882|3542343|FG001|Step 2 (Cross-over to Arm B)|Death|3
1979086|NCT00843882|3542344|FG002|Step 2 (Cross-over to Arm B)|Death|0
1979087|NCT00843882|3542342|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2
1979088|NCT00843882|3542343|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5
1979089|NCT00843882|3542344|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0
1979090|NCT00843882|3542342|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1
1979091|NCT00843882|3542343|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1
1979092|NCT00843882|3542344|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0
1979093|NCT00843882|3542342|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0
1979094|NCT00843882|3542343|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1
1979095|NCT00843882|3542344|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0
1979096|NCT00843882|3542342|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
1979097|NCT00843882|3542343|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1
1979098|NCT00843882|3542344|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
1979099|NCT00659646|3542359|FG000|Overall Study|Protocol Violation|12
1979100|NCT00659646|3542360|FG001|Overall Study|Protocol Violation|8
1979101|NCT00659646|3542359|FG000|Overall Study|Adverse Event|1
1979102|NCT00659646|3542360|FG001|Overall Study|Adverse Event|0
1979103|NCT00659646|3542359|FG000|Overall Study|Lost to Follow-up|1
1979104|NCT00659646|3542360|FG001|Overall Study|Lost to Follow-up|0
1979105|NCT00659646|3542359|FG000|Overall Study|protocol noncompliance after randomized|1
1979106|NCT00659646|3542360|FG001|Overall Study|protocol noncompliance after randomized|0
1979107|NCT00567580|3542371|FG000|Overall Study|Protocol Violation|28
1979108|NCT00567580|3542372|FG001|Overall Study|Protocol Violation|24
1979109|NCT00567580|3542373|FG002|Overall Study|Protocol Violation|24
1979110|NCT00477412|3542388|FG000|Overall Study|Death|0
1979111|NCT00477412|3542389|FG001|Overall Study|Death|0
1979112|NCT00477412|3542390|FG002|Overall Study|Death|0
1979113|NCT00477412|3542391|FG003|Overall Study|Death|4
1979114|NCT00477412|3542388|FG000|Overall Study|Lost to Follow-up|0
1979115|NCT00477412|3542389|FG001|Overall Study|Lost to Follow-up|0
1979116|NCT00477412|3542390|FG002|Overall Study|Lost to Follow-up|0
1979117|NCT00477412|3542391|FG003|Overall Study|Lost to Follow-up|1
1979118|NCT00477412|3542388|FG000|Overall Study|Withdrawal by Subject|0
1979119|NCT00477412|3542389|FG001|Overall Study|Withdrawal by Subject|0
1979120|NCT00477412|3542390|FG002|Overall Study|Withdrawal by Subject|0
1979121|NCT00477412|3542391|FG003|Overall Study|Withdrawal by Subject|2
1979122|NCT00477412|3542388|FG000|Overall Study|Second Malignancy|0
1979123|NCT00477412|3542389|FG001|Overall Study|Second Malignancy|0
1979124|NCT00477412|3542390|FG002|Overall Study|Second Malignancy|0
1979125|NCT00477412|3542391|FG003|Overall Study|Second Malignancy|1
1979126|NCT00477412|3542388|FG000|Overall Study|Adverse Event|1
1979127|NCT00477412|3542389|FG001|Overall Study|Adverse Event|0
1979128|NCT00477412|3542390|FG002|Overall Study|Adverse Event|1
1979129|NCT00477412|3542391|FG003|Overall Study|Adverse Event|0
1979130|NCT00369317|3542399|FG000|Overall Study|Adverse Event|3
1979131|NCT00369317|3542399|FG000|Overall Study|Death|1
1979132|NCT00369317|3542399|FG000|Overall Study|Lack of Efficacy|5
1979133|NCT00369317|3542399|FG000|Overall Study|Physician Decision|2
1979134|NCT00369317|3542399|FG000|Overall Study|Withdrawal by Subject|8
1979135|NCT00369317|3542399|FG000|Overall Study|Ineligible|1
1979136|NCT00261807|3542404|FG000|Overall Study|Lost to Follow-up|2
1979137|NCT00261807|3542404|FG000|Overall Study|Adverse Event|2
1979138|NCT00261807|3542404|FG000|Overall Study|Death|1
1979139|NCT00261807|3542404|FG000|Overall Study|Protocol Violation|2
2023123|NCT00322621|3591060|FG001|Period II - Acute Therapy Phase|Protocol Violation|0
2023124|NCT00322621|3591061|FG002|Period II - Acute Therapy Phase|Protocol Violation|0
2023125|NCT00322621|3591059|FG000|Period II - Acute Therapy Phase|Physician Decision|1
2023126|NCT00322621|3591060|FG001|Period II - Acute Therapy Phase|Physician Decision|0
2023127|NCT00322621|3591061|FG002|Period II - Acute Therapy Phase|Physician Decision|0
2023128|NCT00322621|3591059|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0
2023129|NCT00322621|3591060|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14
2023130|NCT00322621|3591061|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5
2023131|NCT00322621|3591059|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
2023132|NCT00322621|3591060|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
2023133|NCT00322621|3591061|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
2023134|NCT00322621|3591059|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
2023135|NCT00322621|3591060|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
2023136|NCT00322621|3591061|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
2023137|NCT00322621|3591059|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0
2023138|NCT00322621|3591060|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2
2023139|NCT00322621|3591061|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5
2023140|NCT00322621|3591059|FG000|Period III - Maintenance / Rescue Phase|Death|0
2023141|NCT00322621|3591060|FG001|Period III - Maintenance / Rescue Phase|Death|1
2023142|NCT00322621|3591061|FG002|Period III - Maintenance / Rescue Phase|Death|0
2023143|NCT00322621|3591059|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
2023144|NCT00322621|3591060|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
2023145|NCT00322621|3591061|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
2023146|NCT00322712|3591074|FG000|Overall Study|treated with bevacizumab not cetuximab|1
2023147|NCT00322842|3591089|FG000|Overall Study|Withdrawal by Subject|0
2023148|NCT00322842|3591090|FG001|Overall Study|Withdrawal by Subject|1
2023149|NCT00322842|3591089|FG000|Overall Study|Lost to Follow-up|0
1979140|NCT04620798|3542427|FG000|Overall Study|Lost to Follow-up|126
1979141|NCT04620798|3542428|FG001|Overall Study|Lost to Follow-up|138
1979142|NCT04256629|3542453|FG000|Overall Study|Adverse Event|0
1979143|NCT04256629|3542454|FG001|Overall Study|Adverse Event|0
1979144|NCT04256629|3542455|FG002|Overall Study|Adverse Event|0
1979145|NCT04256629|3542456|FG003|Overall Study|Adverse Event|0
1979146|NCT04256629|3542457|FG004|Overall Study|Adverse Event|0
1979147|NCT04256629|3542458|FG005|Overall Study|Adverse Event|1
1979148|NCT04256629|3542453|FG000|Overall Study|Protocol Violation|0
1979149|NCT04256629|3542454|FG001|Overall Study|Protocol Violation|1
1979150|NCT04256629|3542455|FG002|Overall Study|Protocol Violation|0
1979151|NCT04256629|3542456|FG003|Overall Study|Protocol Violation|0
1979152|NCT04256629|3542457|FG004|Overall Study|Protocol Violation|0
1979153|NCT04256629|3542458|FG005|Overall Study|Protocol Violation|0
1979154|NCT04014075|3542470|FG000|Overall Study|Progressive Disease|39
1979155|NCT04014075|3542470|FG000|Overall Study|Adverse Event|9
1979156|NCT04014075|3542470|FG000|Overall Study|Clinical Progression|2
1979157|NCT04014075|3542470|FG000|Overall Study|Death|2
1979158|NCT04014075|3542470|FG000|Overall Study|Withdrawal by Subject|2
1979159|NCT04014075|3542470|FG000|Overall Study|Miscellaneous|1
1979160|NCT04014075|3542470|FG000|Overall Study|Physician Decision|1
1979161|NCT03284853|3542484|FG000|Overall Study|Adverse Event|40
1979162|NCT03284853|3542485|FG001|Overall Study|Adverse Event|4
1979163|NCT03284853|3542484|FG000|Overall Study|Withdrawal by Subject|5
1979164|NCT03284853|3542485|FG001|Overall Study|Withdrawal by Subject|1
1979165|NCT03284853|3542484|FG000|Overall Study|Lost to Follow-up|1
1979166|NCT03284853|3542485|FG001|Overall Study|Lost to Follow-up|0
1979167|NCT03284853|3542484|FG000|Overall Study|Lack of Efficacy|1
1979168|NCT03284853|3542485|FG001|Overall Study|Lack of Efficacy|0
1979169|NCT03284853|3542484|FG000|Overall Study|Disallowed Concurrent Medication|1
1979170|NCT03284853|3542485|FG001|Overall Study|Disallowed Concurrent Medication|1
1979171|NCT03284853|3542484|FG000|Overall Study|Protocol Violation|3
1979172|NCT03284853|3542485|FG001|Overall Study|Protocol Violation|3
1979173|NCT03284853|3542484|FG000|Overall Study|Death|0
1979174|NCT03284853|3542485|FG001|Overall Study|Death|1
1979175|NCT03284853|3542484|FG000|Overall Study|Other - Reason not reported in CSR|4
1979176|NCT03284853|3542485|FG001|Overall Study|Other - Reason not reported in CSR|3
1979177|NCT02774889|3542508|FG000|Overall Study|Lost to Follow-up|2
1979178|NCT02774889|3542509|FG001|Overall Study|Lost to Follow-up|1
1979179|NCT02625090|3542527|FG000|Overall Study|Participant wants to be pregnant|2
1979180|NCT02625090|3542527|FG000|Overall Study|For the Promoter|1
1979181|NCT02625090|3542527|FG000|Overall Study|Sponsor's Decision|9
1979182|NCT02625090|3542527|FG000|Overall Study|Somnolence|1
1979183|NCT02625090|3542527|FG000|Overall Study|Study terminated by Sponsor|7
1979184|NCT02625090|3542527|FG000|Overall Study|Negative Benefit/Risk|1
1979185|NCT02625090|3542527|FG000|Overall Study|Protocol Deviation|2
1979186|NCT02625090|3542527|FG000|Overall Study|Lack of Efficacy|16
1979187|NCT02625090|3542527|FG000|Overall Study|Adverse Event|3
1979188|NCT02367456|3542535|FG000|Overall Study|Death|8
1979189|NCT02367456|3542536|FG001|Overall Study|Death|21
1979190|NCT02367456|3542537|FG002|Overall Study|Death|14
1979191|NCT02367456|3542535|FG000|Overall Study|Lost to Follow-up|1
1979192|NCT02367456|3542536|FG001|Overall Study|Lost to Follow-up|3
1979193|NCT02367456|3542537|FG002|Overall Study|Lost to Follow-up|1
1979194|NCT02367456|3542535|FG000|Overall Study|Ongoing|0
1979195|NCT02367456|3542536|FG001|Overall Study|Ongoing|6
1979196|NCT02367456|3542537|FG002|Overall Study|Ongoing|15
1979197|NCT02367456|3542535|FG000|Overall Study|Other reason|3
1979198|NCT02367456|3542536|FG001|Overall Study|Other reason|0
1979199|NCT02367456|3542537|FG002|Overall Study|Other reason|0
1979200|NCT02297438|3542552|FG000|Overall Study|Death|79
1979201|NCT02297438|3542553|FG001|Overall Study|Death|86
1979202|NCT02297438|3542552|FG000|Overall Study|Lost to Follow-up|9
1979203|NCT02297438|3542553|FG001|Overall Study|Lost to Follow-up|7
1979204|NCT02297438|3542552|FG000|Overall Study|Withdrawal by Subject|7
1979205|NCT02297438|3542553|FG001|Overall Study|Withdrawal by Subject|0
1979206|NCT02297438|3542552|FG000|Overall Study|Other|9
1979207|NCT02297438|3542553|FG001|Overall Study|Other|5
1979208|NCT02297438|3542552|FG000|Overall Study|Ongoing|65
1979209|NCT02297438|3542553|FG001|Overall Study|Ongoing|73
1979210|NCT02297412|3542561|FG000|Overall Study|Canceled|1
1979211|NCT02297412|3542562|FG001|Overall Study|Canceled|1
1979212|NCT02288247|3542577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52
1979213|NCT02288247|3542578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0
1979214|NCT02288247|3542577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35
1979215|NCT02288247|3542578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0
1979216|NCT02288247|3542577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1
1979217|NCT02288247|3542578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0
1979218|NCT02288247|3542577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392
1979219|NCT02288247|3542578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0
1979220|NCT02288247|3542577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9
1979221|NCT02288247|3542578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0
1979222|NCT02288247|3542577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52
1979223|NCT02288247|3542578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0
1979224|NCT02288247|3542577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106
1979225|NCT02288247|3542578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0
1979226|NCT02288247|3542577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10
1979227|NCT02288247|3542578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8
1979228|NCT02288247|3542577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8
1979229|NCT02288247|3542578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4
1979230|NCT02288247|3542577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1
1979231|NCT02288247|3542578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0
1979232|NCT02288247|3542577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87
1979233|NCT02288247|3542578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94
1979234|NCT02288247|3542577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2
1979235|NCT02288247|3542578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1
1979236|NCT02288247|3542577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
1979237|NCT02288247|3542578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
1979238|NCT02288247|3542577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20
1979239|NCT02288247|3542578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21
1979240|NCT02288247|3542577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1
1979241|NCT02288247|3542578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0
1979242|NCT02250326|3542589|FG000|Treatment Period|Death|1
1979243|NCT02250326|3542590|FG001|Treatment Period|Death|12
1979244|NCT02250326|3542591|FG002|Treatment Period|Death|2
1979245|NCT02250326|3542589|FG000|Treatment Period|Adverse Event|8
1979246|NCT02250326|3542590|FG001|Treatment Period|Adverse Event|4
1979247|NCT02250326|3542591|FG002|Treatment Period|Adverse Event|8
1979248|NCT02250326|3542589|FG000|Treatment Period|Progressive Disease|42
1979249|NCT02250326|3542590|FG001|Treatment Period|Progressive Disease|36
1979250|NCT02250326|3542591|FG002|Treatment Period|Progressive Disease|45
1979251|NCT02250326|3542589|FG000|Treatment Period|Symptomatic Deterioration|9
1979252|NCT02250326|3542590|FG001|Treatment Period|Symptomatic Deterioration|4
1979253|NCT02250326|3542591|FG002|Treatment Period|Symptomatic Deterioration|10
1979254|NCT02250326|3542589|FG000|Treatment Period|Withdrawal by Subject|11
1979255|NCT02250326|3542590|FG001|Treatment Period|Withdrawal by Subject|5
1979256|NCT02250326|3542591|FG002|Treatment Period|Withdrawal by Subject|4
1979257|NCT02250326|3542589|FG000|Treatment Period|Miscellaneous|8
1979258|NCT02250326|3542590|FG001|Treatment Period|Miscellaneous|2
1979259|NCT02250326|3542591|FG002|Treatment Period|Miscellaneous|7
1979260|NCT02250326|3542589|FG000|Treatment Period|Randomized or assigned; not treated|2
1979261|NCT02250326|3542590|FG001|Treatment Period|Randomized or assigned; not treated|1
1979262|NCT02250326|3542591|FG002|Treatment Period|Randomized or assigned; not treated|1
1979263|NCT02250326|3542589|FG000|Follow-Up Period|Death|46
1979264|NCT02250326|3542590|FG001|Follow-Up Period|Death|26
1979265|NCT02250326|3542591|FG002|Follow-Up Period|Death|32
1979266|NCT02250326|3542589|FG000|Follow-Up Period|Unknown or Missing|2
1979267|NCT02250326|3542590|FG001|Follow-Up Period|Unknown or Missing|3
1979268|NCT02250326|3542591|FG002|Follow-Up Period|Unknown or Missing|3
1979269|NCT02250326|3542589|FG000|Follow-Up Period|Lost to Follow-up|1
1979270|NCT02250326|3542590|FG001|Follow-Up Period|Lost to Follow-up|1
1979271|NCT02250326|3542591|FG002|Follow-Up Period|Lost to Follow-up|3
1979272|NCT01503515|3542613|FG000|Overall Study|Adverse Event|4
1979273|NCT01503515|3542614|FG001|Overall Study|Adverse Event|5
1979274|NCT01503515|3542613|FG000|Overall Study|Death|0
1979275|NCT01503515|3542614|FG001|Overall Study|Death|1
1979276|NCT01503515|3542613|FG000|Overall Study|Physician Decision|14
1979277|NCT01503515|3542614|FG001|Overall Study|Physician Decision|23
1979278|NCT01503515|3542613|FG000|Overall Study|Withdrawal by Subject|0
1979279|NCT01503515|3542614|FG001|Overall Study|Withdrawal by Subject|1
1979280|NCT01503515|3542613|FG000|Overall Study|Institutional dx of proven/probable IFI|2
1979281|NCT01503515|3542614|FG001|Overall Study|Institutional dx of proven/probable IFI|4
1979282|NCT01503515|3542613|FG000|Overall Study|Ineligible|1
1979283|NCT01503515|3542614|FG001|Overall Study|Ineligible|1
1979284|NCT00565851|3542653|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9
1979285|NCT00565851|3542654|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9
1979286|NCT00565851|3542655|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3
1979287|NCT00565851|3542656|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18
1979288|NCT00565851|3542657|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0
1979289|NCT00565851|3542658|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2
1979290|NCT00565851|3542659|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0
1979291|NCT00565851|3542660|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2
1979292|NCT00565851|3542653|FG000|Chemotherapy Assignment|Still On Chemotherapy|0
1979293|NCT00565851|3542654|FG001|Chemotherapy Assignment|Still On Chemotherapy|14
1979294|NCT00565851|3542655|FG002|Chemotherapy Assignment|Still On Chemotherapy|0
1979295|NCT00565851|3542656|FG003|Chemotherapy Assignment|Still On Chemotherapy|18
1979296|NCT00565851|3542657|FG004|Chemotherapy Assignment|Still On Chemotherapy|0
1979297|NCT00565851|3542658|FG005|Chemotherapy Assignment|Still On Chemotherapy|1
1979298|NCT00565851|3542659|FG006|Chemotherapy Assignment|Still On Chemotherapy|0
1979299|NCT00565851|3542660|FG007|Chemotherapy Assignment|Still On Chemotherapy|1
1979300|NCT00245960|3542684|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6
1979301|NCT00245960|3542685|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7
1979302|NCT00245960|3542684|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0
1979303|NCT00245960|3542685|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1
1979304|NCT00245960|3542684|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2
1979305|NCT00245960|3542685|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0
1979306|NCT00245960|3542684|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2
1979307|NCT00245960|3542685|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1
1979308|NCT00245960|3542684|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3
2213208|NCT01677195|3854649|FG000|Overall Study|Lost to Follow-up|14
2213209|NCT01677195|3854650|FG001|Overall Study|Lost to Follow-up|22
1979309|NCT00245960|3542685|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0
1979310|NCT00245960|3542684|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
1979311|NCT00245960|3542685|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
1979312|NCT00245960|3542684|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8
1979313|NCT00245960|3542685|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4
1979314|NCT00245960|3542684|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
1979315|NCT00245960|3542685|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
1979316|NCT00245960|3542684|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2
1979317|NCT00245960|3542685|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5
1979318|NCT00245960|3542684|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1
1979319|NCT00245960|3542685|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3
1979320|NCT00245960|3542684|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1
1979321|NCT00245960|3542685|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3
1979322|NCT00245960|3542684|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0
1979323|NCT00245960|3542685|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1
2023150|NCT00322842|3591090|FG001|Overall Study|Lost to Follow-up|1
2023151|NCT00322842|3591089|FG000|Overall Study|Refused transplant|1
2023152|NCT00322842|3591090|FG001|Overall Study|Refused transplant|0
2023153|NCT00322842|3591089|FG000|Overall Study|Death|1
2213210|NCT01677195|3854651|FG002|Overall Study|Lost to Follow-up|22
2213211|NCT01677195|3854649|FG000|Overall Study|Withdrawal by Subject|1
2213212|NCT01677195|3854650|FG001|Overall Study|Withdrawal by Subject|0
2213213|NCT01677195|3854651|FG002|Overall Study|Withdrawal by Subject|1
2213214|NCT01677195|3854649|FG000|Overall Study|Adverse Event|6
2213215|NCT01677195|3854650|FG001|Overall Study|Adverse Event|4
2023154|NCT00322842|3591090|FG001|Overall Study|Death|0
2023155|NCT00322868|3591097|FG000|Overall Study|disease progression|1
2023156|NCT00322881|3591102|FG000|Overall Study|Death|2
2023157|NCT00322881|3591102|FG000|Overall Study|Adverse Event|1
2023158|NCT00322881|3591102|FG000|Overall Study|Disease Progression|2
2023159|NCT00323063|3591108|FG000|Overall Study|Adverse Event|1
2023160|NCT00323063|3591109|FG001|Overall Study|Adverse Event|0
2023161|NCT00323063|3591108|FG000|Overall Study|brain mets discovered prior to treatment|1
2023162|NCT00323063|3591109|FG001|Overall Study|brain mets discovered prior to treatment|0
2023163|NCT00323115|3591115|FG000|Vaccine Administration|Adverse Event|1
2023164|NCT00323115|3591115|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8
2023165|NCT00323258|3591135|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1
2023166|NCT00323258|3591136|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2
2023167|NCT00323258|3591135|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
2023168|NCT00323258|3591136|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
2023169|NCT00323258|3591135|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
2023170|NCT00323258|3591136|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
2023171|NCT00323258|3591135|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
2023172|NCT00323258|3591136|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
2023173|NCT00323258|3591135|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1
2023174|NCT00323258|3591136|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2
2023175|NCT00323258|3591135|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
2023176|NCT00323258|3591136|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
2023177|NCT00323258|3591135|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
2023178|NCT00323258|3591136|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
2023179|NCT00323297|3591162|FG000|Part A (Double Blind Randomized)|Reason unspecified|0
2023180|NCT00323297|3591163|FG001|Part A (Double Blind Randomized)|Reason unspecified|1
2023181|NCT00323297|3591162|FG000|Part A (Double Blind Randomized)|Death|0
2023182|NCT00323297|3591163|FG001|Part A (Double Blind Randomized)|Death|1
2023183|NCT00323297|3591162|FG000|Part A (Double Blind Randomized)|Protocol Violation|1
2023184|NCT00323297|3591163|FG001|Part A (Double Blind Randomized)|Protocol Violation|3
2213216|NCT01677195|3854651|FG002|Overall Study|Adverse Event|1
2213217|NCT01677195|3854649|FG000|Overall Study|Physician Decision|1
2213218|NCT01677195|3854650|FG001|Overall Study|Physician Decision|2
2213219|NCT01677195|3854651|FG002|Overall Study|Physician Decision|2
2023185|NCT00323297|3591162|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1
2023186|NCT00323297|3591163|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0
2023187|NCT00323297|3591162|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
2023188|NCT00323297|3591163|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
2025971|NCT00348140|3594698|FG001|Overall Study|Protocol Violation|13
1979324|NCT04015336|3542772|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1
1979325|NCT03920280|3542851|FG000|Overall Study|Adverse Event|2
1979326|NCT03920280|3542852|FG001|Overall Study|Adverse Event|3
1979327|NCT03920280|3542851|FG000|Overall Study|Lost to Follow-up|0
1979328|NCT03920280|3542852|FG001|Overall Study|Lost to Follow-up|1
1979329|NCT03920280|3542851|FG000|Overall Study|Withdrawal by Subject|1
1979330|NCT03920280|3542852|FG001|Overall Study|Withdrawal by Subject|1
1979331|NCT03920280|3542851|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0
1979332|NCT03920280|3542852|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1
1979333|NCT03913091|3542863|FG000|Overall Study|Lost to Follow-up|18
1979334|NCT03913091|3542864|FG001|Overall Study|Lost to Follow-up|11
1979335|NCT03913091|3542863|FG000|Overall Study|Required additional meds/surgery|1
1979336|NCT03913091|3542864|FG001|Overall Study|Required additional meds/surgery|2
1979337|NCT03913091|3542863|FG000|Overall Study|Chronic pain/history of substance abuse|1
1979338|NCT03913091|3542864|FG001|Overall Study|Chronic pain/history of substance abuse|1
1979339|NCT03802565|3542875|FG000|Overall Study|Adverse Event|0
1979340|NCT03802565|3542876|FG001|Overall Study|Adverse Event|1
1979341|NCT03802565|3542877|FG002|Overall Study|Adverse Event|2
1979342|NCT03802565|3542878|FG003|Overall Study|Adverse Event|1
1979343|NCT03802565|3542879|FG004|Overall Study|Adverse Event|1
1979344|NCT03802565|3542875|FG000|Overall Study|Withdrawal by Subject|2
1979345|NCT03802565|3542876|FG001|Overall Study|Withdrawal by Subject|2
1979346|NCT03802565|3542877|FG002|Overall Study|Withdrawal by Subject|2
1979347|NCT03802565|3542878|FG003|Overall Study|Withdrawal by Subject|0
1979348|NCT03802565|3542879|FG004|Overall Study|Withdrawal by Subject|1
1979349|NCT03802565|3542875|FG000|Overall Study|Protocol Violation|2
1979350|NCT03802565|3542876|FG001|Overall Study|Protocol Violation|1
1979351|NCT03802565|3542877|FG002|Overall Study|Protocol Violation|4
1979352|NCT03802565|3542878|FG003|Overall Study|Protocol Violation|5
1979353|NCT03802565|3542879|FG004|Overall Study|Protocol Violation|1
1979354|NCT03802565|3542875|FG000|Overall Study|Lost to Follow-up|0
1979355|NCT03802565|3542876|FG001|Overall Study|Lost to Follow-up|0
1979356|NCT03802565|3542877|FG002|Overall Study|Lost to Follow-up|1
1979357|NCT03802565|3542878|FG003|Overall Study|Lost to Follow-up|0
1979358|NCT03802565|3542879|FG004|Overall Study|Lost to Follow-up|0
1979359|NCT03802565|3542875|FG000|Overall Study|Subjects Related to Each Other|1
1979360|NCT03802565|3542876|FG001|Overall Study|Subjects Related to Each Other|0
1979361|NCT03802565|3542877|FG002|Overall Study|Subjects Related to Each Other|0
1979362|NCT03802565|3542878|FG003|Overall Study|Subjects Related to Each Other|2
1979363|NCT03802565|3542879|FG004|Overall Study|Subjects Related to Each Other|1
1979364|NCT03802565|3542875|FG000|Overall Study|Elevated Enzymes|0
1979365|NCT03802565|3542876|FG001|Overall Study|Elevated Enzymes|0
1979366|NCT03802565|3542877|FG002|Overall Study|Elevated Enzymes|0
1979367|NCT03802565|3542878|FG003|Overall Study|Elevated Enzymes|0
1979368|NCT03802565|3542879|FG004|Overall Study|Elevated Enzymes|2
1979369|NCT03769194|3542895|FG000|Overall Study|Withdrawal by Subject|0
1979370|NCT03769194|3542896|FG001|Overall Study|Withdrawal by Subject|7
1979371|NCT03769194|3542897|FG002|Overall Study|Withdrawal by Subject|4
1979372|NCT03769194|3542898|FG003|Overall Study|Withdrawal by Subject|1
1979373|NCT03769194|3542895|FG000|Overall Study|moved from study area|0
1979374|NCT03769194|3542896|FG001|Overall Study|moved from study area|2
1979375|NCT03769194|3542897|FG002|Overall Study|moved from study area|1
1979376|NCT03769194|3542898|FG003|Overall Study|moved from study area|1
1979377|NCT03769194|3542895|FG000|Overall Study|Lost to Follow-up|3
1979378|NCT03769194|3542896|FG001|Overall Study|Lost to Follow-up|6
1979379|NCT03769194|3542897|FG002|Overall Study|Lost to Follow-up|3
1979380|NCT03769194|3542898|FG003|Overall Study|Lost to Follow-up|6
1979381|NCT03769194|3542895|FG000|Overall Study|other|1
1979382|NCT03769194|3542896|FG001|Overall Study|other|3
1979383|NCT03769194|3542897|FG002|Overall Study|other|0
1979384|NCT03769194|3542898|FG003|Overall Study|other|1
1979385|NCT03738332|3542908|FG000|Overall Study|Withdrawal by Subject|1
1979388|NCT03416179|3542930|FG000|Overall Study|Death|67
1979389|NCT03416179|3542931|FG001|Overall Study|Death|60
1979390|NCT03416179|3542932|FG002|Overall Study|Death|96
1979391|NCT03416179|3542933|FG003|Overall Study|Death|88
1979392|NCT03416179|3542930|FG000|Overall Study|Withdrawal by Subject|13
1979393|NCT03416179|3542931|FG001|Overall Study|Withdrawal by Subject|19
1979394|NCT03416179|3542932|FG002|Overall Study|Withdrawal by Subject|5
1979395|NCT03416179|3542933|FG003|Overall Study|Withdrawal by Subject|6
1979396|NCT03416179|3542930|FG000|Overall Study|Ongoing|121
1979397|NCT03416179|3542931|FG001|Overall Study|Ongoing|123
1979398|NCT03416179|3542932|FG002|Overall Study|Ongoing|62
1979399|NCT03416179|3542933|FG003|Overall Study|Ongoing|66
1979400|NCT03416179|3542930|FG000|Overall Study|Lost to Follow-up|0
1979401|NCT03416179|3542931|FG001|Overall Study|Lost to Follow-up|0
1979402|NCT03416179|3542932|FG002|Overall Study|Lost to Follow-up|0
1979403|NCT03416179|3542933|FG003|Overall Study|Lost to Follow-up|2
1979404|NCT03416179|3542930|FG000|Overall Study|Other|0
1979405|NCT03416179|3542931|FG001|Overall Study|Other|1
1979406|NCT03416179|3542932|FG002|Overall Study|Other|0
1979407|NCT03416179|3542933|FG003|Overall Study|Other|0
1979408|NCT03353922|3542943|FG000|Overall Study|Withdrawal by Subject|1
1979409|NCT03353922|3542944|FG001|Overall Study|Withdrawal by Subject|0
1979410|NCT03353922|3542945|FG002|Overall Study|Withdrawal by Subject|1
1979411|NCT03353922|3542946|FG003|Overall Study|Withdrawal by Subject|1
1979412|NCT03353922|3542947|FG004|Overall Study|Withdrawal by Subject|0
1979413|NCT03353922|3542948|FG005|Overall Study|Withdrawal by Subject|0
1979414|NCT03353922|3542943|FG000|Overall Study|Adverse Event|0
1979415|NCT03353922|3542944|FG001|Overall Study|Adverse Event|1
1979416|NCT03353922|3542945|FG002|Overall Study|Adverse Event|0
1979417|NCT03353922|3542946|FG003|Overall Study|Adverse Event|0
1979418|NCT03353922|3542947|FG004|Overall Study|Adverse Event|0
1979419|NCT03353922|3542948|FG005|Overall Study|Adverse Event|0
1979420|NCT03173456|3542983|FG000|Baseline|Medication dispensing system malfunction'|0
1979421|NCT03173456|3542984|FG001|Baseline|Medication dispensing system malfunction'|1
1979422|NCT03173456|3542985|FG002|Baseline|Medication dispensing system malfunction'|0
1979423|NCT03173456|3542986|FG003|Baseline|Medication dispensing system malfunction'|0
1979424|NCT03173456|3542987|FG004|Baseline|Medication dispensing system malfunction'|2
1979425|NCT03173456|3542983|FG000|2 Hour Follow-up|Withdrawal by Subject|0
1979426|NCT03173456|3542984|FG001|2 Hour Follow-up|Withdrawal by Subject|1
1979427|NCT03173456|3542985|FG002|2 Hour Follow-up|Withdrawal by Subject|1
1979428|NCT03173456|3542986|FG003|2 Hour Follow-up|Withdrawal by Subject|1
1979429|NCT03173456|3542987|FG004|2 Hour Follow-up|Withdrawal by Subject|2
1979430|NCT03020160|3543010|FG000|Overall Study|Continuing to receive emicizumab|7
1979431|NCT03020160|3543011|FG001|Overall Study|Continuing to receive emicizumab|41
1979432|NCT03003520|3543020|FG000|Induction|Ongoing|1
1979433|NCT03003520|3543021|FG001|Induction|Ongoing|0
1979434|NCT03003520|3543020|FG000|Induction|Adverse Event|4
1979435|NCT03003520|3543021|FG001|Induction|Adverse Event|0
1979436|NCT03003520|3543020|FG000|Induction|Death|1
1979437|NCT03003520|3543021|FG001|Induction|Death|0
1979438|NCT03003520|3543020|FG000|Induction|Palliative care|1
1979439|NCT03003520|3543021|FG001|Induction|Palliative care|0
1979440|NCT03003520|3543020|FG000|Induction|Physician Decision|2
1979441|NCT03003520|3543021|FG001|Induction|Physician Decision|0
1979442|NCT03003520|3543020|FG000|Induction|Withdrawal by Subject|3
1979443|NCT03003520|3543021|FG001|Induction|Withdrawal by Subject|0
1979444|NCT03003520|3543020|FG000|Induction|Progressive disease|1
1979445|NCT03003520|3543021|FG001|Induction|Progressive disease|0
1979446|NCT03003520|3543020|FG000|Consolidation|Ongoing|18
1979447|NCT03003520|3543021|FG001|Consolidation|Ongoing|0
1979448|NCT03003520|3543020|FG000|Consolidation|Adverse Event|2
1979449|NCT03003520|3543021|FG001|Consolidation|Adverse Event|0
1979450|NCT03003520|3543020|FG000|Consolidation|Progressive disease|3
1979451|NCT03003520|3543021|FG001|Consolidation|Progressive disease|1
1979452|NCT03003520|3543020|FG000|Consolidation|Withdrawal by Subject|1
1979453|NCT03003520|3543021|FG001|Consolidation|Withdrawal by Subject|0
1979454|NCT03003520|3543020|FG000|Follow-up|Death|1
1979455|NCT03003520|3543021|FG001|Follow-up|Death|1
1979456|NCT03003520|3543020|FG000|Follow-up|Ongoing|12
1979457|NCT03003520|3543021|FG001|Follow-up|Ongoing|2
1979458|NCT03003520|3543020|FG000|Follow-up|Withdrawal by Subject|1
1979459|NCT03003520|3543021|FG001|Follow-up|Withdrawal by Subject|0
1979460|NCT02862457|3543042|FG000|Overall Study|Death|1
1979461|NCT02862457|3543043|FG001|Overall Study|Death|3
1979462|NCT02862457|3543044|FG002|Overall Study|Death|2
1979463|NCT02862457|3543045|FG003|Overall Study|Death|3
1979464|NCT02862457|3543046|FG004|Overall Study|Death|0
1979465|NCT02862457|3543047|FG005|Overall Study|Death|2
1979466|NCT02862457|3543048|FG006|Overall Study|Death|1
1979467|NCT02862457|3543042|FG000|Overall Study|Lost to Follow-up|1
1979468|NCT02862457|3543043|FG001|Overall Study|Lost to Follow-up|0
1979469|NCT02862457|3543044|FG002|Overall Study|Lost to Follow-up|0
1979470|NCT02862457|3543045|FG003|Overall Study|Lost to Follow-up|1
1979471|NCT02862457|3543046|FG004|Overall Study|Lost to Follow-up|0
1979472|NCT02862457|3543047|FG005|Overall Study|Lost to Follow-up|0
1979473|NCT02862457|3543048|FG006|Overall Study|Lost to Follow-up|0
1979474|NCT02862457|3543042|FG000|Overall Study|Withdrawal by Subject|0
1979475|NCT02862457|3543043|FG001|Overall Study|Withdrawal by Subject|0
1979476|NCT02862457|3543044|FG002|Overall Study|Withdrawal by Subject|1
1979477|NCT02862457|3543045|FG003|Overall Study|Withdrawal by Subject|0
1979478|NCT02862457|3543046|FG004|Overall Study|Withdrawal by Subject|0
1979479|NCT02862457|3543047|FG005|Overall Study|Withdrawal by Subject|1
1979480|NCT02862457|3543048|FG006|Overall Study|Withdrawal by Subject|0
1979481|NCT02820753|3543074|FG000|2 Month|Withdrawal by Subject|3
1979482|NCT02820753|3543075|FG001|2 Month|Withdrawal by Subject|3
1979483|NCT02820753|3543074|FG000|2 Month|Lost to Follow-up|24
1979484|NCT02820753|3543075|FG001|2 Month|Lost to Follow-up|26
1979485|NCT02820753|3543074|FG000|2 Month|Stopped per NIH Hold|51
1979486|NCT02820753|3543075|FG001|2 Month|Stopped per NIH Hold|13
1979487|NCT02820753|3543074|FG000|6 Month|Withdrawal by Subject|2
1979488|NCT02820753|3543075|FG001|6 Month|Withdrawal by Subject|2
1979489|NCT02820753|3543074|FG000|6 Month|Lost to Follow-up|20
1979490|NCT02820753|3543075|FG001|6 Month|Lost to Follow-up|27
1979491|NCT02820753|3543074|FG000|6 Month|Stopped per NIH Hold|81
1979492|NCT02820753|3543075|FG001|6 Month|Stopped per NIH Hold|81
1979493|NCT02820753|3543074|FG000|6 Month|Death|0
1979494|NCT02820753|3543075|FG001|6 Month|Death|1
1979495|NCT02733042|3543100|FG000|Treatment Period|Adverse Event|1
1979496|NCT02733042|3543101|FG001|Treatment Period|Adverse Event|0
1979497|NCT02733042|3543102|FG002|Treatment Period|Adverse Event|1
1979498|NCT02733042|3543103|FG003|Treatment Period|Adverse Event|1
1979499|NCT02733042|3543104|FG004|Treatment Period|Adverse Event|0
1979500|NCT02733042|3543105|FG005|Treatment Period|Adverse Event|0
1979501|NCT02733042|3543106|FG006|Treatment Period|Adverse Event|0
1979502|NCT02733042|3543107|FG007|Treatment Period|Adverse Event|0
1979503|NCT02733042|3543108|FG008|Treatment Period|Adverse Event|0
1979504|NCT02733042|3543109|FG009|Treatment Period|Adverse Event|0
1979505|NCT02733042|3543110|FG010|Treatment Period|Adverse Event|2
1979506|NCT02733042|3543111|FG011|Treatment Period|Adverse Event|2
1979507|NCT02733042|3543112|FG012|Treatment Period|Adverse Event|0
1979508|NCT02733042|3543113|FG013|Treatment Period|Adverse Event|2
1979509|NCT02733042|3543114|FG014|Treatment Period|Adverse Event|0
1979510|NCT02733042|3543115|FG015|Treatment Period|Adverse Event|0
1979511|NCT02733042|3543116|FG016|Treatment Period|Adverse Event|0
1979512|NCT02733042|3543117|FG017|Treatment Period|Adverse Event|1
1979513|NCT02733042|3543118|FG018|Treatment Period|Adverse Event|0
1979514|NCT02733042|3543100|FG000|Treatment Period|Progressive Disease|2
1979515|NCT02733042|3543101|FG001|Treatment Period|Progressive Disease|1
1979516|NCT02733042|3543102|FG002|Treatment Period|Progressive Disease|3
1979517|NCT02733042|3543103|FG003|Treatment Period|Progressive Disease|1
1979518|NCT02733042|3543104|FG004|Treatment Period|Progressive Disease|1
1979519|NCT02733042|3543105|FG005|Treatment Period|Progressive Disease|3
1979520|NCT02733042|3543106|FG006|Treatment Period|Progressive Disease|0
1979521|NCT02733042|3543107|FG007|Treatment Period|Progressive Disease|3
1979522|NCT02733042|3543108|FG008|Treatment Period|Progressive Disease|3
1979523|NCT02733042|3543109|FG009|Treatment Period|Progressive Disease|0
1979524|NCT02733042|3543110|FG010|Treatment Period|Progressive Disease|2
1979525|NCT02733042|3543111|FG011|Treatment Period|Progressive Disease|2
1979526|NCT02733042|3543112|FG012|Treatment Period|Progressive Disease|8
1979527|NCT02733042|3543113|FG013|Treatment Period|Progressive Disease|1
1979528|NCT02733042|3543114|FG014|Treatment Period|Progressive Disease|4
1979529|NCT02733042|3543115|FG015|Treatment Period|Progressive Disease|7
1979530|NCT02733042|3543116|FG016|Treatment Period|Progressive Disease|2
1979531|NCT02733042|3543117|FG017|Treatment Period|Progressive Disease|3
1979532|NCT02733042|3543118|FG018|Treatment Period|Progressive Disease|4
1979533|NCT02733042|3543100|FG000|Treatment Period|Withdrawal by Subject|0
1979534|NCT02733042|3543101|FG001|Treatment Period|Withdrawal by Subject|1
1979535|NCT02733042|3543102|FG002|Treatment Period|Withdrawal by Subject|2
1979536|NCT02733042|3543103|FG003|Treatment Period|Withdrawal by Subject|1
1979537|NCT02733042|3543104|FG004|Treatment Period|Withdrawal by Subject|0
1979538|NCT02733042|3543105|FG005|Treatment Period|Withdrawal by Subject|0
1979539|NCT02733042|3543106|FG006|Treatment Period|Withdrawal by Subject|0
1979540|NCT02733042|3543107|FG007|Treatment Period|Withdrawal by Subject|0
1979541|NCT02733042|3543108|FG008|Treatment Period|Withdrawal by Subject|1
1979542|NCT02733042|3543109|FG009|Treatment Period|Withdrawal by Subject|1
1979543|NCT02733042|3543110|FG010|Treatment Period|Withdrawal by Subject|0
1979544|NCT02733042|3543111|FG011|Treatment Period|Withdrawal by Subject|2
1979545|NCT02733042|3543112|FG012|Treatment Period|Withdrawal by Subject|1
1979546|NCT02733042|3543113|FG013|Treatment Period|Withdrawal by Subject|1
1979547|NCT02733042|3543114|FG014|Treatment Period|Withdrawal by Subject|0
1979548|NCT02733042|3543115|FG015|Treatment Period|Withdrawal by Subject|0
1979549|NCT02733042|3543116|FG016|Treatment Period|Withdrawal by Subject|0
1979550|NCT02733042|3543117|FG017|Treatment Period|Withdrawal by Subject|0
1979551|NCT02733042|3543118|FG018|Treatment Period|Withdrawal by Subject|0
1979552|NCT02733042|3543100|FG000|Treatment Period|Other|0
1979553|NCT02733042|3543101|FG001|Treatment Period|Other|0
1979554|NCT02733042|3543102|FG002|Treatment Period|Other|1
1979555|NCT02733042|3543103|FG003|Treatment Period|Other|0
1979556|NCT02733042|3543104|FG004|Treatment Period|Other|0
1979557|NCT02733042|3543105|FG005|Treatment Period|Other|0
1979558|NCT02733042|3543106|FG006|Treatment Period|Other|0
1979559|NCT02733042|3543107|FG007|Treatment Period|Other|0
1979560|NCT02733042|3543108|FG008|Treatment Period|Other|0
1979561|NCT02733042|3543109|FG009|Treatment Period|Other|1
2310365|NCT02732119|4014399|FG003|Phase II|Progressive dissease|30
2310366|NCT02732119|4014400|FG004|Phase II|Progressive dissease|23
2310367|NCT02732119|4014396|FG000|Phase II|Study terminated by sponsor|0
2310368|NCT02732119|4014397|FG001|Phase II|Study terminated by sponsor|0
2310369|NCT02732119|4014398|FG002|Phase II|Study terminated by sponsor|0
2310370|NCT02732119|4014399|FG003|Phase II|Study terminated by sponsor|2
2310371|NCT02732119|4014400|FG004|Phase II|Study terminated by sponsor|2
2310372|NCT02732119|4014396|FG000|Phase II|Other|0
2310373|NCT02732119|4014397|FG001|Phase II|Other|0
2310374|NCT02732119|4014398|FG002|Phase II|Other|0
2310375|NCT02732119|4014399|FG003|Phase II|Other|2
2310376|NCT02732119|4014400|FG004|Phase II|Other|0
2310377|NCT02732119|4014396|FG000|Phase II|Physician Decision|0
1979562|NCT02733042|3543110|FG010|Treatment Period|Other|1
1979563|NCT02733042|3543111|FG011|Treatment Period|Other|0
1979564|NCT02733042|3543112|FG012|Treatment Period|Other|0
1979565|NCT02733042|3543113|FG013|Treatment Period|Other|0
2310378|NCT02732119|4014397|FG001|Phase II|Physician Decision|0
2310379|NCT02732119|4014398|FG002|Phase II|Physician Decision|0
1979566|NCT02733042|3543114|FG014|Treatment Period|Other|0
2310380|NCT02732119|4014399|FG003|Phase II|Physician Decision|8
2310381|NCT02732119|4014400|FG004|Phase II|Physician Decision|5
1979567|NCT02733042|3543115|FG015|Treatment Period|Other|1
1979568|NCT02733042|3543116|FG016|Treatment Period|Other|0
1979569|NCT02733042|3543117|FG017|Treatment Period|Other|1
1979570|NCT02733042|3543118|FG018|Treatment Period|Other|0
1979571|NCT02733042|3543100|FG000|Treatment Period|Ongoing on Assigned Treatment|0
1979572|NCT02733042|3543101|FG001|Treatment Period|Ongoing on Assigned Treatment|0
1979573|NCT02733042|3543102|FG002|Treatment Period|Ongoing on Assigned Treatment|0
1979574|NCT02733042|3543103|FG003|Treatment Period|Ongoing on Assigned Treatment|0
1979575|NCT02733042|3543104|FG004|Treatment Period|Ongoing on Assigned Treatment|3
1979576|NCT02733042|3543105|FG005|Treatment Period|Ongoing on Assigned Treatment|0
1979577|NCT02733042|3543106|FG006|Treatment Period|Ongoing on Assigned Treatment|0
1979578|NCT02733042|3543107|FG007|Treatment Period|Ongoing on Assigned Treatment|0
1979579|NCT02733042|3543108|FG008|Treatment Period|Ongoing on Assigned Treatment|0
1979580|NCT02733042|3543109|FG009|Treatment Period|Ongoing on Assigned Treatment|8
1979581|NCT02733042|3543110|FG010|Treatment Period|Ongoing on Assigned Treatment|4
1979582|NCT02733042|3543111|FG011|Treatment Period|Ongoing on Assigned Treatment|0
1979583|NCT02733042|3543112|FG012|Treatment Period|Ongoing on Assigned Treatment|0
1979584|NCT02733042|3543113|FG013|Treatment Period|Ongoing on Assigned Treatment|0
1979585|NCT02733042|3543114|FG014|Treatment Period|Ongoing on Assigned Treatment|0
1979586|NCT02733042|3543115|FG015|Treatment Period|Ongoing on Assigned Treatment|0
1979587|NCT02733042|3543116|FG016|Treatment Period|Ongoing on Assigned Treatment|0
1979588|NCT02733042|3543117|FG017|Treatment Period|Ongoing on Assigned Treatment|0
1979589|NCT02733042|3543118|FG018|Treatment Period|Ongoing on Assigned Treatment|1
1979590|NCT02733042|3543100|FG000|Treatment Period|Death|0
1979591|NCT02733042|3543101|FG001|Treatment Period|Death|0
1979592|NCT02733042|3543102|FG002|Treatment Period|Death|0
1979593|NCT02733042|3543103|FG003|Treatment Period|Death|0
1979594|NCT02733042|3543104|FG004|Treatment Period|Death|0
1979595|NCT02733042|3543105|FG005|Treatment Period|Death|0
1979596|NCT02733042|3543106|FG006|Treatment Period|Death|1
1979597|NCT02733042|3543107|FG007|Treatment Period|Death|0
1979598|NCT02733042|3543108|FG008|Treatment Period|Death|1
1979599|NCT02733042|3543109|FG009|Treatment Period|Death|0
1979600|NCT02733042|3543110|FG010|Treatment Period|Death|1
1979601|NCT02733042|3543111|FG011|Treatment Period|Death|0
1979602|NCT02733042|3543112|FG012|Treatment Period|Death|0
1979603|NCT02733042|3543113|FG013|Treatment Period|Death|0
1979604|NCT02733042|3543114|FG014|Treatment Period|Death|1
1979605|NCT02733042|3543115|FG015|Treatment Period|Death|2
1979606|NCT02733042|3543116|FG016|Treatment Period|Death|0
1979607|NCT02733042|3543117|FG017|Treatment Period|Death|0
1979608|NCT02733042|3543118|FG018|Treatment Period|Death|0
1979609|NCT02733042|3543100|FG000|Follow-up Period|Ongoing on Follow-up|2
1979610|NCT02733042|3543101|FG001|Follow-up Period|Ongoing on Follow-up|2
1979611|NCT02733042|3543102|FG002|Follow-up Period|Ongoing on Follow-up|4
1979612|NCT02733042|3543103|FG003|Follow-up Period|Ongoing on Follow-up|2
1979613|NCT02733042|3543104|FG004|Follow-up Period|Ongoing on Follow-up|0
1979614|NCT02733042|3543105|FG005|Follow-up Period|Ongoing on Follow-up|0
1979615|NCT02733042|3543106|FG006|Follow-up Period|Ongoing on Follow-up|0
1979616|NCT02733042|3543107|FG007|Follow-up Period|Ongoing on Follow-up|1
1979617|NCT02733042|3543108|FG008|Follow-up Period|Ongoing on Follow-up|0
1979618|NCT02733042|3543109|FG009|Follow-up Period|Ongoing on Follow-up|2
1979619|NCT02733042|3543110|FG010|Follow-up Period|Ongoing on Follow-up|4
1979620|NCT02733042|3543111|FG011|Follow-up Period|Ongoing on Follow-up|9
1979621|NCT02733042|3543112|FG012|Follow-up Period|Ongoing on Follow-up|1
1979622|NCT02733042|3543113|FG013|Follow-up Period|Ongoing on Follow-up|3
1979623|NCT02733042|3543114|FG014|Follow-up Period|Ongoing on Follow-up|0
1979624|NCT02733042|3543115|FG015|Follow-up Period|Ongoing on Follow-up|0
2213220|NCT01677195|3854649|FG000|Overall Study|Pregnancy|0
1979625|NCT02733042|3543116|FG016|Follow-up Period|Ongoing on Follow-up|0
1979626|NCT02733042|3543117|FG017|Follow-up Period|Ongoing on Follow-up|1
1979627|NCT02733042|3543118|FG018|Follow-up Period|Ongoing on Follow-up|0
1979628|NCT02733042|3543100|FG000|Follow-up Period|Death|1
1979629|NCT02733042|3543101|FG001|Follow-up Period|Death|1
1979630|NCT02733042|3543102|FG002|Follow-up Period|Death|2
1979631|NCT02733042|3543103|FG003|Follow-up Period|Death|0
1979632|NCT02733042|3543104|FG004|Follow-up Period|Death|1
1979633|NCT02733042|3543105|FG005|Follow-up Period|Death|2
1979634|NCT02733042|3543106|FG006|Follow-up Period|Death|0
1979635|NCT02733042|3543107|FG007|Follow-up Period|Death|3
1979636|NCT02733042|3543108|FG008|Follow-up Period|Death|3
1979637|NCT02733042|3543109|FG009|Follow-up Period|Death|0
2310382|NCT02732210|4014451|FG000|Overall Study|Site Closed|0
2310383|NCT02732210|4014452|FG001|Overall Study|Site Closed|11
2310384|NCT02732210|4014451|FG000|Overall Study|Study Ended|13
2310385|NCT02732210|4014452|FG001|Overall Study|Study Ended|13
2310386|NCT02732210|4014451|FG000|Overall Study|Withdrawal by Subject|28
2310387|NCT02732210|4014452|FG001|Overall Study|Withdrawal by Subject|87
1979638|NCT02733042|3543110|FG010|Follow-up Period|Death|0
1979639|NCT02733042|3543111|FG011|Follow-up Period|Death|0
1979640|NCT02733042|3543112|FG012|Follow-up Period|Death|8
1979641|NCT02733042|3543113|FG013|Follow-up Period|Death|1
1979642|NCT02733042|3543114|FG014|Follow-up Period|Death|1
1979643|NCT02733042|3543115|FG015|Follow-up Period|Death|4
1979644|NCT02733042|3543116|FG016|Follow-up Period|Death|0
1979645|NCT02733042|3543117|FG017|Follow-up Period|Death|1
1979646|NCT02733042|3543118|FG018|Follow-up Period|Death|2
1979647|NCT02733042|3543100|FG000|Follow-up Period|Other|0
1979648|NCT02733042|3543101|FG001|Follow-up Period|Other|0
1979649|NCT02733042|3543102|FG002|Follow-up Period|Other|0
1979650|NCT02733042|3543103|FG003|Follow-up Period|Other|1
1979651|NCT02733042|3543104|FG004|Follow-up Period|Other|0
1979652|NCT02733042|3543105|FG005|Follow-up Period|Other|0
1979653|NCT02733042|3543106|FG006|Follow-up Period|Other|0
1979654|NCT02733042|3543107|FG007|Follow-up Period|Other|0
1979655|NCT02733042|3543108|FG008|Follow-up Period|Other|0
1979656|NCT02733042|3543109|FG009|Follow-up Period|Other|0
1979657|NCT02733042|3543110|FG010|Follow-up Period|Other|0
1979658|NCT02733042|3543111|FG011|Follow-up Period|Other|0
1979659|NCT02733042|3543112|FG012|Follow-up Period|Other|0
1979660|NCT02733042|3543113|FG013|Follow-up Period|Other|0
1979661|NCT02733042|3543114|FG014|Follow-up Period|Other|0
1979662|NCT02733042|3543115|FG015|Follow-up Period|Other|0
1979663|NCT02733042|3543116|FG016|Follow-up Period|Other|0
1979664|NCT02733042|3543117|FG017|Follow-up Period|Other|0
1979665|NCT02733042|3543118|FG018|Follow-up Period|Other|0
1979666|NCT02733042|3543100|FG000|Follow-up Period|Withdrawal by Subject|0
1979667|NCT02733042|3543101|FG001|Follow-up Period|Withdrawal by Subject|0
1979668|NCT02733042|3543102|FG002|Follow-up Period|Withdrawal by Subject|0
1979669|NCT02733042|3543103|FG003|Follow-up Period|Withdrawal by Subject|0
1979670|NCT02733042|3543104|FG004|Follow-up Period|Withdrawal by Subject|0
1979671|NCT02733042|3543105|FG005|Follow-up Period|Withdrawal by Subject|0
1979672|NCT02733042|3543106|FG006|Follow-up Period|Withdrawal by Subject|0
1979673|NCT02733042|3543107|FG007|Follow-up Period|Withdrawal by Subject|0
1979674|NCT02733042|3543108|FG008|Follow-up Period|Withdrawal by Subject|1
1979675|NCT02733042|3543109|FG009|Follow-up Period|Withdrawal by Subject|0
1979676|NCT02733042|3543110|FG010|Follow-up Period|Withdrawal by Subject|1
1979677|NCT02733042|3543111|FG011|Follow-up Period|Withdrawal by Subject|0
1979678|NCT02733042|3543112|FG012|Follow-up Period|Withdrawal by Subject|0
1979679|NCT02733042|3543113|FG013|Follow-up Period|Withdrawal by Subject|0
1979680|NCT02733042|3543114|FG014|Follow-up Period|Withdrawal by Subject|0
1979681|NCT02733042|3543115|FG015|Follow-up Period|Withdrawal by Subject|1
1979682|NCT02733042|3543116|FG016|Follow-up Period|Withdrawal by Subject|0
1979683|NCT02733042|3543117|FG017|Follow-up Period|Withdrawal by Subject|0
1979684|NCT02733042|3543118|FG018|Follow-up Period|Withdrawal by Subject|0
2023189|NCT00323297|3591162|FG000|Part A (Double Blind Randomized)|Related adverse event|2
2023190|NCT00323297|3591163|FG001|Part A (Double Blind Randomized)|Related adverse event|2
2023191|NCT00323297|3591162|FG000|Part B (Open-label)|Death|0
2023192|NCT00323297|3591163|FG001|Part B (Open-label)|Death|1
2023193|NCT00323297|3591162|FG000|Part B (Open-label)|Reason unspecified|0
2023194|NCT00323297|3591163|FG001|Part B (Open-label)|Reason unspecified|1
2023195|NCT00323297|3591162|FG000|Part B (Open-label)|Withdrawal by Subject|1
2023196|NCT00323297|3591163|FG001|Part B (Open-label)|Withdrawal by Subject|3
2023197|NCT00323297|3591162|FG000|Part B (Open-label)|Lack of Efficacy|3
2023198|NCT00323297|3591163|FG001|Part B (Open-label)|Lack of Efficacy|1
2023199|NCT00323297|3591162|FG000|Part B (Open-label)|Adverse Event|5
2023200|NCT00323297|3591163|FG001|Part B (Open-label)|Adverse Event|5
2023201|NCT00323297|3591162|FG000|Part B (Open-label)|Protocol Violation|0
2023202|NCT00323297|3591163|FG001|Part B (Open-label)|Protocol Violation|1
2023203|NCT00323310|3591169|FG000|Overall Study|Withdrawal by Subject|1
2023204|NCT00323310|3591169|FG000|Overall Study|a parent refused blood draw|1
2023205|NCT00323310|3591169|FG000|Overall Study|did not complete the 24-hr f-up visit|1
2023206|NCT00323414|3591179|FG000|Overall Study|Withdrawal by Subject|0
2023207|NCT00323414|3591180|FG001|Overall Study|Withdrawal by Subject|1
2023208|NCT00323479|3591204|FG000|Overall Study|Adverse Event|2
2023209|NCT00323479|3591204|FG000|Overall Study|Withdrawal by Subject|2
2023210|NCT00323479|3591204|FG000|Overall Study|Protocol Violation|3
2023211|NCT00323479|3591204|FG000|Overall Study|house moving|1
2023212|NCT00323492|3591210|FG000|Study Phase 1|Adverse Event|2
2023213|NCT00323492|3591211|FG001|Study Phase 1|Adverse Event|0
2023214|NCT00323492|3591212|FG002|Study Phase 1|Adverse Event|0
2023215|NCT00323492|3591210|FG000|Study Phase 2|Adverse Event|1
2023216|NCT00323492|3591211|FG001|Study Phase 2|Adverse Event|0
2023217|NCT00323492|3591212|FG002|Study Phase 2|Adverse Event|0
2023218|NCT00323492|3591210|FG000|Study Phase 2|Physician Decision|1
2023219|NCT00323492|3591211|FG001|Study Phase 2|Physician Decision|0
2023220|NCT00323492|3591212|FG002|Study Phase 2|Physician Decision|0
2023221|NCT00323492|3591210|FG000|Study Phase 2|Lost to Follow-up|1
2023222|NCT00323492|3591211|FG001|Study Phase 2|Lost to Follow-up|0
2023223|NCT00323492|3591212|FG002|Study Phase 2|Lost to Follow-up|0
2023224|NCT00323492|3591210|FG000|Study Phase 2|Withdrawal by Subject|0
2023225|NCT00323492|3591211|FG001|Study Phase 2|Withdrawal by Subject|1
2023226|NCT00323492|3591212|FG002|Study Phase 2|Withdrawal by Subject|0
2023227|NCT00323492|3591210|FG000|Study Phase 2|Noncompliance with study schedule|0
2023228|NCT00323492|3591211|FG001|Study Phase 2|Noncompliance with study schedule|0
2023229|NCT00323492|3591212|FG002|Study Phase 2|Noncompliance with study schedule|1
2023230|NCT00323492|3591210|FG000|Study Phase 2|Protocol Violation|1
2023231|NCT00323492|3591211|FG001|Study Phase 2|Protocol Violation|0
2023232|NCT00323492|3591212|FG002|Study Phase 2|Protocol Violation|0
2023233|NCT00323557|3591221|FG000|Overall Study|Physician Decision|1
2023234|NCT00323557|3591222|FG001|Overall Study|Physician Decision|0
2023235|NCT00323609|3591231|FG000|Overall Study|Death|16
2023236|NCT00323609|3591232|FG001|Overall Study|Death|21
1979685|NCT02574286|3543179|FG000|Overall Study|Adverse Event|3
1979686|NCT02574286|3543179|FG000|Overall Study|Withdrawal by Subject|2
1979687|NCT02471144|3543187|FG000|Induction Period (Up to Week 12)|Adverse Event|0
1979688|NCT02471144|3543188|FG001|Induction Period (Up to Week 12)|Adverse Event|1
1979689|NCT02471144|3543189|FG002|Induction Period (Up to Week 12)|Adverse Event|1
1979690|NCT02471144|3543190|FG003|Induction Period (Up to Week 12)|Adverse Event|0
1979691|NCT02471144|3543191|FG004|Induction Period (Up to Week 12)|Adverse Event|0
1979692|NCT02471144|3543192|FG005|Induction Period (Up to Week 12)|Adverse Event|0
1979693|NCT02471144|3543193|FG006|Induction Period (Up to Week 12)|Adverse Event|0
1979694|NCT02471144|3543194|FG007|Induction Period (Up to Week 12)|Adverse Event|0
1979695|NCT02471144|3543195|FG008|Induction Period (Up to Week 12)|Adverse Event|0
1979696|NCT02471144|3543196|FG009|Induction Period (Up to Week 12)|Adverse Event|0
1979697|NCT02471144|3543197|FG010|Induction Period (Up to Week 12)|Adverse Event|0
1979698|NCT02471144|3543187|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0
1979699|NCT02471144|3543188|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0
1979700|NCT02471144|3543189|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0
1979701|NCT02471144|3543190|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1
1979702|NCT02471144|3543191|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0
1979703|NCT02471144|3543192|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0
1979704|NCT02471144|3543193|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0
1979705|NCT02471144|3543194|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0
1979706|NCT02471144|3543195|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0
1979707|NCT02471144|3543196|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0
1979708|NCT02471144|3543197|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0
1979709|NCT02471144|3543187|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0
1979710|NCT02471144|3543188|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0
1979711|NCT02471144|3543189|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1
1979712|NCT02471144|3543190|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0
1979713|NCT02471144|3543191|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0
1979714|NCT02471144|3543192|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0
1979715|NCT02471144|3543193|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0
1979716|NCT02471144|3543194|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0
1979717|NCT02471144|3543195|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0
1979718|NCT02471144|3543196|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0
1979719|NCT02471144|3543197|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0
1979720|NCT02471144|3543187|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
1979721|NCT02471144|3543188|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
1979722|NCT02471144|3543189|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1979723|NCT02471144|3543190|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1979724|NCT02471144|3543191|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1979725|NCT02471144|3543192|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1979726|NCT02471144|3543193|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1979727|NCT02471144|3543194|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1979728|NCT02471144|3543195|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1979729|NCT02471144|3543196|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1979730|NCT02471144|3543197|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
1979731|NCT02471144|3543187|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1979732|NCT02471144|3543188|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1979733|NCT02471144|3543189|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1979734|NCT02471144|3543190|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1979735|NCT02471144|3543191|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
1979736|NCT02471144|3543192|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1979737|NCT02471144|3543193|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
1979738|NCT02471144|3543194|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1979739|NCT02471144|3543195|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
1979740|NCT02471144|3543196|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1979741|NCT02471144|3543197|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
1979742|NCT02471144|3543187|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1979743|NCT02471144|3543188|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1979744|NCT02471144|3543189|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1979745|NCT02471144|3543190|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1979746|NCT02471144|3543191|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1979747|NCT02471144|3543192|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1
1979748|NCT02471144|3543193|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1979749|NCT02471144|3543194|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1979750|NCT02471144|3543195|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3
1979751|NCT02471144|3543196|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1979752|NCT02471144|3543197|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
1979753|NCT02471144|3543187|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1979754|NCT02471144|3543188|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1979755|NCT02471144|3543189|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1979756|NCT02471144|3543190|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1979757|NCT02471144|3543191|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1979758|NCT02471144|3543192|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1979759|NCT02471144|3543193|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1979760|NCT02471144|3543194|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1979761|NCT02471144|3543195|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1
1979762|NCT02471144|3543196|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1979763|NCT02471144|3543197|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
1979764|NCT02471144|3543187|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1979765|NCT02471144|3543188|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1979766|NCT02471144|3543189|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1979767|NCT02471144|3543190|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1979768|NCT02471144|3543191|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1979769|NCT02471144|3543192|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1979770|NCT02471144|3543193|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1979771|NCT02471144|3543194|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2
1979772|NCT02471144|3543195|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1
1979773|NCT02471144|3543196|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1979774|NCT02471144|3543197|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
1979775|NCT02471144|3543187|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1979776|NCT02471144|3543188|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1979777|NCT02471144|3543189|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1979778|NCT02471144|3543190|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1979779|NCT02471144|3543191|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1979780|NCT02471144|3543192|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1979781|NCT02471144|3543193|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1979782|NCT02471144|3543194|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1979783|NCT02471144|3543195|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
1979784|NCT02471144|3543196|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5
1979785|NCT02471144|3543197|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2
1979786|NCT02471144|3543187|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0
1979787|NCT02471144|3543188|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0
1979788|NCT02471144|3543189|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0
1979789|NCT02471144|3543190|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0
1979790|NCT02471144|3543191|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0
1979791|NCT02471144|3543192|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0
1979792|NCT02471144|3543193|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0
1979793|NCT02471144|3543194|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0
1979794|NCT02471144|3543195|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0
1979795|NCT02471144|3543196|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2
1979796|NCT02471144|3543197|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0
1979797|NCT02471144|3543187|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1979798|NCT02471144|3543188|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1979799|NCT02471144|3543189|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1979800|NCT02471144|3543190|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1979801|NCT02471144|3543191|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1979802|NCT02471144|3543192|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1979803|NCT02471144|3543193|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1979804|NCT02471144|3543194|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1979805|NCT02471144|3543195|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1979806|NCT02471144|3543196|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
1979807|NCT02471144|3543197|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2
1979808|NCT02440464|3543215|FG000|Overall Study|Withdrawal by Subject|3
1979809|NCT02440464|3543216|FG001|Overall Study|Withdrawal by Subject|2
1979810|NCT02366728|3543233|FG000|Overall Study|Death|0
1979811|NCT02366728|3543234|FG001|Overall Study|Death|0
1979812|NCT02366728|3543235|FG002|Overall Study|Death|1
1979813|NCT02366728|3543233|FG000|Overall Study|Adverse Event|1
1979814|NCT02366728|3543234|FG001|Overall Study|Adverse Event|0
1979815|NCT02366728|3543235|FG002|Overall Study|Adverse Event|0
1979816|NCT02366728|3543233|FG000|Overall Study|Screen Failure|2
1979817|NCT02366728|3543234|FG001|Overall Study|Screen Failure|1
1979818|NCT02366728|3543235|FG002|Overall Study|Screen Failure|0
1979819|NCT02366728|3543233|FG000|Overall Study|Only yielded 2 vaccines|1
1979820|NCT02366728|3543234|FG001|Overall Study|Only yielded 2 vaccines|0
1979821|NCT02366728|3543235|FG002|Overall Study|Only yielded 2 vaccines|0
1979822|NCT02236572|3543243|FG000|Overall Study|Withdrawal by Subject|1
1979823|NCT02236572|3543243|FG000|Overall Study|Protocol Violation|1
1979824|NCT02236572|3543243|FG000|Overall Study|Lost to Follow-up|1
1979825|NCT02083354|3543247|FG000|Overall Study|Withdrawal by Subject|9
1979826|NCT02083354|3543247|FG000|Overall Study|Lost to Follow-up|1
1979827|NCT02083354|3543247|FG000|Overall Study|Adverse Event|3
1979828|NCT02083354|3543247|FG000|Overall Study|Disease progression|46
1979829|NCT02083354|3543247|FG000|Overall Study|Study closed/terminated|5
1979830|NCT01885078|3543259|FG000|Treatment Period|Adverse Event|52
1979831|NCT01885078|3543260|FG001|Treatment Period|Adverse Event|136
1979832|NCT01885078|3543261|FG002|Treatment Period|Adverse Event|30
1979833|NCT01885078|3543262|FG003|Treatment Period|Adverse Event|73
1979834|NCT01885078|3543263|FG004|Treatment Period|Adverse Event|17
1979835|NCT01885078|3543264|FG005|Treatment Period|Adverse Event|72
1979836|NCT01885078|3543265|FG006|Treatment Period|Adverse Event|24
1979837|NCT01885078|3543266|FG007|Treatment Period|Adverse Event|5
1979838|NCT01885078|3543267|FG008|Treatment Period|Adverse Event|0
1979839|NCT01885078|3543268|FG009|Treatment Period|Adverse Event|0
1979840|NCT01885078|3543259|FG000|Treatment Period|Death|13
1979841|NCT01885078|3543260|FG001|Treatment Period|Death|33
1979842|NCT01885078|3543261|FG002|Treatment Period|Death|5
1979843|NCT01885078|3543262|FG003|Treatment Period|Death|9
1979844|NCT01885078|3543263|FG004|Treatment Period|Death|2
1979845|NCT01885078|3543264|FG005|Treatment Period|Death|10
1979846|NCT01885078|3543265|FG006|Treatment Period|Death|3
1979847|NCT01885078|3543266|FG007|Treatment Period|Death|2
1979848|NCT01885078|3543267|FG008|Treatment Period|Death|0
1979849|NCT01885078|3543268|FG009|Treatment Period|Death|0
1979850|NCT01885078|3543259|FG000|Treatment Period|Lack of Efficacy|12
1979851|NCT01885078|3543260|FG001|Treatment Period|Lack of Efficacy|33
1979852|NCT01885078|3543261|FG002|Treatment Period|Lack of Efficacy|10
1979853|NCT01885078|3543262|FG003|Treatment Period|Lack of Efficacy|23
1979854|NCT01885078|3543263|FG004|Treatment Period|Lack of Efficacy|24
1979855|NCT01885078|3543264|FG005|Treatment Period|Lack of Efficacy|58
1979856|NCT01885078|3543265|FG006|Treatment Period|Lack of Efficacy|9
1979857|NCT01885078|3543266|FG007|Treatment Period|Lack of Efficacy|5
1979858|NCT01885078|3543267|FG008|Treatment Period|Lack of Efficacy|0
1979859|NCT01885078|3543268|FG009|Treatment Period|Lack of Efficacy|0
1979860|NCT01885078|3543259|FG000|Treatment Period|Lost to Follow-up|16
1979861|NCT01885078|3543260|FG001|Treatment Period|Lost to Follow-up|19
1979862|NCT01885078|3543261|FG002|Treatment Period|Lost to Follow-up|7
1979863|NCT01885078|3543262|FG003|Treatment Period|Lost to Follow-up|9
1979864|NCT01885078|3543263|FG004|Treatment Period|Lost to Follow-up|2
1979865|NCT01885078|3543264|FG005|Treatment Period|Lost to Follow-up|8
1979866|NCT01885078|3543265|FG006|Treatment Period|Lost to Follow-up|2
1979867|NCT01885078|3543266|FG007|Treatment Period|Lost to Follow-up|0
1979868|NCT01885078|3543267|FG008|Treatment Period|Lost to Follow-up|0
1979869|NCT01885078|3543268|FG009|Treatment Period|Lost to Follow-up|0
1979870|NCT01885078|3543259|FG000|Treatment Period|Physician Decision|19
1979871|NCT01885078|3543260|FG001|Treatment Period|Physician Decision|21
1979872|NCT01885078|3543261|FG002|Treatment Period|Physician Decision|5
1979873|NCT01885078|3543262|FG003|Treatment Period|Physician Decision|12
1979874|NCT01885078|3543263|FG004|Treatment Period|Physician Decision|9
1979875|NCT01885078|3543264|FG005|Treatment Period|Physician Decision|24
1979876|NCT01885078|3543265|FG006|Treatment Period|Physician Decision|4
1979877|NCT01885078|3543266|FG007|Treatment Period|Physician Decision|3
1979878|NCT01885078|3543267|FG008|Treatment Period|Physician Decision|0
1979879|NCT01885078|3543268|FG009|Treatment Period|Physician Decision|0
1979880|NCT01885078|3543259|FG000|Treatment Period|Protocol Violation|3
1979881|NCT01885078|3543260|FG001|Treatment Period|Protocol Violation|5
1979882|NCT01885078|3543261|FG002|Treatment Period|Protocol Violation|0
1979883|NCT01885078|3543262|FG003|Treatment Period|Protocol Violation|3
1979884|NCT01885078|3543263|FG004|Treatment Period|Protocol Violation|1
1979885|NCT01885078|3543264|FG005|Treatment Period|Protocol Violation|6
1979886|NCT01885078|3543265|FG006|Treatment Period|Protocol Violation|0
1979887|NCT01885078|3543266|FG007|Treatment Period|Protocol Violation|0
1979888|NCT01885078|3543267|FG008|Treatment Period|Protocol Violation|0
1979889|NCT01885078|3543268|FG009|Treatment Period|Protocol Violation|0
1979890|NCT01885078|3543259|FG000|Treatment Period|Sponsor Decision|245
1979891|NCT01885078|3543260|FG001|Treatment Period|Sponsor Decision|648
1979892|NCT01885078|3543261|FG002|Treatment Period|Sponsor Decision|49
1979893|NCT01885078|3543262|FG003|Treatment Period|Sponsor Decision|90
1979894|NCT01885078|3543263|FG004|Treatment Period|Sponsor Decision|20
1979895|NCT01885078|3543264|FG005|Treatment Period|Sponsor Decision|38
1979896|NCT01885078|3543265|FG006|Treatment Period|Sponsor Decision|162
1979897|NCT01885078|3543266|FG007|Treatment Period|Sponsor Decision|3
1979898|NCT01885078|3543267|FG008|Treatment Period|Sponsor Decision|0
1979899|NCT01885078|3543268|FG009|Treatment Period|Sponsor Decision|0
1979900|NCT01885078|3543259|FG000|Treatment Period|Withdrawal by Subject|72
1979901|NCT01885078|3543260|FG001|Treatment Period|Withdrawal by Subject|132
1979902|NCT01885078|3543261|FG002|Treatment Period|Withdrawal by Subject|25
1979903|NCT01885078|3543262|FG003|Treatment Period|Withdrawal by Subject|63
1979904|NCT01885078|3543263|FG004|Treatment Period|Withdrawal by Subject|15
1979905|NCT01885078|3543264|FG005|Treatment Period|Withdrawal by Subject|34
1979906|NCT01885078|3543265|FG006|Treatment Period|Withdrawal by Subject|17
1979907|NCT01885078|3543266|FG007|Treatment Period|Withdrawal by Subject|10
1979908|NCT01885078|3543267|FG008|Treatment Period|Withdrawal by Subject|0
1979909|NCT01885078|3543268|FG009|Treatment Period|Withdrawal by Subject|0
1979910|NCT01885078|3543259|FG000|Treatment Period|Other|0
1979911|NCT01885078|3543260|FG001|Treatment Period|Other|0
1979912|NCT01885078|3543261|FG002|Treatment Period|Other|0
1979913|NCT01885078|3543262|FG003|Treatment Period|Other|1
1979914|NCT01885078|3543263|FG004|Treatment Period|Other|0
1979915|NCT01885078|3543264|FG005|Treatment Period|Other|0
1979916|NCT01885078|3543265|FG006|Treatment Period|Other|0
1979917|NCT01885078|3543266|FG007|Treatment Period|Other|0
1979918|NCT01885078|3543267|FG008|Treatment Period|Other|0
1979919|NCT01885078|3543268|FG009|Treatment Period|Other|0
1979920|NCT01885078|3543259|FG000|Step-down Period|Sponsor Decision|0
1979921|NCT01885078|3543260|FG001|Step-down Period|Sponsor Decision|0
1979922|NCT01885078|3543261|FG002|Step-down Period|Sponsor Decision|0
1979923|NCT01885078|3543262|FG003|Step-down Period|Sponsor Decision|0
1979924|NCT01885078|3543263|FG004|Step-down Period|Sponsor Decision|0
1979925|NCT01885078|3543264|FG005|Step-down Period|Sponsor Decision|0
1979926|NCT01885078|3543265|FG006|Step-down Period|Sponsor Decision|0
1979927|NCT01885078|3543266|FG007|Step-down Period|Sponsor Decision|0
1979928|NCT01885078|3543267|FG008|Step-down Period|Sponsor Decision|1
1979929|NCT01885078|3543268|FG009|Step-down Period|Sponsor Decision|1
1979930|NCT01885078|3543259|FG000|Step-down Period|Adverse Event|0
1979931|NCT01885078|3543260|FG001|Step-down Period|Adverse Event|0
1979932|NCT01885078|3543261|FG002|Step-down Period|Adverse Event|0
1979933|NCT01885078|3543262|FG003|Step-down Period|Adverse Event|0
1979934|NCT01885078|3543263|FG004|Step-down Period|Adverse Event|0
1979935|NCT01885078|3543264|FG005|Step-down Period|Adverse Event|0
1979936|NCT01885078|3543265|FG006|Step-down Period|Adverse Event|0
1979937|NCT01885078|3543266|FG007|Step-down Period|Adverse Event|0
1979938|NCT01885078|3543267|FG008|Step-down Period|Adverse Event|29
1979939|NCT01885078|3543268|FG009|Step-down Period|Adverse Event|38
1979940|NCT01885078|3543259|FG000|Step-down Period|Withdrawal by Subject|0
1979941|NCT01885078|3543260|FG001|Step-down Period|Withdrawal by Subject|0
1979942|NCT01885078|3543261|FG002|Step-down Period|Withdrawal by Subject|0
1979943|NCT01885078|3543262|FG003|Step-down Period|Withdrawal by Subject|0
1979944|NCT01885078|3543263|FG004|Step-down Period|Withdrawal by Subject|0
1979945|NCT01885078|3543264|FG005|Step-down Period|Withdrawal by Subject|0
1979946|NCT01885078|3543265|FG006|Step-down Period|Withdrawal by Subject|0
1979947|NCT01885078|3543266|FG007|Step-down Period|Withdrawal by Subject|0
1979948|NCT01885078|3543267|FG008|Step-down Period|Withdrawal by Subject|25
1979949|NCT01885078|3543268|FG009|Step-down Period|Withdrawal by Subject|15
1979950|NCT01885078|3543259|FG000|Step-down Period|Physician Decision|0
1979951|NCT01885078|3543260|FG001|Step-down Period|Physician Decision|0
1979952|NCT01885078|3543261|FG002|Step-down Period|Physician Decision|0
1979953|NCT01885078|3543262|FG003|Step-down Period|Physician Decision|0
1979954|NCT01885078|3543263|FG004|Step-down Period|Physician Decision|0
1979955|NCT01885078|3543264|FG005|Step-down Period|Physician Decision|0
1979956|NCT01885078|3543265|FG006|Step-down Period|Physician Decision|0
1979957|NCT01885078|3543266|FG007|Step-down Period|Physician Decision|0
1979958|NCT01885078|3543267|FG008|Step-down Period|Physician Decision|7
1979959|NCT01885078|3543268|FG009|Step-down Period|Physician Decision|2
1979960|NCT01885078|3543259|FG000|Step-down Period|Death|0
1979961|NCT01885078|3543260|FG001|Step-down Period|Death|0
1979962|NCT01885078|3543261|FG002|Step-down Period|Death|0
1979963|NCT01885078|3543262|FG003|Step-down Period|Death|0
1979964|NCT01885078|3543263|FG004|Step-down Period|Death|0
1979965|NCT01885078|3543264|FG005|Step-down Period|Death|0
1979966|NCT01885078|3543265|FG006|Step-down Period|Death|0
1979967|NCT01885078|3543266|FG007|Step-down Period|Death|0
1979968|NCT01885078|3543267|FG008|Step-down Period|Death|4
1979969|NCT01885078|3543268|FG009|Step-down Period|Death|3
1979970|NCT01885078|3543259|FG000|Step-down Period|Lost to Follow-up|0
1979971|NCT01885078|3543260|FG001|Step-down Period|Lost to Follow-up|0
1979972|NCT01885078|3543261|FG002|Step-down Period|Lost to Follow-up|0
1979973|NCT01885078|3543262|FG003|Step-down Period|Lost to Follow-up|0
1979974|NCT01885078|3543263|FG004|Step-down Period|Lost to Follow-up|0
1979975|NCT01885078|3543264|FG005|Step-down Period|Lost to Follow-up|0
1979976|NCT01885078|3543265|FG006|Step-down Period|Lost to Follow-up|0
1979977|NCT01885078|3543266|FG007|Step-down Period|Lost to Follow-up|0
1979978|NCT01885078|3543267|FG008|Step-down Period|Lost to Follow-up|1
1979979|NCT01885078|3543268|FG009|Step-down Period|Lost to Follow-up|1
1979980|NCT01885078|3543259|FG000|Step-down Period|Lack of Efficacy|0
1979981|NCT01885078|3543260|FG001|Step-down Period|Lack of Efficacy|0
1979982|NCT01885078|3543261|FG002|Step-down Period|Lack of Efficacy|0
1979983|NCT01885078|3543262|FG003|Step-down Period|Lack of Efficacy|0
1979984|NCT01885078|3543263|FG004|Step-down Period|Lack of Efficacy|0
1979985|NCT01885078|3543264|FG005|Step-down Period|Lack of Efficacy|0
1979986|NCT01885078|3543265|FG006|Step-down Period|Lack of Efficacy|0
1979987|NCT01885078|3543266|FG007|Step-down Period|Lack of Efficacy|0
1979988|NCT01885078|3543267|FG008|Step-down Period|Lack of Efficacy|1
1979989|NCT01885078|3543268|FG009|Step-down Period|Lack of Efficacy|0
1979990|NCT01885078|3543259|FG000|Step-down Period|Protocol Violation|0
2213221|NCT01677195|3854650|FG001|Overall Study|Pregnancy|1
2213222|NCT01677195|3854651|FG002|Overall Study|Pregnancy|0
2213223|NCT01677195|3854649|FG000|Overall Study|Protocol Violation|7
1979991|NCT01885078|3543260|FG001|Step-down Period|Protocol Violation|0
1979992|NCT01885078|3543261|FG002|Step-down Period|Protocol Violation|0
1979993|NCT01885078|3543262|FG003|Step-down Period|Protocol Violation|0
1979994|NCT01885078|3543263|FG004|Step-down Period|Protocol Violation|0
1979995|NCT01885078|3543264|FG005|Step-down Period|Protocol Violation|0
1979996|NCT01885078|3543265|FG006|Step-down Period|Protocol Violation|0
1979997|NCT01885078|3543266|FG007|Step-down Period|Protocol Violation|0
1979998|NCT01885078|3543267|FG008|Step-down Period|Protocol Violation|1
1979999|NCT01885078|3543268|FG009|Step-down Period|Protocol Violation|1
1980000|NCT01446016|3543319|FG000|Overall Study|Lost to Follow-up|3
1980001|NCT01446016|3543319|FG000|Overall Study|Withdrawal by Subject|1
1980002|NCT01446016|3543319|FG000|Overall Study|Toxicity|3
1980003|NCT01434602|3543341|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
1980004|NCT01434602|3543342|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1
1980005|NCT01434602|3543343|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
1980006|NCT01434602|3543344|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
1980007|NCT01434602|3543345|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
1980008|NCT01434602|3543341|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
1980009|NCT01434602|3543342|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
1980010|NCT01434602|3543343|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
1980011|NCT01434602|3543344|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1
1980012|NCT01434602|3543345|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
1980013|NCT01434602|3543341|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
1980014|NCT01434602|3543342|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
1980015|NCT01434602|3543343|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
1980016|NCT01434602|3543344|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1
1980017|NCT01434602|3543345|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
1980018|NCT01434602|3543341|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0
1980019|NCT01434602|3543342|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0
1980020|NCT01434602|3543343|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0
1980021|NCT01434602|3543344|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1
1980022|NCT01434602|3543345|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0
1980023|NCT01434602|3543341|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
1980024|NCT01434602|3543342|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
1980025|NCT01434602|3543343|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
1980026|NCT01434602|3543344|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1
1980027|NCT01434602|3543345|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
1980028|NCT01434602|3543341|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0
1980029|NCT01434602|3543342|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0
1980030|NCT01434602|3543343|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0
1980031|NCT01434602|3543344|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1
1980032|NCT01434602|3543345|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0
1980033|NCT01434602|3543341|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
1980034|NCT01434602|3543342|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
1980035|NCT01434602|3543343|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
1980036|NCT01434602|3543344|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
1980037|NCT01434602|3543345|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1
1980038|NCT01434602|3543341|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0
1980039|NCT01434602|3543342|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0
1980040|NCT01434602|3543343|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0
1980041|NCT01434602|3543344|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1
1980042|NCT01434602|3543345|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1
1980043|NCT01434602|3543341|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
1980044|NCT01434602|3543342|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
1980045|NCT01434602|3543343|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
1980046|NCT01434602|3543344|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1
1980047|NCT01434602|3543345|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
1980048|NCT01434602|3543341|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0
1980049|NCT01434602|3543342|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0
1980050|NCT01434602|3543343|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0
1980051|NCT01434602|3543344|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2
1980052|NCT01434602|3543345|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0
1980053|NCT01411332|3543366|FG000|Overall Study|Lost to Follow-up|1
1980054|NCT01411332|3543367|FG001|Overall Study|Lost to Follow-up|0
1980055|NCT01411332|3543366|FG000|Overall Study|Protocol Violation|1
1980056|NCT01411332|3543367|FG001|Overall Study|Protocol Violation|1
1980057|NCT01411332|3543366|FG000|Overall Study|Withdrawal by Subject|0
1980058|NCT01411332|3543367|FG001|Overall Study|Withdrawal by Subject|1
1980059|NCT01399918|3543373|FG000|Overall Study|Not eligible and not enrolled in the study|2
1980060|NCT01147653|3543383|FG000|Year 2|Withdrawal by Subject|2
1980061|NCT01147653|3543384|FG001|Year 2|Withdrawal by Subject|3
1980062|NCT01078454|3543404|FG000|Overall Study|Adverse Event|1
1980063|NCT01078454|3543405|FG001|Overall Study|Adverse Event|1
1980064|NCT01078454|3543404|FG000|Overall Study|Death|0
1980065|NCT01078454|3543405|FG001|Overall Study|Death|1
1980066|NCT00687596|3543413|FG000|Overall Study|Adverse Event (AE)|10
1980067|NCT00687596|3543414|FG001|Overall Study|Adverse Event (AE)|3
1980068|NCT00687596|3543413|FG000|Overall Study|Radiological Disease Progression|6
1980069|NCT00687596|3543414|FG001|Overall Study|Radiological Disease Progression|2
1980070|NCT00687596|3543413|FG000|Overall Study|Clinical Disease Progression|1
2310388|NCT02732210|4014451|FG000|Overall Study|Lost to Follow-up|5
2310389|NCT02732210|4014452|FG001|Overall Study|Lost to Follow-up|57
2310390|NCT02732210|4014451|FG000|Overall Study|Death|4
2310391|NCT02732210|4014452|FG001|Overall Study|Death|15
2310392|NCT02732210|4014451|FG000|Overall Study|Other|35
2310393|NCT02732210|4014452|FG001|Overall Study|Other|103
2310394|NCT02732210|4014451|FG000|Overall Study|Missing|0
2310395|NCT02732210|4014452|FG001|Overall Study|Missing|8
2310396|NCT02732561|4014472|FG000|Overall Study|Lost to Follow-up|1
2310397|NCT02732561|4014473|FG001|Overall Study|Lost to Follow-up|1
2310398|NCT02732561|4014472|FG000|Overall Study|Withdrawal by Subject|1
2310399|NCT02732561|4014473|FG001|Overall Study|Withdrawal by Subject|0
2310400|NCT02732639|4014493|FG000|Overall Study|Lost to Follow-up|1
2310401|NCT02732847|4014499|FG000|Overall Study|some filled early|42
2310402|NCT02732847|4014500|FG001|Overall Study|some filled early|42
2310403|NCT02732912|4014517|FG000|Overall Study|Discharged before night|2
2310404|NCT02732912|4014518|FG001|Overall Study|Discharged before night|6
2310405|NCT02732912|4014517|FG000|Overall Study|Incomplete completion of questionnaire|2
2310406|NCT02732912|4014518|FG001|Overall Study|Incomplete completion of questionnaire|3
2310407|NCT02732912|4014517|FG000|Overall Study|No outcome; discharged or refused|6
2310408|NCT02732912|4014518|FG001|Overall Study|No outcome; discharged or refused|9
2310409|NCT02732938|4014526|FG000|Overall Study|Death|0
2310410|NCT02732938|4014527|FG001|Overall Study|Death|11
2310411|NCT02732938|4014528|FG002|Overall Study|Death|0
2310412|NCT02732938|4014526|FG000|Overall Study|Randomized but did not receive treatment|0
2310413|NCT02732938|4014527|FG001|Overall Study|Randomized but did not receive treatment|1
2310414|NCT02732938|4014528|FG002|Overall Study|Randomized but did not receive treatment|0
2310415|NCT02732938|4014526|FG000|Overall Study|Refused further follow-up|1
2310416|NCT02732938|4014527|FG001|Overall Study|Refused further follow-up|0
2310417|NCT02732938|4014528|FG002|Overall Study|Refused further follow-up|0
2310418|NCT02732938|4014526|FG000|Overall Study|Study terminated by sponsor|3
2310419|NCT02732938|4014527|FG001|Overall Study|Study terminated by sponsor|6
2310420|NCT02732938|4014528|FG002|Overall Study|Study terminated by sponsor|0
2310421|NCT02732951|4014538|FG000|Overall Study|Other than listed|1
2310422|NCT02732951|4014539|FG001|Overall Study|Other than listed|0
2310423|NCT02732951|4014538|FG000|Overall Study|Lost to Follow-up|0
2310424|NCT02732951|4014539|FG001|Overall Study|Lost to Follow-up|1
2310425|NCT02732951|4014538|FG000|Overall Study|Adverse Event|4
2310426|NCT02732951|4014539|FG001|Overall Study|Adverse Event|4
2310427|NCT02732951|4014538|FG000|Overall Study|Protocol Violation|0
2310428|NCT02732951|4014539|FG001|Overall Study|Protocol Violation|1
2310429|NCT02733367|4014545|FG000|Overall Study|Withdrawal by Subject|6
2310430|NCT02733627|4014558|FG000|Overall Study|Adverse Event|0
2310431|NCT02733627|4014559|FG001|Overall Study|Adverse Event|1
2310432|NCT02733627|4014560|FG002|Overall Study|Adverse Event|1
2310433|NCT02733627|4014561|FG003|Overall Study|Adverse Event|0
2310434|NCT02733627|4014558|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
2310435|NCT02733627|4014559|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
2310436|NCT02733627|4014560|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1
2310437|NCT02733627|4014561|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
2310438|NCT02733991|4014594|FG000|Overall Study|Adverse Event|1
2310439|NCT02733991|4014595|FG001|Overall Study|Adverse Event|0
2310440|NCT02733991|4014594|FG000|Overall Study|Withdrawal by Subject|0
2310441|NCT02733991|4014595|FG001|Overall Study|Withdrawal by Subject|5
2310442|NCT02734212|4014621|FG000|Overall Study|Lost to Follow-up|5
2310443|NCT02734212|4014622|FG001|Overall Study|Lost to Follow-up|10
2310444|NCT02734433|4014649|FG000|Overall Study|Disease progression|1
2310445|NCT02734433|4014650|FG001|Overall Study|Disease progression|5
2310446|NCT02734433|4014649|FG000|Overall Study|Clinical progression|0
2310447|NCT02734433|4014650|FG001|Overall Study|Clinical progression|1
2310448|NCT02734433|4014649|FG000|Overall Study|Withdrawal by Subject|1
2310449|NCT02734433|4014650|FG001|Overall Study|Withdrawal by Subject|2
2310450|NCT02734693|4014685|FG000|Overall Study|Adverse Event|1
2310451|NCT02734693|4014686|FG001|Overall Study|Adverse Event|3
2310452|NCT02734693|4014687|FG002|Overall Study|Adverse Event|3
2310453|NCT02734693|4014685|FG000|Overall Study|Lack of Efficacy|1
2310454|NCT02734693|4014686|FG001|Overall Study|Lack of Efficacy|0
2310455|NCT02734693|4014687|FG002|Overall Study|Lack of Efficacy|0
2310456|NCT02734693|4014685|FG000|Overall Study|Lost to Follow-up|2
2310457|NCT02734693|4014686|FG001|Overall Study|Lost to Follow-up|0
1980071|NCT00687596|3543414|FG001|Overall Study|Clinical Disease Progression|3
1980072|NCT00687596|3543413|FG000|Overall Study|Investigator Discretion|3
1980073|NCT00687596|3543414|FG001|Overall Study|Investigator Discretion|1
1980074|NCT00687596|3543413|FG000|Overall Study|Sponsor Terminated Study|6
1980075|NCT00687596|3543414|FG001|Overall Study|Sponsor Terminated Study|17
1980076|NCT00458536|3543420|FG000|Overall Study|Disease progression prior to treatment|7
1980077|NCT00458536|3543420|FG000|Overall Study|Unable to make vaccine|3
1980078|NCT00458536|3543420|FG000|Overall Study|No measurable disease after surgery|2
1980079|NCT00458536|3543420|FG000|Overall Study|Did not have renal cell carcinoma|2
1980080|NCT00458536|3543420|FG000|Overall Study|Patient did not have surgery|1
1980081|NCT00458536|3543420|FG000|Overall Study|Ineligible due to toxicity|1
1980082|NCT00458536|3543420|FG000|Overall Study|Withdrawal by Subject|1
1980083|NCT00458536|3543420|FG000|Overall Study|Progressive disease during treatment|2
1980084|NCT00112840|3543427|FG000|Overall Study|Physician Decision|1
1980085|NCT00112840|3543428|FG001|Overall Study|Physician Decision|0
1980086|NCT00112840|3543429|FG002|Overall Study|Physician Decision|0
1980087|NCT00112840|3543427|FG000|Overall Study|Withdrawal by Subject|1
1980088|NCT00112840|3543428|FG001|Overall Study|Withdrawal by Subject|0
1980089|NCT00112840|3543429|FG002|Overall Study|Withdrawal by Subject|1
1980090|NCT00112840|3543427|FG000|Overall Study|Protocol Violation|0
1980091|NCT00112840|3543428|FG001|Overall Study|Protocol Violation|0
1980092|NCT00112840|3543429|FG002|Overall Study|Protocol Violation|5
2023237|NCT00323609|3591233|FG002|Overall Study|Death|0
2023238|NCT00323609|3591234|FG003|Overall Study|Death|0
2023239|NCT00323609|3591231|FG000|Overall Study|Lost to Follow-up|9
2023240|NCT00323609|3591232|FG001|Overall Study|Lost to Follow-up|10
2023241|NCT00323609|3591233|FG002|Overall Study|Lost to Follow-up|0
2023242|NCT00323609|3591234|FG003|Overall Study|Lost to Follow-up|0
2023243|NCT00323609|3591231|FG000|Overall Study|Physician Decision|2
2023244|NCT00323609|3591232|FG001|Overall Study|Physician Decision|0
2023245|NCT00323609|3591233|FG002|Overall Study|Physician Decision|0
2023246|NCT00323609|3591234|FG003|Overall Study|Physician Decision|1
2023247|NCT00323609|3591231|FG000|Overall Study|Withdrawal by Subject|11
2023248|NCT00323609|3591232|FG001|Overall Study|Withdrawal by Subject|23
2023249|NCT00323609|3591233|FG002|Overall Study|Withdrawal by Subject|4
2023250|NCT00323609|3591234|FG003|Overall Study|Withdrawal by Subject|4
2023251|NCT00323609|3591231|FG000|Overall Study|Other non-VCF-related medical condition|3
2023252|NCT00323609|3591232|FG001|Overall Study|Other non-VCF-related medical condition|2
2023253|NCT00323609|3591233|FG002|Overall Study|Other non-VCF-related medical condition|0
2023254|NCT00323609|3591234|FG003|Overall Study|Other non-VCF-related medical condition|0
2023255|NCT00323609|3591231|FG000|Overall Study|Sponsor discontinued trial|29
2023256|NCT00323609|3591232|FG001|Overall Study|Sponsor discontinued trial|29
2023257|NCT00323609|3591233|FG002|Overall Study|Sponsor discontinued trial|0
2023258|NCT00323609|3591234|FG003|Overall Study|Sponsor discontinued trial|0
2023259|NCT00323609|3591231|FG000|Overall Study|Unrelenting or severe back pain|1
2023260|NCT00323609|3591232|FG001|Overall Study|Unrelenting or severe back pain|1
2023261|NCT00323609|3591233|FG002|Overall Study|Unrelenting or severe back pain|0
2023262|NCT00323609|3591234|FG003|Overall Study|Unrelenting or severe back pain|0
2023263|NCT00323609|3591231|FG000|Overall Study|Logistical withdrawal|9
2023264|NCT00323609|3591232|FG001|Overall Study|Logistical withdrawal|5
2023265|NCT00323609|3591233|FG002|Overall Study|Logistical withdrawal|0
2023266|NCT00323609|3591234|FG003|Overall Study|Logistical withdrawal|1
2023267|NCT00323609|3591231|FG000|Overall Study|Other reason|11
2023268|NCT00323609|3591232|FG001|Overall Study|Other reason|8
2023269|NCT00323609|3591233|FG002|Overall Study|Other reason|4
2023270|NCT00323609|3591234|FG003|Overall Study|Other reason|9
2023271|NCT00323622|3591248|FG000|Overall Study|Other|30
2023272|NCT00323622|3591249|FG001|Overall Study|Other|91
2023273|NCT00323622|3591250|FG002|Overall Study|Other|4
2023274|NCT00323622|3591251|FG003|Overall Study|Other|12
2023275|NCT00323622|3591252|FG004|Overall Study|Other|32
2023276|NCT00323622|3591253|FG005|Overall Study|Other|74
2023277|NCT00323622|3591254|FG006|Overall Study|Other|5
2023278|NCT00323622|3591255|FG007|Overall Study|Other|13
2023279|NCT00323622|3591248|FG000|Overall Study|Death|1
2023280|NCT00323622|3591249|FG001|Overall Study|Death|1
2023281|NCT00323622|3591250|FG002|Overall Study|Death|0
2023282|NCT00323622|3591251|FG003|Overall Study|Death|0
2023283|NCT00323622|3591252|FG004|Overall Study|Death|7
2023284|NCT00323622|3591253|FG005|Overall Study|Death|0
2023285|NCT00323622|3591254|FG006|Overall Study|Death|0
2023286|NCT00323622|3591255|FG007|Overall Study|Death|2
2023287|NCT00323869|3591285|FG000|Overall Study|Death|1
2023288|NCT00323882|3591294|FG000|Overall Study|Adverse Event|2
2023289|NCT00323882|3591295|FG001|Overall Study|Adverse Event|1
2023290|NCT00323882|3591296|FG002|Overall Study|Adverse Event|1
2023291|NCT00323882|3591297|FG003|Overall Study|Adverse Event|1
2023292|NCT00323882|3591298|FG004|Overall Study|Adverse Event|3
2023293|NCT00323882|3591294|FG000|Overall Study|Disease Progression|6
2023294|NCT00323882|3591295|FG001|Overall Study|Disease Progression|4
2023295|NCT00323882|3591296|FG002|Overall Study|Disease Progression|10
2023296|NCT00323882|3591297|FG003|Overall Study|Disease Progression|5
2023297|NCT00323882|3591298|FG004|Overall Study|Disease Progression|22
2023298|NCT00323882|3591294|FG000|Overall Study|Death|0
2023299|NCT00323882|3591295|FG001|Overall Study|Death|1
2023300|NCT00323882|3591296|FG002|Overall Study|Death|1
2023301|NCT00323882|3591297|FG003|Overall Study|Death|0
2023302|NCT00323882|3591298|FG004|Overall Study|Death|5
2023303|NCT00323882|3591294|FG000|Overall Study|Lost to Follow-up|0
1980093|NCT04207749|3543462|FG000|Overall Study|Lost to Follow-up|0
1980094|NCT04207749|3543463|FG001|Overall Study|Lost to Follow-up|2
1980095|NCT04207749|3543462|FG000|Overall Study|Protocol Violation|0
1980096|NCT04207749|3543463|FG001|Overall Study|Protocol Violation|1
1980097|NCT04207749|3543462|FG000|Overall Study|Withdrawal by Subject|3
1980098|NCT04207749|3543463|FG001|Overall Study|Withdrawal by Subject|0
1980099|NCT04207749|3543462|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1
1980100|NCT04207749|3543463|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4
1980101|NCT04167345|3543477|FG000|Overall Study|Other|1
1980102|NCT04167345|3543478|FG001|Overall Study|Other|1
1980103|NCT04167345|3543479|FG002|Overall Study|Other|0
1980104|NCT04167345|3543480|FG003|Overall Study|Other|0
1980105|NCT04167345|3543481|FG004|Overall Study|Other|0
1980106|NCT04042077|3543499|FG000|Overall Study|Adverse Event|0
1980107|NCT04042077|3543500|FG001|Overall Study|Adverse Event|1
1980108|NCT04042077|3543499|FG000|Overall Study|Death|2
1980109|NCT04042077|3543500|FG001|Overall Study|Death|1
1980110|NCT04042077|3543499|FG000|Overall Study|Physician Decision|2
1980111|NCT04042077|3543500|FG001|Overall Study|Physician Decision|0
1980112|NCT04042077|3543499|FG000|Overall Study|Withdrawal by Subject|3
1980113|NCT04042077|3543500|FG001|Overall Study|Withdrawal by Subject|2
1980114|NCT04042077|3543499|FG000|Overall Study|Lack of Efficacy|0
1980115|NCT04042077|3543500|FG001|Overall Study|Lack of Efficacy|1
1980116|NCT04001803|3543512|FG000|Overall Study|Ongoing at the time of analysis|103
1980117|NCT04001803|3543512|FG000|Overall Study|Adverse Event|2
1980118|NCT04001803|3543512|FG000|Overall Study|Protocol Violation|2
1980119|NCT04001803|3543512|FG000|Overall Study|Lost to Follow-up|2
1980120|NCT04001803|3543512|FG000|Overall Study|Physician Decision|1
1980121|NCT04001803|3543512|FG000|Overall Study|Withdrawal by Subject|4
1980122|NCT03925324|3543528|FG000|Overall Study|Death|1
1980123|NCT03925324|3543529|FG001|Overall Study|Death|1
1980124|NCT03875092|3543537|FG000|Overall Study|Adverse Event|2
1980125|NCT03875092|3543538|FG001|Overall Study|Adverse Event|5
1980126|NCT03875092|3543537|FG000|Overall Study|Death|28
1980127|NCT03875092|3543538|FG001|Overall Study|Death|41
1980128|NCT03875092|3543537|FG000|Overall Study|Ongoing in Study|35
1980129|NCT03875092|3543538|FG001|Overall Study|Ongoing in Study|14
1980130|NCT03738397|3543550|FG000|Overall Study|Adverse Event|3
1980131|NCT03738397|3543551|FG001|Overall Study|Adverse Event|7
1980132|NCT03738397|3543550|FG000|Overall Study|Withdrawal by Subject|8
1980133|NCT03738397|3543551|FG001|Overall Study|Withdrawal by Subject|11
1980134|NCT03738397|3543550|FG000|Overall Study|Lost to Follow-up|8
1980135|NCT03738397|3543551|FG001|Overall Study|Lost to Follow-up|5
1980136|NCT03738397|3543550|FG000|Overall Study|COVID-19 Logistical Restrictions|1
1980137|NCT03738397|3543551|FG001|Overall Study|COVID-19 Logistical Restrictions|1
1980138|NCT03738397|3543550|FG000|Overall Study|Other|4
1980139|NCT03738397|3543551|FG001|Overall Study|Other|6
1980140|NCT03666624|3543559|FG000|Overall Study|participant grieving over recent death of parent|1
1980141|NCT03666624|3543560|FG001|Overall Study|participant grieving over recent death of parent|0
1980142|NCT03649217|3543566|FG000|Overall Study|subject had severe ataxia not initially found|1
1980143|NCT03649217|3543566|FG000|Overall Study|subject had cognitive issues not initially found|1
1980144|NCT03633461|3543572|FG000|Overall Study|Lost to Follow-up|0
1980145|NCT03633461|3543573|FG001|Overall Study|Lost to Follow-up|1
1980146|NCT03569293|3543594|FG000|Overall Study|Adverse Event|4
1980147|NCT03569293|3543595|FG001|Overall Study|Adverse Event|1
1980148|NCT03569293|3543596|FG002|Overall Study|Adverse Event|5
1980149|NCT03569293|3543597|FG003|Overall Study|Adverse Event|1
1980150|NCT03569293|3543598|FG004|Overall Study|Adverse Event|0
1980151|NCT03569293|3543599|FG005|Overall Study|Adverse Event|0
1980152|NCT03569293|3543594|FG000|Overall Study|Withdrawal by Subject|16
1980153|NCT03569293|3543595|FG001|Overall Study|Withdrawal by Subject|2
1980154|NCT03569293|3543596|FG002|Overall Study|Withdrawal by Subject|4
1980155|NCT03569293|3543597|FG003|Overall Study|Withdrawal by Subject|1
1980156|NCT03569293|3543598|FG004|Overall Study|Withdrawal by Subject|0
1980157|NCT03569293|3543599|FG005|Overall Study|Withdrawal by Subject|0
1980158|NCT03569293|3543594|FG000|Overall Study|Lost to Follow-up|1
1980159|NCT03569293|3543595|FG001|Overall Study|Lost to Follow-up|3
1980160|NCT03569293|3543596|FG002|Overall Study|Lost to Follow-up|1
1980161|NCT03569293|3543597|FG003|Overall Study|Lost to Follow-up|1
1980162|NCT03569293|3543598|FG004|Overall Study|Lost to Follow-up|0
1980163|NCT03569293|3543599|FG005|Overall Study|Lost to Follow-up|0
1980164|NCT03569293|3543594|FG000|Overall Study|Other|8
1980165|NCT03569293|3543595|FG001|Overall Study|Other|2
1980166|NCT03569293|3543596|FG002|Overall Study|Other|1
1980167|NCT03569293|3543597|FG003|Overall Study|Other|1
1980168|NCT03569293|3543598|FG004|Overall Study|Other|0
1980169|NCT03569293|3543599|FG005|Overall Study|Other|0
1980170|NCT03569293|3543594|FG000|Overall Study|Ongoing at Time of Analysis|8
1980171|NCT03569293|3543595|FG001|Overall Study|Ongoing at Time of Analysis|1
1980172|NCT03569293|3543596|FG002|Overall Study|Ongoing at Time of Analysis|3
1980173|NCT03569293|3543597|FG003|Overall Study|Ongoing at Time of Analysis|0
1980174|NCT03569293|3543598|FG004|Overall Study|Ongoing at Time of Analysis|0
1980175|NCT03569293|3543599|FG005|Overall Study|Ongoing at Time of Analysis|0
1980176|NCT03415022|3543658|FG000|Overall Study|Withdrawal by Subject|1
1980177|NCT03415022|3543659|FG001|Overall Study|Withdrawal by Subject|2
1980178|NCT03415022|3543658|FG000|Overall Study|COVID-19 Suspension|2
1980179|NCT03415022|3543659|FG001|Overall Study|COVID-19 Suspension|3
1980180|NCT03415022|3543658|FG000|Overall Study|Lost to Follow-up|2
1980181|NCT03415022|3543659|FG001|Overall Study|Lost to Follow-up|0
1980182|NCT03400943|3543669|FG000|Treatment Period 1|Adverse Event|0
1980183|NCT03400943|3543670|FG001|Treatment Period 1|Adverse Event|0
1980184|NCT03400943|3543671|FG002|Treatment Period 1|Adverse Event|0
1980185|NCT03400943|3543672|FG003|Treatment Period 1|Adverse Event|1
1980186|NCT03400943|3543669|FG000|Treatment Period 1|Lost to Follow-up|1
1980187|NCT03400943|3543670|FG001|Treatment Period 1|Lost to Follow-up|0
1980188|NCT03400943|3543671|FG002|Treatment Period 1|Lost to Follow-up|0
1980189|NCT03400943|3543672|FG003|Treatment Period 1|Lost to Follow-up|0
1980190|NCT03400943|3543669|FG000|Treatment Period 1|Protocol Violation|0
1980191|NCT03400943|3543670|FG001|Treatment Period 1|Protocol Violation|1
1980192|NCT03400943|3543671|FG002|Treatment Period 1|Protocol Violation|1
1980193|NCT03400943|3543672|FG003|Treatment Period 1|Protocol Violation|0
1980194|NCT03400943|3543669|FG000|Treatment Period 1|Study terminated by sponsor|2
1980195|NCT03400943|3543670|FG001|Treatment Period 1|Study terminated by sponsor|0
1980196|NCT03400943|3543671|FG002|Treatment Period 1|Study terminated by sponsor|0
1980197|NCT03400943|3543672|FG003|Treatment Period 1|Study terminated by sponsor|1
1980198|NCT03400943|3543669|FG000|Treatment Period 1|Withdrawal by Subject|0
1980199|NCT03400943|3543670|FG001|Treatment Period 1|Withdrawal by Subject|0
1980200|NCT03400943|3543671|FG002|Treatment Period 1|Withdrawal by Subject|3
1980201|NCT03400943|3543672|FG003|Treatment Period 1|Withdrawal by Subject|1
1980202|NCT03400943|3543669|FG000|Treatment Period 1|Other|2
1980203|NCT03400943|3543670|FG001|Treatment Period 1|Other|1
1980204|NCT03400943|3543671|FG002|Treatment Period 1|Other|2
1980205|NCT03400943|3543672|FG003|Treatment Period 1|Other|2
1980206|NCT03400943|3543669|FG000|Post-treatment Period 1|Adverse Event|2
1980207|NCT03400943|3543670|FG001|Post-treatment Period 1|Adverse Event|0
1980208|NCT03400943|3543671|FG002|Post-treatment Period 1|Adverse Event|0
1980209|NCT03400943|3543672|FG003|Post-treatment Period 1|Adverse Event|0
1980210|NCT03400943|3543669|FG000|Post-treatment Period 1|Protocol Violation|1
1980211|NCT03400943|3543670|FG001|Post-treatment Period 1|Protocol Violation|0
1980212|NCT03400943|3543671|FG002|Post-treatment Period 1|Protocol Violation|0
1980213|NCT03400943|3543672|FG003|Post-treatment Period 1|Protocol Violation|0
1980214|NCT03400943|3543669|FG000|Post-treatment Period 1|Study terminated by sponsor|5
1980215|NCT03400943|3543670|FG001|Post-treatment Period 1|Study terminated by sponsor|0
1980216|NCT03400943|3543671|FG002|Post-treatment Period 1|Study terminated by sponsor|5
1980217|NCT03400943|3543672|FG003|Post-treatment Period 1|Study terminated by sponsor|6
1980218|NCT03400943|3543669|FG000|Post-treatment Period 1|Withdrawal by Subject|1
2213224|NCT01677195|3854650|FG001|Overall Study|Protocol Violation|3
1980219|NCT03400943|3543670|FG001|Post-treatment Period 1|Withdrawal by Subject|0
1980220|NCT03400943|3543671|FG002|Post-treatment Period 1|Withdrawal by Subject|2
1980221|NCT03400943|3543672|FG003|Post-treatment Period 1|Withdrawal by Subject|2
1980222|NCT03400943|3543669|FG000|Post-treatment Period 1|Other|2
2213225|NCT01677195|3854651|FG002|Overall Study|Protocol Violation|4
2213226|NCT01677299|3854669|FG000|Overall Study|Adverse Event|0
2213227|NCT01677299|3854670|FG001|Overall Study|Adverse Event|2
2213228|NCT01677299|3854671|FG002|Overall Study|Adverse Event|1
2213229|NCT01677299|3854672|FG003|Overall Study|Adverse Event|0
2213230|NCT01677299|3854669|FG000|Overall Study|Withdrawal by Subject|0
1980223|NCT03400943|3543670|FG001|Post-treatment Period 1|Other|0
1980224|NCT03400943|3543671|FG002|Post-treatment Period 1|Other|4
1980225|NCT03400943|3543672|FG003|Post-treatment Period 1|Other|5
1980226|NCT03400943|3543669|FG000|Treatment Period 2|Study terminated by sponsor|0
1980227|NCT03400943|3543670|FG001|Treatment Period 2|Study terminated by sponsor|1
1980228|NCT03400943|3543671|FG002|Treatment Period 2|Study terminated by sponsor|0
1980229|NCT03400943|3543672|FG003|Treatment Period 2|Study terminated by sponsor|0
1980230|NCT03400943|3543669|FG000|Treatment Period 2|Withdrawal by Subject|0
1980231|NCT03400943|3543670|FG001|Treatment Period 2|Withdrawal by Subject|1
1980232|NCT03400943|3543671|FG002|Treatment Period 2|Withdrawal by Subject|0
1980233|NCT03400943|3543672|FG003|Treatment Period 2|Withdrawal by Subject|0
1980234|NCT03400943|3543669|FG000|Treatment Period 2|Other|1
1980235|NCT03400943|3543670|FG001|Treatment Period 2|Other|6
1980236|NCT03400943|3543671|FG002|Treatment Period 2|Other|0
1980237|NCT03400943|3543672|FG003|Treatment Period 2|Other|0
1980238|NCT03400943|3543669|FG000|Follow-up Period|Withdrawal by Subject|1
1980239|NCT03400943|3543670|FG001|Follow-up Period|Withdrawal by Subject|0
1980240|NCT03400943|3543671|FG002|Follow-up Period|Withdrawal by Subject|0
1980241|NCT03400943|3543672|FG003|Follow-up Period|Withdrawal by Subject|0
1980242|NCT03370133|3543700|FG000|Initial Treatment Period (WK 16)|Adverse Event|5
1980243|NCT03370133|3543701|FG001|Initial Treatment Period (WK 16)|Adverse Event|5
1980244|NCT03370133|3543702|FG002|Initial Treatment Period (WK 16)|Adverse Event|2
1980245|NCT03370133|3543703|FG003|Initial Treatment Period (WK 16)|Adverse Event|0
1980246|NCT03370133|3543704|FG004|Initial Treatment Period (WK 16)|Adverse Event|0
1980247|NCT03370133|3543705|FG005|Initial Treatment Period (WK 16)|Adverse Event|0
1980248|NCT03370133|3543700|FG000|Initial Treatment Period (WK 16)|Death|1
2213231|NCT01677299|3854670|FG001|Overall Study|Withdrawal by Subject|1
1980249|NCT03370133|3543701|FG001|Initial Treatment Period (WK 16)|Death|1
1980250|NCT03370133|3543702|FG002|Initial Treatment Period (WK 16)|Death|1
1980251|NCT03370133|3543703|FG003|Initial Treatment Period (WK 16)|Death|0
1980252|NCT03370133|3543704|FG004|Initial Treatment Period (WK 16)|Death|0
1980253|NCT03370133|3543705|FG005|Initial Treatment Period (WK 16)|Death|0
1980254|NCT03370133|3543700|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2
1980255|NCT03370133|3543701|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1
1980256|NCT03370133|3543702|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0
1980257|NCT03370133|3543703|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0
1980258|NCT03370133|3543704|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0
1980259|NCT03370133|3543705|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0
1980260|NCT03370133|3543700|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0
1980261|NCT03370133|3543701|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0
1980262|NCT03370133|3543702|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2
1980263|NCT03370133|3543703|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0
1980264|NCT03370133|3543704|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0
1980265|NCT03370133|3543705|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0
1980266|NCT03370133|3543700|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0
1980267|NCT03370133|3543701|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3
1980268|NCT03370133|3543702|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0
1980269|NCT03370133|3543703|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0
1980270|NCT03370133|3543704|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0
1980271|NCT03370133|3543705|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0
1980272|NCT03370133|3543700|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1
1980273|NCT03370133|3543701|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2
1980274|NCT03370133|3543702|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1
1980275|NCT03370133|3543703|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
1980276|NCT03370133|3543704|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
1980277|NCT03370133|3543705|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
1980278|NCT03370133|3543700|FG000|Initial Treatment Period (WK 16)|Non-compliance|0
1980279|NCT03370133|3543701|FG001|Initial Treatment Period (WK 16)|Non-compliance|1
1980280|NCT03370133|3543702|FG002|Initial Treatment Period (WK 16)|Non-compliance|0
1980281|NCT03370133|3543703|FG003|Initial Treatment Period (WK 16)|Non-compliance|0
1980282|NCT03370133|3543704|FG004|Initial Treatment Period (WK 16)|Non-compliance|0
1980283|NCT03370133|3543705|FG005|Initial Treatment Period (WK 16)|Non-compliance|0
1980284|NCT03370133|3543700|FG000|Initial Treatment Period (WK 16)|Site closed|0
1980285|NCT03370133|3543701|FG001|Initial Treatment Period (WK 16)|Site closed|2
1980286|NCT03370133|3543702|FG002|Initial Treatment Period (WK 16)|Site closed|0
1980287|NCT03370133|3543703|FG003|Initial Treatment Period (WK 16)|Site closed|0
1980288|NCT03370133|3543704|FG004|Initial Treatment Period (WK 16)|Site closed|0
1980289|NCT03370133|3543705|FG005|Initial Treatment Period (WK 16)|Site closed|0
1980290|NCT03370133|3543700|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0
1980291|NCT03370133|3543701|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0
1980292|NCT03370133|3543702|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0
1980293|NCT03370133|3543703|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3
1980294|NCT03370133|3543704|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12
1980295|NCT03370133|3543705|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4
1980296|NCT03370133|3543700|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
1980297|NCT03370133|3543701|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
1980298|NCT03370133|3543702|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
1980299|NCT03370133|3543703|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
1980300|NCT03370133|3543704|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1
1980301|NCT03370133|3543705|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4
1980302|NCT03370133|3543700|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0
1980303|NCT03370133|3543701|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0
1980304|NCT03370133|3543702|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0
1980305|NCT03370133|3543703|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1
1980306|NCT03370133|3543704|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1
1980307|NCT03370133|3543705|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0
1980308|NCT03370133|3543700|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
1980309|NCT03370133|3543701|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
1980310|NCT03370133|3543702|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
1980311|NCT03370133|3543703|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
2213232|NCT01677299|3854671|FG002|Overall Study|Withdrawal by Subject|0
2213233|NCT01677299|3854672|FG003|Overall Study|Withdrawal by Subject|1
2213234|NCT01677377|3854698|FG000|Overall Study|Protocol Violation|1
2310458|NCT02734693|4014687|FG002|Overall Study|Lost to Follow-up|0
2310459|NCT02734693|4014685|FG000|Overall Study|Protocol Violation|1
2310460|NCT02734693|4014686|FG001|Overall Study|Protocol Violation|0
2310461|NCT02734693|4014687|FG002|Overall Study|Protocol Violation|0
2310462|NCT02734693|4014685|FG000|Overall Study|Withdrawal by Subject|1
2310463|NCT02734693|4014686|FG001|Overall Study|Withdrawal by Subject|0
2310464|NCT02734693|4014687|FG002|Overall Study|Withdrawal by Subject|0
2310465|NCT02734810|4014697|FG000|Overall Study|Adverse Event|1
2310466|NCT02734810|4014698|FG001|Overall Study|Adverse Event|0
2310467|NCT02734810|4014697|FG000|Overall Study|Lack of Efficacy|1
1980312|NCT03370133|3543704|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4
1980313|NCT03370133|3543705|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3
1980314|NCT03370133|3543700|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
1980315|NCT03370133|3543701|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
1980316|NCT03370133|3543702|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
1980317|NCT03370133|3543703|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1
1980318|NCT03370133|3543704|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4
1980319|NCT03370133|3543705|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4
1980320|NCT03370133|3543700|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0
1980321|NCT03370133|3543701|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0
1980322|NCT03370133|3543702|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0
1980323|NCT03370133|3543703|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0
1980324|NCT03370133|3543704|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1
1980325|NCT03370133|3543705|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0
1980326|NCT03370133|3543700|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
1980327|NCT03370133|3543701|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
1980328|NCT03370133|3543702|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
1980329|NCT03370133|3543703|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
1980330|NCT03370133|3543704|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
1980331|NCT03370133|3543705|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1
1980332|NCT03318003|3543738|FG000|Overall Study|Withdrawal by Subject|1
1980333|NCT03318003|3543739|FG001|Overall Study|Withdrawal by Subject|1
1980334|NCT03318003|3543738|FG000|Overall Study|fetal loss|0
1980335|NCT03318003|3543739|FG001|Overall Study|fetal loss|1
1980336|NCT03132753|3543769|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27
1980337|NCT03132753|3543770|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32
1980338|NCT03132753|3543769|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6
1980339|NCT03132753|3543770|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2
1980340|NCT03084471|3543785|FG000|Overall Study|Development of study specific discontinuation criteria|2
1980341|NCT03084471|3543785|FG000|Overall Study|Condition under investigation worsened|84
1980342|NCT03084471|3543785|FG000|Overall Study|Lack of therapeutic response|2
1980343|NCT03084471|3543785|FG000|Overall Study|Protocol Violation|1
1980344|NCT03084471|3543785|FG000|Overall Study|Adverse Event|73
1980345|NCT03084471|3543785|FG000|Overall Study|Withdrawal by Subject|12
1980346|NCT03084471|3543785|FG000|Overall Study|Disease relapse|181
1980347|NCT03084471|3543785|FG000|Overall Study|Subjective disease progression|359
1980348|NCT03084471|3543785|FG000|Overall Study|Other (as recorded)|33
1980349|NCT03084471|3543785|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120
1980350|NCT03067077|3543792|FG000|Overall Study|Did not receive surgery|4
1980351|NCT03067077|3543793|FG001|Overall Study|Did not receive surgery|5
1980352|NCT03067077|3543792|FG000|Overall Study|Lost to Follow-up|3
1980353|NCT03067077|3543793|FG001|Overall Study|Lost to Follow-up|2
1980354|NCT03059446|3543799|FG000|Overall Study|Adverse Event|11
1980355|NCT03059446|3543799|FG000|Overall Study|Withdrawal of Consent|16
1980356|NCT03059446|3543799|FG000|Overall Study|Lost to Follow-up|3
1980357|NCT03059446|3543799|FG000|Overall Study|Protocol Violation|1
1980358|NCT03059446|3543799|FG000|Overall Study|Study Terminated by Sponsor|131
1980359|NCT03059446|3543799|FG000|Overall Study|Reason not Specified|5
2023304|NCT00323882|3591295|FG001|Overall Study|Lost to Follow-up|0
2023305|NCT00323882|3591296|FG002|Overall Study|Lost to Follow-up|1
2023306|NCT00323882|3591297|FG003|Overall Study|Lost to Follow-up|0
2023307|NCT00323882|3591298|FG004|Overall Study|Lost to Follow-up|1
2023308|NCT00323882|3591294|FG000|Overall Study|Other|0
2023309|NCT00323882|3591295|FG001|Overall Study|Other|0
2023310|NCT00323882|3591296|FG002|Overall Study|Other|0
2023311|NCT00323882|3591297|FG003|Overall Study|Other|1
2023312|NCT00323882|3591298|FG004|Overall Study|Other|1
2023313|NCT00324038|3591337|FG000|Overall Study|Adverse Event|38
2023314|NCT00324038|3591338|FG001|Overall Study|Adverse Event|23
2023315|NCT00324038|3591337|FG000|Overall Study|Lack of Efficacy|5
2023316|NCT00324038|3591338|FG001|Overall Study|Lack of Efficacy|13
2023317|NCT00324038|3591337|FG000|Overall Study|Lost to Follow-up|0
2023318|NCT00324038|3591338|FG001|Overall Study|Lost to Follow-up|2
2023319|NCT00324038|3591337|FG000|Overall Study|Other|6
2023320|NCT00324038|3591338|FG001|Overall Study|Other|13
2023321|NCT00324116|3591344|FG000|Overall Study|Adverse Event|5
2023322|NCT00324116|3591344|FG000|Overall Study|Lack of Efficacy|17
2023323|NCT00324116|3591344|FG000|Overall Study|Withdrawal by Subject|5
2023324|NCT00324116|3591344|FG000|Overall Study|Other|5
2023325|NCT00324155|3591350|FG000|Enrolled and Randomized|No longer met study criteria|3
2023326|NCT00324155|3591351|FG001|Enrolled and Randomized|No longer met study criteria|0
2023327|NCT00324155|3591350|FG000|Enrolled and Randomized|Lost to Follow-up|0
2023328|NCT00324155|3591351|FG001|Enrolled and Randomized|Lost to Follow-up|1
2023329|NCT00324155|3591350|FG000|Received Treatment in Induction Phase|Disease Progression|88
2023330|NCT00324155|3591351|FG001|Received Treatment in Induction Phase|Disease Progression|152
2023331|NCT00324155|3591350|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83
2023332|NCT00324155|3591351|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10
1980360|NCT03035409|3543803|FG000|Overall Study|Adverse Event|5
1980361|NCT03035409|3543803|FG000|Overall Study|Death|2
1980362|NCT03035409|3543803|FG000|Overall Study|Withdrawal by Subject|2
1980363|NCT03035409|3543803|FG000|Overall Study|Non compliance|4
1980364|NCT03035409|3543803|FG000|Overall Study|Patient was jittery|1
1980365|NCT03035409|3543803|FG000|Overall Study|Did not like Questionnaire|1
1980366|NCT03035409|3543803|FG000|Overall Study|Aspartate Aminotransferase increased|1
1980367|NCT03035409|3543803|FG000|Overall Study|Did not like taking drugs|1
1980368|NCT03011034|3543813|FG000|Overall Study|Adverse Event|1
1980369|NCT03011034|3543814|FG001|Overall Study|Adverse Event|0
1980370|NCT02921971|3543844|FG000|Overall Study|Adverse Event|1
1980371|NCT02921971|3543845|FG001|Overall Study|Adverse Event|2
1980372|NCT02921971|3543844|FG000|Overall Study|Lack of Efficacy|3
1980373|NCT02921971|3543845|FG001|Overall Study|Lack of Efficacy|1
1980374|NCT02921971|3543844|FG000|Overall Study|Other than specified above|2
1980375|NCT02921971|3543845|FG001|Overall Study|Other than specified above|1
1980376|NCT02853331|3543853|FG000|Overall Study|Death|59
1980377|NCT02853331|3543854|FG001|Overall Study|Death|95
1980378|NCT02853331|3543853|FG000|Overall Study|Withdrawal by Subject|5
1980379|NCT02853331|3543854|FG001|Overall Study|Withdrawal by Subject|9
1980380|NCT02853331|3543853|FG000|Overall Study|Ongoing in study|368
1980381|NCT02853331|3543854|FG001|Overall Study|Ongoing in study|325
1980382|NCT02847637|3543864|FG000|Overall Study|Withdrew from treatment due to AE|0
1980383|NCT02847637|3543865|FG001|Overall Study|Withdrew from treatment due to AE|0
1980384|NCT02847637|3543866|FG002|Overall Study|Withdrew from treatment due to AE|1
1980385|NCT02847637|3543867|FG003|Overall Study|Withdrew from treatment due to AE|0
1980386|NCT02847637|3543864|FG000|Overall Study|Ongoing treatment with emicizumab|16
1980387|NCT02847637|3543865|FG001|Overall Study|Ongoing treatment with emicizumab|35
1980388|NCT02847637|3543866|FG002|Overall Study|Ongoing treatment with emicizumab|34
1980389|NCT02847637|3543867|FG003|Overall Study|Ongoing treatment with emicizumab|63
1980390|NCT02847637|3543864|FG000|Overall Study|First emicizumab dose delayed|1
1980391|NCT02847637|3543865|FG001|Overall Study|First emicizumab dose delayed|0
1980392|NCT02847637|3543866|FG002|Overall Study|First emicizumab dose delayed|0
1980393|NCT02847637|3543867|FG003|Overall Study|First emicizumab dose delayed|0
1980394|NCT02781584|3543909|FG000|Pre-treatment Phase|Investigator's Discretion|0
1980395|NCT02781584|3543910|FG001|Pre-treatment Phase|Investigator's Discretion|0
1980396|NCT02781584|3543911|FG002|Pre-treatment Phase|Investigator's Discretion|0
1980397|NCT02781584|3543912|FG003|Pre-treatment Phase|Investigator's Discretion|0
1980398|NCT02781584|3543913|FG004|Pre-treatment Phase|Investigator's Discretion|0
1980399|NCT02781584|3543914|FG005|Pre-treatment Phase|Investigator's Discretion|0
1980400|NCT02781584|3543915|FG006|Pre-treatment Phase|Investigator's Discretion|0
1980401|NCT02781584|3543916|FG007|Pre-treatment Phase|Investigator's Discretion|0
1980402|NCT02781584|3543917|FG008|Pre-treatment Phase|Investigator's Discretion|0
1980403|NCT02781584|3543918|FG009|Pre-treatment Phase|Investigator's Discretion|0
1980404|NCT02781584|3543919|FG010|Pre-treatment Phase|Investigator's Discretion|0
1980405|NCT02781584|3543920|FG011|Pre-treatment Phase|Investigator's Discretion|2
1980406|NCT02781584|3543921|FG012|Pre-treatment Phase|Investigator's Discretion|1
1980407|NCT02781584|3543909|FG000|Pre-treatment Phase|Adverse Event|0
1980408|NCT02781584|3543910|FG001|Pre-treatment Phase|Adverse Event|0
1980409|NCT02781584|3543911|FG002|Pre-treatment Phase|Adverse Event|0
1980410|NCT02781584|3543912|FG003|Pre-treatment Phase|Adverse Event|0
1980411|NCT02781584|3543913|FG004|Pre-treatment Phase|Adverse Event|0
1980412|NCT02781584|3543914|FG005|Pre-treatment Phase|Adverse Event|0
1980413|NCT02781584|3543915|FG006|Pre-treatment Phase|Adverse Event|0
1980414|NCT02781584|3543916|FG007|Pre-treatment Phase|Adverse Event|0
1980415|NCT02781584|3543917|FG008|Pre-treatment Phase|Adverse Event|0
1980416|NCT02781584|3543918|FG009|Pre-treatment Phase|Adverse Event|0
1980417|NCT02781584|3543919|FG010|Pre-treatment Phase|Adverse Event|0
1980418|NCT02781584|3543920|FG011|Pre-treatment Phase|Adverse Event|1
1980419|NCT02781584|3543921|FG012|Pre-treatment Phase|Adverse Event|0
1980420|NCT02781584|3543909|FG000|Treatment Phase|Withdrew Consent|0
1980421|NCT02781584|3543910|FG001|Treatment Phase|Withdrew Consent|0
1980422|NCT02781584|3543911|FG002|Treatment Phase|Withdrew Consent|0
1980423|NCT02781584|3543912|FG003|Treatment Phase|Withdrew Consent|0
1980424|NCT02781584|3543913|FG004|Treatment Phase|Withdrew Consent|0
1980425|NCT02781584|3543914|FG005|Treatment Phase|Withdrew Consent|1
1980426|NCT02781584|3543915|FG006|Treatment Phase|Withdrew Consent|0
1980427|NCT02781584|3543916|FG007|Treatment Phase|Withdrew Consent|0
1980428|NCT02781584|3543917|FG008|Treatment Phase|Withdrew Consent|0
1980429|NCT02781584|3543918|FG009|Treatment Phase|Withdrew Consent|0
1980430|NCT02781584|3543919|FG010|Treatment Phase|Withdrew Consent|1
1980431|NCT02781584|3543920|FG011|Treatment Phase|Withdrew Consent|2
1980432|NCT02781584|3543921|FG012|Treatment Phase|Withdrew Consent|0
1980433|NCT02781584|3543909|FG000|Treatment Phase|Adverse Event|0
1980434|NCT02781584|3543910|FG001|Treatment Phase|Adverse Event|0
1980435|NCT02781584|3543911|FG002|Treatment Phase|Adverse Event|0
1980436|NCT02781584|3543912|FG003|Treatment Phase|Adverse Event|0
1980437|NCT02781584|3543913|FG004|Treatment Phase|Adverse Event|0
1980438|NCT02781584|3543914|FG005|Treatment Phase|Adverse Event|0
1980439|NCT02781584|3543915|FG006|Treatment Phase|Adverse Event|0
1980440|NCT02781584|3543916|FG007|Treatment Phase|Adverse Event|1
1980441|NCT02781584|3543917|FG008|Treatment Phase|Adverse Event|0
1980442|NCT02781584|3543918|FG009|Treatment Phase|Adverse Event|0
1980443|NCT02781584|3543919|FG010|Treatment Phase|Adverse Event|0
1980444|NCT02781584|3543920|FG011|Treatment Phase|Adverse Event|0
1980445|NCT02781584|3543921|FG012|Treatment Phase|Adverse Event|0
1980446|NCT02667587|3543955|FG000|Pre-Treatment|Not reported|1
1980447|NCT02667587|3543956|FG001|Pre-Treatment|Not reported|0
1980448|NCT02667587|3543955|FG000|Pre-Treatment|Participant no longer meets study criteria|2
1980449|NCT02667587|3543956|FG001|Pre-Treatment|Participant no longer meets study criteria|2
1980450|NCT02667587|3543955|FG000|Pre-Treatment|Participant withdrew consent|0
1980451|NCT02667587|3543956|FG001|Pre-Treatment|Participant withdrew consent|1
1980452|NCT02667587|3543955|FG000|Pre-Treatment|Adverse event unrelated to study drug|1
1980453|NCT02667587|3543956|FG001|Pre-Treatment|Adverse event unrelated to study drug|0
1980454|NCT02667587|3543955|FG000|End of Treatment|Other reasons|11
1980455|NCT02667587|3543956|FG001|End of Treatment|Other reasons|8
1980456|NCT02667587|3543955|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1
1980457|NCT02667587|3543956|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2
1980458|NCT02667587|3543955|FG000|End of Treatment|Poor/Non-Compliance|0
1980459|NCT02667587|3543956|FG001|End of Treatment|Poor/Non-Compliance|1
1980460|NCT02667587|3543955|FG000|End of Treatment|Maximum Clinical Benefit|3
1980461|NCT02667587|3543956|FG001|End of Treatment|Maximum Clinical Benefit|3
1980462|NCT02667587|3543955|FG000|End of Treatment|Participant Withdrew Consent|5
1980463|NCT02667587|3543956|FG001|End of Treatment|Participant Withdrew Consent|6
1980464|NCT02667587|3543955|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25
1980465|NCT02667587|3543956|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26
1980466|NCT02667587|3543955|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19
1980467|NCT02667587|3543956|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20
1980468|NCT02667587|3543955|FG000|End of Treatment|Death|2
1980469|NCT02667587|3543956|FG001|End of Treatment|Death|1
1980470|NCT02667587|3543955|FG000|End of Treatment|Study Drug Toxicity|74
1980471|NCT02667587|3543956|FG001|End of Treatment|Study Drug Toxicity|18
1980472|NCT02667587|3543955|FG000|End of Treatment|Disease progression|177
1980473|NCT02667587|3543956|FG001|End of Treatment|Disease progression|222
1980474|NCT02667587|3543955|FG000|End of Treatment|Lost to Follow-up|1
1980475|NCT02667587|3543956|FG001|End of Treatment|Lost to Follow-up|3
1980476|NCT02601014|3543973|FG000|Overall Study|Adverse Event|3
1980477|NCT02601014|3543974|FG001|Overall Study|Adverse Event|3
1980478|NCT02601014|3543973|FG000|Overall Study|Death|3
1980479|NCT02601014|3543974|FG001|Overall Study|Death|1
1980480|NCT02601014|3543973|FG000|Overall Study|Disease progression|4
1980481|NCT02601014|3543974|FG001|Overall Study|Disease progression|8
1980482|NCT02579096|3543982|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10
1980483|NCT02579096|3543983|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6
1980484|NCT02579096|3543982|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2
1980485|NCT02579096|3543983|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1
1980486|NCT02579096|3543982|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32
1980487|NCT02579096|3543983|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36
1980488|NCT02579096|3543982|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9
1980489|NCT02579096|3543983|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4
1980490|NCT02579096|3543982|FG000|Phase 1, Weeks 0 - 24|Other reasons|4
1980491|NCT02579096|3543983|FG001|Phase 1, Weeks 0 - 24|Other reasons|3
1980492|NCT02579096|3543982|FG000|Phase 2, Weeks 25 - 48|Death|2
1980493|NCT02579096|3543983|FG001|Phase 2, Weeks 25 - 48|Death|4
1980494|NCT02579096|3543982|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3
1980495|NCT02579096|3543983|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1
1980496|NCT02579096|3543982|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4
1980497|NCT02579096|3543983|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0
1980498|NCT02579096|3543982|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9
1980499|NCT02579096|3543983|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12
1980500|NCT02579096|3543982|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4
1980501|NCT02579096|3543983|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9
1980502|NCT02579096|3543982|FG000|Phase 2, Weeks 25 - 48|Other reasons|0
1980503|NCT02579096|3543983|FG001|Phase 2, Weeks 25 - 48|Other reasons|5
1980504|NCT02579096|3543982|FG000|Phase 3, Weeks 49 - 72|Death|3
1980505|NCT02579096|3543983|FG001|Phase 3, Weeks 49 - 72|Death|2
1980506|NCT02579096|3543982|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0
1980507|NCT02579096|3543983|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1
1980508|NCT02579096|3543982|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0
1980509|NCT02579096|3543983|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5
1980510|NCT02579096|3543982|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6
1980511|NCT02579096|3543983|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4
1980512|NCT02579096|3543982|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10
1980513|NCT02579096|3543983|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5
1980514|NCT02579096|3543982|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0
1980515|NCT02579096|3543983|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1
1980516|NCT02579096|3543982|FG000|Phase 3, Weeks 49 - 72|Other reasons|3
1980517|NCT02579096|3543983|FG001|Phase 3, Weeks 49 - 72|Other reasons|0
2213235|NCT01677377|3854699|FG001|Overall Study|Protocol Violation|0
2213236|NCT01677377|3854700|FG002|Overall Study|Protocol Violation|0
2213237|NCT01677377|3854698|FG000|Overall Study|Lost to Follow-up|0
1980518|NCT02545868|3543992|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
1980519|NCT02545868|3543993|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
1980520|NCT02545868|3543994|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
1980521|NCT02538666|3544010|FG000|Overall Study|Disease progression|1
1980522|NCT02538666|3544011|FG001|Overall Study|Disease progression|0
1980523|NCT02538666|3544012|FG002|Overall Study|Disease progression|0
1980524|NCT02538666|3544010|FG000|Overall Study|no longer meets study criteria|1
1980525|NCT02538666|3544011|FG001|Overall Study|no longer meets study criteria|0
1980526|NCT02538666|3544012|FG002|Overall Study|no longer meets study criteria|0
1980527|NCT02538666|3544010|FG000|Overall Study|Withdrew Consent|0
1980528|NCT02538666|3544011|FG001|Overall Study|Withdrew Consent|1
1980529|NCT02538666|3544012|FG002|Overall Study|Withdrew Consent|1
1980530|NCT02527200|3544025|FG000|Overall Study|Withdrawal by Subject|3
1980531|NCT02527200|3544026|FG001|Overall Study|Withdrawal by Subject|2
1980532|NCT02527200|3544027|FG002|Overall Study|Withdrawal by Subject|1
1980533|NCT02527200|3544028|FG003|Overall Study|Withdrawal by Subject|0
1980534|NCT02527200|3544025|FG000|Overall Study|Unclassified|0
1980535|NCT02527200|3544026|FG001|Overall Study|Unclassified|1
1980536|NCT02527200|3544027|FG002|Overall Study|Unclassified|0
1980537|NCT02527200|3544028|FG003|Overall Study|Unclassified|0
1980538|NCT02527200|3544025|FG000|Overall Study|Lost to Follow-up|0
1980539|NCT02527200|3544026|FG001|Overall Study|Lost to Follow-up|0
1980540|NCT02527200|3544027|FG002|Overall Study|Lost to Follow-up|1
1980541|NCT02527200|3544028|FG003|Overall Study|Lost to Follow-up|0
1980542|NCT02511106|3544044|FG000|Overall Study|Lost to Follow-up|1
1980543|NCT02511106|3544045|FG001|Overall Study|Lost to Follow-up|2
1980544|NCT02511106|3544044|FG000|Overall Study|Withdrawal by Subject|19
1980545|NCT02511106|3544045|FG001|Overall Study|Withdrawal by Subject|14
1980546|NCT02511106|3544044|FG000|Overall Study|Ongoing study at data cut-off|309
1980547|NCT02511106|3544045|FG001|Overall Study|Ongoing study at data cut-off|307
1980548|NCT02511106|3544044|FG000|Overall Study|Without specified reason|1
1980549|NCT02511106|3544045|FG001|Overall Study|Without specified reason|0
1980550|NCT02511106|3544044|FG000|Overall Study|Missing|1
1980551|NCT02511106|3544045|FG001|Overall Study|Missing|0
2023333|NCT00324155|3591350|FG000|Received Treatment in Induction Phase|Death|8
2023334|NCT00324155|3591351|FG001|Received Treatment in Induction Phase|Death|15
2023335|NCT00324155|3591350|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
2023336|NCT00324155|3591351|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
2023337|NCT00324155|3591350|FG000|Received Treatment in Induction Phase|Adverse Event|6
2023338|NCT00324155|3591351|FG001|Received Treatment in Induction Phase|Adverse Event|7
2023339|NCT00324155|3591350|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6
2023340|NCT00324155|3591351|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5
2023341|NCT00324155|3591350|FG000|Received Treatment in Induction Phase|Physician Decision|2
2023342|NCT00324155|3591351|FG001|Received Treatment in Induction Phase|Physician Decision|0
2023343|NCT00324155|3591350|FG000|Received Treatment in Maintenance Phase|Disease Progression|26
2023344|NCT00324155|3591351|FG001|Received Treatment in Maintenance Phase|Disease Progression|41
2023345|NCT00324155|3591350|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
2023346|NCT00324155|3591351|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
2023347|NCT00324155|3591350|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
2023348|NCT00324155|3591351|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
2023349|NCT00324155|3591350|FG000|Received Treatment in Maintenance Phase|Adverse Event|0
2023350|NCT00324155|3591351|FG001|Received Treatment in Maintenance Phase|Adverse Event|3
2023351|NCT00324155|3591350|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
2023352|NCT00324155|3591351|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
2023353|NCT00324155|3591350|FG000|Follow-up Phase|On-going participants still on drug|11
2023354|NCT00324155|3591351|FG001|Follow-up Phase|On-going participants still on drug|6
2023355|NCT00324168|3591372|FG000|Overall Study|Lost to Follow-up|19
2023356|NCT00324168|3591373|FG001|Overall Study|Lost to Follow-up|18
2023357|NCT00324168|3591372|FG000|Overall Study|Death|3
2023358|NCT00324168|3591373|FG001|Overall Study|Death|3
2023359|NCT00324168|3591372|FG000|Overall Study|Patient did not visit in f/u window|6
2023360|NCT00324168|3591373|FG001|Overall Study|Patient did not visit in f/u window|9
2023361|NCT00324233|3591381|FG000|First Period|unable to insert catheter|1
2023362|NCT00324233|3591382|FG001|First Period|unable to insert catheter|0
2023363|NCT00324233|3591381|FG000|Second Period|unable to insert catheter|1
2023364|NCT00324233|3591382|FG001|Second Period|unable to insert catheter|1
2023365|NCT00324233|3591381|FG000|Second Period|Protocol Violation|4
2023366|NCT00324233|3591382|FG001|Second Period|Protocol Violation|6
2023367|NCT00324649|3591432|FG000|Overall Study|Adverse Event|1
2023368|NCT00324649|3591433|FG001|Overall Study|Adverse Event|4
2023369|NCT00324649|3591432|FG000|Overall Study|Withdrawal by Subject|0
2023370|NCT00324649|3591433|FG001|Overall Study|Withdrawal by Subject|1
2023371|NCT00324649|3591432|FG000|Overall Study|Noncompliance|1
2023372|NCT00324649|3591433|FG001|Overall Study|Noncompliance|0
2023373|NCT00324675|3591441|FG000|Overall Study|Adverse Event|1
2023374|NCT00324675|3591442|FG001|Overall Study|Adverse Event|0
2023375|NCT00324740|3591457|FG000|Overall Study|Withdrawal by Subject|1
2023376|NCT00324740|3591458|FG001|Overall Study|Withdrawal by Subject|0
1980552|NCT02253316|3544085|FG000|Consolidation|Progression|4
1980553|NCT02253316|3544086|FG001|Consolidation|Progression|0
1980554|NCT02253316|3544087|FG002|Consolidation|Progression|0
1980555|NCT02253316|3544085|FG000|Consolidation|Non-Compliance|1
1980556|NCT02253316|3544086|FG001|Consolidation|Non-Compliance|0
1980557|NCT02253316|3544087|FG002|Consolidation|Non-Compliance|0
1980558|NCT02253316|3544085|FG000|Consolidation|Patient Withdrew Logistical Concerns|2
1980559|NCT02253316|3544086|FG001|Consolidation|Patient Withdrew Logistical Concerns|0
1980560|NCT02253316|3544087|FG002|Consolidation|Patient Withdrew Logistical Concerns|0
1980561|NCT02253316|3544085|FG000|Consolidation|Secondary Malignancy|2
1980562|NCT02253316|3544086|FG001|Consolidation|Secondary Malignancy|0
1980563|NCT02253316|3544087|FG002|Consolidation|Secondary Malignancy|0
1980564|NCT02253316|3544085|FG000|Consolidation|Adverse Event|7
1980565|NCT02253316|3544086|FG001|Consolidation|Adverse Event|0
1980566|NCT02253316|3544087|FG002|Consolidation|Adverse Event|0
1980567|NCT02253316|3544085|FG000|Maintenance|Patient Withdrew Logistical Concerns|0
1980568|NCT02253316|3544086|FG001|Maintenance|Patient Withdrew Logistical Concerns|6
1980569|NCT02253316|3544087|FG002|Maintenance|Patient Withdrew Logistical Concerns|6
1980570|NCT02253316|3544085|FG000|Maintenance|Physician Decision|0
1980571|NCT02253316|3544086|FG001|Maintenance|Physician Decision|5
1980572|NCT02253316|3544087|FG002|Maintenance|Physician Decision|16
1980573|NCT02253316|3544085|FG000|Maintenance|Non-Compliance|0
1980574|NCT02253316|3544086|FG001|Maintenance|Non-Compliance|1
1980575|NCT02253316|3544087|FG002|Maintenance|Non-Compliance|1
1980576|NCT02253316|3544085|FG000|Maintenance|Secondary Malignancy|0
1980577|NCT02253316|3544086|FG001|Maintenance|Secondary Malignancy|1
1980578|NCT02253316|3544087|FG002|Maintenance|Secondary Malignancy|5
1980579|NCT02253316|3544085|FG000|Maintenance|Adverse Event|0
1980580|NCT02253316|3544086|FG001|Maintenance|Adverse Event|8
1980581|NCT02253316|3544087|FG002|Maintenance|Adverse Event|12
1980582|NCT02253316|3544085|FG000|Maintenance|Still receiving active treatment|0
1980583|NCT02253316|3544086|FG001|Maintenance|Still receiving active treatment|25
1980584|NCT02253316|3544087|FG002|Maintenance|Still receiving active treatment|27
1980585|NCT02224573|3544097|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0
1980586|NCT02224573|3544098|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1
1980587|NCT02224573|3544097|FG000|Treatment Phase|Started on Other IMP|1
1980588|NCT02224573|3544098|FG001|Treatment Phase|Started on Other IMP|0
1980589|NCT02224573|3544097|FG000|Treatment Phase|Participant Discontinued IMP|0
1980590|NCT02224573|3544098|FG001|Treatment Phase|Participant Discontinued IMP|1
1980591|NCT02224573|3544097|FG000|Treatment Phase|Lack of Efficacy|15
1980592|NCT02224573|3544098|FG001|Treatment Phase|Lack of Efficacy|8
2213238|NCT01677377|3854699|FG001|Overall Study|Lost to Follow-up|1
2213239|NCT01677377|3854700|FG002|Overall Study|Lost to Follow-up|1
2213240|NCT01677377|3854698|FG000|Overall Study|Withdrawal by Subject|0
1980593|NCT02224573|3544097|FG000|Treatment Phase|Began Commercial Product|1
1980594|NCT02224573|3544098|FG001|Treatment Phase|Began Commercial Product|0
1980595|NCT02224573|3544097|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3
1980596|NCT02224573|3544098|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3
1980597|NCT02224573|3544097|FG000|Treatment Phase|Met Withdrawal Criteria|5
1980598|NCT02224573|3544098|FG001|Treatment Phase|Met Withdrawal Criteria|7
1980599|NCT02224573|3544097|FG000|Treatment Phase|Participant Did Not Return for Visits|0
1980600|NCT02224573|3544098|FG001|Treatment Phase|Participant Did Not Return for Visits|1
1980601|NCT02224573|3544097|FG000|Treatment Phase|Continued Compassionate Use|1
1980602|NCT02224573|3544098|FG001|Treatment Phase|Continued Compassionate Use|0
1980603|NCT02224573|3544097|FG000|Treatment Phase|Lack of Efficiency|2
1980604|NCT02224573|3544098|FG001|Treatment Phase|Lack of Efficiency|1
1980605|NCT02224573|3544097|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0
1980606|NCT02224573|3544098|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1
1980607|NCT02224573|3544097|FG000|Treatment Phase|Participant Moved|2
1980608|NCT02224573|3544098|FG001|Treatment Phase|Participant Moved|0
1980609|NCT02224573|3544097|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62
1980610|NCT02224573|3544098|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48
1980611|NCT02224573|3544097|FG000|Treatment Phase|Refused Medication|1
1980612|NCT02224573|3544098|FG001|Treatment Phase|Refused Medication|1
1980613|NCT02224573|3544097|FG000|Treatment Phase|Adverse Event|26
1980614|NCT02224573|3544098|FG001|Treatment Phase|Adverse Event|38
1980615|NCT02224573|3544097|FG000|Treatment Phase|Placed in Group Home|0
1980616|NCT02224573|3544098|FG001|Treatment Phase|Placed in Group Home|1
1980617|NCT02224573|3544097|FG000|Treatment Phase|Pursued Other Trials|1
1980618|NCT02224573|3544098|FG001|Treatment Phase|Pursued Other Trials|0
1980619|NCT02224573|3544097|FG000|Treatment Phase|Withdrawn by the Investigator|23
1980620|NCT02224573|3544098|FG001|Treatment Phase|Withdrawn by the Investigator|11
1980621|NCT02224573|3544097|FG000|Treatment Phase|Lost to Follow-up|2
1980622|NCT02224573|3544098|FG001|Treatment Phase|Lost to Follow-up|1
1980623|NCT02224573|3544097|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1
1980624|NCT02224573|3544098|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0
1980625|NCT02224573|3544097|FG000|Taper Phase|Hospitalization/Dose Reduction|1
1980626|NCT02224573|3544098|FG001|Taper Phase|Hospitalization/Dose Reduction|0
1980627|NCT02224573|3544097|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0
2310468|NCT02734810|4014698|FG001|Overall Study|Lack of Efficacy|0
2310469|NCT02734862|4014720|FG000|Part A|Death|3
2310470|NCT02734862|4014721|FG001|Part A|Death|4
2310471|NCT02734862|4014722|FG002|Part A|Death|6
2310472|NCT02734862|4014720|FG000|Part A|Lost to Follow-up|2
2310473|NCT02734862|4014721|FG001|Part A|Lost to Follow-up|1
2310474|NCT02734862|4014722|FG002|Part A|Lost to Follow-up|1
2310475|NCT02734862|4014720|FG000|Part A|Withdrawal by Subject|1
2310476|NCT02734862|4014721|FG001|Part A|Withdrawal by Subject|1
2310477|NCT02734862|4014722|FG002|Part A|Withdrawal by Subject|2
2310478|NCT02734862|4014720|FG000|Part A|Physician Decision|2
2310479|NCT02734862|4014721|FG001|Part A|Physician Decision|0
2310480|NCT02734862|4014722|FG002|Part A|Physician Decision|1
2310481|NCT02734862|4014720|FG000|Part A|Adverse Event|2
2310482|NCT02734862|4014721|FG001|Part A|Adverse Event|0
2310483|NCT02734862|4014722|FG002|Part A|Adverse Event|1
2310484|NCT02734862|4014720|FG000|Part A|Noncompliance|1
2310485|NCT02734862|4014721|FG001|Part A|Noncompliance|1
2310486|NCT02734862|4014722|FG002|Part A|Noncompliance|0
2310487|NCT02734862|4014720|FG000|Part A|Other|1
2310488|NCT02734862|4014721|FG001|Part A|Other|1
2310489|NCT02734862|4014722|FG002|Part A|Other|3
2310490|NCT02734862|4014720|FG000|Part B|Death|8
2310491|NCT02734862|4014721|FG001|Part B|Death|3
2310492|NCT02734862|4014722|FG002|Part B|Death|5
2310493|NCT02734862|4014720|FG000|Part B|Lost to Follow-up|2
2310494|NCT02734862|4014721|FG001|Part B|Lost to Follow-up|2
2310495|NCT02734862|4014722|FG002|Part B|Lost to Follow-up|0
2310496|NCT02734862|4014720|FG000|Part B|Withdrawal by Subject|3
2310497|NCT02734862|4014721|FG001|Part B|Withdrawal by Subject|1
2310498|NCT02734862|4014722|FG002|Part B|Withdrawal by Subject|0
2310499|NCT02734862|4014720|FG000|Part B|Other|0
2310500|NCT02734862|4014721|FG001|Part B|Other|1
2310501|NCT02734862|4014722|FG002|Part B|Other|0
2310502|NCT02735044|4014749|FG000|Overall Study|Adverse Event|3
2310503|NCT02735044|4014750|FG001|Overall Study|Adverse Event|3
2310504|NCT02735044|4014749|FG000|Overall Study|Lack of Efficacy|1
2310505|NCT02735044|4014750|FG001|Overall Study|Lack of Efficacy|0
2310506|NCT02735044|4014749|FG000|Overall Study|Poor compliance to protocol|7
2310507|NCT02735044|4014750|FG001|Overall Study|Poor compliance to protocol|7
2310508|NCT02735044|4014749|FG000|Overall Study|Randomized and not treated|0
2310509|NCT02735044|4014750|FG001|Overall Study|Randomized and not treated|2
2310510|NCT02735044|4014749|FG000|Overall Study|Other, not specified above|5
2310511|NCT02735044|4014750|FG001|Overall Study|Other, not specified above|11
2310512|NCT02735096|4014756|FG000|Overall Study|No symptoms in clinic/personal leave|1
2310513|NCT02735200|4014781|FG000|Overall Study|Lost to Follow-up|0
2310514|NCT02735200|4014782|FG001|Overall Study|Lost to Follow-up|5
2310515|NCT02735200|4014781|FG000|Overall Study|Withdrawal by Subject|8
2310516|NCT02735200|4014782|FG001|Overall Study|Withdrawal by Subject|0
2310517|NCT02735421|4014805|FG000|Overall Study|Adverse Event|2
2310518|NCT02735421|4014805|FG000|Overall Study|Withdrawal by Subject|6
2310519|NCT02735421|4014805|FG000|Overall Study|Lost to Follow-up|3
2310520|NCT02735421|4014805|FG000|Overall Study|Inadequate compliance to treatment|1
2310521|NCT02735421|4014805|FG000|Overall Study|Pregnancy|1
2310522|NCT02735577|4014825|FG000|Disulfiram Treatment|Lost to Follow-up|1
2310523|NCT02735577|4014825|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2
2310524|NCT02735915|4014842|FG000|Overall Study|Not vaccinated but subject ID assigned|8
2310525|NCT02735915|4014842|FG000|Overall Study|Withdrawal following SAE|2
2310526|NCT02735915|4014842|FG000|Overall Study|Withdrawal by Subject|1
2310527|NCT02735980|4014851|FG000|Overall Study|Adverse Event|0
2310528|NCT02735980|4014852|FG001|Overall Study|Adverse Event|4
2310529|NCT02735980|4014853|FG002|Overall Study|Adverse Event|1
2310530|NCT02735980|4014851|FG000|Overall Study|Death|5
2310531|NCT02735980|4014852|FG001|Overall Study|Death|4
2310532|NCT02735980|4014853|FG002|Overall Study|Death|0
2310533|NCT02735980|4014851|FG000|Overall Study|Physician Decision|3
2310534|NCT02735980|4014852|FG001|Overall Study|Physician Decision|1
2310535|NCT02735980|4014853|FG002|Overall Study|Physician Decision|0
2310536|NCT02735980|4014851|FG000|Overall Study|Screen failure|1
2310537|NCT02735980|4014852|FG001|Overall Study|Screen failure|0
2310538|NCT02735980|4014853|FG002|Overall Study|Screen failure|0
2310539|NCT02735980|4014851|FG000|Overall Study|Withdrawal by Subject|1
2310540|NCT02735980|4014852|FG001|Overall Study|Withdrawal by Subject|2
2310541|NCT02735980|4014853|FG002|Overall Study|Withdrawal by Subject|0
2310542|NCT02736188|4014875|FG000|Overall Study|Discontinuation of Study by Sponsor|134
2310543|NCT02736188|4014875|FG000|Overall Study|Adverse Event|1
2310544|NCT02736188|4014875|FG000|Overall Study|Withdrawal by Subject|1
2310545|NCT02736188|4014875|FG000|Overall Study|Other|6
2310546|NCT02736409|4014885|FG000|Overall Study|Withdrawal by Subject|4
2310547|NCT02736409|4014886|FG001|Overall Study|Withdrawal by Subject|2
2310548|NCT02736409|4014887|FG002|Overall Study|Withdrawal by Subject|17
2310549|NCT02736409|4014888|FG003|Overall Study|Withdrawal by Subject|3
2310550|NCT02736409|4014885|FG000|Overall Study|Non-Compliance with Study Drug|0
2310551|NCT02736409|4014886|FG001|Overall Study|Non-Compliance with Study Drug|0
2310552|NCT02736409|4014887|FG002|Overall Study|Non-Compliance with Study Drug|0
2310553|NCT02736409|4014888|FG003|Overall Study|Non-Compliance with Study Drug|1
2310554|NCT02736409|4014885|FG000|Overall Study|Adverse Event|0
2310555|NCT02736409|4014886|FG001|Overall Study|Adverse Event|1
2310556|NCT02736409|4014887|FG002|Overall Study|Adverse Event|5
2310557|NCT02736409|4014888|FG003|Overall Study|Adverse Event|4
2310558|NCT02736409|4014885|FG000|Overall Study|Other|0
2310559|NCT02736409|4014886|FG001|Overall Study|Other|0
2310560|NCT02736409|4014887|FG002|Overall Study|Other|1
2310561|NCT02736409|4014888|FG003|Overall Study|Other|1
2310562|NCT02736409|4014885|FG000|Overall Study|Pregnancy|0
2310563|NCT02736409|4014886|FG001|Overall Study|Pregnancy|0
2310564|NCT02736409|4014887|FG002|Overall Study|Pregnancy|1
2310565|NCT02736409|4014888|FG003|Overall Study|Pregnancy|0
2310566|NCT02736409|4014885|FG000|Overall Study|Lost to Follow-up|0
2310567|NCT02736409|4014886|FG001|Overall Study|Lost to Follow-up|0
2310568|NCT02736409|4014887|FG002|Overall Study|Lost to Follow-up|2
2310569|NCT02736409|4014888|FG003|Overall Study|Lost to Follow-up|1
2310570|NCT02736409|4014885|FG000|Overall Study|Physician Decision|0
2310571|NCT02736409|4014886|FG001|Overall Study|Physician Decision|0
2310572|NCT02736409|4014887|FG002|Overall Study|Physician Decision|0
2310573|NCT02736409|4014888|FG003|Overall Study|Physician Decision|2
2310574|NCT02736474|4014901|FG000|Overall Study|Lost to Follow-up|0
2310575|NCT02736474|4014902|FG001|Overall Study|Lost to Follow-up|1
2310576|NCT02736578|4014910|FG000|Overall Study|Adverse Event|1
2310577|NCT02736578|4014911|FG001|Overall Study|Adverse Event|0
2310578|NCT02736721|4014921|FG000|Overall Study|Adverse Event|8
2310579|NCT02736721|4014921|FG000|Overall Study|Lost to Follow-up|3
2310580|NCT02736721|4014921|FG000|Overall Study|Other|5
2310581|NCT02736825|4014927|FG000|Overall Study|Lost to Follow-up|10
2310582|NCT02736825|4014928|FG001|Overall Study|Lost to Follow-up|11
2310583|NCT02736825|4014927|FG000|Overall Study|Early Termination|0
1980628|NCT02224573|3544098|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3
1980629|NCT02224573|3544097|FG000|Taper Phase|Adverse Event|1
1980630|NCT02224573|3544098|FG001|Taper Phase|Adverse Event|1
1980631|NCT01991067|3544107|FG000|Overall Study|Lost to Follow-up|6
1980632|NCT01991067|3544108|FG001|Overall Study|Lost to Follow-up|5
1980633|NCT01966471|3544116|FG000|Overall Study|Death|33
1980634|NCT01966471|3544117|FG001|Overall Study|Death|44
1980635|NCT01966471|3544116|FG000|Overall Study|Lost to Follow-up|14
1980636|NCT01966471|3544117|FG001|Overall Study|Lost to Follow-up|16
1980637|NCT01966471|3544116|FG000|Overall Study|Other|3
1980638|NCT01966471|3544117|FG001|Overall Study|Other|5
1980639|NCT01966471|3544116|FG000|Overall Study|Physician Decision|5
1980640|NCT01966471|3544117|FG001|Overall Study|Physician Decision|5
1980641|NCT01966471|3544116|FG000|Overall Study|Withdrawal by Subject|48
1980642|NCT01966471|3544117|FG001|Overall Study|Withdrawal by Subject|43
1980643|NCT01774721|3544138|FG000|Overall Study|Death|76
1980644|NCT01774721|3544139|FG001|Overall Study|Death|91
1980645|NCT01774721|3544138|FG000|Overall Study|Withdrawal by Subject|14
1980646|NCT01774721|3544139|FG001|Overall Study|Withdrawal by Subject|10
1980647|NCT01774721|3544138|FG000|Overall Study|Lost to Follow-up|1
1980648|NCT01774721|3544139|FG001|Overall Study|Lost to Follow-up|1
1980649|NCT01774721|3544138|FG000|Overall Study|Did not meet eligibility criteria|0
1980650|NCT01774721|3544139|FG001|Overall Study|Did not meet eligibility criteria|3
1980651|NCT01774721|3544138|FG000|Overall Study|Ongoing in study|136
1980652|NCT01774721|3544139|FG001|Overall Study|Ongoing in study|120
1980653|NCT01709331|3544156|FG000|Overall Study|Adverse Event|1
1980654|NCT01659151|3544175|FG000|Overall Study|Inadequate TIL growth|1
1980655|NCT01656434|3544181|FG000|Overall Study|Adverse Event|199
1980656|NCT01656434|3544182|FG001|Overall Study|Adverse Event|63
1980657|NCT01656434|3544181|FG000|Overall Study|Enrollment terminated at trial site|2
1980658|NCT01656434|3544182|FG001|Overall Study|Enrollment terminated at trial site|0
1980659|NCT01656434|3544181|FG000|Overall Study|Lost to Follow-up|309
1980660|NCT01656434|3544182|FG001|Overall Study|Lost to Follow-up|76
1980661|NCT01656434|3544181|FG000|Overall Study|Site discontinued study participation|24
1980662|NCT01656434|3544182|FG001|Overall Study|Site discontinued study participation|9
1980663|NCT01656434|3544181|FG000|Overall Study|Screen failure|2
1980664|NCT01656434|3544182|FG001|Overall Study|Screen failure|0
1980665|NCT01656434|3544181|FG000|Overall Study|Protocol Violation|7
1980666|NCT01656434|3544182|FG001|Overall Study|Protocol Violation|0
1980667|NCT01656434|3544181|FG000|Overall Study|Pregnancy wish|18
1980668|NCT01656434|3544182|FG001|Overall Study|Pregnancy wish|6
1980669|NCT01656434|3544181|FG000|Overall Study|Pregnancy|45
1980670|NCT01656434|3544182|FG001|Overall Study|Pregnancy|10
1980671|NCT01656434|3544181|FG000|Overall Study|Physician Decision|7
1980672|NCT01656434|3544182|FG001|Overall Study|Physician Decision|2
1980673|NCT01656434|3544181|FG000|Overall Study|Non-compliance with study drug|48
1980674|NCT01656434|3544182|FG001|Overall Study|Non-compliance with study drug|9
1980675|NCT01656434|3544181|FG000|Overall Study|Study terminated by sponsor|1501
1980676|NCT01656434|3544182|FG001|Overall Study|Study terminated by sponsor|348
1980677|NCT01656434|3544181|FG000|Overall Study|Participant discontinued; drug related|13
1980678|NCT01656434|3544182|FG001|Overall Study|Participant discontinued; drug related|4
1980679|NCT01656434|3544181|FG000|Overall Study|Part. discontinued; unrelated to drug|55
1980680|NCT01656434|3544182|FG001|Overall Study|Part. discontinued; unrelated to drug|10
1980681|NCT01656434|3544181|FG000|Overall Study|Non-compliance with protocol|39
1980682|NCT01656434|3544182|FG001|Overall Study|Non-compliance with protocol|15
1980683|NCT01656434|3544181|FG000|Overall Study|Participant moved|40
2310584|NCT02736825|4014928|FG001|Overall Study|Early Termination|1
2310585|NCT02736890|4014937|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1
1980684|NCT01656434|3544182|FG001|Overall Study|Participant moved|12
1980685|NCT01656434|3544181|FG000|Overall Study|Participant withdrew consent|28
1980686|NCT01656434|3544182|FG001|Overall Study|Participant withdrew consent|9
1980687|NCT01656434|3544181|FG000|Overall Study|Withdrawal by Subject|64
1980688|NCT01656434|3544182|FG001|Overall Study|Withdrawal by Subject|7
1980689|NCT01496118|3544211|FG000|Overall Study|Disease progression|3
1980690|NCT01496118|3544212|FG001|Overall Study|Disease progression|2
1980691|NCT01496118|3544213|FG002|Overall Study|Disease progression|3
1980692|NCT01496118|3544214|FG003|Overall Study|Disease progression|1
1980693|NCT01496118|3544215|FG004|Overall Study|Disease progression|2
1980694|NCT01496118|3544216|FG005|Overall Study|Disease progression|2
1980695|NCT01496118|3544217|FG006|Overall Study|Disease progression|14
1980696|NCT01496118|3544218|FG007|Overall Study|Disease progression|10
1980697|NCT01496118|3544211|FG000|Overall Study|Physician Decision|0
1980698|NCT01496118|3544212|FG001|Overall Study|Physician Decision|0
1980699|NCT01496118|3544213|FG002|Overall Study|Physician Decision|0
1980700|NCT01496118|3544214|FG003|Overall Study|Physician Decision|0
1980701|NCT01496118|3544215|FG004|Overall Study|Physician Decision|1
1980702|NCT01496118|3544216|FG005|Overall Study|Physician Decision|0
1980703|NCT01496118|3544217|FG006|Overall Study|Physician Decision|3
1980704|NCT01496118|3544218|FG007|Overall Study|Physician Decision|6
1980705|NCT01496118|3544211|FG000|Overall Study|Adverse Event|1
1980706|NCT01496118|3544212|FG001|Overall Study|Adverse Event|1
1980707|NCT01496118|3544213|FG002|Overall Study|Adverse Event|0
1980708|NCT01496118|3544214|FG003|Overall Study|Adverse Event|0
1980709|NCT01496118|3544215|FG004|Overall Study|Adverse Event|0
1980710|NCT01496118|3544216|FG005|Overall Study|Adverse Event|0
1980711|NCT01496118|3544217|FG006|Overall Study|Adverse Event|6
1980712|NCT01496118|3544218|FG007|Overall Study|Adverse Event|10
1980713|NCT01496118|3544211|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0
1980714|NCT01496118|3544212|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0
1980715|NCT01496118|3544213|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0
1980716|NCT01496118|3544214|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0
1980717|NCT01496118|3544215|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0
1980718|NCT01496118|3544216|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0
1980719|NCT01496118|3544217|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1
1980720|NCT01496118|3544218|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0
1980721|NCT01496118|3544211|FG000|Overall Study|Death|0
1980722|NCT01496118|3544212|FG001|Overall Study|Death|0
1980723|NCT01496118|3544213|FG002|Overall Study|Death|0
1980724|NCT01496118|3544214|FG003|Overall Study|Death|0
1980725|NCT01496118|3544215|FG004|Overall Study|Death|0
1980726|NCT01496118|3544216|FG005|Overall Study|Death|0
1980727|NCT01496118|3544217|FG006|Overall Study|Death|1
1980728|NCT01496118|3544218|FG007|Overall Study|Death|1
1980729|NCT01496118|3544211|FG000|Overall Study|Withdrawal by Subject|0
1980730|NCT01496118|3544212|FG001|Overall Study|Withdrawal by Subject|0
1980731|NCT01496118|3544213|FG002|Overall Study|Withdrawal by Subject|0
1980732|NCT01496118|3544214|FG003|Overall Study|Withdrawal by Subject|2
1980733|NCT01496118|3544215|FG004|Overall Study|Withdrawal by Subject|0
1980734|NCT01496118|3544216|FG005|Overall Study|Withdrawal by Subject|1
1980735|NCT01496118|3544217|FG006|Overall Study|Withdrawal by Subject|6
1980736|NCT01496118|3544218|FG007|Overall Study|Withdrawal by Subject|3
1980737|NCT01350934|3544238|FG000|Base Study|Adverse Event|6
1980738|NCT01350934|3544239|FG001|Base Study|Adverse Event|0
1980739|NCT01350934|3544238|FG000|Base Study|Lost to Follow-up|1
1980740|NCT01350934|3544239|FG001|Base Study|Lost to Follow-up|0
1980741|NCT01350934|3544238|FG000|Base Study|Protocol Violation|1
1980742|NCT01350934|3544239|FG001|Base Study|Protocol Violation|1
1980743|NCT01350934|3544238|FG000|Base Study|Withdrawal by Subject|1
1980744|NCT01350934|3544239|FG001|Base Study|Withdrawal by Subject|2
1980745|NCT01350934|3544238|FG000|Base Study|Non-Compliance With Study Drug|2
1980746|NCT01350934|3544239|FG001|Base Study|Non-Compliance With Study Drug|0
1980747|NCT01350934|3544238|FG000|Extension Study|Adverse Event|2
1980748|NCT01350934|3544239|FG001|Extension Study|Adverse Event|1
1980749|NCT01350934|3544238|FG000|Extension Study|Lost to Follow-up|2
1980750|NCT01350934|3544239|FG001|Extension Study|Lost to Follow-up|0
1980751|NCT01350934|3544238|FG000|Extension Study|Protocol Violation|1
1980752|NCT01350934|3544239|FG001|Extension Study|Protocol Violation|1
1980753|NCT01350934|3544238|FG000|Extension Study|Lack of Efficacy|0
1980754|NCT01350934|3544239|FG001|Extension Study|Lack of Efficacy|1
1980755|NCT01350934|3544238|FG000|Extension Study|Withdrawal by Subject|0
1980756|NCT01350934|3544239|FG001|Extension Study|Withdrawal by Subject|1
1980757|NCT01286207|3544248|FG000|Overall Study|Adverse Event|27
1980758|NCT01286207|3544249|FG001|Overall Study|Adverse Event|41
1980759|NCT01286207|3544250|FG002|Overall Study|Adverse Event|8
1980760|NCT01286207|3544248|FG000|Overall Study|Lost to Follow-up|49
1980761|NCT01286207|3544249|FG001|Overall Study|Lost to Follow-up|43
1980762|NCT01286207|3544250|FG002|Overall Study|Lost to Follow-up|20
1980763|NCT01286207|3544248|FG000|Overall Study|Withdrawal by Subject|93
1980764|NCT01286207|3544249|FG001|Overall Study|Withdrawal by Subject|79
1980765|NCT01286207|3544250|FG002|Overall Study|Withdrawal by Subject|41
1980766|NCT01286207|3544248|FG000|Overall Study|Lack of Response|92
1980767|NCT01286207|3544249|FG001|Overall Study|Lack of Response|38
1980768|NCT01286207|3544250|FG002|Overall Study|Lack of Response|8
1980769|NCT01286207|3544248|FG000|Overall Study|Other|37
1980770|NCT01286207|3544249|FG001|Overall Study|Other|47
1980771|NCT01286207|3544250|FG002|Overall Study|Other|13
1980772|NCT01263769|3544258|FG000|Overall Study|Non-Compliant with treatment|1
2213241|NCT01677377|3854699|FG001|Overall Study|Withdrawal by Subject|0
1980773|NCT01227187|3544266|FG000|Overall Study|Physician Decision|0
1980774|NCT01227187|3544267|FG001|Overall Study|Physician Decision|0
1980775|NCT01227187|3544268|FG002|Overall Study|Physician Decision|0
1980776|NCT01227187|3544269|FG003|Overall Study|Physician Decision|1
1980777|NCT01222247|3544281|FG000|Overall Study|Lost to Follow-up|2
1980778|NCT01222247|3544282|FG001|Overall Study|Lost to Follow-up|2
1980779|NCT01144416|3544318|FG000|Intervention Period|Adverse Event|5
1980780|NCT01144416|3544319|FG001|Intervention Period|Adverse Event|6
1980781|NCT01144416|3544318|FG000|Intervention Period|Insufficient ovarian response|11
1980782|NCT01144416|3544319|FG001|Intervention Period|Insufficient ovarian response|17
1980783|NCT01144416|3544318|FG000|Intervention Period|Risk of OHSS|0
1980784|NCT01144416|3544319|FG001|Intervention Period|Risk of OHSS|1
1980785|NCT01144416|3544318|FG000|Intervention Period|Too high ovarian response|4
1980786|NCT01144416|3544319|FG001|Intervention Period|Too high ovarian response|2
1980787|NCT01144416|3544318|FG000|Intervention Period|No/too few/bad oocytes|7
1980788|NCT01144416|3544319|FG001|Intervention Period|No/too few/bad oocytes|5
1980789|NCT01144416|3544318|FG000|Intervention Period|No or abnormal fertilization|25
1980790|NCT01144416|3544319|FG001|Intervention Period|No or abnormal fertilization|10
1980791|NCT01144416|3544318|FG000|Intervention Period|No/too few/bad quality embryos|3
1980792|NCT01144416|3544319|FG001|Intervention Period|No/too few/bad quality embryos|3
1980793|NCT01144416|3544318|FG000|Intervention Period|Other|7
1980794|NCT01144416|3544319|FG001|Intervention Period|Other|5
1980795|NCT01140048|3544329|FG000|Overall Study|Physician Decision|1
1980796|NCT01140048|3544329|FG000|Overall Study|Withdrawal by Subject|13
1980797|NCT01140048|3544329|FG000|Overall Study|Lost to Follow-up|31
1980798|NCT01065779|3544344|FG000|Overall Study|Duplicate Investigation|1
1980799|NCT01065779|3544344|FG000|Overall Study|Investigation Before Contract Date|37
1980800|NCT01065779|3544344|FG000|Overall Study|Non-enrollment Period Administration|10
1980801|NCT01065779|3544344|FG000|Overall Study|Not Administered With Study Drug|17
1980802|NCT01065779|3544344|FG000|Overall Study|Failed to Follow-up|10
1980803|NCT01065779|3544344|FG000|Overall Study|Inclusion Criteria Violation|7
2023377|NCT00324740|3591459|FG002|Overall Study|Withdrawal by Subject|1
2023378|NCT00324961|3591511|FG000|Overall Study|Adverse Event|5
2023379|NCT00324961|3591511|FG000|Overall Study|Consent Withdrawn|11
2023380|NCT00324961|3591511|FG000|Overall Study|Lost to Follow-up|22
2023381|NCT00324961|3591511|FG000|Overall Study|Protocol Violation|3
2023382|NCT00324961|3591511|FG000|Overall Study|Other|2
2023383|NCT00324987|3591519|FG000|Overall Study|Adverse Event|2
2023384|NCT00324987|3591520|FG001|Overall Study|Adverse Event|1
2023385|NCT00324987|3591519|FG000|Overall Study|Withdrawal by Subject|1
2023386|NCT00324987|3591520|FG001|Overall Study|Withdrawal by Subject|1
2023387|NCT00324987|3591519|FG000|Overall Study|Progression|1
2023388|NCT00324987|3591520|FG001|Overall Study|Progression|1
2023389|NCT00324987|3591519|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2
2023390|NCT00324987|3591520|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3
2023391|NCT00325039|3591528|FG000|Overall Study|Lost to Follow-up|18
2023392|NCT00325039|3591529|FG001|Overall Study|Lost to Follow-up|14
2023393|NCT00325130|3591551|FG000|Overall Study|Lost to Follow-up|6
2023394|NCT00325130|3591552|FG001|Overall Study|Lost to Follow-up|14
2023395|NCT00325130|3591551|FG000|Overall Study|Withdrawal by Subject|12
2023396|NCT00325130|3591552|FG001|Overall Study|Withdrawal by Subject|14
2023397|NCT00325130|3591551|FG000|Overall Study|Protocol Deviation|0
2023398|NCT00325130|3591552|FG001|Overall Study|Protocol Deviation|1
2023399|NCT00325130|3591551|FG000|Overall Study|Moved|0
2023400|NCT00325130|3591552|FG001|Overall Study|Moved|1
2023401|NCT00325130|3591551|FG000|Overall Study|Patient Discontinued for Other|1
2023402|NCT00325130|3591552|FG001|Overall Study|Patient Discontinued for Other|0
2023403|NCT00325143|3591558|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13
2023404|NCT00325143|3591558|FG000|Overall Study|Migrated/moved from study area|1
2023405|NCT00325143|3591558|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4
2023406|NCT00325143|3591558|FG000|Overall Study|Withdrawal by Subject|8
2023407|NCT00325156|3591562|FG000|Overall Study|Protocol Violation|8
2023408|NCT00325156|3591562|FG000|Overall Study|Lost to follow-up (complete vaccination)|41
2023409|NCT00325156|3591562|FG000|Overall Study|Migrated/moved from study area|12
2023410|NCT00325156|3591562|FG000|Overall Study|Adverse event, non-fatal|3
2023411|NCT00325156|3591562|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16
2023412|NCT00325156|3591562|FG000|Overall Study|Other|1
2023413|NCT00325156|3591562|FG000|Overall Study|Withdrawal by Subject|31
2023414|NCT00325195|3591569|FG000|Randomized|Not dosed|5
2023415|NCT00325195|3591570|FG001|Randomized|Not dosed|5
2023416|NCT00325195|3591571|FG002|Randomized|Not dosed|3
2023417|NCT00325195|3591569|FG000|Received Intervention: ITT Population|Adverse Event|15
2023418|NCT00325195|3591570|FG001|Received Intervention: ITT Population|Adverse Event|17
2023419|NCT00325195|3591571|FG002|Received Intervention: ITT Population|Adverse Event|1
1980804|NCT00974571|3544351|FG000|Overall Study|Adverse Event|31
1980805|NCT00974571|3544352|FG001|Overall Study|Adverse Event|4
1980806|NCT00974571|3544353|FG002|Overall Study|Adverse Event|27
1980807|NCT00974571|3544351|FG000|Overall Study|Lack of Efficacy|3
1980808|NCT00974571|3544352|FG001|Overall Study|Lack of Efficacy|2
1980809|NCT00974571|3544353|FG002|Overall Study|Lack of Efficacy|9
1980810|NCT00974571|3544351|FG000|Overall Study|Lost to Follow-up|2
1980811|NCT00974571|3544352|FG001|Overall Study|Lost to Follow-up|1
1980812|NCT00974571|3544353|FG002|Overall Study|Lost to Follow-up|2
1980813|NCT00974571|3544351|FG000|Overall Study|Protocol Violation|13
1980814|NCT00974571|3544352|FG001|Overall Study|Protocol Violation|4
1980815|NCT00974571|3544353|FG002|Overall Study|Protocol Violation|18
1980816|NCT00974571|3544351|FG000|Overall Study|Withdrawal by Subject|14
1980817|NCT00974571|3544352|FG001|Overall Study|Withdrawal by Subject|5
1980818|NCT00974571|3544353|FG002|Overall Study|Withdrawal by Subject|16
1980819|NCT00974571|3544351|FG000|Overall Study|Patient Moved|1
1980820|NCT00974571|3544352|FG001|Overall Study|Patient Moved|0
1980821|NCT00974571|3544353|FG002|Overall Study|Patient Moved|1
1980822|NCT00974571|3544351|FG000|Overall Study|Other|4
1980823|NCT00974571|3544352|FG001|Overall Study|Other|0
1980824|NCT00974571|3544353|FG002|Overall Study|Other|10
1980825|NCT00972738|3544364|FG000|Overall Study|Adverse Event|7
1980826|NCT00972738|3544365|FG001|Overall Study|Adverse Event|1
1980827|NCT00972738|3544366|FG002|Overall Study|Adverse Event|8
1980828|NCT00972738|3544364|FG000|Overall Study|Protocol Violation|2
1980829|NCT00972738|3544365|FG001|Overall Study|Protocol Violation|1
1980830|NCT00972738|3544366|FG002|Overall Study|Protocol Violation|3
1980831|NCT00972738|3544364|FG000|Overall Study|Lost to Follow-up|1
1980832|NCT00972738|3544365|FG001|Overall Study|Lost to Follow-up|0
1980833|NCT00972738|3544366|FG002|Overall Study|Lost to Follow-up|1
1980834|NCT00972738|3544364|FG000|Overall Study|Lack of Efficacy|5
2310586|NCT02736890|4014938|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2
2310587|NCT02736890|4014937|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1
1980835|NCT00972738|3544365|FG001|Overall Study|Lack of Efficacy|1
1980836|NCT00972738|3544366|FG002|Overall Study|Lack of Efficacy|11
1980837|NCT00972738|3544364|FG000|Overall Study|Withdrawal by Subject|5
1980838|NCT00972738|3544365|FG001|Overall Study|Withdrawal by Subject|1
1980839|NCT00972738|3544366|FG002|Overall Study|Withdrawal by Subject|4
1980840|NCT00972738|3544364|FG000|Overall Study|Moved|0
1980841|NCT00972738|3544365|FG001|Overall Study|Moved|0
1980842|NCT00972738|3544366|FG002|Overall Study|Moved|1
1980843|NCT00972738|3544364|FG000|Overall Study|Other|1
1980844|NCT00972738|3544365|FG001|Overall Study|Other|2
1980845|NCT00972738|3544366|FG002|Overall Study|Other|1
1980846|NCT00968201|3544376|FG000|Base Study - (Period II)|Adverse Event|8
1980847|NCT00968201|3544377|FG001|Base Study - (Period II)|Adverse Event|0
1980848|NCT00968201|3544378|FG002|Base Study - (Period II)|Adverse Event|16
1980849|NCT00968201|3544376|FG000|Base Study - (Period II)|Lack of Efficacy|0
1980850|NCT00968201|3544377|FG001|Base Study - (Period II)|Lack of Efficacy|0
1980851|NCT00968201|3544378|FG002|Base Study - (Period II)|Lack of Efficacy|1
1980852|NCT00968201|3544376|FG000|Base Study - (Period II)|Lost to Follow-up|2
1980853|NCT00968201|3544377|FG001|Base Study - (Period II)|Lost to Follow-up|0
1980854|NCT00968201|3544378|FG002|Base Study - (Period II)|Lost to Follow-up|7
1980855|NCT00968201|3544376|FG000|Base Study - (Period II)|Protocol Violation|12
1980856|NCT00968201|3544377|FG001|Base Study - (Period II)|Protocol Violation|0
1980857|NCT00968201|3544378|FG002|Base Study - (Period II)|Protocol Violation|12
1980858|NCT00968201|3544376|FG000|Base Study - (Period II)|Withdrawal by Subject|4
1980859|NCT00968201|3544377|FG001|Base Study - (Period II)|Withdrawal by Subject|0
1980860|NCT00968201|3544378|FG002|Base Study - (Period II)|Withdrawal by Subject|8
1980861|NCT00968201|3544376|FG000|Base Study - (Period II)|Site Error|0
1980862|NCT00968201|3544377|FG001|Base Study - (Period II)|Site Error|0
1980863|NCT00968201|3544378|FG002|Base Study - (Period II)|Site Error|1
1980864|NCT00968201|3544376|FG000|Extension Study - (Period III)|Adverse Event|0
1980865|NCT00968201|3544377|FG001|Extension Study - (Period III)|Adverse Event|5
1980866|NCT00968201|3544378|FG002|Extension Study - (Period III)|Adverse Event|22
1980867|NCT00968201|3544376|FG000|Extension Study - (Period III)|Lost to Follow-up|0
1980868|NCT00968201|3544377|FG001|Extension Study - (Period III)|Lost to Follow-up|7
1980869|NCT00968201|3544378|FG002|Extension Study - (Period III)|Lost to Follow-up|13
1980870|NCT00968201|3544376|FG000|Extension Study - (Period III)|Protocol Violation|0
1980871|NCT00968201|3544377|FG001|Extension Study - (Period III)|Protocol Violation|17
1980872|NCT00968201|3544378|FG002|Extension Study - (Period III)|Protocol Violation|14
1980873|NCT00968201|3544376|FG000|Extension Study - (Period III)|Withdrawal by Subject|0
1980874|NCT00968201|3544377|FG001|Extension Study - (Period III)|Withdrawal by Subject|20
1980875|NCT00968201|3544378|FG002|Extension Study - (Period III)|Withdrawal by Subject|40
1980876|NCT00968201|3544376|FG000|Extension Study - (Period III)|Patient Relocated|0
1980877|NCT00968201|3544377|FG001|Extension Study - (Period III)|Patient Relocated|1
1980878|NCT00968201|3544378|FG002|Extension Study - (Period III)|Patient Relocated|1
1980879|NCT00968201|3544376|FG000|Extension Study - (Period III)|Noncompliance|0
1980880|NCT00968201|3544377|FG001|Extension Study - (Period III)|Noncompliance|0
1980881|NCT00968201|3544378|FG002|Extension Study - (Period III)|Noncompliance|3
1980882|NCT00968201|3544376|FG000|Extension Study - (Period III)|Other|0
1980883|NCT00968201|3544377|FG001|Extension Study - (Period III)|Other|0
1980884|NCT00968201|3544378|FG002|Extension Study - (Period III)|Other|2
1980885|NCT00968201|3544376|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
1980886|NCT00968201|3544377|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
1980887|NCT00968201|3544378|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
1980888|NCT00968149|3544389|FG000|Overall Study|Adverse Event|5
1980889|NCT00968149|3544390|FG001|Overall Study|Adverse Event|1
1980890|NCT00968149|3544389|FG000|Overall Study|Lack of Efficacy|0
1980891|NCT00968149|3544390|FG001|Overall Study|Lack of Efficacy|4
1980892|NCT00968149|3544389|FG000|Overall Study|Lost to Follow-up|0
1980893|NCT00968149|3544390|FG001|Overall Study|Lost to Follow-up|1
1980894|NCT00968149|3544389|FG000|Overall Study|Protocol Violation|4
1980895|NCT00968149|3544390|FG001|Overall Study|Protocol Violation|0
1980896|NCT00968149|3544389|FG000|Overall Study|Withdrawal by Subject|2
1980897|NCT00968149|3544390|FG001|Overall Study|Withdrawal by Subject|0
1980898|NCT00963469|3544399|FG000|Overall Study|Adverse Event|15
1980899|NCT00963469|3544400|FG001|Overall Study|Adverse Event|11
1980900|NCT00963469|3544401|FG002|Overall Study|Adverse Event|1
1980901|NCT00963469|3544399|FG000|Overall Study|Lack of Efficacy|10
1980902|NCT00963469|3544400|FG001|Overall Study|Lack of Efficacy|7
1980903|NCT00963469|3544401|FG002|Overall Study|Lack of Efficacy|2
1980904|NCT00963469|3544399|FG000|Overall Study|Lost to Follow-up|1
1980905|NCT00963469|3544400|FG001|Overall Study|Lost to Follow-up|1
1980906|NCT00963469|3544401|FG002|Overall Study|Lost to Follow-up|0
1980907|NCT00963469|3544399|FG000|Overall Study|Protocol Violation|5
1980908|NCT00963469|3544400|FG001|Overall Study|Protocol Violation|5
1980909|NCT00963469|3544401|FG002|Overall Study|Protocol Violation|3
1980910|NCT00963469|3544399|FG000|Overall Study|Withdrawal by Subject|4
1980911|NCT00963469|3544400|FG001|Overall Study|Withdrawal by Subject|1
1980912|NCT00963469|3544401|FG002|Overall Study|Withdrawal by Subject|1
1980913|NCT00963469|3544399|FG000|Overall Study|Pre-randomization Adverse Event|1
1980914|NCT00963469|3544400|FG001|Overall Study|Pre-randomization Adverse Event|2
1980915|NCT00963469|3544401|FG002|Overall Study|Pre-randomization Adverse Event|0
1980916|NCT00963469|3544399|FG000|Overall Study|Moved|1
1980917|NCT00963469|3544400|FG001|Overall Study|Moved|0
1980918|NCT00963469|3544401|FG002|Overall Study|Moved|0
1980919|NCT00963469|3544399|FG000|Overall Study|Site closed (local pollen Season ended)|4
1980920|NCT00963469|3544400|FG001|Overall Study|Site closed (local pollen Season ended)|1
1980921|NCT00963469|3544401|FG002|Overall Study|Site closed (local pollen Season ended)|3
1980922|NCT00960141|3544412|FG000|Overall Study|Adverse Event|4
1980923|NCT00960141|3544413|FG001|Overall Study|Adverse Event|8
1980924|NCT00960141|3544414|FG002|Overall Study|Adverse Event|2
1980925|NCT00960141|3544412|FG000|Overall Study|Lack of Efficacy|3
1980926|NCT00960141|3544413|FG001|Overall Study|Lack of Efficacy|4
1980927|NCT00960141|3544414|FG002|Overall Study|Lack of Efficacy|2
1980928|NCT00960141|3544412|FG000|Overall Study|Lost to Follow-up|1
1980929|NCT00960141|3544413|FG001|Overall Study|Lost to Follow-up|0
1980930|NCT00960141|3544414|FG002|Overall Study|Lost to Follow-up|0
1980931|NCT00960141|3544412|FG000|Overall Study|Protocol Violation|1
1980932|NCT00960141|3544413|FG001|Overall Study|Protocol Violation|3
1980933|NCT00960141|3544414|FG002|Overall Study|Protocol Violation|2
1980934|NCT00960141|3544412|FG000|Overall Study|Withdrawal by Subject|1
1980935|NCT00960141|3544413|FG001|Overall Study|Withdrawal by Subject|2
1980936|NCT00960141|3544414|FG002|Overall Study|Withdrawal by Subject|1
1980937|NCT00943683|3544424|FG000|Overall Study|Adverse Event|3
1980938|NCT00943683|3544425|FG001|Overall Study|Adverse Event|3
1980939|NCT00943683|3544424|FG000|Overall Study|Lost to Follow-up|1
1980940|NCT00943683|3544425|FG001|Overall Study|Lost to Follow-up|1
1980941|NCT00943683|3544424|FG000|Overall Study|Protocol Violation|1
1980942|NCT00943683|3544425|FG001|Overall Study|Protocol Violation|2
1980943|NCT00943683|3544424|FG000|Overall Study|Withdrawal by Subject|1
1980944|NCT00943683|3544425|FG001|Overall Study|Withdrawal by Subject|0
1980945|NCT00943683|3544424|FG000|Overall Study|Patient Moved|1
1980946|NCT00943683|3544425|FG001|Overall Study|Patient Moved|0
1980947|NCT00943397|3544433|FG000|Overall Study|Adverse Event|0
1980948|NCT00943397|3544434|FG001|Overall Study|Adverse Event|6
1980949|NCT00943397|3544433|FG000|Overall Study|Lost to Follow-up|0
1980950|NCT00943397|3544434|FG001|Overall Study|Lost to Follow-up|4
1980951|NCT00943397|3544433|FG000|Overall Study|Protocol Violation|2
1980952|NCT00943397|3544434|FG001|Overall Study|Protocol Violation|5
1980953|NCT00943397|3544433|FG000|Overall Study|Withdrawal by Subject|1
1980954|NCT00943397|3544434|FG001|Overall Study|Withdrawal by Subject|1
1980955|NCT00943397|3544433|FG000|Overall Study|Site terminated and other|12
1980956|NCT00943397|3544434|FG001|Overall Study|Site terminated and other|56
1980957|NCT00937937|3544440|FG000|Overall Study|Adverse Event|6
1980958|NCT00937937|3544440|FG000|Overall Study|Withdrawal by Subject|2
1980959|NCT00937937|3544440|FG000|Overall Study|Progression/relapse|61
1980960|NCT00937937|3544440|FG000|Overall Study|Death|1
1980961|NCT00937937|3544440|FG000|Overall Study|Other|2
1980962|NCT00911547|3544449|FG000|Overall Study|Adverse Event|8
1980963|NCT00911547|3544450|FG001|Overall Study|Adverse Event|27
1980964|NCT00911547|3544451|FG002|Overall Study|Adverse Event|11
1980965|NCT00911547|3544452|FG003|Overall Study|Adverse Event|6
1980966|NCT00911547|3544449|FG000|Overall Study|Lost to Follow-up|0
1980967|NCT00911547|3544450|FG001|Overall Study|Lost to Follow-up|0
1980968|NCT00911547|3544451|FG002|Overall Study|Lost to Follow-up|2
1980969|NCT00911547|3544452|FG003|Overall Study|Lost to Follow-up|1
1980970|NCT00911547|3544449|FG000|Overall Study|Protocol Violation|0
1980971|NCT00911547|3544450|FG001|Overall Study|Protocol Violation|5
1980972|NCT00911547|3544451|FG002|Overall Study|Protocol Violation|5
1980973|NCT00911547|3544452|FG003|Overall Study|Protocol Violation|1
1980974|NCT00911547|3544449|FG000|Overall Study|Withdrawal by Subject|3
1980975|NCT00911547|3544450|FG001|Overall Study|Withdrawal by Subject|10
1980976|NCT00911547|3544451|FG002|Overall Study|Withdrawal by Subject|4
1980977|NCT00911547|3544452|FG003|Overall Study|Withdrawal by Subject|8
1980978|NCT00899379|3544467|FG000|Overall Study|Adverse Event|2
1980979|NCT00899379|3544468|FG001|Overall Study|Adverse Event|2
1980980|NCT00899379|3544469|FG002|Overall Study|Adverse Event|1
1980981|NCT00899379|3544470|FG003|Overall Study|Adverse Event|1
1980982|NCT00899379|3544471|FG004|Overall Study|Adverse Event|2
1980983|NCT00899379|3544467|FG000|Overall Study|Lack of Efficacy|0
1980984|NCT00899379|3544468|FG001|Overall Study|Lack of Efficacy|4
1980985|NCT00899379|3544469|FG002|Overall Study|Lack of Efficacy|3
1980986|NCT00899379|3544470|FG003|Overall Study|Lack of Efficacy|0
1980987|NCT00899379|3544471|FG004|Overall Study|Lack of Efficacy|1
1980988|NCT00899379|3544467|FG000|Overall Study|Lost to Follow-up|9
1980989|NCT00899379|3544468|FG001|Overall Study|Lost to Follow-up|3
1980990|NCT00899379|3544469|FG002|Overall Study|Lost to Follow-up|0
1980991|NCT00899379|3544470|FG003|Overall Study|Lost to Follow-up|6
1980992|NCT00899379|3544471|FG004|Overall Study|Lost to Follow-up|2
1980993|NCT00899379|3544467|FG000|Overall Study|Protocol Violation|0
1980994|NCT00899379|3544468|FG001|Overall Study|Protocol Violation|0
1980995|NCT00899379|3544469|FG002|Overall Study|Protocol Violation|1
1980996|NCT00899379|3544470|FG003|Overall Study|Protocol Violation|1
1980997|NCT00899379|3544471|FG004|Overall Study|Protocol Violation|0
1980998|NCT00899379|3544467|FG000|Overall Study|Withdrawal by Subject|2
1980999|NCT00899379|3544468|FG001|Overall Study|Withdrawal by Subject|4
1981000|NCT00899379|3544469|FG002|Overall Study|Withdrawal by Subject|2
1981001|NCT00899379|3544470|FG003|Overall Study|Withdrawal by Subject|3
1981002|NCT00899379|3544471|FG004|Overall Study|Withdrawal by Subject|6
1981003|NCT00899379|3544467|FG000|Overall Study|Pregnancy|0
1981004|NCT00899379|3544468|FG001|Overall Study|Pregnancy|0
1981005|NCT00899379|3544469|FG002|Overall Study|Pregnancy|1
1981006|NCT00899379|3544470|FG003|Overall Study|Pregnancy|0
1981007|NCT00899379|3544471|FG004|Overall Study|Pregnancy|1
1981008|NCT00899379|3544467|FG000|Overall Study|Patient Uncooperative|0
1981009|NCT00899379|3544468|FG001|Overall Study|Patient Uncooperative|1
1981010|NCT00899379|3544469|FG002|Overall Study|Patient Uncooperative|0
1981011|NCT00899379|3544470|FG003|Overall Study|Patient Uncooperative|1
1981012|NCT00899379|3544471|FG004|Overall Study|Patient Uncooperative|2
1981013|NCT00899379|3544467|FG000|Overall Study|Abnormal Baseline ECG|0
1981014|NCT00899379|3544468|FG001|Overall Study|Abnormal Baseline ECG|0
1981015|NCT00899379|3544469|FG002|Overall Study|Abnormal Baseline ECG|0
1981016|NCT00899379|3544470|FG003|Overall Study|Abnormal Baseline ECG|1
1981017|NCT00899379|3544471|FG004|Overall Study|Abnormal Baseline ECG|0
1981018|NCT00899379|3544467|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
1981019|NCT00899379|3544468|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1
1981020|NCT00899379|3544469|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1
1981021|NCT00899379|3544470|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
1981022|NCT00899379|3544471|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
1981023|NCT00899379|3544467|FG000|Overall Study|Not Completed/Entered Extn|5
1981024|NCT00899379|3544468|FG001|Overall Study|Not Completed/Entered Extn|1
1981025|NCT00899379|3544469|FG002|Overall Study|Not Completed/Entered Extn|6
1981026|NCT00899379|3544470|FG003|Overall Study|Not Completed/Entered Extn|4
1981027|NCT00899379|3544471|FG004|Overall Study|Not Completed/Entered Extn|3
1981028|NCT00899379|3544467|FG000|Overall Study|Study Terminated|3
1981029|NCT00899379|3544468|FG001|Overall Study|Study Terminated|0
1981030|NCT00899379|3544469|FG002|Overall Study|Study Terminated|3
1981031|NCT00899379|3544470|FG003|Overall Study|Study Terminated|3
1981032|NCT00899379|3544471|FG004|Overall Study|Study Terminated|1
1981033|NCT00899379|3544467|FG000|Overall Study|Lost to Follow-up|3
1981034|NCT00899379|3544468|FG001|Overall Study|Lost to Follow-up|1
1981035|NCT00899379|3544469|FG002|Overall Study|Lost to Follow-up|0
1981036|NCT00899379|3544470|FG003|Overall Study|Lost to Follow-up|2
1981037|NCT00899379|3544471|FG004|Overall Study|Lost to Follow-up|5
1981038|NCT00899379|3544467|FG000|Overall Study|Withdrawal by Subject|4
1981039|NCT00899379|3544468|FG001|Overall Study|Withdrawal by Subject|7
1981040|NCT00899379|3544469|FG002|Overall Study|Withdrawal by Subject|4
1981041|NCT00899379|3544470|FG003|Overall Study|Withdrawal by Subject|7
1981042|NCT00899379|3544471|FG004|Overall Study|Withdrawal by Subject|2
1981043|NCT00899379|3544467|FG000|Overall Study|Pregnancy|1
1981044|NCT00899379|3544468|FG001|Overall Study|Pregnancy|0
1981045|NCT00899379|3544469|FG002|Overall Study|Pregnancy|0
1981046|NCT00899379|3544470|FG003|Overall Study|Pregnancy|0
1981047|NCT00899379|3544471|FG004|Overall Study|Pregnancy|0
1981048|NCT00899379|3544467|FG000|Overall Study|Patient Uncooperative|0
1981049|NCT00899379|3544468|FG001|Overall Study|Patient Uncooperative|0
1981050|NCT00899379|3544469|FG002|Overall Study|Patient Uncooperative|0
1981051|NCT00899379|3544470|FG003|Overall Study|Patient Uncooperative|1
1981052|NCT00899379|3544471|FG004|Overall Study|Patient Uncooperative|0
1981053|NCT00899379|3544467|FG000|Overall Study|Abnormal Prestudy Labs|0
1981054|NCT00899379|3544468|FG001|Overall Study|Abnormal Prestudy Labs|0
1981055|NCT00899379|3544469|FG002|Overall Study|Abnormal Prestudy Labs|0
1981056|NCT00899379|3544470|FG003|Overall Study|Abnormal Prestudy Labs|0
1981057|NCT00899379|3544471|FG004|Overall Study|Abnormal Prestudy Labs|2
1981058|NCT00899379|3544467|FG000|Overall Study|Abnormal Baseline ECG|0
1981059|NCT00899379|3544468|FG001|Overall Study|Abnormal Baseline ECG|0
1981060|NCT00899379|3544469|FG002|Overall Study|Abnormal Baseline ECG|1
1981061|NCT00899379|3544470|FG003|Overall Study|Abnormal Baseline ECG|1
1981062|NCT00899379|3544471|FG004|Overall Study|Abnormal Baseline ECG|0
1981063|NCT00899379|3544467|FG000|Overall Study|No Attack Pretreatment|3
1981064|NCT00899379|3544468|FG001|Overall Study|No Attack Pretreatment|5
1981065|NCT00899379|3544469|FG002|Overall Study|No Attack Pretreatment|5
1981066|NCT00899379|3544470|FG003|Overall Study|No Attack Pretreatment|6
1981067|NCT00899379|3544471|FG004|Overall Study|No Attack Pretreatment|4
1981068|NCT00899379|3544467|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
1981069|NCT00899379|3544468|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
1981070|NCT00899379|3544469|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
1981071|NCT00899379|3544470|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
1981072|NCT00899379|3544471|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
1981073|NCT00899379|3544467|FG000|Overall Study|Inc/Exc Criteria Not Met|0
1981074|NCT00899379|3544468|FG001|Overall Study|Inc/Exc Criteria Not Met|0
1981075|NCT00899379|3544469|FG002|Overall Study|Inc/Exc Criteria Not Met|1
1981076|NCT00899379|3544470|FG003|Overall Study|Inc/Exc Criteria Not Met|0
1981077|NCT00899379|3544471|FG004|Overall Study|Inc/Exc Criteria Not Met|0
1981078|NCT00898677|3544481|FG000|Overall Study|Adverse Event|0
1981079|NCT00898677|3544482|FG001|Overall Study|Adverse Event|0
1981080|NCT00898677|3544483|FG002|Overall Study|Adverse Event|1
1981081|NCT00898677|3544484|FG003|Overall Study|Adverse Event|0
1981082|NCT00898677|3544481|FG000|Overall Study|Lost to Follow-up|0
1981083|NCT00898677|3544482|FG001|Overall Study|Lost to Follow-up|0
1981084|NCT00898677|3544483|FG002|Overall Study|Lost to Follow-up|2
1981085|NCT00898677|3544484|FG003|Overall Study|Lost to Follow-up|0
1981086|NCT00898677|3544481|FG000|Overall Study|Protocol Violation|1
1981087|NCT00898677|3544482|FG001|Overall Study|Protocol Violation|1
1981088|NCT00898677|3544483|FG002|Overall Study|Protocol Violation|2
1981089|NCT00898677|3544484|FG003|Overall Study|Protocol Violation|0
1981090|NCT00898677|3544481|FG000|Overall Study|Withdrawal by Subject|0
1981091|NCT00898677|3544482|FG001|Overall Study|Withdrawal by Subject|0
1981092|NCT00898677|3544483|FG002|Overall Study|Withdrawal by Subject|0
1981093|NCT00898677|3544484|FG003|Overall Study|Withdrawal by Subject|1
1981094|NCT00898677|3544481|FG000|Overall Study|Not Treated: Adverse Event|0
1981095|NCT00898677|3544482|FG001|Overall Study|Not Treated: Adverse Event|2
1981096|NCT00898677|3544483|FG002|Overall Study|Not Treated: Adverse Event|1
1981097|NCT00898677|3544484|FG003|Overall Study|Not Treated: Adverse Event|0
1981098|NCT00898677|3544481|FG000|Overall Study|Not Treated: Lost to Follow-Up|0
1981099|NCT00898677|3544482|FG001|Overall Study|Not Treated: Lost to Follow-Up|5
1981100|NCT00898677|3544483|FG002|Overall Study|Not Treated: Lost to Follow-Up|5
1981101|NCT00898677|3544484|FG003|Overall Study|Not Treated: Lost to Follow-Up|2
1981102|NCT00898677|3544481|FG000|Overall Study|Not Treated: Pregnancy|0
1981103|NCT00898677|3544482|FG001|Overall Study|Not Treated: Pregnancy|0
1981104|NCT00898677|3544483|FG002|Overall Study|Not Treated: Pregnancy|1
1981105|NCT00898677|3544484|FG003|Overall Study|Not Treated: Pregnancy|0
1981106|NCT00898677|3544481|FG000|Overall Study|Not Treated: Protocol Violation|2
1981107|NCT00898677|3544482|FG001|Overall Study|Not Treated: Protocol Violation|0
1981108|NCT00898677|3544483|FG002|Overall Study|Not Treated: Protocol Violation|2
1981109|NCT00898677|3544484|FG003|Overall Study|Not Treated: Protocol Violation|0
1981110|NCT00898677|3544481|FG000|Overall Study|Not Treated: Withdraw by Subject|2
1981111|NCT00898677|3544482|FG001|Overall Study|Not Treated: Withdraw by Subject|16
1981112|NCT00898677|3544483|FG002|Overall Study|Not Treated: Withdraw by Subject|11
1981113|NCT00898677|3544484|FG003|Overall Study|Not Treated: Withdraw by Subject|3
1981114|NCT00898677|3544481|FG000|Overall Study|Not Treated: Patient uncooperative|2
1981115|NCT00898677|3544482|FG001|Overall Study|Not Treated: Patient uncooperative|3
1981116|NCT00898677|3544483|FG002|Overall Study|Not Treated: Patient uncooperative|1
1981117|NCT00898677|3544484|FG003|Overall Study|Not Treated: Patient uncooperative|0
1981118|NCT00898677|3544481|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1981119|NCT00898677|3544482|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1981120|NCT00898677|3544483|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1981121|NCT00898677|3544484|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1
1981122|NCT00898677|3544481|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1
1981123|NCT00898677|3544482|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0
1981124|NCT00898677|3544483|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0
1981125|NCT00898677|3544484|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0
1981126|NCT00898677|3544481|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0
1981127|NCT00898677|3544482|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3
1981128|NCT00898677|3544483|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1
1981129|NCT00898677|3544484|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0
1981130|NCT00898677|3544481|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9
1981131|NCT00898677|3544482|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39
2025972|NCT00348140|3594699|FG002|Overall Study|Protocol Violation|14
1981132|NCT00898677|3544483|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43
1981133|NCT00898677|3544484|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12
1981134|NCT00898677|3544481|FG000|Overall Study|Not Treated: Other (Not Specified)|0
1981135|NCT00898677|3544482|FG001|Overall Study|Not Treated: Other (Not Specified)|0
1981136|NCT00898677|3544483|FG002|Overall Study|Not Treated: Other (Not Specified)|2
1981137|NCT00898677|3544484|FG003|Overall Study|Not Treated: Other (Not Specified)|0
1981138|NCT00897949|3544497|FG000|Overall Study|Adverse Event|1
1981139|NCT00897949|3544498|FG001|Overall Study|Adverse Event|1
1981140|NCT00897949|3544499|FG002|Overall Study|Adverse Event|0
1981141|NCT00897949|3544497|FG000|Overall Study|Lost to Follow-up|0
1981142|NCT00897949|3544498|FG001|Overall Study|Lost to Follow-up|2
1981143|NCT00897949|3544499|FG002|Overall Study|Lost to Follow-up|1
1981144|NCT00897949|3544497|FG000|Overall Study|Protocol Violation|6
1981145|NCT00897949|3544498|FG001|Overall Study|Protocol Violation|3
1981146|NCT00897949|3544499|FG002|Overall Study|Protocol Violation|1
1981147|NCT00897949|3544497|FG000|Overall Study|Withdrawal by Subject|1
1981148|NCT00897949|3544498|FG001|Overall Study|Withdrawal by Subject|2
1981149|NCT00897949|3544499|FG002|Overall Study|Withdrawal by Subject|0
1981150|NCT00897949|3544497|FG000|Overall Study|Patient Uncoorperative|0
1981151|NCT00897949|3544498|FG001|Overall Study|Patient Uncoorperative|2
1981152|NCT00897949|3544499|FG002|Overall Study|Patient Uncoorperative|1
1981153|NCT00897949|3544497|FG000|Overall Study|Lost to Follow-up|30
1981154|NCT00897949|3544498|FG001|Overall Study|Lost to Follow-up|23
1981155|NCT00897949|3544499|FG002|Overall Study|Lost to Follow-up|17
1981156|NCT00897949|3544497|FG000|Overall Study|Withdrawal by Subject|24
1981157|NCT00897949|3544498|FG001|Overall Study|Withdrawal by Subject|31
1981158|NCT00897949|3544499|FG002|Overall Study|Withdrawal by Subject|17
1981159|NCT00897949|3544497|FG000|Overall Study|Abnormal Prestudy Labs|2
1981160|NCT00897949|3544498|FG001|Overall Study|Abnormal Prestudy Labs|3
1981161|NCT00897949|3544499|FG002|Overall Study|Abnormal Prestudy Labs|4
1981162|NCT00897949|3544497|FG000|Overall Study|Abnormal Baseline ECG|2
1981163|NCT00897949|3544498|FG001|Overall Study|Abnormal Baseline ECG|2
1981164|NCT00897949|3544499|FG002|Overall Study|Abnormal Baseline ECG|4
1981165|NCT00897949|3544497|FG000|Overall Study|Need for Concom. Med.|0
1981166|NCT00897949|3544498|FG001|Overall Study|Need for Concom. Med.|1
1981167|NCT00897949|3544499|FG002|Overall Study|Need for Concom. Med.|1
1981168|NCT00897949|3544497|FG000|Overall Study|Lack of Migraine Attack|29
1981169|NCT00897949|3544498|FG001|Overall Study|Lack of Migraine Attack|30
1981170|NCT00897949|3544499|FG002|Overall Study|Lack of Migraine Attack|19
1981171|NCT00897949|3544497|FG000|Overall Study|Did not take study drug|9
1981172|NCT00897949|3544498|FG001|Overall Study|Did not take study drug|3
1981173|NCT00897949|3544499|FG002|Overall Study|Did not take study drug|4
1981174|NCT00897104|3544516|FG000|Overall Study|Lost to Follow-up|12
1981175|NCT00897104|3544517|FG001|Overall Study|Lost to Follow-up|17
1981176|NCT00897104|3544518|FG002|Overall Study|Lost to Follow-up|2
1981177|NCT00897104|3544516|FG000|Overall Study|Pregnancy|0
1981178|NCT00897104|3544517|FG001|Overall Study|Pregnancy|1
1981179|NCT00897104|3544518|FG002|Overall Study|Pregnancy|0
1981180|NCT00897104|3544516|FG000|Overall Study|Protocol Violation|0
1981181|NCT00897104|3544517|FG001|Overall Study|Protocol Violation|1
1981182|NCT00897104|3544518|FG002|Overall Study|Protocol Violation|0
1981183|NCT00897104|3544516|FG000|Overall Study|Withdrawal by Subject|23
1981184|NCT00897104|3544517|FG001|Overall Study|Withdrawal by Subject|27
1981185|NCT00897104|3544518|FG002|Overall Study|Withdrawal by Subject|3
1981186|NCT00897104|3544516|FG000|Overall Study|Abnormal Prestudy Labs|2
1981187|NCT00897104|3544517|FG001|Overall Study|Abnormal Prestudy Labs|0
1981188|NCT00897104|3544518|FG002|Overall Study|Abnormal Prestudy Labs|0
1981189|NCT00897104|3544516|FG000|Overall Study|Abnormal Baseline ECG|2
1981190|NCT00897104|3544517|FG001|Overall Study|Abnormal Baseline ECG|2
1981191|NCT00897104|3544518|FG002|Overall Study|Abnormal Baseline ECG|0
2310588|NCT02736890|4014938|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0
2310589|NCT02737358|4014992|FG000|Overall Study|Withdrawal by Subject|7
2310590|NCT02737358|4014993|FG001|Overall Study|Withdrawal by Subject|12
2310591|NCT02737358|4014992|FG000|Overall Study|Lost to Follow-up|2
2310592|NCT02737358|4014993|FG001|Overall Study|Lost to Follow-up|3
2310593|NCT02737501|4015011|FG000|Randomized Phase|Died|41
2310594|NCT02737501|4015012|FG001|Randomized Phase|Died|29
2310595|NCT02737501|4015013|FG002|Randomized Phase|Died|0
2310596|NCT02737501|4015011|FG000|Randomized Phase|Withdrawal by Subject|16
2310597|NCT02737501|4015012|FG001|Randomized Phase|Withdrawal by Subject|6
2310598|NCT02737501|4015013|FG002|Randomized Phase|Withdrawal by Subject|0
2310599|NCT02737501|4015011|FG000|Randomized Phase|Lost to Follow-up|0
2310600|NCT02737501|4015012|FG001|Randomized Phase|Lost to Follow-up|1
2310601|NCT02737501|4015013|FG002|Randomized Phase|Lost to Follow-up|0
2310602|NCT02737501|4015011|FG000|Randomized Phase|Site Terminated by Sponsor|58
2310603|NCT02737501|4015012|FG001|Randomized Phase|Site Terminated by Sponsor|16
2310604|NCT02737501|4015013|FG002|Randomized Phase|Site Terminated by Sponsor|0
2310605|NCT02737501|4015011|FG000|Randomized Phase|Reason not Specified|1
2310606|NCT02737501|4015012|FG001|Randomized Phase|Reason not Specified|1
2310607|NCT02737501|4015013|FG002|Randomized Phase|Reason not Specified|0
1981192|NCT00897104|3544516|FG000|Overall Study|Need for Concom. Med.|0
1981193|NCT00897104|3544517|FG001|Overall Study|Need for Concom. Med.|1
1981194|NCT00897104|3544518|FG002|Overall Study|Need for Concom. Med.|1
1981195|NCT00897104|3544516|FG000|Overall Study|Lack of Migraine Attack|20
1981196|NCT00897104|3544517|FG001|Overall Study|Lack of Migraine Attack|22
1981197|NCT00897104|3544518|FG002|Overall Study|Lack of Migraine Attack|1
1981198|NCT00897104|3544516|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
1981199|NCT00897104|3544517|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
1981200|NCT00897104|3544518|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
1981201|NCT00897104|3544516|FG000|Overall Study|Other|3
1981202|NCT00897104|3544517|FG001|Overall Study|Other|0
1981203|NCT00897104|3544518|FG002|Overall Study|Other|0
1981204|NCT00897104|3544516|FG000|Overall Study|Protocol Violation|1
1981205|NCT00897104|3544517|FG001|Overall Study|Protocol Violation|0
1981206|NCT00897104|3544518|FG002|Overall Study|Protocol Violation|0
1981207|NCT00897104|3544516|FG000|Overall Study|Withdrawal by Subject|0
1981208|NCT00897104|3544517|FG001|Overall Study|Withdrawal by Subject|0
1981209|NCT00897104|3544518|FG002|Overall Study|Withdrawal by Subject|1
1981210|NCT00803790|3544528|FG000|Period 1|Adverse Event|0
1981211|NCT00803790|3544529|FG001|Period 1|Adverse Event|1
1981212|NCT00803790|3544530|FG002|Period 1|Adverse Event|0
1981213|NCT00803790|3544531|FG003|Period 1|Adverse Event|0
1981214|NCT00803790|3544528|FG000|Period 1|Lost to Follow-up|1
1981215|NCT00803790|3544529|FG001|Period 1|Lost to Follow-up|2
1981216|NCT00803790|3544530|FG002|Period 1|Lost to Follow-up|0
1981217|NCT00803790|3544531|FG003|Period 1|Lost to Follow-up|0
1981218|NCT00803790|3544528|FG000|Period 1|Withdrawal by Subject|8
1981219|NCT00803790|3544529|FG001|Period 1|Withdrawal by Subject|6
1981220|NCT00803790|3544530|FG002|Period 1|Withdrawal by Subject|0
1981221|NCT00803790|3544531|FG003|Period 1|Withdrawal by Subject|0
1981222|NCT00803790|3544528|FG000|Period 1|positive drug screen or personal reasons|0
1981223|NCT00803790|3544529|FG001|Period 1|positive drug screen or personal reasons|3
1981224|NCT00803790|3544530|FG002|Period 1|positive drug screen or personal reasons|0
1981225|NCT00803790|3544531|FG003|Period 1|positive drug screen or personal reasons|4
1981226|NCT00803790|3544528|FG000|Period 1|Protocol Violation|0
1981227|NCT00803790|3544529|FG001|Period 1|Protocol Violation|0
1981228|NCT00803790|3544530|FG002|Period 1|Protocol Violation|1
1981229|NCT00803790|3544531|FG003|Period 1|Protocol Violation|0
1981230|NCT00803790|3544528|FG000|Period 2|Adverse Event|0
1981231|NCT00803790|3544529|FG001|Period 2|Adverse Event|0
1981232|NCT00803790|3544530|FG002|Period 2|Adverse Event|1
1981233|NCT00803790|3544531|FG003|Period 2|Adverse Event|1
1981234|NCT00803790|3544528|FG000|Period 2|Withdrawal by Subject|1
1981235|NCT00803790|3544529|FG001|Period 2|Withdrawal by Subject|0
1981236|NCT00803790|3544530|FG002|Period 2|Withdrawal by Subject|0
1981237|NCT00803790|3544531|FG003|Period 2|Withdrawal by Subject|0
1981238|NCT00803790|3544528|FG000|Period 2|Positive Drug Screen or Personal Reasons|1
1981239|NCT00803790|3544529|FG001|Period 2|Positive Drug Screen or Personal Reasons|0
1981240|NCT00803790|3544530|FG002|Period 2|Positive Drug Screen or Personal Reasons|0
1981241|NCT00803790|3544531|FG003|Period 2|Positive Drug Screen or Personal Reasons|0
1981242|NCT00725491|3544544|FG000|Overall Study|Adverse Event|3
1981243|NCT00725491|3544545|FG001|Overall Study|Adverse Event|2
1981244|NCT00725491|3544544|FG000|Overall Study|Pregnancy|0
1981245|NCT00725491|3544545|FG001|Overall Study|Pregnancy|3
1981246|NCT00725491|3544544|FG000|Overall Study|Risk for hyperstimulation|2
1981247|NCT00725491|3544545|FG001|Overall Study|Risk for hyperstimulation|9
1981248|NCT00725491|3544544|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1
1981249|NCT00725491|3544545|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1
1981250|NCT00725491|3544544|FG000|Overall Study|Fertilization failure|0
1981251|NCT00725491|3544545|FG001|Overall Study|Fertilization failure|1
1981252|NCT00725491|3544544|FG000|Overall Study|No/too few embryos/ bad quality embryos|3
1981253|NCT00725491|3544545|FG001|Overall Study|No/too few embryos/ bad quality embryos|2
1981254|NCT00703014|3544553|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
1981255|NCT00703014|3544554|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
1981256|NCT00703014|3544555|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
1981257|NCT00703014|3544556|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
1981258|NCT00703014|3544553|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
1981259|NCT00703014|3544554|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
1981260|NCT00703014|3544555|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
1981261|NCT00703014|3544556|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
1981262|NCT00702845|3544568|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2
1981263|NCT00702845|3544569|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2
1981264|NCT00702845|3544568|FG000|Overall Study|Too high ovarian response|5
1981265|NCT00702845|3544569|FG001|Overall Study|Too high ovarian response|1
1981266|NCT00702845|3544568|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1
1981267|NCT00702845|3544569|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0
1981268|NCT00702845|3544568|FG000|Overall Study|Insufficient ovarian response|1
1981269|NCT00702845|3544569|FG001|Overall Study|Insufficient ovarian response|0
1981270|NCT00702845|3544568|FG000|Overall Study|No/too few/bad quality embryos retrieved|7
1981271|NCT00702845|3544569|FG001|Overall Study|No/too few/bad quality embryos retrieved|1
1981272|NCT00702845|3544568|FG000|Overall Study|No or abnormal fertilization|4
1981273|NCT00702845|3544569|FG001|Overall Study|No or abnormal fertilization|2
1981274|NCT00702845|3544568|FG000|Overall Study|Patient's decision|2
1981275|NCT00702845|3544569|FG001|Overall Study|Patient's decision|1
1981276|NCT00702845|3544568|FG000|Overall Study|Not randomized|0
1981277|NCT00702845|3544569|FG001|Overall Study|Not randomized|1
1981278|NCT00702520|3544604|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1981279|NCT00702520|3544605|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
1981280|NCT00702520|3544606|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1981281|NCT00702520|3544607|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1981282|NCT00702520|3544604|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3
1981283|NCT00702520|3544605|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6
1981284|NCT00702520|3544606|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0
1981285|NCT00702520|3544607|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0
1981286|NCT00702520|3544604|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
1981287|NCT00702520|3544605|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
1981288|NCT00702520|3544606|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
1981289|NCT00702520|3544607|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
1981290|NCT00697255|3544646|FG000|Stage 1a|Insufficient ovarian response|1
1981291|NCT00697255|3544647|FG001|Stage 1a|Insufficient ovarian response|0
1981292|NCT00697255|3544646|FG000|Stage 1a|Multifollicular growth|1
1981293|NCT00697255|3544647|FG001|Stage 1a|Multifollicular growth|0
1981294|NCT00697255|3544646|FG000|Stage 1a|Not growing of dominant follicle|1
1981295|NCT00697255|3544647|FG001|Stage 1a|Not growing of dominant follicle|0
1981296|NCT00697255|3544646|FG000|Stage 1b|Not growing of dominant follicle|0
1981297|NCT00697255|3544647|FG001|Stage 1b|Not growing of dominant follicle|1
1981298|NCT00697255|3544646|FG000|Stage 1b|Insufficient ovarian response|0
1981299|NCT00697255|3544647|FG001|Stage 1b|Insufficient ovarian response|1
1981300|NCT00696878|3544653|FG000|Overall Study|Adverse Event|8
1981301|NCT00696878|3544653|FG000|Overall Study|Withdrawal by Subject|87
1981302|NCT00696878|3544653|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
1981303|NCT00696878|3544653|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304
1981304|NCT00696878|3544653|FG000|Overall Study|Trial stopped|32
1981305|NCT00696878|3544653|FG000|Overall Study|Other reason (not specified)|55
1981306|NCT00696800|3544659|FG000|Overall Study|Adverse Event|16
1981307|NCT00696800|3544660|FG001|Overall Study|Adverse Event|3
1981308|NCT00696800|3544659|FG000|Overall Study|Insufficient compliance with medication|2
1981309|NCT00696800|3544660|FG001|Overall Study|Insufficient compliance with medication|1
1981310|NCT00696800|3544659|FG000|Overall Study|Insufficient ovarian response on Day 8|4
1981311|NCT00696800|3544660|FG001|Overall Study|Insufficient ovarian response on Day 8|1
1981312|NCT00696800|3544659|FG000|Overall Study|Insufficient ovarian response|4
1981313|NCT00696800|3544660|FG001|Overall Study|Insufficient ovarian response|1
1981314|NCT00696800|3544659|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
1981315|NCT00696800|3544660|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
1981316|NCT00696800|3544659|FG000|Overall Study|Too high ovarian response|6
1981317|NCT00696800|3544660|FG001|Overall Study|Too high ovarian response|1
1981318|NCT00696800|3544659|FG000|Overall Study|No/too few/bad quality oocytes|4
1981319|NCT00696800|3544660|FG001|Overall Study|No/too few/bad quality oocytes|3
1981320|NCT00696800|3544659|FG000|Overall Study|No/abnormal fertilization|11
1981321|NCT00696800|3544660|FG001|Overall Study|No/abnormal fertilization|13
1981322|NCT00696800|3544659|FG000|Overall Study|No/too few/bad quality embryos|24
1981323|NCT00696800|3544660|FG001|Overall Study|No/too few/bad quality embryos|18
1981324|NCT00696800|3544659|FG000|Overall Study|Other Reasons|5
1981325|NCT00696800|3544660|FG001|Overall Study|Other Reasons|3
1981326|NCT00696800|3544659|FG000|Overall Study|Not treated|1
1981327|NCT00696800|3544660|FG001|Overall Study|Not treated|2
1981328|NCT00616967|3544668|FG000|Overall Study|Withdrawal by Subject|0
1981329|NCT00616967|3544669|FG001|Overall Study|Withdrawal by Subject|0
1981330|NCT00616967|3544670|FG002|Overall Study|Withdrawal by Subject|1
1981331|NCT00461032|3544690|FG000|Overall Study|Adverse Event|5
1981332|NCT00461032|3544691|FG001|Overall Study|Adverse Event|6
1981333|NCT00461032|3544690|FG000|Overall Study|Lack of Efficacy|5
1981334|NCT00461032|3544691|FG001|Overall Study|Lack of Efficacy|1
1981335|NCT00461032|3544690|FG000|Overall Study|Lost to Follow-up|7
1981336|NCT00461032|3544691|FG001|Overall Study|Lost to Follow-up|12
1981337|NCT00461032|3544690|FG000|Overall Study|Protocol Violation|4
1981338|NCT00461032|3544691|FG001|Overall Study|Protocol Violation|4
1981339|NCT00461032|3544690|FG000|Overall Study|Withdrawal by Subject|7
1981340|NCT00461032|3544691|FG001|Overall Study|Withdrawal by Subject|15
1981341|NCT00461032|3544690|FG000|Overall Study|Patient Moved or Relocated|2
1981342|NCT00461032|3544691|FG001|Overall Study|Patient Moved or Relocated|1
1981343|NCT00461032|3544690|FG000|Overall Study|Other|7
1981344|NCT00461032|3544691|FG001|Overall Study|Other|5
1981345|NCT00335777|3544721|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
1981346|NCT00335777|3544721|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
1981347|NCT00335777|3544721|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
1981348|NCT00335777|3544721|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
1981349|NCT00335777|3544721|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12
1981350|NCT00289874|3544728|FG000|Overall Study|Adverse Event|1
1981351|NCT00289874|3544729|FG001|Overall Study|Adverse Event|5
1981352|NCT00289874|3544728|FG000|Overall Study|Lost to Follow-up|1
1981353|NCT00289874|3544729|FG001|Overall Study|Lost to Follow-up|1
1981354|NCT00289874|3544728|FG000|Overall Study|Protocol Violation|3
1981355|NCT00289874|3544729|FG001|Overall Study|Protocol Violation|2
1981356|NCT00289874|3544728|FG000|Overall Study|Did not meet eligibility|1
1981357|NCT00289874|3544729|FG001|Overall Study|Did not meet eligibility|0
1981358|NCT00250458|3544737|FG000|Overall Study|Lost to Follow-up|4
1981359|NCT00250458|3544738|FG001|Overall Study|Lost to Follow-up|2
1981360|NCT00250458|3544737|FG000|Overall Study|Protocol Violation|0
1981361|NCT00250458|3544738|FG001|Overall Study|Protocol Violation|1
1981362|NCT00250458|3544737|FG000|Overall Study|Withdrawal by Subject|4
1981363|NCT00250458|3544738|FG001|Overall Study|Withdrawal by Subject|2
1981364|NCT00250458|3544737|FG000|Overall Study|Lack of Migraine Attack|20
1981365|NCT00250458|3544738|FG001|Overall Study|Lack of Migraine Attack|9
1981366|NCT00250458|3544737|FG000|Overall Study|Qualifying migraine but did not treat|3
1981367|NCT00250458|3544738|FG001|Overall Study|Qualifying migraine but did not treat|3
1981368|NCT00250458|3544737|FG000|Overall Study|Other|1
1981369|NCT00250458|3544738|FG001|Overall Study|Other|0
1981370|NCT00245570|3544744|FG000|Washout Between Periods III and IV|Adverse Event|0
1981371|NCT00245570|3544745|FG001|Washout Between Periods III and IV|Adverse Event|1
1981372|NCT00245570|3544746|FG002|Washout Between Periods III and IV|Adverse Event|0
1981373|NCT00245570|3544747|FG003|Washout Between Periods III and IV|Adverse Event|0
1981374|NCT00245570|3544748|FG004|Washout Between Periods III and IV|Adverse Event|0
1981375|NCT00245570|3544749|FG005|Washout Between Periods III and IV|Adverse Event|0
1981376|NCT00092131|3544773|FG000|Treatment Period I|Adverse Event|1
1981377|NCT00092131|3544774|FG001|Treatment Period I|Adverse Event|0
1981378|NCT00092131|3544773|FG000|Treatment Period II|Adverse Event|0
1981379|NCT00092131|3544774|FG001|Treatment Period II|Adverse Event|1
1981380|NCT00092118|3544782|FG000|Overall Study|Adverse Event|35
1981381|NCT00092118|3544783|FG001|Overall Study|Adverse Event|32
1981382|NCT00092118|3544782|FG000|Overall Study|Lack of Efficacy|12
1981383|NCT00092118|3544783|FG001|Overall Study|Lack of Efficacy|14
1981384|NCT00092118|3544782|FG000|Overall Study|Lost to Follow-up|4
1981385|NCT00092118|3544783|FG001|Overall Study|Lost to Follow-up|3
1981386|NCT00092118|3544782|FG000|Overall Study|Protocol Violation|23
1981387|NCT00092118|3544783|FG001|Overall Study|Protocol Violation|25
1981388|NCT00092118|3544782|FG000|Overall Study|Withdrawal by Subject|4
1981389|NCT00092118|3544783|FG001|Overall Study|Withdrawal by Subject|10
1981390|NCT00092118|3544782|FG000|Overall Study|Other|6
1981391|NCT00092118|3544783|FG001|Overall Study|Other|5
1981392|NCT00090142|3544789|FG000|Treatment Period I|Lost to Follow-up|1
1981393|NCT00090142|3544790|FG001|Treatment Period I|Lost to Follow-up|2
1981394|NCT00090142|3544789|FG000|Treatment Period I|Protocol Violation|2
1981395|NCT00090142|3544790|FG001|Treatment Period I|Protocol Violation|0
1981396|NCT00090142|3544789|FG000|Treatment Period I|Withdrawal by Subject|2
1981397|NCT00090142|3544790|FG001|Treatment Period I|Withdrawal by Subject|0
1981398|NCT00090142|3544789|FG000|Treatment Period I|Other|0
1981399|NCT00090142|3544790|FG001|Treatment Period I|Other|1
1981400|NCT00090142|3544789|FG000|Treatment Period II|Other|1
1981401|NCT00090142|3544790|FG001|Treatment Period II|Other|0
2023420|NCT00325195|3591569|FG000|Received Intervention: ITT Population|Death|3
2023421|NCT00325195|3591570|FG001|Received Intervention: ITT Population|Death|1
2023422|NCT00325195|3591571|FG002|Received Intervention: ITT Population|Death|0
2023423|NCT00325195|3591569|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7
2023424|NCT00325195|3591570|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6
2023425|NCT00325195|3591571|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1
2023426|NCT00325195|3591569|FG000|Received Intervention: ITT Population|Lost to Follow-up|0
2023427|NCT00325195|3591570|FG001|Received Intervention: ITT Population|Lost to Follow-up|0
2023428|NCT00325195|3591571|FG002|Received Intervention: ITT Population|Lost to Follow-up|2
2023429|NCT00325195|3591569|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1
2023430|NCT00325195|3591570|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1
2023431|NCT00325195|3591571|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0
2023432|NCT00325234|3591581|FG000|Overall Study|Adverse Event|10
2023433|NCT00325234|3591582|FG001|Overall Study|Adverse Event|7
2023434|NCT00325234|3591581|FG000|Overall Study|Death due to Study Disease|1
2023435|NCT00325234|3591582|FG001|Overall Study|Death due to Study Disease|0
2023436|NCT00325234|3591581|FG000|Overall Study|Entry Criteria Not Met|1
2023437|NCT00325234|3591582|FG001|Overall Study|Entry Criteria Not Met|2
2023438|NCT00325234|3591581|FG000|Overall Study|Subject Decision|6
2023439|NCT00325234|3591582|FG001|Overall Study|Subject Decision|8
2023440|NCT00325234|3591581|FG000|Overall Study|Physician Decision|17
2023441|NCT00325234|3591582|FG001|Overall Study|Physician Decision|12
2023442|NCT00325234|3591581|FG000|Overall Study|Progressive Disease|34
2023443|NCT00325234|3591582|FG001|Overall Study|Progressive Disease|37
2023444|NCT00325416|3591603|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8
2023445|NCT00325416|3591604|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9
2023446|NCT00325416|3591603|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7
2023447|NCT00325416|3591604|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4
2023448|NCT00325416|3591603|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7
2023449|NCT00325416|3591604|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2
2025973|NCT00348140|3594697|FG000|Overall Study|Withdrawal by Subject|32
1981402|NCT04771013|3544802|FG000|Overall Study|Withdrawal by Subject|2
1981403|NCT04771013|3544803|FG001|Overall Study|Withdrawal by Subject|0
1981404|NCT04771013|3544802|FG000|Overall Study|Death|0
1981405|NCT04771013|3544803|FG001|Overall Study|Death|5
1981406|NCT04771013|3544802|FG000|Overall Study|Referred to another hospital before day 20|0
1981407|NCT04771013|3544803|FG001|Overall Study|Referred to another hospital before day 20|1
1981408|NCT04497987|3544811|FG000|Overall Study|Adverse Event|1
1981409|NCT04497987|3544812|FG001|Overall Study|Adverse Event|0
1981410|NCT04497987|3544811|FG000|Overall Study|Death|21
1981411|NCT04497987|3544812|FG001|Overall Study|Death|13
1981412|NCT04497987|3544811|FG000|Overall Study|Lost to Follow-up|19
1981413|NCT04497987|3544812|FG001|Overall Study|Lost to Follow-up|17
1981414|NCT04497987|3544811|FG000|Overall Study|Other - as reported by the investigator|22
1981415|NCT04497987|3544812|FG001|Overall Study|Other - as reported by the investigator|16
1981416|NCT04497987|3544811|FG000|Overall Study|Physician Decision|1
1981417|NCT04497987|3544812|FG001|Overall Study|Physician Decision|0
1981418|NCT04497987|3544811|FG000|Overall Study|Withdrawal by Subject|35
1981419|NCT04497987|3544812|FG001|Overall Study|Withdrawal by Subject|21
1981420|NCT03512210|3544868|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3
1981421|NCT03512210|3544868|FG000|Step 1: MINMON Intervention|Protocol Violation|1
1981422|NCT03512210|3544868|FG000|Step 2:Post-MINMON|Death|2
1981423|NCT03512210|3544868|FG000|Step 2:Post-MINMON|Lost to Follow-up|30
1981424|NCT03512210|3544868|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2
1981425|NCT03493854|3544883|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3
1981426|NCT03493854|3544884|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5
1981427|NCT03493854|3544883|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
1981428|NCT03493854|3544884|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
1981429|NCT03493854|3544883|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0
1981430|NCT03493854|3544884|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1
1981431|NCT03493854|3544883|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1
1981432|NCT03493854|3544884|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2
1981433|NCT03493854|3544883|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
1981434|NCT03493854|3544884|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
1981435|NCT03493854|3544883|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
1981436|NCT03493854|3544884|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2
1981437|NCT03493854|3544883|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
1981438|NCT03493854|3544884|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0
1981439|NCT03493854|3544883|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229
1981440|NCT03493854|3544884|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228
1981441|NCT03493854|3544883|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
1981442|NCT03493854|3544884|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
1981443|NCT03493854|3544883|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0
1981444|NCT03493854|3544884|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1
1981445|NCT03493854|3544883|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3
1981446|NCT03493854|3544884|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0
1981447|NCT03493854|3544883|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1
1981448|NCT03493854|3544884|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0
1981449|NCT03493854|3544883|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2
1981450|NCT03493854|3544884|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0
1981451|NCT03493854|3544883|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5
1981452|NCT03493854|3544884|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3
1981453|NCT03493854|3544883|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
1981454|NCT03493854|3544884|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
1981455|NCT03493854|3544883|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18
1981456|NCT03493854|3544884|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16
1981457|NCT03417245|3544905|FG000|Overall Study|Adverse Event|1
1981458|NCT03417245|3544906|FG001|Overall Study|Adverse Event|0
1981459|NCT03417245|3544905|FG000|Overall Study|Protocol Violation|1
1981460|NCT03417245|3544906|FG001|Overall Study|Protocol Violation|0
1981461|NCT03417245|3544905|FG000|Overall Study|Withdrawal by Subject|1
1981462|NCT03417245|3544906|FG001|Overall Study|Withdrawal by Subject|1
1981463|NCT03180307|3544927|FG000|Overall Study|Lost to Follow-up|2
1981464|NCT03180307|3544928|FG001|Overall Study|Lost to Follow-up|0
1981465|NCT03180307|3544927|FG000|Overall Study|Death|1
1981466|NCT03180307|3544928|FG001|Overall Study|Death|0
1981467|NCT03180307|3544927|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3
1981468|NCT03180307|3544928|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0
1981469|NCT02831673|3544947|FG000|Overall Study|Adverse Event|6
1981470|NCT02831673|3544948|FG001|Overall Study|Adverse Event|4
1981471|NCT02831673|3544947|FG000|Overall Study|Lack of Efficacy|3
1981472|NCT02831673|3544948|FG001|Overall Study|Lack of Efficacy|1
2310608|NCT02737501|4015011|FG000|Randomized Phase|Never Treated|1
2310609|NCT02737501|4015012|FG001|Randomized Phase|Never Treated|1
2310610|NCT02737501|4015013|FG002|Randomized Phase|Never Treated|0
2310611|NCT02737501|4015011|FG000|Crossover Phase|Died|0
2310612|NCT02737501|4015012|FG001|Crossover Phase|Died|0
1981473|NCT02831673|3544947|FG000|Overall Study|Protocol Violation|5
1981474|NCT02831673|3544948|FG001|Overall Study|Protocol Violation|4
1981475|NCT02831673|3544947|FG000|Overall Study|Protocol Withdrawal Criterion Met|1
1981476|NCT02831673|3544948|FG001|Overall Study|Protocol Withdrawal Criterion Met|6
1981477|NCT02831673|3544947|FG000|Overall Study|Lost to Follow-up|9
1981478|NCT02831673|3544948|FG001|Overall Study|Lost to Follow-up|6
1981479|NCT02831673|3544947|FG000|Overall Study|Physician Decision|6
1981480|NCT02831673|3544948|FG001|Overall Study|Physician Decision|3
1981481|NCT02831673|3544947|FG000|Overall Study|Withdrawal by Subject|6
1981482|NCT02831673|3544948|FG001|Overall Study|Withdrawal by Subject|4
1981483|NCT02831673|3544947|FG000|Overall Study|Ongoing at Week 48 primary analysis.|320
1981484|NCT02831673|3544948|FG001|Overall Study|Ongoing at Week 48 primary analysis.|330
1981485|NCT02668822|3544956|FG000|Overall Study|Protocol Violation|2
1981486|NCT02668822|3544957|FG001|Overall Study|Protocol Violation|0
1981487|NCT02668822|3544956|FG000|Overall Study|Study Terminated by Sponsor|7
1981488|NCT02668822|3544957|FG001|Overall Study|Study Terminated by Sponsor|9
1981489|NCT02668783|3544965|FG000|Overall Study|Pregnancy|0
1981490|NCT02668783|3544966|FG001|Overall Study|Pregnancy|1
1981491|NCT02668783|3544965|FG000|Overall Study|Protocol Violation|2
1981492|NCT02668783|3544966|FG001|Overall Study|Protocol Violation|1
1981493|NCT02668783|3544965|FG000|Overall Study|Study terminated by sponsor|9
1981494|NCT02668783|3544966|FG001|Overall Study|Study terminated by sponsor|10
1981495|NCT02668783|3544965|FG000|Overall Study|Subject moved|1
1981496|NCT02668783|3544966|FG001|Overall Study|Subject moved|0
1981497|NCT02668783|3544965|FG000|Overall Study|Withdrawal by Subject|1
1981498|NCT02668783|3544966|FG001|Overall Study|Withdrawal by Subject|0
1981499|NCT02616146|3544974|FG000|Overall Study|Adverse Event|64
1981500|NCT02616146|3544975|FG001|Overall Study|Adverse Event|24
1981501|NCT02616146|3544974|FG000|Overall Study|Lost to Follow-up|23
1981502|NCT02616146|3544975|FG001|Overall Study|Lost to Follow-up|13
1981503|NCT02616146|3544974|FG000|Overall Study|Non-compliance with study protocol|2
1981504|NCT02616146|3544975|FG001|Overall Study|Non-compliance with study protocol|0
1981505|NCT02616146|3544974|FG000|Overall Study|Non-compliance with study drug|4
1981506|NCT02616146|3544975|FG001|Overall Study|Non-compliance with study drug|2
1981507|NCT02616146|3544974|FG000|Overall Study|Pregnancy|2
1981508|NCT02616146|3544975|FG001|Overall Study|Pregnancy|2
1981509|NCT02616146|3544974|FG000|Overall Study|Pregnancy wish|3
1981510|NCT02616146|3544975|FG001|Overall Study|Pregnancy wish|0
1981511|NCT02616146|3544974|FG000|Overall Study|Protocol Violation|6
1981512|NCT02616146|3544975|FG001|Overall Study|Protocol Violation|3
1981513|NCT02616146|3544974|FG000|Overall Study|Study terminated by sponsor|1372
1981514|NCT02616146|3544975|FG001|Overall Study|Study terminated by sponsor|432
1981515|NCT02616146|3544974|FG000|Overall Study|Participant moved|4
1981516|NCT02616146|3544975|FG001|Overall Study|Participant moved|3
1981517|NCT02616146|3544974|FG000|Overall Study|Withdrawal by Subject|30
1981518|NCT02616146|3544975|FG001|Overall Study|Withdrawal by Subject|24
1981519|NCT02616146|3544974|FG000|Overall Study|Physician Decision|2
1981520|NCT02616146|3544975|FG001|Overall Study|Physician Decision|1
1981521|NCT02524288|3544994|FG000|Overall Study|Adverse Event|115
1981522|NCT02524288|3544994|FG000|Overall Study|Lost to Follow-up|216
1981523|NCT02524288|3544994|FG000|Overall Study|Non-Compliance With Protocol|32
1981524|NCT02524288|3544994|FG000|Overall Study|Non-Compliance With Study Drug|14
1981525|NCT02524288|3544994|FG000|Overall Study|Pregnancy Wish|6
1981526|NCT02524288|3544994|FG000|Overall Study|Protocol Violation|6
1981527|NCT02524288|3544994|FG000|Overall Study|Screen Failure|2
1981528|NCT02524288|3544994|FG000|Overall Study|Site Discontinued Study Participation|1
1981529|NCT02524288|3544994|FG000|Overall Study|Study Terminated By Sponsor|1417
1981530|NCT02524288|3544994|FG000|Overall Study|Subject Moved|32
1981531|NCT02524288|3544994|FG000|Overall Study|Withdrawal by Subject|76
1981532|NCT02524288|3544994|FG000|Overall Study|Pregnancy|22
1981533|NCT02524288|3544994|FG000|Overall Study|Physician Decision|2
1981534|NCT02489942|3544998|FG000|Overall Study|Request by patient|602
1981535|NCT02489942|3544998|FG000|Overall Study|Improvement/remission|157
1981536|NCT02489942|3544998|FG000|Overall Study|No change/Progressive disease|263
1981537|NCT02489942|3544998|FG000|Overall Study|Adverse Event|522
1981538|NCT02489942|3544998|FG000|Overall Study|Other personal reasons|1218
1981539|NCT02489942|3544998|FG000|Overall Study|Lost to Follow-up|456
1981540|NCT02489942|3544998|FG000|Overall Study|Not continuously investigated|7
1981541|NCT02489942|3544998|FG000|Overall Study|Patient started jardiance treatment out of registration period|1
1981542|NCT02489942|3544998|FG000|Overall Study|Multiple registration|1
1981543|NCT02489942|3544998|FG000|Overall Study|No patient visit after entry|100
1981544|NCT02489942|3544998|FG000|Overall Study|No treatment with Jardiance|2
1981545|NCT02489942|3544998|FG000|Overall Study|Patient received Jardiance before registration|1
1981546|NCT02489942|3544998|FG000|Overall Study|No CRF collected|86
1981547|NCT02409342|3545004|FG000|Overall Study|Death|181
1981548|NCT02409342|3545005|FG001|Overall Study|Death|174
1981549|NCT02409342|3545004|FG000|Overall Study|Withdrawal by Subject|24
1981550|NCT02409342|3545005|FG001|Overall Study|Withdrawal by Subject|16
1981551|NCT02409342|3545004|FG000|Overall Study|On-going in study|79
1981552|NCT02409342|3545005|FG001|Overall Study|On-going in study|92
1981553|NCT02409342|3545004|FG000|Overall Study|Lost to Follow-up|3
1981554|NCT02409342|3545005|FG001|Overall Study|Lost to Follow-up|3
2023450|NCT00325416|3591603|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
1981555|NCT02275546|3545022|FG000|Treatment Period 2|Withdrawal by Subject|2
1981556|NCT02275546|3545023|FG001|Treatment Period 2|Withdrawal by Subject|1
1981557|NCT02275546|3545022|FG000|Treatment Period 2|Protocol Violation|0
1981558|NCT02275546|3545023|FG001|Treatment Period 2|Protocol Violation|1
1981559|NCT02227238|3545031|FG000|Overall Study|Other: Reached stopping criteria|0
1981560|NCT02227238|3545032|FG001|Overall Study|Other: Reached stopping criteria|1
1981561|NCT02227238|3545031|FG000|Overall Study|Adverse Event|8
1981562|NCT02227238|3545032|FG001|Overall Study|Adverse Event|18
1981563|NCT02227238|3545031|FG000|Overall Study|Lack of Efficacy|10
1981564|NCT02227238|3545032|FG001|Overall Study|Lack of Efficacy|22
1981565|NCT02227238|3545031|FG000|Overall Study|Protocol Violation|7
1981566|NCT02227238|3545032|FG001|Overall Study|Protocol Violation|8
1981567|NCT02227238|3545031|FG000|Overall Study|Withdrawal by Subject|5
1981568|NCT02227238|3545032|FG001|Overall Study|Withdrawal by Subject|4
1981569|NCT02227238|3545031|FG000|Overall Study|Physician Decision|0
1981570|NCT02227238|3545032|FG001|Overall Study|Physician Decision|9
1981571|NCT02227238|3545031|FG000|Overall Study|Lost to Follow-up|7
1981572|NCT02227238|3545032|FG001|Overall Study|Lost to Follow-up|5
1981573|NCT02077166|3545045|FG000|Overall Study|Death|6
1981574|NCT02077166|3545046|FG001|Overall Study|Death|7
1981575|NCT02077166|3545047|FG002|Overall Study|Death|5
1981576|NCT02077166|3545048|FG003|Overall Study|Death|6
1981577|NCT02077166|3545049|FG004|Overall Study|Death|4
1981578|NCT02077166|3545050|FG005|Overall Study|Death|32
1981579|NCT02077166|3545051|FG006|Overall Study|Death|22
1981580|NCT02077166|3545045|FG000|Overall Study|Study Closure by Sponsor|3
2213242|NCT01677377|3854700|FG002|Overall Study|Withdrawal by Subject|3
2213243|NCT01677377|3854698|FG000|Overall Study|Lack of Efficacy|0
1981581|NCT02077166|3545046|FG001|Overall Study|Study Closure by Sponsor|0
1981582|NCT02077166|3545047|FG002|Overall Study|Study Closure by Sponsor|2
1981583|NCT02077166|3545048|FG003|Overall Study|Study Closure by Sponsor|2
1981584|NCT02077166|3545049|FG004|Overall Study|Study Closure by Sponsor|2
1981585|NCT02077166|3545050|FG005|Overall Study|Study Closure by Sponsor|12
1981586|NCT02077166|3545051|FG006|Overall Study|Study Closure by Sponsor|4
1981587|NCT02077166|3545045|FG000|Overall Study|Lost to Follow-up|0
1981588|NCT02077166|3545046|FG001|Overall Study|Lost to Follow-up|0
1981589|NCT02077166|3545047|FG002|Overall Study|Lost to Follow-up|0
1981590|NCT02077166|3545048|FG003|Overall Study|Lost to Follow-up|0
1981591|NCT02077166|3545049|FG004|Overall Study|Lost to Follow-up|0
1981592|NCT02077166|3545050|FG005|Overall Study|Lost to Follow-up|1
1981593|NCT02077166|3545051|FG006|Overall Study|Lost to Follow-up|0
1981594|NCT02077166|3545045|FG000|Overall Study|Withdrawal by Subject|3
1981595|NCT02077166|3545046|FG001|Overall Study|Withdrawal by Subject|0
1981596|NCT02077166|3545047|FG002|Overall Study|Withdrawal by Subject|1
1981597|NCT02077166|3545048|FG003|Overall Study|Withdrawal by Subject|1
1981598|NCT02077166|3545049|FG004|Overall Study|Withdrawal by Subject|1
1981599|NCT02077166|3545050|FG005|Overall Study|Withdrawal by Subject|3
1981600|NCT02077166|3545051|FG006|Overall Study|Withdrawal by Subject|0
1981601|NCT02077166|3545045|FG000|Overall Study|Other, Not Specified|0
1981602|NCT02077166|3545046|FG001|Overall Study|Other, Not Specified|0
1981603|NCT02077166|3545047|FG002|Overall Study|Other, Not Specified|1
1981604|NCT02077166|3545048|FG003|Overall Study|Other, Not Specified|0
1981605|NCT02077166|3545049|FG004|Overall Study|Other, Not Specified|1
1981606|NCT02077166|3545050|FG005|Overall Study|Other, Not Specified|7
1981607|NCT02077166|3545051|FG006|Overall Study|Other, Not Specified|8
1981608|NCT01891344|3545076|FG000|Overall Study|Ongoing|6
1981609|NCT01891344|3545077|FG001|Overall Study|Ongoing|2
1981610|NCT01891344|3545078|FG002|Overall Study|Ongoing|0
1981611|NCT01891344|3545079|FG003|Overall Study|Ongoing|1
1981612|NCT01891344|3545080|FG004|Overall Study|Ongoing|4
1981613|NCT01891344|3545081|FG005|Overall Study|Ongoing|1
1981614|NCT01891344|3545082|FG006|Overall Study|Ongoing|0
1981615|NCT01891344|3545083|FG007|Overall Study|Ongoing|0
1981616|NCT01847274|3545105|FG000|Overall Study|Adverse Event|17
1981617|NCT01847274|3545106|FG001|Overall Study|Adverse Event|1
1981618|NCT01847274|3545107|FG002|Overall Study|Adverse Event|33
1981619|NCT01847274|3545108|FG003|Overall Study|Adverse Event|2
1981620|NCT01847274|3545105|FG000|Overall Study|Withdrawal by Subject|8
1981621|NCT01847274|3545106|FG001|Overall Study|Withdrawal by Subject|8
1981622|NCT01847274|3545107|FG002|Overall Study|Withdrawal by Subject|11
1981623|NCT01847274|3545108|FG003|Overall Study|Withdrawal by Subject|1
1981624|NCT01847274|3545105|FG000|Overall Study|Disease Progression|63
1981625|NCT01847274|3545106|FG001|Overall Study|Disease Progression|49
1981626|NCT01847274|3545107|FG002|Overall Study|Disease Progression|129
1981627|NCT01847274|3545108|FG003|Overall Study|Disease Progression|98
1981628|NCT01847274|3545105|FG000|Overall Study|Treatment Associated Risk|0
2213244|NCT01677377|3854699|FG001|Overall Study|Lack of Efficacy|0
1981629|NCT01847274|3545106|FG001|Overall Study|Treatment Associated Risk|2
1981630|NCT01847274|3545107|FG002|Overall Study|Treatment Associated Risk|2
1981631|NCT01847274|3545108|FG003|Overall Study|Treatment Associated Risk|0
1981632|NCT01847274|3545105|FG000|Overall Study|Other Reasons|3
1981633|NCT01847274|3545106|FG001|Overall Study|Other Reasons|1
1981634|NCT01847274|3545107|FG002|Overall Study|Other Reasons|11
1981635|NCT01847274|3545108|FG003|Overall Study|Other Reasons|3
1981636|NCT01847274|3545105|FG000|Overall Study|Non Compliance|0
1981637|NCT01847274|3545106|FG001|Overall Study|Non Compliance|0
1981638|NCT01847274|3545107|FG002|Overall Study|Non Compliance|2
1981639|NCT01847274|3545108|FG003|Overall Study|Non Compliance|0
1981640|NCT01670656|3545123|FG000|Overall Study|Non-compliance with study drug|0
1981641|NCT01670656|3545124|FG001|Overall Study|Non-compliance with study drug|0
1981642|NCT01670656|3545125|FG002|Overall Study|Non-compliance with study drug|3
1981643|NCT01670656|3545126|FG003|Overall Study|Non-compliance with study drug|0
1981644|NCT01670656|3545127|FG004|Overall Study|Non-compliance with study drug|1
1981645|NCT01670656|3545123|FG000|Overall Study|Pregnancy|0
1981646|NCT01670656|3545124|FG001|Overall Study|Pregnancy|0
1981647|NCT01670656|3545125|FG002|Overall Study|Pregnancy|0
1981648|NCT01670656|3545126|FG003|Overall Study|Pregnancy|0
1981649|NCT01670656|3545127|FG004|Overall Study|Pregnancy|1
1981650|NCT01670656|3545123|FG000|Overall Study|Withdrawal by Subject|1
1981651|NCT01670656|3545124|FG001|Overall Study|Withdrawal by Subject|1
1981652|NCT01670656|3545125|FG002|Overall Study|Withdrawal by Subject|0
1981653|NCT01670656|3545126|FG003|Overall Study|Withdrawal by Subject|0
1981654|NCT01670656|3545127|FG004|Overall Study|Withdrawal by Subject|0
1981655|NCT01670656|3545123|FG000|Overall Study|Non-compliance with protocol|0
1981656|NCT01670656|3545124|FG001|Overall Study|Non-compliance with protocol|3
1981657|NCT01670656|3545125|FG002|Overall Study|Non-compliance with protocol|1
1981658|NCT01670656|3545126|FG003|Overall Study|Non-compliance with protocol|1
1981659|NCT01670656|3545127|FG004|Overall Study|Non-compliance with protocol|2
1981660|NCT01670656|3545123|FG000|Overall Study|Adverse Event|2
1981661|NCT01670656|3545124|FG001|Overall Study|Adverse Event|2
1981662|NCT01670656|3545125|FG002|Overall Study|Adverse Event|2
1981663|NCT01670656|3545126|FG003|Overall Study|Adverse Event|3
1981664|NCT01670656|3545127|FG004|Overall Study|Adverse Event|3
1981665|NCT01670656|3545123|FG000|Overall Study|Subject withdrew consent|0
1981666|NCT01670656|3545124|FG001|Overall Study|Subject withdrew consent|1
1981667|NCT01670656|3545125|FG002|Overall Study|Subject withdrew consent|2
1981668|NCT01670656|3545126|FG003|Overall Study|Subject withdrew consent|1
1981669|NCT01670656|3545127|FG004|Overall Study|Subject withdrew consent|1
1981670|NCT01670656|3545123|FG000|Overall Study|Lost to Follow-up|0
1981671|NCT01670656|3545124|FG001|Overall Study|Lost to Follow-up|0
1981672|NCT01670656|3545125|FG002|Overall Study|Lost to Follow-up|0
1981673|NCT01670656|3545126|FG003|Overall Study|Lost to Follow-up|0
1981674|NCT01670656|3545127|FG004|Overall Study|Lost to Follow-up|3
1981675|NCT01670656|3545123|FG000|Overall Study|Subject moved|0
1981676|NCT01670656|3545124|FG001|Overall Study|Subject moved|0
1981677|NCT01670656|3545125|FG002|Overall Study|Subject moved|0
1981678|NCT01670656|3545126|FG003|Overall Study|Subject moved|1
1981679|NCT01670656|3545127|FG004|Overall Study|Subject moved|0
1981680|NCT01501955|3545141|FG000|Overall Study|Withdrawal by Subject|1
1981681|NCT01501955|3545142|FG001|Overall Study|Withdrawal by Subject|0
1981682|NCT01501955|3545141|FG000|Overall Study|Adverse Event|1
1981683|NCT01501955|3545142|FG001|Overall Study|Adverse Event|3
1981684|NCT01335399|3545150|FG000|Pre-treatment Period|No longer meeting study criteria|0
1981685|NCT01335399|3545151|FG001|Pre-treatment Period|No longer meeting study criteria|1
1981686|NCT01335399|3545150|FG000|Pre-treatment Period|Participant request to discontinue|0
1981687|NCT01335399|3545151|FG001|Pre-treatment Period|Participant request to discontinue|1
1981688|NCT01335399|3545150|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0
1981689|NCT01335399|3545151|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1
1981690|NCT01335399|3545150|FG000|Pre-treatment Period|Consent withdrawal|3
1981691|NCT01335399|3545151|FG001|Pre-treatment Period|Consent withdrawal|0
1981692|NCT01335399|3545150|FG000|Treatment Period|Disease progression|114
1981693|NCT01335399|3545151|FG001|Treatment Period|Disease progression|141
1981694|NCT01335399|3545150|FG000|Treatment Period|Adverse event unrelated to study drug|105
1981695|NCT01335399|3545151|FG001|Treatment Period|Adverse event unrelated to study drug|65
1981696|NCT01335399|3545150|FG000|Treatment Period|Study drug toxicity|51
1981697|NCT01335399|3545151|FG001|Treatment Period|Study drug toxicity|64
1981698|NCT01335399|3545150|FG000|Treatment Period|Participant request to discontinue|27
1981699|NCT01335399|3545151|FG001|Treatment Period|Participant request to discontinue|21
1981700|NCT01335399|3545150|FG000|Treatment Period|Other reasons|14
1981701|NCT01335399|3545151|FG001|Treatment Period|Other reasons|26
1981702|NCT01335399|3545150|FG000|Treatment Period|Consent withdrawal|10
1981703|NCT01335399|3545151|FG001|Treatment Period|Consent withdrawal|6
1981704|NCT01335399|3545150|FG000|Treatment Period|Death|7
1981705|NCT01335399|3545151|FG001|Treatment Period|Death|8
1981706|NCT01335399|3545150|FG000|Treatment Period|Poor/Non-compliance|3
1981707|NCT01335399|3545151|FG001|Treatment Period|Poor/Non-compliance|4
1981708|NCT01335399|3545150|FG000|Treatment Period|Lost to Follow-up|0
1981709|NCT01335399|3545151|FG001|Treatment Period|Lost to Follow-up|2
1981710|NCT01335399|3545150|FG000|Treatment Period|Maximum clinical benefit|1
1981711|NCT01335399|3545151|FG001|Treatment Period|Maximum clinical benefit|1
1981712|NCT01335399|3545150|FG000|Treatment Period|No longer meet study criteria|0
1981713|NCT01335399|3545151|FG001|Treatment Period|No longer meet study criteria|1
2108215|NCT00878722|3702052|FG003|Overall Study|Relapse|1
1981714|NCT01335399|3545150|FG000|Treatment Period|Not reported|1
1981715|NCT01335399|3545151|FG001|Treatment Period|Not reported|0
1981716|NCT01277211|3545159|FG000|Overall Study|Adverse Event|60
1981717|NCT01277211|3545160|FG001|Overall Study|Adverse Event|22
1981718|NCT01277211|3545159|FG000|Overall Study|Pregnancy|9
1981719|NCT01277211|3545160|FG001|Overall Study|Pregnancy|4
1981720|NCT01277211|3545159|FG000|Overall Study|Lost to Follow-up|14
1981721|NCT01277211|3545160|FG001|Overall Study|Lost to Follow-up|9
1981722|NCT01277211|3545159|FG000|Overall Study|Did not wish to continue|17
1981723|NCT01277211|3545160|FG001|Overall Study|Did not wish to continue|0
1981724|NCT01277211|3545159|FG000|Overall Study|Withdrew Consent|9
1981725|NCT01277211|3545160|FG001|Overall Study|Withdrew Consent|9
1981726|NCT01277211|3545159|FG000|Overall Study|Non-compliance with protocol|13
1981727|NCT01277211|3545160|FG001|Overall Study|Non-compliance with protocol|4
1981728|NCT01277211|3545159|FG000|Overall Study|Did not meet protocol eligibility|1
1981729|NCT01277211|3545160|FG001|Overall Study|Did not meet protocol eligibility|0
1981730|NCT01277211|3545159|FG000|Overall Study|Administrative|3
1981731|NCT01277211|3545160|FG001|Overall Study|Administrative|0
1981732|NCT01277211|3545159|FG000|Overall Study|Pregnancy wish|0
1981733|NCT01277211|3545160|FG001|Overall Study|Pregnancy wish|2
1981734|NCT01277211|3545159|FG000|Overall Study|Discontinued prior to treatment|24
1981735|NCT01277211|3545160|FG001|Overall Study|Discontinued prior to treatment|13
1981736|NCT01244828|3545170|FG000|Overall Study|Adverse Event|37
1981737|NCT01244828|3545170|FG000|Overall Study|Withdrawal by Subject|31
1981738|NCT01244828|3545170|FG000|Overall Study|Lack of Efficacy|7
1981739|NCT01244828|3545170|FG000|Overall Study|Lost to Follow-up|2
1981740|NCT01244828|3545170|FG000|Overall Study|Other reason (not specified)|1
1981741|NCT01207492|3545174|FG000|Overall Study|Still on study|1
1981742|NCT01207492|3545174|FG000|Overall Study|Withdrawal by Subject|9
1981743|NCT01207492|3545174|FG000|Overall Study|Physician Decision|1
1981744|NCT01207492|3545174|FG000|Overall Study|Progressive disease|3
1981745|NCT01207492|3545174|FG000|Overall Study|Toxicity|1
1981746|NCT01181778|3545178|FG000|Overall Study|Physician Decision|48
1981747|NCT01047540|3545189|FG000|Overall Study|Protocol Violation|1
1981748|NCT01047540|3545190|FG001|Overall Study|Protocol Violation|0
1981749|NCT01047540|3545191|FG002|Overall Study|Protocol Violation|0
1981750|NCT01047540|3545192|FG003|Overall Study|Protocol Violation|0
1981751|NCT01047540|3545193|FG004|Overall Study|Protocol Violation|0
1981752|NCT01047540|3545189|FG000|Overall Study|Lost to Follow-up|1
1981753|NCT01047540|3545190|FG001|Overall Study|Lost to Follow-up|0
1981754|NCT01047540|3545191|FG002|Overall Study|Lost to Follow-up|0
1981755|NCT01047540|3545192|FG003|Overall Study|Lost to Follow-up|0
1981756|NCT01047540|3545193|FG004|Overall Study|Lost to Follow-up|0
1981757|NCT01047540|3545189|FG000|Overall Study|Withdrawal by Subject|1
1981758|NCT01047540|3545190|FG001|Overall Study|Withdrawal by Subject|0
1981759|NCT01047540|3545191|FG002|Overall Study|Withdrawal by Subject|3
1981760|NCT01047540|3545192|FG003|Overall Study|Withdrawal by Subject|0
1981761|NCT01047540|3545193|FG004|Overall Study|Withdrawal by Subject|1
1981762|NCT01047540|3545189|FG000|Overall Study|Pregnancy|1
1981763|NCT01047540|3545190|FG001|Overall Study|Pregnancy|0
1981764|NCT01047540|3545191|FG002|Overall Study|Pregnancy|0
1981765|NCT01047540|3545192|FG003|Overall Study|Pregnancy|0
1981766|NCT01047540|3545193|FG004|Overall Study|Pregnancy|0
1981767|NCT01047540|3545189|FG000|Overall Study|Adverse Event|1
1981768|NCT01047540|3545190|FG001|Overall Study|Adverse Event|0
1981769|NCT01047540|3545191|FG002|Overall Study|Adverse Event|0
1981770|NCT01047540|3545192|FG003|Overall Study|Adverse Event|0
1981771|NCT01047540|3545193|FG004|Overall Study|Adverse Event|0
1981772|NCT00778999|3545238|FG000|Overall Study|Discontinuation: no embryo transfer|14
1981773|NCT00778999|3545239|FG001|Overall Study|Discontinuation: no embryo transfer|14
1981774|NCT00778999|3545238|FG000|Overall Study|Did not receive recFSH|14
1981775|NCT00778999|3545239|FG001|Overall Study|Did not receive recFSH|20
1981776|NCT00620464|3545247|FG000|Overall Study|Adverse Event|15
1981777|NCT00620464|3545248|FG001|Overall Study|Adverse Event|17
1981778|NCT00620464|3545247|FG000|Overall Study|Lost to Follow-up|1
1981779|NCT00620464|3545248|FG001|Overall Study|Lost to Follow-up|1
1981780|NCT00620464|3545247|FG000|Overall Study|Planning Pregnancy|1
1981781|NCT00620464|3545248|FG001|Overall Study|Planning Pregnancy|4
1981782|NCT00620464|3545247|FG000|Overall Study|Personal|2
1981783|NCT00620464|3545248|FG001|Overall Study|Personal|2
1981784|NCT00620464|3545247|FG000|Overall Study|Used prohibited medication|1
1981785|NCT00620464|3545248|FG001|Overall Study|Used prohibited medication|0
1981786|NCT00620035|3545254|FG000|Overall Study|Adverse Event|106
1981787|NCT00620035|3545254|FG000|Overall Study|Withdrawal of Informed Consent|1
1981788|NCT00620035|3545254|FG000|Overall Study|Other Reason|38
1981789|NCT00210249|3545258|FG000|Overall Study|Lost to Follow-up|5
1981790|NCT00210249|3545258|FG000|Overall Study|Protocol Violation|11
2023451|NCT00325416|3591604|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
2023452|NCT00325416|3591603|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0
2023453|NCT00325416|3591604|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1
2023454|NCT00325416|3591603|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0
2023455|NCT00325416|3591604|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1
2023456|NCT00325468|3591627|FG000|Overall Study|Adverse Event|1
2023457|NCT00325468|3591628|FG001|Overall Study|Adverse Event|1
2023458|NCT00325468|3591629|FG002|Overall Study|Adverse Event|0
2023459|NCT00325468|3591630|FG003|Overall Study|Adverse Event|5
2023460|NCT00325468|3591631|FG004|Overall Study|Adverse Event|1
2023461|NCT00325468|3591627|FG000|Overall Study|Death|2
2023462|NCT00325468|3591628|FG001|Overall Study|Death|0
2023463|NCT00325468|3591629|FG002|Overall Study|Death|2
1981791|NCT03513068|3545273|FG000|Overall Study|Death|1
1981792|NCT03513068|3545274|FG001|Overall Study|Death|0
1981793|NCT03513068|3545273|FG000|Overall Study|Withdrawal by Subject|4
1981794|NCT03513068|3545274|FG001|Overall Study|Withdrawal by Subject|6
1981795|NCT03502811|3545280|FG000|Overall Study|Death|157
1981796|NCT03502811|3545280|FG000|Overall Study|Withdrawal by Subject|105
1981797|NCT03502811|3545280|FG000|Overall Study|Lost to Follow-up|26
1981798|NCT03502811|3545280|FG000|Overall Study|No Visits (Missed)|31
1981799|NCT03191903|3545313|FG000|Overall Study|Withdrawal by Subject|6
1981800|NCT03191903|3545314|FG001|Overall Study|Withdrawal by Subject|5
1981801|NCT03191903|3545315|FG002|Overall Study|Withdrawal by Subject|4
1981802|NCT03191903|3545313|FG000|Overall Study|Adverse Event|1
1981803|NCT03191903|3545314|FG001|Overall Study|Adverse Event|0
1981804|NCT03191903|3545315|FG002|Overall Study|Adverse Event|0
1981805|NCT04422990|3545334|FG000|Overall Study|Withdrawal by Subject|0
1981806|NCT04422990|3545335|FG001|Overall Study|Withdrawal by Subject|1
1981807|NCT04422990|3545334|FG000|Overall Study|Travel|3
1981808|NCT04422990|3545335|FG001|Overall Study|Travel|0
2102383|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
2102384|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
2102385|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
1981813|NCT04289051|3545353|FG000|Overall Study|Lost to Follow-up|0
1981814|NCT04289051|3545354|FG001|Overall Study|Lost to Follow-up|0
1981815|NCT04289051|3545355|FG002|Overall Study|Lost to Follow-up|2
1981816|NCT04210180|3545363|FG000|Overall Study|Withdrawal by Subject|2
1981817|NCT03675308|3545415|FG000|Overall Study|Adverse Event|3
1981818|NCT03675308|3545416|FG001|Overall Study|Adverse Event|2
1981819|NCT03675308|3545415|FG000|Overall Study|Withdrawal by Subject|6
1981820|NCT03675308|3545416|FG001|Overall Study|Withdrawal by Subject|4
1981821|NCT03675308|3545415|FG000|Overall Study|Lost to Follow-up|3
1981822|NCT03675308|3545416|FG001|Overall Study|Lost to Follow-up|0
1981823|NCT03675308|3545415|FG000|Overall Study|Lack of Efficacy|1
1981824|NCT03675308|3545416|FG001|Overall Study|Lack of Efficacy|1
1981825|NCT03675308|3545415|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1
1981826|NCT03675308|3545416|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2
1981827|NCT03675308|3545415|FG000|Overall Study|Other|0
1981828|NCT03675308|3545416|FG001|Overall Study|Other|1
1981829|NCT03573817|3545424|FG000|Overall Study|Adverse Event|0
1981830|NCT03573817|3545425|FG001|Overall Study|Adverse Event|2
1981831|NCT03573817|3545424|FG000|Overall Study|Protocol Violation|0
1981832|NCT03573817|3545425|FG001|Overall Study|Protocol Violation|1
1981833|NCT03573817|3545424|FG000|Overall Study|Withdrawal by Subject|1
1981834|NCT03573817|3545425|FG001|Overall Study|Withdrawal by Subject|1
1981835|NCT03318861|3545441|FG000|Overall Study|Death|1
1981836|NCT03318861|3545442|FG001|Overall Study|Death|2
1981837|NCT03318861|3545443|FG002|Overall Study|Death|2
1981838|NCT03318861|3545444|FG003|Overall Study|Death|1
1981839|NCT03318861|3545445|FG004|Overall Study|Death|1
1981840|NCT03318861|3545441|FG000|Overall Study|Still on Study|2
1981841|NCT03318861|3545442|FG001|Overall Study|Still on Study|1
1981842|NCT03318861|3545443|FG002|Overall Study|Still on Study|1
1981843|NCT03318861|3545444|FG003|Overall Study|Still on Study|2
1981844|NCT03318861|3545445|FG004|Overall Study|Still on Study|1
1981845|NCT03318861|3545441|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0
1981846|NCT03318861|3545442|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1
1981847|NCT03318861|3545443|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0
1981848|NCT03318861|3545444|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1
1981849|NCT03318861|3545445|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1
1981850|NCT03170349|3545457|FG000|At 30 Days Follow-up|Death|1
1981851|NCT03170349|3545457|FG000|At 6 Months Follow-up|Death|3
1981852|NCT03170349|3545457|FG000|At 6 Months Follow-up|Withdrawal by Subject|1
1981853|NCT03170349|3545457|FG000|At 6 Months Follow-up|Exited for Other Reasons|5
1981854|NCT03097328|3545472|FG000|Overall Study|Still on Therapy|2
1981855|NCT03097328|3545472|FG000|Overall Study|Progressive Disease|29
1981856|NCT03097328|3545472|FG000|Overall Study|Adverse Event|4
1981857|NCT03097328|3545472|FG000|Overall Study|Withdrawal by Subject|1
1981858|NCT03097328|3545472|FG000|Overall Study|Physician Decision|1
1981859|NCT03097328|3545472|FG000|Overall Study|Patient Decision|1
1981860|NCT03097328|3545472|FG000|Overall Study|Ineligible for Study Drug|1
1981861|NCT02919683|3545517|FG000|Post-Surgery Follow-Up|Death|2
1981862|NCT02919683|3545518|FG001|Post-Surgery Follow-Up|Death|2
1981863|NCT02919683|3545517|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1
1981864|NCT02919683|3545518|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0
1981865|NCT02901548|3545525|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4
1981866|NCT02790138|3545531|FG000|Overall Study|Adverse Event|5
1981867|NCT02790138|3545532|FG001|Overall Study|Adverse Event|2
1981868|NCT02790138|3545531|FG000|Overall Study|Significant Protocol Deviation|0
1981869|NCT02790138|3545532|FG001|Overall Study|Significant Protocol Deviation|1
1981870|NCT02790138|3545531|FG000|Overall Study|Lost to Follow-up|1
1981871|NCT02790138|3545532|FG001|Overall Study|Lost to Follow-up|0
1981872|NCT02790138|3545531|FG000|Overall Study|Voluntary Withdrawal|8
1981873|NCT02790138|3545532|FG001|Overall Study|Voluntary Withdrawal|9
1981874|NCT02790138|3545531|FG000|Overall Study|Lack of Efficacy|6
1981875|NCT02790138|3545532|FG001|Overall Study|Lack of Efficacy|7
1981876|NCT02790138|3545531|FG000|Overall Study|Reason not Specified|1
1981877|NCT02790138|3545532|FG001|Overall Study|Reason not Specified|0
1981878|NCT02514239|3545566|FG000|Overall Study|Refused to continue trial medication|0
1981879|NCT02514239|3545567|FG001|Overall Study|Refused to continue trial medication|0
1981880|NCT02514239|3545568|FG002|Overall Study|Refused to continue trial medication|0
1981881|NCT02514239|3545569|FG003|Overall Study|Refused to continue trial medication|0
1981882|NCT02514239|3545570|FG004|Overall Study|Refused to continue trial medication|0
1981883|NCT02514239|3545571|FG005|Overall Study|Refused to continue trial medication|0
1981884|NCT02514239|3545572|FG006|Overall Study|Refused to continue trial medication|0
1981885|NCT02514239|3545573|FG007|Overall Study|Refused to continue trial medication|0
1981886|NCT02514239|3545574|FG008|Overall Study|Refused to continue trial medication|0
1981887|NCT02514239|3545575|FG009|Overall Study|Refused to continue trial medication|1
1981888|NCT02514239|3545566|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
1981889|NCT02514239|3545567|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
1981890|NCT02514239|3545568|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
1981891|NCT02514239|3545569|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
1981892|NCT02514239|3545570|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
1981893|NCT02514239|3545571|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
1981894|NCT02514239|3545572|FG006|Overall Study|Dose-limiting toxicity (DLT)|0
1981895|NCT02514239|3545573|FG007|Overall Study|Dose-limiting toxicity (DLT)|0
1981896|NCT02514239|3545574|FG008|Overall Study|Dose-limiting toxicity (DLT)|1
1981897|NCT02514239|3545575|FG009|Overall Study|Dose-limiting toxicity (DLT)|2
1981898|NCT02514239|3545566|FG000|Overall Study|Not treated|0
1981899|NCT02514239|3545567|FG001|Overall Study|Not treated|1
1981900|NCT02514239|3545568|FG002|Overall Study|Not treated|0
1981901|NCT02514239|3545569|FG003|Overall Study|Not treated|0
1981902|NCT02514239|3545570|FG004|Overall Study|Not treated|0
1981903|NCT02514239|3545571|FG005|Overall Study|Not treated|0
1981904|NCT02514239|3545572|FG006|Overall Study|Not treated|0
1981905|NCT02514239|3545573|FG007|Overall Study|Not treated|0
1981906|NCT02514239|3545574|FG008|Overall Study|Not treated|0
1981907|NCT02514239|3545575|FG009|Overall Study|Not treated|0
1981908|NCT02514239|3545566|FG000|Overall Study|Other Adverse Events|2
1981909|NCT02514239|3545567|FG001|Overall Study|Other Adverse Events|0
1981910|NCT02514239|3545568|FG002|Overall Study|Other Adverse Events|0
1981911|NCT02514239|3545569|FG003|Overall Study|Other Adverse Events|1
1981912|NCT02514239|3545570|FG004|Overall Study|Other Adverse Events|0
1981913|NCT02514239|3545571|FG005|Overall Study|Other Adverse Events|1
1981914|NCT02514239|3545572|FG006|Overall Study|Other Adverse Events|0
1981915|NCT02514239|3545573|FG007|Overall Study|Other Adverse Events|1
1981916|NCT02514239|3545574|FG008|Overall Study|Other Adverse Events|2
1981917|NCT02514239|3545575|FG009|Overall Study|Other Adverse Events|0
1981918|NCT02514239|3545566|FG000|Overall Study|Progressive disease|3
1981919|NCT02514239|3545567|FG001|Overall Study|Progressive disease|3
1981920|NCT02514239|3545568|FG002|Overall Study|Progressive disease|2
1981921|NCT02514239|3545569|FG003|Overall Study|Progressive disease|2
1981922|NCT02514239|3545570|FG004|Overall Study|Progressive disease|3
1981923|NCT02514239|3545571|FG005|Overall Study|Progressive disease|3
1981924|NCT02514239|3545572|FG006|Overall Study|Progressive disease|4
1981925|NCT02514239|3545573|FG007|Overall Study|Progressive disease|2
1981926|NCT02514239|3545574|FG008|Overall Study|Progressive disease|5
1981927|NCT02514239|3545575|FG009|Overall Study|Progressive disease|0
1981928|NCT02481830|3545630|FG000|Overall Study|No longer meets Study Criteria|1
1981929|NCT02481830|3545631|FG001|Overall Study|No longer meets Study Criteria|4
1981930|NCT02481830|3545630|FG000|Overall Study|Withdrawal by Subject|0
1981931|NCT02481830|3545631|FG001|Overall Study|Withdrawal by Subject|14
1981932|NCT02481830|3545630|FG000|Overall Study|Disease Progression|1
1981933|NCT02481830|3545631|FG001|Overall Study|Disease Progression|1
1981934|NCT02481830|3545630|FG000|Overall Study|Participant not eligible for trial|0
1981935|NCT02481830|3545631|FG001|Overall Study|Participant not eligible for trial|1
1981936|NCT02245672|3545653|FG000|Overall Study|Adverse Event|4
1981937|NCT02245672|3545654|FG001|Overall Study|Adverse Event|4
1981938|NCT02245672|3545655|FG002|Overall Study|Adverse Event|4
1981939|NCT02245672|3545653|FG000|Overall Study|Lost to Follow-up|3
1981940|NCT02245672|3545654|FG001|Overall Study|Lost to Follow-up|5
1981941|NCT02245672|3545655|FG002|Overall Study|Lost to Follow-up|1
1981942|NCT02245672|3545653|FG000|Overall Study|Withdrawal by Subject|6
1981943|NCT02245672|3545654|FG001|Overall Study|Withdrawal by Subject|3
1981944|NCT02245672|3545655|FG002|Overall Study|Withdrawal by Subject|0
1981945|NCT02245672|3545653|FG000|Overall Study|Randomized in error (not treated)|0
1981946|NCT02245672|3545654|FG001|Overall Study|Randomized in error (not treated)|1
1981947|NCT02245672|3545655|FG002|Overall Study|Randomized in error (not treated)|0
1981948|NCT02109172|3545663|FG000|Overall Study|Withdrawal by Subject|1
1981949|NCT02109172|3545664|FG001|Overall Study|Withdrawal by Subject|0
1981950|NCT02109172|3545665|FG002|Overall Study|Withdrawal by Subject|0
1981951|NCT02109172|3545666|FG003|Overall Study|Withdrawal by Subject|1
1981952|NCT02109172|3545667|FG004|Overall Study|Withdrawal by Subject|0
1981953|NCT02109172|3545668|FG005|Overall Study|Withdrawal by Subject|0
1981954|NCT02109172|3545663|FG000|Overall Study|Adverse Event|0
1981955|NCT02109172|3545664|FG001|Overall Study|Adverse Event|0
1981956|NCT02109172|3545665|FG002|Overall Study|Adverse Event|1
1981957|NCT02109172|3545666|FG003|Overall Study|Adverse Event|0
1981958|NCT02109172|3545667|FG004|Overall Study|Adverse Event|0
1981959|NCT02109172|3545668|FG005|Overall Study|Adverse Event|1
1981960|NCT02109172|3545663|FG000|Overall Study|Death|0
1981961|NCT02109172|3545664|FG001|Overall Study|Death|0
1981962|NCT02109172|3545665|FG002|Overall Study|Death|0
1981963|NCT02109172|3545666|FG003|Overall Study|Death|0
1981964|NCT02109172|3545667|FG004|Overall Study|Death|1
1981965|NCT02109172|3545668|FG005|Overall Study|Death|0
1981966|NCT01892722|3545703|FG000|Overall Study|Protocol deviation|0
1981967|NCT01892722|3545704|FG001|Overall Study|Protocol deviation|1
1981968|NCT01892722|3545703|FG000|Overall Study|Administrative problems|0
1981969|NCT01892722|3545704|FG001|Overall Study|Administrative problems|1
1981970|NCT01892722|3545703|FG000|Overall Study|Patient/guardian decision|0
1981971|NCT01892722|3545704|FG001|Overall Study|Patient/guardian decision|2
1981972|NCT01892722|3545703|FG000|Overall Study|Physician Decision|1
1981973|NCT01892722|3545704|FG001|Overall Study|Physician Decision|2
1981974|NCT01892722|3545703|FG000|Overall Study|Adverse Event|3
1981975|NCT01892722|3545704|FG001|Overall Study|Adverse Event|2
1981976|NCT01892722|3545703|FG000|Overall Study|Lack of Efficacy|0
1981977|NCT01892722|3545704|FG001|Overall Study|Lack of Efficacy|7
1981978|NCT01892722|3545703|FG000|Overall Study|Withdrawal by Subject|3
1981979|NCT01892722|3545704|FG001|Overall Study|Withdrawal by Subject|5
1981980|NCT00799396|3545744|FG000|Clopidogrel Treatment|Adverse Event|6
1981981|NCT00799396|3545744|FG000|Clopidogrel Treatment|Physician Decision|5
1981982|NCT00799396|3545744|FG000|Clopidogrel Treatment|Withdrawal by Subject|2
1981983|NCT00799396|3545744|FG000|Clopidogrel Plus Aspirin|Adverse Event|2
1981984|NCT00799396|3545744|FG000|Clopidogrel Plus Aspirin|Physician Decision|4
1981985|NCT00308685|3545750|FG000|Overall Study|Lost to Follow-up|1
1981986|NCT00308685|3545751|FG001|Overall Study|Lost to Follow-up|0
1981987|NCT00308685|3545750|FG000|Overall Study|Need to administer prohibited medication|1
1981988|NCT00308685|3545751|FG001|Overall Study|Need to administer prohibited medication|2
1981989|NCT00308685|3545750|FG000|Overall Study|Other than specified|1
1981990|NCT00308685|3545751|FG001|Overall Study|Other than specified|3
1981991|NCT00069238|3545757|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
1981992|NCT00069238|3545758|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
1981993|NCT00069238|3545759|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
1981994|NCT00069238|3545757|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
1981995|NCT00069238|3545758|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
1981996|NCT00069238|3545759|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
1981997|NCT00069238|3545757|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
1981998|NCT00069238|3545758|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
1981999|NCT00069238|3545759|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
2023464|NCT00325468|3591630|FG003|Overall Study|Death|4
2023465|NCT00325468|3591631|FG004|Overall Study|Death|0
2023466|NCT00325468|3591627|FG000|Overall Study|Lost to Follow-up|0
2023467|NCT00325468|3591628|FG001|Overall Study|Lost to Follow-up|0
2023468|NCT00325468|3591629|FG002|Overall Study|Lost to Follow-up|1
2023469|NCT00325468|3591630|FG003|Overall Study|Lost to Follow-up|2
2023470|NCT00325468|3591631|FG004|Overall Study|Lost to Follow-up|2
2023471|NCT00325468|3591627|FG000|Overall Study|Physician Decision|1
2023472|NCT00325468|3591628|FG001|Overall Study|Physician Decision|1
2023473|NCT00325468|3591629|FG002|Overall Study|Physician Decision|0
2023474|NCT00325468|3591630|FG003|Overall Study|Physician Decision|1
2023475|NCT00325468|3591631|FG004|Overall Study|Physician Decision|0
2023476|NCT00325468|3591627|FG000|Overall Study|Withdrawal by Subject|3
2023477|NCT00325468|3591628|FG001|Overall Study|Withdrawal by Subject|1
2023478|NCT00325468|3591629|FG002|Overall Study|Withdrawal by Subject|0
2023479|NCT00325468|3591630|FG003|Overall Study|Withdrawal by Subject|14
2023480|NCT00325468|3591631|FG004|Overall Study|Withdrawal by Subject|4
2023481|NCT00325468|3591627|FG000|Overall Study|site closure etc|4
2023482|NCT00325468|3591628|FG001|Overall Study|site closure etc|2
2023483|NCT00325468|3591629|FG002|Overall Study|site closure etc|1
2023484|NCT00325468|3591630|FG003|Overall Study|site closure etc|8
2023485|NCT00325468|3591631|FG004|Overall Study|site closure etc|1
2023486|NCT00325754|3591657|FG000|Overall Study|Adverse Event|4
2023487|NCT00325754|3591658|FG001|Overall Study|Adverse Event|1
2023488|NCT00325819|3591670|FG000|Overall Study|Study product lost in mail|2
2023489|NCT00325819|3591671|FG001|Overall Study|Study product lost in mail|1
2023490|NCT00325819|3591670|FG000|Overall Study|Did not take a dose of study product|4
2023491|NCT00325819|3591671|FG001|Overall Study|Did not take a dose of study product|9
2023492|NCT00325819|3591670|FG000|Overall Study|Lost to Follow-up|3
2023493|NCT00325819|3591671|FG001|Overall Study|Lost to Follow-up|3
2023494|NCT00325897|3591681|FG000|Overall Study|Lost to Follow-up|12
2023495|NCT00325897|3591682|FG001|Overall Study|Lost to Follow-up|13
2023496|NCT00326001|3591693|FG000|Overall Study|Adverse Event|4
2023497|NCT00326001|3591694|FG001|Overall Study|Adverse Event|5
2023498|NCT00326001|3591693|FG000|Overall Study|Physician Decision|3
2023499|NCT00326001|3591694|FG001|Overall Study|Physician Decision|3
2023500|NCT00326118|3591702|FG000|Active Phase|Withdrawal by Subject|4
2023501|NCT00326118|3591703|FG001|Active Phase|Withdrawal by Subject|1
2025974|NCT00348140|3594698|FG001|Overall Study|Withdrawal by Subject|40
2025975|NCT00348140|3594699|FG002|Overall Study|Withdrawal by Subject|40
1982000|NCT04482647|3545809|FG000|Overall Study|Time constraints|2
1982001|NCT04482647|3545809|FG000|Overall Study|Health issues|1
1982002|NCT04482647|3545809|FG000|Overall Study|Death in the family|1
1982003|NCT04482647|3545809|FG000|Overall Study|Disliked the intervention|1
1982004|NCT04482647|3545809|FG000|Overall Study|No reasons specified|7
1982005|NCT04405570|3545817|FG000|Overall Study|Adverse Event|0
1982006|NCT04405570|3545818|FG001|Overall Study|Adverse Event|1
1982007|NCT04405570|3545819|FG002|Overall Study|Adverse Event|1
1982008|NCT04405570|3545820|FG003|Overall Study|Adverse Event|1
1982009|NCT04405570|3545817|FG000|Overall Study|Lost to Follow-up|0
1982010|NCT04405570|3545818|FG001|Overall Study|Lost to Follow-up|1
1982011|NCT04405570|3545819|FG002|Overall Study|Lost to Follow-up|0
1982012|NCT04405570|3545820|FG003|Overall Study|Lost to Follow-up|0
1982013|NCT04405570|3545817|FG000|Overall Study|Physician Decision|0
1982014|NCT04405570|3545818|FG001|Overall Study|Physician Decision|0
1982015|NCT04405570|3545819|FG002|Overall Study|Physician Decision|1
1982016|NCT04405570|3545820|FG003|Overall Study|Physician Decision|0
1982017|NCT04405570|3545817|FG000|Overall Study|Withdrawal by Subject|0
1982018|NCT04405570|3545818|FG001|Overall Study|Withdrawal by Subject|1
1982019|NCT04405570|3545819|FG002|Overall Study|Withdrawal by Subject|1
1982020|NCT04405570|3545820|FG003|Overall Study|Withdrawal by Subject|0
1982021|NCT04405570|3545817|FG000|Overall Study|Randomized not dosed|0
1982022|NCT04405570|3545818|FG001|Overall Study|Randomized not dosed|2
1982023|NCT04405570|3545819|FG002|Overall Study|Randomized not dosed|0
1982024|NCT04405570|3545820|FG003|Overall Study|Randomized not dosed|0
1982025|NCT04135937|3545833|FG000|Overall Study|Lost to Follow-up|2
1982026|NCT04135937|3545833|FG000|Overall Study|Withdrawal by Subject|1
1982027|NCT03989232|3545839|FG000|Overall Study|Lost to Follow-up|3
1982028|NCT03989232|3545840|FG001|Overall Study|Lost to Follow-up|10
1982029|NCT03989232|3545839|FG000|Overall Study|Withdrawal by Subject|6
1982030|NCT03989232|3545840|FG001|Overall Study|Withdrawal by Subject|6
1982031|NCT03989232|3545839|FG000|Overall Study|Death|1
1982032|NCT03989232|3545840|FG001|Overall Study|Death|2
1982033|NCT03926611|3545853|FG000|Overall Study|Adverse Event|0
1982034|NCT03926611|3545854|FG001|Overall Study|Adverse Event|0
1982035|NCT03926611|3545855|FG002|Overall Study|Adverse Event|0
1982036|NCT03926611|3545856|FG003|Overall Study|Adverse Event|3
1982037|NCT03926611|3545857|FG004|Overall Study|Adverse Event|1
1982038|NCT03926611|3545858|FG005|Overall Study|Adverse Event|3
1982039|NCT03926611|3545859|FG006|Overall Study|Adverse Event|0
1982040|NCT03926611|3545853|FG000|Overall Study|Lack of Efficacy|1
1982041|NCT03926611|3545854|FG001|Overall Study|Lack of Efficacy|2
1982042|NCT03926611|3545855|FG002|Overall Study|Lack of Efficacy|0
1982043|NCT03926611|3545856|FG003|Overall Study|Lack of Efficacy|0
1982044|NCT03926611|3545857|FG004|Overall Study|Lack of Efficacy|1
1982045|NCT03926611|3545858|FG005|Overall Study|Lack of Efficacy|0
1982046|NCT03926611|3545859|FG006|Overall Study|Lack of Efficacy|1
1982047|NCT03926611|3545853|FG000|Overall Study|Physician Decision|0
1982048|NCT03926611|3545854|FG001|Overall Study|Physician Decision|0
1982049|NCT03926611|3545855|FG002|Overall Study|Physician Decision|0
1982050|NCT03926611|3545856|FG003|Overall Study|Physician Decision|0
1982051|NCT03926611|3545857|FG004|Overall Study|Physician Decision|0
1982052|NCT03926611|3545858|FG005|Overall Study|Physician Decision|1
1982053|NCT03926611|3545859|FG006|Overall Study|Physician Decision|0
1982054|NCT03926611|3545853|FG000|Overall Study|Protocol Violation|1
1982055|NCT03926611|3545854|FG001|Overall Study|Protocol Violation|0
1982056|NCT03926611|3545855|FG002|Overall Study|Protocol Violation|0
1982057|NCT03926611|3545856|FG003|Overall Study|Protocol Violation|1
1982058|NCT03926611|3545857|FG004|Overall Study|Protocol Violation|1
1982059|NCT03926611|3545858|FG005|Overall Study|Protocol Violation|1
1982060|NCT03926611|3545859|FG006|Overall Study|Protocol Violation|1
1982061|NCT03926611|3545853|FG000|Overall Study|Technical problems|0
1982062|NCT03926611|3545854|FG001|Overall Study|Technical problems|0
1982063|NCT03926611|3545855|FG002|Overall Study|Technical problems|0
1982064|NCT03926611|3545856|FG003|Overall Study|Technical problems|0
1982065|NCT03926611|3545857|FG004|Overall Study|Technical problems|0
1982066|NCT03926611|3545858|FG005|Overall Study|Technical problems|1
1982067|NCT03926611|3545859|FG006|Overall Study|Technical problems|0
1982068|NCT03926611|3545853|FG000|Overall Study|Withdrawal by Subject|1
1982069|NCT03926611|3545854|FG001|Overall Study|Withdrawal by Subject|1
1982070|NCT03926611|3545855|FG002|Overall Study|Withdrawal by Subject|1
1982071|NCT03926611|3545856|FG003|Overall Study|Withdrawal by Subject|0
1982072|NCT03926611|3545857|FG004|Overall Study|Withdrawal by Subject|0
1982073|NCT03926611|3545858|FG005|Overall Study|Withdrawal by Subject|1
1982074|NCT03926611|3545859|FG006|Overall Study|Withdrawal by Subject|3
1982075|NCT03926611|3545853|FG000|Overall Study|Covid-19 pandemic|0
1982076|NCT03926611|3545854|FG001|Overall Study|Covid-19 pandemic|0
1982077|NCT03926611|3545855|FG002|Overall Study|Covid-19 pandemic|1
1982078|NCT03926611|3545856|FG003|Overall Study|Covid-19 pandemic|0
1982079|NCT03926611|3545857|FG004|Overall Study|Covid-19 pandemic|1
1982080|NCT03926611|3545858|FG005|Overall Study|Covid-19 pandemic|2
1982081|NCT03926611|3545859|FG006|Overall Study|Covid-19 pandemic|0
1982082|NCT03896295|3545881|FG000|Overall Study|Adverse Event|0
1982083|NCT03896295|3545882|FG001|Overall Study|Adverse Event|1
1982084|NCT03896295|3545881|FG000|Overall Study|COVID-19|7
1982085|NCT03896295|3545882|FG001|Overall Study|COVID-19|29
1982086|NCT03213457|3545896|FG000|Overall Study|Not Treated|1
1982087|NCT03213457|3545897|FG001|Overall Study|Not Treated|1
1982088|NCT03213457|3545898|FG002|Overall Study|Not Treated|0
1982089|NCT03213457|3545896|FG000|Overall Study|Adverse Event|16
1982090|NCT03213457|3545897|FG001|Overall Study|Adverse Event|9
1982091|NCT03213457|3545898|FG002|Overall Study|Adverse Event|41
1982092|NCT03213457|3545896|FG000|Overall Study|Non-Compliance With Study Drug|1
1982093|NCT03213457|3545897|FG001|Overall Study|Non-Compliance With Study Drug|2
1982094|NCT03213457|3545898|FG002|Overall Study|Non-Compliance With Study Drug|7
1982095|NCT03213457|3545896|FG000|Overall Study|Non-Compliance Other, Not Specified|0
1982096|NCT03213457|3545897|FG001|Overall Study|Non-Compliance Other, Not Specified|1
1982097|NCT03213457|3545898|FG002|Overall Study|Non-Compliance Other, Not Specified|5
1982098|NCT03213457|3545896|FG000|Overall Study|Withdrawal by Subject|18
1982099|NCT03213457|3545897|FG001|Overall Study|Withdrawal by Subject|7
1982100|NCT03213457|3545898|FG002|Overall Study|Withdrawal by Subject|35
1982101|NCT03213457|3545896|FG000|Overall Study|Lost to Follow-up|12
1982102|NCT03213457|3545897|FG001|Overall Study|Lost to Follow-up|12
1982103|NCT03213457|3545898|FG002|Overall Study|Lost to Follow-up|33
1982104|NCT03213457|3545896|FG000|Overall Study|Pregnancy|11
1982105|NCT03213457|3545897|FG001|Overall Study|Pregnancy|0
1982106|NCT03213457|3545898|FG002|Overall Study|Pregnancy|7
1982107|NCT03213457|3545896|FG000|Overall Study|Protocol Violation|1
1982108|NCT03213457|3545897|FG001|Overall Study|Protocol Violation|1
1982109|NCT03213457|3545898|FG002|Overall Study|Protocol Violation|6
1982110|NCT03213457|3545896|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4
1982111|NCT03213457|3545897|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0
1982112|NCT03213457|3545898|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2
1982113|NCT03213457|3545896|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
1982114|NCT03213457|3545897|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
1982115|NCT03213457|3545898|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3
1982116|NCT03213457|3545896|FG000|Overall Study|Lack of Efficacy|12
1982117|NCT03213457|3545897|FG001|Overall Study|Lack of Efficacy|2
1982118|NCT03213457|3545898|FG002|Overall Study|Lack of Efficacy|9
1982119|NCT03213457|3545896|FG000|Overall Study|Other, Not Specified|11
1982120|NCT03213457|3545897|FG001|Overall Study|Other, Not Specified|3
1982121|NCT03213457|3545898|FG002|Overall Study|Other, Not Specified|26
1982122|NCT02982720|3545906|FG000|Overall Study|Adverse Event|3
1982123|NCT02982720|3545906|FG000|Overall Study|Death|1
2023502|NCT00326209|3591723|FG000|Overall Study|Adverse Event|28
2023503|NCT00326209|3591723|FG000|Overall Study|Withdrawal by Subject|22
2023504|NCT00326209|3591723|FG000|Overall Study|Lack of Efficacy|31
2023505|NCT00326209|3591723|FG000|Overall Study|Lost to Follow-up|18
2023506|NCT00326209|3591723|FG000|Overall Study|Participant non-compliant|6
2023507|NCT00326209|3591723|FG000|Overall Study|Sponsor closed study|173
2023508|NCT00326209|3591723|FG000|Overall Study|Prohibited medication use|1
2023509|NCT00326209|3591723|FG000|Overall Study|Violation of entry criteria|1
2023510|NCT00326209|3591723|FG000|Overall Study|Withdrawn in error|1
2023511|NCT00326209|3591723|FG000|Overall Study|Pregnancy|1
2023512|NCT00326417|3591729|FG000|Overall Study|Withdrawal by Subject|0
2023513|NCT00326417|3591730|FG001|Overall Study|Withdrawal by Subject|0
2023514|NCT00326417|3591731|FG002|Overall Study|Withdrawal by Subject|1
2023515|NCT00326417|3591732|FG003|Overall Study|Withdrawal by Subject|0
2023516|NCT00326417|3591729|FG000|Overall Study|Arm Closed|7
2023517|NCT00326417|3591730|FG001|Overall Study|Arm Closed|0
2023518|NCT00326417|3591731|FG002|Overall Study|Arm Closed|0
2023519|NCT00326417|3591732|FG003|Overall Study|Arm Closed|3
2023520|NCT00326417|3591729|FG000|Overall Study|Death|7
2023521|NCT00326417|3591730|FG001|Overall Study|Death|0
2023522|NCT00326417|3591731|FG002|Overall Study|Death|0
2023523|NCT00326417|3591732|FG003|Overall Study|Death|0
2023524|NCT00326495|3591740|FG000|Overall Study|Switched to alternative treatment|1
2023525|NCT00326495|3591740|FG000|Overall Study|Disease progression before treatment|1
2023526|NCT00326495|3591740|FG000|Overall Study|Refused further treatment|2
2023527|NCT00326495|3591740|FG000|Overall Study|Subject off study before assessment|1
2023528|NCT00326599|3591748|FG000|Overall Study|Withdrawal by Subject|1
2023529|NCT00326599|3591749|FG001|Overall Study|Withdrawal by Subject|0
2023530|NCT00326599|3591750|FG002|Overall Study|Withdrawal by Subject|5
2023531|NCT00326599|3591751|FG003|Overall Study|Withdrawal by Subject|2
2023532|NCT00326599|3591748|FG000|Overall Study|Adverse Event|1
2023533|NCT00326599|3591749|FG001|Overall Study|Adverse Event|0
2023534|NCT00326599|3591750|FG002|Overall Study|Adverse Event|32
2023535|NCT00326599|3591751|FG003|Overall Study|Adverse Event|3
2023536|NCT00326599|3591748|FG000|Overall Study|Disease Progression|3
2023537|NCT00326599|3591749|FG001|Overall Study|Disease Progression|1
2023538|NCT00326599|3591750|FG002|Overall Study|Disease Progression|13
2023539|NCT00326599|3591751|FG003|Overall Study|Disease Progression|11
2023540|NCT00326599|3591748|FG000|Overall Study|Alternate Treatment|1
2023541|NCT00326599|3591749|FG001|Overall Study|Alternate Treatment|0
2023542|NCT00326599|3591750|FG002|Overall Study|Alternate Treatment|0
2023543|NCT00326599|3591751|FG003|Overall Study|Alternate Treatment|0
2023544|NCT00326599|3591748|FG000|Overall Study|Death|0
2023545|NCT00326599|3591749|FG001|Overall Study|Death|0
2023546|NCT00326599|3591750|FG002|Overall Study|Death|1
2023547|NCT00326599|3591751|FG003|Overall Study|Death|2
2023548|NCT00326599|3591748|FG000|Overall Study|Other Unspecified Reason|0
1982124|NCT02425904|3545921|FG000|Overall Study|Lost to Follow-up|1
1982125|NCT02425904|3545922|FG001|Overall Study|Lost to Follow-up|0
1982126|NCT02425904|3545921|FG000|Overall Study|Withdrawal by Subject|2
1982127|NCT02425904|3545922|FG001|Overall Study|Withdrawal by Subject|0
1982128|NCT02425904|3545921|FG000|Overall Study|Death|0
1982129|NCT02425904|3545922|FG001|Overall Study|Death|3
1982130|NCT02421939|3545931|FG000|Overall Study|Progressive disease|70
1982131|NCT02421939|3545932|FG001|Overall Study|Progressive disease|16
1982132|NCT02421939|3545931|FG000|Overall Study|Lack of Efficacy|21
1982133|NCT02421939|3545932|FG001|Overall Study|Lack of Efficacy|31
1982134|NCT02421939|3545931|FG000|Overall Study|Death|36
1982135|NCT02421939|3545932|FG001|Overall Study|Death|10
1982136|NCT02421939|3545931|FG000|Overall Study|Disease relapse|33
1982137|NCT02421939|3545932|FG001|Overall Study|Disease relapse|2
1982138|NCT02421939|3545931|FG000|Overall Study|Adverse Event|28
1982139|NCT02421939|3545932|FG001|Overall Study|Adverse Event|5
1982140|NCT02421939|3545931|FG000|Overall Study|Withdrawal by Subject|5
1982141|NCT02421939|3545932|FG001|Overall Study|Withdrawal by Subject|24
1982142|NCT02421939|3545931|FG000|Overall Study|Physician Decision|11
1982143|NCT02421939|3545932|FG001|Overall Study|Physician Decision|11
1982144|NCT02421939|3545931|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
1982145|NCT02421939|3545932|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
1982146|NCT02421939|3545931|FG000|Overall Study|Miscellaneous|4
1982147|NCT02421939|3545932|FG001|Overall Study|Miscellaneous|5
1982148|NCT02421939|3545931|FG000|Overall Study|Protocol deviation|1
1982149|NCT02421939|3545932|FG001|Overall Study|Protocol deviation|1
1982150|NCT02375672|3545938|FG000|Overall Study|remain on follow up|20
1982151|NCT02329327|3545944|FG000|Overall Study|Death|78
1982152|NCT02329327|3545945|FG001|Overall Study|Death|0
1982153|NCT02329327|3545944|FG000|Overall Study|Withdrawal by Subject|3
1982154|NCT02329327|3545945|FG001|Overall Study|Withdrawal by Subject|0
1982155|NCT02329327|3545944|FG000|Overall Study|Lost to Follow-up|4
1982156|NCT02329327|3545945|FG001|Overall Study|Lost to Follow-up|0
1982157|NCT02063724|3545990|FG000|Overall Study|Disease progression|1
1982158|NCT01942135|3545996|FG000|Overall Study|Adverse Event|9
1982159|NCT01942135|3545997|FG001|Overall Study|Adverse Event|3
1982160|NCT01942135|3545996|FG000|Overall Study|Global deterioration of health status|8
1982161|NCT01942135|3545997|FG001|Overall Study|Global deterioration of health status|3
1982162|NCT01942135|3545996|FG000|Overall Study|Randomized Not Treated|2
1982163|NCT01942135|3545997|FG001|Overall Study|Randomized Not Treated|2
1982164|NCT01942135|3545996|FG000|Overall Study|Death|0
1982165|NCT01942135|3545997|FG001|Overall Study|Death|1
1982166|NCT01942135|3545996|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85
1982167|NCT01942135|3545997|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87
1982168|NCT01942135|3545996|FG000|Overall Study|Participant Refused toContinue Treatment|1
1982169|NCT01942135|3545997|FG001|Overall Study|Participant Refused toContinue Treatment|1
1982170|NCT01942135|3545996|FG000|Overall Study|Withdrawal by Subject|4
1982171|NCT01942135|3545997|FG001|Overall Study|Withdrawal by Subject|2
1982172|NCT01942135|3545996|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
2213245|NCT01677377|3854700|FG002|Overall Study|Lack of Efficacy|1
2213246|NCT01677377|3854698|FG000|Overall Study|Pregnancy|0
1982173|NCT01942135|3545997|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
1982174|NCT01566149|3546016|FG000|Overall Study|Adverse Event|0
1982175|NCT01566149|3546017|FG001|Overall Study|Adverse Event|1
1982176|NCT01566149|3546016|FG000|Overall Study|Non-compliance with study medication|2
1982177|NCT01566149|3546017|FG001|Overall Study|Non-compliance with study medication|0
1982178|NCT01566149|3546016|FG000|Overall Study|Protocol Violation|0
1982179|NCT01566149|3546017|FG001|Overall Study|Protocol Violation|1
1982180|NCT01566149|3546016|FG000|Overall Study|Withdrawal by Subject|1
1982181|NCT01566149|3546017|FG001|Overall Study|Withdrawal by Subject|0
1982182|NCT01386125|3546034|FG000|Overall Study|Lost to Follow-up|3
1982183|NCT01386125|3546035|FG001|Overall Study|Lost to Follow-up|9
1982184|NCT01386125|3546034|FG000|Overall Study|Physician Decision|0
1982185|NCT01386125|3546035|FG001|Overall Study|Physician Decision|1
1982186|NCT01386125|3546034|FG000|Overall Study|Protocol Violation|5
1982187|NCT01386125|3546035|FG001|Overall Study|Protocol Violation|7
1982188|NCT01386125|3546034|FG000|Overall Study|Disease Progress|1
1982189|NCT01386125|3546035|FG001|Overall Study|Disease Progress|2
1982190|NCT01386125|3546034|FG000|Overall Study|Withdrawal by Subject|13
1982191|NCT01386125|3546035|FG001|Overall Study|Withdrawal by Subject|12
2310613|NCT02737501|4015013|FG002|Crossover Phase|Died|22
2310614|NCT02737501|4015011|FG000|Crossover Phase|Withdrew Consent|0
2310615|NCT02737501|4015012|FG001|Crossover Phase|Withdrew Consent|0
2310616|NCT02737501|4015013|FG002|Crossover Phase|Withdrew Consent|9
2310617|NCT02737501|4015011|FG000|Crossover Phase|Physician Decision|0
2310618|NCT02737501|4015012|FG001|Crossover Phase|Physician Decision|0
2310619|NCT02737501|4015013|FG002|Crossover Phase|Physician Decision|1
2310620|NCT02737501|4015011|FG000|Crossover Phase|Site Terminated by Sponsor|0
1982192|NCT01386125|3546034|FG000|Overall Study|Adverse Event|2
1982193|NCT01386125|3546035|FG001|Overall Study|Adverse Event|5
1982194|NCT01386125|3546034|FG000|Overall Study|Lack of Efficacy|0
1982195|NCT01386125|3546035|FG001|Overall Study|Lack of Efficacy|1
1982196|NCT01386125|3546034|FG000|Overall Study|Participant Leaving Country|1
2310621|NCT02737501|4015012|FG001|Crossover Phase|Site Terminated by Sponsor|0
1982197|NCT01386125|3546035|FG001|Overall Study|Participant Leaving Country|0
1982198|NCT01257568|3546041|FG000|Overall Study|Lost to Follow-up|2
1982199|NCT01257568|3546041|FG000|Overall Study|Withdrawal by Subject|6
1982200|NCT01257568|3546041|FG000|Overall Study|Terminated|1
1982201|NCT01257568|3546041|FG000|Overall Study|Component Revision|24
1982202|NCT01165424|3546047|FG000|Overall Study|Clinical adverse experiences|1
1982203|NCT01165424|3546047|FG000|Overall Study|Laboratory adverse experiences|1
1982204|NCT01165424|3546047|FG000|Overall Study|Did not meet entry criteria|1
1982205|NCT01165424|3546047|FG000|Overall Study|Participant moved (relocated)|1
1982206|NCT01135134|3546053|FG000|Overall Study|Adverse Event|1
1982207|NCT01135134|3546054|FG001|Overall Study|Adverse Event|1
1982208|NCT01135134|3546053|FG000|Overall Study|Did not meet protocol eligibility|1
1982209|NCT01135134|3546054|FG001|Overall Study|Did not meet protocol eligibility|0
1982210|NCT00867165|3546062|FG000|Overall Study|Adverse Event|3
1982211|NCT00867165|3546063|FG001|Overall Study|Adverse Event|0
1982212|NCT00867165|3546062|FG000|Overall Study|Withdrawal by Subject|1
1982213|NCT00867165|3546063|FG001|Overall Study|Withdrawal by Subject|0
1982214|NCT00733005|3546071|FG000|Overall Study|Adverse Event|0
1982215|NCT00733005|3546072|FG001|Overall Study|Adverse Event|1
1982216|NCT00733005|3546071|FG000|Overall Study|Treatment Failure|0
1982217|NCT00733005|3546072|FG001|Overall Study|Treatment Failure|1
1982218|NCT00733005|3546071|FG000|Overall Study|Withdrawal by Subject|0
1982219|NCT00733005|3546072|FG001|Overall Study|Withdrawal by Subject|1
1982220|NCT00733005|3546071|FG000|Overall Study|Protocol Violation|2
1982221|NCT00733005|3546072|FG001|Overall Study|Protocol Violation|0
1982222|NCT00732381|3546080|FG000|Overall Study|Adverse Event|1
1982223|NCT00732381|3546081|FG001|Overall Study|Adverse Event|0
1982224|NCT00732381|3546080|FG000|Overall Study|Treatment Failure|1
1982225|NCT00732381|3546081|FG001|Overall Study|Treatment Failure|1
2023549|NCT00326599|3591749|FG001|Overall Study|Other Unspecified Reason|0
2023550|NCT00326599|3591750|FG002|Overall Study|Other Unspecified Reason|2
2023551|NCT00326599|3591751|FG003|Overall Study|Other Unspecified Reason|1
2023552|NCT00326612|3591762|FG000|Overall Study|They did not have a seizure requiring tx|129
2023553|NCT00326612|3591763|FG001|Overall Study|They did not have a seizure requiring tx|137
2023554|NCT00326625|3591775|FG000|Overall Study|Adverse Event|20
2023555|NCT00326625|3591776|FG001|Overall Study|Adverse Event|9
2023556|NCT00326625|3591775|FG000|Overall Study|Withdrawal by Subject|15
2023557|NCT00326625|3591776|FG001|Overall Study|Withdrawal by Subject|12
2023558|NCT00326625|3591775|FG000|Overall Study|Death|18
2023559|NCT00326625|3591776|FG001|Overall Study|Death|16
2023560|NCT00326625|3591775|FG000|Overall Study|Lost to Follow-up|1
2023561|NCT00326625|3591776|FG001|Overall Study|Lost to Follow-up|0
2023562|NCT00326625|3591775|FG000|Overall Study|prescheduled medical intervention|0
2023563|NCT00326625|3591776|FG001|Overall Study|prescheduled medical intervention|1
2023564|NCT00326716|3591784|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
2023565|NCT00326716|3591785|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
2023566|NCT00326716|3591786|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
2023567|NCT00326716|3591787|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
2023568|NCT00326885|3591830|FG000|Overall Study|Adverse Event|1
2023569|NCT00326885|3591830|FG000|Overall Study|Withdrawal by Subject|3
2023570|NCT00326885|3591830|FG000|Overall Study|Physician Decision|1
2023571|NCT00326885|3591830|FG000|Overall Study|Hospice withdrew consent|2
2023572|NCT00326911|3591837|FG000|Overall Study|Hospitalization prior to treatment|0
2023573|NCT00326911|3591838|FG001|Overall Study|Hospitalization prior to treatment|1
2023574|NCT00326911|3591837|FG000|Overall Study|Physician decision prior to treatment|1
2023575|NCT00326911|3591838|FG001|Overall Study|Physician decision prior to treatment|0
2023576|NCT00326911|3591837|FG000|Overall Study|Withdrawal by subject prior to treatment|0
2023577|NCT00326911|3591838|FG001|Overall Study|Withdrawal by subject prior to treatment|1
2023578|NCT00326950|3591853|FG000|Overall Study|Progressive Disease|1
2023579|NCT00326963|3591857|FG000|Overall Study|Adverse Event|2
2023580|NCT00326963|3591857|FG000|Overall Study|Injection site reaction|1
2023581|NCT00326963|3591857|FG000|Overall Study|Death|1
2023582|NCT00326963|3591857|FG000|Overall Study|Failure to return|10
2023583|NCT00326963|3591857|FG000|Overall Study|Withdrawal by Subject|10
2023584|NCT00326963|3591857|FG000|Overall Study|Refused treatment / did not cooperate|5
2023585|NCT00326963|3591857|FG000|Overall Study|Violation of selection criteria at entry|2
2023586|NCT00326963|3591857|FG000|Overall Study|Other protocol violation|1
2023587|NCT00326963|3591857|FG000|Overall Study|Administrative / other|1
2023588|NCT00327015|3591866|FG000|Overall Study|Lack of Efficacy|18
2023589|NCT00327015|3591867|FG001|Overall Study|Lack of Efficacy|18
2023590|NCT00327015|3591868|FG002|Overall Study|Lack of Efficacy|35
2023591|NCT00327015|3591869|FG003|Overall Study|Lack of Efficacy|29
2023592|NCT00327015|3591866|FG000|Overall Study|Withdrawal of Consent by Subject|20
2023593|NCT00327015|3591867|FG001|Overall Study|Withdrawal of Consent by Subject|24
2023594|NCT00327015|3591868|FG002|Overall Study|Withdrawal of Consent by Subject|28
2023595|NCT00327015|3591869|FG003|Overall Study|Withdrawal of Consent by Subject|25
2023596|NCT00327015|3591866|FG000|Overall Study|Lost to Follow-up|22
2023597|NCT00327015|3591867|FG001|Overall Study|Lost to Follow-up|23
2023598|NCT00327015|3591868|FG002|Overall Study|Lost to Follow-up|29
2023599|NCT00327015|3591869|FG003|Overall Study|Lost to Follow-up|22
2023600|NCT00327015|3591866|FG000|Overall Study|Adverse Event|14
1982226|NCT00654095|3546087|FG000|Overall Study|Drop in low density lipoprotein (1)|2
1982227|NCT00654095|3546087|FG000|Overall Study|Elevated triglyceride level (2)|1
1982228|NCT00654095|3546087|FG000|Overall Study|Elevated alanine aminotransferase (3)|1
1982229|NCT00654095|3546087|FG000|Overall Study|Adverse Event|11
1982230|NCT00654095|3546087|FG000|Overall Study|Withdrawal by Subject|5
1982231|NCT00654095|3546087|FG000|Overall Study|Elevated alanine aminotransferase (4)|7
1982232|NCT00654095|3546087|FG000|Overall Study|Adverse reaction did not improve (5)|4
1982233|NCT00654095|3546087|FG000|Overall Study|Did not meet inclusion criteria|1
1982234|NCT00653523|3546091|FG000|Overall Study|Drop in low density lipoprotein (1)|2
1982235|NCT00653523|3546091|FG000|Overall Study|Elevated creatine phosphokinase (2)|1
1982236|NCT00653523|3546091|FG000|Overall Study|Adverse Event|7
1982237|NCT00653523|3546091|FG000|Overall Study|Withdrawal by Subject|6
1982238|NCT00653523|3546091|FG000|Overall Study|Elevated alanine aminotransferase (3)|2
1982239|NCT00653523|3546091|FG000|Overall Study|Adverse reaction did not improve (4)|1
1982240|NCT00599027|3546097|FG000|Overall Study|Withdrawal by Subject|1
1982241|NCT00599027|3546098|FG001|Overall Study|Withdrawal by Subject|1
1982242|NCT00599027|3546097|FG000|Overall Study|Adverse Event|0
1982243|NCT00599027|3546098|FG001|Overall Study|Adverse Event|1
1982244|NCT00599027|3546097|FG000|Overall Study|Treatment Failure|0
1982245|NCT00599027|3546098|FG001|Overall Study|Treatment Failure|1
1982246|NCT00552032|3546106|FG000|Overall Study|Withdrawal by Subject|2
1982247|NCT00552032|3546107|FG001|Overall Study|Withdrawal by Subject|2
1982248|NCT00552032|3546106|FG000|Overall Study|Protocol Violation|7
1982249|NCT00552032|3546107|FG001|Overall Study|Protocol Violation|12
1982250|NCT00552032|3546106|FG000|Overall Study|Lost to Follow-up|8
1982251|NCT00552032|3546107|FG001|Overall Study|Lost to Follow-up|5
1982252|NCT00546052|3546113|FG000|Overall Study|Adverse Event|47
1982253|NCT00546052|3546113|FG000|Overall Study|Lost to Follow-up|144
1982254|NCT00546052|3546113|FG000|Overall Study|Protocol Violation|9
2213247|NCT01677377|3854699|FG001|Overall Study|Pregnancy|0
2213248|NCT01677377|3854700|FG002|Overall Study|Pregnancy|1
1982255|NCT00546052|3546113|FG000|Overall Study|Withdrawal by Subject|20
1982256|NCT00546052|3546113|FG000|Overall Study|Non Compliance|7
1982257|NCT00442117|3546122|FG000|Overall Study|Adverse Event|3
1982258|NCT00442117|3546123|FG001|Overall Study|Adverse Event|2
1982259|NCT00442117|3546122|FG000|Overall Study|Lack of Efficacy|2
1982260|NCT00442117|3546123|FG001|Overall Study|Lack of Efficacy|6
1982261|NCT00442117|3546122|FG000|Overall Study|Lost to Follow-up|1
1982262|NCT00442117|3546123|FG001|Overall Study|Lost to Follow-up|2
1982263|NCT00442117|3546122|FG000|Overall Study|Withdrawal by Subject|2
1982264|NCT00442117|3546123|FG001|Overall Study|Withdrawal by Subject|2
1982265|NCT00442117|3546122|FG000|Overall Study|Major Deviation|25
1982266|NCT00442117|3546123|FG001|Overall Study|Major Deviation|20
1982267|NCT00442117|3546122|FG000|Overall Study|Non compliance with protocol|3
1982268|NCT00442117|3546123|FG001|Overall Study|Non compliance with protocol|5
1982269|NCT00442117|3546122|FG000|Overall Study|Met Withdrawal Criteria|2
1982270|NCT00442117|3546123|FG001|Overall Study|Met Withdrawal Criteria|1
1982271|NCT00424008|3546131|FG000|Overall Study|Adverse Event|8
1982272|NCT00424008|3546132|FG001|Overall Study|Adverse Event|6
1982273|NCT00424008|3546131|FG000|Overall Study|Lack of Efficacy|40
1982274|NCT00424008|3546132|FG001|Overall Study|Lack of Efficacy|34
1982275|NCT00424008|3546131|FG000|Overall Study|Lost to Follow-up|1
1982276|NCT00424008|3546132|FG001|Overall Study|Lost to Follow-up|2
1982277|NCT00424008|3546131|FG000|Overall Study|Withdrawal by Subject|5
1982278|NCT00424008|3546132|FG001|Overall Study|Withdrawal by Subject|8
1982279|NCT00424008|3546131|FG000|Overall Study|Noncompliance with protocol|13
1982280|NCT00424008|3546132|FG001|Overall Study|Noncompliance with protocol|7
1982281|NCT00424008|3546131|FG000|Overall Study|Did not meet protocol eligibility|16
1982282|NCT00424008|3546132|FG001|Overall Study|Did not meet protocol eligibility|21
1982283|NCT00424008|3546131|FG000|Overall Study|Administrative|266
1982284|NCT00424008|3546132|FG001|Overall Study|Administrative|257
1982285|NCT00423176|3546141|FG000|Overall Study|Adverse Event|4
1982286|NCT00423176|3546142|FG001|Overall Study|Adverse Event|6
1982287|NCT00423176|3546141|FG000|Overall Study|Treatment Failure|1
1982288|NCT00423176|3546142|FG001|Overall Study|Treatment Failure|6
1982289|NCT00423176|3546141|FG000|Overall Study|Lost to Follow-up|4
1982290|NCT00423176|3546142|FG001|Overall Study|Lost to Follow-up|7
1982291|NCT00423176|3546141|FG000|Overall Study|Withdrawal by Subject|4
1982292|NCT00423176|3546142|FG001|Overall Study|Withdrawal by Subject|3
1982293|NCT00423176|3546141|FG000|Overall Study|Protocol Violation|1
1982294|NCT00423176|3546142|FG001|Overall Study|Protocol Violation|3
1982295|NCT00423176|3546141|FG000|Overall Study|Did not meet protocol eligibility|2
1982296|NCT00423176|3546142|FG001|Overall Study|Did not meet protocol eligibility|4
1982297|NCT00383240|3546152|FG000|Overall Study|Adverse Event|4
1982298|NCT00383240|3546153|FG001|Overall Study|Adverse Event|6
1982299|NCT00383240|3546154|FG002|Overall Study|Adverse Event|9
1982300|NCT00383240|3546155|FG003|Overall Study|Adverse Event|7
1982301|NCT00383240|3546152|FG000|Overall Study|Treatment Failure|8
1982302|NCT00383240|3546153|FG001|Overall Study|Treatment Failure|13
1982303|NCT00383240|3546154|FG002|Overall Study|Treatment Failure|47
1982304|NCT00383240|3546155|FG003|Overall Study|Treatment Failure|46
1982305|NCT00383240|3546152|FG000|Overall Study|Lost to Follow-up|3
1982306|NCT00383240|3546153|FG001|Overall Study|Lost to Follow-up|0
2213249|NCT01677507|3854708|FG000|Initial Assignment|Adverse Event|0
1982307|NCT00383240|3546154|FG002|Overall Study|Lost to Follow-up|0
1982308|NCT00383240|3546155|FG003|Overall Study|Lost to Follow-up|2
1982309|NCT00383240|3546152|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6
1982310|NCT00383240|3546153|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3
1982311|NCT00383240|3546154|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8
1982312|NCT00383240|3546155|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8
1982313|NCT00383240|3546152|FG000|Overall Study|Withdrawal by subjects, reasons related|0
1982314|NCT00383240|3546153|FG001|Overall Study|Withdrawal by subjects, reasons related|1
1982315|NCT00383240|3546154|FG002|Overall Study|Withdrawal by subjects, reasons related|3
1982316|NCT00383240|3546155|FG003|Overall Study|Withdrawal by subjects, reasons related|5
1982317|NCT00383240|3546152|FG000|Overall Study|Protocol Violation|4
1982318|NCT00383240|3546153|FG001|Overall Study|Protocol Violation|5
1982319|NCT00383240|3546154|FG002|Overall Study|Protocol Violation|9
1982320|NCT00383240|3546155|FG003|Overall Study|Protocol Violation|6
1982321|NCT00383240|3546152|FG000|Overall Study|Did not meet protocol eligibility|9
1982322|NCT00383240|3546153|FG001|Overall Study|Did not meet protocol eligibility|4
1982323|NCT00383240|3546154|FG002|Overall Study|Did not meet protocol eligibility|9
1982324|NCT00383240|3546155|FG003|Overall Study|Did not meet protocol eligibility|3
1982325|NCT00383240|3546152|FG000|Overall Study|Administrative|1
1982326|NCT00383240|3546153|FG001|Overall Study|Administrative|1
1982327|NCT00383240|3546154|FG002|Overall Study|Administrative|0
1982328|NCT00383240|3546155|FG003|Overall Study|Administrative|0
2023601|NCT00327015|3591867|FG001|Overall Study|Adverse Event|10
2023602|NCT00327015|3591868|FG002|Overall Study|Adverse Event|14
2023603|NCT00327015|3591869|FG003|Overall Study|Adverse Event|14
2023604|NCT00327015|3591866|FG000|Overall Study|Subject no longer meets study criteria|4
2023605|NCT00327015|3591867|FG001|Overall Study|Subject no longer meets study criteria|2
2023606|NCT00327015|3591868|FG002|Overall Study|Subject no longer meets study criteria|8
2023607|NCT00327015|3591869|FG003|Overall Study|Subject no longer meets study criteria|7
2023608|NCT00327015|3591866|FG000|Overall Study|Poor/Noncompliance|11
2023609|NCT00327015|3591867|FG001|Overall Study|Poor/Noncompliance|8
2023610|NCT00327015|3591868|FG002|Overall Study|Poor/Noncompliance|4
2023611|NCT00327015|3591869|FG003|Overall Study|Poor/Noncompliance|5
2023612|NCT00327015|3591866|FG000|Overall Study|Physician Decision|0
2023613|NCT00327015|3591867|FG001|Overall Study|Physician Decision|1
2023614|NCT00327015|3591868|FG002|Overall Study|Physician Decision|3
2023615|NCT00327015|3591869|FG003|Overall Study|Physician Decision|2
2023616|NCT00327015|3591866|FG000|Overall Study|Death|1
2023617|NCT00327015|3591867|FG001|Overall Study|Death|2
2023618|NCT00327015|3591868|FG002|Overall Study|Death|2
2023619|NCT00327015|3591869|FG003|Overall Study|Death|3
2023620|NCT00327015|3591866|FG000|Overall Study|Pregnancy|0
2023621|NCT00327015|3591867|FG001|Overall Study|Pregnancy|2
2023622|NCT00327015|3591868|FG002|Overall Study|Pregnancy|1
2023623|NCT00327015|3591869|FG003|Overall Study|Pregnancy|1
2023624|NCT00327015|3591866|FG000|Overall Study|Administrative Reason by Sponsor|1
2023625|NCT00327015|3591867|FG001|Overall Study|Administrative Reason by Sponsor|2
2023626|NCT00327015|3591868|FG002|Overall Study|Administrative Reason by Sponsor|2
2023627|NCT00327015|3591869|FG003|Overall Study|Administrative Reason by Sponsor|1
2023628|NCT00327171|3591881|FG000|Overall Study|Did not receive study medication|3
2023629|NCT00327171|3591882|FG001|Overall Study|Did not receive study medication|0
2023630|NCT00327171|3591881|FG000|Overall Study|Adverse Event|23
2023631|NCT00327171|3591882|FG001|Overall Study|Adverse Event|23
2023632|NCT00327171|3591881|FG000|Overall Study|Disease progression/lack of efficacy|68
2023633|NCT00327171|3591882|FG001|Overall Study|Disease progression/lack of efficacy|69
2023634|NCT00327171|3591881|FG000|Overall Study|Investigator/participant request|1
2023635|NCT00327171|3591882|FG001|Overall Study|Investigator/participant request|8
2023636|NCT00327171|3591881|FG000|Overall Study|Clinical progression|12
2023637|NCT00327171|3591882|FG001|Overall Study|Clinical progression|8
2023638|NCT00327171|3591881|FG000|Overall Study|Undisclosed history of ischemia|0
2023639|NCT00327171|3591882|FG001|Overall Study|Undisclosed history of ischemia|1
2023640|NCT00327171|3591881|FG000|Overall Study|Other|1
2023641|NCT00327171|3591882|FG001|Overall Study|Other|0
2023642|NCT00327340|3591890|FG000|Overall Study|Withdrawal by Subject|1
2023643|NCT00327340|3591891|FG001|Overall Study|Withdrawal by Subject|5
2023644|NCT00327340|3591890|FG000|Overall Study|Physician Decision|1
2023645|NCT00327340|3591891|FG001|Overall Study|Physician Decision|1
2023646|NCT00327340|3591890|FG000|Overall Study|Disease Progression|10
2023647|NCT00327340|3591891|FG001|Overall Study|Disease Progression|19
2023648|NCT00327340|3591890|FG000|Overall Study|Symptomatic Disease|0
2023649|NCT00327340|3591891|FG001|Overall Study|Symptomatic Disease|2
2023650|NCT00327340|3591890|FG000|Overall Study|Adverse Event|3
2023651|NCT00327340|3591891|FG001|Overall Study|Adverse Event|3
2023652|NCT00327444|3591905|FG000|Double Blind Treatment (DB) Period|Disease progression|10
2023653|NCT00327444|3591906|FG001|Double Blind Treatment (DB) Period|Disease progression|13
2023654|NCT00327444|3591905|FG000|Double Blind Treatment (DB) Period|Adverse Event|5
2023655|NCT00327444|3591906|FG001|Double Blind Treatment (DB) Period|Adverse Event|5
2023656|NCT00327444|3591905|FG000|Double Blind Treatment (DB) Period|Subject request|0
2023657|NCT00327444|3591906|FG001|Double Blind Treatment (DB) Period|Subject request|1
2023658|NCT00327444|3591905|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
2025976|NCT00348140|3594697|FG000|Overall Study|Non-compliance|8
1982329|NCT04471935|3546166|FG000|Overall Study|Withdrawal by Subject|1
1982330|NCT04471935|3546166|FG000|Overall Study|Deemed ineligible to participate|1
1982331|NCT04439344|3546170|FG000|Overall Study|Never started threapy|3
1982332|NCT04439344|3546170|FG000|Overall Study|Ineligible|3
1982333|NCT04439344|3546170|FG000|Overall Study|Adverse Event|13
1982334|NCT04439344|3546170|FG000|Overall Study|Death|2
1982335|NCT04439344|3546170|FG000|Overall Study|Disease progression|29
1982336|NCT04439344|3546170|FG000|Overall Study|Withdrawal by Subject|2
1982337|NCT04439344|3546170|FG000|Overall Study|Alternative therapy|1
1982338|NCT04439279|3546174|FG000|Overall Study|Adverse Event|7
1982339|NCT04439279|3546174|FG000|Overall Study|Death|4
1982340|NCT04439279|3546174|FG000|Overall Study|Disease progression|17
1982341|NCT04439279|3546174|FG000|Overall Study|Complicating disease|3
1982342|NCT04439279|3546174|FG000|Overall Study|Withdrawal by Subject|2
1982343|NCT04439279|3546174|FG000|Overall Study|Ineligible|1
1982344|NCT04439279|3546174|FG000|Overall Study|Treatment still ongoing|1
1982359|NCT03298867|3546241|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1
1982360|NCT03298867|3546242|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1
1982361|NCT03298867|3546241|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
1982362|NCT03298867|3546242|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
1982363|NCT03298867|3546241|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1
1982364|NCT03298867|3546242|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9
1982365|NCT03298867|3546241|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0
1982366|NCT03298867|3546242|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1
1982367|NCT03298867|3546241|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0
1982368|NCT03298867|3546242|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1
1982369|NCT03298867|3546241|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0
1982370|NCT03298867|3546242|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2
1982371|NCT03298867|3546241|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0
1982372|NCT03298867|3546242|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1
1982373|NCT03298867|3546241|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0
1982374|NCT03298867|3546242|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2
1982375|NCT03298867|3546241|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0
1982376|NCT03298867|3546242|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1
1982377|NCT03227224|3546252|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1
1982378|NCT03227224|3546253|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
1982379|NCT03227224|3546254|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2
1982380|NCT03227224|3546255|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
1982381|NCT03227224|3546252|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2
1982382|NCT03227224|3546253|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2
1982383|NCT03227224|3546254|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0
1982384|NCT03227224|3546255|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0
1982385|NCT03227224|3546252|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3
1982386|NCT03227224|3546253|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2
1982387|NCT03227224|3546254|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3
1982388|NCT03227224|3546255|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2
1982389|NCT03227224|3546252|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
1982390|NCT03227224|3546253|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
1982391|NCT03227224|3546254|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
1982392|NCT03227224|3546255|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
1982393|NCT03227224|3546252|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
1982394|NCT03227224|3546253|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
1982395|NCT03227224|3546254|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1
1982396|NCT03227224|3546255|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
1982397|NCT03227224|3546252|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2
1982398|NCT03227224|3546253|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1
1982399|NCT03227224|3546254|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1
1982400|NCT03227224|3546255|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4
1982401|NCT03227224|3546252|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2
1982402|NCT03227224|3546253|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1
1982403|NCT03227224|3546254|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0
1982404|NCT03227224|3546255|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1
1982405|NCT03227224|3546252|FG000|Double-blind Treatment Period (6 Weeks)|Other|4
1982406|NCT03227224|3546253|FG001|Double-blind Treatment Period (6 Weeks)|Other|0
1982407|NCT03227224|3546254|FG002|Double-blind Treatment Period (6 Weeks)|Other|1
1982408|NCT03227224|3546255|FG003|Double-blind Treatment Period (6 Weeks)|Other|0
1982409|NCT03227224|3546252|FG000|Follow-up Phase (2 Weeks)|Other|4
1982410|NCT03227224|3546253|FG001|Follow-up Phase (2 Weeks)|Other|4
1982411|NCT03227224|3546254|FG002|Follow-up Phase (2 Weeks)|Other|6
1982412|NCT03227224|3546255|FG003|Follow-up Phase (2 Weeks)|Other|3
1982345|NCT04439123|3546178|FG000|Overall Study|Adverse Event|11
1982346|NCT04439123|3546178|FG000|Overall Study|Death|1
1982347|NCT04439123|3546178|FG000|Overall Study|Disease progression|19
1982348|NCT04439123|3546178|FG000|Overall Study|Withdrawal by Subject|2
1982349|NCT04439123|3546178|FG000|Overall Study|Still on treatment|2
1982350|NCT04439110|3546182|FG000|Overall Study|Ineligible|2
1982351|NCT04439110|3546182|FG000|Overall Study|Adverse Event|4
1982352|NCT04439110|3546182|FG000|Overall Study|Death|2
1982353|NCT04439110|3546182|FG000|Overall Study|Disease proression|25
1982354|NCT04439110|3546182|FG000|Overall Study|Withdrawal by Subject|1
1982355|NCT04439110|3546182|FG000|Overall Study|Alternative therapy|1
1982356|NCT04439110|3546182|FG000|Overall Study|Other complicating disease|1
1982357|NCT04439110|3546182|FG000|Overall Study|Personal reasons|1
1982358|NCT04439110|3546182|FG000|Overall Study|Still on treatment|1
1982413|NCT03220581|3546274|FG000|Overall Study|Withdrawal by Subject|0
1982414|NCT03220581|3546275|FG001|Overall Study|Withdrawal by Subject|1
1982415|NCT03220581|3546274|FG000|Overall Study|Lost to Follow-up|3
1982416|NCT03220581|3546275|FG001|Overall Study|Lost to Follow-up|6
1982417|NCT02991482|3546289|FG000|Overall Study|Disease progression|56
1982418|NCT02991482|3546290|FG001|Overall Study|Disease progression|47
1982419|NCT02991482|3546289|FG000|Overall Study|Death|4
1982420|NCT02991482|3546290|FG001|Overall Study|Death|4
1982421|NCT02991482|3546289|FG000|Overall Study|Adverse Event|1
1982422|NCT02991482|3546290|FG001|Overall Study|Adverse Event|6
1982423|NCT02991482|3546289|FG000|Overall Study|Patient decision|1
1982424|NCT02991482|3546290|FG001|Overall Study|Patient decision|1
1982425|NCT02991482|3546289|FG000|Overall Study|Physician Decision|0
1982426|NCT02991482|3546290|FG001|Overall Study|Physician Decision|6
1982427|NCT02991482|3546289|FG000|Overall Study|Clinical deterioration|1
1982428|NCT02991482|3546290|FG001|Overall Study|Clinical deterioration|0
1982429|NCT02991482|3546289|FG000|Overall Study|Patient feeling too unwell|1
1982430|NCT02991482|3546290|FG001|Overall Study|Patient feeling too unwell|0
1982431|NCT02991482|3546289|FG000|Overall Study|Worsening of performance status|0
1982432|NCT02991482|3546290|FG001|Overall Study|Worsening of performance status|1
1982433|NCT02991482|3546289|FG000|Overall Study|Death prior to study drug initiation|1
1982434|NCT02991482|3546290|FG001|Overall Study|Death prior to study drug initiation|0
1982435|NCT02991482|3546289|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0
1982436|NCT02991482|3546290|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1
2023659|NCT00327444|3591906|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
2023660|NCT00327444|3591905|FG000|Open Label Treatment (OL) Period|Disease progression|8
2023661|NCT00327444|3591906|FG001|Open Label Treatment (OL) Period|Disease progression|7
2023662|NCT00327444|3591905|FG000|Open Label Treatment (OL) Period|Adverse Event|2
2023663|NCT00327444|3591906|FG001|Open Label Treatment (OL) Period|Adverse Event|2
2023664|NCT00327444|3591905|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0
2023665|NCT00327444|3591906|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1
2023666|NCT00327444|3591905|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1
2023667|NCT00327444|3591906|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0
2023668|NCT00327470|3591916|FG000|Overall Study|Randomized, but not treated|0
2023669|NCT00327470|3591917|FG001|Overall Study|Randomized, but not treated|2
2023670|NCT00327470|3591916|FG000|Overall Study|Adverse Event|9
2023671|NCT00327470|3591917|FG001|Overall Study|Adverse Event|14
2023672|NCT00327470|3591916|FG000|Overall Study|Lack of Efficacy|7
2023673|NCT00327470|3591917|FG001|Overall Study|Lack of Efficacy|19
2023674|NCT00327470|3591916|FG000|Overall Study|Other|5
2023675|NCT00327470|3591917|FG001|Overall Study|Other|9
2023676|NCT00327470|3591916|FG000|Overall Study|Lost to Follow-up|1
2023677|NCT00327470|3591917|FG001|Overall Study|Lost to Follow-up|3
2023678|NCT00327470|3591916|FG000|Overall Study|Withdrawal by Subject|6
2023679|NCT00327470|3591917|FG001|Overall Study|Withdrawal by Subject|12
2023680|NCT00327470|3591916|FG000|Overall Study|Death|1
2023681|NCT00327470|3591917|FG001|Overall Study|Death|4
2023682|NCT00327717|3591925|FG000|Overall Study|Adverse Event|6
2023683|NCT00327717|3591926|FG001|Overall Study|Adverse Event|6
2023684|NCT00327717|3591925|FG000|Overall Study|Lack of Efficacy|0
2023685|NCT00327717|3591926|FG001|Overall Study|Lack of Efficacy|1
2023686|NCT00327717|3591925|FG000|Overall Study|Withdrawal by Subject|3
2023687|NCT00327717|3591926|FG001|Overall Study|Withdrawal by Subject|7
2023688|NCT00328094|3591955|FG000|Overall Study|Physician Decision|3
2023689|NCT00328094|3591956|FG001|Overall Study|Physician Decision|3
2023690|NCT00328172|3591967|FG000|Overall Study|Adverse Event|3
2023691|NCT00328172|3591968|FG001|Overall Study|Adverse Event|2
2023692|NCT00328172|3591969|FG002|Overall Study|Adverse Event|1
2023693|NCT00328172|3591970|FG003|Overall Study|Adverse Event|2
2023694|NCT00328172|3591971|FG004|Overall Study|Adverse Event|1
2023695|NCT00328172|3591967|FG000|Overall Study|Protocol Violation|0
2023696|NCT00328172|3591968|FG001|Overall Study|Protocol Violation|1
2023697|NCT00328172|3591969|FG002|Overall Study|Protocol Violation|1
2023698|NCT00328172|3591970|FG003|Overall Study|Protocol Violation|0
2023699|NCT00328172|3591971|FG004|Overall Study|Protocol Violation|0
2023700|NCT00328172|3591967|FG000|Overall Study|Lost to Follow-up|1
2023701|NCT00328172|3591968|FG001|Overall Study|Lost to Follow-up|1
2023702|NCT00328172|3591969|FG002|Overall Study|Lost to Follow-up|2
2023703|NCT00328172|3591970|FG003|Overall Study|Lost to Follow-up|1
1982437|NCT02768870|3546296|FG000|Overall Study|Not Implanted with Device|2
1982438|NCT02768870|3546296|FG000|Overall Study|Death|1
1982439|NCT02768870|3546296|FG000|Overall Study|Reoperation|4
1982440|NCT02768870|3546296|FG000|Overall Study|On Study|19
1982441|NCT02648698|3546302|FG000|Overall Study|Protocol Violation|1
1982442|NCT02648698|3546303|FG001|Overall Study|Protocol Violation|5
1982443|NCT02432196|3546309|FG000|Overall Study|Not Implanted with Device|1
1982444|NCT02432196|3546309|FG000|Overall Study|Death|2
1982445|NCT02432196|3546309|FG000|Overall Study|Reoperation|3
1982446|NCT02432196|3546309|FG000|Overall Study|On Study|20
1982447|NCT02000882|3546317|FG000|Overall Study|Adverse Event|3
1982448|NCT02000882|3546317|FG000|Overall Study|Physician Decision|2
1982449|NCT02000882|3546317|FG000|Overall Study|Withdrawal by Subject|1
1982450|NCT01642004|3546336|FG000|Randomization|Adverse Event unrelated to study drug|1
1982451|NCT01642004|3546337|FG001|Randomization|Adverse Event unrelated to study drug|0
1982452|NCT01642004|3546336|FG000|Randomization|Withdrawal by Subject|1
1982453|NCT01642004|3546337|FG001|Randomization|Withdrawal by Subject|6
1982454|NCT01642004|3546336|FG000|Randomization|No longer meets study criteria|2
1982455|NCT01642004|3546337|FG001|Randomization|No longer meets study criteria|2
1982456|NCT01642004|3546336|FG000|Treatment|Disease progression|88
1982457|NCT01642004|3546337|FG001|Treatment|Disease progression|80
1982458|NCT01642004|3546336|FG000|Treatment|Study drug toxicity|5
1982459|NCT01642004|3546337|FG001|Treatment|Study drug toxicity|13
1982460|NCT01642004|3546336|FG000|Treatment|Death|1
1982461|NCT01642004|3546337|FG001|Treatment|Death|0
1982462|NCT01642004|3546336|FG000|Treatment|Adverse event unrelated to study drug|6
1982463|NCT01642004|3546337|FG001|Treatment|Adverse event unrelated to study drug|13
1982464|NCT01642004|3546336|FG000|Treatment|Withdrawal by Subject|5
1982465|NCT01642004|3546337|FG001|Treatment|Withdrawal by Subject|9
1982466|NCT01642004|3546336|FG000|Treatment|Maximum clinical benefit|2
1982467|NCT01642004|3546337|FG001|Treatment|Maximum clinical benefit|7
1982468|NCT01642004|3546336|FG000|Treatment|Poor/non-compliance|1
1982469|NCT01642004|3546337|FG001|Treatment|Poor/non-compliance|0
1982470|NCT01642004|3546336|FG000|Treatment|No longer meets study criteria|1
1982471|NCT01642004|3546337|FG001|Treatment|No longer meets study criteria|2
1982472|NCT01642004|3546336|FG000|Treatment|Other|1
1982473|NCT01642004|3546337|FG001|Treatment|Other|2
1982474|NCT01642004|3546336|FG000|Treatment|Missing from data|0
1982475|NCT01642004|3546337|FG001|Treatment|Missing from data|1
1982476|NCT01366092|3546343|FG000|Overall Study|Progressive cGVHD|2
1982477|NCT01366092|3546343|FG000|Overall Study|Physician Decision|1
1982478|NCT01366092|3546343|FG000|Overall Study|Withdrawal by Subject|1
1982479|NCT01326104|3546349|FG000|Overall Study|progressed prior to vaccine|0
1982480|NCT01326104|3546350|FG001|Overall Study|progressed prior to vaccine|2
1982481|NCT01326104|3546349|FG000|Overall Study|unable to make vaccine|0
1982482|NCT01326104|3546350|FG001|Overall Study|unable to make vaccine|2
1982483|NCT01244815|3546360|FG000|Overall Study|Not Treated|0
1982484|NCT01244815|3546361|FG001|Overall Study|Not Treated|1
1982485|NCT01244815|3546362|FG002|Overall Study|Not Treated|0
1982486|NCT01244815|3546363|FG003|Overall Study|Not Treated|0
1982487|NCT01244815|3546360|FG000|Overall Study|Adverse Event|4
1982488|NCT01244815|3546361|FG001|Overall Study|Adverse Event|7
1982489|NCT01244815|3546362|FG002|Overall Study|Adverse Event|5
1982490|NCT01244815|3546363|FG003|Overall Study|Adverse Event|5
1982491|NCT01244815|3546360|FG000|Overall Study|Treatment Failure|0
1982492|NCT01244815|3546361|FG001|Overall Study|Treatment Failure|0
1982493|NCT01244815|3546362|FG002|Overall Study|Treatment Failure|0
1982494|NCT01244815|3546363|FG003|Overall Study|Treatment Failure|1
1982495|NCT01244815|3546360|FG000|Overall Study|Lost to Follow-up|3
1982496|NCT01244815|3546361|FG001|Overall Study|Lost to Follow-up|2
1982497|NCT01244815|3546362|FG002|Overall Study|Lost to Follow-up|3
1982498|NCT01244815|3546363|FG003|Overall Study|Lost to Follow-up|2
1982499|NCT01244815|3546360|FG000|Overall Study|Withdrawal by Subject|0
1982500|NCT01244815|3546361|FG001|Overall Study|Withdrawal by Subject|2
1982501|NCT01244815|3546362|FG002|Overall Study|Withdrawal by Subject|0
1982502|NCT01244815|3546363|FG003|Overall Study|Withdrawal by Subject|3
1982503|NCT01244815|3546360|FG000|Overall Study|Protocol Violation|7
1982504|NCT01244815|3546361|FG001|Overall Study|Protocol Violation|4
1982505|NCT01244815|3546362|FG002|Overall Study|Protocol Violation|3
1982506|NCT01244815|3546363|FG003|Overall Study|Protocol Violation|1
1982507|NCT01244815|3546360|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
1982508|NCT01244815|3546361|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
1982509|NCT01244815|3546362|FG002|Overall Study|Did Not Meet Protocol Eligibility|0
1982510|NCT01244815|3546363|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
1982511|NCT01142596|3546375|FG000|Overall Study|Withdrawal by Subject|9
1982512|NCT01142596|3546376|FG001|Overall Study|Withdrawal by Subject|35
1982513|NCT01142596|3546375|FG000|Overall Study|Adverse Event|8
1982514|NCT01142596|3546376|FG001|Overall Study|Adverse Event|35
1982515|NCT01142596|3546375|FG000|Overall Study|Lack of Efficacy|5
1982516|NCT01142596|3546376|FG001|Overall Study|Lack of Efficacy|9
2310622|NCT02737501|4015013|FG002|Crossover Phase|Site Terminated by Sponsor|23
2310623|NCT02737592|4015021|FG000|Overall Study|Withdrawal by Subject|1
1982517|NCT01142596|3546375|FG000|Overall Study|Lost to Follow-up|2
1982518|NCT01142596|3546376|FG001|Overall Study|Lost to Follow-up|3
1982519|NCT01142596|3546375|FG000|Overall Study|Other reason (not specified)|5
2310624|NCT02737618|4015025|FG000|Overall Study|Withdrawal by Subject|9
1982520|NCT01142596|3546376|FG001|Overall Study|Other reason (not specified)|4
1982521|NCT01098110|3546385|FG000|Overall Study|Withdrawal by Subject|14
1982522|NCT01098110|3546386|FG001|Overall Study|Withdrawal by Subject|24
1982523|NCT01098110|3546387|FG002|Overall Study|Withdrawal by Subject|19
1982524|NCT01098110|3546385|FG000|Overall Study|Adverse Event|30
1982525|NCT01098110|3546386|FG001|Overall Study|Adverse Event|32
1982526|NCT01098110|3546387|FG002|Overall Study|Adverse Event|43
1982527|NCT01098110|3546385|FG000|Overall Study|Lack of Efficacy|13
1982528|NCT01098110|3546386|FG001|Overall Study|Lack of Efficacy|9
1982529|NCT01098110|3546387|FG002|Overall Study|Lack of Efficacy|27
1982530|NCT01098110|3546385|FG000|Overall Study|Other|4
1982531|NCT01098110|3546386|FG001|Overall Study|Other|7
1982532|NCT01098110|3546387|FG002|Overall Study|Other|5
1982533|NCT01098110|3546385|FG000|Overall Study|Untreated|1
1982534|NCT01098110|3546386|FG001|Overall Study|Untreated|1
1982535|NCT01098110|3546387|FG002|Overall Study|Untreated|0
1982536|NCT01006265|3546399|FG000|Overall Study|Lost to Follow-up|1
1982537|NCT01006265|3546400|FG001|Overall Study|Lost to Follow-up|0
1982538|NCT01006265|3546401|FG002|Overall Study|Lost to Follow-up|1
1982539|NCT01006265|3546402|FG003|Overall Study|Lost to Follow-up|0
1982540|NCT01006265|3546399|FG000|Overall Study|Withdrawal by Subject|4
1982541|NCT01006265|3546400|FG001|Overall Study|Withdrawal by Subject|7
1982542|NCT01006265|3546401|FG002|Overall Study|Withdrawal by Subject|5
1982543|NCT01006265|3546402|FG003|Overall Study|Withdrawal by Subject|5
1982544|NCT01006265|3546399|FG000|Overall Study|Administrative reason|1
1982545|NCT01006265|3546400|FG001|Overall Study|Administrative reason|2
1982546|NCT01006265|3546401|FG002|Overall Study|Administrative reason|3
1982547|NCT01006265|3546402|FG003|Overall Study|Administrative reason|0
2023704|NCT00328172|3591971|FG004|Overall Study|Lost to Follow-up|1
2023705|NCT00328172|3591967|FG000|Overall Study|Withdrawal by Subject|1
2023706|NCT00328172|3591968|FG001|Overall Study|Withdrawal by Subject|1
2023707|NCT00328172|3591969|FG002|Overall Study|Withdrawal by Subject|1
2023708|NCT00328172|3591970|FG003|Overall Study|Withdrawal by Subject|6
2023709|NCT00328172|3591971|FG004|Overall Study|Withdrawal by Subject|0
2023710|NCT00328172|3591967|FG000|Overall Study|Lack of Efficacy|14
2023711|NCT00328172|3591968|FG001|Overall Study|Lack of Efficacy|9
2023712|NCT00328172|3591969|FG002|Overall Study|Lack of Efficacy|4
2023713|NCT00328172|3591970|FG003|Overall Study|Lack of Efficacy|4
2023714|NCT00328172|3591971|FG004|Overall Study|Lack of Efficacy|3
2023715|NCT00328172|3591967|FG000|Overall Study|Other reason (not specified)|3
2023716|NCT00328172|3591968|FG001|Overall Study|Other reason (not specified)|0
2023717|NCT00328172|3591969|FG002|Overall Study|Other reason (not specified)|1
2023718|NCT00328172|3591970|FG003|Overall Study|Other reason (not specified)|0
2023719|NCT00328172|3591971|FG004|Overall Study|Other reason (not specified)|0
2023720|NCT00328198|3591983|FG000|Treatment|Adverse Event|21
2023721|NCT00328198|3591983|FG000|Treatment|Death|1
2023722|NCT00328198|3591983|FG000|Treatment|Physician Decision|5
2023723|NCT00328198|3591983|FG000|Treatment|Withdrawal by Subject|5
2023724|NCT00328198|3591983|FG000|Treatment|Evidence of disease progression|2
2023725|NCT00328198|3591983|FG000|Treatment|Non-compliance|1
2023726|NCT00328198|3591983|FG000|Treatment|Confirmed complete response, MRD -|3
2023727|NCT00328198|3591983|FG000|Follow-up|Lost to Follow-up|4
2023728|NCT00328198|3591983|FG000|Follow-up|Death|31
2023729|NCT00328510|3591998|FG000|Overall Study|Gag disorder, could not use frame|4
2023730|NCT00328510|3591999|FG001|Overall Study|Gag disorder, could not use frame|0
2023731|NCT00328510|3591998|FG000|Overall Study|Dentition problems, could not use frame|1
2023732|NCT00328510|3591999|FG001|Overall Study|Dentition problems, could not use frame|0
2023733|NCT00328510|3591998|FG000|Overall Study|Withdrawal by Subject|4
2023734|NCT00328510|3591999|FG001|Overall Study|Withdrawal by Subject|2
2023735|NCT00328510|3591998|FG000|Overall Study|Severe kyphosis, could not use mask|0
2023736|NCT00328510|3591999|FG001|Overall Study|Severe kyphosis, could not use mask|1
2023737|NCT00328510|3591998|FG000|Overall Study|Treatment changed to a single fraction|1
2023738|NCT00328510|3591999|FG001|Overall Study|Treatment changed to a single fraction|1
2023739|NCT00328562|3592005|FG000|Overall Study|Disease progression|1
2023740|NCT00328627|3592041|FG000|Overall Study|Hyperglycemic Rescue|41
2023741|NCT00328627|3592042|FG001|Overall Study|Hyperglycemic Rescue|18
2023742|NCT00328627|3592043|FG002|Overall Study|Hyperglycemic Rescue|16
2023743|NCT00328627|3592044|FG003|Overall Study|Hyperglycemic Rescue|13
2023744|NCT00328627|3592045|FG004|Overall Study|Hyperglycemic Rescue|6
2023745|NCT00328627|3592046|FG005|Overall Study|Hyperglycemic Rescue|5
2023746|NCT00328627|3592047|FG006|Overall Study|Hyperglycemic Rescue|19
2023747|NCT00328627|3592048|FG007|Overall Study|Hyperglycemic Rescue|6
2023748|NCT00328627|3592049|FG008|Overall Study|Hyperglycemic Rescue|6
2023749|NCT00328627|3592050|FG009|Overall Study|Hyperglycemic Rescue|11
2023750|NCT00328627|3592051|FG010|Overall Study|Hyperglycemic Rescue|3
2023751|NCT00328627|3592052|FG011|Overall Study|Hyperglycemic Rescue|2
2023752|NCT00328627|3592041|FG000|Overall Study|Adverse Event|3
2023753|NCT00328627|3592042|FG001|Overall Study|Adverse Event|1
2023754|NCT00328627|3592043|FG002|Overall Study|Adverse Event|2
2023755|NCT00328627|3592044|FG003|Overall Study|Adverse Event|3
2023756|NCT00328627|3592045|FG004|Overall Study|Adverse Event|1
2023757|NCT00328627|3592046|FG005|Overall Study|Adverse Event|2
2023758|NCT00328627|3592047|FG006|Overall Study|Adverse Event|1
2023759|NCT00328627|3592048|FG007|Overall Study|Adverse Event|2
1982548|NCT00534976|3546424|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
1982549|NCT00534976|3546425|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
1982550|NCT00534976|3546424|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
1982551|NCT00534976|3546425|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
1982552|NCT00534976|3546424|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
1982553|NCT00534976|3546425|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
1982554|NCT00337675|3546434|FG000|Overall Study|Adverse Event|10
1982555|NCT00337675|3546435|FG001|Overall Study|Adverse Event|9
1982556|NCT00337675|3546436|FG002|Overall Study|Adverse Event|19
1982557|NCT00337675|3546434|FG000|Overall Study|Lack of Efficacy|10
1982558|NCT00337675|3546435|FG001|Overall Study|Lack of Efficacy|7
1982559|NCT00337675|3546436|FG002|Overall Study|Lack of Efficacy|9
1982560|NCT00337675|3546434|FG000|Overall Study|Lost to Follow-up|22
1982561|NCT00337675|3546435|FG001|Overall Study|Lost to Follow-up|19
1982562|NCT00337675|3546436|FG002|Overall Study|Lost to Follow-up|17
1982563|NCT00337675|3546434|FG000|Overall Study|Physician Decision|9
1982564|NCT00337675|3546435|FG001|Overall Study|Physician Decision|17
1982565|NCT00337675|3546436|FG002|Overall Study|Physician Decision|14
1982566|NCT00337675|3546434|FG000|Overall Study|Protocol Violation|21
1982567|NCT00337675|3546435|FG001|Overall Study|Protocol Violation|24
1982568|NCT00337675|3546436|FG002|Overall Study|Protocol Violation|19
1982569|NCT00337675|3546434|FG000|Overall Study|Withdrawal by Subject|25
1982570|NCT00337675|3546435|FG001|Overall Study|Withdrawal by Subject|25
1982571|NCT00337675|3546436|FG002|Overall Study|Withdrawal by Subject|19
1982572|NCT00337675|3546434|FG000|Overall Study|Progressive Disease|0
1982573|NCT00337675|3546435|FG001|Overall Study|Progressive Disease|2
1982574|NCT00337675|3546436|FG002|Overall Study|Progressive Disease|0
1982575|NCT00337675|3546434|FG000|Overall Study|Trial Terminated|0
1982576|NCT00337675|3546435|FG001|Overall Study|Trial Terminated|0
1982577|NCT00337675|3546436|FG002|Overall Study|Trial Terminated|2
1982578|NCT00317772|3546448|FG000|Overall Study|Adverse Event|0
1982579|NCT00317772|3546449|FG001|Overall Study|Adverse Event|0
1982580|NCT00317772|3546450|FG002|Overall Study|Adverse Event|0
1982581|NCT00317772|3546451|FG003|Overall Study|Adverse Event|2
1982582|NCT00317772|3546448|FG000|Overall Study|Disease Progression|2
1982583|NCT00317772|3546449|FG001|Overall Study|Disease Progression|2
1982584|NCT00317772|3546450|FG002|Overall Study|Disease Progression|1
1982585|NCT00317772|3546451|FG003|Overall Study|Disease Progression|7
1982586|NCT00291486|3546467|FG000|Overall Study|Adverse Event|0
1982587|NCT00291486|3546468|FG001|Overall Study|Adverse Event|3
1982588|NCT00291486|3546469|FG002|Overall Study|Adverse Event|0
1982589|NCT00291486|3546470|FG003|Overall Study|Adverse Event|1
1982590|NCT00291486|3546471|FG004|Overall Study|Adverse Event|0
1982591|NCT00291486|3546467|FG000|Overall Study|Withdrawal by Subject|0
1982592|NCT00291486|3546468|FG001|Overall Study|Withdrawal by Subject|0
1982593|NCT00291486|3546469|FG002|Overall Study|Withdrawal by Subject|0
1982594|NCT00291486|3546470|FG003|Overall Study|Withdrawal by Subject|0
1982595|NCT00291486|3546471|FG004|Overall Study|Withdrawal by Subject|1
1982596|NCT00291486|3546467|FG000|Overall Study|Disease progression|1
1982597|NCT00291486|3546468|FG001|Overall Study|Disease progression|0
1982598|NCT00291486|3546469|FG002|Overall Study|Disease progression|1
1982599|NCT00291486|3546470|FG003|Overall Study|Disease progression|0
1982600|NCT00291486|3546471|FG004|Overall Study|Disease progression|0
1982601|NCT00284856|3546495|FG000|Overall Study|Adverse Event|3
1982602|NCT00284856|3546496|FG001|Overall Study|Adverse Event|3
1982603|NCT00284856|3546497|FG002|Overall Study|Adverse Event|3
1982604|NCT00284856|3546495|FG000|Overall Study|Lack of Efficacy|2
1982605|NCT00284856|3546496|FG001|Overall Study|Lack of Efficacy|1
1982606|NCT00284856|3546497|FG002|Overall Study|Lack of Efficacy|8
1982607|NCT00284856|3546495|FG000|Overall Study|Lost to Follow-up|25
1982608|NCT00284856|3546496|FG001|Overall Study|Lost to Follow-up|21
1982609|NCT00284856|3546497|FG002|Overall Study|Lost to Follow-up|22
1982610|NCT00284856|3546495|FG000|Overall Study|Protocol Violation|5
1982611|NCT00284856|3546496|FG001|Overall Study|Protocol Violation|4
1982612|NCT00284856|3546497|FG002|Overall Study|Protocol Violation|5
1982613|NCT00284856|3546495|FG000|Overall Study|Withdrawal by Subject|12
1982614|NCT00284856|3546496|FG001|Overall Study|Withdrawal by Subject|16
1982615|NCT00284856|3546497|FG002|Overall Study|Withdrawal by Subject|18
1982616|NCT00284856|3546495|FG000|Overall Study|Other|4
1982617|NCT00284856|3546496|FG001|Overall Study|Other|5
1982618|NCT00284856|3546497|FG002|Overall Study|Other|4
1982619|NCT00070707|3546507|FG000|Overall Study|Adverse Event|1
1982620|NCT00070707|3546508|FG001|Overall Study|Adverse Event|2
1982621|NCT00070707|3546507|FG000|Overall Study|Lack of Efficacy|4
1982622|NCT00070707|3546508|FG001|Overall Study|Lack of Efficacy|1
1982623|NCT00070707|3546507|FG000|Overall Study|Protocol Violation|8
1982624|NCT00070707|3546508|FG001|Overall Study|Protocol Violation|4
1982625|NCT00070707|3546507|FG000|Overall Study|Unrelated to Study Medication|1
1982626|NCT00070707|3546508|FG001|Overall Study|Unrelated to Study Medication|0
1982627|NCT03414983|3546536|FG000|Pre-Treatment|Other reasons|1
1982628|NCT03414983|3546537|FG001|Pre-Treatment|Other reasons|0
1982629|NCT03414983|3546536|FG000|Pre-Treatment|Participant no longer meets study criteria|2
1982630|NCT03414983|3546537|FG001|Pre-Treatment|Participant no longer meets study criteria|3
1982631|NCT03414983|3546536|FG000|Pre-Treatment|Participant withdrew consent|1
2310625|NCT02737722|4015037|FG000|Overall Study|Physician Decision|0
2310626|NCT02737722|4015038|FG001|Overall Study|Physician Decision|0
2310627|NCT02737722|4015039|FG002|Overall Study|Physician Decision|1
2310628|NCT02737722|4015040|FG003|Overall Study|Physician Decision|0
2310629|NCT02737826|4015050|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0
2310630|NCT02737826|4015051|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12
2310631|NCT02737826|4015052|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14
2310632|NCT02737852|4015061|FG000|Overall Study|Withdrawal by Subject|2
2310633|NCT02737930|4015085|FG000|Overall Study|Withdrawal by Subject|0
2310634|NCT02737930|4015086|FG001|Overall Study|Withdrawal by Subject|1
2310635|NCT02738008|4015095|FG000|Overall Study|Study Terminated by Sponsor|1
2310636|NCT02738008|4015096|FG001|Overall Study|Study Terminated by Sponsor|5
2310637|NCT02738008|4015097|FG002|Overall Study|Study Terminated by Sponsor|3
2310638|NCT02738008|4015095|FG000|Overall Study|Adverse Event|0
2310639|NCT02738008|4015096|FG001|Overall Study|Adverse Event|1
2310640|NCT02738008|4015097|FG002|Overall Study|Adverse Event|2
2321884|NCT02964325|4036476|FG000|Overall Study|Physician Decision|5
2321885|NCT02964325|4036477|FG001|Overall Study|Physician Decision|4
2321886|NCT02964325|4036476|FG000|Overall Study|Death|1
2321887|NCT02964325|4036477|FG001|Overall Study|Death|3
2321888|NCT02964325|4036476|FG000|Overall Study|Withdrawal by Subject|2
2321889|NCT02964325|4036477|FG001|Overall Study|Withdrawal by Subject|1
2321890|NCT02964325|4036476|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10
2321891|NCT02964325|4036477|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12
2321892|NCT02964338|4036486|FG000|Overall Study|Sponsor terminated study for futility|12
2321893|NCT02964338|4036487|FG001|Overall Study|Sponsor terminated study for futility|15
2321894|NCT02964338|4036488|FG002|Overall Study|Sponsor terminated study for futility|14
2321895|NCT02964338|4036486|FG000|Overall Study|Lack of Efficacy|0
2321896|NCT02964338|4036487|FG001|Overall Study|Lack of Efficacy|3
2321897|NCT02964338|4036488|FG002|Overall Study|Lack of Efficacy|0
2321898|NCT02964338|4036486|FG000|Overall Study|Lost to Follow-up|1
2321899|NCT02964338|4036487|FG001|Overall Study|Lost to Follow-up|0
2321900|NCT02964338|4036488|FG002|Overall Study|Lost to Follow-up|3
2321901|NCT02964338|4036486|FG000|Overall Study|Protocol Violation|0
2321902|NCT02964338|4036487|FG001|Overall Study|Protocol Violation|1
2321903|NCT02964338|4036488|FG002|Overall Study|Protocol Violation|0
2321904|NCT02964338|4036486|FG000|Overall Study|Withdrawal by Subject|1
2321905|NCT02964338|4036487|FG001|Overall Study|Withdrawal by Subject|3
2321906|NCT02964338|4036488|FG002|Overall Study|Withdrawal by Subject|1
2321907|NCT02964338|4036486|FG000|Overall Study|Adverse Event|2
2321908|NCT02964338|4036487|FG001|Overall Study|Adverse Event|1
2321909|NCT02964338|4036488|FG002|Overall Study|Adverse Event|1
2321910|NCT02964338|4036486|FG000|Overall Study|Non-compliant with e-diary|0
2321911|NCT02964338|4036487|FG001|Overall Study|Non-compliant with e-diary|1
1982632|NCT03414983|3546537|FG001|Pre-Treatment|Participant withdrew consent|3
1982633|NCT03414983|3546536|FG000|Treatment|Participant withdrew consent|4
1982634|NCT03414983|3546537|FG001|Treatment|Participant withdrew consent|3
1982635|NCT03414983|3546536|FG000|Treatment|Participant request to discontinue study treatment|8
1982636|NCT03414983|3546537|FG001|Treatment|Participant request to discontinue study treatment|10
1982637|NCT03414983|3546536|FG000|Treatment|Adverse Event Unrelated to Study Drug|5
1982638|NCT03414983|3546537|FG001|Treatment|Adverse Event Unrelated to Study Drug|2
1982639|NCT03414983|3546536|FG000|Treatment|Death|0
1982640|NCT03414983|3546537|FG001|Treatment|Death|2
1982641|NCT03414983|3546536|FG000|Treatment|Study Drug Toxicity|11
1982642|NCT03414983|3546537|FG001|Treatment|Study Drug Toxicity|4
1982643|NCT03414983|3546536|FG000|Treatment|Disease Progression|72
1982644|NCT03414983|3546537|FG001|Treatment|Disease Progression|27
1982645|NCT03414983|3546536|FG000|Treatment|Not reported|1
1982646|NCT03414983|3546537|FG001|Treatment|Not reported|0
1982647|NCT03414983|3546536|FG000|Treatment|Other reasons|3
1982648|NCT03414983|3546537|FG001|Treatment|Other reasons|2
1982649|NCT03414983|3546536|FG000|Treatment|Completed treatment as per protocol|8
1982650|NCT03414983|3546537|FG001|Treatment|Completed treatment as per protocol|0
1982651|NCT03414983|3546536|FG000|Treatment|Poor/non-compliance|2
1982652|NCT03414983|3546537|FG001|Treatment|Poor/non-compliance|0
1982653|NCT03414983|3546536|FG000|Treatment|Maximum clinical benefit|5
1982654|NCT03414983|3546537|FG001|Treatment|Maximum clinical benefit|9
1982655|NCT03414983|3546536|FG000|Treatment|Lost to Follow-up|0
1982656|NCT03414983|3546537|FG001|Treatment|Lost to Follow-up|1
2023760|NCT00328627|3592049|FG008|Overall Study|Adverse Event|0
2023761|NCT00328627|3592050|FG009|Overall Study|Adverse Event|7
2023762|NCT00328627|3592051|FG010|Overall Study|Adverse Event|5
2023763|NCT00328627|3592052|FG011|Overall Study|Adverse Event|4
2023764|NCT00328627|3592041|FG000|Overall Study|Protocol Violation|2
2023765|NCT00328627|3592042|FG001|Overall Study|Protocol Violation|2
2023766|NCT00328627|3592043|FG002|Overall Study|Protocol Violation|2
2023767|NCT00328627|3592044|FG003|Overall Study|Protocol Violation|8
2023768|NCT00328627|3592045|FG004|Overall Study|Protocol Violation|5
2023769|NCT00328627|3592046|FG005|Overall Study|Protocol Violation|5
2321912|NCT02964338|4036488|FG002|Overall Study|Non-compliant with e-diary|0
2321913|NCT02964338|4036486|FG000|Overall Study|Did not meet criteria|1
2321914|NCT02964338|4036487|FG001|Overall Study|Did not meet criteria|0
2023770|NCT00328627|3592047|FG006|Overall Study|Protocol Violation|6
2310641|NCT02738138|4015119|FG000|Overall Study|Adverse Event|0
2310642|NCT02738138|4015120|FG001|Overall Study|Adverse Event|1
1982657|NCT04528641|3546558|FG000|Overall Study|Withdrawal by Subject|0
1982658|NCT04528641|3546559|FG001|Overall Study|Withdrawal by Subject|0
1982659|NCT04528641|3546560|FG002|Overall Study|Withdrawal by Subject|0
1982660|NCT04528641|3546561|FG003|Overall Study|Withdrawal by Subject|1
1982661|NCT04528641|3546562|FG004|Overall Study|Withdrawal by Subject|0
1982662|NCT04528641|3546563|FG005|Overall Study|Withdrawal by Subject|1
1982663|NCT04498832|3546582|FG000|Overall Study|Adverse Event|1
1982664|NCT04498832|3546583|FG001|Overall Study|Adverse Event|3
1982665|NCT04498832|3546582|FG000|Overall Study|Withdrawal by Subject|0
1982666|NCT04498832|3546583|FG001|Overall Study|Withdrawal by Subject|1
1982667|NCT04034238|3546608|FG000|Dose Escalation Phase|Withdrawal by Subject|1
1982668|NCT04034238|3546609|FG001|Dose Escalation Phase|Withdrawal by Subject|0
1982669|NCT04034238|3546610|FG002|Dose Escalation Phase|Withdrawal by Subject|0
1982670|NCT04034238|3546611|FG003|Dose Escalation Phase|Withdrawal by Subject|0
1982671|NCT04034238|3546608|FG000|Dose Escalation Phase|Screen failures|0
1982672|NCT04034238|3546609|FG001|Dose Escalation Phase|Screen failures|0
1982673|NCT04034238|3546610|FG002|Dose Escalation Phase|Screen failures|0
1982674|NCT04034238|3546611|FG003|Dose Escalation Phase|Screen failures|2
1982675|NCT04034238|3546608|FG000|Dose Expansion Phase|Not treated due to study hold.|0
1982676|NCT04034238|3546609|FG001|Dose Expansion Phase|Not treated due to study hold.|0
1982677|NCT04034238|3546610|FG002|Dose Expansion Phase|Not treated due to study hold.|0
1982678|NCT04034238|3546611|FG003|Dose Expansion Phase|Not treated due to study hold.|1
1982679|NCT04034238|3546608|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
1982680|NCT04034238|3546609|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
1982681|NCT04034238|3546610|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1
1982682|NCT04034238|3546611|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
1982683|NCT03984305|3546624|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19
1982684|NCT03984305|3546625|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15
1982685|NCT03984305|3546624|FG000|Overall Study|Withdrawal by Subject|3
1982686|NCT03984305|3546625|FG001|Overall Study|Withdrawal by Subject|3
1982687|NCT03984305|3546624|FG000|Overall Study|Lost to Follow-up|1
1982688|NCT03984305|3546625|FG001|Overall Study|Lost to Follow-up|0
1982689|NCT03982368|3546634|FG000|Overall Study|Adverse Event|6
1982690|NCT03982368|3546635|FG001|Overall Study|Adverse Event|4
1982691|NCT03982368|3546636|FG002|Overall Study|Adverse Event|3
1982692|NCT03982368|3546634|FG000|Overall Study|Lost to Follow-up|2
1982693|NCT03982368|3546635|FG001|Overall Study|Lost to Follow-up|1
1982694|NCT03982368|3546636|FG002|Overall Study|Lost to Follow-up|0
1982695|NCT03982368|3546634|FG000|Overall Study|Withdrawal by Subject|1
1982696|NCT03982368|3546635|FG001|Overall Study|Withdrawal by Subject|2
1982697|NCT03982368|3546636|FG002|Overall Study|Withdrawal by Subject|0
1982698|NCT03982368|3546634|FG000|Overall Study|unknow|4
1982699|NCT03982368|3546635|FG001|Overall Study|unknow|0
1982700|NCT03982368|3546636|FG002|Overall Study|unknow|2
1982701|NCT03952143|3546649|FG000|Lead-In Period|Adverse Event|2
1982702|NCT03952143|3546650|FG001|Lead-In Period|Adverse Event|0
1982703|NCT03952143|3546651|FG002|Lead-In Period|Adverse Event|0
1982704|NCT03952143|3546649|FG000|Lead-In Period|Lack of Efficacy|2
1982705|NCT03952143|3546650|FG001|Lead-In Period|Lack of Efficacy|0
1982706|NCT03952143|3546651|FG002|Lead-In Period|Lack of Efficacy|0
1982707|NCT03952143|3546649|FG000|Lead-In Period|Physician Decision|5
1982708|NCT03952143|3546650|FG001|Lead-In Period|Physician Decision|0
1982709|NCT03952143|3546651|FG002|Lead-In Period|Physician Decision|0
1982710|NCT03952143|3546649|FG000|Lead-In Period|Protocol Violation|5
1982711|NCT03952143|3546650|FG001|Lead-In Period|Protocol Violation|0
1982712|NCT03952143|3546651|FG002|Lead-In Period|Protocol Violation|0
1982713|NCT03952143|3546649|FG000|Lead-In Period|Withdrawal by Subject|19
1982714|NCT03952143|3546650|FG001|Lead-In Period|Withdrawal by Subject|0
1982715|NCT03952143|3546651|FG002|Lead-In Period|Withdrawal by Subject|0
1982716|NCT03952143|3546649|FG000|Treatment Period|Adverse Event|0
1982717|NCT03952143|3546650|FG001|Treatment Period|Adverse Event|0
1982718|NCT03952143|3546651|FG002|Treatment Period|Adverse Event|1
1982719|NCT03952143|3546649|FG000|Treatment Period|Lost to Follow-up|0
1982720|NCT03952143|3546650|FG001|Treatment Period|Lost to Follow-up|2
1982721|NCT03952143|3546651|FG002|Treatment Period|Lost to Follow-up|0
1982722|NCT03952143|3546649|FG000|Treatment Period|Physician Decision|0
1982723|NCT03952143|3546650|FG001|Treatment Period|Physician Decision|0
1982724|NCT03952143|3546651|FG002|Treatment Period|Physician Decision|2
1982725|NCT03952143|3546649|FG000|Treatment Period|Protocol Violation|0
1982726|NCT03952143|3546650|FG001|Treatment Period|Protocol Violation|0
1982727|NCT03952143|3546651|FG002|Treatment Period|Protocol Violation|1
1982728|NCT03952143|3546649|FG000|Treatment Period|Withdrawal by Subject|0
1982729|NCT03952143|3546650|FG001|Treatment Period|Withdrawal by Subject|5
1982730|NCT03952143|3546651|FG002|Treatment Period|Withdrawal by Subject|26
1982731|NCT03952143|3546649|FG000|Treatment Period|Due to COVID 19 restrictions|0
1982732|NCT03952143|3546650|FG001|Treatment Period|Due to COVID 19 restrictions|2
1982733|NCT03952143|3546651|FG002|Treatment Period|Due to COVID 19 restrictions|5
2023771|NCT00328627|3592048|FG007|Overall Study|Protocol Violation|2
1982734|NCT03952143|3546649|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0
1982735|NCT03952143|3546650|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0
1982736|NCT03952143|3546651|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1
2023772|NCT00328627|3592049|FG008|Overall Study|Protocol Violation|1
2023773|NCT00328627|3592050|FG009|Overall Study|Protocol Violation|4
2023774|NCT00328627|3592051|FG010|Overall Study|Protocol Violation|6
2023775|NCT00328627|3592052|FG011|Overall Study|Protocol Violation|2
2023776|NCT00328627|3592041|FG000|Overall Study|Lost to Follow-up|4
2023777|NCT00328627|3592042|FG001|Overall Study|Lost to Follow-up|2
2023778|NCT00328627|3592043|FG002|Overall Study|Lost to Follow-up|2
2023779|NCT00328627|3592044|FG003|Overall Study|Lost to Follow-up|4
2023780|NCT00328627|3592045|FG004|Overall Study|Lost to Follow-up|0
2023781|NCT00328627|3592046|FG005|Overall Study|Lost to Follow-up|2
2023782|NCT00328627|3592047|FG006|Overall Study|Lost to Follow-up|3
2023783|NCT00328627|3592048|FG007|Overall Study|Lost to Follow-up|0
2023784|NCT00328627|3592049|FG008|Overall Study|Lost to Follow-up|3
2023785|NCT00328627|3592050|FG009|Overall Study|Lost to Follow-up|2
2023786|NCT00328627|3592051|FG010|Overall Study|Lost to Follow-up|0
2023787|NCT00328627|3592052|FG011|Overall Study|Lost to Follow-up|1
2023788|NCT00328627|3592041|FG000|Overall Study|Withdrawal by Subject|5
2023789|NCT00328627|3592042|FG001|Overall Study|Withdrawal by Subject|4
2023790|NCT00328627|3592043|FG002|Overall Study|Withdrawal by Subject|5
2023791|NCT00328627|3592044|FG003|Overall Study|Withdrawal by Subject|6
2023792|NCT00328627|3592045|FG004|Overall Study|Withdrawal by Subject|2
2023793|NCT00328627|3592046|FG005|Overall Study|Withdrawal by Subject|5
2023794|NCT00328627|3592047|FG006|Overall Study|Withdrawal by Subject|4
2023795|NCT00328627|3592048|FG007|Overall Study|Withdrawal by Subject|4
2023796|NCT00328627|3592049|FG008|Overall Study|Withdrawal by Subject|4
2023797|NCT00328627|3592050|FG009|Overall Study|Withdrawal by Subject|5
2023798|NCT00328627|3592051|FG010|Overall Study|Withdrawal by Subject|2
2023799|NCT00328627|3592052|FG011|Overall Study|Withdrawal by Subject|7
2023800|NCT00328627|3592041|FG000|Overall Study|Pregnancy|0
2023801|NCT00328627|3592042|FG001|Overall Study|Pregnancy|1
2023802|NCT00328627|3592043|FG002|Overall Study|Pregnancy|0
2023803|NCT00328627|3592044|FG003|Overall Study|Pregnancy|0
2023804|NCT00328627|3592045|FG004|Overall Study|Pregnancy|0
2023805|NCT00328627|3592046|FG005|Overall Study|Pregnancy|0
2023806|NCT00328627|3592047|FG006|Overall Study|Pregnancy|0
2023807|NCT00328627|3592048|FG007|Overall Study|Pregnancy|0
2023808|NCT00328627|3592049|FG008|Overall Study|Pregnancy|0
2023809|NCT00328627|3592050|FG009|Overall Study|Pregnancy|0
2023810|NCT00328627|3592051|FG010|Overall Study|Pregnancy|0
2023811|NCT00328627|3592052|FG011|Overall Study|Pregnancy|0
2023812|NCT00328627|3592041|FG000|Overall Study|Physician Decision|4
2023813|NCT00328627|3592042|FG001|Overall Study|Physician Decision|3
2023814|NCT00328627|3592043|FG002|Overall Study|Physician Decision|1
2023815|NCT00328627|3592044|FG003|Overall Study|Physician Decision|2
2023816|NCT00328627|3592045|FG004|Overall Study|Physician Decision|1
2023817|NCT00328627|3592046|FG005|Overall Study|Physician Decision|1
2023818|NCT00328627|3592047|FG006|Overall Study|Physician Decision|1
2023819|NCT00328627|3592048|FG007|Overall Study|Physician Decision|0
2023820|NCT00328627|3592049|FG008|Overall Study|Physician Decision|3
2023821|NCT00328627|3592050|FG009|Overall Study|Physician Decision|2
2023822|NCT00328627|3592051|FG010|Overall Study|Physician Decision|1
2213250|NCT01677507|3854709|FG001|Initial Assignment|Adverse Event|1
2213251|NCT01677507|3854708|FG000|Initial Assignment|Protocol Violation|0
2213252|NCT01677507|3854709|FG001|Initial Assignment|Protocol Violation|1
2023823|NCT00328627|3592052|FG011|Overall Study|Physician Decision|0
2023824|NCT00328627|3592041|FG000|Overall Study|Other|0
2023825|NCT00328627|3592042|FG001|Overall Study|Other|0
2023826|NCT00328627|3592043|FG002|Overall Study|Other|0
2023827|NCT00328627|3592044|FG003|Overall Study|Other|1
2023828|NCT00328627|3592045|FG004|Overall Study|Other|0
2023829|NCT00328627|3592046|FG005|Overall Study|Other|0
2023830|NCT00328627|3592047|FG006|Overall Study|Other|1
2023831|NCT00328627|3592048|FG007|Overall Study|Other|0
2023832|NCT00328627|3592049|FG008|Overall Study|Other|0
2023833|NCT00328627|3592050|FG009|Overall Study|Other|1
2023834|NCT00328627|3592051|FG010|Overall Study|Other|1
2023835|NCT00328627|3592052|FG011|Overall Study|Other|0
2023836|NCT00328783|3592091|FG000|Overall Study|Could not tolerate ABC|21
2023837|NCT00328783|3592091|FG000|Overall Study|No heart in RT field|4
2023838|NCT00328783|3592091|FG000|Overall Study|Withdrawal by Subject|1
2023839|NCT00328926|3592109|FG000|Overall Study|Pregnancy|2
2023840|NCT00328926|3592110|FG001|Overall Study|Pregnancy|1
2023841|NCT00328926|3592111|FG002|Overall Study|Pregnancy|0
2023842|NCT00328926|3592109|FG000|Overall Study|Lost to Follow-up|0
2023843|NCT00328926|3592110|FG001|Overall Study|Lost to Follow-up|1
2023844|NCT00328926|3592111|FG002|Overall Study|Lost to Follow-up|0
2023845|NCT00328926|3592109|FG000|Overall Study|Death|0
2023846|NCT00328926|3592110|FG001|Overall Study|Death|0
2023847|NCT00328926|3592111|FG002|Overall Study|Death|1
2023848|NCT00328926|3592109|FG000|Overall Study|In vitro fertilization treatment|0
2023849|NCT00328926|3592110|FG001|Overall Study|In vitro fertilization treatment|0
2023850|NCT00328926|3592111|FG002|Overall Study|In vitro fertilization treatment|1
2023851|NCT00328926|3592109|FG000|Overall Study|Lack of ovarian response|0
2023852|NCT00328926|3592110|FG001|Overall Study|Lack of ovarian response|1
1982737|NCT03691428|3546668|FG000|Overall Study|Withdrawal by Subject|6
1982738|NCT03691428|3546669|FG001|Overall Study|Withdrawal by Subject|8
1982739|NCT03685708|3546678|FG000|Overall Study|Withdrawal by Subject|0
1982740|NCT03685708|3546679|FG001|Overall Study|Withdrawal by Subject|0
1982741|NCT03685708|3546680|FG002|Overall Study|Withdrawal by Subject|1
1982742|NCT03685708|3546678|FG000|Overall Study|Screen Fail|0
1982743|NCT03685708|3546679|FG001|Overall Study|Screen Fail|1
1982744|NCT03685708|3546680|FG002|Overall Study|Screen Fail|1
1982745|NCT03685708|3546678|FG000|Overall Study|COVID 19 Pandemic|1
1982746|NCT03685708|3546679|FG001|Overall Study|COVID 19 Pandemic|1
1982747|NCT03685708|3546680|FG002|Overall Study|COVID 19 Pandemic|6
1982748|NCT03685708|3546678|FG000|Overall Study|Disease Progression|0
1982749|NCT03685708|3546679|FG001|Overall Study|Disease Progression|0
1982750|NCT03685708|3546680|FG002|Overall Study|Disease Progression|1
1982751|NCT03669588|3546690|FG000|Overall Study|Adverse Event|1
1982752|NCT03669588|3546691|FG001|Overall Study|Adverse Event|0
1982753|NCT03669588|3546690|FG000|Overall Study|Physician Decision|0
1982754|NCT03669588|3546691|FG001|Overall Study|Physician Decision|1
1982755|NCT03669588|3546690|FG000|Overall Study|Protocol Violation|1
1982756|NCT03669588|3546691|FG001|Overall Study|Protocol Violation|0
1982757|NCT03669588|3546690|FG000|Overall Study|Sponsor Decision|1
1982758|NCT03669588|3546691|FG001|Overall Study|Sponsor Decision|1
1982759|NCT03669588|3546690|FG000|Overall Study|Withdrawal by Subject|1
1982760|NCT03669588|3546691|FG001|Overall Study|Withdrawal by Subject|4
1982761|NCT03669588|3546690|FG000|Overall Study|Rescue Therapy Needed|0
1982762|NCT03669588|3546691|FG001|Overall Study|Rescue Therapy Needed|1
1982763|NCT03531632|3546700|FG000|Overall Study|Adverse Event|0
1982764|NCT03531632|3546701|FG001|Overall Study|Adverse Event|0
1982765|NCT03531632|3546702|FG002|Overall Study|Adverse Event|1
1982766|NCT03531632|3546700|FG000|Overall Study|Death|4
1982767|NCT03531632|3546701|FG001|Overall Study|Death|0
1982768|NCT03531632|3546702|FG002|Overall Study|Death|14
1982769|NCT03531632|3546700|FG000|Overall Study|Study Terminated|1
1982770|NCT03531632|3546701|FG001|Overall Study|Study Terminated|3
1982771|NCT03531632|3546702|FG002|Overall Study|Study Terminated|11
1982772|NCT03474107|3546727|FG000|Overall Study|Adverse Event|42
1982773|NCT03474107|3546728|FG001|Overall Study|Adverse Event|46
1982774|NCT03474107|3546727|FG000|Overall Study|Death|2
1982775|NCT03474107|3546728|FG001|Overall Study|Death|2
1982776|NCT03474107|3546727|FG000|Overall Study|Lost to Follow-up|0
1982777|NCT03474107|3546728|FG001|Overall Study|Lost to Follow-up|1
1982778|NCT03474107|3546727|FG000|Overall Study|Progressive Disease|177
1982779|NCT03474107|3546728|FG001|Overall Study|Progressive Disease|180
1982780|NCT03474107|3546727|FG000|Overall Study|Protocol Violation|1
1982781|NCT03474107|3546728|FG001|Overall Study|Protocol Violation|1
1982782|NCT03474107|3546727|FG000|Overall Study|Withdrawal by Subject|15
1982783|NCT03474107|3546728|FG001|Overall Study|Withdrawal by Subject|27
1982784|NCT03474107|3546727|FG000|Overall Study|Physician Decision|7
1982785|NCT03474107|3546728|FG001|Overall Study|Physician Decision|22
1982786|NCT03474107|3546727|FG000|Overall Study|Miscellaneous|1
1982787|NCT03474107|3546728|FG001|Overall Study|Miscellaneous|6
1982788|NCT03412604|3546734|FG000|Overall Study|Withdrawal by Subject|1
1982789|NCT03206073|3546742|FG000|Overall Study|Participant Noncompliance|0
1982790|NCT03206073|3546743|FG001|Overall Study|Participant Noncompliance|1
1982791|NCT03206073|3546744|FG002|Overall Study|Participant Noncompliance|0
1982792|NCT03206073|3546745|FG003|Overall Study|Participant Noncompliance|0
1982793|NCT03206073|3546742|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1
1982794|NCT03206073|3546743|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0
1982795|NCT03206073|3546744|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0
1982796|NCT03206073|3546745|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0
1982797|NCT03206073|3546742|FG000|Overall Study|Death|0
1982798|NCT03206073|3546743|FG001|Overall Study|Death|0
1982799|NCT03206073|3546744|FG002|Overall Study|Death|1
1982800|NCT03206073|3546745|FG003|Overall Study|Death|0
1982801|NCT03206073|3546742|FG000|Overall Study|Taken off active treatment|0
1982802|NCT03206073|3546743|FG001|Overall Study|Taken off active treatment|0
1982803|NCT03206073|3546744|FG002|Overall Study|Taken off active treatment|3
1982804|NCT03206073|3546745|FG003|Overall Study|Taken off active treatment|0
1982805|NCT03102034|3546770|FG000|Overall Study|Withdrawal by Subject|1
1982806|NCT03102034|3546771|FG001|Overall Study|Withdrawal by Subject|0
1982807|NCT02723864|3546788|FG000|Overall Study|Refused further treatment|1
1982808|NCT02723864|3546789|FG001|Overall Study|Refused further treatment|0
1982809|NCT02723864|3546790|FG002|Overall Study|Refused further treatment|0
1982810|NCT02723864|3546791|FG003|Overall Study|Refused further treatment|0
1982811|NCT02723864|3546792|FG004|Overall Study|Refused further treatment|1
1982812|NCT02723864|3546793|FG005|Overall Study|Refused further treatment|2
1982813|NCT02723864|3546794|FG006|Overall Study|Refused further treatment|0
1982814|NCT02723864|3546788|FG000|Overall Study|Exceed treatment hold time|0
1982815|NCT02723864|3546789|FG001|Overall Study|Exceed treatment hold time|1
1982816|NCT02723864|3546790|FG002|Overall Study|Exceed treatment hold time|0
1982817|NCT02723864|3546791|FG003|Overall Study|Exceed treatment hold time|0
1982818|NCT02723864|3546792|FG004|Overall Study|Exceed treatment hold time|0
1982819|NCT02723864|3546793|FG005|Overall Study|Exceed treatment hold time|0
1982820|NCT02723864|3546794|FG006|Overall Study|Exceed treatment hold time|0
1982821|NCT02723864|3546788|FG000|Overall Study|Clinical progression|0
1982822|NCT02723864|3546789|FG001|Overall Study|Clinical progression|0
1982823|NCT02723864|3546790|FG002|Overall Study|Clinical progression|1
1982824|NCT02723864|3546791|FG003|Overall Study|Clinical progression|0
1982825|NCT02723864|3546792|FG004|Overall Study|Clinical progression|0
1982826|NCT02723864|3546793|FG005|Overall Study|Clinical progression|3
1982827|NCT02723864|3546794|FG006|Overall Study|Clinical progression|1
1982828|NCT02723864|3546788|FG000|Overall Study|Physician Decision|0
1982829|NCT02723864|3546789|FG001|Overall Study|Physician Decision|0
1982830|NCT02723864|3546790|FG002|Overall Study|Physician Decision|0
1982831|NCT02723864|3546791|FG003|Overall Study|Physician Decision|0
1982832|NCT02723864|3546792|FG004|Overall Study|Physician Decision|0
1982833|NCT02723864|3546793|FG005|Overall Study|Physician Decision|0
1982834|NCT02723864|3546794|FG006|Overall Study|Physician Decision|1
1982835|NCT02723864|3546788|FG000|Overall Study|Changes in patient condition|0
1982836|NCT02723864|3546789|FG001|Overall Study|Changes in patient condition|0
1982837|NCT02723864|3546790|FG002|Overall Study|Changes in patient condition|0
1982838|NCT02723864|3546791|FG003|Overall Study|Changes in patient condition|0
1982839|NCT02723864|3546792|FG004|Overall Study|Changes in patient condition|0
1982840|NCT02723864|3546793|FG005|Overall Study|Changes in patient condition|1
1982841|NCT02723864|3546794|FG006|Overall Study|Changes in patient condition|0
1982842|NCT02723864|3546788|FG000|Overall Study|Patient choice|0
1982843|NCT02723864|3546789|FG001|Overall Study|Patient choice|0
1982844|NCT02723864|3546790|FG002|Overall Study|Patient choice|0
1982845|NCT02723864|3546791|FG003|Overall Study|Patient choice|0
1982846|NCT02723864|3546792|FG004|Overall Study|Patient choice|0
1982847|NCT02723864|3546793|FG005|Overall Study|Patient choice|1
1982848|NCT02723864|3546794|FG006|Overall Study|Patient choice|0
1982849|NCT02723864|3546788|FG000|Overall Study|Adverse Event|0
1982850|NCT02723864|3546789|FG001|Overall Study|Adverse Event|0
1982851|NCT02723864|3546790|FG002|Overall Study|Adverse Event|0
1982852|NCT02723864|3546791|FG003|Overall Study|Adverse Event|0
1982853|NCT02723864|3546792|FG004|Overall Study|Adverse Event|0
1982854|NCT02723864|3546793|FG005|Overall Study|Adverse Event|1
2310643|NCT02738138|4015119|FG000|Overall Study|Lost to Follow-up|2
2310644|NCT02738138|4015120|FG001|Overall Study|Lost to Follow-up|0
2310645|NCT02738138|4015119|FG000|Overall Study|Other - not further specified|1
2310646|NCT02738138|4015120|FG001|Overall Study|Other - not further specified|0
2310647|NCT02738151|4015127|FG000|Overall Study|Randomized but not treated|4
2310648|NCT02738151|4015128|FG001|Overall Study|Randomized but not treated|1
2310649|NCT02738151|4015127|FG000|Overall Study|Adverse Event|4
2310650|NCT02738151|4015128|FG001|Overall Study|Adverse Event|5
2310651|NCT02738151|4015127|FG000|Overall Study|Hypoglycemia|0
2310652|NCT02738151|4015128|FG001|Overall Study|Hypoglycemia|1
2310653|NCT02738151|4015127|FG000|Overall Study|Poor Compliance to Protocol|4
2310654|NCT02738151|4015128|FG001|Overall Study|Poor Compliance to Protocol|3
2310655|NCT02738151|4015127|FG000|Overall Study|Other than specified above|11
2310656|NCT02738151|4015128|FG001|Overall Study|Other than specified above|21
2310657|NCT02738203|4015136|FG000|Overall Study|Failed IUD Insertion|2
2310658|NCT02738203|4015137|FG001|Overall Study|Failed IUD Insertion|2
2310659|NCT02738203|4015136|FG000|Overall Study|Protocol Violation|0
2310660|NCT02738203|4015137|FG001|Overall Study|Protocol Violation|1
2310661|NCT02738333|4015159|FG000|Overall Study|Death|1
2310662|NCT02738333|4015160|FG001|Overall Study|Death|0
2310663|NCT02738333|4015161|FG002|Overall Study|Death|0
2310664|NCT02738333|4015159|FG000|Overall Study|Lost to Follow-up|1
2310665|NCT02738333|4015160|FG001|Overall Study|Lost to Follow-up|0
2310666|NCT02738333|4015161|FG002|Overall Study|Lost to Follow-up|0
2310667|NCT02738450|4015173|FG000|Overall Study|Withdrawal by Subject|0
2310668|NCT02738450|4015174|FG001|Overall Study|Withdrawal by Subject|2
2310669|NCT02738450|4015175|FG002|Overall Study|Withdrawal by Subject|0
2310670|NCT02738580|4015186|FG000|Overall Study|Adverse Event|1
2310671|NCT02738580|4015187|FG001|Overall Study|Adverse Event|0
2310672|NCT02738580|4015186|FG000|Overall Study|Lack of Efficacy|3
2310673|NCT02738580|4015187|FG001|Overall Study|Lack of Efficacy|2
2310674|NCT02738580|4015186|FG000|Overall Study|Withdrawal by Subject|0
2310675|NCT02738580|4015187|FG001|Overall Study|Withdrawal by Subject|1
2310676|NCT02738580|4015186|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
2310677|NCT02738580|4015187|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
2310678|NCT02738775|4015199|FG000|Overall Study|Withdrawal by Subject|0
2310679|NCT02738775|4015200|FG001|Overall Study|Withdrawal by Subject|1
2310680|NCT02738775|4015201|FG002|Overall Study|Withdrawal by Subject|0
2310681|NCT02738775|4015202|FG003|Overall Study|Withdrawal by Subject|0
2310682|NCT02738775|4015203|FG004|Overall Study|Withdrawal by Subject|0
2310683|NCT02738775|4015204|FG005|Overall Study|Withdrawal by Subject|0
2310684|NCT02738775|4015199|FG000|Overall Study|Adverse Event|0
2310685|NCT02738775|4015200|FG001|Overall Study|Adverse Event|0
2310686|NCT02738775|4015201|FG002|Overall Study|Adverse Event|0
2310687|NCT02738775|4015202|FG003|Overall Study|Adverse Event|1
2310688|NCT02738775|4015203|FG004|Overall Study|Adverse Event|0
2310689|NCT02738775|4015204|FG005|Overall Study|Adverse Event|0
2310690|NCT02738775|4015199|FG000|Overall Study|Pregnancy|0
2310691|NCT02738775|4015200|FG001|Overall Study|Pregnancy|1
2310692|NCT02738775|4015201|FG002|Overall Study|Pregnancy|0
2310693|NCT02738775|4015202|FG003|Overall Study|Pregnancy|0
2177373|NCT01372605|3801415|FG000|Overall Study|Death|1
2177374|NCT01372605|3801416|FG001|Overall Study|Death|2
2177375|NCT01372605|3801415|FG000|Overall Study|Lost to Follow-up|2
2177376|NCT01372605|3801416|FG001|Overall Study|Lost to Follow-up|1
2177377|NCT01372605|3801415|FG000|Overall Study|Withdrawal by Subject|4
2177378|NCT01372605|3801416|FG001|Overall Study|Withdrawal by Subject|7
2177379|NCT01372605|3801415|FG000|Overall Study|Moved|3
2177380|NCT01372605|3801416|FG001|Overall Study|Moved|0
2177381|NCT01372605|3801415|FG000|Overall Study|Changed medical home|2
2177382|NCT01372605|3801416|FG001|Overall Study|Changed medical home|0
2177383|NCT01372748|3801424|FG000|Overall Study|Lost to Follow-up|16
2177384|NCT01372748|3801425|FG001|Overall Study|Lost to Follow-up|34
2177385|NCT01372748|3801424|FG000|Overall Study|Withdrawal by Subject|7
2177386|NCT01372748|3801425|FG001|Overall Study|Withdrawal by Subject|5
2177387|NCT01372774|3801433|FG000|Overall Study|Withdrawal prior to treatment|4
1982855|NCT02723864|3546794|FG006|Overall Study|Adverse Event|0
1982856|NCT02723864|3546788|FG000|Overall Study|Started new treatment|0
1982857|NCT02723864|3546789|FG001|Overall Study|Started new treatment|0
1982858|NCT02723864|3546790|FG002|Overall Study|Started new treatment|0
1982859|NCT02723864|3546791|FG003|Overall Study|Started new treatment|0
1982860|NCT02723864|3546792|FG004|Overall Study|Started new treatment|0
1982861|NCT02723864|3546793|FG005|Overall Study|Started new treatment|1
1982862|NCT02723864|3546794|FG006|Overall Study|Started new treatment|0
1982863|NCT02723864|3546788|FG000|Overall Study|Switched to alternative treatment|0
1982864|NCT02723864|3546789|FG001|Overall Study|Switched to alternative treatment|0
1982865|NCT02723864|3546790|FG002|Overall Study|Switched to alternative treatment|0
1982866|NCT02723864|3546791|FG003|Overall Study|Switched to alternative treatment|0
1982867|NCT02723864|3546792|FG004|Overall Study|Switched to alternative treatment|0
1982868|NCT02723864|3546793|FG005|Overall Study|Switched to alternative treatment|1
1982869|NCT02723864|3546794|FG006|Overall Study|Switched to alternative treatment|0
1982870|NCT02723864|3546788|FG000|Overall Study|Late determination of ineligibility|0
1982871|NCT02723864|3546789|FG001|Overall Study|Late determination of ineligibility|0
1982872|NCT02723864|3546790|FG002|Overall Study|Late determination of ineligibility|0
1982873|NCT02723864|3546791|FG003|Overall Study|Late determination of ineligibility|0
1982874|NCT02723864|3546792|FG004|Overall Study|Late determination of ineligibility|0
1982875|NCT02723864|3546793|FG005|Overall Study|Late determination of ineligibility|1
1982876|NCT02723864|3546794|FG006|Overall Study|Late determination of ineligibility|0
1982877|NCT02691013|3546842|FG000|Overall Study|Withdrawal by Subject|3
1982878|NCT02691013|3546843|FG001|Overall Study|Withdrawal by Subject|0
1982879|NCT02597062|3546851|FG000|Overall Study|Ineligible|1
1982880|NCT02130882|3546866|FG000|Overall Study|Withdrawal by Subject|0
1982881|NCT02130882|3546867|FG001|Overall Study|Withdrawal by Subject|1
1982882|NCT01920932|3546873|FG000|Overall Study|Death|1
1982883|NCT01920932|3546873|FG000|Overall Study|Withdrawal of consent|1
1982884|NCT01850563|3546896|FG000|Overall Study|Not eligible|3
1982885|NCT01850563|3546897|FG001|Overall Study|Not eligible|0
1982886|NCT01827111|3546904|FG000|Overall Study|Disease Progression|1
1982887|NCT01729754|3546912|FG000|Part 1|Adverse Event|2
1982888|NCT01729754|3546913|FG001|Part 1|Adverse Event|0
1982889|NCT01729754|3546914|FG002|Part 1|Adverse Event|0
1982890|NCT01729754|3546915|FG003|Part 1|Adverse Event|1
1982891|NCT01729754|3546916|FG004|Part 1|Adverse Event|0
1982892|NCT01729754|3546917|FG005|Part 1|Adverse Event|0
1982893|NCT01729754|3546918|FG006|Part 1|Adverse Event|2
1982894|NCT01729754|3546919|FG007|Part 1|Adverse Event|0
1982895|NCT01729754|3546920|FG008|Part 1|Adverse Event|0
1982896|NCT01729754|3546921|FG009|Part 1|Adverse Event|5
1982897|NCT01729754|3546912|FG000|Part 1|Lack of Efficacy|1
1982898|NCT01729754|3546913|FG001|Part 1|Lack of Efficacy|0
1982899|NCT01729754|3546914|FG002|Part 1|Lack of Efficacy|0
1982900|NCT01729754|3546915|FG003|Part 1|Lack of Efficacy|0
1982901|NCT01729754|3546916|FG004|Part 1|Lack of Efficacy|0
1982902|NCT01729754|3546917|FG005|Part 1|Lack of Efficacy|0
1982903|NCT01729754|3546918|FG006|Part 1|Lack of Efficacy|2
1982904|NCT01729754|3546919|FG007|Part 1|Lack of Efficacy|0
1982905|NCT01729754|3546920|FG008|Part 1|Lack of Efficacy|0
1982906|NCT01729754|3546921|FG009|Part 1|Lack of Efficacy|0
1982907|NCT01729754|3546912|FG000|Part 1|Lost to Follow-up|1
1982908|NCT01729754|3546913|FG001|Part 1|Lost to Follow-up|0
1982909|NCT01729754|3546914|FG002|Part 1|Lost to Follow-up|0
1982910|NCT01729754|3546915|FG003|Part 1|Lost to Follow-up|2
1982911|NCT01729754|3546916|FG004|Part 1|Lost to Follow-up|0
1982912|NCT01729754|3546917|FG005|Part 1|Lost to Follow-up|0
1982913|NCT01729754|3546918|FG006|Part 1|Lost to Follow-up|3
1982914|NCT01729754|3546919|FG007|Part 1|Lost to Follow-up|0
1982915|NCT01729754|3546920|FG008|Part 1|Lost to Follow-up|0
1982916|NCT01729754|3546921|FG009|Part 1|Lost to Follow-up|3
1982917|NCT01729754|3546912|FG000|Part 1|Non-compliance with Study Drug|1
1982918|NCT01729754|3546913|FG001|Part 1|Non-compliance with Study Drug|0
1982919|NCT01729754|3546914|FG002|Part 1|Non-compliance with Study Drug|0
1982920|NCT01729754|3546915|FG003|Part 1|Non-compliance with Study Drug|0
1982921|NCT01729754|3546916|FG004|Part 1|Non-compliance with Study Drug|0
1982922|NCT01729754|3546917|FG005|Part 1|Non-compliance with Study Drug|0
1982923|NCT01729754|3546918|FG006|Part 1|Non-compliance with Study Drug|0
1982924|NCT01729754|3546919|FG007|Part 1|Non-compliance with Study Drug|0
1982925|NCT01729754|3546920|FG008|Part 1|Non-compliance with Study Drug|0
1982926|NCT01729754|3546921|FG009|Part 1|Non-compliance with Study Drug|0
1982927|NCT01729754|3546912|FG000|Part 1|Physician Decision|0
1982928|NCT01729754|3546913|FG001|Part 1|Physician Decision|0
1982929|NCT01729754|3546914|FG002|Part 1|Physician Decision|0
1982930|NCT01729754|3546915|FG003|Part 1|Physician Decision|0
1982931|NCT01729754|3546916|FG004|Part 1|Physician Decision|0
1982932|NCT01729754|3546917|FG005|Part 1|Physician Decision|0
1982933|NCT01729754|3546918|FG006|Part 1|Physician Decision|0
1982934|NCT01729754|3546919|FG007|Part 1|Physician Decision|0
1982935|NCT01729754|3546920|FG008|Part 1|Physician Decision|0
1982936|NCT01729754|3546921|FG009|Part 1|Physician Decision|4
1982937|NCT01729754|3546912|FG000|Part 1|Pregnancy|0
1982938|NCT01729754|3546913|FG001|Part 1|Pregnancy|0
1982939|NCT01729754|3546914|FG002|Part 1|Pregnancy|0
1982940|NCT01729754|3546915|FG003|Part 1|Pregnancy|1
1982941|NCT01729754|3546916|FG004|Part 1|Pregnancy|0
1982942|NCT01729754|3546917|FG005|Part 1|Pregnancy|0
1982943|NCT01729754|3546918|FG006|Part 1|Pregnancy|0
1982944|NCT01729754|3546919|FG007|Part 1|Pregnancy|0
1982945|NCT01729754|3546920|FG008|Part 1|Pregnancy|0
1982946|NCT01729754|3546921|FG009|Part 1|Pregnancy|1
1982947|NCT01729754|3546912|FG000|Part 1|Progressive Disease|0
1982948|NCT01729754|3546913|FG001|Part 1|Progressive Disease|0
1982949|NCT01729754|3546914|FG002|Part 1|Progressive Disease|0
1982950|NCT01729754|3546915|FG003|Part 1|Progressive Disease|0
1982951|NCT01729754|3546916|FG004|Part 1|Progressive Disease|0
1982952|NCT01729754|3546917|FG005|Part 1|Progressive Disease|0
1982953|NCT01729754|3546918|FG006|Part 1|Progressive Disease|0
1982954|NCT01729754|3546919|FG007|Part 1|Progressive Disease|0
1982955|NCT01729754|3546920|FG008|Part 1|Progressive Disease|0
1982956|NCT01729754|3546921|FG009|Part 1|Progressive Disease|1
1982957|NCT01729754|3546912|FG000|Part 1|Protocol Violation|2
1982958|NCT01729754|3546913|FG001|Part 1|Protocol Violation|0
1982959|NCT01729754|3546914|FG002|Part 1|Protocol Violation|0
1982960|NCT01729754|3546915|FG003|Part 1|Protocol Violation|1
1982961|NCT01729754|3546916|FG004|Part 1|Protocol Violation|0
1982962|NCT01729754|3546917|FG005|Part 1|Protocol Violation|0
1982963|NCT01729754|3546918|FG006|Part 1|Protocol Violation|1
1982964|NCT01729754|3546919|FG007|Part 1|Protocol Violation|0
1982965|NCT01729754|3546920|FG008|Part 1|Protocol Violation|0
1982966|NCT01729754|3546921|FG009|Part 1|Protocol Violation|0
1982967|NCT01729754|3546912|FG000|Part 1|Withdrawal by Subject|5
1982968|NCT01729754|3546913|FG001|Part 1|Withdrawal by Subject|0
1982969|NCT01729754|3546914|FG002|Part 1|Withdrawal by Subject|0
1982970|NCT01729754|3546915|FG003|Part 1|Withdrawal by Subject|7
1982971|NCT01729754|3546916|FG004|Part 1|Withdrawal by Subject|0
1982972|NCT01729754|3546917|FG005|Part 1|Withdrawal by Subject|0
1982973|NCT01729754|3546918|FG006|Part 1|Withdrawal by Subject|5
1982974|NCT01729754|3546919|FG007|Part 1|Withdrawal by Subject|0
1982975|NCT01729754|3546920|FG008|Part 1|Withdrawal by Subject|0
1982976|NCT01729754|3546921|FG009|Part 1|Withdrawal by Subject|6
1982977|NCT01729754|3546912|FG000|Part 1|Other Protocol Specified Criteria|2
1982978|NCT01729754|3546913|FG001|Part 1|Other Protocol Specified Criteria|0
1982979|NCT01729754|3546914|FG002|Part 1|Other Protocol Specified Criteria|0
1982980|NCT01729754|3546915|FG003|Part 1|Other Protocol Specified Criteria|0
1982981|NCT01729754|3546916|FG004|Part 1|Other Protocol Specified Criteria|0
1982982|NCT01729754|3546917|FG005|Part 1|Other Protocol Specified Criteria|0
1982983|NCT01729754|3546918|FG006|Part 1|Other Protocol Specified Criteria|1
1982984|NCT01729754|3546919|FG007|Part 1|Other Protocol Specified Criteria|0
1982985|NCT01729754|3546920|FG008|Part 1|Other Protocol Specified Criteria|0
1982986|NCT01729754|3546921|FG009|Part 1|Other Protocol Specified Criteria|4
1982987|NCT01729754|3546912|FG000|Part 2|Adverse Event|2
1982988|NCT01729754|3546913|FG001|Part 2|Adverse Event|0
1982989|NCT01729754|3546914|FG002|Part 2|Adverse Event|0
1982990|NCT01729754|3546915|FG003|Part 2|Adverse Event|0
1982991|NCT01729754|3546916|FG004|Part 2|Adverse Event|0
1982992|NCT01729754|3546917|FG005|Part 2|Adverse Event|0
1982993|NCT01729754|3546918|FG006|Part 2|Adverse Event|0
1982994|NCT01729754|3546919|FG007|Part 2|Adverse Event|0
1982995|NCT01729754|3546920|FG008|Part 2|Adverse Event|1
1982996|NCT01729754|3546921|FG009|Part 2|Adverse Event|2
2310694|NCT02738775|4015203|FG004|Overall Study|Pregnancy|0
2310695|NCT02738775|4015204|FG005|Overall Study|Pregnancy|0
2310696|NCT02738775|4015199|FG000|Overall Study|Missing|0
2310697|NCT02738775|4015200|FG001|Overall Study|Missing|0
2310698|NCT02738775|4015201|FG002|Overall Study|Missing|0
2310699|NCT02738775|4015202|FG003|Overall Study|Missing|0
2310700|NCT02738775|4015203|FG004|Overall Study|Missing|0
2310701|NCT02738775|4015204|FG005|Overall Study|Missing|1
2310702|NCT02738801|4015224|FG000|Overall Study|Adverse Event|1
2310703|NCT02738801|4015225|FG001|Overall Study|Adverse Event|1
2310704|NCT02738801|4015224|FG000|Overall Study|Withdrawal by Subject|0
2310705|NCT02738801|4015225|FG001|Overall Study|Withdrawal by Subject|1
2310706|NCT02738840|4015232|FG000|Overall Study|MRI Scan not Performed|5
1982997|NCT01729754|3546912|FG000|Part 2|Lack of Efficacy|0
1982998|NCT01729754|3546913|FG001|Part 2|Lack of Efficacy|0
1982999|NCT01729754|3546914|FG002|Part 2|Lack of Efficacy|0
1983000|NCT01729754|3546915|FG003|Part 2|Lack of Efficacy|0
1983001|NCT01729754|3546916|FG004|Part 2|Lack of Efficacy|0
1983002|NCT01729754|3546917|FG005|Part 2|Lack of Efficacy|0
1983003|NCT01729754|3546918|FG006|Part 2|Lack of Efficacy|0
1983004|NCT01729754|3546919|FG007|Part 2|Lack of Efficacy|0
2310707|NCT02738840|4015232|FG000|Overall Study|Lost to Follow-up|1
1983005|NCT01729754|3546920|FG008|Part 2|Lack of Efficacy|2
1983006|NCT01729754|3546921|FG009|Part 2|Lack of Efficacy|2
1983007|NCT01729754|3546912|FG000|Part 2|Lost to Follow-up|0
1983008|NCT01729754|3546913|FG001|Part 2|Lost to Follow-up|0
1983009|NCT01729754|3546914|FG002|Part 2|Lost to Follow-up|0
1983010|NCT01729754|3546915|FG003|Part 2|Lost to Follow-up|2
1983011|NCT01729754|3546916|FG004|Part 2|Lost to Follow-up|0
1983012|NCT01729754|3546917|FG005|Part 2|Lost to Follow-up|0
1983013|NCT01729754|3546918|FG006|Part 2|Lost to Follow-up|0
1983014|NCT01729754|3546919|FG007|Part 2|Lost to Follow-up|1
1983015|NCT01729754|3546920|FG008|Part 2|Lost to Follow-up|0
1983016|NCT01729754|3546921|FG009|Part 2|Lost to Follow-up|2
1983017|NCT01729754|3546912|FG000|Part 2|Non-Compliance with Study Drug|0
1983018|NCT01729754|3546913|FG001|Part 2|Non-Compliance with Study Drug|0
1983019|NCT01729754|3546914|FG002|Part 2|Non-Compliance with Study Drug|0
1983020|NCT01729754|3546915|FG003|Part 2|Non-Compliance with Study Drug|0
1983021|NCT01729754|3546916|FG004|Part 2|Non-Compliance with Study Drug|0
1983022|NCT01729754|3546917|FG005|Part 2|Non-Compliance with Study Drug|0
1983023|NCT01729754|3546918|FG006|Part 2|Non-Compliance with Study Drug|0
1983024|NCT01729754|3546919|FG007|Part 2|Non-Compliance with Study Drug|0
1983025|NCT01729754|3546920|FG008|Part 2|Non-Compliance with Study Drug|0
1983026|NCT01729754|3546921|FG009|Part 2|Non-Compliance with Study Drug|1
1983027|NCT01729754|3546912|FG000|Part 2|Pregnancy|0
1983028|NCT01729754|3546913|FG001|Part 2|Pregnancy|0
1983029|NCT01729754|3546914|FG002|Part 2|Pregnancy|0
1983030|NCT01729754|3546915|FG003|Part 2|Pregnancy|1
1983031|NCT01729754|3546916|FG004|Part 2|Pregnancy|0
1983032|NCT01729754|3546917|FG005|Part 2|Pregnancy|0
1983033|NCT01729754|3546918|FG006|Part 2|Pregnancy|0
1983034|NCT01729754|3546919|FG007|Part 2|Pregnancy|0
1983035|NCT01729754|3546920|FG008|Part 2|Pregnancy|0
1983036|NCT01729754|3546921|FG009|Part 2|Pregnancy|1
1983037|NCT01729754|3546912|FG000|Part 2|Withdrawal by Subject|3
1983038|NCT01729754|3546913|FG001|Part 2|Withdrawal by Subject|0
1983039|NCT01729754|3546914|FG002|Part 2|Withdrawal by Subject|0
1983040|NCT01729754|3546915|FG003|Part 2|Withdrawal by Subject|2
1983041|NCT01729754|3546916|FG004|Part 2|Withdrawal by Subject|0
1983042|NCT01729754|3546917|FG005|Part 2|Withdrawal by Subject|0
1983043|NCT01729754|3546918|FG006|Part 2|Withdrawal by Subject|0
1983044|NCT01729754|3546919|FG007|Part 2|Withdrawal by Subject|1
1983045|NCT01729754|3546920|FG008|Part 2|Withdrawal by Subject|1
1983046|NCT01729754|3546921|FG009|Part 2|Withdrawal by Subject|4
1983047|NCT01729754|3546912|FG000|Part 2|Other Protocol Specified Criteria|1
1983048|NCT01729754|3546913|FG001|Part 2|Other Protocol Specified Criteria|0
1983049|NCT01729754|3546914|FG002|Part 2|Other Protocol Specified Criteria|0
1983050|NCT01729754|3546915|FG003|Part 2|Other Protocol Specified Criteria|0
1983051|NCT01729754|3546916|FG004|Part 2|Other Protocol Specified Criteria|0
1983052|NCT01729754|3546917|FG005|Part 2|Other Protocol Specified Criteria|0
1983053|NCT01729754|3546918|FG006|Part 2|Other Protocol Specified Criteria|0
1983054|NCT01729754|3546919|FG007|Part 2|Other Protocol Specified Criteria|1
1983055|NCT01729754|3546920|FG008|Part 2|Other Protocol Specified Criteria|0
1983056|NCT01729754|3546921|FG009|Part 2|Other Protocol Specified Criteria|0
1983057|NCT01729754|3546912|FG000|Part 3|Adverse Event|0
1983058|NCT01729754|3546913|FG001|Part 3|Adverse Event|0
1983059|NCT01729754|3546914|FG002|Part 3|Adverse Event|1
1983060|NCT01729754|3546915|FG003|Part 3|Adverse Event|0
1983061|NCT01729754|3546916|FG004|Part 3|Adverse Event|0
1983062|NCT01729754|3546917|FG005|Part 3|Adverse Event|5
1983063|NCT01729754|3546918|FG006|Part 3|Adverse Event|0
1983064|NCT01729754|3546919|FG007|Part 3|Adverse Event|0
1983065|NCT01729754|3546920|FG008|Part 3|Adverse Event|0
1983066|NCT01729754|3546921|FG009|Part 3|Adverse Event|3
1983067|NCT01729754|3546912|FG000|Part 3|Death|0
1983068|NCT01729754|3546913|FG001|Part 3|Death|0
1983069|NCT01729754|3546914|FG002|Part 3|Death|0
1983070|NCT01729754|3546915|FG003|Part 3|Death|0
1983071|NCT01729754|3546916|FG004|Part 3|Death|0
1983072|NCT01729754|3546917|FG005|Part 3|Death|2
1983073|NCT01729754|3546918|FG006|Part 3|Death|0
1983074|NCT01729754|3546919|FG007|Part 3|Death|0
1983075|NCT01729754|3546920|FG008|Part 3|Death|0
1983076|NCT01729754|3546921|FG009|Part 3|Death|0
1983077|NCT01729754|3546912|FG000|Part 3|Lack of Efficacy|0
1983078|NCT01729754|3546913|FG001|Part 3|Lack of Efficacy|0
1983079|NCT01729754|3546914|FG002|Part 3|Lack of Efficacy|0
1983080|NCT01729754|3546915|FG003|Part 3|Lack of Efficacy|0
1983081|NCT01729754|3546916|FG004|Part 3|Lack of Efficacy|2
1983082|NCT01729754|3546917|FG005|Part 3|Lack of Efficacy|0
1983083|NCT01729754|3546918|FG006|Part 3|Lack of Efficacy|0
1983084|NCT01729754|3546919|FG007|Part 3|Lack of Efficacy|0
1983085|NCT01729754|3546920|FG008|Part 3|Lack of Efficacy|0
1983086|NCT01729754|3546921|FG009|Part 3|Lack of Efficacy|4
1983087|NCT01729754|3546912|FG000|Part 3|Lost to Follow-up|0
1983088|NCT01729754|3546913|FG001|Part 3|Lost to Follow-up|1
1983089|NCT01729754|3546914|FG002|Part 3|Lost to Follow-up|2
1983090|NCT01729754|3546915|FG003|Part 3|Lost to Follow-up|0
1983091|NCT01729754|3546916|FG004|Part 3|Lost to Follow-up|0
1983092|NCT01729754|3546917|FG005|Part 3|Lost to Follow-up|3
1983093|NCT01729754|3546918|FG006|Part 3|Lost to Follow-up|0
1983094|NCT01729754|3546919|FG007|Part 3|Lost to Follow-up|0
1983095|NCT01729754|3546920|FG008|Part 3|Lost to Follow-up|1
1983096|NCT01729754|3546921|FG009|Part 3|Lost to Follow-up|0
1983097|NCT01729754|3546912|FG000|Part 3|Physician Decision|0
1983098|NCT01729754|3546913|FG001|Part 3|Physician Decision|0
1983099|NCT01729754|3546914|FG002|Part 3|Physician Decision|1
1983100|NCT01729754|3546915|FG003|Part 3|Physician Decision|0
1983101|NCT01729754|3546916|FG004|Part 3|Physician Decision|0
1983102|NCT01729754|3546917|FG005|Part 3|Physician Decision|0
1983103|NCT01729754|3546918|FG006|Part 3|Physician Decision|0
1983104|NCT01729754|3546919|FG007|Part 3|Physician Decision|0
1983105|NCT01729754|3546920|FG008|Part 3|Physician Decision|0
1983106|NCT01729754|3546921|FG009|Part 3|Physician Decision|0
1983107|NCT01729754|3546912|FG000|Part 3|Withdrawal by Subject|0
1983108|NCT01729754|3546913|FG001|Part 3|Withdrawal by Subject|4
1983109|NCT01729754|3546914|FG002|Part 3|Withdrawal by Subject|1
1983110|NCT01729754|3546915|FG003|Part 3|Withdrawal by Subject|0
1983111|NCT01729754|3546916|FG004|Part 3|Withdrawal by Subject|2
1983112|NCT01729754|3546917|FG005|Part 3|Withdrawal by Subject|1
1983113|NCT01729754|3546918|FG006|Part 3|Withdrawal by Subject|0
1983114|NCT01729754|3546919|FG007|Part 3|Withdrawal by Subject|2
1983115|NCT01729754|3546920|FG008|Part 3|Withdrawal by Subject|0
1983116|NCT01729754|3546921|FG009|Part 3|Withdrawal by Subject|0
1983117|NCT01729754|3546912|FG000|Part 3|Other Protocol Specified Criteria|0
1983118|NCT01729754|3546913|FG001|Part 3|Other Protocol Specified Criteria|0
1983119|NCT01729754|3546914|FG002|Part 3|Other Protocol Specified Criteria|0
1983120|NCT01729754|3546915|FG003|Part 3|Other Protocol Specified Criteria|0
1983121|NCT01729754|3546916|FG004|Part 3|Other Protocol Specified Criteria|0
1983122|NCT01729754|3546917|FG005|Part 3|Other Protocol Specified Criteria|2
1983123|NCT01729754|3546918|FG006|Part 3|Other Protocol Specified Criteria|0
1983124|NCT01729754|3546919|FG007|Part 3|Other Protocol Specified Criteria|1
1983125|NCT01729754|3546920|FG008|Part 3|Other Protocol Specified Criteria|0
1983126|NCT01729754|3546921|FG009|Part 3|Other Protocol Specified Criteria|0
1983127|NCT01553149|3546953|FG000|Overall Study|Adverse Event|0
1983128|NCT01553149|3546954|FG001|Overall Study|Adverse Event|9
1983129|NCT01553149|3546953|FG000|Overall Study|Physician Decision|5
1983130|NCT01553149|3546954|FG001|Overall Study|Physician Decision|10
1983131|NCT01553149|3546953|FG000|Overall Study|Ineligible|0
1983132|NCT01553149|3546954|FG001|Overall Study|Ineligible|1
1983133|NCT01437111|3546960|FG000|Overall Study|Adverse Event|2
1983134|NCT01437111|3546960|FG000|Overall Study|Withdrawal by Subject|4
1983135|NCT01437111|3546960|FG000|Overall Study|Not reported|5
1983136|NCT01437111|3546960|FG000|Overall Study|Physician Decision|1
1983137|NCT01437111|3546960|FG000|Overall Study|Lost to Follow-up|5
1983138|NCT01437111|3546960|FG000|Overall Study|Protocol Violation|1
1983139|NCT01386385|3546972|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1
1983140|NCT01386385|3546973|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0
1983141|NCT01386385|3546974|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0
1983142|NCT01386385|3546975|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0
1983143|NCT01386385|3546976|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0
1983144|NCT01386385|3546977|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0
1983145|NCT01386385|3546978|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0
1983146|NCT01386385|3546979|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0
1983147|NCT01386385|3546972|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1
1983148|NCT01386385|3546973|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
1983149|NCT01386385|3546974|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
1983150|NCT01386385|3546975|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
1983151|NCT01386385|3546976|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
1983152|NCT01386385|3546977|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
1983153|NCT01386385|3546978|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
1983154|NCT01386385|3546979|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
1983155|NCT01386385|3546972|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0
1983156|NCT01386385|3546973|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0
1983157|NCT01386385|3546974|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2
1983158|NCT01386385|3546975|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0
1983159|NCT01386385|3546976|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0
1983160|NCT01386385|3546977|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0
1983161|NCT01386385|3546978|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0
1983162|NCT01386385|3546979|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0
1983163|NCT01386385|3546972|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
1983164|NCT01386385|3546973|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
1983165|NCT01386385|3546974|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
1983166|NCT01386385|3546975|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
1983167|NCT01386385|3546976|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1
1983168|NCT01386385|3546977|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
1983169|NCT01386385|3546978|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
1983170|NCT01386385|3546979|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
1983171|NCT01386385|3546972|FG000|Phase II Concurrent CRT|Adverse Event|0
1983172|NCT01386385|3546973|FG001|Phase II Concurrent CRT|Adverse Event|0
1983173|NCT01386385|3546974|FG002|Phase II Concurrent CRT|Adverse Event|0
1983174|NCT01386385|3546975|FG003|Phase II Concurrent CRT|Adverse Event|0
1983175|NCT01386385|3546976|FG004|Phase II Concurrent CRT|Adverse Event|0
1983176|NCT01386385|3546977|FG005|Phase II Concurrent CRT|Adverse Event|0
1983177|NCT01386385|3546978|FG006|Phase II Concurrent CRT|Adverse Event|3
1983178|NCT01386385|3546979|FG007|Phase II Concurrent CRT|Adverse Event|3
1983179|NCT01386385|3546972|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0
1983180|NCT01386385|3546973|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0
1983181|NCT01386385|3546974|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0
1983182|NCT01386385|3546975|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0
1983183|NCT01386385|3546976|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0
1983184|NCT01386385|3546977|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0
1983185|NCT01386385|3546978|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3
1983186|NCT01386385|3546979|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0
1983187|NCT01386385|3546972|FG000|Phase II: Consolidation Therapy|Adverse Event|0
1983188|NCT01386385|3546973|FG001|Phase II: Consolidation Therapy|Adverse Event|0
1983189|NCT01386385|3546974|FG002|Phase II: Consolidation Therapy|Adverse Event|0
1983190|NCT01386385|3546975|FG003|Phase II: Consolidation Therapy|Adverse Event|0
1983191|NCT01386385|3546976|FG004|Phase II: Consolidation Therapy|Adverse Event|0
1983192|NCT01386385|3546977|FG005|Phase II: Consolidation Therapy|Adverse Event|0
1983193|NCT01386385|3546978|FG006|Phase II: Consolidation Therapy|Adverse Event|2
1983194|NCT01386385|3546979|FG007|Phase II: Consolidation Therapy|Adverse Event|1
1983195|NCT01386385|3546972|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
1983196|NCT01386385|3546973|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
1983197|NCT01386385|3546974|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
1983198|NCT01386385|3546975|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
1983199|NCT01386385|3546976|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
1983200|NCT01386385|3546977|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
1983201|NCT01386385|3546978|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2
1983202|NCT01386385|3546979|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
1983203|NCT01386385|3546972|FG000|Phase II: Consolidation Therapy|Progression/relapse|0
1983204|NCT01386385|3546973|FG001|Phase II: Consolidation Therapy|Progression/relapse|0
1983205|NCT01386385|3546974|FG002|Phase II: Consolidation Therapy|Progression/relapse|0
1983206|NCT01386385|3546975|FG003|Phase II: Consolidation Therapy|Progression/relapse|0
1983207|NCT01386385|3546976|FG004|Phase II: Consolidation Therapy|Progression/relapse|0
1983208|NCT01386385|3546977|FG005|Phase II: Consolidation Therapy|Progression/relapse|0
1983209|NCT01386385|3546978|FG006|Phase II: Consolidation Therapy|Progression/relapse|1
1983210|NCT01386385|3546979|FG007|Phase II: Consolidation Therapy|Progression/relapse|1
1983211|NCT01004263|3547030|FG000|Overall Study|Adverse Event|15
1983212|NCT01004263|3547030|FG000|Overall Study|Withdrawal by Subject|58
1983213|NCT01004263|3547030|FG000|Overall Study|Protocol Violation|10
1983214|NCT01004263|3547030|FG000|Overall Study|Lost to Follow-up|64
1983215|NCT01004263|3547030|FG000|Overall Study|Lack of Efficacy|13
1983216|NCT01004263|3547030|FG000|Overall Study|Pregnancy|2
1983217|NCT01004263|3547030|FG000|Overall Study|Physician Decision|15
1983218|NCT01004263|3547030|FG000|Overall Study|Lack of Qualifying Event|2
1983219|NCT01001234|3547039|FG000|Overall Study|Withdrawal by Subject|2
1983220|NCT01001234|3547040|FG001|Overall Study|Withdrawal by Subject|0
1983221|NCT01001234|3547041|FG002|Overall Study|Withdrawal by Subject|3
1983222|NCT01001234|3547042|FG003|Overall Study|Withdrawal by Subject|0
1983223|NCT01001234|3547043|FG004|Overall Study|Withdrawal by Subject|0
1983224|NCT01001234|3547039|FG000|Overall Study|Protocol Violation|34
1983225|NCT01001234|3547040|FG001|Overall Study|Protocol Violation|3
1983226|NCT01001234|3547041|FG002|Overall Study|Protocol Violation|19
1983227|NCT01001234|3547042|FG003|Overall Study|Protocol Violation|18
1983228|NCT01001234|3547043|FG004|Overall Study|Protocol Violation|0
1983229|NCT01001234|3547039|FG000|Overall Study|Lost to Follow-up|0
1983230|NCT01001234|3547040|FG001|Overall Study|Lost to Follow-up|0
1983231|NCT01001234|3547041|FG002|Overall Study|Lost to Follow-up|1
1983232|NCT01001234|3547042|FG003|Overall Study|Lost to Follow-up|2
1983233|NCT01001234|3547043|FG004|Overall Study|Lost to Follow-up|0
1983234|NCT01001234|3547039|FG000|Overall Study|Physician Decision|1
1983235|NCT01001234|3547040|FG001|Overall Study|Physician Decision|0
1983236|NCT01001234|3547041|FG002|Overall Study|Physician Decision|0
1983237|NCT01001234|3547042|FG003|Overall Study|Physician Decision|0
1983238|NCT01001234|3547043|FG004|Overall Study|Physician Decision|0
1983239|NCT01001234|3547039|FG000|Overall Study|Not Treated: Adverse Event|1
1983240|NCT01001234|3547040|FG001|Overall Study|Not Treated: Adverse Event|0
1983241|NCT01001234|3547041|FG002|Overall Study|Not Treated: Adverse Event|0
1983242|NCT01001234|3547042|FG003|Overall Study|Not Treated: Adverse Event|0
1983243|NCT01001234|3547043|FG004|Overall Study|Not Treated: Adverse Event|0
1983244|NCT01001234|3547039|FG000|Overall Study|Not Treated: Withdrawal by Subject|23
1983245|NCT01001234|3547040|FG001|Overall Study|Not Treated: Withdrawal by Subject|2
1983246|NCT01001234|3547041|FG002|Overall Study|Not Treated: Withdrawal by Subject|2
1983247|NCT01001234|3547042|FG003|Overall Study|Not Treated: Withdrawal by Subject|0
1983248|NCT01001234|3547043|FG004|Overall Study|Not Treated: Withdrawal by Subject|0
1983249|NCT01001234|3547039|FG000|Overall Study|Not Treated: Protocol Violation|3
1983250|NCT01001234|3547040|FG001|Overall Study|Not Treated: Protocol Violation|0
1983251|NCT01001234|3547041|FG002|Overall Study|Not Treated: Protocol Violation|0
1983252|NCT01001234|3547042|FG003|Overall Study|Not Treated: Protocol Violation|0
1983253|NCT01001234|3547043|FG004|Overall Study|Not Treated: Protocol Violation|0
1983254|NCT01001234|3547039|FG000|Overall Study|Not Treated: Lost to Follow-up|53
1983255|NCT01001234|3547040|FG001|Overall Study|Not Treated: Lost to Follow-up|4
1983256|NCT01001234|3547041|FG002|Overall Study|Not Treated: Lost to Follow-up|7
1983257|NCT01001234|3547042|FG003|Overall Study|Not Treated: Lost to Follow-up|5
1983258|NCT01001234|3547043|FG004|Overall Study|Not Treated: Lost to Follow-up|0
1983259|NCT01001234|3547039|FG000|Overall Study|Not Treated: Pregnancy|3
1983260|NCT01001234|3547040|FG001|Overall Study|Not Treated: Pregnancy|0
1983261|NCT01001234|3547041|FG002|Overall Study|Not Treated: Pregnancy|0
1983262|NCT01001234|3547042|FG003|Overall Study|Not Treated: Pregnancy|0
1983263|NCT01001234|3547043|FG004|Overall Study|Not Treated: Pregnancy|0
1983264|NCT01001234|3547039|FG000|Overall Study|Not Treated: Physician Decision|37
1983265|NCT01001234|3547040|FG001|Overall Study|Not Treated: Physician Decision|4
1983266|NCT01001234|3547041|FG002|Overall Study|Not Treated: Physician Decision|0
1983267|NCT01001234|3547042|FG003|Overall Study|Not Treated: Physician Decision|0
1983268|NCT01001234|3547043|FG004|Overall Study|Not Treated: Physician Decision|0
1983269|NCT01001234|3547039|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248
1983270|NCT01001234|3547040|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13
1983271|NCT01001234|3547041|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0
1983272|NCT01001234|3547042|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0
1983273|NCT01001234|3547043|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0
1983274|NCT00924170|3547051|FG000|Overall Study|Refused further treatment|0
1983275|NCT00924170|3547052|FG001|Overall Study|Refused further treatment|1
1983276|NCT00924170|3547051|FG000|Overall Study|Physician Decision|0
1983277|NCT00924170|3547052|FG001|Overall Study|Physician Decision|1
1983278|NCT00924170|3547051|FG000|Overall Study|Progressive disease|3
1983279|NCT00924170|3547052|FG001|Overall Study|Progressive disease|6
1983280|NCT00924170|3547051|FG000|Overall Study|Stopped due to neutralizing antibodies|3
1983281|NCT00924170|3547052|FG001|Overall Study|Stopped due to neutralizing antibodies|0
1983282|NCT00924170|3547051|FG000|Overall Study|Death|1
1983283|NCT00924170|3547052|FG001|Overall Study|Death|0
1983284|NCT00894556|3547067|FG000|Baseline Phase|Did not meet Randomization Criteria|0
1983285|NCT00894556|3547068|FG001|Baseline Phase|Did not meet Randomization Criteria|0
1983286|NCT00894556|3547069|FG002|Baseline Phase|Did not meet Randomization Criteria|0
1983287|NCT00894556|3547070|FG003|Baseline Phase|Did not meet Randomization Criteria|85
1983288|NCT00894556|3547067|FG000|Treatment Phase|Lost to Follow-up|2
1983289|NCT00894556|3547068|FG001|Treatment Phase|Lost to Follow-up|3
1983290|NCT00894556|3547069|FG002|Treatment Phase|Lost to Follow-up|1
1983291|NCT00894556|3547070|FG003|Treatment Phase|Lost to Follow-up|0
1983292|NCT00894556|3547067|FG000|Treatment Phase|Lack of Qualifying Event|2
1983293|NCT00894556|3547068|FG001|Treatment Phase|Lack of Qualifying Event|1
1983294|NCT00894556|3547069|FG002|Treatment Phase|Lack of Qualifying Event|0
1983295|NCT00894556|3547070|FG003|Treatment Phase|Lack of Qualifying Event|0
1983296|NCT00840177|3547080|FG000|Overall Study|Adverse Event|5
1983297|NCT00840177|3547081|FG001|Overall Study|Adverse Event|1
1983298|NCT00840177|3547082|FG002|Overall Study|Adverse Event|1
1983299|NCT00840177|3547080|FG000|Overall Study|Refusal unrelated to adverse events|1
1983300|NCT00840177|3547081|FG001|Overall Study|Refusal unrelated to adverse events|0
1983301|NCT00840177|3547082|FG002|Overall Study|Refusal unrelated to adverse events|1
1983302|NCT00840177|3547080|FG000|Overall Study|Progression/relapse|2
1983303|NCT00840177|3547081|FG001|Overall Study|Progression/relapse|0
1983304|NCT00840177|3547082|FG002|Overall Study|Progression/relapse|0
1983305|NCT00840177|3547080|FG000|Overall Study|Death|4
1983306|NCT00840177|3547081|FG001|Overall Study|Death|5
1983307|NCT00840177|3547082|FG002|Overall Study|Death|5
1983308|NCT00840177|3547080|FG000|Overall Study|not protocol specified|6
1983309|NCT00840177|3547081|FG001|Overall Study|not protocol specified|3
1983310|NCT00840177|3547082|FG002|Overall Study|not protocol specified|0
1983311|NCT00840177|3547080|FG000|Overall Study|Ineligible|0
1983312|NCT00840177|3547081|FG001|Overall Study|Ineligible|0
1983313|NCT00840177|3547082|FG002|Overall Study|Ineligible|3
1983314|NCT00840177|3547080|FG000|Overall Study|Did not start treatment|0
1983315|NCT00840177|3547081|FG001|Overall Study|Did not start treatment|0
1983316|NCT00840177|3547082|FG002|Overall Study|Did not start treatment|1
1983317|NCT00820950|3547095|FG000|Overall Study|Scheduling Conflict|0
1983318|NCT00820950|3547096|FG001|Overall Study|Scheduling Conflict|0
1983319|NCT00820950|3547097|FG002|Overall Study|Scheduling Conflict|0
1983320|NCT00820950|3547098|FG003|Overall Study|Scheduling Conflict|0
1983321|NCT00820950|3547099|FG004|Overall Study|Scheduling Conflict|0
1983322|NCT00820950|3547100|FG005|Overall Study|Scheduling Conflict|0
1983323|NCT00820950|3547101|FG006|Overall Study|Scheduling Conflict|1
1983324|NCT00820950|3547102|FG007|Overall Study|Scheduling Conflict|1
1983325|NCT00820950|3547103|FG008|Overall Study|Scheduling Conflict|0
1983326|NCT00820950|3547104|FG009|Overall Study|Scheduling Conflict|0
1983327|NCT00820950|3547095|FG000|Overall Study|Protocol Violation|1
1983328|NCT00820950|3547096|FG001|Overall Study|Protocol Violation|1
1983329|NCT00820950|3547097|FG002|Overall Study|Protocol Violation|0
1983330|NCT00820950|3547098|FG003|Overall Study|Protocol Violation|0
1983331|NCT00820950|3547099|FG004|Overall Study|Protocol Violation|0
1983332|NCT00820950|3547100|FG005|Overall Study|Protocol Violation|0
1983333|NCT00820950|3547101|FG006|Overall Study|Protocol Violation|0
1983334|NCT00820950|3547102|FG007|Overall Study|Protocol Violation|0
1983335|NCT00820950|3547103|FG008|Overall Study|Protocol Violation|0
1983336|NCT00820950|3547104|FG009|Overall Study|Protocol Violation|0
1983337|NCT00806416|3547146|FG000|Period 1 - Part I|Adverse Event|0
1983338|NCT00806416|3547147|FG001|Period 1 - Part I|Adverse Event|1
1983339|NCT00806416|3547148|FG002|Period 1 - Part I|Adverse Event|0
1983340|NCT00806416|3547149|FG003|Period 1 - Part I|Adverse Event|0
1983341|NCT00806416|3547146|FG000|Period 1 - Part I|Lost to Follow-up|0
1983342|NCT00806416|3547147|FG001|Period 1 - Part I|Lost to Follow-up|2
1983343|NCT00806416|3547148|FG002|Period 1 - Part I|Lost to Follow-up|0
1983344|NCT00806416|3547149|FG003|Period 1 - Part I|Lost to Follow-up|0
1983345|NCT00806416|3547146|FG000|Period 1 - Part I|Withdrawal by Subject|3
1983346|NCT00806416|3547147|FG001|Period 1 - Part I|Withdrawal by Subject|1
1983347|NCT00806416|3547148|FG002|Period 1 - Part I|Withdrawal by Subject|0
1983348|NCT00806416|3547149|FG003|Period 1 - Part I|Withdrawal by Subject|0
1983349|NCT00806416|3547146|FG000|Period 1 - Part II|Withdrawal by Subject|0
1983350|NCT00806416|3547147|FG001|Period 1 - Part II|Withdrawal by Subject|0
1983351|NCT00806416|3547148|FG002|Period 1 - Part II|Withdrawal by Subject|0
1983352|NCT00806416|3547149|FG003|Period 1 - Part II|Withdrawal by Subject|2
2023853|NCT00328926|3592111|FG002|Overall Study|Lack of ovarian response|0
2023854|NCT00329030|3592121|FG000|Overall Study|Withdrawal by Subject|1
2023855|NCT00329030|3592122|FG001|Overall Study|Withdrawal by Subject|3
2023856|NCT00329030|3592121|FG000|Overall Study|Progressive Disease|6
2023857|NCT00329030|3592122|FG001|Overall Study|Progressive Disease|2
2023858|NCT00329030|3592121|FG000|Overall Study|Ineligible Pathology|1
2023859|NCT00329030|3592122|FG001|Overall Study|Ineligible Pathology|1
2023860|NCT00329160|3592128|FG000|Overall Study|Adverse Event|27
2023861|NCT00329160|3592128|FG000|Overall Study|Withdrawal by Subject|13
2023862|NCT00329160|3592128|FG000|Overall Study|Protocol Violation|2
2023863|NCT00329160|3592128|FG000|Overall Study|Did not Receive Study Drug|1
2023864|NCT00329160|3592128|FG000|Overall Study|Incomplete IVUS|45
2023865|NCT00329238|3592134|FG000|Overall Study|Adverse Event|147
2023866|NCT00329238|3592135|FG001|Overall Study|Adverse Event|129
2023867|NCT00329238|3592134|FG000|Overall Study|Protocol Violation|23
2023868|NCT00329238|3592135|FG001|Overall Study|Protocol Violation|34
2023869|NCT00329238|3592134|FG000|Overall Study|Lost to Follow-up|2
2023870|NCT00329238|3592135|FG001|Overall Study|Lost to Follow-up|6
2023871|NCT00329238|3592134|FG000|Overall Study|Withdrawal by Subject|64
2023872|NCT00329238|3592135|FG001|Overall Study|Withdrawal by Subject|58
2023873|NCT00329238|3592134|FG000|Overall Study|Other reason (not specified)|40
2023874|NCT00329238|3592135|FG001|Overall Study|Other reason (not specified)|54
2023875|NCT00329303|3592145|FG000|Overall Study|Lack of Efficacy|1
2023876|NCT00329303|3592146|FG001|Overall Study|Lack of Efficacy|0
2023877|NCT00329303|3592145|FG000|Overall Study|Decision of the sponsor|0
2023878|NCT00329303|3592146|FG001|Overall Study|Decision of the sponsor|1
2023879|NCT00329303|3592145|FG000|Overall Study|Patient no longer available|1
2023880|NCT00329303|3592146|FG001|Overall Study|Patient no longer available|0
2023881|NCT00329303|3592145|FG000|Overall Study|Patient relocated|0
2023882|NCT00329303|3592146|FG001|Overall Study|Patient relocated|1
2023883|NCT00329407|3592153|FG000|Overall Study|Withdrawal by Subject|1
2023884|NCT00329420|3592160|FG000|Re-induction Phase|Lack of Efficacy|0
2023885|NCT00329420|3592161|FG001|Re-induction Phase|Lack of Efficacy|1
2023886|NCT00329420|3592162|FG002|Re-induction Phase|Lack of Efficacy|0
2023887|NCT00329420|3592160|FG000|Re-induction Phase|Withdrawal of Consent|0
2023888|NCT00329420|3592161|FG001|Re-induction Phase|Withdrawal of Consent|0
2023889|NCT00329420|3592162|FG002|Re-induction Phase|Withdrawal of Consent|1
2023890|NCT00329420|3592160|FG000|Re-induction Phase|Did not respond to re-induction|6
2023891|NCT00329420|3592161|FG001|Re-induction Phase|Did not respond to re-induction|5
2023892|NCT00329420|3592162|FG002|Re-induction Phase|Did not respond to re-induction|7
2023893|NCT00329420|3592160|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
2023894|NCT00329420|3592161|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
2023895|NCT00329420|3592162|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
2023896|NCT00329420|3592160|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
2023897|NCT00329420|3592161|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
2023898|NCT00329420|3592162|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
2023899|NCT00329420|3592160|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
2023900|NCT00329420|3592161|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
2023901|NCT00329420|3592162|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
2023902|NCT00329550|3592188|FG000|Overall Study|Adverse Event|3
2023903|NCT00329550|3592189|FG001|Overall Study|Adverse Event|4
2023904|NCT00329550|3592190|FG002|Overall Study|Adverse Event|2
2023905|NCT00329550|3592188|FG000|Overall Study|Withdrawal of Consent|1
2023906|NCT00329550|3592189|FG001|Overall Study|Withdrawal of Consent|0
2023907|NCT00329550|3592190|FG002|Overall Study|Withdrawal of Consent|1
2023908|NCT00329550|3592188|FG000|Overall Study|Due to Relocation|0
2023909|NCT00329550|3592189|FG001|Overall Study|Due to Relocation|0
2023910|NCT00329550|3592190|FG002|Overall Study|Due to Relocation|1
2023911|NCT00329602|3592202|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
2023912|NCT00329602|3592203|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
2023913|NCT00329602|3592204|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
2023914|NCT00329602|3592202|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0
2023915|NCT00329602|3592203|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0
2023916|NCT00329602|3592204|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20
2023917|NCT00329602|3592202|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
1983353|NCT00729651|3547159|FG000|Overall Study|Withdrawal by Subject|5
1983354|NCT00729651|3547160|FG001|Overall Study|Withdrawal by Subject|6
1983355|NCT00729651|3547159|FG000|Overall Study|Lost to Follow-up|5
1983356|NCT00729651|3547160|FG001|Overall Study|Lost to Follow-up|4
1983357|NCT00729651|3547159|FG000|Overall Study|Protocol Violation|0
1983358|NCT00729651|3547160|FG001|Overall Study|Protocol Violation|1
1983359|NCT00729651|3547159|FG000|Overall Study|Adverse Event|7
1983360|NCT00729651|3547160|FG001|Overall Study|Adverse Event|3
1983361|NCT00729651|3547159|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
1983362|NCT00729651|3547160|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
1983363|NCT00729651|3547159|FG000|Overall Study|Subject's private reason|2
1983364|NCT00729651|3547160|FG001|Overall Study|Subject's private reason|0
1983365|NCT00698815|3547169|FG000|Overall Study|Death|1
1983366|NCT00698815|3547170|FG001|Overall Study|Death|2
1983367|NCT00698815|3547171|FG002|Overall Study|Death|4
1983368|NCT00698815|3547169|FG000|Overall Study|Withdrawal by Subject|6
1983369|NCT00698815|3547170|FG001|Overall Study|Withdrawal by Subject|3
1983370|NCT00698815|3547171|FG002|Overall Study|Withdrawal by Subject|2
1983371|NCT00698815|3547169|FG000|Overall Study|MD discretion|2
1983372|NCT00698815|3547170|FG001|Overall Study|MD discretion|7
1983373|NCT00698815|3547171|FG002|Overall Study|MD discretion|2
1983374|NCT00698815|3547169|FG000|Overall Study|Did not receive protocol treatment|1
1983375|NCT00698815|3547170|FG001|Overall Study|Did not receive protocol treatment|2
1983376|NCT00698815|3547171|FG002|Overall Study|Did not receive protocol treatment|2
1983377|NCT00692913|3547194|FG000|Overall Study|Adverse Event|8
1983378|NCT00692913|3547195|FG001|Overall Study|Adverse Event|4
1983379|NCT00692913|3547194|FG000|Overall Study|Lost to Follow-up|3
1983380|NCT00692913|3547195|FG001|Overall Study|Lost to Follow-up|5
1983381|NCT00692913|3547194|FG000|Overall Study|Physician Decision|2
1983382|NCT00692913|3547195|FG001|Overall Study|Physician Decision|0
1983383|NCT00692913|3547194|FG000|Overall Study|Protocol Violation|1
1983384|NCT00692913|3547195|FG001|Overall Study|Protocol Violation|1
1983385|NCT00692913|3547194|FG000|Overall Study|Withdrawal by Subject|15
1983386|NCT00692913|3547195|FG001|Overall Study|Withdrawal by Subject|20
1983387|NCT00617708|3547241|FG000|Overall Study|Adverse Event|0
1983388|NCT00617708|3547242|FG001|Overall Study|Adverse Event|6
1983389|NCT00617708|3547243|FG002|Overall Study|Adverse Event|9
1983390|NCT00617708|3547241|FG000|Overall Study|Withdrawal by Subject|1
1983391|NCT00617708|3547242|FG001|Overall Study|Withdrawal by Subject|1
1983392|NCT00617708|3547243|FG002|Overall Study|Withdrawal by Subject|7
1983393|NCT00617708|3547241|FG000|Overall Study|Death|0
1983394|NCT00617708|3547242|FG001|Overall Study|Death|6
1983395|NCT00617708|3547243|FG002|Overall Study|Death|5
1983396|NCT00617708|3547241|FG000|Overall Study|Progression/Relapse|7
1983397|NCT00617708|3547242|FG001|Overall Study|Progression/Relapse|40
1983398|NCT00617708|3547243|FG002|Overall Study|Progression/Relapse|36
1983399|NCT00617708|3547241|FG000|Overall Study|Not protocol specified|1
1983400|NCT00617708|3547242|FG001|Overall Study|Not protocol specified|4
1983401|NCT00617708|3547243|FG002|Overall Study|Not protocol specified|2
1983402|NCT00617708|3547241|FG000|Overall Study|Not eligible|1
1983403|NCT00617708|3547242|FG001|Overall Study|Not eligible|3
1983404|NCT00617708|3547243|FG002|Overall Study|Not eligible|5
1983405|NCT00516737|3547255|FG000|Overall Study|Lost to Follow-up|2
1983406|NCT00516737|3547256|FG001|Overall Study|Lost to Follow-up|0
1983407|NCT00516737|3547255|FG000|Overall Study|Physician Decision|0
1983408|NCT00516737|3547256|FG001|Overall Study|Physician Decision|1
1983409|NCT00516737|3547255|FG000|Overall Study|Withdrawal by Subject|0
1983410|NCT00516737|3547256|FG001|Overall Study|Withdrawal by Subject|1
1983411|NCT00516737|3547255|FG000|Overall Study|Lack of Qualifying Event|9
1983412|NCT00516737|3547256|FG001|Overall Study|Lack of Qualifying Event|6
1983413|NCT00358527|3547264|FG000|Overall Study|Adverse Event|4
1983414|NCT00358527|3547265|FG001|Overall Study|Adverse Event|0
1983415|NCT00358527|3547264|FG000|Overall Study|Withdrawal by Subject|1
1983416|NCT00358527|3547265|FG001|Overall Study|Withdrawal by Subject|1
1983417|NCT00358527|3547264|FG000|Overall Study|Non-compliance with protocol|6
1983418|NCT00358527|3547265|FG001|Overall Study|Non-compliance with protocol|1
1983419|NCT00358527|3547264|FG000|Overall Study|Administrative|2
1983420|NCT00358527|3547265|FG001|Overall Study|Administrative|1
1983421|NCT00326898|3547274|FG000|Overall Study|Disease progression|52
1983422|NCT00326898|3547275|FG001|Overall Study|Disease progression|54
1983423|NCT00326898|3547276|FG002|Overall Study|Disease progression|102
1983424|NCT00326898|3547274|FG000|Overall Study|Adverse Event|124
1983425|NCT00326898|3547275|FG001|Overall Study|Adverse Event|128
1983426|NCT00326898|3547276|FG002|Overall Study|Adverse Event|33
1983427|NCT00326898|3547274|FG000|Overall Study|Death|2
1983428|NCT00326898|3547275|FG001|Overall Study|Death|0
1983429|NCT00326898|3547276|FG002|Overall Study|Death|0
1983430|NCT00326898|3547274|FG000|Overall Study|Withdrawal by Subject|134
1983431|NCT00326898|3547275|FG001|Overall Study|Withdrawal by Subject|128
1983432|NCT00326898|3547276|FG002|Overall Study|Withdrawal by Subject|32
1983433|NCT00326898|3547274|FG000|Overall Study|Alternative therapy|1
1983434|NCT00326898|3547275|FG001|Overall Study|Alternative therapy|0
1983435|NCT00326898|3547276|FG002|Overall Study|Alternative therapy|0
1983436|NCT00326898|3547274|FG000|Overall Study|Other complicating disease|5
1983437|NCT00326898|3547275|FG001|Overall Study|Other complicating disease|5
1983438|NCT00326898|3547276|FG002|Overall Study|Other complicating disease|4
1983439|NCT00326898|3547274|FG000|Overall Study|Other/Missing/Unknown|33
1983440|NCT00326898|3547275|FG001|Overall Study|Other/Missing/Unknown|28
1983441|NCT00326898|3547276|FG002|Overall Study|Other/Missing/Unknown|32
1983442|NCT00156065|3547287|FG000|Overall Study|Enrolled But Never Received Treatment|1
1983443|NCT00156065|3547288|FG001|Overall Study|Enrolled But Never Received Treatment|1
1983444|NCT00156065|3547289|FG002|Overall Study|Enrolled But Never Received Treatment|0
1983445|NCT00156065|3547287|FG000|Overall Study|Adverse Event|8
1983446|NCT00156065|3547288|FG001|Overall Study|Adverse Event|11
1983447|NCT00156065|3547289|FG002|Overall Study|Adverse Event|4
1983448|NCT00156065|3547287|FG000|Overall Study|Lack of Efficacy|2
1983449|NCT00156065|3547288|FG001|Overall Study|Lack of Efficacy|9
1983450|NCT00156065|3547289|FG002|Overall Study|Lack of Efficacy|3
1983451|NCT00156065|3547287|FG000|Overall Study|Withdrawal by Subject|13
1983452|NCT00156065|3547288|FG001|Overall Study|Withdrawal by Subject|26
1983453|NCT00156065|3547289|FG002|Overall Study|Withdrawal by Subject|16
1983454|NCT00156065|3547287|FG000|Overall Study|Lost to Follow-up|5
1983455|NCT00156065|3547288|FG001|Overall Study|Lost to Follow-up|7
1983456|NCT00156065|3547289|FG002|Overall Study|Lost to Follow-up|1
1983457|NCT00156065|3547287|FG000|Overall Study|Other|2
1983458|NCT00156065|3547288|FG001|Overall Study|Other|9
1983459|NCT00156065|3547289|FG002|Overall Study|Other|3
1983460|NCT00150176|3547299|FG000|Overall Study|Adverse Event|16
1983461|NCT00150176|3547300|FG001|Overall Study|Adverse Event|53
1983462|NCT00150176|3547299|FG000|Overall Study|Relapse/Impending relapse, non-AE|10
1983463|NCT00150176|3547300|FG001|Overall Study|Relapse/Impending relapse, non-AE|39
1983464|NCT00150176|3547299|FG000|Overall Study|Withdrawal by Subject|19
1983465|NCT00150176|3547300|FG001|Overall Study|Withdrawal by Subject|12
1983466|NCT00150176|3547299|FG000|Overall Study|Lost to Follow-up|3
1983467|NCT00150176|3547300|FG001|Overall Study|Lost to Follow-up|3
1983468|NCT00150176|3547299|FG000|Overall Study|OTHER|11
1983469|NCT00150176|3547300|FG001|Overall Study|OTHER|13
1983470|NCT00145509|3547309|FG000|Overall Study|Adverse Event|10
1983471|NCT00145509|3547310|FG001|Overall Study|Adverse Event|3
1983472|NCT00145509|3547309|FG000|Overall Study|Lack of Efficacy|3
1983473|NCT00145509|3547310|FG001|Overall Study|Lack of Efficacy|1
1983474|NCT00145509|3547309|FG000|Overall Study|Lost to Follow-up|5
1983475|NCT00145509|3547310|FG001|Overall Study|Lost to Follow-up|9
1983476|NCT00145509|3547309|FG000|Overall Study|Withdrew Consent|2
1983477|NCT00145509|3547310|FG001|Overall Study|Withdrew Consent|7
1983478|NCT00145509|3547309|FG000|Overall Study|Reason not provided|2
1983479|NCT00145509|3547310|FG001|Overall Study|Reason not provided|1
1983480|NCT00145496|3547318|FG000|Overall Study|Adverse Event|42
1983481|NCT00145496|3547319|FG001|Overall Study|Adverse Event|30
1983482|NCT00145496|3547318|FG000|Overall Study|Lack of Efficacy|12
1983483|NCT00145496|3547319|FG001|Overall Study|Lack of Efficacy|7
1983484|NCT00145496|3547318|FG000|Overall Study|Withdrawal by Subject|32
1983485|NCT00145496|3547319|FG001|Overall Study|Withdrawal by Subject|26
1983486|NCT00145496|3547318|FG000|Overall Study|Lost to Follow-up|12
1983487|NCT00145496|3547319|FG001|Overall Study|Lost to Follow-up|5
1983488|NCT00145496|3547318|FG000|Overall Study|Other|25
1983489|NCT00145496|3547319|FG001|Overall Study|Other|13
1983490|NCT00145470|3547327|FG000|Overall Study|Adverse Event|19
1983491|NCT00145470|3547328|FG001|Overall Study|Adverse Event|25
1983492|NCT00145470|3547327|FG000|Overall Study|Lack of Efficacy|27
1983493|NCT00145470|3547328|FG001|Overall Study|Lack of Efficacy|13
1983494|NCT00145470|3547327|FG000|Overall Study|Withdrawal by Subject|36
1983495|NCT00145470|3547328|FG001|Overall Study|Withdrawal by Subject|34
1983496|NCT00145470|3547327|FG000|Overall Study|Lost to Follow-up|21
1983497|NCT00145470|3547328|FG001|Overall Study|Lost to Follow-up|17
1983498|NCT00145470|3547327|FG000|Overall Study|Reason Not Reported|9
1983499|NCT00145470|3547328|FG001|Overall Study|Reason Not Reported|9
1983500|NCT00129402|3547336|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1983501|NCT00129402|3547337|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1983502|NCT00129402|3547338|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1983503|NCT00129402|3547339|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1983504|NCT00129402|3547340|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1983505|NCT00129402|3547341|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1983506|NCT00129402|3547342|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1983507|NCT00129402|3547336|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1983508|NCT00129402|3547337|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1983509|NCT00129402|3547338|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1983510|NCT00129402|3547339|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1983511|NCT00129402|3547340|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1983512|NCT00129402|3547341|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
1983513|NCT00129402|3547342|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1983514|NCT00129402|3547336|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1983515|NCT00129402|3547337|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1983516|NCT00129402|3547338|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1983517|NCT00129402|3547339|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
1983518|NCT00129402|3547340|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
2310708|NCT02738840|4015232|FG000|Overall Study|Subject Participation Terminated by Investigator|1
2310709|NCT02738840|4015232|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1
2310710|NCT02738879|4015242|FG000|Overall Study|Adverse Event|1
1983519|NCT00129402|3547341|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1983520|NCT00129402|3547342|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1983521|NCT00129402|3547336|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1983522|NCT00129402|3547337|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1983523|NCT00129402|3547338|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
1983524|NCT00129402|3547339|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1983525|NCT00129402|3547340|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
1983526|NCT00129402|3547341|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1983527|NCT00129402|3547342|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1983528|NCT00129402|3547336|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1983529|NCT00129402|3547337|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1983530|NCT00129402|3547338|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
1983531|NCT00129402|3547339|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1983532|NCT00129402|3547340|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1983533|NCT00129402|3547341|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1983534|NCT00129402|3547342|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1983535|NCT00129402|3547336|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1983536|NCT00129402|3547337|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1983537|NCT00129402|3547338|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
1983538|NCT00129402|3547339|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1983539|NCT00129402|3547340|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1983540|NCT00129402|3547341|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
1983541|NCT00129402|3547342|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1983542|NCT00129402|3547336|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1983543|NCT00129402|3547337|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1983544|NCT00129402|3547338|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
1983545|NCT00129402|3547339|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1983546|NCT00129402|3547340|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1983547|NCT00129402|3547341|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1983548|NCT00129402|3547342|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1983549|NCT00129402|3547336|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1983550|NCT00129402|3547337|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1983551|NCT00129402|3547338|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
1983552|NCT00129402|3547339|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1983553|NCT00129402|3547340|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1983554|NCT00129402|3547341|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
1983555|NCT00129402|3547342|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1983556|NCT00129402|3547336|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1983557|NCT00129402|3547337|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1983558|NCT00129402|3547338|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
1983559|NCT00129402|3547339|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1983560|NCT00129402|3547340|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1983561|NCT00129402|3547341|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
1983562|NCT00129402|3547342|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1983563|NCT00129402|3547336|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1983564|NCT00129402|3547337|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1983565|NCT00129402|3547338|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1983566|NCT00129402|3547339|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1983567|NCT00129402|3547340|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1983568|NCT00129402|3547341|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1983569|NCT00129402|3547342|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
1983570|NCT00129402|3547336|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1983571|NCT00129402|3547337|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1983572|NCT00129402|3547338|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1983573|NCT00129402|3547339|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1983574|NCT00129402|3547340|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1983575|NCT00129402|3547341|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1983576|NCT00129402|3547342|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
1983577|NCT00129402|3547336|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1983578|NCT00129402|3547337|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1983579|NCT00129402|3547338|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1983580|NCT00129402|3547339|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1983581|NCT00129402|3547340|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1983582|NCT00129402|3547341|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1983583|NCT00129402|3547342|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1
1983584|NCT00129402|3547336|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1983585|NCT00129402|3547337|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1983586|NCT00129402|3547338|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1983587|NCT00129402|3547339|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1983588|NCT00129402|3547340|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1983589|NCT00129402|3547341|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1983590|NCT00129402|3547342|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
1983591|NCT00101439|3547352|FG000|Period 2|Withdrawal by Subject|0
1983592|NCT00101439|3547353|FG001|Period 2|Withdrawal by Subject|2
1983593|NCT00096200|3547362|FG000|Overall Study|Adverse Event|0
1983594|NCT00096200|3547363|FG001|Overall Study|Adverse Event|4
2213253|NCT01677507|3854708|FG000|Second Assigment|Withdrawal by Subject|2
2213254|NCT01677507|3854709|FG001|Second Assigment|Withdrawal by Subject|2
2213255|NCT01677507|3854708|FG000|Second Assigment|Adverse Event|1
2213256|NCT01677507|3854709|FG001|Second Assigment|Adverse Event|3
1983595|NCT00096200|3547364|FG002|Overall Study|Adverse Event|0
1983596|NCT00096200|3547362|FG000|Overall Study|Withdrawal by Subject|1
1983597|NCT00096200|3547363|FG001|Overall Study|Withdrawal by Subject|2
1983598|NCT00096200|3547364|FG002|Overall Study|Withdrawal by Subject|0
1983599|NCT00096200|3547362|FG000|Overall Study|Ineligible pathology|0
1983600|NCT00096200|3547363|FG001|Overall Study|Ineligible pathology|1
2213257|NCT01677624|3854717|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1
2213258|NCT01677741|3854729|FG000|Overall Study|Death|0
2213259|NCT01677741|3854730|FG001|Overall Study|Death|0
2213260|NCT01677741|3854731|FG002|Overall Study|Death|0
2213261|NCT01677741|3854732|FG003|Overall Study|Death|1
2213262|NCT01677741|3854733|FG004|Overall Study|Death|0
2213263|NCT01677741|3854734|FG005|Overall Study|Death|1
2213264|NCT01677741|3854735|FG006|Overall Study|Death|0
2213265|NCT01677741|3854736|FG007|Overall Study|Death|0
2213266|NCT01677741|3854729|FG000|Overall Study|Withdrawal by Subject|2
2213267|NCT01677741|3854730|FG001|Overall Study|Withdrawal by Subject|7
2213268|NCT01677741|3854731|FG002|Overall Study|Withdrawal by Subject|5
2213269|NCT01677741|3854732|FG003|Overall Study|Withdrawal by Subject|4
2213270|NCT01677741|3854733|FG004|Overall Study|Withdrawal by Subject|11
2213271|NCT01677741|3854734|FG005|Overall Study|Withdrawal by Subject|20
1983601|NCT00096200|3547364|FG002|Overall Study|Ineligible pathology|0
2023918|NCT00329602|3592203|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
2023919|NCT00329602|3592204|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
2023920|NCT00329602|3592202|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0
2023921|NCT00329602|3592203|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0
2023922|NCT00329602|3592204|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2
2023923|NCT00329602|3592202|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
2023924|NCT00329602|3592203|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
2023925|NCT00329602|3592204|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
2023926|NCT00329602|3592202|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0
2023927|NCT00329602|3592203|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0
2023928|NCT00329602|3592204|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4
2023929|NCT00329641|3592220|FG000|Overall Study|Did not start treatment|1
2023930|NCT00329641|3592220|FG000|Overall Study|Not eligible|1
2023931|NCT00329641|3592220|FG000|Overall Study|Adverse Event|3
2023932|NCT00329641|3592220|FG000|Overall Study|Other reason, not protocol specified|1
2023933|NCT00329719|3592229|FG000|Overall Study|Lost to Follow-up|0
2023934|NCT00329719|3592230|FG001|Overall Study|Lost to Follow-up|0
2023935|NCT00329719|3592231|FG002|Overall Study|Lost to Follow-up|0
2023936|NCT00329719|3592232|FG003|Overall Study|Lost to Follow-up|1
2023937|NCT00329745|3592244|FG000|Overall Study|Protocol Violation|1
2023938|NCT00329745|3592245|FG001|Overall Study|Protocol Violation|0
2023939|NCT00329745|3592244|FG000|Overall Study|Withdrawal by Subject|0
2023940|NCT00329745|3592245|FG001|Overall Study|Withdrawal by Subject|1
2023941|NCT00329745|3592244|FG000|Overall Study|Lost to Follow-up|86
2023942|NCT00329745|3592245|FG001|Overall Study|Lost to Follow-up|101
2023943|NCT00329784|3592259|FG000|Overall Study|Lost to Follow-up|0
2023944|NCT00329784|3592260|FG001|Overall Study|Lost to Follow-up|1
2023945|NCT00329784|3592261|FG002|Overall Study|Lost to Follow-up|0
2023946|NCT00329784|3592262|FG003|Overall Study|Lost to Follow-up|0
2023947|NCT00329784|3592259|FG000|Overall Study|Withdrawal by Subject|4
2023948|NCT00329784|3592260|FG001|Overall Study|Withdrawal by Subject|2
2023949|NCT00329784|3592261|FG002|Overall Study|Withdrawal by Subject|0
2023950|NCT00329784|3592262|FG003|Overall Study|Withdrawal by Subject|0
2023951|NCT00329784|3592259|FG000|Overall Study|Other|1
2023952|NCT00329784|3592260|FG001|Overall Study|Other|2
2023953|NCT00329784|3592261|FG002|Overall Study|Other|0
2023954|NCT00329784|3592262|FG003|Overall Study|Other|0
2023955|NCT00329797|3592276|FG000|Overall Study|Protocol Violation|1
2023956|NCT00329797|3592277|FG001|Overall Study|Protocol Violation|0
2023957|NCT00329797|3592276|FG000|Overall Study|Withdrawal by Subject|6
2023958|NCT00329797|3592277|FG001|Overall Study|Withdrawal by Subject|6
1983602|NCT04723173|3547402|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1
1983603|NCT04537078|3547416|FG000|Overall Study|Protocol Violation|3
1983604|NCT04537078|3547417|FG001|Overall Study|Protocol Violation|2
1983605|NCT04537078|3547416|FG000|Overall Study|Lost to Follow-up|1
1983606|NCT04537078|3547417|FG001|Overall Study|Lost to Follow-up|0
1983607|NCT04537078|3547416|FG000|Overall Study|Withdrawal by Subject|0
1983608|NCT04537078|3547417|FG001|Overall Study|Withdrawal by Subject|1
1983609|NCT04425252|3547432|FG000|Overall Study|Withdrawal by Subject|2
1983610|NCT04425252|3547433|FG001|Overall Study|Withdrawal by Subject|1
1983611|NCT04425252|3547432|FG000|Overall Study|Lost to Follow-up|1
1983612|NCT04425252|3547433|FG001|Overall Study|Lost to Follow-up|0
1983613|NCT04425252|3547432|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1
1983614|NCT04425252|3547433|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1
1983615|NCT03875313|3547462|FG000|Overall Study|Withdrawal by Subject|1
1983616|NCT03875313|3547463|FG001|Overall Study|Withdrawal by Subject|3
1983617|NCT03875313|3547464|FG002|Overall Study|Withdrawal by Subject|0
1983618|NCT03875313|3547465|FG003|Overall Study|Withdrawal by Subject|0
1983619|NCT03875313|3547466|FG004|Overall Study|Withdrawal by Subject|0
1983620|NCT03875313|3547462|FG000|Overall Study|Death|0
1983621|NCT03875313|3547463|FG001|Overall Study|Death|0
1983622|NCT03875313|3547464|FG002|Overall Study|Death|0
1983623|NCT03875313|3547465|FG003|Overall Study|Death|0
1983624|NCT03875313|3547466|FG004|Overall Study|Death|1
1983625|NCT03875313|3547462|FG000|Overall Study|Lost to Follow-up|0
1983626|NCT03875313|3547463|FG001|Overall Study|Lost to Follow-up|0
1983627|NCT03875313|3547464|FG002|Overall Study|Lost to Follow-up|0
1983628|NCT03875313|3547465|FG003|Overall Study|Lost to Follow-up|0
1983629|NCT03875313|3547466|FG004|Overall Study|Lost to Follow-up|1
1983630|NCT03875313|3547462|FG000|Overall Study|Study Termination by Sponsor|0
1983631|NCT03875313|3547463|FG001|Overall Study|Study Termination by Sponsor|1
1983632|NCT03875313|3547464|FG002|Overall Study|Study Termination by Sponsor|1
1983633|NCT03875313|3547465|FG003|Overall Study|Study Termination by Sponsor|0
1983634|NCT03875313|3547466|FG004|Overall Study|Study Termination by Sponsor|1
1983635|NCT03875313|3547462|FG000|Overall Study|New Anticancer Treatment|0
1983636|NCT03875313|3547463|FG001|Overall Study|New Anticancer Treatment|1
1983637|NCT03875313|3547464|FG002|Overall Study|New Anticancer Treatment|2
1983638|NCT03875313|3547465|FG003|Overall Study|New Anticancer Treatment|1
1983639|NCT03875313|3547466|FG004|Overall Study|New Anticancer Treatment|0
1983640|NCT03875313|3547462|FG000|Overall Study|Other, Not Specified|2
1983641|NCT03875313|3547463|FG001|Overall Study|Other, Not Specified|11
1983642|NCT03875313|3547464|FG002|Overall Study|Other, Not Specified|3
1983643|NCT03875313|3547465|FG003|Overall Study|Other, Not Specified|3
1983644|NCT03875313|3547466|FG004|Overall Study|Other, Not Specified|1
1983645|NCT03694353|3547478|FG000|Overall Study|Withdrawal by Subject|1
1983646|NCT03694353|3547478|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1
1983647|NCT03692052|3547482|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1
1983648|NCT03692052|3547482|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1
1983649|NCT03692052|3547482|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1
1983650|NCT03692052|3547482|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17
1983651|NCT03583554|3547486|FG000|Period 2|Did not receive treatment due to loss of contact|1
1983652|NCT03583554|3547487|FG001|Period 2|Did not receive treatment due to loss of contact|0
1983653|NCT03583554|3547488|FG002|Period 2|Did not receive treatment due to loss of contact|1
1983654|NCT03408873|3547505|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3
1983655|NCT03408873|3547505|FG000|Visit 2 Assessment|Lost to Follow-up|1
1983656|NCT03408873|3547505|FG000|Visit 3 Assessment|Withdrawal by Subject|1
1983657|NCT03408873|3547505|FG000|Visit 4 Assessment|Lost to Follow-up|2
1983658|NCT03408873|3547505|FG000|Visit 5 Assessment|Lost to Follow-up|1
1983659|NCT03408873|3547505|FG000|Visit 6 Assessment|Withdrawal by Subject|1
1983660|NCT03132467|3547509|FG000|Overall Study|Adverse Event|2
1983661|NCT03132467|3547509|FG000|Overall Study|Withdrawal by Subject|2
1983662|NCT03096288|3547518|FG000|Overall Study|Withdrawal by Subject|0
1983663|NCT03096288|3547519|FG001|Overall Study|Withdrawal by Subject|1
1983664|NCT03096288|3547520|FG002|Overall Study|Withdrawal by Subject|0
1983665|NCT03096288|3547521|FG003|Overall Study|Withdrawal by Subject|1
1983666|NCT02919436|3547533|FG000|Overall Study|Did not undergo surgery|16
1983667|NCT02919436|3547534|FG001|Overall Study|Did not undergo surgery|20
1983668|NCT02919436|3547533|FG000|Overall Study|Enrolled before trial registration|44
1983669|NCT02919436|3547534|FG001|Overall Study|Enrolled before trial registration|33
1983670|NCT02877134|3547549|FG000|Overall Study|Death|0
2213272|NCT01677741|3854735|FG006|Overall Study|Withdrawal by Subject|4
1983671|NCT02877134|3547550|FG001|Overall Study|Death|1
1983672|NCT02877134|3547551|FG002|Overall Study|Death|0
1983673|NCT02877134|3547552|FG003|Overall Study|Death|0
1983674|NCT02877134|3547553|FG004|Overall Study|Death|0
1983675|NCT02877134|3547554|FG005|Overall Study|Death|1
1983676|NCT02877134|3547555|FG006|Overall Study|Death|0
1983677|NCT02877134|3547549|FG000|Overall Study|Lost to Follow-up|0
1983678|NCT02877134|3547550|FG001|Overall Study|Lost to Follow-up|4
1983679|NCT02877134|3547551|FG002|Overall Study|Lost to Follow-up|0
1983680|NCT02877134|3547552|FG003|Overall Study|Lost to Follow-up|1
1983681|NCT02877134|3547553|FG004|Overall Study|Lost to Follow-up|0
2310711|NCT02738879|4015243|FG001|Overall Study|Adverse Event|1
2310712|NCT02738879|4015242|FG000|Overall Study|Death|0
2310713|NCT02738879|4015243|FG001|Overall Study|Death|2
1983682|NCT02877134|3547554|FG005|Overall Study|Lost to Follow-up|0
1983683|NCT02877134|3547555|FG006|Overall Study|Lost to Follow-up|0
1983684|NCT02877134|3547549|FG000|Overall Study|Withdrawal by Subject|13
1983685|NCT02877134|3547550|FG001|Overall Study|Withdrawal by Subject|19
1983686|NCT02877134|3547551|FG002|Overall Study|Withdrawal by Subject|4
1983687|NCT02877134|3547552|FG003|Overall Study|Withdrawal by Subject|6
1983688|NCT02877134|3547553|FG004|Overall Study|Withdrawal by Subject|3
1983689|NCT02877134|3547554|FG005|Overall Study|Withdrawal by Subject|5
1983690|NCT02877134|3547555|FG006|Overall Study|Withdrawal by Subject|0
1983691|NCT02877134|3547549|FG000|Overall Study|Other|1
1983692|NCT02877134|3547550|FG001|Overall Study|Other|1
1983693|NCT02877134|3547551|FG002|Overall Study|Other|2
1983694|NCT02877134|3547552|FG003|Overall Study|Other|6
1983695|NCT02877134|3547553|FG004|Overall Study|Other|3
1983696|NCT02877134|3547554|FG005|Overall Study|Other|1
1983697|NCT02877134|3547555|FG006|Overall Study|Other|1
1983698|NCT02446600|3547577|FG000|Overall Study|Never treated|20
1983699|NCT02446600|3547578|FG001|Overall Study|Never treated|2
1983700|NCT02446600|3547579|FG002|Overall Study|Never treated|6
1983701|NCT02446600|3547580|FG003|Overall Study|Never treated|0
1983702|NCT02446600|3547577|FG000|Overall Study|Withdrawal by Subject|19
1983703|NCT02446600|3547578|FG001|Overall Study|Withdrawal by Subject|5
1983704|NCT02446600|3547579|FG002|Overall Study|Withdrawal by Subject|17
1983705|NCT02446600|3547580|FG003|Overall Study|Withdrawal by Subject|0
1983706|NCT02446600|3547577|FG000|Overall Study|Ineligible|1
1983707|NCT02446600|3547578|FG001|Overall Study|Ineligible|4
1983708|NCT02446600|3547579|FG002|Overall Study|Ineligible|4
1983709|NCT02446600|3547580|FG003|Overall Study|Ineligible|1
1983710|NCT02446600|3547577|FG000|Overall Study|Duplicate Enrollment|0
1983711|NCT02446600|3547578|FG001|Overall Study|Duplicate Enrollment|1
1983712|NCT02446600|3547579|FG002|Overall Study|Duplicate Enrollment|0
1983713|NCT02446600|3547580|FG003|Overall Study|Duplicate Enrollment|0
1983714|NCT02315703|3547598|FG000|Overall Study|Adverse Event|0
1983715|NCT02315703|3547599|FG001|Overall Study|Adverse Event|0
1983716|NCT02315703|3547600|FG002|Overall Study|Adverse Event|0
1983717|NCT02315703|3547601|FG003|Overall Study|Adverse Event|1
1983718|NCT02315703|3547602|FG004|Overall Study|Adverse Event|1
1983719|NCT02315703|3547603|FG005|Overall Study|Adverse Event|0
1983720|NCT02315703|3547604|FG006|Overall Study|Adverse Event|1
1983721|NCT02315703|3547605|FG007|Overall Study|Adverse Event|0
1983722|NCT02315703|3547598|FG000|Overall Study|Lost to Follow-up|1
1983723|NCT02315703|3547599|FG001|Overall Study|Lost to Follow-up|5
1983724|NCT02315703|3547600|FG002|Overall Study|Lost to Follow-up|3
1983725|NCT02315703|3547601|FG003|Overall Study|Lost to Follow-up|3
1983726|NCT02315703|3547602|FG004|Overall Study|Lost to Follow-up|2
1983727|NCT02315703|3547603|FG005|Overall Study|Lost to Follow-up|1
1983728|NCT02315703|3547604|FG006|Overall Study|Lost to Follow-up|2
1983729|NCT02315703|3547605|FG007|Overall Study|Lost to Follow-up|2
1983730|NCT02315703|3547598|FG000|Overall Study|Pregnancy|0
1983731|NCT02315703|3547599|FG001|Overall Study|Pregnancy|0
1983732|NCT02315703|3547600|FG002|Overall Study|Pregnancy|0
1983733|NCT02315703|3547601|FG003|Overall Study|Pregnancy|0
1983734|NCT02315703|3547602|FG004|Overall Study|Pregnancy|0
1983735|NCT02315703|3547603|FG005|Overall Study|Pregnancy|0
1983736|NCT02315703|3547604|FG006|Overall Study|Pregnancy|0
1983737|NCT02315703|3547605|FG007|Overall Study|Pregnancy|1
1983738|NCT02315703|3547598|FG000|Overall Study|Withdrawal by Subject|1
1983739|NCT02315703|3547599|FG001|Overall Study|Withdrawal by Subject|3
1983740|NCT02315703|3547600|FG002|Overall Study|Withdrawal by Subject|0
1983741|NCT02315703|3547601|FG003|Overall Study|Withdrawal by Subject|3
1983742|NCT02315703|3547602|FG004|Overall Study|Withdrawal by Subject|4
1983743|NCT02315703|3547603|FG005|Overall Study|Withdrawal by Subject|1
1983744|NCT02315703|3547604|FG006|Overall Study|Withdrawal by Subject|1
1983745|NCT02315703|3547605|FG007|Overall Study|Withdrawal by Subject|2
1983746|NCT02315703|3547598|FG000|Overall Study|Physician Decision|0
1983747|NCT02315703|3547599|FG001|Overall Study|Physician Decision|0
1983748|NCT02315703|3547600|FG002|Overall Study|Physician Decision|0
1983749|NCT02315703|3547601|FG003|Overall Study|Physician Decision|0
1983750|NCT02315703|3547602|FG004|Overall Study|Physician Decision|0
1983751|NCT02315703|3547603|FG005|Overall Study|Physician Decision|2
1983752|NCT02315703|3547604|FG006|Overall Study|Physician Decision|1
1983753|NCT02315703|3547605|FG007|Overall Study|Physician Decision|0
1983754|NCT02315703|3547598|FG000|Overall Study|Other|4
1983755|NCT02315703|3547599|FG001|Overall Study|Other|2
1983756|NCT02315703|3547600|FG002|Overall Study|Other|2
1983757|NCT02315703|3547601|FG003|Overall Study|Other|2
1983758|NCT02315703|3547602|FG004|Overall Study|Other|1
1983759|NCT02315703|3547603|FG005|Overall Study|Other|2
1983760|NCT02315703|3547604|FG006|Overall Study|Other|8
1983761|NCT02315703|3547605|FG007|Overall Study|Other|2
1983762|NCT02091960|3547627|FG000|Overall Study|Death|7
1983763|NCT02091960|3547627|FG000|Overall Study|Withdrawal by Subject|1
1983764|NCT02091960|3547627|FG000|Overall Study|Miscellaneous Reasons|31
2310714|NCT02738879|4015242|FG000|Overall Study|Lost to Follow-up|1
1983765|NCT02091960|3547627|FG000|Overall Study|On Study at Data Cut-off|12
2310715|NCT02738879|4015243|FG001|Overall Study|Lost to Follow-up|5
1983766|NCT02028884|3547633|FG000|Double-blind Period|Adverse Event|5
1983767|NCT02028884|3547634|FG001|Double-blind Period|Adverse Event|3
1983768|NCT02028884|3547633|FG000|Double-blind Period|Eligibility Violation|1
1983769|NCT02028884|3547634|FG001|Double-blind Period|Eligibility Violation|0
1983770|NCT02028884|3547633|FG000|Double-blind Period|Non-Compliance With Study Drug|2
1983771|NCT02028884|3547634|FG001|Double-blind Period|Non-Compliance With Study Drug|0
1983772|NCT02028884|3547633|FG000|Double-blind Period|Withdrawal by Subject|2
1983773|NCT02028884|3547634|FG001|Double-blind Period|Withdrawal by Subject|0
1983774|NCT02028884|3547633|FG000|Double-blind Period|On-going in Study|8
1983775|NCT02028884|3547634|FG001|Double-blind Period|On-going in Study|20
1983776|NCT02028884|3547633|FG000|Open-label Extension Period|Adverse Event|2
1983777|NCT02028884|3547634|FG001|Open-label Extension Period|Adverse Event|1
1983778|NCT02028884|3547633|FG000|Open-label Extension Period|Lack of Efficacy|3
1983779|NCT02028884|3547634|FG001|Open-label Extension Period|Lack of Efficacy|0
1983780|NCT02028884|3547633|FG000|Open-label Extension Period|Non-Compliance With Study Drug|0
1983781|NCT02028884|3547634|FG001|Open-label Extension Period|Non-Compliance With Study Drug|1
1983782|NCT02028884|3547633|FG000|Open-label Extension Period|Withdrawal by Subject|0
1983783|NCT02028884|3547634|FG001|Open-label Extension Period|Withdrawal by Subject|2
1983784|NCT02028884|3547633|FG000|Open-label Extension Period|On-going in Study|19
1983785|NCT02028884|3547634|FG001|Open-label Extension Period|On-going in Study|14
1983786|NCT01983774|3547645|FG000|Overall Study|Lung Transplant|0
1983787|NCT01983774|3547646|FG001|Overall Study|Lung Transplant|1
1983788|NCT01983774|3547645|FG000|Overall Study|Lost to Follow-up|1
1983789|NCT01983774|3547646|FG001|Overall Study|Lost to Follow-up|0
1983790|NCT01974206|3547656|FG000|Overall Study|Did Not Take Study Drug|0
1983791|NCT01974206|3547657|FG001|Overall Study|Did Not Take Study Drug|1
1983792|NCT01974206|3547656|FG000|Overall Study|Physician Decision|1
1983793|NCT01974206|3547657|FG001|Overall Study|Physician Decision|0
1983794|NCT01974206|3547656|FG000|Overall Study|Withdrawal by Subject|3
1983795|NCT01974206|3547657|FG001|Overall Study|Withdrawal by Subject|0
1983796|NCT01974206|3547656|FG000|Overall Study|Lost to Follow-up|1
1983797|NCT01974206|3547657|FG001|Overall Study|Lost to Follow-up|0
1983798|NCT01974206|3547656|FG000|Overall Study|Death|1
1983799|NCT01974206|3547657|FG001|Overall Study|Death|0
1983800|NCT01970865|3547680|FG000|Overall Study|Death|3
1983801|NCT01970865|3547681|FG001|Overall Study|Death|1
1983802|NCT01970865|3547682|FG002|Overall Study|Death|3
1983803|NCT01970865|3547683|FG003|Overall Study|Death|4
1983804|NCT01970865|3547684|FG004|Overall Study|Death|6
1983805|NCT01970865|3547685|FG005|Overall Study|Death|3
1983806|NCT01970865|3547686|FG006|Overall Study|Death|1
1983807|NCT01970865|3547687|FG007|Overall Study|Death|3
1983808|NCT01970865|3547688|FG008|Overall Study|Death|2
1983809|NCT01970865|3547689|FG009|Overall Study|Death|1
1983810|NCT01970865|3547690|FG010|Overall Study|Death|1
1983811|NCT01970865|3547691|FG011|Overall Study|Death|4
1983812|NCT01970865|3547692|FG012|Overall Study|Death|14
1983813|NCT01970865|3547693|FG013|Overall Study|Death|19
1983814|NCT01970865|3547694|FG014|Overall Study|Death|15
1983815|NCT01970865|3547695|FG015|Overall Study|Death|10
1983816|NCT01970865|3547696|FG016|Overall Study|Death|1
1983817|NCT01970865|3547680|FG000|Overall Study|Lost to Follow-up|0
1983818|NCT01970865|3547681|FG001|Overall Study|Lost to Follow-up|0
1983819|NCT01970865|3547682|FG002|Overall Study|Lost to Follow-up|0
1983820|NCT01970865|3547683|FG003|Overall Study|Lost to Follow-up|1
1983821|NCT01970865|3547684|FG004|Overall Study|Lost to Follow-up|1
1983822|NCT01970865|3547685|FG005|Overall Study|Lost to Follow-up|0
1983823|NCT01970865|3547686|FG006|Overall Study|Lost to Follow-up|0
1983824|NCT01970865|3547687|FG007|Overall Study|Lost to Follow-up|0
1983825|NCT01970865|3547688|FG008|Overall Study|Lost to Follow-up|0
1983826|NCT01970865|3547689|FG009|Overall Study|Lost to Follow-up|0
1983827|NCT01970865|3547690|FG010|Overall Study|Lost to Follow-up|0
1983828|NCT01970865|3547691|FG011|Overall Study|Lost to Follow-up|0
1983829|NCT01970865|3547692|FG012|Overall Study|Lost to Follow-up|1
1983830|NCT01970865|3547693|FG013|Overall Study|Lost to Follow-up|0
1983831|NCT01970865|3547694|FG014|Overall Study|Lost to Follow-up|0
1983832|NCT01970865|3547695|FG015|Overall Study|Lost to Follow-up|0
1983833|NCT01970865|3547696|FG016|Overall Study|Lost to Follow-up|0
1983834|NCT01970865|3547680|FG000|Overall Study|Withdrawal by Subject|0
1983835|NCT01970865|3547681|FG001|Overall Study|Withdrawal by Subject|0
1983836|NCT01970865|3547682|FG002|Overall Study|Withdrawal by Subject|0
1983837|NCT01970865|3547683|FG003|Overall Study|Withdrawal by Subject|1
1983838|NCT01970865|3547684|FG004|Overall Study|Withdrawal by Subject|2
1983839|NCT01970865|3547685|FG005|Overall Study|Withdrawal by Subject|0
1983840|NCT01970865|3547686|FG006|Overall Study|Withdrawal by Subject|0
1983841|NCT01970865|3547687|FG007|Overall Study|Withdrawal by Subject|0
1983842|NCT01970865|3547688|FG008|Overall Study|Withdrawal by Subject|0
1983843|NCT01970865|3547689|FG009|Overall Study|Withdrawal by Subject|0
1983844|NCT01970865|3547690|FG010|Overall Study|Withdrawal by Subject|0
1983845|NCT01970865|3547691|FG011|Overall Study|Withdrawal by Subject|1
1983846|NCT01970865|3547692|FG012|Overall Study|Withdrawal by Subject|2
1983847|NCT01970865|3547693|FG013|Overall Study|Withdrawal by Subject|5
1983848|NCT01970865|3547694|FG014|Overall Study|Withdrawal by Subject|2
1983849|NCT01970865|3547695|FG015|Overall Study|Withdrawal by Subject|7
1983850|NCT01970865|3547696|FG016|Overall Study|Withdrawal by Subject|0
1983851|NCT01970865|3547680|FG000|Overall Study|Other|0
1983852|NCT01970865|3547681|FG001|Overall Study|Other|0
1983853|NCT01970865|3547682|FG002|Overall Study|Other|0
1983854|NCT01970865|3547683|FG003|Overall Study|Other|1
1983855|NCT01970865|3547684|FG004|Overall Study|Other|0
1983856|NCT01970865|3547685|FG005|Overall Study|Other|0
1983857|NCT01970865|3547686|FG006|Overall Study|Other|0
1983858|NCT01970865|3547687|FG007|Overall Study|Other|0
1983859|NCT01970865|3547688|FG008|Overall Study|Other|0
1983860|NCT01970865|3547689|FG009|Overall Study|Other|0
1983861|NCT01970865|3547690|FG010|Overall Study|Other|0
1983862|NCT01970865|3547691|FG011|Overall Study|Other|0
1983863|NCT01970865|3547692|FG012|Overall Study|Other|0
1983864|NCT01970865|3547693|FG013|Overall Study|Other|1
1983865|NCT01970865|3547694|FG014|Overall Study|Other|0
1983866|NCT01970865|3547695|FG015|Overall Study|Other|1
1983867|NCT01970865|3547696|FG016|Overall Study|Other|0
1983868|NCT01970865|3547680|FG000|Overall Study|Study ongoing|0
1983869|NCT01970865|3547681|FG001|Overall Study|Study ongoing|2
1983870|NCT01970865|3547682|FG002|Overall Study|Study ongoing|0
1983871|NCT01970865|3547683|FG003|Overall Study|Study ongoing|6
1983872|NCT01970865|3547684|FG004|Overall Study|Study ongoing|8
1983873|NCT01970865|3547685|FG005|Overall Study|Study ongoing|0
1983874|NCT01970865|3547686|FG006|Overall Study|Study ongoing|2
1983875|NCT01970865|3547687|FG007|Overall Study|Study ongoing|0
1983876|NCT01970865|3547688|FG008|Overall Study|Study ongoing|1
1983877|NCT01970865|3547689|FG009|Overall Study|Study ongoing|3
1983878|NCT01970865|3547690|FG010|Overall Study|Study ongoing|29
1983879|NCT01970865|3547691|FG011|Overall Study|Study ongoing|22
1983880|NCT01970865|3547692|FG012|Overall Study|Study ongoing|43
1983881|NCT01970865|3547693|FG013|Overall Study|Study ongoing|41
1983882|NCT01970865|3547694|FG014|Overall Study|Study ongoing|29
1983883|NCT01970865|3547695|FG015|Overall Study|Study ongoing|29
1983884|NCT01970865|3547696|FG016|Overall Study|Study ongoing|2
1983885|NCT01896531|3547759|FG000|Overall Study|Death|57
1983886|NCT01896531|3547760|FG001|Overall Study|Death|59
1983887|NCT01896531|3547759|FG000|Overall Study|Lost to Follow-up|3
1983888|NCT01896531|3547760|FG001|Overall Study|Lost to Follow-up|0
1983889|NCT01896531|3547759|FG000|Overall Study|Non-compliance|0
1983890|NCT01896531|3547760|FG001|Overall Study|Non-compliance|1
1983891|NCT01896531|3547759|FG000|Overall Study|Study Ended by Sponsor|7
1983892|NCT01896531|3547760|FG001|Overall Study|Study Ended by Sponsor|20
1983893|NCT01896531|3547759|FG000|Overall Study|Withdrawal by Subject|3
1983894|NCT01896531|3547760|FG001|Overall Study|Withdrawal by Subject|2
1983895|NCT01896531|3547759|FG000|Overall Study|Death Prior to Treatment|1
1983896|NCT01896531|3547760|FG001|Overall Study|Death Prior to Treatment|0
1983897|NCT01856192|3547768|FG000|Overall Study|Adverse Event|12
1983898|NCT01856192|3547769|FG001|Overall Study|Adverse Event|4
1983899|NCT01856192|3547768|FG000|Overall Study|Alternative therapy|0
1983900|NCT01856192|3547769|FG001|Overall Study|Alternative therapy|3
1983901|NCT01856192|3547768|FG000|Overall Study|Death|3
1983902|NCT01856192|3547769|FG001|Overall Study|Death|5
1983903|NCT01856192|3547768|FG000|Overall Study|Lack of Efficacy|0
1983904|NCT01856192|3547769|FG001|Overall Study|Lack of Efficacy|5
1983905|NCT01856192|3547768|FG000|Overall Study|Withdrawal by Subject|1
1983906|NCT01856192|3547769|FG001|Overall Study|Withdrawal by Subject|1
1983907|NCT01856192|3547768|FG000|Overall Study|Other diseases|1
1983908|NCT01856192|3547769|FG001|Overall Study|Other diseases|0
1983909|NCT01856192|3547768|FG000|Overall Study|Never started treatment|7
1983910|NCT01856192|3547769|FG001|Overall Study|Never started treatment|5
1983911|NCT01856192|3547768|FG000|Overall Study|Path ineligible|20
1983912|NCT01856192|3547769|FG001|Overall Study|Path ineligible|34
1983913|NCT01856192|3547768|FG000|Overall Study|Non-path ineligible|2
1983914|NCT01856192|3547769|FG001|Overall Study|Non-path ineligible|2
1983915|NCT01856192|3547768|FG000|Overall Study|Physician Decision|1
1983916|NCT01856192|3547769|FG001|Overall Study|Physician Decision|1
1983917|NCT01856192|3547768|FG000|Overall Study|Suspicion of progressive disease|1
1983918|NCT01856192|3547769|FG001|Overall Study|Suspicion of progressive disease|0
1983919|NCT01856192|3547768|FG000|Overall Study|Non-compliance|1
1983920|NCT01856192|3547769|FG001|Overall Study|Non-compliance|0
1983921|NCT01622868|3547777|FG000|Overall Study|Protocol Violation|7
1983922|NCT01622868|3547778|FG001|Overall Study|Protocol Violation|0
1983923|NCT01592370|3547791|FG000|Overall Study|Disease Progression|62
1983924|NCT01592370|3547792|FG001|Overall Study|Disease Progression|16
1983925|NCT01592370|3547793|FG002|Overall Study|Disease Progression|52
1983926|NCT01592370|3547794|FG003|Overall Study|Disease Progression|3
1983927|NCT01592370|3547795|FG004|Overall Study|Disease Progression|3
1983928|NCT01592370|3547796|FG005|Overall Study|Disease Progression|31
1983929|NCT01592370|3547797|FG006|Overall Study|Disease Progression|14
1983930|NCT01592370|3547791|FG000|Overall Study|Study Drug Toxicity|14
1983931|NCT01592370|3547792|FG001|Overall Study|Study Drug Toxicity|3
1983932|NCT01592370|3547793|FG002|Overall Study|Study Drug Toxicity|0
1983933|NCT01592370|3547794|FG003|Overall Study|Study Drug Toxicity|0
1983934|NCT01592370|3547795|FG004|Overall Study|Study Drug Toxicity|0
1983935|NCT01592370|3547796|FG005|Overall Study|Study Drug Toxicity|0
1983936|NCT01592370|3547797|FG006|Overall Study|Study Drug Toxicity|1
1983937|NCT01592370|3547791|FG000|Overall Study|AE unrelated to study drug|4
1983938|NCT01592370|3547792|FG001|Overall Study|AE unrelated to study drug|3
1983939|NCT01592370|3547793|FG002|Overall Study|AE unrelated to study drug|0
1983940|NCT01592370|3547794|FG003|Overall Study|AE unrelated to study drug|0
1983941|NCT01592370|3547795|FG004|Overall Study|AE unrelated to study drug|0
1983942|NCT01592370|3547796|FG005|Overall Study|AE unrelated to study drug|0
1983943|NCT01592370|3547797|FG006|Overall Study|AE unrelated to study drug|1
1983944|NCT01592370|3547791|FG000|Overall Study|Request to discontinue study treatment|5
1983945|NCT01592370|3547792|FG001|Overall Study|Request to discontinue study treatment|0
1983946|NCT01592370|3547793|FG002|Overall Study|Request to discontinue study treatment|2
1983947|NCT01592370|3547794|FG003|Overall Study|Request to discontinue study treatment|0
1983948|NCT01592370|3547795|FG004|Overall Study|Request to discontinue study treatment|1
1983949|NCT01592370|3547796|FG005|Overall Study|Request to discontinue study treatment|2
1983950|NCT01592370|3547797|FG006|Overall Study|Request to discontinue study treatment|0
1983951|NCT01592370|3547791|FG000|Overall Study|Withdrew consent|1
1983952|NCT01592370|3547792|FG001|Overall Study|Withdrew consent|2
1983953|NCT01592370|3547793|FG002|Overall Study|Withdrew consent|1
1983954|NCT01592370|3547794|FG003|Overall Study|Withdrew consent|1
1983955|NCT01592370|3547795|FG004|Overall Study|Withdrew consent|0
1983956|NCT01592370|3547796|FG005|Overall Study|Withdrew consent|0
1983957|NCT01592370|3547797|FG006|Overall Study|Withdrew consent|0
1983958|NCT01592370|3547791|FG000|Overall Study|Maximum clinical benefit|11
1983959|NCT01592370|3547792|FG001|Overall Study|Maximum clinical benefit|1
1983960|NCT01592370|3547793|FG002|Overall Study|Maximum clinical benefit|7
1983961|NCT01592370|3547794|FG003|Overall Study|Maximum clinical benefit|1
1983962|NCT01592370|3547795|FG004|Overall Study|Maximum clinical benefit|0
1983963|NCT01592370|3547796|FG005|Overall Study|Maximum clinical benefit|0
1983964|NCT01592370|3547797|FG006|Overall Study|Maximum clinical benefit|0
1983965|NCT01592370|3547791|FG000|Overall Study|No longer meets study criteria|1
1983966|NCT01592370|3547792|FG001|Overall Study|No longer meets study criteria|0
1983967|NCT01592370|3547793|FG002|Overall Study|No longer meets study criteria|0
1983968|NCT01592370|3547794|FG003|Overall Study|No longer meets study criteria|0
1983969|NCT01592370|3547795|FG004|Overall Study|No longer meets study criteria|0
1983970|NCT01592370|3547796|FG005|Overall Study|No longer meets study criteria|0
1983971|NCT01592370|3547797|FG006|Overall Study|No longer meets study criteria|0
1983972|NCT01592370|3547791|FG000|Overall Study|Other Reasons|6
1983973|NCT01592370|3547792|FG001|Overall Study|Other Reasons|0
1983974|NCT01592370|3547793|FG002|Overall Study|Other Reasons|10
1983975|NCT01592370|3547794|FG003|Overall Study|Other Reasons|0
1983976|NCT01592370|3547795|FG004|Overall Study|Other Reasons|0
1983977|NCT01592370|3547796|FG005|Overall Study|Other Reasons|1
1983978|NCT01592370|3547797|FG006|Overall Study|Other Reasons|0
1983979|NCT01015833|3547819|FG000|Overall Study|Death|1
1983980|NCT01015833|3547820|FG001|Overall Study|Death|0
1983981|NCT01015833|3547819|FG000|Overall Study|Withdrawal by Subject|3
1983982|NCT01015833|3547820|FG001|Overall Study|Withdrawal by Subject|2
1983983|NCT01015833|3547819|FG000|Overall Study|Adverse Event|0
1983984|NCT01015833|3547820|FG001|Overall Study|Adverse Event|1
1983985|NCT01015833|3547819|FG000|Overall Study|Physician Decision|2
1983986|NCT01015833|3547820|FG001|Overall Study|Physician Decision|0
1983987|NCT01015833|3547819|FG000|Overall Study|Symptomatic deterioration|0
1983988|NCT01015833|3547820|FG001|Overall Study|Symptomatic deterioration|1
1983989|NCT01015833|3547819|FG000|Overall Study|Other|5
1983990|NCT01015833|3547820|FG001|Overall Study|Other|1
1983991|NCT01015833|3547819|FG000|Overall Study|Motor Vehicle Accidents|1
1983992|NCT01015833|3547820|FG001|Overall Study|Motor Vehicle Accidents|0
1983993|NCT01015833|3547819|FG000|Overall Study|Did not start treatment|1
1983994|NCT01015833|3547820|FG001|Overall Study|Did not start treatment|0
1983995|NCT00980538|3547826|FG000|Overall Study|Lost to Follow-up|20
1983996|NCT00980538|3547826|FG000|Overall Study|Sponsor's Decision|4
1983997|NCT00980538|3547826|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34
1983998|NCT00980538|3547826|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12
1983999|NCT00980538|3547826|FG000|Overall Study|Switch to Commercially Available Medication|25
1984000|NCT00980538|3547826|FG000|Overall Study|Participant Non-Compliant|9
1984001|NCT00980538|3547826|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9
1984002|NCT00980538|3547826|FG000|Overall Study|Participant Ineligible to Continue the Trial|6
1984003|NCT00980538|3547826|FG000|Overall Study|Other|60
1984004|NCT00980538|3547826|FG000|Overall Study|Other|1
1984005|NCT00589420|3547830|FG000|Overall Study|screen failure|1
1984006|NCT00588770|3547836|FG000|Overall Study|Disease progression|85
1984007|NCT00588770|3547837|FG001|Overall Study|Disease progression|68
1984008|NCT00588770|3547836|FG000|Overall Study|Adverse Event|29
1984009|NCT00588770|3547837|FG001|Overall Study|Adverse Event|58
1984010|NCT00588770|3547836|FG000|Overall Study|Death|13
1984011|NCT00588770|3547837|FG001|Overall Study|Death|22
1984012|NCT00588770|3547836|FG000|Overall Study|Withdrawal by Subject|15
1984013|NCT00588770|3547837|FG001|Overall Study|Withdrawal by Subject|25
1984014|NCT00588770|3547836|FG000|Overall Study|Alternative therapy|2
1984015|NCT00588770|3547837|FG001|Overall Study|Alternative therapy|4
1984016|NCT00588770|3547836|FG000|Overall Study|Other complicating disease|3
1984017|NCT00588770|3547837|FG001|Overall Study|Other complicating disease|2
1984018|NCT00588770|3547836|FG000|Overall Study|Not start protocol therapy|0
1984019|NCT00588770|3547837|FG001|Overall Study|Not start protocol therapy|9
1984020|NCT00588770|3547836|FG000|Overall Study|Lack of Efficacy|8
1984021|NCT00588770|3547837|FG001|Overall Study|Lack of Efficacy|10
1984022|NCT00588770|3547836|FG000|Overall Study|Physician discretion|2
1984023|NCT00588770|3547837|FG001|Overall Study|Physician discretion|0
1984024|NCT00588770|3547836|FG000|Overall Study|Patient non-compliance|2
1984025|NCT00588770|3547837|FG001|Overall Study|Patient non-compliance|2
1984026|NCT00433511|3547846|FG000|Step 1|Adverse Event|50
1984027|NCT00433511|3547847|FG001|Step 1|Adverse Event|157
1984028|NCT00433511|3547848|FG002|Step 1|Adverse Event|153
1984029|NCT00433511|3547846|FG000|Step 1|Withdrawal by Subject|45
1984030|NCT00433511|3547847|FG001|Step 1|Withdrawal by Subject|143
1984031|NCT00433511|3547848|FG002|Step 1|Withdrawal by Subject|154
1984032|NCT00433511|3547846|FG000|Step 1|Death|3
1984033|NCT00433511|3547847|FG001|Step 1|Death|1
1984034|NCT00433511|3547848|FG002|Step 1|Death|1
1984035|NCT00433511|3547846|FG000|Step 1|Physician Decision|1
1984036|NCT00433511|3547847|FG001|Step 1|Physician Decision|4
1984037|NCT00433511|3547848|FG002|Step 1|Physician Decision|3
1984038|NCT00433511|3547846|FG000|Step 1|Never started protocol therapy|28
1984039|NCT00433511|3547847|FG001|Step 1|Never started protocol therapy|64
1984040|NCT00433511|3547848|FG002|Step 1|Never started protocol therapy|66
1984041|NCT00433511|3547846|FG000|Step 1|Alternative therapy|2
1984042|NCT00433511|3547847|FG001|Step 1|Alternative therapy|1
1984043|NCT00433511|3547848|FG002|Step 1|Alternative therapy|3
1984044|NCT00433511|3547846|FG000|Step 1|Disease progression, relapse|5
1984045|NCT00433511|3547847|FG001|Step 1|Disease progression, relapse|3
1984046|NCT00433511|3547848|FG002|Step 1|Disease progression, relapse|3
1984047|NCT00433511|3547846|FG000|Step 1|Other complicating disease|2
1984048|NCT00433511|3547847|FG001|Step 1|Other complicating disease|6
1984049|NCT00433511|3547848|FG002|Step 1|Other complicating disease|3
1984050|NCT00433511|3547846|FG000|Step 1|Non-breast cancer surgery/wound issues|0
1984051|NCT00433511|3547847|FG001|Step 1|Non-breast cancer surgery/wound issues|4
1984052|NCT00433511|3547848|FG002|Step 1|Non-breast cancer surgery/wound issues|1
1984053|NCT00433511|3547846|FG000|Step 1|Suspected recurrence|0
1984054|NCT00433511|3547847|FG001|Step 1|Suspected recurrence|1
1984055|NCT00433511|3547848|FG002|Step 1|Suspected recurrence|0
1984056|NCT00433511|3547846|FG000|Step 1|Insurance/drug distribution issues|0
1984057|NCT00433511|3547847|FG001|Step 1|Insurance/drug distribution issues|1
1984058|NCT00433511|3547848|FG002|Step 1|Insurance/drug distribution issues|2
1984059|NCT00433511|3547846|FG000|Step 1|Patient moved|0
1984060|NCT00433511|3547847|FG001|Step 1|Patient moved|0
1984061|NCT00433511|3547848|FG002|Step 1|Patient moved|1
1984062|NCT00433511|3547846|FG000|Step 2 (Arm D)|Adverse Event|0
1984063|NCT00433511|3547847|FG001|Step 2 (Arm D)|Adverse Event|0
1984064|NCT00433511|3547848|FG002|Step 2 (Arm D)|Adverse Event|135
1984065|NCT00433511|3547846|FG000|Step 2 (Arm D)|Withdrawal by Subject|0
1984066|NCT00433511|3547847|FG001|Step 2 (Arm D)|Withdrawal by Subject|0
1984067|NCT00433511|3547848|FG002|Step 2 (Arm D)|Withdrawal by Subject|181
1984068|NCT00433511|3547846|FG000|Step 2 (Arm D)|Never started protocol therapy|0
1984069|NCT00433511|3547847|FG001|Step 2 (Arm D)|Never started protocol therapy|0
1984070|NCT00433511|3547848|FG002|Step 2 (Arm D)|Never started protocol therapy|148
1984071|NCT00433511|3547846|FG000|Step 2 (Arm D)|Physician Decision|0
1984072|NCT00433511|3547847|FG001|Step 2 (Arm D)|Physician Decision|0
1984073|NCT00433511|3547848|FG002|Step 2 (Arm D)|Physician Decision|9
1984074|NCT00433511|3547846|FG000|Step 2 (Arm D)|Disease progression, relapse|0
1984075|NCT00433511|3547847|FG001|Step 2 (Arm D)|Disease progression, relapse|0
1984076|NCT00433511|3547848|FG002|Step 2 (Arm D)|Disease progression, relapse|7
1984077|NCT00433511|3547846|FG000|Step 2 (Arm D)|Other complicating disease|0
1984078|NCT00433511|3547847|FG001|Step 2 (Arm D)|Other complicating disease|0
1984079|NCT00433511|3547848|FG002|Step 2 (Arm D)|Other complicating disease|3
1984080|NCT00433511|3547846|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
1984081|NCT00433511|3547847|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
1984082|NCT00433511|3547848|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
1984083|NCT00433511|3547846|FG000|Step 2 (Arm D)|Suspected recurrence|0
1984084|NCT00433511|3547847|FG001|Step 2 (Arm D)|Suspected recurrence|0
1984085|NCT00433511|3547848|FG002|Step 2 (Arm D)|Suspected recurrence|1
1984086|NCT00433511|3547846|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0
1984087|NCT00433511|3547847|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0
1984088|NCT00433511|3547848|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4
1984089|NCT00433511|3547846|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
1984090|NCT00433511|3547847|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
1984091|NCT00433511|3547848|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
1984092|NCT00324805|3547861|FG000|Overall Study|Adverse Event|62
1984093|NCT00324805|3547862|FG001|Overall Study|Adverse Event|203
1984094|NCT00324805|3547861|FG000|Overall Study|Progression|7
1984095|NCT00324805|3547862|FG001|Overall Study|Progression|35
1984096|NCT00324805|3547861|FG000|Overall Study|Withdrawal by Subject|51
1984097|NCT00324805|3547862|FG001|Overall Study|Withdrawal by Subject|174
1984098|NCT00324805|3547861|FG000|Overall Study|Death|6
1984099|NCT00324805|3547862|FG001|Overall Study|Death|9
1984100|NCT00324805|3547861|FG000|Overall Study|Alternative therapy|4
1984101|NCT00324805|3547862|FG001|Overall Study|Alternative therapy|8
1984102|NCT00324805|3547861|FG000|Overall Study|Other complicating disease|1
1984103|NCT00324805|3547862|FG001|Overall Study|Other complicating disease|9
1984104|NCT00324805|3547861|FG000|Overall Study|Other reasons|7
1984105|NCT00324805|3547862|FG001|Overall Study|Other reasons|26
1984106|NCT00324805|3547861|FG000|Overall Study|Other|0
1984107|NCT00324805|3547862|FG001|Overall Study|Other|2
1984108|NCT00324805|3547861|FG000|Overall Study|Did not start therapy|12
1984109|NCT00324805|3547862|FG001|Overall Study|Did not start therapy|17
2023959|NCT00329849|3592289|FG000|Overall Study|Withdrawal by Subject|6
2023960|NCT00329849|3592290|FG001|Overall Study|Withdrawal by Subject|4
2023961|NCT00329901|3592303|FG000|Overall Study|Withdrawal by Subject|4
2023962|NCT00329901|3592304|FG001|Overall Study|Withdrawal by Subject|3
2023963|NCT00329901|3592305|FG002|Overall Study|Withdrawal by Subject|2
2023964|NCT00329901|3592303|FG000|Overall Study|Lost to Follow-up|2
2023965|NCT00329901|3592304|FG001|Overall Study|Lost to Follow-up|0
2023966|NCT00329901|3592305|FG002|Overall Study|Lost to Follow-up|1
2023967|NCT00329901|3592303|FG000|Overall Study|Protocol Violation|1
2023968|NCT00329901|3592304|FG001|Overall Study|Protocol Violation|0
2023969|NCT00329901|3592305|FG002|Overall Study|Protocol Violation|1
2023970|NCT00329901|3592303|FG000|Overall Study|Unable to classify|2
2023971|NCT00329901|3592304|FG001|Overall Study|Unable to classify|2
2023972|NCT00329901|3592305|FG002|Overall Study|Unable to classify|0
2023973|NCT00330174|3592323|FG000|Overall Study|Withdrawal by Subject|7
2023974|NCT00330174|3592324|FG001|Overall Study|Withdrawal by Subject|7
2023975|NCT00330174|3592323|FG000|Overall Study|Lost to Follow-up|4
2023976|NCT00330174|3592324|FG001|Overall Study|Lost to Follow-up|1
2023977|NCT00330174|3592323|FG000|Overall Study|Clinical deterioration|1
2023978|NCT00330174|3592324|FG001|Overall Study|Clinical deterioration|2
2023979|NCT00330174|3592323|FG000|Overall Study|Excessive missed visits|3
2023980|NCT00330174|3592324|FG001|Overall Study|Excessive missed visits|8
2023981|NCT00330174|3592323|FG000|Overall Study|Miscellaneous reasons|7
2023982|NCT00330174|3592324|FG001|Overall Study|Miscellaneous reasons|1
2023983|NCT00330187|3592334|FG000|Overall Study|Lost to Follow-up|12
2023984|NCT00330187|3592335|FG001|Overall Study|Lost to Follow-up|13
2023985|NCT00330187|3592336|FG002|Overall Study|Lost to Follow-up|14
2023986|NCT00330187|3592337|FG003|Overall Study|Lost to Follow-up|10
2023987|NCT00330187|3592334|FG000|Overall Study|Withdrawal by Subject|8
2023988|NCT00330187|3592335|FG001|Overall Study|Withdrawal by Subject|5
2023989|NCT00330187|3592336|FG002|Overall Study|Withdrawal by Subject|4
2023990|NCT00330187|3592337|FG003|Overall Study|Withdrawal by Subject|4
2023991|NCT00330343|3592347|FG000|Overall Study|Lost to Follow-up|5
2023992|NCT00330460|3592368|FG000|Overall Study|Physician Decision|1
2023993|NCT00330460|3592369|FG001|Overall Study|Physician Decision|0
2023994|NCT00330460|3592368|FG000|Overall Study|Adverse Event|10
2023995|NCT00330460|3592369|FG001|Overall Study|Adverse Event|8
2023996|NCT00330460|3592368|FG000|Overall Study|Withdrawal by Subject|18
2023997|NCT00330460|3592369|FG001|Overall Study|Withdrawal by Subject|17
2023998|NCT00330460|3592368|FG000|Overall Study|Death|1
2023999|NCT00330460|3592369|FG001|Overall Study|Death|1
2024000|NCT00330460|3592368|FG000|Overall Study|Ineligibility determined|1
2024001|NCT00330460|3592369|FG001|Overall Study|Ineligibility determined|3
2024002|NCT00330460|3592368|FG000|Overall Study|Lost to Follow-up|8
2024003|NCT00330460|3592369|FG001|Overall Study|Lost to Follow-up|3
2024004|NCT00330460|3592368|FG000|Overall Study|Noncompliance|2
2024005|NCT00330460|3592369|FG001|Overall Study|Noncompliance|1
2024006|NCT00330460|3592368|FG000|Overall Study|Other|1
2024007|NCT00330460|3592369|FG001|Overall Study|Other|0
2024008|NCT00330616|3592390|FG000|Overall Study|Adverse Event|13
2024009|NCT00330616|3592390|FG000|Overall Study|Lack of Efficacy|1
2024010|NCT00330616|3592390|FG000|Overall Study|Lost to Follow-up|2
2024011|NCT00330616|3592390|FG000|Overall Study|Withdrawal by Subject|4
2024012|NCT00330616|3592390|FG000|Overall Study|Other|1
2024013|NCT00330668|3592394|FG000|BID Dosing Period|Adverse Event|1
2024014|NCT00330668|3592394|FG000|BID Dosing Period|Lost to Follow-up|7
2024015|NCT00330668|3592394|FG000|BID Dosing Period|Non-Compliance|5
2024016|NCT00330668|3592394|FG000|BID Dosing Period|Withdrawal by Subject|19
2024017|NCT00330668|3592394|FG000|BID Dosing Period|Sponsor's decision|1
2024018|NCT00330668|3592394|FG000|BID Dosing Period|Other|3
2024019|NCT00330668|3592394|FG000|QD Dosing Period|Sponsor decision to terminate study|74
2024020|NCT00330668|3592394|FG000|QD Dosing Period|Other|1
2024021|NCT00330668|3592394|FG000|QD Dosing Period|Withdrawal by Subject|1
2024022|NCT00330668|3592394|FG000|QD Dosing Period|Lost to Follow-up|2
2024023|NCT00330681|3592400|FG000|Overall Study|Adverse Event|3
2024024|NCT00330681|3592401|FG001|Overall Study|Adverse Event|6
2310716|NCT02738879|4015242|FG000|Overall Study|Protocol Violation|1
2024025|NCT00330681|3592400|FG000|Overall Study|Protocol Violation|0
2024026|NCT00330681|3592401|FG001|Overall Study|Protocol Violation|1
2024027|NCT00330681|3592400|FG000|Overall Study|Withdrawal by Subject|5
2024028|NCT00330681|3592401|FG001|Overall Study|Withdrawal by Subject|5
2024029|NCT00330681|3592400|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
2024030|NCT00330681|3592401|FG001|Overall Study|Tracheotomy due to worsening of ALS|2
2024031|NCT00330759|3592418|FG000|Overall Study|Death|316
2024032|NCT00330759|3592419|FG001|Overall Study|Death|310
2024033|NCT00330759|3592418|FG000|Overall Study|Disease progression|104
2024034|NCT00330759|3592419|FG001|Overall Study|Disease progression|126
2024035|NCT00330759|3592418|FG000|Overall Study|Withdrawal by Subject|143
2024036|NCT00330759|3592419|FG001|Overall Study|Withdrawal by Subject|124
2024037|NCT00330759|3592418|FG000|Overall Study|Adverse Event|48
2024038|NCT00330759|3592419|FG001|Overall Study|Adverse Event|36
1984110|NCT04993339|3547891|FG000|Overall Study|Lost to Follow-up|0
1984111|NCT04993339|3547892|FG001|Overall Study|Lost to Follow-up|1
1984112|NCT04993339|3547891|FG000|Overall Study|no MRI scan|3
1984113|NCT04993339|3547892|FG001|Overall Study|no MRI scan|1
1984114|NCT04919161|3547934|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1
1984115|NCT04919161|3547935|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0
1984116|NCT04919161|3547934|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0
1984117|NCT04919161|3547935|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1
1984118|NCT04919161|3547934|FG000|Overall Study|Acute ankle sprain after session 1|0
1984119|NCT04919161|3547935|FG001|Overall Study|Acute ankle sprain after session 1|1
1984120|NCT04883541|3548017|FG000|Overall Study|Not attending regular yoga class|16
1984121|NCT04883541|3548018|FG001|Overall Study|Not attending regular yoga class|0
1984122|NCT04883541|3548017|FG000|Overall Study|Not attending the pregnancy school|0
1984123|NCT04883541|3548018|FG001|Overall Study|Not attending the pregnancy school|9
1984124|NCT04357782|3548034|FG000|Overall Study|Discharged from hospital|1
1984125|NCT04357782|3548035|FG001|Overall Study|Discharged from hospital|0
1984126|NCT04357782|3548034|FG000|Overall Study|Death|0
1984127|NCT04357782|3548035|FG001|Overall Study|Death|2
1984128|NCT03760068|3548071|FG000|Overall Study|Withdrawal by Subject|7
1984129|NCT03760068|3548072|FG001|Overall Study|Withdrawal by Subject|8
1984130|NCT03760068|3548071|FG000|Overall Study|Adverse Event|1
1984131|NCT03760068|3548072|FG001|Overall Study|Adverse Event|2
1984132|NCT03760068|3548071|FG000|Overall Study|Administrative Decision by Sponsor|0
1984133|NCT03760068|3548072|FG001|Overall Study|Administrative Decision by Sponsor|2
1984134|NCT03760068|3548071|FG000|Overall Study|Physician Decision|1
1984135|NCT03760068|3548072|FG001|Overall Study|Physician Decision|2
1984136|NCT03760068|3548071|FG000|Overall Study|Lost to Follow-up|4
1984137|NCT03760068|3548072|FG001|Overall Study|Lost to Follow-up|9
1984138|NCT03760068|3548071|FG000|Overall Study|Subject Moved Out of State|1
1984139|NCT03760068|3548072|FG001|Overall Study|Subject Moved Out of State|0
1984140|NCT03628781|3548090|FG000|Overall Study|Lost to Follow-up|16
1984141|NCT03628781|3548091|FG001|Overall Study|Lost to Follow-up|8
1984142|NCT03628781|3548090|FG000|Overall Study|Withdrawal by Subject|16
1984143|NCT03628781|3548091|FG001|Overall Study|Withdrawal by Subject|1
1984144|NCT03560206|3548099|FG000|Overall Study|Lost to Follow-up|19
1984145|NCT03560206|3548100|FG001|Overall Study|Lost to Follow-up|11
1984146|NCT03560206|3548099|FG000|Overall Study|Withdrawal by Subject|2
1984147|NCT03560206|3548100|FG001|Overall Study|Withdrawal by Subject|4
1984148|NCT03560206|3548099|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5
1984149|NCT03560206|3548100|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0
1984150|NCT03560206|3548099|FG000|Overall Study|Busy schedule|14
1984151|NCT03560206|3548100|FG001|Overall Study|Busy schedule|2
1984152|NCT03560206|3548099|FG000|Overall Study|patients' new health condition such as cancer|10
1984153|NCT03560206|3548100|FG001|Overall Study|patients' new health condition such as cancer|1
1984154|NCT03340766|3548118|FG000|Overall Study|Death|6
1984155|NCT03340766|3548119|FG001|Overall Study|Death|6
1984156|NCT03340766|3548120|FG002|Overall Study|Death|2
1984157|NCT03340766|3548118|FG000|Overall Study|Withdrawal by Subject|2
1984158|NCT03340766|3548119|FG001|Overall Study|Withdrawal by Subject|1
1984159|NCT03340766|3548120|FG002|Overall Study|Withdrawal by Subject|2
1984160|NCT03340766|3548118|FG000|Overall Study|Continuing Study|3
1984161|NCT03340766|3548119|FG001|Overall Study|Continuing Study|3
2310717|NCT02738879|4015243|FG001|Overall Study|Protocol Violation|3
2310718|NCT02738879|4015242|FG000|Overall Study|Physician Decision|3
1984162|NCT03340766|3548120|FG002|Overall Study|Continuing Study|5
1984163|NCT03277105|3548136|FG000|Overall Study|Death|77
1984164|NCT03277105|3548137|FG001|Overall Study|Death|73
1984165|NCT03277105|3548136|FG000|Overall Study|Lost to Follow-up|0
1984166|NCT03277105|3548137|FG001|Overall Study|Lost to Follow-up|3
1984167|NCT03277105|3548136|FG000|Overall Study|Withdrawal by Subject|10
1984168|NCT03277105|3548137|FG001|Overall Study|Withdrawal by Subject|9
1984169|NCT03277105|3548136|FG000|Overall Study|Other|1
1984170|NCT03277105|3548137|FG001|Overall Study|Other|3
1984171|NCT03277105|3548136|FG000|Overall Study|Ongoing|171
1984172|NCT03277105|3548137|FG001|Overall Study|Ongoing|175
1984173|NCT03201965|3548146|FG000|Overall Study|Death|5
1984174|NCT03201965|3548147|FG001|Overall Study|Death|27
1984175|NCT03201965|3548148|FG002|Overall Study|Death|27
1984176|NCT03201965|3548146|FG000|Overall Study|Lost to Follow-up|0
1984177|NCT03201965|3548147|FG001|Overall Study|Lost to Follow-up|1
1984178|NCT03201965|3548148|FG002|Overall Study|Lost to Follow-up|0
1984179|NCT03201965|3548146|FG000|Overall Study|Withdrawal by Subject|3
1984180|NCT03201965|3548147|FG001|Overall Study|Withdrawal by Subject|13
1984181|NCT03201965|3548148|FG002|Overall Study|Withdrawal by Subject|4
1984182|NCT03201965|3548146|FG000|Overall Study|Ongoing|20
1984183|NCT03201965|3548147|FG001|Overall Study|Ongoing|152
1984184|NCT03201965|3548148|FG002|Overall Study|Ongoing|164
1984185|NCT02874742|3548171|FG000|Overall Study|Death|3
1984186|NCT02874742|3548172|FG001|Overall Study|Death|1
1984187|NCT02874742|3548173|FG002|Overall Study|Death|1
1984188|NCT02874742|3548171|FG000|Overall Study|Lost to Follow-up|2
1984189|NCT02874742|3548172|FG001|Overall Study|Lost to Follow-up|0
1984190|NCT02874742|3548173|FG002|Overall Study|Lost to Follow-up|0
2310719|NCT02738879|4015243|FG001|Overall Study|Physician Decision|4
2310720|NCT02738879|4015242|FG000|Overall Study|Pregnancy|0
2310721|NCT02738879|4015243|FG001|Overall Study|Pregnancy|1
2310722|NCT02738879|4015242|FG000|Overall Study|Screen Failure|1
2310723|NCT02738879|4015243|FG001|Overall Study|Screen Failure|2
1984191|NCT02874742|3548171|FG000|Overall Study|Withdrawal by Subject|8
1984192|NCT02874742|3548172|FG001|Overall Study|Withdrawal by Subject|4
1984193|NCT02874742|3548173|FG002|Overall Study|Withdrawal by Subject|0
1984194|NCT02874742|3548171|FG000|Overall Study|Other|3
1984195|NCT02874742|3548172|FG001|Overall Study|Other|1
1984196|NCT02874742|3548173|FG002|Overall Study|Other|0
1984197|NCT02874742|3548171|FG000|Overall Study|Ongoing|87
1984198|NCT02874742|3548172|FG001|Overall Study|Ongoing|98
1984199|NCT02874742|3548173|FG002|Overall Study|Ongoing|15
1984200|NCT02706847|3548188|FG000|Day 1 to Week 12|Adverse Event|2
1984201|NCT02706847|3548189|FG001|Day 1 to Week 12|Adverse Event|2
1984202|NCT02706847|3548190|FG002|Day 1 to Week 12|Adverse Event|1
1984203|NCT02706847|3548191|FG003|Day 1 to Week 12|Adverse Event|12
1984204|NCT02706847|3548188|FG000|Day 1 to Week 12|Withdrawal by Subject|2
1984205|NCT02706847|3548189|FG001|Day 1 to Week 12|Withdrawal by Subject|1
1984206|NCT02706847|3548190|FG002|Day 1 to Week 12|Withdrawal by Subject|4
1984207|NCT02706847|3548191|FG003|Day 1 to Week 12|Withdrawal by Subject|2
1984208|NCT02706847|3548188|FG000|Day 1 to Week 12|Lost to Follow-up|2
1984209|NCT02706847|3548189|FG001|Day 1 to Week 12|Lost to Follow-up|1
1984210|NCT02706847|3548190|FG002|Day 1 to Week 12|Lost to Follow-up|0
1984211|NCT02706847|3548191|FG003|Day 1 to Week 12|Lost to Follow-up|0
1984212|NCT02706847|3548188|FG000|Day 1 to Week 12|Other|4
1984213|NCT02706847|3548189|FG001|Day 1 to Week 12|Other|4
1984214|NCT02706847|3548190|FG002|Day 1 to Week 12|Other|2
1984215|NCT02706847|3548191|FG003|Day 1 to Week 12|Other|2
1984216|NCT02706847|3548188|FG000|Day 1 to Week 12|Randomized in Error|0
1984217|NCT02706847|3548189|FG001|Day 1 to Week 12|Randomized in Error|0
1984218|NCT02706847|3548190|FG002|Day 1 to Week 12|Randomized in Error|1
1984219|NCT02706847|3548191|FG003|Day 1 to Week 12|Randomized in Error|0
1984220|NCT02706847|3548188|FG000|Week 12 to Week 24|Adverse Event|1
1984221|NCT02706847|3548189|FG001|Week 12 to Week 24|Adverse Event|2
1984222|NCT02706847|3548190|FG002|Week 12 to Week 24|Adverse Event|2
1984223|NCT02706847|3548191|FG003|Week 12 to Week 24|Adverse Event|5
1984224|NCT02706847|3548188|FG000|Week 12 to Week 24|Withdrawal by Subject|1
1984225|NCT02706847|3548189|FG001|Week 12 to Week 24|Withdrawal by Subject|0
1984226|NCT02706847|3548190|FG002|Week 12 to Week 24|Withdrawal by Subject|1
1984227|NCT02706847|3548191|FG003|Week 12 to Week 24|Withdrawal by Subject|4
1984228|NCT02706847|3548188|FG000|Week 12 to Week 24|Lost to Follow-up|0
1984229|NCT02706847|3548189|FG001|Week 12 to Week 24|Lost to Follow-up|0
1984230|NCT02706847|3548190|FG002|Week 12 to Week 24|Lost to Follow-up|0
1984231|NCT02706847|3548191|FG003|Week 12 to Week 24|Lost to Follow-up|1
1984232|NCT02706847|3548188|FG000|Week 12 to Week 24|Other|1
1984233|NCT02706847|3548189|FG001|Week 12 to Week 24|Other|0
1984234|NCT02706847|3548190|FG002|Week 12 to Week 24|Other|1
1984235|NCT02706847|3548191|FG003|Week 12 to Week 24|Other|4
1984236|NCT02701777|3548205|FG000|Overall Study|Some subjects did not like the stimulation.|4
1984237|NCT02701777|3548206|FG001|Overall Study|Some subjects did not like the stimulation.|0
1984238|NCT02701777|3548207|FG002|Overall Study|Some subjects did not like the stimulation.|0
1984239|NCT02701777|3548208|FG003|Overall Study|Some subjects did not like the stimulation.|2
1984240|NCT02701777|3548205|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
1984241|NCT02701777|3548206|FG001|Overall Study|Some subjects were unable to commit to the training study.|3
2213273|NCT01677741|3854736|FG007|Overall Study|Withdrawal by Subject|2
2213274|NCT01677741|3854729|FG000|Overall Study|Enrolled in a rollover study|0
1984242|NCT02701777|3548207|FG002|Overall Study|Some subjects were unable to commit to the training study.|4
1984243|NCT02701777|3548208|FG003|Overall Study|Some subjects were unable to commit to the training study.|0
1984244|NCT02677896|3548224|FG000|Overall Study|Adverse Event|28
1984245|NCT02677896|3548225|FG001|Overall Study|Adverse Event|21
1984246|NCT02677896|3548224|FG000|Overall Study|Death|9
1984247|NCT02677896|3548225|FG001|Overall Study|Death|7
2310724|NCT02738879|4015242|FG000|Overall Study|Site Discontinued Study Participation|1
2310725|NCT02738879|4015243|FG001|Overall Study|Site Discontinued Study Participation|0
2310726|NCT02738879|4015242|FG000|Overall Study|Withdrawal by Subject|5
2310727|NCT02738879|4015243|FG001|Overall Study|Withdrawal by Subject|7
2310728|NCT02739269|4015259|FG000|Overall Study|Protocol Violation|5
2310729|NCT02739269|4015260|FG001|Overall Study|Protocol Violation|0
2310730|NCT02739269|4015259|FG000|Overall Study|Cycle cancellation|2
2310731|NCT02739269|4015260|FG001|Overall Study|Cycle cancellation|2
2310732|NCT02739269|4015259|FG000|Overall Study|Withdrawal by Subject|0
2310733|NCT02739269|4015260|FG001|Overall Study|Withdrawal by Subject|2
2310734|NCT02739321|4015268|FG000|Overall Study|Lack of Efficacy|1
2310735|NCT02739321|4015269|FG001|Overall Study|Lack of Efficacy|1
2310736|NCT02739321|4015268|FG000|Overall Study|Lost to Follow-up|1
2310737|NCT02739321|4015269|FG001|Overall Study|Lost to Follow-up|1
2310738|NCT02739321|4015268|FG000|Overall Study|Withdrawal by Subject|1
2310739|NCT02739321|4015269|FG001|Overall Study|Withdrawal by Subject|2
2310740|NCT02739360|4015284|FG000|Overall Study|Adverse Event|1
2310741|NCT02739360|4015284|FG000|Overall Study|Study terminated by Sponsor|2
2310742|NCT02739594|4015290|FG000|Overall Study|Undesired Event|3
1984248|NCT02677896|3548224|FG000|Overall Study|Lost to Follow-up|0
1984249|NCT02677896|3548225|FG001|Overall Study|Lost to Follow-up|1
1984250|NCT02677896|3548224|FG000|Overall Study|Progressive disease:|65
1984251|NCT02677896|3548225|FG001|Overall Study|Progressive disease:|171
1984252|NCT02677896|3548224|FG000|Overall Study|Protocol deviation|2
1984253|NCT02677896|3548225|FG001|Overall Study|Protocol deviation|1
1984254|NCT02677896|3548224|FG000|Overall Study|Withdrawal by patient:|25
1984255|NCT02677896|3548225|FG001|Overall Study|Withdrawal by patient:|30
1984256|NCT02677896|3548224|FG000|Overall Study|Miscellaneous|6
1984257|NCT02677896|3548225|FG001|Overall Study|Miscellaneous|11
1984258|NCT02677896|3548224|FG000|Overall Study|Did not receive study drug|2
1984259|NCT02677896|3548225|FG001|Overall Study|Did not receive study drug|2
1984260|NCT02657434|3548233|FG000|Overall Study|On-Going in Study|77
1984261|NCT02657434|3548234|FG001|Overall Study|On-Going in Study|91
1984262|NCT02657434|3548233|FG000|Overall Study|Death|177
1984263|NCT02657434|3548234|FG001|Overall Study|Death|183
1984264|NCT02657434|3548233|FG000|Overall Study|Lost to Follow-up|2
1984265|NCT02657434|3548234|FG001|Overall Study|Lost to Follow-up|2
1984266|NCT02657434|3548233|FG000|Overall Study|Randomization by Error|2
1984267|NCT02657434|3548234|FG001|Overall Study|Randomization by Error|0
1984268|NCT02657434|3548233|FG000|Overall Study|Withdrawal by Subject|27
1984269|NCT02657434|3548234|FG001|Overall Study|Withdrawal by Subject|16
1984270|NCT02657434|3548233|FG000|Overall Study|Protocol Violation|1
1984271|NCT02657434|3548234|FG001|Overall Study|Protocol Violation|0
1984272|NCT02564900|3548256|FG000|Dose Escalation|Progressive disease per RECIST|2
1984273|NCT02564900|3548257|FG001|Dose Escalation|Progressive disease per RECIST|3
1984274|NCT02564900|3548258|FG002|Dose Escalation|Progressive disease per RECIST|3
1984275|NCT02564900|3548259|FG003|Dose Escalation|Progressive disease per RECIST|3
1984276|NCT02564900|3548260|FG004|Dose Escalation|Progressive disease per RECIST|3
1984277|NCT02564900|3548261|FG005|Dose Escalation|Progressive disease per RECIST|1
1984278|NCT02564900|3548262|FG006|Dose Escalation|Progressive disease per RECIST|0
1984279|NCT02564900|3548263|FG007|Dose Escalation|Progressive disease per RECIST|0
1984280|NCT02564900|3548264|FG008|Dose Escalation|Progressive disease per RECIST|0
1984281|NCT02564900|3548265|FG009|Dose Escalation|Progressive disease per RECIST|0
1984282|NCT02564900|3548266|FG010|Dose Escalation|Progressive disease per RECIST|0
1984283|NCT02564900|3548267|FG011|Dose Escalation|Progressive disease per RECIST|0
1984284|NCT02564900|3548268|FG012|Dose Escalation|Progressive disease per RECIST|0
1984285|NCT02564900|3548269|FG013|Dose Escalation|Progressive disease per RECIST|0
1984286|NCT02564900|3548270|FG014|Dose Escalation|Progressive disease per RECIST|0
1984287|NCT02564900|3548256|FG000|Dose Escalation|Ongoing|1
1984288|NCT02564900|3548257|FG001|Dose Escalation|Ongoing|0
1984289|NCT02564900|3548258|FG002|Dose Escalation|Ongoing|0
1984290|NCT02564900|3548259|FG003|Dose Escalation|Ongoing|2
1984291|NCT02564900|3548260|FG004|Dose Escalation|Ongoing|2
1984292|NCT02564900|3548261|FG005|Dose Escalation|Ongoing|2
1984293|NCT02564900|3548262|FG006|Dose Escalation|Ongoing|0
1984294|NCT02564900|3548263|FG007|Dose Escalation|Ongoing|0
1984295|NCT02564900|3548264|FG008|Dose Escalation|Ongoing|0
1984296|NCT02564900|3548265|FG009|Dose Escalation|Ongoing|0
1984297|NCT02564900|3548266|FG010|Dose Escalation|Ongoing|0
1984298|NCT02564900|3548267|FG011|Dose Escalation|Ongoing|0
1984299|NCT02564900|3548268|FG012|Dose Escalation|Ongoing|0
1984300|NCT02564900|3548269|FG013|Dose Escalation|Ongoing|0
1984301|NCT02564900|3548270|FG014|Dose Escalation|Ongoing|0
1984302|NCT02564900|3548256|FG000|Dose Escalation|Adverse Event|0
1984303|NCT02564900|3548257|FG001|Dose Escalation|Adverse Event|0
1984304|NCT02564900|3548258|FG002|Dose Escalation|Adverse Event|0
1984305|NCT02564900|3548259|FG003|Dose Escalation|Adverse Event|1
1984306|NCT02564900|3548260|FG004|Dose Escalation|Adverse Event|1
1984307|NCT02564900|3548261|FG005|Dose Escalation|Adverse Event|3
1984308|NCT02564900|3548262|FG006|Dose Escalation|Adverse Event|0
1984309|NCT02564900|3548263|FG007|Dose Escalation|Adverse Event|0
1984310|NCT02564900|3548264|FG008|Dose Escalation|Adverse Event|0
1984311|NCT02564900|3548265|FG009|Dose Escalation|Adverse Event|0
1984312|NCT02564900|3548266|FG010|Dose Escalation|Adverse Event|0
1984313|NCT02564900|3548267|FG011|Dose Escalation|Adverse Event|0
1984314|NCT02564900|3548268|FG012|Dose Escalation|Adverse Event|0
1984315|NCT02564900|3548269|FG013|Dose Escalation|Adverse Event|0
1984316|NCT02564900|3548270|FG014|Dose Escalation|Adverse Event|0
1984317|NCT02564900|3548256|FG000|Dose Expansion|Progressive disease per RECIST|0
1984318|NCT02564900|3548257|FG001|Dose Expansion|Progressive disease per RECIST|0
1984319|NCT02564900|3548258|FG002|Dose Expansion|Progressive disease per RECIST|0
1984320|NCT02564900|3548259|FG003|Dose Expansion|Progressive disease per RECIST|0
1984321|NCT02564900|3548260|FG004|Dose Expansion|Progressive disease per RECIST|0
1984322|NCT02564900|3548261|FG005|Dose Expansion|Progressive disease per RECIST|0
1984323|NCT02564900|3548262|FG006|Dose Expansion|Progressive disease per RECIST|19
1984324|NCT02564900|3548263|FG007|Dose Expansion|Progressive disease per RECIST|17
1984325|NCT02564900|3548264|FG008|Dose Expansion|Progressive disease per RECIST|8
1984326|NCT02564900|3548265|FG009|Dose Expansion|Progressive disease per RECIST|16
1984327|NCT02564900|3548266|FG010|Dose Expansion|Progressive disease per RECIST|13
1984328|NCT02564900|3548267|FG011|Dose Expansion|Progressive disease per RECIST|19
1984329|NCT02564900|3548268|FG012|Dose Expansion|Progressive disease per RECIST|10
1984330|NCT02564900|3548269|FG013|Dose Expansion|Progressive disease per RECIST|13
1984331|NCT02564900|3548270|FG014|Dose Expansion|Progressive disease per RECIST|11
1984332|NCT02564900|3548256|FG000|Dose Expansion|Clinical progression|0
1984333|NCT02564900|3548257|FG001|Dose Expansion|Clinical progression|0
1984334|NCT02564900|3548258|FG002|Dose Expansion|Clinical progression|0
1984335|NCT02564900|3548259|FG003|Dose Expansion|Clinical progression|0
1984336|NCT02564900|3548260|FG004|Dose Expansion|Clinical progression|0
1984337|NCT02564900|3548261|FG005|Dose Expansion|Clinical progression|0
1984338|NCT02564900|3548262|FG006|Dose Expansion|Clinical progression|5
1984339|NCT02564900|3548263|FG007|Dose Expansion|Clinical progression|12
1984340|NCT02564900|3548264|FG008|Dose Expansion|Clinical progression|0
1984341|NCT02564900|3548265|FG009|Dose Expansion|Clinical progression|3
1984342|NCT02564900|3548266|FG010|Dose Expansion|Clinical progression|2
1984343|NCT02564900|3548267|FG011|Dose Expansion|Clinical progression|0
1984344|NCT02564900|3548268|FG012|Dose Expansion|Clinical progression|1
1984345|NCT02564900|3548269|FG013|Dose Expansion|Clinical progression|3
1984346|NCT02564900|3548270|FG014|Dose Expansion|Clinical progression|1
1984347|NCT02564900|3548256|FG000|Dose Expansion|Adverse Event|0
1984348|NCT02564900|3548257|FG001|Dose Expansion|Adverse Event|0
1984349|NCT02564900|3548258|FG002|Dose Expansion|Adverse Event|0
1984350|NCT02564900|3548259|FG003|Dose Expansion|Adverse Event|0
1984351|NCT02564900|3548260|FG004|Dose Expansion|Adverse Event|0
1984352|NCT02564900|3548261|FG005|Dose Expansion|Adverse Event|0
1984353|NCT02564900|3548262|FG006|Dose Expansion|Adverse Event|9
1984354|NCT02564900|3548263|FG007|Dose Expansion|Adverse Event|22
1984355|NCT02564900|3548264|FG008|Dose Expansion|Adverse Event|0
1984356|NCT02564900|3548265|FG009|Dose Expansion|Adverse Event|11
1984357|NCT02564900|3548266|FG010|Dose Expansion|Adverse Event|0
1984358|NCT02564900|3548267|FG011|Dose Expansion|Adverse Event|5
1984359|NCT02564900|3548268|FG012|Dose Expansion|Adverse Event|2
1984360|NCT02564900|3548269|FG013|Dose Expansion|Adverse Event|2
1984361|NCT02564900|3548270|FG014|Dose Expansion|Adverse Event|1
1984362|NCT02564900|3548256|FG000|Dose Expansion|Ongoing|0
1984363|NCT02564900|3548257|FG001|Dose Expansion|Ongoing|0
1984364|NCT02564900|3548258|FG002|Dose Expansion|Ongoing|0
1984365|NCT02564900|3548259|FG003|Dose Expansion|Ongoing|0
1984366|NCT02564900|3548260|FG004|Dose Expansion|Ongoing|0
1984367|NCT02564900|3548261|FG005|Dose Expansion|Ongoing|0
1984368|NCT02564900|3548262|FG006|Dose Expansion|Ongoing|9
1984369|NCT02564900|3548263|FG007|Dose Expansion|Ongoing|10
1984370|NCT02564900|3548264|FG008|Dose Expansion|Ongoing|11
1984371|NCT02564900|3548265|FG009|Dose Expansion|Ongoing|3
1984372|NCT02564900|3548266|FG010|Dose Expansion|Ongoing|0
1984373|NCT02564900|3548267|FG011|Dose Expansion|Ongoing|0
1984374|NCT02564900|3548268|FG012|Dose Expansion|Ongoing|4
1984375|NCT02564900|3548269|FG013|Dose Expansion|Ongoing|0
1984376|NCT02564900|3548270|FG014|Dose Expansion|Ongoing|6
1984377|NCT02564900|3548256|FG000|Dose Expansion|Death|0
1984378|NCT02564900|3548257|FG001|Dose Expansion|Death|0
1984379|NCT02564900|3548258|FG002|Dose Expansion|Death|0
1984380|NCT02564900|3548259|FG003|Dose Expansion|Death|0
1984381|NCT02564900|3548260|FG004|Dose Expansion|Death|0
1984382|NCT02564900|3548261|FG005|Dose Expansion|Death|0
1984383|NCT02564900|3548262|FG006|Dose Expansion|Death|1
1984384|NCT02564900|3548263|FG007|Dose Expansion|Death|0
1984385|NCT02564900|3548264|FG008|Dose Expansion|Death|0
1984386|NCT02564900|3548265|FG009|Dose Expansion|Death|0
1984387|NCT02564900|3548266|FG010|Dose Expansion|Death|1
1984388|NCT02564900|3548267|FG011|Dose Expansion|Death|0
1984389|NCT02564900|3548268|FG012|Dose Expansion|Death|1
1984390|NCT02564900|3548269|FG013|Dose Expansion|Death|1
1984391|NCT02564900|3548270|FG014|Dose Expansion|Death|0
1984392|NCT02564900|3548256|FG000|Dose Expansion|Withdrawal by Subject|0
1984393|NCT02564900|3548257|FG001|Dose Expansion|Withdrawal by Subject|0
1984394|NCT02564900|3548258|FG002|Dose Expansion|Withdrawal by Subject|0
1984395|NCT02564900|3548259|FG003|Dose Expansion|Withdrawal by Subject|0
1984396|NCT02564900|3548260|FG004|Dose Expansion|Withdrawal by Subject|0
1984397|NCT02564900|3548261|FG005|Dose Expansion|Withdrawal by Subject|0
1984398|NCT02564900|3548262|FG006|Dose Expansion|Withdrawal by Subject|4
1984399|NCT02564900|3548263|FG007|Dose Expansion|Withdrawal by Subject|0
1984400|NCT02564900|3548264|FG008|Dose Expansion|Withdrawal by Subject|0
1984401|NCT02564900|3548265|FG009|Dose Expansion|Withdrawal by Subject|0
1984402|NCT02564900|3548266|FG010|Dose Expansion|Withdrawal by Subject|1
1984403|NCT02564900|3548267|FG011|Dose Expansion|Withdrawal by Subject|0
1984404|NCT02564900|3548268|FG012|Dose Expansion|Withdrawal by Subject|0
1984405|NCT02564900|3548269|FG013|Dose Expansion|Withdrawal by Subject|1
1984406|NCT02564900|3548270|FG014|Dose Expansion|Withdrawal by Subject|1
1984407|NCT02564900|3548256|FG000|Dose Expansion|Other|0
1984408|NCT02564900|3548257|FG001|Dose Expansion|Other|0
1984409|NCT02564900|3548258|FG002|Dose Expansion|Other|0
1984410|NCT02564900|3548259|FG003|Dose Expansion|Other|0
1984411|NCT02564900|3548260|FG004|Dose Expansion|Other|0
1984412|NCT02564900|3548261|FG005|Dose Expansion|Other|0
1984413|NCT02564900|3548262|FG006|Dose Expansion|Other|1
1984414|NCT02564900|3548263|FG007|Dose Expansion|Other|0
1984415|NCT02564900|3548264|FG008|Dose Expansion|Other|1
1984416|NCT02564900|3548265|FG009|Dose Expansion|Other|0
1984417|NCT02564900|3548266|FG010|Dose Expansion|Other|0
1984418|NCT02564900|3548267|FG011|Dose Expansion|Other|0
1984419|NCT02564900|3548268|FG012|Dose Expansion|Other|0
1984420|NCT02564900|3548269|FG013|Dose Expansion|Other|0
1984421|NCT02564900|3548270|FG014|Dose Expansion|Other|1
1984422|NCT02564900|3548256|FG000|Dose Expansion|Did not receive treatment|0
1984423|NCT02564900|3548257|FG001|Dose Expansion|Did not receive treatment|0
1984424|NCT02564900|3548258|FG002|Dose Expansion|Did not receive treatment|0
1984425|NCT02564900|3548259|FG003|Dose Expansion|Did not receive treatment|0
1984426|NCT02564900|3548260|FG004|Dose Expansion|Did not receive treatment|0
1984427|NCT02564900|3548261|FG005|Dose Expansion|Did not receive treatment|0
1984428|NCT02564900|3548262|FG006|Dose Expansion|Did not receive treatment|1
1984429|NCT02564900|3548263|FG007|Dose Expansion|Did not receive treatment|1
1984430|NCT02564900|3548264|FG008|Dose Expansion|Did not receive treatment|0
1984431|NCT02564900|3548265|FG009|Dose Expansion|Did not receive treatment|0
1984432|NCT02564900|3548266|FG010|Dose Expansion|Did not receive treatment|0
1984433|NCT02564900|3548267|FG011|Dose Expansion|Did not receive treatment|0
1984434|NCT02564900|3548268|FG012|Dose Expansion|Did not receive treatment|0
1984435|NCT02564900|3548269|FG013|Dose Expansion|Did not receive treatment|0
1984436|NCT02564900|3548270|FG014|Dose Expansion|Did not receive treatment|1
1984437|NCT02561299|3548313|FG000|Overall Study|Death|2
1984438|NCT02561299|3548314|FG001|Overall Study|Death|4
1984439|NCT02561299|3548313|FG000|Overall Study|Lost to Follow-up|1
1984440|NCT02561299|3548314|FG001|Overall Study|Lost to Follow-up|0
1984441|NCT02561299|3548313|FG000|Overall Study|Withdrawal by Subject|2
1984442|NCT02561299|3548314|FG001|Overall Study|Withdrawal by Subject|2
1984443|NCT02548143|3548322|FG000|Overall Study|Adverse Event|1
1984444|NCT02548143|3548323|FG001|Overall Study|Adverse Event|0
1984445|NCT02548143|3548322|FG000|Overall Study|Withdrawal by Subject|0
1984446|NCT02548143|3548323|FG001|Overall Study|Withdrawal by Subject|1
2024039|NCT00330759|3592418|FG000|Overall Study|Participant request|31
2024040|NCT00330759|3592419|FG001|Overall Study|Participant request|22
2024041|NCT00330759|3592418|FG000|Overall Study|Lost to Follow-up|16
2024042|NCT00330759|3592419|FG001|Overall Study|Lost to Follow-up|22
2024043|NCT00330759|3592418|FG000|Overall Study|Noncompliance|15
2024044|NCT00330759|3592419|FG001|Overall Study|Noncompliance|17
2024045|NCT00330759|3592418|FG000|Overall Study|Physician Decision|1
2024046|NCT00330759|3592419|FG001|Overall Study|Physician Decision|2
2024047|NCT00330759|3592418|FG000|Overall Study|Protocol deviation|0
2024048|NCT00330759|3592419|FG001|Overall Study|Protocol deviation|2
2024049|NCT00330759|3592418|FG000|Overall Study|Ineligibility determined|2
2024050|NCT00330759|3592419|FG001|Overall Study|Ineligibility determined|1
2024051|NCT00330759|3592418|FG000|Overall Study|Other|36
2024052|NCT00330759|3592419|FG001|Overall Study|Other|44
2024053|NCT00330928|3592445|FG000|Overall Study|Lost to Follow-up|6
2024054|NCT00330928|3592445|FG000|Overall Study|Physician Decision|9
2024055|NCT00330928|3592445|FG000|Overall Study|Death|1
2024056|NCT00330928|3592445|FG000|Overall Study|IVUS could not be performed.|1
2024057|NCT00330967|3592451|FG000|Overall Study|Withdrawal by Subject|0
2024058|NCT00330967|3592452|FG001|Overall Study|Withdrawal by Subject|5
2024059|NCT00330967|3592451|FG000|Overall Study|Physician Decision|0
2213275|NCT01677741|3854730|FG001|Overall Study|Enrolled in a rollover study|3
2213276|NCT01677741|3854731|FG002|Overall Study|Enrolled in a rollover study|2
2024060|NCT00330967|3592452|FG001|Overall Study|Physician Decision|9
2024061|NCT00331006|3592458|FG000|Screening Phase|Withdrawal by Subject|1
2024062|NCT00331006|3592458|FG000|Screening Phase|enrollment halted|1
2024063|NCT00331006|3592458|FG000|Screening Phase|Lost to Follow-up|1
2024064|NCT00331006|3592458|FG000|Screening Phase|Ineligible for treatment phase|4
2024065|NCT00331006|3592458|FG000|Treatment Phase|Withdrawal by Subject|1
2024066|NCT00331006|3592458|FG000|Follow-Up Phase I|Lost to Follow-up|1
2024067|NCT00331006|3592458|FG000|Follow-Up Phase II|Lost to Follow-up|3
2024068|NCT00331136|3592466|FG000|Overall Study|Adverse Event|3
2024069|NCT00331136|3592467|FG001|Overall Study|Adverse Event|5
2024070|NCT00331136|3592468|FG002|Overall Study|Adverse Event|0
2024071|NCT00331136|3592469|FG003|Overall Study|Adverse Event|1
2024072|NCT00331136|3592466|FG000|Overall Study|Withdrawal by Subject|0
2024073|NCT00331136|3592467|FG001|Overall Study|Withdrawal by Subject|1
2024074|NCT00331136|3592468|FG002|Overall Study|Withdrawal by Subject|0
2024075|NCT00331136|3592469|FG003|Overall Study|Withdrawal by Subject|0
2024076|NCT00331136|3592466|FG000|Overall Study|Lost to Follow-up|0
2024077|NCT00331136|3592467|FG001|Overall Study|Lost to Follow-up|1
2024078|NCT00331136|3592468|FG002|Overall Study|Lost to Follow-up|0
2024079|NCT00331136|3592469|FG003|Overall Study|Lost to Follow-up|0
2024080|NCT00331136|3592466|FG000|Overall Study|Protocol Violation|1
2024081|NCT00331136|3592467|FG001|Overall Study|Protocol Violation|0
2024082|NCT00331136|3592468|FG002|Overall Study|Protocol Violation|0
2024083|NCT00331136|3592469|FG003|Overall Study|Protocol Violation|0
2024084|NCT00331136|3592466|FG000|Overall Study|Not treated|1
2024085|NCT00331136|3592467|FG001|Overall Study|Not treated|0
2024086|NCT00331136|3592468|FG002|Overall Study|Not treated|0
2024087|NCT00331136|3592469|FG003|Overall Study|Not treated|0
2217546|NCT01708954|3860856|FG002|Step 1|Off-treatment reason not submitted|1
2024088|NCT00331344|3592488|FG000|Phase I|Adverse Event|0
2024089|NCT00331344|3592489|FG001|Phase I|Adverse Event|0
2024090|NCT00331344|3592490|FG002|Phase I|Adverse Event|0
2024091|NCT00331344|3592491|FG003|Phase I|Adverse Event|1
2024092|NCT00331344|3592492|FG004|Phase I|Adverse Event|2
2024093|NCT00331344|3592493|FG005|Phase I|Adverse Event|2
2024094|NCT00331344|3592494|FG006|Phase I|Adverse Event|0
2024095|NCT00331344|3592495|FG007|Phase I|Adverse Event|1
2024096|NCT00331344|3592496|FG008|Phase I|Adverse Event|0
2024097|NCT00331344|3592488|FG000|Phase II|Death|0
1984447|NCT02489318|3548331|FG000|Randomized|Withdrawal by Subject|0
1984448|NCT02489318|3548332|FG001|Randomized|Withdrawal by Subject|1
1984449|NCT02489318|3548331|FG000|Treated|Adverse Event|19
1984450|NCT02489318|3548332|FG001|Treated|Adverse Event|62
1984451|NCT02489318|3548331|FG000|Treated|Death|13
1984452|NCT02489318|3548332|FG001|Treated|Death|11
1984453|NCT02489318|3548331|FG000|Treated|Physician Decision|4
1984454|NCT02489318|3548332|FG001|Treated|Physician Decision|6
1984455|NCT02489318|3548331|FG000|Treated|Protocol Violation|1
1984456|NCT02489318|3548332|FG001|Treated|Protocol Violation|2
1984457|NCT02489318|3548331|FG000|Treated|Withdrawal by Subject|37
1984458|NCT02489318|3548332|FG001|Treated|Withdrawal by Subject|36
1984459|NCT02489318|3548331|FG000|Treated|Other: Progressive Disease|245
1984460|NCT02489318|3548332|FG001|Treated|Other: Progressive Disease|138
1984461|NCT02489318|3548331|FG000|Treated|Other|0
1984462|NCT02489318|3548332|FG001|Treated|Other|2
1984463|NCT02489318|3548331|FG000|Treated|Ongoing|0
1984464|NCT02489318|3548332|FG001|Treated|Ongoing|267
1984465|NCT02448680|3548341|FG000|Overall Study|Physician Decision|1
1984466|NCT02448680|3548342|FG001|Overall Study|Physician Decision|1
1984467|NCT02448680|3548341|FG000|Overall Study|Withdrawal by Subject|0
1984468|NCT02448680|3548342|FG001|Overall Study|Withdrawal by Subject|2
1984469|NCT02393859|3548352|FG000|Overall Study|Decision by Sponsor|1
1984470|NCT02393859|3548353|FG001|Overall Study|Decision by Sponsor|1
1984471|NCT02393859|3548352|FG000|Overall Study|Withdrawal by Subject|5
1984472|NCT02393859|3548353|FG001|Overall Study|Withdrawal by Subject|2
1984473|NCT02393859|3548352|FG000|Overall Study|Death|16
1984474|NCT02393859|3548353|FG001|Overall Study|Death|8
1984475|NCT02393859|3548352|FG000|Overall Study|Continuing Study|32
1984476|NCT02393859|3548353|FG001|Overall Study|Continuing Study|43
1984477|NCT02277444|3548369|FG000|Overall Study|Adverse Event|10
1984478|NCT02277444|3548369|FG000|Overall Study|Withdrawal by Subject|3
1984479|NCT02277444|3548369|FG000|Overall Study|Other|1
1984480|NCT02277444|3548369|FG000|Overall Study|Enrolled and not Treated|3
1984481|NCT02277444|3548369|FG000|Overall Study|Ongoing|113
1984482|NCT02257736|3548388|FG000|Overall Study|Progressive disease|365
1984483|NCT02257736|3548389|FG001|Overall Study|Progressive disease|327
1984484|NCT02257736|3548388|FG000|Overall Study|Adverse Event|45
1984485|NCT02257736|3548389|FG001|Overall Study|Adverse Event|56
1984486|NCT02257736|3548388|FG000|Overall Study|Withdrawal by Subject|21
1984487|NCT02257736|3548389|FG001|Overall Study|Withdrawal by Subject|38
1984488|NCT02257736|3548388|FG000|Overall Study|Death|11
1984489|NCT02257736|3548389|FG001|Overall Study|Death|6
1984490|NCT02257736|3548388|FG000|Overall Study|Physician Decision|5
1984491|NCT02257736|3548389|FG001|Overall Study|Physician Decision|9
1984492|NCT02257736|3548388|FG000|Overall Study|Non-Compliance with study drug|1
1984493|NCT02257736|3548389|FG001|Overall Study|Non-Compliance with study drug|2
1984494|NCT02257736|3548388|FG000|Overall Study|Protocol Violation|1
1984495|NCT02257736|3548389|FG001|Overall Study|Protocol Violation|0
1984496|NCT02257736|3548388|FG000|Overall Study|Other|1
1984497|NCT02257736|3548389|FG001|Overall Study|Other|7
1984498|NCT02257736|3548388|FG000|Overall Study|Randomized, not treated|1
1984499|NCT02257736|3548389|FG001|Overall Study|Randomized, not treated|2
1984500|NCT02252172|3548397|FG000|Overall Study|Lost to Follow-up|3
1984501|NCT02252172|3548398|FG001|Overall Study|Lost to Follow-up|1
1984502|NCT02252172|3548397|FG000|Overall Study|Ongoing|276
1984503|NCT02252172|3548398|FG001|Overall Study|Ongoing|298
1984504|NCT02195479|3548406|FG000|Overall Study|Lost to Follow-up|3
1984505|NCT02195479|3548407|FG001|Overall Study|Lost to Follow-up|0
1984506|NCT02195479|3548406|FG000|Overall Study|Death|48
1984507|NCT02195479|3548407|FG001|Overall Study|Death|45
1984508|NCT02195479|3548406|FG000|Overall Study|Physician Decision|1
1984509|NCT02195479|3548407|FG001|Overall Study|Physician Decision|0
1984510|NCT02195479|3548406|FG000|Overall Study|Withdrawal by Subject|11
2213277|NCT01677741|3854732|FG003|Overall Study|Enrolled in a rollover study|1
2213278|NCT01677741|3854733|FG004|Overall Study|Enrolled in a rollover study|6
1984511|NCT02195479|3548407|FG001|Overall Study|Withdrawal by Subject|6
1984512|NCT02195479|3548406|FG000|Overall Study|Other|2
1984513|NCT02195479|3548407|FG001|Overall Study|Other|2
1984514|NCT02195479|3548406|FG000|Overall Study|Ongoing|291
1984515|NCT02195479|3548407|FG001|Overall Study|Ongoing|297
1984516|NCT02178358|3548416|FG000|Overall Study|Withdrawal by Subject|0
1984517|NCT02178358|3548417|FG001|Overall Study|Withdrawal by Subject|2
1984518|NCT02178358|3548418|FG002|Overall Study|Withdrawal by Subject|2
1984519|NCT02178358|3548416|FG000|Overall Study|Lost to Follow-up|1
1984520|NCT02178358|3548417|FG001|Overall Study|Lost to Follow-up|0
1984521|NCT02178358|3548418|FG002|Overall Study|Lost to Follow-up|0
1984522|NCT02136134|3548429|FG000|Overall Study|Death|35
1984523|NCT02136134|3548430|FG001|Overall Study|Death|29
1984524|NCT02136134|3548429|FG000|Overall Study|Withdrawal by Subject|14
1984525|NCT02136134|3548430|FG001|Overall Study|Withdrawal by Subject|4
2213279|NCT01677741|3854734|FG005|Overall Study|Enrolled in a rollover study|6
1984526|NCT02136134|3548429|FG000|Overall Study|Other|3
1984527|NCT02136134|3548430|FG001|Overall Study|Other|3
1984528|NCT02136134|3548429|FG000|Overall Study|Ongoing|185
1984529|NCT02136134|3548430|FG001|Overall Study|Ongoing|207
1984530|NCT02136134|3548429|FG000|Overall Study|Subjects randomized but not treated|10
1984531|NCT02136134|3548430|FG001|Overall Study|Subjects randomized but not treated|8
1984532|NCT02076009|3548438|FG000|Overall Study|Death|44
1984533|NCT02076009|3548439|FG001|Overall Study|Death|30
1984534|NCT02076009|3548438|FG000|Overall Study|Withdrawal by Subject|9
1984535|NCT02076009|3548439|FG001|Overall Study|Withdrawal by Subject|3
1984536|NCT02076009|3548438|FG000|Overall Study|Lost to Follow-up|1
1984537|NCT02076009|3548439|FG001|Overall Study|Lost to Follow-up|1
1984538|NCT02076009|3548438|FG000|Overall Study|Progressive disease|1
1984539|NCT02076009|3548439|FG001|Overall Study|Progressive disease|0
1984540|NCT02076009|3548438|FG000|Overall Study|Ongoing|226
1984541|NCT02076009|3548439|FG001|Overall Study|Ongoing|249
1984542|NCT02076009|3548438|FG000|Overall Study|Subjects randomized but not treated|2
1984543|NCT02076009|3548439|FG001|Overall Study|Subjects randomized but not treated|3
1984544|NCT02073279|3548447|FG000|Double-blind Period|Adverse Event|1
1984545|NCT02073279|3548448|FG001|Double-blind Period|Adverse Event|1
1984546|NCT02073279|3548447|FG000|Double-blind Period|Protocol Deviation|0
1984547|NCT02073279|3548448|FG001|Double-blind Period|Protocol Deviation|1
1984548|NCT02073279|3548447|FG000|Double-blind Period|Withdrawal by Subject|2
1984549|NCT02073279|3548448|FG001|Double-blind Period|Withdrawal by Subject|2
1984550|NCT02073279|3548447|FG000|Double-blind Period|Reason Not Specified|1
1984551|NCT02073279|3548448|FG001|Double-blind Period|Reason Not Specified|2
1984552|NCT02073279|3548447|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0
1984553|NCT02073279|3548448|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1
1984554|NCT02073279|3548447|FG000|Double-blind Period|On-going in Study|11
1984555|NCT02073279|3548448|FG001|Double-blind Period|On-going in Study|40
1984556|NCT02073279|3548447|FG000|Open-label Extension Period|Lack of Efficacy|1
1984557|NCT02073279|3548448|FG001|Open-label Extension Period|Lack of Efficacy|0
1984558|NCT02073279|3548447|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0
1984559|NCT02073279|3548448|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1
1984560|NCT02073279|3548447|FG000|Open-label Extension Period|Withdrawal by Subject|1
1984561|NCT02073279|3548448|FG001|Open-label Extension Period|Withdrawal by Subject|1
1984562|NCT02073279|3548447|FG000|Open-label Extension Period|Reason Not Specified|1
1984563|NCT02073279|3548448|FG001|Open-label Extension Period|Reason Not Specified|1
1984564|NCT02073279|3548447|FG000|Open-label Extension Period|On-going in Study|14
1984565|NCT02073279|3548448|FG001|Open-label Extension Period|On-going in Study|13
1984566|NCT02051933|3548459|FG000|Overall Study|Physician Decision|0
1984567|NCT02051933|3548460|FG001|Overall Study|Physician Decision|1
1984568|NCT01946204|3548473|FG000|Overall Study|Death|38
1984569|NCT01946204|3548474|FG001|Overall Study|Death|59
1984570|NCT01946204|3548473|FG000|Overall Study|Withdrawal by Subject|37
1984571|NCT01946204|3548474|FG001|Overall Study|Withdrawal by Subject|50
1984572|NCT01946204|3548473|FG000|Overall Study|Lost to Follow-up|3
1984573|NCT01946204|3548474|FG001|Overall Study|Lost to Follow-up|7
1984574|NCT01946204|3548473|FG000|Overall Study|Ongoing|316
1984575|NCT01946204|3548474|FG001|Overall Study|Ongoing|687
1984576|NCT01946204|3548473|FG000|Overall Study|Other|7
1984577|NCT01946204|3548474|FG001|Overall Study|Other|3
1984578|NCT01615029|3548485|FG000|Overall Study|Adverse Event|0
1984579|NCT01615029|3548486|FG001|Overall Study|Adverse Event|0
1984580|NCT01615029|3548487|FG002|Overall Study|Adverse Event|0
1984581|NCT01615029|3548488|FG003|Overall Study|Adverse Event|0
1984582|NCT01615029|3548489|FG004|Overall Study|Adverse Event|1
1984583|NCT01615029|3548485|FG000|Overall Study|Death|0
1984584|NCT01615029|3548486|FG001|Overall Study|Death|0
1984585|NCT01615029|3548487|FG002|Overall Study|Death|0
1984586|NCT01615029|3548488|FG003|Overall Study|Death|0
1984587|NCT01615029|3548489|FG004|Overall Study|Death|1
1984588|NCT01615029|3548485|FG000|Overall Study|Lost to Follow-up|0
1984589|NCT01615029|3548486|FG001|Overall Study|Lost to Follow-up|0
1984590|NCT01615029|3548487|FG002|Overall Study|Lost to Follow-up|0
1984591|NCT01615029|3548488|FG003|Overall Study|Lost to Follow-up|0
1984592|NCT01615029|3548489|FG004|Overall Study|Lost to Follow-up|1
1984593|NCT01615029|3548485|FG000|Overall Study|Progressive disease|2
1984594|NCT01615029|3548486|FG001|Overall Study|Progressive disease|1
1984595|NCT01615029|3548487|FG002|Overall Study|Progressive disease|1
2213280|NCT01677741|3854735|FG006|Overall Study|Enrolled in a rollover study|7
2213281|NCT01677741|3854736|FG007|Overall Study|Enrolled in a rollover study|0
2213282|NCT01677741|3854729|FG000|Overall Study|Progressive disease|1
2213283|NCT01677741|3854730|FG001|Overall Study|Progressive disease|0
2213284|NCT01677741|3854731|FG002|Overall Study|Progressive disease|1
2213285|NCT01677741|3854732|FG003|Overall Study|Progressive disease|0
2213286|NCT01677741|3854733|FG004|Overall Study|Progressive disease|0
2213287|NCT01677741|3854734|FG005|Overall Study|Progressive disease|1
2213288|NCT01677741|3854735|FG006|Overall Study|Progressive disease|0
1984596|NCT01615029|3548488|FG003|Overall Study|Progressive disease|1
1984597|NCT01615029|3548489|FG004|Overall Study|Progressive disease|5
1984598|NCT01615029|3548485|FG000|Overall Study|Physician Decision|0
1984599|NCT01615029|3548486|FG001|Overall Study|Physician Decision|0
1984600|NCT01615029|3548487|FG002|Overall Study|Physician Decision|0
1984601|NCT01615029|3548488|FG003|Overall Study|Physician Decision|0
1984602|NCT01615029|3548489|FG004|Overall Study|Physician Decision|1
1984603|NCT01615029|3548485|FG000|Overall Study|Ongoing|1
2213289|NCT01677741|3854736|FG007|Overall Study|Progressive disease|0
2213290|NCT01677767|3854770|FG000|Overall Study|Adverse Event|1
1984604|NCT01615029|3548486|FG001|Overall Study|Ongoing|2
1984605|NCT01615029|3548487|FG002|Overall Study|Ongoing|3
1984606|NCT01615029|3548488|FG003|Overall Study|Ongoing|2
1984607|NCT01615029|3548489|FG004|Overall Study|Ongoing|23
1984608|NCT01544127|3548504|FG000|Overall Study|Lost to Follow-up|4
1984609|NCT01544127|3548505|FG001|Overall Study|Lost to Follow-up|2
1984610|NCT01544127|3548506|FG002|Overall Study|Lost to Follow-up|9
1984611|NCT01544127|3548504|FG000|Overall Study|Withdrawal by Subject|2
1984612|NCT01544127|3548505|FG001|Overall Study|Withdrawal by Subject|2
1984613|NCT01544127|3548506|FG002|Overall Study|Withdrawal by Subject|1
1984614|NCT01544127|3548504|FG000|Overall Study|Discharged out of catchment area|1
1984615|NCT01544127|3548505|FG001|Overall Study|Discharged out of catchment area|1
1984616|NCT01544127|3548506|FG002|Overall Study|Discharged out of catchment area|1
1984617|NCT01544127|3548504|FG000|Overall Study|Death|1
1984618|NCT01544127|3548505|FG001|Overall Study|Death|0
1984619|NCT01544127|3548506|FG002|Overall Study|Death|0
1984620|NCT01544127|3548504|FG000|Overall Study|Jail or Prison|1
1984621|NCT01544127|3548505|FG001|Overall Study|Jail or Prison|1
1984622|NCT01544127|3548506|FG002|Overall Study|Jail or Prison|2
1984623|NCT01544127|3548504|FG000|Overall Study|Became Psychotic|1
1984624|NCT01544127|3548505|FG001|Overall Study|Became Psychotic|0
1984625|NCT01544127|3548506|FG002|Overall Study|Became Psychotic|0
1984626|NCT01544127|3548504|FG000|Overall Study|Researcher withdrew|1
1984627|NCT01544127|3548505|FG001|Overall Study|Researcher withdrew|0
1984628|NCT01544127|3548506|FG002|Overall Study|Researcher withdrew|0
1984629|NCT01544127|3548504|FG000|Overall Study|Went active duty|0
1984630|NCT01544127|3548505|FG001|Overall Study|Went active duty|0
1984631|NCT01544127|3548506|FG002|Overall Study|Went active duty|1
1984632|NCT01314118|3548515|FG000|Overall Study|Adverse Event|9
1984633|NCT01314118|3548515|FG000|Overall Study|Progressive disease|27
1984634|NCT01314118|3548515|FG000|Overall Study|Physician Decision|11
1984635|NCT01314118|3548515|FG000|Overall Study|Death|4
1984636|NCT01314118|3548515|FG000|Overall Study|Protocol Violation|5
1984637|NCT01314118|3548515|FG000|Overall Study|Withdrawal by Subject|11
1984638|NCT01314118|3548515|FG000|Overall Study|Other|2
1984639|NCT01314118|3548515|FG000|Overall Study|Ongoing|62
1984640|NCT01171898|3548523|FG000|Overall Study|Death|0
1984641|NCT01171898|3548524|FG001|Overall Study|Death|0
1984642|NCT01171898|3548525|FG002|Overall Study|Death|2
1984643|NCT01171898|3548526|FG003|Overall Study|Death|0
1984644|NCT01171898|3548523|FG000|Overall Study|Lost to Follow-up|0
1984645|NCT01171898|3548524|FG001|Overall Study|Lost to Follow-up|1
1984646|NCT01171898|3548525|FG002|Overall Study|Lost to Follow-up|1
1984647|NCT01171898|3548526|FG003|Overall Study|Lost to Follow-up|1
1984648|NCT01171898|3548523|FG000|Overall Study|Withdrawal by Subject|1
1984649|NCT01171898|3548524|FG001|Overall Study|Withdrawal by Subject|4
1984650|NCT01171898|3548525|FG002|Overall Study|Withdrawal by Subject|6
1984651|NCT01171898|3548526|FG003|Overall Study|Withdrawal by Subject|3
1984652|NCT01171898|3548523|FG000|Overall Study|Terminated by Sponsor|1
1984653|NCT01171898|3548524|FG001|Overall Study|Terminated by Sponsor|0
1984654|NCT01171898|3548525|FG002|Overall Study|Terminated by Sponsor|0
1984655|NCT01171898|3548526|FG003|Overall Study|Terminated by Sponsor|0
2213291|NCT01677767|3854770|FG000|Overall Study|Death|4
2213292|NCT01677767|3854770|FG000|Overall Study|Protocol Violation|4
2213293|NCT01677767|3854770|FG000|Overall Study|Withdrawal by Subject|10
2213294|NCT01677767|3854770|FG000|Overall Study|Non-compliance by the participants|3
2213295|NCT01677858|3854781|FG000|Overall Study|Adverse Event|0
2213296|NCT01677858|3854782|FG001|Overall Study|Adverse Event|0
2213297|NCT01677858|3854783|FG002|Overall Study|Adverse Event|2
2213298|NCT01677858|3854784|FG003|Overall Study|Adverse Event|3
2213299|NCT01677858|3854785|FG004|Overall Study|Adverse Event|13
2213300|NCT01677858|3854781|FG000|Overall Study|Death|0
2213301|NCT01677858|3854782|FG001|Overall Study|Death|0
2213302|NCT01677858|3854783|FG002|Overall Study|Death|0
2213303|NCT01677858|3854784|FG003|Overall Study|Death|0
2213304|NCT01677858|3854785|FG004|Overall Study|Death|1
2213305|NCT01677858|3854781|FG000|Overall Study|Physician Decision|1
2213306|NCT01677858|3854782|FG001|Overall Study|Physician Decision|0
2213307|NCT01677858|3854783|FG002|Overall Study|Physician Decision|2
2213308|NCT01677858|3854784|FG003|Overall Study|Physician Decision|0
2213309|NCT01677858|3854785|FG004|Overall Study|Physician Decision|12
2213310|NCT01677858|3854781|FG000|Overall Study|Progressive Disease|2
2213311|NCT01677858|3854782|FG001|Overall Study|Progressive Disease|1
2213312|NCT01677858|3854783|FG002|Overall Study|Progressive Disease|9
2213313|NCT01677858|3854784|FG003|Overall Study|Progressive Disease|3
1984656|NCT01171898|3548523|FG000|Overall Study|Ongoing|1
1984657|NCT01171898|3548524|FG001|Overall Study|Ongoing|9
1984658|NCT01171898|3548525|FG002|Overall Study|Ongoing|3
1984659|NCT01171898|3548526|FG003|Overall Study|Ongoing|0
1984660|NCT01171898|3548523|FG000|Overall Study|Other|1
1984661|NCT01171898|3548524|FG001|Overall Study|Other|5
1984662|NCT01171898|3548525|FG002|Overall Study|Other|0
1984663|NCT01171898|3548526|FG003|Overall Study|Other|2
1984664|NCT00777036|3548551|FG000|On Treatment|Reason Not Specified|4
2213314|NCT01677858|3854785|FG004|Overall Study|Progressive Disease|43
2213315|NCT01677858|3854781|FG000|Overall Study|Withdrawal by Subject|0
1984665|NCT00777036|3548552|FG001|On Treatment|Reason Not Specified|7
1984666|NCT00777036|3548553|FG002|On Treatment|Reason Not Specified|12
1984667|NCT00777036|3548551|FG000|On Treatment|Failure to Meet Study Criteria|0
1984668|NCT00777036|3548552|FG001|On Treatment|Failure to Meet Study Criteria|1
1984669|NCT00777036|3548553|FG002|On Treatment|Failure to Meet Study Criteria|0
1984670|NCT00777036|3548551|FG000|On Treatment|Non-compliance with Study Drug|1
1984671|NCT00777036|3548552|FG001|On Treatment|Non-compliance with Study Drug|0
1984672|NCT00777036|3548553|FG002|On Treatment|Non-compliance with Study Drug|0
1984673|NCT00777036|3548551|FG000|On Treatment|Maximum Clinical Benefit|2
1984674|NCT00777036|3548552|FG001|On Treatment|Maximum Clinical Benefit|0
1984675|NCT00777036|3548553|FG002|On Treatment|Maximum Clinical Benefit|1
1984676|NCT00777036|3548551|FG000|On Treatment|Withdrawal by Subject|3
1984677|NCT00777036|3548552|FG001|On Treatment|Withdrawal by Subject|2
1984678|NCT00777036|3548553|FG002|On Treatment|Withdrawal by Subject|3
1984679|NCT00777036|3548551|FG000|On Treatment|Death|0
1984680|NCT00777036|3548552|FG001|On Treatment|Death|2
1984681|NCT00777036|3548553|FG002|On Treatment|Death|0
1984682|NCT00777036|3548551|FG000|On Treatment|Study Drug Toxicity|0
1984683|NCT00777036|3548552|FG001|On Treatment|Study Drug Toxicity|0
1984684|NCT00777036|3548553|FG002|On Treatment|Study Drug Toxicity|1
1984685|NCT00777036|3548551|FG000|On Treatment|Progressive Disease|5
1984686|NCT00777036|3548552|FG001|On Treatment|Progressive Disease|4
1984687|NCT00777036|3548553|FG002|On Treatment|Progressive Disease|6
1984688|NCT00777036|3548551|FG000|Follow-Up|Lost to Follow-up|1
1984689|NCT00777036|3548552|FG001|Follow-Up|Lost to Follow-up|0
1984690|NCT00777036|3548553|FG002|Follow-Up|Lost to Follow-up|0
1984691|NCT00777036|3548551|FG000|Follow-Up|Reason Not Specified|2
1984692|NCT00777036|3548552|FG001|Follow-Up|Reason Not Specified|0
1984693|NCT00777036|3548553|FG002|Follow-Up|Reason Not Specified|0
1984694|NCT00777036|3548551|FG000|Follow-Up|Withdrawal by Subject|1
1984695|NCT00777036|3548552|FG001|Follow-Up|Withdrawal by Subject|0
1984696|NCT00777036|3548553|FG002|Follow-Up|Withdrawal by Subject|4
1984697|NCT00777036|3548551|FG000|Follow-Up|Death|1
1984698|NCT00777036|3548552|FG001|Follow-Up|Death|8
1984699|NCT00777036|3548553|FG002|Follow-Up|Death|0
1984700|NCT00442559|3548577|FG000|Overall Study|Lost to Follow-up|32
1984701|NCT00442559|3548578|FG001|Overall Study|Lost to Follow-up|34
1984702|NCT00442559|3548577|FG000|Overall Study|Protocol Violation|1
1984703|NCT00442559|3548578|FG001|Overall Study|Protocol Violation|1
1984704|NCT00442559|3548577|FG000|Overall Study|Withdrawal by Subject|1
1984705|NCT00442559|3548578|FG001|Overall Study|Withdrawal by Subject|0
1984706|NCT00117338|3548592|FG000|Overall Study|Adverse Event|0
1984707|NCT00117338|3548593|FG001|Overall Study|Adverse Event|1
1984708|NCT00117338|3548592|FG000|Overall Study|Protocol Violation|3
1984709|NCT00117338|3548593|FG001|Overall Study|Protocol Violation|2
1984710|NCT00117338|3548592|FG000|Overall Study|Withdrawal by Subject|1
1984711|NCT00117338|3548593|FG001|Overall Study|Withdrawal by Subject|0
1984712|NCT00117338|3548592|FG000|Overall Study|Did not meet Inclusion Criteria|1
1984713|NCT00117338|3548593|FG001|Overall Study|Did not meet Inclusion Criteria|0
1984714|NCT00117338|3548592|FG000|Overall Study|Lack of Efficacy|0
1984715|NCT00117338|3548593|FG001|Overall Study|Lack of Efficacy|1
2024098|NCT00331344|3592489|FG001|Phase II|Death|0
2024099|NCT00331344|3592490|FG002|Phase II|Death|0
2024100|NCT00331344|3592491|FG003|Phase II|Death|0
2024101|NCT00331344|3592492|FG004|Phase II|Death|0
2024102|NCT00331344|3592493|FG005|Phase II|Death|0
2024103|NCT00331344|3592494|FG006|Phase II|Death|0
2024104|NCT00331344|3592495|FG007|Phase II|Death|0
2024105|NCT00331344|3592496|FG008|Phase II|Death|4
2024106|NCT00331409|3592509|FG000|Overall Study|Lack of Efficacy|4
2024107|NCT00331422|3592513|FG000|Overall Study|Did not receive entire study regimen|5
2024108|NCT00331552|3592520|FG000|Period 3: Phase II|Neurological Symptoms|1
2024109|NCT00331552|3592521|FG001|Period 3: Phase II|Neurological Symptoms|0
2024110|NCT00331552|3592520|FG000|Period 3: Phase II|Severe Nausea|1
2024111|NCT00331552|3592521|FG001|Period 3: Phase II|Severe Nausea|0
2024112|NCT00331630|3592532|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1
2024113|NCT00331630|3592532|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
2024114|NCT00331630|3592532|FG000|Follow up for 5 Years|Death|5
2024115|NCT00331630|3592532|FG000|Follow up for 5 Years|Data collection was stopped|24
2024116|NCT00331682|3592536|FG000|Overall Study|Adverse Event|1
2024117|NCT00331760|3592542|FG000|Overall Study|Ineligible / no protocol treatment|15
2024118|NCT00331760|3592543|FG001|Overall Study|Ineligible / no protocol treatment|8
2024119|NCT00331773|3592552|FG000|Overall Study|Withdrawal by Subject|6
2024120|NCT00331773|3592553|FG001|Overall Study|Withdrawal by Subject|4
2024121|NCT00331773|3592552|FG000|Overall Study|Protocol Violation|10
2024122|NCT00331773|3592553|FG001|Overall Study|Protocol Violation|3
2024123|NCT00331799|3592560|FG000|Overall Study|Withdrawal by Subject|2
2024124|NCT00331799|3592560|FG000|Overall Study|Sedation|1
2025977|NCT00348140|3594698|FG001|Overall Study|Non-compliance|13
2025978|NCT00348140|3594699|FG002|Overall Study|Non-compliance|5
2025979|NCT00348140|3594697|FG000|Overall Study|Participant at risk due to study drug|2
2025980|NCT00348140|3594698|FG001|Overall Study|Participant at risk due to study drug|0
2025981|NCT00348140|3594699|FG002|Overall Study|Participant at risk due to study drug|0
2025982|NCT00348140|3594697|FG000|Overall Study|Conditional medication increased dose|1
2025983|NCT00348140|3594698|FG001|Overall Study|Conditional medication increased dose|0
2025984|NCT00348140|3594699|FG002|Overall Study|Conditional medication increased dose|0
2025985|NCT00348140|3594697|FG000|Overall Study|Caregiver related|4
2025986|NCT00348140|3594698|FG001|Overall Study|Caregiver related|7
2025987|NCT00348140|3594699|FG002|Overall Study|Caregiver related|3
2025988|NCT00348140|3594697|FG000|Overall Study|Participant hospitalised|3
2025989|NCT00348140|3594698|FG001|Overall Study|Participant hospitalised|0
1984716|NCT04851314|3548613|FG000|Overall Study|Unable to complete research set-up procedures|0
1984717|NCT04851314|3548614|FG001|Overall Study|Unable to complete research set-up procedures|2
1984718|NCT04851314|3548613|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3
1984719|NCT04851314|3548614|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2
1984720|NCT04821245|3548639|FG000|Overall Study|Withdrawal by Subject|3
1984721|NCT04821245|3548639|FG000|Overall Study|Physician Decision|1
1984722|NCT04821245|3548639|FG000|Overall Study|Protocol Violation|5
1984723|NCT04799782|3548654|FG000|Washout|Physician Decision|2
1984724|NCT04799782|3548655|FG001|Washout|Physician Decision|0
1984725|NCT04799782|3548654|FG000|Washout|Withdrawal by Subject|0
1984726|NCT04799782|3548655|FG001|Washout|Withdrawal by Subject|2
1984727|NCT04799782|3548654|FG000|Washout|Lost to Follow-up|0
1984728|NCT04799782|3548655|FG001|Washout|Lost to Follow-up|1
1984729|NCT04755595|3548690|FG000|Overall Study|Lost to Follow-up|1
1984730|NCT04749745|3548695|FG000|Overall Study|Withdrawal by Subject|1
1984731|NCT04749745|3548696|FG001|Overall Study|Withdrawal by Subject|0
1984734|NCT04737278|3548713|FG000|Overall Study|Lost to Follow-up|1
1984735|NCT04737278|3548714|FG001|Overall Study|Lost to Follow-up|1
1984736|NCT04737278|3548713|FG000|Overall Study|Withdrawal by Subject|1
1984737|NCT04737278|3548714|FG001|Overall Study|Withdrawal by Subject|0
1984738|NCT04737278|3548713|FG000|Overall Study|Protocol Violation|1
1984739|NCT04737278|3548714|FG001|Overall Study|Protocol Violation|1
1984740|NCT04737278|3548713|FG000|Overall Study|failure to complete questionnaire|1
1984741|NCT04737278|3548714|FG001|Overall Study|failure to complete questionnaire|1
1984742|NCT04732338|3548746|FG000|Overall Study|Lost to Follow-up|3
1984743|NCT04732338|3548747|FG001|Overall Study|Lost to Follow-up|3
1984744|NCT04728802|3548755|FG000|Overall Study|Withdrawal by Subject|4
1984745|NCT04728802|3548756|FG001|Overall Study|Withdrawal by Subject|20
1984746|NCT04728802|3548755|FG000|Overall Study|Physician Decision|7
1984747|NCT04728802|3548756|FG001|Overall Study|Physician Decision|7
1984748|NCT04728802|3548755|FG000|Overall Study|Protocol Violation|10
1984749|NCT04728802|3548756|FG001|Overall Study|Protocol Violation|4
1984750|NCT04728802|3548755|FG000|Overall Study|Transfer|1
1984751|NCT04728802|3548756|FG001|Overall Study|Transfer|0
1984752|NCT04728802|3548755|FG000|Overall Study|Death|4
1984753|NCT04728802|3548756|FG001|Overall Study|Death|5
1984754|NCT04728802|3548755|FG000|Overall Study|Other|3
1984755|NCT04728802|3548756|FG001|Overall Study|Other|0
1984756|NCT04725500|3548777|FG000|Screening|Screen Failure|26
1984757|NCT04725500|3548777|FG000|Screening|Withdrawal by Subject|1
1984758|NCT04725500|3548777|FG000|2 Week Take Home|Screen Fail|5
1984759|NCT04716426|3548792|FG000|Overall Study|Vaccination|1
1984760|NCT04716426|3548793|FG001|Overall Study|Vaccination|1
1984761|NCT04716426|3548792|FG000|Overall Study|Contamination|1
1984762|NCT04716426|3548793|FG001|Overall Study|Contamination|0
1984763|NCT04698993|3548825|FG000|Overall Study|PCR results not accessible|2
1984764|NCT04698993|3548826|FG001|Overall Study|PCR results not accessible|7
1984765|NCT04698993|3548825|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1
1984766|NCT04698993|3548826|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0
1984767|NCT04674644|3548853|FG000|Overall Study|with missing data|37
1984768|NCT04668989|3548871|FG000|First Intervention|Covid-19 related self-isolation|0
1984769|NCT04668989|3548872|FG001|First Intervention|Covid-19 related self-isolation|1
1984770|NCT04668989|3548871|FG000|Second Intervention|Adverse Event|0
1984771|NCT04668989|3548872|FG001|Second Intervention|Adverse Event|1
1984772|NCT04646109|3548938|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0
1984773|NCT04646109|3548939|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6
1984774|NCT04633642|3548974|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1
1984775|NCT04633642|3548975|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2
1984776|NCT04633564|3548983|FG000|Period 1|Adverse Event|28
1984777|NCT04633564|3548984|FG001|Period 1|Adverse Event|19
1984778|NCT04633564|3548983|FG000|Period 1|Death|8
1984779|NCT04633564|3548984|FG001|Period 1|Death|7
1984780|NCT04633564|3548983|FG000|Period 1|Lost to Follow-up|3
1984781|NCT04633564|3548984|FG001|Period 1|Lost to Follow-up|5
1984782|NCT04633564|3548983|FG000|Period 1|Physician Decision|4
1984783|NCT04633564|3548984|FG001|Period 1|Physician Decision|12
1984784|NCT04633564|3548983|FG000|Period 1|Protocol Violation|0
1984785|NCT04633564|3548984|FG001|Period 1|Protocol Violation|1
1984786|NCT04633564|3548983|FG000|Period 1|Withdrawal by Subject|10
1984787|NCT04633564|3548984|FG001|Period 1|Withdrawal by Subject|8
1984788|NCT04633564|3548983|FG000|Period 1|Progressive disease|47
1984789|NCT04633564|3548984|FG001|Period 1|Progressive disease|51
1984790|NCT04633564|3548983|FG000|Period 1|Terminated by Sponsor|8
1984791|NCT04633564|3548984|FG001|Period 1|Terminated by Sponsor|6
1984792|NCT04633564|3548983|FG000|Period 2|Adverse Event|3
1984793|NCT04633564|3548984|FG001|Period 2|Adverse Event|4
1984794|NCT04633564|3548983|FG000|Period 2|Death|0
1984795|NCT04633564|3548984|FG001|Period 2|Death|2
1984796|NCT04633564|3548983|FG000|Period 2|Lost to Follow-up|0
1984797|NCT04633564|3548984|FG001|Period 2|Lost to Follow-up|1
1984798|NCT04633564|3548983|FG000|Period 2|Physician Decision|2
1984799|NCT04633564|3548984|FG001|Period 2|Physician Decision|4
1984800|NCT04633564|3548983|FG000|Period 2|Withdrawal by Subject|5
1984801|NCT04633564|3548984|FG001|Period 2|Withdrawal by Subject|1
1984732|NCT04748341|3548704|FG000|Overall Study|Lost to Follow-up|1
1984733|NCT04748341|3548705|FG001|Overall Study|Lost to Follow-up|1
1984802|NCT04633564|3548983|FG000|Period 2|Progressive Disease|74
1984803|NCT04633564|3548984|FG001|Period 2|Progressive Disease|82
1984804|NCT04633564|3548983|FG000|Period 2|Terminated by Sponsor|9
1984805|NCT04633564|3548984|FG001|Period 2|Terminated by Sponsor|3
2024125|NCT00331864|3592566|FG000|Overall Study|Adverse Event|30
2024126|NCT00331864|3592567|FG001|Overall Study|Adverse Event|1
2024127|NCT00331864|3592566|FG000|Overall Study|Lack of Efficacy|4
2024128|NCT00331864|3592567|FG001|Overall Study|Lack of Efficacy|0
2024129|NCT00331864|3592566|FG000|Overall Study|Protocol Violation|3
2024130|NCT00331864|3592567|FG001|Overall Study|Protocol Violation|0
2024131|NCT00331864|3592566|FG000|Overall Study|Withdrawal by Subject|10
2024132|NCT00331864|3592567|FG001|Overall Study|Withdrawal by Subject|0
2024133|NCT00331864|3592566|FG000|Overall Study|Lost to Follow-up|4
2024134|NCT00331864|3592567|FG001|Overall Study|Lost to Follow-up|3
2024135|NCT00331864|3592566|FG000|Overall Study|Administrative Problems|1
2024136|NCT00331864|3592567|FG001|Overall Study|Administrative Problems|0
2024137|NCT00331864|3592566|FG000|Overall Study|Death|6
2024138|NCT00331864|3592567|FG001|Overall Study|Death|0
2024139|NCT00332189|3592582|FG000|Overall Study|Adverse Event|3
2024140|NCT00332189|3592582|FG000|Overall Study|Uncooperative/Noncompliant|3
2024141|NCT00332189|3592582|FG000|Overall Study|Withdrawal by Subject|9
2024142|NCT00332189|3592582|FG000|Overall Study|Lack of Efficacy|4
2024143|NCT00332189|3592582|FG000|Overall Study|Moved out of country|2
2024144|NCT00332202|3592589|FG000|Overall Study|Adverse Event|72
2024145|NCT00332202|3592590|FG001|Overall Study|Adverse Event|28
2024146|NCT00332202|3592589|FG000|Overall Study|Lost to Follow-up|2
2310743|NCT02739594|4015291|FG001|Overall Study|Undesired Event|4
2310744|NCT02739594|4015290|FG000|Overall Study|Violation of Eligibility Criteria|1
2310745|NCT02739594|4015291|FG001|Overall Study|Violation of Eligibility Criteria|2
2310746|NCT02739594|4015290|FG000|Overall Study|Protocol Violation|5
2310747|NCT02739594|4015291|FG001|Overall Study|Protocol Violation|6
2310748|NCT02739594|4015290|FG000|Overall Study|Death|4
2310749|NCT02739594|4015291|FG001|Overall Study|Death|2
2310750|NCT02739594|4015290|FG000|Overall Study|Renal Insufficiency|4
2310751|NCT02739594|4015291|FG001|Overall Study|Renal Insufficiency|6
2310752|NCT02739594|4015290|FG000|Overall Study|Administrative Reasons|1
2310753|NCT02739594|4015291|FG001|Overall Study|Administrative Reasons|3
2310754|NCT02739594|4015290|FG000|Overall Study|Withdrawal by Subject|1
2310755|NCT02739594|4015291|FG001|Overall Study|Withdrawal by Subject|1
2310756|NCT02739594|4015290|FG000|Overall Study|Lost to Follow-up|0
2310757|NCT02739594|4015291|FG001|Overall Study|Lost to Follow-up|1
2310758|NCT02739594|4015290|FG000|Overall Study|Elevated Serum Creatinine|0
2310759|NCT02739594|4015291|FG001|Overall Study|Elevated Serum Creatinine|1
2310760|NCT02739594|4015290|FG000|Overall Study|Other|6
2310761|NCT02739594|4015291|FG001|Overall Study|Other|2
2310762|NCT02739828|4015316|FG000|Overall Study|Adverse Event|1
2310763|NCT02739828|4015316|FG000|Overall Study|Lost to Follow-up|4
2310764|NCT02739984|4015322|FG000|Overall Study|Sponsor Decision|1
2310765|NCT02739984|4015323|FG001|Overall Study|Sponsor Decision|0
2310766|NCT02739984|4015322|FG000|Overall Study|Withdrawal by Subject|1
2310767|NCT02739984|4015323|FG001|Overall Study|Withdrawal by Subject|1
2310768|NCT02739984|4015322|FG000|Overall Study|Death|0
2310769|NCT02739984|4015323|FG001|Overall Study|Death|1
2310770|NCT02739984|4015322|FG000|Overall Study|Lost to Follow-up|3
2310771|NCT02739984|4015323|FG001|Overall Study|Lost to Follow-up|0
2310772|NCT02739997|4015329|FG000|Overall Study|Death|1
2310773|NCT02739997|4015329|FG000|Overall Study|Withdrawal by Subject|1
2310774|NCT02740049|4015333|FG000|Overall Study|Isolated cells did not grow sufficiently|1
2310775|NCT02740478|4015365|FG000|Overall Study|Withdrawal by Subject|1
2310776|NCT02741076|4015421|FG000|Overall Study|Adverse Event|0
2310777|NCT02741076|4015422|FG001|Overall Study|Adverse Event|1
2310778|NCT02741076|4015423|FG002|Overall Study|Adverse Event|1
2310779|NCT02741076|4015424|FG003|Overall Study|Adverse Event|0
2310780|NCT02741076|4015421|FG000|Overall Study|Lack of Efficacy|1
2310781|NCT02741076|4015422|FG001|Overall Study|Lack of Efficacy|0
2310782|NCT02741076|4015423|FG002|Overall Study|Lack of Efficacy|0
2310783|NCT02741076|4015424|FG003|Overall Study|Lack of Efficacy|0
2310784|NCT02741076|4015421|FG000|Overall Study|Withdrawal by Subject|0
2310785|NCT02741076|4015422|FG001|Overall Study|Withdrawal by Subject|1
2310786|NCT02741076|4015423|FG002|Overall Study|Withdrawal by Subject|0
2310787|NCT02741076|4015424|FG003|Overall Study|Withdrawal by Subject|0
2310788|NCT02741076|4015421|FG000|Overall Study|Sponsor Request|2
2310789|NCT02741076|4015422|FG001|Overall Study|Sponsor Request|3
2310790|NCT02741076|4015423|FG002|Overall Study|Sponsor Request|0
2310791|NCT02741076|4015424|FG003|Overall Study|Sponsor Request|1
2310792|NCT02741076|4015421|FG000|Overall Study|No additional information available|0
2310793|NCT02741076|4015422|FG001|Overall Study|No additional information available|0
2310794|NCT02741076|4015423|FG002|Overall Study|No additional information available|1
2024147|NCT00332202|3592590|FG001|Overall Study|Lost to Follow-up|1
2024148|NCT00332202|3592589|FG000|Overall Study|Physician Decision|6
2310795|NCT02741076|4015424|FG003|Overall Study|No additional information available|1
2310796|NCT02741310|4015452|FG000|Overall Study|Sponsor Decision|2
2310797|NCT02741310|4015453|FG001|Overall Study|Sponsor Decision|2
2310798|NCT02741518|4015469|FG000|Overall Study|Withdrawal by Subject|1
1984806|NCT04608500|3549044|FG000|Overall Study|Adverse Event|2
1984807|NCT04608500|3549045|FG001|Overall Study|Adverse Event|0
1984808|NCT04608500|3549044|FG000|Overall Study|Lost to Follow-up|15
1984809|NCT04608500|3549045|FG001|Overall Study|Lost to Follow-up|9
1984810|NCT04608500|3549044|FG000|Overall Study|Participant request|11
1984811|NCT04608500|3549045|FG001|Overall Study|Participant request|7
1984812|NCT04608500|3549044|FG000|Overall Study|Protocol Violation|1
1984813|NCT04608500|3549045|FG001|Overall Study|Protocol Violation|0
1984814|NCT04608500|3549044|FG000|Overall Study|Other|6
1984815|NCT04608500|3549045|FG001|Overall Study|Other|2
1984816|NCT04590027|3549074|FG000|Overall Study|Lost to Follow-up|17
1984817|NCT04590027|3549075|FG001|Overall Study|Lost to Follow-up|14
1984818|NCT04590027|3549074|FG000|Overall Study|Protocol Violation|0
1984819|NCT04590027|3549075|FG001|Overall Study|Protocol Violation|3
1984820|NCT04578457|3549085|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2
1984821|NCT04578457|3549085|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2
1984822|NCT04578457|3549085|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2
1984823|NCT04578457|3549085|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2
1984841|NCT04572997|3549110|FG000|Overall Study|Adverse Event|1
1984844|NCT04542694|3549211|FG000|Overall Study|The need for prohibited therapy|2
1984845|NCT04542694|3549212|FG001|Overall Study|The need for prohibited therapy|0
1984846|NCT04542694|3549211|FG000|Overall Study|Adverse Event|1
1984847|NCT04542694|3549212|FG001|Overall Study|Adverse Event|0
1984848|NCT04542694|3549211|FG000|Overall Study|Protocol Violation|1
1984849|NCT04542694|3549212|FG001|Overall Study|Protocol Violation|0
1984850|NCT04534491|3549254|FG000|Overall Study|Not completed end-of-study interview|24
1984851|NCT04534491|3549254|FG000|Overall Study|Non-users|70
1984852|NCT04534491|3549254|FG000|Overall Study|Non-verifiable users|58
1984867|NCT04093258|3549327|FG000|Period 2|Subject no longer meets the eligibility criteria|1
1984868|NCT04093258|3549328|FG001|Period 2|Subject no longer meets the eligibility criteria|0
1984913|NCT02937818|3549465|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
1984914|NCT02937818|3549462|FG000|Overall Study|Condition under investigation worsened|0
1984915|NCT02937818|3549463|FG001|Overall Study|Condition under investigation worsened|0
1984916|NCT02937818|3549464|FG002|Overall Study|Condition under investigation worsened|1
1984917|NCT02937818|3549465|FG003|Overall Study|Condition under investigation worsened|0
1984918|NCT02937818|3549462|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
2213316|NCT01677858|3854782|FG001|Overall Study|Withdrawal by Subject|1
2213317|NCT01677858|3854783|FG002|Overall Study|Withdrawal by Subject|1
2213318|NCT01677858|3854784|FG003|Overall Study|Withdrawal by Subject|0
2213319|NCT01677858|3854785|FG004|Overall Study|Withdrawal by Subject|15
2213320|NCT01677858|3854781|FG000|Overall Study|Lost to Follow-up|0
2213321|NCT01677858|3854782|FG001|Overall Study|Lost to Follow-up|0
2213322|NCT01677858|3854783|FG002|Overall Study|Lost to Follow-up|0
2213323|NCT01677858|3854784|FG003|Overall Study|Lost to Follow-up|0
2213324|NCT01677858|3854785|FG004|Overall Study|Lost to Follow-up|1
2213325|NCT01677910|3854805|FG000|Double-Blind Treatment Period|Adverse Event|6
2213326|NCT01677910|3854806|FG001|Double-Blind Treatment Period|Adverse Event|2
2213327|NCT01677910|3854807|FG002|Double-Blind Treatment Period|Adverse Event|3
2213328|NCT01677910|3854808|FG003|Double-Blind Treatment Period|Adverse Event|0
2213329|NCT01677910|3854805|FG000|Double-Blind Treatment Period|Physician Decision|0
2213330|NCT01677910|3854806|FG001|Double-Blind Treatment Period|Physician Decision|0
2213331|NCT01677910|3854807|FG002|Double-Blind Treatment Period|Physician Decision|1
2213332|NCT01677910|3854808|FG003|Double-Blind Treatment Period|Physician Decision|0
2213333|NCT01677910|3854805|FG000|Double-Blind Treatment Period|Withdrawal of consent|1
2213334|NCT01677910|3854806|FG001|Double-Blind Treatment Period|Withdrawal of consent|0
2213335|NCT01677910|3854807|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
2213336|NCT01677910|3854808|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
2213337|NCT01677910|3854805|FG000|Double-Blind Treatment Period|Reason Not Specified|0
2213338|NCT01677910|3854806|FG001|Double-Blind Treatment Period|Reason Not Specified|1
2213339|NCT01677910|3854807|FG002|Double-Blind Treatment Period|Reason Not Specified|0
2213340|NCT01677910|3854808|FG003|Double-Blind Treatment Period|Reason Not Specified|0
2213341|NCT01677910|3854805|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
2213342|NCT01677910|3854806|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
2213343|NCT01677910|3854807|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
2213344|NCT01677910|3854808|FG003|Open-Label Extension Period (OLE)|Physician Decision|4
2213345|NCT01677910|3854805|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
2213346|NCT01677910|3854806|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
2213347|NCT01677910|3854807|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
2213348|NCT01677910|3854808|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
2213349|NCT01677910|3854805|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2213350|NCT01677910|3854806|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2213351|NCT01677910|3854807|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2213352|NCT01677910|3854808|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
2213353|NCT01677910|3854805|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2213354|NCT01677910|3854806|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1984919|NCT02937818|3549463|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
1984824|NCT04577183|3549097|FG000|Overall Study|Death|1
1984825|NCT04577183|3549097|FG000|Overall Study|Withdrawal by Subject|3
1984826|NCT04577183|3549097|FG000|Overall Study|Early termination|2
1984842|NCT04570670|3549120|FG000|Overall Study|Withdrawal by Subject|1
1984843|NCT04570670|3549121|FG001|Overall Study|Withdrawal by Subject|0
1984853|NCT04533204|3549276|FG000|Overall Study|Unable to understand training instructions|1
1984854|NCT04533204|3549277|FG001|Overall Study|Unable to understand training instructions|1
1984869|NCT03993379|3549342|FG000|Overall Study|The study was terminated early due to business decision.|0
1984870|NCT03993379|3549343|FG001|Overall Study|The study was terminated early due to business decision.|2
1984871|NCT03993379|3549344|FG002|Overall Study|The study was terminated early due to business decision.|0
1984872|NCT03993379|3549345|FG003|Overall Study|The study was terminated early due to business decision.|0
1984873|NCT03993379|3549342|FG000|Overall Study|Withdrawal by Subject|0
1984874|NCT03993379|3549343|FG001|Overall Study|Withdrawal by Subject|1
1984875|NCT03993379|3549344|FG002|Overall Study|Withdrawal by Subject|0
1984876|NCT03993379|3549345|FG003|Overall Study|Withdrawal by Subject|0
1984877|NCT03956615|3549355|FG000|Overall Study|No multiple myeloma confirmed|2
1984878|NCT03956615|3549355|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1
1984879|NCT03956615|3549355|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2
1984880|NCT03956615|3549355|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2
1984881|NCT03803059|3549359|FG000|Overall Study|Protocol Violation|2
1984882|NCT03803059|3549359|FG000|Overall Study|Lost to Follow-up|1
1984883|NCT03723590|3549364|FG000|Overall Study|Withdrawal by Subject|3
1984884|NCT03430895|3549387|FG000|Overall Study|Not Treated|2
1984885|NCT03402841|3549391|FG000|Overall Study|Withdrawal by Subject|4
1984886|NCT03402841|3549391|FG000|Overall Study|Lost to Follow-up|3
1984887|NCT03402841|3549391|FG000|Overall Study|Death|85
1984888|NCT03388138|3549397|FG000|Overall Study|Protocol Violation|1
1984889|NCT03388138|3549398|FG001|Overall Study|Protocol Violation|0
1984890|NCT03230838|3549423|FG000|Overall Study|Withdrawal by Subject|3
1984891|NCT03230838|3549424|FG001|Overall Study|Withdrawal by Subject|0
1984892|NCT03230838|3549423|FG000|Overall Study|Temperature excursion|1
1984893|NCT03230838|3549424|FG001|Overall Study|Temperature excursion|0
1984894|NCT03183778|3549430|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1
1984895|NCT03029234|3549438|FG000|Overall Study|Sponsor Decision|1
1984896|NCT03029234|3549438|FG000|Overall Study|Withdrawal by Subject|5
1984897|NCT03029234|3549438|FG000|Overall Study|Death|61
1984898|NCT02937818|3549462|FG000|Overall Study|Participants decision|1
1984899|NCT02937818|3549463|FG001|Overall Study|Participants decision|0
1984900|NCT02937818|3549464|FG002|Overall Study|Participants decision|1
1984901|NCT02937818|3549465|FG003|Overall Study|Participants decision|1
1984902|NCT02937818|3549462|FG000|Overall Study|Adverse Event|2
1984903|NCT02937818|3549463|FG001|Overall Study|Adverse Event|4
1984904|NCT02937818|3549464|FG002|Overall Study|Adverse Event|1
1984905|NCT02937818|3549465|FG003|Overall Study|Adverse Event|1
1984906|NCT02937818|3549462|FG000|Overall Study|Disease progression|17
1984907|NCT02937818|3549463|FG001|Overall Study|Disease progression|14
1984908|NCT02937818|3549464|FG002|Overall Study|Disease progression|7
1984909|NCT02937818|3549465|FG003|Overall Study|Disease progression|18
1984910|NCT02937818|3549462|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1
1984911|NCT02937818|3549463|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2
1984912|NCT02937818|3549464|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
2102386|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
2213355|NCT01677910|3854807|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2310799|NCT02741518|4015470|FG001|Overall Study|Withdrawal by Subject|1
2310800|NCT02741596|4015478|FG000|Overall Study|Adverse Event|1
2310801|NCT02741596|4015479|FG001|Overall Study|Adverse Event|5
2310802|NCT02741596|4015478|FG000|Overall Study|Lost to Follow-up|1
2310803|NCT02741596|4015479|FG001|Overall Study|Lost to Follow-up|1
2310804|NCT02741596|4015478|FG000|Overall Study|Physician Decision|2
2310805|NCT02741596|4015479|FG001|Overall Study|Physician Decision|1
2310806|NCT02741596|4015478|FG000|Overall Study|Pregnancy|3
2310807|NCT02741596|4015479|FG001|Overall Study|Pregnancy|1
2310808|NCT02741596|4015478|FG000|Overall Study|Other (Unspecified)|0
2310809|NCT02741596|4015479|FG001|Overall Study|Other (Unspecified)|3
2310810|NCT02741596|4015478|FG000|Overall Study|Subject withdrawn-Other|17
2310811|NCT02741596|4015479|FG001|Overall Study|Subject withdrawn-Other|4
2213356|NCT01677910|3854808|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5
2213357|NCT01677910|3854805|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
2213358|NCT01677910|3854806|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
2213359|NCT01677910|3854807|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
2213360|NCT01677910|3854808|FG003|Open-Label Extension Period (OLE)|Adverse Event|15
2213361|NCT01677910|3854805|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0
2213362|NCT01677910|3854806|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0
2213363|NCT01677910|3854807|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0
2213364|NCT01677910|3854808|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1
2213365|NCT01677936|3854820|FG000|Overall Study|Lost to Follow-up|4
2310812|NCT02741596|4015478|FG000|Overall Study|Subject withdrawn-to commercial product|54
2321915|NCT02964338|4036488|FG002|Overall Study|Did not meet criteria|0
1984827|NCT04574999|3549103|FG000|Overall Study|Adverse Event|1
1984828|NCT04574999|3549104|FG001|Overall Study|Adverse Event|0
1984829|NCT04574999|3549103|FG000|Overall Study|Lack of Efficacy|2
1984830|NCT04574999|3549104|FG001|Overall Study|Lack of Efficacy|3
1984831|NCT04574999|3549103|FG000|Overall Study|Protocol Violation|1
1984832|NCT04574999|3549104|FG001|Overall Study|Protocol Violation|0
1984833|NCT04574999|3549103|FG000|Overall Study|Withdrawal by Subject|2
1984834|NCT04574999|3549104|FG001|Overall Study|Withdrawal by Subject|2
1984835|NCT04574999|3549103|FG000|Overall Study|Lost to Follow-up|1
1984836|NCT04574999|3549104|FG001|Overall Study|Lost to Follow-up|0
1984837|NCT04574999|3549103|FG000|Overall Study|Personal problems|1
1984838|NCT04574999|3549104|FG001|Overall Study|Personal problems|0
1984839|NCT04574999|3549103|FG000|Overall Study|Previous planned surgery|1
1984840|NCT04574999|3549104|FG001|Overall Study|Previous planned surgery|0
1984855|NCT04532164|3549283|FG000|Overall Study|Adverse Event|1
1984856|NCT04532164|3549283|FG000|Overall Study|Protocol Violation|5
1984857|NCT04532164|3549283|FG000|Overall Study|Lost to Follow-up|1
1984858|NCT04532164|3549283|FG000|Overall Study|Found to be Ineligible|3
1984859|NCT04532164|3549283|FG000|Overall Study|Withdrawal by Subject|14
1984860|NCT04531813|3549288|FG000|Overall Study|Protocol Violation|1
1984861|NCT04531813|3549288|FG000|Overall Study|Withdrawal by Subject|1
1984862|NCT04531527|3549292|FG000|Overall Study|Found to be Ineligible|3
1984863|NCT04531540|3549296|FG000|Overall Study|Adverse Event|1
1984864|NCT04531540|3549296|FG000|Overall Study|Protocol Violation|3
1984865|NCT04531540|3549296|FG000|Overall Study|Withdrawal by Subject|4
1984866|NCT04531540|3549296|FG000|Overall Study|Found to be Ineligible|1
1984920|NCT02937818|3549464|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
1984921|NCT02937818|3549465|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1
1984922|NCT02926833|3549482|FG000|Overall Study|Full Consent Withdrawal|0
1984923|NCT02926833|3549483|FG001|Overall Study|Full Consent Withdrawal|0
1984924|NCT02926833|3549484|FG002|Overall Study|Full Consent Withdrawal|0
1984925|NCT02926833|3549485|FG003|Overall Study|Full Consent Withdrawal|2
1984926|NCT02926833|3549482|FG000|Overall Study|Death|1
1984927|NCT02926833|3549483|FG001|Overall Study|Death|1
1984928|NCT02926833|3549484|FG002|Overall Study|Death|1
1984929|NCT02926833|3549485|FG003|Overall Study|Death|7
1984930|NCT02926833|3549482|FG000|Overall Study|Still on study|2
1984931|NCT02926833|3549483|FG001|Overall Study|Still on study|3
1984932|NCT02926833|3549484|FG002|Overall Study|Still on study|5
1984933|NCT02926833|3549485|FG003|Overall Study|Still on study|14
1984934|NCT02926833|3549482|FG000|Overall Study|Adverse Event|0
1984935|NCT02926833|3549483|FG001|Overall Study|Adverse Event|0
1984936|NCT02926833|3549484|FG002|Overall Study|Adverse Event|1
1984937|NCT02926833|3549485|FG003|Overall Study|Adverse Event|0
2024149|NCT00332202|3592590|FG001|Overall Study|Physician Decision|8
2177388|NCT01372774|3801434|FG001|Overall Study|Withdrawal prior to treatment|5
2177389|NCT01372878|3801446|FG000|Overall Study|Withdrawal by Subject|63
2177390|NCT01372878|3801446|FG000|Overall Study|Protocol Violation|17
2177391|NCT01372878|3801446|FG000|Overall Study|incomplete study procedure|104
2177392|NCT01372995|3801453|FG000|Overall Study|Spouse withdrew participant from study|0
2177393|NCT01372995|3801454|FG001|Overall Study|Spouse withdrew participant from study|1
2024150|NCT00332202|3592589|FG000|Overall Study|Protocol Entry Criteria Not Met|6
2024151|NCT00332202|3592590|FG001|Overall Study|Protocol Entry Criteria Not Met|5
2024152|NCT00332202|3592589|FG000|Overall Study|Protocol Violation|7
2024153|NCT00332202|3592590|FG001|Overall Study|Protocol Violation|2
2024154|NCT00332202|3592589|FG000|Overall Study|Sponsor Decision|1
2024155|NCT00332202|3592590|FG001|Overall Study|Sponsor Decision|2
2024156|NCT00332202|3592589|FG000|Overall Study|Withdrawal by Subject|36
2024157|NCT00332202|3592590|FG001|Overall Study|Withdrawal by Subject|17
2024158|NCT00332202|3592589|FG000|Overall Study|Progressive Disease|106
2024159|NCT00332202|3592590|FG001|Overall Study|Progressive Disease|60
2024160|NCT00332202|3592589|FG000|Overall Study|Death|5
2024161|NCT00332202|3592590|FG001|Overall Study|Death|2
2024162|NCT00332241|3592607|FG000|Overall Study|Lack of Efficacy|6
2024163|NCT00332241|3592608|FG001|Overall Study|Lack of Efficacy|1
2024164|NCT00332241|3592607|FG000|Overall Study|Adverse Event|3
2024165|NCT00332241|3592608|FG001|Overall Study|Adverse Event|5
2024166|NCT00332241|3592607|FG000|Overall Study|Withdrawal by Subject|2
2024167|NCT00332241|3592608|FG001|Overall Study|Withdrawal by Subject|1
2024168|NCT00332241|3592607|FG000|Overall Study|Lost to Follow-up|4
2024169|NCT00332241|3592608|FG001|Overall Study|Lost to Follow-up|1
2024170|NCT00332332|3592614|FG000|Overall Study|Adverse Event|13
2024171|NCT00332332|3592614|FG000|Overall Study|Death|1
2024172|NCT00332332|3592614|FG000|Overall Study|Withdrawal by Subject|8
2024173|NCT00332332|3592614|FG000|Overall Study|Physician Decision|1
2024174|NCT00332332|3592614|FG000|Overall Study|Lost to Follow-up|3
2024175|NCT00332332|3592614|FG000|Overall Study|Protocol deviation|4
2024176|NCT00332332|3592614|FG000|Overall Study|Noncompliance|2
2024177|NCT00332332|3592614|FG000|Overall Study|Disease progression|2
2177394|NCT01372995|3801455|FG002|Overall Study|Spouse withdrew participant from study|0
2177395|NCT01372995|3801453|FG000|Overall Study|Physician Decision|0
2177396|NCT01372995|3801454|FG001|Overall Study|Physician Decision|0
2177397|NCT01372995|3801455|FG002|Overall Study|Physician Decision|1
2177398|NCT01373164|3801468|FG000|Overall Study|Lost to Follow-up|0
2177399|NCT01373164|3801469|FG001|Overall Study|Lost to Follow-up|0
1984938|NCT02700698|3549498|FG000|Overall Study|Withdrawal by Subject|1
1984939|NCT02700698|3549499|FG001|Overall Study|Withdrawal by Subject|0
1984940|NCT02698865|3549516|FG000|Overall Study|Other|11
1984941|NCT02698865|3549517|FG001|Overall Study|Other|11
1984942|NCT02698865|3549516|FG000|Overall Study|Withdrawal by Subject|20
1984943|NCT02698865|3549517|FG001|Overall Study|Withdrawal by Subject|16
1984944|NCT02698865|3549516|FG000|Overall Study|Physician Decision|0
1984945|NCT02698865|3549517|FG001|Overall Study|Physician Decision|4
1984946|NCT02698865|3549516|FG000|Overall Study|Lost to Follow-up|4
1984947|NCT02698865|3549517|FG001|Overall Study|Lost to Follow-up|2
1984948|NCT02660086|3549525|FG000|Overall Study- 12-month|Withdrawal by Subject|5
1984949|NCT02660086|3549526|FG001|Overall Study- 12-month|Withdrawal by Subject|5
1984950|NCT02660086|3549525|FG000|Overall Study- 12-month|Left full-time employment|12
1984951|NCT02660086|3549526|FG001|Overall Study- 12-month|Left full-time employment|20
1984952|NCT02660086|3549525|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8
1984953|NCT02660086|3549526|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4
1984954|NCT02660086|3549525|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1
1984955|NCT02660086|3549526|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0
1984956|NCT02660086|3549525|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17
1984957|NCT02660086|3549526|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8
1984958|NCT02660086|3549525|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9
1984959|NCT02660086|3549526|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16
1984960|NCT02653482|3549534|FG000|Overall Study|Death|1
1984961|NCT02653482|3549535|FG001|Overall Study|Death|1
1984962|NCT02454933|3549543|FG000|Overall Study|Progressive disease|7
1984963|NCT02454933|3549544|FG001|Overall Study|Progressive disease|5
1984964|NCT02454933|3549543|FG000|Overall Study|Adverse Event|1
1984965|NCT02454933|3549544|FG001|Overall Study|Adverse Event|1
1984966|NCT02454933|3549543|FG000|Overall Study|Withdrawal by Subject|0
1984967|NCT02454933|3549544|FG001|Overall Study|Withdrawal by Subject|2
1984968|NCT02282020|3549555|FG000|Overall Study|Objective Disease Progression|111
1984969|NCT02282020|3549556|FG001|Overall Study|Objective Disease Progression|30
1984970|NCT02282020|3549555|FG000|Overall Study|Adverse Event|13
1984971|NCT02282020|3549556|FG001|Overall Study|Adverse Event|15
1984972|NCT02282020|3549555|FG000|Overall Study|Withdrawal by Subject|5
1984973|NCT02282020|3549556|FG001|Overall Study|Withdrawal by Subject|10
1984974|NCT02282020|3549555|FG000|Overall Study|Miscellaneous|4
1984975|NCT02282020|3549556|FG001|Overall Study|Miscellaneous|17
1984976|NCT02282020|3549555|FG000|Overall Study|Severe Non-compliance to Protocol|1
1984977|NCT02282020|3549556|FG001|Overall Study|Severe Non-compliance to Protocol|0
1984978|NCT02282020|3549555|FG000|Overall Study|Developed Discontinuation Criteria|1
1984979|NCT02282020|3549556|FG001|Overall Study|Developed Discontinuation Criteria|3
1984980|NCT02282020|3549555|FG000|Overall Study|Withdrew Consent Prior to Dosing|0
1984981|NCT02282020|3549556|FG001|Overall Study|Withdrew Consent Prior to Dosing|12
1984982|NCT02129647|3549562|FG000|Overall Study|Adverse Event|2
1984983|NCT02129647|3549562|FG000|Overall Study|surgical intervention for clinically progressive disease|1
1984984|NCT01959139|3549574|FG000|Phase II|Disease progression|0
1984985|NCT01959139|3549575|FG001|Phase II|Disease progression|0
1984986|NCT01959139|3549576|FG002|Phase II|Disease progression|26
1984987|NCT01959139|3549577|FG003|Phase II|Disease progression|34
1984988|NCT01959139|3549574|FG000|Phase II|Adverse Event|0
1984989|NCT01959139|3549575|FG001|Phase II|Adverse Event|0
1984990|NCT01959139|3549576|FG002|Phase II|Adverse Event|10
1984991|NCT01959139|3549577|FG003|Phase II|Adverse Event|11
1984992|NCT01959139|3549574|FG000|Phase II|Patient Refusal|0
1984993|NCT01959139|3549575|FG001|Phase II|Patient Refusal|0
1984994|NCT01959139|3549576|FG002|Phase II|Patient Refusal|5
1984995|NCT01959139|3549577|FG003|Phase II|Patient Refusal|4
1984996|NCT01959139|3549574|FG000|Phase II|Death|0
1984997|NCT01959139|3549575|FG001|Phase II|Death|0
1984998|NCT01959139|3549576|FG002|Phase II|Death|3
1984999|NCT01959139|3549577|FG003|Phase II|Death|1
1985000|NCT01959139|3549574|FG000|Phase II|Other/Unknown|0
1985001|NCT01959139|3549575|FG001|Phase II|Other/Unknown|0
2310813|NCT02741596|4015479|FG001|Overall Study|Subject withdrawn-to commercial product|63
2310814|NCT02741635|4015485|FG000|Overall Study|Withdrawal by Subject|1
2310815|NCT02741713|4015501|FG000|Overall Study|Surgery type changed intra-operatively|2
2310816|NCT02741713|4015502|FG001|Overall Study|Surgery type changed intra-operatively|1
2310817|NCT02742103|4015515|FG000|Overall Study|Protocol Violation|1
2310818|NCT02742103|4015516|FG001|Overall Study|Protocol Violation|0
2310819|NCT02742103|4015515|FG000|Overall Study|Death|2
2310820|NCT02742103|4015516|FG001|Overall Study|Death|2
2310821|NCT02742103|4015515|FG000|Overall Study|Adverse Event|1
2310822|NCT02742103|4015516|FG001|Overall Study|Adverse Event|0
2310823|NCT02742103|4015515|FG000|Overall Study|Moved to another town|0
2310824|NCT02742103|4015516|FG001|Overall Study|Moved to another town|1
2310825|NCT02742103|4015515|FG000|Overall Study|Withdrawal by Subject|5
2310826|NCT02742103|4015516|FG001|Overall Study|Withdrawal by Subject|2
2310827|NCT02742441|4015536|FG000|Overall Study|Lost to Follow-up|4
2310828|NCT02742441|4015537|FG001|Overall Study|Lost to Follow-up|4
2310829|NCT02742441|4015536|FG000|Overall Study|Withdrawal by Subject|2
2310830|NCT02742441|4015537|FG001|Overall Study|Withdrawal by Subject|2
2310831|NCT02742441|4015536|FG000|Overall Study|Adverse Event|0
1985002|NCT01959139|3549576|FG002|Phase II|Other/Unknown|8
1985003|NCT01959139|3549577|FG003|Phase II|Other/Unknown|5
1985004|NCT01959139|3549574|FG000|Phase II|On treatment|0
1985005|NCT01959139|3549575|FG001|Phase II|On treatment|0
1985006|NCT01959139|3549576|FG002|Phase II|On treatment|4
1985007|NCT01959139|3549577|FG003|Phase II|On treatment|0
1985008|NCT01874353|3549594|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2
1985009|NCT01874353|3549595|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0
1985010|NCT01874353|3549596|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0
1985011|NCT01874353|3549597|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0
1985012|NCT01874353|3549594|FG000|Overall Study|Lost to Follow-up|2
1985013|NCT01874353|3549595|FG001|Overall Study|Lost to Follow-up|2
1985014|NCT01874353|3549596|FG002|Overall Study|Lost to Follow-up|2
1985015|NCT01874353|3549597|FG003|Overall Study|Lost to Follow-up|0
1985016|NCT01874353|3549594|FG000|Overall Study|Death|110
1985017|NCT01874353|3549595|FG001|Overall Study|Death|60
1985018|NCT01874353|3549596|FG002|Overall Study|Death|13
1985019|NCT01874353|3549597|FG003|Overall Study|Death|7
1985020|NCT01874353|3549594|FG000|Overall Study|Withdrawal by Subject|13
1985021|NCT01874353|3549595|FG001|Overall Study|Withdrawal by Subject|11
1985022|NCT01874353|3549596|FG002|Overall Study|Withdrawal by Subject|0
1985023|NCT01874353|3549597|FG003|Overall Study|Withdrawal by Subject|0
1985024|NCT01597778|3549611|FG000|Overall Study|Death|7
1985025|NCT01597778|3549612|FG001|Overall Study|Death|10
1985026|NCT01597778|3549611|FG000|Overall Study|Withdrawal by Subject|3
1985027|NCT01597778|3549612|FG001|Overall Study|Withdrawal by Subject|4
1985028|NCT01597778|3549611|FG000|Overall Study|Adverse Event|1
1985029|NCT01597778|3549612|FG001|Overall Study|Adverse Event|1
1985030|NCT01597778|3549611|FG000|Overall Study|Protocol Violation|1
1985031|NCT01597778|3549612|FG001|Overall Study|Protocol Violation|11
1985032|NCT01597778|3549611|FG000|Overall Study|Transplanted off protocol|2
1985033|NCT01597778|3549612|FG001|Overall Study|Transplanted off protocol|3
1985034|NCT01522976|3549621|FG000|Overall Study|Ineligible|4
1985035|NCT01522976|3549622|FG001|Overall Study|Ineligible|0
1985036|NCT01522976|3549623|FG002|Overall Study|Ineligible|1
1985037|NCT01522976|3549621|FG000|Overall Study|Death|7
1985038|NCT01522976|3549622|FG001|Overall Study|Death|6
1985039|NCT01522976|3549623|FG002|Overall Study|Death|2
1985040|NCT01522976|3549621|FG000|Overall Study|Still on treatment|9
2213366|NCT01677936|3854821|FG001|Overall Study|Lost to Follow-up|1
2213367|NCT01677936|3854820|FG000|Overall Study|Protocol Violation|3
2213368|NCT01677936|3854821|FG001|Overall Study|Protocol Violation|0
2213369|NCT01677936|3854820|FG000|Overall Study|Adverse Event|1
2213370|NCT01677936|3854821|FG001|Overall Study|Adverse Event|0
2213371|NCT01677936|3854820|FG000|Overall Study|Lost to Follow-up|1
2213372|NCT01677936|3854821|FG001|Overall Study|Lost to Follow-up|0
2213373|NCT01677936|3854820|FG000|Overall Study|Protocol Violation|0
2213374|NCT01677936|3854821|FG001|Overall Study|Protocol Violation|4
2213375|NCT01677988|3854827|FG000|Overall Study|Lack of Efficacy|2
2213376|NCT01678131|3854835|FG000|Overall Study|Adverse Event|0
2213377|NCT01678131|3854836|FG001|Overall Study|Adverse Event|1
2213378|NCT01678131|3854837|FG002|Overall Study|Adverse Event|0
2213379|NCT01678131|3854835|FG000|Overall Study|Withdrawal by Subject|0
2213380|NCT01678131|3854836|FG001|Overall Study|Withdrawal by Subject|0
2213381|NCT01678131|3854837|FG002|Overall Study|Withdrawal by Subject|2
2213382|NCT01678144|3854845|FG000|Stage 1: MAR Classic|Adverse Event|1
2213383|NCT01678209|3854861|FG000|Overall Study|could not scan twice|1
2213384|NCT01678209|3854862|FG001|Overall Study|could not scan twice|1
2213385|NCT01678209|3854863|FG002|Overall Study|could not scan twice|1
2213386|NCT01678209|3854861|FG000|Overall Study|scheduling conflicts|0
2213387|NCT01678209|3854862|FG001|Overall Study|scheduling conflicts|0
2213388|NCT01678209|3854863|FG002|Overall Study|scheduling conflicts|1
2213389|NCT01678209|3854861|FG000|Overall Study|screen fail|16
2213390|NCT01678209|3854862|FG001|Overall Study|screen fail|17
2213391|NCT01678209|3854863|FG002|Overall Study|screen fail|16
2213392|NCT01678313|3854873|FG000|Completed the 3-month Therapy|Lost to Follow-up|3
2213393|NCT01678313|3854874|FG001|Completed the 3-month Therapy|Lost to Follow-up|8
2213394|NCT01678313|3854873|FG000|Completed the 3-month Therapy|Physician Decision|3
2213395|NCT01678313|3854874|FG001|Completed the 3-month Therapy|Physician Decision|4
2213396|NCT01678313|3854873|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8
2213397|NCT01678313|3854874|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9
2213398|NCT01678313|3854873|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
2213399|NCT01678313|3854874|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
2213400|NCT01678560|3854886|FG000|Overall Study|Physician Decision|4
2213401|NCT01678560|3854887|FG001|Overall Study|Physician Decision|4
2213402|NCT01678560|3854886|FG000|Overall Study|Death|0
2213403|NCT01678560|3854887|FG001|Overall Study|Death|1
1985041|NCT01522976|3549622|FG001|Overall Study|Still on treatment|9
1985042|NCT01522976|3549623|FG002|Overall Study|Still on treatment|6
1985043|NCT01522976|3549621|FG000|Overall Study|Disease progression|28
1985044|NCT01522976|3549622|FG001|Overall Study|Disease progression|30
1985045|NCT01522976|3549623|FG002|Overall Study|Disease progression|25
1985046|NCT01522976|3549621|FG000|Overall Study|Adverse Event|17
1985047|NCT01522976|3549622|FG001|Overall Study|Adverse Event|7
2213404|NCT01678560|3854886|FG000|Overall Study|Withdrawal by Subject|0
1985048|NCT01522976|3549623|FG002|Overall Study|Adverse Event|18
1985049|NCT01522976|3549621|FG000|Overall Study|Refusal unrelated to adverse event|10
1985050|NCT01522976|3549622|FG001|Overall Study|Refusal unrelated to adverse event|13
1985051|NCT01522976|3549623|FG002|Overall Study|Refusal unrelated to adverse event|14
1985052|NCT01522976|3549621|FG000|Overall Study|Not protocol specified|22
1985053|NCT01522976|3549622|FG001|Overall Study|Not protocol specified|27
1985054|NCT01522976|3549623|FG002|Overall Study|Not protocol specified|27
1985055|NCT01286272|3549636|FG000|Overall Study|Ineligible after beginning treatment|1
1985056|NCT01286272|3549637|FG001|Overall Study|Ineligible after beginning treatment|3
1985057|NCT01145495|3549643|FG000|Overall Study|Adverse Event|6
1985058|NCT01145495|3549643|FG000|Overall Study|Withdrawal by Subject|5
1985059|NCT01145495|3549643|FG000|Overall Study|Disease progression after respone|1
1985060|NCT00879086|3549658|FG000|Overall Study|Adverse Event|3
1985061|NCT00879086|3549659|FG001|Overall Study|Adverse Event|15
1985062|NCT00879086|3549658|FG000|Overall Study|Participant choice|2
1985063|NCT00879086|3549659|FG001|Overall Study|Participant choice|2
1985064|NCT00879086|3549658|FG000|Overall Study|Progression of disease|40
1985065|NCT00879086|3549659|FG001|Overall Study|Progression of disease|26
1985066|NCT00879086|3549658|FG000|Overall Study|Withdrawal of consent|2
1985067|NCT00879086|3549659|FG001|Overall Study|Withdrawal of consent|1
1985068|NCT00879086|3549658|FG000|Overall Study|Other|4
1985069|NCT00879086|3549659|FG001|Overall Study|Other|6
1985070|NCT00879086|3549658|FG000|Overall Study|Death|1
1985071|NCT00879086|3549659|FG001|Overall Study|Death|2
1985072|NCT00864227|3549665|FG000|Overall Study|Withdrawal by Subject|1
1985073|NCT00864227|3549665|FG000|Overall Study|Disease Relapse/Progression|3
1985074|NCT00731731|3549672|FG000|Overall Study|Protocol Violation|0
1985075|NCT00731731|3549673|FG001|Overall Study|Protocol Violation|0
1985076|NCT00731731|3549674|FG002|Overall Study|Protocol Violation|1
1985077|NCT00731731|3549672|FG000|Overall Study|Cancel prior to treatment|0
1985078|NCT00731731|3549673|FG001|Overall Study|Cancel prior to treatment|0
1985079|NCT00731731|3549674|FG002|Overall Study|Cancel prior to treatment|2
1985080|NCT00685360|3549690|FG000|Overall Study|Lost to Follow-up|0
1985081|NCT00685360|3549691|FG001|Overall Study|Lost to Follow-up|1
1985082|NCT00685360|3549692|FG002|Overall Study|Lost to Follow-up|2
1985083|NCT00685360|3549690|FG000|Overall Study|Adverse Event|4
1985084|NCT00685360|3549691|FG001|Overall Study|Adverse Event|6
1985085|NCT00685360|3549692|FG002|Overall Study|Adverse Event|4
1985086|NCT00685360|3549690|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1
1985087|NCT00685360|3549691|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0
1985088|NCT00685360|3549692|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2
1985089|NCT00685360|3549690|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0
1985090|NCT00685360|3549691|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4
1985091|NCT00685360|3549692|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1
1985092|NCT00685360|3549690|FG000|Overall Study|Subject Withdrew Consent to Participate|13
1985093|NCT00685360|3549691|FG001|Overall Study|Subject Withdrew Consent to Participate|2
1985094|NCT00685360|3549692|FG002|Overall Study|Subject Withdrew Consent to Participate|5
1985095|NCT00685360|3549690|FG000|Overall Study|Protocol Deviation|0
2310832|NCT02742441|4015537|FG001|Overall Study|Adverse Event|2
2310833|NCT02742519|4015545|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
2310834|NCT02742519|4015546|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
2310835|NCT02742519|4015547|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
2310836|NCT02742519|4015545|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
2310837|NCT02742519|4015546|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
2310838|NCT02742519|4015547|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
2310839|NCT02742519|4015545|FG000|Part 2 Open Label Period (32 Weeks)|Other|0
2310840|NCT02742519|4015546|FG001|Part 2 Open Label Period (32 Weeks)|Other|0
2310841|NCT02742519|4015547|FG002|Part 2 Open Label Period (32 Weeks)|Other|1
2310842|NCT02742649|4015567|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5
2310843|NCT02742649|4015568|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2310844|NCT02742649|4015569|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2310845|NCT02742649|4015570|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2310846|NCT02742649|4015571|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2310847|NCT02742649|4015567|FG000|Double-Blind Treatment Period|Adverse Event|0
2310848|NCT02742649|4015568|FG001|Double-Blind Treatment Period|Adverse Event|1
2310849|NCT02742649|4015569|FG002|Double-Blind Treatment Period|Adverse Event|0
2310850|NCT02742649|4015570|FG003|Double-Blind Treatment Period|Adverse Event|0
2310851|NCT02742649|4015571|FG004|Double-Blind Treatment Period|Adverse Event|0
2310852|NCT02742649|4015567|FG000|Open-Label Period|Lost to Follow-up|0
2310853|NCT02742649|4015568|FG001|Open-Label Period|Lost to Follow-up|0
2310854|NCT02742649|4015569|FG002|Open-Label Period|Lost to Follow-up|0
2310855|NCT02742649|4015570|FG003|Open-Label Period|Lost to Follow-up|0
2310856|NCT02742649|4015571|FG004|Open-Label Period|Lost to Follow-up|1
1985096|NCT00685360|3549691|FG001|Overall Study|Protocol Deviation|1
1985097|NCT00685360|3549692|FG002|Overall Study|Protocol Deviation|1
1985098|NCT00299728|3549702|FG000|Overall Study|Lost to Follow-up|0
1985099|NCT00299728|3549703|FG001|Overall Study|Lost to Follow-up|1
1985100|NCT00299728|3549702|FG000|Overall Study|Withdrawal by Subject|0
1985101|NCT00299728|3549703|FG001|Overall Study|Withdrawal by Subject|1
1985102|NCT00299728|3549702|FG000|Overall Study|Progressive disease|0
1985103|NCT00299728|3549703|FG001|Overall Study|Progressive disease|1
1985104|NCT00159588|3549712|FG000|5 Month Follow-up|Withdrawal by Subject|2
1985105|NCT00159588|3549713|FG001|5 Month Follow-up|Withdrawal by Subject|4
1985106|NCT00159588|3549714|FG002|5 Month Follow-up|Withdrawal by Subject|2
1985107|NCT00070499|3549731|FG000|Overall Study|Adverse Event|6
1985108|NCT00070499|3549732|FG001|Overall Study|Adverse Event|6
1985109|NCT00070499|3549733|FG002|Overall Study|Adverse Event|19
1985110|NCT00070499|3549734|FG003|Overall Study|Adverse Event|15
1985111|NCT00070499|3549731|FG000|Overall Study|Refusal unrelated to adverse effects|7
1985112|NCT00070499|3549732|FG001|Overall Study|Refusal unrelated to adverse effects|5
1985113|NCT00070499|3549733|FG002|Overall Study|Refusal unrelated to adverse effects|5
1985114|NCT00070499|3549734|FG003|Overall Study|Refusal unrelated to adverse effects|8
1985115|NCT00070499|3549731|FG000|Overall Study|Progression/relapse|4
1985116|NCT00070499|3549732|FG001|Overall Study|Progression/relapse|2
1985117|NCT00070499|3549733|FG002|Overall Study|Progression/relapse|1
1985118|NCT00070499|3549734|FG003|Overall Study|Progression/relapse|4
1985119|NCT00070499|3549731|FG000|Overall Study|Death|1
1985120|NCT00070499|3549732|FG001|Overall Study|Death|1
1985121|NCT00070499|3549733|FG002|Overall Study|Death|1
1985122|NCT00070499|3549734|FG003|Overall Study|Death|2
1985123|NCT00070499|3549731|FG000|Overall Study|Other - not protocol specified|7
1985124|NCT00070499|3549732|FG001|Overall Study|Other - not protocol specified|3
1985125|NCT00070499|3549733|FG002|Overall Study|Other - not protocol specified|12
1985126|NCT00070499|3549734|FG003|Overall Study|Other - not protocol specified|20
1985127|NCT00070499|3549731|FG000|Overall Study|Still on protocol treatment|10
1985128|NCT00070499|3549732|FG001|Overall Study|Still on protocol treatment|4
1985129|NCT00070499|3549733|FG002|Overall Study|Still on protocol treatment|79
1985130|NCT00070499|3549734|FG003|Overall Study|Still on protocol treatment|57
1985131|NCT00070499|3549731|FG000|Overall Study|Did not start treatment|1
1985132|NCT00070499|3549732|FG001|Overall Study|Did not start treatment|0
1985133|NCT00070499|3549733|FG002|Overall Study|Did not start treatment|0
1985134|NCT00070499|3549734|FG003|Overall Study|Did not start treatment|2
1985135|NCT00070499|3549731|FG000|Overall Study|Not eligible|2
1985136|NCT00070499|3549732|FG001|Overall Study|Not eligible|5
1985137|NCT00070499|3549733|FG002|Overall Study|Not eligible|3
1985138|NCT00070499|3549734|FG003|Overall Study|Not eligible|2
2024178|NCT00332332|3592614|FG000|Overall Study|Other|18
2024179|NCT00332332|3592614|FG000|Overall Study|Did not receive study treatment|16
2024180|NCT00332462|3592618|FG000|Overall Study|Adverse Event|5
2024181|NCT00332462|3592618|FG000|Overall Study|Abnormal Lab Value|1
2024182|NCT00332462|3592618|FG000|Overall Study|Unsatisfactory therapeutic effect|4
2024183|NCT00332462|3592618|FG000|Overall Study|no longer requires study drug|1
2024184|NCT00332462|3592618|FG000|Overall Study|Death|3
2024185|NCT00332462|3592618|FG000|Overall Study|Graft Loss|2
2024186|NCT00332488|3592628|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
2024187|NCT00332488|3592629|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
2024188|NCT00332488|3592630|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
2024189|NCT00332488|3592628|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
2024190|NCT00332488|3592629|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
2024191|NCT00332488|3592630|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
2024192|NCT00332488|3592628|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
2024193|NCT00332488|3592629|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
2024194|NCT00332488|3592630|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
2024195|NCT00332488|3592628|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4
2024196|NCT00332488|3592629|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0
2024197|NCT00332488|3592630|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20
2213405|NCT01678560|3854887|FG001|Overall Study|Withdrawal by Subject|1
2213406|NCT01678807|3854909|FG000|Overall Study|Adverse Event|4
2024198|NCT00332488|3592628|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
2024199|NCT00332488|3592629|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
2024200|NCT00332488|3592630|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
2024201|NCT00332488|3592628|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
2024202|NCT00332488|3592629|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
2024203|NCT00332488|3592630|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
2024204|NCT00332488|3592628|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
2024205|NCT00332488|3592629|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
2024206|NCT00332488|3592630|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3
2024207|NCT00332488|3592628|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
2024208|NCT00332488|3592629|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
2024209|NCT00332488|3592630|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1
2024210|NCT00332488|3592628|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
2024211|NCT00332488|3592629|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
2024212|NCT00332488|3592630|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3
1985139|NCT04330157|3549769|FG000|Overall Study|Protocol Violation|4
1985140|NCT04330157|3549769|FG000|Overall Study|Not extubated within 24 h postoperatively|3
1985141|NCT04160988|3549790|FG000|Overall Study|poor image quality|28
1985142|NCT04079114|3549799|FG000|Overall Study|Study prematuely terminated.|166
1985143|NCT03790917|3549946|FG000|Overall Study|Death|1
1985144|NCT05017493|3549962|FG000|Overall Study|Withdrawal by Subject|26
1985145|NCT05017493|3549963|FG001|Overall Study|Withdrawal by Subject|0
1985146|NCT05017493|3549962|FG000|Overall Study|Physician Decision|15
1985147|NCT05017493|3549963|FG001|Overall Study|Physician Decision|0
1985148|NCT05017493|3549962|FG000|Overall Study|Protocol Violation|81
1985149|NCT05017493|3549963|FG001|Overall Study|Protocol Violation|0
1985150|NCT04348500|3549996|FG000|Overall Study|Death|2
1985151|NCT04348500|3549997|FG001|Overall Study|Death|2
1985152|NCT04348500|3549996|FG000|Overall Study|Withdrawn by subject due to dementia|0
1985153|NCT04348500|3549997|FG001|Overall Study|Withdrawn by subject due to dementia|1
1985154|NCT03799198|3550040|FG000|Overall Study|Lost to Follow-up|4
1985155|NCT03799198|3550041|FG001|Overall Study|Lost to Follow-up|8
1985156|NCT03799198|3550040|FG000|Overall Study|Death|0
1985157|NCT03799198|3550041|FG001|Overall Study|Death|1
1985158|NCT03770728|3550051|FG000|Overall Study|Adverse Event|1
1985159|NCT03770728|3550052|FG001|Overall Study|Adverse Event|0
1985160|NCT03770728|3550053|FG002|Overall Study|Adverse Event|1
1985161|NCT03770728|3550054|FG003|Overall Study|Adverse Event|0
1985162|NCT03770728|3550051|FG000|Overall Study|Poor compliance to protocol|0
1985163|NCT03770728|3550052|FG001|Overall Study|Poor compliance to protocol|0
1985164|NCT03770728|3550053|FG002|Overall Study|Poor compliance to protocol|1
1985165|NCT03770728|3550054|FG003|Overall Study|Poor compliance to protocol|0
1985166|NCT03770728|3550051|FG000|Overall Study|Withdrawal by Subject|13
1985167|NCT03770728|3550052|FG001|Overall Study|Withdrawal by Subject|8
1985168|NCT03770728|3550053|FG002|Overall Study|Withdrawal by Subject|9
1985169|NCT03770728|3550054|FG003|Overall Study|Withdrawal by Subject|13
1985170|NCT03770728|3550051|FG000|Overall Study|Other than specified|24
1985171|NCT03770728|3550052|FG001|Overall Study|Other than specified|23
1985172|NCT03770728|3550053|FG002|Overall Study|Other than specified|21
1985173|NCT03770728|3550054|FG003|Overall Study|Other than specified|22
1985174|NCT03760146|3550072|FG000|Overall Study|Adverse Event|11
1985175|NCT03760146|3550073|FG001|Overall Study|Adverse Event|8
1985176|NCT03760146|3550074|FG002|Overall Study|Adverse Event|0
1985177|NCT03760146|3550075|FG003|Overall Study|Adverse Event|0
1985178|NCT03760146|3550076|FG004|Overall Study|Adverse Event|0
1985179|NCT03760146|3550077|FG005|Overall Study|Adverse Event|0
1985180|NCT03760146|3550072|FG000|Overall Study|Death|1
1985181|NCT03760146|3550073|FG001|Overall Study|Death|0
1985182|NCT03760146|3550074|FG002|Overall Study|Death|0
1985183|NCT03760146|3550075|FG003|Overall Study|Death|0
1985184|NCT03760146|3550076|FG004|Overall Study|Death|0
1985185|NCT03760146|3550077|FG005|Overall Study|Death|0
1985186|NCT03760146|3550072|FG000|Overall Study|Lost to Follow-up|41
1985187|NCT03760146|3550073|FG001|Overall Study|Lost to Follow-up|28
1985188|NCT03760146|3550074|FG002|Overall Study|Lost to Follow-up|9
1985189|NCT03760146|3550075|FG003|Overall Study|Lost to Follow-up|2
1985190|NCT03760146|3550076|FG004|Overall Study|Lost to Follow-up|14
1985191|NCT03760146|3550077|FG005|Overall Study|Lost to Follow-up|8
1985192|NCT03760146|3550072|FG000|Overall Study|No longer met eligibility criteria|3
1985193|NCT03760146|3550073|FG001|Overall Study|No longer met eligibility criteria|9
1985194|NCT03760146|3550074|FG002|Overall Study|No longer met eligibility criteria|0
1985195|NCT03760146|3550075|FG003|Overall Study|No longer met eligibility criteria|0
1985196|NCT03760146|3550076|FG004|Overall Study|No longer met eligibility criteria|1
1985197|NCT03760146|3550077|FG005|Overall Study|No longer met eligibility criteria|0
1985198|NCT03760146|3550072|FG000|Overall Study|Protocol Violation|21
1985199|NCT03760146|3550073|FG001|Overall Study|Protocol Violation|13
1985200|NCT03760146|3550074|FG002|Overall Study|Protocol Violation|1
1985201|NCT03760146|3550075|FG003|Overall Study|Protocol Violation|0
1985202|NCT03760146|3550076|FG004|Overall Study|Protocol Violation|1
1985203|NCT03760146|3550077|FG005|Overall Study|Protocol Violation|0
1985204|NCT03760146|3550072|FG000|Overall Study|Withdrawal by Subject|19
1985205|NCT03760146|3550073|FG001|Overall Study|Withdrawal by Subject|20
1985206|NCT03760146|3550074|FG002|Overall Study|Withdrawal by Subject|1
1985207|NCT03760146|3550075|FG003|Overall Study|Withdrawal by Subject|0
1985208|NCT03760146|3550076|FG004|Overall Study|Withdrawal by Subject|1
1985209|NCT03760146|3550077|FG005|Overall Study|Withdrawal by Subject|0
1985210|NCT03760081|3550097|FG000|Overall Study|Miscellaneous|0
1985211|NCT03760081|3550098|FG001|Overall Study|Miscellaneous|1
1985212|NCT03760081|3550097|FG000|Overall Study|Progressive Disease|5
1985213|NCT03760081|3550098|FG001|Overall Study|Progressive Disease|10
1985214|NCT03760081|3550097|FG000|Overall Study|Death|1
1985215|NCT03760081|3550098|FG001|Overall Study|Death|1
1985216|NCT03737110|3550108|FG000|Run-in (RI) Period|Lack of Efficacy|3
1985217|NCT03737110|3550109|FG001|Run-in (RI) Period|Lack of Efficacy|0
1985218|NCT03737110|3550110|FG002|Run-in (RI) Period|Lack of Efficacy|0
2213407|NCT01678807|3854910|FG001|Overall Study|Adverse Event|4
2213408|NCT01678807|3854911|FG002|Overall Study|Adverse Event|0
2213409|NCT01678807|3854909|FG000|Overall Study|Withdrawn by Parent/Guardian|0
2213410|NCT01678807|3854910|FG001|Overall Study|Withdrawn by Parent/Guardian|1
2213411|NCT01678807|3854911|FG002|Overall Study|Withdrawn by Parent/Guardian|0
1985219|NCT03737110|3550108|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3
1985220|NCT03737110|3550109|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
1985221|NCT03737110|3550110|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
1985222|NCT03737110|3550108|FG000|Run-in (RI) Period|Adverse Event|4
1985223|NCT03737110|3550109|FG001|Run-in (RI) Period|Adverse Event|0
1985224|NCT03737110|3550110|FG002|Run-in (RI) Period|Adverse Event|0
1985225|NCT03737110|3550108|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
1985226|NCT03737110|3550109|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1
1985227|NCT03737110|3550110|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
1985228|NCT03737110|3550108|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
1985229|NCT03737110|3550109|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
1985230|NCT03737110|3550110|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
1985231|NCT03713684|3550132|FG000|Overall Study|Adverse Event|1
1985232|NCT03713684|3550133|FG001|Overall Study|Adverse Event|3
1985233|NCT03713684|3550134|FG002|Overall Study|Adverse Event|1
1985234|NCT03713684|3550135|FG003|Overall Study|Adverse Event|0
1985235|NCT03713684|3550132|FG000|Overall Study|Poor compliance to protocol|2
1985236|NCT03713684|3550133|FG001|Overall Study|Poor compliance to protocol|1
1985237|NCT03713684|3550134|FG002|Overall Study|Poor compliance to protocol|0
1985238|NCT03713684|3550135|FG003|Overall Study|Poor compliance to protocol|1
1985239|NCT03713684|3550132|FG000|Overall Study|Withdrawal by Subject|14
1985240|NCT03713684|3550133|FG001|Overall Study|Withdrawal by Subject|6
1985241|NCT03713684|3550134|FG002|Overall Study|Withdrawal by Subject|14
1985242|NCT03713684|3550135|FG003|Overall Study|Withdrawal by Subject|16
1985243|NCT03713684|3550132|FG000|Overall Study|Other than specified|69
1985244|NCT03713684|3550133|FG001|Overall Study|Other than specified|77
1985245|NCT03713684|3550134|FG002|Overall Study|Other than specified|73
1985246|NCT03713684|3550135|FG003|Overall Study|Other than specified|70
1985247|NCT03644550|3550145|FG000|Overall Study|Withdrawal by Subject|3
1985248|NCT03644550|3550145|FG000|Overall Study|Progressive disease|15
1985249|NCT03557970|3550152|FG000|Overall Study|Study closure|1
1985250|NCT03557970|3550153|FG001|Overall Study|Study closure|0
1985251|NCT03557970|3550152|FG000|Overall Study|Physician Decision|0
1985252|NCT03557970|3550153|FG001|Overall Study|Physician Decision|1
2310857|NCT02742766|4015601|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310858|NCT02742766|4015602|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310859|NCT02742766|4015603|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310860|NCT02742766|4015604|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310861|NCT02742766|4015605|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310862|NCT02742766|4015606|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310863|NCT02742766|4015607|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310864|NCT02742766|4015608|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310865|NCT02742766|4015609|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310866|NCT02742766|4015610|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310867|NCT02742766|4015611|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310868|NCT02742766|4015612|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310869|NCT02742766|4015613|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310870|NCT02742766|4015614|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
2310871|NCT02742766|4015615|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310872|NCT02742766|4015616|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310873|NCT02742766|4015617|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310874|NCT02742766|4015618|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310875|NCT02742766|4015619|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2310876|NCT02742766|4015601|FG000|Part 2 (Up to 22 Days)|Physician Decision|0
2310877|NCT02742766|4015602|FG001|Part 2 (Up to 22 Days)|Physician Decision|0
2310878|NCT02742766|4015603|FG002|Part 2 (Up to 22 Days)|Physician Decision|0
2310879|NCT02742766|4015604|FG003|Part 2 (Up to 22 Days)|Physician Decision|0
2310880|NCT02742766|4015605|FG004|Part 2 (Up to 22 Days)|Physician Decision|0
2310881|NCT02742766|4015606|FG005|Part 2 (Up to 22 Days)|Physician Decision|0
2310882|NCT02742766|4015607|FG006|Part 2 (Up to 22 Days)|Physician Decision|0
2310883|NCT02742766|4015608|FG007|Part 2 (Up to 22 Days)|Physician Decision|0
2310884|NCT02742766|4015609|FG008|Part 2 (Up to 22 Days)|Physician Decision|0
2310885|NCT02742766|4015610|FG009|Part 2 (Up to 22 Days)|Physician Decision|0
2310886|NCT02742766|4015611|FG010|Part 2 (Up to 22 Days)|Physician Decision|0
2310887|NCT02742766|4015612|FG011|Part 2 (Up to 22 Days)|Physician Decision|0
2310888|NCT02742766|4015613|FG012|Part 2 (Up to 22 Days)|Physician Decision|2
2310889|NCT02742766|4015614|FG013|Part 2 (Up to 22 Days)|Physician Decision|5
2310890|NCT02742766|4015615|FG014|Part 2 (Up to 22 Days)|Physician Decision|0
2310891|NCT02742766|4015616|FG015|Part 2 (Up to 22 Days)|Physician Decision|1
2310892|NCT02742766|4015617|FG016|Part 2 (Up to 22 Days)|Physician Decision|0
2310893|NCT02742766|4015618|FG017|Part 2 (Up to 22 Days)|Physician Decision|0
2310894|NCT02742766|4015619|FG018|Part 2 (Up to 22 Days)|Physician Decision|0
2310895|NCT02742818|4015681|FG000|Overall Study|Adverse Event|0
2310896|NCT02742818|4015682|FG001|Overall Study|Adverse Event|1
2310897|NCT02742818|4015681|FG000|Overall Study|Protocol Violation|0
2310898|NCT02742818|4015682|FG001|Overall Study|Protocol Violation|1
2310899|NCT02743117|4015705|FG000|Overall Study|Lost to Follow-up|0
2310900|NCT02743117|4015706|FG001|Overall Study|Lost to Follow-up|1
2310901|NCT02743117|4015705|FG000|Overall Study|Other|1
2310902|NCT02743117|4015706|FG001|Overall Study|Other|0
2310903|NCT02743221|4015714|FG000|Overall Study|Progressive disease|29
2310904|NCT02743221|4015715|FG001|Overall Study|Progressive disease|38
2310905|NCT02743221|4015714|FG000|Overall Study|Adverse Event|17
2310906|NCT02743221|4015715|FG001|Overall Study|Adverse Event|14
2310907|NCT02743221|4015714|FG000|Overall Study|non medical reason|8
2310908|NCT02743221|4015715|FG001|Overall Study|non medical reason|2
2310909|NCT02743221|4015714|FG000|Overall Study|Physician Decision|2
2310910|NCT02743221|4015715|FG001|Overall Study|Physician Decision|5
2310911|NCT02743221|4015714|FG000|Overall Study|Patient not eligible, not treated|0
2310912|NCT02743221|4015715|FG001|Overall Study|Patient not eligible, not treated|1
1985253|NCT03557970|3550152|FG000|Overall Study|Death|0
1985254|NCT03557970|3550153|FG001|Overall Study|Death|1
2024213|NCT00332488|3592628|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
2024214|NCT00332488|3592629|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
2024215|NCT00332488|3592630|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1
2024216|NCT00332488|3592628|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
2024217|NCT00332488|3592629|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
2024218|NCT00332488|3592630|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8
2024219|NCT00332488|3592628|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
2024220|NCT00332488|3592629|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
2024221|NCT00332488|3592630|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5
2024222|NCT00332696|3592689|FG000|Overall Study|Death|24
2213412|NCT01678820|3854922|FG000|Overall Study|Study Terminated by Sponsor|45
2213413|NCT01678820|3854923|FG001|Overall Study|Study Terminated by Sponsor|43
2213414|NCT01678820|3854924|FG002|Overall Study|Study Terminated by Sponsor|43
2213415|NCT01678820|3854922|FG000|Overall Study|Withdrawal by Subject|2
2213416|NCT01678820|3854923|FG001|Overall Study|Withdrawal by Subject|5
2213417|NCT01678820|3854924|FG002|Overall Study|Withdrawal by Subject|2
2310913|NCT02743494|4015755|FG000|Pre-treatment Period|Participant request to discontinue treatment|0
2310914|NCT02743494|4015756|FG001|Pre-treatment Period|Participant request to discontinue treatment|1
2024223|NCT00332696|3592690|FG001|Overall Study|Death|14
2024224|NCT00332696|3592689|FG000|Overall Study|Insufficient therapeutic effect|4
2024225|NCT00332696|3592690|FG001|Overall Study|Insufficient therapeutic effect|11
2024226|NCT00332696|3592689|FG000|Overall Study|Adverse Event|1
2024227|NCT00332696|3592690|FG001|Overall Study|Adverse Event|2
2024228|NCT00332696|3592689|FG000|Overall Study|Condition does not justify treatment|0
2024229|NCT00332696|3592690|FG001|Overall Study|Condition does not justify treatment|2
2024230|NCT00332696|3592689|FG000|Overall Study|Lost to Follow-up|0
2024231|NCT00332696|3592690|FG001|Overall Study|Lost to Follow-up|1
2024232|NCT00332696|3592689|FG000|Overall Study|Withdrawal by Subject|1
2024233|NCT00332696|3592690|FG001|Overall Study|Withdrawal by Subject|0
2024234|NCT00332709|3592698|FG000|Overall Study|Adverse Event|11
2024235|NCT00332709|3592699|FG001|Overall Study|Adverse Event|14
2024236|NCT00332709|3592698|FG000|Overall Study|Withdrawal by Subject|2
2024237|NCT00332709|3592699|FG001|Overall Study|Withdrawal by Subject|3
2024238|NCT00332709|3592698|FG000|Overall Study|Lost to Follow-up|2
2024239|NCT00332709|3592699|FG001|Overall Study|Lost to Follow-up|0
2024240|NCT00332709|3592698|FG000|Overall Study|Administrative Problems|0
2024241|NCT00332709|3592699|FG001|Overall Study|Administrative Problems|3
2024242|NCT00332709|3592698|FG000|Overall Study|Abnormal test procedure result|1
2024243|NCT00332709|3592699|FG001|Overall Study|Abnormal test procedure result|0
2024244|NCT00332839|3592716|FG000|Core (Months 0 - 12)|Administrative problems|1
2024245|NCT00332839|3592717|FG001|Core (Months 0 - 12)|Administrative problems|1
2024246|NCT00332839|3592716|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3
2024247|NCT00332839|3592717|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1
2024248|NCT00332839|3592716|FG000|Core (Months 0 - 12)|Protocol deviation|1
2024249|NCT00332839|3592717|FG001|Core (Months 0 - 12)|Protocol deviation|1
2310915|NCT02743494|4015755|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0
2310916|NCT02743494|4015756|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1
2310917|NCT02743494|4015755|FG000|Treatment Period|Completed treatment|229
2310918|NCT02743494|4015756|FG001|Treatment Period|Completed treatment|99
2310919|NCT02743494|4015755|FG000|Treatment Period|Disease recurrence|149
2310920|NCT02743494|4015756|FG001|Treatment Period|Disease recurrence|113
2310921|NCT02743494|4015755|FG000|Treatment Period|Study drug toxicity|57
2310922|NCT02743494|4015756|FG001|Treatment Period|Study drug toxicity|8
2310923|NCT02743494|4015755|FG000|Treatment Period|Death|1
2310924|NCT02743494|4015756|FG001|Treatment Period|Death|0
2310925|NCT02743494|4015755|FG000|Treatment Period|Adverse event unrelated to study drug|15
2310926|NCT02743494|4015756|FG001|Treatment Period|Adverse event unrelated to study drug|9
2310927|NCT02743494|4015755|FG000|Treatment Period|Participant request to discontinue treatment|30
2310928|NCT02743494|4015756|FG001|Treatment Period|Participant request to discontinue treatment|5
2310929|NCT02743494|4015755|FG000|Treatment Period|Participant withdrew consent|12
2310930|NCT02743494|4015756|FG001|Treatment Period|Participant withdrew consent|4
2310931|NCT02743494|4015755|FG000|Treatment Period|Lost to Follow-up|0
2310932|NCT02743494|4015756|FG001|Treatment Period|Lost to Follow-up|1
2310933|NCT02743494|4015755|FG000|Treatment Period|Poor/Non-compliance|1
2310934|NCT02743494|4015756|FG001|Treatment Period|Poor/Non-compliance|0
2310935|NCT02743494|4015755|FG000|Treatment Period|Other reasons|7
1985255|NCT03332095|3550174|FG000|Overall Study|Lost to Follow-up|1
1985256|NCT03332095|3550175|FG001|Overall Study|Lost to Follow-up|0
1985257|NCT03332095|3550174|FG000|Overall Study|Pregnancy|0
1985258|NCT03332095|3550175|FG001|Overall Study|Pregnancy|1
1985259|NCT03022461|3550181|FG000|Overall Study|Death|3
1985260|NCT02964039|3550197|FG000|Overall Study|Medical reason unrelated to study participation|1
1985261|NCT02964039|3550198|FG001|Overall Study|Medical reason unrelated to study participation|0
1985262|NCT02964039|3550199|FG002|Overall Study|Medical reason unrelated to study participation|3
1985263|NCT02964039|3550197|FG000|Overall Study|Research shutdown due to pandemic|2
1985264|NCT02964039|3550198|FG001|Overall Study|Research shutdown due to pandemic|0
1985265|NCT02964039|3550199|FG002|Overall Study|Research shutdown due to pandemic|1
1985266|NCT02964039|3550197|FG000|Overall Study|Withdrawal by Subject|0
1985267|NCT02964039|3550198|FG001|Overall Study|Withdrawal by Subject|1
1985268|NCT02964039|3550199|FG002|Overall Study|Withdrawal by Subject|0
1985269|NCT02964039|3550197|FG000|Overall Study|Lost to Follow-up|1
1985270|NCT02964039|3550198|FG001|Overall Study|Lost to Follow-up|0
1985271|NCT02964039|3550199|FG002|Overall Study|Lost to Follow-up|1
1985272|NCT02930889|3550207|FG000|Overall Study|Lost to Follow-up|2
1985273|NCT02930889|3550207|FG000|Overall Study|Withdrawal by Subject|6
1985274|NCT02930889|3550207|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8
1985275|NCT02919618|3550211|FG000|Overall Study|Death|1
1985276|NCT02844946|3550228|FG000|Overall Study|Lost to Follow-up|7
1985277|NCT02844946|3550229|FG001|Overall Study|Lost to Follow-up|0
1985278|NCT02564796|3550246|FG000|Overall Study|Physician Decision|2
1985279|NCT02564796|3550247|FG001|Overall Study|Physician Decision|2
1985280|NCT02562716|3550255|FG000|Overall Study|Adverse Event|7
1985281|NCT02562716|3550256|FG001|Overall Study|Adverse Event|14
1985282|NCT02562716|3550255|FG000|Overall Study|Withdrawal unrelated to AE|7
1985283|NCT02562716|3550256|FG001|Overall Study|Withdrawal unrelated to AE|1
1985284|NCT02562716|3550255|FG000|Overall Study|Progression|8
1985285|NCT02562716|3550256|FG001|Overall Study|Progression|10
1985286|NCT02562716|3550255|FG000|Overall Study|Death|2
1985287|NCT02562716|3550256|FG001|Overall Study|Death|1
1985288|NCT02562716|3550255|FG000|Overall Study|Not protocol specified|4
2310936|NCT02743494|4015756|FG001|Treatment Period|Other reasons|2
2310937|NCT02743520|4015762|FG000|Overall Study|Withdrawal by Subject|1
2310938|NCT02743780|4015780|FG000|Part 3 (7 Days)|Adverse Event|0
2310939|NCT02743780|4015781|FG001|Part 3 (7 Days)|Adverse Event|0
2310940|NCT02743780|4015782|FG002|Part 3 (7 Days)|Adverse Event|1
2310941|NCT02743780|4015783|FG003|Part 3 (7 Days)|Adverse Event|0
2310942|NCT02743780|4015784|FG004|Part 3 (7 Days)|Adverse Event|0
2310943|NCT02743793|4015806|FG000|Overall Study|Death|1
2310944|NCT02743793|4015807|FG001|Overall Study|Death|1
2310945|NCT02743793|4015806|FG000|Overall Study|Withdrawal by Subject|0
2310946|NCT02743793|4015807|FG001|Overall Study|Withdrawal by Subject|1
2310947|NCT02743793|4015806|FG000|Overall Study|Screen Failure|4
2310948|NCT02743793|4015807|FG001|Overall Study|Screen Failure|0
2310949|NCT02743793|4015806|FG000|Overall Study|No Primary Care Physician|0
2310950|NCT02743793|4015807|FG001|Overall Study|No Primary Care Physician|1
2310951|NCT02743793|4015806|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0
2310952|NCT02743793|4015807|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1
2310953|NCT02743793|4015806|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0
2310954|NCT02743793|4015807|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32
2310955|NCT02743949|4015824|FG000|Overall Study|Adverse Event|0
2310956|NCT02743949|4015825|FG001|Overall Study|Adverse Event|0
2310957|NCT02743949|4015826|FG002|Overall Study|Adverse Event|2
2310958|NCT02743949|4015824|FG000|Overall Study|Significant Protocol Deviation|2
2310959|NCT02743949|4015825|FG001|Overall Study|Significant Protocol Deviation|0
2310960|NCT02743949|4015826|FG002|Overall Study|Significant Protocol Deviation|1
2310961|NCT02743949|4015824|FG000|Overall Study|Voluntary Withdrawal|2
2310962|NCT02743949|4015825|FG001|Overall Study|Voluntary Withdrawal|1
2310963|NCT02743949|4015826|FG002|Overall Study|Voluntary Withdrawal|0
2310964|NCT02743962|4015836|FG000|Overall Study|Atrophic vaginitis diagnosed|1
2310965|NCT02743962|4015837|FG001|Overall Study|Atrophic vaginitis diagnosed|0
2310966|NCT02744066|4015848|FG000|Overall Study|Withdrawal by parent|0
2310967|NCT02744066|4015849|FG001|Overall Study|Withdrawal by parent|1
2310968|NCT02744066|4015848|FG000|Overall Study|Discharged from NICU prior to completion|0
2310969|NCT02744066|4015849|FG001|Overall Study|Discharged from NICU prior to completion|4
2310970|NCT02744391|4015857|FG000|Overall Study|Lost to Follow-up|9
2310971|NCT02744391|4015857|FG000|Overall Study|Physician Decision|2
2310972|NCT02744391|4015857|FG000|Overall Study|Withdrawal by Subject|3
2310973|NCT02744755|4015869|FG000|Study Period 1|Protocol Violation|2
2310974|NCT02744755|4015870|FG001|Study Period 1|Protocol Violation|1
2310975|NCT02744755|4015869|FG000|Study Period 1|not defined|0
2310976|NCT02744755|4015870|FG001|Study Period 1|not defined|1
2310977|NCT02744755|4015869|FG000|Study Period 1|Pregnancy|1
2310978|NCT02744755|4015870|FG001|Study Period 1|Pregnancy|0
2310979|NCT02744755|4015869|FG000|Study Period 1|Adverse Event|1
2310980|NCT02744755|4015870|FG001|Study Period 1|Adverse Event|1
2310981|NCT02744755|4015869|FG000|Study Period 1|Lost to Follow-up|1
2310982|NCT02744755|4015870|FG001|Study Period 1|Lost to Follow-up|1
2310983|NCT02744755|4015869|FG000|Study Period 1|Lack of Efficacy|1
2310984|NCT02744755|4015870|FG001|Study Period 1|Lack of Efficacy|0
1985289|NCT02562716|3550256|FG001|Overall Study|Not protocol specified|2
1985290|NCT02442349|3550264|FG000|Overall Study|Death|14
1985291|NCT02442349|3550264|FG000|Overall Study|Withdrawal by Subject|8
1985292|NCT02442349|3550264|FG000|Overall Study|On-going Study at Data Cut-off|149
1985293|NCT02211131|3550270|FG000|Overall Study|Death|20
1985294|NCT02211131|3550271|FG001|Overall Study|Death|11
1985295|NCT02211131|3550270|FG000|Overall Study|Lost to Follow-up|1
1985296|NCT02211131|3550271|FG001|Overall Study|Lost to Follow-up|0
1985297|NCT02211131|3550270|FG000|Overall Study|Decision by Sponsor|1
1985298|NCT02211131|3550271|FG001|Overall Study|Decision by Sponsor|1
1985299|NCT02211131|3550270|FG000|Overall Study|Withdrawal by Subject|3
1985300|NCT02211131|3550271|FG001|Overall Study|Withdrawal by Subject|4
1985301|NCT02211131|3550270|FG000|Overall Study|Continuing on Study|49
1985302|NCT02211131|3550271|FG001|Overall Study|Continuing on Study|60
1985303|NCT02094261|3550284|FG000|Overall Study|Death|24
1985304|NCT02094261|3550284|FG000|Overall Study|Lost to Follow-up|1
1985305|NCT02094261|3550284|FG000|Overall Study|Withdrawal by Subject|4
1985306|NCT02094261|3550284|FG000|Overall Study|Ongoing Study at Data Cut-off|181
1985307|NCT01496976|3550293|FG000|Overall Study|Withdrew - received stem cell transplant|1
1985308|NCT01472081|3550303|FG000|Overall Study|Continuing treatment at time of analysis|1
1985309|NCT01472081|3550304|FG001|Overall Study|Continuing treatment at time of analysis|4
1985310|NCT01472081|3550305|FG002|Overall Study|Continuing treatment at time of analysis|1
1985311|NCT01472081|3550306|FG003|Overall Study|Continuing treatment at time of analysis|8
1985312|NCT01472081|3550307|FG004|Overall Study|Continuing treatment at time of analysis|9
1985313|NCT01472081|3550308|FG005|Overall Study|Continuing treatment at time of analysis|0
1985314|NCT01472081|3550303|FG000|Overall Study|Disease Progression|4
1985315|NCT01472081|3550304|FG001|Overall Study|Disease Progression|10
1985316|NCT01472081|3550305|FG002|Overall Study|Disease Progression|12
1985317|NCT01472081|3550306|FG003|Overall Study|Disease Progression|31
1985318|NCT01472081|3550307|FG004|Overall Study|Disease Progression|22
1985319|NCT01472081|3550308|FG005|Overall Study|Disease Progression|3
1985320|NCT01472081|3550303|FG000|Overall Study|Study drug toxicity|2
1985321|NCT01472081|3550304|FG001|Overall Study|Study drug toxicity|9
1985322|NCT01472081|3550305|FG002|Overall Study|Study drug toxicity|4
1985323|NCT01472081|3550306|FG003|Overall Study|Study drug toxicity|6
1985324|NCT01472081|3550307|FG004|Overall Study|Study drug toxicity|13
1985325|NCT01472081|3550308|FG005|Overall Study|Study drug toxicity|2
1985326|NCT01472081|3550303|FG000|Overall Study|Death|0
1985327|NCT01472081|3550304|FG001|Overall Study|Death|0
1985328|NCT01472081|3550305|FG002|Overall Study|Death|0
1985329|NCT01472081|3550306|FG003|Overall Study|Death|0
1985330|NCT01472081|3550307|FG004|Overall Study|Death|1
1985331|NCT01472081|3550308|FG005|Overall Study|Death|0
1985332|NCT01472081|3550303|FG000|Overall Study|Adverse Event unrelated to study drug|0
1985333|NCT01472081|3550304|FG001|Overall Study|Adverse Event unrelated to study drug|0
1985334|NCT01472081|3550305|FG002|Overall Study|Adverse Event unrelated to study drug|0
1985335|NCT01472081|3550306|FG003|Overall Study|Adverse Event unrelated to study drug|0
1985336|NCT01472081|3550307|FG004|Overall Study|Adverse Event unrelated to study drug|1
1985337|NCT01472081|3550308|FG005|Overall Study|Adverse Event unrelated to study drug|0
1985338|NCT01472081|3550303|FG000|Overall Study|Withdrawal by Subject|0
1985339|NCT01472081|3550304|FG001|Overall Study|Withdrawal by Subject|0
1985340|NCT01472081|3550305|FG002|Overall Study|Withdrawal by Subject|0
1985341|NCT01472081|3550306|FG003|Overall Study|Withdrawal by Subject|0
1985342|NCT01472081|3550307|FG004|Overall Study|Withdrawal by Subject|0
1985343|NCT01472081|3550308|FG005|Overall Study|Withdrawal by Subject|1
1985344|NCT01472081|3550303|FG000|Overall Study|Poor/non-compliance|0
1985345|NCT01472081|3550304|FG001|Overall Study|Poor/non-compliance|0
1985346|NCT01472081|3550305|FG002|Overall Study|Poor/non-compliance|1
1985347|NCT01472081|3550306|FG003|Overall Study|Poor/non-compliance|0
1985348|NCT01472081|3550307|FG004|Overall Study|Poor/non-compliance|1
1985349|NCT01472081|3550308|FG005|Overall Study|Poor/non-compliance|0
1985350|NCT01472081|3550303|FG000|Overall Study|No longer meets study criteria|0
1985351|NCT01472081|3550304|FG001|Overall Study|No longer meets study criteria|0
1985352|NCT01472081|3550305|FG002|Overall Study|No longer meets study criteria|1
1985353|NCT01472081|3550306|FG003|Overall Study|No longer meets study criteria|0
1985354|NCT01472081|3550307|FG004|Overall Study|No longer meets study criteria|0
1985355|NCT01472081|3550308|FG005|Overall Study|No longer meets study criteria|0
1985356|NCT01472081|3550303|FG000|Overall Study|Subject request to discontinue treatment|0
1985357|NCT01472081|3550304|FG001|Overall Study|Subject request to discontinue treatment|3
1985358|NCT01472081|3550305|FG002|Overall Study|Subject request to discontinue treatment|1
1985359|NCT01472081|3550306|FG003|Overall Study|Subject request to discontinue treatment|1
1985360|NCT01472081|3550307|FG004|Overall Study|Subject request to discontinue treatment|0
1985361|NCT01472081|3550308|FG005|Overall Study|Subject request to discontinue treatment|0
2108216|NCT00878722|3702053|FG004|Overall Study|Relapse|0
2024250|NCT00332839|3592716|FG000|Core (Months 0 - 12)|Adverse Event|5
2024251|NCT00332839|3592717|FG001|Core (Months 0 - 12)|Adverse Event|15
2024252|NCT00332839|3592716|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
2024253|NCT00332839|3592717|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
2024254|NCT00332839|3592716|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2
2024255|NCT00332839|3592717|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1
2024256|NCT00332839|3592716|FG000|Follow-up (Months 12 - 60)|Death|1
1985362|NCT01309672|3550321|FG000|Overall Study|Lack of Efficacy|20
1985363|NCT01309672|3550321|FG000|Overall Study|Other|9
1985364|NCT01309672|3550321|FG000|Overall Study|Adverse Event|5
1985365|NCT01309672|3550321|FG000|Overall Study|Withdrawal by Subject|3
1985366|NCT00774345|3550338|FG000|Pre-treatment|Other reasons|2
1985367|NCT00774345|3550339|FG001|Pre-treatment|Other reasons|0
1985368|NCT00774345|3550338|FG000|Treatment|Adverse Event|61
1985369|NCT00774345|3550339|FG001|Treatment|Adverse Event|15
1985370|NCT00774345|3550338|FG000|Treatment|Progressive Disease without histologic transformation|51
1985371|NCT00774345|3550339|FG001|Treatment|Progressive Disease without histologic transformation|111
1985372|NCT00774345|3550338|FG000|Treatment|Progressive Disease with histologic transformation|4
1985373|NCT00774345|3550339|FG001|Treatment|Progressive Disease with histologic transformation|2
1985374|NCT00774345|3550338|FG000|Treatment|Withdrawal by Subject|5
1985375|NCT00774345|3550339|FG001|Treatment|Withdrawal by Subject|2
1985376|NCT00774345|3550338|FG000|Treatment|Lost to Follow-up|1
1985377|NCT00774345|3550339|FG001|Treatment|Lost to Follow-up|1
1985378|NCT00774345|3550338|FG000|Treatment|Death|4
1985379|NCT00774345|3550339|FG001|Treatment|Death|0
1985380|NCT00774345|3550338|FG000|Treatment|Other Reasons|32
1985381|NCT00774345|3550339|FG001|Treatment|Other Reasons|26
1985382|NCT00000135|3550423|FG000|Overall Study|Death|27
1985383|NCT00000135|3550424|FG001|Overall Study|Death|14
1985384|NCT00000378|3550472|FG000|Overall Study|Lack of Efficacy|16
1985385|NCT00000378|3550473|FG001|Overall Study|Lack of Efficacy|14
1985386|NCT00000620|3550520|FG000|Overall Study|Death|86
1985387|NCT00000620|3550521|FG001|Overall Study|Death|67
1985388|NCT00000620|3550522|FG002|Overall Study|Death|112
1985389|NCT00000620|3550523|FG003|Overall Study|Death|126
1985390|NCT00000620|3550524|FG004|Overall Study|Death|64
1985391|NCT00000620|3550525|FG005|Overall Study|Death|77
1985392|NCT00000620|3550526|FG006|Overall Study|Death|91
1985393|NCT00000620|3550527|FG007|Overall Study|Death|95
1985394|NCT00000620|3550520|FG000|Overall Study|Lost to Follow-up|14
1985395|NCT00000620|3550521|FG001|Overall Study|Lost to Follow-up|14
1985396|NCT00000620|3550522|FG002|Overall Study|Lost to Follow-up|14
1985397|NCT00000620|3550523|FG003|Overall Study|Lost to Follow-up|14
1985398|NCT00000620|3550524|FG004|Overall Study|Lost to Follow-up|15
1985399|NCT00000620|3550525|FG005|Overall Study|Lost to Follow-up|15
1985400|NCT00000620|3550526|FG006|Overall Study|Lost to Follow-up|13
1985401|NCT00000620|3550527|FG007|Overall Study|Lost to Follow-up|14
1985402|NCT00000620|3550520|FG000|Overall Study|Withdrawal by Subject|40
1985403|NCT00000620|3550521|FG001|Overall Study|Withdrawal by Subject|27
1985404|NCT00000620|3550522|FG002|Overall Study|Withdrawal by Subject|28
1985405|NCT00000620|3550523|FG003|Overall Study|Withdrawal by Subject|27
1985406|NCT00000620|3550524|FG004|Overall Study|Withdrawal by Subject|30
1985407|NCT00000620|3550525|FG005|Overall Study|Withdrawal by Subject|32
1985408|NCT00000620|3550526|FG006|Overall Study|Withdrawal by Subject|32
1985409|NCT00000620|3550527|FG007|Overall Study|Withdrawal by Subject|21
1985410|NCT00000620|3550520|FG000|Overall Study|missed closeout visit|22
1985411|NCT00000620|3550521|FG001|Overall Study|missed closeout visit|28
1985412|NCT00000620|3550522|FG002|Overall Study|missed closeout visit|16
1985413|NCT00000620|3550523|FG003|Overall Study|missed closeout visit|11
1985414|NCT00000620|3550524|FG004|Overall Study|missed closeout visit|26
1985415|NCT00000620|3550525|FG005|Overall Study|missed closeout visit|28
1985416|NCT00000620|3550526|FG006|Overall Study|missed closeout visit|13
1985417|NCT00000620|3550527|FG007|Overall Study|missed closeout visit|16
1985418|NCT00001213|3550543|FG000|Overall Study|Death|18
1985419|NCT00001262|3550550|FG000|Overall Study|Death|10
1985420|NCT00001262|3550551|FG001|Overall Study|Death|11
1985421|NCT00001262|3550552|FG002|Overall Study|Death|0
2213418|NCT01678820|3854922|FG000|Overall Study|Protocol Specified Criteria|2
2310985|NCT02744755|4015869|FG000|Study Period 1|Withdrawal by Subject|8
2310986|NCT02744755|4015870|FG001|Study Period 1|Withdrawal by Subject|4
2310987|NCT02744755|4015869|FG000|Study Period 2|Adverse Event|5
2310988|NCT02744755|4015870|FG001|Study Period 2|Adverse Event|0
1985422|NCT00001262|3550550|FG000|Overall Study|Withdrawal by Subject|0
1985423|NCT00001262|3550551|FG001|Overall Study|Withdrawal by Subject|3
1985424|NCT00001262|3550552|FG002|Overall Study|Withdrawal by Subject|0
1985425|NCT00001566|3550573|FG000|Overall Study|patients' choice to discontinue protocol|3
1985426|NCT00001566|3550573|FG000|Overall Study|stopped after C3 due to symptomatic PD|1
1985427|NCT00001566|3550573|FG000|Overall Study|Death|13
1985428|NCT00001566|3550573|FG000|Overall Study|Lost to Follow-up|1
1985429|NCT00001566|3550573|FG000|Overall Study|unable to complete initial apheresis|1
1985430|NCT00001575|3550577|FG000|Overall Study|Screening failures-Ph I portion|22
1985431|NCT00001575|3550577|FG000|Overall Study|Withdrawn/deaths|23
1985432|NCT00001596|3550592|FG000|Overall Study|Death|1
1985433|NCT00001596|3550593|FG001|Overall Study|Death|0
1985434|NCT00001596|3550592|FG000|Overall Study|Withdrawal by Subject|3
1985435|NCT00001596|3550593|FG001|Overall Study|Withdrawal by Subject|1
1985436|NCT00001596|3550592|FG000|Overall Study|Study Termination|12
1985437|NCT00001596|3550593|FG001|Overall Study|Study Termination|9
1985438|NCT00001596|3550592|FG000|Overall Study|Adverse Event|1
1985439|NCT00001596|3550593|FG001|Overall Study|Adverse Event|0
1985440|NCT00001703|3550608|FG000|Overall Study|progressed disease|2
1985441|NCT00001703|3550608|FG000|Overall Study|No evidence of disease|1
2310989|NCT02744755|4015869|FG000|Study Period 2|Protocol Violation|1
1985442|NCT00001703|3550608|FG000|Overall Study|recurrent disease|2
1985443|NCT00001723|3550614|FG000|Overall Study|Lack of Efficacy|6
1985444|NCT00001723|3550615|FG001|Overall Study|Lack of Efficacy|7
1985445|NCT00001723|3550614|FG000|Overall Study|Lack of family interest|4
1985446|NCT00001723|3550615|FG001|Overall Study|Lack of family interest|5
1985447|NCT00001723|3550614|FG000|Overall Study|Lost to Follow-up|2
1985448|NCT00001723|3550615|FG001|Overall Study|Lost to Follow-up|2
1985449|NCT00001723|3550614|FG000|Overall Study|medication intolerance|1
1985450|NCT00001723|3550615|FG001|Overall Study|medication intolerance|2
1985451|NCT00001832|3550639|FG000|Apheresis Period|not able to manufacture treatment cells|60
1985452|NCT00001832|3550640|FG001|Apheresis Period|not able to manufacture treatment cells|0
1985453|NCT00001832|3550641|FG002|Apheresis Period|not able to manufacture treatment cells|0
1985454|NCT00001832|3550642|FG003|Apheresis Period|not able to manufacture treatment cells|0
1985455|NCT00001832|3550643|FG004|Apheresis Period|not able to manufacture treatment cells|0
1985456|NCT00001832|3550644|FG005|Apheresis Period|not able to manufacture treatment cells|0
1985457|NCT00001832|3550645|FG006|Apheresis Period|not able to manufacture treatment cells|0
1985458|NCT00001832|3550646|FG007|Apheresis Period|not able to manufacture treatment cells|0
1985459|NCT00001832|3550647|FG008|Apheresis Period|not able to manufacture treatment cells|0
1985460|NCT00001832|3550648|FG009|Apheresis Period|not able to manufacture treatment cells|0
1985461|NCT00001832|3550649|FG010|Apheresis Period|not able to manufacture treatment cells|0
1985462|NCT00001832|3550650|FG011|Apheresis Period|not able to manufacture treatment cells|0
1985463|NCT00001832|3550651|FG012|Apheresis Period|not able to manufacture treatment cells|0
1985464|NCT00001832|3550652|FG013|Apheresis Period|not able to manufacture treatment cells|0
1985465|NCT00001832|3550653|FG014|Apheresis Period|not able to manufacture treatment cells|0
1985466|NCT00001832|3550639|FG000|Treatment Period|Death during treatment|0
1985467|NCT00001832|3550640|FG001|Treatment Period|Death during treatment|0
1985468|NCT00001832|3550641|FG002|Treatment Period|Death during treatment|0
1985469|NCT00001832|3550642|FG003|Treatment Period|Death during treatment|0
1985470|NCT00001832|3550643|FG004|Treatment Period|Death during treatment|0
1985471|NCT00001832|3550644|FG005|Treatment Period|Death during treatment|1
1985472|NCT00001832|3550645|FG006|Treatment Period|Death during treatment|0
1985473|NCT00001832|3550646|FG007|Treatment Period|Death during treatment|0
1985474|NCT00001832|3550647|FG008|Treatment Period|Death during treatment|0
1985475|NCT00001832|3550648|FG009|Treatment Period|Death during treatment|0
1985476|NCT00001832|3550649|FG010|Treatment Period|Death during treatment|0
1985477|NCT00001832|3550650|FG011|Treatment Period|Death during treatment|0
1985478|NCT00001832|3550651|FG012|Treatment Period|Death during treatment|0
1985479|NCT00001832|3550652|FG013|Treatment Period|Death during treatment|0
1985480|NCT00001832|3550653|FG014|Treatment Period|Death during treatment|0
1985481|NCT00001832|3550639|FG000|Treatment Period|Not treated|0
1985482|NCT00001832|3550640|FG001|Treatment Period|Not treated|0
1985483|NCT00001832|3550641|FG002|Treatment Period|Not treated|0
1985484|NCT00001832|3550642|FG003|Treatment Period|Not treated|0
1985485|NCT00001832|3550643|FG004|Treatment Period|Not treated|0
1985486|NCT00001832|3550644|FG005|Treatment Period|Not treated|0
1985487|NCT00001832|3550645|FG006|Treatment Period|Not treated|0
1985488|NCT00001832|3550646|FG007|Treatment Period|Not treated|1
1985489|NCT00001832|3550647|FG008|Treatment Period|Not treated|0
1985490|NCT00001832|3550648|FG009|Treatment Period|Not treated|0
1985491|NCT00001832|3550649|FG010|Treatment Period|Not treated|0
1985492|NCT00001832|3550650|FG011|Treatment Period|Not treated|0
1985493|NCT00001832|3550651|FG012|Treatment Period|Not treated|0
1985494|NCT00001832|3550652|FG013|Treatment Period|Not treated|0
1985495|NCT00001832|3550653|FG014|Treatment Period|Not treated|0
1985496|NCT00001849|3550683|FG000|Overall Study|Death|4
1985497|NCT00001849|3550683|FG000|Overall Study|Lost to Follow-up|2
1985498|NCT00001849|3550683|FG000|Overall Study|Withdrawal by Subject|2
1985499|NCT00001849|3550683|FG000|Overall Study|tumor remained occult|6
1985500|NCT00001880|3550696|FG000|Overall Study|Death|14
1985501|NCT00001941|3550700|FG000|Overall Study|not treated- rapidly progressing disease|0
1985502|NCT00001941|3550701|FG001|Overall Study|not treated- rapidly progressing disease|0
1985503|NCT00001941|3550702|FG002|Overall Study|not treated- rapidly progressing disease|0
1985504|NCT00001941|3550703|FG003|Overall Study|not treated- rapidly progressing disease|0
1985505|NCT00001941|3550704|FG004|Overall Study|not treated- rapidly progressing disease|1
2024257|NCT00332839|3592717|FG001|Follow-up (Months 12 - 60)|Death|1
2310990|NCT02744755|4015870|FG001|Study Period 2|Protocol Violation|0
2310991|NCT02744755|4015869|FG000|Study Period 2|not defined|3
2310992|NCT02744755|4015870|FG001|Study Period 2|not defined|2
2310993|NCT02744755|4015869|FG000|Study Period 2|Lost to Follow-up|0
2310994|NCT02744755|4015870|FG001|Study Period 2|Lost to Follow-up|2
2310995|NCT02744755|4015869|FG000|Study Period 2|Withdrawal by Subject|2
2310996|NCT02744755|4015870|FG001|Study Period 2|Withdrawal by Subject|2
2310997|NCT02744755|4015869|FG000|Study Period 2|Lack of Efficacy|3
2310998|NCT02744755|4015870|FG001|Study Period 2|Lack of Efficacy|2
2310999|NCT02744898|4015888|FG000|Overall Study|Progressive Disease|2
2311000|NCT02744898|4015888|FG000|Overall Study|Physician Decision|1
2311001|NCT02744898|4015888|FG000|Overall Study|Toxicity|1
2311002|NCT02745080|4015894|FG000|Overall Study|Adverse Event|13
2311003|NCT02745080|4015895|FG001|Overall Study|Adverse Event|21
2311004|NCT02745080|4015894|FG000|Overall Study|Lack of Efficacy|11
2311005|NCT02745080|4015895|FG001|Overall Study|Lack of Efficacy|23
1985506|NCT00001959|3550709|FG000|Overall Study|newly diagnosed colon cancer|1
1985507|NCT00001959|3550709|FG000|Overall Study|disabling sedation|1
1985508|NCT00001959|3550709|FG000|Overall Study|non-compliance|1
1985509|NCT00001962|3550713|FG000|Overall Study|Lack of Efficacy|18
1985510|NCT00001962|3550713|FG000|Overall Study|Lack of Accrual|6
1985511|NCT00001962|3550713|FG000|Overall Study|Death|1
1985512|NCT00001962|3550713|FG000|Overall Study|Lost to Follow-up|2
1985513|NCT00001962|3550713|FG000|Overall Study|Adverse Event|1
1985514|NCT00002525|3550723|FG000|Overall Study|Adverse Event|36
1985515|NCT00002525|3550724|FG001|Overall Study|Adverse Event|0
2213419|NCT01678820|3854923|FG001|Overall Study|Protocol Specified Criteria|3
2213420|NCT01678820|3854924|FG002|Overall Study|Protocol Specified Criteria|1
2213421|NCT01678820|3854922|FG000|Overall Study|Adverse Event|2
2213422|NCT01678820|3854923|FG001|Overall Study|Adverse Event|2
2213423|NCT01678820|3854924|FG002|Overall Study|Adverse Event|2
2213424|NCT01678820|3854922|FG000|Overall Study|Lost to Follow-up|7
1985516|NCT00002525|3550723|FG000|Overall Study|Death|5
1985517|NCT00002525|3550724|FG001|Overall Study|Death|0
1985518|NCT00002525|3550723|FG000|Overall Study|Withdrawal by Subject|11
1985519|NCT00002525|3550724|FG001|Overall Study|Withdrawal by Subject|0
1985520|NCT00002525|3550723|FG000|Overall Study|Start non-protocol therapy|1
1985521|NCT00002525|3550724|FG001|Overall Study|Start non-protocol therapy|0
1985522|NCT00002525|3550723|FG000|Overall Study|Other complicating disease|1
1985523|NCT00002525|3550724|FG001|Overall Study|Other complicating disease|0
1985524|NCT00002525|3550723|FG000|Overall Study|Duke's A, B1, D disease|92
1985525|NCT00002525|3550724|FG001|Overall Study|Duke's A, B1, D disease|0
1985526|NCT00002525|3550723|FG000|Overall Study|Error|6
1985527|NCT00002525|3550724|FG001|Overall Study|Error|0
1985528|NCT00002525|3550723|FG000|Overall Study|Other|26
1985529|NCT00002525|3550724|FG001|Overall Study|Other|0
1985530|NCT00002525|3550723|FG000|Overall Study|Never start protocol therapy|8
1985531|NCT00002525|3550724|FG001|Overall Study|Never start protocol therapy|0
1985532|NCT00002540|3550734|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0
1985533|NCT00002540|3550735|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25
1985534|NCT00002540|3550734|FG000|Overall Study|Died Before Randomization|2
1985535|NCT00002540|3550735|FG001|Overall Study|Died Before Randomization|6
1985536|NCT00002540|3550734|FG000|Overall Study|Died Before ASU (Control)|202
1985537|NCT00002540|3550735|FG001|Overall Study|Died Before ASU (Control)|0
1985538|NCT00002540|3550734|FG000|Overall Study|Refused ASU (Control)|597
1985539|NCT00002540|3550735|FG001|Overall Study|Refused ASU (Control)|0
1985540|NCT00002540|3550734|FG000|Overall Study|Refused Screen (Prostate Screening)|0
1985541|NCT00002540|3550735|FG001|Overall Study|Refused Screen (Prostate Screening)|2433
1985542|NCT00002558|3550743|FG000|Overall Study|Withdrawal by Subject|0
1985543|NCT00002558|3550744|FG001|Overall Study|Withdrawal by Subject|1
1985544|NCT00002597|3550752|FG000|Overall Study|Protocol Violation|19
1985545|NCT00002597|3550753|FG001|Overall Study|Protocol Violation|17
1985546|NCT00002597|3550752|FG000|Overall Study|Withdrawal by Subject|7
1985547|NCT00002597|3550753|FG001|Overall Study|Withdrawal by Subject|6
1985548|NCT00002651|3550767|FG000|Induction|Adverse Event|44
1985549|NCT00002651|3550768|FG001|Induction|Adverse Event|0
1985550|NCT00002651|3550769|FG002|Induction|Adverse Event|0
1985551|NCT00002651|3550767|FG000|Induction|Refusal unrelated to adverse event|50
1985552|NCT00002651|3550768|FG001|Induction|Refusal unrelated to adverse event|0
1985553|NCT00002651|3550769|FG002|Induction|Refusal unrelated to adverse event|0
1985554|NCT00002651|3550767|FG000|Induction|Progression/relapse|274
1985555|NCT00002651|3550768|FG001|Induction|Progression/relapse|0
1985556|NCT00002651|3550769|FG002|Induction|Progression/relapse|0
1985557|NCT00002651|3550767|FG000|Induction|Death|62
1985558|NCT00002651|3550768|FG001|Induction|Death|0
1985559|NCT00002651|3550769|FG002|Induction|Death|0
1985560|NCT00002651|3550767|FG000|Induction|Other|823
1985561|NCT00002651|3550768|FG001|Induction|Other|0
1985562|NCT00002651|3550769|FG002|Induction|Other|0
1985563|NCT00002651|3550767|FG000|Induction|not eligible|90
1985564|NCT00002651|3550768|FG001|Induction|not eligible|0
1985565|NCT00002651|3550769|FG002|Induction|not eligible|0
1985566|NCT00002651|3550767|FG000|Consolidation and Randomization|Adverse Event|0
1985567|NCT00002651|3550768|FG001|Consolidation and Randomization|Adverse Event|36
2213425|NCT01678820|3854923|FG001|Overall Study|Lost to Follow-up|2
2213426|NCT01678820|3854924|FG002|Overall Study|Lost to Follow-up|2
1985568|NCT00002651|3550769|FG002|Consolidation and Randomization|Adverse Event|14
1985569|NCT00002651|3550767|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0
1985570|NCT00002651|3550768|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53
1985571|NCT00002651|3550769|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75
1985572|NCT00002651|3550767|FG000|Consolidation and Randomization|Progression/relapse|0
1985573|NCT00002651|3550768|FG001|Consolidation and Randomization|Progression/relapse|295
1985574|NCT00002651|3550769|FG002|Consolidation and Randomization|Progression/relapse|298
1985575|NCT00002651|3550767|FG000|Consolidation and Randomization|Death|0
1985576|NCT00002651|3550768|FG001|Consolidation and Randomization|Death|38
1985577|NCT00002651|3550769|FG002|Consolidation and Randomization|Death|48
1985578|NCT00002651|3550767|FG000|Consolidation and Randomization|Other|0
1985579|NCT00002651|3550768|FG001|Consolidation and Randomization|Other|314
1985580|NCT00002651|3550769|FG002|Consolidation and Randomization|Other|313
1985581|NCT00002651|3550767|FG000|Consolidation and Randomization|not eligible|0
1985582|NCT00002651|3550768|FG001|Consolidation and Randomization|not eligible|102
1985583|NCT00002651|3550769|FG002|Consolidation and Randomization|not eligible|112
1985584|NCT00002766|3550779|FG000|Overall Study|Withdrawal by Subject|0
1985585|NCT00002766|3550780|FG001|Overall Study|Withdrawal by Subject|1
1985586|NCT00002766|3550779|FG000|Overall Study|Patient Not Treated|1
1985587|NCT00002766|3550780|FG001|Overall Study|Patient Not Treated|2
1985588|NCT00002766|3550779|FG000|Overall Study|Adverse Event|1
1985589|NCT00002766|3550780|FG001|Overall Study|Adverse Event|1
1985590|NCT00002766|3550779|FG000|Overall Study|Protocol Violation|1
1985591|NCT00002766|3550780|FG001|Overall Study|Protocol Violation|0
1985592|NCT00002842|3550786|FG000|Overall Study|ineligible for surgical resection|27
1985593|NCT00002850|3550793|FG000|Overall Study|Death|4
1985594|NCT00002850|3550794|FG001|Overall Study|Death|1
1985595|NCT00002850|3550795|FG002|Overall Study|Death|3
1985596|NCT00002850|3550793|FG000|Overall Study|Protocol Violation|1
1985597|NCT00002850|3550794|FG001|Overall Study|Protocol Violation|0
1985598|NCT00002850|3550795|FG002|Overall Study|Protocol Violation|1
1985599|NCT00002850|3550793|FG000|Overall Study|Withdrawal by Subject|0
1985600|NCT00002850|3550794|FG001|Overall Study|Withdrawal by Subject|1
1985601|NCT00002850|3550795|FG002|Overall Study|Withdrawal by Subject|0
1985602|NCT00002874|3550805|FG000|Overall Study|Withdrawal by Subject|1
1985603|NCT00002874|3550806|FG001|Overall Study|Withdrawal by Subject|1
1985604|NCT00002874|3550805|FG000|Overall Study|Protocol Violation|44
1985605|NCT00002874|3550806|FG001|Overall Study|Protocol Violation|34
1985606|NCT00002931|3550812|FG000|Overall Study|rapidly progressing disease during|2
1985607|NCT00003138|3550827|FG000|Step 1|Reasons off treatment not documented|60
1985608|NCT00003138|3550828|FG001|Step 1|Reasons off treatment not documented|57
1985609|NCT00003138|3550827|FG000|Step 1|Never started treatment|1
1985610|NCT00003138|3550828|FG001|Step 1|Never started treatment|0
1985611|NCT00003138|3550827|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26
1985612|NCT00003138|3550828|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0
1985613|NCT00003138|3550827|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
1985614|NCT00003138|3550828|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
1985615|NCT00003138|3550827|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
1985616|NCT00003138|3550828|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
1985617|NCT00003138|3550827|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
1985618|NCT00003138|3550828|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
1985619|NCT00003199|3550837|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5
1985620|NCT00003199|3550837|FG000|Overall Study|Lack of insurance clearance|2
1985621|NCT00003199|3550837|FG000|Overall Study|Screen fail|15
1985622|NCT00003222|3550843|FG000|Overall Study|Physician Decision|0
1985623|NCT00003222|3550844|FG001|Overall Study|Physician Decision|1
2024258|NCT00333138|3592726|FG000|Core Study (6 Months)|Adverse Event|4
2024259|NCT00333138|3592727|FG001|Core Study (6 Months)|Adverse Event|5
2024260|NCT00333138|3592728|FG002|Core Study (6 Months)|Adverse Event|8
2024261|NCT00333138|3592726|FG000|Core Study (6 Months)|Withdrawal by Subject|1
2024262|NCT00333138|3592727|FG001|Core Study (6 Months)|Withdrawal by Subject|1
2024263|NCT00333138|3592728|FG002|Core Study (6 Months)|Withdrawal by Subject|2
2024264|NCT00333138|3592726|FG000|Core Study (6 Months)|Lack of Efficacy|1
2024265|NCT00333138|3592727|FG001|Core Study (6 Months)|Lack of Efficacy|0
2024266|NCT00333138|3592728|FG002|Core Study (6 Months)|Lack of Efficacy|0
2024267|NCT00333138|3592726|FG000|Core Study (6 Months)|Protocol Violation|1
2024268|NCT00333138|3592727|FG001|Core Study (6 Months)|Protocol Violation|0
2024269|NCT00333138|3592728|FG002|Core Study (6 Months)|Protocol Violation|1
2024270|NCT00333138|3592726|FG000|Core Study (6 Months)|Laboratory abnormality|0
2024271|NCT00333138|3592727|FG001|Core Study (6 Months)|Laboratory abnormality|0
2024272|NCT00333138|3592728|FG002|Core Study (6 Months)|Laboratory abnormality|1
2024273|NCT00333138|3592726|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
2024274|NCT00333138|3592727|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
2024275|NCT00333138|3592728|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
2024276|NCT00333138|3592726|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1
2024277|NCT00333138|3592727|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1
2024278|NCT00333138|3592728|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2
2024279|NCT00333138|3592726|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15
2024280|NCT00333138|3592727|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19
2024281|NCT00333138|3592728|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15
2024282|NCT00333138|3592726|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0
2024283|NCT00333138|3592727|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0
2024284|NCT00333138|3592728|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3
2024285|NCT00333138|3592726|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
2024286|NCT00333138|3592727|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
2024287|NCT00333138|3592728|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
2024288|NCT00333138|3592726|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
2024289|NCT00333138|3592727|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
2025990|NCT00348140|3594699|FG002|Overall Study|Participant hospitalised|0
1985624|NCT04617860|3550880|FG000|Overall Study|Adverse Event|0
1985625|NCT04617860|3550881|FG001|Overall Study|Adverse Event|2
1985626|NCT04617860|3550882|FG002|Overall Study|Adverse Event|2
1985627|NCT04617860|3550880|FG000|Overall Study|Withdrawal by Subject|0
1985628|NCT04617860|3550881|FG001|Overall Study|Withdrawal by Subject|0
1985629|NCT04617860|3550882|FG002|Overall Study|Withdrawal by Subject|2
1985630|NCT04617860|3550880|FG000|Overall Study|Physician Decision|0
1985631|NCT04617860|3550881|FG001|Overall Study|Physician Decision|1
1985632|NCT04617860|3550882|FG002|Overall Study|Physician Decision|0
1985633|NCT04617860|3550880|FG000|Overall Study|Sponsor Decision|0
1985634|NCT04617860|3550881|FG001|Overall Study|Sponsor Decision|3
1985635|NCT04617860|3550882|FG002|Overall Study|Sponsor Decision|1
1985636|NCT04617860|3550880|FG000|Overall Study|Termination of Study by Sponsor|8
1985637|NCT04617860|3550881|FG001|Overall Study|Termination of Study by Sponsor|4
1985638|NCT04617860|3550882|FG002|Overall Study|Termination of Study by Sponsor|13
1985639|NCT04617847|3550894|FG000|Overall Study|Withdrawal by Subject|1
1985640|NCT04617847|3550895|FG001|Overall Study|Withdrawal by Subject|0
1985641|NCT04617847|3550894|FG000|Overall Study|Adverse Event|0
1985642|NCT04617847|3550895|FG001|Overall Study|Adverse Event|2
1985643|NCT04617847|3550894|FG000|Overall Study|Death|0
1985644|NCT04617847|3550895|FG001|Overall Study|Death|1
1985645|NCT04617847|3550894|FG000|Overall Study|Termination of Study by Sponsor|2
1985646|NCT04617847|3550895|FG001|Overall Study|Termination of Study by Sponsor|21
1985647|NCT04426318|3550905|FG000|Overall Study|failed attention checks and had their data removed from analyses|2
1985648|NCT04426318|3550906|FG001|Overall Study|failed attention checks and had their data removed from analyses|2
1985649|NCT04063657|3550918|FG000|Overall Study|Lost to Follow-up|1
1985650|NCT04063657|3550919|FG001|Overall Study|Lost to Follow-up|0
1985651|NCT03882047|3550932|FG000|Overall Study|Adverse Event|0
1985652|NCT03882047|3550933|FG001|Overall Study|Adverse Event|2
1985653|NCT03882047|3550934|FG002|Overall Study|Adverse Event|2
1985654|NCT03882047|3550932|FG000|Overall Study|Treatment Failure|3
1985655|NCT03882047|3550933|FG001|Overall Study|Treatment Failure|3
1985656|NCT03882047|3550934|FG002|Overall Study|Treatment Failure|12
1985657|NCT03882047|3550932|FG000|Overall Study|Lost to Follow-up|0
1985658|NCT03882047|3550933|FG001|Overall Study|Lost to Follow-up|1
1985659|NCT03882047|3550934|FG002|Overall Study|Lost to Follow-up|0
1985660|NCT03882047|3550932|FG000|Overall Study|Did Not Wish to Continue|1
1985661|NCT03882047|3550933|FG001|Overall Study|Did Not Wish to Continue|4
1985662|NCT03882047|3550934|FG002|Overall Study|Did Not Wish to Continue|1
1985663|NCT03882047|3550932|FG000|Overall Study|Noncompliance With Protocol|2
1985664|NCT03882047|3550933|FG001|Overall Study|Noncompliance With Protocol|0
1985665|NCT03882047|3550934|FG002|Overall Study|Noncompliance With Protocol|0
1985666|NCT03882047|3550932|FG000|Overall Study|Did Not Meet Eligibility|0
1985667|NCT03882047|3550933|FG001|Overall Study|Did Not Meet Eligibility|0
1985668|NCT03882047|3550934|FG002|Overall Study|Did Not Meet Eligibility|1
1985669|NCT03879772|3550947|FG000|Overall Study|Adverse Event|2
1985670|NCT03879772|3550948|FG001|Overall Study|Adverse Event|2
1985671|NCT03879772|3550949|FG002|Overall Study|Adverse Event|3
1985672|NCT03879772|3550950|FG003|Overall Study|Adverse Event|4
1985673|NCT03879772|3550951|FG004|Overall Study|Adverse Event|3
1985674|NCT03879772|3550947|FG000|Overall Study|Treatment Failure|1
1985675|NCT03879772|3550948|FG001|Overall Study|Treatment Failure|0
1985676|NCT03879772|3550949|FG002|Overall Study|Treatment Failure|0
1985677|NCT03879772|3550950|FG003|Overall Study|Treatment Failure|2
1985678|NCT03879772|3550951|FG004|Overall Study|Treatment Failure|1
1985679|NCT03879772|3550947|FG000|Overall Study|Lost to Follow-up|0
1985680|NCT03879772|3550948|FG001|Overall Study|Lost to Follow-up|0
1985681|NCT03879772|3550949|FG002|Overall Study|Lost to Follow-up|0
1985682|NCT03879772|3550950|FG003|Overall Study|Lost to Follow-up|0
1985683|NCT03879772|3550951|FG004|Overall Study|Lost to Follow-up|1
1985684|NCT03879772|3550947|FG000|Overall Study|Withdrawal by Subject|0
1985685|NCT03879772|3550948|FG001|Overall Study|Withdrawal by Subject|1
1985686|NCT03879772|3550949|FG002|Overall Study|Withdrawal by Subject|3
1985687|NCT03879772|3550950|FG003|Overall Study|Withdrawal by Subject|1
1985688|NCT03879772|3550951|FG004|Overall Study|Withdrawal by Subject|1
1985689|NCT03879772|3550947|FG000|Overall Study|Protocol Violation|0
1985690|NCT03879772|3550948|FG001|Overall Study|Protocol Violation|0
1985691|NCT03879772|3550949|FG002|Overall Study|Protocol Violation|3
1985692|NCT03879772|3550950|FG003|Overall Study|Protocol Violation|1
1985693|NCT03879772|3550951|FG004|Overall Study|Protocol Violation|2
1985694|NCT03879772|3550947|FG000|Overall Study|Did Not Meet Entry Requirements|1
1985695|NCT03879772|3550948|FG001|Overall Study|Did Not Meet Entry Requirements|0
1985696|NCT03879772|3550949|FG002|Overall Study|Did Not Meet Entry Requirements|1
1985697|NCT03879772|3550950|FG003|Overall Study|Did Not Meet Entry Requirements|0
1985698|NCT03879772|3550951|FG004|Overall Study|Did Not Meet Entry Requirements|0
1985699|NCT03861559|3550965|FG000|Overall Study|Adverse Event|0
1985700|NCT03861559|3550966|FG001|Overall Study|Adverse Event|2
1985701|NCT03861559|3550965|FG000|Overall Study|Treatment failure|0
1985702|NCT03861559|3550966|FG001|Overall Study|Treatment failure|2
1985703|NCT03861559|3550965|FG000|Overall Study|Noncompliance|1
1985704|NCT03861559|3550966|FG001|Overall Study|Noncompliance|1
1985705|NCT03861559|3550965|FG000|Overall Study|Did not meet eligibility requirements|1
1985706|NCT03861559|3550966|FG001|Overall Study|Did not meet eligibility requirements|0
1985707|NCT03855228|3550976|FG000|Overall Study|Adverse Event|2
1985708|NCT03855228|3550977|FG001|Overall Study|Adverse Event|4
1985709|NCT03855228|3550978|FG002|Overall Study|Adverse Event|4
1985710|NCT03855228|3550979|FG003|Overall Study|Adverse Event|8
1985711|NCT03855228|3550976|FG000|Overall Study|Treatment Failure|1
1985712|NCT03855228|3550977|FG001|Overall Study|Treatment Failure|2
1985713|NCT03855228|3550978|FG002|Overall Study|Treatment Failure|1
1985714|NCT03855228|3550979|FG003|Overall Study|Treatment Failure|8
1985715|NCT03855228|3550976|FG000|Overall Study|Lost to Follow-up|0
1985716|NCT03855228|3550977|FG001|Overall Study|Lost to Follow-up|0
1985717|NCT03855228|3550978|FG002|Overall Study|Lost to Follow-up|0
1985718|NCT03855228|3550979|FG003|Overall Study|Lost to Follow-up|1
1985719|NCT03855228|3550976|FG000|Overall Study|Protocol Violation|0
1985720|NCT03855228|3550977|FG001|Overall Study|Protocol Violation|1
1985721|NCT03855228|3550978|FG002|Overall Study|Protocol Violation|2
1985722|NCT03855228|3550979|FG003|Overall Study|Protocol Violation|1
1985723|NCT03855228|3550976|FG000|Overall Study|Did Not Meet Entry Requirements|0
1985724|NCT03855228|3550977|FG001|Overall Study|Did Not Meet Entry Requirements|2
1985725|NCT03855228|3550978|FG002|Overall Study|Did Not Meet Entry Requirements|1
1985726|NCT03855228|3550979|FG003|Overall Study|Did Not Meet Entry Requirements|1
1985727|NCT03855189|3550992|FG000|Overall Study|Adverse Event|5
2177400|NCT01373164|3801470|FG002|Overall Study|Lost to Follow-up|1
2177401|NCT01373164|3801471|FG003|Overall Study|Lost to Follow-up|2
2177402|NCT01373164|3801472|FG004|Overall Study|Lost to Follow-up|0
2177403|NCT01373164|3801468|FG000|Overall Study|Withdrawal by Subject|0
2177404|NCT01373164|3801469|FG001|Overall Study|Withdrawal by Subject|1
2177405|NCT01373164|3801470|FG002|Overall Study|Withdrawal by Subject|0
2177406|NCT01373164|3801471|FG003|Overall Study|Withdrawal by Subject|10
2177407|NCT01373164|3801472|FG004|Overall Study|Withdrawal by Subject|2
2177408|NCT01373229|3801487|FG000|Overall Study|Death|3
2177409|NCT01373229|3801487|FG000|Overall Study|Physician Decision|3
2177410|NCT01373281|3801499|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
2177411|NCT01373281|3801500|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
2177412|NCT01373281|3801499|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
2177413|NCT01373281|3801500|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
2177414|NCT01373281|3801499|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
2177415|NCT01373281|3801500|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
2177416|NCT01373281|3801499|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
2177417|NCT01373281|3801500|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
2177418|NCT01373281|3801499|FG000|Surveillance Expansion Period|Withdrawal by Subject|180
2177419|NCT01373281|3801500|FG001|Surveillance Expansion Period|Withdrawal by Subject|105
2177420|NCT01373281|3801499|FG000|Surveillance Expansion Period|Protocol Violation|9
2177421|NCT01373281|3801500|FG001|Surveillance Expansion Period|Protocol Violation|1
2177422|NCT01373281|3801499|FG000|Surveillance Expansion Period|Lost to Follow-up|10
2177423|NCT01373281|3801500|FG001|Surveillance Expansion Period|Lost to Follow-up|8
2177424|NCT01373281|3801499|FG000|Surveillance Expansion Period|Serious adverse event|3
2177425|NCT01373281|3801500|FG001|Surveillance Expansion Period|Serious adverse event|4
2213427|NCT01678820|3854922|FG000|Overall Study|Non-compliance with study drug|0
2213428|NCT01678820|3854923|FG001|Overall Study|Non-compliance with study drug|1
1985728|NCT03855189|3550993|FG001|Overall Study|Adverse Event|2
1985729|NCT03855189|3550994|FG002|Overall Study|Adverse Event|4
1985730|NCT03855189|3550992|FG000|Overall Study|Treatment Failure|1
1985731|NCT03855189|3550993|FG001|Overall Study|Treatment Failure|1
1985732|NCT03855189|3550994|FG002|Overall Study|Treatment Failure|2
1985733|NCT03855189|3550992|FG000|Overall Study|Noncompliance with Protocol|0
1985734|NCT03855189|3550993|FG001|Overall Study|Noncompliance with Protocol|1
1985735|NCT03855189|3550994|FG002|Overall Study|Noncompliance with Protocol|0
1985736|NCT03855189|3550992|FG000|Overall Study|Did Not Return|4
1985737|NCT03855189|3550993|FG001|Overall Study|Did Not Return|3
1985738|NCT03855189|3550994|FG002|Overall Study|Did Not Return|0
1985739|NCT03847974|3551002|FG000|Overall Study|relocated out of region|3
1985740|NCT03847974|3551002|FG000|Overall Study|Withdrawal by Subject|2
1985741|NCT03847974|3551002|FG000|Overall Study|Adverse Event|1
1985742|NCT03764631|3551008|FG000|Overall Study|Personal Reasons|3
1985743|NCT03764631|3551009|FG001|Overall Study|Personal Reasons|2
1985744|NCT03764631|3551008|FG000|Overall Study|Switching Therapy|3
1985745|NCT03764631|3551009|FG001|Overall Study|Switching Therapy|3
1985746|NCT03764631|3551008|FG000|Overall Study|Adverse Event|0
1985747|NCT03764631|3551009|FG001|Overall Study|Adverse Event|1
1985748|NCT03764631|3551008|FG000|Overall Study|Lost to Follow-up|33
1985749|NCT03764631|3551009|FG001|Overall Study|Lost to Follow-up|41
1985750|NCT03764631|3551008|FG000|Overall Study|No data as study site was closed|2
1985751|NCT03764631|3551009|FG001|Overall Study|No data as study site was closed|6
1985752|NCT03764072|3551021|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
2213429|NCT01678820|3854924|FG002|Overall Study|Non-compliance with study drug|0
2311006|NCT02745080|4015894|FG000|Overall Study|Lost to Follow-up|3
2311007|NCT02745080|4015895|FG001|Overall Study|Lost to Follow-up|3
2311008|NCT02745080|4015894|FG000|Overall Study|Physician Decision|3
2311009|NCT02745080|4015895|FG001|Overall Study|Physician Decision|0
1985753|NCT03764072|3551022|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
1985754|NCT03764072|3551023|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
2213430|NCT01678820|3854922|FG000|Overall Study|Physician Decision|0
2213431|NCT01678820|3854923|FG001|Overall Study|Physician Decision|0
2311010|NCT02745080|4015894|FG000|Overall Study|Protocol Violation|3
1985755|NCT03764072|3551024|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
1985756|NCT03764072|3551025|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
1985757|NCT03764072|3551026|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
1985758|NCT03764072|3551021|FG000|Overall Study|Withdrawal of consent (for other reason)|0
1985759|NCT03764072|3551022|FG001|Overall Study|Withdrawal of consent (for other reason)|0
1985760|NCT03764072|3551023|FG002|Overall Study|Withdrawal of consent (for other reason)|0
1985761|NCT03764072|3551024|FG003|Overall Study|Withdrawal of consent (for other reason)|0
1985762|NCT03764072|3551025|FG004|Overall Study|Withdrawal of consent (for other reason)|0
1985763|NCT03764072|3551026|FG005|Overall Study|Withdrawal of consent (for other reason)|1
1985764|NCT03764072|3551021|FG000|Overall Study|Lost to Follow-up|0
1985765|NCT03764072|3551022|FG001|Overall Study|Lost to Follow-up|0
1985766|NCT03764072|3551023|FG002|Overall Study|Lost to Follow-up|0
1985767|NCT03764072|3551024|FG003|Overall Study|Lost to Follow-up|0
1985768|NCT03764072|3551025|FG004|Overall Study|Lost to Follow-up|1
1985769|NCT03764072|3551026|FG005|Overall Study|Lost to Follow-up|0
1985770|NCT03578809|3551071|FG000|Overall Study|Death|0
1985771|NCT03578809|3551072|FG001|Overall Study|Death|2
1985772|NCT03578809|3551073|FG002|Overall Study|Death|0
1985773|NCT03578809|3551074|FG003|Overall Study|Death|1
1985774|NCT03578809|3551071|FG000|Overall Study|Lost to Follow-up|0
1985775|NCT03578809|3551072|FG001|Overall Study|Lost to Follow-up|1
1985776|NCT03578809|3551073|FG002|Overall Study|Lost to Follow-up|0
1985777|NCT03578809|3551074|FG003|Overall Study|Lost to Follow-up|0
1985778|NCT03578809|3551071|FG000|Overall Study|Withdrawal by Subject|3
1985779|NCT03578809|3551072|FG001|Overall Study|Withdrawal by Subject|5
1985780|NCT03578809|3551073|FG002|Overall Study|Withdrawal by Subject|2
1985781|NCT03578809|3551074|FG003|Overall Study|Withdrawal by Subject|0
1985782|NCT03578809|3551071|FG000|Overall Study|Other|3
1985783|NCT03578809|3551072|FG001|Overall Study|Other|6
1985784|NCT03578809|3551073|FG002|Overall Study|Other|2
1985785|NCT03578809|3551074|FG003|Overall Study|Other|8
2024290|NCT00333138|3592728|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
2024291|NCT00333138|3592726|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
2024292|NCT00333138|3592727|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
2024293|NCT00333138|3592728|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
2024294|NCT00333138|3592726|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
2024295|NCT00333138|3592727|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
2024296|NCT00333138|3592728|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
2024297|NCT00333138|3592726|FG000|Extension Study (Month6 to End of Study)|Death|0
2024298|NCT00333138|3592727|FG001|Extension Study (Month6 to End of Study)|Death|1
2024299|NCT00333138|3592728|FG002|Extension Study (Month6 to End of Study)|Death|0
2024300|NCT00333359|3592759|FG000|Overall Study|Adverse Event|29
2024301|NCT00333359|3592760|FG001|Overall Study|Adverse Event|35
2213432|NCT01678820|3854924|FG002|Overall Study|Physician Decision|1
2311011|NCT02745080|4015895|FG001|Overall Study|Protocol Violation|1
2311012|NCT02745080|4015894|FG000|Overall Study|Withdrawal by Subject|22
2311013|NCT02745080|4015895|FG001|Overall Study|Withdrawal by Subject|41
2311014|NCT02745119|4015906|FG000|Overall Study|Adverse Event|1
2311015|NCT02745119|4015907|FG001|Overall Study|Adverse Event|0
2311016|NCT02745119|4015908|FG002|Overall Study|Adverse Event|1
2311017|NCT02745119|4015909|FG003|Overall Study|Adverse Event|3
2311018|NCT02745119|4015906|FG000|Overall Study|Death|3
2311019|NCT02745119|4015907|FG001|Overall Study|Death|3
2311020|NCT02745119|4015908|FG002|Overall Study|Death|0
2311021|NCT02745119|4015909|FG003|Overall Study|Death|4
2311022|NCT02745119|4015906|FG000|Overall Study|Lost to Follow-up|0
2311023|NCT02745119|4015907|FG001|Overall Study|Lost to Follow-up|0
2311024|NCT02745119|4015908|FG002|Overall Study|Lost to Follow-up|0
2311025|NCT02745119|4015909|FG003|Overall Study|Lost to Follow-up|1
2311026|NCT02745119|4015906|FG000|Overall Study|Protocol Deviation|0
2311027|NCT02745119|4015907|FG001|Overall Study|Protocol Deviation|0
2311028|NCT02745119|4015908|FG002|Overall Study|Protocol Deviation|0
2311029|NCT02745119|4015909|FG003|Overall Study|Protocol Deviation|1
2311030|NCT02745119|4015906|FG000|Overall Study|Withdrawal by Subject|7
2311031|NCT02745119|4015907|FG001|Overall Study|Withdrawal by Subject|15
2311032|NCT02745119|4015908|FG002|Overall Study|Withdrawal by Subject|8
2311033|NCT02745119|4015909|FG003|Overall Study|Withdrawal by Subject|14
2311034|NCT02745119|4015906|FG000|Overall Study|Study Terminated by Sponsor|134
2311035|NCT02745119|4015907|FG001|Overall Study|Study Terminated by Sponsor|252
2311036|NCT02745119|4015908|FG002|Overall Study|Study Terminated by Sponsor|135
2311037|NCT02745119|4015909|FG003|Overall Study|Study Terminated by Sponsor|251
2311038|NCT02745119|4015906|FG000|Overall Study|Physician Decision|0
2311039|NCT02745119|4015907|FG001|Overall Study|Physician Decision|2
2311040|NCT02745119|4015908|FG002|Overall Study|Physician Decision|2
2311041|NCT02745119|4015909|FG003|Overall Study|Physician Decision|2
2311042|NCT02745119|4015906|FG000|Overall Study|Reason Not Specified|0
2311043|NCT02745119|4015907|FG001|Overall Study|Reason Not Specified|2
2311044|NCT02745119|4015908|FG002|Overall Study|Reason Not Specified|0
1985786|NCT03571204|3551090|FG000|Overall Study|Stopped due to COVID-19 pandemic|1
1985787|NCT03571204|3551091|FG001|Overall Study|Stopped due to COVID-19 pandemic|1
1985788|NCT03571204|3551092|FG002|Overall Study|Stopped due to COVID-19 pandemic|0
1985789|NCT03571204|3551090|FG000|Overall Study|Physician Decision|0
1985790|NCT03571204|3551091|FG001|Overall Study|Physician Decision|1
1985791|NCT03571204|3551092|FG002|Overall Study|Physician Decision|0
1985792|NCT03523091|3551103|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1
1985793|NCT03523091|3551104|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0
1985794|NCT03523091|3551103|FG000|Overall Study|Withdrawal by Subject|0
1985795|NCT03523091|3551104|FG001|Overall Study|Withdrawal by Subject|3
1985796|NCT03523091|3551103|FG000|Overall Study|Increase Botox dose|0
1985797|NCT03523091|3551104|FG001|Overall Study|Increase Botox dose|1
1985798|NCT03391960|3551132|FG000|Overall Study|Protocol Violation|0
1985799|NCT03391960|3551133|FG001|Overall Study|Protocol Violation|
1985800|NCT03362190|3551152|FG000|Overall Study|Adverse Event|0
1985801|NCT03362190|3551153|FG001|Overall Study|Adverse Event|0
1985802|NCT03362190|3551154|FG002|Overall Study|Adverse Event|0
1985803|NCT03362190|3551155|FG003|Overall Study|Adverse Event|1
1985804|NCT03362190|3551152|FG000|Overall Study|Withdrawal by Subject|0
1985805|NCT03362190|3551153|FG001|Overall Study|Withdrawal by Subject|0
1985806|NCT03362190|3551154|FG002|Overall Study|Withdrawal by Subject|0
1985807|NCT03362190|3551155|FG003|Overall Study|Withdrawal by Subject|1
1985808|NCT03338790|3551172|FG000|Overall Study|Disease Progression|65
1985809|NCT03338790|3551173|FG001|Overall Study|Disease Progression|43
1985810|NCT03338790|3551174|FG002|Overall Study|Disease Progression|50
1985811|NCT03338790|3551175|FG003|Overall Study|Disease Progression|37
1985812|NCT03338790|3551172|FG000|Overall Study|Study Drug Toxicity|9
1985813|NCT03338790|3551173|FG001|Overall Study|Study Drug Toxicity|8
1985814|NCT03338790|3551174|FG002|Overall Study|Study Drug Toxicity|15
1985815|NCT03338790|3551175|FG003|Overall Study|Study Drug Toxicity|0
1985816|NCT03338790|3551172|FG000|Overall Study|Death|1
1985817|NCT03338790|3551173|FG001|Overall Study|Death|1
1985818|NCT03338790|3551174|FG002|Overall Study|Death|1
2311045|NCT02745119|4015909|FG003|Overall Study|Reason Not Specified|1
2311046|NCT02745145|4015924|FG000|Overall Study|Adverse Event|1
2311047|NCT02745145|4015925|FG001|Overall Study|Adverse Event|0
2311048|NCT02745145|4015926|FG002|Overall Study|Adverse Event|0
2311049|NCT02745145|4015924|FG000|Overall Study|Death|0
2311050|NCT02745145|4015925|FG001|Overall Study|Death|1
2311051|NCT02745145|4015926|FG002|Overall Study|Death|0
2311052|NCT02745145|4015924|FG000|Overall Study|Progressive disease|0
2311053|NCT02745145|4015925|FG001|Overall Study|Progressive disease|0
2311054|NCT02745145|4015926|FG002|Overall Study|Progressive disease|1
2311055|NCT02745145|4015924|FG000|Overall Study|Withdrew consent|1
2311056|NCT02745145|4015925|FG001|Overall Study|Withdrew consent|1
2311057|NCT02745145|4015926|FG002|Overall Study|Withdrew consent|1
2311058|NCT02745145|4015924|FG000|Overall Study|Study Termination|8
2311059|NCT02745145|4015925|FG001|Overall Study|Study Termination|3
2311060|NCT02745145|4015926|FG002|Overall Study|Study Termination|7
2311061|NCT02745392|4015947|FG000|Overall Study|Lost to Follow-up|0
2311062|NCT02745392|4015948|FG001|Overall Study|Lost to Follow-up|1
2311063|NCT02745392|4015949|FG002|Overall Study|Lost to Follow-up|0
2311064|NCT02745392|4015950|FG003|Overall Study|Lost to Follow-up|0
2311065|NCT02745535|4015960|FG000|Overall Study|Death|1
2311066|NCT02745535|4015960|FG000|Overall Study|Adverse Event|3
2311067|NCT02745535|4015960|FG000|Overall Study|Lost to Follow-up|2
2311068|NCT02746575|4015996|FG000|Overall Study|Surgery cancelled or time chaned|13
2311069|NCT02746575|4015996|FG000|Overall Study|Received epidural|10
2311070|NCT02746575|4015996|FG000|Overall Study|Withdrawal by Subject|3
2311071|NCT02746575|4015996|FG000|Overall Study|Bradycardia/hypotension|9
2311072|NCT02746575|4015996|FG000|Overall Study|Study paused|8
2311073|NCT02746575|4015996|FG000|Overall Study|put on beta-blocker|3
2311074|NCT02746575|4015996|FG000|Overall Study|type of surgery|1
2311075|NCT02746575|4015996|FG000|Overall Study|typ of surgery|1
2311076|NCT02746575|4015996|FG000|Overall Study|PI unavailable|1
2311077|NCT02746575|4015996|FG000|Overall Study|Unknown history of CVA|1
2311078|NCT02746627|4016003|FG000|Overall Study|Withdrawal by Subject|1
2311079|NCT02746627|4016004|FG001|Overall Study|Withdrawal by Subject|1
2311080|NCT02746627|4016005|FG002|Overall Study|Withdrawal by Subject|1
2311081|NCT02746679|4016015|FG000|Overall Study|Lost to Follow-up|4
2311082|NCT02746679|4016016|FG001|Overall Study|Lost to Follow-up|6
2311083|NCT02746705|4016024|FG000|Overall Study|Physician Decision|1
1985819|NCT03338790|3551175|FG003|Overall Study|Death|0
2311084|NCT02746705|4016025|FG001|Overall Study|Physician Decision|1
2311085|NCT02746705|4016024|FG000|Overall Study|Lost to Follow-up|1
2311086|NCT02746705|4016025|FG001|Overall Study|Lost to Follow-up|0
2311087|NCT02746705|4016024|FG000|Overall Study|outlier scores deemed not valid|0
2311088|NCT02746705|4016025|FG001|Overall Study|outlier scores deemed not valid|1
2311089|NCT02746874|4016039|FG000|Overall Study|Withdrawal by Subject|0
2311090|NCT02746874|4016040|FG001|Overall Study|Withdrawal by Subject|1
2311091|NCT02746874|4016039|FG000|Overall Study|Surgery Date Changed|0
2311092|NCT02746874|4016040|FG001|Overall Study|Surgery Date Changed|2
2311093|NCT02747004|4016060|FG000|Overall Study|Withdrawal by Subject|8
2311094|NCT02747004|4016061|FG001|Overall Study|Withdrawal by Subject|5
2311095|NCT02747004|4016062|FG002|Overall Study|Withdrawal by Subject|4
1985820|NCT03338790|3551172|FG000|Overall Study|Adverse Event unrelated to Study Drug|4
1985821|NCT03338790|3551173|FG001|Overall Study|Adverse Event unrelated to Study Drug|4
1985822|NCT03338790|3551174|FG002|Overall Study|Adverse Event unrelated to Study Drug|6
1985823|NCT03338790|3551175|FG003|Overall Study|Adverse Event unrelated to Study Drug|4
1985824|NCT03338790|3551172|FG000|Overall Study|Participant request to discontinue study treatment|3
1985825|NCT03338790|3551173|FG001|Overall Study|Participant request to discontinue study treatment|3
1985826|NCT03338790|3551174|FG002|Overall Study|Participant request to discontinue study treatment|2
1985827|NCT03338790|3551175|FG003|Overall Study|Participant request to discontinue study treatment|1
1985828|NCT03338790|3551172|FG000|Overall Study|Poor/non-compliance|0
1985829|NCT03338790|3551173|FG001|Overall Study|Poor/non-compliance|1
1985830|NCT03338790|3551174|FG002|Overall Study|Poor/non-compliance|0
1985831|NCT03338790|3551175|FG003|Overall Study|Poor/non-compliance|0
1985832|NCT03338790|3551172|FG000|Overall Study|Participant withdrew consent|1
1985833|NCT03338790|3551173|FG001|Overall Study|Participant withdrew consent|0
1985834|NCT03338790|3551174|FG002|Overall Study|Participant withdrew consent|1
1985835|NCT03338790|3551175|FG003|Overall Study|Participant withdrew consent|1
1985836|NCT03338790|3551172|FG000|Overall Study|Other reasons|0
1985837|NCT03338790|3551173|FG001|Overall Study|Other reasons|5
1985838|NCT03338790|3551174|FG002|Overall Study|Other reasons|0
1985839|NCT03338790|3551175|FG003|Overall Study|Other reasons|2
1985840|NCT03338790|3551172|FG000|Overall Study|Not reported|0
1985841|NCT03338790|3551173|FG001|Overall Study|Not reported|0
1985842|NCT03338790|3551174|FG002|Overall Study|Not reported|1
1985843|NCT03338790|3551175|FG003|Overall Study|Not reported|0
1985844|NCT03338790|3551172|FG000|Overall Study|Completed treatment period|1
1985845|NCT03338790|3551173|FG001|Overall Study|Completed treatment period|2
1985846|NCT03338790|3551174|FG002|Overall Study|Completed treatment period|0
1985847|NCT03338790|3551175|FG003|Overall Study|Completed treatment period|0
1985848|NCT03252522|3551187|FG000|Overall Study|Adverse Event|3
1985849|NCT03252522|3551188|FG001|Overall Study|Adverse Event|1
1985850|NCT03252522|3551189|FG002|Overall Study|Adverse Event|0
1985851|NCT03252522|3551187|FG000|Overall Study|Unable to swallow pills|4
1985852|NCT03252522|3551188|FG001|Overall Study|Unable to swallow pills|1
1985853|NCT03252522|3551189|FG002|Overall Study|Unable to swallow pills|0
1985854|NCT03252522|3551187|FG000|Overall Study|Commenced stimulant medication|1
1985855|NCT03252522|3551188|FG001|Overall Study|Commenced stimulant medication|1
1985856|NCT03252522|3551189|FG002|Overall Study|Commenced stimulant medication|0
1985857|NCT03252522|3551187|FG000|Overall Study|Protocol Violation|1
1985858|NCT03252522|3551188|FG001|Overall Study|Protocol Violation|0
1985859|NCT03252522|3551189|FG002|Overall Study|Protocol Violation|0
1985860|NCT03235544|3551204|FG000|Overall Study|Participants Still Ongoing in the Study|1
1985861|NCT03235544|3551205|FG001|Overall Study|Participants Still Ongoing in the Study|13
1985862|NCT03235544|3551206|FG002|Overall Study|Participants Still Ongoing in the Study|19
1985863|NCT03235544|3551207|FG003|Overall Study|Participants Still Ongoing in the Study|55
1985864|NCT03235544|3551204|FG000|Overall Study|Death|11
1985865|NCT03235544|3551205|FG001|Overall Study|Death|23
1985866|NCT03235544|3551206|FG002|Overall Study|Death|11
1985867|NCT03235544|3551207|FG003|Overall Study|Death|20
1985868|NCT03235544|3551204|FG000|Overall Study|Lost to Follow-up|0
1985869|NCT03235544|3551205|FG001|Overall Study|Lost to Follow-up|1
1985870|NCT03235544|3551206|FG002|Overall Study|Lost to Follow-up|0
1985871|NCT03235544|3551207|FG003|Overall Study|Lost to Follow-up|1
1985872|NCT03235544|3551204|FG000|Overall Study|Withdrawal by Participant|0
1985873|NCT03235544|3551205|FG001|Overall Study|Withdrawal by Participant|0
1985874|NCT03235544|3551206|FG002|Overall Study|Withdrawal by Participant|1
1985875|NCT03235544|3551207|FG003|Overall Study|Withdrawal by Participant|0
2311096|NCT02747004|4016060|FG000|Overall Study|Lost to Follow-up|1
2311097|NCT02747004|4016061|FG001|Overall Study|Lost to Follow-up|2
2311098|NCT02747004|4016062|FG002|Overall Study|Lost to Follow-up|2
2311099|NCT02747004|4016060|FG000|Overall Study|on study treatment/follow-up|48
2311100|NCT02747004|4016061|FG001|Overall Study|on study treatment/follow-up|42
2311101|NCT02747004|4016062|FG002|Overall Study|on study treatment/follow-up|41
2311102|NCT02747043|4016072|FG000|Overall Study|Other|1
2311103|NCT02747043|4016073|FG001|Overall Study|Other|1
2311104|NCT02747043|4016072|FG000|Overall Study|Adverse Event|3
2311105|NCT02747043|4016073|FG001|Overall Study|Adverse Event|1
2311106|NCT02747043|4016072|FG000|Overall Study|Withdrawal by Subject|1
2311107|NCT02747043|4016073|FG001|Overall Study|Withdrawal by Subject|1
2311108|NCT02747043|4016072|FG000|Overall Study|Physician Decision|1
2311109|NCT02747043|4016073|FG001|Overall Study|Physician Decision|1
2311110|NCT02747043|4016072|FG000|Overall Study|Protocol Violation|0
2311111|NCT02747043|4016073|FG001|Overall Study|Protocol Violation|1
2311112|NCT02747043|4016072|FG000|Overall Study|Disease progression|4
2311113|NCT02747043|4016073|FG001|Overall Study|Disease progression|0
2311114|NCT02747108|4016081|FG000|Overall Study|Death|2
2311115|NCT02747108|4016082|FG001|Overall Study|Death|2
1985876|NCT03235544|3551204|FG000|Overall Study|Reason not Specified|0
1985877|NCT03235544|3551205|FG001|Overall Study|Reason not Specified|4
1985878|NCT03235544|3551206|FG002|Overall Study|Reason not Specified|0
1985879|NCT03235544|3551207|FG003|Overall Study|Reason not Specified|1
2311116|NCT02747108|4016081|FG000|Overall Study|Withdrawal by Subject|1
2311117|NCT02747108|4016082|FG001|Overall Study|Withdrawal by Subject|0
1985880|NCT03225833|3551224|FG000|Overall Study|Adverse Event|0
1985881|NCT03225833|3551225|FG001|Overall Study|Adverse Event|1
1985882|NCT03225833|3551226|FG002|Overall Study|Adverse Event|2
1985883|NCT03225833|3551227|FG003|Overall Study|Adverse Event|0
1985884|NCT03225833|3551228|FG004|Overall Study|Adverse Event|0
1985885|NCT03225833|3551229|FG005|Overall Study|Adverse Event|2
1985886|NCT03225833|3551224|FG000|Overall Study|Withdrawal by Subject|1
1985887|NCT03225833|3551225|FG001|Overall Study|Withdrawal by Subject|0
1985888|NCT03225833|3551226|FG002|Overall Study|Withdrawal by Subject|0
1985889|NCT03225833|3551227|FG003|Overall Study|Withdrawal by Subject|0
1985890|NCT03225833|3551228|FG004|Overall Study|Withdrawal by Subject|1
1985891|NCT03225833|3551229|FG005|Overall Study|Withdrawal by Subject|0
1985892|NCT03225833|3551224|FG000|Overall Study|Termination of Study by Sponsor|4
1985893|NCT03225833|3551225|FG001|Overall Study|Termination of Study by Sponsor|0
1985894|NCT03225833|3551226|FG002|Overall Study|Termination of Study by Sponsor|0
1985895|NCT03225833|3551227|FG003|Overall Study|Termination of Study by Sponsor|0
1985896|NCT03225833|3551228|FG004|Overall Study|Termination of Study by Sponsor|0
1985897|NCT03225833|3551229|FG005|Overall Study|Termination of Study by Sponsor|7
1985898|NCT03225833|3551224|FG000|Overall Study|Sponsor Decision|0
1985899|NCT03225833|3551225|FG001|Overall Study|Sponsor Decision|0
1985900|NCT03225833|3551226|FG002|Overall Study|Sponsor Decision|0
1985901|NCT03225833|3551227|FG003|Overall Study|Sponsor Decision|0
1985902|NCT03225833|3551228|FG004|Overall Study|Sponsor Decision|0
1985903|NCT03225833|3551229|FG005|Overall Study|Sponsor Decision|1
2024302|NCT00333359|3592759|FG000|Overall Study|Withdrawal by Subject|19
2024303|NCT00333359|3592760|FG001|Overall Study|Withdrawal by Subject|37
2024304|NCT00333359|3592759|FG000|Overall Study|Physician Decision|2
2024305|NCT00333359|3592760|FG001|Overall Study|Physician Decision|2
2024306|NCT00333359|3592759|FG000|Overall Study|Protocol Non-compliance|2
2024307|NCT00333359|3592760|FG001|Overall Study|Protocol Non-compliance|8
2024308|NCT00333359|3592759|FG000|Overall Study|Lost to Follow-up|15
2024309|NCT00333359|3592760|FG001|Overall Study|Lost to Follow-up|25
2024310|NCT00333359|3592759|FG000|Overall Study|Termination or Withdrawal by Sponsor|1
2024311|NCT00333359|3592760|FG001|Overall Study|Termination or Withdrawal by Sponsor|1
2024312|NCT00333359|3592759|FG000|Overall Study|Treatment Failure|3
2024313|NCT00333359|3592760|FG001|Overall Study|Treatment Failure|8
2024314|NCT00333359|3592759|FG000|Overall Study|Withdrew before Receiving One Dose|2
2024315|NCT00333359|3592760|FG001|Overall Study|Withdrew before Receiving One Dose|6
2024316|NCT00333619|3592786|FG000|Overall Study|Death|12
2024317|NCT00333619|3592787|FG001|Overall Study|Death|6
2024318|NCT00333619|3592786|FG000|Overall Study|Withdrawal by Subject|6
2024319|NCT00333619|3592787|FG001|Overall Study|Withdrawal by Subject|1
2024320|NCT00333619|3592786|FG000|Overall Study|Lost to Follow-up|3
2024321|NCT00333619|3592787|FG001|Overall Study|Lost to Follow-up|3
2024322|NCT00333775|3592811|FG000|Overall Study|Death|144
2024323|NCT00333775|3592812|FG001|Overall Study|Death|149
2024324|NCT00333775|3592813|FG002|Overall Study|Death|143
2024325|NCT00333775|3592811|FG000|Overall Study|In Follow-up When Study Stopped|87
2024326|NCT00333775|3592812|FG001|Overall Study|In Follow-up When Study Stopped|92
2024327|NCT00333775|3592813|FG002|Overall Study|In Follow-up When Study Stopped|96
2024328|NCT00333775|3592811|FG000|Overall Study|Lost to Follow-up|10
2024329|NCT00333775|3592812|FG001|Overall Study|Lost to Follow-up|7
2024330|NCT00333775|3592813|FG002|Overall Study|Lost to Follow-up|8
2024331|NCT00333788|3592821|FG000|Overall Study|Adverse Event|44
2024332|NCT00333788|3592821|FG000|Overall Study|Lack of Efficacy|80
2024333|NCT00333788|3592821|FG000|Overall Study|Lost to Follow-up|2
2024334|NCT00333788|3592821|FG000|Overall Study|Withdrawal by Subject|24
2024335|NCT00333788|3592821|FG000|Overall Study|Other: Non-compliance|2
2024336|NCT00333788|3592821|FG000|Overall Study|Other: Moved|2
2024337|NCT00333788|3592821|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1
2024338|NCT00333788|3592821|FG000|Overall Study|Other: Investigator decision|1
2024339|NCT00333788|3592821|FG000|Overall Study|Other: Quality of life concern|1
2024340|NCT00333788|3592821|FG000|Overall Study|Other: Sponsor decision|1
2024341|NCT00333788|3592821|FG000|Overall Study|Other: Subject in need of an Entocort|1
2024342|NCT00333788|3592821|FG000|Overall Study|Other: Medical monitor decision|1
2024343|NCT00333788|3592821|FG000|Overall Study|Other: Physician decision|1
2024344|NCT00333788|3592821|FG000|Overall Study|Other: Signed consent for another study|1
2024345|NCT00333801|3592827|FG000|Overall Study|Moved to another state|5
2024346|NCT00333801|3592828|FG001|Overall Study|Moved to another state|3
2024347|NCT00333801|3592827|FG000|Overall Study|Lost to Follow-up|2
2024348|NCT00333801|3592828|FG001|Overall Study|Lost to Follow-up|0
2024349|NCT00333801|3592827|FG000|Overall Study|Incarcerated|1
2024350|NCT00333801|3592828|FG001|Overall Study|Incarcerated|2
2024351|NCT00333801|3592827|FG000|Overall Study|Withdrawal by Subject|0
2024352|NCT00333801|3592828|FG001|Overall Study|Withdrawal by Subject|1
2024353|NCT00333840|3592849|FG000|First-line Treatment Period|Adverse Event|38
2024354|NCT00333840|3592850|FG001|First-line Treatment Period|Adverse Event|37
2024355|NCT00333840|3592851|FG002|First-line Treatment Period|Adverse Event|0
2024356|NCT00333840|3592852|FG003|First-line Treatment Period|Adverse Event|0
2024357|NCT00333840|3592849|FG000|First-line Treatment Period|Abnormal laboratory values|3
2024358|NCT00333840|3592850|FG001|First-line Treatment Period|Abnormal laboratory values|1
2024359|NCT00333840|3592851|FG002|First-line Treatment Period|Abnormal laboratory values|0
1985904|NCT03167242|3551260|FG000|Overall Study|Patient/Guardian Decision|0
1985905|NCT03167242|3551261|FG001|Overall Study|Patient/Guardian Decision|1
1985906|NCT03167242|3551262|FG002|Overall Study|Patient/Guardian Decision|2
1985907|NCT03167242|3551263|FG003|Overall Study|Patient/Guardian Decision|1
1985908|NCT03167242|3551264|FG004|Overall Study|Patient/Guardian Decision|1
1985909|NCT03167242|3551265|FG005|Overall Study|Patient/Guardian Decision|1
1985910|NCT03167242|3551266|FG006|Overall Study|Patient/Guardian Decision|0
1985911|NCT03167242|3551267|FG007|Overall Study|Patient/Guardian Decision|0
1985912|NCT03167242|3551268|FG008|Overall Study|Patient/Guardian Decision|0
1985913|NCT03167242|3551269|FG009|Overall Study|Patient/Guardian Decision|0
1985914|NCT03167242|3551270|FG010|Overall Study|Patient/Guardian Decision|1
1985915|NCT03167242|3551271|FG011|Overall Study|Patient/Guardian Decision|0
1985916|NCT03167242|3551260|FG000|Overall Study|Lost to Follow-up|0
1985917|NCT03167242|3551261|FG001|Overall Study|Lost to Follow-up|0
1985918|NCT03167242|3551262|FG002|Overall Study|Lost to Follow-up|1
1985919|NCT03167242|3551263|FG003|Overall Study|Lost to Follow-up|0
1985920|NCT03167242|3551264|FG004|Overall Study|Lost to Follow-up|0
1985921|NCT03167242|3551265|FG005|Overall Study|Lost to Follow-up|1
1985922|NCT03167242|3551266|FG006|Overall Study|Lost to Follow-up|2
1985923|NCT03167242|3551267|FG007|Overall Study|Lost to Follow-up|1
1985924|NCT03167242|3551268|FG008|Overall Study|Lost to Follow-up|0
1985925|NCT03167242|3551269|FG009|Overall Study|Lost to Follow-up|0
1985926|NCT03167242|3551270|FG010|Overall Study|Lost to Follow-up|1
1985927|NCT03167242|3551271|FG011|Overall Study|Lost to Follow-up|1
1985928|NCT03167242|3551260|FG000|Overall Study|Reason not provided|0
1985929|NCT03167242|3551261|FG001|Overall Study|Reason not provided|0
1985930|NCT03167242|3551262|FG002|Overall Study|Reason not provided|0
1985931|NCT03167242|3551263|FG003|Overall Study|Reason not provided|0
1985932|NCT03167242|3551264|FG004|Overall Study|Reason not provided|0
1985933|NCT03167242|3551265|FG005|Overall Study|Reason not provided|0
1985934|NCT03167242|3551266|FG006|Overall Study|Reason not provided|0
1985935|NCT03167242|3551267|FG007|Overall Study|Reason not provided|0
1985936|NCT03167242|3551268|FG008|Overall Study|Reason not provided|1
1985937|NCT03167242|3551269|FG009|Overall Study|Reason not provided|0
1985938|NCT03167242|3551270|FG010|Overall Study|Reason not provided|0
1985939|NCT03167242|3551271|FG011|Overall Study|Reason not provided|0
1985940|NCT03144674|3551311|FG000|Overall Study|Participants Still Ongoing in the Study|1
1985941|NCT03144674|3551312|FG001|Overall Study|Participants Still Ongoing in the Study|4
1985942|NCT03144674|3551313|FG002|Overall Study|Participants Still Ongoing in the Study|24
1985943|NCT03144674|3551314|FG003|Overall Study|Participants Still Ongoing in the Study|54
1985944|NCT03144674|3551311|FG000|Overall Study|Death|3
1985945|NCT03144674|3551312|FG001|Overall Study|Death|1
1985946|NCT03144674|3551313|FG002|Overall Study|Death|1
1985947|NCT03144674|3551314|FG003|Overall Study|Death|10
1985948|NCT03144674|3551311|FG000|Overall Study|Lost to Follow-up|0
1985949|NCT03144674|3551312|FG001|Overall Study|Lost to Follow-up|1
1985950|NCT03144674|3551313|FG002|Overall Study|Lost to Follow-up|1
1985951|NCT03144674|3551314|FG003|Overall Study|Lost to Follow-up|1
1985952|NCT03144674|3551311|FG000|Overall Study|Withdrawal by Participant|0
1985953|NCT03144674|3551312|FG001|Overall Study|Withdrawal by Participant|0
1985954|NCT03144674|3551313|FG002|Overall Study|Withdrawal by Participant|0
1985955|NCT03144674|3551314|FG003|Overall Study|Withdrawal by Participant|3
1985956|NCT03144674|3551311|FG000|Overall Study|Reason not Specified|0
1985957|NCT03144674|3551312|FG001|Overall Study|Reason not Specified|0
1985958|NCT03144674|3551313|FG002|Overall Study|Reason not Specified|2
1985959|NCT03144674|3551314|FG003|Overall Study|Reason not Specified|4
1985960|NCT03137537|3551331|FG000|Overall Study|Adverse Event|0
1985961|NCT03137537|3551332|FG001|Overall Study|Adverse Event|1
1985962|NCT03126019|3551340|FG000|Overall Study|Participants Still Ongoing in the Study|17
1985963|NCT03126019|3551341|FG001|Overall Study|Participants Still Ongoing in the Study|87
2311118|NCT02747108|4016081|FG000|Overall Study|Protocol Violation|2
2311119|NCT02747108|4016082|FG001|Overall Study|Protocol Violation|0
2311120|NCT02747238|4016104|FG000|Overall Study|Lack of Efficacy|0
2311121|NCT02747238|4016105|FG001|Overall Study|Lack of Efficacy|1
2311122|NCT02747238|4016104|FG000|Overall Study|Data lost|3
2311123|NCT02747238|4016105|FG001|Overall Study|Data lost|5
2311124|NCT02747420|4016113|FG000|Overall Study|Lost to Follow-up|4
2311125|NCT02747420|4016114|FG001|Overall Study|Lost to Follow-up|2
2311126|NCT02747420|4016113|FG000|Overall Study|Withdrawal by Subject|3
2311127|NCT02747420|4016114|FG001|Overall Study|Withdrawal by Subject|2
2311128|NCT02747875|4016156|FG000|Overall Study|Physician Decision|1
2311129|NCT02747875|4016157|FG001|Overall Study|Physician Decision|0
2311130|NCT02747875|4016156|FG000|Overall Study|Adverse Event|0
2311131|NCT02747875|4016157|FG001|Overall Study|Adverse Event|1
2311132|NCT02747927|4016165|FG000|Overall Study|Adverse Event|5
2311133|NCT02747927|4016166|FG001|Overall Study|Adverse Event|14
2311134|NCT02747927|4016165|FG000|Overall Study|Lost to Follow-up|22
2311135|NCT02747927|4016166|FG001|Overall Study|Lost to Follow-up|43
2311136|NCT02747927|4016165|FG000|Overall Study|Pregnancy|34
2311137|NCT02747927|4016166|FG001|Overall Study|Pregnancy|66
2311138|NCT02747927|4016165|FG000|Overall Study|Protocol Violation|2
2311139|NCT02747927|4016166|FG001|Overall Study|Protocol Violation|4
2311140|NCT02747927|4016165|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147
2311141|NCT02747927|4016166|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304
1985964|NCT03126019|3551340|FG000|Overall Study|Death|2
1985965|NCT03126019|3551341|FG001|Overall Study|Death|7
1985966|NCT03126019|3551340|FG000|Overall Study|Lost to Follow-up|2
1985967|NCT03126019|3551341|FG001|Overall Study|Lost to Follow-up|3
1985968|NCT03126019|3551340|FG000|Overall Study|Withdrawal by Participant|1
1985969|NCT03126019|3551341|FG001|Overall Study|Withdrawal by Participant|3
1985970|NCT03126019|3551340|FG000|Overall Study|Reason not Specified|1
1985971|NCT03126019|3551341|FG001|Overall Study|Reason not Specified|3
1985972|NCT03113383|3551348|FG000|Overall Study|Death|4
1985973|NCT03113383|3551349|FG001|Overall Study|Death|0
1985974|NCT02978326|3551380|FG000|Part B (Up to 45 Days)|Adverse Event|0
1985975|NCT02978326|3551381|FG001|Part B (Up to 45 Days)|Adverse Event|0
1985976|NCT02978326|3551382|FG002|Part B (Up to 45 Days)|Adverse Event|1
1985977|NCT02978326|3551380|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0
1985978|NCT02978326|3551381|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3
1985979|NCT02978326|3551382|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0
1985980|NCT02978326|3551380|FG000|Part B (Up to 45 Days)|Non-compliance|0
1985981|NCT02978326|3551381|FG001|Part B (Up to 45 Days)|Non-compliance|2
1985982|NCT02978326|3551382|FG002|Part B (Up to 45 Days)|Non-compliance|0
1985983|NCT02978326|3551380|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0
1985984|NCT02978326|3551381|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2
1985985|NCT02978326|3551382|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3
1985986|NCT02970929|3551392|FG000|Overall Study|Adverse Event|18
1985987|NCT02970929|3551392|FG000|Overall Study|Lack of Efficacy|8
1985988|NCT02970929|3551392|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1
1985989|NCT02970929|3551392|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1
1985990|NCT02970929|3551392|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1
1985991|NCT02970929|3551392|FG000|Overall Study|LOST TO FOLLOWUP|6
1985992|NCT02970929|3551392|FG000|Overall Study|MOVED OUT OF STATE|1
1985993|NCT02970929|3551392|FG000|Overall Study|Withdrawal by Subject|16
1985994|NCT02797951|3551426|FG000|Overall Study|Adverse Event|4
1985995|NCT02797951|3551426|FG000|Overall Study|Death|1
1985996|NCT02797951|3551426|FG000|Overall Study|Lack of Efficacy|19
1985997|NCT02797951|3551426|FG000|Overall Study|Lost to Follow-up|4
1985998|NCT02797951|3551426|FG000|Overall Study|Physician Decision|6
1985999|NCT02797951|3551426|FG000|Overall Study|Withdrawal by Subject|15
1986000|NCT02748057|3551441|FG000|Overall Study|Adverse Event|1
1986001|NCT02748057|3551442|FG001|Overall Study|Adverse Event|0
1986002|NCT02748057|3551441|FG000|Overall Study|Physician Decision|0
1986003|NCT02748057|3551442|FG001|Overall Study|Physician Decision|1
1986004|NCT02748057|3551441|FG000|Overall Study|Protocol Violation|2
1986005|NCT02748057|3551442|FG001|Overall Study|Protocol Violation|1
1986006|NCT02748057|3551441|FG000|Overall Study|Participant Moved|1
1986007|NCT02748057|3551442|FG001|Overall Study|Participant Moved|0
1986008|NCT02748057|3551441|FG000|Overall Study|Withdrawal by Subject|1
1986009|NCT02748057|3551442|FG001|Overall Study|Withdrawal by Subject|0
1986010|NCT02741271|3551450|FG000|Overall Study|Lost to Follow-up|2
1986011|NCT02741271|3551451|FG001|Overall Study|Lost to Follow-up|0
1986012|NCT02741271|3551450|FG000|Overall Study|Withdrawal by Parent/Guardian|0
1986013|NCT02741271|3551451|FG001|Overall Study|Withdrawal by Parent/Guardian|2
1986014|NCT02741245|3551464|FG000|Overall Study|Adverse Event|0
1986015|NCT02741245|3551465|FG001|Overall Study|Adverse Event|0
1986016|NCT02741245|3551466|FG002|Overall Study|Adverse Event|0
1986017|NCT02741245|3551467|FG003|Overall Study|Adverse Event|2
1986018|NCT02741245|3551468|FG004|Overall Study|Adverse Event|2
1986019|NCT02741245|3551464|FG000|Overall Study|Protocol Violation|0
1986020|NCT02741245|3551465|FG001|Overall Study|Protocol Violation|1
1986021|NCT02741245|3551466|FG002|Overall Study|Protocol Violation|0
1986022|NCT02741245|3551467|FG003|Overall Study|Protocol Violation|1
1986023|NCT02741245|3551468|FG004|Overall Study|Protocol Violation|0
1986024|NCT02741245|3551464|FG000|Overall Study|Withdrawal by Subject|0
1986025|NCT02741245|3551465|FG001|Overall Study|Withdrawal by Subject|0
1986026|NCT02741245|3551466|FG002|Overall Study|Withdrawal by Subject|0
1986027|NCT02741245|3551467|FG003|Overall Study|Withdrawal by Subject|1
1986028|NCT02741245|3551468|FG004|Overall Study|Withdrawal by Subject|0
1986029|NCT02717611|3551480|FG000|Overall Study|Death|13
1986030|NCT02717611|3551480|FG000|Overall Study|Withdrawal by Subject|6
1986031|NCT02717611|3551480|FG000|Overall Study|Active, not recruiting|40
2311142|NCT02747927|4016165|FG000|Overall Study|Reason not Specified|11
2311143|NCT02747927|4016166|FG001|Overall Study|Reason not Specified|27
2321916|NCT02965378|4036536|FG000|Overall Study|Progression|16
2321917|NCT02965378|4036537|FG001|Overall Study|Progression|4
2321918|NCT02965378|4036536|FG000|Overall Study|Adverse Event|5
2321919|NCT02965378|4036537|FG001|Overall Study|Adverse Event|2
2321920|NCT02965378|4036536|FG000|Overall Study|Death|2
2321921|NCT02965378|4036537|FG001|Overall Study|Death|0
2321922|NCT02965378|4036536|FG000|Overall Study|Refusal|2
2321923|NCT02965378|4036537|FG001|Overall Study|Refusal|1
2321924|NCT02965378|4036536|FG000|Overall Study|Not protocol specified|0
2321925|NCT02965378|4036537|FG001|Overall Study|Not protocol specified|2
2321926|NCT02965456|4036545|FG000|Overall Study|Lost to Follow-up|40
2321927|NCT02965456|4036546|FG001|Overall Study|Lost to Follow-up|18
1986032|NCT02717611|3551480|FG000|Overall Study|Complicating disease|1
2321928|NCT02965456|4036545|FG000|Overall Study|Subject Request|22
1986033|NCT02688608|3551484|FG000|Overall Study|Lost to Follow-up|1
1986034|NCT02675231|3551491|FG000|Overall Study|Withdrawal by Subject|1
1986035|NCT02675231|3551492|FG001|Overall Study|Withdrawal by Subject|3
1986036|NCT02675231|3551493|FG002|Overall Study|Withdrawal by Subject|1
1986037|NCT02675231|3551491|FG000|Overall Study|Lost to Follow-up|2
1986038|NCT02675231|3551492|FG001|Overall Study|Lost to Follow-up|2
1986039|NCT02675231|3551493|FG002|Overall Study|Lost to Follow-up|2
1986040|NCT02675231|3551491|FG000|Overall Study|On study treatment/follow up|23
2177426|NCT01373294|3801515|FG000|Overall Study|Adverse Event|1
2177427|NCT01373294|3801516|FG001|Overall Study|Adverse Event|0
2177428|NCT01373346|3801522|FG000|Overall Study|Death|1
2177429|NCT01373918|3801570|FG000|Overall Study|Physician Decision|0
2177430|NCT01373918|3801571|FG001|Overall Study|Physician Decision|1
2177431|NCT01373931|3801579|FG000|Lead-in Period|Adverse Event|2
2177432|NCT01373931|3801580|FG001|Lead-in Period|Adverse Event|0
2213433|NCT01678820|3854922|FG000|Overall Study|Protocol Violation|4
2213434|NCT01678820|3854923|FG001|Overall Study|Protocol Violation|5
2213435|NCT01678820|3854924|FG002|Overall Study|Protocol Violation|4
2213436|NCT01678820|3854922|FG000|Overall Study|Not treated with double-blind study drug|0
2213437|NCT01678820|3854923|FG001|Overall Study|Not treated with double-blind study drug|2
2213438|NCT01678820|3854924|FG002|Overall Study|Not treated with double-blind study drug|2
2213439|NCT01678898|3854959|FG000|PB-102-F01|Adverse Event|0
2213440|NCT01678898|3854960|FG001|PB-102-F01|Adverse Event|1
2213441|NCT01678898|3854961|FG002|PB-102-F01|Adverse Event|0
2213442|NCT01678898|3854959|FG000|PB-102-F01|Physician Decision|0
2213443|NCT01678898|3854960|FG001|PB-102-F01|Physician Decision|1
2311144|NCT02748213|4016192|FG000|Overall Study|Withdrawal Prior to Treatment|1
2177433|NCT01373931|3801579|FG000|Period 1|Adverse Event|2
2177434|NCT01373931|3801580|FG001|Period 1|Adverse Event|0
2311145|NCT02748213|4016193|FG001|Overall Study|Withdrawal Prior to Treatment|2
1986041|NCT02675231|3551492|FG001|Overall Study|On study treatment/follow up|31
1986042|NCT02675231|3551493|FG002|Overall Study|On study treatment/follow up|23
2311146|NCT02748213|4016192|FG000|Overall Study|Abnormal Laboratory Test|1
2311147|NCT02748213|4016193|FG001|Overall Study|Abnormal Laboratory Test|0
2311148|NCT02748213|4016192|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
2311149|NCT02748213|4016193|FG001|Overall Study|Adverse Event or Intercurrent Illness|11
2311150|NCT02748213|4016192|FG000|Overall Study|Death|5
2311151|NCT02748213|4016193|FG001|Overall Study|Death|3
2311152|NCT02748213|4016192|FG000|Overall Study|Insufficient Therapeutic Response|56
2311153|NCT02748213|4016193|FG001|Overall Study|Insufficient Therapeutic Response|57
2311154|NCT02748213|4016192|FG000|Overall Study|Violation of Selection Criteria|2
2311155|NCT02748213|4016193|FG001|Overall Study|Violation of Selection Criteria|0
2311156|NCT02748213|4016192|FG000|Overall Study|Protocol Violation|6
2311157|NCT02748213|4016193|FG001|Overall Study|Protocol Violation|4
2311158|NCT02748213|4016192|FG000|Overall Study|Refused Treatment*|6
2311159|NCT02748213|4016193|FG001|Overall Study|Refused Treatment*|6
2311160|NCT02748213|4016192|FG000|Overall Study|Failure to Return|1
2311161|NCT02748213|4016193|FG001|Overall Study|Failure to Return|0
2311162|NCT02748213|4016192|FG000|Overall Study|Other|30
2311163|NCT02748213|4016193|FG001|Overall Study|Other|29
2311164|NCT02748317|4016199|FG000|Overall Study|Withdrawal by Subject|14
2311165|NCT02748317|4016199|FG000|Overall Study|Lost to Follow-up|8
2311166|NCT02748317|4016199|FG000|Overall Study|Death|1
2311167|NCT02748356|4016203|FG000|Overall Study|Withdrawal by Subject|1
2311168|NCT02748512|4016209|FG000|Overall Study|Lost to Follow-up|1
2311169|NCT02748512|4016210|FG001|Overall Study|Lost to Follow-up|1
2311170|NCT02748694|4016235|FG000|Overall Study|Voluntary Withdrawal|0
2311171|NCT02748694|4016236|FG001|Overall Study|Voluntary Withdrawal|0
2311172|NCT02748694|4016237|FG002|Overall Study|Voluntary Withdrawal|0
2311173|NCT02748694|4016238|FG003|Overall Study|Voluntary Withdrawal|0
2311174|NCT02748694|4016239|FG004|Overall Study|Voluntary Withdrawal|0
2311175|NCT02748694|4016240|FG005|Overall Study|Voluntary Withdrawal|0
2311176|NCT02748694|4016241|FG006|Overall Study|Voluntary Withdrawal|0
2311177|NCT02748694|4016242|FG007|Overall Study|Voluntary Withdrawal|0
2311178|NCT02748694|4016243|FG008|Overall Study|Voluntary Withdrawal|0
2311179|NCT02748694|4016244|FG009|Overall Study|Voluntary Withdrawal|0
2311180|NCT02748694|4016245|FG010|Overall Study|Voluntary Withdrawal|0
2311181|NCT02748694|4016246|FG011|Overall Study|Voluntary Withdrawal|0
2311182|NCT02748694|4016247|FG012|Overall Study|Voluntary Withdrawal|0
2311183|NCT02748694|4016248|FG013|Overall Study|Voluntary Withdrawal|0
2311184|NCT02748694|4016249|FG014|Overall Study|Voluntary Withdrawal|2
2311185|NCT02748863|4016325|FG000|Treatment Period 1|Adverse Event|0
2311186|NCT02748863|4016326|FG001|Treatment Period 1|Adverse Event|1
2311187|NCT02748863|4016327|FG002|Treatment Period 1|Adverse Event|0
2311188|NCT02748863|4016328|FG003|Treatment Period 1|Adverse Event|0
2311189|NCT02748863|4016329|FG004|Treatment Period 1|Adverse Event|0
2311190|NCT02748863|4016325|FG000|Treatment Period 1|Lack of Efficacy|0
2311191|NCT02748863|4016326|FG001|Treatment Period 1|Lack of Efficacy|0
2311192|NCT02748863|4016327|FG002|Treatment Period 1|Lack of Efficacy|1
2311193|NCT02748863|4016328|FG003|Treatment Period 1|Lack of Efficacy|0
2311194|NCT02748863|4016329|FG004|Treatment Period 1|Lack of Efficacy|0
2177435|NCT01373931|3801579|FG000|Period 1|Withdrawal by Subject|0
2213444|NCT01678898|3854961|FG002|PB-102-F01|Physician Decision|0
2213445|NCT01678911|3854978|FG000|Second Intervention|Lost to Follow-up|2
1986043|NCT02659514|3551504|FG000|Overall Study|Adverse Event|3
1986044|NCT02659514|3551505|FG001|Overall Study|Adverse Event|12
1986045|NCT02659514|3551504|FG000|Overall Study|Disease Progression|23
1986046|NCT02659514|3551505|FG001|Overall Study|Disease Progression|13
1986047|NCT02659514|3551504|FG000|Overall Study|Withdrawal by Subject|0
1986048|NCT02659514|3551505|FG001|Overall Study|Withdrawal by Subject|4
1986049|NCT02659514|3551504|FG000|Overall Study|Lost to Follow-up|0
1986050|NCT02659514|3551505|FG001|Overall Study|Lost to Follow-up|1
1986051|NCT02659514|3551504|FG000|Overall Study|Death|6
1986052|NCT02659514|3551505|FG001|Overall Study|Death|1
1986053|NCT02659514|3551504|FG000|Overall Study|Reason Unspecified|0
1986054|NCT02659514|3551505|FG001|Overall Study|Reason Unspecified|3
1986055|NCT02605967|3551522|FG000|Overall Study|subject / guardian decision|1
1986056|NCT02605967|3551523|FG001|Overall Study|subject / guardian decision|2
1986057|NCT02605967|3551522|FG000|Overall Study|Physician Decision|10
1986058|NCT02605967|3551523|FG001|Overall Study|Physician Decision|1
1986059|NCT02605967|3551522|FG000|Overall Study|Death|4
1986060|NCT02605967|3551523|FG001|Overall Study|Death|2
1986061|NCT02605967|3551522|FG000|Overall Study|Adverse Event|1
1986062|NCT02605967|3551523|FG001|Overall Study|Adverse Event|0
1986063|NCT02605967|3551522|FG000|Overall Study|progressive disease|66
1986064|NCT02605967|3551523|FG001|Overall Study|progressive disease|35
1986065|NCT02584634|3551535|FG000|Overall Study|Adverse Event|3
1986066|NCT02584634|3551536|FG001|Overall Study|Adverse Event|3
1986067|NCT02584634|3551535|FG000|Overall Study|Death|0
1986068|NCT02584634|3551536|FG001|Overall Study|Death|1
1986069|NCT02584634|3551535|FG000|Overall Study|Lost to Follow-up|0
1986070|NCT02584634|3551536|FG001|Overall Study|Lost to Follow-up|1
1986071|NCT02584634|3551535|FG000|Overall Study|Physician Decision|1
1986072|NCT02584634|3551536|FG001|Overall Study|Physician Decision|1
1986073|NCT02584634|3551535|FG000|Overall Study|Progressive disease|7
1986074|NCT02584634|3551536|FG001|Overall Study|Progressive disease|14
1986075|NCT02584634|3551535|FG000|Overall Study|Withdrawal by Subject|1
2311195|NCT02748863|4016325|FG000|Treatment Period 1|Withdrawal by Subject|0
2311196|NCT02748863|4016326|FG001|Treatment Period 1|Withdrawal by Subject|1
2311197|NCT02748863|4016327|FG002|Treatment Period 1|Withdrawal by Subject|1
2311198|NCT02748863|4016328|FG003|Treatment Period 1|Withdrawal by Subject|0
2311199|NCT02748863|4016329|FG004|Treatment Period 1|Withdrawal by Subject|0
2311200|NCT02748863|4016325|FG000|Treatment Period 2|Lost to Follow-up|2
2311201|NCT02748863|4016326|FG001|Treatment Period 2|Lost to Follow-up|0
2311202|NCT02748863|4016327|FG002|Treatment Period 2|Lost to Follow-up|0
2311203|NCT02748863|4016328|FG003|Treatment Period 2|Lost to Follow-up|0
2311204|NCT02748863|4016329|FG004|Treatment Period 2|Lost to Follow-up|0
2311205|NCT02748863|4016325|FG000|Treatment Period 2|Adverse Event|3
2311206|NCT02748863|4016326|FG001|Treatment Period 2|Adverse Event|2
2311207|NCT02748863|4016327|FG002|Treatment Period 2|Adverse Event|0
2311208|NCT02748863|4016328|FG003|Treatment Period 2|Adverse Event|2
2311209|NCT02748863|4016329|FG004|Treatment Period 2|Adverse Event|0
2311210|NCT02748863|4016325|FG000|Treatment Period 2|Lack of Efficacy|0
2311211|NCT02748863|4016326|FG001|Treatment Period 2|Lack of Efficacy|1
2311212|NCT02748863|4016327|FG002|Treatment Period 2|Lack of Efficacy|0
2311213|NCT02748863|4016328|FG003|Treatment Period 2|Lack of Efficacy|0
2311214|NCT02748863|4016329|FG004|Treatment Period 2|Lack of Efficacy|0
2311215|NCT02748863|4016325|FG000|Treatment Period 2|Pregnancy|0
2311216|NCT02748863|4016326|FG001|Treatment Period 2|Pregnancy|0
2311217|NCT02748863|4016327|FG002|Treatment Period 2|Pregnancy|0
2311218|NCT02748863|4016328|FG003|Treatment Period 2|Pregnancy|0
2311219|NCT02748863|4016329|FG004|Treatment Period 2|Pregnancy|1
2311220|NCT02749370|4016360|FG000|Overall Study|Withdrawal by Subject|11
2311221|NCT02749370|4016360|FG000|Overall Study|Lost to Follow-up|3
2311222|NCT02749721|4016364|FG000|Screening|Withdrawal by Subject|1
2311223|NCT02749721|4016364|FG000|Screening|Lost to Follow-up|2
2311224|NCT02749721|4016364|FG000|Screening|Protocol Violation|3
2311225|NCT02749721|4016364|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2
2311226|NCT02749721|4016364|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1
2311227|NCT02749799|4016370|FG000|Overall Study|Adverse Event|2
2311228|NCT02749799|4016370|FG000|Overall Study|Lost to Follow-up|4
2311229|NCT02749799|4016370|FG000|Overall Study|Protocol Violation|1
2311230|NCT02749799|4016370|FG000|Overall Study|Withdrawal by Subject|1
2311231|NCT02750306|4016391|FG000|Overall Study|Withdrawal by Subject|5
2311232|NCT02750306|4016392|FG001|Overall Study|Withdrawal by Subject|2
2311233|NCT02750306|4016391|FG000|Overall Study|Protocol Violation|1
2311234|NCT02750306|4016392|FG001|Overall Study|Protocol Violation|0
2311235|NCT02750332|4016398|FG000|Treatment Period 1|Withdrawal by Subject|0
2311236|NCT02750332|4016399|FG001|Treatment Period 1|Withdrawal by Subject|1
2311237|NCT02750345|4016405|FG000|Intervention 1|Adverse Event|0
2311238|NCT02750345|4016406|FG001|Intervention 1|Adverse Event|0
2311239|NCT02750345|4016407|FG002|Intervention 1|Adverse Event|0
2311240|NCT02750345|4016408|FG003|Intervention 1|Adverse Event|0
2311241|NCT02750345|4016409|FG004|Intervention 1|Adverse Event|1
2311242|NCT02750345|4016410|FG005|Intervention 1|Adverse Event|0
2311243|NCT02750410|4016422|FG000|Double-Blind Treatment Period|Adverse Event|2
2311244|NCT02750410|4016423|FG001|Double-Blind Treatment Period|Adverse Event|2
1986076|NCT02584634|3551536|FG001|Overall Study|Withdrawal by Subject|1
1986077|NCT02584634|3551535|FG000|Overall Study|Other|0
1986078|NCT02584634|3551536|FG001|Overall Study|Other|2
1986079|NCT02584634|3551535|FG000|Overall Study|Ongoing|0
1986080|NCT02584634|3551536|FG001|Overall Study|Ongoing|8
1986081|NCT02562235|3551549|FG000|Overall Study|Adverse Event|3
1986082|NCT02553265|3551558|FG000|Enrollment|Death|0
1986083|NCT02553265|3551559|FG001|Enrollment|Death|0
1986084|NCT02553265|3551560|FG002|Enrollment|Death|1
1986085|NCT02553265|3551558|FG000|First Intervention (28 Days)|Adverse Event|1
1986086|NCT02553265|3551559|FG001|First Intervention (28 Days)|Adverse Event|0
1986087|NCT02553265|3551560|FG002|First Intervention (28 Days)|Adverse Event|0
1986088|NCT02553265|3551558|FG000|First Intervention (28 Days)|Withdrawal by Subject|0
1986089|NCT02553265|3551559|FG001|First Intervention (28 Days)|Withdrawal by Subject|0
1986090|NCT02553265|3551560|FG002|First Intervention (28 Days)|Withdrawal by Subject|1
1986091|NCT02553265|3551558|FG000|Second Intervention (28 Days)|Adverse Event|1
1986092|NCT02553265|3551559|FG001|Second Intervention (28 Days)|Adverse Event|0
1986093|NCT02553265|3551560|FG002|Second Intervention (28 Days)|Adverse Event|0
1986094|NCT02553265|3551558|FG000|Third Intervention (28 Days)|Adverse Event|1
1986095|NCT02553265|3551559|FG001|Third Intervention (28 Days)|Adverse Event|0
1986096|NCT02553265|3551560|FG002|Third Intervention (28 Days)|Adverse Event|0
1986097|NCT02553265|3551558|FG000|Third Intervention (28 Days)|Lost to Follow-up|0
1986098|NCT02553265|3551559|FG001|Third Intervention (28 Days)|Lost to Follow-up|0
1986099|NCT02553265|3551560|FG002|Third Intervention (28 Days)|Lost to Follow-up|1
1986100|NCT02550288|3551576|FG000|Overall Study|Adverse Event|0
1986101|NCT02550288|3551577|FG001|Overall Study|Adverse Event|1
1986102|NCT02550288|3551578|FG002|Overall Study|Adverse Event|0
1986103|NCT02550288|3551579|FG003|Overall Study|Adverse Event|0
1986104|NCT02550288|3551580|FG004|Overall Study|Adverse Event|0
2311245|NCT02750410|4016422|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
2311246|NCT02750410|4016423|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
2311247|NCT02750410|4016422|FG000|Open-Label Extension Period|Adverse Event|5
2311248|NCT02750410|4016423|FG001|Open-Label Extension Period|Adverse Event|3
2311249|NCT02750410|4016422|FG000|Open-Label Extension Period|Protocol Violation|0
2311250|NCT02750410|4016423|FG001|Open-Label Extension Period|Protocol Violation|1
2311251|NCT02750410|4016422|FG000|Open-Label Extension Period|Withdrawal by Subject|1
2311252|NCT02750410|4016423|FG001|Open-Label Extension Period|Withdrawal by Subject|2
2311253|NCT02750501|4016433|FG000|Overall Study|Adverse Event|4
2311254|NCT02750501|4016433|FG000|Overall Study|Physician Decision|1
2311255|NCT02750501|4016433|FG000|Overall Study|Protocol Violation|1
2311256|NCT02750501|4016433|FG000|Overall Study|G-tube came out|1
2311257|NCT02750501|4016433|FG000|Overall Study|Non-compliant use of PERT|1
2311258|NCT02750514|4016446|FG000|Track 1|Disease progression|20
2311259|NCT02750514|4016447|FG001|Track 1|Disease progression|1
2311260|NCT02750514|4016448|FG002|Track 1|Disease progression|0
2311261|NCT02750514|4016449|FG003|Track 1|Disease progression|1
2311262|NCT02750514|4016450|FG004|Track 1|Disease progression|0
2311263|NCT02750514|4016446|FG000|Track 1|Adverse event unrelated to study drug|1
2311264|NCT02750514|4016447|FG001|Track 1|Adverse event unrelated to study drug|0
2311265|NCT02750514|4016448|FG002|Track 1|Adverse event unrelated to study drug|0
2311266|NCT02750514|4016449|FG003|Track 1|Adverse event unrelated to study drug|0
2311267|NCT02750514|4016450|FG004|Track 1|Adverse event unrelated to study drug|0
2311268|NCT02750514|4016446|FG000|Track 1|Study drug toxicity|4
2311269|NCT02750514|4016447|FG001|Track 1|Study drug toxicity|1
2311270|NCT02750514|4016448|FG002|Track 1|Study drug toxicity|0
2311271|NCT02750514|4016449|FG003|Track 1|Study drug toxicity|1
2311272|NCT02750514|4016450|FG004|Track 1|Study drug toxicity|0
2311273|NCT02750514|4016446|FG000|Track 1|Participant request to discontinue|1
2311274|NCT02750514|4016447|FG001|Track 1|Participant request to discontinue|0
2311275|NCT02750514|4016448|FG002|Track 1|Participant request to discontinue|0
2311276|NCT02750514|4016449|FG003|Track 1|Participant request to discontinue|0
2311277|NCT02750514|4016450|FG004|Track 1|Participant request to discontinue|0
2311278|NCT02750514|4016446|FG000|Track 1|Other reasons|1
2311279|NCT02750514|4016447|FG001|Track 1|Other reasons|0
2311280|NCT02750514|4016448|FG002|Track 1|Other reasons|0
2311281|NCT02750514|4016449|FG003|Track 1|Other reasons|0
2311282|NCT02750514|4016450|FG004|Track 1|Other reasons|0
2311283|NCT02750514|4016446|FG000|Track 2|Disease progression|4
2311284|NCT02750514|4016447|FG001|Track 2|Disease progression|5
2311285|NCT02750514|4016448|FG002|Track 2|Disease progression|2
2311286|NCT02750514|4016449|FG003|Track 2|Disease progression|5
2311287|NCT02750514|4016450|FG004|Track 2|Disease progression|0
2311288|NCT02750514|4016446|FG000|Track 2|Adverse event unrelated to study drug|1
2311289|NCT02750514|4016447|FG001|Track 2|Adverse event unrelated to study drug|0
2311290|NCT02750514|4016448|FG002|Track 2|Adverse event unrelated to study drug|0
2311291|NCT02750514|4016449|FG003|Track 2|Adverse event unrelated to study drug|0
2311292|NCT02750514|4016450|FG004|Track 2|Adverse event unrelated to study drug|0
2311293|NCT02750514|4016446|FG000|Track 2|Study drug toxicity|1
2311294|NCT02750514|4016447|FG001|Track 2|Study drug toxicity|2
2311295|NCT02750514|4016448|FG002|Track 2|Study drug toxicity|0
2311296|NCT02750514|4016449|FG003|Track 2|Study drug toxicity|2
2311297|NCT02750514|4016450|FG004|Track 2|Study drug toxicity|0
2311298|NCT02750514|4016446|FG000|Track 2|Participant withdrew consent|0
2311299|NCT02750514|4016447|FG001|Track 2|Participant withdrew consent|1
2311300|NCT02750514|4016448|FG002|Track 2|Participant withdrew consent|0
1986105|NCT02550288|3551576|FG000|Overall Study|Physician Decision|0
1986106|NCT02550288|3551577|FG001|Overall Study|Physician Decision|0
1986107|NCT02550288|3551578|FG002|Overall Study|Physician Decision|0
1986108|NCT02550288|3551579|FG003|Overall Study|Physician Decision|1
1986109|NCT02550288|3551580|FG004|Overall Study|Physician Decision|0
1986110|NCT02550288|3551576|FG000|Overall Study|Protocol Violation|2
1986111|NCT02550288|3551577|FG001|Overall Study|Protocol Violation|2
1986112|NCT02550288|3551578|FG002|Overall Study|Protocol Violation|1
1986113|NCT02550288|3551579|FG003|Overall Study|Protocol Violation|0
1986114|NCT02550288|3551580|FG004|Overall Study|Protocol Violation|3
1986115|NCT02550288|3551576|FG000|Overall Study|Participant moved|0
1986116|NCT02550288|3551577|FG001|Overall Study|Participant moved|0
1986117|NCT02550288|3551578|FG002|Overall Study|Participant moved|0
1986118|NCT02550288|3551579|FG003|Overall Study|Participant moved|1
1986119|NCT02550288|3551580|FG004|Overall Study|Participant moved|0
2311301|NCT02750514|4016449|FG003|Track 2|Participant withdrew consent|0
2311302|NCT02750514|4016450|FG004|Track 2|Participant withdrew consent|0
2311303|NCT02750514|4016446|FG000|Track 3|Disease progression|0
2311304|NCT02750514|4016447|FG001|Track 3|Disease progression|24
2311305|NCT02750514|4016448|FG002|Track 3|Disease progression|13
2311306|NCT02750514|4016449|FG003|Track 3|Disease progression|14
2311307|NCT02750514|4016450|FG004|Track 3|Disease progression|0
2311308|NCT02750514|4016446|FG000|Track 3|Adverse event unrelated to study drug|0
2311309|NCT02750514|4016447|FG001|Track 3|Adverse event unrelated to study drug|1
2311310|NCT02750514|4016448|FG002|Track 3|Adverse event unrelated to study drug|1
2311311|NCT02750514|4016449|FG003|Track 3|Adverse event unrelated to study drug|1
2311312|NCT02750514|4016450|FG004|Track 3|Adverse event unrelated to study drug|0
2311313|NCT02750514|4016446|FG000|Track 3|Study drug toxicity|0
2311314|NCT02750514|4016447|FG001|Track 3|Study drug toxicity|3
2311315|NCT02750514|4016448|FG002|Track 3|Study drug toxicity|0
2311316|NCT02750514|4016449|FG003|Track 3|Study drug toxicity|1
2311317|NCT02750514|4016450|FG004|Track 3|Study drug toxicity|0
2311318|NCT02750514|4016446|FG000|Track 3|Participant request to discontinue|0
2311319|NCT02750514|4016447|FG001|Track 3|Participant request to discontinue|2
2311320|NCT02750514|4016448|FG002|Track 3|Participant request to discontinue|0
2311321|NCT02750514|4016449|FG003|Track 3|Participant request to discontinue|0
2311322|NCT02750514|4016450|FG004|Track 3|Participant request to discontinue|0
2311323|NCT02750514|4016446|FG000|Track 3|Participant withdrew consent|0
2311324|NCT02750514|4016447|FG001|Track 3|Participant withdrew consent|3
2311325|NCT02750514|4016448|FG002|Track 3|Participant withdrew consent|1
2311326|NCT02750514|4016449|FG003|Track 3|Participant withdrew consent|0
2311327|NCT02750514|4016450|FG004|Track 3|Participant withdrew consent|0
2311328|NCT02750514|4016446|FG000|Track 3|Other reasons|0
2311329|NCT02750514|4016447|FG001|Track 3|Other reasons|3
2311330|NCT02750514|4016448|FG002|Track 3|Other reasons|0
2311331|NCT02750514|4016449|FG003|Track 3|Other reasons|0
2311332|NCT02750514|4016450|FG004|Track 3|Other reasons|0
2311333|NCT02750514|4016446|FG000|Track 4|Study drug toxicity|0
2311334|NCT02750514|4016447|FG001|Track 4|Study drug toxicity|6
2311335|NCT02750514|4016448|FG002|Track 4|Study drug toxicity|0
2311336|NCT02750514|4016449|FG003|Track 4|Study drug toxicity|5
2311337|NCT02750514|4016450|FG004|Track 4|Study drug toxicity|0
2311338|NCT02750514|4016446|FG000|Track 4|Participant request to discontinue|0
2311339|NCT02750514|4016447|FG001|Track 4|Participant request to discontinue|1
2311340|NCT02750514|4016448|FG002|Track 4|Participant request to discontinue|0
2311341|NCT02750514|4016449|FG003|Track 4|Participant request to discontinue|1
2311342|NCT02750514|4016450|FG004|Track 4|Participant request to discontinue|0
2311343|NCT02750514|4016446|FG000|Track 4|Participant withdrew consent|0
2311344|NCT02750514|4016447|FG001|Track 4|Participant withdrew consent|1
2311345|NCT02750514|4016448|FG002|Track 4|Participant withdrew consent|0
2311346|NCT02750514|4016449|FG003|Track 4|Participant withdrew consent|0
2311347|NCT02750514|4016450|FG004|Track 4|Participant withdrew consent|0
2311348|NCT02750514|4016446|FG000|Track 4|Other reasons|0
2311349|NCT02750514|4016447|FG001|Track 4|Other reasons|5
2311350|NCT02750514|4016448|FG002|Track 4|Other reasons|0
2311351|NCT02750514|4016449|FG003|Track 4|Other reasons|3
2311352|NCT02750514|4016450|FG004|Track 4|Other reasons|0
2311353|NCT02750514|4016446|FG000|Track 4|Disease progression|0
2311354|NCT02750514|4016447|FG001|Track 4|Disease progression|33
2311355|NCT02750514|4016448|FG002|Track 4|Disease progression|0
2311356|NCT02750514|4016449|FG003|Track 4|Disease progression|32
2311357|NCT02750514|4016450|FG004|Track 4|Disease progression|0
2311358|NCT02750514|4016446|FG000|Track 4|Adverse event unrelated to study drug|0
2311359|NCT02750514|4016447|FG001|Track 4|Adverse event unrelated to study drug|5
2311360|NCT02750514|4016448|FG002|Track 4|Adverse event unrelated to study drug|0
2311361|NCT02750514|4016449|FG003|Track 4|Adverse event unrelated to study drug|0
2311362|NCT02750514|4016450|FG004|Track 4|Adverse event unrelated to study drug|0
2311363|NCT02750514|4016446|FG000|Track 4|Death|0
2311364|NCT02750514|4016447|FG001|Track 4|Death|0
2311365|NCT02750514|4016448|FG002|Track 4|Death|0
2311366|NCT02750514|4016449|FG003|Track 4|Death|1
2311367|NCT02750514|4016450|FG004|Track 4|Death|0
2311368|NCT02750514|4016446|FG000|Track 5|Disease progression|0
1986120|NCT02550288|3551576|FG000|Overall Study|Withdrawal by Subject|0
2311369|NCT02750514|4016447|FG001|Track 5|Disease progression|0
1986121|NCT02550288|3551577|FG001|Overall Study|Withdrawal by Subject|0
1986122|NCT02550288|3551578|FG002|Overall Study|Withdrawal by Subject|0
1986123|NCT02550288|3551579|FG003|Overall Study|Withdrawal by Subject|1
1986124|NCT02550288|3551580|FG004|Overall Study|Withdrawal by Subject|0
2311370|NCT02750514|4016448|FG002|Track 5|Disease progression|0
2311371|NCT02750514|4016449|FG003|Track 5|Disease progression|0
2311372|NCT02750514|4016450|FG004|Track 5|Disease progression|34
2311373|NCT02750514|4016446|FG000|Track 5|Adverse event unrelated to study drug|0
2311374|NCT02750514|4016447|FG001|Track 5|Adverse event unrelated to study drug|0
2311375|NCT02750514|4016448|FG002|Track 5|Adverse event unrelated to study drug|0
2311376|NCT02750514|4016449|FG003|Track 5|Adverse event unrelated to study drug|0
2311377|NCT02750514|4016450|FG004|Track 5|Adverse event unrelated to study drug|2
2311378|NCT02750514|4016446|FG000|Track 5|Study drug toxicity|0
2311379|NCT02750514|4016447|FG001|Track 5|Study drug toxicity|0
2311380|NCT02750514|4016448|FG002|Track 5|Study drug toxicity|0
2311381|NCT02750514|4016449|FG003|Track 5|Study drug toxicity|0
2311382|NCT02750514|4016450|FG004|Track 5|Study drug toxicity|2
2311383|NCT02750514|4016446|FG000|Track 5|Participant request to discontinue|0
2311384|NCT02750514|4016447|FG001|Track 5|Participant request to discontinue|0
2311385|NCT02750514|4016448|FG002|Track 5|Participant request to discontinue|0
2311386|NCT02750514|4016449|FG003|Track 5|Participant request to discontinue|0
2311387|NCT02750514|4016450|FG004|Track 5|Participant request to discontinue|3
2311388|NCT02750514|4016446|FG000|Track 5|Other reasons|0
2311389|NCT02750514|4016447|FG001|Track 5|Other reasons|0
2311390|NCT02750514|4016448|FG002|Track 5|Other reasons|0
2311391|NCT02750514|4016449|FG003|Track 5|Other reasons|0
2311392|NCT02750514|4016450|FG004|Track 5|Other reasons|2
2311393|NCT02750592|4016470|FG000|Overall Study|Adverse Event|3
2311394|NCT02750592|4016470|FG000|Overall Study|Lack of Efficacy|2
2311395|NCT02750618|4016474|FG000|Overall Study|Withdrawal by Subject|1
2311396|NCT02750709|4016478|FG000|Treatment Period 1|Adverse Event|0
2311397|NCT02750709|4016479|FG001|Treatment Period 1|Adverse Event|0
2311398|NCT02750709|4016480|FG002|Treatment Period 1|Adverse Event|0
2311399|NCT02750709|4016481|FG003|Treatment Period 1|Adverse Event|0
2311400|NCT02750709|4016482|FG004|Treatment Period 1|Adverse Event|0
2311401|NCT02750709|4016483|FG005|Treatment Period 1|Adverse Event|1
2311402|NCT02750761|4016497|FG000|Overall Study|Lost to Follow-up|0
2311403|NCT02750761|4016498|FG001|Overall Study|Lost to Follow-up|0
2311404|NCT02750761|4016499|FG002|Overall Study|Lost to Follow-up|1
2311405|NCT02750761|4016500|FG003|Overall Study|Lost to Follow-up|0
2311406|NCT02750761|4016501|FG004|Overall Study|Lost to Follow-up|0
2311407|NCT02750761|4016502|FG005|Overall Study|Lost to Follow-up|0
2311408|NCT02750800|4016526|FG000|Overall Study|Adverse Event|18
2311409|NCT02750800|4016526|FG000|Overall Study|Lost to Follow-up|12
2311410|NCT02750800|4016526|FG000|Overall Study|Investigator decision|53
2311411|NCT02750800|4016526|FG000|Overall Study|Patient request|12
2311412|NCT02750800|4016526|FG000|Overall Study|Other, not specified|3
2311413|NCT02750813|4016544|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
2311414|NCT02750813|4016545|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
2311415|NCT02750813|4016544|FG000|Period 1, First 14 Days of Wear|Reason not given|0
2311416|NCT02750813|4016545|FG001|Period 1, First 14 Days of Wear|Reason not given|1
2311417|NCT02750930|4016552|FG000|Overall Study|Study closed/terminated|8
2311418|NCT02750943|4016558|FG000|Overall Study|Lost to Follow-up|1
2311419|NCT02750943|4016559|FG001|Overall Study|Lost to Follow-up|2
2311420|NCT02750943|4016558|FG000|Overall Study|Withdrawal by Subject|5
2311421|NCT02750943|4016559|FG001|Overall Study|Withdrawal by Subject|7
2311422|NCT02751320|4016565|FG000|Overall Study|Adverse Event|2
2311423|NCT02751320|4016565|FG000|Overall Study|Withdrawal by Subject|1
2311424|NCT02751359|4016590|FG000|Overall Study|Lost to Follow-up|1
2311425|NCT02751424|4016618|FG000|Part 2|Adverse Event|0
2311426|NCT02751424|4016619|FG001|Part 2|Adverse Event|0
2311427|NCT02751424|4016620|FG002|Part 2|Adverse Event|0
2311428|NCT02751424|4016621|FG003|Part 2|Adverse Event|0
2311429|NCT02751424|4016622|FG004|Part 2|Adverse Event|0
2311430|NCT02751424|4016623|FG005|Part 2|Adverse Event|0
2311431|NCT02751424|4016624|FG006|Part 2|Adverse Event|0
2311432|NCT02751424|4016625|FG007|Part 2|Adverse Event|5
2311433|NCT02751424|4016626|FG008|Part 2|Adverse Event|0
2311434|NCT02751450|4016651|FG000|Overall Study|Adverse Event|1
2311435|NCT02751450|4016652|FG001|Overall Study|Adverse Event|0
2311436|NCT02751580|4016660|FG000|Overall Study|Lost to Follow-up|4
2311437|NCT02751580|4016660|FG000|Overall Study|Death|2
2311438|NCT02751827|4016667|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
2311439|NCT02751827|4016668|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
2311440|NCT02751827|4016669|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1
2311441|NCT02751931|4016691|FG000|Overall Study|Adverse Event|3
2311442|NCT02751931|4016692|FG001|Overall Study|Adverse Event|0
2311443|NCT02751931|4016691|FG000|Overall Study|Other: Miscelleneous|10
2311444|NCT02751931|4016692|FG001|Overall Study|Other: Miscelleneous|8
2311445|NCT02751983|4016706|FG000|Treatment|Stopped ACT, but Remained in study|2
2311446|NCT02751983|4016707|FG001|Treatment|Stopped ACT, but Remained in study|0
2321929|NCT02965456|4036546|FG001|Overall Study|Subject Request|13
1986125|NCT02510040|3551595|FG000|Overall Study|Deemed no longer eligible|18
1986126|NCT02510040|3551596|FG001|Overall Study|Deemed no longer eligible|3
2311447|NCT02751983|4016706|FG000|Treatment|Discharged prior to beginning ACT|2
2311448|NCT02751983|4016707|FG001|Treatment|Discharged prior to beginning ACT|0
2311449|NCT02751983|4016706|FG000|Post-Treatment Assessment|Lost to Follow-up|5
2311450|NCT02751983|4016707|FG001|Post-Treatment Assessment|Lost to Follow-up|0
2311451|NCT02751983|4016706|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14
2311452|NCT02751983|4016707|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12
2311453|NCT02751983|4016706|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12
2311454|NCT02751983|4016707|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16
2311455|NCT02752048|4016716|FG000|Overall Study|Withdrawal by Subject|0
2311456|NCT02752048|4016717|FG001|Overall Study|Withdrawal by Subject|0
2311457|NCT02752048|4016718|FG002|Overall Study|Withdrawal by Subject|3
2311458|NCT02752074|4016728|FG000|Overall Study|Lost to Follow-up|1
2311459|NCT02752074|4016729|FG001|Overall Study|Lost to Follow-up|4
2311460|NCT02752074|4016728|FG000|Overall Study|Death|146
2311461|NCT02752074|4016729|FG001|Overall Study|Death|129
2311462|NCT02752074|4016728|FG000|Overall Study|Withdrawal by Subject|9
2311463|NCT02752074|4016729|FG001|Overall Study|Withdrawal by Subject|10
2311464|NCT02752087|4016735|FG000|Washout|Physician Decision|1
2311465|NCT02752087|4016736|FG001|Washout|Physician Decision|0
2311466|NCT02752633|4016760|FG000|Overall Study|Withdrawal by Subject|1
2311467|NCT02752776|4016767|FG000|Overall Study|Adverse Event|15
2311468|NCT02752776|4016768|FG001|Overall Study|Adverse Event|23
2311469|NCT02752776|4016769|FG002|Overall Study|Adverse Event|11
2311470|NCT02752776|4016767|FG000|Overall Study|Lack of Efficacy|2
2311471|NCT02752776|4016768|FG001|Overall Study|Lack of Efficacy|6
2311472|NCT02752776|4016769|FG002|Overall Study|Lack of Efficacy|14
2311473|NCT02752776|4016767|FG000|Overall Study|Lost to Follow-up|11
2311474|NCT02752776|4016768|FG001|Overall Study|Lost to Follow-up|12
2311475|NCT02752776|4016769|FG002|Overall Study|Lost to Follow-up|4
2311476|NCT02752776|4016767|FG000|Overall Study|Non-compliance with study treatment|0
2311477|NCT02752776|4016768|FG001|Overall Study|Non-compliance with study treatment|0
2311478|NCT02752776|4016769|FG002|Overall Study|Non-compliance with study treatment|1
2311479|NCT02752776|4016767|FG000|Overall Study|Physician Decision|2
2311480|NCT02752776|4016768|FG001|Overall Study|Physician Decision|6
2311481|NCT02752776|4016769|FG002|Overall Study|Physician Decision|2
2311482|NCT02752776|4016767|FG000|Overall Study|Pregnancy|1
2311483|NCT02752776|4016768|FG001|Overall Study|Pregnancy|6
2311484|NCT02752776|4016769|FG002|Overall Study|Pregnancy|3
2311485|NCT02752776|4016767|FG000|Overall Study|Protocol Violation|10
2311486|NCT02752776|4016768|FG001|Overall Study|Protocol Violation|13
2311487|NCT02752776|4016769|FG002|Overall Study|Protocol Violation|6
2311488|NCT02752776|4016767|FG000|Overall Study|Subject/guardian decision|8
2311489|NCT02752776|4016768|FG001|Overall Study|Subject/guardian decision|6
2311490|NCT02752776|4016769|FG002|Overall Study|Subject/guardian decision|4
2311491|NCT02752776|4016767|FG000|Overall Study|Death|0
2311492|NCT02752776|4016768|FG001|Overall Study|Death|0
2311493|NCT02752776|4016769|FG002|Overall Study|Death|1
2311494|NCT02752776|4016767|FG000|Overall Study|Withdrawal by Subject|3
2311495|NCT02752776|4016768|FG001|Overall Study|Withdrawal by Subject|4
2311496|NCT02752776|4016769|FG002|Overall Study|Withdrawal by Subject|2
2311497|NCT02752802|4016781|FG000|Overall Study|Contrast Volume Not Collected|1
2311498|NCT02752802|4016782|FG001|Overall Study|Contrast Volume Not Collected|0
2311499|NCT02752906|4016802|FG000|Overall Study|Protocol Violation|2
2311500|NCT02752906|4016803|FG001|Overall Study|Protocol Violation|1
2311501|NCT02752906|4016802|FG000|Overall Study|Withdrawal by Subject|2
2311502|NCT02752906|4016803|FG001|Overall Study|Withdrawal by Subject|2
2311503|NCT02752906|4016802|FG000|Overall Study|Lost to Follow-up|3
2311504|NCT02752906|4016803|FG001|Overall Study|Lost to Follow-up|2
2311505|NCT02752958|4016809|FG000|Overall Study|Adverse Event|3
2311506|NCT02752958|4016809|FG000|Overall Study|Lost to Follow-up|1
2311507|NCT02752958|4016809|FG000|Overall Study|Protocol Violation|1
2311508|NCT02752958|4016809|FG000|Overall Study|Withdrawal by Subject|2
2311509|NCT02752958|4016809|FG000|Overall Study|Other (Reason not specified)|2
2311510|NCT02753075|4016818|FG000|Overall Study|Adverse Event|2
2311511|NCT02753075|4016819|FG001|Overall Study|Adverse Event|1
2311512|NCT02753075|4016820|FG002|Overall Study|Adverse Event|0
2311513|NCT02753075|4016818|FG000|Overall Study|Lost to Follow-up|2
2311514|NCT02753075|4016819|FG001|Overall Study|Lost to Follow-up|0
2311515|NCT02753075|4016820|FG002|Overall Study|Lost to Follow-up|0
2311516|NCT02753075|4016818|FG000|Overall Study|Withdrawal of Consent|1
2311517|NCT02753075|4016819|FG001|Overall Study|Withdrawal of Consent|1
2311518|NCT02753075|4016820|FG002|Overall Study|Withdrawal of Consent|3
2311519|NCT02753075|4016818|FG000|Overall Study|Physician Decision|3
2311520|NCT02753075|4016819|FG001|Overall Study|Physician Decision|1
2311521|NCT02753075|4016820|FG002|Overall Study|Physician Decision|0
2311522|NCT02753400|4016831|FG000|Overall Study|Adverse Event|3
2311523|NCT02753400|4016832|FG001|Overall Study|Adverse Event|0
2311524|NCT02753400|4016831|FG000|Overall Study|Withdrawal by Subject|2
2311525|NCT02753400|4016832|FG001|Overall Study|Withdrawal by Subject|1
2311526|NCT02753595|4016849|FG000|Overall Study|Sponsor termination|2
2311527|NCT02753595|4016850|FG001|Overall Study|Sponsor termination|2
2311528|NCT02753816|4016873|FG000|Overall Study|Protocol Violation|0
2311529|NCT02753816|4016874|FG001|Overall Study|Protocol Violation|1
2311530|NCT02753816|4016875|FG002|Overall Study|Protocol Violation|0
1986127|NCT02510040|3551597|FG002|Overall Study|Deemed no longer eligible|1
1986128|NCT02499328|3551625|FG000|Overall Study|Withdrawal by Subject|1
2311531|NCT02753946|4016934|FG000|Overall Study|Adverse Event|7
2311532|NCT02753946|4016935|FG001|Overall Study|Adverse Event|6
2311533|NCT02753946|4016934|FG000|Overall Study|Withdrawal by Subject|6
2311534|NCT02753946|4016935|FG001|Overall Study|Withdrawal by Subject|1
2311535|NCT02753946|4016934|FG000|Overall Study|Lack of Efficacy|1
2311536|NCT02753946|4016935|FG001|Overall Study|Lack of Efficacy|0
2311537|NCT02753946|4016934|FG000|Overall Study|Physician Decision|0
2311538|NCT02753946|4016935|FG001|Overall Study|Physician Decision|2
2311539|NCT02754440|4016963|FG000|Overall Study|Protocol Violation|3
2311540|NCT02754440|4016964|FG001|Overall Study|Protocol Violation|2
2311541|NCT02754440|4016965|FG002|Overall Study|Protocol Violation|2
2311542|NCT02754440|4016966|FG003|Overall Study|Protocol Violation|6
2311543|NCT02754440|4016963|FG000|Overall Study|Adverse Event|3
2311544|NCT02754440|4016964|FG001|Overall Study|Adverse Event|1
2311545|NCT02754440|4016965|FG002|Overall Study|Adverse Event|0
2311546|NCT02754440|4016966|FG003|Overall Study|Adverse Event|9
2311547|NCT02754440|4016963|FG000|Overall Study|Withdrawal by Subject|0
2311548|NCT02754440|4016964|FG001|Overall Study|Withdrawal by Subject|0
2311549|NCT02754440|4016965|FG002|Overall Study|Withdrawal by Subject|0
2311550|NCT02754440|4016966|FG003|Overall Study|Withdrawal by Subject|1
2311551|NCT02754440|4016963|FG000|Overall Study|Equipment failure|0
2311552|NCT02754440|4016964|FG001|Overall Study|Equipment failure|5
2311553|NCT02754440|4016965|FG002|Overall Study|Equipment failure|5
2311554|NCT02754440|4016966|FG003|Overall Study|Equipment failure|7
2311555|NCT02754440|4016963|FG000|Overall Study|Subject issues not resulting in AE|0
2311556|NCT02754440|4016964|FG001|Overall Study|Subject issues not resulting in AE|0
2311557|NCT02754440|4016965|FG002|Overall Study|Subject issues not resulting in AE|0
2311558|NCT02754440|4016966|FG003|Overall Study|Subject issues not resulting in AE|12
2311559|NCT02754492|4016979|FG000|Overall Study|Protocol Violation|2
2311560|NCT02754492|4016980|FG001|Overall Study|Protocol Violation|2
2311561|NCT02754492|4016981|FG002|Overall Study|Protocol Violation|0
2311562|NCT02754492|4016982|FG003|Overall Study|Protocol Violation|1
2311563|NCT02754492|4016979|FG000|Overall Study|Withdrawal by Subject|2
2311564|NCT02754492|4016980|FG001|Overall Study|Withdrawal by Subject|0
2311565|NCT02754492|4016981|FG002|Overall Study|Withdrawal by Subject|0
2311566|NCT02754492|4016982|FG003|Overall Study|Withdrawal by Subject|0
2311567|NCT02754492|4016979|FG000|Overall Study|Equipment malfuntion|0
2311568|NCT02754492|4016980|FG001|Overall Study|Equipment malfuntion|0
2311569|NCT02754492|4016981|FG002|Overall Study|Equipment malfuntion|2
2311570|NCT02754492|4016982|FG003|Overall Study|Equipment malfuntion|5
2311571|NCT02754492|4016979|FG000|Overall Study|Adverse Event|0
2311572|NCT02754492|4016980|FG001|Overall Study|Adverse Event|0
2311573|NCT02754492|4016981|FG002|Overall Study|Adverse Event|0
2311574|NCT02754492|4016982|FG003|Overall Study|Adverse Event|13
2311575|NCT02754492|4016979|FG000|Overall Study|Venous access issues not resulting in AE|0
2311576|NCT02754492|4016980|FG001|Overall Study|Venous access issues not resulting in AE|0
2311577|NCT02754492|4016981|FG002|Overall Study|Venous access issues not resulting in AE|0
2311578|NCT02754492|4016982|FG003|Overall Study|Venous access issues not resulting in AE|4
2311579|NCT02755090|4017023|FG000|Overall Study|equipment malfunction|1
2311580|NCT02755090|4017024|FG001|Overall Study|equipment malfunction|0
2311581|NCT02755116|4017032|FG000|Overall Study|surgery converted to open, pt admitted|3
2311582|NCT02755116|4017033|FG001|Overall Study|surgery converted to open, pt admitted|1
2311583|NCT02755649|4017053|FG000|Overall Study|Transitioned into OLE study|99
2311584|NCT02755649|4017054|FG001|Overall Study|Transitioned into OLE study|98
2311585|NCT02755649|4017055|FG002|Overall Study|Transitioned into OLE study|100
2311586|NCT02755649|4017053|FG000|Overall Study|Did Not Complete Follow-up Visits|1
2311587|NCT02755649|4017054|FG001|Overall Study|Did Not Complete Follow-up Visits|0
2311588|NCT02755649|4017055|FG002|Overall Study|Did Not Complete Follow-up Visits|0
2311589|NCT02755649|4017053|FG000|Overall Study|Physician Decision|0
2311590|NCT02755649|4017054|FG001|Overall Study|Physician Decision|0
2311591|NCT02755649|4017055|FG002|Overall Study|Physician Decision|2
2311592|NCT02755649|4017053|FG000|Overall Study|Withdrawal by Subject|0
2311593|NCT02755649|4017054|FG001|Overall Study|Withdrawal by Subject|1
2311594|NCT02755649|4017055|FG002|Overall Study|Withdrawal by Subject|0
2311595|NCT02755649|4017053|FG000|Overall Study|Undecided|1
2311596|NCT02755649|4017054|FG001|Overall Study|Undecided|0
2311597|NCT02755649|4017055|FG002|Overall Study|Undecided|0
2311598|NCT02755805|4017065|FG000|Overall Study|Lost to Follow-up|1
2311599|NCT02755805|4017066|FG001|Overall Study|Lost to Follow-up|2
2311600|NCT02755805|4017065|FG000|Overall Study|Refused assessments|1
2311601|NCT02755805|4017066|FG001|Overall Study|Refused assessments|0
2311602|NCT02755805|4017065|FG000|Overall Study|Withdrawal by Subject|0
2311603|NCT02755805|4017066|FG001|Overall Study|Withdrawal by Subject|2
2311604|NCT02755818|4017076|FG000|Overall Study|Withdrawal by Subject|0
2311605|NCT02755818|4017077|FG001|Overall Study|Withdrawal by Subject|0
2311606|NCT02755818|4017078|FG002|Overall Study|Withdrawal by Subject|0
2311607|NCT02755818|4017079|FG003|Overall Study|Withdrawal by Subject|2
2311608|NCT02755818|4017076|FG000|Overall Study|withdrawal by PI|0
2311609|NCT02755818|4017077|FG001|Overall Study|withdrawal by PI|0
2311610|NCT02755818|4017078|FG002|Overall Study|withdrawal by PI|1
2311611|NCT02755818|4017079|FG003|Overall Study|withdrawal by PI|1
1986129|NCT02499328|3551626|FG001|Overall Study|Withdrawal by Subject|1
1986130|NCT02499328|3551627|FG002|Overall Study|Withdrawal by Subject|5
1986131|NCT02499328|3551628|FG003|Overall Study|Withdrawal by Subject|3
1986132|NCT02499328|3551629|FG004|Overall Study|Withdrawal by Subject|5
1986133|NCT02499328|3551630|FG005|Overall Study|Withdrawal by Subject|0
1986134|NCT02499328|3551631|FG006|Overall Study|Withdrawal by Subject|0
1986135|NCT02499328|3551632|FG007|Overall Study|Withdrawal by Subject|0
1986136|NCT02499328|3551633|FG008|Overall Study|Withdrawal by Subject|2
1986137|NCT02499328|3551634|FG009|Overall Study|Withdrawal by Subject|2
1986138|NCT02499328|3551635|FG010|Overall Study|Withdrawal by Subject|0
1986139|NCT02499328|3551636|FG011|Overall Study|Withdrawal by Subject|3
1986140|NCT02499328|3551637|FG012|Overall Study|Withdrawal by Subject|7
1986141|NCT02499328|3551638|FG013|Overall Study|Withdrawal by Subject|3
1986142|NCT02499328|3551639|FG014|Overall Study|Withdrawal by Subject|1
1986143|NCT02499328|3551640|FG015|Overall Study|Withdrawal by Subject|0
1986144|NCT02499328|3551641|FG016|Overall Study|Withdrawal by Subject|0
1986145|NCT02499328|3551642|FG017|Overall Study|Withdrawal by Subject|3
1986146|NCT02499328|3551643|FG018|Overall Study|Withdrawal by Subject|0
1986147|NCT02499328|3551625|FG000|Overall Study|Lost to Follow-up|0
1986148|NCT02499328|3551626|FG001|Overall Study|Lost to Follow-up|1
1986149|NCT02499328|3551627|FG002|Overall Study|Lost to Follow-up|1
1986150|NCT02499328|3551628|FG003|Overall Study|Lost to Follow-up|2
1986151|NCT02499328|3551629|FG004|Overall Study|Lost to Follow-up|0
1986152|NCT02499328|3551630|FG005|Overall Study|Lost to Follow-up|0
1986153|NCT02499328|3551631|FG006|Overall Study|Lost to Follow-up|0
1986154|NCT02499328|3551632|FG007|Overall Study|Lost to Follow-up|2
1986155|NCT02499328|3551633|FG008|Overall Study|Lost to Follow-up|3
1986156|NCT02499328|3551634|FG009|Overall Study|Lost to Follow-up|0
1986157|NCT02499328|3551635|FG010|Overall Study|Lost to Follow-up|0
1986158|NCT02499328|3551636|FG011|Overall Study|Lost to Follow-up|0
1986159|NCT02499328|3551637|FG012|Overall Study|Lost to Follow-up|0
1986160|NCT02499328|3551638|FG013|Overall Study|Lost to Follow-up|0
1986161|NCT02499328|3551639|FG014|Overall Study|Lost to Follow-up|0
1986162|NCT02499328|3551640|FG015|Overall Study|Lost to Follow-up|0
2311612|NCT02755831|4017093|FG000|Overall Study|Lost to Follow-up|3
2311613|NCT02755831|4017094|FG001|Overall Study|Lost to Follow-up|3
2311614|NCT02756013|4017104|FG000|Overall Study|Adverse Event|1
2311615|NCT02756013|4017104|FG000|Overall Study|Hypersensitivity|1
2311616|NCT02756078|4017108|FG000|Period 1|Unsatisfactory Lens Fitting|0
2311617|NCT02756078|4017109|FG001|Period 1|Unsatisfactory Lens Fitting|1
2311618|NCT02756078|4017108|FG000|Period 1|Lost to Follow-up|0
2311619|NCT02756078|4017109|FG001|Period 1|Lost to Follow-up|2
2311620|NCT02756078|4017108|FG000|Period 1|Protocol Violation|0
2311621|NCT02756078|4017109|FG001|Period 1|Protocol Violation|1
2311622|NCT02756078|4017108|FG000|Period 1|Adverse Event|1
2311623|NCT02756078|4017109|FG001|Period 1|Adverse Event|10
2311624|NCT02756078|4017108|FG000|Period 1|Withdrawal by Subject|6
2311625|NCT02756078|4017109|FG001|Period 1|Withdrawal by Subject|6
2311626|NCT02756078|4017108|FG000|Period 1|Lens Discomfort|2
2311627|NCT02756078|4017109|FG001|Period 1|Lens Discomfort|2
2311628|NCT02756078|4017108|FG000|Period 2|Adverse Event|3
2311629|NCT02756078|4017109|FG001|Period 2|Adverse Event|5
2311630|NCT02756078|4017108|FG000|Period 2|Unsatisfactory Lens Fitting|0
2311631|NCT02756078|4017109|FG001|Period 2|Unsatisfactory Lens Fitting|1
2311632|NCT02756078|4017108|FG000|Period 2|Withdrawal by Subject|3
2311633|NCT02756078|4017109|FG001|Period 2|Withdrawal by Subject|1
2311634|NCT02756182|4017115|FG000|Overall Study|StudyTechnical Difficulties|4
2311635|NCT02756338|4017121|FG000|Overall Study|Withdrawn by Investigator|1
2311636|NCT02756338|4017121|FG000|Overall Study|Device Replaced with Pacemaker|4
2311637|NCT02756364|4017137|FG000|Overall Study|Site Terminated by Sponsor|24
2311638|NCT02756364|4017138|FG001|Overall Study|Site Terminated by Sponsor|30
2311639|NCT02756364|4017139|FG002|Overall Study|Site Terminated by Sponsor|21
2311640|NCT02756364|4017137|FG000|Overall Study|Death|20
2311641|NCT02756364|4017138|FG001|Overall Study|Death|15
2311642|NCT02756364|4017139|FG002|Overall Study|Death|18
2311643|NCT02756364|4017137|FG000|Overall Study|Withdrawal by Patient|2
2311644|NCT02756364|4017138|FG001|Overall Study|Withdrawal by Patient|1
2311645|NCT02756364|4017139|FG002|Overall Study|Withdrawal by Patient|8
2311646|NCT02756364|4017137|FG000|Overall Study|Lost to Follow-up|0
2311647|NCT02756364|4017138|FG001|Overall Study|Lost to Follow-up|1
2311648|NCT02756364|4017139|FG002|Overall Study|Lost to Follow-up|1
2311649|NCT02756611|4017156|FG000|Overall Study|Death|39
2311650|NCT02756611|4017156|FG000|Overall Study|Withdrawal by Subject|1
1986163|NCT02499328|3551641|FG016|Overall Study|Lost to Follow-up|0
1986164|NCT02499328|3551642|FG017|Overall Study|Lost to Follow-up|0
1986165|NCT02499328|3551643|FG018|Overall Study|Lost to Follow-up|1
1986166|NCT02499328|3551625|FG000|Overall Study|Death|0
1986167|NCT02499328|3551626|FG001|Overall Study|Death|3
2311651|NCT02756611|4017156|FG000|Overall Study|Lost to Follow-up|2
2311652|NCT02756611|4017156|FG000|Overall Study|Other|7
2311653|NCT02756611|4017156|FG000|Overall Study|Missing|2
2311654|NCT02756611|4017156|FG000|Overall Study|Active on Study|205
2311655|NCT02756637|4017171|FG000|Overall Study|Not eligible for initial SWOG study|10
2311656|NCT02756637|4017172|FG001|Overall Study|Not eligible for initial SWOG study|10
2311657|NCT02756637|4017171|FG000|Overall Study|No available NLR value|44
2311658|NCT02756637|4017172|FG001|Overall Study|No available NLR value|44
1986168|NCT02499328|3551627|FG002|Overall Study|Death|3
1986169|NCT02499328|3551628|FG003|Overall Study|Death|2
1986170|NCT02499328|3551629|FG004|Overall Study|Death|4
1986171|NCT02499328|3551630|FG005|Overall Study|Death|7
1986172|NCT02499328|3551631|FG006|Overall Study|Death|3
1986173|NCT02499328|3551632|FG007|Overall Study|Death|0
1986174|NCT02499328|3551633|FG008|Overall Study|Death|2
1986175|NCT02499328|3551634|FG009|Overall Study|Death|6
1986176|NCT02499328|3551635|FG010|Overall Study|Death|6
1986177|NCT02499328|3551636|FG011|Overall Study|Death|20
1986178|NCT02499328|3551637|FG012|Overall Study|Death|9
1986179|NCT02499328|3551638|FG013|Overall Study|Death|7
1986180|NCT02499328|3551639|FG014|Overall Study|Death|3
1986181|NCT02499328|3551640|FG015|Overall Study|Death|1
1986182|NCT02499328|3551641|FG016|Overall Study|Death|1
1986183|NCT02499328|3551642|FG017|Overall Study|Death|16
1986184|NCT02499328|3551643|FG018|Overall Study|Death|5
1986185|NCT02499328|3551625|FG000|Overall Study|"Other"|2
1986186|NCT02499328|3551626|FG001|Overall Study|"Other"|2
1986187|NCT02499328|3551627|FG002|Overall Study|"Other"|1
2311659|NCT02756637|4017171|FG000|Overall Study|Did not complete curative therapy|33
2311660|NCT02756637|4017172|FG001|Overall Study|Did not complete curative therapy|0
2311661|NCT02756650|4017178|FG000|Overall Study|Physician Decision|1
2311662|NCT02756650|4017178|FG000|Overall Study|Adverse Event|1
2311663|NCT02756819|4017225|FG000|Overall Study|Lost for observation|23
2311664|NCT02756819|4017225|FG000|Overall Study|Patient's unwillingness|16
2311665|NCT02756819|4017225|FG000|Overall Study|Insufficient efficacy|2
2311666|NCT02756819|4017225|FG000|Overall Study|Adverse Event|2
2311667|NCT02756819|4017225|FG000|Overall Study|Reason not Specified|9
2311668|NCT02756832|4017229|FG000|Overall Study|Lost for Observation after Baseline|6
2311669|NCT02756832|4017229|FG000|Overall Study|Lost for Observation|13
2311670|NCT02756832|4017229|FG000|Overall Study|Patient's Unwillingness|12
2311671|NCT02756832|4017229|FG000|Overall Study|Insufficient Efficacy|2
2311672|NCT02756832|4017229|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1
2311673|NCT02756832|4017229|FG000|Overall Study|Reason not Specified|9
2311674|NCT02756832|4017229|FG000|Overall Study|Protocol Deviation|10
2311675|NCT02757352|4017343|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
2311676|NCT02757352|4017344|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2311677|NCT02757352|4017345|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
2311678|NCT02757352|4017346|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2311679|NCT02757352|4017347|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2311680|NCT02757352|4017348|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2311681|NCT02757352|4017349|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2311682|NCT02757352|4017350|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2311683|NCT02757352|4017351|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2311684|NCT02757352|4017352|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2311685|NCT02757352|4017343|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2311686|NCT02757352|4017344|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2311687|NCT02757352|4017345|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
2311688|NCT02757352|4017346|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2311689|NCT02757352|4017347|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2311690|NCT02757352|4017348|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2311691|NCT02757352|4017349|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2311692|NCT02757352|4017350|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2311693|NCT02757352|4017351|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2311694|NCT02757352|4017352|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2311695|NCT02757352|4017343|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
2311696|NCT02757352|4017344|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
2311697|NCT02757352|4017345|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
2311698|NCT02757352|4017346|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2311699|NCT02757352|4017347|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2311700|NCT02757352|4017348|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2311701|NCT02757352|4017349|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2311702|NCT02757352|4017350|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2311703|NCT02757352|4017351|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2311704|NCT02757352|4017352|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2311705|NCT02757352|4017343|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2311706|NCT02757352|4017344|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
2311707|NCT02757352|4017345|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2311708|NCT02757352|4017346|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2311709|NCT02757352|4017347|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2311710|NCT02757352|4017348|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2311711|NCT02757352|4017349|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2311712|NCT02757352|4017350|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
1986188|NCT02499328|3551628|FG003|Overall Study|"Other"|3
1986189|NCT02499328|3551629|FG004|Overall Study|"Other"|6
1986190|NCT02499328|3551630|FG005|Overall Study|"Other"|2
1986191|NCT02499328|3551631|FG006|Overall Study|"Other"|3
1986192|NCT02499328|3551632|FG007|Overall Study|"Other"|4
1986193|NCT02499328|3551633|FG008|Overall Study|"Other"|6
1986194|NCT02499328|3551634|FG009|Overall Study|"Other"|16
1986195|NCT02499328|3551635|FG010|Overall Study|"Other"|13
1986196|NCT02499328|3551636|FG011|Overall Study|"Other"|31
1986197|NCT02499328|3551637|FG012|Overall Study|"Other"|8
1986198|NCT02499328|3551638|FG013|Overall Study|"Other"|7
1986199|NCT02499328|3551639|FG014|Overall Study|"Other"|6
1986200|NCT02499328|3551640|FG015|Overall Study|"Other"|0
1986201|NCT02499328|3551641|FG016|Overall Study|"Other"|0
1986202|NCT02499328|3551642|FG017|Overall Study|"Other"|34
1986203|NCT02499328|3551643|FG018|Overall Study|"Other"|43
1986204|NCT02499328|3551625|FG000|Overall Study|Disease Progression|0
1986205|NCT02499328|3551626|FG001|Overall Study|Disease Progression|0
1986206|NCT02499328|3551627|FG002|Overall Study|Disease Progression|0
1986207|NCT02499328|3551628|FG003|Overall Study|Disease Progression|0
1986208|NCT02499328|3551629|FG004|Overall Study|Disease Progression|0
1986209|NCT02499328|3551630|FG005|Overall Study|Disease Progression|0
1986210|NCT02499328|3551631|FG006|Overall Study|Disease Progression|1
1986211|NCT02499328|3551632|FG007|Overall Study|Disease Progression|0
1986212|NCT02499328|3551633|FG008|Overall Study|Disease Progression|1
1986213|NCT02499328|3551634|FG009|Overall Study|Disease Progression|0
1986214|NCT02499328|3551635|FG010|Overall Study|Disease Progression|1
1986215|NCT02499328|3551636|FG011|Overall Study|Disease Progression|0
1986216|NCT02499328|3551637|FG012|Overall Study|Disease Progression|0
1986217|NCT02499328|3551638|FG013|Overall Study|Disease Progression|0
1986218|NCT02499328|3551639|FG014|Overall Study|Disease Progression|0
1986219|NCT02499328|3551640|FG015|Overall Study|Disease Progression|0
1986220|NCT02499328|3551641|FG016|Overall Study|Disease Progression|0
1986221|NCT02499328|3551642|FG017|Overall Study|Disease Progression|2
1986222|NCT02499328|3551643|FG018|Overall Study|Disease Progression|0
1986223|NCT02499328|3551625|FG000|Overall Study|Adverse Event|1
1986224|NCT02499328|3551626|FG001|Overall Study|Adverse Event|0
1986225|NCT02499328|3551627|FG002|Overall Study|Adverse Event|0
1986226|NCT02499328|3551628|FG003|Overall Study|Adverse Event|1
1986227|NCT02499328|3551629|FG004|Overall Study|Adverse Event|0
1986228|NCT02499328|3551630|FG005|Overall Study|Adverse Event|0
1986229|NCT02499328|3551631|FG006|Overall Study|Adverse Event|0
1986230|NCT02499328|3551632|FG007|Overall Study|Adverse Event|0
1986231|NCT02499328|3551633|FG008|Overall Study|Adverse Event|0
1986232|NCT02499328|3551634|FG009|Overall Study|Adverse Event|0
1986233|NCT02499328|3551635|FG010|Overall Study|Adverse Event|0
1986234|NCT02499328|3551636|FG011|Overall Study|Adverse Event|0
1986235|NCT02499328|3551637|FG012|Overall Study|Adverse Event|1
1986236|NCT02499328|3551638|FG013|Overall Study|Adverse Event|0
1986237|NCT02499328|3551639|FG014|Overall Study|Adverse Event|0
1986238|NCT02499328|3551640|FG015|Overall Study|Adverse Event|0
1986239|NCT02499328|3551641|FG016|Overall Study|Adverse Event|0
1986240|NCT02499328|3551642|FG017|Overall Study|Adverse Event|0
1986241|NCT02499328|3551643|FG018|Overall Study|Adverse Event|0
1986242|NCT02460224|3551764|FG000|Overall Study|Adverse Event|0
1986243|NCT02460224|3551765|FG001|Overall Study|Adverse Event|0
1986244|NCT02460224|3551766|FG002|Overall Study|Adverse Event|0
1986245|NCT02460224|3551767|FG003|Overall Study|Adverse Event|0
1986246|NCT02460224|3551768|FG004|Overall Study|Adverse Event|0
1986247|NCT02460224|3551769|FG005|Overall Study|Adverse Event|0
1986248|NCT02460224|3551770|FG006|Overall Study|Adverse Event|1
1986249|NCT02460224|3551771|FG007|Overall Study|Adverse Event|0
1986250|NCT02460224|3551772|FG008|Overall Study|Adverse Event|0
1986251|NCT02460224|3551773|FG009|Overall Study|Adverse Event|0
1986252|NCT02460224|3551774|FG010|Overall Study|Adverse Event|0
1986253|NCT02460224|3551775|FG011|Overall Study|Adverse Event|0
1986254|NCT02460224|3551776|FG012|Overall Study|Adverse Event|1
1986255|NCT02460224|3551777|FG013|Overall Study|Adverse Event|0
1986256|NCT02460224|3551778|FG014|Overall Study|Adverse Event|0
1986257|NCT02460224|3551779|FG015|Overall Study|Adverse Event|0
1986258|NCT02460224|3551780|FG016|Overall Study|Adverse Event|1
1986259|NCT02460224|3551781|FG017|Overall Study|Adverse Event|0
1986260|NCT02460224|3551782|FG018|Overall Study|Adverse Event|1
1986261|NCT02460224|3551783|FG019|Overall Study|Adverse Event|0
1986262|NCT02460224|3551784|FG020|Overall Study|Adverse Event|1
1986263|NCT02460224|3551785|FG021|Overall Study|Adverse Event|1
1986264|NCT02460224|3551786|FG022|Overall Study|Adverse Event|1
1986265|NCT02460224|3551787|FG023|Overall Study|Adverse Event|0
1986266|NCT02460224|3551788|FG024|Overall Study|Adverse Event|0
1986267|NCT02460224|3551789|FG025|Overall Study|Adverse Event|0
1986268|NCT02460224|3551790|FG026|Overall Study|Adverse Event|11
1986269|NCT02460224|3551791|FG027|Overall Study|Adverse Event|1
1986270|NCT02460224|3551792|FG028|Overall Study|Adverse Event|6
1986271|NCT02460224|3551764|FG000|Overall Study|Death|0
1986272|NCT02460224|3551765|FG001|Overall Study|Death|0
1986273|NCT02460224|3551766|FG002|Overall Study|Death|0
1986274|NCT02460224|3551767|FG003|Overall Study|Death|0
1986275|NCT02460224|3551768|FG004|Overall Study|Death|0
1986276|NCT02460224|3551769|FG005|Overall Study|Death|2
1986277|NCT02460224|3551770|FG006|Overall Study|Death|1
1986278|NCT02460224|3551771|FG007|Overall Study|Death|0
1986279|NCT02460224|3551772|FG008|Overall Study|Death|0
1986280|NCT02460224|3551773|FG009|Overall Study|Death|1
1986281|NCT02460224|3551774|FG010|Overall Study|Death|0
1986282|NCT02460224|3551775|FG011|Overall Study|Death|0
1986283|NCT02460224|3551776|FG012|Overall Study|Death|0
1986284|NCT02460224|3551777|FG013|Overall Study|Death|1
1986285|NCT02460224|3551778|FG014|Overall Study|Death|0
1986286|NCT02460224|3551779|FG015|Overall Study|Death|0
1986287|NCT02460224|3551780|FG016|Overall Study|Death|2
1986288|NCT02460224|3551781|FG017|Overall Study|Death|1
1986289|NCT02460224|3551782|FG018|Overall Study|Death|0
1986290|NCT02460224|3551783|FG019|Overall Study|Death|2
1986291|NCT02460224|3551784|FG020|Overall Study|Death|0
1986292|NCT02460224|3551785|FG021|Overall Study|Death|0
1986293|NCT02460224|3551786|FG022|Overall Study|Death|0
2311713|NCT02757352|4017351|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2311714|NCT02757352|4017352|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2311715|NCT02757352|4017343|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2311716|NCT02757352|4017344|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
2311717|NCT02757352|4017345|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2311718|NCT02757352|4017346|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2311719|NCT02757352|4017347|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2311720|NCT02757352|4017348|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2311721|NCT02757352|4017349|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2311722|NCT02757352|4017350|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2311723|NCT02757352|4017351|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2311724|NCT02757352|4017352|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2311725|NCT02757352|4017343|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
2311726|NCT02757352|4017344|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
2311727|NCT02757352|4017345|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
2311728|NCT02757352|4017346|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311729|NCT02757352|4017347|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311730|NCT02757352|4017348|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311731|NCT02757352|4017349|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311732|NCT02757352|4017350|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311733|NCT02757352|4017351|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311734|NCT02757352|4017352|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311735|NCT02757352|4017343|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
2311736|NCT02757352|4017344|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
2311737|NCT02757352|4017345|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
2311738|NCT02757352|4017346|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2311739|NCT02757352|4017347|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2311740|NCT02757352|4017348|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2311741|NCT02757352|4017349|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2311742|NCT02757352|4017350|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2311743|NCT02757352|4017351|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2311744|NCT02757352|4017352|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2311745|NCT02757352|4017343|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2311746|NCT02757352|4017344|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2311747|NCT02757352|4017345|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2311748|NCT02757352|4017346|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
2311749|NCT02757352|4017347|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2311750|NCT02757352|4017348|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
2311751|NCT02757352|4017349|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2311752|NCT02757352|4017350|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2311753|NCT02757352|4017351|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2311754|NCT02757352|4017352|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2311755|NCT02757352|4017343|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2311756|NCT02757352|4017344|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2311757|NCT02757352|4017345|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2311758|NCT02757352|4017346|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
2311759|NCT02757352|4017347|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
2311760|NCT02757352|4017348|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
2311761|NCT02757352|4017349|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2311762|NCT02757352|4017350|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2311763|NCT02757352|4017351|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2311764|NCT02757352|4017352|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2311765|NCT02757352|4017343|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2311766|NCT02757352|4017344|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
1986294|NCT02460224|3551787|FG023|Overall Study|Death|0
1986295|NCT02460224|3551788|FG024|Overall Study|Death|1
1986296|NCT02460224|3551789|FG025|Overall Study|Death|1
1986297|NCT02460224|3551790|FG026|Overall Study|Death|5
1986298|NCT02460224|3551791|FG027|Overall Study|Death|0
1986299|NCT02460224|3551792|FG028|Overall Study|Death|1
1986300|NCT02460224|3551764|FG000|Overall Study|Lost to Follow-up|0
1986301|NCT02460224|3551765|FG001|Overall Study|Lost to Follow-up|0
1986302|NCT02460224|3551766|FG002|Overall Study|Lost to Follow-up|0
1986303|NCT02460224|3551767|FG003|Overall Study|Lost to Follow-up|0
1986304|NCT02460224|3551768|FG004|Overall Study|Lost to Follow-up|0
1986305|NCT02460224|3551769|FG005|Overall Study|Lost to Follow-up|0
1986306|NCT02460224|3551770|FG006|Overall Study|Lost to Follow-up|0
1986307|NCT02460224|3551771|FG007|Overall Study|Lost to Follow-up|0
1986308|NCT02460224|3551772|FG008|Overall Study|Lost to Follow-up|0
1986309|NCT02460224|3551773|FG009|Overall Study|Lost to Follow-up|0
1986310|NCT02460224|3551774|FG010|Overall Study|Lost to Follow-up|0
1986311|NCT02460224|3551775|FG011|Overall Study|Lost to Follow-up|0
1986312|NCT02460224|3551776|FG012|Overall Study|Lost to Follow-up|0
1986313|NCT02460224|3551777|FG013|Overall Study|Lost to Follow-up|0
1986314|NCT02460224|3551778|FG014|Overall Study|Lost to Follow-up|0
1986315|NCT02460224|3551779|FG015|Overall Study|Lost to Follow-up|0
1986316|NCT02460224|3551780|FG016|Overall Study|Lost to Follow-up|0
1986317|NCT02460224|3551781|FG017|Overall Study|Lost to Follow-up|0
1986318|NCT02460224|3551782|FG018|Overall Study|Lost to Follow-up|0
1986319|NCT02460224|3551783|FG019|Overall Study|Lost to Follow-up|0
1986320|NCT02460224|3551784|FG020|Overall Study|Lost to Follow-up|0
1986321|NCT02460224|3551785|FG021|Overall Study|Lost to Follow-up|0
1986322|NCT02460224|3551786|FG022|Overall Study|Lost to Follow-up|1
1986323|NCT02460224|3551787|FG023|Overall Study|Lost to Follow-up|0
1986324|NCT02460224|3551788|FG024|Overall Study|Lost to Follow-up|0
1986325|NCT02460224|3551789|FG025|Overall Study|Lost to Follow-up|0
1986326|NCT02460224|3551790|FG026|Overall Study|Lost to Follow-up|0
1986327|NCT02460224|3551791|FG027|Overall Study|Lost to Follow-up|0
1986328|NCT02460224|3551792|FG028|Overall Study|Lost to Follow-up|0
1986329|NCT02460224|3551764|FG000|Overall Study|Physician Decision|0
1986330|NCT02460224|3551765|FG001|Overall Study|Physician Decision|1
1986331|NCT02460224|3551766|FG002|Overall Study|Physician Decision|0
1986332|NCT02460224|3551767|FG003|Overall Study|Physician Decision|0
2311767|NCT02757352|4017345|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2311768|NCT02757352|4017346|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2311769|NCT02757352|4017347|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
2311770|NCT02757352|4017348|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2311771|NCT02757352|4017349|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2311772|NCT02757352|4017350|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2311773|NCT02757352|4017351|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2311774|NCT02757352|4017352|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2311775|NCT02757352|4017343|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2311776|NCT02757352|4017344|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2311777|NCT02757352|4017345|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2311778|NCT02757352|4017346|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2311779|NCT02757352|4017347|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2311780|NCT02757352|4017348|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
2311781|NCT02757352|4017349|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2311782|NCT02757352|4017350|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2311783|NCT02757352|4017351|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2311784|NCT02757352|4017352|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2311785|NCT02757352|4017343|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311786|NCT02757352|4017344|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311787|NCT02757352|4017345|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311788|NCT02757352|4017346|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
2311789|NCT02757352|4017347|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
2311790|NCT02757352|4017348|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
2311791|NCT02757352|4017349|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311792|NCT02757352|4017350|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311793|NCT02757352|4017351|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311794|NCT02757352|4017352|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2311795|NCT02757352|4017343|FG000|Follow-Up Period|Adverse Event|0
2311796|NCT02757352|4017344|FG001|Follow-Up Period|Adverse Event|0
2311797|NCT02757352|4017345|FG002|Follow-Up Period|Adverse Event|0
2311798|NCT02757352|4017346|FG003|Follow-Up Period|Adverse Event|0
2311799|NCT02757352|4017347|FG004|Follow-Up Period|Adverse Event|0
2311800|NCT02757352|4017348|FG005|Follow-Up Period|Adverse Event|0
2311801|NCT02757352|4017349|FG006|Follow-Up Period|Adverse Event|1
2311802|NCT02757352|4017350|FG007|Follow-Up Period|Adverse Event|0
2311803|NCT02757352|4017351|FG008|Follow-Up Period|Adverse Event|2
2311804|NCT02757352|4017352|FG009|Follow-Up Period|Adverse Event|0
2311805|NCT02757352|4017343|FG000|Follow-Up Period|Lost to Follow-up|0
1986333|NCT02460224|3551768|FG004|Overall Study|Physician Decision|1
1986334|NCT02460224|3551769|FG005|Overall Study|Physician Decision|0
1986335|NCT02460224|3551770|FG006|Overall Study|Physician Decision|0
1986336|NCT02460224|3551771|FG007|Overall Study|Physician Decision|1
1986337|NCT02460224|3551772|FG008|Overall Study|Physician Decision|0
1986338|NCT02460224|3551773|FG009|Overall Study|Physician Decision|0
1986339|NCT02460224|3551774|FG010|Overall Study|Physician Decision|0
1986340|NCT02460224|3551775|FG011|Overall Study|Physician Decision|1
1986341|NCT02460224|3551776|FG012|Overall Study|Physician Decision|0
1986342|NCT02460224|3551777|FG013|Overall Study|Physician Decision|1
1986343|NCT02460224|3551778|FG014|Overall Study|Physician Decision|0
1986344|NCT02460224|3551779|FG015|Overall Study|Physician Decision|0
1986345|NCT02460224|3551780|FG016|Overall Study|Physician Decision|2
1986346|NCT02460224|3551781|FG017|Overall Study|Physician Decision|1
1986347|NCT02460224|3551782|FG018|Overall Study|Physician Decision|1
1986348|NCT02460224|3551783|FG019|Overall Study|Physician Decision|2
1986349|NCT02460224|3551784|FG020|Overall Study|Physician Decision|1
1986350|NCT02460224|3551785|FG021|Overall Study|Physician Decision|1
1986351|NCT02460224|3551786|FG022|Overall Study|Physician Decision|0
1986352|NCT02460224|3551787|FG023|Overall Study|Physician Decision|0
1986353|NCT02460224|3551788|FG024|Overall Study|Physician Decision|1
1986354|NCT02460224|3551789|FG025|Overall Study|Physician Decision|0
1986355|NCT02460224|3551790|FG026|Overall Study|Physician Decision|14
1986356|NCT02460224|3551791|FG027|Overall Study|Physician Decision|1
1986357|NCT02460224|3551792|FG028|Overall Study|Physician Decision|6
1986358|NCT02460224|3551764|FG000|Overall Study|Progressive disease|15
1986359|NCT02460224|3551765|FG001|Overall Study|Progressive disease|11
1986360|NCT02460224|3551766|FG002|Overall Study|Progressive disease|5
1986361|NCT02460224|3551767|FG003|Overall Study|Progressive disease|6
1986362|NCT02460224|3551768|FG004|Overall Study|Progressive disease|3
1986363|NCT02460224|3551769|FG005|Overall Study|Progressive disease|26
1986364|NCT02460224|3551770|FG006|Overall Study|Progressive disease|28
1986365|NCT02460224|3551771|FG007|Overall Study|Progressive disease|4
1986366|NCT02460224|3551772|FG008|Overall Study|Progressive disease|5
1986367|NCT02460224|3551773|FG009|Overall Study|Progressive disease|9
1986368|NCT02460224|3551774|FG010|Overall Study|Progressive disease|5
1986369|NCT02460224|3551775|FG011|Overall Study|Progressive disease|4
1986370|NCT02460224|3551776|FG012|Overall Study|Progressive disease|5
1986371|NCT02460224|3551777|FG013|Overall Study|Progressive disease|4
1986372|NCT02460224|3551778|FG014|Overall Study|Progressive disease|5
1986373|NCT02460224|3551779|FG015|Overall Study|Progressive disease|5
1986374|NCT02460224|3551780|FG016|Overall Study|Progressive disease|15
1986375|NCT02460224|3551781|FG017|Overall Study|Progressive disease|3
1986376|NCT02460224|3551782|FG018|Overall Study|Progressive disease|8
1986377|NCT02460224|3551783|FG019|Overall Study|Progressive disease|3
1986378|NCT02460224|3551784|FG020|Overall Study|Progressive disease|4
1986379|NCT02460224|3551785|FG021|Overall Study|Progressive disease|9
1986380|NCT02460224|3551786|FG022|Overall Study|Progressive disease|4
1986381|NCT02460224|3551787|FG023|Overall Study|Progressive disease|11
1986382|NCT02460224|3551788|FG024|Overall Study|Progressive disease|4
1986383|NCT02460224|3551789|FG025|Overall Study|Progressive disease|5
1986384|NCT02460224|3551790|FG026|Overall Study|Progressive disease|85
1986385|NCT02460224|3551791|FG027|Overall Study|Progressive disease|17
1986386|NCT02460224|3551792|FG028|Overall Study|Progressive disease|77
1986387|NCT02460224|3551764|FG000|Overall Study|Subject/guardian decision|2
1986388|NCT02460224|3551765|FG001|Overall Study|Subject/guardian decision|0
1986389|NCT02460224|3551766|FG002|Overall Study|Subject/guardian decision|1
1986390|NCT02460224|3551767|FG003|Overall Study|Subject/guardian decision|0
1986391|NCT02460224|3551768|FG004|Overall Study|Subject/guardian decision|2
1986392|NCT02460224|3551769|FG005|Overall Study|Subject/guardian decision|2
1986393|NCT02460224|3551770|FG006|Overall Study|Subject/guardian decision|0
1986394|NCT02460224|3551771|FG007|Overall Study|Subject/guardian decision|0
1986395|NCT02460224|3551772|FG008|Overall Study|Subject/guardian decision|1
1986396|NCT02460224|3551773|FG009|Overall Study|Subject/guardian decision|1
1986397|NCT02460224|3551774|FG010|Overall Study|Subject/guardian decision|0
1986398|NCT02460224|3551775|FG011|Overall Study|Subject/guardian decision|1
1986399|NCT02460224|3551776|FG012|Overall Study|Subject/guardian decision|0
1986400|NCT02460224|3551777|FG013|Overall Study|Subject/guardian decision|0
1986401|NCT02460224|3551778|FG014|Overall Study|Subject/guardian decision|0
1986402|NCT02460224|3551779|FG015|Overall Study|Subject/guardian decision|1
1986403|NCT02460224|3551780|FG016|Overall Study|Subject/guardian decision|0
1986404|NCT02460224|3551781|FG017|Overall Study|Subject/guardian decision|1
1986405|NCT02460224|3551782|FG018|Overall Study|Subject/guardian decision|2
1986406|NCT02460224|3551783|FG019|Overall Study|Subject/guardian decision|0
1986407|NCT02460224|3551784|FG020|Overall Study|Subject/guardian decision|0
1986408|NCT02460224|3551785|FG021|Overall Study|Subject/guardian decision|1
1986409|NCT02460224|3551786|FG022|Overall Study|Subject/guardian decision|0
1986410|NCT02460224|3551787|FG023|Overall Study|Subject/guardian decision|0
1986411|NCT02460224|3551788|FG024|Overall Study|Subject/guardian decision|0
1986412|NCT02460224|3551789|FG025|Overall Study|Subject/guardian decision|0
1986413|NCT02460224|3551790|FG026|Overall Study|Subject/guardian decision|6
2311806|NCT02757352|4017344|FG001|Follow-Up Period|Lost to Follow-up|0
1986414|NCT02460224|3551791|FG027|Overall Study|Subject/guardian decision|2
1986415|NCT02460224|3551792|FG028|Overall Study|Subject/guardian decision|3
1986416|NCT02460159|3551866|FG000|Overall Study|Adverse Event|4
1986417|NCT02460159|3551867|FG001|Overall Study|Adverse Event|1
1986418|NCT02460159|3551866|FG000|Overall Study|Withdrawal by Subject|2
1986419|NCT02460159|3551867|FG001|Overall Study|Withdrawal by Subject|0
1986420|NCT02457910|3551879|FG000|Overall Study|Withdrawal by Subject|0
1986421|NCT02457910|3551880|FG001|Overall Study|Withdrawal by Subject|0
1986422|NCT02457910|3551881|FG002|Overall Study|Withdrawal by Subject|0
1986423|NCT02457910|3551882|FG003|Overall Study|Withdrawal by Subject|0
1986424|NCT02457910|3551883|FG004|Overall Study|Withdrawal by Subject|0
2213446|NCT01678911|3854979|FG001|Second Intervention|Lost to Follow-up|0
2311807|NCT02757352|4017345|FG002|Follow-Up Period|Lost to Follow-up|0
2311808|NCT02757352|4017346|FG003|Follow-Up Period|Lost to Follow-up|0
2311809|NCT02757352|4017347|FG004|Follow-Up Period|Lost to Follow-up|0
2311810|NCT02757352|4017348|FG005|Follow-Up Period|Lost to Follow-up|0
2311811|NCT02757352|4017349|FG006|Follow-Up Period|Lost to Follow-up|0
2311812|NCT02757352|4017350|FG007|Follow-Up Period|Lost to Follow-up|0
2311813|NCT02757352|4017351|FG008|Follow-Up Period|Lost to Follow-up|1
2311814|NCT02757352|4017352|FG009|Follow-Up Period|Lost to Follow-up|0
2311815|NCT02757352|4017343|FG000|Follow-Up Period|Lack of Efficacy|0
2311816|NCT02757352|4017344|FG001|Follow-Up Period|Lack of Efficacy|0
2311817|NCT02757352|4017345|FG002|Follow-Up Period|Lack of Efficacy|0
2311818|NCT02757352|4017346|FG003|Follow-Up Period|Lack of Efficacy|0
2311819|NCT02757352|4017347|FG004|Follow-Up Period|Lack of Efficacy|0
2311820|NCT02757352|4017348|FG005|Follow-Up Period|Lack of Efficacy|0
2311821|NCT02757352|4017349|FG006|Follow-Up Period|Lack of Efficacy|0
2311822|NCT02757352|4017350|FG007|Follow-Up Period|Lack of Efficacy|0
2311823|NCT02757352|4017351|FG008|Follow-Up Period|Lack of Efficacy|1
2311824|NCT02757352|4017352|FG009|Follow-Up Period|Lack of Efficacy|1
2311825|NCT02757352|4017343|FG000|Follow-Up Period|Withdrawal by Subject|0
2311826|NCT02757352|4017344|FG001|Follow-Up Period|Withdrawal by Subject|0
2311827|NCT02757352|4017345|FG002|Follow-Up Period|Withdrawal by Subject|0
2311828|NCT02757352|4017346|FG003|Follow-Up Period|Withdrawal by Subject|0
2311829|NCT02757352|4017347|FG004|Follow-Up Period|Withdrawal by Subject|0
2311830|NCT02757352|4017348|FG005|Follow-Up Period|Withdrawal by Subject|0
2311831|NCT02757352|4017349|FG006|Follow-Up Period|Withdrawal by Subject|0
2311832|NCT02757352|4017350|FG007|Follow-Up Period|Withdrawal by Subject|1
2311833|NCT02757352|4017351|FG008|Follow-Up Period|Withdrawal by Subject|6
2311834|NCT02757352|4017352|FG009|Follow-Up Period|Withdrawal by Subject|2
2321930|NCT02965456|4036545|FG000|Overall Study|Withdrawal by Parent or Guardian|3
2321931|NCT02965456|4036546|FG001|Overall Study|Withdrawal by Parent or Guardian|6
2321932|NCT02965456|4036545|FG000|Overall Study|Adverse Event|3
2321933|NCT02965456|4036546|FG001|Overall Study|Adverse Event|0
2321934|NCT02965456|4036545|FG000|Overall Study|Noncompliance with Study Drug|1
2321935|NCT02965456|4036546|FG001|Overall Study|Noncompliance with Study Drug|1
2321936|NCT02965456|4036545|FG000|Overall Study|Worsening Condition|0
2321937|NCT02965456|4036546|FG001|Overall Study|Worsening Condition|2
2321938|NCT02965456|4036545|FG000|Overall Study|Lack of Efficacy|1
2321939|NCT02965456|4036546|FG001|Overall Study|Lack of Efficacy|0
2321940|NCT02965456|4036545|FG000|Overall Study|Physician Decision|0
2321941|NCT02965456|4036546|FG001|Overall Study|Physician Decision|1
2321942|NCT02965456|4036545|FG000|Overall Study|Pregnancy|1
2321943|NCT02965456|4036546|FG001|Overall Study|Pregnancy|0
2321944|NCT02965456|4036545|FG000|Overall Study|Protocol Violation|0
2321945|NCT02965456|4036546|FG001|Overall Study|Protocol Violation|1
2321946|NCT02965456|4036545|FG000|Overall Study|Participant ran out of study drug|0
2321947|NCT02965456|4036546|FG001|Overall Study|Participant ran out of study drug|1
2321948|NCT02965573|4036562|FG000|Overall Study|Lack of Efficacy|1
2321949|NCT02965573|4036563|FG001|Overall Study|Lack of Efficacy|0
2321950|NCT02965599|4036571|FG000|Overall Study|Protocol-defined stop criteria reached|1
2321951|NCT02965599|4036572|FG001|Overall Study|Protocol-defined stop criteria reached|0
2321952|NCT02965820|4036592|FG000|Period 2, Second 30 Days|Adverse Event|1
2321953|NCT02965820|4036593|FG001|Period 2, Second 30 Days|Adverse Event|1
2321954|NCT02965833|4036599|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
2321955|NCT02965833|4036600|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
2321956|NCT02965833|4036599|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2321957|NCT02965833|4036600|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2321958|NCT02965833|4036599|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1
2321959|NCT02965833|4036600|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0
2321960|NCT02965833|4036599|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
2321961|NCT02965833|4036600|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
2321962|NCT02965833|4036599|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2
2321963|NCT02965833|4036600|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0
2321964|NCT02966002|4036625|FG000|Overall Study|Withdrawal by Subject|2
2321965|NCT02966002|4036625|FG000|Overall Study|Adverse Event|1
2321966|NCT02966002|4036625|FG000|Overall Study|Lost to Follow-up|1
2321967|NCT02966015|4036631|FG000|Inclusion Visit|did not answer questionnaire|8
2321968|NCT02966015|4036632|FG001|Inclusion Visit|did not answer questionnaire|3
2321969|NCT02966028|4036641|FG000|Overall Study|Adverse Event|7
2321970|NCT02966028|4036642|FG001|Overall Study|Adverse Event|13
2321971|NCT02966028|4036643|FG002|Overall Study|Adverse Event|10
2213447|NCT01678924|3854989|FG000|Overall Study|Adverse Event|1
2213448|NCT01678924|3854990|FG001|Overall Study|Adverse Event|1
2213449|NCT01678924|3854991|FG002|Overall Study|Adverse Event|0
2321972|NCT02966028|4036641|FG000|Overall Study|Physician Decision|1
2321973|NCT02966028|4036642|FG001|Overall Study|Physician Decision|0
2321974|NCT02966028|4036643|FG002|Overall Study|Physician Decision|2
2321975|NCT02966028|4036641|FG000|Overall Study|Withdrawal by Subject|7
2213450|NCT01678924|3854992|FG003|Overall Study|Adverse Event|1
1986425|NCT02457910|3551884|FG005|Overall Study|Withdrawal by Subject|1
1986426|NCT02457910|3551879|FG000|Overall Study|Adverse Event|0
1986427|NCT02457910|3551880|FG001|Overall Study|Adverse Event|2
1986428|NCT02457910|3551881|FG002|Overall Study|Adverse Event|1
2311835|NCT02757430|4017383|FG000|Overall Study|Physician Decision|6
2311836|NCT02757430|4017383|FG000|Overall Study|Inclusion/Exclusion criteria not met|3
2311837|NCT02757430|4017383|FG000|Overall Study|No informed consent|1
2311838|NCT02757430|4017383|FG000|Overall Study|No procedure performed|2
2311839|NCT02757625|4017400|FG000|Overall Study|Investigator's discretion|0
2311840|NCT02757625|4017401|FG001|Overall Study|Investigator's discretion|0
2311841|NCT02757625|4017402|FG002|Overall Study|Investigator's discretion|1
2311842|NCT02757625|4017403|FG003|Overall Study|Investigator's discretion|0
2311843|NCT02757625|4017400|FG000|Overall Study|Adverse Event|0
2311844|NCT02757625|4017401|FG001|Overall Study|Adverse Event|0
2311845|NCT02757625|4017402|FG002|Overall Study|Adverse Event|1
2311846|NCT02757625|4017403|FG003|Overall Study|Adverse Event|0
2311847|NCT02757768|4017417|FG000|Overall Study|Randomized Never Received Study Drug|3
2311848|NCT02757768|4017418|FG001|Overall Study|Randomized Never Received Study Drug|4
2311849|NCT02757768|4017417|FG000|Overall Study|Adverse Event|5
2311850|NCT02757768|4017418|FG001|Overall Study|Adverse Event|3
2311851|NCT02757768|4017417|FG000|Overall Study|Lack of Efficacy|2
2311852|NCT02757768|4017418|FG001|Overall Study|Lack of Efficacy|1
2311853|NCT02757768|4017417|FG000|Overall Study|Lost to Follow-up|1
2311854|NCT02757768|4017418|FG001|Overall Study|Lost to Follow-up|0
2311855|NCT02757768|4017417|FG000|Overall Study|Protocol Deviation|2
2311856|NCT02757768|4017418|FG001|Overall Study|Protocol Deviation|9
2311857|NCT02757768|4017417|FG000|Overall Study|Withdrawal by Subject|16
2311858|NCT02757768|4017418|FG001|Overall Study|Withdrawal by Subject|9
2311859|NCT02757768|4017417|FG000|Overall Study|Miscellaneous|4
2311860|NCT02757768|4017418|FG001|Overall Study|Miscellaneous|2
2311861|NCT02757963|4017436|FG000|Overall Study|Adverse Event|3
2311862|NCT02757963|4017436|FG000|Overall Study|Reached Stopping Criteria|1054
2311863|NCT02757963|4017436|FG000|Overall Study|Lost to Follow-up|5
2311864|NCT02757963|4017436|FG000|Overall Study|Physician Decision|1
2311865|NCT02757963|4017436|FG000|Overall Study|Withdrawal by Subject|34
2311866|NCT02758171|4017464|FG000|Wash-out|Withdrawal by Subject|1
2311867|NCT02758171|4017465|FG001|Wash-out|Withdrawal by Subject|0
2311868|NCT02758171|4017464|FG000|Wash-out|Other reason|1
2311869|NCT02758171|4017465|FG001|Wash-out|Other reason|0
2311870|NCT02758301|4017477|FG000|Overall Study|Death|12
2311871|NCT02758301|4017478|FG001|Overall Study|Death|0
2311872|NCT02758301|4017477|FG000|Overall Study|Physician Decision|10
2311873|NCT02758301|4017478|FG001|Overall Study|Physician Decision|1
2311874|NCT02758301|4017477|FG000|Overall Study|Withdrawal by Subject|5
2311875|NCT02758301|4017478|FG001|Overall Study|Withdrawal by Subject|6
2311876|NCT02758301|4017477|FG000|Overall Study|Lost to Follow-up|7
2311877|NCT02758301|4017478|FG001|Overall Study|Lost to Follow-up|0
2311878|NCT02758301|4017477|FG000|Overall Study|Protocol Violation|0
2311879|NCT02758301|4017478|FG001|Overall Study|Protocol Violation|1
2311880|NCT02758613|4017488|FG000|Treatment|Physician and Sponsor Decision|1
2311881|NCT02758613|4017489|FG001|Treatment|Physician and Sponsor Decision|0
2311882|NCT02758613|4017490|FG002|Treatment|Physician and Sponsor Decision|0
2311883|NCT02758613|4017491|FG003|Treatment|Physician and Sponsor Decision|0
2311884|NCT02758613|4017488|FG000|Treatment|Withdrawal by Subject|1
2311885|NCT02758613|4017489|FG001|Treatment|Withdrawal by Subject|0
2311886|NCT02758613|4017490|FG002|Treatment|Withdrawal by Subject|1
2311887|NCT02758613|4017491|FG003|Treatment|Withdrawal by Subject|0
2311888|NCT02759016|4017515|FG000|Overall Study|Not treated with BI 836826|1
2311889|NCT02759016|4017516|FG001|Overall Study|Not treated with BI 836826|0
2311890|NCT02759016|4017515|FG000|Overall Study|Progressive disease|1
2311891|NCT02759016|4017516|FG001|Overall Study|Progressive disease|0
2311892|NCT02759016|4017515|FG000|Overall Study|SD, PR-MRDpos or PR-L|0
2311893|NCT02759016|4017516|FG001|Overall Study|SD, PR-MRDpos or PR-L|2
2311894|NCT02759016|4017515|FG000|Overall Study|Other not defined above|2
2311895|NCT02759016|4017516|FG001|Overall Study|Other not defined above|1
2311896|NCT02759055|4017525|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927
2311897|NCT02759055|4017526|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508
2311898|NCT02759120|4017534|FG000|Overall Study|Death|34
2311899|NCT02759120|4017535|FG001|Overall Study|Death|36
2311900|NCT02759120|4017534|FG000|Overall Study|Lost to Follow-up|4
2311901|NCT02759120|4017535|FG001|Overall Study|Lost to Follow-up|7
2311902|NCT02759120|4017534|FG000|Overall Study|Physician Decision|3
2311903|NCT02759120|4017535|FG001|Overall Study|Physician Decision|0
2311904|NCT02759120|4017534|FG000|Overall Study|Withdrawal by Subject|28
2311905|NCT02759120|4017535|FG001|Overall Study|Withdrawal by Subject|15
2311906|NCT02759120|4017534|FG000|Overall Study|Moved out of area|3
2311907|NCT02759120|4017535|FG001|Overall Study|Moved out of area|4
2311908|NCT02759120|4017534|FG000|Overall Study|Lung transplant|3
2311909|NCT02759120|4017535|FG001|Overall Study|Lung transplant|5
2311910|NCT02759120|4017534|FG000|Overall Study|Other reason not completed|10
1986429|NCT02457910|3551882|FG003|Overall Study|Adverse Event|1
2311911|NCT02759120|4017535|FG001|Overall Study|Other reason not completed|12
2311912|NCT02759185|4017573|FG000|Overall Study|Adverse Event|0
2311913|NCT02759185|4017574|FG001|Overall Study|Adverse Event|1
1986430|NCT02457910|3551883|FG004|Overall Study|Adverse Event|1
1986431|NCT02457910|3551884|FG005|Overall Study|Adverse Event|3
1986432|NCT02457910|3551879|FG000|Overall Study|Disease progression|3
1986433|NCT02457910|3551880|FG001|Overall Study|Disease progression|3
1986434|NCT02457910|3551881|FG002|Overall Study|Disease progression|1
1986435|NCT02457910|3551882|FG003|Overall Study|Disease progression|1
1986436|NCT02457910|3551883|FG004|Overall Study|Disease progression|4
2311914|NCT02759185|4017575|FG002|Overall Study|Adverse Event|2
2311915|NCT02759185|4017576|FG003|Overall Study|Adverse Event|0
2311916|NCT02759185|4017573|FG000|Overall Study|Withdrawal by Subject|1
2311917|NCT02759185|4017574|FG001|Overall Study|Withdrawal by Subject|0
2311918|NCT02759185|4017575|FG002|Overall Study|Withdrawal by Subject|0
2311919|NCT02759185|4017576|FG003|Overall Study|Withdrawal by Subject|0
2311920|NCT02759315|4017596|FG000|Overall Study|Adverse Event|0
2311921|NCT02759315|4017597|FG001|Overall Study|Adverse Event|0
2311922|NCT02759315|4017598|FG002|Overall Study|Adverse Event|0
2311923|NCT02759315|4017599|FG003|Overall Study|Adverse Event|1
2311924|NCT02759315|4017600|FG004|Overall Study|Adverse Event|0
2311925|NCT02759315|4017596|FG000|Overall Study|Death|0
2311926|NCT02759315|4017597|FG001|Overall Study|Death|0
2311927|NCT02759315|4017598|FG002|Overall Study|Death|1
2311928|NCT02759315|4017599|FG003|Overall Study|Death|0
2311929|NCT02759315|4017600|FG004|Overall Study|Death|0
2311930|NCT02759315|4017596|FG000|Overall Study|Lost to Follow-up|2
2311931|NCT02759315|4017597|FG001|Overall Study|Lost to Follow-up|0
2311932|NCT02759315|4017598|FG002|Overall Study|Lost to Follow-up|4
2311933|NCT02759315|4017599|FG003|Overall Study|Lost to Follow-up|0
2311934|NCT02759315|4017600|FG004|Overall Study|Lost to Follow-up|0
2311935|NCT02759315|4017596|FG000|Overall Study|Protocol Violation|0
2311936|NCT02759315|4017597|FG001|Overall Study|Protocol Violation|1
2311937|NCT02759315|4017598|FG002|Overall Study|Protocol Violation|0
2311938|NCT02759315|4017599|FG003|Overall Study|Protocol Violation|0
2311939|NCT02759315|4017600|FG004|Overall Study|Protocol Violation|0
2311940|NCT02759315|4017596|FG000|Overall Study|Study terminated prior to completion|2
2311941|NCT02759315|4017597|FG001|Overall Study|Study terminated prior to completion|0
2311942|NCT02759315|4017598|FG002|Overall Study|Study terminated prior to completion|5
2311943|NCT02759315|4017599|FG003|Overall Study|Study terminated prior to completion|0
2311944|NCT02759315|4017600|FG004|Overall Study|Study terminated prior to completion|1
2311945|NCT02759471|4017633|FG000|Overall Study|discomfort|2
2311946|NCT02759562|4017641|FG000|Open-Label Treatment Period|Withdrew Consent|1
2311947|NCT02759562|4017642|FG001|Open-Label Treatment Period|Withdrew Consent|0
2311948|NCT02759562|4017641|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1
2311949|NCT02759562|4017642|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2
2311950|NCT02759692|4017653|FG000|Period 1|Test article no longer available|1
2311951|NCT02759692|4017654|FG001|Period 1|Test article no longer available|1
2311952|NCT02759692|4017653|FG000|Period 1|No longer meets eligibility criteria.|1
2311953|NCT02759692|4017654|FG001|Period 1|No longer meets eligibility criteria.|0
2311954|NCT02759692|4017653|FG000|Period 1|Miss-Randomized|1
2311955|NCT02759692|4017654|FG001|Period 1|Miss-Randomized|1
2311956|NCT02759692|4017653|FG000|Period 2|Lost to Follow-up|1
2311957|NCT02759692|4017654|FG001|Period 2|Lost to Follow-up|0
2311958|NCT02759692|4017653|FG000|Period 2|Test article no longer available|0
2311959|NCT02759692|4017654|FG001|Period 2|Test article no longer available|1
2311960|NCT02759939|4017664|FG000|Overall Study|Missing data on first outcome assessed|11
2311961|NCT02759939|4017665|FG001|Overall Study|Missing data on first outcome assessed|2
2311962|NCT02759939|4017666|FG002|Overall Study|Missing data on first outcome assessed|5
2311963|NCT02759939|4017667|FG003|Overall Study|Missing data on first outcome assessed|2
2311964|NCT02759939|4017664|FG000|Overall Study|Ineligible for T2 and T3|310
2311965|NCT02759939|4017665|FG001|Overall Study|Ineligible for T2 and T3|179
2311966|NCT02759939|4017666|FG002|Overall Study|Ineligible for T2 and T3|366
2311967|NCT02759939|4017667|FG003|Overall Study|Ineligible for T2 and T3|391
2311968|NCT02759939|4017664|FG000|Overall Study|Lost to Follow-up|735
2311969|NCT02759939|4017665|FG001|Overall Study|Lost to Follow-up|791
2311970|NCT02759939|4017666|FG002|Overall Study|Lost to Follow-up|783
2311971|NCT02759939|4017667|FG003|Overall Study|Lost to Follow-up|650
2311972|NCT02760069|4017690|FG000|Overall Study|Withdrawal by Subject|0
2311973|NCT02760069|4017691|FG001|Overall Study|Withdrawal by Subject|1
2311974|NCT02760069|4017692|FG002|Overall Study|Withdrawal by Subject|1
2311975|NCT02760368|4017738|FG000|Overall Study|Withdrawal by Subject|12
2311976|NCT02760368|4017739|FG001|Overall Study|Withdrawal by Subject|8
2311977|NCT02760368|4017740|FG002|Overall Study|Withdrawal by Subject|9
2311978|NCT02760368|4017738|FG000|Overall Study|Screen Failure|0
2311979|NCT02760368|4017739|FG001|Overall Study|Screen Failure|0
2311980|NCT02760368|4017740|FG002|Overall Study|Screen Failure|1
2311981|NCT02760368|4017738|FG000|Overall Study|Death|1
2311982|NCT02760368|4017739|FG001|Overall Study|Death|0
2311983|NCT02760368|4017740|FG002|Overall Study|Death|0
2311984|NCT02760368|4017738|FG000|Overall Study|Withdrawal by Sponsor|0
2311985|NCT02760368|4017739|FG001|Overall Study|Withdrawal by Sponsor|0
2311986|NCT02760368|4017740|FG002|Overall Study|Withdrawal by Sponsor|1
2311987|NCT02760407|4017752|FG000|Overall Study|Death|2
2311988|NCT02760407|4017753|FG001|Overall Study|Death|3
2311989|NCT02760407|4017754|FG002|Overall Study|Death|1
2311990|NCT02760407|4017755|FG003|Overall Study|Death|1
1986437|NCT02457910|3551884|FG005|Overall Study|Disease progression|6
1986438|NCT02457910|3551879|FG000|Overall Study|Other complicating illness|0
1986439|NCT02457910|3551880|FG001|Overall Study|Other complicating illness|0
1986440|NCT02457910|3551881|FG002|Overall Study|Other complicating illness|0
1986441|NCT02457910|3551882|FG003|Overall Study|Other complicating illness|0
1986442|NCT02457910|3551883|FG004|Overall Study|Other complicating illness|0
1986443|NCT02457910|3551884|FG005|Overall Study|Other complicating illness|1
1986444|NCT02457910|3551879|FG000|Overall Study|Death|0
1986445|NCT02457910|3551880|FG001|Overall Study|Death|0
2213451|NCT01678924|3854989|FG000|Overall Study|Lack of Efficacy|7
2213452|NCT01678924|3854990|FG001|Overall Study|Lack of Efficacy|2
1986446|NCT02457910|3551881|FG002|Overall Study|Death|1
1986447|NCT02457910|3551882|FG003|Overall Study|Death|0
1986448|NCT02457910|3551883|FG004|Overall Study|Death|0
1986449|NCT02457910|3551884|FG005|Overall Study|Death|0
1986450|NCT02407236|3551909|FG000|Induction Study (8 Weeks)|Adverse Event|3
1986451|NCT02407236|3551910|FG001|Induction Study (8 Weeks)|Adverse Event|0
1986452|NCT02407236|3551911|FG002|Induction Study (8 Weeks)|Adverse Event|1
1986453|NCT02407236|3551912|FG003|Induction Study (8 Weeks)|Adverse Event|0
1986454|NCT02407236|3551913|FG004|Induction Study (8 Weeks)|Adverse Event|0
1986455|NCT02407236|3551914|FG005|Induction Study (8 Weeks)|Adverse Event|0
1986456|NCT02407236|3551915|FG006|Induction Study (8 Weeks)|Adverse Event|0
1986457|NCT02407236|3551916|FG007|Induction Study (8 Weeks)|Adverse Event|0
1986458|NCT02407236|3551909|FG000|Induction Study (8 Weeks)|Death|0
2213453|NCT01678924|3854991|FG002|Overall Study|Lack of Efficacy|0
2213454|NCT01678924|3854992|FG003|Overall Study|Lack of Efficacy|5
2213455|NCT01678924|3854989|FG000|Overall Study|Lost to Follow-up|0
2213456|NCT01678924|3854990|FG001|Overall Study|Lost to Follow-up|4
1986459|NCT02407236|3551910|FG001|Induction Study (8 Weeks)|Death|0
1986460|NCT02407236|3551911|FG002|Induction Study (8 Weeks)|Death|1
1986461|NCT02407236|3551912|FG003|Induction Study (8 Weeks)|Death|0
1986462|NCT02407236|3551913|FG004|Induction Study (8 Weeks)|Death|0
1986463|NCT02407236|3551914|FG005|Induction Study (8 Weeks)|Death|0
1986464|NCT02407236|3551915|FG006|Induction Study (8 Weeks)|Death|0
1986465|NCT02407236|3551916|FG007|Induction Study (8 Weeks)|Death|0
1986466|NCT02407236|3551909|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17
1986467|NCT02407236|3551910|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9
1986468|NCT02407236|3551911|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7
1986469|NCT02407236|3551912|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0
1986470|NCT02407236|3551913|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0
1986471|NCT02407236|3551914|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0
1986472|NCT02407236|3551915|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0
1986473|NCT02407236|3551916|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0
1986474|NCT02407236|3551909|FG000|Induction Study (8 Weeks)|Lost to Follow-up|0
1986475|NCT02407236|3551910|FG001|Induction Study (8 Weeks)|Lost to Follow-up|0
1986476|NCT02407236|3551911|FG002|Induction Study (8 Weeks)|Lost to Follow-up|1
1986477|NCT02407236|3551912|FG003|Induction Study (8 Weeks)|Lost to Follow-up|0
1986478|NCT02407236|3551913|FG004|Induction Study (8 Weeks)|Lost to Follow-up|0
1986479|NCT02407236|3551914|FG005|Induction Study (8 Weeks)|Lost to Follow-up|0
1986480|NCT02407236|3551915|FG006|Induction Study (8 Weeks)|Lost to Follow-up|0
1986481|NCT02407236|3551916|FG007|Induction Study (8 Weeks)|Lost to Follow-up|0
1986482|NCT02407236|3551909|FG000|Induction Study (8 Weeks)|Physician Decision|1
1986483|NCT02407236|3551910|FG001|Induction Study (8 Weeks)|Physician Decision|1
1986484|NCT02407236|3551911|FG002|Induction Study (8 Weeks)|Physician Decision|0
1986485|NCT02407236|3551912|FG003|Induction Study (8 Weeks)|Physician Decision|0
1986486|NCT02407236|3551913|FG004|Induction Study (8 Weeks)|Physician Decision|0
1986487|NCT02407236|3551914|FG005|Induction Study (8 Weeks)|Physician Decision|0
1986488|NCT02407236|3551915|FG006|Induction Study (8 Weeks)|Physician Decision|0
1986489|NCT02407236|3551916|FG007|Induction Study (8 Weeks)|Physician Decision|0
1986490|NCT02407236|3551909|FG000|Induction Study (8 Weeks)|Other|2
1986491|NCT02407236|3551910|FG001|Induction Study (8 Weeks)|Other|1
1986492|NCT02407236|3551911|FG002|Induction Study (8 Weeks)|Other|5
1986493|NCT02407236|3551912|FG003|Induction Study (8 Weeks)|Other|0
1986494|NCT02407236|3551913|FG004|Induction Study (8 Weeks)|Other|0
1986495|NCT02407236|3551914|FG005|Induction Study (8 Weeks)|Other|0
1986496|NCT02407236|3551915|FG006|Induction Study (8 Weeks)|Other|0
1986497|NCT02407236|3551916|FG007|Induction Study (8 Weeks)|Other|0
1986498|NCT02407236|3551909|FG000|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1986499|NCT02407236|3551910|FG001|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1986500|NCT02407236|3551911|FG002|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1986501|NCT02407236|3551912|FG003|Maintenance Study (44 Weeks)|Lost to Follow-up|1
1986502|NCT02407236|3551913|FG004|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1986503|NCT02407236|3551914|FG005|Maintenance Study (44 Weeks)|Lost to Follow-up|1
1986504|NCT02407236|3551915|FG006|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1986505|NCT02407236|3551916|FG007|Maintenance Study (44 Weeks)|Lost to Follow-up|1
1986506|NCT02407236|3551909|FG000|Maintenance Study (44 Weeks)|Death|0
1986507|NCT02407236|3551910|FG001|Maintenance Study (44 Weeks)|Death|0
1986508|NCT02407236|3551911|FG002|Maintenance Study (44 Weeks)|Death|0
1986509|NCT02407236|3551912|FG003|Maintenance Study (44 Weeks)|Death|0
1986510|NCT02407236|3551913|FG004|Maintenance Study (44 Weeks)|Death|0
1986511|NCT02407236|3551914|FG005|Maintenance Study (44 Weeks)|Death|0
1986512|NCT02407236|3551915|FG006|Maintenance Study (44 Weeks)|Death|0
1986513|NCT02407236|3551916|FG007|Maintenance Study (44 Weeks)|Death|1
1986514|NCT02407236|3551909|FG000|Maintenance Study (44 Weeks)|Withdraw of consent|0
1986515|NCT02407236|3551910|FG001|Maintenance Study (44 Weeks)|Withdraw of consent|0
1986516|NCT02407236|3551911|FG002|Maintenance Study (44 Weeks)|Withdraw of consent|0
1986517|NCT02407236|3551912|FG003|Maintenance Study (44 Weeks)|Withdraw of consent|8
1986518|NCT02407236|3551913|FG004|Maintenance Study (44 Weeks)|Withdraw of consent|10
1986519|NCT02407236|3551914|FG005|Maintenance Study (44 Weeks)|Withdraw of consent|5
1986520|NCT02407236|3551915|FG006|Maintenance Study (44 Weeks)|Withdraw of consent|7
1986521|NCT02407236|3551916|FG007|Maintenance Study (44 Weeks)|Withdraw of consent|5
1986522|NCT02407236|3551909|FG000|Maintenance Study (44 Weeks)|Sponsor decision|0
1986523|NCT02407236|3551910|FG001|Maintenance Study (44 Weeks)|Sponsor decision|0
1986524|NCT02407236|3551911|FG002|Maintenance Study (44 Weeks)|Sponsor decision|0
1986525|NCT02407236|3551912|FG003|Maintenance Study (44 Weeks)|Sponsor decision|1
1986526|NCT02407236|3551913|FG004|Maintenance Study (44 Weeks)|Sponsor decision|0
1986527|NCT02407236|3551914|FG005|Maintenance Study (44 Weeks)|Sponsor decision|1
1986528|NCT02407236|3551915|FG006|Maintenance Study (44 Weeks)|Sponsor decision|0
1986529|NCT02407236|3551916|FG007|Maintenance Study (44 Weeks)|Sponsor decision|0
1986530|NCT02407236|3551909|FG000|Maintenance Study (44 Weeks)|Other|0
1986531|NCT02407236|3551910|FG001|Maintenance Study (44 Weeks)|Other|0
1986532|NCT02407236|3551911|FG002|Maintenance Study (44 Weeks)|Other|0
1986533|NCT02407236|3551912|FG003|Maintenance Study (44 Weeks)|Other|0
1986534|NCT02407236|3551913|FG004|Maintenance Study (44 Weeks)|Other|1
1986535|NCT02407236|3551914|FG005|Maintenance Study (44 Weeks)|Other|1
1986536|NCT02407236|3551915|FG006|Maintenance Study (44 Weeks)|Other|2
2213457|NCT01678924|3854991|FG002|Overall Study|Lost to Follow-up|0
2213458|NCT01678924|3854992|FG003|Overall Study|Lost to Follow-up|2
1986537|NCT02407236|3551916|FG007|Maintenance Study (44 Weeks)|Other|1
1986538|NCT02320396|3551936|FG000|Overall Study|Adverse Event|2
1986539|NCT02320396|3551937|FG001|Overall Study|Adverse Event|2
1986540|NCT02320396|3551936|FG000|Overall Study|Pregnancy|0
1986541|NCT02320396|3551937|FG001|Overall Study|Pregnancy|1
1986542|NCT02320396|3551936|FG000|Overall Study|Protocol Violation|0
1986543|NCT02320396|3551937|FG001|Overall Study|Protocol Violation|1
1986544|NCT02320396|3551936|FG000|Overall Study|Withdrawal by Subject|2
1986545|NCT02320396|3551937|FG001|Overall Study|Withdrawal by Subject|0
1986546|NCT02282345|3551945|FG000|Overall Study|Progression|0
1986547|NCT02282345|3551946|FG001|Overall Study|Progression|1
1986548|NCT02230410|3551955|FG000|Overall Study|Screen Failure|3
1986549|NCT02053246|3551959|FG000|Overall Study|Withdrawal by Subject|3
1986550|NCT02053246|3551959|FG000|Overall Study|Physician Decision|1
1986551|NCT02043678|3551965|FG000|Overall Study|Never treated|11
1986552|NCT02043678|3551966|FG001|Overall Study|Never treated|9
1986553|NCT02043678|3551965|FG000|Overall Study|AE with clinical progressive disease(PD)|18
1986554|NCT02043678|3551966|FG001|Overall Study|AE with clinical progressive disease(PD)|18
1986555|NCT02043678|3551965|FG000|Overall Study|AE without clinical PD|51
1986556|NCT02043678|3551966|FG001|Overall Study|AE without clinical PD|34
1986557|NCT02043678|3551965|FG000|Overall Study|Lost to Follow-up|1
1986558|NCT02043678|3551966|FG001|Overall Study|Lost to Follow-up|1
1986559|NCT02043678|3551965|FG000|Overall Study|Other|19
1986560|NCT02043678|3551966|FG001|Overall Study|Other|16
1986561|NCT02043678|3551965|FG000|Overall Study|Clinical PD|108
1986562|NCT02043678|3551966|FG001|Overall Study|Clinical PD|138
1986563|NCT02043678|3551965|FG000|Overall Study|Radiological PD|91
1986564|NCT02043678|3551966|FG001|Overall Study|Radiological PD|80
1986565|NCT02043678|3551965|FG000|Overall Study|Protocol-driven decision point|56
1986566|NCT02043678|3551966|FG001|Overall Study|Protocol-driven decision point|56
1986567|NCT02043678|3551965|FG000|Overall Study|Withdrawal by Subject|12
1986568|NCT02043678|3551966|FG001|Overall Study|Withdrawal by Subject|15
1986569|NCT02043678|3551965|FG000|Overall Study|Ongoing with treatment|34
1986570|NCT02043678|3551966|FG001|Overall Study|Ongoing with treatment|38
1986571|NCT02005471|3551974|FG000|Overall Study|Ongoing in Study|144
1986572|NCT02005471|3551975|FG001|Overall Study|Ongoing in Study|171
1986573|NCT02005471|3551974|FG000|Overall Study|Adverse Event|1
1986574|NCT02005471|3551975|FG001|Overall Study|Adverse Event|0
1986575|NCT02005471|3551974|FG000|Overall Study|Death|26
1986576|NCT02005471|3551975|FG001|Overall Study|Death|15
1986577|NCT02005471|3551974|FG000|Overall Study|Lost to Follow-up|1
1986578|NCT02005471|3551975|FG001|Overall Study|Lost to Follow-up|0
1986579|NCT02005471|3551974|FG000|Overall Study|Physician Decision|2
1986580|NCT02005471|3551975|FG001|Overall Study|Physician Decision|1
1986581|NCT02005471|3551974|FG000|Overall Study|Progressive Disease|3
1986582|NCT02005471|3551975|FG001|Overall Study|Progressive Disease|0
1986583|NCT02005471|3551974|FG000|Overall Study|Withdrawal by Subject|18
1986584|NCT02005471|3551975|FG001|Overall Study|Withdrawal by Subject|7
1986585|NCT01984346|3551986|FG000|Overall Study|Physician Decision|4
1986586|NCT01984346|3551987|FG001|Overall Study|Physician Decision|2
1986587|NCT01984346|3551986|FG000|Overall Study|Withdrawal by Subject|2
1986588|NCT01984346|3551987|FG001|Overall Study|Withdrawal by Subject|2
1986589|NCT01984346|3551986|FG000|Overall Study|Enrollment Closed|8
1986590|NCT01984346|3551987|FG001|Overall Study|Enrollment Closed|1
1986591|NCT01984346|3551986|FG000|Overall Study|Insurance Coverage|1
1986592|NCT01984346|3551987|FG001|Overall Study|Insurance Coverage|0
1986593|NCT01984346|3551986|FG000|Overall Study|Intra-operative Exclusion|2
1986594|NCT01984346|3551987|FG001|Overall Study|Intra-operative Exclusion|0
1986595|NCT01980940|3552001|FG000|Overall Study|Protocol Violation|0
1986596|NCT01980940|3552002|FG001|Overall Study|Protocol Violation|0
1986597|NCT01980940|3552003|FG002|Overall Study|Protocol Violation|0
1986598|NCT01980940|3552004|FG003|Overall Study|Protocol Violation|0
1986599|NCT01980940|3552005|FG004|Overall Study|Protocol Violation|0
1986600|NCT01980940|3552006|FG005|Overall Study|Protocol Violation|2
1986601|NCT01980940|3552007|FG006|Overall Study|Protocol Violation|0
1986602|NCT01980940|3552008|FG007|Overall Study|Protocol Violation|0
1986603|NCT01918033|3552049|FG000|Overall Study|Adverse Event|1
1986604|NCT01918033|3552050|FG001|Overall Study|Adverse Event|0
1986605|NCT01918033|3552051|FG002|Overall Study|Adverse Event|2
1986606|NCT01918033|3552049|FG000|Overall Study|Lost to Follow-up|0
1986607|NCT01918033|3552050|FG001|Overall Study|Lost to Follow-up|1
1986608|NCT01918033|3552051|FG002|Overall Study|Lost to Follow-up|0
1986609|NCT01918033|3552049|FG000|Overall Study|Protocol Violation|2
1986610|NCT01918033|3552050|FG001|Overall Study|Protocol Violation|0
1986611|NCT01918033|3552051|FG002|Overall Study|Protocol Violation|1
1986612|NCT01918033|3552049|FG000|Overall Study|Withdrawal by Subject|2
1986613|NCT01918033|3552050|FG001|Overall Study|Withdrawal by Subject|1
1986614|NCT01918033|3552051|FG002|Overall Study|Withdrawal by Subject|0
1986615|NCT01916980|3552061|FG000|Overall Study|Adverse Event|4
1986616|NCT01916980|3552062|FG001|Overall Study|Adverse Event|2
1986617|NCT01916980|3552061|FG000|Overall Study|Lack of Efficacy|2
1986618|NCT01916980|3552062|FG001|Overall Study|Lack of Efficacy|2
1986619|NCT01916980|3552061|FG000|Overall Study|Withdrawal by Subject|1
1986620|NCT01916980|3552062|FG001|Overall Study|Withdrawal by Subject|0
1986621|NCT01916967|3552071|FG000|Overall Study|Adverse Event|0
1986622|NCT01916967|3552072|FG001|Overall Study|Adverse Event|0
1986623|NCT01916967|3552073|FG002|Overall Study|Adverse Event|2
1986624|NCT01916967|3552071|FG000|Overall Study|Lack of Efficacy|0
1986625|NCT01916967|3552072|FG001|Overall Study|Lack of Efficacy|0
1986626|NCT01916967|3552073|FG002|Overall Study|Lack of Efficacy|6
1986627|NCT01916967|3552071|FG000|Overall Study|Physician Decision|0
1986628|NCT01916967|3552072|FG001|Overall Study|Physician Decision|0
1986629|NCT01916967|3552073|FG002|Overall Study|Physician Decision|1
1986630|NCT01916967|3552071|FG000|Overall Study|Protocol Violation|0
1986631|NCT01916967|3552072|FG001|Overall Study|Protocol Violation|1
1986632|NCT01916967|3552073|FG002|Overall Study|Protocol Violation|0
1986633|NCT01910402|3552085|FG000|Randomized Phase|Adverse Event|10
1986634|NCT01910402|3552086|FG001|Randomized Phase|Adverse Event|18
1986635|NCT01910402|3552085|FG000|Randomized Phase|Physician Decision|1
1986636|NCT01910402|3552086|FG001|Randomized Phase|Physician Decision|0
1986637|NCT01910402|3552085|FG000|Randomized Phase|Lack of Efficacy|5
1986638|NCT01910402|3552086|FG001|Randomized Phase|Lack of Efficacy|4
1986639|NCT01910402|3552085|FG000|Randomized Phase|Lost to Follow-up|11
1986640|NCT01910402|3552086|FG001|Randomized Phase|Lost to Follow-up|13
1986641|NCT01910402|3552085|FG000|Randomized Phase|Protocol Violation|10
1986642|NCT01910402|3552086|FG001|Randomized Phase|Protocol Violation|13
1986643|NCT01910402|3552085|FG000|Randomized Phase|Withdrawal by Subject|5
1986644|NCT01910402|3552086|FG001|Randomized Phase|Withdrawal by Subject|7
1986645|NCT01910402|3552085|FG000|Continuation Phase|Ongoing|84
1986646|NCT01910402|3552086|FG001|Continuation Phase|Ongoing|0
1986647|NCT01910402|3552085|FG000|Continuation Phase|Adverse Event|1
1986648|NCT01910402|3552086|FG001|Continuation Phase|Adverse Event|0
1986649|NCT01910402|3552085|FG000|Continuation Phase|Protocol Violation|3
1986650|NCT01910402|3552086|FG001|Continuation Phase|Protocol Violation|0
1986651|NCT01910402|3552085|FG000|Continuation Phase|Withdrawal by Subject|2
1986652|NCT01910402|3552086|FG001|Continuation Phase|Withdrawal by Subject|0
1986653|NCT01870401|3552105|FG000|Overall Study|Death|48
1986654|NCT01870401|3552106|FG001|Overall Study|Death|24
1986655|NCT01870401|3552105|FG000|Overall Study|Withdrawal by Subject|39
1986656|NCT01870401|3552106|FG001|Overall Study|Withdrawal by Subject|26
1986657|NCT01870401|3552105|FG000|Overall Study|Lost to Follow-up|19
1986658|NCT01870401|3552106|FG001|Overall Study|Lost to Follow-up|14
1986659|NCT01870401|3552105|FG000|Overall Study|Other|9
1986660|NCT01870401|3552106|FG001|Overall Study|Other|7
1986661|NCT01870401|3552105|FG000|Overall Study|On-going in the Study|35
1986662|NCT01870401|3552106|FG001|Overall Study|On-going in the Study|25
1986663|NCT01867606|3552116|FG000|Overall Study|Withdrawal by Subject|10
1986664|NCT01867606|3552117|FG001|Overall Study|Withdrawal by Subject|14
1986665|NCT01867606|3552116|FG000|Overall Study|Protocol Violation|0
1986666|NCT01867606|3552117|FG001|Overall Study|Protocol Violation|1
1986667|NCT01857063|3552131|FG000|Period 1 (7 Days)|Adverse Event|0
1986668|NCT01857063|3552132|FG001|Period 1 (7 Days)|Adverse Event|1
1986669|NCT01857063|3552131|FG000|Period 1 (7 Days)|Physician Decision|1
1986670|NCT01857063|3552132|FG001|Period 1 (7 Days)|Physician Decision|0
1986671|NCT01857063|3552131|FG000|Period 1 (7 Days)|Withdrawal by Subject|1
1986672|NCT01857063|3552132|FG001|Period 1 (7 Days)|Withdrawal by Subject|3
1986673|NCT01857063|3552131|FG000|Period 2 (7 Days)|Adverse Event|2
1986674|NCT01857063|3552132|FG001|Period 2 (7 Days)|Adverse Event|1
1986675|NCT01857063|3552131|FG000|Period 2 (7 Days)|Physician Decision|1
1986676|NCT01857063|3552132|FG001|Period 2 (7 Days)|Physician Decision|1
1986677|NCT01857063|3552131|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
1986678|NCT01857063|3552132|FG001|Period 2 (7 Days)|Withdrawal by Subject|0
1986679|NCT01852812|3552145|FG000|Overall Study|Adverse Event|0
1986680|NCT01852812|3552146|FG001|Overall Study|Adverse Event|0
1986681|NCT01852812|3552147|FG002|Overall Study|Adverse Event|1
1986682|NCT01852812|3552145|FG000|Overall Study|Non-compliance With Study Drug|0
1986683|NCT01852812|3552146|FG001|Overall Study|Non-compliance With Study Drug|1
1986684|NCT01852812|3552147|FG002|Overall Study|Non-compliance With Study Drug|0
1986685|NCT01844986|3552157|FG000|Overall Study|Severe non-compliance to protocol|1
1986686|NCT01844986|3552158|FG001|Overall Study|Severe non-compliance to protocol|0
1986687|NCT01844986|3552157|FG000|Overall Study|Withdrawal by Subject|21
1986688|NCT01844986|3552158|FG001|Overall Study|Withdrawal by Subject|14
1986689|NCT01844986|3552157|FG000|Overall Study|Death|55
1986690|NCT01844986|3552158|FG001|Overall Study|Death|26
1986691|NCT01828021|3552164|FG000|Overall Study|Adverse Event|5
1986692|NCT01828021|3552164|FG000|Overall Study|Lack of Efficacy|17
1986693|NCT01828021|3552164|FG000|Overall Study|Withdrawal by Subject|2
1986694|NCT01828021|3552164|FG000|Overall Study|Ileal obstruction, unrelated|1
1986695|NCT01709318|3552175|FG000|Overall Study|Adverse Event|3
1986696|NCT01709318|3552176|FG001|Overall Study|Adverse Event|4
1986697|NCT01709318|3552177|FG002|Overall Study|Adverse Event|2
1986698|NCT01709318|3552178|FG003|Overall Study|Adverse Event|2
1986699|NCT01709318|3552179|FG004|Overall Study|Adverse Event|0
1986700|NCT01709318|3552180|FG005|Overall Study|Adverse Event|1
1986701|NCT01709318|3552181|FG006|Overall Study|Adverse Event|2
1986702|NCT01709318|3552175|FG000|Overall Study|Lost to Follow-up|2
1986703|NCT01709318|3552176|FG001|Overall Study|Lost to Follow-up|0
1986704|NCT01709318|3552177|FG002|Overall Study|Lost to Follow-up|0
1986705|NCT01709318|3552178|FG003|Overall Study|Lost to Follow-up|0
1986706|NCT01709318|3552179|FG004|Overall Study|Lost to Follow-up|1
1986707|NCT01709318|3552180|FG005|Overall Study|Lost to Follow-up|1
1986708|NCT01709318|3552181|FG006|Overall Study|Lost to Follow-up|1
1986709|NCT01709318|3552175|FG000|Overall Study|Non-compliance with Study Drug|0
1986710|NCT01709318|3552176|FG001|Overall Study|Non-compliance with Study Drug|2
1986711|NCT01709318|3552177|FG002|Overall Study|Non-compliance with Study Drug|1
1986712|NCT01709318|3552178|FG003|Overall Study|Non-compliance with Study Drug|1
1986713|NCT01709318|3552179|FG004|Overall Study|Non-compliance with Study Drug|0
1986714|NCT01709318|3552180|FG005|Overall Study|Non-compliance with Study Drug|0
1986715|NCT01709318|3552181|FG006|Overall Study|Non-compliance with Study Drug|2
1986716|NCT01709318|3552175|FG000|Overall Study|Physician Decision|0
1986717|NCT01709318|3552176|FG001|Overall Study|Physician Decision|0
1986718|NCT01709318|3552177|FG002|Overall Study|Physician Decision|0
1986719|NCT01709318|3552178|FG003|Overall Study|Physician Decision|0
1986720|NCT01709318|3552179|FG004|Overall Study|Physician Decision|0
1986721|NCT01709318|3552180|FG005|Overall Study|Physician Decision|0
1986722|NCT01709318|3552181|FG006|Overall Study|Physician Decision|1
1986723|NCT01709318|3552175|FG000|Overall Study|Pregnancy|0
1986724|NCT01709318|3552176|FG001|Overall Study|Pregnancy|0
1986725|NCT01709318|3552177|FG002|Overall Study|Pregnancy|0
1986726|NCT01709318|3552178|FG003|Overall Study|Pregnancy|0
1986727|NCT01709318|3552179|FG004|Overall Study|Pregnancy|1
1986728|NCT01709318|3552180|FG005|Overall Study|Pregnancy|0
1986729|NCT01709318|3552181|FG006|Overall Study|Pregnancy|0
1986730|NCT01709318|3552175|FG000|Overall Study|Protocol Violation|0
1986731|NCT01709318|3552176|FG001|Overall Study|Protocol Violation|0
1986732|NCT01709318|3552177|FG002|Overall Study|Protocol Violation|0
1986733|NCT01709318|3552178|FG003|Overall Study|Protocol Violation|0
1986734|NCT01709318|3552179|FG004|Overall Study|Protocol Violation|2
1986735|NCT01709318|3552180|FG005|Overall Study|Protocol Violation|0
1986736|NCT01709318|3552181|FG006|Overall Study|Protocol Violation|1
1986737|NCT01709318|3552175|FG000|Overall Study|Technical Problems|1
1986738|NCT01709318|3552176|FG001|Overall Study|Technical Problems|0
1986739|NCT01709318|3552177|FG002|Overall Study|Technical Problems|0
1986740|NCT01709318|3552178|FG003|Overall Study|Technical Problems|0
1986741|NCT01709318|3552179|FG004|Overall Study|Technical Problems|0
1986742|NCT01709318|3552180|FG005|Overall Study|Technical Problems|0
1986743|NCT01709318|3552181|FG006|Overall Study|Technical Problems|0
1986744|NCT01709318|3552175|FG000|Overall Study|Withdrawal by Subject|3
1986745|NCT01709318|3552176|FG001|Overall Study|Withdrawal by Subject|0
1986746|NCT01709318|3552177|FG002|Overall Study|Withdrawal by Subject|3
1986747|NCT01709318|3552178|FG003|Overall Study|Withdrawal by Subject|3
1986748|NCT01709318|3552179|FG004|Overall Study|Withdrawal by Subject|0
1986749|NCT01709318|3552180|FG005|Overall Study|Withdrawal by Subject|2
1986750|NCT01709318|3552181|FG006|Overall Study|Withdrawal by Subject|4
1986751|NCT01709318|3552175|FG000|Overall Study|Other Protocol Specified Criteria|0
1986752|NCT01709318|3552176|FG001|Overall Study|Other Protocol Specified Criteria|1
1986753|NCT01709318|3552177|FG002|Overall Study|Other Protocol Specified Criteria|0
1986754|NCT01709318|3552178|FG003|Overall Study|Other Protocol Specified Criteria|0
1986755|NCT01709318|3552179|FG004|Overall Study|Other Protocol Specified Criteria|0
1986756|NCT01709318|3552180|FG005|Overall Study|Other Protocol Specified Criteria|0
1986757|NCT01709318|3552181|FG006|Overall Study|Other Protocol Specified Criteria|0
1986758|NCT01698918|3552197|FG000|First Line Treatment (Core+Extension)|Adverse Event|33
1986759|NCT01698918|3552197|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11
1986760|NCT01698918|3552197|FG000|First Line Treatment (Core+Extension)|Death|2
1986761|NCT01698918|3552197|FG000|First Line Treatment (Core+Extension)|Disease progression|120
1986762|NCT01698918|3552197|FG000|First Line Treatment (Core+Extension)|Physician Decision|7
1986763|NCT01698918|3552197|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3
1986764|NCT01698918|3552197|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1
1986765|NCT01698918|3552197|FG000|Second Line Treatment (Core+Extension)|Death|1
1986766|NCT01698918|3552197|FG000|Second Line Treatment (Core+Extension)|Disease progression|38
1986767|NCT01698918|3552197|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3
1986768|NCT01673620|3552211|FG000|Overall Study|Adverse Event|1
1986769|NCT01673620|3552212|FG001|Overall Study|Adverse Event|0
1986770|NCT01660243|3552222|FG000|Overall Study|Adverse Event|1
1986771|NCT01660243|3552223|FG001|Overall Study|Adverse Event|0
1986772|NCT01660243|3552224|FG002|Overall Study|Adverse Event|1
1986773|NCT01660243|3552225|FG003|Overall Study|Adverse Event|0
1986774|NCT01660243|3552222|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1
1986775|NCT01660243|3552223|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
1986776|NCT01660243|3552224|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
1986777|NCT01660243|3552225|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
1986778|NCT01660243|3552222|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
1986779|NCT01660243|3552223|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
1986780|NCT01660243|3552224|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1
1986781|NCT01660243|3552225|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
1986782|NCT01660243|3552222|FG000|Overall Study|Randomization error|0
1986783|NCT01660243|3552223|FG001|Overall Study|Randomization error|0
1986784|NCT01660243|3552224|FG002|Overall Study|Randomization error|0
1986785|NCT01660243|3552225|FG003|Overall Study|Randomization error|1
1986786|NCT01617187|3552239|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1986787|NCT01617187|3552240|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1986788|NCT01617187|3552241|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1986789|NCT01617187|3552242|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
1986790|NCT01617187|3552239|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1986791|NCT01617187|3552240|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1986792|NCT01617187|3552241|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1986793|NCT01617187|3552242|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1
1986794|NCT01617187|3552239|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1
1986795|NCT01617187|3552240|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1986796|NCT01617187|3552241|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1986797|NCT01617187|3552242|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1986798|NCT01617187|3552239|FG000|Treatment Through Study Completion|Adverse Event|1
1986799|NCT01617187|3552240|FG001|Treatment Through Study Completion|Adverse Event|1
1986800|NCT01617187|3552241|FG002|Treatment Through Study Completion|Adverse Event|0
1986801|NCT01617187|3552242|FG003|Treatment Through Study Completion|Adverse Event|1
1986802|NCT01617187|3552239|FG000|Treatment Through Study Completion|Lost to Follow-up|4
1986803|NCT01617187|3552240|FG001|Treatment Through Study Completion|Lost to Follow-up|2
1986804|NCT01617187|3552241|FG002|Treatment Through Study Completion|Lost to Follow-up|2
1986805|NCT01617187|3552242|FG003|Treatment Through Study Completion|Lost to Follow-up|2
1986806|NCT01617187|3552239|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
1986807|NCT01617187|3552240|FG001|Treatment Through Study Completion|Withdrawal by Subject|8
1986808|NCT01617187|3552241|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
2213459|NCT01678924|3854989|FG000|Overall Study|Personal Reasons|2
2213460|NCT01678924|3854990|FG001|Overall Study|Personal Reasons|2
2213461|NCT01678924|3854991|FG002|Overall Study|Personal Reasons|2
1986809|NCT01617187|3552242|FG003|Treatment Through Study Completion|Withdrawal by Subject|6
1986810|NCT01617187|3552239|FG000|Treatment Through Study Completion|Protocol Violation|1
1986811|NCT01617187|3552240|FG001|Treatment Through Study Completion|Protocol Violation|0
1986812|NCT01617187|3552241|FG002|Treatment Through Study Completion|Protocol Violation|0
1986813|NCT01617187|3552242|FG003|Treatment Through Study Completion|Protocol Violation|1
1986814|NCT01611883|3552254|FG000|Overall Study|Adverse Event|1
1986815|NCT01611883|3552255|FG001|Overall Study|Adverse Event|1
1986816|NCT01572675|3552263|FG000|Overall Study|End of prescribed treatment|140
1986817|NCT01572675|3552264|FG001|Overall Study|End of prescribed treatment|118
1986818|NCT01572675|3552263|FG000|Overall Study|Recovery|16
1986819|NCT01572675|3552264|FG001|Overall Study|Recovery|23
1986820|NCT01572675|3552263|FG000|Overall Study|Lack of Efficacy|31
1986821|NCT01572675|3552264|FG001|Overall Study|Lack of Efficacy|31
1986822|NCT01572675|3552263|FG000|Overall Study|Intolerance|6
1986823|NCT01572675|3552264|FG001|Overall Study|Intolerance|5
1986824|NCT01572675|3552263|FG000|Overall Study|Improved symptoms|8
1986825|NCT01572675|3552264|FG001|Overall Study|Improved symptoms|2
1986826|NCT01572675|3552263|FG000|Overall Study|Surgical intervention|3
1986827|NCT01572675|3552264|FG001|Overall Study|Surgical intervention|6
1986828|NCT01572675|3552263|FG000|Overall Study|Withdrawal by Subject|5
2213462|NCT01678924|3854992|FG003|Overall Study|Personal Reasons|7
1986829|NCT01572675|3552264|FG001|Overall Study|Withdrawal by Subject|1
1986830|NCT01572675|3552263|FG000|Overall Study|Physician Decision|2
1986831|NCT01572675|3552264|FG001|Overall Study|Physician Decision|2
1986832|NCT01572675|3552263|FG000|Overall Study|Death unrelated to coxibs|1
1986833|NCT01572675|3552264|FG001|Overall Study|Death unrelated to coxibs|1
1986834|NCT01572675|3552263|FG000|Overall Study|Other disease detected|1
1986835|NCT01572675|3552264|FG001|Overall Study|Other disease detected|1
1986836|NCT01572675|3552263|FG000|Overall Study|Unknown reason|1
1986837|NCT01572675|3552264|FG001|Overall Study|Unknown reason|1
1986838|NCT01572675|3552263|FG000|Overall Study|Rheumatologist new evaluation|0
1986839|NCT01572675|3552264|FG001|Overall Study|Rheumatologist new evaluation|1
1986840|NCT01572675|3552263|FG000|Overall Study|Missing data|1
1986841|NCT01572675|3552264|FG001|Overall Study|Missing data|4
1986842|NCT01572675|3552263|FG000|Overall Study|Lost to Follow-up|22
1986843|NCT01572675|3552264|FG001|Overall Study|Lost to Follow-up|27
1986844|NCT01554163|3552285|FG000|Overall Study|Adverse Event|3
1986845|NCT01554163|3552286|FG001|Overall Study|Adverse Event|0
1986846|NCT01554163|3552285|FG000|Overall Study|Lack of Efficacy|1
1986847|NCT01554163|3552286|FG001|Overall Study|Lack of Efficacy|0
1986848|NCT01554163|3552285|FG000|Overall Study|Lost to Follow-up|1
1986849|NCT01554163|3552286|FG001|Overall Study|Lost to Follow-up|0
1986850|NCT01554163|3552285|FG000|Overall Study|Non-Compliance With Study Drug|1
1986851|NCT01554163|3552286|FG001|Overall Study|Non-Compliance With Study Drug|1
1986852|NCT01554163|3552285|FG000|Overall Study|Protocol Violation|0
1986853|NCT01554163|3552286|FG001|Overall Study|Protocol Violation|4
1986854|NCT01554163|3552285|FG000|Overall Study|Withdrawal by Subject|1
1986855|NCT01554163|3552286|FG001|Overall Study|Withdrawal by Subject|5
1986856|NCT01554163|3552285|FG000|Overall Study|Not Treated|1
1986857|NCT01554163|3552286|FG001|Overall Study|Not Treated|0
1986858|NCT01502371|3552297|FG000|Overall Study|Withdrawal by Subject|1
1986859|NCT01502371|3552298|FG001|Overall Study|Withdrawal by Subject|2
1986860|NCT01502371|3552299|FG002|Overall Study|Withdrawal by Subject|1
1986861|NCT01502371|3552300|FG003|Overall Study|Withdrawal by Subject|1
1986862|NCT01502371|3552301|FG004|Overall Study|Withdrawal by Subject|1
1986863|NCT01502371|3552297|FG000|Overall Study|Adverse Event|2
1986864|NCT01502371|3552298|FG001|Overall Study|Adverse Event|1
1986865|NCT01502371|3552299|FG002|Overall Study|Adverse Event|0
1986866|NCT01502371|3552300|FG003|Overall Study|Adverse Event|4
1986867|NCT01502371|3552301|FG004|Overall Study|Adverse Event|3
1986868|NCT01502371|3552297|FG000|Overall Study|Treatment Failure|22
1986869|NCT01502371|3552298|FG001|Overall Study|Treatment Failure|20
1986870|NCT01502371|3552299|FG002|Overall Study|Treatment Failure|12
1986871|NCT01502371|3552300|FG003|Overall Study|Treatment Failure|19
1986872|NCT01502371|3552301|FG004|Overall Study|Treatment Failure|30
1986873|NCT01502371|3552297|FG000|Overall Study|Lack of Efficacy|3
1986874|NCT01502371|3552298|FG001|Overall Study|Lack of Efficacy|3
1986875|NCT01502371|3552299|FG002|Overall Study|Lack of Efficacy|2
1986876|NCT01502371|3552300|FG003|Overall Study|Lack of Efficacy|2
1986877|NCT01502371|3552301|FG004|Overall Study|Lack of Efficacy|4
1986878|NCT01502371|3552297|FG000|Overall Study|Physician Decision|3
1986879|NCT01502371|3552298|FG001|Overall Study|Physician Decision|0
1986880|NCT01502371|3552299|FG002|Overall Study|Physician Decision|0
1986881|NCT01502371|3552300|FG003|Overall Study|Physician Decision|0
1986882|NCT01502371|3552301|FG004|Overall Study|Physician Decision|1
1986883|NCT01502371|3552297|FG000|Overall Study|Noncompliance with Study Drug|0
1986884|NCT01502371|3552298|FG001|Overall Study|Noncompliance with Study Drug|0
1986885|NCT01502371|3552299|FG002|Overall Study|Noncompliance with Study Drug|1
1986886|NCT01502371|3552300|FG003|Overall Study|Noncompliance with Study Drug|2
1986887|NCT01502371|3552301|FG004|Overall Study|Noncompliance with Study Drug|1
1986888|NCT01502371|3552297|FG000|Overall Study|Technical Problems|1
1986889|NCT01502371|3552298|FG001|Overall Study|Technical Problems|0
1986890|NCT01502371|3552299|FG002|Overall Study|Technical Problems|2
1986891|NCT01502371|3552300|FG003|Overall Study|Technical Problems|4
1986892|NCT01502371|3552301|FG004|Overall Study|Technical Problems|1
1986893|NCT01502371|3552297|FG000|Overall Study|Protocol Violation|9
1986894|NCT01502371|3552298|FG001|Overall Study|Protocol Violation|5
1986895|NCT01502371|3552299|FG002|Overall Study|Protocol Violation|6
1986896|NCT01502371|3552300|FG003|Overall Study|Protocol Violation|5
1986897|NCT01502371|3552301|FG004|Overall Study|Protocol Violation|10
1986898|NCT01502371|3552297|FG000|Overall Study|Excluded Medication|0
1986899|NCT01502371|3552298|FG001|Overall Study|Excluded Medication|1
1986900|NCT01502371|3552299|FG002|Overall Study|Excluded Medication|1
1986901|NCT01502371|3552300|FG003|Overall Study|Excluded Medication|0
1986902|NCT01502371|3552301|FG004|Overall Study|Excluded Medication|1
1986903|NCT01490190|3552314|FG000|Overall Study|Withdrawal by Subject|9
1986904|NCT01490190|3552314|FG000|Overall Study|Adverse Event|17
1986905|NCT01490190|3552314|FG000|Overall Study|Protocol Violation|5
1986906|NCT01490190|3552314|FG000|Overall Study|Lost to Follow-up|13
1986907|NCT01490190|3552314|FG000|Overall Study|Relocation|1
1986908|NCT01490190|3552314|FG000|Overall Study|Inconvenience|1
1986909|NCT01490190|3552314|FG000|Overall Study|Ring expulsion|2
1986910|NCT01471340|3552320|FG000|Overall Study|Death|5
1986911|NCT01471340|3552321|FG001|Overall Study|Death|4
1986912|NCT01471340|3552320|FG000|Overall Study|Lost to Follow-up|0
1986913|NCT01471340|3552321|FG001|Overall Study|Lost to Follow-up|1
1986914|NCT01471340|3552320|FG000|Overall Study|Investigational site closure|0
1986915|NCT01471340|3552321|FG001|Overall Study|Investigational site closure|1
1986916|NCT01471340|3552320|FG000|Overall Study|Invalid informed consent|1
1986917|NCT01471340|3552321|FG001|Overall Study|Invalid informed consent|0
1986918|NCT01462370|3552327|FG000|Overall Study|Lack of Qualifying Event|1
1986919|NCT01462370|3552328|FG001|Overall Study|Lack of Qualifying Event|1
1986920|NCT01462370|3552327|FG000|Overall Study|Physician Decision|0
1986921|NCT01462370|3552328|FG001|Overall Study|Physician Decision|1
1986922|NCT01462370|3552327|FG000|Overall Study|Withdrawal by Subject|0
1986923|NCT01462370|3552328|FG001|Overall Study|Withdrawal by Subject|3
1986924|NCT01436253|3552334|FG000|Overall Study|Lost to Follow-up|182
1986925|NCT01436253|3552334|FG000|Overall Study|Not meeting all eligibility criteria|117
1986926|NCT01381679|3552368|FG000|Overall Study|Adverse Event|3
1986927|NCT01381679|3552368|FG000|Overall Study|Lost to Follow-up|885
1986928|NCT01370603|3552374|FG000|Period 1|Adverse Event|5
1986929|NCT01370603|3552375|FG001|Period 1|Adverse Event|3
1986930|NCT01370603|3552374|FG000|Period 1|Lost to Follow-up|2
1986931|NCT01370603|3552375|FG001|Period 1|Lost to Follow-up|0
1986932|NCT01370603|3552374|FG000|Period 1|Protocol Violation|2
1986933|NCT01370603|3552375|FG001|Period 1|Protocol Violation|2
1986934|NCT01370603|3552374|FG000|Period 1|Withdrawal by Subject|5
1986935|NCT01370603|3552375|FG001|Period 1|Withdrawal by Subject|5
1986936|NCT01370603|3552374|FG000|Crossover Washout|Adverse Event|2
1986937|NCT01370603|3552375|FG001|Crossover Washout|Adverse Event|1
1986938|NCT01370603|3552374|FG000|Crossover Washout|Lost to Follow-up|2
1986939|NCT01370603|3552375|FG001|Crossover Washout|Lost to Follow-up|0
1986940|NCT01370603|3552374|FG000|Crossover Washout|Protocol Violation|1
1986941|NCT01370603|3552375|FG001|Crossover Washout|Protocol Violation|0
1986942|NCT01370603|3552374|FG000|Crossover Washout|Withdrawal by Subject|4
1986943|NCT01370603|3552375|FG001|Crossover Washout|Withdrawal by Subject|1
1986944|NCT01370603|3552374|FG000|Crossover Washout|Non-compliance with Study Drug|0
1986945|NCT01370603|3552375|FG001|Crossover Washout|Non-compliance with Study Drug|2
1986946|NCT01370603|3552374|FG000|Period 2|Adverse Event|1
1986947|NCT01370603|3552375|FG001|Period 2|Adverse Event|4
1986948|NCT01370603|3552374|FG000|Period 2|Lost to Follow-up|1
1986949|NCT01370603|3552375|FG001|Period 2|Lost to Follow-up|0
1986950|NCT01370603|3552374|FG000|Period 2|Withdrawal by Subject|1
1986951|NCT01370603|3552375|FG001|Period 2|Withdrawal by Subject|0
1986952|NCT01370590|3552383|FG000|Period 1|Adverse Event|8
1986953|NCT01370590|3552384|FG001|Period 1|Adverse Event|4
1986954|NCT01370590|3552383|FG000|Period 1|Lost to Follow-up|2
1986955|NCT01370590|3552384|FG001|Period 1|Lost to Follow-up|2
1986956|NCT01370590|3552383|FG000|Period 1|Protocol Violation|2
1986957|NCT01370590|3552384|FG001|Period 1|Protocol Violation|2
1986958|NCT01370590|3552383|FG000|Period 1|Withdrawal by Subject|4
1986959|NCT01370590|3552384|FG001|Period 1|Withdrawal by Subject|2
1986960|NCT01370590|3552383|FG000|Period 1|Could not access randomization system|0
1986961|NCT01370590|3552384|FG001|Period 1|Could not access randomization system|1
1986962|NCT01370590|3552383|FG000|Crossover Washout Period|Adverse Event|1
1986963|NCT01370590|3552384|FG001|Crossover Washout Period|Adverse Event|4
1986964|NCT01370590|3552383|FG000|Crossover Washout Period|Lost to Follow-up|2
1986965|NCT01370590|3552384|FG001|Crossover Washout Period|Lost to Follow-up|0
1986966|NCT01370590|3552383|FG000|Crossover Washout Period|Non-compliance with Study Drug|1
1986967|NCT01370590|3552384|FG001|Crossover Washout Period|Non-compliance with Study Drug|0
1986968|NCT01370590|3552383|FG000|Crossover Washout Period|Withdrawal by Subject|2
1986969|NCT01370590|3552384|FG001|Crossover Washout Period|Withdrawal by Subject|2
1986970|NCT01370590|3552383|FG000|Period 2|Adverse Event|0
1986971|NCT01370590|3552384|FG001|Period 2|Adverse Event|1
1986972|NCT01370590|3552383|FG000|Period 2|Withdrawal by Subject|1
1986973|NCT01370590|3552384|FG001|Period 2|Withdrawal by Subject|1
1986974|NCT01349907|3552396|FG000|Overall Study|Adverse Event|37
1986975|NCT01349907|3552397|FG001|Overall Study|Adverse Event|11
1986976|NCT01349907|3552396|FG000|Overall Study|Treatment failure|13
1986977|NCT01349907|3552397|FG001|Overall Study|Treatment failure|4
1986978|NCT01349907|3552396|FG000|Overall Study|Lost to Follow-up|25
1986979|NCT01349907|3552397|FG001|Overall Study|Lost to Follow-up|6
1986980|NCT01349907|3552396|FG000|Overall Study|Withdrawal by Subject|30
1986981|NCT01349907|3552397|FG001|Overall Study|Withdrawal by Subject|8
1986982|NCT01349907|3552396|FG000|Overall Study|Protocol Violation|33
1986983|NCT01349907|3552397|FG001|Overall Study|Protocol Violation|13
1986984|NCT01349907|3552396|FG000|Overall Study|Administrative|1
1986985|NCT01349907|3552397|FG001|Overall Study|Administrative|1
1986986|NCT01345786|3552407|FG000|Overall Study|Adverse Event|0
1986987|NCT01345786|3552408|FG001|Overall Study|Adverse Event|1
1986988|NCT01345786|3552409|FG002|Overall Study|Adverse Event|3
1986989|NCT01345786|3552410|FG003|Overall Study|Adverse Event|1
1986990|NCT01345786|3552407|FG000|Overall Study|Subject withdrew consent|2
1986991|NCT01345786|3552408|FG001|Overall Study|Subject withdrew consent|2
1986992|NCT01345786|3552409|FG002|Overall Study|Subject withdrew consent|1
1986993|NCT01345786|3552410|FG003|Overall Study|Subject withdrew consent|0
1986994|NCT01345786|3552407|FG000|Overall Study|Noncompliance with protocol|1
1986995|NCT01345786|3552408|FG001|Overall Study|Noncompliance with protocol|0
1986996|NCT01345786|3552409|FG002|Overall Study|Noncompliance with protocol|1
1986997|NCT01345786|3552410|FG003|Overall Study|Noncompliance with protocol|0
1986998|NCT01345786|3552407|FG000|Overall Study|Administrative|3
1986999|NCT01345786|3552408|FG001|Overall Study|Administrative|5
1987000|NCT01345786|3552409|FG002|Overall Study|Administrative|0
1987001|NCT01345786|3552410|FG003|Overall Study|Administrative|0
1987002|NCT01345786|3552407|FG000|Overall Study|Lost to Follow-up|0
1987003|NCT01345786|3552408|FG001|Overall Study|Lost to Follow-up|0
1987004|NCT01345786|3552409|FG002|Overall Study|Lost to Follow-up|0
1987005|NCT01345786|3552410|FG003|Overall Study|Lost to Follow-up|2
1987006|NCT01306929|3552420|FG000|Overall Study|Withdrawal by Subject|23
1987007|NCT01306929|3552420|FG000|Overall Study|Adverse Event|21
1987008|NCT01306929|3552420|FG000|Overall Study|Physician Decision|13
1987009|NCT01306929|3552420|FG000|Overall Study|Death|8
1987010|NCT01306929|3552420|FG000|Overall Study|Withdrawal by parent/guardian|5
1987011|NCT01306929|3552420|FG000|Overall Study|Protocol Violation|3
1987012|NCT01306929|3552420|FG000|Overall Study|Non-compliance with study drug|2
1987013|NCT01306929|3552420|FG000|Overall Study|Lost to Follow-up|2
1987014|NCT01306929|3552420|FG000|Overall Study|Various|17
1987015|NCT01294696|3552426|FG000|Overall Study|Screening failures|7
1987016|NCT01294696|3552426|FG000|Overall Study|Protocol Violation|8
1987017|NCT01294696|3552426|FG000|Overall Study|Missing BPI Response|7
1987018|NCT01294696|3552426|FG000|Overall Study|Site closure|52
1987019|NCT01277822|3552433|FG000|Overall Study|Adverse Event|2
1987020|NCT01277822|3552434|FG001|Overall Study|Adverse Event|1
1987021|NCT01277822|3552433|FG000|Overall Study|Withdrawal by Subject|6
1987022|NCT01277822|3552434|FG001|Overall Study|Withdrawal by Subject|7
1987023|NCT01277822|3552433|FG000|Overall Study|Physician Decision|1
1987024|NCT01277822|3552434|FG001|Overall Study|Physician Decision|1
1987025|NCT01277822|3552433|FG000|Overall Study|Protocol Violation|1
1987026|NCT01277822|3552434|FG001|Overall Study|Protocol Violation|0
1987027|NCT01277822|3552433|FG000|Overall Study|Lost to Follow-up|2
1987028|NCT01277822|3552434|FG001|Overall Study|Lost to Follow-up|1
1987029|NCT01277822|3552433|FG000|Overall Study|Contraindicated medication used|2
1987030|NCT01277822|3552434|FG001|Overall Study|Contraindicated medication used|1
2213463|NCT01678924|3854989|FG000|Overall Study|Withdrawal by Subject|0
2213464|NCT01678924|3854990|FG001|Overall Study|Withdrawal by Subject|3
2213465|NCT01678924|3854991|FG002|Overall Study|Withdrawal by Subject|0
1987031|NCT01277822|3552433|FG000|Overall Study|Participant moved|1
1987032|NCT01277822|3552434|FG001|Overall Study|Participant moved|0
1987033|NCT01261247|3552440|FG000|Overall Study|Ineligible|2
1987034|NCT01244763|3552450|FG000|Overall Study|Adverse Event|1
1987035|NCT01244763|3552451|FG001|Overall Study|Adverse Event|0
1987036|NCT01244763|3552452|FG002|Overall Study|Adverse Event|0
1987037|NCT01244763|3552453|FG003|Overall Study|Adverse Event|0
1987038|NCT01244763|3552454|FG004|Overall Study|Adverse Event|0
1987039|NCT01244763|3552455|FG005|Overall Study|Adverse Event|1
1987040|NCT01244763|3552450|FG000|Overall Study|Death|1
1987041|NCT01244763|3552451|FG001|Overall Study|Death|0
1987042|NCT01244763|3552452|FG002|Overall Study|Death|1
1987043|NCT01244763|3552453|FG003|Overall Study|Death|0
1987044|NCT01244763|3552454|FG004|Overall Study|Death|2
1987045|NCT01244763|3552455|FG005|Overall Study|Death|0
1987046|NCT01244763|3552450|FG000|Overall Study|Physician Decision|0
1987047|NCT01244763|3552451|FG001|Overall Study|Physician Decision|0
1987048|NCT01244763|3552452|FG002|Overall Study|Physician Decision|1
1987049|NCT01244763|3552453|FG003|Overall Study|Physician Decision|0
1987050|NCT01244763|3552454|FG004|Overall Study|Physician Decision|0
1987051|NCT01244763|3552455|FG005|Overall Study|Physician Decision|0
1987052|NCT01244763|3552450|FG000|Overall Study|Withdrawal by Subject|1
1987053|NCT01244763|3552451|FG001|Overall Study|Withdrawal by Subject|2
1987054|NCT01244763|3552452|FG002|Overall Study|Withdrawal by Subject|0
1987055|NCT01244763|3552453|FG003|Overall Study|Withdrawal by Subject|1
1987056|NCT01244763|3552454|FG004|Overall Study|Withdrawal by Subject|1
1987057|NCT01244763|3552455|FG005|Overall Study|Withdrawal by Subject|2
1987058|NCT01244763|3552450|FG000|Overall Study|Lost to Follow-up|0
1987059|NCT01244763|3552451|FG001|Overall Study|Lost to Follow-up|1
1987060|NCT01244763|3552452|FG002|Overall Study|Lost to Follow-up|0
1987061|NCT01244763|3552453|FG003|Overall Study|Lost to Follow-up|0
1987062|NCT01244763|3552454|FG004|Overall Study|Lost to Follow-up|0
1987063|NCT01244763|3552455|FG005|Overall Study|Lost to Follow-up|0
1987064|NCT01244763|3552450|FG000|Overall Study|Enrolled into the Extension Study|0
1987065|NCT01244763|3552451|FG001|Overall Study|Enrolled into the Extension Study|0
1987066|NCT01244763|3552452|FG002|Overall Study|Enrolled into the Extension Study|0
1987067|NCT01244763|3552453|FG003|Overall Study|Enrolled into the Extension Study|0
1987068|NCT01244763|3552454|FG004|Overall Study|Enrolled into the Extension Study|0
1987069|NCT01244763|3552455|FG005|Overall Study|Enrolled into the Extension Study|1
1987070|NCT01208207|3552472|FG000|Part I|Adverse Event|19
1987071|NCT01208207|3552473|FG001|Part I|Adverse Event|2
1987072|NCT01208207|3552474|FG002|Part I|Adverse Event|6
2102387|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4
1987073|NCT01208207|3552475|FG003|Part I|Adverse Event|0
1987074|NCT01208207|3552476|FG004|Part I|Adverse Event|0
1987075|NCT01208207|3552477|FG005|Part I|Adverse Event|0
1987076|NCT01208207|3552478|FG006|Part I|Adverse Event|0
1987077|NCT01208207|3552472|FG000|Part I|Lack of Efficacy|21
1987078|NCT01208207|3552473|FG001|Part I|Lack of Efficacy|3
1987079|NCT01208207|3552474|FG002|Part I|Lack of Efficacy|2
1987080|NCT01208207|3552475|FG003|Part I|Lack of Efficacy|0
1987081|NCT01208207|3552476|FG004|Part I|Lack of Efficacy|0
1987082|NCT01208207|3552477|FG005|Part I|Lack of Efficacy|0
1987083|NCT01208207|3552478|FG006|Part I|Lack of Efficacy|0
1987084|NCT01208207|3552472|FG000|Part I|Lost to Follow-up|6
1987085|NCT01208207|3552473|FG001|Part I|Lost to Follow-up|1
1987086|NCT01208207|3552474|FG002|Part I|Lost to Follow-up|0
1987087|NCT01208207|3552475|FG003|Part I|Lost to Follow-up|0
1987088|NCT01208207|3552476|FG004|Part I|Lost to Follow-up|0
1987089|NCT01208207|3552477|FG005|Part I|Lost to Follow-up|0
1987090|NCT01208207|3552478|FG006|Part I|Lost to Follow-up|0
1987091|NCT01208207|3552472|FG000|Part I|Non-Compliance With Study Drug|1
1987092|NCT01208207|3552473|FG001|Part I|Non-Compliance With Study Drug|0
1987093|NCT01208207|3552474|FG002|Part I|Non-Compliance With Study Drug|1
1987094|NCT01208207|3552475|FG003|Part I|Non-Compliance With Study Drug|0
1987095|NCT01208207|3552476|FG004|Part I|Non-Compliance With Study Drug|0
1987096|NCT01208207|3552477|FG005|Part I|Non-Compliance With Study Drug|0
1987097|NCT01208207|3552478|FG006|Part I|Non-Compliance With Study Drug|0
1987098|NCT01208207|3552472|FG000|Part I|Physician Decision|0
1987099|NCT01208207|3552473|FG001|Part I|Physician Decision|1
1987100|NCT01208207|3552474|FG002|Part I|Physician Decision|0
1987101|NCT01208207|3552475|FG003|Part I|Physician Decision|0
1987102|NCT01208207|3552476|FG004|Part I|Physician Decision|0
1987103|NCT01208207|3552477|FG005|Part I|Physician Decision|0
1987104|NCT01208207|3552478|FG006|Part I|Physician Decision|0
1987105|NCT01208207|3552472|FG000|Part I|Progressive Disease|1
1987106|NCT01208207|3552473|FG001|Part I|Progressive Disease|0
1987107|NCT01208207|3552474|FG002|Part I|Progressive Disease|0
1987108|NCT01208207|3552475|FG003|Part I|Progressive Disease|0
1987109|NCT01208207|3552476|FG004|Part I|Progressive Disease|0
1987110|NCT01208207|3552477|FG005|Part I|Progressive Disease|0
1987111|NCT01208207|3552478|FG006|Part I|Progressive Disease|0
1987112|NCT01208207|3552472|FG000|Part I|Protocol Violation|8
1987113|NCT01208207|3552473|FG001|Part I|Protocol Violation|0
1987114|NCT01208207|3552474|FG002|Part I|Protocol Violation|2
1987115|NCT01208207|3552475|FG003|Part I|Protocol Violation|0
1987116|NCT01208207|3552476|FG004|Part I|Protocol Violation|0
1987117|NCT01208207|3552477|FG005|Part I|Protocol Violation|0
1987118|NCT01208207|3552478|FG006|Part I|Protocol Violation|0
1987119|NCT01208207|3552472|FG000|Part I|Withdrawal by Subject|14
1987120|NCT01208207|3552473|FG001|Part I|Withdrawal by Subject|4
1987121|NCT01208207|3552474|FG002|Part I|Withdrawal by Subject|4
1987122|NCT01208207|3552475|FG003|Part I|Withdrawal by Subject|0
1987123|NCT01208207|3552476|FG004|Part I|Withdrawal by Subject|0
1987124|NCT01208207|3552477|FG005|Part I|Withdrawal by Subject|0
1987125|NCT01208207|3552478|FG006|Part I|Withdrawal by Subject|0
1987126|NCT01208207|3552472|FG000|Part II|Withdrawal by Subject|0
1987127|NCT01208207|3552473|FG001|Part II|Withdrawal by Subject|0
1987128|NCT01208207|3552474|FG002|Part II|Withdrawal by Subject|0
1987129|NCT01208207|3552475|FG003|Part II|Withdrawal by Subject|10
1987130|NCT01208207|3552476|FG004|Part II|Withdrawal by Subject|9
1987131|NCT01208207|3552477|FG005|Part II|Withdrawal by Subject|3
1987132|NCT01208207|3552478|FG006|Part II|Withdrawal by Subject|5
1987133|NCT01208207|3552472|FG000|Part II|Adverse Event|0
1987134|NCT01208207|3552473|FG001|Part II|Adverse Event|0
1987135|NCT01208207|3552474|FG002|Part II|Adverse Event|0
1987136|NCT01208207|3552475|FG003|Part II|Adverse Event|5
1987137|NCT01208207|3552476|FG004|Part II|Adverse Event|9
1987138|NCT01208207|3552477|FG005|Part II|Adverse Event|4
1987139|NCT01208207|3552478|FG006|Part II|Adverse Event|2
1987140|NCT01208207|3552472|FG000|Part II|Lack of Efficacy|0
1987141|NCT01208207|3552473|FG001|Part II|Lack of Efficacy|0
1987142|NCT01208207|3552474|FG002|Part II|Lack of Efficacy|0
1987143|NCT01208207|3552475|FG003|Part II|Lack of Efficacy|6
1987144|NCT01208207|3552476|FG004|Part II|Lack of Efficacy|4
1987145|NCT01208207|3552477|FG005|Part II|Lack of Efficacy|3
1987146|NCT01208207|3552478|FG006|Part II|Lack of Efficacy|3
1987147|NCT01208207|3552472|FG000|Part II|Lost to Follow-up|0
1987148|NCT01208207|3552473|FG001|Part II|Lost to Follow-up|0
1987149|NCT01208207|3552474|FG002|Part II|Lost to Follow-up|0
1987150|NCT01208207|3552475|FG003|Part II|Lost to Follow-up|4
1987151|NCT01208207|3552476|FG004|Part II|Lost to Follow-up|0
1987152|NCT01208207|3552477|FG005|Part II|Lost to Follow-up|2
1987153|NCT01208207|3552478|FG006|Part II|Lost to Follow-up|1
1987154|NCT01208207|3552472|FG000|Part II|Non-Compliance With Study Drug|0
1987155|NCT01208207|3552473|FG001|Part II|Non-Compliance With Study Drug|0
1987156|NCT01208207|3552474|FG002|Part II|Non-Compliance With Study Drug|0
1987157|NCT01208207|3552475|FG003|Part II|Non-Compliance With Study Drug|4
1987158|NCT01208207|3552476|FG004|Part II|Non-Compliance With Study Drug|1
1987159|NCT01208207|3552477|FG005|Part II|Non-Compliance With Study Drug|1
1987160|NCT01208207|3552478|FG006|Part II|Non-Compliance With Study Drug|0
1987161|NCT01208207|3552472|FG000|Part II|Physician Decision|0
1987162|NCT01208207|3552473|FG001|Part II|Physician Decision|0
1987163|NCT01208207|3552474|FG002|Part II|Physician Decision|0
1987164|NCT01208207|3552475|FG003|Part II|Physician Decision|1
1987165|NCT01208207|3552476|FG004|Part II|Physician Decision|0
1987166|NCT01208207|3552477|FG005|Part II|Physician Decision|2
1987167|NCT01208207|3552478|FG006|Part II|Physician Decision|0
1987168|NCT01208207|3552472|FG000|Part II|Protocol Violation|0
1987169|NCT01208207|3552473|FG001|Part II|Protocol Violation|0
1987170|NCT01208207|3552474|FG002|Part II|Protocol Violation|0
1987171|NCT01208207|3552475|FG003|Part II|Protocol Violation|1
1987172|NCT01208207|3552476|FG004|Part II|Protocol Violation|0
1987173|NCT01208207|3552477|FG005|Part II|Protocol Violation|0
1987174|NCT01208207|3552478|FG006|Part II|Protocol Violation|0
1987175|NCT01208207|3552472|FG000|Part II|Technical Problems|0
1987176|NCT01208207|3552473|FG001|Part II|Technical Problems|0
1987177|NCT01208207|3552474|FG002|Part II|Technical Problems|0
1987178|NCT01208207|3552475|FG003|Part II|Technical Problems|1
1987179|NCT01208207|3552476|FG004|Part II|Technical Problems|0
1987180|NCT01208207|3552477|FG005|Part II|Technical Problems|1
1987181|NCT01208207|3552478|FG006|Part II|Technical Problems|0
1987182|NCT01208181|3552503|FG000|Part 1|Withdrawal by Subject|11
1987183|NCT01208181|3552504|FG001|Part 1|Withdrawal by Subject|10
1987184|NCT01208181|3552505|FG002|Part 1|Withdrawal by Subject|0
1987185|NCT01208181|3552506|FG003|Part 1|Withdrawal by Subject|0
1987186|NCT01208181|3552507|FG004|Part 1|Withdrawal by Subject|0
1987187|NCT01208181|3552503|FG000|Part 1|Technical problem|5
1987188|NCT01208181|3552504|FG001|Part 1|Technical problem|0
1987189|NCT01208181|3552505|FG002|Part 1|Technical problem|0
1987190|NCT01208181|3552506|FG003|Part 1|Technical problem|0
1987191|NCT01208181|3552507|FG004|Part 1|Technical problem|0
1987192|NCT01208181|3552503|FG000|Part 1|Protocol Violation|10
1987193|NCT01208181|3552504|FG001|Part 1|Protocol Violation|5
1987194|NCT01208181|3552505|FG002|Part 1|Protocol Violation|0
1987195|NCT01208181|3552506|FG003|Part 1|Protocol Violation|0
1987196|NCT01208181|3552507|FG004|Part 1|Protocol Violation|0
1987197|NCT01208181|3552503|FG000|Part 1|Physician Decision|4
1987198|NCT01208181|3552504|FG001|Part 1|Physician Decision|0
1987199|NCT01208181|3552505|FG002|Part 1|Physician Decision|0
1987200|NCT01208181|3552506|FG003|Part 1|Physician Decision|0
1987201|NCT01208181|3552507|FG004|Part 1|Physician Decision|0
1987202|NCT01208181|3552503|FG000|Part 1|Non-compliance with study drug|1
1987203|NCT01208181|3552504|FG001|Part 1|Non-compliance with study drug|1
1987204|NCT01208181|3552505|FG002|Part 1|Non-compliance with study drug|0
1987205|NCT01208181|3552506|FG003|Part 1|Non-compliance with study drug|0
1987206|NCT01208181|3552507|FG004|Part 1|Non-compliance with study drug|0
1987207|NCT01208181|3552503|FG000|Part 1|Lost to Follow-up|5
1987208|NCT01208181|3552504|FG001|Part 1|Lost to Follow-up|3
1987209|NCT01208181|3552505|FG002|Part 1|Lost to Follow-up|0
1987210|NCT01208181|3552506|FG003|Part 1|Lost to Follow-up|0
1987211|NCT01208181|3552507|FG004|Part 1|Lost to Follow-up|1
1987212|NCT01208181|3552503|FG000|Part 1|Lack of Efficacy|37
1987213|NCT01208181|3552504|FG001|Part 1|Lack of Efficacy|12
1987214|NCT01208181|3552505|FG002|Part 1|Lack of Efficacy|0
1987215|NCT01208181|3552506|FG003|Part 1|Lack of Efficacy|0
1987216|NCT01208181|3552507|FG004|Part 1|Lack of Efficacy|17
1987217|NCT01208181|3552503|FG000|Part 1|Adverse Event|26
1987218|NCT01208181|3552504|FG001|Part 1|Adverse Event|24
1987219|NCT01208181|3552505|FG002|Part 1|Adverse Event|0
1987220|NCT01208181|3552506|FG003|Part 1|Adverse Event|0
1987221|NCT01208181|3552507|FG004|Part 1|Adverse Event|4
1987222|NCT01208181|3552503|FG000|Part 2|Adverse Event|0
1987223|NCT01208181|3552504|FG001|Part 2|Adverse Event|0
1987224|NCT01208181|3552505|FG002|Part 2|Adverse Event|6
1987225|NCT01208181|3552506|FG003|Part 2|Adverse Event|7
1987226|NCT01208181|3552507|FG004|Part 2|Adverse Event|0
1987227|NCT01208181|3552503|FG000|Part 2|Withdrawal by Subject|0
1987228|NCT01208181|3552504|FG001|Part 2|Withdrawal by Subject|0
1987229|NCT01208181|3552505|FG002|Part 2|Withdrawal by Subject|1
1987230|NCT01208181|3552506|FG003|Part 2|Withdrawal by Subject|1
1987231|NCT01208181|3552507|FG004|Part 2|Withdrawal by Subject|0
1987232|NCT01208181|3552503|FG000|Part 2|Protocol Violation|0
1987233|NCT01208181|3552504|FG001|Part 2|Protocol Violation|0
1987234|NCT01208181|3552505|FG002|Part 2|Protocol Violation|1
1987235|NCT01208181|3552506|FG003|Part 2|Protocol Violation|0
1987236|NCT01208181|3552507|FG004|Part 2|Protocol Violation|0
1987237|NCT01208181|3552503|FG000|Part 2|Physician Decision|0
1987238|NCT01208181|3552504|FG001|Part 2|Physician Decision|0
1987239|NCT01208181|3552505|FG002|Part 2|Physician Decision|1
1987240|NCT01208181|3552506|FG003|Part 2|Physician Decision|2
1987241|NCT01208181|3552507|FG004|Part 2|Physician Decision|0
1987242|NCT01208181|3552503|FG000|Part 2|Non-compliance with study drug|0
1987243|NCT01208181|3552504|FG001|Part 2|Non-compliance with study drug|0
1987244|NCT01208181|3552505|FG002|Part 2|Non-compliance with study drug|1
1987245|NCT01208181|3552506|FG003|Part 2|Non-compliance with study drug|1
1987246|NCT01208181|3552507|FG004|Part 2|Non-compliance with study drug|0
1987247|NCT01208181|3552503|FG000|Part 2|Lost to Follow-up|0
1987248|NCT01208181|3552504|FG001|Part 2|Lost to Follow-up|0
1987249|NCT01208181|3552505|FG002|Part 2|Lost to Follow-up|1
1987250|NCT01208181|3552506|FG003|Part 2|Lost to Follow-up|2
1987251|NCT01208181|3552507|FG004|Part 2|Lost to Follow-up|0
1987252|NCT01208181|3552503|FG000|Part 2|Lack of Efficacy|0
1987253|NCT01208181|3552504|FG001|Part 2|Lack of Efficacy|0
1987254|NCT01208181|3552505|FG002|Part 2|Lack of Efficacy|5
1987255|NCT01208181|3552506|FG003|Part 2|Lack of Efficacy|7
1987256|NCT01208181|3552507|FG004|Part 2|Lack of Efficacy|0
1987257|NCT01206517|3552530|FG000|Overall Study|Withdrawal by Subject|0
1987258|NCT01206517|3552531|FG001|Overall Study|Withdrawal by Subject|0
1987259|NCT01206517|3552532|FG002|Overall Study|Withdrawal by Subject|2
1987260|NCT01206517|3552533|FG003|Overall Study|Withdrawal by Subject|0
1987261|NCT01206517|3552534|FG004|Overall Study|Withdrawal by Subject|1
1987262|NCT01206517|3552535|FG005|Overall Study|Withdrawal by Subject|0
1987263|NCT01190267|3552548|FG000|Overall Study|Adverse Event|10
1987264|NCT01190267|3552549|FG001|Overall Study|Adverse Event|0
1987265|NCT01190267|3552548|FG000|Overall Study|Treatment Failure|8
1987266|NCT01190267|3552549|FG001|Overall Study|Treatment Failure|2
1987267|NCT01190267|3552548|FG000|Overall Study|Lost to Follow-up|2
1987268|NCT01190267|3552549|FG001|Overall Study|Lost to Follow-up|0
1987269|NCT01190267|3552548|FG000|Overall Study|Withdrawal by Subject|13
1987270|NCT01190267|3552549|FG001|Overall Study|Withdrawal by Subject|1
1987271|NCT01190267|3552548|FG000|Overall Study|Protocol Violation|8
2213466|NCT01678924|3854992|FG003|Overall Study|Withdrawal by Subject|2
2213467|NCT01678924|3854989|FG000|Overall Study|Unable to attend scheduled visits|0
2213468|NCT01678924|3854990|FG001|Overall Study|Unable to attend scheduled visits|0
2213469|NCT01678924|3854991|FG002|Overall Study|Unable to attend scheduled visits|0
2213470|NCT01678924|3854992|FG003|Overall Study|Unable to attend scheduled visits|1
2213471|NCT01679002|3855018|FG000|Overall Study|Adverse Event|1
2213472|NCT01679002|3855019|FG001|Overall Study|Adverse Event|1
2213473|NCT01679002|3855020|FG002|Overall Study|Adverse Event|0
2213474|NCT01679236|3855065|FG000|Overall Study|Lost to Follow-up|15
1987272|NCT01190267|3552549|FG001|Overall Study|Protocol Violation|1
1987273|NCT01190254|3552558|FG000|Overall Study|Adverse Event|3
1987274|NCT01190254|3552559|FG001|Overall Study|Adverse Event|6
1987275|NCT01190254|3552560|FG002|Overall Study|Adverse Event|8
1987276|NCT01190254|3552558|FG000|Overall Study|Lack of Efficacy|7
1987277|NCT01190254|3552559|FG001|Overall Study|Lack of Efficacy|4
1987278|NCT01190254|3552560|FG002|Overall Study|Lack of Efficacy|5
1987279|NCT01190254|3552558|FG000|Overall Study|Lost to Follow-up|4
1987280|NCT01190254|3552559|FG001|Overall Study|Lost to Follow-up|2
1987281|NCT01190254|3552560|FG002|Overall Study|Lost to Follow-up|0
1987282|NCT01190254|3552558|FG000|Overall Study|Withdrawal by Subject|4
1987283|NCT01190254|3552559|FG001|Overall Study|Withdrawal by Subject|5
1987284|NCT01190254|3552560|FG002|Overall Study|Withdrawal by Subject|7
1987285|NCT01190254|3552558|FG000|Overall Study|Protocol Violation|2
1987286|NCT01190254|3552559|FG001|Overall Study|Protocol Violation|0
1987287|NCT01190254|3552560|FG002|Overall Study|Protocol Violation|2
1987288|NCT01190254|3552558|FG000|Overall Study|Did not meet protocol eligibility|1
1987289|NCT01190254|3552559|FG001|Overall Study|Did not meet protocol eligibility|0
1987290|NCT01190254|3552560|FG002|Overall Study|Did not meet protocol eligibility|0
1987291|NCT01154036|3552571|FG000|Phase I|Physician Decision|0
1987292|NCT01154036|3552572|FG001|Phase I|Physician Decision|1
1987293|NCT01154036|3552573|FG002|Phase I|Physician Decision|0
1987294|NCT01154036|3552574|FG003|Phase I|Physician Decision|0
1987295|NCT01154036|3552575|FG004|Phase I|Physician Decision|0
1987296|NCT01154036|3552576|FG005|Phase I|Physician Decision|0
1987297|NCT01154036|3552577|FG006|Phase I|Physician Decision|0
1987298|NCT01154036|3552578|FG007|Phase I|Physician Decision|0
1987299|NCT01154036|3552571|FG000|Phase I|Lost to Follow-up|0
1987300|NCT01154036|3552572|FG001|Phase I|Lost to Follow-up|3
1987301|NCT01154036|3552573|FG002|Phase I|Lost to Follow-up|6
1987302|NCT01154036|3552574|FG003|Phase I|Lost to Follow-up|0
1987303|NCT01154036|3552575|FG004|Phase I|Lost to Follow-up|0
1987304|NCT01154036|3552576|FG005|Phase I|Lost to Follow-up|0
1987305|NCT01154036|3552577|FG006|Phase I|Lost to Follow-up|0
1987306|NCT01154036|3552578|FG007|Phase I|Lost to Follow-up|0
1987307|NCT01154036|3552571|FG000|Phase I|Protocol Violation|0
1987308|NCT01154036|3552572|FG001|Phase I|Protocol Violation|3
1987309|NCT01154036|3552573|FG002|Phase I|Protocol Violation|9
1987310|NCT01154036|3552574|FG003|Phase I|Protocol Violation|0
1987311|NCT01154036|3552575|FG004|Phase I|Protocol Violation|0
1987312|NCT01154036|3552576|FG005|Phase I|Protocol Violation|0
1987313|NCT01154036|3552577|FG006|Phase I|Protocol Violation|0
1987314|NCT01154036|3552578|FG007|Phase I|Protocol Violation|0
1987315|NCT01154036|3552571|FG000|Phase I|Withdrawal by Subject|2
1987316|NCT01154036|3552572|FG001|Phase I|Withdrawal by Subject|10
1987317|NCT01154036|3552573|FG002|Phase I|Withdrawal by Subject|29
1987318|NCT01154036|3552574|FG003|Phase I|Withdrawal by Subject|0
1987319|NCT01154036|3552575|FG004|Phase I|Withdrawal by Subject|0
1987320|NCT01154036|3552576|FG005|Phase I|Withdrawal by Subject|0
1987321|NCT01154036|3552577|FG006|Phase I|Withdrawal by Subject|0
1987322|NCT01154036|3552578|FG007|Phase I|Withdrawal by Subject|0
1987323|NCT01154036|3552571|FG000|Phase I|Adverse Event|1
1987324|NCT01154036|3552572|FG001|Phase I|Adverse Event|11
1987325|NCT01154036|3552573|FG002|Phase I|Adverse Event|12
1987326|NCT01154036|3552574|FG003|Phase I|Adverse Event|0
1987327|NCT01154036|3552575|FG004|Phase I|Adverse Event|0
1987328|NCT01154036|3552576|FG005|Phase I|Adverse Event|0
1987329|NCT01154036|3552577|FG006|Phase I|Adverse Event|0
1987330|NCT01154036|3552578|FG007|Phase I|Adverse Event|0
1987331|NCT01154036|3552571|FG000|Phase II|Adverse Event|0
1987332|NCT01154036|3552572|FG001|Phase II|Adverse Event|0
1987333|NCT01154036|3552573|FG002|Phase II|Adverse Event|0
1987334|NCT01154036|3552574|FG003|Phase II|Adverse Event|0
1987335|NCT01154036|3552575|FG004|Phase II|Adverse Event|1
1987336|NCT01154036|3552576|FG005|Phase II|Adverse Event|1
1987337|NCT01154036|3552577|FG006|Phase II|Adverse Event|1
1987338|NCT01154036|3552578|FG007|Phase II|Adverse Event|1
1987339|NCT01154036|3552571|FG000|Phase II|Physician Decision|0
1987340|NCT01154036|3552572|FG001|Phase II|Physician Decision|0
1987341|NCT01154036|3552573|FG002|Phase II|Physician Decision|0
1987342|NCT01154036|3552574|FG003|Phase II|Physician Decision|0
1987343|NCT01154036|3552575|FG004|Phase II|Physician Decision|0
1987344|NCT01154036|3552576|FG005|Phase II|Physician Decision|0
2213475|NCT01679236|3855066|FG001|Overall Study|Lost to Follow-up|15
1987345|NCT01154036|3552577|FG006|Phase II|Physician Decision|1
1987346|NCT01154036|3552578|FG007|Phase II|Physician Decision|0
1987347|NCT01154036|3552571|FG000|Phase II|Lost to Follow-up|0
1987348|NCT01154036|3552572|FG001|Phase II|Lost to Follow-up|0
1987349|NCT01154036|3552573|FG002|Phase II|Lost to Follow-up|0
1987350|NCT01154036|3552574|FG003|Phase II|Lost to Follow-up|1
1987351|NCT01154036|3552575|FG004|Phase II|Lost to Follow-up|2
1987352|NCT01154036|3552576|FG005|Phase II|Lost to Follow-up|0
1987353|NCT01154036|3552577|FG006|Phase II|Lost to Follow-up|2
1987354|NCT01154036|3552578|FG007|Phase II|Lost to Follow-up|1
1987355|NCT01154036|3552571|FG000|Phase II|Protocol Violation|0
1987356|NCT01154036|3552572|FG001|Phase II|Protocol Violation|0
1987357|NCT01154036|3552573|FG002|Phase II|Protocol Violation|0
1987358|NCT01154036|3552574|FG003|Phase II|Protocol Violation|0
1987359|NCT01154036|3552575|FG004|Phase II|Protocol Violation|1
1987360|NCT01154036|3552576|FG005|Phase II|Protocol Violation|2
1987361|NCT01154036|3552577|FG006|Phase II|Protocol Violation|0
1987362|NCT01154036|3552578|FG007|Phase II|Protocol Violation|0
1987363|NCT01154036|3552571|FG000|Phase II|Withdrawal by Subject|0
1987364|NCT01154036|3552572|FG001|Phase II|Withdrawal by Subject|0
1987365|NCT01154036|3552573|FG002|Phase II|Withdrawal by Subject|0
1987366|NCT01154036|3552574|FG003|Phase II|Withdrawal by Subject|0
1987367|NCT01154036|3552575|FG004|Phase II|Withdrawal by Subject|4
1987368|NCT01154036|3552576|FG005|Phase II|Withdrawal by Subject|2
1987369|NCT01154036|3552577|FG006|Phase II|Withdrawal by Subject|5
1987370|NCT01154036|3552578|FG007|Phase II|Withdrawal by Subject|4
1987371|NCT01098071|3552609|FG000|Overall Study|Surgery (adenoidectomy)|2
1987372|NCT01098071|3552609|FG000|Overall Study|Lost to Follow-up|13
1987373|NCT01070966|3552622|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59
1987374|NCT01070966|3552622|FG000|Participants for Safety Evaluation|Off-label use|9
1987375|NCT01070966|3552622|FG000|Participants for Safety Evaluation|Duplicate Participants|4
1987376|NCT01070966|3552622|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
1987377|NCT01070966|3552622|FG000|Participants for Safety Evaluation|TMT given before date of contract|3
1987378|NCT01070966|3552622|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
1987379|NCT01070966|3552622|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19
1987380|NCT01070966|3552622|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
1987381|NCT01070953|3552633|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612
1987382|NCT01070953|3552633|FG000|Participants for Safety Evaluation|Off-label use|283
1987383|NCT01070953|3552633|FG000|Participants for Safety Evaluation|Duplicated participants|22
1987384|NCT01070953|3552633|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8
1987385|NCT01070953|3552633|FG000|Participants for Safety Evaluation|Uncontracted participants|4
1987386|NCT01070953|3552633|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1
1987387|NCT01070953|3552633|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1
1987388|NCT01070953|3552633|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119
1987389|NCT01070953|3552633|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
1987390|NCT01070953|3552633|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
1987391|NCT01030341|3552643|FG000|Overall Study|Withdrawal by Subject|1
1987392|NCT01030341|3552643|FG000|Overall Study|Lost to Follow-up|2
1987393|NCT00979901|3552651|FG000|Overall Study|Adverse Event|1
1987394|NCT00979901|3552652|FG001|Overall Study|Adverse Event|3
1987395|NCT00979901|3552653|FG002|Overall Study|Adverse Event|9
1987396|NCT00979901|3552654|FG003|Overall Study|Adverse Event|2
1987397|NCT00979901|3552651|FG000|Overall Study|Lack of Efficacy|8
1987398|NCT00979901|3552652|FG001|Overall Study|Lack of Efficacy|4
1987399|NCT00979901|3552653|FG002|Overall Study|Lack of Efficacy|9
1987400|NCT00979901|3552654|FG003|Overall Study|Lack of Efficacy|0
1987401|NCT00979901|3552651|FG000|Overall Study|Lost to Follow-up|1
1987402|NCT00979901|3552652|FG001|Overall Study|Lost to Follow-up|1
1987403|NCT00979901|3552653|FG002|Overall Study|Lost to Follow-up|2
1987404|NCT00979901|3552654|FG003|Overall Study|Lost to Follow-up|0
1987405|NCT00979901|3552651|FG000|Overall Study|Protocol Violation|2
1987406|NCT00979901|3552652|FG001|Overall Study|Protocol Violation|2
1987407|NCT00979901|3552653|FG002|Overall Study|Protocol Violation|7
1987408|NCT00979901|3552654|FG003|Overall Study|Protocol Violation|1
1987409|NCT00979901|3552651|FG000|Overall Study|Withdrawal by Subject|2
1987410|NCT00979901|3552652|FG001|Overall Study|Withdrawal by Subject|1
1987411|NCT00979901|3552653|FG002|Overall Study|Withdrawal by Subject|1
1987412|NCT00979901|3552654|FG003|Overall Study|Withdrawal by Subject|1
1987413|NCT00979901|3552651|FG000|Overall Study|Noncompliance|1
1987414|NCT00979901|3552652|FG001|Overall Study|Noncompliance|0
1987415|NCT00979901|3552653|FG002|Overall Study|Noncompliance|0
1987416|NCT00979901|3552654|FG003|Overall Study|Noncompliance|0
1987417|NCT00979901|3552651|FG000|Overall Study|out-of-state|1
1987418|NCT00979901|3552652|FG001|Overall Study|out-of-state|0
1987419|NCT00979901|3552653|FG002|Overall Study|out-of-state|0
1987420|NCT00979901|3552654|FG003|Overall Study|out-of-state|0
1987421|NCT00979901|3552651|FG000|Overall Study|vacation|1
1987422|NCT00979901|3552652|FG001|Overall Study|vacation|0
1987423|NCT00979901|3552653|FG002|Overall Study|vacation|0
1987424|NCT00979901|3552654|FG003|Overall Study|vacation|0
1987425|NCT00979901|3552651|FG000|Overall Study|elevated lab values pre-randomization|1
1987426|NCT00979901|3552652|FG001|Overall Study|elevated lab values pre-randomization|0
1987427|NCT00979901|3552653|FG002|Overall Study|elevated lab values pre-randomization|0
1987428|NCT00979901|3552654|FG003|Overall Study|elevated lab values pre-randomization|0
1987429|NCT00979901|3552651|FG000|Overall Study|Discontinued in Error|0
1987430|NCT00979901|3552652|FG001|Overall Study|Discontinued in Error|1
1987431|NCT00979901|3552653|FG002|Overall Study|Discontinued in Error|0
1987432|NCT00979901|3552654|FG003|Overall Study|Discontinued in Error|0
1987433|NCT00979901|3552651|FG000|Overall Study|Left Country|0
1987434|NCT00979901|3552652|FG001|Overall Study|Left Country|0
1987435|NCT00979901|3552653|FG002|Overall Study|Left Country|1
1987436|NCT00979901|3552654|FG003|Overall Study|Left Country|0
1987437|NCT00979901|3552651|FG000|Overall Study|Treatment Group Terminated by Sponsor|0
1987438|NCT00979901|3552652|FG001|Overall Study|Treatment Group Terminated by Sponsor|0
1987439|NCT00979901|3552653|FG002|Overall Study|Treatment Group Terminated by Sponsor|0
1987440|NCT00979901|3552654|FG003|Overall Study|Treatment Group Terminated by Sponsor|112
1987441|NCT00977574|3552666|FG000|Overall Study|Never Treated|4
1987442|NCT00977574|3552667|FG001|Overall Study|Never Treated|2
1987443|NCT00977574|3552668|FG002|Overall Study|Never Treated|4
1987444|NCT00963599|3552680|FG000|Overall Study|Adverse Event|2
1987445|NCT00963599|3552681|FG001|Overall Study|Adverse Event|0
1987446|NCT00963599|3552682|FG002|Overall Study|Adverse Event|1
1987447|NCT00963599|3552683|FG003|Overall Study|Adverse Event|2
1987448|NCT00963599|3552680|FG000|Overall Study|Lack of Efficacy|0
1987449|NCT00963599|3552681|FG001|Overall Study|Lack of Efficacy|2
1987450|NCT00963599|3552682|FG002|Overall Study|Lack of Efficacy|1
1987451|NCT00963599|3552683|FG003|Overall Study|Lack of Efficacy|4
1987452|NCT00963599|3552680|FG000|Overall Study|Lost to Follow-up|0
1987453|NCT00963599|3552681|FG001|Overall Study|Lost to Follow-up|1
1987454|NCT00963599|3552682|FG002|Overall Study|Lost to Follow-up|1
1987455|NCT00963599|3552683|FG003|Overall Study|Lost to Follow-up|1
1987456|NCT00963599|3552680|FG000|Overall Study|Protocol Violation|2
1987457|NCT00963599|3552681|FG001|Overall Study|Protocol Violation|2
1987458|NCT00963599|3552682|FG002|Overall Study|Protocol Violation|3
1987459|NCT00963599|3552683|FG003|Overall Study|Protocol Violation|4
1987460|NCT00963599|3552680|FG000|Overall Study|Withdrawal by Subject|2
1987461|NCT00963599|3552681|FG001|Overall Study|Withdrawal by Subject|1
1987462|NCT00963599|3552682|FG002|Overall Study|Withdrawal by Subject|3
1987463|NCT00963599|3552683|FG003|Overall Study|Withdrawal by Subject|3
1987464|NCT00953680|3552698|FG000|Period 1|Withdrawal by Subject|0
1987465|NCT00953680|3552699|FG001|Period 1|Withdrawal by Subject|1
1987466|NCT00943852|3552712|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1987467|NCT00943852|3552713|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1987468|NCT00943852|3552714|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1987469|NCT00943852|3552715|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
1987470|NCT00943852|3552716|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1987471|NCT00943852|3552717|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1987472|NCT00943852|3552718|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1987473|NCT00943852|3552719|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1987474|NCT00943852|3552720|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1987475|NCT00943852|3552721|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1987476|NCT00943852|3552712|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0
1987477|NCT00943852|3552713|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0
1987478|NCT00943852|3552714|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0
1987479|NCT00943852|3552715|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0
1987480|NCT00943852|3552716|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0
1987481|NCT00943852|3552717|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1
1987482|NCT00943852|3552718|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0
1987483|NCT00943852|3552719|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0
1987484|NCT00943852|3552720|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0
1987485|NCT00943852|3552721|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0
1987486|NCT00943852|3552712|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1987487|NCT00943852|3552713|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1987488|NCT00943852|3552714|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1987489|NCT00943852|3552715|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1987490|NCT00943852|3552716|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1987491|NCT00943852|3552717|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1987492|NCT00943852|3552718|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
1987493|NCT00943852|3552719|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1987494|NCT00943852|3552720|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1987495|NCT00943852|3552721|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1987496|NCT00943852|3552712|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1987497|NCT00943852|3552713|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1987498|NCT00943852|3552714|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1987499|NCT00943852|3552715|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1987500|NCT00943852|3552716|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1987501|NCT00943852|3552717|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1987502|NCT00943852|3552718|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1987503|NCT00943852|3552719|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
1987504|NCT00943852|3552720|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1987505|NCT00943852|3552721|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1987506|NCT00943852|3552712|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1
1987507|NCT00943852|3552713|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0
1987508|NCT00943852|3552714|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1
1987509|NCT00943852|3552715|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1
1987510|NCT00943852|3552716|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0
1987511|NCT00943852|3552717|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0
1987512|NCT00943852|3552718|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1
1987513|NCT00943852|3552719|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0
1987514|NCT00943852|3552720|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0
1987515|NCT00943852|3552721|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0
1987516|NCT00927953|3552733|FG000|Overall Study|Death|2
1987517|NCT00927953|3552734|FG001|Overall Study|Death|1
1987518|NCT00909389|3552741|FG000|Overall Study|Adverse Event|6
1987519|NCT00909389|3552741|FG000|Overall Study|Death|4
1987520|NCT00909389|3552741|FG000|Overall Study|Poor Compliance|16
1987521|NCT00909389|3552741|FG000|Overall Study|Lost to Follow-up|4
1987522|NCT00909389|3552741|FG000|Overall Study|No Information|103
1987525|NCT00820027|3552758|FG000|Overall Study|Adverse Event|15
1987526|NCT00820027|3552759|FG001|Overall Study|Adverse Event|8
1987527|NCT00820027|3552760|FG002|Overall Study|Adverse Event|10
1987528|NCT00820027|3552761|FG003|Overall Study|Adverse Event|5
1987529|NCT00820027|3552758|FG000|Overall Study|Lack of Efficacy|2
1987530|NCT00820027|3552759|FG001|Overall Study|Lack of Efficacy|1
1987531|NCT00820027|3552760|FG002|Overall Study|Lack of Efficacy|2
1987532|NCT00820027|3552761|FG003|Overall Study|Lack of Efficacy|2
1987533|NCT00820027|3552758|FG000|Overall Study|Physician Decision|0
1987534|NCT00820027|3552759|FG001|Overall Study|Physician Decision|1
1987535|NCT00820027|3552760|FG002|Overall Study|Physician Decision|1
1987536|NCT00820027|3552761|FG003|Overall Study|Physician Decision|0
1987537|NCT00820027|3552758|FG000|Overall Study|Protocol Violation|3
1987538|NCT00820027|3552759|FG001|Overall Study|Protocol Violation|0
1987539|NCT00820027|3552760|FG002|Overall Study|Protocol Violation|4
1987540|NCT00820027|3552761|FG003|Overall Study|Protocol Violation|0
1987541|NCT00820027|3552758|FG000|Overall Study|Withdrawal by Subject|6
1987542|NCT00820027|3552759|FG001|Overall Study|Withdrawal by Subject|4
1987543|NCT00820027|3552760|FG002|Overall Study|Withdrawal by Subject|4
1987544|NCT00820027|3552761|FG003|Overall Study|Withdrawal by Subject|6
1987545|NCT00788710|3552775|FG000|Overall Study|Adverse Event|1
1987546|NCT00788710|3552776|FG001|Overall Study|Adverse Event|3
1987547|NCT00788710|3552777|FG002|Overall Study|Adverse Event|4
1987548|NCT00788710|3552775|FG000|Overall Study|Lack of Efficacy|0
1987549|NCT00788710|3552776|FG001|Overall Study|Lack of Efficacy|0
1987550|NCT00788710|3552777|FG002|Overall Study|Lack of Efficacy|1
1987551|NCT00788710|3552775|FG000|Overall Study|Lost to Follow-up|0
1987552|NCT00788710|3552776|FG001|Overall Study|Lost to Follow-up|1
1987553|NCT00788710|3552777|FG002|Overall Study|Lost to Follow-up|0
1987554|NCT00788710|3552775|FG000|Overall Study|Physician Decision|2
1987555|NCT00788710|3552776|FG001|Overall Study|Physician Decision|1
1987556|NCT00788710|3552777|FG002|Overall Study|Physician Decision|0
1987557|NCT00788710|3552775|FG000|Overall Study|Protocol Violation|0
1987558|NCT00788710|3552776|FG001|Overall Study|Protocol Violation|1
1987559|NCT00788710|3552777|FG002|Overall Study|Protocol Violation|1
1987560|NCT00788710|3552775|FG000|Overall Study|Withdrawal by Subject|2
1987561|NCT00788710|3552776|FG001|Overall Study|Withdrawal by Subject|2
1987562|NCT00788710|3552777|FG002|Overall Study|Withdrawal by Subject|0
1987563|NCT00785291|3552788|FG000|Overall Study|Never began treatment|8
1987564|NCT00785291|3552789|FG001|Overall Study|Never began treatment|4
1987565|NCT00785291|3552790|FG002|Overall Study|Never began treatment|4
1987566|NCT00785291|3552788|FG000|Overall Study|Adverse Event|39
1987567|NCT00785291|3552789|FG001|Overall Study|Adverse Event|70
1987568|NCT00785291|3552790|FG002|Overall Study|Adverse Event|56
1987569|NCT00785291|3552788|FG000|Overall Study|Death|7
1987570|NCT00785291|3552789|FG001|Overall Study|Death|4
1987571|NCT00785291|3552790|FG002|Overall Study|Death|3
1987572|NCT00785291|3552788|FG000|Overall Study|Withdrawal by Subject|35
1987573|NCT00785291|3552789|FG001|Overall Study|Withdrawal by Subject|36
1987574|NCT00785291|3552790|FG002|Overall Study|Withdrawal by Subject|17
1987575|NCT00785291|3552788|FG000|Overall Study|Alternative Therapy|12
1987576|NCT00785291|3552789|FG001|Overall Study|Alternative Therapy|6
1987577|NCT00785291|3552790|FG002|Overall Study|Alternative Therapy|7
1987578|NCT00785291|3552788|FG000|Overall Study|Complicating illness|6
1987579|NCT00785291|3552789|FG001|Overall Study|Complicating illness|4
1987580|NCT00785291|3552790|FG002|Overall Study|Complicating illness|4
1987581|NCT00785291|3552788|FG000|Overall Study|Other Medical Reasons|29
1987582|NCT00785291|3552789|FG001|Overall Study|Other Medical Reasons|25
1987583|NCT00785291|3552790|FG002|Overall Study|Other Medical Reasons|15
1987584|NCT00783224|3552802|FG000|Overall Study|Adverse Event|0
1987585|NCT00783224|3552803|FG001|Overall Study|Adverse Event|0
1987586|NCT00783224|3552804|FG002|Overall Study|Adverse Event|1
1987587|NCT00783224|3552805|FG003|Overall Study|Adverse Event|0
1987588|NCT00783224|3552802|FG000|Overall Study|Discarded the Investigational Drug Used|0
1987589|NCT00783224|3552803|FG001|Overall Study|Discarded the Investigational Drug Used|0
1987590|NCT00783224|3552804|FG002|Overall Study|Discarded the Investigational Drug Used|0
1987591|NCT00783224|3552805|FG003|Overall Study|Discarded the Investigational Drug Used|1
1987592|NCT00783224|3552802|FG000|Overall Study|Inappropriate as a study subject|0
1987593|NCT00783224|3552803|FG001|Overall Study|Inappropriate as a study subject|0
1987594|NCT00783224|3552804|FG002|Overall Study|Inappropriate as a study subject|0
1987595|NCT00783224|3552805|FG003|Overall Study|Inappropriate as a study subject|1
1987596|NCT00778700|3552834|FG000|Overall Study|Adverse Event|6
1987597|NCT00778700|3552835|FG001|Overall Study|Adverse Event|1
1987598|NCT00778700|3552836|FG002|Overall Study|Adverse Event|3
1987599|NCT00778700|3552837|FG003|Overall Study|Adverse Event|5
1987600|NCT00778700|3552834|FG000|Overall Study|Protocol Violation|1
1987601|NCT00778700|3552835|FG001|Overall Study|Protocol Violation|1
1987602|NCT00778700|3552836|FG002|Overall Study|Protocol Violation|0
1987603|NCT00778700|3552837|FG003|Overall Study|Protocol Violation|0
1987604|NCT00778700|3552834|FG000|Overall Study|Subject Withdrew Consent|6
1987605|NCT00778700|3552835|FG001|Overall Study|Subject Withdrew Consent|4
1987606|NCT00778700|3552836|FG002|Overall Study|Subject Withdrew Consent|1
1987607|NCT00778700|3552837|FG003|Overall Study|Subject Withdrew Consent|4
1987608|NCT00778700|3552834|FG000|Overall Study|Lost to Follow-up|3
1987609|NCT00778700|3552835|FG001|Overall Study|Lost to Follow-up|1
1987610|NCT00778700|3552836|FG002|Overall Study|Lost to Follow-up|0
1987611|NCT00778700|3552837|FG003|Overall Study|Lost to Follow-up|1
1987612|NCT00778700|3552834|FG000|Overall Study|Reason not Specified|2
1987613|NCT00778700|3552835|FG001|Overall Study|Reason not Specified|0
1987614|NCT00778700|3552836|FG002|Overall Study|Reason not Specified|1
1987615|NCT00778700|3552837|FG003|Overall Study|Reason not Specified|3
1987616|NCT00778700|3552834|FG000|Overall Study|Other|0
1987617|NCT00778700|3552835|FG001|Overall Study|Other|0
1987618|NCT00778700|3552836|FG002|Overall Study|Other|1
1987619|NCT00778700|3552837|FG003|Overall Study|Other|0
1987620|NCT00764478|3552854|FG000|Overall Study|Adverse Event|1
1987621|NCT00764478|3552855|FG001|Overall Study|Adverse Event|1
1987622|NCT00764478|3552856|FG002|Overall Study|Adverse Event|1
1987623|NCT00764478|3552854|FG000|Overall Study|Withdrawal by Subject|7
1987624|NCT00764478|3552855|FG001|Overall Study|Withdrawal by Subject|12
1987625|NCT00764478|3552856|FG002|Overall Study|Withdrawal by Subject|1
1987626|NCT00764478|3552854|FG000|Overall Study|Lost to Follow-up|7
1987627|NCT00764478|3552855|FG001|Overall Study|Lost to Follow-up|8
1987628|NCT00764478|3552856|FG002|Overall Study|Lost to Follow-up|5
1987629|NCT00764478|3552854|FG000|Overall Study|Protocol Violation|0
1987630|NCT00764478|3552855|FG001|Overall Study|Protocol Violation|1
1987631|NCT00764478|3552856|FG002|Overall Study|Protocol Violation|1
1987632|NCT00761527|3552864|FG000|Overall Study|Adverse Event|3
1987633|NCT00761527|3552864|FG000|Overall Study|Poor Compliance|8
1987634|NCT00761527|3552864|FG000|Overall Study|Lost to Follow-up|9
1987635|NCT00761527|3552864|FG000|Overall Study|Unknown reason|2
1987636|NCT00757627|3552868|FG000|Overall Study|Adverse Event|15
1987637|NCT00757627|3552868|FG000|Overall Study|Lack of Efficacy|10
1987638|NCT00757627|3552868|FG000|Overall Study|Lost to Follow-up|28
1987639|NCT00757627|3552868|FG000|Overall Study|Withdrawal by Subject|27
1987640|NCT00757627|3552868|FG000|Overall Study|Other|1
1987641|NCT00756938|3552880|FG000|12-week Base Study|Protocol-specific Criteria Met|1
1987642|NCT00756938|3552881|FG001|12-week Base Study|Protocol-specific Criteria Met|0
1987643|NCT00756938|3552882|FG002|12-week Base Study|Protocol-specific Criteria Met|1
1987644|NCT00756938|3552883|FG003|12-week Base Study|Protocol-specific Criteria Met|0
1987645|NCT00756938|3552880|FG000|12-week Base Study|Protocol Violation|0
1987646|NCT00756938|3552881|FG001|12-week Base Study|Protocol Violation|0
1987647|NCT00756938|3552882|FG002|12-week Base Study|Protocol Violation|1
1987648|NCT00756938|3552883|FG003|12-week Base Study|Protocol Violation|0
1987649|NCT00756938|3552880|FG000|12-week Base Study|Lost to Follow-up|1
1987650|NCT00756938|3552881|FG001|12-week Base Study|Lost to Follow-up|0
1987651|NCT00756938|3552882|FG002|12-week Base Study|Lost to Follow-up|0
1987652|NCT00756938|3552883|FG003|12-week Base Study|Lost to Follow-up|0
1987653|NCT00756938|3552880|FG000|Optional Extension|Lack of Efficacy|0
1987654|NCT00756938|3552881|FG001|Optional Extension|Lack of Efficacy|0
1987655|NCT00756938|3552882|FG002|Optional Extension|Lack of Efficacy|0
1987656|NCT00756938|3552883|FG003|Optional Extension|Lack of Efficacy|1
1987657|NCT00756938|3552880|FG000|Optional Extension|End of Study|0
1987658|NCT00756938|3552881|FG001|Optional Extension|End of Study|0
1987659|NCT00756938|3552882|FG002|Optional Extension|End of Study|0
1987660|NCT00756938|3552883|FG003|Optional Extension|End of Study|11
1987661|NCT00756938|3552880|FG000|Optional Extension|Protocol-specific criteria met|0
1987662|NCT00756938|3552881|FG001|Optional Extension|Protocol-specific criteria met|0
1987663|NCT00756938|3552882|FG002|Optional Extension|Protocol-specific criteria met|0
1987664|NCT00756938|3552883|FG003|Optional Extension|Protocol-specific criteria met|9
1987665|NCT00756938|3552880|FG000|Optional Extension|Physician Decision|0
1987666|NCT00756938|3552881|FG001|Optional Extension|Physician Decision|0
1987667|NCT00756938|3552882|FG002|Optional Extension|Physician Decision|0
1987668|NCT00756938|3552883|FG003|Optional Extension|Physician Decision|3
1987669|NCT00756938|3552880|FG000|Optional Extension|Lost to Follow-up|0
1987670|NCT00756938|3552881|FG001|Optional Extension|Lost to Follow-up|0
1987671|NCT00756938|3552882|FG002|Optional Extension|Lost to Follow-up|0
1987672|NCT00756938|3552883|FG003|Optional Extension|Lost to Follow-up|1
1987673|NCT00756938|3552880|FG000|Optional Extension|Protocol Violation|0
1987674|NCT00756938|3552881|FG001|Optional Extension|Protocol Violation|0
1987675|NCT00756938|3552882|FG002|Optional Extension|Protocol Violation|0
1987676|NCT00756938|3552883|FG003|Optional Extension|Protocol Violation|1
1987677|NCT00756938|3552880|FG000|Optional Extension|Withdrawal by Subject|0
1987678|NCT00756938|3552881|FG001|Optional Extension|Withdrawal by Subject|0
1987679|NCT00756938|3552882|FG002|Optional Extension|Withdrawal by Subject|0
1987680|NCT00756938|3552883|FG003|Optional Extension|Withdrawal by Subject|10
1987681|NCT00756938|3552880|FG000|Optional Extension|Adverse Event|0
1987682|NCT00756938|3552881|FG001|Optional Extension|Adverse Event|0
1987683|NCT00756938|3552882|FG002|Optional Extension|Adverse Event|0
1987684|NCT00756938|3552883|FG003|Optional Extension|Adverse Event|1
1987685|NCT00746590|3552901|FG000|Overall Study|Death|1
1987686|NCT00730132|3552905|FG000|Overall Study|Protocol Violation|154
1987687|NCT00730132|3552905|FG000|Overall Study|Death|1
1987688|NCT00728416|3552914|FG000|Overall Study|Adverse Event|1
1987689|NCT00728416|3552915|FG001|Overall Study|Adverse Event|1
1987690|NCT00728416|3552914|FG000|Overall Study|Treatment Failure|0
1987691|NCT00728416|3552915|FG001|Overall Study|Treatment Failure|1
1987692|NCT00728416|3552914|FG000|Overall Study|Withdrawal by Subject|1
1987693|NCT00728416|3552915|FG001|Overall Study|Withdrawal by Subject|0
1987694|NCT00704535|3552942|FG000|Overall Study|Adverse Event|2
1987695|NCT00704535|3552942|FG000|Overall Study|Death|2
1987696|NCT00704535|3552942|FG000|Overall Study|Lost to Follow-up|8
1987697|NCT00704535|3552942|FG000|Overall Study|Protocol Violation|10
1987698|NCT00704535|3552942|FG000|Overall Study|Completed status not on Case Report Form|124
2024360|NCT00333840|3592852|FG003|First-line Treatment Period|Abnormal laboratory values|0
2024361|NCT00333840|3592849|FG000|First-line Treatment Period|Abnormal procedure|2
2024362|NCT00333840|3592850|FG001|First-line Treatment Period|Abnormal procedure|0
2024363|NCT00333840|3592851|FG002|First-line Treatment Period|Abnormal procedure|0
2024364|NCT00333840|3592852|FG003|First-line Treatment Period|Abnormal procedure|0
2024365|NCT00333840|3592849|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88
2024366|NCT00333840|3592850|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29
2024367|NCT00333840|3592851|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0
2024368|NCT00333840|3592852|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0
2024369|NCT00333840|3592849|FG000|First-line Treatment Period|No longer required study drug|21
2024370|NCT00333840|3592850|FG001|First-line Treatment Period|No longer required study drug|8
2024371|NCT00333840|3592851|FG002|First-line Treatment Period|No longer required study drug|0
2024372|NCT00333840|3592852|FG003|First-line Treatment Period|No longer required study drug|0
2024373|NCT00333840|3592849|FG000|First-line Treatment Period|Protocol Violation|17
2024374|NCT00333840|3592850|FG001|First-line Treatment Period|Protocol Violation|17
2024375|NCT00333840|3592851|FG002|First-line Treatment Period|Protocol Violation|0
2024376|NCT00333840|3592852|FG003|First-line Treatment Period|Protocol Violation|0
2024377|NCT00333840|3592849|FG000|First-line Treatment Period|Subject withdrew consent|57
2024378|NCT00333840|3592850|FG001|First-line Treatment Period|Subject withdrew consent|77
2024379|NCT00333840|3592851|FG002|First-line Treatment Period|Subject withdrew consent|0
2024380|NCT00333840|3592852|FG003|First-line Treatment Period|Subject withdrew consent|0
2024381|NCT00333840|3592849|FG000|First-line Treatment Period|Lost to Follow-up|15
2024382|NCT00333840|3592850|FG001|First-line Treatment Period|Lost to Follow-up|6
2024383|NCT00333840|3592851|FG002|First-line Treatment Period|Lost to Follow-up|0
2024384|NCT00333840|3592852|FG003|First-line Treatment Period|Lost to Follow-up|0
2024385|NCT00333840|3592849|FG000|First-line Treatment Period|Administrative problems|12
2024386|NCT00333840|3592850|FG001|First-line Treatment Period|Administrative problems|6
2024387|NCT00333840|3592851|FG002|First-line Treatment Period|Administrative problems|0
2024388|NCT00333840|3592852|FG003|First-line Treatment Period|Administrative problems|0
2024389|NCT00333840|3592849|FG000|First-line Treatment Period|Death|19
2024390|NCT00333840|3592850|FG001|First-line Treatment Period|Death|2
2024391|NCT00333840|3592851|FG002|First-line Treatment Period|Death|0
2024392|NCT00333840|3592852|FG003|First-line Treatment Period|Death|0
2024393|NCT00333840|3592849|FG000|First-line Treatment Period|Crossed over to other treatment arm|14
2024394|NCT00333840|3592850|FG001|First-line Treatment Period|Crossed over to other treatment arm|363
2024395|NCT00333840|3592851|FG002|First-line Treatment Period|Crossed over to other treatment arm|0
2024396|NCT00333840|3592852|FG003|First-line Treatment Period|Crossed over to other treatment arm|0
2024397|NCT00333840|3592849|FG000|Second-line Treatment Period|Adverse Event|0
1987699|NCT00694369|3552951|FG000|Overall Study|Adverse Event|0
1987700|NCT00694369|3552952|FG001|Overall Study|Adverse Event|1
1987701|NCT00694369|3552953|FG002|Overall Study|Adverse Event|0
1987702|NCT00694369|3552954|FG003|Overall Study|Adverse Event|1
1987703|NCT00694369|3552955|FG004|Overall Study|Adverse Event|3
1987704|NCT00694369|3552951|FG000|Overall Study|Lost to Follow-up|0
1987705|NCT00694369|3552952|FG001|Overall Study|Lost to Follow-up|0
1987706|NCT00694369|3552953|FG002|Overall Study|Lost to Follow-up|1
1987707|NCT00694369|3552954|FG003|Overall Study|Lost to Follow-up|1
1987708|NCT00694369|3552955|FG004|Overall Study|Lost to Follow-up|0
1987709|NCT00694369|3552951|FG000|Overall Study|Physician Decision|0
1987710|NCT00694369|3552952|FG001|Overall Study|Physician Decision|0
1987711|NCT00694369|3552953|FG002|Overall Study|Physician Decision|0
1987712|NCT00694369|3552954|FG003|Overall Study|Physician Decision|0
1987713|NCT00694369|3552955|FG004|Overall Study|Physician Decision|1
1987714|NCT00694369|3552951|FG000|Overall Study|Protocol Violation|0
1987715|NCT00694369|3552952|FG001|Overall Study|Protocol Violation|1
1987716|NCT00694369|3552953|FG002|Overall Study|Protocol Violation|0
1987717|NCT00694369|3552954|FG003|Overall Study|Protocol Violation|0
1987718|NCT00694369|3552955|FG004|Overall Study|Protocol Violation|0
1987719|NCT00694369|3552951|FG000|Overall Study|Withdrawal by Subject|1
1987720|NCT00694369|3552952|FG001|Overall Study|Withdrawal by Subject|1
1987721|NCT00694369|3552953|FG002|Overall Study|Withdrawal by Subject|1
1987722|NCT00694369|3552954|FG003|Overall Study|Withdrawal by Subject|1
1987723|NCT00694369|3552955|FG004|Overall Study|Withdrawal by Subject|2
1987724|NCT00667823|3552980|FG000|Overall Study|Lost to Follow-up|5
1987725|NCT00667823|3552980|FG000|Overall Study|Adverse Event|7
1987726|NCT00667823|3552980|FG000|Overall Study|Death|182
1987727|NCT00667823|3552980|FG000|Overall Study|Withdrawal by Subject|12
1987728|NCT00667823|3552980|FG000|Overall Study|Other|8
1987729|NCT00667823|3552980|FG000|Overall Study|Missing (completion page missing)|2
1987730|NCT00652327|3552986|FG000|Overall Study|Adverse Event|0
1987731|NCT00652327|3552987|FG001|Overall Study|Adverse Event|2
1987732|NCT00652327|3552986|FG000|Overall Study|Lost to Follow-up|0
1987733|NCT00652327|3552987|FG001|Overall Study|Lost to Follow-up|3
1987734|NCT00604500|3552993|FG000|Overall Study|Adverse Event|2
1987735|NCT00604500|3552993|FG000|Overall Study|Protocol Violation|2
1987736|NCT00604500|3552993|FG000|Overall Study|Treatment Failure|1
1987737|NCT00604500|3552993|FG000|Overall Study|Withdrawal by Subject|4
1987738|NCT00604500|3552993|FG000|Overall Study|Administrative|1
1987739|NCT00604500|3552993|FG000|Overall Study|Did not meet protocol eligibility|1
1987740|NCT00602641|3552999|FG000|Overall Study|Never started protocol therapy|6
1987741|NCT00602641|3553000|FG001|Overall Study|Never started protocol therapy|2
1987742|NCT00602641|3552999|FG000|Overall Study|Still on treatment at time of analysis|8
1987743|NCT00602641|3553000|FG001|Overall Study|Still on treatment at time of analysis|15
1987744|NCT00602641|3552999|FG000|Overall Study|Adverse Event|62
1987745|NCT00602641|3553000|FG001|Overall Study|Adverse Event|53
1987746|NCT00602641|3552999|FG000|Overall Study|Disease progression|38
1987747|NCT00602641|3553000|FG001|Overall Study|Disease progression|55
1987748|NCT00602641|3552999|FG000|Overall Study|Death|6
1987749|NCT00602641|3553000|FG001|Overall Study|Death|5
1987750|NCT00602641|3552999|FG000|Overall Study|Withdrawal by Subject|15
1987751|NCT00602641|3553000|FG001|Overall Study|Withdrawal by Subject|12
1987752|NCT00602641|3552999|FG000|Overall Study|Alternative therapy|5
1987753|NCT00602641|3553000|FG001|Overall Study|Alternative therapy|2
1987754|NCT00602641|3552999|FG000|Overall Study|Other Complicating Disease|5
1987755|NCT00602641|3553000|FG001|Overall Study|Other Complicating Disease|2
1987756|NCT00602641|3552999|FG000|Overall Study|Physician Decision|5
1987757|NCT00602641|3553000|FG001|Overall Study|Physician Decision|4
1987758|NCT00602641|3552999|FG000|Overall Study|Administrative Closure|1
1987759|NCT00602641|3553000|FG001|Overall Study|Administrative Closure|1
1987760|NCT00602641|3552999|FG000|Overall Study|Other|3
1987761|NCT00602641|3553000|FG001|Overall Study|Other|1
1987762|NCT00568178|3553008|FG000|Double Blind Base Study|Adverse Event|0
1987763|NCT00568178|3553009|FG001|Double Blind Base Study|Adverse Event|2
1987764|NCT00568178|3553010|FG002|Double Blind Base Study|Adverse Event|1
1987765|NCT00568178|3553011|FG003|Double Blind Base Study|Adverse Event|2
1987766|NCT00568178|3553012|FG004|Double Blind Base Study|Adverse Event|0
1987767|NCT00568178|3553013|FG005|Double Blind Base Study|Adverse Event|0
1987768|NCT00568178|3553008|FG000|Double Blind Base Study|Lost to Follow-up|1
1987769|NCT00568178|3553009|FG001|Double Blind Base Study|Lost to Follow-up|0
1987770|NCT00568178|3553010|FG002|Double Blind Base Study|Lost to Follow-up|0
1987771|NCT00568178|3553011|FG003|Double Blind Base Study|Lost to Follow-up|1
1987772|NCT00568178|3553012|FG004|Double Blind Base Study|Lost to Follow-up|0
1987773|NCT00568178|3553013|FG005|Double Blind Base Study|Lost to Follow-up|0
1987774|NCT00568178|3553008|FG000|Double Blind Base Study|Physician Decision|1
1987775|NCT00568178|3553009|FG001|Double Blind Base Study|Physician Decision|1
1987776|NCT00568178|3553010|FG002|Double Blind Base Study|Physician Decision|0
1987777|NCT00568178|3553011|FG003|Double Blind Base Study|Physician Decision|1
1987778|NCT00568178|3553012|FG004|Double Blind Base Study|Physician Decision|0
1987779|NCT00568178|3553013|FG005|Double Blind Base Study|Physician Decision|0
1987780|NCT00568178|3553008|FG000|Double Blind Base Study|Protocol Violation|3
1987781|NCT00568178|3553009|FG001|Double Blind Base Study|Protocol Violation|2
1987782|NCT00568178|3553010|FG002|Double Blind Base Study|Protocol Violation|0
1987783|NCT00568178|3553011|FG003|Double Blind Base Study|Protocol Violation|0
1987784|NCT00568178|3553012|FG004|Double Blind Base Study|Protocol Violation|0
1987785|NCT00568178|3553013|FG005|Double Blind Base Study|Protocol Violation|0
1987786|NCT00568178|3553008|FG000|Double Blind Base Study|Withdrawal by Subject|1
1987787|NCT00568178|3553009|FG001|Double Blind Base Study|Withdrawal by Subject|1
1987788|NCT00568178|3553010|FG002|Double Blind Base Study|Withdrawal by Subject|0
1987789|NCT00568178|3553011|FG003|Double Blind Base Study|Withdrawal by Subject|0
1987790|NCT00568178|3553012|FG004|Double Blind Base Study|Withdrawal by Subject|0
1987791|NCT00568178|3553013|FG005|Double Blind Base Study|Withdrawal by Subject|0
1987792|NCT00568178|3553008|FG000|Double Blind Base Study|Progressive Disease|0
1987793|NCT00568178|3553009|FG001|Double Blind Base Study|Progressive Disease|0
1987794|NCT00568178|3553010|FG002|Double Blind Base Study|Progressive Disease|0
1987795|NCT00568178|3553011|FG003|Double Blind Base Study|Progressive Disease|1
1987796|NCT00568178|3553012|FG004|Double Blind Base Study|Progressive Disease|0
1987797|NCT00568178|3553013|FG005|Double Blind Base Study|Progressive Disease|0
1987798|NCT00568178|3553008|FG000|Open Label Extension|Adverse Event|0
1987799|NCT00568178|3553009|FG001|Open Label Extension|Adverse Event|0
1987800|NCT00568178|3553010|FG002|Open Label Extension|Adverse Event|0
1987801|NCT00568178|3553011|FG003|Open Label Extension|Adverse Event|0
1987802|NCT00568178|3553012|FG004|Open Label Extension|Adverse Event|11
1987803|NCT00568178|3553013|FG005|Open Label Extension|Adverse Event|8
1987804|NCT00568178|3553008|FG000|Open Label Extension|Protocol Violation|0
1987805|NCT00568178|3553009|FG001|Open Label Extension|Protocol Violation|0
1987806|NCT00568178|3553010|FG002|Open Label Extension|Protocol Violation|0
1987807|NCT00568178|3553011|FG003|Open Label Extension|Protocol Violation|0
1987808|NCT00568178|3553012|FG004|Open Label Extension|Protocol Violation|1
1987809|NCT00568178|3553013|FG005|Open Label Extension|Protocol Violation|0
1987810|NCT00568178|3553008|FG000|Open Label Extension|Lost to Follow-up|0
1987811|NCT00568178|3553009|FG001|Open Label Extension|Lost to Follow-up|0
1987812|NCT00568178|3553010|FG002|Open Label Extension|Lost to Follow-up|0
1987813|NCT00568178|3553011|FG003|Open Label Extension|Lost to Follow-up|0
1987814|NCT00568178|3553012|FG004|Open Label Extension|Lost to Follow-up|6
1987815|NCT00568178|3553013|FG005|Open Label Extension|Lost to Follow-up|11
1987816|NCT00568178|3553008|FG000|Open Label Extension|Physician Decision|0
1987817|NCT00568178|3553009|FG001|Open Label Extension|Physician Decision|0
1987818|NCT00568178|3553010|FG002|Open Label Extension|Physician Decision|0
1987819|NCT00568178|3553011|FG003|Open Label Extension|Physician Decision|0
1987820|NCT00568178|3553012|FG004|Open Label Extension|Physician Decision|9
1987821|NCT00568178|3553013|FG005|Open Label Extension|Physician Decision|8
1987822|NCT00568178|3553008|FG000|Open Label Extension|Pregnancy|0
1987823|NCT00568178|3553009|FG001|Open Label Extension|Pregnancy|0
1987824|NCT00568178|3553010|FG002|Open Label Extension|Pregnancy|0
1987825|NCT00568178|3553011|FG003|Open Label Extension|Pregnancy|0
1987826|NCT00568178|3553012|FG004|Open Label Extension|Pregnancy|0
1987827|NCT00568178|3553013|FG005|Open Label Extension|Pregnancy|1
1987828|NCT00568178|3553008|FG000|Open Label Extension|Progressive Disease|0
1987829|NCT00568178|3553009|FG001|Open Label Extension|Progressive Disease|0
1987830|NCT00568178|3553010|FG002|Open Label Extension|Progressive Disease|0
1987831|NCT00568178|3553011|FG003|Open Label Extension|Progressive Disease|0
1987832|NCT00568178|3553012|FG004|Open Label Extension|Progressive Disease|3
1987833|NCT00568178|3553013|FG005|Open Label Extension|Progressive Disease|1
1987834|NCT00568178|3553008|FG000|Open Label Extension|Termination of Trial|0
1987835|NCT00568178|3553009|FG001|Open Label Extension|Termination of Trial|0
1987836|NCT00568178|3553010|FG002|Open Label Extension|Termination of Trial|0
1987837|NCT00568178|3553011|FG003|Open Label Extension|Termination of Trial|0
1987838|NCT00568178|3553012|FG004|Open Label Extension|Termination of Trial|45
1987839|NCT00568178|3553013|FG005|Open Label Extension|Termination of Trial|47
1987840|NCT00568178|3553008|FG000|Open Label Extension|Withdrawal by Subject|0
1987841|NCT00568178|3553009|FG001|Open Label Extension|Withdrawal by Subject|0
1987842|NCT00568178|3553010|FG002|Open Label Extension|Withdrawal by Subject|0
1987843|NCT00568178|3553011|FG003|Open Label Extension|Withdrawal by Subject|0
1987844|NCT00568178|3553012|FG004|Open Label Extension|Withdrawal by Subject|4
1987845|NCT00568178|3553013|FG005|Open Label Extension|Withdrawal by Subject|4
1987846|NCT00549848|3553030|FG000|Overall Study|Death|1
1987847|NCT00549848|3553031|FG001|Overall Study|Death|4
1987848|NCT00549848|3553032|FG002|Overall Study|Death|13
1987849|NCT00549848|3553030|FG000|Overall Study|Physician Decision|0
1987850|NCT00549848|3553031|FG001|Overall Study|Physician Decision|0
1987851|NCT00549848|3553032|FG002|Overall Study|Physician Decision|4
1987852|NCT00549848|3553030|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3
1987853|NCT00549848|3553031|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4
1987854|NCT00549848|3553032|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4
1987855|NCT00549848|3553030|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1
1987856|NCT00549848|3553031|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0
1987857|NCT00549848|3553032|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1
1987858|NCT00549848|3553030|FG000|Overall Study|Participant/Family Withdraw|2
1987859|NCT00549848|3553031|FG001|Overall Study|Participant/Family Withdraw|3
1987860|NCT00549848|3553032|FG002|Overall Study|Participant/Family Withdraw|5
1987861|NCT00549848|3553030|FG000|Overall Study|Second Malignancy|1
1987862|NCT00549848|3553031|FG001|Overall Study|Second Malignancy|0
1987863|NCT00549848|3553032|FG002|Overall Study|Second Malignancy|0
1987864|NCT00549848|3553030|FG000|Overall Study|Transplant|3
2213476|NCT01679301|3855072|FG000|Screening Period|screen failure|3
2213477|NCT01679301|3855073|FG001|Screening Period|screen failure|0
2213478|NCT01679301|3855074|FG002|Screening Period|screen failure|0
2213479|NCT01679405|3855095|FG000|Overall Study|Death|2
2213480|NCT01679405|3855096|FG001|Overall Study|Death|5
2217547|NCT01708954|3860854|FG000|Step 1|Ineligible or never received treatment|4
2217548|NCT01708954|3860855|FG001|Step 1|Ineligible or never received treatment|2
2217549|NCT01708954|3860856|FG002|Step 1|Ineligible or never received treatment|8
2217550|NCT01708954|3860854|FG000|Step 2|Disease progression|9
2217551|NCT01708954|3860855|FG001|Step 2|Disease progression|4
1987865|NCT00549848|3553031|FG001|Overall Study|Transplant|3
1987866|NCT00549848|3553032|FG002|Overall Study|Transplant|18
1987867|NCT00549848|3553030|FG000|Overall Study|Unacceptable Toxicity|1
1987868|NCT00549848|3553031|FG001|Overall Study|Unacceptable Toxicity|6
1987869|NCT00549848|3553032|FG002|Overall Study|Unacceptable Toxicity|6
1987870|NCT00545844|3553048|FG000|Overall Study|Lost to Follow-up|9
1987871|NCT00545844|3553048|FG000|Overall Study|Protocol Violation|1
1987872|NCT00545844|3553048|FG000|Overall Study|Withdrawal by Subject|2
1987873|NCT00511433|3553056|FG000|Overall Study|Adverse Event|5
1987874|NCT00511433|3553057|FG001|Overall Study|Adverse Event|0
1987875|NCT00511433|3553056|FG000|Overall Study|Other Reason|1
1987876|NCT00511433|3553057|FG001|Overall Study|Other Reason|1
1987877|NCT00511355|3553067|FG000|Overall Study|Adverse Event|4
1987878|NCT00511355|3553068|FG001|Overall Study|Adverse Event|4
1987879|NCT00511355|3553067|FG000|Overall Study|Pregnancy Wish|1
1987880|NCT00511355|3553068|FG001|Overall Study|Pregnancy Wish|0
1987881|NCT00511355|3553067|FG000|Overall Study|Lost to Follow-up|2
1987882|NCT00511355|3553068|FG001|Overall Study|Lost to Follow-up|1
1987883|NCT00511355|3553067|FG000|Overall Study|Other Reason|0
1987884|NCT00511355|3553068|FG001|Overall Study|Other Reason|1
1987885|NCT00511355|3553067|FG000|Overall Study|Pre-treatment (serious) adverse event|0
1987886|NCT00511355|3553068|FG001|Overall Study|Pre-treatment (serious) adverse event|1
1987887|NCT00511355|3553067|FG000|Overall Study|Withdrawal of informed consent|0
1987888|NCT00511355|3553068|FG001|Overall Study|Withdrawal of informed consent|1
1987889|NCT00511355|3553067|FG000|Overall Study|Other reason pre-treatment|0
1987890|NCT00511355|3553068|FG001|Overall Study|Other reason pre-treatment|1
1987891|NCT00511342|3553078|FG000|Overall Study|Unacceptable vaginal bleeding|2
1987892|NCT00511342|3553079|FG001|Overall Study|Unacceptable vaginal bleeding|1
1987893|NCT00511342|3553078|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8
1987894|NCT00511342|3553079|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12
1987895|NCT00511342|3553078|FG000|Overall Study|Pregnancy|0
1987896|NCT00511342|3553079|FG001|Overall Study|Pregnancy|1
1987897|NCT00511342|3553078|FG000|Overall Study|Pregnancy wish|0
1987898|NCT00511342|3553079|FG001|Overall Study|Pregnancy wish|1
1987899|NCT00511342|3553078|FG000|Overall Study|Lost to Follow-up|1
1987900|NCT00511342|3553079|FG001|Overall Study|Lost to Follow-up|5
1987901|NCT00511342|3553078|FG000|Overall Study|Other Reason|2
1987902|NCT00511342|3553079|FG001|Overall Study|Other Reason|2
1987903|NCT00511199|3553087|FG000|Overall Study|Unacceptable Vaginal Bleeding|63
1987904|NCT00511199|3553088|FG001|Overall Study|Unacceptable Vaginal Bleeding|4
1987905|NCT00511199|3553087|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227
1987906|NCT00511199|3553088|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52
1987907|NCT00511199|3553087|FG000|Overall Study|Withdrawal of Informed Consent|19
1987908|NCT00511199|3553088|FG001|Overall Study|Withdrawal of Informed Consent|4
1987909|NCT00511199|3553087|FG000|Overall Study|Pregnancy|6
1987910|NCT00511199|3553088|FG001|Overall Study|Pregnancy|3
1987911|NCT00511199|3553087|FG000|Overall Study|Pregnancy Wish|16
1987912|NCT00511199|3553088|FG001|Overall Study|Pregnancy Wish|8
1987913|NCT00511199|3553087|FG000|Overall Study|Lost to Follow-up|40
1987914|NCT00511199|3553088|FG001|Overall Study|Lost to Follow-up|17
1987915|NCT00511199|3553087|FG000|Overall Study|Other Reason|78
1987916|NCT00511199|3553088|FG001|Overall Study|Other Reason|37
1987917|NCT00491504|3553100|FG000|Overall Study|Adverse Event|0
1987918|NCT00491504|3553101|FG001|Overall Study|Adverse Event|1
1987919|NCT00491504|3553102|FG002|Overall Study|Adverse Event|0
1987920|NCT00491504|3553103|FG003|Overall Study|Adverse Event|0
1987921|NCT00491504|3553100|FG000|Overall Study|Withdrawal by Subject|0
1987922|NCT00491504|3553101|FG001|Overall Study|Withdrawal by Subject|0
1987923|NCT00491504|3553102|FG002|Overall Study|Withdrawal by Subject|1
1987924|NCT00491504|3553103|FG003|Overall Study|Withdrawal by Subject|2
1987925|NCT00491504|3553100|FG000|Overall Study|Protocol Violation|0
1987926|NCT00491504|3553101|FG001|Overall Study|Protocol Violation|0
1987927|NCT00491504|3553102|FG002|Overall Study|Protocol Violation|3
1987928|NCT00491504|3553103|FG003|Overall Study|Protocol Violation|2
1987929|NCT00468312|3553113|FG000|Overall Study|Adverse Event|2
1987930|NCT00468312|3553114|FG001|Overall Study|Adverse Event|1
1987931|NCT00468312|3553113|FG000|Overall Study|Lack of Efficacy|0
1987932|NCT00468312|3553114|FG001|Overall Study|Lack of Efficacy|1
1987933|NCT00468312|3553113|FG000|Overall Study|Withdrawal by Subject|0
1987934|NCT00468312|3553114|FG001|Overall Study|Withdrawal by Subject|1
1987935|NCT00468312|3553113|FG000|Overall Study|Protocol Violation|2
1987936|NCT00468312|3553114|FG001|Overall Study|Protocol Violation|1
1987937|NCT00468312|3553113|FG000|Overall Study|Did not meet protocol eligibility|0
1987938|NCT00468312|3553114|FG001|Overall Study|Did not meet protocol eligibility|1
1987939|NCT00453063|3553122|FG000|Overall Study|Adverse Event|1
1987940|NCT00453063|3553123|FG001|Overall Study|Adverse Event|2
1987941|NCT00453063|3553122|FG000|Overall Study|Withdrawal by Subject|1
1987942|NCT00453063|3553123|FG001|Overall Study|Withdrawal by Subject|1
1987943|NCT00453063|3553122|FG000|Overall Study|Protocol Violation|1
1987944|NCT00453063|3553123|FG001|Overall Study|Protocol Violation|0
1987945|NCT00447603|3553129|FG000|Screening|Withdrawal by Subject|1
1987946|NCT00447603|3553130|FG001|Screening|Withdrawal by Subject|0
1987947|NCT00447603|3553131|FG002|Screening|Withdrawal by Subject|0
1987948|NCT00447603|3553129|FG000|Screening|Protocol Violation|1
1987949|NCT00447603|3553130|FG001|Screening|Protocol Violation|0
1987950|NCT00447603|3553131|FG002|Screening|Protocol Violation|0
1987951|NCT00447603|3553129|FG000|Screening|Screen Failure|4
1987952|NCT00447603|3553130|FG001|Screening|Screen Failure|0
1987953|NCT00447603|3553131|FG002|Screening|Screen Failure|0
1987954|NCT00447603|3553129|FG000|Screening|Study Terminated by Sponsor|15
1987955|NCT00447603|3553130|FG001|Screening|Study Terminated by Sponsor|0
1987956|NCT00447603|3553131|FG002|Screening|Study Terminated by Sponsor|0
1987957|NCT00447603|3553129|FG000|Filter Period|Adverse Event|0
1987958|NCT00447603|3553130|FG001|Filter Period|Adverse Event|0
1987959|NCT00447603|3553131|FG002|Filter Period|Adverse Event|1
1987960|NCT00447603|3553129|FG000|Filter Period|Screen Failure|0
1987961|NCT00447603|3553130|FG001|Filter Period|Screen Failure|3
1987962|NCT00447603|3553131|FG002|Filter Period|Screen Failure|4
1987963|NCT00447603|3553129|FG000|Filter Period|Study terminated by Sponsor|0
1987964|NCT00447603|3553130|FG001|Filter Period|Study terminated by Sponsor|1
1987965|NCT00447603|3553131|FG002|Filter Period|Study terminated by Sponsor|10
1987966|NCT00442351|3553141|FG000|Overall Study|Administrative|6
1987967|NCT00442351|3553142|FG001|Overall Study|Administrative|5
1987968|NCT00442351|3553141|FG000|Overall Study|Did not meet protocol eligibility|1
1987969|NCT00442351|3553142|FG001|Overall Study|Did not meet protocol eligibility|0
1987970|NCT00442351|3553141|FG000|Overall Study|Other|0
1987971|NCT00442351|3553142|FG001|Overall Study|Other|1
1987972|NCT00423488|3553150|FG000|Overall Study|No evidence of study drug intake|2
1987973|NCT00423488|3553151|FG001|Overall Study|No evidence of study drug intake|1
1987974|NCT00423488|3553150|FG000|Overall Study|No post baseline data|3
1987975|NCT00423488|3553151|FG001|Overall Study|No post baseline data|0
1987976|NCT00413972|3553161|FG000|Overall Study|Adverse Event|2
1987977|NCT00413972|3553162|FG001|Overall Study|Adverse Event|1
1987978|NCT00413972|3553163|FG002|Overall Study|Adverse Event|0
1987979|NCT00413972|3553164|FG003|Overall Study|Adverse Event|0
1987980|NCT00413972|3553161|FG000|Overall Study|Lost to Follow-up|1
1987981|NCT00413972|3553162|FG001|Overall Study|Lost to Follow-up|2
1987982|NCT00413972|3553163|FG002|Overall Study|Lost to Follow-up|1
1987983|NCT00413972|3553164|FG003|Overall Study|Lost to Follow-up|0
1987984|NCT00413972|3553161|FG000|Overall Study|Withdrawal by Subject|4
1987985|NCT00413972|3553162|FG001|Overall Study|Withdrawal by Subject|5
1987986|NCT00413972|3553163|FG002|Overall Study|Withdrawal by Subject|7
1987987|NCT00413972|3553164|FG003|Overall Study|Withdrawal by Subject|2
1987988|NCT00413972|3553161|FG000|Overall Study|Protocol Violation|0
1987989|NCT00413972|3553162|FG001|Overall Study|Protocol Violation|0
1987990|NCT00413972|3553163|FG002|Overall Study|Protocol Violation|2
1987991|NCT00413972|3553164|FG003|Overall Study|Protocol Violation|0
1987992|NCT00413972|3553161|FG000|Overall Study|Other|0
1987993|NCT00413972|3553162|FG001|Overall Study|Other|0
1987994|NCT00413972|3553163|FG002|Overall Study|Other|0
1987995|NCT00413972|3553164|FG003|Overall Study|Other|1
1987996|NCT00413062|3553176|FG000|Overall Study|Adverse event/serious adverse event|289
1987997|NCT00413062|3553177|FG001|Overall Study|Adverse event/serious adverse event|56
1987998|NCT00413062|3553176|FG000|Overall Study|Pre-treatment (serious) adverse event|1
1987999|NCT00413062|3553177|FG001|Overall Study|Pre-treatment (serious) adverse event|0
1988000|NCT00413062|3553176|FG000|Overall Study|Withdrawal of informed consent|111
1988001|NCT00413062|3553177|FG001|Overall Study|Withdrawal of informed consent|36
1988002|NCT00413062|3553176|FG000|Overall Study|Pregnancy|15
1988003|NCT00413062|3553177|FG001|Overall Study|Pregnancy|5
1988004|NCT00413062|3553176|FG000|Overall Study|Pregnancy wish|17
1988005|NCT00413062|3553177|FG001|Overall Study|Pregnancy wish|6
1988006|NCT00413062|3553176|FG000|Overall Study|Lost to Follow-up|175
1988007|NCT00413062|3553177|FG001|Overall Study|Lost to Follow-up|73
1988008|NCT00413062|3553176|FG000|Overall Study|Other reason|70
1988009|NCT00413062|3553177|FG001|Overall Study|Other reason|34
1988010|NCT00391170|3553187|FG000|Overall Study|Withdrawal by Subject|1
1988011|NCT00391170|3553188|FG001|Overall Study|Withdrawal by Subject|0
1988012|NCT00391170|3553187|FG000|Overall Study|Adverse Event|3
1988013|NCT00391170|3553188|FG001|Overall Study|Adverse Event|2
1988014|NCT00391170|3553187|FG000|Overall Study|Physician Decision|2
1988015|NCT00391170|3553188|FG001|Overall Study|Physician Decision|2
1988016|NCT00319449|3553222|FG000|Overall Study|Subject did not wish to continue|1
1988017|NCT00319449|3553223|FG001|Overall Study|Subject did not wish to continue|0
1988018|NCT00319449|3553222|FG000|Overall Study|Noncompliance with the protocol|1
1988019|NCT00319449|3553223|FG001|Overall Study|Noncompliance with the protocol|0
1988020|NCT00289887|3553235|FG000|Overall Study|Adverse Event|3
1988021|NCT00289887|3553236|FG001|Overall Study|Adverse Event|3
1988022|NCT00289887|3553235|FG000|Overall Study|Lack of Efficacy|3
1988023|NCT00289887|3553236|FG001|Overall Study|Lack of Efficacy|11
1988024|NCT00289887|3553235|FG000|Overall Study|Lost to Follow-up|3
1988025|NCT00289887|3553236|FG001|Overall Study|Lost to Follow-up|3
1988026|NCT00289887|3553235|FG000|Overall Study|Protocol Violation|3
1988027|NCT00289887|3553236|FG001|Overall Study|Protocol Violation|1
1988028|NCT00289887|3553235|FG000|Overall Study|Withdrawal by Subject|3
1988029|NCT00289887|3553236|FG001|Overall Study|Withdrawal by Subject|8
1988030|NCT00289887|3553235|FG000|Overall Study|Other|7
1988031|NCT00289887|3553236|FG001|Overall Study|Other|3
1988032|NCT00281320|3553244|FG000|Overall Study|Adverse Event|12
1988033|NCT00281320|3553245|FG001|Overall Study|Adverse Event|9
1988034|NCT00281320|3553244|FG000|Overall Study|Lack of Efficacy|4
1988035|NCT00281320|3553245|FG001|Overall Study|Lack of Efficacy|3
1988036|NCT00281320|3553244|FG000|Overall Study|Withdrawal by Subject|5
1988037|NCT00281320|3553245|FG001|Overall Study|Withdrawal by Subject|6
1988038|NCT00281320|3553244|FG000|Overall Study|Lost to Follow-up|1
1988039|NCT00281320|3553245|FG001|Overall Study|Lost to Follow-up|2
1988040|NCT00281320|3553244|FG000|Overall Study|Other|3
1988041|NCT00281320|3553245|FG001|Overall Study|Other|1
1988042|NCT00276016|3553263|FG000|Intervention 1|Withdrawal by Subject|0
1988043|NCT00276016|3553264|FG001|Intervention 1|Withdrawal by Subject|1
1988044|NCT00276016|3553265|FG002|Intervention 1|Withdrawal by Subject|0
1988045|NCT00276016|3553266|FG003|Intervention 1|Withdrawal by Subject|0
1988046|NCT00276016|3553267|FG004|Intervention 1|Withdrawal by Subject|0
1988047|NCT00276016|3553268|FG005|Intervention 1|Withdrawal by Subject|0
1988048|NCT00265343|3553279|FG000|Overall Study|Adverse Event|10
1988049|NCT00265343|3553280|FG001|Overall Study|Adverse Event|7
1988050|NCT00265343|3553279|FG000|Overall Study|Withdrawal by Subject|3
1988051|NCT00265343|3553280|FG001|Overall Study|Withdrawal by Subject|9
1988052|NCT00265343|3553279|FG000|Overall Study|Other|8
1988053|NCT00265343|3553280|FG001|Overall Study|Other|3
1988054|NCT00264147|3553291|FG000|Treatment I Period|Adverse Event|3
1988055|NCT00264147|3553292|FG001|Treatment I Period|Adverse Event|6
1988056|NCT00264147|3553293|FG002|Treatment I Period|Adverse Event|3
1988057|NCT00264147|3553294|FG003|Treatment I Period|Adverse Event|5
1988058|NCT00264147|3553295|FG004|Treatment I Period|Adverse Event|7
1988059|NCT00264147|3553296|FG005|Treatment I Period|Adverse Event|0
1988060|NCT00264147|3553291|FG000|Treatment I Period|Laboratory Adverse Event|0
1988061|NCT00264147|3553292|FG001|Treatment I Period|Laboratory Adverse Event|0
1988062|NCT00264147|3553293|FG002|Treatment I Period|Laboratory Adverse Event|0
1988063|NCT00264147|3553294|FG003|Treatment I Period|Laboratory Adverse Event|1
1988064|NCT00264147|3553295|FG004|Treatment I Period|Laboratory Adverse Event|0
1988065|NCT00264147|3553296|FG005|Treatment I Period|Laboratory Adverse Event|0
1988066|NCT00264147|3553291|FG000|Treatment I Period|Lack of Efficacy|6
1988067|NCT00264147|3553292|FG001|Treatment I Period|Lack of Efficacy|2
1988068|NCT00264147|3553293|FG002|Treatment I Period|Lack of Efficacy|8
1988069|NCT00264147|3553294|FG003|Treatment I Period|Lack of Efficacy|0
1988070|NCT00264147|3553295|FG004|Treatment I Period|Lack of Efficacy|1
1988071|NCT00264147|3553296|FG005|Treatment I Period|Lack of Efficacy|0
1988072|NCT00264147|3553291|FG000|Treatment I Period|Lost to Follow-up|1
1988073|NCT00264147|3553292|FG001|Treatment I Period|Lost to Follow-up|0
1988074|NCT00264147|3553293|FG002|Treatment I Period|Lost to Follow-up|0
1988075|NCT00264147|3553294|FG003|Treatment I Period|Lost to Follow-up|1
1988076|NCT00264147|3553295|FG004|Treatment I Period|Lost to Follow-up|1
1988077|NCT00264147|3553296|FG005|Treatment I Period|Lost to Follow-up|0
1988078|NCT00264147|3553291|FG000|Treatment I Period|Protocol Violation|2
1988079|NCT00264147|3553292|FG001|Treatment I Period|Protocol Violation|2
1988080|NCT00264147|3553293|FG002|Treatment I Period|Protocol Violation|0
1988081|NCT00264147|3553294|FG003|Treatment I Period|Protocol Violation|0
1988082|NCT00264147|3553295|FG004|Treatment I Period|Protocol Violation|0
1988083|NCT00264147|3553296|FG005|Treatment I Period|Protocol Violation|0
1988084|NCT00264147|3553291|FG000|Treatment I Period|Withdrawal by Subject|2
2213481|NCT01679613|3855111|FG000|Overall Study|other than stated above|0
2213482|NCT01679613|3855112|FG001|Overall Study|other than stated above|1
1988085|NCT00264147|3553292|FG001|Treatment I Period|Withdrawal by Subject|0
1988086|NCT00264147|3553293|FG002|Treatment I Period|Withdrawal by Subject|0
1988087|NCT00264147|3553294|FG003|Treatment I Period|Withdrawal by Subject|2
1988088|NCT00264147|3553295|FG004|Treatment I Period|Withdrawal by Subject|2
1988089|NCT00264147|3553296|FG005|Treatment I Period|Withdrawal by Subject|0
1988090|NCT00264147|3553291|FG000|Treatment I Period|Patient out of town for an extended time|0
1988091|NCT00264147|3553292|FG001|Treatment I Period|Patient out of town for an extended time|1
1988092|NCT00264147|3553293|FG002|Treatment I Period|Patient out of town for an extended time|0
1988093|NCT00264147|3553294|FG003|Treatment I Period|Patient out of town for an extended time|0
1988094|NCT00264147|3553295|FG004|Treatment I Period|Patient out of town for an extended time|0
1988095|NCT00264147|3553296|FG005|Treatment I Period|Patient out of town for an extended time|0
1988096|NCT00264147|3553291|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0
1988097|NCT00264147|3553292|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0
1988098|NCT00264147|3553293|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1
1988099|NCT00264147|3553294|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0
1988100|NCT00264147|3553295|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0
1988101|NCT00264147|3553296|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0
1988102|NCT00264147|3553291|FG000|Treatment I Period|Reassigned to Treatment II Period|84
1988103|NCT00264147|3553292|FG001|Treatment I Period|Reassigned to Treatment II Period|72
1988104|NCT00264147|3553293|FG002|Treatment I Period|Reassigned to Treatment II Period|65
1988105|NCT00264147|3553294|FG003|Treatment I Period|Reassigned to Treatment II Period|63
1988106|NCT00264147|3553295|FG004|Treatment I Period|Reassigned to Treatment II Period|45
1988107|NCT00264147|3553296|FG005|Treatment I Period|Reassigned to Treatment II Period|0
1988108|NCT00264147|3553291|FG000|Treatment II Period|Adverse Event|0
1988109|NCT00264147|3553292|FG001|Treatment II Period|Adverse Event|0
1988110|NCT00264147|3553293|FG002|Treatment II Period|Adverse Event|0
1988111|NCT00264147|3553294|FG003|Treatment II Period|Adverse Event|0
1988112|NCT00264147|3553295|FG004|Treatment II Period|Adverse Event|9
1988113|NCT00264147|3553296|FG005|Treatment II Period|Adverse Event|9
1988114|NCT00264147|3553291|FG000|Treatment II Period|Laboratory Adverse Event|0
1988115|NCT00264147|3553292|FG001|Treatment II Period|Laboratory Adverse Event|0
1988116|NCT00264147|3553293|FG002|Treatment II Period|Laboratory Adverse Event|0
1988117|NCT00264147|3553294|FG003|Treatment II Period|Laboratory Adverse Event|0
2213483|NCT01679613|3855113|FG002|Overall Study|other than stated above|2
2213484|NCT01679613|3855114|FG003|Overall Study|other than stated above|2
2213485|NCT01680016|3855123|FG000|Overall Study|Adverse Event|0
2213486|NCT01680016|3855124|FG001|Overall Study|Adverse Event|0
2213487|NCT01680016|3855125|FG002|Overall Study|Adverse Event|1
1988118|NCT00264147|3553295|FG004|Treatment II Period|Laboratory Adverse Event|0
1988119|NCT00264147|3553296|FG005|Treatment II Period|Laboratory Adverse Event|1
1988120|NCT00264147|3553291|FG000|Treatment II Period|Lack of Efficacy|0
1988121|NCT00264147|3553292|FG001|Treatment II Period|Lack of Efficacy|0
1988122|NCT00264147|3553293|FG002|Treatment II Period|Lack of Efficacy|0
1988123|NCT00264147|3553294|FG003|Treatment II Period|Lack of Efficacy|0
1988124|NCT00264147|3553295|FG004|Treatment II Period|Lack of Efficacy|20
1988125|NCT00264147|3553296|FG005|Treatment II Period|Lack of Efficacy|19
1988126|NCT00264147|3553291|FG000|Treatment II Period|Lost to Follow-up|0
1988127|NCT00264147|3553292|FG001|Treatment II Period|Lost to Follow-up|0
1988128|NCT00264147|3553293|FG002|Treatment II Period|Lost to Follow-up|0
1988129|NCT00264147|3553294|FG003|Treatment II Period|Lost to Follow-up|0
1988130|NCT00264147|3553295|FG004|Treatment II Period|Lost to Follow-up|1
1988131|NCT00264147|3553296|FG005|Treatment II Period|Lost to Follow-up|1
1988132|NCT00264147|3553291|FG000|Treatment II Period|Withdrawal by Subject|0
1988133|NCT00264147|3553292|FG001|Treatment II Period|Withdrawal by Subject|0
1988134|NCT00264147|3553293|FG002|Treatment II Period|Withdrawal by Subject|0
1988135|NCT00264147|3553294|FG003|Treatment II Period|Withdrawal by Subject|0
1988136|NCT00264147|3553295|FG004|Treatment II Period|Withdrawal by Subject|3
1988137|NCT00264147|3553296|FG005|Treatment II Period|Withdrawal by Subject|2
1988138|NCT00264147|3553291|FG000|Treatment II Period|Pre-scheduled total hip replacement|0
1988139|NCT00264147|3553292|FG001|Treatment II Period|Pre-scheduled total hip replacement|0
1988140|NCT00264147|3553293|FG002|Treatment II Period|Pre-scheduled total hip replacement|0
1988141|NCT00264147|3553294|FG003|Treatment II Period|Pre-scheduled total hip replacement|0
1988142|NCT00264147|3553295|FG004|Treatment II Period|Pre-scheduled total hip replacement|0
1988143|NCT00264147|3553296|FG005|Treatment II Period|Pre-scheduled total hip replacement|1
1988144|NCT00202878|3553312|FG000|Overall Study|Death|964
1988145|NCT00202878|3553313|FG001|Overall Study|Death|968
1988146|NCT00202878|3553312|FG000|Overall Study|Only Vital Status Known|357
1988147|NCT00202878|3553313|FG001|Overall Study|Only Vital Status Known|356
1988148|NCT00202878|3553312|FG000|Overall Study|Lost to Follow-up|44
1988149|NCT00202878|3553313|FG001|Overall Study|Lost to Follow-up|49
1988150|NCT00202878|3553312|FG000|Overall Study|Site Closure|39
1988151|NCT00202878|3553313|FG001|Overall Study|Site Closure|36
1988152|NCT00202878|3553312|FG000|Overall Study|Withdrawal by Subject|795
1988153|NCT00202878|3553313|FG001|Overall Study|Withdrawal by Subject|808
1988154|NCT00174265|3553321|FG000|Overall Study|Adverse Event|7
1988155|NCT00174265|3553322|FG001|Overall Study|Adverse Event|4
1988156|NCT00174265|3553321|FG000|Overall Study|Lack of Efficacy|2
1988157|NCT00174265|3553322|FG001|Overall Study|Lack of Efficacy|2
1988158|NCT00174265|3553321|FG000|Overall Study|Withdrawal by Subject|3
1988159|NCT00174265|3553322|FG001|Overall Study|Withdrawal by Subject|5
1988160|NCT00174265|3553321|FG000|Overall Study|Lost to Follow-up|1
1988161|NCT00174265|3553322|FG001|Overall Study|Lost to Follow-up|0
1988162|NCT00174265|3553321|FG000|Overall Study|Other (Not specified)|16
1988163|NCT00174265|3553322|FG001|Overall Study|Other (Not specified)|10
1988164|NCT00159783|3553331|FG000|Overall Study|Adverse Event|5
1988165|NCT00159783|3553332|FG001|Overall Study|Adverse Event|7
1988166|NCT00159783|3553333|FG002|Overall Study|Adverse Event|9
1988167|NCT00159783|3553331|FG000|Overall Study|Lack of Efficacy|1
1988168|NCT00159783|3553332|FG001|Overall Study|Lack of Efficacy|2
1988169|NCT00159783|3553333|FG002|Overall Study|Lack of Efficacy|3
1988170|NCT00159783|3553331|FG000|Overall Study|Withdrawal by Subject|7
1988171|NCT00159783|3553332|FG001|Overall Study|Withdrawal by Subject|11
1988172|NCT00159783|3553333|FG002|Overall Study|Withdrawal by Subject|12
1988173|NCT00159783|3553331|FG000|Overall Study|Lost to Follow-up|6
1988174|NCT00159783|3553332|FG001|Overall Study|Lost to Follow-up|5
1988175|NCT00159783|3553333|FG002|Overall Study|Lost to Follow-up|11
1988176|NCT00159783|3553331|FG000|Overall Study|Other|0
1988177|NCT00159783|3553332|FG001|Overall Study|Other|2
1988178|NCT00159783|3553333|FG002|Overall Study|Other|4
1988179|NCT00092677|3553355|FG000|Overall Study|Lost to Follow-up|0
1988180|NCT00092677|3553356|FG001|Overall Study|Lost to Follow-up|2
1988181|NCT00092677|3553355|FG000|Overall Study|Adminstrative|5
1988182|NCT00092677|3553356|FG001|Overall Study|Adminstrative|9
1988183|NCT00090259|3553364|FG000|Overall Study|Lost to Follow-up|30
1988184|NCT00090259|3553365|FG001|Overall Study|Lost to Follow-up|26
1988185|NCT00090259|3553364|FG000|Overall Study|Withdrawal by Subject|21
1988186|NCT00090259|3553365|FG001|Overall Study|Withdrawal by Subject|15
1988187|NCT00090259|3553364|FG000|Overall Study|Investigator site closed|11
1988188|NCT00090259|3553365|FG001|Overall Study|Investigator site closed|7
1988189|NCT00003298|3553371|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
1988190|NCT00003298|3553371|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
1988191|NCT00003298|3553371|FG000|Surgery|Unresectable at surgery|3
1988192|NCT00003298|3553371|FG000|Surgery|Progression before surgery|2
1988193|NCT00003298|3553371|FG000|Surgery|Unevaluable and off study|2
1988194|NCT00003298|3553371|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
1988195|NCT00003298|3553371|FG000|Re-register to Step 2 After Surgery|Positive margins|5
1988196|NCT00003298|3553371|FG000|Re-register to Step 2 After Surgery|Other complications|2
1988197|NCT00003298|3553371|FG000|Re-register to Step 2 After Surgery|Reason unknown|1
1988198|NCT00003298|3553371|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
1988199|NCT00003298|3553371|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1
1988200|NCT00003298|3553371|FG000|Step 2 (Adjuvant Therapy)|Death|1
1988201|NCT00003298|3553371|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
1988202|NCT00003298|3553371|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1
1988203|NCT00003298|3553371|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
1988204|NCT00003377|3553381|FG000|Period I|Dose Limiting Toxicity(DLT)|0
1988205|NCT00003377|3553382|FG001|Period I|Dose Limiting Toxicity(DLT)|0
1988206|NCT00003377|3553383|FG002|Period I|Dose Limiting Toxicity(DLT)|1
1988207|NCT00003377|3553384|FG003|Period I|Dose Limiting Toxicity(DLT)|1
1988208|NCT00003377|3553385|FG004|Period I|Dose Limiting Toxicity(DLT)|0
1988209|NCT00003377|3553381|FG000|Period II|Ureteral stent complications|0
1988210|NCT00003377|3553382|FG001|Period II|Ureteral stent complications|0
1988211|NCT00003377|3553383|FG002|Period II|Ureteral stent complications|0
1988212|NCT00003377|3553384|FG003|Period II|Ureteral stent complications|0
1988213|NCT00003377|3553385|FG004|Period II|Ureteral stent complications|1
1988214|NCT00003389|3553400|FG000|Overall Study|Disease progression|6
1988215|NCT00003389|3553401|FG001|Overall Study|Disease progression|1
1988216|NCT00003389|3553400|FG000|Overall Study|Adverse Event|13
1988217|NCT00003389|3553401|FG001|Overall Study|Adverse Event|2
1988218|NCT00003389|3553400|FG000|Overall Study|Death|0
1988219|NCT00003389|3553401|FG001|Overall Study|Death|3
1988220|NCT00003389|3553400|FG000|Overall Study|Withdrawal by Subject|12
1988221|NCT00003389|3553401|FG001|Overall Study|Withdrawal by Subject|5
1988222|NCT00003389|3553400|FG000|Overall Study|Alternative therapy|2
1988223|NCT00003389|3553401|FG001|Overall Study|Alternative therapy|1
1988224|NCT00003389|3553400|FG000|Overall Study|Complicating disease|1
1988225|NCT00003389|3553401|FG001|Overall Study|Complicating disease|0
1988226|NCT00003389|3553400|FG000|Overall Study|Off-treatment reason missing|31
1988227|NCT00003389|3553401|FG001|Overall Study|Off-treatment reason missing|21
1988228|NCT00003389|3553400|FG000|Overall Study|Ineligible|33
1988229|NCT00003389|3553401|FG001|Overall Study|Ineligible|27
1988230|NCT00003456|3553416|FG000|Overall Study|Not evaluable|8
1988231|NCT00003457|3553420|FG000|Overall Study|Not evaluable|9
1988232|NCT00003470|3553440|FG000|Overall Study|Not evaluable|6
1988233|NCT00003471|3553444|FG000|Overall Study|Not evaluable|4
1988234|NCT00003472|3553448|FG000|Overall Study|Not evaluable|3
1988235|NCT00003473|3553452|FG000|Overall Study|Three patients were not evaluable.|3
1988236|NCT00003474|3553456|FG000|Overall Study|Not Evaluable|14
1988237|NCT00003475|3553460|FG000|Overall Study|Not evaluable|13
1988238|NCT00003476|3553465|FG000|Overall Study|Not evaluable|1
1988239|NCT00003477|3553469|FG000|Overall Study|Not evalauable|4
1988240|NCT00003483|3553473|FG000|Overall Study|Not evaluable|1
1988241|NCT00003487|3553477|FG000|Overall Study|Not evaluable|2
1988242|NCT00003492|3553481|FG000|Overall Study|Not evaluable|6
1988243|NCT00003498|3553485|FG000|Overall Study|Not evaluable.|4
1988244|NCT00003499|3553489|FG000|Overall Study|Not evaluable|8
1988245|NCT00003508|3553493|FG000|Overall Study|Not evaluable|5
1988246|NCT00003509|3553497|FG000|Overall Study|Not evaluable|5
1988247|NCT00003511|3553501|FG000|Overall Study|Not evaluable|4
1988248|NCT00003526|3553505|FG000|Overall Study|Not evaluable|6
1988249|NCT00003531|3553509|FG000|Overall Study|Not evaluable|10
1988250|NCT00003535|3553513|FG000|Overall Study|Not evaluable|5
1988251|NCT00003537|3553517|FG000|Overall Study|Not evalauable|1
1988252|NCT00003590|3553521|FG000|Overall Study|Ineligible Patient|1
1988253|NCT00003590|3553521|FG000|Overall Study|Adverse Event|7
1988254|NCT00003590|3553521|FG000|Overall Study|Withdrawal by Subject|1
1988255|NCT00003590|3553521|FG000|Overall Study|Lack of Efficacy|11
1988256|NCT00003590|3553521|FG000|Overall Study|Death|1
1988257|NCT00003590|3553521|FG000|Overall Study|Physician Decision|1
1988258|NCT00003631|3553528|FG000|Overall Study|Patient not treated|1
1988259|NCT00003631|3553529|FG001|Overall Study|Patient not treated|0
1988260|NCT00003631|3553530|FG002|Overall Study|Patient not treated|1
1988261|NCT00003631|3553528|FG000|Overall Study|Protocol Violation|1
1988262|NCT00003631|3553529|FG001|Overall Study|Protocol Violation|0
1988263|NCT00003631|3553530|FG002|Overall Study|Protocol Violation|0
1988264|NCT00003631|3553528|FG000|Overall Study|Adverse Event|1
1988265|NCT00003631|3553529|FG001|Overall Study|Adverse Event|1
1988266|NCT00003631|3553530|FG002|Overall Study|Adverse Event|5
1988267|NCT00003631|3553528|FG000|Overall Study|Death|0
1988268|NCT00003631|3553529|FG001|Overall Study|Death|0
1988269|NCT00003631|3553530|FG002|Overall Study|Death|1
1988270|NCT00003631|3553528|FG000|Overall Study|Evaluable for toxicity only|0
1988271|NCT00003631|3553529|FG001|Overall Study|Evaluable for toxicity only|0
1988272|NCT00003631|3553530|FG002|Overall Study|Evaluable for toxicity only|2
1988273|NCT00003641|3553540|FG000|Overall Study|Withdrawal by Subject|0
1988274|NCT00003641|3553541|FG001|Overall Study|Withdrawal by Subject|100
1988275|NCT00003641|3553540|FG000|Overall Study|Adverse Event|0
1988276|NCT00003641|3553541|FG001|Overall Study|Adverse Event|38
1988277|NCT00003641|3553540|FG000|Overall Study|Disease progression|0
1988278|NCT00003641|3553541|FG001|Overall Study|Disease progression|2
1988279|NCT00003641|3553540|FG000|Overall Study|Unknown/missing|0
1988280|NCT00003641|3553541|FG001|Overall Study|Unknown/missing|22
1988281|NCT00003641|3553540|FG000|Overall Study|Should not receive interferon therapy|2
1988282|NCT00003641|3553541|FG001|Overall Study|Should not receive interferon therapy|0
1988283|NCT00003641|3553540|FG000|Overall Study|Never started interferon|567
1988284|NCT00003641|3553541|FG001|Overall Study|Never started interferon|12
1988285|NCT00003645|3553560|FG000|Overall Study|Death|4
1988286|NCT00003645|3553561|FG001|Overall Study|Death|1
1988287|NCT00003645|3553560|FG000|Overall Study|Lost to Follow-up|7
1988288|NCT00003645|3553561|FG001|Overall Study|Lost to Follow-up|8
1988289|NCT00003645|3553560|FG000|Overall Study|Withdrawal by Subject|1
1988290|NCT00003645|3553561|FG001|Overall Study|Withdrawal by Subject|3
1988291|NCT00003659|3553569|FG000|Overall Study|Withdrawal by Subject|3
1988292|NCT00003702|3553575|FG000|Overall Study|Ineligible cell types|2
1988293|NCT00003702|3553576|FG001|Overall Study|Ineligible cell types|2
1988294|NCT00003702|3553575|FG000|Overall Study|Did not meet criteria for persistence|8
1988295|NCT00003702|3553576|FG001|Overall Study|Did not meet criteria for persistence|5
1988296|NCT00003702|3553575|FG000|Overall Study|WHO score > 6|2
1988297|NCT00003702|3553576|FG001|Overall Study|WHO score > 6|1
1988298|NCT00003702|3553575|FG000|Overall Study|Inadequate documentation of disease|1
1988299|NCT00003702|3553576|FG001|Overall Study|Inadequate documentation of disease|3
1988300|NCT00003782|3553586|FG000|Overall Study|No follow up data|30
1988301|NCT00003782|3553587|FG001|Overall Study|No follow up data|31
1988302|NCT00003782|3553588|FG002|Overall Study|No follow up data|26
1988303|NCT00003830|3553626|FG000|Overall Study|No follow up data|3
1988304|NCT00003830|3553627|FG001|Overall Study|No follow up data|0
1988305|NCT00003830|3553626|FG000|Overall Study|Sentinel node positive patients|829
1988306|NCT00003830|3553627|FG001|Overall Study|Sentinel node positive patients|793
1988307|NCT00003869|3553637|FG000|Overall Study|Adverse Event|14
1988308|NCT00003869|3553638|FG001|Overall Study|Adverse Event|3
1988309|NCT00003869|3553637|FG000|Overall Study|Withdrawal by Subject|21
1988310|NCT00003869|3553638|FG001|Overall Study|Withdrawal by Subject|3
1988311|NCT00003869|3553637|FG000|Overall Study|Death|1
1988312|NCT00003869|3553638|FG001|Overall Study|Death|2
1988313|NCT00003869|3553637|FG000|Overall Study|Alternative treatmnt, medical problems|5
1988314|NCT00003869|3553638|FG001|Overall Study|Alternative treatmnt, medical problems|4
1988315|NCT00003875|3553644|FG000|Overall Study|Screen Failed|1
1988316|NCT00003895|3553650|FG000|Overall Study|Adverse Event|4
1988317|NCT00003895|3553651|FG001|Overall Study|Adverse Event|0
1988318|NCT00003895|3553650|FG000|Overall Study|Lack of Efficacy|1
1988319|NCT00003895|3553651|FG001|Overall Study|Lack of Efficacy|1
1988320|NCT00003895|3553650|FG000|Overall Study|Patient Vacation|2
1988321|NCT00003895|3553651|FG001|Overall Study|Patient Vacation|0
1988322|NCT00003895|3553650|FG000|Overall Study|Withdrawal by Subject|0
1988323|NCT00003895|3553651|FG001|Overall Study|Withdrawal by Subject|3
1988324|NCT00003896|3553657|FG000|Overall Study|Adverse Event|16
1988325|NCT00003896|3553657|FG000|Overall Study|Withdrawal by Subject|1
1988326|NCT00003896|3553657|FG000|Overall Study|Lack of Efficacy|1
1988327|NCT00003896|3553657|FG000|Overall Study|Death|3
1988328|NCT00003896|3553657|FG000|Overall Study|not protocol specified|3
1988329|NCT00003896|3553657|FG000|Overall Study|ineligible|5
1988330|NCT00003901|3553662|FG000|Overall Study|Adverse Event|1
1988331|NCT00003901|3553662|FG000|Overall Study|Withdrawal by Subject|1
1988332|NCT00003901|3553662|FG000|Overall Study|Ineligible|6
1988333|NCT00003901|3553662|FG000|Overall Study|CT Scan not within protocol requirement|2
1988334|NCT00003901|3553662|FG000|Overall Study|Chest X-Ray not done prior registration|1
1988335|NCT00003901|3553662|FG000|Overall Study|Medical problems|6
1988336|NCT00003907|3553671|FG000|Overall Study|Adverse Event|2
1988337|NCT00003907|3553672|FG001|Overall Study|Adverse Event|11
1988338|NCT00003907|3553671|FG000|Overall Study|Death|2
1988339|NCT00003907|3553672|FG001|Overall Study|Death|0
1988340|NCT00003907|3553671|FG000|Overall Study|Withdrawal by Subject|1
1988341|NCT00003907|3553672|FG001|Overall Study|Withdrawal by Subject|3
1988342|NCT00003907|3553671|FG000|Overall Study|Progressive disease|4
1988343|NCT00003907|3553672|FG001|Overall Study|Progressive disease|4
1988344|NCT00003907|3553671|FG000|Overall Study|Complicating disease|1
1988345|NCT00003907|3553672|FG001|Overall Study|Complicating disease|0
1988346|NCT00003907|3553671|FG000|Overall Study|Other|1
1988347|NCT00003907|3553672|FG001|Overall Study|Other|3
1988348|NCT00003907|3553671|FG000|Overall Study|ineligible or not treated|2
1988349|NCT00003907|3553672|FG001|Overall Study|ineligible or not treated|2
1988350|NCT00004031|3553687|FG000|Overall Study|Adverse Event|5
1988351|NCT00004031|3553688|FG001|Overall Study|Adverse Event|0
1988352|NCT00004031|3553687|FG000|Overall Study|Refusal unrelated to adverse events|2
1988353|NCT00004031|3553688|FG001|Overall Study|Refusal unrelated to adverse events|11
1988354|NCT00004031|3553687|FG000|Overall Study|Progression/relapse|9
1988355|NCT00004031|3553688|FG001|Overall Study|Progression/relapse|4
1988356|NCT00004031|3553687|FG000|Overall Study|Death|3
1988357|NCT00004031|3553688|FG001|Overall Study|Death|1
1988358|NCT00004031|3553687|FG000|Overall Study|Other- not protocol specified|3
1988359|NCT00004031|3553688|FG001|Overall Study|Other- not protocol specified|3
1988360|NCT00004031|3553687|FG000|Overall Study|Reason under review|3
1988361|NCT00004031|3553688|FG001|Overall Study|Reason under review|2
1988362|NCT00004088|3553705|FG000|Overall Study|No C2 given due to study on hold by IRB|4
1988363|NCT00004088|3553705|FG000|Overall Study|Withdrawal by Subject|1
1988364|NCT00004088|3553705|FG000|Overall Study|Protocol Violation|3
1988365|NCT00004088|3553705|FG000|Overall Study|Physician Decision|1
2024398|NCT00333840|3592850|FG001|Second-line Treatment Period|Adverse Event|0
2024399|NCT00333840|3592851|FG002|Second-line Treatment Period|Adverse Event|3
2024400|NCT00333840|3592852|FG003|Second-line Treatment Period|Adverse Event|34
2024401|NCT00333840|3592849|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0
2024402|NCT00333840|3592850|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0
2024403|NCT00333840|3592851|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0
2024404|NCT00333840|3592852|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3
2024405|NCT00333840|3592849|FG000|Second-line Treatment Period|Abnormal procedure|0
2024406|NCT00333840|3592850|FG001|Second-line Treatment Period|Abnormal procedure|0
2024407|NCT00333840|3592851|FG002|Second-line Treatment Period|Abnormal procedure|0
2024408|NCT00333840|3592852|FG003|Second-line Treatment Period|Abnormal procedure|1
2024409|NCT00333840|3592849|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
2024410|NCT00333840|3592850|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
2024411|NCT00333840|3592851|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
2024412|NCT00333840|3592852|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
2024413|NCT00333840|3592849|FG000|Second-line Treatment Period|No longer required study drug|0
2024414|NCT00333840|3592850|FG001|Second-line Treatment Period|No longer required study drug|0
2024415|NCT00333840|3592851|FG002|Second-line Treatment Period|No longer required study drug|1
2024416|NCT00333840|3592852|FG003|Second-line Treatment Period|No longer required study drug|14
2024417|NCT00333840|3592849|FG000|Second-line Treatment Period|Protocol Violation|0
2024418|NCT00333840|3592850|FG001|Second-line Treatment Period|Protocol Violation|0
2024419|NCT00333840|3592851|FG002|Second-line Treatment Period|Protocol Violation|1
2024420|NCT00333840|3592852|FG003|Second-line Treatment Period|Protocol Violation|10
2024421|NCT00333840|3592849|FG000|Second-line Treatment Period|Subject withdrew consent|0
2024422|NCT00333840|3592850|FG001|Second-line Treatment Period|Subject withdrew consent|0
2024423|NCT00333840|3592851|FG002|Second-line Treatment Period|Subject withdrew consent|0
2024424|NCT00333840|3592852|FG003|Second-line Treatment Period|Subject withdrew consent|34
2024425|NCT00333840|3592849|FG000|Second-line Treatment Period|Lost to Follow-up|0
2024426|NCT00333840|3592850|FG001|Second-line Treatment Period|Lost to Follow-up|0
2024427|NCT00333840|3592851|FG002|Second-line Treatment Period|Lost to Follow-up|0
2024428|NCT00333840|3592852|FG003|Second-line Treatment Period|Lost to Follow-up|6
2024429|NCT00333840|3592849|FG000|Second-line Treatment Period|Administrative problems|0
2024430|NCT00333840|3592850|FG001|Second-line Treatment Period|Administrative problems|0
2024431|NCT00333840|3592851|FG002|Second-line Treatment Period|Administrative problems|0
2024432|NCT00333840|3592852|FG003|Second-line Treatment Period|Administrative problems|7
2024433|NCT00333840|3592849|FG000|Second-line Treatment Period|Death|0
2024434|NCT00333840|3592850|FG001|Second-line Treatment Period|Death|0
2024435|NCT00333840|3592851|FG002|Second-line Treatment Period|Death|0
2024436|NCT00333840|3592852|FG003|Second-line Treatment Period|Death|9
2024437|NCT00333866|3592870|FG000|Overall Study|Adverse Event|23
2024438|NCT00333866|3592871|FG001|Overall Study|Adverse Event|37
2024439|NCT00333866|3592872|FG002|Overall Study|Adverse Event|38
2024440|NCT00333866|3592873|FG003|Overall Study|Adverse Event|47
2024441|NCT00333866|3592870|FG000|Overall Study|Other|3
2024442|NCT00333866|3592871|FG001|Overall Study|Other|2
2024443|NCT00333866|3592872|FG002|Overall Study|Other|2
2024444|NCT00333866|3592873|FG003|Overall Study|Other|2
2024445|NCT00333866|3592870|FG000|Overall Study|Lack of Efficacy|8
2024446|NCT00333866|3592871|FG001|Overall Study|Lack of Efficacy|6
2024447|NCT00333866|3592872|FG002|Overall Study|Lack of Efficacy|3
2024448|NCT00333866|3592873|FG003|Overall Study|Lack of Efficacy|5
2024449|NCT00333866|3592870|FG000|Overall Study|Lost to Follow-up|1
2024450|NCT00333866|3592871|FG001|Overall Study|Lost to Follow-up|2
2213488|NCT01680016|3855126|FG003|Overall Study|Adverse Event|4
2024451|NCT00333866|3592872|FG002|Overall Study|Lost to Follow-up|2
2024452|NCT00333866|3592873|FG003|Overall Study|Lost to Follow-up|2
2024453|NCT00333866|3592870|FG000|Overall Study|Withdrawal by Subject|8
2024454|NCT00333866|3592871|FG001|Overall Study|Withdrawal by Subject|14
1988366|NCT00004124|3553720|FG000|Overall Study|Received no protocol therapy|12
1988367|NCT00004124|3553721|FG001|Overall Study|Received no protocol therapy|20
1988368|NCT00004228|3553744|FG000|Overall Study|Adverse Event|0
1988369|NCT00004228|3553745|FG001|Overall Study|Adverse Event|1
1988370|NCT00004228|3553746|FG002|Overall Study|Adverse Event|0
1988371|NCT00004228|3553747|FG003|Overall Study|Adverse Event|0
1988372|NCT00004228|3553748|FG004|Overall Study|Adverse Event|1
1988373|NCT00004228|3553749|FG005|Overall Study|Adverse Event|0
1988374|NCT00004228|3553750|FG006|Overall Study|Adverse Event|0
1988375|NCT00004228|3553744|FG000|Overall Study|Death|0
1988376|NCT00004228|3553745|FG001|Overall Study|Death|1
1988377|NCT00004228|3553746|FG002|Overall Study|Death|2
1988378|NCT00004228|3553747|FG003|Overall Study|Death|0
1988379|NCT00004228|3553748|FG004|Overall Study|Death|1
1988380|NCT00004228|3553749|FG005|Overall Study|Death|0
1988381|NCT00004228|3553750|FG006|Overall Study|Death|0
1988382|NCT00004228|3553744|FG000|Overall Study|Lack of Efficacy|1
1988383|NCT00004228|3553745|FG001|Overall Study|Lack of Efficacy|6
1988384|NCT00004228|3553746|FG002|Overall Study|Lack of Efficacy|5
1988385|NCT00004228|3553747|FG003|Overall Study|Lack of Efficacy|3
1988386|NCT00004228|3553748|FG004|Overall Study|Lack of Efficacy|9
1988387|NCT00004228|3553749|FG005|Overall Study|Lack of Efficacy|8
1988388|NCT00004228|3553750|FG006|Overall Study|Lack of Efficacy|4
1988389|NCT00004228|3553744|FG000|Overall Study|Lost to Follow-up|0
1988390|NCT00004228|3553745|FG001|Overall Study|Lost to Follow-up|0
1988391|NCT00004228|3553746|FG002|Overall Study|Lost to Follow-up|1
1988392|NCT00004228|3553747|FG003|Overall Study|Lost to Follow-up|0
1988393|NCT00004228|3553748|FG004|Overall Study|Lost to Follow-up|0
1988394|NCT00004228|3553749|FG005|Overall Study|Lost to Follow-up|0
1988395|NCT00004228|3553750|FG006|Overall Study|Lost to Follow-up|0
1988396|NCT00004228|3553744|FG000|Overall Study|Physician Decision|1
1988397|NCT00004228|3553745|FG001|Overall Study|Physician Decision|0
1988398|NCT00004228|3553746|FG002|Overall Study|Physician Decision|3
1988399|NCT00004228|3553747|FG003|Overall Study|Physician Decision|2
1988400|NCT00004228|3553748|FG004|Overall Study|Physician Decision|1
1988401|NCT00004228|3553749|FG005|Overall Study|Physician Decision|1
1988402|NCT00004228|3553750|FG006|Overall Study|Physician Decision|1
1988403|NCT00004228|3553744|FG000|Overall Study|Protocol Violation|0
1988404|NCT00004228|3553745|FG001|Overall Study|Protocol Violation|5
1988405|NCT00004228|3553746|FG002|Overall Study|Protocol Violation|2
1988406|NCT00004228|3553747|FG003|Overall Study|Protocol Violation|1
1988407|NCT00004228|3553748|FG004|Overall Study|Protocol Violation|1
1988408|NCT00004228|3553749|FG005|Overall Study|Protocol Violation|2
1988409|NCT00004228|3553750|FG006|Overall Study|Protocol Violation|0
2213489|NCT01680016|3855123|FG000|Overall Study|The Subject went out of The Trial|1
2213490|NCT01680016|3855124|FG001|Overall Study|The Subject went out of The Trial|0
2213491|NCT01680016|3855125|FG002|Overall Study|The Subject went out of The Trial|3
1988410|NCT00004228|3553744|FG000|Overall Study|Withdrawal by Subject|3
1988411|NCT00004228|3553745|FG001|Overall Study|Withdrawal by Subject|0
1988412|NCT00004228|3553746|FG002|Overall Study|Withdrawal by Subject|1
1988413|NCT00004228|3553747|FG003|Overall Study|Withdrawal by Subject|0
1988414|NCT00004228|3553748|FG004|Overall Study|Withdrawal by Subject|2
1988415|NCT00004228|3553749|FG005|Overall Study|Withdrawal by Subject|1
1988416|NCT00004228|3553750|FG006|Overall Study|Withdrawal by Subject|2
1988417|NCT00004228|3553744|FG000|Overall Study|Other|0
1988418|NCT00004228|3553745|FG001|Overall Study|Other|0
1988419|NCT00004228|3553746|FG002|Overall Study|Other|1
1988420|NCT00004228|3553747|FG003|Overall Study|Other|0
1988421|NCT00004228|3553748|FG004|Overall Study|Other|0
1988422|NCT00004228|3553749|FG005|Overall Study|Other|0
1988423|NCT00004228|3553750|FG006|Overall Study|Other|0
1988424|NCT00004228|3553744|FG000|Overall Study|ineligible|4
1988425|NCT00004228|3553745|FG001|Overall Study|ineligible|2
1988426|NCT00004228|3553746|FG002|Overall Study|ineligible|4
1988427|NCT00004228|3553747|FG003|Overall Study|ineligible|1
1988428|NCT00004228|3553748|FG004|Overall Study|ineligible|1
1988429|NCT00004228|3553749|FG005|Overall Study|ineligible|2
1988430|NCT00004228|3553750|FG006|Overall Study|ineligible|5
1988431|NCT00004259|3553771|FG000|Overall Study|Protocol Violation|1
1988432|NCT00004259|3553772|FG001|Overall Study|Protocol Violation|2
1988433|NCT00004259|3553773|FG002|Overall Study|Protocol Violation|0
1988434|NCT00004259|3553774|FG003|Overall Study|Protocol Violation|0
1988435|NCT00004259|3553771|FG000|Overall Study|Withdrawal by Subject|0
1988436|NCT00004259|3553772|FG001|Overall Study|Withdrawal by Subject|2
1988437|NCT00004259|3553773|FG002|Overall Study|Withdrawal by Subject|0
1988438|NCT00004259|3553774|FG003|Overall Study|Withdrawal by Subject|0
1988439|NCT00004412|3553790|FG000|Randomized Period|Moved to Crossover Period|3
1988440|NCT00004412|3553791|FG001|Randomized Period|Moved to Crossover Period|0
1988441|NCT00004412|3553792|FG002|Randomized Period|Moved to Crossover Period|0
1988442|NCT00004445|3553802|FG000|Overall Study|Physician Decision|2
1988443|NCT00004445|3553802|FG000|Overall Study|Withdrawal by Subject|1
1988444|NCT00004562|3553831|FG000|Overall Study|Lost to Follow-up|102
1988445|NCT00004562|3553832|FG001|Overall Study|Lost to Follow-up|91
1988446|NCT00004563|3553840|FG000|Overall Study|Withdrawal by Subject|20
1988447|NCT00004563|3553841|FG001|Overall Study|Withdrawal by Subject|16
1988448|NCT00004563|3553840|FG000|Overall Study|Lack of Efficacy|3
1988449|NCT00004563|3553841|FG001|Overall Study|Lack of Efficacy|5
1988450|NCT00004563|3553840|FG000|Overall Study|Death|2
1988451|NCT00004563|3553841|FG001|Overall Study|Death|3
1988452|NCT00004635|3553849|FG000|Period One|refused|2
1988453|NCT00004635|3553850|FG001|Period One|refused|1
1988454|NCT00004635|3553849|FG000|Period One|Withdrawal by Subject|1
1988455|NCT00004635|3553850|FG001|Period One|Withdrawal by Subject|1
1988456|NCT00004635|3553849|FG000|Period One|Protocol Violation|1
1988457|NCT00004635|3553850|FG001|Period One|Protocol Violation|0
1988458|NCT00004635|3553849|FG000|Period One|PSA did not go <5 ng/mL|1
1988459|NCT00004635|3553850|FG001|Period One|PSA did not go <5 ng/mL|0
1988460|NCT00004635|3553849|FG000|Period One|second malignancy|1
1988461|NCT00004635|3553850|FG001|Period One|second malignancy|0
1988462|NCT00004635|3553849|FG000|Period One|progressed|0
1988463|NCT00004635|3553850|FG001|Period One|progressed|2
1988464|NCT00004635|3553849|FG000|Period One|health problem|0
1988465|NCT00004635|3553850|FG001|Period One|health problem|1
1988466|NCT00004635|3553849|FG000|Period One|discrepancy in data entry|0
1988467|NCT00004635|3553850|FG001|Period One|discrepancy in data entry|1
1988468|NCT00004635|3553849|FG000|Period Two|progression|2
1988469|NCT00004635|3553850|FG001|Period Two|progression|3
1988470|NCT00004635|3553849|FG000|Period Two|Adverse Event|1
1988471|NCT00004635|3553850|FG001|Period Two|Adverse Event|0
1988472|NCT00004635|3553849|FG000|Period Two|refused|0
1988473|NCT00004635|3553850|FG001|Period Two|refused|2
1988474|NCT00004635|3553849|FG000|Period Two|health problem|1
1988475|NCT00004635|3553850|FG001|Period Two|health problem|1
1988476|NCT00004635|3553849|FG000|Period Two|travel issues|0
1988477|NCT00004635|3553850|FG001|Period Two|travel issues|1
1988478|NCT00004635|3553849|FG000|Period Two|secondary malignancy|1
1988479|NCT00004635|3553850|FG001|Period Two|secondary malignancy|1
1988480|NCT00004635|3553849|FG000|Period Two|Lost to Follow-up|1
1988481|NCT00004635|3553850|FG001|Period Two|Lost to Follow-up|0
1988482|NCT00004635|3553849|FG000|Period Two|discrepancy in data entry|0
1988483|NCT00004635|3553850|FG001|Period Two|discrepancy in data entry|1
1988484|NCT00004732|3553861|FG000|Overall Study|Withdrawal by Subject|36
1988485|NCT00004732|3553862|FG001|Overall Study|Withdrawal by Subject|64
1988486|NCT00004732|3553861|FG000|Overall Study|Lost to Follow-up|33
1988487|NCT00004732|3553862|FG001|Overall Study|Lost to Follow-up|47
1988488|NCT00004859|3553872|FG000|Overall Study|Lack of Efficacy|43
1988489|NCT00004859|3553873|FG001|Overall Study|Lack of Efficacy|113
1988490|NCT00004859|3553872|FG000|Overall Study|Adverse Event|31
1988491|NCT00004859|3553873|FG001|Overall Study|Adverse Event|93
1988492|NCT00004859|3553872|FG000|Overall Study|Death|5
1988493|NCT00004859|3553873|FG001|Overall Study|Death|5
1988494|NCT00004859|3553872|FG000|Overall Study|Withdrawal by Subject|7
1988495|NCT00004859|3553873|FG001|Overall Study|Withdrawal by Subject|33
1988496|NCT00004859|3553872|FG000|Overall Study|Protocol Violation|2
1988497|NCT00004859|3553873|FG001|Overall Study|Protocol Violation|2
1988498|NCT00004859|3553872|FG000|Overall Study|other disease|0
1988499|NCT00004859|3553873|FG001|Overall Study|other disease|3
1988500|NCT00004859|3553872|FG000|Overall Study|error|3
1988501|NCT00004859|3553873|FG001|Overall Study|error|1
1988502|NCT00004859|3553872|FG000|Overall Study|missing data|14
1988503|NCT00004859|3553873|FG001|Overall Study|missing data|11
1988504|NCT00004859|3553872|FG000|Overall Study|Other|13
1988505|NCT00004859|3553873|FG001|Overall Study|Other|21
1988506|NCT00004888|3553883|FG000|Overall Study|Adverse Event|5
1988507|NCT00004888|3553884|FG001|Overall Study|Adverse Event|10
1988508|NCT00004888|3553883|FG000|Overall Study|Withdrawal by Subject|0
1988509|NCT00004888|3553884|FG001|Overall Study|Withdrawal by Subject|3
1988510|NCT00004888|3553883|FG000|Overall Study|Physician Decision|1
1988511|NCT00004888|3553884|FG001|Overall Study|Physician Decision|1
1988512|NCT00004888|3553883|FG000|Overall Study|Progressive Disease|4
1988513|NCT00004888|3553884|FG001|Overall Study|Progressive Disease|9
1988514|NCT00004888|3553883|FG000|Overall Study|Death without progressive disease|0
1988515|NCT00004888|3553884|FG001|Overall Study|Death without progressive disease|1
1988516|NCT00004888|3553883|FG000|Overall Study|Toxic death|1
1988517|NCT00004888|3553884|FG001|Overall Study|Toxic death|0
1988518|NCT00004978|3553892|FG000|Overall Study|Death|107
1988519|NCT00004978|3553893|FG001|Overall Study|Death|116
1988520|NCT00004978|3553892|FG000|Overall Study|Lost to Follow-up|101
1988521|NCT00004978|3553893|FG001|Overall Study|Lost to Follow-up|108
1988522|NCT00004978|3553892|FG000|Overall Study|Withdrawal by Subject|17
1988523|NCT00004978|3553893|FG001|Overall Study|Withdrawal by Subject|26
2213492|NCT01680016|3855126|FG003|Overall Study|The Subject went out of The Trial|0
2213493|NCT01680016|3855123|FG000|Overall Study|Protocol Violation|0
1988524|NCT00004978|3553892|FG000|Overall Study|site closure - not in analysis cohort|19
1988525|NCT00004978|3553893|FG001|Overall Study|site closure - not in analysis cohort|20
1988526|NCT00004980|3553901|FG000|Overall Study|Withdrawal by Subject|1
1988527|NCT00004980|3553902|FG001|Overall Study|Withdrawal by Subject|0
1988528|NCT00004980|3553901|FG000|Overall Study|memory difficulties|1
1988529|NCT00004980|3553902|FG001|Overall Study|memory difficulties|1
1988530|NCT00004980|3553901|FG000|Overall Study|Physician Decision|0
1988531|NCT00004980|3553902|FG001|Overall Study|Physician Decision|1
1988532|NCT00005044|3553910|FG000|Overall Study|Protocol Violation|37
1988533|NCT00005044|3553911|FG001|Overall Study|Protocol Violation|46
1988534|NCT00005044|3553910|FG000|Overall Study|Withdrawal by Subject|1
1988535|NCT00005044|3553911|FG001|Overall Study|Withdrawal by Subject|5
1988536|NCT00005044|3553910|FG000|Overall Study|No protocol treatment|0
1988537|NCT00005044|3553911|FG001|Overall Study|No protocol treatment|1
1988538|NCT00005047|3553921|FG000|Overall Study|Withdrawal by Subject|12
1988539|NCT00005047|3553922|FG001|Overall Study|Withdrawal by Subject|0
1988540|NCT00005047|3553923|FG002|Overall Study|Withdrawal by Subject|0
1988541|NCT00005047|3553924|FG003|Overall Study|Withdrawal by Subject|0
1988542|NCT00005047|3553921|FG000|Overall Study|Adverse Event|5
1988543|NCT00005047|3553922|FG001|Overall Study|Adverse Event|0
1988544|NCT00005047|3553923|FG002|Overall Study|Adverse Event|0
1988545|NCT00005047|3553924|FG003|Overall Study|Adverse Event|0
1988546|NCT00005047|3553921|FG000|Overall Study|Lost to Follow-up|1
1988547|NCT00005047|3553922|FG001|Overall Study|Lost to Follow-up|0
1988548|NCT00005047|3553923|FG002|Overall Study|Lost to Follow-up|0
1988549|NCT00005047|3553924|FG003|Overall Study|Lost to Follow-up|0
1988550|NCT00005047|3553921|FG000|Overall Study|Lack of Efficacy|1
1988551|NCT00005047|3553922|FG001|Overall Study|Lack of Efficacy|0
1988552|NCT00005047|3553923|FG002|Overall Study|Lack of Efficacy|0
1988553|NCT00005047|3553924|FG003|Overall Study|Lack of Efficacy|0
1988554|NCT00005879|3553952|FG000|Overall Study|Withdrawal by Subject|8
1988555|NCT00005879|3553953|FG001|Overall Study|Withdrawal by Subject|10
1988556|NCT00005906|3553968|FG000|Overall Study|Lack of Efficacy|3
2311991|NCT02760407|4017752|FG000|Overall Study|Lost to Follow-up|1
2311992|NCT02760407|4017753|FG001|Overall Study|Lost to Follow-up|7
2311993|NCT02760407|4017754|FG002|Overall Study|Lost to Follow-up|4
2311994|NCT02760407|4017755|FG003|Overall Study|Lost to Follow-up|6
1988557|NCT00005908|3553972|FG000|Overall Study|Withdrawal by Subject|1
1988558|NCT00005908|3553973|FG001|Overall Study|Withdrawal by Subject|0
1988559|NCT00005937|3553982|FG000|Overall Study|Lack of Efficacy|5
1988560|NCT00005947|3553988|FG000|Overall Study|Death|54
1988561|NCT00005947|3553989|FG001|Overall Study|Death|40
1988562|NCT00005947|3553988|FG000|Overall Study|Patient Refused to Continue|2
1988563|NCT00005947|3553989|FG001|Overall Study|Patient Refused to Continue|1
1988564|NCT00005947|3553988|FG000|Overall Study|Site Closure|1
1988565|NCT00005947|3553989|FG001|Overall Study|Site Closure|0
1988566|NCT00005957|3553999|FG000|Overall Study|No treated|3
1988567|NCT00005957|3554000|FG001|Overall Study|No treated|9
1988568|NCT00005957|3553999|FG000|Overall Study|Crossover to the other arm|5
1988569|NCT00005957|3554000|FG001|Overall Study|Crossover to the other arm|19
1988570|NCT00006011|3554009|FG000|Overall Study|Disease progression|13
1988571|NCT00006011|3554010|FG001|Overall Study|Disease progression|6
1988572|NCT00006011|3554011|FG002|Overall Study|Disease progression|26
1988573|NCT00006011|3554009|FG000|Overall Study|Refused further treatment|15
1988574|NCT00006011|3554010|FG001|Overall Study|Refused further treatment|13
1988575|NCT00006011|3554011|FG002|Overall Study|Refused further treatment|26
1988576|NCT00006011|3554009|FG000|Overall Study|Adverse Event|15
1988577|NCT00006011|3554010|FG001|Overall Study|Adverse Event|39
1988578|NCT00006011|3554011|FG002|Overall Study|Adverse Event|5
2311995|NCT02760407|4017752|FG000|Overall Study|Withdrawal by Subject|25
2311996|NCT02760407|4017753|FG001|Overall Study|Withdrawal by Subject|31
2311997|NCT02760407|4017754|FG002|Overall Study|Withdrawal by Subject|37
2311998|NCT02760407|4017755|FG003|Overall Study|Withdrawal by Subject|25
1988579|NCT00006011|3554009|FG000|Overall Study|Death|0
1988580|NCT00006011|3554010|FG001|Overall Study|Death|1
1988581|NCT00006011|3554011|FG002|Overall Study|Death|2
1988582|NCT00006011|3554009|FG000|Overall Study|Other|4
1988583|NCT00006011|3554010|FG001|Overall Study|Other|2
1988584|NCT00006011|3554011|FG002|Overall Study|Other|5
1988585|NCT00006011|3554009|FG000|Overall Study|Ineligible|18
1988586|NCT00006011|3554010|FG001|Overall Study|Ineligible|16
1988587|NCT00006011|3554011|FG002|Overall Study|Ineligible|9
1988588|NCT00006046|3554022|FG000|Overall Study|Adverse Event|3
1988589|NCT00006046|3554023|FG001|Overall Study|Adverse Event|0
1988590|NCT00006046|3554024|FG002|Overall Study|Adverse Event|0
1988591|NCT00006046|3554025|FG003|Overall Study|Adverse Event|0
1988592|NCT00006046|3554026|FG004|Overall Study|Adverse Event|0
1988593|NCT00006046|3554022|FG000|Overall Study|Disease Progression|2
1988594|NCT00006046|3554023|FG001|Overall Study|Disease Progression|0
1988595|NCT00006046|3554024|FG002|Overall Study|Disease Progression|0
1988596|NCT00006046|3554025|FG003|Overall Study|Disease Progression|0
1988597|NCT00006046|3554026|FG004|Overall Study|Disease Progression|0
1988598|NCT00006164|3554090|FG000|Overall Study|Withdrew or lost to follow-up|70
1988599|NCT00006164|3554091|FG001|Overall Study|Withdrew or lost to follow-up|81
1988600|NCT00006184|3554120|FG000|Overall Study|Death|1
1988601|NCT00006184|3554121|FG001|Overall Study|Death|0
1988602|NCT00006237|3554133|FG000|Overall Study|Adverse Event|39
1988603|NCT00006237|3554134|FG001|Overall Study|Adverse Event|29
1988604|NCT00006237|3554133|FG000|Overall Study|Death|1
1988605|NCT00006237|3554134|FG001|Overall Study|Death|0
1988606|NCT00006237|3554133|FG000|Overall Study|Refusal unrelated to adverse effects|8
1988607|NCT00006237|3554134|FG001|Overall Study|Refusal unrelated to adverse effects|4
1988608|NCT00006237|3554133|FG000|Overall Study|Progression/relapse|54
1988609|NCT00006237|3554134|FG001|Overall Study|Progression/relapse|2
1988610|NCT00006237|3554133|FG000|Overall Study|Not eligible|9
1988611|NCT00006237|3554134|FG001|Overall Study|Not eligible|20
1988612|NCT00006237|3554133|FG000|Overall Study|Withdrawal by Subject|0
1988613|NCT00006237|3554134|FG001|Overall Study|Withdrawal by Subject|1
1988614|NCT00006237|3554133|FG000|Overall Study|Not protocol specified|14
1988615|NCT00006237|3554134|FG001|Overall Study|Not protocol specified|5
1988616|NCT00006289|3554149|FG000|First Intervention (5 Weeks)|Adverse Event|1
1988617|NCT00006289|3554150|FG001|First Intervention (5 Weeks)|Adverse Event|0
1988618|NCT00006289|3554149|FG000|Second Intervention (5 Weeks)|Protocol Violation|1
1988619|NCT00006289|3554150|FG001|Second Intervention (5 Weeks)|Protocol Violation|1
1988620|NCT00006305|3554170|FG000|Overall Study|Withdrawal by Subject|17
1988621|NCT00006305|3554171|FG001|Overall Study|Withdrawal by Subject|10
1988622|NCT00006305|3554172|FG002|Overall Study|Withdrawal by Subject|15
1988623|NCT00006305|3554173|FG003|Overall Study|Withdrawal by Subject|14
1988624|NCT00006389|3554183|FG000|Overall Study|Adverse Event|1
1988625|NCT00006392|3554192|FG000|Overall Study|Ineligible|11
1988626|NCT00006392|3554193|FG001|Overall Study|Ineligible|3
1988627|NCT00006392|3554194|FG002|Overall Study|Ineligible|5
1988628|NCT00006392|3554195|FG003|Overall Study|Ineligible|5
1988629|NCT00006392|3554192|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156
1988630|NCT00006392|3554193|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1988631|NCT00006392|3554194|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1988632|NCT00006392|3554195|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1988633|NCT00006409|3554220|FG000|Baseline|Protocol Violation|48
1988634|NCT00006409|3554221|FG001|Baseline|Protocol Violation|70
1988635|NCT00006409|3554222|FG002|Baseline|Protocol Violation|0
1988636|NCT00006409|3554223|FG003|Baseline|Protocol Violation|0
1988637|NCT00006409|3554224|FG004|Baseline|Protocol Violation|0
1988638|NCT00006409|3554225|FG005|Baseline|Protocol Violation|0
1988639|NCT00006409|3554220|FG000|Post-2 Year Intervention|Protocol Violation|0
1988640|NCT00006409|3554221|FG001|Post-2 Year Intervention|Protocol Violation|0
1988641|NCT00006409|3554222|FG002|Post-2 Year Intervention|Protocol Violation|251
1988642|NCT00006409|3554223|FG003|Post-2 Year Intervention|Protocol Violation|168
1988643|NCT00006409|3554224|FG004|Post-2 Year Intervention|Protocol Violation|0
1988644|NCT00006409|3554225|FG005|Post-2 Year Intervention|Protocol Violation|0
1988645|NCT00006409|3554220|FG000|Post-3 Year Intervention|Protocol Violation|0
1988646|NCT00006409|3554221|FG001|Post-3 Year Intervention|Protocol Violation|0
1988647|NCT00006409|3554222|FG002|Post-3 Year Intervention|Protocol Violation|0
1988648|NCT00006409|3554223|FG003|Post-3 Year Intervention|Protocol Violation|0
1988649|NCT00006409|3554224|FG004|Post-3 Year Intervention|Protocol Violation|62
1988650|NCT00006409|3554225|FG005|Post-3 Year Intervention|Protocol Violation|62
1988651|NCT00006489|3554252|FG000|Overall Study|Adverse Event|3
1988652|NCT00006489|3554253|FG001|Overall Study|Adverse Event|2
1988653|NCT00006489|3554254|FG002|Overall Study|Adverse Event|4
1988654|NCT00006489|3554255|FG003|Overall Study|Adverse Event|3
1988655|NCT00006489|3554252|FG000|Overall Study|Withdrawal by Subject|10
1988656|NCT00006489|3554253|FG001|Overall Study|Withdrawal by Subject|9
1988657|NCT00006489|3554254|FG002|Overall Study|Withdrawal by Subject|9
1988658|NCT00006489|3554255|FG003|Overall Study|Withdrawal by Subject|6
1988659|NCT00006489|3554252|FG000|Overall Study|Scheduling Conflict|0
1988660|NCT00006489|3554253|FG001|Overall Study|Scheduling Conflict|3
1988661|NCT00006489|3554254|FG002|Overall Study|Scheduling Conflict|2
1988662|NCT00006489|3554255|FG003|Overall Study|Scheduling Conflict|1
1988663|NCT00006489|3554252|FG000|Overall Study|Death|0
1988664|NCT00006489|3554253|FG001|Overall Study|Death|0
1988665|NCT00006489|3554254|FG002|Overall Study|Death|0
1988666|NCT00006489|3554255|FG003|Overall Study|Death|1
1988667|NCT00006604|3554272|FG000|Overall Study|Met study objective - no further FU|1
1988668|NCT00006604|3554273|FG001|Overall Study|Met study objective - no further FU|0
1988669|NCT00006604|3554274|FG002|Overall Study|Met study objective - no further FU|0
1988670|NCT00006604|3554275|FG003|Overall Study|Met study objective - no further FU|0
1988671|NCT00006604|3554276|FG004|Overall Study|Met study objective - no further FU|0
1988672|NCT00006604|3554277|FG005|Overall Study|Met study objective - no further FU|0
1988673|NCT00006604|3554278|FG006|Overall Study|Met study objective - no further FU|0
1988674|NCT00006604|3554279|FG007|Overall Study|Met study objective - no further FU|0
1988675|NCT00006604|3554280|FG008|Overall Study|Met study objective - no further FU|0
1988676|NCT00006604|3554281|FG009|Overall Study|Met study objective - no further FU|0
1988677|NCT00006604|3554282|FG010|Overall Study|Met study objective - no further FU|0
1988678|NCT00006604|3554283|FG011|Overall Study|Met study objective - no further FU|0
2213494|NCT01680016|3855124|FG001|Overall Study|Protocol Violation|1
1988679|NCT00006604|3554284|FG012|Overall Study|Met study objective - no further FU|0
1988680|NCT00006604|3554285|FG013|Overall Study|Met study objective - no further FU|0
1988681|NCT00006604|3554286|FG014|Overall Study|Met study objective - no further FU|1
1988682|NCT00006604|3554287|FG015|Overall Study|Met study objective - no further FU|1
1988683|NCT00006604|3554288|FG016|Overall Study|Met study objective - no further FU|0
1988684|NCT00006604|3554272|FG000|Overall Study|Randomization entry error-no RX, no FU|0
1988685|NCT00006604|3554273|FG001|Overall Study|Randomization entry error-no RX, no FU|0
1988686|NCT00006604|3554274|FG002|Overall Study|Randomization entry error-no RX, no FU|0
1988687|NCT00006604|3554275|FG003|Overall Study|Randomization entry error-no RX, no FU|0
1988688|NCT00006604|3554276|FG004|Overall Study|Randomization entry error-no RX, no FU|0
1988689|NCT00006604|3554277|FG005|Overall Study|Randomization entry error-no RX, no FU|0
1988690|NCT00006604|3554278|FG006|Overall Study|Randomization entry error-no RX, no FU|0
1988691|NCT00006604|3554279|FG007|Overall Study|Randomization entry error-no RX, no FU|0
1988692|NCT00006604|3554280|FG008|Overall Study|Randomization entry error-no RX, no FU|0
1988693|NCT00006604|3554281|FG009|Overall Study|Randomization entry error-no RX, no FU|0
1988694|NCT00006604|3554282|FG010|Overall Study|Randomization entry error-no RX, no FU|0
1988695|NCT00006604|3554283|FG011|Overall Study|Randomization entry error-no RX, no FU|1
1988696|NCT00006604|3554284|FG012|Overall Study|Randomization entry error-no RX, no FU|0
1988697|NCT00006604|3554285|FG013|Overall Study|Randomization entry error-no RX, no FU|0
1988698|NCT00006604|3554286|FG014|Overall Study|Randomization entry error-no RX, no FU|0
1988699|NCT00006604|3554287|FG015|Overall Study|Randomization entry error-no RX, no FU|0
1988700|NCT00006604|3554288|FG016|Overall Study|Randomization entry error-no RX, no FU|0
1988701|NCT00006604|3554272|FG000|Overall Study|Death|0
1988702|NCT00006604|3554273|FG001|Overall Study|Death|0
1988703|NCT00006604|3554274|FG002|Overall Study|Death|0
1988704|NCT00006604|3554275|FG003|Overall Study|Death|0
1988705|NCT00006604|3554276|FG004|Overall Study|Death|0
1988706|NCT00006604|3554277|FG005|Overall Study|Death|0
1988707|NCT00006604|3554278|FG006|Overall Study|Death|0
1988708|NCT00006604|3554279|FG007|Overall Study|Death|0
1988709|NCT00006604|3554280|FG008|Overall Study|Death|0
1988710|NCT00006604|3554281|FG009|Overall Study|Death|1
1988711|NCT00006604|3554282|FG010|Overall Study|Death|1
1988712|NCT00006604|3554283|FG011|Overall Study|Death|1
1988713|NCT00006604|3554284|FG012|Overall Study|Death|0
1988714|NCT00006604|3554285|FG013|Overall Study|Death|0
1988715|NCT00006604|3554286|FG014|Overall Study|Death|0
1988716|NCT00006604|3554287|FG015|Overall Study|Death|0
1988717|NCT00006604|3554288|FG016|Overall Study|Death|0
1988718|NCT00006604|3554272|FG000|Overall Study|Severe debilitation, unable to continue|0
1988719|NCT00006604|3554273|FG001|Overall Study|Severe debilitation, unable to continue|0
1988720|NCT00006604|3554274|FG002|Overall Study|Severe debilitation, unable to continue|0
1988721|NCT00006604|3554275|FG003|Overall Study|Severe debilitation, unable to continue|0
1988722|NCT00006604|3554276|FG004|Overall Study|Severe debilitation, unable to continue|0
1988723|NCT00006604|3554277|FG005|Overall Study|Severe debilitation, unable to continue|0
1988724|NCT00006604|3554278|FG006|Overall Study|Severe debilitation, unable to continue|3
1988725|NCT00006604|3554279|FG007|Overall Study|Severe debilitation, unable to continue|0
1988726|NCT00006604|3554280|FG008|Overall Study|Severe debilitation, unable to continue|0
1988727|NCT00006604|3554281|FG009|Overall Study|Severe debilitation, unable to continue|5
1988728|NCT00006604|3554282|FG010|Overall Study|Severe debilitation, unable to continue|0
1988729|NCT00006604|3554283|FG011|Overall Study|Severe debilitation, unable to continue|2
1988730|NCT00006604|3554284|FG012|Overall Study|Severe debilitation, unable to continue|1
1988731|NCT00006604|3554285|FG013|Overall Study|Severe debilitation, unable to continue|0
1988732|NCT00006604|3554286|FG014|Overall Study|Severe debilitation, unable to continue|2
1988733|NCT00006604|3554287|FG015|Overall Study|Severe debilitation, unable to continue|0
1988734|NCT00006604|3554288|FG016|Overall Study|Severe debilitation, unable to continue|0
1988735|NCT00006604|3554272|FG000|Overall Study|Subj/Parent not able to get to clinic|0
1988736|NCT00006604|3554273|FG001|Overall Study|Subj/Parent not able to get to clinic|0
1988737|NCT00006604|3554274|FG002|Overall Study|Subj/Parent not able to get to clinic|0
1988738|NCT00006604|3554275|FG003|Overall Study|Subj/Parent not able to get to clinic|1
1988739|NCT00006604|3554276|FG004|Overall Study|Subj/Parent not able to get to clinic|1
1988740|NCT00006604|3554277|FG005|Overall Study|Subj/Parent not able to get to clinic|0
1988741|NCT00006604|3554278|FG006|Overall Study|Subj/Parent not able to get to clinic|1
1988742|NCT00006604|3554279|FG007|Overall Study|Subj/Parent not able to get to clinic|0
1988743|NCT00006604|3554280|FG008|Overall Study|Subj/Parent not able to get to clinic|0
1988744|NCT00006604|3554281|FG009|Overall Study|Subj/Parent not able to get to clinic|1
1988745|NCT00006604|3554282|FG010|Overall Study|Subj/Parent not able to get to clinic|2
1988746|NCT00006604|3554283|FG011|Overall Study|Subj/Parent not able to get to clinic|1
1988747|NCT00006604|3554284|FG012|Overall Study|Subj/Parent not able to get to clinic|1
1988748|NCT00006604|3554285|FG013|Overall Study|Subj/Parent not able to get to clinic|1
1988749|NCT00006604|3554286|FG014|Overall Study|Subj/Parent not able to get to clinic|3
1988750|NCT00006604|3554287|FG015|Overall Study|Subj/Parent not able to get to clinic|0
1988751|NCT00006604|3554288|FG016|Overall Study|Subj/Parent not able to get to clinic|0
1988752|NCT00006604|3554272|FG000|Overall Study|Site closing|0
1988753|NCT00006604|3554273|FG001|Overall Study|Site closing|0
1988754|NCT00006604|3554274|FG002|Overall Study|Site closing|1
1988755|NCT00006604|3554275|FG003|Overall Study|Site closing|1
1988756|NCT00006604|3554276|FG004|Overall Study|Site closing|0
2213495|NCT01680016|3855125|FG002|Overall Study|Protocol Violation|0
1988757|NCT00006604|3554277|FG005|Overall Study|Site closing|0
1988758|NCT00006604|3554278|FG006|Overall Study|Site closing|0
1988759|NCT00006604|3554279|FG007|Overall Study|Site closing|1
1988760|NCT00006604|3554280|FG008|Overall Study|Site closing|0
1988761|NCT00006604|3554281|FG009|Overall Study|Site closing|0
1988762|NCT00006604|3554282|FG010|Overall Study|Site closing|0
1988763|NCT00006604|3554283|FG011|Overall Study|Site closing|1
1988764|NCT00006604|3554284|FG012|Overall Study|Site closing|1
1988765|NCT00006604|3554285|FG013|Overall Study|Site closing|1
1988766|NCT00006604|3554286|FG014|Overall Study|Site closing|0
1988767|NCT00006604|3554287|FG015|Overall Study|Site closing|0
1988768|NCT00006604|3554288|FG016|Overall Study|Site closing|1
1988769|NCT00006604|3554272|FG000|Overall Study|Withdrawal by Subject|1
1988770|NCT00006604|3554273|FG001|Overall Study|Withdrawal by Subject|0
2213496|NCT01680016|3855126|FG003|Overall Study|Protocol Violation|0
1988771|NCT00006604|3554274|FG002|Overall Study|Withdrawal by Subject|2
1988772|NCT00006604|3554275|FG003|Overall Study|Withdrawal by Subject|0
1988773|NCT00006604|3554276|FG004|Overall Study|Withdrawal by Subject|1
1988774|NCT00006604|3554277|FG005|Overall Study|Withdrawal by Subject|2
1988775|NCT00006604|3554278|FG006|Overall Study|Withdrawal by Subject|2
1988776|NCT00006604|3554279|FG007|Overall Study|Withdrawal by Subject|0
1988777|NCT00006604|3554280|FG008|Overall Study|Withdrawal by Subject|1
1988778|NCT00006604|3554281|FG009|Overall Study|Withdrawal by Subject|3
1988779|NCT00006604|3554282|FG010|Overall Study|Withdrawal by Subject|2
1988780|NCT00006604|3554283|FG011|Overall Study|Withdrawal by Subject|0
1988781|NCT00006604|3554284|FG012|Overall Study|Withdrawal by Subject|1
1988782|NCT00006604|3554285|FG013|Overall Study|Withdrawal by Subject|2
1988783|NCT00006604|3554286|FG014|Overall Study|Withdrawal by Subject|1
1988784|NCT00006604|3554287|FG015|Overall Study|Withdrawal by Subject|0
1988785|NCT00006604|3554288|FG016|Overall Study|Withdrawal by Subject|1
1988786|NCT00006604|3554272|FG000|Overall Study|Subj/parent not willing to adhere to req|0
1988787|NCT00006604|3554273|FG001|Overall Study|Subj/parent not willing to adhere to req|0
1988788|NCT00006604|3554274|FG002|Overall Study|Subj/parent not willing to adhere to req|1
1988789|NCT00006604|3554275|FG003|Overall Study|Subj/parent not willing to adhere to req|3
1988790|NCT00006604|3554276|FG004|Overall Study|Subj/parent not willing to adhere to req|0
1988791|NCT00006604|3554277|FG005|Overall Study|Subj/parent not willing to adhere to req|0
1988792|NCT00006604|3554278|FG006|Overall Study|Subj/parent not willing to adhere to req|3
1988793|NCT00006604|3554279|FG007|Overall Study|Subj/parent not willing to adhere to req|1
1988794|NCT00006604|3554280|FG008|Overall Study|Subj/parent not willing to adhere to req|0
1988795|NCT00006604|3554281|FG009|Overall Study|Subj/parent not willing to adhere to req|6
1988796|NCT00006604|3554282|FG010|Overall Study|Subj/parent not willing to adhere to req|3
1988797|NCT00006604|3554283|FG011|Overall Study|Subj/parent not willing to adhere to req|0
1988798|NCT00006604|3554284|FG012|Overall Study|Subj/parent not willing to adhere to req|0
1988799|NCT00006604|3554285|FG013|Overall Study|Subj/parent not willing to adhere to req|2
1988800|NCT00006604|3554286|FG014|Overall Study|Subj/parent not willing to adhere to req|3
1988801|NCT00006604|3554287|FG015|Overall Study|Subj/parent not willing to adhere to req|3
1988802|NCT00006604|3554288|FG016|Overall Study|Subj/parent not willing to adhere to req|4
1988803|NCT00006604|3554272|FG000|Overall Study|Lost to Follow-up|0
1988804|NCT00006604|3554273|FG001|Overall Study|Lost to Follow-up|0
1988805|NCT00006604|3554274|FG002|Overall Study|Lost to Follow-up|0
1988806|NCT00006604|3554275|FG003|Overall Study|Lost to Follow-up|0
1988807|NCT00006604|3554276|FG004|Overall Study|Lost to Follow-up|0
1988808|NCT00006604|3554277|FG005|Overall Study|Lost to Follow-up|0
1988809|NCT00006604|3554278|FG006|Overall Study|Lost to Follow-up|0
1988810|NCT00006604|3554279|FG007|Overall Study|Lost to Follow-up|1
1988811|NCT00006604|3554280|FG008|Overall Study|Lost to Follow-up|0
1988812|NCT00006604|3554281|FG009|Overall Study|Lost to Follow-up|2
1988813|NCT00006604|3554282|FG010|Overall Study|Lost to Follow-up|0
1988814|NCT00006604|3554283|FG011|Overall Study|Lost to Follow-up|0
1988815|NCT00006604|3554284|FG012|Overall Study|Lost to Follow-up|0
1988816|NCT00006604|3554285|FG013|Overall Study|Lost to Follow-up|0
1988817|NCT00006604|3554286|FG014|Overall Study|Lost to Follow-up|0
1988818|NCT00006604|3554287|FG015|Overall Study|Lost to Follow-up|1
1988819|NCT00006604|3554288|FG016|Overall Study|Lost to Follow-up|3
1988820|NCT00006604|3554272|FG000|Overall Study|Other Reason|0
1988821|NCT00006604|3554273|FG001|Overall Study|Other Reason|0
1988822|NCT00006604|3554274|FG002|Overall Study|Other Reason|0
1988823|NCT00006604|3554275|FG003|Overall Study|Other Reason|0
1988824|NCT00006604|3554276|FG004|Overall Study|Other Reason|0
1988825|NCT00006604|3554277|FG005|Overall Study|Other Reason|1
1988826|NCT00006604|3554278|FG006|Overall Study|Other Reason|0
1988827|NCT00006604|3554279|FG007|Overall Study|Other Reason|0
1988828|NCT00006604|3554280|FG008|Overall Study|Other Reason|0
1988829|NCT00006604|3554281|FG009|Overall Study|Other Reason|1
1988830|NCT00006604|3554282|FG010|Overall Study|Other Reason|0
1988831|NCT00006604|3554283|FG011|Overall Study|Other Reason|0
1988832|NCT00006604|3554284|FG012|Overall Study|Other Reason|0
1988833|NCT00006604|3554285|FG013|Overall Study|Other Reason|0
1988834|NCT00006604|3554286|FG014|Overall Study|Other Reason|0
1988835|NCT00006604|3554287|FG015|Overall Study|Other Reason|0
1988836|NCT00006604|3554288|FG016|Overall Study|Other Reason|0
1988837|NCT00006721|3554314|FG000|Overall Study|Adverse Event|0
1988838|NCT00006721|3554315|FG001|Overall Study|Adverse Event|4
1988839|NCT00006721|3554316|FG002|Overall Study|Adverse Event|4
1988840|NCT00006721|3554314|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
1988841|NCT00006721|3554315|FG001|Overall Study|Refusal Unrelated to Adverse Event|0
1988842|NCT00006721|3554316|FG002|Overall Study|Refusal Unrelated to Adverse Event|8
1988843|NCT00006721|3554314|FG000|Overall Study|Progression/Relapse|0
1988844|NCT00006721|3554315|FG001|Overall Study|Progression/Relapse|1
1988845|NCT00006721|3554316|FG002|Overall Study|Progression/Relapse|2
1988846|NCT00006721|3554314|FG000|Overall Study|Death|0
1988847|NCT00006721|3554315|FG001|Overall Study|Death|1
1988848|NCT00006721|3554316|FG002|Overall Study|Death|2
1988849|NCT00006721|3554314|FG000|Overall Study|Other - Not Protocol Specified|0
1988850|NCT00006721|3554315|FG001|Overall Study|Other - Not Protocol Specified|7
1988851|NCT00006721|3554316|FG002|Overall Study|Other - Not Protocol Specified|7
1988852|NCT00006721|3554314|FG000|Overall Study|Ineligible|2
1988853|NCT00006721|3554315|FG001|Overall Study|Ineligible|12
1988854|NCT00006721|3554316|FG002|Overall Study|Ineligible|10
1988855|NCT00006721|3554314|FG000|Overall Study|Eligible but no Treatment Received|1
1988856|NCT00006721|3554315|FG001|Overall Study|Eligible but no Treatment Received|0
1988857|NCT00006721|3554316|FG002|Overall Study|Eligible but no Treatment Received|0
1988858|NCT00006903|3554328|FG000|Overall Study|Still receiving treatment|0
1988859|NCT00006903|3554329|FG001|Overall Study|Still receiving treatment|0
1988860|NCT00006903|3554330|FG002|Overall Study|Still receiving treatment|1
1988861|NCT00006903|3554328|FG000|Overall Study|Refused further treatment|0
1988862|NCT00006903|3554329|FG001|Overall Study|Refused further treatment|2
1988863|NCT00006903|3554330|FG002|Overall Study|Refused further treatment|1
1988864|NCT00006903|3554328|FG000|Overall Study|Adverse Event|0
1988865|NCT00006903|3554329|FG001|Overall Study|Adverse Event|0
1988866|NCT00006903|3554330|FG002|Overall Study|Adverse Event|1
1988867|NCT00006903|3554328|FG000|Overall Study|Death|0
1988868|NCT00006903|3554329|FG001|Overall Study|Death|1
1988869|NCT00006903|3554330|FG002|Overall Study|Death|0
1988870|NCT00006903|3554328|FG000|Overall Study|Patient never treated|0
1988871|NCT00006903|3554329|FG001|Overall Study|Patient never treated|0
1988872|NCT00006903|3554330|FG002|Overall Study|Patient never treated|1
1988873|NCT00006903|3554328|FG000|Overall Study|Ineligible|10
1988874|NCT00006903|3554329|FG001|Overall Study|Ineligible|1
1988875|NCT00006903|3554330|FG002|Overall Study|Ineligible|2
1988876|NCT00007020|3554338|FG000|Overall Study|Death|16
1988877|NCT00007020|3554338|FG000|Overall Study|Lost to Follow-up|13
1988878|NCT00007020|3554338|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1
1988879|NCT00007020|3554338|FG000|Overall Study|Pt withdrawn (liver transplant)|4
1988880|NCT00007020|3554338|FG000|Overall Study|Pt cared for by outside physician|4
1988881|NCT00007020|3554338|FG000|Overall Study|No evidence of treatment|6
1988882|NCT00007345|3554346|FG000|Overall Study|Refused further treatment|0
1988883|NCT00007345|3554347|FG001|Overall Study|Refused further treatment|7
1988884|NCT00007345|3554346|FG000|Overall Study|Switched to alternative treatment|0
1988885|NCT00007345|3554347|FG001|Overall Study|Switched to alternative treatment|3
1988886|NCT00007345|3554346|FG000|Overall Study|Intercurrent illness|1
1988887|NCT00007345|3554347|FG001|Overall Study|Intercurrent illness|0
1988888|NCT00007345|3554346|FG000|Overall Study|Death on study|1
1988889|NCT00007345|3554347|FG001|Overall Study|Death on study|1
1988890|NCT00007475|3554356|FG000|Overall Study|Withdrawal by Subject|1
2213497|NCT01680016|3855123|FG000|Overall Study|Withdrawal by Subject|5
2213498|NCT01680016|3855124|FG001|Overall Study|Withdrawal by Subject|7
2213499|NCT01680016|3855125|FG002|Overall Study|Withdrawal by Subject|1
2213500|NCT01680016|3855126|FG003|Overall Study|Withdrawal by Subject|1
2213501|NCT01680159|3855152|FG000|Screening Period|Not meet criteria for dose-up period|7
2213502|NCT01680159|3855152|FG000|Increased Dose Period|Adverse Event|6
1988891|NCT00007475|3554357|FG001|Overall Study|Withdrawal by Subject|0
1988892|NCT00007475|3554358|FG002|Overall Study|Withdrawal by Subject|0
1988893|NCT00007475|3554359|FG003|Overall Study|Withdrawal by Subject|0
1988894|NCT00007475|3554356|FG000|Overall Study|Adverse Event|3
1988895|NCT00007475|3554357|FG001|Overall Study|Adverse Event|0
1988896|NCT00007475|3554358|FG002|Overall Study|Adverse Event|0
1988897|NCT00007475|3554359|FG003|Overall Study|Adverse Event|0
1988898|NCT00008138|3554378|FG000|Neoadjuvant Chemotherapy|Adverse Event|3
1988899|NCT00008138|3554378|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
1988900|NCT00008138|3554378|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6
1988901|NCT00008138|3554378|FG000|Neoadjuvant Chemotherapy|not protocol specified|8
1988902|NCT00008138|3554378|FG000|Interval Debulking|Withdrawal by Subject|2
1988903|NCT00008138|3554378|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6
1988904|NCT00008138|3554378|FG000|Post-Cytoreduction Chemotherapy|Progression|1
1988905|NCT00008138|3554378|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1
1988906|NCT00008385|3554385|FG000|Overall Study|Off treatment reasons not reported|79
1988907|NCT00008385|3554386|FG001|Overall Study|Off treatment reasons not reported|70
1988908|NCT00008385|3554385|FG000|Overall Study|Progressive disease|52
1988909|NCT00008385|3554386|FG001|Overall Study|Progressive disease|117
1988910|NCT00008385|3554385|FG000|Overall Study|Adverse Event|8
1988911|NCT00008385|3554386|FG001|Overall Study|Adverse Event|20
1988912|NCT00008385|3554385|FG000|Overall Study|Death|12
1988913|NCT00008385|3554386|FG001|Overall Study|Death|18
1988914|NCT00008385|3554385|FG000|Overall Study|Withdrawal by Subject|67
1988915|NCT00008385|3554386|FG001|Overall Study|Withdrawal by Subject|157
1988916|NCT00008385|3554385|FG000|Overall Study|Start non-protocol therapy|3
1988917|NCT00008385|3554386|FG001|Overall Study|Start non-protocol therapy|1
1988918|NCT00008385|3554385|FG000|Overall Study|Other complicating disease|17
1988919|NCT00008385|3554386|FG001|Overall Study|Other complicating disease|30
1988920|NCT00008385|3554385|FG000|Overall Study|Maximum dose reached|0
1988921|NCT00008385|3554386|FG001|Overall Study|Maximum dose reached|2
1988922|NCT00008385|3554385|FG000|Overall Study|Other|105
1988923|NCT00008385|3554386|FG001|Overall Study|Other|212
1988924|NCT00008385|3554385|FG000|Overall Study|Not start protocol therapy|44
1988925|NCT00008385|3554386|FG001|Overall Study|Not start protocol therapy|175
1988926|NCT00009737|3554394|FG000|Overall Study|Adverse Event|112
1988927|NCT00009737|3554395|FG001|Overall Study|Adverse Event|75
1988928|NCT00009737|3554394|FG000|Overall Study|Death|4
1988929|NCT00009737|3554395|FG001|Overall Study|Death|6
1988930|NCT00009737|3554394|FG000|Overall Study|Lack of Efficacy|17
1988931|NCT00009737|3554395|FG001|Overall Study|Lack of Efficacy|15
1988932|NCT00009737|3554394|FG000|Overall Study|Violation of Selection Criteria at Entry|13
1988933|NCT00009737|3554395|FG001|Overall Study|Violation of Selection Criteria at Entry|9
1988934|NCT00009737|3554394|FG000|Overall Study|Other Protocol Violation|1
1988935|NCT00009737|3554395|FG001|Overall Study|Other Protocol Violation|0
1988936|NCT00009737|3554394|FG000|Overall Study|Refused Treatment|15
1988937|NCT00009737|3554395|FG001|Overall Study|Refused Treatment|16
1988938|NCT00009737|3554394|FG000|Overall Study|Lost to Follow-up|1
1988939|NCT00009737|3554395|FG001|Overall Study|Lost to Follow-up|1
1988940|NCT00009737|3554394|FG000|Overall Study|Administrative/Other Reasons|7
1988941|NCT00009737|3554395|FG001|Overall Study|Administrative/Other Reasons|1
1988942|NCT00009945|3554403|FG000|Overall Study|no follow up data|7
1988943|NCT00009945|3554404|FG001|Overall Study|no follow up data|5
1988944|NCT00010257|3554412|FG000|Overall Study|Withdrawal by Subject|1
1988945|NCT00010257|3554413|FG001|Overall Study|Withdrawal by Subject|0
1988946|NCT00010374|3554419|FG000|Overall Study|False positive phrenic nerve test|1
1988947|NCT00010803|3554430|FG000|Overall Study|Withdrawal by Subject|97
1988948|NCT00010803|3554431|FG001|Overall Study|Withdrawal by Subject|98
1988949|NCT00012012|3554465|FG000|Overall Study|Protocol Violation|1
1988950|NCT00012012|3554466|FG001|Overall Study|Protocol Violation|1
1988951|NCT00012012|3554465|FG000|Overall Study|Withdrawal by Subject|0
1988952|NCT00012012|3554466|FG001|Overall Study|Withdrawal by Subject|2
1988953|NCT00013611|3554505|FG000|Overall Study|Lost to Follow-up|91
1988954|NCT00013611|3554506|FG001|Overall Study|Lost to Follow-up|100
1988955|NCT00014495|3554529|FG000|Overall Study|Death|0
1988956|NCT00014495|3554530|FG001|Overall Study|Death|0
1988957|NCT00014495|3554531|FG002|Overall Study|Death|1
1988958|NCT00014495|3554532|FG003|Overall Study|Death|0
1988959|NCT00014495|3554529|FG000|Overall Study|Clinical deterioration|0
1988960|NCT00014495|3554530|FG001|Overall Study|Clinical deterioration|0
1988961|NCT00014495|3554531|FG002|Overall Study|Clinical deterioration|0
1988962|NCT00014495|3554532|FG003|Overall Study|Clinical deterioration|1
1988963|NCT00014911|3554539|FG000|Overall Study|Adverse Event|1
1988964|NCT00014911|3554539|FG000|Overall Study|Lost to Follow-up|1
1988965|NCT00014911|3554539|FG000|Overall Study|Withdrawal by Subject|6
1988966|NCT00014911|3554539|FG000|Overall Study|Unknown Reasons|2
1988967|NCT00014911|3554539|FG000|Overall Study|Immunosuppression-related Side Effects|1
1988968|NCT00015457|3554543|FG000|First Intervention|Adverse Event|0
1988969|NCT00015457|3554544|FG001|First Intervention|Adverse Event|2
1988970|NCT00015457|3554543|FG000|First Intervention|Lack of Efficacy|0
1988971|NCT00015457|3554544|FG001|First Intervention|Lack of Efficacy|1
1988972|NCT00015457|3554543|FG000|Second Intervention|Withdrawal by Subject|1
1988973|NCT00015457|3554544|FG001|Second Intervention|Withdrawal by Subject|0
1988974|NCT00016354|3554554|FG000|Overall Study|Lack of Efficacy|0
1988975|NCT00016354|3554555|FG001|Overall Study|Lack of Efficacy|0
1988976|NCT00016354|3554556|FG002|Overall Study|Lack of Efficacy|0
1988977|NCT00016354|3554557|FG003|Overall Study|Lack of Efficacy|0
1988978|NCT00016354|3554558|FG004|Overall Study|Lack of Efficacy|0
1988979|NCT00016354|3554559|FG005|Overall Study|Lack of Efficacy|0
1988980|NCT00016354|3554560|FG006|Overall Study|Lack of Efficacy|0
1988981|NCT00016354|3554561|FG007|Overall Study|Lack of Efficacy|1
1988982|NCT00019604|3554590|FG000|Overall Study|Death|1
1988983|NCT00019604|3554590|FG000|Overall Study|Progressive disease|23
1988984|NCT00019604|3554590|FG000|Overall Study|Refused treatment|1
1988985|NCT00019604|3554590|FG000|Overall Study|Carcinoid tumor, not treatable|1
1988986|NCT00019604|3554590|FG000|Overall Study|Going to have liver transplant|1
1988987|NCT00019604|3554590|FG000|Overall Study|Move to a different study|1
1988988|NCT00019604|3554590|FG000|Overall Study|Non compliant on systemic CH|1
1988989|NCT00019604|3554590|FG000|Overall Study|Non compliant|1
1988990|NCT00019604|3554590|FG000|Overall Study|Resectable disease|1
1988991|NCT00019604|3554590|FG000|Overall Study|Started new chemo regimen|1
1988992|NCT00019604|3554590|FG000|Overall Study|Pt going to immunotherapy study|1
1988993|NCT00019604|3554590|FG000|Overall Study|Too much disease|1
1988994|NCT00019604|3554590|FG000|Overall Study|Unable to evaluate|1
1988995|NCT00019604|3554590|FG000|Overall Study|Details for other not available|4
1988996|NCT00021229|3554606|FG000|Overall Study|Adverse Event|10
1988997|NCT00021229|3554607|FG001|Overall Study|Adverse Event|5
1988998|NCT00021229|3554608|FG002|Overall Study|Adverse Event|2
1988999|NCT00021229|3554606|FG000|Overall Study|Death|0
1989000|NCT00021229|3554607|FG001|Overall Study|Death|1
1989001|NCT00021229|3554608|FG002|Overall Study|Death|0
1989002|NCT00021229|3554606|FG000|Overall Study|Withdrawal by Subject|7
1989003|NCT00021229|3554607|FG001|Overall Study|Withdrawal by Subject|7
1989004|NCT00021229|3554608|FG002|Overall Study|Withdrawal by Subject|1
1989005|NCT00021229|3554606|FG000|Overall Study|Progressive Disease|15
1989006|NCT00021229|3554607|FG001|Overall Study|Progressive Disease|19
1989007|NCT00021229|3554608|FG002|Overall Study|Progressive Disease|12
1989008|NCT00021229|3554606|FG000|Overall Study|Protocol Violation|1
1989009|NCT00021229|3554607|FG001|Overall Study|Protocol Violation|1
1989010|NCT00021229|3554608|FG002|Overall Study|Protocol Violation|0
1989011|NCT00021229|3554606|FG000|Overall Study|Physician Decision|0
1989012|NCT00021229|3554607|FG001|Overall Study|Physician Decision|0
1989013|NCT00021229|3554608|FG002|Overall Study|Physician Decision|1
1989014|NCT00021229|3554606|FG000|Overall Study|Punctate hemmorrhage post RT|2
1989015|NCT00021229|3554607|FG001|Overall Study|Punctate hemmorrhage post RT|0
1989016|NCT00021229|3554608|FG002|Overall Study|Punctate hemmorrhage post RT|0
1989017|NCT00021255|3554621|FG000|Overall Study|Death|1
1989018|NCT00021255|3554622|FG001|Overall Study|Death|0
1989019|NCT00021255|3554623|FG002|Overall Study|Death|2
1989020|NCT00021255|3554621|FG000|Overall Study|Breast cancer relapse|5
1989021|NCT00021255|3554622|FG001|Overall Study|Breast cancer relapse|18
1989022|NCT00021255|3554623|FG002|Overall Study|Breast cancer relapse|11
1989023|NCT00021255|3554621|FG000|Overall Study|Second primary malignancy|0
1989024|NCT00021255|3554622|FG001|Overall Study|Second primary malignancy|4
1989025|NCT00021255|3554623|FG002|Overall Study|Second primary malignancy|1
1989026|NCT00021255|3554621|FG000|Overall Study|Withdrawal by Subject|41
1989027|NCT00021255|3554622|FG001|Overall Study|Withdrawal by Subject|64
1989028|NCT00021255|3554623|FG002|Overall Study|Withdrawal by Subject|26
1989029|NCT00021255|3554621|FG000|Overall Study|Lost to Follow-up|0
1989030|NCT00021255|3554622|FG001|Overall Study|Lost to Follow-up|2
1989031|NCT00021255|3554623|FG002|Overall Study|Lost to Follow-up|3
1989032|NCT00021255|3554621|FG000|Overall Study|Cardiac toxicity|0
1989033|NCT00021255|3554622|FG001|Overall Study|Cardiac toxicity|61
1989034|NCT00021255|3554623|FG002|Overall Study|Cardiac toxicity|32
1989035|NCT00021255|3554621|FG000|Overall Study|Herceptin toxicity|0
1989036|NCT00021255|3554622|FG001|Overall Study|Herceptin toxicity|22
1989037|NCT00021255|3554623|FG002|Overall Study|Herceptin toxicity|6
1989038|NCT00021255|3554621|FG000|Overall Study|Adverse Event|46
1989039|NCT00021255|3554622|FG001|Overall Study|Adverse Event|30
1989040|NCT00021255|3554623|FG002|Overall Study|Adverse Event|18
1989041|NCT00021255|3554621|FG000|Overall Study|Protocol Violation|0
1989042|NCT00021255|3554622|FG001|Overall Study|Protocol Violation|2
1989043|NCT00021255|3554623|FG002|Overall Study|Protocol Violation|0
1989044|NCT00021255|3554621|FG000|Overall Study|Other than specified above|0
1989045|NCT00021255|3554622|FG001|Overall Study|Other than specified above|38
1989046|NCT00021255|3554623|FG002|Overall Study|Other than specified above|19
1989047|NCT00021255|3554621|FG000|Overall Study|Missing|0
1989048|NCT00021255|3554622|FG001|Overall Study|Missing|27
1989049|NCT00021255|3554623|FG002|Overall Study|Missing|13
1989050|NCT00021255|3554621|FG000|Overall Study|Randomized but not treated|28
1989051|NCT00021255|3554622|FG001|Overall Study|Randomized but not treated|2
1989052|NCT00021255|3554623|FG002|Overall Study|Randomized but not treated|18
1989053|NCT00021541|3554633|FG000|Period 1-First Treatment|Withdrawal by Subject|3
1989054|NCT00021541|3554634|FG001|Period 1-First Treatment|Withdrawal by Subject|3
1989055|NCT00021541|3554633|FG000|Period 1-First Treatment|Adverse Event|2
1989056|NCT00021541|3554634|FG001|Period 1-First Treatment|Adverse Event|1
1989057|NCT00021541|3554633|FG000|Period 1-First Treatment|non-adherence|3
1989058|NCT00021541|3554634|FG001|Period 1-First Treatment|non-adherence|0
1989059|NCT00021541|3554633|FG000|Period 1-First Treatment|Death|1
1989060|NCT00021541|3554634|FG001|Period 1-First Treatment|Death|0
1989061|NCT00021541|3554633|FG000|Period 1-First Treatment|Pts that did not progress|2
1989062|NCT00021541|3554634|FG001|Period 1-First Treatment|Pts that did not progress|2
1989063|NCT00021541|3554633|FG000|Period 1-First Treatment|Ineligible|0
1989064|NCT00021541|3554634|FG001|Period 1-First Treatment|Ineligible|2
1989065|NCT00021541|3554633|FG000|Period 2-crossover|refused phase B|2
1989066|NCT00021541|3554634|FG001|Period 2-crossover|refused phase B|2
1989067|NCT00021541|3554633|FG000|Period 2-crossover|Withdrawal by Subject|3
1989068|NCT00021541|3554634|FG001|Period 2-crossover|Withdrawal by Subject|4
1989069|NCT00021541|3554633|FG000|Period 2-crossover|Adverse Event|2
1989070|NCT00021541|3554634|FG001|Period 2-crossover|Adverse Event|2
1989071|NCT00021541|3554633|FG000|Period 2-crossover|non-adherence|1
1989072|NCT00021541|3554634|FG001|Period 2-crossover|non-adherence|0
1989073|NCT00021541|3554633|FG000|Period 2-crossover|Pts that did not progress|2
1989074|NCT00021541|3554634|FG001|Period 2-crossover|Pts that did not progress|3
1989075|NCT00022516|3554648|FG000|Overall Study|Adverse Event|0
1989076|NCT00022516|3554649|FG001|Overall Study|Adverse Event|59
1989077|NCT00022516|3554648|FG000|Overall Study|Lack of Efficacy|0
1989078|NCT00022516|3554649|FG001|Overall Study|Lack of Efficacy|27
1989079|NCT00022516|3554648|FG000|Overall Study|Physician Decision|0
1989080|NCT00022516|3554649|FG001|Overall Study|Physician Decision|1
1989081|NCT00022516|3554648|FG000|Overall Study|Protocol Violation|1
1989082|NCT00022516|3554649|FG001|Overall Study|Protocol Violation|3
1989083|NCT00022516|3554648|FG000|Overall Study|Withdrawal by Subject|2
1989084|NCT00022516|3554649|FG001|Overall Study|Withdrawal by Subject|113
1989085|NCT00022516|3554648|FG000|Overall Study|Incomplete documentation|0
1989086|NCT00022516|3554649|FG001|Overall Study|Incomplete documentation|27
1989087|NCT00022633|3554657|FG000|Overall Study|Adverse Event|11
1989088|NCT00022633|3554658|FG001|Overall Study|Adverse Event|1
1989089|NCT00022633|3554657|FG000|Overall Study|Refusal unrelated to adverse event|1
1989090|NCT00022633|3554658|FG001|Overall Study|Refusal unrelated to adverse event|0
1989091|NCT00022633|3554657|FG000|Overall Study|Progression/relapse|9
1989092|NCT00022633|3554658|FG001|Overall Study|Progression/relapse|2
1989093|NCT00022633|3554657|FG000|Overall Study|Death|4
1989094|NCT00022633|3554658|FG001|Overall Study|Death|0
1989095|NCT00022633|3554657|FG000|Overall Study|Other - not protocol specified|3
1989096|NCT00022633|3554658|FG001|Overall Study|Other - not protocol specified|2
1989097|NCT00022633|3554657|FG000|Overall Study|Ineligible|4
1989098|NCT00022633|3554658|FG001|Overall Study|Ineligible|0
1989099|NCT00022659|3554663|FG000|Overall Study|Ineligible: wrong primary|1
1989100|NCT00022659|3554663|FG000|Overall Study|Never treated|1
1989101|NCT00022672|3554673|FG000|Main Phase: 24 Months|Adverse Event|6
1989102|NCT00022672|3554674|FG001|Main Phase: 24 Months|Adverse Event|0
1989103|NCT00022672|3554673|FG000|Main Phase: 24 Months|Death|0
1989104|NCT00022672|3554674|FG001|Main Phase: 24 Months|Death|3
1989105|NCT00022672|3554673|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75
1989106|NCT00022672|3554674|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91
1989107|NCT00022672|3554673|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
1989108|NCT00022672|3554674|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
1989109|NCT00022672|3554673|FG000|Main Phase: 24 Months|Other Protocol Violation|1
1989110|NCT00022672|3554674|FG001|Main Phase: 24 Months|Other Protocol Violation|0
1989111|NCT00022672|3554673|FG000|Main Phase: 24 Months|Refused Treatment|3
1989112|NCT00022672|3554674|FG001|Main Phase: 24 Months|Refused Treatment|4
1989113|NCT00022672|3554673|FG000|Main Phase: 24 Months|Failure to Return|1
1989114|NCT00022672|3554674|FG001|Main Phase: 24 Months|Failure to Return|1
1989115|NCT00022672|3554673|FG000|Main Phase: 24 Months|Other|1
1989116|NCT00022672|3554674|FG001|Main Phase: 24 Months|Other|0
1989117|NCT00022672|3554673|FG000|Extension Phase|Adverse Event|1
1989118|NCT00022672|3554674|FG001|Extension Phase|Adverse Event|3
1989119|NCT00022672|3554673|FG000|Extension Phase|Death|0
1989120|NCT00022672|3554674|FG001|Extension Phase|Death|1
1989121|NCT00022672|3554673|FG000|Extension Phase|Insufficient Therapeutic Response|1
1989122|NCT00022672|3554674|FG001|Extension Phase|Insufficient Therapeutic Response|44
1989123|NCT00022672|3554673|FG000|Extension Phase|Refused Treatment|0
1989124|NCT00022672|3554674|FG001|Extension Phase|Refused Treatment|2
1989125|NCT00022672|3554673|FG000|Extension Phase|Other|1
1989126|NCT00022672|3554674|FG001|Extension Phase|Other|1
1989127|NCT00022698|3554683|FG000|Overall Study|Adverse Event|5
1989128|NCT00022698|3554684|FG001|Overall Study|Adverse Event|9
1989129|NCT00022698|3554683|FG000|Overall Study|Death|0
1989130|NCT00022698|3554684|FG001|Overall Study|Death|2
1989131|NCT00022698|3554683|FG000|Overall Study|Failure to return|0
1989132|NCT00022698|3554684|FG001|Overall Study|Failure to return|1
1989133|NCT00022698|3554683|FG000|Overall Study|Refused treatment|0
1989134|NCT00022698|3554684|FG001|Overall Study|Refused treatment|2
1989135|NCT00022698|3554683|FG000|Overall Study|Insufficient therapeutic response|2
1989136|NCT00022698|3554684|FG001|Overall Study|Insufficient therapeutic response|14
1989137|NCT00022698|3554683|FG000|Overall Study|Administrative /other|1
1989138|NCT00022698|3554684|FG001|Overall Study|Administrative /other|7
1989139|NCT00022763|3554694|FG000|Overall Study|Adverse Event|1
2213503|NCT01680159|3855152|FG000|Increased Dose Period|Withdrawal by Subject|2
2213504|NCT01680341|3855218|FG000|Overall Study|Adverse Event|3
2213505|NCT01680341|3855219|FG001|Overall Study|Adverse Event|2
2213506|NCT01680341|3855218|FG000|Overall Study|Unclassified|18
2213507|NCT01680341|3855219|FG001|Overall Study|Unclassified|15
2213508|NCT01680458|3855225|FG000|Overall Study|Protocol Violation|3
2213509|NCT01680497|3855229|FG000|Overall Study|Lost to Follow-up|2
2213510|NCT01680861|3855296|FG000|Early Post-transplant Period|Protocol Violation|1
2213511|NCT01680861|3855297|FG001|Early Post-transplant Period|Protocol Violation|1
2213512|NCT01680965|3855327|FG000|Overall Study|Death|0
2213513|NCT01680965|3855328|FG001|Overall Study|Death|0
2213514|NCT01680965|3855329|FG002|Overall Study|Death|0
1989140|NCT00022763|3554695|FG001|Overall Study|Adverse Event|2
1989141|NCT00022763|3554694|FG000|Overall Study|Injection Site Reactions|0
1989142|NCT00022763|3554695|FG001|Overall Study|Injection Site Reactions|2
1989143|NCT00022763|3554694|FG000|Overall Study|Death|0
1989144|NCT00022763|3554695|FG001|Overall Study|Death|1
1989145|NCT00022763|3554694|FG000|Overall Study|Lost to Follow-up|0
1989146|NCT00022763|3554695|FG001|Overall Study|Lost to Follow-up|3
1989147|NCT00022763|3554694|FG000|Overall Study|Withdrawal by Subject|4
1989148|NCT00022763|3554695|FG001|Overall Study|Withdrawal by Subject|7
1989149|NCT00022763|3554694|FG000|Overall Study|Insufficient Therapy|1
1989150|NCT00022763|3554695|FG001|Overall Study|Insufficient Therapy|0
1989151|NCT00022763|3554694|FG000|Overall Study|Admin|3
1989152|NCT00022763|3554695|FG001|Overall Study|Admin|2
1989153|NCT00023322|3554709|FG000|Overall Study|Lost to Follow-up|1
1989154|NCT00023452|3554715|FG000|Overall Study|Ineligible for Study|163
1989155|NCT00023452|3554716|FG001|Overall Study|Ineligible for Study|159
1989156|NCT00023452|3554715|FG000|Overall Study|Out of Window|129
1989157|NCT00023452|3554716|FG001|Overall Study|Out of Window|69
1989158|NCT00023452|3554715|FG000|Overall Study|Death|2
1989159|NCT00023452|3554716|FG001|Overall Study|Death|0
1989160|NCT00023452|3554715|FG000|Overall Study|Withdrawal by Subject|66
1989161|NCT00023452|3554716|FG001|Overall Study|Withdrawal by Subject|54
1989162|NCT00023452|3554715|FG000|Overall Study|Adverse Event|139
1989163|NCT00023452|3554716|FG001|Overall Study|Adverse Event|196
1989164|NCT00023452|3554715|FG000|Overall Study|Lost to Follow-up|293
1989165|NCT00023452|3554716|FG001|Overall Study|Lost to Follow-up|60
1989166|NCT00023452|3554715|FG000|Overall Study|Physician Decision|49
1989167|NCT00023452|3554716|FG001|Overall Study|Physician Decision|21
1989168|NCT00023452|3554715|FG000|Overall Study|Refused Treatment (continued follow-up)|225
2213515|NCT01680965|3855330|FG003|Overall Study|Death|6
2213516|NCT01680991|3855341|FG000|Overall Study|Adverse Event|1
2213517|NCT01680991|3855342|FG001|Overall Study|Adverse Event|0
1989169|NCT00023452|3554716|FG001|Overall Study|Refused Treatment (continued follow-up)|224
1989170|NCT00023452|3554715|FG000|Overall Study|Pregnant|53
1989171|NCT00023452|3554716|FG001|Overall Study|Pregnant|20
1989172|NCT00023452|3554715|FG000|Overall Study|Other|204
1989173|NCT00023452|3554716|FG001|Overall Study|Other|69
1989174|NCT00023595|3554731|FG000|5 Year Follow up|Lost to Follow-up|2
1989175|NCT00023595|3554732|FG001|5 Year Follow up|Lost to Follow-up|2
1989176|NCT00023595|3554733|FG002|5 Year Follow up|Lost to Follow-up|1
1989177|NCT00023595|3554734|FG003|5 Year Follow up|Lost to Follow-up|7
1989178|NCT00023595|3554735|FG004|5 Year Follow up|Lost to Follow-up|3
1989179|NCT00023595|3554731|FG000|10 Year Follow up|Lost to Follow-up|12
1989180|NCT00023595|3554732|FG001|10 Year Follow up|Lost to Follow-up|10
1989181|NCT00023595|3554733|FG002|10 Year Follow up|Lost to Follow-up|3
1989182|NCT00023595|3554734|FG003|10 Year Follow up|Lost to Follow-up|0
1989183|NCT00023595|3554735|FG004|10 Year Follow up|Lost to Follow-up|0
1989184|NCT00023673|3554761|FG000|Overall Study|Ineligible / no protocol treatment|0
1989185|NCT00023673|3554762|FG001|Overall Study|Ineligible / no protocol treatment|0
1989186|NCT00023673|3554763|FG002|Overall Study|Ineligible / no protocol treatment|0
1989187|NCT00023673|3554764|FG003|Overall Study|Ineligible / no protocol treatment|1
1989188|NCT00023673|3554761|FG000|Overall Study|Patient withdrew consent|0
1989189|NCT00023673|3554762|FG001|Overall Study|Patient withdrew consent|0
1989190|NCT00023673|3554763|FG002|Overall Study|Patient withdrew consent|0
1989191|NCT00023673|3554764|FG003|Overall Study|Patient withdrew consent|1
1989192|NCT00023712|3554776|FG000|Overall Study|Not platinum sensitive|1
1989193|NCT00023712|3554777|FG001|Overall Study|Not platinum sensitive|0
1989194|NCT00023712|3554776|FG000|Overall Study|Never treated|1
1989195|NCT00023712|3554777|FG001|Overall Study|Never treated|1
1989196|NCT00023764|3554793|FG000|Overall Study|Other|1
1989197|NCT00023764|3554793|FG000|Overall Study|Adverse Event|4
1989198|NCT00023764|3554793|FG000|Overall Study|Withdrawal by Subject|1
1989199|NCT00023764|3554793|FG000|Overall Study|Progression of disease|6
1989200|NCT00023764|3554793|FG000|Overall Study|patient received other treatment|1
1989201|NCT00023764|3554793|FG000|Overall Study|delay in obtaining staging images|1
2024455|NCT00333866|3592872|FG002|Overall Study|Withdrawal by Subject|4
2024456|NCT00333866|3592873|FG003|Overall Study|Withdrawal by Subject|9
2024457|NCT00333866|3592870|FG000|Overall Study|Randomized but not Treated|5
2024458|NCT00333866|3592871|FG001|Overall Study|Randomized but not Treated|3
2024459|NCT00333866|3592872|FG002|Overall Study|Randomized but not Treated|2
2024460|NCT00333866|3592873|FG003|Overall Study|Randomized but not Treated|1
2024461|NCT00333970|3592889|FG000|Overall Study|Withdrawal by Subject|13
2024462|NCT00333970|3592890|FG001|Overall Study|Withdrawal by Subject|7
2024463|NCT00333983|3592899|FG000|Overall Study|Lost to Follow-up|2
2024464|NCT00333983|3592900|FG001|Overall Study|Lost to Follow-up|1
2024465|NCT00333983|3592901|FG002|Overall Study|Lost to Follow-up|0
2024466|NCT00333983|3592899|FG000|Overall Study|Adverse Event|1
2024467|NCT00333983|3592900|FG001|Overall Study|Adverse Event|1
2024468|NCT00333983|3592901|FG002|Overall Study|Adverse Event|1
2024469|NCT00333983|3592899|FG000|Overall Study|Withdrawal by Subject|0
2024470|NCT00333983|3592900|FG001|Overall Study|Withdrawal by Subject|3
2024471|NCT00333983|3592901|FG002|Overall Study|Withdrawal by Subject|1
2024472|NCT00334113|3592920|FG000|Overall Study|Lost to Follow-up|2
2024473|NCT00334113|3592921|FG001|Overall Study|Lost to Follow-up|2
2024474|NCT00334113|3592920|FG000|Overall Study|Withdrawal by Subject|0
2024475|NCT00334113|3592921|FG001|Overall Study|Withdrawal by Subject|1
2024476|NCT00334282|3592934|FG000|Overall Study|Lost to Follow-up|11
2024477|NCT00334282|3592935|FG001|Overall Study|Lost to Follow-up|5
2024478|NCT00334282|3592934|FG000|Overall Study|Withdrawal by Subject|17
2024479|NCT00334282|3592935|FG001|Overall Study|Withdrawal by Subject|3
2024480|NCT00334282|3592934|FG000|Overall Study|Death|194
2024481|NCT00334282|3592935|FG001|Overall Study|Death|100
2024482|NCT00334295|3592945|FG000|Overall Study|Patients received fewer than 3 injection|5
2024483|NCT00334542|3592949|FG000|Overall Study|Adverse Event|3
2024484|NCT00334542|3592949|FG000|Overall Study|Withdrawal by Subject|1
2024485|NCT00334542|3592949|FG000|Overall Study|New cancer diagnosis|1
2024486|NCT00334737|3592973|FG000|Hospital Phase|Death|1
2024487|NCT00334737|3592974|FG001|Hospital Phase|Death|2
2024488|NCT00334737|3592975|FG002|Hospital Phase|Death|3
2024489|NCT00334737|3592973|FG000|Hospital Phase|Withdrawal by Subject|0
2024490|NCT00334737|3592974|FG001|Hospital Phase|Withdrawal by Subject|0
2024491|NCT00334737|3592975|FG002|Hospital Phase|Withdrawal by Subject|1
2024492|NCT00334737|3592973|FG000|Hospital Phase|Did not receive study drug|1
2024493|NCT00334737|3592974|FG001|Hospital Phase|Did not receive study drug|0
2024494|NCT00334737|3592975|FG002|Hospital Phase|Did not receive study drug|0
2024495|NCT00334737|3592973|FG000|Follow up Phase|Lost to Follow-up|5
2024496|NCT00334737|3592974|FG001|Follow up Phase|Lost to Follow-up|3
2024497|NCT00334737|3592975|FG002|Follow up Phase|Lost to Follow-up|6
2024498|NCT00334802|3592985|FG000|Overall Study|Progressive Disease|2
2024499|NCT00334802|3592986|FG001|Overall Study|Progressive Disease|24
2024500|NCT00334802|3592985|FG000|Overall Study|Toxicity|1
2024501|NCT00334802|3592986|FG001|Overall Study|Toxicity|5
2024502|NCT00334802|3592985|FG000|Overall Study|Lack of Efficacy|1
2024503|NCT00334802|3592986|FG001|Overall Study|Lack of Efficacy|3
2024504|NCT00334802|3592985|FG000|Overall Study|Patient Condition Aggrevated|1
2024505|NCT00334802|3592986|FG001|Overall Study|Patient Condition Aggrevated|0
1989202|NCT00024167|3554814|FG000|Overall Study|Death|53
1989203|NCT00024167|3554815|FG001|Overall Study|Death|47
1989204|NCT00024258|3554822|FG000|Overall Study|Withdrawal by Subject|1
1989205|NCT00024258|3554822|FG000|Overall Study|Disease Progression|8
1989206|NCT00025155|3554826|FG000|Overall Study|Ineligible: Wrong primary cancer site|1
1989207|NCT00025155|3554826|FG000|Overall Study|Ineligible: Second primary cancer site|1
1989208|NCT00025233|3554835|FG000|Overall Study|Ineligible: wrong cell type|1
1989209|NCT00025233|3554835|FG000|Overall Study|Ineligible: wrong primary|1
1989210|NCT00025233|3554835|FG000|Overall Study|Ineligible: improper prior treatment|1
1989211|NCT00025233|3554835|FG000|Overall Study|Never treated|1
1989212|NCT00025259|3554852|FG000|Overall Study|Death|1
1989213|NCT00025259|3554853|FG001|Overall Study|Death|3
1989214|NCT00025259|3554854|FG002|Overall Study|Death|0
1989215|NCT00025259|3554855|FG003|Overall Study|Death|3
1989216|NCT00025259|3554856|FG004|Overall Study|Death|0
1989217|NCT00025259|3554857|FG005|Overall Study|Death|1
1989218|NCT00025259|3554858|FG006|Overall Study|Death|2
1989219|NCT00025259|3554852|FG000|Overall Study|Lack of Efficacy|2
1989220|NCT00025259|3554853|FG001|Overall Study|Lack of Efficacy|46
1989221|NCT00025259|3554854|FG002|Overall Study|Lack of Efficacy|60
1989222|NCT00025259|3554855|FG003|Overall Study|Lack of Efficacy|78
1989223|NCT00025259|3554856|FG004|Overall Study|Lack of Efficacy|11
1989224|NCT00025259|3554857|FG005|Overall Study|Lack of Efficacy|30
1989225|NCT00025259|3554858|FG006|Overall Study|Lack of Efficacy|38
1989226|NCT00025259|3554852|FG000|Overall Study|Lost to Follow-up|2
1989227|NCT00025259|3554853|FG001|Overall Study|Lost to Follow-up|9
1989228|NCT00025259|3554854|FG002|Overall Study|Lost to Follow-up|13
1989229|NCT00025259|3554855|FG003|Overall Study|Lost to Follow-up|13
1989230|NCT00025259|3554856|FG004|Overall Study|Lost to Follow-up|1
1989231|NCT00025259|3554857|FG005|Overall Study|Lost to Follow-up|3
1989232|NCT00025259|3554858|FG006|Overall Study|Lost to Follow-up|1
1989233|NCT00025259|3554852|FG000|Overall Study|Physician Decision|12
1989234|NCT00025259|3554853|FG001|Overall Study|Physician Decision|1
1989235|NCT00025259|3554854|FG002|Overall Study|Physician Decision|0
1989236|NCT00025259|3554855|FG003|Overall Study|Physician Decision|5
1989237|NCT00025259|3554856|FG004|Overall Study|Physician Decision|4
1989238|NCT00025259|3554857|FG005|Overall Study|Physician Decision|2
1989239|NCT00025259|3554858|FG006|Overall Study|Physician Decision|1
1989240|NCT00025259|3554852|FG000|Overall Study|Protocol Violation|3
1989241|NCT00025259|3554853|FG001|Overall Study|Protocol Violation|2
1989242|NCT00025259|3554854|FG002|Overall Study|Protocol Violation|2
1989243|NCT00025259|3554855|FG003|Overall Study|Protocol Violation|1
1989244|NCT00025259|3554856|FG004|Overall Study|Protocol Violation|2
1989245|NCT00025259|3554857|FG005|Overall Study|Protocol Violation|1
1989246|NCT00025259|3554858|FG006|Overall Study|Protocol Violation|3
1989247|NCT00025259|3554852|FG000|Overall Study|Withdrawal by Subject|9
1989248|NCT00025259|3554853|FG001|Overall Study|Withdrawal by Subject|27
1989249|NCT00025259|3554854|FG002|Overall Study|Withdrawal by Subject|6
1989250|NCT00025259|3554855|FG003|Overall Study|Withdrawal by Subject|14
1989251|NCT00025259|3554856|FG004|Overall Study|Withdrawal by Subject|11
1989252|NCT00025259|3554857|FG005|Overall Study|Withdrawal by Subject|8
1989253|NCT00025259|3554858|FG006|Overall Study|Withdrawal by Subject|3
1989254|NCT00025259|3554852|FG000|Overall Study|Ineligible|14
1989255|NCT00025259|3554853|FG001|Overall Study|Ineligible|1
1989256|NCT00025259|3554854|FG002|Overall Study|Ineligible|0
1989257|NCT00025259|3554855|FG003|Overall Study|Ineligible|0
1989258|NCT00025259|3554856|FG004|Overall Study|Ineligible|6
1989259|NCT00025259|3554857|FG005|Overall Study|Ineligible|0
1989260|NCT00025259|3554858|FG006|Overall Study|Ineligible|1
1989261|NCT00025259|3554852|FG000|Overall Study|Randomization error|1
1989262|NCT00025259|3554853|FG001|Overall Study|Randomization error|0
1989263|NCT00025259|3554854|FG002|Overall Study|Randomization error|0
1989264|NCT00025259|3554855|FG003|Overall Study|Randomization error|0
1989265|NCT00025259|3554856|FG004|Overall Study|Randomization error|1
1989266|NCT00025259|3554857|FG005|Overall Study|Randomization error|7
1989267|NCT00025259|3554858|FG006|Overall Study|Randomization error|2
1989268|NCT00025259|3554852|FG000|Overall Study|Adverse Event|1
1989269|NCT00025259|3554853|FG001|Overall Study|Adverse Event|0
1989270|NCT00025259|3554854|FG002|Overall Study|Adverse Event|0
1989271|NCT00025259|3554855|FG003|Overall Study|Adverse Event|0
1989272|NCT00025259|3554856|FG004|Overall Study|Adverse Event|0
1989273|NCT00025259|3554857|FG005|Overall Study|Adverse Event|0
1989274|NCT00025259|3554858|FG006|Overall Study|Adverse Event|0
1989275|NCT00025506|3554877|FG000|Overall Study|Ineligible: clerical error|1
1989276|NCT00025506|3554877|FG000|Overall Study|Ineligible: wrong cell type|5
1989277|NCT00025506|3554877|FG000|Overall Study|Ineligible: inadequate pathology|2
1989278|NCT00025506|3554877|FG000|Overall Study|Never Treated|2
1989279|NCT00025662|3554886|FG000|Overall Study|Withdrawal by Subject|2
1989280|NCT00025662|3554886|FG000|Overall Study|Technical failure of manipulation|1
1989281|NCT00025883|3554892|FG000|Overall Study|had atypical progeriod lipodystrophy|4
1989282|NCT00025883|3554892|FG000|Overall Study|no baseline data|1
1989283|NCT00025883|3554892|FG000|Overall Study|Death|1
1989284|NCT00025883|3554892|FG000|Overall Study|Adverse Event|1
1989285|NCT00025883|3554892|FG000|Overall Study|didn't reach 6 months of Metreleptin|10
1989286|NCT00026208|3554899|FG000|Overall Study|Complications of auto accident|1
1989287|NCT00026208|3554900|FG001|Overall Study|Complications of auto accident|0
1989288|NCT00026312|3554921|FG000|Overall Study|Adverse Event|0
1989289|NCT00026312|3554922|FG001|Overall Study|Adverse Event|32
1989290|NCT00026312|3554921|FG000|Overall Study|Death|1
1989291|NCT00026312|3554922|FG001|Overall Study|Death|7
1989292|NCT00026312|3554921|FG000|Overall Study|Lack of Efficacy|19
1989293|NCT00026312|3554922|FG001|Overall Study|Lack of Efficacy|114
1989294|NCT00026312|3554921|FG000|Overall Study|Lost to Follow-up|0
1989295|NCT00026312|3554922|FG001|Overall Study|Lost to Follow-up|5
1989296|NCT00026312|3554921|FG000|Overall Study|Physician Decision|1
1989297|NCT00026312|3554922|FG001|Overall Study|Physician Decision|37
1989298|NCT00026312|3554921|FG000|Overall Study|Protocol Violation|0
1989299|NCT00026312|3554922|FG001|Overall Study|Protocol Violation|3
1989300|NCT00026312|3554921|FG000|Overall Study|Withdrawal by Subject|1
1989301|NCT00026312|3554922|FG001|Overall Study|Withdrawal by Subject|6
1989302|NCT00026312|3554921|FG000|Overall Study|Ineligible|4
1989303|NCT00026312|3554922|FG001|Overall Study|Ineligible|5
1989304|NCT00026312|3554921|FG000|Overall Study|Entry onto another COG study|0
1989305|NCT00026312|3554922|FG001|Overall Study|Entry onto another COG study|1
1989306|NCT00026312|3554921|FG000|Overall Study|Refusal by patient/parent/guardian|8
1989307|NCT00026312|3554922|FG001|Overall Study|Refusal by patient/parent/guardian|59
1989308|NCT00026494|3554936|FG000|Overall Study|Withdrawal by Subject|1
1989309|NCT00026494|3554937|FG001|Overall Study|Withdrawal by Subject|0
1989310|NCT00026494|3554938|FG002|Overall Study|Withdrawal by Subject|1
1989311|NCT00026494|3554939|FG003|Overall Study|Withdrawal by Subject|0
1989312|NCT00026494|3554936|FG000|Overall Study|Patient non-compliance|1
1989313|NCT00026494|3554937|FG001|Overall Study|Patient non-compliance|0
1989314|NCT00026494|3554938|FG002|Overall Study|Patient non-compliance|0
1989315|NCT00026494|3554939|FG003|Overall Study|Patient non-compliance|0
1989316|NCT00026494|3554936|FG000|Overall Study|Patient not treated|0
1989317|NCT00026494|3554937|FG001|Overall Study|Patient not treated|0
1989318|NCT00026494|3554938|FG002|Overall Study|Patient not treated|2
1989319|NCT00026494|3554939|FG003|Overall Study|Patient not treated|0
1989320|NCT00026494|3554936|FG000|Overall Study|Clinical progression|0
1989321|NCT00026494|3554937|FG001|Overall Study|Clinical progression|0
1989322|NCT00026494|3554938|FG002|Overall Study|Clinical progression|3
1989323|NCT00026494|3554939|FG003|Overall Study|Clinical progression|0
1989324|NCT00026793|3554949|FG000|Overall Study|Death on study due to underlying disease|4
1989325|NCT00026793|3554949|FG000|Overall Study|Physician Decision|2
1989326|NCT00026793|3554949|FG000|Overall Study|Off study|2
1989327|NCT00027027|3554958|FG000|Overall Study|Adverse Event|0
1989328|NCT00027027|3554959|FG001|Overall Study|Adverse Event|0
1989329|NCT00027027|3554960|FG002|Overall Study|Adverse Event|1
1989330|NCT00027027|3554961|FG003|Overall Study|Adverse Event|0
1989331|NCT00027027|3554962|FG004|Overall Study|Adverse Event|1
1989332|NCT00027027|3554958|FG000|Overall Study|Admitted for Signs of PD|0
1989333|NCT00027027|3554959|FG001|Overall Study|Admitted for Signs of PD|0
1989334|NCT00027027|3554960|FG002|Overall Study|Admitted for Signs of PD|0
1989335|NCT00027027|3554961|FG003|Overall Study|Admitted for Signs of PD|0
1989336|NCT00027027|3554962|FG004|Overall Study|Admitted for Signs of PD|1
1989337|NCT00027027|3554958|FG000|Overall Study|Clinical Symptoms Progression not PD|1
1989338|NCT00027027|3554959|FG001|Overall Study|Clinical Symptoms Progression not PD|0
1989339|NCT00027027|3554960|FG002|Overall Study|Clinical Symptoms Progression not PD|0
1989340|NCT00027027|3554961|FG003|Overall Study|Clinical Symptoms Progression not PD|0
1989341|NCT00027027|3554962|FG004|Overall Study|Clinical Symptoms Progression not PD|0
1989342|NCT00027027|3554958|FG000|Overall Study|PD Requiring Surgery|0
1989343|NCT00027027|3554959|FG001|Overall Study|PD Requiring Surgery|0
1989344|NCT00027027|3554960|FG002|Overall Study|PD Requiring Surgery|1
1989345|NCT00027027|3554961|FG003|Overall Study|PD Requiring Surgery|0
1989346|NCT00027027|3554962|FG004|Overall Study|PD Requiring Surgery|0
1989347|NCT00027027|3554958|FG000|Overall Study|Physician Decision Due To PD|2
1989348|NCT00027027|3554959|FG001|Overall Study|Physician Decision Due To PD|3
1989349|NCT00027027|3554960|FG002|Overall Study|Physician Decision Due To PD|2
1989350|NCT00027027|3554961|FG003|Overall Study|Physician Decision Due To PD|3
1989351|NCT00027027|3554962|FG004|Overall Study|Physician Decision Due To PD|5
1989352|NCT00027027|3554958|FG000|Overall Study|Withdrawal by Subject|0
1989353|NCT00027027|3554959|FG001|Overall Study|Withdrawal by Subject|0
1989354|NCT00027027|3554960|FG002|Overall Study|Withdrawal by Subject|0
1989355|NCT00027027|3554961|FG003|Overall Study|Withdrawal by Subject|0
1989356|NCT00027027|3554962|FG004|Overall Study|Withdrawal by Subject|1
1989357|NCT00027378|3554980|FG000|Overall Study|Physician Decision|0
1989358|NCT00027378|3554981|FG001|Overall Study|Physician Decision|3
1989359|NCT00027560|3554987|FG000|Overall Study|Withdrawal by Subject|1
1989360|NCT00027846|3554996|FG000|Overall Study|Lost to Follow-up|0
1989361|NCT00027846|3554997|FG001|Overall Study|Lost to Follow-up|41
1989362|NCT00027846|3554998|FG002|Overall Study|Lost to Follow-up|9
1989363|NCT00027846|3554996|FG000|Overall Study|Withdrawal by Subject|0
1989364|NCT00027846|3554997|FG001|Overall Study|Withdrawal by Subject|14
1989365|NCT00027846|3554998|FG002|Overall Study|Withdrawal by Subject|7
1989366|NCT00027846|3554996|FG000|Overall Study|Ineligible for study|2
1989367|NCT00027846|3554997|FG001|Overall Study|Ineligible for study|6
1989368|NCT00027846|3554998|FG002|Overall Study|Ineligible for study|14
1989369|NCT00027846|3554996|FG000|Overall Study|Entry into another COG therapeutic study|0
1989370|NCT00027846|3554997|FG001|Overall Study|Entry into another COG therapeutic study|5
1989371|NCT00027846|3554998|FG002|Overall Study|Entry into another COG therapeutic study|2
1989372|NCT00027846|3554996|FG000|Overall Study|Neuraxis dissemination during/after ther|0
1989373|NCT00027846|3554997|FG001|Overall Study|Neuraxis dissemination during/after ther|2
1989374|NCT00027846|3554998|FG002|Overall Study|Neuraxis dissemination during/after ther|5
1989375|NCT00028002|3555008|FG000|Overall Study|Withdrawal by Subject|3
1989376|NCT00028002|3555008|FG000|Overall Study|Ineligible|8
1989377|NCT00028769|3555026|FG000|Overall Study|Adverse Event|2
1989378|NCT00028769|3555026|FG000|Overall Study|Refusal Unrelated to Adverse Events|1
1989379|NCT00028769|3555026|FG000|Overall Study|Progression or Death|31
1989380|NCT00028769|3555026|FG000|Overall Study|Other - Not Protocol Specified|1
1989381|NCT00028769|3555026|FG000|Overall Study|Ineligible|5
1989382|NCT00028769|3555026|FG000|Overall Study|Not Analyzable|1
1989383|NCT00029146|3555041|FG000|Overall Study|Lost to Follow-up|2
1989384|NCT00029146|3555042|FG001|Overall Study|Lost to Follow-up|1
1989385|NCT00030823|3555092|FG000|Overall Study|Withdrawal by Subject|1
1989386|NCT00030901|3555098|FG000|Initial Registration|Ineligible|167
1989387|NCT00030901|3555099|FG001|Initial Registration|Ineligible|0
1989388|NCT00030901|3555100|FG002|Initial Registration|Ineligible|0
1989389|NCT00030901|3555098|FG000|Randomization|Adverse Event|0
1989390|NCT00030901|3555099|FG001|Randomization|Adverse Event|11
1989391|NCT00030901|3555100|FG002|Randomization|Adverse Event|7
1989392|NCT00030901|3555098|FG000|Randomization|Refusal Unrelated to Adverse Event|0
1989393|NCT00030901|3555099|FG001|Randomization|Refusal Unrelated to Adverse Event|16
1989394|NCT00030901|3555100|FG002|Randomization|Refusal Unrelated to Adverse Event|10
1989395|NCT00030901|3555098|FG000|Randomization|Progression/Relapse|0
1989396|NCT00030901|3555099|FG001|Randomization|Progression/Relapse|22
1989397|NCT00030901|3555100|FG002|Randomization|Progression/Relapse|21
1989398|NCT00030901|3555098|FG000|Randomization|Death|0
1989399|NCT00030901|3555099|FG001|Randomization|Death|1
1989400|NCT00030901|3555100|FG002|Randomization|Death|3
1989401|NCT00030901|3555098|FG000|Randomization|Other|0
1989402|NCT00030901|3555099|FG001|Randomization|Other|36
1989403|NCT00030901|3555100|FG002|Randomization|Other|33
1989404|NCT00030901|3555098|FG000|Randomization|Ineligible|0
1989405|NCT00030901|3555099|FG001|Randomization|Ineligible|15
1989406|NCT00030901|3555100|FG002|Randomization|Ineligible|14
1989407|NCT00031447|3555112|FG000|Overall Study|Lost to Follow-up|0
1989408|NCT00031447|3555113|FG001|Overall Study|Lost to Follow-up|1
1989409|NCT00031447|3555112|FG000|Overall Study|Non-compliant|1
1989410|NCT00031447|3555113|FG001|Overall Study|Non-compliant|1
1989411|NCT00031447|3555112|FG000|Overall Study|Re-activation of Disease|2
1989412|NCT00031447|3555113|FG001|Overall Study|Re-activation of Disease|1
1989413|NCT00031447|3555112|FG000|Overall Study|Disruption of blinded study drug supply|7
1989414|NCT00031447|3555113|FG001|Overall Study|Disruption of blinded study drug supply|4
1989415|NCT00031460|3555121|FG000|Overall Study|Lost to Follow-up|0
1989416|NCT00031460|3555122|FG001|Overall Study|Lost to Follow-up|1
1989417|NCT00031460|3555121|FG000|Overall Study|Withdrawal by Subject|1
1989418|NCT00031460|3555122|FG001|Overall Study|Withdrawal by Subject|1
1989419|NCT00031460|3555121|FG000|Overall Study|Non-Compliant|1
1989420|NCT00031460|3555122|FG001|Overall Study|Non-Compliant|1
1989421|NCT00031460|3555121|FG000|Overall Study|Death|0
1989422|NCT00031460|3555122|FG001|Overall Study|Death|1
1989423|NCT00031460|3555121|FG000|Overall Study|Reactivation of Disease|5
1989424|NCT00031460|3555122|FG001|Overall Study|Reactivation of Disease|9
1989425|NCT00031460|3555121|FG000|Overall Study|Disruption of blinded drug supply|2
1989426|NCT00031460|3555122|FG001|Overall Study|Disruption of blinded drug supply|0
1989427|NCT00031460|3555121|FG000|Overall Study|Confirmed unevaluable|0
1989428|NCT00031460|3555122|FG001|Overall Study|Confirmed unevaluable|1
1989429|NCT00031486|3555130|FG000|Overall Study|Adverse Event|1
1989430|NCT00031486|3555131|FG001|Overall Study|Adverse Event|0
1989431|NCT00031486|3555130|FG000|Overall Study|Lost to Follow-up|0
1989432|NCT00031486|3555131|FG001|Overall Study|Lost to Follow-up|1
1989433|NCT00031486|3555130|FG000|Overall Study|Withdrawal by Subject|3
1989434|NCT00031486|3555131|FG001|Overall Study|Withdrawal by Subject|2
1989435|NCT00031486|3555130|FG000|Overall Study|Death|0
1989436|NCT00031486|3555131|FG001|Overall Study|Death|3
1989437|NCT00031486|3555130|FG000|Overall Study|Non-compliant|0
1989438|NCT00031486|3555131|FG001|Overall Study|Non-compliant|4
1989439|NCT00031486|3555130|FG000|Overall Study|Did not meet eligibility requirement|2
1989440|NCT00031486|3555131|FG001|Overall Study|Did not meet eligibility requirement|1
1989441|NCT00031486|3555130|FG000|Overall Study|Other|1
1989442|NCT00031486|3555131|FG001|Overall Study|Other|1
1989443|NCT00031551|3555141|FG000|Overall Study|Withdrew due to chemotherapy effects|2
1989444|NCT00031551|3555142|FG001|Overall Study|Withdrew due to chemotherapy effects|0
1989445|NCT00031590|3555152|FG000|Overall Study|Adverse Event|1
1989446|NCT00031590|3555152|FG000|Overall Study|Withdrawal by parents|2
1989447|NCT00031694|3555157|FG000|Overall Study|Adverse Event|12
1989448|NCT00031694|3555157|FG000|Overall Study|Death|2
1989449|NCT00031694|3555157|FG000|Overall Study|Withdrawal by Subject|5
1989450|NCT00032487|3555164|FG000|Overall Study|Withdrawal by Subject|67
1989451|NCT00032487|3555165|FG001|Overall Study|Withdrawal by Subject|43
1989452|NCT00032487|3555164|FG000|Overall Study|Adverse Event|3
1989453|NCT00032487|3555165|FG001|Overall Study|Adverse Event|7
1989454|NCT00032487|3555164|FG000|Overall Study|Lost to Follow-up|57
1989455|NCT00032487|3555165|FG001|Overall Study|Lost to Follow-up|58
1989456|NCT00032487|3555164|FG000|Overall Study|Had other reason|12
1989457|NCT00032487|3555165|FG001|Overall Study|Had other reason|12
1989458|NCT00033371|3555191|FG000|Overall Study|Adverse Event|1
1989459|NCT00033371|3555192|FG001|Overall Study|Adverse Event|5
1989460|NCT00033371|3555191|FG000|Overall Study|Lost to Follow-up|2
1989461|NCT00033371|3555192|FG001|Overall Study|Lost to Follow-up|1
1989462|NCT00033371|3555191|FG000|Overall Study|Withdrawal by Subject|3
1989463|NCT00033371|3555192|FG001|Overall Study|Withdrawal by Subject|3
1989464|NCT00033371|3555191|FG000|Overall Study|Disease Progression|0
1989465|NCT00033371|3555192|FG001|Overall Study|Disease Progression|1
1989466|NCT00033514|3555204|FG000|Overall Study|Lost to Follow-up|1
1989467|NCT00033514|3555205|FG001|Overall Study|Lost to Follow-up|1
1989468|NCT00033514|3555204|FG000|Overall Study|Withdrawal by Subject|0
1989469|NCT00033514|3555205|FG001|Overall Study|Withdrawal by Subject|3
1989470|NCT00033540|3555212|FG000|Overall Study|Adverse Event|14
1989471|NCT00033540|3555212|FG000|Overall Study|Death|1
1989472|NCT00033540|3555212|FG000|Overall Study|Progression|26
1989473|NCT00033540|3555212|FG000|Overall Study|Withdrawal by Subject|6
1989474|NCT00033540|3555212|FG000|Overall Study|Other|5
1989475|NCT00033540|3555212|FG000|Overall Study|Ineligible|3
1989476|NCT00033540|3555212|FG000|Overall Study|Never received treatment|2
1989477|NCT00033631|3555219|FG000|Overall Study|Protocol Violation|14
1989478|NCT00033631|3555220|FG001|Overall Study|Protocol Violation|11
1989479|NCT00033631|3555219|FG000|Overall Study|Withdrawal by Subject|4
1989480|NCT00033631|3555220|FG001|Overall Study|Withdrawal by Subject|4
1989481|NCT00033657|3555229|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1
1989482|NCT00033657|3555230|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2
1989483|NCT00033657|3555229|FG000|Neoadjuvant Chemotherapy|Adverse Event|0
1989484|NCT00033657|3555230|FG001|Neoadjuvant Chemotherapy|Adverse Event|2
1989485|NCT00033657|3555229|FG000|Neoadjuvant Chemotherapy|Death|1
1989486|NCT00033657|3555230|FG001|Neoadjuvant Chemotherapy|Death|1
1989487|NCT00033657|3555229|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
1989488|NCT00033657|3555230|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
1989489|NCT00033657|3555229|FG000|Neoadjuvant Chemotherapy|other complicating disease|0
1989490|NCT00033657|3555230|FG001|Neoadjuvant Chemotherapy|other complicating disease|1
1989491|NCT00033657|3555229|FG000|Neoadjuvant Chemotherapy|Ineligible|8
1989492|NCT00033657|3555230|FG001|Neoadjuvant Chemotherapy|Ineligible|4
1989493|NCT00033657|3555229|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3
1989494|NCT00033657|3555230|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1
1989495|NCT00033657|3555229|FG000|Surgical Resection|not complete resection|0
1989496|NCT00033657|3555230|FG001|Surgical Resection|not complete resection|3
1989497|NCT00033657|3555229|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3
1989498|NCT00033657|3555230|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1
1989499|NCT00033657|3555229|FG000|Adjuvant Chemotherapy|Adverse Event|7
1989500|NCT00033657|3555230|FG001|Adjuvant Chemotherapy|Adverse Event|10
1989501|NCT00033657|3555229|FG000|Adjuvant Chemotherapy|Death|2
1989502|NCT00033657|3555230|FG001|Adjuvant Chemotherapy|Death|1
1989503|NCT00033657|3555229|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5
1989504|NCT00033657|3555230|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3
1989505|NCT00033657|3555229|FG000|Adjuvant Chemotherapy|alternative therapy|1
1989506|NCT00033657|3555230|FG001|Adjuvant Chemotherapy|alternative therapy|0
1989507|NCT00033657|3555229|FG000|Adjuvant Chemotherapy|Other|0
1989508|NCT00033657|3555230|FG001|Adjuvant Chemotherapy|Other|2
1989509|NCT00035555|3555254|FG000|Overall Study|Adverse Event|5
1989510|NCT00035555|3555255|FG001|Overall Study|Adverse Event|8
1989511|NCT00035555|3555256|FG002|Overall Study|Adverse Event|9
1989512|NCT00035555|3555254|FG000|Overall Study|Allograft loss|1
1989513|NCT00035555|3555255|FG001|Overall Study|Allograft loss|1
1989514|NCT00035555|3555256|FG002|Overall Study|Allograft loss|2
1989515|NCT00035555|3555254|FG000|Overall Study|Death|0
1989516|NCT00035555|3555255|FG001|Overall Study|Death|0
1989517|NCT00035555|3555256|FG002|Overall Study|Death|2
1989518|NCT00035555|3555254|FG000|Overall Study|Lost to Follow-up|0
1989519|NCT00035555|3555255|FG001|Overall Study|Lost to Follow-up|0
1989520|NCT00035555|3555256|FG002|Overall Study|Lost to Follow-up|1
1989521|NCT00035555|3555254|FG000|Overall Study|Noncompliance|0
1989522|NCT00035555|3555255|FG001|Overall Study|Noncompliance|1
1989523|NCT00035555|3555256|FG002|Overall Study|Noncompliance|1
1989524|NCT00035555|3555254|FG000|Overall Study|Prohibited medication|1
1989525|NCT00035555|3555255|FG001|Overall Study|Prohibited medication|1
1989526|NCT00035555|3555256|FG002|Overall Study|Prohibited medication|0
1989527|NCT00035555|3555254|FG000|Overall Study|Treatment failure/lack of efficacy|7
1989528|NCT00035555|3555255|FG001|Overall Study|Treatment failure/lack of efficacy|5
1989529|NCT00035555|3555256|FG002|Overall Study|Treatment failure/lack of efficacy|3
1989530|NCT00035555|3555254|FG000|Overall Study|Withdrawal by Subject|2
1989531|NCT00035555|3555255|FG001|Overall Study|Withdrawal by Subject|0
1989532|NCT00035555|3555256|FG002|Overall Study|Withdrawal by Subject|2
1989533|NCT00035555|3555254|FG000|Overall Study|Investigator deemed not a good candidate|0
1989534|NCT00035555|3555255|FG001|Overall Study|Investigator deemed not a good candidate|0
1989535|NCT00035555|3555256|FG002|Overall Study|Investigator deemed not a good candidate|1
1989536|NCT00035555|3555254|FG000|Overall Study|Received cyclosporin in error|0
1989537|NCT00035555|3555255|FG001|Overall Study|Received cyclosporin in error|0
1989538|NCT00035555|3555256|FG002|Overall Study|Received cyclosporin in error|1
1989539|NCT00035815|3555267|FG000|Overall Study|Withdrawal by Subject|17
1989540|NCT00035815|3555268|FG001|Overall Study|Withdrawal by Subject|11
1989541|NCT00035932|3555277|FG000|Overall Study|Adverse Event|10
1989542|NCT00035932|3555278|FG001|Overall Study|Adverse Event|9
1989543|NCT00035932|3555279|FG002|Overall Study|Adverse Event|9
1989544|NCT00035932|3555277|FG000|Overall Study|Death|0
1989545|NCT00035932|3555278|FG001|Overall Study|Death|0
1989546|NCT00035932|3555279|FG002|Overall Study|Death|1
1989547|NCT00035932|3555277|FG000|Overall Study|Disease Progression / Relapse|1
1989548|NCT00035932|3555278|FG001|Overall Study|Disease Progression / Relapse|1
1989549|NCT00035932|3555279|FG002|Overall Study|Disease Progression / Relapse|0
1989550|NCT00035932|3555277|FG000|Overall Study|Lost to Follow-up|4
1989551|NCT00035932|3555278|FG001|Overall Study|Lost to Follow-up|4
1989552|NCT00035932|3555279|FG002|Overall Study|Lost to Follow-up|3
1989553|NCT00035932|3555277|FG000|Overall Study|Noncompliance|6
1989554|NCT00035932|3555278|FG001|Overall Study|Noncompliance|7
1989555|NCT00035932|3555279|FG002|Overall Study|Noncompliance|6
1989556|NCT00035932|3555277|FG000|Overall Study|Protocol Violation While on Study|0
1989557|NCT00035932|3555278|FG001|Overall Study|Protocol Violation While on Study|1
1989558|NCT00035932|3555279|FG002|Overall Study|Protocol Violation While on Study|2
1989559|NCT00035932|3555277|FG000|Overall Study|Withdrawal by Subject|1
1989560|NCT00035932|3555278|FG001|Overall Study|Withdrawal by Subject|5
1989561|NCT00035932|3555279|FG002|Overall Study|Withdrawal by Subject|0
1989562|NCT00035932|3555277|FG000|Overall Study|Study Termination by Sponsor|1
1989563|NCT00035932|3555278|FG001|Overall Study|Study Termination by Sponsor|0
1989564|NCT00035932|3555279|FG002|Overall Study|Study Termination by Sponsor|0
1989565|NCT00035932|3555277|FG000|Overall Study|Lack of Efficacy|33
1989566|NCT00035932|3555278|FG001|Overall Study|Lack of Efficacy|33
1989567|NCT00035932|3555279|FG002|Overall Study|Lack of Efficacy|28
1989568|NCT00036270|3555294|FG000|Randomized to Study Treatment|Withdrawal by Subject|6
1989569|NCT00036270|3555295|FG001|Randomized to Study Treatment|Withdrawal by Subject|7
1989570|NCT00036270|3555294|FG000|Study Treatment to 5 Year Report|Ongoing|1081
1989571|NCT00036270|3555295|FG001|Study Treatment to 5 Year Report|Ongoing|736
1989572|NCT00036270|3555294|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
1989573|NCT00036270|3555295|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
1989574|NCT00036270|3555294|FG000|Study Treatment to 5 Year Report|Adverse Event|501
1989575|NCT00036270|3555295|FG001|Study Treatment to 5 Year Report|Adverse Event|782
1989576|NCT00036270|3555294|FG000|Study Treatment to 5 Year Report|Other|277
1989577|NCT00036270|3555295|FG001|Study Treatment to 5 Year Report|Other|288
1989578|NCT00036270|3555294|FG000|Study Treatment to 5 Year Report|Treatment refusal|113
1989579|NCT00036270|3555295|FG001|Study Treatment to 5 Year Report|Treatment refusal|208
1989580|NCT00036270|3555294|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46
1989581|NCT00036270|3555295|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54
1989582|NCT00036270|3555294|FG000|Study Treatment to 5 Year Report|Protocol Violation|23
1989583|NCT00036270|3555295|FG001|Study Treatment to 5 Year Report|Protocol Violation|91
1989584|NCT00036270|3555294|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17
1989585|NCT00036270|3555295|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29
1989586|NCT00036270|3555294|FG000|Study Treatment to 5 Year Report|Too early switch|0
1989587|NCT00036270|3555295|FG001|Study Treatment to 5 Year Report|Too early switch|103
1989588|NCT00036270|3555294|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
1989589|NCT00036270|3555295|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
1989590|NCT00037830|3555314|FG000|Overall Study|Adverse Event|2
1989591|NCT00037830|3555315|FG001|Overall Study|Adverse Event|0
1989592|NCT00037830|3555316|FG002|Overall Study|Adverse Event|0
1989593|NCT00037830|3555314|FG000|Overall Study|Withdrawal by Subject|4
1989594|NCT00037830|3555315|FG001|Overall Study|Withdrawal by Subject|5
1989595|NCT00037830|3555316|FG002|Overall Study|Withdrawal by Subject|1
1989596|NCT00037830|3555314|FG000|Overall Study|Protocol Violation|2
1989597|NCT00037830|3555315|FG001|Overall Study|Protocol Violation|2
1989598|NCT00037830|3555316|FG002|Overall Study|Protocol Violation|0
1989599|NCT00037830|3555314|FG000|Overall Study|Unrelated Medical Problem|2
1989600|NCT00037830|3555315|FG001|Overall Study|Unrelated Medical Problem|0
1989601|NCT00037830|3555316|FG002|Overall Study|Unrelated Medical Problem|0
1989602|NCT00038103|3555326|FG000|Overall Study|Adverse Event|5
1989603|NCT00038103|3555327|FG001|Overall Study|Adverse Event|6
1989604|NCT00038103|3555326|FG000|Overall Study|Lack of Efficacy|48
1989605|NCT00038103|3555327|FG001|Overall Study|Lack of Efficacy|41
1989606|NCT00038103|3555326|FG000|Overall Study|Withdrawal by Subject|0
1989607|NCT00038103|3555327|FG001|Overall Study|Withdrawal by Subject|3
1989608|NCT00038103|3555326|FG000|Overall Study|Lost to Follow-up|0
1989609|NCT00038103|3555327|FG001|Overall Study|Lost to Follow-up|3
1989610|NCT00038103|3555326|FG000|Overall Study|Protocol Violation|0
1989611|NCT00038103|3555327|FG001|Overall Study|Protocol Violation|2
1989612|NCT00038103|3555326|FG000|Overall Study|Sponsor Decision|0
1989613|NCT00038103|3555327|FG001|Overall Study|Sponsor Decision|1
1989614|NCT00038103|3555326|FG000|Overall Study|Randomized/never treated|2
1989615|NCT00038103|3555327|FG001|Overall Study|Randomized/never treated|0
1989616|NCT00038467|3555335|FG000|Overall Study|Adverse Event|170
1989617|NCT00038467|3555336|FG001|Overall Study|Adverse Event|145
1989618|NCT00038467|3555335|FG000|Overall Study|Withdrawal by Subject|150
1989619|NCT00038467|3555336|FG001|Overall Study|Withdrawal by Subject|107
1989620|NCT00038467|3555335|FG000|Overall Study|Protocol Violation|19
1989621|NCT00038467|3555336|FG001|Overall Study|Protocol Violation|22
1989622|NCT00038467|3555335|FG000|Overall Study|Death|22
1989623|NCT00038467|3555336|FG001|Overall Study|Death|16
1989624|NCT00038467|3555335|FG000|Overall Study|Lost to Follow-up|15
1989625|NCT00038467|3555336|FG001|Overall Study|Lost to Follow-up|10
1989626|NCT00038467|3555335|FG000|Overall Study|Recurrence|109
1989627|NCT00038467|3555336|FG001|Overall Study|Recurrence|179
1989628|NCT00038467|3555335|FG000|Overall Study|Randomized, but not treated|31
1989629|NCT00038467|3555336|FG001|Overall Study|Randomized, but not treated|35
1989630|NCT00038467|3555335|FG000|Overall Study|Other|26
1989631|NCT00038467|3555336|FG001|Overall Study|Other|28
1989632|NCT00038649|3555346|FG000|Overall Study|Adverse Event|9
1989633|NCT00038948|3555356|FG000|Overall Study|Adverse Event|131
1989634|NCT00038948|3555357|FG001|Overall Study|Adverse Event|43
1989635|NCT00038948|3555356|FG000|Overall Study|Lost to Follow-up|4
1989636|NCT00038948|3555357|FG001|Overall Study|Lost to Follow-up|4
1989637|NCT00038948|3555356|FG000|Overall Study|Nonmedical event|5
1989638|NCT00038948|3555357|FG001|Overall Study|Nonmedical event|7
1989639|NCT00038948|3555356|FG000|Overall Study|Withdrawal by Subject|23
1989640|NCT00038948|3555357|FG001|Overall Study|Withdrawal by Subject|10
1989641|NCT00038948|3555356|FG000|Overall Study|Protocol Violation|3
1989642|NCT00038948|3555357|FG001|Overall Study|Protocol Violation|7
1989643|NCT00038948|3555356|FG000|Overall Study|Lack of Efficacy|3
1989644|NCT00038948|3555357|FG001|Overall Study|Lack of Efficacy|6
1989645|NCT00039130|3555369|FG000|Overall Study|Adverse Event|11
1989646|NCT00039130|3555369|FG000|Overall Study|Death|9
1989647|NCT00039130|3555369|FG000|Overall Study|Withdrawal by Subject|3
1989648|NCT00039130|3555369|FG000|Overall Study|Progression|2
1989649|NCT00039130|3555369|FG000|Overall Study|Subsequent treatment|2
1989650|NCT00039130|3555369|FG000|Overall Study|Physician Decision|3
1989651|NCT00039377|3555377|FG000|Initial Registration|Adverse Event|2
1989652|NCT00039377|3555378|FG001|Initial Registration|Adverse Event|0
1989653|NCT00039377|3555379|FG002|Initial Registration|Adverse Event|0
1989654|NCT00039377|3555380|FG003|Initial Registration|Adverse Event|0
1989655|NCT00039377|3555377|FG000|Initial Registration|Relapsed|6
1989656|NCT00039377|3555378|FG001|Initial Registration|Relapsed|0
1989657|NCT00039377|3555379|FG002|Initial Registration|Relapsed|0
1989658|NCT00039377|3555380|FG003|Initial Registration|Relapsed|0
1989659|NCT00039377|3555377|FG000|Initial Registration|Received non-protocol therapy|11
1989660|NCT00039377|3555378|FG001|Initial Registration|Received non-protocol therapy|0
1989661|NCT00039377|3555379|FG002|Initial Registration|Received non-protocol therapy|0
1989662|NCT00039377|3555380|FG003|Initial Registration|Received non-protocol therapy|0
1989663|NCT00039377|3555377|FG000|Initial Registration|Withdrawal by Subject|3
1989664|NCT00039377|3555378|FG001|Initial Registration|Withdrawal by Subject|0
1989665|NCT00039377|3555379|FG002|Initial Registration|Withdrawal by Subject|0
1989666|NCT00039377|3555380|FG003|Initial Registration|Withdrawal by Subject|0
1989667|NCT00039741|3555392|FG000|Overall Study|Death|0
1989668|NCT00039741|3555393|FG001|Overall Study|Death|1
1989669|NCT00039741|3555394|FG002|Overall Study|Death|0
1989670|NCT00039741|3555395|FG003|Overall Study|Death|0
1989671|NCT00039741|3555392|FG000|Overall Study|Lost to Follow-up|3
1989672|NCT00039741|3555393|FG001|Overall Study|Lost to Follow-up|1
1989673|NCT00039741|3555394|FG002|Overall Study|Lost to Follow-up|5
1989674|NCT00039741|3555395|FG003|Overall Study|Lost to Follow-up|2
1989675|NCT00039741|3555392|FG000|Overall Study|Confounding medical condition|1
1989676|NCT00039741|3555393|FG001|Overall Study|Confounding medical condition|0
1989677|NCT00039741|3555394|FG002|Overall Study|Confounding medical condition|0
1989678|NCT00039741|3555395|FG003|Overall Study|Confounding medical condition|0
1989679|NCT00039741|3555392|FG000|Overall Study|Not able to get to clinic|5
1989680|NCT00039741|3555393|FG001|Overall Study|Not able to get to clinic|2
1989681|NCT00039741|3555394|FG002|Overall Study|Not able to get to clinic|0
1989682|NCT00039741|3555395|FG003|Overall Study|Not able to get to clinic|3
1989683|NCT00039741|3555392|FG000|Overall Study|Moved|3
1989684|NCT00039741|3555393|FG001|Overall Study|Moved|2
1989685|NCT00039741|3555394|FG002|Overall Study|Moved|3
1989686|NCT00039741|3555395|FG003|Overall Study|Moved|6
1989687|NCT00039741|3555392|FG000|Overall Study|Non-compliance with protocol|1
2213518|NCT01680991|3855343|FG002|Overall Study|Adverse Event|0
2213519|NCT01680991|3855341|FG000|Overall Study|Death|1
1989688|NCT00039741|3555393|FG001|Overall Study|Non-compliance with protocol|0
1989689|NCT00039741|3555394|FG002|Overall Study|Non-compliance with protocol|1
1989690|NCT00039741|3555395|FG003|Overall Study|Non-compliance with protocol|0
1989691|NCT00039741|3555392|FG000|Overall Study|Withdrew consent|0
1989692|NCT00039741|3555393|FG001|Overall Study|Withdrew consent|5
1989693|NCT00039741|3555394|FG002|Overall Study|Withdrew consent|0
1989694|NCT00039741|3555395|FG003|Overall Study|Withdrew consent|1
1989695|NCT00039741|3555392|FG000|Overall Study|Missed final visit|2
1989696|NCT00039741|3555393|FG001|Overall Study|Missed final visit|1
1989697|NCT00039741|3555394|FG002|Overall Study|Missed final visit|2
1989698|NCT00039741|3555395|FG003|Overall Study|Missed final visit|2
2213520|NCT01680991|3855342|FG001|Overall Study|Death|0
1989699|NCT00039871|3555405|FG000|Overall Study|Adverse Event|165
1989700|NCT00039871|3555405|FG000|Overall Study|Lost to Follow-up|18
2213521|NCT01680991|3855343|FG002|Overall Study|Death|1
1989701|NCT00039871|3555405|FG000|Overall Study|Protocol Violation|24
1989702|NCT00039871|3555405|FG000|Overall Study|Withdrawal by Subject|97
1989703|NCT00039871|3555405|FG000|Overall Study|Did not meet eligibility criteria|11
1989704|NCT00039871|3555405|FG000|Overall Study|Administrative|1
1989705|NCT00039871|3555405|FG000|Overall Study|Discontinued at Week 12 per protocol|1061
1989706|NCT00039871|3555405|FG000|Overall Study|Never entered follow-up|7
1989707|NCT00040365|3555409|FG000|Overall Study|Death|1
1989708|NCT00040365|3555409|FG000|Overall Study|Progressive disease|7
1989709|NCT00040365|3555409|FG000|Overall Study|Lost to Follow-up|3
1989710|NCT00040664|3555422|FG000|Overall Study|Adverse Event|12
1989711|NCT00040664|3555423|FG001|Overall Study|Adverse Event|3
1989712|NCT00040664|3555424|FG002|Overall Study|Adverse Event|2
1989713|NCT00040664|3555425|FG003|Overall Study|Adverse Event|7
1989714|NCT00040664|3555422|FG000|Overall Study|Lack of Efficacy|9
1989715|NCT00040664|3555423|FG001|Overall Study|Lack of Efficacy|2
1989716|NCT00040664|3555424|FG002|Overall Study|Lack of Efficacy|3
1989717|NCT00040664|3555425|FG003|Overall Study|Lack of Efficacy|4
1989718|NCT00040664|3555422|FG000|Overall Study|Insufficient CD4 response|1
1989719|NCT00040664|3555423|FG001|Overall Study|Insufficient CD4 response|0
1989720|NCT00040664|3555424|FG002|Overall Study|Insufficient CD4 response|1
1989721|NCT00040664|3555425|FG003|Overall Study|Insufficient CD4 response|0
1989722|NCT00040664|3555422|FG000|Overall Study|Lost to Follow-up|4
1989723|NCT00040664|3555423|FG001|Overall Study|Lost to Follow-up|2
1989724|NCT00040664|3555424|FG002|Overall Study|Lost to Follow-up|0
1989725|NCT00040664|3555425|FG003|Overall Study|Lost to Follow-up|2
1989726|NCT00040664|3555422|FG000|Overall Study|Protocol Violation|2
1989727|NCT00040664|3555423|FG001|Overall Study|Protocol Violation|1
1989728|NCT00040664|3555424|FG002|Overall Study|Protocol Violation|0
1989729|NCT00040664|3555425|FG003|Overall Study|Protocol Violation|1
1989730|NCT00040664|3555422|FG000|Overall Study|Withdrawal by Subject|7
1989731|NCT00040664|3555423|FG001|Overall Study|Withdrawal by Subject|0
1989732|NCT00040664|3555424|FG002|Overall Study|Withdrawal by Subject|3
1989733|NCT00040664|3555425|FG003|Overall Study|Withdrawal by Subject|4
1989734|NCT00040664|3555422|FG000|Overall Study|Pregnancy|3
1989735|NCT00040664|3555423|FG001|Overall Study|Pregnancy|0
1989736|NCT00040664|3555424|FG002|Overall Study|Pregnancy|0
1989737|NCT00040664|3555425|FG003|Overall Study|Pregnancy|3
1989738|NCT00040664|3555422|FG000|Overall Study|Medication adherence/compliance problems|8
1989739|NCT00040664|3555423|FG001|Overall Study|Medication adherence/compliance problems|2
1989740|NCT00040664|3555424|FG002|Overall Study|Medication adherence/compliance problems|1
1989741|NCT00040664|3555425|FG003|Overall Study|Medication adherence/compliance problems|5
1989742|NCT00040664|3555422|FG000|Overall Study|Poor taste|2
1989743|NCT00040664|3555423|FG001|Overall Study|Poor taste|0
1989744|NCT00040664|3555424|FG002|Overall Study|Poor taste|2
1989745|NCT00040664|3555425|FG003|Overall Study|Poor taste|0
1989746|NCT00040664|3555422|FG000|Overall Study|Pharmacokinetic target not achieved|2
1989747|NCT00040664|3555423|FG001|Overall Study|Pharmacokinetic target not achieved|1
1989748|NCT00040664|3555424|FG002|Overall Study|Pharmacokinetic target not achieved|0
1989749|NCT00040664|3555425|FG003|Overall Study|Pharmacokinetic target not achieved|1
1989750|NCT00040664|3555422|FG000|Overall Study|Change of formulation|2
1989751|NCT00040664|3555423|FG001|Overall Study|Change of formulation|2
1989752|NCT00040664|3555424|FG002|Overall Study|Change of formulation|0
1989753|NCT00040664|3555425|FG003|Overall Study|Change of formulation|0
1989754|NCT00040664|3555422|FG000|Overall Study|Non-viability of oral suspension|1
1989755|NCT00040664|3555423|FG001|Overall Study|Non-viability of oral suspension|0
1989756|NCT00040664|3555424|FG002|Overall Study|Non-viability of oral suspension|1
1989757|NCT00040664|3555425|FG003|Overall Study|Non-viability of oral suspension|0
1989758|NCT00040742|3555447|FG000|Overall Study|Death|0
2213522|NCT01680991|3855341|FG000|Overall Study|Protocol Violation|0
2213523|NCT01680991|3855342|FG001|Overall Study|Protocol Violation|1
1989759|NCT00040742|3555448|FG001|Overall Study|Death|0
1989760|NCT00040742|3555449|FG002|Overall Study|Death|1
1989761|NCT00040742|3555450|FG003|Overall Study|Death|0
1989762|NCT00040742|3555447|FG000|Overall Study|Adverse Event|15
1989763|NCT00040742|3555448|FG001|Overall Study|Adverse Event|16
1989764|NCT00040742|3555449|FG002|Overall Study|Adverse Event|21
1989765|NCT00040742|3555450|FG003|Overall Study|Adverse Event|9
1989766|NCT00040742|3555447|FG000|Overall Study|Withdrawal by Subject|7
1989767|NCT00040742|3555448|FG001|Overall Study|Withdrawal by Subject|15
1989768|NCT00040742|3555449|FG002|Overall Study|Withdrawal by Subject|10
1989769|NCT00040742|3555450|FG003|Overall Study|Withdrawal by Subject|13
1989770|NCT00040742|3555447|FG000|Overall Study|Chemotoxicity|4
1989771|NCT00040742|3555448|FG001|Overall Study|Chemotoxicity|3
1989772|NCT00040742|3555449|FG002|Overall Study|Chemotoxicity|5
1989773|NCT00040742|3555450|FG003|Overall Study|Chemotoxicity|2
1989774|NCT00040742|3555447|FG000|Overall Study|Incomplete Forms|6
1989775|NCT00040742|3555448|FG001|Overall Study|Incomplete Forms|10
1989776|NCT00040742|3555449|FG002|Overall Study|Incomplete Forms|4
1989777|NCT00040742|3555450|FG003|Overall Study|Incomplete Forms|5
1989778|NCT00040742|3555447|FG000|Overall Study|Other medical|7
1989779|NCT00040742|3555448|FG001|Overall Study|Other medical|5
1989780|NCT00040742|3555449|FG002|Overall Study|Other medical|5
1989781|NCT00040742|3555450|FG003|Overall Study|Other medical|5
1989782|NCT00041067|3555492|FG000|Overall Study|Adverse Event|20
2213524|NCT01680991|3855343|FG002|Overall Study|Protocol Violation|0
1989783|NCT00041067|3555492|FG000|Overall Study|Progression|19
1989784|NCT00041067|3555492|FG000|Overall Study|Patient refusal|12
1989785|NCT00041067|3555492|FG000|Overall Study|Other reasons|23
1989786|NCT00041067|3555492|FG000|Overall Study|Ineligible|2
1989787|NCT00041080|3555499|FG000|Overall Study|Adverse Event|21
1989788|NCT00041080|3555500|FG001|Overall Study|Adverse Event|1
1989789|NCT00041080|3555499|FG000|Overall Study|Withdrawal by Subject|6
1989790|NCT00041080|3555500|FG001|Overall Study|Withdrawal by Subject|6
1989791|NCT00041080|3555499|FG000|Overall Study|Concommitant Illness/Other|1
1989792|NCT00041080|3555500|FG001|Overall Study|Concommitant Illness/Other|2
1989793|NCT00041080|3555499|FG000|Overall Study|Did not start therapy|1
1989794|NCT00041080|3555500|FG001|Overall Study|Did not start therapy|1
1989795|NCT00041080|3555499|FG000|Overall Study|Ineligible|1
1989796|NCT00041080|3555500|FG001|Overall Study|Ineligible|0
1989797|NCT00041132|3555527|FG000|Overall Study|Adverse Event|19
1989798|NCT00041132|3555527|FG000|Overall Study|Death|1
1989799|NCT00041132|3555527|FG000|Overall Study|Not Eligible|7
1989800|NCT00041132|3555527|FG000|Overall Study|Withdrawal by Subject|1
1989801|NCT00041132|3555527|FG000|Overall Study|Physician Decision|2
1989802|NCT00041470|3555540|FG000|Overall Study|Loss of Funding|38
1989803|NCT00041756|3555558|FG000|Overall Study|Adverse Event|4
1989804|NCT00041756|3555559|FG001|Overall Study|Adverse Event|10
1989805|NCT00041756|3555560|FG002|Overall Study|Adverse Event|6
1989806|NCT00041756|3555561|FG003|Overall Study|Adverse Event|11
1989807|NCT00041756|3555562|FG004|Overall Study|Adverse Event|34
1989808|NCT00041756|3555558|FG000|Overall Study|Protocol Violation|1
1989809|NCT00041756|3555559|FG001|Overall Study|Protocol Violation|1
1989810|NCT00041756|3555560|FG002|Overall Study|Protocol Violation|2
1989811|NCT00041756|3555561|FG003|Overall Study|Protocol Violation|2
1989812|NCT00041756|3555562|FG004|Overall Study|Protocol Violation|1
1989813|NCT00041756|3555558|FG000|Overall Study|Withdrawal by Subject|3
1989814|NCT00041756|3555559|FG001|Overall Study|Withdrawal by Subject|3
1989815|NCT00041756|3555560|FG002|Overall Study|Withdrawal by Subject|4
1989816|NCT00041756|3555561|FG003|Overall Study|Withdrawal by Subject|2
1989817|NCT00041756|3555562|FG004|Overall Study|Withdrawal by Subject|3
1989818|NCT00041756|3555558|FG000|Overall Study|Lost to Follow-up|0
1989819|NCT00041756|3555559|FG001|Overall Study|Lost to Follow-up|1
1989820|NCT00041756|3555560|FG002|Overall Study|Lost to Follow-up|0
1989821|NCT00041756|3555561|FG003|Overall Study|Lost to Follow-up|1
1989822|NCT00041756|3555562|FG004|Overall Study|Lost to Follow-up|0
1989823|NCT00041756|3555558|FG000|Overall Study|Unable to meet protocol criteria|0
1989824|NCT00041756|3555559|FG001|Overall Study|Unable to meet protocol criteria|0
1989825|NCT00041756|3555560|FG002|Overall Study|Unable to meet protocol criteria|1
1989826|NCT00041756|3555561|FG003|Overall Study|Unable to meet protocol criteria|0
1989827|NCT00041756|3555562|FG004|Overall Study|Unable to meet protocol criteria|1
1989828|NCT00041756|3555558|FG000|Overall Study|Data Monitoring Committee Recommendation|0
1989829|NCT00041756|3555559|FG001|Overall Study|Data Monitoring Committee Recommendation|0
1989830|NCT00041756|3555560|FG002|Overall Study|Data Monitoring Committee Recommendation|0
1989831|NCT00041756|3555561|FG003|Overall Study|Data Monitoring Committee Recommendation|0
1989832|NCT00041756|3555562|FG004|Overall Study|Data Monitoring Committee Recommendation|21
1989833|NCT00042432|3555594|FG000|Overall Study|Adverse Event|4
1989834|NCT00042432|3555595|FG001|Overall Study|Adverse Event|1
1989835|NCT00042432|3555594|FG000|Overall Study|Withdrawal by Subject|1
1989836|NCT00042432|3555595|FG001|Overall Study|Withdrawal by Subject|3
1989837|NCT00042432|3555594|FG000|Overall Study|Death|0
1989838|NCT00042432|3555595|FG001|Overall Study|Death|2
1989839|NCT00042432|3555594|FG000|Overall Study|Ineligibility determined|1
1989840|NCT00042432|3555595|FG001|Overall Study|Ineligibility determined|0
2311999|NCT02760407|4017752|FG000|Overall Study|Violation of Eligibility criteria|0
2312000|NCT02760407|4017753|FG001|Overall Study|Violation of Eligibility criteria|0
2312001|NCT02760407|4017754|FG002|Overall Study|Violation of Eligibility criteria|1
2312002|NCT02760407|4017755|FG003|Overall Study|Violation of Eligibility criteria|1
2312003|NCT02760407|4017752|FG000|Overall Study|Personal reasons|0
2312004|NCT02760407|4017753|FG001|Overall Study|Personal reasons|0
2312005|NCT02760407|4017754|FG002|Overall Study|Personal reasons|0
2312006|NCT02760407|4017755|FG003|Overall Study|Personal reasons|1
2312007|NCT02760407|4017752|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1
2312008|NCT02760407|4017753|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
2312009|NCT02760407|4017754|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
2312010|NCT02760407|4017755|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
2312011|NCT02760407|4017752|FG000|Overall Study|Use of prohibited Medication|0
1989841|NCT00042432|3555594|FG000|Overall Study|Initiation of maintenance dialysis|1
1989842|NCT00042432|3555595|FG001|Overall Study|Initiation of maintenance dialysis|1
1989843|NCT00042432|3555594|FG000|Overall Study|Other|2
1989844|NCT00042432|3555595|FG001|Overall Study|Other|0
1989845|NCT00042666|3555601|FG000|Overall Study|Adverse Event|2
1989846|NCT00042666|3555601|FG000|Overall Study|Death|4
1989847|NCT00042666|3555601|FG000|Overall Study|Protocol Violation|1
1989848|NCT00042666|3555601|FG000|Overall Study|Participant/Physician Perception|1
1989849|NCT00042666|3555601|FG000|Overall Study|Progressive Disease|41
1989850|NCT00042666|3555601|FG000|Overall Study|Other|1
1989851|NCT00042666|3555601|FG000|Overall Study|Other|4
1989852|NCT00042939|3555608|FG000|Overall Study|Adverse Event|6
1989853|NCT00042939|3555609|FG001|Overall Study|Adverse Event|7
1989854|NCT00042939|3555608|FG000|Overall Study|Death|3
1989855|NCT00042939|3555609|FG001|Overall Study|Death|2
1989856|NCT00042939|3555608|FG000|Overall Study|Withdrawal by Subject|3
1989857|NCT00042939|3555609|FG001|Overall Study|Withdrawal by Subject|4
1989858|NCT00042939|3555608|FG000|Overall Study|Other disease|1
1989859|NCT00042939|3555609|FG001|Overall Study|Other disease|0
1989860|NCT00042939|3555608|FG000|Overall Study|Ineligible|2
1989861|NCT00042939|3555609|FG001|Overall Study|Ineligible|2
1989862|NCT00042939|3555608|FG000|Overall Study|Deterioration of health|3
1989863|NCT00042939|3555609|FG001|Overall Study|Deterioration of health|4
1989864|NCT00042939|3555608|FG000|Overall Study|QOL diminished|1
1989865|NCT00042939|3555609|FG001|Overall Study|QOL diminished|0
1989866|NCT00042939|3555608|FG000|Overall Study|Rising ca 19-9|1
1989867|NCT00042939|3555609|FG001|Overall Study|Rising ca 19-9|0
1989868|NCT00042939|3555608|FG000|Overall Study|Patient non-compliance|1
1989869|NCT00042939|3555609|FG001|Overall Study|Patient non-compliance|0
1989870|NCT00042939|3555608|FG000|Overall Study|Still on treatment|1
1989871|NCT00042939|3555609|FG001|Overall Study|Still on treatment|0
1989872|NCT00042939|3555608|FG000|Overall Study|Treatment break > 4 weeks|0
1989873|NCT00042939|3555609|FG001|Overall Study|Treatment break > 4 weeks|1
1989874|NCT00042939|3555608|FG000|Overall Study|Did not start treatment|2
1989875|NCT00042939|3555609|FG001|Overall Study|Did not start treatment|1
1989876|NCT00042991|3555622|FG000|Overall Study|Adverse Event|1
1989877|NCT00042991|3555623|FG001|Overall Study|Adverse Event|4
1989878|NCT00042991|3555624|FG002|Overall Study|Adverse Event|2
1989879|NCT00042991|3555625|FG003|Overall Study|Adverse Event|0
2213525|NCT01680991|3855341|FG000|Overall Study|Withdrawal by Subject|5
2213526|NCT01680991|3855342|FG001|Overall Study|Withdrawal by Subject|1
2213527|NCT01680991|3855343|FG002|Overall Study|Withdrawal by Subject|0
1989880|NCT00042991|3555626|FG004|Overall Study|Adverse Event|0
1989881|NCT00042991|3555627|FG005|Overall Study|Adverse Event|1
1989882|NCT00042991|3555628|FG006|Overall Study|Adverse Event|0
1989883|NCT00042991|3555622|FG000|Overall Study|Withdrawal by Subject|0
1989884|NCT00042991|3555623|FG001|Overall Study|Withdrawal by Subject|7
1989885|NCT00042991|3555624|FG002|Overall Study|Withdrawal by Subject|2
1989886|NCT00042991|3555625|FG003|Overall Study|Withdrawal by Subject|0
1989887|NCT00042991|3555626|FG004|Overall Study|Withdrawal by Subject|1
1989888|NCT00042991|3555627|FG005|Overall Study|Withdrawal by Subject|0
1989889|NCT00042991|3555628|FG006|Overall Study|Withdrawal by Subject|0
1989890|NCT00042991|3555622|FG000|Overall Study|Disease Progression|5
1989891|NCT00042991|3555623|FG001|Overall Study|Disease Progression|29
1989892|NCT00042991|3555624|FG002|Overall Study|Disease Progression|2
1989893|NCT00042991|3555625|FG003|Overall Study|Disease Progression|2
1989894|NCT00042991|3555626|FG004|Overall Study|Disease Progression|1
1989895|NCT00042991|3555627|FG005|Overall Study|Disease Progression|4
1989896|NCT00042991|3555628|FG006|Overall Study|Disease Progression|2
1989897|NCT00042991|3555622|FG000|Overall Study|Alternative Therapy|0
1989898|NCT00042991|3555623|FG001|Overall Study|Alternative Therapy|0
1989899|NCT00042991|3555624|FG002|Overall Study|Alternative Therapy|0
1989900|NCT00042991|3555625|FG003|Overall Study|Alternative Therapy|0
1989901|NCT00042991|3555626|FG004|Overall Study|Alternative Therapy|1
1989902|NCT00042991|3555627|FG005|Overall Study|Alternative Therapy|0
1989903|NCT00042991|3555628|FG006|Overall Study|Alternative Therapy|0
1989904|NCT00043186|3555655|FG000|Overall Study|Physician Decision|0
1989905|NCT00043186|3555656|FG001|Overall Study|Physician Decision|0
1989906|NCT00043186|3555657|FG002|Overall Study|Physician Decision|3
1989907|NCT00043186|3555658|FG003|Overall Study|Physician Decision|0
1989908|NCT00043186|3555659|FG004|Overall Study|Physician Decision|1
1989909|NCT00043186|3555660|FG005|Overall Study|Physician Decision|0
1989910|NCT00043186|3555661|FG006|Overall Study|Physician Decision|0
1989911|NCT00043186|3555662|FG007|Overall Study|Physician Decision|1
1989912|NCT00043186|3555663|FG008|Overall Study|Physician Decision|1
1989913|NCT00043186|3555655|FG000|Overall Study|Adverse Event|2
1989914|NCT00043186|3555656|FG001|Overall Study|Adverse Event|2
1989915|NCT00043186|3555657|FG002|Overall Study|Adverse Event|2
1989916|NCT00043186|3555658|FG003|Overall Study|Adverse Event|3
1989917|NCT00043186|3555659|FG004|Overall Study|Adverse Event|2
1989918|NCT00043186|3555660|FG005|Overall Study|Adverse Event|1
1989919|NCT00043186|3555661|FG006|Overall Study|Adverse Event|2
1989920|NCT00043186|3555662|FG007|Overall Study|Adverse Event|1
1989921|NCT00043186|3555663|FG008|Overall Study|Adverse Event|3
1989922|NCT00043186|3555655|FG000|Overall Study|Withdrawal by Subject|11
1989923|NCT00043186|3555656|FG001|Overall Study|Withdrawal by Subject|8
1989924|NCT00043186|3555657|FG002|Overall Study|Withdrawal by Subject|11
1989925|NCT00043186|3555658|FG003|Overall Study|Withdrawal by Subject|13
1989926|NCT00043186|3555659|FG004|Overall Study|Withdrawal by Subject|14
1989927|NCT00043186|3555660|FG005|Overall Study|Withdrawal by Subject|6
1989928|NCT00043186|3555661|FG006|Overall Study|Withdrawal by Subject|12
1989929|NCT00043186|3555662|FG007|Overall Study|Withdrawal by Subject|9
1989930|NCT00043186|3555663|FG008|Overall Study|Withdrawal by Subject|10
1989931|NCT00043186|3555655|FG000|Overall Study|Death|0
1989932|NCT00043186|3555656|FG001|Overall Study|Death|0
1989933|NCT00043186|3555657|FG002|Overall Study|Death|1
1989934|NCT00043186|3555658|FG003|Overall Study|Death|0
1989935|NCT00043186|3555659|FG004|Overall Study|Death|0
1989936|NCT00043186|3555660|FG005|Overall Study|Death|0
1989937|NCT00043186|3555661|FG006|Overall Study|Death|2
1989938|NCT00043186|3555662|FG007|Overall Study|Death|0
1989939|NCT00043186|3555663|FG008|Overall Study|Death|0
1989940|NCT00043186|3555655|FG000|Overall Study|Disease progression|1
1989941|NCT00043186|3555656|FG001|Overall Study|Disease progression|0
1989942|NCT00043186|3555657|FG002|Overall Study|Disease progression|0
1989943|NCT00043186|3555658|FG003|Overall Study|Disease progression|3
1989944|NCT00043186|3555659|FG004|Overall Study|Disease progression|0
1989945|NCT00043186|3555660|FG005|Overall Study|Disease progression|0
1989946|NCT00043186|3555661|FG006|Overall Study|Disease progression|0
1989947|NCT00043186|3555662|FG007|Overall Study|Disease progression|4
1989948|NCT00043186|3555663|FG008|Overall Study|Disease progression|0
1989949|NCT00043186|3555655|FG000|Overall Study|Ineligibility determined|0
1989950|NCT00043186|3555656|FG001|Overall Study|Ineligibility determined|0
1989951|NCT00043186|3555657|FG002|Overall Study|Ineligibility determined|0
1989952|NCT00043186|3555658|FG003|Overall Study|Ineligibility determined|0
1989953|NCT00043186|3555659|FG004|Overall Study|Ineligibility determined|0
1989954|NCT00043186|3555660|FG005|Overall Study|Ineligibility determined|0
1989955|NCT00043186|3555661|FG006|Overall Study|Ineligibility determined|0
1989956|NCT00043186|3555662|FG007|Overall Study|Ineligibility determined|0
1989957|NCT00043186|3555663|FG008|Overall Study|Ineligibility determined|1
1989958|NCT00043186|3555655|FG000|Overall Study|Lost to Follow-up|3
1989959|NCT00043186|3555656|FG001|Overall Study|Lost to Follow-up|5
1989960|NCT00043186|3555657|FG002|Overall Study|Lost to Follow-up|1
1989961|NCT00043186|3555658|FG003|Overall Study|Lost to Follow-up|1
1989962|NCT00043186|3555659|FG004|Overall Study|Lost to Follow-up|1
1989963|NCT00043186|3555660|FG005|Overall Study|Lost to Follow-up|1
1989964|NCT00043186|3555661|FG006|Overall Study|Lost to Follow-up|1
1989965|NCT00043186|3555662|FG007|Overall Study|Lost to Follow-up|1
1989966|NCT00043186|3555663|FG008|Overall Study|Lost to Follow-up|2
1989967|NCT00043186|3555655|FG000|Overall Study|Noncompliance|0
1989968|NCT00043186|3555656|FG001|Overall Study|Noncompliance|0
1989969|NCT00043186|3555657|FG002|Overall Study|Noncompliance|1
1989970|NCT00043186|3555658|FG003|Overall Study|Noncompliance|1
1989971|NCT00043186|3555659|FG004|Overall Study|Noncompliance|0
1989972|NCT00043186|3555660|FG005|Overall Study|Noncompliance|0
2213528|NCT01680991|3855341|FG000|Overall Study|Progressive disease (PD)|0
2213529|NCT01680991|3855342|FG001|Overall Study|Progressive disease (PD)|10
1989973|NCT00043186|3555661|FG006|Overall Study|Noncompliance|0
1989974|NCT00043186|3555662|FG007|Overall Study|Noncompliance|0
1989975|NCT00043186|3555663|FG008|Overall Study|Noncompliance|0
1989976|NCT00043186|3555655|FG000|Overall Study|Other|0
1989977|NCT00043186|3555656|FG001|Overall Study|Other|0
1989978|NCT00043186|3555657|FG002|Overall Study|Other|1
1989979|NCT00043186|3555658|FG003|Overall Study|Other|1
1989980|NCT00043186|3555659|FG004|Overall Study|Other|0
1989981|NCT00043186|3555660|FG005|Overall Study|Other|0
1989982|NCT00043186|3555661|FG006|Overall Study|Other|0
1989983|NCT00043186|3555662|FG007|Overall Study|Other|0
1989984|NCT00043186|3555663|FG008|Overall Study|Other|0
1989985|NCT00043550|3555687|FG000|Overall Study|Withdrawal by Subject|22
1989986|NCT00043550|3555688|FG001|Overall Study|Withdrawal by Subject|12
1989987|NCT00043550|3555689|FG002|Overall Study|Withdrawal by Subject|20
1989988|NCT00043979|3555699|FG000|Period 1|recipient with progressive disease|7
1989989|NCT00043979|3555700|FG001|Period 1|recipient with progressive disease|4
1989990|NCT00043979|3555701|FG002|Period 1|recipient with progressive disease|3
1989991|NCT00044083|3555743|FG000|First Intervention (One Week)- HV's|Adverse Event|1
1989992|NCT00044083|3555744|FG001|First Intervention (One Week)- HV's|Adverse Event|0
1989993|NCT00044083|3555743|FG000|First Intervention (One Week)- HV's|Not follow directions|2
1989994|NCT00044083|3555744|FG001|First Intervention (One Week)- HV's|Not follow directions|2
1989995|NCT00044083|3555743|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5
1989996|NCT00044083|3555744|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3
1989997|NCT00044083|3555743|FG000|First Intervention (One Week)- HV's|Pregnancy|1
1989998|NCT00044083|3555744|FG001|First Intervention (One Week)- HV's|Pregnancy|0
1989999|NCT00044083|3555743|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1
1990000|NCT00044083|3555744|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0
1990001|NCT00044083|3555743|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0
1990002|NCT00044083|3555744|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1
1990003|NCT00044083|3555743|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0
1990004|NCT00044083|3555744|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1
1990005|NCT00044083|3555743|FG000|First Intervention (One Week) Patients|Not follow directions|0
1990006|NCT00044083|3555744|FG001|First Intervention (One Week) Patients|Not follow directions|2
1990007|NCT00044083|3555743|FG000|First Intervention (One Week) Patients|Used illegal drug|1
1990008|NCT00044083|3555744|FG001|First Intervention (One Week) Patients|Used illegal drug|0
1990009|NCT00044083|3555743|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0
1990010|NCT00044083|3555744|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1
1990011|NCT00044213|3555781|FG000|Overall Study|Withdrawal by Subject|50
1990012|NCT00044213|3555782|FG001|Overall Study|Withdrawal by Subject|65
1990013|NCT00044213|3555783|FG002|Overall Study|Withdrawal by Subject|91
1990014|NCT00044213|3555784|FG003|Overall Study|Withdrawal by Subject|83
1990015|NCT00044213|3555781|FG000|Overall Study|Death|42
1990016|NCT00044213|3555782|FG001|Overall Study|Death|42
1990017|NCT00044213|3555783|FG002|Overall Study|Death|42
1990018|NCT00044213|3555784|FG003|Overall Study|Death|49
1990019|NCT00044213|3555781|FG000|Overall Study|Lost to Follow-up|8
1990020|NCT00044213|3555782|FG001|Overall Study|Lost to Follow-up|5
1990021|NCT00044213|3555783|FG002|Overall Study|Lost to Follow-up|5
1990022|NCT00044213|3555784|FG003|Overall Study|Lost to Follow-up|4
1990023|NCT00044512|3555794|FG000|Follow Up|Lost to Follow-up|2
1990024|NCT00045032|3555810|FG000|Overall Study|Adverse Event/Intercurrent Illness|2
1990025|NCT00045032|3555811|FG001|Overall Study|Adverse Event/Intercurrent Illness|2
2213530|NCT01680991|3855343|FG002|Overall Study|Progressive disease (PD)|0
2213531|NCT01680991|3855341|FG000|Overall Study|Physician Decision|0
2213532|NCT01680991|3855342|FG001|Overall Study|Physician Decision|7
2213533|NCT01680991|3855343|FG002|Overall Study|Physician Decision|2
2213534|NCT01680991|3855341|FG000|Overall Study|Bad physical condition|0
2213535|NCT01680991|3855342|FG001|Overall Study|Bad physical condition|0
1990026|NCT00045032|3555812|FG002|Overall Study|Adverse Event/Intercurrent Illness|7
1990027|NCT00045032|3555810|FG000|Overall Study|Death|22
1990028|NCT00045032|3555811|FG001|Overall Study|Death|24
1990029|NCT00045032|3555812|FG002|Overall Study|Death|17
1990030|NCT00045032|3555810|FG000|Overall Study|Insufficient Therapeutic Response|542
1990031|NCT00045032|3555811|FG001|Overall Study|Insufficient Therapeutic Response|437
1990032|NCT00045032|3555812|FG002|Overall Study|Insufficient Therapeutic Response|445
1990033|NCT00045032|3555810|FG000|Overall Study|Violation of Selection Criteria at Entry|3
1990034|NCT00045032|3555811|FG001|Overall Study|Violation of Selection Criteria at Entry|6
1990035|NCT00045032|3555812|FG002|Overall Study|Violation of Selection Criteria at Entry|6
1990036|NCT00045032|3555810|FG000|Overall Study|Other Protocol Violation|2
1990037|NCT00045032|3555811|FG001|Overall Study|Other Protocol Violation|0
1990038|NCT00045032|3555812|FG002|Overall Study|Other Protocol Violation|1
1990039|NCT00045032|3555810|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142
1990040|NCT00045032|3555811|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93
1990041|NCT00045032|3555812|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84
1990042|NCT00045032|3555810|FG000|Overall Study|Failure to Return|57
1990043|NCT00045032|3555811|FG001|Overall Study|Failure to Return|62
1990044|NCT00045032|3555812|FG002|Overall Study|Failure to Return|61
1990045|NCT00045032|3555810|FG000|Overall Study|Other|93
1990046|NCT00045032|3555811|FG001|Overall Study|Other|84
1990047|NCT00045032|3555812|FG002|Overall Study|Other|105
1990048|NCT00045110|3555825|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
1990049|NCT00045110|3555826|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
1990050|NCT00045110|3555827|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
1990051|NCT00045110|3555825|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0
1990052|NCT00045110|3555826|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4
1990053|NCT00045110|3555827|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0
1990054|NCT00045110|3555825|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0
1990055|NCT00045110|3555826|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0
1990056|NCT00045110|3555827|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1
1990057|NCT00045162|3555846|FG000|Overall Study|Ineligible|12
1990058|NCT00045162|3555847|FG001|Overall Study|Ineligible|8
1990059|NCT00045162|3555846|FG000|Overall Study|Not treated|7
1990060|NCT00045162|3555847|FG001|Overall Study|Not treated|2
1990061|NCT00045162|3555846|FG000|Overall Study|Adverse Event|55
1990062|NCT00045162|3555847|FG001|Overall Study|Adverse Event|50
1990063|NCT00045162|3555846|FG000|Overall Study|Lack of Efficacy|32
1990064|NCT00045162|3555847|FG001|Overall Study|Lack of Efficacy|29
1990065|NCT00045162|3555846|FG000|Overall Study|Death|10
1990066|NCT00045162|3555847|FG001|Overall Study|Death|10
1990067|NCT00045162|3555846|FG000|Overall Study|Withdrawal by Subject|5
1990068|NCT00045162|3555847|FG001|Overall Study|Withdrawal by Subject|3
1990069|NCT00045162|3555846|FG000|Overall Study|Other|21
1990070|NCT00045162|3555847|FG001|Overall Study|Other|16
1990071|NCT00045305|3555853|FG000|Overall Study|Lack of Efficacy|6
2213536|NCT01680991|3855343|FG002|Overall Study|Bad physical condition|1
2213537|NCT01680991|3855341|FG000|Overall Study|PD confirmed in other hospital|1
2213538|NCT01680991|3855342|FG001|Overall Study|PD confirmed in other hospital|0
1990072|NCT00045305|3555853|FG000|Overall Study|Adverse Event|3
1990073|NCT00045305|3555853|FG000|Overall Study|Death|3
1990074|NCT00045305|3555853|FG000|Overall Study|site error|2
1990075|NCT00045630|3555865|FG000|Overall Study|Adverse Event|1
1990076|NCT00045630|3555865|FG000|Overall Study|Refusal unrelated to adverse event|1
1990077|NCT00045630|3555865|FG000|Overall Study|Progression/relapse|1
1990078|NCT00045630|3555865|FG000|Overall Study|Death|1
1990079|NCT00045630|3555865|FG000|Overall Study|Ineligible|2
2024506|NCT00334802|3592985|FG000|Overall Study|Physician Decision|1
2024507|NCT00334802|3592986|FG001|Overall Study|Physician Decision|0
2024508|NCT00334802|3592985|FG000|Overall Study|Withdrawal by Subject|0
2024509|NCT00334802|3592986|FG001|Overall Study|Withdrawal by Subject|4
2024510|NCT00334802|3592985|FG000|Overall Study|Adverse Event|0
2024511|NCT00334802|3592986|FG001|Overall Study|Adverse Event|3
2024512|NCT00334802|3592985|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0
2024513|NCT00334802|3592986|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1
2213539|NCT01680991|3855343|FG002|Overall Study|PD confirmed in other hospital|0
1990080|NCT00045708|3555872|FG000|Phase 1|early progressive disease|0
1990081|NCT00045708|3555873|FG001|Phase 1|early progressive disease|1
1990082|NCT00045708|3555874|FG002|Phase 1|early progressive disease|0
1990083|NCT00045734|3555891|FG000|Overall Study|Protocol Violation|1
1990084|NCT00045942|3555904|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1
1990085|NCT00045942|3555905|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0
1990086|NCT00045942|3555906|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0
1990087|NCT00045942|3555907|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0
1990088|NCT00045942|3555908|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0
1990089|NCT00045942|3555909|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0
1990090|NCT00045942|3555910|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0
1990091|NCT00045942|3555911|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0
1990092|NCT00045942|3555912|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0
1990093|NCT00045942|3555904|FG000|PKC412A2104 (Core)|Adverse Event|5
1990094|NCT00045942|3555905|FG001|PKC412A2104 (Core)|Adverse Event|0
1990095|NCT00045942|3555906|FG002|PKC412A2104 (Core)|Adverse Event|0
1990096|NCT00045942|3555907|FG003|PKC412A2104 (Core)|Adverse Event|0
1990097|NCT00045942|3555908|FG004|PKC412A2104 (Core)|Adverse Event|0
1990098|NCT00045942|3555909|FG005|PKC412A2104 (Core)|Adverse Event|0
1990099|NCT00045942|3555910|FG006|PKC412A2104 (Core)|Adverse Event|0
1990100|NCT00045942|3555911|FG007|PKC412A2104 (Core)|Adverse Event|0
1990101|NCT00045942|3555912|FG008|PKC412A2104 (Core)|Adverse Event|0
1990102|NCT00045942|3555904|FG000|PKC412A2104 (Core)|Lack of Efficacy|13
1990103|NCT00045942|3555905|FG001|PKC412A2104 (Core)|Lack of Efficacy|0
1990104|NCT00045942|3555906|FG002|PKC412A2104 (Core)|Lack of Efficacy|0
1990105|NCT00045942|3555907|FG003|PKC412A2104 (Core)|Lack of Efficacy|0
1990106|NCT00045942|3555908|FG004|PKC412A2104 (Core)|Lack of Efficacy|0
1990107|NCT00045942|3555909|FG005|PKC412A2104 (Core)|Lack of Efficacy|0
1990108|NCT00045942|3555910|FG006|PKC412A2104 (Core)|Lack of Efficacy|0
1990109|NCT00045942|3555911|FG007|PKC412A2104 (Core)|Lack of Efficacy|0
1990110|NCT00045942|3555912|FG008|PKC412A2104 (Core)|Lack of Efficacy|0
1990111|NCT00045942|3555904|FG000|PKC412A2104 (Core)|Death|1
1990112|NCT00045942|3555905|FG001|PKC412A2104 (Core)|Death|0
1990113|NCT00045942|3555906|FG002|PKC412A2104 (Core)|Death|0
1990114|NCT00045942|3555907|FG003|PKC412A2104 (Core)|Death|0
1990115|NCT00045942|3555908|FG004|PKC412A2104 (Core)|Death|0
1990116|NCT00045942|3555909|FG005|PKC412A2104 (Core)|Death|0
1990117|NCT00045942|3555910|FG006|PKC412A2104 (Core)|Death|0
1990118|NCT00045942|3555911|FG007|PKC412A2104 (Core)|Death|0
1990119|NCT00045942|3555912|FG008|PKC412A2104 (Core)|Death|0
1990120|NCT00045942|3555904|FG000|PKC412A2104E1|Withdrawal by Subject|0
1990121|NCT00045942|3555905|FG001|PKC412A2104E1|Withdrawal by Subject|0
1990122|NCT00045942|3555906|FG002|PKC412A2104E1|Withdrawal by Subject|2
1990123|NCT00045942|3555907|FG003|PKC412A2104E1|Withdrawal by Subject|5
1990124|NCT00045942|3555908|FG004|PKC412A2104E1|Withdrawal by Subject|2
1990125|NCT00045942|3555909|FG005|PKC412A2104E1|Withdrawal by Subject|0
1990126|NCT00045942|3555910|FG006|PKC412A2104E1|Withdrawal by Subject|0
1990127|NCT00045942|3555911|FG007|PKC412A2104E1|Withdrawal by Subject|0
1990128|NCT00045942|3555912|FG008|PKC412A2104E1|Withdrawal by Subject|0
1990129|NCT00045942|3555904|FG000|PKC412A2104E1|Condition no longer requires study drug|0
1990130|NCT00045942|3555905|FG001|PKC412A2104E1|Condition no longer requires study drug|1
1990131|NCT00045942|3555906|FG002|PKC412A2104E1|Condition no longer requires study drug|1
1990132|NCT00045942|3555907|FG003|PKC412A2104E1|Condition no longer requires study drug|0
1990133|NCT00045942|3555908|FG004|PKC412A2104E1|Condition no longer requires study drug|1
1990134|NCT00045942|3555909|FG005|PKC412A2104E1|Condition no longer requires study drug|0
1990135|NCT00045942|3555910|FG006|PKC412A2104E1|Condition no longer requires study drug|0
1990136|NCT00045942|3555911|FG007|PKC412A2104E1|Condition no longer requires study drug|0
1990137|NCT00045942|3555912|FG008|PKC412A2104E1|Condition no longer requires study drug|0
1990138|NCT00045942|3555904|FG000|PKC412A2104E1|Lack of Efficacy|0
1990139|NCT00045942|3555905|FG001|PKC412A2104E1|Lack of Efficacy|11
1990140|NCT00045942|3555906|FG002|PKC412A2104E1|Lack of Efficacy|11
1990141|NCT00045942|3555907|FG003|PKC412A2104E1|Lack of Efficacy|23
1990142|NCT00045942|3555908|FG004|PKC412A2104E1|Lack of Efficacy|17
1990143|NCT00045942|3555909|FG005|PKC412A2104E1|Lack of Efficacy|0
1990144|NCT00045942|3555910|FG006|PKC412A2104E1|Lack of Efficacy|0
1990145|NCT00045942|3555911|FG007|PKC412A2104E1|Lack of Efficacy|0
1990146|NCT00045942|3555912|FG008|PKC412A2104E1|Lack of Efficacy|0
1990147|NCT00045942|3555904|FG000|PKC412A2104E1|Abnormal laboratory value|0
1990148|NCT00045942|3555905|FG001|PKC412A2104E1|Abnormal laboratory value|1
1990149|NCT00045942|3555906|FG002|PKC412A2104E1|Abnormal laboratory value|0
1990150|NCT00045942|3555907|FG003|PKC412A2104E1|Abnormal laboratory value|0
1990151|NCT00045942|3555908|FG004|PKC412A2104E1|Abnormal laboratory value|0
1990152|NCT00045942|3555909|FG005|PKC412A2104E1|Abnormal laboratory value|0
1990153|NCT00045942|3555910|FG006|PKC412A2104E1|Abnormal laboratory value|0
1990154|NCT00045942|3555911|FG007|PKC412A2104E1|Abnormal laboratory value|0
1990155|NCT00045942|3555912|FG008|PKC412A2104E1|Abnormal laboratory value|0
1990156|NCT00045942|3555904|FG000|PKC412A2104E1|Adverse Event|0
1990157|NCT00045942|3555905|FG001|PKC412A2104E1|Adverse Event|1
1990158|NCT00045942|3555906|FG002|PKC412A2104E1|Adverse Event|1
1990159|NCT00045942|3555907|FG003|PKC412A2104E1|Adverse Event|3
1990160|NCT00045942|3555908|FG004|PKC412A2104E1|Adverse Event|6
1990161|NCT00045942|3555909|FG005|PKC412A2104E1|Adverse Event|0
1990162|NCT00045942|3555910|FG006|PKC412A2104E1|Adverse Event|0
1990163|NCT00045942|3555911|FG007|PKC412A2104E1|Adverse Event|0
1990164|NCT00045942|3555912|FG008|PKC412A2104E1|Adverse Event|0
1990165|NCT00045942|3555904|FG000|PKC412A2104E1|Death|0
1990166|NCT00045942|3555905|FG001|PKC412A2104E1|Death|4
1990167|NCT00045942|3555906|FG002|PKC412A2104E1|Death|1
1990168|NCT00045942|3555907|FG003|PKC412A2104E1|Death|1
1990169|NCT00045942|3555908|FG004|PKC412A2104E1|Death|1
1990170|NCT00045942|3555909|FG005|PKC412A2104E1|Death|0
1990171|NCT00045942|3555910|FG006|PKC412A2104E1|Death|0
1990172|NCT00045942|3555911|FG007|PKC412A2104E1|Death|0
1990173|NCT00045942|3555912|FG008|PKC412A2104E1|Death|0
1990174|NCT00045942|3555904|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1990175|NCT00045942|3555905|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1990176|NCT00045942|3555906|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1
1990177|NCT00045942|3555907|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1
1990178|NCT00045942|3555908|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1990179|NCT00045942|3555909|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1990180|NCT00045942|3555910|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1990181|NCT00045942|3555911|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1990182|NCT00045942|3555912|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1990183|NCT00045942|3555904|FG000|PKC412A2104E2|Lost to Follow-up|0
1990184|NCT00045942|3555905|FG001|PKC412A2104E2|Lost to Follow-up|0
1990185|NCT00045942|3555906|FG002|PKC412A2104E2|Lost to Follow-up|0
1990186|NCT00045942|3555907|FG003|PKC412A2104E2|Lost to Follow-up|0
1990187|NCT00045942|3555908|FG004|PKC412A2104E2|Lost to Follow-up|0
1990188|NCT00045942|3555909|FG005|PKC412A2104E2|Lost to Follow-up|0
1990189|NCT00045942|3555910|FG006|PKC412A2104E2|Lost to Follow-up|0
1990190|NCT00045942|3555911|FG007|PKC412A2104E2|Lost to Follow-up|3
1990191|NCT00045942|3555912|FG008|PKC412A2104E2|Lost to Follow-up|0
1990192|NCT00045942|3555904|FG000|PKC412A2104E2|Withdrawal by Subject|0
1990193|NCT00045942|3555905|FG001|PKC412A2104E2|Withdrawal by Subject|0
1990194|NCT00045942|3555906|FG002|PKC412A2104E2|Withdrawal by Subject|0
1990195|NCT00045942|3555907|FG003|PKC412A2104E2|Withdrawal by Subject|0
1990196|NCT00045942|3555908|FG004|PKC412A2104E2|Withdrawal by Subject|0
1990197|NCT00045942|3555909|FG005|PKC412A2104E2|Withdrawal by Subject|1
1990198|NCT00045942|3555910|FG006|PKC412A2104E2|Withdrawal by Subject|0
1990199|NCT00045942|3555911|FG007|PKC412A2104E2|Withdrawal by Subject|1
1990200|NCT00045942|3555912|FG008|PKC412A2104E2|Withdrawal by Subject|0
1990201|NCT00045942|3555904|FG000|PKC412A2104E2|Lack of Efficacy|0
1990202|NCT00045942|3555905|FG001|PKC412A2104E2|Lack of Efficacy|0
1990203|NCT00045942|3555906|FG002|PKC412A2104E2|Lack of Efficacy|0
1990204|NCT00045942|3555907|FG003|PKC412A2104E2|Lack of Efficacy|0
1990205|NCT00045942|3555908|FG004|PKC412A2104E2|Lack of Efficacy|0
1990206|NCT00045942|3555909|FG005|PKC412A2104E2|Lack of Efficacy|3
1990207|NCT00045942|3555910|FG006|PKC412A2104E2|Lack of Efficacy|2
1990208|NCT00045942|3555911|FG007|PKC412A2104E2|Lack of Efficacy|2
1990209|NCT00045942|3555912|FG008|PKC412A2104E2|Lack of Efficacy|6
1990210|NCT00045942|3555904|FG000|PKC412A2104E2|Adverse Event|0
1990211|NCT00045942|3555905|FG001|PKC412A2104E2|Adverse Event|0
1990212|NCT00045942|3555906|FG002|PKC412A2104E2|Adverse Event|0
1990213|NCT00045942|3555907|FG003|PKC412A2104E2|Adverse Event|0
1990214|NCT00045942|3555908|FG004|PKC412A2104E2|Adverse Event|0
1990215|NCT00045942|3555909|FG005|PKC412A2104E2|Adverse Event|4
1990216|NCT00045942|3555910|FG006|PKC412A2104E2|Adverse Event|3
1990217|NCT00045942|3555911|FG007|PKC412A2104E2|Adverse Event|1
1990218|NCT00045942|3555912|FG008|PKC412A2104E2|Adverse Event|0
1990219|NCT00045942|3555904|FG000|PKC412A2104E2|Death|0
1990220|NCT00045942|3555905|FG001|PKC412A2104E2|Death|0
1990221|NCT00045942|3555906|FG002|PKC412A2104E2|Death|0
1990222|NCT00045942|3555907|FG003|PKC412A2104E2|Death|0
1990223|NCT00045942|3555908|FG004|PKC412A2104E2|Death|0
1990224|NCT00045942|3555909|FG005|PKC412A2104E2|Death|1
1990225|NCT00045942|3555910|FG006|PKC412A2104E2|Death|2
1990226|NCT00045942|3555911|FG007|PKC412A2104E2|Death|0
1990227|NCT00045942|3555912|FG008|PKC412A2104E2|Death|0
1990228|NCT00046839|3555979|FG000|Overall Study|Ineligible / No protocol treatment|0
1990229|NCT00046839|3555980|FG001|Overall Study|Ineligible / No protocol treatment|2
1990230|NCT00046839|3555979|FG000|Overall Study|Withdrawal of consent|1
1990231|NCT00046839|3555980|FG001|Overall Study|Withdrawal of consent|0
1990232|NCT00046891|3555989|FG000|Overall Study|Cancels|5
1990233|NCT00046891|3555990|FG001|Overall Study|Cancels|9
1990234|NCT00046891|3555989|FG000|Overall Study|Ineligible|1
2102388|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16
1990235|NCT00046891|3555990|FG001|Overall Study|Ineligible|1
1990236|NCT00046891|3555989|FG000|Overall Study|Withdrawal by Subject|18
1990237|NCT00046891|3555990|FG001|Overall Study|Withdrawal by Subject|15
1990238|NCT00046891|3555989|FG000|Overall Study|Adverse Event|5
1990239|NCT00046891|3555990|FG001|Overall Study|Adverse Event|5
1990240|NCT00046930|3556006|FG000|Overall Study|Ineligible|12
1990241|NCT00046930|3556007|FG001|Overall Study|Ineligible|4
1990242|NCT00047008|3556018|FG000|Overall Study|Withdrawn consent|2
1990243|NCT00047008|3556019|FG001|Overall Study|Withdrawn consent|3
1990244|NCT00047008|3556018|FG000|Overall Study|Ineligible|9
1990245|NCT00047008|3556019|FG001|Overall Study|Ineligible|8
1990246|NCT00047320|3556029|FG000|Overall Study|Lack of Efficacy|8
1990247|NCT00047320|3556029|FG000|Overall Study|Lost to Follow-up|1
1990248|NCT00047320|3556029|FG000|Overall Study|Physician Decision|8
1990249|NCT00047320|3556029|FG000|Overall Study|Withdrawal by Subject|9
1990250|NCT00047320|3556029|FG000|Overall Study|Ineligible|2
1990251|NCT00047385|3556035|FG000|Overall Study|Death before any screening|2
1990252|NCT00047385|3556036|FG001|Overall Study|Death before any screening|5
1990253|NCT00047385|3556035|FG000|Overall Study|Lung Cancer diagnosed before screening|5
1990254|NCT00047385|3556036|FG001|Overall Study|Lung Cancer diagnosed before screening|3
1990255|NCT00047385|3556035|FG000|Overall Study|Eligible for screening but had no screen|260
1990256|NCT00047385|3556036|FG001|Overall Study|Eligible for screening but had no screen|492
1990257|NCT00047463|3556044|FG000|Overall Study|Withdrawal by Subject|0
1990258|NCT00047463|3556045|FG001|Overall Study|Withdrawal by Subject|3
1990259|NCT00047879|3556075|FG000|Overall Study|Progressive disease|4
1990260|NCT00047879|3556076|FG001|Overall Study|Progressive disease|3
1990261|NCT00048035|3556088|FG000|Core Period|Early Withdrawals|4
1990262|NCT00048035|3556089|FG001|Core Period|Early Withdrawals|2
1990263|NCT00048035|3556090|FG002|Core Period|Early Withdrawals|1
1990264|NCT00048035|3556091|FG003|Core Period|Early Withdrawals|1
1990265|NCT00048035|3556092|FG004|Core Period|Early Withdrawals|1
1990266|NCT00048035|3556093|FG005|Core Period|Early Withdrawals|1
1990267|NCT00048035|3556094|FG006|Core Period|Early Withdrawals|0
1990268|NCT00048035|3556095|FG007|Core Period|Early Withdrawals|0
1990269|NCT00048035|3556088|FG000|Extension Year 1|Early Withdrawals|0
1990270|NCT00048035|3556089|FG001|Extension Year 1|Early Withdrawals|0
1990271|NCT00048035|3556090|FG002|Extension Year 1|Early Withdrawals|0
1990272|NCT00048035|3556091|FG003|Extension Year 1|Early Withdrawals|0
1990273|NCT00048035|3556092|FG004|Extension Year 1|Early Withdrawals|0
1990274|NCT00048035|3556093|FG005|Extension Year 1|Early Withdrawals|0
1990275|NCT00048035|3556094|FG006|Extension Year 1|Early Withdrawals|11
1990276|NCT00048035|3556095|FG007|Extension Year 1|Early Withdrawals|11
1990277|NCT00048035|3556088|FG000|Extension Year 2|Early Withdrawals|0
1990278|NCT00048035|3556089|FG001|Extension Year 2|Early Withdrawals|0
1990279|NCT00048035|3556090|FG002|Extension Year 2|Early Withdrawals|0
1990280|NCT00048035|3556091|FG003|Extension Year 2|Early Withdrawals|0
1990281|NCT00048035|3556092|FG004|Extension Year 2|Early Withdrawals|0
1990282|NCT00048035|3556093|FG005|Extension Year 2|Early Withdrawals|0
1990283|NCT00048035|3556094|FG006|Extension Year 2|Early Withdrawals|3
1990284|NCT00048035|3556095|FG007|Extension Year 2|Early Withdrawals|3
1990285|NCT00048048|3556119|FG000|Core Treatment|Withdrawal by Subject|0
1990286|NCT00048048|3556120|FG001|Core Treatment|Withdrawal by Subject|0
1990287|NCT00048048|3556121|FG002|Core Treatment|Withdrawal by Subject|1
1990288|NCT00048048|3556122|FG003|Core Treatment|Withdrawal by Subject|0
1990289|NCT00048048|3556123|FG004|Core Treatment|Withdrawal by Subject|0
1990290|NCT00048048|3556124|FG005|Core Treatment|Withdrawal by Subject|0
1990291|NCT00048048|3556125|FG006|Core Treatment|Withdrawal by Subject|0
1990292|NCT00048048|3556126|FG007|Core Treatment|Withdrawal by Subject|0
1990293|NCT00048048|3556127|FG008|Core Treatment|Withdrawal by Subject|0
1990294|NCT00048048|3556128|FG009|Core Treatment|Withdrawal by Subject|0
1990295|NCT00048048|3556129|FG010|Core Treatment|Withdrawal by Subject|0
1990296|NCT00048048|3556130|FG011|Core Treatment|Withdrawal by Subject|0
1990297|NCT00048048|3556119|FG000|Core Treatment|Adverse Event|0
1990298|NCT00048048|3556120|FG001|Core Treatment|Adverse Event|0
1990299|NCT00048048|3556121|FG002|Core Treatment|Adverse Event|0
1990300|NCT00048048|3556122|FG003|Core Treatment|Adverse Event|0
1990301|NCT00048048|3556123|FG004|Core Treatment|Adverse Event|0
1990302|NCT00048048|3556124|FG005|Core Treatment|Adverse Event|0
1990303|NCT00048048|3556125|FG006|Core Treatment|Adverse Event|0
1990304|NCT00048048|3556126|FG007|Core Treatment|Adverse Event|1
1990305|NCT00048048|3556127|FG008|Core Treatment|Adverse Event|0
1990306|NCT00048048|3556128|FG009|Core Treatment|Adverse Event|0
1990307|NCT00048048|3556129|FG010|Core Treatment|Adverse Event|0
1990308|NCT00048048|3556130|FG011|Core Treatment|Adverse Event|0
1990309|NCT00048048|3556119|FG000|Extension Year 1|Early withdrawals|0
1990310|NCT00048048|3556120|FG001|Extension Year 1|Early withdrawals|0
1990311|NCT00048048|3556121|FG002|Extension Year 1|Early withdrawals|0
1990312|NCT00048048|3556122|FG003|Extension Year 1|Early withdrawals|0
1990313|NCT00048048|3556123|FG004|Extension Year 1|Early withdrawals|0
1990314|NCT00048048|3556124|FG005|Extension Year 1|Early withdrawals|0
1990315|NCT00048048|3556125|FG006|Extension Year 1|Early withdrawals|0
1990316|NCT00048048|3556126|FG007|Extension Year 1|Early withdrawals|0
1990317|NCT00048048|3556127|FG008|Extension Year 1|Early withdrawals|0
1990318|NCT00048048|3556128|FG009|Extension Year 1|Early withdrawals|2
1990319|NCT00048048|3556129|FG010|Extension Year 1|Early withdrawals|2
1990320|NCT00048048|3556130|FG011|Extension Year 1|Early withdrawals|4
1990321|NCT00048048|3556119|FG000|Extension Year 2|Early withdrawals|0
1990322|NCT00048048|3556120|FG001|Extension Year 2|Early withdrawals|0
1990323|NCT00048048|3556121|FG002|Extension Year 2|Early withdrawals|0
1990324|NCT00048048|3556122|FG003|Extension Year 2|Early withdrawals|0
1990325|NCT00048048|3556123|FG004|Extension Year 2|Early withdrawals|0
1990326|NCT00048048|3556124|FG005|Extension Year 2|Early withdrawals|0
1990327|NCT00048048|3556125|FG006|Extension Year 2|Early withdrawals|0
1990328|NCT00048048|3556126|FG007|Extension Year 2|Early withdrawals|0
1990329|NCT00048048|3556127|FG008|Extension Year 2|Early withdrawals|0
1990330|NCT00048048|3556128|FG009|Extension Year 2|Early withdrawals|0
1990331|NCT00048048|3556129|FG010|Extension Year 2|Early withdrawals|4
1990332|NCT00048048|3556130|FG011|Extension Year 2|Early withdrawals|2
1990333|NCT00048061|3556161|FG000|Overall Study|Adverse Event|41
1990334|NCT00048061|3556162|FG001|Overall Study|Adverse Event|32
1990335|NCT00048061|3556163|FG002|Overall Study|Adverse Event|44
1990336|NCT00048061|3556164|FG003|Overall Study|Adverse Event|37
1990337|NCT00048061|3556161|FG000|Overall Study|Lost to Follow-up|3
1990338|NCT00048061|3556162|FG001|Overall Study|Lost to Follow-up|2
1990339|NCT00048061|3556163|FG002|Overall Study|Lost to Follow-up|4
1990340|NCT00048061|3556164|FG003|Overall Study|Lost to Follow-up|5
1990341|NCT00048061|3556161|FG000|Overall Study|Withdrawal by Subject|20
1990342|NCT00048061|3556162|FG001|Overall Study|Withdrawal by Subject|29
1990343|NCT00048061|3556163|FG002|Overall Study|Withdrawal by Subject|29
1990344|NCT00048061|3556164|FG003|Overall Study|Withdrawal by Subject|32
1990345|NCT00048061|3556161|FG000|Overall Study|Did not follow-up|5
1990346|NCT00048061|3556162|FG001|Overall Study|Did not follow-up|5
1990347|NCT00048061|3556163|FG002|Overall Study|Did not follow-up|4
1990348|NCT00048061|3556164|FG003|Overall Study|Did not follow-up|5
1990349|NCT00048061|3556161|FG000|Overall Study|Early improvement|6
1990350|NCT00048061|3556162|FG001|Overall Study|Early improvement|5
1990351|NCT00048061|3556163|FG002|Overall Study|Early improvement|3
1990352|NCT00048061|3556164|FG003|Overall Study|Early improvement|0
1990353|NCT00048074|3556177|FG000|Overall Study|Adverse Event|46
1990354|NCT00048074|3556178|FG001|Overall Study|Adverse Event|41
1990355|NCT00048074|3556179|FG002|Overall Study|Adverse Event|53
1990356|NCT00048074|3556177|FG000|Overall Study|Death|3
1990357|NCT00048074|3556178|FG001|Overall Study|Death|3
2312012|NCT02760407|4017753|FG001|Overall Study|Use of prohibited Medication|0
2312013|NCT02760407|4017754|FG002|Overall Study|Use of prohibited Medication|1
2312014|NCT02760407|4017755|FG003|Overall Study|Use of prohibited Medication|0
2312015|NCT02760407|4017752|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
2321976|NCT02966028|4036642|FG001|Overall Study|Withdrawal by Subject|5
1990358|NCT00048074|3556179|FG002|Overall Study|Death|2
1990359|NCT00048074|3556177|FG000|Overall Study|Lost to Follow-up|2
1990360|NCT00048074|3556178|FG001|Overall Study|Lost to Follow-up|6
1990361|NCT00048074|3556179|FG002|Overall Study|Lost to Follow-up|6
1990362|NCT00048074|3556177|FG000|Overall Study|Withdrawal by Subject|28
1990363|NCT00048074|3556178|FG001|Overall Study|Withdrawal by Subject|30
1990364|NCT00048074|3556179|FG002|Overall Study|Withdrawal by Subject|35
1990365|NCT00048074|3556177|FG000|Overall Study|Protocol Violation|1
1990366|NCT00048074|3556178|FG001|Overall Study|Protocol Violation|3
1990367|NCT00048074|3556179|FG002|Overall Study|Protocol Violation|0
1990368|NCT00048074|3556177|FG000|Overall Study|Study participation was terminated|0
1990369|NCT00048074|3556178|FG001|Overall Study|Study participation was terminated|1
1990370|NCT00048074|3556179|FG002|Overall Study|Study participation was terminated|0
1990371|NCT00048074|3556177|FG000|Overall Study|Husband ill|0
1990372|NCT00048074|3556178|FG001|Overall Study|Husband ill|1
1990373|NCT00048074|3556179|FG002|Overall Study|Husband ill|0
1990374|NCT00048074|3556177|FG000|Overall Study|Poor compliance|0
1990375|NCT00048074|3556178|FG001|Overall Study|Poor compliance|1
1990376|NCT00048074|3556179|FG002|Overall Study|Poor compliance|0
1990377|NCT00048074|3556177|FG000|Overall Study|Out of station|0
1990378|NCT00048074|3556178|FG001|Overall Study|Out of station|1
1990379|NCT00048074|3556179|FG002|Overall Study|Out of station|1
1990380|NCT00048074|3556177|FG000|Overall Study|Social reasons|1
1990381|NCT00048074|3556178|FG001|Overall Study|Social reasons|0
1990382|NCT00048074|3556179|FG002|Overall Study|Social reasons|0
1990383|NCT00048165|3556189|FG000|Completed 6 Months Study|Administration/Other|8
1990384|NCT00048165|3556190|FG001|Completed 6 Months Study|Administration/Other|8
1990385|NCT00048165|3556189|FG000|Completed 6 Months Study|Abnormality of laboratory test|1
1990386|NCT00048165|3556190|FG001|Completed 6 Months Study|Abnormality of laboratory test|0
1990387|NCT00048165|3556189|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14
1990388|NCT00048165|3556190|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11
1990389|NCT00048165|3556189|FG000|Completed 6 Months Study|Death|12
1990390|NCT00048165|3556190|FG001|Completed 6 Months Study|Death|6
1990391|NCT00048165|3556189|FG000|Completed 6 Months Study|Insufficient therapy|1
1990392|NCT00048165|3556190|FG001|Completed 6 Months Study|Insufficient therapy|4
1990393|NCT00048165|3556189|FG000|Completed 6 Months Study|Other violation|4
1990394|NCT00048165|3556190|FG001|Completed 6 Months Study|Other violation|6
1990395|NCT00048165|3556189|FG000|Completed 6 Months Study|Refused treatment|5
1990396|NCT00048165|3556190|FG001|Completed 6 Months Study|Refused treatment|5
1990397|NCT00048165|3556189|FG000|Completed 6 Months Study|Violation criteria|0
1990398|NCT00048165|3556190|FG001|Completed 6 Months Study|Violation criteria|2
1990399|NCT00048165|3556189|FG000|Completed 6 Months Study|Did not receive study drug|6
1990400|NCT00048165|3556190|FG001|Completed 6 Months Study|Did not receive study drug|6
1990401|NCT00048165|3556189|FG000|Completed 12 Months Study|Administration/Other|0
1990402|NCT00048165|3556190|FG001|Completed 12 Months Study|Administration/Other|2
1990403|NCT00048165|3556189|FG000|Completed 12 Months Study|Death|2
1990404|NCT00048165|3556190|FG001|Completed 12 Months Study|Death|1
1990405|NCT00048165|3556189|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1
1990406|NCT00048165|3556190|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0
1990407|NCT00048347|3556198|FG000|Overall Study|Screen failure|2
1990408|NCT00048542|3556206|FG000|Double-Blind Phase|Withdrawal by Subject|0
1990409|NCT00048542|3556207|FG001|Double-Blind Phase|Withdrawal by Subject|1
1990410|NCT00048542|3556208|FG002|Double-Blind Phase|Withdrawal by Subject|0
1990411|NCT00048542|3556209|FG003|Double-Blind Phase|Withdrawal by Subject|0
1990412|NCT00048542|3556210|FG004|Double-Blind Phase|Withdrawal by Subject|0
1990413|NCT00048542|3556211|FG005|Double-Blind Phase|Withdrawal by Subject|0
1990414|NCT00048542|3556212|FG006|Double-Blind Phase|Withdrawal by Subject|0
1990415|NCT00048542|3556213|FG007|Double-Blind Phase|Withdrawal by Subject|0
1990416|NCT00048542|3556206|FG000|Double-Blind Phase|Protocol Violation|0
1990417|NCT00048542|3556207|FG001|Double-Blind Phase|Protocol Violation|0
1990418|NCT00048542|3556208|FG002|Double-Blind Phase|Protocol Violation|1
1990419|NCT00048542|3556209|FG003|Double-Blind Phase|Protocol Violation|0
1990420|NCT00048542|3556210|FG004|Double-Blind Phase|Protocol Violation|0
1990421|NCT00048542|3556211|FG005|Double-Blind Phase|Protocol Violation|0
1990422|NCT00048542|3556212|FG006|Double-Blind Phase|Protocol Violation|0
1990423|NCT00048542|3556213|FG007|Double-Blind Phase|Protocol Violation|0
1990424|NCT00048542|3556206|FG000|Double-Blind Phase|Sponsor request or decision|2
1990425|NCT00048542|3556207|FG001|Double-Blind Phase|Sponsor request or decision|0
1990426|NCT00048542|3556208|FG002|Double-Blind Phase|Sponsor request or decision|0
1990427|NCT00048542|3556209|FG003|Double-Blind Phase|Sponsor request or decision|0
1990428|NCT00048542|3556210|FG004|Double-Blind Phase|Sponsor request or decision|0
1990429|NCT00048542|3556211|FG005|Double-Blind Phase|Sponsor request or decision|0
1990430|NCT00048542|3556212|FG006|Double-Blind Phase|Sponsor request or decision|0
1990431|NCT00048542|3556213|FG007|Double-Blind Phase|Sponsor request or decision|0
1990432|NCT00048542|3556206|FG000|Double-Blind Phase|Randomized in error|1
1990433|NCT00048542|3556207|FG001|Double-Blind Phase|Randomized in error|0
1990434|NCT00048542|3556208|FG002|Double-Blind Phase|Randomized in error|0
1990435|NCT00048542|3556209|FG003|Double-Blind Phase|Randomized in error|0
1990436|NCT00048542|3556210|FG004|Double-Blind Phase|Randomized in error|0
1990437|NCT00048542|3556211|FG005|Double-Blind Phase|Randomized in error|0
1990438|NCT00048542|3556212|FG006|Double-Blind Phase|Randomized in error|0
1990439|NCT00048542|3556213|FG007|Double-Blind Phase|Randomized in error|0
1990440|NCT00048542|3556206|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1990441|NCT00048542|3556207|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1990442|NCT00048542|3556208|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1990443|NCT00048542|3556209|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1990444|NCT00048542|3556210|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3
1990445|NCT00048542|3556211|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6
1990446|NCT00048542|3556212|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1990447|NCT00048542|3556213|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1990448|NCT00048542|3556206|FG000|Open-Label Extension BSA Phase|Protocol Violation|0
1990449|NCT00048542|3556207|FG001|Open-Label Extension BSA Phase|Protocol Violation|0
1990450|NCT00048542|3556208|FG002|Open-Label Extension BSA Phase|Protocol Violation|0
1990451|NCT00048542|3556209|FG003|Open-Label Extension BSA Phase|Protocol Violation|0
1990452|NCT00048542|3556210|FG004|Open-Label Extension BSA Phase|Protocol Violation|0
1990453|NCT00048542|3556211|FG005|Open-Label Extension BSA Phase|Protocol Violation|1
1990454|NCT00048542|3556212|FG006|Open-Label Extension BSA Phase|Protocol Violation|0
1990455|NCT00048542|3556213|FG007|Open-Label Extension BSA Phase|Protocol Violation|0
1990456|NCT00048542|3556206|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0
2213540|NCT01681004|3855355|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1
1990457|NCT00048542|3556207|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0
1990458|NCT00048542|3556208|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0
1990459|NCT00048542|3556209|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0
1990460|NCT00048542|3556210|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5
1990461|NCT00048542|3556211|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1
1990462|NCT00048542|3556212|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0
1990463|NCT00048542|3556213|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0
1990464|NCT00048542|3556206|FG000|Open-Label Extension BSA Phase|Adverse Event|0
1990465|NCT00048542|3556207|FG001|Open-Label Extension BSA Phase|Adverse Event|0
1990466|NCT00048542|3556208|FG002|Open-Label Extension BSA Phase|Adverse Event|0
1990467|NCT00048542|3556209|FG003|Open-Label Extension BSA Phase|Adverse Event|0
1990468|NCT00048542|3556210|FG004|Open-Label Extension BSA Phase|Adverse Event|1
1990469|NCT00048542|3556211|FG005|Open-Label Extension BSA Phase|Adverse Event|1
1990470|NCT00048542|3556212|FG006|Open-Label Extension BSA Phase|Adverse Event|0
1990471|NCT00048542|3556213|FG007|Open-Label Extension BSA Phase|Adverse Event|0
1990472|NCT00048542|3556206|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0
1990473|NCT00048542|3556207|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0
1990474|NCT00048542|3556208|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0
1990475|NCT00048542|3556209|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0
1990476|NCT00048542|3556210|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3
1990477|NCT00048542|3556211|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1
1990478|NCT00048542|3556212|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0
1990479|NCT00048542|3556213|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0
1990480|NCT00048542|3556206|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1990481|NCT00048542|3556207|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1990482|NCT00048542|3556208|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1990483|NCT00048542|3556209|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1990484|NCT00048542|3556210|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1990485|NCT00048542|3556211|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1990486|NCT00048542|3556212|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
1990487|NCT00048542|3556213|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
1990488|NCT00048542|3556206|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1990489|NCT00048542|3556207|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1990490|NCT00048542|3556208|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1990491|NCT00048542|3556209|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1990492|NCT00048542|3556210|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1990493|NCT00048542|3556211|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1990494|NCT00048542|3556212|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
1990495|NCT00048542|3556213|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
1990496|NCT00048542|3556206|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1990497|NCT00048542|3556207|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1990498|NCT00048542|3556208|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1990499|NCT00048542|3556209|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1990500|NCT00048542|3556210|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1990501|NCT00048542|3556211|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1990502|NCT00048542|3556212|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
1990503|NCT00048542|3556213|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
1990504|NCT00048542|3556206|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1990505|NCT00048542|3556207|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1990506|NCT00048542|3556208|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1990507|NCT00048542|3556209|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1990508|NCT00048542|3556210|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1990509|NCT00048542|3556211|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1990510|NCT00048542|3556212|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2
1990511|NCT00048542|3556213|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2
1990512|NCT00048542|3556206|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1990513|NCT00048542|3556207|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1990514|NCT00048542|3556208|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1990515|NCT00048542|3556209|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1990516|NCT00048542|3556210|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1990517|NCT00048542|3556211|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1990518|NCT00048542|3556212|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
1990519|NCT00048542|3556213|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
1990520|NCT00048542|3556206|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1990521|NCT00048542|3556207|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1990522|NCT00048542|3556208|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1990523|NCT00048542|3556209|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1990524|NCT00048542|3556210|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1990525|NCT00048542|3556211|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1990526|NCT00048542|3556212|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
1990527|NCT00048542|3556213|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
1990528|NCT00048568|3556244|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11
1990529|NCT00048568|3556245|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3
1990530|NCT00048568|3556246|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0
1990531|NCT00048568|3556244|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
1990532|NCT00048568|3556245|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
1990533|NCT00048568|3556246|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
1990534|NCT00048568|3556244|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
1990535|NCT00048568|3556245|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
1990536|NCT00048568|3556246|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
1990537|NCT00048568|3556244|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
1990538|NCT00048568|3556245|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
1990539|NCT00048568|3556246|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
1990540|NCT00048568|3556244|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2
1990541|NCT00048568|3556245|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4
1990542|NCT00048568|3556246|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0
1990543|NCT00048568|3556244|FG000|Double-Blind Period Days 170 to 365|Death|1
1990544|NCT00048568|3556245|FG001|Double-Blind Period Days 170 to 365|Death|1
1990545|NCT00048568|3556246|FG002|Double-Blind Period Days 170 to 365|Death|0
1990546|NCT00048568|3556244|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7
1990547|NCT00048568|3556245|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1
1990548|NCT00048568|3556246|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0
1990549|NCT00048568|3556244|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
1990550|NCT00048568|3556245|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
2024514|NCT00334815|3592997|FG000|Overall Study|Adverse Event|3
1990551|NCT00048568|3556246|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
1990552|NCT00048568|3556244|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
1990553|NCT00048568|3556245|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
1990554|NCT00048568|3556246|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
1990555|NCT00048568|3556244|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
1990556|NCT00048568|3556245|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
1990557|NCT00048568|3556246|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
1990558|NCT00048568|3556244|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2
1990559|NCT00048568|3556245|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0
1990560|NCT00048568|3556246|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0
1990561|NCT00048568|3556244|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
1990562|NCT00048568|3556245|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
1990563|NCT00048568|3556246|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
1990564|NCT00048568|3556244|FG000|Open-Label Period|Death|0
1990565|NCT00048568|3556245|FG001|Open-Label Period|Death|0
1990566|NCT00048568|3556246|FG002|Open-Label Period|Death|13
1990567|NCT00048568|3556244|FG000|Open-Label Period|Adverse Event|0
1990568|NCT00048568|3556245|FG001|Open-Label Period|Adverse Event|0
1990569|NCT00048568|3556246|FG002|Open-Label Period|Adverse Event|49
1990570|NCT00048568|3556244|FG000|Open-Label Period|Lack of Efficacy|0
1990571|NCT00048568|3556245|FG001|Open-Label Period|Lack of Efficacy|0
1990572|NCT00048568|3556246|FG002|Open-Label Period|Lack of Efficacy|32
1990573|NCT00048568|3556244|FG000|Open-Label Period|Withdrawal by Subject|0
1990574|NCT00048568|3556245|FG001|Open-Label Period|Withdrawal by Subject|0
1990575|NCT00048568|3556246|FG002|Open-Label Period|Withdrawal by Subject|26
1990576|NCT00048568|3556244|FG000|Open-Label Period|Pregnancy|0
1990577|NCT00048568|3556245|FG001|Open-Label Period|Pregnancy|0
1990578|NCT00048568|3556246|FG002|Open-Label Period|Pregnancy|5
1990579|NCT00048568|3556244|FG000|Open-Label Period|No Longer Met Study Criteria|0
1990580|NCT00048568|3556245|FG001|Open-Label Period|No Longer Met Study Criteria|0
1990581|NCT00048568|3556246|FG002|Open-Label Period|No Longer Met Study Criteria|2
1990582|NCT00048568|3556244|FG000|Open-Label Period|Administrative Decision By Sponsor|0
1990583|NCT00048568|3556245|FG001|Open-Label Period|Administrative Decision By Sponsor|0
1990584|NCT00048568|3556246|FG002|Open-Label Period|Administrative Decision By Sponsor|1
1990585|NCT00048568|3556244|FG000|Open-Label Period|Unknown Reasons|0
1990586|NCT00048568|3556245|FG001|Open-Label Period|Unknown Reasons|0
1990587|NCT00048568|3556246|FG002|Open-Label Period|Unknown Reasons|25
1990588|NCT00048568|3556244|FG000|Open-Label Period|Lost to Follow-up|0
1990589|NCT00048568|3556245|FG001|Open-Label Period|Lost to Follow-up|0
2213541|NCT01681004|3855356|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2
2213542|NCT01681004|3855355|FG000|Study Completion|Lost to Follow-up|8
1990590|NCT00048568|3556246|FG002|Open-Label Period|Lost to Follow-up|7
1990591|NCT00048581|3556269|FG000|Double-Blind Period|Adverse Event|9
1990592|NCT00048581|3556270|FG001|Double-Blind Period|Adverse Event|5
1990593|NCT00048581|3556271|FG002|Double-Blind Period|Adverse Event|0
1990594|NCT00048581|3556269|FG000|Double-Blind Period|Lack of Efficacy|14
1990595|NCT00048581|3556270|FG001|Double-Blind Period|Lack of Efficacy|27
1990596|NCT00048581|3556271|FG002|Double-Blind Period|Lack of Efficacy|0
1990597|NCT00048581|3556269|FG000|Double-Blind Period|Lost to Follow-up|5
1990598|NCT00048581|3556270|FG001|Double-Blind Period|Lost to Follow-up|0
1990599|NCT00048581|3556271|FG002|Double-Blind Period|Lost to Follow-up|0
1990600|NCT00048581|3556269|FG000|Double-Blind Period|Withdrawal by Subject|5
1990601|NCT00048581|3556270|FG001|Double-Blind Period|Withdrawal by Subject|2
1990602|NCT00048581|3556271|FG002|Double-Blind Period|Withdrawal by Subject|0
1990603|NCT00048581|3556269|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1
1990604|NCT00048581|3556270|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0
1990605|NCT00048581|3556271|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0
1990606|NCT00048581|3556269|FG000|Double-Blind Period|Investigator Decision|1
1990607|NCT00048581|3556270|FG001|Double-Blind Period|Investigator Decision|0
1990608|NCT00048581|3556271|FG002|Double-Blind Period|Investigator Decision|0
1990609|NCT00048581|3556269|FG000|Open-Label Period|Death|0
1990610|NCT00048581|3556270|FG001|Open-Label Period|Death|0
1990611|NCT00048581|3556271|FG002|Open-Label Period|Death|4
1990612|NCT00048581|3556269|FG000|Open-Label Period|Adverse Event|0
1990613|NCT00048581|3556270|FG001|Open-Label Period|Adverse Event|0
1990614|NCT00048581|3556271|FG002|Open-Label Period|Adverse Event|37
1990615|NCT00048581|3556269|FG000|Open-Label Period|Lack of Efficacy|0
1990616|NCT00048581|3556270|FG001|Open-Label Period|Lack of Efficacy|0
1990617|NCT00048581|3556271|FG002|Open-Label Period|Lack of Efficacy|69
1990618|NCT00048581|3556269|FG000|Open-Label Period|Lost to Follow-up|0
1990619|NCT00048581|3556270|FG001|Open-Label Period|Lost to Follow-up|0
1990620|NCT00048581|3556271|FG002|Open-Label Period|Lost to Follow-up|14
1990621|NCT00048581|3556269|FG000|Open-Label Period|Withdrawal by Subject|0
1990622|NCT00048581|3556270|FG001|Open-Label Period|Withdrawal by Subject|0
1990623|NCT00048581|3556271|FG002|Open-Label Period|Withdrawal by Subject|20
1990624|NCT00048581|3556269|FG000|Open-Label Period|No Longer Meets Study Criteria|0
1990625|NCT00048581|3556270|FG001|Open-Label Period|No Longer Meets Study Criteria|0
1990626|NCT00048581|3556271|FG002|Open-Label Period|No Longer Meets Study Criteria|2
1990627|NCT00048581|3556269|FG000|Open-Label Period|Poor/Non-compliance|0
1990628|NCT00048581|3556270|FG001|Open-Label Period|Poor/Non-compliance|0
1990629|NCT00048581|3556271|FG002|Open-Label Period|Poor/Non-compliance|5
1990630|NCT00048581|3556269|FG000|Open-Label Period|Pregnancy|0
1990631|NCT00048581|3556270|FG001|Open-Label Period|Pregnancy|0
1990632|NCT00048581|3556271|FG002|Open-Label Period|Pregnancy|7
1990633|NCT00048581|3556269|FG000|Open-Label Period|Study Site Closure|0
1990634|NCT00048581|3556270|FG001|Open-Label Period|Study Site Closure|0
1990635|NCT00048581|3556271|FG002|Open-Label Period|Study Site Closure|2
1990636|NCT00048581|3556269|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0
1990637|NCT00048581|3556270|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0
1990638|NCT00048581|3556271|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3
1990639|NCT00048581|3556269|FG000|Open-Label Period|Problem With Transportation To Site|0
1990640|NCT00048581|3556270|FG001|Open-Label Period|Problem With Transportation To Site|0
1990641|NCT00048581|3556271|FG002|Open-Label Period|Problem With Transportation To Site|1
1990642|NCT00048581|3556269|FG000|Open-Label Period|Primary Investigator Retired|0
1990643|NCT00048581|3556270|FG001|Open-Label Period|Primary Investigator Retired|0
1990644|NCT00048581|3556271|FG002|Open-Label Period|Primary Investigator Retired|2
1990645|NCT00048581|3556269|FG000|Open-Label Period|Study Ended By Sponsor|0
1990646|NCT00048581|3556270|FG001|Open-Label Period|Study Ended By Sponsor|0
1990647|NCT00048581|3556271|FG002|Open-Label Period|Study Ended By Sponsor|1
1990648|NCT00048724|3556286|FG000|Overall Study|Adverse Event|53
1990649|NCT00048724|3556287|FG001|Overall Study|Adverse Event|12
1990650|NCT00048724|3556286|FG000|Overall Study|Withdrawal by Subject|34
1990651|NCT00048724|3556287|FG001|Overall Study|Withdrawal by Subject|54
1990652|NCT00048724|3556286|FG000|Overall Study|Lost to Follow-up|5
1990653|NCT00048724|3556287|FG001|Overall Study|Lost to Follow-up|5
1990654|NCT00048724|3556286|FG000|Overall Study|Protocol-defined Clinical Event|17
1990655|NCT00048724|3556287|FG001|Overall Study|Protocol-defined Clinical Event|32
1990656|NCT00048724|3556286|FG000|Overall Study|Noncompliance With Protocol|4
1990657|NCT00048724|3556287|FG001|Overall Study|Noncompliance With Protocol|12
1990658|NCT00048724|3556286|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
1990659|NCT00048724|3556287|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
1990660|NCT00048724|3556286|FG000|Overall Study|Administrative|1
1990661|NCT00048724|3556287|FG001|Overall Study|Administrative|1
1990662|NCT00048932|3556316|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1
1990663|NCT00048932|3556317|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0
1990664|NCT00048932|3556318|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0
1990665|NCT00048932|3556316|FG000|Double Blind Period (DB)|Adverse Event|51
1990666|NCT00048932|3556317|FG001|Double Blind Period (DB)|Adverse Event|19
1990667|NCT00048932|3556318|FG002|Double Blind Period (DB)|Adverse Event|0
1990668|NCT00048932|3556316|FG000|Double Blind Period (DB)|Death|5
1990669|NCT00048932|3556317|FG001|Double Blind Period (DB)|Death|3
1990670|NCT00048932|3556318|FG002|Double Blind Period (DB)|Death|0
1990671|NCT00048932|3556316|FG000|Double Blind Period (DB)|Lack of Efficacy|26
1990672|NCT00048932|3556317|FG001|Double Blind Period (DB)|Lack of Efficacy|44
1990673|NCT00048932|3556318|FG002|Double Blind Period (DB)|Lack of Efficacy|0
1990674|NCT00048932|3556316|FG000|Double Blind Period (DB)|Lost to Follow-up|3
1990675|NCT00048932|3556317|FG001|Double Blind Period (DB)|Lost to Follow-up|4
1990676|NCT00048932|3556318|FG002|Double Blind Period (DB)|Lost to Follow-up|0
1990677|NCT00048932|3556316|FG000|Double Blind Period (DB)|Relocation|1
1990678|NCT00048932|3556317|FG001|Double Blind Period (DB)|Relocation|0
1990679|NCT00048932|3556318|FG002|Double Blind Period (DB)|Relocation|0
1990680|NCT00048932|3556316|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0
1990681|NCT00048932|3556317|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1
1990682|NCT00048932|3556318|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0
1990683|NCT00048932|3556316|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
1990684|NCT00048932|3556317|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
1990685|NCT00048932|3556318|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
1990686|NCT00048932|3556316|FG000|Double Blind Period (DB)|Pregnancy|1
1990687|NCT00048932|3556317|FG001|Double Blind Period (DB)|Pregnancy|0
1990688|NCT00048932|3556318|FG002|Double Blind Period (DB)|Pregnancy|0
1990689|NCT00048932|3556316|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8
1990690|NCT00048932|3556317|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2
1990691|NCT00048932|3556318|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0
1990692|NCT00048932|3556316|FG000|Double Blind Period (DB)|Withdrawal by Subject|24
1990693|NCT00048932|3556317|FG001|Double Blind Period (DB)|Withdrawal by Subject|10
1990694|NCT00048932|3556318|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
1990695|NCT00048932|3556316|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2
1990696|NCT00048932|3556317|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4
1990697|NCT00048932|3556318|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0
1990698|NCT00048932|3556316|FG000|Open Label Period (OL)|Death|0
1990699|NCT00048932|3556317|FG001|Open Label Period (OL)|Death|0
1990700|NCT00048932|3556318|FG002|Open Label Period (OL)|Death|25
1990701|NCT00048932|3556316|FG000|Open Label Period (OL)|Adverse Event|0
1990702|NCT00048932|3556317|FG001|Open Label Period (OL)|Adverse Event|0
1990703|NCT00048932|3556318|FG002|Open Label Period (OL)|Adverse Event|103
1990704|NCT00048932|3556316|FG000|Open Label Period (OL)|Lack of Efficacy|0
1990705|NCT00048932|3556317|FG001|Open Label Period (OL)|Lack of Efficacy|0
1990706|NCT00048932|3556318|FG002|Open Label Period (OL)|Lack of Efficacy|81
1990707|NCT00048932|3556316|FG000|Open Label Period (OL)|Lost to Follow-up|0
1990708|NCT00048932|3556317|FG001|Open Label Period (OL)|Lost to Follow-up|0
1990709|NCT00048932|3556318|FG002|Open Label Period (OL)|Lost to Follow-up|27
1990710|NCT00048932|3556316|FG000|Open Label Period (OL)|Withdrawal by Subject|0
1990711|NCT00048932|3556317|FG001|Open Label Period (OL)|Withdrawal by Subject|0
1990712|NCT00048932|3556318|FG002|Open Label Period (OL)|Withdrawal by Subject|117
1990713|NCT00048932|3556316|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0
1990714|NCT00048932|3556317|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0
1990715|NCT00048932|3556318|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5
1990716|NCT00048932|3556316|FG000|Open Label Period (OL)|Poor/Non-Compliance|0
1990717|NCT00048932|3556317|FG001|Open Label Period (OL)|Poor/Non-Compliance|0
1990718|NCT00048932|3556318|FG002|Open Label Period (OL)|Poor/Non-Compliance|13
1990719|NCT00048932|3556316|FG000|Open Label Period (OL)|Pregnancy|0
1990720|NCT00048932|3556317|FG001|Open Label Period (OL)|Pregnancy|0
1990721|NCT00048932|3556318|FG002|Open Label Period (OL)|Pregnancy|6
1990722|NCT00048932|3556316|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0
1990723|NCT00048932|3556317|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0
1990724|NCT00048932|3556318|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20
1990725|NCT00048932|3556316|FG000|Open Label Period (OL)|Investigator Retiring|0
1990726|NCT00048932|3556317|FG001|Open Label Period (OL)|Investigator Retiring|0
1990727|NCT00048932|3556318|FG002|Open Label Period (OL)|Investigator Retiring|2
1990728|NCT00048932|3556316|FG000|Open Label Period (OL)|Participant Transportation Issues|0
1990729|NCT00048932|3556317|FG001|Open Label Period (OL)|Participant Transportation Issues|0
1990730|NCT00048932|3556318|FG002|Open Label Period (OL)|Participant Transportation Issues|1
1990731|NCT00048932|3556316|FG000|Open Label Period (OL)|Participant Relocated|0
1990732|NCT00048932|3556317|FG001|Open Label Period (OL)|Participant Relocated|0
1990733|NCT00048932|3556318|FG002|Open Label Period (OL)|Participant Relocated|6
1990734|NCT00048932|3556316|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0
1990735|NCT00048932|3556317|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0
1990736|NCT00048932|3556318|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1
1990737|NCT00048932|3556316|FG000|Open Label Period (OL)|Site Closure|0
1990738|NCT00048932|3556317|FG001|Open Label Period (OL)|Site Closure|0
1990739|NCT00048932|3556318|FG002|Open Label Period (OL)|Site Closure|3
1990740|NCT00048932|3556316|FG000|Open Label Period (OL)|Trial Terminated|0
1990741|NCT00048932|3556317|FG001|Open Label Period (OL)|Trial Terminated|0
1990742|NCT00048932|3556318|FG002|Open Label Period (OL)|Trial Terminated|1
1990743|NCT00048932|3556316|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0
1990744|NCT00048932|3556317|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0
1990745|NCT00048932|3556318|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1
1990746|NCT00048932|3556316|FG000|Open Label Period (OL)|Patient Decision|0
1990747|NCT00048932|3556317|FG001|Open Label Period (OL)|Patient Decision|0
1990748|NCT00048932|3556318|FG002|Open Label Period (OL)|Patient Decision|4
1990749|NCT00048932|3556316|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0
1990750|NCT00048932|3556317|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0
1990751|NCT00048932|3556318|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1
1990752|NCT00048932|3556316|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0
1990753|NCT00048932|3556317|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0
1990754|NCT00048932|3556318|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2
1990755|NCT00048932|3556316|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0
1990756|NCT00048932|3556317|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0
1990757|NCT00048932|3556318|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5
1990758|NCT00048932|3556316|FG000|Open Label Period (OL)|Medication Lost Efficacy|0
1990759|NCT00048932|3556317|FG001|Open Label Period (OL)|Medication Lost Efficacy|0
1990760|NCT00048932|3556318|FG002|Open Label Period (OL)|Medication Lost Efficacy|1
1990761|NCT00048932|3556316|FG000|Open Label Period (OL)|Investigator Decision|0
1990762|NCT00048932|3556317|FG001|Open Label Period (OL)|Investigator Decision|0
1990763|NCT00048932|3556318|FG002|Open Label Period (OL)|Investigator Decision|4
1990764|NCT00048932|3556316|FG000|Open Label Period (OL)|Site Staff Issues|0
1990765|NCT00048932|3556317|FG001|Open Label Period (OL)|Site Staff Issues|0
1990766|NCT00048932|3556318|FG002|Open Label Period (OL)|Site Staff Issues|2
1990767|NCT00048932|3556316|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0
1990768|NCT00048932|3556317|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0
1990769|NCT00048932|3556318|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9
1990770|NCT00048932|3556316|FG000|Open Label Period (OL)|Participant Surgery|0
1990771|NCT00048932|3556317|FG001|Open Label Period (OL)|Participant Surgery|0
1990772|NCT00048932|3556318|FG002|Open Label Period (OL)|Participant Surgery|1
1990773|NCT00048997|3556329|FG000|Overall Study|Protocol Violation|7
1990774|NCT00048997|3556330|FG001|Overall Study|Protocol Violation|2
1990775|NCT00048997|3556329|FG000|Overall Study|Withdrawal by Subject|6
1990776|NCT00048997|3556330|FG001|Overall Study|Withdrawal by Subject|1
1990777|NCT00049127|3556349|FG000|Overall Study|Withdrawal by Subject|0
1990778|NCT00049127|3556350|FG001|Overall Study|Withdrawal by Subject|0
1990779|NCT00049127|3556351|FG002|Overall Study|Withdrawal by Subject|1
1990780|NCT00049127|3556352|FG003|Overall Study|Withdrawal by Subject|0
1990781|NCT00049127|3556353|FG004|Overall Study|Withdrawal by Subject|0
1990782|NCT00049257|3556365|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10
1990783|NCT00049257|3556365|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1
1990784|NCT00049257|3556365|FG000|Carboplatin, Paclitaxel|Death|2
1990785|NCT00049257|3556365|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4
1990786|NCT00049322|3556371|FG000|Overall Study|disease burden|0
1990787|NCT00049322|3556372|FG001|Overall Study|disease burden|3
1990788|NCT00049322|3556371|FG000|Overall Study|Adverse Event|1
1990789|NCT00049322|3556372|FG001|Overall Study|Adverse Event|0
1990790|NCT00049322|3556371|FG000|Overall Study|refused angio|0
1990791|NCT00049322|3556372|FG001|Overall Study|refused angio|3
1990792|NCT00049517|3556386|FG000|Induction|Disease progression|0
1990793|NCT00049517|3556387|FG001|Induction|Disease progression|0
1990794|NCT00049517|3556388|FG002|Induction|Disease progression|0
1990795|NCT00049517|3556389|FG003|Induction|Disease progression|0
1990796|NCT00049517|3556390|FG004|Induction|Disease progression|18
1990797|NCT00049517|3556391|FG005|Induction|Disease progression|11
1990798|NCT00049517|3556386|FG000|Induction|Adverse Event|0
1990799|NCT00049517|3556387|FG001|Induction|Adverse Event|0
1990800|NCT00049517|3556388|FG002|Induction|Adverse Event|0
1990801|NCT00049517|3556389|FG003|Induction|Adverse Event|0
1990802|NCT00049517|3556390|FG004|Induction|Adverse Event|5
1990803|NCT00049517|3556391|FG005|Induction|Adverse Event|7
1990804|NCT00049517|3556386|FG000|Induction|Death|0
1990805|NCT00049517|3556387|FG001|Induction|Death|0
1990806|NCT00049517|3556388|FG002|Induction|Death|0
1990807|NCT00049517|3556389|FG003|Induction|Death|0
1990808|NCT00049517|3556390|FG004|Induction|Death|9
1990809|NCT00049517|3556391|FG005|Induction|Death|6
1990810|NCT00049517|3556386|FG000|Induction|Withdrawal by Subject|0
1990811|NCT00049517|3556387|FG001|Induction|Withdrawal by Subject|0
1990812|NCT00049517|3556388|FG002|Induction|Withdrawal by Subject|0
1990813|NCT00049517|3556389|FG003|Induction|Withdrawal by Subject|0
1990814|NCT00049517|3556390|FG004|Induction|Withdrawal by Subject|1
1990815|NCT00049517|3556391|FG005|Induction|Withdrawal by Subject|3
1990816|NCT00049517|3556386|FG000|Induction|Alternative therapy|0
1990817|NCT00049517|3556387|FG001|Induction|Alternative therapy|0
1990818|NCT00049517|3556388|FG002|Induction|Alternative therapy|0
1990819|NCT00049517|3556389|FG003|Induction|Alternative therapy|0
1990820|NCT00049517|3556390|FG004|Induction|Alternative therapy|2
1990821|NCT00049517|3556391|FG005|Induction|Alternative therapy|2
1990822|NCT00049517|3556386|FG000|Induction|Other complicating disease|0
1990823|NCT00049517|3556387|FG001|Induction|Other complicating disease|0
1990824|NCT00049517|3556388|FG002|Induction|Other complicating disease|0
1990825|NCT00049517|3556389|FG003|Induction|Other complicating disease|0
1990826|NCT00049517|3556390|FG004|Induction|Other complicating disease|3
1990827|NCT00049517|3556391|FG005|Induction|Other complicating disease|0
1990828|NCT00049517|3556386|FG000|Induction|Reasons not reported|0
1990829|NCT00049517|3556387|FG001|Induction|Reasons not reported|0
1990830|NCT00049517|3556388|FG002|Induction|Reasons not reported|0
1990831|NCT00049517|3556389|FG003|Induction|Reasons not reported|0
1990832|NCT00049517|3556390|FG004|Induction|Reasons not reported|22
1990833|NCT00049517|3556391|FG005|Induction|Reasons not reported|25
1990834|NCT00049517|3556386|FG000|Conditioning/Transplant|Disease progression|14
1990835|NCT00049517|3556387|FG001|Conditioning/Transplant|Disease progression|6
1990836|NCT00049517|3556388|FG002|Conditioning/Transplant|Disease progression|10
1990837|NCT00049517|3556389|FG003|Conditioning/Transplant|Disease progression|6
1990838|NCT00049517|3556390|FG004|Conditioning/Transplant|Disease progression|0
1990839|NCT00049517|3556391|FG005|Conditioning/Transplant|Disease progression|0
1990840|NCT00049517|3556386|FG000|Conditioning/Transplant|Adverse Event|2
1990841|NCT00049517|3556387|FG001|Conditioning/Transplant|Adverse Event|1
1990842|NCT00049517|3556388|FG002|Conditioning/Transplant|Adverse Event|4
1990843|NCT00049517|3556389|FG003|Conditioning/Transplant|Adverse Event|8
1990844|NCT00049517|3556390|FG004|Conditioning/Transplant|Adverse Event|0
1990845|NCT00049517|3556391|FG005|Conditioning/Transplant|Adverse Event|0
1990846|NCT00049517|3556386|FG000|Conditioning/Transplant|Death|1
1990847|NCT00049517|3556387|FG001|Conditioning/Transplant|Death|0
1990848|NCT00049517|3556388|FG002|Conditioning/Transplant|Death|0
1990849|NCT00049517|3556389|FG003|Conditioning/Transplant|Death|2
1990850|NCT00049517|3556390|FG004|Conditioning/Transplant|Death|0
1990851|NCT00049517|3556391|FG005|Conditioning/Transplant|Death|0
1990852|NCT00049517|3556386|FG000|Conditioning/Transplant|Withdrawal by Subject|4
1990853|NCT00049517|3556387|FG001|Conditioning/Transplant|Withdrawal by Subject|8
1990854|NCT00049517|3556388|FG002|Conditioning/Transplant|Withdrawal by Subject|4
1990855|NCT00049517|3556389|FG003|Conditioning/Transplant|Withdrawal by Subject|7
1990856|NCT00049517|3556390|FG004|Conditioning/Transplant|Withdrawal by Subject|0
1990857|NCT00049517|3556391|FG005|Conditioning/Transplant|Withdrawal by Subject|0
1990858|NCT00049517|3556386|FG000|Conditioning/Transplant|Alternative therapy|4
1990859|NCT00049517|3556387|FG001|Conditioning/Transplant|Alternative therapy|4
1990860|NCT00049517|3556388|FG002|Conditioning/Transplant|Alternative therapy|2
1990861|NCT00049517|3556389|FG003|Conditioning/Transplant|Alternative therapy|1
1990862|NCT00049517|3556390|FG004|Conditioning/Transplant|Alternative therapy|1
1990863|NCT00049517|3556391|FG005|Conditioning/Transplant|Alternative therapy|0
1990864|NCT00049517|3556386|FG000|Conditioning/Transplant|Other complicating disease|2
1990865|NCT00049517|3556387|FG001|Conditioning/Transplant|Other complicating disease|0
1990866|NCT00049517|3556388|FG002|Conditioning/Transplant|Other complicating disease|0
1990867|NCT00049517|3556389|FG003|Conditioning/Transplant|Other complicating disease|4
1990868|NCT00049517|3556390|FG004|Conditioning/Transplant|Other complicating disease|0
1990869|NCT00049517|3556391|FG005|Conditioning/Transplant|Other complicating disease|1
1990870|NCT00049517|3556386|FG000|Conditioning/Transplant|Reasons not reported|25
1990871|NCT00049517|3556387|FG001|Conditioning/Transplant|Reasons not reported|31
1990872|NCT00049517|3556388|FG002|Conditioning/Transplant|Reasons not reported|18
1990873|NCT00049517|3556389|FG003|Conditioning/Transplant|Reasons not reported|15
1990874|NCT00049517|3556390|FG004|Conditioning/Transplant|Reasons not reported|5
1990875|NCT00049517|3556391|FG005|Conditioning/Transplant|Reasons not reported|5
1990876|NCT00049530|3556399|FG000|Overall Study|Lack of Efficacy|25
1990877|NCT00049530|3556399|FG000|Overall Study|Adverse Event|2
1990878|NCT00049530|3556399|FG000|Overall Study|Death|1
1990879|NCT00049530|3556399|FG000|Overall Study|symptomatic deterioration|1
1990880|NCT00049530|3556399|FG000|Overall Study|ineligible|3
1990881|NCT00049543|3556405|FG000|Overall Study|still on treatment|2
1990882|NCT00049543|3556406|FG001|Overall Study|still on treatment|9
1990883|NCT00049673|3556414|FG000|Overall Study|No receive treatment/lost to follow-up|1
1990884|NCT00049673|3556415|FG001|Overall Study|No receive treatment/lost to follow-up|3
1990885|NCT00049842|3556423|FG000|Treatment Phase|Adverse Event|47
1990886|NCT00049842|3556424|FG001|Treatment Phase|Adverse Event|12
1990887|NCT00049842|3556423|FG000|Treatment Phase|Withdrawal by Subject|35
1990888|NCT00049842|3556424|FG001|Treatment Phase|Withdrawal by Subject|46
1990889|NCT00049842|3556423|FG000|Treatment Phase|Non-compliance with protocol|7
1990890|NCT00049842|3556424|FG001|Treatment Phase|Non-compliance with protocol|8
1990891|NCT00049842|3556423|FG000|Treatment Phase|Lost to Follow-up|4
1990892|NCT00049842|3556424|FG001|Treatment Phase|Lost to Follow-up|8
1990893|NCT00049842|3556423|FG000|Treatment Phase|Administrative|0
1990894|NCT00049842|3556424|FG001|Treatment Phase|Administrative|3
1990895|NCT00049842|3556423|FG000|Treatment Phase|Did not meet protocol eligibility|0
1990896|NCT00049842|3556424|FG001|Treatment Phase|Did not meet protocol eligibility|1
1990897|NCT00049842|3556423|FG000|Follow-up Phase|Adverse Event|6
1990898|NCT00049842|3556424|FG001|Follow-up Phase|Adverse Event|1
1990899|NCT00049842|3556423|FG000|Follow-up Phase|Other|1
1990900|NCT00049842|3556424|FG001|Follow-up Phase|Other|4
1990901|NCT00050011|3556432|FG000|Overall Study|Adverse Event|41
1990902|NCT00050011|3556433|FG001|Overall Study|Adverse Event|46
1990903|NCT00050011|3556432|FG000|Overall Study|Abnormal laboratory value(s)|1
1990904|NCT00050011|3556433|FG001|Overall Study|Abnormal laboratory value(s)|1
1990905|NCT00050011|3556432|FG000|Overall Study|Abnormal test procedure results|0
1990906|NCT00050011|3556433|FG001|Overall Study|Abnormal test procedure results|1
1990907|NCT00050011|3556432|FG000|Overall Study|Lack of Efficacy|16
1990908|NCT00050011|3556433|FG001|Overall Study|Lack of Efficacy|21
1990909|NCT00050011|3556432|FG000|Overall Study|Participant condition no longer required|1
1990910|NCT00050011|3556433|FG001|Overall Study|Participant condition no longer required|0
1990911|NCT00050011|3556432|FG000|Overall Study|Protocol Violation|4
1990912|NCT00050011|3556433|FG001|Overall Study|Protocol Violation|10
1990913|NCT00050011|3556432|FG000|Overall Study|Withdrawal by Subject|34
1990914|NCT00050011|3556433|FG001|Overall Study|Withdrawal by Subject|26
1990915|NCT00050011|3556432|FG000|Overall Study|Lost to Follow-up|7
1990916|NCT00050011|3556433|FG001|Overall Study|Lost to Follow-up|9
1990917|NCT00050011|3556432|FG000|Overall Study|Administrative problems|10
1990918|NCT00050011|3556433|FG001|Overall Study|Administrative problems|6
1990919|NCT00050011|3556432|FG000|Overall Study|Death|7
1990920|NCT00050011|3556433|FG001|Overall Study|Death|4
1990921|NCT00050011|3556432|FG000|Overall Study|Unknown - Reason is missing|0
1990922|NCT00050011|3556433|FG001|Overall Study|Unknown - Reason is missing|2
1990923|NCT00050167|3556463|FG000|Overall Study|not eligible not invasive|1
1990924|NCT00050167|3556464|FG001|Overall Study|not eligible not invasive|1
1990925|NCT00050622|3556470|FG000|Overall Study|Adverse Event|1
1990926|NCT00050778|3556497|FG000|Overall Study|Adverse Event|13
1990927|NCT00050778|3556498|FG001|Overall Study|Adverse Event|3
1990928|NCT00050778|3556499|FG002|Overall Study|Adverse Event|2
1990929|NCT00050778|3556497|FG000|Overall Study|Death|0
1990930|NCT00050778|3556498|FG001|Overall Study|Death|1
1990931|NCT00050778|3556499|FG002|Overall Study|Death|1
1990932|NCT00050778|3556497|FG000|Overall Study|Lack of Efficacy|16
1990933|NCT00050778|3556498|FG001|Overall Study|Lack of Efficacy|2
1990934|NCT00050778|3556499|FG002|Overall Study|Lack of Efficacy|2
1990935|NCT00050778|3556497|FG000|Overall Study|Lost to Follow-up|0
1990936|NCT00050778|3556498|FG001|Overall Study|Lost to Follow-up|2
1990937|NCT00050778|3556499|FG002|Overall Study|Lost to Follow-up|4
1990938|NCT00050778|3556497|FG000|Overall Study|Physician Decision|3
1990939|NCT00050778|3556498|FG001|Overall Study|Physician Decision|0
1990940|NCT00050778|3556499|FG002|Overall Study|Physician Decision|2
1990941|NCT00050778|3556497|FG000|Overall Study|Protocol Violation|2
1990942|NCT00050778|3556498|FG001|Overall Study|Protocol Violation|0
1990943|NCT00050778|3556499|FG002|Overall Study|Protocol Violation|1
1990944|NCT00050778|3556497|FG000|Overall Study|Withdrawal by Subject|6
1990945|NCT00050778|3556498|FG001|Overall Study|Withdrawal by Subject|8
1990946|NCT00050778|3556499|FG002|Overall Study|Withdrawal by Subject|4
1990947|NCT00050778|3556497|FG000|Overall Study|Randomized but not treated|4
1990948|NCT00050778|3556498|FG001|Overall Study|Randomized but not treated|5
1990949|NCT00050778|3556499|FG002|Overall Study|Randomized but not treated|2
1990950|NCT00050778|3556497|FG000|Overall Study|Familial and personal reasons|1
1990951|NCT00050778|3556498|FG001|Overall Study|Familial and personal reasons|0
1990952|NCT00050778|3556499|FG002|Overall Study|Familial and personal reasons|0
1990953|NCT00050960|3556511|FG000|Overall Study|Progressive Disease|137
1990954|NCT00050960|3556512|FG001|Overall Study|Progressive Disease|93
1990955|NCT00050960|3556511|FG000|Overall Study|Stable Disease|19
1990956|NCT00050960|3556512|FG001|Overall Study|Stable Disease|48
1990957|NCT00050960|3556511|FG000|Overall Study|Partial Response|14
1990958|NCT00050960|3556512|FG001|Overall Study|Partial Response|19
1990959|NCT00050960|3556511|FG000|Overall Study|Complete Response|0
1990960|NCT00050960|3556512|FG001|Overall Study|Complete Response|2
1990961|NCT00050960|3556511|FG000|Overall Study|Adverse Event|62
1990962|NCT00050960|3556512|FG001|Overall Study|Adverse Event|61
1990963|NCT00050960|3556511|FG000|Overall Study|Lost to Follow-up|0
1990964|NCT00050960|3556512|FG001|Overall Study|Lost to Follow-up|1
1990965|NCT00050960|3556511|FG000|Overall Study|Withdrawal by Subject|23
1990966|NCT00050960|3556512|FG001|Overall Study|Withdrawal by Subject|18
1990967|NCT00050960|3556511|FG000|Overall Study|Administrative|31
1990968|NCT00050960|3556512|FG001|Overall Study|Administrative|46
1990969|NCT00050960|3556511|FG000|Overall Study|Non-compliance|3
1990970|NCT00050960|3556512|FG001|Overall Study|Non-compliance|1
1990971|NCT00050960|3556511|FG000|Overall Study|Death|13
1990972|NCT00050960|3556512|FG001|Overall Study|Death|15
1990973|NCT00051025|3556524|FG000|Overall Study|Progressive Disease|1
1990974|NCT00051025|3556525|FG001|Overall Study|Progressive Disease|1
1990975|NCT00051025|3556524|FG000|Overall Study|Adverse Event|1
1990976|NCT00051025|3556525|FG001|Overall Study|Adverse Event|1
1990977|NCT00051025|3556524|FG000|Overall Study|Withdrawal by Subject|0
1990978|NCT00051025|3556525|FG001|Overall Study|Withdrawal by Subject|1
1990979|NCT00051025|3556524|FG000|Overall Study|Death|0
1990980|NCT00051025|3556525|FG001|Overall Study|Death|1
1990981|NCT00051311|3556537|FG000|Overall Study|Starting new study|0
1990982|NCT00051311|3556538|FG001|Overall Study|Starting new study|1
1990983|NCT00051311|3556537|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0
1990984|NCT00051311|3556538|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1
1990985|NCT00051311|3556537|FG000|Overall Study|Death of recipient|8
1990986|NCT00051311|3556538|FG001|Overall Study|Death of recipient|8
1990987|NCT00051311|3556537|FG000|Overall Study|Recipient taken off study|4
1990988|NCT00051311|3556538|FG001|Overall Study|Recipient taken off study|4
1990989|NCT00051363|3556544|FG000|Overall Study|Dropped Post-Rand for Any Reason|102
1990990|NCT00051363|3556545|FG001|Overall Study|Dropped Post-Rand for Any Reason|126
1990991|NCT00051363|3556544|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9
2213543|NCT01681004|3855356|FG001|Study Completion|Lost to Follow-up|3
2213544|NCT01681004|3855355|FG000|Study Completion|Physician Decision|1
2213545|NCT01681004|3855356|FG001|Study Completion|Physician Decision|3
2213546|NCT01681004|3855355|FG000|Study Completion|Site Termination|2
2213547|NCT01681004|3855356|FG001|Study Completion|Site Termination|1
2213548|NCT01681004|3855355|FG000|Study Completion|Death|1
2213549|NCT01681004|3855356|FG001|Study Completion|Death|1
2213550|NCT01681069|3855381|FG000|Overall Study|Withdrawal by Subject|4
2213551|NCT01681069|3855382|FG001|Overall Study|Withdrawal by Subject|5
2213552|NCT01681069|3855381|FG000|Overall Study|Protocol Violation|1
2213553|NCT01681069|3855382|FG001|Overall Study|Protocol Violation|1
2213554|NCT01681069|3855381|FG000|Overall Study|Adverse Event|0
2213555|NCT01681069|3855382|FG001|Overall Study|Adverse Event|1
2213556|NCT01681186|3855416|FG000|Washout Period From Second Intervention|Adverse Event|0
2213557|NCT01681186|3855417|FG001|Washout Period From Second Intervention|Adverse Event|0
2213558|NCT01681186|3855418|FG002|Washout Period From Second Intervention|Adverse Event|0
2213559|NCT01681186|3855419|FG003|Washout Period From Second Intervention|Adverse Event|0
1990992|NCT00051363|3556545|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11
1990993|NCT00051363|3556544|FG000|Overall Study|Death|2
1990994|NCT00051363|3556545|FG001|Overall Study|Death|2
1990995|NCT00051363|3556544|FG000|Overall Study|Excluded Pre-Randomization|2
1990996|NCT00051363|3556545|FG001|Overall Study|Excluded Pre-Randomization|5
1990997|NCT00051558|3556553|FG000|Overall Study|Adverse Event|30
1990998|NCT00051558|3556554|FG001|Overall Study|Adverse Event|18
1990999|NCT00051558|3556553|FG000|Overall Study|Withdrawal by Subject|29
1991000|NCT00051558|3556554|FG001|Overall Study|Withdrawal by Subject|42
1991001|NCT00051558|3556553|FG000|Overall Study|Death|9
1991002|NCT00051558|3556554|FG001|Overall Study|Death|15
1991003|NCT00051558|3556553|FG000|Overall Study|Lost to Follow-up|4
2108217|NCT00878722|3702054|FG005|Overall Study|Relapse|0
1991004|NCT00051558|3556554|FG001|Overall Study|Lost to Follow-up|13
1991005|NCT00051558|3556553|FG000|Overall Study|Protocol Violation|3
1991006|NCT00051558|3556554|FG001|Overall Study|Protocol Violation|4
1991007|NCT00051558|3556553|FG000|Overall Study|Protocol Entry Criteria Unmet|1
1991008|NCT00051558|3556554|FG001|Overall Study|Protocol Entry Criteria Unmet|2
1991009|NCT00051558|3556553|FG000|Overall Study|Sponsor Decision|6
1991010|NCT00051558|3556554|FG001|Overall Study|Sponsor Decision|1
2213560|NCT01681186|3855420|FG004|Washout Period From Second Intervention|Adverse Event|0
2217552|NCT01708954|3860856|FG002|Step 2|Disease progression|0
1991011|NCT00051558|3556553|FG000|Overall Study|Other|2
1991012|NCT00051558|3556554|FG001|Overall Study|Other|1
1991013|NCT00051558|3556553|FG000|Overall Study|Significant Lab Value|2
1991014|NCT00051558|3556554|FG001|Overall Study|Significant Lab Value|0
1991015|NCT00051558|3556553|FG000|Overall Study|Physician Decision|5
1991016|NCT00051558|3556554|FG001|Overall Study|Physician Decision|0
1991017|NCT00051636|3556562|FG000|Period 1 - Core|Adverse Event|2
1991018|NCT00051636|3556563|FG001|Period 1 - Core|Adverse Event|2
1991019|NCT00051636|3556562|FG000|Period 1 - Core|Protocol Violation|1
1991020|NCT00051636|3556563|FG001|Period 1 - Core|Protocol Violation|0
1991021|NCT00051636|3556562|FG000|Period 1 - Core|Withdrawal by Subject|1
1991022|NCT00051636|3556563|FG001|Period 1 - Core|Withdrawal by Subject|2
1991023|NCT00051636|3556562|FG000|Period 1 - Core|Lost to Follow-up|0
1991024|NCT00051636|3556563|FG001|Period 1 - Core|Lost to Follow-up|2
1991025|NCT00051636|3556562|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5
1991026|NCT00051636|3556563|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4
1991027|NCT00051636|3556562|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
1991028|NCT00051636|3556563|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
1991029|NCT00051636|3556562|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
1991030|NCT00051636|3556563|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
1991031|NCT00051636|3556562|FG000|Period 2- Extended Observation Period|Death|4
1991032|NCT00051636|3556563|FG001|Period 2- Extended Observation Period|Death|5
1991033|NCT00051636|3556562|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
1991034|NCT00051636|3556563|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
1991035|NCT00052715|3556611|FG000|Overall Study|wrong histology|1
1991036|NCT00052962|3556626|FG000|Overall Study|Not evaluable|0
1991037|NCT00052962|3556627|FG001|Overall Study|Not evaluable|2
1991038|NCT00052962|3556626|FG000|Overall Study|Not randomized/not evaluable|1
1991039|NCT00052962|3556627|FG001|Overall Study|Not randomized/not evaluable|0
1991040|NCT00053352|3556639|FG000|Overall Study|Lost to Follow-up|0
1991041|NCT00053352|3556640|FG001|Overall Study|Lost to Follow-up|1
1991042|NCT00053352|3556639|FG000|Overall Study|Physician Decision|11
1991043|NCT00053352|3556640|FG001|Overall Study|Physician Decision|1
1991044|NCT00053352|3556639|FG000|Overall Study|Withdrawal by Subject|1
1991045|NCT00053352|3556640|FG001|Overall Study|Withdrawal by Subject|0
1991046|NCT00053352|3556639|FG000|Overall Study|Ineligible|8
1991047|NCT00053352|3556640|FG001|Overall Study|Ineligible|8
1991048|NCT00053352|3556639|FG000|Overall Study|Disease at new site|1
1991049|NCT00053352|3556640|FG001|Overall Study|Disease at new site|0
1991050|NCT00053365|3556647|FG000|Overall Study|Incorrect cell type|1
1991051|NCT00053365|3556647|FG000|Overall Study|Platinum-sensitive interval >12 months|1
1991052|NCT00053365|3556647|FG000|Overall Study|Never treated|4
1991053|NCT00053417|3556657|FG000|Overall Study|Adverse Event|1
1991054|NCT00053417|3556658|FG001|Overall Study|Adverse Event|0
1991055|NCT00053417|3556659|FG002|Overall Study|Adverse Event|1
1991056|NCT00053417|3556660|FG003|Overall Study|Adverse Event|5
1991057|NCT00053417|3556657|FG000|Overall Study|Non-Compliance|0
1991058|NCT00053417|3556658|FG001|Overall Study|Non-Compliance|0
1991059|NCT00053417|3556659|FG002|Overall Study|Non-Compliance|0
1991060|NCT00053417|3556660|FG003|Overall Study|Non-Compliance|1
1991061|NCT00053417|3556657|FG000|Overall Study|Withdrawal by Subject|0
1991062|NCT00053417|3556658|FG001|Overall Study|Withdrawal by Subject|1
1991063|NCT00053417|3556659|FG002|Overall Study|Withdrawal by Subject|0
1991064|NCT00053417|3556660|FG003|Overall Study|Withdrawal by Subject|0
1991065|NCT00053417|3556657|FG000|Overall Study|Lost to Follow-up|1
1991066|NCT00053417|3556658|FG001|Overall Study|Lost to Follow-up|1
1991067|NCT00053417|3556659|FG002|Overall Study|Lost to Follow-up|0
1991068|NCT00053417|3556660|FG003|Overall Study|Lost to Follow-up|0
1991069|NCT00053846|3556736|FG000|Overall Study|Changed mind|8
1991070|NCT00053846|3556737|FG001|Overall Study|Changed mind|13
1991071|NCT00053846|3556736|FG000|Overall Study|Became too ill|8
1991072|NCT00053846|3556737|FG001|Overall Study|Became too ill|7
1991073|NCT00053846|3556736|FG000|Overall Study|Expired|5
1991074|NCT00053846|3556737|FG001|Overall Study|Expired|0
1991075|NCT00053846|3556736|FG000|Overall Study|Became ineligible|3
1991076|NCT00053846|3556737|FG001|Overall Study|Became ineligible|1
1991077|NCT00053846|3556736|FG000|Overall Study|Did not return data|1
1991078|NCT00053846|3556737|FG001|Overall Study|Did not return data|2
1991079|NCT00053846|3556736|FG000|Overall Study|Quit due to side effects|1
1991080|NCT00053846|3556737|FG001|Overall Study|Quit due to side effects|3
1991081|NCT00053846|3556736|FG000|Overall Study|Pills too large|0
1991082|NCT00053846|3556737|FG001|Overall Study|Pills too large|1
1991083|NCT00053898|3556745|FG000|Overall Study|No follow-up data from any source|9
1991084|NCT00053898|3556746|FG001|Overall Study|No follow-up data from any source|12
1991085|NCT00053898|3556745|FG000|Overall Study|Follow-up from telephone contact only|5
1991086|NCT00053898|3556746|FG001|Overall Study|Follow-up from telephone contact only|1
1991087|NCT00054132|3556763|FG000|Overall Study|Not Treated|1
1991088|NCT00054275|3556768|FG000|Overall Study|Withdrawal by Subject|4
1991089|NCT00054275|3556768|FG000|Overall Study|Adverse Event|5
1991090|NCT00054275|3556768|FG000|Overall Study|Progressive disease in cycle 1|1
1991091|NCT00054275|3556768|FG000|Overall Study|Physician Decision|1
1991092|NCT00054327|3556778|FG000|Overall Study|Engraftment failure|1
1991093|NCT00054327|3556779|FG001|Overall Study|Engraftment failure|0
1991094|NCT00054327|3556780|FG002|Overall Study|Engraftment failure|0
1991095|NCT00054327|3556781|FG003|Overall Study|Engraftment failure|0
1991096|NCT00054327|3556782|FG004|Overall Study|Engraftment failure|0
1991097|NCT00054327|3556783|FG005|Overall Study|Engraftment failure|0
1991098|NCT00054639|3556810|FG000|Overall Study|Lack of Efficacy|1
1991099|NCT00054639|3556810|FG000|Overall Study|Physician Decision|1
1991100|NCT00054691|3556823|FG000|Overall Study|Unmeasurable Disease|2
1991101|NCT00054691|3556823|FG000|Overall Study|Noncompliant|1
1991102|NCT00054704|3556829|FG000|Overall Study|Lack of Efficacy|2
1991103|NCT00054704|3556830|FG001|Overall Study|Lack of Efficacy|3
1991104|NCT00054704|3556829|FG000|Overall Study|Adverse Event|3
1991105|NCT00054704|3556830|FG001|Overall Study|Adverse Event|1
1991106|NCT00054704|3556829|FG000|Overall Study|Lost to Follow-up|0
1991107|NCT00054704|3556830|FG001|Overall Study|Lost to Follow-up|1
1991108|NCT00054717|3556838|FG000|Overall Study|Randomized but not treated|2
1991109|NCT00054717|3556839|FG001|Overall Study|Randomized but not treated|8
1991110|NCT00054717|3556838|FG000|Overall Study|Adverse Event|70
1991111|NCT00054717|3556839|FG001|Overall Study|Adverse Event|22
1991112|NCT00054717|3556838|FG000|Overall Study|Protocol Violation|18
1991113|NCT00054717|3556839|FG001|Overall Study|Protocol Violation|19
1991114|NCT00054717|3556838|FG000|Overall Study|Lost to Follow-up|23
1991115|NCT00054717|3556839|FG001|Overall Study|Lost to Follow-up|13
1991116|NCT00054717|3556838|FG000|Overall Study|Withdrawal by Subject|32
1991117|NCT00054717|3556839|FG001|Overall Study|Withdrawal by Subject|20
1991118|NCT00054717|3556838|FG000|Overall Study|Other reason not defined above|117
1991119|NCT00054717|3556839|FG001|Overall Study|Other reason not defined above|217
1991120|NCT00055471|3556873|FG000|Period 1: Dose Escalation Period|Adverse Event|0
1991121|NCT00055471|3556874|FG001|Period 1: Dose Escalation Period|Adverse Event|1
1991122|NCT00055471|3556875|FG002|Period 1: Dose Escalation Period|Adverse Event|2
1991123|NCT00055471|3556873|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
1991124|NCT00055471|3556874|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
1991125|NCT00055471|3556875|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
1991126|NCT00055471|3556873|FG000|Period 1: Dose Escalation Period|Disease progression|0
1991127|NCT00055471|3556874|FG001|Period 1: Dose Escalation Period|Disease progression|1
1991128|NCT00055471|3556875|FG002|Period 1: Dose Escalation Period|Disease progression|0
1991129|NCT00055497|3556887|FG000|Overall Study|Adverse Event|1
1991130|NCT00055497|3556888|FG001|Overall Study|Adverse Event|1
1991131|NCT00055497|3556889|FG002|Overall Study|Adverse Event|1
1991132|NCT00055497|3556890|FG003|Overall Study|Adverse Event|28
1991133|NCT00055497|3556887|FG000|Overall Study|Withdrawal by Subject|3
1991134|NCT00055497|3556888|FG001|Overall Study|Withdrawal by Subject|1
1991135|NCT00055497|3556889|FG002|Overall Study|Withdrawal by Subject|1
1991136|NCT00055497|3556890|FG003|Overall Study|Withdrawal by Subject|15
1991137|NCT00055497|3556887|FG000|Overall Study|Lost to Follow-up|0
1991138|NCT00055497|3556888|FG001|Overall Study|Lost to Follow-up|1
1991139|NCT00055497|3556889|FG002|Overall Study|Lost to Follow-up|0
1991140|NCT00055497|3556890|FG003|Overall Study|Lost to Follow-up|5
1991141|NCT00055497|3556887|FG000|Overall Study|Protocol Violation|0
1991142|NCT00055497|3556888|FG001|Overall Study|Protocol Violation|0
1991143|NCT00055497|3556889|FG002|Overall Study|Protocol Violation|0
1991144|NCT00055497|3556890|FG003|Overall Study|Protocol Violation|3
1991145|NCT00055497|3556887|FG000|Overall Study|Lack of Efficacy|1
1991146|NCT00055497|3556888|FG001|Overall Study|Lack of Efficacy|0
1991147|NCT00055497|3556889|FG002|Overall Study|Lack of Efficacy|0
1991148|NCT00055497|3556890|FG003|Overall Study|Lack of Efficacy|27
1991149|NCT00055497|3556887|FG000|Overall Study|Administrative Reasons|0
1991150|NCT00055497|3556888|FG001|Overall Study|Administrative Reasons|0
1991151|NCT00055497|3556889|FG002|Overall Study|Administrative Reasons|0
1991152|NCT00055497|3556890|FG003|Overall Study|Administrative Reasons|1
1991153|NCT00055497|3556887|FG000|Overall Study|Other|0
1991154|NCT00055497|3556888|FG001|Overall Study|Other|0
1991155|NCT00055497|3556889|FG002|Overall Study|Other|0
1991156|NCT00055497|3556890|FG003|Overall Study|Other|11
1991157|NCT00055601|3556907|FG000|Overall Study|Protocol Violation|1
1991158|NCT00055601|3556908|FG001|Overall Study|Protocol Violation|1
1991159|NCT00055601|3556907|FG000|Overall Study|No protocol treatment received|1
1991160|NCT00055601|3556908|FG001|Overall Study|No protocol treatment received|1
1991161|NCT00056160|3556922|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35
1991162|NCT00056160|3556923|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18
1991163|NCT00056160|3556922|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57
1991164|NCT00056160|3556923|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124
1991165|NCT00056160|3556922|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
1991166|NCT00056160|3556923|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
1991167|NCT00056160|3556922|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
1991168|NCT00056160|3556923|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
1991169|NCT00056160|3556922|FG000|Up to Unblinding (07 Jun 2005)|Death|2
1991170|NCT00056160|3556923|FG001|Up to Unblinding (07 Jun 2005)|Death|1
1991171|NCT00056160|3556922|FG000|Up to Unblinding (07 Jun 2005)|Other|8
1991172|NCT00056160|3556923|FG001|Up to Unblinding (07 Jun 2005)|Other|7
1991173|NCT00056160|3556922|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
2024515|NCT00334815|3592998|FG001|Overall Study|Adverse Event|2
1991174|NCT00056160|3556923|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
1991175|NCT00056160|3556922|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
1991176|NCT00056160|3556923|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
1991177|NCT00056160|3556922|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
1991178|NCT00056160|3556923|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
1991179|NCT00056160|3556922|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
1991180|NCT00056160|3556923|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
1991181|NCT00056160|3556922|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
1991182|NCT00056160|3556923|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
1991183|NCT00056160|3556922|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
1991184|NCT00056160|3556923|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
1991185|NCT00056160|3556922|FG000|Final Follow-up|Transferred into expanded access study.|3
1991186|NCT00056160|3556923|FG001|Final Follow-up|Transferred into expanded access study.|0
1991187|NCT00056160|3556922|FG000|Final Follow-up|Transferred into RevAssist Program|2
1991188|NCT00056160|3556923|FG001|Final Follow-up|Transferred into RevAssist Program|0
1991189|NCT00056160|3556922|FG000|Final Follow-up|Adverse Event|1
1991190|NCT00056160|3556923|FG001|Final Follow-up|Adverse Event|0
1991191|NCT00056316|3556931|FG000|Overall Study|Withdrawal by Subject|2
1991192|NCT00056316|3556932|FG001|Overall Study|Withdrawal by Subject|2
1991193|NCT00056316|3556931|FG000|Overall Study|Death/NH placement of pt|1
1991194|NCT00056316|3556932|FG001|Overall Study|Death/NH placement of pt|1
1991195|NCT00056407|3556940|FG000|Overall Study|Adverse Event|282
1991196|NCT00056407|3556941|FG001|Overall Study|Adverse Event|364
1991197|NCT00056407|3556940|FG000|Overall Study|Withdrawal by Subject|377
1991198|NCT00056407|3556941|FG001|Overall Study|Withdrawal by Subject|361
1991199|NCT00056407|3556940|FG000|Overall Study|Lost to Follow-up|123
1991200|NCT00056407|3556941|FG001|Overall Study|Lost to Follow-up|113
1991201|NCT00056407|3556940|FG000|Overall Study|Protocol Violation|104
1991202|NCT00056407|3556941|FG001|Overall Study|Protocol Violation|95
1991203|NCT00056407|3556940|FG000|Overall Study|Diagnosed with Prostate Cancer|202
1991204|NCT00056407|3556941|FG001|Overall Study|Diagnosed with Prostate Cancer|166
1991205|NCT00056407|3556940|FG000|Overall Study|"Listed as Other on Case Report Form"|98
1991206|NCT00056407|3556941|FG001|Overall Study|"Listed as Other on Case Report Form"|60
1991207|NCT00056407|3556940|FG000|Overall Study|Missing|25
1991208|NCT00056407|3556941|FG001|Overall Study|Missing|34
1991209|NCT00056862|3556981|FG000|Overall Study|Protocol Violation|1
1991210|NCT00056862|3556982|FG001|Overall Study|Protocol Violation|0
1991211|NCT00057330|3556990|FG000|Overall Study|Adverse Event|9
1991212|NCT00057330|3556991|FG001|Overall Study|Adverse Event|12
1991213|NCT00057330|3556990|FG000|Overall Study|Death|1
1991214|NCT00057330|3556991|FG001|Overall Study|Death|0
1991215|NCT00057330|3556990|FG000|Overall Study|Protocol Violation|1
1991216|NCT00057330|3556991|FG001|Overall Study|Protocol Violation|1
1991217|NCT00057330|3556990|FG000|Overall Study|Withdrawal by Subject|115
1991218|NCT00057330|3556991|FG001|Overall Study|Withdrawal by Subject|84
1991219|NCT00057330|3556990|FG000|Overall Study|Lost to Follow-up|745
1991220|NCT00057330|3556991|FG001|Overall Study|Lost to Follow-up|617
1991221|NCT00057330|3556990|FG000|Overall Study|Physician Decision|1
1991222|NCT00057330|3556991|FG001|Overall Study|Physician Decision|0
1991223|NCT00057330|3556990|FG000|Overall Study|Other|260
1991224|NCT00057330|3556991|FG001|Overall Study|Other|206
2024516|NCT00334815|3592997|FG000|Overall Study|Death|0
2024517|NCT00334815|3592998|FG001|Overall Study|Death|2
2024518|NCT00334815|3592997|FG000|Overall Study|Progression|1
2024519|NCT00334815|3592998|FG001|Overall Study|Progression|0
2024520|NCT00334815|3592997|FG000|Overall Study|ineligible|1
2024521|NCT00334815|3592998|FG001|Overall Study|ineligible|1
2024522|NCT00334815|3592997|FG000|Overall Study|patient refused treatment|0
2024523|NCT00334815|3592998|FG001|Overall Study|patient refused treatment|1
2024524|NCT00334815|3592997|FG000|Overall Study|Physician Decision|2
2024525|NCT00334815|3592998|FG001|Overall Study|Physician Decision|4
2024526|NCT00334893|3593008|FG000|Overall Study|Not Treated|1
2024527|NCT00334893|3593009|FG001|Overall Study|Not Treated|0
2024528|NCT00334958|3593019|FG000|Overall Study|Medication Noncompliance|0
2024529|NCT00334958|3593020|FG001|Overall Study|Medication Noncompliance|3
2024530|NCT00334958|3593019|FG000|Overall Study|Protocol Violation|2
2024531|NCT00334958|3593020|FG001|Overall Study|Protocol Violation|2
2024532|NCT00334958|3593019|FG000|Overall Study|Request of the investigator or sponsor|0
2024533|NCT00334958|3593020|FG001|Overall Study|Request of the investigator or sponsor|1
2024534|NCT00334958|3593019|FG000|Overall Study|Withdrawal by Subject|7
2024535|NCT00334958|3593020|FG001|Overall Study|Withdrawal by Subject|4
2024536|NCT00334958|3593019|FG000|Overall Study|Adverse Event|27
2024537|NCT00334958|3593020|FG001|Overall Study|Adverse Event|12
2024538|NCT00334958|3593019|FG000|Overall Study|Other|1
2024539|NCT00334958|3593020|FG001|Overall Study|Other|2
2024540|NCT00335140|3593026|FG000|Overall Study|Ineligible|1
2024541|NCT00335153|3593030|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5
2024542|NCT00335153|3593030|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
2024543|NCT00335153|3593030|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
2024544|NCT00335153|3593030|FG000|Nasojejunal (NJ) Test Period|Administrative|1
2024545|NCT00335153|3593030|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7
2024546|NCT00335153|3593030|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
1991225|NCT00057746|3557040|FG000|Overall Study|Withdrawal by Subject|0
1991226|NCT00057746|3557041|FG001|Overall Study|Withdrawal by Subject|0
1991227|NCT00057746|3557042|FG002|Overall Study|Withdrawal by Subject|1
1991228|NCT00057811|3557056|FG000|Overall Study|Lack of Efficacy|1
1991229|NCT00057811|3557057|FG001|Overall Study|Lack of Efficacy|4
1991230|NCT00057811|3557056|FG000|Overall Study|Physician Decision|1
1991231|NCT00057811|3557057|FG001|Overall Study|Physician Decision|0
1991232|NCT00057811|3557056|FG000|Overall Study|Withdrawal by Subject|3
1991233|NCT00057811|3557057|FG001|Overall Study|Withdrawal by Subject|4
1991234|NCT00057811|3557056|FG000|Overall Study|Ineligible|4
1991235|NCT00057811|3557057|FG001|Overall Study|Ineligible|2
1991236|NCT00057811|3557056|FG000|Overall Study|Inevaluable|1
1991237|NCT00057811|3557057|FG001|Overall Study|Inevaluable|2
1991238|NCT00057837|3557065|FG000|Overall Study|Progression/relapse|12
1991239|NCT00057837|3557066|FG001|Overall Study|Progression/relapse|14
1991240|NCT00057837|3557065|FG000|Overall Study|Adverse Event|2
1991241|NCT00057837|3557066|FG001|Overall Study|Adverse Event|12
1991242|NCT00057837|3557065|FG000|Overall Study|Death|5
1991243|NCT00057837|3557066|FG001|Overall Study|Death|4
1991244|NCT00057837|3557065|FG000|Overall Study|Withdrawal by Subject|5
1991245|NCT00057837|3557066|FG001|Overall Study|Withdrawal by Subject|3
1991246|NCT00057837|3557065|FG000|Overall Study|Alternative therapy|0
1991247|NCT00057837|3557066|FG001|Overall Study|Alternative therapy|1
1991248|NCT00057837|3557065|FG000|Overall Study|Other complicating disease|2
1991249|NCT00057837|3557066|FG001|Overall Study|Other complicating disease|1
1991250|NCT00057837|3557065|FG000|Overall Study|Physician Decision|1
1991251|NCT00057837|3557066|FG001|Overall Study|Physician Decision|0
1991252|NCT00057837|3557065|FG000|Overall Study|Ineligible|3
1991253|NCT00057837|3557066|FG001|Overall Study|Ineligible|3
1991254|NCT00057837|3557065|FG000|Overall Study|Never started treatment|1
1991255|NCT00057837|3557066|FG001|Overall Study|Never started treatment|1
1991256|NCT00057863|3557072|FG000|Overall Study|Death|1
1991257|NCT00057863|3557072|FG000|Overall Study|Withdrawal by Subject|2
1991258|NCT00057876|3557078|FG000|Overall Study|Adverse Event|8
1991259|NCT00057876|3557079|FG001|Overall Study|Adverse Event|8
1991260|NCT00057876|3557078|FG000|Overall Study|Death|2
1991261|NCT00057876|3557079|FG001|Overall Study|Death|1
1991262|NCT00057876|3557078|FG000|Overall Study|Withdrawal by Subject|5
1991263|NCT00057876|3557079|FG001|Overall Study|Withdrawal by Subject|6
1991264|NCT00057876|3557078|FG000|Overall Study|Lack of Efficacy|10
1991265|NCT00057876|3557079|FG001|Overall Study|Lack of Efficacy|8
1991266|NCT00057876|3557078|FG000|Overall Study|Ineligible|1
1991267|NCT00057876|3557079|FG001|Overall Study|Ineligible|2
1991268|NCT00057876|3557078|FG000|Overall Study|other reason|2
1991269|NCT00057876|3557079|FG001|Overall Study|other reason|2
1991270|NCT00057876|3557078|FG000|Overall Study|other complicating disease|1
1991271|NCT00057876|3557079|FG001|Overall Study|other complicating disease|0
1991272|NCT00057941|3557087|FG000|Overall Study|Death|1
1991273|NCT00057941|3557088|FG001|Overall Study|Death|2
1991274|NCT00057941|3557087|FG000|Overall Study|Adverse Event|7
1991275|NCT00057941|3557088|FG001|Overall Study|Adverse Event|9
1991276|NCT00057941|3557087|FG000|Overall Study|Lack of Efficacy|54
1991277|NCT00057941|3557088|FG001|Overall Study|Lack of Efficacy|53
1991278|NCT00057941|3557087|FG000|Overall Study|Withdrawal by Subject|6
1991279|NCT00057941|3557088|FG001|Overall Study|Withdrawal by Subject|1
1991280|NCT00057941|3557087|FG000|Overall Study|still on treatment|3
1991281|NCT00057941|3557088|FG001|Overall Study|still on treatment|1
1991282|NCT00057941|3557087|FG000|Overall Study|insurance, symptomatic deterioration|1
1991283|NCT00057941|3557088|FG001|Overall Study|insurance, symptomatic deterioration|3
1991284|NCT00057941|3557087|FG000|Overall Study|Ineligible|2
1991285|NCT00057941|3557088|FG001|Overall Study|Ineligible|5
1991286|NCT00057954|3557094|FG000|Overall Study|Death|1
1991287|NCT00057954|3557094|FG000|Overall Study|Disease progression|1
1991288|NCT00058058|3557106|FG000|Overall Study|Withdrawal by Subject|4
1991289|NCT00058058|3557106|FG000|Overall Study|Ineligible|20
1991290|NCT00058058|3557106|FG000|Overall Study|Claustrophobic|5
1991291|NCT00058058|3557106|FG000|Overall Study|technical issues|6
1991292|NCT00058058|3557106|FG000|Overall Study|Poor positioning, illness,pain|3
1991293|NCT00058123|3557111|FG000|Overall Study|Wrong histology|9
1991294|NCT00058123|3557111|FG000|Overall Study|Received >3 prior treatments|1
1991295|NCT00058214|3557116|FG000|Overall Study|Adverse Event|1
1991296|NCT00058422|3557141|FG000|Overall Study|Not treated|2
1991297|NCT00058539|3557145|FG000|Overall Study|Disease progression|24
1991298|NCT00058539|3557145|FG000|Overall Study|Adverse Event|3
1991299|NCT00058539|3557145|FG000|Overall Study|Withdrawal by Subject|5
1991300|NCT00058539|3557145|FG000|Overall Study|Physician Decision|9
1991301|NCT00058539|3557145|FG000|Overall Study|Death|1
1991302|NCT00058552|3557151|FG000|Overall Study|Died prior to receiving treatment|4
1991303|NCT00058552|3557152|FG001|Overall Study|Died prior to receiving treatment|2
1991304|NCT00058552|3557151|FG000|Overall Study|Disease progression|52
1991305|NCT00058552|3557152|FG001|Overall Study|Disease progression|44
1991306|NCT00058552|3557151|FG000|Overall Study|Adverse Event|4
1991307|NCT00058552|3557152|FG001|Overall Study|Adverse Event|2
1991308|NCT00058552|3557151|FG000|Overall Study|Withdrawal by Subject|3
1991309|NCT00058552|3557152|FG001|Overall Study|Withdrawal by Subject|5
1991310|NCT00058552|3557151|FG000|Overall Study|Physician Decision|2
1991311|NCT00058552|3557152|FG001|Overall Study|Physician Decision|5
1991312|NCT00058552|3557151|FG000|Overall Study|Clinical disease progression|0
1991313|NCT00058552|3557152|FG001|Overall Study|Clinical disease progression|4
1991314|NCT00058825|3557160|FG000|Overall Study|Relapse|9
1991315|NCT00058825|3557160|FG000|Overall Study|Progressive Disease|5
1991316|NCT00058825|3557160|FG000|Overall Study|Graft Failure|5
1991317|NCT00058825|3557160|FG000|Overall Study|Death|3
1991318|NCT00059202|3557168|FG000|Overall Study|Withdrawal by Subject|5
1991319|NCT00059202|3557169|FG001|Overall Study|Withdrawal by Subject|9
1991320|NCT00059202|3557168|FG000|Overall Study|Protocol Violation|1
1991321|NCT00059202|3557169|FG001|Overall Study|Protocol Violation|3
1991322|NCT00059202|3557168|FG000|Overall Study|drug toxicity|0
1991323|NCT00059202|3557169|FG001|Overall Study|drug toxicity|3
1991324|NCT00059215|3557182|FG000|Overall Study|Adverse Event|5
1991325|NCT00059215|3557183|FG001|Overall Study|Adverse Event|5
1991326|NCT00059215|3557184|FG002|Overall Study|Adverse Event|9
1991327|NCT00059215|3557185|FG003|Overall Study|Adverse Event|9
1991328|NCT00059215|3557182|FG000|Overall Study|Death|0
1991329|NCT00059215|3557183|FG001|Overall Study|Death|0
1991330|NCT00059215|3557184|FG002|Overall Study|Death|3
1991331|NCT00059215|3557185|FG003|Overall Study|Death|0
1991332|NCT00059215|3557182|FG000|Overall Study|Lost to Follow-up|1
1991333|NCT00059215|3557183|FG001|Overall Study|Lost to Follow-up|2
1991334|NCT00059215|3557184|FG002|Overall Study|Lost to Follow-up|0
1991335|NCT00059215|3557185|FG003|Overall Study|Lost to Follow-up|0
1991336|NCT00059215|3557182|FG000|Overall Study|Withdrawal by Subject|4
1991337|NCT00059215|3557183|FG001|Overall Study|Withdrawal by Subject|4
1991338|NCT00059215|3557184|FG002|Overall Study|Withdrawal by Subject|1
1991339|NCT00059215|3557185|FG003|Overall Study|Withdrawal by Subject|3
1991340|NCT00059215|3557182|FG000|Overall Study|Protocol Violation|1
1991341|NCT00059215|3557183|FG001|Overall Study|Protocol Violation|0
1991342|NCT00059215|3557184|FG002|Overall Study|Protocol Violation|1
1991343|NCT00059215|3557185|FG003|Overall Study|Protocol Violation|0
1991344|NCT00059215|3557182|FG000|Overall Study|Protocol entry criteria not met|1
1991345|NCT00059215|3557183|FG001|Overall Study|Protocol entry criteria not met|1
1991346|NCT00059215|3557184|FG002|Overall Study|Protocol entry criteria not met|0
1991347|NCT00059215|3557185|FG003|Overall Study|Protocol entry criteria not met|2
1991348|NCT00059215|3557182|FG000|Overall Study|Physician Decision|1
1991349|NCT00059215|3557183|FG001|Overall Study|Physician Decision|2
1991350|NCT00059215|3557184|FG002|Overall Study|Physician Decision|1
1991351|NCT00059215|3557185|FG003|Overall Study|Physician Decision|1
1991352|NCT00059332|3557207|FG000|Overall Study|Withdrawal by Subject|2
1991353|NCT00059332|3557208|FG001|Overall Study|Withdrawal by Subject|1
1991354|NCT00059332|3557207|FG000|Overall Study|Lost to Follow-up|1
1991355|NCT00059332|3557208|FG001|Overall Study|Lost to Follow-up|1
1991356|NCT00059787|3557254|FG000|Overall Study|Adverse Event|13
1991357|NCT00059787|3557254|FG000|Overall Study|disease progression|2
1991358|NCT00059787|3557254|FG000|Overall Study|ineligible|1
1991359|NCT00059787|3557254|FG000|Overall Study|Other|4
1991360|NCT00059839|3557261|FG000|Overall Study|Death|1
1991361|NCT00059839|3557262|FG001|Overall Study|Death|1
1991362|NCT00059839|3557261|FG000|Overall Study|Lack of Efficacy|6
1991363|NCT00059839|3557262|FG001|Overall Study|Lack of Efficacy|5
1991364|NCT00059839|3557261|FG000|Overall Study|Lost to Follow-up|2
1991365|NCT00059839|3557262|FG001|Overall Study|Lost to Follow-up|0
1991366|NCT00059839|3557261|FG000|Overall Study|Physician Decision|1
1991367|NCT00059839|3557262|FG001|Overall Study|Physician Decision|2
1991368|NCT00059839|3557261|FG000|Overall Study|Withdrawal by Subject|1
1991369|NCT00059839|3557262|FG001|Overall Study|Withdrawal by Subject|6
1991370|NCT00059839|3557261|FG000|Overall Study|Ineligible|1
1991371|NCT00059839|3557262|FG001|Overall Study|Ineligible|3
1991372|NCT00060840|3557315|FG000|Overall Study|Change in surgical plan|2
1991373|NCT00060840|3557316|FG001|Overall Study|Change in surgical plan|6
1991374|NCT00060840|3557315|FG000|Overall Study|Death|0
1991375|NCT00060840|3557316|FG001|Overall Study|Death|1
1991376|NCT00060840|3557315|FG000|Overall Study|Withdrawal by Subject|0
1991377|NCT00060840|3557316|FG001|Overall Study|Withdrawal by Subject|1
1991378|NCT00060840|3557315|FG000|Overall Study|Subinvestigator unavailable|0
1991379|NCT00060840|3557316|FG001|Overall Study|Subinvestigator unavailable|1
1991380|NCT00060840|3557315|FG000|Overall Study|Physician Decision|1
1991381|NCT00060840|3557316|FG001|Overall Study|Physician Decision|0
1991382|NCT00060840|3557315|FG000|Overall Study|Other|1
1991383|NCT00060840|3557316|FG001|Overall Study|Other|0
1991384|NCT00060944|3557324|FG000|Overall Study|Adverse Event|12
1991385|NCT00060944|3557325|FG001|Overall Study|Adverse Event|10
1991386|NCT00060944|3557324|FG000|Overall Study|Death|2
1991387|NCT00060944|3557325|FG001|Overall Study|Death|3
1991388|NCT00060944|3557324|FG000|Overall Study|Withdrawal by Subject|18
1991389|NCT00060944|3557325|FG001|Overall Study|Withdrawal by Subject|5
1991390|NCT00060944|3557324|FG000|Overall Study|Disease Progression|93
1991391|NCT00060944|3557325|FG001|Overall Study|Disease Progression|94
1991392|NCT00060944|3557324|FG000|Overall Study|Lost to Follow-up|1
1991393|NCT00060944|3557325|FG001|Overall Study|Lost to Follow-up|0
1991394|NCT00060944|3557324|FG000|Overall Study|Subject Ineligible To Continue|2
1991395|NCT00060944|3557325|FG001|Overall Study|Subject Ineligible To Continue|1
1991396|NCT00060944|3557324|FG000|Overall Study|Treatment Switch|0
1991397|NCT00060944|3557325|FG001|Overall Study|Treatment Switch|13
1991398|NCT00060944|3557324|FG000|Overall Study|Other|2
1991399|NCT00060944|3557325|FG001|Overall Study|Other|4
1991400|NCT00060944|3557324|FG000|Overall Study|randomized but not treated|6
1991401|NCT00060944|3557325|FG001|Overall Study|randomized but not treated|4
1991402|NCT00061048|3557331|FG000|Overall Study|Adverse Event|2
1991403|NCT00061048|3557331|FG000|Overall Study|disease progression|20
1991404|NCT00061633|3557346|FG000|Overall Study|Adverse Event|1
1991405|NCT00061633|3557347|FG001|Overall Study|Adverse Event|2
1991406|NCT00061633|3557346|FG000|Overall Study|Withdrawal by Subject|2
1991407|NCT00061633|3557347|FG001|Overall Study|Withdrawal by Subject|2
1991408|NCT00061633|3557346|FG000|Overall Study|Lost to Follow-up|1
1991409|NCT00061633|3557347|FG001|Overall Study|Lost to Follow-up|4
1991410|NCT00061633|3557346|FG000|Overall Study|Other|1
1991411|NCT00061633|3557347|FG001|Overall Study|Other|1
1991412|NCT00061633|3557346|FG000|Overall Study|Never received study treatment|0
1991413|NCT00061633|3557347|FG001|Overall Study|Never received study treatment|2
1991414|NCT00061932|3557359|FG000|Overall Study|Withdrawal by Subject|13
1991415|NCT00061932|3557360|FG001|Overall Study|Withdrawal by Subject|4
1991416|NCT00061945|3557369|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18
1991417|NCT00061945|3557370|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25
1991418|NCT00061945|3557369|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76
1991419|NCT00061945|3557370|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90
1991420|NCT00061945|3557369|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1
1991421|NCT00061945|3557370|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1
1991422|NCT00061945|3557369|FG000|Course IV: Alemtuzumab|Early exits|6
1991423|NCT00061945|3557370|FG001|Course IV: Alemtuzumab|Early exits|15
1991424|NCT00062010|3557378|FG000|Overall Study|Ineligible|3
1991425|NCT00062166|3557382|FG000|Overall Study|Withdrawal by Subject|6
1991426|NCT00062374|3557387|FG000|Overall Study|Not treated|12
1991427|NCT00062439|3557391|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1
1991428|NCT00062439|3557391|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
1991429|NCT00062439|3557391|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3
1991430|NCT00062439|3557391|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
1991431|NCT00062439|3557391|FG000|Post Chemoradiation Assessment|Death|1
1991432|NCT00062439|3557391|FG000|Post Chemoradiation Assessment|Disease progression|2
1991433|NCT00062439|3557391|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1
1991434|NCT00062439|3557391|FG000|Post Chemoradiation Assessment|Physician Decision|1
1991435|NCT00062439|3557391|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
1991436|NCT00062439|3557391|FG000|Surgery|Physician Decision|4
1991437|NCT00062439|3557391|FG000|Surgery|Death|1
1991438|NCT00062439|3557391|FG000|Surgery|Adverse Event|2
1991439|NCT00062439|3557391|FG000|Consolidation Chemotherapy|Adverse Event|2
1991440|NCT00062647|3557402|FG000|Overall Study|Death|2
1991441|NCT00062647|3557403|FG001|Overall Study|Death|2
1991442|NCT00062647|3557402|FG000|Overall Study|Adverse Event|1
1991443|NCT00062647|3557403|FG001|Overall Study|Adverse Event|1
1991444|NCT00062647|3557402|FG000|Overall Study|Withdrawal by Subject|2
1991445|NCT00062647|3557403|FG001|Overall Study|Withdrawal by Subject|1
1991446|NCT00062647|3557402|FG000|Overall Study|Protocol Violation|1
1991447|NCT00062647|3557403|FG001|Overall Study|Protocol Violation|0
1991448|NCT00062647|3557402|FG000|Overall Study|Lost to Follow-up|1
1991449|NCT00062647|3557403|FG001|Overall Study|Lost to Follow-up|2
1991450|NCT00062647|3557402|FG000|Overall Study|Failed continuation criteria|4
1991451|NCT00062647|3557403|FG001|Overall Study|Failed continuation criteria|2
1991452|NCT00062647|3557402|FG000|Overall Study|Other|4
1991453|NCT00062647|3557403|FG001|Overall Study|Other|4
1991454|NCT00062647|3557402|FG000|Overall Study|Never received study treatment|1
1991455|NCT00062647|3557403|FG001|Overall Study|Never received study treatment|1
1991456|NCT00062868|3557450|FG000|Dose Level 1|Death|2
1991457|NCT00062868|3557451|FG001|Dose Level 1|Death|0
1991458|NCT00062868|3557452|FG002|Dose Level 1|Death|0
1991459|NCT00062868|3557453|FG003|Dose Level 1|Death|2
1991460|NCT00062868|3557454|FG004|Dose Level 1|Death|0
1991461|NCT00062868|3557455|FG005|Dose Level 1|Death|0
1991462|NCT00062868|3557456|FG006|Dose Level 1|Death|3
1991463|NCT00062868|3557457|FG007|Dose Level 1|Death|0
1991464|NCT00062868|3557458|FG008|Dose Level 1|Death|0
1991465|NCT00062868|3557459|FG009|Dose Level 1|Death|0
1991466|NCT00062868|3557460|FG010|Dose Level 1|Death|0
1991467|NCT00062868|3557461|FG011|Dose Level 1|Death|0
1991468|NCT00062868|3557462|FG012|Dose Level 1|Death|0
1991469|NCT00062868|3557463|FG013|Dose Level 1|Death|0
1991470|NCT00062868|3557464|FG014|Dose Level 1|Death|0
1991471|NCT00062868|3557465|FG015|Dose Level 1|Death|0
2213561|NCT01681186|3855421|FG005|Washout Period From Second Intervention|Adverse Event|0
2213562|NCT01681186|3855422|FG006|Washout Period From Second Intervention|Adverse Event|1
2213563|NCT01681186|3855423|FG007|Washout Period From Second Intervention|Adverse Event|0
2213564|NCT01681186|3855416|FG000|Washout Period From Second Intervention|Protocol Violation|0
2213565|NCT01681186|3855417|FG001|Washout Period From Second Intervention|Protocol Violation|0
2213566|NCT01681186|3855418|FG002|Washout Period From Second Intervention|Protocol Violation|0
1991472|NCT00062868|3557466|FG016|Dose Level 1|Death|0
1991473|NCT00062868|3557467|FG017|Dose Level 1|Death|0
1991474|NCT00062868|3557468|FG018|Dose Level 1|Death|7
1991475|NCT00062868|3557469|FG019|Dose Level 1|Death|0
2213567|NCT01681186|3855419|FG003|Washout Period From Second Intervention|Protocol Violation|0
2213568|NCT01681186|3855420|FG004|Washout Period From Second Intervention|Protocol Violation|0
2213569|NCT01681186|3855421|FG005|Washout Period From Second Intervention|Protocol Violation|0
2213570|NCT01681186|3855422|FG006|Washout Period From Second Intervention|Protocol Violation|0
2213571|NCT01681186|3855423|FG007|Washout Period From Second Intervention|Protocol Violation|1
2213572|NCT01681186|3855416|FG000|Washout Period From Third Intervention|Lost to Follow-up|0
2213573|NCT01681186|3855417|FG001|Washout Period From Third Intervention|Lost to Follow-up|0
1991476|NCT00062868|3557470|FG020|Dose Level 1|Death|1
1991477|NCT00062868|3557450|FG000|Dose Level 1|Lost to Follow-up|0
1991478|NCT00062868|3557451|FG001|Dose Level 1|Lost to Follow-up|0
1991479|NCT00062868|3557452|FG002|Dose Level 1|Lost to Follow-up|0
1991480|NCT00062868|3557453|FG003|Dose Level 1|Lost to Follow-up|0
1991481|NCT00062868|3557454|FG004|Dose Level 1|Lost to Follow-up|0
1991482|NCT00062868|3557455|FG005|Dose Level 1|Lost to Follow-up|0
1991483|NCT00062868|3557456|FG006|Dose Level 1|Lost to Follow-up|0
1991484|NCT00062868|3557457|FG007|Dose Level 1|Lost to Follow-up|0
1991485|NCT00062868|3557458|FG008|Dose Level 1|Lost to Follow-up|0
1991486|NCT00062868|3557459|FG009|Dose Level 1|Lost to Follow-up|0
1991487|NCT00062868|3557460|FG010|Dose Level 1|Lost to Follow-up|0
1991488|NCT00062868|3557461|FG011|Dose Level 1|Lost to Follow-up|0
1991489|NCT00062868|3557462|FG012|Dose Level 1|Lost to Follow-up|1
1991490|NCT00062868|3557463|FG013|Dose Level 1|Lost to Follow-up|0
1991491|NCT00062868|3557464|FG014|Dose Level 1|Lost to Follow-up|0
1991492|NCT00062868|3557465|FG015|Dose Level 1|Lost to Follow-up|0
1991493|NCT00062868|3557466|FG016|Dose Level 1|Lost to Follow-up|0
1991494|NCT00062868|3557467|FG017|Dose Level 1|Lost to Follow-up|0
1991495|NCT00062868|3557468|FG018|Dose Level 1|Lost to Follow-up|2
1991496|NCT00062868|3557469|FG019|Dose Level 1|Lost to Follow-up|0
1991497|NCT00062868|3557470|FG020|Dose Level 1|Lost to Follow-up|1
1991498|NCT00062868|3557450|FG000|Dose Level 2|Death|0
1991499|NCT00062868|3557451|FG001|Dose Level 2|Death|3
1991500|NCT00062868|3557452|FG002|Dose Level 2|Death|0
1991501|NCT00062868|3557453|FG003|Dose Level 2|Death|0
1991502|NCT00062868|3557454|FG004|Dose Level 2|Death|2
1991503|NCT00062868|3557455|FG005|Dose Level 2|Death|0
1991504|NCT00062868|3557456|FG006|Dose Level 2|Death|0
1991505|NCT00062868|3557457|FG007|Dose Level 2|Death|0
1991506|NCT00062868|3557458|FG008|Dose Level 2|Death|0
1991507|NCT00062868|3557459|FG009|Dose Level 2|Death|0
1991508|NCT00062868|3557460|FG010|Dose Level 2|Death|1
1991509|NCT00062868|3557461|FG011|Dose Level 2|Death|0
1991510|NCT00062868|3557462|FG012|Dose Level 2|Death|0
1991511|NCT00062868|3557463|FG013|Dose Level 2|Death|0
1991512|NCT00062868|3557464|FG014|Dose Level 2|Death|0
1991513|NCT00062868|3557465|FG015|Dose Level 2|Death|0
1991514|NCT00062868|3557466|FG016|Dose Level 2|Death|2
1991515|NCT00062868|3557467|FG017|Dose Level 2|Death|0
1991516|NCT00062868|3557468|FG018|Dose Level 2|Death|0
1991517|NCT00062868|3557469|FG019|Dose Level 2|Death|0
1991518|NCT00062868|3557470|FG020|Dose Level 2|Death|0
1991519|NCT00062868|3557450|FG000|Dose Level 2|Lost to Follow-up|0
1991520|NCT00062868|3557451|FG001|Dose Level 2|Lost to Follow-up|0
1991521|NCT00062868|3557452|FG002|Dose Level 2|Lost to Follow-up|0
1991522|NCT00062868|3557453|FG003|Dose Level 2|Lost to Follow-up|0
1991523|NCT00062868|3557454|FG004|Dose Level 2|Lost to Follow-up|0
1991524|NCT00062868|3557455|FG005|Dose Level 2|Lost to Follow-up|0
1991525|NCT00062868|3557456|FG006|Dose Level 2|Lost to Follow-up|0
1991526|NCT00062868|3557457|FG007|Dose Level 2|Lost to Follow-up|0
1991527|NCT00062868|3557458|FG008|Dose Level 2|Lost to Follow-up|0
1991528|NCT00062868|3557459|FG009|Dose Level 2|Lost to Follow-up|0
1991529|NCT00062868|3557460|FG010|Dose Level 2|Lost to Follow-up|0
1991530|NCT00062868|3557461|FG011|Dose Level 2|Lost to Follow-up|0
1991531|NCT00062868|3557462|FG012|Dose Level 2|Lost to Follow-up|0
1991532|NCT00062868|3557463|FG013|Dose Level 2|Lost to Follow-up|1
1991533|NCT00062868|3557464|FG014|Dose Level 2|Lost to Follow-up|0
1991534|NCT00062868|3557465|FG015|Dose Level 2|Lost to Follow-up|0
1991535|NCT00062868|3557466|FG016|Dose Level 2|Lost to Follow-up|1
1991536|NCT00062868|3557467|FG017|Dose Level 2|Lost to Follow-up|0
1991537|NCT00062868|3557468|FG018|Dose Level 2|Lost to Follow-up|0
1991538|NCT00062868|3557469|FG019|Dose Level 2|Lost to Follow-up|0
1991539|NCT00062868|3557470|FG020|Dose Level 2|Lost to Follow-up|0
1991540|NCT00062868|3557450|FG000|Dose Level 3|Death|0
1991541|NCT00062868|3557451|FG001|Dose Level 3|Death|0
1991542|NCT00062868|3557452|FG002|Dose Level 3|Death|0
1991543|NCT00062868|3557453|FG003|Dose Level 3|Death|0
1991544|NCT00062868|3557454|FG004|Dose Level 3|Death|0
1991545|NCT00062868|3557455|FG005|Dose Level 3|Death|0
1991546|NCT00062868|3557456|FG006|Dose Level 3|Death|0
1991547|NCT00062868|3557457|FG007|Dose Level 3|Death|0
1991548|NCT00062868|3557458|FG008|Dose Level 3|Death|0
1991549|NCT00062868|3557459|FG009|Dose Level 3|Death|0
1991550|NCT00062868|3557460|FG010|Dose Level 3|Death|0
1991551|NCT00062868|3557461|FG011|Dose Level 3|Death|1
1991552|NCT00062868|3557462|FG012|Dose Level 3|Death|0
1991553|NCT00062868|3557463|FG013|Dose Level 3|Death|0
1991554|NCT00062868|3557464|FG014|Dose Level 3|Death|0
1991555|NCT00062868|3557465|FG015|Dose Level 3|Death|0
1991556|NCT00062868|3557466|FG016|Dose Level 3|Death|0
1991557|NCT00062868|3557467|FG017|Dose Level 3|Death|1
1991558|NCT00062868|3557468|FG018|Dose Level 3|Death|0
1991559|NCT00062868|3557469|FG019|Dose Level 3|Death|0
1991560|NCT00062868|3557470|FG020|Dose Level 3|Death|0
1991561|NCT00062868|3557450|FG000|Dose Level 3|Lost to Follow-up|0
1991562|NCT00062868|3557451|FG001|Dose Level 3|Lost to Follow-up|0
1991563|NCT00062868|3557452|FG002|Dose Level 3|Lost to Follow-up|0
1991564|NCT00062868|3557453|FG003|Dose Level 3|Lost to Follow-up|0
1991565|NCT00062868|3557454|FG004|Dose Level 3|Lost to Follow-up|0
1991566|NCT00062868|3557455|FG005|Dose Level 3|Lost to Follow-up|0
1991567|NCT00062868|3557456|FG006|Dose Level 3|Lost to Follow-up|0
1991568|NCT00062868|3557457|FG007|Dose Level 3|Lost to Follow-up|0
1991569|NCT00062868|3557458|FG008|Dose Level 3|Lost to Follow-up|0
1991570|NCT00062868|3557459|FG009|Dose Level 3|Lost to Follow-up|0
2213574|NCT01681186|3855418|FG002|Washout Period From Third Intervention|Lost to Follow-up|0
2213575|NCT01681186|3855419|FG003|Washout Period From Third Intervention|Lost to Follow-up|0
2213576|NCT01681186|3855420|FG004|Washout Period From Third Intervention|Lost to Follow-up|0
2213577|NCT01681186|3855421|FG005|Washout Period From Third Intervention|Lost to Follow-up|0
2213578|NCT01681186|3855422|FG006|Washout Period From Third Intervention|Lost to Follow-up|1
2213579|NCT01681186|3855423|FG007|Washout Period From Third Intervention|Lost to Follow-up|0
2213580|NCT01681186|3855416|FG000|Fourth Intervention|Protocol Violation|0
2213581|NCT01681186|3855417|FG001|Fourth Intervention|Protocol Violation|0
2213582|NCT01681186|3855418|FG002|Fourth Intervention|Protocol Violation|0
2213583|NCT01681186|3855419|FG003|Fourth Intervention|Protocol Violation|0
1991571|NCT00062868|3557460|FG010|Dose Level 3|Lost to Follow-up|0
1991572|NCT00062868|3557461|FG011|Dose Level 3|Lost to Follow-up|0
1991573|NCT00062868|3557462|FG012|Dose Level 3|Lost to Follow-up|0
1991574|NCT00062868|3557463|FG013|Dose Level 3|Lost to Follow-up|0
1991575|NCT00062868|3557464|FG014|Dose Level 3|Lost to Follow-up|1
1991576|NCT00062868|3557465|FG015|Dose Level 3|Lost to Follow-up|0
1991577|NCT00062868|3557466|FG016|Dose Level 3|Lost to Follow-up|0
1991578|NCT00062868|3557467|FG017|Dose Level 3|Lost to Follow-up|0
1991579|NCT00062868|3557468|FG018|Dose Level 3|Lost to Follow-up|0
1991580|NCT00062868|3557469|FG019|Dose Level 3|Lost to Follow-up|0
1991581|NCT00062868|3557470|FG020|Dose Level 3|Lost to Follow-up|0
1991582|NCT00062868|3557450|FG000|Dose Level 3|Withdrew|0
1991583|NCT00062868|3557451|FG001|Dose Level 3|Withdrew|0
1991584|NCT00062868|3557452|FG002|Dose Level 3|Withdrew|2
1991585|NCT00062868|3557453|FG003|Dose Level 3|Withdrew|0
1991586|NCT00062868|3557454|FG004|Dose Level 3|Withdrew|0
1991587|NCT00062868|3557455|FG005|Dose Level 3|Withdrew|0
1991588|NCT00062868|3557456|FG006|Dose Level 3|Withdrew|0
1991589|NCT00062868|3557457|FG007|Dose Level 3|Withdrew|0
1991590|NCT00062868|3557458|FG008|Dose Level 3|Withdrew|0
1991591|NCT00062868|3557459|FG009|Dose Level 3|Withdrew|0
1991592|NCT00062868|3557460|FG010|Dose Level 3|Withdrew|0
1991593|NCT00062868|3557461|FG011|Dose Level 3|Withdrew|0
1991594|NCT00062868|3557462|FG012|Dose Level 3|Withdrew|0
1991595|NCT00062868|3557463|FG013|Dose Level 3|Withdrew|0
1991596|NCT00062868|3557464|FG014|Dose Level 3|Withdrew|0
1991597|NCT00062868|3557465|FG015|Dose Level 3|Withdrew|0
1991598|NCT00062868|3557466|FG016|Dose Level 3|Withdrew|0
1991599|NCT00062868|3557467|FG017|Dose Level 3|Withdrew|0
1991600|NCT00062868|3557468|FG018|Dose Level 3|Withdrew|0
1991601|NCT00062868|3557469|FG019|Dose Level 3|Withdrew|0
1991602|NCT00062868|3557470|FG020|Dose Level 3|Withdrew|0
1991603|NCT00063154|3557514|FG000|Overall Study|Disease progression|27
1991604|NCT00063154|3557514|FG000|Overall Study|Adverse Event|2
1991605|NCT00063154|3557514|FG000|Overall Study|Physician Decision|10
1991606|NCT00063154|3557514|FG000|Overall Study|Death|3
1991607|NCT00063154|3557514|FG000|Overall Study|Reason unspecified|1
1991608|NCT00063154|3557514|FG000|Overall Study|Did not receive treatment|8
1991609|NCT00063258|3557524|FG000|Overall Study|Physician Decision|2
1991610|NCT00063258|3557525|FG001|Overall Study|Physician Decision|0
1991611|NCT00063258|3557524|FG000|Overall Study|Lack of Efficacy|2
1991612|NCT00063258|3557525|FG001|Overall Study|Lack of Efficacy|0
1991613|NCT00063882|3557577|FG000|Overall Study|Protocol Violation|3
1991614|NCT00063882|3557578|FG001|Overall Study|Protocol Violation|3
1991615|NCT00063882|3557577|FG000|Overall Study|Withdrawal by Subject|2
1991616|NCT00063882|3557578|FG001|Overall Study|Withdrawal by Subject|1
1991617|NCT00063934|3557584|FG000|Overall Study|Ineligible|1
1991618|NCT00063986|3557588|FG000|Overall Study|Withdrawal by Subject|1
1991619|NCT00063986|3557588|FG000|Overall Study|Ineligible|1
1991620|NCT00063986|3557588|FG000|Overall Study|Intra-operatively ineligible|4
1991621|NCT00063999|3557594|FG000|Overall Study|Withdrawal by Subject|1
1991622|NCT00063999|3557595|FG001|Overall Study|Withdrawal by Subject|0
1991623|NCT00063999|3557594|FG000|Overall Study|Ineligible|44
1991624|NCT00063999|3557595|FG001|Overall Study|Ineligible|24
1991625|NCT00064025|3557608|FG000|Overall Study|Ineligible|4
1991626|NCT00064025|3557608|FG000|Overall Study|Inevaluable|3
1991627|NCT00064077|3557631|FG000|Overall Study|Improper prior treatment|1
1991628|NCT00064077|3557632|FG001|Overall Study|Improper prior treatment|0
1991629|NCT00064077|3557633|FG002|Overall Study|Improper prior treatment|0
1991630|NCT00064077|3557634|FG003|Overall Study|Improper prior treatment|0
1991631|NCT00064077|3557631|FG000|Overall Study|Poor risk|2
1991632|NCT00064077|3557632|FG001|Overall Study|Poor risk|0
1991633|NCT00064077|3557633|FG002|Overall Study|Poor risk|1
1991634|NCT00064077|3557634|FG003|Overall Study|Poor risk|1
1991635|NCT00064077|3557631|FG000|Overall Study|Pathology|10
1991636|NCT00064077|3557632|FG001|Overall Study|Pathology|7
1991637|NCT00064077|3557633|FG002|Overall Study|Pathology|3
1991638|NCT00064077|3557634|FG003|Overall Study|Pathology|4
1991639|NCT00064077|3557631|FG000|Overall Study|No surgery|0
1991640|NCT00064077|3557632|FG001|Overall Study|No surgery|0
1991641|NCT00064077|3557633|FG002|Overall Study|No surgery|1
1991642|NCT00064077|3557634|FG003|Overall Study|No surgery|0
1991643|NCT00064077|3557631|FG000|Overall Study|No tumor|0
1991644|NCT00064077|3557632|FG001|Overall Study|No tumor|0
1991645|NCT00064077|3557633|FG002|Overall Study|No tumor|1
1991646|NCT00064077|3557634|FG003|Overall Study|No tumor|0
1991647|NCT00064077|3557631|FG000|Overall Study|Other reasons|2
1991648|NCT00064077|3557632|FG001|Overall Study|Other reasons|2
1991649|NCT00064077|3557633|FG002|Overall Study|Other reasons|1
1991650|NCT00064077|3557634|FG003|Overall Study|Other reasons|2
1991651|NCT00064259|3557644|FG000|Overall Study|Adverse Event|1
1991652|NCT00064259|3557645|FG001|Overall Study|Adverse Event|0
1991653|NCT00064259|3557646|FG002|Overall Study|Adverse Event|0
1991654|NCT00064259|3557647|FG003|Overall Study|Adverse Event|1
1991655|NCT00064298|3557654|FG000|Overall Study|Withdrawal by Subject|2
2213584|NCT01681186|3855420|FG004|Fourth Intervention|Protocol Violation|0
2213585|NCT01681186|3855421|FG005|Fourth Intervention|Protocol Violation|0
1991656|NCT00064298|3557655|FG001|Overall Study|Withdrawal by Subject|1
1991657|NCT00064298|3557654|FG000|Overall Study|Lost to Follow-up|2
1991658|NCT00064298|3557655|FG001|Overall Study|Lost to Follow-up|2
1991659|NCT00064298|3557654|FG000|Overall Study|Death|0
1991660|NCT00064298|3557655|FG001|Overall Study|Death|1
1991661|NCT00064298|3557654|FG000|Overall Study|Disease Progression|2
1991662|NCT00064298|3557655|FG001|Overall Study|Disease Progression|1
1991663|NCT00064337|3557661|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7
1991664|NCT00064337|3557661|FG000|PBSCC or Induction/PBSCC|Adverse Event|6
1991665|NCT00064337|3557661|FG000|PBSCC or Induction/PBSCC|Progression|3
1991666|NCT00064337|3557661|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2
1991667|NCT00064337|3557661|FG000|PBSCC or Induction/PBSCC|Death|2
1991668|NCT00064337|3557661|FG000|Transplant|Adverse Event|9
1991669|NCT00064337|3557661|FG000|Transplant|Not protocol-specified|5
1991670|NCT00064337|3557661|FG000|Transplant|Death|3
1991671|NCT00064337|3557661|FG000|Transplant|Patient Refusal|2
1991672|NCT00064337|3557661|FG000|Transplant|Progression|2
1991673|NCT00064337|3557661|FG000|Maintenance|Adverse Event|3
1991674|NCT00064337|3557661|FG000|Maintenance|Progression|2
1991675|NCT00064337|3557661|FG000|Maintenance|On treatment at time of analysis|2
1991676|NCT00064337|3557661|FG000|Maintenance|Not protocol-specified|2
1991677|NCT00064337|3557661|FG000|Maintenance|Death|1
1991678|NCT00064350|3557671|FG000|Induction Treatment|Disease Progression|5
1991679|NCT00064350|3557672|FG001|Induction Treatment|Disease Progression|1
1991680|NCT00064350|3557673|FG002|Induction Treatment|Disease Progression|110
1991681|NCT00064350|3557671|FG000|Induction Treatment|Adverse Event|0
1991682|NCT00064350|3557672|FG001|Induction Treatment|Adverse Event|2
1991683|NCT00064350|3557673|FG002|Induction Treatment|Adverse Event|49
1991684|NCT00064350|3557671|FG000|Induction Treatment|Death|0
1991685|NCT00064350|3557672|FG001|Induction Treatment|Death|0
1991686|NCT00064350|3557673|FG002|Induction Treatment|Death|9
1991687|NCT00064350|3557671|FG000|Induction Treatment|Withdrawal by Subject|0
1991688|NCT00064350|3557672|FG001|Induction Treatment|Withdrawal by Subject|0
1991689|NCT00064350|3557673|FG002|Induction Treatment|Withdrawal by Subject|21
1991690|NCT00064350|3557671|FG000|Induction Treatment|Ineligible or never started treatment|3
1991691|NCT00064350|3557672|FG001|Induction Treatment|Ineligible or never started treatment|6
1991692|NCT00064350|3557673|FG002|Induction Treatment|Ineligible or never started treatment|34
1991693|NCT00064350|3557671|FG000|Induction Treatment|Other|0
1991694|NCT00064350|3557672|FG001|Induction Treatment|Other|0
1991695|NCT00064350|3557673|FG002|Induction Treatment|Other|13
1991696|NCT00064350|3557671|FG000|Randomization|Adverse Event|8
1991697|NCT00064350|3557672|FG001|Randomization|Adverse Event|3
1991698|NCT00064350|3557673|FG002|Randomization|Adverse Event|0
1991699|NCT00064350|3557671|FG000|Randomization|Death|3
1991700|NCT00064350|3557672|FG001|Randomization|Death|0
1991701|NCT00064350|3557673|FG002|Randomization|Death|0
1991702|NCT00064350|3557671|FG000|Randomization|Withdrawal by Subject|1
1991703|NCT00064350|3557672|FG001|Randomization|Withdrawal by Subject|0
1991704|NCT00064350|3557673|FG002|Randomization|Withdrawal by Subject|0
1991705|NCT00064350|3557671|FG000|Randomization|Ineligible or never started treatment|9
1991706|NCT00064350|3557672|FG001|Randomization|Ineligible or never started treatment|15
1991707|NCT00064350|3557673|FG002|Randomization|Ineligible or never started treatment|0
1991708|NCT00064350|3557671|FG000|Randomization|Other|5
1991709|NCT00064350|3557672|FG001|Randomization|Other|0
1991710|NCT00064350|3557673|FG002|Randomization|Other|0
1991711|NCT00064350|3557671|FG000|Cross-Over|Adverse Event|0
1991712|NCT00064350|3557672|FG001|Cross-Over|Adverse Event|1
1991713|NCT00064350|3557673|FG002|Cross-Over|Adverse Event|0
1991714|NCT00064350|3557671|FG000|Cross-Over|Death|1
1991715|NCT00064350|3557672|FG001|Cross-Over|Death|3
1991716|NCT00064350|3557673|FG002|Cross-Over|Death|0
1991717|NCT00064350|3557671|FG000|Cross-Over|Withdrawal by Subject|2
1991718|NCT00064350|3557672|FG001|Cross-Over|Withdrawal by Subject|2
1991719|NCT00064350|3557673|FG002|Cross-Over|Withdrawal by Subject|0
1991720|NCT00064350|3557671|FG000|Cross-Over|Ineligible or never started treatment|3
1991721|NCT00064350|3557672|FG001|Cross-Over|Ineligible or never started treatment|6
1991722|NCT00064350|3557673|FG002|Cross-Over|Ineligible or never started treatment|0
1991723|NCT00064350|3557671|FG000|Cross-Over|Other|0
1991724|NCT00064350|3557672|FG001|Cross-Over|Other|2
1991725|NCT00064350|3557673|FG002|Cross-Over|Other|0
1991726|NCT00064662|3557684|FG000|Overall Study|Death|1
1991727|NCT00064662|3557685|FG001|Overall Study|Death|1
1991728|NCT00064662|3557684|FG000|Overall Study|Lost to Follow-up|57
1991729|NCT00064662|3557685|FG001|Overall Study|Lost to Follow-up|44
1991730|NCT00064662|3557684|FG000|Overall Study|Withdrawal by Subject|14
1991731|NCT00064662|3557685|FG001|Overall Study|Withdrawal by Subject|14
1991732|NCT00064662|3557684|FG000|Overall Study|Administratively withdrawn|2
1991733|NCT00064662|3557685|FG001|Overall Study|Administratively withdrawn|2
1991734|NCT00064701|3557694|FG000|One Year Post-transplant|Did not receive study drug|7
1991735|NCT00064701|3557695|FG001|One Year Post-transplant|Did not receive study drug|12
1991736|NCT00064701|3557696|FG002|One Year Post-transplant|Did not receive study drug|11
1991737|NCT00064701|3557694|FG000|One Year Post-transplant|Adverse Event|23
1991738|NCT00064701|3557695|FG001|One Year Post-transplant|Adverse Event|19
1991739|NCT00064701|3557696|FG002|One Year Post-transplant|Adverse Event|37
1991740|NCT00064701|3557694|FG000|One Year Post-transplant|Rejection|0
1991741|NCT00064701|3557695|FG001|One Year Post-transplant|Rejection|1
1991742|NCT00064701|3557696|FG002|One Year Post-transplant|Rejection|16
1991743|NCT00064701|3557694|FG000|One Year Post-transplant|Non-compliance|4
1991744|NCT00064701|3557695|FG001|One Year Post-transplant|Non-compliance|2
1991745|NCT00064701|3557696|FG002|One Year Post-transplant|Non-compliance|5
1991746|NCT00064701|3557694|FG000|One Year Post-transplant|Graft Failure|3
1991747|NCT00064701|3557695|FG001|One Year Post-transplant|Graft Failure|2
1991748|NCT00064701|3557696|FG002|One Year Post-transplant|Graft Failure|1
1991749|NCT00064701|3557694|FG000|One Year Post-transplant|Withdrawal by Subject|0
1991750|NCT00064701|3557695|FG001|One Year Post-transplant|Withdrawal by Subject|4
1991751|NCT00064701|3557696|FG002|One Year Post-transplant|Withdrawal by Subject|1
1991752|NCT00064701|3557694|FG000|One Year Post-transplant|Lost to Follow-up|1
1991753|NCT00064701|3557695|FG001|One Year Post-transplant|Lost to Follow-up|0
1991754|NCT00064701|3557696|FG002|One Year Post-transplant|Lost to Follow-up|0
1991755|NCT00064701|3557694|FG000|One Year Post-transplant|Converted to rapamycin|1
1991756|NCT00064701|3557695|FG001|One Year Post-transplant|Converted to rapamycin|0
1991757|NCT00064701|3557696|FG002|One Year Post-transplant|Converted to rapamycin|0
1991758|NCT00064701|3557694|FG000|One Year Post-transplant|Acute tubular necrosis|1
1991759|NCT00064701|3557695|FG001|One Year Post-transplant|Acute tubular necrosis|0
1991760|NCT00064701|3557696|FG002|One Year Post-transplant|Acute tubular necrosis|0
1991761|NCT00064701|3557694|FG000|One Year Post-transplant|Incorrect study drug dispensed|0
1991762|NCT00064701|3557695|FG001|One Year Post-transplant|Incorrect study drug dispensed|1
1991763|NCT00064701|3557696|FG002|One Year Post-transplant|Incorrect study drug dispensed|0
1991764|NCT00064701|3557694|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0
1991765|NCT00064701|3557695|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1
1991766|NCT00064701|3557696|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0
1991767|NCT00064701|3557694|FG000|One Year Post-transplant|Poor absorption|0
1991768|NCT00064701|3557695|FG001|One Year Post-transplant|Poor absorption|1
1991769|NCT00064701|3557696|FG002|One Year Post-transplant|Poor absorption|0
1991770|NCT00064701|3557694|FG000|One Year Post-transplant|Pancreas transplant|0
1991771|NCT00064701|3557695|FG001|One Year Post-transplant|Pancreas transplant|0
1991772|NCT00064701|3557696|FG002|One Year Post-transplant|Pancreas transplant|1
1991773|NCT00064701|3557694|FG000|Clinical Continuation Phase|Adverse Event|12
1991774|NCT00064701|3557695|FG001|Clinical Continuation Phase|Adverse Event|21
1991775|NCT00064701|3557696|FG002|Clinical Continuation Phase|Adverse Event|14
1991776|NCT00064701|3557694|FG000|Clinical Continuation Phase|Non-compliance|8
1991777|NCT00064701|3557695|FG001|Clinical Continuation Phase|Non-compliance|6
1991778|NCT00064701|3557696|FG002|Clinical Continuation Phase|Non-compliance|7
1991779|NCT00064701|3557694|FG000|Clinical Continuation Phase|Withdrawal by Subject|22
1991780|NCT00064701|3557695|FG001|Clinical Continuation Phase|Withdrawal by Subject|3
1991781|NCT00064701|3557696|FG002|Clinical Continuation Phase|Withdrawal by Subject|22
1991782|NCT00064701|3557694|FG000|Clinical Continuation Phase|Lost to Follow-up|6
1991783|NCT00064701|3557695|FG001|Clinical Continuation Phase|Lost to Follow-up|3
1991784|NCT00064701|3557696|FG002|Clinical Continuation Phase|Lost to Follow-up|6
1991785|NCT00064701|3557694|FG000|Clinical Continuation Phase|Graft Failure|5
1991786|NCT00064701|3557695|FG001|Clinical Continuation Phase|Graft Failure|5
1991787|NCT00064701|3557696|FG002|Clinical Continuation Phase|Graft Failure|2
1991788|NCT00064701|3557694|FG000|Clinical Continuation Phase|Rejection|1
1991789|NCT00064701|3557695|FG001|Clinical Continuation Phase|Rejection|2
1991790|NCT00064701|3557696|FG002|Clinical Continuation Phase|Rejection|2
1991791|NCT00064701|3557694|FG000|Clinical Continuation Phase|Sponsor discontinued study|113
1991792|NCT00064701|3557695|FG001|Clinical Continuation Phase|Sponsor discontinued study|129
1991793|NCT00064701|3557696|FG002|Clinical Continuation Phase|Sponsor discontinued study|79
1991794|NCT00064701|3557694|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
1991795|NCT00064701|3557695|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
1991796|NCT00064701|3557696|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
1991797|NCT00064701|3557694|FG000|Clinical Continuation Phase|Physician Decision|1
1991798|NCT00064701|3557695|FG001|Clinical Continuation Phase|Physician Decision|3
1991799|NCT00064701|3557696|FG002|Clinical Continuation Phase|Physician Decision|0
1991800|NCT00064701|3557694|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1
1991801|NCT00064701|3557695|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0
1991802|NCT00064701|3557696|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1
1991803|NCT00064701|3557694|FG000|Clinical Continuation Phase|Pancreas transplant|1
1991804|NCT00064701|3557695|FG001|Clinical Continuation Phase|Pancreas transplant|0
1991805|NCT00064701|3557696|FG002|Clinical Continuation Phase|Pancreas transplant|0
1991806|NCT00064701|3557694|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
1991807|NCT00064701|3557695|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
1991808|NCT00064701|3557696|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
1991809|NCT00064701|3557694|FG000|Clinical Continuation Phase|Discharged to nursing home|0
1991810|NCT00064701|3557695|FG001|Clinical Continuation Phase|Discharged to nursing home|1
1991811|NCT00064701|3557696|FG002|Clinical Continuation Phase|Discharged to nursing home|0
1991812|NCT00064701|3557694|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0
1991813|NCT00064701|3557695|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1
1991814|NCT00064701|3557696|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0
1991815|NCT00064701|3557694|FG000|Clinical Continuation Phase|Patient opted out|0
1991816|NCT00064701|3557695|FG001|Clinical Continuation Phase|Patient opted out|0
1991817|NCT00064701|3557696|FG002|Clinical Continuation Phase|Patient opted out|1
1991818|NCT00064753|3557706|FG000|Overall Study|Death|251
1991819|NCT00064753|3557707|FG001|Overall Study|Death|242
1991820|NCT00064753|3557706|FG000|Overall Study|Withdrawal by Subject|198
1991821|NCT00064753|3557707|FG001|Overall Study|Withdrawal by Subject|171
1991822|NCT00064753|3557706|FG000|Overall Study|Lost to Follow-up|225
1991823|NCT00064753|3557707|FG001|Overall Study|Lost to Follow-up|235
1991824|NCT00064792|3557715|FG000|Overall Study|Withdrawal by Subject|2
1991825|NCT00064792|3557716|FG001|Overall Study|Withdrawal by Subject|0
1991826|NCT00064792|3557715|FG000|Overall Study|Adverse Event|3
1991827|NCT00064792|3557716|FG001|Overall Study|Adverse Event|0
1991828|NCT00064987|3557733|FG000|Overall Study|Physician Decision|3
1991829|NCT00064987|3557734|FG001|Overall Study|Physician Decision|0
1991830|NCT00065065|3557742|FG000|Overall Study|Adverse Event|3
1991831|NCT00065065|3557743|FG001|Overall Study|Adverse Event|2
1991832|NCT00065065|3557742|FG000|Overall Study|Withdrawal by Subject|1
1991833|NCT00065065|3557743|FG001|Overall Study|Withdrawal by Subject|5
1991834|NCT00065065|3557742|FG000|Overall Study|Lack of Efficacy|4
1991835|NCT00065065|3557743|FG001|Overall Study|Lack of Efficacy|11
1991836|NCT00065065|3557742|FG000|Overall Study|Other|2
1991837|NCT00065065|3557743|FG001|Overall Study|Other|2
1991838|NCT00065156|3557751|FG000|Overall Study|Adverse Event|37
1991839|NCT00065156|3557751|FG000|Overall Study|Lack of Efficacy|52
1991840|NCT00065156|3557751|FG000|Overall Study|Withdrawal by Subject|8
1991841|NCT00065156|3557751|FG000|Overall Study|Lost to Follow-up|1
1991842|NCT00065156|3557751|FG000|Overall Study|Death|11
1991843|NCT00065156|3557751|FG000|Overall Study|Study Closed by Sponsor|2
1991844|NCT00065156|3557751|FG000|Overall Study|Disease Progression|7
1991845|NCT00065156|3557751|FG000|Overall Study|Investigator Decision|2
1991846|NCT00065156|3557751|FG000|Overall Study|Non-Compliance|2
1991847|NCT00065156|3557751|FG000|Overall Study|Loss of Response|1
1991848|NCT00065156|3557751|FG000|Overall Study|Secondary Malign Disease|1
1991849|NCT00065182|3557757|FG000|Overall Study|Adverse Event|24
1991850|NCT00065182|3557758|FG001|Overall Study|Adverse Event|17
1991851|NCT00065182|3557757|FG000|Overall Study|Lost to Follow-up|0
1991852|NCT00065182|3557758|FG001|Overall Study|Lost to Follow-up|4
1991853|NCT00065182|3557757|FG000|Overall Study|Protocol Violation|3
1991854|NCT00065182|3557758|FG001|Overall Study|Protocol Violation|4
1991855|NCT00065182|3557757|FG000|Overall Study|Serious adverse events (SAE)|1
1991856|NCT00065182|3557758|FG001|Overall Study|Serious adverse events (SAE)|0
1991857|NCT00065182|3557757|FG000|Overall Study|Sponsor Decision|11
1991858|NCT00065182|3557758|FG001|Overall Study|Sponsor Decision|7
1991859|NCT00065182|3557757|FG000|Overall Study|Withdrawal by Subject|8
1991860|NCT00065182|3557758|FG001|Overall Study|Withdrawal by Subject|3
1991861|NCT00065182|3557757|FG000|Overall Study|No clinical benefit|1
1991862|NCT00065182|3557758|FG001|Overall Study|No clinical benefit|0
1991863|NCT00065182|3557757|FG000|Overall Study|Death|0
1991864|NCT00065182|3557758|FG001|Overall Study|Death|1
1991865|NCT00065182|3557757|FG000|Overall Study|Decline in Status|0
1991866|NCT00065182|3557758|FG001|Overall Study|Decline in Status|1
1991867|NCT00065260|3557766|FG000|Overall Study|Death|0
1991868|NCT00065260|3557767|FG001|Overall Study|Death|1
1991869|NCT00065429|3557780|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1991870|NCT00065429|3557781|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1991871|NCT00065429|3557782|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1991872|NCT00065429|3557783|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1991873|NCT00065429|3557784|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1991874|NCT00065429|3557785|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
1991875|NCT00065429|3557786|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1991876|NCT00065429|3557780|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1991877|NCT00065429|3557781|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1991878|NCT00065429|3557782|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
1991879|NCT00065429|3557783|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1991880|NCT00065429|3557784|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1991881|NCT00065429|3557785|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1991882|NCT00065429|3557786|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1991883|NCT00065429|3557780|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1
1991884|NCT00065429|3557781|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0
1991885|NCT00065429|3557782|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0
1991886|NCT00065429|3557783|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0
1991887|NCT00065429|3557784|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0
1991888|NCT00065429|3557785|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0
1991889|NCT00065429|3557786|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0
1991890|NCT00065429|3557780|FG000|Phase I - May 2001 - Oct 2002|Death|0
1991891|NCT00065429|3557781|FG001|Phase I - May 2001 - Oct 2002|Death|0
1991892|NCT00065429|3557782|FG002|Phase I - May 2001 - Oct 2002|Death|0
1991893|NCT00065429|3557783|FG003|Phase I - May 2001 - Oct 2002|Death|0
1991894|NCT00065429|3557784|FG004|Phase I - May 2001 - Oct 2002|Death|1
1991895|NCT00065429|3557785|FG005|Phase I - May 2001 - Oct 2002|Death|0
1991896|NCT00065429|3557786|FG006|Phase I - May 2001 - Oct 2002|Death|0
1991897|NCT00065429|3557780|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0
1991898|NCT00065429|3557781|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0
1991899|NCT00065429|3557782|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0
1991900|NCT00065429|3557783|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1
1991901|NCT00065429|3557784|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0
1991902|NCT00065429|3557785|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1
1991903|NCT00065429|3557786|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2
1991904|NCT00065429|3557780|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1991905|NCT00065429|3557781|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1991906|NCT00065429|3557782|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1991907|NCT00065429|3557783|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1991908|NCT00065429|3557784|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
1991909|NCT00065429|3557785|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1991910|NCT00065429|3557786|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1991911|NCT00065429|3557780|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1991912|NCT00065429|3557781|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1991913|NCT00065429|3557782|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1991914|NCT00065429|3557783|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1991915|NCT00065429|3557784|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
1991916|NCT00065429|3557785|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1991917|NCT00065429|3557786|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1991918|NCT00065442|3557799|FG000|Overall Study|Lost to Follow-up|1
1991919|NCT00065442|3557800|FG001|Overall Study|Lost to Follow-up|1
1991920|NCT00065442|3557799|FG000|Overall Study|Death|121
1991921|NCT00065442|3557800|FG001|Overall Study|Death|210
1991922|NCT00065442|3557799|FG000|Overall Study|Withdrawal by Subject|3
1991923|NCT00065442|3557800|FG001|Overall Study|Withdrawal by Subject|9
1991924|NCT00065468|3557809|FG000|Overall Study|Death|172
1991925|NCT00065468|3557810|FG001|Overall Study|Death|169
1991926|NCT00065468|3557811|FG002|Overall Study|Death|171
1991927|NCT00065468|3557809|FG000|Overall Study|Withdrawal by Subject|3
1991928|NCT00065468|3557810|FG001|Overall Study|Withdrawal by Subject|4
1991929|NCT00065468|3557811|FG002|Overall Study|Withdrawal by Subject|5
1991930|NCT00065468|3557809|FG000|Overall Study|Lost to Follow-up|5
1991931|NCT00065468|3557810|FG001|Overall Study|Lost to Follow-up|3
1991932|NCT00065468|3557811|FG002|Overall Study|Lost to Follow-up|2
1991933|NCT00065468|3557809|FG000|Overall Study|Discontinuation of study by Sponsor|13
1991934|NCT00065468|3557810|FG001|Overall Study|Discontinuation of study by Sponsor|9
1991935|NCT00065468|3557811|FG002|Overall Study|Discontinuation of study by Sponsor|13
1991936|NCT00065468|3557809|FG000|Overall Study|Disease progression|0
1991937|NCT00065468|3557810|FG001|Overall Study|Disease progression|0
1991938|NCT00065468|3557811|FG002|Overall Study|Disease progression|1
1991939|NCT00065468|3557809|FG000|Overall Study|Other|14
1991940|NCT00065468|3557810|FG001|Overall Study|Other|24
1991941|NCT00065468|3557811|FG002|Overall Study|Other|18
1991942|NCT00065507|3557821|FG000|Overall Study|Death|16
1991943|NCT00065507|3557822|FG001|Overall Study|Death|17
1991944|NCT00065507|3557821|FG000|Overall Study|Adverse Event|4
1991945|NCT00065507|3557822|FG001|Overall Study|Adverse Event|3
1991946|NCT00065507|3557821|FG000|Overall Study|Lack of Efficacy|0
1991947|NCT00065507|3557822|FG001|Overall Study|Lack of Efficacy|6
1991948|NCT00065507|3557821|FG000|Overall Study|Poor/Non-compliance|3
1991949|NCT00065507|3557822|FG001|Overall Study|Poor/Non-compliance|2
1991950|NCT00065507|3557821|FG000|Overall Study|Lost to Follow-up|3
1991951|NCT00065507|3557822|FG001|Overall Study|Lost to Follow-up|0
1991952|NCT00065507|3557821|FG000|Overall Study|Subject Withdrew Consent|2
1991953|NCT00065507|3557822|FG001|Overall Study|Subject Withdrew Consent|1
1991954|NCT00065507|3557821|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
1991955|NCT00065507|3557822|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
1991956|NCT00066066|3557853|FG000|Overall Study|Lost to Follow-up|6
1991957|NCT00066066|3557854|FG001|Overall Study|Lost to Follow-up|4
1991958|NCT00066066|3557855|FG002|Overall Study|Lost to Follow-up|7
1991959|NCT00066066|3557856|FG003|Overall Study|Lost to Follow-up|4
1991960|NCT00066066|3557857|FG004|Overall Study|Lost to Follow-up|3
1991961|NCT00066066|3557858|FG005|Overall Study|Lost to Follow-up|5
1991962|NCT00066170|3557876|FG000|Overall Study|Adverse Event|2
1991963|NCT00066170|3557877|FG001|Overall Study|Adverse Event|4
1991964|NCT00066170|3557878|FG002|Overall Study|Adverse Event|1
1991965|NCT00066170|3557879|FG003|Overall Study|Adverse Event|7
1991966|NCT00066170|3557876|FG000|Overall Study|Serious Adverse Event|0
1991967|NCT00066170|3557877|FG001|Overall Study|Serious Adverse Event|0
1991968|NCT00066170|3557878|FG002|Overall Study|Serious Adverse Event|1
1991969|NCT00066170|3557879|FG003|Overall Study|Serious Adverse Event|1
1991970|NCT00066170|3557876|FG000|Overall Study|Lost to Follow-up|0
1991971|NCT00066170|3557877|FG001|Overall Study|Lost to Follow-up|1
1991972|NCT00066170|3557878|FG002|Overall Study|Lost to Follow-up|0
1991973|NCT00066170|3557879|FG003|Overall Study|Lost to Follow-up|0
1991974|NCT00066170|3557876|FG000|Overall Study|Non-Compliance with Trial Medicine|1
1991975|NCT00066170|3557877|FG001|Overall Study|Non-Compliance with Trial Medicine|0
1991976|NCT00066170|3557878|FG002|Overall Study|Non-Compliance with Trial Medicine|0
1991977|NCT00066170|3557879|FG003|Overall Study|Non-Compliance with Trial Medicine|1
1991978|NCT00066170|3557876|FG000|Overall Study|Protocol Violation|3
1991979|NCT00066170|3557877|FG001|Overall Study|Protocol Violation|0
1991980|NCT00066170|3557878|FG002|Overall Study|Protocol Violation|0
1991981|NCT00066170|3557879|FG003|Overall Study|Protocol Violation|0
1991982|NCT00066170|3557876|FG000|Overall Study|Other|1
1991983|NCT00066170|3557877|FG001|Overall Study|Other|5
1991984|NCT00066170|3557878|FG002|Overall Study|Other|2
1991985|NCT00066170|3557879|FG003|Overall Study|Other|0
1991986|NCT00066222|3557889|FG000|Overall Study|No protocol treatment received|1
1991987|NCT00066365|3557895|FG000|Overall Study|Adverse Event|1
1991988|NCT00066365|3557896|FG001|Overall Study|Adverse Event|0
1991989|NCT00066365|3557895|FG000|Overall Study|Lack of Efficacy|15
1991990|NCT00066365|3557896|FG001|Overall Study|Lack of Efficacy|12
1991991|NCT00066365|3557895|FG000|Overall Study|Physician Decision|1
1991992|NCT00066365|3557896|FG001|Overall Study|Physician Decision|0
1991993|NCT00066365|3557895|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2
1991994|NCT00066365|3557896|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0
1991995|NCT00066365|3557895|FG000|Overall Study|Ineligible|4
1991996|NCT00066365|3557896|FG001|Overall Study|Ineligible|2
1991997|NCT00066469|3557904|FG000|Overall Study|Death|3
1991998|NCT00066469|3557904|FG000|Overall Study|Lack of Efficacy|9
1991999|NCT00066469|3557904|FG000|Overall Study|Lost to Follow-up|1
1992000|NCT00066469|3557904|FG000|Overall Study|Physician Decision|1
1992001|NCT00066469|3557904|FG000|Overall Study|Withdrawal by Subject|1
1992002|NCT00066469|3557904|FG000|Overall Study|ineligible|1
1992003|NCT00066573|3557910|FG000|Overall Study|Did not received protocol treatment|28
1992004|NCT00066573|3557911|FG001|Overall Study|Did not received protocol treatment|28
1992005|NCT00066690|3557929|FG000|Overall Study|Adverse Event|145
1992006|NCT00066690|3557930|FG001|Overall Study|Adverse Event|58
1992007|NCT00066690|3557931|FG002|Overall Study|Adverse Event|126
1992008|NCT00066690|3557929|FG000|Overall Study|Death|3
1992009|NCT00066690|3557930|FG001|Overall Study|Death|0
1992010|NCT00066690|3557931|FG002|Overall Study|Death|2
1992011|NCT00066690|3557929|FG000|Overall Study|Lack of Efficacy|114
1992012|NCT00066690|3557930|FG001|Overall Study|Lack of Efficacy|110
1992013|NCT00066690|3557931|FG002|Overall Study|Lack of Efficacy|76
1992014|NCT00066690|3557929|FG000|Overall Study|Lost to Follow-up|40
1992015|NCT00066690|3557930|FG001|Overall Study|Lost to Follow-up|21
1992016|NCT00066690|3557931|FG002|Overall Study|Lost to Follow-up|29
1992017|NCT00066690|3557929|FG000|Overall Study|Withdrawal by Subject|50
1992018|NCT00066690|3557930|FG001|Overall Study|Withdrawal by Subject|55
1992019|NCT00066690|3557931|FG002|Overall Study|Withdrawal by Subject|49
1992020|NCT00066690|3557929|FG000|Overall Study|Treatment Ongoing|246
1992021|NCT00066690|3557930|FG001|Overall Study|Treatment Ongoing|278
1992022|NCT00066690|3557931|FG002|Overall Study|Treatment Ongoing|282
1992023|NCT00066703|3557944|FG000|Overall Study|Adverse Event|80
1992024|NCT00066703|3557945|FG001|Overall Study|Adverse Event|111
1992025|NCT00066703|3557944|FG000|Overall Study|Death|3
1992026|NCT00066703|3557945|FG001|Overall Study|Death|0
1992027|NCT00066703|3557944|FG000|Overall Study|Lack of Efficacy|114
1992028|NCT00066703|3557945|FG001|Overall Study|Lack of Efficacy|69
1992029|NCT00066703|3557944|FG000|Overall Study|Lost to Follow-up|31
1992030|NCT00066703|3557945|FG001|Overall Study|Lost to Follow-up|28
1992031|NCT00066703|3557944|FG000|Overall Study|Withdrawal by Subject|38
1992032|NCT00066703|3557945|FG001|Overall Study|Withdrawal by Subject|63
1992033|NCT00066703|3557944|FG000|Overall Study|Treatment ongoing|346
1992034|NCT00066703|3557945|FG001|Overall Study|Treatment ongoing|311
1992035|NCT00066729|3557951|FG000|Overall Study|Lost to Follow-up|1
1992036|NCT00066729|3557951|FG000|Overall Study|Disease progression|1
1992037|NCT00066742|3557955|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
1992038|NCT00066742|3557955|FG000|Induction Chemoradiotherapy|Adverse Event|21
1992039|NCT00066742|3557955|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2
1992040|NCT00066742|3557955|FG000|Induction Chemoradiotherapy|not protocol specified|2
1992041|NCT00066742|3557955|FG000|Induction Chemoradiotherapy|Ineligible|3
1992042|NCT00066742|3557955|FG000|Consolidation Chemotherapy|not protocol specified|1
1992043|NCT00066742|3557955|FG000|Consolidation Chemotherapy|Ineligible|2
1992044|NCT00067002|3558002|FG000|Overall Study|Early Death|1
1992045|NCT00067002|3558003|FG001|Overall Study|Early Death|2
1992046|NCT00067002|3558002|FG000|Overall Study|Delayed|1
1992047|NCT00067002|3558003|FG001|Overall Study|Delayed|1
1992048|NCT00067002|3558002|FG000|Overall Study|Graft Failure|5
1992049|NCT00067002|3558003|FG001|Overall Study|Graft Failure|6
1992050|NCT00067470|3558035|FG000|Overall Study|Withdrawal by Subject|0
1992051|NCT00067470|3558036|FG001|Overall Study|Withdrawal by Subject|1
2024547|NCT00335153|3593030|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
2024548|NCT00335153|3593030|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
2024549|NCT00335153|3593030|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13
2024550|NCT00335153|3593030|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
2024551|NCT00335322|3593065|FG000|Overall Study|Randomised but withdrew prior to ART sta|1
2024552|NCT00335322|3593066|FG001|Overall Study|Randomised but withdrew prior to ART sta|2
2024553|NCT00335322|3593067|FG002|Overall Study|Randomised but withdrew prior to ART sta|2
2024554|NCT00335452|3593082|FG000|Overall Study|Death|156
2213586|NCT01681186|3855422|FG006|Fourth Intervention|Protocol Violation|0
2213587|NCT01681186|3855423|FG007|Fourth Intervention|Protocol Violation|1
2024555|NCT00335452|3593083|FG001|Overall Study|Death|144
2024556|NCT00335452|3593084|FG002|Overall Study|Death|158
2024557|NCT00335452|3593085|FG003|Overall Study|Death|129
2024558|NCT00335452|3593082|FG000|Overall Study|Lost to Follow-up|2
2024559|NCT00335452|3593083|FG001|Overall Study|Lost to Follow-up|3
2024560|NCT00335452|3593084|FG002|Overall Study|Lost to Follow-up|1
2024561|NCT00335452|3593085|FG003|Overall Study|Lost to Follow-up|2
2024562|NCT00335556|3593131|FG000|Overall Study|Death|0
2024563|NCT00335556|3593132|FG001|Overall Study|Death|5
2024564|NCT00335556|3593133|FG002|Overall Study|Death|0
2024565|NCT00335556|3593134|FG003|Overall Study|Death|0
2024566|NCT00335556|3593135|FG004|Overall Study|Death|1
2024567|NCT00335556|3593136|FG005|Overall Study|Death|0
2024568|NCT00335556|3593131|FG000|Overall Study|Lack of Efficacy|0
2024569|NCT00335556|3593132|FG001|Overall Study|Lack of Efficacy|19
2024570|NCT00335556|3593133|FG002|Overall Study|Lack of Efficacy|3
2024571|NCT00335556|3593134|FG003|Overall Study|Lack of Efficacy|3
2024572|NCT00335556|3593135|FG004|Overall Study|Lack of Efficacy|0
2024573|NCT00335556|3593136|FG005|Overall Study|Lack of Efficacy|1
2024574|NCT00335556|3593131|FG000|Overall Study|Physician Decision|0
2024575|NCT00335556|3593132|FG001|Overall Study|Physician Decision|6
2024576|NCT00335556|3593133|FG002|Overall Study|Physician Decision|2
2024577|NCT00335556|3593134|FG003|Overall Study|Physician Decision|1
2024578|NCT00335556|3593135|FG004|Overall Study|Physician Decision|0
2024579|NCT00335556|3593136|FG005|Overall Study|Physician Decision|0
2024580|NCT00335556|3593131|FG000|Overall Study|Ineligible|2
2024581|NCT00335556|3593132|FG001|Overall Study|Ineligible|0
2024582|NCT00335556|3593133|FG002|Overall Study|Ineligible|0
2024583|NCT00335556|3593134|FG003|Overall Study|Ineligible|0
2024584|NCT00335556|3593135|FG004|Overall Study|Ineligible|0
2024585|NCT00335556|3593136|FG005|Overall Study|Ineligible|0
2024586|NCT00335556|3593131|FG000|Overall Study|Refusal of further protocol therapy|0
2024587|NCT00335556|3593132|FG001|Overall Study|Refusal of further protocol therapy|4
2024588|NCT00335556|3593133|FG002|Overall Study|Refusal of further protocol therapy|0
2024589|NCT00335556|3593134|FG003|Overall Study|Refusal of further protocol therapy|1
2024590|NCT00335556|3593135|FG004|Overall Study|Refusal of further protocol therapy|0
2024591|NCT00335556|3593136|FG005|Overall Study|Refusal of further protocol therapy|0
2024592|NCT00335738|3593167|FG000|Overall Study|Physician Decision|6
2024593|NCT00335738|3593168|FG001|Overall Study|Physician Decision|0
2024594|NCT00335738|3593167|FG000|Overall Study|Withdrawal by Subject|2
2024595|NCT00335738|3593168|FG001|Overall Study|Withdrawal by Subject|0
2024596|NCT00335738|3593167|FG000|Overall Study|Ineligible|3
2024597|NCT00335738|3593168|FG001|Overall Study|Ineligible|4
2024598|NCT00335764|3593180|FG000|Overall Study|wrong histology|1
2024599|NCT00335764|3593181|FG001|Overall Study|wrong histology|0
2024600|NCT00335764|3593182|FG002|Overall Study|wrong histology|0
2024601|NCT00335764|3593183|FG003|Overall Study|wrong histology|0
2024602|NCT00335764|3593184|FG004|Overall Study|wrong histology|1
2024603|NCT00335829|3593220|FG000|Overall Study|Withdrawal by Subject|1
2024604|NCT00335829|3593220|FG000|Overall Study|Lost to Follow-up|1
2024605|NCT00335829|3593220|FG000|Overall Study|Adverse Event|1
2024606|NCT00335959|3593224|FG000|Overall Study|Adverse Event|2
2024607|NCT00335959|3593224|FG000|Overall Study|Ineligible|1
2024608|NCT00335972|3593231|FG000|Overall Study|not given treatments|0
2024609|NCT00335972|3593232|FG001|Overall Study|not given treatments|3
2024610|NCT00336024|3593240|FG000|Overall Study|Death|2
2024611|NCT00336024|3593241|FG001|Overall Study|Death|1
2024612|NCT00336024|3593240|FG000|Overall Study|Physician Decision|4
2024613|NCT00336024|3593241|FG001|Overall Study|Physician Decision|1
2024614|NCT00336024|3593240|FG000|Overall Study|Protocol Violation|1
2024615|NCT00336024|3593241|FG001|Overall Study|Protocol Violation|0
2024616|NCT00336024|3593240|FG000|Overall Study|Withdrawal by Subject|1
2024617|NCT00336024|3593241|FG001|Overall Study|Withdrawal by Subject|2
2024618|NCT00336024|3593240|FG000|Overall Study|Failure to fulfill consolidation|1
2024619|NCT00336024|3593241|FG001|Overall Study|Failure to fulfill consolidation|1
2024620|NCT00336024|3593240|FG000|Overall Study|Progressive Disease|4
2024621|NCT00336024|3593241|FG001|Overall Study|Progressive Disease|7
2024622|NCT00336024|3593240|FG000|Overall Study|Ineligible|7
2024623|NCT00336024|3593241|FG001|Overall Study|Ineligible|7
2024624|NCT00336284|3593253|FG000|Overall Study|Death|52
1992052|NCT00067990|3558057|FG000|Overall Study|Death|5
1992053|NCT00067990|3558058|FG001|Overall Study|Death|7
1992054|NCT00067990|3558057|FG000|Overall Study|ESRD, Non IF/TA|1
1992055|NCT00067990|3558058|FG001|Overall Study|ESRD, Non IF/TA|3
1992056|NCT00067990|3558057|FG000|Overall Study|Withdrawal by Subject|4
1992057|NCT00067990|3558058|FG001|Overall Study|Withdrawal by Subject|12
1992058|NCT00068107|3558064|FG000|Overall Study|end-stage renal disease|6
1992059|NCT00068107|3558064|FG000|Overall Study|Death|2
1992060|NCT00068107|3558064|FG000|Overall Study|Withdrawal by Subject|1
1992061|NCT00068237|3558071|FG000|Overall Study|Ineligible|3
1992062|NCT00068237|3558071|FG000|Overall Study|No protocol treatment received|2
1992063|NCT00068250|3558078|FG000|Phase I: Dose Level 2|Protocol Violation|0
1992064|NCT00068250|3558079|FG001|Phase I: Dose Level 2|Protocol Violation|1
1992065|NCT00068250|3558080|FG002|Phase I: Dose Level 2|Protocol Violation|0
1992066|NCT00068250|3558081|FG003|Phase I: Dose Level 2|Protocol Violation|0
1992067|NCT00068380|3558119|FG000|Overall Study|Withdrawal by Subject|3
1992068|NCT00068380|3558119|FG000|Overall Study|Adverse Event|2
1992069|NCT00068393|3558123|FG000|Overall Study|Adverse Event|2
1992070|NCT00068393|3558123|FG000|Overall Study|Death|3
1992071|NCT00068393|3558123|FG000|Overall Study|Withdrawal by Subject|3
1992072|NCT00068393|3558123|FG000|Overall Study|Alternative treatment|1
1992073|NCT00068393|3558123|FG000|Overall Study|Quality of life worsening|1
1992074|NCT00068406|3558127|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1
1992075|NCT00068406|3558127|FG000|Overall Study|Ineligible-Inadequate Pathology|2
1992076|NCT00068419|3558131|FG000|Overall Study|Adverse Event|3
1992077|NCT00068419|3558131|FG000|Overall Study|Lack of Efficacy|24
1992078|NCT00068419|3558131|FG000|Overall Study|Lost to Follow-up|1
1992079|NCT00068419|3558131|FG000|Overall Study|Physician Decision|7
1992080|NCT00068419|3558131|FG000|Overall Study|Withdrawal by Subject|14
1992081|NCT00068419|3558131|FG000|Overall Study|Ineligible|11
1992082|NCT00068445|3558137|FG000|Randomization|Cancel|1
1992083|NCT00068445|3558138|FG001|Randomization|Cancel|3
1992084|NCT00068445|3558137|FG000|Randomization|Ineligible|1
1992085|NCT00068445|3558138|FG001|Randomization|Ineligible|1
1992086|NCT00068445|3558137|FG000|Treatment|Refused Further Treatment|13
1992087|NCT00068445|3558138|FG001|Treatment|Refused Further Treatment|10
1992088|NCT00068445|3558137|FG000|Treatment|Adverse Event|7
1992089|NCT00068445|3558138|FG001|Treatment|Adverse Event|1
1992090|NCT00068445|3558137|FG000|Treatment|Other (Specifics not available)|9
1992091|NCT00068445|3558138|FG001|Treatment|Other (Specifics not available)|5
1992092|NCT00068588|3558151|FG000|Overall Study|Adverse Event|0
1992093|NCT00068588|3558152|FG001|Overall Study|Adverse Event|0
1992094|NCT00068588|3558153|FG002|Overall Study|Adverse Event|2
1992095|NCT00068588|3558151|FG000|Overall Study|Withdrawal by Subject|0
1992096|NCT00068588|3558152|FG001|Overall Study|Withdrawal by Subject|0
1992097|NCT00068588|3558153|FG002|Overall Study|Withdrawal by Subject|1
1992098|NCT00068588|3558151|FG000|Overall Study|Poor KPS|0
1992099|NCT00068588|3558152|FG001|Overall Study|Poor KPS|0
1992100|NCT00068588|3558153|FG002|Overall Study|Poor KPS|1
1992101|NCT00068601|3558162|FG000|Overall Study|Ineligible|11
1992102|NCT00068601|3558163|FG001|Overall Study|Ineligible|13
1992103|NCT00068601|3558162|FG000|Overall Study|Not evaluable: withdrew consent|5
1992104|NCT00068601|3558163|FG001|Overall Study|Not evaluable: withdrew consent|4
1992105|NCT00068601|3558162|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
1992106|NCT00068601|3558163|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
1992107|NCT00068601|3558162|FG000|Overall Study|Death|11
1992108|NCT00068601|3558163|FG001|Overall Study|Death|3
1992109|NCT00068601|3558162|FG000|Overall Study|Lost to Follow-up|3
1992110|NCT00068601|3558163|FG001|Overall Study|Lost to Follow-up|2
1992111|NCT00068601|3558162|FG000|Overall Study|Missing primary outcome data|30
1992112|NCT00068601|3558163|FG001|Overall Study|Missing primary outcome data|34
1992113|NCT00068692|3558172|FG000|Step 1: Registration|Disese progression/relapse|5
1992114|NCT00068692|3558173|FG001|Step 1: Registration|Disese progression/relapse|0
1992115|NCT00068692|3558174|FG002|Step 1: Registration|Disese progression/relapse|0
1992116|NCT00068692|3558175|FG003|Step 1: Registration|Disese progression/relapse|0
1992117|NCT00068692|3558176|FG004|Step 1: Registration|Disese progression/relapse|0
1992118|NCT00068692|3558177|FG005|Step 1: Registration|Disese progression/relapse|0
1992119|NCT00068692|3558178|FG006|Step 1: Registration|Disese progression/relapse|0
1992120|NCT00068692|3558179|FG007|Step 1: Registration|Disese progression/relapse|0
1992121|NCT00068692|3558172|FG000|Step 1: Registration|Adverse Event|7
1992122|NCT00068692|3558173|FG001|Step 1: Registration|Adverse Event|0
1992123|NCT00068692|3558174|FG002|Step 1: Registration|Adverse Event|0
1992124|NCT00068692|3558175|FG003|Step 1: Registration|Adverse Event|0
1992125|NCT00068692|3558176|FG004|Step 1: Registration|Adverse Event|0
1992126|NCT00068692|3558177|FG005|Step 1: Registration|Adverse Event|0
1992127|NCT00068692|3558178|FG006|Step 1: Registration|Adverse Event|0
1992128|NCT00068692|3558179|FG007|Step 1: Registration|Adverse Event|0
1992129|NCT00068692|3558172|FG000|Step 1: Registration|Death|1
1992130|NCT00068692|3558173|FG001|Step 1: Registration|Death|0
1992131|NCT00068692|3558174|FG002|Step 1: Registration|Death|0
1992132|NCT00068692|3558175|FG003|Step 1: Registration|Death|0
1992133|NCT00068692|3558176|FG004|Step 1: Registration|Death|0
1992134|NCT00068692|3558177|FG005|Step 1: Registration|Death|0
1992135|NCT00068692|3558178|FG006|Step 1: Registration|Death|0
1992136|NCT00068692|3558179|FG007|Step 1: Registration|Death|0
1992137|NCT00068692|3558172|FG000|Step 1: Registration|Withdrawal by Subject|11
1992138|NCT00068692|3558173|FG001|Step 1: Registration|Withdrawal by Subject|0
1992139|NCT00068692|3558174|FG002|Step 1: Registration|Withdrawal by Subject|0
1992140|NCT00068692|3558175|FG003|Step 1: Registration|Withdrawal by Subject|0
1992141|NCT00068692|3558176|FG004|Step 1: Registration|Withdrawal by Subject|0
1992142|NCT00068692|3558177|FG005|Step 1: Registration|Withdrawal by Subject|0
1992143|NCT00068692|3558178|FG006|Step 1: Registration|Withdrawal by Subject|0
1992144|NCT00068692|3558179|FG007|Step 1: Registration|Withdrawal by Subject|0
1992145|NCT00068692|3558172|FG000|Step 1: Registration|Alternative therapy|2
1992146|NCT00068692|3558173|FG001|Step 1: Registration|Alternative therapy|0
1992147|NCT00068692|3558174|FG002|Step 1: Registration|Alternative therapy|0
1992148|NCT00068692|3558175|FG003|Step 1: Registration|Alternative therapy|0
1992149|NCT00068692|3558176|FG004|Step 1: Registration|Alternative therapy|0
1992150|NCT00068692|3558177|FG005|Step 1: Registration|Alternative therapy|0
1992151|NCT00068692|3558178|FG006|Step 1: Registration|Alternative therapy|0
1992152|NCT00068692|3558179|FG007|Step 1: Registration|Alternative therapy|0
1992153|NCT00068692|3558172|FG000|Step 1: Registration|Complicating disease|2
1992154|NCT00068692|3558173|FG001|Step 1: Registration|Complicating disease|0
1992155|NCT00068692|3558174|FG002|Step 1: Registration|Complicating disease|0
1992156|NCT00068692|3558175|FG003|Step 1: Registration|Complicating disease|0
1992157|NCT00068692|3558176|FG004|Step 1: Registration|Complicating disease|0
1992158|NCT00068692|3558177|FG005|Step 1: Registration|Complicating disease|0
1992159|NCT00068692|3558178|FG006|Step 1: Registration|Complicating disease|0
1992160|NCT00068692|3558179|FG007|Step 1: Registration|Complicating disease|0
1992161|NCT00068692|3558172|FG000|Step 1: Registration|Protocol Violation|1
1992162|NCT00068692|3558173|FG001|Step 1: Registration|Protocol Violation|0
1992163|NCT00068692|3558174|FG002|Step 1: Registration|Protocol Violation|0
1992164|NCT00068692|3558175|FG003|Step 1: Registration|Protocol Violation|0
1992165|NCT00068692|3558176|FG004|Step 1: Registration|Protocol Violation|0
1992166|NCT00068692|3558177|FG005|Step 1: Registration|Protocol Violation|0
1992167|NCT00068692|3558178|FG006|Step 1: Registration|Protocol Violation|0
1992168|NCT00068692|3558179|FG007|Step 1: Registration|Protocol Violation|0
1992169|NCT00068692|3558172|FG000|Step 1: Registration|Not eligible|6
1992170|NCT00068692|3558173|FG001|Step 1: Registration|Not eligible|0
1992171|NCT00068692|3558174|FG002|Step 1: Registration|Not eligible|0
1992172|NCT00068692|3558175|FG003|Step 1: Registration|Not eligible|0
1992173|NCT00068692|3558176|FG004|Step 1: Registration|Not eligible|0
1992174|NCT00068692|3558177|FG005|Step 1: Registration|Not eligible|0
1992175|NCT00068692|3558178|FG006|Step 1: Registration|Not eligible|0
1992176|NCT00068692|3558179|FG007|Step 1: Registration|Not eligible|0
1992177|NCT00068692|3558172|FG000|Step 1: Registration|Other|2
1992178|NCT00068692|3558173|FG001|Step 1: Registration|Other|0
1992179|NCT00068692|3558174|FG002|Step 1: Registration|Other|0
1992180|NCT00068692|3558175|FG003|Step 1: Registration|Other|0
1992181|NCT00068692|3558176|FG004|Step 1: Registration|Other|0
1992182|NCT00068692|3558177|FG005|Step 1: Registration|Other|0
1992183|NCT00068692|3558178|FG006|Step 1: Registration|Other|0
1992184|NCT00068692|3558179|FG007|Step 1: Registration|Other|0
1992185|NCT00068692|3558172|FG000|Step 1: Registration|Not start protocol therapy|3
1992186|NCT00068692|3558173|FG001|Step 1: Registration|Not start protocol therapy|0
1992187|NCT00068692|3558174|FG002|Step 1: Registration|Not start protocol therapy|0
1992188|NCT00068692|3558175|FG003|Step 1: Registration|Not start protocol therapy|0
1992189|NCT00068692|3558176|FG004|Step 1: Registration|Not start protocol therapy|0
1992190|NCT00068692|3558177|FG005|Step 1: Registration|Not start protocol therapy|0
1992191|NCT00068692|3558178|FG006|Step 1: Registration|Not start protocol therapy|0
1992192|NCT00068692|3558179|FG007|Step 1: Registration|Not start protocol therapy|0
1992193|NCT00068692|3558172|FG000|Step 1: Registration|Registered but not randomized|0
1992194|NCT00068692|3558173|FG001|Step 1: Registration|Registered but not randomized|1
1992195|NCT00068692|3558174|FG002|Step 1: Registration|Registered but not randomized|0
1992196|NCT00068692|3558175|FG003|Step 1: Registration|Registered but not randomized|0
1992197|NCT00068692|3558176|FG004|Step 1: Registration|Registered but not randomized|0
1992198|NCT00068692|3558177|FG005|Step 1: Registration|Registered but not randomized|0
1992199|NCT00068692|3558178|FG006|Step 1: Registration|Registered but not randomized|0
1992200|NCT00068692|3558179|FG007|Step 1: Registration|Registered but not randomized|0
1992201|NCT00068692|3558172|FG000|Step 2: Randomization|Disesae progression/replase|0
1992202|NCT00068692|3558173|FG001|Step 2: Randomization|Disesae progression/replase|0
1992203|NCT00068692|3558174|FG002|Step 2: Randomization|Disesae progression/replase|1
1992204|NCT00068692|3558175|FG003|Step 2: Randomization|Disesae progression/replase|1
1992205|NCT00068692|3558176|FG004|Step 2: Randomization|Disesae progression/replase|0
1992206|NCT00068692|3558177|FG005|Step 2: Randomization|Disesae progression/replase|0
1992207|NCT00068692|3558178|FG006|Step 2: Randomization|Disesae progression/replase|0
1992208|NCT00068692|3558179|FG007|Step 2: Randomization|Disesae progression/replase|0
1992209|NCT00068692|3558172|FG000|Step 2: Randomization|Adverse Event|0
1992210|NCT00068692|3558173|FG001|Step 2: Randomization|Adverse Event|0
1992211|NCT00068692|3558174|FG002|Step 2: Randomization|Adverse Event|4
1992212|NCT00068692|3558175|FG003|Step 2: Randomization|Adverse Event|2
1992213|NCT00068692|3558176|FG004|Step 2: Randomization|Adverse Event|2
1992214|NCT00068692|3558177|FG005|Step 2: Randomization|Adverse Event|3
1992215|NCT00068692|3558178|FG006|Step 2: Randomization|Adverse Event|4
1992216|NCT00068692|3558179|FG007|Step 2: Randomization|Adverse Event|4
1992217|NCT00068692|3558172|FG000|Step 2: Randomization|Death|0
1992218|NCT00068692|3558173|FG001|Step 2: Randomization|Death|0
1992219|NCT00068692|3558174|FG002|Step 2: Randomization|Death|0
1992220|NCT00068692|3558175|FG003|Step 2: Randomization|Death|0
1992221|NCT00068692|3558176|FG004|Step 2: Randomization|Death|1
1992222|NCT00068692|3558177|FG005|Step 2: Randomization|Death|0
1992223|NCT00068692|3558178|FG006|Step 2: Randomization|Death|0
1992224|NCT00068692|3558179|FG007|Step 2: Randomization|Death|1
1992225|NCT00068692|3558172|FG000|Step 2: Randomization|Withdrawal by Subject|0
1992226|NCT00068692|3558173|FG001|Step 2: Randomization|Withdrawal by Subject|0
1992227|NCT00068692|3558174|FG002|Step 2: Randomization|Withdrawal by Subject|4
1992228|NCT00068692|3558175|FG003|Step 2: Randomization|Withdrawal by Subject|6
1992229|NCT00068692|3558176|FG004|Step 2: Randomization|Withdrawal by Subject|3
1992230|NCT00068692|3558177|FG005|Step 2: Randomization|Withdrawal by Subject|2
1992231|NCT00068692|3558178|FG006|Step 2: Randomization|Withdrawal by Subject|0
1992232|NCT00068692|3558179|FG007|Step 2: Randomization|Withdrawal by Subject|3
1992233|NCT00068692|3558172|FG000|Step 2: Randomization|alternative therapy|0
1992234|NCT00068692|3558173|FG001|Step 2: Randomization|alternative therapy|0
1992235|NCT00068692|3558174|FG002|Step 2: Randomization|alternative therapy|0
1992236|NCT00068692|3558175|FG003|Step 2: Randomization|alternative therapy|1
1992237|NCT00068692|3558176|FG004|Step 2: Randomization|alternative therapy|1
1992238|NCT00068692|3558177|FG005|Step 2: Randomization|alternative therapy|0
1992239|NCT00068692|3558178|FG006|Step 2: Randomization|alternative therapy|0
1992240|NCT00068692|3558179|FG007|Step 2: Randomization|alternative therapy|0
1992241|NCT00068692|3558172|FG000|Step 2: Randomization|Physician Decision|0
1992242|NCT00068692|3558173|FG001|Step 2: Randomization|Physician Decision|0
1992243|NCT00068692|3558174|FG002|Step 2: Randomization|Physician Decision|0
1992244|NCT00068692|3558175|FG003|Step 2: Randomization|Physician Decision|1
1992245|NCT00068692|3558176|FG004|Step 2: Randomization|Physician Decision|1
1992246|NCT00068692|3558177|FG005|Step 2: Randomization|Physician Decision|0
1992247|NCT00068692|3558178|FG006|Step 2: Randomization|Physician Decision|0
1992248|NCT00068692|3558179|FG007|Step 2: Randomization|Physician Decision|0
1992249|NCT00068692|3558172|FG000|Step 2: Randomization|Other|0
1992250|NCT00068692|3558173|FG001|Step 2: Randomization|Other|0
1992251|NCT00068692|3558174|FG002|Step 2: Randomization|Other|0
1992252|NCT00068692|3558175|FG003|Step 2: Randomization|Other|1
1992253|NCT00068692|3558176|FG004|Step 2: Randomization|Other|0
1992254|NCT00068692|3558177|FG005|Step 2: Randomization|Other|1
1992255|NCT00068692|3558178|FG006|Step 2: Randomization|Other|0
1992256|NCT00068692|3558179|FG007|Step 2: Randomization|Other|0
1992257|NCT00068692|3558172|FG000|Step 2: Randomization|never start protocol therapy|0
1992258|NCT00068692|3558173|FG001|Step 2: Randomization|never start protocol therapy|0
1992259|NCT00068692|3558174|FG002|Step 2: Randomization|never start protocol therapy|1
1992260|NCT00068692|3558175|FG003|Step 2: Randomization|never start protocol therapy|0
1992261|NCT00068692|3558176|FG004|Step 2: Randomization|never start protocol therapy|1
1992262|NCT00068692|3558177|FG005|Step 2: Randomization|never start protocol therapy|0
1992263|NCT00068692|3558178|FG006|Step 2: Randomization|never start protocol therapy|0
1992264|NCT00068692|3558179|FG007|Step 2: Randomization|never start protocol therapy|0
1992265|NCT00068822|3558209|FG000|First Randomized Intervention|Lost to Follow-up|1
1992266|NCT00068822|3558210|FG001|First Randomized Intervention|Lost to Follow-up|2
1992267|NCT00069095|3558222|FG000|Primary Treatment Phase|Ongoing|0
1992268|NCT00069095|3558223|FG001|Primary Treatment Phase|Ongoing|0
1992269|NCT00069095|3558224|FG002|Primary Treatment Phase|Ongoing|5
1992270|NCT00069095|3558225|FG003|Primary Treatment Phase|Ongoing|7
1992271|NCT00069095|3558226|FG004|Primary Treatment Phase|Ongoing|7
1992272|NCT00069095|3558227|FG005|Primary Treatment Phase|Ongoing|4
1992273|NCT00069095|3558222|FG000|Primary Treatment Phase|Admin/Other|29
1992274|NCT00069095|3558223|FG001|Primary Treatment Phase|Admin/Other|38
1992275|NCT00069095|3558224|FG002|Primary Treatment Phase|Admin/Other|31
1992276|NCT00069095|3558225|FG003|Primary Treatment Phase|Admin/Other|45
1992277|NCT00069095|3558226|FG004|Primary Treatment Phase|Admin/Other|48
1992278|NCT00069095|3558227|FG005|Primary Treatment Phase|Admin/Other|42
1992279|NCT00069095|3558222|FG000|Primary Treatment Phase|Adverse Event|99
1992280|NCT00069095|3558223|FG001|Primary Treatment Phase|Adverse Event|92
1992281|NCT00069095|3558224|FG002|Primary Treatment Phase|Adverse Event|71
1992282|NCT00069095|3558225|FG003|Primary Treatment Phase|Adverse Event|72
1992283|NCT00069095|3558226|FG004|Primary Treatment Phase|Adverse Event|109
1992284|NCT00069095|3558227|FG005|Primary Treatment Phase|Adverse Event|101
1992285|NCT00069095|3558222|FG000|Primary Treatment Phase|Death|14
1992286|NCT00069095|3558223|FG001|Primary Treatment Phase|Death|8
1992287|NCT00069095|3558224|FG002|Primary Treatment Phase|Death|2
1992288|NCT00069095|3558225|FG003|Primary Treatment Phase|Death|5
1992289|NCT00069095|3558226|FG004|Primary Treatment Phase|Death|8
1992290|NCT00069095|3558227|FG005|Primary Treatment Phase|Death|8
1992291|NCT00069095|3558222|FG000|Primary Treatment Phase|Failure to return|5
1992292|NCT00069095|3558223|FG001|Primary Treatment Phase|Failure to return|5
1992293|NCT00069095|3558224|FG002|Primary Treatment Phase|Failure to return|0
1992294|NCT00069095|3558225|FG003|Primary Treatment Phase|Failure to return|0
1992295|NCT00069095|3558226|FG004|Primary Treatment Phase|Failure to return|0
1992296|NCT00069095|3558227|FG005|Primary Treatment Phase|Failure to return|2
1992297|NCT00069095|3558222|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131
1992298|NCT00069095|3558223|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127
1992299|NCT00069095|3558224|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175
1992300|NCT00069095|3558225|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154
1992301|NCT00069095|3558226|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101
1992302|NCT00069095|3558227|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102
1992303|NCT00069095|3558222|FG000|Primary Treatment Phase|Refused treatment|15
1992304|NCT00069095|3558223|FG001|Primary Treatment Phase|Refused treatment|26
1992305|NCT00069095|3558224|FG002|Primary Treatment Phase|Refused treatment|17
1992306|NCT00069095|3558225|FG003|Primary Treatment Phase|Refused treatment|31
1992307|NCT00069095|3558226|FG004|Primary Treatment Phase|Refused treatment|24
1992308|NCT00069095|3558227|FG005|Primary Treatment Phase|Refused treatment|27
1992309|NCT00069095|3558222|FG000|Primary Treatment Phase|Withdrew|2
1992310|NCT00069095|3558223|FG001|Primary Treatment Phase|Withdrew|3
1992311|NCT00069095|3558224|FG002|Primary Treatment Phase|Withdrew|8
1992312|NCT00069095|3558225|FG003|Primary Treatment Phase|Withdrew|2
1992313|NCT00069095|3558226|FG004|Primary Treatment Phase|Withdrew|4
1992314|NCT00069095|3558227|FG005|Primary Treatment Phase|Withdrew|9
1992315|NCT00069095|3558222|FG000|Primary Treatment Phase|Other Violation|0
1992316|NCT00069095|3558223|FG001|Primary Treatment Phase|Other Violation|1
1992317|NCT00069095|3558224|FG002|Primary Treatment Phase|Other Violation|1
1992318|NCT00069095|3558225|FG003|Primary Treatment Phase|Other Violation|1
1992319|NCT00069095|3558226|FG004|Primary Treatment Phase|Other Violation|0
1992320|NCT00069095|3558227|FG005|Primary Treatment Phase|Other Violation|1
1992321|NCT00069095|3558222|FG000|Primary Treatment Phase|Violation criteria|0
1992322|NCT00069095|3558223|FG001|Primary Treatment Phase|Violation criteria|2
1992323|NCT00069095|3558224|FG002|Primary Treatment Phase|Violation criteria|4
1992324|NCT00069095|3558225|FG003|Primary Treatment Phase|Violation criteria|3
1992325|NCT00069095|3558226|FG004|Primary Treatment Phase|Violation criteria|1
1992326|NCT00069095|3558227|FG005|Primary Treatment Phase|Violation criteria|5
1992327|NCT00069095|3558222|FG000|Post-study Treatment Phase|Missing reason|1
1992328|NCT00069095|3558223|FG001|Post-study Treatment Phase|Missing reason|3
1992329|NCT00069095|3558224|FG002|Post-study Treatment Phase|Missing reason|12
1992330|NCT00069095|3558225|FG003|Post-study Treatment Phase|Missing reason|8
1992331|NCT00069095|3558226|FG004|Post-study Treatment Phase|Missing reason|18
1992332|NCT00069095|3558227|FG005|Post-study Treatment Phase|Missing reason|17
1992333|NCT00069095|3558222|FG000|Post-study Treatment Phase|Adverse Event|2
1992334|NCT00069095|3558223|FG001|Post-study Treatment Phase|Adverse Event|3
1992335|NCT00069095|3558224|FG002|Post-study Treatment Phase|Adverse Event|1
1992336|NCT00069095|3558225|FG003|Post-study Treatment Phase|Adverse Event|0
1992337|NCT00069095|3558226|FG004|Post-study Treatment Phase|Adverse Event|5
1992338|NCT00069095|3558227|FG005|Post-study Treatment Phase|Adverse Event|1
1992339|NCT00069095|3558222|FG000|Post-study Treatment Phase|Eligible for surgery|2
1992340|NCT00069095|3558223|FG001|Post-study Treatment Phase|Eligible for surgery|0
1992341|NCT00069095|3558224|FG002|Post-study Treatment Phase|Eligible for surgery|0
1992342|NCT00069095|3558225|FG003|Post-study Treatment Phase|Eligible for surgery|0
1992343|NCT00069095|3558226|FG004|Post-study Treatment Phase|Eligible for surgery|0
1992344|NCT00069095|3558227|FG005|Post-study Treatment Phase|Eligible for surgery|0
1992345|NCT00069095|3558222|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1
1992346|NCT00069095|3558223|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4
1992347|NCT00069095|3558224|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5
2213588|NCT01681212|3855453|FG000|Overall Study|No longer met study criteria|5
2213589|NCT01681212|3855453|FG000|Overall Study|Administrative reason by sponsor|1
2213590|NCT01681277|3855462|FG000|Overall Study|Adverse Event|1
2213591|NCT01681277|3855463|FG001|Overall Study|Adverse Event|0
2213592|NCT01681277|3855464|FG002|Overall Study|Adverse Event|0
2213593|NCT01681277|3855465|FG003|Overall Study|Adverse Event|0
2213594|NCT01681277|3855466|FG004|Overall Study|Adverse Event|0
2213595|NCT01681368|3855482|FG000|Overall Study|Refused further treatment|1
2213596|NCT01681368|3855482|FG000|Overall Study|Refused further follow up|1
2213597|NCT01681433|3855488|FG000|Overall Study|Lack of Efficacy|23
2213598|NCT01681433|3855489|FG001|Overall Study|Lack of Efficacy|23
2213599|NCT01681433|3855488|FG000|Overall Study|Withdrawal by Subject|5
1992348|NCT00069095|3558225|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6
1992349|NCT00069095|3558226|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7
1992350|NCT00069095|3558227|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9
1992351|NCT00069095|3558222|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1
1992352|NCT00069095|3558223|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1992353|NCT00069095|3558224|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1992354|NCT00069095|3558225|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1992355|NCT00069095|3558226|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1992356|NCT00069095|3558227|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1
1992357|NCT00069095|3558222|FG000|Post-study Treatment Phase|Participant had complete response|1
1992358|NCT00069095|3558223|FG001|Post-study Treatment Phase|Participant had complete response|1
2213600|NCT01681433|3855489|FG001|Overall Study|Withdrawal by Subject|5
1992359|NCT00069095|3558224|FG002|Post-study Treatment Phase|Participant had complete response|0
1992360|NCT00069095|3558225|FG003|Post-study Treatment Phase|Participant had complete response|0
1992361|NCT00069095|3558226|FG004|Post-study Treatment Phase|Participant had complete response|0
1992362|NCT00069095|3558227|FG005|Post-study Treatment Phase|Participant had complete response|0
1992363|NCT00069095|3558222|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0
1992364|NCT00069095|3558223|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1
1992365|NCT00069095|3558224|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0
1992366|NCT00069095|3558225|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0
1992367|NCT00069095|3558226|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0
1992368|NCT00069095|3558227|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0
1992369|NCT00069095|3558222|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1992370|NCT00069095|3558223|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1992371|NCT00069095|3558224|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1992372|NCT00069095|3558225|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1992373|NCT00069095|3558226|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1992374|NCT00069095|3558227|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1992375|NCT00069095|3558222|FG000|Post-study Treatment Phase|Participant withdrew consent|0
1992376|NCT00069095|3558223|FG001|Post-study Treatment Phase|Participant withdrew consent|0
1992377|NCT00069095|3558224|FG002|Post-study Treatment Phase|Participant withdrew consent|1
1992378|NCT00069095|3558225|FG003|Post-study Treatment Phase|Participant withdrew consent|0
1992379|NCT00069095|3558226|FG004|Post-study Treatment Phase|Participant withdrew consent|0
1992380|NCT00069095|3558227|FG005|Post-study Treatment Phase|Participant withdrew consent|0
1992381|NCT00069095|3558222|FG000|Post-study Treatment Phase|Participant will start new treatment|0
1992382|NCT00069095|3558223|FG001|Post-study Treatment Phase|Participant will start new treatment|0
1992383|NCT00069095|3558224|FG002|Post-study Treatment Phase|Participant will start new treatment|1
1992384|NCT00069095|3558225|FG003|Post-study Treatment Phase|Participant will start new treatment|0
1992385|NCT00069095|3558226|FG004|Post-study Treatment Phase|Participant will start new treatment|0
1992386|NCT00069095|3558227|FG005|Post-study Treatment Phase|Participant will start new treatment|0
1992387|NCT00069095|3558222|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0
1992388|NCT00069095|3558223|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0
1992389|NCT00069095|3558224|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0
1992390|NCT00069095|3558225|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1
1992391|NCT00069095|3558226|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0
1992392|NCT00069095|3558227|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0
1992393|NCT00069095|3558222|FG000|Post-study Treatment Phase|Participant completed treatment|0
1992394|NCT00069095|3558223|FG001|Post-study Treatment Phase|Participant completed treatment|0
1992395|NCT00069095|3558224|FG002|Post-study Treatment Phase|Participant completed treatment|0
1992396|NCT00069095|3558225|FG003|Post-study Treatment Phase|Participant completed treatment|1
1992397|NCT00069095|3558226|FG004|Post-study Treatment Phase|Participant completed treatment|0
1992398|NCT00069095|3558227|FG005|Post-study Treatment Phase|Participant completed treatment|0
1992399|NCT00069095|3558222|FG000|Post-study Treatment Phase|Surgery|0
1992400|NCT00069095|3558223|FG001|Post-study Treatment Phase|Surgery|0
1992401|NCT00069095|3558224|FG002|Post-study Treatment Phase|Surgery|0
1992402|NCT00069095|3558225|FG003|Post-study Treatment Phase|Surgery|1
1992403|NCT00069095|3558226|FG004|Post-study Treatment Phase|Surgery|1
1992404|NCT00069095|3558227|FG005|Post-study Treatment Phase|Surgery|0
1992405|NCT00069095|3558222|FG000|Post-study Treatment Phase|Death|0
1992406|NCT00069095|3558223|FG001|Post-study Treatment Phase|Death|0
1992407|NCT00069095|3558224|FG002|Post-study Treatment Phase|Death|0
1992408|NCT00069095|3558225|FG003|Post-study Treatment Phase|Death|0
1992409|NCT00069095|3558226|FG004|Post-study Treatment Phase|Death|1
1992410|NCT00069095|3558227|FG005|Post-study Treatment Phase|Death|0
1992411|NCT00069095|3558222|FG000|Post-study Treatment Phase|Participant had progressive disease|0
1992412|NCT00069095|3558223|FG001|Post-study Treatment Phase|Participant had progressive disease|0
1992413|NCT00069095|3558224|FG002|Post-study Treatment Phase|Participant had progressive disease|0
1992414|NCT00069095|3558225|FG003|Post-study Treatment Phase|Participant had progressive disease|0
1992415|NCT00069095|3558226|FG004|Post-study Treatment Phase|Participant had progressive disease|1
1992416|NCT00069095|3558227|FG005|Post-study Treatment Phase|Participant had progressive disease|0
1992417|NCT00069095|3558222|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0
1992418|NCT00069095|3558223|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0
1992419|NCT00069095|3558224|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0
1992420|NCT00069095|3558225|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0
1992421|NCT00069095|3558226|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1
1992422|NCT00069095|3558227|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0
1992423|NCT00069095|3558222|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1992424|NCT00069095|3558223|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1992425|NCT00069095|3558224|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1992426|NCT00069095|3558225|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1992427|NCT00069095|3558226|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
1992428|NCT00069095|3558227|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1992429|NCT00069095|3558222|FG000|Post-study Treatment Phase|Investigator decision|0
1992430|NCT00069095|3558223|FG001|Post-study Treatment Phase|Investigator decision|0
1992431|NCT00069095|3558224|FG002|Post-study Treatment Phase|Investigator decision|0
1992432|NCT00069095|3558225|FG003|Post-study Treatment Phase|Investigator decision|0
1992433|NCT00069095|3558226|FG004|Post-study Treatment Phase|Investigator decision|0
1992434|NCT00069095|3558227|FG005|Post-study Treatment Phase|Investigator decision|1
1992435|NCT00069095|3558222|FG000|Follow-up Phase|Death|174
1992436|NCT00069095|3558223|FG001|Follow-up Phase|Death|206
1992437|NCT00069095|3558224|FG002|Follow-up Phase|Death|120
1992438|NCT00069095|3558225|FG003|Follow-up Phase|Death|112
1992439|NCT00069095|3558226|FG004|Follow-up Phase|Death|92
1992440|NCT00069095|3558227|FG005|Follow-up Phase|Death|101
1992441|NCT00069108|3558241|FG000|Overall Study|Withdrawal by Subject|5
1992442|NCT00069108|3558242|FG001|Overall Study|Withdrawal by Subject|9
1992443|NCT00069108|3558241|FG000|Overall Study|Adverse Event|64
1992444|NCT00069108|3558242|FG001|Overall Study|Adverse Event|42
1992445|NCT00069108|3558241|FG000|Overall Study|Death|6
1992446|NCT00069108|3558242|FG001|Overall Study|Death|6
1992447|NCT00069108|3558241|FG000|Overall Study|Administration|15
1992448|NCT00069108|3558242|FG001|Overall Study|Administration|4
1992449|NCT00069108|3558241|FG000|Overall Study|Insufficient therapy|117
1992450|NCT00069108|3558242|FG001|Overall Study|Insufficient therapy|144
1992451|NCT00069108|3558241|FG000|Overall Study|Violation criteria|1
1992452|NCT00069108|3558242|FG001|Overall Study|Violation criteria|4
1992453|NCT00069108|3558241|FG000|Overall Study|Refused treatment|5
1992454|NCT00069108|3558242|FG001|Overall Study|Refused treatment|10
1992455|NCT00069121|3558251|FG000|Overall Study|Death|286
1992456|NCT00069121|3558252|FG001|Overall Study|Death|242
1992457|NCT00069121|3558251|FG000|Overall Study|Withdrawal by Subject|18
1992458|NCT00069121|3558252|FG001|Overall Study|Withdrawal by Subject|20
1992459|NCT00069121|3558251|FG000|Overall Study|Lost to Follow-up|63
1992460|NCT00069121|3558252|FG001|Overall Study|Lost to Follow-up|63
1992461|NCT00069264|3558274|FG000|Overall Study|Adverse Event|3
1992462|NCT00069264|3558274|FG000|Overall Study|Progressive Disease|23
1992463|NCT00069264|3558274|FG000|Overall Study|Withdrawal by Subject|3
1992464|NCT00069264|3558274|FG000|Overall Study|Discon Therapy|3
1992465|NCT00069277|3558278|FG000|Overall Study|Adverse Event|3
1992466|NCT00069277|3558278|FG000|Overall Study|Withdrawal by Subject|1
1992467|NCT00069277|3558278|FG000|Overall Study|Progressive Disease|15
1992468|NCT00069277|3558278|FG000|Overall Study|Physician Decision|2
1992469|NCT00069576|3558288|FG000|Original Trial|Lost to Follow-up|25
1992470|NCT00069576|3558289|FG001|Original Trial|Lost to Follow-up|33
1992471|NCT00069576|3558288|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
1992472|NCT00069576|3558289|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
1992473|NCT00069641|3558298|FG000|Overall Study|Death|1
1992474|NCT00069641|3558299|FG001|Overall Study|Death|0
1992475|NCT00069641|3558300|FG002|Overall Study|Death|1
1992476|NCT00069784|3558311|FG000|Overall Study|Adverse Event|105
1992477|NCT00069784|3558312|FG001|Overall Study|Adverse Event|0
1992478|NCT00069784|3558311|FG000|Overall Study|Withdrawal by Subject|1090
1992479|NCT00069784|3558312|FG001|Overall Study|Withdrawal by Subject|0
1992480|NCT00069784|3558311|FG000|Overall Study|Other|17
1992481|NCT00069784|3558312|FG001|Overall Study|Other|0
1992482|NCT00069823|3558320|FG000|Overall Study|Did not have follow-up diary cards|6
1992483|NCT00069823|3558321|FG001|Overall Study|Did not have follow-up diary cards|3
1992484|NCT00069953|3558327|FG000|Overall Study|Protocol Violation|2
1992485|NCT00070109|3558353|FG000|Overall Study|Death|1
1992486|NCT00070109|3558354|FG001|Overall Study|Death|1
1992487|NCT00070109|3558355|FG002|Overall Study|Death|0
1992488|NCT00070109|3558356|FG003|Overall Study|Death|0
1992489|NCT00070109|3558357|FG004|Overall Study|Death|1
1992490|NCT00070109|3558353|FG000|Overall Study|Lack of Efficacy|6
1992491|NCT00070109|3558354|FG001|Overall Study|Lack of Efficacy|4
1992492|NCT00070109|3558355|FG002|Overall Study|Lack of Efficacy|5
1992493|NCT00070109|3558356|FG003|Overall Study|Lack of Efficacy|15
1992494|NCT00070109|3558357|FG004|Overall Study|Lack of Efficacy|5
1992495|NCT00070109|3558353|FG000|Overall Study|Physician Decision|1
1992496|NCT00070109|3558354|FG001|Overall Study|Physician Decision|0
1992497|NCT00070109|3558355|FG002|Overall Study|Physician Decision|0
1992498|NCT00070109|3558356|FG003|Overall Study|Physician Decision|0
1992499|NCT00070109|3558357|FG004|Overall Study|Physician Decision|0
1992500|NCT00070109|3558353|FG000|Overall Study|Withdrawal by Subject|0
1992501|NCT00070109|3558354|FG001|Overall Study|Withdrawal by Subject|1
1992502|NCT00070109|3558355|FG002|Overall Study|Withdrawal by Subject|1
1992503|NCT00070109|3558356|FG003|Overall Study|Withdrawal by Subject|0
1992504|NCT00070109|3558357|FG004|Overall Study|Withdrawal by Subject|0
1992505|NCT00070109|3558353|FG000|Overall Study|Adverse Event|0
1992506|NCT00070109|3558354|FG001|Overall Study|Adverse Event|0
1992507|NCT00070109|3558355|FG002|Overall Study|Adverse Event|2
1992508|NCT00070109|3558356|FG003|Overall Study|Adverse Event|4
1992509|NCT00070109|3558357|FG004|Overall Study|Adverse Event|2
1992510|NCT00070109|3558353|FG000|Overall Study|removed from prot thpy prior to chemo|0
1992511|NCT00070109|3558354|FG001|Overall Study|removed from prot thpy prior to chemo|0
1992512|NCT00070109|3558355|FG002|Overall Study|removed from prot thpy prior to chemo|0
1992513|NCT00070109|3558356|FG003|Overall Study|removed from prot thpy prior to chemo|1
1992514|NCT00070109|3558357|FG004|Overall Study|removed from prot thpy prior to chemo|0
1992515|NCT00070291|3558380|FG000|Step 1|Withdrawal by Subject|1
1992516|NCT00070291|3558380|FG000|Step 1|Adverse Event|1
1992517|NCT00070291|3558380|FG000|Step 2|Adverse Event|1
1992518|NCT00070317|3558384|FG000|Overall Study|Inevaluable (Never Treated)|1
1992519|NCT00070317|3558384|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3
1992520|NCT00070317|3558384|FG000|Overall Study|Ineligible required test not done|1
1992521|NCT00070317|3558384|FG000|Overall Study|Ineligible-Improper prior treatment|2
1992522|NCT00070317|3558384|FG000|Overall Study|Ineligible-Inadequate pathology|6
1992523|NCT00070941|3558391|FG000|Overall Study|Adverse Event|10
1992524|NCT00070941|3558392|FG001|Overall Study|Adverse Event|8
1992525|NCT00070941|3558393|FG002|Overall Study|Adverse Event|4
1992526|NCT00071006|3558401|FG000|Overall Study|Lack of Efficacy|7
1992527|NCT00071006|3558401|FG000|Overall Study|Adverse Event|1
1992528|NCT00071006|3558401|FG000|Overall Study|Withdrawal by Subject|1
1992529|NCT00071006|3558401|FG000|Overall Study|Other|3
1992530|NCT00071032|3558407|FG000|Overall Study|Lost to Follow-up|1
1992531|NCT00071032|3558408|FG001|Overall Study|Lost to Follow-up|1
1992532|NCT00071032|3558407|FG000|Overall Study|Withdrawal by Subject|8
1992533|NCT00071032|3558408|FG001|Overall Study|Withdrawal by Subject|6
1992534|NCT00071032|3558407|FG000|Overall Study|Missing Primary Outcome|0
1992535|NCT00071032|3558408|FG001|Overall Study|Missing Primary Outcome|1
1992536|NCT00071058|3558415|FG000|Overall Study|brain tumor-removed from study|1
1992537|NCT00071110|3558422|FG000|Overall Study|Protocol Violation|0
1992538|NCT00071110|3558423|FG001|Overall Study|Protocol Violation|4
1992539|NCT00071396|3558429|FG000|Overall Study|Withdrawal by Subject|1
1992540|NCT00071396|3558429|FG000|Overall Study|Physician Decision|2
1992541|NCT00071487|3558437|FG000|52-Week Double-Blind Period|Adverse Event|5
1992542|NCT00071487|3558438|FG001|52-Week Double-Blind Period|Adverse Event|8
1992543|NCT00071487|3558439|FG002|52-Week Double-Blind Period|Adverse Event|4
1992544|NCT00071487|3558440|FG003|52-Week Double-Blind Period|Adverse Event|8
1992545|NCT00071487|3558437|FG000|52-Week Double-Blind Period|Lack of Efficacy|1
1992546|NCT00071487|3558438|FG001|52-Week Double-Blind Period|Lack of Efficacy|2
1992547|NCT00071487|3558439|FG002|52-Week Double-Blind Period|Lack of Efficacy|0
1992548|NCT00071487|3558440|FG003|52-Week Double-Blind Period|Lack of Efficacy|1
1992549|NCT00071487|3558437|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7
1992550|NCT00071487|3558438|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11
1992551|NCT00071487|3558439|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7
1992552|NCT00071487|3558440|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7
1992553|NCT00071487|3558437|FG000|52-Week Double-Blind Period|Physician Decision|1
1992554|NCT00071487|3558438|FG001|52-Week Double-Blind Period|Physician Decision|0
1992555|NCT00071487|3558439|FG002|52-Week Double-Blind Period|Physician Decision|0
1992556|NCT00071487|3558440|FG003|52-Week Double-Blind Period|Physician Decision|0
1992557|NCT00071487|3558437|FG000|52-Week Double-Blind Period|Lost to Follow-up|0
1992558|NCT00071487|3558438|FG001|52-Week Double-Blind Period|Lost to Follow-up|0
1992559|NCT00071487|3558439|FG002|52-Week Double-Blind Period|Lost to Follow-up|2
1992560|NCT00071487|3558440|FG003|52-Week Double-Blind Period|Lost to Follow-up|2
1992561|NCT00071487|3558437|FG000|52-Week Double-Blind Period|Pregnancy|0
1992562|NCT00071487|3558438|FG001|52-Week Double-Blind Period|Pregnancy|1
1992563|NCT00071487|3558439|FG002|52-Week Double-Blind Period|Pregnancy|0
1992564|NCT00071487|3558440|FG003|52-Week Double-Blind Period|Pregnancy|0
1992565|NCT00071487|3558437|FG000|52-Week Double-Blind Period|Protocol Violation|0
1992566|NCT00071487|3558438|FG001|52-Week Double-Blind Period|Protocol Violation|1
1992567|NCT00071487|3558439|FG002|52-Week Double-Blind Period|Protocol Violation|1
1992568|NCT00071487|3558440|FG003|52-Week Double-Blind Period|Protocol Violation|0
1992569|NCT00071487|3558437|FG000|52-Week Double-Blind Period|Death|0
1992570|NCT00071487|3558438|FG001|52-Week Double-Blind Period|Death|1
1992571|NCT00071487|3558439|FG002|52-Week Double-Blind Period|Death|0
1992572|NCT00071487|3558440|FG003|52-Week Double-Blind Period|Death|0
1992573|NCT00071487|3558437|FG000|52-Week Double-Blind Period|Lack of Compliance|6
1992574|NCT00071487|3558438|FG001|52-Week Double-Blind Period|Lack of Compliance|3
1992575|NCT00071487|3558439|FG002|52-Week Double-Blind Period|Lack of Compliance|3
1992576|NCT00071487|3558440|FG003|52-Week Double-Blind Period|Lack of Compliance|3
1992577|NCT00071487|3558437|FG000|24-Week Open-Label Extension Period|Adverse Event|0
1992578|NCT00071487|3558438|FG001|24-Week Open-Label Extension Period|Adverse Event|0
1992579|NCT00071487|3558439|FG002|24-Week Open-Label Extension Period|Adverse Event|1
1992580|NCT00071487|3558440|FG003|24-Week Open-Label Extension Period|Adverse Event|6
1992581|NCT00071487|3558437|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
1992582|NCT00071487|3558438|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
1992583|NCT00071487|3558439|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
1992584|NCT00071487|3558440|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3
1992585|NCT00071487|3558437|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1992586|NCT00071487|3558438|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1992587|NCT00071487|3558439|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1992588|NCT00071487|3558440|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9
1992589|NCT00071487|3558437|FG000|24-Week Open-Label Extension Period|Pregnancy|0
1992590|NCT00071487|3558438|FG001|24-Week Open-Label Extension Period|Pregnancy|0
1992591|NCT00071487|3558439|FG002|24-Week Open-Label Extension Period|Pregnancy|0
1992592|NCT00071487|3558440|FG003|24-Week Open-Label Extension Period|Pregnancy|1
1992593|NCT00071487|3558437|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
1992594|NCT00071487|3558438|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
1992595|NCT00071487|3558439|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
1992596|NCT00071487|3558440|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
1992597|NCT00071487|3558437|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
1992598|NCT00071487|3558438|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
1992599|NCT00071487|3558439|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0
1992600|NCT00071487|3558440|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
1992601|NCT00071513|3558454|FG000|Intervention Component|Withdrawal by Subject|2
1992602|NCT00071513|3558455|FG001|Intervention Component|Withdrawal by Subject|3
1992603|NCT00071513|3558454|FG000|Follow-up Assessment|Withdrawal by Subject|6
1992604|NCT00071513|3558455|FG001|Follow-up Assessment|Withdrawal by Subject|6
1992605|NCT00071760|3558472|FG000|Overall Study|Adverse Event|3
1992606|NCT00071760|3558472|FG000|Overall Study|Lost to Follow-up|4
1992607|NCT00071760|3558472|FG000|Overall Study|Protocol Violation|1
1992608|NCT00071760|3558472|FG000|Overall Study|Withdrawal by Subject|3
1992609|NCT00071760|3558472|FG000|Overall Study|Insufficient Viral Load Response|3
1992610|NCT00071760|3558472|FG000|Overall Study|Pulmonary Tuberculosis|1
1992611|NCT00071760|3558472|FG000|Overall Study|Unavailability of RTV|8
1992612|NCT00071760|3558472|FG000|Overall Study|Relocation|1
1992613|NCT00071760|3558472|FG000|Overall Study|Investigator's Recommendation (Rec.)|4
1992614|NCT00071760|3558472|FG000|Overall Study|Study Team Rec./Resistance|1
1992615|NCT00071760|3558472|FG000|Overall Study|Ongoing|25
1992616|NCT00071799|3558484|FG000|Overall Study|Adverse Event|19
1992617|NCT00071799|3558485|FG001|Overall Study|Adverse Event|10
1992618|NCT00071799|3558484|FG000|Overall Study|Protocol Violation|1
1992619|NCT00071799|3558485|FG001|Overall Study|Protocol Violation|7
1992620|NCT00071799|3558484|FG000|Overall Study|Lost to Follow-up|1
1992621|NCT00071799|3558485|FG001|Overall Study|Lost to Follow-up|1
1992622|NCT00071799|3558484|FG000|Overall Study|Withdrawal by Subject|15
1992623|NCT00071799|3558485|FG001|Overall Study|Withdrawal by Subject|37
1992624|NCT00071799|3558484|FG000|Overall Study|Physician Decision|0
1992625|NCT00071799|3558485|FG001|Overall Study|Physician Decision|2
1992626|NCT00071799|3558484|FG000|Overall Study|Lack of Efficacy|11
1992627|NCT00071799|3558485|FG001|Overall Study|Lack of Efficacy|18
1992628|NCT00071799|3558484|FG000|Overall Study|Disease Progression|23
1992629|NCT00071799|3558485|FG001|Overall Study|Disease Progression|20
1992630|NCT00071799|3558484|FG000|Overall Study|Different Central+Local Pathology Review|0
1992631|NCT00071799|3558485|FG001|Overall Study|Different Central+Local Pathology Review|1
1992632|NCT00071799|3558484|FG000|Overall Study|Not Documented|0
1992633|NCT00071799|3558485|FG001|Overall Study|Not Documented|2
1992634|NCT00071812|3558501|FG000|24-Week Double-Blind Period|Adverse Event|2
1992635|NCT00071812|3558502|FG001|24-Week Double-Blind Period|Adverse Event|3
1992636|NCT00071812|3558503|FG002|24-Week Double-Blind Period|Adverse Event|4
1992637|NCT00071812|3558504|FG003|24-Week Double-Blind Period|Adverse Event|4
1992638|NCT00071812|3558501|FG000|24-Week Double-Blind Period|Lack of Efficacy|3
1992639|NCT00071812|3558502|FG001|24-Week Double-Blind Period|Lack of Efficacy|1
1992640|NCT00071812|3558503|FG002|24-Week Double-Blind Period|Lack of Efficacy|2
1992641|NCT00071812|3558504|FG003|24-Week Double-Blind Period|Lack of Efficacy|1
1992642|NCT00071812|3558501|FG000|24-Week Double-Blind Period|Lost to Follow-up|0
1992643|NCT00071812|3558502|FG001|24-Week Double-Blind Period|Lost to Follow-up|1
1992644|NCT00071812|3558503|FG002|24-Week Double-Blind Period|Lost to Follow-up|1
1992645|NCT00071812|3558504|FG003|24-Week Double-Blind Period|Lost to Follow-up|0
1992646|NCT00071812|3558501|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5
1992647|NCT00071812|3558502|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1
1992648|NCT00071812|3558503|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1
1992649|NCT00071812|3558504|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5
1992650|NCT00071812|3558501|FG000|24-Week Double-Blind Period|Protocol Violation|0
1992651|NCT00071812|3558502|FG001|24-Week Double-Blind Period|Protocol Violation|0
1992652|NCT00071812|3558503|FG002|24-Week Double-Blind Period|Protocol Violation|0
1992653|NCT00071812|3558504|FG003|24-Week Double-Blind Period|Protocol Violation|1
1992654|NCT00071812|3558501|FG000|24-Week Open-Label Extension Period|Adverse Event|0
1992655|NCT00071812|3558502|FG001|24-Week Open-Label Extension Period|Adverse Event|0
1992656|NCT00071812|3558503|FG002|24-Week Open-Label Extension Period|Adverse Event|0
1992657|NCT00071812|3558504|FG003|24-Week Open-Label Extension Period|Adverse Event|7
1992658|NCT00071812|3558501|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
1992659|NCT00071812|3558502|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
1992660|NCT00071812|3558503|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
1992661|NCT00071812|3558504|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17
1992662|NCT00071812|3558501|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
1992663|NCT00071812|3558502|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
1992664|NCT00071812|3558503|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
1992665|NCT00071812|3558504|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
1992666|NCT00071812|3558501|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1992667|NCT00071812|3558502|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1992668|NCT00071812|3558503|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1992669|NCT00071812|3558504|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12
1992670|NCT00071812|3558501|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
1992671|NCT00071812|3558502|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
1992672|NCT00071812|3558503|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1
1992673|NCT00071812|3558504|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
1992674|NCT00071981|3558529|FG000|Overall Study|Lack of Efficacy|37
1992675|NCT00071981|3558530|FG001|Overall Study|Lack of Efficacy|29
1992676|NCT00071981|3558531|FG002|Overall Study|Lack of Efficacy|30
1992677|NCT00071981|3558532|FG003|Overall Study|Lack of Efficacy|43
1992678|NCT00071981|3558529|FG000|Overall Study|Adverse Event|4
1992679|NCT00071981|3558530|FG001|Overall Study|Adverse Event|4
1992680|NCT00071981|3558531|FG002|Overall Study|Adverse Event|3
1992681|NCT00071981|3558532|FG003|Overall Study|Adverse Event|1
1992682|NCT00071981|3558529|FG000|Overall Study|Death|0
1992683|NCT00071981|3558530|FG001|Overall Study|Death|0
1992684|NCT00071981|3558531|FG002|Overall Study|Death|1
1992685|NCT00071981|3558532|FG003|Overall Study|Death|1
1992686|NCT00071981|3558529|FG000|Overall Study|Withdrawal by Subject|3
1992687|NCT00071981|3558530|FG001|Overall Study|Withdrawal by Subject|1
1992688|NCT00071981|3558531|FG002|Overall Study|Withdrawal by Subject|0
1992689|NCT00071981|3558532|FG003|Overall Study|Withdrawal by Subject|0
1992690|NCT00071981|3558529|FG000|Overall Study|No protocol therapy|2
1992691|NCT00071981|3558530|FG001|Overall Study|No protocol therapy|5
1992692|NCT00071981|3558531|FG002|Overall Study|No protocol therapy|1
1992693|NCT00071981|3558532|FG003|Overall Study|No protocol therapy|0
1992694|NCT00071981|3558529|FG000|Overall Study|others (not specified in the study)|0
1992695|NCT00071981|3558530|FG001|Overall Study|others (not specified in the study)|2
1992696|NCT00071981|3558531|FG002|Overall Study|others (not specified in the study)|2
1992697|NCT00071981|3558532|FG003|Overall Study|others (not specified in the study)|0
1992698|NCT00072176|3558544|FG000|Overall Study|Withdrawal by Subject|1
1992699|NCT00072176|3558545|FG001|Overall Study|Withdrawal by Subject|0
1992700|NCT00072176|3558544|FG000|Overall Study|Protocol Violation|0
1992701|NCT00072176|3558545|FG001|Overall Study|Protocol Violation|1
1992702|NCT00072189|3558551|FG000|Overall Study|Withdrawal by Subject|1
1992703|NCT00072280|3558557|FG000|Treatment|Found ineligible|1
1992704|NCT00072280|3558558|FG001|Treatment|Found ineligible|2
1992705|NCT00072280|3558557|FG000|Follow-up|Early termination of study|2
1992706|NCT00072280|3558558|FG001|Follow-up|Early termination of study|2
1992707|NCT00072293|3558565|FG000|Overall Study|Lost to Follow-up|1
1992708|NCT00072293|3558566|FG001|Overall Study|Lost to Follow-up|1
1992709|NCT00072293|3558565|FG000|Overall Study|Withdrawal by Subject|0
1992710|NCT00072293|3558566|FG001|Overall Study|Withdrawal by Subject|1
1992711|NCT00072384|3558572|FG000|Overall Study|Physician Decision|1
1992712|NCT00072384|3558572|FG000|Overall Study|Ineligible|8
1992713|NCT00072475|3558582|FG000|Overall Study|Adverse Event|44
1992714|NCT00072475|3558582|FG000|Overall Study|Death|3
1992715|NCT00072475|3558582|FG000|Overall Study|Withdrawal by Subject|46
1992716|NCT00072475|3558582|FG000|Overall Study|Patient/Investigator Decision|4
1992717|NCT00073008|3558605|FG000|Overall Study|Missing|6
1992718|NCT00073008|3558606|FG001|Overall Study|Missing|6
1992719|NCT00073008|3558605|FG000|Overall Study|Withdrawal by Subject|2
1992720|NCT00073008|3558606|FG001|Overall Study|Withdrawal by Subject|2
1992721|NCT00073008|3558605|FG000|Overall Study|Lost to Follow-up|1
1992722|NCT00073008|3558606|FG001|Overall Study|Lost to Follow-up|3
1992723|NCT00073008|3558605|FG000|Overall Study|Death|46
1992724|NCT00073008|3558606|FG001|Overall Study|Death|47
1992725|NCT00073008|3558605|FG000|Overall Study|"Other selected on Case Report Form"|7
1992726|NCT00073008|3558606|FG001|Overall Study|"Other selected on Case Report Form"|5
1992727|NCT00073021|3558614|FG000|Overall Study|Protocol Violation|2
1992728|NCT00073021|3558615|FG001|Overall Study|Protocol Violation|1
1992729|NCT00073021|3558614|FG000|Overall Study|Adverse Event|4
1992730|NCT00073021|3558615|FG001|Overall Study|Adverse Event|4
1992731|NCT00073021|3558614|FG000|Overall Study|Withdrawal by Subject|6
1992732|NCT00073021|3558615|FG001|Overall Study|Withdrawal by Subject|5
1992733|NCT00073021|3558614|FG000|Overall Study|Physician Decision|3
1992734|NCT00073021|3558615|FG001|Overall Study|Physician Decision|1
1992735|NCT00073021|3558614|FG000|Overall Study|Lack of Efficacy|11
1992736|NCT00073021|3558615|FG001|Overall Study|Lack of Efficacy|5
1992737|NCT00073307|3558627|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
1992738|NCT00073307|3558628|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
1992739|NCT00073307|3558629|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
1992740|NCT00073307|3558627|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
1992741|NCT00073307|3558628|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
1992742|NCT00073307|3558629|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
1992743|NCT00073307|3558627|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
1992744|NCT00073307|3558628|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
1992745|NCT00073307|3558629|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
1992746|NCT00073307|3558627|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
2024625|NCT00336284|3593254|FG001|Overall Study|Death|26
1992747|NCT00073307|3558628|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
1992748|NCT00073307|3558629|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
1992749|NCT00073307|3558627|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
1992750|NCT00073307|3558628|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
1992751|NCT00073307|3558629|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
1992752|NCT00073307|3558627|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
1992753|NCT00073307|3558628|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
1992754|NCT00073307|3558629|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
1992755|NCT00073307|3558627|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
1992756|NCT00073307|3558628|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
1992757|NCT00073307|3558629|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
1992758|NCT00073307|3558627|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
1992759|NCT00073307|3558628|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
1992760|NCT00073307|3558629|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
1992761|NCT00073307|3558627|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
1992762|NCT00073307|3558628|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
1992763|NCT00073307|3558629|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
1992764|NCT00073307|3558627|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
1992765|NCT00073307|3558628|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
1992766|NCT00073307|3558629|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
1992767|NCT00073307|3558627|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
1992768|NCT00073307|3558628|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
1992769|NCT00073307|3558629|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
1992770|NCT00073307|3558627|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
1992771|NCT00073307|3558628|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
1992772|NCT00073307|3558629|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
1992773|NCT00073307|3558627|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
1992774|NCT00073307|3558628|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
1992775|NCT00073307|3558629|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
1992776|NCT00073307|3558627|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
1992777|NCT00073307|3558628|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
1992778|NCT00073307|3558629|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
1992779|NCT00073307|3558627|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
1992780|NCT00073307|3558628|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
1992781|NCT00073307|3558629|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
1992782|NCT00073307|3558627|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
1992783|NCT00073307|3558628|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
1992784|NCT00073307|3558629|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
1992785|NCT00073307|3558627|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3
1992786|NCT00073307|3558628|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0
1992787|NCT00073307|3558629|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1
1992788|NCT00073307|3558627|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
1992789|NCT00073307|3558628|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
1992790|NCT00073307|3558629|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
1992791|NCT00073307|3558627|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
1992792|NCT00073307|3558628|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
1992793|NCT00073307|3558629|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
1992794|NCT00073528|3558653|FG000|Overall Study|Death|488
1992795|NCT00073528|3558654|FG001|Overall Study|Death|473
1992796|NCT00073528|3558653|FG000|Overall Study|Lost to Follow-up|52
1992797|NCT00073528|3558654|FG001|Overall Study|Lost to Follow-up|45
1992798|NCT00073528|3558653|FG000|Overall Study|Withdrawal by Subject|50
1992799|NCT00073528|3558654|FG001|Overall Study|Withdrawal by Subject|45
1992800|NCT00073528|3558653|FG000|Overall Study|Study terminated by Sponsor|10
1992801|NCT00073528|3558654|FG001|Overall Study|Study terminated by Sponsor|29
1992802|NCT00073528|3558653|FG000|Overall Study|Other|18
1992803|NCT00073528|3558654|FG001|Overall Study|Other|19
1992804|NCT00073528|3558653|FG000|Overall Study|Other|9
1992805|NCT00073528|3558654|FG001|Overall Study|Other|12
1992806|NCT00073528|3558653|FG000|Overall Study|Protocol Violation|3
1992807|NCT00073528|3558654|FG001|Overall Study|Protocol Violation|5
1992808|NCT00073749|3558667|FG000|Overall Study|Disease Progression|2
1992809|NCT00073749|3558668|FG001|Overall Study|Disease Progression|0
1992810|NCT00073749|3558669|FG002|Overall Study|Disease Progression|3
1992811|NCT00073749|3558670|FG003|Overall Study|Disease Progression|2
1992812|NCT00073749|3558671|FG004|Overall Study|Disease Progression|3
1992813|NCT00073749|3558672|FG005|Overall Study|Disease Progression|1
1992814|NCT00073749|3558673|FG006|Overall Study|Disease Progression|3
1992815|NCT00073749|3558667|FG000|Overall Study|Death|0
1992816|NCT00073749|3558668|FG001|Overall Study|Death|1
1992817|NCT00073749|3558669|FG002|Overall Study|Death|1
1992818|NCT00073749|3558670|FG003|Overall Study|Death|0
1992819|NCT00073749|3558671|FG004|Overall Study|Death|0
1992820|NCT00073749|3558672|FG005|Overall Study|Death|0
1992821|NCT00073749|3558673|FG006|Overall Study|Death|29
1992822|NCT00073749|3558667|FG000|Overall Study|Adverse Event|0
1992823|NCT00073749|3558668|FG001|Overall Study|Adverse Event|3
1992824|NCT00073749|3558669|FG002|Overall Study|Adverse Event|6
1992825|NCT00073749|3558670|FG003|Overall Study|Adverse Event|4
1992826|NCT00073749|3558671|FG004|Overall Study|Adverse Event|2
1992827|NCT00073749|3558672|FG005|Overall Study|Adverse Event|1
1992828|NCT00073749|3558673|FG006|Overall Study|Adverse Event|0
1992829|NCT00073749|3558667|FG000|Overall Study|Physician Decision|0
1992830|NCT00073749|3558668|FG001|Overall Study|Physician Decision|0
1992831|NCT00073749|3558669|FG002|Overall Study|Physician Decision|1
1992832|NCT00073749|3558670|FG003|Overall Study|Physician Decision|0
1992833|NCT00073749|3558671|FG004|Overall Study|Physician Decision|0
1992834|NCT00073749|3558672|FG005|Overall Study|Physician Decision|2
1992835|NCT00073749|3558673|FG006|Overall Study|Physician Decision|0
1992836|NCT00073749|3558667|FG000|Overall Study|Withdrawal by Subject|0
1992837|NCT00073749|3558668|FG001|Overall Study|Withdrawal by Subject|1
1992838|NCT00073749|3558669|FG002|Overall Study|Withdrawal by Subject|0
1992839|NCT00073749|3558670|FG003|Overall Study|Withdrawal by Subject|0
1992840|NCT00073749|3558671|FG004|Overall Study|Withdrawal by Subject|1
1992841|NCT00073749|3558672|FG005|Overall Study|Withdrawal by Subject|0
1992842|NCT00073749|3558673|FG006|Overall Study|Withdrawal by Subject|2
1992843|NCT00073749|3558667|FG000|Overall Study|Discontinuation of Study by Sponsor|0
1992844|NCT00073749|3558668|FG001|Overall Study|Discontinuation of Study by Sponsor|0
1992845|NCT00073749|3558669|FG002|Overall Study|Discontinuation of Study by Sponsor|0
1992846|NCT00073749|3558670|FG003|Overall Study|Discontinuation of Study by Sponsor|0
1992847|NCT00073749|3558671|FG004|Overall Study|Discontinuation of Study by Sponsor|0
1992848|NCT00073749|3558672|FG005|Overall Study|Discontinuation of Study by Sponsor|0
1992849|NCT00073749|3558673|FG006|Overall Study|Discontinuation of Study by Sponsor|4
1992850|NCT00073749|3558667|FG000|Overall Study|Lost to Follow-up|0
1992851|NCT00073749|3558668|FG001|Overall Study|Lost to Follow-up|0
1992852|NCT00073749|3558669|FG002|Overall Study|Lost to Follow-up|0
1992853|NCT00073749|3558670|FG003|Overall Study|Lost to Follow-up|0
1992854|NCT00073749|3558671|FG004|Overall Study|Lost to Follow-up|0
1992855|NCT00073749|3558672|FG005|Overall Study|Lost to Follow-up|0
1992856|NCT00073749|3558673|FG006|Overall Study|Lost to Follow-up|2
1992857|NCT00073749|3558667|FG000|Overall Study|Other|0
1992858|NCT00073749|3558668|FG001|Overall Study|Other|0
1992859|NCT00073749|3558669|FG002|Overall Study|Other|0
1992860|NCT00073749|3558670|FG003|Overall Study|Other|0
1992861|NCT00073749|3558671|FG004|Overall Study|Other|0
1992862|NCT00073749|3558672|FG005|Overall Study|Other|2
1992863|NCT00073749|3558673|FG006|Overall Study|Other|0
1992864|NCT00073918|3558692|FG000|Overall Study|Eligibility requirement not met - HAMA+|1
1992865|NCT00073918|3558692|FG000|Overall Study|Rapid disease progression|2
1992866|NCT00073918|3558692|FG000|Overall Study|Eligibility requirement not met-low CD20|1
1992867|NCT00073983|3558702|FG000|Overall Study|not evaluable|1
1992868|NCT00074152|3558714|FG000|Overall Study|Death|21
1992869|NCT00074152|3558715|FG001|Overall Study|Death|9
1992870|NCT00074152|3558714|FG000|Overall Study|Lack of Efficacy|34
1992871|NCT00074152|3558715|FG001|Overall Study|Lack of Efficacy|24
1992872|NCT00074282|3558734|FG000|Step 1|Adverse Event|32
1992873|NCT00074282|3558735|FG001|Step 1|Adverse Event|0
1992874|NCT00074282|3558736|FG002|Step 1|Adverse Event|0
1992875|NCT00074282|3558734|FG000|Step 1|Death|6
1992876|NCT00074282|3558735|FG001|Step 1|Death|0
1992877|NCT00074282|3558736|FG002|Step 1|Death|0
1992878|NCT00074282|3558734|FG000|Step 1|Withdrawal by Subject|7
1992879|NCT00074282|3558735|FG001|Step 1|Withdrawal by Subject|0
1992880|NCT00074282|3558736|FG002|Step 1|Withdrawal by Subject|0
1992881|NCT00074282|3558734|FG000|Step 1|Disease progression|2
1992882|NCT00074282|3558735|FG001|Step 1|Disease progression|0
1992883|NCT00074282|3558736|FG002|Step 1|Disease progression|0
1992884|NCT00074282|3558734|FG000|Step 1|Alternative therapy|2
1992885|NCT00074282|3558735|FG001|Step 1|Alternative therapy|0
1992886|NCT00074282|3558736|FG002|Step 1|Alternative therapy|0
1992887|NCT00074282|3558734|FG000|Step 1|Other complicating disease|2
1992888|NCT00074282|3558735|FG001|Step 1|Other complicating disease|0
1992889|NCT00074282|3558736|FG002|Step 1|Other complicating disease|0
1992890|NCT00074282|3558734|FG000|Step 1|Physician Decision|1
1992891|NCT00074282|3558735|FG001|Step 1|Physician Decision|0
1992892|NCT00074282|3558736|FG002|Step 1|Physician Decision|0
1992893|NCT00074282|3558734|FG000|Step 1|Ineligible|4
1992894|NCT00074282|3558735|FG001|Step 1|Ineligible|0
1992895|NCT00074282|3558736|FG002|Step 1|Ineligible|0
1992896|NCT00074282|3558734|FG000|Step 1|Never started treatment|2
1992897|NCT00074282|3558735|FG001|Step 1|Never started treatment|0
1992898|NCT00074282|3558736|FG002|Step 1|Never started treatment|0
1992899|NCT00074282|3558734|FG000|Step 2|Adverse Event|0
1992900|NCT00074282|3558735|FG001|Step 2|Adverse Event|2
1992901|NCT00074282|3558736|FG002|Step 2|Adverse Event|12
1992902|NCT00074282|3558734|FG000|Step 2|Disease progression|0
1992903|NCT00074282|3558735|FG001|Step 2|Disease progression|0
1992904|NCT00074282|3558736|FG002|Step 2|Disease progression|5
1992905|NCT00074282|3558734|FG000|Step 2|Death|0
1992906|NCT00074282|3558735|FG001|Step 2|Death|0
1992907|NCT00074282|3558736|FG002|Step 2|Death|3
1992908|NCT00074282|3558734|FG000|Step 2|Withdrawal by Subject|0
1992909|NCT00074282|3558735|FG001|Step 2|Withdrawal by Subject|0
1992910|NCT00074282|3558736|FG002|Step 2|Withdrawal by Subject|2
1992911|NCT00074282|3558734|FG000|Step 2|Physician Decision|0
1992912|NCT00074282|3558735|FG001|Step 2|Physician Decision|0
1992913|NCT00074282|3558736|FG002|Step 2|Physician Decision|1
1992914|NCT00074282|3558734|FG000|Step 2|Ineligible|0
1992915|NCT00074282|3558735|FG001|Step 2|Ineligible|0
1992916|NCT00074282|3558736|FG002|Step 2|Ineligible|1
1992917|NCT00074412|3558762|FG000|Overall Study|Death|30
1992918|NCT00074412|3558763|FG001|Overall Study|Death|26
1992919|NCT00074412|3558762|FG000|Overall Study|Lost to Follow-up|52
1992920|NCT00074412|3558763|FG001|Overall Study|Lost to Follow-up|58
1992921|NCT00074490|3558775|FG000|Overall Study|Progressive malignancy|0
1992922|NCT00074490|3558776|FG001|Overall Study|Progressive malignancy|7
1992923|NCT00074490|3558777|FG002|Overall Study|Progressive malignancy|0
1992924|NCT00074490|3558778|FG003|Overall Study|Progressive malignancy|0
1992925|NCT00074490|3558779|FG004|Overall Study|Progressive malignancy|3
1992926|NCT00074490|3558780|FG005|Overall Study|Progressive malignancy|0
1992927|NCT00074581|3558795|FG000|Overall Study|Death|15
1992928|NCT00074581|3558796|FG001|Overall Study|Death|16
1992929|NCT00074581|3558795|FG000|Overall Study|Withdrawal by Subject|50
1992930|NCT00074581|3558796|FG001|Overall Study|Withdrawal by Subject|49
1992931|NCT00074581|3558795|FG000|Overall Study|Unable to adhere to visit schedule|13
1992932|NCT00074581|3558796|FG001|Overall Study|Unable to adhere to visit schedule|14
1992933|NCT00074581|3558795|FG000|Overall Study|Relocated|14
1992934|NCT00074581|3558796|FG001|Overall Study|Relocated|9
1992935|NCT00074581|3558795|FG000|Overall Study|Were withdrawn by investigator|5
1992936|NCT00074581|3558796|FG001|Overall Study|Were withdrawn by investigator|2
1992937|NCT00074581|3558795|FG000|Overall Study|Lost to Follow-up|16
1992938|NCT00074581|3558796|FG001|Overall Study|Lost to Follow-up|11
1992939|NCT00074581|3558795|FG000|Overall Study|Ended relationship w. index participant|117
1992940|NCT00074581|3558796|FG001|Overall Study|Ended relationship w. index participant|106
1992941|NCT00074581|3558795|FG000|Overall Study|Other|14
1992942|NCT00074581|3558796|FG001|Overall Study|Other|19
1992943|NCT00074711|3558804|FG000|Overall Study|Withdrawal by Subject|1
1992944|NCT00074711|3558805|FG001|Overall Study|Withdrawal by Subject|1
1992945|NCT00074711|3558804|FG000|Overall Study|Lost to Follow-up|10
1992946|NCT00074711|3558805|FG001|Overall Study|Lost to Follow-up|8
1992947|NCT00074711|3558804|FG000|Overall Study|Participant stopped study drug|4
1992948|NCT00074711|3558805|FG001|Overall Study|Participant stopped study drug|6
1992949|NCT00074958|3558833|FG000|Overall Study|Adverse Event|1
1992950|NCT00074984|3558839|FG000|Overall Study|Death|1
1992951|NCT00074984|3558840|FG001|Overall Study|Death|2
1992952|NCT00074984|3558839|FG000|Overall Study|Withdrawal by Subject|2
1992953|NCT00074984|3558840|FG001|Overall Study|Withdrawal by Subject|3
1992954|NCT00074984|3558839|FG000|Overall Study|Patient Withdrawn Per Protocol|0
1992955|NCT00074984|3558840|FG001|Overall Study|Patient Withdrawn Per Protocol|3
1992956|NCT00075023|3558849|FG000|Pilot Study|Physician Decision|1
1992957|NCT00075023|3558850|FG001|Pilot Study|Physician Decision|2
1992958|NCT00075023|3558849|FG000|Pilot Study|Withdrawal by Subject|1
1992959|NCT00075023|3558850|FG001|Pilot Study|Withdrawal by Subject|0
1992960|NCT00075218|3558869|FG000|Double-Blind Treatment|Adverse Event|23
1992961|NCT00075218|3558870|FG001|Double-Blind Treatment|Adverse Event|4
1992962|NCT00075218|3558871|FG002|Double-Blind Treatment|Adverse Event|0
1992963|NCT00075218|3558869|FG000|Double-Blind Treatment|Withdrawal by Subject|7
1992964|NCT00075218|3558870|FG001|Double-Blind Treatment|Withdrawal by Subject|4
1992965|NCT00075218|3558871|FG002|Double-Blind Treatment|Withdrawal by Subject|0
1992966|NCT00075218|3558869|FG000|Double-Blind Treatment|Lost to Follow-up|1
1992967|NCT00075218|3558870|FG001|Double-Blind Treatment|Lost to Follow-up|0
1992968|NCT00075218|3558871|FG002|Double-Blind Treatment|Lost to Follow-up|0
1992969|NCT00075218|3558869|FG000|Double-Blind Treatment|Lack of Efficacy|58
1992970|NCT00075218|3558870|FG001|Double-Blind Treatment|Lack of Efficacy|6
1992971|NCT00075218|3558871|FG002|Double-Blind Treatment|Lack of Efficacy|0
1992972|NCT00075218|3558869|FG000|Double-Blind Treatment|Decision of Sponsor|0
1992973|NCT00075218|3558870|FG001|Double-Blind Treatment|Decision of Sponsor|1
1992974|NCT00075218|3558871|FG002|Double-Blind Treatment|Decision of Sponsor|0
1992975|NCT00075218|3558869|FG000|Double-Blind Treatment|No study medication taken|2
1992976|NCT00075218|3558870|FG001|Double-Blind Treatment|No study medication taken|0
1992977|NCT00075218|3558871|FG002|Double-Blind Treatment|No study medication taken|0
1992978|NCT00075218|3558869|FG000|Open-Label Treatment|Lack of Efficacy|0
1992979|NCT00075218|3558870|FG001|Open-Label Treatment|Lack of Efficacy|0
1992980|NCT00075218|3558871|FG002|Open-Label Treatment|Lack of Efficacy|174
1992981|NCT00075218|3558869|FG000|Open-Label Treatment|Adverse Event|0
1992982|NCT00075218|3558870|FG001|Open-Label Treatment|Adverse Event|0
1992983|NCT00075218|3558871|FG002|Open-Label Treatment|Adverse Event|51
1992984|NCT00075218|3558869|FG000|Open-Label Treatment|Withdrawal by Subject|0
1992985|NCT00075218|3558870|FG001|Open-Label Treatment|Withdrawal by Subject|0
1992986|NCT00075218|3558871|FG002|Open-Label Treatment|Withdrawal by Subject|12
1992987|NCT00075218|3558869|FG000|Open-Label Treatment|Decision of Sponsor|0
1992988|NCT00075218|3558870|FG001|Open-Label Treatment|Decision of Sponsor|0
1992989|NCT00075218|3558871|FG002|Open-Label Treatment|Decision of Sponsor|8
1992990|NCT00075218|3558869|FG000|Open-Label Treatment|Protocol Violation|0
1992991|NCT00075218|3558870|FG001|Open-Label Treatment|Protocol Violation|0
1992992|NCT00075218|3558871|FG002|Open-Label Treatment|Protocol Violation|1
1992993|NCT00075218|3558869|FG000|Open-Label Treatment|enrolled in a separate continuation|0
1992994|NCT00075218|3558870|FG001|Open-Label Treatment|enrolled in a separate continuation|0
1992995|NCT00075218|3558871|FG002|Open-Label Treatment|enrolled in a separate continuation|9
1992996|NCT00075270|3558880|FG000|Overall Study|Withdrawal by Subject|28
1992997|NCT00075270|3558881|FG001|Overall Study|Withdrawal by Subject|21
1992998|NCT00075270|3558880|FG000|Overall Study|Lost to Follow-up|25
1992999|NCT00075270|3558881|FG001|Overall Study|Lost to Follow-up|28
1993000|NCT00075270|3558880|FG000|Overall Study|Protocol Violation|0
1993001|NCT00075270|3558881|FG001|Overall Study|Protocol Violation|2
1993002|NCT00075270|3558880|FG000|Overall Study|Death|198
1993003|NCT00075270|3558881|FG001|Overall Study|Death|215
1993004|NCT00075270|3558880|FG000|Overall Study|Other/Unknown|9
1993005|NCT00075270|3558881|FG001|Overall Study|Other/Unknown|5
1993006|NCT00075270|3558880|FG000|Overall Study|Missing|26
1993007|NCT00075270|3558881|FG001|Overall Study|Missing|13
1993008|NCT00075400|3558892|FG000|Overall Study|Ineligible: wrong primary|1
1993009|NCT00075400|3558892|FG000|Overall Study|Never treated|2
1993010|NCT00075478|3558903|FG000|Overall Study|not eligible|1
1993011|NCT00075478|3558904|FG001|Overall Study|not eligible|0
1993012|NCT00075478|3558903|FG000|Overall Study|Physician Decision|0
1993013|NCT00075478|3558904|FG001|Overall Study|Physician Decision|1
1993014|NCT00075504|3558912|FG000|Overall Study|Withdrawal by Subject|9
1993015|NCT00075504|3558913|FG001|Overall Study|Withdrawal by Subject|7
1993016|NCT00075582|3558921|FG000|Overall Study|Adverse Event|3
1993017|NCT00075582|3558922|FG001|Overall Study|Adverse Event|1
1993018|NCT00075582|3558921|FG000|Overall Study|Lack of Efficacy|4
1993019|NCT00075582|3558922|FG001|Overall Study|Lack of Efficacy|8
1993020|NCT00075582|3558921|FG000|Overall Study|Physician Decision|5
1993021|NCT00075582|3558922|FG001|Overall Study|Physician Decision|8
1993022|NCT00075582|3558921|FG000|Overall Study|Withdrawal by Subject|2
1993023|NCT00075582|3558922|FG001|Overall Study|Withdrawal by Subject|2
1993024|NCT00075582|3558921|FG000|Overall Study|Ineligible for study|36
1993025|NCT00075582|3558922|FG001|Overall Study|Ineligible for study|16
1993026|NCT00075725|3558944|FG000|Overall Study|Adverse Event|6
1993027|NCT00075725|3558945|FG001|Overall Study|Adverse Event|6
1993028|NCT00075725|3558946|FG002|Overall Study|Adverse Event|20
1993029|NCT00075725|3558947|FG003|Overall Study|Adverse Event|8
1993030|NCT00075725|3558948|FG004|Overall Study|Adverse Event|4
1993031|NCT00075725|3558949|FG005|Overall Study|Adverse Event|38
1993032|NCT00075725|3558950|FG006|Overall Study|Adverse Event|3
1993033|NCT00075725|3558951|FG007|Overall Study|Adverse Event|51
1993034|NCT00075725|3558952|FG008|Overall Study|Adverse Event|15
1993035|NCT00075725|3558953|FG009|Overall Study|Adverse Event|4
1993036|NCT00075725|3558954|FG010|Overall Study|Adverse Event|2
1993037|NCT00075725|3558955|FG011|Overall Study|Adverse Event|2
1993038|NCT00075725|3558944|FG000|Overall Study|Death|3
1993039|NCT00075725|3558945|FG001|Overall Study|Death|5
1993040|NCT00075725|3558946|FG002|Overall Study|Death|10
1993041|NCT00075725|3558947|FG003|Overall Study|Death|2
1993042|NCT00075725|3558948|FG004|Overall Study|Death|3
1993043|NCT00075725|3558949|FG005|Overall Study|Death|25
1993044|NCT00075725|3558950|FG006|Overall Study|Death|4
1993045|NCT00075725|3558951|FG007|Overall Study|Death|22
1993046|NCT00075725|3558952|FG008|Overall Study|Death|14
1993047|NCT00075725|3558953|FG009|Overall Study|Death|4
1993048|NCT00075725|3558954|FG010|Overall Study|Death|3
1993049|NCT00075725|3558955|FG011|Overall Study|Death|0
1993050|NCT00075725|3558944|FG000|Overall Study|Lost to Follow-up|1
1993051|NCT00075725|3558945|FG001|Overall Study|Lost to Follow-up|1
1993052|NCT00075725|3558946|FG002|Overall Study|Lost to Follow-up|4
1993053|NCT00075725|3558947|FG003|Overall Study|Lost to Follow-up|1
1993054|NCT00075725|3558948|FG004|Overall Study|Lost to Follow-up|0
1993055|NCT00075725|3558949|FG005|Overall Study|Lost to Follow-up|13
1993056|NCT00075725|3558950|FG006|Overall Study|Lost to Follow-up|2
1993057|NCT00075725|3558951|FG007|Overall Study|Lost to Follow-up|4
1993058|NCT00075725|3558952|FG008|Overall Study|Lost to Follow-up|1
1993059|NCT00075725|3558953|FG009|Overall Study|Lost to Follow-up|0
1993060|NCT00075725|3558954|FG010|Overall Study|Lost to Follow-up|0
1993061|NCT00075725|3558955|FG011|Overall Study|Lost to Follow-up|0
1993062|NCT00075725|3558944|FG000|Overall Study|Physician Decision|2
1993063|NCT00075725|3558945|FG001|Overall Study|Physician Decision|6
1993064|NCT00075725|3558946|FG002|Overall Study|Physician Decision|5
1993065|NCT00075725|3558947|FG003|Overall Study|Physician Decision|8
1993066|NCT00075725|3558948|FG004|Overall Study|Physician Decision|4
1993067|NCT00075725|3558949|FG005|Overall Study|Physician Decision|19
1993068|NCT00075725|3558950|FG006|Overall Study|Physician Decision|3
1993069|NCT00075725|3558951|FG007|Overall Study|Physician Decision|17
1993070|NCT00075725|3558952|FG008|Overall Study|Physician Decision|5
1993071|NCT00075725|3558953|FG009|Overall Study|Physician Decision|0
1993072|NCT00075725|3558954|FG010|Overall Study|Physician Decision|1
1993073|NCT00075725|3558955|FG011|Overall Study|Physician Decision|0
1993074|NCT00075725|3558944|FG000|Overall Study|Pregnancy|0
1993075|NCT00075725|3558945|FG001|Overall Study|Pregnancy|0
1993076|NCT00075725|3558946|FG002|Overall Study|Pregnancy|0
1993077|NCT00075725|3558947|FG003|Overall Study|Pregnancy|0
1993078|NCT00075725|3558948|FG004|Overall Study|Pregnancy|0
1993079|NCT00075725|3558949|FG005|Overall Study|Pregnancy|1
1993080|NCT00075725|3558950|FG006|Overall Study|Pregnancy|0
1993081|NCT00075725|3558951|FG007|Overall Study|Pregnancy|1
1993082|NCT00075725|3558952|FG008|Overall Study|Pregnancy|0
1993083|NCT00075725|3558953|FG009|Overall Study|Pregnancy|0
1993084|NCT00075725|3558954|FG010|Overall Study|Pregnancy|0
1993085|NCT00075725|3558955|FG011|Overall Study|Pregnancy|0
1993086|NCT00075725|3558944|FG000|Overall Study|Protocol Violation|1
1993087|NCT00075725|3558945|FG001|Overall Study|Protocol Violation|1
1993088|NCT00075725|3558946|FG002|Overall Study|Protocol Violation|0
1993089|NCT00075725|3558947|FG003|Overall Study|Protocol Violation|3
1993090|NCT00075725|3558948|FG004|Overall Study|Protocol Violation|3
1993091|NCT00075725|3558949|FG005|Overall Study|Protocol Violation|2
1993092|NCT00075725|3558950|FG006|Overall Study|Protocol Violation|1
1993093|NCT00075725|3558951|FG007|Overall Study|Protocol Violation|2
1993094|NCT00075725|3558952|FG008|Overall Study|Protocol Violation|3
1993095|NCT00075725|3558953|FG009|Overall Study|Protocol Violation|0
1993096|NCT00075725|3558954|FG010|Overall Study|Protocol Violation|0
1993097|NCT00075725|3558955|FG011|Overall Study|Protocol Violation|1
1993098|NCT00075725|3558944|FG000|Overall Study|Withdrawal by Subject|12
1993099|NCT00075725|3558945|FG001|Overall Study|Withdrawal by Subject|3
1993100|NCT00075725|3558946|FG002|Overall Study|Withdrawal by Subject|6
1993101|NCT00075725|3558947|FG003|Overall Study|Withdrawal by Subject|10
1993102|NCT00075725|3558948|FG004|Overall Study|Withdrawal by Subject|6
1993103|NCT00075725|3558949|FG005|Overall Study|Withdrawal by Subject|27
1993104|NCT00075725|3558950|FG006|Overall Study|Withdrawal by Subject|7
1993105|NCT00075725|3558951|FG007|Overall Study|Withdrawal by Subject|31
1993106|NCT00075725|3558952|FG008|Overall Study|Withdrawal by Subject|10
1993107|NCT00075725|3558953|FG009|Overall Study|Withdrawal by Subject|2
1993108|NCT00075725|3558954|FG010|Overall Study|Withdrawal by Subject|0
1993109|NCT00075725|3558955|FG011|Overall Study|Withdrawal by Subject|0
1993110|NCT00075725|3558944|FG000|Overall Study|Disease Progression, all other reasons|17
1993111|NCT00075725|3558945|FG001|Overall Study|Disease Progression, all other reasons|5
1993112|NCT00075725|3558946|FG002|Overall Study|Disease Progression, all other reasons|33
1993113|NCT00075725|3558947|FG003|Overall Study|Disease Progression, all other reasons|6
1993114|NCT00075725|3558948|FG004|Overall Study|Disease Progression, all other reasons|21
1993115|NCT00075725|3558949|FG005|Overall Study|Disease Progression, all other reasons|59
1993116|NCT00075725|3558950|FG006|Overall Study|Disease Progression, all other reasons|20
1993117|NCT00075725|3558951|FG007|Overall Study|Disease Progression, all other reasons|46
1993118|NCT00075725|3558952|FG008|Overall Study|Disease Progression, all other reasons|21
1993119|NCT00075725|3558953|FG009|Overall Study|Disease Progression, all other reasons|4
1993120|NCT00075725|3558954|FG010|Overall Study|Disease Progression, all other reasons|0
1993121|NCT00075725|3558955|FG011|Overall Study|Disease Progression, all other reasons|5
1993122|NCT00075725|3558944|FG000|Overall Study|Patient off treatment|0
1993123|NCT00075725|3558945|FG001|Overall Study|Patient off treatment|0
1993124|NCT00075725|3558946|FG002|Overall Study|Patient off treatment|1
1993125|NCT00075725|3558947|FG003|Overall Study|Patient off treatment|2
1993126|NCT00075725|3558948|FG004|Overall Study|Patient off treatment|1
1993127|NCT00075725|3558949|FG005|Overall Study|Patient off treatment|0
1993128|NCT00075725|3558950|FG006|Overall Study|Patient off treatment|0
1993129|NCT00075725|3558951|FG007|Overall Study|Patient off treatment|2
1993130|NCT00075725|3558952|FG008|Overall Study|Patient off treatment|1
1993131|NCT00075725|3558953|FG009|Overall Study|Patient off treatment|0
1993132|NCT00075725|3558954|FG010|Overall Study|Patient off treatment|0
1993133|NCT00075725|3558955|FG011|Overall Study|Patient off treatment|0
1993134|NCT00075725|3558944|FG000|Overall Study|Ineligible or wrong diagnosis|8
1993135|NCT00075725|3558945|FG001|Overall Study|Ineligible or wrong diagnosis|3
1993136|NCT00075725|3558946|FG002|Overall Study|Ineligible or wrong diagnosis|3
1993137|NCT00075725|3558947|FG003|Overall Study|Ineligible or wrong diagnosis|10
1993138|NCT00075725|3558948|FG004|Overall Study|Ineligible or wrong diagnosis|3
1993139|NCT00075725|3558949|FG005|Overall Study|Ineligible or wrong diagnosis|17
1993140|NCT00075725|3558950|FG006|Overall Study|Ineligible or wrong diagnosis|6
1993141|NCT00075725|3558951|FG007|Overall Study|Ineligible or wrong diagnosis|9
1993142|NCT00075725|3558952|FG008|Overall Study|Ineligible or wrong diagnosis|10
1993143|NCT00075725|3558953|FG009|Overall Study|Ineligible or wrong diagnosis|1
1993144|NCT00075725|3558954|FG010|Overall Study|Ineligible or wrong diagnosis|2
1993145|NCT00075725|3558955|FG011|Overall Study|Ineligible or wrong diagnosis|4
1993146|NCT00075725|3558944|FG000|Overall Study|Pt/Guardian refused RT therapy|1
1993147|NCT00075725|3558945|FG001|Overall Study|Pt/Guardian refused RT therapy|0
1993148|NCT00075725|3558946|FG002|Overall Study|Pt/Guardian refused RT therapy|1
1993149|NCT00075725|3558947|FG003|Overall Study|Pt/Guardian refused RT therapy|2
1993150|NCT00075725|3558948|FG004|Overall Study|Pt/Guardian refused RT therapy|1
1993151|NCT00075725|3558949|FG005|Overall Study|Pt/Guardian refused RT therapy|0
1993152|NCT00075725|3558950|FG006|Overall Study|Pt/Guardian refused RT therapy|0
1993153|NCT00075725|3558951|FG007|Overall Study|Pt/Guardian refused RT therapy|0
1993154|NCT00075725|3558952|FG008|Overall Study|Pt/Guardian refused RT therapy|0
1993155|NCT00075725|3558953|FG009|Overall Study|Pt/Guardian refused RT therapy|0
1993156|NCT00075725|3558954|FG010|Overall Study|Pt/Guardian refused RT therapy|0
1993157|NCT00075725|3558955|FG011|Overall Study|Pt/Guardian refused RT therapy|0
1993158|NCT00075725|3558944|FG000|Overall Study|Pt non compliant with therapy|2
1993159|NCT00075725|3558945|FG001|Overall Study|Pt non compliant with therapy|1
1993160|NCT00075725|3558946|FG002|Overall Study|Pt non compliant with therapy|1
1993161|NCT00075725|3558947|FG003|Overall Study|Pt non compliant with therapy|0
1993162|NCT00075725|3558948|FG004|Overall Study|Pt non compliant with therapy|2
1993163|NCT00075725|3558949|FG005|Overall Study|Pt non compliant with therapy|14
1993164|NCT00075725|3558950|FG006|Overall Study|Pt non compliant with therapy|2
1993165|NCT00075725|3558951|FG007|Overall Study|Pt non compliant with therapy|5
1993166|NCT00075725|3558952|FG008|Overall Study|Pt non compliant with therapy|3
1993167|NCT00075725|3558953|FG009|Overall Study|Pt non compliant with therapy|0
1993168|NCT00075725|3558954|FG010|Overall Study|Pt non compliant with therapy|0
1993169|NCT00075725|3558955|FG011|Overall Study|Pt non compliant with therapy|0
1993170|NCT00075725|3558944|FG000|Overall Study|Pt age out of range for treatment|0
1993171|NCT00075725|3558945|FG001|Overall Study|Pt age out of range for treatment|1
1993172|NCT00075725|3558946|FG002|Overall Study|Pt age out of range for treatment|0
1993173|NCT00075725|3558947|FG003|Overall Study|Pt age out of range for treatment|0
1993174|NCT00075725|3558948|FG004|Overall Study|Pt age out of range for treatment|0
1993175|NCT00075725|3558949|FG005|Overall Study|Pt age out of range for treatment|1
1993176|NCT00075725|3558950|FG006|Overall Study|Pt age out of range for treatment|0
1993177|NCT00075725|3558951|FG007|Overall Study|Pt age out of range for treatment|1
1993178|NCT00075725|3558952|FG008|Overall Study|Pt age out of range for treatment|0
1993179|NCT00075725|3558953|FG009|Overall Study|Pt age out of range for treatment|0
1993180|NCT00075725|3558954|FG010|Overall Study|Pt age out of range for treatment|0
1993181|NCT00075725|3558955|FG011|Overall Study|Pt age out of range for treatment|0
1993182|NCT00075725|3558944|FG000|Overall Study|Insurance issues|0
1993183|NCT00075725|3558945|FG001|Overall Study|Insurance issues|1
1993184|NCT00075725|3558946|FG002|Overall Study|Insurance issues|0
1993185|NCT00075725|3558947|FG003|Overall Study|Insurance issues|1
1993186|NCT00075725|3558948|FG004|Overall Study|Insurance issues|1
1993187|NCT00075725|3558949|FG005|Overall Study|Insurance issues|1
1993188|NCT00075725|3558950|FG006|Overall Study|Insurance issues|0
1993189|NCT00075725|3558951|FG007|Overall Study|Insurance issues|1
1993190|NCT00075725|3558952|FG008|Overall Study|Insurance issues|0
1993191|NCT00075725|3558953|FG009|Overall Study|Insurance issues|0
1993192|NCT00075725|3558954|FG010|Overall Study|Insurance issues|0
1993193|NCT00075725|3558955|FG011|Overall Study|Insurance issues|0
1993194|NCT00075725|3558944|FG000|Overall Study|MRD positive after extended ind|0
1993195|NCT00075725|3558945|FG001|Overall Study|MRD positive after extended ind|1
1993196|NCT00075725|3558946|FG002|Overall Study|MRD positive after extended ind|1
1993197|NCT00075725|3558947|FG003|Overall Study|MRD positive after extended ind|0
1993198|NCT00075725|3558948|FG004|Overall Study|MRD positive after extended ind|1
1993199|NCT00075725|3558949|FG005|Overall Study|MRD positive after extended ind|2
1993200|NCT00075725|3558950|FG006|Overall Study|MRD positive after extended ind|0
1993201|NCT00075725|3558951|FG007|Overall Study|MRD positive after extended ind|1
1993202|NCT00075725|3558952|FG008|Overall Study|MRD positive after extended ind|0
1993203|NCT00075725|3558953|FG009|Overall Study|MRD positive after extended ind|0
1993204|NCT00075725|3558954|FG010|Overall Study|MRD positive after extended ind|0
1993205|NCT00075725|3558955|FG011|Overall Study|MRD positive after extended ind|0
1993206|NCT00075725|3558944|FG000|Overall Study|Pt has very high risk ALL characteristic|15
1993207|NCT00075725|3558945|FG001|Overall Study|Pt has very high risk ALL characteristic|11
1993208|NCT00075725|3558946|FG002|Overall Study|Pt has very high risk ALL characteristic|26
1993209|NCT00075725|3558947|FG003|Overall Study|Pt has very high risk ALL characteristic|18
1993210|NCT00075725|3558948|FG004|Overall Study|Pt has very high risk ALL characteristic|11
1993211|NCT00075725|3558949|FG005|Overall Study|Pt has very high risk ALL characteristic|75
1993212|NCT00075725|3558950|FG006|Overall Study|Pt has very high risk ALL characteristic|23
1993213|NCT00075725|3558951|FG007|Overall Study|Pt has very high risk ALL characteristic|74
1993214|NCT00075725|3558952|FG008|Overall Study|Pt has very high risk ALL characteristic|29
1993215|NCT00075725|3558953|FG009|Overall Study|Pt has very high risk ALL characteristic|1
1993216|NCT00075725|3558954|FG010|Overall Study|Pt has very high risk ALL characteristic|0
1993217|NCT00075725|3558955|FG011|Overall Study|Pt has very high risk ALL characteristic|3
1993218|NCT00075725|3558944|FG000|Overall Study|Inevaluable|1
1993219|NCT00075725|3558945|FG001|Overall Study|Inevaluable|1
1993220|NCT00075725|3558946|FG002|Overall Study|Inevaluable|4
1993221|NCT00075725|3558947|FG003|Overall Study|Inevaluable|2
1993222|NCT00075725|3558948|FG004|Overall Study|Inevaluable|2
1993223|NCT00075725|3558949|FG005|Overall Study|Inevaluable|9
1993224|NCT00075725|3558950|FG006|Overall Study|Inevaluable|1
1993225|NCT00075725|3558951|FG007|Overall Study|Inevaluable|11
1993226|NCT00075725|3558952|FG008|Overall Study|Inevaluable|2
1993227|NCT00075725|3558953|FG009|Overall Study|Inevaluable|0
1993228|NCT00075725|3558954|FG010|Overall Study|Inevaluable|1
1993229|NCT00075725|3558955|FG011|Overall Study|Inevaluable|0
1993230|NCT00075725|3558944|FG000|Overall Study|Other|4
1993231|NCT00075725|3558945|FG001|Overall Study|Other|2
1993232|NCT00075725|3558946|FG002|Overall Study|Other|1
1993233|NCT00075725|3558947|FG003|Overall Study|Other|1
1993234|NCT00075725|3558948|FG004|Overall Study|Other|1
1993235|NCT00075725|3558949|FG005|Overall Study|Other|4
1993236|NCT00075725|3558950|FG006|Overall Study|Other|2
1993237|NCT00075725|3558951|FG007|Overall Study|Other|9
1993238|NCT00075725|3558952|FG008|Overall Study|Other|2
1993239|NCT00075725|3558953|FG009|Overall Study|Other|1
1993240|NCT00075725|3558954|FG010|Overall Study|Other|0
1993241|NCT00075725|3558955|FG011|Overall Study|Other|3
1993242|NCT00075725|3558944|FG000|Overall Study|Pt trying to find a BM donor|0
1993243|NCT00075725|3558945|FG001|Overall Study|Pt trying to find a BM donor|1
1993244|NCT00075725|3558946|FG002|Overall Study|Pt trying to find a BM donor|0
1993245|NCT00075725|3558947|FG003|Overall Study|Pt trying to find a BM donor|0
1993246|NCT00075725|3558948|FG004|Overall Study|Pt trying to find a BM donor|0
1993247|NCT00075725|3558949|FG005|Overall Study|Pt trying to find a BM donor|0
1993248|NCT00075725|3558950|FG006|Overall Study|Pt trying to find a BM donor|0
1993249|NCT00075725|3558951|FG007|Overall Study|Pt trying to find a BM donor|0
1993250|NCT00075725|3558952|FG008|Overall Study|Pt trying to find a BM donor|0
1993251|NCT00075725|3558953|FG009|Overall Study|Pt trying to find a BM donor|0
1993252|NCT00075725|3558954|FG010|Overall Study|Pt trying to find a BM donor|0
1993253|NCT00075725|3558955|FG011|Overall Study|Pt trying to find a BM donor|0
1993254|NCT00075725|3558944|FG000|Overall Study|Clinic chart lost unable to recreate|0
1993255|NCT00075725|3558945|FG001|Overall Study|Clinic chart lost unable to recreate|0
1993256|NCT00075725|3558946|FG002|Overall Study|Clinic chart lost unable to recreate|1
1993257|NCT00075725|3558947|FG003|Overall Study|Clinic chart lost unable to recreate|0
1993258|NCT00075725|3558948|FG004|Overall Study|Clinic chart lost unable to recreate|0
1993259|NCT00075725|3558949|FG005|Overall Study|Clinic chart lost unable to recreate|0
1993260|NCT00075725|3558950|FG006|Overall Study|Clinic chart lost unable to recreate|0
1993261|NCT00075725|3558951|FG007|Overall Study|Clinic chart lost unable to recreate|0
1993262|NCT00075725|3558952|FG008|Overall Study|Clinic chart lost unable to recreate|0
1993263|NCT00075725|3558953|FG009|Overall Study|Clinic chart lost unable to recreate|0
1993264|NCT00075725|3558954|FG010|Overall Study|Clinic chart lost unable to recreate|0
1993265|NCT00075725|3558955|FG011|Overall Study|Clinic chart lost unable to recreate|0
1993266|NCT00075725|3558944|FG000|Overall Study|Unsuccessful institutional transfer|0
1993267|NCT00075725|3558945|FG001|Overall Study|Unsuccessful institutional transfer|0
1993268|NCT00075725|3558946|FG002|Overall Study|Unsuccessful institutional transfer|2
1993269|NCT00075725|3558947|FG003|Overall Study|Unsuccessful institutional transfer|0
1993270|NCT00075725|3558948|FG004|Overall Study|Unsuccessful institutional transfer|0
1993271|NCT00075725|3558949|FG005|Overall Study|Unsuccessful institutional transfer|0
1993272|NCT00075725|3558950|FG006|Overall Study|Unsuccessful institutional transfer|0
1993273|NCT00075725|3558951|FG007|Overall Study|Unsuccessful institutional transfer|0
1993274|NCT00075725|3558952|FG008|Overall Study|Unsuccessful institutional transfer|0
1993275|NCT00075725|3558953|FG009|Overall Study|Unsuccessful institutional transfer|1
1993276|NCT00075725|3558954|FG010|Overall Study|Unsuccessful institutional transfer|0
1993277|NCT00075725|3558955|FG011|Overall Study|Unsuccessful institutional transfer|0
1993278|NCT00075725|3558944|FG000|Overall Study|specimen(s) not submitted|0
1993279|NCT00075725|3558945|FG001|Overall Study|specimen(s) not submitted|0
1993280|NCT00075725|3558946|FG002|Overall Study|specimen(s) not submitted|2
1993281|NCT00075725|3558947|FG003|Overall Study|specimen(s) not submitted|0
1993282|NCT00075725|3558948|FG004|Overall Study|specimen(s) not submitted|0
1993283|NCT00075725|3558949|FG005|Overall Study|specimen(s) not submitted|0
1993284|NCT00075725|3558950|FG006|Overall Study|specimen(s) not submitted|0
1993285|NCT00075725|3558951|FG007|Overall Study|specimen(s) not submitted|0
1993286|NCT00075725|3558952|FG008|Overall Study|specimen(s) not submitted|0
1993287|NCT00075725|3558953|FG009|Overall Study|specimen(s) not submitted|0
1993288|NCT00075725|3558954|FG010|Overall Study|specimen(s) not submitted|0
1993289|NCT00075725|3558955|FG011|Overall Study|specimen(s) not submitted|0
1993290|NCT00075725|3558944|FG000|Overall Study|Pt went to transplant|0
1993291|NCT00075725|3558945|FG001|Overall Study|Pt went to transplant|0
1993292|NCT00075725|3558946|FG002|Overall Study|Pt went to transplant|0
1993293|NCT00075725|3558947|FG003|Overall Study|Pt went to transplant|1
1993294|NCT00075725|3558948|FG004|Overall Study|Pt went to transplant|0
1993295|NCT00075725|3558949|FG005|Overall Study|Pt went to transplant|1
1993296|NCT00075725|3558950|FG006|Overall Study|Pt went to transplant|0
1993297|NCT00075725|3558951|FG007|Overall Study|Pt went to transplant|0
1993298|NCT00075725|3558952|FG008|Overall Study|Pt went to transplant|0
1993299|NCT00075725|3558953|FG009|Overall Study|Pt went to transplant|0
1993300|NCT00075725|3558954|FG010|Overall Study|Pt went to transplant|0
1993301|NCT00075725|3558955|FG011|Overall Study|Pt went to transplant|0
1993302|NCT00075725|3558944|FG000|Overall Study|Pt received additional steroids|0
1993303|NCT00075725|3558945|FG001|Overall Study|Pt received additional steroids|0
1993304|NCT00075725|3558946|FG002|Overall Study|Pt received additional steroids|0
1993305|NCT00075725|3558947|FG003|Overall Study|Pt received additional steroids|1
1993306|NCT00075725|3558948|FG004|Overall Study|Pt received additional steroids|0
1993307|NCT00075725|3558949|FG005|Overall Study|Pt received additional steroids|0
1993308|NCT00075725|3558950|FG006|Overall Study|Pt received additional steroids|0
1993309|NCT00075725|3558951|FG007|Overall Study|Pt received additional steroids|0
1993310|NCT00075725|3558952|FG008|Overall Study|Pt received additional steroids|0
1993311|NCT00075725|3558953|FG009|Overall Study|Pt received additional steroids|0
1993312|NCT00075725|3558954|FG010|Overall Study|Pt received additional steroids|0
1993313|NCT00075725|3558955|FG011|Overall Study|Pt received additional steroids|0
1993314|NCT00075725|3558944|FG000|Overall Study|Pt relocated|0
1993315|NCT00075725|3558945|FG001|Overall Study|Pt relocated|0
1993316|NCT00075725|3558946|FG002|Overall Study|Pt relocated|0
1993317|NCT00075725|3558947|FG003|Overall Study|Pt relocated|2
1993318|NCT00075725|3558948|FG004|Overall Study|Pt relocated|0
1993319|NCT00075725|3558949|FG005|Overall Study|Pt relocated|1
1993320|NCT00075725|3558950|FG006|Overall Study|Pt relocated|1
1993321|NCT00075725|3558951|FG007|Overall Study|Pt relocated|2
1993322|NCT00075725|3558952|FG008|Overall Study|Pt relocated|1
1993323|NCT00075725|3558953|FG009|Overall Study|Pt relocated|0
1993324|NCT00075725|3558954|FG010|Overall Study|Pt relocated|0
1993325|NCT00075725|3558955|FG011|Overall Study|Pt relocated|0
1993326|NCT00075725|3558944|FG000|Overall Study|Institution Terminated|0
1993327|NCT00075725|3558945|FG001|Overall Study|Institution Terminated|0
1993328|NCT00075725|3558946|FG002|Overall Study|Institution Terminated|0
1993329|NCT00075725|3558947|FG003|Overall Study|Institution Terminated|0
1993330|NCT00075725|3558948|FG004|Overall Study|Institution Terminated|1
1993331|NCT00075725|3558949|FG005|Overall Study|Institution Terminated|0
1993332|NCT00075725|3558950|FG006|Overall Study|Institution Terminated|0
1993333|NCT00075725|3558951|FG007|Overall Study|Institution Terminated|3
1993334|NCT00075725|3558952|FG008|Overall Study|Institution Terminated|0
1993335|NCT00075725|3558953|FG009|Overall Study|Institution Terminated|0
1993336|NCT00075725|3558954|FG010|Overall Study|Institution Terminated|0
1993337|NCT00075725|3558955|FG011|Overall Study|Institution Terminated|0
1993338|NCT00075725|3558944|FG000|Overall Study|Study Closure|1
1993339|NCT00075725|3558945|FG001|Overall Study|Study Closure|0
1993340|NCT00075725|3558946|FG002|Overall Study|Study Closure|0
1993341|NCT00075725|3558947|FG003|Overall Study|Study Closure|0
1993342|NCT00075725|3558948|FG004|Overall Study|Study Closure|1
1993343|NCT00075725|3558949|FG005|Overall Study|Study Closure|3
1993344|NCT00075725|3558950|FG006|Overall Study|Study Closure|0
1993345|NCT00075725|3558951|FG007|Overall Study|Study Closure|1
1993346|NCT00075725|3558952|FG008|Overall Study|Study Closure|0
1993347|NCT00075725|3558953|FG009|Overall Study|Study Closure|0
1993348|NCT00075725|3558954|FG010|Overall Study|Study Closure|0
1993349|NCT00075725|3558955|FG011|Overall Study|Study Closure|0
1993350|NCT00075725|3558944|FG000|Overall Study|Other complications|0
1993351|NCT00075725|3558945|FG001|Overall Study|Other complications|0
1993352|NCT00075725|3558946|FG002|Overall Study|Other complications|0
1993353|NCT00075725|3558947|FG003|Overall Study|Other complications|0
1993354|NCT00075725|3558948|FG004|Overall Study|Other complications|0
1993355|NCT00075725|3558949|FG005|Overall Study|Other complications|1
1993356|NCT00075725|3558950|FG006|Overall Study|Other complications|0
1993357|NCT00075725|3558951|FG007|Overall Study|Other complications|0
1993358|NCT00075725|3558952|FG008|Overall Study|Other complications|0
1993359|NCT00075725|3558953|FG009|Overall Study|Other complications|0
1993360|NCT00075725|3558954|FG010|Overall Study|Other complications|0
1993361|NCT00075725|3558955|FG011|Overall Study|Other complications|0
1993362|NCT00075725|3558944|FG000|Overall Study|Pt care terminated due to pt behavior|0
1993363|NCT00075725|3558945|FG001|Overall Study|Pt care terminated due to pt behavior|0
1993364|NCT00075725|3558946|FG002|Overall Study|Pt care terminated due to pt behavior|0
1993365|NCT00075725|3558947|FG003|Overall Study|Pt care terminated due to pt behavior|0
1993366|NCT00075725|3558948|FG004|Overall Study|Pt care terminated due to pt behavior|0
1993367|NCT00075725|3558949|FG005|Overall Study|Pt care terminated due to pt behavior|0
1993368|NCT00075725|3558950|FG006|Overall Study|Pt care terminated due to pt behavior|0
1993369|NCT00075725|3558951|FG007|Overall Study|Pt care terminated due to pt behavior|1
1993370|NCT00075725|3558952|FG008|Overall Study|Pt care terminated due to pt behavior|0
1993371|NCT00075725|3558953|FG009|Overall Study|Pt care terminated due to pt behavior|0
1993372|NCT00075725|3558954|FG010|Overall Study|Pt care terminated due to pt behavior|0
1993373|NCT00075725|3558955|FG011|Overall Study|Pt care terminated due to pt behavior|0
1993374|NCT00075725|3558944|FG000|Overall Study|Pt incarcerated|0
1993375|NCT00075725|3558945|FG001|Overall Study|Pt incarcerated|0
1993376|NCT00075725|3558946|FG002|Overall Study|Pt incarcerated|0
1993377|NCT00075725|3558947|FG003|Overall Study|Pt incarcerated|0
1993378|NCT00075725|3558948|FG004|Overall Study|Pt incarcerated|0
1993379|NCT00075725|3558949|FG005|Overall Study|Pt incarcerated|0
1993380|NCT00075725|3558950|FG006|Overall Study|Pt incarcerated|0
1993381|NCT00075725|3558951|FG007|Overall Study|Pt incarcerated|1
1993382|NCT00075725|3558952|FG008|Overall Study|Pt incarcerated|0
1993383|NCT00075725|3558953|FG009|Overall Study|Pt incarcerated|0
1993384|NCT00075725|3558954|FG010|Overall Study|Pt incarcerated|0
1993385|NCT00075725|3558955|FG011|Overall Study|Pt incarcerated|0
1993386|NCT00075764|3558988|FG000|Overall Study|Adverse Event|5
1993387|NCT00075764|3558989|FG001|Overall Study|Adverse Event|12
1993388|NCT00075764|3558988|FG000|Overall Study|Death|4
1993389|NCT00075764|3558989|FG001|Overall Study|Death|8
1993390|NCT00075764|3558988|FG000|Overall Study|Withdrawal by Subject|28
1993391|NCT00075764|3558989|FG001|Overall Study|Withdrawal by Subject|18
1993392|NCT00075764|3558988|FG000|Overall Study|Progression|269
1993393|NCT00075764|3558989|FG001|Overall Study|Progression|274
1993394|NCT00075764|3558988|FG000|Overall Study|Still on treatment|8
1993395|NCT00075764|3558989|FG001|Overall Study|Still on treatment|15
1993396|NCT00075764|3558988|FG000|Overall Study|Delinquent|4
1993397|NCT00075764|3558989|FG001|Overall Study|Delinquent|2
1993398|NCT00075764|3558988|FG000|Overall Study|Not protocol specified|27
1993399|NCT00075764|3558989|FG001|Overall Study|Not protocol specified|19
1993400|NCT00075764|3558988|FG000|Overall Study|Under review|0
1993401|NCT00075764|3558989|FG001|Overall Study|Under review|1
1993402|NCT00075816|3559008|FG000|Overall Study|Did not undergo transplantation|14
1993403|NCT00075816|3559009|FG001|Overall Study|Did not undergo transplantation|11
1993404|NCT00075881|3559037|FG000|Overall Study|Lack of Efficacy|18
1993405|NCT00075881|3559037|FG000|Overall Study|Adverse Event|7
1993406|NCT00075881|3559037|FG000|Overall Study|Death|1
1993407|NCT00075881|3559037|FG000|Overall Study|Withdrawal by Subject|2
1993408|NCT00075881|3559037|FG000|Overall Study|Protocol Violation|4
1993409|NCT00075881|3559037|FG000|Overall Study|other complicating disease|3
1993410|NCT00075881|3559037|FG000|Overall Study|other|4
1993411|NCT00075881|3559037|FG000|Overall Study|missing data|2
1993412|NCT00075881|3559037|FG000|Overall Study|Ineligible|1
1993413|NCT00075881|3559037|FG000|Overall Study|never start protocol therapy|1
1993414|NCT00075946|3559047|FG000|Overall Study|Path ineligible: undetermined histology|0
1993415|NCT00075946|3559048|FG001|Overall Study|Path ineligible: undetermined histology|0
1993416|NCT00075946|3559049|FG002|Overall Study|Path ineligible: undetermined histology|0
1993417|NCT00075946|3559050|FG003|Overall Study|Path ineligible: undetermined histology|0
1993418|NCT00075946|3559051|FG004|Overall Study|Path ineligible: undetermined histology|6
1993419|NCT00075946|3559047|FG000|Overall Study|Did not achieve response after induction|0
1993420|NCT00075946|3559048|FG001|Overall Study|Did not achieve response after induction|0
1993421|NCT00075946|3559049|FG002|Overall Study|Did not achieve response after induction|0
1993422|NCT00075946|3559050|FG003|Overall Study|Did not achieve response after induction|0
1993423|NCT00075946|3559051|FG004|Overall Study|Did not achieve response after induction|182
1993424|NCT00075946|3559047|FG000|Overall Study|Incorrectly randomized (no response)|5
1993425|NCT00075946|3559048|FG001|Overall Study|Incorrectly randomized (no response)|5
1993426|NCT00075946|3559049|FG002|Overall Study|Incorrectly randomized (no response)|5
1993427|NCT00075946|3559050|FG003|Overall Study|Incorrectly randomized (no response)|1
1993428|NCT00075946|3559051|FG004|Overall Study|Incorrectly randomized (no response)|0
1993429|NCT00075946|3559047|FG000|Overall Study|Still on treatment at time of analysis|52
1993430|NCT00075946|3559048|FG001|Overall Study|Still on treatment at time of analysis|19
1993431|NCT00075946|3559049|FG002|Overall Study|Still on treatment at time of analysis|3
1993432|NCT00075946|3559050|FG003|Overall Study|Still on treatment at time of analysis|9
1993433|NCT00075946|3559051|FG004|Overall Study|Still on treatment at time of analysis|0
1993434|NCT00075946|3559047|FG000|Overall Study|Adverse Event|2
1993435|NCT00075946|3559048|FG001|Overall Study|Adverse Event|10
1993436|NCT00075946|3559049|FG002|Overall Study|Adverse Event|0
1993437|NCT00075946|3559050|FG003|Overall Study|Adverse Event|2
1993438|NCT00075946|3559051|FG004|Overall Study|Adverse Event|0
1993439|NCT00075946|3559047|FG000|Overall Study|Death|0
1993440|NCT00075946|3559048|FG001|Overall Study|Death|1
1993441|NCT00075946|3559049|FG002|Overall Study|Death|0
1993442|NCT00075946|3559050|FG003|Overall Study|Death|0
1993443|NCT00075946|3559051|FG004|Overall Study|Death|0
1993444|NCT00075946|3559047|FG000|Overall Study|Withdrawal by Subject|23
1993445|NCT00075946|3559048|FG001|Overall Study|Withdrawal by Subject|58
1993446|NCT00075946|3559049|FG002|Overall Study|Withdrawal by Subject|4
1993447|NCT00075946|3559050|FG003|Overall Study|Withdrawal by Subject|9
1993448|NCT00075946|3559051|FG004|Overall Study|Withdrawal by Subject|0
1993449|NCT00075946|3559047|FG000|Overall Study|Alternative therapy|16
1993450|NCT00075946|3559048|FG001|Overall Study|Alternative therapy|2
1993451|NCT00075946|3559049|FG002|Overall Study|Alternative therapy|5
1993452|NCT00075946|3559050|FG003|Overall Study|Alternative therapy|0
1993453|NCT00075946|3559051|FG004|Overall Study|Alternative therapy|0
1993454|NCT00075946|3559047|FG000|Overall Study|Other complicating disease|7
1993455|NCT00075946|3559048|FG001|Overall Study|Other complicating disease|13
2102389|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15
2102390|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13
2102391|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20
2102392|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55
2102393|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56
2213601|NCT01681433|3855488|FG000|Overall Study|Protocol Violation|2
2213602|NCT01681433|3855489|FG001|Overall Study|Protocol Violation|0
2213603|NCT01681433|3855488|FG000|Overall Study|Adverse Event|2
2213604|NCT01681433|3855489|FG001|Overall Study|Adverse Event|4
2213605|NCT01681433|3855488|FG000|Overall Study|Lost to Follow-up|0
2213606|NCT01681433|3855489|FG001|Overall Study|Lost to Follow-up|1
2213607|NCT01681472|3855499|FG000|Overall Study|Adverse Event|0
2213608|NCT01681472|3855500|FG001|Overall Study|Adverse Event|1
2213609|NCT01681472|3855501|FG002|Overall Study|Adverse Event|0
2213610|NCT01681472|3855502|FG003|Overall Study|Adverse Event|0
1993456|NCT00075946|3559049|FG002|Overall Study|Other complicating disease|1
1993457|NCT00075946|3559050|FG003|Overall Study|Other complicating disease|4
2213611|NCT01681511|3855523|FG000|Overall Study|No Treatment Received|1
1993458|NCT00075946|3559051|FG004|Overall Study|Other complicating disease|0
1993459|NCT00075946|3559047|FG000|Overall Study|No response to retreatment|23
2213612|NCT01681511|3855524|FG001|Overall Study|No Treatment Received|3
1993460|NCT00075946|3559048|FG001|Overall Study|No response to retreatment|0
1993461|NCT00075946|3559049|FG002|Overall Study|No response to retreatment|2
1993462|NCT00075946|3559050|FG003|Overall Study|No response to retreatment|0
1993463|NCT00075946|3559051|FG004|Overall Study|No response to retreatment|0
1993464|NCT00075946|3559047|FG000|Overall Study|Time to progression less than 6 months|15
1993465|NCT00075946|3559048|FG001|Overall Study|Time to progression less than 6 months|30
1993466|NCT00075946|3559049|FG002|Overall Study|Time to progression less than 6 months|8
1993467|NCT00075946|3559050|FG003|Overall Study|Time to progression less than 6 months|3
1993468|NCT00075946|3559051|FG004|Overall Study|Time to progression less than 6 months|0
1993469|NCT00075946|3559047|FG000|Overall Study|Other|5
1993470|NCT00075946|3559048|FG001|Overall Study|Other|13
1993471|NCT00075946|3559049|FG002|Overall Study|Other|0
1993472|NCT00075946|3559050|FG003|Overall Study|Other|2
1993473|NCT00075946|3559051|FG004|Overall Study|Other|0
2213613|NCT01681511|3855523|FG000|Overall Study|Failed Inclusion/Exclusion|3
2213614|NCT01681511|3855524|FG001|Overall Study|Failed Inclusion/Exclusion|0
2213615|NCT01681511|3855523|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3
2213616|NCT01681511|3855524|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6
2213617|NCT01681511|3855523|FG000|Overall Study|No Daily Urine Sample Collected|0
2024626|NCT00336284|3593253|FG000|Overall Study|Lost to Follow-up|82
2024627|NCT00336284|3593254|FG001|Overall Study|Lost to Follow-up|61
2024628|NCT00336284|3593253|FG000|Overall Study|Withdrawal by Physician or Subject|102
2024629|NCT00336284|3593254|FG001|Overall Study|Withdrawal by Physician or Subject|64
2024630|NCT00336479|3593289|FG000|Overall Study|Adverse Event|8
2024631|NCT00336479|3593290|FG001|Overall Study|Adverse Event|11
2024632|NCT00336479|3593291|FG002|Overall Study|Adverse Event|18
2024633|NCT00336479|3593292|FG003|Overall Study|Adverse Event|4
2024634|NCT00336479|3593289|FG000|Overall Study|Noncompliant|1
2024635|NCT00336479|3593290|FG001|Overall Study|Noncompliant|7
2024636|NCT00336479|3593291|FG002|Overall Study|Noncompliant|3
2024637|NCT00336479|3593292|FG003|Overall Study|Noncompliant|0
2024638|NCT00336479|3593289|FG000|Overall Study|Physician Decision|2
2024639|NCT00336479|3593290|FG001|Overall Study|Physician Decision|3
2024640|NCT00336479|3593291|FG002|Overall Study|Physician Decision|1
2024641|NCT00336479|3593292|FG003|Overall Study|Physician Decision|0
2024642|NCT00336479|3593289|FG000|Overall Study|Lost to Follow-up|3
2024643|NCT00336479|3593290|FG001|Overall Study|Lost to Follow-up|2
2024644|NCT00336479|3593291|FG002|Overall Study|Lost to Follow-up|0
2024645|NCT00336479|3593292|FG003|Overall Study|Lost to Follow-up|0
2024646|NCT00336479|3593289|FG000|Overall Study|Withdrawal by Subject|3
2024647|NCT00336479|3593290|FG001|Overall Study|Withdrawal by Subject|2
2024648|NCT00336479|3593291|FG002|Overall Study|Withdrawal by Subject|3
2024649|NCT00336479|3593292|FG003|Overall Study|Withdrawal by Subject|0
2024650|NCT00336479|3593289|FG000|Overall Study|Other|0
2024651|NCT00336479|3593290|FG001|Overall Study|Other|0
2024652|NCT00336479|3593291|FG002|Overall Study|Other|1
2024653|NCT00336479|3593292|FG003|Overall Study|Other|0
2024654|NCT00336479|3593289|FG000|Overall Study|Virologic Stopping Rule|20
2024655|NCT00336479|3593290|FG001|Overall Study|Virologic Stopping Rule|0
2024656|NCT00336479|3593291|FG002|Overall Study|Virologic Stopping Rule|0
2024657|NCT00336479|3593292|FG003|Overall Study|Virologic Stopping Rule|0
2024658|NCT00336492|3593306|FG000|Overall Study|Adverse Event|4
2024659|NCT00336492|3593307|FG001|Overall Study|Adverse Event|3
2024660|NCT00336492|3593308|FG002|Overall Study|Adverse Event|6
2024661|NCT00336492|3593306|FG000|Overall Study|Lack of Efficacy|6
2024662|NCT00336492|3593307|FG001|Overall Study|Lack of Efficacy|1
2024663|NCT00336492|3593308|FG002|Overall Study|Lack of Efficacy|4
2024664|NCT00336492|3593306|FG000|Overall Study|Other|5
2024665|NCT00336492|3593307|FG001|Overall Study|Other|0
2024666|NCT00336492|3593308|FG002|Overall Study|Other|1
2024667|NCT00336505|3593318|FG000|Overall Study|Adverse Event|10
2024668|NCT00336505|3593319|FG001|Overall Study|Adverse Event|9
2024669|NCT00336505|3593318|FG000|Overall Study|Lack of Efficacy|8
2024670|NCT00336505|3593319|FG001|Overall Study|Lack of Efficacy|4
2024671|NCT00336505|3593318|FG000|Overall Study|Lost to Follow-up|7
2024672|NCT00336505|3593319|FG001|Overall Study|Lost to Follow-up|4
2024673|NCT00336505|3593318|FG000|Overall Study|Withdrawal by Subject|5
2024674|NCT00336505|3593319|FG001|Overall Study|Withdrawal by Subject|3
2024675|NCT00336505|3593318|FG000|Overall Study|Other|7
2024676|NCT00336505|3593319|FG001|Overall Study|Other|7
2024677|NCT00336544|3593327|FG000|Overall Study|Lack of Efficacy|8
2024678|NCT00336544|3593328|FG001|Overall Study|Lack of Efficacy|5
2024679|NCT00336544|3593327|FG000|Overall Study|Adverse Event|4
2024680|NCT00336544|3593328|FG001|Overall Study|Adverse Event|9
2024681|NCT00336544|3593327|FG000|Overall Study|Withdrawal by Subject|4
2024682|NCT00336544|3593328|FG001|Overall Study|Withdrawal by Subject|3
2024683|NCT00336544|3593327|FG000|Overall Study|Other|3
2024684|NCT00336544|3593328|FG001|Overall Study|Other|5
2024685|NCT00336583|3593334|FG000|Overall Study|Lost to Follow-up|1
2024686|NCT00336583|3593334|FG000|Overall Study|Death|1
2024687|NCT00336856|3593353|FG000|Overall Study|Withdrawal by Subject|3
2024688|NCT00336856|3593353|FG000|Overall Study|Found ineligible at time of analysis|1
2024689|NCT00336895|3593357|FG000|Overall Study|diarrhea|1
2024690|NCT00336895|3593357|FG000|Overall Study|nausea and upset stomach|1
2024691|NCT00336895|3593357|FG000|Overall Study|Physician Decision|1
1993474|NCT00076011|3559062|FG000|Overall Study|Death|1
1993475|NCT00076011|3559062|FG000|Overall Study|Adverse Event|10
1993476|NCT00076011|3559062|FG000|Overall Study|Lack of Efficacy|25
1993477|NCT00076011|3559062|FG000|Overall Study|Withdrawal by Subject|1
1993478|NCT00076011|3559062|FG000|Overall Study|Study terminated by sponsor|3
1993479|NCT00076011|3559062|FG000|Overall Study|Other|11
1993480|NCT00076011|3559062|FG000|Overall Study|Ongoing|1
1993481|NCT00076024|3559069|FG000|Phase 1, Lead-in|Lack of Efficacy|4
1993482|NCT00076024|3559070|FG001|Phase 1, Lead-in|Lack of Efficacy|0
1993483|NCT00076024|3559071|FG002|Phase 1, Lead-in|Lack of Efficacy|0
1993484|NCT00076024|3559072|FG003|Phase 1, Lead-in|Lack of Efficacy|0
1993485|NCT00076024|3559069|FG000|Phase 1, Lead-in|Adverse Event|1
1993486|NCT00076024|3559070|FG001|Phase 1, Lead-in|Adverse Event|0
1993487|NCT00076024|3559071|FG002|Phase 1, Lead-in|Adverse Event|0
1993488|NCT00076024|3559072|FG003|Phase 1, Lead-in|Adverse Event|0
1993489|NCT00076024|3559069|FG000|Phase 1, Lead-in|Clinical progression|1
1993490|NCT00076024|3559070|FG001|Phase 1, Lead-in|Clinical progression|0
1993491|NCT00076024|3559071|FG002|Phase 1, Lead-in|Clinical progression|0
1993492|NCT00076024|3559072|FG003|Phase 1, Lead-in|Clinical progression|0
1993493|NCT00076024|3559069|FG000|Phase 2, Double-blind|Lack of Efficacy|0
1993494|NCT00076024|3559070|FG001|Phase 2, Double-blind|Lack of Efficacy|59
1993495|NCT00076024|3559071|FG002|Phase 2, Double-blind|Lack of Efficacy|40
1993496|NCT00076024|3559072|FG003|Phase 2, Double-blind|Lack of Efficacy|0
1993497|NCT00076024|3559069|FG000|Phase 2, Double-blind|Withdrawal by Subject|0
1993498|NCT00076024|3559070|FG001|Phase 2, Double-blind|Withdrawal by Subject|13
1993499|NCT00076024|3559071|FG002|Phase 2, Double-blind|Withdrawal by Subject|4
1993500|NCT00076024|3559072|FG003|Phase 2, Double-blind|Withdrawal by Subject|0
1993501|NCT00076024|3559069|FG000|Phase 2, Double-blind|Adverse Event|0
1993502|NCT00076024|3559070|FG001|Phase 2, Double-blind|Adverse Event|25
1993503|NCT00076024|3559071|FG002|Phase 2, Double-blind|Adverse Event|6
1993504|NCT00076024|3559072|FG003|Phase 2, Double-blind|Adverse Event|0
1993505|NCT00076024|3559069|FG000|Phase 2, Double-blind|Un-specified|0
1993506|NCT00076024|3559070|FG001|Phase 2, Double-blind|Un-specified|14
1993507|NCT00076024|3559071|FG002|Phase 2, Double-blind|Un-specified|6
1993508|NCT00076024|3559072|FG003|Phase 2, Double-blind|Un-specified|0
1993509|NCT00076024|3559069|FG000|Phase 2, Double-blind|Randomized but not treated|0
1993510|NCT00076024|3559070|FG001|Phase 2, Double-blind|Randomized but not treated|1
1993511|NCT00076024|3559071|FG002|Phase 2, Double-blind|Randomized but not treated|0
1993512|NCT00076024|3559072|FG003|Phase 2, Double-blind|Randomized but not treated|0
1993513|NCT00076024|3559069|FG000|Phase 2, Open-label|Adverse Event|0
1993514|NCT00076024|3559070|FG001|Phase 2, Open-label|Adverse Event|0
1993515|NCT00076024|3559071|FG002|Phase 2, Open-label|Adverse Event|0
1993516|NCT00076024|3559072|FG003|Phase 2, Open-label|Adverse Event|2
1993517|NCT00076024|3559069|FG000|Phase 2, Open-label|Lack of Efficacy|0
1993518|NCT00076024|3559070|FG001|Phase 2, Open-label|Lack of Efficacy|0
1993519|NCT00076024|3559071|FG002|Phase 2, Open-label|Lack of Efficacy|0
1993520|NCT00076024|3559072|FG003|Phase 2, Open-label|Lack of Efficacy|11
1993521|NCT00076024|3559069|FG000|Phase 2, Open-label|Withdrawal by Subject|0
1993522|NCT00076024|3559070|FG001|Phase 2, Open-label|Withdrawal by Subject|0
1993523|NCT00076024|3559071|FG002|Phase 2, Open-label|Withdrawal by Subject|0
1993524|NCT00076024|3559072|FG003|Phase 2, Open-label|Withdrawal by Subject|1
1993525|NCT00076024|3559069|FG000|Phase 2, Open-label|Other|0
1993526|NCT00076024|3559070|FG001|Phase 2, Open-label|Other|0
1993527|NCT00076024|3559071|FG002|Phase 2, Open-label|Other|0
1993528|NCT00076024|3559072|FG003|Phase 2, Open-label|Other|2
1993529|NCT00076102|3559090|FG000|Overall Study|Clinical progression|1
1993530|NCT00076102|3559090|FG000|Overall Study|Progression in pre-existing brain tumor|1
1993531|NCT00076102|3559090|FG000|Overall Study|plexiform neurofibroma surgery|1
1993532|NCT00076102|3559090|FG000|Overall Study|refusal of further therapy|2
1993533|NCT00076336|3559133|FG000|Overall Study|Death|13
1993534|NCT00076336|3559134|FG001|Overall Study|Death|17
1993535|NCT00076336|3559133|FG000|Overall Study|Adverse Event|4
1993536|NCT00076336|3559134|FG001|Overall Study|Adverse Event|4
1993537|NCT00076336|3559133|FG000|Overall Study|Lost to Follow-up|4
1993538|NCT00076336|3559134|FG001|Overall Study|Lost to Follow-up|4
1993539|NCT00076336|3559133|FG000|Overall Study|Non-Compliance|2
1993540|NCT00076336|3559134|FG001|Overall Study|Non-Compliance|0
1993541|NCT00076336|3559133|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0
1993542|NCT00076336|3559134|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1
1993543|NCT00076336|3559133|FG000|Overall Study|Patient, Investigator, Sponsor request|8
1993544|NCT00076336|3559134|FG001|Overall Study|Patient, Investigator, Sponsor request|6
1993545|NCT00076336|3559133|FG000|Overall Study|Liver Transplantation|3
1993546|NCT00076336|3559134|FG001|Overall Study|Liver Transplantation|3
1993547|NCT00076336|3559133|FG000|Overall Study|Virologic Breakthrough|14
1993548|NCT00076336|3559134|FG001|Overall Study|Virologic Breakthrough|16
1993549|NCT00076336|3559133|FG000|Overall Study|Treatment failure|4
1993550|NCT00076336|3559134|FG001|Overall Study|Treatment failure|5
1993551|NCT00076570|3559142|FG000|Overall Study|Drug intolerance|8
1993552|NCT00076570|3559143|FG001|Overall Study|Drug intolerance|8
1993553|NCT00076752|3559183|FG000|Overall Study|Death|2
1993554|NCT00076752|3559183|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1
1993555|NCT00076804|3559190|FG000|Overall Study|Death|9
1993556|NCT00076804|3559191|FG001|Overall Study|Death|20
1993557|NCT00076804|3559190|FG000|Overall Study|Lost to Follow-up|9
1993558|NCT00076804|3559191|FG001|Overall Study|Lost to Follow-up|9
1993559|NCT00076804|3559190|FG000|Overall Study|Withdrawal by Subject|10
1993560|NCT00076804|3559191|FG001|Overall Study|Withdrawal by Subject|8
1993561|NCT00076804|3559190|FG000|Overall Study|Early study Closure|32
1993562|NCT00076804|3559191|FG001|Overall Study|Early study Closure|32
1993563|NCT00076999|3559201|FG000|Overall Study|Adverse Event|2
1993564|NCT00076999|3559202|FG001|Overall Study|Adverse Event|8
1993565|NCT00076999|3559203|FG002|Overall Study|Adverse Event|6
1993566|NCT00076999|3559204|FG003|Overall Study|Adverse Event|0
1993567|NCT00076999|3559205|FG004|Overall Study|Adverse Event|2
1993568|NCT00076999|3559201|FG000|Overall Study|Protocol Violation|0
1993569|NCT00076999|3559202|FG001|Overall Study|Protocol Violation|3
1993570|NCT00076999|3559203|FG002|Overall Study|Protocol Violation|4
1993571|NCT00076999|3559204|FG003|Overall Study|Protocol Violation|0
1993572|NCT00076999|3559205|FG004|Overall Study|Protocol Violation|9
1993573|NCT00076999|3559201|FG000|Overall Study|Lost to Follow-up|2
1993574|NCT00076999|3559202|FG001|Overall Study|Lost to Follow-up|1
1993575|NCT00076999|3559203|FG002|Overall Study|Lost to Follow-up|0
1993576|NCT00076999|3559204|FG003|Overall Study|Lost to Follow-up|0
1993577|NCT00076999|3559205|FG004|Overall Study|Lost to Follow-up|0
1993578|NCT00076999|3559201|FG000|Overall Study|Withdrawal by Subject|0
1993579|NCT00076999|3559202|FG001|Overall Study|Withdrawal by Subject|4
1993580|NCT00076999|3559203|FG002|Overall Study|Withdrawal by Subject|3
1993581|NCT00076999|3559204|FG003|Overall Study|Withdrawal by Subject|0
1993582|NCT00076999|3559205|FG004|Overall Study|Withdrawal by Subject|1
1993583|NCT00076999|3559201|FG000|Overall Study|Other reason (not specified)|8
1993584|NCT00076999|3559202|FG001|Overall Study|Other reason (not specified)|8
1993585|NCT00076999|3559203|FG002|Overall Study|Other reason (not specified)|4
1993586|NCT00076999|3559204|FG003|Overall Study|Other reason (not specified)|1
1993587|NCT00076999|3559205|FG004|Overall Study|Other reason (not specified)|13
1993588|NCT00077064|3559220|FG000|Overall Study|Adverse Event|0
1993589|NCT00077064|3559221|FG001|Overall Study|Adverse Event|4
1993590|NCT00077064|3559220|FG000|Overall Study|Patient refusal|0
1993591|NCT00077064|3559221|FG001|Overall Study|Patient refusal|2
1993592|NCT00077207|3559228|FG000|Overall Study|Adverse Event|5
1993593|NCT00077207|3559228|FG000|Overall Study|Lack of Efficacy|12
1993594|NCT00077207|3559228|FG000|Overall Study|Physician Decision|6
1993595|NCT00077207|3559228|FG000|Overall Study|Withdrawal by Subject|6
1993596|NCT00077207|3559228|FG000|Overall Study|Ineligible|1
1993597|NCT00077376|3559233|FG000|Overall Study|Adverse Event|8
1993598|NCT00077376|3559233|FG000|Overall Study|Withdrawal by Subject|2
1993599|NCT00077376|3559233|FG000|Overall Study|Death|1
2213618|NCT01681511|3855524|FG001|Overall Study|No Daily Urine Sample Collected|1
1993600|NCT00077376|3559233|FG000|Overall Study|Physician Decision|1
1993601|NCT00077376|3559233|FG000|Overall Study|Alternative therapy|5
1993602|NCT00077376|3559233|FG000|Overall Study|Complicating disease|1
1993603|NCT00077376|3559233|FG000|Overall Study|Still on treatment|1
1993604|NCT00077376|3559233|FG000|Overall Study|Symptomatic deterioration|1
1993605|NCT00077376|3559233|FG000|Overall Study|Surgery|1
1993606|NCT00077376|3559233|FG000|Overall Study|Insurance ran out|1
1993607|NCT00077610|3559240|FG000|Overall Study|Adverse Event|9
1993608|NCT00077610|3559241|FG001|Overall Study|Adverse Event|7
1993609|NCT00077610|3559242|FG002|Overall Study|Adverse Event|1
1993610|NCT00077610|3559240|FG000|Overall Study|Lost to Follow-up|0
1993611|NCT00077610|3559241|FG001|Overall Study|Lost to Follow-up|1
1993612|NCT00077610|3559242|FG002|Overall Study|Lost to Follow-up|2
1993613|NCT00077610|3559240|FG000|Overall Study|Withdrawal by Subject|4
1993614|NCT00077610|3559241|FG001|Overall Study|Withdrawal by Subject|10
1993615|NCT00077610|3559242|FG002|Overall Study|Withdrawal by Subject|6
1993616|NCT00077610|3559240|FG000|Overall Study|Death|17
1993617|NCT00077610|3559241|FG001|Overall Study|Death|13
1993618|NCT00077610|3559242|FG002|Overall Study|Death|13
1993619|NCT00077610|3559240|FG000|Overall Study|Renal transplant|12
1993620|NCT00077610|3559241|FG001|Overall Study|Renal transplant|15
1993621|NCT00077610|3559242|FG002|Overall Study|Renal transplant|11
1993622|NCT00077610|3559240|FG000|Overall Study|Withdrew from dialysis care|5
1993623|NCT00077610|3559241|FG001|Overall Study|Withdrew from dialysis care|0
1993624|NCT00077610|3559242|FG002|Overall Study|Withdrew from dialysis care|3
1993625|NCT00077610|3559240|FG000|Overall Study|Insufficient Therapeutic Response|1
1993626|NCT00077610|3559241|FG001|Overall Study|Insufficient Therapeutic Response|0
1993627|NCT00077610|3559242|FG002|Overall Study|Insufficient Therapeutic Response|0
1993628|NCT00077610|3559240|FG000|Overall Study|Multiple blood transfusions|0
1993629|NCT00077610|3559241|FG001|Overall Study|Multiple blood transfusions|0
1993630|NCT00077610|3559242|FG002|Overall Study|Multiple blood transfusions|1
1993631|NCT00077610|3559240|FG000|Overall Study|Principal Investigator's decision|1
1993632|NCT00077610|3559241|FG001|Overall Study|Principal Investigator's decision|0
1993633|NCT00077610|3559242|FG002|Overall Study|Principal Investigator's decision|1
1993634|NCT00077610|3559240|FG000|Overall Study|Worsening of health condition|1
1993635|NCT00077610|3559241|FG001|Overall Study|Worsening of health condition|1
1993636|NCT00077610|3559242|FG002|Overall Study|Worsening of health condition|0
1993637|NCT00077610|3559240|FG000|Overall Study|Given Epogen in hospital|1
1993638|NCT00077610|3559241|FG001|Overall Study|Given Epogen in hospital|0
1993639|NCT00077610|3559242|FG002|Overall Study|Given Epogen in hospital|0
1993640|NCT00077610|3559240|FG000|Overall Study|Transferred to other unit|0
1993641|NCT00077610|3559241|FG001|Overall Study|Transferred to other unit|0
1993642|NCT00077610|3559242|FG002|Overall Study|Transferred to other unit|1
1993643|NCT00077610|3559240|FG000|Overall Study|Transferred to nursing home|0
1993644|NCT00077610|3559241|FG001|Overall Study|Transferred to nursing home|0
1993645|NCT00077610|3559242|FG002|Overall Study|Transferred to nursing home|1
1993646|NCT00077610|3559240|FG000|Overall Study|Transfer to satellite unit|1
1993647|NCT00077610|3559241|FG001|Overall Study|Transfer to satellite unit|0
1993648|NCT00077610|3559242|FG002|Overall Study|Transfer to satellite unit|0
1993649|NCT00077610|3559240|FG000|Overall Study|Transfer to other center for surgery|1
1993650|NCT00077610|3559241|FG001|Overall Study|Transfer to other center for surgery|0
1993651|NCT00077610|3559242|FG002|Overall Study|Transfer to other center for surgery|0
1993652|NCT00077610|3559240|FG000|Overall Study|Change in dialysis modality|1
1993653|NCT00077610|3559241|FG001|Overall Study|Change in dialysis modality|0
1993654|NCT00077610|3559242|FG002|Overall Study|Change in dialysis modality|0
1993655|NCT00077610|3559240|FG000|Overall Study|Relocation|0
1993656|NCT00077610|3559241|FG001|Overall Study|Relocation|8
1993657|NCT00077610|3559242|FG002|Overall Study|Relocation|5
1993658|NCT00077610|3559240|FG000|Overall Study|Financial issues|0
1993659|NCT00077610|3559241|FG001|Overall Study|Financial issues|1
1993660|NCT00077610|3559242|FG002|Overall Study|Financial issues|0
1993661|NCT00077610|3559240|FG000|Overall Study|Sponsors decision to withdraw|0
1993662|NCT00077610|3559241|FG001|Overall Study|Sponsors decision to withdraw|0
1993663|NCT00077610|3559242|FG002|Overall Study|Sponsors decision to withdraw|1
1993664|NCT00077623|3559258|FG000|Overall Study|Adverse Event|1
1993665|NCT00077623|3559259|FG001|Overall Study|Adverse Event|0
1993666|NCT00077623|3559260|FG002|Overall Study|Adverse Event|1
1993667|NCT00077623|3559258|FG000|Overall Study|Withdrawal by Subject|2
1993668|NCT00077623|3559259|FG001|Overall Study|Withdrawal by Subject|10
1993669|NCT00077623|3559260|FG002|Overall Study|Withdrawal by Subject|1
1993670|NCT00077623|3559258|FG000|Overall Study|Other-Non safety reason|18
1993671|NCT00077623|3559259|FG001|Overall Study|Other-Non safety reason|15
1993672|NCT00077623|3559260|FG002|Overall Study|Other-Non safety reason|19
1993673|NCT00077623|3559258|FG000|Overall Study|Insufficient therapeutic response|2
1993674|NCT00077623|3559259|FG001|Overall Study|Insufficient therapeutic response|0
1993675|NCT00077623|3559260|FG002|Overall Study|Insufficient therapeutic response|0
1993676|NCT00077623|3559258|FG000|Overall Study|Death|12
1993677|NCT00077623|3559259|FG001|Overall Study|Death|18
1993678|NCT00077623|3559260|FG002|Overall Study|Death|11
1993679|NCT00077623|3559258|FG000|Overall Study|Failure to return|1
1993680|NCT00077623|3559259|FG001|Overall Study|Failure to return|0
1993681|NCT00077623|3559260|FG002|Overall Study|Failure to return|0
1993682|NCT00077636|3559270|FG000|Overall Study|Refused Treatment|9
1993683|NCT00077636|3559271|FG001|Overall Study|Refused Treatment|31
1993684|NCT00077636|3559270|FG000|Overall Study|Admin|3
1993685|NCT00077636|3559271|FG001|Overall Study|Admin|3
1993686|NCT00077636|3559270|FG000|Overall Study|Withdrawal by Subject|2
1993687|NCT00077636|3559271|FG001|Overall Study|Withdrawal by Subject|2
1993688|NCT00077636|3559270|FG000|Overall Study|Adverse Event|17
1993689|NCT00077636|3559271|FG001|Overall Study|Adverse Event|34
1993690|NCT00077636|3559270|FG000|Overall Study|Protocol Violation|0
1993691|NCT00077636|3559271|FG001|Overall Study|Protocol Violation|2
1993692|NCT00077636|3559270|FG000|Overall Study|Lost to Follow-up|10
1993693|NCT00077636|3559271|FG001|Overall Study|Lost to Follow-up|18
1993694|NCT00077636|3559270|FG000|Overall Study|Abnormality Of Laboratory Test|3
1993695|NCT00077636|3559271|FG001|Overall Study|Abnormality Of Laboratory Test|2
1993696|NCT00077649|3559282|FG000|Overall Study|Adverse Event|5
1993697|NCT00077649|3559283|FG001|Overall Study|Adverse Event|1
1993698|NCT00077649|3559284|FG002|Overall Study|Adverse Event|7
1993699|NCT00077649|3559285|FG003|Overall Study|Adverse Event|9
1993700|NCT00077649|3559282|FG000|Overall Study|Lack of Efficacy|5
1993701|NCT00077649|3559283|FG001|Overall Study|Lack of Efficacy|3
1993702|NCT00077649|3559284|FG002|Overall Study|Lack of Efficacy|3
1993703|NCT00077649|3559285|FG003|Overall Study|Lack of Efficacy|2
1993704|NCT00077649|3559282|FG000|Overall Study|Withdrawal by Subject|0
1993705|NCT00077649|3559283|FG001|Overall Study|Withdrawal by Subject|1
1993706|NCT00077649|3559284|FG002|Overall Study|Withdrawal by Subject|1
1993707|NCT00077649|3559285|FG003|Overall Study|Withdrawal by Subject|2
1993708|NCT00077649|3559282|FG000|Overall Study|Lost to Follow-up|2
1993709|NCT00077649|3559283|FG001|Overall Study|Lost to Follow-up|2
1993710|NCT00077649|3559284|FG002|Overall Study|Lost to Follow-up|3
1993711|NCT00077649|3559285|FG003|Overall Study|Lost to Follow-up|2
1993712|NCT00077649|3559282|FG000|Overall Study|Abnormality of Laboratory Test|1
1993713|NCT00077649|3559283|FG001|Overall Study|Abnormality of Laboratory Test|2
1993714|NCT00077649|3559284|FG002|Overall Study|Abnormality of Laboratory Test|1
1993715|NCT00077649|3559285|FG003|Overall Study|Abnormality of Laboratory Test|2
1993716|NCT00077649|3559282|FG000|Overall Study|Randomized but never dosed|1
1993717|NCT00077649|3559283|FG001|Overall Study|Randomized but never dosed|0
1993718|NCT00077649|3559284|FG002|Overall Study|Randomized but never dosed|0
1993719|NCT00077649|3559285|FG003|Overall Study|Randomized but never dosed|0
1993720|NCT00077675|3559301|FG000|Overall Study|Adverse Event|1
1993721|NCT00077675|3559302|FG001|Overall Study|Adverse Event|2
1993722|NCT00077675|3559301|FG000|Overall Study|Lost to Follow-up|6
1993723|NCT00077675|3559302|FG001|Overall Study|Lost to Follow-up|3
1993724|NCT00077675|3559301|FG000|Overall Study|Withdrawal by Subject|1
1993725|NCT00077675|3559302|FG001|Overall Study|Withdrawal by Subject|0
1993726|NCT00077675|3559301|FG000|Overall Study|Other|0
1993727|NCT00077675|3559302|FG001|Overall Study|Other|1
1993728|NCT00077675|3559301|FG000|Overall Study|Never received study treatment|3
1993729|NCT00077675|3559302|FG001|Overall Study|Never received study treatment|3
1993730|NCT00077766|3559310|FG000|Overall Study|Adverse Event|1
1993731|NCT00077766|3559311|FG001|Overall Study|Adverse Event|1
1993732|NCT00077766|3559310|FG000|Overall Study|Withdrawal by Subject|4
1993733|NCT00077766|3559311|FG001|Overall Study|Withdrawal by Subject|3
1993734|NCT00077766|3559310|FG000|Overall Study|Death|12
1993735|NCT00077766|3559311|FG001|Overall Study|Death|10
1993736|NCT00077766|3559310|FG000|Overall Study|Lost to Follow-up|2
1993737|NCT00077766|3559311|FG001|Overall Study|Lost to Follow-up|0
1993738|NCT00077766|3559310|FG000|Overall Study|Protocol Violation|1
1993739|NCT00077766|3559311|FG001|Overall Study|Protocol Violation|0
1993740|NCT00077766|3559310|FG000|Overall Study|Kidney Transplantation|9
1993741|NCT00077766|3559311|FG001|Overall Study|Kidney Transplantation|5
1993742|NCT00077766|3559310|FG000|Overall Study|Transplantation|5
1993743|NCT00077766|3559311|FG001|Overall Study|Transplantation|1
1993744|NCT00077766|3559310|FG000|Overall Study|Investigators Discretion|1
1993745|NCT00077766|3559311|FG001|Overall Study|Investigators Discretion|0
1993746|NCT00077766|3559310|FG000|Overall Study|Participant's decision|1
1993747|NCT00077766|3559311|FG001|Overall Study|Participant's decision|0
1993748|NCT00077766|3559310|FG000|Overall Study|Dialysis Discontinued|1
1993749|NCT00077766|3559311|FG001|Overall Study|Dialysis Discontinued|0
1993750|NCT00077766|3559310|FG000|Overall Study|Dialysis|0
1993751|NCT00077766|3559311|FG001|Overall Study|Dialysis|1
1993752|NCT00077766|3559310|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
1993753|NCT00077766|3559311|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
1993754|NCT00077766|3559310|FG000|Overall Study|Started Nocturnal Dialysis|0
1993755|NCT00077766|3559311|FG001|Overall Study|Started Nocturnal Dialysis|1
1993756|NCT00077766|3559310|FG000|Overall Study|Stop Dialysis|0
1993757|NCT00077766|3559311|FG001|Overall Study|Stop Dialysis|1
1993758|NCT00077766|3559310|FG000|Overall Study|Participants Vacation|2
1993759|NCT00077766|3559311|FG001|Overall Study|Participants Vacation|1
1993760|NCT00077857|3559320|FG000|Overall Study|Adverse Event|30
1993761|NCT00077857|3559321|FG001|Overall Study|Adverse Event|32
1993762|NCT00077857|3559320|FG000|Overall Study|Death|7
1993763|NCT00077857|3559321|FG001|Overall Study|Death|3
1993764|NCT00077857|3559320|FG000|Overall Study|Insufficient therapeutic response|112
1993765|NCT00077857|3559321|FG001|Overall Study|Insufficient therapeutic response|128
1993766|NCT00077857|3559320|FG000|Overall Study|Violation of selection criteria at entry|3
1993767|NCT00077857|3559321|FG001|Overall Study|Violation of selection criteria at entry|1
1993768|NCT00077857|3559320|FG000|Overall Study|Other protocol violation|0
1993769|NCT00077857|3559321|FG001|Overall Study|Other protocol violation|1
1993770|NCT00077857|3559320|FG000|Overall Study|Refused treatment|29
1993771|NCT00077857|3559321|FG001|Overall Study|Refused treatment|21
1993772|NCT00077857|3559320|FG000|Overall Study|Failure to return|5
1993773|NCT00077857|3559321|FG001|Overall Study|Failure to return|5
1993774|NCT00077857|3559320|FG000|Overall Study|Other|15
1993775|NCT00077857|3559321|FG001|Overall Study|Other|13
1993776|NCT00077974|3559331|FG000|Overall Study|Adverse Event|22
1993777|NCT00077974|3559331|FG000|Overall Study|Protocol Violation|1
1993778|NCT00077974|3559331|FG000|Overall Study|Withdrawal by Subject|3
1993779|NCT00077974|3559331|FG000|Overall Study|Lack of Efficacy|76
1993780|NCT00077974|3559331|FG000|Overall Study|Decision of Sponsor|2
1993781|NCT00078312|3559344|FG000|Overall Study|Adverse Event|43
1993782|NCT00078312|3559344|FG000|Overall Study|Lack of Efficacy|15
1993783|NCT00078312|3559344|FG000|Overall Study|Lost to Follow-up|41
1993784|NCT00078312|3559344|FG000|Overall Study|Physician Decision|9
1993785|NCT00078312|3559344|FG000|Overall Study|Protocol Violation|3
1993786|NCT00078312|3559344|FG000|Overall Study|Withdrawal by Subject|33
1993787|NCT00078312|3559344|FG000|Overall Study|Miscellaneous|33
1993788|NCT00078325|3559351|FG000|Overall Study|Adverse Event|15
1993789|NCT00078325|3559352|FG001|Overall Study|Adverse Event|10
1993790|NCT00078325|3559353|FG002|Overall Study|Adverse Event|5
1993791|NCT00078325|3559351|FG000|Overall Study|Protocol Violation|2
1993792|NCT00078325|3559352|FG001|Overall Study|Protocol Violation|2
1993793|NCT00078325|3559353|FG002|Overall Study|Protocol Violation|0
1993794|NCT00078325|3559351|FG000|Overall Study|Withdrawal by Subject|1
1993795|NCT00078325|3559352|FG001|Overall Study|Withdrawal by Subject|5
1993796|NCT00078325|3559353|FG002|Overall Study|Withdrawal by Subject|3
1993797|NCT00078325|3559351|FG000|Overall Study|Lost to Follow-up|0
1993798|NCT00078325|3559352|FG001|Overall Study|Lost to Follow-up|1
1993799|NCT00078325|3559353|FG002|Overall Study|Lost to Follow-up|1
1993800|NCT00078325|3559351|FG000|Overall Study|Physician Decision|2
1993801|NCT00078325|3559352|FG001|Overall Study|Physician Decision|0
1993802|NCT00078325|3559353|FG002|Overall Study|Physician Decision|1
2213619|NCT01681511|3855523|FG000|Overall Study|No post-catheter sample collected|11
1993803|NCT00078325|3559351|FG000|Overall Study|Miscellaneous|1
1993804|NCT00078325|3559352|FG001|Overall Study|Miscellaneous|1
1993805|NCT00078325|3559353|FG002|Overall Study|Miscellaneous|1
1993806|NCT00078338|3559363|FG000|Overall Study|Adverse Event|31
1993807|NCT00078338|3559364|FG001|Overall Study|Adverse Event|24
1993808|NCT00078338|3559363|FG000|Overall Study|Lost to Follow-up|17
1993809|NCT00078338|3559364|FG001|Overall Study|Lost to Follow-up|2
1993810|NCT00078338|3559363|FG000|Overall Study|Protocol Violation|2
1993811|NCT00078338|3559364|FG001|Overall Study|Protocol Violation|2
1993812|NCT00078338|3559363|FG000|Overall Study|Disease Progression|4
1993813|NCT00078338|3559364|FG001|Overall Study|Disease Progression|7
2217553|NCT01708954|3860854|FG000|Step 2|Adverse Event|3
1993814|NCT00078338|3559363|FG000|Overall Study|Other|28
1993815|NCT00078338|3559364|FG001|Overall Study|Other|16
1993816|NCT00078338|3559363|FG000|Overall Study|Subjects randomized, but not treated|3
1993817|NCT00078338|3559364|FG001|Overall Study|Subjects randomized, but not treated|3
1993818|NCT00078377|3559373|FG000|Overall Study|Adverse Event|2
1993819|NCT00078377|3559374|FG001|Overall Study|Adverse Event|5
1993820|NCT00078377|3559375|FG002|Overall Study|Adverse Event|1
1993821|NCT00078377|3559373|FG000|Overall Study|Lack of Efficacy|2
1993822|NCT00078377|3559374|FG001|Overall Study|Lack of Efficacy|0
1993823|NCT00078377|3559375|FG002|Overall Study|Lack of Efficacy|2
1993824|NCT00078377|3559373|FG000|Overall Study|Lost to Follow-up|0
1993825|NCT00078377|3559374|FG001|Overall Study|Lost to Follow-up|1
1993826|NCT00078377|3559375|FG002|Overall Study|Lost to Follow-up|1
1993827|NCT00078377|3559373|FG000|Overall Study|Physician Decision|2
1993828|NCT00078377|3559374|FG001|Overall Study|Physician Decision|0
1993829|NCT00078377|3559375|FG002|Overall Study|Physician Decision|0
1993830|NCT00078377|3559373|FG000|Overall Study|Withdrawal by Subject|3
1993831|NCT00078377|3559374|FG001|Overall Study|Withdrawal by Subject|4
1993832|NCT00078377|3559375|FG002|Overall Study|Withdrawal by Subject|4
1993833|NCT00078377|3559373|FG000|Overall Study|Miscellaneous|2
1993834|NCT00078377|3559374|FG001|Overall Study|Miscellaneous|6
1993835|NCT00078377|3559375|FG002|Overall Study|Miscellaneous|1
1993836|NCT00078767|3559440|FG000|Overall Study|Withdrawal by Subject|1
1993837|NCT00078767|3559441|FG001|Overall Study|Withdrawal by Subject|1
1993838|NCT00078819|3559449|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0
1993839|NCT00078819|3559450|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1
1993840|NCT00078819|3559451|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0
1993841|NCT00078819|3559452|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0
1993842|NCT00078819|3559449|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
1993843|NCT00078819|3559450|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
1993844|NCT00078819|3559451|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
1993845|NCT00078819|3559452|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
1993846|NCT00078819|3559449|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
1993847|NCT00078819|3559450|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
1993848|NCT00078819|3559451|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
1993849|NCT00078819|3559452|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
1993850|NCT00078819|3559449|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
1993851|NCT00078819|3559450|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
1993852|NCT00078819|3559451|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
1993853|NCT00078819|3559452|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
1993854|NCT00078819|3559449|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
1993855|NCT00078819|3559450|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
1993856|NCT00078819|3559451|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
1993857|NCT00078819|3559452|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
1993858|NCT00078819|3559449|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
1993859|NCT00078819|3559450|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
1993860|NCT00078819|3559451|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
1993861|NCT00078819|3559452|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
1993862|NCT00078819|3559449|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
1993863|NCT00078819|3559450|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
1993864|NCT00078819|3559451|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
1993865|NCT00078819|3559452|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
1993866|NCT00078819|3559449|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
1993867|NCT00078819|3559450|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
1993868|NCT00078819|3559451|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
1993869|NCT00078819|3559452|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
1993870|NCT00078949|3559482|FG000|Overall Study|No treated|4
1993871|NCT00078949|3559483|FG001|Overall Study|No treated|5
1993872|NCT00078949|3559484|FG002|Overall Study|No treated|3
1993873|NCT00078949|3559485|FG003|Overall Study|No treated|3
1993874|NCT00079040|3559506|FG000|Overall Study|Withdrew before treatment|1
1993875|NCT00079040|3559506|FG000|Overall Study|Ineligible|1
1993876|NCT00079183|3559510|FG000|Overall Study|Withdrawal by Subject|4
1993877|NCT00079183|3559510|FG000|Overall Study|Study medication non-compliance|2
1993878|NCT00079183|3559510|FG000|Overall Study|Specimen collection non-compliance|1
1993879|NCT00079274|3559522|FG000|Overall Study|Withdrawal by Subject|111
1993880|NCT00079274|3559523|FG001|Overall Study|Withdrawal by Subject|10
1993881|NCT00079274|3559524|FG002|Overall Study|Withdrawal by Subject|12
1993882|NCT00079274|3559525|FG003|Overall Study|Withdrawal by Subject|163
1993883|NCT00079274|3559526|FG004|Overall Study|Withdrawal by Subject|7
1993884|NCT00079274|3559527|FG005|Overall Study|Withdrawal by Subject|8
1993885|NCT00079274|3559528|FG006|Overall Study|Withdrawal by Subject|0
1993886|NCT00079274|3559522|FG000|Overall Study|Adverse Event|130
1993887|NCT00079274|3559523|FG001|Overall Study|Adverse Event|8
1993888|NCT00079274|3559524|FG002|Overall Study|Adverse Event|8
1993889|NCT00079274|3559525|FG003|Overall Study|Adverse Event|184
1993890|NCT00079274|3559526|FG004|Overall Study|Adverse Event|7
1993891|NCT00079274|3559527|FG005|Overall Study|Adverse Event|8
1993892|NCT00079274|3559528|FG006|Overall Study|Adverse Event|0
1993893|NCT00079274|3559522|FG000|Overall Study|Recurrence|21
1993894|NCT00079274|3559523|FG001|Overall Study|Recurrence|0
1993895|NCT00079274|3559524|FG002|Overall Study|Recurrence|1
1993896|NCT00079274|3559525|FG003|Overall Study|Recurrence|15
1993897|NCT00079274|3559526|FG004|Overall Study|Recurrence|0
1993898|NCT00079274|3559527|FG005|Overall Study|Recurrence|2
1993899|NCT00079274|3559528|FG006|Overall Study|Recurrence|0
1993900|NCT00079274|3559522|FG000|Overall Study|Alternate Treatment|6
1993901|NCT00079274|3559523|FG001|Overall Study|Alternate Treatment|1
1993902|NCT00079274|3559524|FG002|Overall Study|Alternate Treatment|0
1993903|NCT00079274|3559525|FG003|Overall Study|Alternate Treatment|3
1993904|NCT00079274|3559526|FG004|Overall Study|Alternate Treatment|0
1993905|NCT00079274|3559527|FG005|Overall Study|Alternate Treatment|0
1993906|NCT00079274|3559528|FG006|Overall Study|Alternate Treatment|0
1993907|NCT00079274|3559522|FG000|Overall Study|Other Medical Problems|6
1993908|NCT00079274|3559523|FG001|Overall Study|Other Medical Problems|1
1993909|NCT00079274|3559524|FG002|Overall Study|Other Medical Problems|0
1993910|NCT00079274|3559525|FG003|Overall Study|Other Medical Problems|7
1993911|NCT00079274|3559526|FG004|Overall Study|Other Medical Problems|0
1993912|NCT00079274|3559527|FG005|Overall Study|Other Medical Problems|0
1993913|NCT00079274|3559528|FG006|Overall Study|Other Medical Problems|0
1993914|NCT00079274|3559522|FG000|Overall Study|Death|4
1993915|NCT00079274|3559523|FG001|Overall Study|Death|0
1993916|NCT00079274|3559524|FG002|Overall Study|Death|1
1993917|NCT00079274|3559525|FG003|Overall Study|Death|15
1993918|NCT00079274|3559526|FG004|Overall Study|Death|0
1993919|NCT00079274|3559527|FG005|Overall Study|Death|0
1993920|NCT00079274|3559528|FG006|Overall Study|Death|0
1993921|NCT00079274|3559522|FG000|Overall Study|Cytogenetic resistance|0
1993922|NCT00079274|3559523|FG001|Overall Study|Cytogenetic resistance|0
1993923|NCT00079274|3559524|FG002|Overall Study|Cytogenetic resistance|0
1993924|NCT00079274|3559525|FG003|Overall Study|Cytogenetic resistance|2
1993925|NCT00079274|3559526|FG004|Overall Study|Cytogenetic resistance|0
1993926|NCT00079274|3559527|FG005|Overall Study|Cytogenetic resistance|0
1993927|NCT00079274|3559528|FG006|Overall Study|Cytogenetic resistance|0
1993928|NCT00079274|3559522|FG000|Overall Study|Other|43
1993929|NCT00079274|3559523|FG001|Overall Study|Other|7
1993930|NCT00079274|3559524|FG002|Overall Study|Other|5
1993931|NCT00079274|3559525|FG003|Overall Study|Other|55
1993932|NCT00079274|3559526|FG004|Overall Study|Other|1
1993933|NCT00079274|3559527|FG005|Overall Study|Other|2
1993934|NCT00079274|3559528|FG006|Overall Study|Other|0
1993935|NCT00079339|3559552|FG000|Overall Study|Adverse Event|1
1993936|NCT00079339|3559553|FG001|Overall Study|Adverse Event|7
1993937|NCT00079339|3559554|FG002|Overall Study|Adverse Event|2
1993938|NCT00079339|3559552|FG000|Overall Study|Death|1
1993939|NCT00079339|3559553|FG001|Overall Study|Death|0
1993940|NCT00079339|3559554|FG002|Overall Study|Death|0
1993941|NCT00079339|3559552|FG000|Overall Study|Non-compliance|0
1993942|NCT00079339|3559553|FG001|Overall Study|Non-compliance|0
1993943|NCT00079339|3559554|FG002|Overall Study|Non-compliance|1
1993944|NCT00079339|3559552|FG000|Overall Study|Withdrawal by Subject|0
1993945|NCT00079339|3559553|FG001|Overall Study|Withdrawal by Subject|4
1993946|NCT00079339|3559554|FG002|Overall Study|Withdrawal by Subject|1
1993947|NCT00079339|3559552|FG000|Overall Study|Disease progression|3
1993948|NCT00079339|3559553|FG001|Overall Study|Disease progression|28
1993949|NCT00079339|3559554|FG002|Overall Study|Disease progression|2
1993950|NCT00079391|3559567|FG000|Overall Study|Withdrawal by Subject|1
1993951|NCT00079417|3559573|FG000|Overall Study|Physician Decision|2
1993952|NCT00079417|3559573|FG000|Overall Study|Ineligible|7
1993953|NCT00079677|3559579|FG000|Overall Study|Adverse Event|5
1993954|NCT00079677|3559580|FG001|Overall Study|Adverse Event|6
1993955|NCT00079677|3559579|FG000|Overall Study|Lack of Efficacy|1
1993956|NCT00079677|3559580|FG001|Overall Study|Lack of Efficacy|0
1993957|NCT00079677|3559579|FG000|Overall Study|Lost to Follow-up|2
1993958|NCT00079677|3559580|FG001|Overall Study|Lost to Follow-up|2
1993959|NCT00079677|3559579|FG000|Overall Study|Physician Decision|3
1993960|NCT00079677|3559580|FG001|Overall Study|Physician Decision|0
1993961|NCT00079677|3559579|FG000|Overall Study|Protocol Violation|2
1993962|NCT00079677|3559580|FG001|Overall Study|Protocol Violation|3
1993963|NCT00079677|3559579|FG000|Overall Study|Withdrawal by Subject|5
1993964|NCT00079677|3559580|FG001|Overall Study|Withdrawal by Subject|3
1993965|NCT00079677|3559579|FG000|Overall Study|Miscellaneous|2
1993966|NCT00079677|3559580|FG001|Overall Study|Miscellaneous|0
1993967|NCT00079781|3559589|FG000|Pre-implant Period|Withdrawal by Subject|2
1993968|NCT00079781|3559590|FG001|Pre-implant Period|Withdrawal by Subject|0
1993969|NCT00079781|3559591|FG002|Pre-implant Period|Withdrawal by Subject|0
1993970|NCT00079781|3559589|FG000|Pre-implant Period|Did not meet I/E criteria|1
1993971|NCT00079781|3559590|FG001|Pre-implant Period|Did not meet I/E criteria|1
1993972|NCT00079781|3559591|FG002|Pre-implant Period|Did not meet I/E criteria|1
1993973|NCT00079781|3559589|FG000|Follow-up Period|Withdrawal by Subject|3
1993974|NCT00079781|3559590|FG001|Follow-up Period|Withdrawal by Subject|0
1993975|NCT00079781|3559591|FG002|Follow-up Period|Withdrawal by Subject|1
1993976|NCT00079781|3559589|FG000|Follow-up Period|Lost to Follow-up|1
1993977|NCT00079781|3559590|FG001|Follow-up Period|Lost to Follow-up|0
1993978|NCT00079781|3559591|FG002|Follow-up Period|Lost to Follow-up|0
1993979|NCT00079781|3559589|FG000|Follow-up Period|Death|0
1993980|NCT00079781|3559590|FG001|Follow-up Period|Death|0
1993981|NCT00079781|3559591|FG002|Follow-up Period|Death|1
1993982|NCT00079937|3559599|FG000|Overall Study|Adverse Event|2
1993983|NCT00079937|3559600|FG001|Overall Study|Adverse Event|1
1993984|NCT00079937|3559599|FG000|Overall Study|Unsatisfactory therapeutic effect|1
1993985|NCT00079937|3559600|FG001|Overall Study|Unsatisfactory therapeutic effect|2
1993986|NCT00079937|3559599|FG000|Overall Study|Subject no longer requires study drug|3
1993987|NCT00079937|3559600|FG001|Overall Study|Subject no longer requires study drug|0
1993988|NCT00079937|3559599|FG000|Overall Study|Protocol Violation|8
1993989|NCT00079937|3559600|FG001|Overall Study|Protocol Violation|6
1993990|NCT00079937|3559599|FG000|Overall Study|Withdrawal by Subject|21
1993991|NCT00079937|3559600|FG001|Overall Study|Withdrawal by Subject|7
1993992|NCT00079937|3559599|FG000|Overall Study|Lost to Follow-up|12
1993993|NCT00079937|3559600|FG001|Overall Study|Lost to Follow-up|5
1993994|NCT00079937|3559599|FG000|Overall Study|Administrative problems|22
1993995|NCT00079937|3559600|FG001|Overall Study|Administrative problems|11
1993996|NCT00080119|3559610|FG000|Overall Study|Discontinued because of study closure|0
1993997|NCT00080119|3559611|FG001|Overall Study|Discontinued because of study closure|0
1993998|NCT00080119|3559612|FG002|Overall Study|Discontinued because of study closure|130
1993999|NCT00080119|3559613|FG003|Overall Study|Discontinued because of study closure|141
1994000|NCT00080119|3559610|FG000|Overall Study|Unable to get to clinic|24
1994001|NCT00080119|3559611|FG001|Overall Study|Unable to get to clinic|24
1994002|NCT00080119|3559612|FG002|Overall Study|Unable to get to clinic|7
1994003|NCT00080119|3559613|FG003|Overall Study|Unable to get to clinic|1
1994004|NCT00080119|3559610|FG000|Overall Study|Consent withdrawn|13
1994005|NCT00080119|3559611|FG001|Overall Study|Consent withdrawn|17
1994006|NCT00080119|3559612|FG002|Overall Study|Consent withdrawn|4
1994007|NCT00080119|3559613|FG003|Overall Study|Consent withdrawn|6
1994008|NCT00080119|3559610|FG000|Overall Study|Unwilling to adhere to study requirement|3
1994009|NCT00080119|3559611|FG001|Overall Study|Unwilling to adhere to study requirement|2
1994010|NCT00080119|3559612|FG002|Overall Study|Unwilling to adhere to study requirement|5
1994011|NCT00080119|3559613|FG003|Overall Study|Unwilling to adhere to study requirement|1
1994012|NCT00080119|3559610|FG000|Overall Study|Lost to Follow-up|16
1994013|NCT00080119|3559611|FG001|Overall Study|Lost to Follow-up|19
1994014|NCT00080119|3559612|FG002|Overall Study|Lost to Follow-up|19
1994015|NCT00080119|3559613|FG003|Overall Study|Lost to Follow-up|14
1994016|NCT00080223|3559625|FG000|Overall Study|Adverse Event|23
1994017|NCT00080223|3559625|FG000|Overall Study|Death|21
1994018|NCT00080223|3559625|FG000|Overall Study|Withdrawal by Subject|13
1994019|NCT00080223|3559625|FG000|Overall Study|Lung Transplantation|9
1994020|NCT00080223|3559625|FG000|Overall Study|Non-compliance With Study Treatment|7
1994021|NCT00080223|3559625|FG000|Overall Study|Participant unwilling to continue|2
2213620|NCT01681511|3855524|FG001|Overall Study|No post-catheter sample collected|4
2213621|NCT01681576|3855532|FG000|Period 1|Adverse Event|1
2213622|NCT01681576|3855533|FG001|Period 1|Adverse Event|0
2213623|NCT01681576|3855532|FG000|Period 1|Protocol Deviation|1
2213624|NCT01681576|3855533|FG001|Period 1|Protocol Deviation|0
2213625|NCT01681576|3855532|FG000|Period 2|subject/guardian decision|3
2213626|NCT01681576|3855533|FG001|Period 2|subject/guardian decision|1
2213627|NCT01681576|3855532|FG000|Period 2|Non-compliance with study treatment|1
2213628|NCT01681576|3855533|FG001|Period 2|Non-compliance with study treatment|0
2213629|NCT01681628|3855543|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
2213630|NCT01681628|3855544|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
2213631|NCT01681628|3855543|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
2213632|NCT01681628|3855544|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
2213633|NCT01681628|3855543|FG000|19 Months Follow-up|Death|1
2213634|NCT01681628|3855544|FG001|19 Months Follow-up|Death|0
2213635|NCT01681628|3855543|FG000|19 Months Follow-up|Lost to Follow-up|61
2213636|NCT01681628|3855544|FG001|19 Months Follow-up|Lost to Follow-up|43
2213637|NCT01681771|3855555|FG000|Overall Study|Lost to Follow-up|4
2213638|NCT01681771|3855556|FG001|Overall Study|Lost to Follow-up|2
1994022|NCT00080223|3559625|FG000|Overall Study|Physician Decision|1
1994023|NCT00080288|3559631|FG000|Overall Study|Adverse Event|7
1994024|NCT00080288|3559632|FG001|Overall Study|Adverse Event|4
1994025|NCT00080288|3559631|FG000|Overall Study|Lost to Follow-up|3
1994026|NCT00080288|3559632|FG001|Overall Study|Lost to Follow-up|5
1994027|NCT00080288|3559631|FG000|Overall Study|Physician Decision|6
1994028|NCT00080288|3559632|FG001|Overall Study|Physician Decision|2
1994029|NCT00080288|3559631|FG000|Overall Study|Withdrawal by Subject|3
1994030|NCT00080288|3559632|FG001|Overall Study|Withdrawal by Subject|16
1994031|NCT00080288|3559631|FG000|Overall Study|Miscellaneous|11
1994032|NCT00080288|3559632|FG001|Overall Study|Miscellaneous|11
2213639|NCT01681836|3855566|FG000|Second Intervention|Withdrawal by Subject|0
2213640|NCT01681836|3855567|FG001|Second Intervention|Withdrawal by Subject|1
1994033|NCT00080301|3559640|FG000|Overall Study|Randomized but Never Treated|5
1994034|NCT00080301|3559641|FG001|Overall Study|Randomized but Never Treated|10
1994035|NCT00080301|3559640|FG000|Overall Study|Still on Treatment as of CSR date|0
1994036|NCT00080301|3559641|FG001|Overall Study|Still on Treatment as of CSR date|1
1994037|NCT00080483|3559661|FG000|Overall Study|Lost to Follow-up|1
1994038|NCT00080483|3559662|FG001|Overall Study|Lost to Follow-up|1
1994039|NCT00080483|3559661|FG000|Overall Study|Physician Decision|1
1994040|NCT00080483|3559662|FG001|Overall Study|Physician Decision|1
1994041|NCT00080899|3559672|FG000|Overall Study|Adverse Event|1
1994042|NCT00080938|3559685|FG000|Overall Study|Adverse Event|3
1994043|NCT00080938|3559685|FG000|Overall Study|Withdrawal by Subject|6
1994044|NCT00080938|3559685|FG000|Overall Study|Death|2
1994045|NCT00080938|3559685|FG000|Overall Study|Lack of Efficacy|7
1994046|NCT00080938|3559685|FG000|Overall Study|other disease|1
1994047|NCT00080938|3559685|FG000|Overall Study|Not started protocol therapy|1
1994048|NCT00080938|3559685|FG000|Overall Study|Ineligible|4
1994049|NCT00081159|3559691|FG000|Overall Study|Withdrawal by Subject|0
1994050|NCT00081159|3559692|FG001|Overall Study|Withdrawal by Subject|3
1994051|NCT00081159|3559691|FG000|Overall Study|Myelosuppression prior to treatment|0
1994052|NCT00081159|3559692|FG001|Overall Study|Myelosuppression prior to treatment|1
1994053|NCT00081159|3559691|FG000|Overall Study|Lost to Follow-up|2
1994054|NCT00081159|3559692|FG001|Overall Study|Lost to Follow-up|1
1994055|NCT00081263|3559700|FG000|Overall Study|clerical error|1
1994056|NCT00081263|3559701|FG001|Overall Study|clerical error|0
1994057|NCT00081263|3559700|FG000|Overall Study|wrong cell type|7
1994058|NCT00081263|3559701|FG001|Overall Study|wrong cell type|5
1994059|NCT00081263|3559700|FG000|Overall Study|improper pre-protocol therapy|0
1994060|NCT00081263|3559701|FG001|Overall Study|improper pre-protocol therapy|1
1994061|NCT00081263|3559700|FG000|Overall Study|Inadequate pathology|0
1994062|NCT00081263|3559701|FG001|Overall Study|Inadequate pathology|1
1994063|NCT00081263|3559700|FG000|Overall Study|Never treated|4
1994064|NCT00081263|3559701|FG001|Overall Study|Never treated|5
1994065|NCT00081263|3559700|FG000|Overall Study|Inadequate data|5
1994066|NCT00081263|3559701|FG001|Overall Study|Inadequate data|10
1994067|NCT00081289|3559709|FG000|Overall Study|Accrued prior to chemotherapy amendment|18
1994068|NCT00081289|3559710|FG001|Overall Study|Accrued prior to chemotherapy amendment|17
1994069|NCT00081289|3559709|FG000|Overall Study|Ineligible / no protocol treatment|3
1994070|NCT00081289|3559710|FG001|Overall Study|Ineligible / no protocol treatment|4
1994071|NCT00081458|3559734|FG000|Overall Study|Adverse Event|1
1994072|NCT00081458|3559735|FG001|Overall Study|Adverse Event|5
1994073|NCT00081458|3559736|FG002|Overall Study|Adverse Event|2
1994074|NCT00081458|3559734|FG000|Overall Study|Withdrawal by Subject|0
1994075|NCT00081458|3559735|FG001|Overall Study|Withdrawal by Subject|3
1994076|NCT00081458|3559736|FG002|Overall Study|Withdrawal by Subject|1
1994077|NCT00081458|3559734|FG000|Overall Study|Randomized but not dosed|0
1994078|NCT00081458|3559735|FG001|Overall Study|Randomized but not dosed|0
1994079|NCT00081458|3559736|FG002|Overall Study|Randomized but not dosed|1
1994080|NCT00081497|3559747|FG000|Overall Study|Adverse Event|2
1994081|NCT00081497|3559748|FG001|Overall Study|Adverse Event|0
1994082|NCT00081497|3559747|FG000|Overall Study|Death|0
1994083|NCT00081497|3559748|FG001|Overall Study|Death|1
1994084|NCT00081497|3559747|FG000|Overall Study|Withdrawal by Subject|1
1994085|NCT00081497|3559748|FG001|Overall Study|Withdrawal by Subject|0
1994086|NCT00081497|3559747|FG000|Overall Study|Non-compliance|0
1994087|NCT00081497|3559748|FG001|Overall Study|Non-compliance|1
1994088|NCT00081653|3559762|FG000|Overall Study|Adverse Event|23
1994089|NCT00081653|3559763|FG001|Overall Study|Adverse Event|17
1994090|NCT00081653|3559762|FG000|Overall Study|Lost to Follow-up|2
1994091|NCT00081653|3559763|FG001|Overall Study|Lost to Follow-up|4
1994092|NCT00081653|3559762|FG000|Overall Study|Refused Treatment|18
1994093|NCT00081653|3559763|FG001|Overall Study|Refused Treatment|14
1994094|NCT00081653|3559762|FG000|Overall Study|Low bone mineral density|1
1994095|NCT00081653|3559763|FG001|Overall Study|Low bone mineral density|0
1994096|NCT00081653|3559762|FG000|Overall Study|Bone loss|2
1994097|NCT00081653|3559763|FG001|Overall Study|Bone loss|0
1994098|NCT00081653|3559762|FG000|Overall Study|Participant leaving country|1
1994099|NCT00081653|3559763|FG001|Overall Study|Participant leaving country|0
1994100|NCT00081653|3559762|FG000|Overall Study|Loss of bone mass|0
1994101|NCT00081653|3559763|FG001|Overall Study|Loss of bone mass|2
1994102|NCT00081731|3559772|FG000|Overall Study|scientific integrity issue|8
1994103|NCT00081731|3559773|FG001|Overall Study|scientific integrity issue|8
1994104|NCT00081770|3559782|FG000|Overall Study|Adverse Event|130
1994105|NCT00081770|3559783|FG001|Overall Study|Adverse Event|98
1994106|NCT00081770|3559784|FG002|Overall Study|Adverse Event|136
1994107|NCT00081770|3559782|FG000|Overall Study|Lack of Efficacy|262
1994108|NCT00081770|3559783|FG001|Overall Study|Lack of Efficacy|357
1994109|NCT00081770|3559784|FG002|Overall Study|Lack of Efficacy|211
1994110|NCT00081770|3559782|FG000|Overall Study|Lost to Follow-up|45
1994111|NCT00081770|3559783|FG001|Overall Study|Lost to Follow-up|34
1994112|NCT00081770|3559784|FG002|Overall Study|Lost to Follow-up|45
1994113|NCT00081770|3559782|FG000|Overall Study|Protocol Violation|15
1994114|NCT00081770|3559783|FG001|Overall Study|Protocol Violation|10
1994115|NCT00081770|3559784|FG002|Overall Study|Protocol Violation|10
1994116|NCT00081770|3559782|FG000|Overall Study|Withdrawal by Subject|45
1994117|NCT00081770|3559783|FG001|Overall Study|Withdrawal by Subject|40
1994118|NCT00081770|3559784|FG002|Overall Study|Withdrawal by Subject|42
1994119|NCT00081770|3559782|FG000|Overall Study|Did not meet protocol eligibility|2
1994120|NCT00081770|3559783|FG001|Overall Study|Did not meet protocol eligibility|0
1994121|NCT00081770|3559784|FG002|Overall Study|Did not meet protocol eligibility|3
1994122|NCT00081770|3559782|FG000|Overall Study|Administrative|1
1994123|NCT00081770|3559783|FG001|Overall Study|Administrative|0
1994124|NCT00081770|3559784|FG002|Overall Study|Administrative|1
1994125|NCT00081770|3559782|FG000|Overall Study|Other|2
1994126|NCT00081770|3559783|FG001|Overall Study|Other|7
1994127|NCT00081770|3559784|FG002|Overall Study|Other|8
1994128|NCT00082173|3559809|FG000|Overall Study|Withdrawal by Subject|3
1994129|NCT00082173|3559810|FG001|Overall Study|Withdrawal by Subject|5
1994130|NCT00082173|3559809|FG000|Overall Study|Lost to Follow-up|1
1994131|NCT00082173|3559810|FG001|Overall Study|Lost to Follow-up|0
1994132|NCT00082173|3559809|FG000|Overall Study|Adverse Event|1
1994133|NCT00082173|3559810|FG001|Overall Study|Adverse Event|0
1994134|NCT00082173|3559809|FG000|Overall Study|Culture negative or resistant at baselin|5
1994135|NCT00082173|3559810|FG001|Overall Study|Culture negative or resistant at baselin|6
1994136|NCT00082355|3559843|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
1994137|NCT00082355|3559843|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
1994138|NCT00082355|3559843|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
1994139|NCT00082368|3559847|FG000|Overall Study|Not treated-pt had poor IV access|1
1994140|NCT00082381|3559853|FG000|Overall Study|Adverse Event|27
1994141|NCT00082381|3559854|FG001|Overall Study|Adverse Event|2
1994142|NCT00082381|3559853|FG000|Overall Study|Lost to Follow-up|5
1994143|NCT00082381|3559854|FG001|Overall Study|Lost to Follow-up|7
1994144|NCT00082381|3559853|FG000|Overall Study|Patient Decision|8
1994145|NCT00082381|3559854|FG001|Overall Study|Patient Decision|4
1994146|NCT00082381|3559853|FG000|Overall Study|Physician Decision|1
1994147|NCT00082381|3559854|FG001|Overall Study|Physician Decision|2
1994148|NCT00082381|3559853|FG000|Overall Study|Protocol Violation|10
1994149|NCT00082381|3559854|FG001|Overall Study|Protocol Violation|11
1994150|NCT00082381|3559853|FG000|Overall Study|Loss of Glucose Control|4
1994151|NCT00082381|3559854|FG001|Overall Study|Loss of Glucose Control|0
1994152|NCT00082407|3559862|FG000|Overall Study|Adverse Event|20
2213641|NCT01681849|3855576|FG000|Overall Study|Protocol Violation|2
2213642|NCT01681849|3855577|FG001|Overall Study|Protocol Violation|0
2213643|NCT01681849|3855578|FG002|Overall Study|Protocol Violation|0
2213644|NCT01681849|3855576|FG000|Overall Study|Withdrawal by Subject|3
2213645|NCT01681849|3855577|FG001|Overall Study|Withdrawal by Subject|5
2213646|NCT01681849|3855578|FG002|Overall Study|Withdrawal by Subject|33
2213647|NCT01681849|3855576|FG000|Overall Study|Lost to Follow-up|3
2213648|NCT01681849|3855577|FG001|Overall Study|Lost to Follow-up|2
2213649|NCT01681849|3855578|FG002|Overall Study|Lost to Follow-up|6
2213650|NCT01681992|3855588|FG000|Overall Study|Adverse Event|3
2213651|NCT01681992|3855589|FG001|Overall Study|Adverse Event|2
2213652|NCT01681992|3855590|FG002|Overall Study|Adverse Event|3
2213653|NCT01681992|3855588|FG000|Overall Study|Lost to Follow-up|36
2213654|NCT01681992|3855589|FG001|Overall Study|Lost to Follow-up|38
2213655|NCT01681992|3855590|FG002|Overall Study|Lost to Follow-up|53
2213656|NCT01681992|3855588|FG000|Overall Study|As Per Sponsor Decision|0
1994153|NCT00082407|3559863|FG001|Overall Study|Adverse Event|0
1994154|NCT00082407|3559862|FG000|Overall Study|Protocol Violation|14
1994155|NCT00082407|3559863|FG001|Overall Study|Protocol Violation|12
1994156|NCT00082407|3559862|FG000|Overall Study|Patient Decision|13
1994157|NCT00082407|3559863|FG001|Overall Study|Patient Decision|6
1994158|NCT00082407|3559862|FG000|Overall Study|Physician Decision|5
1994159|NCT00082407|3559863|FG001|Overall Study|Physician Decision|3
1994160|NCT00082407|3559862|FG000|Overall Study|Loss of Glucose Control|2
1994161|NCT00082407|3559863|FG001|Overall Study|Loss of Glucose Control|2
1994162|NCT00082407|3559862|FG000|Overall Study|Death|2
1994163|NCT00082407|3559863|FG001|Overall Study|Death|1
1994164|NCT00082407|3559862|FG000|Overall Study|Lost to Follow-up|0
1994165|NCT00082407|3559863|FG001|Overall Study|Lost to Follow-up|3
1994166|NCT00082433|3559871|FG000|Overall Study|Adverse Event|12
1994167|NCT00082433|3559872|FG001|Overall Study|Adverse Event|17
1994168|NCT00082433|3559871|FG000|Overall Study|Death|8
1994169|NCT00082433|3559872|FG001|Overall Study|Death|18
1994170|NCT00082433|3559871|FG000|Overall Study|Disease Progression/Relapse|270
1994171|NCT00082433|3559872|FG001|Overall Study|Disease Progression/Relapse|388
1994172|NCT00082433|3559871|FG000|Overall Study|Physician Decision|50
1994173|NCT00082433|3559872|FG001|Overall Study|Physician Decision|61
1994174|NCT00082433|3559871|FG000|Overall Study|Lost to Follow-up|1
1994175|NCT00082433|3559872|FG001|Overall Study|Lost to Follow-up|2
1994176|NCT00082433|3559871|FG000|Overall Study|Study Drug Toxicity|179
1994177|NCT00082433|3559872|FG001|Overall Study|Study Drug Toxicity|66
1994178|NCT00082433|3559871|FG000|Overall Study|Withdrawal by Subject|55
1994179|NCT00082433|3559872|FG001|Overall Study|Withdrawal by Subject|30
1994180|NCT00082433|3559871|FG000|Overall Study|Still On Treatment|2
1994181|NCT00082433|3559872|FG001|Overall Study|Still On Treatment|1
1994182|NCT00082433|3559871|FG000|Overall Study|Not Treated|12
1994183|NCT00082433|3559872|FG001|Overall Study|Not Treated|11
2213657|NCT01681992|3855589|FG001|Overall Study|As Per Sponsor Decision|0
2213658|NCT01681992|3855590|FG002|Overall Study|As Per Sponsor Decision|1
1994184|NCT00082433|3559871|FG000|Overall Study|Ineligible|2
1994185|NCT00082433|3559872|FG001|Overall Study|Ineligible|1
1994186|NCT00082433|3559871|FG000|Overall Study|Noncompliance|2
1994187|NCT00082433|3559872|FG001|Overall Study|Noncompliance|1
1994188|NCT00082433|3559871|FG000|Overall Study|New primary cancer|1
1994189|NCT00082433|3559872|FG001|Overall Study|New primary cancer|0
1994190|NCT00082433|3559871|FG000|Overall Study|Impending surgery|0
1994191|NCT00082433|3559872|FG001|Overall Study|Impending surgery|1
1994192|NCT00082628|3559880|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1994193|NCT00082628|3559881|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
1994194|NCT00082628|3559882|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1994195|NCT00082628|3559883|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1994196|NCT00082628|3559884|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1994197|NCT00082628|3559880|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
1994198|NCT00082628|3559881|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
1994199|NCT00082628|3559882|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1994200|NCT00082628|3559883|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1994201|NCT00082628|3559884|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1994202|NCT00082628|3559880|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
1994203|NCT00082628|3559881|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
1994204|NCT00082628|3559882|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1994205|NCT00082628|3559883|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1994206|NCT00082628|3559884|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1994207|NCT00082628|3559880|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
1994208|NCT00082628|3559881|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
1994209|NCT00082628|3559882|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1994210|NCT00082628|3559883|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1994211|NCT00082628|3559884|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1994212|NCT00082628|3559880|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1994213|NCT00082628|3559881|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1994214|NCT00082628|3559882|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1994215|NCT00082628|3559883|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1994216|NCT00082628|3559884|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
1994217|NCT00082628|3559880|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1994218|NCT00082628|3559881|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1994219|NCT00082628|3559882|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1994220|NCT00082628|3559883|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
1994221|NCT00082628|3559884|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1994222|NCT00082628|3559880|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
1994223|NCT00082628|3559881|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
1994224|NCT00082628|3559882|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
1994225|NCT00082628|3559883|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
1994226|NCT00082628|3559884|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
1994227|NCT00082758|3559909|FG000|Overall Study|Adverse Event|0
1994228|NCT00082758|3559910|FG001|Overall Study|Adverse Event|2
1994229|NCT00082758|3559911|FG002|Overall Study|Adverse Event|0
1994230|NCT00082758|3559909|FG000|Overall Study|Lack of Efficacy|12
1994231|NCT00082758|3559910|FG001|Overall Study|Lack of Efficacy|13
1994232|NCT00082758|3559911|FG002|Overall Study|Lack of Efficacy|0
1994233|NCT00082758|3559909|FG000|Overall Study|Physician Decision|0
1994234|NCT00082758|3559910|FG001|Overall Study|Physician Decision|1
1994235|NCT00082758|3559911|FG002|Overall Study|Physician Decision|0
1994236|NCT00082758|3559909|FG000|Overall Study|Withdrawal by Subject|3
1994237|NCT00082758|3559910|FG001|Overall Study|Withdrawal by Subject|0
1994238|NCT00082758|3559911|FG002|Overall Study|Withdrawal by Subject|0
1994239|NCT00082758|3559909|FG000|Overall Study|Protocol Violation|0
1994240|NCT00082758|3559910|FG001|Overall Study|Protocol Violation|1
1994241|NCT00082758|3559911|FG002|Overall Study|Protocol Violation|0
1994242|NCT00082810|3559919|FG000|Overall Study|Adverse Event|3
1994243|NCT00082810|3559919|FG000|Overall Study|Progressive disease|24
1994244|NCT00082810|3559919|FG000|Overall Study|Withdrawal by Subject|4
1994245|NCT00082888|3559927|FG000|Overall Study|Ineligible|1
1994246|NCT00082888|3559928|FG001|Overall Study|Ineligible|0
1994247|NCT00082888|3559929|FG002|Overall Study|Ineligible|0
1994248|NCT00083226|3559961|FG000|Overall Study|Lack of Efficacy|19
1994249|NCT00083226|3559961|FG000|Overall Study|Adverse Event|9
1994250|NCT00083226|3559961|FG000|Overall Study|Death|4
1994251|NCT00083226|3559961|FG000|Overall Study|Withdrawal by Subject|4
1994252|NCT00083226|3559961|FG000|Overall Study|Other|2
1994253|NCT00083226|3559961|FG000|Overall Study|ineligible or not receiving treatment|4
1994254|NCT00083616|3559978|FG000|Overall Study|Disease Progression|16
1994255|NCT00083616|3559978|FG000|Overall Study|Lost to Follow-up|1
1994256|NCT00083616|3559978|FG000|Overall Study|Physician Decision|2
1994257|NCT00083616|3559978|FG000|Overall Study|Withdrawal by Subject|3
1994258|NCT00083616|3559978|FG000|Overall Study|Ineligibility determined|2
1994259|NCT00083616|3559978|FG000|Overall Study|Non-compliance|1
1994260|NCT00083616|3559978|FG000|Overall Study|Other|6
1994261|NCT00083889|3559988|FG000|Overall Study|Adverse Event|76
1994262|NCT00083889|3559989|FG001|Overall Study|Adverse Event|86
1994263|NCT00083889|3559988|FG000|Overall Study|Protocol Violation|2
1994264|NCT00083889|3559989|FG001|Overall Study|Protocol Violation|2
1994265|NCT00083889|3559988|FG000|Overall Study|Withdrawal by Subject|22
1994266|NCT00083889|3559989|FG001|Overall Study|Withdrawal by Subject|24
1994267|NCT00083889|3559988|FG000|Overall Study|Lack of Efficacy|240
1994268|NCT00083889|3559989|FG001|Overall Study|Lack of Efficacy|219
1994269|NCT00083889|3559988|FG000|Overall Study|Decision of sponsor|32
1994270|NCT00083889|3559989|FG001|Overall Study|Decision of sponsor|4
1994271|NCT00083889|3559988|FG000|Overall Study|Randomized: did not take study drug|0
1994272|NCT00083889|3559989|FG001|Overall Study|Randomized: did not take study drug|15
1994273|NCT00083889|3559988|FG000|Overall Study|Completed on marketed sunitinub|3
1994274|NCT00083889|3559989|FG001|Overall Study|Completed on marketed sunitinub|0
1994275|NCT00083889|3559988|FG000|Overall Study|Crossover to SU011248|0
1994276|NCT00083889|3559989|FG001|Overall Study|Crossover to SU011248|25
1994277|NCT00084084|3559998|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
1994278|NCT00084084|3559998|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
1994279|NCT00084136|3560006|FG000|PI Comparison|Death|10
1994280|NCT00084136|3560007|FG001|PI Comparison|Death|9
1994281|NCT00084136|3560008|FG002|PI Comparison|Death|0
1994282|NCT00084136|3560006|FG000|PI Comparison|Lost to Follow-up|11
1994283|NCT00084136|3560007|FG001|PI Comparison|Lost to Follow-up|8
1994284|NCT00084136|3560008|FG002|PI Comparison|Lost to Follow-up|0
1994285|NCT00084136|3560006|FG000|PI Comparison|Withdrawal by Subject|33
1994286|NCT00084136|3560007|FG001|PI Comparison|Withdrawal by Subject|30
1994287|NCT00084136|3560008|FG002|PI Comparison|Withdrawal by Subject|0
1994288|NCT00084136|3560006|FG000|PI Comparison|Clinic site closed|1
1994289|NCT00084136|3560007|FG001|PI Comparison|Clinic site closed|0
1994290|NCT00084136|3560008|FG002|PI Comparison|Clinic site closed|0
1994291|NCT00084136|3560006|FG000|NRTI Comparison|Death|20
1994292|NCT00084136|3560007|FG001|NRTI Comparison|Death|0
1994293|NCT00084136|3560008|FG002|NRTI Comparison|Death|18
1994294|NCT00084136|3560006|FG000|NRTI Comparison|Lost to Follow-up|14
1994295|NCT00084136|3560007|FG001|NRTI Comparison|Lost to Follow-up|0
1994296|NCT00084136|3560008|FG002|NRTI Comparison|Lost to Follow-up|12
1994297|NCT00084136|3560006|FG000|NRTI Comparison|Withdrawal by Subject|54
1994298|NCT00084136|3560007|FG001|NRTI Comparison|Withdrawal by Subject|0
1994299|NCT00084136|3560008|FG002|NRTI Comparison|Withdrawal by Subject|38
1994300|NCT00084136|3560006|FG000|NRTI Comparison|Clinic site closed|12
1994301|NCT00084136|3560007|FG001|NRTI Comparison|Clinic site closed|0
1994302|NCT00084136|3560008|FG002|NRTI Comparison|Clinic site closed|14
1994303|NCT00084136|3560006|FG000|NRTI Comparison|Not reason above|1
1994304|NCT00084136|3560007|FG001|NRTI Comparison|Not reason above|0
1994305|NCT00084136|3560008|FG002|NRTI Comparison|Not reason above|0
1994306|NCT00084266|3560032|FG000|Overall Study|Death|42
1994307|NCT00084266|3560033|FG001|Overall Study|Death|39
1994308|NCT00084266|3560032|FG000|Overall Study|Adverse Event|8
1994309|NCT00084266|3560033|FG001|Overall Study|Adverse Event|5
1994310|NCT00084266|3560032|FG000|Overall Study|Lack of Efficacy|2
1994311|NCT00084266|3560033|FG001|Overall Study|Lack of Efficacy|4
1994312|NCT00084266|3560032|FG000|Overall Study|Lost to Follow-up|5
1994313|NCT00084266|3560033|FG001|Overall Study|Lost to Follow-up|3
1994314|NCT00084266|3560032|FG000|Overall Study|Participant not willing to participate|3
1994315|NCT00084266|3560033|FG001|Overall Study|Participant not willing to participate|8
1994316|NCT00084266|3560032|FG000|Overall Study|Other|360
1994317|NCT00084266|3560033|FG001|Overall Study|Other|344
1994318|NCT00084266|3560032|FG000|Overall Study|Randomized not treated|21
1994319|NCT00084266|3560033|FG001|Overall Study|Randomized not treated|20
2213659|NCT01681992|3855588|FG000|Overall Study|Protocol Violation|0
2213660|NCT01681992|3855589|FG001|Overall Study|Protocol Violation|0
1994320|NCT00084318|3560041|FG000|Overall Study|Withdrawal by Subject|5
1994321|NCT00084318|3560042|FG001|Overall Study|Withdrawal by Subject|2
1994322|NCT00084318|3560041|FG000|Overall Study|Protocol Violation|15
1994323|NCT00084318|3560042|FG001|Overall Study|Protocol Violation|11
1994324|NCT00084318|3560041|FG000|Overall Study|No protocol treatment|2
1994325|NCT00084318|3560042|FG001|Overall Study|No protocol treatment|0
2024692|NCT00336895|3593357|FG000|Overall Study|screen failed|1
2024693|NCT00337077|3593364|FG000|Overall Study|Progressive disease|25
2024694|NCT00337077|3593365|FG001|Overall Study|Progressive disease|37
2024695|NCT00337077|3593366|FG002|Overall Study|Progressive disease|19
2024696|NCT00337077|3593364|FG000|Overall Study|Adverse Event|7
2024697|NCT00337077|3593365|FG001|Overall Study|Adverse Event|7
2024698|NCT00337077|3593366|FG002|Overall Study|Adverse Event|1
2024699|NCT00337077|3593364|FG000|Overall Study|Death|0
2024700|NCT00337077|3593365|FG001|Overall Study|Death|1
2024701|NCT00337077|3593366|FG002|Overall Study|Death|0
2024702|NCT00337077|3593364|FG000|Overall Study|Withdrawal by Subject|7
2024703|NCT00337077|3593365|FG001|Overall Study|Withdrawal by Subject|2
2024704|NCT00337077|3593366|FG002|Overall Study|Withdrawal by Subject|2
2024705|NCT00337077|3593364|FG000|Overall Study|Alternative therapy|1
1994326|NCT00084487|3560065|FG000|Overall Study|Death|1
1994327|NCT00084617|3560078|FG000|Overall Study|Withdrawal by Subject|7
1994328|NCT00084617|3560078|FG000|Overall Study|Lack of Efficacy|1
1994329|NCT00084617|3560078|FG000|Overall Study|Protocol Violation|1
1994330|NCT00084682|3560082|FG000|Overall Study|Withdrawal by Subject|1
1994331|NCT00084747|3560087|FG000|Overall Study|Relapsed|8
1994332|NCT00084747|3560087|FG000|Overall Study|Death|3
1994333|NCT00084747|3560087|FG000|Overall Study|Withdrawal by Subject|2
1994334|NCT00084838|3560092|FG000|Overall Study|Death|1
1994335|NCT00084838|3560092|FG000|Overall Study|Adverse Event|2
1994336|NCT00084838|3560092|FG000|Overall Study|Withdrawal by Subject|1
1994337|NCT00084838|3560092|FG000|Overall Study|Progressive Disease|4
1994338|NCT00084838|3560092|FG000|Overall Study|Pt Non-Compliance|1
1994339|NCT00084838|3560092|FG000|Overall Study|Ineligible|4
1994340|NCT00084864|3560102|FG000|Overall Study|Adverse Event|1
1994341|NCT00084864|3560103|FG001|Overall Study|Adverse Event|0
1994342|NCT00084864|3560104|FG002|Overall Study|Adverse Event|0
1994343|NCT00084864|3560105|FG003|Overall Study|Adverse Event|0
1994344|NCT00084929|3560115|FG000|Overall Study|ineligible - medical contraindication|1
1994345|NCT00084929|3560115|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1
1994346|NCT00084929|3560115|FG000|Overall Study|Ineligible - Medical history|6
1994347|NCT00084929|3560115|FG000|Overall Study|Withdrawal by Subject|10
1994348|NCT00084929|3560115|FG000|Overall Study|Missing/incomplete CTC exam|9
1994349|NCT00084929|3560115|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42
1994350|NCT00085098|3560125|FG000|Overall Study|Withdrawal by Subject|0
1994351|NCT00085098|3560126|FG001|Overall Study|Withdrawal by Subject|1
2213661|NCT01681992|3855590|FG002|Overall Study|Protocol Violation|1
2213662|NCT01681992|3855588|FG000|Overall Study|Withdrawal by Subject|27
2213663|NCT01681992|3855589|FG001|Overall Study|Withdrawal by Subject|30
2213664|NCT01681992|3855590|FG002|Overall Study|Withdrawal by Subject|25
2213665|NCT01682031|3855600|FG000|Overall Study|Withdrawal by Subject|0
1994352|NCT00085098|3560125|FG000|Overall Study|Ineligible|1
1994353|NCT00085098|3560126|FG001|Overall Study|Ineligible|1
1994354|NCT00085423|3560163|FG000|Overall Study|Withdrawal by Subject|1
1994355|NCT00085423|3560163|FG000|Overall Study|screen failure|1
1994356|NCT00085540|3560174|FG000|Overall Study|Withdrawal by Subject|0
1994357|NCT00085540|3560175|FG001|Overall Study|Withdrawal by Subject|1
1994358|NCT00085540|3560174|FG000|Overall Study|Protocol Violation|0
1994359|NCT00085540|3560175|FG001|Overall Study|Protocol Violation|1
1994360|NCT00085566|3560184|FG000|Overall Study|Adverse Event|0
1994361|NCT00085566|3560185|FG001|Overall Study|Adverse Event|0
1994362|NCT00085566|3560186|FG002|Overall Study|Adverse Event|10
1994363|NCT00085566|3560184|FG000|Overall Study|Patient Not treated|0
1994364|NCT00085566|3560185|FG001|Overall Study|Patient Not treated|0
1994365|NCT00085566|3560186|FG002|Overall Study|Patient Not treated|3
1994366|NCT00085566|3560184|FG000|Overall Study|Clinical progression|0
1994367|NCT00085566|3560185|FG001|Overall Study|Clinical progression|0
1994368|NCT00085566|3560186|FG002|Overall Study|Clinical progression|1
1994369|NCT00085644|3560196|FG000|Double-Blind Period|Adverse Event|5
1994370|NCT00085644|3560197|FG001|Double-Blind Period|Adverse Event|2
1994371|NCT00085644|3560198|FG002|Double-Blind Period|Adverse Event|0
1994372|NCT00085644|3560196|FG000|Double-Blind Period|Withdrawal by Subject|3
1994373|NCT00085644|3560197|FG001|Double-Blind Period|Withdrawal by Subject|0
1994374|NCT00085644|3560198|FG002|Double-Blind Period|Withdrawal by Subject|0
1994375|NCT00085644|3560196|FG000|Double-Blind Period|Lost to Follow-up|2
1994376|NCT00085644|3560197|FG001|Double-Blind Period|Lost to Follow-up|1
1994377|NCT00085644|3560198|FG002|Double-Blind Period|Lost to Follow-up|0
1994378|NCT00085644|3560196|FG000|Double-Blind Period|Lack/loss of efficacy|2
1994379|NCT00085644|3560197|FG001|Double-Blind Period|Lack/loss of efficacy|2
1994380|NCT00085644|3560198|FG002|Double-Blind Period|Lack/loss of efficacy|0
1994381|NCT00085644|3560196|FG000|Double-Blind Period|Contemplating pregnancy|1
1994382|NCT00085644|3560197|FG001|Double-Blind Period|Contemplating pregnancy|0
1994383|NCT00085644|3560198|FG002|Double-Blind Period|Contemplating pregnancy|0
1994384|NCT00085644|3560196|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0
1994385|NCT00085644|3560197|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1
1994386|NCT00085644|3560198|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0
1994387|NCT00085644|3560196|FG000|Open-Label Period|Adverse Event|0
1994388|NCT00085644|3560197|FG001|Open-Label Period|Adverse Event|0
1994389|NCT00085644|3560198|FG002|Open-Label Period|Adverse Event|38
1994390|NCT00085644|3560196|FG000|Open-Label Period|Withdrawal by Subject|0
1994391|NCT00085644|3560197|FG001|Open-Label Period|Withdrawal by Subject|0
1994392|NCT00085644|3560198|FG002|Open-Label Period|Withdrawal by Subject|29
1994393|NCT00085644|3560196|FG000|Open-Label Period|Lost to Follow-up|0
1994394|NCT00085644|3560197|FG001|Open-Label Period|Lost to Follow-up|0
1994395|NCT00085644|3560198|FG002|Open-Label Period|Lost to Follow-up|13
1994396|NCT00085644|3560196|FG000|Open-Label Period|Lack of Efficacy|0
1994397|NCT00085644|3560197|FG001|Open-Label Period|Lack of Efficacy|0
1994398|NCT00085644|3560198|FG002|Open-Label Period|Lack of Efficacy|15
1994399|NCT00085644|3560196|FG000|Open-Label Period|Pregnancy|0
1994400|NCT00085644|3560197|FG001|Open-Label Period|Pregnancy|0
1994401|NCT00085644|3560198|FG002|Open-Label Period|Pregnancy|3
1994402|NCT00085644|3560196|FG000|Open-Label Period|Contemplating pregnancy|0
1994403|NCT00085644|3560197|FG001|Open-Label Period|Contemplating pregnancy|0
1994404|NCT00085644|3560198|FG002|Open-Label Period|Contemplating pregnancy|3
1994405|NCT00085644|3560196|FG000|Open-Label Period|Protocol Violation|0
1994406|NCT00085644|3560197|FG001|Open-Label Period|Protocol Violation|0
1994407|NCT00085644|3560198|FG002|Open-Label Period|Protocol Violation|4
1994408|NCT00085644|3560196|FG000|Open-Label Period|Personal reason|0
1994409|NCT00085644|3560197|FG001|Open-Label Period|Personal reason|0
1994410|NCT00085644|3560198|FG002|Open-Label Period|Personal reason|4
1994411|NCT00085709|3560207|FG000|Overall Study|Adverse Event|8
1994412|NCT00085709|3560208|FG001|Overall Study|Adverse Event|0
1994413|NCT00085709|3560207|FG000|Overall Study|Death|8
1994414|NCT00085709|3560208|FG001|Overall Study|Death|2
1994415|NCT00085709|3560207|FG000|Overall Study|Refusal unrelated to adverse events|1
1994416|NCT00085709|3560208|FG001|Overall Study|Refusal unrelated to adverse events|2
1994417|NCT00085709|3560207|FG000|Overall Study|Progression|3
1994418|NCT00085709|3560208|FG001|Overall Study|Progression|4
1994419|NCT00085709|3560207|FG000|Overall Study|Not protocol specified|12
1994420|NCT00085709|3560208|FG001|Overall Study|Not protocol specified|22
1994421|NCT00085709|3560207|FG000|Overall Study|Not eligible|19
1994422|NCT00085709|3560208|FG001|Overall Study|Not eligible|19
1994423|NCT00085709|3560207|FG000|Overall Study|Withdrawal by Subject|2
1994424|NCT00085709|3560208|FG001|Overall Study|Withdrawal by Subject|1
1994425|NCT00085735|3560228|FG000|Overall Study|Adverse Event|1
1994426|NCT00085735|3560229|FG001|Overall Study|Adverse Event|0
1994427|NCT00085735|3560230|FG002|Overall Study|Adverse Event|0
1994428|NCT00085735|3560231|FG003|Overall Study|Adverse Event|0
1994429|NCT00085735|3560232|FG004|Overall Study|Adverse Event|0
1994430|NCT00085735|3560233|FG005|Overall Study|Adverse Event|0
1994431|NCT00085735|3560228|FG000|Overall Study|Lack of Efficacy|2
1994432|NCT00085735|3560229|FG001|Overall Study|Lack of Efficacy|4
1994433|NCT00085735|3560230|FG002|Overall Study|Lack of Efficacy|6
1994434|NCT00085735|3560231|FG003|Overall Study|Lack of Efficacy|3
1994435|NCT00085735|3560232|FG004|Overall Study|Lack of Efficacy|4
1994436|NCT00085735|3560233|FG005|Overall Study|Lack of Efficacy|3
1994437|NCT00085735|3560228|FG000|Overall Study|Lost to Follow-up|0
1994438|NCT00085735|3560229|FG001|Overall Study|Lost to Follow-up|1
1994439|NCT00085735|3560230|FG002|Overall Study|Lost to Follow-up|0
1994440|NCT00085735|3560231|FG003|Overall Study|Lost to Follow-up|0
1994441|NCT00085735|3560232|FG004|Overall Study|Lost to Follow-up|1
1994442|NCT00085735|3560233|FG005|Overall Study|Lost to Follow-up|0
1994443|NCT00085735|3560228|FG000|Overall Study|Physician Decision|2
1994444|NCT00085735|3560229|FG001|Overall Study|Physician Decision|3
1994445|NCT00085735|3560230|FG002|Overall Study|Physician Decision|2
1994446|NCT00085735|3560231|FG003|Overall Study|Physician Decision|3
1994447|NCT00085735|3560232|FG004|Overall Study|Physician Decision|11
1994448|NCT00085735|3560233|FG005|Overall Study|Physician Decision|8
1994449|NCT00085735|3560228|FG000|Overall Study|Protocol Violation|1
1994450|NCT00085735|3560229|FG001|Overall Study|Protocol Violation|0
1994451|NCT00085735|3560230|FG002|Overall Study|Protocol Violation|0
1994452|NCT00085735|3560231|FG003|Overall Study|Protocol Violation|0
1994453|NCT00085735|3560232|FG004|Overall Study|Protocol Violation|0
1994454|NCT00085735|3560233|FG005|Overall Study|Protocol Violation|0
1994455|NCT00085735|3560228|FG000|Overall Study|Withdrawal by Subject|1
1994456|NCT00085735|3560229|FG001|Overall Study|Withdrawal by Subject|0
1994457|NCT00085735|3560230|FG002|Overall Study|Withdrawal by Subject|4
1994458|NCT00085735|3560231|FG003|Overall Study|Withdrawal by Subject|5
1994459|NCT00085735|3560232|FG004|Overall Study|Withdrawal by Subject|7
1994460|NCT00085735|3560233|FG005|Overall Study|Withdrawal by Subject|8
1994461|NCT00085735|3560228|FG000|Overall Study|Patient ineligible|1
1994462|NCT00085735|3560229|FG001|Overall Study|Patient ineligible|0
1994463|NCT00085735|3560230|FG002|Overall Study|Patient ineligible|3
1994464|NCT00085735|3560231|FG003|Overall Study|Patient ineligible|7
1994465|NCT00085735|3560232|FG004|Overall Study|Patient ineligible|17
1994466|NCT00085735|3560233|FG005|Overall Study|Patient ineligible|8
1994467|NCT00085735|3560228|FG000|Overall Study|Excess residual disease|2
1994468|NCT00085735|3560229|FG001|Overall Study|Excess residual disease|2
1994469|NCT00085735|3560230|FG002|Overall Study|Excess residual disease|1
1994470|NCT00085735|3560231|FG003|Overall Study|Excess residual disease|1
1994471|NCT00085735|3560232|FG004|Overall Study|Excess residual disease|1
1994472|NCT00085735|3560233|FG005|Overall Study|Excess residual disease|4
1994473|NCT00085735|3560228|FG000|Overall Study|Reason not documented|1
1994474|NCT00085735|3560229|FG001|Overall Study|Reason not documented|0
1994475|NCT00085735|3560230|FG002|Overall Study|Reason not documented|1
1994476|NCT00085735|3560231|FG003|Overall Study|Reason not documented|0
1994477|NCT00085735|3560232|FG004|Overall Study|Reason not documented|1
1994478|NCT00085735|3560233|FG005|Overall Study|Reason not documented|0
1994479|NCT00085735|3560228|FG000|Overall Study|Pt transferred to inst w/out study open|1
1994480|NCT00085735|3560229|FG001|Overall Study|Pt transferred to inst w/out study open|0
1994481|NCT00085735|3560230|FG002|Overall Study|Pt transferred to inst w/out study open|0
1994482|NCT00085735|3560231|FG003|Overall Study|Pt transferred to inst w/out study open|0
1994483|NCT00085735|3560232|FG004|Overall Study|Pt transferred to inst w/out study open|0
1994484|NCT00085735|3560233|FG005|Overall Study|Pt transferred to inst w/out study open|0
1994485|NCT00085917|3560271|FG000|Overall Study|Adverse Event|4
1994486|NCT00085917|3560272|FG001|Overall Study|Adverse Event|3
1994487|NCT00086047|3560280|FG000|Overall Study|Lost to Follow-up|7
1994488|NCT00086047|3560281|FG001|Overall Study|Lost to Follow-up|6
1994489|NCT00086047|3560280|FG000|Overall Study|Physician Decision|0
1994490|NCT00086047|3560281|FG001|Overall Study|Physician Decision|1
1994491|NCT00086190|3560299|FG000|Overall Study|Adverse Event|6
1994492|NCT00086190|3560300|FG001|Overall Study|Adverse Event|2
1994493|NCT00086190|3560301|FG002|Overall Study|Adverse Event|2
1994494|NCT00086190|3560299|FG000|Overall Study|Withdrawal by Subject|0
1994495|NCT00086190|3560300|FG001|Overall Study|Withdrawal by Subject|2
1994496|NCT00086190|3560301|FG002|Overall Study|Withdrawal by Subject|2
1994497|NCT00086190|3560299|FG000|Overall Study|Protocol Violation|1
1994498|NCT00086190|3560300|FG001|Overall Study|Protocol Violation|0
1994499|NCT00086190|3560301|FG002|Overall Study|Protocol Violation|0
1994500|NCT00086190|3560299|FG000|Overall Study|Moved|1
1994501|NCT00086190|3560300|FG001|Overall Study|Moved|0
1994502|NCT00086190|3560301|FG002|Overall Study|Moved|0
1994503|NCT00086190|3560299|FG000|Overall Study|Worsening depression|0
1994504|NCT00086190|3560300|FG001|Overall Study|Worsening depression|0
1994505|NCT00086190|3560301|FG002|Overall Study|Worsening depression|2
1994506|NCT00086281|3560324|FG000|Phase 1|Adverse Event|0
1994507|NCT00086281|3560325|FG001|Phase 1|Adverse Event|0
1994508|NCT00086281|3560326|FG002|Phase 1|Adverse Event|0
1994509|NCT00086281|3560327|FG003|Phase 1|Adverse Event|0
1994510|NCT00086281|3560328|FG004|Phase 1|Adverse Event|0
1994511|NCT00086281|3560329|FG005|Phase 1|Adverse Event|0
1994512|NCT00086281|3560330|FG006|Phase 1|Adverse Event|0
1994513|NCT00086281|3560331|FG007|Phase 1|Adverse Event|0
1994514|NCT00086281|3560332|FG008|Phase 1|Adverse Event|0
1994515|NCT00086281|3560333|FG009|Phase 1|Adverse Event|1
1994516|NCT00086281|3560334|FG010|Phase 1|Adverse Event|2
1994517|NCT00086281|3560335|FG011|Phase 1|Adverse Event|1
1994518|NCT00086281|3560336|FG012|Phase 1|Adverse Event|1
1994519|NCT00086281|3560337|FG013|Phase 1|Adverse Event|1
1994520|NCT00086281|3560338|FG014|Phase 1|Adverse Event|2
1994521|NCT00086281|3560324|FG000|Phase 1|Protocol Violation|0
1994522|NCT00086281|3560325|FG001|Phase 1|Protocol Violation|0
1994523|NCT00086281|3560326|FG002|Phase 1|Protocol Violation|0
2213666|NCT01682031|3855601|FG001|Overall Study|Withdrawal by Subject|1
2213667|NCT01682031|3855600|FG000|Overall Study|Adverse Event|0
2213668|NCT01682031|3855601|FG001|Overall Study|Adverse Event|2
2213669|NCT01682031|3855600|FG000|Overall Study|MRI results indicate increased nodul|0
2213670|NCT01682031|3855601|FG001|Overall Study|MRI results indicate increased nodul|1
2213671|NCT01682031|3855600|FG000|Overall Study|Patient could not swallow tablets|1
2213672|NCT01682031|3855601|FG001|Overall Study|Patient could not swallow tablets|0
1994524|NCT00086281|3560327|FG003|Phase 1|Protocol Violation|0
1994525|NCT00086281|3560328|FG004|Phase 1|Protocol Violation|0
1994526|NCT00086281|3560329|FG005|Phase 1|Protocol Violation|0
1994527|NCT00086281|3560330|FG006|Phase 1|Protocol Violation|0
1994528|NCT00086281|3560331|FG007|Phase 1|Protocol Violation|0
1994529|NCT00086281|3560332|FG008|Phase 1|Protocol Violation|0
1994530|NCT00086281|3560333|FG009|Phase 1|Protocol Violation|0
1994531|NCT00086281|3560334|FG010|Phase 1|Protocol Violation|1
1994532|NCT00086281|3560335|FG011|Phase 1|Protocol Violation|0
1994533|NCT00086281|3560336|FG012|Phase 1|Protocol Violation|0
1994534|NCT00086281|3560337|FG013|Phase 1|Protocol Violation|0
1994535|NCT00086281|3560338|FG014|Phase 1|Protocol Violation|0
1994536|NCT00086281|3560324|FG000|Phase 1|Serious Adverse Event|0
1994537|NCT00086281|3560325|FG001|Phase 1|Serious Adverse Event|0
1994538|NCT00086281|3560326|FG002|Phase 1|Serious Adverse Event|0
1994539|NCT00086281|3560327|FG003|Phase 1|Serious Adverse Event|0
1994540|NCT00086281|3560328|FG004|Phase 1|Serious Adverse Event|0
1994541|NCT00086281|3560329|FG005|Phase 1|Serious Adverse Event|0
1994542|NCT00086281|3560330|FG006|Phase 1|Serious Adverse Event|0
1994543|NCT00086281|3560331|FG007|Phase 1|Serious Adverse Event|0
1994544|NCT00086281|3560332|FG008|Phase 1|Serious Adverse Event|0
1994545|NCT00086281|3560333|FG009|Phase 1|Serious Adverse Event|0
1994546|NCT00086281|3560334|FG010|Phase 1|Serious Adverse Event|0
1994547|NCT00086281|3560335|FG011|Phase 1|Serious Adverse Event|0
1994548|NCT00086281|3560336|FG012|Phase 1|Serious Adverse Event|0
1994549|NCT00086281|3560337|FG013|Phase 1|Serious Adverse Event|0
1994550|NCT00086281|3560338|FG014|Phase 1|Serious Adverse Event|1
1994551|NCT00086281|3560324|FG000|Phase 2|Adverse Event|0
1994552|NCT00086281|3560325|FG001|Phase 2|Adverse Event|0
1994553|NCT00086281|3560326|FG002|Phase 2|Adverse Event|0
1994554|NCT00086281|3560327|FG003|Phase 2|Adverse Event|0
1994555|NCT00086281|3560328|FG004|Phase 2|Adverse Event|0
1994556|NCT00086281|3560329|FG005|Phase 2|Adverse Event|0
1994557|NCT00086281|3560330|FG006|Phase 2|Adverse Event|0
1994558|NCT00086281|3560331|FG007|Phase 2|Adverse Event|0
1994559|NCT00086281|3560332|FG008|Phase 2|Adverse Event|0
1994560|NCT00086281|3560333|FG009|Phase 2|Adverse Event|0
1994561|NCT00086281|3560334|FG010|Phase 2|Adverse Event|0
1994562|NCT00086281|3560335|FG011|Phase 2|Adverse Event|0
1994563|NCT00086281|3560336|FG012|Phase 2|Adverse Event|1
1994564|NCT00086281|3560337|FG013|Phase 2|Adverse Event|1
1994565|NCT00086281|3560338|FG014|Phase 2|Adverse Event|0
1994566|NCT00086307|3560351|FG000|Overall Study|Lack of Efficacy|1
1994567|NCT00086307|3560352|FG001|Overall Study|Lack of Efficacy|1
1994568|NCT00086307|3560353|FG002|Overall Study|Lack of Efficacy|2
1994569|NCT00086307|3560351|FG000|Overall Study|Shortness of breath and muscle spasms|1
1994570|NCT00086307|3560352|FG001|Overall Study|Shortness of breath and muscle spasms|0
1994571|NCT00086307|3560353|FG002|Overall Study|Shortness of breath and muscle spasms|0
1994572|NCT00086307|3560351|FG000|Overall Study|Nausea and headaches|0
1994573|NCT00086307|3560352|FG001|Overall Study|Nausea and headaches|0
1994574|NCT00086307|3560353|FG002|Overall Study|Nausea and headaches|1
2213673|NCT01682031|3855600|FG000|Overall Study|Patient stopped selenium on his own|0
2213674|NCT01682031|3855601|FG001|Overall Study|Patient stopped selenium on his own|1
2213675|NCT01682044|3855607|FG000|Overall Study|Death|1
2213676|NCT01682044|3855607|FG000|Overall Study|Progression|3
2213677|NCT01682083|3855613|FG000|Overall Study|Lost to Follow-up|11
2213678|NCT01682083|3855614|FG001|Overall Study|Lost to Follow-up|18
2213679|NCT01682083|3855613|FG000|Overall Study|Withdrawal by Subject|31
2213680|NCT01682083|3855614|FG001|Overall Study|Withdrawal by Subject|40
2213681|NCT01682083|3855613|FG000|Overall Study|Death|60
2213682|NCT01682083|3855614|FG001|Overall Study|Death|93
1994575|NCT00086307|3560351|FG000|Overall Study|Constipation and sleepiness|0
1994576|NCT00086307|3560352|FG001|Overall Study|Constipation and sleepiness|0
1994577|NCT00086307|3560353|FG002|Overall Study|Constipation and sleepiness|1
1994578|NCT00086307|3560351|FG000|Overall Study|Suicidal ideation|0
1994579|NCT00086307|3560352|FG001|Overall Study|Suicidal ideation|0
1994580|NCT00086307|3560353|FG002|Overall Study|Suicidal ideation|1
1994581|NCT00086307|3560351|FG000|Overall Study|Fatigue and difficulty falling asleep|0
1994582|NCT00086307|3560352|FG001|Overall Study|Fatigue and difficulty falling asleep|0
1994583|NCT00086307|3560353|FG002|Overall Study|Fatigue and difficulty falling asleep|1
1994584|NCT00086307|3560351|FG000|Overall Study|Withdrawal by Subject|0
1994585|NCT00086307|3560352|FG001|Overall Study|Withdrawal by Subject|0
1994586|NCT00086307|3560353|FG002|Overall Study|Withdrawal by Subject|2
1994587|NCT00086346|3560363|FG000|Randomization|Did not receive test article|4
1994588|NCT00086346|3560364|FG001|Randomization|Did not receive test article|4
1994589|NCT00086346|3560363|FG000|Patients Dosed With Test Article|Adverse Event|94
1994590|NCT00086346|3560364|FG001|Patients Dosed With Test Article|Adverse Event|11
1994591|NCT00086346|3560363|FG000|Patients Dosed With Test Article|Lost to Follow-up|1
1994592|NCT00086346|3560364|FG001|Patients Dosed With Test Article|Lost to Follow-up|3
1994593|NCT00086346|3560363|FG000|Patients Dosed With Test Article|Nonmedical event|7
1994594|NCT00086346|3560364|FG001|Patients Dosed With Test Article|Nonmedical event|3
1994595|NCT00086346|3560363|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16
1994596|NCT00086346|3560364|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3
2213683|NCT01682083|3855613|FG000|Overall Study|Physician Decision|5
2213684|NCT01682083|3855614|FG001|Overall Study|Physician Decision|4
1994597|NCT00086346|3560363|FG000|Patients Dosed With Test Article|Protocol Violation|11
1994598|NCT00086346|3560364|FG001|Patients Dosed With Test Article|Protocol Violation|3
1994599|NCT00086346|3560363|FG000|Patients Dosed With Test Article|Lack of Efficacy|11
1994600|NCT00086346|3560364|FG001|Patients Dosed With Test Article|Lack of Efficacy|0
1994601|NCT00086385|3560374|FG000|Overall Study|Death|2
1994602|NCT00086385|3560375|FG001|Overall Study|Death|2
1994603|NCT00086385|3560376|FG002|Overall Study|Death|1
1994604|NCT00086385|3560377|FG003|Overall Study|Death|1
1994605|NCT00086411|3560391|FG000|Overall Study|Lost to Follow-up|11
1994606|NCT00086411|3560392|FG001|Overall Study|Lost to Follow-up|11
1994607|NCT00086411|3560393|FG002|Overall Study|Lost to Follow-up|13
1994608|NCT00086411|3560394|FG003|Overall Study|Lost to Follow-up|12
1994609|NCT00086502|3560416|FG000|Overall Study|Adverse Event|11
1994610|NCT00086502|3560417|FG001|Overall Study|Adverse Event|2
1994611|NCT00086502|3560416|FG000|Overall Study|Lack of Efficacy|0
1994612|NCT00086502|3560417|FG001|Overall Study|Lack of Efficacy|2
1994613|NCT00086502|3560416|FG000|Overall Study|Lost to Follow-up|3
1994614|NCT00086502|3560417|FG001|Overall Study|Lost to Follow-up|1
1994615|NCT00086502|3560416|FG000|Overall Study|Physician Decision|1
1994616|NCT00086502|3560417|FG001|Overall Study|Physician Decision|1
1994617|NCT00086502|3560416|FG000|Overall Study|Pregnancy|0
1994618|NCT00086502|3560417|FG001|Overall Study|Pregnancy|1
1994619|NCT00086502|3560416|FG000|Overall Study|Protocol Violation|3
1994620|NCT00086502|3560417|FG001|Overall Study|Protocol Violation|3
1994621|NCT00086502|3560416|FG000|Overall Study|Withdrawal by Subject|5
1994622|NCT00086502|3560417|FG001|Overall Study|Withdrawal by Subject|6
1994623|NCT00086502|3560416|FG000|Overall Study|Patient Moved|1
1994624|NCT00086502|3560417|FG001|Overall Study|Patient Moved|1
1994625|NCT00086502|3560416|FG000|Overall Study|Protocol Discontinuation Criteria|1
1994626|NCT00086502|3560417|FG001|Overall Study|Protocol Discontinuation Criteria|3
1994627|NCT00086502|3560416|FG000|Overall Study|Patient Accidentally Unblinded|1
1994628|NCT00086502|3560417|FG001|Overall Study|Patient Accidentally Unblinded|0
1994629|NCT00086515|3560425|FG000|Phase A (Weeks 0-24)|Adverse Event|17
1994630|NCT00086515|3560426|FG001|Phase A (Weeks 0-24)|Adverse Event|9
1994631|NCT00086515|3560425|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7
1994632|NCT00086515|3560426|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13
1994633|NCT00086515|3560425|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4
1994634|NCT00086515|3560426|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5
1994635|NCT00086515|3560425|FG000|Phase A (Weeks 0-24)|Protocol Violation|3
1994636|NCT00086515|3560426|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
1994637|NCT00086515|3560425|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10
2213685|NCT01682148|3855637|FG000|Overall Study|Withdrawal by Subject|2
1994638|NCT00086515|3560426|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10
1994639|NCT00086515|3560425|FG000|Phase A (Weeks 0-24)|Patient Moved|2
1994640|NCT00086515|3560426|FG001|Phase A (Weeks 0-24)|Patient Moved|3
1994641|NCT00086515|3560425|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
1994642|NCT00086515|3560426|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
1994643|NCT00086515|3560425|FG000|Phase A (Weeks 0-24)|Poor compliance|1
1994644|NCT00086515|3560426|FG001|Phase A (Weeks 0-24)|Poor compliance|0
1994645|NCT00086515|3560425|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
1994646|NCT00086515|3560426|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
1994647|NCT00086515|3560425|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1
1994648|NCT00086515|3560426|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0
1994649|NCT00086515|3560425|FG000|Phase A to Phase B Transition Period|Adverse Event|2
1994650|NCT00086515|3560426|FG001|Phase A to Phase B Transition Period|Adverse Event|1
1994651|NCT00086515|3560425|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2
1994652|NCT00086515|3560426|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2
1994653|NCT00086515|3560425|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1
1994654|NCT00086515|3560426|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0
1994655|NCT00086515|3560425|FG000|Phase A to Phase B Transition Period|Protocol Violation|0
1994656|NCT00086515|3560426|FG001|Phase A to Phase B Transition Period|Protocol Violation|1
1994657|NCT00086515|3560425|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
1994658|NCT00086515|3560426|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
1994659|NCT00086515|3560425|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
1994660|NCT00086515|3560426|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
1994661|NCT00086515|3560425|FG000|Phase A to Phase B Transition Period|Poor compliance|1
1994662|NCT00086515|3560426|FG001|Phase A to Phase B Transition Period|Poor compliance|0
1994663|NCT00086515|3560425|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
1994664|NCT00086515|3560426|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
1994665|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Adverse Event|16
1994666|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Adverse Event|10
1994667|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94
1994668|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19
1994669|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13
1994670|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4
1994671|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Physician Decision|3
1994672|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Physician Decision|0
1994673|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Protocol Violation|1
1994674|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Protocol Violation|0
1994675|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15
1994676|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5
1994677|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Patient Moved|2
1994678|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Patient Moved|2
1994679|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
1994680|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
1994681|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
1994682|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
1994683|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Patient Died|3
1994684|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Patient Died|1
1994685|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
1994686|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
1994687|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1
1994688|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0
1994689|NCT00086515|3560425|FG000|Phase B (Weeks 24-104)|Discontinued in error|1
1994690|NCT00086515|3560426|FG001|Phase B (Weeks 24-104)|Discontinued in error|0
1994691|NCT00086580|3560434|FG000|Treatment Period|Disease progression|9
1994692|NCT00086580|3560435|FG001|Treatment Period|Disease progression|8
1994693|NCT00086580|3560434|FG000|Treatment Period|Unable to comply with protocol|3
1994694|NCT00086580|3560435|FG001|Treatment Period|Unable to comply with protocol|1
1994695|NCT00086580|3560434|FG000|Treatment Period|Withdrawal by Subject|7
1994696|NCT00086580|3560435|FG001|Treatment Period|Withdrawal by Subject|8
1994697|NCT00086580|3560434|FG000|Treatment Period|Physician Decision|13
1994698|NCT00086580|3560435|FG001|Treatment Period|Physician Decision|7
1994699|NCT00086580|3560434|FG000|Treatment Period|AE - not treatment related|7
1994700|NCT00086580|3560435|FG001|Treatment Period|AE - not treatment related|7
1994701|NCT00086580|3560434|FG000|Treatment Period|Toxicity - treatment related|15
1994702|NCT00086580|3560435|FG001|Treatment Period|Toxicity - treatment related|15
1994703|NCT00086580|3560434|FG000|Treatment Period|Anemia or thrombocytopenia|1
1994704|NCT00086580|3560435|FG001|Treatment Period|Anemia or thrombocytopenia|4
1994705|NCT00086580|3560434|FG000|Treatment Period|Death|5
1994706|NCT00086580|3560435|FG001|Treatment Period|Death|7
1994707|NCT00086580|3560434|FG000|Treatment Period|Other|5
1994708|NCT00086580|3560435|FG001|Treatment Period|Other|3
1994709|NCT00086580|3560434|FG000|Follow-up Period|Disease progression|72
1994710|NCT00086580|3560435|FG001|Follow-up Period|Disease progression|99
1994711|NCT00086580|3560434|FG000|Follow-up Period|Unable to comply with protocol|5
1994712|NCT00086580|3560435|FG001|Follow-up Period|Unable to comply with protocol|0
1994713|NCT00086580|3560434|FG000|Follow-up Period|Withdrawal by Subject|6
1994714|NCT00086580|3560435|FG001|Follow-up Period|Withdrawal by Subject|6
1994715|NCT00086580|3560434|FG000|Follow-up Period|Physician Decision|0
1994716|NCT00086580|3560435|FG001|Follow-up Period|Physician Decision|1
1994717|NCT00086580|3560434|FG000|Follow-up Period|AE - not related|1
1994718|NCT00086580|3560435|FG001|Follow-up Period|AE - not related|0
1994719|NCT00086580|3560434|FG000|Follow-up Period|Death|13
1994720|NCT00086580|3560435|FG001|Follow-up Period|Death|7
1994721|NCT00086580|3560434|FG000|Follow-up Period|Other|7
1994722|NCT00086580|3560435|FG001|Follow-up Period|Other|6
1994723|NCT00086580|3560434|FG000|Observation Period|Unable to comply with protocol|1
1994724|NCT00086580|3560435|FG001|Observation Period|Unable to comply with protocol|1
1994725|NCT00086580|3560434|FG000|Observation Period|Withdrawal by Subject|4
1994726|NCT00086580|3560435|FG001|Observation Period|Withdrawal by Subject|2
1994727|NCT00086580|3560434|FG000|Observation Period|Death|33
1994728|NCT00086580|3560435|FG001|Observation Period|Death|55
1994729|NCT00086580|3560434|FG000|Observation Period|Other|8
1994730|NCT00086580|3560435|FG001|Observation Period|Other|7
1994731|NCT00086619|3560443|FG000|Overall Study|Withdrawal by Subject|6
1994732|NCT00086619|3560444|FG001|Overall Study|Withdrawal by Subject|6
1994733|NCT00086619|3560443|FG000|Overall Study|Adverse Event|8
1994734|NCT00086619|3560444|FG001|Overall Study|Adverse Event|10
1994735|NCT00086619|3560443|FG000|Overall Study|Protocol Violation|1
1994736|NCT00086619|3560444|FG001|Overall Study|Protocol Violation|1
1994737|NCT00086684|3560453|FG000|Overall Study|Adverse Event|12
1994738|NCT00086684|3560454|FG001|Overall Study|Adverse Event|17
1994739|NCT00086684|3560455|FG002|Overall Study|Adverse Event|14
1994740|NCT00086684|3560453|FG000|Overall Study|Lack of Efficacy|6
1994741|NCT00086684|3560454|FG001|Overall Study|Lack of Efficacy|6
1994742|NCT00086684|3560455|FG002|Overall Study|Lack of Efficacy|5
1994743|NCT00086684|3560453|FG000|Overall Study|Lost to Follow-up|15
1994744|NCT00086684|3560454|FG001|Overall Study|Lost to Follow-up|8
1994745|NCT00086684|3560455|FG002|Overall Study|Lost to Follow-up|10
1994746|NCT00086684|3560453|FG000|Overall Study|Protocol Violation|8
1994747|NCT00086684|3560454|FG001|Overall Study|Protocol Violation|3
1994748|NCT00086684|3560455|FG002|Overall Study|Protocol Violation|0
1994749|NCT00086684|3560453|FG000|Overall Study|Withdrawal by Subject|0
1994750|NCT00086684|3560454|FG001|Overall Study|Withdrawal by Subject|4
1994751|NCT00086684|3560455|FG002|Overall Study|Withdrawal by Subject|10
1994752|NCT00086684|3560453|FG000|Overall Study|NONCOMPLIANCE|5
1994753|NCT00086684|3560454|FG001|Overall Study|NONCOMPLIANCE|7
1994754|NCT00086684|3560455|FG002|Overall Study|NONCOMPLIANCE|6
1994755|NCT00086684|3560453|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0
1994756|NCT00086684|3560454|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1
1994757|NCT00086684|3560455|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0
1994758|NCT00086684|3560453|FG000|Overall Study|WITHDRAWAL OF CONSENT|5
1994759|NCT00086684|3560454|FG001|Overall Study|WITHDRAWAL OF CONSENT|7
1994760|NCT00086684|3560455|FG002|Overall Study|WITHDRAWAL OF CONSENT|5
1994761|NCT00086684|3560453|FG000|Overall Study|Other|4
1994762|NCT00086684|3560454|FG001|Overall Study|Other|2
1994763|NCT00086684|3560455|FG002|Overall Study|Other|3
1994764|NCT00086996|3560474|FG000|Overall Study|Adverse Event|29
1994765|NCT00086996|3560474|FG000|Overall Study|Death|4
1994766|NCT00086996|3560474|FG000|Overall Study|progression/relapse|7
1994767|NCT00086996|3560474|FG000|Overall Study|Withdrawal by Subject|13
1994768|NCT00086996|3560474|FG000|Overall Study|Other|6
1994769|NCT00086996|3560474|FG000|Overall Study|not eligible|5
1994770|NCT00087126|3560487|FG000|Overall Study|Ineligible - second primary|1
1994771|NCT00087126|3560487|FG000|Overall Study|Never treated|1
1994772|NCT00087139|3560499|FG000|Overall Study|Adverse Event|18
1994773|NCT00087139|3560500|FG001|Overall Study|Adverse Event|17
1994774|NCT00087139|3560501|FG002|Overall Study|Adverse Event|13
1994775|NCT00087139|3560499|FG000|Overall Study|Death|2
1994776|NCT00087139|3560500|FG001|Overall Study|Death|1
1994777|NCT00087139|3560501|FG002|Overall Study|Death|0
1994778|NCT00087139|3560499|FG000|Overall Study|Withdrawal by Subject|3
1994779|NCT00087139|3560500|FG001|Overall Study|Withdrawal by Subject|2
1994780|NCT00087139|3560501|FG002|Overall Study|Withdrawal by Subject|2
1994781|NCT00087139|3560499|FG000|Overall Study|Physician Decision|1
1994782|NCT00087139|3560500|FG001|Overall Study|Physician Decision|1
1994783|NCT00087139|3560501|FG002|Overall Study|Physician Decision|1
1994784|NCT00087139|3560499|FG000|Overall Study|Disease progression|9
1994785|NCT00087139|3560500|FG001|Overall Study|Disease progression|19
1994786|NCT00087139|3560501|FG002|Overall Study|Disease progression|12
1994787|NCT00087139|3560499|FG000|Overall Study|Ineligible|4
1994788|NCT00087139|3560500|FG001|Overall Study|Ineligible|7
1994789|NCT00087139|3560501|FG002|Overall Study|Ineligible|4
1994790|NCT00087139|3560499|FG000|Overall Study|Symptomatic deterioration|1
1994791|NCT00087139|3560500|FG001|Overall Study|Symptomatic deterioration|1
1994792|NCT00087139|3560501|FG002|Overall Study|Symptomatic deterioration|3
1994793|NCT00087139|3560499|FG000|Overall Study|Use of coumadin|1
1994794|NCT00087139|3560500|FG001|Overall Study|Use of coumadin|0
1994795|NCT00087139|3560501|FG002|Overall Study|Use of coumadin|0
1994796|NCT00087139|3560499|FG000|Overall Study|Response achieved|0
1994797|NCT00087139|3560500|FG001|Overall Study|Response achieved|1
1994798|NCT00087139|3560501|FG002|Overall Study|Response achieved|0
1994799|NCT00087139|3560499|FG000|Overall Study|Extradural disease|0
1994800|NCT00087139|3560500|FG001|Overall Study|Extradural disease|0
1994801|NCT00087139|3560501|FG002|Overall Study|Extradural disease|1
1994802|NCT00087152|3560507|FG000|Overall Study|Ineligible|6
1994803|NCT00087438|3560512|FG000|Overall Study|Ineligible / No protocol treatment|4
1994804|NCT00087490|3560520|FG000|Overall Study|Death|6
1994805|NCT00087490|3560521|FG001|Overall Study|Death|4
1994806|NCT00087490|3560520|FG000|Overall Study|Adverse Event|3
1994807|NCT00087490|3560521|FG001|Overall Study|Adverse Event|8
1994808|NCT00087490|3560520|FG000|Overall Study|Lack of Efficacy|0
1994809|NCT00087490|3560521|FG001|Overall Study|Lack of Efficacy|2
1994810|NCT00087490|3560520|FG000|Overall Study|Protocol Violation or (/) Unspecified|214
1994811|NCT00087490|3560521|FG001|Overall Study|Protocol Violation or (/) Unspecified|201
1994812|NCT00087490|3560520|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28
1994813|NCT00087490|3560521|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36
1994814|NCT00087490|3560520|FG000|Overall Study|Randomized but not treated|7
1994815|NCT00087490|3560521|FG001|Overall Study|Randomized but not treated|18
1994816|NCT00087516|3560530|FG000|Overall Study|Adverse Event|10
1994817|NCT00087516|3560531|FG001|Overall Study|Adverse Event|10
1994818|NCT00087516|3560532|FG002|Overall Study|Adverse Event|3
1994819|NCT00087516|3560533|FG003|Overall Study|Adverse Event|6
1994820|NCT00087516|3560530|FG000|Overall Study|Lack of Efficacy|82
1994821|NCT00087516|3560531|FG001|Overall Study|Lack of Efficacy|80
1994822|NCT00087516|3560532|FG002|Overall Study|Lack of Efficacy|39
1994823|NCT00087516|3560533|FG003|Overall Study|Lack of Efficacy|29
1994824|NCT00087516|3560530|FG000|Overall Study|Lost to Follow-up|8
1994825|NCT00087516|3560531|FG001|Overall Study|Lost to Follow-up|6
1994826|NCT00087516|3560532|FG002|Overall Study|Lost to Follow-up|5
1994827|NCT00087516|3560533|FG003|Overall Study|Lost to Follow-up|5
1994828|NCT00087516|3560530|FG000|Overall Study|Protocol Violation|4
1994829|NCT00087516|3560531|FG001|Overall Study|Protocol Violation|8
1994830|NCT00087516|3560532|FG002|Overall Study|Protocol Violation|3
1994831|NCT00087516|3560533|FG003|Overall Study|Protocol Violation|6
1994832|NCT00087516|3560530|FG000|Overall Study|Withdrawal by Subject|16
1994833|NCT00087516|3560531|FG001|Overall Study|Withdrawal by Subject|27
1994834|NCT00087516|3560532|FG002|Overall Study|Withdrawal by Subject|11
1994835|NCT00087516|3560533|FG003|Overall Study|Withdrawal by Subject|12
1994836|NCT00087516|3560530|FG000|Overall Study|Site terminated|0
1994837|NCT00087516|3560531|FG001|Overall Study|Site terminated|2
1994838|NCT00087516|3560532|FG002|Overall Study|Site terminated|1
1994839|NCT00087516|3560533|FG003|Overall Study|Site terminated|0
1994840|NCT00087516|3560530|FG000|Overall Study|Protocol specified discontinuation|35
1994841|NCT00087516|3560531|FG001|Overall Study|Protocol specified discontinuation|33
1994842|NCT00087516|3560532|FG002|Overall Study|Protocol specified discontinuation|33
1994843|NCT00087516|3560533|FG003|Overall Study|Protocol specified discontinuation|26
1994844|NCT00087516|3560530|FG000|Overall Study|Patient moved|3
1994845|NCT00087516|3560531|FG001|Overall Study|Patient moved|2
1994846|NCT00087516|3560532|FG002|Overall Study|Patient moved|1
1994847|NCT00087516|3560533|FG003|Overall Study|Patient moved|0
1994848|NCT00087516|3560530|FG000|Overall Study|Patient was non-compliant|3
1994849|NCT00087516|3560531|FG001|Overall Study|Patient was non-compliant|1
1994850|NCT00087516|3560532|FG002|Overall Study|Patient was non-compliant|0
1994851|NCT00087516|3560533|FG003|Overall Study|Patient was non-compliant|0
1994852|NCT00087516|3560530|FG000|Overall Study|Recommendation of Primary Care Physician|0
1994853|NCT00087516|3560531|FG001|Overall Study|Recommendation of Primary Care Physician|0
1994854|NCT00087516|3560532|FG002|Overall Study|Recommendation of Primary Care Physician|0
1994855|NCT00087516|3560533|FG003|Overall Study|Recommendation of Primary Care Physician|1
1994856|NCT00087516|3560530|FG000|Overall Study|Other|0
1994857|NCT00087516|3560531|FG001|Overall Study|Other|0
1994858|NCT00087516|3560532|FG002|Overall Study|Other|1
1994859|NCT00087516|3560533|FG003|Overall Study|Other|0
1994860|NCT00087529|3560549|FG000|Overall Study|Death|1
1994861|NCT00087529|3560550|FG001|Overall Study|Death|0
1994862|NCT00087529|3560549|FG000|Overall Study|Adverse Event|0
1994863|NCT00087529|3560550|FG001|Overall Study|Adverse Event|8
1994864|NCT00087529|3560549|FG000|Overall Study|Pregnancy|0
1994865|NCT00087529|3560550|FG001|Overall Study|Pregnancy|1
1994866|NCT00087529|3560549|FG000|Overall Study|Lost to Follow-up|2
1994867|NCT00087529|3560550|FG001|Overall Study|Lost to Follow-up|3
1994868|NCT00087529|3560549|FG000|Overall Study|Participant Decision|14
1994869|NCT00087529|3560550|FG001|Overall Study|Participant Decision|37
1994870|NCT00087529|3560549|FG000|Overall Study|Physician Decision|4
1994871|NCT00087529|3560550|FG001|Overall Study|Physician Decision|8
1994872|NCT00087529|3560549|FG000|Overall Study|Initiation of Excluded Therapy|0
1994873|NCT00087529|3560550|FG001|Overall Study|Initiation of Excluded Therapy|1
1994874|NCT00087529|3560549|FG000|Overall Study|Participant Noncompliance|0
1994875|NCT00087529|3560550|FG001|Overall Study|Participant Noncompliance|1
1994876|NCT00087529|3560549|FG000|Overall Study|Disease Progression|5
1994877|NCT00087529|3560550|FG001|Overall Study|Disease Progression|4
1994878|NCT00087529|3560549|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5
1994879|NCT00087529|3560550|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5
1994880|NCT00087555|3560559|FG000|Overall Study|Adverse Event|3
1994881|NCT00087555|3560560|FG001|Overall Study|Adverse Event|6
1994882|NCT00087555|3560561|FG002|Overall Study|Adverse Event|14
1994883|NCT00087555|3560559|FG000|Overall Study|Lost to Follow-up|0
1994884|NCT00087555|3560560|FG001|Overall Study|Lost to Follow-up|1
1994885|NCT00087555|3560561|FG002|Overall Study|Lost to Follow-up|1
1994886|NCT00087555|3560559|FG000|Overall Study|Non - Compliance|1
1994887|NCT00087555|3560560|FG001|Overall Study|Non - Compliance|0
1994888|NCT00087555|3560561|FG002|Overall Study|Non - Compliance|0
1994889|NCT00087555|3560559|FG000|Overall Study|Protocol Violation|0
1994890|NCT00087555|3560560|FG001|Overall Study|Protocol Violation|0
1994891|NCT00087555|3560561|FG002|Overall Study|Protocol Violation|2
1994892|NCT00087555|3560559|FG000|Overall Study|Screen Failure|1
1994893|NCT00087555|3560560|FG001|Overall Study|Screen Failure|1
1994894|NCT00087555|3560561|FG002|Overall Study|Screen Failure|0
1994895|NCT00087555|3560559|FG000|Overall Study|Pregnancy|0
1994896|NCT00087555|3560560|FG001|Overall Study|Pregnancy|1
1994897|NCT00087555|3560561|FG002|Overall Study|Pregnancy|1
1994898|NCT00087555|3560559|FG000|Overall Study|Withdrawal by Subject|3
1994899|NCT00087555|3560560|FG001|Overall Study|Withdrawal by Subject|2
1994900|NCT00087555|3560561|FG002|Overall Study|Withdrawal by Subject|1
1994901|NCT00087555|3560559|FG000|Overall Study|Lack of Efficacy|2
1994902|NCT00087555|3560560|FG001|Overall Study|Lack of Efficacy|0
1994903|NCT00087555|3560561|FG002|Overall Study|Lack of Efficacy|1
1994904|NCT00087555|3560559|FG000|Overall Study|Non Compliance|0
1994905|NCT00087555|3560560|FG001|Overall Study|Non Compliance|0
1994906|NCT00087555|3560561|FG002|Overall Study|Non Compliance|1
1994907|NCT00087555|3560559|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1
1994908|NCT00087555|3560560|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0
1994909|NCT00087555|3560561|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0
1994910|NCT00087555|3560559|FG000|Overall Study|Patient wanted to go back on Med|1
1994911|NCT00087555|3560560|FG001|Overall Study|Patient wanted to go back on Med|0
1994912|NCT00087555|3560561|FG002|Overall Study|Patient wanted to go back on Med|0
1994913|NCT00087568|3560571|FG000|Overall Study|Adverse Event|4
1994914|NCT00087568|3560572|FG001|Overall Study|Adverse Event|0
1994915|NCT00087568|3560571|FG000|Overall Study|Withdrawal by Subject|1
1994916|NCT00087568|3560572|FG001|Overall Study|Withdrawal by Subject|1
1994917|NCT00087568|3560571|FG000|Overall Study|Lost to Follow-up|1
1994918|NCT00087568|3560572|FG001|Overall Study|Lost to Follow-up|0
1994919|NCT00087568|3560571|FG000|Overall Study|Lack of Efficacy|24
1994920|NCT00087568|3560572|FG001|Overall Study|Lack of Efficacy|1
1994921|NCT00087594|3560580|FG000|Overall Study|Adverse Event|2
1994922|NCT00087594|3560581|FG001|Overall Study|Adverse Event|3
1994923|NCT00087594|3560580|FG000|Overall Study|Lost to Follow-up|0
1994924|NCT00087594|3560581|FG001|Overall Study|Lost to Follow-up|2
1994925|NCT00087594|3560580|FG000|Overall Study|Withdrawal by Subject|4
1994926|NCT00087594|3560581|FG001|Overall Study|Withdrawal by Subject|2
1994927|NCT00087594|3560580|FG000|Overall Study|Lack of Efficacy|2
1994928|NCT00087594|3560581|FG001|Overall Study|Lack of Efficacy|5
1994929|NCT00087607|3560589|FG000|Overall Study|Adverse Event|14
1994930|NCT00087607|3560590|FG001|Overall Study|Adverse Event|24
1994931|NCT00087607|3560589|FG000|Overall Study|Death|0
1994932|NCT00087607|3560590|FG001|Overall Study|Death|1
1994933|NCT00087607|3560589|FG000|Overall Study|Insufficient Therapeutic Response|53
1994934|NCT00087607|3560590|FG001|Overall Study|Insufficient Therapeutic Response|42
1994935|NCT00087607|3560589|FG000|Overall Study|Failure to return|21
1994936|NCT00087607|3560590|FG001|Overall Study|Failure to return|17
1994937|NCT00087607|3560589|FG000|Overall Study|Withdrew Consent|12
1994938|NCT00087607|3560590|FG001|Overall Study|Withdrew Consent|16
1994939|NCT00087607|3560589|FG000|Overall Study|Administrative|12
1994940|NCT00087607|3560590|FG001|Overall Study|Administrative|12
1994941|NCT00087607|3560589|FG000|Overall Study|Refused Treatment|5
1994942|NCT00087607|3560590|FG001|Overall Study|Refused Treatment|7
1994943|NCT00087607|3560589|FG000|Overall Study|Other Protocol Violation|5
1994944|NCT00087607|3560590|FG001|Overall Study|Other Protocol Violation|2
1994945|NCT00087607|3560589|FG000|Overall Study|Violation of Selection Criteria at Entry|0
1994946|NCT00087607|3560590|FG001|Overall Study|Violation of Selection Criteria at Entry|1
1994947|NCT00087646|3560613|FG000|Overall Study|Adverse Event|37
1994948|NCT00087646|3560614|FG001|Overall Study|Adverse Event|6
1994949|NCT00087646|3560615|FG002|Overall Study|Adverse Event|18
1994950|NCT00087646|3560616|FG003|Overall Study|Adverse Event|20
1994951|NCT00087646|3560613|FG000|Overall Study|Death|0
1994952|NCT00087646|3560614|FG001|Overall Study|Death|1
1994953|NCT00087646|3560615|FG002|Overall Study|Death|0
1994954|NCT00087646|3560616|FG003|Overall Study|Death|0
1994955|NCT00087646|3560613|FG000|Overall Study|Withdrawal by Subject|6
1994956|NCT00087646|3560614|FG001|Overall Study|Withdrawal by Subject|1
1994957|NCT00087646|3560615|FG002|Overall Study|Withdrawal by Subject|2
1994958|NCT00087646|3560616|FG003|Overall Study|Withdrawal by Subject|2
1994959|NCT00087646|3560613|FG000|Overall Study|Insufficient therapeutic response|64
1994960|NCT00087646|3560614|FG001|Overall Study|Insufficient therapeutic response|24
1994961|NCT00087646|3560615|FG002|Overall Study|Insufficient therapeutic response|38
1994962|NCT00087646|3560616|FG003|Overall Study|Insufficient therapeutic response|51
1994963|NCT00087646|3560613|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13
1994964|NCT00087646|3560614|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6
1994965|NCT00087646|3560615|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4
1994966|NCT00087646|3560616|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5
1994967|NCT00087646|3560613|FG000|Overall Study|Failure to Return|5
1994968|NCT00087646|3560614|FG001|Overall Study|Failure to Return|2
1994969|NCT00087646|3560615|FG002|Overall Study|Failure to Return|2
1994970|NCT00087646|3560616|FG003|Overall Study|Failure to Return|3
1994971|NCT00087646|3560613|FG000|Overall Study|Administrative/Other|6
1994972|NCT00087646|3560614|FG001|Overall Study|Administrative/Other|1
1994973|NCT00087646|3560615|FG002|Overall Study|Administrative/Other|1
1994974|NCT00087646|3560616|FG003|Overall Study|Administrative/Other|2
1994975|NCT00087646|3560613|FG000|Overall Study|Other Protocol Violation|3
1994976|NCT00087646|3560614|FG001|Overall Study|Other Protocol Violation|1
1994977|NCT00087646|3560615|FG002|Overall Study|Other Protocol Violation|0
1994978|NCT00087646|3560616|FG003|Overall Study|Other Protocol Violation|0
1994979|NCT00087646|3560613|FG000|Overall Study|Violation of Selection Criteria at Entry|1
1994980|NCT00087646|3560614|FG001|Overall Study|Violation of Selection Criteria at Entry|0
1994981|NCT00087646|3560615|FG002|Overall Study|Violation of Selection Criteria at Entry|0
1994982|NCT00087646|3560616|FG003|Overall Study|Violation of Selection Criteria at Entry|1
1994983|NCT00087685|3560635|FG000|Overall Study|Adverse Event|5
1994984|NCT00087685|3560635|FG000|Overall Study|Non-Compliance|1
1994985|NCT00087685|3560635|FG000|Overall Study|Progressive Disease|5
1994986|NCT00087685|3560635|FG000|Overall Study|Withdrawal by Subject|3
1994987|NCT00087698|3560639|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14
1994988|NCT00087698|3560639|FG000|Overall Study|Death from Other Causes|3
1994989|NCT00087698|3560639|FG000|Overall Study|Adverse Event|4
1994990|NCT00087698|3560639|FG000|Overall Study|Withdrawal by Subject|4
1994991|NCT00087698|3560639|FG000|Overall Study|Lack of Efficacy, Physician Perception|3
1994992|NCT00087698|3560639|FG000|Overall Study|Protocol Entry Criteria Not Met|2
1994993|NCT00087698|3560639|FG000|Overall Study|Clinical Relapse|1
1994994|NCT00087698|3560639|FG000|Overall Study|Death from Study Disease|2
1994995|NCT00087698|3560639|FG000|Overall Study|Death from Study Drug Toxicity|2
1994996|NCT00087698|3560639|FG000|Overall Study|Protocol Violation|1
1994997|NCT00088153|3560645|FG000|Overall Study|Physician Decision|3
1994998|NCT00088153|3560646|FG001|Overall Study|Physician Decision|3
1994999|NCT00088153|3560645|FG000|Overall Study|Withdrawal by Subject|10
1995000|NCT00088153|3560646|FG001|Overall Study|Withdrawal by Subject|10
1995001|NCT00088153|3560645|FG000|Overall Study|Lost to Follow-up|11
1995002|NCT00088153|3560646|FG001|Overall Study|Lost to Follow-up|12
1995003|NCT00088166|3560654|FG000|Overall Study|Adverse Event|11
1995004|NCT00088166|3560655|FG001|Overall Study|Adverse Event|9
1995005|NCT00088166|3560654|FG000|Overall Study|Death|3
1995006|NCT00088166|3560655|FG001|Overall Study|Death|1
1995007|NCT00088166|3560654|FG000|Overall Study|Lost to Follow-up|0
1995008|NCT00088166|3560655|FG001|Overall Study|Lost to Follow-up|1
1995009|NCT00088166|3560654|FG000|Overall Study|Physician Decision|4
1995010|NCT00088166|3560655|FG001|Overall Study|Physician Decision|1
1995011|NCT00088166|3560654|FG000|Overall Study|Protocol Violation|1
1995012|NCT00088166|3560655|FG001|Overall Study|Protocol Violation|5
1995013|NCT00088166|3560654|FG000|Overall Study|Patient deterioration|29
1995014|NCT00088166|3560655|FG001|Overall Study|Patient deterioration|39
1995015|NCT00088166|3560654|FG000|Overall Study|Withdrawal by Subject|5
1995016|NCT00088166|3560655|FG001|Overall Study|Withdrawal by Subject|5
1995017|NCT00088205|3560661|FG000|Overall Study|Adverse Event|4
1995018|NCT00088205|3560661|FG000|Overall Study|Progressive Disease|51
1995019|NCT00088205|3560661|FG000|Overall Study|Physician Decision|1
1995020|NCT00088205|3560661|FG000|Overall Study|Death Due to Study Disease|4
1995021|NCT00088374|3560674|FG000|Overall Study|patient did not receive any 17AAG|1
1995022|NCT00088374|3560674|FG000|Overall Study|patient received <1 cycle only of 17AAG|1
1995023|NCT00088413|3560682|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
1995024|NCT00088413|3560683|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
1995025|NCT00088413|3560684|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
1995026|NCT00088413|3560685|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
1995027|NCT00088413|3560682|FG000|Overall Study|Adverse Events/Side Effects|0
1995028|NCT00088413|3560683|FG001|Overall Study|Adverse Events/Side Effects|1
1995029|NCT00088413|3560684|FG002|Overall Study|Adverse Events/Side Effects|1
1995030|NCT00088413|3560685|FG003|Overall Study|Adverse Events/Side Effects|0
1995031|NCT00088413|3560682|FG000|Overall Study|Refused trmt Off-study per pt wishes|0
1995032|NCT00088413|3560683|FG001|Overall Study|Refused trmt Off-study per pt wishes|1
1995033|NCT00088413|3560684|FG002|Overall Study|Refused trmt Off-study per pt wishes|1
1995034|NCT00088413|3560685|FG003|Overall Study|Refused trmt Off-study per pt wishes|0
1995035|NCT00088413|3560682|FG000|Overall Study|Off study due to missing a vaccine dose|1
1995036|NCT00088413|3560683|FG001|Overall Study|Off study due to missing a vaccine dose|0
1995037|NCT00088413|3560684|FG002|Overall Study|Off study due to missing a vaccine dose|0
1995038|NCT00088413|3560685|FG003|Overall Study|Off study due to missing a vaccine dose|0
1995039|NCT00088413|3560682|FG000|Overall Study|Death|0
1995040|NCT00088413|3560683|FG001|Overall Study|Death|1
1995041|NCT00088413|3560684|FG002|Overall Study|Death|0
1995042|NCT00088413|3560685|FG003|Overall Study|Death|0
1995043|NCT00088413|3560682|FG000|Overall Study|Progressive disease|9
1995044|NCT00088413|3560683|FG001|Overall Study|Progressive disease|11
1995045|NCT00088413|3560684|FG002|Overall Study|Progressive disease|8
1995046|NCT00088413|3560685|FG003|Overall Study|Progressive disease|14
1995047|NCT00088413|3560682|FG000|Overall Study|Other|0
1995048|NCT00088413|3560683|FG001|Overall Study|Other|1
1995049|NCT00088413|3560684|FG002|Overall Study|Other|0
1995050|NCT00088413|3560685|FG003|Overall Study|Other|0
1995051|NCT00088413|3560682|FG000|Overall Study|Patient unevaluable due to adverse event|0
1995052|NCT00088413|3560683|FG001|Overall Study|Patient unevaluable due to adverse event|0
1995053|NCT00088413|3560684|FG002|Overall Study|Patient unevaluable due to adverse event|1
1995054|NCT00088413|3560685|FG003|Overall Study|Patient unevaluable due to adverse event|0
1995055|NCT00088452|3560700|FG000|Overall Study|Did not receive intervention|1
1995056|NCT00088452|3560701|FG001|Overall Study|Did not receive intervention|0
1995057|NCT00088452|3560702|FG002|Overall Study|Did not receive intervention|1
1995058|NCT00088465|3560710|FG000|Overall Study|Withdrawal by Subject|290
1995059|NCT00088465|3560710|FG000|Overall Study|Adverse Event|77
1995060|NCT00088465|3560710|FG000|Overall Study|Lost to Follow-up|57
1995061|NCT00088465|3560710|FG000|Overall Study|Physician Decision|45
1995062|NCT00088465|3560710|FG000|Overall Study|Sponsor Decision|37
1995063|NCT00088465|3560710|FG000|Overall Study|Lack of Efficacy|27
1995064|NCT00088465|3560710|FG000|Overall Study|Protocol Violation|17
1995065|NCT00088465|3560710|FG000|Overall Study|Death|11
1995066|NCT00088530|3560716|FG000|Overall Study|Progressive/Relapsed Disease|28
1995067|NCT00088530|3560717|FG001|Overall Study|Progressive/Relapsed Disease|39
1995068|NCT00088530|3560716|FG000|Overall Study|Adverse Event|15
1995069|NCT00088530|3560717|FG001|Overall Study|Adverse Event|9
1995070|NCT00088530|3560716|FG000|Overall Study|Withdrawal by Subject|2
1995071|NCT00088530|3560717|FG001|Overall Study|Withdrawal by Subject|5
1995072|NCT00088530|3560716|FG000|Overall Study|Lost to Follow-up|2
1995073|NCT00088530|3560717|FG001|Overall Study|Lost to Follow-up|0
1995074|NCT00088530|3560716|FG000|Overall Study|Physician Decision|2
1995075|NCT00088530|3560717|FG001|Overall Study|Physician Decision|0
1995076|NCT00088530|3560716|FG000|Overall Study|Sponsor decision|0
1995077|NCT00088530|3560717|FG001|Overall Study|Sponsor decision|1
1995078|NCT00088530|3560716|FG000|Overall Study|Patient never treated|1
1995079|NCT00088530|3560717|FG001|Overall Study|Patient never treated|0
1995080|NCT00088595|3560723|FG000|Overall Study|Adverse Event|11
1995081|NCT00088595|3560723|FG000|Overall Study|Withdrawal by Subject|8
1995082|NCT00088595|3560723|FG000|Overall Study|Ongoing (After Core)|7
1995083|NCT00088595|3560723|FG000|Overall Study|New Cancer Therapy|2
1995084|NCT00088881|3560765|FG000|Step 1 - R-CHOP|Patient ineligible|9
1995085|NCT00088881|3560765|FG000|Step 1 - R-CHOP|Adverse Event|1
1995086|NCT00088881|3560765|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2
1995087|NCT00088881|3560765|FG000|Step 1 - R-CHOP|Physician Decision|1
1995088|NCT00088881|3560765|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1
1995089|NCT00088881|3560765|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
1995090|NCT00088881|3560765|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
1995091|NCT00088907|3560773|FG000|Randomized Study (Step 1)|Lack of Efficacy|55
1995092|NCT00088907|3560774|FG001|Randomized Study (Step 1)|Lack of Efficacy|62
1995093|NCT00088907|3560773|FG000|Randomized Study (Step 1)|Adverse Event|14
1995094|NCT00088907|3560774|FG001|Randomized Study (Step 1)|Adverse Event|19
1995095|NCT00088907|3560773|FG000|Randomized Study (Step 1)|Death|11
1995096|NCT00088907|3560774|FG001|Randomized Study (Step 1)|Death|12
1995097|NCT00088907|3560773|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10
1995098|NCT00088907|3560774|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15
1995099|NCT00088907|3560773|FG000|Randomized Study (Step 1)|complicating disease|3
1995100|NCT00088907|3560774|FG001|Randomized Study (Step 1)|complicating disease|1
1995101|NCT00088907|3560773|FG000|Randomized Study (Step 1)|unknown/not specify|24
1995102|NCT00088907|3560774|FG001|Randomized Study (Step 1)|unknown/not specify|13
1995103|NCT00088907|3560773|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
1995104|NCT00088907|3560774|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
1995105|NCT00088907|3560773|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
1995106|NCT00088907|3560774|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
1995107|NCT00088907|3560773|FG000|Single Gefitinib Treatment (Step 2)|Death|1
1995108|NCT00088907|3560774|FG001|Single Gefitinib Treatment (Step 2)|Death|0
1995109|NCT00088907|3560773|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
1995110|NCT00088907|3560774|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
1995111|NCT00088907|3560773|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
1995112|NCT00088907|3560774|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
1995113|NCT00089076|3560798|FG000|Overall Study|Alternate Therapy|1
1995114|NCT00089076|3560798|FG000|Overall Study|Withdrawal by Subject|2
1995115|NCT00089076|3560798|FG000|Overall Study|Progression|7
1995116|NCT00089284|3560811|FG000|Overall Study|Adverse event before starting treatment|0
1995117|NCT00089284|3560812|FG001|Overall Study|Adverse event before starting treatment|0
1995118|NCT00089284|3560813|FG002|Overall Study|Adverse event before starting treatment|0
1995119|NCT00089284|3560814|FG003|Overall Study|Adverse event before starting treatment|0
1995120|NCT00089284|3560815|FG004|Overall Study|Adverse event before starting treatment|0
1995121|NCT00089284|3560816|FG005|Overall Study|Adverse event before starting treatment|0
1995122|NCT00089284|3560817|FG006|Overall Study|Adverse event before starting treatment|1
1995123|NCT00089297|3560839|FG000|Overall Study|Adverse Event|9
1995124|NCT00089297|3560839|FG000|Overall Study|Death|1
1995125|NCT00089297|3560839|FG000|Overall Study|Withdrawal by Subject|12
1995126|NCT00089297|3560839|FG000|Overall Study|Disease progression|2
1995127|NCT00089297|3560839|FG000|Overall Study|Ineligible|11
1995128|NCT00089297|3560839|FG000|Overall Study|Secondary malignancy|1
1995129|NCT00089297|3560839|FG000|Overall Study|IRB approval not ready|1
1995130|NCT00089297|3560839|FG000|Overall Study|Non-compliance|1
1995131|NCT00089479|3560845|FG000|Overall Study|Death|108
1995132|NCT00089479|3560846|FG001|Overall Study|Death|75
1995133|NCT00089479|3560845|FG000|Overall Study|Withdrawal by Subject|86
1995134|NCT00089479|3560846|FG001|Overall Study|Withdrawal by Subject|107
1995135|NCT00089479|3560845|FG000|Overall Study|Lost to Follow-up|137
1995136|NCT00089479|3560846|FG001|Overall Study|Lost to Follow-up|107
1995137|NCT00089505|3560856|FG000|Overall Study|Death|4
1995138|NCT00089505|3560857|FG001|Overall Study|Death|1
1995139|NCT00089505|3560858|FG002|Overall Study|Death|5
1995140|NCT00089505|3560859|FG003|Overall Study|Death|8
1995141|NCT00089505|3560856|FG000|Overall Study|Withdrawal by Subject|3
1995142|NCT00089505|3560857|FG001|Overall Study|Withdrawal by Subject|0
1995143|NCT00089505|3560858|FG002|Overall Study|Withdrawal by Subject|6
1995144|NCT00089505|3560859|FG003|Overall Study|Withdrawal by Subject|6
1995145|NCT00089505|3560856|FG000|Overall Study|Lost to Follow-up|1
1995146|NCT00089505|3560857|FG001|Overall Study|Lost to Follow-up|1
1995147|NCT00089505|3560858|FG002|Overall Study|Lost to Follow-up|9
1995148|NCT00089505|3560859|FG003|Overall Study|Lost to Follow-up|7
1995149|NCT00089505|3560856|FG000|Overall Study|Physician Decision|1
1995150|NCT00089505|3560857|FG001|Overall Study|Physician Decision|0
1995151|NCT00089505|3560858|FG002|Overall Study|Physician Decision|0
1995152|NCT00089505|3560859|FG003|Overall Study|Physician Decision|0
1995153|NCT00089505|3560856|FG000|Overall Study|Protocol Violation|0
1995154|NCT00089505|3560857|FG001|Overall Study|Protocol Violation|0
1995155|NCT00089505|3560858|FG002|Overall Study|Protocol Violation|1
1995156|NCT00089505|3560859|FG003|Overall Study|Protocol Violation|0
1995157|NCT00089544|3560871|FG000|Overall Study|Ineligible|1
1995158|NCT00089544|3560872|FG001|Overall Study|Ineligible|0
1995159|NCT00089583|3560880|FG000|Overall Study|Adverse Event|0
1995160|NCT00089583|3560881|FG001|Overall Study|Adverse Event|3
1995161|NCT00089583|3560880|FG000|Overall Study|Insufficient Viral Load Response|5
1995162|NCT00089583|3560881|FG001|Overall Study|Insufficient Viral Load Response|5
1995163|NCT00089583|3560880|FG000|Overall Study|Withdrawal by Subject|0
1995164|NCT00089583|3560881|FG001|Overall Study|Withdrawal by Subject|4
1995165|NCT00089583|3560880|FG000|Overall Study|Participant (Par) Didn't Take Medication|1
1995166|NCT00089583|3560881|FG001|Overall Study|Participant (Par) Didn't Take Medication|0
1995167|NCT00089583|3560880|FG000|Overall Study|Participant Refused Study Medication|0
1995168|NCT00089583|3560881|FG001|Overall Study|Participant Refused Study Medication|2
1995169|NCT00089583|3560880|FG000|Overall Study|Non-Compliance|0
1995170|NCT00089583|3560881|FG001|Overall Study|Non-Compliance|4
1995171|NCT00089583|3560880|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0
1995172|NCT00089583|3560881|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3
1995173|NCT00089583|3560880|FG000|Overall Study|Participant Management Criteria Met|0
1995174|NCT00089583|3560881|FG001|Overall Study|Participant Management Criteria Met|1
1995175|NCT00089583|3560880|FG000|Overall Study|Reason Not Provided|0
1995176|NCT00089583|3560881|FG001|Overall Study|Reason Not Provided|1
1995177|NCT00089583|3560880|FG000|Overall Study|Protocol Violation|0
1995178|NCT00089583|3560881|FG001|Overall Study|Protocol Violation|3
1995179|NCT00089583|3560880|FG000|Overall Study|Principal Investigator Decision|0
1995180|NCT00089583|3560881|FG001|Overall Study|Principal Investigator Decision|10
1995181|NCT00089583|3560880|FG000|Overall Study|Start of Disallowed Medication|0
1995182|NCT00089583|3560881|FG001|Overall Study|Start of Disallowed Medication|1
1995183|NCT00089583|3560880|FG000|Overall Study|Necessity to Use Prohibited Drug|1
1995184|NCT00089583|3560881|FG001|Overall Study|Necessity to Use Prohibited Drug|0
1995185|NCT00089583|3560880|FG000|Overall Study|Participant Incarcerated|0
1995186|NCT00089583|3560881|FG001|Overall Study|Participant Incarcerated|1
1995187|NCT00089609|3560895|FG000|Overall Study|Withdrawal by Subject|3
1995188|NCT00089609|3560896|FG001|Overall Study|Withdrawal by Subject|1
1995189|NCT00089635|3560905|FG000|Overall Study|Adverse Event|2
1995190|NCT00089635|3560905|FG000|Overall Study|Death|17
1995191|NCT00089635|3560905|FG000|Overall Study|Disease Progression|12
1995192|NCT00089635|3560905|FG000|Overall Study|Lost to Follow-up|3
1995193|NCT00089635|3560905|FG000|Overall Study|Withdrawal by Subject|6
1995194|NCT00089635|3560905|FG000|Overall Study|Ineligibility determined|1
1995195|NCT00089635|3560905|FG000|Overall Study|Other|2
1995196|NCT00089648|3560909|FG000|Overall Study|Adverse Event|7
1995197|NCT00089648|3560909|FG000|Overall Study|Withdrawal by Subject|1
1995198|NCT00089648|3560909|FG000|Overall Study|Lack of Efficacy|33
1995199|NCT00089661|3560915|FG000|Overall Study|Adverse Event|0
1995200|NCT00089661|3560916|FG001|Overall Study|Adverse Event|2
1995201|NCT00089661|3560915|FG000|Overall Study|Death|1
1995202|NCT00089661|3560916|FG001|Overall Study|Death|0
1995203|NCT00089661|3560915|FG000|Overall Study|Lost to Follow-up|0
1995204|NCT00089661|3560916|FG001|Overall Study|Lost to Follow-up|3
1995205|NCT00089661|3560915|FG000|Overall Study|Withdrawal by Subject|11
1995206|NCT00089661|3560916|FG001|Overall Study|Withdrawal by Subject|9
1995207|NCT00089661|3560915|FG000|Overall Study|Disease progression|1
1995208|NCT00089661|3560916|FG001|Overall Study|Disease progression|3
1995209|NCT00089661|3560915|FG000|Overall Study|Ineligibility determined|4
1995210|NCT00089661|3560916|FG001|Overall Study|Ineligibility determined|4
1995211|NCT00089661|3560915|FG000|Overall Study|Noncompliance|2
1995212|NCT00089661|3560916|FG001|Overall Study|Noncompliance|4
1995213|NCT00089661|3560915|FG000|Overall Study|Other|2
1995214|NCT00089661|3560916|FG001|Overall Study|Other|1
1995215|NCT00089674|3560924|FG000|Overall Study|Physician Decision|4
1995216|NCT00089674|3560925|FG001|Overall Study|Physician Decision|2
1995217|NCT00089674|3560924|FG000|Overall Study|Adverse Event|23
1995218|NCT00089674|3560925|FG001|Overall Study|Adverse Event|29
1995219|NCT00089674|3560924|FG000|Overall Study|Withdrawal by Subject|143
1995220|NCT00089674|3560925|FG001|Overall Study|Withdrawal by Subject|127
1995221|NCT00089674|3560924|FG000|Overall Study|Death|43
1995222|NCT00089674|3560925|FG001|Overall Study|Death|43
1995223|NCT00089674|3560924|FG000|Overall Study|Disease progression|21
1995224|NCT00089674|3560925|FG001|Overall Study|Disease progression|23
1995225|NCT00089674|3560924|FG000|Overall Study|Ineligibility determined|8
1995226|NCT00089674|3560925|FG001|Overall Study|Ineligibility determined|10
1995227|NCT00089674|3560924|FG000|Overall Study|Lost to Follow-up|21
1995228|NCT00089674|3560925|FG001|Overall Study|Lost to Follow-up|17
1995229|NCT00089674|3560924|FG000|Overall Study|Noncompliance|7
1995230|NCT00089674|3560925|FG001|Overall Study|Noncompliance|3
1995231|NCT00089674|3560924|FG000|Overall Study|Other|5
1995232|NCT00089674|3560925|FG001|Overall Study|Other|9
1995233|NCT00089674|3560924|FG000|Overall Study|Requirement for alternative therapy|14
1995234|NCT00089674|3560925|FG001|Overall Study|Requirement for alternative therapy|4
1995235|NCT00089778|3560945|FG000|Overall Study|Protocol Violation|0
1995236|NCT00089778|3560946|FG001|Overall Study|Protocol Violation|0
1995237|NCT00089778|3560947|FG002|Overall Study|Protocol Violation|1
1995238|NCT00089791|3560959|FG000|Overall Study|Physician Decision|6
1995239|NCT00089791|3560960|FG001|Overall Study|Physician Decision|3
1995240|NCT00089791|3560959|FG000|Overall Study|Adverse Event|81
1995241|NCT00089791|3560960|FG001|Overall Study|Adverse Event|93
1995242|NCT00089791|3560959|FG000|Overall Study|Withdrawal by Subject|403
1995243|NCT00089791|3560960|FG001|Overall Study|Withdrawal by Subject|344
1995244|NCT00089791|3560959|FG000|Overall Study|Death|78
1995245|NCT00089791|3560960|FG001|Overall Study|Death|62
1995246|NCT00089791|3560959|FG000|Overall Study|Disease progression|7
1995247|NCT00089791|3560960|FG001|Overall Study|Disease progression|3
1995248|NCT00089791|3560959|FG000|Overall Study|Ineligibility determined|12
1995249|NCT00089791|3560960|FG001|Overall Study|Ineligibility determined|9
1995250|NCT00089791|3560959|FG000|Overall Study|Lost to Follow-up|57
1995251|NCT00089791|3560960|FG001|Overall Study|Lost to Follow-up|57
1995252|NCT00089791|3560959|FG000|Overall Study|Noncompliance|17
1995253|NCT00089791|3560960|FG001|Overall Study|Noncompliance|13
1995254|NCT00089791|3560959|FG000|Overall Study|Other|20
1995255|NCT00089791|3560960|FG001|Overall Study|Other|32
1995256|NCT00089791|3560959|FG000|Overall Study|Protocol deviation|12
1995257|NCT00089791|3560960|FG001|Overall Study|Protocol deviation|10
1995258|NCT00089791|3560959|FG000|Overall Study|Requirement for alternative therapy|7
1995259|NCT00089791|3560960|FG001|Overall Study|Requirement for alternative therapy|4
1995260|NCT00089843|3560970|FG000|Overall Study|Withdrawal by Subject|1
1995261|NCT00089843|3560971|FG001|Overall Study|Withdrawal by Subject|4
1995262|NCT00089843|3560972|FG002|Overall Study|Withdrawal by Subject|5
1995263|NCT00089843|3560973|FG003|Overall Study|Withdrawal by Subject|6
1995264|NCT00089843|3560970|FG000|Overall Study|Physician Decision|1
1995265|NCT00089843|3560971|FG001|Overall Study|Physician Decision|0
1995266|NCT00089843|3560972|FG002|Overall Study|Physician Decision|0
1995267|NCT00089843|3560973|FG003|Overall Study|Physician Decision|1
1995268|NCT00089973|3560983|FG000|Overall Study|Adverse Event|3
1995269|NCT00089973|3560983|FG000|Overall Study|Withdrawal by Subject|1
1995270|NCT00089973|3560983|FG000|Overall Study|Disease progression|45
1995271|NCT00089973|3560983|FG000|Overall Study|Death|1
1995272|NCT00089986|3560990|FG000|Overall Study|Adverse Event|6
1995273|NCT00089986|3560991|FG001|Overall Study|Adverse Event|9
1995274|NCT00089986|3560992|FG002|Overall Study|Adverse Event|6
1995275|NCT00089986|3560990|FG000|Overall Study|Lost to Follow-up|3
1995276|NCT00089986|3560991|FG001|Overall Study|Lost to Follow-up|1
1995277|NCT00089986|3560992|FG002|Overall Study|Lost to Follow-up|1
1995278|NCT00089986|3560990|FG000|Overall Study|Protocol Violation|0
1995279|NCT00089986|3560991|FG001|Overall Study|Protocol Violation|1
1995280|NCT00089986|3560992|FG002|Overall Study|Protocol Violation|0
1995281|NCT00089986|3560990|FG000|Overall Study|Patient transferred to another hospital|2
1995282|NCT00089986|3560991|FG001|Overall Study|Patient transferred to another hospital|1
1995283|NCT00089986|3560992|FG002|Overall Study|Patient transferred to another hospital|0
1995284|NCT00089986|3560990|FG000|Overall Study|Subject withdrew but agreed follow up|1
1995285|NCT00089986|3560991|FG001|Overall Study|Subject withdrew but agreed follow up|2
1995286|NCT00089986|3560992|FG002|Overall Study|Subject withdrew but agreed follow up|0
1995287|NCT00089986|3560990|FG000|Overall Study|Hemohlobin stopping rule|0
1995288|NCT00089986|3560991|FG001|Overall Study|Hemohlobin stopping rule|1
1995289|NCT00089986|3560992|FG002|Overall Study|Hemohlobin stopping rule|0
1995290|NCT00089986|3560990|FG000|Overall Study|Investigator decision to withdrew|0
1995291|NCT00089986|3560991|FG001|Overall Study|Investigator decision to withdrew|1
1995292|NCT00089986|3560992|FG002|Overall Study|Investigator decision to withdrew|0
1995293|NCT00089986|3560990|FG000|Overall Study|Enrollment in another study|0
1995294|NCT00089986|3560991|FG001|Overall Study|Enrollment in another study|1
1995295|NCT00089986|3560992|FG002|Overall Study|Enrollment in another study|0
1995296|NCT00089986|3560990|FG000|Overall Study|Family decision|0
1995297|NCT00089986|3560991|FG001|Overall Study|Family decision|1
1995298|NCT00089986|3560992|FG002|Overall Study|Family decision|0
1995299|NCT00089986|3560990|FG000|Overall Study|Do not resuscitate (DNR)|0
1995300|NCT00089986|3560991|FG001|Overall Study|Do not resuscitate (DNR)|0
1995301|NCT00089986|3560992|FG002|Overall Study|Do not resuscitate (DNR)|1
1995302|NCT00089986|3560990|FG000|Overall Study|Withdrawal by Subject|3
1995303|NCT00089986|3560991|FG001|Overall Study|Withdrawal by Subject|6
1995304|NCT00089986|3560992|FG002|Overall Study|Withdrawal by Subject|2
1995305|NCT00089999|3561002|FG000|Overall Study|Adverse Event|4
1995306|NCT00089999|3561003|FG001|Overall Study|Adverse Event|7
1995307|NCT00089999|3561002|FG000|Overall Study|Withdrawal by Subject|0
1995308|NCT00089999|3561003|FG001|Overall Study|Withdrawal by Subject|4
1995309|NCT00089999|3561002|FG000|Overall Study|Lost to Follow-up|2
1995310|NCT00089999|3561003|FG001|Overall Study|Lost to Follow-up|1
1995311|NCT00089999|3561002|FG000|Overall Study|Radiological Progression of Cancer|52
1995312|NCT00089999|3561003|FG001|Overall Study|Radiological Progression of Cancer|44
1995313|NCT00089999|3561002|FG000|Overall Study|Symptomatic Progression of Cancer|2
1995314|NCT00089999|3561003|FG001|Overall Study|Symptomatic Progression of Cancer|5
1995315|NCT00089999|3561002|FG000|Overall Study|Death|3
1995316|NCT00089999|3561003|FG001|Overall Study|Death|3
1995317|NCT00089999|3561002|FG000|Overall Study|Poor General Condition|1
1995318|NCT00089999|3561003|FG001|Overall Study|Poor General Condition|0
1995319|NCT00089999|3561002|FG000|Overall Study|Clinical Progression|1
1995320|NCT00089999|3561003|FG001|Overall Study|Clinical Progression|2
1995321|NCT00089999|3561002|FG000|Overall Study|Physician Decision|2
1995322|NCT00089999|3561003|FG001|Overall Study|Physician Decision|2
1995323|NCT00089999|3561002|FG000|Overall Study|Patient Underwent Surgery|2
1995324|NCT00089999|3561003|FG001|Overall Study|Patient Underwent Surgery|0
1995325|NCT00089999|3561002|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0
1995326|NCT00089999|3561003|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1
1995327|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211
1995328|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185
1995329|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210
1995330|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
1995331|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
1995332|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
1995333|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
1995334|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
1995335|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
1995336|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29
1995337|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29
1995338|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34
1995339|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
1995340|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
1995341|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
1995342|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7
1995343|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2
1995344|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8
1995345|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
1995346|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
1995347|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
1995348|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
1995349|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
1995350|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
1995351|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
1995352|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
1995353|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
1995354|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
1995355|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
1995356|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
1995357|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
1995358|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
1995359|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
1995360|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
1995361|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
1995362|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
1995363|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2
1995364|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0
1995365|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0
1995366|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
1995367|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
1995368|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
1995369|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1
1995370|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0
1995371|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0
1995372|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1
1995373|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0
1995374|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0
1995375|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
1995376|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
1995377|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
1995378|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1
1995379|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0
1995380|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0
1995381|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1
1995382|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0
1995383|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0
1995384|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
1995385|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
1995386|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
1995387|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0
1995388|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1
1995389|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0
1995390|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
1995391|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
1995392|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
1995393|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
1995394|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
1995395|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
1995396|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
1995397|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
1995398|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
1995399|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0
1995400|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1
1995401|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0
1995402|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
1995403|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
1995404|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
1995405|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
1995406|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
1995407|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
1995408|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0
1995409|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1
1995410|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3
1995411|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0
1995412|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0
1995413|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2
1995414|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
1995415|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
1995416|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
1995417|NCT00090103|3561034|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
1995418|NCT00090103|3561035|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
1995419|NCT00090103|3561036|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
1995420|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Adverse Event|34
1995421|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Adverse Event|39
1995422|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Adverse Event|44
1995423|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185
1995424|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212
1995425|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229
1995426|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101
1995427|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97
1995428|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111
1995429|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Protocol Violation|18
1995430|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Protocol Violation|18
1995431|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Protocol Violation|17
1995432|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
1995433|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
1995434|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
1995435|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
1995436|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
1995437|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
1995438|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Loss of Contact|4
1995439|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Loss of Contact|0
1995440|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Loss of Contact|2
1995441|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
1995442|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
1995443|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
1995444|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Participant relocated|2
1995445|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Participant relocated|3
1995446|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Participant relocated|1
1995447|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
1995448|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
1995449|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
1995450|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2
1995451|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3
1995452|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5
1995453|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1
1995454|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0
1995455|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1
1995456|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
1995457|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
1995458|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
1995459|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Loss of Libido|1
1995460|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Loss of Libido|0
1995461|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Loss of Libido|0
1995462|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Enrollment Error|1
1995463|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Enrollment Error|0
1995464|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Enrollment Error|2
1995465|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
1995466|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
1995467|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
1995468|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Death|1
1995469|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Death|0
1995470|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Death|1
1995471|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Gyneomastia|1
1995472|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Gyneomastia|0
1995473|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Gyneomastia|0
1995474|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
1995475|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
1995476|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
1995477|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
1995478|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
1995479|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
1995480|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0
1995481|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1
1995482|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0
1995483|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Back Pain|0
1995484|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Back Pain|1
1995485|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Back Pain|0
1995486|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0
1995487|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2
1995488|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4
1995489|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
1995490|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
1995491|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
1995492|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Depression|0
1995493|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Depression|1
1995494|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Depression|0
1995495|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
1995496|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
1995497|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
1995498|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Jailed|0
1995499|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Jailed|1
1995500|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Jailed|0
1995501|NCT00090103|3561034|FG000|16-Week Safety Follow-up Period|Other|0
1995502|NCT00090103|3561035|FG001|16-Week Safety Follow-up Period|Other|1
1995503|NCT00090103|3561036|FG002|16-Week Safety Follow-up Period|Other|0
1995504|NCT00090220|3561046|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1
1995505|NCT00090220|3561047|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1
1995506|NCT00090220|3561048|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
1995507|NCT00090220|3561049|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
1995508|NCT00090220|3561050|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
1995509|NCT00090220|3561051|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0
1995510|NCT00090220|3561046|FG000|Base Study Vaccination Period|Adverse Event|6
1995511|NCT00090220|3561047|FG001|Base Study Vaccination Period|Adverse Event|1
1995512|NCT00090220|3561048|FG002|Base Study Vaccination Period|Adverse Event|0
1995513|NCT00090220|3561049|FG003|Base Study Vaccination Period|Adverse Event|0
1995514|NCT00090220|3561050|FG004|Base Study Vaccination Period|Adverse Event|0
1995515|NCT00090220|3561051|FG005|Base Study Vaccination Period|Adverse Event|0
1995516|NCT00090220|3561046|FG000|Base Study Vaccination Period|Lost to Follow-up|24
1995517|NCT00090220|3561047|FG001|Base Study Vaccination Period|Lost to Follow-up|28
1995518|NCT00090220|3561048|FG002|Base Study Vaccination Period|Lost to Follow-up|0
1995519|NCT00090220|3561049|FG003|Base Study Vaccination Period|Lost to Follow-up|0
1995520|NCT00090220|3561050|FG004|Base Study Vaccination Period|Lost to Follow-up|0
1995521|NCT00090220|3561051|FG005|Base Study Vaccination Period|Lost to Follow-up|0
1995522|NCT00090220|3561046|FG000|Base Study Vaccination Period|Withdrawal by Subject|23
1995523|NCT00090220|3561047|FG001|Base Study Vaccination Period|Withdrawal by Subject|27
1995524|NCT00090220|3561048|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
1995525|NCT00090220|3561049|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
1995526|NCT00090220|3561050|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
1995527|NCT00090220|3561051|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
1995528|NCT00090220|3561046|FG000|Base Study Vaccination Period|Patient Moved|6
1995529|NCT00090220|3561047|FG001|Base Study Vaccination Period|Patient Moved|2
1995530|NCT00090220|3561048|FG002|Base Study Vaccination Period|Patient Moved|0
1995531|NCT00090220|3561049|FG003|Base Study Vaccination Period|Patient Moved|0
1995532|NCT00090220|3561050|FG004|Base Study Vaccination Period|Patient Moved|0
1995533|NCT00090220|3561051|FG005|Base Study Vaccination Period|Patient Moved|0
1995534|NCT00090220|3561046|FG000|Base Study Vaccination Period|Other|4
1995535|NCT00090220|3561047|FG001|Base Study Vaccination Period|Other|4
1995536|NCT00090220|3561048|FG002|Base Study Vaccination Period|Other|0
1995537|NCT00090220|3561049|FG003|Base Study Vaccination Period|Other|0
1995538|NCT00090220|3561050|FG004|Base Study Vaccination Period|Other|0
1995539|NCT00090220|3561051|FG005|Base Study Vaccination Period|Other|0
1995540|NCT00090220|3561046|FG000|Base Study Follow-up Period|Adverse Event|6
1995541|NCT00090220|3561047|FG001|Base Study Follow-up Period|Adverse Event|1
1995542|NCT00090220|3561048|FG002|Base Study Follow-up Period|Adverse Event|0
1995543|NCT00090220|3561049|FG003|Base Study Follow-up Period|Adverse Event|0
1995544|NCT00090220|3561050|FG004|Base Study Follow-up Period|Adverse Event|0
1995545|NCT00090220|3561051|FG005|Base Study Follow-up Period|Adverse Event|0
1995546|NCT00090220|3561046|FG000|Base Study Follow-up Period|Lost to Follow-up|88
1995547|NCT00090220|3561047|FG001|Base Study Follow-up Period|Lost to Follow-up|78
1995548|NCT00090220|3561048|FG002|Base Study Follow-up Period|Lost to Follow-up|0
1995549|NCT00090220|3561049|FG003|Base Study Follow-up Period|Lost to Follow-up|0
1995550|NCT00090220|3561050|FG004|Base Study Follow-up Period|Lost to Follow-up|0
1995551|NCT00090220|3561051|FG005|Base Study Follow-up Period|Lost to Follow-up|0
1995552|NCT00090220|3561046|FG000|Base Study Follow-up Period|Withdrawal by Subject|27
1995553|NCT00090220|3561047|FG001|Base Study Follow-up Period|Withdrawal by Subject|36
1995554|NCT00090220|3561048|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
1995555|NCT00090220|3561049|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
1995556|NCT00090220|3561050|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
1995557|NCT00090220|3561051|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
1995558|NCT00090220|3561046|FG000|Base Study Follow-up Period|Patient Moved|20
1995559|NCT00090220|3561047|FG001|Base Study Follow-up Period|Patient Moved|28
1995560|NCT00090220|3561048|FG002|Base Study Follow-up Period|Patient Moved|0
1995561|NCT00090220|3561049|FG003|Base Study Follow-up Period|Patient Moved|0
1995562|NCT00090220|3561050|FG004|Base Study Follow-up Period|Patient Moved|0
1995563|NCT00090220|3561051|FG005|Base Study Follow-up Period|Patient Moved|0
1995564|NCT00090220|3561046|FG000|Base Study Follow-up Period|Other|19
1995565|NCT00090220|3561047|FG001|Base Study Follow-up Period|Other|21
1995566|NCT00090220|3561048|FG002|Base Study Follow-up Period|Other|0
1995567|NCT00090220|3561049|FG003|Base Study Follow-up Period|Other|0
1995568|NCT00090220|3561050|FG004|Base Study Follow-up Period|Other|0
1995569|NCT00090220|3561051|FG005|Base Study Follow-up Period|Other|0
1995570|NCT00090220|3561046|FG000|Extension 1 (EXT1)|Adverse Event|0
1995571|NCT00090220|3561047|FG001|Extension 1 (EXT1)|Adverse Event|0
1995572|NCT00090220|3561048|FG002|Extension 1 (EXT1)|Adverse Event|4
1995573|NCT00090220|3561049|FG003|Extension 1 (EXT1)|Adverse Event|0
1995574|NCT00090220|3561050|FG004|Extension 1 (EXT1)|Adverse Event|0
1995575|NCT00090220|3561051|FG005|Extension 1 (EXT1)|Adverse Event|0
1995576|NCT00090220|3561046|FG000|Extension 1 (EXT1)|Lost to Follow-up|0
1995577|NCT00090220|3561047|FG001|Extension 1 (EXT1)|Lost to Follow-up|0
2213686|NCT01682148|3855638|FG001|Overall Study|Withdrawal by Subject|0
2213687|NCT01682148|3855637|FG000|Overall Study|Lost to Follow-up|1
2213688|NCT01682148|3855638|FG001|Overall Study|Lost to Follow-up|2
2213689|NCT01682148|3855637|FG000|Overall Study|Protocol Violation|1
2213690|NCT01682148|3855638|FG001|Overall Study|Protocol Violation|1
2213691|NCT01682213|3855649|FG000|Overall Study|Withdrawal by Subject|2
1995578|NCT00090220|3561048|FG002|Extension 1 (EXT1)|Lost to Follow-up|22
1995579|NCT00090220|3561049|FG003|Extension 1 (EXT1)|Lost to Follow-up|0
1995580|NCT00090220|3561050|FG004|Extension 1 (EXT1)|Lost to Follow-up|0
1995581|NCT00090220|3561051|FG005|Extension 1 (EXT1)|Lost to Follow-up|0
1995582|NCT00090220|3561046|FG000|Extension 1 (EXT1)|Moved|0
1995583|NCT00090220|3561047|FG001|Extension 1 (EXT1)|Moved|0
1995584|NCT00090220|3561048|FG002|Extension 1 (EXT1)|Moved|2
1995585|NCT00090220|3561049|FG003|Extension 1 (EXT1)|Moved|1
1995586|NCT00090220|3561050|FG004|Extension 1 (EXT1)|Moved|0
1995587|NCT00090220|3561051|FG005|Extension 1 (EXT1)|Moved|0
1995588|NCT00090220|3561046|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0
1995589|NCT00090220|3561047|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0
1995590|NCT00090220|3561048|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25
1995591|NCT00090220|3561049|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0
1995592|NCT00090220|3561050|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0
1995593|NCT00090220|3561051|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0
1995594|NCT00090220|3561046|FG000|Extension 1 (EXT1)|Protocol Violation|0
1995595|NCT00090220|3561047|FG001|Extension 1 (EXT1)|Protocol Violation|0
1995596|NCT00090220|3561048|FG002|Extension 1 (EXT1)|Protocol Violation|0
1995597|NCT00090220|3561049|FG003|Extension 1 (EXT1)|Protocol Violation|1
1995598|NCT00090220|3561050|FG004|Extension 1 (EXT1)|Protocol Violation|0
1995599|NCT00090220|3561051|FG005|Extension 1 (EXT1)|Protocol Violation|0
1995600|NCT00090220|3561046|FG000|Extension 1 (EXT1)|Other reason|0
1995601|NCT00090220|3561047|FG001|Extension 1 (EXT1)|Other reason|0
1995602|NCT00090220|3561048|FG002|Extension 1 (EXT1)|Other reason|2
1995603|NCT00090220|3561049|FG003|Extension 1 (EXT1)|Other reason|0
1995604|NCT00090220|3561050|FG004|Extension 1 (EXT1)|Other reason|0
1995605|NCT00090220|3561051|FG005|Extension 1 (EXT1)|Other reason|0
1995606|NCT00090220|3561046|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1995607|NCT00090220|3561047|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1995608|NCT00090220|3561048|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1995609|NCT00090220|3561049|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1995610|NCT00090220|3561050|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38
1995611|NCT00090220|3561051|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23
1995612|NCT00090220|3561046|FG000|Long-term Follow-up (EXT2)|Death|0
1995613|NCT00090220|3561047|FG001|Long-term Follow-up (EXT2)|Death|0
1995614|NCT00090220|3561048|FG002|Long-term Follow-up (EXT2)|Death|0
1995615|NCT00090220|3561049|FG003|Long-term Follow-up (EXT2)|Death|0
1995616|NCT00090220|3561050|FG004|Long-term Follow-up (EXT2)|Death|1
1995617|NCT00090220|3561051|FG005|Long-term Follow-up (EXT2)|Death|1
1995618|NCT00090220|3561046|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1995619|NCT00090220|3561047|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1995620|NCT00090220|3561048|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1995621|NCT00090220|3561049|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1995622|NCT00090220|3561050|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
1995623|NCT00090220|3561051|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
1995624|NCT00090220|3561046|FG000|Long-term Follow-up (EXT2)|Other|0
1995625|NCT00090220|3561047|FG001|Long-term Follow-up (EXT2)|Other|0
1995626|NCT00090220|3561048|FG002|Long-term Follow-up (EXT2)|Other|0
1995627|NCT00090220|3561049|FG003|Long-term Follow-up (EXT2)|Other|0
1995628|NCT00090220|3561050|FG004|Long-term Follow-up (EXT2)|Other|1
1995629|NCT00090220|3561051|FG005|Long-term Follow-up (EXT2)|Other|0
1995630|NCT00090233|3561070|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609
1995631|NCT00090233|3561071|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627
1995632|NCT00090233|3561070|FG000|Overall Study|Adverse Event|214
1995633|NCT00090233|3561071|FG001|Overall Study|Adverse Event|198
1995634|NCT00090233|3561070|FG000|Overall Study|Lost to Follow-up|68
1995635|NCT00090233|3561071|FG001|Overall Study|Lost to Follow-up|95
1995636|NCT00090233|3561070|FG000|Overall Study|Protocol Violation|960
1995637|NCT00090233|3561071|FG001|Overall Study|Protocol Violation|1022
1995638|NCT00090233|3561070|FG000|Overall Study|Withdrawal by Subject|182
1995639|NCT00090233|3561071|FG001|Overall Study|Withdrawal by Subject|211
1995640|NCT00090233|3561070|FG000|Overall Study|Moved|203
1995641|NCT00090233|3561071|FG001|Overall Study|Moved|189
1995642|NCT00090233|3561070|FG000|Overall Study|Other|1211
1995643|NCT00090233|3561071|FG001|Overall Study|Other|1160
1995644|NCT00090233|3561070|FG000|Overall Study|Data not available at data cut-off point|1552
1995645|NCT00090233|3561071|FG001|Overall Study|Data not available at data cut-off point|1563
1995646|NCT00090285|3561083|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7
1995647|NCT00090285|3561084|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3
1995648|NCT00090285|3561085|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
1995649|NCT00090285|3561086|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0
1995650|NCT00090285|3561087|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
1995651|NCT00090285|3561088|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0
1995652|NCT00090285|3561083|FG000|Base Study Vaccination Period|Adverse Event|2
1995653|NCT00090285|3561084|FG001|Base Study Vaccination Period|Adverse Event|4
1995654|NCT00090285|3561085|FG002|Base Study Vaccination Period|Adverse Event|0
1995655|NCT00090285|3561086|FG003|Base Study Vaccination Period|Adverse Event|0
1995656|NCT00090285|3561087|FG004|Base Study Vaccination Period|Adverse Event|0
1995657|NCT00090285|3561088|FG005|Base Study Vaccination Period|Adverse Event|0
1995658|NCT00090285|3561083|FG000|Base Study Vaccination Period|Lost to Follow-up|111
1995659|NCT00090285|3561084|FG001|Base Study Vaccination Period|Lost to Follow-up|112
1995660|NCT00090285|3561085|FG002|Base Study Vaccination Period|Lost to Follow-up|0
1995661|NCT00090285|3561086|FG003|Base Study Vaccination Period|Lost to Follow-up|0
1995662|NCT00090285|3561087|FG004|Base Study Vaccination Period|Lost to Follow-up|0
1995663|NCT00090285|3561088|FG005|Base Study Vaccination Period|Lost to Follow-up|0
1995664|NCT00090285|3561083|FG000|Base Study Vaccination Period|Protocol Violation|2
1995665|NCT00090285|3561084|FG001|Base Study Vaccination Period|Protocol Violation|3
1995666|NCT00090285|3561085|FG002|Base Study Vaccination Period|Protocol Violation|0
1995667|NCT00090285|3561086|FG003|Base Study Vaccination Period|Protocol Violation|0
1995668|NCT00090285|3561087|FG004|Base Study Vaccination Period|Protocol Violation|0
1995669|NCT00090285|3561088|FG005|Base Study Vaccination Period|Protocol Violation|0
1995670|NCT00090285|3561083|FG000|Base Study Vaccination Period|Withdrawal by Subject|64
1995671|NCT00090285|3561084|FG001|Base Study Vaccination Period|Withdrawal by Subject|69
1995672|NCT00090285|3561085|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
1995673|NCT00090285|3561086|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
1995674|NCT00090285|3561087|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
1995675|NCT00090285|3561088|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
1995676|NCT00090285|3561083|FG000|Base Study Vaccination Period|Uncooperative|2
1995677|NCT00090285|3561084|FG001|Base Study Vaccination Period|Uncooperative|2
1995678|NCT00090285|3561085|FG002|Base Study Vaccination Period|Uncooperative|0
1995679|NCT00090285|3561086|FG003|Base Study Vaccination Period|Uncooperative|0
1995680|NCT00090285|3561087|FG004|Base Study Vaccination Period|Uncooperative|0
1995681|NCT00090285|3561088|FG005|Base Study Vaccination Period|Uncooperative|0
1995682|NCT00090285|3561083|FG000|Base Study Vaccination Period|Moved|20
1995683|NCT00090285|3561084|FG001|Base Study Vaccination Period|Moved|21
1995684|NCT00090285|3561085|FG002|Base Study Vaccination Period|Moved|0
1995685|NCT00090285|3561086|FG003|Base Study Vaccination Period|Moved|0
1995686|NCT00090285|3561087|FG004|Base Study Vaccination Period|Moved|0
1995687|NCT00090285|3561088|FG005|Base Study Vaccination Period|Moved|0
1995688|NCT00090285|3561083|FG000|Base Study Vaccination Period|Site Terminated|1
1995689|NCT00090285|3561084|FG001|Base Study Vaccination Period|Site Terminated|0
1995690|NCT00090285|3561085|FG002|Base Study Vaccination Period|Site Terminated|0
1995691|NCT00090285|3561086|FG003|Base Study Vaccination Period|Site Terminated|0
1995692|NCT00090285|3561087|FG004|Base Study Vaccination Period|Site Terminated|0
1995693|NCT00090285|3561088|FG005|Base Study Vaccination Period|Site Terminated|0
1995694|NCT00090285|3561083|FG000|Base Study Vaccination Period|Other|2
1995695|NCT00090285|3561084|FG001|Base Study Vaccination Period|Other|2
1995696|NCT00090285|3561085|FG002|Base Study Vaccination Period|Other|0
1995697|NCT00090285|3561086|FG003|Base Study Vaccination Period|Other|0
1995698|NCT00090285|3561087|FG004|Base Study Vaccination Period|Other|0
1995699|NCT00090285|3561088|FG005|Base Study Vaccination Period|Other|0
1995700|NCT00090285|3561083|FG000|Base Study Vaccination Period|Subject Incarcerated|2
1995701|NCT00090285|3561084|FG001|Base Study Vaccination Period|Subject Incarcerated|2
1995702|NCT00090285|3561085|FG002|Base Study Vaccination Period|Subject Incarcerated|0
1995703|NCT00090285|3561086|FG003|Base Study Vaccination Period|Subject Incarcerated|0
1995704|NCT00090285|3561087|FG004|Base Study Vaccination Period|Subject Incarcerated|0
1995705|NCT00090285|3561088|FG005|Base Study Vaccination Period|Subject Incarcerated|0
1995706|NCT00090285|3561083|FG000|Base Study Vaccination Period|HIV positive|1
1995707|NCT00090285|3561084|FG001|Base Study Vaccination Period|HIV positive|1
1995708|NCT00090285|3561085|FG002|Base Study Vaccination Period|HIV positive|0
1995709|NCT00090285|3561086|FG003|Base Study Vaccination Period|HIV positive|0
1995710|NCT00090285|3561087|FG004|Base Study Vaccination Period|HIV positive|0
1995711|NCT00090285|3561088|FG005|Base Study Vaccination Period|HIV positive|0
1995712|NCT00090285|3561083|FG000|Base Study Follow-up Period|Adverse Event|3
1995713|NCT00090285|3561084|FG001|Base Study Follow-up Period|Adverse Event|10
1995714|NCT00090285|3561085|FG002|Base Study Follow-up Period|Adverse Event|0
1995715|NCT00090285|3561086|FG003|Base Study Follow-up Period|Adverse Event|0
1995716|NCT00090285|3561087|FG004|Base Study Follow-up Period|Adverse Event|0
1995717|NCT00090285|3561088|FG005|Base Study Follow-up Period|Adverse Event|0
1995718|NCT00090285|3561083|FG000|Base Study Follow-up Period|Lost to Follow-up|232
1995719|NCT00090285|3561084|FG001|Base Study Follow-up Period|Lost to Follow-up|226
1995720|NCT00090285|3561085|FG002|Base Study Follow-up Period|Lost to Follow-up|0
1995721|NCT00090285|3561086|FG003|Base Study Follow-up Period|Lost to Follow-up|0
1995722|NCT00090285|3561087|FG004|Base Study Follow-up Period|Lost to Follow-up|0
1995723|NCT00090285|3561088|FG005|Base Study Follow-up Period|Lost to Follow-up|0
1995724|NCT00090285|3561083|FG000|Base Study Follow-up Period|Withdrawal by Subject|53
1995725|NCT00090285|3561084|FG001|Base Study Follow-up Period|Withdrawal by Subject|64
1995726|NCT00090285|3561085|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
1995727|NCT00090285|3561086|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
1995728|NCT00090285|3561087|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
1995729|NCT00090285|3561088|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
1995730|NCT00090285|3561083|FG000|Base Study Follow-up Period|Moved|41
1995731|NCT00090285|3561084|FG001|Base Study Follow-up Period|Moved|36
1995732|NCT00090285|3561085|FG002|Base Study Follow-up Period|Moved|0
2108218|NCT00878722|3702055|FG006|Overall Study|Relapse|0
1995733|NCT00090285|3561086|FG003|Base Study Follow-up Period|Moved|0
1995734|NCT00090285|3561087|FG004|Base Study Follow-up Period|Moved|0
1995735|NCT00090285|3561088|FG005|Base Study Follow-up Period|Moved|0
1995736|NCT00090285|3561083|FG000|Base Study Follow-up Period|Other|2
1995737|NCT00090285|3561084|FG001|Base Study Follow-up Period|Other|0
1995738|NCT00090285|3561085|FG002|Base Study Follow-up Period|Other|0
1995739|NCT00090285|3561086|FG003|Base Study Follow-up Period|Other|0
1995740|NCT00090285|3561087|FG004|Base Study Follow-up Period|Other|0
1995741|NCT00090285|3561088|FG005|Base Study Follow-up Period|Other|0
1995742|NCT00090285|3561083|FG000|Base Study Follow-up Period|Protocol Violation|1
1995743|NCT00090285|3561084|FG001|Base Study Follow-up Period|Protocol Violation|0
1995744|NCT00090285|3561085|FG002|Base Study Follow-up Period|Protocol Violation|0
1995745|NCT00090285|3561086|FG003|Base Study Follow-up Period|Protocol Violation|0
1995746|NCT00090285|3561087|FG004|Base Study Follow-up Period|Protocol Violation|0
1995747|NCT00090285|3561088|FG005|Base Study Follow-up Period|Protocol Violation|0
1995748|NCT00090285|3561083|FG000|Base Study Follow-up Period|Uncooperative|3
1995749|NCT00090285|3561084|FG001|Base Study Follow-up Period|Uncooperative|4
1995750|NCT00090285|3561085|FG002|Base Study Follow-up Period|Uncooperative|0
1995751|NCT00090285|3561086|FG003|Base Study Follow-up Period|Uncooperative|0
1995752|NCT00090285|3561087|FG004|Base Study Follow-up Period|Uncooperative|0
1995753|NCT00090285|3561088|FG005|Base Study Follow-up Period|Uncooperative|0
1995754|NCT00090285|3561083|FG000|Base Study Follow-up Period|Subject Incarcerated|0
1995755|NCT00090285|3561084|FG001|Base Study Follow-up Period|Subject Incarcerated|2
1995756|NCT00090285|3561085|FG002|Base Study Follow-up Period|Subject Incarcerated|0
1995757|NCT00090285|3561086|FG003|Base Study Follow-up Period|Subject Incarcerated|0
1995758|NCT00090285|3561087|FG004|Base Study Follow-up Period|Subject Incarcerated|0
1995759|NCT00090285|3561088|FG005|Base Study Follow-up Period|Subject Incarcerated|0
1995760|NCT00090285|3561083|FG000|Extension 1|Adverse Event|0
1995761|NCT00090285|3561084|FG001|Extension 1|Adverse Event|0
1995762|NCT00090285|3561085|FG002|Extension 1|Adverse Event|2
1995763|NCT00090285|3561086|FG003|Extension 1|Adverse Event|0
1995764|NCT00090285|3561087|FG004|Extension 1|Adverse Event|0
1995765|NCT00090285|3561088|FG005|Extension 1|Adverse Event|0
1995766|NCT00090285|3561083|FG000|Extension 1|Lost to Follow-up|0
1995767|NCT00090285|3561084|FG001|Extension 1|Lost to Follow-up|0
1995768|NCT00090285|3561085|FG002|Extension 1|Lost to Follow-up|35
1995769|NCT00090285|3561086|FG003|Extension 1|Lost to Follow-up|0
1995770|NCT00090285|3561087|FG004|Extension 1|Lost to Follow-up|0
1995771|NCT00090285|3561088|FG005|Extension 1|Lost to Follow-up|0
1995772|NCT00090285|3561083|FG000|Extension 1|Withdrawal by Subject|0
1995773|NCT00090285|3561084|FG001|Extension 1|Withdrawal by Subject|0
1995774|NCT00090285|3561085|FG002|Extension 1|Withdrawal by Subject|13
1995775|NCT00090285|3561086|FG003|Extension 1|Withdrawal by Subject|1
1995776|NCT00090285|3561087|FG004|Extension 1|Withdrawal by Subject|0
1995777|NCT00090285|3561088|FG005|Extension 1|Withdrawal by Subject|0
1995778|NCT00090285|3561083|FG000|Extension 1|Other|0
1995779|NCT00090285|3561084|FG001|Extension 1|Other|0
1995780|NCT00090285|3561085|FG002|Extension 1|Other|4
1995781|NCT00090285|3561086|FG003|Extension 1|Other|0
1995782|NCT00090285|3561087|FG004|Extension 1|Other|0
1995783|NCT00090285|3561088|FG005|Extension 1|Other|0
1995784|NCT00090285|3561083|FG000|Extension 1|Moved|0
1995785|NCT00090285|3561084|FG001|Extension 1|Moved|0
1995786|NCT00090285|3561085|FG002|Extension 1|Moved|3
1995787|NCT00090285|3561086|FG003|Extension 1|Moved|0
1995788|NCT00090285|3561087|FG004|Extension 1|Moved|0
1995789|NCT00090285|3561088|FG005|Extension 1|Moved|0
1995790|NCT00090285|3561083|FG000|Long-term Follow-up (EXT2)|Adverse Event|0
1995791|NCT00090285|3561084|FG001|Long-term Follow-up (EXT2)|Adverse Event|0
1995792|NCT00090285|3561085|FG002|Long-term Follow-up (EXT2)|Adverse Event|0
1995793|NCT00090285|3561086|FG003|Long-term Follow-up (EXT2)|Adverse Event|0
1995794|NCT00090285|3561087|FG004|Long-term Follow-up (EXT2)|Adverse Event|5
1995795|NCT00090285|3561088|FG005|Long-term Follow-up (EXT2)|Adverse Event|2
1995796|NCT00090285|3561083|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1995797|NCT00090285|3561084|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1995798|NCT00090285|3561085|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1995799|NCT00090285|3561086|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1995800|NCT00090285|3561087|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156
1995801|NCT00090285|3561088|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143
1995802|NCT00090285|3561083|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1995803|NCT00090285|3561084|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1995804|NCT00090285|3561085|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1995805|NCT00090285|3561086|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
2213692|NCT01682460|3855654|FG000|Overall Study|Withdrawal by Subject|2
2213693|NCT01682460|3855654|FG000|Overall Study|Did not meet inclusion criteria|2
1995806|NCT00090285|3561087|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
1995807|NCT00090285|3561088|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
1995808|NCT00090285|3561083|FG000|Long-term Follow-up (EXT2)|Physician Decision|0
1995809|NCT00090285|3561084|FG001|Long-term Follow-up (EXT2)|Physician Decision|0
1995810|NCT00090285|3561085|FG002|Long-term Follow-up (EXT2)|Physician Decision|0
1995811|NCT00090285|3561086|FG003|Long-term Follow-up (EXT2)|Physician Decision|0
1995812|NCT00090285|3561087|FG004|Long-term Follow-up (EXT2)|Physician Decision|6
1995813|NCT00090285|3561088|FG005|Long-term Follow-up (EXT2)|Physician Decision|5
1995814|NCT00090363|3561106|FG000|Overall Study|Lost to Follow-up|1
1995815|NCT00090363|3561107|FG001|Overall Study|Lost to Follow-up|2
1995816|NCT00090363|3561108|FG002|Overall Study|Lost to Follow-up|1
1995817|NCT00090363|3561106|FG000|Overall Study|Withdrawal by Subject|7
1995818|NCT00090363|3561107|FG001|Overall Study|Withdrawal by Subject|7
1995819|NCT00090363|3561108|FG002|Overall Study|Withdrawal by Subject|6
1995820|NCT00090363|3561106|FG000|Overall Study|Study-specific discontinuation criteria|75
1995821|NCT00090363|3561107|FG001|Overall Study|Study-specific discontinuation criteria|74
1995822|NCT00090363|3561108|FG002|Overall Study|Study-specific discontinuation criteria|62
1995823|NCT00090363|3561106|FG000|Overall Study|Eligibility criteria not fulfilled|0
1995824|NCT00090363|3561107|FG001|Overall Study|Eligibility criteria not fulfilled|0
1995825|NCT00090363|3561108|FG002|Overall Study|Eligibility criteria not fulfilled|1
1995826|NCT00090363|3561106|FG000|Overall Study|Consent expired|7
1995827|NCT00090363|3561107|FG001|Overall Study|Consent expired|10
1995828|NCT00090363|3561108|FG002|Overall Study|Consent expired|9
1995829|NCT00090363|3561106|FG000|Overall Study|Reasons not specified|2
1995830|NCT00090363|3561107|FG001|Overall Study|Reasons not specified|1
1995831|NCT00090363|3561108|FG002|Overall Study|Reasons not specified|1
1995832|NCT00090363|3561106|FG000|Overall Study|Continuing on study off treatment|14
1995833|NCT00090363|3561107|FG001|Overall Study|Continuing on study off treatment|13
1995834|NCT00090363|3561108|FG002|Overall Study|Continuing on study off treatment|16
2024706|NCT00337077|3593365|FG001|Overall Study|Alternative therapy|0
2024707|NCT00337077|3593366|FG002|Overall Study|Alternative therapy|0
2024708|NCT00337077|3593364|FG000|Overall Study|Physician Decision|1
2024709|NCT00337077|3593365|FG001|Overall Study|Physician Decision|4
2024710|NCT00337077|3593366|FG002|Overall Study|Physician Decision|2
2024711|NCT00337077|3593364|FG000|Overall Study|Never started treatment|1
2024712|NCT00337077|3593365|FG001|Overall Study|Never started treatment|1
2024713|NCT00337077|3593366|FG002|Overall Study|Never started treatment|0
2024714|NCT00337077|3593364|FG000|Overall Study|Ineligible|1
2024715|NCT00337077|3593365|FG001|Overall Study|Ineligible|1
2024716|NCT00337077|3593366|FG002|Overall Study|Ineligible|1
2024717|NCT00337103|3593374|FG000|Overall Study|Progressive Disease|414
2024718|NCT00337103|3593375|FG001|Overall Study|Progressive Disease|410
2024719|NCT00337103|3593374|FG000|Overall Study|Adverse Event|45
2024720|NCT00337103|3593375|FG001|Overall Study|Adverse Event|59
2024721|NCT00337103|3593374|FG000|Overall Study|Subject Choice|34
2024722|NCT00337103|3593375|FG001|Overall Study|Subject Choice|27
2024723|NCT00337103|3593374|FG000|Overall Study|Clinical Progression|27
2024724|NCT00337103|3593375|FG001|Overall Study|Clinical Progression|24
2024725|NCT00337103|3593374|FG000|Overall Study|Physician Decision|15
2024726|NCT00337103|3593375|FG001|Overall Study|Physician Decision|14
2024727|NCT00337103|3593374|FG000|Overall Study|Withdrawal by Subject|8
2024728|NCT00337103|3593375|FG001|Overall Study|Withdrawal by Subject|5
2024729|NCT00337103|3593374|FG000|Overall Study|Other|5
2024730|NCT00337103|3593375|FG001|Overall Study|Other|6
2024731|NCT00337103|3593374|FG000|Overall Study|Entry Criteria Not Met|4
2024732|NCT00337103|3593375|FG001|Overall Study|Entry Criteria Not Met|1
2024733|NCT00337103|3593374|FG000|Overall Study|Lost to Follow-up|1
2024734|NCT00337103|3593375|FG001|Overall Study|Lost to Follow-up|2
2024735|NCT00337103|3593374|FG000|Overall Study|Death|1
2024736|NCT00337103|3593375|FG001|Overall Study|Death|0
2024737|NCT00337129|3593382|FG000|Overall Study|Adverse Event|4
2024738|NCT00337129|3593382|FG000|Overall Study|Withdrawal by Subject|1
2213694|NCT01682512|3855661|FG000|Overall Study|Adverse Event|6
2213695|NCT01682512|3855662|FG001|Overall Study|Adverse Event|5
2213696|NCT01682512|3855663|FG002|Overall Study|Adverse Event|2
2213697|NCT01682512|3855661|FG000|Overall Study|Withdrawal by Subject|2
2213698|NCT01682512|3855662|FG001|Overall Study|Withdrawal by Subject|6
2213699|NCT01682512|3855663|FG002|Overall Study|Withdrawal by Subject|3
2213700|NCT01682512|3855661|FG000|Overall Study|Physician Decision|0
2213701|NCT01682512|3855662|FG001|Overall Study|Physician Decision|2
2213702|NCT01682512|3855663|FG002|Overall Study|Physician Decision|0
2213703|NCT01682512|3855661|FG000|Overall Study|Study terminated by sponsor|46
2024739|NCT00337129|3593382|FG000|Overall Study|Lack of Efficacy|32
2024740|NCT00337129|3593382|FG000|Overall Study|Death|2
2024741|NCT00337129|3593382|FG000|Overall Study|not protocol specified|1
2024742|NCT00337168|3593386|FG000|Overall Study|Death|5
2024743|NCT00337168|3593386|FG000|Overall Study|Not protocol specified|2
2024744|NCT00337168|3593386|FG000|Overall Study|Did not start therapy|1
2024745|NCT00337194|3593402|FG000|Overall Study|Adverse Event|5
2024746|NCT00337194|3593403|FG001|Overall Study|Adverse Event|1
2024747|NCT00337194|3593402|FG000|Overall Study|Death|2
2024748|NCT00337194|3593403|FG001|Overall Study|Death|0
2024749|NCT00337194|3593402|FG000|Overall Study|Withdrawal by Subject|1
2024750|NCT00337194|3593403|FG001|Overall Study|Withdrawal by Subject|0
2024751|NCT00337194|3593402|FG000|Overall Study|Disease progression|1
2024752|NCT00337194|3593403|FG001|Overall Study|Disease progression|2
2024753|NCT00337194|3593402|FG000|Overall Study|Subsequent non-protocol therapy|3
2024754|NCT00337194|3593403|FG001|Overall Study|Subsequent non-protocol therapy|1
2024755|NCT00337207|3593411|FG000|Overall Study|Withdrawal by Subject|3
2024756|NCT00337272|3593418|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2
2024757|NCT00337272|3593419|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0
2213704|NCT01682512|3855662|FG001|Overall Study|Study terminated by sponsor|43
2213705|NCT01682512|3855663|FG002|Overall Study|Study terminated by sponsor|0
1995835|NCT00090402|3561119|FG000|Overall Study|Death|1
1995836|NCT00090402|3561120|FG001|Overall Study|Death|1
1995837|NCT00090402|3561121|FG002|Overall Study|Death|0
1995838|NCT00090402|3561119|FG000|Overall Study|subject moved|0
1995839|NCT00090402|3561120|FG001|Overall Study|subject moved|1
1995840|NCT00090402|3561121|FG002|Overall Study|subject moved|0
1995841|NCT00090402|3561119|FG000|Overall Study|stopped taking study medication|1
1995842|NCT00090402|3561120|FG001|Overall Study|stopped taking study medication|0
1995843|NCT00090402|3561121|FG002|Overall Study|stopped taking study medication|1
1995844|NCT00090493|3561132|FG000|Overall Study|Physician Decision|2
1995845|NCT00090519|3561138|FG000|Overall Study|Adverse Event|5
1995846|NCT00090519|3561139|FG001|Overall Study|Adverse Event|4
1995847|NCT00090519|3561138|FG000|Overall Study|Death|9
1995848|NCT00090519|3561139|FG001|Overall Study|Death|9
1995849|NCT00090519|3561138|FG000|Overall Study|Lost to Follow-up|26
1995850|NCT00090519|3561139|FG001|Overall Study|Lost to Follow-up|29
1995851|NCT00090519|3561138|FG000|Overall Study|Withdrawal by Subject|28
1995852|NCT00090519|3561139|FG001|Overall Study|Withdrawal by Subject|29
1995853|NCT00090519|3561138|FG000|Overall Study|Physician Decision|2
1995854|NCT00090519|3561139|FG001|Overall Study|Physician Decision|3
1995855|NCT00090519|3561138|FG000|Overall Study|Sponsor Decision|3
1995856|NCT00090519|3561139|FG001|Overall Study|Sponsor Decision|1
1995857|NCT00090545|3561147|FG000|Overall Study|Disease progression on study|21
1995858|NCT00090545|3561148|FG001|Overall Study|Disease progression on study|17
1995859|NCT00090545|3561147|FG000|Overall Study|Refused further treatment|1
1995860|NCT00090545|3561148|FG001|Overall Study|Refused further treatment|4
1995861|NCT00090545|3561147|FG000|Overall Study|Death|0
1995862|NCT00090545|3561148|FG001|Overall Study|Death|1
1995863|NCT00090545|3561147|FG000|Overall Study|Adverse Event|0
1995864|NCT00090545|3561148|FG001|Overall Study|Adverse Event|2
1995865|NCT00090584|3561158|FG000|Baseline to 10 Weeks|Lost to Follow-up|15
1995866|NCT00090584|3561159|FG001|Baseline to 10 Weeks|Lost to Follow-up|12
1995867|NCT00090584|3561158|FG000|Baseline to 8 Months|Lost to Follow-up|44
1995868|NCT00090584|3561159|FG001|Baseline to 8 Months|Lost to Follow-up|41
1995869|NCT00090610|3561175|FG000|Overall Study|Withdrawal by Subject|1
1995870|NCT00090610|3561176|FG001|Overall Study|Withdrawal by Subject|1
1995871|NCT00090753|3561184|FG000|First Treatment Period|Adverse Event|20
1995872|NCT00090753|3561185|FG001|First Treatment Period|Adverse Event|8
1995873|NCT00090753|3561184|FG000|First Treatment Period|Death|88
1995874|NCT00090753|3561185|FG001|First Treatment Period|Death|62
1995875|NCT00090753|3561184|FG000|First Treatment Period|Lack of Efficacy|2
1995876|NCT00090753|3561185|FG001|First Treatment Period|Lack of Efficacy|1
1995877|NCT00090753|3561184|FG000|First Treatment Period|Refused Treatment|32
1995878|NCT00090753|3561185|FG001|First Treatment Period|Refused Treatment|25
1995879|NCT00090753|3561184|FG000|First Treatment Period|Lost to Follow-up|4
1995880|NCT00090753|3561185|FG001|First Treatment Period|Lost to Follow-up|4
1995881|NCT00090753|3561184|FG000|First Treatment Period|Renal Transplant|70
1995882|NCT00090753|3561185|FG001|First Treatment Period|Renal Transplant|50
1995883|NCT00090753|3561184|FG000|First Treatment Period|Mircera Commercialization|1
1995884|NCT00090753|3561185|FG001|First Treatment Period|Mircera Commercialization|0
1995885|NCT00090753|3561184|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39
1995886|NCT00090753|3561185|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28
1995887|NCT00090753|3561184|FG000|Extended Treatment Period|Adverse Event|11
1995888|NCT00090753|3561185|FG001|Extended Treatment Period|Adverse Event|0
1995889|NCT00090753|3561184|FG000|Extended Treatment Period|Death|58
1995890|NCT00090753|3561185|FG001|Extended Treatment Period|Death|30
1995891|NCT00090753|3561184|FG000|Extended Treatment Period|Lack of Efficacy|1
1995892|NCT00090753|3561185|FG001|Extended Treatment Period|Lack of Efficacy|0
1995893|NCT00090753|3561184|FG000|Extended Treatment Period|Refused Treatment|18
1995894|NCT00090753|3561185|FG001|Extended Treatment Period|Refused Treatment|12
1995895|NCT00090753|3561184|FG000|Extended Treatment Period|Lost to Follow-up|3
1995896|NCT00090753|3561185|FG001|Extended Treatment Period|Lost to Follow-up|1
1995897|NCT00090753|3561184|FG000|Extended Treatment Period|Renal Transplant|15
1995898|NCT00090753|3561185|FG001|Extended Treatment Period|Renal Transplant|12
1995899|NCT00090753|3561184|FG000|Extended Treatment Period|Mircera Commercialization|188
1995900|NCT00090753|3561185|FG001|Extended Treatment Period|Mircera Commercialization|93
1995901|NCT00090753|3561184|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
1995902|NCT00090753|3561185|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
1995903|NCT00090766|3561194|FG000|Overall Study|Nephrectomy Planned|0
1995904|NCT00090766|3561195|FG001|Overall Study|Nephrectomy Planned|0
1995905|NCT00090766|3561196|FG002|Overall Study|Nephrectomy Planned|1
1995906|NCT00090766|3561194|FG000|Overall Study|Death|1
1995907|NCT00090766|3561195|FG001|Overall Study|Death|0
1995908|NCT00090766|3561196|FG002|Overall Study|Death|0
1995909|NCT00090766|3561194|FG000|Overall Study|Admin|0
1995910|NCT00090766|3561195|FG001|Overall Study|Admin|2
1995911|NCT00090766|3561196|FG002|Overall Study|Admin|0
1995912|NCT00090766|3561194|FG000|Overall Study|Lost to Follow-up|2
1995913|NCT00090766|3561195|FG001|Overall Study|Lost to Follow-up|0
1995914|NCT00090766|3561196|FG002|Overall Study|Lost to Follow-up|2
1995915|NCT00090779|3561208|FG000|Step 1|Withdrawal by Subject|4
1995916|NCT00090779|3561209|FG001|Step 1|Withdrawal by Subject|2
1995917|NCT00090779|3561208|FG000|Step 1|Lost to Follow-up|3
1995918|NCT00090779|3561209|FG001|Step 1|Lost to Follow-up|2
1995919|NCT00090779|3561208|FG000|Step 1|Death|0
1995920|NCT00090779|3561209|FG001|Step 1|Death|2
1995921|NCT00090779|3561208|FG000|Step 1|Physician Decision|1
1995922|NCT00090779|3561209|FG001|Step 1|Physician Decision|0
1995923|NCT00090779|3561208|FG000|Step 1|Pregnancy|1
1995924|NCT00090779|3561209|FG001|Step 1|Pregnancy|0
1995925|NCT00090779|3561208|FG000|Step 1|Non-compliance to study requirements|0
1995926|NCT00090779|3561209|FG001|Step 1|Non-compliance to study requirements|1
1995927|NCT00090779|3561208|FG000|Step 1|Subject relocated|2
1995928|NCT00090779|3561209|FG001|Step 1|Subject relocated|8
1995929|NCT00090779|3561208|FG000|Step 2|Off study per study closure|6
1995930|NCT00090779|3561209|FG001|Step 2|Off study per study closure|16
1995931|NCT00090779|3561208|FG000|Step 2|Subject relocated|0
1995932|NCT00090779|3561209|FG001|Step 2|Subject relocated|1
1995933|NCT00090779|3561208|FG000|Step 2|Non-compliance to study requirements|0
1995934|NCT00090779|3561209|FG001|Step 2|Non-compliance to study requirements|1
1995935|NCT00090779|3561208|FG000|Step 3|Initiation of ART and off extended study|3
1995936|NCT00090779|3561209|FG001|Step 3|Initiation of ART and off extended study|2
1995937|NCT00090779|3561208|FG000|Step 3|Off extended study due to study closure|4
1995938|NCT00090779|3561209|FG001|Step 3|Off extended study due to study closure|3
1995939|NCT00090857|3561227|FG000|Overall Study|Lost to Follow-up|0
1995940|NCT00090857|3561228|FG001|Overall Study|Lost to Follow-up|1
1995941|NCT00090857|3561227|FG000|Overall Study|Withdrawal by Subject|2
1995942|NCT00090857|3561228|FG001|Overall Study|Withdrawal by Subject|0
1995943|NCT00090857|3561227|FG000|Overall Study|Adverse Event|2
1995944|NCT00090857|3561228|FG001|Overall Study|Adverse Event|2
1995945|NCT00090987|3561234|FG000|Overall Study|Adverse Event|5
1995946|NCT00090987|3561234|FG000|Overall Study|Lack of Efficacy|7
1995947|NCT00090987|3561234|FG000|Overall Study|Withdrawal by Subject|3
1995948|NCT00090987|3561234|FG000|Overall Study|alternative therapy|1
1995949|NCT00090987|3561234|FG000|Overall Study|Non-compliance|4
1995950|NCT00090987|3561234|FG000|Overall Study|Incarcerated|1
1995951|NCT00091026|3561240|FG000|Overall Study|Patient deemed non eligible-never receiv|1
1995952|NCT00091026|3561241|FG001|Overall Study|Patient deemed non eligible-never receiv|0
1995953|NCT00091026|3561240|FG000|Overall Study|Patient withdrew and never received trea|0
1995954|NCT00091026|3561241|FG001|Overall Study|Patient withdrew and never received trea|2
1995955|NCT00091026|3561240|FG000|Overall Study|Unknown-never received treatment|0
1995956|NCT00091026|3561241|FG001|Overall Study|Unknown-never received treatment|1
1995957|NCT00091169|3561249|FG000|Overall Study|Disease progression|3
1995958|NCT00091169|3561250|FG001|Overall Study|Disease progression|1
1995959|NCT00091169|3561249|FG000|Overall Study|Adverse Event|11
1995960|NCT00091169|3561250|FG001|Overall Study|Adverse Event|17
1995961|NCT00091169|3561249|FG000|Overall Study|Death|4
1995962|NCT00091169|3561250|FG001|Overall Study|Death|1
1995963|NCT00091169|3561249|FG000|Overall Study|Withdrawal by Subject|10
1995964|NCT00091169|3561250|FG001|Overall Study|Withdrawal by Subject|13
1995965|NCT00091169|3561249|FG000|Overall Study|Other|3
1995966|NCT00091169|3561250|FG001|Overall Study|Other|4
1995967|NCT00091169|3561249|FG000|Overall Study|Not start protocol therapy|26
1995968|NCT00091169|3561250|FG001|Overall Study|Not start protocol therapy|17
1995969|NCT00091390|3561267|FG000|Overall Study|Protocol Violation|1
1995970|NCT00091390|3561267|FG000|Overall Study|No protocol treatment|3
1995971|NCT00091442|3561273|FG000|Overall Study|Progressive Disease|220
1995972|NCT00091442|3561274|FG001|Overall Study|Progressive Disease|189
1995973|NCT00091442|3561273|FG000|Overall Study|Physician Decision|61
1995974|NCT00091442|3561274|FG001|Overall Study|Physician Decision|58
1995975|NCT00091442|3561273|FG000|Overall Study|Withdrawal by Subject|38
1995976|NCT00091442|3561274|FG001|Overall Study|Withdrawal by Subject|46
1995977|NCT00091442|3561273|FG000|Overall Study|Adverse Event|29
1995978|NCT00091442|3561274|FG001|Overall Study|Adverse Event|48
1995979|NCT00091442|3561273|FG000|Overall Study|2cycles therapy beyond Complete response|9
1995980|NCT00091442|3561274|FG001|Overall Study|2cycles therapy beyond Complete response|16
1995981|NCT00091442|3561273|FG000|Overall Study|Death|9
1995982|NCT00091442|3561274|FG001|Overall Study|Death|7
1995983|NCT00091442|3561273|FG000|Overall Study|Lost to Follow-up|1
1995984|NCT00091442|3561274|FG001|Overall Study|Lost to Follow-up|3
1995985|NCT00091442|3561273|FG000|Overall Study|Other|2
1995986|NCT00091442|3561274|FG001|Overall Study|Other|6
1995987|NCT00091572|3561291|FG000|Overall Study|Lost to Follow-up|1
2213706|NCT01682512|3855661|FG000|Overall Study|Lost to Follow-up|3
1995988|NCT00091572|3561292|FG001|Overall Study|Lost to Follow-up|1
1995989|NCT00091572|3561291|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14
1995990|NCT00091572|3561292|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22
1995991|NCT00091572|3561291|FG000|Overall Study|Death not due to malignancy/toxicity|1
1995992|NCT00091572|3561292|FG001|Overall Study|Death not due to malignancy/toxicity|3
1995993|NCT00091572|3561291|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10
1995994|NCT00091572|3561292|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22
1995995|NCT00091572|3561291|FG000|Overall Study|Other Reason|6
1995996|NCT00091572|3561292|FG001|Overall Study|Other Reason|13
1995997|NCT00091572|3561291|FG000|Overall Study|Ongoing (still on treatment)|8
1995998|NCT00091572|3561292|FG001|Overall Study|Ongoing (still on treatment)|12
1995999|NCT00091572|3561291|FG000|Overall Study|Major Protocol Violation|2
1996000|NCT00091572|3561292|FG001|Overall Study|Major Protocol Violation|0
1996001|NCT00091572|3561291|FG000|Overall Study|Toxicity (Related AE)|53
1996002|NCT00091572|3561292|FG001|Overall Study|Toxicity (Related AE)|9
1996003|NCT00091793|3561300|FG000|Overall Study|Adverse Event|1
1996004|NCT00091793|3561301|FG001|Overall Study|Adverse Event|2
1996005|NCT00091793|3561300|FG000|Overall Study|Withdrawal by Subject|10
1996006|NCT00091793|3561301|FG001|Overall Study|Withdrawal by Subject|15
1996007|NCT00091793|3561300|FG000|Overall Study|Ineligibility determined|2
1996008|NCT00091793|3561301|FG001|Overall Study|Ineligibility determined|0
1996009|NCT00091793|3561300|FG000|Overall Study|Lost to Follow-up|7
1996010|NCT00091793|3561301|FG001|Overall Study|Lost to Follow-up|5
1996011|NCT00091793|3561300|FG000|Overall Study|Noncompliance|2
1996012|NCT00091793|3561301|FG001|Overall Study|Noncompliance|0
1996013|NCT00091793|3561300|FG000|Overall Study|Other|2
1996014|NCT00091793|3561301|FG001|Overall Study|Other|0
1996015|NCT00091819|3561309|FG000|Overall Study|Adverse Event|1
1996016|NCT00091819|3561310|FG001|Overall Study|Adverse Event|1
1996017|NCT00091819|3561309|FG000|Overall Study|Death|4
1996018|NCT00091819|3561310|FG001|Overall Study|Death|5
1996019|NCT00091819|3561309|FG000|Overall Study|Lost to Follow-up|26
1996020|NCT00091819|3561310|FG001|Overall Study|Lost to Follow-up|23
1996021|NCT00091819|3561309|FG000|Overall Study|Withdrawal by Subject|5
1996022|NCT00091819|3561310|FG001|Overall Study|Withdrawal by Subject|8
1996023|NCT00091819|3561309|FG000|Overall Study|Protocol Violation|1
1996024|NCT00091819|3561310|FG001|Overall Study|Protocol Violation|2
1996025|NCT00091819|3561309|FG000|Overall Study|Other|2
1996026|NCT00091819|3561310|FG001|Overall Study|Other|3
1996027|NCT00091819|3561309|FG000|Overall Study|Never received study treatment|3
1996028|NCT00091819|3561310|FG001|Overall Study|Never received study treatment|4
1996029|NCT00091832|3561322|FG000|Overall Study|Physician Decision|1
1996030|NCT00091832|3561323|FG001|Overall Study|Physician Decision|0
1996031|NCT00091832|3561324|FG002|Overall Study|Physician Decision|0
1996032|NCT00091832|3561325|FG003|Overall Study|Physician Decision|0
1996033|NCT00091832|3561326|FG004|Overall Study|Physician Decision|0
1996034|NCT00091832|3561327|FG005|Overall Study|Physician Decision|0
1996035|NCT00091832|3561322|FG000|Overall Study|Adverse Event|0
1996036|NCT00091832|3561323|FG001|Overall Study|Adverse Event|0
1996037|NCT00091832|3561324|FG002|Overall Study|Adverse Event|0
1996038|NCT00091832|3561325|FG003|Overall Study|Adverse Event|1
1996039|NCT00091832|3561326|FG004|Overall Study|Adverse Event|3
1996040|NCT00091832|3561327|FG005|Overall Study|Adverse Event|0
1996041|NCT00091832|3561322|FG000|Overall Study|Withdrawal by Subject|4
1996042|NCT00091832|3561323|FG001|Overall Study|Withdrawal by Subject|5
1996043|NCT00091832|3561324|FG002|Overall Study|Withdrawal by Subject|0
1996044|NCT00091832|3561325|FG003|Overall Study|Withdrawal by Subject|1
1996045|NCT00091832|3561326|FG004|Overall Study|Withdrawal by Subject|3
1996046|NCT00091832|3561327|FG005|Overall Study|Withdrawal by Subject|1
1996047|NCT00091832|3561322|FG000|Overall Study|Death|6
1996048|NCT00091832|3561323|FG001|Overall Study|Death|4
1996049|NCT00091832|3561324|FG002|Overall Study|Death|5
1996050|NCT00091832|3561325|FG003|Overall Study|Death|8
1996051|NCT00091832|3561326|FG004|Overall Study|Death|5
1996052|NCT00091832|3561327|FG005|Overall Study|Death|6
1996053|NCT00091832|3561322|FG000|Overall Study|Disease Progression|2
1996054|NCT00091832|3561323|FG001|Overall Study|Disease Progression|0
1996055|NCT00091832|3561324|FG002|Overall Study|Disease Progression|0
1996056|NCT00091832|3561325|FG003|Overall Study|Disease Progression|1
1996057|NCT00091832|3561326|FG004|Overall Study|Disease Progression|1
1996058|NCT00091832|3561327|FG005|Overall Study|Disease Progression|2
1996059|NCT00091832|3561322|FG000|Overall Study|Ineligibility Determined|0
1996060|NCT00091832|3561323|FG001|Overall Study|Ineligibility Determined|0
1996061|NCT00091832|3561324|FG002|Overall Study|Ineligibility Determined|1
1996062|NCT00091832|3561325|FG003|Overall Study|Ineligibility Determined|0
1996063|NCT00091832|3561326|FG004|Overall Study|Ineligibility Determined|1
1996064|NCT00091832|3561327|FG005|Overall Study|Ineligibility Determined|0
1996065|NCT00091832|3561322|FG000|Overall Study|Lost to Follow-up|1
1996066|NCT00091832|3561323|FG001|Overall Study|Lost to Follow-up|0
1996067|NCT00091832|3561324|FG002|Overall Study|Lost to Follow-up|3
1996068|NCT00091832|3561325|FG003|Overall Study|Lost to Follow-up|3
1996069|NCT00091832|3561326|FG004|Overall Study|Lost to Follow-up|2
1996070|NCT00091832|3561327|FG005|Overall Study|Lost to Follow-up|1
1996071|NCT00091832|3561322|FG000|Overall Study|Noncompliance|0
1996072|NCT00091832|3561323|FG001|Overall Study|Noncompliance|1
1996073|NCT00091832|3561324|FG002|Overall Study|Noncompliance|0
1996074|NCT00091832|3561325|FG003|Overall Study|Noncompliance|0
1996075|NCT00091832|3561326|FG004|Overall Study|Noncompliance|0
1996076|NCT00091832|3561327|FG005|Overall Study|Noncompliance|0
1996077|NCT00091832|3561322|FG000|Overall Study|Other|0
1996078|NCT00091832|3561323|FG001|Overall Study|Other|1
1996079|NCT00091832|3561324|FG002|Overall Study|Other|2
1996080|NCT00091832|3561325|FG003|Overall Study|Other|0
1996081|NCT00091832|3561326|FG004|Overall Study|Other|0
1996082|NCT00091832|3561327|FG005|Overall Study|Other|0
1996083|NCT00091832|3561322|FG000|Overall Study|Protocol Violation|0
1996084|NCT00091832|3561323|FG001|Overall Study|Protocol Violation|0
1996085|NCT00091832|3561324|FG002|Overall Study|Protocol Violation|1
1996086|NCT00091832|3561325|FG003|Overall Study|Protocol Violation|0
1996087|NCT00091832|3561326|FG004|Overall Study|Protocol Violation|0
1996088|NCT00091832|3561327|FG005|Overall Study|Protocol Violation|1
1996089|NCT00091949|3561343|FG000|Overall Study|Withdrawal by Subject|117
1996090|NCT00091949|3561344|FG001|Overall Study|Withdrawal by Subject|110
1996091|NCT00091949|3561343|FG000|Overall Study|Lost to Follow-up|58
1996092|NCT00091949|3561344|FG001|Overall Study|Lost to Follow-up|41
1996093|NCT00092417|3561368|FG000|Overall Study|Lost to Follow-up|2
1996094|NCT00092417|3561369|FG001|Overall Study|Lost to Follow-up|0
1996095|NCT00092417|3561368|FG000|Overall Study|Withdrawal by Subject|2
1996096|NCT00092417|3561369|FG001|Overall Study|Withdrawal by Subject|1
1996097|NCT00092417|3561368|FG000|Overall Study|Other|1
1996098|NCT00092417|3561369|FG001|Overall Study|Other|0
1996099|NCT00092443|3561377|FG000|Overall Study|Adverse Event|9
1996100|NCT00092443|3561378|FG001|Overall Study|Adverse Event|13
1996101|NCT00092443|3561377|FG000|Overall Study|Lost to Follow-up|7
1996102|NCT00092443|3561378|FG001|Overall Study|Lost to Follow-up|3
1996103|NCT00092443|3561377|FG000|Overall Study|Protocol Violation|11
1996104|NCT00092443|3561378|FG001|Overall Study|Protocol Violation|9
1996105|NCT00092443|3561377|FG000|Overall Study|Withdrawal by Subject|9
1996106|NCT00092443|3561378|FG001|Overall Study|Withdrawal by Subject|11
1996107|NCT00092443|3561377|FG000|Overall Study|Moved|5
1996108|NCT00092443|3561378|FG001|Overall Study|Moved|5
1996109|NCT00092443|3561377|FG000|Overall Study|Other|17
1996110|NCT00092443|3561378|FG001|Overall Study|Other|13
1996111|NCT00092456|3561398|FG000|Overall Study|Adverse Event|0
1996112|NCT00092456|3561399|FG001|Overall Study|Adverse Event|0
1996113|NCT00092456|3561400|FG002|Overall Study|Adverse Event|1
1996114|NCT00092456|3561401|FG003|Overall Study|Adverse Event|1
1996115|NCT00092456|3561398|FG000|Overall Study|Lost to Follow-up|2
1996116|NCT00092456|3561399|FG001|Overall Study|Lost to Follow-up|2
1996117|NCT00092456|3561400|FG002|Overall Study|Lost to Follow-up|1
1996118|NCT00092456|3561401|FG003|Overall Study|Lost to Follow-up|2
1996119|NCT00092456|3561398|FG000|Overall Study|Protocol Violation|5
1996120|NCT00092456|3561399|FG001|Overall Study|Protocol Violation|7
1996121|NCT00092456|3561400|FG002|Overall Study|Protocol Violation|8
1996122|NCT00092456|3561401|FG003|Overall Study|Protocol Violation|6
1996123|NCT00092456|3561398|FG000|Overall Study|Withdrawal by Subject|13
1996124|NCT00092456|3561399|FG001|Overall Study|Withdrawal by Subject|5
1996125|NCT00092456|3561400|FG002|Overall Study|Withdrawal by Subject|16
1996126|NCT00092456|3561401|FG003|Overall Study|Withdrawal by Subject|6
1996127|NCT00092456|3561398|FG000|Overall Study|Moved|1
1996128|NCT00092456|3561399|FG001|Overall Study|Moved|1
1996129|NCT00092456|3561400|FG002|Overall Study|Moved|0
1996130|NCT00092456|3561401|FG003|Overall Study|Moved|1
1996131|NCT00092456|3561398|FG000|Overall Study|Other|4
1996132|NCT00092456|3561399|FG001|Overall Study|Other|2
1996133|NCT00092456|3561400|FG002|Overall Study|Other|3
1996134|NCT00092456|3561401|FG003|Overall Study|Other|0
1996135|NCT00092495|3561415|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1
1996136|NCT00092495|3561416|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1
1996137|NCT00092495|3561417|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
1996138|NCT00092495|3561418|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4
1996139|NCT00092495|3561419|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
1996140|NCT00092495|3561415|FG000|Base Study Vaccination Period|Extended|0
1996141|NCT00092495|3561416|FG001|Base Study Vaccination Period|Extended|0
1996142|NCT00092495|3561417|FG002|Base Study Vaccination Period|Extended|0
1996143|NCT00092495|3561418|FG003|Base Study Vaccination Period|Extended|1
1996144|NCT00092495|3561419|FG004|Base Study Vaccination Period|Extended|0
1996145|NCT00092495|3561415|FG000|Base Study Vaccination Period|*Clinical AE|1
1996146|NCT00092495|3561416|FG001|Base Study Vaccination Period|*Clinical AE|0
1996147|NCT00092495|3561417|FG002|Base Study Vaccination Period|*Clinical AE|1
1996148|NCT00092495|3561418|FG003|Base Study Vaccination Period|*Clinical AE|2
1996149|NCT00092495|3561419|FG004|Base Study Vaccination Period|*Clinical AE|0
1996150|NCT00092495|3561415|FG000|Base Study Vaccination Period|*Other reasons|1
1996151|NCT00092495|3561416|FG001|Base Study Vaccination Period|*Other reasons|0
1996152|NCT00092495|3561417|FG002|Base Study Vaccination Period|*Other reasons|0
1996153|NCT00092495|3561418|FG003|Base Study Vaccination Period|*Other reasons|1
1996154|NCT00092495|3561419|FG004|Base Study Vaccination Period|*Other reasons|0
1996155|NCT00092495|3561415|FG000|Base Study Vaccination Period|*Pregnancy|0
1996156|NCT00092495|3561416|FG001|Base Study Vaccination Period|*Pregnancy|2
1996157|NCT00092495|3561417|FG002|Base Study Vaccination Period|*Pregnancy|5
1996158|NCT00092495|3561418|FG003|Base Study Vaccination Period|*Pregnancy|7
1996159|NCT00092495|3561419|FG004|Base Study Vaccination Period|*Pregnancy|0
1996160|NCT00092495|3561415|FG000|Base Study Vaccination Period|Adverse Event|1
1996161|NCT00092495|3561416|FG001|Base Study Vaccination Period|Adverse Event|0
1996162|NCT00092495|3561417|FG002|Base Study Vaccination Period|Adverse Event|0
1996163|NCT00092495|3561418|FG003|Base Study Vaccination Period|Adverse Event|3
1996164|NCT00092495|3561419|FG004|Base Study Vaccination Period|Adverse Event|0
1996165|NCT00092495|3561415|FG000|Base Study Vaccination Period|Lost to Follow-up|16
1996166|NCT00092495|3561416|FG001|Base Study Vaccination Period|Lost to Follow-up|6
1996167|NCT00092495|3561417|FG002|Base Study Vaccination Period|Lost to Follow-up|11
1996168|NCT00092495|3561418|FG003|Base Study Vaccination Period|Lost to Follow-up|36
1996169|NCT00092495|3561419|FG004|Base Study Vaccination Period|Lost to Follow-up|0
1996170|NCT00092495|3561415|FG000|Base Study Vaccination Period|Moved|3
1996171|NCT00092495|3561416|FG001|Base Study Vaccination Period|Moved|1
1996172|NCT00092495|3561417|FG002|Base Study Vaccination Period|Moved|2
1996173|NCT00092495|3561418|FG003|Base Study Vaccination Period|Moved|2
1996174|NCT00092495|3561419|FG004|Base Study Vaccination Period|Moved|0
1996175|NCT00092495|3561415|FG000|Base Study Vaccination Period|Other|1
1996176|NCT00092495|3561416|FG001|Base Study Vaccination Period|Other|1
1996177|NCT00092495|3561417|FG002|Base Study Vaccination Period|Other|0
1996178|NCT00092495|3561418|FG003|Base Study Vaccination Period|Other|2
1996179|NCT00092495|3561419|FG004|Base Study Vaccination Period|Other|0
1996180|NCT00092495|3561415|FG000|Base Study Vaccination Period|Pregnancy|2
1996181|NCT00092495|3561416|FG001|Base Study Vaccination Period|Pregnancy|0
1996182|NCT00092495|3561417|FG002|Base Study Vaccination Period|Pregnancy|0
1996183|NCT00092495|3561418|FG003|Base Study Vaccination Period|Pregnancy|0
1996184|NCT00092495|3561419|FG004|Base Study Vaccination Period|Pregnancy|0
1996185|NCT00092495|3561415|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1
1996186|NCT00092495|3561416|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1
1996187|NCT00092495|3561417|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1
1996188|NCT00092495|3561418|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5
1996189|NCT00092495|3561419|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0
1996190|NCT00092495|3561415|FG000|Base Study Vaccination Period|Protocol Violation|1
1996191|NCT00092495|3561416|FG001|Base Study Vaccination Period|Protocol Violation|0
1996192|NCT00092495|3561417|FG002|Base Study Vaccination Period|Protocol Violation|0
1996193|NCT00092495|3561418|FG003|Base Study Vaccination Period|Protocol Violation|0
1996194|NCT00092495|3561419|FG004|Base Study Vaccination Period|Protocol Violation|0
1996195|NCT00092495|3561415|FG000|Base Study Vaccination Period|Withdrawal by Subject|9
1996196|NCT00092495|3561416|FG001|Base Study Vaccination Period|Withdrawal by Subject|10
1996197|NCT00092495|3561417|FG002|Base Study Vaccination Period|Withdrawal by Subject|14
1996198|NCT00092495|3561418|FG003|Base Study Vaccination Period|Withdrawal by Subject|25
1996199|NCT00092495|3561419|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
1996200|NCT00092495|3561415|FG000|Base Study Follow-up Period|Extended|0
1996201|NCT00092495|3561416|FG001|Base Study Follow-up Period|Extended|0
1996202|NCT00092495|3561417|FG002|Base Study Follow-up Period|Extended|1
1996203|NCT00092495|3561418|FG003|Base Study Follow-up Period|Extended|2
1996204|NCT00092495|3561419|FG004|Base Study Follow-up Period|Extended|0
1996205|NCT00092495|3561415|FG000|Base Study Follow-up Period|Lost to Follow-up|1
1996206|NCT00092495|3561416|FG001|Base Study Follow-up Period|Lost to Follow-up|3
1996207|NCT00092495|3561417|FG002|Base Study Follow-up Period|Lost to Follow-up|3
1996208|NCT00092495|3561418|FG003|Base Study Follow-up Period|Lost to Follow-up|12
1996209|NCT00092495|3561419|FG004|Base Study Follow-up Period|Lost to Follow-up|0
1996210|NCT00092495|3561415|FG000|Base Study Follow-up Period|Withdrawal by Subject|2
1996211|NCT00092495|3561416|FG001|Base Study Follow-up Period|Withdrawal by Subject|0
1996212|NCT00092495|3561417|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
1996213|NCT00092495|3561418|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
1996214|NCT00092495|3561419|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
1996215|NCT00092521|3561435|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
1996216|NCT00092521|3561436|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
1996217|NCT00092521|3561437|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
1996218|NCT00092521|3561438|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
1996219|NCT00092521|3561435|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1
1996220|NCT00092521|3561436|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0
1996221|NCT00092521|3561437|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7
1996222|NCT00092521|3561438|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0
1996223|NCT00092521|3561435|FG000|Vaccination (Day 1 Through Month 7)|Death|0
1996224|NCT00092521|3561436|FG001|Vaccination (Day 1 Through Month 7)|Death|0
1996225|NCT00092521|3561437|FG002|Vaccination (Day 1 Through Month 7)|Death|1
1996226|NCT00092521|3561438|FG003|Vaccination (Day 1 Through Month 7)|Death|0
1996227|NCT00092521|3561435|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
1996228|NCT00092521|3561436|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
1996229|NCT00092521|3561437|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
1996230|NCT00092521|3561438|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
1996231|NCT00092521|3561435|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5
1996232|NCT00092521|3561436|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0
1996233|NCT00092521|3561437|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7
1996234|NCT00092521|3561438|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0
1996235|NCT00092521|3561435|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
1996236|NCT00092521|3561436|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
1996237|NCT00092521|3561437|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
1996238|NCT00092521|3561438|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
1996239|NCT00092521|3561435|FG000|Vaccination (Day 1 Through Month 7)|Moved|14
1996240|NCT00092521|3561436|FG001|Vaccination (Day 1 Through Month 7)|Moved|1
1996241|NCT00092521|3561437|FG002|Vaccination (Day 1 Through Month 7)|Moved|18
1996242|NCT00092521|3561438|FG003|Vaccination (Day 1 Through Month 7)|Moved|0
1996243|NCT00092521|3561435|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2
1996244|NCT00092521|3561436|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0
1996245|NCT00092521|3561437|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0
1996246|NCT00092521|3561438|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0
1996247|NCT00092521|3561435|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
1996248|NCT00092521|3561436|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1996249|NCT00092521|3561437|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1996250|NCT00092521|3561438|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1996251|NCT00092521|3561435|FG000|Follow-Up (After Month 7)|Subjects Continuing|34
1996252|NCT00092521|3561436|FG001|Follow-Up (After Month 7)|Subjects Continuing|4
1996253|NCT00092521|3561437|FG002|Follow-Up (After Month 7)|Subjects Continuing|35
1996254|NCT00092521|3561438|FG003|Follow-Up (After Month 7)|Subjects Continuing|0
1996255|NCT00092521|3561435|FG000|Follow-Up (After Month 7)|Subjects in Extension|13
1996256|NCT00092521|3561436|FG001|Follow-Up (After Month 7)|Subjects in Extension|109
1996257|NCT00092521|3561437|FG002|Follow-Up (After Month 7)|Subjects in Extension|412
1996258|NCT00092521|3561438|FG003|Follow-Up (After Month 7)|Subjects in Extension|0
1996259|NCT00092521|3561435|FG000|Follow-Up (After Month 7)|Adverse Event|1
1996260|NCT00092521|3561436|FG001|Follow-Up (After Month 7)|Adverse Event|0
1996261|NCT00092521|3561437|FG002|Follow-Up (After Month 7)|Adverse Event|0
1996262|NCT00092521|3561438|FG003|Follow-Up (After Month 7)|Adverse Event|0
1996263|NCT00092521|3561435|FG000|Follow-Up (After Month 7)|Death|2
1996264|NCT00092521|3561436|FG001|Follow-Up (After Month 7)|Death|0
1996265|NCT00092521|3561437|FG002|Follow-Up (After Month 7)|Death|1
1996266|NCT00092521|3561438|FG003|Follow-Up (After Month 7)|Death|0
1996267|NCT00092521|3561435|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113
1996268|NCT00092521|3561436|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14
1996269|NCT00092521|3561437|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108
1996270|NCT00092521|3561438|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0
1996271|NCT00092521|3561435|FG000|Follow-Up (After Month 7)|Protocol Violation|1
1996272|NCT00092521|3561436|FG001|Follow-Up (After Month 7)|Protocol Violation|1
1996273|NCT00092521|3561437|FG002|Follow-Up (After Month 7)|Protocol Violation|5
1996274|NCT00092521|3561438|FG003|Follow-Up (After Month 7)|Protocol Violation|0
1996275|NCT00092521|3561435|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40
1996276|NCT00092521|3561436|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6
1996277|NCT00092521|3561437|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51
1996278|NCT00092521|3561438|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0
1996279|NCT00092521|3561435|FG000|Follow-Up (After Month 7)|Moved|32
1996280|NCT00092521|3561436|FG001|Follow-Up (After Month 7)|Moved|2
1996281|NCT00092521|3561437|FG002|Follow-Up (After Month 7)|Moved|28
1996282|NCT00092521|3561438|FG003|Follow-Up (After Month 7)|Moved|0
1996283|NCT00092521|3561435|FG000|Follow-Up (After Month 7)|Site Terminated|3
1996284|NCT00092521|3561436|FG001|Follow-Up (After Month 7)|Site Terminated|0
1996285|NCT00092521|3561437|FG002|Follow-Up (After Month 7)|Site Terminated|3
1996286|NCT00092521|3561438|FG003|Follow-Up (After Month 7)|Site Terminated|0
1996287|NCT00092521|3561435|FG000|Follow-Up (After Month 7)|Travel|2
1996288|NCT00092521|3561436|FG001|Follow-Up (After Month 7)|Travel|0
1996289|NCT00092521|3561437|FG002|Follow-Up (After Month 7)|Travel|0
1996290|NCT00092521|3561438|FG003|Follow-Up (After Month 7)|Travel|0
1996291|NCT00092521|3561435|FG000|Follow-Up (After Month 7)|Visits Compressed|5
1996292|NCT00092521|3561436|FG001|Follow-Up (After Month 7)|Visits Compressed|0
1996293|NCT00092521|3561437|FG002|Follow-Up (After Month 7)|Visits Compressed|5
1996294|NCT00092521|3561438|FG003|Follow-Up (After Month 7)|Visits Compressed|0
1996295|NCT00092521|3561435|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0
1996296|NCT00092521|3561436|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0
1996297|NCT00092521|3561437|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0
1996298|NCT00092521|3561438|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23
1996299|NCT00092521|3561435|FG000|Extension Study (Group 4)|Adverse Event|0
1996300|NCT00092521|3561436|FG001|Extension Study (Group 4)|Adverse Event|0
1996301|NCT00092521|3561437|FG002|Extension Study (Group 4)|Adverse Event|0
1996302|NCT00092521|3561438|FG003|Extension Study (Group 4)|Adverse Event|2
1996303|NCT00092521|3561435|FG000|Extension Study (Group 4)|Lost to Follow-up|0
1996304|NCT00092521|3561436|FG001|Extension Study (Group 4)|Lost to Follow-up|0
1996305|NCT00092521|3561437|FG002|Extension Study (Group 4)|Lost to Follow-up|0
1996306|NCT00092521|3561438|FG003|Extension Study (Group 4)|Lost to Follow-up|87
1996307|NCT00092521|3561435|FG000|Extension Study (Group 4)|Pregnancy|0
1996308|NCT00092521|3561436|FG001|Extension Study (Group 4)|Pregnancy|0
1996309|NCT00092521|3561437|FG002|Extension Study (Group 4)|Pregnancy|0
1996310|NCT00092521|3561438|FG003|Extension Study (Group 4)|Pregnancy|4
1996311|NCT00092521|3561435|FG000|Extension Study (Group 4)|Protocol Violation|0
1996312|NCT00092521|3561436|FG001|Extension Study (Group 4)|Protocol Violation|0
1996313|NCT00092521|3561437|FG002|Extension Study (Group 4)|Protocol Violation|0
1996314|NCT00092521|3561438|FG003|Extension Study (Group 4)|Protocol Violation|2
1996315|NCT00092521|3561435|FG000|Extension Study (Group 4)|Withdrawal by Subject|0
1996316|NCT00092521|3561436|FG001|Extension Study (Group 4)|Withdrawal by Subject|0
1996317|NCT00092521|3561437|FG002|Extension Study (Group 4)|Withdrawal by Subject|0
1996318|NCT00092521|3561438|FG003|Extension Study (Group 4)|Withdrawal by Subject|46
1996319|NCT00092521|3561435|FG000|Extension Study (Group 4)|Moved|0
1996320|NCT00092521|3561436|FG001|Extension Study (Group 4)|Moved|0
1996321|NCT00092521|3561437|FG002|Extension Study (Group 4)|Moved|0
1996322|NCT00092521|3561438|FG003|Extension Study (Group 4)|Moved|16
1996323|NCT00092521|3561435|FG000|Extension Study (Group 4)|Site Terminated|0
1996324|NCT00092521|3561436|FG001|Extension Study (Group 4)|Site Terminated|0
1996325|NCT00092521|3561437|FG002|Extension Study (Group 4)|Site Terminated|0
1996326|NCT00092521|3561438|FG003|Extension Study (Group 4)|Site Terminated|4
1996327|NCT00092521|3561435|FG000|Extension Study (Group 4)|Unable/unwilling to return|0
1996328|NCT00092521|3561436|FG001|Extension Study (Group 4)|Unable/unwilling to return|0
1996329|NCT00092521|3561437|FG002|Extension Study (Group 4)|Unable/unwilling to return|0
1996330|NCT00092521|3561438|FG003|Extension Study (Group 4)|Unable/unwilling to return|25
1996331|NCT00092534|3561448|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5
1996332|NCT00092534|3561449|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5
1996333|NCT00092534|3561450|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
1996334|NCT00092534|3561451|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
1996335|NCT00092534|3561452|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
1996336|NCT00092534|3561448|FG000|Base Study Vaccination Period|Adverse Event|3
1996337|NCT00092534|3561449|FG001|Base Study Vaccination Period|Adverse Event|1
1996338|NCT00092534|3561450|FG002|Base Study Vaccination Period|Adverse Event|0
1996339|NCT00092534|3561451|FG003|Base Study Vaccination Period|Adverse Event|0
1996340|NCT00092534|3561452|FG004|Base Study Vaccination Period|Adverse Event|0
1996341|NCT00092534|3561448|FG000|Base Study Vaccination Period|Death|5
1996342|NCT00092534|3561449|FG001|Base Study Vaccination Period|Death|4
1996343|NCT00092534|3561450|FG002|Base Study Vaccination Period|Death|0
1996344|NCT00092534|3561451|FG003|Base Study Vaccination Period|Death|0
1996345|NCT00092534|3561452|FG004|Base Study Vaccination Period|Death|0
1996346|NCT00092534|3561448|FG000|Base Study Vaccination Period|Lost to Follow-up|41
1996347|NCT00092534|3561449|FG001|Base Study Vaccination Period|Lost to Follow-up|37
1996348|NCT00092534|3561450|FG002|Base Study Vaccination Period|Lost to Follow-up|0
1996349|NCT00092534|3561451|FG003|Base Study Vaccination Period|Lost to Follow-up|0
1996350|NCT00092534|3561452|FG004|Base Study Vaccination Period|Lost to Follow-up|0
1996351|NCT00092534|3561448|FG000|Base Study Vaccination Period|Physician Decision|1
1996352|NCT00092534|3561449|FG001|Base Study Vaccination Period|Physician Decision|0
1996353|NCT00092534|3561450|FG002|Base Study Vaccination Period|Physician Decision|0
1996354|NCT00092534|3561451|FG003|Base Study Vaccination Period|Physician Decision|0
1996355|NCT00092534|3561452|FG004|Base Study Vaccination Period|Physician Decision|0
1996356|NCT00092534|3561448|FG000|Base Study Vaccination Period|Pregnancy|9
1996357|NCT00092534|3561449|FG001|Base Study Vaccination Period|Pregnancy|7
1996358|NCT00092534|3561450|FG002|Base Study Vaccination Period|Pregnancy|0
1996359|NCT00092534|3561451|FG003|Base Study Vaccination Period|Pregnancy|0
1996360|NCT00092534|3561452|FG004|Base Study Vaccination Period|Pregnancy|0
1996361|NCT00092534|3561448|FG000|Base Study Vaccination Period|Protocol Violation|2
1996362|NCT00092534|3561449|FG001|Base Study Vaccination Period|Protocol Violation|1
1996363|NCT00092534|3561450|FG002|Base Study Vaccination Period|Protocol Violation|0
1996364|NCT00092534|3561451|FG003|Base Study Vaccination Period|Protocol Violation|0
1996365|NCT00092534|3561452|FG004|Base Study Vaccination Period|Protocol Violation|0
1996366|NCT00092534|3561448|FG000|Base Study Vaccination Period|Withdrawal by Subject|85
1996367|NCT00092534|3561449|FG001|Base Study Vaccination Period|Withdrawal by Subject|58
1996368|NCT00092534|3561450|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
1996369|NCT00092534|3561451|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
1996370|NCT00092534|3561452|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
1996371|NCT00092534|3561448|FG000|Base Study Vaccination Period|Moved|14
1996372|NCT00092534|3561449|FG001|Base Study Vaccination Period|Moved|12
1996373|NCT00092534|3561450|FG002|Base Study Vaccination Period|Moved|0
1996374|NCT00092534|3561451|FG003|Base Study Vaccination Period|Moved|0
1996375|NCT00092534|3561452|FG004|Base Study Vaccination Period|Moved|0
1996376|NCT00092534|3561448|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5
1996377|NCT00092534|3561449|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0
1996378|NCT00092534|3561450|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0
1996379|NCT00092534|3561451|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0
1996380|NCT00092534|3561452|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0
1996381|NCT00092534|3561448|FG000|Base Study Vaccination Period|Travel|1
1996382|NCT00092534|3561449|FG001|Base Study Vaccination Period|Travel|0
1996383|NCT00092534|3561450|FG002|Base Study Vaccination Period|Travel|0
1996384|NCT00092534|3561451|FG003|Base Study Vaccination Period|Travel|0
1996385|NCT00092534|3561452|FG004|Base Study Vaccination Period|Travel|0
1996386|NCT00092534|3561448|FG000|Base Study Vaccination Period|Site Closed|0
1996387|NCT00092534|3561449|FG001|Base Study Vaccination Period|Site Closed|1
1996388|NCT00092534|3561450|FG002|Base Study Vaccination Period|Site Closed|0
1996389|NCT00092534|3561451|FG003|Base Study Vaccination Period|Site Closed|0
1996390|NCT00092534|3561452|FG004|Base Study Vaccination Period|Site Closed|0
1996391|NCT00092534|3561448|FG000|Base Study Follow-Up Period|Adverse Event|2
1996392|NCT00092534|3561449|FG001|Base Study Follow-Up Period|Adverse Event|4
1996393|NCT00092534|3561450|FG002|Base Study Follow-Up Period|Adverse Event|0
1996394|NCT00092534|3561451|FG003|Base Study Follow-Up Period|Adverse Event|0
1996395|NCT00092534|3561452|FG004|Base Study Follow-Up Period|Adverse Event|0
1996396|NCT00092534|3561448|FG000|Base Study Follow-Up Period|Death|2
1996397|NCT00092534|3561449|FG001|Base Study Follow-Up Period|Death|1
1996398|NCT00092534|3561450|FG002|Base Study Follow-Up Period|Death|0
1996399|NCT00092534|3561451|FG003|Base Study Follow-Up Period|Death|0
1996400|NCT00092534|3561452|FG004|Base Study Follow-Up Period|Death|0
1996401|NCT00092534|3561448|FG000|Base Study Follow-Up Period|Lost to Follow-up|120
1996402|NCT00092534|3561449|FG001|Base Study Follow-Up Period|Lost to Follow-up|146
1996403|NCT00092534|3561450|FG002|Base Study Follow-Up Period|Lost to Follow-up|0
1996404|NCT00092534|3561451|FG003|Base Study Follow-Up Period|Lost to Follow-up|0
1996405|NCT00092534|3561452|FG004|Base Study Follow-Up Period|Lost to Follow-up|0
1996406|NCT00092534|3561448|FG000|Base Study Follow-Up Period|Pregnancy|6
1996407|NCT00092534|3561449|FG001|Base Study Follow-Up Period|Pregnancy|10
1996408|NCT00092534|3561450|FG002|Base Study Follow-Up Period|Pregnancy|0
1996409|NCT00092534|3561451|FG003|Base Study Follow-Up Period|Pregnancy|0
1996410|NCT00092534|3561452|FG004|Base Study Follow-Up Period|Pregnancy|0
1996411|NCT00092534|3561448|FG000|Base Study Follow-Up Period|Protocol Violation|1
1996412|NCT00092534|3561449|FG001|Base Study Follow-Up Period|Protocol Violation|2
1996413|NCT00092534|3561450|FG002|Base Study Follow-Up Period|Protocol Violation|0
1996414|NCT00092534|3561451|FG003|Base Study Follow-Up Period|Protocol Violation|0
1996415|NCT00092534|3561452|FG004|Base Study Follow-Up Period|Protocol Violation|0
1996416|NCT00092534|3561448|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71
1996417|NCT00092534|3561449|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62
1996418|NCT00092534|3561450|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0
1996419|NCT00092534|3561451|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0
1996420|NCT00092534|3561452|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0
1996421|NCT00092534|3561448|FG000|Base Study Follow-Up Period|Moved|62
1996422|NCT00092534|3561449|FG001|Base Study Follow-Up Period|Moved|58
1996423|NCT00092534|3561450|FG002|Base Study Follow-Up Period|Moved|0
1996424|NCT00092534|3561451|FG003|Base Study Follow-Up Period|Moved|0
1996425|NCT00092534|3561452|FG004|Base Study Follow-Up Period|Moved|0
1996426|NCT00092534|3561448|FG000|Base Study Follow-Up Period|Travel|10
1996427|NCT00092534|3561449|FG001|Base Study Follow-Up Period|Travel|7
1996428|NCT00092534|3561450|FG002|Base Study Follow-Up Period|Travel|0
1996429|NCT00092534|3561451|FG003|Base Study Follow-Up Period|Travel|0
1996430|NCT00092534|3561452|FG004|Base Study Follow-Up Period|Travel|0
1996431|NCT00092534|3561448|FG000|Base Study Follow-Up Period|Site Closed|0
1996432|NCT00092534|3561449|FG001|Base Study Follow-Up Period|Site Closed|2
1996433|NCT00092534|3561450|FG002|Base Study Follow-Up Period|Site Closed|0
1996434|NCT00092534|3561451|FG003|Base Study Follow-Up Period|Site Closed|0
1996435|NCT00092534|3561452|FG004|Base Study Follow-Up Period|Site Closed|0
1996436|NCT00092534|3561448|FG000|Base Study Follow-Up Period|Subjects continuing|27
1996437|NCT00092534|3561449|FG001|Base Study Follow-Up Period|Subjects continuing|31
1996438|NCT00092534|3561450|FG002|Base Study Follow-Up Period|Subjects continuing|0
1996439|NCT00092534|3561451|FG003|Base Study Follow-Up Period|Subjects continuing|0
1996440|NCT00092534|3561452|FG004|Base Study Follow-Up Period|Subjects continuing|0
1996441|NCT00092534|3561448|FG000|Base Study Follow-Up Period|Subjects in extension|15
1996442|NCT00092534|3561449|FG001|Base Study Follow-Up Period|Subjects in extension|371
1996443|NCT00092534|3561450|FG002|Base Study Follow-Up Period|Subjects in extension|0
1996444|NCT00092534|3561451|FG003|Base Study Follow-Up Period|Subjects in extension|0
1996445|NCT00092534|3561452|FG004|Base Study Follow-Up Period|Subjects in extension|0
1996446|NCT00092534|3561448|FG000|Base Study EXT|Lost to Follow-up|0
1996447|NCT00092534|3561449|FG001|Base Study EXT|Lost to Follow-up|0
1996448|NCT00092534|3561450|FG002|Base Study EXT|Lost to Follow-up|41
1996449|NCT00092534|3561451|FG003|Base Study EXT|Lost to Follow-up|0
1996450|NCT00092534|3561452|FG004|Base Study EXT|Lost to Follow-up|0
1996451|NCT00092534|3561448|FG000|Base Study EXT|Physician Decision|0
1996452|NCT00092534|3561449|FG001|Base Study EXT|Physician Decision|0
1996453|NCT00092534|3561450|FG002|Base Study EXT|Physician Decision|1
1996454|NCT00092534|3561451|FG003|Base Study EXT|Physician Decision|0
1996455|NCT00092534|3561452|FG004|Base Study EXT|Physician Decision|0
1996456|NCT00092534|3561448|FG000|Base Study EXT|Pregnancy|0
1996457|NCT00092534|3561449|FG001|Base Study EXT|Pregnancy|0
1996458|NCT00092534|3561450|FG002|Base Study EXT|Pregnancy|12
1996459|NCT00092534|3561451|FG003|Base Study EXT|Pregnancy|0
1996460|NCT00092534|3561452|FG004|Base Study EXT|Pregnancy|0
1996461|NCT00092534|3561448|FG000|Base Study EXT|Withdrawal by Subject|0
1996462|NCT00092534|3561449|FG001|Base Study EXT|Withdrawal by Subject|0
1996463|NCT00092534|3561450|FG002|Base Study EXT|Withdrawal by Subject|18
1996464|NCT00092534|3561451|FG003|Base Study EXT|Withdrawal by Subject|0
1996465|NCT00092534|3561452|FG004|Base Study EXT|Withdrawal by Subject|0
1996466|NCT00092534|3561448|FG000|Base Study EXT|Participant moved|0
1996467|NCT00092534|3561449|FG001|Base Study EXT|Participant moved|0
1996468|NCT00092534|3561450|FG002|Base Study EXT|Participant moved|6
1996469|NCT00092534|3561451|FG003|Base Study EXT|Participant moved|0
1996470|NCT00092534|3561452|FG004|Base Study EXT|Participant moved|0
1996471|NCT00092534|3561448|FG000|Base Study EXT|Travel|0
1996472|NCT00092534|3561449|FG001|Base Study EXT|Travel|0
1996473|NCT00092534|3561450|FG002|Base Study EXT|Travel|2
1996474|NCT00092534|3561451|FG003|Base Study EXT|Travel|0
1996475|NCT00092534|3561452|FG004|Base Study EXT|Travel|0
1996476|NCT00092534|3561448|FG000|Base Study EXT|Site closed|0
1996477|NCT00092534|3561449|FG001|Base Study EXT|Site closed|0
1996478|NCT00092534|3561450|FG002|Base Study EXT|Site closed|21
1996479|NCT00092534|3561451|FG003|Base Study EXT|Site closed|0
1996480|NCT00092534|3561452|FG004|Base Study EXT|Site closed|0
1996481|NCT00092534|3561448|FG000|Base Study EXT|Study ended|0
1996482|NCT00092534|3561449|FG001|Base Study EXT|Study ended|0
1996483|NCT00092534|3561450|FG002|Base Study EXT|Study ended|29
1996484|NCT00092534|3561451|FG003|Base Study EXT|Study ended|0
1996485|NCT00092534|3561452|FG004|Base Study EXT|Study ended|0
1996486|NCT00092534|3561448|FG000|Base Study EXT|Protocol Violation|0
1996487|NCT00092534|3561449|FG001|Base Study EXT|Protocol Violation|0
1996488|NCT00092534|3561450|FG002|Base Study EXT|Protocol Violation|15
1996489|NCT00092534|3561451|FG003|Base Study EXT|Protocol Violation|0
1996490|NCT00092534|3561452|FG004|Base Study EXT|Protocol Violation|0
1996491|NCT00092534|3561448|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
1996492|NCT00092534|3561449|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
1996493|NCT00092534|3561450|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
1996494|NCT00092534|3561451|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
1996495|NCT00092534|3561452|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
1996496|NCT00092547|3561464|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
1996497|NCT00092547|3561465|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
1996498|NCT00092547|3561466|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
1996499|NCT00092547|3561464|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
1996500|NCT00092547|3561465|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
1996501|NCT00092547|3561466|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
1996502|NCT00092547|3561464|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
1996503|NCT00092547|3561465|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
1996504|NCT00092547|3561466|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
1996505|NCT00092547|3561464|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
1996506|NCT00092547|3561465|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
1996507|NCT00092547|3561466|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
1996508|NCT00092547|3561464|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
1996509|NCT00092547|3561465|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
2213707|NCT01682512|3855662|FG001|Overall Study|Lost to Follow-up|0
2213708|NCT01682512|3855663|FG002|Overall Study|Lost to Follow-up|2
2213709|NCT01682512|3855661|FG000|Overall Study|Protocol Violation|2
2213710|NCT01682512|3855662|FG001|Overall Study|Protocol Violation|3
2213711|NCT01682512|3855663|FG002|Overall Study|Protocol Violation|2
1996510|NCT00092547|3561466|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
1996511|NCT00092547|3561464|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
1996512|NCT00092547|3561465|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
1996513|NCT00092547|3561466|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
1996514|NCT00092547|3561464|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
1996515|NCT00092547|3561465|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
1996516|NCT00092547|3561466|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
1996517|NCT00092547|3561464|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
1996518|NCT00092547|3561465|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
1996519|NCT00092547|3561466|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
1996520|NCT00092547|3561464|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
1996521|NCT00092547|3561465|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
1996522|NCT00092547|3561466|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
1996523|NCT00092547|3561464|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
1996524|NCT00092547|3561465|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
1996525|NCT00092547|3561466|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
1996526|NCT00092547|3561464|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
1996527|NCT00092547|3561465|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
1996528|NCT00092547|3561466|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
1996529|NCT00092547|3561464|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
1996530|NCT00092547|3561465|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
1996531|NCT00092547|3561466|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
1996532|NCT00092547|3561464|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
1996533|NCT00092547|3561465|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
1996534|NCT00092547|3561466|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
1996535|NCT00092547|3561464|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
1996536|NCT00092547|3561465|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
1996537|NCT00092547|3561466|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
1996538|NCT00092547|3561464|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
1996539|NCT00092547|3561465|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
1996540|NCT00092547|3561466|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
1996541|NCT00092547|3561464|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
1996542|NCT00092547|3561465|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
1996543|NCT00092547|3561466|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
1996544|NCT00092547|3561464|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
1996545|NCT00092547|3561465|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
1996546|NCT00092547|3561466|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
1996547|NCT00092547|3561464|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
2213712|NCT01682512|3855661|FG000|Overall Study|Primary lack of efficacy|10
1996548|NCT00092547|3561465|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
1996549|NCT00092547|3561466|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
1996550|NCT00092547|3561464|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
1996551|NCT00092547|3561465|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
1996552|NCT00092547|3561466|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
1996553|NCT00092547|3561464|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
1996554|NCT00092547|3561465|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
1996555|NCT00092547|3561466|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
1996556|NCT00092547|3561464|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
1996557|NCT00092547|3561465|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
1996558|NCT00092547|3561466|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
1996559|NCT00093015|3561479|FG000|Overall Study|Withdrawal by Subject|194
1996560|NCT00093015|3561480|FG001|Overall Study|Withdrawal by Subject|171
1996561|NCT00093015|3561479|FG000|Overall Study|Lost to Follow-up|96
1996562|NCT00093015|3561480|FG001|Overall Study|Lost to Follow-up|108
1996563|NCT00093015|3561479|FG000|Overall Study|Death|375
1996564|NCT00093015|3561480|FG001|Overall Study|Death|385
1996565|NCT00093145|3561511|FG000|Overall Study|Unacceptable Toxicity Only|2
1996566|NCT00093145|3561511|FG000|Overall Study|Physician Decision|5
1996567|NCT00093145|3561511|FG000|Overall Study|Withdrawal by Subject|9
1996568|NCT00093145|3561511|FG000|Overall Study|Other|1
1996569|NCT00093470|3561521|FG000|Overall Study|Disease progression|39
1996570|NCT00093470|3561522|FG001|Overall Study|Disease progression|0
1996571|NCT00093470|3561521|FG000|Overall Study|Adverse Event|15
1996572|NCT00093470|3561522|FG001|Overall Study|Adverse Event|0
1996573|NCT00093470|3561521|FG000|Overall Study|Death|2
1996574|NCT00093470|3561522|FG001|Overall Study|Death|0
1996575|NCT00093470|3561521|FG000|Overall Study|Withdrawal by Subject|8
1996576|NCT00093470|3561522|FG001|Overall Study|Withdrawal by Subject|0
1996577|NCT00093470|3561521|FG000|Overall Study|Alternative therapy|2
1996578|NCT00093470|3561522|FG001|Overall Study|Alternative therapy|0
1996579|NCT00093470|3561521|FG000|Overall Study|Other complicating disease|3
1996580|NCT00093470|3561522|FG001|Overall Study|Other complicating disease|0
1996581|NCT00093470|3561521|FG000|Overall Study|Physician Decision|2
1996582|NCT00093470|3561522|FG001|Overall Study|Physician Decision|0
1996583|NCT00093470|3561521|FG000|Overall Study|Never started treatment|1
1996584|NCT00093470|3561522|FG001|Overall Study|Never started treatment|0
1996585|NCT00093470|3561521|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1
1996586|NCT00093470|3561522|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0
1996587|NCT00093496|3561530|FG000|Overall Study|Protocol Violation|1
1996588|NCT00093496|3561531|FG001|Overall Study|Protocol Violation|3
1996589|NCT00093795|3561554|FG000|Overall Study|No follow up data|20
1996590|NCT00093795|3561555|FG001|Overall Study|No follow up data|16
1996591|NCT00093795|3561556|FG002|Overall Study|No follow up data|17
1996592|NCT00093808|3561564|FG000|Overall Study|Cancel participation before receiving tx|1
1996593|NCT00093808|3561564|FG000|Overall Study|Protocol Violation|1
1996594|NCT00094055|3561588|FG000|Overall Study|Adverse Event|11
1996595|NCT00094055|3561588|FG000|Overall Study|Death|4
1996596|NCT00094055|3561588|FG000|Overall Study|Lack of Efficacy|17
1996597|NCT00094055|3561588|FG000|Overall Study|Lost to Follow-up|2
1996598|NCT00094055|3561588|FG000|Overall Study|progressive disease|2
1996599|NCT00094055|3561588|FG000|Overall Study|clinical progression|1
1996600|NCT00094055|3561588|FG000|Overall Study|roll-over to another study|14
1996601|NCT00094055|3561588|FG000|Overall Study|Withdrawal by Subject|9
1996602|NCT00094094|3561592|FG000|Overall Study|Death|2
1996603|NCT00094094|3561592|FG000|Overall Study|Lack of Efficacy|23
1996604|NCT00094094|3561592|FG000|Overall Study|Adverse Event|7
1996605|NCT00094107|3561596|FG000|Overall Study|Lack of Efficacy|23
1996606|NCT00094107|3561596|FG000|Overall Study|Death|5
1996607|NCT00094107|3561596|FG000|Overall Study|Adverse Event|3
1996608|NCT00094107|3561596|FG000|Overall Study|Withdrawal due to Disease Progression|1
1996609|NCT00094172|3561602|FG000|Overall Study|Adverse Event|0
1996610|NCT00094172|3561603|FG001|Overall Study|Adverse Event|1
1996611|NCT00094172|3561602|FG000|Overall Study|Lost to Follow-up|2
1996612|NCT00094172|3561603|FG001|Overall Study|Lost to Follow-up|0
1996613|NCT00094172|3561602|FG000|Overall Study|Protocol Violation|0
1996614|NCT00094172|3561603|FG001|Overall Study|Protocol Violation|1
1996615|NCT00094172|3561602|FG000|Overall Study|Withdrawal by Subject|10
1996616|NCT00094172|3561603|FG001|Overall Study|Withdrawal by Subject|5
1996617|NCT00094172|3561602|FG000|Overall Study|Primary endpoint met.|1
1996618|NCT00094172|3561603|FG001|Overall Study|Primary endpoint met.|0
1996619|NCT00094172|3561602|FG000|Overall Study|Started other MS therapy due to disease|1
1996620|NCT00094172|3561603|FG001|Overall Study|Started other MS therapy due to disease|0
1996621|NCT00094302|3561632|FG000|Overall Study|Lost to Follow-up|43
1996622|NCT00094302|3561633|FG001|Overall Study|Lost to Follow-up|41
1996623|NCT00094302|3561632|FG000|Overall Study|Physician Decision|5
1996624|NCT00094302|3561633|FG001|Overall Study|Physician Decision|8
1996625|NCT00094302|3561632|FG000|Overall Study|Withdrawal by Subject|103
1996626|NCT00094302|3561633|FG001|Overall Study|Withdrawal by Subject|111
1996627|NCT00094302|3561632|FG000|Overall Study|Death|266
1996628|NCT00094302|3561633|FG001|Overall Study|Death|246
1996629|NCT00094328|3561639|FG000|Overall Study|Lost to Follow-up|1
1996630|NCT00094445|3561643|FG000|Overall Study|Withdrawal by Subject|3
1996631|NCT00094445|3561643|FG000|Overall Study|Lost to Follow-up|1
1996632|NCT00094445|3561643|FG000|Overall Study|Progressive Disease|2
1996633|NCT00094458|3561650|FG000|Main Study: Through Week 30|Eligibility criteria not met|3
1996634|NCT00094458|3561651|FG001|Main Study: Through Week 30|Eligibility criteria not met|8
1996635|NCT00094458|3561652|FG002|Main Study: Through Week 30|Eligibility criteria not met|2
1996636|NCT00094458|3561653|FG003|Main Study: Through Week 30|Eligibility criteria not met|0
1996637|NCT00094458|3561654|FG004|Main Study: Through Week 30|Eligibility criteria not met|0
1996638|NCT00094458|3561655|FG005|Main Study: Through Week 30|Eligibility criteria not met|0
1996639|NCT00094458|3561650|FG000|Main Study: Through Week 30|Lost to Follow-up|5
1996640|NCT00094458|3561651|FG001|Main Study: Through Week 30|Lost to Follow-up|5
1996641|NCT00094458|3561652|FG002|Main Study: Through Week 30|Lost to Follow-up|2
1996642|NCT00094458|3561653|FG003|Main Study: Through Week 30|Lost to Follow-up|0
1996643|NCT00094458|3561654|FG004|Main Study: Through Week 30|Lost to Follow-up|0
1996644|NCT00094458|3561655|FG005|Main Study: Through Week 30|Lost to Follow-up|0
1996645|NCT00094458|3561650|FG000|Main Study: Through Week 30|Withdrawal by Subject|18
1996646|NCT00094458|3561651|FG001|Main Study: Through Week 30|Withdrawal by Subject|9
1996647|NCT00094458|3561652|FG002|Main Study: Through Week 30|Withdrawal by Subject|7
1996648|NCT00094458|3561653|FG003|Main Study: Through Week 30|Withdrawal by Subject|0
1996649|NCT00094458|3561654|FG004|Main Study: Through Week 30|Withdrawal by Subject|0
1996650|NCT00094458|3561655|FG005|Main Study: Through Week 30|Withdrawal by Subject|0
1996651|NCT00094458|3561650|FG000|Main Study: Through Week 30|Adverse Event|38
1996652|NCT00094458|3561651|FG001|Main Study: Through Week 30|Adverse Event|20
1996653|NCT00094458|3561652|FG002|Main Study: Through Week 30|Adverse Event|28
1996654|NCT00094458|3561653|FG003|Main Study: Through Week 30|Adverse Event|0
1996655|NCT00094458|3561654|FG004|Main Study: Through Week 30|Adverse Event|0
1996656|NCT00094458|3561655|FG005|Main Study: Through Week 30|Adverse Event|0
1996657|NCT00094458|3561650|FG000|Main Study: Through Week 30|Death|1
1996658|NCT00094458|3561651|FG001|Main Study: Through Week 30|Death|0
1996659|NCT00094458|3561652|FG002|Main Study: Through Week 30|Death|0
1996660|NCT00094458|3561653|FG003|Main Study: Through Week 30|Death|0
1996661|NCT00094458|3561654|FG004|Main Study: Through Week 30|Death|0
1996662|NCT00094458|3561655|FG005|Main Study: Through Week 30|Death|0
1996663|NCT00094458|3561650|FG000|Main Study: Through Week 30|Other|19
1996664|NCT00094458|3561651|FG001|Main Study: Through Week 30|Other|16
1996665|NCT00094458|3561652|FG002|Main Study: Through Week 30|Other|9
1996666|NCT00094458|3561653|FG003|Main Study: Through Week 30|Other|0
1996667|NCT00094458|3561654|FG004|Main Study: Through Week 30|Other|0
1996668|NCT00094458|3561655|FG005|Main Study: Through Week 30|Other|0
1996669|NCT00094458|3561650|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
1996670|NCT00094458|3561651|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
1996671|NCT00094458|3561652|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
1996672|NCT00094458|3561653|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1996673|NCT00094458|3561654|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1996674|NCT00094458|3561655|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1996675|NCT00094458|3561650|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
1996676|NCT00094458|3561651|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1996677|NCT00094458|3561652|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
1996678|NCT00094458|3561653|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1996679|NCT00094458|3561654|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1996680|NCT00094458|3561655|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1996681|NCT00094458|3561650|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3
1996682|NCT00094458|3561651|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9
1996683|NCT00094458|3561652|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7
1996684|NCT00094458|3561653|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0
1996685|NCT00094458|3561654|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0
1996686|NCT00094458|3561655|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0
1996687|NCT00094458|3561650|FG000|Study Extension: Week 30 Through Week 50|Other|1
1996688|NCT00094458|3561651|FG001|Study Extension: Week 30 Through Week 50|Other|2
1996689|NCT00094458|3561652|FG002|Study Extension: Week 30 Through Week 50|Other|3
1996690|NCT00094458|3561653|FG003|Study Extension: Week 30 Through Week 50|Other|0
1996691|NCT00094458|3561654|FG004|Study Extension: Week 30 Through Week 50|Other|0
1996692|NCT00094458|3561655|FG005|Study Extension: Week 30 Through Week 50|Other|0
1996693|NCT00094458|3561650|FG000|OLE: Open-Label Extension|Adverse Event|0
1996694|NCT00094458|3561651|FG001|OLE: Open-Label Extension|Adverse Event|0
1996695|NCT00094458|3561652|FG002|OLE: Open-Label Extension|Adverse Event|0
1996696|NCT00094458|3561653|FG003|OLE: Open-Label Extension|Adverse Event|0
1996697|NCT00094458|3561654|FG004|OLE: Open-Label Extension|Adverse Event|3
1996698|NCT00094458|3561655|FG005|OLE: Open-Label Extension|Adverse Event|4
1996699|NCT00094458|3561650|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1996700|NCT00094458|3561651|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1996701|NCT00094458|3561652|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1996702|NCT00094458|3561653|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1
1996703|NCT00094458|3561654|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1
1996704|NCT00094458|3561655|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1996705|NCT00094458|3561650|FG000|OLE: Open-Label Extension|Patient decision|0
1996706|NCT00094458|3561651|FG001|OLE: Open-Label Extension|Patient decision|0
1996707|NCT00094458|3561652|FG002|OLE: Open-Label Extension|Patient decision|0
1996708|NCT00094458|3561653|FG003|OLE: Open-Label Extension|Patient decision|0
1996709|NCT00094458|3561654|FG004|OLE: Open-Label Extension|Patient decision|1
1996710|NCT00094458|3561655|FG005|OLE: Open-Label Extension|Patient decision|0
1996711|NCT00094536|3561678|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
1996712|NCT00094536|3561678|FG000|Treatment and Follow-up|Adverse Event|4
1996713|NCT00094536|3561678|FG000|Treatment and Follow-up|Lack of Efficacy|9
1996714|NCT00094536|3561678|FG000|Treatment and Follow-up|Lost to Follow-up|7
1996715|NCT00094536|3561678|FG000|Treatment and Follow-up|Withdrawal by Subject|1
1996716|NCT00094536|3561678|FG000|Treatment and Follow-up|Subject non-compliance|9
1996717|NCT00094536|3561678|FG000|Treatment and Follow-up|Unable to attend visits|1
1996718|NCT00094575|3561684|FG000|Overall Study|Death|146
1996719|NCT00094575|3561685|FG001|Overall Study|Death|146
1996720|NCT00094653|3561696|FG000|Overall Study|Death|306
1996721|NCT00094653|3561697|FG001|Overall Study|Death|100
1996722|NCT00094653|3561698|FG002|Overall Study|Death|119
1996723|NCT00094653|3561696|FG000|Overall Study|Subject Withdrew Consent|10
1996724|NCT00094653|3561697|FG001|Overall Study|Subject Withdrew Consent|2
1996725|NCT00094653|3561698|FG002|Overall Study|Subject Withdrew Consent|3
1996726|NCT00094653|3561696|FG000|Overall Study|Other|2
1996727|NCT00094653|3561697|FG001|Overall Study|Other|2
1996728|NCT00094653|3561698|FG002|Overall Study|Other|2
1996729|NCT00094653|3561696|FG000|Overall Study|Lost to Follow-up|3
1996730|NCT00094653|3561697|FG001|Overall Study|Lost to Follow-up|2
1996731|NCT00094653|3561698|FG002|Overall Study|Lost to Follow-up|1
1996732|NCT00094653|3561696|FG000|Overall Study|Protocol Violation|0
1996733|NCT00094653|3561697|FG001|Overall Study|Protocol Violation|0
1996734|NCT00094653|3561698|FG002|Overall Study|Protocol Violation|1
1996735|NCT00094757|3561710|FG000|Overall Study|Adverse Event|11
1996736|NCT00094757|3561711|FG001|Overall Study|Adverse Event|9
1996737|NCT00094757|3561712|FG002|Overall Study|Adverse Event|6
1996738|NCT00094757|3561710|FG000|Overall Study|Lack of Efficacy|11
1996739|NCT00094757|3561711|FG001|Overall Study|Lack of Efficacy|15
1996740|NCT00094757|3561712|FG002|Overall Study|Lack of Efficacy|8
1996741|NCT00094757|3561710|FG000|Overall Study|Lost to Follow-up|3
1996742|NCT00094757|3561711|FG001|Overall Study|Lost to Follow-up|5
1996743|NCT00094757|3561712|FG002|Overall Study|Lost to Follow-up|6
1996744|NCT00094757|3561710|FG000|Overall Study|Patient Moved|2
1996745|NCT00094757|3561711|FG001|Overall Study|Patient Moved|1
1996746|NCT00094757|3561712|FG002|Overall Study|Patient Moved|1
1996747|NCT00094757|3561710|FG000|Overall Study|Protocol Violation|8
1996748|NCT00094757|3561711|FG001|Overall Study|Protocol Violation|5
1996749|NCT00094757|3561712|FG002|Overall Study|Protocol Violation|3
1996750|NCT00094757|3561710|FG000|Overall Study|Withdrawal by Subject|14
1996751|NCT00094757|3561711|FG001|Overall Study|Withdrawal by Subject|21
1996752|NCT00094757|3561712|FG002|Overall Study|Withdrawal by Subject|5
1996753|NCT00094757|3561710|FG000|Overall Study|Other|3
1996754|NCT00094757|3561711|FG001|Overall Study|Other|3
1996755|NCT00094757|3561712|FG002|Overall Study|Other|1
1996756|NCT00094757|3561710|FG000|Overall Study|Protocol specified discontinuation|1
1996757|NCT00094757|3561711|FG001|Overall Study|Protocol specified discontinuation|3
1996758|NCT00094757|3561712|FG002|Overall Study|Protocol specified discontinuation|0
1996759|NCT00094770|3561722|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25
1996760|NCT00094770|3561723|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26
2312016|NCT02760407|4017753|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
2312017|NCT02760407|4017754|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1
2312018|NCT02760407|4017755|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
2312019|NCT02760407|4017752|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1
2312020|NCT02760407|4017753|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
2312021|NCT02760407|4017754|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
2312022|NCT02760407|4017755|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
2312023|NCT02760407|4017752|FG000|Overall Study|Investigator's Decision (Adverse Event)|0
2312024|NCT02760407|4017753|FG001|Overall Study|Investigator's Decision (Adverse Event)|1
2312025|NCT02760407|4017754|FG002|Overall Study|Investigator's Decision (Adverse Event)|0
2312026|NCT02760407|4017755|FG003|Overall Study|Investigator's Decision (Adverse Event)|0
2312027|NCT02760407|4017752|FG000|Overall Study|Inadequately Enrolled|0
2312028|NCT02760407|4017753|FG001|Overall Study|Inadequately Enrolled|0
2312029|NCT02760407|4017754|FG002|Overall Study|Inadequately Enrolled|0
2312030|NCT02760407|4017755|FG003|Overall Study|Inadequately Enrolled|1
2312031|NCT02760407|4017752|FG000|Overall Study|Withdrawal By PI's Decision|0
1996761|NCT00094770|3561722|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
1996762|NCT00094770|3561723|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
1996763|NCT00094770|3561722|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
1996764|NCT00094770|3561723|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
1996765|NCT00094770|3561722|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
1996766|NCT00094770|3561723|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
1996767|NCT00094770|3561722|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
1996768|NCT00094770|3561723|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
1996769|NCT00094770|3561722|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6
1996770|NCT00094770|3561723|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2
1996771|NCT00094770|3561722|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
1996772|NCT00094770|3561723|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
1996773|NCT00094770|3561722|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2
1996774|NCT00094770|3561723|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2
1996775|NCT00094770|3561722|FG000|Year 1 ( Week 0 to Week 52)|Other|10
2213713|NCT01682512|3855662|FG001|Overall Study|Primary lack of efficacy|7
2213714|NCT01682512|3855663|FG002|Overall Study|Primary lack of efficacy|7
2213715|NCT01682512|3855661|FG000|Overall Study|Secondary lack of efficacy|1
2213716|NCT01682512|3855662|FG001|Overall Study|Secondary lack of efficacy|1
2213717|NCT01682512|3855663|FG002|Overall Study|Secondary lack of efficacy|0
2312032|NCT02760407|4017753|FG001|Overall Study|Withdrawal By PI's Decision|1
1996776|NCT00094770|3561723|FG001|Year 1 ( Week 0 to Week 52)|Other|11
1996777|NCT00094770|3561722|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35
1996778|NCT00094770|3561723|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36
1996779|NCT00094770|3561722|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
1996780|NCT00094770|3561723|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
1996781|NCT00094770|3561722|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
1996782|NCT00094770|3561723|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
1996783|NCT00094770|3561722|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13
1996784|NCT00094770|3561723|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12
1996785|NCT00094770|3561722|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
1996786|NCT00094770|3561723|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
1996787|NCT00094770|3561722|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6
1996788|NCT00094770|3561723|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2
1996789|NCT00094770|3561722|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
1996790|NCT00094770|3561723|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
1996791|NCT00094770|3561722|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2
1996792|NCT00094770|3561723|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2
1996793|NCT00094770|3561722|FG000|Year 2 (Week 0 to Week 104)|Other|15
1996794|NCT00094770|3561723|FG001|Year 2 (Week 0 to Week 104)|Other|23
1996795|NCT00094809|3561731|FG000|Overall Study|Protocol deviation|2
1996796|NCT00094809|3561732|FG001|Overall Study|Protocol deviation|2
1996797|NCT00094809|3561731|FG000|Overall Study|Noncompliance|1
1996798|NCT00094809|3561732|FG001|Overall Study|Noncompliance|0
1996799|NCT00094809|3561731|FG000|Overall Study|Adverse Event|3
1996800|NCT00094809|3561732|FG001|Overall Study|Adverse Event|1
1996801|NCT00094809|3561731|FG000|Overall Study|Withdrawal by Subject|8
1996802|NCT00094809|3561732|FG001|Overall Study|Withdrawal by Subject|9
1996803|NCT00094809|3561731|FG000|Overall Study|Disease progression|3
1996804|NCT00094809|3561732|FG001|Overall Study|Disease progression|3
1996805|NCT00094809|3561731|FG000|Overall Study|Physician Decision|3
1996806|NCT00094809|3561732|FG001|Overall Study|Physician Decision|5
1996807|NCT00094809|3561731|FG000|Overall Study|Lost to Follow-up|6
1996808|NCT00094809|3561732|FG001|Overall Study|Lost to Follow-up|6
1996809|NCT00094809|3561731|FG000|Overall Study|Death|19
1996810|NCT00094809|3561732|FG001|Overall Study|Death|25
1996811|NCT00094809|3561731|FG000|Overall Study|Protocol-specified criteria|1
1996812|NCT00094809|3561732|FG001|Overall Study|Protocol-specified criteria|1
1996813|NCT00094809|3561731|FG000|Overall Study|Other|2
1996814|NCT00094809|3561732|FG001|Overall Study|Other|4
1996815|NCT00094809|3561731|FG000|Overall Study|Informed consent signed after treatment|1
1996816|NCT00094809|3561732|FG001|Overall Study|Informed consent signed after treatment|0
1996817|NCT00094809|3561731|FG000|Overall Study|Study drug not received|2
1996818|NCT00094809|3561732|FG001|Overall Study|Study drug not received|8
1996819|NCT00094809|3561731|FG000|Overall Study|Other|1
1996820|NCT00094809|3561732|FG001|Overall Study|Other|1
1996821|NCT00094835|3561745|FG000|Overall Study|Physician Decision|1
1996822|NCT00094835|3561746|FG001|Overall Study|Physician Decision|0
1996823|NCT00094835|3561747|FG002|Overall Study|Physician Decision|0
1996824|NCT00094835|3561748|FG003|Overall Study|Physician Decision|0
1996825|NCT00094835|3561749|FG004|Overall Study|Physician Decision|0
1996826|NCT00094835|3561750|FG005|Overall Study|Physician Decision|1
1996827|NCT00094835|3561751|FG006|Overall Study|Physician Decision|0
1996828|NCT00094835|3561745|FG000|Overall Study|Withdrawal by Subject|0
1996829|NCT00094835|3561746|FG001|Overall Study|Withdrawal by Subject|0
1996830|NCT00094835|3561747|FG002|Overall Study|Withdrawal by Subject|0
1996831|NCT00094835|3561748|FG003|Overall Study|Withdrawal by Subject|0
1996832|NCT00094835|3561749|FG004|Overall Study|Withdrawal by Subject|0
1996833|NCT00094835|3561750|FG005|Overall Study|Withdrawal by Subject|0
1996834|NCT00094835|3561751|FG006|Overall Study|Withdrawal by Subject|1
1996835|NCT00094835|3561745|FG000|Overall Study|Lost to Follow-up|0
1996836|NCT00094835|3561746|FG001|Overall Study|Lost to Follow-up|0
1996837|NCT00094835|3561747|FG002|Overall Study|Lost to Follow-up|0
1996838|NCT00094835|3561748|FG003|Overall Study|Lost to Follow-up|0
2312033|NCT02760407|4017754|FG002|Overall Study|Withdrawal By PI's Decision|0
2312034|NCT02760407|4017755|FG003|Overall Study|Withdrawal By PI's Decision|0
2312035|NCT02760407|4017752|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
1996839|NCT00094835|3561749|FG004|Overall Study|Lost to Follow-up|1
1996840|NCT00094835|3561750|FG005|Overall Study|Lost to Follow-up|0
1996841|NCT00094835|3561751|FG006|Overall Study|Lost to Follow-up|0
1996842|NCT00094835|3561745|FG000|Overall Study|Death|1
1996843|NCT00094835|3561746|FG001|Overall Study|Death|0
1996844|NCT00094835|3561747|FG002|Overall Study|Death|0
1996845|NCT00094835|3561748|FG003|Overall Study|Death|0
1996846|NCT00094835|3561749|FG004|Overall Study|Death|1
1996847|NCT00094835|3561750|FG005|Overall Study|Death|0
1996848|NCT00094835|3561751|FG006|Overall Study|Death|0
1996849|NCT00094835|3561745|FG000|Overall Study|Non-compliance|1
1996850|NCT00094835|3561746|FG001|Overall Study|Non-compliance|2
1996851|NCT00094835|3561747|FG002|Overall Study|Non-compliance|2
1996852|NCT00094835|3561748|FG003|Overall Study|Non-compliance|0
1996853|NCT00094835|3561749|FG004|Overall Study|Non-compliance|2
1996854|NCT00094835|3561750|FG005|Overall Study|Non-compliance|2
1996855|NCT00094835|3561751|FG006|Overall Study|Non-compliance|1
1996856|NCT00094835|3561745|FG000|Overall Study|Other|1
1996857|NCT00094835|3561746|FG001|Overall Study|Other|1
1996858|NCT00094835|3561747|FG002|Overall Study|Other|1
1996859|NCT00094835|3561748|FG003|Overall Study|Other|1
1996860|NCT00094835|3561749|FG004|Overall Study|Other|0
1996861|NCT00094835|3561750|FG005|Overall Study|Other|0
1996862|NCT00094835|3561751|FG006|Overall Study|Other|0
1996863|NCT00094861|3561774|FG000|Overall Study|Adverse Event|5
1996864|NCT00094861|3561775|FG001|Overall Study|Adverse Event|2
1996865|NCT00094861|3561774|FG000|Overall Study|Withdrawal by Subject|5
1996866|NCT00094861|3561775|FG001|Overall Study|Withdrawal by Subject|3
1996867|NCT00094861|3561774|FG000|Overall Study|Physician Decision|1
1996868|NCT00094861|3561775|FG001|Overall Study|Physician Decision|1
1996869|NCT00094861|3561774|FG000|Overall Study|Lost to Follow-up|0
1996870|NCT00094861|3561775|FG001|Overall Study|Lost to Follow-up|1
1996871|NCT00094861|3561774|FG000|Overall Study|Death|4
1996872|NCT00094861|3561775|FG001|Overall Study|Death|2
1996873|NCT00094861|3561774|FG000|Overall Study|Other|3
1996874|NCT00094861|3561775|FG001|Overall Study|Other|0
1996875|NCT00095056|3561796|FG000|Phase A (Weeks 0-12)|Adverse Event|1
1996876|NCT00095056|3561797|FG001|Phase A (Weeks 0-12)|Adverse Event|1
1996877|NCT00095056|3561796|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3
1996878|NCT00095056|3561797|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0
1996879|NCT00095056|3561796|FG000|Phase A (Weeks 0-12)|Death|1
1996880|NCT00095056|3561797|FG001|Phase A (Weeks 0-12)|Death|0
1996881|NCT00095056|3561796|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2
1996882|NCT00095056|3561797|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0
1996883|NCT00095056|3561796|FG000|Phase B (Weeks 12-54)|Adverse Event|2
1996884|NCT00095056|3561797|FG001|Phase B (Weeks 12-54)|Adverse Event|2
1996885|NCT00095056|3561796|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1
1996886|NCT00095056|3561797|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0
1996887|NCT00095056|3561796|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2
1996888|NCT00095056|3561797|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1
1996889|NCT00095056|3561796|FG000|Phase B (Weeks 12-54)|Patient Moved|1
1996890|NCT00095056|3561797|FG001|Phase B (Weeks 12-54)|Patient Moved|0
1996891|NCT00095056|3561796|FG000|Phase B (Weeks 12-54)|Death|3
1996892|NCT00095056|3561797|FG001|Phase B (Weeks 12-54)|Death|1
1996893|NCT00095056|3561796|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1
1996894|NCT00095056|3561797|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0
1996895|NCT00095056|3561796|FG000|Phase B (Weeks 12-54)|Protocol Violation|0
1996896|NCT00095056|3561797|FG001|Phase B (Weeks 12-54)|Protocol Violation|1
1996897|NCT00095121|3561805|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
1996898|NCT00095121|3561806|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
1996899|NCT00095121|3561805|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
1996900|NCT00095121|3561806|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
1996901|NCT00095147|3561825|FG000|Double-blind Period 1 (Days 1-197)|Death|1
1996902|NCT00095147|3561826|FG001|Double-blind Period 1 (Days 1-197)|Death|0
1996903|NCT00095147|3561827|FG002|Double-blind Period 1 (Days 1-197)|Death|0
1996904|NCT00095147|3561828|FG003|Double-blind Period 1 (Days 1-197)|Death|0
1996905|NCT00095147|3561829|FG004|Double-blind Period 1 (Days 1-197)|Death|0
1996906|NCT00095147|3561825|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2
1996907|NCT00095147|3561826|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8
1996908|NCT00095147|3561827|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1
1996909|NCT00095147|3561828|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0
1996910|NCT00095147|3561829|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0
1996911|NCT00095147|3561825|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
1996912|NCT00095147|3561826|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
1996913|NCT00095147|3561827|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
1996914|NCT00095147|3561828|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
1996915|NCT00095147|3561829|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
1996916|NCT00095147|3561825|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
1996917|NCT00095147|3561826|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
1996918|NCT00095147|3561827|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1996919|NCT00095147|3561828|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1996920|NCT00095147|3561829|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1996921|NCT00095147|3561825|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
1996922|NCT00095147|3561826|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1996923|NCT00095147|3561827|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
1996924|NCT00095147|3561828|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1996925|NCT00095147|3561829|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1996926|NCT00095147|3561825|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1
1996927|NCT00095147|3561826|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1
1996928|NCT00095147|3561827|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1996929|NCT00095147|3561828|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1996930|NCT00095147|3561829|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1996931|NCT00095147|3561825|FG000|Double-blind Period 2 (Days 198-365)|Death|0
1996932|NCT00095147|3561826|FG001|Double-blind Period 2 (Days 198-365)|Death|1
1996933|NCT00095147|3561827|FG002|Double-blind Period 2 (Days 198-365)|Death|0
1996934|NCT00095147|3561828|FG003|Double-blind Period 2 (Days 198-365)|Death|1
1996935|NCT00095147|3561829|FG004|Double-blind Period 2 (Days 198-365)|Death|0
1996936|NCT00095147|3561825|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2
1996937|NCT00095147|3561826|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4
1996938|NCT00095147|3561827|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1996939|NCT00095147|3561828|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1996940|NCT00095147|3561829|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1996941|NCT00095147|3561825|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
1996942|NCT00095147|3561826|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
1996943|NCT00095147|3561827|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
1996944|NCT00095147|3561828|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
1996945|NCT00095147|3561829|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
1996946|NCT00095147|3561825|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
1996947|NCT00095147|3561826|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
1996948|NCT00095147|3561827|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1996949|NCT00095147|3561828|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1996950|NCT00095147|3561829|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1996951|NCT00095147|3561825|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1
1996952|NCT00095147|3561826|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1996953|NCT00095147|3561827|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1996954|NCT00095147|3561828|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1
1996955|NCT00095147|3561829|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1996956|NCT00095147|3561825|FG000|Long-term Extension Period|Death|0
1996957|NCT00095147|3561826|FG001|Long-term Extension Period|Death|0
1996958|NCT00095147|3561827|FG002|Long-term Extension Period|Death|0
1996959|NCT00095147|3561828|FG003|Long-term Extension Period|Death|0
1996960|NCT00095147|3561829|FG004|Long-term Extension Period|Death|3
1996961|NCT00095147|3561825|FG000|Long-term Extension Period|Adverse Event|0
1996962|NCT00095147|3561826|FG001|Long-term Extension Period|Adverse Event|0
1996963|NCT00095147|3561827|FG002|Long-term Extension Period|Adverse Event|0
1996964|NCT00095147|3561828|FG003|Long-term Extension Period|Adverse Event|0
1996965|NCT00095147|3561829|FG004|Long-term Extension Period|Adverse Event|11
1996966|NCT00095147|3561825|FG000|Long-term Extension Period|Lack of Efficacy|0
1996967|NCT00095147|3561826|FG001|Long-term Extension Period|Lack of Efficacy|0
1996968|NCT00095147|3561827|FG002|Long-term Extension Period|Lack of Efficacy|0
1996969|NCT00095147|3561828|FG003|Long-term Extension Period|Lack of Efficacy|0
1996970|NCT00095147|3561829|FG004|Long-term Extension Period|Lack of Efficacy|9
1996971|NCT00095147|3561825|FG000|Long-term Extension Period|Lost to Follow-up|0
1996972|NCT00095147|3561826|FG001|Long-term Extension Period|Lost to Follow-up|0
1996973|NCT00095147|3561827|FG002|Long-term Extension Period|Lost to Follow-up|0
1996974|NCT00095147|3561828|FG003|Long-term Extension Period|Lost to Follow-up|0
1996975|NCT00095147|3561829|FG004|Long-term Extension Period|Lost to Follow-up|6
1996976|NCT00095147|3561825|FG000|Long-term Extension Period|Withdrawal of consent|0
1996977|NCT00095147|3561826|FG001|Long-term Extension Period|Withdrawal of consent|0
1996978|NCT00095147|3561827|FG002|Long-term Extension Period|Withdrawal of consent|0
1996979|NCT00095147|3561828|FG003|Long-term Extension Period|Withdrawal of consent|0
1996980|NCT00095147|3561829|FG004|Long-term Extension Period|Withdrawal of consent|12
1996981|NCT00095147|3561825|FG000|Long-term Extension Period|Pregnancy|0
1996982|NCT00095147|3561826|FG001|Long-term Extension Period|Pregnancy|0
1996983|NCT00095147|3561827|FG002|Long-term Extension Period|Pregnancy|0
1996984|NCT00095147|3561828|FG003|Long-term Extension Period|Pregnancy|0
1996985|NCT00095147|3561829|FG004|Long-term Extension Period|Pregnancy|1
1996986|NCT00095147|3561825|FG000|Long-term Extension Period|No longer meets study criteria|0
1996987|NCT00095147|3561826|FG001|Long-term Extension Period|No longer meets study criteria|0
1996988|NCT00095147|3561827|FG002|Long-term Extension Period|No longer meets study criteria|0
1996989|NCT00095147|3561828|FG003|Long-term Extension Period|No longer meets study criteria|0
1996990|NCT00095147|3561829|FG004|Long-term Extension Period|No longer meets study criteria|1
1996991|NCT00095147|3561825|FG000|Long-term Extension Period|Participant chose to use Revellex|0
1996992|NCT00095147|3561826|FG001|Long-term Extension Period|Participant chose to use Revellex|0
1996993|NCT00095147|3561827|FG002|Long-term Extension Period|Participant chose to use Revellex|0
1996994|NCT00095147|3561828|FG003|Long-term Extension Period|Participant chose to use Revellex|0
1996995|NCT00095147|3561829|FG004|Long-term Extension Period|Participant chose to use Revellex|1
1996996|NCT00095147|3561825|FG000|Long-term Extension Period|Leaving country|0
1996997|NCT00095147|3561826|FG001|Long-term Extension Period|Leaving country|0
1996998|NCT00095147|3561827|FG002|Long-term Extension Period|Leaving country|0
1996999|NCT00095147|3561828|FG003|Long-term Extension Period|Leaving country|0
1997000|NCT00095147|3561829|FG004|Long-term Extension Period|Leaving country|1
1997001|NCT00095173|3561847|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1
1997002|NCT00095173|3561848|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1997003|NCT00095173|3561849|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1997004|NCT00095173|3561850|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1997005|NCT00095173|3561851|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1997006|NCT00095173|3561852|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1997007|NCT00095173|3561847|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
1997008|NCT00095173|3561848|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1997009|NCT00095173|3561849|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1997010|NCT00095173|3561850|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1997011|NCT00095173|3561851|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1997012|NCT00095173|3561852|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1997013|NCT00095173|3561847|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
1997014|NCT00095173|3561848|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1997015|NCT00095173|3561849|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1997016|NCT00095173|3561850|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1997017|NCT00095173|3561851|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1997018|NCT00095173|3561852|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1997019|NCT00095173|3561847|FG000|Open-Label Lead-In Phase (Period A)|Other|1
1997020|NCT00095173|3561848|FG001|Open-Label Lead-In Phase (Period A)|Other|0
1997021|NCT00095173|3561849|FG002|Open-Label Lead-In Phase (Period A)|Other|0
1997022|NCT00095173|3561850|FG003|Open-Label Lead-In Phase (Period A)|Other|0
1997023|NCT00095173|3561851|FG004|Open-Label Lead-In Phase (Period A)|Other|0
1997024|NCT00095173|3561852|FG005|Open-Label Lead-In Phase (Period A)|Other|0
1997025|NCT00095173|3561847|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0
1997026|NCT00095173|3561848|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10
1997027|NCT00095173|3561849|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31
1997028|NCT00095173|3561850|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0
1997029|NCT00095173|3561851|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0
1997030|NCT00095173|3561852|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0
1997031|NCT00095173|3561847|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1997032|NCT00095173|3561848|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1
1997033|NCT00095173|3561849|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1997034|NCT00095173|3561850|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1997035|NCT00095173|3561851|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1997036|NCT00095173|3561852|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1997037|NCT00095173|3561847|FG000|Open-Label Extension Phase (Period C)|Death|0
1997038|NCT00095173|3561848|FG001|Open-Label Extension Phase (Period C)|Death|0
1997039|NCT00095173|3561849|FG002|Open-Label Extension Phase (Period C)|Death|0
1997040|NCT00095173|3561850|FG003|Open-Label Extension Phase (Period C)|Death|0
1997041|NCT00095173|3561851|FG004|Open-Label Extension Phase (Period C)|Death|0
1997042|NCT00095173|3561852|FG005|Open-Label Extension Phase (Period C)|Death|1
1997043|NCT00095173|3561847|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0
1997044|NCT00095173|3561848|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0
1997045|NCT00095173|3561849|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0
1997046|NCT00095173|3561850|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1
1997047|NCT00095173|3561851|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2
1997048|NCT00095173|3561852|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3
1997049|NCT00095173|3561847|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1997050|NCT00095173|3561848|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1997051|NCT00095173|3561849|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1997052|NCT00095173|3561850|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
1997053|NCT00095173|3561851|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
1997054|NCT00095173|3561852|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
1997055|NCT00095173|3561847|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1997056|NCT00095173|3561848|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1997057|NCT00095173|3561849|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1997058|NCT00095173|3561850|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
1997059|NCT00095173|3561851|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
1997060|NCT00095173|3561852|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
1997061|NCT00095173|3561847|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1997062|NCT00095173|3561848|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1997063|NCT00095173|3561849|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1997064|NCT00095173|3561850|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
1997065|NCT00095173|3561851|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
1997066|NCT00095173|3561852|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1997067|NCT00095173|3561847|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1997068|NCT00095173|3561848|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1997069|NCT00095173|3561849|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1997070|NCT00095173|3561850|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1997071|NCT00095173|3561851|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
1997072|NCT00095173|3561852|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
1997073|NCT00095173|3561847|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1997074|NCT00095173|3561848|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1997075|NCT00095173|3561849|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1997076|NCT00095173|3561850|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1997077|NCT00095173|3561851|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
1997078|NCT00095173|3561852|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
1997079|NCT00095173|3561847|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0
1997080|NCT00095173|3561848|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0
1997081|NCT00095173|3561849|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0
1997082|NCT00095173|3561850|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1
1997083|NCT00095173|3561851|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2
1997084|NCT00095173|3561852|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3
1997085|NCT00095173|3561847|FG000|Open-Label Extension Phase (Period C)|Other|0
1997086|NCT00095173|3561848|FG001|Open-Label Extension Phase (Period C)|Other|0
1997087|NCT00095173|3561849|FG002|Open-Label Extension Phase (Period C)|Other|0
1997088|NCT00095173|3561850|FG003|Open-Label Extension Phase (Period C)|Other|4
1997089|NCT00095173|3561851|FG004|Open-Label Extension Phase (Period C)|Other|6
1997090|NCT00095173|3561852|FG005|Open-Label Extension Phase (Period C)|Other|8
1997091|NCT00095199|3561870|FG000|Overall Study|Adverse Event|40
1997092|NCT00095199|3561871|FG001|Overall Study|Adverse Event|22
1997093|NCT00095199|3561872|FG002|Overall Study|Adverse Event|26
1997094|NCT00095199|3561873|FG003|Overall Study|Adverse Event|11
1997095|NCT00095199|3561870|FG000|Overall Study|Progressive disease|213
1997096|NCT00095199|3561871|FG001|Overall Study|Progressive disease|179
1997097|NCT00095199|3561872|FG002|Overall Study|Progressive disease|105
1997098|NCT00095199|3561873|FG003|Overall Study|Progressive disease|98
1997099|NCT00095199|3561870|FG000|Overall Study|Death|10
1997100|NCT00095199|3561871|FG001|Overall Study|Death|6
1997101|NCT00095199|3561872|FG002|Overall Study|Death|11
1997102|NCT00095199|3561873|FG003|Overall Study|Death|9
1997103|NCT00095199|3561870|FG000|Overall Study|Withdrawal by Subject|21
1997104|NCT00095199|3561871|FG001|Overall Study|Withdrawal by Subject|16
1997105|NCT00095199|3561872|FG002|Overall Study|Withdrawal by Subject|13
1997106|NCT00095199|3561873|FG003|Overall Study|Withdrawal by Subject|22
1997107|NCT00095199|3561870|FG000|Overall Study|Protocol Violation|4
1997108|NCT00095199|3561871|FG001|Overall Study|Protocol Violation|4
2213718|NCT01682512|3855661|FG000|Overall Study|Other than stated above|2
2213719|NCT01682512|3855662|FG001|Overall Study|Other than stated above|4
2213720|NCT01682512|3855663|FG002|Overall Study|Other than stated above|2
1997109|NCT00095199|3561872|FG002|Overall Study|Protocol Violation|2
1997110|NCT00095199|3561873|FG003|Overall Study|Protocol Violation|0
1997111|NCT00095199|3561870|FG000|Overall Study|Liver function test results elevated|0
1997112|NCT00095199|3561871|FG001|Overall Study|Liver function test results elevated|0
1997113|NCT00095199|3561872|FG002|Overall Study|Liver function test results elevated|1
1997114|NCT00095199|3561873|FG003|Overall Study|Liver function test results elevated|1
1997115|NCT00095199|3561870|FG000|Overall Study|Surgery needed could not start in 7 days|0
1997116|NCT00095199|3561871|FG001|Overall Study|Surgery needed could not start in 7 days|0
1997117|NCT00095199|3561872|FG002|Overall Study|Surgery needed could not start in 7 days|1
1997118|NCT00095199|3561873|FG003|Overall Study|Surgery needed could not start in 7 days|0
1997119|NCT00095199|3561870|FG000|Overall Study|Physician Decision|5
1997120|NCT00095199|3561871|FG001|Overall Study|Physician Decision|6
1997121|NCT00095199|3561872|FG002|Overall Study|Physician Decision|1
1997122|NCT00095199|3561873|FG003|Overall Study|Physician Decision|1
1997123|NCT00095199|3561870|FG000|Overall Study|Not eligible|1
1997124|NCT00095199|3561871|FG001|Overall Study|Not eligible|7
1997125|NCT00095199|3561872|FG002|Overall Study|Not eligible|0
1997126|NCT00095199|3561873|FG003|Overall Study|Not eligible|1
1997127|NCT00095199|3561870|FG000|Overall Study|Started Palliative Radiotherapy|1
1997128|NCT00095199|3561871|FG001|Overall Study|Started Palliative Radiotherapy|0
1997129|NCT00095199|3561872|FG002|Overall Study|Started Palliative Radiotherapy|0
1997130|NCT00095199|3561873|FG003|Overall Study|Started Palliative Radiotherapy|0
1997131|NCT00095199|3561870|FG000|Overall Study|Started radiotherapy regimen|0
1997132|NCT00095199|3561871|FG001|Overall Study|Started radiotherapy regimen|1
1997133|NCT00095199|3561872|FG002|Overall Study|Started radiotherapy regimen|0
1997134|NCT00095199|3561873|FG003|Overall Study|Started radiotherapy regimen|0
1997135|NCT00095199|3561870|FG000|Overall Study|Primary tumor removed in other surgery|0
1997136|NCT00095199|3561871|FG001|Overall Study|Primary tumor removed in other surgery|1
1997137|NCT00095199|3561872|FG002|Overall Study|Primary tumor removed in other surgery|0
1997138|NCT00095199|3561873|FG003|Overall Study|Primary tumor removed in other surgery|0
1997139|NCT00095199|3561870|FG000|Overall Study|Data inadvertently lost by site|1
2213721|NCT01682603|3855686|FG000|Overall Study|Lost to Follow-up|3
2213722|NCT01682681|3855707|FG000|Overall Study|Lack of Efficacy|62
2213723|NCT01682681|3855707|FG000|Overall Study|Withdrawal by Subject|1
2213724|NCT01682681|3855707|FG000|Overall Study|Moved to other hospital|10
2213725|NCT01682681|3855707|FG000|Overall Study|Lost to Follow-up|174
2213726|NCT01682681|3855707|FG000|Overall Study|Adverse Event|46
2213727|NCT01682681|3855707|FG000|Overall Study|tapering of topiramate|5
2213728|NCT01682681|3855707|FG000|Overall Study|Other|21
2213729|NCT01682681|3855707|FG000|Overall Study|Low compliance|13
2213730|NCT01682720|3855715|FG000|Overall Study|Randomized but Not Treated|0
1997140|NCT00095199|3561871|FG001|Overall Study|Data inadvertently lost by site|0
1997141|NCT00095199|3561872|FG002|Overall Study|Data inadvertently lost by site|0
1997142|NCT00095199|3561873|FG003|Overall Study|Data inadvertently lost by site|0
2213731|NCT01682720|3855716|FG001|Overall Study|Randomized but Not Treated|1
2213732|NCT01682720|3855717|FG002|Overall Study|Randomized but Not Treated|1
1997143|NCT00095212|3561890|FG000|Overall Study|Withdrawal by Subject|1
1997144|NCT00095212|3561891|FG001|Overall Study|Withdrawal by Subject|3
1997145|NCT00095238|3561899|FG000|Overall Study|Lack of Efficacy|9
1997146|NCT00095238|3561900|FG001|Overall Study|Lack of Efficacy|9
1997147|NCT00095238|3561899|FG000|Overall Study|Adverse Event|331
1997148|NCT00095238|3561900|FG001|Overall Study|Adverse Event|287
1997149|NCT00095238|3561899|FG000|Overall Study|Subject Withdrew Consent|208
1997150|NCT00095238|3561900|FG001|Overall Study|Subject Withdrew Consent|223
1997151|NCT00095238|3561899|FG000|Overall Study|Death|154
1997152|NCT00095238|3561900|FG001|Overall Study|Death|170
1997153|NCT00095238|3561899|FG000|Overall Study|Lost to Follow-up|19
1997154|NCT00095238|3561900|FG001|Overall Study|Lost to Follow-up|24
1997155|NCT00095238|3561899|FG000|Overall Study|Noncompliance|44
1997156|NCT00095238|3561900|FG001|Overall Study|Noncompliance|45
1997157|NCT00095238|3561899|FG000|Overall Study|No longer met study criteria|4
1997158|NCT00095238|3561900|FG001|Overall Study|No longer met study criteria|5
1997159|NCT00095238|3561899|FG000|Overall Study|Study terminated by sponsor|0
1997160|NCT00095238|3561900|FG001|Overall Study|Study terminated by sponsor|1
1997161|NCT00095238|3561899|FG000|Overall Study|Missing|1
1997162|NCT00095238|3561900|FG001|Overall Study|Missing|0
1997163|NCT00095238|3561899|FG000|Overall Study|Other Reasons|87
1997164|NCT00095238|3561900|FG001|Overall Study|Other Reasons|88
1997165|NCT00095303|3561940|FG000|Main Study|Lost to Follow-up|91
1997166|NCT00095303|3561941|FG001|Main Study|Lost to Follow-up|87
1997167|NCT00095303|3561940|FG000|Follow Up Study|Lost to Follow-up|59
1997168|NCT00095303|3561941|FG001|Follow Up Study|Lost to Follow-up|58
1997169|NCT00095498|3561950|FG000|Overall Study|Physician Decision|9
1997170|NCT00095498|3561951|FG001|Overall Study|Physician Decision|10
1997171|NCT00095498|3561952|FG002|Overall Study|Physician Decision|8
1997172|NCT00095498|3561950|FG000|Overall Study|Adverse Event|1
1997173|NCT00095498|3561951|FG001|Overall Study|Adverse Event|0
1997174|NCT00095498|3561952|FG002|Overall Study|Adverse Event|1
1997175|NCT00095498|3561950|FG000|Overall Study|Withdrawal by Subject|15
1997176|NCT00095498|3561951|FG001|Overall Study|Withdrawal by Subject|16
1997177|NCT00095498|3561952|FG002|Overall Study|Withdrawal by Subject|15
1997178|NCT00095498|3561950|FG000|Overall Study|Disease progression|0
1997179|NCT00095498|3561951|FG001|Overall Study|Disease progression|1
1997180|NCT00095498|3561952|FG002|Overall Study|Disease progression|1
1997181|NCT00095498|3561950|FG000|Overall Study|Ineligibility determined|3
1997182|NCT00095498|3561951|FG001|Overall Study|Ineligibility determined|0
1997183|NCT00095498|3561952|FG002|Overall Study|Ineligibility determined|2
1997184|NCT00095498|3561950|FG000|Overall Study|Lost to Follow-up|1
1997185|NCT00095498|3561951|FG001|Overall Study|Lost to Follow-up|1
1997186|NCT00095498|3561952|FG002|Overall Study|Lost to Follow-up|2
1997187|NCT00095498|3561950|FG000|Overall Study|Noncompliance|1
1997188|NCT00095498|3561951|FG001|Overall Study|Noncompliance|0
1997189|NCT00095498|3561952|FG002|Overall Study|Noncompliance|1
1997190|NCT00095498|3561950|FG000|Overall Study|Other|6
1997191|NCT00095498|3561951|FG001|Overall Study|Other|7
1997192|NCT00095498|3561952|FG002|Overall Study|Other|6
1997193|NCT00095498|3561950|FG000|Overall Study|Protocol Violation|0
1997194|NCT00095498|3561951|FG001|Overall Study|Protocol Violation|0
1997195|NCT00095498|3561952|FG002|Overall Study|Protocol Violation|1
1997196|NCT00095498|3561950|FG000|Overall Study|Requirement for alternative therapy|1
1997197|NCT00095498|3561951|FG001|Overall Study|Requirement for alternative therapy|0
1997198|NCT00095498|3561952|FG002|Overall Study|Requirement for alternative therapy|2
1997199|NCT00095576|3561966|FG000|Overall Study|Adverse Event|5
1997200|NCT00095576|3561967|FG001|Overall Study|Adverse Event|3
1997201|NCT00095576|3561966|FG000|Overall Study|Lost to Follow-up|233
1997202|NCT00095576|3561967|FG001|Overall Study|Lost to Follow-up|229
1997203|NCT00095576|3561966|FG000|Overall Study|Protocol Violation|1
1997204|NCT00095576|3561967|FG001|Overall Study|Protocol Violation|0
1997205|NCT00095576|3561966|FG000|Overall Study|Withdrawal by Subject|34
1997206|NCT00095576|3561967|FG001|Overall Study|Withdrawal by Subject|47
1997207|NCT00095576|3561966|FG000|Overall Study|Option to switch to a rollover study|1097
2213733|NCT01682720|3855718|FG003|Overall Study|Randomized but Not Treated|0
2213734|NCT01682720|3855715|FG000|Overall Study|Terminated by Sponsor|83
2213735|NCT01682720|3855716|FG001|Overall Study|Terminated by Sponsor|0
1997208|NCT00095576|3561967|FG001|Overall Study|Option to switch to a rollover study|1099
1997209|NCT00095576|3561966|FG000|Overall Study|Site terminated|75
1997210|NCT00095576|3561967|FG001|Overall Study|Site terminated|67
1997211|NCT00095576|3561966|FG000|Overall Study|Subject moved|30
1997212|NCT00095576|3561967|FG001|Overall Study|Subject moved|36
1997213|NCT00095628|3561973|FG000|Overall Study|Disease progression prior to treatment|1
1997214|NCT00095836|3561977|FG000|Overall Study|Lost to Follow-up|1
1997215|NCT00095836|3561977|FG000|Overall Study|Adverse Event|1
1997216|NCT00095836|3561977|FG000|Overall Study|Death|2
1997217|NCT00095940|3561997|FG000|Lapatinib Continuation/Phase II|Disease Progression|1
1997218|NCT00095940|3561998|FG001|Lapatinib Continuation/Phase II|Disease Progression|1
1997219|NCT00095940|3561999|FG002|Lapatinib Continuation/Phase II|Disease Progression|15
1997220|NCT00095940|3562000|FG003|Lapatinib Continuation/Phase II|Disease Progression|0
1997221|NCT00095940|3562001|FG004|Lapatinib Continuation/Phase II|Disease Progression|0
1997222|NCT00095940|3562002|FG005|Lapatinib Continuation/Phase II|Disease Progression|13
1997223|NCT00095940|3562003|FG006|Lapatinib Continuation/Phase II|Disease Progression|2
1997224|NCT00095940|3562004|FG007|Lapatinib Continuation/Phase II|Disease Progression|1
1997225|NCT00095940|3562005|FG008|Lapatinib Continuation/Phase II|Disease Progression|12
1997226|NCT00095940|3561997|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1997227|NCT00095940|3561998|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1997228|NCT00095940|3561999|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1997229|NCT00095940|3562000|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1997230|NCT00095940|3562001|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1997231|NCT00095940|3562002|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1997232|NCT00095940|3562003|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1997233|NCT00095940|3562004|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1997234|NCT00095940|3562005|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1997235|NCT00095940|3561997|FG000|Lapatinib Continuation/Phase II|Adverse Event|0
1997236|NCT00095940|3561998|FG001|Lapatinib Continuation/Phase II|Adverse Event|0
1997237|NCT00095940|3561999|FG002|Lapatinib Continuation/Phase II|Adverse Event|0
1997238|NCT00095940|3562000|FG003|Lapatinib Continuation/Phase II|Adverse Event|0
1997239|NCT00095940|3562001|FG004|Lapatinib Continuation/Phase II|Adverse Event|0
1997240|NCT00095940|3562002|FG005|Lapatinib Continuation/Phase II|Adverse Event|0
1997241|NCT00095940|3562003|FG006|Lapatinib Continuation/Phase II|Adverse Event|0
1997242|NCT00095940|3562004|FG007|Lapatinib Continuation/Phase II|Adverse Event|1
1997243|NCT00095940|3562005|FG008|Lapatinib Continuation/Phase II|Adverse Event|0
1997244|NCT00095979|3562023|FG000|Overall Study|Ineligible: Second primary cancer site|2
1997245|NCT00096018|3562034|FG000|Overall Study|Became Ineligible (not treated)|0
1997246|NCT00096018|3562035|FG001|Overall Study|Became Ineligible (not treated)|3
1997247|NCT00096018|3562034|FG000|Overall Study|Miscellaneous (not treated)|0
1997248|NCT00096018|3562035|FG001|Overall Study|Miscellaneous (not treated)|2
1997249|NCT00096018|3562034|FG000|Overall Study|Adverse Event|0
1997250|NCT00096018|3562035|FG001|Overall Study|Adverse Event|5
1997251|NCT00096018|3562034|FG000|Overall Study|Death|0
1997252|NCT00096018|3562035|FG001|Overall Study|Death|1
1997253|NCT00096018|3562034|FG000|Overall Study|Withdrawal by Subject|0
1997254|NCT00096018|3562035|FG001|Overall Study|Withdrawal by Subject|2
1997255|NCT00096018|3562034|FG000|Overall Study|Miscellaneous|2
1997256|NCT00096018|3562035|FG001|Overall Study|Miscellaneous|1
1997257|NCT00096031|3562041|FG000|Overall Study|Adverse Event|3
1997258|NCT00096031|3562041|FG000|Overall Study|Lack of Efficacy|42
1997259|NCT00096031|3562041|FG000|Overall Study|Death|4
1997260|NCT00096031|3562041|FG000|Overall Study|Withdrawal by Subject|1
1997261|NCT00096031|3562041|FG000|Overall Study|Ineligible|8
1997262|NCT00096031|3562041|FG000|Overall Study|Not protocol specified|5
1997263|NCT00096044|3562045|FG000|Overall Study|Withdrawal by Subject|9
1997264|NCT00096044|3562045|FG000|Overall Study|Adverse Event|21
1997265|NCT00096044|3562045|FG000|Overall Study|Disease Progression|4
1997266|NCT00096135|3562059|FG000|Overall Study|Physician Decision|20
1997267|NCT00096135|3562060|FG001|Overall Study|Physician Decision|4
1997268|NCT00096135|3562059|FG000|Overall Study|Refusal of further protocol therapy|4
1997269|NCT00096135|3562060|FG001|Overall Study|Refusal of further protocol therapy|1
1997270|NCT00096135|3562059|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
1997271|NCT00096135|3562060|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
1997272|NCT00096135|3562059|FG000|Overall Study|Other, specify|15
1997273|NCT00096135|3562060|FG001|Overall Study|Other, specify|3
1997274|NCT00096135|3562059|FG000|Overall Study|Ineligible|2
1997275|NCT00096135|3562060|FG001|Overall Study|Ineligible|0
1997276|NCT00096174|3562083|FG000|Overall Study|Lack of Efficacy|9
1997277|NCT00096174|3562083|FG000|Overall Study|Adverse Event|15
1997278|NCT00096174|3562083|FG000|Overall Study|Death|6
1997279|NCT00096174|3562083|FG000|Overall Study|Withdrawal by Subject|15
1997280|NCT00096174|3562083|FG000|Overall Study|Not started protocol therapy|3
1997281|NCT00096174|3562083|FG000|Overall Study|Ineligible|6
1997282|NCT00096174|3562083|FG000|Overall Study|other reason|8
1997283|NCT00096226|3562087|FG000|Overall Study|Ineligible|2
1997284|NCT00096226|3562087|FG000|Overall Study|Protocol treatment not started|1
1997285|NCT00096265|3562094|FG000|Overall Study|Ineligible|1
1997286|NCT00096265|3562095|FG001|Overall Study|Ineligible|0
1997287|NCT00096265|3562096|FG002|Overall Study|Ineligible|0
1997288|NCT00096278|3562107|FG000|Overall Study|No follow-up data|15
1997289|NCT00096278|3562108|FG001|Overall Study|No follow-up data|18
1997290|NCT00096278|3562107|FG000|Overall Study|Patient not at risk for primary endpoint|3
1997291|NCT00096278|3562108|FG001|Overall Study|Patient not at risk for primary endpoint|2
1997292|NCT00096356|3562118|FG000|Overall Study|Adverse Event|11
1997293|NCT00096356|3562119|FG001|Overall Study|Adverse Event|9
1997294|NCT00096356|3562118|FG000|Overall Study|Physician Decision|5
1997295|NCT00096356|3562119|FG001|Overall Study|Physician Decision|3
1997296|NCT00096356|3562118|FG000|Overall Study|Withdrawal by Subject|17
1997297|NCT00096356|3562119|FG001|Overall Study|Withdrawal by Subject|23
1997298|NCT00096356|3562118|FG000|Overall Study|Lack of Efficacy|1
1997299|NCT00096356|3562119|FG001|Overall Study|Lack of Efficacy|0
1997300|NCT00096356|3562118|FG000|Overall Study|multiple reasons|10
1997301|NCT00096356|3562119|FG001|Overall Study|multiple reasons|18
1997302|NCT00096382|3562128|FG000|Overall Study|Not treated|1
1997303|NCT00096382|3562129|FG001|Overall Study|Not treated|0
1997304|NCT00096382|3562128|FG000|Overall Study|Death during treatment|1
1997305|NCT00096382|3562129|FG001|Overall Study|Death during treatment|0
1997306|NCT00096447|3562135|FG000|Overall Study|Never treated|1
1997307|NCT00096486|3562157|FG000|Overall Study|Withdrawal by Subject|0
1997308|NCT00096486|3562158|FG001|Overall Study|Withdrawal by Subject|0
1997309|NCT00096486|3562159|FG002|Overall Study|Withdrawal by Subject|1
1997310|NCT00096486|3562160|FG003|Overall Study|Withdrawal by Subject|1
1997311|NCT00096486|3562157|FG000|Overall Study|Not Treated|0
1997312|NCT00096486|3562158|FG001|Overall Study|Not Treated|0
1997313|NCT00096486|3562159|FG002|Overall Study|Not Treated|1
1997314|NCT00096486|3562160|FG003|Overall Study|Not Treated|1
1997315|NCT00096538|3562170|FG000|Overall Study|Withdrawal by Subject|1
1997316|NCT00096785|3562180|FG000|Overall Study|Lost to Follow-up|1
1997317|NCT00096785|3562181|FG001|Overall Study|Lost to Follow-up|0
1997318|NCT00096785|3562180|FG000|Overall Study|Withdrawal by Subject|0
1997319|NCT00096785|3562181|FG001|Overall Study|Withdrawal by Subject|1
1997320|NCT00096785|3562180|FG000|Overall Study|Relocated|1
1997321|NCT00096785|3562181|FG001|Overall Study|Relocated|0
1997322|NCT00096941|3562187|FG000|Overall Study|disease progression|3
2024758|NCT00337272|3593418|FG000|Screening Period (Pre-randomization)|Non-compliance|1
2024759|NCT00337272|3593419|FG001|Screening Period (Pre-randomization)|Non-compliance|0
2024760|NCT00337272|3593418|FG000|Screening Period (Pre-randomization)|Screen failure|3
2024761|NCT00337272|3593419|FG001|Screening Period (Pre-randomization)|Screen failure|0
2024762|NCT00337272|3593418|FG000|Treatment Period|Non-compliance|1
2024763|NCT00337272|3593419|FG001|Treatment Period|Non-compliance|1
2024764|NCT00337272|3593418|FG000|Treatment Period|Withdrawal by Subject|0
2024765|NCT00337272|3593419|FG001|Treatment Period|Withdrawal by Subject|1
2024766|NCT00337272|3593418|FG000|Withdrawal Period|Non-compliance|0
2024767|NCT00337272|3593419|FG001|Withdrawal Period|Non-compliance|1
2024768|NCT00337285|3593425|FG000|Overall Study|Withdrawal by Subject|42
2024769|NCT00337285|3593425|FG000|Overall Study|Lost to Follow-up|41
2024770|NCT00337285|3593425|FG000|Overall Study|Adverse Event|28
2024771|NCT00337285|3593425|FG000|Overall Study|Protocol Violation|27
2024772|NCT00337285|3593425|FG000|Overall Study|Lack of Efficacy|11
2024773|NCT00337285|3593425|FG000|Overall Study|Death|1
2024774|NCT00337285|3593425|FG000|Overall Study|Physician Decision|1
2024775|NCT00337285|3593425|FG000|Overall Study|Lack of protocol compliance|7
2024776|NCT00337428|3593440|FG000|Overall Study|Withdrawal by Subject|1
2024777|NCT00337428|3593441|FG001|Overall Study|Withdrawal by Subject|2
2024778|NCT00337428|3593440|FG000|Overall Study|Lack of Time|1
2024779|NCT00337428|3593441|FG001|Overall Study|Lack of Time|1
2024780|NCT00337428|3593440|FG000|Overall Study|Unwilling to Continue|1
2024781|NCT00337428|3593441|FG001|Overall Study|Unwilling to Continue|0
2024782|NCT00337428|3593440|FG000|Overall Study|Anorexia|1
2024783|NCT00337428|3593441|FG001|Overall Study|Anorexia|0
2024784|NCT00337467|3593447|FG000|Overall Study|Adverse Event|3
2024785|NCT00337467|3593447|FG000|Overall Study|Subject Withdrew Consent|2
2024786|NCT00337467|3593447|FG000|Overall Study|Pregnancy|1
2024787|NCT00337467|3593447|FG000|Overall Study|Lost to Follow-up|2
2024788|NCT00337467|3593447|FG000|Overall Study|Subject No Longer Met Study Criteria|2
2024789|NCT00337571|3593458|FG000|Overall Study|Lack of Efficacy|3
2024790|NCT00337571|3593459|FG001|Overall Study|Lack of Efficacy|0
2024791|NCT00337571|3593460|FG002|Overall Study|Lack of Efficacy|0
2024792|NCT00337571|3593461|FG003|Overall Study|Lack of Efficacy|0
2024793|NCT00337571|3593458|FG000|Overall Study|Adverse Event|4
2024794|NCT00337571|3593459|FG001|Overall Study|Adverse Event|5
2024795|NCT00337571|3593460|FG002|Overall Study|Adverse Event|8
2024796|NCT00337571|3593461|FG003|Overall Study|Adverse Event|4
2024797|NCT00337571|3593458|FG000|Overall Study|Withdrawal by Subject|2
2024798|NCT00337571|3593459|FG001|Overall Study|Withdrawal by Subject|2
2024799|NCT00337571|3593460|FG002|Overall Study|Withdrawal by Subject|1
2024800|NCT00337571|3593461|FG003|Overall Study|Withdrawal by Subject|0
2024801|NCT00337571|3593458|FG000|Overall Study|Lost to Follow-up|3
2024802|NCT00337571|3593459|FG001|Overall Study|Lost to Follow-up|1
2024803|NCT00337571|3593460|FG002|Overall Study|Lost to Follow-up|0
2024804|NCT00337571|3593461|FG003|Overall Study|Lost to Follow-up|1
2024805|NCT00337571|3593458|FG000|Overall Study|Poor/noncompliance|1
2024806|NCT00337571|3593459|FG001|Overall Study|Poor/noncompliance|1
2024807|NCT00337571|3593460|FG002|Overall Study|Poor/noncompliance|1
1997323|NCT00096954|3562193|FG000|Overall Study|Adverse Event|3
1997324|NCT00096954|3562194|FG001|Overall Study|Adverse Event|1
1997325|NCT00096954|3562193|FG000|Overall Study|Withdrawal by Subject|9
1997326|NCT00096954|3562194|FG001|Overall Study|Withdrawal by Subject|8
1997327|NCT00096954|3562193|FG000|Overall Study|Physician Decision|1
1997328|NCT00096954|3562194|FG001|Overall Study|Physician Decision|1
1997329|NCT00096954|3562193|FG000|Overall Study|Sponsors Decision|1
1997330|NCT00096954|3562194|FG001|Overall Study|Sponsors Decision|1
1997331|NCT00096954|3562193|FG000|Overall Study|Pregnancy|1
1997332|NCT00096954|3562194|FG001|Overall Study|Pregnancy|1
1997333|NCT00096954|3562193|FG000|Overall Study|Initiation of immunotherapy|1
1997334|NCT00096954|3562194|FG001|Overall Study|Initiation of immunotherapy|0
1997335|NCT00096954|3562193|FG000|Overall Study|Non-compliance|0
1997336|NCT00096954|3562194|FG001|Overall Study|Non-compliance|3
1997337|NCT00096954|3562193|FG000|Overall Study|Lost to Follow-up|8
1997338|NCT00096954|3562194|FG001|Overall Study|Lost to Follow-up|5
1997339|NCT00096993|3562202|FG000|Overall Study|Death|1
1997340|NCT00096993|3562203|FG001|Overall Study|Death|0
1997341|NCT00096993|3562202|FG000|Overall Study|Disease progression|56
1997342|NCT00096993|3562203|FG001|Overall Study|Disease progression|53
1997343|NCT00096993|3562202|FG000|Overall Study|Adverse Event|2
1997344|NCT00096993|3562203|FG001|Overall Study|Adverse Event|8
1997345|NCT00096993|3562202|FG000|Overall Study|Subject's decision|3
1997346|NCT00096993|3562203|FG001|Overall Study|Subject's decision|1
1997347|NCT00096993|3562202|FG000|Overall Study|Physician Decision|2
1997348|NCT00096993|3562203|FG001|Overall Study|Physician Decision|1
1997349|NCT00096993|3562202|FG000|Overall Study|Non-compliance|0
1997350|NCT00096993|3562203|FG001|Overall Study|Non-compliance|1
1997351|NCT00096993|3562202|FG000|Overall Study|Other unspecified|1
1997352|NCT00096993|3562203|FG001|Overall Study|Other unspecified|1
1997353|NCT00097370|3562217|FG000|Stage 1|Adverse Event|3
1997354|NCT00097370|3562217|FG000|Stage 1|Withdrawal by Subject|1
1997355|NCT00097370|3562217|FG000|Stage 1|Lack of Efficacy|2
1997356|NCT00097370|3562217|FG000|Stage 2|Adverse Event|5
1997357|NCT00097370|3562217|FG000|Stage 2|Withdrawal by Subject|1
1997358|NCT00097370|3562217|FG000|Stage 2|Lack of Efficacy|3
1997359|NCT00097370|3562217|FG000|Stage 2|Pregnancy|1
1997360|NCT00097370|3562217|FG000|Stage 2|Sponsor Terminated Study|2
1997361|NCT00097370|3562217|FG000|Stage 2|Lost to Follow-up|1
1997362|NCT00097370|3562217|FG000|Stage 3|Adverse Event|2
1997363|NCT00097370|3562217|FG000|Stage 3|Withdrawal by Subject|3
1997364|NCT00097370|3562217|FG000|Stage 3|Lack of Efficacy|1
1997365|NCT00097370|3562217|FG000|Stage 3|Sponsor Terminated Study|52
1997366|NCT00097370|3562217|FG000|Stage 3|Lost to Follow-up|1
1997367|NCT00097500|3562232|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
1997368|NCT00097500|3562233|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
1997369|NCT00097500|3562232|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5
1997370|NCT00097500|3562233|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0
1997371|NCT00097500|3562232|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0
1997372|NCT00097500|3562233|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1
1997373|NCT00097500|3562232|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
1997374|NCT00097500|3562233|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
1997375|NCT00097500|3562232|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
1997376|NCT00097500|3562233|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
1997377|NCT00097500|3562232|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
1997378|NCT00097500|3562233|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
1997379|NCT00097500|3562232|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
1997380|NCT00097500|3562233|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
1997381|NCT00097539|3562246|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959
1997382|NCT00097539|3562247|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948
1997383|NCT00097539|3562248|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646
1997384|NCT00097539|3562249|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170
1997385|NCT00097539|3562250|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106
1997386|NCT00097539|3562251|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546
1997387|NCT00097539|3562252|FG006|Overall Study|Status Unknown (Or no final evaluation)|108
1997388|NCT00097539|3562246|FG000|Overall Study|Withdrawal by Subject|925
1997389|NCT00097539|3562247|FG001|Overall Study|Withdrawal by Subject|323
1997390|NCT00097539|3562248|FG002|Overall Study|Withdrawal by Subject|346
1997391|NCT00097539|3562249|FG003|Overall Study|Withdrawal by Subject|217
1997392|NCT00097539|3562250|FG004|Overall Study|Withdrawal by Subject|68
1997393|NCT00097539|3562251|FG005|Overall Study|Withdrawal by Subject|229
1997394|NCT00097539|3562252|FG006|Overall Study|Withdrawal by Subject|3
1997395|NCT00097539|3562246|FG000|Overall Study|Participant Non-compliant|2140
1997396|NCT00097539|3562247|FG001|Overall Study|Participant Non-compliant|567
1997397|NCT00097539|3562248|FG002|Overall Study|Participant Non-compliant|1067
1997398|NCT00097539|3562249|FG003|Overall Study|Participant Non-compliant|353
1997399|NCT00097539|3562250|FG004|Overall Study|Participant Non-compliant|136
1997400|NCT00097539|3562251|FG005|Overall Study|Participant Non-compliant|543
1997401|NCT00097539|3562252|FG006|Overall Study|Participant Non-compliant|18
1997402|NCT00097539|3562246|FG000|Overall Study|Lack of Efficacy|249
1997403|NCT00097539|3562247|FG001|Overall Study|Lack of Efficacy|122
1997404|NCT00097539|3562248|FG002|Overall Study|Lack of Efficacy|202
1997405|NCT00097539|3562249|FG003|Overall Study|Lack of Efficacy|105
1997406|NCT00097539|3562250|FG004|Overall Study|Lack of Efficacy|45
1997407|NCT00097539|3562251|FG005|Overall Study|Lack of Efficacy|228
1997408|NCT00097539|3562252|FG006|Overall Study|Lack of Efficacy|5
1997409|NCT00097539|3562246|FG000|Overall Study|Adverse Event|78
1997410|NCT00097539|3562247|FG001|Overall Study|Adverse Event|133
1997411|NCT00097539|3562248|FG002|Overall Study|Adverse Event|37
1997412|NCT00097539|3562249|FG003|Overall Study|Adverse Event|27
1997413|NCT00097539|3562250|FG004|Overall Study|Adverse Event|30
1997414|NCT00097539|3562251|FG005|Overall Study|Adverse Event|59
1997415|NCT00097539|3562252|FG006|Overall Study|Adverse Event|1
1997416|NCT00097539|3562246|FG000|Overall Study|Death|2
1997417|NCT00097539|3562247|FG001|Overall Study|Death|7
1997418|NCT00097539|3562248|FG002|Overall Study|Death|0
1997419|NCT00097539|3562249|FG003|Overall Study|Death|0
1997420|NCT00097539|3562250|FG004|Overall Study|Death|1
1997421|NCT00097539|3562251|FG005|Overall Study|Death|3
1997422|NCT00097539|3562252|FG006|Overall Study|Death|0
1997423|NCT00097539|3562246|FG000|Overall Study|Reasons Other Than Above|3602
1997424|NCT00097539|3562247|FG001|Overall Study|Reasons Other Than Above|1382
1997425|NCT00097539|3562248|FG002|Overall Study|Reasons Other Than Above|1757
1997426|NCT00097539|3562249|FG003|Overall Study|Reasons Other Than Above|692
1997427|NCT00097539|3562250|FG004|Overall Study|Reasons Other Than Above|361
1997428|NCT00097539|3562251|FG005|Overall Study|Reasons Other Than Above|1244
1997429|NCT00097539|3562252|FG006|Overall Study|Reasons Other Than Above|34
1997430|NCT00097539|3562246|FG000|Overall Study|Reason not Specified|111
1997431|NCT00097539|3562247|FG001|Overall Study|Reason not Specified|49
1997432|NCT00097539|3562248|FG002|Overall Study|Reason not Specified|53
1997433|NCT00097539|3562249|FG003|Overall Study|Reason not Specified|21
1997434|NCT00097539|3562250|FG004|Overall Study|Reason not Specified|11
1997435|NCT00097539|3562251|FG005|Overall Study|Reason not Specified|40
1997436|NCT00097539|3562252|FG006|Overall Study|Reason not Specified|2
1997437|NCT00097591|3562270|FG000|Overall Study|Withdrawal of consent|342
1997438|NCT00097591|3562271|FG001|Overall Study|Withdrawal of consent|323
1997439|NCT00097591|3562270|FG000|Overall Study|Less than 6 months on study drug|9
1997440|NCT00097591|3562271|FG001|Overall Study|Less than 6 months on study drug|7
1997441|NCT00097591|3562270|FG000|Overall Study|Unable to attend termination visit|53
1997442|NCT00097591|3562271|FG001|Overall Study|Unable to attend termination visit|51
1997443|NCT00097591|3562270|FG000|Overall Study|Lost to follow up|6
1997444|NCT00097591|3562271|FG001|Overall Study|Lost to follow up|10
1997445|NCT00097591|3562270|FG000|Overall Study|Other|0
1997446|NCT00097591|3562271|FG001|Overall Study|Other|3
1997447|NCT00097721|3562320|FG000|Overall Study|Adverse Event|8
1997448|NCT00097721|3562321|FG001|Overall Study|Adverse Event|1
1997449|NCT00097721|3562320|FG000|Overall Study|Withdrawal by Subject|6
1997450|NCT00097721|3562321|FG001|Overall Study|Withdrawal by Subject|1
1997451|NCT00097721|3562320|FG000|Overall Study|Progressive Disease|55
1997452|NCT00097721|3562321|FG001|Overall Study|Progressive Disease|27
1997453|NCT00097721|3562320|FG000|Overall Study|Physician Decision|1
1997454|NCT00097721|3562321|FG001|Overall Study|Physician Decision|3
1997455|NCT00097721|3562320|FG000|Overall Study|Reason not given|1
1997456|NCT00097721|3562321|FG001|Overall Study|Reason not given|1
2108219|NCT00878722|3702056|FG007|Overall Study|Relapse|0
2213736|NCT01682720|3855717|FG002|Overall Study|Terminated by Sponsor|0
2213737|NCT01682720|3855718|FG003|Overall Study|Terminated by Sponsor|0
2213738|NCT01682720|3855715|FG000|Overall Study|Efficacy Failure|0
2213739|NCT01682720|3855716|FG001|Overall Study|Efficacy Failure|3
2213740|NCT01682720|3855717|FG002|Overall Study|Efficacy Failure|3
2213741|NCT01682720|3855718|FG003|Overall Study|Efficacy Failure|30
2213742|NCT01682720|3855715|FG000|Overall Study|Lost to Follow-up|1
2213743|NCT01682720|3855716|FG001|Overall Study|Lost to Follow-up|1
2213744|NCT01682720|3855717|FG002|Overall Study|Lost to Follow-up|0
2213745|NCT01682720|3855718|FG003|Overall Study|Lost to Follow-up|6
2213746|NCT01682720|3855715|FG000|Overall Study|Subject Withdrew Consent|0
2213747|NCT01682720|3855716|FG001|Overall Study|Subject Withdrew Consent|0
2213748|NCT01682720|3855717|FG002|Overall Study|Subject Withdrew Consent|2
2213749|NCT01682720|3855718|FG003|Overall Study|Subject Withdrew Consent|2
2213750|NCT01682720|3855715|FG000|Overall Study|Adverse Event|1
2213751|NCT01682720|3855716|FG001|Overall Study|Adverse Event|0
2213752|NCT01682720|3855717|FG002|Overall Study|Adverse Event|1
2213753|NCT01682720|3855718|FG003|Overall Study|Adverse Event|1
2213754|NCT01682759|3855730|FG000|Overall Study|Death|2
2213755|NCT01682759|3855731|FG001|Overall Study|Death|1
2213756|NCT01682759|3855730|FG000|Overall Study|Lost to Follow-up|10
2213757|NCT01682759|3855731|FG001|Overall Study|Lost to Follow-up|13
2213758|NCT01682759|3855730|FG000|Overall Study|Physician Decision|1
2213759|NCT01682759|3855731|FG001|Overall Study|Physician Decision|1
1997457|NCT00097773|3562331|FG000|Overall Study|Lost to Follow-up|2
1997458|NCT00097773|3562332|FG001|Overall Study|Lost to Follow-up|2
1997459|NCT00097773|3562333|FG002|Overall Study|Lost to Follow-up|0
1997460|NCT00097773|3562334|FG003|Overall Study|Lost to Follow-up|1
1997461|NCT00097773|3562331|FG000|Overall Study|Physician Decision|2
1997462|NCT00097773|3562332|FG001|Overall Study|Physician Decision|2
1997463|NCT00097773|3562333|FG002|Overall Study|Physician Decision|3
1997464|NCT00097773|3562334|FG003|Overall Study|Physician Decision|1
2213760|NCT01682759|3855730|FG000|Overall Study|Withdrawal by Subject|56
2213761|NCT01682759|3855731|FG001|Overall Study|Withdrawal by Subject|55
2213762|NCT01682811|3855744|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0
2213763|NCT01682811|3855745|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0
2213764|NCT01682811|3855746|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0
2213765|NCT01682811|3855747|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0
2213766|NCT01682811|3855748|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1
2213767|NCT01682811|3855749|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0
2213768|NCT01682811|3855750|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0
2213769|NCT01682811|3855744|FG000|Part 2 Dose Level 1|Protocol Violation|0
2213770|NCT01682811|3855745|FG001|Part 2 Dose Level 1|Protocol Violation|0
2213771|NCT01682811|3855746|FG002|Part 2 Dose Level 1|Protocol Violation|0
2213772|NCT01682811|3855747|FG003|Part 2 Dose Level 1|Protocol Violation|0
2213773|NCT01682811|3855748|FG004|Part 2 Dose Level 1|Protocol Violation|4
2213774|NCT01682811|3855749|FG005|Part 2 Dose Level 1|Protocol Violation|0
2213775|NCT01682811|3855750|FG006|Part 2 Dose Level 1|Protocol Violation|0
1997465|NCT00097773|3562331|FG000|Overall Study|Withdrawal by Subject|3
1997466|NCT00097773|3562332|FG001|Overall Study|Withdrawal by Subject|3
1997467|NCT00097773|3562333|FG002|Overall Study|Withdrawal by Subject|3
1997468|NCT00097773|3562334|FG003|Overall Study|Withdrawal by Subject|1
1997469|NCT00097773|3562331|FG000|Overall Study|Adverse Event|0
1997470|NCT00097773|3562332|FG001|Overall Study|Adverse Event|1
1997471|NCT00097773|3562333|FG002|Overall Study|Adverse Event|0
1997472|NCT00097773|3562334|FG003|Overall Study|Adverse Event|0
1997473|NCT00097773|3562331|FG000|Overall Study|Other|1
1997474|NCT00097773|3562332|FG001|Overall Study|Other|0
1997475|NCT00097773|3562333|FG002|Overall Study|Other|2
1997476|NCT00097773|3562334|FG003|Overall Study|Other|0
1997477|NCT00097786|3562353|FG000|Overall Study|lost to follow-up for all-cause death|296
1997478|NCT00097786|3562354|FG001|Overall Study|lost to follow-up for all-cause death|292
1997479|NCT00097786|3562355|FG002|Overall Study|lost to follow-up for all-cause death|313
1997480|NCT00097786|3562356|FG003|Overall Study|lost to follow-up for all-cause death|310
1997481|NCT00097981|3562368|FG000|Overall Study|Adverse Event|31
1997482|NCT00097981|3562369|FG001|Overall Study|Adverse Event|44
1997483|NCT00097981|3562368|FG000|Overall Study|Withdrawal by Subject|10
1997484|NCT00097981|3562369|FG001|Overall Study|Withdrawal by Subject|8
1997485|NCT00097981|3562368|FG000|Overall Study|Protocol Violation|1
1997486|NCT00097981|3562369|FG001|Overall Study|Protocol Violation|1
1997487|NCT00097981|3562368|FG000|Overall Study|Death|2
1997488|NCT00097981|3562369|FG001|Overall Study|Death|4
1997489|NCT00097981|3562368|FG000|Overall Study|Physician Decision|7
1997490|NCT00097981|3562369|FG001|Overall Study|Physician Decision|1
1997491|NCT00097981|3562368|FG000|Overall Study|Disease Progression|8
1997492|NCT00097981|3562369|FG001|Overall Study|Disease Progression|2
1997493|NCT00097981|3562368|FG000|Overall Study|Transplant planned|28
1997494|NCT00097981|3562369|FG001|Overall Study|Transplant planned|27
1997495|NCT00097981|3562368|FG000|Overall Study|Other|19
1997496|NCT00097981|3562369|FG001|Overall Study|Other|13
1997497|NCT00098020|3562375|FG000|Overall Study|Adverse Event|2
1997498|NCT00098020|3562375|FG000|Overall Study|Lost to Follow-up|1
1997499|NCT00098020|3562375|FG000|Overall Study|elevated liver enzymes|1
1997500|NCT00098020|3562375|FG000|Overall Study|Low urine PCR|1
1997501|NCT00098020|3562375|FG000|Overall Study|Low epidermal growth factor receptor|1
1997502|NCT00098254|3562393|FG000|Overall Study|Adverse Event|2
1997503|NCT00098254|3562393|FG000|Overall Study|Death|1
1997504|NCT00098293|3562400|FG000|Double-blind (DB) Phase|Adverse Event|14
1997505|NCT00098293|3562401|FG001|Double-blind (DB) Phase|Adverse Event|27
1997506|NCT00098293|3562402|FG002|Double-blind (DB) Phase|Adverse Event|60
1997507|NCT00098293|3562403|FG003|Double-blind (DB) Phase|Adverse Event|0
1997508|NCT00098293|3562404|FG004|Double-blind (DB) Phase|Adverse Event|0
1997509|NCT00098293|3562400|FG000|Double-blind (DB) Phase|Pregnancy|0
1997510|NCT00098293|3562401|FG001|Double-blind (DB) Phase|Pregnancy|7
1997511|NCT00098293|3562402|FG002|Double-blind (DB) Phase|Pregnancy|9
1997512|NCT00098293|3562403|FG003|Double-blind (DB) Phase|Pregnancy|0
1997513|NCT00098293|3562404|FG004|Double-blind (DB) Phase|Pregnancy|0
1997514|NCT00098293|3562400|FG000|Double-blind (DB) Phase|Participant Defaulted|11
1997515|NCT00098293|3562401|FG001|Double-blind (DB) Phase|Participant Defaulted|40
1997516|NCT00098293|3562402|FG002|Double-blind (DB) Phase|Participant Defaulted|36
1997517|NCT00098293|3562403|FG003|Double-blind (DB) Phase|Participant Defaulted|0
1997518|NCT00098293|3562404|FG004|Double-blind (DB) Phase|Participant Defaulted|0
1997519|NCT00098293|3562400|FG000|Double-blind (DB) Phase|Lack of Efficacy|11
1997520|NCT00098293|3562401|FG001|Double-blind (DB) Phase|Lack of Efficacy|64
1997521|NCT00098293|3562402|FG002|Double-blind (DB) Phase|Lack of Efficacy|30
1997522|NCT00098293|3562403|FG003|Double-blind (DB) Phase|Lack of Efficacy|0
2213776|NCT01682811|3855744|FG000|Part 2 Dose Level 1|Lost to Follow-up|0
2213777|NCT01682811|3855745|FG001|Part 2 Dose Level 1|Lost to Follow-up|0
1997523|NCT00098293|3562404|FG004|Double-blind (DB) Phase|Lack of Efficacy|0
1997524|NCT00098293|3562400|FG000|Double-blind (DB) Phase|Death|1
1997525|NCT00098293|3562401|FG001|Double-blind (DB) Phase|Death|2
1997526|NCT00098293|3562402|FG002|Double-blind (DB) Phase|Death|2
1997527|NCT00098293|3562403|FG003|Double-blind (DB) Phase|Death|0
1997528|NCT00098293|3562404|FG004|Double-blind (DB) Phase|Death|0
1997529|NCT00098293|3562400|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3
1997530|NCT00098293|3562401|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8
1997531|NCT00098293|3562402|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11
1997532|NCT00098293|3562403|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0
1997533|NCT00098293|3562404|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0
1997534|NCT00098293|3562400|FG000|Double-blind (DB) Phase|Protocol Violation|2
1997535|NCT00098293|3562401|FG001|Double-blind (DB) Phase|Protocol Violation|18
1997536|NCT00098293|3562402|FG002|Double-blind (DB) Phase|Protocol Violation|22
1997537|NCT00098293|3562403|FG003|Double-blind (DB) Phase|Protocol Violation|0
1997538|NCT00098293|3562404|FG004|Double-blind (DB) Phase|Protocol Violation|0
1997539|NCT00098293|3562400|FG000|Double-blind (DB) Phase|Terminated by sponsor|135
1997540|NCT00098293|3562401|FG001|Double-blind (DB) Phase|Terminated by sponsor|0
1997541|NCT00098293|3562402|FG002|Double-blind (DB) Phase|Terminated by sponsor|0
1997542|NCT00098293|3562403|FG003|Double-blind (DB) Phase|Terminated by sponsor|0
1997543|NCT00098293|3562404|FG004|Double-blind (DB) Phase|Terminated by sponsor|0
1997544|NCT00098293|3562400|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1997545|NCT00098293|3562401|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1997546|NCT00098293|3562402|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3
1997547|NCT00098293|3562403|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1997548|NCT00098293|3562404|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1997549|NCT00098293|3562400|FG000|Open-label (OL) Phase|Adverse Event|0
1997550|NCT00098293|3562401|FG001|Open-label (OL) Phase|Adverse Event|3
1997551|NCT00098293|3562402|FG002|Open-label (OL) Phase|Adverse Event|7
1997552|NCT00098293|3562403|FG003|Open-label (OL) Phase|Adverse Event|6
1997553|NCT00098293|3562404|FG004|Open-label (OL) Phase|Adverse Event|0
1997554|NCT00098293|3562400|FG000|Open-label (OL) Phase|Lack of Efficacy|0
1997555|NCT00098293|3562401|FG001|Open-label (OL) Phase|Lack of Efficacy|7
1997556|NCT00098293|3562402|FG002|Open-label (OL) Phase|Lack of Efficacy|2
2213778|NCT01682811|3855746|FG002|Part 2 Dose Level 1|Lost to Follow-up|0
2213779|NCT01682811|3855747|FG003|Part 2 Dose Level 1|Lost to Follow-up|0
2213780|NCT01682811|3855748|FG004|Part 2 Dose Level 1|Lost to Follow-up|6
2213781|NCT01682811|3855749|FG005|Part 2 Dose Level 1|Lost to Follow-up|0
2213782|NCT01682811|3855750|FG006|Part 2 Dose Level 1|Lost to Follow-up|0
1997557|NCT00098293|3562403|FG003|Open-label (OL) Phase|Lack of Efficacy|20
1997558|NCT00098293|3562404|FG004|Open-label (OL) Phase|Lack of Efficacy|0
1997559|NCT00098293|3562400|FG000|Open-label (OL) Phase|Pregnancy|0
1997560|NCT00098293|3562401|FG001|Open-label (OL) Phase|Pregnancy|1
1997561|NCT00098293|3562402|FG002|Open-label (OL) Phase|Pregnancy|0
1997562|NCT00098293|3562403|FG003|Open-label (OL) Phase|Pregnancy|3
1997563|NCT00098293|3562404|FG004|Open-label (OL) Phase|Pregnancy|0
1997564|NCT00098293|3562400|FG000|Open-label (OL) Phase|Protocol Violation|0
1997565|NCT00098293|3562401|FG001|Open-label (OL) Phase|Protocol Violation|6
1997566|NCT00098293|3562402|FG002|Open-label (OL) Phase|Protocol Violation|13
1997567|NCT00098293|3562403|FG003|Open-label (OL) Phase|Protocol Violation|16
1997568|NCT00098293|3562404|FG004|Open-label (OL) Phase|Protocol Violation|0
1997569|NCT00098293|3562400|FG000|Open-label (OL) Phase|Participant Defaulted|0
1997570|NCT00098293|3562401|FG001|Open-label (OL) Phase|Participant Defaulted|6
1997571|NCT00098293|3562402|FG002|Open-label (OL) Phase|Participant Defaulted|16
1997572|NCT00098293|3562403|FG003|Open-label (OL) Phase|Participant Defaulted|20
1997573|NCT00098293|3562404|FG004|Open-label (OL) Phase|Participant Defaulted|0
1997574|NCT00098293|3562400|FG000|Open-label (OL) Phase|Death|0
1997575|NCT00098293|3562401|FG001|Open-label (OL) Phase|Death|2
1997576|NCT00098293|3562402|FG002|Open-label (OL) Phase|Death|3
1997577|NCT00098293|3562403|FG003|Open-label (OL) Phase|Death|0
1997578|NCT00098293|3562404|FG004|Open-label (OL) Phase|Death|0
1997579|NCT00098293|3562400|FG000|Supplemental Phase (SP)|Death|0
1997580|NCT00098293|3562401|FG001|Supplemental Phase (SP)|Death|0
1997581|NCT00098293|3562402|FG002|Supplemental Phase (SP)|Death|0
1997582|NCT00098293|3562403|FG003|Supplemental Phase (SP)|Death|0
1997583|NCT00098293|3562404|FG004|Supplemental Phase (SP)|Death|1
1997584|NCT00098293|3562400|FG000|Supplemental Phase (SP)|Lost to Follow-up|0
1997585|NCT00098293|3562401|FG001|Supplemental Phase (SP)|Lost to Follow-up|0
1997586|NCT00098293|3562402|FG002|Supplemental Phase (SP)|Lost to Follow-up|0
1997587|NCT00098293|3562403|FG003|Supplemental Phase (SP)|Lost to Follow-up|0
1997588|NCT00098293|3562404|FG004|Supplemental Phase (SP)|Lost to Follow-up|2
1997589|NCT00098293|3562400|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0
1997590|NCT00098293|3562401|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0
1997591|NCT00098293|3562402|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0
1997592|NCT00098293|3562403|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0
1997593|NCT00098293|3562404|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8
1997594|NCT00098293|3562400|FG000|Supplemental Phase (SP)|Other|0
1997595|NCT00098293|3562401|FG001|Supplemental Phase (SP)|Other|0
1997596|NCT00098293|3562402|FG002|Supplemental Phase (SP)|Other|0
1997597|NCT00098293|3562403|FG003|Supplemental Phase (SP)|Other|0
1997598|NCT00098293|3562404|FG004|Supplemental Phase (SP)|Other|22
1997599|NCT00098306|3562418|FG000|Double Blind|Randomized, not treated|9
1997600|NCT00098306|3562419|FG001|Double Blind|Randomized, not treated|5
1997601|NCT00098306|3562420|FG002|Double Blind|Randomized, not treated|2
1997602|NCT00098306|3562421|FG003|Double Blind|Randomized, not treated|0
1997603|NCT00098306|3562422|FG004|Double Blind|Randomized, not treated|0
1997604|NCT00098306|3562423|FG005|Double Blind|Randomized, not treated|0
1997605|NCT00098306|3562424|FG006|Double Blind|Randomized, not treated|0
1997606|NCT00098306|3562418|FG000|Double Blind|Ongoing at cut-off date|151
1997607|NCT00098306|3562419|FG001|Double Blind|Ongoing at cut-off date|166
1997608|NCT00098306|3562420|FG002|Double Blind|Ongoing at cut-off date|72
1997609|NCT00098306|3562421|FG003|Double Blind|Ongoing at cut-off date|0
1997610|NCT00098306|3562422|FG004|Double Blind|Ongoing at cut-off date|0
1997611|NCT00098306|3562423|FG005|Double Blind|Ongoing at cut-off date|0
1997612|NCT00098306|3562424|FG006|Double Blind|Ongoing at cut-off date|0
1997613|NCT00098306|3562418|FG000|Double Blind|Adverse Event|11
1997614|NCT00098306|3562419|FG001|Double Blind|Adverse Event|10
1997615|NCT00098306|3562420|FG002|Double Blind|Adverse Event|6
1997616|NCT00098306|3562421|FG003|Double Blind|Adverse Event|0
1997617|NCT00098306|3562422|FG004|Double Blind|Adverse Event|0
1997618|NCT00098306|3562423|FG005|Double Blind|Adverse Event|0
1997619|NCT00098306|3562424|FG006|Double Blind|Adverse Event|0
1997620|NCT00098306|3562418|FG000|Double Blind|Lack of Efficacy|43
1997621|NCT00098306|3562419|FG001|Double Blind|Lack of Efficacy|34
1997622|NCT00098306|3562420|FG002|Double Blind|Lack of Efficacy|17
1997623|NCT00098306|3562421|FG003|Double Blind|Lack of Efficacy|0
1997624|NCT00098306|3562422|FG004|Double Blind|Lack of Efficacy|0
1997625|NCT00098306|3562423|FG005|Double Blind|Lack of Efficacy|0
1997626|NCT00098306|3562424|FG006|Double Blind|Lack of Efficacy|0
1997627|NCT00098306|3562418|FG000|Double Blind|Death|1
1997628|NCT00098306|3562419|FG001|Double Blind|Death|4
1997629|NCT00098306|3562420|FG002|Double Blind|Death|1
1997630|NCT00098306|3562421|FG003|Double Blind|Death|0
1997631|NCT00098306|3562422|FG004|Double Blind|Death|0
1997632|NCT00098306|3562423|FG005|Double Blind|Death|0
1997633|NCT00098306|3562424|FG006|Double Blind|Death|0
1997634|NCT00098306|3562418|FG000|Double Blind|Participant defaulted|19
1997635|NCT00098306|3562419|FG001|Double Blind|Participant defaulted|18
1997636|NCT00098306|3562420|FG002|Double Blind|Participant defaulted|11
1997637|NCT00098306|3562421|FG003|Double Blind|Participant defaulted|0
1997638|NCT00098306|3562422|FG004|Double Blind|Participant defaulted|0
1997639|NCT00098306|3562423|FG005|Double Blind|Participant defaulted|0
1997640|NCT00098306|3562424|FG006|Double Blind|Participant defaulted|0
1997641|NCT00098306|3562418|FG000|Double Blind|Un-specified|7
1997642|NCT00098306|3562419|FG001|Double Blind|Un-specified|3
1997643|NCT00098306|3562420|FG002|Double Blind|Un-specified|11
1997644|NCT00098306|3562421|FG003|Double Blind|Un-specified|0
1997645|NCT00098306|3562422|FG004|Double Blind|Un-specified|0
1997646|NCT00098306|3562423|FG005|Double Blind|Un-specified|0
1997647|NCT00098306|3562424|FG006|Double Blind|Un-specified|0
1997648|NCT00098306|3562418|FG000|Open Label|Lack of Efficacy|0
1997649|NCT00098306|3562419|FG001|Open Label|Lack of Efficacy|0
1997650|NCT00098306|3562420|FG002|Open Label|Lack of Efficacy|0
1997651|NCT00098306|3562421|FG003|Open Label|Lack of Efficacy|13
1997652|NCT00098306|3562422|FG004|Open Label|Lack of Efficacy|0
1997653|NCT00098306|3562423|FG005|Open Label|Lack of Efficacy|0
1997654|NCT00098306|3562424|FG006|Open Label|Lack of Efficacy|0
1997655|NCT00098306|3562418|FG000|Open Label|Adverse Event|0
1997656|NCT00098306|3562419|FG001|Open Label|Adverse Event|0
1997657|NCT00098306|3562420|FG002|Open Label|Adverse Event|0
1997658|NCT00098306|3562421|FG003|Open Label|Adverse Event|2
1997659|NCT00098306|3562422|FG004|Open Label|Adverse Event|0
1997660|NCT00098306|3562423|FG005|Open Label|Adverse Event|0
1997661|NCT00098306|3562424|FG006|Open Label|Adverse Event|0
1997662|NCT00098306|3562418|FG000|Open Label|Death|0
1997663|NCT00098306|3562419|FG001|Open Label|Death|0
1997664|NCT00098306|3562420|FG002|Open Label|Death|0
1997665|NCT00098306|3562421|FG003|Open Label|Death|4
1997666|NCT00098306|3562422|FG004|Open Label|Death|0
1997667|NCT00098306|3562423|FG005|Open Label|Death|0
1997668|NCT00098306|3562424|FG006|Open Label|Death|0
1997669|NCT00098306|3562418|FG000|Open Label|Participant defaulted|0
1997670|NCT00098306|3562419|FG001|Open Label|Participant defaulted|0
1997671|NCT00098306|3562420|FG002|Open Label|Participant defaulted|0
1997672|NCT00098306|3562421|FG003|Open Label|Participant defaulted|24
1997673|NCT00098306|3562422|FG004|Open Label|Participant defaulted|0
1997674|NCT00098306|3562423|FG005|Open Label|Participant defaulted|0
1997675|NCT00098306|3562424|FG006|Open Label|Participant defaulted|0
1997676|NCT00098306|3562418|FG000|Open Label|Un-specified|0
1997677|NCT00098306|3562419|FG001|Open Label|Un-specified|0
1997678|NCT00098306|3562420|FG002|Open Label|Un-specified|0
1997679|NCT00098306|3562421|FG003|Open Label|Un-specified|15
1997680|NCT00098306|3562422|FG004|Open Label|Un-specified|0
1997681|NCT00098306|3562423|FG005|Open Label|Un-specified|0
1997682|NCT00098306|3562424|FG006|Open Label|Un-specified|0
1997683|NCT00098306|3562418|FG000|Open Label|Ongoing at cut-off date|0
1997684|NCT00098306|3562419|FG001|Open Label|Ongoing at cut-off date|0
1997685|NCT00098306|3562420|FG002|Open Label|Ongoing at cut-off date|0
1997686|NCT00098306|3562421|FG003|Open Label|Ongoing at cut-off date|269
1997687|NCT00098306|3562422|FG004|Open Label|Ongoing at cut-off date|62
1997688|NCT00098306|3562423|FG005|Open Label|Ongoing at cut-off date|0
1997689|NCT00098306|3562424|FG006|Open Label|Ongoing at cut-off date|0
1997690|NCT00098306|3562418|FG000|Observational Phase|Death|0
1997691|NCT00098306|3562419|FG001|Observational Phase|Death|0
1997692|NCT00098306|3562420|FG002|Observational Phase|Death|0
1997693|NCT00098306|3562421|FG003|Observational Phase|Death|0
1997694|NCT00098306|3562422|FG004|Observational Phase|Death|0
1997695|NCT00098306|3562423|FG005|Observational Phase|Death|5
1997696|NCT00098306|3562424|FG006|Observational Phase|Death|4
1997697|NCT00098306|3562418|FG000|Observational Phase|Participant defaulted|0
1997698|NCT00098306|3562419|FG001|Observational Phase|Participant defaulted|0
1997699|NCT00098306|3562420|FG002|Observational Phase|Participant defaulted|0
1997700|NCT00098306|3562421|FG003|Observational Phase|Participant defaulted|0
1997701|NCT00098306|3562422|FG004|Observational Phase|Participant defaulted|0
1997702|NCT00098306|3562423|FG005|Observational Phase|Participant defaulted|34
1997703|NCT00098306|3562424|FG006|Observational Phase|Participant defaulted|18
1997704|NCT00098306|3562418|FG000|Observational Phase|Un-specified|0
1997705|NCT00098306|3562419|FG001|Observational Phase|Un-specified|0
1997706|NCT00098306|3562420|FG002|Observational Phase|Un-specified|0
1997707|NCT00098306|3562421|FG003|Observational Phase|Un-specified|0
1997708|NCT00098306|3562422|FG004|Observational Phase|Un-specified|0
1997709|NCT00098306|3562423|FG005|Observational Phase|Un-specified|7
1997710|NCT00098306|3562424|FG006|Observational Phase|Un-specified|4
1997711|NCT00098345|3562437|FG000|Overall Study|Adverse Event|7
1997712|NCT00098345|3562437|FG000|Overall Study|Withdrawal by Subject|2
1997713|NCT00098345|3562437|FG000|Overall Study|progression|4
1997714|NCT00098475|3562458|FG000|Step 1|Progressive disease|33
1997715|NCT00098475|3562459|FG001|Step 1|Progressive disease|35
1997716|NCT00098475|3562460|FG002|Step 1|Progressive disease|2
1997717|NCT00098475|3562461|FG003|Step 1|Progressive disease|1
1997718|NCT00098475|3562458|FG000|Step 1|Adverse Event|56
1997719|NCT00098475|3562459|FG001|Step 1|Adverse Event|37
1997720|NCT00098475|3562460|FG002|Step 1|Adverse Event|0
1997721|NCT00098475|3562461|FG003|Step 1|Adverse Event|1
1997722|NCT00098475|3562458|FG000|Step 1|Death|8
1997723|NCT00098475|3562459|FG001|Step 1|Death|5
1997724|NCT00098475|3562460|FG002|Step 1|Death|0
1997725|NCT00098475|3562461|FG003|Step 1|Death|1
1997726|NCT00098475|3562458|FG000|Step 1|Withdrawal by Subject|14
1997727|NCT00098475|3562459|FG001|Step 1|Withdrawal by Subject|11
1997728|NCT00098475|3562460|FG002|Step 1|Withdrawal by Subject|0
1997729|NCT00098475|3562461|FG003|Step 1|Withdrawal by Subject|0
1997730|NCT00098475|3562458|FG000|Step 1|Physician Decision|5
1997731|NCT00098475|3562459|FG001|Step 1|Physician Decision|2
1997732|NCT00098475|3562460|FG002|Step 1|Physician Decision|0
1997733|NCT00098475|3562461|FG003|Step 1|Physician Decision|0
1997734|NCT00098475|3562458|FG000|Step 1|Alternative therapy|31
1997735|NCT00098475|3562459|FG001|Step 1|Alternative therapy|43
1997736|NCT00098475|3562460|FG002|Step 1|Alternative therapy|1
1997737|NCT00098475|3562461|FG003|Step 1|Alternative therapy|0
1997738|NCT00098475|3562458|FG000|Step 1|Other disease|2
1997739|NCT00098475|3562459|FG001|Step 1|Other disease|1
1997740|NCT00098475|3562460|FG002|Step 1|Other disease|1
1997741|NCT00098475|3562461|FG003|Step 1|Other disease|0
1997742|NCT00098475|3562458|FG000|Step 1|Never started treatment|0
1997743|NCT00098475|3562459|FG001|Step 1|Never started treatment|2
1997744|NCT00098475|3562460|FG002|Step 1|Never started treatment|0
1997745|NCT00098475|3562461|FG003|Step 1|Never started treatment|0
1997746|NCT00098475|3562458|FG000|Step 1|Still on treatment as of this analysis|14
1997747|NCT00098475|3562459|FG001|Step 1|Still on treatment as of this analysis|27
1997748|NCT00098475|3562460|FG002|Step 1|Still on treatment as of this analysis|0
1997749|NCT00098475|3562461|FG003|Step 1|Still on treatment as of this analysis|0
1997750|NCT00098475|3562458|FG000|Step 1|Knee surgery|1
1997751|NCT00098475|3562459|FG001|Step 1|Knee surgery|0
1997752|NCT00098475|3562460|FG002|Step 1|Knee surgery|0
1997753|NCT00098475|3562461|FG003|Step 1|Knee surgery|0
1997754|NCT00098475|3562458|FG000|Step 1|Complications|1
1997755|NCT00098475|3562459|FG001|Step 1|Complications|0
1997756|NCT00098475|3562460|FG002|Step 1|Complications|0
1997757|NCT00098475|3562461|FG003|Step 1|Complications|0
1997758|NCT00098475|3562458|FG000|Step 1|Cannot comply due to other tx|0
1997759|NCT00098475|3562459|FG001|Step 1|Cannot comply due to other tx|1
1997760|NCT00098475|3562460|FG002|Step 1|Cannot comply due to other tx|0
1997761|NCT00098475|3562461|FG003|Step 1|Cannot comply due to other tx|0
1997762|NCT00098475|3562458|FG000|Step 1|Both patient and physician's decision|2
1997763|NCT00098475|3562459|FG001|Step 1|Both patient and physician's decision|1
1997764|NCT00098475|3562460|FG002|Step 1|Both patient and physician's decision|0
1997765|NCT00098475|3562461|FG003|Step 1|Both patient and physician's decision|0
1997766|NCT00098475|3562458|FG000|Step 1|Incorrect disease assessment|2
1997767|NCT00098475|3562459|FG001|Step 1|Incorrect disease assessment|0
1997768|NCT00098475|3562460|FG002|Step 1|Incorrect disease assessment|0
1997769|NCT00098475|3562461|FG003|Step 1|Incorrect disease assessment|0
1997770|NCT00098475|3562458|FG000|Step 1|Off treatment for > specified timeframe|1
1997771|NCT00098475|3562459|FG001|Step 1|Off treatment for > specified timeframe|1
1997772|NCT00098475|3562460|FG002|Step 1|Off treatment for > specified timeframe|0
1997773|NCT00098475|3562461|FG003|Step 1|Off treatment for > specified timeframe|0
1997774|NCT00098475|3562458|FG000|Step 1|Declining performance status|0
1997775|NCT00098475|3562459|FG001|Step 1|Declining performance status|1
1997776|NCT00098475|3562460|FG002|Step 1|Declining performance status|0
1997777|NCT00098475|3562461|FG003|Step 1|Declining performance status|0
1997778|NCT00098475|3562458|FG000|Step 1|Insurance issue|0
1997779|NCT00098475|3562459|FG001|Step 1|Insurance issue|1
1997780|NCT00098475|3562460|FG002|Step 1|Insurance issue|0
1997781|NCT00098475|3562461|FG003|Step 1|Insurance issue|0
1997782|NCT00098475|3562458|FG000|Step 1|Rising paraprotein|0
1997783|NCT00098475|3562459|FG001|Step 1|Rising paraprotein|1
1997784|NCT00098475|3562460|FG002|Step 1|Rising paraprotein|0
1997785|NCT00098475|3562461|FG003|Step 1|Rising paraprotein|0
1997786|NCT00098475|3562458|FG000|Step 1|Referred to other physicians|0
1997787|NCT00098475|3562459|FG001|Step 1|Referred to other physicians|1
1997788|NCT00098475|3562460|FG002|Step 1|Referred to other physicians|0
1997789|NCT00098475|3562461|FG003|Step 1|Referred to other physicians|0
1997790|NCT00098475|3562458|FG000|Step 1|Criteria to continue treatment not met|0
1997791|NCT00098475|3562459|FG001|Step 1|Criteria to continue treatment not met|1
1997792|NCT00098475|3562460|FG002|Step 1|Criteria to continue treatment not met|0
1997793|NCT00098475|3562461|FG003|Step 1|Criteria to continue treatment not met|0
1997794|NCT00098475|3562458|FG000|Step 1|Misinterpretation of lab data|0
1997795|NCT00098475|3562459|FG001|Step 1|Misinterpretation of lab data|1
1997796|NCT00098475|3562460|FG002|Step 1|Misinterpretation of lab data|0
1997797|NCT00098475|3562461|FG003|Step 1|Misinterpretation of lab data|0
1997798|NCT00098475|3562458|FG000|Step 1|Patient fell with fracture|1
1997799|NCT00098475|3562459|FG001|Step 1|Patient fell with fracture|0
1997800|NCT00098475|3562460|FG002|Step 1|Patient fell with fracture|0
1997801|NCT00098475|3562461|FG003|Step 1|Patient fell with fracture|0
1997802|NCT00098475|3562458|FG000|Step 1|Not documented|0
1997803|NCT00098475|3562459|FG001|Step 1|Not documented|1
1997804|NCT00098475|3562460|FG002|Step 1|Not documented|0
1997805|NCT00098475|3562461|FG003|Step 1|Not documented|0
1997806|NCT00098475|3562458|FG000|Step 2|Disease progression|1
1997807|NCT00098475|3562459|FG001|Step 2|Disease progression|4
1997808|NCT00098475|3562460|FG002|Step 2|Disease progression|0
1997809|NCT00098475|3562461|FG003|Step 2|Disease progression|0
1997810|NCT00098475|3562458|FG000|Step 2|Adverse Event|2
1997811|NCT00098475|3562459|FG001|Step 2|Adverse Event|0
1997812|NCT00098475|3562460|FG002|Step 2|Adverse Event|0
1997813|NCT00098475|3562461|FG003|Step 2|Adverse Event|0
1997814|NCT00098475|3562458|FG000|Step 2|Withdrawal by Subject|0
1997815|NCT00098475|3562459|FG001|Step 2|Withdrawal by Subject|2
1997816|NCT00098475|3562460|FG002|Step 2|Withdrawal by Subject|0
1997817|NCT00098475|3562461|FG003|Step 2|Withdrawal by Subject|0
1997818|NCT00098475|3562458|FG000|Step 2|Physician Decision|0
1997819|NCT00098475|3562459|FG001|Step 2|Physician Decision|1
1997820|NCT00098475|3562460|FG002|Step 2|Physician Decision|0
1997821|NCT00098475|3562461|FG003|Step 2|Physician Decision|0
1997822|NCT00098475|3562458|FG000|Step 2|Alternative therapy|1
1997823|NCT00098475|3562459|FG001|Step 2|Alternative therapy|2
1997824|NCT00098475|3562460|FG002|Step 2|Alternative therapy|0
1997825|NCT00098475|3562461|FG003|Step 2|Alternative therapy|0
1997826|NCT00098475|3562458|FG000|Step 2|Never started treatment|1
1997827|NCT00098475|3562459|FG001|Step 2|Never started treatment|1
1997828|NCT00098475|3562460|FG002|Step 2|Never started treatment|0
1997829|NCT00098475|3562461|FG003|Step 2|Never started treatment|0
1997830|NCT00098722|3562479|FG000|Double Blind Phase|Adverse Event|7
1997831|NCT00098722|3562480|FG001|Double Blind Phase|Adverse Event|7
1997832|NCT00098722|3562481|FG002|Double Blind Phase|Adverse Event|3
1997833|NCT00098722|3562482|FG003|Double Blind Phase|Adverse Event|0
1997834|NCT00098722|3562483|FG004|Double Blind Phase|Adverse Event|0
1997835|NCT00098722|3562484|FG005|Double Blind Phase|Adverse Event|0
1997836|NCT00098722|3562485|FG006|Double Blind Phase|Adverse Event|0
1997837|NCT00098722|3562479|FG000|Double Blind Phase|Death|2
1997838|NCT00098722|3562480|FG001|Double Blind Phase|Death|5
1997839|NCT00098722|3562481|FG002|Double Blind Phase|Death|0
1997840|NCT00098722|3562482|FG003|Double Blind Phase|Death|0
1997841|NCT00098722|3562483|FG004|Double Blind Phase|Death|0
1997842|NCT00098722|3562484|FG005|Double Blind Phase|Death|0
1997843|NCT00098722|3562485|FG006|Double Blind Phase|Death|0
1997844|NCT00098722|3562479|FG000|Double Blind Phase|Lack of Efficacy|21
1997845|NCT00098722|3562480|FG001|Double Blind Phase|Lack of Efficacy|23
1997846|NCT00098722|3562481|FG002|Double Blind Phase|Lack of Efficacy|15
1997847|NCT00098722|3562482|FG003|Double Blind Phase|Lack of Efficacy|0
1997848|NCT00098722|3562483|FG004|Double Blind Phase|Lack of Efficacy|0
1997849|NCT00098722|3562484|FG005|Double Blind Phase|Lack of Efficacy|0
1997850|NCT00098722|3562485|FG006|Double Blind Phase|Lack of Efficacy|0
1997851|NCT00098722|3562479|FG000|Double Blind Phase|Participant defaulted|16
1997852|NCT00098722|3562480|FG001|Double Blind Phase|Participant defaulted|11
1997853|NCT00098722|3562481|FG002|Double Blind Phase|Participant defaulted|9
1997854|NCT00098722|3562482|FG003|Double Blind Phase|Participant defaulted|0
1997855|NCT00098722|3562483|FG004|Double Blind Phase|Participant defaulted|0
1997856|NCT00098722|3562484|FG005|Double Blind Phase|Participant defaulted|0
1997857|NCT00098722|3562485|FG006|Double Blind Phase|Participant defaulted|0
1997858|NCT00098722|3562479|FG000|Double Blind Phase|Pregnancy|1
1997859|NCT00098722|3562480|FG001|Double Blind Phase|Pregnancy|0
1997860|NCT00098722|3562481|FG002|Double Blind Phase|Pregnancy|0
1997861|NCT00098722|3562482|FG003|Double Blind Phase|Pregnancy|0
1997862|NCT00098722|3562483|FG004|Double Blind Phase|Pregnancy|0
1997863|NCT00098722|3562484|FG005|Double Blind Phase|Pregnancy|0
1997864|NCT00098722|3562485|FG006|Double Blind Phase|Pregnancy|0
1997865|NCT00098722|3562479|FG000|Double Blind Phase|Randomized, not treated|4
1997866|NCT00098722|3562480|FG001|Double Blind Phase|Randomized, not treated|3
1997867|NCT00098722|3562481|FG002|Double Blind Phase|Randomized, not treated|3
1997868|NCT00098722|3562482|FG003|Double Blind Phase|Randomized, not treated|0
1997869|NCT00098722|3562483|FG004|Double Blind Phase|Randomized, not treated|0
1997870|NCT00098722|3562484|FG005|Double Blind Phase|Randomized, not treated|0
1997871|NCT00098722|3562485|FG006|Double Blind Phase|Randomized, not treated|0
1997872|NCT00098722|3562479|FG000|Double Blind Phase|Ongoing at cut-off date|128
1997873|NCT00098722|3562480|FG001|Double Blind Phase|Ongoing at cut-off date|137
1997874|NCT00098722|3562481|FG002|Double Blind Phase|Ongoing at cut-off date|57
1997875|NCT00098722|3562482|FG003|Double Blind Phase|Ongoing at cut-off date|0
1997876|NCT00098722|3562483|FG004|Double Blind Phase|Ongoing at cut-off date|0
1997877|NCT00098722|3562484|FG005|Double Blind Phase|Ongoing at cut-off date|0
1997878|NCT00098722|3562485|FG006|Double Blind Phase|Ongoing at cut-off date|0
1997879|NCT00098722|3562479|FG000|Double Blind Phase|Other|7
1997880|NCT00098722|3562480|FG001|Double Blind Phase|Other|8
1997881|NCT00098722|3562481|FG002|Double Blind Phase|Other|7
1997882|NCT00098722|3562482|FG003|Double Blind Phase|Other|0
1997883|NCT00098722|3562483|FG004|Double Blind Phase|Other|0
1997884|NCT00098722|3562484|FG005|Double Blind Phase|Other|0
1997885|NCT00098722|3562485|FG006|Double Blind Phase|Other|0
1997886|NCT00098722|3562479|FG000|Open Label Phase|Adverse Event|0
1997887|NCT00098722|3562480|FG001|Open Label Phase|Adverse Event|0
1997888|NCT00098722|3562481|FG002|Open Label Phase|Adverse Event|0
1997889|NCT00098722|3562482|FG003|Open Label Phase|Adverse Event|5
1997890|NCT00098722|3562483|FG004|Open Label Phase|Adverse Event|0
1997891|NCT00098722|3562484|FG005|Open Label Phase|Adverse Event|0
1997892|NCT00098722|3562485|FG006|Open Label Phase|Adverse Event|0
1997893|NCT00098722|3562479|FG000|Open Label Phase|Death|0
1997894|NCT00098722|3562480|FG001|Open Label Phase|Death|0
1997895|NCT00098722|3562481|FG002|Open Label Phase|Death|0
1997896|NCT00098722|3562482|FG003|Open Label Phase|Death|2
1997897|NCT00098722|3562483|FG004|Open Label Phase|Death|0
1997898|NCT00098722|3562484|FG005|Open Label Phase|Death|0
1997899|NCT00098722|3562485|FG006|Open Label Phase|Death|0
1997900|NCT00098722|3562479|FG000|Open Label Phase|Lack of Efficacy|0
1997901|NCT00098722|3562480|FG001|Open Label Phase|Lack of Efficacy|0
1997902|NCT00098722|3562481|FG002|Open Label Phase|Lack of Efficacy|0
1997903|NCT00098722|3562482|FG003|Open Label Phase|Lack of Efficacy|8
1997904|NCT00098722|3562483|FG004|Open Label Phase|Lack of Efficacy|0
1997905|NCT00098722|3562484|FG005|Open Label Phase|Lack of Efficacy|0
1997906|NCT00098722|3562485|FG006|Open Label Phase|Lack of Efficacy|0
1997907|NCT00098722|3562479|FG000|Open Label Phase|Pregnancy|0
1997908|NCT00098722|3562480|FG001|Open Label Phase|Pregnancy|0
1997909|NCT00098722|3562481|FG002|Open Label Phase|Pregnancy|0
1997910|NCT00098722|3562482|FG003|Open Label Phase|Pregnancy|1
1997911|NCT00098722|3562483|FG004|Open Label Phase|Pregnancy|0
1997912|NCT00098722|3562484|FG005|Open Label Phase|Pregnancy|0
1997913|NCT00098722|3562485|FG006|Open Label Phase|Pregnancy|0
1997914|NCT00098722|3562479|FG000|Open Label Phase|Participant defaulted|0
1997915|NCT00098722|3562480|FG001|Open Label Phase|Participant defaulted|0
1997916|NCT00098722|3562481|FG002|Open Label Phase|Participant defaulted|0
1997917|NCT00098722|3562482|FG003|Open Label Phase|Participant defaulted|18
1997918|NCT00098722|3562483|FG004|Open Label Phase|Participant defaulted|0
1997919|NCT00098722|3562484|FG005|Open Label Phase|Participant defaulted|0
1997920|NCT00098722|3562485|FG006|Open Label Phase|Participant defaulted|0
1997921|NCT00098722|3562479|FG000|Open Label Phase|Ongoing at cut-off date|0
1997922|NCT00098722|3562480|FG001|Open Label Phase|Ongoing at cut-off date|0
1997923|NCT00098722|3562481|FG002|Open Label Phase|Ongoing at cut-off date|0
1997924|NCT00098722|3562482|FG003|Open Label Phase|Ongoing at cut-off date|220
1997925|NCT00098722|3562483|FG004|Open Label Phase|Ongoing at cut-off date|50
1997926|NCT00098722|3562484|FG005|Open Label Phase|Ongoing at cut-off date|0
1997927|NCT00098722|3562485|FG006|Open Label Phase|Ongoing at cut-off date|0
1997928|NCT00098722|3562479|FG000|Open Label Phase|Other|0
1997929|NCT00098722|3562480|FG001|Open Label Phase|Other|0
1997930|NCT00098722|3562481|FG002|Open Label Phase|Other|0
1997931|NCT00098722|3562482|FG003|Open Label Phase|Other|18
1997932|NCT00098722|3562483|FG004|Open Label Phase|Other|0
1997933|NCT00098722|3562484|FG005|Open Label Phase|Other|0
1997934|NCT00098722|3562485|FG006|Open Label Phase|Other|0
1997935|NCT00098722|3562479|FG000|Observation Phase|Death|0
1997936|NCT00098722|3562480|FG001|Observation Phase|Death|0
1997937|NCT00098722|3562481|FG002|Observation Phase|Death|0
1997938|NCT00098722|3562482|FG003|Observation Phase|Death|0
1997939|NCT00098722|3562483|FG004|Observation Phase|Death|0
1997940|NCT00098722|3562484|FG005|Observation Phase|Death|5
1997941|NCT00098722|3562485|FG006|Observation Phase|Death|3
1997942|NCT00098722|3562479|FG000|Observation Phase|Lack of Efficacy|0
1997943|NCT00098722|3562480|FG001|Observation Phase|Lack of Efficacy|0
1997944|NCT00098722|3562481|FG002|Observation Phase|Lack of Efficacy|0
1997945|NCT00098722|3562482|FG003|Observation Phase|Lack of Efficacy|0
1997946|NCT00098722|3562483|FG004|Observation Phase|Lack of Efficacy|0
1997947|NCT00098722|3562484|FG005|Observation Phase|Lack of Efficacy|2
1997948|NCT00098722|3562485|FG006|Observation Phase|Lack of Efficacy|0
1997949|NCT00098722|3562479|FG000|Observation Phase|Participant defaulted|0
1997950|NCT00098722|3562480|FG001|Observation Phase|Participant defaulted|0
1997951|NCT00098722|3562481|FG002|Observation Phase|Participant defaulted|0
1997952|NCT00098722|3562482|FG003|Observation Phase|Participant defaulted|0
2102394|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53
1997953|NCT00098722|3562483|FG004|Observation Phase|Participant defaulted|0
1997954|NCT00098722|3562484|FG005|Observation Phase|Participant defaulted|17
1997955|NCT00098722|3562485|FG006|Observation Phase|Participant defaulted|4
1997956|NCT00098722|3562479|FG000|Observation Phase|Other|0
1997957|NCT00098722|3562480|FG001|Observation Phase|Other|0
1997958|NCT00098722|3562481|FG002|Observation Phase|Other|0
1997959|NCT00098722|3562482|FG003|Observation Phase|Other|0
1997960|NCT00098722|3562483|FG004|Observation Phase|Other|0
1997961|NCT00098722|3562484|FG005|Observation Phase|Other|21
1997962|NCT00098722|3562485|FG006|Observation Phase|Other|10
1997963|NCT00098748|3562500|FG000|Assigned to Study Treatment|Randomized, but not treated|0
1997964|NCT00098748|3562501|FG001|Assigned to Study Treatment|Randomized, but not treated|2
1997965|NCT00098748|3562502|FG002|Assigned to Study Treatment|Randomized, but not treated|2
1997966|NCT00098748|3562500|FG000|Received Study Treatment|Death|2
1997967|NCT00098748|3562501|FG001|Received Study Treatment|Death|1
1997968|NCT00098748|3562502|FG002|Received Study Treatment|Death|2
1997969|NCT00098748|3562500|FG000|Received Study Treatment|Adverse Event|1
1997970|NCT00098748|3562501|FG001|Received Study Treatment|Adverse Event|2
1997971|NCT00098748|3562502|FG002|Received Study Treatment|Adverse Event|5
2213783|NCT01682811|3855744|FG000|Part 2 Dose Level 2|Lost to Follow-up|0
2213784|NCT01682811|3855745|FG001|Part 2 Dose Level 2|Lost to Follow-up|0
1997972|NCT00098748|3562500|FG000|Received Study Treatment|Lack of Efficacy|40
1997973|NCT00098748|3562501|FG001|Received Study Treatment|Lack of Efficacy|27
1997974|NCT00098748|3562502|FG002|Received Study Treatment|Lack of Efficacy|27
1997975|NCT00098748|3562500|FG000|Received Study Treatment|Other|2
1997976|NCT00098748|3562501|FG001|Received Study Treatment|Other|2
1997977|NCT00098748|3562502|FG002|Received Study Treatment|Other|6
1997978|NCT00098748|3562500|FG000|Received Study Treatment|Subject defaulted|3
1997979|NCT00098748|3562501|FG001|Received Study Treatment|Subject defaulted|4
1997980|NCT00098748|3562502|FG002|Received Study Treatment|Subject defaulted|4
1997981|NCT00098748|3562500|FG000|Continued on Open-Label Treatment|Adverse Event|0
1997982|NCT00098748|3562501|FG001|Continued on Open-Label Treatment|Adverse Event|1
1997983|NCT00098748|3562502|FG002|Continued on Open-Label Treatment|Adverse Event|0
1997984|NCT00098748|3562500|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1
1997985|NCT00098748|3562501|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2
1997986|NCT00098748|3562502|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0
1997987|NCT00098748|3562500|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6
1997988|NCT00098748|3562501|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7
1997989|NCT00098748|3562502|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0
1997990|NCT00098748|3562500|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1
1997991|NCT00098748|3562501|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1
1997992|NCT00098748|3562502|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0
1997993|NCT00098748|3562500|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0
1997994|NCT00098748|3562501|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4
1997995|NCT00098748|3562502|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0
1997996|NCT00098774|3562510|FG000|Overall Study|Adverse Event|2
1997997|NCT00098774|3562510|FG000|Overall Study|Disease Progression|9
1997998|NCT00098774|3562510|FG000|Overall Study|Withdrawal by Subject|1
1997999|NCT00098774|3562510|FG000|Overall Study|Failed (to respond) during induction|4
1998000|NCT00098774|3562510|FG000|Overall Study|Physician Decision|2
1998001|NCT00098787|3562517|FG000|Overall Study|Never started treatment|3
1998002|NCT00098787|3562518|FG001|Overall Study|Never started treatment|2
1998003|NCT00098787|3562519|FG002|Overall Study|Never started treatment|1
1998004|NCT00098787|3562517|FG000|Overall Study|Ineligible|9
1998005|NCT00098787|3562518|FG001|Overall Study|Ineligible|7
1998006|NCT00098787|3562519|FG002|Overall Study|Ineligible|3
1998007|NCT00098787|3562517|FG000|Overall Study|Disease progression|28
1998008|NCT00098787|3562518|FG001|Overall Study|Disease progression|17
1998009|NCT00098787|3562519|FG002|Overall Study|Disease progression|23
1998010|NCT00098787|3562517|FG000|Overall Study|Adverse Event|8
1998011|NCT00098787|3562518|FG001|Overall Study|Adverse Event|17
1998012|NCT00098787|3562519|FG002|Overall Study|Adverse Event|8
1998013|NCT00098787|3562517|FG000|Overall Study|Death|6
1998014|NCT00098787|3562518|FG001|Overall Study|Death|1
1998015|NCT00098787|3562519|FG002|Overall Study|Death|0
1998016|NCT00098787|3562517|FG000|Overall Study|Withdrawal by Subject|4
1998017|NCT00098787|3562518|FG001|Overall Study|Withdrawal by Subject|12
1998018|NCT00098787|3562519|FG002|Overall Study|Withdrawal by Subject|6
1998019|NCT00098787|3562517|FG000|Overall Study|Alternative therapy|8
1998020|NCT00098787|3562518|FG001|Overall Study|Alternative therapy|13
1998021|NCT00098787|3562519|FG002|Overall Study|Alternative therapy|13
1998022|NCT00098787|3562517|FG000|Overall Study|Other|7
1998023|NCT00098787|3562518|FG001|Overall Study|Other|6
1998024|NCT00098787|3562519|FG002|Overall Study|Other|9
1998025|NCT00098813|3562527|FG000|Overall Study|Death|8
1998026|NCT00098813|3562527|FG000|Overall Study|Protocol Violation|1
1998027|NCT00098813|3562527|FG000|Overall Study|Withdrawal by Subject|7
1998028|NCT00098813|3562527|FG000|Overall Study|Progression of Disease|1
1998029|NCT00098813|3562527|FG000|Overall Study|Other complicating disease|1
1998030|NCT00098813|3562527|FG000|Overall Study|Reversal of RAI resistance|1
1998031|NCT00098839|3562533|FG000|Overall Study|Adverse Event|5
1998032|NCT00098839|3562534|FG001|Overall Study|Adverse Event|2
1998033|NCT00098839|3562533|FG000|Overall Study|Death|1
1998034|NCT00098839|3562534|FG001|Overall Study|Death|2
1998035|NCT00098839|3562533|FG000|Overall Study|Physician Decision|4
1998036|NCT00098839|3562534|FG001|Overall Study|Physician Decision|14
1998037|NCT00098839|3562533|FG000|Overall Study|Withdrawal by Subject|1
1998038|NCT00098839|3562534|FG001|Overall Study|Withdrawal by Subject|0
1998039|NCT00098839|3562533|FG000|Overall Study|Refusal of further protocol therapy|3
1998040|NCT00098839|3562534|FG001|Overall Study|Refusal of further protocol therapy|1
1998041|NCT00098839|3562533|FG000|Overall Study|Relapse|6
1998042|NCT00098839|3562534|FG001|Overall Study|Relapse|3
1998043|NCT00098839|3562533|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
1998044|NCT00098839|3562534|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
1998045|NCT00098839|3562533|FG000|Overall Study|Ineligible|2
1998046|NCT00098839|3562534|FG001|Overall Study|Ineligible|0
1998047|NCT00098865|3562541|FG000|Overall Study|Progressive Disease|6
1998048|NCT00098865|3562541|FG000|Overall Study|Adverse Event|2
1998049|NCT00098865|3562541|FG000|Overall Study|Alternative Therapy|1
1998050|NCT00099268|3562564|FG000|Overall Study|Withdrawal by Subject|46
1998051|NCT00099268|3562565|FG001|Overall Study|Withdrawal by Subject|28
1998052|NCT00099268|3562564|FG000|Overall Study|Adverse Event|19
1998053|NCT00099268|3562565|FG001|Overall Study|Adverse Event|19
1998054|NCT00099268|3562564|FG000|Overall Study|Protocol Violation|9
1998055|NCT00099268|3562565|FG001|Overall Study|Protocol Violation|8
1998056|NCT00099268|3562564|FG000|Overall Study|Lost to Follow-up|6
1998057|NCT00099268|3562565|FG001|Overall Study|Lost to Follow-up|4
1998058|NCT00099268|3562564|FG000|Overall Study|Lack of Efficacy|5
1998059|NCT00099268|3562565|FG001|Overall Study|Lack of Efficacy|18
1998060|NCT00099268|3562564|FG000|Overall Study|Administrative problems|4
1998061|NCT00099268|3562565|FG001|Overall Study|Administrative problems|4
1998062|NCT00099268|3562564|FG000|Overall Study|Death|3
1998063|NCT00099268|3562565|FG001|Overall Study|Death|1
1998064|NCT00099359|3562574|FG000|Overall Study|Death|11
1998065|NCT00099359|3562575|FG001|Overall Study|Death|15
1998066|NCT00099359|3562576|FG002|Overall Study|Death|17
1998067|NCT00099359|3562574|FG000|Overall Study|Withdrawal by Subject|19
1998068|NCT00099359|3562575|FG001|Overall Study|Withdrawal by Subject|19
1998069|NCT00099359|3562576|FG002|Overall Study|Withdrawal by Subject|23
1998070|NCT00099359|3562574|FG000|Overall Study|Lost to Follow-up|15
1998071|NCT00099359|3562575|FG001|Overall Study|Lost to Follow-up|24
1998072|NCT00099359|3562576|FG002|Overall Study|Lost to Follow-up|24
1998073|NCT00099359|3562574|FG000|Overall Study|moved out of area|9
1998074|NCT00099359|3562575|FG001|Overall Study|moved out of area|7
1998075|NCT00099359|3562576|FG002|Overall Study|moved out of area|4
1998076|NCT00099632|3562611|FG000|Overall Study|Lost to Follow-up|1
1998077|NCT00099632|3562612|FG001|Overall Study|Lost to Follow-up|0
1998078|NCT00099632|3562613|FG002|Overall Study|Lost to Follow-up|3
1998079|NCT00099632|3562614|FG003|Overall Study|Lost to Follow-up|1
1998080|NCT00099632|3562615|FG004|Overall Study|Lost to Follow-up|1
1998081|NCT00099632|3562616|FG005|Overall Study|Lost to Follow-up|0
1998082|NCT00099632|3562611|FG000|Overall Study|Withdrawal by Subject|0
1998083|NCT00099632|3562612|FG001|Overall Study|Withdrawal by Subject|1
1998084|NCT00099632|3562613|FG002|Overall Study|Withdrawal by Subject|0
1998085|NCT00099632|3562614|FG003|Overall Study|Withdrawal by Subject|0
1998086|NCT00099632|3562615|FG004|Overall Study|Withdrawal by Subject|0
1998087|NCT00099632|3562616|FG005|Overall Study|Withdrawal by Subject|1
1998088|NCT00099632|3562611|FG000|Overall Study|Protocol Violation|0
1998089|NCT00099632|3562612|FG001|Overall Study|Protocol Violation|0
1998090|NCT00099632|3562613|FG002|Overall Study|Protocol Violation|0
1998091|NCT00099632|3562614|FG003|Overall Study|Protocol Violation|0
1998092|NCT00099632|3562615|FG004|Overall Study|Protocol Violation|0
1998093|NCT00099632|3562616|FG005|Overall Study|Protocol Violation|1
1998094|NCT00099983|3562632|FG000|Overall Study|Lost to Follow-up|2
1998095|NCT00099983|3562633|FG001|Overall Study|Lost to Follow-up|3
1998096|NCT00099983|3562632|FG000|Overall Study|Missing Source Documents|14
1998097|NCT00099983|3562633|FG001|Overall Study|Missing Source Documents|15
1998098|NCT00099983|3562632|FG000|Overall Study|Withdrawal by Subject|3
1998099|NCT00099983|3562633|FG001|Overall Study|Withdrawal by Subject|2
1998100|NCT00099983|3562632|FG000|Overall Study|Adverse Event|1
1998101|NCT00099983|3562633|FG001|Overall Study|Adverse Event|1
1998102|NCT00099983|3562632|FG000|Overall Study|Lack of Efficacy|0
1998103|NCT00099983|3562633|FG001|Overall Study|Lack of Efficacy|1
1998104|NCT00099983|3562632|FG000|Overall Study|Unable to return for appointments|1
1998105|NCT00099983|3562633|FG001|Overall Study|Unable to return for appointments|1
1998106|NCT00099983|3562632|FG000|Overall Study|Moved|1
1998107|NCT00099983|3562633|FG001|Overall Study|Moved|0
1998108|NCT00099983|3562632|FG000|Overall Study|Other psychiatric problem|1
1998109|NCT00099983|3562633|FG001|Overall Study|Other psychiatric problem|0
1998110|NCT00099983|3562632|FG000|Overall Study|Incarcerated|0
1998111|NCT00099983|3562633|FG001|Overall Study|Incarcerated|1
1998112|NCT00099983|3562632|FG000|Overall Study|Intolerant of burden of visits|0
1998113|NCT00099983|3562633|FG001|Overall Study|Intolerant of burden of visits|1
1998114|NCT00099983|3562632|FG000|Overall Study|Other issue|1
1998115|NCT00099983|3562633|FG001|Overall Study|Other issue|0
1998116|NCT00100048|3562644|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2
1998117|NCT00100048|3562645|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0
1998118|NCT00100048|3562646|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0
1998119|NCT00100048|3562647|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0
1998120|NCT00100048|3562648|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0
2024808|NCT00337571|3593461|FG003|Overall Study|Poor/noncompliance|1
1998121|NCT00100048|3562649|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1
1998122|NCT00100048|3562644|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1998123|NCT00100048|3562645|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1
1998124|NCT00100048|3562646|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2
1998125|NCT00100048|3562647|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1998126|NCT00100048|3562648|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1998127|NCT00100048|3562649|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1
1998128|NCT00100048|3562644|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
1998129|NCT00100048|3562645|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
1998130|NCT00100048|3562646|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1998131|NCT00100048|3562647|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1998132|NCT00100048|3562648|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1998133|NCT00100048|3562649|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
1998134|NCT00100048|3562644|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
1998135|NCT00100048|3562645|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
1998136|NCT00100048|3562646|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
1998137|NCT00100048|3562647|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
1998138|NCT00100048|3562648|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
1998139|NCT00100048|3562649|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
1998140|NCT00100048|3562644|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
1998141|NCT00100048|3562645|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
1998142|NCT00100048|3562646|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
1998143|NCT00100048|3562647|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
1998144|NCT00100048|3562648|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
1998145|NCT00100048|3562649|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
1998146|NCT00100048|3562644|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7
1998147|NCT00100048|3562645|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1
1998148|NCT00100048|3562646|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4
1998149|NCT00100048|3562647|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2
1998150|NCT00100048|3562648|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0
1998151|NCT00100048|3562649|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0
1998152|NCT00100048|3562644|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
1998153|NCT00100048|3562645|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
1998154|NCT00100048|3562646|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
1998155|NCT00100048|3562647|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
1998156|NCT00100048|3562648|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
1998157|NCT00100048|3562649|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
1998158|NCT00100048|3562644|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1998159|NCT00100048|3562645|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1998160|NCT00100048|3562646|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1998161|NCT00100048|3562647|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
1998162|NCT00100048|3562648|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1998163|NCT00100048|3562649|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1998164|NCT00100178|3562693|FG000|Overall Study|Lost to Follow-up|0
1998165|NCT00100178|3562694|FG001|Overall Study|Lost to Follow-up|6
1998166|NCT00100178|3562695|FG002|Overall Study|Lost to Follow-up|5
1998167|NCT00100178|3562693|FG000|Overall Study|Adverse Event|2
1998168|NCT00100178|3562694|FG001|Overall Study|Adverse Event|2
1998169|NCT00100178|3562695|FG002|Overall Study|Adverse Event|1
1998170|NCT00100178|3562693|FG000|Overall Study|Withdrawal by Subject|1
1998171|NCT00100178|3562694|FG001|Overall Study|Withdrawal by Subject|1
1998172|NCT00100178|3562695|FG002|Overall Study|Withdrawal by Subject|1
1998173|NCT00100178|3562693|FG000|Overall Study|Physician Decision|6
1998174|NCT00100178|3562694|FG001|Overall Study|Physician Decision|1
1998175|NCT00100178|3562695|FG002|Overall Study|Physician Decision|3
1998176|NCT00100789|3562734|FG000|Overall Study|Adverse Event|10
1998177|NCT00100789|3562734|FG000|Overall Study|Withdrawal by Subject|1
1998178|NCT00100789|3562734|FG000|Overall Study|Progression/relapse|42
1998179|NCT00100789|3562734|FG000|Overall Study|Death|2
1998180|NCT00100789|3562734|FG000|Overall Study|Not protocol specified|5
1998181|NCT00100789|3562734|FG000|Overall Study|Ineligible|3
1998182|NCT00100789|3562734|FG000|Overall Study|Never received treatment|1
1998183|NCT00100802|3562739|FG000|Overall Study|Adverse Event|9
1998184|NCT00100802|3562739|FG000|Overall Study|Death|1
1998185|NCT00100802|3562739|FG000|Overall Study|Lack of Efficacy|47
1998186|NCT00100802|3562739|FG000|Overall Study|Physician Decision|5
1998187|NCT00100802|3562739|FG000|Overall Study|Protocol Violation|1
1998188|NCT00100802|3562739|FG000|Overall Study|Withdrawal by Subject|5
1998189|NCT00100802|3562739|FG000|Overall Study|Ineligible|12
1998190|NCT00100815|3562743|FG000|Overall Study|Progression|24
1998191|NCT00100815|3562743|FG000|Overall Study|Adverse Event|18
1998192|NCT00100815|3562743|FG000|Overall Study|Death|4
1998193|NCT00100815|3562743|FG000|Overall Study|Other|3
1998194|NCT00100932|3562753|FG000|Overall Study|Adverse Event|11
1998195|NCT00100932|3562754|FG001|Overall Study|Adverse Event|2
1998196|NCT00100932|3562753|FG000|Overall Study|Withdrawal by Subject|6
1998197|NCT00100932|3562754|FG001|Overall Study|Withdrawal by Subject|0
1998198|NCT00100932|3562753|FG000|Overall Study|Progressive Disease|44
1998199|NCT00100932|3562754|FG001|Overall Study|Progressive Disease|18
1998200|NCT00100932|3562753|FG000|Overall Study|Physician Decision|7
1998201|NCT00100932|3562754|FG001|Overall Study|Physician Decision|5
1998202|NCT00100932|3562753|FG000|Overall Study|Other|5
1998203|NCT00100932|3562754|FG001|Overall Study|Other|2
1998204|NCT00101010|3562760|FG000|Overall Study|Physician Decision|1
1998205|NCT00101101|3562773|FG000|Overall Study|never received vaccine|20
1998206|NCT00101166|3562777|FG000|Overall Study|progressive disease|10
1998207|NCT00101192|3562781|FG000|Overall Study|Ineligible|6
1998208|NCT00101192|3562781|FG000|Overall Study|Inevaluable|1
1998209|NCT00101283|3562787|FG000|Overall Study|Withdrawal by Subject|0
1998210|NCT00101283|3562788|FG001|Overall Study|Withdrawal by Subject|1
1998211|NCT00101283|3562787|FG000|Overall Study|Insurance Refusal|0
1998212|NCT00101283|3562788|FG001|Overall Study|Insurance Refusal|1
1998213|NCT00101283|3562787|FG000|Overall Study|Prostate Cancer Recurrence|0
1998214|NCT00101283|3562788|FG001|Overall Study|Prostate Cancer Recurrence|1
1998215|NCT00101400|3562803|FG000|Survival Follow-Up|Alive|7
1998216|NCT00101452|3562814|FG000|Overall Study|Adverse Event|2
1998217|NCT00101452|3562815|FG001|Overall Study|Adverse Event|0
1998218|NCT00101452|3562816|FG002|Overall Study|Adverse Event|1
1998219|NCT00101452|3562814|FG000|Overall Study|Lost to Follow-up|13
1998220|NCT00101452|3562815|FG001|Overall Study|Lost to Follow-up|8
1998221|NCT00101452|3562816|FG002|Overall Study|Lost to Follow-up|14
1998222|NCT00101452|3562814|FG000|Overall Study|Withdrawal by Subject|10
1998223|NCT00101452|3562815|FG001|Overall Study|Withdrawal by Subject|14
1998224|NCT00101452|3562816|FG002|Overall Study|Withdrawal by Subject|9
1998225|NCT00101452|3562814|FG000|Overall Study|Baseline Fail|2
1998226|NCT00101452|3562815|FG001|Overall Study|Baseline Fail|1
1998227|NCT00101452|3562816|FG002|Overall Study|Baseline Fail|2
1998228|NCT00101452|3562814|FG000|Overall Study|Physician Decision|0
1998229|NCT00101452|3562815|FG001|Overall Study|Physician Decision|3
1998230|NCT00101452|3562816|FG002|Overall Study|Physician Decision|2
1998231|NCT00101452|3562814|FG000|Overall Study|Protocol Violation|2
1998232|NCT00101452|3562815|FG001|Overall Study|Protocol Violation|1
1998233|NCT00101452|3562816|FG002|Overall Study|Protocol Violation|3
1998234|NCT00101452|3562814|FG000|Overall Study|Other|15
1998235|NCT00101452|3562815|FG001|Overall Study|Other|16
2213785|NCT01682811|3855746|FG002|Part 2 Dose Level 2|Lost to Follow-up|0
2213786|NCT01682811|3855747|FG003|Part 2 Dose Level 2|Lost to Follow-up|0
2213787|NCT01682811|3855748|FG004|Part 2 Dose Level 2|Lost to Follow-up|0
2213788|NCT01682811|3855749|FG005|Part 2 Dose Level 2|Lost to Follow-up|3
2213789|NCT01682811|3855750|FG006|Part 2 Dose Level 2|Lost to Follow-up|0
2213790|NCT01682837|3855769|FG000|Baseline|Withdrawal by Subject|5
2213791|NCT01682863|3855782|FG000|Overall Study|Subject/guardian decision|19
2213792|NCT01682863|3855783|FG001|Overall Study|Subject/guardian decision|12
2213793|NCT01682863|3855784|FG002|Overall Study|Subject/guardian decision|10
2213794|NCT01682863|3855782|FG000|Overall Study|Lost to Follow-up|5
2213795|NCT01682863|3855783|FG001|Overall Study|Lost to Follow-up|1
2213796|NCT01682863|3855784|FG002|Overall Study|Lost to Follow-up|6
1998236|NCT00101452|3562816|FG002|Overall Study|Other|12
1998237|NCT00101582|3562830|FG000|Overall Study|Ineligibility determined|0
1998238|NCT00101582|3562831|FG001|Overall Study|Ineligibility determined|1
1998239|NCT00101582|3562830|FG000|Overall Study|Adverse Event|1
1998240|NCT00101582|3562831|FG001|Overall Study|Adverse Event|4
1998241|NCT00101582|3562830|FG000|Overall Study|Withdrawal by Subject|6
1998242|NCT00101582|3562831|FG001|Overall Study|Withdrawal by Subject|4
1998243|NCT00101582|3562830|FG000|Overall Study|Physician Decision|1
1998244|NCT00101582|3562831|FG001|Overall Study|Physician Decision|0
1998245|NCT00101582|3562830|FG000|Overall Study|Death|3
1998246|NCT00101582|3562831|FG001|Overall Study|Death|5
1998247|NCT00101582|3562830|FG000|Overall Study|Other|0
1998248|NCT00101582|3562831|FG001|Overall Study|Other|1
1998249|NCT00101686|3562881|FG000|Overall Study|Progressive Disease|37
1998250|NCT00101686|3562882|FG001|Overall Study|Progressive Disease|28
1998251|NCT00101686|3562883|FG002|Overall Study|Progressive Disease|37
1998252|NCT00101686|3562884|FG003|Overall Study|Progressive Disease|38
1998253|NCT00101686|3562885|FG004|Overall Study|Progressive Disease|28
1998254|NCT00101686|3562886|FG005|Overall Study|Progressive Disease|25
1998255|NCT00101686|3562887|FG006|Overall Study|Progressive Disease|5
1998256|NCT00101686|3562888|FG007|Overall Study|Progressive Disease|7
1998257|NCT00101686|3562889|FG008|Overall Study|Progressive Disease|10
1998258|NCT00101686|3562890|FG009|Overall Study|Progressive Disease|8
1998259|NCT00101686|3562881|FG000|Overall Study|initiation other anti-cancer treatment|4
1998260|NCT00101686|3562882|FG001|Overall Study|initiation other anti-cancer treatment|3
1998261|NCT00101686|3562883|FG002|Overall Study|initiation other anti-cancer treatment|4
1998262|NCT00101686|3562884|FG003|Overall Study|initiation other anti-cancer treatment|3
1998263|NCT00101686|3562885|FG004|Overall Study|initiation other anti-cancer treatment|1
1998264|NCT00101686|3562886|FG005|Overall Study|initiation other anti-cancer treatment|1
1998265|NCT00101686|3562887|FG006|Overall Study|initiation other anti-cancer treatment|2
1998266|NCT00101686|3562888|FG007|Overall Study|initiation other anti-cancer treatment|2
1998267|NCT00101686|3562889|FG008|Overall Study|initiation other anti-cancer treatment|3
1998268|NCT00101686|3562890|FG009|Overall Study|initiation other anti-cancer treatment|3
1998269|NCT00101686|3562881|FG000|Overall Study|>3 week delay treatment due toxicity|6
1998270|NCT00101686|3562882|FG001|Overall Study|>3 week delay treatment due toxicity|2
1998271|NCT00101686|3562883|FG002|Overall Study|>3 week delay treatment due toxicity|1
1998272|NCT00101686|3562884|FG003|Overall Study|>3 week delay treatment due toxicity|2
1998273|NCT00101686|3562885|FG004|Overall Study|>3 week delay treatment due toxicity|7
1998274|NCT00101686|3562886|FG005|Overall Study|>3 week delay treatment due toxicity|3
1998275|NCT00101686|3562887|FG006|Overall Study|>3 week delay treatment due toxicity|2
1998276|NCT00101686|3562888|FG007|Overall Study|>3 week delay treatment due toxicity|1
1998277|NCT00101686|3562889|FG008|Overall Study|>3 week delay treatment due toxicity|3
1998278|NCT00101686|3562890|FG009|Overall Study|>3 week delay treatment due toxicity|0
1998279|NCT00101686|3562881|FG000|Overall Study|unacceptable toxicity|3
1998280|NCT00101686|3562882|FG001|Overall Study|unacceptable toxicity|9
1998281|NCT00101686|3562883|FG002|Overall Study|unacceptable toxicity|10
1998282|NCT00101686|3562884|FG003|Overall Study|unacceptable toxicity|6
1998283|NCT00101686|3562885|FG004|Overall Study|unacceptable toxicity|16
1998284|NCT00101686|3562886|FG005|Overall Study|unacceptable toxicity|10
1998285|NCT00101686|3562887|FG006|Overall Study|unacceptable toxicity|4
1998286|NCT00101686|3562888|FG007|Overall Study|unacceptable toxicity|2
1998287|NCT00101686|3562889|FG008|Overall Study|unacceptable toxicity|1
1998288|NCT00101686|3562890|FG009|Overall Study|unacceptable toxicity|4
1998289|NCT00101686|3562881|FG000|Overall Study|Randomized but did not receive treament|1
1998290|NCT00101686|3562882|FG001|Overall Study|Randomized but did not receive treament|6
1998291|NCT00101686|3562883|FG002|Overall Study|Randomized but did not receive treament|2
1998292|NCT00101686|3562884|FG003|Overall Study|Randomized but did not receive treament|2
1998293|NCT00101686|3562885|FG004|Overall Study|Randomized but did not receive treament|2
1998294|NCT00101686|3562886|FG005|Overall Study|Randomized but did not receive treament|2
1998295|NCT00101686|3562887|FG006|Overall Study|Randomized but did not receive treament|0
2213797|NCT01682863|3855782|FG000|Overall Study|Death|1
2213798|NCT01682863|3855783|FG001|Overall Study|Death|3
2213799|NCT01682863|3855784|FG002|Overall Study|Death|4
2213800|NCT01682863|3855782|FG000|Overall Study|Protocol deviation|1
2213801|NCT01682863|3855783|FG001|Overall Study|Protocol deviation|0
2213802|NCT01682863|3855784|FG002|Overall Study|Protocol deviation|1
2213803|NCT01682863|3855782|FG000|Overall Study|Technical problems|1
2213804|NCT01682863|3855783|FG001|Overall Study|Technical problems|0
1998296|NCT00101686|3562888|FG007|Overall Study|Randomized but did not receive treament|1
1998297|NCT00101686|3562889|FG008|Overall Study|Randomized but did not receive treament|0
1998298|NCT00101686|3562890|FG009|Overall Study|Randomized but did not receive treament|1
1998299|NCT00101686|3562881|FG000|Overall Study|intercurrent non-cancer related illness|0
1998300|NCT00101686|3562882|FG001|Overall Study|intercurrent non-cancer related illness|0
1998301|NCT00101686|3562883|FG002|Overall Study|intercurrent non-cancer related illness|2
1998302|NCT00101686|3562884|FG003|Overall Study|intercurrent non-cancer related illness|0
1998303|NCT00101686|3562885|FG004|Overall Study|intercurrent non-cancer related illness|1
1998304|NCT00101686|3562886|FG005|Overall Study|intercurrent non-cancer related illness|3
1998305|NCT00101686|3562887|FG006|Overall Study|intercurrent non-cancer related illness|1
1998306|NCT00101686|3562888|FG007|Overall Study|intercurrent non-cancer related illness|0
1998307|NCT00101686|3562889|FG008|Overall Study|intercurrent non-cancer related illness|1
2312036|NCT02760407|4017753|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
2312037|NCT02760407|4017754|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
2312038|NCT02760407|4017755|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
2312039|NCT02760407|4017752|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
1998308|NCT00101686|3562890|FG009|Overall Study|intercurrent non-cancer related illness|1
1998309|NCT00101686|3562881|FG000|Overall Study|Physician Decision|10
1998310|NCT00101686|3562882|FG001|Overall Study|Physician Decision|13
1998311|NCT00101686|3562883|FG002|Overall Study|Physician Decision|6
1998312|NCT00101686|3562884|FG003|Overall Study|Physician Decision|7
1998313|NCT00101686|3562885|FG004|Overall Study|Physician Decision|8
1998314|NCT00101686|3562886|FG005|Overall Study|Physician Decision|9
1998315|NCT00101686|3562887|FG006|Overall Study|Physician Decision|5
1998316|NCT00101686|3562888|FG007|Overall Study|Physician Decision|5
1998317|NCT00101686|3562889|FG008|Overall Study|Physician Decision|1
1998318|NCT00101686|3562890|FG009|Overall Study|Physician Decision|1
1998319|NCT00101686|3562881|FG000|Overall Study|Other|1
1998320|NCT00101686|3562882|FG001|Overall Study|Other|4
1998321|NCT00101686|3562883|FG002|Overall Study|Other|1
1998322|NCT00101686|3562884|FG003|Overall Study|Other|6
1998323|NCT00101686|3562885|FG004|Overall Study|Other|2
1998324|NCT00101686|3562886|FG005|Overall Study|Other|12
1998325|NCT00101686|3562887|FG006|Overall Study|Other|1
1998326|NCT00101686|3562888|FG007|Overall Study|Other|5
1998327|NCT00101686|3562889|FG008|Overall Study|Other|3
1998328|NCT00101686|3562890|FG009|Overall Study|Other|3
1998329|NCT00101686|3562881|FG000|Overall Study|Withdrawal by Subject|9
1998330|NCT00101686|3562882|FG001|Overall Study|Withdrawal by Subject|8
1998331|NCT00101686|3562883|FG002|Overall Study|Withdrawal by Subject|6
1998332|NCT00101686|3562884|FG003|Overall Study|Withdrawal by Subject|8
1998333|NCT00101686|3562885|FG004|Overall Study|Withdrawal by Subject|8
1998334|NCT00101686|3562886|FG005|Overall Study|Withdrawal by Subject|7
1998335|NCT00101686|3562887|FG006|Overall Study|Withdrawal by Subject|7
1998336|NCT00101686|3562888|FG007|Overall Study|Withdrawal by Subject|7
1998337|NCT00101686|3562889|FG008|Overall Study|Withdrawal by Subject|8
1998338|NCT00101686|3562890|FG009|Overall Study|Withdrawal by Subject|9
1998339|NCT00101868|3562926|FG000|Overall Study|Death|10
2213805|NCT01682863|3855784|FG002|Overall Study|Technical problems|0
1998340|NCT00101868|3562927|FG001|Overall Study|Death|10
1998341|NCT00101868|3562926|FG000|Overall Study|Withdrawal by Subject|8
1998342|NCT00101868|3562927|FG001|Overall Study|Withdrawal by Subject|9
1998343|NCT00101868|3562926|FG000|Overall Study|Protocol Violation|3
1998344|NCT00101868|3562927|FG001|Overall Study|Protocol Violation|0
1998345|NCT00101868|3562926|FG000|Overall Study|Lost to Follow-up|8
1998346|NCT00101868|3562927|FG001|Overall Study|Lost to Follow-up|13
1998347|NCT00101907|3562941|FG000|Overall Study|Adverse Event|1
1998348|NCT00101907|3562942|FG001|Overall Study|Adverse Event|0
1998349|NCT00101907|3562943|FG002|Overall Study|Adverse Event|0
1998350|NCT00101907|3562944|FG003|Overall Study|Adverse Event|0
1998351|NCT00101907|3562945|FG004|Overall Study|Adverse Event|0
1998352|NCT00101907|3562946|FG005|Overall Study|Adverse Event|0
1998353|NCT00101907|3562941|FG000|Overall Study|Death|0
1998354|NCT00101907|3562942|FG001|Overall Study|Death|1
1998355|NCT00101907|3562943|FG002|Overall Study|Death|0
1998356|NCT00101907|3562944|FG003|Overall Study|Death|0
1998357|NCT00101907|3562945|FG004|Overall Study|Death|3
1998358|NCT00101907|3562946|FG005|Overall Study|Death|0
1998359|NCT00101907|3562941|FG000|Overall Study|Physician Decision|0
1998360|NCT00101907|3562942|FG001|Overall Study|Physician Decision|0
1998361|NCT00101907|3562943|FG002|Overall Study|Physician Decision|0
1998362|NCT00101907|3562944|FG003|Overall Study|Physician Decision|1
1998363|NCT00101907|3562945|FG004|Overall Study|Physician Decision|1
1998364|NCT00101907|3562946|FG005|Overall Study|Physician Decision|0
1998365|NCT00101907|3562941|FG000|Overall Study|Withdrawal by Subject|1
1998366|NCT00101907|3562942|FG001|Overall Study|Withdrawal by Subject|0
1998367|NCT00101907|3562943|FG002|Overall Study|Withdrawal by Subject|1
1998368|NCT00101907|3562944|FG003|Overall Study|Withdrawal by Subject|0
1998369|NCT00101907|3562945|FG004|Overall Study|Withdrawal by Subject|1
1998370|NCT00101907|3562946|FG005|Overall Study|Withdrawal by Subject|0
1998371|NCT00102063|3562980|FG000|Overall Study|Lack of Efficacy|5
1998372|NCT00102063|3562981|FG001|Overall Study|Lack of Efficacy|1
1998373|NCT00102063|3562982|FG002|Overall Study|Lack of Efficacy|1
1998374|NCT00102063|3562980|FG000|Overall Study|Adverse Event|7
1998375|NCT00102063|3562981|FG001|Overall Study|Adverse Event|4
1998376|NCT00102063|3562982|FG002|Overall Study|Adverse Event|2
1998377|NCT00102063|3562980|FG000|Overall Study|Withdrawal by Subject|4
1998378|NCT00102063|3562981|FG001|Overall Study|Withdrawal by Subject|12
1998379|NCT00102063|3562982|FG002|Overall Study|Withdrawal by Subject|5
1998380|NCT00102063|3562980|FG000|Overall Study|Lost to Follow-up|0
1998381|NCT00102063|3562981|FG001|Overall Study|Lost to Follow-up|0
1998382|NCT00102063|3562982|FG002|Overall Study|Lost to Follow-up|1
1998383|NCT00102063|3562980|FG000|Overall Study|Protocol Violation|0
1998384|NCT00102063|3562981|FG001|Overall Study|Protocol Violation|1
1998385|NCT00102063|3562982|FG002|Overall Study|Protocol Violation|1
1998386|NCT00102440|3562993|FG000|Overall Study|Lost to Follow-up|25
1998387|NCT00102440|3562994|FG001|Overall Study|Lost to Follow-up|18
1998388|NCT00102440|3562995|FG002|Overall Study|Lost to Follow-up|21
1998389|NCT00102440|3562993|FG000|Overall Study|Adverse Event|16
1998390|NCT00102440|3562994|FG001|Overall Study|Adverse Event|23
1998391|NCT00102440|3562995|FG002|Overall Study|Adverse Event|8
1998392|NCT00102440|3562993|FG000|Overall Study|Gout Flare|10
1998393|NCT00102440|3562994|FG001|Overall Study|Gout Flare|28
1998394|NCT00102440|3562995|FG002|Overall Study|Gout Flare|9
1998395|NCT00102440|3562993|FG000|Overall Study|Personal Reason(s)|19
1998396|NCT00102440|3562994|FG001|Overall Study|Personal Reason(s)|13
1998397|NCT00102440|3562995|FG002|Overall Study|Personal Reason(s)|13
1998398|NCT00102440|3562993|FG000|Overall Study|Other|11
1998399|NCT00102440|3562994|FG001|Overall Study|Other|14
1998400|NCT00102440|3562995|FG002|Overall Study|Other|14
1998401|NCT00102440|3562993|FG000|Overall Study|Protocol Violation|7
1998402|NCT00102440|3562994|FG001|Overall Study|Protocol Violation|2
1998403|NCT00102440|3562995|FG002|Overall Study|Protocol Violation|1
1998404|NCT00102531|3563009|FG000|Overall Study|Adverse Event|0
1998405|NCT00102531|3563010|FG001|Overall Study|Adverse Event|1
1998406|NCT00102531|3563009|FG000|Overall Study|Disease Progression|5
1998407|NCT00102531|3563010|FG001|Overall Study|Disease Progression|9
1998408|NCT00102531|3563009|FG000|Overall Study|Physician Decision|0
1998409|NCT00102531|3563010|FG001|Overall Study|Physician Decision|1
1998410|NCT00102596|3563016|FG000|Part A|Screen failures|6
1998411|NCT00102596|3563017|FG001|Part A|Screen failures|0
1998412|NCT00102596|3563016|FG000|Part A|Adverse Event|1
1998413|NCT00102596|3563017|FG001|Part A|Adverse Event|0
1998414|NCT00102687|3563027|FG000|Initial Period|Withdrawal by Subject|6
1998415|NCT00102687|3563028|FG001|Initial Period|Withdrawal by Subject|3
1998416|NCT00102687|3563029|FG002|Initial Period|Withdrawal by Subject|5
1998417|NCT00102687|3563030|FG003|Initial Period|Withdrawal by Subject|0
1998418|NCT00102687|3563031|FG004|Initial Period|Withdrawal by Subject|0
1998419|NCT00102687|3563027|FG000|Initial Period|Adverse Event|4
1998420|NCT00102687|3563028|FG001|Initial Period|Adverse Event|7
1998421|NCT00102687|3563029|FG002|Initial Period|Adverse Event|9
1998422|NCT00102687|3563030|FG003|Initial Period|Adverse Event|0
1998423|NCT00102687|3563031|FG004|Initial Period|Adverse Event|0
1998424|NCT00102687|3563027|FG000|Initial Period|Transformation to AML (blast > 30%)|1
1998425|NCT00102687|3563028|FG001|Initial Period|Transformation to AML (blast > 30%)|3
1998426|NCT00102687|3563029|FG002|Initial Period|Transformation to AML (blast > 30%)|0
1998427|NCT00102687|3563030|FG003|Initial Period|Transformation to AML (blast > 30%)|0
1998428|NCT00102687|3563031|FG004|Initial Period|Transformation to AML (blast > 30%)|0
1998429|NCT00102687|3563027|FG000|Initial Period|Protocol Violation|0
1998430|NCT00102687|3563028|FG001|Initial Period|Protocol Violation|0
1998431|NCT00102687|3563029|FG002|Initial Period|Protocol Violation|2
1998432|NCT00102687|3563030|FG003|Initial Period|Protocol Violation|0
1998433|NCT00102687|3563031|FG004|Initial Period|Protocol Violation|0
1998434|NCT00102687|3563027|FG000|Initial Period|Physician Decision|2
1998435|NCT00102687|3563028|FG001|Initial Period|Physician Decision|9
1998436|NCT00102687|3563029|FG002|Initial Period|Physician Decision|6
1998437|NCT00102687|3563030|FG003|Initial Period|Physician Decision|0
1998438|NCT00102687|3563031|FG004|Initial Period|Physician Decision|0
1998439|NCT00102687|3563027|FG000|Initial Period|Sponsor's decision|0
1998440|NCT00102687|3563028|FG001|Initial Period|Sponsor's decision|1
1998441|NCT00102687|3563029|FG002|Initial Period|Sponsor's decision|1
1998442|NCT00102687|3563030|FG003|Initial Period|Sponsor's decision|0
1998443|NCT00102687|3563031|FG004|Initial Period|Sponsor's decision|0
1998444|NCT00102687|3563027|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4
1998445|NCT00102687|3563028|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4
1998446|NCT00102687|3563029|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2
1998447|NCT00102687|3563030|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0
1998448|NCT00102687|3563031|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0
1998449|NCT00102687|3563027|FG000|Initial Period|Death|1
1998450|NCT00102687|3563028|FG001|Initial Period|Death|1
1998451|NCT00102687|3563029|FG002|Initial Period|Death|1
1998452|NCT00102687|3563030|FG003|Initial Period|Death|0
1998453|NCT00102687|3563031|FG004|Initial Period|Death|0
1998454|NCT00102687|3563027|FG000|Maintenance Period|Withdrawal by Subject|4
1998455|NCT00102687|3563028|FG001|Maintenance Period|Withdrawal by Subject|0
1998456|NCT00102687|3563029|FG002|Maintenance Period|Withdrawal by Subject|2
1998457|NCT00102687|3563030|FG003|Maintenance Period|Withdrawal by Subject|3
1998458|NCT00102687|3563031|FG004|Maintenance Period|Withdrawal by Subject|1
1998459|NCT00102687|3563027|FG000|Maintenance Period|Adverse Event|1
1998460|NCT00102687|3563028|FG001|Maintenance Period|Adverse Event|0
1998461|NCT00102687|3563029|FG002|Maintenance Period|Adverse Event|0
1998462|NCT00102687|3563030|FG003|Maintenance Period|Adverse Event|1
1998463|NCT00102687|3563031|FG004|Maintenance Period|Adverse Event|3
1998464|NCT00102687|3563027|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0
1998465|NCT00102687|3563028|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1
1998466|NCT00102687|3563029|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0
1998467|NCT00102687|3563030|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2
1998468|NCT00102687|3563031|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0
1998469|NCT00102687|3563027|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1998470|NCT00102687|3563028|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1998471|NCT00102687|3563029|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1998472|NCT00102687|3563030|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3
1998473|NCT00102687|3563031|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4
1998474|NCT00102687|3563027|FG000|Maintenance Period|Death|0
1998475|NCT00102687|3563028|FG001|Maintenance Period|Death|0
1998476|NCT00102687|3563029|FG002|Maintenance Period|Death|0
1998477|NCT00102687|3563030|FG003|Maintenance Period|Death|1
1998478|NCT00102687|3563031|FG004|Maintenance Period|Death|1
1998479|NCT00102687|3563027|FG000|Maintenance Period|Physician Decision|1
1998480|NCT00102687|3563028|FG001|Maintenance Period|Physician Decision|2
1998481|NCT00102687|3563029|FG002|Maintenance Period|Physician Decision|3
1998482|NCT00102687|3563030|FG003|Maintenance Period|Physician Decision|0
1998483|NCT00102687|3563031|FG004|Maintenance Period|Physician Decision|4
1998484|NCT00102804|3563049|FG000|Overall Study|Progressive Disease (PD)|307
1998485|NCT00102804|3563050|FG001|Overall Study|Progressive Disease (PD)|196
1998486|NCT00102804|3563049|FG000|Overall Study|Withdrawal by Subject|46
1998487|NCT00102804|3563050|FG001|Overall Study|Withdrawal by Subject|7
1998488|NCT00102804|3563049|FG000|Overall Study|Adverse Event|37
1998489|NCT00102804|3563050|FG001|Overall Study|Adverse Event|3
1998490|NCT00102804|3563049|FG000|Overall Study|Physician Decision|24
1998491|NCT00102804|3563050|FG001|Overall Study|Physician Decision|6
1998492|NCT00102804|3563049|FG000|Overall Study|Death|5
1998493|NCT00102804|3563050|FG001|Overall Study|Death|6
1998494|NCT00102804|3563049|FG000|Overall Study|Enrollment Criteria Not Met|6
1998495|NCT00102804|3563050|FG001|Overall Study|Enrollment Criteria Not Met|0
1998496|NCT00102804|3563049|FG000|Overall Study|Lost to Follow-up|4
1998497|NCT00102804|3563050|FG001|Overall Study|Lost to Follow-up|1
1998498|NCT00102804|3563049|FG000|Overall Study|Protocol Violation|2
1998499|NCT00102804|3563050|FG001|Overall Study|Protocol Violation|1
1998500|NCT00102804|3563049|FG000|Overall Study|Satisfactory Response|2
1998501|NCT00102804|3563050|FG001|Overall Study|Satisfactory Response|0
2213806|NCT01682863|3855782|FG000|Overall Study|Adverse Event|0
2213807|NCT01682863|3855783|FG001|Overall Study|Adverse Event|1
2213808|NCT01682863|3855784|FG002|Overall Study|Adverse Event|2
2213809|NCT01682863|3855782|FG000|Overall Study|Physician Decision|0
2213810|NCT01682863|3855783|FG001|Overall Study|Physician Decision|0
2213811|NCT01682863|3855784|FG002|Overall Study|Physician Decision|1
2213812|NCT01682876|3855796|FG000|Overall Study|Administrative reason|4
2213813|NCT01682876|3855797|FG001|Overall Study|Administrative reason|4
2213814|NCT01682876|3855798|FG002|Overall Study|Administrative reason|0
2213815|NCT01682876|3855799|FG003|Overall Study|Administrative reason|3
2213816|NCT01682876|3855796|FG000|Overall Study|Adverse Event|0
2213817|NCT01682876|3855797|FG001|Overall Study|Adverse Event|0
1998502|NCT00102804|3563049|FG000|Overall Study|Sponsor Decision|1
1998503|NCT00102804|3563050|FG001|Overall Study|Sponsor Decision|0
1998504|NCT00102804|3563049|FG000|Overall Study|Alive, Receiving Treatment|7
1998505|NCT00102804|3563050|FG001|Overall Study|Alive, Receiving Treatment|2
1998506|NCT00102960|3563059|FG000|Overall Study|Death|23
1998507|NCT00102960|3563060|FG001|Overall Study|Death|11
1998508|NCT00102960|3563061|FG002|Overall Study|Death|11
1998509|NCT00102960|3563059|FG000|Overall Study|Lost to Follow-up|6
1998510|NCT00102960|3563060|FG001|Overall Study|Lost to Follow-up|12
1998511|NCT00102960|3563061|FG002|Overall Study|Lost to Follow-up|16
1998512|NCT00102960|3563059|FG000|Overall Study|Withdrawal by Subject|1
1998513|NCT00102960|3563060|FG001|Overall Study|Withdrawal by Subject|0
1998514|NCT00102960|3563061|FG002|Overall Study|Withdrawal by Subject|1
1998515|NCT00103012|3563076|FG000|Overall Study|Withdrawal by Subject|2
1998516|NCT00103012|3563077|FG001|Overall Study|Withdrawal by Subject|1
1998517|NCT00103012|3563078|FG002|Overall Study|Withdrawal by Subject|2
1998518|NCT00103012|3563076|FG000|Overall Study|Pregnancy|1
1998519|NCT00103012|3563077|FG001|Overall Study|Pregnancy|0
1998520|NCT00103012|3563078|FG002|Overall Study|Pregnancy|0
1998521|NCT00103012|3563076|FG000|Overall Study|Adverse Event|0
1998522|NCT00103012|3563077|FG001|Overall Study|Adverse Event|0
1998523|NCT00103012|3563078|FG002|Overall Study|Adverse Event|1
1998524|NCT00103012|3563076|FG000|Overall Study|Subject non-compliant with medications|0
1998525|NCT00103012|3563077|FG001|Overall Study|Subject non-compliant with medications|0
1998526|NCT00103012|3563078|FG002|Overall Study|Subject non-compliant with medications|1
1998527|NCT00103142|3563092|FG000|Overall Study|Adverse Event|1
1998528|NCT00103142|3563093|FG001|Overall Study|Adverse Event|0
1998529|NCT00103142|3563092|FG000|Overall Study|Progression of disease|2
1998530|NCT00103142|3563093|FG001|Overall Study|Progression of disease|1
1998531|NCT00103207|3563105|FG000|Overall Study|Adverse Event|3
1998532|NCT00103207|3563105|FG000|Overall Study|Death|1
1998533|NCT00103207|3563105|FG000|Overall Study|Withdrawal by Subject|2
1998534|NCT00103207|3563105|FG000|Overall Study|Other complicating disease|1
1998535|NCT00103207|3563105|FG000|Overall Study|Ineligible|4
1998536|NCT00103207|3563105|FG000|Overall Study|Diagnosis of BAC not confirmed|27
1998537|NCT00103259|3563113|FG000|Overall Study|Death|3
1998538|NCT00103259|3563114|FG001|Overall Study|Death|2
1998539|NCT00103259|3563113|FG000|Overall Study|Withdrawal by Subject|2
1998540|NCT00103259|3563114|FG001|Overall Study|Withdrawal by Subject|3
1998541|NCT00103259|3563113|FG000|Overall Study|alternative therapy|1
1998542|NCT00103259|3563114|FG001|Overall Study|alternative therapy|0
1998543|NCT00103259|3563113|FG000|Overall Study|other (reasons were not specified)|2
1998544|NCT00103259|3563114|FG001|Overall Study|other (reasons were not specified)|1
1998545|NCT00103259|3563113|FG000|Overall Study|ineligible/no protocol therapy|4
1998546|NCT00103259|3563114|FG001|Overall Study|ineligible/no protocol therapy|6
1998547|NCT00103285|3563122|FG000|Induction|Adverse Event|14
1998548|NCT00103285|3563123|FG001|Induction|Adverse Event|0
1998549|NCT00103285|3563124|FG002|Induction|Adverse Event|0
1998550|NCT00103285|3563125|FG003|Induction|Adverse Event|0
1998551|NCT00103285|3563126|FG004|Induction|Adverse Event|0
1998552|NCT00103285|3563127|FG005|Induction|Adverse Event|0
1998553|NCT00103285|3563128|FG006|Induction|Adverse Event|0
1998554|NCT00103285|3563129|FG007|Induction|Adverse Event|0
1998555|NCT00103285|3563122|FG000|Induction|Death|24
1998556|NCT00103285|3563123|FG001|Induction|Death|0
1998557|NCT00103285|3563124|FG002|Induction|Death|0
1998558|NCT00103285|3563125|FG003|Induction|Death|0
1998559|NCT00103285|3563126|FG004|Induction|Death|0
1998560|NCT00103285|3563127|FG005|Induction|Death|0
1998561|NCT00103285|3563128|FG006|Induction|Death|0
1998562|NCT00103285|3563129|FG007|Induction|Death|0
1998563|NCT00103285|3563122|FG000|Induction|Physician Decision|103
1998564|NCT00103285|3563123|FG001|Induction|Physician Decision|0
1998565|NCT00103285|3563124|FG002|Induction|Physician Decision|0
1998566|NCT00103285|3563125|FG003|Induction|Physician Decision|0
1998567|NCT00103285|3563126|FG004|Induction|Physician Decision|0
1998568|NCT00103285|3563127|FG005|Induction|Physician Decision|0
1998569|NCT00103285|3563128|FG006|Induction|Physician Decision|0
1998570|NCT00103285|3563129|FG007|Induction|Physician Decision|0
1998571|NCT00103285|3563122|FG000|Induction|Withdrawal by Subject|1
1998572|NCT00103285|3563123|FG001|Induction|Withdrawal by Subject|0
1998573|NCT00103285|3563124|FG002|Induction|Withdrawal by Subject|0
1998574|NCT00103285|3563125|FG003|Induction|Withdrawal by Subject|0
1998575|NCT00103285|3563126|FG004|Induction|Withdrawal by Subject|0
1998576|NCT00103285|3563127|FG005|Induction|Withdrawal by Subject|0
1998577|NCT00103285|3563128|FG006|Induction|Withdrawal by Subject|0
1998578|NCT00103285|3563129|FG007|Induction|Withdrawal by Subject|0
1998579|NCT00103285|3563122|FG000|Induction|Ineligible|43
1998580|NCT00103285|3563123|FG001|Induction|Ineligible|0
1998581|NCT00103285|3563124|FG002|Induction|Ineligible|0
1998582|NCT00103285|3563125|FG003|Induction|Ineligible|0
1998583|NCT00103285|3563126|FG004|Induction|Ineligible|0
1998584|NCT00103285|3563127|FG005|Induction|Ineligible|0
1998585|NCT00103285|3563128|FG006|Induction|Ineligible|0
1998586|NCT00103285|3563129|FG007|Induction|Ineligible|0
1998587|NCT00103285|3563122|FG000|Induction|Refusal|906
1998588|NCT00103285|3563123|FG001|Induction|Refusal|0
1998589|NCT00103285|3563124|FG002|Induction|Refusal|0
1998590|NCT00103285|3563125|FG003|Induction|Refusal|0
1998591|NCT00103285|3563126|FG004|Induction|Refusal|0
1998592|NCT00103285|3563127|FG005|Induction|Refusal|0
1998593|NCT00103285|3563128|FG006|Induction|Refusal|0
1998594|NCT00103285|3563129|FG007|Induction|Refusal|0
1998595|NCT00103285|3563122|FG000|Induction|Other|258
1998596|NCT00103285|3563123|FG001|Induction|Other|0
1998597|NCT00103285|3563124|FG002|Induction|Other|0
1998598|NCT00103285|3563125|FG003|Induction|Other|0
1998599|NCT00103285|3563126|FG004|Induction|Other|0
1998600|NCT00103285|3563127|FG005|Induction|Other|0
1998601|NCT00103285|3563128|FG006|Induction|Other|0
1998602|NCT00103285|3563129|FG007|Induction|Other|0
1998603|NCT00103285|3563122|FG000|Response Assignment|Adverse Event|0
1998604|NCT00103285|3563123|FG001|Response Assignment|Adverse Event|8
1998605|NCT00103285|3563124|FG002|Response Assignment|Adverse Event|3
1998606|NCT00103285|3563125|FG003|Response Assignment|Adverse Event|2
1998607|NCT00103285|3563126|FG004|Response Assignment|Adverse Event|3
1998608|NCT00103285|3563127|FG005|Response Assignment|Adverse Event|1
1998609|NCT00103285|3563128|FG006|Response Assignment|Adverse Event|1
1998610|NCT00103285|3563129|FG007|Response Assignment|Adverse Event|2
1998611|NCT00103285|3563122|FG000|Response Assignment|Death|0
1998612|NCT00103285|3563123|FG001|Response Assignment|Death|5
1998613|NCT00103285|3563124|FG002|Response Assignment|Death|2
1998614|NCT00103285|3563125|FG003|Response Assignment|Death|2
1998615|NCT00103285|3563126|FG004|Response Assignment|Death|3
1998616|NCT00103285|3563127|FG005|Response Assignment|Death|1
1998617|NCT00103285|3563128|FG006|Response Assignment|Death|0
1998618|NCT00103285|3563129|FG007|Response Assignment|Death|8
1998619|NCT00103285|3563122|FG000|Response Assignment|Lost to Follow-up|0
1998620|NCT00103285|3563123|FG001|Response Assignment|Lost to Follow-up|9
1998621|NCT00103285|3563124|FG002|Response Assignment|Lost to Follow-up|5
1998622|NCT00103285|3563125|FG003|Response Assignment|Lost to Follow-up|5
1998623|NCT00103285|3563126|FG004|Response Assignment|Lost to Follow-up|1
1998624|NCT00103285|3563127|FG005|Response Assignment|Lost to Follow-up|2
1998625|NCT00103285|3563128|FG006|Response Assignment|Lost to Follow-up|2
1998626|NCT00103285|3563129|FG007|Response Assignment|Lost to Follow-up|5
1998627|NCT00103285|3563122|FG000|Response Assignment|Physician Decision|0
1998628|NCT00103285|3563123|FG001|Response Assignment|Physician Decision|13
1998629|NCT00103285|3563124|FG002|Response Assignment|Physician Decision|14
1998630|NCT00103285|3563125|FG003|Response Assignment|Physician Decision|9
1998631|NCT00103285|3563126|FG004|Response Assignment|Physician Decision|13
1998632|NCT00103285|3563127|FG005|Response Assignment|Physician Decision|7
1998633|NCT00103285|3563128|FG006|Response Assignment|Physician Decision|4
1998634|NCT00103285|3563129|FG007|Response Assignment|Physician Decision|35
1998635|NCT00103285|3563122|FG000|Response Assignment|Protocol Violation|0
1998636|NCT00103285|3563123|FG001|Response Assignment|Protocol Violation|2
1998637|NCT00103285|3563124|FG002|Response Assignment|Protocol Violation|0
1998638|NCT00103285|3563125|FG003|Response Assignment|Protocol Violation|0
1998639|NCT00103285|3563126|FG004|Response Assignment|Protocol Violation|0
1998640|NCT00103285|3563127|FG005|Response Assignment|Protocol Violation|0
1998641|NCT00103285|3563128|FG006|Response Assignment|Protocol Violation|0
1998642|NCT00103285|3563129|FG007|Response Assignment|Protocol Violation|0
1998643|NCT00103285|3563122|FG000|Response Assignment|Withdrawal by Subject|0
1998644|NCT00103285|3563123|FG001|Response Assignment|Withdrawal by Subject|4
1998645|NCT00103285|3563124|FG002|Response Assignment|Withdrawal by Subject|1
1998646|NCT00103285|3563125|FG003|Response Assignment|Withdrawal by Subject|1
1998647|NCT00103285|3563126|FG004|Response Assignment|Withdrawal by Subject|2
1998648|NCT00103285|3563127|FG005|Response Assignment|Withdrawal by Subject|2
1998649|NCT00103285|3563128|FG006|Response Assignment|Withdrawal by Subject|0
1998650|NCT00103285|3563129|FG007|Response Assignment|Withdrawal by Subject|2
1998651|NCT00103285|3563122|FG000|Response Assignment|Ineligible|0
1998652|NCT00103285|3563123|FG001|Response Assignment|Ineligible|8
1998653|NCT00103285|3563124|FG002|Response Assignment|Ineligible|6
1998654|NCT00103285|3563125|FG003|Response Assignment|Ineligible|2
1998655|NCT00103285|3563126|FG004|Response Assignment|Ineligible|0
1998656|NCT00103285|3563127|FG005|Response Assignment|Ineligible|3
1998657|NCT00103285|3563128|FG006|Response Assignment|Ineligible|1
1998658|NCT00103285|3563129|FG007|Response Assignment|Ineligible|5
1998659|NCT00103285|3563122|FG000|Response Assignment|Refusal|0
1998660|NCT00103285|3563123|FG001|Response Assignment|Refusal|53
1998661|NCT00103285|3563124|FG002|Response Assignment|Refusal|5
1998662|NCT00103285|3563125|FG003|Response Assignment|Refusal|3
1998663|NCT00103285|3563126|FG004|Response Assignment|Refusal|25
1998664|NCT00103285|3563127|FG005|Response Assignment|Refusal|15
1998665|NCT00103285|3563128|FG006|Response Assignment|Refusal|30
1998666|NCT00103285|3563129|FG007|Response Assignment|Refusal|10
1998667|NCT00103285|3563122|FG000|Response Assignment|Other|0
1998668|NCT00103285|3563123|FG001|Response Assignment|Other|30
1998669|NCT00103285|3563124|FG002|Response Assignment|Other|48
1998670|NCT00103285|3563125|FG003|Response Assignment|Other|38
1998671|NCT00103285|3563126|FG004|Response Assignment|Other|37
1998672|NCT00103285|3563127|FG005|Response Assignment|Other|17
1998673|NCT00103285|3563128|FG006|Response Assignment|Other|11
1998674|NCT00103285|3563129|FG007|Response Assignment|Other|53
1998675|NCT00103311|3563156|FG000|Overall Study|Lost to Follow-up|1
1998676|NCT00103311|3563157|FG001|Overall Study|Lost to Follow-up|0
1998677|NCT00103311|3563156|FG000|Overall Study|Withdrawal by Subject|2
1998678|NCT00103311|3563157|FG001|Overall Study|Withdrawal by Subject|1
1998679|NCT00103311|3563156|FG000|Overall Study|Adverse Event|1
1998680|NCT00103311|3563157|FG001|Overall Study|Adverse Event|0
1998681|NCT00103402|3563184|FG000|Overall Study|Adverse Event|3
1998682|NCT00103402|3563185|FG001|Overall Study|Adverse Event|4
1998683|NCT00103402|3563184|FG000|Overall Study|Lost to Follow-up|8
1998684|NCT00103402|3563185|FG001|Overall Study|Lost to Follow-up|7
1998685|NCT00103402|3563184|FG000|Overall Study|Dissatisfied/No longer interested|6
1998686|NCT00103402|3563185|FG001|Overall Study|Dissatisfied/No longer interested|6
1998687|NCT00103402|3563184|FG000|Overall Study|Personal constraints/Other|5
1998688|NCT00103402|3563185|FG001|Overall Study|Personal constraints/Other|0
1998689|NCT00103506|3563193|FG000|Overall Study|Study closed by sponsor|34
1998690|NCT00103506|3563194|FG001|Overall Study|Study closed by sponsor|37
1998691|NCT00103506|3563193|FG000|Overall Study|Death|257
1998692|NCT00103506|3563194|FG001|Overall Study|Death|253
1998693|NCT00103506|3563193|FG000|Overall Study|Lost to Follow-up|13
1998694|NCT00103506|3563194|FG001|Overall Study|Lost to Follow-up|13
1998695|NCT00103506|3563193|FG000|Overall Study|Withdrawal by Subject|18
1998696|NCT00103506|3563194|FG001|Overall Study|Withdrawal by Subject|21
1998697|NCT00103610|3563202|FG000|Overall Study|Entered Rescue Procedure|10
1998698|NCT00103610|3563203|FG001|Overall Study|Entered Rescue Procedure|52
1998699|NCT00103610|3563202|FG000|Overall Study|Death|16
1998700|NCT00103610|3563203|FG001|Overall Study|Death|12
1998701|NCT00103610|3563202|FG000|Overall Study|Elective Withdrawal|4
1998702|NCT00103610|3563203|FG001|Overall Study|Elective Withdrawal|0
1998703|NCT00103610|3563202|FG000|Overall Study|Lost to Follow-up|3
1998704|NCT00103610|3563203|FG001|Overall Study|Lost to Follow-up|1
1998705|NCT00103610|3563202|FG000|Overall Study|Adverse Event|2
1998706|NCT00103610|3563203|FG001|Overall Study|Adverse Event|2
1998707|NCT00103610|3563202|FG000|Overall Study|Other|2
1998708|NCT00103610|3563203|FG001|Overall Study|Other|7
1998709|NCT00103610|3563202|FG000|Overall Study|Failed mobilization|1
1998710|NCT00103610|3563203|FG001|Overall Study|Failed mobilization|5
1998711|NCT00103610|3563202|FG000|Overall Study|Noncompliance|0
1998712|NCT00103610|3563203|FG001|Overall Study|Noncompliance|1
1998713|NCT00103662|3563212|FG000|Overall Study|Entered Rescue Procedure|0
1998714|NCT00103662|3563213|FG001|Overall Study|Entered Rescue Procedure|7
1998715|NCT00103662|3563212|FG000|Overall Study|Death|7
1998716|NCT00103662|3563213|FG001|Overall Study|Death|7
1998717|NCT00103662|3563212|FG000|Overall Study|Elective Withdrawal|5
1998718|NCT00103662|3563213|FG001|Overall Study|Elective Withdrawal|5
1998719|NCT00103662|3563212|FG000|Overall Study|Lost to Follow-up|0
1998720|NCT00103662|3563213|FG001|Overall Study|Lost to Follow-up|1
1998721|NCT00103662|3563212|FG000|Overall Study|Other|6
1998722|NCT00103662|3563213|FG001|Overall Study|Other|9
1998723|NCT00103662|3563212|FG000|Overall Study|Failed mobilization|0
1998724|NCT00103662|3563213|FG001|Overall Study|Failed mobilization|4
1998725|NCT00103662|3563212|FG000|Overall Study|Intercurrent illness|1
1998726|NCT00103662|3563213|FG001|Overall Study|Intercurrent illness|0
1998727|NCT00103740|3563221|FG000|Period 1 - Core|Adverse Event|1
1998728|NCT00103740|3563222|FG001|Period 1 - Core|Adverse Event|0
1998729|NCT00103740|3563221|FG000|Period 1 - Core|Protocol Violation|3
1998730|NCT00103740|3563222|FG001|Period 1 - Core|Protocol Violation|2
1998731|NCT00103740|3563221|FG000|Period 1 - Core|Patient withdrew consent|3
1998732|NCT00103740|3563222|FG001|Period 1 - Core|Patient withdrew consent|2
1998733|NCT00103740|3563221|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7
1998734|NCT00103740|3563222|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6
1998735|NCT00103740|3563221|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
1998736|NCT00103740|3563222|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
1998737|NCT00103740|3563221|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
1998738|NCT00103740|3563222|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
1998739|NCT00103740|3563221|FG000|Period 2 - Extended Observation Period|Death|6
1998740|NCT00103740|3563222|FG001|Period 2 - Extended Observation Period|Death|2
1998741|NCT00103740|3563221|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
1998742|NCT00103740|3563222|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
1998743|NCT00103857|3563244|FG000|54-Week Base Study|Adverse Event|12
1998744|NCT00103857|3563245|FG001|54-Week Base Study|Adverse Event|9
1998745|NCT00103857|3563246|FG002|54-Week Base Study|Adverse Event|11
1998746|NCT00103857|3563247|FG003|54-Week Base Study|Adverse Event|6
1998747|NCT00103857|3563248|FG004|54-Week Base Study|Adverse Event|5
1998748|NCT00103857|3563249|FG005|54-Week Base Study|Adverse Event|11
1998749|NCT00103857|3563250|FG006|54-Week Base Study|Adverse Event|3
1998750|NCT00103857|3563244|FG000|54-Week Base Study|Death|0
1998751|NCT00103857|3563245|FG001|54-Week Base Study|Death|0
1998752|NCT00103857|3563246|FG002|54-Week Base Study|Death|0
1998753|NCT00103857|3563247|FG003|54-Week Base Study|Death|0
1998754|NCT00103857|3563248|FG004|54-Week Base Study|Death|1
1998755|NCT00103857|3563249|FG005|54-Week Base Study|Death|1
1998756|NCT00103857|3563250|FG006|54-Week Base Study|Death|0
1998757|NCT00103857|3563244|FG000|54-Week Base Study|Lack of Efficacy|11
1998758|NCT00103857|3563245|FG001|54-Week Base Study|Lack of Efficacy|14
1998759|NCT00103857|3563246|FG002|54-Week Base Study|Lack of Efficacy|8
1998760|NCT00103857|3563247|FG003|54-Week Base Study|Lack of Efficacy|4
1998761|NCT00103857|3563248|FG004|54-Week Base Study|Lack of Efficacy|3
1998762|NCT00103857|3563249|FG005|54-Week Base Study|Lack of Efficacy|14
1998763|NCT00103857|3563250|FG006|54-Week Base Study|Lack of Efficacy|19
1998764|NCT00103857|3563244|FG000|54-Week Base Study|Lost to Follow-up|5
1998765|NCT00103857|3563245|FG001|54-Week Base Study|Lost to Follow-up|4
1998766|NCT00103857|3563246|FG002|54-Week Base Study|Lost to Follow-up|7
1998767|NCT00103857|3563247|FG003|54-Week Base Study|Lost to Follow-up|5
1998768|NCT00103857|3563248|FG004|54-Week Base Study|Lost to Follow-up|10
1998769|NCT00103857|3563249|FG005|54-Week Base Study|Lost to Follow-up|9
1998770|NCT00103857|3563250|FG006|54-Week Base Study|Lost to Follow-up|3
1998771|NCT00103857|3563244|FG000|54-Week Base Study|Physician Decision|1
1998772|NCT00103857|3563245|FG001|54-Week Base Study|Physician Decision|1
1998773|NCT00103857|3563246|FG002|54-Week Base Study|Physician Decision|0
1998774|NCT00103857|3563247|FG003|54-Week Base Study|Physician Decision|0
1998775|NCT00103857|3563248|FG004|54-Week Base Study|Physician Decision|1
1998776|NCT00103857|3563249|FG005|54-Week Base Study|Physician Decision|0
1998777|NCT00103857|3563250|FG006|54-Week Base Study|Physician Decision|0
1998778|NCT00103857|3563244|FG000|54-Week Base Study|Pregnancy|1
1998779|NCT00103857|3563245|FG001|54-Week Base Study|Pregnancy|0
1998780|NCT00103857|3563246|FG002|54-Week Base Study|Pregnancy|0
1998781|NCT00103857|3563247|FG003|54-Week Base Study|Pregnancy|0
1998782|NCT00103857|3563248|FG004|54-Week Base Study|Pregnancy|1
1998783|NCT00103857|3563249|FG005|54-Week Base Study|Pregnancy|0
1998784|NCT00103857|3563250|FG006|54-Week Base Study|Pregnancy|1
1998785|NCT00103857|3563244|FG000|54-Week Base Study|Protocol Violation|6
1998786|NCT00103857|3563245|FG001|54-Week Base Study|Protocol Violation|4
1998787|NCT00103857|3563246|FG002|54-Week Base Study|Protocol Violation|2
1998788|NCT00103857|3563247|FG003|54-Week Base Study|Protocol Violation|4
1998789|NCT00103857|3563248|FG004|54-Week Base Study|Protocol Violation|0
1998790|NCT00103857|3563249|FG005|54-Week Base Study|Protocol Violation|3
1998791|NCT00103857|3563250|FG006|54-Week Base Study|Protocol Violation|3
1998792|NCT00103857|3563244|FG000|54-Week Base Study|Withdrawal by Subject|17
1998793|NCT00103857|3563245|FG001|54-Week Base Study|Withdrawal by Subject|16
1998794|NCT00103857|3563246|FG002|54-Week Base Study|Withdrawal by Subject|16
1998795|NCT00103857|3563247|FG003|54-Week Base Study|Withdrawal by Subject|15
1998796|NCT00103857|3563248|FG004|54-Week Base Study|Withdrawal by Subject|10
1998797|NCT00103857|3563249|FG005|54-Week Base Study|Withdrawal by Subject|15
1998798|NCT00103857|3563250|FG006|54-Week Base Study|Withdrawal by Subject|4
1998799|NCT00103857|3563244|FG000|54-Week Base Study|protocol discontinuation criteria|2
1998800|NCT00103857|3563245|FG001|54-Week Base Study|protocol discontinuation criteria|5
1998801|NCT00103857|3563246|FG002|54-Week Base Study|protocol discontinuation criteria|2
1998802|NCT00103857|3563247|FG003|54-Week Base Study|protocol discontinuation criteria|6
1998803|NCT00103857|3563248|FG004|54-Week Base Study|protocol discontinuation criteria|5
1998804|NCT00103857|3563249|FG005|54-Week Base Study|protocol discontinuation criteria|3
1998805|NCT00103857|3563250|FG006|54-Week Base Study|protocol discontinuation criteria|5
1998806|NCT00103857|3563244|FG000|54-Week Base Study|patient moved|0
1998807|NCT00103857|3563245|FG001|54-Week Base Study|patient moved|1
1998808|NCT00103857|3563246|FG002|54-Week Base Study|patient moved|1
1998809|NCT00103857|3563247|FG003|54-Week Base Study|patient moved|2
1998810|NCT00103857|3563248|FG004|54-Week Base Study|patient moved|3
1998811|NCT00103857|3563249|FG005|54-Week Base Study|patient moved|1
1998812|NCT00103857|3563250|FG006|54-Week Base Study|patient moved|0
1998813|NCT00103857|3563244|FG000|54-Week Base Study|non-compliance with study procedures|1
1998814|NCT00103857|3563245|FG001|54-Week Base Study|non-compliance with study procedures|2
1998815|NCT00103857|3563246|FG002|54-Week Base Study|non-compliance with study procedures|0
1998816|NCT00103857|3563247|FG003|54-Week Base Study|non-compliance with study procedures|0
1998817|NCT00103857|3563248|FG004|54-Week Base Study|non-compliance with study procedures|0
1998818|NCT00103857|3563249|FG005|54-Week Base Study|non-compliance with study procedures|2
1998819|NCT00103857|3563250|FG006|54-Week Base Study|non-compliance with study procedures|0
1998820|NCT00103857|3563244|FG000|54-Week Base Study|patient incarcerated|0
1998821|NCT00103857|3563245|FG001|54-Week Base Study|patient incarcerated|0
1998822|NCT00103857|3563246|FG002|54-Week Base Study|patient incarcerated|0
1998823|NCT00103857|3563247|FG003|54-Week Base Study|patient incarcerated|0
1998824|NCT00103857|3563248|FG004|54-Week Base Study|patient incarcerated|1
1998825|NCT00103857|3563249|FG005|54-Week Base Study|patient incarcerated|1
1998826|NCT00103857|3563250|FG006|54-Week Base Study|patient incarcerated|0
1998827|NCT00103857|3563244|FG000|54-Week Base Study|laboratory reporting error|0
1998828|NCT00103857|3563245|FG001|54-Week Base Study|laboratory reporting error|0
1998829|NCT00103857|3563246|FG002|54-Week Base Study|laboratory reporting error|0
1998830|NCT00103857|3563247|FG003|54-Week Base Study|laboratory reporting error|0
1998831|NCT00103857|3563248|FG004|54-Week Base Study|laboratory reporting error|1
1998832|NCT00103857|3563249|FG005|54-Week Base Study|laboratory reporting error|0
1998833|NCT00103857|3563250|FG006|54-Week Base Study|laboratory reporting error|0
1998834|NCT00103857|3563244|FG000|54-Week Base Study|site error|0
1998835|NCT00103857|3563245|FG001|54-Week Base Study|site error|0
1998836|NCT00103857|3563246|FG002|54-Week Base Study|site error|0
1998837|NCT00103857|3563247|FG003|54-Week Base Study|site error|0
1998838|NCT00103857|3563248|FG004|54-Week Base Study|site error|0
1998839|NCT00103857|3563249|FG005|54-Week Base Study|site error|1
1998840|NCT00103857|3563250|FG006|54-Week Base Study|site error|0
1998841|NCT00103857|3563244|FG000|54-Week Base Study|patient intolerance to rescue therapy|1
1998842|NCT00103857|3563245|FG001|54-Week Base Study|patient intolerance to rescue therapy|0
1998843|NCT00103857|3563246|FG002|54-Week Base Study|patient intolerance to rescue therapy|0
1998844|NCT00103857|3563247|FG003|54-Week Base Study|patient intolerance to rescue therapy|0
1998845|NCT00103857|3563248|FG004|54-Week Base Study|patient intolerance to rescue therapy|0
1998846|NCT00103857|3563249|FG005|54-Week Base Study|patient intolerance to rescue therapy|0
1998847|NCT00103857|3563250|FG006|54-Week Base Study|patient intolerance to rescue therapy|0
1998848|NCT00103857|3563244|FG000|50-Week Extension Study|Adverse Event|2
1998849|NCT00103857|3563245|FG001|50-Week Extension Study|Adverse Event|3
1998850|NCT00103857|3563246|FG002|50-Week Extension Study|Adverse Event|2
1998851|NCT00103857|3563247|FG003|50-Week Extension Study|Adverse Event|0
1998852|NCT00103857|3563248|FG004|50-Week Extension Study|Adverse Event|1
1998853|NCT00103857|3563249|FG005|50-Week Extension Study|Adverse Event|1
1998854|NCT00103857|3563250|FG006|50-Week Extension Study|Adverse Event|0
1998855|NCT00103857|3563244|FG000|50-Week Extension Study|Death|0
1998856|NCT00103857|3563245|FG001|50-Week Extension Study|Death|0
1998857|NCT00103857|3563246|FG002|50-Week Extension Study|Death|0
1998858|NCT00103857|3563247|FG003|50-Week Extension Study|Death|1
1998859|NCT00103857|3563248|FG004|50-Week Extension Study|Death|0
1998860|NCT00103857|3563249|FG005|50-Week Extension Study|Death|1
1998861|NCT00103857|3563250|FG006|50-Week Extension Study|Death|0
1998862|NCT00103857|3563244|FG000|50-Week Extension Study|Lack of Efficacy|26
1998863|NCT00103857|3563245|FG001|50-Week Extension Study|Lack of Efficacy|15
1998864|NCT00103857|3563246|FG002|50-Week Extension Study|Lack of Efficacy|13
1998865|NCT00103857|3563247|FG003|50-Week Extension Study|Lack of Efficacy|16
1998866|NCT00103857|3563248|FG004|50-Week Extension Study|Lack of Efficacy|8
1998867|NCT00103857|3563249|FG005|50-Week Extension Study|Lack of Efficacy|8
1998868|NCT00103857|3563250|FG006|50-Week Extension Study|Lack of Efficacy|0
1998869|NCT00103857|3563244|FG000|50-Week Extension Study|Lost to Follow-up|4
1998870|NCT00103857|3563245|FG001|50-Week Extension Study|Lost to Follow-up|0
1998871|NCT00103857|3563246|FG002|50-Week Extension Study|Lost to Follow-up|1
1998872|NCT00103857|3563247|FG003|50-Week Extension Study|Lost to Follow-up|4
1998873|NCT00103857|3563248|FG004|50-Week Extension Study|Lost to Follow-up|3
1998874|NCT00103857|3563249|FG005|50-Week Extension Study|Lost to Follow-up|3
1998875|NCT00103857|3563250|FG006|50-Week Extension Study|Lost to Follow-up|0
1998876|NCT00103857|3563244|FG000|50-Week Extension Study|Physician Decision|0
1998877|NCT00103857|3563245|FG001|50-Week Extension Study|Physician Decision|1
1998878|NCT00103857|3563246|FG002|50-Week Extension Study|Physician Decision|1
1998879|NCT00103857|3563247|FG003|50-Week Extension Study|Physician Decision|0
1998880|NCT00103857|3563248|FG004|50-Week Extension Study|Physician Decision|0
1998881|NCT00103857|3563249|FG005|50-Week Extension Study|Physician Decision|0
1998882|NCT00103857|3563250|FG006|50-Week Extension Study|Physician Decision|0
1998883|NCT00103857|3563244|FG000|50-Week Extension Study|Pregnancy|0
1998884|NCT00103857|3563245|FG001|50-Week Extension Study|Pregnancy|0
1998885|NCT00103857|3563246|FG002|50-Week Extension Study|Pregnancy|1
1998886|NCT00103857|3563247|FG003|50-Week Extension Study|Pregnancy|0
1998887|NCT00103857|3563248|FG004|50-Week Extension Study|Pregnancy|1
1998888|NCT00103857|3563249|FG005|50-Week Extension Study|Pregnancy|0
1998889|NCT00103857|3563250|FG006|50-Week Extension Study|Pregnancy|0
2312040|NCT02760407|4017753|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
2312041|NCT02760407|4017754|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1
2312042|NCT02760407|4017755|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
2312043|NCT02760407|4017752|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1
2321977|NCT02966028|4036643|FG002|Overall Study|Withdrawal by Subject|5
1998890|NCT00103857|3563244|FG000|50-Week Extension Study|Protocol Violation|1
2213818|NCT01682876|3855798|FG002|Overall Study|Adverse Event|0
2213819|NCT01682876|3855799|FG003|Overall Study|Adverse Event|1
2213820|NCT01682876|3855796|FG000|Overall Study|Lost to Follow-up|11
2213821|NCT01682876|3855797|FG001|Overall Study|Lost to Follow-up|15
2213822|NCT01682876|3855798|FG002|Overall Study|Lost to Follow-up|9
2213823|NCT01682876|3855799|FG003|Overall Study|Lost to Follow-up|11
2213824|NCT01682876|3855796|FG000|Overall Study|Protocol Violation|1
2213825|NCT01682876|3855797|FG001|Overall Study|Protocol Violation|1
2213826|NCT01682876|3855798|FG002|Overall Study|Protocol Violation|1
2213827|NCT01682876|3855799|FG003|Overall Study|Protocol Violation|1
2213828|NCT01682876|3855796|FG000|Overall Study|Withdrawal by Subject|4
2213829|NCT01682876|3855797|FG001|Overall Study|Withdrawal by Subject|0
2213830|NCT01682876|3855798|FG002|Overall Study|Withdrawal by Subject|0
2213831|NCT01682876|3855799|FG003|Overall Study|Withdrawal by Subject|2
2213832|NCT01682876|3855796|FG000|Overall Study|Other|1
2213833|NCT01682876|3855797|FG001|Overall Study|Other|0
2213834|NCT01682876|3855798|FG002|Overall Study|Other|1
2213835|NCT01682876|3855799|FG003|Overall Study|Other|1
2213836|NCT01683019|3855824|FG000|Overall Study|Withdrawal by Subject|2
2213837|NCT01683019|3855825|FG001|Overall Study|Withdrawal by Subject|1
2213838|NCT01683019|3855826|FG002|Overall Study|Withdrawal by Subject|4
2213839|NCT01683058|3855834|FG000|Overall Study|Lost to Follow-up|9
2213840|NCT01683058|3855834|FG000|Overall Study|Adverse Event|6
2213841|NCT01683058|3855834|FG000|Overall Study|Subject Met Withdrawal Criteria|5
2213842|NCT01683058|3855834|FG000|Overall Study|Withdrawal by Subject|7
2213843|NCT01683058|3855834|FG000|Overall Study|Lack of Efficacy|2
2213844|NCT01683071|3855845|FG000|Part 1|Lack of Efficacy|1
2213845|NCT01683071|3855846|FG001|Part 1|Lack of Efficacy|0
2213846|NCT01683071|3855847|FG002|Part 1|Lack of Efficacy|0
2213847|NCT01683071|3855848|FG003|Part 1|Lack of Efficacy|3
2213848|NCT01683071|3855849|FG004|Part 1|Lack of Efficacy|0
2213849|NCT01683071|3855850|FG005|Part 1|Lack of Efficacy|0
2213850|NCT01683071|3855845|FG000|Part 1|Withdrawal by Subject|1
2213851|NCT01683071|3855846|FG001|Part 1|Withdrawal by Subject|2
2213852|NCT01683071|3855847|FG002|Part 1|Withdrawal by Subject|2
2213853|NCT01683071|3855848|FG003|Part 1|Withdrawal by Subject|1
2213854|NCT01683071|3855849|FG004|Part 1|Withdrawal by Subject|0
2213855|NCT01683071|3855850|FG005|Part 1|Withdrawal by Subject|0
2213856|NCT01683071|3855845|FG000|Part 1|Surgery Cancelled|1
2213857|NCT01683071|3855846|FG001|Part 1|Surgery Cancelled|0
2213858|NCT01683071|3855847|FG002|Part 1|Surgery Cancelled|0
2213859|NCT01683071|3855848|FG003|Part 1|Surgery Cancelled|0
2213860|NCT01683071|3855849|FG004|Part 1|Surgery Cancelled|0
2213861|NCT01683071|3855850|FG005|Part 1|Surgery Cancelled|0
2213862|NCT01683071|3855845|FG000|Part 1|Did not receive study drug|1
2213863|NCT01683071|3855846|FG001|Part 1|Did not receive study drug|0
2213864|NCT01683071|3855847|FG002|Part 1|Did not receive study drug|0
2213865|NCT01683071|3855848|FG003|Part 1|Did not receive study drug|1
2213866|NCT01683071|3855849|FG004|Part 1|Did not receive study drug|0
2213867|NCT01683071|3855850|FG005|Part 1|Did not receive study drug|0
2213868|NCT01683071|3855845|FG000|Part 1|Early termination; met exclusion criteria|0
2213869|NCT01683071|3855846|FG001|Part 1|Early termination; met exclusion criteria|2
2213870|NCT01683071|3855847|FG002|Part 1|Early termination; met exclusion criteria|1
2213871|NCT01683071|3855848|FG003|Part 1|Early termination; met exclusion criteria|0
2213872|NCT01683071|3855849|FG004|Part 1|Early termination; met exclusion criteria|0
2213873|NCT01683071|3855850|FG005|Part 1|Early termination; met exclusion criteria|0
2213874|NCT01683071|3855845|FG000|Part 2|Lack of Efficacy|0
2213875|NCT01683071|3855846|FG001|Part 2|Lack of Efficacy|0
2213876|NCT01683071|3855847|FG002|Part 2|Lack of Efficacy|0
2213877|NCT01683071|3855848|FG003|Part 2|Lack of Efficacy|0
2213878|NCT01683071|3855849|FG004|Part 2|Lack of Efficacy|3
2213879|NCT01683071|3855850|FG005|Part 2|Lack of Efficacy|4
2213880|NCT01683071|3855845|FG000|Part 2|Lost to Follow-up|0
2213881|NCT01683071|3855846|FG001|Part 2|Lost to Follow-up|0
2213882|NCT01683071|3855847|FG002|Part 2|Lost to Follow-up|0
2213883|NCT01683071|3855848|FG003|Part 2|Lost to Follow-up|0
2213884|NCT01683071|3855849|FG004|Part 2|Lost to Follow-up|2
2213885|NCT01683071|3855850|FG005|Part 2|Lost to Follow-up|0
2213886|NCT01683071|3855845|FG000|Part 2|Withdrawal by Subject|0
2213887|NCT01683071|3855846|FG001|Part 2|Withdrawal by Subject|0
2213888|NCT01683071|3855847|FG002|Part 2|Withdrawal by Subject|0
2213889|NCT01683071|3855848|FG003|Part 2|Withdrawal by Subject|0
2213890|NCT01683071|3855849|FG004|Part 2|Withdrawal by Subject|3
2213891|NCT01683071|3855850|FG005|Part 2|Withdrawal by Subject|3
2213892|NCT01683071|3855845|FG000|Part 2|Surgery cancelled|0
2213893|NCT01683071|3855846|FG001|Part 2|Surgery cancelled|0
2213894|NCT01683071|3855847|FG002|Part 2|Surgery cancelled|0
2213895|NCT01683071|3855848|FG003|Part 2|Surgery cancelled|0
2213896|NCT01683071|3855849|FG004|Part 2|Surgery cancelled|4
2213897|NCT01683071|3855850|FG005|Part 2|Surgery cancelled|2
2213898|NCT01683071|3855845|FG000|Part 2|Did not receive study drug|0
2213899|NCT01683071|3855846|FG001|Part 2|Did not receive study drug|0
2213900|NCT01683071|3855847|FG002|Part 2|Did not receive study drug|0
2213901|NCT01683071|3855848|FG003|Part 2|Did not receive study drug|0
2213902|NCT01683071|3855849|FG004|Part 2|Did not receive study drug|2
2213903|NCT01683071|3855850|FG005|Part 2|Did not receive study drug|1
2213904|NCT01683071|3855845|FG000|Part 2|Met exclusion criterion|0
1998891|NCT00103857|3563245|FG001|50-Week Extension Study|Protocol Violation|1
2102395|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Physician Decision|1
2213905|NCT01683071|3855846|FG001|Part 2|Met exclusion criterion|0
2213906|NCT01683071|3855847|FG002|Part 2|Met exclusion criterion|0
2213907|NCT01683071|3855848|FG003|Part 2|Met exclusion criterion|0
2213908|NCT01683071|3855849|FG004|Part 2|Met exclusion criterion|1
2213909|NCT01683071|3855850|FG005|Part 2|Met exclusion criterion|1
2213910|NCT01683071|3855845|FG000|Part 2|Protocol deviation|0
2213911|NCT01683071|3855846|FG001|Part 2|Protocol deviation|0
2213912|NCT01683071|3855847|FG002|Part 2|Protocol deviation|0
2213913|NCT01683071|3855848|FG003|Part 2|Protocol deviation|0
2213914|NCT01683071|3855849|FG004|Part 2|Protocol deviation|1
2213915|NCT01683071|3855850|FG005|Part 2|Protocol deviation|2
2213916|NCT01683071|3855845|FG000|Part 2|Withdrawal by investigator decision|0
2213917|NCT01683071|3855846|FG001|Part 2|Withdrawal by investigator decision|0
2213918|NCT01683071|3855847|FG002|Part 2|Withdrawal by investigator decision|0
1998892|NCT00103857|3563246|FG002|50-Week Extension Study|Protocol Violation|1
1998893|NCT00103857|3563247|FG003|50-Week Extension Study|Protocol Violation|2
1998894|NCT00103857|3563248|FG004|50-Week Extension Study|Protocol Violation|0
1998895|NCT00103857|3563249|FG005|50-Week Extension Study|Protocol Violation|1
1998896|NCT00103857|3563250|FG006|50-Week Extension Study|Protocol Violation|0
1998897|NCT00103857|3563244|FG000|50-Week Extension Study|Withdrawal by Subject|2
1998898|NCT00103857|3563245|FG001|50-Week Extension Study|Withdrawal by Subject|5
1998899|NCT00103857|3563246|FG002|50-Week Extension Study|Withdrawal by Subject|2
1998900|NCT00103857|3563247|FG003|50-Week Extension Study|Withdrawal by Subject|8
1998901|NCT00103857|3563248|FG004|50-Week Extension Study|Withdrawal by Subject|3
1998902|NCT00103857|3563249|FG005|50-Week Extension Study|Withdrawal by Subject|3
1998903|NCT00103857|3563250|FG006|50-Week Extension Study|Withdrawal by Subject|0
1998904|NCT00103857|3563244|FG000|50-Week Extension Study|protocol discontinuation criteria|2
1998905|NCT00103857|3563245|FG001|50-Week Extension Study|protocol discontinuation criteria|2
1998906|NCT00103857|3563246|FG002|50-Week Extension Study|protocol discontinuation criteria|3
1998907|NCT00103857|3563247|FG003|50-Week Extension Study|protocol discontinuation criteria|2
1998908|NCT00103857|3563248|FG004|50-Week Extension Study|protocol discontinuation criteria|3
1998909|NCT00103857|3563249|FG005|50-Week Extension Study|protocol discontinuation criteria|3
1998910|NCT00103857|3563250|FG006|50-Week Extension Study|protocol discontinuation criteria|0
1998911|NCT00103857|3563244|FG000|50-Week Extension Study|non-compliance with study procedures|1
1998912|NCT00103857|3563245|FG001|50-Week Extension Study|non-compliance with study procedures|0
1998913|NCT00103857|3563246|FG002|50-Week Extension Study|non-compliance with study procedures|0
1998914|NCT00103857|3563247|FG003|50-Week Extension Study|non-compliance with study procedures|1
1998915|NCT00103857|3563248|FG004|50-Week Extension Study|non-compliance with study procedures|1
1998916|NCT00103857|3563249|FG005|50-Week Extension Study|non-compliance with study procedures|0
1998917|NCT00103857|3563250|FG006|50-Week Extension Study|non-compliance with study procedures|0
1998918|NCT00103857|3563244|FG000|50-Week Extension Study|patient moved|0
1998919|NCT00103857|3563245|FG001|50-Week Extension Study|patient moved|0
1998920|NCT00103857|3563246|FG002|50-Week Extension Study|patient moved|1
1998921|NCT00103857|3563247|FG003|50-Week Extension Study|patient moved|2
1998922|NCT00103857|3563248|FG004|50-Week Extension Study|patient moved|0
1998923|NCT00103857|3563249|FG005|50-Week Extension Study|patient moved|0
1998924|NCT00103857|3563250|FG006|50-Week Extension Study|patient moved|0
1998925|NCT00103857|3563244|FG000|50-Week Extension Study|patient scheduled for elective surgery|0
1998926|NCT00103857|3563245|FG001|50-Week Extension Study|patient scheduled for elective surgery|0
1998927|NCT00103857|3563246|FG002|50-Week Extension Study|patient scheduled for elective surgery|1
1998928|NCT00103857|3563247|FG003|50-Week Extension Study|patient scheduled for elective surgery|0
1998929|NCT00103857|3563248|FG004|50-Week Extension Study|patient scheduled for elective surgery|0
1998930|NCT00103857|3563249|FG005|50-Week Extension Study|patient scheduled for elective surgery|0
1998931|NCT00103857|3563250|FG006|50-Week Extension Study|patient scheduled for elective surgery|0
1998932|NCT00103857|3563244|FG000|50-Week Extension Study|reason unspecified|0
1998933|NCT00103857|3563245|FG001|50-Week Extension Study|reason unspecified|0
1998934|NCT00103857|3563246|FG002|50-Week Extension Study|reason unspecified|0
1998935|NCT00103857|3563247|FG003|50-Week Extension Study|reason unspecified|0
1998936|NCT00103857|3563248|FG004|50-Week Extension Study|reason unspecified|1
1998937|NCT00103857|3563249|FG005|50-Week Extension Study|reason unspecified|0
1998938|NCT00103857|3563250|FG006|50-Week Extension Study|reason unspecified|0
1998939|NCT00104052|3563265|FG000|Overall Study|Adverse Event|1
1998940|NCT00104052|3563265|FG000|Overall Study|Lack of Efficacy|26
1998941|NCT00104052|3563265|FG000|Overall Study|Discontinuation unrelated to treatment|2
1998942|NCT00104104|3563271|FG000|Overall Study|Adverse Event|8
1998943|NCT00104104|3563272|FG001|Overall Study|Adverse Event|8
1998944|NCT00104104|3563271|FG000|Overall Study|Abnormal laboratory value(s)|20
1998945|NCT00104104|3563272|FG001|Overall Study|Abnormal laboratory value(s)|14
1998946|NCT00104104|3563271|FG000|Overall Study|Lack of Efficacy|0
1998947|NCT00104104|3563272|FG001|Overall Study|Lack of Efficacy|3
1998948|NCT00104104|3563271|FG000|Overall Study|Condition no longer requires study drug|7
1998949|NCT00104104|3563272|FG001|Overall Study|Condition no longer requires study drug|4
1998950|NCT00104104|3563271|FG000|Overall Study|Protocol Violation|5
1998951|NCT00104104|3563272|FG001|Overall Study|Protocol Violation|2
1998952|NCT00104104|3563271|FG000|Overall Study|Withdrawal by Subject|11
1998953|NCT00104104|3563272|FG001|Overall Study|Withdrawal by Subject|15
1998954|NCT00104104|3563271|FG000|Overall Study|Lost to Follow-up|3
1998955|NCT00104104|3563272|FG001|Overall Study|Lost to Follow-up|7
1998956|NCT00104104|3563271|FG000|Overall Study|Administrative problems|12
1998957|NCT00104104|3563272|FG001|Overall Study|Administrative problems|13
1998958|NCT00104104|3563271|FG000|Overall Study|Death|9
1998959|NCT00104104|3563272|FG001|Overall Study|Death|6
1998960|NCT00104247|3563289|FG000|Overall Study|Withdrawal by Subject|1
1998961|NCT00104247|3563290|FG001|Overall Study|Withdrawal by Subject|0
1998962|NCT00104247|3563289|FG000|Overall Study|Noncompliant with dosing|0
1998963|NCT00104247|3563290|FG001|Overall Study|Noncompliant with dosing|1
1998964|NCT00104299|3563298|FG000|Overall Study|Adverse Event|3
1998965|NCT00104299|3563299|FG001|Overall Study|Adverse Event|1
1998966|NCT00104299|3563298|FG000|Overall Study|Death|2
1998967|NCT00104299|3563299|FG001|Overall Study|Death|2
1998968|NCT00104299|3563298|FG000|Overall Study|Withdrawal by Subject|2
1998969|NCT00104299|3563299|FG001|Overall Study|Withdrawal by Subject|6
1998970|NCT00104299|3563298|FG000|Overall Study|Physician Decision|1
1998971|NCT00104299|3563299|FG001|Overall Study|Physician Decision|1
2213919|NCT01683071|3855848|FG003|Part 2|Withdrawal by investigator decision|0
2213920|NCT01683071|3855849|FG004|Part 2|Withdrawal by investigator decision|1
2213921|NCT01683071|3855850|FG005|Part 2|Withdrawal by investigator decision|2
2213922|NCT01683266|3855872|FG000|Overall Study|Adverse Event|5
2213923|NCT01683266|3855873|FG001|Overall Study|Adverse Event|4
2213924|NCT01683266|3855872|FG000|Overall Study|Lack of Efficacy|5
2213925|NCT01683266|3855873|FG001|Overall Study|Lack of Efficacy|2
2213926|NCT01683266|3855872|FG000|Overall Study|Protocol Violation|13
2213927|NCT01683266|3855873|FG001|Overall Study|Protocol Violation|6
2213928|NCT01683266|3855872|FG000|Overall Study|Personal Reason|17
2213929|NCT01683266|3855873|FG001|Overall Study|Personal Reason|25
2213930|NCT01683266|3855872|FG000|Overall Study|Selection Criterion / Protocol Violation|7
2213931|NCT01683266|3855873|FG001|Overall Study|Selection Criterion / Protocol Violation|5
2213932|NCT01683266|3855872|FG000|Overall Study|Lost to Follow-up|5
2213933|NCT01683266|3855873|FG001|Overall Study|Lost to Follow-up|0
2213934|NCT01683266|3855872|FG000|Overall Study|Site Closure / Site Withdrawal|1
2213935|NCT01683266|3855873|FG001|Overall Study|Site Closure / Site Withdrawal|3
2213936|NCT01683266|3855872|FG000|Overall Study|Nonserious Hypoglycemia|0
2213937|NCT01683266|3855873|FG001|Overall Study|Nonserious Hypoglycemia|3
2213938|NCT01683266|3855872|FG000|Overall Study|Perceived Lack of Efficacy|1
2213939|NCT01683266|3855873|FG001|Overall Study|Perceived Lack of Efficacy|1
2213940|NCT01683266|3855872|FG000|Overall Study|Possibly Hypoglycemia|1
2213941|NCT01683266|3855873|FG001|Overall Study|Possibly Hypoglycemia|0
2213942|NCT01683266|3855872|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0
2213943|NCT01683266|3855873|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1
2213944|NCT01683383|3855890|FG000|Overall Study|Infant was not transported|1
2312044|NCT02760407|4017753|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
2312045|NCT02760407|4017754|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
1998972|NCT00104299|3563298|FG000|Overall Study|To have renal transplant|1
1998973|NCT00104299|3563299|FG001|Overall Study|To have renal transplant|0
1998974|NCT00104416|3563307|FG000|Double-Blind Phase|Adverse Event|2
1998975|NCT00104416|3563308|FG001|Double-Blind Phase|Adverse Event|1
1998976|NCT00104416|3563309|FG002|Double-Blind Phase|Adverse Event|0
1998977|NCT00104416|3563310|FG003|Double-Blind Phase|Adverse Event|0
1998978|NCT00104416|3563311|FG004|Double-Blind Phase|Adverse Event|0
1998979|NCT00104416|3563307|FG000|Double-Blind Phase|Lost to Follow-up|0
1998980|NCT00104416|3563308|FG001|Double-Blind Phase|Lost to Follow-up|1
1998981|NCT00104416|3563309|FG002|Double-Blind Phase|Lost to Follow-up|0
1998982|NCT00104416|3563310|FG003|Double-Blind Phase|Lost to Follow-up|0
1998983|NCT00104416|3563311|FG004|Double-Blind Phase|Lost to Follow-up|0
1998984|NCT00104416|3563307|FG000|Double-Blind Phase|Protocol Violation|0
1998985|NCT00104416|3563308|FG001|Double-Blind Phase|Protocol Violation|1
1998986|NCT00104416|3563309|FG002|Double-Blind Phase|Protocol Violation|0
1998987|NCT00104416|3563310|FG003|Double-Blind Phase|Protocol Violation|0
1998988|NCT00104416|3563311|FG004|Double-Blind Phase|Protocol Violation|0
1998989|NCT00104416|3563307|FG000|Double-Blind Phase|Withdrawal by Subject|2
1998990|NCT00104416|3563308|FG001|Double-Blind Phase|Withdrawal by Subject|3
1998991|NCT00104416|3563309|FG002|Double-Blind Phase|Withdrawal by Subject|0
1998992|NCT00104416|3563310|FG003|Double-Blind Phase|Withdrawal by Subject|0
1998993|NCT00104416|3563311|FG004|Double-Blind Phase|Withdrawal by Subject|0
1998994|NCT00104416|3563307|FG000|Double-Blind Phase|Pregnancy|1
1998995|NCT00104416|3563308|FG001|Double-Blind Phase|Pregnancy|0
1998996|NCT00104416|3563309|FG002|Double-Blind Phase|Pregnancy|0
1998997|NCT00104416|3563310|FG003|Double-Blind Phase|Pregnancy|0
1998998|NCT00104416|3563311|FG004|Double-Blind Phase|Pregnancy|0
1998999|NCT00104416|3563307|FG000|Double-Blind Phase|Participant Did Not Take Drug|3
1999000|NCT00104416|3563308|FG001|Double-Blind Phase|Participant Did Not Take Drug|4
1999001|NCT00104416|3563309|FG002|Double-Blind Phase|Participant Did Not Take Drug|0
1999002|NCT00104416|3563310|FG003|Double-Blind Phase|Participant Did Not Take Drug|0
1999003|NCT00104416|3563311|FG004|Double-Blind Phase|Participant Did Not Take Drug|0
1999004|NCT00104416|3563307|FG000|Continuation Phase|Adverse Event|0
1999005|NCT00104416|3563308|FG001|Continuation Phase|Adverse Event|0
1999006|NCT00104416|3563309|FG002|Continuation Phase|Adverse Event|2
1999007|NCT00104416|3563310|FG003|Continuation Phase|Adverse Event|0
2321978|NCT02966028|4036641|FG000|Overall Study|Kidney transplant Changed dialysis units|9
1999008|NCT00104416|3563311|FG004|Continuation Phase|Adverse Event|2
1999009|NCT00104416|3563307|FG000|Continuation Phase|Lost to Follow-up|0
1999010|NCT00104416|3563308|FG001|Continuation Phase|Lost to Follow-up|0
1999011|NCT00104416|3563309|FG002|Continuation Phase|Lost to Follow-up|1
1999012|NCT00104416|3563310|FG003|Continuation Phase|Lost to Follow-up|0
1999013|NCT00104416|3563311|FG004|Continuation Phase|Lost to Follow-up|1
1999014|NCT00104416|3563307|FG000|Continuation Phase|Withdrawal by Subject|0
1999015|NCT00104416|3563308|FG001|Continuation Phase|Withdrawal by Subject|0
1999016|NCT00104416|3563309|FG002|Continuation Phase|Withdrawal by Subject|2
1999017|NCT00104416|3563310|FG003|Continuation Phase|Withdrawal by Subject|1
1999018|NCT00104416|3563311|FG004|Continuation Phase|Withdrawal by Subject|1
1999019|NCT00104416|3563307|FG000|Continuation Phase|Pregnancy|0
1999020|NCT00104416|3563308|FG001|Continuation Phase|Pregnancy|0
1999021|NCT00104416|3563309|FG002|Continuation Phase|Pregnancy|1
1999022|NCT00104416|3563310|FG003|Continuation Phase|Pregnancy|1
1999023|NCT00104416|3563311|FG004|Continuation Phase|Pregnancy|0
1999024|NCT00104416|3563307|FG000|Continuation Phase|Non-compliance|0
1999025|NCT00104416|3563308|FG001|Continuation Phase|Non-compliance|0
1999026|NCT00104416|3563309|FG002|Continuation Phase|Non-compliance|0
1999027|NCT00104416|3563310|FG003|Continuation Phase|Non-compliance|0
1999028|NCT00104416|3563311|FG004|Continuation Phase|Non-compliance|1
1999029|NCT00104520|3563325|FG000|Overall Study|Unrelated adverse event|34
1999030|NCT00104520|3563326|FG001|Overall Study|Unrelated adverse event|47
1999031|NCT00104520|3563325|FG000|Overall Study|Study drug intolerance|0
1999032|NCT00104520|3563326|FG001|Overall Study|Study drug intolerance|1
1999033|NCT00104520|3563325|FG000|Overall Study|Related adverse event|13
1999034|NCT00104520|3563326|FG001|Overall Study|Related adverse event|15
1999035|NCT00104520|3563325|FG000|Overall Study|Lost to Follow-up|1
1999036|NCT00104520|3563326|FG001|Overall Study|Lost to Follow-up|0
1999037|NCT00104520|3563325|FG000|Overall Study|Noncompliance|0
1999038|NCT00104520|3563326|FG001|Overall Study|Noncompliance|2
1999039|NCT00104520|3563325|FG000|Overall Study|Personal/administrative|1
1999040|NCT00104520|3563326|FG001|Overall Study|Personal/administrative|1
1999041|NCT00104520|3563325|FG000|Overall Study|Other|1
1999042|NCT00104520|3563326|FG001|Overall Study|Other|5
1999043|NCT00104572|3563335|FG000|Overall Study|Withdrawal by Subject|3
1999044|NCT00104572|3563336|FG001|Overall Study|Withdrawal by Subject|3
1999045|NCT00104572|3563337|FG002|Overall Study|Withdrawal by Subject|0
2024809|NCT00337571|3593458|FG000|Overall Study|No longer met study criteria|1
2024810|NCT00337571|3593459|FG001|Overall Study|No longer met study criteria|0
2024811|NCT00337571|3593460|FG002|Overall Study|No longer met study criteria|0
2024812|NCT00337571|3593461|FG003|Overall Study|No longer met study criteria|0
2024813|NCT00337571|3593458|FG000|Overall Study|High Potassium level|0
2024814|NCT00337571|3593459|FG001|Overall Study|High Potassium level|0
2024815|NCT00337571|3593460|FG002|Overall Study|High Potassium level|0
2024816|NCT00337571|3593461|FG003|Overall Study|High Potassium level|1
2024817|NCT00337610|3593473|FG000|Overall Study|Adverse Event|2
2024818|NCT00337610|3593474|FG001|Overall Study|Adverse Event|2
2024819|NCT00337610|3593473|FG000|Overall Study|Death|0
2024820|NCT00337610|3593474|FG001|Overall Study|Death|1
2024821|NCT00337610|3593473|FG000|Overall Study|Lack of Efficacy|6
2024822|NCT00337610|3593474|FG001|Overall Study|Lack of Efficacy|3
2024823|NCT00337610|3593473|FG000|Overall Study|Lost to Follow-up|3
2024824|NCT00337610|3593474|FG001|Overall Study|Lost to Follow-up|3
2024825|NCT00337610|3593473|FG000|Overall Study|Withdrawal by Subject|6
2024826|NCT00337610|3593474|FG001|Overall Study|Withdrawal by Subject|5
2024827|NCT00337662|3593483|FG000|Study Period II|Lost to Follow-up|0
2024828|NCT00337662|3593484|FG001|Study Period II|Lost to Follow-up|0
2024829|NCT00337662|3593485|FG002|Study Period II|Lost to Follow-up|0
2024830|NCT00337662|3593486|FG003|Study Period II|Lost to Follow-up|35
2024831|NCT00337662|3593483|FG000|Study Period II|Withdrawal by Subject|0
2024832|NCT00337662|3593484|FG001|Study Period II|Withdrawal by Subject|0
2024833|NCT00337662|3593485|FG002|Study Period II|Withdrawal by Subject|0
2024834|NCT00337662|3593486|FG003|Study Period II|Withdrawal by Subject|20
2024835|NCT00337662|3593483|FG000|Study Period II|Adverse Event|0
2024836|NCT00337662|3593484|FG001|Study Period II|Adverse Event|0
2024837|NCT00337662|3593485|FG002|Study Period II|Adverse Event|0
2024838|NCT00337662|3593486|FG003|Study Period II|Adverse Event|16
2024839|NCT00337662|3593483|FG000|Study Period II|Physician Decision|0
2024840|NCT00337662|3593484|FG001|Study Period II|Physician Decision|0
2024841|NCT00337662|3593485|FG002|Study Period II|Physician Decision|0
2024842|NCT00337662|3593486|FG003|Study Period II|Physician Decision|13
2024843|NCT00337662|3593483|FG000|Study Period II|Entry Criteria Not Met|0
2024844|NCT00337662|3593484|FG001|Study Period II|Entry Criteria Not Met|0
2024845|NCT00337662|3593485|FG002|Study Period II|Entry Criteria Not Met|0
2024846|NCT00337662|3593486|FG003|Study Period II|Entry Criteria Not Met|6
2024847|NCT00337662|3593483|FG000|Study Period II|Protocol Violation|0
2024848|NCT00337662|3593484|FG001|Study Period II|Protocol Violation|0
2024849|NCT00337662|3593485|FG002|Study Period II|Protocol Violation|0
2024850|NCT00337662|3593486|FG003|Study Period II|Protocol Violation|6
2024851|NCT00337662|3593483|FG000|Study Period II|Lack of Efficacy|0
2024852|NCT00337662|3593484|FG001|Study Period II|Lack of Efficacy|0
2024853|NCT00337662|3593485|FG002|Study Period II|Lack of Efficacy|0
2024854|NCT00337662|3593486|FG003|Study Period II|Lack of Efficacy|7
2024855|NCT00337662|3593483|FG000|Study Period II|Sponsor Decision|0
2024856|NCT00337662|3593484|FG001|Study Period II|Sponsor Decision|0
2024857|NCT00337662|3593485|FG002|Study Period II|Sponsor Decision|0
2024858|NCT00337662|3593486|FG003|Study Period II|Sponsor Decision|2
2024859|NCT00337662|3593483|FG000|Study Period II|Parent/Caregiver Decision|0
2024860|NCT00337662|3593484|FG001|Study Period II|Parent/Caregiver Decision|0
2024861|NCT00337662|3593485|FG002|Study Period II|Parent/Caregiver Decision|0
2024862|NCT00337662|3593486|FG003|Study Period II|Parent/Caregiver Decision|1
2024863|NCT00337662|3593483|FG000|Study Period III|Lost to Follow-up|14
2024864|NCT00337662|3593484|FG001|Study Period III|Lost to Follow-up|16
2024865|NCT00337662|3593485|FG002|Study Period III|Lost to Follow-up|14
1999046|NCT00104637|3563345|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
1999047|NCT00104637|3563346|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
1999048|NCT00104650|3563358|FG000|Treatment Period (25 Weeks)|Physician Decision|0
1999049|NCT00104650|3563359|FG001|Treatment Period (25 Weeks)|Physician Decision|0
1999050|NCT00104650|3563360|FG002|Treatment Period (25 Weeks)|Physician Decision|1
1999051|NCT00104650|3563358|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2
1999052|NCT00104650|3563359|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1
1999053|NCT00104650|3563360|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1
1999054|NCT00104650|3563358|FG000|Treatment Period (25 Weeks)|Death|7
1999055|NCT00104650|3563359|FG001|Treatment Period (25 Weeks)|Death|5
1999056|NCT00104650|3563360|FG002|Treatment Period (25 Weeks)|Death|6
1999057|NCT00104650|3563358|FG000|Treatment Period (25 Weeks)|Disease progression|2
1999058|NCT00104650|3563359|FG001|Treatment Period (25 Weeks)|Disease progression|3
1999059|NCT00104650|3563360|FG002|Treatment Period (25 Weeks)|Disease progression|2
1999060|NCT00104650|3563358|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0
1999061|NCT00104650|3563359|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1
1999062|NCT00104650|3563360|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0
1999063|NCT00104650|3563358|FG000|Treatment Period (25 Weeks)|Other|1
1999064|NCT00104650|3563359|FG001|Treatment Period (25 Weeks)|Other|0
1999065|NCT00104650|3563360|FG002|Treatment Period (25 Weeks)|Other|0
1999066|NCT00104650|3563358|FG000|Treatment Period (25 Weeks)|Protocol deviation|0
1999067|NCT00104650|3563359|FG001|Treatment Period (25 Weeks)|Protocol deviation|1
1999068|NCT00104650|3563360|FG002|Treatment Period (25 Weeks)|Protocol deviation|0
1999069|NCT00104650|3563358|FG000|Follow-up Period|Physician Decision|1
1999070|NCT00104650|3563359|FG001|Follow-up Period|Physician Decision|1
1999071|NCT00104650|3563360|FG002|Follow-up Period|Physician Decision|0
1999072|NCT00104650|3563358|FG000|Follow-up Period|Adverse Event|1
1999073|NCT00104650|3563359|FG001|Follow-up Period|Adverse Event|0
1999074|NCT00104650|3563360|FG002|Follow-up Period|Adverse Event|1
1999075|NCT00104650|3563358|FG000|Follow-up Period|Withdrawal by Subject|0
1999076|NCT00104650|3563359|FG001|Follow-up Period|Withdrawal by Subject|3
1999077|NCT00104650|3563360|FG002|Follow-up Period|Withdrawal by Subject|3
1999078|NCT00104650|3563358|FG000|Follow-up Period|Death|6
1999079|NCT00104650|3563359|FG001|Follow-up Period|Death|6
1999080|NCT00104650|3563360|FG002|Follow-up Period|Death|4
1999081|NCT00104650|3563358|FG000|Follow-up Period|Disease progression|3
1999082|NCT00104650|3563359|FG001|Follow-up Period|Disease progression|1
1999083|NCT00104650|3563360|FG002|Follow-up Period|Disease progression|0
1999084|NCT00104650|3563358|FG000|Follow-up Period|Lost to Follow-up|0
1999085|NCT00104650|3563359|FG001|Follow-up Period|Lost to Follow-up|1
1999086|NCT00104650|3563360|FG002|Follow-up Period|Lost to Follow-up|2
1999087|NCT00104650|3563358|FG000|Follow-up Period|Other|0
1999088|NCT00104650|3563359|FG001|Follow-up Period|Other|1
1999089|NCT00104650|3563360|FG002|Follow-up Period|Other|0
1999090|NCT00104676|3563370|FG000|Overall Study|Death|3
1999091|NCT00104676|3563371|FG001|Overall Study|Death|2
1999092|NCT00104676|3563370|FG000|Overall Study|Withdrawal by Subject|0
1999093|NCT00104676|3563371|FG001|Overall Study|Withdrawal by Subject|2
1999094|NCT00104676|3563370|FG000|Overall Study|treatment interruption|4
1999095|NCT00104676|3563371|FG001|Overall Study|treatment interruption|10
1999096|NCT00104871|3563383|FG000|Overall Study|Not evaluable|1
1999097|NCT00104884|3563387|FG000|Overall Study|Disease progression|4
1999098|NCT00105066|3563431|FG000|Overall Study|Adverse Event|2
1999099|NCT00105066|3563432|FG001|Overall Study|Adverse Event|5
1999100|NCT00105079|3563440|FG000|Overall Study|Adverse Event|5
1999101|NCT00105079|3563441|FG001|Overall Study|Adverse Event|12
1999102|NCT00105079|3563440|FG000|Overall Study|Death|3
1999103|NCT00105079|3563441|FG001|Overall Study|Death|1
1999104|NCT00105079|3563440|FG000|Overall Study|Lost to Follow-up|12
1999105|NCT00105079|3563441|FG001|Overall Study|Lost to Follow-up|12
1999106|NCT00105079|3563440|FG000|Overall Study|Lack of Efficacy|9
1999107|NCT00105079|3563441|FG001|Overall Study|Lack of Efficacy|3
1999108|NCT00105079|3563440|FG000|Overall Study|Refused treatment|6
1999109|NCT00105079|3563441|FG001|Overall Study|Refused treatment|4
1999110|NCT00105079|3563440|FG000|Overall Study|Violation of selection criteria at entry|0
1999111|NCT00105079|3563441|FG001|Overall Study|Violation of selection criteria at entry|2
1999112|NCT00105079|3563440|FG000|Overall Study|Protocol Violation|1
1999113|NCT00105079|3563441|FG001|Overall Study|Protocol Violation|0
1999114|NCT00105079|3563440|FG000|Overall Study|Other|3
1999115|NCT00105079|3563441|FG001|Overall Study|Other|1
1999116|NCT00105157|3563451|FG000|Double-Blind (DB)|Never Treated|1
1999117|NCT00105157|3563452|FG001|Double-Blind (DB)|Never Treated|0
1999118|NCT00105157|3563453|FG002|Double-Blind (DB)|Never Treated|0
1999119|NCT00105157|3563454|FG003|Double-Blind (DB)|Never Treated|0
1999120|NCT00105157|3563451|FG000|Double-Blind (DB)|Adverse Event|2
1999121|NCT00105157|3563452|FG001|Double-Blind (DB)|Adverse Event|0
1999122|NCT00105157|3563453|FG002|Double-Blind (DB)|Adverse Event|1
1999123|NCT00105157|3563454|FG003|Double-Blind (DB)|Adverse Event|1
1999124|NCT00105157|3563451|FG000|Double-Blind (DB)|Lack of Efficacy|11
1999125|NCT00105157|3563452|FG001|Double-Blind (DB)|Lack of Efficacy|14
1999126|NCT00105157|3563453|FG002|Double-Blind (DB)|Lack of Efficacy|11
1999127|NCT00105157|3563454|FG003|Double-Blind (DB)|Lack of Efficacy|38
1999128|NCT00105157|3563451|FG000|Open-Label Continuation of DB|Adverse Event|3
1999129|NCT00105157|3563452|FG001|Open-Label Continuation of DB|Adverse Event|1
1999130|NCT00105157|3563453|FG002|Open-Label Continuation of DB|Adverse Event|0
1999131|NCT00105157|3563454|FG003|Open-Label Continuation of DB|Adverse Event|0
1999132|NCT00105157|3563451|FG000|Open-Label Continuation of DB|Lack of Efficacy|1
1999133|NCT00105157|3563452|FG001|Open-Label Continuation of DB|Lack of Efficacy|4
1999134|NCT00105157|3563453|FG002|Open-Label Continuation of DB|Lack of Efficacy|3
1999135|NCT00105157|3563454|FG003|Open-Label Continuation of DB|Lack of Efficacy|1
1999136|NCT00105157|3563451|FG000|Open-Label Continuation of DB|Lost to Follow-up|1
1999137|NCT00105157|3563452|FG001|Open-Label Continuation of DB|Lost to Follow-up|1
1999138|NCT00105157|3563453|FG002|Open-Label Continuation of DB|Lost to Follow-up|1
1999139|NCT00105157|3563454|FG003|Open-Label Continuation of DB|Lost to Follow-up|0
1999140|NCT00105157|3563451|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0
1999141|NCT00105157|3563452|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1
1999142|NCT00105157|3563453|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3
1999143|NCT00105157|3563454|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0
1999144|NCT00105157|3563451|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1
1999145|NCT00105157|3563452|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0
1999146|NCT00105157|3563453|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0
1999147|NCT00105157|3563454|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0
1999148|NCT00105157|3563451|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1
1999149|NCT00105157|3563452|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3
1999150|NCT00105157|3563453|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2
1999151|NCT00105157|3563454|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0
1999152|NCT00105157|3563451|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1999153|NCT00105157|3563452|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1999154|NCT00105157|3563453|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1999155|NCT00105157|3563454|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
1999156|NCT00105157|3563451|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
1999157|NCT00105157|3563452|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
1999158|NCT00105157|3563453|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
1999159|NCT00105157|3563454|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
1999160|NCT00105157|3563451|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
1999161|NCT00105157|3563452|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
1999162|NCT00105157|3563453|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
1999163|NCT00105157|3563454|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
1999164|NCT00105157|3563451|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1999165|NCT00105157|3563452|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1999166|NCT00105157|3563453|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1999167|NCT00105157|3563454|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
1999168|NCT00105157|3563451|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1999169|NCT00105157|3563452|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
1999170|NCT00105157|3563453|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1999171|NCT00105157|3563454|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1999172|NCT00105183|3563465|FG000|Overall Study|Death|19
1999173|NCT00105183|3563466|FG001|Overall Study|Death|13
1999174|NCT00105183|3563467|FG002|Overall Study|Death|15
1999175|NCT00105183|3563465|FG000|Overall Study|Withdrawal by Subject|1
1999176|NCT00105183|3563466|FG001|Overall Study|Withdrawal by Subject|1
1999177|NCT00105183|3563467|FG002|Overall Study|Withdrawal by Subject|4
1999178|NCT00105183|3563465|FG000|Overall Study|Physician Decision|1
1999179|NCT00105183|3563466|FG001|Overall Study|Physician Decision|2
1999180|NCT00105183|3563467|FG002|Overall Study|Physician Decision|3
1999181|NCT00105183|3563465|FG000|Overall Study|Lost to Follow-up|0
1999182|NCT00105183|3563466|FG001|Overall Study|Lost to Follow-up|1
1999183|NCT00105183|3563467|FG002|Overall Study|Lost to Follow-up|1
1999184|NCT00105183|3563465|FG000|Overall Study|Other reason|1
1999185|NCT00105183|3563466|FG001|Overall Study|Other reason|2
1999186|NCT00105183|3563467|FG002|Overall Study|Other reason|0
1999187|NCT00105196|3563477|FG000|Overall Study|Lack of Efficacy|2
1999188|NCT00105196|3563478|FG001|Overall Study|Lack of Efficacy|3
1999189|NCT00105196|3563477|FG000|Overall Study|Adverse Event|11
1999190|NCT00105196|3563478|FG001|Overall Study|Adverse Event|3
1999191|NCT00105196|3563477|FG000|Overall Study|Withdrawal by Subject|6
1999192|NCT00105196|3563478|FG001|Overall Study|Withdrawal by Subject|6
1999193|NCT00105196|3563477|FG000|Overall Study|Lost to Follow-up|3
1999194|NCT00105196|3563478|FG001|Overall Study|Lost to Follow-up|2
1999195|NCT00105196|3563477|FG000|Overall Study|Poor/noncompliance|3
1999196|NCT00105196|3563478|FG001|Overall Study|Poor/noncompliance|4
1999197|NCT00105196|3563477|FG000|Overall Study|Protocol Violation|5
1999198|NCT00105196|3563478|FG001|Overall Study|Protocol Violation|2
1999199|NCT00105196|3563477|FG000|Overall Study|pending surgery|0
1999200|NCT00105196|3563478|FG001|Overall Study|pending surgery|1
1999201|NCT00105196|3563477|FG000|Overall Study|marijuana use|0
1999202|NCT00105196|3563478|FG001|Overall Study|marijuana use|1
1999203|NCT00105196|3563477|FG000|Overall Study|Subject became unblinded|0
1999204|NCT00105196|3563478|FG001|Overall Study|Subject became unblinded|1
1999205|NCT00105235|3563484|FG000|Overall Study|Death|4
1999206|NCT00105235|3563484|FG000|Overall Study|Physician Decision|1
1999207|NCT00105235|3563484|FG000|Overall Study|Withdrawal by Subject|2
1999208|NCT00105443|3563494|FG000|Double-Blind Treatment|Adverse Event|1
1999209|NCT00105443|3563495|FG001|Double-Blind Treatment|Adverse Event|0
1999210|NCT00105443|3563496|FG002|Double-Blind Treatment|Adverse Event|0
1999211|NCT00105443|3563497|FG003|Double-Blind Treatment|Adverse Event|0
1999212|NCT00105443|3563494|FG000|Double-Blind Treatment|Lost to Follow-up|0
1999213|NCT00105443|3563495|FG001|Double-Blind Treatment|Lost to Follow-up|0
1999214|NCT00105443|3563496|FG002|Double-Blind Treatment|Lost to Follow-up|1
1999215|NCT00105443|3563497|FG003|Double-Blind Treatment|Lost to Follow-up|0
1999216|NCT00105443|3563494|FG000|Double-Blind Treatment|Withdrawal by Subject|8
1999217|NCT00105443|3563495|FG001|Double-Blind Treatment|Withdrawal by Subject|0
1999218|NCT00105443|3563496|FG002|Double-Blind Treatment|Withdrawal by Subject|7
1999219|NCT00105443|3563497|FG003|Double-Blind Treatment|Withdrawal by Subject|0
1999220|NCT00105443|3563494|FG000|Double-Blind Treatment|Physician Decision|1
1999221|NCT00105443|3563495|FG001|Double-Blind Treatment|Physician Decision|0
1999222|NCT00105443|3563496|FG002|Double-Blind Treatment|Physician Decision|2
1999223|NCT00105443|3563497|FG003|Double-Blind Treatment|Physician Decision|0
1999224|NCT00105443|3563494|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4
1999225|NCT00105443|3563495|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0
1999226|NCT00105443|3563496|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1
1999227|NCT00105443|3563497|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0
1999228|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Death|180
1999229|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Death|7
1999230|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Death|219
1999231|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Death|4
1999232|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
1999233|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
1999234|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
1999235|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
1999236|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
1999237|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
1999238|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
1999239|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
1999240|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0
1999241|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14
1999242|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0
1999243|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16
1999244|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1
1999245|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0
1999246|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1
1999247|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0
1999248|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1999249|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2
1999250|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1999251|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1999252|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
1999253|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
1999254|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
1999255|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
1999256|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
1999257|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
1999258|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
1999259|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
1999260|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
1999261|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
1999262|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
1999263|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
1999264|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1999265|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1999266|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
1999267|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1999268|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
1999269|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1999270|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1999271|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1999272|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
2024866|NCT00337662|3593486|FG003|Study Period III|Lost to Follow-up|0
1999273|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1999274|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1999275|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
1999276|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
1999277|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
1999278|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
1999279|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
1999280|NCT00105443|3563494|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
1999281|NCT00105443|3563495|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
1999282|NCT00105443|3563496|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
1999283|NCT00105443|3563497|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
1999284|NCT00105469|3563508|FG000|Overall Study|Adverse Event|9
1999285|NCT00105469|3563509|FG001|Overall Study|Adverse Event|8
1999286|NCT00105469|3563508|FG000|Overall Study|Protocol Violation|4
1999287|NCT00105469|3563509|FG001|Overall Study|Protocol Violation|0
1999288|NCT00105469|3563508|FG000|Overall Study|Withdrawal by Subject|2
1999289|NCT00105469|3563509|FG001|Overall Study|Withdrawal by Subject|3
1999290|NCT00105469|3563508|FG000|Overall Study|Lost to Follow-up|1
1999291|NCT00105469|3563509|FG001|Overall Study|Lost to Follow-up|0
1999292|NCT00105469|3563508|FG000|Overall Study|Lack of Efficacy|2
1999293|NCT00105469|3563509|FG001|Overall Study|Lack of Efficacy|0
1999294|NCT00105469|3563508|FG000|Overall Study|Other Reason|4
1999295|NCT00105469|3563509|FG001|Overall Study|Other Reason|0
1999296|NCT00105482|3563517|FG000|Overall Study|Adverse Event|1
1999297|NCT00105482|3563518|FG001|Overall Study|Adverse Event|1
1999298|NCT00105482|3563517|FG000|Overall Study|Lost to Follow-up|26
1999299|NCT00105482|3563518|FG001|Overall Study|Lost to Follow-up|17
1999300|NCT00105482|3563517|FG000|Overall Study|Withdrawal by Subject|0
1999301|NCT00105482|3563518|FG001|Overall Study|Withdrawal by Subject|1
1999302|NCT00105482|3563517|FG000|Overall Study|Lost Interest|29
1999303|NCT00105482|3563518|FG001|Overall Study|Lost Interest|32
1999304|NCT00105482|3563517|FG000|Overall Study|Scheduling Conflict|2
1999305|NCT00105482|3563518|FG001|Overall Study|Scheduling Conflict|3
1999306|NCT00105482|3563517|FG000|Overall Study|Withdrawn by PI|1
1999307|NCT00105482|3563518|FG001|Overall Study|Withdrawn by PI|1
1999308|NCT00105508|3563526|FG000|Overall Study|Prephase Dropout|1
1999309|NCT00105508|3563527|FG001|Overall Study|Prephase Dropout|0
1999310|NCT00105508|3563526|FG000|Overall Study|Adverse Event|16
1999311|NCT00105508|3563527|FG001|Overall Study|Adverse Event|19
1999312|NCT00105508|3563526|FG000|Overall Study|Insufficient Efficacy|1
1999313|NCT00105508|3563527|FG001|Overall Study|Insufficient Efficacy|0
1999314|NCT00105508|3563526|FG000|Overall Study|Withdrawal by Subject|10
1999315|NCT00105508|3563527|FG001|Overall Study|Withdrawal by Subject|6
1999316|NCT00105508|3563526|FG000|Overall Study|Lost to Follow-up|3
1999317|NCT00105508|3563527|FG001|Overall Study|Lost to Follow-up|0
1999318|NCT00105508|3563526|FG000|Overall Study|Protocol Violation|1
1999319|NCT00105508|3563527|FG001|Overall Study|Protocol Violation|2
1999320|NCT00105508|3563526|FG000|Overall Study|Other|8
1999321|NCT00105508|3563527|FG001|Overall Study|Other|9
1999322|NCT00105521|3563537|FG000|Overall Study|Other|1
1999323|NCT00105521|3563538|FG001|Overall Study|Other|1
1999324|NCT00105521|3563539|FG002|Overall Study|Other|2
1999325|NCT00105521|3563540|FG003|Overall Study|Other|0
1999326|NCT00105521|3563537|FG000|Overall Study|Adverse Event|10
1999327|NCT00105521|3563538|FG001|Overall Study|Adverse Event|4
1999328|NCT00105521|3563539|FG002|Overall Study|Adverse Event|10
1999329|NCT00105521|3563540|FG003|Overall Study|Adverse Event|8
1999330|NCT00105521|3563537|FG000|Overall Study|Withdrawal by Subject|1
1999331|NCT00105521|3563538|FG001|Overall Study|Withdrawal by Subject|0
1999332|NCT00105521|3563539|FG002|Overall Study|Withdrawal by Subject|1
1999333|NCT00105521|3563540|FG003|Overall Study|Withdrawal by Subject|4
1999334|NCT00105521|3563537|FG000|Overall Study|Lack of Efficacy|0
1999335|NCT00105521|3563538|FG001|Overall Study|Lack of Efficacy|0
1999336|NCT00105521|3563539|FG002|Overall Study|Lack of Efficacy|0
1999337|NCT00105521|3563540|FG003|Overall Study|Lack of Efficacy|1
1999338|NCT00105521|3563537|FG000|Overall Study|Protocol Violation|3
1999339|NCT00105521|3563538|FG001|Overall Study|Protocol Violation|5
1999340|NCT00105521|3563539|FG002|Overall Study|Protocol Violation|4
1999341|NCT00105521|3563540|FG003|Overall Study|Protocol Violation|4
1999342|NCT00105521|3563537|FG000|Overall Study|Lost to Follow-up|0
1999343|NCT00105521|3563538|FG001|Overall Study|Lost to Follow-up|1
1999344|NCT00105521|3563539|FG002|Overall Study|Lost to Follow-up|0
1999345|NCT00105521|3563540|FG003|Overall Study|Lost to Follow-up|0
1999346|NCT00105534|3563552|FG000|Overall Study|Adverse Event|2
1999347|NCT00105534|3563553|FG001|Overall Study|Adverse Event|5
1999348|NCT00105534|3563552|FG000|Overall Study|Protocol Violation|1
1999349|NCT00105534|3563553|FG001|Overall Study|Protocol Violation|4
1999350|NCT00105534|3563552|FG000|Overall Study|Withdrawal by Subject|6
1999351|NCT00105534|3563553|FG001|Overall Study|Withdrawal by Subject|6
1999352|NCT00105534|3563552|FG000|Overall Study|Lost to Follow-up|5
1999353|NCT00105534|3563553|FG001|Overall Study|Lost to Follow-up|1
1999354|NCT00105534|3563552|FG000|Overall Study|Lack of Efficacy|7
1999355|NCT00105534|3563553|FG001|Overall Study|Lack of Efficacy|15
1999356|NCT00105534|3563552|FG000|Overall Study|Treatment unmasked|1
1999357|NCT00105534|3563553|FG001|Overall Study|Treatment unmasked|0
1999358|NCT00105534|3563552|FG000|Overall Study|Other Reason|0
1999359|NCT00105534|3563553|FG001|Overall Study|Other Reason|2
1999360|NCT00105586|3563561|FG000|Overall Study|Adverse Event|4
1999361|NCT00105586|3563562|FG001|Overall Study|Adverse Event|3
1999362|NCT00105586|3563561|FG000|Overall Study|Physician Decision|13
1999363|NCT00105586|3563562|FG001|Overall Study|Physician Decision|13
1999364|NCT00105989|3563570|FG000|Acute - Open Label: Week 0-10|Adverse Event|33
1999365|NCT00105989|3563571|FG001|Acute - Open Label: Week 0-10|Adverse Event|0
1999366|NCT00105989|3563570|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
1999367|NCT00105989|3563571|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
1999368|NCT00105989|3563570|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17
1999369|NCT00105989|3563571|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0
1999370|NCT00105989|3563570|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
1999371|NCT00105989|3563571|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
1999372|NCT00105989|3563570|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8
1999373|NCT00105989|3563571|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0
1999374|NCT00105989|3563570|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4
1999375|NCT00105989|3563571|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0
1999376|NCT00105989|3563570|FG000|Acute - Open Label: Week 0-10|Physician Decision|0
1999377|NCT00105989|3563571|FG001|Acute - Open Label: Week 0-10|Physician Decision|0
1999378|NCT00105989|3563570|FG000|Acute - Open Label: Week 0-10|Death|1
1999379|NCT00105989|3563571|FG001|Acute - Open Label: Week 0-10|Death|0
1999380|NCT00105989|3563570|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
1999381|NCT00105989|3563571|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
1999382|NCT00105989|3563570|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
1999383|NCT00105989|3563571|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
1999384|NCT00105989|3563570|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25
1999385|NCT00105989|3563571|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0
1999386|NCT00105989|3563570|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
1999387|NCT00105989|3563571|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
1999388|NCT00105989|3563570|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
1999389|NCT00105989|3563571|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
1999390|NCT00105989|3563570|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
1999391|NCT00105989|3563571|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
1999392|NCT00105989|3563570|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5
1999393|NCT00105989|3563571|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0
1999394|NCT00105989|3563570|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
1999395|NCT00105989|3563571|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
1999396|NCT00105989|3563570|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3
1999397|NCT00105989|3563571|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0
1999398|NCT00105989|3563570|FG000|Continuation - Open Label:Week 10-34|Death|0
1999399|NCT00105989|3563571|FG001|Continuation - Open Label:Week 10-34|Death|0
1999400|NCT00105989|3563570|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
2213945|NCT01683383|3855891|FG001|Overall Study|Infant was not transported|0
1999401|NCT00105989|3563571|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
1999402|NCT00105989|3563570|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
1999403|NCT00105989|3563571|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
1999404|NCT00105989|3563570|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
1999405|NCT00105989|3563571|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
1999406|NCT00105989|3563570|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
1999407|NCT00105989|3563571|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
1999408|NCT00105989|3563570|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
1999409|NCT00105989|3563571|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
1999410|NCT00105989|3563570|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
1999411|NCT00105989|3563571|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
1999412|NCT00105989|3563570|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
1999413|NCT00105989|3563571|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
1999414|NCT00105989|3563570|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
1999415|NCT00105989|3563571|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
1999416|NCT00105989|3563570|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
1999417|NCT00105989|3563571|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
1999418|NCT00105989|3563570|FG000|Maintenance - Double-Blind:Week 34-86|Death|0
1999419|NCT00105989|3563571|FG001|Maintenance - Double-Blind:Week 34-86|Death|0
1999420|NCT00105989|3563570|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
1999421|NCT00105989|3563571|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
1999422|NCT00105989|3563570|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
1999423|NCT00105989|3563571|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
1999424|NCT00106002|3563587|FG000|Overall Study|Did not take any study drug|1
1999425|NCT00106002|3563587|FG000|Overall Study|Ineligible after Registration|1
2108220|NCT00878800|3702082|FG000|Overall Study|Adverse Event|0
1999426|NCT00106028|3563593|FG000|Overall Study|Adverse Event|3
1999427|NCT00106028|3563594|FG001|Overall Study|Adverse Event|2
1999428|NCT00106028|3563593|FG000|Overall Study|Protocol Violation|1
1999429|NCT00106028|3563594|FG001|Overall Study|Protocol Violation|1
1999430|NCT00106028|3563593|FG000|Overall Study|Withdrawal by Subject|2
1999431|NCT00106028|3563594|FG001|Overall Study|Withdrawal by Subject|8
1999432|NCT00106028|3563593|FG000|Overall Study|Lost to Follow-up|0
1999433|NCT00106028|3563594|FG001|Overall Study|Lost to Follow-up|1
1999434|NCT00106080|3563604|FG000|Overall Study|Withdrew/Loss to follow-up|43
1999435|NCT00106080|3563605|FG001|Overall Study|Withdrew/Loss to follow-up|27
1999436|NCT00106184|3563629|FG000|Overall Study|Withdrawal by Subject|3
1999437|NCT00106184|3563630|FG001|Overall Study|Withdrawal by Subject|2
1999438|NCT00106249|3563640|FG000|Overall Study|Lost to Follow-up|3
1999439|NCT00106249|3563641|FG001|Overall Study|Lost to Follow-up|2
1999440|NCT00106353|3563649|FG000|Part 1|Disease progression|3
1999441|NCT00106353|3563650|FG001|Part 1|Disease progression|4
1999442|NCT00106353|3563651|FG002|Part 1|Disease progression|1
1999443|NCT00106353|3563652|FG003|Part 1|Disease progression|3
1999444|NCT00106353|3563653|FG004|Part 1|Disease progression|0
1999445|NCT00106353|3563654|FG005|Part 1|Disease progression|0
1999446|NCT00106353|3563655|FG006|Part 1|Disease progression|0
1999447|NCT00106353|3563649|FG000|Part 1|Withdrawal by Subject|0
1999448|NCT00106353|3563650|FG001|Part 1|Withdrawal by Subject|0
1999449|NCT00106353|3563651|FG002|Part 1|Withdrawal by Subject|1
1999450|NCT00106353|3563652|FG003|Part 1|Withdrawal by Subject|2
1999451|NCT00106353|3563653|FG004|Part 1|Withdrawal by Subject|0
1999452|NCT00106353|3563654|FG005|Part 1|Withdrawal by Subject|0
1999453|NCT00106353|3563655|FG006|Part 1|Withdrawal by Subject|0
1999454|NCT00106353|3563649|FG000|Part 1|Symptomatic deterioration|0
1999455|NCT00106353|3563650|FG001|Part 1|Symptomatic deterioration|0
1999456|NCT00106353|3563651|FG002|Part 1|Symptomatic deterioration|1
1999457|NCT00106353|3563652|FG003|Part 1|Symptomatic deterioration|0
1999458|NCT00106353|3563653|FG004|Part 1|Symptomatic deterioration|0
1999459|NCT00106353|3563654|FG005|Part 1|Symptomatic deterioration|0
1999460|NCT00106353|3563655|FG006|Part 1|Symptomatic deterioration|0
1999461|NCT00106353|3563649|FG000|Part 1|Entered follow-up phase|1
1999462|NCT00106353|3563650|FG001|Part 1|Entered follow-up phase|1
1999463|NCT00106353|3563651|FG002|Part 1|Entered follow-up phase|0
1999464|NCT00106353|3563652|FG003|Part 1|Entered follow-up phase|1
1999465|NCT00106353|3563653|FG004|Part 1|Entered follow-up phase|0
1999466|NCT00106353|3563654|FG005|Part 1|Entered follow-up phase|0
2213946|NCT01683409|3855902|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1999467|NCT00106353|3563655|FG006|Part 1|Entered follow-up phase|0
1999468|NCT00106353|3563649|FG000|Part 1|Adverse Event|0
1999469|NCT00106353|3563650|FG001|Part 1|Adverse Event|0
1999470|NCT00106353|3563651|FG002|Part 1|Adverse Event|0
1999471|NCT00106353|3563652|FG003|Part 1|Adverse Event|1
1999472|NCT00106353|3563653|FG004|Part 1|Adverse Event|0
1999473|NCT00106353|3563654|FG005|Part 1|Adverse Event|0
1999474|NCT00106353|3563655|FG006|Part 1|Adverse Event|0
1999475|NCT00106353|3563649|FG000|Part 2|Disease progression|0
1999476|NCT00106353|3563650|FG001|Part 2|Disease progression|0
1999477|NCT00106353|3563651|FG002|Part 2|Disease progression|0
1999478|NCT00106353|3563652|FG003|Part 2|Disease progression|0
1999479|NCT00106353|3563653|FG004|Part 2|Disease progression|8
1999480|NCT00106353|3563654|FG005|Part 2|Disease progression|14
1999481|NCT00106353|3563655|FG006|Part 2|Disease progression|13
1999482|NCT00106353|3563649|FG000|Part 2|Death|0
1999483|NCT00106353|3563650|FG001|Part 2|Death|0
1999484|NCT00106353|3563651|FG002|Part 2|Death|0
1999485|NCT00106353|3563652|FG003|Part 2|Death|0
1999486|NCT00106353|3563653|FG004|Part 2|Death|3
1999487|NCT00106353|3563654|FG005|Part 2|Death|0
1999488|NCT00106353|3563655|FG006|Part 2|Death|1
1999489|NCT00106353|3563649|FG000|Part 2|Symptomatic deterioration|0
1999490|NCT00106353|3563650|FG001|Part 2|Symptomatic deterioration|0
1999491|NCT00106353|3563651|FG002|Part 2|Symptomatic deterioration|0
1999492|NCT00106353|3563652|FG003|Part 2|Symptomatic deterioration|0
1999493|NCT00106353|3563653|FG004|Part 2|Symptomatic deterioration|3
1999494|NCT00106353|3563654|FG005|Part 2|Symptomatic deterioration|0
1999495|NCT00106353|3563655|FG006|Part 2|Symptomatic deterioration|0
1999496|NCT00106353|3563649|FG000|Part 2|Adverse Event|0
1999497|NCT00106353|3563650|FG001|Part 2|Adverse Event|0
1999498|NCT00106353|3563651|FG002|Part 2|Adverse Event|0
1999499|NCT00106353|3563652|FG003|Part 2|Adverse Event|0
1999500|NCT00106353|3563653|FG004|Part 2|Adverse Event|0
1999501|NCT00106353|3563654|FG005|Part 2|Adverse Event|2
1999502|NCT00106353|3563655|FG006|Part 2|Adverse Event|1
1999503|NCT00106353|3563649|FG000|Part 2|Other|0
1999504|NCT00106353|3563650|FG001|Part 2|Other|0
1999505|NCT00106353|3563651|FG002|Part 2|Other|0
1999506|NCT00106353|3563652|FG003|Part 2|Other|0
1999507|NCT00106353|3563653|FG004|Part 2|Other|1
1999508|NCT00106353|3563654|FG005|Part 2|Other|1
1999509|NCT00106353|3563655|FG006|Part 2|Other|1
1999510|NCT00106353|3563649|FG000|Part 2|Withdrawal by Subject|0
1999511|NCT00106353|3563650|FG001|Part 2|Withdrawal by Subject|0
1999512|NCT00106353|3563651|FG002|Part 2|Withdrawal by Subject|0
1999513|NCT00106353|3563652|FG003|Part 2|Withdrawal by Subject|0
1999514|NCT00106353|3563653|FG004|Part 2|Withdrawal by Subject|1
1999515|NCT00106353|3563654|FG005|Part 2|Withdrawal by Subject|0
1999516|NCT00106353|3563655|FG006|Part 2|Withdrawal by Subject|0
1999517|NCT00106353|3563649|FG000|Part 2|Physician Decision|0
1999518|NCT00106353|3563650|FG001|Part 2|Physician Decision|0
1999519|NCT00106353|3563651|FG002|Part 2|Physician Decision|0
1999520|NCT00106353|3563652|FG003|Part 2|Physician Decision|0
1999521|NCT00106353|3563653|FG004|Part 2|Physician Decision|0
1999522|NCT00106353|3563654|FG005|Part 2|Physician Decision|1
1999523|NCT00106353|3563655|FG006|Part 2|Physician Decision|0
1999524|NCT00106639|3563710|FG000|Overall Study|Adverse Event|3
1999525|NCT00106639|3563711|FG001|Overall Study|Adverse Event|4
1999526|NCT00106639|3563712|FG002|Overall Study|Adverse Event|1
1999527|NCT00106639|3563710|FG000|Overall Study|Protocol Violation|0
1999528|NCT00106639|3563711|FG001|Overall Study|Protocol Violation|1
1999529|NCT00106639|3563712|FG002|Overall Study|Protocol Violation|0
1999530|NCT00106639|3563710|FG000|Overall Study|Withdrawal by Subject|0
1999531|NCT00106639|3563711|FG001|Overall Study|Withdrawal by Subject|1
1999532|NCT00106639|3563712|FG002|Overall Study|Withdrawal by Subject|0
1999533|NCT00106639|3563710|FG000|Overall Study|Participant defaulted|0
1999534|NCT00106639|3563711|FG001|Overall Study|Participant defaulted|1
1999535|NCT00106639|3563712|FG002|Overall Study|Participant defaulted|1
1999536|NCT00106704|3563723|FG000|Overall Study|Adverse Event|10
1999537|NCT00106704|3563724|FG001|Overall Study|Adverse Event|7
1999538|NCT00106704|3563723|FG000|Overall Study|Death|2
1999539|NCT00106704|3563724|FG001|Overall Study|Death|1
1999540|NCT00106704|3563723|FG000|Overall Study|Lack of Efficacy|67
1999541|NCT00106704|3563724|FG001|Overall Study|Lack of Efficacy|69
1999542|NCT00106704|3563723|FG000|Overall Study|Lost to Follow-up|7
1999543|NCT00106704|3563724|FG001|Overall Study|Lost to Follow-up|3
1999544|NCT00106704|3563723|FG000|Overall Study|Pregnancy|1
1999545|NCT00106704|3563724|FG001|Overall Study|Pregnancy|0
1999546|NCT00106704|3563723|FG000|Overall Study|Protocol Violation|4
1999547|NCT00106704|3563724|FG001|Overall Study|Protocol Violation|7
1999548|NCT00106704|3563723|FG000|Overall Study|Withdrawal by Subject|14
1999549|NCT00106704|3563724|FG001|Overall Study|Withdrawal by Subject|21
1999550|NCT00106704|3563723|FG000|Overall Study|Patient moved|1
1999551|NCT00106704|3563724|FG001|Overall Study|Patient moved|0
1999552|NCT00106704|3563723|FG000|Overall Study|Site terminated|0
1999553|NCT00106704|3563724|FG001|Overall Study|Site terminated|1
1999554|NCT00106704|3563723|FG000|Overall Study|Planned major surgery|1
1999555|NCT00106704|3563724|FG001|Overall Study|Planned major surgery|0
1999556|NCT00106704|3563723|FG000|Overall Study|Patient Received Glycemic Medication|22
1999557|NCT00106704|3563724|FG001|Overall Study|Patient Received Glycemic Medication|41
1999558|NCT00106704|3563723|FG000|Overall Study|Unable to re-enter US|1
1999559|NCT00106704|3563724|FG001|Overall Study|Unable to re-enter US|0
1999560|NCT00106704|3563723|FG000|Overall Study|Laboratory test|1
1999561|NCT00106704|3563724|FG001|Overall Study|Laboratory test|1
1999562|NCT00106964|3563742|FG000|Overall Study|Lost to Follow-up|8
1999563|NCT00106964|3563743|FG001|Overall Study|Lost to Follow-up|6
1999564|NCT00106964|3563744|FG002|Overall Study|Lost to Follow-up|2
1999565|NCT00106964|3563742|FG000|Overall Study|Pregnancy|2
1999566|NCT00106964|3563743|FG001|Overall Study|Pregnancy|3
1999567|NCT00106964|3563744|FG002|Overall Study|Pregnancy|2
1999568|NCT00106964|3563742|FG000|Overall Study|Death|1
1999569|NCT00106964|3563743|FG001|Overall Study|Death|1
1999570|NCT00106964|3563744|FG002|Overall Study|Death|0
1999571|NCT00106964|3563742|FG000|Overall Study|Incarceration|0
1999572|NCT00106964|3563743|FG001|Overall Study|Incarceration|1
1999573|NCT00106964|3563744|FG002|Overall Study|Incarceration|0
1999574|NCT00106964|3563742|FG000|Overall Study|Site Funding Terminated|0
1999575|NCT00106964|3563743|FG001|Overall Study|Site Funding Terminated|1
1999576|NCT00106964|3563744|FG002|Overall Study|Site Funding Terminated|1
1999577|NCT00106964|3563742|FG000|Overall Study|Failure to adhere|2
1999578|NCT00106964|3563743|FG001|Overall Study|Failure to adhere|0
1999579|NCT00106964|3563744|FG002|Overall Study|Failure to adhere|0
1999580|NCT00106964|3563742|FG000|Overall Study|Did not meet eligibility criteria|0
1999581|NCT00106964|3563743|FG001|Overall Study|Did not meet eligibility criteria|2
1999582|NCT00106964|3563744|FG002|Overall Study|Did not meet eligibility criteria|2
1999583|NCT00106964|3563742|FG000|Overall Study|Required disallowed medication|0
1999584|NCT00106964|3563743|FG001|Overall Study|Required disallowed medication|1
1999585|NCT00106964|3563744|FG002|Overall Study|Required disallowed medication|0
1999586|NCT00107042|3563763|FG000|Overall Study|Lost to Follow-up|9
1999587|NCT00107042|3563764|FG001|Overall Study|Lost to Follow-up|7
1999588|NCT00107042|3563763|FG000|Overall Study|Withdrawal by Subject|6
1999589|NCT00107042|3563764|FG001|Overall Study|Withdrawal by Subject|1
1999590|NCT00107042|3563763|FG000|Overall Study|Moved out of area|5
1999591|NCT00107042|3563764|FG001|Overall Study|Moved out of area|3
1999592|NCT00107042|3563763|FG000|Overall Study|Pregnancy|1
1999593|NCT00107042|3563764|FG001|Overall Study|Pregnancy|1
1999594|NCT00107042|3563763|FG000|Overall Study|Inadvertent enrollment|0
1999595|NCT00107042|3563764|FG001|Overall Study|Inadvertent enrollment|1
1999596|NCT00107042|3563763|FG000|Overall Study|vaccinated outside window|1
1999597|NCT00107042|3563764|FG001|Overall Study|vaccinated outside window|1
1999598|NCT00107042|3563763|FG000|Overall Study|Disallowed medications|0
1999599|NCT00107042|3563764|FG001|Overall Study|Disallowed medications|2
1999600|NCT00107120|3563814|FG000|Overall Study|Adverse Event|4
1999601|NCT00107120|3563815|FG001|Overall Study|Adverse Event|1
1999602|NCT00107120|3563814|FG000|Overall Study|Lack of Efficacy|5
1999603|NCT00107120|3563815|FG001|Overall Study|Lack of Efficacy|5
1999604|NCT00107120|3563814|FG000|Overall Study|Protocol Violation|3
1999605|NCT00107120|3563815|FG001|Overall Study|Protocol Violation|0
1999606|NCT00107120|3563814|FG000|Overall Study|Withdrawal by Subject|8
1999607|NCT00107120|3563815|FG001|Overall Study|Withdrawal by Subject|9
1999608|NCT00107120|3563814|FG000|Overall Study|Lost to Follow-up|8
1999609|NCT00107120|3563815|FG001|Overall Study|Lost to Follow-up|6
1999610|NCT00107120|3563814|FG000|Overall Study|Pregnancy|0
1999611|NCT00107120|3563815|FG001|Overall Study|Pregnancy|1
1999612|NCT00107120|3563814|FG000|Overall Study|moving away from site|1
1999613|NCT00107120|3563815|FG001|Overall Study|moving away from site|1
1999614|NCT00107120|3563814|FG000|Overall Study|death of parent|0
1999615|NCT00107120|3563815|FG001|Overall Study|death of parent|1
1999616|NCT00107172|3563823|FG000|Overall Study|Withdrawal by Subject|1
1999617|NCT00107172|3563824|FG001|Overall Study|Withdrawal by Subject|0
1999618|NCT00107172|3563823|FG000|Overall Study|Death|0
1999619|NCT00107172|3563824|FG001|Overall Study|Death|2
1999620|NCT00107172|3563823|FG000|Overall Study|Other Reason|4
1999621|NCT00107172|3563824|FG001|Overall Study|Other Reason|3
1999622|NCT00107198|3563830|FG000|Overall Study|Lack of Efficacy|28
1999623|NCT00107198|3563830|FG000|Overall Study|Lost to Follow-up|12
1999624|NCT00107198|3563830|FG000|Overall Study|Protocol Violation|1
1999625|NCT00107198|3563830|FG000|Overall Study|Withdrawal by Subject|6
1999626|NCT00107198|3563830|FG000|Overall Study|Ineligible|5
1999627|NCT00107276|3563834|FG000|Overall Study|Progression|46
1999628|NCT00107276|3563834|FG000|Overall Study|Adverse Event|6
1999629|NCT00107276|3563834|FG000|Overall Study|M.D. decision|2
1999630|NCT00107276|3563834|FG000|Overall Study|Patient refusal|1
1999631|NCT00107276|3563834|FG000|Overall Study|Death|1
1999632|NCT00107276|3563834|FG000|Overall Study|Ineligible|16
1999633|NCT00107380|3563839|FG000|Overall Study|Adverse Event|7
1999634|NCT00107380|3563839|FG000|Overall Study|Refusal Unrelated to Adverse Event|7
1999635|NCT00107380|3563839|FG000|Overall Study|Progression/relapse|4
1999636|NCT00107380|3563839|FG000|Overall Study|Death|3
1999637|NCT00107380|3563839|FG000|Overall Study|Other - not protocol specified|7
1999638|NCT00107380|3563839|FG000|Overall Study|Ineligible|2
1999639|NCT00107653|3563859|FG000|Overall Study|Adverse Event|24
1999640|NCT00107653|3563860|FG001|Overall Study|Adverse Event|43
1999641|NCT00107653|3563859|FG000|Overall Study|Insufficient Therapeutic Response|25
1999642|NCT00107653|3563860|FG001|Overall Study|Insufficient Therapeutic Response|11
1999643|NCT00107653|3563859|FG000|Overall Study|Violation of Selection Criteria at Entry|1
1999644|NCT00107653|3563860|FG001|Overall Study|Violation of Selection Criteria at Entry|1
1999645|NCT00107653|3563859|FG000|Overall Study|Protocol Violation|1
1999646|NCT00107653|3563860|FG001|Overall Study|Protocol Violation|0
1999647|NCT00107653|3563859|FG000|Overall Study|Withdrawal by Subject|12
1999648|NCT00107653|3563860|FG001|Overall Study|Withdrawal by Subject|13
1999649|NCT00107653|3563859|FG000|Overall Study|Lost to Follow-up|13
1999650|NCT00107653|3563860|FG001|Overall Study|Lost to Follow-up|5
1999651|NCT00107653|3563859|FG000|Overall Study|Administrative Reasons|3
1999652|NCT00107653|3563860|FG001|Overall Study|Administrative Reasons|3
1999653|NCT00107783|3563881|FG000|Overall Study|Adverse Event|0
1999654|NCT00107783|3563882|FG001|Overall Study|Adverse Event|2
1999655|NCT00107783|3563881|FG000|Overall Study|Death|0
1999656|NCT00107783|3563882|FG001|Overall Study|Death|1
1999657|NCT00107783|3563881|FG000|Overall Study|Withdrawal by Subject|2
1999658|NCT00107783|3563882|FG001|Overall Study|Withdrawal by Subject|0
1999659|NCT00107783|3563881|FG000|Overall Study|Second hip replacement|1
1999660|NCT00107783|3563882|FG001|Overall Study|Second hip replacement|1
1999661|NCT00107900|3563894|FG000|Overall Study|Adverse Event|3
1999662|NCT00107900|3563895|FG001|Overall Study|Adverse Event|2
1999663|NCT00107900|3563896|FG002|Overall Study|Adverse Event|10
1999664|NCT00107900|3563897|FG003|Overall Study|Adverse Event|3
1999665|NCT00107900|3563898|FG004|Overall Study|Adverse Event|5
1999666|NCT00107900|3563899|FG005|Overall Study|Adverse Event|3
1999667|NCT00107900|3563894|FG000|Overall Study|Death|0
1999668|NCT00107900|3563895|FG001|Overall Study|Death|0
1999669|NCT00107900|3563896|FG002|Overall Study|Death|0
1999670|NCT00107900|3563897|FG003|Overall Study|Death|0
1999671|NCT00107900|3563898|FG004|Overall Study|Death|1
1999672|NCT00107900|3563899|FG005|Overall Study|Death|0
1999673|NCT00107900|3563894|FG000|Overall Study|Lost to Follow-up|4
1999674|NCT00107900|3563895|FG001|Overall Study|Lost to Follow-up|1
1999675|NCT00107900|3563896|FG002|Overall Study|Lost to Follow-up|3
1999676|NCT00107900|3563897|FG003|Overall Study|Lost to Follow-up|2
1999677|NCT00107900|3563898|FG004|Overall Study|Lost to Follow-up|5
1999678|NCT00107900|3563899|FG005|Overall Study|Lost to Follow-up|5
1999679|NCT00107900|3563894|FG000|Overall Study|Protocol Violation|1
1999680|NCT00107900|3563895|FG001|Overall Study|Protocol Violation|0
1999681|NCT00107900|3563896|FG002|Overall Study|Protocol Violation|5
1999682|NCT00107900|3563897|FG003|Overall Study|Protocol Violation|5
1999683|NCT00107900|3563898|FG004|Overall Study|Protocol Violation|7
1999684|NCT00107900|3563899|FG005|Overall Study|Protocol Violation|0
1999685|NCT00107900|3563894|FG000|Overall Study|Withdrawal by Subject|1
1999686|NCT00107900|3563895|FG001|Overall Study|Withdrawal by Subject|0
1999687|NCT00107900|3563896|FG002|Overall Study|Withdrawal by Subject|5
1999688|NCT00107900|3563897|FG003|Overall Study|Withdrawal by Subject|0
1999689|NCT00107900|3563898|FG004|Overall Study|Withdrawal by Subject|1
1999690|NCT00107900|3563899|FG005|Overall Study|Withdrawal by Subject|1
1999691|NCT00107900|3563894|FG000|Overall Study|Administrative Reasons|1
1999692|NCT00107900|3563895|FG001|Overall Study|Administrative Reasons|0
1999693|NCT00107900|3563896|FG002|Overall Study|Administrative Reasons|2
1999694|NCT00107900|3563897|FG003|Overall Study|Administrative Reasons|2
1999695|NCT00107900|3563898|FG004|Overall Study|Administrative Reasons|2
1999696|NCT00107900|3563899|FG005|Overall Study|Administrative Reasons|0
1999697|NCT00107952|3563915|FG000|Overall Study|Death|75
1999698|NCT00107952|3563916|FG001|Overall Study|Death|61
1999699|NCT00107952|3563915|FG000|Overall Study|Lost to Follow-up|0
1999700|NCT00107952|3563916|FG001|Overall Study|Lost to Follow-up|3
1999701|NCT00107952|3563915|FG000|Overall Study|Withdrawal by Subject|9
1999702|NCT00107952|3563916|FG001|Overall Study|Withdrawal by Subject|6
1999703|NCT00107952|3563915|FG000|Overall Study|Other|2
1999704|NCT00107952|3563916|FG001|Overall Study|Other|5
1999705|NCT00107952|3563915|FG000|Overall Study|Never received study treatment|9
1999706|NCT00107952|3563916|FG001|Overall Study|Never received study treatment|6
1999707|NCT00107978|3563924|FG000|Overall Study|Adverse Event|1
1999708|NCT00107978|3563925|FG001|Overall Study|Adverse Event|5
1999709|NCT00107978|3563924|FG000|Overall Study|Death|3
1999710|NCT00107978|3563925|FG001|Overall Study|Death|3
1999711|NCT00107978|3563924|FG000|Overall Study|Lost to Follow-up|20
1999712|NCT00107978|3563925|FG001|Overall Study|Lost to Follow-up|28
1999713|NCT00107978|3563924|FG000|Overall Study|Withdrawal by Subject|4
1999714|NCT00107978|3563925|FG001|Overall Study|Withdrawal by Subject|9
1999715|NCT00107978|3563924|FG000|Overall Study|Protocol Violation|0
1999716|NCT00107978|3563925|FG001|Overall Study|Protocol Violation|1
1999717|NCT00107978|3563924|FG000|Overall Study|Other|5
1999718|NCT00107978|3563925|FG001|Overall Study|Other|4
1999719|NCT00107991|3563931|FG000|Eligibility Assessment|Disease not severe enough|7
1999720|NCT00107991|3563931|FG000|Eligibility Assessment|Unwilling to participate|7
1999721|NCT00107991|3563931|FG000|Eligibility Assessment|Positive purified protein derivative|4
1999722|NCT00107991|3563931|FG000|Eligibility Assessment|Abnormal labs|2
1999723|NCT00107991|3563931|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1
1999724|NCT00107991|3563931|FG000|Eligibility Assessment|chronic uncontrolled asthma|1
1999725|NCT00107991|3563931|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
1999726|NCT00107991|3563931|FG000|12 Week Treatment Period|Lack of Efficacy|2
1999727|NCT00107991|3563931|FG000|12 Week Treatment Period|Adverse Event|1
1999728|NCT00107991|3563931|FG000|12 Week Treatment Period|Protocol Violation|1
1999729|NCT00107991|3563931|FG000|12 Week Treatment Period|Incarcerated|1
1999730|NCT00107991|3563931|FG000|18-Week Post Treatment Assessment|Adverse Event|2
1999731|NCT00108069|3563937|FG000|Overall Study|Never rec'd study drug|0
1999732|NCT00108069|3563938|FG001|Overall Study|Never rec'd study drug|1
1999733|NCT00108069|3563937|FG000|Overall Study|Adverse Event|1
1999734|NCT00108069|3563938|FG001|Overall Study|Adverse Event|1
1999735|NCT00108069|3563937|FG000|Overall Study|Withdrawal by Subject|1
1999736|NCT00108069|3563938|FG001|Overall Study|Withdrawal by Subject|0
1999737|NCT00108069|3563937|FG000|Overall Study|Death|1
1999738|NCT00108069|3563938|FG001|Overall Study|Death|0
1999739|NCT00108069|3563937|FG000|Overall Study|Progessive disease|27
1999740|NCT00108069|3563938|FG001|Overall Study|Progessive disease|11
1999741|NCT00108082|3563953|FG000|Overall Study|Adverse Event|14
1999742|NCT00108082|3563954|FG001|Overall Study|Adverse Event|12
1999743|NCT00108082|3563955|FG002|Overall Study|Adverse Event|17
1999744|NCT00108082|3563953|FG000|Overall Study|Lost to Follow-up|6
1999745|NCT00108082|3563954|FG001|Overall Study|Lost to Follow-up|3
1999746|NCT00108082|3563955|FG002|Overall Study|Lost to Follow-up|7
1999747|NCT00108082|3563953|FG000|Overall Study|Consent Withdrawn|3
1999748|NCT00108082|3563954|FG001|Overall Study|Consent Withdrawn|3
1999749|NCT00108082|3563955|FG002|Overall Study|Consent Withdrawn|5
1999750|NCT00108082|3563953|FG000|Overall Study|Protocol Violation|1
1999751|NCT00108082|3563954|FG001|Overall Study|Protocol Violation|2
1999752|NCT00108082|3563955|FG002|Overall Study|Protocol Violation|0
1999753|NCT00108082|3563953|FG000|Overall Study|Lack of Efficacy|3
1999754|NCT00108082|3563954|FG001|Overall Study|Lack of Efficacy|1
1999755|NCT00108082|3563955|FG002|Overall Study|Lack of Efficacy|2
1999756|NCT00108082|3563953|FG000|Overall Study|Amendment 4: > Month 12|5
1999757|NCT00108082|3563954|FG001|Overall Study|Amendment 4: > Month 12|7
1999758|NCT00108082|3563955|FG002|Overall Study|Amendment 4: > Month 12|5
1999759|NCT00108082|3563953|FG000|Overall Study|Woman of Child-bearing Potential|2
1999760|NCT00108082|3563954|FG001|Overall Study|Woman of Child-bearing Potential|0
1999761|NCT00108082|3563955|FG002|Overall Study|Woman of Child-bearing Potential|2
1999762|NCT00108082|3563953|FG000|Overall Study|Incorrectly Randomized|0
1999763|NCT00108082|3563954|FG001|Overall Study|Incorrectly Randomized|0
1999764|NCT00108082|3563955|FG002|Overall Study|Incorrectly Randomized|2
1999765|NCT00108082|3563953|FG000|Overall Study|Non-compliance|1
1999766|NCT00108082|3563954|FG001|Overall Study|Non-compliance|0
1999767|NCT00108082|3563955|FG002|Overall Study|Non-compliance|2
1999768|NCT00108082|3563953|FG000|Overall Study|Stopped Study Medication|0
1999769|NCT00108082|3563954|FG001|Overall Study|Stopped Study Medication|0
1999770|NCT00108082|3563955|FG002|Overall Study|Stopped Study Medication|1
1999771|NCT00108082|3563953|FG000|Overall Study|Site Closed Study|0
1999772|NCT00108082|3563954|FG001|Overall Study|Site Closed Study|2
1999773|NCT00108082|3563955|FG002|Overall Study|Site Closed Study|0
1999774|NCT00108082|3563953|FG000|Overall Study|Protocol Amendment|0
1999775|NCT00108082|3563954|FG001|Overall Study|Protocol Amendment|1
1999776|NCT00108082|3563955|FG002|Overall Study|Protocol Amendment|0
2213947|NCT01683409|3855903|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
2213948|NCT01683409|3855904|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
2213949|NCT01683409|3855905|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
2213950|NCT01683409|3855906|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1999777|NCT00108082|3563953|FG000|Overall Study|Study Medication Not Tapered|0
1999778|NCT00108082|3563954|FG001|Overall Study|Study Medication Not Tapered|1
1999779|NCT00108082|3563955|FG002|Overall Study|Study Medication Not Tapered|0
1999780|NCT00108082|3563953|FG000|Overall Study|Subject Left Site Location|1
1999781|NCT00108082|3563954|FG001|Overall Study|Subject Left Site Location|0
1999782|NCT00108082|3563955|FG002|Overall Study|Subject Left Site Location|0
1999783|NCT00108082|3563953|FG000|Overall Study|Investigator Not at Site|1
1999784|NCT00108082|3563954|FG001|Overall Study|Investigator Not at Site|0
1999785|NCT00108082|3563955|FG002|Overall Study|Investigator Not at Site|0
1999786|NCT00108082|3563953|FG000|Overall Study|Blood Pressure Not Controlled|1
1999787|NCT00108082|3563954|FG001|Overall Study|Blood Pressure Not Controlled|0
1999788|NCT00108082|3563955|FG002|Overall Study|Blood Pressure Not Controlled|0
1999789|NCT00108160|3563965|FG000|Overall Study|Lost to Follow-up|25
1999790|NCT00108160|3563966|FG001|Overall Study|Lost to Follow-up|12
1999791|NCT00108160|3563965|FG000|Overall Study|Death|1
1999792|NCT00108160|3563966|FG001|Overall Study|Death|2
1999793|NCT00108160|3563965|FG000|Overall Study|Withdrawal by Subject|4
1999794|NCT00108160|3563966|FG001|Overall Study|Withdrawal by Subject|2
1999795|NCT00108160|3563965|FG000|Overall Study|Protocol Violation|9
1999796|NCT00108160|3563966|FG001|Overall Study|Protocol Violation|5
1999797|NCT00108355|3564006|FG000|Overall Study|Peritonitis at index paracentesis|1
1999798|NCT00108355|3564007|FG001|Overall Study|Peritonitis at index paracentesis|1
1999799|NCT00108355|3564006|FG000|Overall Study|Loculated ascites, limiting paracentesis|1
1999800|NCT00108355|3564007|FG001|Overall Study|Loculated ascites, limiting paracentesis|1
1999801|NCT00108485|3564015|FG000|Overall Study|Withdrawal by Subject|3
1999802|NCT00108485|3564016|FG001|Overall Study|Withdrawal by Subject|0
1999803|NCT00108485|3564015|FG000|Overall Study|Lost to Follow-up|0
1999804|NCT00108485|3564016|FG001|Overall Study|Lost to Follow-up|2
1999805|NCT00108628|3564042|FG000|Overall Study|Withdrawal by Subject|17
1999806|NCT00108628|3564043|FG001|Overall Study|Withdrawal by Subject|9
1999807|NCT00108628|3564042|FG000|Overall Study|Lack of Efficacy|2
1999808|NCT00108628|3564043|FG001|Overall Study|Lack of Efficacy|1
1999809|NCT00108628|3564042|FG000|Overall Study|Death|1
1999810|NCT00108628|3564043|FG001|Overall Study|Death|0
1999811|NCT00108732|3564049|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
1999812|NCT00108732|3564049|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
1999813|NCT00108732|3564049|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
1999814|NCT00108732|3564049|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
1999815|NCT00108732|3564049|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
1999816|NCT00108732|3564049|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
1999817|NCT00108732|3564049|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1
1999818|NCT00108745|3564056|FG000|Overall Study|Withdrawal by Subject|19
1999819|NCT00108745|3564057|FG001|Overall Study|Withdrawal by Subject|12
1999820|NCT00108745|3564058|FG002|Overall Study|Withdrawal by Subject|12
1999821|NCT00108745|3564056|FG000|Overall Study|Never Treated|8
1999822|NCT00108745|3564057|FG001|Overall Study|Never Treated|10
1999823|NCT00108745|3564058|FG002|Overall Study|Never Treated|12
1999824|NCT00108745|3564056|FG000|Overall Study|Ineligible|7
1999825|NCT00108745|3564057|FG001|Overall Study|Ineligible|13
1999826|NCT00108745|3564058|FG002|Overall Study|Ineligible|13
1999827|NCT00108862|3564068|FG000|Overall Study|Death|31
1999828|NCT00108862|3564069|FG001|Overall Study|Death|37
1999829|NCT00108862|3564068|FG000|Overall Study|Withdrawal by Subject|10
1999830|NCT00108862|3564069|FG001|Overall Study|Withdrawal by Subject|6
1999831|NCT00108862|3564068|FG000|Overall Study|Lost to Follow-up|27
1999832|NCT00108862|3564069|FG001|Overall Study|Lost to Follow-up|19
1999833|NCT00108953|3564077|FG000|Follow-up|Death|18
1999834|NCT00108953|3564078|FG001|Follow-up|Death|26
1999835|NCT00108953|3564077|FG000|Follow-up|Lost to Follow-up|1
1999836|NCT00108953|3564078|FG001|Follow-up|Lost to Follow-up|1
1999837|NCT00108953|3564077|FG000|Follow-up|Study terminated by sponsor|10
1999838|NCT00108953|3564078|FG001|Follow-up|Study terminated by sponsor|6
1999839|NCT00109031|3564100|FG000|Overall Study|Adverse Event|0
1999840|NCT00109031|3564101|FG001|Overall Study|Adverse Event|0
1999841|NCT00109031|3564102|FG002|Overall Study|Adverse Event|1
1999842|NCT00109031|3564103|FG003|Overall Study|Adverse Event|0
1999843|NCT00109031|3564100|FG000|Overall Study|Withdrawal by Subject|0
1999844|NCT00109031|3564101|FG001|Overall Study|Withdrawal by Subject|1
1999845|NCT00109031|3564102|FG002|Overall Study|Withdrawal by Subject|0
1999846|NCT00109031|3564103|FG003|Overall Study|Withdrawal by Subject|0
1999847|NCT00109031|3564100|FG000|Overall Study|Physician Decision|0
1999848|NCT00109031|3564101|FG001|Overall Study|Physician Decision|1
1999849|NCT00109031|3564102|FG002|Overall Study|Physician Decision|0
1999850|NCT00109031|3564103|FG003|Overall Study|Physician Decision|0
1999851|NCT00109031|3564100|FG000|Overall Study|Protocol Violation|0
1999852|NCT00109031|3564101|FG001|Overall Study|Protocol Violation|0
1999853|NCT00109031|3564102|FG002|Overall Study|Protocol Violation|1
1999854|NCT00109031|3564103|FG003|Overall Study|Protocol Violation|0
1999855|NCT00109343|3564116|FG000|Overall Study|Adverse Event|1
1999856|NCT00109343|3564117|FG001|Overall Study|Adverse Event|0
1999857|NCT00109343|3564118|FG002|Overall Study|Adverse Event|2
1999858|NCT00109343|3564116|FG000|Overall Study|Lack of Efficacy|1
1999859|NCT00109343|3564117|FG001|Overall Study|Lack of Efficacy|0
1999860|NCT00109343|3564118|FG002|Overall Study|Lack of Efficacy|0
1999861|NCT00109343|3564116|FG000|Overall Study|Lost to Follow-up|35
1999862|NCT00109343|3564117|FG001|Overall Study|Lost to Follow-up|20
1999863|NCT00109343|3564118|FG002|Overall Study|Lost to Follow-up|14
1999864|NCT00109343|3564116|FG000|Overall Study|Protocol Violation|1
1999865|NCT00109343|3564117|FG001|Overall Study|Protocol Violation|2
1999866|NCT00109343|3564118|FG002|Overall Study|Protocol Violation|2
1999867|NCT00109343|3564116|FG000|Overall Study|Withdrawal by Subject|15
1999868|NCT00109343|3564117|FG001|Overall Study|Withdrawal by Subject|11
1999869|NCT00109343|3564118|FG002|Overall Study|Withdrawal by Subject|10
1999870|NCT00109343|3564116|FG000|Overall Study|Subject Moved|6
1999871|NCT00109343|3564117|FG001|Overall Study|Subject Moved|2
1999872|NCT00109343|3564118|FG002|Overall Study|Subject Moved|1
1999873|NCT00109343|3564116|FG000|Overall Study|Other|5
1999874|NCT00109343|3564117|FG001|Overall Study|Other|2
1999875|NCT00109343|3564118|FG002|Overall Study|Other|1
1999876|NCT00109577|3564140|FG000|Overall Study|Withdrawal by Subject|3
1999877|NCT00109577|3564141|FG001|Overall Study|Withdrawal by Subject|3
1999878|NCT00109590|3564150|FG000|Overall Study|Lost to Follow-up|1
1999879|NCT00109590|3564151|FG001|Overall Study|Lost to Follow-up|0
1999880|NCT00109590|3564152|FG002|Overall Study|Lost to Follow-up|1
1999881|NCT00109590|3564150|FG000|Overall Study|Never Started Treatment|1
1999882|NCT00109590|3564151|FG001|Overall Study|Never Started Treatment|2
1999883|NCT00109590|3564152|FG002|Overall Study|Never Started Treatment|3
1999884|NCT00109707|3564177|FG000|Overall Study|Discontinued in core study without entering the extension study|215
1999885|NCT00109707|3564178|FG001|Overall Study|Discontinued in core study without entering the extension study|122
1999886|NCT00109707|3564179|FG002|Overall Study|Discontinued in core study without entering the extension study|34
1999887|NCT00109707|3564177|FG000|Overall Study|Abnormal laboratory values|1
1999888|NCT00109707|3564178|FG001|Overall Study|Abnormal laboratory values|0
1999889|NCT00109707|3564179|FG002|Overall Study|Abnormal laboratory values|0
1999890|NCT00109707|3564177|FG000|Overall Study|Administrative problems|2
1999891|NCT00109707|3564178|FG001|Overall Study|Administrative problems|0
1999892|NCT00109707|3564179|FG002|Overall Study|Administrative problems|1
1999893|NCT00109707|3564177|FG000|Overall Study|Adverse Event|10
1999894|NCT00109707|3564178|FG001|Overall Study|Adverse Event|2
1999895|NCT00109707|3564179|FG002|Overall Study|Adverse Event|3
1999896|NCT00109707|3564177|FG000|Overall Study|Death|4
1999897|NCT00109707|3564178|FG001|Overall Study|Death|0
1999898|NCT00109707|3564179|FG002|Overall Study|Death|0
1999899|NCT00109707|3564177|FG000|Overall Study|Disease progression|12
1999900|NCT00109707|3564178|FG001|Overall Study|Disease progression|4
1999901|NCT00109707|3564179|FG002|Overall Study|Disease progression|3
1999902|NCT00109707|3564177|FG000|Overall Study|Lost to Follow-up|3
1999903|NCT00109707|3564178|FG001|Overall Study|Lost to Follow-up|0
1999904|NCT00109707|3564179|FG002|Overall Study|Lost to Follow-up|0
1999905|NCT00109707|3564177|FG000|Overall Study|Protocol Violation|1
1999906|NCT00109707|3564178|FG001|Overall Study|Protocol Violation|0
1999907|NCT00109707|3564179|FG002|Overall Study|Protocol Violation|0
1999908|NCT00109707|3564177|FG000|Overall Study|Patient withdrew consent|6
1999909|NCT00109707|3564178|FG001|Overall Study|Patient withdrew consent|1
1999910|NCT00109707|3564179|FG002|Overall Study|Patient withdrew consent|0
1999911|NCT00109733|3564193|FG000|Overall Study|Protocol Violation|0
1999912|NCT00109733|3564194|FG001|Overall Study|Protocol Violation|1
1999913|NCT00109733|3564193|FG000|Overall Study|Stopped taking study drug|1
1999914|NCT00109733|3564194|FG001|Overall Study|Stopped taking study drug|1
1999915|NCT00109733|3564193|FG000|Overall Study|Non-compliant|0
1999916|NCT00109733|3564194|FG001|Overall Study|Non-compliant|1
1999917|NCT00109733|3564193|FG000|Overall Study|Could not commit time for study|1
1999918|NCT00109733|3564194|FG001|Overall Study|Could not commit time for study|1
1999919|NCT00109772|3564202|FG000|Double-blind Treatment|Adverse Event|14
1999920|NCT00109772|3564203|FG001|Double-blind Treatment|Adverse Event|5
1999921|NCT00109772|3564202|FG000|Double-blind Treatment|Lack of Efficacy|1
1999922|NCT00109772|3564203|FG001|Double-blind Treatment|Lack of Efficacy|0
1999923|NCT00109772|3564202|FG000|Double-blind Treatment|Withdrawal by Subject|2
1999924|NCT00109772|3564203|FG001|Double-blind Treatment|Withdrawal by Subject|1
1999925|NCT00109772|3564202|FG000|Double-blind Treatment|Lost to Follow-up|2
1999926|NCT00109772|3564203|FG001|Double-blind Treatment|Lost to Follow-up|3
1999927|NCT00109772|3564202|FG000|Double-blind Treatment|Protocol Violation|0
1999928|NCT00109772|3564203|FG001|Double-blind Treatment|Protocol Violation|1
1999929|NCT00109772|3564202|FG000|Double-blind Treatment|Other|0
1999930|NCT00109772|3564203|FG001|Double-blind Treatment|Other|4
1999931|NCT00109772|3564202|FG000|Double-blind Treatment|Withdrew prior to treatment|3
1999932|NCT00109772|3564203|FG001|Double-blind Treatment|Withdrew prior to treatment|1
1999933|NCT00109772|3564202|FG000|Open-label Extension|Adverse Event|10
1999934|NCT00109772|3564203|FG001|Open-label Extension|Adverse Event|19
1999935|NCT00109772|3564202|FG000|Open-label Extension|Lack of Efficacy|19
1999936|NCT00109772|3564203|FG001|Open-label Extension|Lack of Efficacy|11
1999937|NCT00109772|3564202|FG000|Open-label Extension|Withdrawal by Subject|9
1999938|NCT00109772|3564203|FG001|Open-label Extension|Withdrawal by Subject|6
1999939|NCT00109772|3564202|FG000|Open-label Extension|Lost to Follow-up|1
1999940|NCT00109772|3564203|FG001|Open-label Extension|Lost to Follow-up|0
1999941|NCT00109772|3564202|FG000|Open-label Extension|Death|0
1999942|NCT00109772|3564203|FG001|Open-label Extension|Death|1
1999943|NCT00109772|3564202|FG000|Open-label Extension|Protocol Violation|2
1999944|NCT00109772|3564203|FG001|Open-label Extension|Protocol Violation|2
1999945|NCT00109772|3564202|FG000|Open-label Extension|Other|4
1999946|NCT00109772|3564203|FG001|Open-label Extension|Other|10
1999947|NCT00109837|3564209|FG000|Overall Study|Adverse Event|2
1999948|NCT00109837|3564209|FG000|Overall Study|Refusal unrelated to adverse effects|1
1999949|NCT00109837|3564209|FG000|Overall Study|Death|1
1999950|NCT00109837|3564209|FG000|Overall Study|BCR/ABL+ or Ph+|17
1999951|NCT00109837|3564209|FG000|Overall Study|Not treated|1
1999952|NCT00109837|3564209|FG000|Overall Study|Ineligible|1
1999953|NCT00109850|3564217|FG000|Overall Study|Adverse Event|1
1999954|NCT00109850|3564217|FG000|Overall Study|Death|2
1999955|NCT00109850|3564217|FG000|Overall Study|Ineligible|1
1999956|NCT00109928|3564225|FG000|Overall Study|Adverse Event|2
1999957|NCT00109928|3564225|FG000|Overall Study|Progression|6
1999958|NCT00109928|3564225|FG000|Overall Study|Death|2
1999959|NCT00109928|3564225|FG000|Overall Study|not protocol specified|2
1999960|NCT00109928|3564225|FG000|Overall Study|not eligible|1
1999961|NCT00109967|3564232|FG000|Overall Study|Cancel Prior to Treatment|2
1999962|NCT00109967|3564233|FG001|Overall Study|Cancel Prior to Treatment|0
1999963|NCT00109967|3564232|FG000|Overall Study|Adverse Event|12
1999964|NCT00109967|3564233|FG001|Overall Study|Adverse Event|1
1999965|NCT00109967|3564232|FG000|Overall Study|Withdrawal by Subject|5
1999966|NCT00109967|3564233|FG001|Overall Study|Withdrawal by Subject|0
1999967|NCT00109967|3564232|FG000|Overall Study|Physician Decision|1
1999968|NCT00109967|3564233|FG001|Overall Study|Physician Decision|3
1999969|NCT00109967|3564232|FG000|Overall Study|Death|0
1999970|NCT00109967|3564233|FG001|Overall Study|Death|2
1999971|NCT00110019|3564241|FG000|Overall Study|Lack of Efficacy|253
1999972|NCT00110019|3564242|FG001|Overall Study|Lack of Efficacy|285
1999973|NCT00110019|3564241|FG000|Overall Study|Adverse Event|61
1999974|NCT00110019|3564242|FG001|Overall Study|Adverse Event|40
1999975|NCT00110019|3564241|FG000|Overall Study|Death|13
1999976|NCT00110019|3564242|FG001|Overall Study|Death|15
1999977|NCT00110019|3564241|FG000|Overall Study|Withdrawal by Subject|21
1999978|NCT00110019|3564242|FG001|Overall Study|Withdrawal by Subject|9
1999979|NCT00110019|3564241|FG000|Overall Study|alternative therapy|5
1999980|NCT00110019|3564242|FG001|Overall Study|alternative therapy|1
1999981|NCT00110019|3564241|FG000|Overall Study|complicating disease|1
1999982|NCT00110019|3564242|FG001|Overall Study|complicating disease|1
1999983|NCT00110019|3564241|FG000|Overall Study|symptom deterioration|13
1999984|NCT00110019|3564242|FG001|Overall Study|symptom deterioration|16
1999985|NCT00110019|3564241|FG000|Overall Study|Not start protocol therapy|17
1999986|NCT00110019|3564242|FG001|Overall Study|Not start protocol therapy|16
1999987|NCT00110019|3564241|FG000|Overall Study|other reasons|22
1999988|NCT00110019|3564242|FG001|Overall Study|other reasons|30
1999989|NCT00110084|3564248|FG000|Overall Study|Adverse Event|9
1999990|NCT00110084|3564248|FG000|Overall Study|Death|1
1999991|NCT00110084|3564248|FG000|Overall Study|Patient Refusal|10
1999992|NCT00110084|3564248|FG000|Overall Study|Alternate Therapy|5
1999993|NCT00110084|3564248|FG000|Overall Study|Intercurrent Illness|1
1999994|NCT00110084|3564248|FG000|Overall Study|Other|2
1999995|NCT00110149|3564257|FG000|Overall Study|Physician Decision|3
1999996|NCT00110214|3564264|FG000|Overall Study|Never started treatment|21
1999997|NCT00110214|3564265|FG001|Overall Study|Never started treatment|20
1999998|NCT00110214|3564264|FG000|Overall Study|Disease progression or death|260
1999999|NCT00110214|3564265|FG001|Overall Study|Disease progression or death|151
2000000|NCT00110214|3564264|FG000|Overall Study|Adverse Event|115
2000001|NCT00110214|3564265|FG001|Overall Study|Adverse Event|192
2000002|NCT00110214|3564264|FG000|Overall Study|Refused further treatment|52
2000003|NCT00110214|3564265|FG001|Overall Study|Refused further treatment|65
2000004|NCT00110214|3564264|FG000|Overall Study|Other (not specified)|61
2000005|NCT00110214|3564265|FG001|Overall Study|Other (not specified)|75
2000006|NCT00110266|3564271|FG000|Overall Study|Adverse Event|27
2000007|NCT00110266|3564271|FG000|Overall Study|Abnormal laboratory value|15
2000008|NCT00110266|3564271|FG000|Overall Study|Withdrawal by Subject|16
2000009|NCT00110266|3564271|FG000|Overall Study|Death|17
2000010|NCT00110266|3564271|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2000011|NCT00110266|3564271|FG000|Overall Study|Participant condition no longer requires study drug|1
2000012|NCT00110305|3564280|FG000|Overall Study|Adverse Event|46
2000013|NCT00110305|3564281|FG001|Overall Study|Adverse Event|13
2000014|NCT00110305|3564280|FG000|Overall Study|Sponsors Decision|1
2000015|NCT00110305|3564281|FG001|Overall Study|Sponsors Decision|0
2000016|NCT00110305|3564280|FG000|Overall Study|Subject Non-Compliant|9
2000017|NCT00110305|3564281|FG001|Overall Study|Subject Non-Compliant|2
2000018|NCT00110305|3564280|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
2000019|NCT00110305|3564281|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
2000020|NCT00110305|3564280|FG000|Overall Study|Subject Reached A Virologic Endpoint|21
2000021|NCT00110305|3564281|FG001|Overall Study|Subject Reached A Virologic Endpoint|3
2000022|NCT00110305|3564280|FG000|Overall Study|Protocol Violation|0
2000023|NCT00110305|3564281|FG001|Overall Study|Protocol Violation|1
2000024|NCT00110305|3564280|FG000|Overall Study|Withdrawal by Subject|7
2000025|NCT00110305|3564281|FG001|Overall Study|Withdrawal by Subject|7
2000026|NCT00110305|3564280|FG000|Overall Study|Lost to Follow-up|20
2000027|NCT00110305|3564281|FG001|Overall Study|Lost to Follow-up|3
2000028|NCT00110305|3564280|FG000|Overall Study|Other|8
2000029|NCT00110305|3564281|FG001|Overall Study|Other|2
2000030|NCT00110357|3564300|FG000|Overall Study|Deterioration without progression|2
2000031|NCT00110357|3564301|FG001|Overall Study|Deterioration without progression|0
2000032|NCT00110357|3564300|FG000|Overall Study|Disease progression/relapse|20
2000033|NCT00110357|3564301|FG001|Overall Study|Disease progression/relapse|15
2000034|NCT00110357|3564300|FG000|Overall Study|Study Closure|1
2000035|NCT00110357|3564301|FG001|Overall Study|Study Closure|0
2000036|NCT00110357|3564300|FG000|Overall Study|Study Drug Toxicity|1
2000037|NCT00110357|3564301|FG001|Overall Study|Study Drug Toxicity|3
2000038|NCT00110357|3564300|FG000|Overall Study|Withdrawal by Subject|3
2000039|NCT00110357|3564301|FG001|Overall Study|Withdrawal by Subject|1
2000040|NCT00110396|3564334|FG000|Overall Study|Adverse Event|15
2000041|NCT00110396|3564334|FG000|Overall Study|Lost to Follow-up|1
2000042|NCT00110396|3564334|FG000|Overall Study|Administration of plasmapheresis|1
2000043|NCT00110396|3564334|FG000|Overall Study|Initiated mitoxantrone therapy|1
2000044|NCT00110396|3564334|FG000|Overall Study|Lack of Efficacy|1
2000045|NCT00110396|3564334|FG000|Overall Study|Decided not to continue treatment|1
2000046|NCT00110396|3564334|FG000|Overall Study|Patient non-compliance|1
2000047|NCT00110396|3564334|FG000|Overall Study|Patient refused to continue|1
2000048|NCT00110396|3564334|FG000|Overall Study|Patient refused to participate|1
2000049|NCT00110396|3564334|FG000|Overall Study|Patient will|1
2000050|NCT00110396|3564334|FG000|Overall Study|Patient's decision|1
2000051|NCT00110396|3564334|FG000|Overall Study|Participation in MS vaccine study|1
2000052|NCT00110396|3564334|FG000|Overall Study|Pregnancy|1
2000053|NCT00110396|3564334|FG000|Overall Study|Pregnancy (Protocol violation)|2
2000054|NCT00110396|3564334|FG000|Overall Study|Protocol Violation|2
2000055|NCT00110396|3564334|FG000|Overall Study|Patient refused to come back|1
2000056|NCT00110396|3564334|FG000|Overall Study|The patient has refused|2
2000057|NCT00110396|3564334|FG000|Overall Study|The patient has refused to visit site|1
2000058|NCT00110396|3564334|FG000|Overall Study|Patient is to be administered copaxone|1
2000059|NCT00110617|3564357|FG000|Overall Study|Adverse Event|2
2000060|NCT00110617|3564358|FG001|Overall Study|Adverse Event|4
2000061|NCT00110617|3564357|FG000|Overall Study|Abnormal Laboratory Value|4
2000062|NCT00110617|3564358|FG001|Overall Study|Abnormal Laboratory Value|2
2000063|NCT00110617|3564357|FG000|Overall Study|Lack of Efficacy|1
2000064|NCT00110617|3564358|FG001|Overall Study|Lack of Efficacy|0
2000065|NCT00110617|3564357|FG000|Overall Study|Patient no longer requires study drug|1
2000066|NCT00110617|3564358|FG001|Overall Study|Patient no longer requires study drug|0
2000067|NCT00110617|3564357|FG000|Overall Study|Protocol Violation|5
2000068|NCT00110617|3564358|FG001|Overall Study|Protocol Violation|0
2000069|NCT00110617|3564357|FG000|Overall Study|Withdrawal by Subject|10
2000070|NCT00110617|3564358|FG001|Overall Study|Withdrawal by Subject|4
2000071|NCT00110617|3564357|FG000|Overall Study|Lost to Follow-up|9
2000072|NCT00110617|3564358|FG001|Overall Study|Lost to Follow-up|1
2000073|NCT00110617|3564357|FG000|Overall Study|Administrative problems|6
2000074|NCT00110617|3564358|FG001|Overall Study|Administrative problems|5
2000075|NCT00110617|3564357|FG000|Overall Study|Death|1
2000076|NCT00110617|3564358|FG001|Overall Study|Death|1
2000077|NCT00110617|3564357|FG000|Overall Study|Did not receive study drug|0
2000078|NCT00110617|3564358|FG001|Overall Study|Did not receive study drug|12
2000079|NCT00110812|3564369|FG000|Main Study|Death|0
2000080|NCT00110812|3564370|FG001|Main Study|Death|0
2000081|NCT00110812|3564371|FG002|Main Study|Death|2
2000082|NCT00110812|3564369|FG000|Main Study|Withdrawal by Subject|0
2000083|NCT00110812|3564370|FG001|Main Study|Withdrawal by Subject|0
2000084|NCT00110812|3564371|FG002|Main Study|Withdrawal by Subject|1
2000085|NCT00110812|3564369|FG000|Main Study|Lost to Follow-up|8
2000086|NCT00110812|3564370|FG001|Main Study|Lost to Follow-up|11
2000087|NCT00110812|3564371|FG002|Main Study|Lost to Follow-up|10
2000088|NCT00110812|3564369|FG000|Extended Follow-up|Death|1
2000089|NCT00110812|3564370|FG001|Extended Follow-up|Death|0
2000090|NCT00110812|3564371|FG002|Extended Follow-up|Death|3
2000091|NCT00110812|3564369|FG000|Extended Follow-up|Withdrawal by Subject|0
2000092|NCT00110812|3564370|FG001|Extended Follow-up|Withdrawal by Subject|1
2000093|NCT00110812|3564371|FG002|Extended Follow-up|Withdrawal by Subject|0
2000094|NCT00110812|3564369|FG000|Extended Follow-up|Lost to Follow-up|1
2000095|NCT00110812|3564370|FG001|Extended Follow-up|Lost to Follow-up|3
2000096|NCT00110812|3564371|FG002|Extended Follow-up|Lost to Follow-up|1
2000097|NCT00110890|3564386|FG000|Overall Study|Adverse Event|30
2000098|NCT00110890|3564387|FG001|Overall Study|Adverse Event|7
2000099|NCT00110890|3564386|FG000|Overall Study|Death|16
2000100|NCT00110890|3564387|FG001|Overall Study|Death|9
2000101|NCT00110890|3564386|FG000|Overall Study|Lost to Follow-up|3
2000102|NCT00110890|3564387|FG001|Overall Study|Lost to Follow-up|1
2312046|NCT02760407|4017755|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
2312047|NCT02760407|4017752|FG000|Overall Study|Study Treatment Was Terminated At The Site|0
2000103|NCT00110890|3564386|FG000|Overall Study|Physician Decision|4
2000104|NCT00110890|3564387|FG001|Overall Study|Physician Decision|5
2000105|NCT00110890|3564386|FG000|Overall Study|Withdrawal by Subject|17
2000106|NCT00110890|3564387|FG001|Overall Study|Withdrawal by Subject|5
2000107|NCT00110890|3564386|FG000|Overall Study|Protocol Deviation|1
2000108|NCT00110890|3564387|FG001|Overall Study|Protocol Deviation|0
2000109|NCT00110890|3564386|FG000|Overall Study|Noncompliance|10
2000110|NCT00110890|3564387|FG001|Overall Study|Noncompliance|0
2000111|NCT00110890|3564386|FG000|Overall Study|Kidney Transplant|16
2000112|NCT00110890|3564387|FG001|Overall Study|Kidney Transplant|12
2000113|NCT00110890|3564386|FG000|Overall Study|Invest. Product Commercially Available|217
2000114|NCT00110890|3564387|FG001|Overall Study|Invest. Product Commercially Available|110
2000115|NCT00110890|3564386|FG000|Overall Study|Other|34
2000116|NCT00110890|3564387|FG001|Overall Study|Other|23
2000117|NCT00110890|3564386|FG000|Overall Study|Ineligibility determined|3
2000118|NCT00110890|3564387|FG001|Overall Study|Ineligibility determined|0
2000119|NCT00110890|3564386|FG000|Overall Study|Requirement for alternative therapy|0
2000120|NCT00110890|3564387|FG001|Overall Study|Requirement for alternative therapy|1
2000121|NCT00110890|3564386|FG000|Overall Study|Disease progression|0
2000122|NCT00110890|3564387|FG001|Overall Study|Disease progression|1
2000123|NCT00110890|3564386|FG000|Overall Study|Parathyroidectomy|0
2000124|NCT00110890|3564387|FG001|Overall Study|Parathyroidectomy|1
2000125|NCT00110890|3564386|FG000|Overall Study|Did not enter follow-up phase|10
2000126|NCT00110890|3564387|FG001|Overall Study|Did not enter follow-up phase|4
2000127|NCT00110994|3564395|FG000|Double-blind (DB) Treatment|Adverse Event|3
2000128|NCT00110994|3564396|FG001|Double-blind (DB) Treatment|Adverse Event|0
2000129|NCT00110994|3564395|FG000|Double-blind (DB) Treatment|Death|1
2000130|NCT00110994|3564396|FG001|Double-blind (DB) Treatment|Death|0
2000131|NCT00110994|3564395|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0
2000132|NCT00110994|3564396|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2
2000133|NCT00110994|3564395|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2
2000134|NCT00110994|3564396|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1
2000135|NCT00110994|3564395|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
2000136|NCT00110994|3564396|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
2000137|NCT00110994|3564395|FG000|Double-blind (DB) Treatment|other reasons|2
2000138|NCT00110994|3564396|FG001|Double-blind (DB) Treatment|other reasons|3
2000139|NCT00110994|3564395|FG000|Active Follow-up|Disease progression/recurrence/replace|1
2000140|NCT00110994|3564396|FG001|Active Follow-up|Disease progression/recurrence/replace|0
2000141|NCT00110994|3564395|FG000|Active Follow-up|Other reasons|0
2000142|NCT00110994|3564396|FG001|Active Follow-up|Other reasons|2
2000143|NCT00110994|3564395|FG000|Long Term Follow-up|Death|19
2000144|NCT00110994|3564396|FG001|Long Term Follow-up|Death|17
2000145|NCT00111007|3564404|FG000|Double-blind (DB) Treatment|Adverse Event|12
2000146|NCT00111007|3564405|FG001|Double-blind (DB) Treatment|Adverse Event|4
2000147|NCT00111007|3564404|FG000|Double-blind (DB) Treatment|Death|5
2000148|NCT00111007|3564405|FG001|Double-blind (DB) Treatment|Death|2
2000149|NCT00111007|3564404|FG000|Double-blind (DB) Treatment|Protocol Violation|0
2000150|NCT00111007|3564405|FG001|Double-blind (DB) Treatment|Protocol Violation|1
2000151|NCT00111007|3564404|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6
2000152|NCT00111007|3564405|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8
2000153|NCT00111007|3564404|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
2000154|NCT00111007|3564405|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
2000155|NCT00111007|3564404|FG000|Double-blind (DB) Treatment|Relapse|1
2000156|NCT00111007|3564405|FG001|Double-blind (DB) Treatment|Relapse|0
2000157|NCT00111007|3564404|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0
2000158|NCT00111007|3564405|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2
2000159|NCT00111007|3564404|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
2000160|NCT00111007|3564405|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
2000161|NCT00111007|3564404|FG000|Double-blind (DB) Treatment|Primary reason with other category|0
2000162|NCT00111007|3564405|FG001|Double-blind (DB) Treatment|Primary reason with other category|1
2000163|NCT00111007|3564404|FG000|Active Follow-up|Adverse Event|1
2000164|NCT00111007|3564405|FG001|Active Follow-up|Adverse Event|0
2000165|NCT00111007|3564404|FG000|Active Follow-up|Death|2
2000166|NCT00111007|3564405|FG001|Active Follow-up|Death|0
2000167|NCT00111007|3564404|FG000|Active Follow-up|Disease progression/recurrence/relapse|3
2000168|NCT00111007|3564405|FG001|Active Follow-up|Disease progression/recurrence/relapse|2
2000169|NCT00111007|3564404|FG000|Long Term Follow-up|Death|34
2000170|NCT00111007|3564405|FG001|Long Term Follow-up|Death|39
2000171|NCT00111007|3564404|FG000|Long Term Follow-up|Lost to Follow-up|1
2000172|NCT00111007|3564405|FG001|Long Term Follow-up|Lost to Follow-up|1
2000173|NCT00111007|3564404|FG000|Long Term Follow-up|Withdrawal by Subject|0
2000174|NCT00111007|3564405|FG001|Long Term Follow-up|Withdrawal by Subject|1
2000175|NCT00111007|3564404|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2
2000176|NCT00111007|3564405|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1
2000177|NCT00111007|3564404|FG000|Long Term Follow-up|Missing|10
2000178|NCT00111007|3564405|FG001|Long Term Follow-up|Missing|3
2000179|NCT00111228|3564414|FG000|Overall Study|Withdrawal by Subject|5
2000180|NCT00111228|3564415|FG001|Overall Study|Withdrawal by Subject|1
2000181|NCT00111228|3564416|FG002|Overall Study|Withdrawal by Subject|0
2000182|NCT00111241|3564426|FG000|Overall Study|Lost to Follow-up|1
2000183|NCT00111241|3564427|FG001|Overall Study|Lost to Follow-up|0
2000184|NCT00111241|3564426|FG000|Overall Study|Withdrawal by Subject|4
2000185|NCT00111241|3564427|FG001|Overall Study|Withdrawal by Subject|0
2000186|NCT00111241|3564426|FG000|Overall Study|Protocol Violation|9
2000187|NCT00111241|3564427|FG001|Overall Study|Protocol Violation|8
2000188|NCT00111241|3564426|FG000|Overall Study|Adverse Event|1
2000189|NCT00111241|3564427|FG001|Overall Study|Adverse Event|0
2000190|NCT00111475|3564445|FG000|Overall Study|Lost to Follow-up|0
2000191|NCT00111475|3564446|FG001|Overall Study|Lost to Follow-up|0
2000192|NCT00111475|3564447|FG002|Overall Study|Lost to Follow-up|0
2000193|NCT00111475|3564448|FG003|Overall Study|Lost to Follow-up|0
2000194|NCT00111475|3564449|FG004|Overall Study|Lost to Follow-up|0
2000195|NCT00111475|3564450|FG005|Overall Study|Lost to Follow-up|1
2000196|NCT00111475|3564451|FG006|Overall Study|Lost to Follow-up|0
2000197|NCT00111475|3564452|FG007|Overall Study|Lost to Follow-up|0
2000198|NCT00111475|3564453|FG008|Overall Study|Lost to Follow-up|0
2000199|NCT00111475|3564454|FG009|Overall Study|Lost to Follow-up|0
2024867|NCT00337662|3593483|FG000|Study Period III|Withdrawal by Subject|18
2024868|NCT00337662|3593484|FG001|Study Period III|Withdrawal by Subject|14
2024869|NCT00337662|3593485|FG002|Study Period III|Withdrawal by Subject|12
2024870|NCT00337662|3593486|FG003|Study Period III|Withdrawal by Subject|0
2024871|NCT00337662|3593483|FG000|Study Period III|Adverse Event|9
2024872|NCT00337662|3593484|FG001|Study Period III|Adverse Event|10
2024873|NCT00337662|3593485|FG002|Study Period III|Adverse Event|8
2024874|NCT00337662|3593486|FG003|Study Period III|Adverse Event|0
2024875|NCT00337662|3593483|FG000|Study Period III|Protocol Violation|3
2024876|NCT00337662|3593484|FG001|Study Period III|Protocol Violation|8
2024877|NCT00337662|3593485|FG002|Study Period III|Protocol Violation|2
2024878|NCT00337662|3593486|FG003|Study Period III|Protocol Violation|0
2024879|NCT00337662|3593483|FG000|Study Period III|Physician Decision|6
2024880|NCT00337662|3593484|FG001|Study Period III|Physician Decision|5
2024881|NCT00337662|3593485|FG002|Study Period III|Physician Decision|0
2024882|NCT00337662|3593486|FG003|Study Period III|Physician Decision|0
2024883|NCT00337662|3593483|FG000|Study Period III|Entry Criteria Not Met|4
2024884|NCT00337662|3593484|FG001|Study Period III|Entry Criteria Not Met|1
2024885|NCT00337662|3593485|FG002|Study Period III|Entry Criteria Not Met|3
2024886|NCT00337662|3593486|FG003|Study Period III|Entry Criteria Not Met|0
2024887|NCT00337662|3593483|FG000|Study Period III|Lack of Efficacy|4
2024888|NCT00337662|3593484|FG001|Study Period III|Lack of Efficacy|4
2024889|NCT00337662|3593485|FG002|Study Period III|Lack of Efficacy|2
2024890|NCT00337662|3593486|FG003|Study Period III|Lack of Efficacy|0
2024891|NCT00337662|3593483|FG000|Study Period III|Parent/Caregiver Decision|0
2024892|NCT00337662|3593484|FG001|Study Period III|Parent/Caregiver Decision|0
2024893|NCT00337662|3593485|FG002|Study Period III|Parent/Caregiver Decision|2
2024894|NCT00337662|3593486|FG003|Study Period III|Parent/Caregiver Decision|0
2024895|NCT00337662|3593483|FG000|Study Period III|Sponsor Decision|1
2024896|NCT00337662|3593484|FG001|Study Period III|Sponsor Decision|0
2024897|NCT00337662|3593485|FG002|Study Period III|Sponsor Decision|1
2024898|NCT00337662|3593486|FG003|Study Period III|Sponsor Decision|0
2024899|NCT00337662|3593483|FG000|Study Period III|Clinical Relapse|1
2024900|NCT00337662|3593484|FG001|Study Period III|Clinical Relapse|0
2024901|NCT00337662|3593485|FG002|Study Period III|Clinical Relapse|0
2024902|NCT00337662|3593486|FG003|Study Period III|Clinical Relapse|0
2024903|NCT00337727|3593499|FG000|Overall Study|Adverse Event|5
2024904|NCT00337727|3593500|FG001|Overall Study|Adverse Event|3
2024905|NCT00337727|3593499|FG000|Overall Study|Lost to Follow-up|5
2024906|NCT00337727|3593500|FG001|Overall Study|Lost to Follow-up|4
2024907|NCT00337727|3593499|FG000|Overall Study|Physician Decision|1
2024908|NCT00337727|3593500|FG001|Overall Study|Physician Decision|0
2024909|NCT00337727|3593499|FG000|Overall Study|Protocol Violation|4
2024910|NCT00337727|3593500|FG001|Overall Study|Protocol Violation|0
2024911|NCT00337727|3593499|FG000|Overall Study|Withdrawal by Subject|3
2024912|NCT00337727|3593500|FG001|Overall Study|Withdrawal by Subject|5
2024913|NCT00337779|3593508|FG000|Overall Study|Withdrawal by Subject|10
2024914|NCT00337779|3593509|FG001|Overall Study|Withdrawal by Subject|12
2024915|NCT00337779|3593508|FG000|Overall Study|Sponsor decision|1
2024916|NCT00337779|3593509|FG001|Overall Study|Sponsor decision|1
2024917|NCT00337779|3593508|FG000|Overall Study|Physician Decision|3
2024918|NCT00337779|3593509|FG001|Overall Study|Physician Decision|6
2024919|NCT00337779|3593508|FG000|Overall Study|Protocol Violation|1
2024920|NCT00337779|3593509|FG001|Overall Study|Protocol Violation|1
2024921|NCT00337779|3593508|FG000|Overall Study|Lost to Follow-up|6
2024922|NCT00337779|3593509|FG001|Overall Study|Lost to Follow-up|5
2024923|NCT00337779|3593508|FG000|Overall Study|Adverse Event|28
2024924|NCT00337779|3593509|FG001|Overall Study|Adverse Event|51
2024925|NCT00337779|3593508|FG000|Overall Study|Pregnancy|3
2024926|NCT00337779|3593509|FG001|Overall Study|Pregnancy|2
2024927|NCT00337779|3593508|FG000|Overall Study|Death|0
2024928|NCT00337779|3593509|FG001|Overall Study|Death|1
2024929|NCT00337818|3593518|FG000|Overall Study|Lost to Follow-up|289
2024930|NCT00337818|3593519|FG001|Overall Study|Lost to Follow-up|91
2024931|NCT00337818|3593520|FG002|Overall Study|Lost to Follow-up|107
2000200|NCT00111761|3564489|FG000|Part 1|Physician Decision|0
2000201|NCT00111761|3564490|FG001|Part 1|Physician Decision|1
2000202|NCT00111761|3564489|FG000|Part 1|Death|0
2000203|NCT00111761|3564490|FG001|Part 1|Death|2
2000204|NCT00111761|3564489|FG000|Part 1|Other|0
2000205|NCT00111761|3564490|FG001|Part 1|Other|1
2000206|NCT00111761|3564489|FG000|Part 1|Withdrawal by Subject|0
2000207|NCT00111761|3564490|FG001|Part 1|Withdrawal by Subject|1
2000208|NCT00111761|3564489|FG000|Part 2|Adverse Event|1
2000209|NCT00111761|3564490|FG001|Part 2|Adverse Event|0
2000210|NCT00111761|3564489|FG000|Part 2|Physician Decision|1
2000211|NCT00111761|3564490|FG001|Part 2|Physician Decision|0
2000212|NCT00111761|3564489|FG000|Part 2|Death|1
2000213|NCT00111761|3564490|FG001|Part 2|Death|0
2000214|NCT00111761|3564489|FG000|Part 2|Disease progression|3
2000215|NCT00111761|3564490|FG001|Part 2|Disease progression|0
2000216|NCT00111761|3564489|FG000|Part 2|Protocol-specified criteria|1
2000217|NCT00111761|3564490|FG001|Part 2|Protocol-specified criteria|0
2000218|NCT00111761|3564489|FG000|Part 2|Other|1
2000219|NCT00111761|3564490|FG001|Part 2|Other|0
2000220|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5
2000221|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4
2000222|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0
2000223|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0
2000224|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1
2000225|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0
2000226|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
2000227|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
2000228|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
2000229|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
2000230|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
2000231|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
2000232|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
2000233|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
2000234|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
2000235|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
2000236|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
2000237|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
2000238|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
2000239|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
2000240|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
2000241|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
2000242|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
2000243|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
2000244|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
2000245|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
2000246|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
2000247|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
2000248|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
2000249|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
2000250|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
2000251|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
2000252|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
2000253|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
2000254|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
2000255|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
2000256|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
2000257|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
2000258|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
2000259|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
2000260|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
2000261|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
2000262|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
2000263|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
2000264|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
2000265|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
2000266|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
2000267|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
2000268|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
2000269|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
2000270|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
2000271|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
2000272|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
2000273|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
2000274|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
2000275|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
2000276|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
2000277|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
2000278|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
2000279|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
2000280|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
2000281|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
2000282|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
2000283|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
2000284|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
2000285|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
2000286|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
2000287|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
2000288|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
2000289|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
2000290|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
2000291|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
2000292|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
2000293|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
2000294|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
2000295|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
2000296|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
2000297|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
2000298|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
2000299|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
2000300|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
2000301|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
2000302|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
2000303|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
2000304|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
2000305|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
2000306|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
2000307|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
2000308|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
2000309|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
2000310|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
2000311|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
2000312|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
2000313|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
2000314|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
2000315|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
2000316|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
2000317|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
2000318|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
2000319|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
2000320|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
2000321|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
2000322|NCT00111800|3564502|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
2000323|NCT00111800|3564503|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
2000324|NCT00111800|3564504|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
2000325|NCT00111800|3564505|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
2000326|NCT00111800|3564506|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
2000327|NCT00111800|3564507|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
2000328|NCT00111800|3564502|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
2000329|NCT00111800|3564503|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
2000330|NCT00111800|3564504|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
2000331|NCT00111800|3564505|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
2000332|NCT00111800|3564506|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
2000333|NCT00111800|3564507|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
2000334|NCT00111800|3564502|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
2000335|NCT00111800|3564503|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
2000336|NCT00111800|3564504|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
2000337|NCT00111800|3564505|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
2000338|NCT00111800|3564506|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
2000339|NCT00111800|3564507|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
2000340|NCT00111800|3564502|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
2000341|NCT00111800|3564503|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
2000342|NCT00111800|3564504|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
2000343|NCT00111800|3564505|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
2000344|NCT00111800|3564506|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
2000345|NCT00111800|3564507|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
2000346|NCT00111800|3564502|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
2000347|NCT00111800|3564503|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
2000348|NCT00111800|3564504|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
2000349|NCT00111800|3564505|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
2000350|NCT00111800|3564506|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
2000351|NCT00111800|3564507|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
2000352|NCT00111800|3564502|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
2000353|NCT00111800|3564503|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
2000354|NCT00111800|3564504|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
2000355|NCT00111800|3564505|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
2000356|NCT00111800|3564506|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
2000357|NCT00111800|3564507|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
2000358|NCT00111800|3564502|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
2000359|NCT00111800|3564503|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
2000360|NCT00111800|3564504|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
2000361|NCT00111800|3564505|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
2000362|NCT00111800|3564506|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
2000363|NCT00111800|3564507|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
2000364|NCT00111800|3564502|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
2000365|NCT00111800|3564503|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
2000366|NCT00111800|3564504|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
2312048|NCT02760407|4017753|FG001|Overall Study|Study Treatment Was Terminated At The Site|0
2312049|NCT02760407|4017754|FG002|Overall Study|Study Treatment Was Terminated At The Site|1
2312050|NCT02760407|4017755|FG003|Overall Study|Study Treatment Was Terminated At The Site|0
2000367|NCT00111800|3564505|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
2000368|NCT00111800|3564506|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
2000369|NCT00111800|3564507|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
2000370|NCT00111800|3564502|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
2000371|NCT00111800|3564503|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
2000372|NCT00111800|3564504|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
2000373|NCT00111800|3564505|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
2000374|NCT00111800|3564506|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
2000375|NCT00111800|3564507|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
2000376|NCT00111813|3564530|FG000|Overall Study|Adverse Event|1
2000377|NCT00111813|3564531|FG001|Overall Study|Adverse Event|2
2000378|NCT00111813|3564532|FG002|Overall Study|Adverse Event|4
2000379|NCT00111813|3564533|FG003|Overall Study|Adverse Event|2
2000380|NCT00111813|3564534|FG004|Overall Study|Adverse Event|2
2000381|NCT00111813|3564535|FG005|Overall Study|Adverse Event|2
2000382|NCT00111813|3564530|FG000|Overall Study|Progressive disease|2
2000383|NCT00111813|3564531|FG001|Overall Study|Progressive disease|1
2000384|NCT00111813|3564532|FG002|Overall Study|Progressive disease|5
2000385|NCT00111813|3564533|FG003|Overall Study|Progressive disease|3
2000386|NCT00111813|3564534|FG004|Overall Study|Progressive disease|4
2000387|NCT00111813|3564535|FG005|Overall Study|Progressive disease|3
2000388|NCT00111813|3564530|FG000|Overall Study|Lack of Efficacy|0
2000389|NCT00111813|3564531|FG001|Overall Study|Lack of Efficacy|0
2000390|NCT00111813|3564532|FG002|Overall Study|Lack of Efficacy|0
2000391|NCT00111813|3564533|FG003|Overall Study|Lack of Efficacy|0
2000392|NCT00111813|3564534|FG004|Overall Study|Lack of Efficacy|0
2000393|NCT00111813|3564535|FG005|Overall Study|Lack of Efficacy|1
2000394|NCT00111813|3564530|FG000|Overall Study|Other|0
2000395|NCT00111813|3564531|FG001|Overall Study|Other|0
2000396|NCT00111813|3564532|FG002|Overall Study|Other|1
2000397|NCT00111813|3564533|FG003|Overall Study|Other|0
2000398|NCT00111813|3564534|FG004|Overall Study|Other|0
2000399|NCT00111813|3564535|FG005|Overall Study|Other|0
2000400|NCT00111839|3564553|FG000|Overall Study|Disease Progression|30
2000401|NCT00111839|3564554|FG001|Overall Study|Disease Progression|33
2000402|NCT00111839|3564555|FG002|Overall Study|Disease Progression|33
2000403|NCT00111839|3564553|FG000|Overall Study|Adverse Event|5
2000404|NCT00111839|3564554|FG001|Overall Study|Adverse Event|3
2000405|NCT00111839|3564555|FG002|Overall Study|Adverse Event|1
2000406|NCT00111839|3564553|FG000|Overall Study|Protocol Violation|2
2000407|NCT00111839|3564554|FG001|Overall Study|Protocol Violation|4
2000408|NCT00111839|3564555|FG002|Overall Study|Protocol Violation|2
2000409|NCT00111839|3564553|FG000|Overall Study|Death|1
2000410|NCT00111839|3564554|FG001|Overall Study|Death|1
2000411|NCT00111839|3564555|FG002|Overall Study|Death|6
2000412|NCT00111839|3564553|FG000|Overall Study|Withdrawal by Subject|2
2000413|NCT00111839|3564554|FG001|Overall Study|Withdrawal by Subject|2
2000414|NCT00111839|3564555|FG002|Overall Study|Withdrawal by Subject|2
2000415|NCT00111839|3564553|FG000|Overall Study|Lost to Follow-up|1
2000416|NCT00111839|3564554|FG001|Overall Study|Lost to Follow-up|0
2000417|NCT00111839|3564555|FG002|Overall Study|Lost to Follow-up|0
2000418|NCT00111839|3564553|FG000|Overall Study|Logistical Constraint|1
2000419|NCT00111839|3564554|FG001|Overall Study|Logistical Constraint|0
2000420|NCT00111839|3564555|FG002|Overall Study|Logistical Constraint|0
2000421|NCT00111839|3564553|FG000|Overall Study|Other|6
2000422|NCT00111839|3564554|FG001|Overall Study|Other|3
2000423|NCT00111839|3564555|FG002|Overall Study|Other|3
2000424|NCT00111839|3564553|FG000|Overall Study|Randomized but Not Treated|0
2000425|NCT00111839|3564554|FG001|Overall Study|Randomized but Not Treated|0
2000426|NCT00111839|3564555|FG002|Overall Study|Randomized but Not Treated|2
2000427|NCT00111917|3564565|FG000|Overall Study|Withdrawal by Subject|1
2000428|NCT00111917|3564566|FG001|Overall Study|Withdrawal by Subject|1
2000429|NCT00112047|3564578|FG000|Randomized Phase|Lost to Follow-up|26
2000430|NCT00112047|3564579|FG001|Randomized Phase|Lost to Follow-up|33
2000431|NCT00112047|3564578|FG000|Randomized Phase|Adverse Event|10
2000432|NCT00112047|3564579|FG001|Randomized Phase|Adverse Event|10
2000433|NCT00112047|3564578|FG000|Randomized Phase|Withrawal of consent|10
2000434|NCT00112047|3564579|FG001|Randomized Phase|Withrawal of consent|18
2000435|NCT00112047|3564578|FG000|Randomized Phase|Sub-optimal virological response|3
2000436|NCT00112047|3564579|FG001|Randomized Phase|Sub-optimal virological response|13
2000437|NCT00112047|3564578|FG000|Randomized Phase|Noncompliance|8
2000438|NCT00112047|3564579|FG001|Randomized Phase|Noncompliance|4
2000439|NCT00112047|3564578|FG000|Randomized Phase|Protocol Violation|2
2000440|NCT00112047|3564579|FG001|Randomized Phase|Protocol Violation|0
2000441|NCT00112047|3564578|FG000|Randomized Phase|Pregnancy|3
2000442|NCT00112047|3564579|FG001|Randomized Phase|Pregnancy|1
2000443|NCT00112047|3564578|FG000|Randomized Phase|Death|1
2000444|NCT00112047|3564579|FG001|Randomized Phase|Death|3
2000445|NCT00112047|3564578|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0
2000446|NCT00112047|3564579|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1
2000447|NCT00112047|3564578|FG000|Randomized Phase|Inability to swallow pills|0
2000448|NCT00112047|3564579|FG001|Randomized Phase|Inability to swallow pills|1
2000449|NCT00112047|3564578|FG000|Randomized Phase|Incarceration|3
2000450|NCT00112047|3564579|FG001|Randomized Phase|Incarceration|2
2000451|NCT00112047|3564578|FG000|Randomized Phase|Moved out of State|0
2000452|NCT00112047|3564579|FG001|Randomized Phase|Moved out of State|1
2000453|NCT00112047|3564578|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4
2000454|NCT00112047|3564579|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0
2000455|NCT00112047|3564578|FG000|Randomized Phase|High Hepatitis B DNA|0
2000456|NCT00112047|3564579|FG001|Randomized Phase|High Hepatitis B DNA|1
2000457|NCT00112047|3564578|FG000|Atripla Phase|Adverse Event|2
2000458|NCT00112047|3564579|FG001|Atripla Phase|Adverse Event|1
2000459|NCT00112047|3564578|FG000|Atripla Phase|Lost to Follow-up|5
2000460|NCT00112047|3564579|FG001|Atripla Phase|Lost to Follow-up|7
2000461|NCT00112047|3564578|FG000|Atripla Phase|Pregnancy|0
2000462|NCT00112047|3564579|FG001|Atripla Phase|Pregnancy|1
2000463|NCT00112047|3564578|FG000|Atripla Phase|Death|0
2000464|NCT00112047|3564579|FG001|Atripla Phase|Death|2
2000465|NCT00112047|3564578|FG000|Atripla Phase|Withdrew consent|7
2000466|NCT00112047|3564579|FG001|Atripla Phase|Withdrew consent|7
2000467|NCT00112047|3564578|FG000|Atripla Phase|Sub-optimal virological response|0
2000468|NCT00112047|3564579|FG001|Atripla Phase|Sub-optimal virological response|1
2000469|NCT00112047|3564578|FG000|Atripla Phase|Non-compliance|1
2000470|NCT00112047|3564579|FG001|Atripla Phase|Non-compliance|0
2000471|NCT00112047|3564578|FG000|Atripla Phase|Other|3
2000472|NCT00112047|3564579|FG001|Atripla Phase|Other|1
2000473|NCT00112294|3564661|FG000|Overall Study|Still on study|5
2000474|NCT00112294|3564662|FG001|Overall Study|Still on study|0
2000475|NCT00112359|3564670|FG000|Overall Study|Unrelated adverse event|16
2000476|NCT00112359|3564671|FG001|Overall Study|Unrelated adverse event|8
2000477|NCT00112359|3564670|FG000|Overall Study|Trial drug intolerance (adverse event)|2
2000478|NCT00112359|3564671|FG001|Overall Study|Trial drug intolerance (adverse event)|0
2000479|NCT00112359|3564670|FG000|Overall Study|Related adverse event|5
2000480|NCT00112359|3564671|FG001|Overall Study|Related adverse event|3
2000481|NCT00112359|3564670|FG000|Overall Study|Lost to Follow-up|0
2000482|NCT00112359|3564671|FG001|Overall Study|Lost to Follow-up|1
2000483|NCT00112359|3564670|FG000|Overall Study|Personal/administrative|1
2000484|NCT00112359|3564671|FG001|Overall Study|Personal/administrative|1
2000485|NCT00112359|3564670|FG000|Overall Study|Other|3
2000486|NCT00112359|3564671|FG001|Overall Study|Other|0
2000487|NCT00112385|3564679|FG000|Overall Study|Lost to Follow-up|1
2000488|NCT00112385|3564680|FG001|Overall Study|Lost to Follow-up|0
2000489|NCT00112385|3564679|FG000|Overall Study|Withdrawal by Subject|0
2000490|NCT00112385|3564680|FG001|Overall Study|Withdrawal by Subject|1
2000491|NCT00112437|3564691|FG000|Year 1 (12-Month Base Study)|Adverse Event|9
2000492|NCT00112437|3564692|FG001|Year 1 (12-Month Base Study)|Adverse Event|10
2000493|NCT00112437|3564693|FG002|Year 1 (12-Month Base Study)|Adverse Event|6
2000494|NCT00112437|3564694|FG003|Year 1 (12-Month Base Study)|Adverse Event|4
2000495|NCT00112437|3564695|FG004|Year 1 (12-Month Base Study)|Adverse Event|3
2000496|NCT00112437|3564696|FG005|Year 1 (12-Month Base Study)|Adverse Event|0
2000497|NCT00112437|3564697|FG006|Year 1 (12-Month Base Study)|Adverse Event|0
2000498|NCT00112437|3564698|FG007|Year 1 (12-Month Base Study)|Adverse Event|0
2312051|NCT02760407|4017752|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1
2312052|NCT02760407|4017753|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
2312053|NCT02760407|4017754|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
2312054|NCT02760407|4017755|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
2312055|NCT02760407|4017752|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1
2312056|NCT02760407|4017753|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
2312057|NCT02760407|4017754|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
2312058|NCT02760407|4017755|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
2312059|NCT02760407|4017752|FG000|Overall Study|Lack Of Efficacy Per PI|0
2312060|NCT02760407|4017753|FG001|Overall Study|Lack Of Efficacy Per PI|0
2312061|NCT02760407|4017754|FG002|Overall Study|Lack Of Efficacy Per PI|0
2312062|NCT02760407|4017755|FG003|Overall Study|Lack Of Efficacy Per PI|1
2312063|NCT02760407|4017752|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1
2312064|NCT02760407|4017753|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
2000499|NCT00112437|3564699|FG008|Year 1 (12-Month Base Study)|Adverse Event|0
2000500|NCT00112437|3564700|FG009|Year 1 (12-Month Base Study)|Adverse Event|0
2000501|NCT00112437|3564701|FG010|Year 1 (12-Month Base Study)|Adverse Event|0
2000502|NCT00112437|3564702|FG011|Year 1 (12-Month Base Study)|Adverse Event|0
2000503|NCT00112437|3564703|FG012|Year 1 (12-Month Base Study)|Adverse Event|0
2000504|NCT00112437|3564704|FG013|Year 1 (12-Month Base Study)|Adverse Event|0
2000505|NCT00112437|3564705|FG014|Year 1 (12-Month Base Study)|Adverse Event|0
2000506|NCT00112437|3564706|FG015|Year 1 (12-Month Base Study)|Adverse Event|0
2000507|NCT00112437|3564707|FG016|Year 1 (12-Month Base Study)|Adverse Event|0
2000508|NCT00112437|3564708|FG017|Year 1 (12-Month Base Study)|Adverse Event|0
2000509|NCT00112437|3564709|FG018|Year 1 (12-Month Base Study)|Adverse Event|0
2000510|NCT00112437|3564710|FG019|Year 1 (12-Month Base Study)|Adverse Event|0
2000511|NCT00112437|3564711|FG020|Year 1 (12-Month Base Study)|Adverse Event|0
2000512|NCT00112437|3564712|FG021|Year 1 (12-Month Base Study)|Adverse Event|0
2000513|NCT00112437|3564713|FG022|Year 1 (12-Month Base Study)|Adverse Event|0
2000514|NCT00112437|3564714|FG023|Year 1 (12-Month Base Study)|Adverse Event|0
2000515|NCT00112437|3564715|FG024|Year 1 (12-Month Base Study)|Adverse Event|0
2000516|NCT00112437|3564716|FG025|Year 1 (12-Month Base Study)|Adverse Event|0
2000517|NCT00112437|3564691|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000518|NCT00112437|3564692|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1
2000519|NCT00112437|3564693|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000520|NCT00112437|3564694|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000521|NCT00112437|3564695|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000522|NCT00112437|3564696|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000523|NCT00112437|3564697|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000524|NCT00112437|3564698|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000525|NCT00112437|3564699|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000526|NCT00112437|3564700|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000527|NCT00112437|3564701|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000528|NCT00112437|3564702|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000529|NCT00112437|3564703|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000530|NCT00112437|3564704|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000531|NCT00112437|3564705|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000532|NCT00112437|3564706|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000533|NCT00112437|3564707|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000534|NCT00112437|3564708|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000535|NCT00112437|3564709|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000536|NCT00112437|3564710|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000537|NCT00112437|3564711|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000538|NCT00112437|3564712|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000539|NCT00112437|3564713|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000540|NCT00112437|3564714|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000541|NCT00112437|3564715|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000542|NCT00112437|3564716|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2000543|NCT00112437|3564691|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000544|NCT00112437|3564692|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1
2000545|NCT00112437|3564693|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000546|NCT00112437|3564694|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000547|NCT00112437|3564695|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000548|NCT00112437|3564696|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000549|NCT00112437|3564697|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000550|NCT00112437|3564698|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000551|NCT00112437|3564699|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000552|NCT00112437|3564700|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000553|NCT00112437|3564701|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000554|NCT00112437|3564702|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000555|NCT00112437|3564703|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000556|NCT00112437|3564704|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000557|NCT00112437|3564705|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000558|NCT00112437|3564706|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000559|NCT00112437|3564707|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000560|NCT00112437|3564708|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000561|NCT00112437|3564709|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000562|NCT00112437|3564710|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000563|NCT00112437|3564711|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000564|NCT00112437|3564712|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000565|NCT00112437|3564713|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000566|NCT00112437|3564714|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000567|NCT00112437|3564715|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000568|NCT00112437|3564716|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2000569|NCT00112437|3564691|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1
2000570|NCT00112437|3564692|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0
2000571|NCT00112437|3564693|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3
2000572|NCT00112437|3564694|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1
2000573|NCT00112437|3564695|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1
2000574|NCT00112437|3564696|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0
2000575|NCT00112437|3564697|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0
2000576|NCT00112437|3564698|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0
2000577|NCT00112437|3564699|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0
2000578|NCT00112437|3564700|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0
2000579|NCT00112437|3564701|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0
2000580|NCT00112437|3564702|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0
2000581|NCT00112437|3564703|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0
2000582|NCT00112437|3564704|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0
2000583|NCT00112437|3564705|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0
2000584|NCT00112437|3564706|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0
2000585|NCT00112437|3564707|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0
2000586|NCT00112437|3564708|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0
2000587|NCT00112437|3564709|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0
2000588|NCT00112437|3564710|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0
2000589|NCT00112437|3564711|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0
2000590|NCT00112437|3564712|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0
2000591|NCT00112437|3564713|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0
2000592|NCT00112437|3564714|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0
2000593|NCT00112437|3564715|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0
2000594|NCT00112437|3564716|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0
2000595|NCT00112437|3564691|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
2000596|NCT00112437|3564692|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
2000597|NCT00112437|3564693|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
2000598|NCT00112437|3564694|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
2000599|NCT00112437|3564695|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
2000600|NCT00112437|3564696|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000601|NCT00112437|3564697|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000602|NCT00112437|3564698|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000603|NCT00112437|3564699|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000604|NCT00112437|3564700|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000605|NCT00112437|3564701|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000606|NCT00112437|3564702|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000607|NCT00112437|3564703|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000608|NCT00112437|3564704|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000609|NCT00112437|3564705|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000610|NCT00112437|3564706|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000611|NCT00112437|3564707|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000612|NCT00112437|3564708|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000613|NCT00112437|3564709|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000614|NCT00112437|3564710|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000615|NCT00112437|3564711|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000616|NCT00112437|3564712|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000617|NCT00112437|3564713|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000618|NCT00112437|3564714|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2312065|NCT02760407|4017754|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
2000619|NCT00112437|3564715|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2000620|NCT00112437|3564716|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2213951|NCT01683409|3855902|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0
2213952|NCT01683409|3855903|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3
2213953|NCT01683409|3855904|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0
2000621|NCT00112437|3564691|FG000|Year 1 (12-Month Base Study)|moved|0
2000622|NCT00112437|3564692|FG001|Year 1 (12-Month Base Study)|moved|1
2000623|NCT00112437|3564693|FG002|Year 1 (12-Month Base Study)|moved|1
2000624|NCT00112437|3564694|FG003|Year 1 (12-Month Base Study)|moved|0
2000625|NCT00112437|3564695|FG004|Year 1 (12-Month Base Study)|moved|0
2000626|NCT00112437|3564696|FG005|Year 1 (12-Month Base Study)|moved|0
2000627|NCT00112437|3564697|FG006|Year 1 (12-Month Base Study)|moved|0
2000628|NCT00112437|3564698|FG007|Year 1 (12-Month Base Study)|moved|0
2000629|NCT00112437|3564699|FG008|Year 1 (12-Month Base Study)|moved|0
2000630|NCT00112437|3564700|FG009|Year 1 (12-Month Base Study)|moved|0
2000631|NCT00112437|3564701|FG010|Year 1 (12-Month Base Study)|moved|0
2000632|NCT00112437|3564702|FG011|Year 1 (12-Month Base Study)|moved|0
2000633|NCT00112437|3564703|FG012|Year 1 (12-Month Base Study)|moved|0
2000634|NCT00112437|3564704|FG013|Year 1 (12-Month Base Study)|moved|0
2000635|NCT00112437|3564705|FG014|Year 1 (12-Month Base Study)|moved|0
2000636|NCT00112437|3564706|FG015|Year 1 (12-Month Base Study)|moved|0
2000637|NCT00112437|3564707|FG016|Year 1 (12-Month Base Study)|moved|0
2000638|NCT00112437|3564708|FG017|Year 1 (12-Month Base Study)|moved|0
2000639|NCT00112437|3564709|FG018|Year 1 (12-Month Base Study)|moved|0
2000640|NCT00112437|3564710|FG019|Year 1 (12-Month Base Study)|moved|0
2000641|NCT00112437|3564711|FG020|Year 1 (12-Month Base Study)|moved|0
2000642|NCT00112437|3564712|FG021|Year 1 (12-Month Base Study)|moved|0
2000643|NCT00112437|3564713|FG022|Year 1 (12-Month Base Study)|moved|0
2000644|NCT00112437|3564714|FG023|Year 1 (12-Month Base Study)|moved|0
2000645|NCT00112437|3564715|FG024|Year 1 (12-Month Base Study)|moved|0
2000646|NCT00112437|3564716|FG025|Year 1 (12-Month Base Study)|moved|0
2000647|NCT00112437|3564691|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000648|NCT00112437|3564692|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000649|NCT00112437|3564693|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000650|NCT00112437|3564694|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
2000651|NCT00112437|3564695|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000652|NCT00112437|3564696|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000653|NCT00112437|3564697|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000654|NCT00112437|3564698|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000655|NCT00112437|3564699|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000656|NCT00112437|3564700|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000657|NCT00112437|3564701|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000658|NCT00112437|3564702|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000659|NCT00112437|3564703|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000660|NCT00112437|3564704|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000661|NCT00112437|3564705|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000662|NCT00112437|3564706|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000663|NCT00112437|3564707|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000664|NCT00112437|3564708|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000665|NCT00112437|3564709|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000666|NCT00112437|3564710|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000667|NCT00112437|3564711|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000668|NCT00112437|3564712|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000669|NCT00112437|3564713|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000670|NCT00112437|3564714|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000671|NCT00112437|3564715|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000672|NCT00112437|3564716|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2000673|NCT00112437|3564691|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000674|NCT00112437|3564692|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000675|NCT00112437|3564693|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000676|NCT00112437|3564694|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000677|NCT00112437|3564695|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
2000678|NCT00112437|3564696|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000679|NCT00112437|3564697|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000680|NCT00112437|3564698|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000681|NCT00112437|3564699|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000682|NCT00112437|3564700|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000683|NCT00112437|3564701|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000684|NCT00112437|3564702|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000685|NCT00112437|3564703|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000686|NCT00112437|3564704|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000687|NCT00112437|3564705|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000688|NCT00112437|3564706|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000689|NCT00112437|3564707|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000690|NCT00112437|3564708|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000691|NCT00112437|3564709|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000692|NCT00112437|3564710|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000693|NCT00112437|3564711|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000694|NCT00112437|3564712|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000695|NCT00112437|3564713|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000696|NCT00112437|3564714|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000697|NCT00112437|3564715|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000698|NCT00112437|3564716|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2000699|NCT00112437|3564691|FG000|Year 2 (12-Month Extension)|Adverse Event|0
2000700|NCT00112437|3564692|FG001|Year 2 (12-Month Extension)|Adverse Event|0
2000701|NCT00112437|3564693|FG002|Year 2 (12-Month Extension)|Adverse Event|0
2000702|NCT00112437|3564694|FG003|Year 2 (12-Month Extension)|Adverse Event|0
2000703|NCT00112437|3564695|FG004|Year 2 (12-Month Extension)|Adverse Event|0
2000704|NCT00112437|3564696|FG005|Year 2 (12-Month Extension)|Adverse Event|1
2000705|NCT00112437|3564697|FG006|Year 2 (12-Month Extension)|Adverse Event|2
2000706|NCT00112437|3564698|FG007|Year 2 (12-Month Extension)|Adverse Event|6
2000707|NCT00112437|3564699|FG008|Year 2 (12-Month Extension)|Adverse Event|1
2000708|NCT00112437|3564700|FG009|Year 2 (12-Month Extension)|Adverse Event|7
2000709|NCT00112437|3564701|FG010|Year 2 (12-Month Extension)|Adverse Event|0
2000710|NCT00112437|3564702|FG011|Year 2 (12-Month Extension)|Adverse Event|0
2000711|NCT00112437|3564703|FG012|Year 2 (12-Month Extension)|Adverse Event|0
2000712|NCT00112437|3564704|FG013|Year 2 (12-Month Extension)|Adverse Event|0
2000713|NCT00112437|3564705|FG014|Year 2 (12-Month Extension)|Adverse Event|0
2000714|NCT00112437|3564706|FG015|Year 2 (12-Month Extension)|Adverse Event|0
2000715|NCT00112437|3564707|FG016|Year 2 (12-Month Extension)|Adverse Event|0
2000716|NCT00112437|3564708|FG017|Year 2 (12-Month Extension)|Adverse Event|0
2000717|NCT00112437|3564709|FG018|Year 2 (12-Month Extension)|Adverse Event|0
2000718|NCT00112437|3564710|FG019|Year 2 (12-Month Extension)|Adverse Event|0
2000719|NCT00112437|3564711|FG020|Year 2 (12-Month Extension)|Adverse Event|0
2000720|NCT00112437|3564712|FG021|Year 2 (12-Month Extension)|Adverse Event|0
2000721|NCT00112437|3564713|FG022|Year 2 (12-Month Extension)|Adverse Event|0
2000722|NCT00112437|3564714|FG023|Year 2 (12-Month Extension)|Adverse Event|0
2000723|NCT00112437|3564715|FG024|Year 2 (12-Month Extension)|Adverse Event|0
2000724|NCT00112437|3564716|FG025|Year 2 (12-Month Extension)|Adverse Event|0
2000725|NCT00112437|3564691|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000726|NCT00112437|3564692|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000727|NCT00112437|3564693|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000728|NCT00112437|3564694|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000729|NCT00112437|3564695|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000730|NCT00112437|3564696|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1
2000731|NCT00112437|3564697|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6
2000732|NCT00112437|3564698|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000733|NCT00112437|3564699|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000734|NCT00112437|3564700|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2
2000735|NCT00112437|3564701|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000736|NCT00112437|3564702|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000737|NCT00112437|3564703|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000738|NCT00112437|3564704|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000739|NCT00112437|3564705|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000740|NCT00112437|3564706|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000741|NCT00112437|3564707|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000742|NCT00112437|3564708|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000743|NCT00112437|3564709|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000744|NCT00112437|3564710|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000745|NCT00112437|3564711|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000746|NCT00112437|3564712|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000747|NCT00112437|3564713|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000748|NCT00112437|3564714|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000749|NCT00112437|3564715|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000750|NCT00112437|3564716|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0
2000751|NCT00112437|3564691|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000752|NCT00112437|3564692|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000753|NCT00112437|3564693|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000754|NCT00112437|3564694|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000755|NCT00112437|3564695|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000756|NCT00112437|3564696|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000757|NCT00112437|3564697|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000758|NCT00112437|3564698|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000759|NCT00112437|3564699|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1
2000760|NCT00112437|3564700|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000761|NCT00112437|3564701|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000762|NCT00112437|3564702|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000763|NCT00112437|3564703|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000764|NCT00112437|3564704|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000765|NCT00112437|3564705|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000766|NCT00112437|3564706|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000767|NCT00112437|3564707|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000768|NCT00112437|3564708|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000769|NCT00112437|3564709|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000770|NCT00112437|3564710|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000771|NCT00112437|3564711|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000772|NCT00112437|3564712|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000773|NCT00112437|3564713|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000774|NCT00112437|3564714|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000775|NCT00112437|3564715|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000776|NCT00112437|3564716|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0
2000777|NCT00112437|3564691|FG000|Year 2 (12-Month Extension)|Protocol Violation|0
2000778|NCT00112437|3564692|FG001|Year 2 (12-Month Extension)|Protocol Violation|0
2000779|NCT00112437|3564693|FG002|Year 2 (12-Month Extension)|Protocol Violation|0
2000780|NCT00112437|3564694|FG003|Year 2 (12-Month Extension)|Protocol Violation|0
2000781|NCT00112437|3564695|FG004|Year 2 (12-Month Extension)|Protocol Violation|0
2000782|NCT00112437|3564696|FG005|Year 2 (12-Month Extension)|Protocol Violation|0
2000783|NCT00112437|3564697|FG006|Year 2 (12-Month Extension)|Protocol Violation|0
2000784|NCT00112437|3564698|FG007|Year 2 (12-Month Extension)|Protocol Violation|0
2000785|NCT00112437|3564699|FG008|Year 2 (12-Month Extension)|Protocol Violation|1
2000786|NCT00112437|3564700|FG009|Year 2 (12-Month Extension)|Protocol Violation|0
2000787|NCT00112437|3564701|FG010|Year 2 (12-Month Extension)|Protocol Violation|0
2000788|NCT00112437|3564702|FG011|Year 2 (12-Month Extension)|Protocol Violation|0
2000789|NCT00112437|3564703|FG012|Year 2 (12-Month Extension)|Protocol Violation|0
2000790|NCT00112437|3564704|FG013|Year 2 (12-Month Extension)|Protocol Violation|0
2000791|NCT00112437|3564705|FG014|Year 2 (12-Month Extension)|Protocol Violation|0
2000792|NCT00112437|3564706|FG015|Year 2 (12-Month Extension)|Protocol Violation|0
2000793|NCT00112437|3564707|FG016|Year 2 (12-Month Extension)|Protocol Violation|0
2000794|NCT00112437|3564708|FG017|Year 2 (12-Month Extension)|Protocol Violation|0
2000795|NCT00112437|3564709|FG018|Year 2 (12-Month Extension)|Protocol Violation|0
2000796|NCT00112437|3564710|FG019|Year 2 (12-Month Extension)|Protocol Violation|0
2000797|NCT00112437|3564711|FG020|Year 2 (12-Month Extension)|Protocol Violation|0
2000798|NCT00112437|3564712|FG021|Year 2 (12-Month Extension)|Protocol Violation|0
2000799|NCT00112437|3564713|FG022|Year 2 (12-Month Extension)|Protocol Violation|0
2000800|NCT00112437|3564714|FG023|Year 2 (12-Month Extension)|Protocol Violation|0
2000801|NCT00112437|3564715|FG024|Year 2 (12-Month Extension)|Protocol Violation|0
2000802|NCT00112437|3564716|FG025|Year 2 (12-Month Extension)|Protocol Violation|0
2000803|NCT00112437|3564691|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000804|NCT00112437|3564692|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000805|NCT00112437|3564693|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000806|NCT00112437|3564694|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000807|NCT00112437|3564695|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000808|NCT00112437|3564696|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1
2000809|NCT00112437|3564697|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1
2000810|NCT00112437|3564698|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2
2000811|NCT00112437|3564699|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4
2000812|NCT00112437|3564700|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1
2000813|NCT00112437|3564701|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000814|NCT00112437|3564702|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000815|NCT00112437|3564703|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000816|NCT00112437|3564704|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000817|NCT00112437|3564705|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2102396|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Physician Decision|2
2312066|NCT02760407|4017755|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
2312067|NCT02760407|4017752|FG000|Overall Study|Investigator recorded as Adverse Event|1
2312068|NCT02760407|4017753|FG001|Overall Study|Investigator recorded as Adverse Event|0
2312069|NCT02760407|4017754|FG002|Overall Study|Investigator recorded as Adverse Event|2
2312070|NCT02760407|4017755|FG003|Overall Study|Investigator recorded as Adverse Event|0
2312071|NCT02760433|4017771|FG000|Overall Study|Lost to Follow-up|1
2312072|NCT02760433|4017772|FG001|Overall Study|Lost to Follow-up|0
2312073|NCT02760433|4017773|FG002|Overall Study|Lost to Follow-up|1
2312074|NCT02760433|4017774|FG003|Overall Study|Lost to Follow-up|0
2312075|NCT02760433|4017775|FG004|Overall Study|Lost to Follow-up|0
2312076|NCT02760433|4017771|FG000|Overall Study|Withdrawal by Subject|23
2312077|NCT02760433|4017772|FG001|Overall Study|Withdrawal by Subject|9
2312078|NCT02760433|4017773|FG002|Overall Study|Withdrawal by Subject|0
2312079|NCT02760433|4017774|FG003|Overall Study|Withdrawal by Subject|2
2312080|NCT02760433|4017775|FG004|Overall Study|Withdrawal by Subject|9
2312081|NCT02760433|4017771|FG000|Overall Study|Lack of Response At Week 14|0
2312082|NCT02760433|4017772|FG001|Overall Study|Lack of Response At Week 14|0
2000818|NCT00112437|3564706|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000819|NCT00112437|3564707|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000820|NCT00112437|3564708|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000821|NCT00112437|3564709|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000822|NCT00112437|3564710|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000823|NCT00112437|3564711|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000824|NCT00112437|3564712|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000825|NCT00112437|3564713|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000826|NCT00112437|3564714|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000827|NCT00112437|3564715|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000828|NCT00112437|3564716|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2000829|NCT00112437|3564691|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000830|NCT00112437|3564692|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000831|NCT00112437|3564693|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000832|NCT00112437|3564694|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000833|NCT00112437|3564695|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000834|NCT00112437|3564696|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000835|NCT00112437|3564697|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000836|NCT00112437|3564698|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000837|NCT00112437|3564699|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000838|NCT00112437|3564700|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1
2000839|NCT00112437|3564701|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000840|NCT00112437|3564702|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000841|NCT00112437|3564703|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000842|NCT00112437|3564704|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000843|NCT00112437|3564705|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000844|NCT00112437|3564706|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000845|NCT00112437|3564707|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000846|NCT00112437|3564708|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000847|NCT00112437|3564709|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2024932|NCT00337935|3593530|FG000|Overall Study|Adverse Event|2
2213954|NCT01683409|3855905|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1
2213955|NCT01683409|3855906|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1
2213956|NCT01683409|3855902|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2213957|NCT01683409|3855903|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
2213958|NCT01683409|3855904|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2213959|NCT01683409|3855905|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2213960|NCT01683409|3855906|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2213961|NCT01683409|3855902|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
2213962|NCT01683409|3855903|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
2213963|NCT01683409|3855904|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
2213964|NCT01683409|3855905|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
2213965|NCT01683409|3855906|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
2213966|NCT01683409|3855902|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2213967|NCT01683409|3855903|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2213968|NCT01683409|3855904|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
2213969|NCT01683409|3855905|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2213970|NCT01683409|3855906|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2213971|NCT01683409|3855902|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
2213972|NCT01683409|3855903|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
2213973|NCT01683409|3855904|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
2213974|NCT01683409|3855905|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
2213975|NCT01683409|3855906|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
2213976|NCT01683409|3855902|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
2213977|NCT01683409|3855903|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
2213978|NCT01683409|3855904|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
2213979|NCT01683409|3855905|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
2213980|NCT01683409|3855906|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
2213981|NCT01683409|3855902|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1
2213982|NCT01683409|3855903|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2213983|NCT01683409|3855904|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2213984|NCT01683409|3855905|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2213985|NCT01683409|3855906|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2213986|NCT01683409|3855902|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0
2213987|NCT01683409|3855903|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4
2213988|NCT01683409|3855904|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0
2213989|NCT01683409|3855905|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1
2213990|NCT01683409|3855906|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2
2213991|NCT01683409|3855902|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2213992|NCT01683409|3855903|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2213993|NCT01683409|3855904|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2213994|NCT01683409|3855905|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2213995|NCT01683409|3855906|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3
2000848|NCT00112437|3564710|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000849|NCT00112437|3564711|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000850|NCT00112437|3564712|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000851|NCT00112437|3564713|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000852|NCT00112437|3564714|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000853|NCT00112437|3564715|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000854|NCT00112437|3564716|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2000855|NCT00112437|3564691|FG000|Year 2 (12-Month Extension)|patient was out of windows|0
2000856|NCT00112437|3564692|FG001|Year 2 (12-Month Extension)|patient was out of windows|0
2000857|NCT00112437|3564693|FG002|Year 2 (12-Month Extension)|patient was out of windows|0
2000858|NCT00112437|3564694|FG003|Year 2 (12-Month Extension)|patient was out of windows|0
2000859|NCT00112437|3564695|FG004|Year 2 (12-Month Extension)|patient was out of windows|0
2000860|NCT00112437|3564696|FG005|Year 2 (12-Month Extension)|patient was out of windows|0
2000861|NCT00112437|3564697|FG006|Year 2 (12-Month Extension)|patient was out of windows|0
2000862|NCT00112437|3564698|FG007|Year 2 (12-Month Extension)|patient was out of windows|0
2000863|NCT00112437|3564699|FG008|Year 2 (12-Month Extension)|patient was out of windows|0
2000864|NCT00112437|3564700|FG009|Year 2 (12-Month Extension)|patient was out of windows|1
2000865|NCT00112437|3564701|FG010|Year 2 (12-Month Extension)|patient was out of windows|0
2000866|NCT00112437|3564702|FG011|Year 2 (12-Month Extension)|patient was out of windows|0
2000867|NCT00112437|3564703|FG012|Year 2 (12-Month Extension)|patient was out of windows|0
2000868|NCT00112437|3564704|FG013|Year 2 (12-Month Extension)|patient was out of windows|0
2000869|NCT00112437|3564705|FG014|Year 2 (12-Month Extension)|patient was out of windows|0
2000870|NCT00112437|3564706|FG015|Year 2 (12-Month Extension)|patient was out of windows|0
2000871|NCT00112437|3564707|FG016|Year 2 (12-Month Extension)|patient was out of windows|0
2000872|NCT00112437|3564708|FG017|Year 2 (12-Month Extension)|patient was out of windows|0
2000873|NCT00112437|3564709|FG018|Year 2 (12-Month Extension)|patient was out of windows|0
2000874|NCT00112437|3564710|FG019|Year 2 (12-Month Extension)|patient was out of windows|0
2000875|NCT00112437|3564711|FG020|Year 2 (12-Month Extension)|patient was out of windows|0
2000876|NCT00112437|3564712|FG021|Year 2 (12-Month Extension)|patient was out of windows|0
2000877|NCT00112437|3564713|FG022|Year 2 (12-Month Extension)|patient was out of windows|0
2000878|NCT00112437|3564714|FG023|Year 2 (12-Month Extension)|patient was out of windows|0
2000879|NCT00112437|3564715|FG024|Year 2 (12-Month Extension)|patient was out of windows|0
2000880|NCT00112437|3564716|FG025|Year 2 (12-Month Extension)|patient was out of windows|0
2000881|NCT00112437|3564691|FG000|Year 2 (12-Month Extension)|Moved|0
2000882|NCT00112437|3564692|FG001|Year 2 (12-Month Extension)|Moved|0
2000883|NCT00112437|3564693|FG002|Year 2 (12-Month Extension)|Moved|0
2000884|NCT00112437|3564694|FG003|Year 2 (12-Month Extension)|Moved|0
2000885|NCT00112437|3564695|FG004|Year 2 (12-Month Extension)|Moved|0
2000886|NCT00112437|3564696|FG005|Year 2 (12-Month Extension)|Moved|0
2000887|NCT00112437|3564697|FG006|Year 2 (12-Month Extension)|Moved|0
2000888|NCT00112437|3564698|FG007|Year 2 (12-Month Extension)|Moved|0
2000889|NCT00112437|3564699|FG008|Year 2 (12-Month Extension)|Moved|0
2213996|NCT01683409|3855902|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2213997|NCT01683409|3855903|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2213998|NCT01683409|3855904|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1
2213999|NCT01683409|3855905|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2214000|NCT01683409|3855906|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2214001|NCT01683565|3855947|FG000|Overall Study|Lost to Follow-up|2
2214002|NCT01683565|3855948|FG001|Overall Study|Lost to Follow-up|0
2214003|NCT01683565|3855947|FG000|Overall Study|Discontinued Intervention|1
2214004|NCT01683565|3855948|FG001|Overall Study|Discontinued Intervention|1
2214005|NCT01683604|3855956|FG000|Overall Study|Adverse Event|2
2214006|NCT01683604|3855956|FG000|Overall Study|Lack of Efficacy|1
2214007|NCT01683604|3855956|FG000|Overall Study|Other|2
2214008|NCT01683838|3855980|FG000|Overall Study|Adverse Event|12
2214009|NCT01683838|3855981|FG001|Overall Study|Adverse Event|2
2214010|NCT01683838|3855980|FG000|Overall Study|Protocol Violation|3
2000890|NCT00112437|3564700|FG009|Year 2 (12-Month Extension)|Moved|1
2000891|NCT00112437|3564701|FG010|Year 2 (12-Month Extension)|Moved|0
2000892|NCT00112437|3564702|FG011|Year 2 (12-Month Extension)|Moved|0
2000893|NCT00112437|3564703|FG012|Year 2 (12-Month Extension)|Moved|0
2000894|NCT00112437|3564704|FG013|Year 2 (12-Month Extension)|Moved|0
2000895|NCT00112437|3564705|FG014|Year 2 (12-Month Extension)|Moved|0
2000896|NCT00112437|3564706|FG015|Year 2 (12-Month Extension)|Moved|0
2000897|NCT00112437|3564707|FG016|Year 2 (12-Month Extension)|Moved|0
2000898|NCT00112437|3564708|FG017|Year 2 (12-Month Extension)|Moved|0
2000899|NCT00112437|3564709|FG018|Year 2 (12-Month Extension)|Moved|0
2000900|NCT00112437|3564710|FG019|Year 2 (12-Month Extension)|Moved|0
2000901|NCT00112437|3564711|FG020|Year 2 (12-Month Extension)|Moved|0
2000902|NCT00112437|3564712|FG021|Year 2 (12-Month Extension)|Moved|0
2000903|NCT00112437|3564713|FG022|Year 2 (12-Month Extension)|Moved|0
2000904|NCT00112437|3564714|FG023|Year 2 (12-Month Extension)|Moved|0
2000905|NCT00112437|3564715|FG024|Year 2 (12-Month Extension)|Moved|0
2214011|NCT01683838|3855981|FG001|Overall Study|Protocol Violation|1
2214012|NCT01683838|3855980|FG000|Overall Study|Withdrawal by Subject|6
2000906|NCT00112437|3564716|FG025|Year 2 (12-Month Extension)|Moved|0
2000907|NCT00112437|3564691|FG000|Year 3 (12-Month Extension)|Adverse Event|0
2000908|NCT00112437|3564692|FG001|Year 3 (12-Month Extension)|Adverse Event|0
2000909|NCT00112437|3564693|FG002|Year 3 (12-Month Extension)|Adverse Event|0
2000910|NCT00112437|3564694|FG003|Year 3 (12-Month Extension)|Adverse Event|0
2000911|NCT00112437|3564695|FG004|Year 3 (12-Month Extension)|Adverse Event|0
2000912|NCT00112437|3564696|FG005|Year 3 (12-Month Extension)|Adverse Event|0
2000913|NCT00112437|3564697|FG006|Year 3 (12-Month Extension)|Adverse Event|0
2214013|NCT01683838|3855981|FG001|Overall Study|Withdrawal by Subject|5
2214014|NCT01683838|3855980|FG000|Overall Study|Lost to Follow-up|1
2214015|NCT01683838|3855981|FG001|Overall Study|Lost to Follow-up|1
2214016|NCT01683838|3855980|FG000|Overall Study|Other|4
2214017|NCT01683838|3855981|FG001|Overall Study|Other|3
2214018|NCT01683994|3855992|FG000|Overall Study|Withdrawal by Subject|1
2214019|NCT01683994|3855993|FG001|Overall Study|Withdrawal by Subject|0
2214020|NCT01683994|3855994|FG002|Overall Study|Withdrawal by Subject|0
2214021|NCT01683994|3855995|FG003|Overall Study|Withdrawal by Subject|1
2214022|NCT01683994|3855996|FG004|Overall Study|Withdrawal by Subject|0
2214023|NCT01683994|3855992|FG000|Overall Study|Intercurrent illness|0
2214024|NCT01683994|3855993|FG001|Overall Study|Intercurrent illness|0
2214025|NCT01683994|3855994|FG002|Overall Study|Intercurrent illness|0
2000914|NCT00112437|3564698|FG007|Year 3 (12-Month Extension)|Adverse Event|0
2000915|NCT00112437|3564699|FG008|Year 3 (12-Month Extension)|Adverse Event|0
2000916|NCT00112437|3564700|FG009|Year 3 (12-Month Extension)|Adverse Event|0
2000917|NCT00112437|3564701|FG010|Year 3 (12-Month Extension)|Adverse Event|1
2000918|NCT00112437|3564702|FG011|Year 3 (12-Month Extension)|Adverse Event|0
2000919|NCT00112437|3564703|FG012|Year 3 (12-Month Extension)|Adverse Event|0
2000920|NCT00112437|3564704|FG013|Year 3 (12-Month Extension)|Adverse Event|0
2000921|NCT00112437|3564705|FG014|Year 3 (12-Month Extension)|Adverse Event|0
2000922|NCT00112437|3564706|FG015|Year 3 (12-Month Extension)|Adverse Event|1
2000923|NCT00112437|3564707|FG016|Year 3 (12-Month Extension)|Adverse Event|3
2000924|NCT00112437|3564708|FG017|Year 3 (12-Month Extension)|Adverse Event|1
2000925|NCT00112437|3564709|FG018|Year 3 (12-Month Extension)|Adverse Event|0
2000926|NCT00112437|3564710|FG019|Year 3 (12-Month Extension)|Adverse Event|1
2000927|NCT00112437|3564711|FG020|Year 3 (12-Month Extension)|Adverse Event|0
2000928|NCT00112437|3564712|FG021|Year 3 (12-Month Extension)|Adverse Event|0
2000929|NCT00112437|3564713|FG022|Year 3 (12-Month Extension)|Adverse Event|0
2000930|NCT00112437|3564714|FG023|Year 3 (12-Month Extension)|Adverse Event|0
2000931|NCT00112437|3564715|FG024|Year 3 (12-Month Extension)|Adverse Event|0
2000932|NCT00112437|3564716|FG025|Year 3 (12-Month Extension)|Adverse Event|0
2000933|NCT00112437|3564691|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000934|NCT00112437|3564692|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000935|NCT00112437|3564693|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000936|NCT00112437|3564694|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000937|NCT00112437|3564695|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000938|NCT00112437|3564696|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000939|NCT00112437|3564697|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000940|NCT00112437|3564698|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000941|NCT00112437|3564699|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000942|NCT00112437|3564700|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000943|NCT00112437|3564701|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000944|NCT00112437|3564702|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1
2000945|NCT00112437|3564703|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000946|NCT00112437|3564704|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1
2000947|NCT00112437|3564705|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000948|NCT00112437|3564706|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1
2000949|NCT00112437|3564707|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000950|NCT00112437|3564708|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000951|NCT00112437|3564709|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2
2000952|NCT00112437|3564710|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000953|NCT00112437|3564711|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000954|NCT00112437|3564712|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000955|NCT00112437|3564713|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000956|NCT00112437|3564714|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000957|NCT00112437|3564715|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000958|NCT00112437|3564716|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0
2000959|NCT00112437|3564691|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000960|NCT00112437|3564692|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000961|NCT00112437|3564693|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000962|NCT00112437|3564694|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000963|NCT00112437|3564695|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000964|NCT00112437|3564696|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000965|NCT00112437|3564697|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000966|NCT00112437|3564698|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000967|NCT00112437|3564699|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000968|NCT00112437|3564700|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000969|NCT00112437|3564701|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000970|NCT00112437|3564702|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0
2214026|NCT01683994|3855995|FG003|Overall Study|Intercurrent illness|2
2000971|NCT00112437|3564703|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000972|NCT00112437|3564704|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000973|NCT00112437|3564705|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000974|NCT00112437|3564706|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1
2000975|NCT00112437|3564707|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000976|NCT00112437|3564708|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000977|NCT00112437|3564709|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000978|NCT00112437|3564710|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000979|NCT00112437|3564711|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000980|NCT00112437|3564712|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000981|NCT00112437|3564713|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000982|NCT00112437|3564714|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000983|NCT00112437|3564715|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000984|NCT00112437|3564716|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0
2000985|NCT00112437|3564691|FG000|Year 3 (12-Month Extension)|Protocol Violation|0
2000986|NCT00112437|3564692|FG001|Year 3 (12-Month Extension)|Protocol Violation|0
2000987|NCT00112437|3564693|FG002|Year 3 (12-Month Extension)|Protocol Violation|0
2000988|NCT00112437|3564694|FG003|Year 3 (12-Month Extension)|Protocol Violation|0
2000989|NCT00112437|3564695|FG004|Year 3 (12-Month Extension)|Protocol Violation|0
2000990|NCT00112437|3564696|FG005|Year 3 (12-Month Extension)|Protocol Violation|0
2000991|NCT00112437|3564697|FG006|Year 3 (12-Month Extension)|Protocol Violation|0
2000992|NCT00112437|3564698|FG007|Year 3 (12-Month Extension)|Protocol Violation|0
2000993|NCT00112437|3564699|FG008|Year 3 (12-Month Extension)|Protocol Violation|0
2000994|NCT00112437|3564700|FG009|Year 3 (12-Month Extension)|Protocol Violation|0
2000995|NCT00112437|3564701|FG010|Year 3 (12-Month Extension)|Protocol Violation|0
2000996|NCT00112437|3564702|FG011|Year 3 (12-Month Extension)|Protocol Violation|0
2000997|NCT00112437|3564703|FG012|Year 3 (12-Month Extension)|Protocol Violation|0
2000998|NCT00112437|3564704|FG013|Year 3 (12-Month Extension)|Protocol Violation|0
2000999|NCT00112437|3564705|FG014|Year 3 (12-Month Extension)|Protocol Violation|0
2001000|NCT00112437|3564706|FG015|Year 3 (12-Month Extension)|Protocol Violation|1
2001001|NCT00112437|3564707|FG016|Year 3 (12-Month Extension)|Protocol Violation|0
2001002|NCT00112437|3564708|FG017|Year 3 (12-Month Extension)|Protocol Violation|0
2001003|NCT00112437|3564709|FG018|Year 3 (12-Month Extension)|Protocol Violation|0
2001004|NCT00112437|3564710|FG019|Year 3 (12-Month Extension)|Protocol Violation|0
2001005|NCT00112437|3564711|FG020|Year 3 (12-Month Extension)|Protocol Violation|0
2001006|NCT00112437|3564712|FG021|Year 3 (12-Month Extension)|Protocol Violation|0
2001007|NCT00112437|3564713|FG022|Year 3 (12-Month Extension)|Protocol Violation|0
2001008|NCT00112437|3564714|FG023|Year 3 (12-Month Extension)|Protocol Violation|0
2001009|NCT00112437|3564715|FG024|Year 3 (12-Month Extension)|Protocol Violation|0
2001010|NCT00112437|3564716|FG025|Year 3 (12-Month Extension)|Protocol Violation|0
2001011|NCT00112437|3564691|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001012|NCT00112437|3564692|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001013|NCT00112437|3564693|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001014|NCT00112437|3564694|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001015|NCT00112437|3564695|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001016|NCT00112437|3564696|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001017|NCT00112437|3564697|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001018|NCT00112437|3564698|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001019|NCT00112437|3564699|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001020|NCT00112437|3564700|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001021|NCT00112437|3564701|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001022|NCT00112437|3564702|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3
2001023|NCT00112437|3564703|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001024|NCT00112437|3564704|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001025|NCT00112437|3564705|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1
2001026|NCT00112437|3564706|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001027|NCT00112437|3564707|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001028|NCT00112437|3564708|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001029|NCT00112437|3564709|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001030|NCT00112437|3564710|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001031|NCT00112437|3564711|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001032|NCT00112437|3564712|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001033|NCT00112437|3564713|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001034|NCT00112437|3564714|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001035|NCT00112437|3564715|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001036|NCT00112437|3564716|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2001037|NCT00112437|3564691|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001038|NCT00112437|3564692|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001039|NCT00112437|3564693|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001040|NCT00112437|3564694|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001041|NCT00112437|3564695|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001042|NCT00112437|3564696|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001043|NCT00112437|3564697|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2024933|NCT00337935|3593531|FG001|Overall Study|Adverse Event|5
2001044|NCT00112437|3564698|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001045|NCT00112437|3564699|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001046|NCT00112437|3564700|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001047|NCT00112437|3564701|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
2001048|NCT00112437|3564702|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
2001049|NCT00112437|3564703|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001050|NCT00112437|3564704|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001051|NCT00112437|3564705|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001052|NCT00112437|3564706|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001053|NCT00112437|3564707|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001054|NCT00112437|3564708|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001055|NCT00112437|3564709|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001056|NCT00112437|3564710|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001057|NCT00112437|3564711|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001058|NCT00112437|3564712|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001059|NCT00112437|3564713|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001060|NCT00112437|3564714|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001061|NCT00112437|3564715|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001062|NCT00112437|3564716|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2001063|NCT00112437|3564691|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001064|NCT00112437|3564692|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001065|NCT00112437|3564693|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001066|NCT00112437|3564694|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001067|NCT00112437|3564695|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001068|NCT00112437|3564696|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001069|NCT00112437|3564697|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001070|NCT00112437|3564698|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001071|NCT00112437|3564699|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001072|NCT00112437|3564700|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001073|NCT00112437|3564701|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001074|NCT00112437|3564702|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001075|NCT00112437|3564703|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001076|NCT00112437|3564704|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001077|NCT00112437|3564705|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001078|NCT00112437|3564706|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001079|NCT00112437|3564707|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001080|NCT00112437|3564708|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001081|NCT00112437|3564709|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001082|NCT00112437|3564710|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001083|NCT00112437|3564711|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
2001084|NCT00112437|3564712|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
2001085|NCT00112437|3564713|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001086|NCT00112437|3564714|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001087|NCT00112437|3564715|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001088|NCT00112437|3564716|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2001089|NCT00112437|3564691|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001090|NCT00112437|3564692|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001091|NCT00112437|3564693|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001092|NCT00112437|3564694|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001093|NCT00112437|3564695|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001094|NCT00112437|3564696|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001095|NCT00112437|3564697|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001096|NCT00112437|3564698|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001097|NCT00112437|3564699|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001098|NCT00112437|3564700|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001099|NCT00112437|3564701|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001100|NCT00112437|3564702|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001101|NCT00112437|3564703|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001102|NCT00112437|3564704|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001103|NCT00112437|3564705|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001104|NCT00112437|3564706|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001105|NCT00112437|3564707|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001106|NCT00112437|3564708|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001107|NCT00112437|3564709|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001108|NCT00112437|3564710|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001109|NCT00112437|3564711|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
2001110|NCT00112437|3564712|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001111|NCT00112437|3564713|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001112|NCT00112437|3564714|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001113|NCT00112437|3564715|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001114|NCT00112437|3564716|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2001115|NCT00112437|3564691|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0
2001116|NCT00112437|3564692|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0
2001117|NCT00112437|3564693|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0
2001118|NCT00112437|3564694|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0
2001119|NCT00112437|3564695|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0
2001120|NCT00112437|3564696|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0
2001121|NCT00112437|3564697|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0
2001122|NCT00112437|3564698|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0
2001123|NCT00112437|3564699|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0
2001124|NCT00112437|3564700|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0
2001125|NCT00112437|3564701|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0
2001126|NCT00112437|3564702|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0
2001127|NCT00112437|3564703|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0
2001128|NCT00112437|3564704|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0
2001129|NCT00112437|3564705|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0
2001130|NCT00112437|3564706|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0
2001131|NCT00112437|3564707|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0
2001132|NCT00112437|3564708|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0
2001133|NCT00112437|3564709|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0
2001134|NCT00112437|3564710|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0
2001135|NCT00112437|3564711|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0
2001136|NCT00112437|3564712|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4
2001137|NCT00112437|3564713|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0
2001138|NCT00112437|3564714|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0
2001139|NCT00112437|3564715|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0
2001140|NCT00112437|3564716|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0
2001141|NCT00112437|3564691|FG000|Years 4-5 (24-Month Extension)|Participant moved|0
2001142|NCT00112437|3564692|FG001|Years 4-5 (24-Month Extension)|Participant moved|0
2001143|NCT00112437|3564693|FG002|Years 4-5 (24-Month Extension)|Participant moved|0
2001144|NCT00112437|3564694|FG003|Years 4-5 (24-Month Extension)|Participant moved|0
2001145|NCT00112437|3564695|FG004|Years 4-5 (24-Month Extension)|Participant moved|0
2001146|NCT00112437|3564696|FG005|Years 4-5 (24-Month Extension)|Participant moved|0
2001147|NCT00112437|3564697|FG006|Years 4-5 (24-Month Extension)|Participant moved|0
2001148|NCT00112437|3564698|FG007|Years 4-5 (24-Month Extension)|Participant moved|0
2001149|NCT00112437|3564699|FG008|Years 4-5 (24-Month Extension)|Participant moved|0
2001150|NCT00112437|3564700|FG009|Years 4-5 (24-Month Extension)|Participant moved|0
2001151|NCT00112437|3564701|FG010|Years 4-5 (24-Month Extension)|Participant moved|0
2001152|NCT00112437|3564702|FG011|Years 4-5 (24-Month Extension)|Participant moved|0
2001153|NCT00112437|3564703|FG012|Years 4-5 (24-Month Extension)|Participant moved|0
2001154|NCT00112437|3564704|FG013|Years 4-5 (24-Month Extension)|Participant moved|0
2001155|NCT00112437|3564705|FG014|Years 4-5 (24-Month Extension)|Participant moved|0
2001156|NCT00112437|3564706|FG015|Years 4-5 (24-Month Extension)|Participant moved|0
2001157|NCT00112437|3564707|FG016|Years 4-5 (24-Month Extension)|Participant moved|0
2001158|NCT00112437|3564708|FG017|Years 4-5 (24-Month Extension)|Participant moved|0
2001159|NCT00112437|3564709|FG018|Years 4-5 (24-Month Extension)|Participant moved|0
2001160|NCT00112437|3564710|FG019|Years 4-5 (24-Month Extension)|Participant moved|0
2001161|NCT00112437|3564711|FG020|Years 4-5 (24-Month Extension)|Participant moved|0
2001162|NCT00112437|3564712|FG021|Years 4-5 (24-Month Extension)|Participant moved|1
2001163|NCT00112437|3564713|FG022|Years 4-5 (24-Month Extension)|Participant moved|0
2001164|NCT00112437|3564714|FG023|Years 4-5 (24-Month Extension)|Participant moved|0
2001165|NCT00112437|3564715|FG024|Years 4-5 (24-Month Extension)|Participant moved|0
2001166|NCT00112437|3564716|FG025|Years 4-5 (24-Month Extension)|Participant moved|0
2001167|NCT00112437|3564691|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001168|NCT00112437|3564692|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001169|NCT00112437|3564693|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001170|NCT00112437|3564694|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001171|NCT00112437|3564695|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001172|NCT00112437|3564696|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001173|NCT00112437|3564697|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001174|NCT00112437|3564698|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001175|NCT00112437|3564699|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001176|NCT00112437|3564700|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001177|NCT00112437|3564701|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001178|NCT00112437|3564702|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001179|NCT00112437|3564703|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001180|NCT00112437|3564704|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001181|NCT00112437|3564705|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001182|NCT00112437|3564706|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001183|NCT00112437|3564707|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001184|NCT00112437|3564708|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001185|NCT00112437|3564709|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001186|NCT00112437|3564710|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001187|NCT00112437|3564711|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
2001188|NCT00112437|3564712|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
2001189|NCT00112437|3564713|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001190|NCT00112437|3564714|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001191|NCT00112437|3564715|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001192|NCT00112437|3564716|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2001193|NCT00112437|3564691|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0
2001194|NCT00112437|3564692|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0
2001195|NCT00112437|3564693|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0
2001196|NCT00112437|3564694|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0
2001197|NCT00112437|3564695|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0
2001198|NCT00112437|3564696|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0
2001199|NCT00112437|3564697|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0
2001200|NCT00112437|3564698|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0
2001201|NCT00112437|3564699|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0
2001202|NCT00112437|3564700|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0
2001203|NCT00112437|3564701|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0
2001204|NCT00112437|3564702|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0
2001205|NCT00112437|3564703|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0
2001206|NCT00112437|3564704|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0
2214027|NCT01683994|3855996|FG004|Overall Study|Intercurrent illness|1
2214028|NCT01684033|3856032|FG000|Period 1, First 30 Days|Adverse Event|1
2001207|NCT00112437|3564705|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0
2001208|NCT00112437|3564706|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0
2001209|NCT00112437|3564707|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0
2001210|NCT00112437|3564708|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0
2001211|NCT00112437|3564709|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0
2001212|NCT00112437|3564710|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0
2001213|NCT00112437|3564711|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0
2001214|NCT00112437|3564712|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0
2001215|NCT00112437|3564713|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1
2001216|NCT00112437|3564714|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2
2001217|NCT00112437|3564715|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0
2001218|NCT00112437|3564716|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1
2001219|NCT00112437|3564691|FG000|Years 6-10 (60-Month Extension)|Death|0
2001220|NCT00112437|3564692|FG001|Years 6-10 (60-Month Extension)|Death|0
2001221|NCT00112437|3564693|FG002|Years 6-10 (60-Month Extension)|Death|0
2001222|NCT00112437|3564694|FG003|Years 6-10 (60-Month Extension)|Death|0
2001223|NCT00112437|3564695|FG004|Years 6-10 (60-Month Extension)|Death|0
2001224|NCT00112437|3564696|FG005|Years 6-10 (60-Month Extension)|Death|0
2001225|NCT00112437|3564697|FG006|Years 6-10 (60-Month Extension)|Death|0
2001226|NCT00112437|3564698|FG007|Years 6-10 (60-Month Extension)|Death|0
2001227|NCT00112437|3564699|FG008|Years 6-10 (60-Month Extension)|Death|0
2001228|NCT00112437|3564700|FG009|Years 6-10 (60-Month Extension)|Death|0
2001229|NCT00112437|3564701|FG010|Years 6-10 (60-Month Extension)|Death|0
2001230|NCT00112437|3564702|FG011|Years 6-10 (60-Month Extension)|Death|0
2001231|NCT00112437|3564703|FG012|Years 6-10 (60-Month Extension)|Death|0
2001232|NCT00112437|3564704|FG013|Years 6-10 (60-Month Extension)|Death|0
2001233|NCT00112437|3564705|FG014|Years 6-10 (60-Month Extension)|Death|0
2001234|NCT00112437|3564706|FG015|Years 6-10 (60-Month Extension)|Death|0
2001235|NCT00112437|3564707|FG016|Years 6-10 (60-Month Extension)|Death|0
2001236|NCT00112437|3564708|FG017|Years 6-10 (60-Month Extension)|Death|0
2001237|NCT00112437|3564709|FG018|Years 6-10 (60-Month Extension)|Death|0
2001238|NCT00112437|3564710|FG019|Years 6-10 (60-Month Extension)|Death|0
2001239|NCT00112437|3564711|FG020|Years 6-10 (60-Month Extension)|Death|0
2001240|NCT00112437|3564712|FG021|Years 6-10 (60-Month Extension)|Death|0
2001241|NCT00112437|3564713|FG022|Years 6-10 (60-Month Extension)|Death|0
2001242|NCT00112437|3564714|FG023|Years 6-10 (60-Month Extension)|Death|2
2001243|NCT00112437|3564715|FG024|Years 6-10 (60-Month Extension)|Death|0
2001244|NCT00112437|3564716|FG025|Years 6-10 (60-Month Extension)|Death|0
2001245|NCT00112437|3564691|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001246|NCT00112437|3564692|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001247|NCT00112437|3564693|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001248|NCT00112437|3564694|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001249|NCT00112437|3564695|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001250|NCT00112437|3564696|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001251|NCT00112437|3564697|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001252|NCT00112437|3564698|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001253|NCT00112437|3564699|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001254|NCT00112437|3564700|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001255|NCT00112437|3564701|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001256|NCT00112437|3564702|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001257|NCT00112437|3564703|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001258|NCT00112437|3564704|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001259|NCT00112437|3564705|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001260|NCT00112437|3564706|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001261|NCT00112437|3564707|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001262|NCT00112437|3564708|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001263|NCT00112437|3564709|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001264|NCT00112437|3564710|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001265|NCT00112437|3564711|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001266|NCT00112437|3564712|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001267|NCT00112437|3564713|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001268|NCT00112437|3564714|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001269|NCT00112437|3564715|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2001270|NCT00112437|3564716|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
2001271|NCT00112437|3564691|FG000|Years 6-10 (60-Month Extension)|Other|0
2001272|NCT00112437|3564692|FG001|Years 6-10 (60-Month Extension)|Other|0
2001273|NCT00112437|3564693|FG002|Years 6-10 (60-Month Extension)|Other|0
2001274|NCT00112437|3564694|FG003|Years 6-10 (60-Month Extension)|Other|0
2001275|NCT00112437|3564695|FG004|Years 6-10 (60-Month Extension)|Other|0
2001276|NCT00112437|3564696|FG005|Years 6-10 (60-Month Extension)|Other|0
2001277|NCT00112437|3564697|FG006|Years 6-10 (60-Month Extension)|Other|0
2001278|NCT00112437|3564698|FG007|Years 6-10 (60-Month Extension)|Other|0
2001279|NCT00112437|3564699|FG008|Years 6-10 (60-Month Extension)|Other|0
2001280|NCT00112437|3564700|FG009|Years 6-10 (60-Month Extension)|Other|0
2001281|NCT00112437|3564701|FG010|Years 6-10 (60-Month Extension)|Other|0
2001282|NCT00112437|3564702|FG011|Years 6-10 (60-Month Extension)|Other|0
2001283|NCT00112437|3564703|FG012|Years 6-10 (60-Month Extension)|Other|0
2001284|NCT00112437|3564704|FG013|Years 6-10 (60-Month Extension)|Other|0
2001285|NCT00112437|3564705|FG014|Years 6-10 (60-Month Extension)|Other|0
2001286|NCT00112437|3564706|FG015|Years 6-10 (60-Month Extension)|Other|0
2001287|NCT00112437|3564707|FG016|Years 6-10 (60-Month Extension)|Other|0
2001288|NCT00112437|3564708|FG017|Years 6-10 (60-Month Extension)|Other|0
2001289|NCT00112437|3564709|FG018|Years 6-10 (60-Month Extension)|Other|0
2001290|NCT00112437|3564710|FG019|Years 6-10 (60-Month Extension)|Other|0
2001291|NCT00112437|3564711|FG020|Years 6-10 (60-Month Extension)|Other|0
2001292|NCT00112437|3564712|FG021|Years 6-10 (60-Month Extension)|Other|0
2001293|NCT00112437|3564713|FG022|Years 6-10 (60-Month Extension)|Other|0
2001294|NCT00112437|3564714|FG023|Years 6-10 (60-Month Extension)|Other|0
2001295|NCT00112437|3564715|FG024|Years 6-10 (60-Month Extension)|Other|1
2001296|NCT00112437|3564716|FG025|Years 6-10 (60-Month Extension)|Other|0
2001297|NCT00112437|3564691|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0
2001298|NCT00112437|3564692|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0
2001299|NCT00112437|3564693|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0
2001300|NCT00112437|3564694|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0
2001301|NCT00112437|3564695|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0
2001302|NCT00112437|3564696|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0
2001303|NCT00112437|3564697|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0
2001304|NCT00112437|3564698|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0
2001305|NCT00112437|3564699|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0
2001306|NCT00112437|3564700|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0
2001307|NCT00112437|3564701|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0
2001308|NCT00112437|3564702|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0
2001309|NCT00112437|3564703|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0
2001310|NCT00112437|3564704|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0
2001311|NCT00112437|3564705|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0
2001312|NCT00112437|3564706|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0
2001313|NCT00112437|3564707|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0
2001314|NCT00112437|3564708|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0
2001315|NCT00112437|3564709|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0
2001316|NCT00112437|3564710|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0
2001317|NCT00112437|3564711|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0
2312083|NCT02760433|4017773|FG002|Overall Study|Lack of Response At Week 14|0
2312084|NCT02760433|4017774|FG003|Overall Study|Lack of Response At Week 14|0
2312085|NCT02760433|4017775|FG004|Overall Study|Lack of Response At Week 14|1
2312086|NCT02760433|4017771|FG000|Overall Study|Subject refused to continue the study|1
2312087|NCT02760433|4017772|FG001|Overall Study|Subject refused to continue the study|0
2312088|NCT02760433|4017773|FG002|Overall Study|Subject refused to continue the study|0
2312089|NCT02760433|4017774|FG003|Overall Study|Subject refused to continue the study|0
2312090|NCT02760433|4017775|FG004|Overall Study|Subject refused to continue the study|0
2312091|NCT02760433|4017771|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2
2312092|NCT02760433|4017772|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0
2312093|NCT02760433|4017773|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0
2312094|NCT02760433|4017774|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0
2312095|NCT02760433|4017775|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0
2312096|NCT02760433|4017771|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
2001318|NCT00112437|3564712|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0
2001319|NCT00112437|3564713|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0
2001320|NCT00112437|3564714|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2
2001321|NCT00112437|3564715|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0
2001322|NCT00112437|3564716|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0
2001323|NCT00112437|3564691|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001324|NCT00112437|3564692|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001325|NCT00112437|3564693|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001326|NCT00112437|3564694|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001327|NCT00112437|3564695|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001328|NCT00112437|3564696|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001329|NCT00112437|3564697|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001330|NCT00112437|3564698|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001331|NCT00112437|3564699|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001332|NCT00112437|3564700|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001333|NCT00112437|3564701|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001334|NCT00112437|3564702|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001335|NCT00112437|3564703|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001336|NCT00112437|3564704|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001337|NCT00112437|3564705|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001338|NCT00112437|3564706|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001339|NCT00112437|3564707|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001340|NCT00112437|3564708|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001341|NCT00112437|3564709|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001342|NCT00112437|3564710|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001343|NCT00112437|3564711|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001344|NCT00112437|3564712|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001345|NCT00112437|3564713|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
2001346|NCT00112437|3564714|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
2001347|NCT00112437|3564715|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2001348|NCT00112437|3564716|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
2001349|NCT00112463|3564770|FG000|Overall Study|Physician Decision|1
2001350|NCT00112463|3564770|FG000|Overall Study|Progression|30
2001351|NCT00112463|3564770|FG000|Overall Study|Second Primary|1
2001352|NCT00112463|3564770|FG000|Overall Study|Toxicity|3
2001353|NCT00112463|3564770|FG000|Overall Study|Withdrawal by Subject|2
2001354|NCT00112463|3564770|FG000|Overall Study|Never started treatment|2
2001355|NCT00112489|3564775|FG000|Overall Study|Refused further treatment|8
2001356|NCT00112489|3564775|FG000|Overall Study|Adverse Event|12
2001357|NCT00112489|3564775|FG000|Overall Study|Death|2
2001358|NCT00112489|3564775|FG000|Overall Study|Other, Not Specified|9
2001359|NCT00112489|3564775|FG000|Overall Study|Patient never treated|2
2001360|NCT00112489|3564775|FG000|Overall Study|Ineligible|7
2001361|NCT00112502|3564793|FG000|Overall Study|Withdrawal by Subject|0
2001362|NCT00112502|3564794|FG001|Overall Study|Withdrawal by Subject|1
2001363|NCT00112502|3564795|FG002|Overall Study|Withdrawal by Subject|1
2001364|NCT00112502|3564796|FG003|Overall Study|Withdrawal by Subject|4
2001365|NCT00112502|3564797|FG004|Overall Study|Withdrawal by Subject|2
2001366|NCT00112502|3564798|FG005|Overall Study|Withdrawal by Subject|5
2001367|NCT00112502|3564799|FG006|Overall Study|Withdrawal by Subject|3
2001368|NCT00112502|3564800|FG007|Overall Study|Withdrawal by Subject|7
2001369|NCT00112580|3564830|FG000|Overall Study|Adverse Event|1
2001370|NCT00112580|3564831|FG001|Overall Study|Adverse Event|2
2001371|NCT00112580|3564830|FG000|Overall Study|Disease progression|5
2001372|NCT00112580|3564831|FG001|Overall Study|Disease progression|16
2001373|NCT00112580|3564830|FG000|Overall Study|Participant withdrew consent|2
2001374|NCT00112580|3564831|FG001|Overall Study|Participant withdrew consent|1
2001375|NCT00112736|3564870|FG000|Overall Study|1 pt never had had RX due rapid decline|1
2001376|NCT00112736|3564871|FG001|Overall Study|1 pt never had had RX due rapid decline|0
2001377|NCT00112866|3564907|FG000|Overall Study|Protocol Violation|1
2001378|NCT00112866|3564908|FG001|Overall Study|Protocol Violation|0
2001379|NCT00112866|3564907|FG000|Overall Study|did not start treatment post-op|1
2001380|NCT00112866|3564908|FG001|Overall Study|did not start treatment post-op|2
2001381|NCT00112905|3564922|FG000|Overall Study|Adverse Event|4
2001382|NCT00112905|3564922|FG000|Overall Study|Death|1
2001383|NCT00112905|3564922|FG000|Overall Study|Ineligibility|5
2001384|NCT00112905|3564922|FG000|Overall Study|Alternative treatment|1
2001385|NCT00112905|3564922|FG000|Overall Study|performance status was deteiorating|1
2001386|NCT00112957|3564939|FG000|Overall Study|Progressive disease|18
2001387|NCT00112957|3564939|FG000|Overall Study|Physician Decision|1
2001388|NCT00113087|3564954|FG000|Overall Study|Death or Transplant|14
2001389|NCT00113087|3564955|FG001|Overall Study|Death or Transplant|16
2001390|NCT00113087|3564954|FG000|Overall Study|Family or MD withdrew subject|10
2001391|NCT00113087|3564955|FG001|Overall Study|Family or MD withdrew subject|5
2001392|NCT00113269|3564973|FG000|Overall Study|Not transplanted, donor issues|4
2001393|NCT00113269|3564974|FG001|Overall Study|Not transplanted, donor issues|0
2001394|NCT00113269|3564975|FG002|Overall Study|Not transplanted, donor issues|2
2214029|NCT01684033|3856033|FG001|Period 1, First 30 Days|Adverse Event|1
2214030|NCT01684033|3856032|FG000|Period 1, First 30 Days|Noncompliance|1
2214031|NCT01684033|3856033|FG001|Period 1, First 30 Days|Noncompliance|0
2001395|NCT00113269|3564976|FG003|Overall Study|Not transplanted, donor issues|2
2001396|NCT00113269|3564973|FG000|Overall Study|Not transplanted, recipient issues|2
2001397|NCT00113269|3564974|FG001|Overall Study|Not transplanted, recipient issues|1
2001398|NCT00113269|3564975|FG002|Overall Study|Not transplanted, recipient issues|7
2001399|NCT00113269|3564976|FG003|Overall Study|Not transplanted, recipient issues|4
2001400|NCT00113269|3564973|FG000|Overall Study|Early graft loss, technical|0
2001401|NCT00113269|3564974|FG001|Overall Study|Early graft loss, technical|0
2001402|NCT00113269|3564975|FG002|Overall Study|Early graft loss, technical|2
2001403|NCT00113269|3564976|FG003|Overall Study|Early graft loss, technical|0
2001404|NCT00113269|3564973|FG000|Overall Study|Death in operating room|0
2001405|NCT00113269|3564974|FG001|Overall Study|Death in operating room|0
2001406|NCT00113269|3564975|FG002|Overall Study|Death in operating room|0
2001407|NCT00113269|3564976|FG003|Overall Study|Death in operating room|1
2001408|NCT00113269|3564973|FG000|Overall Study|Did not meet eligibility - pre-treatment|0
2001409|NCT00113269|3564974|FG001|Overall Study|Did not meet eligibility - pre-treatment|0
2001410|NCT00113269|3564975|FG002|Overall Study|Did not meet eligibility - pre-treatment|0
2001411|NCT00113269|3564976|FG003|Overall Study|Did not meet eligibility - pre-treatment|2
2001412|NCT00113269|3564973|FG000|Overall Study|Adverse Event|2
2001413|NCT00113269|3564974|FG001|Overall Study|Adverse Event|7
2001414|NCT00113269|3564975|FG002|Overall Study|Adverse Event|11
2001415|NCT00113269|3564976|FG003|Overall Study|Adverse Event|7
2001416|NCT00113269|3564973|FG000|Overall Study|Withdrawal by Subject|4
2001417|NCT00113269|3564974|FG001|Overall Study|Withdrawal by Subject|3
2001418|NCT00113269|3564975|FG002|Overall Study|Withdrawal by Subject|4
2001419|NCT00113269|3564976|FG003|Overall Study|Withdrawal by Subject|2
2001420|NCT00113269|3564973|FG000|Overall Study|Graft loss|6
2001421|NCT00113269|3564974|FG001|Overall Study|Graft loss|6
2001422|NCT00113269|3564975|FG002|Overall Study|Graft loss|4
2001423|NCT00113269|3564976|FG003|Overall Study|Graft loss|9
2001424|NCT00113269|3564973|FG000|Overall Study|Protocol Violation|1
2001425|NCT00113269|3564974|FG001|Overall Study|Protocol Violation|0
2001426|NCT00113269|3564975|FG002|Overall Study|Protocol Violation|4
2001427|NCT00113269|3564976|FG003|Overall Study|Protocol Violation|2
2001428|NCT00113269|3564973|FG000|Overall Study|Lost to Follow-up|2
2001429|NCT00113269|3564974|FG001|Overall Study|Lost to Follow-up|3
2001430|NCT00113269|3564975|FG002|Overall Study|Lost to Follow-up|6
2001431|NCT00113269|3564976|FG003|Overall Study|Lost to Follow-up|3
2001432|NCT00113269|3564973|FG000|Overall Study|Sponsor elected to discontinue patient|1
2001433|NCT00113269|3564974|FG001|Overall Study|Sponsor elected to discontinue patient|0
2001434|NCT00113269|3564975|FG002|Overall Study|Sponsor elected to discontinue patient|0
2001435|NCT00113269|3564976|FG003|Overall Study|Sponsor elected to discontinue patient|1
2001436|NCT00113269|3564973|FG000|Overall Study|Discontinued due to rejection|0
2001437|NCT00113269|3564974|FG001|Overall Study|Discontinued due to rejection|0
2001438|NCT00113269|3564975|FG002|Overall Study|Discontinued due to rejection|1
2001439|NCT00113269|3564976|FG003|Overall Study|Discontinued due to rejection|0
2001440|NCT00113269|3564973|FG000|Overall Study|Moved|0
2001441|NCT00113269|3564974|FG001|Overall Study|Moved|1
2001442|NCT00113269|3564975|FG002|Overall Study|Moved|0
2001443|NCT00113269|3564976|FG003|Overall Study|Moved|3
2001444|NCT00113269|3564973|FG000|Overall Study|Received pancreas transplant|0
2001445|NCT00113269|3564974|FG001|Overall Study|Received pancreas transplant|0
2001446|NCT00113269|3564975|FG002|Overall Study|Received pancreas transplant|0
2001447|NCT00113269|3564976|FG003|Overall Study|Received pancreas transplant|2
2001448|NCT00113269|3564973|FG000|Overall Study|Withdrew consent, Prednisone initiated|0
2001449|NCT00113269|3564974|FG001|Overall Study|Withdrew consent, Prednisone initiated|0
2001450|NCT00113269|3564975|FG002|Overall Study|Withdrew consent, Prednisone initiated|0
2001451|NCT00113269|3564976|FG003|Overall Study|Withdrew consent, Prednisone initiated|1
2001452|NCT00113269|3564973|FG000|Overall Study|Did not meet eligibility criteria|1
2001453|NCT00113269|3564974|FG001|Overall Study|Did not meet eligibility criteria|0
2001454|NCT00113269|3564975|FG002|Overall Study|Did not meet eligibility criteria|0
2001455|NCT00113269|3564976|FG003|Overall Study|Did not meet eligibility criteria|1
2001456|NCT00113269|3564973|FG000|Overall Study|Unable to return for follow up|2
2001457|NCT00113269|3564974|FG001|Overall Study|Unable to return for follow up|1
2001458|NCT00113269|3564975|FG002|Overall Study|Unable to return for follow up|0
2001459|NCT00113269|3564976|FG003|Overall Study|Unable to return for follow up|0
2001460|NCT00113295|3564988|FG000|Overall Study|Adverse Event|4
2001461|NCT00113295|3564989|FG001|Overall Study|Adverse Event|1
2001462|NCT00113295|3564988|FG000|Overall Study|Unrelated Medical Illness|1
2001463|NCT00113295|3564989|FG001|Overall Study|Unrelated Medical Illness|0
2001464|NCT00113360|3565005|FG000|Overall Study|Adverse Event|3
2001465|NCT00113360|3565005|FG000|Overall Study|Subject required surgery|1
2001466|NCT00113360|3565005|FG000|Overall Study|Did not meet eligibility criteria|3
2001467|NCT00113373|3565009|FG000|Overall Study|Ineligible: wrong primary|1
2001468|NCT00113373|3565009|FG000|Overall Study|Ineligible: second primary|1
2001469|NCT00113373|3565009|FG000|Overall Study|Never Treated|1
2001470|NCT00113490|3565025|FG000|Overall Study|Withdrawal by Subject|1
2001471|NCT00113490|3565026|FG001|Overall Study|Withdrawal by Subject|3
2001472|NCT00113490|3565025|FG000|Overall Study|Lost to Follow-up|1
2001473|NCT00113490|3565026|FG001|Overall Study|Lost to Follow-up|0
2001474|NCT00113516|3565032|FG000|Part 1|Adverse Event|6
2001475|NCT00113516|3565033|FG001|Part 1|Adverse Event|0
2001476|NCT00113516|3565032|FG000|Part 1|Death|3
2001477|NCT00113516|3565033|FG001|Part 1|Death|0
2001478|NCT00113516|3565032|FG000|Part 1|Other|3
2001479|NCT00113516|3565033|FG001|Part 1|Other|0
2001480|NCT00113516|3565032|FG000|Part 1|Withdrawal by Subject|2
2001481|NCT00113516|3565033|FG001|Part 1|Withdrawal by Subject|0
2001482|NCT00113516|3565032|FG000|Part 1|Lack of Efficacy|2
2001483|NCT00113516|3565033|FG001|Part 1|Lack of Efficacy|0
2001484|NCT00113516|3565032|FG000|Part 1|Did Not Meet Entrance Criteria|1
2001485|NCT00113516|3565033|FG001|Part 1|Did Not Meet Entrance Criteria|0
2001486|NCT00113516|3565032|FG000|Part 1|Laboratory Abnormality|1
2001487|NCT00113516|3565033|FG001|Part 1|Laboratory Abnormality|0
2001488|NCT00113516|3565032|FG000|Part 1|Ongoing|1
2001489|NCT00113516|3565033|FG001|Part 1|Ongoing|0
2001490|NCT00113516|3565032|FG000|Part 1|Missing|65
2001491|NCT00113516|3565033|FG001|Part 1|Missing|0
2001492|NCT00113516|3565032|FG000|Part 2|Adverse Event|0
2001493|NCT00113516|3565033|FG001|Part 2|Adverse Event|16
2001494|NCT00113516|3565032|FG000|Part 2|Death|0
2001495|NCT00113516|3565033|FG001|Part 2|Death|5
2001496|NCT00113516|3565032|FG000|Part 2|Lack of Efficacy|0
2001497|NCT00113516|3565033|FG001|Part 2|Lack of Efficacy|37
2001498|NCT00113516|3565032|FG000|Part 2|Withdrawal by Subject|0
2001499|NCT00113516|3565033|FG001|Part 2|Withdrawal by Subject|3
2001500|NCT00113516|3565032|FG000|Part 2|Other|0
2001501|NCT00113516|3565033|FG001|Part 2|Other|3
2001502|NCT00113516|3565032|FG000|Part 2|Laboratory Abnormality|0
2001503|NCT00113516|3565033|FG001|Part 2|Laboratory Abnormality|1
2001504|NCT00113516|3565032|FG000|Part 2|Ongoing|0
2001505|NCT00113516|3565033|FG001|Part 2|Ongoing|1
2001506|NCT00113529|3565039|FG000|Overall Study|Adverse Event|4
2001507|NCT00113529|3565039|FG000|Overall Study|Lack of Efficacy|20
2001508|NCT00113529|3565039|FG000|Overall Study|Decision of sponsor|6
2001509|NCT00113529|3565039|FG000|Overall Study|Withdrawal by Subject|4
2001510|NCT00113555|3565043|FG000|Overall Study|Baseline Failure|59
2001511|NCT00113555|3565043|FG000|Overall Study|Permanently Explanted|7
2001512|NCT00113555|3565043|FG000|Overall Study|Death|1
2001513|NCT00113555|3565043|FG000|Overall Study|Missed Followup|4
2001514|NCT00113555|3565043|FG000|Overall Study|Lost to Follow-up|8
2001515|NCT00113568|3565048|FG000|Overall Study|Adverse Event|97
2214032|NCT01684033|3856032|FG000|Period 1, First 30 Days|Withdrawal by Subject|1
2214033|NCT01684033|3856033|FG001|Period 1, First 30 Days|Withdrawal by Subject|0
2001516|NCT00113568|3565048|FG000|Overall Study|Death|1
2001517|NCT00113568|3565048|FG000|Overall Study|Lack of Efficacy|30
2001518|NCT00113568|3565048|FG000|Overall Study|Lost to Follow-up|156
2001519|NCT00113568|3565048|FG000|Overall Study|Protocol Violation|32
2001520|NCT00113568|3565048|FG000|Overall Study|Withdrawal by Subject|117
2001521|NCT00113568|3565048|FG000|Overall Study|Other|112
2001522|NCT00113607|3565054|FG000|Overall Study|Adverse Event|40
2001523|NCT00113607|3565055|FG001|Overall Study|Adverse Event|71
2001524|NCT00113607|3565054|FG000|Overall Study|Death|8
2001525|NCT00113607|3565055|FG001|Overall Study|Death|8
2001526|NCT00113607|3565054|FG000|Overall Study|Withdrawal by Subject|50
2001527|NCT00113607|3565055|FG001|Overall Study|Withdrawal by Subject|58
2001528|NCT00113607|3565054|FG000|Overall Study|Lost to Follow-up|0
2001529|NCT00113607|3565055|FG001|Overall Study|Lost to Follow-up|2
2001530|NCT00113607|3565054|FG000|Overall Study|Disease Progression|180
2001531|NCT00113607|3565055|FG001|Overall Study|Disease Progression|142
2001532|NCT00113607|3565054|FG000|Overall Study|Complete Response (Confirmed)|14
2001533|NCT00113607|3565055|FG001|Overall Study|Complete Response (Confirmed)|24
2001534|NCT00113607|3565054|FG000|Overall Study|Other|43
2001535|NCT00113607|3565055|FG001|Overall Study|Other|32
2001536|NCT00113763|3565064|FG000|Overall Study|Adverse Event|5
2001537|NCT00113763|3565065|FG001|Overall Study|Adverse Event|2
2001538|NCT00113763|3565064|FG000|Overall Study|Disease Progression|28
2001539|NCT00113763|3565065|FG001|Overall Study|Disease Progression|14
2001540|NCT00113763|3565064|FG000|Overall Study|Lost to Follow-up|10
2001541|NCT00113763|3565065|FG001|Overall Study|Lost to Follow-up|0
2001542|NCT00113763|3565064|FG000|Overall Study|Withdrawal by Subject|1
2001543|NCT00113763|3565065|FG001|Overall Study|Withdrawal by Subject|4
2001544|NCT00113763|3565064|FG000|Overall Study|Other|27
2001545|NCT00113763|3565065|FG001|Overall Study|Other|6
2001546|NCT00113763|3565064|FG000|Overall Study|Non-compliance|1
2001547|NCT00113763|3565065|FG001|Overall Study|Non-compliance|0
2001548|NCT00113763|3565064|FG000|Overall Study|Ongoing|1
2001549|NCT00113763|3565065|FG001|Overall Study|Ongoing|0
2001550|NCT00113841|3565074|FG000|Overall Study|Disease progression|0
2001551|NCT00113841|3565075|FG001|Overall Study|Disease progression|2
2001552|NCT00113841|3565074|FG000|Overall Study|Non-compliant|1
2001553|NCT00113841|3565075|FG001|Overall Study|Non-compliant|0
2001554|NCT00114127|3565130|FG000|Overall Study|Adverse Event|2
2001555|NCT00114127|3565131|FG001|Overall Study|Adverse Event|1
2001556|NCT00114127|3565130|FG000|Overall Study|Lost to Follow-up|1
2001557|NCT00114127|3565131|FG001|Overall Study|Lost to Follow-up|0
2001558|NCT00114127|3565130|FG000|Overall Study|Withdrawal by Subject|1
2001559|NCT00114127|3565131|FG001|Overall Study|Withdrawal by Subject|3
2001560|NCT00114140|3565137|FG000|Overall Study|Protocol Violation|7
2001561|NCT00114166|3565150|FG000|Overall Study|Wrong primary|0
2001562|NCT00114166|3565151|FG001|Overall Study|Wrong primary|1
2001563|NCT00114218|3565159|FG000|Overall Study|Wrong Cell Type|2
2001564|NCT00114218|3565159|FG000|Overall Study|Wrong Primary|1
2001565|NCT00114218|3565159|FG000|Overall Study|Never Treated|1
2001566|NCT00114231|3565165|FG000|Overall Study|No consent|2
2001567|NCT00114231|3565166|FG001|Overall Study|No consent|0
2001568|NCT00114231|3565165|FG000|Overall Study|QARC requirement not met|1
2001569|NCT00114231|3565166|FG001|Overall Study|QARC requirement not met|0
2001570|NCT00114231|3565165|FG000|Overall Study|Suspected metastatic disease|1
2001571|NCT00114231|3565166|FG001|Overall Study|Suspected metastatic disease|0
2001572|NCT00114231|3565165|FG000|Overall Study|No adenocarcinoma|1
2001573|NCT00114231|3565166|FG001|Overall Study|No adenocarcinoma|0
2001574|NCT00114231|3565165|FG000|Overall Study|Low creatinine clearance|0
2001575|NCT00114231|3565166|FG001|Overall Study|Low creatinine clearance|1
2001576|NCT00114231|3565165|FG000|Overall Study|Tumor size > 4cm|1
2001577|NCT00114231|3565166|FG001|Overall Study|Tumor size > 4cm|0
2001578|NCT00114231|3565165|FG000|Overall Study|Tumor fixed on digital exam|0
2001579|NCT00114231|3565166|FG001|Overall Study|Tumor fixed on digital exam|1
2001580|NCT00114231|3565165|FG000|Overall Study|No Absolute Neutrophil Count|2
2001581|NCT00114231|3565166|FG001|Overall Study|No Absolute Neutrophil Count|0
2001582|NCT00114231|3565165|FG000|Overall Study|Biopsy done after registration|1
2001583|NCT00114231|3565166|FG001|Overall Study|Biopsy done after registration|0
2001584|NCT00114244|3565173|FG000|Overall Study|Adverse Event|2
2001585|NCT00114244|3565174|FG001|Overall Study|Adverse Event|5
2001586|NCT00114244|3565173|FG000|Overall Study|Withdrawal by Subject|0
2001587|NCT00114244|3565174|FG001|Overall Study|Withdrawal by Subject|2
2001588|NCT00114530|3565208|FG000|Overall Study|Death|3
2001589|NCT00114530|3565209|FG001|Overall Study|Death|11
2001590|NCT00114530|3565208|FG000|Overall Study|Lost to Follow-up|1
2001591|NCT00114530|3565209|FG001|Overall Study|Lost to Follow-up|1
2001592|NCT00114530|3565208|FG000|Overall Study|Physician Decision|1
2001593|NCT00114530|3565209|FG001|Overall Study|Physician Decision|1
2001594|NCT00114530|3565208|FG000|Overall Study|Withdrawal by Subject|2
2001595|NCT00114530|3565209|FG001|Overall Study|Withdrawal by Subject|6
2001596|NCT00114530|3565208|FG000|Overall Study|Breast Cancer|1
2001597|NCT00114530|3565209|FG001|Overall Study|Breast Cancer|0
2001598|NCT00114530|3565208|FG000|Overall Study|Subject decision after endpoint failure|0
2001599|NCT00114530|3565209|FG001|Overall Study|Subject decision after endpoint failure|1
2001600|NCT00114530|3565208|FG000|Overall Study|Ineligible|1
2001601|NCT00114530|3565209|FG001|Overall Study|Ineligible|0
2001602|NCT00114634|3565219|FG000|Overall Study|failure to return forms|3
2001603|NCT00114738|3565225|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
2001604|NCT00114738|3565226|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
2001605|NCT00114738|3565227|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
2214034|NCT01684033|3856032|FG000|Period 1, First 30 Days|Lost to Follow-up|1
2214035|NCT01684033|3856033|FG001|Period 1, First 30 Days|Lost to Follow-up|0
2214036|NCT01684033|3856032|FG000|Period 2, Second 30 Days|Adverse Event|1
2214037|NCT01684033|3856033|FG001|Period 2, Second 30 Days|Adverse Event|0
2214038|NCT01684046|3856039|FG000|Period 1, First 30 Days|Adverse Event|0
2214039|NCT01684046|3856040|FG001|Period 1, First 30 Days|Adverse Event|2
2214040|NCT01684202|3856050|FG000|Dose-escalation Period|Adverse Event|0
2001606|NCT00114738|3565225|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
2001607|NCT00114738|3565226|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
2001608|NCT00114738|3565227|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
2001609|NCT00114738|3565225|FG000|Screening for Randomization|Neuropathy|17
2001610|NCT00114738|3565226|FG001|Screening for Randomization|Neuropathy|0
2001611|NCT00114738|3565227|FG002|Screening for Randomization|Neuropathy|0
2001612|NCT00114738|3565225|FG000|Screening for Randomization|Progressive disease|2
2001613|NCT00114738|3565226|FG001|Screening for Randomization|Progressive disease|0
2001614|NCT00114738|3565227|FG002|Screening for Randomization|Progressive disease|0
2001615|NCT00114738|3565225|FG000|Screening for Randomization|CNS Hemorrhage|1
2001616|NCT00114738|3565226|FG001|Screening for Randomization|CNS Hemorrhage|0
2001617|NCT00114738|3565227|FG002|Screening for Randomization|CNS Hemorrhage|0
2001618|NCT00114738|3565225|FG000|Screening for Randomization|Other|1
2001619|NCT00114738|3565226|FG001|Screening for Randomization|Other|0
2001620|NCT00114738|3565227|FG002|Screening for Randomization|Other|0
2001621|NCT00114777|3565237|FG000|Randomization to Month 36|Death|10
2001622|NCT00114777|3565238|FG001|Randomization to Month 36|Death|4
2001623|NCT00114777|3565239|FG002|Randomization to Month 36|Death|3
2001624|NCT00114777|3565237|FG000|Randomization to Month 36|No Longer Met Study Criteria|0
2001625|NCT00114777|3565238|FG001|Randomization to Month 36|No Longer Met Study Criteria|0
2001626|NCT00114777|3565239|FG002|Randomization to Month 36|No Longer Met Study Criteria|2
2001627|NCT00114777|3565237|FG000|Randomization to Month 36|Lack of Efficacy|19
2001628|NCT00114777|3565238|FG001|Randomization to Month 36|Lack of Efficacy|15
2001629|NCT00114777|3565239|FG002|Randomization to Month 36|Lack of Efficacy|17
2001630|NCT00114777|3565237|FG000|Randomization to Month 36|Poor or Non-Compliance|0
2001631|NCT00114777|3565238|FG001|Randomization to Month 36|Poor or Non-Compliance|0
2001632|NCT00114777|3565239|FG002|Randomization to Month 36|Poor or Non-Compliance|1
2214041|NCT01684202|3856051|FG001|Dose-escalation Period|Adverse Event|1
2001633|NCT00114777|3565237|FG000|Randomization to Month 36|Adverse Event|34
2001634|NCT00114777|3565238|FG001|Randomization to Month 36|Adverse Event|35
2001635|NCT00114777|3565239|FG002|Randomization to Month 36|Adverse Event|44
2001636|NCT00114777|3565237|FG000|Randomization to Month 36|Withdrawal by Subject|3
2001637|NCT00114777|3565238|FG001|Randomization to Month 36|Withdrawal by Subject|4
2001638|NCT00114777|3565239|FG002|Randomization to Month 36|Withdrawal by Subject|5
2001639|NCT00114777|3565237|FG000|Randomization to Month 36|Other|9
2001640|NCT00114777|3565238|FG001|Randomization to Month 36|Other|3
2001641|NCT00114777|3565239|FG002|Randomization to Month 36|Other|12
2001642|NCT00114777|3565237|FG000|Long-Term Extension to Month 84|Death|8
2001643|NCT00114777|3565238|FG001|Long-Term Extension to Month 84|Death|13
2001644|NCT00114777|3565239|FG002|Long-Term Extension to Month 84|Death|7
2001645|NCT00114777|3565237|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
2001646|NCT00114777|3565238|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
2001647|NCT00114777|3565239|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
2001648|NCT00114777|3565237|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1
2001649|NCT00114777|3565238|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0
2001650|NCT00114777|3565239|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1
2001651|NCT00114777|3565237|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1
2001652|NCT00114777|3565238|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1
2001653|NCT00114777|3565239|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3
2001654|NCT00114777|3565237|FG000|Long-Term Extension to Month 84|Adverse Event|15
2001655|NCT00114777|3565238|FG001|Long-Term Extension to Month 84|Adverse Event|14
2001656|NCT00114777|3565239|FG002|Long-Term Extension to Month 84|Adverse Event|7
2001657|NCT00114777|3565237|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2
2001658|NCT00114777|3565238|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1
2001659|NCT00114777|3565239|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6
2001660|NCT00114777|3565237|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0
2001661|NCT00114777|3565238|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0
2001662|NCT00114777|3565239|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2
2001663|NCT00114777|3565237|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
2001664|NCT00114777|3565238|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
2001665|NCT00114777|3565239|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
2001666|NCT00114777|3565237|FG000|Long-Term Extension to Month 84|Other|2
2001667|NCT00114777|3565238|FG001|Long-Term Extension to Month 84|Other|0
2001668|NCT00114777|3565239|FG002|Long-Term Extension to Month 84|Other|2
2001669|NCT00114959|3565248|FG000|Overall Study|Lack of Efficacy|6
2001670|NCT00114959|3565248|FG000|Overall Study|Physician Decision|1
2001671|NCT00114959|3565248|FG000|Overall Study|Death|1
2001672|NCT00114972|3565254|FG000|Overall Study|Withdrawal by Subject|40
2001673|NCT00114972|3565255|FG001|Overall Study|Withdrawal by Subject|7
2001674|NCT00114972|3565254|FG000|Overall Study|Lost to Follow-up|8
2001675|NCT00114972|3565255|FG001|Overall Study|Lost to Follow-up|5
2001676|NCT00115037|3565263|FG000|Phase1|Lost to Follow-up|16
2001677|NCT00115037|3565264|FG001|Phase1|Lost to Follow-up|23
2001678|NCT00115037|3565265|FG002|Phase1|Lost to Follow-up|0
2001679|NCT00115037|3565266|FG003|Phase1|Lost to Follow-up|0
2001680|NCT00115037|3565267|FG004|Phase1|Lost to Follow-up|0
2001681|NCT00115037|3565268|FG005|Phase1|Lost to Follow-up|0
2001682|NCT00115037|3565263|FG000|Phase1|Withdrawal by Subject|9
2001683|NCT00115037|3565264|FG001|Phase1|Withdrawal by Subject|4
2001684|NCT00115037|3565265|FG002|Phase1|Withdrawal by Subject|0
2001685|NCT00115037|3565266|FG003|Phase1|Withdrawal by Subject|0
2001686|NCT00115037|3565267|FG004|Phase1|Withdrawal by Subject|0
2001687|NCT00115037|3565268|FG005|Phase1|Withdrawal by Subject|0
2001688|NCT00115037|3565263|FG000|Phase2|Death|0
2001689|NCT00115037|3565264|FG001|Phase2|Death|0
2312097|NCT02760433|4017772|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1
2312098|NCT02760433|4017773|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
2312099|NCT02760433|4017774|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
2312100|NCT02760433|4017775|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
2312101|NCT02760654|4017794|FG000|Overall Study|Lost to Follow-up|3
2312102|NCT02760654|4017795|FG001|Overall Study|Lost to Follow-up|3
2312103|NCT02760654|4017794|FG000|Overall Study|Withdrawal by Subject|4
2001690|NCT00115037|3565265|FG002|Phase2|Death|1
2001691|NCT00115037|3565266|FG003|Phase2|Death|0
2001692|NCT00115037|3565267|FG004|Phase2|Death|0
2001693|NCT00115037|3565268|FG005|Phase2|Death|1
2001694|NCT00115037|3565263|FG000|Phase2|Withdrawal by Subject|0
2001695|NCT00115037|3565264|FG001|Phase2|Withdrawal by Subject|0
2001696|NCT00115037|3565265|FG002|Phase2|Withdrawal by Subject|2
2001697|NCT00115037|3565266|FG003|Phase2|Withdrawal by Subject|1
2001698|NCT00115037|3565267|FG004|Phase2|Withdrawal by Subject|2
2001699|NCT00115037|3565268|FG005|Phase2|Withdrawal by Subject|1
2001700|NCT00115037|3565263|FG000|Phase2|Lost to Follow-up|0
2001701|NCT00115037|3565264|FG001|Phase2|Lost to Follow-up|0
2001702|NCT00115037|3565265|FG002|Phase2|Lost to Follow-up|12
2001703|NCT00115037|3565266|FG003|Phase2|Lost to Follow-up|14
2001704|NCT00115037|3565267|FG004|Phase2|Lost to Follow-up|4
2001705|NCT00115037|3565268|FG005|Phase2|Lost to Follow-up|10
2001706|NCT00115063|3565284|FG000|Overall Study|Lost to Follow-up|98
2001707|NCT00115063|3565285|FG001|Overall Study|Lost to Follow-up|104
2001708|NCT00115063|3565284|FG000|Overall Study|Death|1
2001709|NCT00115063|3565285|FG001|Overall Study|Death|0
2001710|NCT00115336|3565309|FG000|Overall Study|Hospital discharge before study drug|0
2001711|NCT00115336|3565310|FG001|Overall Study|Hospital discharge before study drug|1
2001712|NCT00115349|3565320|FG000|Overall Study|Study closed due to low enrollment.|11
2001713|NCT00115349|3565321|FG001|Overall Study|Study closed due to low enrollment.|9
2001714|NCT00115739|3565327|FG000|Overall Study|Lost to Follow-up|3
2001715|NCT00115765|3565337|FG000|Overall Study|Withdrawal by Subject|22
2001716|NCT00115765|3565338|FG001|Overall Study|Withdrawal by Subject|53
2001717|NCT00115765|3565339|FG002|Overall Study|Withdrawal by Subject|76
2001718|NCT00115765|3565340|FG003|Overall Study|Withdrawal by Subject|15
2001719|NCT00115765|3565337|FG000|Overall Study|Physician Decision|4
2001720|NCT00115765|3565338|FG001|Overall Study|Physician Decision|15
2001721|NCT00115765|3565339|FG002|Overall Study|Physician Decision|18
2001722|NCT00115765|3565340|FG003|Overall Study|Physician Decision|13
2001723|NCT00115765|3565337|FG000|Overall Study|Lost to Follow-up|3
2001724|NCT00115765|3565338|FG001|Overall Study|Lost to Follow-up|20
2001725|NCT00115765|3565339|FG002|Overall Study|Lost to Follow-up|18
2001726|NCT00115765|3565340|FG003|Overall Study|Lost to Follow-up|1
2001727|NCT00115765|3565337|FG000|Overall Study|Other|6
2001728|NCT00115765|3565338|FG001|Overall Study|Other|12
2001729|NCT00115765|3565339|FG002|Overall Study|Other|9
2001730|NCT00115765|3565340|FG003|Overall Study|Other|2
2001731|NCT00115778|3565348|FG000|Overall Study|Withdrawal by Subject|0
2001732|NCT00115778|3565349|FG001|Overall Study|Withdrawal by Subject|1
2001733|NCT00115804|3565355|FG000|Overall Study|Adverse Event|2
2001734|NCT00115934|3565374|FG000|Overall Study|Lost to Follow-up|1
2001735|NCT00115934|3565375|FG001|Overall Study|Lost to Follow-up|0
2001736|NCT00115934|3565374|FG000|Overall Study|Did not receive intervention|3
2001737|NCT00115934|3565375|FG001|Overall Study|Did not receive intervention|2
2001738|NCT00116168|3565385|FG000|Overall Study|Lost to Follow-up|6
2001739|NCT00116168|3565386|FG001|Overall Study|Lost to Follow-up|5
2001740|NCT00116168|3565387|FG002|Overall Study|Lost to Follow-up|0
2001741|NCT00116168|3565388|FG003|Overall Study|Lost to Follow-up|0
2001742|NCT00116272|3565409|FG000|Overall Study|Lost to Follow-up|11
2001743|NCT00116272|3565410|FG001|Overall Study|Lost to Follow-up|6
2001744|NCT00116428|3565431|FG000|Overall Study|Withdrawal by Subject|2
2001745|NCT00116428|3565432|FG001|Overall Study|Withdrawal by Subject|5
2001746|NCT00116428|3565431|FG000|Overall Study|Did not meet inclusion criteria|1
2001747|NCT00116428|3565432|FG001|Overall Study|Did not meet inclusion criteria|0
2001748|NCT00116558|3565444|FG000|Overall Study|Death|11
2001749|NCT00116558|3565445|FG001|Overall Study|Death|5
2001750|NCT00116558|3565446|FG002|Overall Study|Death|3
2001751|NCT00116558|3565444|FG000|Overall Study|Withdrawal by Subject|17
2001752|NCT00116558|3565445|FG001|Overall Study|Withdrawal by Subject|3
2001753|NCT00116558|3565446|FG002|Overall Study|Withdrawal by Subject|12
2001754|NCT00116558|3565444|FG000|Overall Study|disease progression|3
2001755|NCT00116558|3565445|FG001|Overall Study|disease progression|7
2001756|NCT00116558|3565446|FG002|Overall Study|disease progression|18
2001757|NCT00116584|3565455|FG000|Overall Study|Withdrawal by Subject|1
2001758|NCT00116584|3565456|FG001|Overall Study|Withdrawal by Subject|0
2001759|NCT00116584|3565455|FG000|Overall Study|Protocol Violation|1
2001760|NCT00116584|3565456|FG001|Overall Study|Protocol Violation|1
2001761|NCT00116649|3565462|FG000|Overall Study|Adverse Event|20
2001762|NCT00116649|3565462|FG000|Overall Study|Lack of Efficacy|1
2001763|NCT00116649|3565462|FG000|Overall Study|Lost to Follow-up|32
2001764|NCT00116649|3565462|FG000|Overall Study|Withdrawal by Subject|68
2001765|NCT00116649|3565462|FG000|Overall Study|Local Skin Reaction|9
2001766|NCT00116649|3565462|FG000|Overall Study|Various Reasons|18
2001767|NCT00116649|3565462|FG000|Overall Study|Protocol Specified|7
2001768|NCT00116688|3565468|FG000|Overall Study|Protocol deviation|1
2001769|NCT00116688|3565469|FG001|Overall Study|Protocol deviation|0
2001770|NCT00116688|3565468|FG000|Overall Study|Noncompliance|3
2001771|NCT00116688|3565469|FG001|Overall Study|Noncompliance|1
2001772|NCT00116688|3565468|FG000|Overall Study|Adverse Event|11
2001773|NCT00116688|3565469|FG001|Overall Study|Adverse Event|0
2001774|NCT00116688|3565468|FG000|Overall Study|Withdrawal by Subject|26
2001775|NCT00116688|3565469|FG001|Overall Study|Withdrawal by Subject|2
2001776|NCT00116688|3565468|FG000|Overall Study|Requirement for alternative therapy|11
2001777|NCT00116688|3565469|FG001|Overall Study|Requirement for alternative therapy|1
2001778|NCT00116688|3565468|FG000|Overall Study|Physician Decision|7
2001779|NCT00116688|3565469|FG001|Overall Study|Physician Decision|0
2001780|NCT00116688|3565468|FG000|Overall Study|Lost to Follow-up|3
2001781|NCT00116688|3565469|FG001|Overall Study|Lost to Follow-up|0
2001782|NCT00116688|3565468|FG000|Overall Study|Death|15
2001783|NCT00116688|3565469|FG001|Overall Study|Death|0
2001784|NCT00116688|3565468|FG000|Overall Study|Protocol-specified criteria|3
2001785|NCT00116688|3565469|FG001|Overall Study|Protocol-specified criteria|0
2001786|NCT00116688|3565468|FG000|Overall Study|Pregnancy|1
2001787|NCT00116688|3565469|FG001|Overall Study|Pregnancy|0
2001788|NCT00116688|3565468|FG000|Overall Study|Other|11
2001789|NCT00116688|3565469|FG001|Overall Study|Other|0
2001790|NCT00116753|3565478|FG000|Overall Study|Adverse Event|16
2001791|NCT00116753|3565479|FG001|Overall Study|Adverse Event|10
2001792|NCT00116753|3565480|FG002|Overall Study|Adverse Event|7
2001793|NCT00116753|3565478|FG000|Overall Study|Withdrawal by Subject|11
2001794|NCT00116753|3565479|FG001|Overall Study|Withdrawal by Subject|12
2001795|NCT00116753|3565480|FG002|Overall Study|Withdrawal by Subject|8
2001796|NCT00116753|3565478|FG000|Overall Study|Lost to Follow-up|0
2001797|NCT00116753|3565479|FG001|Overall Study|Lost to Follow-up|2
2001798|NCT00116753|3565480|FG002|Overall Study|Lost to Follow-up|1
2001799|NCT00116753|3565478|FG000|Overall Study|Protocol Violation|0
2001800|NCT00116753|3565479|FG001|Overall Study|Protocol Violation|0
2001801|NCT00116753|3565480|FG002|Overall Study|Protocol Violation|1
2001802|NCT00116753|3565478|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1
2001803|NCT00116753|3565479|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1
2001804|NCT00116753|3565480|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3
2001805|NCT00116753|3565478|FG000|Overall Study|Disease Progression|3
2001806|NCT00116753|3565479|FG001|Overall Study|Disease Progression|4
2001807|NCT00116753|3565480|FG002|Overall Study|Disease Progression|3
2001808|NCT00116753|3565478|FG000|Overall Study|Abnormal Echocardiogram|0
2001809|NCT00116753|3565479|FG001|Overall Study|Abnormal Echocardiogram|0
2001810|NCT00116753|3565480|FG002|Overall Study|Abnormal Echocardiogram|1
2001811|NCT00116753|3565478|FG000|Overall Study|Progressive Parkinson's Disease|1
2001812|NCT00116753|3565479|FG001|Overall Study|Progressive Parkinson's Disease|0
2001813|NCT00116753|3565480|FG002|Overall Study|Progressive Parkinson's Disease|0
2001814|NCT00116753|3565478|FG000|Overall Study|Dosing Error|0
2001815|NCT00116753|3565479|FG001|Overall Study|Dosing Error|1
2001816|NCT00116753|3565480|FG002|Overall Study|Dosing Error|0
2001817|NCT00116779|3565490|FG000|Overall Study|Adverse Event|4
2001818|NCT00116779|3565491|FG001|Overall Study|Adverse Event|2
2001819|NCT00116779|3565490|FG000|Overall Study|Protocol Violation|1
2001820|NCT00116779|3565491|FG001|Overall Study|Protocol Violation|4
2001821|NCT00116779|3565490|FG000|Overall Study|Withdrawal by Subject|4
2001822|NCT00116779|3565491|FG001|Overall Study|Withdrawal by Subject|1
2001823|NCT00116779|3565490|FG000|Overall Study|Inadequate testosterone suppression|7
2001824|NCT00116779|3565491|FG001|Overall Study|Inadequate testosterone suppression|9
2001825|NCT00116779|3565490|FG000|Overall Study|Physician Decision|3
2001826|NCT00116779|3565491|FG001|Overall Study|Physician Decision|1
2001827|NCT00116779|3565490|FG000|Overall Study|Elevated PSA levels|2
2001828|NCT00116779|3565491|FG001|Overall Study|Elevated PSA levels|2
2001829|NCT00116805|3565499|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6
2001830|NCT00116805|3565500|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2
2001831|NCT00116805|3565499|FG000|Double-blind Period Through Week 48|Protocol Violation|1
2001832|NCT00116805|3565500|FG001|Double-blind Period Through Week 48|Protocol Violation|1
2001833|NCT00116805|3565499|FG000|Double-blind Period Through Week 48|Withdrew Consent|4
2001834|NCT00116805|3565500|FG001|Double-blind Period Through Week 48|Withdrew Consent|2
2001835|NCT00116805|3565499|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
2001836|NCT00116805|3565500|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
2001837|NCT00116805|3565499|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
2001838|NCT00116805|3565500|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
2001839|NCT00116805|3565499|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2
2001840|NCT00116805|3565500|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0
2001841|NCT00116805|3565499|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
2001842|NCT00116805|3565500|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
2001843|NCT00116805|3565499|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2
2001844|NCT00116805|3565500|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0
2001845|NCT00116805|3565499|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2
2001846|NCT00116805|3565500|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1
2001847|NCT00116805|3565499|FG000|Open-label Period Weeks 97 - 144|Completed Study|1
2001848|NCT00116805|3565500|FG001|Open-label Period Weeks 97 - 144|Completed Study|0
2001849|NCT00116805|3565499|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
2001850|NCT00116805|3565500|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
2001851|NCT00116805|3565499|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
2001852|NCT00116805|3565500|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
2001853|NCT00116805|3565499|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0
2001854|NCT00116805|3565500|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1
2001855|NCT00116805|3565499|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2
2001856|NCT00116805|3565500|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3
2001857|NCT00116805|3565499|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1
2001858|NCT00116805|3565500|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3
2001859|NCT00116805|3565499|FG000|Open-label Period Weeks 145 - 192|Completed Study|1
2001860|NCT00116805|3565500|FG001|Open-label Period Weeks 145 - 192|Completed Study|1
2001861|NCT00116805|3565499|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
2001862|NCT00116805|3565500|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
2001863|NCT00116805|3565499|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
2001864|NCT00116805|3565500|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
2001865|NCT00116805|3565499|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1
2001866|NCT00116805|3565500|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0
2001867|NCT00116805|3565499|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
2001868|NCT00116805|3565500|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
2001869|NCT00116805|3565499|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0
2001870|NCT00116805|3565500|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1
2001871|NCT00116805|3565499|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3
2001872|NCT00116805|3565500|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2
2001873|NCT00116805|3565499|FG000|Open-label Period Weeks 193 - 240|Completed Study|0
2001874|NCT00116805|3565500|FG001|Open-label Period Weeks 193 - 240|Completed Study|1
2001875|NCT00116805|3565499|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
2001876|NCT00116805|3565500|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
2001877|NCT00116805|3565499|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
2001878|NCT00116805|3565500|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
2001879|NCT00116805|3565499|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
2001880|NCT00116805|3565500|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
2001881|NCT00116805|3565499|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7
2001882|NCT00116805|3565500|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1
2001883|NCT00116805|3565499|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
2001884|NCT00116805|3565500|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
2001885|NCT00116805|3565499|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4
2001886|NCT00116805|3565500|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0
2001887|NCT00116805|3565499|FG000|Open-label Period Weeks 289 - 336|Completed Study|0
2001888|NCT00116805|3565500|FG001|Open-label Period Weeks 289 - 336|Completed Study|1
2001889|NCT00116805|3565499|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
2001890|NCT00116805|3565500|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
2001891|NCT00116805|3565499|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
2001892|NCT00116805|3565500|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
2001893|NCT00116805|3565499|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0
2001894|NCT00116805|3565500|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1
2001895|NCT00116805|3565499|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
2001896|NCT00116805|3565500|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
2001897|NCT00116805|3565499|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
2001898|NCT00116805|3565500|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
2001899|NCT00116805|3565499|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2
2001900|NCT00116805|3565500|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0
2001901|NCT00116805|3565499|FG000|Open-label Period Weeks 337 - 384|Completed Study|1
2001902|NCT00116805|3565500|FG001|Open-label Period Weeks 337 - 384|Completed Study|0
2001903|NCT00116805|3565499|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
2001904|NCT00116805|3565500|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
2001905|NCT00116805|3565499|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
2001906|NCT00116805|3565500|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
2001907|NCT00116805|3565499|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1
2001908|NCT00116805|3565500|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0
2001909|NCT00116805|3565499|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3
2001910|NCT00116805|3565500|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1
2001911|NCT00116805|3565499|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1
2001912|NCT00116805|3565500|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0
2001913|NCT00116805|3565499|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1
2001914|NCT00116805|3565500|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0
2001915|NCT00116805|3565499|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1
2001916|NCT00116805|3565500|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0
2001917|NCT00116805|3565499|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3
2001918|NCT00116805|3565500|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0
2001919|NCT00116831|3565517|FG000|Overall Study|Adverse Event|14
2001920|NCT00116831|3565518|FG001|Overall Study|Adverse Event|16
2001921|NCT00116831|3565517|FG000|Overall Study|Baseline IVUS determined unevaluable|12
2001922|NCT00116831|3565518|FG001|Overall Study|Baseline IVUS determined unevaluable|11
2001923|NCT00116831|3565517|FG000|Overall Study|Lost to Follow-up|8
2001924|NCT00116831|3565518|FG001|Overall Study|Lost to Follow-up|6
2001925|NCT00116831|3565517|FG000|Overall Study|Protocol Violation|3
2001926|NCT00116831|3565518|FG001|Overall Study|Protocol Violation|6
2001927|NCT00116831|3565517|FG000|Overall Study|Hypoglycaemic events|1
2001928|NCT00116831|3565518|FG001|Overall Study|Hypoglycaemic events|0
2001929|NCT00116831|3565517|FG000|Overall Study|Low haemoglobin on screening|1
2001930|NCT00116831|3565518|FG001|Overall Study|Low haemoglobin on screening|0
2001931|NCT00116831|3565517|FG000|Overall Study|Withdrawn investigational product|1
2001932|NCT00116831|3565518|FG001|Overall Study|Withdrawn investigational product|0
2312104|NCT02760654|4017795|FG001|Overall Study|Withdrawal by Subject|3
2312105|NCT02760810|4017801|FG000|Overall Study|Protocol Violation|1
2312106|NCT02760927|4017814|FG000|Overall Study|Tube Slippage from Device|1
2312107|NCT02761330|4017833|FG000|Treatment Week 1|Withdrawal by Subject|0
2001933|NCT00116831|3565517|FG000|Overall Study|Withdrawal by Subject|32
2001934|NCT00116831|3565518|FG001|Overall Study|Withdrawal by Subject|32
2001935|NCT00116831|3565517|FG000|Overall Study|Insufficient therapeutic effect|0
2001936|NCT00116831|3565518|FG001|Overall Study|Insufficient therapeutic effect|1
2001937|NCT00116831|3565517|FG000|Overall Study|Missing data for participant|1
2001938|NCT00116831|3565518|FG001|Overall Study|Missing data for participant|0
2001939|NCT00116844|3565526|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
2001940|NCT00116844|3565527|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
2001941|NCT00116844|3565526|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
2001942|NCT00116844|3565527|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
2001943|NCT00116844|3565526|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
2001944|NCT00116844|3565527|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
2001945|NCT00116844|3565526|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1
2001946|NCT00116844|3565527|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1
2001947|NCT00116844|3565526|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
2001948|NCT00116844|3565527|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
2001949|NCT00116844|3565526|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
2001950|NCT00116844|3565527|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
2001951|NCT00116844|3565526|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0
2001952|NCT00116844|3565527|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2
2001953|NCT00116844|3565526|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
2001954|NCT00116844|3565527|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
2001955|NCT00116844|3565526|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
2001956|NCT00116844|3565527|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
2001957|NCT00117156|3565559|FG000|Overall Study|Adverse Event|9
2001958|NCT00117156|3565559|FG000|Overall Study|Physician Decision|1
2001959|NCT00117156|3565559|FG000|Overall Study|Trt for Pre-Exist Second Primary|1
2001960|NCT00117286|3565565|FG000|Overall Study|Adverse Event|12
2001961|NCT00117286|3565566|FG001|Overall Study|Adverse Event|6
2001962|NCT00117286|3565565|FG000|Overall Study|Lost to Follow-up|2
2001963|NCT00117286|3565566|FG001|Overall Study|Lost to Follow-up|0
2001964|NCT00117286|3565565|FG000|Overall Study|Protocol Violation|3
2001965|NCT00117286|3565566|FG001|Overall Study|Protocol Violation|3
2001966|NCT00117286|3565565|FG000|Overall Study|Withdrawal by Subject|6
2001967|NCT00117286|3565566|FG001|Overall Study|Withdrawal by Subject|2
2001968|NCT00117286|3565565|FG000|Overall Study|Physician Decision|3
2001969|NCT00117286|3565566|FG001|Overall Study|Physician Decision|7
2001970|NCT00117286|3565565|FG000|Overall Study|Lack of Efficacy|2
2001971|NCT00117286|3565566|FG001|Overall Study|Lack of Efficacy|1
2001972|NCT00117286|3565565|FG000|Overall Study|Research site closing|0
2001973|NCT00117286|3565566|FG001|Overall Study|Research site closing|2
2001974|NCT00117312|3565576|FG000|Overall Study|Testosterone >1.0 ng/mL|9
2001975|NCT00117312|3565577|FG001|Overall Study|Testosterone >1.0 ng/mL|9
2001976|NCT00117312|3565578|FG002|Overall Study|Testosterone >1.0 ng/mL|5
2001977|NCT00117312|3565579|FG003|Overall Study|Testosterone >1.0 ng/mL|9
2001978|NCT00117312|3565576|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
2001979|NCT00117312|3565577|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
2001980|NCT00117312|3565578|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
2001981|NCT00117312|3565579|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
2001982|NCT00117312|3565576|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
2001983|NCT00117312|3565577|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
2001984|NCT00117312|3565578|FG002|Overall Study|Prostate-specific antigen increase >=25%|5
2001985|NCT00117312|3565579|FG003|Overall Study|Prostate-specific antigen increase >=25%|3
2001986|NCT00117312|3565576|FG000|Overall Study|Other|0
2001987|NCT00117312|3565577|FG001|Overall Study|Other|1
2001988|NCT00117312|3565578|FG002|Overall Study|Other|3
2001989|NCT00117312|3565579|FG003|Overall Study|Other|1
2001990|NCT00117312|3565576|FG000|Overall Study|Patient choice|0
2001991|NCT00117312|3565577|FG001|Overall Study|Patient choice|0
2001992|NCT00117312|3565578|FG002|Overall Study|Patient choice|2
2001993|NCT00117312|3565579|FG003|Overall Study|Patient choice|1
2001994|NCT00117312|3565576|FG000|Overall Study|Adverse Event|0
2001995|NCT00117312|3565577|FG001|Overall Study|Adverse Event|2
2001996|NCT00117312|3565578|FG002|Overall Study|Adverse Event|0
2001997|NCT00117312|3565579|FG003|Overall Study|Adverse Event|0
2001998|NCT00117312|3565576|FG000|Overall Study|Protocol Violation|0
2001999|NCT00117312|3565577|FG001|Overall Study|Protocol Violation|1
2002000|NCT00117312|3565578|FG002|Overall Study|Protocol Violation|3
2002001|NCT00117312|3565579|FG003|Overall Study|Protocol Violation|0
2002002|NCT00117312|3565576|FG000|Overall Study|PSA decrease <=50%|0
2002003|NCT00117312|3565577|FG001|Overall Study|PSA decrease <=50%|2
2002004|NCT00117312|3565578|FG002|Overall Study|PSA decrease <=50%|2
2002005|NCT00117312|3565579|FG003|Overall Study|PSA decrease <=50%|4
2002006|NCT00117312|3565576|FG000|Overall Study|PSA increase >= 10ng/mL|0
2002007|NCT00117312|3565577|FG001|Overall Study|PSA increase >= 10ng/mL|1
2002008|NCT00117312|3565578|FG002|Overall Study|PSA increase >= 10ng/mL|1
2002009|NCT00117312|3565579|FG003|Overall Study|PSA increase >= 10ng/mL|0
2002010|NCT00117312|3565576|FG000|Overall Study|Hepatic abnormality|0
2002011|NCT00117312|3565577|FG001|Overall Study|Hepatic abnormality|1
2002012|NCT00117312|3565578|FG002|Overall Study|Hepatic abnormality|0
2002013|NCT00117312|3565579|FG003|Overall Study|Hepatic abnormality|1
2002014|NCT00117312|3565576|FG000|Overall Study|Withdrawal by Subject|0
2002015|NCT00117312|3565577|FG001|Overall Study|Withdrawal by Subject|2
2002016|NCT00117312|3565578|FG002|Overall Study|Withdrawal by Subject|0
2002017|NCT00117312|3565579|FG003|Overall Study|Withdrawal by Subject|0
2002018|NCT00117325|3565591|FG000|Overall Study|Adverse Event|3
2002019|NCT00117325|3565592|FG001|Overall Study|Adverse Event|3
2002020|NCT00117325|3565591|FG000|Overall Study|Lost to Follow-up|1
2002021|NCT00117325|3565592|FG001|Overall Study|Lost to Follow-up|1
2002022|NCT00117325|3565591|FG000|Overall Study|Protocol Violation|2
2002023|NCT00117325|3565592|FG001|Overall Study|Protocol Violation|3
2002024|NCT00117325|3565591|FG000|Overall Study|Withdrawal by Subject|3
2002025|NCT00117325|3565592|FG001|Overall Study|Withdrawal by Subject|2
2002026|NCT00117325|3565591|FG000|Overall Study|Lack of Efficacy|1
2002027|NCT00117325|3565592|FG001|Overall Study|Lack of Efficacy|0
2002028|NCT00117325|3565591|FG000|Overall Study|Use of prohibited medicine|1
2002029|NCT00117325|3565592|FG001|Overall Study|Use of prohibited medicine|2
2002030|NCT00117325|3565591|FG000|Overall Study|Early termination|1
2002031|NCT00117325|3565592|FG001|Overall Study|Early termination|1
2002032|NCT00117325|3565591|FG000|Overall Study|Admisnitrative|1
2002033|NCT00117325|3565592|FG001|Overall Study|Admisnitrative|0
2002034|NCT00117507|3565599|FG000|Overall Study|Adverse Event|4
2002035|NCT00117507|3565599|FG000|Overall Study|Abnormal laboratory values|3
2002036|NCT00117507|3565599|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2002037|NCT00117507|3565599|FG000|Overall Study|Patient withdrew consent|4
2002038|NCT00117507|3565599|FG000|Overall Study|Death|3
2002039|NCT00117572|3565615|FG000|Overall Study|Site withdrew before starting treatment|2
2002040|NCT00117572|3565616|FG001|Overall Study|Site withdrew before starting treatment|3
2002041|NCT00117572|3565615|FG000|Overall Study|Withdrawal by Subject|3
2002042|NCT00117572|3565616|FG001|Overall Study|Withdrawal by Subject|3
2002043|NCT00117572|3565615|FG000|Overall Study|Protocol Violation|1
2002044|NCT00117572|3565616|FG001|Overall Study|Protocol Violation|0
2002045|NCT00117598|3565629|FG000|Prior to Treatment Cross Over|Death|40
2002046|NCT00117598|3565630|FG001|Prior to Treatment Cross Over|Death|41
2002047|NCT00117598|3565631|FG002|Prior to Treatment Cross Over|Death|37
2002048|NCT00117598|3565632|FG003|Prior to Treatment Cross Over|Death|0
2002049|NCT00117598|3565633|FG004|Prior to Treatment Cross Over|Death|0
2002050|NCT00117598|3565629|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0
2002051|NCT00117598|3565630|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2
2002052|NCT00117598|3565631|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2
2002053|NCT00117598|3565632|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0
2002054|NCT00117598|3565633|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0
2002055|NCT00117598|3565629|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2
2002056|NCT00117598|3565630|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1
2002057|NCT00117598|3565631|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4
2002058|NCT00117598|3565632|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0
2002059|NCT00117598|3565633|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0
2002060|NCT00117598|3565629|FG000|Prior to Treatment Cross Over|Other|15
2002061|NCT00117598|3565630|FG001|Prior to Treatment Cross Over|Other|9
2002062|NCT00117598|3565631|FG002|Prior to Treatment Cross Over|Other|9
2002063|NCT00117598|3565632|FG003|Prior to Treatment Cross Over|Other|0
2002064|NCT00117598|3565633|FG004|Prior to Treatment Cross Over|Other|0
2002065|NCT00117598|3565629|FG000|After Treament Cross Over|Death|0
2002066|NCT00117598|3565630|FG001|After Treament Cross Over|Death|0
2002067|NCT00117598|3565631|FG002|After Treament Cross Over|Death|0
2002068|NCT00117598|3565632|FG003|After Treament Cross Over|Death|1
2002069|NCT00117598|3565633|FG004|After Treament Cross Over|Death|2
2002070|NCT00117598|3565629|FG000|After Treament Cross Over|Withdrawal by Subject|0
2002071|NCT00117598|3565630|FG001|After Treament Cross Over|Withdrawal by Subject|0
2002072|NCT00117598|3565631|FG002|After Treament Cross Over|Withdrawal by Subject|0
2002073|NCT00117598|3565632|FG003|After Treament Cross Over|Withdrawal by Subject|1
2002074|NCT00117598|3565633|FG004|After Treament Cross Over|Withdrawal by Subject|0
2002075|NCT00117598|3565629|FG000|After Treament Cross Over|Other|0
2002076|NCT00117598|3565630|FG001|After Treament Cross Over|Other|0
2002077|NCT00117598|3565631|FG002|After Treament Cross Over|Other|0
2002078|NCT00117598|3565632|FG003|After Treament Cross Over|Other|1
2002079|NCT00117598|3565633|FG004|After Treament Cross Over|Other|2
2002080|NCT00117637|3565645|FG000|First Intervention (Period 1)|Adverse Event|11
2002081|NCT00117637|3565646|FG001|First Intervention (Period 1)|Adverse Event|16
2002082|NCT00117637|3565645|FG000|First Intervention (Period 1)|Lost to Follow-up|0
2002083|NCT00117637|3565646|FG001|First Intervention (Period 1)|Lost to Follow-up|2
2002084|NCT00117637|3565645|FG000|First Intervention (Period 1)|Protocol Violation|1
2002085|NCT00117637|3565646|FG001|First Intervention (Period 1)|Protocol Violation|0
2002086|NCT00117637|3565645|FG000|First Intervention (Period 1)|Withdrawal by Subject|2
2002087|NCT00117637|3565646|FG001|First Intervention (Period 1)|Withdrawal by Subject|4
2002088|NCT00117637|3565645|FG000|First Intervention (Period 1)|study terminated by the sponsor|3
2002089|NCT00117637|3565646|FG001|First Intervention (Period 1)|study terminated by the sponsor|1
2002090|NCT00117637|3565645|FG000|First Intervention (Period 1)|protocol driven decision point|1
2002091|NCT00117637|3565646|FG001|First Intervention (Period 1)|protocol driven decision point|0
2002092|NCT00117637|3565645|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0
2002093|NCT00117637|3565646|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1
2002094|NCT00117637|3565645|FG000|First Intervention (Period 1)|reason not reported|0
2002095|NCT00117637|3565646|FG001|First Intervention (Period 1)|reason not reported|1
2002096|NCT00117637|3565645|FG000|Second Intervention (Period 2)|Adverse Event|0
2002097|NCT00117637|3565646|FG001|Second Intervention (Period 2)|Adverse Event|9
2002098|NCT00117637|3565645|FG000|Second Intervention (Period 2)|Lost to Follow-up|1
2002099|NCT00117637|3565646|FG001|Second Intervention (Period 2)|Lost to Follow-up|0
2002100|NCT00117637|3565645|FG000|Second Intervention (Period 2)|Protocol Violation|1
2002101|NCT00117637|3565646|FG001|Second Intervention (Period 2)|Protocol Violation|0
2002102|NCT00117637|3565645|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4
2002103|NCT00117637|3565646|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3
2002104|NCT00117637|3565645|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2
2002105|NCT00117637|3565646|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9
2002106|NCT00117637|3565645|FG000|Second Intervention (Period 2)|non compliant with study medication|1
2002107|NCT00117637|3565646|FG001|Second Intervention (Period 2)|non compliant with study medication|1
2002108|NCT00117637|3565645|FG000|Second Intervention (Period 2)|reason not reported|1
2002109|NCT00117637|3565646|FG001|Second Intervention (Period 2)|reason not reported|0
2024934|NCT00337935|3593530|FG000|Overall Study|Death|2
2024935|NCT00337935|3593531|FG001|Overall Study|Death|8
2024936|NCT00337935|3593530|FG000|Overall Study|Physician Decision|1
2024937|NCT00337935|3593531|FG001|Overall Study|Physician Decision|1
2024938|NCT00337935|3593530|FG000|Overall Study|Lost to Follow-up|0
2024939|NCT00337935|3593531|FG001|Overall Study|Lost to Follow-up|1
2024940|NCT00337935|3593530|FG000|Overall Study|Protocol Violation|4
2024941|NCT00337935|3593531|FG001|Overall Study|Protocol Violation|3
2024942|NCT00337935|3593530|FG000|Overall Study|Withdrawal by Subject|1
2024943|NCT00337935|3593531|FG001|Overall Study|Withdrawal by Subject|7
2024944|NCT00337935|3593530|FG000|Overall Study|Other|0
2024945|NCT00337935|3593531|FG001|Overall Study|Other|1
2024946|NCT00337935|3593530|FG000|Overall Study|Lack of Efficacy|0
2024947|NCT00337935|3593531|FG001|Overall Study|Lack of Efficacy|1
2024948|NCT00338286|3593548|FG000|Overall Study|Withdrawal by Subject|50
2024949|NCT00338286|3593549|FG001|Overall Study|Withdrawal by Subject|54
2024950|NCT00338286|3593548|FG000|Overall Study|Lost to Follow-up|80
2024951|NCT00338286|3593549|FG001|Overall Study|Lost to Follow-up|66
2024952|NCT00338286|3593548|FG000|Overall Study|Other|103
2024953|NCT00338286|3593549|FG001|Overall Study|Other|93
2024954|NCT00338728|3593564|FG000|Overall Study|Screen Failure|14
2024955|NCT00338741|3593570|FG000|Overall Study|Lost to Follow-up|2
2024956|NCT00338741|3593571|FG001|Overall Study|Lost to Follow-up|0
2024957|NCT00338806|3593579|FG000|Acute Phase|Withdrawal by Subject|0
2024958|NCT00338806|3593580|FG001|Acute Phase|Withdrawal by Subject|1
2024959|NCT00338806|3593579|FG000|Follow-up|Lost to Follow-up|1
2024960|NCT00338806|3593580|FG001|Follow-up|Lost to Follow-up|3
2024961|NCT00338884|3593588|FG000|Overall Study|Objective Disease Progression or Relapse|44
2024962|NCT00338884|3593588|FG000|Overall Study|Adverse Event|14
2024963|NCT00338884|3593588|FG000|Overall Study|Death|8
2024964|NCT00338884|3593588|FG000|Overall Study|Other|4
2024965|NCT00338884|3593588|FG000|Overall Study|Global Deterioration of Health Status|3
2024966|NCT00338884|3593588|FG000|Overall Study|Withdrawal by Subject|3
2024967|NCT00338884|3593588|FG000|Overall Study|Lost to Follow-up|1
2024968|NCT00338884|3593588|FG000|Overall Study|Randomized But Did Not Receive Treatment|1
2024969|NCT00338949|3593594|FG000|Subject Screening|Screen failures|11
2024970|NCT00338949|3593595|FG001|Subject Screening|Screen failures|11
2024971|NCT00338949|3593594|FG000|Randomization|Withdrawal by Subject|1
2024972|NCT00338949|3593595|FG001|Randomization|Withdrawal by Subject|0
2024973|NCT00338949|3593594|FG000|Randomization|Adverse Event|0
2024974|NCT00338949|3593595|FG001|Randomization|Adverse Event|5
2024975|NCT00338962|3593605|FG000|Overall Study|Lost to Follow-up|3
2024976|NCT00338962|3593606|FG001|Overall Study|Lost to Follow-up|3
2024977|NCT00338962|3593607|FG002|Overall Study|Lost to Follow-up|2
2024978|NCT00338962|3593608|FG003|Overall Study|Lost to Follow-up|3
2024979|NCT00338962|3593605|FG000|Overall Study|Withdrawal by Subject|1
2024980|NCT00338962|3593606|FG001|Overall Study|Withdrawal by Subject|0
2024981|NCT00338962|3593607|FG002|Overall Study|Withdrawal by Subject|0
2024982|NCT00338962|3593608|FG003|Overall Study|Withdrawal by Subject|0
2024983|NCT00338962|3593605|FG000|Overall Study|No Transportation|2
2024984|NCT00338962|3593606|FG001|Overall Study|No Transportation|0
2024985|NCT00338962|3593607|FG002|Overall Study|No Transportation|0
2024986|NCT00338962|3593608|FG003|Overall Study|No Transportation|0
2214042|NCT01684202|3856052|FG002|Dose-escalation Period|Adverse Event|0
2312108|NCT02761330|4017834|FG001|Treatment Week 1|Withdrawal by Subject|0
2024987|NCT00338962|3593605|FG000|Overall Study|Time Constraint|2
2024988|NCT00338962|3593606|FG001|Overall Study|Time Constraint|0
2024989|NCT00338962|3593607|FG002|Overall Study|Time Constraint|0
2024990|NCT00338962|3593608|FG003|Overall Study|Time Constraint|0
2024991|NCT00338962|3593605|FG000|Overall Study|Moved|0
2024992|NCT00338962|3593606|FG001|Overall Study|Moved|1
2024993|NCT00338962|3593607|FG002|Overall Study|Moved|0
2024994|NCT00338962|3593608|FG003|Overall Study|Moved|0
2024995|NCT00338962|3593605|FG000|Overall Study|Adverse Event|0
2002110|NCT00117676|3565661|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4
2002111|NCT00117676|3565662|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3
2002112|NCT00117676|3565661|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1
2002113|NCT00117676|3565662|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0
2002114|NCT00117676|3565661|FG000|Double-blind Period Through Week 48|Protocol Violation|0
2002115|NCT00117676|3565662|FG001|Double-blind Period Through Week 48|Protocol Violation|1
2002116|NCT00117676|3565661|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
2002117|NCT00117676|3565662|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
2002118|NCT00117676|3565661|FG000|Double-blind Period Through Week 48|Withdrew Consent|0
2002119|NCT00117676|3565662|FG001|Double-blind Period Through Week 48|Withdrew Consent|1
2002120|NCT00117676|3565661|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
2002121|NCT00117676|3565662|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
2002122|NCT00117676|3565661|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
2002123|NCT00117676|3565662|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
2002124|NCT00117676|3565661|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
2002125|NCT00117676|3565662|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
2002126|NCT00117676|3565661|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
2002127|NCT00117676|3565662|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
2002128|NCT00117676|3565661|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
2002129|NCT00117676|3565662|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
2002130|NCT00117676|3565661|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
2002131|NCT00117676|3565662|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
2002132|NCT00117676|3565661|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
2002133|NCT00117676|3565662|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
2002134|NCT00117676|3565661|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
2002135|NCT00117676|3565662|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
2002136|NCT00117676|3565661|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
2002137|NCT00117676|3565662|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
2002138|NCT00117676|3565661|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
2002139|NCT00117676|3565662|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
2002140|NCT00117676|3565661|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
2002141|NCT00117676|3565662|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
2002142|NCT00117676|3565661|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
2002143|NCT00117676|3565662|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
2002144|NCT00117676|3565661|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
2002145|NCT00117676|3565662|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
2002146|NCT00117676|3565661|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
2002147|NCT00117676|3565662|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
2002148|NCT00117676|3565661|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
2002149|NCT00117676|3565662|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
2002150|NCT00117676|3565661|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2
2002151|NCT00117676|3565662|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0
2002152|NCT00117676|3565661|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
2002153|NCT00117676|3565662|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
2002154|NCT00117676|3565661|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
2312109|NCT02761330|4017835|FG002|Treatment Week 1|Withdrawal by Subject|0
2312110|NCT02761330|4017836|FG003|Treatment Week 1|Withdrawal by Subject|1
2312111|NCT02761330|4017837|FG004|Treatment Week 1|Withdrawal by Subject|0
2312112|NCT02761330|4017838|FG005|Treatment Week 1|Withdrawal by Subject|1
2312113|NCT02761629|4017854|FG000|Overall Study|Adverse Event/Intercurrent Illness|7
2312114|NCT02761629|4017855|FG001|Overall Study|Adverse Event/Intercurrent Illness|5
2312115|NCT02761629|4017854|FG000|Overall Study|Insufficient Therapeutic Response|2
2312116|NCT02761629|4017855|FG001|Overall Study|Insufficient Therapeutic Response|7
2312117|NCT02761629|4017854|FG000|Overall Study|Failure to Return|2
2312118|NCT02761629|4017855|FG001|Overall Study|Failure to Return|4
2312119|NCT02761629|4017854|FG000|Overall Study|Did not Cooperate/Refused Treatment|2
2312120|NCT02761629|4017855|FG001|Overall Study|Did not Cooperate/Refused Treatment|4
2312121|NCT02761629|4017854|FG000|Overall Study|Protocol Violation|2
2312122|NCT02761629|4017855|FG001|Overall Study|Protocol Violation|2
2312123|NCT02761629|4017854|FG000|Overall Study|Withdrawal by Subject|0
2312124|NCT02761629|4017855|FG001|Overall Study|Withdrawal by Subject|3
2312125|NCT02761629|4017854|FG000|Overall Study|Other|0
2312126|NCT02761629|4017855|FG001|Overall Study|Other|2
2312127|NCT02761629|4017854|FG000|Overall Study|Lost to Follow-up|4
2312128|NCT02761629|4017855|FG001|Overall Study|Lost to Follow-up|1
2312129|NCT02761629|4017854|FG000|Overall Study|Randomized But Not Treated|8
2312130|NCT02761629|4017855|FG001|Overall Study|Randomized But Not Treated|4
2312131|NCT02761642|4017861|FG000|Overall Study|Did not Receive Study Treatment|3
2312132|NCT02761642|4017861|FG000|Overall Study|Adverse Event|13
2312133|NCT02761642|4017861|FG000|Overall Study|Withdrawal by Subject|2
2312134|NCT02761642|4017861|FG000|Overall Study|Non-compliant|7
2002155|NCT00117676|3565662|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
2002156|NCT00117676|3565661|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
2002157|NCT00117676|3565662|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
2002158|NCT00117676|3565661|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
2002159|NCT00117676|3565662|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
2002160|NCT00117676|3565661|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
2002161|NCT00117676|3565662|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
2002162|NCT00117676|3565661|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
2002163|NCT00117676|3565662|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
2002164|NCT00117676|3565661|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
2002165|NCT00117676|3565662|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
2002166|NCT00117676|3565661|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
2002167|NCT00117676|3565662|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
2002168|NCT00117676|3565661|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
2002169|NCT00117676|3565662|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
2002170|NCT00117676|3565661|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0
2002171|NCT00117676|3565662|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1
2002172|NCT00117676|3565661|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
2002173|NCT00117676|3565662|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
2002174|NCT00117676|3565661|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
2002175|NCT00117676|3565662|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
2002176|NCT00117676|3565661|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
2002177|NCT00117676|3565662|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
2002178|NCT00117676|3565661|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
2002179|NCT00117676|3565662|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
2002180|NCT00117793|3565677|FG000|Overall Study|Withdrawal by Subject|12
2002181|NCT00117845|3565694|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1
2002182|NCT00117949|3565702|FG000|Overall Study|Testosterone >1.0 ng/mL|10
2002183|NCT00117949|3565703|FG001|Overall Study|Testosterone >1.0 ng/mL|18
2002184|NCT00117949|3565704|FG002|Overall Study|Testosterone >1.0 ng/mL|17
2002185|NCT00117949|3565705|FG003|Overall Study|Testosterone >1.0 ng/mL|15
2002186|NCT00117949|3565702|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
2002187|NCT00117949|3565703|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
2002188|NCT00117949|3565704|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
2002189|NCT00117949|3565705|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
2002190|NCT00117949|3565702|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
2002191|NCT00117949|3565703|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
2002192|NCT00117949|3565704|FG002|Overall Study|Prostate-specific antigen increase >=25%|1
2002193|NCT00117949|3565705|FG003|Overall Study|Prostate-specific antigen increase >=25%|2
2002194|NCT00117949|3565702|FG000|Overall Study|PSA increase >=10ng/mL|0
2002195|NCT00117949|3565703|FG001|Overall Study|PSA increase >=10ng/mL|1
2002196|NCT00117949|3565704|FG002|Overall Study|PSA increase >=10ng/mL|1
2002197|NCT00117949|3565705|FG003|Overall Study|PSA increase >=10ng/mL|0
2002198|NCT00117949|3565702|FG000|Overall Study|PSA reduction <=50%|0
2002199|NCT00117949|3565703|FG001|Overall Study|PSA reduction <=50%|2
2002200|NCT00117949|3565704|FG002|Overall Study|PSA reduction <=50%|2
2002201|NCT00117949|3565705|FG003|Overall Study|PSA reduction <=50%|4
2002202|NCT00117949|3565702|FG000|Overall Study|Hepatic abnormalities|0
2002203|NCT00117949|3565703|FG001|Overall Study|Hepatic abnormalities|1
2002204|NCT00117949|3565704|FG002|Overall Study|Hepatic abnormalities|0
2002205|NCT00117949|3565705|FG003|Overall Study|Hepatic abnormalities|1
2002206|NCT00117988|3565724|FG000|Overall Study|Death|3
2002207|NCT00117988|3565724|FG000|Overall Study|Adverse Event|1
2002208|NCT00118040|3565731|FG000|Overall Study|Adverse Event|0
2002209|NCT00118040|3565732|FG001|Overall Study|Adverse Event|1
2002210|NCT00118040|3565733|FG002|Overall Study|Adverse Event|0
2002211|NCT00118040|3565731|FG000|Overall Study|Withdrawal by Subject|0
2002212|NCT00118040|3565732|FG001|Overall Study|Withdrawal by Subject|0
2002213|NCT00118040|3565733|FG002|Overall Study|Withdrawal by Subject|2
2002214|NCT00118040|3565731|FG000|Overall Study|Medical Contraindication|0
2002215|NCT00118040|3565732|FG001|Overall Study|Medical Contraindication|0
2002216|NCT00118040|3565733|FG002|Overall Study|Medical Contraindication|1
2002217|NCT00118040|3565731|FG000|Overall Study|Non-Compliant Participant|1
2002218|NCT00118040|3565732|FG001|Overall Study|Non-Compliant Participant|1
2002219|NCT00118040|3565733|FG002|Overall Study|Non-Compliant Participant|2
2002220|NCT00118040|3565731|FG000|Overall Study|Other|0
2002221|NCT00118040|3565732|FG001|Overall Study|Other|0
2002222|NCT00118040|3565733|FG002|Overall Study|Other|1
2002223|NCT00118092|3565746|FG000|Overall Study|Withdrawal by Subject|1
2002224|NCT00118092|3565746|FG000|Overall Study|Protocol Violation|1
2002225|NCT00118157|3565760|FG000|Overall Study|Adverse Event|2
2002226|NCT00118157|3565760|FG000|Overall Study|Death|8
2002227|NCT00118157|3565760|FG000|Overall Study|Withdrawal by Subject|2
2002228|NCT00118287|3565799|FG000|Overall Study|Intracranial haemorrhage|1
2002229|NCT00118287|3565799|FG000|Overall Study|Muscle pain|1
2002230|NCT00118417|3565879|FG000|Phase I (Weeks 0 to 6)|Remission|8
2002231|NCT00118417|3565880|FG001|Phase I (Weeks 0 to 6)|Remission|0
2002232|NCT00118417|3565879|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
2002233|NCT00118417|3565880|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
2002234|NCT00118417|3565879|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
2002235|NCT00118417|3565880|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
2002236|NCT00118417|3565879|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
2002237|NCT00118417|3565880|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
2002238|NCT00118417|3565879|FG000|Phase II (Weeks 6 to 12)|Remission|1
2002239|NCT00118417|3565880|FG001|Phase II (Weeks 6 to 12)|Remission|2
2002240|NCT00118430|3565893|FG000|Overall Study|Withdrawal by Subject|6
2002241|NCT00118430|3565894|FG001|Overall Study|Withdrawal by Subject|2
2002242|NCT00118430|3565895|FG002|Overall Study|Withdrawal by Subject|0
2002243|NCT00118430|3565893|FG000|Overall Study|Lost to Follow-up|15
2002244|NCT00118430|3565894|FG001|Overall Study|Lost to Follow-up|22
2002245|NCT00118430|3565895|FG002|Overall Study|Lost to Follow-up|28
2002246|NCT00118482|3565904|FG000|Overall Study|Lost to Follow-up|7
2002247|NCT00118482|3565905|FG001|Overall Study|Lost to Follow-up|7
2002248|NCT00118482|3565904|FG000|Overall Study|Withdrawal by Subject|23
2002249|NCT00118482|3565905|FG001|Overall Study|Withdrawal by Subject|22
2002250|NCT00118703|3565923|FG000|Overall Study|Protocol Violation|1
2002251|NCT00118703|3565924|FG001|Overall Study|Protocol Violation|0
2002252|NCT00118703|3565923|FG000|Overall Study|Adverse Event|1
2002253|NCT00118703|3565924|FG001|Overall Study|Adverse Event|1
2002254|NCT00118703|3565923|FG000|Overall Study|Participant took two different treatment|0
2002255|NCT00118703|3565924|FG001|Overall Study|Participant took two different treatment|1
2002256|NCT00118703|3565923|FG000|Overall Study|Withdrawal by Subject|2
2002257|NCT00118703|3565924|FG001|Overall Study|Withdrawal by Subject|5
2002258|NCT00118703|3565923|FG000|Overall Study|Lost to Follow-up|1
2002259|NCT00118703|3565924|FG001|Overall Study|Lost to Follow-up|2
2002260|NCT00118716|3565932|FG000|Overall Study|Adverse Event|2
2002261|NCT00118716|3565933|FG001|Overall Study|Adverse Event|7
2002262|NCT00118716|3565932|FG000|Overall Study|Protocol Violation|5
2002263|NCT00118716|3565933|FG001|Overall Study|Protocol Violation|4
2002264|NCT00118716|3565932|FG000|Overall Study|Withdrawal by Subject|0
2002265|NCT00118716|3565933|FG001|Overall Study|Withdrawal by Subject|1
2002266|NCT00118716|3565932|FG000|Overall Study|Exacerbation|2
2002267|NCT00118716|3565933|FG001|Overall Study|Exacerbation|2
2002268|NCT00118716|3565932|FG000|Overall Study|Discontinued by sponsor|1
2002269|NCT00118716|3565933|FG001|Overall Study|Discontinued by sponsor|1
2002270|NCT00118716|3565932|FG000|Overall Study|Non-compliance|1
2002271|NCT00118716|3565933|FG001|Overall Study|Non-compliance|3
2002272|NCT00118716|3565932|FG000|Overall Study|misrandomized|1
2002273|NCT00118716|3565933|FG001|Overall Study|misrandomized|1
2002274|NCT00118716|3565932|FG000|Overall Study|Expired drug use|1
2002275|NCT00118716|3565933|FG001|Overall Study|Expired drug use|2
2002276|NCT00118716|3565932|FG000|Overall Study|Investigator discretion|0
2002277|NCT00118716|3565933|FG001|Overall Study|Investigator discretion|1
2002278|NCT00118898|3565961|FG000|Overall Study|Death|6
2002279|NCT00118898|3565962|FG001|Overall Study|Death|11
2002280|NCT00118898|3565963|FG002|Overall Study|Death|6
2002281|NCT00118898|3565964|FG003|Overall Study|Death|8
2002282|NCT00118898|3565961|FG000|Overall Study|Lost to Follow-up|26
2002283|NCT00118898|3565962|FG001|Overall Study|Lost to Follow-up|34
2002284|NCT00118898|3565963|FG002|Overall Study|Lost to Follow-up|33
2002285|NCT00118898|3565964|FG003|Overall Study|Lost to Follow-up|33
2002286|NCT00118898|3565961|FG000|Overall Study|Withdrawal by Subject|10
2002287|NCT00118898|3565962|FG001|Overall Study|Withdrawal by Subject|5
2002288|NCT00118898|3565963|FG002|Overall Study|Withdrawal by Subject|8
2002289|NCT00118898|3565964|FG003|Overall Study|Withdrawal by Subject|8
2002290|NCT00118898|3565961|FG000|Overall Study|Site Closure|33
2002291|NCT00118898|3565962|FG001|Overall Study|Site Closure|31
2002292|NCT00118898|3565963|FG002|Overall Study|Site Closure|28
2002293|NCT00118898|3565964|FG003|Overall Study|Site Closure|37
2002294|NCT00118898|3565961|FG000|Overall Study|Severe debilitation|1
2002295|NCT00118898|3565962|FG001|Overall Study|Severe debilitation|4
2002296|NCT00118898|3565963|FG002|Overall Study|Severe debilitation|6
2002297|NCT00118898|3565964|FG003|Overall Study|Severe debilitation|4
2002298|NCT00118898|3565961|FG000|Overall Study|Not compliant with requirements|11
2002299|NCT00118898|3565962|FG001|Overall Study|Not compliant with requirements|13
2002300|NCT00118898|3565963|FG002|Overall Study|Not compliant with requirements|11
2002301|NCT00118898|3565964|FG003|Overall Study|Not compliant with requirements|11
2002302|NCT00118898|3565961|FG000|Overall Study|Not able to get to clinic|34
2002303|NCT00118898|3565962|FG001|Overall Study|Not able to get to clinic|43
2002304|NCT00118898|3565963|FG002|Overall Study|Not able to get to clinic|31
2002305|NCT00118898|3565964|FG003|Overall Study|Not able to get to clinic|40
2002306|NCT00118911|3565976|FG000|Overall Study|Withdrawal by Subject|2
2002307|NCT00118911|3565977|FG001|Overall Study|Withdrawal by Subject|5
2002308|NCT00119015|3565985|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
2002309|NCT00119015|3565986|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
2002310|NCT00119015|3565987|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
2002311|NCT00119106|3566009|FG000|Overall Study|HIV infected at baseline|179
2002312|NCT00119106|3566010|FG001|Overall Study|HIV infected at baseline|178
2002313|NCT00119262|3566035|FG000|Overall Study|Lack of Efficacy|0
2002314|NCT00119262|3566036|FG001|Overall Study|Lack of Efficacy|3
2002315|NCT00119262|3566035|FG000|Overall Study|Withdrawal by Subject|12
2002316|NCT00119262|3566036|FG001|Overall Study|Withdrawal by Subject|11
2002317|NCT00119262|3566035|FG000|Overall Study|Adverse Event|33
2002318|NCT00119262|3566036|FG001|Overall Study|Adverse Event|35
2002319|NCT00119262|3566035|FG000|Overall Study|other disease|0
2002320|NCT00119262|3566036|FG001|Overall Study|other disease|2
2002321|NCT00119262|3566035|FG000|Overall Study|ineligble|1
2002322|NCT00119262|3566036|FG001|Overall Study|ineligble|2
2002323|NCT00119262|3566035|FG000|Overall Study|others|0
2002324|NCT00119262|3566036|FG001|Overall Study|others|5
2002325|NCT00119379|3566044|FG000|Overall Study|Adverse Event|4
2002326|NCT00119379|3566045|FG001|Overall Study|Adverse Event|1
2002327|NCT00119405|3566055|FG000|Overall Study|Withdrawal by Subject|1
2002328|NCT00119678|3566061|FG000|Double-blind Treatment Period|Death|1
2002329|NCT00119678|3566062|FG001|Double-blind Treatment Period|Death|0
2002330|NCT00119678|3566061|FG000|Double-blind Treatment Period|Adverse Event|7
2002331|NCT00119678|3566062|FG001|Double-blind Treatment Period|Adverse Event|1
2002332|NCT00119678|3566061|FG000|Double-blind Treatment Period|Lack of Efficacy|21
2002333|NCT00119678|3566062|FG001|Double-blind Treatment Period|Lack of Efficacy|12
2002334|NCT00119678|3566061|FG000|Double-blind Treatment Period|Lost to Follow-up|1
2002335|NCT00119678|3566062|FG001|Double-blind Treatment Period|Lost to Follow-up|2
2002336|NCT00119678|3566061|FG000|Double-blind Treatment Period|Participant withdrew consent|4
2002337|NCT00119678|3566062|FG001|Double-blind Treatment Period|Participant withdrew consent|4
2002338|NCT00119678|3566061|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0
2002339|NCT00119678|3566062|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1
2002340|NCT00119678|3566061|FG000|Double-blind Treatment Period|Poor/Non-compliance|3
2002341|NCT00119678|3566062|FG001|Double-blind Treatment Period|Poor/Non-compliance|0
2002342|NCT00119678|3566061|FG000|Double-blind Treatment Period|Pregnancy|0
2002343|NCT00119678|3566062|FG001|Double-blind Treatment Period|Pregnancy|2
2002344|NCT00119678|3566061|FG000|Double-blind Treatment Period|Not treated|1
2002345|NCT00119678|3566062|FG001|Double-blind Treatment Period|Not treated|2
2002346|NCT00119678|3566061|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3
2002347|NCT00119678|3566062|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2
2002348|NCT00119678|3566061|FG000|Open-label Treatment Period|Death|1
2002349|NCT00119678|3566062|FG001|Open-label Treatment Period|Death|0
2002350|NCT00119678|3566061|FG000|Open-label Treatment Period|Adverse Event|3
2002351|NCT00119678|3566062|FG001|Open-label Treatment Period|Adverse Event|0
2002352|NCT00119678|3566061|FG000|Open-label Treatment Period|Lack of Efficacy|9
2002353|NCT00119678|3566062|FG001|Open-label Treatment Period|Lack of Efficacy|0
2002354|NCT00119678|3566061|FG000|Open-label Treatment Period|Lost to Follow-up|3
2002355|NCT00119678|3566062|FG001|Open-label Treatment Period|Lost to Follow-up|0
2002356|NCT00119678|3566061|FG000|Open-label Treatment Period|Participant withdrew consent|4
2002357|NCT00119678|3566062|FG001|Open-label Treatment Period|Participant withdrew consent|0
2002358|NCT00119678|3566061|FG000|Open-label Treatment Period|Participants not meeting study criteria|2
2002359|NCT00119678|3566062|FG001|Open-label Treatment Period|Participants not meeting study criteria|0
2002360|NCT00119678|3566061|FG000|Open-label Treatment Period|Pregnancy|1
2002361|NCT00119678|3566062|FG001|Open-label Treatment Period|Pregnancy|0
2002362|NCT00119678|3566061|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87
2002363|NCT00119678|3566062|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0
2002364|NCT00120250|3566079|FG000|Overall Study|Lost to Follow-up|1
2002365|NCT00120250|3566080|FG001|Overall Study|Lost to Follow-up|1
2002366|NCT00120250|3566079|FG000|Overall Study|Protocol Violation|0
2002367|NCT00120250|3566080|FG001|Overall Study|Protocol Violation|1
2002368|NCT00120289|3566089|FG000|Overall Study|Death|96
2002369|NCT00120289|3566090|FG001|Overall Study|Death|82
2002370|NCT00120289|3566089|FG000|Overall Study|Lost to Follow-up|11
2002371|NCT00120289|3566090|FG001|Overall Study|Lost to Follow-up|14
2002372|NCT00120289|3566089|FG000|Overall Study|Withdrawal by Subject|14
2002373|NCT00120289|3566090|FG001|Overall Study|Withdrawal by Subject|13
2002374|NCT00120406|3566098|FG000|Overall Study|Death|9
2002375|NCT00120406|3566099|FG001|Overall Study|Death|4
2002376|NCT00120406|3566098|FG000|Overall Study|Withdrawal by Subject|5
2002377|NCT00120406|3566099|FG001|Overall Study|Withdrawal by Subject|7
2214043|NCT01684202|3856053|FG003|Dose-escalation Period|Adverse Event|0
2214044|NCT01684202|3856050|FG000|Dose-escalation Period|Withdrawal by Subject|1
2214045|NCT01684202|3856051|FG001|Dose-escalation Period|Withdrawal by Subject|0
2214046|NCT01684202|3856052|FG002|Dose-escalation Period|Withdrawal by Subject|0
2214047|NCT01684202|3856053|FG003|Dose-escalation Period|Withdrawal by Subject|0
2214048|NCT01684202|3856050|FG000|Maintenance Period|Adverse Event|1
2214049|NCT01684202|3856051|FG001|Maintenance Period|Adverse Event|1
2214050|NCT01684202|3856052|FG002|Maintenance Period|Adverse Event|1
2214051|NCT01684202|3856053|FG003|Maintenance Period|Adverse Event|1
2214052|NCT01684202|3856050|FG000|Maintenance Period|Physician Decision|0
2214053|NCT01684202|3856051|FG001|Maintenance Period|Physician Decision|1
2214054|NCT01684202|3856052|FG002|Maintenance Period|Physician Decision|0
2214055|NCT01684202|3856053|FG003|Maintenance Period|Physician Decision|0
2214056|NCT01684202|3856050|FG000|Maintenance Period|Withdrawal by Subject|0
2214057|NCT01684202|3856051|FG001|Maintenance Period|Withdrawal by Subject|1
2214058|NCT01684202|3856052|FG002|Maintenance Period|Withdrawal by Subject|0
2002378|NCT00120406|3566098|FG000|Overall Study|Lost to Follow-up|5
2002379|NCT00120406|3566099|FG001|Overall Study|Lost to Follow-up|2
2002380|NCT00120406|3566098|FG000|Overall Study|received non-study stent|0
2002381|NCT00120406|3566099|FG001|Overall Study|received non-study stent|2
2002382|NCT00120406|3566098|FG000|Overall Study|patient moved but has not withdrawn|0
2002383|NCT00120406|3566099|FG001|Overall Study|patient moved but has not withdrawn|1
2002384|NCT00120627|3566117|FG000|Overall Study|Withdrawal by Subject|5
2002385|NCT00120627|3566118|FG001|Overall Study|Withdrawal by Subject|5
2002386|NCT00120874|3566135|FG000|Overall Study|Death|0
2002387|NCT00120874|3566136|FG001|Overall Study|Death|1
2002388|NCT00121134|3566146|FG000|Overall Study|Progression of Disease|5
2002389|NCT00121134|3566147|FG001|Overall Study|Progression of Disease|3
2002390|NCT00121134|3566148|FG002|Overall Study|Progression of Disease|4
2002391|NCT00121134|3566149|FG003|Overall Study|Progression of Disease|2
2002392|NCT00121134|3566146|FG000|Overall Study|Toxicity|4
2002393|NCT00121134|3566147|FG001|Overall Study|Toxicity|7
2002394|NCT00121134|3566148|FG002|Overall Study|Toxicity|13
2002395|NCT00121134|3566149|FG003|Overall Study|Toxicity|5
2002396|NCT00121134|3566146|FG000|Overall Study|Physician Decision|6
2002397|NCT00121134|3566147|FG001|Overall Study|Physician Decision|4
2002398|NCT00121134|3566148|FG002|Overall Study|Physician Decision|4
2002399|NCT00121134|3566149|FG003|Overall Study|Physician Decision|1
2002400|NCT00121134|3566146|FG000|Overall Study|Treatment Delay|1
2002401|NCT00121134|3566147|FG001|Overall Study|Treatment Delay|0
2002402|NCT00121134|3566148|FG002|Overall Study|Treatment Delay|0
2002403|NCT00121134|3566149|FG003|Overall Study|Treatment Delay|0
2002404|NCT00121134|3566146|FG000|Overall Study|Intercurrent Illness|0
2002405|NCT00121134|3566147|FG001|Overall Study|Intercurrent Illness|0
2002406|NCT00121134|3566148|FG002|Overall Study|Intercurrent Illness|0
2002407|NCT00121134|3566149|FG003|Overall Study|Intercurrent Illness|1
2002408|NCT00121134|3566146|FG000|Overall Study|Patient Personal Reasons|0
2002409|NCT00121134|3566147|FG001|Overall Study|Patient Personal Reasons|1
2002410|NCT00121134|3566148|FG002|Overall Study|Patient Personal Reasons|0
2002411|NCT00121134|3566149|FG003|Overall Study|Patient Personal Reasons|0
2002412|NCT00121199|3566179|FG000|Overall Study|Adverse Event|11
2002413|NCT00121199|3566179|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
2002414|NCT00121199|3566179|FG000|Overall Study|Progression/Relapse|1
2002415|NCT00121199|3566179|FG000|Overall Study|Death|3
2002416|NCT00121199|3566179|FG000|Overall Study|Other - Not Protocol Specified|3
2002417|NCT00121199|3566179|FG000|Overall Study|Ineligible|9
2002418|NCT00121238|3566188|FG000|Overall Study|disease progression before intervention|1
2002419|NCT00121238|3566188|FG000|Overall Study|Protocol Violation|2
2002420|NCT00121485|3566206|FG000|Overall Study|Not implanted|1
2002421|NCT00121485|3566207|FG001|Overall Study|Not implanted|5
2002422|NCT00121485|3566206|FG000|Overall Study|Crossover|0
2002423|NCT00121485|3566207|FG001|Overall Study|Crossover|2
2002424|NCT00121641|3566218|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15
2002425|NCT00121641|3566219|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21
2002426|NCT00121641|3566220|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14
2002427|NCT00121641|3566221|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25
2002428|NCT00121641|3566222|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30
2002429|NCT00121641|3566218|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9
2002430|NCT00121641|3566219|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11
2002431|NCT00121641|3566220|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5
2002432|NCT00121641|3566221|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10
2002433|NCT00121641|3566222|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3
2002434|NCT00121641|3566218|FG000|24-week Short-term Treatment Period|Adverse Event|3
2002435|NCT00121641|3566219|FG001|24-week Short-term Treatment Period|Adverse Event|3
2002436|NCT00121641|3566220|FG002|24-week Short-term Treatment Period|Adverse Event|4
2002437|NCT00121641|3566221|FG003|24-week Short-term Treatment Period|Adverse Event|0
2002438|NCT00121641|3566222|FG004|24-week Short-term Treatment Period|Adverse Event|2
2002439|NCT00121641|3566218|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0
2002440|NCT00121641|3566219|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2
2002441|NCT00121641|3566220|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3
2002442|NCT00121641|3566221|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4
2002443|NCT00121641|3566222|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4
2002444|NCT00121641|3566218|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0
2002445|NCT00121641|3566219|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0
2002446|NCT00121641|3566220|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3
2002447|NCT00121641|3566221|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1
2002448|NCT00121641|3566222|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1
2002449|NCT00121641|3566218|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
2002450|NCT00121641|3566219|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
2002451|NCT00121641|3566220|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
2002452|NCT00121641|3566221|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
2002453|NCT00121641|3566222|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
2002454|NCT00121641|3566218|FG000|24-week Short-term Treatment Period|Other Reason|1
2002455|NCT00121641|3566219|FG001|24-week Short-term Treatment Period|Other Reason|0
2002456|NCT00121641|3566220|FG002|24-week Short-term Treatment Period|Other Reason|0
2214059|NCT01684202|3856053|FG003|Maintenance Period|Withdrawal by Subject|0
2214060|NCT01684215|3856067|FG000|Phase 1, Part 1|Adverse Event|1
2002457|NCT00121641|3566221|FG003|24-week Short-term Treatment Period|Other Reason|0
2002458|NCT00121641|3566222|FG004|24-week Short-term Treatment Period|Other Reason|0
2002459|NCT00121641|3566218|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26
2002460|NCT00121641|3566219|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27
2002461|NCT00121641|3566220|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21
2002462|NCT00121641|3566221|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26
2002463|NCT00121641|3566222|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25
2002464|NCT00121641|3566218|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
2002465|NCT00121641|3566219|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
2002466|NCT00121641|3566220|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
2002467|NCT00121641|3566221|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
2002468|NCT00121641|3566222|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
2002469|NCT00121641|3566218|FG000|48-month Short Term + Long Term Period|Adverse Event|9
2002470|NCT00121641|3566219|FG001|48-month Short Term + Long Term Period|Adverse Event|10
2002471|NCT00121641|3566220|FG002|48-month Short Term + Long Term Period|Adverse Event|10
2002472|NCT00121641|3566221|FG003|48-month Short Term + Long Term Period|Adverse Event|5
2002473|NCT00121641|3566222|FG004|48-month Short Term + Long Term Period|Adverse Event|5
2002474|NCT00121641|3566218|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9
2002475|NCT00121641|3566219|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7
2002476|NCT00121641|3566220|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12
2002477|NCT00121641|3566221|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11
2002478|NCT00121641|3566222|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12
2002479|NCT00121641|3566218|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4
2002480|NCT00121641|3566219|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1
2002481|NCT00121641|3566220|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4
2002482|NCT00121641|3566221|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2
2002483|NCT00121641|3566222|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2
2002484|NCT00121641|3566218|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
2002485|NCT00121641|3566219|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
2002486|NCT00121641|3566220|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
2002487|NCT00121641|3566221|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
2002488|NCT00121641|3566222|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
2002489|NCT00121641|3566218|FG000|48-month Short Term + Long Term Period|Pregnancy|0
2002490|NCT00121641|3566219|FG001|48-month Short Term + Long Term Period|Pregnancy|1
2002491|NCT00121641|3566220|FG002|48-month Short Term + Long Term Period|Pregnancy|0
2002492|NCT00121641|3566221|FG003|48-month Short Term + Long Term Period|Pregnancy|1
2002493|NCT00121641|3566222|FG004|48-month Short Term + Long Term Period|Pregnancy|0
2002494|NCT00121641|3566218|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
2002495|NCT00121641|3566219|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
2002496|NCT00121641|3566220|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
2002497|NCT00121641|3566221|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
2002498|NCT00121641|3566222|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
2002499|NCT00121641|3566218|FG000|48-month Short Term + Long Term Period|Death|0
2002500|NCT00121641|3566219|FG001|48-month Short Term + Long Term Period|Death|0
2002501|NCT00121641|3566220|FG002|48-month Short Term + Long Term Period|Death|0
2002502|NCT00121641|3566221|FG003|48-month Short Term + Long Term Period|Death|1
2002503|NCT00121641|3566222|FG004|48-month Short Term + Long Term Period|Death|0
2002504|NCT00121641|3566218|FG000|48-month Short Term + Long Term Period|Missing|0
2002505|NCT00121641|3566219|FG001|48-month Short Term + Long Term Period|Missing|0
2002506|NCT00121641|3566220|FG002|48-month Short Term + Long Term Period|Missing|1
2002507|NCT00121641|3566221|FG003|48-month Short Term + Long Term Period|Missing|0
2002508|NCT00121641|3566222|FG004|48-month Short Term + Long Term Period|Missing|0
2002509|NCT00121641|3566218|FG000|48-month Short Term + Long Term Period|Other Reason|5
2002510|NCT00121641|3566219|FG001|48-month Short Term + Long Term Period|Other Reason|3
2002511|NCT00121641|3566220|FG002|48-month Short Term + Long Term Period|Other Reason|2
2002512|NCT00121641|3566221|FG003|48-month Short Term + Long Term Period|Other Reason|0
2002513|NCT00121641|3566222|FG004|48-month Short Term + Long Term Period|Other Reason|1
2002514|NCT00121667|3566240|FG000|Short Term (ST) Period|Lack of Efficacy|25
2002515|NCT00121667|3566241|FG001|Short Term (ST) Period|Lack of Efficacy|22
2002516|NCT00121667|3566242|FG002|Short Term (ST) Period|Lack of Efficacy|27
2002517|NCT00121667|3566243|FG003|Short Term (ST) Period|Lack of Efficacy|44
2002518|NCT00121667|3566240|FG000|Short Term (ST) Period|Subject Withdrew Consent|8
2002519|NCT00121667|3566241|FG001|Short Term (ST) Period|Subject Withdrew Consent|13
2002520|NCT00121667|3566242|FG002|Short Term (ST) Period|Subject Withdrew Consent|4
2214061|NCT01684215|3856068|FG001|Phase 1, Part 1|Adverse Event|0
2002521|NCT00121667|3566243|FG003|Short Term (ST) Period|Subject Withdrew Consent|11
2002522|NCT00121667|3566240|FG000|Short Term (ST) Period|Adverse Event|5
2002523|NCT00121667|3566241|FG001|Short Term (ST) Period|Adverse Event|6
2002524|NCT00121667|3566242|FG002|Short Term (ST) Period|Adverse Event|5
2002525|NCT00121667|3566243|FG003|Short Term (ST) Period|Adverse Event|3
2002526|NCT00121667|3566240|FG000|Short Term (ST) Period|Lost to Follow-up|3
2002527|NCT00121667|3566241|FG001|Short Term (ST) Period|Lost to Follow-up|4
2002528|NCT00121667|3566242|FG002|Short Term (ST) Period|Lost to Follow-up|4
2002529|NCT00121667|3566243|FG003|Short Term (ST) Period|Lost to Follow-up|3
2002530|NCT00121667|3566240|FG000|Short Term (ST) Period|Poor / Non-compliance|0
2002531|NCT00121667|3566241|FG001|Short Term (ST) Period|Poor / Non-compliance|1
2002532|NCT00121667|3566242|FG002|Short Term (ST) Period|Poor / Non-compliance|1
2002533|NCT00121667|3566243|FG003|Short Term (ST) Period|Poor / Non-compliance|2
2002534|NCT00121667|3566240|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
2002535|NCT00121667|3566241|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
2002536|NCT00121667|3566242|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
2002537|NCT00121667|3566243|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
2002538|NCT00121667|3566240|FG000|Short Term (ST) Period|Other Reason|3
2002539|NCT00121667|3566241|FG001|Short Term (ST) Period|Other Reason|0
2002540|NCT00121667|3566242|FG002|Short Term (ST) Period|Other Reason|0
2002541|NCT00121667|3566243|FG003|Short Term (ST) Period|Other Reason|0
2002542|NCT00121667|3566240|FG000|Short Term (ST) Period|Death|0
2002543|NCT00121667|3566241|FG001|Short Term (ST) Period|Death|0
2002544|NCT00121667|3566242|FG002|Short Term (ST) Period|Death|0
2002545|NCT00121667|3566243|FG003|Short Term (ST) Period|Death|1
2002546|NCT00121667|3566240|FG000|Short Term (ST) Period|Pregnancy|0
2002547|NCT00121667|3566241|FG001|Short Term (ST) Period|Pregnancy|0
2002548|NCT00121667|3566242|FG002|Short Term (ST) Period|Pregnancy|0
2002549|NCT00121667|3566243|FG003|Short Term (ST) Period|Pregnancy|1
2002550|NCT00121667|3566240|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
2002551|NCT00121667|3566241|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
2002552|NCT00121667|3566242|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
2002553|NCT00121667|3566243|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
2002554|NCT00121667|3566240|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
2002555|NCT00121667|3566241|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
2002556|NCT00121667|3566242|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
2002557|NCT00121667|3566243|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
2002558|NCT00121667|3566240|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
2002559|NCT00121667|3566241|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
2002560|NCT00121667|3566242|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
2002561|NCT00121667|3566243|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
2002562|NCT00121667|3566240|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
2002563|NCT00121667|3566241|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
2002564|NCT00121667|3566242|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
2002565|NCT00121667|3566243|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
2002566|NCT00121667|3566240|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5
2002567|NCT00121667|3566241|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7
2002568|NCT00121667|3566242|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6
2002569|NCT00121667|3566243|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3
2002570|NCT00121667|3566240|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
2002571|NCT00121667|3566241|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
2002572|NCT00121667|3566242|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
2002573|NCT00121667|3566243|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
2002574|NCT00121667|3566240|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
2002575|NCT00121667|3566241|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
2002576|NCT00121667|3566242|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
2002577|NCT00121667|3566243|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
2002578|NCT00121667|3566240|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
2002579|NCT00121667|3566241|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
2002580|NCT00121667|3566242|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
2002581|NCT00121667|3566243|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
2002582|NCT00121667|3566240|FG000|Short Term (ST) + Long Term (LT) Period|Death|1
2002583|NCT00121667|3566241|FG001|Short Term (ST) + Long Term (LT) Period|Death|0
2002584|NCT00121667|3566242|FG002|Short Term (ST) + Long Term (LT) Period|Death|0
2002585|NCT00121667|3566243|FG003|Short Term (ST) + Long Term (LT) Period|Death|2
2002586|NCT00121992|3566336|FG000|Overall Study|Treatment not received|2
2002587|NCT00121992|3566337|FG001|Overall Study|Treatment not received|11
2002588|NCT00122109|3566345|FG000|Overall Study|Did not meet criteria|6
2002589|NCT00122109|3566346|FG001|Overall Study|Did not meet criteria|7
2002590|NCT00122135|3566357|FG000|Overall Study|Withdrawal by Subject|3
2002591|NCT00122135|3566358|FG001|Overall Study|Withdrawal by Subject|0
2002592|NCT00122187|3566366|FG000|Overall Study|Withdrew because of resource limitations|2
2002593|NCT00122187|3566367|FG001|Overall Study|Withdrew because of resource limitations|2
2002594|NCT00122278|3566377|FG000|Overall Study|Lost to Follow-up|2
2002595|NCT00122278|3566378|FG001|Overall Study|Lost to Follow-up|0
2002596|NCT00122317|3566384|FG000|Overall Study|Death|3
2002597|NCT00122317|3566384|FG000|Overall Study|Adverse Event|4
2002598|NCT00122317|3566384|FG000|Overall Study|Physician Decision|2
2002599|NCT00122317|3566384|FG000|Overall Study|patient non-compliance|1
2002600|NCT00122317|3566384|FG000|Overall Study|Withdrawal by Subject|1
2002601|NCT00122382|3566406|FG000|Double-Blind Study|Adverse Event|9
2002602|NCT00122382|3566407|FG001|Double-Blind Study|Adverse Event|11
2002603|NCT00122382|3566408|FG002|Double-Blind Study|Adverse Event|0
2002604|NCT00122382|3566406|FG000|Double-Blind Study|Death|2
2002605|NCT00122382|3566407|FG001|Double-Blind Study|Death|2
2002606|NCT00122382|3566408|FG002|Double-Blind Study|Death|0
2002607|NCT00122382|3566406|FG000|Double-Blind Study|Lack of Efficacy|0
2002608|NCT00122382|3566407|FG001|Double-Blind Study|Lack of Efficacy|8
2002609|NCT00122382|3566408|FG002|Double-Blind Study|Lack of Efficacy|0
2002610|NCT00122382|3566406|FG000|Double-Blind Study|Lost to Follow-up|2
2002611|NCT00122382|3566407|FG001|Double-Blind Study|Lost to Follow-up|1
2002612|NCT00122382|3566408|FG002|Double-Blind Study|Lost to Follow-up|0
2002613|NCT00122382|3566406|FG000|Double-Blind Study|Pregnancy|2
2002614|NCT00122382|3566407|FG001|Double-Blind Study|Pregnancy|0
2002615|NCT00122382|3566408|FG002|Double-Blind Study|Pregnancy|0
2002616|NCT00122382|3566406|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1
2002617|NCT00122382|3566407|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0
2002618|NCT00122382|3566408|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0
2002619|NCT00122382|3566406|FG000|Double-Blind Study|Withdrawal of Consent|7
2002620|NCT00122382|3566407|FG001|Double-Blind Study|Withdrawal of Consent|3
2002621|NCT00122382|3566408|FG002|Double-Blind Study|Withdrawal of Consent|0
2002622|NCT00122382|3566406|FG000|Double-Blind Study|Protocol Violation|1
2002623|NCT00122382|3566407|FG001|Double-Blind Study|Protocol Violation|0
2002624|NCT00122382|3566408|FG002|Double-Blind Study|Protocol Violation|0
2002625|NCT00122382|3566406|FG000|Double-Blind Study|Methotrexate Discontinued|0
2002626|NCT00122382|3566407|FG001|Double-Blind Study|Methotrexate Discontinued|1
2002627|NCT00122382|3566408|FG002|Double-Blind Study|Methotrexate Discontinued|0
2002628|NCT00122382|3566406|FG000|Double-Blind Study|Randomized but not treated|0
2002629|NCT00122382|3566407|FG001|Double-Blind Study|Randomized but not treated|2
2002630|NCT00122382|3566408|FG002|Double-Blind Study|Randomized but not treated|0
2002631|NCT00122382|3566406|FG000|Open-Label Study|Adverse Event|0
2002632|NCT00122382|3566407|FG001|Open-Label Study|Adverse Event|0
2002633|NCT00122382|3566408|FG002|Open-Label Study|Adverse Event|11
2002634|NCT00122382|3566406|FG000|Open-Label Study|Death|0
2002635|NCT00122382|3566407|FG001|Open-Label Study|Death|0
2002636|NCT00122382|3566408|FG002|Open-Label Study|Death|2
2002637|NCT00122382|3566406|FG000|Open-Label Study|Lack of Efficacy|0
2002638|NCT00122382|3566407|FG001|Open-Label Study|Lack of Efficacy|0
2002639|NCT00122382|3566408|FG002|Open-Label Study|Lack of Efficacy|3
2002640|NCT00122382|3566406|FG000|Open-Label Study|Lost to Follow-up|0
2002641|NCT00122382|3566407|FG001|Open-Label Study|Lost to Follow-up|0
2002642|NCT00122382|3566408|FG002|Open-Label Study|Lost to Follow-up|3
2002643|NCT00122382|3566406|FG000|Open-Label Study|Pregnancy|0
2002644|NCT00122382|3566407|FG001|Open-Label Study|Pregnancy|0
2002645|NCT00122382|3566408|FG002|Open-Label Study|Pregnancy|2
2002646|NCT00122382|3566406|FG000|Open-Label Study|Poor/Non-Compliance|0
2002647|NCT00122382|3566407|FG001|Open-Label Study|Poor/Non-Compliance|0
2002648|NCT00122382|3566408|FG002|Open-Label Study|Poor/Non-Compliance|1
2002649|NCT00122382|3566406|FG000|Open-Label Study|Withdrawal of Consent|0
2002650|NCT00122382|3566407|FG001|Open-Label Study|Withdrawal of Consent|0
2002651|NCT00122382|3566408|FG002|Open-Label Study|Withdrawal of Consent|4
2002652|NCT00122460|3566449|FG000|Overall Study|investigational study phase ongoing|7
2002653|NCT00122460|3566450|FG001|Overall Study|investigational study phase ongoing|1
2002654|NCT00122681|3566458|FG000|Overall Study|Adverse Event|20
2002655|NCT00122681|3566459|FG001|Overall Study|Adverse Event|16
2002656|NCT00122681|3566458|FG000|Overall Study|Lost to Follow-up|1080
2002657|NCT00122681|3566459|FG001|Overall Study|Lost to Follow-up|1097
2002658|NCT00122681|3566458|FG000|Overall Study|Protocol Violation|7
2002659|NCT00122681|3566459|FG001|Overall Study|Protocol Violation|10
2002660|NCT00122681|3566458|FG000|Overall Study|Withdrawal by Subject|257
2002661|NCT00122681|3566459|FG001|Overall Study|Withdrawal by Subject|251
2002662|NCT00122681|3566458|FG000|Overall Study|Personal reasons|150
2002663|NCT00122681|3566459|FG001|Overall Study|Personal reasons|147
2002664|NCT00122954|3566475|FG000|Overall Study|Withdrawal by Subject|2
2002665|NCT00122954|3566476|FG001|Overall Study|Withdrawal by Subject|2
2002666|NCT00122954|3566475|FG000|Overall Study|Protocol Violation|0
2002667|NCT00122954|3566476|FG001|Overall Study|Protocol Violation|1
2002668|NCT00122980|3566484|FG000|Overall Study|Death|0
2002669|NCT00122980|3566485|FG001|Overall Study|Death|1
2002670|NCT00122980|3566484|FG000|Overall Study|Physician Decision|2
2002671|NCT00122980|3566485|FG001|Overall Study|Physician Decision|0
2002672|NCT00122980|3566484|FG000|Overall Study|Protocol Violation|5
2002673|NCT00122980|3566485|FG001|Overall Study|Protocol Violation|1
2002674|NCT00122980|3566484|FG000|Overall Study|Withdrawal by Subject|2
2002675|NCT00122980|3566485|FG001|Overall Study|Withdrawal by Subject|3
2002676|NCT00122980|3566484|FG000|Overall Study|Adjudicated stroke (study endpoint)|7
2002677|NCT00122980|3566485|FG001|Overall Study|Adjudicated stroke (study endpoint)|0
2002678|NCT00122980|3566484|FG000|Overall Study|Study termination|27
2002679|NCT00122980|3566485|FG001|Overall Study|Study termination|35
2002680|NCT00123422|3566540|FG000|Overall Study|Physician Decision|2
2002681|NCT00123422|3566541|FG001|Overall Study|Physician Decision|2
2002682|NCT00123422|3566542|FG002|Overall Study|Physician Decision|6
2002683|NCT00123422|3566540|FG000|Overall Study|Withdrawal by Subject|1
2002684|NCT00123422|3566541|FG001|Overall Study|Withdrawal by Subject|2
2002685|NCT00123422|3566542|FG002|Overall Study|Withdrawal by Subject|2
2002686|NCT00123422|3566540|FG000|Overall Study|Lost to Follow-up|1
2002687|NCT00123422|3566541|FG001|Overall Study|Lost to Follow-up|2
2002688|NCT00123422|3566542|FG002|Overall Study|Lost to Follow-up|2
2002689|NCT00123474|3566554|FG000|Randomized to Treatment|Randomized, never treated|1
2002690|NCT00123474|3566555|FG001|Randomized to Treatment|Randomized, never treated|4
2002691|NCT00123474|3566556|FG002|Randomized to Treatment|Randomized, never treated|2
2002692|NCT00123474|3566557|FG003|Randomized to Treatment|Randomized, never treated|1
2002693|NCT00123474|3566554|FG000|As Treated at Study Closure|not reported when site closed|1
2002694|NCT00123474|3566555|FG001|As Treated at Study Closure|not reported when site closed|0
2002695|NCT00123474|3566556|FG002|As Treated at Study Closure|not reported when site closed|1
2002696|NCT00123474|3566557|FG003|As Treated at Study Closure|not reported when site closed|0
2002697|NCT00123474|3566554|FG000|As Treated at Study Closure|Adverse Event|10
2002698|NCT00123474|3566555|FG001|As Treated at Study Closure|Adverse Event|4
2002699|NCT00123474|3566556|FG002|As Treated at Study Closure|Adverse Event|10
2002700|NCT00123474|3566557|FG003|As Treated at Study Closure|Adverse Event|8
2002701|NCT00123474|3566554|FG000|As Treated at Study Closure|Disease Progression|35
2002702|NCT00123474|3566555|FG001|As Treated at Study Closure|Disease Progression|42
2002703|NCT00123474|3566556|FG002|As Treated at Study Closure|Disease Progression|29
2002704|NCT00123474|3566557|FG003|As Treated at Study Closure|Disease Progression|27
2002705|NCT00123474|3566554|FG000|As Treated at Study Closure|Investigator Request|12
2002706|NCT00123474|3566555|FG001|As Treated at Study Closure|Investigator Request|6
2002707|NCT00123474|3566556|FG002|As Treated at Study Closure|Investigator Request|7
2002708|NCT00123474|3566557|FG003|As Treated at Study Closure|Investigator Request|5
2002709|NCT00123474|3566554|FG000|As Treated at Study Closure|non-specified|54
2002710|NCT00123474|3566555|FG001|As Treated at Study Closure|non-specified|47
2002711|NCT00123474|3566556|FG002|As Treated at Study Closure|non-specified|57
2002712|NCT00123474|3566557|FG003|As Treated at Study Closure|non-specified|60
2002713|NCT00123474|3566554|FG000|As Treated at Study Closure|Study Drug Toxicity|39
2002714|NCT00123474|3566555|FG001|As Treated at Study Closure|Study Drug Toxicity|45
2002715|NCT00123474|3566556|FG002|As Treated at Study Closure|Study Drug Toxicity|45
2002716|NCT00123474|3566557|FG003|As Treated at Study Closure|Study Drug Toxicity|51
2002717|NCT00123474|3566554|FG000|As Treated at Study Closure|Withdrawal by Subject|14
2002718|NCT00123474|3566555|FG001|As Treated at Study Closure|Withdrawal by Subject|19
2002719|NCT00123474|3566556|FG002|As Treated at Study Closure|Withdrawal by Subject|18
2002720|NCT00123474|3566557|FG003|As Treated at Study Closure|Withdrawal by Subject|16
2002721|NCT00123487|3566590|FG000|Randomized|Death prior to starting treatment|0
2002722|NCT00123487|3566591|FG001|Randomized|Death prior to starting treatment|1
2002723|NCT00123487|3566590|FG000|Randomized|SAE prior to starting treatment|1
2002724|NCT00123487|3566591|FG001|Randomized|SAE prior to starting treatment|0
2002725|NCT00123487|3566590|FG000|Treated With Study Drug|Adverse Event|23
2002726|NCT00123487|3566591|FG001|Treated With Study Drug|Adverse Event|22
2002727|NCT00123487|3566590|FG000|Treated With Study Drug|Disease Progression|141
2002728|NCT00123487|3566591|FG001|Treated With Study Drug|Disease Progression|122
2002729|NCT00123487|3566590|FG000|Treated With Study Drug|Physician Decision|8
2002730|NCT00123487|3566591|FG001|Treated With Study Drug|Physician Decision|9
2002731|NCT00123487|3566590|FG000|Treated With Study Drug|Other|59
2002732|NCT00123487|3566591|FG001|Treated With Study Drug|Other|58
2002733|NCT00123487|3566590|FG000|Treated With Study Drug|Study Drug Toxicity|62
2002734|NCT00123487|3566591|FG001|Treated With Study Drug|Study Drug Toxicity|80
2002735|NCT00123487|3566590|FG000|Treated With Study Drug|Withdrawal by Subject|11
2002736|NCT00123487|3566591|FG001|Treated With Study Drug|Withdrawal by Subject|13
2002737|NCT00123487|3566590|FG000|Treated With Study Drug|Unknown (case report form lost)|0
2002738|NCT00123487|3566591|FG001|Treated With Study Drug|Unknown (case report form lost)|1
2002739|NCT00123734|3566646|FG000|Overall Study|Death|3
2002740|NCT00123734|3566646|FG000|Overall Study|Lost to Follow-up|3
2002741|NCT00123734|3566646|FG000|Overall Study|Dropout|1
2002742|NCT00123734|3566646|FG000|Overall Study|Withdrawal by Subject|1
2002743|NCT00123955|3566655|FG000|Overall Study|Adverse Event|1
2002744|NCT00123955|3566656|FG001|Overall Study|Adverse Event|0
2002745|NCT00123955|3566655|FG000|Overall Study|Withdrawal by Subject|4
2002746|NCT00123955|3566656|FG001|Overall Study|Withdrawal by Subject|3
2002747|NCT00123955|3566655|FG000|Overall Study|Death|0
2002748|NCT00123955|3566656|FG001|Overall Study|Death|1
2002749|NCT00124020|3566664|FG000|Overall Study|Death|67
2002750|NCT00124020|3566665|FG001|Overall Study|Death|71
2002751|NCT00124020|3566664|FG000|Overall Study|Withdrawal by Subject|13
2312135|NCT02761642|4017861|FG000|Overall Study|Death|3
2312136|NCT02761642|4017861|FG000|Overall Study|Lack of Efficacy|20
2312137|NCT02761642|4017861|FG000|Overall Study|Physician Decision|1
2312138|NCT02761642|4017861|FG000|Overall Study|Reason Unspecified|21
2312139|NCT02761733|4017869|FG000|Overall Study|Death|3
2312140|NCT02761733|4017870|FG001|Overall Study|Death|5
2002752|NCT00124020|3566665|FG001|Overall Study|Withdrawal by Subject|11
2002753|NCT00124020|3566664|FG000|Overall Study|Lost to Follow-up|5
2002754|NCT00124020|3566665|FG001|Overall Study|Lost to Follow-up|8
2002755|NCT00124020|3566664|FG000|Overall Study|Other|1
2002756|NCT00124020|3566665|FG001|Overall Study|Other|1
2002757|NCT00124020|3566664|FG000|Overall Study|Transfer to another hospital|2
2002758|NCT00124020|3566665|FG001|Overall Study|Transfer to another hospital|0
2002759|NCT00124072|3566675|FG000|Overall Study|Lost to Follow-up for Mortality|0
2002760|NCT00124072|3566676|FG001|Overall Study|Lost to Follow-up for Mortality|3
2002761|NCT00124072|3566677|FG002|Overall Study|Lost to Follow-up for Mortality|2
2002762|NCT00124072|3566678|FG003|Overall Study|Lost to Follow-up for Mortality|2
2002763|NCT00124072|3566675|FG000|Overall Study|Lost to Follow-up for Morbidity|15
2002764|NCT00124072|3566676|FG001|Overall Study|Lost to Follow-up for Morbidity|25
2002765|NCT00124072|3566677|FG002|Overall Study|Lost to Follow-up for Morbidity|19
2002766|NCT00124072|3566678|FG003|Overall Study|Lost to Follow-up for Morbidity|18
2002767|NCT00124072|3566675|FG000|Overall Study|Death|499
2002768|NCT00124072|3566676|FG001|Overall Study|Death|484
2002769|NCT00124072|3566677|FG002|Overall Study|Death|471
2002770|NCT00124072|3566678|FG003|Overall Study|Death|480
2002771|NCT00124449|3566699|FG000|6-month Double-Blind Treatment Period|Adverse Event|1
2002772|NCT00124449|3566700|FG001|6-month Double-Blind Treatment Period|Adverse Event|0
2002773|NCT00124449|3566699|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3
2002774|NCT00124449|3566700|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8
2002775|NCT00124449|3566699|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
2002776|NCT00124449|3566700|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
2002777|NCT00124449|3566699|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
2002778|NCT00124449|3566700|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
2214062|NCT01684215|3856069|FG002|Phase 1, Part 1|Adverse Event|0
2214063|NCT01684215|3856070|FG003|Phase 1, Part 1|Adverse Event|0
2214064|NCT01684215|3856067|FG000|Phase 1, Part 1|Objective progression or relapse|5
2214065|NCT01684215|3856068|FG001|Phase 1, Part 1|Objective progression or relapse|6
2214066|NCT01684215|3856069|FG002|Phase 1, Part 1|Objective progression or relapse|0
2214067|NCT01684215|3856070|FG003|Phase 1, Part 1|Objective progression or relapse|0
2214068|NCT01684215|3856067|FG000|Phase 1, Part 2|Adverse Event|0
2214069|NCT01684215|3856068|FG001|Phase 1, Part 2|Adverse Event|0
2214070|NCT01684215|3856069|FG002|Phase 1, Part 2|Adverse Event|1
2214071|NCT01684215|3856070|FG003|Phase 1, Part 2|Adverse Event|0
2214072|NCT01684215|3856067|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
2214073|NCT01684215|3856068|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
2214074|NCT01684215|3856069|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
2214075|NCT01684215|3856070|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
2214076|NCT01684215|3856067|FG000|Phase 1, Part 2|Withdrawal by Subject|0
2214077|NCT01684215|3856068|FG001|Phase 1, Part 2|Withdrawal by Subject|0
2214078|NCT01684215|3856069|FG002|Phase 1, Part 2|Withdrawal by Subject|1
2214079|NCT01684215|3856070|FG003|Phase 1, Part 2|Withdrawal by Subject|0
2312141|NCT02761733|4017871|FG002|Overall Study|Death|1
2312142|NCT02761733|4017872|FG003|Overall Study|Death|1
2002779|NCT00124449|3566699|FG000|6-month Double-Blind Treatment Period|Sponsor request|0
2002780|NCT00124449|3566700|FG001|6-month Double-Blind Treatment Period|Sponsor request|1
2002781|NCT00124449|3566699|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
2002782|NCT00124449|3566700|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
2002783|NCT00124449|3566699|FG000|18-Month Untreated Observation Period|Adverse Event|0
2002784|NCT00124449|3566700|FG001|18-Month Untreated Observation Period|Adverse Event|1
2002785|NCT00124449|3566699|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11
2312143|NCT02761733|4017869|FG000|Overall Study|Lost to Follow-up|6
2312144|NCT02761733|4017870|FG001|Overall Study|Lost to Follow-up|7
2002786|NCT00124449|3566700|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12
2002787|NCT00124449|3566699|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1
2002788|NCT00124449|3566700|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0
2002789|NCT00124449|3566699|FG000|18-Month Untreated Observation Period|Pregnancy|1
2002790|NCT00124449|3566700|FG001|18-Month Untreated Observation Period|Pregnancy|0
2002791|NCT00124449|3566699|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1
2002792|NCT00124449|3566700|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0
2002793|NCT00124449|3566699|FG000|18-Month Untreated Observation Period|Relocated|1
2002794|NCT00124449|3566700|FG001|18-Month Untreated Observation Period|Relocated|0
2002795|NCT00124462|3566709|FG000|Overall Study|Lost to Follow-up|3
2002796|NCT00124462|3566710|FG001|Overall Study|Lost to Follow-up|3
2002797|NCT00124462|3566709|FG000|Overall Study|Physician Decision|3
2214080|NCT01684215|3856067|FG000|Phase 2|Death|0
2214081|NCT01684215|3856068|FG001|Phase 2|Death|0
2214082|NCT01684215|3856069|FG002|Phase 2|Death|0
2312145|NCT02761733|4017871|FG002|Overall Study|Lost to Follow-up|0
2312146|NCT02761733|4017872|FG003|Overall Study|Lost to Follow-up|3
2312147|NCT02761733|4017869|FG000|Overall Study|Physician Decision|4
2312148|NCT02761733|4017870|FG001|Overall Study|Physician Decision|0
2312149|NCT02761733|4017871|FG002|Overall Study|Physician Decision|0
2214083|NCT01684215|3856070|FG003|Phase 2|Death|8
2214084|NCT01684215|3856067|FG000|Phase 2|Study terminated by sponsor|0
2002798|NCT00124462|3566710|FG001|Overall Study|Physician Decision|4
2002799|NCT00124462|3566709|FG000|Overall Study|Withdrawal by Subject|4
2002800|NCT00124462|3566710|FG001|Overall Study|Withdrawal by Subject|5
2002801|NCT00124462|3566709|FG000|Overall Study|Device fitting, n=2, other hlth issues|1
2002802|NCT00124462|3566710|FG001|Overall Study|Device fitting, n=2, other hlth issues|1
2002803|NCT00124618|3566737|FG000|Overall Study|Ineligible|1
2002804|NCT00124657|3566744|FG000|Overall Study|Toxicity|0
2002805|NCT00124657|3566745|FG001|Overall Study|Toxicity|0
2002806|NCT00124657|3566746|FG002|Overall Study|Toxicity|1
2002807|NCT00124657|3566744|FG000|Overall Study|Non-compliance|1
2002808|NCT00124657|3566745|FG001|Overall Study|Non-compliance|0
2002809|NCT00124657|3566746|FG002|Overall Study|Non-compliance|4
2002810|NCT00124657|3566744|FG000|Overall Study|Progressive disease|14
2002811|NCT00124657|3566745|FG001|Overall Study|Progressive disease|5
2002812|NCT00124657|3566746|FG002|Overall Study|Progressive disease|27
2002813|NCT00124657|3566744|FG000|Overall Study|Intercurrent illness|1
2002814|NCT00124657|3566745|FG001|Overall Study|Intercurrent illness|0
2002815|NCT00124657|3566746|FG002|Overall Study|Intercurrent illness|0
2002816|NCT00124709|3566769|FG000|Overall Study|Randomized but did not take medication|3
2002817|NCT00124709|3566770|FG001|Overall Study|Randomized but did not take medication|1
2002818|NCT00124709|3566769|FG000|Overall Study|Adverse Event|3
2002819|NCT00124709|3566770|FG001|Overall Study|Adverse Event|0
2002820|NCT00124709|3566769|FG000|Overall Study|Lack of Efficacy|5
2002821|NCT00124709|3566770|FG001|Overall Study|Lack of Efficacy|10
2002822|NCT00124709|3566769|FG000|Overall Study|Protocol Violation|3
2002823|NCT00124709|3566770|FG001|Overall Study|Protocol Violation|5
2002824|NCT00124709|3566769|FG000|Overall Study|Withdrawal by Subject|127
2002825|NCT00124709|3566770|FG001|Overall Study|Withdrawal by Subject|136
2002826|NCT00124709|3566769|FG000|Overall Study|Lost to Follow-up|114
2002827|NCT00124709|3566770|FG001|Overall Study|Lost to Follow-up|120
2002828|NCT00124748|3566811|FG000|Overall Study|Adverse Event|8
2002829|NCT00124748|3566812|FG001|Overall Study|Adverse Event|39
2002830|NCT00124748|3566811|FG000|Overall Study|Abnormal laboratory Value|2
2002831|NCT00124748|3566812|FG001|Overall Study|Abnormal laboratory Value|2
2002832|NCT00124748|3566811|FG000|Overall Study|Abnormal Procedure|0
2002833|NCT00124748|3566812|FG001|Overall Study|Abnormal Procedure|1
2002834|NCT00124748|3566811|FG000|Overall Study|Lack of Efficacy|20
2002835|NCT00124748|3566812|FG001|Overall Study|Lack of Efficacy|41
2002836|NCT00124748|3566811|FG000|Overall Study|No longer requires study drug|1
2002837|NCT00124748|3566812|FG001|Overall Study|No longer requires study drug|1
2002838|NCT00124748|3566811|FG000|Overall Study|Protocol Violation|3
2002839|NCT00124748|3566812|FG001|Overall Study|Protocol Violation|1
2002840|NCT00124748|3566811|FG000|Overall Study|Withdrawal by Subject|5
2002841|NCT00124748|3566812|FG001|Overall Study|Withdrawal by Subject|15
2002842|NCT00124748|3566811|FG000|Overall Study|Lost to Follow-up|2
2002843|NCT00124748|3566812|FG001|Overall Study|Lost to Follow-up|7
2002844|NCT00124748|3566811|FG000|Overall Study|Administrative Problem(Study Terminated)|101
2002845|NCT00124748|3566812|FG001|Overall Study|Administrative Problem(Study Terminated)|174
2002846|NCT00124748|3566811|FG000|Overall Study|Death|1
2002847|NCT00124748|3566812|FG001|Overall Study|Death|3
2002848|NCT00124917|3566818|FG000|Overall Study|Physician Decision|3
2024996|NCT00338962|3593606|FG001|Overall Study|Adverse Event|0
2024997|NCT00338962|3593607|FG002|Overall Study|Adverse Event|2
2024998|NCT00338962|3593608|FG003|Overall Study|Adverse Event|0
2024999|NCT00338962|3593605|FG000|Overall Study|Poor Compliance|0
2025000|NCT00338962|3593606|FG001|Overall Study|Poor Compliance|0
2025001|NCT00338962|3593607|FG002|Overall Study|Poor Compliance|2
2025002|NCT00338962|3593608|FG003|Overall Study|Poor Compliance|0
2025003|NCT00339040|3593625|FG000|Stage I|Not able to attend clinic|1
2025004|NCT00339040|3593626|FG001|Stage I|Not able to attend clinic|0
2025005|NCT00339040|3593625|FG000|Stage I|Protocol Violation|1
2025006|NCT00339040|3593626|FG001|Stage I|Protocol Violation|1
2025007|NCT00339040|3593625|FG000|Stage II|Lost to Follow-up|3
2025008|NCT00339040|3593626|FG001|Stage II|Lost to Follow-up|0
2025009|NCT00339040|3593625|FG000|Stage II|Withdrawal by Subject|1
2025010|NCT00339040|3593626|FG001|Stage II|Withdrawal by Subject|2
2025011|NCT00339040|3593625|FG000|Stage II|Protocol Violation|3
2025012|NCT00339040|3593626|FG001|Stage II|Protocol Violation|0
2025013|NCT00339040|3593625|FG000|Stage II|Not able to attend clinic|1
2025014|NCT00339040|3593626|FG001|Stage II|Not able to attend clinic|0
2025015|NCT00339040|3593625|FG000|Stage II|Site closing|2
2025016|NCT00339040|3593626|FG001|Stage II|Site closing|0
2025017|NCT00339144|3593656|FG000|Overall Study|Disease progression|5
2025018|NCT00339144|3593657|FG001|Overall Study|Disease progression|2
2025019|NCT00339144|3593658|FG002|Overall Study|Disease progression|2
2025020|NCT00339144|3593656|FG000|Overall Study|Study drug toxicity|3
2025021|NCT00339144|3593657|FG001|Overall Study|Study drug toxicity|1
2025022|NCT00339144|3593658|FG002|Overall Study|Study drug toxicity|1
2025023|NCT00339144|3593656|FG000|Overall Study|Participant's request to discontinuation|1
2025024|NCT00339144|3593657|FG001|Overall Study|Participant's request to discontinuation|0
2025025|NCT00339144|3593658|FG002|Overall Study|Participant's request to discontinuation|1
2025026|NCT00339183|3593669|FG000|Overall Study|Adverse Event|5
2025027|NCT00339183|3593670|FG001|Overall Study|Adverse Event|3
2025028|NCT00339183|3593669|FG000|Overall Study|Withdrawal by Subject|16
2025029|NCT00339183|3593670|FG001|Overall Study|Withdrawal by Subject|19
2002849|NCT00124943|3566827|FG000|Phase II|Adverse Event|0
2002850|NCT00124943|3566828|FG001|Phase II|Adverse Event|2
2002851|NCT00124943|3566829|FG002|Phase II|Adverse Event|0
2002852|NCT00124943|3566830|FG003|Phase II|Adverse Event|1
2002853|NCT00124943|3566827|FG000|Phase II|Protocol Violation|0
2002854|NCT00124943|3566828|FG001|Phase II|Protocol Violation|0
2002855|NCT00124943|3566829|FG002|Phase II|Protocol Violation|0
2002856|NCT00124943|3566830|FG003|Phase II|Protocol Violation|1
2002857|NCT00124943|3566827|FG000|Phase II|Lost to Follow-up|0
2002858|NCT00124943|3566828|FG001|Phase II|Lost to Follow-up|0
2002859|NCT00124943|3566829|FG002|Phase II|Lost to Follow-up|0
2002860|NCT00124943|3566830|FG003|Phase II|Lost to Follow-up|1
2002861|NCT00124943|3566827|FG000|Phase II|Withdrawal by Subject|0
2002862|NCT00124943|3566828|FG001|Phase II|Withdrawal by Subject|0
2002863|NCT00124943|3566829|FG002|Phase II|Withdrawal by Subject|0
2002864|NCT00124943|3566830|FG003|Phase II|Withdrawal by Subject|2
2002865|NCT00124982|3566842|FG000|Short-term Period|Death|1
2002866|NCT00124982|3566843|FG001|Short-term Period|Death|1
2002867|NCT00124982|3566844|FG002|Short-term Period|Death|0
2002868|NCT00124982|3566842|FG000|Short-term Period|Adverse Event|17
2002869|NCT00124982|3566843|FG001|Short-term Period|Adverse Event|22
2002870|NCT00124982|3566844|FG002|Short-term Period|Adverse Event|0
2002871|NCT00124982|3566842|FG000|Short-term Period|Lack of Efficacy|32
2002872|NCT00124982|3566843|FG001|Short-term Period|Lack of Efficacy|73
2002873|NCT00124982|3566844|FG002|Short-term Period|Lack of Efficacy|0
2002874|NCT00124982|3566842|FG000|Short-term Period|Lost to Follow-up|8
2002875|NCT00124982|3566843|FG001|Short-term Period|Lost to Follow-up|5
2002876|NCT00124982|3566844|FG002|Short-term Period|Lost to Follow-up|0
2002877|NCT00124982|3566842|FG000|Short-term Period|Withdrawal of Consent|7
2002878|NCT00124982|3566843|FG001|Short-term Period|Withdrawal of Consent|9
2002879|NCT00124982|3566844|FG002|Short-term Period|Withdrawal of Consent|0
2002880|NCT00124982|3566842|FG000|Short-term Period|Poor/Non-compliance|3
2002881|NCT00124982|3566843|FG001|Short-term Period|Poor/Non-compliance|1
2002882|NCT00124982|3566844|FG002|Short-term Period|Poor/Non-compliance|0
2002883|NCT00124982|3566842|FG000|Short-term Period|No Longer Meets Study Criteria|1
2002884|NCT00124982|3566843|FG001|Short-term Period|No Longer Meets Study Criteria|2
2002885|NCT00124982|3566844|FG002|Short-term Period|No Longer Meets Study Criteria|0
2312150|NCT02761733|4017872|FG003|Overall Study|Physician Decision|0
2312151|NCT02761733|4017869|FG000|Overall Study|Withdrawal by Subject|2
2312152|NCT02761733|4017870|FG001|Overall Study|Withdrawal by Subject|0
2312153|NCT02761733|4017871|FG002|Overall Study|Withdrawal by Subject|0
2312154|NCT02761733|4017872|FG003|Overall Study|Withdrawal by Subject|0
2312155|NCT02761733|4017869|FG000|Overall Study|Discharged from Study Site|10
2312156|NCT02761733|4017870|FG001|Overall Study|Discharged from Study Site|9
2312157|NCT02761733|4017871|FG002|Overall Study|Discharged from Study Site|25
2312158|NCT02761733|4017872|FG003|Overall Study|Discharged from Study Site|11
2312159|NCT02761733|4017869|FG000|Overall Study|Cognitive Impairment|5
2312160|NCT02761733|4017870|FG001|Overall Study|Cognitive Impairment|0
2312161|NCT02761733|4017871|FG002|Overall Study|Cognitive Impairment|1
2312162|NCT02761733|4017872|FG003|Overall Study|Cognitive Impairment|0
2312163|NCT02761915|4017888|FG000|Overall Study|Death|3
2312164|NCT02761915|4017889|FG001|Overall Study|Death|1
2312165|NCT02761915|4017890|FG002|Overall Study|Death|1
2312166|NCT02761915|4017891|FG003|Overall Study|Death|1
2312167|NCT02761915|4017892|FG004|Overall Study|Death|0
2312168|NCT02761915|4017893|FG005|Overall Study|Death|1
2312169|NCT02761915|4017888|FG000|Overall Study|Withdrawal by Subject|1
2312170|NCT02761915|4017889|FG001|Overall Study|Withdrawal by Subject|0
2312171|NCT02761915|4017890|FG002|Overall Study|Withdrawal by Subject|0
2312172|NCT02761915|4017891|FG003|Overall Study|Withdrawal by Subject|0
2312173|NCT02761915|4017892|FG004|Overall Study|Withdrawal by Subject|1
2312174|NCT02761915|4017893|FG005|Overall Study|Withdrawal by Subject|2
2312175|NCT02761915|4017888|FG000|Overall Study|Disease Progression|0
2312176|NCT02761915|4017889|FG001|Overall Study|Disease Progression|0
2312177|NCT02761915|4017890|FG002|Overall Study|Disease Progression|0
2312178|NCT02761915|4017891|FG003|Overall Study|Disease Progression|2
2312179|NCT02761915|4017892|FG004|Overall Study|Disease Progression|2
2312180|NCT02761915|4017893|FG005|Overall Study|Disease Progression|2
2312181|NCT02761980|4017927|FG000|Overall Study|Adverse Event|4
2312182|NCT02761980|4017928|FG001|Overall Study|Adverse Event|6
2312183|NCT02761980|4017929|FG002|Overall Study|Adverse Event|5
2312184|NCT02761980|4017930|FG003|Overall Study|Adverse Event|6
2312185|NCT02761980|4017927|FG000|Overall Study|Withdrawal by Subject|0
2312186|NCT02761980|4017928|FG001|Overall Study|Withdrawal by Subject|1
2312187|NCT02761980|4017929|FG002|Overall Study|Withdrawal by Subject|0
2312188|NCT02761980|4017930|FG003|Overall Study|Withdrawal by Subject|0
2312189|NCT02761980|4017927|FG000|Overall Study|Other|0
2312190|NCT02761980|4017928|FG001|Overall Study|Other|0
2312191|NCT02761980|4017929|FG002|Overall Study|Other|1
2002886|NCT00124982|3566842|FG000|Short-term Period|Participant Decision|1
2002887|NCT00124982|3566843|FG001|Short-term Period|Participant Decision|0
2002888|NCT00124982|3566844|FG002|Short-term Period|Participant Decision|0
2312192|NCT02761980|4017930|FG003|Overall Study|Other|0
2312193|NCT02761993|4017943|FG000|Overall Study|Adverse Event|0
2312194|NCT02761993|4017944|FG001|Overall Study|Adverse Event|2
2312195|NCT02761993|4017945|FG002|Overall Study|Adverse Event|0
2002889|NCT00124982|3566842|FG000|Short-term Period|Participant Chose Own Doctor|0
2002890|NCT00124982|3566843|FG001|Short-term Period|Participant Chose Own Doctor|1
2002891|NCT00124982|3566844|FG002|Short-term Period|Participant Chose Own Doctor|0
2002892|NCT00124982|3566842|FG000|Short-term Period|Investigator Decision-No Specific AE|1
2214085|NCT01684215|3856068|FG001|Phase 2|Study terminated by sponsor|0
2312196|NCT02761993|4017943|FG000|Overall Study|Lost to Follow-up|1
2002893|NCT00124982|3566843|FG001|Short-term Period|Investigator Decision-No Specific AE|0
2002894|NCT00124982|3566844|FG002|Short-term Period|Investigator Decision-No Specific AE|0
2002895|NCT00124982|3566842|FG000|Short-term Period|Participant Had Lymphopenia|1
2002896|NCT00124982|3566843|FG001|Short-term Period|Participant Had Lymphopenia|0
2002897|NCT00124982|3566844|FG002|Short-term Period|Participant Had Lymphopenia|0
2002898|NCT00124982|3566842|FG000|Long-term Period|Death|0
2002899|NCT00124982|3566843|FG001|Long-term Period|Death|0
2002900|NCT00124982|3566844|FG002|Long-term Period|Death|1
2002901|NCT00124982|3566842|FG000|Long-term Period|Adverse Event|0
2002902|NCT00124982|3566843|FG001|Long-term Period|Adverse Event|0
2002903|NCT00124982|3566844|FG002|Long-term Period|Adverse Event|17
2002904|NCT00124982|3566842|FG000|Long-term Period|Lack of Efficacy|0
2002905|NCT00124982|3566843|FG001|Long-term Period|Lack of Efficacy|0
2002906|NCT00124982|3566844|FG002|Long-term Period|Lack of Efficacy|46
2002907|NCT00124982|3566842|FG000|Long-term Period|Lost to Follow-up|0
2002908|NCT00124982|3566843|FG001|Long-term Period|Lost to Follow-up|0
2002909|NCT00124982|3566844|FG002|Long-term Period|Lost to Follow-up|4
2002910|NCT00124982|3566842|FG000|Long-term Period|Withdrawal by Subject|0
2002911|NCT00124982|3566843|FG001|Long-term Period|Withdrawal by Subject|0
2002912|NCT00124982|3566844|FG002|Long-term Period|Withdrawal by Subject|16
2002913|NCT00124982|3566842|FG000|Long-term Period|Pregnancy|0
2002914|NCT00124982|3566843|FG001|Long-term Period|Pregnancy|0
2002915|NCT00124982|3566844|FG002|Long-term Period|Pregnancy|1
2002916|NCT00124982|3566842|FG000|Long-term Period|Poor/Non-compliance|0
2002917|NCT00124982|3566843|FG001|Long-term Period|Poor/Non-compliance|0
2002918|NCT00124982|3566844|FG002|Long-term Period|Poor/Non-compliance|2
2002919|NCT00124982|3566842|FG000|Long-term Period|Administrative Reason by Sponsor|0
2002920|NCT00124982|3566843|FG001|Long-term Period|Administrative Reason by Sponsor|0
2002921|NCT00124982|3566844|FG002|Long-term Period|Administrative Reason by Sponsor|1
2002922|NCT00124982|3566842|FG000|Long-term Period|Neurologist Recommendation|0
2002923|NCT00124982|3566843|FG001|Long-term Period|Neurologist Recommendation|0
2002924|NCT00124982|3566844|FG002|Long-term Period|Neurologist Recommendation|1
2002925|NCT00125138|3566866|FG000|Overall Study|Adverse Event|1
2002926|NCT00125138|3566867|FG001|Overall Study|Adverse Event|0
2002927|NCT00125138|3566868|FG002|Overall Study|Adverse Event|3
2002928|NCT00125138|3566869|FG003|Overall Study|Adverse Event|2
2002929|NCT00125138|3566866|FG000|Overall Study|Withdrawal by Subject|2
2002930|NCT00125138|3566867|FG001|Overall Study|Withdrawal by Subject|3
2002931|NCT00125138|3566868|FG002|Overall Study|Withdrawal by Subject|1
2002932|NCT00125138|3566869|FG003|Overall Study|Withdrawal by Subject|1
2002933|NCT00125138|3566866|FG000|Overall Study|Lack of Efficacy|0
2002934|NCT00125138|3566867|FG001|Overall Study|Lack of Efficacy|0
2002935|NCT00125138|3566868|FG002|Overall Study|Lack of Efficacy|0
2002936|NCT00125138|3566869|FG003|Overall Study|Lack of Efficacy|1
2002937|NCT00125138|3566866|FG000|Overall Study|Sponsor decision-pt moved to assist care|0
2002938|NCT00125138|3566867|FG001|Overall Study|Sponsor decision-pt moved to assist care|0
2002939|NCT00125138|3566868|FG002|Overall Study|Sponsor decision-pt moved to assist care|0
2002940|NCT00125138|3566869|FG003|Overall Study|Sponsor decision-pt moved to assist care|1
2002941|NCT00125164|3566883|FG000|Overall Study|Adverse Event|0
2002942|NCT00125164|3566884|FG001|Overall Study|Adverse Event|0
2002943|NCT00125164|3566885|FG002|Overall Study|Adverse Event|2
2002944|NCT00125164|3566886|FG003|Overall Study|Adverse Event|4
2002945|NCT00125164|3566883|FG000|Overall Study|Lost to Follow-up|0
2002946|NCT00125164|3566884|FG001|Overall Study|Lost to Follow-up|0
2002947|NCT00125164|3566885|FG002|Overall Study|Lost to Follow-up|1
2002948|NCT00125164|3566886|FG003|Overall Study|Lost to Follow-up|1
2002949|NCT00125164|3566883|FG000|Overall Study|Withdrawal by Subject|2
2002950|NCT00125164|3566884|FG001|Overall Study|Withdrawal by Subject|0
2002951|NCT00125164|3566885|FG002|Overall Study|Withdrawal by Subject|1
2002952|NCT00125164|3566886|FG003|Overall Study|Withdrawal by Subject|1
2002953|NCT00125190|3566896|FG000|Overall Study|Subject/Parent Decision|7
2002954|NCT00125190|3566896|FG000|Overall Study|Non-compliance|2
2002955|NCT00125190|3566896|FG000|Overall Study|Adverse Event|1
2002956|NCT00125190|3566896|FG000|Overall Study|Other|1
2002957|NCT00125190|3566896|FG000|Overall Study|Lost to Follow-up|4
2312197|NCT02761993|4017944|FG001|Overall Study|Lost to Follow-up|3
2312198|NCT02761993|4017945|FG002|Overall Study|Lost to Follow-up|2
2312199|NCT02761993|4017943|FG000|Overall Study|Withdrawal by Subject|1
2312200|NCT02761993|4017944|FG001|Overall Study|Withdrawal by Subject|1
2002958|NCT00125242|3566903|FG000|Overall Study|did not qualify|7
2002959|NCT00125242|3566904|FG001|Overall Study|did not qualify|2
2002960|NCT00125359|3566909|FG000|Overall Study|Death|4
2002961|NCT00125359|3566909|FG000|Overall Study|Adverse Event|5
2002962|NCT00125359|3566909|FG000|Overall Study|Physician Decision|14
2002963|NCT00125853|3566982|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3
2002964|NCT00125853|3566983|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7
2002965|NCT00126126|3567013|FG000|Overall Study|Lost to Follow-up|0
2002966|NCT00126126|3567014|FG001|Overall Study|Lost to Follow-up|2
2002967|NCT00126191|3567022|FG000|Overall Study|Physician Decision|0
2002968|NCT00126191|3567023|FG001|Overall Study|Physician Decision|1
2002969|NCT00126191|3567022|FG000|Overall Study|Death|0
2002970|NCT00126191|3567023|FG001|Overall Study|Death|1
2002971|NCT00126425|3567031|FG000|Overall Study|Withdrawal by Subject|17
2002972|NCT00126425|3567032|FG001|Overall Study|Withdrawal by Subject|1
2002973|NCT00126425|3567031|FG000|Overall Study|Lost to Follow-up|8
2002974|NCT00126425|3567032|FG001|Overall Study|Lost to Follow-up|4
2002975|NCT00126425|3567031|FG000|Overall Study|Protocol Violation|9
2002976|NCT00126425|3567032|FG001|Overall Study|Protocol Violation|6
2002977|NCT00126425|3567031|FG000|Overall Study|Adverse Event|1
2002978|NCT00126425|3567032|FG001|Overall Study|Adverse Event|0
2002979|NCT00126425|3567031|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1
2002980|NCT00126425|3567032|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0
2002981|NCT00126425|3567031|FG000|Overall Study|Other|5
2002982|NCT00126425|3567032|FG001|Overall Study|Other|0
2002983|NCT00126438|3567040|FG000|Overall Study|Withdrawal due to adverse event|1
2002984|NCT00126438|3567041|FG001|Overall Study|Withdrawal due to adverse event|0
2002985|NCT00126438|3567040|FG000|Overall Study|Lost to Follow-up|22
2002986|NCT00126438|3567041|FG001|Overall Study|Lost to Follow-up|0
2002987|NCT00126438|3567040|FG000|Overall Study|Protocol Violation|8
2002988|NCT00126438|3567041|FG001|Overall Study|Protocol Violation|8
2002989|NCT00126438|3567040|FG000|Overall Study|Withdrawal by Subject|3
2002990|NCT00126438|3567041|FG001|Overall Study|Withdrawal by Subject|2
2002991|NCT00126490|3567047|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1
2002992|NCT00126503|3567053|FG000|Overall Study|disease progression|23
2002993|NCT00126503|3567054|FG001|Overall Study|disease progression|14
2002994|NCT00126503|3567053|FG000|Overall Study|Withdrawal by Subject|0
2002995|NCT00126503|3567054|FG001|Overall Study|Withdrawal by Subject|1
2002996|NCT00126503|3567053|FG000|Overall Study|alternative therapy|1
2002997|NCT00126503|3567054|FG001|Overall Study|alternative therapy|1
2312201|NCT02761993|4017945|FG002|Overall Study|Withdrawal by Subject|2
2312202|NCT02762084|4017966|FG000|Overall Study|Withdrawal by Subject|1
2312203|NCT02762084|4017967|FG001|Overall Study|Withdrawal by Subject|0
2312204|NCT02762084|4017968|FG002|Overall Study|Withdrawal by Subject|0
2312205|NCT02762084|4017966|FG000|Overall Study|Adverse Event|0
2312206|NCT02762084|4017967|FG001|Overall Study|Adverse Event|0
2312207|NCT02762084|4017968|FG002|Overall Study|Adverse Event|1
2312208|NCT02762370|4017989|FG000|Overall Study|Protocol Violation|1
2312209|NCT02762370|4017990|FG001|Overall Study|Protocol Violation|0
2312210|NCT02762500|4018000|FG000|Overall Study|Lack of Efficacy|1
2312211|NCT02762500|4018001|FG001|Overall Study|Lack of Efficacy|0
2312212|NCT02762500|4018000|FG000|Overall Study|Withdrawal by Subject|1
2312213|NCT02762500|4018001|FG001|Overall Study|Withdrawal by Subject|1
2312214|NCT02762500|4018000|FG000|Overall Study|Adverse Event|0
2312215|NCT02762500|4018001|FG001|Overall Study|Adverse Event|2
2312216|NCT02762565|4018011|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11
2312217|NCT02762578|4018017|FG000|Overall Study|Adverse Event|1
2312218|NCT02762578|4018018|FG001|Overall Study|Adverse Event|6
2312219|NCT02762578|4018017|FG000|Overall Study|Protocol Violation|4
2312220|NCT02762578|4018018|FG001|Overall Study|Protocol Violation|2
2312221|NCT02762578|4018017|FG000|Overall Study|Withdrawal by Subject|4
2312222|NCT02762578|4018018|FG001|Overall Study|Withdrawal by Subject|2
2312223|NCT02762578|4018017|FG000|Overall Study|Unclassified|6
2312224|NCT02762578|4018018|FG001|Overall Study|Unclassified|0
2312225|NCT02762994|4018057|FG000|Overall Study|Withdrawal by Subject|0
2312226|NCT02762994|4018058|FG001|Overall Study|Withdrawal by Subject|1
2312227|NCT02762994|4018059|FG002|Overall Study|Withdrawal by Subject|2
2312228|NCT02762994|4018060|FG003|Overall Study|Withdrawal by Subject|0
2312229|NCT02762994|4018057|FG000|Overall Study|Protocol Violation|1
2312230|NCT02762994|4018058|FG001|Overall Study|Protocol Violation|0
2312231|NCT02762994|4018059|FG002|Overall Study|Protocol Violation|0
2312232|NCT02762994|4018060|FG003|Overall Study|Protocol Violation|2
2312233|NCT02763046|4018077|FG000|Overall Study|Adverse Event|5
2312234|NCT02763046|4018078|FG001|Overall Study|Adverse Event|4
2312235|NCT02763046|4018079|FG002|Overall Study|Adverse Event|0
2312236|NCT02763046|4018077|FG000|Overall Study|Lack of Efficacy|1
2312237|NCT02763046|4018078|FG001|Overall Study|Lack of Efficacy|1
2312238|NCT02763046|4018079|FG002|Overall Study|Lack of Efficacy|3
2312239|NCT02763046|4018077|FG000|Overall Study|Physician Decision|1
2312240|NCT02763046|4018078|FG001|Overall Study|Physician Decision|0
2312241|NCT02763046|4018079|FG002|Overall Study|Physician Decision|1
2312242|NCT02763046|4018077|FG000|Overall Study|Subject/guardian decision|2
2312243|NCT02763046|4018078|FG001|Overall Study|Subject/guardian decision|0
2312244|NCT02763046|4018079|FG002|Overall Study|Subject/guardian decision|4
2312245|NCT02763189|4018099|FG000|Overall Study|Device failure|0
2312246|NCT02763189|4018100|FG001|Overall Study|Device failure|2
2002998|NCT00126503|3567053|FG000|Overall Study|other complicating disease|4
2002999|NCT00126503|3567054|FG001|Overall Study|other complicating disease|1
2312247|NCT02763215|4018106|FG000|Overall Study|Participants withdrew from study|3
2312248|NCT02763215|4018106|FG000|Overall Study|Missed visit|1
2312249|NCT02763215|4018106|FG000|Overall Study|Visit outside visit-window|1
2003000|NCT00126503|3567053|FG000|Overall Study|Death|3
2003001|NCT00126503|3567054|FG001|Overall Study|Death|0
2003002|NCT00126503|3567053|FG000|Overall Study|Adverse Event|13
2003003|NCT00126503|3567054|FG001|Overall Study|Adverse Event|3
2003004|NCT00126503|3567053|FG000|Overall Study|non-compliant|1
2003005|NCT00126503|3567054|FG001|Overall Study|non-compliant|0
2003006|NCT00126503|3567053|FG000|Overall Study|Physician Decision|2
2003007|NCT00126503|3567054|FG001|Overall Study|Physician Decision|1
2003008|NCT00126555|3567064|FG000|Overall Study|Withdrawal by Subject|1
2003009|NCT00126555|3567064|FG000|Overall Study|Adverse Event|2
2003010|NCT00126555|3567064|FG000|Overall Study|Progressive Disease|3
2003011|NCT00126568|3567080|FG000|Overall Study|Death|2
2003012|NCT00126581|3567087|FG000|Overall Study|Adverse Event|3
2003013|NCT00126581|3567088|FG001|Overall Study|Adverse Event|7
2003014|NCT00126581|3567087|FG000|Overall Study|Death|3
2003015|NCT00126581|3567088|FG001|Overall Study|Death|2
2003016|NCT00126581|3567087|FG000|Overall Study|Withdrawal by Subject|1
2003017|NCT00126581|3567088|FG001|Overall Study|Withdrawal by Subject|4
2003018|NCT00126581|3567087|FG000|Overall Study|Alternative therapy|3
2003019|NCT00126581|3567088|FG001|Overall Study|Alternative therapy|3
2003020|NCT00126581|3567087|FG000|Overall Study|Other illness/MD discretion|3
2003021|NCT00126581|3567088|FG001|Overall Study|Other illness/MD discretion|4
2003022|NCT00126594|3567098|FG000|Overall Study|Ineligible|2
2003023|NCT00126594|3567099|FG001|Overall Study|Ineligible|0
2003024|NCT00126594|3567098|FG000|Overall Study|Withdrawal by Subject|0
2003025|NCT00126594|3567099|FG001|Overall Study|Withdrawal by Subject|4
2003026|NCT00126594|3567098|FG000|Overall Study|Physician Decision|1
2003027|NCT00126594|3567099|FG001|Overall Study|Physician Decision|3
2003028|NCT00126594|3567098|FG000|Overall Study|Adverse Event|7
2003029|NCT00126594|3567099|FG001|Overall Study|Adverse Event|5
2003030|NCT00126594|3567098|FG000|Overall Study|Non-compliance|0
2003031|NCT00126594|3567099|FG001|Overall Study|Non-compliance|1
2003032|NCT00126594|3567098|FG000|Overall Study|Disease Progression|29
2003033|NCT00126594|3567099|FG001|Overall Study|Disease Progression|24
2003034|NCT00127036|3567137|FG000|Overall Study|Insufficient Data for Analysis|6
2003035|NCT00127036|3567138|FG001|Overall Study|Insufficient Data for Analysis|11
2003036|NCT00127036|3567137|FG000|Overall Study|Screen Failure|2
2003037|NCT00127036|3567138|FG001|Overall Study|Screen Failure|0
2003038|NCT00127101|3567163|FG000|Base Protocol|Adverse Event|0
2003039|NCT00127101|3567164|FG001|Base Protocol|Adverse Event|2
2003040|NCT00127101|3567165|FG002|Base Protocol|Adverse Event|1
2003041|NCT00127101|3567166|FG003|Base Protocol|Adverse Event|0
2003042|NCT00127101|3567167|FG004|Base Protocol|Adverse Event|0
2003043|NCT00127101|3567168|FG005|Base Protocol|Adverse Event|0
2003044|NCT00127101|3567163|FG000|Base Protocol|Lack of Efficacy|1
2003045|NCT00127101|3567164|FG001|Base Protocol|Lack of Efficacy|0
2003046|NCT00127101|3567165|FG002|Base Protocol|Lack of Efficacy|0
2003047|NCT00127101|3567166|FG003|Base Protocol|Lack of Efficacy|0
2003048|NCT00127101|3567167|FG004|Base Protocol|Lack of Efficacy|2
2003049|NCT00127101|3567168|FG005|Base Protocol|Lack of Efficacy|0
2003050|NCT00127101|3567163|FG000|Base Protocol|Withdrawal by Subject|1
2003051|NCT00127101|3567164|FG001|Base Protocol|Withdrawal by Subject|2
2003052|NCT00127101|3567165|FG002|Base Protocol|Withdrawal by Subject|1
2003053|NCT00127101|3567166|FG003|Base Protocol|Withdrawal by Subject|0
2003054|NCT00127101|3567167|FG004|Base Protocol|Withdrawal by Subject|0
2003055|NCT00127101|3567168|FG005|Base Protocol|Withdrawal by Subject|1
2003056|NCT00127101|3567163|FG000|Continuation Phase|Adverse Event|0
2003057|NCT00127101|3567164|FG001|Continuation Phase|Adverse Event|0
2003058|NCT00127101|3567165|FG002|Continuation Phase|Adverse Event|0
2003059|NCT00127101|3567166|FG003|Continuation Phase|Adverse Event|0
2003060|NCT00127101|3567167|FG004|Continuation Phase|Adverse Event|1
2003061|NCT00127101|3567168|FG005|Continuation Phase|Adverse Event|1
2003062|NCT00127101|3567163|FG000|Continuation Phase|Lack of Efficacy|0
2003063|NCT00127101|3567164|FG001|Continuation Phase|Lack of Efficacy|0
2003064|NCT00127101|3567165|FG002|Continuation Phase|Lack of Efficacy|0
2003065|NCT00127101|3567166|FG003|Continuation Phase|Lack of Efficacy|0
2003066|NCT00127101|3567167|FG004|Continuation Phase|Lack of Efficacy|0
2003067|NCT00127101|3567168|FG005|Continuation Phase|Lack of Efficacy|1
2003068|NCT00127101|3567163|FG000|Continuation Phase|Withdrawal by Subject|0
2003069|NCT00127101|3567164|FG001|Continuation Phase|Withdrawal by Subject|0
2003070|NCT00127101|3567165|FG002|Continuation Phase|Withdrawal by Subject|1
2003071|NCT00127101|3567166|FG003|Continuation Phase|Withdrawal by Subject|0
2003072|NCT00127101|3567167|FG004|Continuation Phase|Withdrawal by Subject|2
2003073|NCT00127101|3567168|FG005|Continuation Phase|Withdrawal by Subject|1
2003074|NCT00127166|3567184|FG000|Period I|Protocol Violation|0
2003075|NCT00127166|3567185|FG001|Period I|Protocol Violation|2
2003076|NCT00127166|3567184|FG000|Period I|Withdrawal by Subject|2
2003077|NCT00127166|3567185|FG001|Period I|Withdrawal by Subject|0
2003078|NCT00127166|3567184|FG000|Period I|Patient did not meet inclusion criteria|1
2003079|NCT00127166|3567185|FG001|Period I|Patient did not meet inclusion criteria|0
2003080|NCT00127166|3567184|FG000|Washout Period|Patient did not meet inclusion criteria|0
2003081|NCT00127166|3567185|FG001|Washout Period|Patient did not meet inclusion criteria|1
2003082|NCT00127166|3567184|FG000|Period II|Withdrawal by Subject|2
2003083|NCT00127166|3567185|FG001|Period II|Withdrawal by Subject|0
2003084|NCT00127166|3567184|FG000|Period II|Patient did not perform Visit 6 exercise|1
2003085|NCT00127166|3567185|FG001|Period II|Patient did not perform Visit 6 exercise|0
2003086|NCT00127192|3567196|FG000|Overall Study|Adverse Event|0
2003087|NCT00127192|3567197|FG001|Overall Study|Adverse Event|1
2003088|NCT00127192|3567198|FG002|Overall Study|Adverse Event|1
2003089|NCT00127192|3567199|FG003|Overall Study|Adverse Event|1
2003090|NCT00127192|3567200|FG004|Overall Study|Adverse Event|0
2003091|NCT00127192|3567196|FG000|Overall Study|Lack of Efficacy|2
2003092|NCT00127192|3567197|FG001|Overall Study|Lack of Efficacy|0
2003093|NCT00127192|3567198|FG002|Overall Study|Lack of Efficacy|0
2003094|NCT00127192|3567199|FG003|Overall Study|Lack of Efficacy|0
2003095|NCT00127192|3567200|FG004|Overall Study|Lack of Efficacy|2
2003096|NCT00127192|3567196|FG000|Overall Study|Withdrawal by Subject|0
2003097|NCT00127192|3567197|FG001|Overall Study|Withdrawal by Subject|0
2003098|NCT00127192|3567198|FG002|Overall Study|Withdrawal by Subject|1
2003099|NCT00127192|3567199|FG003|Overall Study|Withdrawal by Subject|0
2003100|NCT00127192|3567200|FG004|Overall Study|Withdrawal by Subject|3
2003101|NCT00127192|3567196|FG000|Overall Study|Adverse event in pre-treatment period|1
2003102|NCT00127192|3567197|FG001|Overall Study|Adverse event in pre-treatment period|0
2003103|NCT00127192|3567198|FG002|Overall Study|Adverse event in pre-treatment period|0
2003104|NCT00127192|3567199|FG003|Overall Study|Adverse event in pre-treatment period|0
2003105|NCT00127192|3567200|FG004|Overall Study|Adverse event in pre-treatment period|0
2003106|NCT00127205|3567215|FG000|Overall Study|Adverse Event|228
2003107|NCT00127205|3567216|FG001|Overall Study|Adverse Event|387
2003108|NCT00127205|3567217|FG002|Overall Study|Adverse Event|273
2003109|NCT00127205|3567215|FG000|Overall Study|Death|8
2003110|NCT00127205|3567216|FG001|Overall Study|Death|6
2003111|NCT00127205|3567217|FG002|Overall Study|Death|5
2003112|NCT00127205|3567215|FG000|Overall Study|Withdrawal by Subject|318
2003113|NCT00127205|3567216|FG001|Overall Study|Withdrawal by Subject|310
2003114|NCT00127205|3567217|FG002|Overall Study|Withdrawal by Subject|172
2003115|NCT00127205|3567215|FG000|Overall Study|Other-non protocol specified|142
2003116|NCT00127205|3567216|FG001|Overall Study|Other-non protocol specified|129
2003117|NCT00127205|3567217|FG002|Overall Study|Other-non protocol specified|77
2003118|NCT00127205|3567215|FG000|Overall Study|Data not reported|6
2003119|NCT00127205|3567216|FG001|Overall Study|Data not reported|10
2003120|NCT00127205|3567217|FG002|Overall Study|Data not reported|1
2003121|NCT00127205|3567215|FG000|Overall Study|Progression|127
2003122|NCT00127205|3567216|FG001|Overall Study|Progression|131
2003123|NCT00127205|3567217|FG002|Overall Study|Progression|84
2003124|NCT00127413|3567251|FG000|Overall Study|Lost to Follow-up|6
2003125|NCT00127413|3567252|FG001|Overall Study|Lost to Follow-up|4
2003126|NCT00127413|3567253|FG002|Overall Study|Lost to Follow-up|8
2003127|NCT00127413|3567254|FG003|Overall Study|Lost to Follow-up|2
2003128|NCT00127608|3567285|FG000|Overall Study|VZV DNA negative|1
2003129|NCT00127660|3567293|FG000|Overall Study|Protocol Violation|3
2003130|NCT00127660|3567294|FG001|Overall Study|Protocol Violation|3
2003131|NCT00127660|3567295|FG002|Overall Study|Protocol Violation|5
2003132|NCT00127660|3567296|FG003|Overall Study|Protocol Violation|0
2003133|NCT00127712|3567308|FG000|Overall Study|Adverse Event|3
2003134|NCT00127712|3567309|FG001|Overall Study|Adverse Event|0
2003135|NCT00127712|3567308|FG000|Overall Study|Lack of GI access to continue|2
2003136|NCT00127712|3567309|FG001|Overall Study|Lack of GI access to continue|0
2003137|NCT00127803|3567336|FG000|Overall Study|Adverse Event|2
2003138|NCT00127803|3567337|FG001|Overall Study|Adverse Event|0
2003139|NCT00127803|3567338|FG002|Overall Study|Adverse Event|0
2003140|NCT00127803|3567339|FG003|Overall Study|Adverse Event|0
2003141|NCT00127803|3567336|FG000|Overall Study|Withdrawal by Subject|1
2003142|NCT00127803|3567337|FG001|Overall Study|Withdrawal by Subject|0
2003143|NCT00127803|3567338|FG002|Overall Study|Withdrawal by Subject|0
2003144|NCT00127803|3567339|FG003|Overall Study|Withdrawal by Subject|0
2003145|NCT00127803|3567336|FG000|Overall Study|Lost to Follow-up|0
2003146|NCT00127803|3567337|FG001|Overall Study|Lost to Follow-up|0
2003147|NCT00127803|3567338|FG002|Overall Study|Lost to Follow-up|0
2003148|NCT00127803|3567339|FG003|Overall Study|Lost to Follow-up|1
2003149|NCT00127842|3567349|FG000|Overall Study|Adverse Event|15
2003150|NCT00127842|3567349|FG000|Overall Study|Withdrawal by Subject|3
2003151|NCT00127842|3567349|FG000|Overall Study|Lost to Follow-up|1
2003152|NCT00127842|3567349|FG000|Overall Study|Lack of Efficacy|12
2003153|NCT00127842|3567349|FG000|Overall Study|Noncompliance|2
2003154|NCT00127842|3567349|FG000|Overall Study|Protocol Violation|1
2003155|NCT00127842|3567349|FG000|Overall Study|Other|5
2003156|NCT00127855|3567358|FG000|Primary Vaccination Course|Adverse Event|0
2003157|NCT00127855|3567359|FG001|Primary Vaccination Course|Adverse Event|0
2003158|NCT00127855|3567360|FG002|Primary Vaccination Course|Adverse Event|1
2003159|NCT00127855|3567361|FG003|Primary Vaccination Course|Adverse Event|0
2003160|NCT00127855|3567362|FG004|Primary Vaccination Course|Adverse Event|0
2003161|NCT00127855|3567358|FG000|Primary Vaccination Course|Withdrawal by Subject|1
2003162|NCT00127855|3567359|FG001|Primary Vaccination Course|Withdrawal by Subject|0
2003163|NCT00127855|3567360|FG002|Primary Vaccination Course|Withdrawal by Subject|0
2003164|NCT00127855|3567361|FG003|Primary Vaccination Course|Withdrawal by Subject|0
2003165|NCT00127855|3567362|FG004|Primary Vaccination Course|Withdrawal by Subject|1
2003166|NCT00127855|3567358|FG000|Primary Vaccination Course|Lost to Follow-up|1
2003167|NCT00127855|3567359|FG001|Primary Vaccination Course|Lost to Follow-up|1
2003168|NCT00127855|3567360|FG002|Primary Vaccination Course|Lost to Follow-up|1
2003169|NCT00127855|3567361|FG003|Primary Vaccination Course|Lost to Follow-up|0
2003170|NCT00127855|3567362|FG004|Primary Vaccination Course|Lost to Follow-up|2
2003171|NCT00127855|3567358|FG000|Primary Vaccination Course|Other|0
2003172|NCT00127855|3567359|FG001|Primary Vaccination Course|Other|0
2003173|NCT00127855|3567360|FG002|Primary Vaccination Course|Other|0
2003174|NCT00127855|3567361|FG003|Primary Vaccination Course|Other|0
2003175|NCT00127855|3567362|FG004|Primary Vaccination Course|Other|1
2003176|NCT00127933|3567376|FG000|Overall Study|Randomized but not dosed|1
2003177|NCT00127933|3567377|FG001|Overall Study|Randomized but not dosed|0
2003178|NCT00128102|3567385|FG000|Overall Study|Site Discontinued|3
2003179|NCT00128102|3567386|FG001|Overall Study|Site Discontinued|6
2003180|NCT00128102|3567385|FG000|Overall Study|Other|0
2003181|NCT00128102|3567386|FG001|Overall Study|Other|1
2003182|NCT00128102|3567385|FG000|Overall Study|Progressive Disease|255
2003183|NCT00128102|3567386|FG001|Overall Study|Progressive Disease|285
2003184|NCT00128102|3567385|FG000|Overall Study|Adverse Event|34
2003185|NCT00128102|3567386|FG001|Overall Study|Adverse Event|11
2003186|NCT00128102|3567385|FG000|Overall Study|Death|12
2003187|NCT00128102|3567386|FG001|Overall Study|Death|13
2003188|NCT00128102|3567385|FG000|Overall Study|Physician Decision|3
2003189|NCT00128102|3567386|FG001|Overall Study|Physician Decision|3
2003190|NCT00128102|3567385|FG000|Overall Study|Withdrawal by Subject|19
2003191|NCT00128102|3567386|FG001|Overall Study|Withdrawal by Subject|11
2003192|NCT00128102|3567385|FG000|Overall Study|Protocol Violation|2
2003193|NCT00128102|3567386|FG001|Overall Study|Protocol Violation|2
2003194|NCT00128206|3567506|FG000|Overall Study|Lost to Follow-up|137
2003195|NCT00128206|3567507|FG001|Overall Study|Lost to Follow-up|118
2003196|NCT00128206|3567506|FG000|Overall Study|Adverse Event|0
2003197|NCT00128206|3567507|FG001|Overall Study|Adverse Event|2
2003198|NCT00128492|3567534|FG000|Overall Study|AE unrelated to study|2
2003199|NCT00128492|3567535|FG001|Overall Study|AE unrelated to study|9
2003200|NCT00128492|3567534|FG000|Overall Study|Study drug intolerance (AE)|2
2003201|NCT00128492|3567535|FG001|Overall Study|Study drug intolerance (AE)|8
2003202|NCT00128492|3567534|FG000|Overall Study|AE related to study|1
2003203|NCT00128492|3567535|FG001|Overall Study|AE related to study|4
2003204|NCT00128492|3567534|FG000|Overall Study|Death|1
2003205|NCT00128492|3567535|FG001|Overall Study|Death|0
2003206|NCT00128492|3567534|FG000|Overall Study|Lost to Follow-up|1
2003207|NCT00128492|3567535|FG001|Overall Study|Lost to Follow-up|5
2003208|NCT00128492|3567534|FG000|Overall Study|Noncompliance|0
2003209|NCT00128492|3567535|FG001|Overall Study|Noncompliance|5
2003210|NCT00128492|3567534|FG000|Overall Study|Personal or administrative|10
2003211|NCT00128492|3567535|FG001|Overall Study|Personal or administrative|22
2003212|NCT00128492|3567534|FG000|Overall Study|Withdrawal by Subject|3
2003213|NCT00128492|3567535|FG001|Overall Study|Withdrawal by Subject|5
2003214|NCT00128492|3567534|FG000|Overall Study|Pregnancy|0
2003215|NCT00128492|3567535|FG001|Overall Study|Pregnancy|1
2003216|NCT00128661|3567543|FG000|Overall Study|Adverse Event|14
2003217|NCT00128661|3567544|FG001|Overall Study|Adverse Event|11
2003218|NCT00128661|3567543|FG000|Overall Study|Lost to Follow-up|10
2003219|NCT00128661|3567544|FG001|Overall Study|Lost to Follow-up|7
2003220|NCT00128661|3567543|FG000|Overall Study|Withdrawal by Subject|243
2003221|NCT00128661|3567544|FG001|Overall Study|Withdrawal by Subject|232
2003222|NCT00128661|3567543|FG000|Overall Study|Other|7
2312250|NCT02763215|4018106|FG000|Overall Study|Death|1
2312251|NCT02763215|4018106|FG000|Overall Study|Lost to Follow-up|1
2312252|NCT02763254|4018110|FG000|Overall Study|Adverse Event|1
2312253|NCT02763566|4018118|FG000|Overall Study|Lost to Follow-up|1
2312254|NCT02763566|4018119|FG001|Overall Study|Lost to Follow-up|4
2312255|NCT02763566|4018120|FG002|Overall Study|Lost to Follow-up|0
2312256|NCT02763566|4018121|FG003|Overall Study|Lost to Follow-up|1
2312257|NCT02763566|4018118|FG000|Overall Study|On study treatment at study conclusion|114
2312258|NCT02763566|4018119|FG001|Overall Study|On study treatment at study conclusion|34
2312259|NCT02763566|4018120|FG002|Overall Study|On study treatment at study conclusion|54
2312260|NCT02763566|4018121|FG003|Overall Study|On study treatment at study conclusion|13
2312261|NCT02763566|4018118|FG000|Overall Study|Withdrawal by Subject|3
2312262|NCT02763566|4018119|FG001|Overall Study|Withdrawal by Subject|1
2312263|NCT02763566|4018120|FG002|Overall Study|Withdrawal by Subject|0
2312264|NCT02763566|4018121|FG003|Overall Study|Withdrawal by Subject|0
2312265|NCT02763579|4018137|FG000|Overall Study|Death|101
2312266|NCT02763579|4018138|FG001|Overall Study|Death|132
2312267|NCT02763579|4018137|FG000|Overall Study|Lost to Follow-up|3
2312268|NCT02763579|4018138|FG001|Overall Study|Lost to Follow-up|1
2312269|NCT02763579|4018137|FG000|Overall Study|Withdrawal by Subject|18
2312270|NCT02763579|4018138|FG001|Overall Study|Withdrawal by Subject|9
2312271|NCT02763579|4018137|FG000|Overall Study|Physician Decision|2
2312272|NCT02763579|4018138|FG001|Overall Study|Physician Decision|0
2312273|NCT02763579|4018137|FG000|Overall Study|On-going in study|77
2003223|NCT00128661|3567544|FG001|Overall Study|Other|8
2003224|NCT00128830|3567563|FG000|Overall Study|Adverse Event|10
2003225|NCT00128830|3567563|FG000|Overall Study|Withdrawal by Subject|14
2003226|NCT00128830|3567563|FG000|Overall Study|Lost to Follow-up|4
2003227|NCT00128830|3567563|FG000|Overall Study|Reached a virologic endpoint|29
2003228|NCT00128830|3567563|FG000|Overall Study|Non-compliant|4
2003229|NCT00128830|3567563|FG000|Overall Study|Discontinued or ineligible for study|2
2003230|NCT00128830|3567563|FG000|Overall Study|Other|9
2312274|NCT02763579|4018138|FG001|Overall Study|On-going in study|60
2003231|NCT00129116|3567589|FG000|Primary Phase|Lost to Follow-up|1
2003232|NCT00129116|3567590|FG001|Primary Phase|Lost to Follow-up|1
2003233|NCT00129116|3567591|FG002|Primary Phase|Lost to Follow-up|0
2003234|NCT00129116|3567592|FG003|Primary Phase|Lost to Follow-up|1
2003235|NCT00129116|3567593|FG004|Primary Phase|Lost to Follow-up|1
2003236|NCT00129116|3567589|FG000|Primary Phase|Protocol Violation|0
2003237|NCT00129116|3567590|FG001|Primary Phase|Protocol Violation|1
2003238|NCT00129116|3567591|FG002|Primary Phase|Protocol Violation|0
2003239|NCT00129116|3567592|FG003|Primary Phase|Protocol Violation|0
2003240|NCT00129116|3567593|FG004|Primary Phase|Protocol Violation|0
2003241|NCT00129116|3567589|FG000|Primary Phase|Adverse Event|1
2003242|NCT00129116|3567590|FG001|Primary Phase|Adverse Event|1
2003243|NCT00129116|3567591|FG002|Primary Phase|Adverse Event|0
2003244|NCT00129116|3567592|FG003|Primary Phase|Adverse Event|0
2003245|NCT00129116|3567593|FG004|Primary Phase|Adverse Event|0
2003246|NCT00129116|3567589|FG000|Primary Phase|Withdrawal by Subject|0
2003247|NCT00129116|3567590|FG001|Primary Phase|Withdrawal by Subject|1
2003248|NCT00129116|3567591|FG002|Primary Phase|Withdrawal by Subject|0
2003249|NCT00129116|3567592|FG003|Primary Phase|Withdrawal by Subject|0
2003250|NCT00129116|3567593|FG004|Primary Phase|Withdrawal by Subject|0
2003251|NCT00129116|3567589|FG000|Primary Phase|Other|0
2003252|NCT00129116|3567590|FG001|Primary Phase|Other|0
2003253|NCT00129116|3567591|FG002|Primary Phase|Other|1
2003254|NCT00129116|3567592|FG003|Primary Phase|Other|0
2003255|NCT00129116|3567593|FG004|Primary Phase|Other|0
2003256|NCT00129116|3567589|FG000|Booster Phase|Lost to Follow-up|2
2003257|NCT00129116|3567590|FG001|Booster Phase|Lost to Follow-up|0
2003258|NCT00129116|3567591|FG002|Booster Phase|Lost to Follow-up|0
2003259|NCT00129116|3567592|FG003|Booster Phase|Lost to Follow-up|0
2003260|NCT00129116|3567593|FG004|Booster Phase|Lost to Follow-up|1
2312275|NCT02763644|4018146|FG000|Overall Study|Patient/guardian decision|1
2312276|NCT02763644|4018147|FG001|Overall Study|Patient/guardian decision|0
2312277|NCT02763644|4018146|FG000|Overall Study|Death|1
2312278|NCT02763644|4018147|FG001|Overall Study|Death|1
2312279|NCT02763644|4018146|FG000|Overall Study|Adverse Event|1
2312280|NCT02763644|4018147|FG001|Overall Study|Adverse Event|1
2312281|NCT02764151|4018202|FG000|Overall Study|Subject refused further follow-up|0
2312282|NCT02764151|4018203|FG001|Overall Study|Subject refused further follow-up|0
2312283|NCT02764151|4018204|FG002|Overall Study|Subject refused further follow-up|0
2312284|NCT02764151|4018205|FG003|Overall Study|Subject refused further follow-up|1
2214086|NCT01684215|3856069|FG002|Phase 2|Study terminated by sponsor|0
2214087|NCT01684215|3856070|FG003|Phase 2|Study terminated by sponsor|30
2214088|NCT01684215|3856067|FG000|Phase 2|Enrolled but not treated|0
2214089|NCT01684215|3856068|FG001|Phase 2|Enrolled but not treated|0
2214090|NCT01684215|3856069|FG002|Phase 2|Enrolled but not treated|0
2214091|NCT01684215|3856070|FG003|Phase 2|Enrolled but not treated|1
2214092|NCT01684215|3856067|FG000|Phase 2|Lost to Follow-up|0
2214093|NCT01684215|3856068|FG001|Phase 2|Lost to Follow-up|0
2214094|NCT01684215|3856069|FG002|Phase 2|Lost to Follow-up|0
2214095|NCT01684215|3856070|FG003|Phase 2|Lost to Follow-up|4
2214096|NCT01684423|3856101|FG000|Overall Study|Withdrawal by Subject|0
2214097|NCT01684423|3856102|FG001|Overall Study|Withdrawal by Subject|0
2312285|NCT02764151|4018202|FG000|Overall Study|Other|0
2312286|NCT02764151|4018203|FG001|Overall Study|Other|0
2312287|NCT02764151|4018204|FG002|Overall Study|Other|0
2312288|NCT02764151|4018205|FG003|Overall Study|Other|2
2312289|NCT02764190|4018221|FG000|Overall Study|Lost to Follow-up|17
2312290|NCT02764190|4018222|FG001|Overall Study|Lost to Follow-up|13
2312291|NCT02764229|4018228|FG000|Overall Study|Withdrawal by Subject|15
2312292|NCT02764229|4018228|FG000|Overall Study|Adverse Event|9
2312293|NCT02764229|4018228|FG000|Overall Study|Physician Decision|5
2312294|NCT02764229|4018228|FG000|Overall Study|Lost to Follow-up|3
2312295|NCT02764229|4018228|FG000|Overall Study|Lack of Efficacy|1
2312296|NCT02764229|4018228|FG000|Overall Study|Study Stopped by Sponsor|69
2312297|NCT02764320|4018234|FG000|Overall Study|Withdrawal by Subject|35
2312298|NCT02764320|4018235|FG001|Overall Study|Withdrawal by Subject|38
2312299|NCT02764320|4018234|FG000|Overall Study|Protocol Violation|11
2312300|NCT02764320|4018235|FG001|Overall Study|Protocol Violation|6
2312301|NCT02764320|4018234|FG000|Overall Study|Adverse Event|2
2312302|NCT02764320|4018235|FG001|Overall Study|Adverse Event|0
2312303|NCT02764320|4018234|FG000|Overall Study|Health Issues unable to continue|2
2312304|NCT02764320|4018235|FG001|Overall Study|Health Issues unable to continue|0
2312305|NCT02764320|4018234|FG000|Overall Study|Did not meet inclusion criteria|1
2312306|NCT02764320|4018235|FG001|Overall Study|Did not meet inclusion criteria|0
2312307|NCT02764320|4018234|FG000|Overall Study|Subject moved|0
2312308|NCT02764320|4018235|FG001|Overall Study|Subject moved|2
2312309|NCT02764320|4018234|FG000|Overall Study|Overused medication unavailable|0
2312310|NCT02764320|4018235|FG001|Overall Study|Overused medication unavailable|1
2312311|NCT02764320|4018234|FG000|Overall Study|Seeking care outside site|0
2312312|NCT02764320|4018235|FG001|Overall Study|Seeking care outside site|1
2312313|NCT02764320|4018234|FG000|Overall Study|Technology barriers|0
2003261|NCT00129129|3567608|FG000|Primary Phase|Adverse Event|2
2003262|NCT00129129|3567609|FG001|Primary Phase|Adverse Event|1
2214098|NCT01684423|3856103|FG002|Overall Study|Withdrawal by Subject|1
2214099|NCT01684423|3856104|FG003|Overall Study|Withdrawal by Subject|0
2312314|NCT02764320|4018235|FG001|Overall Study|Technology barriers|1
2003263|NCT00129129|3567610|FG002|Primary Phase|Adverse Event|0
2003264|NCT00129129|3567611|FG003|Primary Phase|Adverse Event|0
2003265|NCT00129129|3567612|FG004|Primary Phase|Adverse Event|0
2003266|NCT00129129|3567608|FG000|Primary Phase|Withdrawal by Subject|12
2003267|NCT00129129|3567609|FG001|Primary Phase|Withdrawal by Subject|10
2003268|NCT00129129|3567610|FG002|Primary Phase|Withdrawal by Subject|0
2003269|NCT00129129|3567611|FG003|Primary Phase|Withdrawal by Subject|0
2003270|NCT00129129|3567612|FG004|Primary Phase|Withdrawal by Subject|0
2003271|NCT00129129|3567608|FG000|Primary Phase|Migration from study area|1
2003272|NCT00129129|3567609|FG001|Primary Phase|Migration from study area|3
2003273|NCT00129129|3567610|FG002|Primary Phase|Migration from study area|0
2003274|NCT00129129|3567611|FG003|Primary Phase|Migration from study area|0
2003275|NCT00129129|3567612|FG004|Primary Phase|Migration from study area|0
2003276|NCT00129129|3567608|FG000|Primary Phase|Lost to Follow-up|8
2003277|NCT00129129|3567609|FG001|Primary Phase|Lost to Follow-up|6
2003278|NCT00129129|3567610|FG002|Primary Phase|Lost to Follow-up|0
2003279|NCT00129129|3567611|FG003|Primary Phase|Lost to Follow-up|0
2003280|NCT00129129|3567612|FG004|Primary Phase|Lost to Follow-up|0
2003281|NCT00129129|3567608|FG000|Primary Phase|Other|2
2003282|NCT00129129|3567609|FG001|Primary Phase|Other|5
2003283|NCT00129129|3567610|FG002|Primary Phase|Other|0
2003284|NCT00129129|3567611|FG003|Primary Phase|Other|0
2003285|NCT00129129|3567612|FG004|Primary Phase|Other|0
2003286|NCT00129129|3567608|FG000|Fourth Dose Phase|Lost to Follow-up|4
2003287|NCT00129129|3567609|FG001|Fourth Dose Phase|Lost to Follow-up|0
2003288|NCT00129129|3567610|FG002|Fourth Dose Phase|Lost to Follow-up|0
2003289|NCT00129129|3567611|FG003|Fourth Dose Phase|Lost to Follow-up|2
2003290|NCT00129129|3567612|FG004|Fourth Dose Phase|Lost to Follow-up|2
2003291|NCT00129129|3567608|FG000|Fourth Dose Phase|Withdrawal by Subject|0
2003292|NCT00129129|3567609|FG001|Fourth Dose Phase|Withdrawal by Subject|0
2003293|NCT00129129|3567610|FG002|Fourth Dose Phase|Withdrawal by Subject|0
2003294|NCT00129129|3567611|FG003|Fourth Dose Phase|Withdrawal by Subject|0
2003295|NCT00129129|3567612|FG004|Fourth Dose Phase|Withdrawal by Subject|1
2003296|NCT00129129|3567608|FG000|Fourth Dose Phase|Migration from study area|0
2003297|NCT00129129|3567609|FG001|Fourth Dose Phase|Migration from study area|0
2003298|NCT00129129|3567610|FG002|Fourth Dose Phase|Migration from study area|0
2003299|NCT00129129|3567611|FG003|Fourth Dose Phase|Migration from study area|0
2003300|NCT00129129|3567612|FG004|Fourth Dose Phase|Migration from study area|2
2003301|NCT00129129|3567608|FG000|Fourth Dose Phase|Other|0
2003302|NCT00129129|3567609|FG001|Fourth Dose Phase|Other|0
2003303|NCT00129129|3567610|FG002|Fourth Dose Phase|Other|0
2003304|NCT00129129|3567611|FG003|Fourth Dose Phase|Other|1
2003305|NCT00129129|3567612|FG004|Fourth Dose Phase|Other|1
2003306|NCT00129129|3567608|FG000|Fourth Dose Phase|Protocol Violation|0
2003307|NCT00129129|3567609|FG001|Fourth Dose Phase|Protocol Violation|0
2003308|NCT00129129|3567610|FG002|Fourth Dose Phase|Protocol Violation|0
2003309|NCT00129129|3567611|FG003|Fourth Dose Phase|Protocol Violation|1
2003310|NCT00129129|3567612|FG004|Fourth Dose Phase|Protocol Violation|0
2003311|NCT00129220|3567635|FG000|Study Period II|Adverse Event|9
2003312|NCT00129220|3567636|FG001|Study Period II|Adverse Event|5
2003313|NCT00129220|3567637|FG002|Study Period II|Adverse Event|7
2003314|NCT00129220|3567635|FG000|Study Period II|Lack of Efficacy|15
2003315|NCT00129220|3567636|FG001|Study Period II|Lack of Efficacy|1
2003316|NCT00129220|3567637|FG002|Study Period II|Lack of Efficacy|28
2003317|NCT00129220|3567635|FG000|Study Period II|Entry Criteria Not Met|2
2003318|NCT00129220|3567636|FG001|Study Period II|Entry Criteria Not Met|0
2003319|NCT00129220|3567637|FG002|Study Period II|Entry Criteria Not Met|2
2003320|NCT00129220|3567635|FG000|Study Period II|Protocol Violation|4
2003321|NCT00129220|3567636|FG001|Study Period II|Protocol Violation|2
2003322|NCT00129220|3567637|FG002|Study Period II|Protocol Violation|1
2003323|NCT00129220|3567635|FG000|Study Period II|Physician Decision|0
2003324|NCT00129220|3567636|FG001|Study Period II|Physician Decision|1
2003325|NCT00129220|3567637|FG002|Study Period II|Physician Decision|0
2003326|NCT00129220|3567635|FG000|Study Period II|Withdrawal by Subject|1
2003327|NCT00129220|3567636|FG001|Study Period II|Withdrawal by Subject|3
2003328|NCT00129220|3567637|FG002|Study Period II|Withdrawal by Subject|4
2003329|NCT00129220|3567635|FG000|Study Period II|Reason Not Specified|2
2003330|NCT00129220|3567636|FG001|Study Period II|Reason Not Specified|0
2003331|NCT00129220|3567637|FG002|Study Period II|Reason Not Specified|5
2003332|NCT00129220|3567635|FG000|Study Period III|Adverse Event|1
2003333|NCT00129220|3567636|FG001|Study Period III|Adverse Event|0
2003334|NCT00129220|3567637|FG002|Study Period III|Adverse Event|3
2003335|NCT00129220|3567635|FG000|Study Period III|Protocol Violation|1
2003336|NCT00129220|3567636|FG001|Study Period III|Protocol Violation|1
2003337|NCT00129220|3567637|FG002|Study Period III|Protocol Violation|2
2003338|NCT00129220|3567635|FG000|Study Period III|Withdrawal by Subject|1
2003339|NCT00129220|3567636|FG001|Study Period III|Withdrawal by Subject|0
2003340|NCT00129220|3567637|FG002|Study Period III|Withdrawal by Subject|3
2003341|NCT00129220|3567635|FG000|Study Period III|Sponsor Decision|1
2003342|NCT00129220|3567636|FG001|Study Period III|Sponsor Decision|0
2003343|NCT00129220|3567637|FG002|Study Period III|Sponsor Decision|0
2003344|NCT00129220|3567635|FG000|Study Period III|Reason Not Specified|9
2003345|NCT00129220|3567636|FG001|Study Period III|Reason Not Specified|0
2003346|NCT00129220|3567637|FG002|Study Period III|Reason Not Specified|2
2003347|NCT00129259|3567658|FG000|Overall Study|Lost to Follow-up|1
2003348|NCT00129259|3567659|FG001|Overall Study|Lost to Follow-up|1
2003349|NCT00129259|3567658|FG000|Overall Study|Withdrawal by Subject|2
2003350|NCT00129259|3567659|FG001|Overall Study|Withdrawal by Subject|1
2003351|NCT00129259|3567658|FG000|Overall Study|Only available minimal phone assessments|0
2003352|NCT00129259|3567659|FG001|Overall Study|Only available minimal phone assessments|1
2003353|NCT00129272|3567667|FG000|Overall Study|Lost to Follow-up|12
2003354|NCT00129272|3567668|FG001|Overall Study|Lost to Follow-up|11
2003355|NCT00129272|3567667|FG000|Overall Study|Withdrawal by Subject|5
2003356|NCT00129272|3567668|FG001|Overall Study|Withdrawal by Subject|11
2003357|NCT00129311|3567693|FG000|Overall Study|Withdrawal by Subject|12
2003358|NCT00129311|3567694|FG001|Overall Study|Withdrawal by Subject|19
2003359|NCT00129376|3567700|FG000|Overall Study|Adverse Event|1
2003360|NCT00129376|3567700|FG000|Overall Study|Lack of Efficacy|1
2003361|NCT00129389|3567706|FG000|Overall Study|Adverse Event|19
2003362|NCT00129389|3567707|FG001|Overall Study|Adverse Event|87
2003363|NCT00129389|3567706|FG000|Overall Study|Death|0
2003364|NCT00129389|3567707|FG001|Overall Study|Death|1
2003365|NCT00129389|3567706|FG000|Overall Study|Lost to Follow-up|2
2003366|NCT00129389|3567707|FG001|Overall Study|Lost to Follow-up|1
2003367|NCT00129389|3567706|FG000|Overall Study|Physician Decision|0
2003368|NCT00129389|3567707|FG001|Overall Study|Physician Decision|4
2003369|NCT00129389|3567706|FG000|Overall Study|Protocol Violation|0
2003370|NCT00129389|3567707|FG001|Overall Study|Protocol Violation|6
2003371|NCT00129389|3567706|FG000|Overall Study|Withdrawal by Subject|9
2003372|NCT00129389|3567707|FG001|Overall Study|Withdrawal by Subject|23
2003373|NCT00129389|3567706|FG000|Overall Study|Relapse|1
2003374|NCT00129389|3567707|FG001|Overall Study|Relapse|0
2003375|NCT00129389|3567706|FG000|Overall Study|Not eligible|1
2003376|NCT00129389|3567707|FG001|Overall Study|Not eligible|2
2003377|NCT00129389|3567706|FG000|Overall Study|Crossed to the other arm|1
2003378|NCT00129389|3567707|FG001|Overall Study|Crossed to the other arm|16
2003379|NCT00129467|3567724|FG000|Received Intervention|Death|1
2312315|NCT02764333|4018241|FG000|Overall Study|Ineligible|1
2312316|NCT02764697|4018254|FG000|Overall Study|Lack of Efficacy|3
2312317|NCT02764762|4018258|FG000|Overall Study|Adverse Event|5
2312318|NCT02764762|4018258|FG000|Overall Study|Voluntary Withdrawal|3
2312319|NCT02764762|4018258|FG000|Overall Study|Significant Deviation|1
2312320|NCT02764775|4018262|FG000|Overall Study|Death|1
2312321|NCT02764775|4018262|FG000|Overall Study|Lost to Follow-up|2
2312322|NCT02764775|4018262|FG000|Overall Study|Withdrawal by Subject|3
2312323|NCT02765035|4018277|FG000|First Intervention (90 Days)|Adverse Event|1
2312324|NCT02765035|4018278|FG001|First Intervention (90 Days)|Adverse Event|1
2312325|NCT02765035|4018277|FG000|Second Intervention (30 Days)|Protocol Violation|2
2312326|NCT02765035|4018278|FG001|Second Intervention (30 Days)|Protocol Violation|2
2312327|NCT02765100|4018287|FG000|Overall Study|subject found ineligible after baseline|1
2312328|NCT02765100|4018288|FG001|Overall Study|subject found ineligible after baseline|1
2312329|NCT02765100|4018287|FG000|Overall Study|Lost to Follow-up|0
2312330|NCT02765100|4018288|FG001|Overall Study|Lost to Follow-up|1
2312331|NCT02765165|4018301|FG000|Treatment Period|Progressive disease|3
2312332|NCT02765165|4018302|FG001|Treatment Period|Progressive disease|2
2312333|NCT02765165|4018303|FG002|Treatment Period|Progressive disease|3
2312334|NCT02765165|4018304|FG003|Treatment Period|Progressive disease|3
2312335|NCT02765165|4018305|FG004|Treatment Period|Progressive disease|4
2312336|NCT02765165|4018306|FG005|Treatment Period|Progressive disease|2
2312337|NCT02765165|4018307|FG006|Treatment Period|Progressive disease|2
2312338|NCT02765165|4018301|FG000|Treatment Period|Physician Decision|0
2312339|NCT02765165|4018302|FG001|Treatment Period|Physician Decision|1
2312340|NCT02765165|4018303|FG002|Treatment Period|Physician Decision|0
2312341|NCT02765165|4018304|FG003|Treatment Period|Physician Decision|0
2312342|NCT02765165|4018305|FG004|Treatment Period|Physician Decision|0
2312343|NCT02765165|4018306|FG005|Treatment Period|Physician Decision|0
2312344|NCT02765165|4018307|FG006|Treatment Period|Physician Decision|0
2312345|NCT02765165|4018301|FG000|Treatment Period|Adverse Event|0
2312346|NCT02765165|4018302|FG001|Treatment Period|Adverse Event|1
2312347|NCT02765165|4018303|FG002|Treatment Period|Adverse Event|0
2312348|NCT02765165|4018304|FG003|Treatment Period|Adverse Event|0
2312349|NCT02765165|4018305|FG004|Treatment Period|Adverse Event|0
2312350|NCT02765165|4018306|FG005|Treatment Period|Adverse Event|0
2312351|NCT02765165|4018307|FG006|Treatment Period|Adverse Event|0
2312352|NCT02765165|4018301|FG000|Treatment Period|Withdrawal by Subject|0
2312353|NCT02765165|4018302|FG001|Treatment Period|Withdrawal by Subject|0
2312354|NCT02765165|4018303|FG002|Treatment Period|Withdrawal by Subject|0
2312355|NCT02765165|4018304|FG003|Treatment Period|Withdrawal by Subject|0
2312356|NCT02765165|4018305|FG004|Treatment Period|Withdrawal by Subject|2
2003380|NCT00129467|3567725|FG001|Received Intervention|Death|1
2312357|NCT02765165|4018306|FG005|Treatment Period|Withdrawal by Subject|0
2312358|NCT02765165|4018307|FG006|Treatment Period|Withdrawal by Subject|0
2312359|NCT02765165|4018301|FG000|Treatment Period|Study terminated|0
2312360|NCT02765165|4018302|FG001|Treatment Period|Study terminated|0
2312361|NCT02765165|4018303|FG002|Treatment Period|Study terminated|0
2312362|NCT02765165|4018304|FG003|Treatment Period|Study terminated|0
2003381|NCT00129467|3567724|FG000|Received Intervention|Cardiac SAE (hypertension)|1
2003382|NCT00129467|3567725|FG001|Received Intervention|Cardiac SAE (hypertension)|1
2003383|NCT00129467|3567724|FG000|Received Intervention|Delirium|2
2003384|NCT00129467|3567725|FG001|Received Intervention|Delirium|0
2003385|NCT00129467|3567724|FG000|Received Intervention|Withdrawal by Subject|1
2003386|NCT00129467|3567725|FG001|Received Intervention|Withdrawal by Subject|0
2003387|NCT00129467|3567724|FG000|Received Intervention|Nausea|1
2003388|NCT00129467|3567725|FG001|Received Intervention|Nausea|0
2003389|NCT00129467|3567724|FG000|Received Intervention|Intolerance to citalopram|0
2003390|NCT00129467|3567725|FG001|Received Intervention|Intolerance to citalopram|1
2003391|NCT00129467|3567724|FG000|Received Intervention|Dizzyness, fatigue|0
2003392|NCT00129467|3567725|FG001|Received Intervention|Dizzyness, fatigue|1
2003393|NCT00129467|3567724|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1
2003394|NCT00129467|3567725|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0
2003395|NCT00129467|3567724|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1
2003396|NCT00129467|3567725|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0
2003397|NCT00129545|3567743|FG000|Overall Study|Death|5
2003398|NCT00129545|3567744|FG001|Overall Study|Death|60
2003399|NCT00129545|3567745|FG002|Overall Study|Death|44
2003400|NCT00129545|3567743|FG000|Overall Study|Withdrawal by Subject|3
2003401|NCT00129545|3567744|FG001|Overall Study|Withdrawal by Subject|18
2003402|NCT00129545|3567745|FG002|Overall Study|Withdrawal by Subject|44
2003403|NCT00129545|3567743|FG000|Overall Study|Lost to Follow-up|2
2003404|NCT00129545|3567744|FG001|Overall Study|Lost to Follow-up|22
2003405|NCT00129545|3567745|FG002|Overall Study|Lost to Follow-up|13
2003406|NCT00129545|3567743|FG000|Overall Study|Physician Decision|0
2003407|NCT00129545|3567744|FG001|Overall Study|Physician Decision|3
2003408|NCT00129545|3567745|FG002|Overall Study|Physician Decision|10
2003409|NCT00129545|3567743|FG000|Overall Study|Device not implanted|16
2003410|NCT00129545|3567744|FG001|Overall Study|Device not implanted|61
2312363|NCT02765165|4018305|FG004|Treatment Period|Study terminated|0
2312364|NCT02765165|4018306|FG005|Treatment Period|Study terminated|1
2312365|NCT02765165|4018307|FG006|Treatment Period|Study terminated|2
2312366|NCT02765165|4018301|FG000|Post-treatment Follow-up|Death|1
2312367|NCT02765165|4018302|FG001|Post-treatment Follow-up|Death|2
2312368|NCT02765165|4018303|FG002|Post-treatment Follow-up|Death|1
2312369|NCT02765165|4018304|FG003|Post-treatment Follow-up|Death|1
2312370|NCT02765165|4018305|FG004|Post-treatment Follow-up|Death|1
2312371|NCT02765165|4018306|FG005|Post-treatment Follow-up|Death|1
2312372|NCT02765165|4018307|FG006|Post-treatment Follow-up|Death|0
2312373|NCT02765165|4018301|FG000|Post-treatment Follow-up|Lost to Follow-up|0
2312374|NCT02765165|4018302|FG001|Post-treatment Follow-up|Lost to Follow-up|0
2312375|NCT02765165|4018303|FG002|Post-treatment Follow-up|Lost to Follow-up|0
2312376|NCT02765165|4018304|FG003|Post-treatment Follow-up|Lost to Follow-up|1
2312377|NCT02765165|4018305|FG004|Post-treatment Follow-up|Lost to Follow-up|0
2312378|NCT02765165|4018306|FG005|Post-treatment Follow-up|Lost to Follow-up|0
2312379|NCT02765165|4018307|FG006|Post-treatment Follow-up|Lost to Follow-up|0
2312380|NCT02765165|4018301|FG000|Post-treatment Follow-up|Site terminated by sponsor|0
2312381|NCT02765165|4018302|FG001|Post-treatment Follow-up|Site terminated by sponsor|0
2312382|NCT02765165|4018303|FG002|Post-treatment Follow-up|Site terminated by sponsor|1
2312383|NCT02765165|4018304|FG003|Post-treatment Follow-up|Site terminated by sponsor|0
2312384|NCT02765165|4018305|FG004|Post-treatment Follow-up|Site terminated by sponsor|0
2312385|NCT02765165|4018306|FG005|Post-treatment Follow-up|Site terminated by sponsor|0
2312386|NCT02765165|4018307|FG006|Post-treatment Follow-up|Site terminated by sponsor|0
2312387|NCT02765165|4018301|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0
2312388|NCT02765165|4018302|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0
2312389|NCT02765165|4018303|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1
2312390|NCT02765165|4018304|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1
2312391|NCT02765165|4018305|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0
2312392|NCT02765165|4018306|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0
2312393|NCT02765165|4018307|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0
2312394|NCT02765165|4018301|FG000|Post-treatment Follow-up|Withdrawal by Subject|0
2312395|NCT02765165|4018302|FG001|Post-treatment Follow-up|Withdrawal by Subject|1
2312396|NCT02765165|4018303|FG002|Post-treatment Follow-up|Withdrawal by Subject|0
2312397|NCT02765165|4018304|FG003|Post-treatment Follow-up|Withdrawal by Subject|0
2312398|NCT02765165|4018305|FG004|Post-treatment Follow-up|Withdrawal by Subject|0
2312399|NCT02765165|4018306|FG005|Post-treatment Follow-up|Withdrawal by Subject|0
2312400|NCT02765165|4018307|FG006|Post-treatment Follow-up|Withdrawal by Subject|0
2312401|NCT02765165|4018301|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0
2312402|NCT02765165|4018302|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0
2312403|NCT02765165|4018303|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0
2312404|NCT02765165|4018304|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0
2312405|NCT02765165|4018305|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2
2312406|NCT02765165|4018306|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2
2312407|NCT02765165|4018307|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1
2312408|NCT02765490|4018347|FG000|Overall Study|Lost to Follow-up|1
2003411|NCT00129545|3567745|FG002|Overall Study|Device not implanted|0
2003412|NCT00129623|3567755|FG000|Overall Study|Adverse Event|3
2003413|NCT00129623|3567756|FG001|Overall Study|Adverse Event|7
2003414|NCT00129623|3567755|FG000|Overall Study|Refused Treatment|5
2003415|NCT00129623|3567756|FG001|Overall Study|Refused Treatment|3
2003416|NCT00129623|3567755|FG000|Overall Study|Failure to Return|1
2003417|NCT00129623|3567756|FG001|Overall Study|Failure to Return|1
2003418|NCT00129623|3567755|FG000|Overall Study|Relocated job out of state|1
2003419|NCT00129623|3567756|FG001|Overall Study|Relocated job out of state|0
2003420|NCT00129623|3567755|FG000|Overall Study|Uncertainty to return|0
2003421|NCT00129623|3567756|FG001|Overall Study|Uncertainty to return|1
2003422|NCT00129649|3567766|FG000|Overall Study|Withdrawal by Subject|76
2003423|NCT00129649|3567767|FG001|Overall Study|Withdrawal by Subject|65
2003424|NCT00129701|3567773|FG000|Overall Study|Withdrawal by Subject|33
2003425|NCT00129766|3567790|FG000|Overall Study|Death|3
2003426|NCT00129766|3567791|FG001|Overall Study|Death|8
2003427|NCT00129766|3567790|FG000|Overall Study|Withdrawal of consent|31
2003428|NCT00129766|3567791|FG001|Overall Study|Withdrawal of consent|30
2003429|NCT00129766|3567790|FG000|Overall Study|Lost to Follow-up|26
2003430|NCT00129766|3567791|FG001|Overall Study|Lost to Follow-up|21
2003431|NCT00129935|3567800|FG000|Overall Study|Adverse Event|18
2003432|NCT00129935|3567801|FG001|Overall Study|Adverse Event|56
2003433|NCT00129935|3567800|FG000|Overall Study|Death|1
2003434|NCT00129935|3567801|FG001|Overall Study|Death|1
2003435|NCT00129935|3567800|FG000|Overall Study|Withdrawal by Subject|7
2003436|NCT00129935|3567801|FG001|Overall Study|Withdrawal by Subject|20
2003437|NCT00129935|3567800|FG000|Overall Study|Protocol Violation|0
2003438|NCT00129935|3567801|FG001|Overall Study|Protocol Violation|4
2003439|NCT00129935|3567800|FG000|Overall Study|Physician Decision|3
2003440|NCT00129935|3567801|FG001|Overall Study|Physician Decision|4
2003441|NCT00129935|3567800|FG000|Overall Study|Recurrence|1
2003442|NCT00129935|3567801|FG001|Overall Study|Recurrence|3
2003443|NCT00129935|3567800|FG000|Overall Study|Second primary|0
2003444|NCT00129935|3567801|FG001|Overall Study|Second primary|1
2003445|NCT00129935|3567800|FG000|Overall Study|Other|3
2003446|NCT00129935|3567801|FG001|Overall Study|Other|2
2003447|NCT00129935|3567800|FG000|Overall Study|Crossed to the other arm|2
2003448|NCT00129935|3567801|FG001|Overall Study|Crossed to the other arm|1
2003449|NCT00129935|3567800|FG000|Overall Study|Incorrect study treatment|1
2003450|NCT00129935|3567801|FG001|Overall Study|Incorrect study treatment|0
2003451|NCT00129961|3567809|FG000|Overall Study|Adverse Event|1
2003452|NCT00129961|3567810|FG001|Overall Study|Adverse Event|0
2003453|NCT00129961|3567809|FG000|Overall Study|Death|1
2003454|NCT00129961|3567810|FG001|Overall Study|Death|1
2003455|NCT00129961|3567809|FG000|Overall Study|Withdrawal by Sponsor|14
2003456|NCT00129961|3567810|FG001|Overall Study|Withdrawal by Sponsor|20
2003457|NCT00129961|3567809|FG000|Overall Study|Physician Decision|1
2003458|NCT00129961|3567810|FG001|Overall Study|Physician Decision|0
2003459|NCT00129961|3567809|FG000|Overall Study|Withdrawal by Subject|2
2003460|NCT00129961|3567810|FG001|Overall Study|Withdrawal by Subject|1
2003461|NCT00129961|3567809|FG000|Overall Study|Missing Record|0
2003462|NCT00129961|3567810|FG001|Overall Study|Missing Record|1
2003463|NCT00129987|3567818|FG000|1st Educational Session|Withdrawal by Subject|141
2003464|NCT00129987|3567819|FG001|1st Educational Session|Withdrawal by Subject|109
2003465|NCT00129987|3567818|FG000|1 Year|Withdrawal by Subject|32
2003466|NCT00129987|3567819|FG001|1 Year|Withdrawal by Subject|21
2003467|NCT00130039|3567827|FG000|Overall Study|Withdrawal by Subject|15
2003468|NCT00130039|3567828|FG001|Overall Study|Withdrawal by Subject|11
2003469|NCT00130039|3567827|FG000|Overall Study|Lost to Follow-up|3
2003470|NCT00130039|3567828|FG001|Overall Study|Lost to Follow-up|1
2003471|NCT00130039|3567827|FG000|Overall Study|Adverse Event|4
2312409|NCT02765490|4018348|FG001|Overall Study|Lost to Follow-up|1
2312410|NCT02765490|4018347|FG000|Overall Study|Other|0
2003472|NCT00130039|3567828|FG001|Overall Study|Adverse Event|2
2003473|NCT00130039|3567827|FG000|Overall Study|Physician Decision|3
2003474|NCT00130039|3567828|FG001|Overall Study|Physician Decision|0
2003475|NCT00130039|3567827|FG000|Overall Study|clinical events without follow up MRI|5
2003476|NCT00130039|3567828|FG001|Overall Study|clinical events without follow up MRI|4
2003477|NCT00130208|3567846|FG000|Maintenance Period (26 Weeks)|Adverse Event|10
2003478|NCT00130208|3567847|FG001|Maintenance Period (26 Weeks)|Adverse Event|12
2003479|NCT00130208|3567846|FG000|Maintenance Period (26 Weeks)|Physician Decision|0
2003480|NCT00130208|3567847|FG001|Maintenance Period (26 Weeks)|Physician Decision|2
2003481|NCT00130208|3567846|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
2003482|NCT00130208|3567847|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
2003483|NCT00130208|3567846|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5
2003484|NCT00130208|3567847|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4
2003485|NCT00130208|3567846|FG000|Maintenance Period (26 Weeks)|Other|1
2003486|NCT00130208|3567847|FG001|Maintenance Period (26 Weeks)|Other|1
2003487|NCT00130208|3567846|FG000|Washout Period (8 Weeks)|Adverse Event|3
2003488|NCT00130208|3567847|FG001|Washout Period (8 Weeks)|Adverse Event|6
2003489|NCT00130208|3567846|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2
2312411|NCT02765490|4018348|FG001|Overall Study|Other|1
2312412|NCT02765490|4018347|FG000|Overall Study|Death|0
2003490|NCT00130208|3567847|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4
2003491|NCT00130208|3567846|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0
2003492|NCT00130208|3567847|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1
2003493|NCT00130208|3567846|FG000|Washout Period (8 Weeks)|Other|1
2003494|NCT00130208|3567847|FG001|Washout Period (8 Weeks)|Other|1
2003495|NCT00130247|3567855|FG000|Overall Study|Pregnancy|1
2003496|NCT00130247|3567856|FG001|Overall Study|Pregnancy|0
2003497|NCT00130247|3567855|FG000|Overall Study|Post-randomization exclusion|1
2003498|NCT00130247|3567856|FG001|Overall Study|Post-randomization exclusion|2
2214100|NCT01684423|3856105|FG004|Overall Study|Withdrawal by Subject|0
2214101|NCT01684722|3856145|FG000|Overall Study|Lost to Follow-up|78
2214102|NCT01684722|3856146|FG001|Overall Study|Lost to Follow-up|56
2003499|NCT00130247|3567855|FG000|Overall Study|Not compliant with DOT|0
2003500|NCT00130247|3567856|FG001|Overall Study|Not compliant with DOT|2
2003501|NCT00130286|3567866|FG000|Overall Study|Withdrawal by Subject|0
2003502|NCT00130286|3567867|FG001|Overall Study|Withdrawal by Subject|1
2003503|NCT00130286|3567868|FG002|Overall Study|Withdrawal by Subject|2
2003504|NCT00130286|3567869|FG003|Overall Study|Withdrawal by Subject|2
2003505|NCT00130286|3567866|FG000|Overall Study|Adverse Event|0
2003506|NCT00130286|3567867|FG001|Overall Study|Adverse Event|0
2003507|NCT00130286|3567868|FG002|Overall Study|Adverse Event|2
2003508|NCT00130286|3567869|FG003|Overall Study|Adverse Event|0
2003509|NCT00130286|3567866|FG000|Overall Study|Missing lab specimens|0
2003510|NCT00130286|3567867|FG001|Overall Study|Missing lab specimens|2
2003511|NCT00130286|3567868|FG002|Overall Study|Missing lab specimens|0
2003512|NCT00130286|3567869|FG003|Overall Study|Missing lab specimens|0
2003513|NCT00130442|3567881|FG000|Overall Study|Withdrawal by Subject|0
2003514|NCT00130442|3567882|FG001|Overall Study|Withdrawal by Subject|1
2003515|NCT00130442|3567881|FG000|Overall Study|did not meet criteria|1
2003516|NCT00130442|3567882|FG001|Overall Study|did not meet criteria|1
2003517|NCT00130520|3567890|FG000|Overall Study|Adverse Event|11
2003518|NCT00130520|3567890|FG000|Overall Study|Death|1
2003519|NCT00130520|3567890|FG000|Overall Study|Physician Decision|1
2003520|NCT00130520|3567890|FG000|Overall Study|Withdrawal by Subject|1
2003521|NCT00130520|3567890|FG000|Overall Study|Disease Progression|23
2003522|NCT00130520|3567890|FG000|Overall Study|Protocol non-compliance|1
2003523|NCT00130520|3567890|FG000|Overall Study|Did not meet re-treatment criteria|1
2003524|NCT00130533|3567896|FG000|Overall Study|Withdrawal by Subject|33
2003525|NCT00130533|3567897|FG001|Overall Study|Withdrawal by Subject|6
2003526|NCT00130533|3567896|FG000|Overall Study|Adverse Event|34
2003527|NCT00130533|3567897|FG001|Overall Study|Adverse Event|1
2003528|NCT00130533|3567896|FG000|Overall Study|Disease relapse|9
2003529|NCT00130533|3567897|FG001|Overall Study|Disease relapse|13
2003530|NCT00130533|3567896|FG000|Overall Study|Interruption of treatment > 3 weeks|11
2003531|NCT00130533|3567897|FG001|Overall Study|Interruption of treatment > 3 weeks|0
2003532|NCT00130533|3567896|FG000|Overall Study|Death|4
2003533|NCT00130533|3567897|FG001|Overall Study|Death|2
2003534|NCT00130533|3567896|FG000|Overall Study|Protocol Violation|5
2003535|NCT00130533|3567897|FG001|Overall Study|Protocol Violation|1
2003536|NCT00130533|3567896|FG000|Overall Study|Lost to Follow-up|1
2003537|NCT00130533|3567897|FG001|Overall Study|Lost to Follow-up|1
2312413|NCT02765490|4018348|FG001|Overall Study|Death|1
2312414|NCT02766023|4018356|FG000|Overall Study|Lost to Follow-up|23
2312415|NCT02766023|4018357|FG001|Overall Study|Lost to Follow-up|11
2312416|NCT02766023|4018356|FG000|Overall Study|Pregnancy|1
2312417|NCT02766023|4018357|FG001|Overall Study|Pregnancy|0
2312418|NCT02766023|4018356|FG000|Overall Study|Adverse Event|1
2312419|NCT02766023|4018357|FG001|Overall Study|Adverse Event|0
2312420|NCT02766023|4018356|FG000|Overall Study|Withdrawal by Subject|4
2312421|NCT02766023|4018357|FG001|Overall Study|Withdrawal by Subject|5
2312422|NCT02766023|4018356|FG000|Overall Study|Physician Decision|1
2312423|NCT02766023|4018357|FG001|Overall Study|Physician Decision|0
2312424|NCT02766023|4018356|FG000|Overall Study|Not Eligible at Enrollment|0
2312425|NCT02766023|4018357|FG001|Overall Study|Not Eligible at Enrollment|1
2312426|NCT02766088|4018363|FG000|Overall Study|Sponsor study termination|498
2312427|NCT02766088|4018363|FG000|Overall Study|Migrated/moved from the study area|1
2312428|NCT02766088|4018363|FG000|Overall Study|Lost to Follow-up|5
2312429|NCT02766088|4018363|FG000|Overall Study|Other|1
2312430|NCT02766088|4018363|FG000|Overall Study|Death|1
2312431|NCT02766283|4018376|FG000|Overall Study|Lost to Follow-up|27
2312432|NCT02766400|4018395|FG000|Overall Study|Death|1
2312433|NCT02766400|4018396|FG001|Overall Study|Death|2
2312434|NCT02766400|4018395|FG000|Overall Study|Withdrawal by Subject|1
2312435|NCT02766400|4018396|FG001|Overall Study|Withdrawal by Subject|0
2312436|NCT02766608|4018420|FG000|Overall Study|Adverse Event|27
2312437|NCT02766608|4018421|FG001|Overall Study|Adverse Event|22
2312438|NCT02766608|4018422|FG002|Overall Study|Adverse Event|17
2312439|NCT02766608|4018423|FG003|Overall Study|Adverse Event|13
2312440|NCT02766608|4018424|FG004|Overall Study|Adverse Event|12
2312441|NCT02766608|4018420|FG000|Overall Study|Withdrawal by Subject|21
2312442|NCT02766608|4018421|FG001|Overall Study|Withdrawal by Subject|20
2312443|NCT02766608|4018422|FG002|Overall Study|Withdrawal by Subject|24
2312444|NCT02766608|4018423|FG003|Overall Study|Withdrawal by Subject|13
2312445|NCT02766608|4018424|FG004|Overall Study|Withdrawal by Subject|10
2312446|NCT02766608|4018420|FG000|Overall Study|Lack of Efficacy|16
2003538|NCT00130533|3567896|FG000|Overall Study|Sponsor´s decision|2
2214103|NCT01684722|3856147|FG002|Overall Study|Lost to Follow-up|75
2312447|NCT02766608|4018421|FG001|Overall Study|Lack of Efficacy|15
2312448|NCT02766608|4018422|FG002|Overall Study|Lack of Efficacy|32
2312449|NCT02766608|4018423|FG003|Overall Study|Lack of Efficacy|8
2003539|NCT00130533|3567897|FG001|Overall Study|Sponsor´s decision|0
2003540|NCT00130533|3567896|FG000|Overall Study|Second Primary Malignancy|0
2003541|NCT00130533|3567897|FG001|Overall Study|Second Primary Malignancy|1
2003542|NCT00130533|3567896|FG000|Overall Study|Other|12
2003543|NCT00130533|3567897|FG001|Overall Study|Other|5
2003544|NCT00130637|3567903|FG000|Overall Study|Adverse Event|2
2003545|NCT00130637|3567903|FG000|Overall Study|Withdrawal by Subject|1
2003546|NCT00130689|3567907|FG000|Overall Study|Progressive Disease|29
2003547|NCT00130689|3567907|FG000|Overall Study|Death|1
2003548|NCT00130689|3567907|FG000|Overall Study|Clinical Deterioration|4
2003549|NCT00130689|3567907|FG000|Overall Study|Withdrawal by Subject|3
2003550|NCT00130689|3567907|FG000|Overall Study|Ineligible|6
2003551|NCT00130728|3567913|FG000|Overall Study|Death|258
2003552|NCT00130728|3567914|FG001|Overall Study|Death|258
2003553|NCT00130728|3567913|FG000|Overall Study|Lost to Follow-up|4
2003554|NCT00130728|3567914|FG001|Overall Study|Lost to Follow-up|0
2003555|NCT00130728|3567913|FG000|Overall Study|Withdrawal by Subject|0
2003556|NCT00130728|3567914|FG001|Overall Study|Withdrawal by Subject|2
2003557|NCT00130793|3567931|FG000|Overall Study|Lost to Follow-up|1
2003558|NCT00130793|3567932|FG001|Overall Study|Lost to Follow-up|4
2003559|NCT00130793|3567931|FG000|Overall Study|Withdrew consent|2
2003560|NCT00130793|3567932|FG001|Overall Study|Withdrew consent|0
2003561|NCT00130832|3567941|FG000|Overall Study|Adverse Event|1
2003562|NCT00130832|3567942|FG001|Overall Study|Adverse Event|1
2003563|NCT00130832|3567941|FG000|Overall Study|Lost to Follow-up|1
2003564|NCT00130832|3567942|FG001|Overall Study|Lost to Follow-up|2
2003565|NCT00130832|3567941|FG000|Overall Study|Protocol Violation|6
2214104|NCT01684722|3856148|FG003|Overall Study|Lost to Follow-up|89
2214105|NCT01684722|3856145|FG000|Overall Study|Death|19
2214106|NCT01684722|3856146|FG001|Overall Study|Death|21
2214107|NCT01684722|3856147|FG002|Overall Study|Death|19
2214108|NCT01684722|3856148|FG003|Overall Study|Death|21
2214109|NCT01684878|3856191|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1
2214110|NCT01684878|3856192|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1
2214111|NCT01684878|3856193|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0
2312450|NCT02766608|4018424|FG004|Overall Study|Lack of Efficacy|2
2312451|NCT02766608|4018420|FG000|Overall Study|Lost to Follow-up|6
2312452|NCT02766608|4018421|FG001|Overall Study|Lost to Follow-up|3
2312453|NCT02766608|4018422|FG002|Overall Study|Lost to Follow-up|5
2312454|NCT02766608|4018423|FG003|Overall Study|Lost to Follow-up|2
2312455|NCT02766608|4018424|FG004|Overall Study|Lost to Follow-up|2
2312456|NCT02766608|4018420|FG000|Overall Study|Physician Decision|3
2312457|NCT02766608|4018421|FG001|Overall Study|Physician Decision|2
2312458|NCT02766608|4018422|FG002|Overall Study|Physician Decision|3
2312459|NCT02766608|4018423|FG003|Overall Study|Physician Decision|1
2312460|NCT02766608|4018424|FG004|Overall Study|Physician Decision|2
2312461|NCT02766608|4018420|FG000|Overall Study|Protocol disc criteria|3
2312462|NCT02766608|4018421|FG001|Overall Study|Protocol disc criteria|3
2312463|NCT02766608|4018422|FG002|Overall Study|Protocol disc criteria|4
2312464|NCT02766608|4018423|FG003|Overall Study|Protocol disc criteria|0
2312465|NCT02766608|4018424|FG004|Overall Study|Protocol disc criteria|0
2312466|NCT02766608|4018420|FG000|Overall Study|Protocol Violation|0
2312467|NCT02766608|4018421|FG001|Overall Study|Protocol Violation|4
2312468|NCT02766608|4018422|FG002|Overall Study|Protocol Violation|4
2312469|NCT02766608|4018423|FG003|Overall Study|Protocol Violation|0
2312470|NCT02766608|4018424|FG004|Overall Study|Protocol Violation|1
2312471|NCT02766608|4018420|FG000|Overall Study|Administrative Reasons|3
2312472|NCT02766608|4018421|FG001|Overall Study|Administrative Reasons|1
2312473|NCT02766608|4018422|FG002|Overall Study|Administrative Reasons|1
2312474|NCT02766608|4018423|FG003|Overall Study|Administrative Reasons|0
2312475|NCT02766608|4018424|FG004|Overall Study|Administrative Reasons|0
2312476|NCT02766777|4018452|FG000|Overall Study|Adverse Event|12
2312477|NCT02766777|4018452|FG000|Overall Study|Lost to Follow-up|16
2312478|NCT02766777|4018452|FG000|Overall Study|Non-Compliance With Study Drug|1
2312479|NCT02766777|4018452|FG000|Overall Study|Protocol Violation|1
2312480|NCT02766777|4018452|FG000|Overall Study|Withdrawal by Subject|4
2312481|NCT02767323|4018501|FG000|Overall Study|Withdrawal by Subject|17
2312482|NCT02767323|4018502|FG001|Overall Study|Withdrawal by Subject|5
2312483|NCT02767323|4018503|FG002|Overall Study|Withdrawal by Subject|13
2312484|NCT02767323|4018504|FG003|Overall Study|Withdrawal by Subject|0
2312485|NCT02767323|4018501|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
2312486|NCT02767323|4018502|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20
2312487|NCT02767323|4018503|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
2312488|NCT02767323|4018504|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0
2321979|NCT02966028|4036642|FG001|Overall Study|Kidney transplant Changed dialysis units|16
2321980|NCT02966028|4036643|FG002|Overall Study|Kidney transplant Changed dialysis units|14
2321981|NCT02966314|4036664|FG000|Overall Study|Lost to Follow-up|1
2003566|NCT00130832|3567942|FG001|Overall Study|Protocol Violation|8
2003567|NCT00130832|3567941|FG000|Overall Study|Withdrawal by Subject|6
2003568|NCT00130832|3567942|FG001|Overall Study|Withdrawal by Subject|1
2214112|NCT01684878|3856194|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0
2321982|NCT02966314|4036665|FG001|Overall Study|Lost to Follow-up|0
2321983|NCT02966340|4036671|FG000|Overall Study|Adverse Event|0
2214113|NCT01684878|3856191|FG000|Part 1: Safety Run in Phase|Death|15
2214114|NCT01684878|3856192|FG001|Part 1: Safety Run in Phase|Death|20
2214115|NCT01684878|3856193|FG002|Part 1: Safety Run in Phase|Death|0
2214116|NCT01684878|3856194|FG003|Part 1: Safety Run in Phase|Death|0
2214117|NCT01684878|3856191|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0
2214118|NCT01684878|3856192|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2
2214119|NCT01684878|3856193|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0
2214120|NCT01684878|3856194|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0
2214121|NCT01684878|3856191|FG000|Part 2: Randomized Phase|Participant withdrew consent|0
2214122|NCT01684878|3856192|FG001|Part 2: Randomized Phase|Participant withdrew consent|0
2214123|NCT01684878|3856193|FG002|Part 2: Randomized Phase|Participant withdrew consent|1
2214124|NCT01684878|3856194|FG003|Part 2: Randomized Phase|Participant withdrew consent|2
2214125|NCT01684878|3856191|FG000|Part 2: Randomized Phase|Lost to Follow-up|0
2214126|NCT01684878|3856192|FG001|Part 2: Randomized Phase|Lost to Follow-up|0
2214127|NCT01684878|3856193|FG002|Part 2: Randomized Phase|Lost to Follow-up|2
2214128|NCT01684878|3856194|FG003|Part 2: Randomized Phase|Lost to Follow-up|0
2214129|NCT01684878|3856191|FG000|Part 2: Randomized Phase|Death|0
2214130|NCT01684878|3856192|FG001|Part 2: Randomized Phase|Death|0
2214131|NCT01684878|3856193|FG002|Part 2: Randomized Phase|Death|62
2214132|NCT01684878|3856194|FG003|Part 2: Randomized Phase|Death|68
2214133|NCT01684878|3856191|FG000|Part 2: Randomized Phase|Alive at data-cut|0
2214134|NCT01684878|3856192|FG001|Part 2: Randomized Phase|Alive at data-cut|0
2214135|NCT01684878|3856193|FG002|Part 2: Randomized Phase|Alive at data-cut|13
2214136|NCT01684878|3856194|FG003|Part 2: Randomized Phase|Alive at data-cut|7
2214137|NCT01684878|3856191|FG000|Part 2: Randomized Phase|Participant noncompliance|0
2214138|NCT01684878|3856192|FG001|Part 2: Randomized Phase|Participant noncompliance|0
2214139|NCT01684878|3856193|FG002|Part 2: Randomized Phase|Participant noncompliance|0
2214140|NCT01684878|3856194|FG003|Part 2: Randomized Phase|Participant noncompliance|1
2214141|NCT01684930|3856223|FG000|Overall Study|Withdrawal by Subject|3
2214142|NCT01684930|3856224|FG001|Overall Study|Withdrawal by Subject|1
2214143|NCT01684943|3856233|FG000|Overall Study|Inadequate Venous Access|3
2214144|NCT01684943|3856234|FG001|Overall Study|Inadequate Venous Access|0
2214145|NCT01684943|3856235|FG002|Overall Study|Inadequate Venous Access|0
2214146|NCT01684943|3856233|FG000|Overall Study|Principal Investigator Determination|1
2214147|NCT01684943|3856234|FG001|Overall Study|Principal Investigator Determination|0
2214148|NCT01684943|3856235|FG002|Overall Study|Principal Investigator Determination|0
2214149|NCT01684943|3856233|FG000|Overall Study|Excluded from Analysis|1
2214150|NCT01684943|3856234|FG001|Overall Study|Excluded from Analysis|1
2214151|NCT01684943|3856235|FG002|Overall Study|Excluded from Analysis|1
2214152|NCT01684943|3856233|FG000|Overall Study|Lost to Follow-up|3
2214153|NCT01684943|3856234|FG001|Overall Study|Lost to Follow-up|0
2214154|NCT01684943|3856235|FG002|Overall Study|Lost to Follow-up|0
2214155|NCT01684943|3856233|FG000|Overall Study|Planning Pregnancy|1
2214156|NCT01684943|3856234|FG001|Overall Study|Planning Pregnancy|0
2312489|NCT02767765|4018552|FG000|Overall Study|Adverse Event|4
2312490|NCT02767765|4018552|FG000|Overall Study|Death|1
2312491|NCT02767765|4018552|FG000|Overall Study|Insufficient response|1
2312492|NCT02767765|4018552|FG000|Overall Study|Lost to Follow-up|2
2312493|NCT02767765|4018552|FG000|Overall Study|Investigator decision|1
2312494|NCT02767765|4018552|FG000|Overall Study|Non-Compliance|1
2312495|NCT02767765|4018552|FG000|Overall Study|Withdrawal by Subject|1
2312496|NCT02768103|4018585|FG000|Overall Study|1 participant did not fit in the fMRI|1
2312497|NCT02768194|4018598|FG000|Period 1|Adverse Event|0
2312498|NCT02768194|4018599|FG001|Period 1|Adverse Event|0
2312499|NCT02768194|4018600|FG002|Period 1|Adverse Event|0
2312500|NCT02768194|4018601|FG003|Period 1|Adverse Event|1
2312501|NCT02768194|4018602|FG004|Period 1|Adverse Event|0
2312502|NCT02768194|4018603|FG005|Period 1|Adverse Event|0
2312503|NCT02768194|4018598|FG000|Period 2|Other (Reason not specified)|1
2312504|NCT02768194|4018599|FG001|Period 2|Other (Reason not specified)|0
2312505|NCT02768194|4018600|FG002|Period 2|Other (Reason not specified)|0
2312506|NCT02768194|4018601|FG003|Period 2|Other (Reason not specified)|0
2312507|NCT02768194|4018602|FG004|Period 2|Other (Reason not specified)|0
2312508|NCT02768194|4018603|FG005|Period 2|Other (Reason not specified)|0
2312509|NCT02768194|4018598|FG000|Period 3|Other (Reason not specified)|0
2312510|NCT02768194|4018599|FG001|Period 3|Other (Reason not specified)|1
2312511|NCT02768194|4018600|FG002|Period 3|Other (Reason not specified)|0
2312512|NCT02768194|4018601|FG003|Period 3|Other (Reason not specified)|0
2312513|NCT02768194|4018602|FG004|Period 3|Other (Reason not specified)|0
2312514|NCT02768194|4018603|FG005|Period 3|Other (Reason not specified)|0
2312515|NCT02768298|4018613|FG000|Overall Study|Adverse Event|1
2312516|NCT02768298|4018614|FG001|Overall Study|Adverse Event|4
2312517|NCT02768298|4018613|FG000|Overall Study|Death|2
2312518|NCT02768298|4018614|FG001|Overall Study|Death|1
2312519|NCT02768298|4018613|FG000|Overall Study|Non-compliance with study treatment|0
2312520|NCT02768298|4018614|FG001|Overall Study|Non-compliance with study treatment|1
2312521|NCT02768298|4018613|FG000|Overall Study|Subject/guardian decision|1
2312522|NCT02768298|4018614|FG001|Overall Study|Subject/guardian decision|0
2312523|NCT02768298|4018613|FG000|Overall Study|Withdrawal of informed consent|0
2312524|NCT02768298|4018614|FG001|Overall Study|Withdrawal of informed consent|1
2214157|NCT01684943|3856235|FG002|Overall Study|Planning Pregnancy|0
2214158|NCT01685047|3856252|FG000|Overall Study|Withdrawal by Subject|20
2214159|NCT01685047|3856252|FG000|Overall Study|Death|26
2214160|NCT01685047|3856252|FG000|Overall Study|Lost to Follow-up|8
2214161|NCT01685047|3856252|FG000|Overall Study|Physician Decision|25
2214162|NCT01685047|3856252|FG000|Overall Study|Adverse Event|5
2214163|NCT01685047|3856252|FG000|Overall Study|patient withdrawn by sponsor|1
2214164|NCT01685060|3856256|FG000|Overall Study|Rollover patients|16
2214165|NCT01685060|3856256|FG000|Overall Study|Adverse Event|12
2214166|NCT01685060|3856256|FG000|Overall Study|Progressive disease|69
2214167|NCT01685060|3856256|FG000|Overall Study|Physician Decision|14
2214168|NCT01685060|3856256|FG000|Overall Study|Subject/guardian decision|20
2214169|NCT01685060|3856256|FG000|Overall Study|Lost to Follow-up|1
2214170|NCT01685060|3856256|FG000|Overall Study|Death|8
2214171|NCT01685073|3856262|FG000|Overall Study|Lost to Follow-up|6
2214172|NCT01685073|3856263|FG001|Overall Study|Lost to Follow-up|8
2214173|NCT01685073|3856262|FG000|Overall Study|Withdrawal by Subject|24
2214174|NCT01685073|3856263|FG001|Overall Study|Withdrawal by Subject|24
2214175|NCT01685138|3856269|FG000|Overall Study|Lost to Follow-up|1
2214176|NCT01685138|3856269|FG000|Overall Study|Protocol Violation|1
2214177|NCT01685138|3856269|FG000|Overall Study|No longer requires treatment|1
2214178|NCT01685138|3856269|FG000|Overall Study|Subject/guardian decision|2
2214179|NCT01685138|3856269|FG000|Overall Study|Physician Decision|6
2214180|NCT01685138|3856269|FG000|Overall Study|Death|10
2214181|NCT01685138|3856269|FG000|Overall Study|Adverse Event|18
2214182|NCT01685138|3856269|FG000|Overall Study|Progressive disease|53
2214183|NCT01685203|3856280|FG000|Overall Study|Lost to Follow-up|3
2214184|NCT01685203|3856281|FG001|Overall Study|Lost to Follow-up|3
2214185|NCT01685203|3856282|FG002|Overall Study|Lost to Follow-up|0
2214186|NCT01685203|3856283|FG003|Overall Study|Lost to Follow-up|1
2214187|NCT01685203|3856284|FG004|Overall Study|Lost to Follow-up|0
2214188|NCT01685203|3856285|FG005|Overall Study|Lost to Follow-up|0
2312525|NCT02768792|4018638|FG000|Overall Study|Adverse Event|1
2312526|NCT02769065|4018672|FG000|Overall Study|Voluntary Withdrawal|1
2312527|NCT02769065|4018673|FG001|Overall Study|Voluntary Withdrawal|0
2312528|NCT02769065|4018674|FG002|Overall Study|Voluntary Withdrawal|0
2312529|NCT02769065|4018675|FG003|Overall Study|Voluntary Withdrawal|0
2312530|NCT02769065|4018676|FG004|Overall Study|Voluntary Withdrawal|0
2312531|NCT02769065|4018677|FG005|Overall Study|Voluntary Withdrawal|0
2312532|NCT02769065|4018678|FG006|Overall Study|Voluntary Withdrawal|0
2312533|NCT02769065|4018679|FG007|Overall Study|Voluntary Withdrawal|0
2312534|NCT02769065|4018680|FG008|Overall Study|Voluntary Withdrawal|0
2312535|NCT02769065|4018681|FG009|Overall Study|Voluntary Withdrawal|0
2312536|NCT02769065|4018682|FG010|Overall Study|Voluntary Withdrawal|0
2312537|NCT02769065|4018683|FG011|Overall Study|Voluntary Withdrawal|0
2312538|NCT02769065|4018684|FG012|Overall Study|Voluntary Withdrawal|0
2312539|NCT02769065|4018685|FG013|Overall Study|Voluntary Withdrawal|0
2312540|NCT02769065|4018686|FG014|Overall Study|Voluntary Withdrawal|0
2312541|NCT02769065|4018687|FG015|Overall Study|Voluntary Withdrawal|0
2312542|NCT02769065|4018688|FG016|Overall Study|Voluntary Withdrawal|0
2312543|NCT02769065|4018689|FG017|Overall Study|Voluntary Withdrawal|0
2312544|NCT02769065|4018690|FG018|Overall Study|Voluntary Withdrawal|0
2312545|NCT02769065|4018691|FG019|Overall Study|Voluntary Withdrawal|0
2312546|NCT02769065|4018692|FG020|Overall Study|Voluntary Withdrawal|0
2312547|NCT02769065|4018693|FG021|Overall Study|Voluntary Withdrawal|0
2312548|NCT02769065|4018694|FG022|Overall Study|Voluntary Withdrawal|0
2312549|NCT02769065|4018695|FG023|Overall Study|Voluntary Withdrawal|0
2312550|NCT02769065|4018696|FG024|Overall Study|Voluntary Withdrawal|0
2312551|NCT02769065|4018697|FG025|Overall Study|Voluntary Withdrawal|0
2312552|NCT02769065|4018698|FG026|Overall Study|Voluntary Withdrawal|0
2312553|NCT02769065|4018699|FG027|Overall Study|Voluntary Withdrawal|0
2312554|NCT02769065|4018700|FG028|Overall Study|Voluntary Withdrawal|0
2312555|NCT02769065|4018701|FG029|Overall Study|Voluntary Withdrawal|0
2312556|NCT02769065|4018672|FG000|Overall Study|Reason Not Specified|0
2312557|NCT02769065|4018673|FG001|Overall Study|Reason Not Specified|0
2312558|NCT02769065|4018674|FG002|Overall Study|Reason Not Specified|0
2312559|NCT02769065|4018675|FG003|Overall Study|Reason Not Specified|0
2312560|NCT02769065|4018676|FG004|Overall Study|Reason Not Specified|0
2312561|NCT02769065|4018677|FG005|Overall Study|Reason Not Specified|0
2312562|NCT02769065|4018678|FG006|Overall Study|Reason Not Specified|1
2312563|NCT02769065|4018679|FG007|Overall Study|Reason Not Specified|0
2312564|NCT02769065|4018680|FG008|Overall Study|Reason Not Specified|0
2312565|NCT02769065|4018681|FG009|Overall Study|Reason Not Specified|0
2312566|NCT02769065|4018682|FG010|Overall Study|Reason Not Specified|0
2312567|NCT02769065|4018683|FG011|Overall Study|Reason Not Specified|0
2312568|NCT02769065|4018684|FG012|Overall Study|Reason Not Specified|0
2312569|NCT02769065|4018685|FG013|Overall Study|Reason Not Specified|0
2312570|NCT02769065|4018686|FG014|Overall Study|Reason Not Specified|0
2312571|NCT02769065|4018687|FG015|Overall Study|Reason Not Specified|0
2312572|NCT02769065|4018688|FG016|Overall Study|Reason Not Specified|0
2312573|NCT02769065|4018689|FG017|Overall Study|Reason Not Specified|0
2312574|NCT02769065|4018690|FG018|Overall Study|Reason Not Specified|0
2214189|NCT01685203|3856286|FG006|Overall Study|Lost to Follow-up|0
2214190|NCT01685203|3856280|FG000|Overall Study|Adverse Event|0
2312575|NCT02769065|4018691|FG019|Overall Study|Reason Not Specified|0
2312576|NCT02769065|4018692|FG020|Overall Study|Reason Not Specified|0
2312577|NCT02769065|4018693|FG021|Overall Study|Reason Not Specified|0
2214191|NCT01685203|3856281|FG001|Overall Study|Adverse Event|0
2214192|NCT01685203|3856282|FG002|Overall Study|Adverse Event|0
2214193|NCT01685203|3856283|FG003|Overall Study|Adverse Event|0
2214194|NCT01685203|3856284|FG004|Overall Study|Adverse Event|0
2214195|NCT01685203|3856285|FG005|Overall Study|Adverse Event|2
2214196|NCT01685203|3856286|FG006|Overall Study|Adverse Event|0
2214197|NCT01685203|3856280|FG000|Overall Study|Adverse event and withdrew consent|1
2214198|NCT01685203|3856281|FG001|Overall Study|Adverse event and withdrew consent|0
2312578|NCT02769065|4018694|FG022|Overall Study|Reason Not Specified|0
2312579|NCT02769065|4018695|FG023|Overall Study|Reason Not Specified|0
2312580|NCT02769065|4018696|FG024|Overall Study|Reason Not Specified|0
2312581|NCT02769065|4018697|FG025|Overall Study|Reason Not Specified|0
2312582|NCT02769065|4018698|FG026|Overall Study|Reason Not Specified|0
2312583|NCT02769065|4018699|FG027|Overall Study|Reason Not Specified|0
2312584|NCT02769065|4018700|FG028|Overall Study|Reason Not Specified|0
2312585|NCT02769065|4018701|FG029|Overall Study|Reason Not Specified|0
2312586|NCT02769065|4018672|FG000|Overall Study|Pre-treatment Event/Adverse Event|0
2312587|NCT02769065|4018673|FG001|Overall Study|Pre-treatment Event/Adverse Event|0
2312588|NCT02769065|4018674|FG002|Overall Study|Pre-treatment Event/Adverse Event|0
2312589|NCT02769065|4018675|FG003|Overall Study|Pre-treatment Event/Adverse Event|0
2312590|NCT02769065|4018676|FG004|Overall Study|Pre-treatment Event/Adverse Event|0
2312591|NCT02769065|4018677|FG005|Overall Study|Pre-treatment Event/Adverse Event|0
2312592|NCT02769065|4018678|FG006|Overall Study|Pre-treatment Event/Adverse Event|0
2312593|NCT02769065|4018679|FG007|Overall Study|Pre-treatment Event/Adverse Event|0
2312594|NCT02769065|4018680|FG008|Overall Study|Pre-treatment Event/Adverse Event|0
2312595|NCT02769065|4018681|FG009|Overall Study|Pre-treatment Event/Adverse Event|0
2312596|NCT02769065|4018682|FG010|Overall Study|Pre-treatment Event/Adverse Event|1
2312597|NCT02769065|4018683|FG011|Overall Study|Pre-treatment Event/Adverse Event|0
2312598|NCT02769065|4018684|FG012|Overall Study|Pre-treatment Event/Adverse Event|0
2312599|NCT02769065|4018685|FG013|Overall Study|Pre-treatment Event/Adverse Event|0
2312600|NCT02769065|4018686|FG014|Overall Study|Pre-treatment Event/Adverse Event|0
2312601|NCT02769065|4018687|FG015|Overall Study|Pre-treatment Event/Adverse Event|0
2312602|NCT02769065|4018688|FG016|Overall Study|Pre-treatment Event/Adverse Event|0
2312603|NCT02769065|4018689|FG017|Overall Study|Pre-treatment Event/Adverse Event|0
2312604|NCT02769065|4018690|FG018|Overall Study|Pre-treatment Event/Adverse Event|0
2312605|NCT02769065|4018691|FG019|Overall Study|Pre-treatment Event/Adverse Event|0
2312606|NCT02769065|4018692|FG020|Overall Study|Pre-treatment Event/Adverse Event|0
2312607|NCT02769065|4018693|FG021|Overall Study|Pre-treatment Event/Adverse Event|0
2312608|NCT02769065|4018694|FG022|Overall Study|Pre-treatment Event/Adverse Event|0
2312609|NCT02769065|4018695|FG023|Overall Study|Pre-treatment Event/Adverse Event|0
2312610|NCT02769065|4018696|FG024|Overall Study|Pre-treatment Event/Adverse Event|0
2312611|NCT02769065|4018697|FG025|Overall Study|Pre-treatment Event/Adverse Event|0
2312612|NCT02769065|4018698|FG026|Overall Study|Pre-treatment Event/Adverse Event|0
2312613|NCT02769065|4018699|FG027|Overall Study|Pre-treatment Event/Adverse Event|0
2312614|NCT02769065|4018700|FG028|Overall Study|Pre-treatment Event/Adverse Event|0
2312615|NCT02769065|4018701|FG029|Overall Study|Pre-treatment Event/Adverse Event|0
2312616|NCT02769247|4018798|FG000|Overall Study|Withdrawal by Subject|1
2312617|NCT02769247|4018799|FG001|Overall Study|Withdrawal by Subject|0
2312618|NCT02769247|4018800|FG002|Overall Study|Withdrawal by Subject|0
2312619|NCT02769247|4018801|FG003|Overall Study|Withdrawal by Subject|1
2312620|NCT02769247|4018798|FG000|Overall Study|Protocol Violation|0
2312621|NCT02769247|4018799|FG001|Overall Study|Protocol Violation|0
2312622|NCT02769247|4018800|FG002|Overall Study|Protocol Violation|1
2312623|NCT02769247|4018801|FG003|Overall Study|Protocol Violation|0
2312624|NCT02769247|4018798|FG000|Overall Study|Physician Decision|1
2312625|NCT02769247|4018799|FG001|Overall Study|Physician Decision|0
2312626|NCT02769247|4018800|FG002|Overall Study|Physician Decision|0
2312627|NCT02769247|4018801|FG003|Overall Study|Physician Decision|0
2312628|NCT02769312|4018817|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
2312629|NCT02769312|4018818|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
2312630|NCT02769312|4018817|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1
2312631|NCT02769312|4018818|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0
2312632|NCT02769312|4018817|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
2312633|NCT02769312|4018818|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
2312634|NCT02769312|4018817|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
2312635|NCT02769312|4018818|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
2312636|NCT02769312|4018817|FG000|Follow-up|Lost to Follow-up|1
2312637|NCT02769312|4018818|FG001|Follow-up|Lost to Follow-up|1
2312638|NCT02769481|4018841|FG000|Overall Study|Protocol Violation|1
2312639|NCT02769481|4018842|FG001|Overall Study|Protocol Violation|0
2312640|NCT02769481|4018841|FG000|Overall Study|Adverse Event|3
2312641|NCT02769481|4018842|FG001|Overall Study|Adverse Event|6
2312642|NCT02769481|4018841|FG000|Overall Study|Entry Criteria Not Met|1
2312643|NCT02769481|4018842|FG001|Overall Study|Entry Criteria Not Met|2
2312644|NCT02769481|4018841|FG000|Overall Study|Withdrawal by Subject|14
2214199|NCT01685203|3856282|FG002|Overall Study|Adverse event and withdrew consent|0
2214200|NCT01685203|3856283|FG003|Overall Study|Adverse event and withdrew consent|0
2214201|NCT01685203|3856284|FG004|Overall Study|Adverse event and withdrew consent|0
2214202|NCT01685203|3856285|FG005|Overall Study|Adverse event and withdrew consent|0
2312645|NCT02769481|4018842|FG001|Overall Study|Withdrawal by Subject|16
2003569|NCT00130832|3567941|FG000|Overall Study|Moved|2
2003570|NCT00130832|3567942|FG001|Overall Study|Moved|2
2003571|NCT00130832|3567941|FG000|Overall Study|Other|0
2003572|NCT00130832|3567942|FG001|Overall Study|Other|3
2025030|NCT00339183|3593669|FG000|Overall Study|Physician Decision|2
2025031|NCT00339183|3593670|FG001|Overall Study|Physician Decision|4
2025032|NCT00339183|3593669|FG000|Overall Study|Lost to Follow-up|17
2025033|NCT00339183|3593670|FG001|Overall Study|Lost to Follow-up|17
2025034|NCT00339183|3593669|FG000|Overall Study|Protocol-specified criteria|12
2025035|NCT00339183|3593670|FG001|Overall Study|Protocol-specified criteria|8
2025036|NCT00339183|3593669|FG000|Overall Study|Missing reason|3
2025037|NCT00339183|3593670|FG001|Overall Study|Missing reason|1
2025038|NCT00339183|3593669|FG000|Overall Study|Other|46
2025039|NCT00339183|3593670|FG001|Overall Study|Other|40
2025040|NCT00339183|3593669|FG000|Overall Study|Ongoing|20
2025041|NCT00339183|3593670|FG001|Overall Study|Ongoing|13
2025042|NCT00339833|3593682|FG000|Overall Study|Withdrawal by Subject|1
2025043|NCT00339833|3593683|FG001|Overall Study|Withdrawal by Subject|2
2025044|NCT00339833|3593682|FG000|Overall Study|toothache|0
2025045|NCT00339833|3593683|FG001|Overall Study|toothache|1
2025046|NCT00339833|3593682|FG000|Overall Study|indigestion|0
2025047|NCT00339833|3593683|FG001|Overall Study|indigestion|1
2025048|NCT00339833|3593682|FG000|Overall Study|Chest pain|0
2025049|NCT00339833|3593683|FG001|Overall Study|Chest pain|1
2025050|NCT00339833|3593682|FG000|Overall Study|minor infection|0
2025051|NCT00339833|3593683|FG001|Overall Study|minor infection|1
2025052|NCT00339833|3593682|FG000|Overall Study|Poor venous access|2
2025053|NCT00339833|3593683|FG001|Overall Study|Poor venous access|2
2025054|NCT00339833|3593682|FG000|Overall Study|anaemia or excess drop in glycaemia|2
2025055|NCT00339833|3593683|FG001|Overall Study|anaemia or excess drop in glycaemia|0
2025056|NCT00339833|3593682|FG000|Overall Study|Error in data records|1
2025057|NCT00339833|3593683|FG001|Overall Study|Error in data records|0
2025058|NCT00340678|3593702|FG000|Overall Study|Lost to Follow-up|1
2025059|NCT00340678|3593703|FG001|Overall Study|Lost to Follow-up|0
2025060|NCT00340678|3593704|FG002|Overall Study|Lost to Follow-up|0
2025061|NCT00340678|3593705|FG003|Overall Study|Lost to Follow-up|0
2025062|NCT00340704|3593722|FG000|PK Study|Adverse Event|0
2025063|NCT00340704|3593723|FG001|PK Study|Adverse Event|1
2025064|NCT00340704|3593724|FG002|PK Study|Adverse Event|0
2025065|NCT00340704|3593725|FG003|PK Study|Adverse Event|0
2025066|NCT00340704|3593726|FG004|PK Study|Adverse Event|0
2025067|NCT00340704|3593727|FG005|PK Study|Adverse Event|0
2025068|NCT00340704|3593728|FG006|PK Study|Adverse Event|0
2025069|NCT00340704|3593729|FG007|PK Study|Adverse Event|0
2025070|NCT00340704|3593730|FG008|PK Study|Adverse Event|0
2025071|NCT00340704|3593722|FG000|PK Study|Not treated|0
2025072|NCT00340704|3593723|FG001|PK Study|Not treated|0
2025073|NCT00340704|3593724|FG002|PK Study|Not treated|1
2025074|NCT00340704|3593725|FG003|PK Study|Not treated|0
2025075|NCT00340704|3593726|FG004|PK Study|Not treated|0
2025076|NCT00340704|3593727|FG005|PK Study|Not treated|0
2025077|NCT00340704|3593728|FG006|PK Study|Not treated|0
2025078|NCT00340704|3593729|FG007|PK Study|Not treated|0
2025079|NCT00340704|3593730|FG008|PK Study|Not treated|0
2025080|NCT00340704|3593722|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
2025081|NCT00340704|3593723|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
2025082|NCT00340704|3593724|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
2312646|NCT02769481|4018841|FG000|Overall Study|Lost to Follow-up|9
2312647|NCT02769481|4018842|FG001|Overall Study|Lost to Follow-up|9
2312648|NCT02769481|4018841|FG000|Overall Study|Physician Decision|0
2312649|NCT02769481|4018842|FG001|Overall Study|Physician Decision|1
2312650|NCT02769481|4018841|FG000|Overall Study|Terminated by Sponsor|1
2312651|NCT02769481|4018842|FG001|Overall Study|Terminated by Sponsor|0
2312652|NCT02769481|4018841|FG000|Overall Study|Death|0
2312653|NCT02769481|4018842|FG001|Overall Study|Death|1
2312654|NCT02769481|4018841|FG000|Overall Study|Undefined|4
2312655|NCT02769481|4018842|FG001|Overall Study|Undefined|1
2312656|NCT02769624|4018848|FG000|Overall Study|Lost to Follow-up|0
2312657|NCT02769624|4018849|FG001|Overall Study|Lost to Follow-up|1
2312658|NCT02769858|4018859|FG000|Overall Study|Withdrawal by Subject|2
2312659|NCT02770170|4018872|FG000|Overall Study|Withdrawal by Subject|0
2312660|NCT02770170|4018873|FG001|Overall Study|Withdrawal by Subject|0
2025083|NCT00340704|3593725|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
2025084|NCT00340704|3593726|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
2025085|NCT00340704|3593727|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
2025086|NCT00340704|3593728|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
2025087|NCT00340704|3593729|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
2025088|NCT00340704|3593730|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
2025089|NCT00340704|3593722|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2025090|NCT00340704|3593723|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2025091|NCT00340704|3593724|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2312661|NCT02770170|4018874|FG002|Overall Study|Withdrawal by Subject|0
2003573|NCT00131248|3567958|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1
2003574|NCT00131248|3567959|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0
2003575|NCT00131352|3567967|FG000|Initial Treatment Period|Adverse Event|1
2003576|NCT00131352|3567968|FG001|Initial Treatment Period|Adverse Event|3
2003577|NCT00131352|3567967|FG000|Initial Treatment Period|Non-compliant|1
2003578|NCT00131352|3567968|FG001|Initial Treatment Period|Non-compliant|2
2003579|NCT00131352|3567967|FG000|Initial Treatment Period|Withdrawal by Subject|1
2003580|NCT00131352|3567968|FG001|Initial Treatment Period|Withdrawal by Subject|1
2003581|NCT00131352|3567967|FG000|Initial Treatment Period|Lack of Efficacy|6
2003582|NCT00131352|3567968|FG001|Initial Treatment Period|Lack of Efficacy|4
2003583|NCT00131352|3567967|FG000|Initial Treatment Period|Other|0
2003584|NCT00131352|3567968|FG001|Initial Treatment Period|Other|2
2003585|NCT00131352|3567967|FG000|Repeat Treatment Period|Adverse Event|1
2003586|NCT00131352|3567968|FG001|Repeat Treatment Period|Adverse Event|0
2003587|NCT00131352|3567967|FG000|Repeat Treatment Period|Other|1
2003588|NCT00131352|3567968|FG001|Repeat Treatment Period|Other|0
2003589|NCT00131365|3567976|FG000|Overall Study|Withdrawal by Subject|1
2003590|NCT00131365|3567976|FG000|Overall Study|Alternative treatment|3
2003591|NCT00131469|3568011|FG000|Overall Study|Withdrawal by Subject|3
2003592|NCT00131469|3568012|FG001|Overall Study|Withdrawal by Subject|4
2003593|NCT00131469|3568011|FG000|Overall Study|Protocol Violation|3
2003594|NCT00131469|3568012|FG001|Overall Study|Protocol Violation|1
2003595|NCT00131469|3568011|FG000|Overall Study|Death|0
2003596|NCT00131469|3568012|FG001|Overall Study|Death|1
2003597|NCT00131469|3568011|FG000|Overall Study|Lost to Follow-up|0
2003598|NCT00131469|3568012|FG001|Overall Study|Lost to Follow-up|1
2003599|NCT00131469|3568011|FG000|Overall Study|scan not analyzable|3
2003600|NCT00131469|3568012|FG001|Overall Study|scan not analyzable|6
2003601|NCT00131508|3568020|FG000|Overall Study|Disease progression|0
2003602|NCT00131508|3568021|FG001|Overall Study|Disease progression|2
2003603|NCT00131508|3568020|FG000|Overall Study|Non-Compliance|2
2003604|NCT00131508|3568021|FG001|Overall Study|Non-Compliance|4
2003605|NCT00131508|3568020|FG000|Overall Study|Withdrawal by Subject|1
2003606|NCT00131508|3568021|FG001|Overall Study|Withdrawal by Subject|2
2003607|NCT00131664|3568040|FG000|First Period (First 6 Months)|Lost to Follow-up|7
2003608|NCT00131664|3568041|FG001|First Period (First 6 Months)|Lost to Follow-up|3
2003609|NCT00131664|3568042|FG002|First Period (First 6 Months)|Lost to Follow-up|3
2003610|NCT00131664|3568043|FG003|First Period (First 6 Months)|Lost to Follow-up|0
2003611|NCT00131664|3568044|FG004|First Period (First 6 Months)|Lost to Follow-up|0
2003612|NCT00131664|3568045|FG005|First Period (First 6 Months)|Lost to Follow-up|0
2003613|NCT00131664|3568040|FG000|First Period (First 6 Months)|Death|0
2003614|NCT00131664|3568041|FG001|First Period (First 6 Months)|Death|1
2003615|NCT00131664|3568042|FG002|First Period (First 6 Months)|Death|0
2003616|NCT00131664|3568043|FG003|First Period (First 6 Months)|Death|0
2003617|NCT00131664|3568044|FG004|First Period (First 6 Months)|Death|0
2003618|NCT00131664|3568045|FG005|First Period (First 6 Months)|Death|0
2003619|NCT00131664|3568040|FG000|First Period (First 6 Months)|Protocol Violation|2
2003620|NCT00131664|3568041|FG001|First Period (First 6 Months)|Protocol Violation|2
2003621|NCT00131664|3568042|FG002|First Period (First 6 Months)|Protocol Violation|1
2003622|NCT00131664|3568043|FG003|First Period (First 6 Months)|Protocol Violation|0
2003623|NCT00131664|3568044|FG004|First Period (First 6 Months)|Protocol Violation|0
2003624|NCT00131664|3568045|FG005|First Period (First 6 Months)|Protocol Violation|0
2003625|NCT00131664|3568040|FG000|First Period (First 6 Months)|Withdrawal by Subject|4
2003626|NCT00131664|3568041|FG001|First Period (First 6 Months)|Withdrawal by Subject|6
2003627|NCT00131664|3568042|FG002|First Period (First 6 Months)|Withdrawal by Subject|2
2003628|NCT00131664|3568043|FG003|First Period (First 6 Months)|Withdrawal by Subject|0
2003629|NCT00131664|3568044|FG004|First Period (First 6 Months)|Withdrawal by Subject|0
2003630|NCT00131664|3568045|FG005|First Period (First 6 Months)|Withdrawal by Subject|0
2003631|NCT00131664|3568040|FG000|First Period (First 6 Months)|Adverse Event|9
2003632|NCT00131664|3568041|FG001|First Period (First 6 Months)|Adverse Event|4
2003633|NCT00131664|3568042|FG002|First Period (First 6 Months)|Adverse Event|5
2003634|NCT00131664|3568043|FG003|First Period (First 6 Months)|Adverse Event|0
2003635|NCT00131664|3568044|FG004|First Period (First 6 Months)|Adverse Event|0
2003636|NCT00131664|3568045|FG005|First Period (First 6 Months)|Adverse Event|0
2003637|NCT00131664|3568040|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1
2003638|NCT00131664|3568041|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2
2003639|NCT00131664|3568042|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0
2003640|NCT00131664|3568043|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0
2003641|NCT00131664|3568044|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0
2003642|NCT00131664|3568045|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0
2003643|NCT00131664|3568040|FG000|First Period (First 6 Months)|Administrative reasons|2
2003644|NCT00131664|3568041|FG001|First Period (First 6 Months)|Administrative reasons|0
2003645|NCT00131664|3568042|FG002|First Period (First 6 Months)|Administrative reasons|5
2003646|NCT00131664|3568043|FG003|First Period (First 6 Months)|Administrative reasons|0
2003647|NCT00131664|3568044|FG004|First Period (First 6 Months)|Administrative reasons|0
2003648|NCT00131664|3568045|FG005|First Period (First 6 Months)|Administrative reasons|0
2003649|NCT00131664|3568040|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3
2003650|NCT00131664|3568041|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0
2003651|NCT00131664|3568042|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2
2003652|NCT00131664|3568043|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1
2003653|NCT00131664|3568044|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0
2003654|NCT00131664|3568045|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2
2003655|NCT00131664|3568040|FG000|Second Period (Additional Drug Added)|Protocol Violation|0
2003656|NCT00131664|3568041|FG001|Second Period (Additional Drug Added)|Protocol Violation|1
2003657|NCT00131664|3568042|FG002|Second Period (Additional Drug Added)|Protocol Violation|1
2003658|NCT00131664|3568043|FG003|Second Period (Additional Drug Added)|Protocol Violation|0
2003659|NCT00131664|3568044|FG004|Second Period (Additional Drug Added)|Protocol Violation|0
2003660|NCT00131664|3568045|FG005|Second Period (Additional Drug Added)|Protocol Violation|0
2003661|NCT00131664|3568040|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2
2003662|NCT00131664|3568041|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0
2003663|NCT00131664|3568042|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0
2003664|NCT00131664|3568043|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0
2003665|NCT00131664|3568044|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0
2003666|NCT00131664|3568045|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0
2003667|NCT00131664|3568040|FG000|Second Period (Additional Drug Added)|Adverse Event|0
2003668|NCT00131664|3568041|FG001|Second Period (Additional Drug Added)|Adverse Event|1
2003669|NCT00131664|3568042|FG002|Second Period (Additional Drug Added)|Adverse Event|0
2003670|NCT00131664|3568043|FG003|Second Period (Additional Drug Added)|Adverse Event|0
2003671|NCT00131664|3568044|FG004|Second Period (Additional Drug Added)|Adverse Event|0
2003672|NCT00131664|3568045|FG005|Second Period (Additional Drug Added)|Adverse Event|1
2003673|NCT00131664|3568040|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
2003674|NCT00131664|3568041|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
2003675|NCT00131664|3568042|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
2003676|NCT00131664|3568043|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
2003677|NCT00131664|3568044|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
2003678|NCT00131664|3568045|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
2003679|NCT00131664|3568040|FG000|Second Period (Additional Drug Added)|Administrative reasons|4
2003680|NCT00131664|3568041|FG001|Second Period (Additional Drug Added)|Administrative reasons|2
2003681|NCT00131664|3568042|FG002|Second Period (Additional Drug Added)|Administrative reasons|0
2003682|NCT00131664|3568043|FG003|Second Period (Additional Drug Added)|Administrative reasons|0
2003683|NCT00131664|3568044|FG004|Second Period (Additional Drug Added)|Administrative reasons|1
2003684|NCT00131664|3568045|FG005|Second Period (Additional Drug Added)|Administrative reasons|0
2003685|NCT00131911|3568089|FG000|Overall Study|Withdrawal by Subject|1
2003686|NCT00131911|3568090|FG001|Overall Study|Withdrawal by Subject|0
2312662|NCT02770170|4018875|FG003|Overall Study|Withdrawal by Subject|2
2312663|NCT02770170|4018872|FG000|Overall Study|due to pregnancy|1
2312664|NCT02770170|4018873|FG001|Overall Study|due to pregnancy|0
2312665|NCT02770170|4018874|FG002|Overall Study|due to pregnancy|0
2312666|NCT02770170|4018875|FG003|Overall Study|due to pregnancy|0
2312667|NCT02770170|4018872|FG000|Overall Study|Lack of Efficacy|2
2312668|NCT02770170|4018873|FG001|Overall Study|Lack of Efficacy|0
2312669|NCT02770170|4018874|FG002|Overall Study|Lack of Efficacy|0
2312670|NCT02770170|4018875|FG003|Overall Study|Lack of Efficacy|1
2312671|NCT02770170|4018872|FG000|Overall Study|Adverse Event|4
2312672|NCT02770170|4018873|FG001|Overall Study|Adverse Event|3
2312673|NCT02770170|4018874|FG002|Overall Study|Adverse Event|5
2312674|NCT02770170|4018875|FG003|Overall Study|Adverse Event|3
2312675|NCT02770170|4018872|FG000|Overall Study|due to disease worsening|0
2312676|NCT02770170|4018873|FG001|Overall Study|due to disease worsening|0
2312677|NCT02770170|4018874|FG002|Overall Study|due to disease worsening|0
2312678|NCT02770170|4018875|FG003|Overall Study|due to disease worsening|1
2312679|NCT02770248|4018887|FG000|Overall Study|Adverse Event|0
2312680|NCT02770248|4018888|FG001|Overall Study|Adverse Event|1
2312681|NCT02770248|4018887|FG000|Overall Study|Randomized in error, prior to treatment|0
2312682|NCT02770248|4018888|FG001|Overall Study|Randomized in error, prior to treatment|1
2312683|NCT02770547|4018941|FG000|Overall Study|Patient non-compliant|1
2312684|NCT02770547|4018942|FG001|Overall Study|Patient non-compliant|0
2312685|NCT02770547|4018941|FG000|Overall Study|Adverse Event|0
2312686|NCT02770547|4018942|FG001|Overall Study|Adverse Event|1
2312687|NCT02770612|4018948|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1
2312688|NCT02770820|4018956|FG000|Overall Study|Death|1
2312689|NCT02770820|4018956|FG000|Overall Study|Physician Decision|2
2312690|NCT02771145|4018980|FG000|Overall Study|Adverse Event|3
2312691|NCT02771145|4018980|FG000|Overall Study|Lost to Follow-up|1
2312692|NCT02771210|4019002|FG000|Period 1|Adverse Event|5
2312693|NCT02771210|4019003|FG001|Period 1|Adverse Event|3
2312694|NCT02771210|4019002|FG000|Period 1|Lack of Efficacy|3
2312695|NCT02771210|4019003|FG001|Period 1|Lack of Efficacy|6
2312696|NCT02771210|4019002|FG000|Period 1|Lost to Follow-up|2
2312697|NCT02771210|4019003|FG001|Period 1|Lost to Follow-up|0
2312698|NCT02771210|4019002|FG000|Period 1|Physician Decision|0
2003687|NCT00131937|3568095|FG000|Overall Study|Adverse Event|3
2003688|NCT00131937|3568095|FG000|Overall Study|Withdrawal by Subject|2
2003689|NCT00131937|3568095|FG000|Overall Study|Physician Decision|1
2003690|NCT00131937|3568095|FG000|Overall Study|Disease Progression|7
2003691|NCT00131937|3568095|FG000|Overall Study|Alternative therapy|1
2003692|NCT00132028|3568103|FG000|Overall Study|Adverse Event|7
2003693|NCT00132028|3568103|FG000|Overall Study|Death|2
2003694|NCT00132028|3568103|FG000|Overall Study|Lack of Efficacy|11
2003695|NCT00132028|3568103|FG000|Overall Study|Withdrawal by Subject|2
2003696|NCT00132028|3568103|FG000|Overall Study|not eligible|2
2003697|NCT00132028|3568103|FG000|Overall Study|Physician Decision|3
2003698|NCT00132041|3568107|FG000|Baseline|Ineligible|6
2003699|NCT00132041|3568107|FG000|3 Months Post Ablation|Transplant|1
2003700|NCT00132041|3568107|FG000|3 Months Post Ablation|Non-Protocol Treatment|2
2003701|NCT00132041|3568107|FG000|6 Months Post Ablation|Withdrawal by Subject|2
2003702|NCT00132041|3568107|FG000|6 Months Post Ablation|Death|2
2003703|NCT00132041|3568107|FG000|6 Months Post Ablation|Transplant|6
2003704|NCT00132041|3568107|FG000|9 Months Post Ablation|Death|1
2003705|NCT00132041|3568107|FG000|9 Months Post Ablation|Transplant|1
2003706|NCT00132041|3568107|FG000|12 Months Post Ablation|Withdrawal by Subject|1
2003707|NCT00132041|3568107|FG000|12 Months Post Ablation|Death|1
2312699|NCT02771210|4019003|FG001|Period 1|Physician Decision|1
2312700|NCT02771210|4019002|FG000|Period 1|Withdrawal by Subject|0
2312701|NCT02771210|4019003|FG001|Period 1|Withdrawal by Subject|3
2312702|NCT02771210|4019002|FG000|Period 1|Withdrawal of informed consent|1
2312703|NCT02771210|4019003|FG001|Period 1|Withdrawal of informed consent|5
2312704|NCT02771210|4019002|FG000|Period 2|Adverse Event|1
2312705|NCT02771210|4019003|FG001|Period 2|Adverse Event|0
2312706|NCT02771210|4019002|FG000|Period 2|Lack of Efficacy|0
2312707|NCT02771210|4019003|FG001|Period 2|Lack of Efficacy|1
2312708|NCT02771210|4019002|FG000|Period 2|Withdrawal by Subject|1
2312709|NCT02771210|4019003|FG001|Period 2|Withdrawal by Subject|0
2312710|NCT02771210|4019002|FG000|Period 2|Withdrawal of informed consent|0
2312711|NCT02771210|4019003|FG001|Period 2|Withdrawal of informed consent|2
2312712|NCT02771275|4019009|FG000|Overall Study|Reoperation|2
2312713|NCT02771275|4019009|FG000|Overall Study|On Study|11
2312714|NCT02771366|4019028|FG000|Period 1|Withdrawal by Subject|0
2312715|NCT02771366|4019029|FG001|Period 1|Withdrawal by Subject|2
2312716|NCT02771366|4019028|FG000|Period 2 (Crossover)|Withdrawal by Subject|2
2312717|NCT02771366|4019029|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
2312718|NCT02771522|4019036|FG000|Overall Study|Lost to Follow-up|3
2312719|NCT02771522|4019036|FG000|Overall Study|Withdrawal by Subject|2
2312720|NCT02771522|4019036|FG000|Overall Study|No white spot lesions|3
2312721|NCT02772757|4019104|FG000|Overall Study|Withdrawal by Subject|1
2312722|NCT02772757|4019105|FG001|Overall Study|Withdrawal by Subject|0
2003708|NCT00132041|3568107|FG000|12 Months Post Ablation|Transplant|1
2003709|NCT00132041|3568107|FG000|12 Months Post Ablation|non-protocol Treatment|1
2003710|NCT00132041|3568107|FG000|15 Months Post Ablation|Withdrawal by Subject|1
2003711|NCT00132041|3568107|FG000|15 Months Post Ablation|Death|1
2003712|NCT00132041|3568107|FG000|15 Months Post Ablation|Transplant|5
2003713|NCT00132041|3568107|FG000|15 Months Post Ablation|Non-Protocol Treatment|1
2003714|NCT00132041|3568107|FG000|18 Months Post Ablation|Withdrawal by Subject|1
2003715|NCT00132041|3568107|FG000|18 Months Post Ablation|Transplant|1
2003716|NCT00132041|3568107|FG000|18 Months Post Ablation|Non-Protocol Treatment|3
2003717|NCT00132041|3568107|FG000|18 Months Post Ablation|ExtraHepatic tumor|1
2003718|NCT00132132|3568119|FG000|Overall Study|Lost to Follow-up|7
2003719|NCT00132132|3568120|FG001|Overall Study|Lost to Follow-up|2
2003720|NCT00132301|3568128|FG000|Overall Study|Death|7
2003721|NCT00132301|3568129|FG001|Overall Study|Death|6
2003722|NCT00132301|3568128|FG000|Overall Study|Withdrawal by Subject|5
2312723|NCT02772757|4019106|FG002|Overall Study|Withdrawal by Subject|1
2312724|NCT02772757|4019104|FG000|Overall Study|Protocol Violation|0
2312725|NCT02772757|4019105|FG001|Overall Study|Protocol Violation|0
2312726|NCT02772757|4019106|FG002|Overall Study|Protocol Violation|1
2312727|NCT02772757|4019104|FG000|Overall Study|Physician Decision|0
2312728|NCT02772757|4019105|FG001|Overall Study|Physician Decision|3
2312729|NCT02772757|4019106|FG002|Overall Study|Physician Decision|3
2312730|NCT02772809|4019124|FG000|Overall Study|not completed some tasks|6
2312731|NCT02772978|4019133|FG000|Overall Study|Withdrawal by Subject|1
2312732|NCT02772978|4019134|FG001|Overall Study|Withdrawal by Subject|1
2312733|NCT02773368|4019141|FG000|Overall Study|Lost to Follow-up|4
2312734|NCT02773368|4019142|FG001|Overall Study|Lost to Follow-up|1
2312735|NCT02773368|4019141|FG000|Overall Study|Withdrawal by Subject|5
2312736|NCT02773368|4019142|FG001|Overall Study|Withdrawal by Subject|1
2312737|NCT02773368|4019141|FG000|Overall Study|Unclassified|1
2312738|NCT02773368|4019142|FG001|Overall Study|Unclassified|1
2312739|NCT02773368|4019141|FG000|Overall Study|Missing|0
2312740|NCT02773368|4019142|FG001|Overall Study|Missing|1
2312741|NCT02773446|4019154|FG000|First Admission|Withdrawal by Subject|0
2312742|NCT02773446|4019155|FG001|First Admission|Withdrawal by Subject|0
2312743|NCT02773446|4019156|FG002|First Admission|Withdrawal by Subject|0
2312744|NCT02773446|4019157|FG003|First Admission|Withdrawal by Subject|1
2312745|NCT02773446|4019158|FG004|First Admission|Withdrawal by Subject|0
2312746|NCT02773446|4019159|FG005|First Admission|Withdrawal by Subject|0
2312747|NCT02773446|4019154|FG000|First Admission|Lost to Follow-up|1
2003723|NCT00132301|3568129|FG001|Overall Study|Withdrawal by Subject|2
2003724|NCT00132301|3568128|FG000|Overall Study|Physician Decision|1
2003725|NCT00132301|3568129|FG001|Overall Study|Physician Decision|1
2003726|NCT00132301|3568128|FG000|Overall Study|Lost to Follow-up|5
2003727|NCT00132301|3568129|FG001|Overall Study|Lost to Follow-up|3
2003728|NCT00132301|3568128|FG000|Overall Study|Other|1
2003729|NCT00132301|3568129|FG001|Overall Study|Other|1
2003730|NCT00132301|3568128|FG000|Overall Study|Excluded by Data Monitoring Committee|1
2003731|NCT00132301|3568129|FG001|Overall Study|Excluded by Data Monitoring Committee|0
2003732|NCT00132314|3568137|FG000|Overall Study|Lost to Follow-up|70
2003733|NCT00132314|3568138|FG001|Overall Study|Lost to Follow-up|62
2003734|NCT00132314|3568137|FG000|Overall Study|Lacked SSN|1
2003735|NCT00132314|3568138|FG001|Overall Study|Lacked SSN|3
2003736|NCT00132314|3568137|FG000|Overall Study|Refused intervention at baseline|2
2003737|NCT00132314|3568138|FG001|Overall Study|Refused intervention at baseline|7
2312748|NCT02773446|4019155|FG001|First Admission|Lost to Follow-up|0
2312749|NCT02773446|4019156|FG002|First Admission|Lost to Follow-up|0
2312750|NCT02773446|4019157|FG003|First Admission|Lost to Follow-up|0
2312751|NCT02773446|4019158|FG004|First Admission|Lost to Follow-up|0
2312752|NCT02773446|4019159|FG005|First Admission|Lost to Follow-up|0
2312753|NCT02773537|4019179|FG000|Overall Study|Lost to Follow-up|0
2312754|NCT02773537|4019180|FG001|Overall Study|Lost to Follow-up|1
2312755|NCT02773537|4019181|FG002|Overall Study|Lost to Follow-up|4
2312756|NCT02774278|4019242|FG000|Overall Study|Lack of Efficacy|199
2312757|NCT02774278|4019242|FG000|Overall Study|Death|29
2312758|NCT02774278|4019242|FG000|Overall Study|Adverse event/intercurrent illness|16
2312759|NCT02774278|4019242|FG000|Overall Study|Refused treatment/did not cooperate|9
2312760|NCT02774278|4019242|FG000|Overall Study|Administrative reasons|6
2312761|NCT02774278|4019242|FG000|Overall Study|Withdrawal by Subject|3
2312762|NCT02774278|4019242|FG000|Overall Study|Protocol Violation|2
2312763|NCT02774681|4019270|FG000|Treatment on Study|Progressive Disease|7
2312764|NCT02774681|4019270|FG000|Follow-Up for 3 Years|Death|11
2312765|NCT02774681|4019270|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1
2312766|NCT02775344|4019313|FG000|Overall Study|No ovarian cyst identified|3
2312767|NCT02775344|4019314|FG001|Overall Study|No ovarian cyst identified|2
2312768|NCT02775864|4019333|FG000|Overall Study|Data ended end of 2010|1764
2312769|NCT02775864|4019334|FG001|Overall Study|Data ended end of 2010|2880
2312770|NCT02775864|4019335|FG002|Overall Study|Data ended end of 2010|1140
2312771|NCT02775864|4019336|FG003|Overall Study|Data ended end of 2010|1194
2312772|NCT02775864|4019333|FG000|Overall Study|Medicaid eligibility discontinued|1478
2312773|NCT02775864|4019334|FG001|Overall Study|Medicaid eligibility discontinued|2019
2312774|NCT02775864|4019335|FG002|Overall Study|Medicaid eligibility discontinued|720
2312775|NCT02775864|4019336|FG003|Overall Study|Medicaid eligibility discontinued|890
2312776|NCT02775903|4019351|FG000|Overall Study|Ongoing|14
2312777|NCT02775903|4019352|FG001|Overall Study|Ongoing|15
2312778|NCT02775903|4019353|FG002|Overall Study|Ongoing|15
2312779|NCT02775903|4019354|FG003|Overall Study|Ongoing|19
2312780|NCT02775903|4019351|FG000|Overall Study|Death|19
2312781|NCT02775903|4019352|FG001|Overall Study|Death|18
2312782|NCT02775903|4019353|FG002|Overall Study|Death|38
2312783|NCT02775903|4019354|FG003|Overall Study|Death|35
2312784|NCT02775903|4019351|FG000|Overall Study|Withdrawal by Subject|5
2312785|NCT02775903|4019352|FG001|Overall Study|Withdrawal by Subject|5
2312786|NCT02775903|4019353|FG002|Overall Study|Withdrawal by Subject|5
2312787|NCT02775903|4019354|FG003|Overall Study|Withdrawal by Subject|4
2312788|NCT02775903|4019351|FG000|Overall Study|Adverse Event|0
2312789|NCT02775903|4019352|FG001|Overall Study|Adverse Event|0
2312790|NCT02775903|4019353|FG002|Overall Study|Adverse Event|1
2312791|NCT02775903|4019354|FG003|Overall Study|Adverse Event|1
2312792|NCT02775903|4019351|FG000|Overall Study|Lost to Follow-up|0
2312793|NCT02775903|4019352|FG001|Overall Study|Lost to Follow-up|0
2312794|NCT02775903|4019353|FG002|Overall Study|Lost to Follow-up|1
2312795|NCT02775903|4019354|FG003|Overall Study|Lost to Follow-up|1
2312796|NCT02775903|4019351|FG000|Overall Study|Other-Miscellaneous|4
2312797|NCT02775903|4019352|FG001|Overall Study|Other-Miscellaneous|3
2312798|NCT02775903|4019353|FG002|Overall Study|Other-Miscellaneous|4
2312799|NCT02775903|4019354|FG003|Overall Study|Other-Miscellaneous|5
2312800|NCT02775916|4019370|FG000|Overall Study|Adverse Event|1
2312801|NCT02775916|4019371|FG001|Overall Study|Adverse Event|0
2312802|NCT02775916|4019370|FG000|Overall Study|Subject/Guardian Decision|2
2312803|NCT02775916|4019371|FG001|Overall Study|Subject/Guardian Decision|0
2312804|NCT02776033|4019380|FG000|Overall Study|Withdrawal by Subject|0
2312805|NCT02776033|4019381|FG001|Overall Study|Withdrawal by Subject|0
2312806|NCT02776033|4019382|FG002|Overall Study|Withdrawal by Subject|2
2312807|NCT02776033|4019380|FG000|Overall Study|Physician Decision|2
2312808|NCT02776033|4019381|FG001|Overall Study|Physician Decision|0
2312809|NCT02776033|4019382|FG002|Overall Study|Physician Decision|0
2312810|NCT02776033|4019380|FG000|Overall Study|Lost to Follow-up|1
2312811|NCT02776033|4019381|FG001|Overall Study|Lost to Follow-up|0
2312812|NCT02776033|4019382|FG002|Overall Study|Lost to Follow-up|0
2312813|NCT02776033|4019380|FG000|Overall Study|Adverse Event|1
2312814|NCT02776033|4019381|FG001|Overall Study|Adverse Event|2
2312815|NCT02776033|4019382|FG002|Overall Study|Adverse Event|0
2312816|NCT02776553|4019398|FG000|Overall Study|Lost to Follow-up|1
2312817|NCT02776553|4019399|FG001|Overall Study|Lost to Follow-up|0
2003738|NCT00132496|3568146|FG000|Overall Study|Withdrawal by Subject|1
2003739|NCT00132496|3568147|FG001|Overall Study|Withdrawal by Subject|2
2003740|NCT00132496|3568146|FG000|Overall Study|Physician Decision|1
2003741|NCT00132496|3568147|FG001|Overall Study|Physician Decision|0
2214203|NCT01685203|3856286|FG006|Overall Study|Adverse event and withdrew consent|0
2312818|NCT02776553|4019398|FG000|Overall Study|got liver transplant|1
2312819|NCT02776553|4019399|FG001|Overall Study|got liver transplant|2
2312820|NCT02776553|4019398|FG000|Overall Study|had other surgery|1
2312821|NCT02776553|4019399|FG001|Overall Study|had other surgery|0
2312822|NCT02776553|4019398|FG000|Overall Study|Protocol Violation|0
2312823|NCT02776553|4019399|FG001|Overall Study|Protocol Violation|1
2312824|NCT02776670|4019416|FG000|Overall Study|Adverse Event|0
2312825|NCT02776670|4019417|FG001|Overall Study|Adverse Event|2
2312826|NCT02776670|4019416|FG000|Overall Study|Protocol Violation|0
2312827|NCT02776670|4019417|FG001|Overall Study|Protocol Violation|2
2312828|NCT02776670|4019416|FG000|Overall Study|Withdrawal by Subject|0
2312829|NCT02776670|4019417|FG001|Overall Study|Withdrawal by Subject|1
2312830|NCT02776670|4019416|FG000|Overall Study|Other - Reason not given|0
2312831|NCT02776670|4019417|FG001|Overall Study|Other - Reason not given|1
2312832|NCT02776683|4019423|FG000|Pre-switch Period|Protocol Violation|1
2312833|NCT02776683|4019424|FG001|Pre-switch Period|Protocol Violation|0
2312834|NCT02776683|4019423|FG000|Pre-switch Period|Adverse Event|21
2312835|NCT02776683|4019424|FG001|Pre-switch Period|Adverse Event|0
2312836|NCT02776683|4019423|FG000|Pre-switch Period|Withdrawal by Subject|9
2312837|NCT02776683|4019424|FG001|Pre-switch Period|Withdrawal by Subject|0
2312838|NCT02776683|4019423|FG000|Pre-switch Period|Physician Decision|7
2312839|NCT02776683|4019424|FG001|Pre-switch Period|Physician Decision|0
2312840|NCT02776683|4019423|FG000|Pre-switch Period|Progressive disease|39
2312841|NCT02776683|4019424|FG001|Pre-switch Period|Progressive disease|0
2312842|NCT02776683|4019423|FG000|Pre-switch Period|Other than listed|3
2312843|NCT02776683|4019424|FG001|Pre-switch Period|Other than listed|0
2312844|NCT02776683|4019423|FG000|Post-switch Period|Adverse Event|0
2312845|NCT02776683|4019424|FG001|Post-switch Period|Adverse Event|3
2312846|NCT02776683|4019423|FG000|Post-switch Period|Withdrawal by Subject|0
2312847|NCT02776683|4019424|FG001|Post-switch Period|Withdrawal by Subject|2
2312848|NCT02776683|4019423|FG000|Post-switch Period|Physician Decision|0
2312849|NCT02776683|4019424|FG001|Post-switch Period|Physician Decision|3
2312850|NCT02776683|4019423|FG000|Post-switch Period|Progressive disease|0
2312851|NCT02776683|4019424|FG001|Post-switch Period|Progressive disease|20
2312852|NCT02776683|4019423|FG000|Post-switch Period|Other than listed|0
2312853|NCT02776683|4019424|FG001|Post-switch Period|Other than listed|15
2312854|NCT02777086|4019459|FG000|Overall Study|Lost to Follow-up|96
2214204|NCT01685203|3856280|FG000|Overall Study|Patient's decision|0
2214205|NCT01685203|3856281|FG001|Overall Study|Patient's decision|0
2214206|NCT01685203|3856282|FG002|Overall Study|Patient's decision|0
2214207|NCT01685203|3856283|FG003|Overall Study|Patient's decision|0
2214208|NCT01685203|3856284|FG004|Overall Study|Patient's decision|0
2214209|NCT01685203|3856285|FG005|Overall Study|Patient's decision|1
2214210|NCT01685203|3856286|FG006|Overall Study|Patient's decision|0
2214211|NCT01685216|3856302|FG000|Overall Study|Did not receive study drug|1
2217554|NCT01708954|3860855|FG001|Step 2|Adverse Event|2
2217555|NCT01708954|3860856|FG002|Step 2|Adverse Event|0
2217556|NCT01708954|3860854|FG000|Step 2|Withdrawal by Subject|1
2217557|NCT01708954|3860855|FG001|Step 2|Withdrawal by Subject|1
2217558|NCT01708954|3860856|FG002|Step 2|Withdrawal by Subject|0
2217559|NCT01709084|3860881|FG000|Overall Study|Lost to Follow-up|4
2217560|NCT01709084|3860882|FG001|Overall Study|Lost to Follow-up|7
2217561|NCT01709084|3860881|FG000|Overall Study|Withdrawal by Subject|2
2217562|NCT01709084|3860882|FG001|Overall Study|Withdrawal by Subject|2
2217563|NCT01709084|3860881|FG000|Overall Study|Adverse Event|5
2217564|NCT01709084|3860882|FG001|Overall Study|Adverse Event|0
2217565|NCT01709084|3860881|FG000|Overall Study|Other|5
2217566|NCT01709084|3860882|FG001|Overall Study|Other|3
2312855|NCT02777086|4019460|FG001|Overall Study|Lost to Follow-up|99
2312856|NCT02777125|4019468|FG000|Overall Study|Consent form violation|14
2312857|NCT02777125|4019469|FG001|Overall Study|Consent form violation|12
2312858|NCT02777125|4019468|FG000|Overall Study|Assent form violation|21
2312859|NCT02777125|4019469|FG001|Overall Study|Assent form violation|23
2312860|NCT02777125|4019468|FG000|Overall Study|Protocol Violation|8
2312861|NCT02777125|4019469|FG001|Overall Study|Protocol Violation|12
2312862|NCT02777242|4019476|FG000|Overall Study|Other|2
2312863|NCT02777242|4019476|FG000|Overall Study|Lost to Follow-up|1
2312864|NCT02777242|4019476|FG000|Overall Study|Multiple|1
2312865|NCT02777242|4019476|FG000|Overall Study|Sponsor's request|1
2312866|NCT02777242|4019476|FG000|Overall Study|Withdrawal by Subject|1
2312867|NCT02777333|4019504|FG000|Overall Study|Withdrawal by Subject|0
2312868|NCT02777333|4019505|FG001|Overall Study|Withdrawal by Subject|1
2312869|NCT02777333|4019504|FG000|Overall Study|Lost to Follow-up|0
2312870|NCT02777333|4019505|FG001|Overall Study|Lost to Follow-up|1
2312871|NCT02777554|4019513|FG000|Overall Study|Adverse Event|4
2312872|NCT02777554|4019514|FG001|Overall Study|Adverse Event|4
2312873|NCT02777554|4019515|FG002|Overall Study|Adverse Event|0
2312874|NCT02777554|4019516|FG003|Overall Study|Adverse Event|1
2312875|NCT02777554|4019517|FG004|Overall Study|Adverse Event|0
2217567|NCT01709084|3860881|FG000|Overall Study|Participant Reached a Virologic Endpoint|0
2003742|NCT00132678|3568155|FG000|Period II (Open-Label Oral Risperidone)|Death|0
2003743|NCT00132678|3568156|FG001|Period II (Open-Label Oral Risperidone)|Death|0
2003744|NCT00132678|3568157|FG002|Period II (Open-Label Oral Risperidone)|Death|1
2003745|NCT00132678|3568155|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0
2003746|NCT00132678|3568156|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0
2003747|NCT00132678|3568157|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13
2003748|NCT00132678|3568155|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0
2003749|NCT00132678|3568156|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0
2003750|NCT00132678|3568157|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6
2003751|NCT00132678|3568155|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
2003752|NCT00132678|3568156|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
2003753|NCT00132678|3568157|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
2003754|NCT00132678|3568155|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
2003755|NCT00132678|3568156|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
2003756|NCT00132678|3568157|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
2003757|NCT00132678|3568155|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
2003758|NCT00132678|3568156|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
2003759|NCT00132678|3568157|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
2214212|NCT01685229|3856308|FG000|Overall Study|Subjects missing Study Exit form|3
2214213|NCT01685229|3856309|FG001|Overall Study|Subjects missing Study Exit form|1
2312876|NCT02777554|4019518|FG005|Overall Study|Adverse Event|0
2312877|NCT02777554|4019513|FG000|Overall Study|Withdrawal by Subject|3
2312878|NCT02777554|4019514|FG001|Overall Study|Withdrawal by Subject|1
2312879|NCT02777554|4019515|FG002|Overall Study|Withdrawal by Subject|1
2312880|NCT02777554|4019516|FG003|Overall Study|Withdrawal by Subject|0
2312881|NCT02777554|4019517|FG004|Overall Study|Withdrawal by Subject|0
2312882|NCT02777554|4019518|FG005|Overall Study|Withdrawal by Subject|0
2312883|NCT02777554|4019513|FG000|Overall Study|Discharged early due to hurricane|22
2312884|NCT02777554|4019514|FG001|Overall Study|Discharged early due to hurricane|20
2312885|NCT02777554|4019515|FG002|Overall Study|Discharged early due to hurricane|0
2312886|NCT02777554|4019516|FG003|Overall Study|Discharged early due to hurricane|0
2312887|NCT02777554|4019517|FG004|Overall Study|Discharged early due to hurricane|0
2312888|NCT02777554|4019518|FG005|Overall Study|Discharged early due to hurricane|0
2312889|NCT02777554|4019513|FG000|Overall Study|Other - Miscellaneous|1
2312890|NCT02777554|4019514|FG001|Overall Study|Other - Miscellaneous|0
2312891|NCT02777554|4019515|FG002|Overall Study|Other - Miscellaneous|0
2312892|NCT02777554|4019516|FG003|Overall Study|Other - Miscellaneous|0
2312893|NCT02777554|4019517|FG004|Overall Study|Other - Miscellaneous|0
2312894|NCT02777554|4019518|FG005|Overall Study|Other - Miscellaneous|0
2312895|NCT02777827|4019555|FG000|Washout Between Periods 3 and 4|Protocol Violation|0
2312896|NCT02777827|4019556|FG001|Washout Between Periods 3 and 4|Protocol Violation|0
2312897|NCT02777827|4019557|FG002|Washout Between Periods 3 and 4|Protocol Violation|1
2312898|NCT02777827|4019558|FG003|Washout Between Periods 3 and 4|Protocol Violation|0
2312899|NCT02777827|4019559|FG004|Washout Between Periods 3 and 4|Protocol Violation|0
2312900|NCT02777827|4019560|FG005|Washout Between Periods 3 and 4|Protocol Violation|0
2312901|NCT02777918|4019576|FG000|Overall Study|Medical reasons|1
2312902|NCT02777918|4019577|FG001|Overall Study|Medical reasons|2
2312903|NCT02777918|4019576|FG000|Overall Study|Too busy / stressed|1
2312904|NCT02777918|4019577|FG001|Overall Study|Too busy / stressed|1
2312905|NCT02777918|4019576|FG000|Overall Study|Withdrawal by Subject|1
2312906|NCT02777918|4019577|FG001|Overall Study|Withdrawal by Subject|1
2312907|NCT02777970|4019604|FG000|Overall Study|Lost to Follow-up|0
2312908|NCT02777970|4019605|FG001|Overall Study|Lost to Follow-up|1
2312909|NCT02777970|4019606|FG002|Overall Study|Lost to Follow-up|0
2312910|NCT02777970|4019604|FG000|Overall Study|Protocol Violation|1
2312911|NCT02777970|4019605|FG001|Overall Study|Protocol Violation|0
2312912|NCT02777970|4019606|FG002|Overall Study|Protocol Violation|0
2312913|NCT02778074|4019618|FG000|Overall Study|Lost to Follow-up|7
2312914|NCT02778074|4019619|FG001|Overall Study|Lost to Follow-up|10
2312915|NCT02778100|4019627|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1
2312916|NCT02778100|4019628|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0
2312917|NCT02778555|4019658|FG000|Overall Study|Withdrawal by Subject|55
2312918|NCT02778555|4019659|FG001|Overall Study|Withdrawal by Subject|32
2312919|NCT02778555|4019660|FG002|Overall Study|Withdrawal by Subject|107
2312920|NCT02778867|4019670|FG000|Phase 1|Withdrawal by Subject|2
2312921|NCT02778867|4019671|FG001|Phase 1|Withdrawal by Subject|3
2312922|NCT02778867|4019672|FG002|Phase 1|Withdrawal by Subject|0
2312923|NCT02778867|4019673|FG003|Phase 1|Withdrawal by Subject|0
2312924|NCT02778867|4019670|FG000|Phase 2|Withdrawal by Subject|0
2312925|NCT02778867|4019671|FG001|Phase 2|Withdrawal by Subject|0
2312926|NCT02778867|4019672|FG002|Phase 2|Withdrawal by Subject|1
2312927|NCT02778867|4019673|FG003|Phase 2|Withdrawal by Subject|0
2312928|NCT02778867|4019670|FG000|Phase 2|Physician Decision|0
2312929|NCT02778867|4019671|FG001|Phase 2|Physician Decision|0
2312930|NCT02778867|4019672|FG002|Phase 2|Physician Decision|0
2312931|NCT02778867|4019673|FG003|Phase 2|Physician Decision|1
2312932|NCT02778867|4019670|FG000|Phase 2|Adverse Event|0
2312933|NCT02778867|4019671|FG001|Phase 2|Adverse Event|0
2003760|NCT00132678|3568155|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0
2003761|NCT00132678|3568156|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0
2003762|NCT00132678|3568157|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1
2003763|NCT00132678|3568155|FG000|Period III (Open-Label Stabilization)|Death|2
2003764|NCT00132678|3568156|FG001|Period III (Open-Label Stabilization)|Death|0
2003765|NCT00132678|3568157|FG002|Period III (Open-Label Stabilization)|Death|0
2003766|NCT00132678|3568155|FG000|Period III (Open-Label Stabilization)|Adverse Event|12
2003767|NCT00132678|3568156|FG001|Period III (Open-Label Stabilization)|Adverse Event|0
2003768|NCT00132678|3568157|FG002|Period III (Open-Label Stabilization)|Adverse Event|0
2003769|NCT00132678|3568155|FG000|Period III (Open-Label Stabilization)|Non responder|107
2003770|NCT00132678|3568156|FG001|Period III (Open-Label Stabilization)|Non responder|0
2003771|NCT00132678|3568157|FG002|Period III (Open-Label Stabilization)|Non responder|0
2003772|NCT00132678|3568155|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
2003773|NCT00132678|3568156|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
2003774|NCT00132678|3568157|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
2003775|NCT00132678|3568155|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19
2003776|NCT00132678|3568156|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0
2003777|NCT00132678|3568157|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0
2003778|NCT00132678|3568155|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
2003779|NCT00132678|3568156|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
2003780|NCT00132678|3568157|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
2003781|NCT00132678|3568155|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1
2003782|NCT00132678|3568156|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0
2003783|NCT00132678|3568157|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0
2003784|NCT00132678|3568155|FG000|Period III (Open-Label Stabilization)|Physician Decision|1
2003785|NCT00132678|3568156|FG001|Period III (Open-Label Stabilization)|Physician Decision|0
2003786|NCT00132678|3568157|FG002|Period III (Open-Label Stabilization)|Physician Decision|0
2003787|NCT00132678|3568155|FG000|Period III (Open-Label Stabilization)|Pregnancy|2
2003788|NCT00132678|3568156|FG001|Period III (Open-Label Stabilization)|Pregnancy|0
2003789|NCT00132678|3568157|FG002|Period III (Open-Label Stabilization)|Pregnancy|0
2003790|NCT00132678|3568155|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1
2003791|NCT00132678|3568156|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1
2003792|NCT00132678|3568157|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0
2003793|NCT00132678|3568155|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
2003794|NCT00132678|3568156|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
2003795|NCT00132678|3568157|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
2003796|NCT00132678|3568155|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
2003797|NCT00132678|3568156|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
2003798|NCT00132678|3568157|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
2003799|NCT00132678|3568155|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
2003800|NCT00132678|3568156|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
2003801|NCT00132678|3568157|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
2003802|NCT00132678|3568155|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10
2003803|NCT00132678|3568156|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14
2003804|NCT00132678|3568157|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0
2003805|NCT00132678|3568155|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
2003806|NCT00132678|3568156|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
2003807|NCT00132678|3568157|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
2003808|NCT00132678|3568155|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0
2003809|NCT00132678|3568156|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2
2003810|NCT00132678|3568157|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0
2003811|NCT00132691|3568167|FG000|Overall Study|Lost to Follow-up|5
2003812|NCT00132691|3568168|FG001|Overall Study|Lost to Follow-up|8
2003813|NCT00132691|3568167|FG000|Overall Study|Missed 2-year visit|4
2003814|NCT00132691|3568168|FG001|Overall Study|Missed 2-year visit|4
2003815|NCT00132691|3568167|FG000|Overall Study|Death|2
2003816|NCT00132691|3568168|FG001|Overall Study|Death|0
2102397|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Physician Decision|1
2312934|NCT02778867|4019672|FG002|Phase 2|Adverse Event|0
2312935|NCT02778867|4019673|FG003|Phase 2|Adverse Event|1
2312936|NCT02779075|4019703|FG000|Overall Study|Withdrawal by Subject|1
2312937|NCT02779075|4019704|FG001|Overall Study|Withdrawal by Subject|3
2312938|NCT02779075|4019703|FG000|Overall Study|IV lost during 2nd study|1
2312939|NCT02779075|4019704|FG001|Overall Study|IV lost during 2nd study|0
2321984|NCT02966340|4036672|FG001|Overall Study|Adverse Event|1
2321985|NCT02966340|4036671|FG000|Overall Study|Lost to Follow-up|0
2321986|NCT02966340|4036672|FG001|Overall Study|Lost to Follow-up|1
2321987|NCT02966340|4036671|FG000|Overall Study|Withdrawal by Subject|1
2321988|NCT02966340|4036672|FG001|Overall Study|Withdrawal by Subject|0
2321989|NCT02966340|4036671|FG000|Overall Study|data acquisition error|1
2321990|NCT02966340|4036672|FG001|Overall Study|data acquisition error|0
2321991|NCT02966340|4036671|FG000|Overall Study|startle non-responder|1
2321992|NCT02966340|4036672|FG001|Overall Study|startle non-responder|1
2003817|NCT00132730|3568183|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
2003818|NCT00132730|3568184|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
2312940|NCT02780115|4019751|FG000|Overall Study|Withdrawal by Subject|0
2312941|NCT02780115|4019752|FG001|Overall Study|Withdrawal by Subject|1
2312942|NCT02780115|4019753|FG002|Overall Study|Withdrawal by Subject|1
2312943|NCT02780115|4019754|FG003|Overall Study|Withdrawal by Subject|0
2312944|NCT02780115|4019755|FG004|Overall Study|Withdrawal by Subject|0
2312945|NCT02780115|4019751|FG000|Overall Study|Adverse Event|0
2312946|NCT02780115|4019752|FG001|Overall Study|Adverse Event|0
2312947|NCT02780115|4019753|FG002|Overall Study|Adverse Event|0
2312948|NCT02780115|4019754|FG003|Overall Study|Adverse Event|1
2312949|NCT02780115|4019755|FG004|Overall Study|Adverse Event|1
2312950|NCT02780167|4019772|FG000|Overall Study|Adverse Event|9
2312951|NCT02780167|4019773|FG001|Overall Study|Adverse Event|8
2312952|NCT02780167|4019774|FG002|Overall Study|Adverse Event|8
2312953|NCT02780167|4019775|FG003|Overall Study|Adverse Event|12
2312954|NCT02780167|4019776|FG004|Overall Study|Adverse Event|8
2312955|NCT02780167|4019772|FG000|Overall Study|Lack of Efficacy|6
2312956|NCT02780167|4019773|FG001|Overall Study|Lack of Efficacy|5
2312957|NCT02780167|4019774|FG002|Overall Study|Lack of Efficacy|6
2312958|NCT02780167|4019775|FG003|Overall Study|Lack of Efficacy|1
2312959|NCT02780167|4019776|FG004|Overall Study|Lack of Efficacy|0
2312960|NCT02780167|4019772|FG000|Overall Study|Lost to Follow-up|2
2312961|NCT02780167|4019773|FG001|Overall Study|Lost to Follow-up|0
2312962|NCT02780167|4019774|FG002|Overall Study|Lost to Follow-up|1
2312963|NCT02780167|4019775|FG003|Overall Study|Lost to Follow-up|0
2312964|NCT02780167|4019776|FG004|Overall Study|Lost to Follow-up|0
2312965|NCT02780167|4019772|FG000|Overall Study|Does not meet entrance criteria|0
2312966|NCT02780167|4019773|FG001|Overall Study|Does not meet entrance criteria|0
2312967|NCT02780167|4019774|FG002|Overall Study|Does not meet entrance criteria|1
2312968|NCT02780167|4019775|FG003|Overall Study|Does not meet entrance criteria|0
2312969|NCT02780167|4019776|FG004|Overall Study|Does not meet entrance criteria|0
2312970|NCT02780167|4019772|FG000|Overall Study|No longer meets eligibility criteria|0
2312971|NCT02780167|4019773|FG001|Overall Study|No longer meets eligibility criteria|0
2312972|NCT02780167|4019774|FG002|Overall Study|No longer meets eligibility criteria|0
2312973|NCT02780167|4019775|FG003|Overall Study|No longer meets eligibility criteria|1
2312974|NCT02780167|4019776|FG004|Overall Study|No longer meets eligibility criteria|1
2312975|NCT02780167|4019772|FG000|Overall Study|Protocol Violation|5
2312976|NCT02780167|4019773|FG001|Overall Study|Protocol Violation|5
2312977|NCT02780167|4019774|FG002|Overall Study|Protocol Violation|1
2312978|NCT02780167|4019775|FG003|Overall Study|Protocol Violation|1
2312979|NCT02780167|4019776|FG004|Overall Study|Protocol Violation|2
2312980|NCT02780167|4019772|FG000|Overall Study|Withdrawal by Subject|6
2312981|NCT02780167|4019773|FG001|Overall Study|Withdrawal by Subject|4
2312982|NCT02780167|4019774|FG002|Overall Study|Withdrawal by Subject|4
2312983|NCT02780167|4019775|FG003|Overall Study|Withdrawal by Subject|3
2312984|NCT02780167|4019776|FG004|Overall Study|Withdrawal by Subject|4
2312985|NCT02780167|4019772|FG000|Overall Study|Other|0
2312986|NCT02780167|4019773|FG001|Overall Study|Other|0
2312987|NCT02780167|4019774|FG002|Overall Study|Other|3
2312988|NCT02780167|4019775|FG003|Overall Study|Other|1
2312989|NCT02780167|4019776|FG004|Overall Study|Other|2
2312990|NCT02780388|4019797|FG000|Overall Study|Lost to Follow-up|0
2312991|NCT02780388|4019798|FG001|Overall Study|Lost to Follow-up|1
2312992|NCT02780388|4019799|FG002|Overall Study|Lost to Follow-up|0
2312993|NCT02780388|4019800|FG003|Overall Study|Lost to Follow-up|0
2312994|NCT02780388|4019801|FG004|Overall Study|Lost to Follow-up|0
2312995|NCT02780388|4019797|FG000|Overall Study|Withdrawal by Subject|1
2312996|NCT02780388|4019798|FG001|Overall Study|Withdrawal by Subject|1
2312997|NCT02780388|4019799|FG002|Overall Study|Withdrawal by Subject|0
2312998|NCT02780388|4019800|FG003|Overall Study|Withdrawal by Subject|0
2312999|NCT02780388|4019801|FG004|Overall Study|Withdrawal by Subject|0
2313000|NCT02780687|4019835|FG000|Overall Study|Adverse Event|1
2313001|NCT02780687|4019836|FG001|Overall Study|Adverse Event|1
2313002|NCT02780687|4019835|FG000|Overall Study|Withdrawal by Subject|2
2313003|NCT02780687|4019836|FG001|Overall Study|Withdrawal by Subject|1
2313004|NCT02780687|4019835|FG000|Overall Study|Switched to commercial program (in CTP)|2
2313005|NCT02780687|4019836|FG001|Overall Study|Switched to commercial program (in CTP)|0
2313006|NCT02780687|4019835|FG000|Overall Study|progressive disease|29
2313007|NCT02780687|4019836|FG001|Overall Study|progressive disease|6
2313008|NCT02780700|4019841|FG000|Overall Study|Progressive disease|1
2313009|NCT02780713|4019845|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0
2313010|NCT02780713|4019846|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0
2313011|NCT02780713|4019847|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2
2313012|NCT02780713|4019848|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0
2313013|NCT02780713|4019849|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0
2313014|NCT02780856|4019877|FG000|Overall Study|Lost to Follow-up|1
2313015|NCT02781311|4019901|FG000|Overall Study|Adverse Event|2
2313016|NCT02781311|4019902|FG001|Overall Study|Adverse Event|6
2313017|NCT02781311|4019903|FG002|Overall Study|Adverse Event|1
2313018|NCT02781311|4019901|FG000|Overall Study|Withdrawal of Consent|11
2313019|NCT02781311|4019902|FG001|Overall Study|Withdrawal of Consent|12
2313020|NCT02781311|4019903|FG002|Overall Study|Withdrawal of Consent|2
2003819|NCT00132730|3568185|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
2003820|NCT00132730|3568186|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
2003821|NCT00132730|3568187|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
2003822|NCT00132730|3568188|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
2003823|NCT00132730|3568183|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
2025991|NCT00348140|3594697|FG000|Overall Study|Efficacy related|1
2313021|NCT02781311|4019901|FG000|Overall Study|Lost to Follow-up|11
2313022|NCT02781311|4019902|FG001|Overall Study|Lost to Follow-up|8
2313023|NCT02781311|4019903|FG002|Overall Study|Lost to Follow-up|1
2313024|NCT02781311|4019901|FG000|Overall Study|Non-Compliance with Study Drug|2
2313025|NCT02781311|4019902|FG001|Overall Study|Non-Compliance with Study Drug|0
2313026|NCT02781311|4019903|FG002|Overall Study|Non-Compliance with Study Drug|0
2313027|NCT02781324|4019912|FG000|Overall Study|Withdrawal by Subject|1
2313028|NCT02781324|4019913|FG001|Overall Study|Withdrawal by Subject|0
2313029|NCT02781324|4019912|FG000|Overall Study|Physician Decision|1
2313030|NCT02781324|4019913|FG001|Overall Study|Physician Decision|2
2313031|NCT02781558|4019949|FG000|Overall Study|Lost to Follow-up|2
2313032|NCT02781558|4019950|FG001|Overall Study|Lost to Follow-up|2
2313033|NCT02781558|4019949|FG000|Overall Study|Adverse Event|1
2313034|NCT02781558|4019950|FG001|Overall Study|Adverse Event|0
2313035|NCT02781818|4019994|FG000|Overall Study|Lost to Follow-up|4
2313036|NCT02781818|4019995|FG001|Overall Study|Lost to Follow-up|2
2313037|NCT02781818|4019996|FG002|Overall Study|Lost to Follow-up|1
2313038|NCT02781844|4020008|FG000|Treatment Period 1|Adverse Event|0
2313039|NCT02781844|4020009|FG001|Treatment Period 1|Adverse Event|0
2313040|NCT02781844|4020010|FG002|Treatment Period 1|Adverse Event|0
2313041|NCT02781844|4020011|FG003|Treatment Period 1|Adverse Event|0
2313042|NCT02781844|4020012|FG004|Treatment Period 1|Adverse Event|0
2313043|NCT02781844|4020013|FG005|Treatment Period 1|Adverse Event|1
2313044|NCT02781844|4020014|FG006|Treatment Period 1|Adverse Event|0
2313045|NCT02781844|4020015|FG007|Treatment Period 1|Adverse Event|0
2313046|NCT02782169|4020038|FG000|Overall Study|Lost to Follow-up|1
2313047|NCT02782169|4020039|FG001|Overall Study|Lost to Follow-up|2
2313048|NCT02782325|4020047|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
2313049|NCT02782325|4020048|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
2313050|NCT02782325|4020049|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
2313051|NCT02782325|4020047|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
2313052|NCT02782325|4020048|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
2313053|NCT02782325|4020049|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
2313054|NCT02782377|4020065|FG000|Overall Study|Physician Decision|5
2313055|NCT02782676|4020070|FG000|Overall Study|Lost to Follow-up|0
2313056|NCT02782676|4020071|FG001|Overall Study|Lost to Follow-up|1
2313057|NCT02782741|4020079|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0
2313058|NCT02782741|4020080|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4
2313059|NCT02782741|4020079|FG000|Blinded Treatment Period: up to Week 49|Other|0
2313060|NCT02782741|4020080|FG001|Blinded Treatment Period: up to Week 49|Other|1
2313061|NCT02782741|4020079|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2
2313062|NCT02782741|4020080|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1
2313063|NCT02782741|4020079|FG000|Open-label Long-term: Week 50 to 145|Other|1
2313064|NCT02782741|4020080|FG001|Open-label Long-term: Week 50 to 145|Other|0
2313065|NCT02782741|4020079|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48
2313066|NCT02782741|4020080|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43
2313067|NCT02782780|4020092|FG000|Overall Study|dropped out after randomization.|7
2313068|NCT02782780|4020093|FG001|Overall Study|dropped out after randomization.|5
2313069|NCT02782780|4020092|FG000|Overall Study|Protocol Violation|0
2313070|NCT02782780|4020093|FG001|Overall Study|Protocol Violation|2
2313071|NCT02782923|4020099|FG000|Overall Study|Lost to Follow-up|15
2313072|NCT02783066|4020112|FG000|Overall Study|Withdrawal by Subject|13
2313073|NCT02783170|4020119|FG000|Overall Study|Randomized but not Vaccinated|1
2313074|NCT02783170|4020120|FG001|Overall Study|Randomized but not Vaccinated|0
2313075|NCT02783573|4020143|FG000|Placebo-Controlled Treatment Period|Adverse Event|13
2313076|NCT02783573|4020144|FG001|Placebo-Controlled Treatment Period|Adverse Event|17
2313077|NCT02783573|4020145|FG002|Placebo-Controlled Treatment Period|Adverse Event|13
2313078|NCT02783573|4020143|FG000|Placebo-Controlled Treatment Period|Death|4
2313079|NCT02783573|4020144|FG001|Placebo-Controlled Treatment Period|Death|2
2313080|NCT02783573|4020145|FG002|Placebo-Controlled Treatment Period|Death|3
2313081|NCT02783573|4020143|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0
2313082|NCT02783573|4020144|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0
2313083|NCT02783573|4020145|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2
2313084|NCT02783573|4020143|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3
2313085|NCT02783573|4020144|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3
2313086|NCT02783573|4020145|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1
2313087|NCT02783573|4020143|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0
2313088|NCT02783573|4020144|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1
2313089|NCT02783573|4020145|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0
2313090|NCT02783573|4020143|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
2313091|NCT02783573|4020144|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
2003824|NCT00132730|3568184|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
2003825|NCT00132730|3568185|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
2003826|NCT00132730|3568186|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
2003827|NCT00132730|3568187|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
2003828|NCT00132730|3568188|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
2003829|NCT00132730|3568183|FG000|Period II - 12-week Treatment (Base)|Other reasons|11
2003830|NCT00132730|3568184|FG001|Period II - 12-week Treatment (Base)|Other reasons|10
2003831|NCT00132730|3568185|FG002|Period II - 12-week Treatment (Base)|Other reasons|9
2003832|NCT00132730|3568186|FG003|Period II - 12-week Treatment (Base)|Other reasons|13
2003833|NCT00132730|3568187|FG004|Period II - 12-week Treatment (Base)|Other reasons|0
2313092|NCT02783573|4020145|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
2313093|NCT02783573|4020143|FG000|Placebo-Controlled Treatment Period|Physician Decision|3
2313094|NCT02783573|4020144|FG001|Placebo-Controlled Treatment Period|Physician Decision|1
2313095|NCT02783573|4020145|FG002|Placebo-Controlled Treatment Period|Physician Decision|3
2313096|NCT02783573|4020143|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1
2313097|NCT02783573|4020144|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2
2313098|NCT02783573|4020145|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0
2313099|NCT02783573|4020143|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
2313100|NCT02783573|4020144|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
2313101|NCT02783573|4020145|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
2313102|NCT02783573|4020143|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
2313103|NCT02783573|4020144|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
2313104|NCT02783573|4020145|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
2313105|NCT02783573|4020143|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494
2313106|NCT02783573|4020144|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512
2313107|NCT02783573|4020145|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492
2313108|NCT02783573|4020143|FG000|Delayed-Start Period|Sponsor Decision|0
2313109|NCT02783573|4020144|FG001|Delayed-Start Period|Sponsor Decision|17
2313110|NCT02783573|4020145|FG002|Delayed-Start Period|Sponsor Decision|12
2313111|NCT02783599|4020156|FG000|Overall Study|Progressive disease|23
2313112|NCT02783599|4020156|FG000|Overall Study|Surgical Resection|10
2313113|NCT02783599|4020156|FG000|Overall Study|Adverse Event|4
2313114|NCT02783599|4020156|FG000|Overall Study|Physician Decision|2
2313115|NCT02783599|4020156|FG000|Overall Study|Death|1
2313116|NCT02783729|4020171|FG000|Overall Study|Lack of Efficacy|1
2313117|NCT02783729|4020172|FG001|Overall Study|Lack of Efficacy|0
2313118|NCT02783729|4020173|FG002|Overall Study|Lack of Efficacy|0
2313119|NCT02783729|4020174|FG003|Overall Study|Lack of Efficacy|0
2313120|NCT02783729|4020171|FG000|Overall Study|Adverse Event|2
2313121|NCT02783729|4020172|FG001|Overall Study|Adverse Event|6
2313122|NCT02783729|4020173|FG002|Overall Study|Adverse Event|2
2313123|NCT02783729|4020174|FG003|Overall Study|Adverse Event|3
2313124|NCT02783729|4020171|FG000|Overall Study|Other|1
2313125|NCT02783729|4020172|FG001|Overall Study|Other|6
2313126|NCT02783729|4020173|FG002|Overall Study|Other|2
2313127|NCT02783729|4020174|FG003|Overall Study|Other|3
2313128|NCT02783729|4020171|FG000|Overall Study|Withdrawal by Subject|2
2313129|NCT02783729|4020172|FG001|Overall Study|Withdrawal by Subject|3
2313130|NCT02783729|4020173|FG002|Overall Study|Withdrawal by Subject|1
2313131|NCT02783729|4020174|FG003|Overall Study|Withdrawal by Subject|2
2313132|NCT02783729|4020171|FG000|Overall Study|Participant's choice|2
2313133|NCT02783729|4020172|FG001|Overall Study|Participant's choice|1
2313134|NCT02783729|4020173|FG002|Overall Study|Participant's choice|2
2313135|NCT02783729|4020174|FG003|Overall Study|Participant's choice|1
2313136|NCT02783729|4020171|FG000|Overall Study|Lost to Follow-up|2
2313137|NCT02783729|4020172|FG001|Overall Study|Lost to Follow-up|1
2313138|NCT02783729|4020173|FG002|Overall Study|Lost to Follow-up|1
2313139|NCT02783729|4020174|FG003|Overall Study|Lost to Follow-up|0
2313140|NCT02783768|4020189|FG000|Overall Study|Lost to Follow-up|1
2313141|NCT02783768|4020190|FG001|Overall Study|Lost to Follow-up|0
2313142|NCT02783911|4020226|FG000|Overall Study|Lost to Follow-up|3
2313143|NCT02783911|4020227|FG001|Overall Study|Lost to Follow-up|32
2313144|NCT02784106|4020244|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
2313145|NCT02784106|4020245|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
2313146|NCT02784106|4020246|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
2313147|NCT02784106|4020247|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
2313148|NCT02784106|4020244|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
2313149|NCT02784106|4020245|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
2313150|NCT02784106|4020246|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2313151|NCT02784106|4020247|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2313152|NCT02784106|4020244|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2
2313153|NCT02784106|4020245|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0
2313154|NCT02784106|4020246|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0
2313155|NCT02784106|4020247|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0
2313156|NCT02784106|4020244|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
2003834|NCT00132730|3568188|FG005|Period II - 12-week Treatment (Base)|Other reasons|0
2003835|NCT00132730|3568183|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0
2003836|NCT00132730|3568184|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0
2003837|NCT00132730|3568185|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57
2003838|NCT00132730|3568186|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20
2003839|NCT00132730|3568187|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0
2003840|NCT00132730|3568188|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0
2003841|NCT00132730|3568183|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
2003842|NCT00132730|3568184|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
2003843|NCT00132730|3568185|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
2313157|NCT02784106|4020245|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2313158|NCT02784106|4020246|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2313159|NCT02784106|4020247|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2313160|NCT02784106|4020244|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0
2313161|NCT02784106|4020245|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0
2313162|NCT02784106|4020246|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2
2313163|NCT02784106|4020247|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1
2313164|NCT02784106|4020244|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
2313165|NCT02784106|4020245|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
2313166|NCT02784106|4020246|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
2313167|NCT02784106|4020247|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
2313168|NCT02784431|4020273|FG000|Overall Study|Unsuccessful Implant Attempt|1
2313169|NCT02784431|4020273|FG000|Overall Study|Early Study Termination|19
2313170|NCT02784834|4020307|FG000|Overall Study|Lack of Efficacy|1
2313171|NCT02785458|4020400|FG000|1 Month|Withdrawal by Subject|2
2313172|NCT02785458|4020401|FG001|1 Month|Withdrawal by Subject|1
2313173|NCT02785458|4020400|FG000|1 Month|Lost to Follow-up|38
2313174|NCT02785458|4020401|FG001|1 Month|Lost to Follow-up|31
2313175|NCT02785458|4020400|FG000|1 Month|Deemed Ineligible|1
2313176|NCT02785458|4020401|FG001|1 Month|Deemed Ineligible|0
2313177|NCT02785458|4020400|FG000|1 Month|Completed Evaluation by Baseline|42
2313178|NCT02785458|4020401|FG001|1 Month|Completed Evaluation by Baseline|39
2313179|NCT02785458|4020400|FG000|1 Month|Partial Interview|0
2313180|NCT02785458|4020401|FG001|1 Month|Partial Interview|4
2313181|NCT02785458|4020400|FG000|3 Months|Withdrawal by Subject|3
2313182|NCT02785458|4020401|FG001|3 Months|Withdrawal by Subject|1
2313183|NCT02785458|4020400|FG000|3 Months|Lost to Follow-up|25
2313184|NCT02785458|4020401|FG001|3 Months|Lost to Follow-up|21
2313185|NCT02785458|4020400|FG000|3 Months|Completed Evaluation at 1 Month|100
2313186|NCT02785458|4020401|FG001|3 Months|Completed Evaluation at 1 Month|89
2313187|NCT02785588|4020407|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
2313188|NCT02785588|4020407|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
2313189|NCT02785770|4020411|FG000|Intervention Period 2 (1 Day)|Adverse Event|0
2313190|NCT02785770|4020412|FG001|Intervention Period 2 (1 Day)|Adverse Event|1
2313191|NCT02785770|4020413|FG002|Intervention Period 2 (1 Day)|Adverse Event|0
2313192|NCT02785770|4020414|FG003|Intervention Period 2 (1 Day)|Adverse Event|0
2313193|NCT02785770|4020411|FG000|Intervention Period 2 (1 Day)|Family related obligations|0
2313194|NCT02785770|4020412|FG001|Intervention Period 2 (1 Day)|Family related obligations|0
2313195|NCT02785770|4020413|FG002|Intervention Period 2 (1 Day)|Family related obligations|1
2313196|NCT02785770|4020414|FG003|Intervention Period 2 (1 Day)|Family related obligations|0
2313197|NCT02785770|4020411|FG000|Intervention Period 3 (1 Day)|Adverse Event|0
2313198|NCT02785770|4020412|FG001|Intervention Period 3 (1 Day)|Adverse Event|0
2313199|NCT02785770|4020413|FG002|Intervention Period 3 (1 Day)|Adverse Event|0
2313200|NCT02785770|4020414|FG003|Intervention Period 3 (1 Day)|Adverse Event|1
2313201|NCT02785900|4020429|FG000|Overall Study|Study Termination by Sponsor|64
2313202|NCT02785900|4020430|FG001|Overall Study|Study Termination by Sponsor|81
2313203|NCT02785900|4020429|FG000|Overall Study|Death|46
2313204|NCT02785900|4020430|FG001|Overall Study|Death|32
2313205|NCT02785900|4020429|FG000|Overall Study|Withdrawal by Subject|4
2313206|NCT02785900|4020430|FG001|Overall Study|Withdrawal by Subject|8
2313207|NCT02785900|4020429|FG000|Overall Study|Physician Decision|3
2313208|NCT02785900|4020430|FG001|Overall Study|Physician Decision|2
2313209|NCT02785913|4020436|FG000|Overall Study|Adverse Event|5
2313210|NCT02785913|4020436|FG000|Overall Study|Death|2
2313211|NCT02785913|4020436|FG000|Overall Study|Progression|18
2313212|NCT02785913|4020436|FG000|Overall Study|Not protocol specified|1
2313213|NCT02785939|4020443|FG000|Overall Study|Progression|25
2313214|NCT02785939|4020444|FG001|Overall Study|Progression|8
2313215|NCT02785939|4020443|FG000|Overall Study|Adverse Event|3
2313216|NCT02785939|4020444|FG001|Overall Study|Adverse Event|1
2313217|NCT02785939|4020443|FG000|Overall Study|Death|1
2313218|NCT02785939|4020444|FG001|Overall Study|Death|0
2313219|NCT02785939|4020443|FG000|Overall Study|Refusal|1
2313220|NCT02785939|4020444|FG001|Overall Study|Refusal|0
2313221|NCT02785939|4020443|FG000|Overall Study|Deteriorating health|1
2313222|NCT02785939|4020444|FG001|Overall Study|Deteriorating health|0
2313223|NCT02785939|4020443|FG000|Overall Study|Not protocol specified|0
2313224|NCT02785939|4020444|FG001|Overall Study|Not protocol specified|1
2313225|NCT02786004|4020452|FG000|Overall Study|Withdrawal by Subject|0
2003844|NCT00132730|3568186|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
2003845|NCT00132730|3568187|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
2003846|NCT00132730|3568188|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
2003847|NCT00132730|3568183|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
2003848|NCT00132730|3568184|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
2003849|NCT00132730|3568185|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
2003850|NCT00132730|3568186|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
2003851|NCT00132730|3568187|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
2003852|NCT00132730|3568188|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
2003853|NCT00132730|3568183|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0
2003854|NCT00132730|3568184|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0
2003855|NCT00132730|3568185|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14
2003856|NCT00132730|3568186|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3
2003857|NCT00132730|3568187|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0
2003858|NCT00132730|3568188|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0
2003859|NCT00132730|3568183|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0
2003860|NCT00132730|3568184|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0
2003861|NCT00132730|3568185|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0
2214214|NCT01685229|3856308|FG000|Overall Study|Lost to Follow-up|16
2214215|NCT01685229|3856309|FG001|Overall Study|Lost to Follow-up|10
2214216|NCT01685229|3856308|FG000|Overall Study|Withdrawal by Subject|6
2003862|NCT00132730|3568186|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0
2003863|NCT00132730|3568187|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169
2003864|NCT00132730|3568188|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68
2214217|NCT01685229|3856309|FG001|Overall Study|Withdrawal by Subject|5
2214218|NCT01685229|3856308|FG000|Overall Study|Death|1
2214219|NCT01685229|3856309|FG001|Overall Study|Death|0
2214220|NCT01685372|3856338|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
2003865|NCT00132730|3568183|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
2003866|NCT00132730|3568184|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
2003867|NCT00132730|3568185|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
2003868|NCT00132730|3568186|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
2003869|NCT00132730|3568187|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
2003870|NCT00132730|3568188|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
2003871|NCT00132730|3568183|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
2003872|NCT00132730|3568184|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
2003873|NCT00132730|3568185|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
2003874|NCT00132730|3568186|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
2003875|NCT00132730|3568187|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
2003876|NCT00132730|3568188|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
2003877|NCT00132730|3568183|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0
2003878|NCT00132730|3568184|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0
2003879|NCT00132730|3568185|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0
2003880|NCT00132730|3568186|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0
2003881|NCT00132730|3568187|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6
2003882|NCT00132730|3568188|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0
2003883|NCT00132730|3568183|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0
2003884|NCT00132730|3568184|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0
2003885|NCT00132730|3568185|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0
2003886|NCT00132730|3568186|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0
2003887|NCT00132730|3568187|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7
2003888|NCT00132730|3568188|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2
2003889|NCT00132769|3568204|FG000|Overall Study|Withdrawal by Subject|1
2003890|NCT00132769|3568205|FG001|Overall Study|Withdrawal by Subject|3
2003891|NCT00132769|3568204|FG000|Overall Study|Lack of Efficacy|7
2003892|NCT00132769|3568205|FG001|Overall Study|Lack of Efficacy|6
2003893|NCT00132769|3568204|FG000|Overall Study|Adverse Event|2
2003894|NCT00132769|3568205|FG001|Overall Study|Adverse Event|1
2003895|NCT00132769|3568204|FG000|Overall Study|Protocol Violation|1
2003896|NCT00132769|3568205|FG001|Overall Study|Protocol Violation|1
2003897|NCT00132808|3568214|FG000|Stratum I|Adverse Event|2
2003898|NCT00132808|3568215|FG001|Stratum I|Adverse Event|1
2003899|NCT00132808|3568216|FG002|Stratum I|Adverse Event|0
2003900|NCT00132808|3568214|FG000|Stratum I|Lost to Follow-up|3
2003901|NCT00132808|3568215|FG001|Stratum I|Lost to Follow-up|4
2003902|NCT00132808|3568216|FG002|Stratum I|Lost to Follow-up|1
2003903|NCT00132808|3568214|FG000|Stratum I|Withdrawal by Subject|4
2003904|NCT00132808|3568215|FG001|Stratum I|Withdrawal by Subject|7
2003905|NCT00132808|3568216|FG002|Stratum I|Withdrawal by Subject|3
2003906|NCT00132808|3568214|FG000|Stratum I|Abnormal test procedure result (s)|0
2003907|NCT00132808|3568215|FG001|Stratum I|Abnormal test procedure result (s)|0
2214221|NCT01685372|3856339|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
2003908|NCT00132808|3568216|FG002|Stratum I|Abnormal test procedure result (s)|1
2003909|NCT00132808|3568214|FG000|Stratum II|Adverse Event|1
2003910|NCT00132808|3568215|FG001|Stratum II|Adverse Event|2
2003911|NCT00132808|3568216|FG002|Stratum II|Adverse Event|1
2003912|NCT00132808|3568214|FG000|Stratum II|Death|1
2003913|NCT00132808|3568215|FG001|Stratum II|Death|0
2003914|NCT00132808|3568216|FG002|Stratum II|Death|0
2003915|NCT00132808|3568214|FG000|Stratum II|Lost to Follow-up|2
2003916|NCT00132808|3568215|FG001|Stratum II|Lost to Follow-up|2
2003917|NCT00132808|3568216|FG002|Stratum II|Lost to Follow-up|1
2003918|NCT00132808|3568214|FG000|Stratum II|Protocol Violation|0
2003919|NCT00132808|3568215|FG001|Stratum II|Protocol Violation|2
2003920|NCT00132808|3568216|FG002|Stratum II|Protocol Violation|1
2003921|NCT00132808|3568214|FG000|Stratum II|Withdrawal by Subject|4
2003922|NCT00132808|3568215|FG001|Stratum II|Withdrawal by Subject|9
2003923|NCT00132808|3568216|FG002|Stratum II|Withdrawal by Subject|6
2003924|NCT00132873|3568224|FG000|Overall Study|Adverse Event|3
2003925|NCT00132873|3568224|FG000|Overall Study|Lost to Follow-up|1
2003926|NCT00132873|3568224|FG000|Overall Study|Lack of Efficacy|1
2003927|NCT00132873|3568224|FG000|Overall Study|Withdrawal by Subject|3
2003928|NCT00132873|3568224|FG000|Overall Study|Planned Pregnancy|1
2003929|NCT00133705|3568268|FG000|Overall Study|Withdrawal by Subject|2
2003930|NCT00133705|3568269|FG001|Overall Study|Withdrawal by Subject|3
2003931|NCT00133952|3568281|FG000|Overall Study|Adverse Event|1
2003932|NCT00133952|3568282|FG001|Overall Study|Adverse Event|2
2003933|NCT00133952|3568281|FG000|Overall Study|Death|3
2003934|NCT00133952|3568282|FG001|Overall Study|Death|2
2003935|NCT00133952|3568281|FG000|Overall Study|Lost to Follow-up|9
2003936|NCT00133952|3568282|FG001|Overall Study|Lost to Follow-up|14
2003937|NCT00133952|3568281|FG000|Overall Study|Protocol Entry Criteria Exclusion|4
2003938|NCT00133952|3568282|FG001|Overall Study|Protocol Entry Criteria Exclusion|1
2003939|NCT00133952|3568281|FG000|Overall Study|Protocol Violation|1
2003940|NCT00133952|3568282|FG001|Overall Study|Protocol Violation|1
2003941|NCT00133952|3568281|FG000|Overall Study|Withdrawal by Subject|20
2003942|NCT00133952|3568282|FG001|Overall Study|Withdrawal by Subject|4
2003943|NCT00133952|3568281|FG000|Overall Study|Physician Decision|4
2003944|NCT00133952|3568282|FG001|Overall Study|Physician Decision|3
2003945|NCT00133952|3568281|FG000|Overall Study|Sponsor Decision|0
2003946|NCT00133952|3568282|FG001|Overall Study|Sponsor Decision|1
2003947|NCT00133991|3568309|FG000|Overall Study|Death|4
2003948|NCT00134056|3568331|FG000|Randomization|Not eligible for assigned treatment|22
2003949|NCT00134056|3568332|FG001|Randomization|Not eligible for assigned treatment|20
2003950|NCT00134056|3568331|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
2003951|NCT00134056|3568332|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
2003952|NCT00134056|3568331|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81
2003953|NCT00134056|3568332|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67
2003954|NCT00134056|3568331|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
2003955|NCT00134056|3568332|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
2003956|NCT00134056|3568331|FG000|Eligible for Protocol Assigned Treatment|Other|55
2003957|NCT00134056|3568332|FG001|Eligible for Protocol Assigned Treatment|Other|56
2003958|NCT00134082|3568341|FG000|Overall Study|Adverse Event|2
2003959|NCT00134082|3568341|FG000|Overall Study|Death|1
2003960|NCT00134563|3568370|FG000|Overall Study|Not treated due to protocol violation|0
2003961|NCT00134563|3568371|FG001|Overall Study|Not treated due to protocol violation|1
2003962|NCT00134563|3568372|FG002|Overall Study|Not treated due to protocol violation|1
2003963|NCT00134563|3568370|FG000|Overall Study|Adverse Event|29
2003964|NCT00134563|3568371|FG001|Overall Study|Adverse Event|37
2003965|NCT00134563|3568372|FG002|Overall Study|Adverse Event|38
2003966|NCT00134563|3568370|FG000|Overall Study|Lack of Efficacy|24
2003967|NCT00134563|3568371|FG001|Overall Study|Lack of Efficacy|14
2003968|NCT00134563|3568372|FG002|Overall Study|Lack of Efficacy|17
2003969|NCT00134563|3568370|FG000|Overall Study|Protocol Violation|3
2003970|NCT00134563|3568371|FG001|Overall Study|Protocol Violation|2
2003971|NCT00134563|3568372|FG002|Overall Study|Protocol Violation|5
2003972|NCT00134563|3568370|FG000|Overall Study|Lost to Follow-up|4
2003973|NCT00134563|3568371|FG001|Overall Study|Lost to Follow-up|0
2108221|NCT00878800|3702083|FG001|Overall Study|Adverse Event|0
2003974|NCT00134563|3568372|FG002|Overall Study|Lost to Follow-up|2
2003975|NCT00134563|3568370|FG000|Overall Study|progressive disease|11
2003976|NCT00134563|3568371|FG001|Overall Study|progressive disease|4
2003977|NCT00134563|3568372|FG002|Overall Study|progressive disease|2
2003978|NCT00134563|3568370|FG000|Overall Study|did not wish to continue|33
2003979|NCT00134563|3568371|FG001|Overall Study|did not wish to continue|32
2003980|NCT00134563|3568372|FG002|Overall Study|did not wish to continue|26
2003981|NCT00134563|3568370|FG000|Overall Study|Reason other than above|0
2003982|NCT00134563|3568371|FG001|Overall Study|Reason other than above|2
2003983|NCT00134563|3568372|FG002|Overall Study|Reason other than above|5
2003984|NCT00134719|3568383|FG000|Primary Vaccination Phase|Adverse Event|4
2003985|NCT00134719|3568384|FG001|Primary Vaccination Phase|Adverse Event|0
2003986|NCT00134719|3568385|FG002|Primary Vaccination Phase|Adverse Event|0
2003987|NCT00134719|3568383|FG000|Primary Vaccination Phase|Protocol Violation|1
2003988|NCT00134719|3568384|FG001|Primary Vaccination Phase|Protocol Violation|0
2003989|NCT00134719|3568385|FG002|Primary Vaccination Phase|Protocol Violation|0
2003990|NCT00134719|3568383|FG000|Primary Vaccination Phase|Withdrawal by Subject|2
2003991|NCT00134719|3568384|FG001|Primary Vaccination Phase|Withdrawal by Subject|3
2003992|NCT00134719|3568385|FG002|Primary Vaccination Phase|Withdrawal by Subject|2
2003993|NCT00134719|3568383|FG000|Primary Vaccination Phase|Lost to Follow-up|7
2003994|NCT00134719|3568384|FG001|Primary Vaccination Phase|Lost to Follow-up|3
2003995|NCT00134719|3568385|FG002|Primary Vaccination Phase|Lost to Follow-up|3
2003996|NCT00134719|3568383|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1
2003997|NCT00134719|3568384|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3
2003998|NCT00134719|3568385|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1
2003999|NCT00134719|3568383|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
2004000|NCT00134719|3568384|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
2004001|NCT00134719|3568385|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
2004002|NCT00134784|3568397|FG000|Overall Study|Withdrawal by Subject|2
2004003|NCT00134784|3568398|FG001|Overall Study|Withdrawal by Subject|2
2214222|NCT01685437|3856349|FG000|Overall Study|Withdrawal by Subject|22
2004004|NCT00134784|3568399|FG002|Overall Study|Withdrawal by Subject|2
2004005|NCT00134784|3568400|FG003|Overall Study|Withdrawal by Subject|1
2004006|NCT00134901|3568409|FG000|Overall Study|Lost to Follow-up|5
2004007|NCT00134901|3568410|FG001|Overall Study|Lost to Follow-up|5
2004008|NCT00134901|3568409|FG000|Overall Study|discontinued intervention|12
2004009|NCT00134901|3568410|FG001|Overall Study|discontinued intervention|10
2004010|NCT00135330|3568444|FG000|Overall Study|Adverse Event|2
2004011|NCT00135330|3568445|FG001|Overall Study|Adverse Event|5
2004012|NCT00135330|3568446|FG002|Overall Study|Adverse Event|1
2004013|NCT00135330|3568444|FG000|Overall Study|Lost to Follow-up|0
2004014|NCT00135330|3568445|FG001|Overall Study|Lost to Follow-up|2
2004015|NCT00135330|3568446|FG002|Overall Study|Lost to Follow-up|3
2004016|NCT00135330|3568444|FG000|Overall Study|Physician Decision|1
2004017|NCT00135330|3568445|FG001|Overall Study|Physician Decision|1
2004018|NCT00135330|3568446|FG002|Overall Study|Physician Decision|0
2004019|NCT00135330|3568444|FG000|Overall Study|Protocol Violation|4
2004020|NCT00135330|3568445|FG001|Overall Study|Protocol Violation|3
2004021|NCT00135330|3568446|FG002|Overall Study|Protocol Violation|3
2004022|NCT00135330|3568444|FG000|Overall Study|Patient Decision|5
2004023|NCT00135330|3568445|FG001|Overall Study|Patient Decision|1
2004024|NCT00135330|3568446|FG002|Overall Study|Patient Decision|4
2004025|NCT00135330|3568444|FG000|Overall Study|Sponsor Decision|0
2004026|NCT00135330|3568445|FG001|Overall Study|Sponsor Decision|1
2004027|NCT00135330|3568446|FG002|Overall Study|Sponsor Decision|0
2004028|NCT00135356|3568456|FG000|Overall Study|Adverse Event|6
2004029|NCT00135356|3568457|FG001|Overall Study|Adverse Event|2
2004030|NCT00135356|3568456|FG000|Overall Study|Lack of Efficacy|2
2004031|NCT00135356|3568457|FG001|Overall Study|Lack of Efficacy|0
2004032|NCT00135356|3568456|FG000|Overall Study|Lost to Follow-up|3
2004033|NCT00135356|3568457|FG001|Overall Study|Lost to Follow-up|1
2004034|NCT00135356|3568456|FG000|Overall Study|Surgery for abdominal fat|1
2004035|NCT00135356|3568457|FG001|Overall Study|Surgery for abdominal fat|0
2004036|NCT00135356|3568456|FG000|Overall Study|Change in antiviral regimen|0
2004037|NCT00135356|3568457|FG001|Overall Study|Change in antiviral regimen|1
2004038|NCT00135356|3568456|FG000|Overall Study|Poor/noncompliance|1
2004039|NCT00135356|3568457|FG001|Overall Study|Poor/noncompliance|1
2004040|NCT00135356|3568456|FG000|Overall Study|No longer meets study criteria|2
2004041|NCT00135356|3568457|FG001|Overall Study|No longer meets study criteria|0
2004042|NCT00135356|3568456|FG000|Overall Study|Withdrawal by Subject|2
2004043|NCT00135356|3568457|FG001|Overall Study|Withdrawal by Subject|4
2004044|NCT00135512|3568463|FG000|Overall Study|Adverse Event|56
2004045|NCT00135512|3568463|FG000|Overall Study|Lack of Efficacy|25
2004046|NCT00135512|3568463|FG000|Overall Study|Other|42
2004047|NCT00135694|3568470|FG000|Overall Study|Adverse Event|17
2004048|NCT00135694|3568471|FG001|Overall Study|Adverse Event|4
2004049|NCT00135694|3568472|FG002|Overall Study|Adverse Event|0
2004050|NCT00135694|3568470|FG000|Overall Study|Death|14
2004051|NCT00135694|3568471|FG001|Overall Study|Death|1
2004052|NCT00135694|3568472|FG002|Overall Study|Death|2
2004053|NCT00135694|3568470|FG000|Overall Study|Lost to Follow-up|8
2004054|NCT00135694|3568471|FG001|Overall Study|Lost to Follow-up|7
2004055|NCT00135694|3568472|FG002|Overall Study|Lost to Follow-up|1
2004056|NCT00135694|3568470|FG000|Overall Study|Withdrawal by Subject|41
2004057|NCT00135694|3568471|FG001|Overall Study|Withdrawal by Subject|7
2004058|NCT00135694|3568472|FG002|Overall Study|Withdrawal by Subject|4
2004059|NCT00135694|3568470|FG000|Overall Study|Protocol Violation|19
2004060|NCT00135694|3568471|FG001|Overall Study|Protocol Violation|1
2004061|NCT00135694|3568472|FG002|Overall Study|Protocol Violation|0
2004062|NCT00135694|3568470|FG000|Overall Study|Hepatitis C related reasons|39
2004063|NCT00135694|3568471|FG001|Overall Study|Hepatitis C related reasons|1
2004064|NCT00135694|3568472|FG002|Overall Study|Hepatitis C related reasons|0
2004065|NCT00135694|3568470|FG000|Overall Study|Ineligible for Random assignment|42
2004066|NCT00135694|3568471|FG001|Overall Study|Ineligible for Random assignment|0
2004067|NCT00135694|3568472|FG002|Overall Study|Ineligible for Random assignment|0
2004068|NCT00135707|3568482|FG000|Overall Study|Lost to Follow-up|94
2004069|NCT00135707|3568483|FG001|Overall Study|Lost to Follow-up|89
2004070|NCT00135707|3568482|FG000|Overall Study|Withdrawal by Subject|0
2004071|NCT00135707|3568483|FG001|Overall Study|Withdrawal by Subject|1
2004072|NCT00135707|3568482|FG000|Overall Study|Institutional review board request|1
2004073|NCT00135707|3568483|FG001|Overall Study|Institutional review board request|0
2004074|NCT00136084|3568507|FG000|Overall Study|Death|12
2004075|NCT00136084|3568508|FG001|Overall Study|Death|5
2004076|NCT00136084|3568507|FG000|Overall Study|Unacceptable toxicity|8
2004077|NCT00136084|3568508|FG001|Overall Study|Unacceptable toxicity|11
2004078|NCT00136084|3568507|FG000|Overall Study|Relapse|20
2004079|NCT00136084|3568508|FG001|Overall Study|Relapse|23
2004080|NCT00136084|3568507|FG000|Overall Study|Lost to Follow-up|2
2004081|NCT00136084|3568508|FG001|Overall Study|Lost to Follow-up|0
2004082|NCT00136084|3568507|FG000|Overall Study|No Response|1
2004083|NCT00136084|3568508|FG001|Overall Study|No Response|2
2004084|NCT00136084|3568507|FG000|Overall Study|Withdrawal by Subject|5
2004085|NCT00136084|3568508|FG001|Overall Study|Withdrawal by Subject|1
2004086|NCT00136318|3568533|FG000|Overall Study|Adverse Event|5
2004087|NCT00136318|3568534|FG001|Overall Study|Adverse Event|5
2004088|NCT00136318|3568533|FG000|Overall Study|Withdrawal by Subject|2
2004089|NCT00136318|3568534|FG001|Overall Study|Withdrawal by Subject|2
2004090|NCT00136357|3568543|FG000|Overall Study|Withdrawal by Subject|3
2004091|NCT00136357|3568544|FG001|Overall Study|Withdrawal by Subject|2
2004092|NCT00136604|3568555|FG000|Overall Study|Lost to Follow-up|1
2004093|NCT00136604|3568556|FG001|Overall Study|Lost to Follow-up|0
2004094|NCT00136604|3568557|FG002|Overall Study|Lost to Follow-up|0
2004095|NCT00136604|3568558|FG003|Overall Study|Lost to Follow-up|0
2004096|NCT00136604|3568559|FG004|Overall Study|Lost to Follow-up|1
2004097|NCT00136604|3568555|FG000|Overall Study|Migrated/moved from study area|0
2004098|NCT00136604|3568556|FG001|Overall Study|Migrated/moved from study area|1
2004099|NCT00136604|3568557|FG002|Overall Study|Migrated/moved from study area|0
2004100|NCT00136604|3568558|FG003|Overall Study|Migrated/moved from study area|0
2004101|NCT00136604|3568559|FG004|Overall Study|Migrated/moved from study area|0
2004102|NCT00136916|3568621|FG000|Overall Study|Never received study treatment|3
2004103|NCT00136916|3568622|FG001|Overall Study|Never received study treatment|5
2004104|NCT00136916|3568621|FG000|Overall Study|Death|1
2004105|NCT00136916|3568622|FG001|Overall Study|Death|3
2004106|NCT00136916|3568621|FG000|Overall Study|Adverse Event|27
2004107|NCT00136916|3568622|FG001|Overall Study|Adverse Event|8
2004108|NCT00136916|3568621|FG000|Overall Study|Laboratory abnormality|0
2004109|NCT00136916|3568622|FG001|Overall Study|Laboratory abnormality|1
2004110|NCT00136916|3568621|FG000|Overall Study|Lack of Efficacy|13
2004111|NCT00136916|3568622|FG001|Overall Study|Lack of Efficacy|3
2004112|NCT00136916|3568621|FG000|Overall Study|Lost to Follow-up|12
2004113|NCT00136916|3568622|FG001|Overall Study|Lost to Follow-up|14
2004114|NCT00136916|3568621|FG000|Overall Study|Withdrawal by Subject|44
2004115|NCT00136916|3568622|FG001|Overall Study|Withdrawal by Subject|46
2004116|NCT00136916|3568621|FG000|Overall Study|Other|22
2004117|NCT00136916|3568622|FG001|Overall Study|Other|24
2004118|NCT00136916|3568621|FG000|Overall Study|Discontinued in follow up period|3
2004119|NCT00136916|3568622|FG001|Overall Study|Discontinued in follow up period|0
2004120|NCT00136955|3568630|FG000|Overall Study|Adverse Event|8
2004121|NCT00136955|3568630|FG000|Overall Study|Lost to Follow-up|1
2004122|NCT00136955|3568630|FG000|Overall Study|Withdrawal by Subject|2
2004123|NCT00136955|3568630|FG000|Overall Study|Incl. prog. disease, protocol violation|12
2004124|NCT00137046|3568636|FG000|Overall Study|Death|2
2004125|NCT00137046|3568637|FG001|Overall Study|Death|1
2004126|NCT00137046|3568636|FG000|Overall Study|Adverse Event|16
2004127|NCT00137046|3568637|FG001|Overall Study|Adverse Event|5
2004128|NCT00137046|3568636|FG000|Overall Study|Laboratory Abnormality|2
2004129|NCT00137046|3568637|FG001|Overall Study|Laboratory Abnormality|0
2004130|NCT00137046|3568636|FG000|Overall Study|Lack of Efficacy|13
2004131|NCT00137046|3568637|FG001|Overall Study|Lack of Efficacy|1
2004132|NCT00137046|3568636|FG000|Overall Study|Lost to Follow-up|8
2004133|NCT00137046|3568637|FG001|Overall Study|Lost to Follow-up|24
2004134|NCT00137046|3568636|FG000|Overall Study|Other|23
2004135|NCT00137046|3568637|FG001|Overall Study|Other|19
2004136|NCT00137046|3568636|FG000|Overall Study|Withdrawal by Subject|33
2004137|NCT00137046|3568637|FG001|Overall Study|Withdrawal by Subject|42
2004138|NCT00137046|3568636|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1
2004139|NCT00137046|3568637|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0
2004140|NCT00137046|3568636|FG000|Overall Study|Withdrew prior to study treatment|1
2004141|NCT00137046|3568637|FG001|Overall Study|Withdrew prior to study treatment|1
2004142|NCT00137111|3568651|FG000|Total Therapy|Death|35
2004143|NCT00137111|3568652|FG001|Total Therapy|Death|0
2004144|NCT00137111|3568653|FG002|Total Therapy|Death|0
2004145|NCT00137111|3568654|FG003|Total Therapy|Death|0
2004146|NCT00137111|3568651|FG000|Total Therapy|Non Compliance|5
2004147|NCT00137111|3568652|FG001|Total Therapy|Non Compliance|0
2004148|NCT00137111|3568653|FG002|Total Therapy|Non Compliance|0
2004149|NCT00137111|3568654|FG003|Total Therapy|Non Compliance|0
2004150|NCT00137267|3568663|FG000|Overall Study|Lost to Follow-up|15
2004151|NCT00137267|3568664|FG001|Overall Study|Lost to Follow-up|21
2004152|NCT00137423|3568681|FG000|Overall Study|Adverse Event|7
2004153|NCT00137423|3568682|FG001|Overall Study|Adverse Event|9
2004154|NCT00137423|3568681|FG000|Overall Study|consent withdrawn|1
2004155|NCT00137423|3568682|FG001|Overall Study|consent withdrawn|1
2004156|NCT00137423|3568681|FG000|Overall Study|Lack of Efficacy|31
2004157|NCT00137423|3568682|FG001|Overall Study|Lack of Efficacy|33
2004158|NCT00137423|3568681|FG000|Overall Study|Death|0
2004159|NCT00137423|3568682|FG001|Overall Study|Death|1
2004160|NCT00137436|3568692|FG000|Overall Study|Adverse Event|13
2004161|NCT00137436|3568692|FG000|Overall Study|Death|2
2004162|NCT00137436|3568692|FG000|Overall Study|Lack of Efficacy|17
2004163|NCT00137436|3568692|FG000|Overall Study|Withdrawal by Subject|6
2004164|NCT00137436|3568692|FG000|Overall Study|Other|5
2004165|NCT00137449|3568698|FG000|Overall Study|Disease Progression|8
2004166|NCT00137449|3568699|FG001|Overall Study|Disease Progression|13
2004167|NCT00137449|3568698|FG000|Overall Study|Death|4
2004168|NCT00137449|3568699|FG001|Overall Study|Death|3
2004169|NCT00137449|3568698|FG000|Overall Study|Adverse Event|3
2004170|NCT00137449|3568699|FG001|Overall Study|Adverse Event|1
2004171|NCT00137449|3568698|FG000|Overall Study|Withdrawal by Subject|1
2004172|NCT00137449|3568699|FG001|Overall Study|Withdrawal by Subject|1
2004173|NCT00137631|3568708|FG000|Overall Study|Lost to Follow-up|37
2004174|NCT00137631|3568709|FG001|Overall Study|Lost to Follow-up|41
2004175|NCT00137839|3568715|FG000|Overall Study|Adverse Event|7
2004176|NCT00137839|3568715|FG000|Overall Study|Physician Decision|7
2004177|NCT00137839|3568715|FG000|Overall Study|Death|8
2004178|NCT00137839|3568715|FG000|Overall Study|Disease Progression|60
2004179|NCT00137839|3568715|FG000|Overall Study|Not Start Treatment|1
2004180|NCT00137839|3568715|FG000|Overall Study|Prolonged Treatment Delay|1
2004181|NCT00138424|3568760|FG000|Overall Study|Physician Decision|0
2004182|NCT00138424|3568761|FG001|Overall Study|Physician Decision|1
2004183|NCT00138424|3568762|FG002|Overall Study|Physician Decision|0
2004184|NCT00138424|3568763|FG003|Overall Study|Physician Decision|0
2004185|NCT00138658|3568784|FG000|Overall Study|Adverse Event|23
2004186|NCT00138658|3568784|FG000|Overall Study|Death|1
2004187|NCT00138658|3568784|FG000|Overall Study|Disease Progression|21
2004188|NCT00138658|3568784|FG000|Overall Study|Physician Decision|11
2004189|NCT00138658|3568784|FG000|Overall Study|Withdrawal by Subject|5
2004190|NCT00138671|3568792|FG000|Overall Study|Death|0
2004191|NCT00138671|3568793|FG001|Overall Study|Death|3
2004192|NCT00138671|3568792|FG000|Overall Study|Adverse Event|6
2004193|NCT00138671|3568793|FG001|Overall Study|Adverse Event|3
2004194|NCT00138671|3568792|FG000|Overall Study|Lost to Follow-up|1
2004195|NCT00138671|3568793|FG001|Overall Study|Lost to Follow-up|2
2004196|NCT00138671|3568792|FG000|Overall Study|Withdrawal by Subject|3
2004197|NCT00138671|3568793|FG001|Overall Study|Withdrawal by Subject|5
2004198|NCT00138671|3568792|FG000|Overall Study|Other|3
2004199|NCT00138671|3568793|FG001|Overall Study|Other|3
2004200|NCT00139477|3568812|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6
2004201|NCT00139477|3568813|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7
2004202|NCT00139477|3568812|FG000|First Intervention -Baseline to 6Months|Relocation|1
2004203|NCT00139477|3568813|FG001|First Intervention -Baseline to 6Months|Relocation|2
2004204|NCT00139477|3568812|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3
2004205|NCT00139477|3568813|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3
2004206|NCT00139477|3568812|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
2004207|NCT00139477|3568813|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
2004208|NCT00139477|3568812|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0
2004209|NCT00139477|3568813|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2
2004210|NCT00139477|3568812|FG000|Second Intervention -6Months to 12Months|Relocation|1
2004211|NCT00139477|3568813|FG001|Second Intervention -6Months to 12Months|Relocation|0
2004212|NCT00139477|3568812|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4
2004213|NCT00139477|3568813|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3
2025092|NCT00340704|3593725|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2025093|NCT00340704|3593726|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2025094|NCT00340704|3593727|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
2025095|NCT00340704|3593728|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2025096|NCT00340704|3593729|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2025097|NCT00340704|3593730|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2025098|NCT00340704|3593722|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2025099|NCT00340704|3593723|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2025100|NCT00340704|3593724|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2025101|NCT00340704|3593725|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2025102|NCT00340704|3593726|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
2025103|NCT00340704|3593727|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
2025104|NCT00340704|3593728|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2025105|NCT00340704|3593729|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2025106|NCT00340704|3593730|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2025107|NCT00340704|3593722|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
2025108|NCT00340704|3593723|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
2025109|NCT00340704|3593724|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
2025110|NCT00340704|3593725|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
2025111|NCT00340704|3593726|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
2004214|NCT00139659|3568823|FG000|Overall Study|Adverse Event|12
2004215|NCT00139659|3568824|FG001|Overall Study|Adverse Event|1
2004216|NCT00139659|3568823|FG000|Overall Study|Lack of Efficacy|1
2004217|NCT00139659|3568824|FG001|Overall Study|Lack of Efficacy|1
2004218|NCT00139659|3568823|FG000|Overall Study|Lost to Follow-up|7
2004219|NCT00139659|3568824|FG001|Overall Study|Lost to Follow-up|3
2004220|NCT00139659|3568823|FG000|Overall Study|Reason not Specified|6
2004221|NCT00139659|3568824|FG001|Overall Study|Reason not Specified|3
2004222|NCT00139659|3568823|FG000|Overall Study|Withdrawal by Subject|14
2004223|NCT00139659|3568824|FG001|Overall Study|Withdrawal by Subject|10
2004224|NCT00139737|3568834|FG000|Overall Study|Withdrawal by Subject|190
2004225|NCT00139737|3568834|FG000|Overall Study|Adverse Event|58
2004226|NCT00139737|3568834|FG000|Overall Study|Lack of Efficacy|40
2004227|NCT00139737|3568834|FG000|Overall Study|Lost to Follow-up|8
2004228|NCT00139737|3568834|FG000|Overall Study|Death|3
2004229|NCT00139737|3568834|FG000|Overall Study|Laboratory Abnormality|2
2004230|NCT00139737|3568834|FG000|Overall Study|Protocol Violation|18
2004231|NCT00139737|3568834|FG000|Overall Study|Withdrew During Screening Phase|8
2004232|NCT00139737|3568834|FG000|Overall Study|Did Not Meet Entrance Criteria|1
2004233|NCT00139737|3568834|FG000|Overall Study|Screened, Not Treated|13
2004234|NCT00139776|3568840|FG000|Period I|Did not enter Period II|575
2004235|NCT00139776|3568841|FG001|Period I|Did not enter Period II|0
2004236|NCT00139776|3568842|FG002|Period I|Did not enter Period II|0
2004237|NCT00139776|3568843|FG003|Period I|Did not enter Period II|0
2004238|NCT00139776|3568840|FG000|Period II|Not Randomized into Period III|0
2004239|NCT00139776|3568841|FG001|Period II|Not Randomized into Period III|322
2004240|NCT00139776|3568842|FG002|Period II|Not Randomized into Period III|0
2004241|NCT00139776|3568843|FG003|Period II|Not Randomized into Period III|0
2004242|NCT00139776|3568840|FG000|Period III|Adverse Event|0
2004243|NCT00139776|3568841|FG001|Period III|Adverse Event|0
2004244|NCT00139776|3568842|FG002|Period III|Adverse Event|22
2004245|NCT00139776|3568843|FG003|Period III|Adverse Event|23
2004246|NCT00139776|3568840|FG000|Period III|Other|0
2004247|NCT00139776|3568841|FG001|Period III|Other|0
2004248|NCT00139776|3568842|FG002|Period III|Other|23
2004249|NCT00139776|3568843|FG003|Period III|Other|34
2004250|NCT00139776|3568840|FG000|Period III|Lack of Efficacy|0
2004251|NCT00139776|3568841|FG001|Period III|Lack of Efficacy|0
2004252|NCT00139776|3568842|FG002|Period III|Lack of Efficacy|10
2004253|NCT00139776|3568843|FG003|Period III|Lack of Efficacy|24
2004254|NCT00139776|3568840|FG000|Period III|Lost to Follow-up|0
2004255|NCT00139776|3568841|FG001|Period III|Lost to Follow-up|0
2004256|NCT00139776|3568842|FG002|Period III|Lost to Follow-up|5
2004257|NCT00139776|3568843|FG003|Period III|Lost to Follow-up|4
2004258|NCT00139776|3568840|FG000|Period III|Withdrawal by Subject|0
2004259|NCT00139776|3568841|FG001|Period III|Withdrawal by Subject|0
2004260|NCT00139776|3568842|FG002|Period III|Withdrawal by Subject|16
2004261|NCT00139776|3568843|FG003|Period III|Withdrawal by Subject|21
2004262|NCT00140140|3568862|FG000|Overall Study|Unacceptable toxicity|1
2004263|NCT00140140|3568863|FG001|Overall Study|Unacceptable toxicity|1
2004264|NCT00140140|3568864|FG002|Overall Study|Unacceptable toxicity|2
2004265|NCT00140140|3568862|FG000|Overall Study|Physician Decision|1
2004266|NCT00140140|3568863|FG001|Overall Study|Physician Decision|1
2004267|NCT00140140|3568864|FG002|Overall Study|Physician Decision|0
2004268|NCT00140413|3568925|FG000|Overall Study|Lost to Follow-up|1
2004269|NCT00140413|3568926|FG001|Overall Study|Lost to Follow-up|0
2004270|NCT00140413|3568925|FG000|Overall Study|Withdrawal by Subject|2
2004271|NCT00140413|3568926|FG001|Overall Study|Withdrawal by Subject|0
2004272|NCT00140426|3568935|FG000|Overall Study|Withdrawal by Subject|0
2004273|NCT00140426|3568936|FG001|Overall Study|Withdrawal by Subject|3
2004274|NCT00140855|3568964|FG000|Overall Study|Progressive disease|2
2004275|NCT00141037|3568970|FG000|Overall Study|Physician Decision|1
2004276|NCT00141037|3568971|FG001|Overall Study|Physician Decision|2
2004277|NCT00141037|3568970|FG000|Overall Study|Lost to Follow-up|3
2004278|NCT00141037|3568971|FG001|Overall Study|Lost to Follow-up|1
2004279|NCT00141037|3568970|FG000|Overall Study|Protocol Violation|0
2004280|NCT00141037|3568971|FG001|Overall Study|Protocol Violation|2
2004281|NCT00141037|3568970|FG000|Overall Study|Withdrawal by Subject|2
2004282|NCT00141037|3568971|FG001|Overall Study|Withdrawal by Subject|1
2004283|NCT00141037|3568970|FG000|Overall Study|Other|0
2004284|NCT00141037|3568971|FG001|Overall Study|Other|1
2004285|NCT00141037|3568970|FG000|Overall Study|Moved from area|1
2004286|NCT00141037|3568971|FG001|Overall Study|Moved from area|7
2004287|NCT00141037|3568970|FG000|Overall Study|Graft Failure|3
2004288|NCT00141037|3568971|FG001|Overall Study|Graft Failure|4
2004289|NCT00141102|3568979|FG000|Overall Study|Adverse Event|233
2004290|NCT00141102|3568980|FG001|Overall Study|Adverse Event|305
2004291|NCT00141102|3568979|FG000|Overall Study|Laboratory Abnormality|9
2004292|NCT00141102|3568980|FG001|Overall Study|Laboratory Abnormality|33
2004293|NCT00141102|3568979|FG000|Overall Study|Lack of Efficacy|21
2004294|NCT00141102|3568980|FG001|Overall Study|Lack of Efficacy|26
2004295|NCT00141102|3568979|FG000|Overall Study|Lost to Follow-up|29
2004296|NCT00141102|3568980|FG001|Overall Study|Lost to Follow-up|32
2004297|NCT00141102|3568979|FG000|Overall Study|Other|87
2004298|NCT00141102|3568980|FG001|Overall Study|Other|76
2004299|NCT00141102|3568979|FG000|Overall Study|Withdrawal by Subject|112
2004300|NCT00141102|3568980|FG001|Overall Study|Withdrawal by Subject|142
2004301|NCT00141102|3568979|FG000|Overall Study|Randomized But Did Not Receive Treatment|15
2004302|NCT00141102|3568980|FG001|Overall Study|Randomized But Did Not Receive Treatment|9
2004303|NCT00141102|3568979|FG000|Overall Study|Death|2
2004304|NCT00141102|3568980|FG001|Overall Study|Death|2
2004305|NCT00141219|3568994|FG000|Overall Study|Protocol violations|5
2004306|NCT00141219|3568995|FG001|Overall Study|Protocol violations|4
2004307|NCT00141219|3568994|FG000|Overall Study|Adverse Event|8
2004308|NCT00141219|3568995|FG001|Overall Study|Adverse Event|6
2004309|NCT00141219|3568994|FG000|Overall Study|Lack of Efficacy|5
2004310|NCT00141219|3568995|FG001|Overall Study|Lack of Efficacy|4
2004311|NCT00141219|3568994|FG000|Overall Study|Withdrawal by Subject|6
2004312|NCT00141219|3568995|FG001|Overall Study|Withdrawal by Subject|2
2025112|NCT00340704|3593727|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
2025113|NCT00340704|3593728|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
2025114|NCT00340704|3593729|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
2025115|NCT00340704|3593730|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
2025116|NCT00340834|3593761|FG000|Core Phase of Study|Adverse Event|26
2025117|NCT00340834|3593762|FG001|Core Phase of Study|Adverse Event|9
2025118|NCT00340834|3593763|FG002|Core Phase of Study|Adverse Event|9
2025119|NCT00340834|3593764|FG003|Core Phase of Study|Adverse Event|0
2025120|NCT00340834|3593765|FG004|Core Phase of Study|Adverse Event|0
2025121|NCT00340834|3593761|FG000|Core Phase of Study|Withdrawal by Subject|11
2025122|NCT00340834|3593762|FG001|Core Phase of Study|Withdrawal by Subject|9
2025123|NCT00340834|3593763|FG002|Core Phase of Study|Withdrawal by Subject|16
2025124|NCT00340834|3593764|FG003|Core Phase of Study|Withdrawal by Subject|0
2025125|NCT00340834|3593765|FG004|Core Phase of Study|Withdrawal by Subject|0
2025126|NCT00340834|3593761|FG000|Core Phase of Study|Administrative Problems|6
2025127|NCT00340834|3593762|FG001|Core Phase of Study|Administrative Problems|2
2025128|NCT00340834|3593763|FG002|Core Phase of Study|Administrative Problems|7
2025129|NCT00340834|3593764|FG003|Core Phase of Study|Administrative Problems|0
2025130|NCT00340834|3593765|FG004|Core Phase of Study|Administrative Problems|0
2025131|NCT00340834|3593761|FG000|Core Phase of Study|Lack of Efficacy|3
2025132|NCT00340834|3593762|FG001|Core Phase of Study|Lack of Efficacy|3
2025133|NCT00340834|3593763|FG002|Core Phase of Study|Lack of Efficacy|7
2025134|NCT00340834|3593764|FG003|Core Phase of Study|Lack of Efficacy|0
2025135|NCT00340834|3593765|FG004|Core Phase of Study|Lack of Efficacy|0
2025136|NCT00340834|3593761|FG000|Core Phase of Study|Abnormal laboratory value(s)|4
2025137|NCT00340834|3593762|FG001|Core Phase of Study|Abnormal laboratory value(s)|6
2025138|NCT00340834|3593763|FG002|Core Phase of Study|Abnormal laboratory value(s)|1
2025139|NCT00340834|3593764|FG003|Core Phase of Study|Abnormal laboratory value(s)|0
2025140|NCT00340834|3593765|FG004|Core Phase of Study|Abnormal laboratory value(s)|0
2025141|NCT00340834|3593761|FG000|Core Phase of Study|Abnormal test procedure result(s)|4
2025142|NCT00340834|3593762|FG001|Core Phase of Study|Abnormal test procedure result(s)|3
2025143|NCT00340834|3593763|FG002|Core Phase of Study|Abnormal test procedure result(s)|3
2025144|NCT00340834|3593764|FG003|Core Phase of Study|Abnormal test procedure result(s)|0
2025145|NCT00340834|3593765|FG004|Core Phase of Study|Abnormal test procedure result(s)|0
2025146|NCT00340834|3593761|FG000|Core Phase of Study|Lost to Follow-up|1
2025147|NCT00340834|3593762|FG001|Core Phase of Study|Lost to Follow-up|1
2025148|NCT00340834|3593763|FG002|Core Phase of Study|Lost to Follow-up|4
2025149|NCT00340834|3593764|FG003|Core Phase of Study|Lost to Follow-up|0
2025150|NCT00340834|3593765|FG004|Core Phase of Study|Lost to Follow-up|0
2025151|NCT00340834|3593761|FG000|Core Phase of Study|Death|2
2025152|NCT00340834|3593762|FG001|Core Phase of Study|Death|0
2025153|NCT00340834|3593763|FG002|Core Phase of Study|Death|0
2025154|NCT00340834|3593764|FG003|Core Phase of Study|Death|0
2025155|NCT00340834|3593765|FG004|Core Phase of Study|Death|0
2025156|NCT00340834|3593761|FG000|Core Phase of Study|Protocol Violation|0
2025157|NCT00340834|3593762|FG001|Core Phase of Study|Protocol Violation|0
2025158|NCT00340834|3593763|FG002|Core Phase of Study|Protocol Violation|2
2025159|NCT00340834|3593764|FG003|Core Phase of Study|Protocol Violation|0
2025160|NCT00340834|3593765|FG004|Core Phase of Study|Protocol Violation|0
2025161|NCT00340834|3593761|FG000|Extension Phase of Study|Subject did not receive study drug|0
2025162|NCT00340834|3593762|FG001|Extension Phase of Study|Subject did not receive study drug|1
2025163|NCT00340834|3593763|FG002|Extension Phase of Study|Subject did not receive study drug|0
2025164|NCT00340834|3593764|FG003|Extension Phase of Study|Subject did not receive study drug|2
2025165|NCT00340834|3593765|FG004|Extension Phase of Study|Subject did not receive study drug|0
2025166|NCT00340834|3593761|FG000|Extension Phase of Study|Subject withdrew consent|26
2025167|NCT00340834|3593762|FG001|Extension Phase of Study|Subject withdrew consent|31
2025168|NCT00340834|3593763|FG002|Extension Phase of Study|Subject withdrew consent|0
2025169|NCT00340834|3593764|FG003|Extension Phase of Study|Subject withdrew consent|12
2025170|NCT00340834|3593765|FG004|Extension Phase of Study|Subject withdrew consent|15
2025171|NCT00340834|3593761|FG000|Extension Phase of Study|Adverse Event|21
2025172|NCT00340834|3593762|FG001|Extension Phase of Study|Adverse Event|22
2025173|NCT00340834|3593763|FG002|Extension Phase of Study|Adverse Event|0
2025174|NCT00340834|3593764|FG003|Extension Phase of Study|Adverse Event|19
2025175|NCT00340834|3593765|FG004|Extension Phase of Study|Adverse Event|7
2025176|NCT00340834|3593761|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14
2025177|NCT00340834|3593762|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13
2004313|NCT00141271|3569004|FG000|Overall Study|Adverse Event|31
2004314|NCT00141271|3569005|FG001|Overall Study|Adverse Event|19
2004315|NCT00141271|3569006|FG002|Overall Study|Adverse Event|17
2004316|NCT00141271|3569004|FG000|Overall Study|Laboratory Abnormality|2
2004317|NCT00141271|3569005|FG001|Overall Study|Laboratory Abnormality|1
2004318|NCT00141271|3569006|FG002|Overall Study|Laboratory Abnormality|1
2004319|NCT00141271|3569004|FG000|Overall Study|Lack of Efficacy|7
2004320|NCT00141271|3569005|FG001|Overall Study|Lack of Efficacy|7
2004321|NCT00141271|3569006|FG002|Overall Study|Lack of Efficacy|3
2004322|NCT00141271|3569004|FG000|Overall Study|Lost to Follow-up|15
2004323|NCT00141271|3569005|FG001|Overall Study|Lost to Follow-up|15
2004324|NCT00141271|3569006|FG002|Overall Study|Lost to Follow-up|21
2004325|NCT00141271|3569004|FG000|Overall Study|Withdrawal by Subject|14
2004326|NCT00141271|3569005|FG001|Overall Study|Withdrawal by Subject|9
2004327|NCT00141271|3569006|FG002|Overall Study|Withdrawal by Subject|10
2004328|NCT00141271|3569004|FG000|Overall Study|Other|11
2004329|NCT00141271|3569005|FG001|Overall Study|Other|12
2004330|NCT00141271|3569006|FG002|Overall Study|Other|5
2004331|NCT00141297|3569016|FG000|Overall Study|Adverse Event|0
2004332|NCT00141297|3569017|FG001|Overall Study|Adverse Event|0
2004333|NCT00141297|3569018|FG002|Overall Study|Adverse Event|1
2004334|NCT00141297|3569019|FG003|Overall Study|Adverse Event|0
2004335|NCT00141297|3569020|FG004|Overall Study|Adverse Event|1
2214223|NCT01685437|3856349|FG000|Overall Study|Lost to Follow-up|3
2214224|NCT01685437|3856349|FG000|Overall Study|Adverse Event|1
2214225|NCT01685437|3856349|FG000|Overall Study|Protocol Violation|4
2214226|NCT01685437|3856349|FG000|Overall Study|Unable to make visits due to work|1
2214227|NCT01685606|3856366|FG000|Overall Study|Withdrawal by Subject|1
2214228|NCT01685697|3856384|FG000|Overall Study|Protocol Violation|3
2214229|NCT01685697|3856385|FG001|Overall Study|Protocol Violation|3
2214230|NCT01685801|3856395|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
2214231|NCT01685801|3856396|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
2214232|NCT01685801|3856397|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
2214233|NCT01685801|3856398|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
2214234|NCT01685801|3856395|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
2214235|NCT01685801|3856396|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
2214236|NCT01685801|3856397|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
2214237|NCT01685801|3856398|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
2214238|NCT01685840|3856417|FG000|Overall Study|Death|77
2214239|NCT01685840|3856418|FG001|Overall Study|Death|66
2214240|NCT01685840|3856417|FG000|Overall Study|Lost to Follow-up|27
2214241|NCT01685840|3856418|FG001|Overall Study|Lost to Follow-up|25
2313226|NCT02786004|4020453|FG001|Overall Study|Withdrawal by Subject|1
2004336|NCT00141297|3569021|FG005|Overall Study|Adverse Event|1
2004337|NCT00141297|3569022|FG006|Overall Study|Adverse Event|0
2004338|NCT00141297|3569023|FG007|Overall Study|Adverse Event|1
2004339|NCT00141297|3569024|FG008|Overall Study|Adverse Event|1
2004340|NCT00141297|3569025|FG009|Overall Study|Adverse Event|0
2004341|NCT00141297|3569016|FG000|Overall Study|Death|1
2004342|NCT00141297|3569017|FG001|Overall Study|Death|0
2004343|NCT00141297|3569018|FG002|Overall Study|Death|0
2004344|NCT00141297|3569019|FG003|Overall Study|Death|0
2004345|NCT00141297|3569020|FG004|Overall Study|Death|0
2004346|NCT00141297|3569021|FG005|Overall Study|Death|0
2004347|NCT00141297|3569022|FG006|Overall Study|Death|0
2004348|NCT00141297|3569023|FG007|Overall Study|Death|0
2004349|NCT00141297|3569024|FG008|Overall Study|Death|1
2004350|NCT00141297|3569025|FG009|Overall Study|Death|0
2004351|NCT00141297|3569016|FG000|Overall Study|Withdrawal by Subject|0
2004352|NCT00141297|3569017|FG001|Overall Study|Withdrawal by Subject|0
2004353|NCT00141297|3569018|FG002|Overall Study|Withdrawal by Subject|0
2004354|NCT00141297|3569019|FG003|Overall Study|Withdrawal by Subject|0
2004355|NCT00141297|3569020|FG004|Overall Study|Withdrawal by Subject|0
2004356|NCT00141297|3569021|FG005|Overall Study|Withdrawal by Subject|0
2004357|NCT00141297|3569022|FG006|Overall Study|Withdrawal by Subject|0
2004358|NCT00141297|3569023|FG007|Overall Study|Withdrawal by Subject|0
2004359|NCT00141297|3569024|FG008|Overall Study|Withdrawal by Subject|1
2004360|NCT00141297|3569025|FG009|Overall Study|Withdrawal by Subject|0
2004361|NCT00141297|3569016|FG000|Overall Study|Other|0
2004362|NCT00141297|3569017|FG001|Overall Study|Other|0
2004363|NCT00141297|3569018|FG002|Overall Study|Other|0
2313227|NCT02786836|4020511|FG000|Overall Study|Death|1
2313228|NCT02786836|4020511|FG000|Overall Study|Lack of Efficacy|2
2313229|NCT02786836|4020511|FG000|Overall Study|Protocol Violation|3
2313230|NCT02786836|4020511|FG000|Overall Study|Withdrawal by Subject|3
2313231|NCT02786836|4020511|FG000|Overall Study|Liver Transplantation|2
2313232|NCT02786836|4020511|FG000|Overall Study|Device or Pharmacy Issues|3
2313233|NCT02786901|4020519|FG000|Overall Study|Adverse Event|1
2313234|NCT02786901|4020520|FG001|Overall Study|Adverse Event|1
2313235|NCT02786901|4020521|FG002|Overall Study|Adverse Event|2
2004364|NCT00141297|3569019|FG003|Overall Study|Other|1
2004365|NCT00141297|3569020|FG004|Overall Study|Other|5
2004366|NCT00141297|3569021|FG005|Overall Study|Other|0
2004367|NCT00141297|3569022|FG006|Overall Study|Other|0
2004368|NCT00141297|3569023|FG007|Overall Study|Other|0
2004369|NCT00141297|3569024|FG008|Overall Study|Other|2
2004370|NCT00141297|3569025|FG009|Overall Study|Other|0
2004371|NCT00141297|3569016|FG000|Overall Study|Progressive Disease|2
2004372|NCT00141297|3569017|FG001|Overall Study|Progressive Disease|3
2004373|NCT00141297|3569018|FG002|Overall Study|Progressive Disease|6
2004374|NCT00141297|3569019|FG003|Overall Study|Progressive Disease|2
2004375|NCT00141297|3569020|FG004|Overall Study|Progressive Disease|15
2004376|NCT00141297|3569021|FG005|Overall Study|Progressive Disease|2
2004377|NCT00141297|3569022|FG006|Overall Study|Progressive Disease|3
2004378|NCT00141297|3569023|FG007|Overall Study|Progressive Disease|3
2004379|NCT00141297|3569024|FG008|Overall Study|Progressive Disease|15
2004380|NCT00141297|3569025|FG009|Overall Study|Progressive Disease|6
2004381|NCT00141297|3569016|FG000|Overall Study|Transitioned|0
2004382|NCT00141297|3569017|FG001|Overall Study|Transitioned|0
2004383|NCT00141297|3569018|FG002|Overall Study|Transitioned|0
2004384|NCT00141297|3569019|FG003|Overall Study|Transitioned|0
2004385|NCT00141297|3569020|FG004|Overall Study|Transitioned|1
2004386|NCT00141297|3569021|FG005|Overall Study|Transitioned|0
2004387|NCT00141297|3569022|FG006|Overall Study|Transitioned|0
2004388|NCT00141297|3569023|FG007|Overall Study|Transitioned|0
2004389|NCT00141297|3569024|FG008|Overall Study|Transitioned|0
2004390|NCT00141297|3569025|FG009|Overall Study|Transitioned|0
2004391|NCT00141453|3569060|FG000|Overall Study|Protocol Violation|6
2004392|NCT00141453|3569061|FG001|Overall Study|Protocol Violation|5
2004393|NCT00141518|3569070|FG000|Overall Study|Withdrew Consent Prior to Treatment|1
2004394|NCT00141518|3569071|FG001|Overall Study|Withdrew Consent Prior to Treatment|0
2004395|NCT00141518|3569072|FG002|Overall Study|Withdrew Consent Prior to Treatment|0
2004396|NCT00141518|3569070|FG000|Overall Study|Adverse Event|7
2004397|NCT00141518|3569071|FG001|Overall Study|Adverse Event|5
2004398|NCT00141518|3569072|FG002|Overall Study|Adverse Event|2
2004399|NCT00141518|3569070|FG000|Overall Study|Withdrawal by Subject|2
2004400|NCT00141518|3569071|FG001|Overall Study|Withdrawal by Subject|0
2004401|NCT00141518|3569072|FG002|Overall Study|Withdrawal by Subject|2
2004402|NCT00141518|3569070|FG000|Overall Study|Protocol Violation|1
2004403|NCT00141518|3569071|FG001|Overall Study|Protocol Violation|1
2004404|NCT00141518|3569072|FG002|Overall Study|Protocol Violation|2
2004405|NCT00141518|3569070|FG000|Overall Study|Lack of Efficacy|5
2004406|NCT00141518|3569071|FG001|Overall Study|Lack of Efficacy|0
2004407|NCT00141518|3569072|FG002|Overall Study|Lack of Efficacy|0
2004408|NCT00141726|3569082|FG000|Overall Study|Completed <50% Scheduled Dosing|3
2004409|NCT00141778|3569099|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5
2004410|NCT00141778|3569100|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2
2004411|NCT00141778|3569101|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6
2004412|NCT00141778|3569099|FG000|Started Study Medication|Met safety criteria for discontinuation|2
2004413|NCT00141778|3569100|FG001|Started Study Medication|Met safety criteria for discontinuation|4
2004414|NCT00141778|3569101|FG002|Started Study Medication|Met safety criteria for discontinuation|3
2004415|NCT00141778|3569099|FG000|Started Study Medication|Withdrawal by Subject|0
2004416|NCT00141778|3569100|FG001|Started Study Medication|Withdrawal by Subject|2
2004417|NCT00141778|3569101|FG002|Started Study Medication|Withdrawal by Subject|0
2004418|NCT00141778|3569099|FG000|Started Study Medication|Difficulty Swallowing|0
2004419|NCT00141778|3569100|FG001|Started Study Medication|Difficulty Swallowing|1
2004420|NCT00141778|3569101|FG002|Started Study Medication|Difficulty Swallowing|0
2004421|NCT00141778|3569099|FG000|Started Study Medication|Chest Discomfort|0
2004422|NCT00141778|3569100|FG001|Started Study Medication|Chest Discomfort|0
2004423|NCT00141778|3569101|FG002|Started Study Medication|Chest Discomfort|1
2004424|NCT00141817|3569113|FG000|Overall Study|Protocol Violation|0
2004425|NCT00141817|3569114|FG001|Overall Study|Protocol Violation|0
2004426|NCT00141817|3569115|FG002|Overall Study|Protocol Violation|1
2004427|NCT00141817|3569116|FG003|Overall Study|Protocol Violation|0
2004428|NCT00141817|3569113|FG000|Overall Study|Parent request|1
2004429|NCT00141817|3569114|FG001|Overall Study|Parent request|0
2004430|NCT00141817|3569115|FG002|Overall Study|Parent request|0
2004431|NCT00141817|3569116|FG003|Overall Study|Parent request|0
2004432|NCT00141921|3569126|FG000|Overall Study|Remain on Study|28
2004433|NCT00141921|3569126|FG000|Overall Study|Withdrawal by Subject|42
2004434|NCT00141921|3569126|FG000|Overall Study|Lost to Follow-up|19
2004435|NCT00141921|3569126|FG000|Overall Study|Noncompliance|17
2004436|NCT00141921|3569126|FG000|Overall Study|Disease Progression|7
2004437|NCT00141921|3569126|FG000|Overall Study|Protocol Deviation|7
2004438|NCT00141921|3569126|FG000|Overall Study|Adverse Event|5
2004439|NCT00141921|3569126|FG000|Overall Study|Administrative Decision|2
2004440|NCT00141921|3569126|FG000|Overall Study|Pregnancy|4
2004441|NCT00141921|3569126|FG000|Overall Study|Ineligibility Determined|2
2004442|NCT00141921|3569126|FG000|Overall Study|Other|8
2004443|NCT00142298|3569149|FG000|Overall Study|Adverse Event|10
2004444|NCT00142298|3569150|FG001|Overall Study|Adverse Event|10
2004445|NCT00142298|3569151|FG002|Overall Study|Adverse Event|1
2004446|NCT00142298|3569152|FG003|Overall Study|Adverse Event|5
2004447|NCT00142298|3569153|FG004|Overall Study|Adverse Event|2
2004448|NCT00142298|3569154|FG005|Overall Study|Adverse Event|2
2004449|NCT00142298|3569155|FG006|Overall Study|Adverse Event|0
2004450|NCT00142298|3569156|FG007|Overall Study|Adverse Event|0
2004451|NCT00142298|3569157|FG008|Overall Study|Adverse Event|0
2004452|NCT00142298|3569158|FG009|Overall Study|Adverse Event|0
2004453|NCT00142298|3569149|FG000|Overall Study|Clinical disease progression|1
2004454|NCT00142298|3569150|FG001|Overall Study|Clinical disease progression|0
2004455|NCT00142298|3569151|FG002|Overall Study|Clinical disease progression|0
2004456|NCT00142298|3569152|FG003|Overall Study|Clinical disease progression|0
2004457|NCT00142298|3569153|FG004|Overall Study|Clinical disease progression|0
2004458|NCT00142298|3569154|FG005|Overall Study|Clinical disease progression|0
2004459|NCT00142298|3569155|FG006|Overall Study|Clinical disease progression|0
2004460|NCT00142298|3569156|FG007|Overall Study|Clinical disease progression|0
2004461|NCT00142298|3569157|FG008|Overall Study|Clinical disease progression|0
2004462|NCT00142298|3569158|FG009|Overall Study|Clinical disease progression|0
2004463|NCT00142298|3569149|FG000|Overall Study|Death|1
2004464|NCT00142298|3569150|FG001|Overall Study|Death|1
2004465|NCT00142298|3569151|FG002|Overall Study|Death|1
2004466|NCT00142298|3569152|FG003|Overall Study|Death|0
2004467|NCT00142298|3569153|FG004|Overall Study|Death|0
2004468|NCT00142298|3569154|FG005|Overall Study|Death|6
2004469|NCT00142298|3569155|FG006|Overall Study|Death|0
2004470|NCT00142298|3569156|FG007|Overall Study|Death|0
2004471|NCT00142298|3569157|FG008|Overall Study|Death|0
2004472|NCT00142298|3569158|FG009|Overall Study|Death|0
2004473|NCT00142298|3569149|FG000|Overall Study|Lack of Efficacy|44
2004474|NCT00142298|3569150|FG001|Overall Study|Lack of Efficacy|62
2004475|NCT00142298|3569151|FG002|Overall Study|Lack of Efficacy|9
2004476|NCT00142298|3569152|FG003|Overall Study|Lack of Efficacy|12
2004477|NCT00142298|3569153|FG004|Overall Study|Lack of Efficacy|1
2004478|NCT00142298|3569154|FG005|Overall Study|Lack of Efficacy|0
2004479|NCT00142298|3569155|FG006|Overall Study|Lack of Efficacy|0
2004480|NCT00142298|3569156|FG007|Overall Study|Lack of Efficacy|1
2004481|NCT00142298|3569157|FG008|Overall Study|Lack of Efficacy|0
2004482|NCT00142298|3569158|FG009|Overall Study|Lack of Efficacy|0
2004483|NCT00142298|3569149|FG000|Overall Study|Non-compliance|15
2004484|NCT00142298|3569150|FG001|Overall Study|Non-compliance|13
2004485|NCT00142298|3569151|FG002|Overall Study|Non-compliance|0
2004486|NCT00142298|3569152|FG003|Overall Study|Non-compliance|6
2004487|NCT00142298|3569153|FG004|Overall Study|Non-compliance|1
2004488|NCT00142298|3569154|FG005|Overall Study|Non-compliance|0
2004489|NCT00142298|3569155|FG006|Overall Study|Non-compliance|0
2004490|NCT00142298|3569156|FG007|Overall Study|Non-compliance|3
2004491|NCT00142298|3569157|FG008|Overall Study|Non-compliance|3
2004492|NCT00142298|3569158|FG009|Overall Study|Non-compliance|0
2004493|NCT00142298|3569149|FG000|Overall Study|Patient, Investigator,or Sponsor request|66
2004494|NCT00142298|3569150|FG001|Overall Study|Patient, Investigator,or Sponsor request|60
2004495|NCT00142298|3569151|FG002|Overall Study|Patient, Investigator,or Sponsor request|11
2004496|NCT00142298|3569152|FG003|Overall Study|Patient, Investigator,or Sponsor request|51
2004497|NCT00142298|3569153|FG004|Overall Study|Patient, Investigator,or Sponsor request|4
2004498|NCT00142298|3569154|FG005|Overall Study|Patient, Investigator,or Sponsor request|3
2004499|NCT00142298|3569155|FG006|Overall Study|Patient, Investigator,or Sponsor request|1
2004500|NCT00142298|3569156|FG007|Overall Study|Patient, Investigator,or Sponsor request|4
2004501|NCT00142298|3569157|FG008|Overall Study|Patient, Investigator,or Sponsor request|1
2004502|NCT00142298|3569158|FG009|Overall Study|Patient, Investigator,or Sponsor request|0
2004503|NCT00142298|3569149|FG000|Overall Study|Pregnancy|4
2004504|NCT00142298|3569150|FG001|Overall Study|Pregnancy|4
2004505|NCT00142298|3569151|FG002|Overall Study|Pregnancy|2
2004506|NCT00142298|3569152|FG003|Overall Study|Pregnancy|3
2004507|NCT00142298|3569153|FG004|Overall Study|Pregnancy|0
2004508|NCT00142298|3569154|FG005|Overall Study|Pregnancy|0
2004509|NCT00142298|3569155|FG006|Overall Study|Pregnancy|0
2004510|NCT00142298|3569156|FG007|Overall Study|Pregnancy|0
2004511|NCT00142298|3569157|FG008|Overall Study|Pregnancy|1
2004512|NCT00142298|3569158|FG009|Overall Study|Pregnancy|0
2004513|NCT00142298|3569149|FG000|Overall Study|Virologic breakthrough|19
2004514|NCT00142298|3569150|FG001|Overall Study|Virologic breakthrough|23
2004515|NCT00142298|3569151|FG002|Overall Study|Virologic breakthrough|9
2004516|NCT00142298|3569152|FG003|Overall Study|Virologic breakthrough|7
2004517|NCT00142298|3569153|FG004|Overall Study|Virologic breakthrough|2
2004518|NCT00142298|3569154|FG005|Overall Study|Virologic breakthrough|3
2004519|NCT00142298|3569155|FG006|Overall Study|Virologic breakthrough|3
2004520|NCT00142298|3569156|FG007|Overall Study|Virologic breakthrough|0
2004521|NCT00142298|3569157|FG008|Overall Study|Virologic breakthrough|0
2004522|NCT00142298|3569158|FG009|Overall Study|Virologic breakthrough|0
2004523|NCT00142298|3569149|FG000|Overall Study|Other- not specified|0
2004524|NCT00142298|3569150|FG001|Overall Study|Other- not specified|3
2004525|NCT00142298|3569151|FG002|Overall Study|Other- not specified|0
2004526|NCT00142298|3569152|FG003|Overall Study|Other- not specified|1
2004527|NCT00142298|3569153|FG004|Overall Study|Other- not specified|0
2004528|NCT00142298|3569154|FG005|Overall Study|Other- not specified|0
2004529|NCT00142298|3569155|FG006|Overall Study|Other- not specified|0
2004530|NCT00142298|3569156|FG007|Overall Study|Other- not specified|0
2004531|NCT00142298|3569157|FG008|Overall Study|Other- not specified|0
2004532|NCT00142298|3569158|FG009|Overall Study|Other- not specified|0
2004533|NCT00142298|3569149|FG000|Overall Study|Lost to Follow-up|0
2004534|NCT00142298|3569150|FG001|Overall Study|Lost to Follow-up|0
2004535|NCT00142298|3569151|FG002|Overall Study|Lost to Follow-up|0
2004536|NCT00142298|3569152|FG003|Overall Study|Lost to Follow-up|0
2004537|NCT00142298|3569153|FG004|Overall Study|Lost to Follow-up|0
2004538|NCT00142298|3569154|FG005|Overall Study|Lost to Follow-up|0
2004539|NCT00142298|3569155|FG006|Overall Study|Lost to Follow-up|2
2004540|NCT00142298|3569156|FG007|Overall Study|Lost to Follow-up|0
2004541|NCT00142298|3569157|FG008|Overall Study|Lost to Follow-up|0
2004542|NCT00142298|3569158|FG009|Overall Study|Lost to Follow-up|0
2004543|NCT00142298|3569149|FG000|Overall Study|Treatment Failure|0
2004544|NCT00142298|3569150|FG001|Overall Study|Treatment Failure|0
2004545|NCT00142298|3569151|FG002|Overall Study|Treatment Failure|0
2004546|NCT00142298|3569152|FG003|Overall Study|Treatment Failure|0
2004547|NCT00142298|3569153|FG004|Overall Study|Treatment Failure|0
2004548|NCT00142298|3569154|FG005|Overall Study|Treatment Failure|2
2004549|NCT00142298|3569155|FG006|Overall Study|Treatment Failure|2
2004550|NCT00142298|3569156|FG007|Overall Study|Treatment Failure|0
2004551|NCT00142298|3569157|FG008|Overall Study|Treatment Failure|0
2004552|NCT00142298|3569158|FG009|Overall Study|Treatment Failure|0
2004553|NCT00142415|3569186|FG000|Overall Study|Physician Decision|0
2004554|NCT00142415|3569187|FG001|Overall Study|Physician Decision|0
2004555|NCT00142415|3569188|FG002|Overall Study|Physician Decision|0
2004556|NCT00142415|3569189|FG003|Overall Study|Physician Decision|0
2004557|NCT00142415|3569190|FG004|Overall Study|Physician Decision|1
2004558|NCT00142415|3569191|FG005|Overall Study|Physician Decision|2
2004559|NCT00142792|3569232|FG000|Overall Study|Death|0
2004560|NCT00142792|3569233|FG001|Overall Study|Death|0
2004561|NCT00142792|3569234|FG002|Overall Study|Death|1
2004562|NCT00142792|3569232|FG000|Overall Study|Withdrawal by Subject|3
2004563|NCT00142792|3569233|FG001|Overall Study|Withdrawal by Subject|2
2004564|NCT00142792|3569234|FG002|Overall Study|Withdrawal by Subject|3
2004565|NCT00142792|3569232|FG000|Overall Study|Lost to Follow-up|8
2004566|NCT00142792|3569233|FG001|Overall Study|Lost to Follow-up|11
2004567|NCT00142792|3569234|FG002|Overall Study|Lost to Follow-up|7
2004568|NCT00142792|3569232|FG000|Overall Study|No category|1
2004569|NCT00142792|3569233|FG001|Overall Study|No category|2
2004570|NCT00142792|3569234|FG002|Overall Study|No category|1
2004571|NCT00142909|3569265|FG000|Randomization|Various Reasons|7
2004572|NCT00142909|3569266|FG001|Randomization|Various Reasons|10
2004573|NCT00142909|3569265|FG000|Medications Begin|Protocol Violation|2
2004574|NCT00142909|3569266|FG001|Medications Begin|Protocol Violation|0
2004575|NCT00142909|3569265|FG000|Medications Begin|Withdrawal by Subject|5
2004576|NCT00142909|3569266|FG001|Medications Begin|Withdrawal by Subject|3
2004577|NCT00142909|3569265|FG000|Medications Begin|Withdrawal by Subject|2
2004578|NCT00142909|3569266|FG001|Medications Begin|Withdrawal by Subject|0
2004579|NCT00142935|3569275|FG000|Overall Study|Other reason|1
2004580|NCT00142935|3569276|FG001|Overall Study|Other reason|1
2004581|NCT00142935|3569277|FG002|Overall Study|Other reason|1
2004582|NCT00142935|3569275|FG000|Overall Study|Lost to Follow-up|2
2004583|NCT00142935|3569276|FG001|Overall Study|Lost to Follow-up|5
2004584|NCT00142935|3569277|FG002|Overall Study|Lost to Follow-up|5
2004585|NCT00142935|3569275|FG000|Overall Study|Death|0
2004586|NCT00142935|3569276|FG001|Overall Study|Death|2
2004587|NCT00142935|3569277|FG002|Overall Study|Death|1
2004588|NCT00143247|3569289|FG000|Overall Study|Death|8
2004589|NCT00143247|3569289|FG000|Overall Study|Adverse Event|19
2004590|NCT00143247|3569289|FG000|Overall Study|Lack of Efficacy|3
2004591|NCT00143247|3569289|FG000|Overall Study|Withdrawal by Subject|55
2004592|NCT00143247|3569289|FG000|Overall Study|Study terminated by sponsor|31
2004593|NCT00143247|3569289|FG000|Overall Study|Protocol Violation|15
2004594|NCT00143247|3569289|FG000|Overall Study|Lost to Follow-up|12
2004595|NCT00143247|3569289|FG000|Overall Study|following inaccurate lab adverse event|1
2004596|NCT00143247|3569289|FG000|Overall Study|Other|12
2004597|NCT00143312|3569293|FG000|Overall Study|Death|11
2004598|NCT00143312|3569293|FG000|Overall Study|Adverse Event|2
2004599|NCT00143312|3569293|FG000|Overall Study|Lost to Follow-up|1
2004600|NCT00143312|3569293|FG000|Overall Study|Other|1
2004601|NCT00143312|3569293|FG000|Overall Study|Withdrawal by Subject|1
2004602|NCT00143390|3569299|FG000|Overall Study|Death|2
2004603|NCT00143390|3569300|FG001|Overall Study|Death|0
2004604|NCT00143390|3569299|FG000|Overall Study|Not meeting entry criteria|2
2004605|NCT00143390|3569300|FG001|Overall Study|Not meeting entry criteria|5
2004606|NCT00143390|3569299|FG000|Overall Study|Withdrawal by Subject|4
2004607|NCT00143390|3569300|FG001|Overall Study|Withdrawal by Subject|4
2004608|NCT00143390|3569299|FG000|Overall Study|Progressive disease|119
2004609|NCT00143390|3569300|FG001|Overall Study|Progressive disease|115
2004610|NCT00143390|3569299|FG000|Overall Study|Protocol Violation|2
2004611|NCT00143390|3569300|FG001|Overall Study|Protocol Violation|0
2004612|NCT00143390|3569299|FG000|Overall Study|Study termination|10
2004613|NCT00143390|3569300|FG001|Overall Study|Study termination|15
2004614|NCT00143390|3569299|FG000|Overall Study|Adverse Event|9
2004615|NCT00143390|3569300|FG001|Overall Study|Adverse Event|8
2004616|NCT00143390|3569299|FG000|Overall Study|Other|1
2004617|NCT00143390|3569300|FG001|Overall Study|Other|2
2004618|NCT00143403|3569308|FG000|Overall Study|Adverse Event|3
2004619|NCT00143403|3569309|FG001|Overall Study|Adverse Event|8
2004620|NCT00143403|3569308|FG000|Overall Study|Death|1
2004621|NCT00143403|3569309|FG001|Overall Study|Death|0
2004622|NCT00143403|3569308|FG000|Overall Study|Withdrawal by Subject|3
2004623|NCT00143403|3569309|FG001|Overall Study|Withdrawal by Subject|12
2004624|NCT00143403|3569308|FG000|Overall Study|Relapse|15
2004625|NCT00143403|3569309|FG001|Overall Study|Relapse|7
2004626|NCT00143403|3569308|FG000|Overall Study|Protocol Violation|2
2004627|NCT00143403|3569309|FG001|Overall Study|Protocol Violation|2
2004628|NCT00143403|3569308|FG000|Overall Study|specified by site|4
2004629|NCT00143403|3569309|FG001|Overall Study|specified by site|9
2004630|NCT00143403|3569308|FG000|Overall Study|Randomized Not Treated|7
2004631|NCT00143403|3569309|FG001|Overall Study|Randomized Not Treated|8
2004632|NCT00143455|3569319|FG000|Cohort 1|Adverse Event|8
2004633|NCT00143455|3569320|FG001|Cohort 1|Adverse Event|4
2004634|NCT00143455|3569321|FG002|Cohort 1|Adverse Event|0
2004635|NCT00143455|3569322|FG003|Cohort 1|Adverse Event|0
2004636|NCT00143455|3569319|FG000|Cohort 1|Death|5
2004637|NCT00143455|3569320|FG001|Cohort 1|Death|2
2004638|NCT00143455|3569321|FG002|Cohort 1|Death|0
2004639|NCT00143455|3569322|FG003|Cohort 1|Death|0
2004640|NCT00143455|3569319|FG000|Cohort 1|Progressive Disease|0
2004641|NCT00143455|3569320|FG001|Cohort 1|Progressive Disease|6
2004642|NCT00143455|3569321|FG002|Cohort 1|Progressive Disease|0
2004643|NCT00143455|3569322|FG003|Cohort 1|Progressive Disease|0
2004644|NCT00143455|3569319|FG000|Cohort 1|Withdrawal by Subject|1
2004645|NCT00143455|3569320|FG001|Cohort 1|Withdrawal by Subject|4
2004646|NCT00143455|3569321|FG002|Cohort 1|Withdrawal by Subject|0
2004647|NCT00143455|3569322|FG003|Cohort 1|Withdrawal by Subject|0
2004648|NCT00143455|3569319|FG000|Cohort 1|Randomized But Not Treated|0
2004649|NCT00143455|3569320|FG001|Cohort 1|Randomized But Not Treated|1
2004650|NCT00143455|3569321|FG002|Cohort 1|Randomized But Not Treated|0
2004651|NCT00143455|3569322|FG003|Cohort 1|Randomized But Not Treated|0
2004652|NCT00143455|3569319|FG000|Cohort 2|Adverse Event|0
2004653|NCT00143455|3569320|FG001|Cohort 2|Adverse Event|0
2004654|NCT00143455|3569321|FG002|Cohort 2|Adverse Event|42
2004655|NCT00143455|3569322|FG003|Cohort 2|Adverse Event|30
2004656|NCT00143455|3569319|FG000|Cohort 2|No Longer Required Study Treatment|0
2004657|NCT00143455|3569320|FG001|Cohort 2|No Longer Required Study Treatment|0
2004658|NCT00143455|3569321|FG002|Cohort 2|No Longer Required Study Treatment|1
2004659|NCT00143455|3569322|FG003|Cohort 2|No Longer Required Study Treatment|0
2004660|NCT00143455|3569319|FG000|Cohort 2|Protocol Violation|0
2004661|NCT00143455|3569320|FG001|Cohort 2|Protocol Violation|0
2004662|NCT00143455|3569321|FG002|Cohort 2|Protocol Violation|1
2004663|NCT00143455|3569322|FG003|Cohort 2|Protocol Violation|1
2004664|NCT00143455|3569319|FG000|Cohort 2|Lost to Follow-up|0
2004665|NCT00143455|3569320|FG001|Cohort 2|Lost to Follow-up|0
2004666|NCT00143455|3569321|FG002|Cohort 2|Lost to Follow-up|1
2004667|NCT00143455|3569322|FG003|Cohort 2|Lost to Follow-up|4
2004668|NCT00143455|3569319|FG000|Cohort 2|Death|0
2004669|NCT00143455|3569320|FG001|Cohort 2|Death|0
2004670|NCT00143455|3569321|FG002|Cohort 2|Death|20
2004671|NCT00143455|3569322|FG003|Cohort 2|Death|12
2004672|NCT00143455|3569319|FG000|Cohort 2|Progressive Disease|0
2004673|NCT00143455|3569320|FG001|Cohort 2|Progressive Disease|0
2004674|NCT00143455|3569321|FG002|Cohort 2|Progressive Disease|20
2004675|NCT00143455|3569322|FG003|Cohort 2|Progressive Disease|27
2004676|NCT00143455|3569319|FG000|Cohort 2|Withdrawal by Subject|0
2004677|NCT00143455|3569320|FG001|Cohort 2|Withdrawal by Subject|0
2004678|NCT00143455|3569321|FG002|Cohort 2|Withdrawal by Subject|13
2004679|NCT00143455|3569322|FG003|Cohort 2|Withdrawal by Subject|12
2004680|NCT00143455|3569319|FG000|Cohort 2|Other|0
2004681|NCT00143455|3569320|FG001|Cohort 2|Other|0
2004682|NCT00143455|3569321|FG002|Cohort 2|Other|7
2004683|NCT00143455|3569322|FG003|Cohort 2|Other|6
2004684|NCT00143455|3569319|FG000|Cohort 2|Randomized But Not Treated|0
2004685|NCT00143455|3569320|FG001|Cohort 2|Randomized But Not Treated|0
2004686|NCT00143455|3569321|FG002|Cohort 2|Randomized But Not Treated|1
2004687|NCT00143455|3569322|FG003|Cohort 2|Randomized But Not Treated|1
2004688|NCT00143507|3569336|FG000|Overall Study|Death|572
2004689|NCT00143507|3569337|FG001|Overall Study|Death|547
2004690|NCT00143507|3569336|FG000|Overall Study|Withdrawal by Subject|114
2004691|NCT00143507|3569337|FG001|Overall Study|Withdrawal by Subject|102
2004692|NCT00143507|3569336|FG000|Overall Study|Lost to Follow-up|1
2004693|NCT00143507|3569337|FG001|Overall Study|Lost to Follow-up|0
2004694|NCT00143507|3569336|FG000|Overall Study|Withdrawn by sponsor's decision|0
2004695|NCT00143507|3569337|FG001|Overall Study|Withdrawn by sponsor's decision|3
2004696|NCT00143598|3569345|FG000|Overall Study|Lost to Follow-up|23
2004697|NCT00143598|3569346|FG001|Overall Study|Lost to Follow-up|21
2004698|NCT00143598|3569345|FG000|Overall Study|Withdrawal by Subject|33
2004699|NCT00143598|3569346|FG001|Overall Study|Withdrawal by Subject|37
2004700|NCT00143598|3569345|FG000|Overall Study|Death|36
2004701|NCT00143598|3569346|FG001|Overall Study|Death|36
2004702|NCT00144027|3569371|FG000|Overall Study|Lost to Follow-up|1
2004703|NCT00144027|3569372|FG001|Overall Study|Lost to Follow-up|3
2004704|NCT00144027|3569371|FG000|Overall Study|Withdrawal by Subject|2
2004705|NCT00144027|3569372|FG001|Overall Study|Withdrawal by Subject|2
2004706|NCT00144027|3569371|FG000|Overall Study|did not complete baseline assessment|0
2004707|NCT00144027|3569372|FG001|Overall Study|did not complete baseline assessment|6
2004708|NCT00144170|3569380|FG000|Overall Study|Adverse Event|84
2004709|NCT00144170|3569381|FG001|Overall Study|Adverse Event|41
2004710|NCT00144170|3569380|FG000|Overall Study|Protocol Violation|23
2004711|NCT00144170|3569381|FG001|Overall Study|Protocol Violation|16
2004712|NCT00144170|3569380|FG000|Overall Study|Lost to Follow-up|5
2004713|NCT00144170|3569381|FG001|Overall Study|Lost to Follow-up|10
2004714|NCT00144170|3569380|FG000|Overall Study|Withdrawal by Subject|29
2004715|NCT00144170|3569381|FG001|Overall Study|Withdrawal by Subject|13
2004716|NCT00144170|3569380|FG000|Overall Study|Other reason not defined above|211
2004717|NCT00144170|3569381|FG001|Overall Study|Other reason not defined above|316
2004718|NCT00144300|3569389|FG000|Overall Study|Adverse Event|18
2004719|NCT00144300|3569390|FG001|Overall Study|Adverse Event|16
2004720|NCT00144300|3569389|FG000|Overall Study|Protocol Violation|1
2004721|NCT00144300|3569390|FG001|Overall Study|Protocol Violation|3
2004722|NCT00144300|3569389|FG000|Overall Study|Lost to Follow-up|3
2004723|NCT00144300|3569390|FG001|Overall Study|Lost to Follow-up|0
2004724|NCT00144300|3569389|FG000|Overall Study|Withdrawal by Subject|6
2004725|NCT00144300|3569390|FG001|Overall Study|Withdrawal by Subject|6
2004726|NCT00144300|3569389|FG000|Overall Study|Other reason (not specified)|1
2004727|NCT00144300|3569390|FG001|Overall Study|Other reason (not specified)|3
2004728|NCT00144339|3569398|FG000|Overall Study|Adverse Event|746
2004729|NCT00144339|3569399|FG001|Overall Study|Adverse Event|627
2004730|NCT00144339|3569398|FG000|Overall Study|Protocol Violation|75
2004731|NCT00144339|3569399|FG001|Overall Study|Protocol Violation|48
2004732|NCT00144339|3569398|FG000|Overall Study|Withdrawal by Subject|403
2004733|NCT00144339|3569399|FG001|Overall Study|Withdrawal by Subject|300
2004734|NCT00144339|3569398|FG000|Overall Study|Lost to Follow-up|76
2004735|NCT00144339|3569399|FG001|Overall Study|Lost to Follow-up|64
2004736|NCT00144339|3569398|FG000|Overall Study|Other|58
2004737|NCT00144339|3569399|FG001|Overall Study|Other|60
2004738|NCT00144781|3569418|FG000|Overall Study|Adverse Event|0
2004739|NCT00144781|3569419|FG001|Overall Study|Adverse Event|1
2004740|NCT00144781|3569420|FG002|Overall Study|Adverse Event|0
2004741|NCT00144781|3569421|FG003|Overall Study|Adverse Event|0
2004742|NCT00144781|3569418|FG000|Overall Study|Non-compliant|0
2004743|NCT00144781|3569419|FG001|Overall Study|Non-compliant|1
2004744|NCT00144781|3569420|FG002|Overall Study|Non-compliant|0
2004745|NCT00144781|3569421|FG003|Overall Study|Non-compliant|0
2004746|NCT00145119|3569439|FG000|Overall Study|Death|45
2004747|NCT00145327|3569463|FG000|Overall Study|Withdrawal by Subject|77
2004748|NCT00145327|3569464|FG001|Overall Study|Withdrawal by Subject|72
2004749|NCT00145327|3569465|FG002|Overall Study|Withdrawal by Subject|164
2004750|NCT00145327|3569463|FG000|Overall Study|Death|26
2004751|NCT00145327|3569464|FG001|Overall Study|Death|18
2004752|NCT00145327|3569465|FG002|Overall Study|Death|30
2004753|NCT00145327|3569463|FG000|Overall Study|Adverse Event|14
2004754|NCT00145327|3569464|FG001|Overall Study|Adverse Event|11
2004755|NCT00145327|3569465|FG002|Overall Study|Adverse Event|22
2004756|NCT00145327|3569463|FG000|Overall Study|Lost to Follow-up|9
2004757|NCT00145327|3569464|FG001|Overall Study|Lost to Follow-up|14
2004758|NCT00145327|3569465|FG002|Overall Study|Lost to Follow-up|14
2004759|NCT00145327|3569463|FG000|Overall Study|Administrative problems|12
2004760|NCT00145327|3569464|FG001|Overall Study|Administrative problems|9
2004761|NCT00145327|3569465|FG002|Overall Study|Administrative problems|13
2004762|NCT00145327|3569463|FG000|Overall Study|Protocol Violation|2
2004763|NCT00145327|3569464|FG001|Overall Study|Protocol Violation|0
2004764|NCT00145327|3569465|FG002|Overall Study|Protocol Violation|2
2004765|NCT00145327|3569463|FG000|Overall Study|Abnormal laboratory value(s)|1
2004766|NCT00145327|3569464|FG001|Overall Study|Abnormal laboratory value(s)|0
2004767|NCT00145327|3569465|FG002|Overall Study|Abnormal laboratory value(s)|2
2004768|NCT00145327|3569463|FG000|Overall Study|Missing - not stated|1
2004769|NCT00145327|3569464|FG001|Overall Study|Missing - not stated|0
2004770|NCT00145327|3569465|FG002|Overall Study|Missing - not stated|1
2004771|NCT00145574|3569480|FG000|Double Blind|Adverse Event|0
2004772|NCT00145574|3569481|FG001|Double Blind|Adverse Event|3
2004773|NCT00145574|3569482|FG002|Double Blind|Adverse Event|1
2004774|NCT00145574|3569480|FG000|Double Blind|Withdrawal by Subject|1
2004775|NCT00145574|3569481|FG001|Double Blind|Withdrawal by Subject|1
2004776|NCT00145574|3569482|FG002|Double Blind|Withdrawal by Subject|1
2004777|NCT00145574|3569480|FG000|Double Blind|required restricted medicine|0
2004778|NCT00145574|3569481|FG001|Double Blind|required restricted medicine|1
2004779|NCT00145574|3569482|FG002|Double Blind|required restricted medicine|0
2004780|NCT00145574|3569480|FG000|Open Label Long-term Extension|Adverse Event|0
2004781|NCT00145574|3569481|FG001|Open Label Long-term Extension|Adverse Event|0
2004782|NCT00145574|3569482|FG002|Open Label Long-term Extension|Adverse Event|5
2004783|NCT00145574|3569480|FG000|Open Label Long-term Extension|Lost to Follow-up|0
2004784|NCT00145574|3569481|FG001|Open Label Long-term Extension|Lost to Follow-up|0
2004785|NCT00145574|3569482|FG002|Open Label Long-term Extension|Lost to Follow-up|1
2004786|NCT00145574|3569480|FG000|Open Label Long-term Extension|Withdrawal by Subject|0
2313236|NCT02786901|4020519|FG000|Overall Study|Physician Decision|1
2313237|NCT02786901|4020520|FG001|Overall Study|Physician Decision|0
2004787|NCT00145574|3569481|FG001|Open Label Long-term Extension|Withdrawal by Subject|0
2004788|NCT00145574|3569482|FG002|Open Label Long-term Extension|Withdrawal by Subject|4
2004789|NCT00145574|3569480|FG000|Open Label Long-term Extension|required restricted medicine|0
2004790|NCT00145574|3569481|FG001|Open Label Long-term Extension|required restricted medicine|0
2004791|NCT00145574|3569482|FG002|Open Label Long-term Extension|required restricted medicine|1
2004792|NCT00145600|3569508|FG000|Overall Study|Death|1
2004793|NCT00145600|3569509|FG001|Overall Study|Death|2
2004794|NCT00145600|3569510|FG002|Overall Study|Death|2
2004795|NCT00145600|3569511|FG003|Overall Study|Death|6
2004796|NCT00145600|3569508|FG000|Overall Study|Ineligible|3
2004797|NCT00145600|3569509|FG001|Overall Study|Ineligible|0
2004798|NCT00145600|3569510|FG002|Overall Study|Ineligible|1
2004799|NCT00145600|3569511|FG003|Overall Study|Ineligible|5
2214242|NCT01685840|3856417|FG000|Overall Study|Physician Decision|3
2214243|NCT01685840|3856418|FG001|Overall Study|Physician Decision|7
2004800|NCT00145600|3569508|FG000|Overall Study|Lost to Follow-up|2
2004801|NCT00145600|3569509|FG001|Overall Study|Lost to Follow-up|6
2004802|NCT00145600|3569510|FG002|Overall Study|Lost to Follow-up|2
2004803|NCT00145600|3569511|FG003|Overall Study|Lost to Follow-up|4
2004804|NCT00145600|3569508|FG000|Overall Study|Noncompliance|1
2004805|NCT00145600|3569509|FG001|Overall Study|Noncompliance|0
2004806|NCT00145600|3569510|FG002|Overall Study|Noncompliance|0
2004807|NCT00145600|3569511|FG003|Overall Study|Noncompliance|0
2004808|NCT00145600|3569508|FG000|Overall Study|Withdrawal by Subject|1
2004809|NCT00145600|3569509|FG001|Overall Study|Withdrawal by Subject|2
2004810|NCT00145600|3569510|FG002|Overall Study|Withdrawal by Subject|0
2004811|NCT00145600|3569511|FG003|Overall Study|Withdrawal by Subject|1
2004812|NCT00145626|3569537|FG000|Overall Study|Did not have NK infusions|2
2004813|NCT00145626|3569537|FG000|Overall Study|Turned 2 years old before treatment|1
2004814|NCT00145626|3569537|FG000|Overall Study|Death|1
2004815|NCT00145626|3569537|FG000|Overall Study|Withdrawal by Subject|1
2004816|NCT00145795|3569559|FG000|Overall Study|Adverse Event|1
2004817|NCT00145795|3569560|FG001|Overall Study|Adverse Event|0
2004818|NCT00145977|3569568|FG000|Overall Study|Lack of Efficacy|0
2004819|NCT00145977|3569569|FG001|Overall Study|Lack of Efficacy|4
2004820|NCT00145977|3569568|FG000|Overall Study|Lost to Follow-up|1
2004821|NCT00145977|3569569|FG001|Overall Study|Lost to Follow-up|0
2004822|NCT00145977|3569568|FG000|Overall Study|Withdrawal by Subject|1
2004823|NCT00145977|3569569|FG001|Overall Study|Withdrawal by Subject|0
2004824|NCT00146172|3569583|FG000|Overall Study|Adverse Event|0
2004825|NCT00146172|3569584|FG001|Overall Study|Adverse Event|0
2004826|NCT00146172|3569585|FG002|Overall Study|Adverse Event|1
2004827|NCT00146172|3569586|FG003|Overall Study|Adverse Event|1
2004828|NCT00146172|3569587|FG004|Overall Study|Adverse Event|0
2004829|NCT00146172|3569588|FG005|Overall Study|Adverse Event|2
2004830|NCT00146172|3569589|FG006|Overall Study|Adverse Event|3
2004831|NCT00146172|3569590|FG007|Overall Study|Adverse Event|10
2004832|NCT00146172|3569583|FG000|Overall Study|Lost to Follow-up|0
2004833|NCT00146172|3569584|FG001|Overall Study|Lost to Follow-up|0
2004834|NCT00146172|3569585|FG002|Overall Study|Lost to Follow-up|0
2004835|NCT00146172|3569586|FG003|Overall Study|Lost to Follow-up|0
2004836|NCT00146172|3569587|FG004|Overall Study|Lost to Follow-up|0
2004837|NCT00146172|3569588|FG005|Overall Study|Lost to Follow-up|0
2004838|NCT00146172|3569589|FG006|Overall Study|Lost to Follow-up|0
2004839|NCT00146172|3569590|FG007|Overall Study|Lost to Follow-up|1
2004840|NCT00146172|3569583|FG000|Overall Study|Disease Progression|2
2004841|NCT00146172|3569584|FG001|Overall Study|Disease Progression|4
2004842|NCT00146172|3569585|FG002|Overall Study|Disease Progression|2
2004843|NCT00146172|3569586|FG003|Overall Study|Disease Progression|5
2004844|NCT00146172|3569587|FG004|Overall Study|Disease Progression|2
2004845|NCT00146172|3569588|FG005|Overall Study|Disease Progression|2
2004846|NCT00146172|3569589|FG006|Overall Study|Disease Progression|1
2004847|NCT00146172|3569590|FG007|Overall Study|Disease Progression|22
2004848|NCT00146172|3569583|FG000|Overall Study|Death|0
2004849|NCT00146172|3569584|FG001|Overall Study|Death|0
2004850|NCT00146172|3569585|FG002|Overall Study|Death|0
2004851|NCT00146172|3569586|FG003|Overall Study|Death|0
2004852|NCT00146172|3569587|FG004|Overall Study|Death|0
2004853|NCT00146172|3569588|FG005|Overall Study|Death|0
2004854|NCT00146172|3569589|FG006|Overall Study|Death|1
2004855|NCT00146172|3569590|FG007|Overall Study|Death|0
2004856|NCT00146172|3569583|FG000|Overall Study|Physician Decision|0
2004857|NCT00146172|3569584|FG001|Overall Study|Physician Decision|0
2004858|NCT00146172|3569585|FG002|Overall Study|Physician Decision|0
2004859|NCT00146172|3569586|FG003|Overall Study|Physician Decision|0
2214244|NCT01685840|3856417|FG000|Overall Study|Withdrawal by Subject|14
2214245|NCT01685840|3856418|FG001|Overall Study|Withdrawal by Subject|17
2214246|NCT01685840|3856417|FG000|Overall Study|Futility|197
2214247|NCT01685840|3856418|FG001|Overall Study|Futility|200
2214248|NCT01685840|3856417|FG000|Overall Study|Had VAD, Dialysis or Transplant|11
2214249|NCT01685840|3856418|FG001|Overall Study|Had VAD, Dialysis or Transplant|17
2214250|NCT01685983|3856426|FG000|Overall Study|Adverse Event|7
2004860|NCT00146172|3569587|FG004|Overall Study|Physician Decision|0
2004861|NCT00146172|3569588|FG005|Overall Study|Physician Decision|0
2004862|NCT00146172|3569589|FG006|Overall Study|Physician Decision|0
2004863|NCT00146172|3569590|FG007|Overall Study|Physician Decision|1
2004864|NCT00146172|3569583|FG000|Overall Study|Withdrawal by Subject|0
2004865|NCT00146172|3569584|FG001|Overall Study|Withdrawal by Subject|0
2004866|NCT00146172|3569585|FG002|Overall Study|Withdrawal by Subject|0
2004867|NCT00146172|3569586|FG003|Overall Study|Withdrawal by Subject|0
2004868|NCT00146172|3569587|FG004|Overall Study|Withdrawal by Subject|0
2004869|NCT00146172|3569588|FG005|Overall Study|Withdrawal by Subject|1
2004870|NCT00146172|3569589|FG006|Overall Study|Withdrawal by Subject|1
2004871|NCT00146172|3569590|FG007|Overall Study|Withdrawal by Subject|4
2004872|NCT00146172|3569583|FG000|Overall Study|Symptomatic Deterioration|1
2214251|NCT01685983|3856426|FG000|Overall Study|Death|1
2004873|NCT00146172|3569584|FG001|Overall Study|Symptomatic Deterioration|0
2004874|NCT00146172|3569585|FG002|Overall Study|Symptomatic Deterioration|1
2004875|NCT00146172|3569586|FG003|Overall Study|Symptomatic Deterioration|0
2004876|NCT00146172|3569587|FG004|Overall Study|Symptomatic Deterioration|1
2004877|NCT00146172|3569588|FG005|Overall Study|Symptomatic Deterioration|2
2004878|NCT00146172|3569589|FG006|Overall Study|Symptomatic Deterioration|0
2004879|NCT00146172|3569590|FG007|Overall Study|Symptomatic Deterioration|2
2004880|NCT00146328|3569619|FG000|Overall Study|Adverse Event|39
2004881|NCT00146328|3569620|FG001|Overall Study|Adverse Event|48
2004882|NCT00146328|3569621|FG002|Overall Study|Adverse Event|79
2004883|NCT00146328|3569619|FG000|Overall Study|Protocol Violation|11
2004884|NCT00146328|3569620|FG001|Overall Study|Protocol Violation|6
2004885|NCT00146328|3569621|FG002|Overall Study|Protocol Violation|12
2004886|NCT00146328|3569619|FG000|Overall Study|Lost to Follow-up|7
2004887|NCT00146328|3569620|FG001|Overall Study|Lost to Follow-up|4
2004888|NCT00146328|3569621|FG002|Overall Study|Lost to Follow-up|7
2004889|NCT00146328|3569619|FG000|Overall Study|Withdrawal by Subject|16
2004890|NCT00146328|3569620|FG001|Overall Study|Withdrawal by Subject|16
2004891|NCT00146328|3569621|FG002|Overall Study|Withdrawal by Subject|22
2004892|NCT00146328|3569619|FG000|Overall Study|Virologic Failure/lack of efficacy|54
2004893|NCT00146328|3569620|FG001|Overall Study|Virologic Failure/lack of efficacy|72
2004894|NCT00146328|3569621|FG002|Overall Study|Virologic Failure/lack of efficacy|142
2004895|NCT00146328|3569619|FG000|Overall Study|Trial ended/site closed|8
2004896|NCT00146328|3569620|FG001|Overall Study|Trial ended/site closed|2
2004897|NCT00146328|3569621|FG002|Overall Study|Trial ended/site closed|19
2004898|NCT00146328|3569619|FG000|Overall Study|Patient decision to end|0
2004899|NCT00146328|3569620|FG001|Overall Study|Patient decision to end|1
2004900|NCT00146328|3569621|FG002|Overall Study|Patient decision to end|6
2004901|NCT00146328|3569619|FG000|Overall Study|Enroll into other trial|2
2004902|NCT00146328|3569620|FG001|Overall Study|Enroll into other trial|4
2004903|NCT00146328|3569621|FG002|Overall Study|Enroll into other trial|2
2004904|NCT00146328|3569619|FG000|Overall Study|Death|0
2004905|NCT00146328|3569620|FG001|Overall Study|Death|1
2004906|NCT00146328|3569621|FG002|Overall Study|Death|1
2004907|NCT00146328|3569619|FG000|Overall Study|Moved|2
2004908|NCT00146328|3569620|FG001|Overall Study|Moved|0
2004909|NCT00146328|3569621|FG002|Overall Study|Moved|0
2004910|NCT00146328|3569619|FG000|Overall Study|Interaction with other medication|2
2004911|NCT00146328|3569620|FG001|Overall Study|Interaction with other medication|0
2004912|NCT00146328|3569621|FG002|Overall Study|Interaction with other medication|1
2004913|NCT00146640|3569631|FG000|Overall Study|Adverse Event|12
2004914|NCT00146640|3569632|FG001|Overall Study|Adverse Event|10
2004915|NCT00146640|3569631|FG000|Overall Study|Medical Reasons|3
2004916|NCT00146640|3569632|FG001|Overall Study|Medical Reasons|0
2004917|NCT00146640|3569631|FG000|Overall Study|Non-Medical Reasons|8
2004918|NCT00146640|3569632|FG001|Overall Study|Non-Medical Reasons|4
2004919|NCT00146757|3569638|FG000|Overall Study|Death|1
2004920|NCT00146757|3569639|FG001|Overall Study|Death|0
2004921|NCT00146757|3569638|FG000|Overall Study|Adverse Event|1
2004922|NCT00146757|3569639|FG001|Overall Study|Adverse Event|0
2004923|NCT00146770|3569647|FG000|Overall Study|Adverse Event|2
2004924|NCT00146770|3569648|FG001|Overall Study|Adverse Event|0
2004925|NCT00146770|3569647|FG000|Overall Study|Pregnancy|1
2004926|NCT00146770|3569648|FG001|Overall Study|Pregnancy|0
2004927|NCT00146770|3569647|FG000|Overall Study|Withdrawal by Subject|2
2004928|NCT00146770|3569648|FG001|Overall Study|Withdrawal by Subject|0
2004929|NCT00146848|3569657|FG000|Pre-randomization|Death|19
2004930|NCT00146848|3569658|FG001|Pre-randomization|Death|0
2004931|NCT00146848|3569659|FG002|Pre-randomization|Death|0
2004932|NCT00146848|3569657|FG000|Pre-randomization|Lost to Follow-up|70
2004933|NCT00146848|3569658|FG001|Pre-randomization|Lost to Follow-up|0
2004934|NCT00146848|3569659|FG002|Pre-randomization|Lost to Follow-up|0
2004935|NCT00146848|3569657|FG000|Pre-randomization|Physician Decision|8
2004936|NCT00146848|3569658|FG001|Pre-randomization|Physician Decision|0
2004937|NCT00146848|3569659|FG002|Pre-randomization|Physician Decision|0
2004938|NCT00146848|3569657|FG000|Pre-randomization|Protocol Violation|172
2004939|NCT00146848|3569658|FG001|Pre-randomization|Protocol Violation|0
2004940|NCT00146848|3569659|FG002|Pre-randomization|Protocol Violation|0
2004941|NCT00146848|3569657|FG000|Pre-randomization|Withdrawal by Subject|40
2004942|NCT00146848|3569658|FG001|Pre-randomization|Withdrawal by Subject|0
2004943|NCT00146848|3569659|FG002|Pre-randomization|Withdrawal by Subject|0
2004944|NCT00146848|3569657|FG000|Post-randomization|Lost to Follow-up|12
2004945|NCT00146848|3569658|FG001|Post-randomization|Lost to Follow-up|15
2004946|NCT00146848|3569659|FG002|Post-randomization|Lost to Follow-up|12
2004947|NCT00146848|3569657|FG000|Post-randomization|Withdrawn|26
2004948|NCT00146848|3569658|FG001|Post-randomization|Withdrawn|32
2004949|NCT00146848|3569659|FG002|Post-randomization|Withdrawn|27
2004950|NCT00147225|3569745|FG000|Overall Study|Withdrawal by Subject|1
2004951|NCT00147225|3569746|FG001|Overall Study|Withdrawal by Subject|0
2004952|NCT00147225|3569747|FG002|Overall Study|Withdrawal by Subject|1
2004953|NCT00147225|3569748|FG003|Overall Study|Withdrawal by Subject|0
2004954|NCT00147225|3569749|FG004|Overall Study|Withdrawal by Subject|0
2004955|NCT00147225|3569750|FG005|Overall Study|Withdrawal by Subject|1
2004956|NCT00147225|3569745|FG000|Overall Study|Adverse Event|0
2004957|NCT00147225|3569746|FG001|Overall Study|Adverse Event|0
2004958|NCT00147225|3569747|FG002|Overall Study|Adverse Event|1
2004959|NCT00147225|3569748|FG003|Overall Study|Adverse Event|1
2004960|NCT00147225|3569749|FG004|Overall Study|Adverse Event|0
2004961|NCT00147225|3569750|FG005|Overall Study|Adverse Event|0
2004962|NCT00147225|3569745|FG000|Overall Study|Screen Failure|0
2004963|NCT00147225|3569746|FG001|Overall Study|Screen Failure|0
2004964|NCT00147225|3569747|FG002|Overall Study|Screen Failure|0
2004965|NCT00147225|3569748|FG003|Overall Study|Screen Failure|0
2004966|NCT00147225|3569749|FG004|Overall Study|Screen Failure|1
2004967|NCT00147225|3569750|FG005|Overall Study|Screen Failure|0
2004968|NCT00147225|3569745|FG000|Overall Study|Chemotherapy Changed|0
2004969|NCT00147225|3569746|FG001|Overall Study|Chemotherapy Changed|0
2004970|NCT00147225|3569747|FG002|Overall Study|Chemotherapy Changed|0
2004971|NCT00147225|3569748|FG003|Overall Study|Chemotherapy Changed|0
2004972|NCT00147225|3569749|FG004|Overall Study|Chemotherapy Changed|0
2004973|NCT00147225|3569750|FG005|Overall Study|Chemotherapy Changed|1
2004974|NCT00147251|3569766|FG000|Recruitment and Enrollment|change in treatment guidelines|24
2004975|NCT00147251|3569767|FG001|Recruitment and Enrollment|change in treatment guidelines|25
2004976|NCT00147498|3569794|FG000|Overall Study|Adverse Event|1
2004977|NCT00147498|3569795|FG001|Overall Study|Adverse Event|6
2004978|NCT00147498|3569796|FG002|Overall Study|Adverse Event|7
2004979|NCT00147498|3569797|FG003|Overall Study|Adverse Event|3
2004980|NCT00147498|3569794|FG000|Overall Study|Lack of Efficacy|1
2004981|NCT00147498|3569795|FG001|Overall Study|Lack of Efficacy|1
2004982|NCT00147498|3569796|FG002|Overall Study|Lack of Efficacy|1
2004983|NCT00147498|3569797|FG003|Overall Study|Lack of Efficacy|8
2004984|NCT00147498|3569794|FG000|Overall Study|Laboratory abnormality|0
2004985|NCT00147498|3569795|FG001|Overall Study|Laboratory abnormality|0
2004986|NCT00147498|3569796|FG002|Overall Study|Laboratory abnormality|2
2004987|NCT00147498|3569797|FG003|Overall Study|Laboratory abnormality|0
2004988|NCT00147498|3569794|FG000|Overall Study|Participant defaulted|0
2004989|NCT00147498|3569795|FG001|Overall Study|Participant defaulted|1
2004990|NCT00147498|3569796|FG002|Overall Study|Participant defaulted|4
2004991|NCT00147498|3569797|FG003|Overall Study|Participant defaulted|3
2004992|NCT00147498|3569794|FG000|Overall Study|Other|1
2004993|NCT00147498|3569795|FG001|Overall Study|Other|1
2004994|NCT00147498|3569796|FG002|Overall Study|Other|3
2004995|NCT00147498|3569797|FG003|Overall Study|Other|3
2004996|NCT00147537|3569811|FG000|Phase 1b|Death|0
2004997|NCT00147537|3569812|FG001|Phase 1b|Death|1
2004998|NCT00147537|3569813|FG002|Phase 1b|Death|2
2004999|NCT00147537|3569814|FG003|Phase 1b|Death|1
2005000|NCT00147537|3569815|FG004|Phase 1b|Death|2
2005001|NCT00147537|3569816|FG005|Phase 1b|Death|2
2005002|NCT00147537|3569817|FG006|Phase 1b|Death|1
2005003|NCT00147537|3569818|FG007|Phase 1b|Death|3
2005004|NCT00147537|3569819|FG008|Phase 1b|Death|9
2005005|NCT00147537|3569820|FG009|Phase 1b|Death|0
2005006|NCT00147537|3569821|FG010|Phase 1b|Death|0
2005007|NCT00147537|3569811|FG000|Phase 1b|Lost to Follow-up|2
2005008|NCT00147537|3569812|FG001|Phase 1b|Lost to Follow-up|1
2005009|NCT00147537|3569813|FG002|Phase 1b|Lost to Follow-up|0
2005010|NCT00147537|3569814|FG003|Phase 1b|Lost to Follow-up|0
2005011|NCT00147537|3569815|FG004|Phase 1b|Lost to Follow-up|0
2005012|NCT00147537|3569816|FG005|Phase 1b|Lost to Follow-up|0
2005013|NCT00147537|3569817|FG006|Phase 1b|Lost to Follow-up|2
2005014|NCT00147537|3569818|FG007|Phase 1b|Lost to Follow-up|0
2005015|NCT00147537|3569819|FG008|Phase 1b|Lost to Follow-up|1
2005016|NCT00147537|3569820|FG009|Phase 1b|Lost to Follow-up|0
2005017|NCT00147537|3569821|FG010|Phase 1b|Lost to Follow-up|0
2005018|NCT00147537|3569811|FG000|Phase 1b|Other|0
2005019|NCT00147537|3569812|FG001|Phase 1b|Other|0
2005020|NCT00147537|3569813|FG002|Phase 1b|Other|2
2005021|NCT00147537|3569814|FG003|Phase 1b|Other|1
2005022|NCT00147537|3569815|FG004|Phase 1b|Other|1
2005023|NCT00147537|3569816|FG005|Phase 1b|Other|1
2005024|NCT00147537|3569817|FG006|Phase 1b|Other|14
2005025|NCT00147537|3569818|FG007|Phase 1b|Other|4
2005026|NCT00147537|3569819|FG008|Phase 1b|Other|4
2005027|NCT00147537|3569820|FG009|Phase 1b|Other|0
2005028|NCT00147537|3569821|FG010|Phase 1b|Other|0
2005029|NCT00147537|3569811|FG000|Phase 1b|Withdrawal by Subject|0
2005030|NCT00147537|3569812|FG001|Phase 1b|Withdrawal by Subject|0
2005031|NCT00147537|3569813|FG002|Phase 1b|Withdrawal by Subject|0
2005032|NCT00147537|3569814|FG003|Phase 1b|Withdrawal by Subject|0
2005033|NCT00147537|3569815|FG004|Phase 1b|Withdrawal by Subject|0
2005034|NCT00147537|3569816|FG005|Phase 1b|Withdrawal by Subject|0
2005035|NCT00147537|3569817|FG006|Phase 1b|Withdrawal by Subject|0
2005036|NCT00147537|3569818|FG007|Phase 1b|Withdrawal by Subject|0
2005037|NCT00147537|3569819|FG008|Phase 1b|Withdrawal by Subject|2
2005038|NCT00147537|3569820|FG009|Phase 1b|Withdrawal by Subject|0
2005039|NCT00147537|3569821|FG010|Phase 1b|Withdrawal by Subject|0
2005040|NCT00147537|3569811|FG000|Phase 1b|Randomized but not treated|0
2005041|NCT00147537|3569812|FG001|Phase 1b|Randomized but not treated|0
2005042|NCT00147537|3569813|FG002|Phase 1b|Randomized but not treated|0
2005043|NCT00147537|3569814|FG003|Phase 1b|Randomized but not treated|0
2005044|NCT00147537|3569815|FG004|Phase 1b|Randomized but not treated|0
2005045|NCT00147537|3569816|FG005|Phase 1b|Randomized but not treated|0
2005046|NCT00147537|3569817|FG006|Phase 1b|Randomized but not treated|1
2005047|NCT00147537|3569818|FG007|Phase 1b|Randomized but not treated|0
2005048|NCT00147537|3569819|FG008|Phase 1b|Randomized but not treated|1
2005049|NCT00147537|3569820|FG009|Phase 1b|Randomized but not treated|0
2005050|NCT00147537|3569821|FG010|Phase 1b|Randomized but not treated|0
2005051|NCT00147537|3569811|FG000|Phase 2|Death|0
2005052|NCT00147537|3569812|FG001|Phase 2|Death|0
2005053|NCT00147537|3569813|FG002|Phase 2|Death|0
2005054|NCT00147537|3569814|FG003|Phase 2|Death|0
2005055|NCT00147537|3569815|FG004|Phase 2|Death|0
2005056|NCT00147537|3569816|FG005|Phase 2|Death|0
2005057|NCT00147537|3569817|FG006|Phase 2|Death|0
2005058|NCT00147537|3569818|FG007|Phase 2|Death|0
2005059|NCT00147537|3569819|FG008|Phase 2|Death|0
2005060|NCT00147537|3569820|FG009|Phase 2|Death|85
2005061|NCT00147537|3569821|FG010|Phase 2|Death|31
2005062|NCT00147537|3569811|FG000|Phase 2|Lost to Follow-up|0
2005063|NCT00147537|3569812|FG001|Phase 2|Lost to Follow-up|0
2005064|NCT00147537|3569813|FG002|Phase 2|Lost to Follow-up|0
2005065|NCT00147537|3569814|FG003|Phase 2|Lost to Follow-up|0
2005066|NCT00147537|3569815|FG004|Phase 2|Lost to Follow-up|0
2005067|NCT00147537|3569816|FG005|Phase 2|Lost to Follow-up|0
2005068|NCT00147537|3569817|FG006|Phase 2|Lost to Follow-up|0
2005069|NCT00147537|3569818|FG007|Phase 2|Lost to Follow-up|0
2005070|NCT00147537|3569819|FG008|Phase 2|Lost to Follow-up|0
2005071|NCT00147537|3569820|FG009|Phase 2|Lost to Follow-up|12
2005072|NCT00147537|3569821|FG010|Phase 2|Lost to Follow-up|4
2005073|NCT00147537|3569811|FG000|Phase 2|Other|0
2005074|NCT00147537|3569812|FG001|Phase 2|Other|0
2005075|NCT00147537|3569813|FG002|Phase 2|Other|0
2005076|NCT00147537|3569814|FG003|Phase 2|Other|0
2005077|NCT00147537|3569815|FG004|Phase 2|Other|0
2005078|NCT00147537|3569816|FG005|Phase 2|Other|0
2005079|NCT00147537|3569817|FG006|Phase 2|Other|0
2005080|NCT00147537|3569818|FG007|Phase 2|Other|0
2005081|NCT00147537|3569819|FG008|Phase 2|Other|0
2005082|NCT00147537|3569820|FG009|Phase 2|Other|47
2005083|NCT00147537|3569821|FG010|Phase 2|Other|12
2005084|NCT00147537|3569811|FG000|Phase 2|Withdrawal by Subject|0
2005085|NCT00147537|3569812|FG001|Phase 2|Withdrawal by Subject|0
2005086|NCT00147537|3569813|FG002|Phase 2|Withdrawal by Subject|0
2005087|NCT00147537|3569814|FG003|Phase 2|Withdrawal by Subject|0
2005088|NCT00147537|3569815|FG004|Phase 2|Withdrawal by Subject|0
2005089|NCT00147537|3569816|FG005|Phase 2|Withdrawal by Subject|0
2005090|NCT00147537|3569817|FG006|Phase 2|Withdrawal by Subject|0
2005091|NCT00147537|3569818|FG007|Phase 2|Withdrawal by Subject|0
2005092|NCT00147537|3569819|FG008|Phase 2|Withdrawal by Subject|0
2005093|NCT00147537|3569820|FG009|Phase 2|Withdrawal by Subject|16
2005094|NCT00147537|3569821|FG010|Phase 2|Withdrawal by Subject|4
2005095|NCT00147537|3569811|FG000|Phase 2|Randomized but not treated|0
2005096|NCT00147537|3569812|FG001|Phase 2|Randomized but not treated|0
2005097|NCT00147537|3569813|FG002|Phase 2|Randomized but not treated|0
2005098|NCT00147537|3569814|FG003|Phase 2|Randomized but not treated|0
2005099|NCT00147537|3569815|FG004|Phase 2|Randomized but not treated|0
2005100|NCT00147537|3569816|FG005|Phase 2|Randomized but not treated|0
2005101|NCT00147537|3569817|FG006|Phase 2|Randomized but not treated|0
2005102|NCT00147537|3569818|FG007|Phase 2|Randomized but not treated|0
2005103|NCT00147537|3569819|FG008|Phase 2|Randomized but not treated|0
2005104|NCT00147537|3569820|FG009|Phase 2|Randomized but not treated|1
2005105|NCT00147537|3569821|FG010|Phase 2|Randomized but not treated|1
2005106|NCT00147745|3569869|FG000|Overall Study|Withdrawal by Subject|1
2005107|NCT00147745|3569870|FG001|Overall Study|Withdrawal by Subject|0
2005108|NCT00147745|3569871|FG002|Overall Study|Withdrawal by Subject|0
2005109|NCT00147823|3569881|FG000|Overall Study|Lost to Follow-up|6
2005110|NCT00147823|3569882|FG001|Overall Study|Lost to Follow-up|12
2005111|NCT00147823|3569881|FG000|Overall Study|Physician Decision|1
2005112|NCT00147823|3569882|FG001|Overall Study|Physician Decision|0
2005113|NCT00147823|3569881|FG000|Overall Study|Withdrawal by Subject|0
2005114|NCT00147823|3569882|FG001|Overall Study|Withdrawal by Subject|1
2005115|NCT00147823|3569881|FG000|Overall Study|Did not receive vitoss due to infection|6
2005116|NCT00147823|3569882|FG001|Overall Study|Did not receive vitoss due to infection|2
2005117|NCT00148109|3569894|FG000|Overall Study|Lack of Efficacy|10
2005118|NCT00148109|3569895|FG001|Overall Study|Lack of Efficacy|18
2005119|NCT00148109|3569894|FG000|Overall Study|Adverse Event|0
2005120|NCT00148109|3569895|FG001|Overall Study|Adverse Event|2
2005121|NCT00148109|3569894|FG000|Overall Study|Withdrawal by Subject|2
2005122|NCT00148109|3569895|FG001|Overall Study|Withdrawal by Subject|0
2005123|NCT00148122|3569901|FG000|Overall Study|Withdrawal by Subject|2
2005124|NCT00148317|3569905|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
2005125|NCT00148317|3569905|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
2005126|NCT00148317|3569905|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
2005127|NCT00148343|3569914|FG000|Overall Study|Withdrawal by Subject|12
2005128|NCT00148343|3569915|FG001|Overall Study|Withdrawal by Subject|7
2005129|NCT00148343|3569914|FG000|Overall Study|Physician Decision|3
2005130|NCT00148343|3569915|FG001|Overall Study|Physician Decision|4
2005131|NCT00148759|3569941|FG000|Overall Study|Withdrawal by Subject|1
2005132|NCT00148759|3569942|FG001|Overall Study|Withdrawal by Subject|1
2005133|NCT00148759|3569941|FG000|Overall Study|Lost to Follow-up|1
2005134|NCT00148759|3569942|FG001|Overall Study|Lost to Follow-up|0
2005135|NCT00148941|3569963|FG000|Overall Study|Lost to Follow-up|17
2005136|NCT00148941|3569964|FG001|Overall Study|Lost to Follow-up|24
2005137|NCT00148941|3569965|FG002|Overall Study|Lost to Follow-up|18
2005138|NCT00148941|3569966|FG003|Overall Study|Lost to Follow-up|22
2005139|NCT00148941|3569963|FG000|Overall Study|Withdrawal by Subject|1
2005140|NCT00148941|3569964|FG001|Overall Study|Withdrawal by Subject|0
2005141|NCT00148941|3569965|FG002|Overall Study|Withdrawal by Subject|1
2005142|NCT00148941|3569966|FG003|Overall Study|Withdrawal by Subject|0
2005143|NCT00148941|3569963|FG000|Overall Study|Other|0
2005144|NCT00148941|3569964|FG001|Overall Study|Other|0
2005145|NCT00148941|3569965|FG002|Overall Study|Other|1
2005146|NCT00148941|3569966|FG003|Overall Study|Other|2
2005147|NCT00149214|3569987|FG000|Overall Study|Adverse Event|12
2005148|NCT00149214|3569988|FG001|Overall Study|Adverse Event|9
2005149|NCT00149214|3569987|FG000|Overall Study|Withdrawal by Subject|4
2005150|NCT00149214|3569988|FG001|Overall Study|Withdrawal by Subject|1
2005151|NCT00149214|3569987|FG000|Overall Study|Physician Decision|3
2005152|NCT00149214|3569988|FG001|Overall Study|Physician Decision|3
2005153|NCT00149214|3569987|FG000|Overall Study|Sponsor Decision|0
2005154|NCT00149214|3569988|FG001|Overall Study|Sponsor Decision|1
2005155|NCT00149214|3569987|FG000|Overall Study|Progressive Disease|7
2005156|NCT00149214|3569988|FG001|Overall Study|Progressive Disease|3
2005157|NCT00149396|3570003|FG000|Overall Study|Death|15
2005158|NCT00149396|3570003|FG000|Overall Study|Withdrawal by Subject|1
2005159|NCT00149396|3570003|FG000|Overall Study|Subject noncompliance|2
2005160|NCT00149396|3570003|FG000|Overall Study|other treatment|5
2005161|NCT00149630|3570016|FG000|Overall Study|Incarceration|2
2005162|NCT00149630|3570017|FG001|Overall Study|Incarceration|0
2005163|NCT00149630|3570016|FG000|Overall Study|Treatment Programs|4
2005164|NCT00149630|3570017|FG001|Overall Study|Treatment Programs|5
2005165|NCT00149630|3570016|FG000|Overall Study|Adverse Event|2
2005166|NCT00149630|3570017|FG001|Overall Study|Adverse Event|0
2005167|NCT00149747|3570056|FG000|Overall Study|Death|1
2005168|NCT00149747|3570057|FG001|Overall Study|Death|0
2005169|NCT00149747|3570056|FG000|Overall Study|Withdrawal by Subject|3
2005170|NCT00149747|3570057|FG001|Overall Study|Withdrawal by Subject|3
2005171|NCT00149825|3570077|FG000|Overall Study|Intolerance to medication side effects|1
2005172|NCT00149825|3570078|FG001|Overall Study|Intolerance to medication side effects|2
2005173|NCT00149825|3570077|FG000|Overall Study|Time commitments|2
2005174|NCT00149825|3570078|FG001|Overall Study|Time commitments|1
2005175|NCT00149825|3570077|FG000|Overall Study|Not liking insomnia therapy|1
2005176|NCT00149825|3570078|FG001|Overall Study|Not liking insomnia therapy|0
2005177|NCT00149825|3570077|FG000|Overall Study|Other|1
2005178|NCT00149825|3570078|FG001|Overall Study|Other|0
2005179|NCT00149890|3570101|FG000|Overall Study|Adverse Event|1
2005180|NCT00149890|3570102|FG001|Overall Study|Adverse Event|8
2005181|NCT00149890|3570101|FG000|Overall Study|Lack of Efficacy|8
2005182|NCT00149890|3570102|FG001|Overall Study|Lack of Efficacy|9
2005183|NCT00149890|3570101|FG000|Overall Study|Protocol Violation|1
2005184|NCT00149890|3570102|FG001|Overall Study|Protocol Violation|0
2005185|NCT00149890|3570101|FG000|Overall Study|Lost to Follow-up|1
2005186|NCT00149890|3570102|FG001|Overall Study|Lost to Follow-up|0
2005187|NCT00149890|3570101|FG000|Overall Study|Graft Loss|2
2005188|NCT00149890|3570102|FG001|Overall Study|Graft Loss|1
2005189|NCT00149994|3570110|FG000|Overall Study|Administrative problems:|1
2005190|NCT00149994|3570111|FG001|Overall Study|Administrative problems:|0
2005191|NCT00149994|3570110|FG000|Overall Study|Protocol Violation|0
2005192|NCT00149994|3570111|FG001|Overall Study|Protocol Violation|1
2005193|NCT00150345|3570119|FG000|Overall Study|Death|5
2005194|NCT00150345|3570120|FG001|Overall Study|Death|2
2005195|NCT00150345|3570119|FG000|Overall Study|Adverse Event|8
2005196|NCT00150345|3570120|FG001|Overall Study|Adverse Event|6
2005197|NCT00150345|3570119|FG000|Overall Study|Lack of Efficacy|5
2005198|NCT00150345|3570120|FG001|Overall Study|Lack of Efficacy|4
2005199|NCT00150345|3570119|FG000|Overall Study|Withdrawal by Subject|3
2005200|NCT00150345|3570120|FG001|Overall Study|Withdrawal by Subject|4
2005201|NCT00150345|3570119|FG000|Overall Study|Laboratory abnormality|1
2005202|NCT00150345|3570120|FG001|Overall Study|Laboratory abnormality|2
2005203|NCT00150345|3570119|FG000|Overall Study|Other|12
2005204|NCT00150345|3570120|FG001|Overall Study|Other|14
2005205|NCT00150462|3570138|FG000|Overall Study|Disease Progression or Relapse|3
2005206|NCT00150462|3570139|FG001|Overall Study|Disease Progression or Relapse|1
2005207|NCT00150462|3570140|FG002|Overall Study|Disease Progression or Relapse|2
2005208|NCT00150462|3570141|FG003|Overall Study|Disease Progression or Relapse|1
2005209|NCT00150462|3570142|FG004|Overall Study|Disease Progression or Relapse|2
2005210|NCT00150462|3570143|FG005|Overall Study|Disease Progression or Relapse|2
2005211|NCT00150462|3570144|FG006|Overall Study|Disease Progression or Relapse|3
2005212|NCT00150462|3570145|FG007|Overall Study|Disease Progression or Relapse|5
2005213|NCT00150462|3570146|FG008|Overall Study|Disease Progression or Relapse|5
2005214|NCT00150462|3570147|FG009|Overall Study|Disease Progression or Relapse|3
2005215|NCT00150462|3570148|FG010|Overall Study|Disease Progression or Relapse|2
2005216|NCT00150462|3570138|FG000|Overall Study|Withdrawal by Subject|0
2005217|NCT00150462|3570139|FG001|Overall Study|Withdrawal by Subject|1
2005218|NCT00150462|3570140|FG002|Overall Study|Withdrawal by Subject|1
2005219|NCT00150462|3570141|FG003|Overall Study|Withdrawal by Subject|0
2005220|NCT00150462|3570142|FG004|Overall Study|Withdrawal by Subject|1
2005221|NCT00150462|3570143|FG005|Overall Study|Withdrawal by Subject|2
2005222|NCT00150462|3570144|FG006|Overall Study|Withdrawal by Subject|0
2005223|NCT00150462|3570145|FG007|Overall Study|Withdrawal by Subject|1
2005224|NCT00150462|3570146|FG008|Overall Study|Withdrawal by Subject|0
2005225|NCT00150462|3570147|FG009|Overall Study|Withdrawal by Subject|1
2005226|NCT00150462|3570148|FG010|Overall Study|Withdrawal by Subject|0
2005227|NCT00150462|3570138|FG000|Overall Study|Death|0
2005228|NCT00150462|3570139|FG001|Overall Study|Death|1
2005229|NCT00150462|3570140|FG002|Overall Study|Death|0
2005230|NCT00150462|3570141|FG003|Overall Study|Death|0
2005231|NCT00150462|3570142|FG004|Overall Study|Death|0
2005232|NCT00150462|3570143|FG005|Overall Study|Death|0
2005233|NCT00150462|3570144|FG006|Overall Study|Death|0
2005234|NCT00150462|3570145|FG007|Overall Study|Death|0
2005235|NCT00150462|3570146|FG008|Overall Study|Death|1
2005236|NCT00150462|3570147|FG009|Overall Study|Death|0
2005237|NCT00150462|3570148|FG010|Overall Study|Death|0
2005238|NCT00150462|3570138|FG000|Overall Study|Adverse Event|0
2005239|NCT00150462|3570139|FG001|Overall Study|Adverse Event|0
2005240|NCT00150462|3570140|FG002|Overall Study|Adverse Event|0
2005241|NCT00150462|3570141|FG003|Overall Study|Adverse Event|1
2005242|NCT00150462|3570142|FG004|Overall Study|Adverse Event|0
2005243|NCT00150462|3570143|FG005|Overall Study|Adverse Event|0
2005244|NCT00150462|3570144|FG006|Overall Study|Adverse Event|0
2005245|NCT00150462|3570145|FG007|Overall Study|Adverse Event|2
2005246|NCT00150462|3570146|FG008|Overall Study|Adverse Event|0
2005247|NCT00150462|3570147|FG009|Overall Study|Adverse Event|1
2005248|NCT00150462|3570148|FG010|Overall Study|Adverse Event|0
2005249|NCT00150462|3570138|FG000|Overall Study|Physician Decision|0
2005250|NCT00150462|3570139|FG001|Overall Study|Physician Decision|0
2005251|NCT00150462|3570140|FG002|Overall Study|Physician Decision|1
2005252|NCT00150462|3570141|FG003|Overall Study|Physician Decision|1
2005253|NCT00150462|3570142|FG004|Overall Study|Physician Decision|0
2005254|NCT00150462|3570143|FG005|Overall Study|Physician Decision|0
2005255|NCT00150462|3570144|FG006|Overall Study|Physician Decision|0
2005256|NCT00150462|3570145|FG007|Overall Study|Physician Decision|0
2005257|NCT00150462|3570146|FG008|Overall Study|Physician Decision|0
2005258|NCT00150462|3570147|FG009|Overall Study|Physician Decision|0
2005259|NCT00150462|3570148|FG010|Overall Study|Physician Decision|0
2005260|NCT00150462|3570138|FG000|Overall Study|Other|0
2005261|NCT00150462|3570139|FG001|Overall Study|Other|0
2005262|NCT00150462|3570140|FG002|Overall Study|Other|0
2005263|NCT00150462|3570141|FG003|Overall Study|Other|0
2005264|NCT00150462|3570142|FG004|Overall Study|Other|0
2005265|NCT00150462|3570143|FG005|Overall Study|Other|0
2005266|NCT00150462|3570144|FG006|Overall Study|Other|0
2005267|NCT00150462|3570145|FG007|Overall Study|Other|0
2005268|NCT00150462|3570146|FG008|Overall Study|Other|0
2005269|NCT00150462|3570147|FG009|Overall Study|Other|1
2005270|NCT00150462|3570148|FG010|Overall Study|Other|1
2005271|NCT00150592|3570177|FG000|Overall Study|Adverse Event|4
2005272|NCT00150592|3570178|FG001|Overall Study|Adverse Event|1
2005273|NCT00150592|3570177|FG000|Overall Study|Protocol Violation|1
2005274|NCT00150592|3570178|FG001|Overall Study|Protocol Violation|0
2005275|NCT00150592|3570177|FG000|Overall Study|Withdrawal by Subject|1
2005276|NCT00150592|3570178|FG001|Overall Study|Withdrawal by Subject|2
2005277|NCT00150592|3570177|FG000|Overall Study|Non-compliance|1
2005278|NCT00150592|3570178|FG001|Overall Study|Non-compliance|0
2005279|NCT00150618|3570189|FG000|Overall Study|Adverse Event|2
2005280|NCT00150618|3570190|FG001|Overall Study|Adverse Event|2
2005281|NCT00150618|3570191|FG002|Overall Study|Adverse Event|6
2005282|NCT00150618|3570192|FG003|Overall Study|Adverse Event|9
2005283|NCT00150618|3570193|FG004|Overall Study|Adverse Event|5
2005284|NCT00150618|3570189|FG000|Overall Study|Withdrawal by Subject|6
2005285|NCT00150618|3570190|FG001|Overall Study|Withdrawal by Subject|8
2005286|NCT00150618|3570191|FG002|Overall Study|Withdrawal by Subject|8
2005287|NCT00150618|3570192|FG003|Overall Study|Withdrawal by Subject|4
2005288|NCT00150618|3570193|FG004|Overall Study|Withdrawal by Subject|5
2005289|NCT00150618|3570189|FG000|Overall Study|Lost to Follow-up|4
2005290|NCT00150618|3570190|FG001|Overall Study|Lost to Follow-up|1
2005291|NCT00150618|3570191|FG002|Overall Study|Lost to Follow-up|5
2005292|NCT00150618|3570192|FG003|Overall Study|Lost to Follow-up|8
2005293|NCT00150618|3570193|FG004|Overall Study|Lost to Follow-up|4
2005294|NCT00150618|3570189|FG000|Overall Study|Protocol Violation|1
2005295|NCT00150618|3570190|FG001|Overall Study|Protocol Violation|0
2005296|NCT00150618|3570191|FG002|Overall Study|Protocol Violation|0
2005297|NCT00150618|3570192|FG003|Overall Study|Protocol Violation|0
2005298|NCT00150618|3570193|FG004|Overall Study|Protocol Violation|1
2005299|NCT00150618|3570189|FG000|Overall Study|Lack of Efficacy|1
2005300|NCT00150618|3570190|FG001|Overall Study|Lack of Efficacy|4
2005301|NCT00150618|3570191|FG002|Overall Study|Lack of Efficacy|7
2005302|NCT00150618|3570192|FG003|Overall Study|Lack of Efficacy|4
2005303|NCT00150618|3570193|FG004|Overall Study|Lack of Efficacy|6
2005304|NCT00150618|3570189|FG000|Overall Study|No study meds|0
2005305|NCT00150618|3570190|FG001|Overall Study|No study meds|0
2005306|NCT00150618|3570191|FG002|Overall Study|No study meds|0
2005307|NCT00150618|3570192|FG003|Overall Study|No study meds|0
2005308|NCT00150618|3570193|FG004|Overall Study|No study meds|2
2005309|NCT00150618|3570189|FG000|Overall Study|Physician Decision|0
2005310|NCT00150618|3570190|FG001|Overall Study|Physician Decision|2
2005311|NCT00150618|3570191|FG002|Overall Study|Physician Decision|0
2005312|NCT00150618|3570192|FG003|Overall Study|Physician Decision|0
2005313|NCT00150618|3570193|FG004|Overall Study|Physician Decision|1
2005314|NCT00150618|3570189|FG000|Overall Study|Lack of compliance|2
2005315|NCT00150618|3570190|FG001|Overall Study|Lack of compliance|1
2005316|NCT00150618|3570191|FG002|Overall Study|Lack of compliance|1
2005317|NCT00150618|3570192|FG003|Overall Study|Lack of compliance|0
2005318|NCT00150618|3570193|FG004|Overall Study|Lack of compliance|1
2005319|NCT00150618|3570189|FG000|Overall Study|Abnormal ECG|1
2005320|NCT00150618|3570190|FG001|Overall Study|Abnormal ECG|0
2005321|NCT00150618|3570191|FG002|Overall Study|Abnormal ECG|0
2005322|NCT00150618|3570192|FG003|Overall Study|Abnormal ECG|0
2005323|NCT00150618|3570193|FG004|Overall Study|Abnormal ECG|0
2005324|NCT00150618|3570189|FG000|Overall Study|Sponsor's decision|0
2005325|NCT00150618|3570190|FG001|Overall Study|Sponsor's decision|0
2005326|NCT00150618|3570191|FG002|Overall Study|Sponsor's decision|0
2005327|NCT00150618|3570192|FG003|Overall Study|Sponsor's decision|1
2005328|NCT00150618|3570193|FG004|Overall Study|Sponsor's decision|0
2005329|NCT00150800|3570205|FG000|Overall Study|Adverse Event|89
2005330|NCT00150800|3570205|FG000|Overall Study|Death|18
2005331|NCT00150800|3570205|FG000|Overall Study|Lack of Efficacy|166
2005332|NCT00150800|3570205|FG000|Overall Study|Lost to Follow-up|58
2005333|NCT00150800|3570205|FG000|Overall Study|Subject's choice|90
2005334|NCT00150800|3570205|FG000|Overall Study|No compliance|18
2005335|NCT00150800|3570205|FG000|Overall Study|IP misshandling|1
2005336|NCT00150800|3570205|FG000|Overall Study|Site closure|24
2005337|NCT00150800|3570205|FG000|Overall Study|Protocol non-adherence|2
2005338|NCT00150800|3570205|FG000|Overall Study|Nobody to accompany patient|1
2005339|NCT00150800|3570205|FG000|Overall Study|Distance too long for patient|1
2005340|NCT00150800|3570205|FG000|Overall Study|Neurosurgery|2
2005341|NCT00150800|3570205|FG000|Overall Study|BRV monotherapy|1
2005342|NCT00150800|3570205|FG000|Overall Study|Visit refusal|3
2005343|NCT00150800|3570205|FG000|Overall Study|Sponsor's request|2
2005344|NCT00150800|3570205|FG000|Overall Study|Generalized Epilepsy|1
2005345|NCT00150800|3570205|FG000|Overall Study|Moved from area/country|8
2005346|NCT00150800|3570205|FG000|Overall Study|PI retiring|2
2005347|NCT00150800|3570205|FG000|Overall Study|PI leaving site|2
2005348|NCT00150800|3570205|FG000|Overall Study|Patient insurance|1
2005349|NCT00150800|3570205|FG000|Overall Study|Surgical intervention|4
2005350|NCT00150800|3570205|FG000|Overall Study|Pregnancy planned|1
2005351|NCT00150800|3570205|FG000|Overall Study|PI discontinuation request|1
2005352|NCT00150813|3570210|FG000|Overall Study|Adverse Event|1
2005353|NCT00150813|3570210|FG000|Overall Study|Lack of Efficacy|1
2005354|NCT00150813|3570210|FG000|Overall Study|Lost to Follow-up|5
2005355|NCT00150813|3570210|FG000|Overall Study|Withdrawal by Subject|5
2005356|NCT00150813|3570210|FG000|Overall Study|Remission|3
2005357|NCT00150813|3570210|FG000|Overall Study|Planned pregancy|1
2005358|NCT00150813|3570210|FG000|Overall Study|Switch to commercially available LEV|2
2025178|NCT00340834|3593763|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0
2025179|NCT00340834|3593764|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13
2025180|NCT00340834|3593765|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4
2025181|NCT00340834|3593761|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13
2025182|NCT00340834|3593762|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7
2025183|NCT00340834|3593763|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0
2025184|NCT00340834|3593764|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4
2025185|NCT00340834|3593765|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9
2025186|NCT00340834|3593761|FG000|Extension Phase of Study|Lost to Follow-up|1
2025187|NCT00340834|3593762|FG001|Extension Phase of Study|Lost to Follow-up|1
2025188|NCT00340834|3593763|FG002|Extension Phase of Study|Lost to Follow-up|0
2025189|NCT00340834|3593764|FG003|Extension Phase of Study|Lost to Follow-up|2
2025190|NCT00340834|3593765|FG004|Extension Phase of Study|Lost to Follow-up|3
2025191|NCT00340834|3593761|FG000|Extension Phase of Study|Subject no longer requires study drug|4
2025192|NCT00340834|3593762|FG001|Extension Phase of Study|Subject no longer requires study drug|0
2025193|NCT00340834|3593763|FG002|Extension Phase of Study|Subject no longer requires study drug|0
2025194|NCT00340834|3593764|FG003|Extension Phase of Study|Subject no longer requires study drug|0
2025195|NCT00340834|3593765|FG004|Extension Phase of Study|Subject no longer requires study drug|2
2025196|NCT00340834|3593761|FG000|Extension Phase of Study|Administrative problems|3
2025197|NCT00340834|3593762|FG001|Extension Phase of Study|Administrative problems|0
2025198|NCT00340834|3593763|FG002|Extension Phase of Study|Administrative problems|0
2025199|NCT00340834|3593764|FG003|Extension Phase of Study|Administrative problems|1
2025200|NCT00340834|3593765|FG004|Extension Phase of Study|Administrative problems|1
2025201|NCT00340834|3593761|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0
2025202|NCT00340834|3593762|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1
2025203|NCT00340834|3593763|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0
2025204|NCT00340834|3593764|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0
2025205|NCT00340834|3593765|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2
2025206|NCT00340834|3593761|FG000|Extension Phase of Study|Protocol Violation|3
2025207|NCT00340834|3593762|FG001|Extension Phase of Study|Protocol Violation|0
2025208|NCT00340834|3593763|FG002|Extension Phase of Study|Protocol Violation|0
2025209|NCT00340834|3593764|FG003|Extension Phase of Study|Protocol Violation|0
2005359|NCT00150969|3570216|FG000|24 Month Main Study|Adverse Event|3
2005360|NCT00150969|3570217|FG001|24 Month Main Study|Adverse Event|4
2005361|NCT00150969|3570216|FG000|24 Month Main Study|Death|1
2005362|NCT00150969|3570217|FG001|24 Month Main Study|Death|1
2005363|NCT00150969|3570216|FG000|24 Month Main Study|Lack of Efficacy|1
2005364|NCT00150969|3570217|FG001|24 Month Main Study|Lack of Efficacy|8
2005365|NCT00150969|3570216|FG000|24 Month Main Study|Lost to Follow-up|3
2005366|NCT00150969|3570217|FG001|24 Month Main Study|Lost to Follow-up|2
2005367|NCT00150969|3570216|FG000|24 Month Main Study|Protocol Violation|4
2005368|NCT00150969|3570217|FG001|24 Month Main Study|Protocol Violation|2
2005369|NCT00150969|3570216|FG000|24 Month Main Study|Withdrawal by Subject|7
2005370|NCT00150969|3570217|FG001|24 Month Main Study|Withdrawal by Subject|4
2005371|NCT00150969|3570216|FG000|24-48 Month Extension|Withdrawal by Subject|6
2005372|NCT00150969|3570217|FG001|24-48 Month Extension|Withdrawal by Subject|5
2005373|NCT00150969|3570216|FG000|24-48 Month Extension|Lack of Efficacy|0
2005374|NCT00150969|3570217|FG001|24-48 Month Extension|Lack of Efficacy|1
2005375|NCT00150969|3570216|FG000|24-48 Month Extension|Adverse Event|1
2005376|NCT00150969|3570217|FG001|24-48 Month Extension|Adverse Event|3
2005377|NCT00150969|3570216|FG000|24-48 Month Extension|Other Reason|81
2005378|NCT00150969|3570217|FG001|24-48 Month Extension|Other Reason|91
2005379|NCT00151281|3570224|FG000|Overall Study|Not evaluable|3
2005380|NCT00151372|3570238|FG000|Overall Study|Death|12
2005381|NCT00151372|3570239|FG001|Overall Study|Death|11
2005382|NCT00151372|3570238|FG000|Overall Study|Lost to Follow-up|5
2005383|NCT00151372|3570239|FG001|Overall Study|Lost to Follow-up|5
2005384|NCT00151372|3570238|FG000|Overall Study|Too sick medically to continue|5
2005385|NCT00151372|3570239|FG001|Overall Study|Too sick medically to continue|6
2005386|NCT00151372|3570238|FG000|Overall Study|Withdrawal by Subject|7
2005387|NCT00151372|3570239|FG001|Overall Study|Withdrawal by Subject|7
2005388|NCT00151411|3570247|FG000|Overall Study|Lost to Follow-up|15
2005389|NCT00151411|3570248|FG001|Overall Study|Lost to Follow-up|19
2005390|NCT00151411|3570247|FG000|Overall Study|Withdrawal by Subject|12
2005391|NCT00151411|3570248|FG001|Overall Study|Withdrawal by Subject|20
2005392|NCT00151411|3570247|FG000|Overall Study|Adverse Event|6
2005393|NCT00151411|3570248|FG001|Overall Study|Adverse Event|0
2005394|NCT00151411|3570247|FG000|Overall Study|Pregnancy|0
2005395|NCT00151411|3570248|FG001|Overall Study|Pregnancy|4
2005396|NCT00151476|3570257|FG000|FAP Identified Subjects|Protocol Violation|0
2005397|NCT00151476|3570258|FG001|FAP Identified Subjects|Protocol Violation|1
2005398|NCT00151476|3570257|FG000|FAP Analyzed Subjects|Lost to Follow-up|0
2005399|NCT00151476|3570258|FG001|FAP Analyzed Subjects|Lost to Follow-up|2
2005400|NCT00151476|3570257|FG000|FAP Analyzed Subjects|Other study participation|0
2005401|NCT00151476|3570258|FG001|FAP Analyzed Subjects|Other study participation|1
2005402|NCT00151775|3570270|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1
2005403|NCT00151775|3570271|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2
2005404|NCT00151775|3570272|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0
2005405|NCT00151775|3570273|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0
2005406|NCT00151775|3570274|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0
2005407|NCT00151775|3570275|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0
2005408|NCT00151775|3570276|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0
2005409|NCT00151775|3570277|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0
2005410|NCT00151775|3570278|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0
2005411|NCT00151775|3570279|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0
2005412|NCT00151775|3570280|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0
2005413|NCT00151775|3570281|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0
2005414|NCT00151775|3570270|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
2005415|NCT00151775|3570271|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2005416|NCT00151775|3570272|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2005417|NCT00151775|3570273|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2005418|NCT00151775|3570274|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2005419|NCT00151775|3570275|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2005420|NCT00151775|3570276|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
2005421|NCT00151775|3570277|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2005422|NCT00151775|3570278|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2005423|NCT00151775|3570279|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2005424|NCT00151775|3570280|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
2005425|NCT00151775|3570281|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2214252|NCT01685983|3856426|FG000|Overall Study|Withdrawal by Subject|19
2005426|NCT00151775|3570270|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2005427|NCT00151775|3570271|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4
2005428|NCT00151775|3570272|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2005429|NCT00151775|3570273|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2005430|NCT00151775|3570274|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2005431|NCT00151775|3570275|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2005432|NCT00151775|3570276|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2005433|NCT00151775|3570277|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2025992|NCT00348140|3594698|FG001|Overall Study|Efficacy related|1
2005434|NCT00151775|3570278|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2005435|NCT00151775|3570279|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2005436|NCT00151775|3570280|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2005437|NCT00151775|3570281|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2005438|NCT00151775|3570270|FG000|Period 2 - Double-Blind Dose Response|Other|0
2005439|NCT00151775|3570271|FG001|Period 2 - Double-Blind Dose Response|Other|0
2005440|NCT00151775|3570272|FG002|Period 2 - Double-Blind Dose Response|Other|0
2005441|NCT00151775|3570273|FG003|Period 2 - Double-Blind Dose Response|Other|0
2005442|NCT00151775|3570274|FG004|Period 2 - Double-Blind Dose Response|Other|0
2005443|NCT00151775|3570275|FG005|Period 2 - Double-Blind Dose Response|Other|0
2005444|NCT00151775|3570276|FG006|Period 2 - Double-Blind Dose Response|Other|1
2005445|NCT00151775|3570277|FG007|Period 2 - Double-Blind Dose Response|Other|0
2005446|NCT00151775|3570278|FG008|Period 2 - Double-Blind Dose Response|Other|0
2005447|NCT00151775|3570279|FG009|Period 2 - Double-Blind Dose Response|Other|0
2005448|NCT00151775|3570280|FG010|Period 2 - Double-Blind Dose Response|Other|0
2005449|NCT00151775|3570281|FG011|Period 2 - Double-Blind Dose Response|Other|0
2005450|NCT00151775|3570270|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0
2005451|NCT00151775|3570271|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0
2005452|NCT00151775|3570272|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0
2005453|NCT00151775|3570273|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0
2005454|NCT00151775|3570274|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0
2005455|NCT00151775|3570275|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1
2005456|NCT00151775|3570276|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0
2005457|NCT00151775|3570277|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0
2005458|NCT00151775|3570278|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0
2005459|NCT00151775|3570279|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0
2005460|NCT00151775|3570280|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0
2005461|NCT00151775|3570281|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0
2005462|NCT00151775|3570270|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0
2005463|NCT00151775|3570271|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0
2005464|NCT00151775|3570272|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0
2005465|NCT00151775|3570273|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0
2005466|NCT00151775|3570274|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0
2005467|NCT00151775|3570275|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1
2005468|NCT00151775|3570276|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0
2005469|NCT00151775|3570277|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0
2005470|NCT00151775|3570278|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0
2005471|NCT00151775|3570279|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0
2005472|NCT00151775|3570280|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0
2005473|NCT00151775|3570281|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0
2005474|NCT00151775|3570270|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2005475|NCT00151775|3570271|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2005476|NCT00151775|3570272|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2005477|NCT00151775|3570273|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2005478|NCT00151775|3570274|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2005479|NCT00151775|3570275|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2005480|NCT00151775|3570276|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
2005481|NCT00151775|3570277|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2005482|NCT00151775|3570278|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2005483|NCT00151775|3570279|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2005484|NCT00151775|3570280|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2005485|NCT00151775|3570281|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2005486|NCT00151775|3570270|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2005487|NCT00151775|3570271|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2005488|NCT00151775|3570272|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2005489|NCT00151775|3570273|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2005490|NCT00151775|3570274|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2005491|NCT00151775|3570275|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
2005492|NCT00151775|3570276|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2005493|NCT00151775|3570277|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2005494|NCT00151775|3570278|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2005495|NCT00151775|3570279|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2005496|NCT00151775|3570280|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2005497|NCT00151775|3570281|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2005498|NCT00151775|3570270|FG000|Period 3: Double-blind, Withdrawal|Other|0
2005499|NCT00151775|3570271|FG001|Period 3: Double-blind, Withdrawal|Other|0
2005500|NCT00151775|3570272|FG002|Period 3: Double-blind, Withdrawal|Other|1
2005501|NCT00151775|3570273|FG003|Period 3: Double-blind, Withdrawal|Other|0
2005502|NCT00151775|3570274|FG004|Period 3: Double-blind, Withdrawal|Other|0
2005503|NCT00151775|3570275|FG005|Period 3: Double-blind, Withdrawal|Other|0
2005504|NCT00151775|3570276|FG006|Period 3: Double-blind, Withdrawal|Other|0
2005505|NCT00151775|3570277|FG007|Period 3: Double-blind, Withdrawal|Other|1
2005506|NCT00151775|3570278|FG008|Period 3: Double-blind, Withdrawal|Other|0
2214253|NCT01685983|3856426|FG000|Overall Study|Protocol Violation|2
2005507|NCT00151775|3570279|FG009|Period 3: Double-blind, Withdrawal|Other|0
2005508|NCT00151775|3570280|FG010|Period 3: Double-blind, Withdrawal|Other|0
2005509|NCT00151775|3570281|FG011|Period 3: Double-blind, Withdrawal|Other|0
2005510|NCT00151775|3570270|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2005511|NCT00151775|3570271|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2005512|NCT00151775|3570272|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2005513|NCT00151775|3570273|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2005514|NCT00151775|3570274|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2005515|NCT00151775|3570275|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2005516|NCT00151775|3570276|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
2005517|NCT00151775|3570277|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2005518|NCT00151775|3570278|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2005519|NCT00151775|3570279|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2005520|NCT00151775|3570280|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2005521|NCT00151775|3570281|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2005522|NCT00151775|3570270|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0
2005523|NCT00151775|3570271|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0
2005524|NCT00151775|3570272|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1
2005525|NCT00151775|3570273|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0
2005526|NCT00151775|3570274|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0
2005527|NCT00151775|3570275|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0
2005528|NCT00151775|3570276|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0
2005529|NCT00151775|3570277|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0
2005530|NCT00151775|3570278|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0
2005531|NCT00151775|3570279|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0
2005532|NCT00151775|3570280|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0
2005533|NCT00151775|3570281|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0
2005534|NCT00151775|3570270|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2005535|NCT00151775|3570271|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2005536|NCT00151775|3570272|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1
2005537|NCT00151775|3570273|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2005538|NCT00151775|3570274|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2005539|NCT00151775|3570275|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2005540|NCT00151775|3570276|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2005541|NCT00151775|3570277|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2005542|NCT00151775|3570278|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2005543|NCT00151775|3570279|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2005544|NCT00151775|3570280|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2005545|NCT00151775|3570281|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2005546|NCT00151775|3570270|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2005547|NCT00151775|3570271|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2005548|NCT00151775|3570272|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2214254|NCT01685983|3856426|FG000|Overall Study|Physician Decision|13
2214255|NCT01685983|3856426|FG000|Overall Study|Other|7
2214256|NCT01685983|3856426|FG000|Overall Study|Progressive Disease|32
2214257|NCT01685983|3856426|FG000|Overall Study|Noncompliance with Study Drug|1
2214258|NCT01686152|3856442|FG000|Overall Study|Withdrawal by Subject|11
2214259|NCT01686152|3856443|FG001|Overall Study|Withdrawal by Subject|11
2214260|NCT01686152|3856444|FG002|Overall Study|Withdrawal by Subject|3
2005549|NCT00151775|3570273|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2005550|NCT00151775|3570274|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2005551|NCT00151775|3570275|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2005552|NCT00151775|3570276|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2005553|NCT00151775|3570277|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2005554|NCT00151775|3570278|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2005555|NCT00151775|3570279|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2005556|NCT00151775|3570280|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2005557|NCT00151775|3570281|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
2005558|NCT00151775|3570270|FG000|Period 4: Open Label|Increased blood pressure|0
2005559|NCT00151775|3570271|FG001|Period 4: Open Label|Increased blood pressure|0
2005560|NCT00151775|3570272|FG002|Period 4: Open Label|Increased blood pressure|0
2005561|NCT00151775|3570273|FG003|Period 4: Open Label|Increased blood pressure|0
2005562|NCT00151775|3570274|FG004|Period 4: Open Label|Increased blood pressure|1
2005563|NCT00151775|3570275|FG005|Period 4: Open Label|Increased blood pressure|0
2005564|NCT00151775|3570276|FG006|Period 4: Open Label|Increased blood pressure|0
2005565|NCT00151775|3570277|FG007|Period 4: Open Label|Increased blood pressure|0
2005566|NCT00151775|3570278|FG008|Period 4: Open Label|Increased blood pressure|0
2005567|NCT00151775|3570279|FG009|Period 4: Open Label|Increased blood pressure|1
2005568|NCT00151775|3570280|FG010|Period 4: Open Label|Increased blood pressure|0
2005569|NCT00151775|3570281|FG011|Period 4: Open Label|Increased blood pressure|0
2005570|NCT00151775|3570270|FG000|Period 4: Open Label|Withdrawal by Subject|0
2005571|NCT00151775|3570271|FG001|Period 4: Open Label|Withdrawal by Subject|0
2005572|NCT00151775|3570272|FG002|Period 4: Open Label|Withdrawal by Subject|0
2005573|NCT00151775|3570273|FG003|Period 4: Open Label|Withdrawal by Subject|0
2005574|NCT00151775|3570274|FG004|Period 4: Open Label|Withdrawal by Subject|5
2005575|NCT00151775|3570275|FG005|Period 4: Open Label|Withdrawal by Subject|0
2005576|NCT00151775|3570276|FG006|Period 4: Open Label|Withdrawal by Subject|0
2005577|NCT00151775|3570277|FG007|Period 4: Open Label|Withdrawal by Subject|0
2005578|NCT00151775|3570278|FG008|Period 4: Open Label|Withdrawal by Subject|0
2005579|NCT00151775|3570279|FG009|Period 4: Open Label|Withdrawal by Subject|2
2005580|NCT00151775|3570280|FG010|Period 4: Open Label|Withdrawal by Subject|0
2005581|NCT00151775|3570281|FG011|Period 4: Open Label|Withdrawal by Subject|0
2005582|NCT00151775|3570270|FG000|Period 4: Open Label|Adverse Event|0
2005583|NCT00151775|3570271|FG001|Period 4: Open Label|Adverse Event|0
2005584|NCT00151775|3570272|FG002|Period 4: Open Label|Adverse Event|0
2005585|NCT00151775|3570273|FG003|Period 4: Open Label|Adverse Event|0
2005586|NCT00151775|3570274|FG004|Period 4: Open Label|Adverse Event|1
2005587|NCT00151775|3570275|FG005|Period 4: Open Label|Adverse Event|0
2005588|NCT00151775|3570276|FG006|Period 4: Open Label|Adverse Event|0
2005589|NCT00151775|3570277|FG007|Period 4: Open Label|Adverse Event|0
2005590|NCT00151775|3570278|FG008|Period 4: Open Label|Adverse Event|0
2005591|NCT00151775|3570279|FG009|Period 4: Open Label|Adverse Event|2
2005592|NCT00151775|3570280|FG010|Period 4: Open Label|Adverse Event|0
2005593|NCT00151775|3570281|FG011|Period 4: Open Label|Adverse Event|0
2005594|NCT00151775|3570270|FG000|Period 4: Open Label|Lost to Follow-up|0
2005595|NCT00151775|3570271|FG001|Period 4: Open Label|Lost to Follow-up|0
2005596|NCT00151775|3570272|FG002|Period 4: Open Label|Lost to Follow-up|0
2005597|NCT00151775|3570273|FG003|Period 4: Open Label|Lost to Follow-up|0
2005598|NCT00151775|3570274|FG004|Period 4: Open Label|Lost to Follow-up|17
2005599|NCT00151775|3570275|FG005|Period 4: Open Label|Lost to Follow-up|0
2005600|NCT00151775|3570276|FG006|Period 4: Open Label|Lost to Follow-up|0
2005601|NCT00151775|3570277|FG007|Period 4: Open Label|Lost to Follow-up|0
2005602|NCT00151775|3570278|FG008|Period 4: Open Label|Lost to Follow-up|0
2005603|NCT00151775|3570279|FG009|Period 4: Open Label|Lost to Follow-up|7
2005604|NCT00151775|3570280|FG010|Period 4: Open Label|Lost to Follow-up|0
2005605|NCT00151775|3570281|FG011|Period 4: Open Label|Lost to Follow-up|0
2005606|NCT00151775|3570270|FG000|Period 4: Open Label|Non-compliance with protocol|0
2005607|NCT00151775|3570271|FG001|Period 4: Open Label|Non-compliance with protocol|0
2005608|NCT00151775|3570272|FG002|Period 4: Open Label|Non-compliance with protocol|0
2005609|NCT00151775|3570273|FG003|Period 4: Open Label|Non-compliance with protocol|0
2005610|NCT00151775|3570274|FG004|Period 4: Open Label|Non-compliance with protocol|4
2005611|NCT00151775|3570275|FG005|Period 4: Open Label|Non-compliance with protocol|0
2005612|NCT00151775|3570276|FG006|Period 4: Open Label|Non-compliance with protocol|0
2005613|NCT00151775|3570277|FG007|Period 4: Open Label|Non-compliance with protocol|0
2005614|NCT00151775|3570278|FG008|Period 4: Open Label|Non-compliance with protocol|0
2005615|NCT00151775|3570279|FG009|Period 4: Open Label|Non-compliance with protocol|4
2005616|NCT00151775|3570280|FG010|Period 4: Open Label|Non-compliance with protocol|0
2005617|NCT00151775|3570281|FG011|Period 4: Open Label|Non-compliance with protocol|0
2005618|NCT00151775|3570270|FG000|Period 4: Open Label|Other|0
2005619|NCT00151775|3570271|FG001|Period 4: Open Label|Other|0
2005620|NCT00151775|3570272|FG002|Period 4: Open Label|Other|0
2005621|NCT00151775|3570273|FG003|Period 4: Open Label|Other|0
2005622|NCT00151775|3570274|FG004|Period 4: Open Label|Other|1
2005623|NCT00151775|3570275|FG005|Period 4: Open Label|Other|0
2005624|NCT00151775|3570276|FG006|Period 4: Open Label|Other|0
2005625|NCT00151775|3570277|FG007|Period 4: Open Label|Other|0
2005626|NCT00151775|3570278|FG008|Period 4: Open Label|Other|0
2005627|NCT00151775|3570279|FG009|Period 4: Open Label|Other|3
2005628|NCT00151775|3570280|FG010|Period 4: Open Label|Other|0
2005629|NCT00151775|3570281|FG011|Period 4: Open Label|Other|0
2005630|NCT00151775|3570270|FG000|Period 4: Open Label|Physician Decision|0
2005631|NCT00151775|3570271|FG001|Period 4: Open Label|Physician Decision|0
2005632|NCT00151775|3570272|FG002|Period 4: Open Label|Physician Decision|0
2005633|NCT00151775|3570273|FG003|Period 4: Open Label|Physician Decision|0
2005634|NCT00151775|3570274|FG004|Period 4: Open Label|Physician Decision|0
2005635|NCT00151775|3570275|FG005|Period 4: Open Label|Physician Decision|0
2005636|NCT00151775|3570276|FG006|Period 4: Open Label|Physician Decision|0
2005637|NCT00151775|3570277|FG007|Period 4: Open Label|Physician Decision|0
2005638|NCT00151775|3570278|FG008|Period 4: Open Label|Physician Decision|0
2005639|NCT00151775|3570279|FG009|Period 4: Open Label|Physician Decision|2
2005640|NCT00151775|3570280|FG010|Period 4: Open Label|Physician Decision|0
2005641|NCT00151775|3570281|FG011|Period 4: Open Label|Physician Decision|0
2005642|NCT00151775|3570270|FG000|Period 4: Open Label|Protocol Violation|0
2005643|NCT00151775|3570271|FG001|Period 4: Open Label|Protocol Violation|0
2005644|NCT00151775|3570272|FG002|Period 4: Open Label|Protocol Violation|0
2005645|NCT00151775|3570273|FG003|Period 4: Open Label|Protocol Violation|0
2005646|NCT00151775|3570274|FG004|Period 4: Open Label|Protocol Violation|1
2005647|NCT00151775|3570275|FG005|Period 4: Open Label|Protocol Violation|0
2005648|NCT00151775|3570276|FG006|Period 4: Open Label|Protocol Violation|0
2005649|NCT00151775|3570277|FG007|Period 4: Open Label|Protocol Violation|0
2005650|NCT00151775|3570278|FG008|Period 4: Open Label|Protocol Violation|0
2005651|NCT00151775|3570279|FG009|Period 4: Open Label|Protocol Violation|0
2005652|NCT00151775|3570280|FG010|Period 4: Open Label|Protocol Violation|0
2005653|NCT00151775|3570281|FG011|Period 4: Open Label|Protocol Violation|0
2005654|NCT00151892|3570336|FG000|Overall Study|Lack of Efficacy|50
2005655|NCT00151892|3570337|FG001|Overall Study|Lack of Efficacy|57
2005656|NCT00151892|3570336|FG000|Overall Study|Patient request|10
2005657|NCT00151892|3570337|FG001|Overall Study|Patient request|7
2005658|NCT00151892|3570336|FG000|Overall Study|Lost to Follow-up|5
2005659|NCT00151892|3570337|FG001|Overall Study|Lost to Follow-up|10
2005660|NCT00151892|3570336|FG000|Overall Study|Adverse Event|6
2005661|NCT00151892|3570337|FG001|Overall Study|Adverse Event|3
2005662|NCT00151892|3570336|FG000|Overall Study|Protocol Violation|3
2005663|NCT00151892|3570337|FG001|Overall Study|Protocol Violation|3
2005664|NCT00151892|3570336|FG000|Overall Study|Non-compliance|0
2005665|NCT00151892|3570337|FG001|Overall Study|Non-compliance|1
2005666|NCT00151892|3570336|FG000|Overall Study|Pregnancy|0
2005667|NCT00151892|3570337|FG001|Overall Study|Pregnancy|1
2005668|NCT00151892|3570336|FG000|Overall Study|Did not return for a visit|1
2005669|NCT00151892|3570337|FG001|Overall Study|Did not return for a visit|0
2005670|NCT00151892|3570336|FG000|Overall Study|Used prohibited corticosteroids|1
2005671|NCT00151892|3570337|FG001|Overall Study|Used prohibited corticosteroids|0
2005672|NCT00151892|3570336|FG000|Overall Study|Lack of study medication at center|0
2005673|NCT00151892|3570337|FG001|Overall Study|Lack of study medication at center|1
2005674|NCT00151996|3570345|FG000|Overall Study|Adverse Event|3
2005675|NCT00151996|3570346|FG001|Overall Study|Adverse Event|2
2005676|NCT00151996|3570345|FG000|Overall Study|Withdrawal by Subject|1
2005677|NCT00151996|3570346|FG001|Overall Study|Withdrawal by Subject|1
2005678|NCT00151996|3570345|FG000|Overall Study|Protocol Violation|1
2005679|NCT00151996|3570346|FG001|Overall Study|Protocol Violation|2
2005680|NCT00151996|3570345|FG000|Overall Study|Sponsor's decision|0
2005681|NCT00151996|3570346|FG001|Overall Study|Sponsor's decision|2
2005682|NCT00152009|3570356|FG000|Overall Study|Adverse Event|9
2005683|NCT00152009|3570357|FG001|Overall Study|Adverse Event|13
2005684|NCT00152009|3570358|FG002|Overall Study|Adverse Event|20
2005685|NCT00152009|3570359|FG003|Overall Study|Adverse Event|1
2005686|NCT00152009|3570356|FG000|Overall Study|Protocol Violation|3
2005687|NCT00152009|3570357|FG001|Overall Study|Protocol Violation|0
2005688|NCT00152009|3570358|FG002|Overall Study|Protocol Violation|0
2005689|NCT00152009|3570359|FG003|Overall Study|Protocol Violation|1
2005690|NCT00152009|3570356|FG000|Overall Study|Withdrawal by Subject|2
2005691|NCT00152009|3570357|FG001|Overall Study|Withdrawal by Subject|3
2005692|NCT00152009|3570358|FG002|Overall Study|Withdrawal by Subject|4
2005693|NCT00152009|3570359|FG003|Overall Study|Withdrawal by Subject|9
2005694|NCT00152009|3570356|FG000|Overall Study|Lost to Follow-up|2
2005695|NCT00152009|3570357|FG001|Overall Study|Lost to Follow-up|4
2005696|NCT00152009|3570358|FG002|Overall Study|Lost to Follow-up|3
2005697|NCT00152009|3570359|FG003|Overall Study|Lost to Follow-up|3
2005698|NCT00152009|3570356|FG000|Overall Study|Lack of Efficacy|8
2005699|NCT00152009|3570357|FG001|Overall Study|Lack of Efficacy|6
2005700|NCT00152009|3570358|FG002|Overall Study|Lack of Efficacy|7
2005701|NCT00152009|3570359|FG003|Overall Study|Lack of Efficacy|15
2005702|NCT00152009|3570356|FG000|Overall Study|ECG abnormalities|2
2005703|NCT00152009|3570357|FG001|Overall Study|ECG abnormalities|2
2005704|NCT00152009|3570358|FG002|Overall Study|ECG abnormalities|2
2005705|NCT00152009|3570359|FG003|Overall Study|ECG abnormalities|1
2005706|NCT00152009|3570356|FG000|Overall Study|Sponsor's decision|3
2005707|NCT00152009|3570357|FG001|Overall Study|Sponsor's decision|3
2005708|NCT00152009|3570358|FG002|Overall Study|Sponsor's decision|1
2005709|NCT00152009|3570359|FG003|Overall Study|Sponsor's decision|3
2005710|NCT00152464|3570371|FG000|Overall Study|Adverse Event|3
2005711|NCT00152464|3570372|FG001|Overall Study|Adverse Event|6
2005712|NCT00152464|3570371|FG000|Overall Study|Lost to Follow-up|8
2005713|NCT00152464|3570372|FG001|Overall Study|Lost to Follow-up|4
2005714|NCT00152464|3570371|FG000|Overall Study|Protocol Violation|3
2005715|NCT00152464|3570372|FG001|Overall Study|Protocol Violation|1
2005716|NCT00152464|3570371|FG000|Overall Study|Withdrawal by Subject|21
2005717|NCT00152464|3570372|FG001|Overall Study|Withdrawal by Subject|22
2005718|NCT00152464|3570371|FG000|Overall Study|Atopic dermatitis poorly controlled|0
2005719|NCT00152464|3570372|FG001|Overall Study|Atopic dermatitis poorly controlled|1
2005720|NCT00152464|3570371|FG000|Overall Study|Eczema deterioration|0
2005721|NCT00152464|3570372|FG001|Overall Study|Eczema deterioration|1
2005722|NCT00152464|3570371|FG000|Overall Study|Parent decision|1
2005723|NCT00152464|3570372|FG001|Overall Study|Parent decision|1
2005724|NCT00152464|3570371|FG000|Overall Study|Investigator decision|1
2005725|NCT00152464|3570372|FG001|Overall Study|Investigator decision|0
2005726|NCT00152464|3570371|FG000|Overall Study|Lack of Efficacy|1
2005727|NCT00152464|3570372|FG001|Overall Study|Lack of Efficacy|0
2005728|NCT00152464|3570371|FG000|Overall Study|Eczema poorly controlled|1
2005729|NCT00152464|3570372|FG001|Overall Study|Eczema poorly controlled|0
2005730|NCT00152464|3570371|FG000|Overall Study|Patient relocated|1
2005731|NCT00152464|3570372|FG001|Overall Study|Patient relocated|0
2005732|NCT00152516|3570378|FG000|Overall Study|Adverse Event|18
2005733|NCT00152516|3570378|FG000|Overall Study|Lack and Loss of Efficacy|30
2005734|NCT00152516|3570378|FG000|Overall Study|Lost to Follow-up|5
2005735|NCT00152516|3570378|FG000|Overall Study|Withdrawal by Subject|8
2005736|NCT00152516|3570378|FG000|Overall Study|Protocol Violation|3
2005737|NCT00152516|3570378|FG000|Overall Study|Other: Mother Refused To Cooperate|1
2005738|NCT00152516|3570378|FG000|Overall Study|Other: Given Commercial Drug in Error|2
2005739|NCT00152516|3570378|FG000|Overall Study|Other: Parents Withdrew Consent|2
2005740|NCT00152516|3570378|FG000|Overall Study|Other: Non-Compliance|2
2005741|NCT00152516|3570378|FG000|Overall Study|Other: Primary Care Physician's Decision|1
2005742|NCT00152516|3570378|FG000|Overall Study|Other: Moved Out Of State|1
2005743|NCT00152516|3570378|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1
2005744|NCT00152516|3570378|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
2005745|NCT00152763|3570386|FG000|Overall Study|Death|4
2005746|NCT00152763|3570387|FG001|Overall Study|Death|1
2005747|NCT00152763|3570388|FG002|Overall Study|Death|2
2005748|NCT00152763|3570389|FG003|Overall Study|Death|1
2005749|NCT00152763|3570386|FG000|Overall Study|Lost to Follow-up|6
2005750|NCT00152763|3570387|FG001|Overall Study|Lost to Follow-up|4
2005751|NCT00152763|3570388|FG002|Overall Study|Lost to Follow-up|2
2005752|NCT00152763|3570389|FG003|Overall Study|Lost to Follow-up|13
2005753|NCT00152971|3570404|FG000|Overall Study|Adverse Event|12
2005754|NCT00152971|3570405|FG001|Overall Study|Adverse Event|10
2005755|NCT00152971|3570406|FG002|Overall Study|Adverse Event|9
2005756|NCT00152971|3570404|FG000|Overall Study|Protocol Violation|10
2005757|NCT00152971|3570405|FG001|Overall Study|Protocol Violation|11
2005758|NCT00152971|3570406|FG002|Overall Study|Protocol Violation|8
2005759|NCT00152971|3570404|FG000|Overall Study|Lost to Follow-up|17
2005760|NCT00152971|3570405|FG001|Overall Study|Lost to Follow-up|14
2005761|NCT00152971|3570406|FG002|Overall Study|Lost to Follow-up|13
2005762|NCT00152971|3570404|FG000|Overall Study|Withdrawal by Subject|9
2005763|NCT00152971|3570405|FG001|Overall Study|Withdrawal by Subject|8
2005764|NCT00152971|3570406|FG002|Overall Study|Withdrawal by Subject|14
2005765|NCT00152971|3570404|FG000|Overall Study|Other|3
2005766|NCT00152971|3570405|FG001|Overall Study|Other|5
2005767|NCT00152971|3570406|FG002|Overall Study|Other|5
2005768|NCT00152971|3570404|FG000|Treatment|Adverse Event|49
2005769|NCT00152971|3570405|FG001|Treatment|Adverse Event|40
2005770|NCT00152971|3570406|FG002|Treatment|Adverse Event|54
2005771|NCT00152971|3570404|FG000|Treatment|Protocol Violation|8
2005772|NCT00152971|3570405|FG001|Treatment|Protocol Violation|6
2005773|NCT00152971|3570406|FG002|Treatment|Protocol Violation|10
2005774|NCT00152971|3570404|FG000|Treatment|Lost to Follow-up|1
2005775|NCT00152971|3570405|FG001|Treatment|Lost to Follow-up|2
2005776|NCT00152971|3570406|FG002|Treatment|Lost to Follow-up|1
2005777|NCT00152971|3570404|FG000|Treatment|Withdrawal by Subject|4
2005778|NCT00152971|3570405|FG001|Treatment|Withdrawal by Subject|4
2005779|NCT00152971|3570406|FG002|Treatment|Withdrawal by Subject|5
2005780|NCT00152971|3570404|FG000|Treatment|Other|9
2005781|NCT00152971|3570405|FG001|Treatment|Other|11
2005782|NCT00152971|3570406|FG002|Treatment|Other|10
2005783|NCT00153062|3570418|FG000|Overall Study|Death|360
2005784|NCT00153062|3570419|FG001|Overall Study|Death|352
2005785|NCT00153062|3570420|FG002|Overall Study|Death|369
2005786|NCT00153062|3570421|FG003|Overall Study|Death|365
2005787|NCT00153062|3570418|FG000|Overall Study|Withdrawal by Subject|14
2005788|NCT00153062|3570419|FG001|Overall Study|Withdrawal by Subject|30
2005789|NCT00153062|3570420|FG002|Overall Study|Withdrawal by Subject|27
2005790|NCT00153062|3570421|FG003|Overall Study|Withdrawal by Subject|28
2005791|NCT00153062|3570418|FG000|Overall Study|Lost to Follow-up|12
2005792|NCT00153062|3570419|FG001|Overall Study|Lost to Follow-up|20
2005793|NCT00153062|3570420|FG002|Overall Study|Lost to Follow-up|15
2005794|NCT00153062|3570421|FG003|Overall Study|Lost to Follow-up|16
2005795|NCT00153062|3570418|FG000|Overall Study|Adverse Event|0
2005796|NCT00153062|3570419|FG001|Overall Study|Adverse Event|1
2005797|NCT00153062|3570420|FG002|Overall Study|Adverse Event|1
2005798|NCT00153062|3570421|FG003|Overall Study|Adverse Event|0
2005799|NCT00153062|3570418|FG000|Overall Study|Protocol Violation|0
2005800|NCT00153062|3570419|FG001|Overall Study|Protocol Violation|2
2005801|NCT00153062|3570420|FG002|Overall Study|Protocol Violation|1
2005802|NCT00153062|3570421|FG003|Overall Study|Protocol Violation|1
2005803|NCT00153062|3570418|FG000|Overall Study|No disposition data available|1
2005804|NCT00153062|3570419|FG001|Overall Study|No disposition data available|1
2005805|NCT00153062|3570420|FG002|Overall Study|No disposition data available|1
2005806|NCT00153062|3570421|FG003|Overall Study|No disposition data available|1
2005807|NCT00153062|3570418|FG000|Overall Study|Other|0
2005808|NCT00153062|3570419|FG001|Overall Study|Other|0
2005809|NCT00153062|3570420|FG002|Overall Study|Other|1
2005810|NCT00153062|3570421|FG003|Overall Study|Other|0
2005811|NCT00153101|3570436|FG000|Overall Study|Lost to Follow-up|14
2005812|NCT00153101|3570437|FG001|Overall Study|Lost to Follow-up|14
2005813|NCT00153101|3570438|FG002|Overall Study|Lost to Follow-up|12
2005814|NCT00153101|3570439|FG003|Overall Study|Lost to Follow-up|5
2005815|NCT00153101|3570440|FG004|Overall Study|Lost to Follow-up|5
2005816|NCT00153101|3570436|FG000|Overall Study|Withdrawal by Subject|3
2005817|NCT00153101|3570437|FG001|Overall Study|Withdrawal by Subject|4
2005818|NCT00153101|3570438|FG002|Overall Study|Withdrawal by Subject|3
2005819|NCT00153101|3570439|FG003|Overall Study|Withdrawal by Subject|3
2005820|NCT00153101|3570440|FG004|Overall Study|Withdrawal by Subject|5
2005821|NCT00153179|3570470|FG000|Study Visit Day 2|Withdrawal by Subject|1
2005822|NCT00153179|3570471|FG001|Study Visit Day 2|Withdrawal by Subject|0
2005823|NCT00153179|3570472|FG002|Study Visit Day 2|Withdrawal by Subject|2
2005824|NCT00153179|3570473|FG003|Study Visit Day 2|Withdrawal by Subject|2
2005825|NCT00153816|3570499|FG000|Overall Study|Death|6
2005826|NCT00153816|3570500|FG001|Overall Study|Death|5
2005827|NCT00153816|3570501|FG002|Overall Study|Death|4
2005828|NCT00153816|3570502|FG003|Overall Study|Death|6
2005829|NCT00153816|3570503|FG004|Overall Study|Death|0
2005830|NCT00153816|3570504|FG005|Overall Study|Death|2
2005831|NCT00153816|3570499|FG000|Overall Study|Lost to Follow-up|7
2005832|NCT00153816|3570500|FG001|Overall Study|Lost to Follow-up|8
2005833|NCT00153816|3570501|FG002|Overall Study|Lost to Follow-up|5
2005834|NCT00153816|3570502|FG003|Overall Study|Lost to Follow-up|8
2005835|NCT00153816|3570503|FG004|Overall Study|Lost to Follow-up|7
2005836|NCT00153816|3570504|FG005|Overall Study|Lost to Follow-up|9
2005837|NCT00153816|3570499|FG000|Overall Study|Withdrawal by Subject|9
2005838|NCT00153816|3570500|FG001|Overall Study|Withdrawal by Subject|9
2005839|NCT00153816|3570501|FG002|Overall Study|Withdrawal by Subject|9
2005840|NCT00153816|3570502|FG003|Overall Study|Withdrawal by Subject|4
2005841|NCT00153816|3570503|FG004|Overall Study|Withdrawal by Subject|1
2005842|NCT00153816|3570504|FG005|Overall Study|Withdrawal by Subject|5
2005843|NCT00153816|3570499|FG000|Overall Study|Follow-up exam not done|8
2005844|NCT00153816|3570500|FG001|Overall Study|Follow-up exam not done|7
2005845|NCT00153816|3570501|FG002|Overall Study|Follow-up exam not done|11
2005846|NCT00153816|3570502|FG003|Overall Study|Follow-up exam not done|10
2005847|NCT00153816|3570503|FG004|Overall Study|Follow-up exam not done|8
2005848|NCT00153816|3570504|FG005|Overall Study|Follow-up exam not done|9
2005849|NCT00153816|3570499|FG000|Overall Study|Follow-up exam done, histology missing|2
2005850|NCT00153816|3570500|FG001|Overall Study|Follow-up exam done, histology missing|3
2005851|NCT00153816|3570501|FG002|Overall Study|Follow-up exam done, histology missing|3
2005852|NCT00153816|3570502|FG003|Overall Study|Follow-up exam done, histology missing|3
2005853|NCT00153816|3570503|FG004|Overall Study|Follow-up exam done, histology missing|1
2005854|NCT00153816|3570504|FG005|Overall Study|Follow-up exam done, histology missing|2
2005855|NCT00153920|3570529|FG000|Overall Study|Adverse Event|9
2005856|NCT00153920|3570529|FG000|Overall Study|Progressive Disease|9
2005857|NCT00153920|3570529|FG000|Overall Study|Physician Decision|3
2005858|NCT00153920|3570529|FG000|Overall Study|Lack of Response|3
2005859|NCT00153920|3570529|FG000|Overall Study|Death|2
2005860|NCT00153920|3570529|FG000|Overall Study|Withdrawal by Subject|1
2005861|NCT00153920|3570529|FG000|Overall Study|Non-Protocol Therapy|1
2005862|NCT00153920|3570529|FG000|Overall Study|Withdrawal of Consent before Trt|1
2005863|NCT00153920|3570529|FG000|Overall Study|Progressive Disease before Trt|1
2005864|NCT00154063|3570539|FG000|Overall Study|Adverse Event|4
2005865|NCT00154063|3570540|FG001|Overall Study|Adverse Event|8
2005866|NCT00154063|3570539|FG000|Overall Study|Protocol Violation|1
2005867|NCT00154063|3570540|FG001|Overall Study|Protocol Violation|1
2005868|NCT00154063|3570539|FG000|Overall Study|Investigator or Sponsor Request|0
2005869|NCT00154063|3570540|FG001|Overall Study|Investigator or Sponsor Request|1
2005870|NCT00154063|3570539|FG000|Overall Study|Withdrawal by Subject|4
2005871|NCT00154063|3570540|FG001|Overall Study|Withdrawal by Subject|9
2005872|NCT00154063|3570539|FG000|Overall Study|Other|3
2005873|NCT00154063|3570540|FG001|Overall Study|Other|3
2005874|NCT00154102|3570552|FG000|Overall Study|investigational study phase ongoing|7
2005875|NCT00154102|3570553|FG001|Overall Study|investigational study phase ongoing|2
2005876|NCT00154284|3570561|FG000|Overall Study|Adverse Event|6
2005877|NCT00154284|3570562|FG001|Overall Study|Adverse Event|9
2005878|NCT00154284|3570561|FG000|Overall Study|Abnormal laboratory value(s)|0
2005879|NCT00154284|3570562|FG001|Overall Study|Abnormal laboratory value(s)|1
2005880|NCT00154284|3570561|FG000|Overall Study|Lack of Efficacy|1
2005881|NCT00154284|3570562|FG001|Overall Study|Lack of Efficacy|2
2005882|NCT00154284|3570561|FG000|Overall Study|Protocol Violation|0
2005883|NCT00154284|3570562|FG001|Overall Study|Protocol Violation|1
2005884|NCT00154297|3570572|FG000|Overall Study|Death|5
2005885|NCT00154297|3570573|FG001|Overall Study|Death|2
2005886|NCT00154297|3570572|FG000|Overall Study|Withdrawal by Subject|0
2005887|NCT00154297|3570573|FG001|Overall Study|Withdrawal by Subject|5
2005888|NCT00154297|3570572|FG000|Overall Study|Lost to Follow-up|3
2005889|NCT00154297|3570573|FG001|Overall Study|Lost to Follow-up|0
2005890|NCT00154310|3570581|FG000|Overall Study|Adverse Event|19
2005891|NCT00154310|3570582|FG001|Overall Study|Adverse Event|9
2005892|NCT00154310|3570581|FG000|Overall Study|Lack of Efficacy|5
2005893|NCT00154310|3570582|FG001|Overall Study|Lack of Efficacy|4
2005894|NCT00154310|3570581|FG000|Overall Study|Protocol Violation|4
2005895|NCT00154310|3570582|FG001|Overall Study|Protocol Violation|2
2005896|NCT00154310|3570581|FG000|Overall Study|Withdrawal by Subject|9
2005897|NCT00154310|3570582|FG001|Overall Study|Withdrawal by Subject|3
2005898|NCT00154310|3570581|FG000|Overall Study|Lost to Follow-up|0
2005899|NCT00154310|3570582|FG001|Overall Study|Lost to Follow-up|8
2005900|NCT00154310|3570581|FG000|Overall Study|Administrative problems|0
2005901|NCT00154310|3570582|FG001|Overall Study|Administrative problems|1
2005902|NCT00154310|3570581|FG000|Overall Study|Death|0
2005903|NCT00154310|3570582|FG001|Overall Study|Death|1
2005904|NCT00154375|3570590|FG000|Overall Study|Unsatisfactory therapeutic effect|25
2005905|NCT00154375|3570591|FG001|Overall Study|Unsatisfactory therapeutic effect|26
2005906|NCT00154375|3570590|FG000|Overall Study|Adverse Event|18
2005907|NCT00154375|3570591|FG001|Overall Study|Adverse Event|20
2005908|NCT00154375|3570590|FG000|Overall Study|Withdrawal by Subject|14
2005909|NCT00154375|3570591|FG001|Overall Study|Withdrawal by Subject|10
2005910|NCT00154375|3570590|FG000|Overall Study|Death|5
2005911|NCT00154375|3570591|FG001|Overall Study|Death|13
2005912|NCT00154375|3570590|FG000|Overall Study|Study drug no longer required|5
2005913|NCT00154375|3570591|FG001|Overall Study|Study drug no longer required|3
2005914|NCT00154375|3570590|FG000|Overall Study|Lost to Follow-up|2
2005915|NCT00154375|3570591|FG001|Overall Study|Lost to Follow-up|1
2005916|NCT00154375|3570590|FG000|Overall Study|Abnormal laboratory value(s)|0
2005917|NCT00154375|3570591|FG001|Overall Study|Abnormal laboratory value(s)|2
2005918|NCT00154375|3570590|FG000|Overall Study|Protocol Violation|0
2005919|NCT00154375|3570591|FG001|Overall Study|Protocol Violation|1
2005920|NCT00154375|3570590|FG000|Overall Study|Suspected progression of disease|44
2005921|NCT00154375|3570591|FG001|Overall Study|Suspected progression of disease|30
2005922|NCT00156533|3570637|FG000|Overall Study|Withdrawn - Medication Expiration|0
2005923|NCT00156533|3570638|FG001|Overall Study|Withdrawn - Medication Expiration|2
2005924|NCT00156533|3570639|FG002|Overall Study|Withdrawn - Medication Expiration|1
2005925|NCT00156533|3570640|FG003|Overall Study|Withdrawn - Medication Expiration|0
2005926|NCT00156533|3570637|FG000|Overall Study|Withdrawal by Subject|1
2005927|NCT00156533|3570638|FG001|Overall Study|Withdrawal by Subject|0
2005928|NCT00156533|3570639|FG002|Overall Study|Withdrawal by Subject|0
2005929|NCT00156533|3570640|FG003|Overall Study|Withdrawal by Subject|1
2005930|NCT00156533|3570637|FG000|Overall Study|Failed Screening|1
2005931|NCT00156533|3570638|FG001|Overall Study|Failed Screening|0
2005932|NCT00156533|3570639|FG002|Overall Study|Failed Screening|1
2005933|NCT00156533|3570640|FG003|Overall Study|Failed Screening|1
2005934|NCT00156819|3570659|FG000|Overall Study|Lost to Follow-up|1
2005935|NCT00156819|3570660|FG001|Overall Study|Lost to Follow-up|1
2005936|NCT00156819|3570661|FG002|Overall Study|Lost to Follow-up|3
2005937|NCT00157014|3570700|FG000|Overall Study|Death|4
2005938|NCT00157014|3570701|FG001|Overall Study|Death|2
2005939|NCT00157014|3570702|FG002|Overall Study|Death|1
2005940|NCT00157014|3570703|FG003|Overall Study|Death|1
2005941|NCT00157014|3570700|FG000|Overall Study|Physician Decision|0
2005942|NCT00157014|3570701|FG001|Overall Study|Physician Decision|1
2005943|NCT00157014|3570702|FG002|Overall Study|Physician Decision|0
2005944|NCT00157014|3570703|FG003|Overall Study|Physician Decision|0
2005945|NCT00157014|3570700|FG000|Overall Study|Medications withdrawn on family request|0
2005946|NCT00157014|3570701|FG001|Overall Study|Medications withdrawn on family request|1
2005947|NCT00157014|3570702|FG002|Overall Study|Medications withdrawn on family request|0
2005948|NCT00157014|3570703|FG003|Overall Study|Medications withdrawn on family request|0
2005949|NCT00157014|3570700|FG000|Overall Study|Patient withdrawn by investigator|1
2005950|NCT00157014|3570701|FG001|Overall Study|Patient withdrawn by investigator|0
2005951|NCT00157014|3570702|FG002|Overall Study|Patient withdrawn by investigator|0
2005952|NCT00157014|3570703|FG003|Overall Study|Patient withdrawn by investigator|0
2005953|NCT00157014|3570700|FG000|Overall Study|Patient unable to return in nursing home|1
2005954|NCT00157014|3570701|FG001|Overall Study|Patient unable to return in nursing home|0
2005955|NCT00157014|3570702|FG002|Overall Study|Patient unable to return in nursing home|0
2005956|NCT00157014|3570703|FG003|Overall Study|Patient unable to return in nursing home|0
2005957|NCT00157014|3570700|FG000|Overall Study|Patient would not receive transplant|0
2005958|NCT00157014|3570701|FG001|Overall Study|Patient would not receive transplant|1
2005959|NCT00157014|3570702|FG002|Overall Study|Patient would not receive transplant|0
2005960|NCT00157014|3570703|FG003|Overall Study|Patient would not receive transplant|0
2005961|NCT00157014|3570700|FG000|Overall Study|Withdrawal by Subject|1
2005962|NCT00157014|3570701|FG001|Overall Study|Withdrawal by Subject|0
2005963|NCT00157014|3570702|FG002|Overall Study|Withdrawal by Subject|0
2005964|NCT00157014|3570703|FG003|Overall Study|Withdrawal by Subject|0
2005965|NCT00157157|3570713|FG000|Overall Study|Withdrawal by Subject|6
2005966|NCT00157157|3570713|FG000|Overall Study|Physician Decision|1
2005967|NCT00157157|3570713|FG000|Overall Study|Lost to Follow-up|1
2005968|NCT00157157|3570713|FG000|Overall Study|Enrolled in another study|1
2005969|NCT00157157|3570713|FG000|Overall Study|Met exclusion criteria|1
2005970|NCT00157157|3570713|FG000|Overall Study|Inclusion not met- baseline FVIII value|1
2005971|NCT00157196|3570724|FG000|Overall Study|Ongoing at data cut-off|9
2005972|NCT00157209|3570730|FG000|Overall Study|Ongoing at data cut-off|10
2005973|NCT00157209|3570731|FG001|Overall Study|Ongoing at data cut-off|0
2214261|NCT01686152|3856442|FG000|Overall Study|Drug Code Unblinded|0
2005974|NCT00157248|3570741|FG000|Overall Study|Adverse Event|36
2005975|NCT00157248|3570742|FG001|Overall Study|Adverse Event|25
2005976|NCT00157248|3570743|FG002|Overall Study|Adverse Event|13
2005977|NCT00157248|3570744|FG003|Overall Study|Adverse Event|33
2005978|NCT00157248|3570741|FG000|Overall Study|Protocol Violation|4
2005979|NCT00157248|3570742|FG001|Overall Study|Protocol Violation|0
2005980|NCT00157248|3570743|FG002|Overall Study|Protocol Violation|2
2005981|NCT00157248|3570744|FG003|Overall Study|Protocol Violation|2
2005982|NCT00157248|3570741|FG000|Overall Study|Lost to Follow-up|0
2005983|NCT00157248|3570742|FG001|Overall Study|Lost to Follow-up|1
2005984|NCT00157248|3570743|FG002|Overall Study|Lost to Follow-up|0
2005985|NCT00157248|3570744|FG003|Overall Study|Lost to Follow-up|0
2005986|NCT00157248|3570741|FG000|Overall Study|Withdrawal by Subject|1
2005987|NCT00157248|3570742|FG001|Overall Study|Withdrawal by Subject|4
2005988|NCT00157248|3570743|FG002|Overall Study|Withdrawal by Subject|3
2005989|NCT00157248|3570744|FG003|Overall Study|Withdrawal by Subject|3
2005990|NCT00157248|3570741|FG000|Overall Study|site closures, subject moving|7
2005991|NCT00157248|3570742|FG001|Overall Study|site closures, subject moving|7
2005992|NCT00157248|3570743|FG002|Overall Study|site closures, subject moving|3
2005993|NCT00157248|3570744|FG003|Overall Study|site closures, subject moving|9
2005994|NCT00157755|3570766|FG000|Overall Study|Death|2
2005995|NCT00157755|3570767|FG001|Overall Study|Death|3
2005996|NCT00157755|3570768|FG002|Overall Study|Death|3
2005997|NCT00157755|3570769|FG003|Overall Study|Death|2
2005998|NCT00157755|3570770|FG004|Overall Study|Death|0
2005999|NCT00157755|3570771|FG005|Overall Study|Death|0
2006000|NCT00157755|3570766|FG000|Overall Study|Lost to Follow-up|0
2006001|NCT00157755|3570767|FG001|Overall Study|Lost to Follow-up|0
2006002|NCT00157755|3570768|FG002|Overall Study|Lost to Follow-up|1
2006003|NCT00157755|3570769|FG003|Overall Study|Lost to Follow-up|0
2006004|NCT00157755|3570770|FG004|Overall Study|Lost to Follow-up|0
2006005|NCT00157755|3570771|FG005|Overall Study|Lost to Follow-up|0
2006006|NCT00157755|3570766|FG000|Overall Study|Withdrawal by Subject|0
2006007|NCT00157755|3570767|FG001|Overall Study|Withdrawal by Subject|0
2006008|NCT00157755|3570768|FG002|Overall Study|Withdrawal by Subject|1
2006009|NCT00157755|3570769|FG003|Overall Study|Withdrawal by Subject|1
2006010|NCT00157755|3570770|FG004|Overall Study|Withdrawal by Subject|1
2006011|NCT00157755|3570771|FG005|Overall Study|Withdrawal by Subject|2
2006012|NCT00157755|3570766|FG000|Overall Study|Explant due to infection|0
2006013|NCT00157755|3570767|FG001|Overall Study|Explant due to infection|0
2006014|NCT00157755|3570768|FG002|Overall Study|Explant due to infection|1
2006015|NCT00157755|3570769|FG003|Overall Study|Explant due to infection|0
2006016|NCT00157755|3570770|FG004|Overall Study|Explant due to infection|0
2006017|NCT00157755|3570771|FG005|Overall Study|Explant due to infection|0
2006018|NCT00157755|3570766|FG000|Overall Study|Medical reason|0
2006019|NCT00157755|3570767|FG001|Overall Study|Medical reason|0
2006020|NCT00157755|3570768|FG002|Overall Study|Medical reason|1
2006021|NCT00157755|3570769|FG003|Overall Study|Medical reason|1
2006022|NCT00157755|3570770|FG004|Overall Study|Medical reason|0
2006023|NCT00157755|3570771|FG005|Overall Study|Medical reason|0
2006024|NCT00157755|3570766|FG000|Overall Study|Study site closure|0
2006025|NCT00157755|3570767|FG001|Overall Study|Study site closure|1
2006026|NCT00157755|3570768|FG002|Overall Study|Study site closure|0
2006027|NCT00157755|3570769|FG003|Overall Study|Study site closure|0
2006028|NCT00157755|3570770|FG004|Overall Study|Study site closure|0
2006029|NCT00157755|3570771|FG005|Overall Study|Study site closure|0
2006030|NCT00157755|3570766|FG000|Overall Study|Subject non-compliance|0
2006031|NCT00157755|3570767|FG001|Overall Study|Subject non-compliance|0
2006032|NCT00157755|3570768|FG002|Overall Study|Subject non-compliance|0
2006033|NCT00157755|3570769|FG003|Overall Study|Subject non-compliance|0
2006034|NCT00157755|3570770|FG004|Overall Study|Subject non-compliance|0
2006035|NCT00157755|3570771|FG005|Overall Study|Subject non-compliance|1
2006036|NCT00157755|3570766|FG000|Overall Study|Study completion|0
2006037|NCT00157755|3570767|FG001|Overall Study|Study completion|0
2006038|NCT00157755|3570768|FG002|Overall Study|Study completion|0
2006039|NCT00157755|3570769|FG003|Overall Study|Study completion|0
2006040|NCT00157755|3570770|FG004|Overall Study|Study completion|1
2006041|NCT00157755|3570771|FG005|Overall Study|Study completion|2
2006042|NCT00157820|3570780|FG000|Randomized|Physician Decision|4
2006043|NCT00157820|3570781|FG001|Randomized|Physician Decision|2
2006044|NCT00157820|3570782|FG002|Randomized|Physician Decision|3
2006045|NCT00157820|3570780|FG000|Randomized|Withdrawal by Subject|1
2006046|NCT00157820|3570781|FG001|Randomized|Withdrawal by Subject|2
2006047|NCT00157820|3570782|FG002|Randomized|Withdrawal by Subject|3
2006048|NCT00157820|3570780|FG000|Randomized|Protocol Violation|2
2006049|NCT00157820|3570781|FG001|Randomized|Protocol Violation|1
2006050|NCT00157820|3570782|FG002|Randomized|Protocol Violation|2
2006051|NCT00157820|3570780|FG000|1st 8 Month|Death|7
2006052|NCT00157820|3570781|FG001|1st 8 Month|Death|8
2006053|NCT00157820|3570782|FG002|1st 8 Month|Death|3
2006054|NCT00157820|3570780|FG000|1st 8 Month|Lost to Follow-up|1
2006055|NCT00157820|3570781|FG001|1st 8 Month|Lost to Follow-up|2
2006056|NCT00157820|3570782|FG002|1st 8 Month|Lost to Follow-up|1
2006057|NCT00157820|3570780|FG000|1st 8 Month|Premature cross-over|0
2006058|NCT00157820|3570781|FG001|1st 8 Month|Premature cross-over|2
2006059|NCT00157820|3570782|FG002|1st 8 Month|Premature cross-over|2
2006060|NCT00157820|3570780|FG000|2nd 8 Months|Death|3
2006061|NCT00157820|3570781|FG001|2nd 8 Months|Death|1
2006062|NCT00157820|3570782|FG002|2nd 8 Months|Death|3
2006063|NCT00157820|3570780|FG000|2nd 8 Months|Lost to Follow-up|1
2006064|NCT00157820|3570781|FG001|2nd 8 Months|Lost to Follow-up|5
2006065|NCT00157820|3570782|FG002|2nd 8 Months|Lost to Follow-up|2
2006066|NCT00157820|3570780|FG000|2nd 8 Months|Premature cross-over|1
2006067|NCT00157820|3570781|FG001|2nd 8 Months|Premature cross-over|7
2006068|NCT00157820|3570782|FG002|2nd 8 Months|Premature cross-over|9
2006069|NCT00157950|3570793|FG000|Overall Study|Death|1
2006070|NCT00157950|3570794|FG001|Overall Study|Death|0
2006071|NCT00158054|3570802|FG000|Overall Study|Refused to continue|3
2006072|NCT00158054|3570803|FG001|Overall Study|Refused to continue|0
2006073|NCT00158054|3570802|FG000|Overall Study|Unavailable for follow up|7
2006074|NCT00158054|3570803|FG001|Overall Study|Unavailable for follow up|3
2006075|NCT00158184|3570811|FG000|Overall Study|personal issues|3
2006076|NCT00158184|3570812|FG001|Overall Study|personal issues|1
2006077|NCT00158184|3570811|FG000|Overall Study|failed for follow unit/study rules|2
2006078|NCT00158184|3570812|FG001|Overall Study|failed for follow unit/study rules|0
2006079|NCT00158184|3570811|FG000|Overall Study|Adverse Event|1
2006080|NCT00158184|3570812|FG001|Overall Study|Adverse Event|1
2006081|NCT00158262|3570857|FG000|Overall Study|Lost to Follow-up|1
2006082|NCT00158262|3570858|FG001|Overall Study|Lost to Follow-up|1
2006083|NCT00158600|3570870|FG000|Overall Study|unable to commit time to study|0
2006084|NCT00158600|3570871|FG001|Overall Study|unable to commit time to study|1
2006085|NCT00158600|3570870|FG000|Overall Study|Adverse Event|2
2006086|NCT00158600|3570871|FG001|Overall Study|Adverse Event|1
2006087|NCT00158600|3570870|FG000|Overall Study|Death|1
2006088|NCT00158600|3570871|FG001|Overall Study|Death|0
2006089|NCT00158600|3570870|FG000|Overall Study|Withdrawal by Subject|2
2006090|NCT00158600|3570871|FG001|Overall Study|Withdrawal by Subject|2
2006091|NCT00158756|3570892|FG000|Overall Study|Withdrawal by Subject|5
2006092|NCT00158756|3570893|FG001|Overall Study|Withdrawal by Subject|0
2006093|NCT00158756|3570894|FG002|Overall Study|Withdrawal by Subject|6
2006094|NCT00158756|3570895|FG003|Overall Study|Withdrawal by Subject|1
2006095|NCT00158756|3570896|FG004|Overall Study|Withdrawal by Subject|3
2006096|NCT00158756|3570892|FG000|Overall Study|Adverse Event|0
2006097|NCT00158756|3570893|FG001|Overall Study|Adverse Event|0
2006098|NCT00158756|3570894|FG002|Overall Study|Adverse Event|1
2006099|NCT00158756|3570895|FG003|Overall Study|Adverse Event|0
2006100|NCT00158756|3570896|FG004|Overall Study|Adverse Event|0
2006101|NCT00158756|3570892|FG000|Overall Study|Serious adverse event|0
2006102|NCT00158756|3570893|FG001|Overall Study|Serious adverse event|0
2006103|NCT00158756|3570894|FG002|Overall Study|Serious adverse event|1
2006104|NCT00158756|3570895|FG003|Overall Study|Serious adverse event|0
2006105|NCT00158756|3570896|FG004|Overall Study|Serious adverse event|0
2006106|NCT00158860|3570910|FG000|Overall Study|Adverse Event|3
2006107|NCT00158860|3570911|FG001|Overall Study|Adverse Event|6
2006108|NCT00158860|3570910|FG000|Overall Study|Lost to Follow-up|11
2006109|NCT00158860|3570911|FG001|Overall Study|Lost to Follow-up|17
2006110|NCT00158860|3570910|FG000|Overall Study|Protocol Violation|8
2006111|NCT00158860|3570911|FG001|Overall Study|Protocol Violation|23
2006112|NCT00158860|3570910|FG000|Overall Study|Withdrawal by Subject|7
2006113|NCT00158860|3570911|FG001|Overall Study|Withdrawal by Subject|17
2006114|NCT00158860|3570910|FG000|Overall Study|MOVING OUT OF STATE|1
2006115|NCT00158860|3570911|FG001|Overall Study|MOVING OUT OF STATE|0
2006116|NCT00158860|3570910|FG000|Overall Study|Pregnancy|3
2006117|NCT00158860|3570911|FG001|Overall Study|Pregnancy|3
2006118|NCT00158860|3570910|FG000|Overall Study|SPONSOR STOPPED STUDY|2
2006119|NCT00158860|3570911|FG001|Overall Study|SPONSOR STOPPED STUDY|2
2006120|NCT00158860|3570910|FG000|Overall Study|SPONSOR REQUEST|0
2006121|NCT00158860|3570911|FG001|Overall Study|SPONSOR REQUEST|1
2006122|NCT00158860|3570910|FG000|Overall Study|Lost to Follow up but returned per GSK|0
2006123|NCT00158860|3570911|FG001|Overall Study|Lost to Follow up but returned per GSK|1
2006124|NCT00158860|3570910|FG000|Overall Study|Closed per sponsor|0
2006125|NCT00158860|3570911|FG001|Overall Study|Closed per sponsor|1
2006126|NCT00159432|3570959|FG000|Overall Study|Adverse Event|1
2006127|NCT00159432|3570959|FG000|Overall Study|Death|1
2006128|NCT00159432|3570959|FG000|Overall Study|Lack of Efficacy|8
2006129|NCT00159822|3570963|FG000|Voriconazole Treatment Period|Lack of Efficacy|3
2006130|NCT00159822|3570963|FG000|Voriconazole Treatment Period|Adverse Event|9
2006131|NCT00159822|3570963|FG000|Voriconazole Treatment Period|Death|4
2006132|NCT00159822|3570963|FG000|Voriconazole Treatment Period|Protocol Violation|2
2006133|NCT00159822|3570963|FG000|Voriconazole Treatment Period|Lost to Follow-up|2
2006134|NCT00159822|3570963|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2
2006135|NCT00159822|3570963|FG000|Post-treatment Follow-up Period|Death|1
2006136|NCT00159822|3570963|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1
2006137|NCT00159822|3570963|FG000|Post-treatment Follow-up Period|Reason unspecified|1
2006138|NCT00159861|3570969|FG000|Core Study - 16 Weeks|Death|3
2006139|NCT00159861|3570970|FG001|Core Study - 16 Weeks|Death|0
2006140|NCT00159861|3570969|FG000|Core Study - 16 Weeks|Adverse Event|12
2006141|NCT00159861|3570970|FG001|Core Study - 16 Weeks|Adverse Event|6
2006142|NCT00159861|3570969|FG000|Core Study - 16 Weeks|Lack of Efficacy|2
2006143|NCT00159861|3570970|FG001|Core Study - 16 Weeks|Lack of Efficacy|3
2006144|NCT00159861|3570969|FG000|Core Study - 16 Weeks|Reason Unspecified|5
2006145|NCT00159861|3570970|FG001|Core Study - 16 Weeks|Reason Unspecified|3
2006146|NCT00159861|3570969|FG000|Core Study - 16 Weeks|Subject Defaulted|1
2006147|NCT00159861|3570970|FG001|Core Study - 16 Weeks|Subject Defaulted|0
2006148|NCT00159861|3570969|FG000|Core Study - 16 Weeks|Randomized but not Treated|2
2006149|NCT00159861|3570970|FG001|Core Study - 16 Weeks|Randomized but not Treated|0
2006150|NCT00159861|3570969|FG000|Extension Study - up to 3 Years|Death|24
2006151|NCT00159861|3570970|FG001|Extension Study - up to 3 Years|Death|28
2214262|NCT01686152|3856443|FG001|Overall Study|Drug Code Unblinded|1
2006152|NCT00159861|3570969|FG000|Extension Study - up to 3 Years|Adverse Event|14
2006153|NCT00159861|3570970|FG001|Extension Study - up to 3 Years|Adverse Event|14
2006154|NCT00159861|3570969|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5
2006155|NCT00159861|3570970|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1
2006156|NCT00159861|3570969|FG000|Extension Study - up to 3 Years|Reason Unspecified|12
2006157|NCT00159861|3570970|FG001|Extension Study - up to 3 Years|Reason Unspecified|19
2006158|NCT00159861|3570969|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7
2006159|NCT00159861|3570970|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9
2006160|NCT00159874|3570988|FG000|Overall Study|Adverse Event|2
2006161|NCT00159874|3570989|FG001|Overall Study|Adverse Event|2
2006162|NCT00159874|3570990|FG002|Overall Study|Adverse Event|5
2006163|NCT00159874|3570991|FG003|Overall Study|Adverse Event|1
2006164|NCT00159874|3570992|FG004|Overall Study|Adverse Event|1
2006165|NCT00159874|3570993|FG005|Overall Study|Adverse Event|2
2006166|NCT00159874|3570994|FG006|Overall Study|Adverse Event|0
2006167|NCT00159874|3570988|FG000|Overall Study|Does Not Meet Entrance Criteria|1
2006168|NCT00159874|3570989|FG001|Overall Study|Does Not Meet Entrance Criteria|0
2006169|NCT00159874|3570990|FG002|Overall Study|Does Not Meet Entrance Criteria|1
2006170|NCT00159874|3570991|FG003|Overall Study|Does Not Meet Entrance Criteria|0
2006171|NCT00159874|3570992|FG004|Overall Study|Does Not Meet Entrance Criteria|0
2006172|NCT00159874|3570993|FG005|Overall Study|Does Not Meet Entrance Criteria|0
2006173|NCT00159874|3570994|FG006|Overall Study|Does Not Meet Entrance Criteria|0
2006174|NCT00159874|3570988|FG000|Overall Study|Lack of Efficacy|2
2006175|NCT00159874|3570989|FG001|Overall Study|Lack of Efficacy|0
2006176|NCT00159874|3570990|FG002|Overall Study|Lack of Efficacy|1
2006177|NCT00159874|3570991|FG003|Overall Study|Lack of Efficacy|1
2006178|NCT00159874|3570992|FG004|Overall Study|Lack of Efficacy|0
2006179|NCT00159874|3570993|FG005|Overall Study|Lack of Efficacy|3
2006180|NCT00159874|3570994|FG006|Overall Study|Lack of Efficacy|0
2006181|NCT00159874|3570988|FG000|Overall Study|Lost to Follow-up|1
2006182|NCT00159874|3570989|FG001|Overall Study|Lost to Follow-up|0
2006183|NCT00159874|3570990|FG002|Overall Study|Lost to Follow-up|3
2006184|NCT00159874|3570991|FG003|Overall Study|Lost to Follow-up|0
2006185|NCT00159874|3570992|FG004|Overall Study|Lost to Follow-up|1
2006186|NCT00159874|3570993|FG005|Overall Study|Lost to Follow-up|2
2006187|NCT00159874|3570994|FG006|Overall Study|Lost to Follow-up|1
2006188|NCT00159874|3570988|FG000|Overall Study|Other|8
2006189|NCT00159874|3570989|FG001|Overall Study|Other|8
2214263|NCT01686152|3856444|FG002|Overall Study|Drug Code Unblinded|0
2006190|NCT00159874|3570990|FG002|Overall Study|Other|8
2006191|NCT00159874|3570991|FG003|Overall Study|Other|0
2006192|NCT00159874|3570992|FG004|Overall Study|Other|2
2006193|NCT00159874|3570993|FG005|Overall Study|Other|1
2006194|NCT00159874|3570994|FG006|Overall Study|Other|3
2006195|NCT00159874|3570988|FG000|Overall Study|Protocol Violation|0
2006196|NCT00159874|3570989|FG001|Overall Study|Protocol Violation|5
2006197|NCT00159874|3570990|FG002|Overall Study|Protocol Violation|2
2006198|NCT00159874|3570991|FG003|Overall Study|Protocol Violation|0
2006199|NCT00159874|3570992|FG004|Overall Study|Protocol Violation|0
2006200|NCT00159874|3570993|FG005|Overall Study|Protocol Violation|0
2006201|NCT00159874|3570994|FG006|Overall Study|Protocol Violation|0
2006202|NCT00159874|3570988|FG000|Overall Study|Death|3
2006203|NCT00159874|3570989|FG001|Overall Study|Death|8
2006204|NCT00159874|3570990|FG002|Overall Study|Death|15
2006205|NCT00159874|3570991|FG003|Overall Study|Death|0
2006206|NCT00159874|3570992|FG004|Overall Study|Death|1
2006207|NCT00159874|3570993|FG005|Overall Study|Death|2
2006208|NCT00159874|3570994|FG006|Overall Study|Death|0
2006209|NCT00159874|3570988|FG000|Overall Study|Withdrawal by Subject|2
2006210|NCT00159874|3570989|FG001|Overall Study|Withdrawal by Subject|6
2006211|NCT00159874|3570990|FG002|Overall Study|Withdrawal by Subject|8
2006212|NCT00159874|3570991|FG003|Overall Study|Withdrawal by Subject|4
2006213|NCT00159874|3570992|FG004|Overall Study|Withdrawal by Subject|3
2006214|NCT00159874|3570993|FG005|Overall Study|Withdrawal by Subject|2
2006215|NCT00159874|3570994|FG006|Overall Study|Withdrawal by Subject|1
2006216|NCT00159874|3570988|FG000|Overall Study|Pregnancy|1
2006217|NCT00159874|3570989|FG001|Overall Study|Pregnancy|1
2006218|NCT00159874|3570990|FG002|Overall Study|Pregnancy|0
2006219|NCT00159874|3570991|FG003|Overall Study|Pregnancy|0
2006220|NCT00159874|3570992|FG004|Overall Study|Pregnancy|0
2006221|NCT00159874|3570993|FG005|Overall Study|Pregnancy|0
2006222|NCT00159874|3570994|FG006|Overall Study|Pregnancy|0
2006223|NCT00159913|3571014|FG000|Overall Study|Adverse Event|1
2006224|NCT00159913|3571015|FG001|Overall Study|Adverse Event|0
2006225|NCT00159913|3571016|FG002|Overall Study|Adverse Event|1
2006226|NCT00159913|3571017|FG003|Overall Study|Adverse Event|0
2006227|NCT00159913|3571014|FG000|Overall Study|Withdrawal by Subject|0
2006228|NCT00159913|3571015|FG001|Overall Study|Withdrawal by Subject|0
2006229|NCT00159913|3571016|FG002|Overall Study|Withdrawal by Subject|0
2006230|NCT00159913|3571017|FG003|Overall Study|Withdrawal by Subject|1
2006231|NCT00159913|3571014|FG000|Overall Study|Lost to Follow-up|0
2006232|NCT00159913|3571015|FG001|Overall Study|Lost to Follow-up|0
2006233|NCT00159913|3571016|FG002|Overall Study|Lost to Follow-up|0
2006234|NCT00159913|3571017|FG003|Overall Study|Lost to Follow-up|1
2006235|NCT00159913|3571014|FG000|Overall Study|Protocol Violation|1
2006236|NCT00159913|3571015|FG001|Overall Study|Protocol Violation|0
2006237|NCT00159913|3571016|FG002|Overall Study|Protocol Violation|1
2006238|NCT00159913|3571017|FG003|Overall Study|Protocol Violation|0
2006239|NCT00160199|3571040|FG000|Overall Study|Adverse Event|5
2006240|NCT00160199|3571041|FG001|Overall Study|Adverse Event|14
2006241|NCT00160199|3571040|FG000|Overall Study|Lack of Efficacy|0
2006242|NCT00160199|3571041|FG001|Overall Study|Lack of Efficacy|1
2006243|NCT00160199|3571040|FG000|Overall Study|Lost to Follow-up|7
2006244|NCT00160199|3571041|FG001|Overall Study|Lost to Follow-up|7
2006245|NCT00160199|3571040|FG000|Overall Study|Withdrawal by Subject|4
2006246|NCT00160199|3571041|FG001|Overall Study|Withdrawal by Subject|6
2006247|NCT00160199|3571040|FG000|Overall Study|Administrative|0
2006248|NCT00160199|3571041|FG001|Overall Study|Administrative|1
2006249|NCT00160199|3571040|FG000|Overall Study|Protocol Violation|8
2006250|NCT00160199|3571041|FG001|Overall Study|Protocol Violation|8
2006251|NCT00160251|3571053|FG000|Prior to Amendment 2|Adverse Event|2
2006252|NCT00160251|3571054|FG001|Prior to Amendment 2|Adverse Event|1
2006253|NCT00160251|3571055|FG002|Prior to Amendment 2|Adverse Event|3
2006254|NCT00160251|3571056|FG003|Prior to Amendment 2|Adverse Event|1
2006255|NCT00160251|3571057|FG004|Prior to Amendment 2|Adverse Event|1
2006256|NCT00160251|3571058|FG005|Prior to Amendment 2|Adverse Event|1
2006257|NCT00160251|3571059|FG006|Prior to Amendment 2|Adverse Event|1
2006258|NCT00160251|3571060|FG007|Prior to Amendment 2|Adverse Event|0
2006259|NCT00160251|3571053|FG000|Prior to Amendment 2|Lack of Efficacy|0
2006260|NCT00160251|3571054|FG001|Prior to Amendment 2|Lack of Efficacy|4
2006261|NCT00160251|3571055|FG002|Prior to Amendment 2|Lack of Efficacy|37
2006262|NCT00160251|3571056|FG003|Prior to Amendment 2|Lack of Efficacy|35
2006263|NCT00160251|3571057|FG004|Prior to Amendment 2|Lack of Efficacy|24
2006264|NCT00160251|3571058|FG005|Prior to Amendment 2|Lack of Efficacy|55
2006265|NCT00160251|3571059|FG006|Prior to Amendment 2|Lack of Efficacy|0
2006266|NCT00160251|3571060|FG007|Prior to Amendment 2|Lack of Efficacy|0
2006267|NCT00160251|3571053|FG000|Prior to Amendment 2|Lost to Follow-up|0
2006268|NCT00160251|3571054|FG001|Prior to Amendment 2|Lost to Follow-up|0
2006269|NCT00160251|3571055|FG002|Prior to Amendment 2|Lost to Follow-up|1
2006270|NCT00160251|3571056|FG003|Prior to Amendment 2|Lost to Follow-up|0
2006271|NCT00160251|3571057|FG004|Prior to Amendment 2|Lost to Follow-up|1
2006272|NCT00160251|3571058|FG005|Prior to Amendment 2|Lost to Follow-up|1
2006273|NCT00160251|3571059|FG006|Prior to Amendment 2|Lost to Follow-up|0
2006274|NCT00160251|3571060|FG007|Prior to Amendment 2|Lost to Follow-up|0
2006275|NCT00160251|3571053|FG000|Prior to Amendment 2|Withdrawal by Subject|3
2006276|NCT00160251|3571054|FG001|Prior to Amendment 2|Withdrawal by Subject|1
2006277|NCT00160251|3571055|FG002|Prior to Amendment 2|Withdrawal by Subject|3
2006278|NCT00160251|3571056|FG003|Prior to Amendment 2|Withdrawal by Subject|4
2006279|NCT00160251|3571057|FG004|Prior to Amendment 2|Withdrawal by Subject|2
2006280|NCT00160251|3571058|FG005|Prior to Amendment 2|Withdrawal by Subject|3
2006281|NCT00160251|3571059|FG006|Prior to Amendment 2|Withdrawal by Subject|3
2006282|NCT00160251|3571060|FG007|Prior to Amendment 2|Withdrawal by Subject|0
2006283|NCT00160251|3571053|FG000|Prior to Amendment 2|Noncompliance with protocol|1
2006284|NCT00160251|3571054|FG001|Prior to Amendment 2|Noncompliance with protocol|0
2006285|NCT00160251|3571055|FG002|Prior to Amendment 2|Noncompliance with protocol|0
2006286|NCT00160251|3571056|FG003|Prior to Amendment 2|Noncompliance with protocol|0
2006287|NCT00160251|3571057|FG004|Prior to Amendment 2|Noncompliance with protocol|0
2006288|NCT00160251|3571058|FG005|Prior to Amendment 2|Noncompliance with protocol|0
2006289|NCT00160251|3571059|FG006|Prior to Amendment 2|Noncompliance with protocol|0
2006290|NCT00160251|3571060|FG007|Prior to Amendment 2|Noncompliance with protocol|0
2006291|NCT00160251|3571053|FG000|Prior to Amendment 2|Completed Treatment Phase|3
2006292|NCT00160251|3571054|FG001|Prior to Amendment 2|Completed Treatment Phase|0
2006293|NCT00160251|3571055|FG002|Prior to Amendment 2|Completed Treatment Phase|0
2006294|NCT00160251|3571056|FG003|Prior to Amendment 2|Completed Treatment Phase|0
2006295|NCT00160251|3571057|FG004|Prior to Amendment 2|Completed Treatment Phase|0
2006296|NCT00160251|3571058|FG005|Prior to Amendment 2|Completed Treatment Phase|23
2006297|NCT00160251|3571059|FG006|Prior to Amendment 2|Completed Treatment Phase|0
2006298|NCT00160251|3571060|FG007|Prior to Amendment 2|Completed Treatment Phase|0
2006299|NCT00160251|3571053|FG000|Post-amendment 2|Adverse Event|0
2006300|NCT00160251|3571054|FG001|Post-amendment 2|Adverse Event|0
2006301|NCT00160251|3571055|FG002|Post-amendment 2|Adverse Event|0
2006302|NCT00160251|3571056|FG003|Post-amendment 2|Adverse Event|0
2006303|NCT00160251|3571057|FG004|Post-amendment 2|Adverse Event|0
2006304|NCT00160251|3571058|FG005|Post-amendment 2|Adverse Event|0
2006305|NCT00160251|3571059|FG006|Post-amendment 2|Adverse Event|0
2006306|NCT00160251|3571060|FG007|Post-amendment 2|Adverse Event|20
2006307|NCT00160251|3571053|FG000|Post-amendment 2|Lack of Efficacy|0
2006308|NCT00160251|3571054|FG001|Post-amendment 2|Lack of Efficacy|0
2006309|NCT00160251|3571055|FG002|Post-amendment 2|Lack of Efficacy|0
2006310|NCT00160251|3571056|FG003|Post-amendment 2|Lack of Efficacy|0
2006311|NCT00160251|3571057|FG004|Post-amendment 2|Lack of Efficacy|0
2006312|NCT00160251|3571058|FG005|Post-amendment 2|Lack of Efficacy|0
2006313|NCT00160251|3571059|FG006|Post-amendment 2|Lack of Efficacy|0
2006314|NCT00160251|3571060|FG007|Post-amendment 2|Lack of Efficacy|24
2006315|NCT00160251|3571053|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2006316|NCT00160251|3571054|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2006317|NCT00160251|3571055|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2006318|NCT00160251|3571056|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2006319|NCT00160251|3571057|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2006320|NCT00160251|3571058|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2006321|NCT00160251|3571059|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2006322|NCT00160251|3571060|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
2006323|NCT00160524|3571117|FG000|Overall Study|Adverse Event|119
2006324|NCT00160524|3571117|FG000|Overall Study|Adverse Event and Other|94
2006325|NCT00160524|3571117|FG000|Overall Study|Protocol Violation|16
2006326|NCT00160524|3571117|FG000|Overall Study|Protocol Violation and Other|2
2006327|NCT00160524|3571117|FG000|Overall Study|Withdrawal by Subject|141
2006328|NCT00160524|3571117|FG000|Overall Study|Withdrawal by Subject and Other|17
2006329|NCT00160524|3571117|FG000|Overall Study|Physician Decision|27
2006330|NCT00160524|3571117|FG000|Overall Study|Physician Decision and Other|6
2006331|NCT00160524|3571117|FG000|Overall Study|Lost to Follow-up|13
2006332|NCT00160524|3571117|FG000|Overall Study|Lost to Follow-up and Other|1
2006333|NCT00160524|3571117|FG000|Overall Study|Lack of Efficacy|21
2006334|NCT00160524|3571117|FG000|Overall Study|Lack of Efficacy and Other|1
2006335|NCT00160524|3571117|FG000|Overall Study|Other|20
2006336|NCT00160615|3571123|FG000|Overall Study|Adverse Event|5
2006337|NCT00160615|3571124|FG001|Overall Study|Adverse Event|12
2006338|NCT00160615|3571123|FG000|Overall Study|Withdrawal by Subject|0
2006339|NCT00160615|3571124|FG001|Overall Study|Withdrawal by Subject|2
2006340|NCT00160615|3571123|FG000|Overall Study|Lack of Efficacy|11
2006341|NCT00160615|3571124|FG001|Overall Study|Lack of Efficacy|23
2006342|NCT00160615|3571123|FG000|Overall Study|Patient decision|1
2006343|NCT00160615|3571124|FG001|Overall Study|Patient decision|2
2006344|NCT00160615|3571123|FG000|Overall Study|Investigator decision|1
2006345|NCT00160615|3571124|FG001|Overall Study|Investigator decision|1
2006346|NCT00160615|3571123|FG000|Overall Study|AE agents had to be discontinued (exam.)|0
2006347|NCT00160615|3571124|FG001|Overall Study|AE agents had to be discontinued (exam.)|1
2006348|NCT00160615|3571123|FG000|Overall Study|Switch to surgical treatment|0
2006349|NCT00160615|3571124|FG001|Overall Study|Switch to surgical treatment|2
2006350|NCT00160615|3571123|FG000|Overall Study|Non-compliance was suspected|0
2006351|NCT00160615|3571124|FG001|Overall Study|Non-compliance was suspected|1
2006352|NCT00160615|3571123|FG000|Overall Study|Poor compliance|0
2006353|NCT00160615|3571124|FG001|Overall Study|Poor compliance|1
2006354|NCT00160641|3571132|FG000|Overall Study|Adverse Event|102
2006355|NCT00160641|3571132|FG000|Overall Study|Withdrawal by Subject|87
2006356|NCT00160641|3571132|FG000|Overall Study|Lost to Follow-up|8
2006357|NCT00160641|3571132|FG000|Overall Study|Lack of Efficacy|12
2006358|NCT00160641|3571132|FG000|Overall Study|Protocol Violation|3
2006359|NCT00160641|3571132|FG000|Overall Study|Other|9
2006360|NCT00160654|3571136|FG000|Overall Study|Adverse Event|14
2006361|NCT00160654|3571136|FG000|Overall Study|Lack of Efficacy|4
2006362|NCT00160654|3571136|FG000|Overall Study|Lost to Follow-up|2
2214264|NCT01686152|3856442|FG000|Overall Study|Protocol Violation|6
2214265|NCT01686152|3856443|FG001|Overall Study|Protocol Violation|1
2006363|NCT00160654|3571136|FG000|Overall Study|Intake of expired drug|7
2006364|NCT00160654|3571136|FG000|Overall Study|Psychological trauma|1
2006365|NCT00160654|3571136|FG000|Overall Study|Sponsor decision|1
2006366|NCT00160654|3571136|FG000|Overall Study|Patient met exclusion criteria|1
2006367|NCT00160654|3571136|FG000|Overall Study|Patient decision|1
2006368|NCT00160654|3571136|FG000|Overall Study|Poor compliance, dilantin toxicity|1
2006369|NCT00160654|3571136|FG000|Overall Study|Met exclusion criteria|1
2006370|NCT00160667|3571143|FG000|Overall Study|Adverse Event|3
2006371|NCT00160667|3571144|FG001|Overall Study|Adverse Event|1
2006372|NCT00160667|3571145|FG002|Overall Study|Adverse Event|4
2006373|NCT00160667|3571143|FG000|Overall Study|Withdrawal by Subject|2
2006374|NCT00160667|3571144|FG001|Overall Study|Withdrawal by Subject|0
2006375|NCT00160667|3571145|FG002|Overall Study|Withdrawal by Subject|1
2006376|NCT00160667|3571143|FG000|Overall Study|Lack of Efficacy|0
2006377|NCT00160667|3571144|FG001|Overall Study|Lack of Efficacy|1
2006378|NCT00160667|3571145|FG002|Overall Study|Lack of Efficacy|0
2006379|NCT00160667|3571143|FG000|Overall Study|Protocol Violation|0
2006380|NCT00160667|3571144|FG001|Overall Study|Protocol Violation|1
2006381|NCT00160667|3571145|FG002|Overall Study|Protocol Violation|0
2006382|NCT00160667|3571143|FG000|Overall Study|Patient decision|0
2006383|NCT00160667|3571144|FG001|Overall Study|Patient decision|0
2006384|NCT00160667|3571145|FG002|Overall Study|Patient decision|1
2006385|NCT00160680|3571156|FG000|Overall Study|Adverse Event|0
2006386|NCT00160680|3571157|FG001|Overall Study|Adverse Event|1
2006387|NCT00160680|3571156|FG000|Overall Study|Lack of Efficacy|2
2006388|NCT00160680|3571157|FG001|Overall Study|Lack of Efficacy|1
2006389|NCT00160680|3571156|FG000|Overall Study|Lost to Follow-up|3
2006390|NCT00160680|3571157|FG001|Overall Study|Lost to Follow-up|2
2006391|NCT00160680|3571156|FG000|Overall Study|Withdrawal by Subject|4
2006392|NCT00160680|3571157|FG001|Overall Study|Withdrawal by Subject|9
2006393|NCT00160693|3571163|FG000|Overall Study|Adverse Event|97
2006394|NCT00160693|3571163|FG000|Overall Study|Lack of Efficacy|30
2006395|NCT00160693|3571163|FG000|Overall Study|Protocol Violation|24
2006396|NCT00160693|3571163|FG000|Overall Study|Lost to Follow-up|15
2006397|NCT00160693|3571163|FG000|Overall Study|Withdrawal by Subject|54
2006398|NCT00160693|3571163|FG000|Overall Study|Study terminated by sponsor|15
2006399|NCT00160706|3571167|FG000|Overall Study|Adverse Event|53
2006400|NCT00160706|3571167|FG000|Overall Study|Adverse Event and Other Reason|105
2006401|NCT00160706|3571167|FG000|Overall Study|Protocol Violation|3
2006402|NCT00160706|3571167|FG000|Overall Study|Withdrawal by Subject|41
2006403|NCT00160706|3571167|FG000|Overall Study|Withdrawal by Subject and Other|12
2006404|NCT00160706|3571167|FG000|Overall Study|Physician Decision|10
2006405|NCT00160706|3571167|FG000|Overall Study|Physician Decision and Other|3
2006406|NCT00160706|3571167|FG000|Overall Study|Lost to Follow-up|4
2006407|NCT00160706|3571167|FG000|Overall Study|Lost to Follow-up and Other|1
2006408|NCT00160706|3571167|FG000|Overall Study|Lack of Efficacy|42
2006409|NCT00160706|3571167|FG000|Overall Study|Lack of Efficacy and Other|1
2006410|NCT00160706|3571167|FG000|Overall Study|Other Reason|11
2006411|NCT00161213|3571171|FG000|Overall Study|Withdrawal by Subject|1
2006412|NCT00161213|3571171|FG000|Overall Study|Evaluable for toxicity but not response|1
2006413|NCT00161616|3571195|FG000|Overall Study|Withdrawal by Subject|6
2006414|NCT00161616|3571196|FG001|Overall Study|Withdrawal by Subject|5
2006415|NCT00161616|3571195|FG000|Overall Study|Physician Decision|1
2006416|NCT00161616|3571196|FG001|Overall Study|Physician Decision|0
2006417|NCT00161616|3571195|FG000|Overall Study|Death|1
2006418|NCT00161616|3571196|FG001|Overall Study|Death|1
2006419|NCT00161616|3571195|FG000|Overall Study|Lost to Follow-up|17
2006420|NCT00161616|3571196|FG001|Overall Study|Lost to Follow-up|13
2006421|NCT00161616|3571195|FG000|Overall Study|Protocol deviation|1
2006422|NCT00161616|3571196|FG001|Overall Study|Protocol deviation|0
2006423|NCT00162032|3571204|FG000|Overall Study|Lost to Follow-up|4
2006424|NCT00162032|3571205|FG001|Overall Study|Lost to Follow-up|2
2006425|NCT00162032|3571204|FG000|Overall Study|Reason not specified|1
2006426|NCT00162032|3571205|FG001|Overall Study|Reason not specified|0
2006427|NCT00162097|3571220|FG000|Overall Study|Participant no longer met study criteria|0
2006428|NCT00162097|3571221|FG001|Overall Study|Participant no longer met study criteria|0
2006429|NCT00162097|3571222|FG002|Overall Study|Participant no longer met study criteria|0
2006430|NCT00162097|3571223|FG003|Overall Study|Participant no longer met study criteria|1
2006431|NCT00162123|3571247|FG000|Overall Study|Disease progression|27
2006432|NCT00162123|3571248|FG001|Overall Study|Disease progression|19
2006433|NCT00162123|3571249|FG002|Overall Study|Disease progression|10
2006434|NCT00162123|3571250|FG003|Overall Study|Disease progression|4
2006435|NCT00162123|3571251|FG004|Overall Study|Disease progression|8
2006436|NCT00162123|3571252|FG005|Overall Study|Disease progression|3
2006437|NCT00162123|3571253|FG006|Overall Study|Disease progression|1
2006438|NCT00162123|3571254|FG007|Overall Study|Disease progression|0
2006439|NCT00162123|3571247|FG000|Overall Study|Study drug toxicity|6
2006440|NCT00162123|3571248|FG001|Overall Study|Study drug toxicity|1
2006441|NCT00162123|3571249|FG002|Overall Study|Study drug toxicity|5
2006442|NCT00162123|3571250|FG003|Overall Study|Study drug toxicity|0
2006443|NCT00162123|3571251|FG004|Overall Study|Study drug toxicity|4
2006444|NCT00162123|3571252|FG005|Overall Study|Study drug toxicity|1
2006445|NCT00162123|3571253|FG006|Overall Study|Study drug toxicity|1
2006446|NCT00162123|3571254|FG007|Overall Study|Study drug toxicity|0
2006447|NCT00162123|3571247|FG000|Overall Study|Death|3
2006448|NCT00162123|3571248|FG001|Overall Study|Death|3
2006449|NCT00162123|3571249|FG002|Overall Study|Death|1
2006450|NCT00162123|3571250|FG003|Overall Study|Death|1
2006451|NCT00162123|3571251|FG004|Overall Study|Death|1
2006452|NCT00162123|3571252|FG005|Overall Study|Death|1
2006453|NCT00162123|3571253|FG006|Overall Study|Death|0
2006454|NCT00162123|3571254|FG007|Overall Study|Death|0
2006455|NCT00162123|3571247|FG000|Overall Study|Withdrawal by Subject|2
2006456|NCT00162123|3571248|FG001|Overall Study|Withdrawal by Subject|0
2006457|NCT00162123|3571249|FG002|Overall Study|Withdrawal by Subject|2
2006458|NCT00162123|3571250|FG003|Overall Study|Withdrawal by Subject|1
2006459|NCT00162123|3571251|FG004|Overall Study|Withdrawal by Subject|1
2006460|NCT00162123|3571252|FG005|Overall Study|Withdrawal by Subject|2
2006461|NCT00162123|3571253|FG006|Overall Study|Withdrawal by Subject|1
2006462|NCT00162123|3571254|FG007|Overall Study|Withdrawal by Subject|0
2006463|NCT00162123|3571247|FG000|Overall Study|Deterioration without progression|2
2006464|NCT00162123|3571248|FG001|Overall Study|Deterioration without progression|2
2006465|NCT00162123|3571249|FG002|Overall Study|Deterioration without progression|3
2006466|NCT00162123|3571250|FG003|Overall Study|Deterioration without progression|0
2006467|NCT00162123|3571251|FG004|Overall Study|Deterioration without progression|1
2006468|NCT00162123|3571252|FG005|Overall Study|Deterioration without progression|0
2006469|NCT00162123|3571253|FG006|Overall Study|Deterioration without progression|0
2006470|NCT00162123|3571254|FG007|Overall Study|Deterioration without progression|0
2006471|NCT00162123|3571247|FG000|Overall Study|Adverse Event|1
2006472|NCT00162123|3571248|FG001|Overall Study|Adverse Event|2
2006473|NCT00162123|3571249|FG002|Overall Study|Adverse Event|0
2006474|NCT00162123|3571250|FG003|Overall Study|Adverse Event|2
2006475|NCT00162123|3571251|FG004|Overall Study|Adverse Event|1
2006476|NCT00162123|3571252|FG005|Overall Study|Adverse Event|0
2006477|NCT00162123|3571253|FG006|Overall Study|Adverse Event|0
2006478|NCT00162123|3571254|FG007|Overall Study|Adverse Event|0
2006479|NCT00162123|3571247|FG000|Overall Study|Not specified (before treatment)|2
2006480|NCT00162123|3571248|FG001|Overall Study|Not specified (before treatment)|0
2006481|NCT00162123|3571249|FG002|Overall Study|Not specified (before treatment)|0
2006482|NCT00162123|3571250|FG003|Overall Study|Not specified (before treatment)|0
2006483|NCT00162123|3571251|FG004|Overall Study|Not specified (before treatment)|12
2006484|NCT00162123|3571252|FG005|Overall Study|Not specified (before treatment)|1
2006485|NCT00162123|3571253|FG006|Overall Study|Not specified (before treatment)|0
2006486|NCT00162123|3571254|FG007|Overall Study|Not specified (before treatment)|0
2006487|NCT00162123|3571247|FG000|Overall Study|Not specified (after start of treatment)|0
2006488|NCT00162123|3571248|FG001|Overall Study|Not specified (after start of treatment)|0
2006489|NCT00162123|3571249|FG002|Overall Study|Not specified (after start of treatment)|0
2006490|NCT00162123|3571250|FG003|Overall Study|Not specified (after start of treatment)|0
2006491|NCT00162123|3571251|FG004|Overall Study|Not specified (after start of treatment)|3
2006492|NCT00162123|3571252|FG005|Overall Study|Not specified (after start of treatment)|0
2006493|NCT00162123|3571253|FG006|Overall Study|Not specified (after start of treatment)|0
2006494|NCT00162123|3571254|FG007|Overall Study|Not specified (after start of treatment)|0
2006495|NCT00162123|3571247|FG000|Overall Study|Physician Decision|1
2006496|NCT00162123|3571248|FG001|Overall Study|Physician Decision|2
2006497|NCT00162123|3571249|FG002|Overall Study|Physician Decision|0
2006498|NCT00162123|3571250|FG003|Overall Study|Physician Decision|0
2006499|NCT00162123|3571251|FG004|Overall Study|Physician Decision|0
2006500|NCT00162123|3571252|FG005|Overall Study|Physician Decision|1
2006501|NCT00162123|3571253|FG006|Overall Study|Physician Decision|1
2006502|NCT00162123|3571254|FG007|Overall Study|Physician Decision|0
2006503|NCT00162123|3571247|FG000|Overall Study|Tumor assessment only (not treated)|0
2006504|NCT00162123|3571248|FG001|Overall Study|Tumor assessment only (not treated)|0
2006505|NCT00162123|3571249|FG002|Overall Study|Tumor assessment only (not treated)|0
2006506|NCT00162123|3571250|FG003|Overall Study|Tumor assessment only (not treated)|0
2006507|NCT00162123|3571251|FG004|Overall Study|Tumor assessment only (not treated)|0
2006508|NCT00162123|3571252|FG005|Overall Study|Tumor assessment only (not treated)|0
2006509|NCT00162123|3571253|FG006|Overall Study|Tumor assessment only (not treated)|0
2006510|NCT00162123|3571254|FG007|Overall Study|Tumor assessment only (not treated)|1
2006511|NCT00162123|3571247|FG000|Overall Study|Follow-up only (not treated or assessed)|0
2006512|NCT00162123|3571248|FG001|Overall Study|Follow-up only (not treated or assessed)|0
2006513|NCT00162123|3571249|FG002|Overall Study|Follow-up only (not treated or assessed)|0
2006514|NCT00162123|3571250|FG003|Overall Study|Follow-up only (not treated or assessed)|0
2006515|NCT00162123|3571251|FG004|Overall Study|Follow-up only (not treated or assessed)|0
2006516|NCT00162123|3571252|FG005|Overall Study|Follow-up only (not treated or assessed)|0
2006517|NCT00162123|3571253|FG006|Overall Study|Follow-up only (not treated or assessed)|0
2006518|NCT00162123|3571254|FG007|Overall Study|Follow-up only (not treated or assessed)|57
2006519|NCT00162136|3571279|FG000|Overall Study|Adverse Event|1
2006520|NCT00162136|3571279|FG000|Overall Study|Death|1
2006521|NCT00162136|3571279|FG000|Overall Study|Disease Progression/Relapse|23
2006522|NCT00162136|3571279|FG000|Overall Study|Investigator Request|5
2006523|NCT00162136|3571279|FG000|Overall Study|Study Drug Toxicity|4
2006524|NCT00162136|3571279|FG000|Overall Study|Withdrawal by Subject|1
2006525|NCT00162266|3571306|FG000|Double-Blind Period|Adverse Event|5
2006526|NCT00162266|3571307|FG001|Double-Blind Period|Adverse Event|9
2006527|NCT00162266|3571308|FG002|Double-Blind Period|Adverse Event|11
2006528|NCT00162266|3571309|FG003|Double-Blind Period|Adverse Event|0
2006529|NCT00162266|3571306|FG000|Double-Blind Period|Death|0
2006530|NCT00162266|3571307|FG001|Double-Blind Period|Death|1
2006531|NCT00162266|3571308|FG002|Double-Blind Period|Death|0
2006532|NCT00162266|3571309|FG003|Double-Blind Period|Death|0
2006533|NCT00162266|3571306|FG000|Double-Blind Period|Lost to Follow-up|1
2006534|NCT00162266|3571307|FG001|Double-Blind Period|Lost to Follow-up|2
2006535|NCT00162266|3571308|FG002|Double-Blind Period|Lost to Follow-up|0
2006536|NCT00162266|3571309|FG003|Double-Blind Period|Lost to Follow-up|0
2006537|NCT00162266|3571306|FG000|Double-Blind Period|Other Reason|1
2006538|NCT00162266|3571307|FG001|Double-Blind Period|Other Reason|0
2006539|NCT00162266|3571308|FG002|Double-Blind Period|Other Reason|1
2006540|NCT00162266|3571309|FG003|Double-Blind Period|Other Reason|0
2006541|NCT00162266|3571306|FG000|Double-Blind Period|Lack of Efficacy|13
2006542|NCT00162266|3571307|FG001|Double-Blind Period|Lack of Efficacy|17
2006543|NCT00162266|3571308|FG002|Double-Blind Period|Lack of Efficacy|30
2006544|NCT00162266|3571309|FG003|Double-Blind Period|Lack of Efficacy|0
2006545|NCT00162266|3571306|FG000|Double-Blind Period|Withdrawal by Subject|5
2006546|NCT00162266|3571307|FG001|Double-Blind Period|Withdrawal by Subject|2
2006547|NCT00162266|3571308|FG002|Double-Blind Period|Withdrawal by Subject|6
2006548|NCT00162266|3571309|FG003|Double-Blind Period|Withdrawal by Subject|0
2006549|NCT00162266|3571306|FG000|Open-Label Period|Death|0
2006550|NCT00162266|3571307|FG001|Open-Label Period|Death|0
2006551|NCT00162266|3571308|FG002|Open-Label Period|Death|0
2006552|NCT00162266|3571309|FG003|Open-Label Period|Death|7
2006553|NCT00162266|3571306|FG000|Open-Label Period|Adverse Event|0
2006554|NCT00162266|3571307|FG001|Open-Label Period|Adverse Event|0
2006555|NCT00162266|3571308|FG002|Open-Label Period|Adverse Event|0
2006556|NCT00162266|3571309|FG003|Open-Label Period|Adverse Event|46
2006557|NCT00162266|3571306|FG000|Open-Label Period|Lack of Efficacy|0
2006558|NCT00162266|3571307|FG001|Open-Label Period|Lack of Efficacy|0
2006559|NCT00162266|3571308|FG002|Open-Label Period|Lack of Efficacy|0
2006560|NCT00162266|3571309|FG003|Open-Label Period|Lack of Efficacy|26
2006561|NCT00162266|3571306|FG000|Open-Label Period|Lost to Follow-up|0
2006562|NCT00162266|3571307|FG001|Open-Label Period|Lost to Follow-up|0
2006563|NCT00162266|3571308|FG002|Open-Label Period|Lost to Follow-up|0
2006564|NCT00162266|3571309|FG003|Open-Label Period|Lost to Follow-up|3
2006565|NCT00162266|3571306|FG000|Open-Label Period|Withdrawal by Subject|0
2006566|NCT00162266|3571307|FG001|Open-Label Period|Withdrawal by Subject|0
2006567|NCT00162266|3571308|FG002|Open-Label Period|Withdrawal by Subject|0
2006568|NCT00162266|3571309|FG003|Open-Label Period|Withdrawal by Subject|31
2006569|NCT00162266|3571306|FG000|Open-Label Period|Administrative Reason By Sponsor|0
2006570|NCT00162266|3571307|FG001|Open-Label Period|Administrative Reason By Sponsor|0
2006571|NCT00162266|3571308|FG002|Open-Label Period|Administrative Reason By Sponsor|0
2006572|NCT00162266|3571309|FG003|Open-Label Period|Administrative Reason By Sponsor|9
2006573|NCT00162266|3571306|FG000|Open-Label Period|Other Reasons|0
2006574|NCT00162266|3571307|FG001|Open-Label Period|Other Reasons|0
2006575|NCT00162266|3571308|FG002|Open-Label Period|Other Reasons|0
2006576|NCT00162266|3571309|FG003|Open-Label Period|Other Reasons|15
2006577|NCT00162981|3571363|FG000|Overall Study|Adverse Event|2
2006578|NCT00162981|3571364|FG001|Overall Study|Adverse Event|5
2006579|NCT00162981|3571363|FG000|Overall Study|Withdrawal by Subject|1
2006580|NCT00162981|3571364|FG001|Overall Study|Withdrawal by Subject|1
2006581|NCT00162981|3571363|FG000|Overall Study|Physician Decision|1
2006582|NCT00162981|3571364|FG001|Overall Study|Physician Decision|0
2006583|NCT00163020|3571372|FG000|Overall Study|Lost to Follow-up|0
2006584|NCT00163020|3571373|FG001|Overall Study|Lost to Follow-up|2
2006585|NCT00163189|3571381|FG000|Overall Study|Other|6
2006586|NCT00163189|3571381|FG000|Overall Study|Lost to Follow-up|1
2006587|NCT00163189|3571381|FG000|Overall Study|Protocol Violation|2
2006588|NCT00163189|3571381|FG000|Overall Study|Death|3
2006589|NCT00163189|3571381|FG000|Overall Study|Adverse Event|6
2006590|NCT00163189|3571381|FG000|Overall Study|Lack of Efficacy|7
2006591|NCT00163189|3571381|FG000|Overall Study|Study terminated by sponsor|11
2006592|NCT00163189|3571381|FG000|Overall Study|Withdrawal by Subject|11
2006593|NCT00163189|3571381|FG000|Overall Study|Did not meet continuation criterion|16
2006594|NCT00163215|3571385|FG000|Overall Study|Lack of Efficacy|3
2006595|NCT00163215|3571385|FG000|Overall Study|Withdrawal by Subject|5
2006596|NCT00163215|3571385|FG000|Overall Study|Other|7
2006597|NCT00163657|3571405|FG000|Overall Study|Death|12
2006598|NCT00163657|3571406|FG001|Overall Study|Death|14
2006599|NCT00163657|3571407|FG002|Overall Study|Death|19
2006600|NCT00163657|3571405|FG000|Overall Study|graft loss|4
2006601|NCT00163657|3571406|FG001|Overall Study|graft loss|1
2006602|NCT00163657|3571407|FG002|Overall Study|graft loss|2
2006603|NCT00163657|3571405|FG000|Overall Study|Withdrawal by Subject|2
2006604|NCT00163657|3571406|FG001|Overall Study|Withdrawal by Subject|3
2006605|NCT00163657|3571407|FG002|Overall Study|Withdrawal by Subject|2
2006606|NCT00163657|3571405|FG000|Overall Study|Physician Decision|0
2006607|NCT00163657|3571406|FG001|Overall Study|Physician Decision|1
2006608|NCT00163657|3571407|FG002|Overall Study|Physician Decision|1
2006609|NCT00163657|3571405|FG000|Overall Study|Non Compliance|1
2006610|NCT00163657|3571406|FG001|Overall Study|Non Compliance|0
2006611|NCT00163657|3571407|FG002|Overall Study|Non Compliance|0
2006612|NCT00163657|3571405|FG000|Overall Study|Lost to Follow-up|1
2006613|NCT00163657|3571406|FG001|Overall Study|Lost to Follow-up|3
2006614|NCT00163657|3571407|FG002|Overall Study|Lost to Follow-up|10
2006615|NCT00163657|3571405|FG000|Overall Study|Other reason|0
2006616|NCT00163657|3571406|FG001|Overall Study|Other reason|1
2006617|NCT00163657|3571407|FG002|Overall Study|Other reason|3
2006618|NCT00165646|3571418|FG000|Overall Study|Adverse Event|1
2006619|NCT00165646|3571419|FG001|Overall Study|Adverse Event|1
2006620|NCT00165646|3571420|FG002|Overall Study|Adverse Event|1
2006621|NCT00165646|3571418|FG000|Overall Study|Lack of Efficacy|1
2006622|NCT00165646|3571419|FG001|Overall Study|Lack of Efficacy|2
2006623|NCT00165646|3571420|FG002|Overall Study|Lack of Efficacy|0
2006624|NCT00165646|3571418|FG000|Overall Study|Withdrawal by Subject|0
2006625|NCT00165646|3571419|FG001|Overall Study|Withdrawal by Subject|2
2006626|NCT00165646|3571420|FG002|Overall Study|Withdrawal by Subject|1
2006627|NCT00165646|3571418|FG000|Overall Study|Physician Decision|2
2006628|NCT00165646|3571419|FG001|Overall Study|Physician Decision|0
2006629|NCT00165646|3571420|FG002|Overall Study|Physician Decision|2
2006630|NCT00165646|3571418|FG000|Overall Study|Protocol Violation|1
2006631|NCT00165646|3571419|FG001|Overall Study|Protocol Violation|0
2006632|NCT00165646|3571420|FG002|Overall Study|Protocol Violation|0
2006633|NCT00165672|3571430|FG000|Overall Study|Adverse Event|0
2006634|NCT00165672|3571431|FG001|Overall Study|Adverse Event|1
2006635|NCT00165698|3571439|FG000|Overall Study|Adverse Event|2
2006636|NCT00165698|3571440|FG001|Overall Study|Adverse Event|10
2006637|NCT00165698|3571439|FG000|Overall Study|Lost to Follow-up|2
2006638|NCT00165698|3571440|FG001|Overall Study|Lost to Follow-up|2
2006639|NCT00165698|3571439|FG000|Overall Study|Withdrawal by Subject|2
2006640|NCT00165698|3571440|FG001|Overall Study|Withdrawal by Subject|1
2006641|NCT00165698|3571439|FG000|Overall Study|Protocol Violation|1
2006642|NCT00165698|3571440|FG001|Overall Study|Protocol Violation|0
2006643|NCT00165698|3571439|FG000|Overall Study|Not Taken/Lost the medicine|1
2006644|NCT00165698|3571440|FG001|Overall Study|Not Taken/Lost the medicine|2
2006645|NCT00165776|3571450|FG000|Overall Study|Lack of Efficacy|0
2006646|NCT00165776|3571451|FG001|Overall Study|Lack of Efficacy|0
2006647|NCT00165776|3571452|FG002|Overall Study|Lack of Efficacy|0
2006648|NCT00165776|3571453|FG003|Overall Study|Lack of Efficacy|1
2006649|NCT00165776|3571450|FG000|Overall Study|Withdrawal by Subject|4
2006650|NCT00165776|3571451|FG001|Overall Study|Withdrawal by Subject|1
2006651|NCT00165776|3571452|FG002|Overall Study|Withdrawal by Subject|2
2006652|NCT00165776|3571453|FG003|Overall Study|Withdrawal by Subject|0
2006653|NCT00165776|3571450|FG000|Overall Study|Worsening of Cervical Dystonia|0
2006654|NCT00165776|3571451|FG001|Overall Study|Worsening of Cervical Dystonia|0
2006655|NCT00165776|3571452|FG002|Overall Study|Worsening of Cervical Dystonia|0
2006656|NCT00165776|3571453|FG003|Overall Study|Worsening of Cervical Dystonia|1
2006657|NCT00165789|3571467|FG000|Overall Study|Adverse Event|0
2006658|NCT00165789|3571468|FG001|Overall Study|Adverse Event|3
2006659|NCT00165789|3571469|FG002|Overall Study|Adverse Event|0
2006660|NCT00165789|3571470|FG003|Overall Study|Adverse Event|12
2006661|NCT00165789|3571467|FG000|Overall Study|Withdrawal by Subject|0
2006662|NCT00165789|3571468|FG001|Overall Study|Withdrawal by Subject|1
2006663|NCT00165789|3571469|FG002|Overall Study|Withdrawal by Subject|1
2006664|NCT00165789|3571470|FG003|Overall Study|Withdrawal by Subject|2
2025210|NCT00340834|3593765|FG004|Extension Phase of Study|Protocol Violation|0
2025211|NCT00340834|3593761|FG000|Extension Phase of Study|Death|0
2025212|NCT00340834|3593762|FG001|Extension Phase of Study|Death|0
2025213|NCT00340834|3593763|FG002|Extension Phase of Study|Death|0
2025214|NCT00340834|3593764|FG003|Extension Phase of Study|Death|0
2025215|NCT00340834|3593765|FG004|Extension Phase of Study|Death|1
2025216|NCT00342628|3593814|FG000|Overall Study|Withdrawal by Subject|19
2025217|NCT00342628|3593815|FG001|Overall Study|Withdrawal by Subject|19
2025218|NCT00342628|3593816|FG002|Overall Study|Withdrawal by Subject|18
2025219|NCT00342628|3593814|FG000|Overall Study|Death|1
2025220|NCT00342628|3593815|FG001|Overall Study|Death|1
2025221|NCT00342628|3593816|FG002|Overall Study|Death|0
2025222|NCT00342628|3593814|FG000|Overall Study|moved residence|0
2025223|NCT00342628|3593815|FG001|Overall Study|moved residence|1
2025224|NCT00342628|3593816|FG002|Overall Study|moved residence|1
2025993|NCT00348140|3594699|FG002|Overall Study|Efficacy related|0
2025994|NCT00348140|3594697|FG000|Overall Study|Administration related|3
2025995|NCT00348140|3594698|FG001|Overall Study|Administration related|1
2025996|NCT00348140|3594699|FG002|Overall Study|Administration related|1
2025997|NCT00348140|3594697|FG000|Overall Study|Unmet inclusion-exclusion criteria|1
2025998|NCT00348140|3594698|FG001|Overall Study|Unmet inclusion-exclusion criteria|0
2025999|NCT00348140|3594699|FG002|Overall Study|Unmet inclusion-exclusion criteria|1
2026000|NCT00348140|3594697|FG000|Overall Study|Participant unwell|1
2026001|NCT00348140|3594698|FG001|Overall Study|Participant unwell|0
2026002|NCT00348140|3594699|FG002|Overall Study|Participant unwell|0
2026003|NCT00348140|3594697|FG000|Overall Study|Screen failure|1
2026004|NCT00348140|3594698|FG001|Overall Study|Screen failure|0
2026005|NCT00348140|3594699|FG002|Overall Study|Screen failure|0
2026006|NCT00348140|3594697|FG000|Overall Study|Investigator decided to discontinue|4
2026007|NCT00348140|3594698|FG001|Overall Study|Investigator decided to discontinue|1
2026008|NCT00348140|3594699|FG002|Overall Study|Investigator decided to discontinue|4
2026009|NCT00348140|3594697|FG000|Overall Study|Decided to discontinue on their own|1
2026010|NCT00348140|3594698|FG001|Overall Study|Decided to discontinue on their own|4
2026011|NCT00348140|3594699|FG002|Overall Study|Decided to discontinue on their own|1
2026012|NCT00348140|3594697|FG000|Overall Study|Use of prohibited drug|1
2026013|NCT00348140|3594698|FG001|Overall Study|Use of prohibited drug|0
2026014|NCT00348140|3594699|FG002|Overall Study|Use of prohibited drug|2
2026015|NCT00348140|3594697|FG000|Overall Study|Disease progression|1
2026016|NCT00348140|3594698|FG001|Overall Study|Disease progression|2
2026017|NCT00348140|3594699|FG002|Overall Study|Disease progression|5
2026018|NCT00348140|3594697|FG000|Overall Study|Increased risk of cardiac infarction|0
2026019|NCT00348140|3594698|FG001|Overall Study|Increased risk of cardiac infarction|1
2026020|NCT00348140|3594699|FG002|Overall Study|Increased risk of cardiac infarction|0
2026021|NCT00348140|3594697|FG000|Overall Study|Serious adverse event|0
2026022|NCT00348140|3594698|FG001|Overall Study|Serious adverse event|1
2026023|NCT00348140|3594699|FG002|Overall Study|Serious adverse event|0
2026024|NCT00348140|3594697|FG000|Overall Study|Abnormal ECG|0
2026025|NCT00348140|3594698|FG001|Overall Study|Abnormal ECG|1
2026026|NCT00348140|3594699|FG002|Overall Study|Abnormal ECG|3
2026027|NCT00348140|3594697|FG000|Overall Study|Participant died|0
2026028|NCT00348140|3594698|FG001|Overall Study|Participant died|1
2026029|NCT00348140|3594699|FG002|Overall Study|Participant died|0
2026030|NCT00348140|3594697|FG000|Overall Study|Exclusion criteria met|0
2026031|NCT00348140|3594698|FG001|Overall Study|Exclusion criteria met|0
2026032|NCT00348140|3594699|FG002|Overall Study|Exclusion criteria met|1
2026033|NCT00348140|3594697|FG000|Overall Study|Memory declined|0
2026034|NCT00348140|3594698|FG001|Overall Study|Memory declined|0
2026035|NCT00348140|3594699|FG002|Overall Study|Memory declined|1
2026036|NCT00348283|3594714|FG000|Induction|Adverse Event|0
2026037|NCT00348283|3594715|FG001|Induction|Adverse Event|2
2026038|NCT00348283|3594714|FG000|Induction|Protocol Violation|0
2026039|NCT00348283|3594715|FG001|Induction|Protocol Violation|4
2026040|NCT00348283|3594714|FG000|Double Blind|Adverse Event|2
2026041|NCT00348283|3594715|FG001|Double Blind|Adverse Event|5
2026042|NCT00348283|3594714|FG000|Double Blind|Withdrawal by Subject|1
2026043|NCT00348283|3594715|FG001|Double Blind|Withdrawal by Subject|1
2006665|NCT00165841|3571482|FG000|Overall Study|Adverse Event|2
2006666|NCT00165841|3571483|FG001|Overall Study|Adverse Event|3
2006667|NCT00165841|3571482|FG000|Overall Study|Lack of Efficacy|6
2006668|NCT00165841|3571483|FG001|Overall Study|Lack of Efficacy|33
2006669|NCT00165841|3571482|FG000|Overall Study|Lost to Follow-up|4
2006670|NCT00165841|3571483|FG001|Overall Study|Lost to Follow-up|4
2006671|NCT00165841|3571482|FG000|Overall Study|Withdrawal by Subject|7
2006672|NCT00165841|3571483|FG001|Overall Study|Withdrawal by Subject|8
2006673|NCT00165841|3571482|FG000|Overall Study|Physician Decision|1
2006674|NCT00165841|3571483|FG001|Overall Study|Physician Decision|0
2006675|NCT00165841|3571482|FG000|Overall Study|Protocol Violation|6
2006676|NCT00165841|3571483|FG001|Overall Study|Protocol Violation|8
2006677|NCT00165841|3571482|FG000|Overall Study|Other|3
2006678|NCT00165841|3571483|FG001|Overall Study|Other|5
2006679|NCT00165841|3571482|FG000|Overall Study|Medication Noncompliance|1
2006680|NCT00165841|3571483|FG001|Overall Study|Medication Noncompliance|1
2006681|NCT00165984|3571498|FG000|Overall Study|Death|15
2006682|NCT00166114|3571517|FG000|Overall Study|Protocol Violation|2
2006683|NCT00166114|3571518|FG001|Overall Study|Protocol Violation|1
2006684|NCT00166114|3571517|FG000|Overall Study|Withdrawal by Subject|10
2006685|NCT00166114|3571518|FG001|Overall Study|Withdrawal by Subject|4
2006686|NCT00166114|3571517|FG000|Overall Study|Adverse Event|2
2006687|NCT00166114|3571518|FG001|Overall Study|Adverse Event|1
2006688|NCT00166296|3571552|FG000|Overall Study|Withdrawal by Subject|1
2006689|NCT00166296|3571553|FG001|Overall Study|Withdrawal by Subject|3
2006690|NCT00166296|3571552|FG000|Overall Study|Adverse Event|2
2006691|NCT00166296|3571553|FG001|Overall Study|Adverse Event|4
2006692|NCT00166296|3571552|FG000|Overall Study|Lost to Follow-up|4
2006693|NCT00166296|3571553|FG001|Overall Study|Lost to Follow-up|2
2006694|NCT00166439|3571568|FG000|Overall Study|Ineligible|5
2006695|NCT00166517|3571574|FG000|Overall Study|Lost to Follow-up|1
2006696|NCT00166517|3571575|FG001|Overall Study|Lost to Follow-up|0
2006697|NCT00166517|3571574|FG000|Overall Study|Protocol Violation|4
2006698|NCT00166517|3571575|FG001|Overall Study|Protocol Violation|1
2006699|NCT00166517|3571574|FG000|Overall Study|Withdrawal by Subject|0
2214266|NCT01686152|3856444|FG002|Overall Study|Protocol Violation|0
2214267|NCT01686152|3856442|FG000|Overall Study|Adverse Event|12
2214268|NCT01686152|3856443|FG001|Overall Study|Adverse Event|11
2214269|NCT01686152|3856444|FG002|Overall Study|Adverse Event|0
2214270|NCT01686152|3856442|FG000|Overall Study|Lack of Efficacy|0
2214271|NCT01686152|3856443|FG001|Overall Study|Lack of Efficacy|0
2214272|NCT01686152|3856444|FG002|Overall Study|Lack of Efficacy|1
2214273|NCT01686152|3856442|FG000|Overall Study|IP Non-compliance|5
2214274|NCT01686152|3856443|FG001|Overall Study|IP Non-compliance|5
2214275|NCT01686152|3856444|FG002|Overall Study|IP Non-compliance|0
2214276|NCT01686152|3856442|FG000|Overall Study|Lost to Follow-up|7
2214277|NCT01686152|3856443|FG001|Overall Study|Lost to Follow-up|6
2214278|NCT01686152|3856444|FG002|Overall Study|Lost to Follow-up|5
2214279|NCT01686373|3856458|FG000|Overall Study|Lost to Follow-up|3
2214280|NCT01686373|3856459|FG001|Overall Study|Lost to Follow-up|0
2214281|NCT01686373|3856458|FG000|Overall Study|Withdrawal by Subject|0
2214282|NCT01686373|3856459|FG001|Overall Study|Withdrawal by Subject|1
2214283|NCT01686373|3856458|FG000|Overall Study|Adverse Event|0
2214284|NCT01686373|3856459|FG001|Overall Study|Adverse Event|1
2214285|NCT01686438|3856468|FG000|Overall Study|Lost to Follow-up|8
2214286|NCT01686438|3856469|FG001|Overall Study|Lost to Follow-up|9
2214287|NCT01686438|3856470|FG002|Overall Study|Lost to Follow-up|10
2006700|NCT00166517|3571575|FG001|Overall Study|Withdrawal by Subject|1
2006701|NCT00166712|3571583|FG000|Overall Study|Death|0
2006702|NCT00166712|3571584|FG001|Overall Study|Death|1
2006703|NCT00166712|3571583|FG000|Overall Study|Adverse Event|1
2006704|NCT00166712|3571584|FG001|Overall Study|Adverse Event|0
2006705|NCT00166712|3571583|FG000|Overall Study|Withdrawal by Subject|1
2006706|NCT00166712|3571584|FG001|Overall Study|Withdrawal by Subject|2
2006707|NCT00166712|3571583|FG000|Overall Study|Physician Decision|0
2006708|NCT00166712|3571584|FG001|Overall Study|Physician Decision|2
2006709|NCT00167245|3571620|FG000|Overall Study|Lost to Follow-up|20
2006710|NCT00167245|3571621|FG001|Overall Study|Lost to Follow-up|31
2006711|NCT00167245|3571620|FG000|Overall Study|Withdrawal by Subject|5
2006712|NCT00167245|3571621|FG001|Overall Study|Withdrawal by Subject|8
2006713|NCT00167245|3571620|FG000|Overall Study|Incarcerated|3
2006714|NCT00167245|3571621|FG001|Overall Study|Incarcerated|2
2006715|NCT00167245|3571620|FG000|Overall Study|Drowsy|1
2006716|NCT00167245|3571621|FG001|Overall Study|Drowsy|0
2006717|NCT00167310|3571632|FG000|Overall Study|Protocol Violation|5
2006718|NCT00167310|3571633|FG001|Overall Study|Protocol Violation|3
2006719|NCT00167310|3571632|FG000|Overall Study|Withdrawal by Subject|3
2006720|NCT00167310|3571633|FG001|Overall Study|Withdrawal by Subject|7
2214288|NCT01686438|3856468|FG000|Overall Study|Adverse Event|0
2214289|NCT01686438|3856469|FG001|Overall Study|Adverse Event|0
2006721|NCT00167414|3571654|FG000|Overall Study|Death|10
2006722|NCT00167778|3571671|FG000|Overall Study|Withdrawal by Subject|1
2006723|NCT00168038|3571685|FG000|Overall Study|Adverse Event|1
2006724|NCT00168038|3571685|FG000|Overall Study|Therapy failure|1
2006725|NCT00168064|3571691|FG000|Overall Study|Adverse Event|26
2006726|NCT00168064|3571692|FG001|Overall Study|Adverse Event|22
2214290|NCT01686438|3856470|FG002|Overall Study|Adverse Event|1
2006727|NCT00168064|3571691|FG000|Overall Study|Withdrawal by Subject|3
2006728|NCT00168064|3571692|FG001|Overall Study|Withdrawal by Subject|4
2006729|NCT00168064|3571691|FG000|Overall Study|Lack of Efficacy|4
2006730|NCT00168064|3571692|FG001|Overall Study|Lack of Efficacy|4
2006731|NCT00168064|3571691|FG000|Overall Study|Lost to Follow-up|4
2006732|NCT00168064|3571692|FG001|Overall Study|Lost to Follow-up|3
2006733|NCT00168064|3571691|FG000|Overall Study|Non-compliance|2
2006734|NCT00168064|3571692|FG001|Overall Study|Non-compliance|3
2006735|NCT00168064|3571691|FG000|Overall Study|Concurrent Illness|4
2006736|NCT00168064|3571692|FG001|Overall Study|Concurrent Illness|3
2006737|NCT00168064|3571691|FG000|Overall Study|Subject's Best interest|2
2006738|NCT00168064|3571692|FG001|Overall Study|Subject's Best interest|2
2006739|NCT00168064|3571691|FG000|Overall Study|Various|4
2006740|NCT00168064|3571692|FG001|Overall Study|Various|3
2006741|NCT00168103|3571703|FG000|Overall Study|Withdrawal by Subject|1
2006742|NCT00168103|3571704|FG001|Overall Study|Withdrawal by Subject|2
2006743|NCT00168103|3571705|FG002|Overall Study|Withdrawal by Subject|1
2006744|NCT00168103|3571706|FG003|Overall Study|Withdrawal by Subject|0
2006745|NCT00168103|3571703|FG000|Overall Study|Lost to Follow-up|1
2006746|NCT00168103|3571704|FG001|Overall Study|Lost to Follow-up|3
2006747|NCT00168103|3571705|FG002|Overall Study|Lost to Follow-up|0
2006748|NCT00168103|3571706|FG003|Overall Study|Lost to Follow-up|0
2006749|NCT00168805|3571812|FG000|Overall Study|Adverse Event|7
2006750|NCT00168805|3571813|FG001|Overall Study|Adverse Event|11
2006751|NCT00168805|3571814|FG002|Overall Study|Adverse Event|16
2006752|NCT00168805|3571812|FG000|Overall Study|Protocol Violation|12
2006753|NCT00168805|3571813|FG001|Overall Study|Protocol Violation|11
2006754|NCT00168805|3571814|FG002|Overall Study|Protocol Violation|8
2006755|NCT00168805|3571812|FG000|Overall Study|Lost to Follow-up|12
2006756|NCT00168805|3571813|FG001|Overall Study|Lost to Follow-up|17
2006757|NCT00168805|3571814|FG002|Overall Study|Lost to Follow-up|11
2006758|NCT00168805|3571812|FG000|Overall Study|Withdrawal by Subject|16
2006759|NCT00168805|3571813|FG001|Overall Study|Withdrawal by Subject|18
2006760|NCT00168805|3571814|FG002|Overall Study|Withdrawal by Subject|21
2006761|NCT00168805|3571812|FG000|Overall Study|Other|24
2006762|NCT00168805|3571813|FG001|Overall Study|Other|21
2006763|NCT00168805|3571814|FG002|Overall Study|Other|22
2006764|NCT00168805|3571812|FG000|Treatment|Adverse Event|25
2006765|NCT00168805|3571813|FG001|Treatment|Adverse Event|26
2006766|NCT00168805|3571814|FG002|Treatment|Adverse Event|32
2006767|NCT00168805|3571812|FG000|Treatment|Protocol Violation|3
2006768|NCT00168805|3571813|FG001|Treatment|Protocol Violation|5
2006769|NCT00168805|3571814|FG002|Treatment|Protocol Violation|5
2006770|NCT00168805|3571812|FG000|Treatment|Withdrawal by Subject|3
2006771|NCT00168805|3571813|FG001|Treatment|Withdrawal by Subject|7
2006772|NCT00168805|3571814|FG002|Treatment|Withdrawal by Subject|8
2006773|NCT00168805|3571812|FG000|Treatment|Other|18
2006774|NCT00168805|3571813|FG001|Treatment|Other|18
2006775|NCT00168805|3571814|FG002|Treatment|Other|17
2006776|NCT00168818|3571825|FG000|Overall Study|Adverse Event|23
2006777|NCT00168818|3571826|FG001|Overall Study|Adverse Event|29
2006778|NCT00168818|3571827|FG002|Overall Study|Adverse Event|31
2006779|NCT00168818|3571825|FG000|Overall Study|Protocol Violation|16
2006780|NCT00168818|3571826|FG001|Overall Study|Protocol Violation|11
2006781|NCT00168818|3571827|FG002|Overall Study|Protocol Violation|11
2006782|NCT00168818|3571825|FG000|Overall Study|Lost to Follow-up|13
2006783|NCT00168818|3571826|FG001|Overall Study|Lost to Follow-up|4
2006784|NCT00168818|3571827|FG002|Overall Study|Lost to Follow-up|15
2006785|NCT00168818|3571825|FG000|Overall Study|Withdrawal by Subject|43
2006786|NCT00168818|3571826|FG001|Overall Study|Withdrawal by Subject|41
2006787|NCT00168818|3571827|FG002|Overall Study|Withdrawal by Subject|37
2006788|NCT00168818|3571825|FG000|Overall Study|Other|22
2006789|NCT00168818|3571826|FG001|Overall Study|Other|24
2006790|NCT00168818|3571827|FG002|Overall Study|Other|30
2006791|NCT00168818|3571825|FG000|Treatment|Adverse Event|77
2006792|NCT00168818|3571826|FG001|Treatment|Adverse Event|89
2006793|NCT00168818|3571827|FG002|Treatment|Adverse Event|68
2006794|NCT00168818|3571825|FG000|Treatment|Protocol Violation|8
2006795|NCT00168818|3571826|FG001|Treatment|Protocol Violation|11
2006796|NCT00168818|3571827|FG002|Treatment|Protocol Violation|11
2006797|NCT00168818|3571825|FG000|Treatment|Lost to Follow-up|0
2006798|NCT00168818|3571826|FG001|Treatment|Lost to Follow-up|2
2006799|NCT00168818|3571827|FG002|Treatment|Lost to Follow-up|1
2006800|NCT00168818|3571825|FG000|Treatment|Withdrawal by Subject|25
2006801|NCT00168818|3571826|FG001|Treatment|Withdrawal by Subject|20
2006802|NCT00168818|3571827|FG002|Treatment|Withdrawal by Subject|22
2006803|NCT00168818|3571825|FG000|Treatment|Other|23
2006804|NCT00168818|3571826|FG001|Treatment|Other|29
2006805|NCT00168818|3571827|FG002|Treatment|Other|31
2006806|NCT00168831|3571838|FG000|Overall Study|Adverse Event|36
2006807|NCT00168831|3571839|FG001|Overall Study|Adverse Event|47
2006808|NCT00168831|3571840|FG002|Overall Study|Adverse Event|74
2006809|NCT00168831|3571838|FG000|Overall Study|Lost to Follow-up|5
2006810|NCT00168831|3571839|FG001|Overall Study|Lost to Follow-up|6
2006811|NCT00168831|3571840|FG002|Overall Study|Lost to Follow-up|4
2006812|NCT00168831|3571838|FG000|Overall Study|Withdrawal by Subject|7
2006813|NCT00168831|3571839|FG001|Overall Study|Withdrawal by Subject|14
2006814|NCT00168831|3571840|FG002|Overall Study|Withdrawal by Subject|19
2006815|NCT00168831|3571838|FG000|Overall Study|Protocol Violation|6
2313238|NCT02786901|4020521|FG002|Overall Study|Physician Decision|0
2214291|NCT01686438|3856468|FG000|Overall Study|Protocol Violation|0
2214292|NCT01686438|3856469|FG001|Overall Study|Protocol Violation|0
2214293|NCT01686438|3856470|FG002|Overall Study|Protocol Violation|1
2006816|NCT00168831|3571839|FG001|Overall Study|Protocol Violation|11
2006817|NCT00168831|3571840|FG002|Overall Study|Protocol Violation|11
2006818|NCT00168831|3571838|FG000|Overall Study|Other|6
2006819|NCT00168831|3571839|FG001|Overall Study|Other|3
2006820|NCT00168831|3571840|FG002|Overall Study|Other|6
2006821|NCT00168844|3571851|FG000|Overall Study|Adverse Event|31
2006822|NCT00168844|3571852|FG001|Overall Study|Adverse Event|32
2006823|NCT00168844|3571853|FG002|Overall Study|Adverse Event|48
2006824|NCT00168844|3571851|FG000|Overall Study|Lost to Follow-up|4
2006825|NCT00168844|3571852|FG001|Overall Study|Lost to Follow-up|5
2006826|NCT00168844|3571853|FG002|Overall Study|Lost to Follow-up|11
2006827|NCT00168844|3571851|FG000|Overall Study|Withdrawal by Subject|12
2006828|NCT00168844|3571852|FG001|Overall Study|Withdrawal by Subject|9
2006829|NCT00168844|3571853|FG002|Overall Study|Withdrawal by Subject|19
2006830|NCT00168844|3571851|FG000|Overall Study|Protocol Violation|2
2006831|NCT00168844|3571852|FG001|Overall Study|Protocol Violation|2
2006832|NCT00168844|3571853|FG002|Overall Study|Protocol Violation|4
2006833|NCT00168844|3571851|FG000|Overall Study|Other|6
2006834|NCT00168844|3571852|FG001|Overall Study|Other|7
2006835|NCT00168844|3571853|FG002|Overall Study|Other|9
2006836|NCT00169104|3571863|FG000|Overall Study|Withdrawal by Subject|2
2006837|NCT00169104|3571864|FG001|Overall Study|Withdrawal by Subject|0
2006838|NCT00169104|3571863|FG000|Overall Study|Protocol Violation|0
2006839|NCT00169104|3571864|FG001|Overall Study|Protocol Violation|1
2006840|NCT00169104|3571863|FG000|Overall Study|Physician Decision|0
2006841|NCT00169104|3571864|FG001|Overall Study|Physician Decision|1
2006842|NCT00169442|3571877|FG000|Overall Study|Withdrawal by Subject|0
2006843|NCT00169442|3571878|FG001|Overall Study|Withdrawal by Subject|0
2006844|NCT00169442|3571879|FG002|Overall Study|Withdrawal by Subject|1
2006845|NCT00169442|3571880|FG003|Overall Study|Withdrawal by Subject|0
2006846|NCT00169442|3571881|FG004|Overall Study|Withdrawal by Subject|0
2006847|NCT00169442|3571882|FG005|Overall Study|Withdrawal by Subject|0
2006848|NCT00169442|3571877|FG000|Overall Study|Migrated/moved from study area|0
2006849|NCT00169442|3571878|FG001|Overall Study|Migrated/moved from study area|0
2006850|NCT00169442|3571879|FG002|Overall Study|Migrated/moved from study area|0
2006851|NCT00169442|3571880|FG003|Overall Study|Migrated/moved from study area|0
2006852|NCT00169442|3571881|FG004|Overall Study|Migrated/moved from study area|0
2006853|NCT00169442|3571882|FG005|Overall Study|Migrated/moved from study area|2
2006854|NCT00169442|3571877|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0
2006855|NCT00169442|3571878|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
2006856|NCT00169442|3571879|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0
2006857|NCT00169442|3571880|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0
2006858|NCT00169442|3571881|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1
2006859|NCT00169442|3571882|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0
2006860|NCT00169442|3571877|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0
2006861|NCT00169442|3571878|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1
2006862|NCT00169442|3571879|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0
2006863|NCT00169442|3571880|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0
2006864|NCT00169442|3571881|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0
2006865|NCT00169442|3571882|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0
2006866|NCT00170846|3571912|FG000|Overall Study|Subject withdrew Informed Consent|5
2006867|NCT00170846|3571913|FG001|Overall Study|Subject withdrew Informed Consent|12
2006868|NCT00170846|3571914|FG002|Overall Study|Subject withdrew Informed Consent|8
2006869|NCT00170846|3571912|FG000|Overall Study|Lost to Follow-up|6
2006870|NCT00170846|3571913|FG001|Overall Study|Lost to Follow-up|3
2006871|NCT00170846|3571914|FG002|Overall Study|Lost to Follow-up|2
2006872|NCT00170846|3571912|FG000|Overall Study|Death|0
2006873|NCT00170846|3571913|FG001|Overall Study|Death|3
2006874|NCT00170846|3571914|FG002|Overall Study|Death|3
2006875|NCT00170846|3571912|FG000|Overall Study|Reason Missing|0
2006876|NCT00170846|3571913|FG001|Overall Study|Reason Missing|1
2006877|NCT00170846|3571914|FG002|Overall Study|Reason Missing|0
2006878|NCT00170950|3571924|FG000|Overall Study|Death|236
2006879|NCT00170950|3571925|FG001|Overall Study|Death|274
2006880|NCT00170950|3571924|FG000|Overall Study|Withdrawal by Subject|496
2006881|NCT00170950|3571925|FG001|Overall Study|Withdrawal by Subject|498
2006882|NCT00170950|3571924|FG000|Overall Study|Lost to Follow-up|134
2006883|NCT00170950|3571925|FG001|Overall Study|Lost to Follow-up|115
2006884|NCT00170950|3571924|FG000|Overall Study|Missing|2
2006885|NCT00170950|3571925|FG001|Overall Study|Missing|1
2006886|NCT00170950|3571924|FG000|Overall Study|Termination Data Not Recorded|17
2006887|NCT00170950|3571925|FG001|Overall Study|Termination Data Not Recorded|22
2006888|NCT00171054|3571933|FG000|Overall Study|Protocol Violation|1
2006889|NCT00171054|3571934|FG001|Overall Study|Protocol Violation|2
2006890|NCT00171054|3571933|FG000|Overall Study|Patient withdrew consent|1
2006891|NCT00171054|3571934|FG001|Overall Study|Patient withdrew consent|0
2006892|NCT00171054|3571933|FG000|Overall Study|Lost to Follow-up|0
2006893|NCT00171054|3571934|FG001|Overall Study|Lost to Follow-up|1
2214294|NCT01686438|3856468|FG000|Overall Study|Withdrawal by Subject|0
2006894|NCT00171054|3571933|FG000|Overall Study|Adverse Event|8
2006895|NCT00171054|3571934|FG001|Overall Study|Adverse Event|8
2006896|NCT00171054|3571933|FG000|Overall Study|Condition no longer required study drug|0
2006897|NCT00171054|3571934|FG001|Overall Study|Condition no longer required study drug|1
2006898|NCT00171158|3571940|FG000|Core Study|Death|27
2006899|NCT00171158|3571940|FG000|Core Study|Unsatisfactory therapeutic effect|163
2006900|NCT00171158|3571940|FG000|Core Study|Protocol Violation|4
2006901|NCT00171158|3571940|FG000|Core Study|Administrative problems|1
2006902|NCT00171158|3571940|FG000|Core Study|Adverse event, non-fatal|21
2006903|NCT00171158|3571940|FG000|Core Study|Consent withdrawn by subject|6
2006904|NCT00171158|3571940|FG000|Core Study|No longer required drug (BMT)|14
2006905|NCT00171158|3571940|FG000|Core Study|Abnormal Laboratory Values|2
2006906|NCT00171158|3571940|FG000|Core Study|Lost to Follow-up|1
2006907|NCT00171158|3571940|FG000|E2 Extension|Other|7
2006908|NCT00171210|3571946|FG000|Overall Study|Adverse Event|16
2006909|NCT00171210|3571947|FG001|Overall Study|Adverse Event|27
2006910|NCT00171210|3571946|FG000|Overall Study|Abnormal laboratory value(s)|6
2006911|NCT00171210|3571947|FG001|Overall Study|Abnormal laboratory value(s)|3
2006912|NCT00171210|3571946|FG000|Overall Study|Abnormal test procedure result(s)|0
2006913|NCT00171210|3571947|FG001|Overall Study|Abnormal test procedure result(s)|1
2006914|NCT00171210|3571946|FG000|Overall Study|Unsatisfactory therapeutic effect|11
2006915|NCT00171210|3571947|FG001|Overall Study|Unsatisfactory therapeutic effect|15
2006916|NCT00171210|3571946|FG000|Overall Study|Protocol Violation|0
2006917|NCT00171210|3571947|FG001|Overall Study|Protocol Violation|2
2006918|NCT00171210|3571946|FG000|Overall Study|Withdrawal by Subject|32
2006919|NCT00171210|3571947|FG001|Overall Study|Withdrawal by Subject|30
2006920|NCT00171210|3571946|FG000|Overall Study|Lost to Follow-up|1
2006921|NCT00171210|3571947|FG001|Overall Study|Lost to Follow-up|0
2006922|NCT00171210|3571946|FG000|Overall Study|Administrative problems|1
2006923|NCT00171210|3571947|FG001|Overall Study|Administrative problems|1
2006924|NCT00171210|3571946|FG000|Overall Study|Death|2
2006925|NCT00171210|3571947|FG001|Overall Study|Death|3
2006926|NCT00171210|3571946|FG000|Overall Study|Stopped at end of core|0
2006927|NCT00171210|3571947|FG001|Overall Study|Stopped at end of core|32
2006928|NCT00171210|3571946|FG000|Overall Study|Stopped at end of extension 1|0
2006929|NCT00171210|3571947|FG001|Overall Study|Stopped at end of extension 1|1
2006930|NCT00171223|3571956|FG000|Overall Study|Adverse Event (Non-fatal)|6
2006931|NCT00171223|3571957|FG001|Overall Study|Adverse Event (Non-fatal)|5
2006932|NCT00171223|3571958|FG002|Overall Study|Adverse Event (Non-fatal)|19
2006933|NCT00171223|3571956|FG000|Overall Study|Abnormal Laboratory Value (s)|4
2006934|NCT00171223|3571957|FG001|Overall Study|Abnormal Laboratory Value (s)|2
2006935|NCT00171223|3571958|FG002|Overall Study|Abnormal Laboratory Value (s)|3
2006936|NCT00171223|3571956|FG000|Overall Study|Abnormal Procedure|1
2006937|NCT00171223|3571957|FG001|Overall Study|Abnormal Procedure|0
2006938|NCT00171223|3571958|FG002|Overall Study|Abnormal Procedure|0
2006939|NCT00171223|3571956|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57
2006940|NCT00171223|3571957|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43
2006941|NCT00171223|3571958|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52
2006942|NCT00171223|3571956|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
2006943|NCT00171223|3571957|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4
2006944|NCT00171223|3571958|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
2006945|NCT00171223|3571956|FG000|Overall Study|Protocol Violation|2
2006946|NCT00171223|3571957|FG001|Overall Study|Protocol Violation|2
2006947|NCT00171223|3571958|FG002|Overall Study|Protocol Violation|3
2006948|NCT00171223|3571956|FG000|Overall Study|Participant Withdrew Consent|12
2006949|NCT00171223|3571957|FG001|Overall Study|Participant Withdrew Consent|21
2006950|NCT00171223|3571958|FG002|Overall Study|Participant Withdrew Consent|15
2006951|NCT00171223|3571956|FG000|Overall Study|Lost to Follow-up|5
2006952|NCT00171223|3571957|FG001|Overall Study|Lost to Follow-up|2
2006953|NCT00171223|3571958|FG002|Overall Study|Lost to Follow-up|3
2006954|NCT00171223|3571956|FG000|Overall Study|Administrative Problems|4
2006955|NCT00171223|3571957|FG001|Overall Study|Administrative Problems|7
2006956|NCT00171223|3571958|FG002|Overall Study|Administrative Problems|6
2006957|NCT00171223|3571956|FG000|Overall Study|Adverse Event (Serious Fatal)|6
2006958|NCT00171223|3571957|FG001|Overall Study|Adverse Event (Serious Fatal)|8
2006959|NCT00171223|3571958|FG002|Overall Study|Adverse Event (Serious Fatal)|9
2006960|NCT00171223|3571956|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41
2214295|NCT01686438|3856469|FG001|Overall Study|Withdrawal by Subject|0
2214296|NCT01686438|3856470|FG002|Overall Study|Withdrawal by Subject|1
2214297|NCT01686568|3856510|FG000|Main Study|Withdrawal by Subject|1
2214298|NCT01686568|3856511|FG001|Main Study|Withdrawal by Subject|3
2214299|NCT01686568|3856510|FG000|Main Study|Noncompliance with protocol|0
2214300|NCT01686568|3856511|FG001|Main Study|Noncompliance with protocol|1
2214301|NCT01686568|3856510|FG000|Main Study|Liver enzymes above range of exclusion|1
2214302|NCT01686568|3856511|FG001|Main Study|Liver enzymes above range of exclusion|0
2214303|NCT01686568|3856510|FG000|Sub-Study|Not consented for sub-study|2
2214304|NCT01686568|3856511|FG001|Sub-Study|Not consented for sub-study|2
2214305|NCT01686581|3856517|FG000|Overall Study|Side-effects or Health Problems|15
2006961|NCT00171223|3571957|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47
2026044|NCT00348283|3594714|FG000|Double Blind|Protocol Violation|0
2214306|NCT01686581|3856517|FG000|Overall Study|Lack of Efficacy|90
2214307|NCT01686581|3856517|FG000|Overall Study|Participant Concerned about Risks|6
2214308|NCT01686581|3856517|FG000|Overall Study|Thinks Injections Too Painful|8
2214309|NCT01686581|3856517|FG000|Overall Study|Thinks Injections Take Too Much Time|2
2214310|NCT01686581|3856517|FG000|Overall Study|Trying to get Pregnant or Nursing|2
2214311|NCT01686581|3856517|FG000|Overall Study|Thinks it is Inconvenient|17
2214312|NCT01686581|3856517|FG000|Overall Study|Other Miscellaneous Reasons|36
2214313|NCT01686581|3856517|FG000|Overall Study|Reason Missing|1
2214314|NCT01686633|3856524|FG000|Overall Study|Lack of Efficacy|33
2214315|NCT01686633|3856525|FG001|Overall Study|Lack of Efficacy|13
2214316|NCT01686633|3856526|FG002|Overall Study|Lack of Efficacy|11
2214317|NCT01686633|3856524|FG000|Overall Study|Withdrawal by Subject|8
2006962|NCT00171223|3571958|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58
2006963|NCT00171249|3571964|FG000|Overall Study|Withdrawal by Subject|2
2006964|NCT00171249|3571965|FG001|Overall Study|Withdrawal by Subject|0
2006965|NCT00171249|3571966|FG002|Overall Study|Withdrawal by Subject|0
2006966|NCT00171249|3571967|FG003|Overall Study|Withdrawal by Subject|6
2006967|NCT00171249|3571968|FG004|Overall Study|Withdrawal by Subject|0
2006968|NCT00171249|3571969|FG005|Overall Study|Withdrawal by Subject|0
2006969|NCT00171249|3571970|FG006|Overall Study|Withdrawal by Subject|0
2006970|NCT00171249|3571964|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44
2006971|NCT00171249|3571965|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
2006972|NCT00171249|3571966|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5
2006973|NCT00171249|3571967|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70
2006974|NCT00171249|3571968|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3
2006975|NCT00171249|3571969|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31
2006976|NCT00171249|3571970|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1
2006977|NCT00171249|3571964|FG000|Overall Study|Death|7
2006978|NCT00171249|3571965|FG001|Overall Study|Death|1
2006979|NCT00171249|3571966|FG002|Overall Study|Death|0
2006980|NCT00171249|3571967|FG003|Overall Study|Death|4
2006981|NCT00171249|3571968|FG004|Overall Study|Death|0
2006982|NCT00171249|3571969|FG005|Overall Study|Death|3
2006983|NCT00171249|3571970|FG006|Overall Study|Death|1
2006984|NCT00171249|3571964|FG000|Overall Study|Other|10
2006985|NCT00171249|3571965|FG001|Overall Study|Other|0
2006986|NCT00171249|3571966|FG002|Overall Study|Other|0
2006987|NCT00171249|3571967|FG003|Overall Study|Other|43
2006988|NCT00171249|3571968|FG004|Overall Study|Other|0
2006989|NCT00171249|3571969|FG005|Overall Study|Other|2
2006990|NCT00171249|3571970|FG006|Overall Study|Other|0
2006991|NCT00171249|3571964|FG000|Overall Study|No Longer Requires Study Drug|4
2006992|NCT00171249|3571965|FG001|Overall Study|No Longer Requires Study Drug|0
2006993|NCT00171249|3571966|FG002|Overall Study|No Longer Requires Study Drug|0
2006994|NCT00171249|3571967|FG003|Overall Study|No Longer Requires Study Drug|3
2006995|NCT00171249|3571968|FG004|Overall Study|No Longer Requires Study Drug|0
2006996|NCT00171249|3571969|FG005|Overall Study|No Longer Requires Study Drug|5
2006997|NCT00171249|3571970|FG006|Overall Study|No Longer Requires Study Drug|0
2006998|NCT00171249|3571964|FG000|Overall Study|Administrative Problems|1
2006999|NCT00171249|3571965|FG001|Overall Study|Administrative Problems|0
2007000|NCT00171249|3571966|FG002|Overall Study|Administrative Problems|0
2007001|NCT00171249|3571967|FG003|Overall Study|Administrative Problems|2
2007002|NCT00171249|3571968|FG004|Overall Study|Administrative Problems|0
2007003|NCT00171249|3571969|FG005|Overall Study|Administrative Problems|0
2007004|NCT00171249|3571970|FG006|Overall Study|Administrative Problems|0
2007005|NCT00171249|3571964|FG000|Overall Study|Adverse Event|3
2007006|NCT00171249|3571965|FG001|Overall Study|Adverse Event|1
2007007|NCT00171249|3571966|FG002|Overall Study|Adverse Event|0
2007008|NCT00171249|3571967|FG003|Overall Study|Adverse Event|15
2007009|NCT00171249|3571968|FG004|Overall Study|Adverse Event|0
2007010|NCT00171249|3571969|FG005|Overall Study|Adverse Event|2
2007011|NCT00171249|3571970|FG006|Overall Study|Adverse Event|0
2007012|NCT00171249|3571964|FG000|Overall Study|Lost to Follow-up|5
2007013|NCT00171249|3571965|FG001|Overall Study|Lost to Follow-up|0
2007014|NCT00171249|3571966|FG002|Overall Study|Lost to Follow-up|0
2007015|NCT00171249|3571967|FG003|Overall Study|Lost to Follow-up|9
2007016|NCT00171249|3571968|FG004|Overall Study|Lost to Follow-up|0
2007017|NCT00171249|3571969|FG005|Overall Study|Lost to Follow-up|0
2007018|NCT00171249|3571970|FG006|Overall Study|Lost to Follow-up|0
2007019|NCT00171301|3571981|FG000|Overall Study|Death|1
2007020|NCT00171301|3571982|FG001|Overall Study|Death|2
2007021|NCT00171301|3571981|FG000|Overall Study|Adverse Event|1
2007022|NCT00171301|3571982|FG001|Overall Study|Adverse Event|2
2007023|NCT00171301|3571981|FG000|Overall Study|Lost to Follow-up|6
2007024|NCT00171301|3571982|FG001|Overall Study|Lost to Follow-up|2
2007025|NCT00171301|3571981|FG000|Overall Study|Protocol Violation|0
2007026|NCT00171301|3571982|FG001|Overall Study|Protocol Violation|2
2007027|NCT00171301|3571981|FG000|Overall Study|Withdrawal by Subject|0
2007028|NCT00171301|3571982|FG001|Overall Study|Withdrawal by Subject|1
2007029|NCT00171314|3571991|FG000|Overall Study|Adverse Event|44
2007030|NCT00171314|3571992|FG001|Overall Study|Adverse Event|41
2007031|NCT00171314|3571991|FG000|Overall Study|Lack of Efficacy|19
2007032|NCT00171314|3571992|FG001|Overall Study|Lack of Efficacy|14
2007033|NCT00171314|3571991|FG000|Overall Study|Withdrawal by Subject|9
2007034|NCT00171314|3571992|FG001|Overall Study|Withdrawal by Subject|6
2007035|NCT00171314|3571991|FG000|Overall Study|Abnormal Test Procedure Results|9
2007036|NCT00171314|3571992|FG001|Overall Study|Abnormal Test Procedure Results|3
2007037|NCT00171314|3571991|FG000|Overall Study|Protocol Violation|3
2007038|NCT00171314|3571992|FG001|Overall Study|Protocol Violation|7
2007039|NCT00171314|3571991|FG000|Overall Study|Administrative Problems|4
2007040|NCT00171314|3571992|FG001|Overall Study|Administrative Problems|3
2007041|NCT00171314|3571991|FG000|Overall Study|Lost to Follow-up|1
2007042|NCT00171314|3571992|FG001|Overall Study|Lost to Follow-up|3
2007043|NCT00171314|3571991|FG000|Overall Study|Death|2
2007044|NCT00171314|3571992|FG001|Overall Study|Death|1
2007045|NCT00171340|3572000|FG000|Overall Study|Adverse Event|46
2007046|NCT00171340|3572001|FG001|Overall Study|Adverse Event|42
2007047|NCT00171340|3572000|FG000|Overall Study|Lack of Efficacy|29
2007048|NCT00171340|3572001|FG001|Overall Study|Lack of Efficacy|41
2007049|NCT00171340|3572000|FG000|Overall Study|Protocol Violation|7
2007050|NCT00171340|3572001|FG001|Overall Study|Protocol Violation|8
2214318|NCT01686633|3856525|FG001|Overall Study|Withdrawal by Subject|8
2214319|NCT01686633|3856526|FG002|Overall Study|Withdrawal by Subject|5
2214320|NCT01686633|3856524|FG000|Overall Study|Physician Decision|3
2007051|NCT00171340|3572000|FG000|Overall Study|Withdrawal by Subject|22
2007052|NCT00171340|3572001|FG001|Overall Study|Withdrawal by Subject|19
2007053|NCT00171340|3572000|FG000|Overall Study|Lost to Follow-up|0
2007054|NCT00171340|3572001|FG001|Overall Study|Lost to Follow-up|5
2007055|NCT00171340|3572000|FG000|Overall Study|Abnormal Laboratory Results|2
2007056|NCT00171340|3572001|FG001|Overall Study|Abnormal Laboratory Results|0
2007057|NCT00171340|3572000|FG000|Overall Study|Abnormal Test Procedure Results|6
2007058|NCT00171340|3572001|FG001|Overall Study|Abnormal Test Procedure Results|11
2007059|NCT00171340|3572000|FG000|Overall Study|No Longer Required Study Drug|1
2007060|NCT00171340|3572001|FG001|Overall Study|No Longer Required Study Drug|1
2007061|NCT00171340|3572000|FG000|Overall Study|Administrative Problems|5
2007062|NCT00171340|3572001|FG001|Overall Study|Administrative Problems|2
2007063|NCT00171340|3572000|FG000|Overall Study|Death|6
2007064|NCT00171340|3572001|FG001|Overall Study|Death|6
2007065|NCT00171704|3572011|FG000|Overall Study|Adverse Event|24
2007066|NCT00171704|3572012|FG001|Overall Study|Adverse Event|33
2007067|NCT00171704|3572011|FG000|Overall Study|Disease Progression|14
2007068|NCT00171704|3572012|FG001|Overall Study|Disease Progression|9
2007069|NCT00171704|3572011|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1
2007070|NCT00171704|3572012|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0
2007071|NCT00171704|3572011|FG000|Overall Study|Administrative Problems|2
2007072|NCT00171704|3572012|FG001|Overall Study|Administrative Problems|1
2007073|NCT00171704|3572011|FG000|Overall Study|Death|2
2007074|NCT00171704|3572012|FG001|Overall Study|Death|2
2007075|NCT00171704|3572011|FG000|Overall Study|Withdrawal by Subject|1
2007076|NCT00171704|3572012|FG001|Overall Study|Withdrawal by Subject|3
2007077|NCT00171704|3572011|FG000|Overall Study|Protocol Violation|0
2007078|NCT00171704|3572012|FG001|Overall Study|Protocol Violation|1
2007079|NCT00171730|3572018|FG000|Overall Study|Adverse Event|3
2007080|NCT00171730|3572018|FG000|Overall Study|Abnormal Laboratory Value(s)|1
2007081|NCT00171730|3572018|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8
2007082|NCT00171730|3572018|FG000|Overall Study|Withdrawal by Subject|3
2007083|NCT00171834|3572035|FG000|Overall Study|Adverse Event|2
2007084|NCT00171834|3572036|FG001|Overall Study|Adverse Event|1
2007085|NCT00171834|3572037|FG002|Overall Study|Adverse Event|3
2007086|NCT00171834|3572038|FG003|Overall Study|Adverse Event|2
2007087|NCT00171834|3572039|FG004|Overall Study|Adverse Event|2
2007088|NCT00171834|3572040|FG005|Overall Study|Adverse Event|15
2007089|NCT00171834|3572041|FG006|Overall Study|Adverse Event|1
2007090|NCT00171834|3572035|FG000|Overall Study|Withdrawal by Subject|0
2007091|NCT00171834|3572036|FG001|Overall Study|Withdrawal by Subject|2
2007092|NCT00171834|3572037|FG002|Overall Study|Withdrawal by Subject|0
2007093|NCT00171834|3572038|FG003|Overall Study|Withdrawal by Subject|1
2007094|NCT00171834|3572039|FG004|Overall Study|Withdrawal by Subject|1
2007095|NCT00171834|3572040|FG005|Overall Study|Withdrawal by Subject|1
2007096|NCT00171834|3572041|FG006|Overall Study|Withdrawal by Subject|0
2007097|NCT00171834|3572035|FG000|Overall Study|Death from study indication|0
2007098|NCT00171834|3572036|FG001|Overall Study|Death from study indication|1
2007099|NCT00171834|3572037|FG002|Overall Study|Death from study indication|0
2007100|NCT00171834|3572038|FG003|Overall Study|Death from study indication|0
2007101|NCT00171834|3572039|FG004|Overall Study|Death from study indication|1
2007102|NCT00171834|3572040|FG005|Overall Study|Death from study indication|0
2007103|NCT00171834|3572041|FG006|Overall Study|Death from study indication|0
2007104|NCT00171834|3572035|FG000|Overall Study|Disease Progression|4
2007105|NCT00171834|3572036|FG001|Overall Study|Disease Progression|8
2007106|NCT00171834|3572037|FG002|Overall Study|Disease Progression|8
2007107|NCT00171834|3572038|FG003|Overall Study|Disease Progression|9
2007108|NCT00171834|3572039|FG004|Overall Study|Disease Progression|2
2007109|NCT00171834|3572040|FG005|Overall Study|Disease Progression|18
2007110|NCT00171834|3572041|FG006|Overall Study|Disease Progression|3
2007111|NCT00171834|3572035|FG000|Overall Study|Treatment Duration Completed|0
2007112|NCT00171834|3572036|FG001|Overall Study|Treatment Duration Completed|0
2007113|NCT00171834|3572037|FG002|Overall Study|Treatment Duration Completed|1
2214321|NCT01686633|3856525|FG001|Overall Study|Physician Decision|4
2007114|NCT00171834|3572038|FG003|Overall Study|Treatment Duration Completed|0
2007115|NCT00171834|3572039|FG004|Overall Study|Treatment Duration Completed|2
2007116|NCT00171834|3572040|FG005|Overall Study|Treatment Duration Completed|1
2007117|NCT00171834|3572041|FG006|Overall Study|Treatment Duration Completed|0
2007118|NCT00171873|3572073|FG000|Overall Study|Withdrawal by Subject|4
2007119|NCT00171873|3572074|FG001|Overall Study|Withdrawal by Subject|2
2007120|NCT00171873|3572073|FG000|Overall Study|Adverse Event|5
2007121|NCT00171873|3572074|FG001|Overall Study|Adverse Event|0
2007122|NCT00171873|3572073|FG000|Overall Study|Switched to Octreotide|0
2007123|NCT00171873|3572074|FG001|Overall Study|Switched to Octreotide|1
2007124|NCT00171925|3572082|FG000|Overall Study|Adverse Event|10
2007125|NCT00171925|3572083|FG001|Overall Study|Adverse Event|6
2007126|NCT00171925|3572082|FG000|Overall Study|Protocol Violation|1
2007127|NCT00171925|3572083|FG001|Overall Study|Protocol Violation|1
2007128|NCT00171925|3572082|FG000|Overall Study|Withdrawal by Subject|6
2007129|NCT00171925|3572083|FG001|Overall Study|Withdrawal by Subject|9
2007130|NCT00171925|3572082|FG000|Overall Study|Lost to Follow-up|2
2007131|NCT00171925|3572083|FG001|Overall Study|Lost to Follow-up|2
2007132|NCT00171925|3572082|FG000|Overall Study|Administrative problems|10
2007133|NCT00171925|3572083|FG001|Overall Study|Administrative problems|11
2007134|NCT00171925|3572082|FG000|Overall Study|Death|1
2007135|NCT00171925|3572083|FG001|Overall Study|Death|2
2007136|NCT00171951|3572089|FG000|Overall Study|Adverse Event|1
2007137|NCT00171951|3572089|FG000|Overall Study|Abnormal Laboratory Values|2
2007138|NCT00171951|3572089|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
2007139|NCT00171951|3572089|FG000|Overall Study|Participants Withdrew Consent|3
2007140|NCT00171951|3572089|FG000|Overall Study|New Cancer Therapy|5
2007141|NCT00171951|3572089|FG000|Overall Study|Reason not Specified|2
2007142|NCT00172042|3572098|FG000|Overall Study|Adverse Event|27
2007143|NCT00172042|3572099|FG001|Overall Study|Adverse Event|13
2007144|NCT00172042|3572098|FG000|Overall Study|Abnormal laboratory value(s)|5
2007145|NCT00172042|3572099|FG001|Overall Study|Abnormal laboratory value(s)|1
2007146|NCT00172042|3572098|FG000|Overall Study|Abnormal test procedure(s)|0
2007147|NCT00172042|3572099|FG001|Overall Study|Abnormal test procedure(s)|3
2007148|NCT00172042|3572098|FG000|Overall Study|Unsatisfactory therapeutic effect|13
2007149|NCT00172042|3572099|FG001|Overall Study|Unsatisfactory therapeutic effect|11
2007150|NCT00172042|3572098|FG000|Overall Study|Patient no longer requires study drug|10
2007151|NCT00172042|3572099|FG001|Overall Study|Patient no longer requires study drug|8
2007152|NCT00172042|3572098|FG000|Overall Study|Protocol Violation|8
2007153|NCT00172042|3572099|FG001|Overall Study|Protocol Violation|7
2007154|NCT00172042|3572098|FG000|Overall Study|Withdrawal by Subject|37
2007155|NCT00172042|3572099|FG001|Overall Study|Withdrawal by Subject|25
2007156|NCT00172042|3572098|FG000|Overall Study|Lost to Follow-up|3
2007157|NCT00172042|3572099|FG001|Overall Study|Lost to Follow-up|5
2007158|NCT00172042|3572098|FG000|Overall Study|Administrative problems|13
2007159|NCT00172042|3572099|FG001|Overall Study|Administrative problems|10
2007160|NCT00172042|3572098|FG000|Overall Study|Death|42
2007161|NCT00172042|3572099|FG001|Overall Study|Death|42
2007162|NCT00172185|3572109|FG000|Overall Study|Adverse Event|0
2007163|NCT00172185|3572110|FG001|Overall Study|Adverse Event|1
2007164|NCT00172185|3572111|FG002|Overall Study|Adverse Event|3
2007165|NCT00172185|3572112|FG003|Overall Study|Adverse Event|4
2007166|NCT00172185|3572109|FG000|Overall Study|Physician Decision|0
2007167|NCT00172185|3572110|FG001|Overall Study|Physician Decision|0
2007168|NCT00172185|3572111|FG002|Overall Study|Physician Decision|1
2007169|NCT00172185|3572112|FG003|Overall Study|Physician Decision|0
2007170|NCT00172185|3572109|FG000|Overall Study|SPONSOR Decision|0
2007171|NCT00172185|3572110|FG001|Overall Study|SPONSOR Decision|1
2007172|NCT00172185|3572111|FG002|Overall Study|SPONSOR Decision|0
2007173|NCT00172185|3572112|FG003|Overall Study|SPONSOR Decision|0
2007174|NCT00172185|3572109|FG000|Overall Study|Withdrawal by Subject|0
2007175|NCT00172185|3572110|FG001|Overall Study|Withdrawal by Subject|0
2007176|NCT00172185|3572111|FG002|Overall Study|Withdrawal by Subject|1
2007177|NCT00172185|3572112|FG003|Overall Study|Withdrawal by Subject|0
2007178|NCT00174187|3572128|FG000|Period 1 (up to 3 Years)|Serious adverse event|0
2007179|NCT00174187|3572129|FG001|Period 1 (up to 3 Years)|Serious adverse event|1
2007180|NCT00174187|3572130|FG002|Period 1 (up to 3 Years)|Serious adverse event|0
2007181|NCT00174187|3572128|FG000|Period 1 (up to 3 Years)|Non compliance|0
2007182|NCT00174187|3572129|FG001|Period 1 (up to 3 Years)|Non compliance|1
2007183|NCT00174187|3572130|FG002|Period 1 (up to 3 Years)|Non compliance|0
2007184|NCT00174187|3572128|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0
2007185|NCT00174187|3572129|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1
2007186|NCT00174187|3572130|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0
2007187|NCT00174187|3572128|FG000|Period 1 (up to 3 Years)|Other|0
2007188|NCT00174187|3572129|FG001|Period 1 (up to 3 Years)|Other|1
2007189|NCT00174187|3572130|FG002|Period 1 (up to 3 Years)|Other|0
2007190|NCT00174187|3572128|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0
2007191|NCT00174187|3572129|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0
2007192|NCT00174187|3572130|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2
2007193|NCT00174187|3572128|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0
2007194|NCT00174187|3572129|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0
2007195|NCT00174187|3572130|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3
2007196|NCT00174187|3572128|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0
2007197|NCT00174187|3572129|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0
2007198|NCT00174187|3572130|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2
2007199|NCT00174187|3572128|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0
2007200|NCT00174187|3572129|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0
2007201|NCT00174187|3572130|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1
2007202|NCT00174187|3572128|FG000|Period 2 (After 3 Years)|Other|0
2007203|NCT00174187|3572129|FG001|Period 2 (After 3 Years)|Other|0
2007204|NCT00174187|3572130|FG002|Period 2 (After 3 Years)|Other|5
2007205|NCT00174252|3572138|FG000|Overall Study|Protocol Violation|2
2007206|NCT00174291|3572146|FG000|Overall Study|Lost to Follow-up|1
2007207|NCT00174291|3572147|FG001|Overall Study|Lost to Follow-up|1
2007208|NCT00174291|3572146|FG000|Overall Study|Protocol Violation|0
2007209|NCT00174291|3572147|FG001|Overall Study|Protocol Violation|2
2007210|NCT00174291|3572146|FG000|Overall Study|Study terminated by sponsor|1
2007211|NCT00174291|3572147|FG001|Overall Study|Study terminated by sponsor|0
2007212|NCT00174291|3572146|FG000|Overall Study|Withdrawal by Subject|3
2007213|NCT00174291|3572147|FG001|Overall Study|Withdrawal by Subject|3
2007214|NCT00174382|3572153|FG000|Overall Study|Death|2
2007215|NCT00174382|3572153|FG000|Overall Study|Adverse Event|19
2007216|NCT00174382|3572153|FG000|Overall Study|Withdrawal by Subject|6
2007217|NCT00174382|3572153|FG000|Overall Study|Protocol Violation|3
2007218|NCT00174382|3572153|FG000|Overall Study|Arrived early for last visit in error|1
2007219|NCT00174382|3572153|FG000|Overall Study|Subject felt pill not effective enough|1
2007220|NCT00174382|3572153|FG000|Overall Study|Lost to Follow-up|1
2007221|NCT00174447|3572157|FG000|Overall Study|Adverse Event|19
2007222|NCT00174447|3572157|FG000|Overall Study|Withdrawal by Subject|15
2007223|NCT00174447|3572157|FG000|Overall Study|Protocol Violation|1
2007224|NCT00174447|3572157|FG000|Overall Study|Lack of Efficacy|1
2007225|NCT00174447|3572157|FG000|Overall Study|Administrative reason/Other|2
2007226|NCT00174460|3572163|FG000|Overall Study|Withdrawal by Subject|0
2007227|NCT00174460|3572164|FG001|Overall Study|Withdrawal by Subject|1
2007228|NCT00174785|3572173|FG000|Overall Study|Adverse Event|293
2007229|NCT00174785|3572174|FG001|Overall Study|Adverse Event|191
2007230|NCT00174785|3572173|FG000|Overall Study|Protocol Violation|14
2007231|NCT00174785|3572174|FG001|Overall Study|Protocol Violation|14
2007232|NCT00174785|3572173|FG000|Overall Study|Withdrawal by Subject|173
2007233|NCT00174785|3572174|FG001|Overall Study|Withdrawal by Subject|175
2007234|NCT00174785|3572173|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110
2007235|NCT00174785|3572174|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167
2007236|NCT00174785|3572173|FG000|Overall Study|Prohibited antiarrhythmic medication|39
2007237|NCT00174785|3572174|FG001|Overall Study|Prohibited antiarrhythmic medication|88
2007238|NCT00174785|3572173|FG000|Overall Study|Other prohibited medication|5
2007239|NCT00174785|3572174|FG001|Overall Study|Other prohibited medication|3
2007240|NCT00174785|3572173|FG000|Overall Study|Family request|6
2007241|NCT00174785|3572174|FG001|Overall Study|Family request|8
2007242|NCT00174785|3572173|FG000|Overall Study|Not pre-specified/Not coded|56
2007243|NCT00174785|3572174|FG001|Overall Study|Not pre-specified/Not coded|70
2007244|NCT00174915|3572185|FG000|Overall Study|Lost to Follow-up|19
2007245|NCT00174915|3572186|FG001|Overall Study|Lost to Follow-up|17
2007246|NCT00174915|3572187|FG002|Overall Study|Lost to Follow-up|9
2007247|NCT00174915|3572188|FG003|Overall Study|Lost to Follow-up|17
2007248|NCT00174915|3572189|FG004|Overall Study|Lost to Follow-up|10
2007249|NCT00174915|3572185|FG000|Overall Study|Adverse Event|18
2007250|NCT00174915|3572186|FG001|Overall Study|Adverse Event|16
2007251|NCT00174915|3572187|FG002|Overall Study|Adverse Event|11
2007252|NCT00174915|3572188|FG003|Overall Study|Adverse Event|18
2007253|NCT00174915|3572189|FG004|Overall Study|Adverse Event|5
2007254|NCT00174915|3572185|FG000|Overall Study|Personal Reason(s)|16
2007255|NCT00174915|3572186|FG001|Overall Study|Personal Reason(s)|16
2007256|NCT00174915|3572187|FG002|Overall Study|Personal Reason(s)|9
2007257|NCT00174915|3572188|FG003|Overall Study|Personal Reason(s)|9
2007258|NCT00174915|3572189|FG004|Overall Study|Personal Reason(s)|9
2007259|NCT00174915|3572185|FG000|Overall Study|Other|15
2007260|NCT00174915|3572186|FG001|Overall Study|Other|8
2007261|NCT00174915|3572187|FG002|Overall Study|Other|6
2007262|NCT00174915|3572188|FG003|Overall Study|Other|5
2007263|NCT00174915|3572189|FG004|Overall Study|Other|3
2007264|NCT00174915|3572185|FG000|Overall Study|Gout Flare|13
2007265|NCT00174915|3572186|FG001|Overall Study|Gout Flare|6
2007266|NCT00174915|3572187|FG002|Overall Study|Gout Flare|8
2007267|NCT00174915|3572188|FG003|Overall Study|Gout Flare|1
2007268|NCT00174915|3572189|FG004|Overall Study|Gout Flare|0
2007269|NCT00174915|3572185|FG000|Overall Study|Protocol Violation|6
2007270|NCT00174915|3572186|FG001|Overall Study|Protocol Violation|3
2007271|NCT00174915|3572187|FG002|Overall Study|Protocol Violation|3
2007272|NCT00174915|3572188|FG003|Overall Study|Protocol Violation|6
2007273|NCT00174915|3572189|FG004|Overall Study|Protocol Violation|3
2007274|NCT00174915|3572185|FG000|Overall Study|Therapeutic Failure|6
2007275|NCT00174915|3572186|FG001|Overall Study|Therapeutic Failure|3
2007276|NCT00174915|3572187|FG002|Overall Study|Therapeutic Failure|2
2007277|NCT00174915|3572188|FG003|Overall Study|Therapeutic Failure|1
2007278|NCT00174915|3572189|FG004|Overall Study|Therapeutic Failure|3
2007279|NCT00174941|3572204|FG000|Overall Study|Adverse Event|1
2007280|NCT00174941|3572205|FG001|Overall Study|Adverse Event|10
2007281|NCT00174941|3572206|FG002|Overall Study|Adverse Event|2
2007282|NCT00174941|3572207|FG003|Overall Study|Adverse Event|13
2007283|NCT00174941|3572204|FG000|Overall Study|Protocol Violation|0
2007284|NCT00174941|3572205|FG001|Overall Study|Protocol Violation|1
2007285|NCT00174941|3572206|FG002|Overall Study|Protocol Violation|0
2007286|NCT00174941|3572207|FG003|Overall Study|Protocol Violation|1
2007287|NCT00174941|3572204|FG000|Overall Study|Lost to Follow-up|0
2007288|NCT00174941|3572205|FG001|Overall Study|Lost to Follow-up|3
2007289|NCT00174941|3572206|FG002|Overall Study|Lost to Follow-up|2
2007290|NCT00174941|3572207|FG003|Overall Study|Lost to Follow-up|5
2007291|NCT00174941|3572204|FG000|Overall Study|Personal Reason(s)|0
2007292|NCT00174941|3572205|FG001|Overall Study|Personal Reason(s)|14
2007293|NCT00174941|3572206|FG002|Overall Study|Personal Reason(s)|8
2007294|NCT00174941|3572207|FG003|Overall Study|Personal Reason(s)|22
2007295|NCT00174941|3572204|FG000|Overall Study|Gout Flare|0
2007296|NCT00174941|3572205|FG001|Overall Study|Gout Flare|4
2007297|NCT00174941|3572206|FG002|Overall Study|Gout Flare|4
2007298|NCT00174941|3572207|FG003|Overall Study|Gout Flare|8
2007299|NCT00174941|3572204|FG000|Overall Study|Reason Not Specified|1
2007300|NCT00174941|3572205|FG001|Overall Study|Reason Not Specified|6
2007301|NCT00174941|3572206|FG002|Overall Study|Reason Not Specified|2
2007302|NCT00174941|3572207|FG003|Overall Study|Reason Not Specified|9
2007303|NCT00174954|3572217|FG000|Overall Study|Adverse Event|2
2007304|NCT00174954|3572217|FG000|Overall Study|No tophi found in MRI|1
2007305|NCT00174954|3572217|FG000|Overall Study|Physician Decision|1
2007306|NCT00174967|3572225|FG000|Overall Study|Adverse Event|1
2007307|NCT00174967|3572226|FG001|Overall Study|Adverse Event|2
2007308|NCT00174967|3572227|FG002|Overall Study|Adverse Event|2
2007309|NCT00174967|3572228|FG003|Overall Study|Adverse Event|1
2007310|NCT00174967|3572225|FG000|Overall Study|Gout Flare|0
2007311|NCT00174967|3572226|FG001|Overall Study|Gout Flare|0
2007312|NCT00174967|3572227|FG002|Overall Study|Gout Flare|0
2007313|NCT00174967|3572228|FG003|Overall Study|Gout Flare|1
2007314|NCT00174967|3572225|FG000|Overall Study|Other|0
2007315|NCT00174967|3572226|FG001|Overall Study|Other|1
2007316|NCT00174967|3572227|FG002|Overall Study|Other|0
2007317|NCT00174967|3572228|FG003|Overall Study|Other|0
2007318|NCT00175019|3572245|FG000|Overall Study|Adverse Event|54
2007319|NCT00175019|3572246|FG001|Overall Study|Adverse Event|22
2007320|NCT00175019|3572247|FG002|Overall Study|Adverse Event|2
2007321|NCT00175019|3572245|FG000|Overall Study|Protocol Violation|6
2007322|NCT00175019|3572246|FG001|Overall Study|Protocol Violation|3
2007323|NCT00175019|3572247|FG002|Overall Study|Protocol Violation|3
2007324|NCT00175019|3572245|FG000|Overall Study|Lost to Follow-up|42
2007325|NCT00175019|3572246|FG001|Overall Study|Lost to Follow-up|39
2007326|NCT00175019|3572247|FG002|Overall Study|Lost to Follow-up|9
2007327|NCT00175019|3572245|FG000|Overall Study|Did not continue under Amendment 4|1
2007328|NCT00175019|3572246|FG001|Overall Study|Did not continue under Amendment 4|1
2007329|NCT00175019|3572247|FG002|Overall Study|Did not continue under Amendment 4|2
2007330|NCT00175019|3572245|FG000|Overall Study|Personal Reason(s)|39
2007331|NCT00175019|3572246|FG001|Overall Study|Personal Reason(s)|31
2007332|NCT00175019|3572247|FG002|Overall Study|Personal Reason(s)|8
2007333|NCT00175019|3572245|FG000|Overall Study|Therapeutic Failure|10
2007334|NCT00175019|3572246|FG001|Overall Study|Therapeutic Failure|38
2007335|NCT00175019|3572247|FG002|Overall Study|Therapeutic Failure|22
2007336|NCT00175019|3572245|FG000|Overall Study|Gout Flare|2
2007337|NCT00175019|3572246|FG001|Overall Study|Gout Flare|3
2007338|NCT00175019|3572247|FG002|Overall Study|Gout Flare|0
2007339|NCT00175019|3572245|FG000|Overall Study|Reason Not Specified|40
2007340|NCT00175019|3572246|FG001|Overall Study|Reason Not Specified|34
2007341|NCT00175019|3572247|FG002|Overall Study|Reason Not Specified|11
2007342|NCT00175825|3572259|FG000|Overall Study|Adverse Event|3
2007343|NCT00175825|3572260|FG001|Overall Study|Adverse Event|2
2007344|NCT00175825|3572261|FG002|Overall Study|Adverse Event|1
2007345|NCT00175825|3572262|FG003|Overall Study|Adverse Event|1
2007346|NCT00175825|3572259|FG000|Overall Study|Lost to Follow-up|1
2007347|NCT00175825|3572260|FG001|Overall Study|Lost to Follow-up|2
2007348|NCT00175825|3572261|FG002|Overall Study|Lost to Follow-up|0
2007349|NCT00175825|3572262|FG003|Overall Study|Lost to Follow-up|0
2007350|NCT00175825|3572259|FG000|Overall Study|Withdrawal by Subject|1
2007351|NCT00175825|3572260|FG001|Overall Study|Withdrawal by Subject|0
2007352|NCT00175825|3572261|FG002|Overall Study|Withdrawal by Subject|0
2007353|NCT00175825|3572262|FG003|Overall Study|Withdrawal by Subject|0
2007354|NCT00175877|3572272|FG000|Overall Study|Adverse Event|136
2007355|NCT00175877|3572272|FG000|Overall Study|Withdrawal by Subject|141
2007356|NCT00175877|3572272|FG000|Overall Study|Lost to Follow-up|9
2007357|NCT00175877|3572272|FG000|Overall Study|Lack of Efficacy|26
2007358|NCT00175877|3572272|FG000|Overall Study|Protocol Violation|15
2007359|NCT00175877|3572272|FG000|Overall Study|Other Reason|20
2007360|NCT00175877|3572272|FG000|Overall Study|AE & Other|1
2007361|NCT00175877|3572272|FG000|Overall Study|Withdrawal by subject & Other|1
2007362|NCT00175916|3572276|FG000|Overall Study|Death|19
2007363|NCT00175916|3572276|FG000|Overall Study|Adverse Event|81
2007364|NCT00175916|3572276|FG000|Overall Study|Lack of Efficacy|354
2007365|NCT00175916|3572276|FG000|Overall Study|Lost to Follow-up|17
2007366|NCT00175916|3572276|FG000|Overall Study|Subject Choice|98
2007367|NCT00175916|3572276|FG000|Overall Study|Lack of compliance|8
2007368|NCT00175916|3572276|FG000|Overall Study|Patient cannot record seizures|1
2007369|NCT00175916|3572276|FG000|Overall Study|Sponsor decision|17
2007370|NCT00175916|3572276|FG000|Overall Study|Vigabatrin intake|1
2007371|NCT00175916|3572276|FG000|Overall Study|Suicidal behaviour|1
2007372|NCT00175916|3572276|FG000|Overall Study|Withdrawal by Subject|1
2007373|NCT00175916|3572276|FG000|Overall Study|Seizure - free|4
2007374|NCT00175916|3572276|FG000|Overall Study|Administrative reason|1
2007375|NCT00175916|3572276|FG000|Overall Study|Pregnancy|1
2007376|NCT00175916|3572276|FG000|Overall Study|Patient's request|2
2007377|NCT00175916|3572276|FG000|Overall Study|Treating physiciant's choice|1
2007378|NCT00175916|3572276|FG000|Overall Study|Moved overseas|1
2007379|NCT00175916|3572276|FG000|Overall Study|Loss of job and economic burden|1
2007380|NCT00175916|3572276|FG000|Overall Study|Site was closed|9
2007381|NCT00175916|3572276|FG000|Overall Study|Patient went to prison|1
2007382|NCT00176254|3572297|FG000|Overall Study|Lost to Follow-up|1
2007383|NCT00176462|3572325|FG000|Induction (4 Weeks)|Withdrawal by Subject|0
2007384|NCT00176462|3572326|FG001|Induction (4 Weeks)|Withdrawal by Subject|2
2007385|NCT00176462|3572325|FG000|Induction (4 Weeks)|Death|1
2007386|NCT00176462|3572326|FG001|Induction (4 Weeks)|Death|2
2007387|NCT00176462|3572325|FG000|Induction (4 Weeks)|Lack of Efficacy|0
2007388|NCT00176462|3572326|FG001|Induction (4 Weeks)|Lack of Efficacy|1
2007389|NCT00176462|3572325|FG000|Consolidation (12 Weeks)|Patient moved to another state|0
2007390|NCT00176462|3572326|FG001|Consolidation (12 Weeks)|Patient moved to another state|1
2007391|NCT00176462|3572325|FG000|Consolidation (12 Weeks)|Adverse Event|0
2007392|NCT00176462|3572326|FG001|Consolidation (12 Weeks)|Adverse Event|1
2007393|NCT00176462|3572325|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0
2007394|NCT00176462|3572326|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2
2007395|NCT00176462|3572325|FG000|Consolidation (12 Weeks)|Not documented|0
2007396|NCT00176462|3572326|FG001|Consolidation (12 Weeks)|Not documented|1
2007397|NCT00176462|3572325|FG000|Intensive Continuation (8X8-week Cycles)|Death|1
2007398|NCT00176462|3572326|FG001|Intensive Continuation (8X8-week Cycles)|Death|0
2007399|NCT00176462|3572325|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
2007400|NCT00176462|3572326|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
2007401|NCT00176605|3572342|FG000|Overall Study|Withdrawal by Subject|2
2007402|NCT00176644|3572346|FG000|Overall Study|Withdrawal by Subject|1
2007403|NCT00177164|3572443|FG000|Overall Study|Protocol Violation|0
2007404|NCT00177164|3572444|FG001|Overall Study|Protocol Violation|7
2007405|NCT00177164|3572443|FG000|Overall Study|Lost to Follow-up|4
2007406|NCT00177164|3572444|FG001|Overall Study|Lost to Follow-up|5
2007407|NCT00177164|3572443|FG000|Overall Study|increase in alcohol and drug use|1
2007408|NCT00177164|3572444|FG001|Overall Study|increase in alcohol and drug use|2
2007409|NCT00177164|3572443|FG000|Overall Study|Adverse Event|1
2007410|NCT00177164|3572444|FG001|Overall Study|Adverse Event|0
2007411|NCT00177164|3572443|FG000|Overall Study|discharge from hospital|1
2007412|NCT00177164|3572444|FG001|Overall Study|discharge from hospital|0
2007413|NCT00177164|3572443|FG000|Overall Study|Lack of Efficacy|2
2007414|NCT00177164|3572444|FG001|Overall Study|Lack of Efficacy|1
2007415|NCT00177164|3572443|FG000|Overall Study|Pregnancy|0
2007416|NCT00177164|3572444|FG001|Overall Study|Pregnancy|1
2007417|NCT00177216|3572453|FG000|Overall Study|Withdrawal by Subject|6
2007418|NCT00177216|3572454|FG001|Overall Study|Withdrawal by Subject|3
2007419|NCT00177216|3572455|FG002|Overall Study|Withdrawal by Subject|1
2007420|NCT00177294|3572473|FG000|Overall Study|Withdrawal by Subject|7
2007421|NCT00177294|3572474|FG001|Overall Study|Withdrawal by Subject|5
2025225|NCT00343252|3593835|FG000|6 Months (All Treated Participants)|Adverse Event|17
2025226|NCT00343252|3593836|FG001|6 Months (All Treated Participants)|Adverse Event|11
2025227|NCT00343252|3593835|FG000|6 Months (All Treated Participants)|Death|0
2025228|NCT00343252|3593836|FG001|6 Months (All Treated Participants)|Death|2
2025229|NCT00343252|3593835|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10
2025230|NCT00343252|3593836|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8
2025231|NCT00343252|3593835|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0
2025232|NCT00343252|3593836|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1
2025233|NCT00343252|3593835|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0
2025234|NCT00343252|3593836|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4
2025235|NCT00343252|3593835|FG000|6 Months (All Treated Participants)|Physician Decision|1
2025236|NCT00343252|3593836|FG001|6 Months (All Treated Participants)|Physician Decision|3
2025237|NCT00343252|3593835|FG000|6 Months (All Treated Participants)|Protocol Violation|2
2025238|NCT00343252|3593836|FG001|6 Months (All Treated Participants)|Protocol Violation|2
2025239|NCT00343252|3593835|FG000|6 Months (All Treated Participants)|Sponsor Decision|7
2025240|NCT00343252|3593836|FG001|6 Months (All Treated Participants)|Sponsor Decision|4
2025241|NCT00343252|3593835|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19
2025242|NCT00343252|3593836|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9
2025243|NCT00343252|3593835|FG000|12 Months (All Treated Participants)|Adverse Event|22
2025244|NCT00343252|3593836|FG001|12 Months (All Treated Participants)|Adverse Event|20
2025245|NCT00343252|3593835|FG000|12 Months (All Treated Participants)|Death|3
2025246|NCT00343252|3593836|FG001|12 Months (All Treated Participants)|Death|3
2025247|NCT00343252|3593835|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10
2025248|NCT00343252|3593836|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10
2007422|NCT00177307|3572480|FG000|Overall Study|Withdrawal by Subject|1
2007423|NCT00177671|3572486|FG000|Overall Study|Withdrawal by Subject|5
2007424|NCT00177671|3572487|FG001|Overall Study|Withdrawal by Subject|6
2007425|NCT00177671|3572486|FG000|Overall Study|medical complications|2
2007426|NCT00177671|3572487|FG001|Overall Study|medical complications|0
2007427|NCT00177671|3572486|FG000|Overall Study|Adverse Event|6
2007428|NCT00177671|3572487|FG001|Overall Study|Adverse Event|0
2007429|NCT00177671|3572486|FG000|Overall Study|Physician Decision|12
2007430|NCT00177671|3572487|FG001|Overall Study|Physician Decision|8
2007431|NCT00178126|3572495|FG000|Overall Study|Lost to Follow-up|21
2007432|NCT00178126|3572496|FG001|Overall Study|Lost to Follow-up|21
2007433|NCT00178126|3572495|FG000|Overall Study|did not receive intervention|4
2007434|NCT00178126|3572496|FG001|Overall Study|did not receive intervention|6
2007435|NCT00178256|3572532|FG000|Overall Study|Adverse Event|2
2007436|NCT00178256|3572533|FG001|Overall Study|Adverse Event|0
2007437|NCT00178256|3572534|FG002|Overall Study|Adverse Event|0
2007438|NCT00178256|3572535|FG003|Overall Study|Adverse Event|0
2007439|NCT00178256|3572532|FG000|Overall Study|Death|0
2007440|NCT00178256|3572533|FG001|Overall Study|Death|1
2007441|NCT00178256|3572534|FG002|Overall Study|Death|0
2007442|NCT00178256|3572535|FG003|Overall Study|Death|1
2007443|NCT00178256|3572532|FG000|Overall Study|Cancer progression|2
2007444|NCT00178256|3572533|FG001|Overall Study|Cancer progression|0
2007445|NCT00178256|3572534|FG002|Overall Study|Cancer progression|0
2007446|NCT00178256|3572535|FG003|Overall Study|Cancer progression|1
2007447|NCT00178399|3572542|FG000|Overall Study|Physician Decision|4
2007448|NCT00178399|3572542|FG000|Overall Study|Withdrawal by Subject|8
2007449|NCT00178399|3572542|FG000|Overall Study|Lost to Follow-up|1
2007450|NCT00178464|3572547|FG000|Overall Study|Withdrawal by Subject|1
2007451|NCT00178464|3572547|FG000|Overall Study|Physician Decision|1
2007452|NCT00178633|3572566|FG000|Overall Study|Lost to Follow-up|6
2007453|NCT00178685|3572590|FG000|Overall Study|Death|3
2007454|NCT00178685|3572591|FG001|Overall Study|Death|3
2007455|NCT00178685|3572592|FG002|Overall Study|Death|6
2007456|NCT00178685|3572590|FG000|Overall Study|Lost to Follow-up|100
2007457|NCT00178685|3572591|FG001|Overall Study|Lost to Follow-up|187
2007458|NCT00178685|3572592|FG002|Overall Study|Lost to Follow-up|183
2007459|NCT00178685|3572590|FG000|Overall Study|Withdrawal by Subject|8
2007460|NCT00178685|3572591|FG001|Overall Study|Withdrawal by Subject|14
2007461|NCT00178685|3572592|FG002|Overall Study|Withdrawal by Subject|7
2007462|NCT00179010|3572627|FG000|Overall Study|Muscle probe defective|1
2007463|NCT00179010|3572628|FG001|Overall Study|Muscle probe defective|1
2007464|NCT00179010|3572627|FG000|Overall Study|Failure to place arterial line|0
2007465|NCT00179010|3572628|FG001|Overall Study|Failure to place arterial line|1
2007466|NCT00179309|3572637|FG000|Treatment|Toxicity|2
2007467|NCT00179309|3572638|FG001|Treatment|Toxicity|3
2007468|NCT00179309|3572637|FG000|Treatment|Withdrawal by Subject|1
2007469|NCT00179309|3572638|FG001|Treatment|Withdrawal by Subject|2
2007470|NCT00179309|3572637|FG000|Treatment|Allergy|1
2007471|NCT00179309|3572638|FG001|Treatment|Allergy|0
2007472|NCT00179413|3572646|FG000|Overall Study|Adverse Event|38
2007473|NCT00179413|3572647|FG001|Overall Study|Adverse Event|20
2007474|NCT00179413|3572646|FG000|Overall Study|Withdrawal by Subject|87
2007475|NCT00179413|3572647|FG001|Overall Study|Withdrawal by Subject|95
2007476|NCT00179517|3572663|FG000|Overall Study|Withdrawal by Subject|2
2007477|NCT00179517|3572664|FG001|Overall Study|Withdrawal by Subject|1
2007478|NCT00179621|3572673|FG000|Double-Blind Period|Lack of Therapeutic Effect|59
2007479|NCT00179621|3572674|FG001|Double-Blind Period|Lack of Therapeutic Effect|35
2007480|NCT00179621|3572675|FG002|Double-Blind Period|Lack of Therapeutic Effect|19
2007481|NCT00179621|3572676|FG003|Double-Blind Period|Lack of Therapeutic Effect|0
2007482|NCT00179621|3572673|FG000|Double-Blind Period|Adverse Event|2
2007483|NCT00179621|3572674|FG001|Double-Blind Period|Adverse Event|7
2007484|NCT00179621|3572675|FG002|Double-Blind Period|Adverse Event|4
2007485|NCT00179621|3572676|FG003|Double-Blind Period|Adverse Event|0
2007486|NCT00179621|3572673|FG000|Double-Blind Period|Withdrawal by Subject|2
2007487|NCT00179621|3572674|FG001|Double-Blind Period|Withdrawal by Subject|1
2007488|NCT00179621|3572675|FG002|Double-Blind Period|Withdrawal by Subject|3
2007489|NCT00179621|3572676|FG003|Double-Blind Period|Withdrawal by Subject|0
2007490|NCT00179621|3572673|FG000|Double-Blind Period|Death|0
2007491|NCT00179621|3572674|FG001|Double-Blind Period|Death|1
2007492|NCT00179621|3572675|FG002|Double-Blind Period|Death|2
2007493|NCT00179621|3572676|FG003|Double-Blind Period|Death|0
2007494|NCT00179621|3572673|FG000|Double-Blind Period|Protocol Violation|1
2007495|NCT00179621|3572674|FG001|Double-Blind Period|Protocol Violation|0
2007496|NCT00179621|3572675|FG002|Double-Blind Period|Protocol Violation|0
2007497|NCT00179621|3572676|FG003|Double-Blind Period|Protocol Violation|0
2007498|NCT00179621|3572673|FG000|Double-Blind Period|Other|0
2007499|NCT00179621|3572674|FG001|Double-Blind Period|Other|2
2007500|NCT00179621|3572675|FG002|Double-Blind Period|Other|2
2007501|NCT00179621|3572676|FG003|Double-Blind Period|Other|0
2007502|NCT00179621|3572673|FG000|Open-Label Period|Lack of Therapeutic Effect|0
2007503|NCT00179621|3572674|FG001|Open-Label Period|Lack of Therapeutic Effect|19
2007504|NCT00179621|3572675|FG002|Open-Label Period|Lack of Therapeutic Effect|19
2007505|NCT00179621|3572676|FG003|Open-Label Period|Lack of Therapeutic Effect|31
2007506|NCT00179621|3572673|FG000|Open-Label Period|Adverse Event|0
2007507|NCT00179621|3572674|FG001|Open-Label Period|Adverse Event|6
2007508|NCT00179621|3572675|FG002|Open-Label Period|Adverse Event|5
2007509|NCT00179621|3572676|FG003|Open-Label Period|Adverse Event|6
2007510|NCT00179621|3572673|FG000|Open-Label Period|Withdrawal by Subject|0
2007511|NCT00179621|3572674|FG001|Open-Label Period|Withdrawal by Subject|2
2007512|NCT00179621|3572675|FG002|Open-Label Period|Withdrawal by Subject|2
2007513|NCT00179621|3572676|FG003|Open-Label Period|Withdrawal by Subject|2
2007514|NCT00179621|3572673|FG000|Open-Label Period|Death|0
2007515|NCT00179621|3572674|FG001|Open-Label Period|Death|0
2007516|NCT00179621|3572675|FG002|Open-Label Period|Death|1
2007517|NCT00179621|3572676|FG003|Open-Label Period|Death|2
2007518|NCT00179621|3572673|FG000|Open-Label Period|Other|0
2007519|NCT00179621|3572674|FG001|Open-Label Period|Other|1
2007520|NCT00179621|3572675|FG002|Open-Label Period|Other|1
2007521|NCT00179621|3572676|FG003|Open-Label Period|Other|2
2007522|NCT00179647|3572685|FG000|Overall Study|Adverse Event|294
2007523|NCT00179647|3572685|FG000|Overall Study|Lack of Efficacy|478
2007524|NCT00179647|3572685|FG000|Overall Study|Withdrawal by Subject|83
2007525|NCT00179647|3572685|FG000|Overall Study|Lost to Follow-up|4
2007526|NCT00179647|3572685|FG000|Overall Study|Death|94
2007527|NCT00179647|3572685|FG000|Overall Study|Other|960
2007528|NCT00179660|3572689|FG000|Overall Study|Adverse Event|7
2007529|NCT00179660|3572689|FG000|Overall Study|Lack of therapeutic effect|28
2007530|NCT00179660|3572689|FG000|Overall Study|Withdrawal by Subject|2
2007531|NCT00179660|3572689|FG000|Overall Study|Lost to Follow-up|1
2007532|NCT00179660|3572689|FG000|Overall Study|Death|3
2007533|NCT00179660|3572689|FG000|Overall Study|Other - Unspecified|9
2007534|NCT00179673|3572693|FG000|Overall Study|Adverse Event|7
2007535|NCT00179673|3572693|FG000|Overall Study|Lack of Efficacy|15
2007536|NCT00179673|3572693|FG000|Overall Study|Withdrawal by Subject|3
2007537|NCT00179673|3572693|FG000|Overall Study|Death|4
2007538|NCT00179673|3572693|FG000|Overall Study|Other Observations and options|14
2007539|NCT00179959|3572710|FG000|Overall Study|Lost to Follow-up|3
2007540|NCT00179959|3572711|FG001|Overall Study|Lost to Follow-up|1
2007541|NCT00179959|3572710|FG000|Overall Study|Withdrawal by Subject|3
2007542|NCT00179959|3572711|FG001|Overall Study|Withdrawal by Subject|2
2007543|NCT00180479|3572758|FG000|Overall Study|Death|4
2007544|NCT00180479|3572759|FG001|Overall Study|Death|2
2007545|NCT00180479|3572758|FG000|Overall Study|Lost to Follow-up|9
2007546|NCT00180479|3572759|FG001|Overall Study|Lost to Follow-up|7
2007547|NCT00180479|3572758|FG000|Overall Study|Withdrawal by Subject|3
2007548|NCT00180479|3572759|FG001|Overall Study|Withdrawal by Subject|3
2007549|NCT00180479|3572758|FG000|Overall Study|Informed consent not signed|0
2007550|NCT00180479|3572759|FG001|Overall Study|Informed consent not signed|1
2007551|NCT00180674|3572774|FG000|Phase 1, Observation Period|Withdrawal by Subject|4
2007552|NCT00180674|3572774|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1
2007553|NCT00180713|3572801|FG000|Overall Study|Withdrawal by Subject|2
2007554|NCT00180713|3572802|FG001|Overall Study|Withdrawal by Subject|0
2007555|NCT00180713|3572801|FG000|Overall Study|Adverse Event|3
2007556|NCT00180713|3572802|FG001|Overall Study|Adverse Event|3
2007557|NCT00181155|3572808|FG000|Overall Study|Physician Decision|1
2007558|NCT00181155|3572809|FG001|Overall Study|Physician Decision|0
2007559|NCT00181155|3572808|FG000|Overall Study|Withdrawal by Subject|1
2007560|NCT00181155|3572809|FG001|Overall Study|Withdrawal by Subject|0
2007561|NCT00181766|3572873|FG000|Overall Study|Lost to Follow-up|6
2007562|NCT00181766|3572873|FG000|Overall Study|Adverse Event|4
2007563|NCT00181766|3572873|FG000|Overall Study|non-compliance|2
2007564|NCT00181844|3572877|FG000|Signed Consent|Withdrawal by Subject|5
2007565|NCT00181844|3572877|FG000|Signed Consent|Did not meet entrance criteria|7
2007566|NCT00181844|3572877|FG000|Exposed to Study Medication|Adverse Event|10
2007567|NCT00181844|3572877|FG000|Exposed to Study Medication|Lack of Efficacy|2
2007568|NCT00181844|3572877|FG000|Exposed to Study Medication|Non-compliance|2
2007569|NCT00181844|3572877|FG000|Exposed to Study Medication|Withdrawal by Subject|1
2007570|NCT00181844|3572877|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2
2007571|NCT00181883|3572881|FG000|Overall Study|Lack of Efficacy|2
2007572|NCT00181883|3572881|FG000|Overall Study|Treatment Limiting AEs|3
2007573|NCT00181883|3572881|FG000|Overall Study|Withdrawal by Subject|4
2007574|NCT00181883|3572881|FG000|Overall Study|Lost to Follow-up|1
2007575|NCT00182078|3572905|FG000|Overall Study|Withdrawal by Subject|1
2007576|NCT00182078|3572906|FG001|Overall Study|Withdrawal by Subject|0
2007577|NCT00182091|3572916|FG000|Overall Study|Withdrawal by Subject|1
2007578|NCT00182091|3572917|FG001|Overall Study|Withdrawal by Subject|0
2007579|NCT00182091|3572918|FG002|Overall Study|Withdrawal by Subject|0
2007580|NCT00182091|3572919|FG003|Overall Study|Withdrawal by Subject|0
2007581|NCT00182325|3572929|FG000|Overall Study|Lost to Follow-up|7
2007582|NCT00182325|3572930|FG001|Overall Study|Lost to Follow-up|7
2007583|NCT00182325|3572929|FG000|Overall Study|Miscarriage|5
2007584|NCT00182325|3572930|FG001|Overall Study|Miscarriage|3
2007585|NCT00182325|3572929|FG000|Overall Study|Did not complete survey|22
2007586|NCT00182325|3572930|FG001|Overall Study|Did not complete survey|43
2007587|NCT00182689|3572938|FG000|Overall Study|Adverse Event|8
2007588|NCT00182689|3572939|FG001|Overall Study|Adverse Event|11
2007589|NCT00182689|3572938|FG000|Overall Study|Withdrawal by Subject|2
2007590|NCT00182689|3572939|FG001|Overall Study|Withdrawal by Subject|2
2007591|NCT00182689|3572938|FG000|Overall Study|Progression|27
2007592|NCT00182689|3572939|FG001|Overall Study|Progression|29
2007593|NCT00182689|3572938|FG000|Overall Study|Death|1
2007594|NCT00182689|3572939|FG001|Overall Study|Death|0
2007595|NCT00182689|3572938|FG000|Overall Study|not protocol specified|0
2007596|NCT00182689|3572939|FG001|Overall Study|not protocol specified|3
2007597|NCT00182689|3572938|FG000|Overall Study|Ineligible|1
2007598|NCT00182689|3572939|FG001|Overall Study|Ineligible|4
2007599|NCT00182689|3572938|FG000|Overall Study|Never received treatment|1
2007600|NCT00182689|3572939|FG001|Overall Study|Never received treatment|0
2007601|NCT00183170|3572994|FG000|First Intervention|Did not complete study|1
2007602|NCT00183170|3572995|FG001|First Intervention|Did not complete study|0
2007603|NCT00183170|3572994|FG000|First Intervention|Did not meet targeted BrAC|1
2007604|NCT00183170|3572995|FG001|First Intervention|Did not meet targeted BrAC|0
2007605|NCT00183170|3572994|FG000|Washout 1 Week|Did not complete study|6
2007606|NCT00183170|3572995|FG001|Washout 1 Week|Did not complete study|8
2007607|NCT00183170|3572994|FG000|Second Intervention|Did not complete study|1
2007608|NCT00183170|3572995|FG001|Second Intervention|Did not complete study|0
2007609|NCT00183170|3572994|FG000|Second Intervention|Did not meet targeted BrAC|0
2007610|NCT00183170|3572995|FG001|Second Intervention|Did not meet targeted BrAC|2
2007611|NCT00183196|3573004|FG000|Overall Study|Withdrawal by Subject|18
2007612|NCT00183196|3573005|FG001|Overall Study|Withdrawal by Subject|11
2007613|NCT00183196|3573006|FG002|Overall Study|Withdrawal by Subject|13
2007614|NCT00183196|3573004|FG000|Overall Study|Adverse Event|1
2007615|NCT00183196|3573005|FG001|Overall Study|Adverse Event|2
2007616|NCT00183196|3573006|FG002|Overall Study|Adverse Event|2
2007617|NCT00183196|3573004|FG000|Overall Study|Legal event|1
2007618|NCT00183196|3573005|FG001|Overall Study|Legal event|1
2007619|NCT00183196|3573006|FG002|Overall Study|Legal event|1
2007620|NCT00183196|3573004|FG000|Overall Study|Required more intensive care|0
2007621|NCT00183196|3573005|FG001|Overall Study|Required more intensive care|1
2007622|NCT00183196|3573006|FG002|Overall Study|Required more intensive care|2
2007623|NCT00183248|3573016|FG000|Overall Study|Lost to Follow-up|0
2007624|NCT00183248|3573017|FG001|Overall Study|Lost to Follow-up|1
2214322|NCT01686633|3856526|FG002|Overall Study|Physician Decision|4
2214323|NCT01686633|3856524|FG000|Overall Study|Adverse Event|4
2214324|NCT01686633|3856525|FG001|Overall Study|Adverse Event|3
2214325|NCT01686633|3856526|FG002|Overall Study|Adverse Event|3
2007625|NCT00183248|3573016|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1
2007626|NCT00183248|3573017|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0
2007627|NCT00183274|3573023|FG000|Phase 1: Open-Label|Adverse Event|31
2007628|NCT00183274|3573024|FG001|Phase 1: Open-Label|Adverse Event|0
2007629|NCT00183274|3573025|FG002|Phase 1: Open-Label|Adverse Event|0
2007630|NCT00183274|3573026|FG003|Phase 1: Open-Label|Adverse Event|0
2007631|NCT00183274|3573027|FG004|Phase 1: Open-Label|Adverse Event|0
2007632|NCT00183274|3573028|FG005|Phase 1: Open-Label|Adverse Event|0
2007633|NCT00183274|3573023|FG000|Phase 1: Open-Label|Lack of Efficacy|13
2007634|NCT00183274|3573024|FG001|Phase 1: Open-Label|Lack of Efficacy|0
2007635|NCT00183274|3573025|FG002|Phase 1: Open-Label|Lack of Efficacy|0
2007636|NCT00183274|3573026|FG003|Phase 1: Open-Label|Lack of Efficacy|0
2007637|NCT00183274|3573027|FG004|Phase 1: Open-Label|Lack of Efficacy|0
2007638|NCT00183274|3573028|FG005|Phase 1: Open-Label|Lack of Efficacy|0
2007639|NCT00183274|3573023|FG000|Phase 1: Open-Label|Protocol Violation|11
2007640|NCT00183274|3573024|FG001|Phase 1: Open-Label|Protocol Violation|0
2007641|NCT00183274|3573025|FG002|Phase 1: Open-Label|Protocol Violation|0
2007642|NCT00183274|3573026|FG003|Phase 1: Open-Label|Protocol Violation|0
2007643|NCT00183274|3573027|FG004|Phase 1: Open-Label|Protocol Violation|0
2007644|NCT00183274|3573028|FG005|Phase 1: Open-Label|Protocol Violation|0
2007645|NCT00183274|3573023|FG000|Phase 1: Open-Label|Withdrawal by Subject|13
2007646|NCT00183274|3573024|FG001|Phase 1: Open-Label|Withdrawal by Subject|0
2007647|NCT00183274|3573025|FG002|Phase 1: Open-Label|Withdrawal by Subject|0
2007648|NCT00183274|3573026|FG003|Phase 1: Open-Label|Withdrawal by Subject|0
2007649|NCT00183274|3573027|FG004|Phase 1: Open-Label|Withdrawal by Subject|0
2007650|NCT00183274|3573028|FG005|Phase 1: Open-Label|Withdrawal by Subject|0
2007651|NCT00183274|3573023|FG000|Phase 1: Open-Label|Lost to Follow-up|33
2007652|NCT00183274|3573024|FG001|Phase 1: Open-Label|Lost to Follow-up|0
2007653|NCT00183274|3573025|FG002|Phase 1: Open-Label|Lost to Follow-up|0
2007654|NCT00183274|3573026|FG003|Phase 1: Open-Label|Lost to Follow-up|0
2007655|NCT00183274|3573027|FG004|Phase 1: Open-Label|Lost to Follow-up|0
2007656|NCT00183274|3573028|FG005|Phase 1: Open-Label|Lost to Follow-up|0
2007657|NCT00183274|3573023|FG000|Phase 1: Open-Label|Other|9
2007658|NCT00183274|3573024|FG001|Phase 1: Open-Label|Other|0
2007659|NCT00183274|3573025|FG002|Phase 1: Open-Label|Other|0
2007660|NCT00183274|3573026|FG003|Phase 1: Open-Label|Other|0
2007661|NCT00183274|3573027|FG004|Phase 1: Open-Label|Other|0
2007662|NCT00183274|3573028|FG005|Phase 1: Open-Label|Other|0
2214326|NCT01686633|3856524|FG000|Overall Study|Protocol Violation|2
2007663|NCT00183274|3573023|FG000|Phase 2: Double-Blind|Relapsed|0
2007664|NCT00183274|3573024|FG001|Phase 2: Double-Blind|Relapsed|8
2007665|NCT00183274|3573025|FG002|Phase 2: Double-Blind|Relapsed|29
2007666|NCT00183274|3573026|FG003|Phase 2: Double-Blind|Relapsed|0
2007667|NCT00183274|3573027|FG004|Phase 2: Double-Blind|Relapsed|0
2007668|NCT00183274|3573028|FG005|Phase 2: Double-Blind|Relapsed|0
2007669|NCT00183274|3573023|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0
2007670|NCT00183274|3573024|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18
2007671|NCT00183274|3573025|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14
2007672|NCT00183274|3573026|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0
2007673|NCT00183274|3573027|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0
2007674|NCT00183274|3573028|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0
2007675|NCT00183274|3573023|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0
2007676|NCT00183274|3573024|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0
2007677|NCT00183274|3573025|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0
2007678|NCT00183274|3573026|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1
2007679|NCT00183274|3573027|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9
2007680|NCT00183274|3573028|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2
2007681|NCT00183274|3573023|FG000|Phase 3: Double-Blind|Relapsed|0
2007682|NCT00183274|3573024|FG001|Phase 3: Double-Blind|Relapsed|0
2007683|NCT00183274|3573025|FG002|Phase 3: Double-Blind|Relapsed|0
2007684|NCT00183274|3573026|FG003|Phase 3: Double-Blind|Relapsed|1
2007685|NCT00183274|3573027|FG004|Phase 3: Double-Blind|Relapsed|11
2007686|NCT00183274|3573028|FG005|Phase 3: Double-Blind|Relapsed|2
2007687|NCT00183391|3573057|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13
2007688|NCT00183391|3573058|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14
2007689|NCT00183391|3573057|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4
2007690|NCT00183391|3573058|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2
2007691|NCT00183430|3573068|FG000|Overall Study|Adverse Event|1
2007692|NCT00183430|3573069|FG001|Overall Study|Adverse Event|0
2007693|NCT00183430|3573068|FG000|Overall Study|Lost to Follow-up|3
2007694|NCT00183430|3573069|FG001|Overall Study|Lost to Follow-up|0
2007695|NCT00183430|3573068|FG000|Overall Study|did not meet inclusion criteria|1
2007696|NCT00183430|3573069|FG001|Overall Study|did not meet inclusion criteria|0
2007697|NCT00183430|3573068|FG000|Overall Study|Withdrawal by Subject|1
2007698|NCT00183430|3573069|FG001|Overall Study|Withdrawal by Subject|0
2007699|NCT00183625|3573116|FG000|Overall Study|Withdrawal by Subject|18
2007700|NCT00183625|3573117|FG001|Overall Study|Withdrawal by Subject|18
2007701|NCT00183625|3573118|FG002|Overall Study|Withdrawal by Subject|19
2007702|NCT00183625|3573119|FG003|Overall Study|Withdrawal by Subject|14
2007703|NCT00183872|3573144|FG000|Overall Study|Death|3
2007704|NCT00183872|3573144|FG000|Overall Study|Adverse Event|9
2007705|NCT00183872|3573144|FG000|Overall Study|Withdrawal by Subject|2
2007706|NCT00183872|3573144|FG000|Overall Study|Drug delayed more than 28 days|2
2007707|NCT00184002|3573148|FG000|Overall Study|Adverse Event|9
2007708|NCT00184002|3573148|FG000|Overall Study|Death|3
2007709|NCT00184002|3573148|FG000|Overall Study|Physician Decision|1
2007710|NCT00184002|3573148|FG000|Overall Study|Withdrawal by Subject|4
2007711|NCT00184028|3573152|FG000|Overall Study|Death|1
2007712|NCT00184028|3573152|FG000|Overall Study|Lack of Efficacy|4
2007713|NCT00184028|3573152|FG000|Overall Study|Adverse Event|2
2007714|NCT00184028|3573152|FG000|Overall Study|Withdrawal by Subject|1
2007715|NCT00184028|3573152|FG000|Overall Study|Non-compliance|2
2007716|NCT00184054|3573157|FG000|Overall Study|Adverse Event|1
2007717|NCT00184093|3573161|FG000|Overall Study|Adverse Event|3
2007718|NCT00184093|3573161|FG000|Overall Study|Lost to Follow-up|3
2007719|NCT00184093|3573161|FG000|Overall Study|Physician Decision|1
2007720|NCT00184093|3573161|FG000|Overall Study|Withdrawal by Subject|2
2007721|NCT00184600|3573185|FG000|Overall Study|Adverse Event|9
2007722|NCT00184600|3573186|FG001|Overall Study|Adverse Event|0
2007723|NCT00184600|3573187|FG002|Overall Study|Adverse Event|5
2007724|NCT00184600|3573185|FG000|Overall Study|Death|3
2007725|NCT00184600|3573186|FG001|Overall Study|Death|9
2007726|NCT00184600|3573187|FG002|Overall Study|Death|7
2007727|NCT00184600|3573185|FG000|Overall Study|Lack of Efficacy|3
2007728|NCT00184600|3573186|FG001|Overall Study|Lack of Efficacy|1
2007729|NCT00184600|3573187|FG002|Overall Study|Lack of Efficacy|3
2214327|NCT01686633|3856525|FG001|Overall Study|Protocol Violation|3
2214328|NCT01686633|3856526|FG002|Overall Study|Protocol Violation|0
2214329|NCT01686633|3856524|FG000|Overall Study|Protocol-defined Stopping Criteria|1
2214330|NCT01686633|3856525|FG001|Overall Study|Protocol-defined Stopping Criteria|0
2007730|NCT00184600|3573185|FG000|Overall Study|Lost to Follow-up|4
2007731|NCT00184600|3573186|FG001|Overall Study|Lost to Follow-up|6
2007732|NCT00184600|3573187|FG002|Overall Study|Lost to Follow-up|1
2007733|NCT00184600|3573185|FG000|Overall Study|Protocol Violation|2
2007734|NCT00184600|3573186|FG001|Overall Study|Protocol Violation|2
2007735|NCT00184600|3573187|FG002|Overall Study|Protocol Violation|3
2007736|NCT00184600|3573185|FG000|Overall Study|Withdrawal by Subject|20
2007737|NCT00184600|3573186|FG001|Overall Study|Withdrawal by Subject|28
2007738|NCT00184600|3573187|FG002|Overall Study|Withdrawal by Subject|12
2007739|NCT00184600|3573185|FG000|Overall Study|Unclassified|4
2007740|NCT00184600|3573186|FG001|Overall Study|Unclassified|5
2007741|NCT00184600|3573187|FG002|Overall Study|Unclassified|3
2007742|NCT00185211|3573214|FG000|Placebo-controlled Study (92012)|Adverse Event|8
2007743|NCT00185211|3573215|FG001|Placebo-controlled Study (92012)|Adverse Event|0
2007744|NCT00185211|3573214|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3
2007745|NCT00185211|3573215|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2
2007746|NCT00185211|3573214|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9
2007747|NCT00185211|3573215|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7
2007748|NCT00185211|3573214|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
2007749|NCT00185211|3573215|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
2026045|NCT00348283|3594715|FG001|Double Blind|Protocol Violation|1
2007750|NCT00185211|3573214|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
2007751|NCT00185211|3573215|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
2007752|NCT00185211|3573214|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5
2217690|NCT01709305|3860930|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0
2007753|NCT00185211|3573215|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6
2007754|NCT00185211|3573214|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
2007755|NCT00185211|3573215|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
2007756|NCT00185211|3573214|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
2007757|NCT00185211|3573215|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
2007758|NCT00185211|3573214|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1
2007759|NCT00185211|3573215|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0
2007760|NCT00185211|3573214|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0
2007761|NCT00185211|3573215|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1
2007762|NCT00185211|3573214|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
2007763|NCT00185211|3573215|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
2007764|NCT00185211|3573214|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
2007765|NCT00185211|3573215|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
2007766|NCT00185380|3573225|FG000|Overall Study|Adverse Event|41
2007767|NCT00185380|3573226|FG001|Overall Study|Adverse Event|43
2007768|NCT00185380|3573227|FG002|Overall Study|Adverse Event|48
2007769|NCT00185380|3573225|FG000|Overall Study|Lost to Follow-up|0
2007770|NCT00185380|3573226|FG001|Overall Study|Lost to Follow-up|4
2007771|NCT00185380|3573227|FG002|Overall Study|Lost to Follow-up|3
2007772|NCT00185380|3573225|FG000|Overall Study|Pregnancy|1
2007773|NCT00185380|3573226|FG001|Overall Study|Pregnancy|4
2007774|NCT00185380|3573227|FG002|Overall Study|Pregnancy|0
2007775|NCT00185380|3573225|FG000|Overall Study|Protocol Violation|2
2007776|NCT00185380|3573226|FG001|Overall Study|Protocol Violation|2
2007777|NCT00185380|3573227|FG002|Overall Study|Protocol Violation|1
2007778|NCT00185380|3573225|FG000|Overall Study|Withdrawal by Subject|1
2007779|NCT00185380|3573226|FG001|Overall Study|Withdrawal by Subject|2
2007780|NCT00185380|3573227|FG002|Overall Study|Withdrawal by Subject|0
2007781|NCT00185380|3573225|FG000|Overall Study|Failed insertion|1
2007782|NCT00185380|3573226|FG001|Overall Study|Failed insertion|1
2007783|NCT00185380|3573227|FG002|Overall Study|Failed insertion|2
2007784|NCT00185380|3573225|FG000|Overall Study|Planned pregnancy|9
2007785|NCT00185380|3573226|FG001|Overall Study|Planned pregnancy|12
2007786|NCT00185380|3573227|FG002|Overall Study|Planned pregnancy|12
2007787|NCT00185380|3573225|FG000|Overall Study|No need for contraception|3
2007788|NCT00185380|3573226|FG001|Overall Study|No need for contraception|3
2007789|NCT00185380|3573227|FG002|Overall Study|No need for contraception|3
2007790|NCT00185380|3573225|FG000|Overall Study|Could not attend visits|2
2007791|NCT00185380|3573226|FG001|Overall Study|Could not attend visits|0
2007792|NCT00185380|3573227|FG002|Overall Study|Could not attend visits|4
2007793|NCT00185380|3573225|FG000|Overall Study|personal reason|6
2007794|NCT00185380|3573226|FG001|Overall Study|personal reason|1
2007795|NCT00185380|3573227|FG002|Overall Study|personal reason|1
2007796|NCT00185458|3573235|FG000|Contraception Phase|Adverse Event|37
2007797|NCT00185458|3573235|FG000|Contraception Phase|Lost to Follow-up|10
2007798|NCT00185458|3573235|FG000|Contraception Phase|Protocol Violation|2
2007799|NCT00185458|3573235|FG000|Contraception Phase|Physician Decision|2
2007800|NCT00185458|3573235|FG000|Contraception Phase|Withdrawal by Subject|7
2007801|NCT00185458|3573235|FG000|HRT Phase|Adverse Event|18
2007802|NCT00185458|3573235|FG000|HRT Phase|Lost to Follow-up|4
2007803|NCT00185458|3573235|FG000|HRT Phase|Protocol Violation|2
2007804|NCT00185458|3573235|FG000|HRT Phase|Withdrawal by Subject|3
2007805|NCT00185588|3573251|FG000|Overall Study|Adverse Event|3
2007806|NCT00185588|3573252|FG001|Overall Study|Adverse Event|1
2007807|NCT00185588|3573253|FG002|Overall Study|Adverse Event|4
2007808|NCT00185588|3573254|FG003|Overall Study|Adverse Event|2
2007809|NCT00185588|3573251|FG000|Overall Study|Lost to Follow-up|0
2007810|NCT00185588|3573252|FG001|Overall Study|Lost to Follow-up|0
2007811|NCT00185588|3573253|FG002|Overall Study|Lost to Follow-up|1
2007812|NCT00185588|3573254|FG003|Overall Study|Lost to Follow-up|2
2007813|NCT00185588|3573251|FG000|Overall Study|Withdrawal by Subject|0
2007814|NCT00185588|3573252|FG001|Overall Study|Withdrawal by Subject|1
2007815|NCT00185588|3573253|FG002|Overall Study|Withdrawal by Subject|0
2007816|NCT00185588|3573254|FG003|Overall Study|Withdrawal by Subject|0
2007817|NCT00185588|3573251|FG000|Overall Study|Physician Decision|0
2007818|NCT00185588|3573252|FG001|Overall Study|Physician Decision|0
2007819|NCT00185588|3573253|FG002|Overall Study|Physician Decision|1
2007820|NCT00185588|3573254|FG003|Overall Study|Physician Decision|0
2007821|NCT00185614|3573264|FG000|Inter-treatment Period|Physician Decision|1
2007822|NCT00185614|3573264|FG000|Inter-treatment Period|Relapse|2
2007823|NCT00185614|3573264|FG000|Inter-treatment Period|Lack of allogenic donor|1
2007824|NCT00185640|3573268|FG000|Overall Study|Not Eligible|4
2007825|NCT00185640|3573268|FG000|Overall Study|Withdrawal by Subject|3
2007826|NCT00185640|3573268|FG000|Overall Study|Death|138
2007827|NCT00185731|3573280|FG000|Overall Study|Withdrawal by Subject|1
2007828|NCT00185731|3573280|FG000|Overall Study|Not Eligible|1
2007829|NCT00185965|3573297|FG000|Overall Study|Adverse Event|0
2007830|NCT00185965|3573298|FG001|Overall Study|Adverse Event|1
2007831|NCT00186043|3573316|FG000|Overall Study|Lack of Efficacy|1
2007832|NCT00186043|3573317|FG001|Overall Study|Lack of Efficacy|3
2007833|NCT00186043|3573316|FG000|Overall Study|Lost to Follow-up|4
2007834|NCT00186043|3573317|FG001|Overall Study|Lost to Follow-up|6
2007835|NCT00186043|3573316|FG000|Overall Study|Withdrawal by Subject|1
2007836|NCT00186043|3573317|FG001|Overall Study|Withdrawal by Subject|0
2007837|NCT00186043|3573316|FG000|Overall Study|Adverse Event|7
2007838|NCT00186043|3573317|FG001|Overall Study|Adverse Event|3
2007839|NCT00186043|3573316|FG000|Overall Study|Protocol Violation|2
2007840|NCT00186043|3573317|FG001|Overall Study|Protocol Violation|1
2007841|NCT00186121|3573341|FG000|Overall Study|Subject withdrawal (no treatment)|1
2007842|NCT00186121|3573341|FG000|Overall Study|Underwent oophorectomy (no treatment)|1
2007843|NCT00186121|3573341|FG000|Overall Study|Not eligible (no treatment)|1
2007844|NCT00186186|3573345|FG000|Overall Study|Lack of Efficacy|3
2007845|NCT00186186|3573345|FG000|Overall Study|Withdrawal by Subject|3
2007846|NCT00186186|3573345|FG000|Overall Study|Not reported as to reason|2
2007847|NCT00186485|3573356|FG000|Overall Study|Lost to Follow-up|3
2007848|NCT00186537|3573372|FG000|Overall Study|Withdrawal by Subject|4
2007849|NCT00186537|3573373|FG001|Overall Study|Withdrawal by Subject|0
2007850|NCT00186537|3573374|FG002|Overall Study|Withdrawal by Subject|3
2007851|NCT00186537|3573372|FG000|Overall Study|ALT > 1.5 x ULN|3
2007852|NCT00186537|3573373|FG001|Overall Study|ALT > 1.5 x ULN|0
2007853|NCT00186537|3573374|FG002|Overall Study|ALT > 1.5 x ULN|0
2007854|NCT00186628|3573382|FG000|Overall Study|Death|2
2007855|NCT00186628|3573382|FG000|Overall Study|Withdrawal by subject (before treatment)|1
2025249|NCT00343252|3593835|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1
2025250|NCT00343252|3593836|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1
2025251|NCT00343252|3593835|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1
2025252|NCT00343252|3593836|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5
2025253|NCT00343252|3593835|FG000|12 Months (All Treated Participants)|Physician Decision|4
2025254|NCT00343252|3593836|FG001|12 Months (All Treated Participants)|Physician Decision|5
2025255|NCT00343252|3593835|FG000|12 Months (All Treated Participants)|Protocol Violation|3
2025256|NCT00343252|3593836|FG001|12 Months (All Treated Participants)|Protocol Violation|2
2025257|NCT00343252|3593835|FG000|12 Months (All Treated Participants)|Sponsor Decision|9
2025258|NCT00343252|3593836|FG001|12 Months (All Treated Participants)|Sponsor Decision|6
2025259|NCT00343252|3593835|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33
2025260|NCT00343252|3593836|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17
2025261|NCT00343252|3593835|FG000|18 Months (All Treated Participants)|Adverse Event|31
2025262|NCT00343252|3593836|FG001|18 Months (All Treated Participants)|Adverse Event|23
2025263|NCT00343252|3593835|FG000|18 Months (All Treated Participants)|Death|4
2025264|NCT00343252|3593836|FG001|18 Months (All Treated Participants)|Death|5
2025265|NCT00343252|3593835|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11
2025266|NCT00343252|3593836|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10
2025267|NCT00343252|3593835|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1
2025268|NCT00343252|3593836|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1
2025269|NCT00343252|3593835|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3
2025270|NCT00343252|3593836|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7
2025271|NCT00343252|3593835|FG000|18 Months (All Treated Participants)|Physician Decision|4
2025272|NCT00343252|3593836|FG001|18 Months (All Treated Participants)|Physician Decision|7
2025273|NCT00343252|3593835|FG000|18 Months (All Treated Participants)|Protocol Violation|3
2025274|NCT00343252|3593836|FG001|18 Months (All Treated Participants)|Protocol Violation|3
2025275|NCT00343252|3593835|FG000|18 Months (All Treated Participants)|Sponsor Decision|8
2025276|NCT00343252|3593836|FG001|18 Months (All Treated Participants)|Sponsor Decision|5
2025277|NCT00343252|3593835|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36
2025278|NCT00343252|3593836|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20
2025279|NCT00343291|3593844|FG000|Overall Study|Adverse Event|13
2025280|NCT00343291|3593845|FG001|Overall Study|Adverse Event|13
2025281|NCT00343291|3593844|FG000|Overall Study|Death|3
2025282|NCT00343291|3593845|FG001|Overall Study|Death|2
2025283|NCT00343291|3593844|FG000|Overall Study|Progressive disease|33
2025284|NCT00343291|3593845|FG001|Overall Study|Progressive disease|34
2025285|NCT00343291|3593844|FG000|Overall Study|Withdrawal by Subject|0
2025286|NCT00343291|3593845|FG001|Overall Study|Withdrawal by Subject|2
2025287|NCT00343291|3593844|FG000|Overall Study|Other|8
2025288|NCT00343291|3593845|FG001|Overall Study|Other|5
2025289|NCT00343382|3593854|FG000|Overall Study|Adverse Event|2
2025290|NCT00343382|3593855|FG001|Overall Study|Adverse Event|10
2025291|NCT00343382|3593856|FG002|Overall Study|Adverse Event|7
2025292|NCT00343382|3593854|FG000|Overall Study|Withdrawal by Subject|1
2025293|NCT00343382|3593855|FG001|Overall Study|Withdrawal by Subject|2
2025294|NCT00343382|3593856|FG002|Overall Study|Withdrawal by Subject|6
2025295|NCT00343382|3593854|FG000|Overall Study|Other Reason Not Specified|1
2025296|NCT00343382|3593855|FG001|Overall Study|Other Reason Not Specified|2
2025297|NCT00343382|3593856|FG002|Overall Study|Other Reason Not Specified|4
2025298|NCT00343512|3593890|FG000|Overall Study|Withdrawal by Subject|2
2214331|NCT01686633|3856526|FG002|Overall Study|Protocol-defined Stopping Criteria|1
2214332|NCT01686633|3856524|FG000|Overall Study|Lost to Follow-up|0
2214333|NCT01686633|3856525|FG001|Overall Study|Lost to Follow-up|1
2007856|NCT00186901|3573401|FG000|Overall Study|Pregnancy|6
2007857|NCT00186901|3573402|FG001|Overall Study|Pregnancy|3
2007858|NCT00186901|3573403|FG002|Overall Study|Pregnancy|0
2007859|NCT00186901|3573401|FG000|Overall Study|Lost to Follow-up|6
2007860|NCT00186901|3573402|FG001|Overall Study|Lost to Follow-up|3
2007861|NCT00186901|3573403|FG002|Overall Study|Lost to Follow-up|0
2007862|NCT00186901|3573401|FG000|Overall Study|Bone Mineral Density dropped > 5%|9
2007863|NCT00186901|3573402|FG001|Overall Study|Bone Mineral Density dropped > 5%|7
2007864|NCT00186901|3573403|FG002|Overall Study|Bone Mineral Density dropped > 5%|0
2007865|NCT00186901|3573401|FG000|Overall Study|ALL relapse or second malignancy|1
2007866|NCT00186901|3573402|FG001|Overall Study|ALL relapse or second malignancy|2
2007867|NCT00186901|3573403|FG002|Overall Study|ALL relapse or second malignancy|0
2007868|NCT00186901|3573401|FG000|Overall Study|Withdrawal by Subject|4
2007869|NCT00186901|3573402|FG001|Overall Study|Withdrawal by Subject|5
2007870|NCT00186901|3573403|FG002|Overall Study|Withdrawal by Subject|0
2007871|NCT00186901|3573401|FG000|Overall Study|Open label|3
2007872|NCT00186901|3573402|FG001|Overall Study|Open label|2
2007873|NCT00186901|3573403|FG002|Overall Study|Open label|0
2007874|NCT00186901|3573401|FG000|Overall Study|Limited adherence to study requirements|20
2007875|NCT00186901|3573402|FG001|Overall Study|Limited adherence to study requirements|23
2007876|NCT00186901|3573403|FG002|Overall Study|Limited adherence to study requirements|0
2007877|NCT00186901|3573401|FG000|Overall Study|Bone Mineral Density > 0|0
2007878|NCT00186901|3573402|FG001|Overall Study|Bone Mineral Density > 0|0
2007879|NCT00186901|3573403|FG002|Overall Study|Bone Mineral Density > 0|149
2007880|NCT00187096|3573443|FG000|Overall Study|unacceptable toxicity|0
2007881|NCT00187096|3573444|FG001|Overall Study|unacceptable toxicity|0
2007882|NCT00187096|3573445|FG002|Overall Study|unacceptable toxicity|1
2007883|NCT00187135|3573459|FG000|Visit One|Withdrawal by Subject|1
2007884|NCT00187135|3573460|FG001|Visit One|Withdrawal by Subject|0
2007885|NCT00187135|3573461|FG002|Visit One|Withdrawal by Subject|0
2007886|NCT00187135|3573462|FG003|Visit One|Withdrawal by Subject|0
2007887|NCT00187135|3573463|FG004|Visit One|Withdrawal by Subject|0
2007888|NCT00187135|3573464|FG005|Visit One|Withdrawal by Subject|1
2007889|NCT00187135|3573459|FG000|Visit One|Physician Decision|3
2007890|NCT00187135|3573460|FG001|Visit One|Physician Decision|1
2007891|NCT00187135|3573461|FG002|Visit One|Physician Decision|0
2007892|NCT00187135|3573462|FG003|Visit One|Physician Decision|0
2007893|NCT00187135|3573463|FG004|Visit One|Physician Decision|0
2007894|NCT00187135|3573464|FG005|Visit One|Physician Decision|1
2007895|NCT00187135|3573459|FG000|Visit Two|Death|0
2007896|NCT00187135|3573460|FG001|Visit Two|Death|0
2007897|NCT00187135|3573461|FG002|Visit Two|Death|0
2007898|NCT00187135|3573462|FG003|Visit Two|Death|1
2007899|NCT00187135|3573463|FG004|Visit Two|Death|0
2007900|NCT00187135|3573464|FG005|Visit Two|Death|1
2007901|NCT00187135|3573459|FG000|Visit Two|Physician Decision|1
2007902|NCT00187135|3573460|FG001|Visit Two|Physician Decision|0
2007903|NCT00187135|3573461|FG002|Visit Two|Physician Decision|0
2007904|NCT00187135|3573462|FG003|Visit Two|Physician Decision|0
2007905|NCT00187135|3573463|FG004|Visit Two|Physician Decision|0
2007906|NCT00187135|3573464|FG005|Visit Two|Physician Decision|0
2007907|NCT00187135|3573459|FG000|Visit Two|Withdrawal by Subject|1
2007908|NCT00187135|3573460|FG001|Visit Two|Withdrawal by Subject|1
2007909|NCT00187135|3573461|FG002|Visit Two|Withdrawal by Subject|1
2214334|NCT01686633|3856526|FG002|Overall Study|Lost to Follow-up|1
2214335|NCT01686828|3856566|FG000|Overall Study|Physician Decision|1
2214336|NCT01686828|3856567|FG001|Overall Study|Physician Decision|0
2214337|NCT01686828|3856568|FG002|Overall Study|Physician Decision|0
2214338|NCT01686828|3856569|FG003|Overall Study|Physician Decision|0
2214339|NCT01686828|3856566|FG000|Overall Study|New Job|0
2214340|NCT01686828|3856567|FG001|Overall Study|New Job|1
2214341|NCT01686828|3856568|FG002|Overall Study|New Job|0
2007910|NCT00187135|3573462|FG003|Visit Two|Withdrawal by Subject|0
2007911|NCT00187135|3573463|FG004|Visit Two|Withdrawal by Subject|1
2007912|NCT00187135|3573464|FG005|Visit Two|Withdrawal by Subject|1
2007913|NCT00187135|3573459|FG000|Visit Two|Study Discontinued|3
2007914|NCT00187135|3573460|FG001|Visit Two|Study Discontinued|2
2007915|NCT00187135|3573461|FG002|Visit Two|Study Discontinued|1
2007916|NCT00187135|3573462|FG003|Visit Two|Study Discontinued|7
2007917|NCT00187135|3573463|FG004|Visit Two|Study Discontinued|5
2007918|NCT00187135|3573464|FG005|Visit Two|Study Discontinued|6
2007919|NCT00187135|3573459|FG000|Visit Three|Death|0
2007920|NCT00187135|3573460|FG001|Visit Three|Death|0
2007921|NCT00187135|3573461|FG002|Visit Three|Death|1
2007922|NCT00187135|3573462|FG003|Visit Three|Death|0
2007923|NCT00187135|3573463|FG004|Visit Three|Death|1
2007924|NCT00187135|3573464|FG005|Visit Three|Death|0
2007925|NCT00187135|3573459|FG000|Visit Three|Withdrawal by Subject|0
2007926|NCT00187135|3573460|FG001|Visit Three|Withdrawal by Subject|1
2007927|NCT00187135|3573461|FG002|Visit Three|Withdrawal by Subject|1
2007928|NCT00187135|3573462|FG003|Visit Three|Withdrawal by Subject|2
2007929|NCT00187135|3573463|FG004|Visit Three|Withdrawal by Subject|0
2007930|NCT00187135|3573464|FG005|Visit Three|Withdrawal by Subject|0
2007931|NCT00187135|3573459|FG000|Visit Three|Study Discontinued|7
2007932|NCT00187135|3573460|FG001|Visit Three|Study Discontinued|6
2007933|NCT00187135|3573461|FG002|Visit Three|Study Discontinued|7
2007934|NCT00187135|3573462|FG003|Visit Three|Study Discontinued|7
2007935|NCT00187135|3573463|FG004|Visit Three|Study Discontinued|7
2214342|NCT01686828|3856569|FG003|Overall Study|New Job|0
2007936|NCT00187135|3573464|FG005|Visit Three|Study Discontinued|6
2007937|NCT00187278|3573514|FG000|Overall Study|Protocol Violation|10
2007938|NCT00187278|3573515|FG001|Overall Study|Protocol Violation|13
2007939|NCT00187486|3573538|FG000|Overall Study|Protocol Violation|1
2007940|NCT00187889|3573578|FG000|Overall Study|Withdrawal by Subject|6
2007941|NCT00187889|3573579|FG001|Overall Study|Withdrawal by Subject|4
2007942|NCT00189202|3573606|FG000|Overall Study|Physician Decision|5
2007943|NCT00189306|3573614|FG000|Treatment Period|Withdrawal by Subject|2
2007944|NCT00189306|3573614|FG000|Treatment Period|Adverse Event|2
2007945|NCT00189306|3573614|FG000|Treatment Period|Protocol Violation|1
2007946|NCT00189306|3573614|FG000|Posttreatment Period|Death|1
2007947|NCT00189306|3573614|FG000|Posttreatment Period|Withdrawal by Subject|2
2007948|NCT00189306|3573614|FG000|Posttreatment Period|Noncompliance|1
2007949|NCT00189306|3573614|FG000|Posttreatment Period|Target lesion excised|1
2007950|NCT00189306|3573614|FG000|Posttreatment Period|Protocol Violation|1
2007951|NCT00189306|3573614|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
2007952|NCT00189306|3573614|FG000|Posttreatment Period|Local skin reaction/sign|1
2007953|NCT00189306|3573614|FG000|Long-Term Follow-up|Adverse Event|2
2007954|NCT00189306|3573614|FG000|Long-Term Follow-up|Death|4
2007955|NCT00189306|3573614|FG000|Long-Term Follow-up|Withdrawal by Subject|1
2007956|NCT00189306|3573614|FG000|Long-Term Follow-up|Intercurrent disease|2
2007957|NCT00189306|3573614|FG000|Long-Term Follow-up|Lost to Follow-up|9
2007958|NCT00189306|3573614|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
2007959|NCT00189423|3573620|FG000|Overall Study|Death|746
2007960|NCT00189423|3573621|FG001|Overall Study|Death|747
2007961|NCT00189423|3573620|FG000|Overall Study|Withdrawal by Subject|9
2007962|NCT00189423|3573621|FG001|Overall Study|Withdrawal by Subject|9
2007963|NCT00189423|3573620|FG000|Overall Study|Lost to Follow-up|10
2007964|NCT00189423|3573621|FG001|Overall Study|Lost to Follow-up|10
2007965|NCT00189462|3573638|FG000|Overall Study|Lack of Efficacy|5
2007966|NCT00189462|3573639|FG001|Overall Study|Lack of Efficacy|1
2007967|NCT00189462|3573638|FG000|Overall Study|Lost to Follow-up|18
2007968|NCT00189462|3573639|FG001|Overall Study|Lost to Follow-up|20
2007969|NCT00189488|3573656|FG000|Overall Study|Ineligibility determined|1
2007970|NCT00189488|3573657|FG001|Overall Study|Ineligibility determined|0
2007971|NCT00189488|3573656|FG000|Overall Study|Protocol deviation|2
2007972|NCT00189488|3573657|FG001|Overall Study|Protocol deviation|1
2007973|NCT00189488|3573656|FG000|Overall Study|Adverse Event|2
2007974|NCT00189488|3573657|FG001|Overall Study|Adverse Event|1
2007975|NCT00189488|3573656|FG000|Overall Study|Withdrawal by Subject|2
2007976|NCT00189488|3573657|FG001|Overall Study|Withdrawal by Subject|6
2007977|NCT00189488|3573656|FG000|Overall Study|Disease progression|2
2007978|NCT00189488|3573657|FG001|Overall Study|Disease progression|4
2007979|NCT00189488|3573656|FG000|Overall Study|Administrative Decision|0
2007980|NCT00189488|3573657|FG001|Overall Study|Administrative Decision|2
2007981|NCT00189488|3573656|FG000|Overall Study|Death|5
2007982|NCT00189488|3573657|FG001|Overall Study|Death|8
2007983|NCT00189488|3573656|FG000|Overall Study|Other|1
2007984|NCT00189488|3573657|FG001|Overall Study|Other|0
2007985|NCT00189540|3573666|FG000|Overall Study|Withdrawal by Subject|3
2007986|NCT00189540|3573667|FG001|Overall Study|Withdrawal by Subject|0
2007987|NCT00189540|3573666|FG000|Overall Study|Death|4
2007988|NCT00189540|3573667|FG001|Overall Study|Death|1
2007989|NCT00190671|3573675|FG000|Overall Study|Satisfactory Response|4
2007990|NCT00190671|3573676|FG001|Overall Study|Satisfactory Response|7
2007991|NCT00190671|3573675|FG000|Overall Study|Lack of Efficacy|19
2007992|NCT00190671|3573676|FG001|Overall Study|Lack of Efficacy|24
2007993|NCT00190671|3573675|FG000|Overall Study|Death from Study Disease|1
2007994|NCT00190671|3573676|FG001|Overall Study|Death from Study Disease|1
2007995|NCT00190671|3573675|FG000|Overall Study|Adverse Event|3
2007996|NCT00190671|3573676|FG001|Overall Study|Adverse Event|2
2007997|NCT00190671|3573675|FG000|Overall Study|Clinical Relapse|0
2007998|NCT00190671|3573676|FG001|Overall Study|Clinical Relapse|1
2007999|NCT00190671|3573675|FG000|Overall Study|Death from Study-Drug Toxicity|0
2008000|NCT00190671|3573676|FG001|Overall Study|Death from Study-Drug Toxicity|2
2008001|NCT00190671|3573675|FG000|Overall Study|Death from Other Causes|0
2008002|NCT00190671|3573676|FG001|Overall Study|Death from Other Causes|2
2008003|NCT00190671|3573675|FG000|Overall Study|Protocol Violation|0
2008004|NCT00190671|3573676|FG001|Overall Study|Protocol Violation|1
2008005|NCT00190671|3573675|FG000|Overall Study|Withdrawal by Subject|0
2008006|NCT00190671|3573676|FG001|Overall Study|Withdrawal by Subject|2
2008007|NCT00190684|3573683|FG000|Overall Study|Adverse Event|86
2008008|NCT00190684|3573683|FG000|Overall Study|Satisfactory response|80
2008009|NCT00190684|3573683|FG000|Overall Study|Lack of efficacy|204
2008010|NCT00190684|3573683|FG000|Overall Study|Lost to Follow-up|232
2008011|NCT00190684|3573683|FG000|Overall Study|Patient moved|60
2008012|NCT00190684|3573683|FG000|Overall Study|Patient Decision|432
2008013|NCT00190684|3573683|FG000|Overall Study|Clinical relapse|67
2008014|NCT00190684|3573683|FG000|Overall Study|Sponsor's decision|17
2008015|NCT00190684|3573683|FG000|Overall Study|Physician Decision|84
2008016|NCT00190684|3573683|FG000|Overall Study|Protocol Violation|123
2008017|NCT00190684|3573683|FG000|Overall Study|Study Period III Completed|103
2008018|NCT00190684|3573683|FG000|Overall Study|Study Period V Completed|1
2008019|NCT00190749|3573689|FG000|Overall Study|Lost to Follow-up|8
2008020|NCT00190749|3573690|FG001|Overall Study|Lost to Follow-up|11
2008021|NCT00190749|3573689|FG000|Overall Study|Withdrawal by Subject|10
2008022|NCT00190749|3573690|FG001|Overall Study|Withdrawal by Subject|6
2008023|NCT00190749|3573689|FG000|Overall Study|Protocol Violation|5
2008024|NCT00190749|3573690|FG001|Overall Study|Protocol Violation|4
2008025|NCT00190749|3573689|FG000|Overall Study|Adverse Event|0
2008026|NCT00190749|3573690|FG001|Overall Study|Adverse Event|5
2008027|NCT00190749|3573689|FG000|Overall Study|Lack of Efficacy|2
2008028|NCT00190749|3573690|FG001|Overall Study|Lack of Efficacy|3
2008029|NCT00190749|3573689|FG000|Overall Study|Reason Not Specified|0
2008030|NCT00190749|3573690|FG001|Overall Study|Reason Not Specified|2
2008031|NCT00190749|3573689|FG000|Overall Study|Sponsor Decision|1
2008032|NCT00190749|3573690|FG001|Overall Study|Sponsor Decision|0
2008033|NCT00190775|3573698|FG000|Overall Study|Adverse Event|57
2008034|NCT00190775|3573699|FG001|Overall Study|Adverse Event|22
2008035|NCT00190775|3573698|FG000|Overall Study|Satisfactory Response|1
2008036|NCT00190775|3573699|FG001|Overall Study|Satisfactory Response|0
2008037|NCT00190775|3573698|FG000|Overall Study|Lack of Efficacy|28
2008038|NCT00190775|3573699|FG001|Overall Study|Lack of Efficacy|32
2008039|NCT00190775|3573698|FG000|Overall Study|Lost to Follow-up|31
2008040|NCT00190775|3573699|FG001|Overall Study|Lost to Follow-up|23
2008041|NCT00190775|3573698|FG000|Overall Study|Participant Moved|0
2008042|NCT00190775|3573699|FG001|Overall Study|Participant Moved|1
2008043|NCT00190775|3573698|FG000|Overall Study|Withdrawal by Subject|24
2008044|NCT00190775|3573699|FG001|Overall Study|Withdrawal by Subject|13
2008045|NCT00190775|3573698|FG000|Overall Study|Sponsor Decision|1
2008046|NCT00190775|3573699|FG001|Overall Study|Sponsor Decision|0
2008047|NCT00190775|3573698|FG000|Overall Study|Physician Decision|3
2008048|NCT00190775|3573699|FG001|Overall Study|Physician Decision|0
2008049|NCT00190775|3573698|FG000|Overall Study|Noncompliance|3
2008050|NCT00190775|3573699|FG001|Overall Study|Noncompliance|5
2008051|NCT00190775|3573698|FG000|Overall Study|Protocol Violation|0
2008052|NCT00190775|3573699|FG001|Overall Study|Protocol Violation|1
2008053|NCT00190775|3573698|FG000|Overall Study|Exclusion Criteria Met|1
2008054|NCT00190775|3573699|FG001|Overall Study|Exclusion Criteria Met|3
2008055|NCT00190983|3573712|FG000|Overall Study|Inevaluable (never treated)|2
2008056|NCT00191100|3573718|FG000|Overall Study|Adverse Event|18
2008057|NCT00191100|3573719|FG001|Overall Study|Adverse Event|1
2008058|NCT00191100|3573718|FG000|Overall Study|Lost to Follow-up|2
2008059|NCT00191100|3573719|FG001|Overall Study|Lost to Follow-up|0
2008060|NCT00191100|3573718|FG000|Overall Study|Patient Moved|0
2008061|NCT00191100|3573719|FG001|Overall Study|Patient Moved|1
2008062|NCT00191100|3573718|FG000|Overall Study|Withdrawal by Subject|9
2008063|NCT00191100|3573719|FG001|Overall Study|Withdrawal by Subject|3
2008064|NCT00191100|3573718|FG000|Overall Study|Protocol Entry Criteria Not Met|2
2008065|NCT00191100|3573719|FG001|Overall Study|Protocol Entry Criteria Not Met|1
2008066|NCT00191100|3573718|FG000|Overall Study|Clinical Relapse|2
2008067|NCT00191100|3573719|FG001|Overall Study|Clinical Relapse|1
2008068|NCT00191100|3573718|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1
2008069|NCT00191100|3573719|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2
2008070|NCT00191100|3573718|FG000|Overall Study|Lack of Efficacy, Stable Disease|1
2008071|NCT00191100|3573719|FG001|Overall Study|Lack of Efficacy, Stable Disease|0
2008072|NCT00191100|3573718|FG000|Overall Study|Physician Decision|3
2008073|NCT00191100|3573719|FG001|Overall Study|Physician Decision|1
2008074|NCT00191100|3573718|FG000|Overall Study|Death from Study Drug Toxicity|2
2008075|NCT00191100|3573719|FG001|Overall Study|Death from Study Drug Toxicity|0
2008076|NCT00191100|3573718|FG000|Overall Study|Protocol Violation|1
2008077|NCT00191100|3573719|FG001|Overall Study|Protocol Violation|1
2008078|NCT00191100|3573718|FG000|Overall Study|Death from Other Cause|1
2008079|NCT00191100|3573719|FG001|Overall Study|Death from Other Cause|0
2008080|NCT00191100|3573718|FG000|Overall Study|Reason Not Specified|0
2008081|NCT00191100|3573719|FG001|Overall Study|Reason Not Specified|1
2008082|NCT00191113|3573727|FG000|Core Study|Withdrawal by Subject|25
2008083|NCT00191113|3573728|FG001|Core Study|Withdrawal by Subject|9
2008084|NCT00191113|3573727|FG000|Core Study|Protocol Violation|6
2008085|NCT00191113|3573728|FG001|Core Study|Protocol Violation|2
2008086|NCT00191113|3573727|FG000|Core Study|Lost to Follow-up|3
2008087|NCT00191113|3573728|FG001|Core Study|Lost to Follow-up|0
2008088|NCT00191113|3573727|FG000|Core Study|Adverse Event|0
2008089|NCT00191113|3573728|FG001|Core Study|Adverse Event|2
2008090|NCT00191113|3573727|FG000|Core Study|Lack of Efficacy|0
2008091|NCT00191113|3573728|FG001|Core Study|Lack of Efficacy|2
2008092|NCT00191113|3573727|FG000|Core Study|Death|1
2008093|NCT00191113|3573728|FG001|Core Study|Death|0
2008094|NCT00191139|3573742|FG000|Overall Study|Adverse Event|2
2008095|NCT00191139|3573743|FG001|Overall Study|Adverse Event|6
2008096|NCT00191139|3573742|FG000|Overall Study|Death|2
2008097|NCT00191139|3573743|FG001|Overall Study|Death|0
2008098|NCT00191139|3573742|FG000|Overall Study|Withdrawal by Subject|0
2008099|NCT00191139|3573743|FG001|Overall Study|Withdrawal by Subject|3
2008100|NCT00191139|3573742|FG000|Overall Study|Disease Progression|0
2008101|NCT00191139|3573743|FG001|Overall Study|Disease Progression|1
2008102|NCT00191139|3573742|FG000|Overall Study|Other|1
2008103|NCT00191139|3573743|FG001|Overall Study|Other|2
2008104|NCT00191152|3573751|FG000|Initial Treatment|Adverse Event|43
2008105|NCT00191152|3573752|FG001|Initial Treatment|Adverse Event|67
2008106|NCT00191152|3573751|FG000|Initial Treatment|Physician Decision|40
2008107|NCT00191152|3573752|FG001|Initial Treatment|Physician Decision|31
2008108|NCT00191152|3573751|FG000|Initial Treatment|Withdrawal by Subject|40
2008109|NCT00191152|3573752|FG001|Initial Treatment|Withdrawal by Subject|28
2008110|NCT00191152|3573751|FG000|Initial Treatment|Lost to Follow-up|0
2008111|NCT00191152|3573752|FG001|Initial Treatment|Lost to Follow-up|6
2008112|NCT00191152|3573751|FG000|Initial Treatment|Other|18
2008113|NCT00191152|3573752|FG001|Initial Treatment|Other|21
2008114|NCT00191152|3573751|FG000|Crossover Treatment|Adverse Event|8
2008115|NCT00191152|3573752|FG001|Crossover Treatment|Adverse Event|8
2008116|NCT00191152|3573751|FG000|Crossover Treatment|Physician Decision|7
2008117|NCT00191152|3573752|FG001|Crossover Treatment|Physician Decision|7
2008118|NCT00191152|3573751|FG000|Crossover Treatment|Withdrawal by Subject|6
2008119|NCT00191152|3573752|FG001|Crossover Treatment|Withdrawal by Subject|9
2008120|NCT00191152|3573751|FG000|Crossover Treatment|Lost to Follow-up|2
2008121|NCT00191152|3573752|FG001|Crossover Treatment|Lost to Follow-up|1
2008122|NCT00191152|3573751|FG000|Crossover Treatment|Other|4
2008123|NCT00191152|3573752|FG001|Crossover Treatment|Other|3
2008124|NCT00191165|3573772|FG000|Overall Study|Adverse Event|2
2008125|NCT00191165|3573773|FG001|Overall Study|Adverse Event|0
2008126|NCT00191165|3573772|FG000|Overall Study|Protocol Violation|0
2008127|NCT00191165|3573773|FG001|Overall Study|Protocol Violation|1
2008128|NCT00191165|3573772|FG000|Overall Study|Participant Moved Away|0
2008129|NCT00191165|3573773|FG001|Overall Study|Participant Moved Away|1
2008130|NCT00191191|3573781|FG000|Overall Study|Entry Criteria Exclusion|2
2008131|NCT00191191|3573782|FG001|Overall Study|Entry Criteria Exclusion|0
2008132|NCT00191191|3573781|FG000|Overall Study|Treated with Another Systemic Agent|1
2008133|NCT00191191|3573782|FG001|Overall Study|Treated with Another Systemic Agent|1
2008134|NCT00191191|3573781|FG000|Overall Study|Adverse Event|11
2008135|NCT00191191|3573782|FG001|Overall Study|Adverse Event|21
2008136|NCT00191191|3573781|FG000|Overall Study|Progressive Disease|84
2008137|NCT00191191|3573782|FG001|Overall Study|Progressive Disease|72
2008138|NCT00191191|3573781|FG000|Overall Study|Toxicity After Dose Reduction|7
2008139|NCT00191191|3573782|FG001|Overall Study|Toxicity After Dose Reduction|8
2008140|NCT00191191|3573781|FG000|Overall Study|Family/Caregiver Decision|5
2008141|NCT00191191|3573782|FG001|Overall Study|Family/Caregiver Decision|7
2008142|NCT00191191|3573781|FG000|Overall Study|Lost to Follow-up|1
2008143|NCT00191191|3573782|FG001|Overall Study|Lost to Follow-up|0
2008144|NCT00191191|3573781|FG000|Overall Study|Physician Decision|3
2008145|NCT00191191|3573782|FG001|Overall Study|Physician Decision|2
2008146|NCT00191191|3573781|FG000|Overall Study|Good Clinical Practice Violation|0
2008147|NCT00191191|3573782|FG001|Overall Study|Good Clinical Practice Violation|1
2008148|NCT00191269|3573790|FG000|Overall Study|Protocol Violation|0
2008149|NCT00191269|3573791|FG001|Overall Study|Protocol Violation|2
2008150|NCT00191269|3573790|FG000|Overall Study|Adverse Event|1
2008151|NCT00191269|3573791|FG001|Overall Study|Adverse Event|4
2008152|NCT00191269|3573790|FG000|Overall Study|Progression of Disease|4
2008153|NCT00191269|3573791|FG001|Overall Study|Progression of Disease|42
2008154|NCT00191269|3573790|FG000|Overall Study|Lack of Efficacy|1
2008155|NCT00191269|3573791|FG001|Overall Study|Lack of Efficacy|5
2008156|NCT00191269|3573790|FG000|Overall Study|Withdrawal by Subject|0
2008157|NCT00191269|3573791|FG001|Overall Study|Withdrawal by Subject|1
2008158|NCT00191269|3573790|FG000|Overall Study|Pathologic Aggrevation|0
2008159|NCT00191269|3573791|FG001|Overall Study|Pathologic Aggrevation|1
2008160|NCT00191269|3573790|FG000|Overall Study|Physician Decision|0
2008161|NCT00191269|3573791|FG001|Overall Study|Physician Decision|3
2008162|NCT00191282|3573800|FG000|Overall Study|Adverse Event|5
2008163|NCT00191282|3573801|FG001|Overall Study|Adverse Event|6
2008164|NCT00191282|3573800|FG000|Overall Study|Death|51
2008165|NCT00191282|3573801|FG001|Overall Study|Death|51
2008166|NCT00191282|3573800|FG000|Overall Study|Lack of Efficacy|11
2008167|NCT00191282|3573801|FG001|Overall Study|Lack of Efficacy|6
2008168|NCT00191282|3573800|FG000|Overall Study|Noncompliance|14
2008169|NCT00191282|3573801|FG001|Overall Study|Noncompliance|17
2008170|NCT00191282|3573800|FG000|Overall Study|Patient moved|11
2008171|NCT00191282|3573801|FG001|Overall Study|Patient moved|14
2214343|NCT01686828|3856566|FG000|Overall Study|Weight Loss|0
2214344|NCT01686828|3856567|FG001|Overall Study|Weight Loss|0
2214345|NCT01686828|3856568|FG002|Overall Study|Weight Loss|1
2214346|NCT01686828|3856569|FG003|Overall Study|Weight Loss|0
2008172|NCT00191282|3573800|FG000|Overall Study|Withdrawal by Subject|59
2008173|NCT00191282|3573801|FG001|Overall Study|Withdrawal by Subject|44
2008174|NCT00191282|3573800|FG000|Overall Study|Physician Decision|18
2008175|NCT00191282|3573801|FG001|Overall Study|Physician Decision|15
2008176|NCT00191282|3573800|FG000|Overall Study|Protocol entry criteria not met|14
2008177|NCT00191282|3573801|FG001|Overall Study|Protocol entry criteria not met|9
2008178|NCT00191282|3573800|FG000|Overall Study|Protocol Violation|9
2008179|NCT00191282|3573801|FG001|Overall Study|Protocol Violation|12
2008180|NCT00191282|3573800|FG000|Overall Study|Severity of outcome|2
2008181|NCT00191282|3573801|FG001|Overall Study|Severity of outcome|5
2008182|NCT00191282|3573800|FG000|Overall Study|Sponsor's decision|2
2008183|NCT00191282|3573801|FG001|Overall Study|Sponsor's decision|2
2008184|NCT00191282|3573800|FG000|Overall Study|Lost to Follow-up|24
2008185|NCT00191282|3573801|FG001|Overall Study|Lost to Follow-up|31
2214347|NCT01686932|3856585|FG000|Period 1|Adverse Event|1
2008186|NCT00191308|3573807|FG000|Overall Study|Adverse Event|1
2214348|NCT01686932|3856586|FG001|Period 1|Adverse Event|1
2008187|NCT00191334|3573811|FG000|Overall Study|Adverse Event|4
2008188|NCT00191334|3573811|FG000|Overall Study|Disease Progression or Relapse|8
2008189|NCT00191334|3573811|FG000|Overall Study|Physician Decision|1
2008190|NCT00191334|3573811|FG000|Overall Study|Withdrawal by Subject|4
2008191|NCT00191386|3573815|FG000|Overall Study|Adverse Event|16
2008192|NCT00191386|3573815|FG000|Overall Study|Lost to Follow-up|1
2008193|NCT00191386|3573815|FG000|Overall Study|Entry Criteria Exclusion|3
2008194|NCT00191386|3573815|FG000|Overall Study|Protocol Violation|18
2008195|NCT00191386|3573815|FG000|Overall Study|Withdrawal by Subject|96
2008196|NCT00191386|3573815|FG000|Overall Study|Physician Decision|11
2008197|NCT00191386|3573815|FG000|Overall Study|Lack of Efficacy|15
2008198|NCT00191451|3573822|FG000|Overall Study|Withdrawal by Subject|2
2008199|NCT00191451|3573823|FG001|Overall Study|Withdrawal by Subject|3
2008200|NCT00191451|3573824|FG002|Overall Study|Withdrawal by Subject|5
2008201|NCT00191451|3573822|FG000|Overall Study|Physician Decision|2
2008202|NCT00191451|3573823|FG001|Overall Study|Physician Decision|9
2008203|NCT00191451|3573824|FG002|Overall Study|Physician Decision|6
2008204|NCT00191451|3573822|FG000|Overall Study|Sponsor Decision|1
2008205|NCT00191451|3573823|FG001|Overall Study|Sponsor Decision|0
2008206|NCT00191451|3573824|FG002|Overall Study|Sponsor Decision|0
2008207|NCT00191451|3573822|FG000|Overall Study|Ineligible|0
2008208|NCT00191451|3573823|FG001|Overall Study|Ineligible|1
2008209|NCT00191451|3573824|FG002|Overall Study|Ineligible|0
2008210|NCT00191451|3573822|FG000|Overall Study|Reason Not Specified|2
2008211|NCT00191451|3573823|FG001|Overall Study|Reason Not Specified|1
2008212|NCT00191451|3573824|FG002|Overall Study|Reason Not Specified|3
2008213|NCT00191477|3573834|FG000|Overall Study|Tumor Recurrence|49
2008214|NCT00191477|3573835|FG001|Overall Study|Tumor Recurrence|48
2008215|NCT00191477|3573834|FG000|Overall Study|Death, Study Disease|1
2008216|NCT00191477|3573835|FG001|Overall Study|Death, Study Disease|1
2008217|NCT00191477|3573834|FG000|Overall Study|Death, Other Cause|3
2008218|NCT00191477|3573835|FG001|Overall Study|Death, Other Cause|6
2008219|NCT00191477|3573834|FG000|Overall Study|Lost to Follow-up|23
2008220|NCT00191477|3573835|FG001|Overall Study|Lost to Follow-up|21
2008221|NCT00191477|3573834|FG000|Overall Study|Protocol Violation|1
2008222|NCT00191477|3573835|FG001|Overall Study|Protocol Violation|1
2008223|NCT00191477|3573834|FG000|Overall Study|Treatment Change|2
2008224|NCT00191477|3573835|FG001|Overall Study|Treatment Change|0
2008225|NCT00191477|3573834|FG000|Overall Study|Withdrawal by Subject|2
2008226|NCT00191477|3573835|FG001|Overall Study|Withdrawal by Subject|0
2008227|NCT00191477|3573834|FG000|Overall Study|Other|2
2008228|NCT00191477|3573835|FG001|Overall Study|Other|0
2008229|NCT00191477|3573834|FG000|Overall Study|Not Eligible|41
2008230|NCT00191477|3573835|FG001|Overall Study|Not Eligible|38
2008231|NCT00191477|3573834|FG000|Overall Study|Pathological Specimen Lost|1
2008232|NCT00191477|3573835|FG001|Overall Study|Pathological Specimen Lost|0
2008233|NCT00191477|3573834|FG000|Overall Study|Discontinued Prior to Instillation|13
2008234|NCT00191477|3573835|FG001|Overall Study|Discontinued Prior to Instillation|14
2008235|NCT00191646|3573843|FG000|Overall Study|Toxicity|26
2008236|NCT00191646|3573844|FG001|Overall Study|Toxicity|37
2008237|NCT00191646|3573843|FG000|Overall Study|Disease Progression|5
2008238|NCT00191646|3573844|FG001|Overall Study|Disease Progression|6
2008239|NCT00191646|3573843|FG000|Overall Study|Physician Decision|20
2008240|NCT00191646|3573844|FG001|Overall Study|Physician Decision|11
2008241|NCT00191646|3573843|FG000|Overall Study|Withdrawal by Subject|58
2008242|NCT00191646|3573844|FG001|Overall Study|Withdrawal by Subject|39
2008243|NCT00191646|3573843|FG000|Overall Study|Protocol Violation|5
2008244|NCT00191646|3573844|FG001|Overall Study|Protocol Violation|7
2008245|NCT00191646|3573843|FG000|Overall Study|Death|6
2008246|NCT00191646|3573844|FG001|Overall Study|Death|8
2008247|NCT00191646|3573843|FG000|Overall Study|Other|33
2008248|NCT00191646|3573844|FG001|Overall Study|Other|34
2008249|NCT00191646|3573843|FG000|Overall Study|Missing Data|18
2008250|NCT00191646|3573844|FG001|Overall Study|Missing Data|11
2008251|NCT00191724|3573863|FG000|Overall Study|Adverse Event|0
2008252|NCT00191724|3573864|FG001|Overall Study|Adverse Event|0
2008253|NCT00191724|3573865|FG002|Overall Study|Adverse Event|1
2008254|NCT00191724|3573866|FG003|Overall Study|Adverse Event|0
2008255|NCT00191724|3573867|FG004|Overall Study|Adverse Event|0
2008256|NCT00191724|3573863|FG000|Overall Study|Lost to Follow-up|1
2008257|NCT00191724|3573864|FG001|Overall Study|Lost to Follow-up|1
2008258|NCT00191724|3573865|FG002|Overall Study|Lost to Follow-up|0
2008259|NCT00191724|3573866|FG003|Overall Study|Lost to Follow-up|2
2008260|NCT00191724|3573867|FG004|Overall Study|Lost to Follow-up|3
2008261|NCT00191724|3573863|FG000|Overall Study|Withdrawal by Subject|0
2008262|NCT00191724|3573864|FG001|Overall Study|Withdrawal by Subject|0
2008263|NCT00191724|3573865|FG002|Overall Study|Withdrawal by Subject|0
2008264|NCT00191724|3573866|FG003|Overall Study|Withdrawal by Subject|1
2008265|NCT00191724|3573867|FG004|Overall Study|Withdrawal by Subject|0
2008266|NCT00191789|3573879|FG000|Overall Study|Adverse Event|5
2008267|NCT00191789|3573879|FG000|Overall Study|Patient: Satisfactory Response|5
2008268|NCT00191789|3573879|FG000|Overall Study|Patient/Physician: Satisfactory Response|4
2008269|NCT00191789|3573879|FG000|Overall Study|Withdrawal by Subject|4
2008270|NCT00191789|3573879|FG000|Overall Study|Death - Possibly Study Drug Related|4
2008271|NCT00191789|3573879|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2
2008272|NCT00191789|3573879|FG000|Overall Study|Death - Not Study-Drug Related|1
2008273|NCT00191815|3573883|FG000|Overall Study|Adverse Event|2
2008274|NCT00191815|3573883|FG000|Overall Study|Disease progression or relapse|24
2008275|NCT00191815|3573883|FG000|Overall Study|Death|2
2008276|NCT00191815|3573883|FG000|Overall Study|Protocol Violation|3
2008277|NCT00191815|3573883|FG000|Overall Study|Physician Decision|2
2008278|NCT00191815|3573883|FG000|Overall Study|Withdrawal by Subject|7
2008279|NCT00191854|3573890|FG000|Overall Study|Death|26
2008280|NCT00191854|3573891|FG001|Overall Study|Death|23
2008281|NCT00191854|3573892|FG002|Overall Study|Death|29
2008282|NCT00191854|3573890|FG000|Overall Study|Lost to Follow-up|7
2008283|NCT00191854|3573891|FG001|Overall Study|Lost to Follow-up|5
2008284|NCT00191854|3573892|FG002|Overall Study|Lost to Follow-up|5
2008285|NCT00191854|3573890|FG000|Overall Study|Withdrawal by Subject|4
2008286|NCT00191854|3573891|FG001|Overall Study|Withdrawal by Subject|2
2008287|NCT00191854|3573892|FG002|Overall Study|Withdrawal by Subject|3
2008288|NCT00191854|3573890|FG000|Overall Study|Sponsor Decision|0
2008289|NCT00191854|3573891|FG001|Overall Study|Sponsor Decision|0
2008290|NCT00191854|3573892|FG002|Overall Study|Sponsor Decision|1
2008291|NCT00191854|3573890|FG000|Overall Study|Screen Failure|0
2008292|NCT00191854|3573891|FG001|Overall Study|Screen Failure|0
2008293|NCT00191854|3573892|FG002|Overall Study|Screen Failure|1
2008294|NCT00191906|3573904|FG000|Study Period II|Adverse Event|0
2008295|NCT00191906|3573905|FG001|Study Period II|Adverse Event|1
2008296|NCT00191906|3573906|FG002|Study Period II|Adverse Event|0
2008297|NCT00191906|3573907|FG003|Study Period II|Adverse Event|0
2008298|NCT00191906|3573904|FG000|Study Period II|Withdrawal by Subject|0
2008299|NCT00191906|3573905|FG001|Study Period II|Withdrawal by Subject|3
2008300|NCT00191906|3573906|FG002|Study Period II|Withdrawal by Subject|0
2008301|NCT00191906|3573907|FG003|Study Period II|Withdrawal by Subject|0
2008302|NCT00191906|3573904|FG000|Study Period II|Parent/Caregiver Decision|0
2008303|NCT00191906|3573905|FG001|Study Period II|Parent/Caregiver Decision|1
2008304|NCT00191906|3573906|FG002|Study Period II|Parent/Caregiver Decision|0
2008305|NCT00191906|3573907|FG003|Study Period II|Parent/Caregiver Decision|0
2008306|NCT00191906|3573904|FG000|Study Period II|Entry Criteria Exclusion|0
2008307|NCT00191906|3573905|FG001|Study Period II|Entry Criteria Exclusion|0
2008308|NCT00191906|3573906|FG002|Study Period II|Entry Criteria Exclusion|1
2008309|NCT00191906|3573907|FG003|Study Period II|Entry Criteria Exclusion|0
2008310|NCT00191906|3573904|FG000|Study Period III|Adverse Event|1
2008311|NCT00191906|3573905|FG001|Study Period III|Adverse Event|0
2214349|NCT01686958|3856592|FG000|Overall Study|Withdrawal by Subject|1
2008312|NCT00191906|3573906|FG002|Study Period III|Adverse Event|0
2008313|NCT00191906|3573907|FG003|Study Period III|Adverse Event|0
2008314|NCT00191906|3573904|FG000|Study Period III|Lost to Follow-up|0
2008315|NCT00191906|3573905|FG001|Study Period III|Lost to Follow-up|1
2008316|NCT00191906|3573906|FG002|Study Period III|Lost to Follow-up|0
2008317|NCT00191906|3573907|FG003|Study Period III|Lost to Follow-up|0
2008318|NCT00191906|3573904|FG000|Study Period III|Parent/Caregiver Decision|1
2008319|NCT00191906|3573905|FG001|Study Period III|Parent/Caregiver Decision|0
2008320|NCT00191906|3573906|FG002|Study Period III|Parent/Caregiver Decision|0
2008321|NCT00191906|3573907|FG003|Study Period III|Parent/Caregiver Decision|0
2008322|NCT00191906|3573904|FG000|Study Period III|Lack of Efficacy|3
2008323|NCT00191906|3573905|FG001|Study Period III|Lack of Efficacy|3
2008324|NCT00191906|3573906|FG002|Study Period III|Lack of Efficacy|0
2008325|NCT00191906|3573907|FG003|Study Period III|Lack of Efficacy|0
2008326|NCT00191945|3573925|FG000|Double-Blind Acute Treatment|Parent's Decision|3
2008327|NCT00191945|3573926|FG001|Double-Blind Acute Treatment|Parent's Decision|0
2008328|NCT00191945|3573925|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0
2008329|NCT00191945|3573926|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1
2008330|NCT00191945|3573925|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3
2008331|NCT00191945|3573926|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0
2008332|NCT00191945|3573925|FG000|Double-Blind Acute Treatment|Physician Decision|0
2008333|NCT00191945|3573926|FG001|Double-Blind Acute Treatment|Physician Decision|2
2008334|NCT00191984|3573933|FG000|Overall Study|Disease Progression|21
2008335|NCT00191984|3573933|FG000|Overall Study|Adverse Event|4
2008336|NCT00191984|3573933|FG000|Overall Study|Death|2
2008337|NCT00191984|3573933|FG000|Overall Study|Entry Criteria Exclusion|1
2008338|NCT00191984|3573933|FG000|Overall Study|Withdrawal by Subject|7
2008339|NCT00191984|3573933|FG000|Overall Study|Physician Decision|4
2008340|NCT00192023|3573939|FG000|Period III - Double-Blind|Adverse Event|3
2008341|NCT00192023|3573940|FG001|Period III - Double-Blind|Adverse Event|0
2008342|NCT00192023|3573939|FG000|Period III - Double-Blind|Physician Decision|2
2008343|NCT00192023|3573940|FG001|Period III - Double-Blind|Physician Decision|0
2008344|NCT00192023|3573939|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2
2008345|NCT00192023|3573940|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0
2008346|NCT00192023|3573939|FG000|Period IV - Optional Open-Label|Adverse Event|6
2008347|NCT00192023|3573940|FG001|Period IV - Optional Open-Label|Adverse Event|0
2008348|NCT00192023|3573939|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7
2008349|NCT00192023|3573940|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0
2008350|NCT00192023|3573939|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
2008351|NCT00192023|3573940|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
2008352|NCT00192023|3573939|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2
2008353|NCT00192023|3573940|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0
2008354|NCT00192023|3573939|FG000|Period IV - Optional Open-Label|Protocol Violation|1
2008355|NCT00192023|3573940|FG001|Period IV - Optional Open-Label|Protocol Violation|0
2008356|NCT00192023|3573939|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4
2008357|NCT00192023|3573940|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0
2008358|NCT00192023|3573939|FG000|Period IV - Optional Open-Label|Physician Decision|9
2008359|NCT00192023|3573940|FG001|Period IV - Optional Open-Label|Physician Decision|0
2008360|NCT00192036|3573946|FG000|Overall Study|Protocol Violation|3
2008361|NCT00192036|3573946|FG000|Overall Study|Adverse Event|6
2008362|NCT00192036|3573946|FG000|Overall Study|Patient/Physician Perception|1
2008363|NCT00192036|3573946|FG000|Overall Study|Objective Tumor Progression|4
2008364|NCT00192036|3573946|FG000|Overall Study|Clinical Disease Progression|1
2008365|NCT00192036|3573946|FG000|Overall Study|Death|1
2008366|NCT00192036|3573946|FG000|Overall Study|Unknown or Not Specified|5
2008367|NCT00192075|3573952|FG000|Overall Study|Disease Progression|23
2008368|NCT00192075|3573953|FG001|Overall Study|Disease Progression|6
2008369|NCT00192075|3573952|FG000|Overall Study|Adverse Event|1
2008370|NCT00192075|3573953|FG001|Overall Study|Adverse Event|3
2008371|NCT00192075|3573952|FG000|Overall Study|Death|0
2008372|NCT00192075|3573953|FG001|Overall Study|Death|1
2008373|NCT00192075|3573952|FG000|Overall Study|Lack of Efficacy|0
2008374|NCT00192075|3573953|FG001|Overall Study|Lack of Efficacy|0
2008375|NCT00192075|3573952|FG000|Overall Study|Physician Decision|3
2008376|NCT00192075|3573953|FG001|Overall Study|Physician Decision|0
2008377|NCT00192075|3573952|FG000|Overall Study|Withdrawal by Subject|5
2008378|NCT00192075|3573953|FG001|Overall Study|Withdrawal by Subject|5
2008379|NCT00192075|3573952|FG000|Overall Study|Patient Non-Compliance|0
2008380|NCT00192075|3573953|FG001|Overall Study|Patient Non-Compliance|1
2008381|NCT00192075|3573952|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
2008382|NCT00192075|3573953|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
2008383|NCT00192075|3573952|FG000|Overall Study|Other|5
2008384|NCT00192075|3573953|FG001|Overall Study|Other|2
2008385|NCT00192114|3573964|FG000|Overall Study|Objective Tumor Progression|19
2008386|NCT00192114|3573964|FG000|Overall Study|Adverse Event|2
2008387|NCT00192114|3573964|FG000|Overall Study|Clinical Progression|2
2008388|NCT00192114|3573964|FG000|Overall Study|Death|1
2008389|NCT00192296|3573972|FG000|Overall Study|Withdrawal by Subject|0
2008390|NCT00192296|3573973|FG001|Overall Study|Withdrawal by Subject|1
2008391|NCT00192296|3573974|FG002|Overall Study|Withdrawal by Subject|0
2008392|NCT00192296|3573975|FG003|Overall Study|Withdrawal by Subject|0
2008393|NCT00192504|3573989|FG000|Overall Study|Lost to Follow-up|1
2008394|NCT00192504|3573990|FG001|Overall Study|Lost to Follow-up|0
2008395|NCT00192504|3573991|FG002|Overall Study|Lost to Follow-up|0
2008396|NCT00192504|3573992|FG003|Overall Study|Lost to Follow-up|0
2008397|NCT00192504|3573989|FG000|Overall Study|Dosing window missed|0
2008398|NCT00192504|3573990|FG001|Overall Study|Dosing window missed|0
2008399|NCT00192504|3573991|FG002|Overall Study|Dosing window missed|1
2008400|NCT00192504|3573992|FG003|Overall Study|Dosing window missed|0
2008401|NCT00192647|3574004|FG000|Overall Study|Death|1
2008402|NCT00192647|3574005|FG001|Overall Study|Death|1
2008403|NCT00192647|3574004|FG000|Overall Study|Adverse Event|35
2008404|NCT00192647|3574005|FG001|Overall Study|Adverse Event|29
2008405|NCT00192647|3574004|FG000|Overall Study|Laboratory Test Abnormality|4
2008406|NCT00192647|3574005|FG001|Overall Study|Laboratory Test Abnormality|2
2008407|NCT00192647|3574004|FG000|Overall Study|Insufficient Therapeutic Response|53
2008408|NCT00192647|3574005|FG001|Overall Study|Insufficient Therapeutic Response|83
2008409|NCT00192647|3574004|FG000|Overall Study|Entry Criteria Violation|6
2008410|NCT00192647|3574005|FG001|Overall Study|Entry Criteria Violation|6
2008411|NCT00192647|3574004|FG000|Overall Study|Protocol Violation|3
2008412|NCT00192647|3574005|FG001|Overall Study|Protocol Violation|1
2008413|NCT00192647|3574004|FG000|Overall Study|Refused Treatment/Did not Cooperate|10
2008414|NCT00192647|3574005|FG001|Overall Study|Refused Treatment/Did not Cooperate|8
2008415|NCT00192647|3574004|FG000|Overall Study|Failure to Return|11
2008416|NCT00192647|3574005|FG001|Overall Study|Failure to Return|13
2008417|NCT00192647|3574004|FG000|Overall Study|Other/Administrative|5
2008418|NCT00192647|3574005|FG001|Overall Study|Other/Administrative|3
2008419|NCT00193050|3574020|FG000|Neoadjuvant Treatment|Lack of Efficacy|2
2008420|NCT00193050|3574020|FG000|Neoadjuvant Treatment|Intercurrent Illness|3
2008421|NCT00193050|3574020|FG000|Neoadjuvant Treatment|Physician Decision|2
2008422|NCT00193050|3574020|FG000|Neoadjuvant Treatment|Adverse Event|2
2008423|NCT00193050|3574020|FG000|Adjuvant|Physician Decision|5
2008424|NCT00193050|3574020|FG000|Adjuvant|Intercurrent Hospitalization|3
2008425|NCT00193050|3574020|FG000|Adjuvant|Lack of Efficacy|2
2008426|NCT00193063|3574025|FG000|Overall Study|Lack of Efficacy|3
2008427|NCT00193063|3574025|FG000|Overall Study|Adverse Event|1
2008428|NCT00193180|3574040|FG000|Overall Study|Lack of Efficacy|1
2008429|NCT00193180|3574040|FG000|Overall Study|Adverse Event|8
2008430|NCT00193180|3574040|FG000|Overall Study|Protocol Violation|1
2008431|NCT00193206|3574045|FG000|Preoperative Therapy|Lack of Efficacy|2
2008432|NCT00193206|3574045|FG000|Preoperative Therapy|Adverse Event|2
2008433|NCT00193206|3574045|FG000|Preoperative Therapy|Withdrawal by Subject|2
2008434|NCT00193206|3574045|FG000|Preoperative Therapy|False Positive Pregnancy Test|1
2008435|NCT00193206|3574045|FG000|Postoperative Therapy|Withdrawal by Subject|7
2008436|NCT00193206|3574045|FG000|Postoperative Therapy|Physician Decision|3
2008437|NCT00193206|3574045|FG000|Postoperative Therapy|Intercurrent Illness|2
2008438|NCT00193206|3574045|FG000|Postoperative Therapy|Lack of Efficacy|1
2008439|NCT00193206|3574045|FG000|Postoperative Therapy|Protocol Violation|1
2008440|NCT00193479|3574070|FG000|Induction Chemotherapy|Adverse Event|2
2008441|NCT00193479|3574070|FG000|Induction Chemotherapy|Disease Progression|1
2008442|NCT00193609|3574092|FG000|Overall Study|Lack of Efficacy|2
2008443|NCT00193609|3574092|FG000|Overall Study|Adverse Event|2
2008444|NCT00194012|3574098|FG000|Randomized Phase|Lack of Efficacy|8
2008445|NCT00194012|3574099|FG001|Randomized Phase|Lack of Efficacy|18
2008446|NCT00194012|3574098|FG000|Randomized Phase|Study nonadherence|2
2008447|NCT00194012|3574099|FG001|Randomized Phase|Study nonadherence|1
2008448|NCT00194012|3574098|FG000|Randomized Phase|Withdrawal by Subject|3
2008449|NCT00194012|3574099|FG001|Randomized Phase|Withdrawal by Subject|3
2008450|NCT00194012|3574098|FG000|Randomized Phase|Adverse Event|2
2008451|NCT00194012|3574099|FG001|Randomized Phase|Adverse Event|1
2008452|NCT00194012|3574098|FG000|Randomized Phase|Participant reported having a rash|1
2008453|NCT00194012|3574099|FG001|Randomized Phase|Participant reported having a rash|0
2008454|NCT00194012|3574098|FG000|Randomized Phase|Emesis and enuresis|0
2008455|NCT00194012|3574099|FG001|Randomized Phase|Emesis and enuresis|1
2008456|NCT00194012|3574098|FG000|Randomized Phase|Oral/nasal twitching|0
2008457|NCT00194012|3574099|FG001|Randomized Phase|Oral/nasal twitching|1
2008458|NCT00194012|3574098|FG000|Open Label Extension (OLE)|Weight Gain|1
2008459|NCT00194012|3574099|FG001|Open Label Extension (OLE)|Weight Gain|0
2008460|NCT00194012|3574098|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0
2008461|NCT00194012|3574099|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1
2008462|NCT00194012|3574098|FG000|Open Label Extension (OLE)|Lost to Follow-up|3
2008463|NCT00194012|3574099|FG001|Open Label Extension (OLE)|Lost to Follow-up|5
2008464|NCT00194012|3574098|FG000|Open Label Extension (OLE)|Lack of Efficacy|1
2008465|NCT00194012|3574099|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
2008466|NCT00194025|3574111|FG000|Overall Study|Adverse Event|1
2008467|NCT00194025|3574111|FG000|Overall Study|non-adherence with study medication|4
2008468|NCT00194077|3574117|FG000|Overall Study|Lack of Efficacy|22
2008469|NCT00194077|3574118|FG001|Overall Study|Lack of Efficacy|29
2008470|NCT00194077|3574117|FG000|Overall Study|Study nonadherence|1
2008471|NCT00194077|3574118|FG001|Overall Study|Study nonadherence|0
2008472|NCT00194077|3574117|FG000|Overall Study|Withdrawal by Subject|1
2008473|NCT00194077|3574118|FG001|Overall Study|Withdrawal by Subject|1
2008474|NCT00194675|3574169|FG000|Overall Study|Lost to Follow-up|1
2008475|NCT00194675|3574170|FG001|Overall Study|Lost to Follow-up|1
2008476|NCT00194675|3574169|FG000|Overall Study|lack of interest|1
2008477|NCT00194675|3574170|FG001|Overall Study|lack of interest|1
2008478|NCT00194675|3574169|FG000|Overall Study|"withdrew due to edgy feeling"|1
2008479|NCT00194675|3574170|FG001|Overall Study|"withdrew due to edgy feeling"|0
2008480|NCT00194675|3574169|FG000|Overall Study|Protocol Violation|1
2008481|NCT00194675|3574170|FG001|Overall Study|Protocol Violation|0
2008482|NCT00194675|3574169|FG000|Overall Study|Death|1
2008483|NCT00194675|3574170|FG001|Overall Study|Death|0
2008484|NCT00194792|3574182|FG000|Overall Study|Withdrawal by Subject|1
2008485|NCT00194987|3574205|FG000|Overall Study|Withdrawal by Subject|0
2008486|NCT00194987|3574206|FG001|Overall Study|Withdrawal by Subject|3
2008487|NCT00195260|3574229|FG000|Part 1: Dose Escalation|Adverse Event|0
2008488|NCT00195260|3574230|FG001|Part 1: Dose Escalation|Adverse Event|1
2214350|NCT01687101|3856610|FG000|Overall Study|Lost to Follow-up|7
2214351|NCT01687166|3856622|FG000|Overall Study|Attempt subject|2
2214352|NCT01687166|3856623|FG001|Overall Study|Attempt subject|3
2214353|NCT01687166|3856624|FG002|Overall Study|Attempt subject|2
2214354|NCT01687166|3856625|FG003|Overall Study|Attempt subject|0
2214355|NCT01687166|3856622|FG000|Overall Study|Did not meet eligibility criteria|4
2214356|NCT01687166|3856623|FG001|Overall Study|Did not meet eligibility criteria|6
2214357|NCT01687166|3856624|FG002|Overall Study|Did not meet eligibility criteria|1
2214358|NCT01687166|3856625|FG003|Overall Study|Did not meet eligibility criteria|1
2214359|NCT01687166|3856622|FG000|Overall Study|Adverse Event|2
2214360|NCT01687166|3856623|FG001|Overall Study|Adverse Event|1
2214361|NCT01687166|3856624|FG002|Overall Study|Adverse Event|0
2008489|NCT00195260|3574231|FG002|Part 1: Dose Escalation|Adverse Event|0
2008490|NCT00195260|3574232|FG003|Part 1: Dose Escalation|Adverse Event|1
2008491|NCT00195260|3574233|FG004|Part 1: Dose Escalation|Adverse Event|1
2008492|NCT00195260|3574234|FG005|Part 1: Dose Escalation|Adverse Event|0
2008493|NCT00195260|3574235|FG006|Part 1: Dose Escalation|Adverse Event|3
2008494|NCT00195260|3574236|FG007|Part 1: Dose Escalation|Adverse Event|0
2008495|NCT00195260|3574237|FG008|Part 1: Dose Escalation|Adverse Event|0
2008496|NCT00195260|3574238|FG009|Part 1: Dose Escalation|Adverse Event|0
2008497|NCT00195260|3574239|FG010|Part 1: Dose Escalation|Adverse Event|0
2008498|NCT00195260|3574229|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
2008499|NCT00195260|3574230|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
2008500|NCT00195260|3574231|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
2008501|NCT00195260|3574232|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0
2008502|NCT00195260|3574233|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2
2214362|NCT01687166|3856625|FG003|Overall Study|Adverse Event|0
2008503|NCT00195260|3574234|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
2008504|NCT00195260|3574235|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
2008505|NCT00195260|3574236|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1
2008506|NCT00195260|3574237|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0
2008507|NCT00195260|3574238|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0
2008508|NCT00195260|3574239|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0
2008509|NCT00195260|3574229|FG000|Part 1: Dose Escalation|Death|0
2008510|NCT00195260|3574230|FG001|Part 1: Dose Escalation|Death|0
2008511|NCT00195260|3574231|FG002|Part 1: Dose Escalation|Death|0
2008512|NCT00195260|3574232|FG003|Part 1: Dose Escalation|Death|0
2008513|NCT00195260|3574233|FG004|Part 1: Dose Escalation|Death|0
2008514|NCT00195260|3574234|FG005|Part 1: Dose Escalation|Death|0
2008515|NCT00195260|3574235|FG006|Part 1: Dose Escalation|Death|0
2008516|NCT00195260|3574236|FG007|Part 1: Dose Escalation|Death|1
2008517|NCT00195260|3574237|FG008|Part 1: Dose Escalation|Death|0
2008518|NCT00195260|3574238|FG009|Part 1: Dose Escalation|Death|0
2008519|NCT00195260|3574239|FG010|Part 1: Dose Escalation|Death|0
2008520|NCT00195260|3574229|FG000|Part 1: Dose Escalation|Disease Progression|3
2008521|NCT00195260|3574230|FG001|Part 1: Dose Escalation|Disease Progression|2
2008522|NCT00195260|3574231|FG002|Part 1: Dose Escalation|Disease Progression|5
2008523|NCT00195260|3574232|FG003|Part 1: Dose Escalation|Disease Progression|6
2008524|NCT00195260|3574233|FG004|Part 1: Dose Escalation|Disease Progression|4
2008525|NCT00195260|3574234|FG005|Part 1: Dose Escalation|Disease Progression|6
2008526|NCT00195260|3574235|FG006|Part 1: Dose Escalation|Disease Progression|7
2008527|NCT00195260|3574236|FG007|Part 1: Dose Escalation|Disease Progression|4
2008528|NCT00195260|3574237|FG008|Part 1: Dose Escalation|Disease Progression|0
2008529|NCT00195260|3574238|FG009|Part 1: Dose Escalation|Disease Progression|0
2008530|NCT00195260|3574239|FG010|Part 1: Dose Escalation|Disease Progression|0
2008531|NCT00195260|3574229|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1
2008532|NCT00195260|3574230|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1
2008533|NCT00195260|3574231|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1
2008534|NCT00195260|3574232|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0
2008535|NCT00195260|3574233|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0
2008536|NCT00195260|3574234|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1
2008537|NCT00195260|3574235|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0
2008538|NCT00195260|3574236|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0
2008539|NCT00195260|3574237|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0
2008540|NCT00195260|3574238|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0
2008541|NCT00195260|3574239|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0
2008542|NCT00195260|3574229|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2008543|NCT00195260|3574230|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2008544|NCT00195260|3574231|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2008545|NCT00195260|3574232|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2008546|NCT00195260|3574233|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2008547|NCT00195260|3574234|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2008548|NCT00195260|3574235|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2008549|NCT00195260|3574236|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2008550|NCT00195260|3574237|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
2008551|NCT00195260|3574238|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
2008552|NCT00195260|3574239|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
2008553|NCT00195260|3574229|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2008554|NCT00195260|3574230|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2008555|NCT00195260|3574231|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2008556|NCT00195260|3574232|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2008557|NCT00195260|3574233|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2008558|NCT00195260|3574234|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2008559|NCT00195260|3574235|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2008560|NCT00195260|3574236|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2008561|NCT00195260|3574237|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
2008562|NCT00195260|3574238|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
2008563|NCT00195260|3574239|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
2008564|NCT00195260|3574229|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2008565|NCT00195260|3574230|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2008566|NCT00195260|3574231|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2008567|NCT00195260|3574232|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2008568|NCT00195260|3574233|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2008569|NCT00195260|3574234|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2008570|NCT00195260|3574235|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2008571|NCT00195260|3574236|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2008572|NCT00195260|3574237|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
2008573|NCT00195260|3574238|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
2008574|NCT00195260|3574239|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
2008575|NCT00195260|3574229|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2008576|NCT00195260|3574230|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2008577|NCT00195260|3574231|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2008578|NCT00195260|3574232|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2008579|NCT00195260|3574233|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2008580|NCT00195260|3574234|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2008581|NCT00195260|3574235|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2008582|NCT00195260|3574236|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2008583|NCT00195260|3574237|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
2008584|NCT00195260|3574238|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
2008585|NCT00195260|3574239|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
2008586|NCT00195273|3574269|FG000|Overall Study|Adverse Event|9
2008587|NCT00195273|3574270|FG001|Overall Study|Adverse Event|9
2008588|NCT00195273|3574269|FG000|Overall Study|Protocol deviation|0
2008589|NCT00195273|3574270|FG001|Overall Study|Protocol deviation|1
2008590|NCT00195273|3574269|FG000|Overall Study|Lack of Efficacy|3
2008591|NCT00195273|3574270|FG001|Overall Study|Lack of Efficacy|1
2008592|NCT00195273|3574269|FG000|Overall Study|Procedural complications|9
2008593|NCT00195273|3574270|FG001|Overall Study|Procedural complications|3
2008594|NCT00195338|3574276|FG000|Overall Study|Lost to Follow-up|2
2008595|NCT00195338|3574276|FG000|Overall Study|Adverse Event|5
2008596|NCT00195338|3574276|FG000|Overall Study|Lack of Efficacy|1
2008597|NCT00195338|3574276|FG000|Overall Study|Early closure of the site|4
2008598|NCT00195351|3574282|FG000|Overall Study|Lost to Follow-up|9
2008599|NCT00195351|3574283|FG001|Overall Study|Lost to Follow-up|9
2008600|NCT00195351|3574282|FG000|Overall Study|Withdrawal by Subject|6
2008601|NCT00195351|3574283|FG001|Overall Study|Withdrawal by Subject|3
2008602|NCT00195351|3574282|FG000|Overall Study|Protocol Deviation|3
2008603|NCT00195351|3574283|FG001|Overall Study|Protocol Deviation|2
2008604|NCT00195351|3574282|FG000|Overall Study|Death|3
2008605|NCT00195351|3574283|FG001|Overall Study|Death|1
2008606|NCT00195351|3574282|FG000|Overall Study|Lack of Efficacy|0
2008607|NCT00195351|3574283|FG001|Overall Study|Lack of Efficacy|1
2008608|NCT00195429|3574295|FG000|Overall Study|Adverse Event|2
2008609|NCT00195429|3574296|FG001|Overall Study|Adverse Event|4
2008610|NCT00195429|3574295|FG000|Overall Study|Lack of Efficacy|2
2008611|NCT00195429|3574296|FG001|Overall Study|Lack of Efficacy|1
2008612|NCT00195429|3574295|FG000|Overall Study|Lost to Follow-up|1
2008613|NCT00195429|3574296|FG001|Overall Study|Lost to Follow-up|0
2008614|NCT00195442|3574302|FG000|Overall Study|Less than expected therapeutic effect|38
2008615|NCT00195442|3574302|FG000|Overall Study|Lost to Follow-up|27
2008616|NCT00195442|3574302|FG000|Overall Study|Switch to other Factor VIII preparation|23
2008617|NCT00195442|3574302|FG000|Overall Study|Intermittent product shortage|21
2008618|NCT00195442|3574302|FG000|Overall Study|Death|7
2008619|NCT00195442|3574302|FG000|Overall Study|No reason specified|4
2008620|NCT00195442|3574302|FG000|Overall Study|Poor cooperation|2
2008621|NCT00195442|3574302|FG000|Overall Study|Other|14
2008622|NCT00195494|3574308|FG000|Year 1|Adverse Event|0
2008623|NCT00195494|3574309|FG001|Year 1|Adverse Event|0
2008624|NCT00195494|3574310|FG002|Year 1|Adverse Event|0
2008625|NCT00195494|3574311|FG003|Year 1|Adverse Event|0
2008626|NCT00195494|3574312|FG004|Year 1|Adverse Event|34
2008627|NCT00195494|3574313|FG005|Year 1|Adverse Event|27
2008628|NCT00195494|3574308|FG000|Year 1|System Toxicity|0
2008629|NCT00195494|3574309|FG001|Year 1|System Toxicity|0
2008630|NCT00195494|3574310|FG002|Year 1|System Toxicity|0
2214363|NCT01687166|3856622|FG000|Overall Study|Physician Decision|3
2214364|NCT01687166|3856623|FG001|Overall Study|Physician Decision|2
2214365|NCT01687166|3856624|FG002|Overall Study|Physician Decision|1
2214366|NCT01687166|3856625|FG003|Overall Study|Physician Decision|0
2008631|NCT00195494|3574311|FG003|Year 1|System Toxicity|0
2008632|NCT00195494|3574312|FG004|Year 1|System Toxicity|0
2008633|NCT00195494|3574313|FG005|Year 1|System Toxicity|1
2008634|NCT00195494|3574308|FG000|Year 1|Lack of Efficacy|0
2008635|NCT00195494|3574309|FG001|Year 1|Lack of Efficacy|0
2008636|NCT00195494|3574310|FG002|Year 1|Lack of Efficacy|0
2008637|NCT00195494|3574311|FG003|Year 1|Lack of Efficacy|0
2008638|NCT00195494|3574312|FG004|Year 1|Lack of Efficacy|24
2008639|NCT00195494|3574313|FG005|Year 1|Lack of Efficacy|9
2008640|NCT00195494|3574308|FG000|Year 1|Compliance|0
2008641|NCT00195494|3574309|FG001|Year 1|Compliance|0
2008642|NCT00195494|3574310|FG002|Year 1|Compliance|0
2008643|NCT00195494|3574311|FG003|Year 1|Compliance|0
2008644|NCT00195494|3574312|FG004|Year 1|Compliance|5
2008645|NCT00195494|3574313|FG005|Year 1|Compliance|1
2008646|NCT00195494|3574308|FG000|Year 1|Lost to Follow-up|0
2008647|NCT00195494|3574309|FG001|Year 1|Lost to Follow-up|0
2008648|NCT00195494|3574310|FG002|Year 1|Lost to Follow-up|0
2008649|NCT00195494|3574311|FG003|Year 1|Lost to Follow-up|0
2008650|NCT00195494|3574312|FG004|Year 1|Lost to Follow-up|1
2008651|NCT00195494|3574313|FG005|Year 1|Lost to Follow-up|0
2008652|NCT00195494|3574308|FG000|Year 1|Missed >4 consecutive doses|0
2008653|NCT00195494|3574309|FG001|Year 1|Missed >4 consecutive doses|0
2008654|NCT00195494|3574310|FG002|Year 1|Missed >4 consecutive doses|0
2008655|NCT00195494|3574311|FG003|Year 1|Missed >4 consecutive doses|0
2008656|NCT00195494|3574312|FG004|Year 1|Missed >4 consecutive doses|3
2008657|NCT00195494|3574313|FG005|Year 1|Missed >4 consecutive doses|2
2008658|NCT00195494|3574308|FG000|Year 1|Protocol deviation|0
2008659|NCT00195494|3574309|FG001|Year 1|Protocol deviation|0
2008660|NCT00195494|3574310|FG002|Year 1|Protocol deviation|0
2214367|NCT01687166|3856622|FG000|Overall Study|Withdrawal by Subject|11
2008661|NCT00195494|3574311|FG003|Year 1|Protocol deviation|0
2008662|NCT00195494|3574312|FG004|Year 1|Protocol deviation|2
2008663|NCT00195494|3574313|FG005|Year 1|Protocol deviation|3
2008664|NCT00195494|3574308|FG000|Year 1|Physician Decision|0
2008665|NCT00195494|3574309|FG001|Year 1|Physician Decision|0
2008666|NCT00195494|3574310|FG002|Year 1|Physician Decision|0
2008667|NCT00195494|3574311|FG003|Year 1|Physician Decision|0
2008668|NCT00195494|3574312|FG004|Year 1|Physician Decision|1
2008669|NCT00195494|3574313|FG005|Year 1|Physician Decision|0
2214368|NCT01687166|3856623|FG001|Overall Study|Withdrawal by Subject|4
2214369|NCT01687166|3856624|FG002|Overall Study|Withdrawal by Subject|3
2214370|NCT01687166|3856625|FG003|Overall Study|Withdrawal by Subject|0
2008670|NCT00195494|3574308|FG000|Year 1|Withdrawal by Subject|0
2008671|NCT00195494|3574309|FG001|Year 1|Withdrawal by Subject|0
2008672|NCT00195494|3574310|FG002|Year 1|Withdrawal by Subject|0
2008673|NCT00195494|3574311|FG003|Year 1|Withdrawal by Subject|0
2008674|NCT00195494|3574312|FG004|Year 1|Withdrawal by Subject|8
2008675|NCT00195494|3574313|FG005|Year 1|Withdrawal by Subject|9
2008676|NCT00195494|3574308|FG000|Year 1|Protocol Violation|0
2008677|NCT00195494|3574309|FG001|Year 1|Protocol Violation|0
2008678|NCT00195494|3574310|FG002|Year 1|Protocol Violation|0
2008679|NCT00195494|3574311|FG003|Year 1|Protocol Violation|0
2008680|NCT00195494|3574312|FG004|Year 1|Protocol Violation|1
2008681|NCT00195494|3574313|FG005|Year 1|Protocol Violation|1
2008682|NCT00195494|3574308|FG000|Year 2|Adverse Event|3
2008683|NCT00195494|3574309|FG001|Year 2|Adverse Event|7
2008684|NCT00195494|3574310|FG002|Year 2|Adverse Event|5
2008685|NCT00195494|3574311|FG003|Year 2|Adverse Event|9
2008686|NCT00195494|3574312|FG004|Year 2|Adverse Event|0
2008687|NCT00195494|3574313|FG005|Year 2|Adverse Event|0
2008688|NCT00195494|3574308|FG000|Year 2|Lack of Efficacy|0
2008689|NCT00195494|3574309|FG001|Year 2|Lack of Efficacy|1
2008690|NCT00195494|3574310|FG002|Year 2|Lack of Efficacy|7
2008691|NCT00195494|3574311|FG003|Year 2|Lack of Efficacy|7
2008692|NCT00195494|3574312|FG004|Year 2|Lack of Efficacy|0
2008693|NCT00195494|3574313|FG005|Year 2|Lack of Efficacy|0
2008694|NCT00195494|3574308|FG000|Year 2|Compliance|1
2008695|NCT00195494|3574309|FG001|Year 2|Compliance|0
2008696|NCT00195494|3574310|FG002|Year 2|Compliance|0
2008697|NCT00195494|3574311|FG003|Year 2|Compliance|2
2008698|NCT00195494|3574312|FG004|Year 2|Compliance|0
2008699|NCT00195494|3574313|FG005|Year 2|Compliance|0
2008700|NCT00195494|3574308|FG000|Year 2|Lost to Follow-up|0
2008701|NCT00195494|3574309|FG001|Year 2|Lost to Follow-up|0
2008702|NCT00195494|3574310|FG002|Year 2|Lost to Follow-up|1
2008703|NCT00195494|3574311|FG003|Year 2|Lost to Follow-up|1
2008704|NCT00195494|3574312|FG004|Year 2|Lost to Follow-up|0
2008705|NCT00195494|3574313|FG005|Year 2|Lost to Follow-up|0
2008706|NCT00195494|3574308|FG000|Year 2|Missed >4 consecutive doses|1
2008707|NCT00195494|3574309|FG001|Year 2|Missed >4 consecutive doses|1
2008708|NCT00195494|3574310|FG002|Year 2|Missed >4 consecutive doses|1
2008709|NCT00195494|3574311|FG003|Year 2|Missed >4 consecutive doses|0
2008710|NCT00195494|3574312|FG004|Year 2|Missed >4 consecutive doses|0
2008711|NCT00195494|3574313|FG005|Year 2|Missed >4 consecutive doses|0
2008712|NCT00195494|3574308|FG000|Year 2|Protocol deviation|0
2008713|NCT00195494|3574309|FG001|Year 2|Protocol deviation|1
2008714|NCT00195494|3574310|FG002|Year 2|Protocol deviation|0
2008715|NCT00195494|3574311|FG003|Year 2|Protocol deviation|0
2008716|NCT00195494|3574312|FG004|Year 2|Protocol deviation|0
2008717|NCT00195494|3574313|FG005|Year 2|Protocol deviation|0
2008718|NCT00195494|3574308|FG000|Year 2|Physician Decision|1
2008719|NCT00195494|3574309|FG001|Year 2|Physician Decision|1
2008720|NCT00195494|3574310|FG002|Year 2|Physician Decision|0
2008721|NCT00195494|3574311|FG003|Year 2|Physician Decision|0
2008722|NCT00195494|3574312|FG004|Year 2|Physician Decision|0
2008723|NCT00195494|3574313|FG005|Year 2|Physician Decision|0
2008724|NCT00195494|3574308|FG000|Year 2|Withdrawal by Subject|1
2008725|NCT00195494|3574309|FG001|Year 2|Withdrawal by Subject|5
2008726|NCT00195494|3574310|FG002|Year 2|Withdrawal by Subject|4
2008727|NCT00195494|3574311|FG003|Year 2|Withdrawal by Subject|3
2008728|NCT00195494|3574312|FG004|Year 2|Withdrawal by Subject|0
2008729|NCT00195494|3574313|FG005|Year 2|Withdrawal by Subject|0
2008730|NCT00195494|3574308|FG000|Year 2|System toxicity|0
2008731|NCT00195494|3574309|FG001|Year 2|System toxicity|0
2008732|NCT00195494|3574310|FG002|Year 2|System toxicity|0
2008733|NCT00195494|3574311|FG003|Year 2|System toxicity|1
2008734|NCT00195494|3574312|FG004|Year 2|System toxicity|0
2008735|NCT00195494|3574313|FG005|Year 2|System toxicity|0
2008736|NCT00195507|3574331|FG000|Overall Study|Adverse Event|24
2008737|NCT00195507|3574332|FG001|Overall Study|Adverse Event|13
2008738|NCT00195507|3574331|FG000|Overall Study|Death|0
2008739|NCT00195507|3574332|FG001|Overall Study|Death|1
2008740|NCT00195507|3574331|FG000|Overall Study|Failed to Return|4
2008741|NCT00195507|3574332|FG001|Overall Study|Failed to Return|3
2008742|NCT00195507|3574331|FG000|Overall Study|Physician Decision|1
2008743|NCT00195507|3574332|FG001|Overall Study|Physician Decision|2
2008744|NCT00195507|3574331|FG000|Overall Study|Lost to Follow-up|3
2008745|NCT00195507|3574332|FG001|Overall Study|Lost to Follow-up|2
2008746|NCT00195507|3574331|FG000|Overall Study|Protocol Violation|5
2008747|NCT00195507|3574332|FG001|Overall Study|Protocol Violation|4
2008748|NCT00195507|3574331|FG000|Overall Study|Lack of Efficacy|40
2008749|NCT00195507|3574332|FG001|Overall Study|Lack of Efficacy|67
2008750|NCT00195507|3574331|FG000|Overall Study|Withdrawal by Subject|16
2008751|NCT00195507|3574332|FG001|Overall Study|Withdrawal by Subject|23
2008752|NCT00195507|3574331|FG000|Overall Study|Protocol Deviation|6
2008753|NCT00195507|3574332|FG001|Overall Study|Protocol Deviation|3
2008754|NCT00195650|3574347|FG000|Overall Study|Adverse Event|194
2008755|NCT00195650|3574347|FG000|Overall Study|Lack of Efficacy|99
2008756|NCT00195650|3574347|FG000|Overall Study|Withdrawal by Subject|67
2008757|NCT00195650|3574347|FG000|Overall Study|Lost to Follow-up|44
2008758|NCT00195650|3574347|FG000|Overall Study|Death|23
2008759|NCT00195650|3574347|FG000|Overall Study|Protocol Violation|15
2008760|NCT00195650|3574347|FG000|Overall Study|Administrative reasons|83
2008761|NCT00195663|3574354|FG000|2-year Double-blind Treatment Period|Adverse Event|21
2008762|NCT00195663|3574355|FG001|2-year Double-blind Treatment Period|Adverse Event|27
2008763|NCT00195663|3574356|FG002|2-year Double-blind Treatment Period|Adverse Event|32
2008764|NCT00195663|3574354|FG000|2-year Double-blind Treatment Period|Death|0
2008765|NCT00195663|3574355|FG001|2-year Double-blind Treatment Period|Death|2
2008766|NCT00195663|3574356|FG002|2-year Double-blind Treatment Period|Death|0
2008767|NCT00195663|3574354|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0
2008768|NCT00195663|3574355|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0
2008769|NCT00195663|3574356|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1
2008770|NCT00195663|3574354|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15
2008771|NCT00195663|3574355|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18
2008772|NCT00195663|3574356|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12
2008773|NCT00195663|3574354|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47
2008774|NCT00195663|3574355|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52
2008775|NCT00195663|3574356|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13
2008776|NCT00195663|3574354|FG000|2-year Double-blind Treatment Period|Protocol Violation|6
2008777|NCT00195663|3574355|FG001|2-year Double-blind Treatment Period|Protocol Violation|6
2008778|NCT00195663|3574356|FG002|2-year Double-blind Treatment Period|Protocol Violation|4
2008779|NCT00195663|3574354|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0
2008780|NCT00195663|3574355|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1
2008781|NCT00195663|3574356|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0
2008782|NCT00195663|3574354|FG000|2-year Double-blind Treatment Period|Recovery|1
2008783|NCT00195663|3574355|FG001|2-year Double-blind Treatment Period|Recovery|0
2008784|NCT00195663|3574356|FG002|2-year Double-blind Treatment Period|Recovery|1
2008785|NCT00195663|3574354|FG000|2-year Double-blind Treatment Period|Administrative reasons|3
2008786|NCT00195663|3574355|FG001|2-year Double-blind Treatment Period|Administrative reasons|2
2008787|NCT00195663|3574356|FG002|2-year Double-blind Treatment Period|Administrative reasons|9
2008788|NCT00195663|3574354|FG000|Open-Label Extension Period|Adverse Event|21
2008789|NCT00195663|3574355|FG001|Open-Label Extension Period|Adverse Event|32
2008790|NCT00195663|3574356|FG002|Open-Label Extension Period|Adverse Event|36
2008791|NCT00195663|3574354|FG000|Open-Label Extension Period|Lost to Follow-up|9
2008792|NCT00195663|3574355|FG001|Open-Label Extension Period|Lost to Follow-up|2
2008793|NCT00195663|3574356|FG002|Open-Label Extension Period|Lost to Follow-up|6
2008794|NCT00195663|3574354|FG000|Open-Label Extension Period|Recovery|0
2008795|NCT00195663|3574355|FG001|Open-Label Extension Period|Recovery|2
2008796|NCT00195663|3574356|FG002|Open-Label Extension Period|Recovery|2
2008797|NCT00195663|3574354|FG000|Open-Label Extension Period|Protocol Violation|3
2008798|NCT00195663|3574355|FG001|Open-Label Extension Period|Protocol Violation|4
2008799|NCT00195663|3574356|FG002|Open-Label Extension Period|Protocol Violation|4
2008800|NCT00195663|3574354|FG000|Open-Label Extension Period|Death|2
2008801|NCT00195663|3574355|FG001|Open-Label Extension Period|Death|2
2008802|NCT00195663|3574356|FG002|Open-Label Extension Period|Death|2
2008803|NCT00195663|3574354|FG000|Open-Label Extension Period|Withdrawal by Subject|16
2008804|NCT00195663|3574355|FG001|Open-Label Extension Period|Withdrawal by Subject|15
2008805|NCT00195663|3574356|FG002|Open-Label Extension Period|Withdrawal by Subject|22
2008806|NCT00195663|3574354|FG000|Open-Label Extension Period|Lack of Efficacy|14
2008807|NCT00195663|3574355|FG001|Open-Label Extension Period|Lack of Efficacy|6
2008808|NCT00195663|3574356|FG002|Open-Label Extension Period|Lack of Efficacy|12
2008809|NCT00195663|3574354|FG000|Open-Label Extension Period|Administrative reasons|11
2008810|NCT00195663|3574355|FG001|Open-Label Extension Period|Administrative reasons|11
2008811|NCT00195663|3574356|FG002|Open-Label Extension Period|Administrative reasons|13
2008812|NCT00195676|3574374|FG000|Period O - Open-label Treatment|Adverse Event|82
2008813|NCT00195676|3574374|FG000|Period O - Open-label Treatment|Death|6
2008814|NCT00195676|3574374|FG000|Period O - Open-label Treatment|Lack of Efficacy|198
2008815|NCT00195676|3574374|FG000|Period O - Open-label Treatment|Lost to Follow-up|91
2008816|NCT00195676|3574374|FG000|Period O - Open-label Treatment|Protocol Violation|12
2008817|NCT00195676|3574374|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147
2008818|NCT00195676|3574374|FG000|Period O - Open-label Treatment|Administrative reasons|2
2008819|NCT00195676|3574374|FG000|Period O - Open-label Treatment|Other reasons|68
2008820|NCT00195676|3574374|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4
2008821|NCT00195676|3574374|FG000|Period W (Withdrawal) - No Treatment|Death|2
2008822|NCT00195676|3574374|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
2008823|NCT00195676|3574374|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
2008824|NCT00195676|3574374|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
2008825|NCT00195676|3574374|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129
2008826|NCT00195676|3574374|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1
2008827|NCT00195676|3574374|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18
2008828|NCT00195676|3574374|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4
2008829|NCT00195676|3574374|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
2008830|NCT00195676|3574374|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
2008831|NCT00195676|3574374|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
2008832|NCT00195676|3574374|FG000|Period R - Retreatment 16 Weeks|Other reasons|6
2025299|NCT00343642|3594014|FG000|Overall Study|Lost to Follow-up|0
2025300|NCT00343642|3594015|FG001|Overall Study|Lost to Follow-up|1
2025301|NCT00343642|3594016|FG002|Overall Study|Lost to Follow-up|0
2025302|NCT00343642|3594014|FG000|Overall Study|Pregnancy|1
2025303|NCT00343642|3594015|FG001|Overall Study|Pregnancy|0
2025304|NCT00343642|3594016|FG002|Overall Study|Pregnancy|2
2025305|NCT00343642|3594014|FG000|Overall Study|Withdrawal by Subject|2
2025306|NCT00343642|3594015|FG001|Overall Study|Withdrawal by Subject|3
2025307|NCT00343642|3594016|FG002|Overall Study|Withdrawal by Subject|4
2025308|NCT00343642|3594014|FG000|Overall Study|Adverse Event|0
2025309|NCT00343642|3594015|FG001|Overall Study|Adverse Event|0
2025310|NCT00343642|3594016|FG002|Overall Study|Adverse Event|1
2025311|NCT00343642|3594014|FG000|Overall Study|Flare up|6
2025312|NCT00343642|3594015|FG001|Overall Study|Flare up|4
2025313|NCT00343642|3594016|FG002|Overall Study|Flare up|0
2025314|NCT00343889|3594045|FG000|Overall Study|Lost to Follow-up|2
2025315|NCT00343889|3594046|FG001|Overall Study|Lost to Follow-up|0
2025316|NCT00343889|3594045|FG000|Overall Study|Withdrawal by Subject|0
2025317|NCT00343889|3594046|FG001|Overall Study|Withdrawal by Subject|1
2025318|NCT00343889|3594045|FG000|Overall Study|Protocol Violation|1
2025319|NCT00343889|3594046|FG001|Overall Study|Protocol Violation|0
2025320|NCT00343915|3594054|FG000|Primary Study|Withdrawal by Subject|1
2025321|NCT00343915|3594055|FG001|Primary Study|Withdrawal by Subject|0
2025322|NCT00343915|3594054|FG000|Primary Study|Lost to Follow-up|2
2025323|NCT00343915|3594055|FG001|Primary Study|Lost to Follow-up|3
2025324|NCT00343915|3594054|FG000|Primary Study|Other|1
2025325|NCT00343915|3594055|FG001|Primary Study|Other|0
2025326|NCT00344032|3594066|FG000|Overall Study|Adverse Event|0
2025327|NCT00344032|3594067|FG001|Overall Study|Adverse Event|1
2025328|NCT00344032|3594066|FG000|Overall Study|Withdrawal by Subject|6
2025329|NCT00344032|3594067|FG001|Overall Study|Withdrawal by Subject|2
2025330|NCT00344032|3594066|FG000|Overall Study|Lost to Follow-up|4
2025331|NCT00344032|3594067|FG001|Overall Study|Lost to Follow-up|6
2025332|NCT00344032|3594066|FG000|Overall Study|Physician Decision|4
2025333|NCT00344032|3594067|FG001|Overall Study|Physician Decision|1
2025334|NCT00344305|3594084|FG000|Overall Study|Lost to Follow-up|2
2025335|NCT00344305|3594085|FG001|Overall Study|Lost to Follow-up|0
2025336|NCT00344305|3594084|FG000|Overall Study|Participant was not contacted in window|0
2025337|NCT00344305|3594085|FG001|Overall Study|Participant was not contacted in window|1
2025338|NCT00344318|3594096|FG000|Overall Study|Adverse Event|0
2025339|NCT00344318|3594097|FG001|Overall Study|Adverse Event|3
2025340|NCT00344318|3594098|FG002|Overall Study|Adverse Event|0
2025341|NCT00344318|3594099|FG003|Overall Study|Adverse Event|1
2025342|NCT00344318|3594096|FG000|Overall Study|Withdrawal by Subject|2
2025343|NCT00344318|3594097|FG001|Overall Study|Withdrawal by Subject|2
2025344|NCT00344318|3594098|FG002|Overall Study|Withdrawal by Subject|0
2025345|NCT00344318|3594099|FG003|Overall Study|Withdrawal by Subject|2
2025346|NCT00344318|3594096|FG000|Overall Study|Lost to Follow-up|2
2025347|NCT00344318|3594097|FG001|Overall Study|Lost to Follow-up|0
2025348|NCT00344318|3594098|FG002|Overall Study|Lost to Follow-up|1
2025349|NCT00344318|3594099|FG003|Overall Study|Lost to Follow-up|0
2025350|NCT00344448|3594122|FG000|Screening|Withdrawal by Subject|0
2025351|NCT00344448|3594123|FG001|Screening|Withdrawal by Subject|1
2025352|NCT00344448|3594122|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1
2025353|NCT00344448|3594123|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0
2025354|NCT00344448|3594122|FG000|Double Blind, Placebo Controlled|Study terminated|1
2025355|NCT00344448|3594123|FG001|Double Blind, Placebo Controlled|Study terminated|0
2025356|NCT00344448|3594122|FG000|Open Label|Withdrawal by Subject|1
2025357|NCT00344448|3594123|FG001|Open Label|Withdrawal by Subject|1
2025358|NCT00344448|3594122|FG000|Open Label|Study terminated|1
2025359|NCT00344448|3594123|FG001|Open Label|Study terminated|0
2025360|NCT00344461|3594129|FG000|Overall Study|Adverse Event|6
2025361|NCT00344461|3594129|FG000|Overall Study|Death|1
2025362|NCT00344461|3594129|FG000|Overall Study|Lack of Efficacy|2
2025363|NCT00344461|3594129|FG000|Overall Study|Lost to Follow-up|2
2025364|NCT00344461|3594129|FG000|Overall Study|Physician Decision|2
2025365|NCT00344461|3594129|FG000|Overall Study|Protocol Violation|6
2025366|NCT00344461|3594129|FG000|Overall Study|Withdrawal by Subject|2
2025367|NCT00344500|3594136|FG000|Overall Study|Adverse Event|6
2025368|NCT00344500|3594137|FG001|Overall Study|Adverse Event|2
2025369|NCT00344500|3594138|FG002|Overall Study|Adverse Event|0
2025370|NCT00344500|3594136|FG000|Overall Study|Lost to Follow-up|5
2025371|NCT00344500|3594137|FG001|Overall Study|Lost to Follow-up|13
2025372|NCT00344500|3594138|FG002|Overall Study|Lost to Follow-up|1
2025373|NCT00344500|3594136|FG000|Overall Study|Withdrawal by Subject|7
2025374|NCT00344500|3594137|FG001|Overall Study|Withdrawal by Subject|10
2008833|NCT00195715|3574403|FG000|Overall Study|Adverse Event|122
2008834|NCT00195715|3574403|FG000|Overall Study|Withdrawal by Subject|58
2008835|NCT00195715|3574403|FG000|Overall Study|Lost to Follow-up|27
2008836|NCT00195715|3574403|FG000|Overall Study|Protocol Violation|13
2008837|NCT00195715|3574403|FG000|Overall Study|Lack of Efficacy|93
2008838|NCT00195715|3574403|FG000|Overall Study|Pregnancy|14
2008839|NCT00195715|3574403|FG000|Overall Study|Investigative site closure|8
2008840|NCT00195715|3574403|FG000|Overall Study|Subject moved/relocated|7
2008841|NCT00195715|3574403|FG000|Overall Study|Subject non-compliance|6
2008842|NCT00195715|3574403|FG000|Overall Study|Subject started commercial Humira|5
2008843|NCT00195715|3574403|FG000|Overall Study|Subject choice|3
2008844|NCT00195715|3574403|FG000|Overall Study|Loss of response/no improvement|3
2008845|NCT00195715|3574403|FG000|Overall Study|Sponsor stopped study|1
2008846|NCT00195715|3574403|FG000|Overall Study|Administrative reasons|2
2008847|NCT00195715|3574403|FG000|Overall Study|Investigator's decision|2
2008848|NCT00195715|3574403|FG000|Overall Study|Subject wants to get pregnant|4
2008849|NCT00195715|3574403|FG000|Overall Study|Use of prohibited medication|2
2008850|NCT00195715|3574403|FG000|Overall Study|Planned surgery|2
2008851|NCT00195715|3574403|FG000|Overall Study|Increased infection rate|1
2008852|NCT00195715|3574403|FG000|Overall Study|Ineligible|1
2008853|NCT00195715|3574403|FG000|Overall Study|Colonic stricture|1
2008854|NCT00195715|3574403|FG000|Overall Study|Sponsor discontinued trial|1
2008855|NCT00195715|3574403|FG000|Overall Study|Sponsor discretion - trial ended early|1
2008856|NCT00195819|3574407|FG000|Double-Blind|Withdrawal by Subject|1
2008857|NCT00195819|3574408|FG001|Double-Blind|Withdrawal by Subject|0
2008858|NCT00195819|3574407|FG000|Double-Blind|Moved|1
2008859|NCT00195819|3574408|FG001|Double-Blind|Moved|0
2008860|NCT00195819|3574407|FG000|Open-label|Adverse Event|0
2008861|NCT00195819|3574408|FG001|Open-label|Adverse Event|9
2008862|NCT00195819|3574407|FG000|Open-label|Lack of Efficacy|0
2008863|NCT00195819|3574408|FG001|Open-label|Lack of Efficacy|2
2008864|NCT00195819|3574407|FG000|Open-label|Pregnancy|0
2008865|NCT00195819|3574408|FG001|Open-label|Pregnancy|1
2008866|NCT00195819|3574407|FG000|Open-label|Protocol Violation|0
2008867|NCT00195819|3574408|FG001|Open-label|Protocol Violation|2
2008868|NCT00195819|3574407|FG000|Open-label|Moved|0
2008869|NCT00195819|3574408|FG001|Open-label|Moved|1
2008870|NCT00195819|3574407|FG000|Open-label|Withdrawal by Subject|0
2008871|NCT00195819|3574408|FG001|Open-label|Withdrawal by Subject|5
2008872|NCT00196105|3574423|FG000|Overall Study|Lost to Follow-up|4
2008873|NCT00196105|3574424|FG001|Overall Study|Lost to Follow-up|5
2008874|NCT00196105|3574425|FG002|Overall Study|Lost to Follow-up|7
2008875|NCT00196196|3574433|FG000|Overall Study|Withdrawal by Subject|2
2008876|NCT00196196|3574433|FG000|Overall Study|Did not have required condition (hydroce|5
2008877|NCT00196313|3574439|FG000|Overall Study|Protocol Violation|2
2008878|NCT00196313|3574440|FG001|Overall Study|Protocol Violation|3
2008879|NCT00196313|3574439|FG000|Overall Study|Withdrawal by Subject|3
2008880|NCT00196313|3574440|FG001|Overall Study|Withdrawal by Subject|1
2008881|NCT00196313|3574439|FG000|Overall Study|Adverse Event|3
2008882|NCT00196313|3574440|FG001|Overall Study|Adverse Event|1
2008883|NCT00196313|3574439|FG000|Overall Study|Subject Pregnant|1
2008884|NCT00196313|3574440|FG001|Overall Study|Subject Pregnant|1
2008885|NCT00196313|3574439|FG000|Overall Study|Lost to Follow-up|2
2008886|NCT00196313|3574440|FG001|Overall Study|Lost to Follow-up|2
2008887|NCT00196326|3574447|FG000|Overall Study|Did not meet protocol requirements|64
2008888|NCT00196326|3574447|FG000|Overall Study|Non-compliance with the protocol|81
2008889|NCT00196326|3574447|FG000|Overall Study|Physician Decision|3
2008890|NCT00196326|3574447|FG000|Overall Study|Withdrawal by Subject|225
2008891|NCT00196326|3574447|FG000|Overall Study|Adverse Event|253
2008892|NCT00196326|3574447|FG000|Overall Study|Pregnancy|34
2008893|NCT00196326|3574447|FG000|Overall Study|Lost to Follow-up|304
2008894|NCT00196326|3574447|FG000|Overall Study|Other|22
2008895|NCT00196937|3574460|FG000|Overall Study|Serious Adverse Event|1
2008896|NCT00196937|3574461|FG001|Overall Study|Serious Adverse Event|0
2008897|NCT00196937|3574462|FG002|Overall Study|Serious Adverse Event|0
2008898|NCT00196937|3574460|FG000|Overall Study|Non-serious adverse event|1
2008899|NCT00196937|3574461|FG001|Overall Study|Non-serious adverse event|1
2008900|NCT00196937|3574462|FG002|Overall Study|Non-serious adverse event|1
2008901|NCT00196937|3574460|FG000|Overall Study|Withdrawal by Subject|0
2008902|NCT00196937|3574461|FG001|Overall Study|Withdrawal by Subject|0
2008903|NCT00196937|3574462|FG002|Overall Study|Withdrawal by Subject|2
2008904|NCT00196937|3574460|FG000|Overall Study|Lost to Follow-up|4
2008905|NCT00196937|3574461|FG001|Overall Study|Lost to Follow-up|3
2008906|NCT00196937|3574462|FG002|Overall Study|Lost to Follow-up|3
2008907|NCT00196937|3574460|FG000|Overall Study|Other|3
2008908|NCT00196937|3574461|FG001|Overall Study|Other|1
2008909|NCT00196937|3574462|FG002|Overall Study|Other|1
2008910|NCT00196976|3574485|FG000|Primary Study|Migrated from study area|0
2008911|NCT00196976|3574486|FG001|Primary Study|Migrated from study area|0
2008912|NCT00196976|3574487|FG002|Primary Study|Migrated from study area|0
2008913|NCT00196976|3574488|FG003|Primary Study|Migrated from study area|0
2008914|NCT00196976|3574489|FG004|Primary Study|Migrated from study area|0
2008915|NCT00196976|3574490|FG005|Primary Study|Migrated from study area|0
2008916|NCT00196976|3574491|FG006|Primary Study|Migrated from study area|0
2008917|NCT00196976|3574492|FG007|Primary Study|Migrated from study area|1
2008918|NCT00196976|3574493|FG008|Primary Study|Migrated from study area|0
2008919|NCT00196976|3574494|FG009|Primary Study|Migrated from study area|0
2008920|NCT00196976|3574495|FG010|Primary Study|Migrated from study area|0
2008921|NCT00196976|3574496|FG011|Primary Study|Migrated from study area|0
2008922|NCT00196976|3574497|FG012|Primary Study|Migrated from study area|0
2008923|NCT00196976|3574498|FG013|Primary Study|Migrated from study area|0
2008924|NCT00196976|3574485|FG000|Primary Study|Protocol Violation|0
2008925|NCT00196976|3574486|FG001|Primary Study|Protocol Violation|1
2008926|NCT00196976|3574487|FG002|Primary Study|Protocol Violation|1
2008927|NCT00196976|3574488|FG003|Primary Study|Protocol Violation|0
2008928|NCT00196976|3574489|FG004|Primary Study|Protocol Violation|0
2008929|NCT00196976|3574490|FG005|Primary Study|Protocol Violation|0
2008930|NCT00196976|3574491|FG006|Primary Study|Protocol Violation|0
2008931|NCT00196976|3574492|FG007|Primary Study|Protocol Violation|0
2008932|NCT00196976|3574493|FG008|Primary Study|Protocol Violation|0
2008933|NCT00196976|3574494|FG009|Primary Study|Protocol Violation|0
2008934|NCT00196976|3574495|FG010|Primary Study|Protocol Violation|0
2008935|NCT00196976|3574496|FG011|Primary Study|Protocol Violation|0
2008936|NCT00196976|3574497|FG012|Primary Study|Protocol Violation|0
2008937|NCT00196976|3574498|FG013|Primary Study|Protocol Violation|0
2008938|NCT00196976|3574485|FG000|Primary Study|Withdrawal by Subject|1
2008939|NCT00196976|3574486|FG001|Primary Study|Withdrawal by Subject|0
2008940|NCT00196976|3574487|FG002|Primary Study|Withdrawal by Subject|1
2008941|NCT00196976|3574488|FG003|Primary Study|Withdrawal by Subject|1
2008942|NCT00196976|3574489|FG004|Primary Study|Withdrawal by Subject|2
2008943|NCT00196976|3574490|FG005|Primary Study|Withdrawal by Subject|1
2008944|NCT00196976|3574491|FG006|Primary Study|Withdrawal by Subject|0
2008945|NCT00196976|3574492|FG007|Primary Study|Withdrawal by Subject|0
2008946|NCT00196976|3574493|FG008|Primary Study|Withdrawal by Subject|0
2008947|NCT00196976|3574494|FG009|Primary Study|Withdrawal by Subject|1
2008948|NCT00196976|3574495|FG010|Primary Study|Withdrawal by Subject|0
2008949|NCT00196976|3574496|FG011|Primary Study|Withdrawal by Subject|0
2008950|NCT00196976|3574497|FG012|Primary Study|Withdrawal by Subject|0
2008951|NCT00196976|3574498|FG013|Primary Study|Withdrawal by Subject|0
2008952|NCT00196976|3574485|FG000|Primary Study|Lost to Follow-up|0
2008953|NCT00196976|3574486|FG001|Primary Study|Lost to Follow-up|0
2008954|NCT00196976|3574487|FG002|Primary Study|Lost to Follow-up|0
2008955|NCT00196976|3574488|FG003|Primary Study|Lost to Follow-up|0
2008956|NCT00196976|3574489|FG004|Primary Study|Lost to Follow-up|1
2008957|NCT00196976|3574490|FG005|Primary Study|Lost to Follow-up|1
2008958|NCT00196976|3574491|FG006|Primary Study|Lost to Follow-up|0
2008959|NCT00196976|3574492|FG007|Primary Study|Lost to Follow-up|2
2008960|NCT00196976|3574493|FG008|Primary Study|Lost to Follow-up|0
2008961|NCT00196976|3574494|FG009|Primary Study|Lost to Follow-up|0
2008962|NCT00196976|3574495|FG010|Primary Study|Lost to Follow-up|0
2008963|NCT00196976|3574496|FG011|Primary Study|Lost to Follow-up|0
2008964|NCT00196976|3574497|FG012|Primary Study|Lost to Follow-up|0
2008965|NCT00196976|3574498|FG013|Primary Study|Lost to Follow-up|0
2008966|NCT00196976|3574485|FG000|Primary Study|Other|0
2008967|NCT00196976|3574486|FG001|Primary Study|Other|0
2008968|NCT00196976|3574487|FG002|Primary Study|Other|2
2008969|NCT00196976|3574488|FG003|Primary Study|Other|0
2008970|NCT00196976|3574489|FG004|Primary Study|Other|0
2008971|NCT00196976|3574490|FG005|Primary Study|Other|0
2008972|NCT00196976|3574491|FG006|Primary Study|Other|0
2008973|NCT00196976|3574492|FG007|Primary Study|Other|0
2008974|NCT00196976|3574493|FG008|Primary Study|Other|0
2008975|NCT00196976|3574494|FG009|Primary Study|Other|0
2008976|NCT00196976|3574495|FG010|Primary Study|Other|0
2008977|NCT00196976|3574496|FG011|Primary Study|Other|0
2008978|NCT00196976|3574497|FG012|Primary Study|Other|0
2008979|NCT00196976|3574498|FG013|Primary Study|Other|0
2008980|NCT00196976|3574485|FG000|Booster Study|Withdrawal by Subject|0
2008981|NCT00196976|3574486|FG001|Booster Study|Withdrawal by Subject|0
2008982|NCT00196976|3574487|FG002|Booster Study|Withdrawal by Subject|0
2008983|NCT00196976|3574488|FG003|Booster Study|Withdrawal by Subject|0
2008984|NCT00196976|3574489|FG004|Booster Study|Withdrawal by Subject|0
2008985|NCT00196976|3574490|FG005|Booster Study|Withdrawal by Subject|0
2008986|NCT00196976|3574491|FG006|Booster Study|Withdrawal by Subject|0
2008987|NCT00196976|3574492|FG007|Booster Study|Withdrawal by Subject|0
2008988|NCT00196976|3574493|FG008|Booster Study|Withdrawal by Subject|0
2008989|NCT00196976|3574494|FG009|Booster Study|Withdrawal by Subject|0
2008990|NCT00196976|3574495|FG010|Booster Study|Withdrawal by Subject|1
2008991|NCT00196976|3574496|FG011|Booster Study|Withdrawal by Subject|0
2008992|NCT00196976|3574497|FG012|Booster Study|Withdrawal by Subject|0
2008993|NCT00196976|3574498|FG013|Booster Study|Withdrawal by Subject|0
2008994|NCT00196976|3574485|FG000|Booster Study|Lost to Follow-up|0
2008995|NCT00196976|3574486|FG001|Booster Study|Lost to Follow-up|0
2008996|NCT00196976|3574487|FG002|Booster Study|Lost to Follow-up|0
2008997|NCT00196976|3574488|FG003|Booster Study|Lost to Follow-up|0
2008998|NCT00196976|3574489|FG004|Booster Study|Lost to Follow-up|0
2008999|NCT00196976|3574490|FG005|Booster Study|Lost to Follow-up|0
2009000|NCT00196976|3574491|FG006|Booster Study|Lost to Follow-up|0
2009001|NCT00196976|3574492|FG007|Booster Study|Lost to Follow-up|0
2009002|NCT00196976|3574493|FG008|Booster Study|Lost to Follow-up|0
2009003|NCT00196976|3574494|FG009|Booster Study|Lost to Follow-up|0
2009004|NCT00196976|3574495|FG010|Booster Study|Lost to Follow-up|1
2009005|NCT00196976|3574496|FG011|Booster Study|Lost to Follow-up|2
2009006|NCT00196976|3574497|FG012|Booster Study|Lost to Follow-up|0
2009007|NCT00196976|3574498|FG013|Booster Study|Lost to Follow-up|0
2009008|NCT00197002|3574541|FG000|Overall Study|Adverse Event|0
2009009|NCT00197002|3574542|FG001|Overall Study|Adverse Event|1
2009010|NCT00197002|3574543|FG002|Overall Study|Adverse Event|0
2009011|NCT00197002|3574541|FG000|Overall Study|Protocol Violation|1
2009012|NCT00197002|3574542|FG001|Overall Study|Protocol Violation|0
2009013|NCT00197002|3574543|FG002|Overall Study|Protocol Violation|2
2009014|NCT00197002|3574541|FG000|Overall Study|Withdrawal by Subject|9
2009015|NCT00197002|3574542|FG001|Overall Study|Withdrawal by Subject|5
2009016|NCT00197002|3574543|FG002|Overall Study|Withdrawal by Subject|7
2009017|NCT00197002|3574541|FG000|Overall Study|Migrated/moved from study area|3
2009018|NCT00197002|3574542|FG001|Overall Study|Migrated/moved from study area|5
2009019|NCT00197002|3574543|FG002|Overall Study|Migrated/moved from study area|1
2009020|NCT00197002|3574541|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4
2009021|NCT00197002|3574542|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4
2009022|NCT00197002|3574543|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5
2009023|NCT00197002|3574541|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2
2009024|NCT00197002|3574542|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2
2009025|NCT00197002|3574543|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1
2009026|NCT00197002|3574541|FG000|Overall Study|Others|3
2009027|NCT00197002|3574542|FG001|Overall Study|Others|1
2009028|NCT00197002|3574543|FG002|Overall Study|Others|1
2009029|NCT00197015|3574557|FG000|Overall Study|Adverse Event|3
2009030|NCT00197015|3574558|FG001|Overall Study|Adverse Event|0
2009031|NCT00197015|3574559|FG002|Overall Study|Adverse Event|1
2009032|NCT00197015|3574557|FG000|Overall Study|Protocol Violation|0
2009033|NCT00197015|3574558|FG001|Overall Study|Protocol Violation|3
2009034|NCT00197015|3574559|FG002|Overall Study|Protocol Violation|3
2009035|NCT00197015|3574557|FG000|Overall Study|Withdrawal by Subject|17
2009036|NCT00197015|3574558|FG001|Overall Study|Withdrawal by Subject|37
2009037|NCT00197015|3574559|FG002|Overall Study|Withdrawal by Subject|34
2009038|NCT00197015|3574557|FG000|Overall Study|Lost to Follow-up|28
2009039|NCT00197015|3574558|FG001|Overall Study|Lost to Follow-up|46
2009040|NCT00197015|3574559|FG002|Overall Study|Lost to Follow-up|37
2009041|NCT00197015|3574557|FG000|Overall Study|Other|2
2009042|NCT00197015|3574558|FG001|Overall Study|Other|3
2009043|NCT00197015|3574559|FG002|Overall Study|Other|2
2009044|NCT00197028|3574569|FG000|Overall Study|Adverse Event|2
2009045|NCT00197028|3574570|FG001|Overall Study|Adverse Event|2
2009046|NCT00197028|3574569|FG000|Overall Study|Protocol Violation|2
2009047|NCT00197028|3574570|FG001|Overall Study|Protocol Violation|1
2009048|NCT00197028|3574569|FG000|Overall Study|Withdrawal by Subject|8
2009049|NCT00197028|3574570|FG001|Overall Study|Withdrawal by Subject|12
2009050|NCT00197028|3574569|FG000|Overall Study|Lost to Follow-up|1
2009051|NCT00197028|3574570|FG001|Overall Study|Lost to Follow-up|0
2009052|NCT00197028|3574569|FG000|Overall Study|Other|3
2009053|NCT00197028|3574570|FG001|Overall Study|Other|6
2009054|NCT00197054|3574579|FG000|Overall Study|Withdrawal by Subject|9
2009055|NCT00197054|3574580|FG001|Overall Study|Withdrawal by Subject|3
2009056|NCT00197054|3574581|FG002|Overall Study|Withdrawal by Subject|3
2009057|NCT00197054|3574579|FG000|Overall Study|Moved from area|7
2009058|NCT00197054|3574580|FG001|Overall Study|Moved from area|14
2009059|NCT00197054|3574581|FG002|Overall Study|Moved from area|9
2009060|NCT00197054|3574579|FG000|Overall Study|Lost to Follow-up|1
2009061|NCT00197054|3574580|FG001|Overall Study|Lost to Follow-up|4
2009062|NCT00197054|3574581|FG002|Overall Study|Lost to Follow-up|0
2009063|NCT00197106|3574601|FG000|4-Week Run-In Period|Did not meet entry criteria|99
2009064|NCT00197106|3574602|FG001|4-Week Run-In Period|Did not meet entry criteria|0
2009065|NCT00197106|3574603|FG002|4-Week Run-In Period|Did not meet entry criteria|0
2009066|NCT00197106|3574601|FG000|Overall Treatment Period|Lack of Efficacy|0
2009067|NCT00197106|3574602|FG001|Overall Treatment Period|Lack of Efficacy|1
2009068|NCT00197106|3574603|FG002|Overall Treatment Period|Lack of Efficacy|0
2009069|NCT00197106|3574601|FG000|Overall Treatment Period|Lost to Follow-up|0
2009070|NCT00197106|3574602|FG001|Overall Treatment Period|Lost to Follow-up|0
2009071|NCT00197106|3574603|FG002|Overall Treatment Period|Lost to Follow-up|2
2009072|NCT00197106|3574601|FG000|Overall Treatment Period|Protocol Violation|0
2009073|NCT00197106|3574602|FG001|Overall Treatment Period|Protocol Violation|0
2009074|NCT00197106|3574603|FG002|Overall Treatment Period|Protocol Violation|2
2009075|NCT00197106|3574601|FG000|Overall Treatment Period|Withdrawal by Subject|0
2009076|NCT00197106|3574602|FG001|Overall Treatment Period|Withdrawal by Subject|0
2009077|NCT00197106|3574603|FG002|Overall Treatment Period|Withdrawal by Subject|2
2009078|NCT00197145|3574620|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
2009079|NCT00197145|3574621|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
2009080|NCT00197145|3574620|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
2009081|NCT00197145|3574621|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
2009082|NCT00197145|3574620|FG000|Period 1: Randomized Treatment Phase|Other|2
2009083|NCT00197145|3574621|FG001|Period 1: Randomized Treatment Phase|Other|2
2009084|NCT00197145|3574620|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1
2009085|NCT00197145|3574621|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0
2009086|NCT00197145|3574620|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3
2009087|NCT00197145|3574621|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0
2009088|NCT00197145|3574620|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2
2009089|NCT00197145|3574621|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0
2009090|NCT00197145|3574620|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3
2009091|NCT00197145|3574621|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0
2009092|NCT00197145|3574620|FG000|Period 2 : Open Label Phase|Other|1
2009093|NCT00197145|3574621|FG001|Period 2 : Open Label Phase|Other|0
2009094|NCT00197236|3574640|FG000|Overall Study|Adverse Event|1
2009095|NCT00197236|3574641|FG001|Overall Study|Adverse Event|0
2009096|NCT00197236|3574642|FG002|Overall Study|Adverse Event|1
2009097|NCT00197236|3574640|FG000|Overall Study|Lost to Follow-up|5
2009098|NCT00197236|3574641|FG001|Overall Study|Lost to Follow-up|14
2009099|NCT00197236|3574642|FG002|Overall Study|Lost to Follow-up|6
2009100|NCT00197236|3574640|FG000|Overall Study|Protocol Violation|0
2009101|NCT00197236|3574641|FG001|Overall Study|Protocol Violation|0
2009102|NCT00197236|3574642|FG002|Overall Study|Protocol Violation|1
2009103|NCT00197236|3574640|FG000|Overall Study|Withdrawal by Subject|7
2009104|NCT00197236|3574641|FG001|Overall Study|Withdrawal by Subject|3
2009105|NCT00197236|3574642|FG002|Overall Study|Withdrawal by Subject|11
2009106|NCT00197236|3574640|FG000|Overall Study|Study drug/medication expiration|1
2009107|NCT00197236|3574641|FG001|Overall Study|Study drug/medication expiration|0
2009108|NCT00197236|3574642|FG002|Overall Study|Study drug/medication expiration|3
2009109|NCT00197236|3574640|FG000|Overall Study|Returned out of specified time window|0
2009110|NCT00197236|3574641|FG001|Overall Study|Returned out of specified time window|0
2009111|NCT00197236|3574642|FG002|Overall Study|Returned out of specified time window|1
2009112|NCT00197496|3574680|FG000|Baseline to Discharge|not interested|1
2009113|NCT00197496|3574681|FG001|Baseline to Discharge|not interested|0
2009114|NCT00197496|3574680|FG000|Baseline to Discharge|MRSA|1
2009115|NCT00197496|3574681|FG001|Baseline to Discharge|MRSA|0
2009116|NCT00197496|3574680|FG000|Baseline to Discharge|Physician Decision|0
2009117|NCT00197496|3574681|FG001|Baseline to Discharge|Physician Decision|1
2009118|NCT00197496|3574680|FG000|Baseline to Discharge|Protocol Violation|0
2009119|NCT00197496|3574681|FG001|Baseline to Discharge|Protocol Violation|1
2009120|NCT00197496|3574680|FG000|Follow-up|Lost to Follow-up|2
2009121|NCT00197496|3574681|FG001|Follow-up|Lost to Follow-up|1
2009122|NCT00198029|3574687|FG000|Overall Study|Withdrawal by Subject|4
2009123|NCT00198107|3574711|FG000|Double-Blind Period|Adverse Event|1
2009124|NCT00198107|3574712|FG001|Double-Blind Period|Adverse Event|1
2009125|NCT00198107|3574713|FG002|Double-Blind Period|Adverse Event|0
2009126|NCT00198107|3574711|FG000|Double-Blind Period|Lack of Efficacy|2
2009127|NCT00198107|3574712|FG001|Double-Blind Period|Lack of Efficacy|0
2009128|NCT00198107|3574713|FG002|Double-Blind Period|Lack of Efficacy|0
2009129|NCT00198107|3574711|FG000|Double-Blind Period|Lost to Follow-up|2
2009130|NCT00198107|3574712|FG001|Double-Blind Period|Lost to Follow-up|1
2009131|NCT00198107|3574713|FG002|Double-Blind Period|Lost to Follow-up|0
2009132|NCT00198107|3574711|FG000|Double-Blind Period|Physician Decision|1
2009133|NCT00198107|3574712|FG001|Double-Blind Period|Physician Decision|0
2009134|NCT00198107|3574713|FG002|Double-Blind Period|Physician Decision|0
2009135|NCT00198107|3574711|FG000|Double-Blind Period|Withdrawal by Subject|0
2009136|NCT00198107|3574712|FG001|Double-Blind Period|Withdrawal by Subject|1
2009137|NCT00198107|3574713|FG002|Double-Blind Period|Withdrawal by Subject|0
2009138|NCT00198107|3574711|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
2009139|NCT00198107|3574712|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
2009140|NCT00198107|3574713|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
2009141|NCT00198133|3574723|FG000|Overall Study|Disease progression|2
2009142|NCT00198133|3574724|FG001|Overall Study|Disease progression|5
2214371|NCT01687166|3856622|FG000|Overall Study|Lost to Follow-up|2
2214372|NCT01687166|3856623|FG001|Overall Study|Lost to Follow-up|5
2214373|NCT01687166|3856624|FG002|Overall Study|Lost to Follow-up|1
2214374|NCT01687166|3856625|FG003|Overall Study|Lost to Follow-up|0
2214375|NCT01687166|3856622|FG000|Overall Study|Equipment/Device Availability|0
2214376|NCT01687166|3856623|FG001|Overall Study|Equipment/Device Availability|1
2214377|NCT01687166|3856624|FG002|Overall Study|Equipment/Device Availability|0
2214378|NCT01687166|3856625|FG003|Overall Study|Equipment/Device Availability|0
2214379|NCT01687166|3856622|FG000|Overall Study|Death|1
2214380|NCT01687166|3856623|FG001|Overall Study|Death|1
2214381|NCT01687166|3856624|FG002|Overall Study|Death|0
2313239|NCT02786901|4020519|FG000|Overall Study|Rescue Therapy Use|71
2313240|NCT02786901|4020520|FG001|Overall Study|Rescue Therapy Use|49
2313241|NCT02786901|4020521|FG002|Overall Study|Rescue Therapy Use|33
2313242|NCT02786901|4020519|FG000|Overall Study|Subject Request/Lost to Follow up|1
2313243|NCT02786901|4020520|FG001|Overall Study|Subject Request/Lost to Follow up|5
2313244|NCT02786901|4020521|FG002|Overall Study|Subject Request/Lost to Follow up|5
2313245|NCT02786901|4020519|FG000|Overall Study|Disallowed medication|1
2313246|NCT02786901|4020520|FG001|Overall Study|Disallowed medication|1
2313247|NCT02786901|4020521|FG002|Overall Study|Disallowed medication|0
2313248|NCT02786901|4020519|FG000|Overall Study|Randomized in error|2
2313249|NCT02786901|4020520|FG001|Overall Study|Randomized in error|0
2009143|NCT00198133|3574723|FG000|Overall Study|Adverse Event|1
2009144|NCT00198133|3574724|FG001|Overall Study|Adverse Event|3
2009145|NCT00198133|3574723|FG000|Overall Study|Withdrawal by Subject|1
2009146|NCT00198133|3574724|FG001|Overall Study|Withdrawal by Subject|0
2009147|NCT00198133|3574723|FG000|Overall Study|Physician Decision|1
2009148|NCT00198133|3574724|FG001|Overall Study|Physician Decision|0
2009149|NCT00198822|3574733|FG000|Overall Study|Lost to Follow-up|14
2009150|NCT00198822|3574734|FG001|Overall Study|Lost to Follow-up|20
2009151|NCT00198822|3574735|FG002|Overall Study|Lost to Follow-up|21
2009152|NCT00199381|3574743|FG000|Overall Study|Withdrawal by Subject|38
2009153|NCT00199381|3574743|FG000|Overall Study|Adverse Event|73
2009154|NCT00199381|3574743|FG000|Overall Study|Protocol Violation|6
2009155|NCT00199381|3574743|FG000|Overall Study|Lack of Efficacy|27
2009156|NCT00199381|3574743|FG000|Overall Study|Not including due to early termination|37
2009157|NCT00199381|3574743|FG000|Overall Study|Study termination by Sponsor|323
2009158|NCT00199797|3574747|FG000|Overall Study|Progressive Disease|1
2009159|NCT00199797|3574747|FG000|Overall Study|Adverse Event|1
2009160|NCT00199797|3574747|FG000|Overall Study|Physician Decision|1
2009161|NCT00199836|3574752|FG000|Overall Study|Progressive Disease|5
2009162|NCT00199836|3574752|FG000|Overall Study|Death|1
2009163|NCT00199849|3574760|FG000|Overall Study|Unrelated illness or complication|0
2009164|NCT00199849|3574761|FG001|Overall Study|Unrelated illness or complication|1
2009165|NCT00199849|3574762|FG002|Overall Study|Unrelated illness or complication|0
2009166|NCT00199849|3574760|FG000|Overall Study|Progressive disease requiring intervention|0
2009167|NCT00199849|3574761|FG001|Overall Study|Progressive disease requiring intervention|0
2009168|NCT00199849|3574762|FG002|Overall Study|Progressive disease requiring intervention|1
2009169|NCT00199849|3574760|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0
2009170|NCT00199849|3574761|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0
2009171|NCT00199849|3574762|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1
2009172|NCT00199875|3574775|FG000|Overall Study|Withdrawal by Subject|0
2009173|NCT00199875|3574776|FG001|Overall Study|Withdrawal by Subject|0
2009174|NCT00199875|3574777|FG002|Overall Study|Withdrawal by Subject|0
2009175|NCT00199875|3574778|FG003|Overall Study|Withdrawal by Subject|0
2009176|NCT00199875|3574779|FG004|Overall Study|Withdrawal by Subject|1
2009177|NCT00199888|3574791|FG000|Overall Study|Lost to Follow-up|1
2009178|NCT00199901|3574797|FG000|Overall Study|Protocol Violation|2
2009179|NCT00199901|3574798|FG001|Overall Study|Protocol Violation|0
2009180|NCT00199901|3574797|FG000|Overall Study|Withdrawal by Subject|1
2009181|NCT00199901|3574798|FG001|Overall Study|Withdrawal by Subject|0
2009182|NCT00199901|3574797|FG000|Overall Study|Progressive Disease|24
2009183|NCT00199901|3574798|FG001|Overall Study|Progressive Disease|24
2009184|NCT00200057|3574815|FG000|Overall Study|Lack of Efficacy|3
2009185|NCT00200057|3574815|FG000|Overall Study|Exited due to terminal illness of PI|2
2009186|NCT00200057|3574815|FG000|Overall Study|Withdrawal by Subject|1
2009187|NCT00200057|3574815|FG000|Overall Study|Change in medical condition|1
2009188|NCT00200057|3574815|FG000|Overall Study|Infection|1
2009189|NCT00200057|3574815|FG000|Overall Study|Death|1
2009190|NCT00200356|3574843|FG000|Overall Study|Lack of Efficacy|3
2009191|NCT00200356|3574844|FG001|Overall Study|Lack of Efficacy|3
2009192|NCT00200356|3574843|FG000|Overall Study|Protocol Violation|4
2009193|NCT00200356|3574844|FG001|Overall Study|Protocol Violation|4
2009194|NCT00200356|3574843|FG000|Overall Study|Nontreatment|1
2009195|NCT00200356|3574844|FG001|Overall Study|Nontreatment|0
2009196|NCT00200850|3574862|FG000|Overall Study|relocation|1
2009197|NCT00200850|3574863|FG001|Overall Study|relocation|0
2009198|NCT00200850|3574864|FG002|Overall Study|relocation|1
2009199|NCT00200850|3574862|FG000|Overall Study|too busy|1
2009200|NCT00200850|3574863|FG001|Overall Study|too busy|0
2009201|NCT00200850|3574864|FG002|Overall Study|too busy|0
2009202|NCT00200850|3574862|FG000|Overall Study|Pregnancy|0
2009203|NCT00200850|3574863|FG001|Overall Study|Pregnancy|0
2009204|NCT00200850|3574864|FG002|Overall Study|Pregnancy|1
2009205|NCT00200850|3574862|FG000|Overall Study|Poor adherence|0
2009206|NCT00200850|3574863|FG001|Overall Study|Poor adherence|0
2009207|NCT00200850|3574864|FG002|Overall Study|Poor adherence|1
2009208|NCT00200850|3574862|FG000|Overall Study|optic neuritis|0
2009209|NCT00200850|3574863|FG001|Overall Study|optic neuritis|0
2009210|NCT00200850|3574864|FG002|Overall Study|optic neuritis|1
2009211|NCT00200850|3574862|FG000|Overall Study|Adverse Event|1
2009212|NCT00200850|3574863|FG001|Overall Study|Adverse Event|1
2009213|NCT00200850|3574864|FG002|Overall Study|Adverse Event|2
2009214|NCT00200967|3574893|FG000|First Treatment Period|Withdrawal by Subject|5
2009215|NCT00200967|3574894|FG001|First Treatment Period|Withdrawal by Subject|1
2009216|NCT00200967|3574893|FG000|First Treatment Period|Pregnancy|1
2009217|NCT00200967|3574894|FG001|First Treatment Period|Pregnancy|0
2009218|NCT00200967|3574893|FG000|Wash-out Period|Lost to Follow-up|0
2009219|NCT00200967|3574894|FG001|Wash-out Period|Lost to Follow-up|1
2009220|NCT00200967|3574893|FG000|Second Treatment Period|Withdrawal by Subject|1
2009221|NCT00200967|3574894|FG001|Second Treatment Period|Withdrawal by Subject|2
2009222|NCT00200967|3574893|FG000|Run-out Period|Lost to Follow-up|1
2009223|NCT00200967|3574894|FG001|Run-out Period|Lost to Follow-up|0
2009224|NCT00201006|3574903|FG000|Overall Study|Withdrawal by Subject|7
2009225|NCT00201006|3574904|FG001|Overall Study|Withdrawal by Subject|2
2009226|NCT00201006|3574905|FG002|Overall Study|Withdrawal by Subject|3
2009227|NCT00201006|3574903|FG000|Overall Study|Adverse Event|1
2009228|NCT00201006|3574904|FG001|Overall Study|Adverse Event|0
2009229|NCT00201006|3574905|FG002|Overall Study|Adverse Event|1
2009230|NCT00201201|3574932|FG000|Overall Study|Death|0
2009231|NCT00201201|3574933|FG001|Overall Study|Death|2
2009232|NCT00201201|3574932|FG000|Overall Study|Withdrawal by Subject|5
2009233|NCT00201201|3574933|FG001|Overall Study|Withdrawal by Subject|5
2009234|NCT00201643|3574966|FG000|Overall Study|Withdrawal by Subject|5
2009235|NCT00201643|3574967|FG001|Overall Study|Withdrawal by Subject|4
2009236|NCT00201851|3575021|FG000|Overall Study|Lost to Follow-up|2
2009237|NCT00201851|3575022|FG001|Overall Study|Lost to Follow-up|1
2009238|NCT00201851|3575023|FG002|Overall Study|Lost to Follow-up|0
2009239|NCT00201851|3575021|FG000|Overall Study|Ineligible post enrollment|6
2009240|NCT00201851|3575022|FG001|Overall Study|Ineligible post enrollment|1
2009241|NCT00201851|3575023|FG002|Overall Study|Ineligible post enrollment|1
2009242|NCT00202644|3575057|FG000|Overall Study|Adverse Event|12
2009243|NCT00202644|3575058|FG001|Overall Study|Adverse Event|13
2009244|NCT00202644|3575057|FG000|Overall Study|Withdrawal by Subject|8
2009245|NCT00202644|3575058|FG001|Overall Study|Withdrawal by Subject|6
2009246|NCT00202644|3575057|FG000|Overall Study|Lack of Efficacy|6
2009247|NCT00202644|3575058|FG001|Overall Study|Lack of Efficacy|6
2009248|NCT00202644|3575057|FG000|Overall Study|Lost to Follow-up|0
2009249|NCT00202644|3575058|FG001|Overall Study|Lost to Follow-up|1
2009250|NCT00202644|3575057|FG000|Overall Study|Other|9
2009251|NCT00202644|3575058|FG001|Overall Study|Other|1
2009252|NCT00202839|3575071|FG000|Overall Study|Adverse Event|1
2009253|NCT00202839|3575072|FG001|Overall Study|Adverse Event|5
2009254|NCT00202839|3575071|FG000|Overall Study|Physician Decision|12
2009255|NCT00202839|3575072|FG001|Overall Study|Physician Decision|0
2009256|NCT00202839|3575071|FG000|Overall Study|Withdrawal by Subject|6
2009257|NCT00202839|3575072|FG001|Overall Study|Withdrawal by Subject|2
2009258|NCT00202839|3575071|FG000|Overall Study|Protocol Violation|2
2009259|NCT00202839|3575072|FG001|Overall Study|Protocol Violation|1
2009260|NCT00202839|3575071|FG000|Overall Study|Lost to Follow-up|3
2009261|NCT00202839|3575072|FG001|Overall Study|Lost to Follow-up|2
2009262|NCT00203021|3575084|FG000|Overall Study|Death|4
2009263|NCT00203021|3575085|FG001|Overall Study|Death|1
2009264|NCT00203021|3575084|FG000|Overall Study|Adverse Event|10
2009265|NCT00203021|3575085|FG001|Overall Study|Adverse Event|5
2009266|NCT00203021|3575084|FG000|Overall Study|Withdrawal by Subject|45
2009267|NCT00203021|3575085|FG001|Overall Study|Withdrawal by Subject|48
2009268|NCT00203021|3575084|FG000|Overall Study|Lost to Follow-up|9
2214382|NCT01687166|3856625|FG003|Overall Study|Death|0
2214383|NCT01687166|3856622|FG000|Overall Study|Protocol Violation|1
2214384|NCT01687166|3856623|FG001|Overall Study|Protocol Violation|1
2214385|NCT01687166|3856624|FG002|Overall Study|Protocol Violation|1
2214386|NCT01687166|3856625|FG003|Overall Study|Protocol Violation|0
2009269|NCT00203021|3575085|FG001|Overall Study|Lost to Follow-up|7
2009270|NCT00203021|3575084|FG000|Overall Study|Other than specified|11
2009271|NCT00203021|3575085|FG001|Overall Study|Other than specified|16
2009272|NCT00203047|3575093|FG000|Overall Study|Ongoing: in database - January 29, 2009|131
2009273|NCT00203047|3575094|FG001|Overall Study|Ongoing: in database - January 29, 2009|109
2009274|NCT00203047|3575093|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5
2009275|NCT00203047|3575094|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1
2009276|NCT00203047|3575093|FG000|Overall Study|Withdrawal by Subject|13
2009277|NCT00203047|3575094|FG001|Overall Study|Withdrawal by Subject|47
2009278|NCT00203047|3575093|FG000|Overall Study|Teva requested participant withdrawal|1
2009279|NCT00203047|3575094|FG001|Overall Study|Teva requested participant withdrawal|1
2009280|NCT00203047|3575093|FG000|Overall Study|Physician Decision|8
2177436|NCT01373931|3801580|FG001|Period 1|Withdrawal by Subject|2
2009281|NCT00203047|3575094|FG001|Overall Study|Physician Decision|7
2009282|NCT00203047|3575093|FG000|Overall Study|Non-compliance|4
2009283|NCT00203047|3575094|FG001|Overall Study|Non-compliance|8
2009284|NCT00203047|3575093|FG000|Overall Study|Protocol Violation|1
2009285|NCT00203047|3575094|FG001|Overall Study|Protocol Violation|0
2009286|NCT00203047|3575093|FG000|Overall Study|Lost to Follow-up|11
2009287|NCT00203047|3575094|FG001|Overall Study|Lost to Follow-up|5
2009288|NCT00203047|3575093|FG000|Overall Study|Adverse Event|8
2009289|NCT00203047|3575094|FG001|Overall Study|Adverse Event|18
2009290|NCT00203047|3575093|FG000|Overall Study|Death|1
2009291|NCT00203047|3575094|FG001|Overall Study|Death|2
2009292|NCT00203047|3575093|FG000|Overall Study|Pregnancy|3
2009293|NCT00203047|3575094|FG001|Overall Study|Pregnancy|0
2177437|NCT01374087|3801589|FG000|Overall Study|Adverse Event|1
2177438|NCT01374087|3801590|FG001|Overall Study|Adverse Event|0
2177439|NCT01374087|3801589|FG000|Overall Study|Disease progression|2
2177440|NCT01374087|3801590|FG001|Overall Study|Disease progression|2
2177441|NCT01374087|3801589|FG000|Overall Study|Study discontinued|13
2177442|NCT01374087|3801590|FG001|Overall Study|Study discontinued|13
2177443|NCT01374178|3801596|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1
2177444|NCT01374178|3801597|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0
2177445|NCT01374178|3801596|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
2177446|NCT01374178|3801597|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
2177447|NCT01374217|3801603|FG000|Overall Study|Lack of Efficacy|13
2214387|NCT01687166|3856622|FG000|Overall Study|Subject moved out of state|0
2009294|NCT00203047|3575093|FG000|Overall Study|Other|5
2009295|NCT00203047|3575094|FG001|Overall Study|Other|5
2009296|NCT00203242|3575122|FG000|Overall Study|Lost to Follow-up|1
2009297|NCT00203268|3575126|FG000|Early Treatment|only treated one headache|2
2009298|NCT00203268|3575126|FG000|Early Treatment|Lost to Follow-up|1
2009299|NCT00203268|3575126|FG000|Early Treatment|Withdrawal by Subject|1
2009300|NCT00203294|3575134|FG000|Overall Study|Withdrawal by Subject|8
2009301|NCT00203294|3575135|FG001|Overall Study|Withdrawal by Subject|13
2009302|NCT00203307|3575143|FG000|First Intervention|Adverse Event|2
2009303|NCT00203307|3575144|FG001|First Intervention|Adverse Event|0
2009304|NCT00203411|3575150|FG000|Follow-up|Progressive Disease|4
2009305|NCT00203424|3575155|FG000|Treatment Period|Withdrawal by Subject|4
2009306|NCT00203424|3575155|FG000|Treatment Period|Adverse Event|5
2009307|NCT00203424|3575155|FG000|Treatment Period|progressive disease|2
2009308|NCT00203424|3575155|FG000|Follow-up Period|Withdrawal by Subject|1
2009309|NCT00203424|3575155|FG000|Follow-up Period|progressive disease|4
2009310|NCT00203424|3575155|FG000|Follow-up Period|Lost to Follow-up|1
2009311|NCT00203476|3575162|FG000|Overall Study|Lost to Follow-up|1
2009312|NCT00203476|3575163|FG001|Overall Study|Lost to Follow-up|0
2009313|NCT00203476|3575164|FG002|Overall Study|Lost to Follow-up|0
2214388|NCT01687166|3856623|FG001|Overall Study|Subject moved out of state|1
2214389|NCT01687166|3856624|FG002|Overall Study|Subject moved out of state|0
2009314|NCT00203476|3575162|FG000|Overall Study|Withdrawal by Subject|0
2009315|NCT00203476|3575163|FG001|Overall Study|Withdrawal by Subject|1
2009316|NCT00203476|3575164|FG002|Overall Study|Withdrawal by Subject|0
2009317|NCT00203502|3575172|FG000|Overall Study|Death|1
2009318|NCT00203892|3575179|FG000|Overall Study|Physician Decision|1
2009319|NCT00203892|3575180|FG001|Overall Study|Physician Decision|2
2009320|NCT00203892|3575181|FG002|Overall Study|Physician Decision|0
2009321|NCT00203892|3575179|FG000|Overall Study|Death|1
2009322|NCT00203892|3575180|FG001|Overall Study|Death|0
2009323|NCT00203892|3575181|FG002|Overall Study|Death|0
2009324|NCT00203996|3575208|FG000|Overall Study|Lost to Follow-up|0
2009325|NCT00203996|3575209|FG001|Overall Study|Lost to Follow-up|0
2009326|NCT00203996|3575210|FG002|Overall Study|Lost to Follow-up|0
2009327|NCT00203996|3575211|FG003|Overall Study|Lost to Follow-up|1
2009328|NCT00203996|3575212|FG004|Overall Study|Lost to Follow-up|0
2009329|NCT00203996|3575213|FG005|Overall Study|Lost to Follow-up|0
2009330|NCT00203996|3575214|FG006|Overall Study|Lost to Follow-up|0
2009331|NCT00203996|3575215|FG007|Overall Study|Lost to Follow-up|0
2009332|NCT00203996|3575216|FG008|Overall Study|Lost to Follow-up|0
2009333|NCT00203996|3575217|FG009|Overall Study|Lost to Follow-up|0
2009334|NCT00203996|3575208|FG000|Overall Study|Protocol Violation|0
2009335|NCT00203996|3575209|FG001|Overall Study|Protocol Violation|0
2009336|NCT00203996|3575210|FG002|Overall Study|Protocol Violation|0
2009337|NCT00203996|3575211|FG003|Overall Study|Protocol Violation|6
2009338|NCT00203996|3575212|FG004|Overall Study|Protocol Violation|1
2009339|NCT00203996|3575213|FG005|Overall Study|Protocol Violation|0
2009340|NCT00203996|3575214|FG006|Overall Study|Protocol Violation|0
2009341|NCT00203996|3575215|FG007|Overall Study|Protocol Violation|0
2009342|NCT00203996|3575216|FG008|Overall Study|Protocol Violation|0
2009343|NCT00203996|3575217|FG009|Overall Study|Protocol Violation|0
2009344|NCT00203996|3575208|FG000|Overall Study|Physician Decision|0
2009345|NCT00203996|3575209|FG001|Overall Study|Physician Decision|0
2009346|NCT00203996|3575210|FG002|Overall Study|Physician Decision|0
2009347|NCT00203996|3575211|FG003|Overall Study|Physician Decision|2
2009348|NCT00203996|3575212|FG004|Overall Study|Physician Decision|0
2009349|NCT00203996|3575213|FG005|Overall Study|Physician Decision|0
2009350|NCT00203996|3575214|FG006|Overall Study|Physician Decision|0
2009351|NCT00203996|3575215|FG007|Overall Study|Physician Decision|0
2009352|NCT00203996|3575216|FG008|Overall Study|Physician Decision|0
2009353|NCT00203996|3575217|FG009|Overall Study|Physician Decision|1
2009354|NCT00203996|3575208|FG000|Overall Study|CPAP machine malfunction|0
2009355|NCT00203996|3575209|FG001|Overall Study|CPAP machine malfunction|0
2009356|NCT00203996|3575210|FG002|Overall Study|CPAP machine malfunction|0
2009357|NCT00203996|3575211|FG003|Overall Study|CPAP machine malfunction|1
2009358|NCT00203996|3575212|FG004|Overall Study|CPAP machine malfunction|0
2009359|NCT00203996|3575213|FG005|Overall Study|CPAP machine malfunction|0
2009360|NCT00203996|3575214|FG006|Overall Study|CPAP machine malfunction|0
2009361|NCT00203996|3575215|FG007|Overall Study|CPAP machine malfunction|0
2009362|NCT00203996|3575216|FG008|Overall Study|CPAP machine malfunction|0
2009363|NCT00203996|3575217|FG009|Overall Study|CPAP machine malfunction|0
2009364|NCT00203996|3575208|FG000|Overall Study|Scheduling issue|0
2009365|NCT00203996|3575209|FG001|Overall Study|Scheduling issue|0
2009366|NCT00203996|3575210|FG002|Overall Study|Scheduling issue|0
2009367|NCT00203996|3575211|FG003|Overall Study|Scheduling issue|0
2009368|NCT00203996|3575212|FG004|Overall Study|Scheduling issue|0
2009369|NCT00203996|3575213|FG005|Overall Study|Scheduling issue|0
2009370|NCT00203996|3575214|FG006|Overall Study|Scheduling issue|0
2009371|NCT00203996|3575215|FG007|Overall Study|Scheduling issue|2
2009372|NCT00203996|3575216|FG008|Overall Study|Scheduling issue|0
2214390|NCT01687166|3856625|FG003|Overall Study|Subject moved out of state|0
2009373|NCT00203996|3575217|FG009|Overall Study|Scheduling issue|0
2009374|NCT00205179|3575248|FG000|Overall Study|Death|0
2009375|NCT00205179|3575249|FG001|Overall Study|Death|2
2009376|NCT00205179|3575248|FG000|Overall Study|Physician Decision|1
2009377|NCT00205179|3575249|FG001|Overall Study|Physician Decision|1
2009378|NCT00205179|3575248|FG000|Overall Study|Adverse Event|1
2009379|NCT00205179|3575249|FG001|Overall Study|Adverse Event|1
2009380|NCT00205699|3575295|FG000|Overall Study|Lost to Follow-up|1
2009381|NCT00205699|3575296|FG001|Overall Study|Lost to Follow-up|3
2009382|NCT00205699|3575297|FG002|Overall Study|Lost to Follow-up|5
2009383|NCT00205699|3575295|FG000|Overall Study|Adverse Event|1
2009384|NCT00205699|3575296|FG001|Overall Study|Adverse Event|0
2009385|NCT00205699|3575297|FG002|Overall Study|Adverse Event|0
2009386|NCT00205699|3575295|FG000|Overall Study|Withdrawal by Subject|1
2009387|NCT00205699|3575296|FG001|Overall Study|Withdrawal by Subject|2
2009388|NCT00205699|3575297|FG002|Overall Study|Withdrawal by Subject|1
2009389|NCT00205699|3575295|FG000|Overall Study|Lack of Efficacy|0
2009390|NCT00205699|3575296|FG001|Overall Study|Lack of Efficacy|1
2009391|NCT00205699|3575297|FG002|Overall Study|Lack of Efficacy|0
2009392|NCT00205712|3575310|FG000|Overall Study|Lost to Follow-up|0
2009393|NCT00205712|3575311|FG001|Overall Study|Lost to Follow-up|1
2009394|NCT00205777|3575323|FG000|Core Study (Up to 3 Years)|Adverse Event|260
2009395|NCT00205777|3575324|FG001|Core Study (Up to 3 Years)|Adverse Event|267
2009396|NCT00205777|3575325|FG002|Core Study (Up to 3 Years)|Adverse Event|252
2009397|NCT00205777|3575326|FG003|Core Study (Up to 3 Years)|Adverse Event|232
2009398|NCT00205777|3575327|FG004|Core Study (Up to 3 Years)|Adverse Event|0
2009399|NCT00205777|3575328|FG005|Core Study (Up to 3 Years)|Adverse Event|0
2009400|NCT00205777|3575323|FG000|Core Study (Up to 3 Years)|Death|9
2009401|NCT00205777|3575324|FG001|Core Study (Up to 3 Years)|Death|7
2009402|NCT00205777|3575325|FG002|Core Study (Up to 3 Years)|Death|14
2009403|NCT00205777|3575326|FG003|Core Study (Up to 3 Years)|Death|7
2009404|NCT00205777|3575327|FG004|Core Study (Up to 3 Years)|Death|0
2009405|NCT00205777|3575328|FG005|Core Study (Up to 3 Years)|Death|0
2009406|NCT00205777|3575323|FG000|Core Study (Up to 3 Years)|Failed to return|40
2009407|NCT00205777|3575324|FG001|Core Study (Up to 3 Years)|Failed to return|25
2009408|NCT00205777|3575325|FG002|Core Study (Up to 3 Years)|Failed to return|27
2009409|NCT00205777|3575326|FG003|Core Study (Up to 3 Years)|Failed to return|27
2009410|NCT00205777|3575327|FG004|Core Study (Up to 3 Years)|Failed to return|0
2009411|NCT00205777|3575328|FG005|Core Study (Up to 3 Years)|Failed to return|0
2009412|NCT00205777|3575323|FG000|Core Study (Up to 3 Years)|Other Event|49
2009413|NCT00205777|3575324|FG001|Core Study (Up to 3 Years)|Other Event|52
2009414|NCT00205777|3575325|FG002|Core Study (Up to 3 Years)|Other Event|41
2009415|NCT00205777|3575326|FG003|Core Study (Up to 3 Years)|Other Event|58
2009416|NCT00205777|3575327|FG004|Core Study (Up to 3 Years)|Other Event|0
2009417|NCT00205777|3575328|FG005|Core Study (Up to 3 Years)|Other Event|0
2009418|NCT00205777|3575323|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144
2009419|NCT00205777|3575324|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169
2009420|NCT00205777|3575325|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149
2009421|NCT00205777|3575326|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162
2009422|NCT00205777|3575327|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0
2009423|NCT00205777|3575328|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0
2009424|NCT00205777|3575323|FG000|Core Study (Up to 3 Years)|Protocol Violation|53
2009425|NCT00205777|3575324|FG001|Core Study (Up to 3 Years)|Protocol Violation|55
2009426|NCT00205777|3575325|FG002|Core Study (Up to 3 Years)|Protocol Violation|50
2009427|NCT00205777|3575326|FG003|Core Study (Up to 3 Years)|Protocol Violation|42
2009428|NCT00205777|3575327|FG004|Core Study (Up to 3 Years)|Protocol Violation|0
2009429|NCT00205777|3575328|FG005|Core Study (Up to 3 Years)|Protocol Violation|0
2009430|NCT00205777|3575323|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52
2009431|NCT00205777|3575324|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52
2009432|NCT00205777|3575325|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39
2009433|NCT00205777|3575326|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75
2009434|NCT00205777|3575327|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0
2009435|NCT00205777|3575328|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0
2009436|NCT00205777|3575323|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21
2009437|NCT00205777|3575324|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32
2009438|NCT00205777|3575325|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35
2009439|NCT00205777|3575326|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29
2009440|NCT00205777|3575327|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0
2009441|NCT00205777|3575328|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0
2009442|NCT00205777|3575323|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180
2009443|NCT00205777|3575324|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158
2009444|NCT00205777|3575325|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160
2009445|NCT00205777|3575326|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174
2009446|NCT00205777|3575327|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0
2009447|NCT00205777|3575328|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0
2009448|NCT00205777|3575323|FG000|Completed Core Study, Entered SE I|Other Event|52
2009449|NCT00205777|3575324|FG001|Completed Core Study, Entered SE I|Other Event|46
2009450|NCT00205777|3575325|FG002|Completed Core Study, Entered SE I|Other Event|47
2009451|NCT00205777|3575326|FG003|Completed Core Study, Entered SE I|Other Event|50
2009452|NCT00205777|3575327|FG004|Completed Core Study, Entered SE I|Other Event|0
2009453|NCT00205777|3575328|FG005|Completed Core Study, Entered SE I|Other Event|0
2009454|NCT00205777|3575323|FG000|Study Extension I|Adverse Event|57
2009455|NCT00205777|3575324|FG001|Study Extension I|Adverse Event|0
2009456|NCT00205777|3575325|FG002|Study Extension I|Adverse Event|0
2009457|NCT00205777|3575326|FG003|Study Extension I|Adverse Event|61
2009458|NCT00205777|3575327|FG004|Study Extension I|Adverse Event|58
2009459|NCT00205777|3575328|FG005|Study Extension I|Adverse Event|0
2009460|NCT00205777|3575323|FG000|Study Extension I|Death|5
2009461|NCT00205777|3575324|FG001|Study Extension I|Death|0
2009462|NCT00205777|3575325|FG002|Study Extension I|Death|0
2009463|NCT00205777|3575326|FG003|Study Extension I|Death|1
2009464|NCT00205777|3575327|FG004|Study Extension I|Death|2
2009465|NCT00205777|3575328|FG005|Study Extension I|Death|0
2009466|NCT00205777|3575323|FG000|Study Extension I|Withdrawal by Subject|99
2009467|NCT00205777|3575324|FG001|Study Extension I|Withdrawal by Subject|0
2009468|NCT00205777|3575325|FG002|Study Extension I|Withdrawal by Subject|0
2009469|NCT00205777|3575326|FG003|Study Extension I|Withdrawal by Subject|106
2009470|NCT00205777|3575327|FG004|Study Extension I|Withdrawal by Subject|89
2009471|NCT00205777|3575328|FG005|Study Extension I|Withdrawal by Subject|0
2009472|NCT00205777|3575323|FG000|Study Extension I|Protocol Violation|4
2009473|NCT00205777|3575324|FG001|Study Extension I|Protocol Violation|0
2009474|NCT00205777|3575325|FG002|Study Extension I|Protocol Violation|0
2009475|NCT00205777|3575326|FG003|Study Extension I|Protocol Violation|8
2009476|NCT00205777|3575327|FG004|Study Extension I|Protocol Violation|8
2009477|NCT00205777|3575328|FG005|Study Extension I|Protocol Violation|0
2009478|NCT00205777|3575323|FG000|Study Extension I|Lack of Efficacy|0
2009479|NCT00205777|3575324|FG001|Study Extension I|Lack of Efficacy|0
2009480|NCT00205777|3575325|FG002|Study Extension I|Lack of Efficacy|0
2009481|NCT00205777|3575326|FG003|Study Extension I|Lack of Efficacy|1
2009482|NCT00205777|3575327|FG004|Study Extension I|Lack of Efficacy|2
2009483|NCT00205777|3575328|FG005|Study Extension I|Lack of Efficacy|0
2009484|NCT00205777|3575323|FG000|Study Extension I|Failed to return|15
2009485|NCT00205777|3575324|FG001|Study Extension I|Failed to return|0
2009486|NCT00205777|3575325|FG002|Study Extension I|Failed to return|0
2009487|NCT00205777|3575326|FG003|Study Extension I|Failed to return|17
2009488|NCT00205777|3575327|FG004|Study Extension I|Failed to return|13
2009489|NCT00205777|3575328|FG005|Study Extension I|Failed to return|0
2009490|NCT00205777|3575323|FG000|Study Extension I|Other Event|34
2009491|NCT00205777|3575324|FG001|Study Extension I|Other Event|0
2009492|NCT00205777|3575325|FG002|Study Extension I|Other Event|0
2009493|NCT00205777|3575326|FG003|Study Extension I|Other Event|34
2009494|NCT00205777|3575327|FG004|Study Extension I|Other Event|29
2009495|NCT00205777|3575328|FG005|Study Extension I|Other Event|0
2009496|NCT00205777|3575323|FG000|Study Extension I|Withdrawn as per protocol|0
2009497|NCT00205777|3575324|FG001|Study Extension I|Withdrawn as per protocol|0
2009498|NCT00205777|3575325|FG002|Study Extension I|Withdrawn as per protocol|1070
2009499|NCT00205777|3575326|FG003|Study Extension I|Withdrawn as per protocol|0
2009500|NCT00205777|3575327|FG004|Study Extension I|Withdrawn as per protocol|0
2009501|NCT00205777|3575328|FG005|Study Extension I|Withdrawn as per protocol|0
2009502|NCT00205777|3575323|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
2009503|NCT00205777|3575324|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
2009504|NCT00205777|3575325|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
2009505|NCT00205777|3575326|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
2009506|NCT00205777|3575327|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
2009507|NCT00205777|3575328|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
2009508|NCT00205777|3575323|FG000|Study Extension II|Adverse Event|0
2009509|NCT00205777|3575324|FG001|Study Extension II|Adverse Event|0
2009510|NCT00205777|3575325|FG002|Study Extension II|Adverse Event|0
2009511|NCT00205777|3575326|FG003|Study Extension II|Adverse Event|14
2009512|NCT00205777|3575327|FG004|Study Extension II|Adverse Event|0
2009513|NCT00205777|3575328|FG005|Study Extension II|Adverse Event|30
2009514|NCT00205777|3575323|FG000|Study Extension II|Death|0
2009515|NCT00205777|3575324|FG001|Study Extension II|Death|0
2009516|NCT00205777|3575325|FG002|Study Extension II|Death|0
2009517|NCT00205777|3575326|FG003|Study Extension II|Death|2
2009518|NCT00205777|3575327|FG004|Study Extension II|Death|0
2009519|NCT00205777|3575328|FG005|Study Extension II|Death|5
2009520|NCT00205777|3575323|FG000|Study Extension II|Withdrawal by Subject|0
2009521|NCT00205777|3575324|FG001|Study Extension II|Withdrawal by Subject|0
2009522|NCT00205777|3575325|FG002|Study Extension II|Withdrawal by Subject|0
2009523|NCT00205777|3575326|FG003|Study Extension II|Withdrawal by Subject|35
2009524|NCT00205777|3575327|FG004|Study Extension II|Withdrawal by Subject|0
2009525|NCT00205777|3575328|FG005|Study Extension II|Withdrawal by Subject|59
2009526|NCT00205777|3575323|FG000|Study Extension II|Protocol Violation|0
2009527|NCT00205777|3575324|FG001|Study Extension II|Protocol Violation|0
2009528|NCT00205777|3575325|FG002|Study Extension II|Protocol Violation|0
2009529|NCT00205777|3575326|FG003|Study Extension II|Protocol Violation|1
2009530|NCT00205777|3575327|FG004|Study Extension II|Protocol Violation|0
2009531|NCT00205777|3575328|FG005|Study Extension II|Protocol Violation|10
2009532|NCT00205777|3575323|FG000|Study Extension II|Lack of Efficacy|0
2009533|NCT00205777|3575324|FG001|Study Extension II|Lack of Efficacy|0
2009534|NCT00205777|3575325|FG002|Study Extension II|Lack of Efficacy|0
2009535|NCT00205777|3575326|FG003|Study Extension II|Lack of Efficacy|0
2009536|NCT00205777|3575327|FG004|Study Extension II|Lack of Efficacy|0
2009537|NCT00205777|3575328|FG005|Study Extension II|Lack of Efficacy|1
2009538|NCT00205777|3575323|FG000|Study Extension II|Failed to return|0
2009539|NCT00205777|3575324|FG001|Study Extension II|Failed to return|0
2009540|NCT00205777|3575325|FG002|Study Extension II|Failed to return|0
2009541|NCT00205777|3575326|FG003|Study Extension II|Failed to return|14
2009542|NCT00205777|3575327|FG004|Study Extension II|Failed to return|0
2009543|NCT00205777|3575328|FG005|Study Extension II|Failed to return|26
2009544|NCT00205777|3575323|FG000|Study Extension II|Other Event|0
2009545|NCT00205777|3575324|FG001|Study Extension II|Other Event|0
2009546|NCT00205777|3575325|FG002|Study Extension II|Other Event|0
2009547|NCT00205777|3575326|FG003|Study Extension II|Other Event|12
2009548|NCT00205777|3575327|FG004|Study Extension II|Other Event|0
2009549|NCT00205777|3575328|FG005|Study Extension II|Other Event|20
2009550|NCT00205777|3575323|FG000|Study Extension II|Enrolled but not treated|0
2009551|NCT00205777|3575324|FG001|Study Extension II|Enrolled but not treated|0
2009552|NCT00205777|3575325|FG002|Study Extension II|Enrolled but not treated|0
2009553|NCT00205777|3575326|FG003|Study Extension II|Enrolled but not treated|71
2009554|NCT00205777|3575327|FG004|Study Extension II|Enrolled but not treated|0
2009555|NCT00205777|3575328|FG005|Study Extension II|Enrolled but not treated|131
2009556|NCT00205803|3575345|FG000|Infant Series|Lost to Follow-up|10
2009557|NCT00205803|3575346|FG001|Infant Series|Lost to Follow-up|4
2009558|NCT00205803|3575345|FG000|Infant Series|Withdrawal by Subject|2
2009559|NCT00205803|3575346|FG001|Infant Series|Withdrawal by Subject|5
2009560|NCT00205803|3575345|FG000|Infant Series|Physician Decision|3
2009561|NCT00205803|3575346|FG001|Infant Series|Physician Decision|1
2009562|NCT00205803|3575345|FG000|Infant Series|Protocol Violation|1
2009563|NCT00205803|3575346|FG001|Infant Series|Protocol Violation|0
2009564|NCT00205803|3575345|FG000|Infant Series|Lost Kaiser coverage|0
2009565|NCT00205803|3575346|FG001|Infant Series|Lost Kaiser coverage|1
2009566|NCT00205803|3575345|FG000|Infant Series|Non-compliant|1
2009567|NCT00205803|3575346|FG001|Infant Series|Non-compliant|0
2009568|NCT00205803|3575345|FG000|Infant Series|Sponsor request|1
2009569|NCT00205803|3575346|FG001|Infant Series|Sponsor request|0
2009570|NCT00205803|3575345|FG000|After Infant Series|Adverse Event|1
2009571|NCT00205803|3575346|FG001|After Infant Series|Adverse Event|1
2009572|NCT00205803|3575345|FG000|After Infant Series|Protocol Violation|1
2009573|NCT00205803|3575346|FG001|After Infant Series|Protocol Violation|1
2009574|NCT00205803|3575345|FG000|After Infant Series|Lost to Follow-up|2
2009575|NCT00205803|3575346|FG001|After Infant Series|Lost to Follow-up|1
2009576|NCT00205803|3575345|FG000|After Infant Series|Physician Decision|3
2009577|NCT00205803|3575346|FG001|After Infant Series|Physician Decision|2
2009578|NCT00205803|3575345|FG000|After Infant Series|Withdrawal by Subject|1
2009579|NCT00205803|3575346|FG001|After Infant Series|Withdrawal by Subject|4
2009580|NCT00205803|3575345|FG000|After Infant Series|Other|10
2009581|NCT00205803|3575346|FG001|After Infant Series|Other|4
2009582|NCT00205803|3575345|FG000|Toddler Dose|Lost to Follow-up|2
2009583|NCT00205803|3575346|FG001|Toddler Dose|Lost to Follow-up|3
2009584|NCT00205855|3575370|FG000|Overall Study|Only received temporary implants|16
2009585|NCT00205855|3575370|FG000|Overall Study|Withdrawal by Subject|5
2009586|NCT00205881|3575374|FG000|Overall Study|Withdrawal by Subject|16
2009587|NCT00206076|3575381|FG000|Overall Study|Physician Decision|2
2009588|NCT00206076|3575382|FG001|Overall Study|Physician Decision|0
2009589|NCT00206076|3575381|FG000|Overall Study|Withdrawal by Subject|1
2009590|NCT00206076|3575382|FG001|Overall Study|Withdrawal by Subject|1
2009591|NCT00206102|3575392|FG000|Overall Study|Adverse Event|119
2009592|NCT00206102|3575393|FG001|Overall Study|Adverse Event|82
2009593|NCT00206102|3575392|FG000|Overall Study|Protocol Violation|0
2009594|NCT00206102|3575393|FG001|Overall Study|Protocol Violation|2
2009595|NCT00206102|3575392|FG000|Overall Study|Lack of therapeutic response|16
2009596|NCT00206102|3575393|FG001|Overall Study|Lack of therapeutic response|11
2009597|NCT00206102|3575392|FG000|Overall Study|Lost to Follow-up|95
2009598|NCT00206102|3575393|FG001|Overall Study|Lost to Follow-up|66
2009599|NCT00206102|3575392|FG000|Overall Study|Withdrawal by Subject|118
2009600|NCT00206102|3575393|FG001|Overall Study|Withdrawal by Subject|101
2009601|NCT00206102|3575392|FG000|Overall Study|Study-specific discontinuation criteria|18
2009602|NCT00206102|3575393|FG001|Overall Study|Study-specific discontinuation criteria|17
2009603|NCT00206102|3575392|FG000|Overall Study|None of those categories|42
2009604|NCT00206102|3575393|FG001|Overall Study|None of those categories|36
2009605|NCT00206323|3575401|FG000|Overall Study|Lack of Efficacy|4
2009606|NCT00206323|3575402|FG001|Overall Study|Lack of Efficacy|1
2009607|NCT00206323|3575401|FG000|Overall Study|Adverse Event|1
2009608|NCT00206323|3575402|FG001|Overall Study|Adverse Event|1
2009609|NCT00206323|3575401|FG000|Overall Study|Lost to Follow-up|1
2009610|NCT00206323|3575402|FG001|Overall Study|Lost to Follow-up|1
2009611|NCT00206427|3575412|FG000|Overall Study|Adverse Event|2
2009612|NCT00206440|3575418|FG000|Overall Study|Protocol Violation|1
2009613|NCT00206440|3575419|FG001|Overall Study|Protocol Violation|2
2009614|NCT00206440|3575418|FG000|Overall Study|Adverse Event|4
2009615|NCT00206440|3575419|FG001|Overall Study|Adverse Event|2
2009616|NCT00206518|3575427|FG000|Overall Study|Lack of Efficacy|6
2009617|NCT00206518|3575428|FG001|Overall Study|Lack of Efficacy|4
2009618|NCT00206518|3575427|FG000|Overall Study|Adverse Event|2
2009619|NCT00206518|3575428|FG001|Overall Study|Adverse Event|1
2009620|NCT00206518|3575427|FG000|Overall Study|Physician Decision|1
2009621|NCT00206518|3575428|FG001|Overall Study|Physician Decision|0
2009622|NCT00206518|3575427|FG000|Overall Study|Protocol Violation|1
2009623|NCT00206518|3575428|FG001|Overall Study|Protocol Violation|1
2009624|NCT00206726|3575434|FG000|Overall Study|Delayed recovery of blood counts|1
2009625|NCT00206726|3575434|FG000|Overall Study|Progressive disease or relapsed disease|18
2009626|NCT00206726|3575434|FG000|Overall Study|Placed on new protocol|1
2009627|NCT00206726|3575434|FG000|Overall Study|Bone marrow transplant|1
2009628|NCT00206726|3575434|FG000|Overall Study|Adverse Event|17
2009629|NCT00206726|3575434|FG000|Overall Study|Death|4
2009630|NCT00206726|3575434|FG000|Overall Study|Protocol Violation|1
2009631|NCT00206726|3575434|FG000|Overall Study|Withdrawal by Subject|8
2025375|NCT00344500|3594138|FG002|Overall Study|Withdrawal by Subject|0
2025376|NCT00344500|3594136|FG000|Overall Study|Protocol Violation|4
2025377|NCT00344500|3594137|FG001|Overall Study|Protocol Violation|7
2025378|NCT00344500|3594138|FG002|Overall Study|Protocol Violation|1
2025379|NCT00344500|3594136|FG000|Overall Study|Not Noted|1
2025380|NCT00344500|3594137|FG001|Overall Study|Not Noted|3
2025381|NCT00344500|3594138|FG002|Overall Study|Not Noted|0
2025382|NCT00344773|3594154|FG000|Overall Study|Adverse Event|2
2025383|NCT00344773|3594154|FG000|Overall Study|Objective Disease Progression|16
2025384|NCT00344773|3594154|FG000|Overall Study|Withdrawal by Subject|1
2025385|NCT00344773|3594154|FG000|Overall Study|Not Eligible for the study|2
2025386|NCT00344968|3594161|FG000|Overall Study|Adverse Event|5
2025387|NCT00344968|3594162|FG001|Overall Study|Adverse Event|4
2025388|NCT00344968|3594163|FG002|Overall Study|Adverse Event|15
2025389|NCT00344968|3594161|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
2025390|NCT00344968|3594162|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
2025391|NCT00344968|3594163|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
2025392|NCT00344968|3594161|FG000|Overall Study|Protocol Violation|2
2025393|NCT00344968|3594162|FG001|Overall Study|Protocol Violation|2
2025394|NCT00344968|3594163|FG002|Overall Study|Protocol Violation|5
2025395|NCT00344968|3594161|FG000|Overall Study|Withdrawal by Subject|14
2025396|NCT00344968|3594162|FG001|Overall Study|Withdrawal by Subject|31
2025397|NCT00344968|3594163|FG002|Overall Study|Withdrawal by Subject|27
2025398|NCT00344968|3594161|FG000|Overall Study|Lost to Follow-up|24
2025399|NCT00344968|3594162|FG001|Overall Study|Lost to Follow-up|37
2025400|NCT00344968|3594163|FG002|Overall Study|Lost to Follow-up|37
2025401|NCT00344968|3594161|FG000|Overall Study|Death|11
2025402|NCT00344968|3594162|FG001|Overall Study|Death|27
2025403|NCT00344968|3594163|FG002|Overall Study|Death|31
2025404|NCT00344968|3594161|FG000|Overall Study|Other|0
2025405|NCT00344968|3594162|FG001|Overall Study|Other|1
2025406|NCT00344968|3594163|FG002|Overall Study|Other|0
2025407|NCT00345046|3594184|FG000|Overall Study|Protocol Violation|1
2025408|NCT00345046|3594185|FG001|Overall Study|Protocol Violation|1
2025409|NCT00345046|3594186|FG002|Overall Study|Protocol Violation|2
2025410|NCT00345293|3594222|FG000|Overall Study|Unable to access line for sample|1
2025411|NCT00345293|3594223|FG001|Overall Study|Unable to access line for sample|0
2025412|NCT00345293|3594222|FG000|Overall Study|Withdrawal by Subject|1
2025413|NCT00345293|3594223|FG001|Overall Study|Withdrawal by Subject|0
2025414|NCT00345397|3594258|FG000|Overall Study|Death|1
2025415|NCT00345540|3594263|FG000|Overall Study|Withdrawal by Subject|1
2025416|NCT00345579|3594269|FG000|Overall Study|Adverse Event|9
2025417|NCT00345579|3594270|FG001|Overall Study|Adverse Event|6
2025418|NCT00345579|3594269|FG000|Overall Study|Protocol Violation|14
2025419|NCT00345579|3594270|FG001|Overall Study|Protocol Violation|5
2025420|NCT00345579|3594269|FG000|Overall Study|Withdrawal by Subject|50
2025421|NCT00345579|3594270|FG001|Overall Study|Withdrawal by Subject|17
2025422|NCT00345579|3594269|FG000|Overall Study|Lost to Follow-up|82
2025423|NCT00345579|3594270|FG001|Overall Study|Lost to Follow-up|36
2025424|NCT00345579|3594269|FG000|Overall Study|Other|9
2025425|NCT00345579|3594270|FG001|Overall Study|Other|1
2025426|NCT00345592|3594279|FG000|Overall Study|Death|14
2025427|NCT00345592|3594280|FG001|Overall Study|Death|16
2025428|NCT00345592|3594279|FG000|Overall Study|Withdrawal by Subject|11
2025429|NCT00345592|3594280|FG001|Overall Study|Withdrawal by Subject|8
2025430|NCT00345605|3594286|FG000|Arm 1|Adverse Event|0
2025431|NCT00345605|3594287|FG001|Arm 1|Adverse Event|1
2025432|NCT00345605|3594286|FG000|Arm 2, Opposite Treatment|Adverse Event|1
2025433|NCT00345605|3594287|FG001|Arm 2, Opposite Treatment|Adverse Event|0
2025434|NCT00345631|3594298|FG000|Overall Study|Withdrawal by Subject|1
2025435|NCT00345631|3594299|FG001|Overall Study|Withdrawal by Subject|0
2025436|NCT00345631|3594300|FG002|Overall Study|Withdrawal by Subject|1
2025437|NCT00345631|3594298|FG000|Overall Study|Adverse Event|0
2025438|NCT00345631|3594299|FG001|Overall Study|Adverse Event|1
2025439|NCT00345631|3594300|FG002|Overall Study|Adverse Event|0
2025440|NCT00345631|3594298|FG000|Overall Study|Lost to Follow-up|3
2025441|NCT00345631|3594299|FG001|Overall Study|Lost to Follow-up|7
2025442|NCT00345631|3594300|FG002|Overall Study|Lost to Follow-up|4
2025443|NCT00345631|3594298|FG000|Overall Study|Other reasons|0
2025444|NCT00345631|3594299|FG001|Overall Study|Other reasons|0
2025445|NCT00345631|3594300|FG002|Overall Study|Other reasons|1
2025446|NCT00345683|3594312|FG000|Overall Study|Lost to Follow-up|19
2025447|NCT00345683|3594313|FG001|Overall Study|Lost to Follow-up|7
2025448|NCT00345683|3594312|FG000|Overall Study|Other|6
2025449|NCT00345683|3594313|FG001|Overall Study|Other|2
2025450|NCT00345839|3594321|FG000|Overall Study|Withdrawal by Subject|91
2009632|NCT00207090|3575438|FG000|Overall Study|Study drug toxicity|3
2009633|NCT00207090|3575438|FG000|Overall Study|Chest wall mass larger|1
2009634|NCT00207090|3575438|FG000|Overall Study|Disease progression/relapse|2
2009635|NCT00207090|3575438|FG000|Overall Study|Physician Decision|1
2009636|NCT00207142|3575450|FG000|Induction Phase|Adverse Event|9
2009637|NCT00207142|3575451|FG001|Induction Phase|Adverse Event|0
2009638|NCT00207142|3575452|FG002|Induction Phase|Adverse Event|0
2009639|NCT00207142|3575453|FG003|Induction Phase|Adverse Event|0
2009640|NCT00207142|3575450|FG000|Induction Phase|Death|1
2009641|NCT00207142|3575451|FG001|Induction Phase|Death|0
2009642|NCT00207142|3575452|FG002|Induction Phase|Death|0
2009643|NCT00207142|3575453|FG003|Induction Phase|Death|0
2009644|NCT00207142|3575450|FG000|Induction Phase|Lack of Efficacy|1
2009645|NCT00207142|3575451|FG001|Induction Phase|Lack of Efficacy|0
2009646|NCT00207142|3575452|FG002|Induction Phase|Lack of Efficacy|0
2009647|NCT00207142|3575453|FG003|Induction Phase|Lack of Efficacy|0
2009648|NCT00207142|3575450|FG000|Induction Phase|Lost to Follow-up|5
2009649|NCT00207142|3575451|FG001|Induction Phase|Lost to Follow-up|0
2009650|NCT00207142|3575452|FG002|Induction Phase|Lost to Follow-up|0
2009651|NCT00207142|3575453|FG003|Induction Phase|Lost to Follow-up|0
2009652|NCT00207142|3575450|FG000|Induction Phase|Physician Decision|2
2009653|NCT00207142|3575451|FG001|Induction Phase|Physician Decision|0
2009654|NCT00207142|3575452|FG002|Induction Phase|Physician Decision|0
2009655|NCT00207142|3575453|FG003|Induction Phase|Physician Decision|0
2009656|NCT00207142|3575450|FG000|Induction Phase|Poor/noncompliance|2
2009657|NCT00207142|3575451|FG001|Induction Phase|Poor/noncompliance|0
2009658|NCT00207142|3575452|FG002|Induction Phase|Poor/noncompliance|0
2009659|NCT00207142|3575453|FG003|Induction Phase|Poor/noncompliance|0
2009660|NCT00207142|3575450|FG000|Induction Phase|Pregnancy|1
2009661|NCT00207142|3575451|FG001|Induction Phase|Pregnancy|0
2009662|NCT00207142|3575452|FG002|Induction Phase|Pregnancy|0
2009663|NCT00207142|3575453|FG003|Induction Phase|Pregnancy|0
2009664|NCT00207142|3575450|FG000|Induction Phase|Subject no longer meets study criteria|3
2009665|NCT00207142|3575451|FG001|Induction Phase|Subject no longer meets study criteria|0
2009666|NCT00207142|3575452|FG002|Induction Phase|Subject no longer meets study criteria|0
2009667|NCT00207142|3575453|FG003|Induction Phase|Subject no longer meets study criteria|0
2009668|NCT00207142|3575450|FG000|Induction Phase|Withdrawal by Subject|4
2009669|NCT00207142|3575451|FG001|Induction Phase|Withdrawal by Subject|0
2009670|NCT00207142|3575452|FG002|Induction Phase|Withdrawal by Subject|0
2009671|NCT00207142|3575453|FG003|Induction Phase|Withdrawal by Subject|0
2009672|NCT00207142|3575450|FG000|Induction Phase|Incarceration|1
2009673|NCT00207142|3575451|FG001|Induction Phase|Incarceration|0
2009674|NCT00207142|3575452|FG002|Induction Phase|Incarceration|0
2009675|NCT00207142|3575453|FG003|Induction Phase|Incarceration|0
2009676|NCT00207142|3575450|FG000|Induction Phase|Missing lab data|1
2009677|NCT00207142|3575451|FG001|Induction Phase|Missing lab data|0
2009678|NCT00207142|3575452|FG002|Induction Phase|Missing lab data|0
2009679|NCT00207142|3575453|FG003|Induction Phase|Missing lab data|0
2009680|NCT00207142|3575450|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0
2009681|NCT00207142|3575451|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1
2009682|NCT00207142|3575452|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4
2009683|NCT00207142|3575453|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1
2009684|NCT00207142|3575450|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
2009685|NCT00207142|3575451|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
2009686|NCT00207142|3575452|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
2009687|NCT00207142|3575453|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
2009688|NCT00207142|3575450|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0
2009689|NCT00207142|3575451|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0
2009690|NCT00207142|3575452|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1
2009691|NCT00207142|3575453|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0
2009692|NCT00207142|3575450|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
2009693|NCT00207142|3575451|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
2009694|NCT00207142|3575452|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
2009695|NCT00207142|3575453|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
2009696|NCT00207142|3575450|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0
2009697|NCT00207142|3575451|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2
2009698|NCT00207142|3575452|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2
2009699|NCT00207142|3575453|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0
2009700|NCT00207142|3575450|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
2009701|NCT00207142|3575451|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
2009702|NCT00207142|3575452|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
2009703|NCT00207142|3575453|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
2009704|NCT00207142|3575450|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
2009705|NCT00207142|3575451|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
2009706|NCT00207142|3575452|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
2009707|NCT00207142|3575453|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
2009708|NCT00207142|3575450|FG000|Maintenance Phase/Rescue Phase|Death|0
2009709|NCT00207142|3575451|FG001|Maintenance Phase/Rescue Phase|Death|0
2009710|NCT00207142|3575452|FG002|Maintenance Phase/Rescue Phase|Death|0
2009711|NCT00207142|3575453|FG003|Maintenance Phase/Rescue Phase|Death|1
2009712|NCT00207142|3575450|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
2009713|NCT00207142|3575451|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
2009714|NCT00207142|3575452|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
2009715|NCT00207142|3575453|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
2009716|NCT00207714|3575473|FG000|Overall Study|Adverse Event|6
2009717|NCT00207714|3575474|FG001|Overall Study|Adverse Event|2
2009718|NCT00207714|3575475|FG002|Overall Study|Adverse Event|4
2009719|NCT00207714|3575476|FG003|Overall Study|Adverse Event|3
2009720|NCT00207714|3575477|FG004|Overall Study|Adverse Event|1
2009721|NCT00207714|3575473|FG000|Overall Study|Unsatisfactory therapeutic effect|5
2009722|NCT00207714|3575474|FG001|Overall Study|Unsatisfactory therapeutic effect|3
2009723|NCT00207714|3575475|FG002|Overall Study|Unsatisfactory therapeutic effect|1
2009724|NCT00207714|3575476|FG003|Overall Study|Unsatisfactory therapeutic effect|4
2009725|NCT00207714|3575477|FG004|Overall Study|Unsatisfactory therapeutic effect|4
2009726|NCT00207714|3575473|FG000|Overall Study|Other|3
2009727|NCT00207714|3575474|FG001|Overall Study|Other|2
2009728|NCT00207714|3575475|FG002|Overall Study|Other|5
2009729|NCT00207714|3575476|FG003|Overall Study|Other|1
2009730|NCT00207714|3575477|FG004|Overall Study|Other|0
2214391|NCT01687166|3856622|FG000|Overall Study|Patient unable to be compliant|1
2214392|NCT01687166|3856623|FG001|Overall Study|Patient unable to be compliant|0
2214393|NCT01687166|3856624|FG002|Overall Study|Patient unable to be compliant|0
2214394|NCT01687166|3856625|FG003|Overall Study|Patient unable to be compliant|0
2009731|NCT00207727|3575501|FG000|Overall Study|Withdrawal by Subject|0
2009732|NCT00207727|3575502|FG001|Overall Study|Withdrawal by Subject|0
2009733|NCT00207727|3575503|FG002|Overall Study|Withdrawal by Subject|0
2009734|NCT00207727|3575504|FG003|Overall Study|Withdrawal by Subject|0
2009735|NCT00207727|3575505|FG004|Overall Study|Withdrawal by Subject|1
2009736|NCT00207727|3575501|FG000|Overall Study|Lost to Follow-up|0
2009737|NCT00207727|3575502|FG001|Overall Study|Lost to Follow-up|1
2009738|NCT00207727|3575503|FG002|Overall Study|Lost to Follow-up|0
2009739|NCT00207727|3575504|FG003|Overall Study|Lost to Follow-up|0
2214395|NCT01687166|3856622|FG000|Overall Study|Physician choice to use different device|1
2214396|NCT01687166|3856623|FG001|Overall Study|Physician choice to use different device|2
2214397|NCT01687166|3856624|FG002|Overall Study|Physician choice to use different device|4
2214398|NCT01687166|3856625|FG003|Overall Study|Physician choice to use different device|0
2214399|NCT01687166|3856622|FG000|Overall Study|Insurance|0
2214400|NCT01687166|3856623|FG001|Overall Study|Insurance|0
2214401|NCT01687166|3856624|FG002|Overall Study|Insurance|1
2214402|NCT01687166|3856625|FG003|Overall Study|Insurance|1
2214403|NCT01687218|3856646|FG000|Overall Study|Withdrawal by Subject|2
2214404|NCT01687218|3856647|FG001|Overall Study|Withdrawal by Subject|3
2214405|NCT01687218|3856648|FG002|Overall Study|Withdrawal by Subject|0
2214406|NCT01687218|3856649|FG003|Overall Study|Withdrawal by Subject|1
2214407|NCT01687218|3856650|FG004|Overall Study|Withdrawal by Subject|1
2214408|NCT01687218|3856651|FG005|Overall Study|Withdrawal by Subject|0
2214409|NCT01687218|3856646|FG000|Overall Study|Relocated, no follow-up planned|1
2214410|NCT01687218|3856647|FG001|Overall Study|Relocated, no follow-up planned|0
2214411|NCT01687218|3856648|FG002|Overall Study|Relocated, no follow-up planned|1
2214412|NCT01687218|3856649|FG003|Overall Study|Relocated, no follow-up planned|1
2214413|NCT01687218|3856650|FG004|Overall Study|Relocated, no follow-up planned|0
2214414|NCT01687218|3856651|FG005|Overall Study|Relocated, no follow-up planned|0
2214415|NCT01687257|3856678|FG000|Overall Study|Efficacy Failure|6
2214416|NCT01687257|3856679|FG001|Overall Study|Efficacy Failure|0
2214417|NCT01687257|3856680|FG002|Overall Study|Efficacy Failure|5
2214418|NCT01687257|3856678|FG000|Overall Study|Subject Withdrew Consent|1
2214419|NCT01687257|3856679|FG001|Overall Study|Subject Withdrew Consent|1
2214420|NCT01687257|3856680|FG002|Overall Study|Subject Withdrew Consent|1
2214421|NCT01687257|3856678|FG000|Overall Study|Adverse Event|1
2214422|NCT01687257|3856679|FG001|Overall Study|Adverse Event|0
2214423|NCT01687257|3856680|FG002|Overall Study|Adverse Event|0
2214424|NCT01687257|3856678|FG000|Overall Study|Investigator's Discretion|0
2214425|NCT01687257|3856679|FG001|Overall Study|Investigator's Discretion|3
2009740|NCT00207727|3575505|FG004|Overall Study|Lost to Follow-up|0
2009741|NCT00207727|3575501|FG000|Overall Study|Other|38
2009742|NCT00207727|3575502|FG001|Overall Study|Other|41
2009743|NCT00207727|3575503|FG002|Overall Study|Other|41
2009744|NCT00207727|3575504|FG003|Overall Study|Other|37
2009745|NCT00207727|3575505|FG004|Overall Study|Other|33
2009746|NCT00207740|3575521|FG000|Overall Study|Adverse Event|4
2009747|NCT00207740|3575522|FG001|Overall Study|Adverse Event|14
2009748|NCT00207740|3575523|FG002|Overall Study|Adverse Event|14
2009749|NCT00207740|3575524|FG003|Overall Study|Adverse Event|11
2009750|NCT00207740|3575521|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2009751|NCT00207740|3575522|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2009752|NCT00207740|3575523|FG002|Overall Study|Unsatisfactory therapeutic effect|2
2009753|NCT00207740|3575524|FG003|Overall Study|Unsatisfactory therapeutic effect|4
2214426|NCT01687257|3856680|FG002|Overall Study|Investigator's Discretion|0
2214427|NCT01687270|3856694|FG000|Overall Study|Lack of Efficacy|11
2214428|NCT01687270|3856694|FG000|Overall Study|Lost to Follow-up|1
2214429|NCT01687283|3856700|FG000|Overall Study|Adverse Event|11
2214430|NCT01687283|3856701|FG001|Overall Study|Adverse Event|4
2214431|NCT01687283|3856700|FG000|Overall Study|Lack of Efficacy|3
2009754|NCT00207740|3575521|FG000|Overall Study|Lost to Follow-up|0
2009755|NCT00207740|3575522|FG001|Overall Study|Lost to Follow-up|2
2009756|NCT00207740|3575523|FG002|Overall Study|Lost to Follow-up|1
2009757|NCT00207740|3575524|FG003|Overall Study|Lost to Follow-up|1
2009758|NCT00207740|3575521|FG000|Overall Study|Death|0
2009759|NCT00207740|3575522|FG001|Overall Study|Death|0
2009760|NCT00207740|3575523|FG002|Overall Study|Death|0
2009761|NCT00207740|3575524|FG003|Overall Study|Death|1
2009762|NCT00207740|3575521|FG000|Overall Study|Sponsor Directive|22
2009763|NCT00207740|3575522|FG001|Overall Study|Sponsor Directive|15
2009764|NCT00207740|3575523|FG002|Overall Study|Sponsor Directive|16
2009765|NCT00207740|3575524|FG003|Overall Study|Sponsor Directive|21
2009766|NCT00207740|3575521|FG000|Overall Study|Other|2
2009767|NCT00207740|3575522|FG001|Overall Study|Other|10
2009768|NCT00207740|3575523|FG002|Overall Study|Other|7
2009769|NCT00207740|3575524|FG003|Overall Study|Other|5
2009770|NCT00208325|3575565|FG000|Overall Study|Death|18
2009771|NCT00208325|3575566|FG001|Overall Study|Death|19
2009772|NCT00208325|3575567|FG002|Overall Study|Death|7
2009773|NCT00208325|3575568|FG003|Overall Study|Death|5
2009774|NCT00208325|3575565|FG000|Overall Study|Withdrawal by Subject|0
2009775|NCT00208325|3575566|FG001|Overall Study|Withdrawal by Subject|1
2009776|NCT00208325|3575567|FG002|Overall Study|Withdrawal by Subject|0
2009777|NCT00208325|3575568|FG003|Overall Study|Withdrawal by Subject|0
2009778|NCT00208325|3575565|FG000|Overall Study|Revision|4
2009779|NCT00208325|3575566|FG001|Overall Study|Revision|1
2009780|NCT00208325|3575567|FG002|Overall Study|Revision|0
2009781|NCT00208325|3575568|FG003|Overall Study|Revision|4
2009782|NCT00208325|3575565|FG000|Overall Study|Lost to Follow-up|1
2009783|NCT00208325|3575566|FG001|Overall Study|Lost to Follow-up|0
2009784|NCT00208325|3575567|FG002|Overall Study|Lost to Follow-up|2
2009785|NCT00208325|3575568|FG003|Overall Study|Lost to Follow-up|0
2009786|NCT00208325|3575565|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4
2009787|NCT00208325|3575566|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4
2009788|NCT00208325|3575567|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1
2009789|NCT00208325|3575568|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3
2009790|NCT00208325|3575565|FG000|Overall Study|Does not wish to Continue in Study|5
2009791|NCT00208325|3575566|FG001|Overall Study|Does not wish to Continue in Study|8
2009792|NCT00208325|3575567|FG002|Overall Study|Does not wish to Continue in Study|3
2009793|NCT00208325|3575568|FG003|Overall Study|Does not wish to Continue in Study|2
2009794|NCT00208325|3575565|FG000|Overall Study|Other|2
2009795|NCT00208325|3575566|FG001|Overall Study|Other|1
2009796|NCT00208325|3575567|FG002|Overall Study|Other|1
2009797|NCT00208325|3575568|FG003|Overall Study|Other|0
2009798|NCT00208325|3575565|FG000|Overall Study|Mis-Randomized|17
2009799|NCT00208325|3575566|FG001|Overall Study|Mis-Randomized|20
2009800|NCT00208325|3575567|FG002|Overall Study|Mis-Randomized|0
2009801|NCT00208325|3575568|FG003|Overall Study|Mis-Randomized|0
2009802|NCT00208767|3575598|FG000|Overall Study|Adverse Event|9
2009803|NCT00208767|3575599|FG001|Overall Study|Adverse Event|1
2009804|NCT00208767|3575598|FG000|Overall Study|Withdrawal by Subject|14
2009805|NCT00208767|3575599|FG001|Overall Study|Withdrawal by Subject|3
2009806|NCT00208767|3575598|FG000|Overall Study|Death|1
2009807|NCT00208767|3575599|FG001|Overall Study|Death|0
2009808|NCT00208767|3575598|FG000|Overall Study|Lost to Follow-up|3
2009809|NCT00208767|3575599|FG001|Overall Study|Lost to Follow-up|3
2009810|NCT00209092|3575621|FG000|Overall Study|Progression of disease|7
2009811|NCT00209092|3575622|FG001|Overall Study|Progression of disease|1
2009812|NCT00209092|3575621|FG000|Overall Study|Adverse Event|0
2009813|NCT00209092|3575622|FG001|Overall Study|Adverse Event|1
2009814|NCT00209092|3575621|FG000|Overall Study|Withdrawal by Subject|1
2009815|NCT00209092|3575622|FG001|Overall Study|Withdrawal by Subject|0
2009816|NCT00209170|3575630|FG000|Overall Study|Adverse Event|0
2009817|NCT00209170|3575631|FG001|Overall Study|Adverse Event|1
2009818|NCT00209170|3575630|FG000|Overall Study|Withdrawal by Subject|2
2009819|NCT00209170|3575631|FG001|Overall Study|Withdrawal by Subject|1
2009820|NCT00209170|3575630|FG000|Overall Study|Lack of Efficacy|0
2009821|NCT00209170|3575631|FG001|Overall Study|Lack of Efficacy|1
2009822|NCT00209274|3575639|FG000|Overall Study|Missed visit|3
2009823|NCT00209274|3575640|FG001|Overall Study|Missed visit|2
2009824|NCT00209274|3575639|FG000|Overall Study|Death|32
2009825|NCT00209274|3575640|FG001|Overall Study|Death|15
2009826|NCT00209274|3575639|FG000|Overall Study|Withdrawal by Subject|30
2009827|NCT00209274|3575640|FG001|Overall Study|Withdrawal by Subject|15
2009828|NCT00209274|3575639|FG000|Overall Study|Randomized not treated (RNT)|6
2009829|NCT00209274|3575640|FG001|Overall Study|Randomized not treated (RNT)|15
2009830|NCT00209339|3575646|FG000|At 12 Months Follow-up|Withdrawal by Subject|8
2009831|NCT00209339|3575646|FG000|At 12 Months Follow-up|Death|1
2009832|NCT00209339|3575646|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6
2009833|NCT00209339|3575646|FG000|At 24 Months Follow-up|Withdrawal by Subject|4
2009834|NCT00209339|3575646|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6
2009835|NCT00209339|3575646|FG000|At 24 Months Follow-up|Death|1
2009836|NCT00209339|3575646|FG000|At 3 Years Follow-up|Withdrawal by Subject|1
2009837|NCT00209339|3575646|FG000|At 4 Years Follow-up|Withdrawal by Subject|4
2009838|NCT00209339|3575646|FG000|At 4 Years Follow-up|Death|1
2009839|NCT00209339|3575646|FG000|At 5 Years Follow-up|Withdrawal by Subject|2
2009840|NCT00209339|3575646|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5
2009841|NCT00209339|3575646|FG000|At 5 Years Follow-up|Death|1
2009842|NCT00209560|3575661|FG000|Overall Study|Lack of Efficacy|1
2009843|NCT00209560|3575662|FG001|Overall Study|Lack of Efficacy|0
2009844|NCT00210106|3575668|FG000|Overall Study|Death|1
2009845|NCT00210106|3575668|FG000|Overall Study|Protocol Violation|13
2009846|NCT00210119|3575673|FG000|Overall Study|Protocol Violation|1
2009847|NCT00210119|3575673|FG000|Overall Study|Withdrawal by Subject|1
2009848|NCT00210184|3575677|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2
2009849|NCT00210626|3575708|FG000|Overall Study|Adverse Event|1
2009850|NCT00210626|3575709|FG001|Overall Study|Adverse Event|2
2009851|NCT00210626|3575708|FG000|Overall Study|Protocol Violation|1
2009852|NCT00210626|3575709|FG001|Overall Study|Protocol Violation|5
2009853|NCT00210626|3575708|FG000|Overall Study|Lost to Follow-up|11
2009854|NCT00210626|3575709|FG001|Overall Study|Lost to Follow-up|11
2009855|NCT00210626|3575708|FG000|Overall Study|Death|1
2009856|NCT00210626|3575709|FG001|Overall Study|Death|0
2009857|NCT00210626|3575708|FG000|Overall Study|Withdrawal by Subject|29
2009858|NCT00210626|3575709|FG001|Overall Study|Withdrawal by Subject|20
2009859|NCT00210626|3575708|FG000|Overall Study|Physician Decision|0
2009860|NCT00210626|3575709|FG001|Overall Study|Physician Decision|2
2009861|NCT00210626|3575708|FG000|Overall Study|Sponser Request|1
2009862|NCT00210626|3575709|FG001|Overall Study|Sponser Request|0
2009863|NCT00210626|3575708|FG000|Overall Study|Other|4
2009864|NCT00210626|3575709|FG001|Overall Study|Other|5
2009865|NCT00210639|3575717|FG000|Overall Study|Lost to Follow-up|37
2009866|NCT00210639|3575718|FG001|Overall Study|Lost to Follow-up|29
2009867|NCT00210639|3575717|FG000|Overall Study|Withdrawal by Subject|8
2009868|NCT00210639|3575718|FG001|Overall Study|Withdrawal by Subject|1
2009869|NCT00210639|3575717|FG000|Overall Study|Other|18
2009870|NCT00210639|3575718|FG001|Overall Study|Other|12
2009871|NCT00211081|3575724|FG000|Overall Study|Withdrawal by Subject|2
2009872|NCT00211172|3575730|FG000|Overall Study|Died or lost health plan eligibility|39
2009873|NCT00211172|3575731|FG001|Overall Study|Died or lost health plan eligibility|32
2009874|NCT00211185|3575737|FG000|Overall Study|Death|2
2009875|NCT00211185|3575737|FG000|Overall Study|Disease progression|7
2009876|NCT00211185|3575737|FG000|Overall Study|Withdrawal by Subject|6
2009877|NCT00211185|3575737|FG000|Overall Study|Physician Decision|5
2009878|NCT00211237|3575743|FG000|Baseline|Withdrew|1
2009879|NCT00211237|3575744|FG001|Baseline|Withdrew|3
2009880|NCT00211237|3575745|FG002|Baseline|Withdrew|0
2009881|NCT00211237|3575743|FG000|Baseline|Refused random assignment|1
2009882|NCT00211237|3575744|FG001|Baseline|Refused random assignment|0
2009883|NCT00211237|3575745|FG002|Baseline|Refused random assignment|0
2009884|NCT00211237|3575743|FG000|1 Month|Death|2
2009885|NCT00211237|3575744|FG001|1 Month|Death|1
2009886|NCT00211237|3575745|FG002|1 Month|Death|0
2009887|NCT00211237|3575743|FG000|1 Month|Lost to Follow-up|0
2009888|NCT00211237|3575744|FG001|1 Month|Lost to Follow-up|2
2009889|NCT00211237|3575745|FG002|1 Month|Lost to Follow-up|0
2009890|NCT00211237|3575743|FG000|1 Month|Withdrew|0
2009891|NCT00211237|3575744|FG001|1 Month|Withdrew|4
2009892|NCT00211237|3575745|FG002|1 Month|Withdrew|0
2009893|NCT00211237|3575743|FG000|1 Month|Additional surgery needed|1
2009894|NCT00211237|3575744|FG001|1 Month|Additional surgery needed|0
2009895|NCT00211237|3575745|FG002|1 Month|Additional surgery needed|0
2009896|NCT00211237|3575743|FG000|1 Month|Non-medical problem|0
2009897|NCT00211237|3575744|FG001|1 Month|Non-medical problem|2
2009898|NCT00211237|3575745|FG002|1 Month|Non-medical problem|0
2009899|NCT00211237|3575743|FG000|3 Months|Death|7
2009900|NCT00211237|3575744|FG001|3 Months|Death|3
2009901|NCT00211237|3575745|FG002|3 Months|Death|0
2009902|NCT00211237|3575743|FG000|3 Months|Could not comply with protocol|1
2009903|NCT00211237|3575744|FG001|3 Months|Could not comply with protocol|0
2009904|NCT00211237|3575745|FG002|3 Months|Could not comply with protocol|0
2009905|NCT00211237|3575743|FG000|3 Months|Withdrew|0
2009906|NCT00211237|3575744|FG001|3 Months|Withdrew|1
2009907|NCT00211237|3575745|FG002|3 Months|Withdrew|0
2009908|NCT00211237|3575743|FG000|3 Months|Non-medical problem|0
2009909|NCT00211237|3575744|FG001|3 Months|Non-medical problem|0
2009910|NCT00211237|3575745|FG002|3 Months|Non-medical problem|1
2009911|NCT00211237|3575743|FG000|6 Months|Death|6
2009912|NCT00211237|3575744|FG001|6 Months|Death|0
2009913|NCT00211237|3575745|FG002|6 Months|Death|3
2009914|NCT00211237|3575743|FG000|6 Months|Lost to Follow-up|2
2009915|NCT00211237|3575744|FG001|6 Months|Lost to Follow-up|0
2009916|NCT00211237|3575745|FG002|6 Months|Lost to Follow-up|0
2009917|NCT00211237|3575743|FG000|6 Months|Could not comply with protocol|0
2009918|NCT00211237|3575744|FG001|6 Months|Could not comply with protocol|2
2009919|NCT00211237|3575745|FG002|6 Months|Could not comply with protocol|0
2009920|NCT00211237|3575743|FG000|12 Months|Death|8
2009921|NCT00211237|3575744|FG001|12 Months|Death|2
2009922|NCT00211237|3575745|FG002|12 Months|Death|3
2009923|NCT00211237|3575743|FG000|12 Months|Lost to Follow-up|1
2009924|NCT00211237|3575744|FG001|12 Months|Lost to Follow-up|0
2009925|NCT00211237|3575745|FG002|12 Months|Lost to Follow-up|1
2009926|NCT00211237|3575743|FG000|12 Months|Withdrew|0
2009927|NCT00211237|3575744|FG001|12 Months|Withdrew|0
2009928|NCT00211237|3575745|FG002|12 Months|Withdrew|1
2009929|NCT00211237|3575743|FG000|12 Months|unrelated medical problem|0
2009930|NCT00211237|3575744|FG001|12 Months|unrelated medical problem|0
2009931|NCT00211237|3575745|FG002|12 Months|unrelated medical problem|1
2009932|NCT00211510|3575764|FG000|Overall Study|Physician Decision|3
2009933|NCT00211510|3575765|FG001|Overall Study|Physician Decision|1
2009934|NCT00211510|3575764|FG000|Overall Study|Withdrawal by Subject|3
2009935|NCT00211510|3575765|FG001|Overall Study|Withdrawal by Subject|1
2009936|NCT00211536|3575776|FG000|Overall Study|Withdrawal by Subject|2
2009937|NCT00211536|3575777|FG001|Overall Study|Withdrawal by Subject|2
2009938|NCT00211536|3575776|FG000|Overall Study|Physician Decision|0
2009939|NCT00211536|3575777|FG001|Overall Study|Physician Decision|5
2009940|NCT00211536|3575776|FG000|Overall Study|Adverse Event|2
2009941|NCT00211536|3575777|FG001|Overall Study|Adverse Event|0
2009942|NCT00211757|3575794|FG000|Overall Study|Withdrawal by Subject|1
2009943|NCT00211757|3575795|FG001|Overall Study|Withdrawal by Subject|1
2009944|NCT00211757|3575794|FG000|Overall Study|Lack of Efficacy|0
2009945|NCT00211757|3575795|FG001|Overall Study|Lack of Efficacy|1
2009946|NCT00211809|3575803|FG000|Overall Study|Lack of Efficacy|1
2009947|NCT00211809|3575803|FG000|Overall Study|Lost to Follow-up|2
2009948|NCT00211809|3575803|FG000|Overall Study|Pregnancy|1
2009949|NCT00211809|3575803|FG000|Overall Study|side effects|2
2009950|NCT00211887|3575812|FG000|Overall Study|Adverse Event|8
2009951|NCT00211887|3575813|FG001|Overall Study|Adverse Event|4
2009952|NCT00211887|3575814|FG002|Overall Study|Adverse Event|6
2009953|NCT00211887|3575812|FG000|Overall Study|Death|1
2009954|NCT00211887|3575813|FG001|Overall Study|Death|1
2009955|NCT00211887|3575814|FG002|Overall Study|Death|1
2009956|NCT00211887|3575812|FG000|Overall Study|Lost to Follow-up|28
2009957|NCT00211887|3575813|FG001|Overall Study|Lost to Follow-up|13
2009958|NCT00211887|3575814|FG002|Overall Study|Lost to Follow-up|9
2009959|NCT00211887|3575812|FG000|Overall Study|Non-medical reason|31
2009960|NCT00211887|3575813|FG001|Overall Study|Non-medical reason|14
2009961|NCT00211887|3575814|FG002|Overall Study|Non-medical reason|8
2009962|NCT00211887|3575812|FG000|Overall Study|Other medical reason|15
2009963|NCT00211887|3575813|FG001|Overall Study|Other medical reason|11
2009964|NCT00211887|3575814|FG002|Overall Study|Other medical reason|7
2009965|NCT00211887|3575812|FG000|Overall Study|Side effects|19
2009966|NCT00211887|3575813|FG001|Overall Study|Side effects|13
2009967|NCT00211887|3575814|FG002|Overall Study|Side effects|5
2009968|NCT00212355|3575848|FG000|Overall Study|Adverse Event|1
2009969|NCT00212355|3575848|FG000|Overall Study|Withdrawal by Subject|1
2009970|NCT00212355|3575848|FG000|Overall Study|A change of address|1
2009971|NCT00212758|3575856|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1
2009972|NCT00212758|3575857|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0
2009973|NCT00212758|3575856|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
2009974|NCT00212758|3575857|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
2009975|NCT00213135|3575881|FG000|Overall Study|Adverse Event|9
2009976|NCT00213135|3575882|FG001|Overall Study|Adverse Event|5
2009977|NCT00213135|3575883|FG002|Overall Study|Adverse Event|5
2009978|NCT00213135|3575881|FG000|Overall Study|Lost to Follow-up|11
2009979|NCT00213135|3575882|FG001|Overall Study|Lost to Follow-up|8
2009980|NCT00213135|3575883|FG002|Overall Study|Lost to Follow-up|4
2009981|NCT00213135|3575881|FG000|Overall Study|Protocol Violation|4
2009982|NCT00213135|3575882|FG001|Overall Study|Protocol Violation|4
2009983|NCT00213135|3575883|FG002|Overall Study|Protocol Violation|10
2009984|NCT00213135|3575881|FG000|Overall Study|Death|1
2009985|NCT00213135|3575882|FG001|Overall Study|Death|1
2009986|NCT00213135|3575883|FG002|Overall Study|Death|2
2009987|NCT00213135|3575881|FG000|Overall Study|Disease progression|4
2009988|NCT00213135|3575882|FG001|Overall Study|Disease progression|5
2009989|NCT00213135|3575883|FG002|Overall Study|Disease progression|21
2009990|NCT00213135|3575881|FG000|Overall Study|Other|21
2009991|NCT00213135|3575882|FG001|Overall Study|Other|12
2009992|NCT00213135|3575883|FG002|Overall Study|Other|15
2009993|NCT00213148|3575895|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1
2009994|NCT00213148|3575896|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0
2009995|NCT00213148|3575897|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2
2009996|NCT00213148|3575898|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2
2009997|NCT00213148|3575899|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1
2009998|NCT00213148|3575895|FG000|Cycle 1 (1 Month)|Adverse Event|0
2009999|NCT00213148|3575896|FG001|Cycle 1 (1 Month)|Adverse Event|0
2010000|NCT00213148|3575897|FG002|Cycle 1 (1 Month)|Adverse Event|1
2010001|NCT00213148|3575898|FG003|Cycle 1 (1 Month)|Adverse Event|0
2010002|NCT00213148|3575899|FG004|Cycle 1 (1 Month)|Adverse Event|0
2010003|NCT00213148|3575895|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4
2010004|NCT00213148|3575896|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0
2010005|NCT00213148|3575897|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8
2010006|NCT00213148|3575898|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5
2010007|NCT00213148|3575899|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8
2010008|NCT00213148|3575895|FG000|Cycle 1 (1 Month)|Protocol Violation|1
2010009|NCT00213148|3575896|FG001|Cycle 1 (1 Month)|Protocol Violation|0
2010010|NCT00213148|3575897|FG002|Cycle 1 (1 Month)|Protocol Violation|1
2010011|NCT00213148|3575898|FG003|Cycle 1 (1 Month)|Protocol Violation|0
2010012|NCT00213148|3575899|FG004|Cycle 1 (1 Month)|Protocol Violation|0
2010013|NCT00213148|3575895|FG000|Cycle 1 (1 Month)|Other|3
2010014|NCT00213148|3575896|FG001|Cycle 1 (1 Month)|Other|0
2010015|NCT00213148|3575897|FG002|Cycle 1 (1 Month)|Other|2
2010016|NCT00213148|3575898|FG003|Cycle 1 (1 Month)|Other|2
2010017|NCT00213148|3575899|FG004|Cycle 1 (1 Month)|Other|7
2010018|NCT00213148|3575895|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
2010019|NCT00213148|3575896|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
2010020|NCT00213148|3575897|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
2010021|NCT00213148|3575898|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
2010022|NCT00213148|3575899|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
2010023|NCT00213148|3575895|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
2010024|NCT00213148|3575896|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
2010025|NCT00213148|3575897|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
2010026|NCT00213148|3575898|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
2010027|NCT00213148|3575899|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
2010028|NCT00213148|3575895|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
2010029|NCT00213148|3575896|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
2010030|NCT00213148|3575897|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
2010031|NCT00213148|3575898|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
2010032|NCT00213148|3575899|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
2010033|NCT00213148|3575895|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0
2010034|NCT00213148|3575896|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0
2010035|NCT00213148|3575897|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2
2010036|NCT00213148|3575898|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2
2010037|NCT00213148|3575899|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1
2010038|NCT00213148|3575895|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1
2010039|NCT00213148|3575896|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3
2010040|NCT00213148|3575897|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7
2010041|NCT00213148|3575898|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6
2010042|NCT00213148|3575899|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16
2010043|NCT00213148|3575895|FG000|Cycle 2 (1 Month)|Other|2
2010044|NCT00213148|3575896|FG001|Cycle 2 (1 Month)|Other|1
2010045|NCT00213148|3575897|FG002|Cycle 2 (1 Month)|Other|2
2010046|NCT00213148|3575898|FG003|Cycle 2 (1 Month)|Other|8
2010047|NCT00213148|3575899|FG004|Cycle 2 (1 Month)|Other|7
2010048|NCT00213148|3575895|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
2010049|NCT00213148|3575896|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
2010050|NCT00213148|3575897|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
2010051|NCT00213148|3575898|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
2010052|NCT00213148|3575899|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
2010053|NCT00213148|3575895|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
2010054|NCT00213148|3575896|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
2010055|NCT00213148|3575897|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
2010056|NCT00213148|3575898|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
2010057|NCT00213148|3575899|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
2010058|NCT00213148|3575895|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
2010059|NCT00213148|3575896|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
2010060|NCT00213148|3575897|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
2010061|NCT00213148|3575898|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
2010062|NCT00213148|3575899|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
2010063|NCT00213148|3575895|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0
2010064|NCT00213148|3575896|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2
2010065|NCT00213148|3575897|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0
2010066|NCT00213148|3575898|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0
2010067|NCT00213148|3575899|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1
2010068|NCT00213148|3575895|FG000|Cycle 3 (1 Month)|Other|0
2010069|NCT00213148|3575896|FG001|Cycle 3 (1 Month)|Other|0
2010070|NCT00213148|3575897|FG002|Cycle 3 (1 Month)|Other|1
2010071|NCT00213148|3575898|FG003|Cycle 3 (1 Month)|Other|1
2010072|NCT00213148|3575899|FG004|Cycle 3 (1 Month)|Other|0
2010073|NCT00213980|3575930|FG000|Overall Study|Withdrawal by Subject|3
2010074|NCT00213980|3575931|FG001|Overall Study|Withdrawal by Subject|1
2010075|NCT00213980|3575930|FG000|Overall Study|Adverse Event|1
2010076|NCT00213980|3575931|FG001|Overall Study|Adverse Event|1
2010077|NCT00213980|3575930|FG000|Overall Study|Disease progression|0
2010078|NCT00213980|3575931|FG001|Overall Study|Disease progression|2
2010079|NCT00213980|3575930|FG000|Overall Study|Developed ovarian cancer|1
2010080|NCT00213980|3575931|FG001|Overall Study|Developed ovarian cancer|0
2010081|NCT00213980|3575930|FG000|Overall Study|Failed to obtain all 3 DXAs|1
2010082|NCT00213980|3575931|FG001|Overall Study|Failed to obtain all 3 DXAs|3
2010083|NCT00214019|3575937|FG000|Overall Study|Lost to Follow-up|11
2010084|NCT00214019|3575937|FG000|Overall Study|Withdrawal by Subject|2
2010085|NCT00214019|3575937|FG000|Overall Study|Screen Failed prior to randomization|17
2010086|NCT00214136|3575972|FG000|Overall Study|Death|5
2010087|NCT00214201|3575978|FG000|Overall Study|Withdrawal by Subject|2
2010088|NCT00214201|3575979|FG001|Overall Study|Withdrawal by Subject|0
2010089|NCT00214201|3575978|FG000|Overall Study|Death|0
2010090|NCT00214201|3575979|FG001|Overall Study|Death|2
2010091|NCT00214383|3575988|FG000|Overall Study|Lost to Follow-up|16
2010092|NCT00214383|3575989|FG001|Overall Study|Lost to Follow-up|26
2010093|NCT00214422|3575998|FG000|Overall Study|Physician Decision|2
2010094|NCT00214422|3575999|FG001|Overall Study|Physician Decision|0
2010095|NCT00214422|3576000|FG002|Overall Study|Physician Decision|0
2010096|NCT00214422|3575998|FG000|Overall Study|Developed esophageal ca|1
2010097|NCT00214422|3575999|FG001|Overall Study|Developed esophageal ca|0
2010098|NCT00214422|3576000|FG002|Overall Study|Developed esophageal ca|0
2010099|NCT00214422|3575998|FG000|Overall Study|Pt taken off study|1
2010100|NCT00214422|3575999|FG001|Overall Study|Pt taken off study|1
2010101|NCT00214422|3576000|FG002|Overall Study|Pt taken off study|0
2010102|NCT00214422|3575998|FG000|Overall Study|Disease progression on study|1
2010103|NCT00214422|3575999|FG001|Overall Study|Disease progression on study|0
2010104|NCT00214422|3576000|FG002|Overall Study|Disease progression on study|0
2010105|NCT00214422|3575998|FG000|Overall Study|Unable to make a radiation treatment|0
2010106|NCT00214422|3575999|FG001|Overall Study|Unable to make a radiation treatment|0
2010107|NCT00214422|3576000|FG002|Overall Study|Unable to make a radiation treatment|1
2010108|NCT00214461|3576016|FG000|Overall Study|Adverse Event|0
2010109|NCT00214461|3576017|FG001|Overall Study|Adverse Event|0
2010110|NCT00214461|3576018|FG002|Overall Study|Adverse Event|1
2010111|NCT00214461|3576019|FG003|Overall Study|Adverse Event|1
2010112|NCT00214461|3576016|FG000|Overall Study|Withdrawal by Subject|0
2010113|NCT00214461|3576017|FG001|Overall Study|Withdrawal by Subject|0
2010114|NCT00214461|3576018|FG002|Overall Study|Withdrawal by Subject|1
2010115|NCT00214461|3576019|FG003|Overall Study|Withdrawal by Subject|0
2010116|NCT00215137|3576092|FG000|Open Label Escitalopram|Lack of Efficacy|1
2010117|NCT00215137|3576093|FG001|Open Label Escitalopram|Lack of Efficacy|0
2010118|NCT00215137|3576094|FG002|Open Label Escitalopram|Lack of Efficacy|0
2010119|NCT00215137|3576092|FG000|Randomization Period|Lost to Follow-up|0
2010120|NCT00215137|3576093|FG001|Randomization Period|Lost to Follow-up|1
2010121|NCT00215137|3576094|FG002|Randomization Period|Lost to Follow-up|0
2010122|NCT00215137|3576092|FG000|Randomization Period|Withdrawal by Subject|0
2010123|NCT00215137|3576093|FG001|Randomization Period|Withdrawal by Subject|1
2010124|NCT00215137|3576094|FG002|Randomization Period|Withdrawal by Subject|0
2010125|NCT00215150|3576102|FG000|Open Label Phase|Lost to Follow-up|7
2010126|NCT00215150|3576102|FG000|Open Label Phase|Withdrawal by Subject|1
2010127|NCT00215150|3576102|FG000|Open Label Phase|Did not complete a post base visit|13
2010128|NCT00215150|3576102|FG000|Open Label Phase|Did not meet randomization criteria|9
2010129|NCT00215150|3576102|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2
2010130|NCT00215150|3576102|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1
2010131|NCT00215150|3576102|FG000|Randomization Phase Placebo|Withdrawal by Subject|1
2010132|NCT00215540|3576113|FG000|Overall Study|Withdrew from study medication|1
2010133|NCT00215540|3576114|FG001|Overall Study|Withdrew from study medication|0
2010134|NCT00215540|3576115|FG002|Overall Study|Withdrew from study medication|0
2010135|NCT00215553|3576130|FG000|Overall Study|Adverse Event|0
2177448|NCT01374269|3801609|FG000|Overall Study|Withdrawal by Subject|4
2177449|NCT01374269|3801610|FG001|Overall Study|Withdrawal by Subject|0
2177450|NCT01374269|3801609|FG000|Overall Study|Lost to Follow-up|1
2177451|NCT01374269|3801610|FG001|Overall Study|Lost to Follow-up|3
2177452|NCT01374269|3801609|FG000|Overall Study|closed research|1
2177453|NCT01374269|3801610|FG001|Overall Study|closed research|2
2177454|NCT01374425|3801618|FG000|Overall Study|Radiographic Disease Progression|86
2177455|NCT01374425|3801619|FG001|Overall Study|Radiographic Disease Progression|81
2177456|NCT01374425|3801618|FG000|Overall Study|Clinical Disease Progression|9
2177457|NCT01374425|3801619|FG001|Overall Study|Clinical Disease Progression|6
2177458|NCT01374425|3801618|FG000|Overall Study|Adverse Event|29
2177459|NCT01374425|3801619|FG001|Overall Study|Adverse Event|18
2177460|NCT01374425|3801618|FG000|Overall Study|Death (Progression of Disease)|1
2177461|NCT01374425|3801619|FG001|Overall Study|Death (Progression of Disease)|0
2177462|NCT01374425|3801618|FG000|Overall Study|Death (Adverse Event)|2
2177463|NCT01374425|3801619|FG001|Overall Study|Death (Adverse Event)|4
2177464|NCT01374425|3801618|FG000|Overall Study|Withdrawal by Subject|6
2177465|NCT01374425|3801619|FG001|Overall Study|Withdrawal by Subject|7
2177466|NCT01374425|3801618|FG000|Overall Study|Refused Treatment|10
2177467|NCT01374425|3801619|FG001|Overall Study|Refused Treatment|24
2177468|NCT01374425|3801618|FG000|Overall Study|Protocol Violation|2
2177469|NCT01374425|3801619|FG001|Overall Study|Protocol Violation|3
2177470|NCT01374425|3801618|FG000|Overall Study|Sponsor Decision|0
2177471|NCT01374425|3801619|FG001|Overall Study|Sponsor Decision|1
2177472|NCT01374425|3801618|FG000|Overall Study|Lost to Follow-up|2
2177473|NCT01374425|3801619|FG001|Overall Study|Lost to Follow-up|1
2177474|NCT01374425|3801618|FG000|Overall Study|Other|41
2177475|NCT01374425|3801619|FG001|Overall Study|Other|43
2177476|NCT01374451|3801657|FG000|Overall Study|Administrative problems|1
2177477|NCT01374451|3801658|FG001|Overall Study|Administrative problems|0
2177478|NCT01374516|3801670|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
2177479|NCT01374516|3801671|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
2177480|NCT01374516|3801670|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3
2177481|NCT01374516|3801671|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0
2177482|NCT01374516|3801670|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
2010136|NCT00215553|3576131|FG001|Overall Study|Adverse Event|1
2010137|NCT00215553|3576132|FG002|Overall Study|Adverse Event|2
2010138|NCT00215553|3576133|FG003|Overall Study|Adverse Event|1
2010139|NCT00215553|3576134|FG004|Overall Study|Adverse Event|2
2010140|NCT00215553|3576135|FG005|Overall Study|Adverse Event|6
2177483|NCT01374516|3801671|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
2010141|NCT00215553|3576136|FG006|Overall Study|Adverse Event|0
2010142|NCT00215644|3576154|FG000|Overall Study|Disease Progression|28
2010143|NCT00215644|3576155|FG001|Overall Study|Disease Progression|10
2010144|NCT00215644|3576154|FG000|Overall Study|Adverse Event|2
2010145|NCT00215644|3576155|FG001|Overall Study|Adverse Event|9
2010146|NCT00215644|3576154|FG000|Overall Study|Death|1
2010147|NCT00215644|3576155|FG001|Overall Study|Death|2
2010148|NCT00215644|3576154|FG000|Overall Study|Withdrawal by Subject|1
2010149|NCT00215644|3576155|FG001|Overall Study|Withdrawal by Subject|0
2010150|NCT00215644|3576154|FG000|Overall Study|Other|3
2010151|NCT00215644|3576155|FG001|Overall Study|Other|15
2010152|NCT00215644|3576154|FG000|Overall Study|Randomized but Not Treated|1
2010153|NCT00215644|3576155|FG001|Overall Study|Randomized but Not Treated|0
2010154|NCT00215657|3576169|FG000|Overall Study|Adverse Event|5
2010155|NCT00215657|3576170|FG001|Overall Study|Adverse Event|1
2010156|NCT00215657|3576171|FG002|Overall Study|Adverse Event|3
2010157|NCT00215657|3576172|FG003|Overall Study|Adverse Event|0
2010158|NCT00215657|3576173|FG004|Overall Study|Adverse Event|3
2010159|NCT00215657|3576174|FG005|Overall Study|Adverse Event|1
2010160|NCT00215657|3576175|FG006|Overall Study|Adverse Event|0
2010161|NCT00215657|3576176|FG007|Overall Study|Adverse Event|3
2010162|NCT00215657|3576169|FG000|Overall Study|Withdrawal by Subject|6
2010163|NCT00215657|3576170|FG001|Overall Study|Withdrawal by Subject|3
2010164|NCT00215657|3576171|FG002|Overall Study|Withdrawal by Subject|3
2010165|NCT00215657|3576172|FG003|Overall Study|Withdrawal by Subject|1
2010166|NCT00215657|3576173|FG004|Overall Study|Withdrawal by Subject|6
2010167|NCT00215657|3576174|FG005|Overall Study|Withdrawal by Subject|1
2010168|NCT00215657|3576175|FG006|Overall Study|Withdrawal by Subject|10
2010169|NCT00215657|3576176|FG007|Overall Study|Withdrawal by Subject|3
2010170|NCT00215657|3576169|FG000|Overall Study|Insuff prostate specific antigen resp|3
2010171|NCT00215657|3576170|FG001|Overall Study|Insuff prostate specific antigen resp|2
2010172|NCT00215657|3576171|FG002|Overall Study|Insuff prostate specific antigen resp|2
2010173|NCT00215657|3576172|FG003|Overall Study|Insuff prostate specific antigen resp|2
2010174|NCT00215657|3576173|FG004|Overall Study|Insuff prostate specific antigen resp|1
2010175|NCT00215657|3576174|FG005|Overall Study|Insuff prostate specific antigen resp|2
2010176|NCT00215657|3576175|FG006|Overall Study|Insuff prostate specific antigen resp|3
2010177|NCT00215657|3576176|FG007|Overall Study|Insuff prostate specific antigen resp|2
2010178|NCT00215657|3576169|FG000|Overall Study|Insufficient testosterone response|5
2010179|NCT00215657|3576170|FG001|Overall Study|Insufficient testosterone response|4
2010180|NCT00215657|3576171|FG002|Overall Study|Insufficient testosterone response|1
2010181|NCT00215657|3576172|FG003|Overall Study|Insufficient testosterone response|12
2010182|NCT00215657|3576173|FG004|Overall Study|Insufficient testosterone response|8
2010183|NCT00215657|3576174|FG005|Overall Study|Insufficient testosterone response|12
2010184|NCT00215657|3576175|FG006|Overall Study|Insufficient testosterone response|4
2010185|NCT00215657|3576176|FG007|Overall Study|Insufficient testosterone response|7
2010186|NCT00215657|3576169|FG000|Overall Study|Other|3
2010187|NCT00215657|3576170|FG001|Overall Study|Other|1
2010188|NCT00215657|3576171|FG002|Overall Study|Other|2
2010189|NCT00215657|3576172|FG003|Overall Study|Other|3
2010190|NCT00215657|3576173|FG004|Overall Study|Other|5
2010191|NCT00215657|3576174|FG005|Overall Study|Other|4
2010192|NCT00215657|3576175|FG006|Overall Study|Other|6
2010193|NCT00215657|3576176|FG007|Overall Study|Other|1
2010194|NCT00215683|3576197|FG000|Overall Study|Adverse Event|15
2010195|NCT00215683|3576198|FG001|Overall Study|Adverse Event|16
2010196|NCT00215683|3576199|FG002|Overall Study|Adverse Event|15
2010197|NCT00215683|3576197|FG000|Overall Study|Lack of Efficacy|5
2010198|NCT00215683|3576198|FG001|Overall Study|Lack of Efficacy|1
2010199|NCT00215683|3576199|FG002|Overall Study|Lack of Efficacy|2
2010200|NCT00215683|3576197|FG000|Overall Study|Lost to Follow-up|0
2010201|NCT00215683|3576198|FG001|Overall Study|Lost to Follow-up|2
2010202|NCT00215683|3576199|FG002|Overall Study|Lost to Follow-up|1
2010203|NCT00215683|3576197|FG000|Overall Study|Withdrawal by Subject|9
2010204|NCT00215683|3576198|FG001|Overall Study|Withdrawal by Subject|4
2010205|NCT00215683|3576199|FG002|Overall Study|Withdrawal by Subject|13
2010206|NCT00215683|3576197|FG000|Overall Study|Physician Decision|0
2010207|NCT00215683|3576198|FG001|Overall Study|Physician Decision|0
2010208|NCT00215683|3576199|FG002|Overall Study|Physician Decision|1
2010209|NCT00215683|3576197|FG000|Overall Study|Difficult to attend visits|0
2010210|NCT00215683|3576198|FG001|Overall Study|Difficult to attend visits|1
2010211|NCT00215683|3576199|FG002|Overall Study|Difficult to attend visits|0
2010212|NCT00215683|3576197|FG000|Overall Study|No study drug available|0
2010213|NCT00215683|3576198|FG001|Overall Study|No study drug available|1
2010214|NCT00215683|3576199|FG002|Overall Study|No study drug available|0
2010215|NCT00215683|3576197|FG000|Overall Study|Intermittent therapy required|0
2010216|NCT00215683|3576198|FG001|Overall Study|Intermittent therapy required|1
2010217|NCT00215683|3576199|FG002|Overall Study|Intermittent therapy required|0
2010218|NCT00215943|3576218|FG000|Overall Study|Disease Progression|3
2010219|NCT00215943|3576219|FG001|Overall Study|Disease Progression|5
2010220|NCT00215943|3576218|FG000|Overall Study|Alternate therapy|0
2010221|NCT00215943|3576219|FG001|Overall Study|Alternate therapy|1
2010222|NCT00215943|3576218|FG000|Overall Study|Adverse Event|3
2010223|NCT00215943|3576219|FG001|Overall Study|Adverse Event|6
2010224|NCT00215943|3576218|FG000|Overall Study|Other disease|0
2010225|NCT00215943|3576219|FG001|Overall Study|Other disease|1
2010226|NCT00215943|3576218|FG000|Overall Study|Other complications|3
2010227|NCT00215943|3576219|FG001|Overall Study|Other complications|1
2010228|NCT00216086|3576236|FG000|Overall Study|Protocol Violation|1
2010229|NCT00216086|3576236|FG000|Overall Study|Diagnosis of Metastatic Disease|1
2010230|NCT00216086|3576236|FG000|Overall Study|Social Reasons|2
2010231|NCT00216203|3576253|FG000|Overall Study|Withdrawal by Subject|2
2010232|NCT00216476|3576274|FG000|Overall Study|Withdrawal by Subject|59
2010233|NCT00216476|3576275|FG001|Overall Study|Withdrawal by Subject|72
2010234|NCT00216476|3576276|FG002|Overall Study|Withdrawal by Subject|9
2010235|NCT00216476|3576274|FG000|Overall Study|Lost to Follow-up|10
2010236|NCT00216476|3576275|FG001|Overall Study|Lost to Follow-up|9
2010237|NCT00216476|3576276|FG002|Overall Study|Lost to Follow-up|1
2010238|NCT00216476|3576274|FG000|Overall Study|Adverse Event|6
2010239|NCT00216476|3576275|FG001|Overall Study|Adverse Event|10
2010240|NCT00216476|3576276|FG002|Overall Study|Adverse Event|1
2010241|NCT00216476|3576274|FG000|Overall Study|Lack of Efficacy|4
2010242|NCT00216476|3576275|FG001|Overall Study|Lack of Efficacy|3
2010243|NCT00216476|3576276|FG002|Overall Study|Lack of Efficacy|0
2010244|NCT00216476|3576274|FG000|Overall Study|Death|2
2010245|NCT00216476|3576275|FG001|Overall Study|Death|0
2010246|NCT00216476|3576276|FG002|Overall Study|Death|0
2010247|NCT00216476|3576274|FG000|Overall Study|Pregnancy|0
2010248|NCT00216476|3576275|FG001|Overall Study|Pregnancy|1
2010249|NCT00216476|3576276|FG002|Overall Study|Pregnancy|1
2010250|NCT00216476|3576274|FG000|Overall Study|Other|0
2010251|NCT00216476|3576275|FG001|Overall Study|Other|0
2010252|NCT00216476|3576276|FG002|Overall Study|Other|1
2010253|NCT00216476|3576274|FG000|Overall Study|Refuses Injection|11
2010254|NCT00216476|3576275|FG001|Overall Study|Refuses Injection|0
2010255|NCT00216476|3576276|FG002|Overall Study|Refuses Injection|0
2010256|NCT00216476|3576274|FG000|Overall Study|No Further Need for Treatment|3
2010257|NCT00216476|3576275|FG001|Overall Study|No Further Need for Treatment|4
2010258|NCT00216476|3576276|FG002|Overall Study|No Further Need for Treatment|1
2010259|NCT00216476|3576274|FG000|Overall Study|Non-compliance|0
2010260|NCT00216476|3576275|FG001|Overall Study|Non-compliance|4
2010261|NCT00216476|3576276|FG002|Overall Study|Non-compliance|1
2010262|NCT00216476|3576274|FG000|Overall Study|Higher dose/Extra Medication Required|2
2010263|NCT00216476|3576275|FG001|Overall Study|Higher dose/Extra Medication Required|0
2010264|NCT00216476|3576276|FG002|Overall Study|Higher dose/Extra Medication Required|2
2010265|NCT00216476|3576274|FG000|Overall Study|Administrative Reasons|1
2010266|NCT00216476|3576275|FG001|Overall Study|Administrative Reasons|1
2010267|NCT00216476|3576276|FG002|Overall Study|Administrative Reasons|0
2010268|NCT00216476|3576274|FG000|Overall Study|Protocol Deviation|5
2010269|NCT00216476|3576275|FG001|Overall Study|Protocol Deviation|1
2010270|NCT00216476|3576276|FG002|Overall Study|Protocol Deviation|0
2010271|NCT00216476|3576274|FG000|Overall Study|Patient Moved|2
2010272|NCT00216476|3576275|FG001|Overall Study|Patient Moved|2
2010273|NCT00216476|3576276|FG002|Overall Study|Patient Moved|0
2010274|NCT00216671|3576289|FG000|Overall Study|Adverse Event|4
2010275|NCT00216671|3576290|FG001|Overall Study|Adverse Event|9
2010276|NCT00216671|3576289|FG000|Overall Study|Pregnancy|0
2010277|NCT00216671|3576290|FG001|Overall Study|Pregnancy|1
2010278|NCT00216671|3576289|FG000|Overall Study|Withdrawal by Subject|4
2010279|NCT00216671|3576290|FG001|Overall Study|Withdrawal by Subject|2
2010280|NCT00216671|3576289|FG000|Overall Study|Refused Injections|3
2010281|NCT00216671|3576290|FG001|Overall Study|Refused Injections|13
2010282|NCT00216671|3576289|FG000|Overall Study|No Need to Continue Medication|1
2010283|NCT00216671|3576290|FG001|Overall Study|No Need to Continue Medication|1
2010284|NCT00216671|3576289|FG000|Overall Study|Insufficient Response|9
2010285|NCT00216671|3576290|FG001|Overall Study|Insufficient Response|4
2010286|NCT00216671|3576289|FG000|Overall Study|Lost to Follow-up|3
2010287|NCT00216671|3576290|FG001|Overall Study|Lost to Follow-up|5
2010288|NCT00216671|3576289|FG000|Overall Study|Non compliant|2
2010289|NCT00216671|3576290|FG001|Overall Study|Non compliant|2
2010290|NCT00216671|3576289|FG000|Overall Study|Ineligible|0
2010291|NCT00216671|3576290|FG001|Overall Study|Ineligible|2
2010292|NCT00216671|3576289|FG000|Overall Study|Physician Decision|1
2010293|NCT00216671|3576290|FG001|Overall Study|Physician Decision|1
2010294|NCT00216671|3576289|FG000|Overall Study|Protocol Violation|3
2010295|NCT00216671|3576290|FG001|Overall Study|Protocol Violation|5
2010296|NCT00216671|3576289|FG000|Overall Study|Relapse|1
2010297|NCT00216671|3576290|FG001|Overall Study|Relapse|0
2010298|NCT00216671|3576289|FG000|Overall Study|Investigator Illness|0
2010299|NCT00216671|3576290|FG001|Overall Study|Investigator Illness|1
2010300|NCT00216671|3576289|FG000|Overall Study|Patient Moved|0
2010301|NCT00216671|3576290|FG001|Overall Study|Patient Moved|1
2010302|NCT00216671|3576289|FG000|Overall Study|Ineligible, no efficacy data|2
2010303|NCT00216671|3576290|FG001|Overall Study|Ineligible, no efficacy data|2
2010304|NCT00216671|3576289|FG000|Overall Study|Insufficient Response Adverse Event|2
2010305|NCT00216671|3576290|FG001|Overall Study|Insufficient Response Adverse Event|1
2010306|NCT00216736|3576298|FG000|Overall Study|Lost to Follow-up|1
2010307|NCT00216736|3576299|FG001|Overall Study|Lost to Follow-up|1
2010308|NCT00217022|3576307|FG000|Overall Study|Withdrawal by Subject|1
2010309|NCT00217022|3576308|FG001|Overall Study|Withdrawal by Subject|1
2010310|NCT00217087|3576316|FG000|Overall Study|decided to have esophagectomy|1
2010311|NCT00217087|3576317|FG001|Overall Study|decided to have esophagectomy|2
2010312|NCT00217087|3576316|FG000|Overall Study|completed less than 12 months return|10
2010313|NCT00217087|3576317|FG001|Overall Study|completed less than 12 months return|18
2010314|NCT00217425|3576335|FG000|Overall Study|Never started treatment|2
2010315|NCT00217425|3576335|FG000|Overall Study|Patient ineligible|5
2010316|NCT00217425|3576335|FG000|Overall Study|Lack of Efficacy|13
2010317|NCT00217425|3576335|FG000|Overall Study|Adverse Event|8
2010318|NCT00217425|3576335|FG000|Overall Study|Withdrawal by Subject|4
2010319|NCT00217425|3576335|FG000|Overall Study|Other complicating disease|1
2010320|NCT00217425|3576335|FG000|Overall Study|Other|4
2010321|NCT00217464|3576348|FG000|Overall Study|Progression|15
2010322|NCT00217464|3576348|FG000|Overall Study|Other|2
2010323|NCT00217581|3576373|FG000|Overall Study|Withdrawal by Subject|1
2010324|NCT00217620|3576382|FG000|Overall Study|Adverse Event|2
2010325|NCT00217620|3576382|FG000|Overall Study|Progression|31
2010326|NCT00217620|3576382|FG000|Overall Study|Not Protocol Specified|4
2010327|NCT00217620|3576382|FG000|Overall Study|Ineligible|13
2010328|NCT00217620|3576382|FG000|Overall Study|Never received treatment|1
2010329|NCT00217672|3576390|FG000|Allocation|Ineligible|2
2010330|NCT00217672|3576391|FG001|Allocation|Ineligible|0
2010331|NCT00217672|3576390|FG000|Treatment|disease progression|33
2010332|NCT00217672|3576391|FG001|Treatment|disease progression|4
2010333|NCT00217672|3576390|FG000|Treatment|Adverse Event|18
2010334|NCT00217672|3576391|FG001|Treatment|Adverse Event|2
2010335|NCT00217672|3576390|FG000|Treatment|reqd treatment not permitted by protocol|6
2010336|NCT00217672|3576391|FG001|Treatment|reqd treatment not permitted by protocol|0
2010337|NCT00217672|3576390|FG000|Treatment|Physician Decision|6
2010338|NCT00217672|3576391|FG001|Treatment|Physician Decision|0
2010339|NCT00217672|3576390|FG000|Treatment|insurance issues|1
2010340|NCT00217672|3576391|FG001|Treatment|insurance issues|1
2010341|NCT00217672|3576390|FG000|Treatment|Death|2
2010342|NCT00217672|3576391|FG001|Treatment|Death|0
2010343|NCT00217672|3576390|FG000|Treatment|secondary malignancy|1
2010344|NCT00217672|3576391|FG001|Treatment|secondary malignancy|0
2010345|NCT00217672|3576390|FG000|Follow-up|Withdrawal by Subject|4
2010346|NCT00217672|3576391|FG001|Follow-up|Withdrawal by Subject|0
2010347|NCT00217672|3576390|FG000|Follow-up|Lost to Follow-up|1
2010348|NCT00217672|3576391|FG001|Follow-up|Lost to Follow-up|0
2010349|NCT00217971|3576404|FG000|Overall Study|Adverse Event|1
2010350|NCT00217971|3576405|FG001|Overall Study|Adverse Event|1
2010351|NCT00217971|3576404|FG000|Overall Study|Lost to Follow-up|15
2010352|NCT00217971|3576405|FG001|Overall Study|Lost to Follow-up|19
2010353|NCT00217971|3576404|FG000|Overall Study|Physician Decision|0
2010354|NCT00217971|3576405|FG001|Overall Study|Physician Decision|1
2010355|NCT00217971|3576404|FG000|Overall Study|Withdrawal by Subject|7
2010356|NCT00217971|3576405|FG001|Overall Study|Withdrawal by Subject|12
2010357|NCT00217971|3576404|FG000|Overall Study|non compliant|1
2010358|NCT00217971|3576405|FG001|Overall Study|non compliant|0
2010359|NCT00218257|3576445|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4
2010360|NCT00218257|3576446|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3
2010361|NCT00218296|3576457|FG000|Overall Study|Lost to Follow-up|9
2010362|NCT00218296|3576458|FG001|Overall Study|Lost to Follow-up|7
2010363|NCT00218296|3576457|FG000|Overall Study|Withdrawal by Subject|36
2010364|NCT00218296|3576458|FG001|Overall Study|Withdrawal by Subject|47
2010365|NCT00218296|3576457|FG000|Overall Study|Randomized but did not enter treatment|66
2010366|NCT00218296|3576458|FG001|Overall Study|Randomized but did not enter treatment|67
2025451|NCT00345839|3594322|FG001|Overall Study|Withdrawal by Subject|98
2025452|NCT00345839|3594321|FG000|Overall Study|Lost to Follow-up|58
2025453|NCT00345839|3594322|FG001|Overall Study|Lost to Follow-up|61
2025454|NCT00345878|3594351|FG000|Overall Study|Adverse Event|1
2025455|NCT00345878|3594352|FG001|Overall Study|Adverse Event|0
2025456|NCT00345878|3594351|FG000|Overall Study|Lost to Follow-up|2
2025457|NCT00345878|3594352|FG001|Overall Study|Lost to Follow-up|1
2025458|NCT00345878|3594351|FG000|Overall Study|Other|1
2025459|NCT00345878|3594352|FG001|Overall Study|Other|0
2025460|NCT00346034|3594367|FG000|Overall Study|Adverse Event|34
2025461|NCT00346034|3594367|FG000|Overall Study|Lack of Efficacy|8
2025462|NCT00346034|3594367|FG000|Overall Study|Withdrawal by Subject|13
2025463|NCT00346034|3594367|FG000|Overall Study|Patient Stopped Taking Study Drug|1
2025464|NCT00346034|3594367|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1
2025465|NCT00346073|3594373|FG000|Overall Study|Serious Adverse Event|2
2025466|NCT00346073|3594374|FG001|Overall Study|Serious Adverse Event|0
2025467|NCT00346073|3594373|FG000|Overall Study|Lost to Follow-up|39
2025468|NCT00346073|3594374|FG001|Overall Study|Lost to Follow-up|24
2025469|NCT00346151|3594380|FG000|Overall Study|Withdrawal by Subject|3
2025470|NCT00346164|3594388|FG000|Overall Study|Adverse Event|0
2025471|NCT00346164|3594389|FG001|Overall Study|Adverse Event|0
2025472|NCT00346164|3594390|FG002|Overall Study|Adverse Event|0
2025473|NCT00346164|3594391|FG003|Overall Study|Adverse Event|1
2025474|NCT00346164|3594388|FG000|Overall Study|Lack of Efficacy|0
2025475|NCT00346164|3594389|FG001|Overall Study|Lack of Efficacy|1
2025476|NCT00346164|3594390|FG002|Overall Study|Lack of Efficacy|7
2025477|NCT00346164|3594391|FG003|Overall Study|Lack of Efficacy|25
2025478|NCT00346164|3594388|FG000|Overall Study|Physician Decision|0
2025479|NCT00346164|3594389|FG001|Overall Study|Physician Decision|1
2010367|NCT00218543|3576553|FG000|Overall Study|Lost to Follow-up|8
2010368|NCT00218543|3576553|FG000|Overall Study|relocated|1
2010369|NCT00218543|3576553|FG000|Overall Study|Withdrawal by Subject|1
2010370|NCT00218543|3576553|FG000|Overall Study|Physician Decision|3
2010371|NCT00218543|3576553|FG000|Overall Study|Adverse Event|2
2010372|NCT00218634|3576559|FG000|Overall Study|Lost to Follow-up|8
2010373|NCT00218634|3576560|FG001|Overall Study|Lost to Follow-up|15
2010374|NCT00219141|3576572|FG000|Overall Study|Adverse Event|4
2010375|NCT00219141|3576573|FG001|Overall Study|Adverse Event|10
2010376|NCT00219141|3576574|FG002|Overall Study|Adverse Event|5
2010377|NCT00219141|3576572|FG000|Overall Study|Lack of Efficacy|3
2010378|NCT00219141|3576573|FG001|Overall Study|Lack of Efficacy|2
2010379|NCT00219141|3576574|FG002|Overall Study|Lack of Efficacy|0
2010380|NCT00219141|3576572|FG000|Overall Study|Administrative problems|0
2010381|NCT00219141|3576573|FG001|Overall Study|Administrative problems|1
2010382|NCT00219141|3576574|FG002|Overall Study|Administrative problems|0
2010383|NCT00219141|3576572|FG000|Overall Study|Lost to Follow-up|2
2010384|NCT00219141|3576573|FG001|Overall Study|Lost to Follow-up|4
2010385|NCT00219141|3576574|FG002|Overall Study|Lost to Follow-up|1
2010386|NCT00219141|3576572|FG000|Overall Study|Protocol Violation|3
2010387|NCT00219141|3576573|FG001|Overall Study|Protocol Violation|1
2010388|NCT00219141|3576574|FG002|Overall Study|Protocol Violation|1
2010389|NCT00219141|3576572|FG000|Overall Study|Withdrawal by Subject|1
2010390|NCT00219141|3576573|FG001|Overall Study|Withdrawal by Subject|3
2010391|NCT00219141|3576574|FG002|Overall Study|Withdrawal by Subject|5
2010392|NCT00219141|3576572|FG000|Overall Study|Condition no longer requires study drug|1
2010393|NCT00219141|3576573|FG001|Overall Study|Condition no longer requires study drug|0
2010394|NCT00219141|3576574|FG002|Overall Study|Condition no longer requires study drug|0
2010395|NCT00219284|3576584|FG000|Treatment Phase - 16 Weeks|Adverse Event|26
2010396|NCT00219284|3576585|FG001|Treatment Phase - 16 Weeks|Adverse Event|24
2010397|NCT00219284|3576584|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
2010398|NCT00219284|3576585|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
2010399|NCT00219284|3576584|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3
2010400|NCT00219284|3576585|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10
2010401|NCT00219284|3576584|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9
2010402|NCT00219284|3576585|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5
2010403|NCT00219284|3576584|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
2010404|NCT00219284|3576585|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
2010405|NCT00219284|3576584|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1
2010406|NCT00219284|3576585|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2
2010407|NCT00219284|3576584|FG000|Extension Phase - 8 Weeks|Adverse Event|2
2010408|NCT00219284|3576585|FG001|Extension Phase - 8 Weeks|Adverse Event|3
2010409|NCT00219284|3576584|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0
2010410|NCT00219284|3576585|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2
2010411|NCT00219284|3576584|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0
2010412|NCT00219284|3576585|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2
2010413|NCT00219349|3576591|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
2010414|NCT00219349|3576591|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
2010415|NCT00219349|3576591|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2
2010416|NCT00219349|3576591|FG000|Escitalopram Phase|Withdrawal by Subject|3
2010417|NCT00219544|3576595|FG000|Single Blind Treatment Period|Lack of Efficacy|5
2010418|NCT00219544|3576596|FG001|Single Blind Treatment Period|Lack of Efficacy|0
2010419|NCT00219544|3576595|FG000|Single Blind Treatment Period|Adverse Event|9
2010420|NCT00219544|3576596|FG001|Single Blind Treatment Period|Adverse Event|0
2010421|NCT00219544|3576595|FG000|Single Blind Treatment Period|Protocol Violation|4
2010422|NCT00219544|3576596|FG001|Single Blind Treatment Period|Protocol Violation|0
2010423|NCT00219544|3576595|FG000|Single Blind Treatment Period|Lost to Follow-up|2
2010424|NCT00219544|3576596|FG001|Single Blind Treatment Period|Lost to Follow-up|0
2010425|NCT00219544|3576595|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1
2010426|NCT00219544|3576596|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0
2010427|NCT00219544|3576595|FG000|Single Blind Treatment Period|Withdrawal by Subject|1
2010428|NCT00219544|3576596|FG001|Single Blind Treatment Period|Withdrawal by Subject|0
2010429|NCT00219557|3576607|FG000|Phase 1|Lack of Efficacy|3
2010430|NCT00219557|3576608|FG001|Phase 1|Lack of Efficacy|0
2010431|NCT00219557|3576609|FG002|Phase 1|Lack of Efficacy|0
2010432|NCT00219557|3576607|FG000|Phase 1|Adverse Event|2
2010433|NCT00219557|3576608|FG001|Phase 1|Adverse Event|0
2010434|NCT00219557|3576609|FG002|Phase 1|Adverse Event|0
2010435|NCT00219557|3576607|FG000|Phase 1|Withdrawal by Subject|1
2010436|NCT00219557|3576608|FG001|Phase 1|Withdrawal by Subject|0
2010437|NCT00219557|3576609|FG002|Phase 1|Withdrawal by Subject|0
2010438|NCT00219557|3576607|FG000|Phase 1|Started chemotherapy at other institute|1
2010439|NCT00219557|3576608|FG001|Phase 1|Started chemotherapy at other institute|0
2010440|NCT00219557|3576609|FG002|Phase 1|Started chemotherapy at other institute|0
2010441|NCT00219557|3576607|FG000|Phase 2|Lack of Efficacy|0
2010442|NCT00219557|3576608|FG001|Phase 2|Lack of Efficacy|21
2010443|NCT00219557|3576609|FG002|Phase 2|Lack of Efficacy|15
2010444|NCT00219557|3576607|FG000|Phase 2|Adverse Event|0
2010445|NCT00219557|3576608|FG001|Phase 2|Adverse Event|22
2010446|NCT00219557|3576609|FG002|Phase 2|Adverse Event|2
2010447|NCT00219557|3576607|FG000|Phase 2|Death|0
2010448|NCT00219557|3576608|FG001|Phase 2|Death|8
2010449|NCT00219557|3576609|FG002|Phase 2|Death|2
2010450|NCT00219557|3576607|FG000|Phase 2|Other|0
2010451|NCT00219557|3576608|FG001|Phase 2|Other|8
2010452|NCT00219557|3576609|FG002|Phase 2|Other|6
2010453|NCT00219557|3576607|FG000|Phase 2|Withdrawal by Subject|0
2010454|NCT00219557|3576608|FG001|Phase 2|Withdrawal by Subject|9
2010455|NCT00219557|3576609|FG002|Phase 2|Withdrawal by Subject|5
2010456|NCT00219557|3576607|FG000|Phase 2|Treatment not received|0
2010457|NCT00219557|3576608|FG001|Phase 2|Treatment not received|1
2010458|NCT00219557|3576609|FG002|Phase 2|Treatment not received|3
2010459|NCT00220636|3576618|FG000|Overall Study|Withdrawal by Subject|4
2010460|NCT00220701|3576625|FG000|Overall Study|Lost to Follow-up|5
2010461|NCT00220701|3576626|FG001|Overall Study|Lost to Follow-up|4
2010462|NCT00220727|3576634|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1
2010463|NCT00220727|3576635|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0
2010464|NCT00220740|3576645|FG000|Efficacy Period|Entered rescue treatment with placebo|23
2010465|NCT00220740|3576646|FG001|Efficacy Period|Entered rescue treatment with placebo|0
2010466|NCT00220740|3576645|FG000|Efficacy Period|Adverse Event|1
2010467|NCT00220740|3576646|FG001|Efficacy Period|Adverse Event|1
2010468|NCT00220740|3576645|FG000|Efficacy Period|Withdrawal by Subject|1
2010469|NCT00220740|3576646|FG001|Efficacy Period|Withdrawal by Subject|0
2010470|NCT00220740|3576645|FG000|Efficacy Period|Protocol Violation|1
2010471|NCT00220740|3576646|FG001|Efficacy Period|Protocol Violation|0
2010472|NCT00220740|3576645|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
2010473|NCT00220740|3576646|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
2010474|NCT00220779|3576657|FG000|Overall Study|Adverse Event|1
2010475|NCT00220779|3576658|FG001|Overall Study|Adverse Event|0
2010476|NCT00220779|3576659|FG002|Overall Study|Adverse Event|0
2010477|NCT00220779|3576657|FG000|Overall Study|Withdrawal by Subject|1
2010478|NCT00220779|3576658|FG001|Overall Study|Withdrawal by Subject|4
2010479|NCT00220779|3576659|FG002|Overall Study|Withdrawal by Subject|1
2010480|NCT00220779|3576657|FG000|Overall Study|Non-compliance|1
2010481|NCT00220779|3576658|FG001|Overall Study|Non-compliance|0
2010482|NCT00220779|3576659|FG002|Overall Study|Non-compliance|0
2010483|NCT00220779|3576657|FG000|Overall Study|Too time consuming|1
2010484|NCT00220779|3576658|FG001|Overall Study|Too time consuming|0
2010485|NCT00220779|3576659|FG002|Overall Study|Too time consuming|0
2010486|NCT00220779|3576657|FG000|Overall Study|Pregnancy|0
2010487|NCT00220779|3576658|FG001|Overall Study|Pregnancy|0
2010488|NCT00220779|3576659|FG002|Overall Study|Pregnancy|2
2010489|NCT00220779|3576657|FG000|Overall Study|Lack of Efficacy|3
2010490|NCT00220779|3576658|FG001|Overall Study|Lack of Efficacy|0
2010491|NCT00220779|3576659|FG002|Overall Study|Lack of Efficacy|1
2010492|NCT00220805|3576669|FG000|Overall Study|Adverse Event|1
2010493|NCT00220805|3576670|FG001|Overall Study|Adverse Event|3
2010494|NCT00220805|3576669|FG000|Overall Study|Withdrawal by Subject|3
2010495|NCT00220805|3576670|FG001|Overall Study|Withdrawal by Subject|0
2010496|NCT00220805|3576669|FG000|Overall Study|Lack of Efficacy|1
2010497|NCT00220805|3576670|FG001|Overall Study|Lack of Efficacy|0
2010498|NCT00220805|3576669|FG000|Overall Study|Develop. of choroidal neovascularization|3
2010499|NCT00220805|3576670|FG001|Overall Study|Develop. of choroidal neovascularization|8
2214432|NCT01687283|3856701|FG001|Overall Study|Lack of Efficacy|1
2010500|NCT00221104|3576687|FG000|Overall Study|Adverse Event|1
2010501|NCT00221104|3576688|FG001|Overall Study|Adverse Event|0
2010502|NCT00221104|3576687|FG000|Overall Study|Physician Decision|1
2010503|NCT00221104|3576688|FG001|Overall Study|Physician Decision|0
2010504|NCT00221104|3576687|FG000|Overall Study|Protocol Violation|2
2010505|NCT00221104|3576688|FG001|Overall Study|Protocol Violation|0
2010506|NCT00221104|3576687|FG000|Overall Study|Withdrawal by Subject|42
2010507|NCT00221104|3576688|FG001|Overall Study|Withdrawal by Subject|29
2010508|NCT00221104|3576687|FG000|Overall Study|Others|37
2010509|NCT00221104|3576688|FG001|Overall Study|Others|47
2010510|NCT00221195|3576709|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
2010511|NCT00221195|3576710|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
2010512|NCT00221195|3576709|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0
2010513|NCT00221195|3576710|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1
2010514|NCT00221195|3576709|FG000|Washout Period (Months 7-9)|Death|0
2010515|NCT00221195|3576710|FG001|Washout Period (Months 7-9)|Death|1
2010516|NCT00221195|3576709|FG000|Therapy 2 (Months 10-15)|Death|1
2010517|NCT00221195|3576710|FG001|Therapy 2 (Months 10-15)|Death|0
2010518|NCT00221195|3576709|FG000|Therapy 2 (Months 10-15)|Adverse Event|1
2010519|NCT00221195|3576710|FG001|Therapy 2 (Months 10-15)|Adverse Event|0
2010520|NCT00221403|3576743|FG000|Overall Study|Protocol Violation|1
2010521|NCT00221403|3576744|FG001|Overall Study|Protocol Violation|0
2010522|NCT00221403|3576745|FG002|Overall Study|Protocol Violation|0
2010523|NCT00221403|3576743|FG000|Overall Study|Physician Decision|1
2010524|NCT00221403|3576744|FG001|Overall Study|Physician Decision|0
2010525|NCT00221403|3576745|FG002|Overall Study|Physician Decision|0
2010526|NCT00221403|3576743|FG000|Overall Study|Withdrawal by Subject|0
2010527|NCT00221403|3576744|FG001|Overall Study|Withdrawal by Subject|3
2010528|NCT00221403|3576745|FG002|Overall Study|Withdrawal by Subject|0
2010529|NCT00221403|3576743|FG000|Overall Study|Lack of Efficacy|0
2010530|NCT00221403|3576744|FG001|Overall Study|Lack of Efficacy|1
2010531|NCT00221403|3576745|FG002|Overall Study|Lack of Efficacy|0
2010532|NCT00221403|3576743|FG000|Overall Study|Adverse Event|0
2010533|NCT00221403|3576744|FG001|Overall Study|Adverse Event|1
2010534|NCT00221403|3576745|FG002|Overall Study|Adverse Event|0
2010535|NCT00222105|3576753|FG000|Overall Study|Removed due to wrong diagnosis|1
2010536|NCT00222105|3576753|FG000|Overall Study|Withdrawal by Subject|1
2010537|NCT00222105|3576753|FG000|Overall Study|Adverse Event|8
2010538|NCT00222105|3576753|FG000|Overall Study|Treatment delays|2
2010539|NCT00222105|3576753|FG000|Overall Study|Death|2
2010540|NCT00222729|3576766|FG000|Overall Study|Adverse Event|3
2010541|NCT00223080|3576772|FG000|Overall Study|Withdrawal by Subject|253
2010542|NCT00223080|3576773|FG001|Overall Study|Withdrawal by Subject|232
2010543|NCT00223080|3576772|FG000|Overall Study|Required contraindicated med|0
2010544|NCT00223080|3576773|FG001|Overall Study|Required contraindicated med|1
2010545|NCT00223080|3576772|FG000|Overall Study|Non-compliant|7
2010546|NCT00223080|3576773|FG001|Overall Study|Non-compliant|7
2010547|NCT00223080|3576772|FG000|Overall Study|Moved from study area|37
2010548|NCT00223080|3576773|FG001|Overall Study|Moved from study area|47
2010549|NCT00223080|3576772|FG000|Overall Study|Lost to Follow-up|259
2010550|NCT00223080|3576773|FG001|Overall Study|Lost to Follow-up|284
2010551|NCT00223080|3576772|FG000|Overall Study|Death|85
2010552|NCT00223080|3576773|FG001|Overall Study|Death|74
2010553|NCT00223080|3576772|FG000|Overall Study|Other|14
2010554|NCT00223080|3576773|FG001|Overall Study|Other|11
2010555|NCT00223080|3576772|FG000|Overall Study|Reason not provided|141
2010556|NCT00223080|3576773|FG001|Overall Study|Reason not provided|140
2010557|NCT00223080|3576772|FG000|Overall Study|Adverse Event|0
2010558|NCT00223080|3576773|FG001|Overall Study|Adverse Event|1
2010559|NCT00223496|3576797|FG000|Overall Study|screen failure|9
2010560|NCT00223496|3576797|FG000|Overall Study|Lost to Follow-up|4
2010561|NCT00223496|3576797|FG000|Overall Study|Lack of Efficacy|6
2010562|NCT00223496|3576797|FG000|Overall Study|Withdrawal by Subject|1
2010563|NCT00223496|3576797|FG000|Overall Study|Physician Decision|2
2010564|NCT00223795|3576838|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7
2010565|NCT00223795|3576839|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9
2010566|NCT00223795|3576838|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
2010567|NCT00223795|3576839|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
2010568|NCT00223808|3576849|FG000|Overall Study|<5 hrs therapy before discharge|3
2010569|NCT00223808|3576850|FG001|Overall Study|<5 hrs therapy before discharge|5
2010570|NCT00223808|3576851|FG002|Overall Study|<5 hrs therapy before discharge|5
2010571|NCT00223977|3576871|FG000|Overall Study|Adverse Event|7
2010572|NCT00223977|3576872|FG001|Overall Study|Adverse Event|10
2010573|NCT00223977|3576873|FG002|Overall Study|Adverse Event|0
2010574|NCT00223977|3576871|FG000|Overall Study|Protocol Violation|0
2010575|NCT00223977|3576872|FG001|Overall Study|Protocol Violation|0
2010576|NCT00223977|3576873|FG002|Overall Study|Protocol Violation|1
2010577|NCT00223977|3576871|FG000|Overall Study|Withdrawal by Subject|1
2010578|NCT00223977|3576872|FG001|Overall Study|Withdrawal by Subject|1
2010579|NCT00223977|3576873|FG002|Overall Study|Withdrawal by Subject|2
2010580|NCT00223977|3576871|FG000|Overall Study|Other|1
2010581|NCT00223977|3576872|FG001|Overall Study|Other|0
2010582|NCT00223977|3576873|FG002|Overall Study|Other|0
2010583|NCT00223990|3576883|FG000|Overall Study|Moved from area|2
2010584|NCT00223990|3576884|FG001|Overall Study|Moved from area|1
2010585|NCT00223990|3576883|FG000|Overall Study|Withdrawal by Subject|4
2010586|NCT00223990|3576884|FG001|Overall Study|Withdrawal by Subject|8
2010587|NCT00223990|3576883|FG000|Overall Study|Lost to Follow-up|1
2010588|NCT00223990|3576884|FG001|Overall Study|Lost to Follow-up|0
2010589|NCT00224016|3576892|FG000|Titration Period|Withdrawal by Subject|0
2010590|NCT00224016|3576893|FG001|Titration Period|Withdrawal by Subject|1
2010591|NCT00224016|3576892|FG000|Titration Period|Lost to Follow-up|1
2010592|NCT00224016|3576893|FG001|Titration Period|Lost to Follow-up|0
2010593|NCT00224016|3576892|FG000|Maintenance Period|Withdrawal by Subject|2
2010594|NCT00224016|3576893|FG001|Maintenance Period|Withdrawal by Subject|0
2010595|NCT00224016|3576892|FG000|Maintenance Period|Lost to Follow-up|0
2010596|NCT00224016|3576893|FG001|Maintenance Period|Lost to Follow-up|1
2010597|NCT00224029|3576899|FG000|Overall Study|Lost to Follow-up|1
2010598|NCT00224029|3576899|FG000|Overall Study|Withdrawal by Subject|4
2010599|NCT00224029|3576899|FG000|Overall Study|Other|1
2010600|NCT00224042|3576905|FG000|Overall Study|Adverse Event|2
2010601|NCT00224042|3576906|FG001|Overall Study|Adverse Event|1
2010602|NCT00224042|3576905|FG000|Overall Study|Protocol Violation|0
2010603|NCT00224042|3576906|FG001|Overall Study|Protocol Violation|1
2010604|NCT00224042|3576905|FG000|Overall Study|Physician Decision|0
2010605|NCT00224042|3576906|FG001|Overall Study|Physician Decision|1
2010606|NCT00224042|3576905|FG000|Overall Study|Did not meet lab incusion criteria|2
2010607|NCT00224042|3576906|FG001|Overall Study|Did not meet lab incusion criteria|3
2010608|NCT00224042|3576905|FG000|Overall Study|Other|2
2010609|NCT00224042|3576906|FG001|Overall Study|Other|0
2010610|NCT00224055|3576914|FG000|Overall Study|Adverse Event|9
2010611|NCT00224055|3576915|FG001|Overall Study|Adverse Event|3
2010612|NCT00224055|3576914|FG000|Overall Study|Lost to Follow-up|1
2010613|NCT00224055|3576915|FG001|Overall Study|Lost to Follow-up|2
2010614|NCT00224055|3576914|FG000|Overall Study|Protocol Violation|1
2010615|NCT00224055|3576915|FG001|Overall Study|Protocol Violation|1
2010616|NCT00224055|3576914|FG000|Overall Study|Inclusion Violation|3
2010617|NCT00224055|3576915|FG001|Overall Study|Inclusion Violation|6
2010618|NCT00224055|3576914|FG000|Overall Study|Withdrawal by Subject|0
2010619|NCT00224055|3576915|FG001|Overall Study|Withdrawal by Subject|2
2010620|NCT00224055|3576914|FG000|Overall Study|Other|1
2010621|NCT00224055|3576915|FG001|Overall Study|Other|0
2010622|NCT00224107|3576923|FG000|Overall Study|Adverse Event|20
2010623|NCT00224107|3576924|FG001|Overall Study|Adverse Event|6
2010624|NCT00224107|3576923|FG000|Overall Study|Protocol Violation|2
2010625|NCT00224107|3576924|FG001|Overall Study|Protocol Violation|3
2010626|NCT00224107|3576923|FG000|Overall Study|Withdrawal by Subject|1
2010627|NCT00224107|3576924|FG001|Overall Study|Withdrawal by Subject|4
2010628|NCT00224107|3576923|FG000|Overall Study|Lack of Efficacy|2
2010629|NCT00224107|3576924|FG001|Overall Study|Lack of Efficacy|0
2010630|NCT00224107|3576923|FG000|Overall Study|Lost to Follow-up|4
2010631|NCT00224107|3576924|FG001|Overall Study|Lost to Follow-up|0
2010632|NCT00224107|3576923|FG000|Overall Study|Physician Decision|1
2010633|NCT00224107|3576924|FG001|Overall Study|Physician Decision|0
2010634|NCT00224107|3576923|FG000|Overall Study|Other|1
2010635|NCT00224107|3576924|FG001|Overall Study|Other|1
2010636|NCT00224120|3576932|FG000|Overall Study|Adverse Event|10
2010637|NCT00224120|3576933|FG001|Overall Study|Adverse Event|4
2010638|NCT00224120|3576932|FG000|Overall Study|Protocol Violation|1
2010639|NCT00224120|3576933|FG001|Overall Study|Protocol Violation|0
2010640|NCT00224120|3576932|FG000|Overall Study|Withdrawal by Subject|5
2010641|NCT00224120|3576933|FG001|Overall Study|Withdrawal by Subject|10
2010642|NCT00224120|3576932|FG000|Overall Study|Lack of Efficacy|0
2010643|NCT00224120|3576933|FG001|Overall Study|Lack of Efficacy|2
2010644|NCT00224120|3576932|FG000|Overall Study|Lost to Follow-up|2
2010645|NCT00224120|3576933|FG001|Overall Study|Lost to Follow-up|3
2010646|NCT00224120|3576932|FG000|Overall Study|Other|4
2010647|NCT00224120|3576933|FG001|Overall Study|Other|5
2010648|NCT00224133|3576939|FG000|Overall Study|Adverse Event|93
2010649|NCT00224133|3576939|FG000|Overall Study|Protocol Violation|6
2010650|NCT00224133|3576939|FG000|Overall Study|Withdrawal by Subject|33
2010651|NCT00224133|3576939|FG000|Overall Study|Lack of Efficacy|58
2010652|NCT00224133|3576939|FG000|Overall Study|Lost to Follow-up|21
2010653|NCT00224133|3576939|FG000|Overall Study|Physician Decision|1
2010654|NCT00224133|3576939|FG000|Overall Study|Other|14
2010655|NCT00224484|3576950|FG000|Overall Study|Serious Adverse Event|1
2010656|NCT00224484|3576951|FG001|Overall Study|Serious Adverse Event|1
2010657|NCT00224484|3576952|FG002|Overall Study|Serious Adverse Event|0
2010658|NCT00224484|3576950|FG000|Overall Study|Non-Serious Adverse Event|5
2010659|NCT00224484|3576951|FG001|Overall Study|Non-Serious Adverse Event|7
2010660|NCT00224484|3576952|FG002|Overall Study|Non-Serious Adverse Event|3
2010661|NCT00224484|3576950|FG000|Overall Study|Protocol Violation|2
2010662|NCT00224484|3576951|FG001|Overall Study|Protocol Violation|2
2010663|NCT00224484|3576952|FG002|Overall Study|Protocol Violation|0
2010664|NCT00224484|3576950|FG000|Overall Study|Withdrawal by Subject|49
2010665|NCT00224484|3576951|FG001|Overall Study|Withdrawal by Subject|18
2010666|NCT00224484|3576952|FG002|Overall Study|Withdrawal by Subject|16
2010667|NCT00224484|3576950|FG000|Overall Study|Migrated/moved from study area|18
2010668|NCT00224484|3576951|FG001|Overall Study|Migrated/moved from study area|5
2010669|NCT00224484|3576952|FG002|Overall Study|Migrated/moved from study area|5
2010670|NCT00224484|3576950|FG000|Overall Study|Lost to Follow-up|66
2010671|NCT00224484|3576951|FG001|Overall Study|Lost to Follow-up|28
2010672|NCT00224484|3576952|FG002|Overall Study|Lost to Follow-up|36
2010673|NCT00224484|3576950|FG000|Overall Study|Reason not specified|5
2010674|NCT00224484|3576951|FG001|Overall Study|Reason not specified|4
2010675|NCT00224484|3576952|FG002|Overall Study|Reason not specified|2
2010676|NCT00224770|3576966|FG000|Overall Study|Lost to Follow-up|4
2010677|NCT00224770|3576967|FG001|Overall Study|Lost to Follow-up|2
2010678|NCT00224770|3576968|FG002|Overall Study|Lost to Follow-up|0
2010679|NCT00224874|3576981|FG000|Overall Study|Withdrawal by Subject|0
2010680|NCT00224874|3576982|FG001|Overall Study|Withdrawal by Subject|0
2010681|NCT00224874|3576983|FG002|Overall Study|Withdrawal by Subject|1
2010682|NCT00224874|3576984|FG003|Overall Study|Withdrawal by Subject|0
2010683|NCT00224887|3576996|FG000|Overall Study|Pregnancy|6
2010684|NCT00224887|3576997|FG001|Overall Study|Pregnancy|6
2010685|NCT00225147|3577030|FG000|Open-label Phase|Lost to Follow-up|0
2010686|NCT00225147|3577031|FG001|Open-label Phase|Lost to Follow-up|0
2010687|NCT00225147|3577032|FG002|Open-label Phase|Lost to Follow-up|0
2010688|NCT00225147|3577033|FG003|Open-label Phase|Lost to Follow-up|4
2010689|NCT00225147|3577030|FG000|Open-label Phase|Withdrawal by Subject|0
2010690|NCT00225147|3577031|FG001|Open-label Phase|Withdrawal by Subject|0
2010691|NCT00225147|3577032|FG002|Open-label Phase|Withdrawal by Subject|0
2010692|NCT00225147|3577033|FG003|Open-label Phase|Withdrawal by Subject|6
2010693|NCT00225212|3577045|FG000|Overall Study|Disease progression|2
2010694|NCT00225212|3577045|FG000|Overall Study|Death|1
2010695|NCT00225212|3577045|FG000|Overall Study|Adverse Event|2
2010696|NCT00225212|3577045|FG000|Overall Study|Intercurrent illness|1
2010697|NCT00225251|3577051|FG000|Overall Study|Withdrawal by Subject|1
2010698|NCT00225251|3577052|FG001|Overall Study|Withdrawal by Subject|1
2010699|NCT00225277|3577060|FG000|Overall Study|Adverse Event|30
2010700|NCT00225277|3577061|FG001|Overall Study|Adverse Event|34
2010701|NCT00225277|3577060|FG000|Overall Study|Lack of Efficacy|4
2010702|NCT00225277|3577061|FG001|Overall Study|Lack of Efficacy|1
2010703|NCT00225277|3577060|FG000|Overall Study|Lost to Follow-up|4
2010704|NCT00225277|3577061|FG001|Overall Study|Lost to Follow-up|6
2010705|NCT00225277|3577060|FG000|Overall Study|Physician Decision|6
2010706|NCT00225277|3577061|FG001|Overall Study|Physician Decision|8
2010707|NCT00225277|3577060|FG000|Overall Study|Protocol Violation|6
2010708|NCT00225277|3577061|FG001|Overall Study|Protocol Violation|3
2010709|NCT00225277|3577060|FG000|Overall Study|Withdrawal by Subject|40
2010710|NCT00225277|3577061|FG001|Overall Study|Withdrawal by Subject|34
2010711|NCT00225277|3577060|FG000|Overall Study|Other|7
2010712|NCT00225277|3577061|FG001|Overall Study|Other|9
2010713|NCT00225758|3577089|FG000|Overall Study|Adverse Event|4
2010714|NCT00226499|3577110|FG000|Overall Study|Adverse Event|10
2010715|NCT00226499|3577111|FG001|Overall Study|Adverse Event|6
2010716|NCT00226499|3577112|FG002|Overall Study|Adverse Event|3
2010717|NCT00226499|3577110|FG000|Overall Study|Others|1064
2010718|NCT00226499|3577111|FG001|Overall Study|Others|1066
2010719|NCT00226499|3577112|FG002|Overall Study|Others|356
2010720|NCT00226655|3577131|FG000|Overall Study|Death|13
2010721|NCT00226655|3577131|FG000|Overall Study|Withdrawal by Subject|15
2010722|NCT00226655|3577131|FG000|Overall Study|Adverse Event|35
2010723|NCT00226655|3577131|FG000|Overall Study|Physician Decision|6
2010724|NCT00226655|3577131|FG000|Overall Study|Clinical deterioration|10
2010725|NCT00226811|3577135|FG000|Overall Study|Death|8
2010726|NCT00226811|3577135|FG000|Overall Study|Adverse Event|11
2010727|NCT00226811|3577135|FG000|Overall Study|Lack of Efficacy|55
2010728|NCT00226811|3577135|FG000|Overall Study|Withdrawal by Subject|2
2010729|NCT00226941|3577143|FG000|Overall Study|Withdrawal by subject - toxicity|0
2010730|NCT00226941|3577144|FG001|Overall Study|Withdrawal by subject - toxicity|0
2010731|NCT00226941|3577145|FG002|Overall Study|Withdrawal by subject - toxicity|0
2010732|NCT00226941|3577146|FG003|Overall Study|Withdrawal by subject - toxicity|1
2010733|NCT00226941|3577143|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0
2010734|NCT00226941|3577144|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0
2010735|NCT00226941|3577145|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0
2010736|NCT00226941|3577146|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1
2010737|NCT00227266|3577170|FG000|Overall Study|Withdrawal by Subject|0
2010738|NCT00227266|3577171|FG001|Overall Study|Withdrawal by Subject|0
2010739|NCT00227266|3577172|FG002|Overall Study|Withdrawal by Subject|1
2010740|NCT00227266|3577170|FG000|Overall Study|Protocol Violation|1
2010741|NCT00227266|3577171|FG001|Overall Study|Protocol Violation|0
2010742|NCT00227266|3577172|FG002|Overall Study|Protocol Violation|1
2010743|NCT00227266|3577170|FG000|Overall Study|Excessive weight gain|0
2010744|NCT00227266|3577171|FG001|Overall Study|Excessive weight gain|0
2010745|NCT00227266|3577172|FG002|Overall Study|Excessive weight gain|2
2010746|NCT00227305|3577183|FG000|Overall Study|Adverse Event|40
2010747|NCT00227305|3577183|FG000|Overall Study|Withdrawal by Subject|42
2010748|NCT00227305|3577183|FG000|Overall Study|Lost to Follow-up|33
2010749|NCT00227305|3577183|FG000|Overall Study|Study specific discontinuation|13
2010750|NCT00227305|3577183|FG000|Overall Study|MOVED OUT OF AREA|3
2010751|NCT00227305|3577183|FG000|Overall Study|Lack of Efficacy|7
2010752|NCT00227305|3577183|FG000|Overall Study|Physician Decision|3
2010753|NCT00227305|3577183|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
2010754|NCT00227305|3577183|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
2010755|NCT00227305|3577183|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
2010756|NCT00227344|3577189|FG000|Overall Study|study terminated early|12
2010757|NCT00227344|3577190|FG001|Overall Study|study terminated early|5
2010758|NCT00227370|3577198|FG000|Overall Study|Withdrawal by Subject|1
2010759|NCT00227370|3577199|FG001|Overall Study|Withdrawal by Subject|2
2010760|NCT00227370|3577198|FG000|Overall Study|Death|3
2010761|NCT00227370|3577199|FG001|Overall Study|Death|4
2010762|NCT00227370|3577198|FG000|Overall Study|Adverse Event|6
2010763|NCT00227370|3577199|FG001|Overall Study|Adverse Event|11
2010764|NCT00227370|3577198|FG000|Overall Study|Physician Decision|9
2010765|NCT00227370|3577199|FG001|Overall Study|Physician Decision|6
2010766|NCT00227370|3577198|FG000|Overall Study|Other reasons|2
2010767|NCT00227370|3577199|FG001|Overall Study|Other reasons|1
2010768|NCT00227539|3577205|FG000|Overall Study|Protocol Violation|1
2010769|NCT00227591|3577209|FG000|Overall Study|Withdrawal by Subject|1
2010770|NCT00227721|3577227|FG000|Overall Study|On study, but never treated.|1
2010771|NCT00227877|3577239|FG000|Pre-visit Assessment|Technical difficulties|7
2010772|NCT00227877|3577240|FG001|Pre-visit Assessment|Technical difficulties|3
2010773|NCT00227877|3577241|FG002|Pre-visit Assessment|Technical difficulties|0
2010774|NCT00227877|3577242|FG003|Pre-visit Assessment|Technical difficulties|0
2010775|NCT00227877|3577239|FG000|Post-visit Checklist|Lost to Follow-up|24
2010776|NCT00227877|3577240|FG001|Post-visit Checklist|Lost to Follow-up|13
2010777|NCT00227877|3577241|FG002|Post-visit Checklist|Lost to Follow-up|1
2010778|NCT00227877|3577242|FG003|Post-visit Checklist|Lost to Follow-up|0
2010779|NCT00227877|3577239|FG000|3-months Follow-up|Completed late|135
2010780|NCT00227877|3577240|FG001|3-months Follow-up|Completed late|128
2010781|NCT00227877|3577241|FG002|3-months Follow-up|Completed late|34
2010782|NCT00227877|3577242|FG003|3-months Follow-up|Completed late|8
2010783|NCT00227877|3577239|FG000|3-months Follow-up|Lost to Follow-up|178
2010784|NCT00227877|3577240|FG001|3-months Follow-up|Lost to Follow-up|139
2010785|NCT00227877|3577241|FG002|3-months Follow-up|Lost to Follow-up|18
2010786|NCT00227877|3577242|FG003|3-months Follow-up|Lost to Follow-up|13
2010787|NCT00227877|3577239|FG000|12-months Follow-up|Completed late|78
2010788|NCT00227877|3577240|FG001|12-months Follow-up|Completed late|74
2010789|NCT00227877|3577241|FG002|12-months Follow-up|Completed late|1
2010790|NCT00227877|3577242|FG003|12-months Follow-up|Completed late|0
2010791|NCT00227877|3577239|FG000|12-months Follow-up|Lost to Follow-up|232
2010792|NCT00227877|3577240|FG001|12-months Follow-up|Lost to Follow-up|189
2010793|NCT00227877|3577241|FG002|12-months Follow-up|Lost to Follow-up|30
2010794|NCT00227877|3577242|FG003|12-months Follow-up|Lost to Follow-up|26
2010795|NCT00227903|3577256|FG000|Overall Study|Withdrawal by Subject|2
2010796|NCT00227903|3577257|FG001|Overall Study|Withdrawal by Subject|5
2010797|NCT00227903|3577256|FG000|Overall Study|Subject moved out of area|1
2010798|NCT00227903|3577257|FG001|Overall Study|Subject moved out of area|2
2010799|NCT00227903|3577256|FG000|Overall Study|Lost to Follow-up|1
2010800|NCT00227903|3577257|FG001|Overall Study|Lost to Follow-up|3
2010801|NCT00227903|3577256|FG000|Overall Study|Miscarriage|1
2010802|NCT00227903|3577257|FG001|Overall Study|Miscarriage|0
2010803|NCT00228384|3577274|FG000|Overall Study|Death|9
2010804|NCT00228384|3577275|FG001|Overall Study|Death|3
2010805|NCT00228384|3577274|FG000|Overall Study|Lost to Follow-up|6
2010806|NCT00228384|3577275|FG001|Overall Study|Lost to Follow-up|10
2010807|NCT00228384|3577274|FG000|Overall Study|Surgical Intervention (bypass)|5
2010808|NCT00228384|3577275|FG001|Overall Study|Surgical Intervention (bypass)|5
2010809|NCT00228384|3577274|FG000|Overall Study|Withdrawal by Subject|9
2010810|NCT00228384|3577275|FG001|Overall Study|Withdrawal by Subject|10
2010811|NCT00228384|3577274|FG000|Overall Study|Physician Decision|0
2010812|NCT00228384|3577275|FG001|Overall Study|Physician Decision|1
2010813|NCT00228423|3577283|FG000|Overall Study|Adverse Event|2
2010814|NCT00228423|3577284|FG001|Overall Study|Adverse Event|5
2010815|NCT00228423|3577283|FG000|Overall Study|Withdrawal by Subject|7
2010816|NCT00228423|3577284|FG001|Overall Study|Withdrawal by Subject|3
2010817|NCT00228423|3577283|FG000|Overall Study|Protocol Violation|1
2010818|NCT00228423|3577284|FG001|Overall Study|Protocol Violation|3
2010819|NCT00228423|3577283|FG000|Overall Study|Physician Decision|0
2010820|NCT00228423|3577284|FG001|Overall Study|Physician Decision|1
2010821|NCT00228553|3577290|FG000|Overall Study|Adverse Event|112
2010822|NCT00228553|3577290|FG000|Overall Study|Lack of Efficacy|34
2010823|NCT00228553|3577290|FG000|Overall Study|Lost to Follow-up|67
2010824|NCT00228553|3577290|FG000|Overall Study|Physician Decision|48
2010825|NCT00228553|3577290|FG000|Overall Study|Protocol Violation|6
2010826|NCT00228553|3577290|FG000|Overall Study|Withdrawal by Subject|115
2010827|NCT00228553|3577290|FG000|Overall Study|Pregnancy|2
2010828|NCT00228553|3577290|FG000|Overall Study|Miscellaneous|46
2010829|NCT00228566|3577294|FG000|Overall Study|Adverse Event|31
2010830|NCT00228566|3577294|FG000|Overall Study|Lack of Efficacy|14
2010831|NCT00228566|3577294|FG000|Overall Study|Lost to Follow-up|16
2010832|NCT00228566|3577294|FG000|Overall Study|Physician Decision|5
2010833|NCT00228566|3577294|FG000|Overall Study|Withdrawal by Subject|4
2010834|NCT00228566|3577294|FG000|Overall Study|Miscellaneous|1
2010835|NCT00228813|3577298|FG000|Overall Study|Death|4
2010836|NCT00228917|3577310|FG000|Overall Study|Migrated/moved from study area|0
2010837|NCT00228917|3577311|FG001|Overall Study|Migrated/moved from study area|0
2010838|NCT00228917|3577312|FG002|Overall Study|Migrated/moved from study area|0
2010839|NCT00228917|3577313|FG003|Overall Study|Migrated/moved from study area|0
2010840|NCT00228917|3577314|FG004|Overall Study|Migrated/moved from study area|0
2010841|NCT00228917|3577315|FG005|Overall Study|Migrated/moved from study area|2
2010842|NCT00228917|3577316|FG006|Overall Study|Migrated/moved from study area|0
2010843|NCT00228917|3577317|FG007|Overall Study|Migrated/moved from study area|0
2010844|NCT00229203|3577339|FG000|Overall Study|Progressive disease|18
2010845|NCT00229203|3577340|FG001|Overall Study|Progressive disease|9
2010846|NCT00229203|3577339|FG000|Overall Study|Toxicity|6
2010847|NCT00229203|3577340|FG001|Overall Study|Toxicity|1
2010848|NCT00229203|3577339|FG000|Overall Study|Death|4
2010849|NCT00229203|3577340|FG001|Overall Study|Death|2
2010850|NCT00229203|3577339|FG000|Overall Study|Other|3
2010851|NCT00229203|3577340|FG001|Overall Study|Other|3
2010852|NCT00229203|3577339|FG000|Overall Study|Withdrawal by Subject|1
2010853|NCT00229203|3577340|FG001|Overall Study|Withdrawal by Subject|4
2010854|NCT00229658|3577354|FG000|Overall Study|Administrative|2
2010855|NCT00229658|3577355|FG001|Overall Study|Administrative|1
2010856|NCT00229658|3577354|FG000|Overall Study|Investigator decision|13
2010857|NCT00229658|3577355|FG001|Overall Study|Investigator decision|10
2010858|NCT00229658|3577354|FG000|Overall Study|Other|80
2010859|NCT00229658|3577355|FG001|Overall Study|Other|60
2010860|NCT00229658|3577354|FG000|Overall Study|Lost to Follow-up|82
2010861|NCT00229658|3577355|FG001|Overall Study|Lost to Follow-up|55
2010862|NCT00229658|3577354|FG000|Overall Study|Serious Adverse Event|2
2010863|NCT00229658|3577355|FG001|Overall Study|Serious Adverse Event|2
2010864|NCT00229658|3577354|FG000|Overall Study|Withdrawal of consent|46
2010865|NCT00229658|3577355|FG001|Overall Study|Withdrawal of consent|39
2010866|NCT00229723|3577368|FG000|Concomitant Phase|Adverse Event|4
2010867|NCT00229723|3577369|FG001|Concomitant Phase|Adverse Event|2
2010868|NCT00229723|3577370|FG002|Concomitant Phase|Adverse Event|5
2010869|NCT00229723|3577371|FG003|Concomitant Phase|Adverse Event|2
2010870|NCT00229723|3577372|FG004|Concomitant Phase|Adverse Event|0
2010871|NCT00229723|3577373|FG005|Concomitant Phase|Adverse Event|1
2010872|NCT00229723|3577374|FG006|Concomitant Phase|Adverse Event|2
2010873|NCT00229723|3577368|FG000|Concomitant Phase|Objective disease progression|0
2010874|NCT00229723|3577369|FG001|Concomitant Phase|Objective disease progression|0
2010875|NCT00229723|3577370|FG002|Concomitant Phase|Objective disease progression|0
2010876|NCT00229723|3577371|FG003|Concomitant Phase|Objective disease progression|0
2010877|NCT00229723|3577372|FG004|Concomitant Phase|Objective disease progression|0
2010878|NCT00229723|3577373|FG005|Concomitant Phase|Objective disease progression|0
2010879|NCT00229723|3577374|FG006|Concomitant Phase|Objective disease progression|0
2010880|NCT00229723|3577368|FG000|Concomitant Phase|Clinical progression|0
2010881|NCT00229723|3577369|FG001|Concomitant Phase|Clinical progression|0
2010882|NCT00229723|3577370|FG002|Concomitant Phase|Clinical progression|0
2010883|NCT00229723|3577371|FG003|Concomitant Phase|Clinical progression|0
2010884|NCT00229723|3577372|FG004|Concomitant Phase|Clinical progression|0
2010885|NCT00229723|3577373|FG005|Concomitant Phase|Clinical progression|0
2010886|NCT00229723|3577374|FG006|Concomitant Phase|Clinical progression|1
2010887|NCT00229723|3577368|FG000|Concomitant Phase|Lost to Follow-up|0
2010888|NCT00229723|3577369|FG001|Concomitant Phase|Lost to Follow-up|0
2010889|NCT00229723|3577370|FG002|Concomitant Phase|Lost to Follow-up|0
2010890|NCT00229723|3577371|FG003|Concomitant Phase|Lost to Follow-up|0
2010891|NCT00229723|3577372|FG004|Concomitant Phase|Lost to Follow-up|1
2010892|NCT00229723|3577373|FG005|Concomitant Phase|Lost to Follow-up|0
2010893|NCT00229723|3577374|FG006|Concomitant Phase|Lost to Follow-up|0
2010894|NCT00229723|3577368|FG000|Concomitant Phase|Informed consent withdrawn|3
2010895|NCT00229723|3577369|FG001|Concomitant Phase|Informed consent withdrawn|2
2010896|NCT00229723|3577370|FG002|Concomitant Phase|Informed consent withdrawn|0
2010897|NCT00229723|3577371|FG003|Concomitant Phase|Informed consent withdrawn|2
2010898|NCT00229723|3577372|FG004|Concomitant Phase|Informed consent withdrawn|0
2010899|NCT00229723|3577373|FG005|Concomitant Phase|Informed consent withdrawn|0
2010900|NCT00229723|3577374|FG006|Concomitant Phase|Informed consent withdrawn|0
2010901|NCT00229723|3577368|FG000|Concomitant Phase|Severe non-compliance|0
2010902|NCT00229723|3577369|FG001|Concomitant Phase|Severe non-compliance|1
2010903|NCT00229723|3577370|FG002|Concomitant Phase|Severe non-compliance|0
2010904|NCT00229723|3577371|FG003|Concomitant Phase|Severe non-compliance|0
2010905|NCT00229723|3577372|FG004|Concomitant Phase|Severe non-compliance|1
2010906|NCT00229723|3577373|FG005|Concomitant Phase|Severe non-compliance|0
2010907|NCT00229723|3577374|FG006|Concomitant Phase|Severe non-compliance|0
2010908|NCT00229723|3577368|FG000|Concomitant Phase|Other|3
2010909|NCT00229723|3577369|FG001|Concomitant Phase|Other|0
2010910|NCT00229723|3577370|FG002|Concomitant Phase|Other|1
2010911|NCT00229723|3577371|FG003|Concomitant Phase|Other|1
2010912|NCT00229723|3577372|FG004|Concomitant Phase|Other|0
2010913|NCT00229723|3577373|FG005|Concomitant Phase|Other|2
2010914|NCT00229723|3577374|FG006|Concomitant Phase|Other|0
2010915|NCT00229723|3577368|FG000|Maintenance Phase|Adverse Event|7
2010916|NCT00229723|3577369|FG001|Maintenance Phase|Adverse Event|2
2010917|NCT00229723|3577370|FG002|Maintenance Phase|Adverse Event|1
2010918|NCT00229723|3577371|FG003|Maintenance Phase|Adverse Event|4
2010919|NCT00229723|3577372|FG004|Maintenance Phase|Adverse Event|7
2010920|NCT00229723|3577373|FG005|Maintenance Phase|Adverse Event|5
2010921|NCT00229723|3577374|FG006|Maintenance Phase|Adverse Event|2
2010922|NCT00229723|3577368|FG000|Maintenance Phase|Objective disease progression|5
2010923|NCT00229723|3577369|FG001|Maintenance Phase|Objective disease progression|5
2010924|NCT00229723|3577370|FG002|Maintenance Phase|Objective disease progression|3
2010925|NCT00229723|3577371|FG003|Maintenance Phase|Objective disease progression|6
2010926|NCT00229723|3577372|FG004|Maintenance Phase|Objective disease progression|2
2010927|NCT00229723|3577373|FG005|Maintenance Phase|Objective disease progression|9
2010928|NCT00229723|3577374|FG006|Maintenance Phase|Objective disease progression|5
2010929|NCT00229723|3577368|FG000|Maintenance Phase|Clinical progression|4
2010930|NCT00229723|3577369|FG001|Maintenance Phase|Clinical progression|1
2010931|NCT00229723|3577370|FG002|Maintenance Phase|Clinical progression|2
2010932|NCT00229723|3577371|FG003|Maintenance Phase|Clinical progression|2
2010933|NCT00229723|3577372|FG004|Maintenance Phase|Clinical progression|1
2010934|NCT00229723|3577373|FG005|Maintenance Phase|Clinical progression|1
2010935|NCT00229723|3577374|FG006|Maintenance Phase|Clinical progression|1
2010936|NCT00229723|3577368|FG000|Maintenance Phase|Lost to Follow-up|0
2010937|NCT00229723|3577369|FG001|Maintenance Phase|Lost to Follow-up|1
2010938|NCT00229723|3577370|FG002|Maintenance Phase|Lost to Follow-up|2
2010939|NCT00229723|3577371|FG003|Maintenance Phase|Lost to Follow-up|2
2010940|NCT00229723|3577372|FG004|Maintenance Phase|Lost to Follow-up|0
2010941|NCT00229723|3577373|FG005|Maintenance Phase|Lost to Follow-up|0
2010942|NCT00229723|3577374|FG006|Maintenance Phase|Lost to Follow-up|1
2010943|NCT00229723|3577368|FG000|Maintenance Phase|Informed consent withdrawn|1
2010944|NCT00229723|3577369|FG001|Maintenance Phase|Informed consent withdrawn|0
2010945|NCT00229723|3577370|FG002|Maintenance Phase|Informed consent withdrawn|0
2010946|NCT00229723|3577371|FG003|Maintenance Phase|Informed consent withdrawn|1
2010947|NCT00229723|3577372|FG004|Maintenance Phase|Informed consent withdrawn|1
2010948|NCT00229723|3577373|FG005|Maintenance Phase|Informed consent withdrawn|1
2010949|NCT00229723|3577374|FG006|Maintenance Phase|Informed consent withdrawn|0
2010950|NCT00229723|3577368|FG000|Maintenance Phase|Severe non-compliance|3
2010951|NCT00229723|3577369|FG001|Maintenance Phase|Severe non-compliance|1
2010952|NCT00229723|3577370|FG002|Maintenance Phase|Severe non-compliance|0
2010953|NCT00229723|3577371|FG003|Maintenance Phase|Severe non-compliance|0
2010954|NCT00229723|3577372|FG004|Maintenance Phase|Severe non-compliance|1
2010955|NCT00229723|3577373|FG005|Maintenance Phase|Severe non-compliance|0
2010956|NCT00229723|3577374|FG006|Maintenance Phase|Severe non-compliance|0
2010957|NCT00229723|3577368|FG000|Maintenance Phase|Other|5
2010958|NCT00229723|3577369|FG001|Maintenance Phase|Other|4
2010959|NCT00229723|3577370|FG002|Maintenance Phase|Other|1
2010960|NCT00229723|3577371|FG003|Maintenance Phase|Other|2
2010961|NCT00229723|3577372|FG004|Maintenance Phase|Other|3
2010962|NCT00229723|3577373|FG005|Maintenance Phase|Other|3
2010963|NCT00229723|3577374|FG006|Maintenance Phase|Other|1
2010964|NCT00230048|3577419|FG000|Overall Study|Lost to Follow-up|13
2010965|NCT00230048|3577420|FG001|Overall Study|Lost to Follow-up|18
2010966|NCT00230178|3577451|FG000|Overall Study|Adverse Event|1
2010967|NCT00230178|3577452|FG001|Overall Study|Adverse Event|5
2010968|NCT00230178|3577453|FG002|Overall Study|Adverse Event|2
2010969|NCT00230178|3577451|FG000|Overall Study|Withdrawal by Subject|0
2010970|NCT00230178|3577452|FG001|Overall Study|Withdrawal by Subject|0
2010971|NCT00230178|3577453|FG002|Overall Study|Withdrawal by Subject|1
2010972|NCT00230178|3577451|FG000|Overall Study|Various other reasons|3
2010973|NCT00230178|3577452|FG001|Overall Study|Various other reasons|2
2010974|NCT00230178|3577453|FG002|Overall Study|Various other reasons|4
2025480|NCT00346164|3594390|FG002|Overall Study|Physician Decision|2
2025481|NCT00346164|3594391|FG003|Overall Study|Physician Decision|27
2025482|NCT00346164|3594388|FG000|Overall Study|Protocol Violation|6
2025483|NCT00346164|3594389|FG001|Overall Study|Protocol Violation|2
2025484|NCT00346164|3594390|FG002|Overall Study|Protocol Violation|10
2025485|NCT00346164|3594391|FG003|Overall Study|Protocol Violation|4
2025486|NCT00346164|3594388|FG000|Overall Study|Withdrawal by Subject|0
2025487|NCT00346164|3594389|FG001|Overall Study|Withdrawal by Subject|0
2025488|NCT00346164|3594390|FG002|Overall Study|Withdrawal by Subject|2
2025489|NCT00346164|3594391|FG003|Overall Study|Withdrawal by Subject|0
2025490|NCT00346164|3594388|FG000|Overall Study|Ineligible|11
2025491|NCT00346164|3594389|FG001|Overall Study|Ineligible|2
2025492|NCT00346164|3594390|FG002|Overall Study|Ineligible|2
2025493|NCT00346164|3594391|FG003|Overall Study|Ineligible|23
2025494|NCT00346164|3594388|FG000|Overall Study|Refusal of further protocol therapy|0
2025495|NCT00346164|3594389|FG001|Overall Study|Refusal of further protocol therapy|1
2025496|NCT00346164|3594390|FG002|Overall Study|Refusal of further protocol therapy|3
2025497|NCT00346164|3594391|FG003|Overall Study|Refusal of further protocol therapy|15
2025498|NCT00346164|3594388|FG000|Overall Study|Inability to start week 16 tx on time|0
2025499|NCT00346164|3594389|FG001|Overall Study|Inability to start week 16 tx on time|0
2025500|NCT00346164|3594390|FG002|Overall Study|Inability to start week 16 tx on time|0
2025501|NCT00346164|3594391|FG003|Overall Study|Inability to start week 16 tx on time|11
2025502|NCT00346216|3594420|FG000|Overall Study|Other|181
2025503|NCT00346216|3594421|FG001|Overall Study|Other|231
2025504|NCT00346216|3594422|FG002|Overall Study|Other|205
2025505|NCT00346216|3594420|FG000|Overall Study|No longer willing to participate|600
2025506|NCT00346216|3594421|FG001|Overall Study|No longer willing to participate|606
2025507|NCT00346216|3594422|FG002|Overall Study|No longer willing to participate|585
2025508|NCT00346216|3594420|FG000|Overall Study|Withdrawal by Subject|661
2025509|NCT00346216|3594421|FG001|Overall Study|Withdrawal by Subject|692
2025510|NCT00346216|3594422|FG002|Overall Study|Withdrawal by Subject|651
2025511|NCT00346216|3594420|FG000|Overall Study|Lost to Follow-up|611
2025512|NCT00346216|3594421|FG001|Overall Study|Lost to Follow-up|588
2025513|NCT00346216|3594422|FG002|Overall Study|Lost to Follow-up|542
2025514|NCT00346216|3594420|FG000|Overall Study|Physician Decision|80
2025515|NCT00346216|3594421|FG001|Overall Study|Physician Decision|76
2025516|NCT00346216|3594422|FG002|Overall Study|Physician Decision|59
2025517|NCT00346216|3594420|FG000|Overall Study|Does not meet entrance criteria|13
2025518|NCT00346216|3594421|FG001|Overall Study|Does not meet entrance criteria|10
2025519|NCT00346216|3594422|FG002|Overall Study|Does not meet entrance criteria|8
2025520|NCT00346216|3594420|FG000|Overall Study|Death|189
2025521|NCT00346216|3594421|FG001|Overall Study|Death|192
2025522|NCT00346216|3594422|FG002|Overall Study|Death|228
2025523|NCT00346216|3594420|FG000|Overall Study|Study terminated by sponsor|11
2025524|NCT00346216|3594421|FG001|Overall Study|Study terminated by sponsor|4
2025525|NCT00346216|3594422|FG002|Overall Study|Study terminated by sponsor|8
2025526|NCT00346216|3594420|FG000|Overall Study|Missing Subject Summary Status|62
2025527|NCT00346216|3594421|FG001|Overall Study|Missing Subject Summary Status|61
2025528|NCT00346216|3594422|FG002|Overall Study|Missing Subject Summary Status|62
2025529|NCT00346268|3594432|FG000|Overall Study|Adverse Event|1
2025530|NCT00346268|3594433|FG001|Overall Study|Adverse Event|0
2025531|NCT00346268|3594432|FG000|Overall Study|Protocol Violation|1
2025532|NCT00346268|3594433|FG001|Overall Study|Protocol Violation|0
2025533|NCT00346268|3594432|FG000|Overall Study|Participant refused|0
2025534|NCT00346268|3594433|FG001|Overall Study|Participant refused|3
2025535|NCT00346333|3594441|FG000|Overall Study|Death|1
2025536|NCT00346333|3594442|FG001|Overall Study|Death|0
2025537|NCT00346333|3594441|FG000|Overall Study|unwilling or unable to continue|4
2025538|NCT00346333|3594442|FG001|Overall Study|unwilling or unable to continue|8
2025539|NCT00346398|3594452|FG000|Overall Study|Lost to Follow-up|3
2025540|NCT00346398|3594453|FG001|Overall Study|Lost to Follow-up|0
2010975|NCT00230282|3577461|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
2010976|NCT00230282|3577461|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
2010977|NCT00230282|3577461|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1
2010978|NCT00230282|3577461|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
2010979|NCT00230971|3577491|FG000|Randomization|No study drug administered|3
2010980|NCT00230971|3577492|FG001|Randomization|No study drug administered|3
2010981|NCT00230971|3577491|FG000|Baseline Participants|Lost to Follow-up|5
2010982|NCT00230971|3577492|FG001|Baseline Participants|Lost to Follow-up|12
2010983|NCT00230971|3577491|FG000|Baseline Participants|Death|6
2010984|NCT00230971|3577492|FG001|Baseline Participants|Death|5
2010985|NCT00230971|3577491|FG000|Baseline Participants|Withdrawal by Subject|7
2010986|NCT00230971|3577492|FG001|Baseline Participants|Withdrawal by Subject|1
2010987|NCT00230971|3577491|FG000|Baseline Participants|Adverse Event|1
2010988|NCT00230971|3577492|FG001|Baseline Participants|Adverse Event|0
2010989|NCT00230971|3577491|FG000|Baseline Participants|No bacteria observed|1
2010990|NCT00230971|3577492|FG001|Baseline Participants|No bacteria observed|0
2010991|NCT00230971|3577491|FG000|Baseline Participants|Failure to return|1
2010992|NCT00230971|3577492|FG001|Baseline Participants|Failure to return|1
2010993|NCT00230971|3577491|FG000|Baseline Participants|Reintervention|1
2010994|NCT00230971|3577492|FG001|Baseline Participants|Reintervention|0
2010995|NCT00231062|3577498|FG000|Overall Study|Physician Decision|6
2010996|NCT00231114|3577504|FG000|Randomized|Withdrawal by Subject|6
2010997|NCT00231114|3577505|FG001|Randomized|Withdrawal by Subject|3
2010998|NCT00231114|3577504|FG000|Treatment Period|Death: Motor Vehicle Accident|1
2010999|NCT00231114|3577505|FG001|Treatment Period|Death: Motor Vehicle Accident|0
2011000|NCT00231114|3577504|FG000|Post-Treatment Period|Lost to Follow-up|6
2011001|NCT00231114|3577505|FG001|Post-Treatment Period|Lost to Follow-up|1
2011002|NCT00231114|3577504|FG000|Post-Treatment Period|Physician Decision|1
2011003|NCT00231114|3577505|FG001|Post-Treatment Period|Physician Decision|0
2011004|NCT00231114|3577504|FG000|Post-Treatment Period|Withdrawal by Subject|1
2011005|NCT00231114|3577505|FG001|Post-Treatment Period|Withdrawal by Subject|0
2011006|NCT00231179|3577515|FG000|Overall Study|Lost to Follow-up|21
2011007|NCT00231179|3577516|FG001|Overall Study|Lost to Follow-up|21
2011008|NCT00231179|3577515|FG000|Overall Study|Withdrawal by Subject|3
2011009|NCT00231179|3577516|FG001|Overall Study|Withdrawal by Subject|3
2011010|NCT00231413|3577538|FG000|Overall Study|Non-serious AE|0
2011011|NCT00231413|3577539|FG001|Overall Study|Non-serious AE|0
2011012|NCT00231413|3577540|FG002|Overall Study|Non-serious AE|1
2011013|NCT00231413|3577541|FG003|Overall Study|Non-serious AE|0
2011014|NCT00231413|3577542|FG004|Overall Study|Non-serious AE|0
2011015|NCT00231413|3577543|FG005|Overall Study|Non-serious AE|0
2011016|NCT00231413|3577544|FG006|Overall Study|Non-serious AE|1
2011017|NCT00231413|3577538|FG000|Overall Study|Withdrawal by Subject|3
2011018|NCT00231413|3577539|FG001|Overall Study|Withdrawal by Subject|1
2011019|NCT00231413|3577540|FG002|Overall Study|Withdrawal by Subject|4
2011020|NCT00231413|3577541|FG003|Overall Study|Withdrawal by Subject|2
2011021|NCT00231413|3577542|FG004|Overall Study|Withdrawal by Subject|2
2011022|NCT00231413|3577543|FG005|Overall Study|Withdrawal by Subject|0
2011023|NCT00231413|3577544|FG006|Overall Study|Withdrawal by Subject|3
2011024|NCT00231413|3577538|FG000|Overall Study|Migrated/moved from study area|0
2011025|NCT00231413|3577539|FG001|Overall Study|Migrated/moved from study area|0
2011026|NCT00231413|3577540|FG002|Overall Study|Migrated/moved from study area|1
2011027|NCT00231413|3577541|FG003|Overall Study|Migrated/moved from study area|0
2011028|NCT00231413|3577542|FG004|Overall Study|Migrated/moved from study area|0
2011029|NCT00231413|3577543|FG005|Overall Study|Migrated/moved from study area|1
2011030|NCT00231413|3577544|FG006|Overall Study|Migrated/moved from study area|0
2011031|NCT00231413|3577538|FG000|Overall Study|Lost to Follow-up|4
2011032|NCT00231413|3577539|FG001|Overall Study|Lost to Follow-up|4
2011033|NCT00231413|3577540|FG002|Overall Study|Lost to Follow-up|1
2011034|NCT00231413|3577541|FG003|Overall Study|Lost to Follow-up|1
2011035|NCT00231413|3577542|FG004|Overall Study|Lost to Follow-up|1
2011036|NCT00231413|3577543|FG005|Overall Study|Lost to Follow-up|4
2011037|NCT00231413|3577544|FG006|Overall Study|Lost to Follow-up|0
2011038|NCT00231413|3577538|FG000|Overall Study|Pregnancy|1
2011039|NCT00231413|3577539|FG001|Overall Study|Pregnancy|0
2011040|NCT00231413|3577540|FG002|Overall Study|Pregnancy|0
2011041|NCT00231413|3577541|FG003|Overall Study|Pregnancy|0
2011042|NCT00231413|3577542|FG004|Overall Study|Pregnancy|0
2011043|NCT00231413|3577543|FG005|Overall Study|Pregnancy|0
2011044|NCT00231413|3577544|FG006|Overall Study|Pregnancy|0
2011045|NCT00231465|3577560|FG000|Overall Study|Completed only one cycle|1
2011046|NCT00231465|3577560|FG000|Overall Study|Did not have follow up CT scans|1
2011047|NCT00231478|3577566|FG000|Overall Study|Protocol Violation|3
2011048|NCT00231478|3577567|FG001|Overall Study|Protocol Violation|2
2011049|NCT00231478|3577566|FG000|Overall Study|Refused Treatment|1
2011050|NCT00231478|3577567|FG001|Overall Study|Refused Treatment|1
2011051|NCT00231478|3577566|FG000|Overall Study|Withdrawal by Subject|1
2011052|NCT00231478|3577567|FG001|Overall Study|Withdrawal by Subject|0
2011053|NCT00231478|3577566|FG000|Overall Study|Adverse Event|0
2011054|NCT00231478|3577567|FG001|Overall Study|Adverse Event|1
2011055|NCT00231478|3577566|FG000|Overall Study|Administrative|3
2011056|NCT00231478|3577567|FG001|Overall Study|Administrative|2
2011057|NCT00231777|3577575|FG000|Overall Study|Lost to Follow-up|3
2011058|NCT00231777|3577576|FG001|Overall Study|Lost to Follow-up|0
2011059|NCT00231777|3577575|FG000|Overall Study|Other|3
2011060|NCT00231777|3577576|FG001|Overall Study|Other|2
2011061|NCT00231816|3577584|FG000|Overall Study|Adverse Event|1
2011062|NCT00231816|3577585|FG001|Overall Study|Adverse Event|0
2011063|NCT00231816|3577584|FG000|Overall Study|Lost to Follow-up|8
2011064|NCT00231816|3577585|FG001|Overall Study|Lost to Follow-up|5
2011065|NCT00231816|3577584|FG000|Overall Study|Protocol Violation|2
2011066|NCT00231816|3577585|FG001|Overall Study|Protocol Violation|3
2011067|NCT00231816|3577584|FG000|Overall Study|Withdrawal by Subject|3
2011068|NCT00231816|3577585|FG001|Overall Study|Withdrawal by Subject|3
2011069|NCT00231816|3577584|FG000|Overall Study|Other|2
2011070|NCT00231816|3577585|FG001|Overall Study|Other|1
2011071|NCT00231842|3577592|FG000|Overall Study|Withdrawal by Subject|3
2011072|NCT00231842|3577592|FG000|Overall Study|Did not complete the last 3 cycle|8
2011073|NCT00231894|3577603|FG000|Overall Study|Withdrawal by Subject|1
2011074|NCT00231894|3577604|FG001|Overall Study|Withdrawal by Subject|1
2011075|NCT00232180|3577618|FG000|Double-blind (DB) Phase|Death|186
2011076|NCT00232180|3577619|FG001|Double-blind (DB) Phase|Death|222
2011077|NCT00232180|3577620|FG002|Double-blind (DB) Phase|Death|0
2011078|NCT00232180|3577618|FG000|Double-blind (DB) Phase|Lost to Follow-up|34
2011079|NCT00232180|3577619|FG001|Double-blind (DB) Phase|Lost to Follow-up|28
2011080|NCT00232180|3577620|FG002|Double-blind (DB) Phase|Lost to Follow-up|0
2011081|NCT00232180|3577618|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131
2011082|NCT00232180|3577619|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148
2011083|NCT00232180|3577620|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0
2011084|NCT00232180|3577618|FG000|Double-blind (DB) Phase|Protocol Violation|28
2011085|NCT00232180|3577619|FG001|Double-blind (DB) Phase|Protocol Violation|21
2011086|NCT00232180|3577620|FG002|Double-blind (DB) Phase|Protocol Violation|0
2011087|NCT00232180|3577618|FG000|Double-blind (DB) Phase|Adverse Event|83
2011088|NCT00232180|3577619|FG001|Double-blind (DB) Phase|Adverse Event|100
2011089|NCT00232180|3577620|FG002|Double-blind (DB) Phase|Adverse Event|0
2011090|NCT00232180|3577618|FG000|Double-blind (DB) Phase|Other|70
2011091|NCT00232180|3577619|FG001|Double-blind (DB) Phase|Other|75
2102398|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Physician Decision|2
2102399|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
2102400|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
2102401|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
2102402|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
2102403|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
2102404|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
2102405|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
2102406|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
2102407|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0
2102408|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0
2102409|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0
2102410|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1
2102411|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
2102412|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
2102413|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
2102414|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
2102415|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Pregnancy|0
2102416|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Pregnancy|0
2102417|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Pregnancy|1
2102418|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Pregnancy|0
2102419|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
2102420|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
2102421|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
2102422|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
2102423|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Site closed|0
2102424|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Site closed|0
2102425|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Site closed|1
2102426|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Site closed|0
2102427|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
2102428|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
2102429|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
2102430|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
2102431|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
2102432|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
2102433|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
2102434|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
2102435|NCT00838903|3694187|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
2108222|NCT00878800|3702084|FG002|Overall Study|Adverse Event|2
2011092|NCT00232180|3577620|FG002|Double-blind (DB) Phase|Other|0
2011093|NCT00232180|3577618|FG000|Double-blind (DB) Phase|Randomized but not treated|3
2011094|NCT00232180|3577619|FG001|Double-blind (DB) Phase|Randomized but not treated|4
2011095|NCT00232180|3577620|FG002|Double-blind (DB) Phase|Randomized but not treated|0
2011096|NCT00232180|3577618|FG000|Double-blind (DB) Phase|Laboratory abnormality|6
2011097|NCT00232180|3577619|FG001|Double-blind (DB) Phase|Laboratory abnormality|7
2011098|NCT00232180|3577620|FG002|Double-blind (DB) Phase|Laboratory abnormality|0
2011099|NCT00232180|3577618|FG000|Open Label Phase|Death|0
2011100|NCT00232180|3577619|FG001|Open Label Phase|Death|0
2011101|NCT00232180|3577620|FG002|Open Label Phase|Death|48
2011102|NCT00232180|3577618|FG000|Open Label Phase|Lost to Follow-up|0
2011103|NCT00232180|3577619|FG001|Open Label Phase|Lost to Follow-up|0
2011104|NCT00232180|3577620|FG002|Open Label Phase|Lost to Follow-up|5
2011105|NCT00232180|3577618|FG000|Open Label Phase|Protocol Violation|0
2011106|NCT00232180|3577619|FG001|Open Label Phase|Protocol Violation|0
2011107|NCT00232180|3577620|FG002|Open Label Phase|Protocol Violation|3
2011108|NCT00232180|3577618|FG000|Open Label Phase|Study terminated by sponsor|0
2011109|NCT00232180|3577619|FG001|Open Label Phase|Study terminated by sponsor|0
2011110|NCT00232180|3577620|FG002|Open Label Phase|Study terminated by sponsor|3
2011111|NCT00232180|3577618|FG000|Open Label Phase|Withdrawal by Subject|0
2011112|NCT00232180|3577619|FG001|Open Label Phase|Withdrawal by Subject|0
2011113|NCT00232180|3577620|FG002|Open Label Phase|Withdrawal by Subject|37
2011114|NCT00232180|3577618|FG000|Open Label Phase|Other|0
2011115|NCT00232180|3577619|FG001|Open Label Phase|Other|0
2011116|NCT00232180|3577620|FG002|Open Label Phase|Other|16
2011117|NCT00232180|3577618|FG000|Open Label Phase|Adverse Event|0
2011118|NCT00232180|3577619|FG001|Open Label Phase|Adverse Event|0
2011119|NCT00232180|3577620|FG002|Open Label Phase|Adverse Event|25
2011120|NCT00232180|3577618|FG000|Open Label Phase|Laboratory abnormality|0
2011121|NCT00232180|3577619|FG001|Open Label Phase|Laboratory abnormality|0
2011122|NCT00232180|3577620|FG002|Open Label Phase|Laboratory abnormality|10
2011123|NCT00232180|3577618|FG000|Open Label Phase|Randomized but not treated|0
2011124|NCT00232180|3577619|FG001|Open Label Phase|Randomized but not treated|0
2011125|NCT00232180|3577620|FG002|Open Label Phase|Randomized but not treated|1
2011126|NCT00232544|3577649|FG000|Overall Study|Lost to Follow-up|20
2011127|NCT00232544|3577650|FG001|Overall Study|Lost to Follow-up|15
2011128|NCT00232557|3577658|FG000|Overall Study|Lost to Follow-up|3
2011129|NCT00232557|3577659|FG001|Overall Study|Lost to Follow-up|5
2011130|NCT00232596|3577680|FG000|6-Week Titration Phase|Adverse Event|6
2011131|NCT00232596|3577681|FG001|6-Week Titration Phase|Adverse Event|19
2011132|NCT00232596|3577680|FG000|6-Week Titration Phase|Failed to Return|2
2011133|NCT00232596|3577681|FG001|6-Week Titration Phase|Failed to Return|1
2011134|NCT00232596|3577680|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
2011135|NCT00232596|3577681|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
2011136|NCT00232596|3577680|FG000|6-Week Titration Phase|Protocol Violation|1
2011137|NCT00232596|3577681|FG001|6-Week Titration Phase|Protocol Violation|3
2011138|NCT00232596|3577680|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1
2011139|NCT00232596|3577681|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0
2011140|NCT00232596|3577680|FG000|6-Week Titration Phase|Other|3
2011141|NCT00232596|3577681|FG001|6-Week Titration Phase|Other|3
2011142|NCT00232596|3577680|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
2011143|NCT00232596|3577681|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
2011144|NCT00232596|3577680|FG000|12-Week Maintenance Phase|Adverse Event|7
2011145|NCT00232596|3577681|FG001|12-Week Maintenance Phase|Adverse Event|22
2011146|NCT00232596|3577680|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
2011147|NCT00232596|3577681|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
2011148|NCT00232596|3577680|FG000|12-Week Maintenance Phase|Protocol Violation|3
2011149|NCT00232596|3577681|FG001|12-Week Maintenance Phase|Protocol Violation|1
2011150|NCT00232596|3577680|FG000|12-Week Maintenance Phase|Other|1
2011151|NCT00232596|3577681|FG001|12-Week Maintenance Phase|Other|3
2011152|NCT00233064|3577705|FG000|Overall Study|Lost to Follow-up|7
2011153|NCT00233064|3577706|FG001|Overall Study|Lost to Follow-up|7
2011154|NCT00233064|3577705|FG000|Overall Study|Withdrawal by Subject|5
2011155|NCT00233064|3577706|FG001|Overall Study|Withdrawal by Subject|3
2011156|NCT00233064|3577705|FG000|Overall Study|Death|0
2011157|NCT00233064|3577706|FG001|Overall Study|Death|1
2011158|NCT00233064|3577705|FG000|Overall Study|Relocation|0
2011159|NCT00233064|3577706|FG001|Overall Study|Relocation|1
2011160|NCT00233064|3577705|FG000|Overall Study|Protocol Violation|1
2011161|NCT00233064|3577706|FG001|Overall Study|Protocol Violation|0
2011162|NCT00233064|3577705|FG000|Overall Study|Moved to Dom. Republic|1
2011163|NCT00233064|3577706|FG001|Overall Study|Moved to Dom. Republic|0
2011164|NCT00233324|3577726|FG000|Main Study|Death|68
2313250|NCT02786901|4020521|FG002|Overall Study|Randomized in error|1
2313251|NCT02786927|4020529|FG000|Overall Study|Adverse Event|1
2313252|NCT02786927|4020529|FG000|Overall Study|Protocol Violation|4
2313253|NCT02786953|4020536|FG000|Overall Study|Withdrawal by Subject|3
2313254|NCT02786953|4020537|FG001|Overall Study|Withdrawal by Subject|0
2011165|NCT00233324|3577727|FG001|Main Study|Death|60
2011166|NCT00233324|3577728|FG002|Main Study|Death|62
2011167|NCT00233324|3577729|FG003|Main Study|Death|47
2313255|NCT02786953|4020536|FG000|Overall Study|Physician Decision|0
2011168|NCT00233324|3577726|FG000|Follow up at 18-22 Months Corrected Age|Death|5
2011169|NCT00233324|3577727|FG001|Follow up at 18-22 Months Corrected Age|Death|7
2011170|NCT00233324|3577728|FG002|Follow up at 18-22 Months Corrected Age|Death|5
2011171|NCT00233324|3577729|FG003|Follow up at 18-22 Months Corrected Age|Death|4
2011172|NCT00233324|3577726|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
2011173|NCT00233324|3577727|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
2011174|NCT00233324|3577728|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
2011175|NCT00233324|3577729|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
2011176|NCT00233363|3577748|FG000|Overall Study|Adverse Event|1
2011177|NCT00233363|3577749|FG001|Overall Study|Adverse Event|2
2011178|NCT00233363|3577748|FG000|Overall Study|Lack of Efficacy|0
2011179|NCT00233363|3577749|FG001|Overall Study|Lack of Efficacy|2
2011180|NCT00233363|3577748|FG000|Overall Study|Withdrawal by Subject|1
2011181|NCT00233363|3577749|FG001|Overall Study|Withdrawal by Subject|1
2011182|NCT00233363|3577748|FG000|Overall Study|Aggravation of complication|1
2011183|NCT00233363|3577749|FG001|Overall Study|Aggravation of complication|0
2011184|NCT00233389|3577757|FG000|Overall Study|Adverse Event|5
2011185|NCT00233389|3577758|FG001|Overall Study|Adverse Event|5
2011186|NCT00233389|3577757|FG000|Overall Study|Lack of Efficacy|11
2011187|NCT00233389|3577758|FG001|Overall Study|Lack of Efficacy|8
2011188|NCT00233389|3577757|FG000|Overall Study|Lost to Follow-up|1
2011189|NCT00233389|3577758|FG001|Overall Study|Lost to Follow-up|1
2011190|NCT00233389|3577757|FG000|Overall Study|Physician Decision|1
2011191|NCT00233389|3577758|FG001|Overall Study|Physician Decision|0
2011192|NCT00233389|3577757|FG000|Overall Study|Protocol Violation|0
2011193|NCT00233389|3577758|FG001|Overall Study|Protocol Violation|1
2011194|NCT00233389|3577757|FG000|Overall Study|Withdrawal by Subject|0
2011195|NCT00233389|3577758|FG001|Overall Study|Withdrawal by Subject|1
2011196|NCT00233402|3577766|FG000|Overall Study|No pathology data|12
2011197|NCT00233402|3577767|FG001|Overall Study|No pathology data|9
2011198|NCT00233402|3577766|FG000|Overall Study|No Ta/T1|89
2011199|NCT00233402|3577767|FG001|Overall Study|No Ta/T1|94
2011200|NCT00233402|3577766|FG000|Overall Study|Lost to follow up etc|3
2011201|NCT00233402|3577767|FG001|Overall Study|Lost to follow up etc|21
2011202|NCT00233454|3577775|FG000|Overall Study|Death|6
2011203|NCT00233480|3577781|FG000|Overall Study|Underwent status II heart transplant|0
2011204|NCT00233480|3577782|FG001|Overall Study|Underwent status II heart transplant|1
2011205|NCT00233948|3577801|FG000|Overall Study|Adverse Event|1
2011206|NCT00233948|3577802|FG001|Overall Study|Adverse Event|0
2011207|NCT00233948|3577803|FG002|Overall Study|Adverse Event|0
2011208|NCT00233948|3577804|FG003|Overall Study|Adverse Event|0
2011209|NCT00233948|3577805|FG004|Overall Study|Adverse Event|0
2011210|NCT00233948|3577806|FG005|Overall Study|Adverse Event|0
2011211|NCT00233987|3577821|FG000|Overall Study|Withdrawal by Subject|1
2011212|NCT00233987|3577821|FG000|Overall Study|Lack of Efficacy|2
2011213|NCT00233987|3577821|FG000|Overall Study|Reason Under Review|1
2214433|NCT01687283|3856700|FG000|Overall Study|Protocol Violation|1
2011214|NCT00233987|3577821|FG000|Overall Study|Other - Not Protocol Specified|5
2011215|NCT00233987|3577821|FG000|Overall Study|Eligible but No Treatment Received|2
2011216|NCT00233987|3577821|FG000|Overall Study|Ineligible|4
2011217|NCT00234039|3577825|FG000|Overall Study|Adverse Event|2
2011218|NCT00234039|3577825|FG000|Overall Study|Progression/relapse|34
2011219|NCT00234039|3577825|FG000|Overall Study|Other - Not Protocol Specified|3
2011220|NCT00234039|3577825|FG000|Overall Study|Ineligible|9
2011221|NCT00234039|3577825|FG000|Overall Study|No Protocol Treatment Received|2
2011222|NCT00234052|3577829|FG000|Treatment|Withdrawal by Subject|3
2011223|NCT00234052|3577829|FG000|Treatment|Adverse Event|5
2011224|NCT00234052|3577829|FG000|Treatment|Death|2
2011225|NCT00234052|3577829|FG000|Treatment|Progressive Disease|11
2011226|NCT00234052|3577829|FG000|Follow-up for 5 Years|Death|41
2011227|NCT00234052|3577829|FG000|Follow-up for 5 Years|Lost to Follow-up|1
2011228|NCT00234052|3577829|FG000|Follow-up for 5 Years|Other|7
2011229|NCT00234065|3577835|FG000|Overall Study|Adverse Event|268
2011230|NCT00234065|3577836|FG001|Overall Study|Adverse Event|166
2011231|NCT00234065|3577835|FG000|Overall Study|Withdrawal by Subject|73
2011232|NCT00234065|3577836|FG001|Overall Study|Withdrawal by Subject|56
2011233|NCT00234065|3577835|FG000|Overall Study|Physician Decision|23
2011234|NCT00234065|3577836|FG001|Overall Study|Physician Decision|22
2011235|NCT00234065|3577835|FG000|Overall Study|Not Classified|111
2011236|NCT00234065|3577836|FG001|Overall Study|Not Classified|112
2011237|NCT00234104|3577863|FG000|Overall Study|Adverse Event|4
2011238|NCT00234104|3577864|FG001|Overall Study|Adverse Event|0
2011239|NCT00234104|3577865|FG002|Overall Study|Adverse Event|3
2011240|NCT00234104|3577866|FG003|Overall Study|Adverse Event|5
2011241|NCT00234104|3577863|FG000|Overall Study|Protocol Violation|0
2011242|NCT00234104|3577864|FG001|Overall Study|Protocol Violation|0
2011243|NCT00234104|3577865|FG002|Overall Study|Protocol Violation|0
2011244|NCT00234104|3577866|FG003|Overall Study|Protocol Violation|1
2102436|NCT00838903|3694188|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
2011245|NCT00234104|3577863|FG000|Overall Study|Physician Decision|0
2011246|NCT00234104|3577864|FG001|Overall Study|Physician Decision|1
2011247|NCT00234104|3577865|FG002|Overall Study|Physician Decision|2
2011248|NCT00234104|3577866|FG003|Overall Study|Physician Decision|2
2011249|NCT00234494|3577909|FG000|Overall Study|Protocol Violation|2
2011250|NCT00234533|3577913|FG000|Overall Study|Withdrawal by Subject|6
2011251|NCT00234533|3577913|FG000|Overall Study|Adverse Event|2
2011252|NCT00234533|3577913|FG000|Overall Study|Enrolled but not treated|3
2011253|NCT00235391|3577944|FG000|Overall Study|Adverse Event|4
2011254|NCT00235391|3577945|FG001|Overall Study|Adverse Event|5
2011255|NCT00235391|3577946|FG002|Overall Study|Adverse Event|10
2011256|NCT00235391|3577947|FG003|Overall Study|Adverse Event|72
2011257|NCT00235391|3577948|FG004|Overall Study|Adverse Event|5
2011258|NCT00235391|3577949|FG005|Overall Study|Adverse Event|2
2011259|NCT00235391|3577944|FG000|Overall Study|Abnormal laboratory value(s)|3
2011260|NCT00235391|3577945|FG001|Overall Study|Abnormal laboratory value(s)|5
2011261|NCT00235391|3577946|FG002|Overall Study|Abnormal laboratory value(s)|4
2011262|NCT00235391|3577947|FG003|Overall Study|Abnormal laboratory value(s)|27
2011263|NCT00235391|3577948|FG004|Overall Study|Abnormal laboratory value(s)|1
2011264|NCT00235391|3577949|FG005|Overall Study|Abnormal laboratory value(s)|2
2011265|NCT00235391|3577944|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2011266|NCT00235391|3577945|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2011267|NCT00235391|3577946|FG002|Overall Study|Unsatisfactory therapeutic effect|2
2011268|NCT00235391|3577947|FG003|Overall Study|Unsatisfactory therapeutic effect|17
2011269|NCT00235391|3577948|FG004|Overall Study|Unsatisfactory therapeutic effect|0
2011270|NCT00235391|3577949|FG005|Overall Study|Unsatisfactory therapeutic effect|0
2011271|NCT00235391|3577944|FG000|Overall Study|Condition no longer requires treatment|3
2011272|NCT00235391|3577945|FG001|Overall Study|Condition no longer requires treatment|0
2011273|NCT00235391|3577946|FG002|Overall Study|Condition no longer requires treatment|0
2011274|NCT00235391|3577947|FG003|Overall Study|Condition no longer requires treatment|11
2011275|NCT00235391|3577948|FG004|Overall Study|Condition no longer requires treatment|1
2011276|NCT00235391|3577949|FG005|Overall Study|Condition no longer requires treatment|0
2011277|NCT00235391|3577944|FG000|Overall Study|Protocol deviation|0
2011278|NCT00235391|3577945|FG001|Overall Study|Protocol deviation|0
2011279|NCT00235391|3577946|FG002|Overall Study|Protocol deviation|1
2011280|NCT00235391|3577947|FG003|Overall Study|Protocol deviation|11
2011281|NCT00235391|3577948|FG004|Overall Study|Protocol deviation|0
2011282|NCT00235391|3577949|FG005|Overall Study|Protocol deviation|0
2011283|NCT00235391|3577944|FG000|Overall Study|Withdrawal by Subject|2
2011284|NCT00235391|3577945|FG001|Overall Study|Withdrawal by Subject|3
2011285|NCT00235391|3577946|FG002|Overall Study|Withdrawal by Subject|3
2011286|NCT00235391|3577947|FG003|Overall Study|Withdrawal by Subject|61
2011287|NCT00235391|3577948|FG004|Overall Study|Withdrawal by Subject|5
2011288|NCT00235391|3577949|FG005|Overall Study|Withdrawal by Subject|0
2011289|NCT00235391|3577944|FG000|Overall Study|Lost to Follow-up|0
2011290|NCT00235391|3577945|FG001|Overall Study|Lost to Follow-up|3
2011291|NCT00235391|3577946|FG002|Overall Study|Lost to Follow-up|3
2011292|NCT00235391|3577947|FG003|Overall Study|Lost to Follow-up|16
2011293|NCT00235391|3577948|FG004|Overall Study|Lost to Follow-up|0
2011294|NCT00235391|3577949|FG005|Overall Study|Lost to Follow-up|0
2011295|NCT00235391|3577944|FG000|Overall Study|Administrative problems|0
2011296|NCT00235391|3577945|FG001|Overall Study|Administrative problems|0
2011297|NCT00235391|3577946|FG002|Overall Study|Administrative problems|0
2011298|NCT00235391|3577947|FG003|Overall Study|Administrative problems|1
2011299|NCT00235391|3577948|FG004|Overall Study|Administrative problems|0
2011300|NCT00235391|3577949|FG005|Overall Study|Administrative problems|0
2011301|NCT00235391|3577944|FG000|Overall Study|Death|0
2011302|NCT00235391|3577945|FG001|Overall Study|Death|0
2011303|NCT00235391|3577946|FG002|Overall Study|Death|1
2011304|NCT00235391|3577947|FG003|Overall Study|Death|4
2011305|NCT00235391|3577948|FG004|Overall Study|Death|0
2011306|NCT00235391|3577949|FG005|Overall Study|Death|0
2011307|NCT00235443|3577964|FG000|Overall Study|Adverse Event|4
2011308|NCT00235443|3577965|FG001|Overall Study|Adverse Event|12
2011309|NCT00235443|3577966|FG002|Overall Study|Adverse Event|17
2011310|NCT00235443|3577967|FG003|Overall Study|Adverse Event|44
2011311|NCT00235443|3577968|FG004|Overall Study|Adverse Event|10
2011312|NCT00235443|3577969|FG005|Overall Study|Adverse Event|15
2011313|NCT00235443|3577964|FG000|Overall Study|Lack of Efficacy|0
2011314|NCT00235443|3577965|FG001|Overall Study|Lack of Efficacy|1
2011315|NCT00235443|3577966|FG002|Overall Study|Lack of Efficacy|5
2011316|NCT00235443|3577967|FG003|Overall Study|Lack of Efficacy|12
2011317|NCT00235443|3577968|FG004|Overall Study|Lack of Efficacy|2
2011318|NCT00235443|3577969|FG005|Overall Study|Lack of Efficacy|9
2011319|NCT00235443|3577964|FG000|Overall Study|Withdrawal by Subject|3
2011320|NCT00235443|3577965|FG001|Overall Study|Withdrawal by Subject|9
2011321|NCT00235443|3577966|FG002|Overall Study|Withdrawal by Subject|25
2011322|NCT00235443|3577967|FG003|Overall Study|Withdrawal by Subject|24
2011323|NCT00235443|3577968|FG004|Overall Study|Withdrawal by Subject|10
2011324|NCT00235443|3577969|FG005|Overall Study|Withdrawal by Subject|12
2011325|NCT00235443|3577964|FG000|Overall Study|Lost to Follow-up|0
2011326|NCT00235443|3577965|FG001|Overall Study|Lost to Follow-up|8
2011327|NCT00235443|3577966|FG002|Overall Study|Lost to Follow-up|6
2011328|NCT00235443|3577967|FG003|Overall Study|Lost to Follow-up|6
2011329|NCT00235443|3577968|FG004|Overall Study|Lost to Follow-up|4
2011330|NCT00235443|3577969|FG005|Overall Study|Lost to Follow-up|3
2011331|NCT00235443|3577964|FG000|Overall Study|Unsatisfactory compliance|0
2011332|NCT00235443|3577965|FG001|Overall Study|Unsatisfactory compliance|2
2011333|NCT00235443|3577966|FG002|Overall Study|Unsatisfactory compliance|3
2011334|NCT00235443|3577967|FG003|Overall Study|Unsatisfactory compliance|4
2313256|NCT02786953|4020537|FG001|Overall Study|Physician Decision|1
2313257|NCT02787083|4020554|FG000|Overall Study|Adverse Event|1
2313258|NCT02787083|4020555|FG001|Overall Study|Adverse Event|0
2313259|NCT02787083|4020554|FG000|Overall Study|Withdrawal by Subject|2
2313260|NCT02787083|4020555|FG001|Overall Study|Withdrawal by Subject|2
2011335|NCT00235443|3577968|FG004|Overall Study|Unsatisfactory compliance|1
2011336|NCT00235443|3577969|FG005|Overall Study|Unsatisfactory compliance|0
2011337|NCT00235443|3577964|FG000|Overall Study|Other reasons for premature termination|1
2011338|NCT00235443|3577965|FG001|Overall Study|Other reasons for premature termination|6
2011339|NCT00235443|3577966|FG002|Overall Study|Other reasons for premature termination|6
2011340|NCT00235443|3577967|FG003|Overall Study|Other reasons for premature termination|7
2011341|NCT00235443|3577968|FG004|Overall Study|Other reasons for premature termination|3
2011342|NCT00235443|3577969|FG005|Overall Study|Other reasons for premature termination|6
2011343|NCT00235495|3577996|FG000|Overall Study|Death|52
2011344|NCT00235495|3577997|FG001|Overall Study|Death|42
2011345|NCT00235495|3577996|FG000|Overall Study|Withdrawal by Subject|5
2011346|NCT00235495|3577997|FG001|Overall Study|Withdrawal by Subject|3
2011347|NCT00235495|3577996|FG000|Overall Study|Lost to Follow-up|11
2011348|NCT00235495|3577997|FG001|Overall Study|Lost to Follow-up|13
2011349|NCT00235495|3577996|FG000|Overall Study|Visit/assessmen outside window/missing|0
2011350|NCT00235495|3577997|FG001|Overall Study|Visit/assessmen outside window/missing|10
2011351|NCT00235716|3578020|FG000|Overall Study|Death|26
2011352|NCT00235716|3578021|FG001|Overall Study|Death|39
2011353|NCT00235716|3578022|FG002|Overall Study|Death|32
2011354|NCT00235716|3578023|FG003|Overall Study|Death|31
2011355|NCT00235716|3578020|FG000|Overall Study|Withdrawal by Subject|23
2011356|NCT00235716|3578021|FG001|Overall Study|Withdrawal by Subject|19
2011357|NCT00235716|3578022|FG002|Overall Study|Withdrawal by Subject|17
2011358|NCT00235716|3578023|FG003|Overall Study|Withdrawal by Subject|18
2011359|NCT00235716|3578020|FG000|Overall Study|Lost to Follow-up|12
2011360|NCT00235716|3578021|FG001|Overall Study|Lost to Follow-up|7
2011361|NCT00235716|3578022|FG002|Overall Study|Lost to Follow-up|14
2011362|NCT00235716|3578023|FG003|Overall Study|Lost to Follow-up|10
2011363|NCT00235716|3578020|FG000|Overall Study|Adverse Event|1
2011364|NCT00235716|3578021|FG001|Overall Study|Adverse Event|1
2011365|NCT00235716|3578022|FG002|Overall Study|Adverse Event|1
2011366|NCT00235716|3578023|FG003|Overall Study|Adverse Event|0
2011367|NCT00235716|3578020|FG000|Overall Study|Physician Decision|0
2011368|NCT00235716|3578021|FG001|Overall Study|Physician Decision|1
2011369|NCT00235716|3578022|FG002|Overall Study|Physician Decision|1
2011370|NCT00235716|3578023|FG003|Overall Study|Physician Decision|3
2011371|NCT00235755|3578036|FG000|4-Week Titration Phase|Adverse Event|6
2011372|NCT00235755|3578037|FG001|4-Week Titration Phase|Adverse Event|14
2011373|NCT00235755|3578038|FG002|4-Week Titration Phase|Adverse Event|20
2011374|NCT00235755|3578036|FG000|4-Week Titration Phase|Lost to Follow-up|0
2011375|NCT00235755|3578037|FG001|4-Week Titration Phase|Lost to Follow-up|1
2011376|NCT00235755|3578038|FG002|4-Week Titration Phase|Lost to Follow-up|1
2011377|NCT00235755|3578036|FG000|4-Week Titration Phase|Protocol Violation|2
2011378|NCT00235755|3578037|FG001|4-Week Titration Phase|Protocol Violation|2
2011379|NCT00235755|3578038|FG002|4-Week Titration Phase|Protocol Violation|1
2011380|NCT00235755|3578036|FG000|4-Week Titration Phase|Withdrawal by Subject|1
2011381|NCT00235755|3578037|FG001|4-Week Titration Phase|Withdrawal by Subject|2
2011382|NCT00235755|3578038|FG002|4-Week Titration Phase|Withdrawal by Subject|3
2011383|NCT00235755|3578036|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
2011384|NCT00235755|3578037|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
2011385|NCT00235755|3578038|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
2011386|NCT00235755|3578036|FG000|4-Week Titration Phase|Randomization Occurred in Error|1
2011387|NCT00235755|3578037|FG001|4-Week Titration Phase|Randomization Occurred in Error|0
2011388|NCT00235755|3578038|FG002|4-Week Titration Phase|Randomization Occurred in Error|0
2011389|NCT00235755|3578036|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
2011390|NCT00235755|3578037|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
2011391|NCT00235755|3578038|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
2011392|NCT00235755|3578036|FG000|12-Week Maintenance Phase|Adverse Event|8
2011393|NCT00235755|3578037|FG001|12-Week Maintenance Phase|Adverse Event|12
2011394|NCT00235755|3578038|FG002|12-Week Maintenance Phase|Adverse Event|26
2011395|NCT00235755|3578036|FG000|12-Week Maintenance Phase|Lost to Follow-up|2
2011396|NCT00235755|3578037|FG001|12-Week Maintenance Phase|Lost to Follow-up|3
2011397|NCT00235755|3578038|FG002|12-Week Maintenance Phase|Lost to Follow-up|0
2011398|NCT00235755|3578036|FG000|12-Week Maintenance Phase|Lack of Efficacy|5
2011399|NCT00235755|3578037|FG001|12-Week Maintenance Phase|Lack of Efficacy|0
2011400|NCT00235755|3578038|FG002|12-Week Maintenance Phase|Lack of Efficacy|0
2011401|NCT00235755|3578036|FG000|12-Week Maintenance Phase|Protocol Violation|0
2011402|NCT00235755|3578037|FG001|12-Week Maintenance Phase|Protocol Violation|4
2011403|NCT00235755|3578038|FG002|12-Week Maintenance Phase|Protocol Violation|2
2011404|NCT00235755|3578036|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0
2011405|NCT00235755|3578037|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8
2011406|NCT00235755|3578038|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3
2011407|NCT00235755|3578036|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
2313261|NCT02787304|4020569|FG000|Overall Study|Adverse Event|9
2011408|NCT00235755|3578037|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
2011409|NCT00235755|3578038|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
2011410|NCT00235872|3578065|FG000|Overall Study|Adverse Event|34
2011411|NCT00235872|3578065|FG000|Overall Study|Death|1
2011412|NCT00235872|3578065|FG000|Overall Study|Lost to Follow-up|1
2011413|NCT00235872|3578065|FG000|Overall Study|Withdrawal by Subject|50
2011414|NCT00235872|3578065|FG000|Overall Study|Administrative reason|61
2011415|NCT00235989|3578073|FG000|Core Treatment Period (CT)|Lost to Follow-up|0
2011416|NCT00235989|3578074|FG001|Core Treatment Period (CT)|Lost to Follow-up|0
2011417|NCT00235989|3578075|FG002|Core Treatment Period (CT)|Lost to Follow-up|0
2011418|NCT00235989|3578076|FG003|Core Treatment Period (CT)|Lost to Follow-up|0
2011419|NCT00235989|3578077|FG004|Core Treatment Period (CT)|Lost to Follow-up|0
2011420|NCT00235989|3578078|FG005|Core Treatment Period (CT)|Lost to Follow-up|2
2011421|NCT00235989|3578073|FG000|Extension Treatment Period (ET)|Adverse Event|3
2011422|NCT00235989|3578074|FG001|Extension Treatment Period (ET)|Adverse Event|0
2011423|NCT00235989|3578075|FG002|Extension Treatment Period (ET)|Adverse Event|2
2011424|NCT00235989|3578076|FG003|Extension Treatment Period (ET)|Adverse Event|0
2011425|NCT00235989|3578077|FG004|Extension Treatment Period (ET)|Adverse Event|0
2011426|NCT00235989|3578078|FG005|Extension Treatment Period (ET)|Adverse Event|0
2011427|NCT00235989|3578073|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2
2011428|NCT00235989|3578074|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0
2011429|NCT00235989|3578075|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1
2011430|NCT00235989|3578076|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0
2011431|NCT00235989|3578077|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0
2011432|NCT00235989|3578078|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0
2011433|NCT00235989|3578073|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1
2011434|NCT00235989|3578074|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1
2011435|NCT00235989|3578075|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1
2011436|NCT00235989|3578076|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4
2011437|NCT00235989|3578077|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0
2011438|NCT00235989|3578078|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0
2011439|NCT00235989|3578073|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2
2011440|NCT00235989|3578074|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3
2011441|NCT00235989|3578075|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1
2011442|NCT00235989|3578076|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2
2011443|NCT00235989|3578077|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0
2011444|NCT00235989|3578078|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0
2011445|NCT00236080|3578093|FG000|Overall Study|Adverse Event|0
2011446|NCT00236080|3578094|FG001|Overall Study|Adverse Event|0
2011447|NCT00236080|3578095|FG002|Overall Study|Adverse Event|3
2011448|NCT00236080|3578096|FG003|Overall Study|Adverse Event|1
2011449|NCT00236080|3578097|FG004|Overall Study|Adverse Event|0
2011450|NCT00236080|3578093|FG000|Overall Study|Lost to Follow-up|0
2011451|NCT00236080|3578094|FG001|Overall Study|Lost to Follow-up|1
2011452|NCT00236080|3578095|FG002|Overall Study|Lost to Follow-up|0
2011453|NCT00236080|3578096|FG003|Overall Study|Lost to Follow-up|0
2011454|NCT00236080|3578097|FG004|Overall Study|Lost to Follow-up|0
2011455|NCT00236080|3578093|FG000|Overall Study|Physician Decision|1
2011456|NCT00236080|3578094|FG001|Overall Study|Physician Decision|0
2011457|NCT00236080|3578095|FG002|Overall Study|Physician Decision|1
2011458|NCT00236080|3578096|FG003|Overall Study|Physician Decision|1
2011459|NCT00236080|3578097|FG004|Overall Study|Physician Decision|1
2011460|NCT00236080|3578093|FG000|Overall Study|Withdrawal by Subject|1
2011461|NCT00236080|3578094|FG001|Overall Study|Withdrawal by Subject|0
2011462|NCT00236080|3578095|FG002|Overall Study|Withdrawal by Subject|0
2011463|NCT00236080|3578096|FG003|Overall Study|Withdrawal by Subject|0
2011464|NCT00236080|3578097|FG004|Overall Study|Withdrawal by Subject|0
2011465|NCT00236080|3578093|FG000|Overall Study|Miscellaneous|0
2011466|NCT00236080|3578094|FG001|Overall Study|Miscellaneous|0
2011467|NCT00236080|3578095|FG002|Overall Study|Miscellaneous|1
2011468|NCT00236080|3578096|FG003|Overall Study|Miscellaneous|0
2011469|NCT00236080|3578097|FG004|Overall Study|Miscellaneous|0
2011470|NCT00236184|3578111|FG000|Overall Study|Adverse Event|5
2011471|NCT00236184|3578112|FG001|Overall Study|Adverse Event|2
2011472|NCT00236184|3578111|FG000|Overall Study|Lack of Efficacy|0
2011473|NCT00236184|3578112|FG001|Overall Study|Lack of Efficacy|1
2011474|NCT00236184|3578111|FG000|Overall Study|Lost to Follow-up|3
2011475|NCT00236184|3578112|FG001|Overall Study|Lost to Follow-up|4
2011476|NCT00236184|3578111|FG000|Overall Study|Physician Decision|1
2011477|NCT00236184|3578112|FG001|Overall Study|Physician Decision|1
2011478|NCT00236184|3578111|FG000|Overall Study|Withdrawal by Subject|3
2011479|NCT00236184|3578112|FG001|Overall Study|Withdrawal by Subject|0
2011480|NCT00236184|3578111|FG000|Overall Study|Protocol Violation|3
2011481|NCT00236184|3578112|FG001|Overall Study|Protocol Violation|0
2011482|NCT00236184|3578111|FG000|Overall Study|non-compliance with study drug|2
2011483|NCT00236184|3578112|FG001|Overall Study|non-compliance with study drug|1
2011484|NCT00236184|3578111|FG000|Overall Study|other|1
2011485|NCT00236184|3578112|FG001|Overall Study|other|2
2011486|NCT00236197|3578120|FG000|Overall Study|Withdrawal by Subject|3
2011487|NCT00236197|3578121|FG001|Overall Study|Withdrawal by Subject|2
2011488|NCT00236197|3578120|FG000|Overall Study|Lost to Follow-up|1
2011489|NCT00236197|3578121|FG001|Overall Study|Lost to Follow-up|5
2011490|NCT00236197|3578120|FG000|Overall Study|Protocol Violation|0
2011491|NCT00236197|3578121|FG001|Overall Study|Protocol Violation|3
2011492|NCT00236197|3578120|FG000|Overall Study|Medication non-compliance|1
2011493|NCT00236197|3578121|FG001|Overall Study|Medication non-compliance|2
2011494|NCT00236197|3578120|FG000|Overall Study|Other|0
2011495|NCT00236197|3578121|FG001|Overall Study|Other|2
2011496|NCT00236899|3578131|FG000|Overall Study|Adverse Event (Study Related)|1
2011497|NCT00236899|3578132|FG001|Overall Study|Adverse Event (Study Related)|1
2011498|NCT00236899|3578133|FG002|Overall Study|Adverse Event (Study Related)|2
2011499|NCT00236899|3578134|FG003|Overall Study|Adverse Event (Study Related)|1
2011500|NCT00236899|3578131|FG000|Overall Study|Adverse Event (Not Study Related)|3
2214434|NCT01687283|3856701|FG001|Overall Study|Protocol Violation|3
2214435|NCT01687283|3856700|FG000|Overall Study|protocol defined stopping criteria|8
2011501|NCT00236899|3578132|FG001|Overall Study|Adverse Event (Not Study Related)|3
2011502|NCT00236899|3578133|FG002|Overall Study|Adverse Event (Not Study Related)|4
2011503|NCT00236899|3578134|FG003|Overall Study|Adverse Event (Not Study Related)|7
2011504|NCT00236899|3578131|FG000|Overall Study|Death (Study Disease)|1
2011505|NCT00236899|3578132|FG001|Overall Study|Death (Study Disease)|4
2011506|NCT00236899|3578133|FG002|Overall Study|Death (Study Disease)|0
2011507|NCT00236899|3578134|FG003|Overall Study|Death (Study Disease)|0
2011508|NCT00236899|3578131|FG000|Overall Study|Death (Not Study Related)|2
2011509|NCT00236899|3578132|FG001|Overall Study|Death (Not Study Related)|0
2011510|NCT00236899|3578133|FG002|Overall Study|Death (Not Study Related)|0
2011511|NCT00236899|3578134|FG003|Overall Study|Death (Not Study Related)|0
2011512|NCT00236899|3578131|FG000|Overall Study|Death (Study Drug Toxicity)|1
2011513|NCT00236899|3578132|FG001|Overall Study|Death (Study Drug Toxicity)|0
2011514|NCT00236899|3578133|FG002|Overall Study|Death (Study Drug Toxicity)|0
2011515|NCT00236899|3578134|FG003|Overall Study|Death (Study Drug Toxicity)|0
2011516|NCT00236899|3578131|FG000|Overall Study|Lost to Follow-up|0
2011517|NCT00236899|3578132|FG001|Overall Study|Lost to Follow-up|1
2011518|NCT00236899|3578133|FG002|Overall Study|Lost to Follow-up|0
2011519|NCT00236899|3578134|FG003|Overall Study|Lost to Follow-up|0
2011520|NCT00236899|3578131|FG000|Overall Study|Entry Criteria Exclusion|0
2011521|NCT00236899|3578132|FG001|Overall Study|Entry Criteria Exclusion|1
2011522|NCT00236899|3578133|FG002|Overall Study|Entry Criteria Exclusion|1
2011523|NCT00236899|3578134|FG003|Overall Study|Entry Criteria Exclusion|0
2011524|NCT00236899|3578131|FG000|Overall Study|Protocol Violation|1
2011525|NCT00236899|3578132|FG001|Overall Study|Protocol Violation|0
2011526|NCT00236899|3578133|FG002|Overall Study|Protocol Violation|0
2011527|NCT00236899|3578134|FG003|Overall Study|Protocol Violation|0
2011528|NCT00236899|3578131|FG000|Overall Study|Withdrawal by Subject|6
2011529|NCT00236899|3578132|FG001|Overall Study|Withdrawal by Subject|4
2011530|NCT00236899|3578133|FG002|Overall Study|Withdrawal by Subject|5
2011531|NCT00236899|3578134|FG003|Overall Study|Withdrawal by Subject|2
2011532|NCT00236899|3578131|FG000|Overall Study|Physician Decision|7
2011533|NCT00236899|3578132|FG001|Overall Study|Physician Decision|8
2011534|NCT00236899|3578133|FG002|Overall Study|Physician Decision|7
2011535|NCT00236899|3578134|FG003|Overall Study|Physician Decision|6
2011536|NCT00236899|3578131|FG000|Overall Study|Satisfactory Response|2
2011537|NCT00236899|3578132|FG001|Overall Study|Satisfactory Response|0
2011538|NCT00236899|3578133|FG002|Overall Study|Satisfactory Response|0
2011539|NCT00236899|3578134|FG003|Overall Study|Satisfactory Response|1
2011540|NCT00236899|3578131|FG000|Overall Study|Lack of Efficacy|18
2011541|NCT00236899|3578132|FG001|Overall Study|Lack of Efficacy|18
2011542|NCT00236899|3578133|FG002|Overall Study|Lack of Efficacy|25
2011543|NCT00236899|3578134|FG003|Overall Study|Lack of Efficacy|23
2011544|NCT00237042|3578189|FG000|Treatment|Became ineligible post-randomization|0
2011545|NCT00237042|3578190|FG001|Treatment|Became ineligible post-randomization|1
2011546|NCT00237042|3578191|FG002|Treatment|Became ineligible post-randomization|16
2011547|NCT00237042|3578189|FG000|Treatment|Moved out of state|1
2011548|NCT00237042|3578190|FG001|Treatment|Moved out of state|1
2011549|NCT00237042|3578191|FG002|Treatment|Moved out of state|1
2011550|NCT00237042|3578189|FG000|Treatment|Completed no treatment|5
2011551|NCT00237042|3578190|FG001|Treatment|Completed no treatment|5
2011552|NCT00237042|3578191|FG002|Treatment|Completed no treatment|21
2011553|NCT00237042|3578189|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9
2011554|NCT00237042|3578190|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8
2011555|NCT00237042|3578191|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11
2011556|NCT00237042|3578189|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11
2011557|NCT00237042|3578190|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9
2011558|NCT00237042|3578191|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9
2011559|NCT00237185|3578201|FG000|Core|Adverse Event|3
2011560|NCT00237185|3578202|FG001|Core|Adverse Event|4
2011561|NCT00237185|3578201|FG000|Core|Abnormal laboratory value|0
2011562|NCT00237185|3578202|FG001|Core|Abnormal laboratory value|4
2011563|NCT00237185|3578201|FG000|Core|Abnormal test procedure results|1
2011564|NCT00237185|3578202|FG001|Core|Abnormal test procedure results|0
2011565|NCT00237185|3578201|FG000|Core|Lack of Efficacy|30
2011566|NCT00237185|3578202|FG001|Core|Lack of Efficacy|23
2011567|NCT00237185|3578201|FG000|Core|Protocol Violation|1
2011568|NCT00237185|3578202|FG001|Core|Protocol Violation|1
2011569|NCT00237185|3578201|FG000|Core|Withdrawal by Subject|4
2011570|NCT00237185|3578202|FG001|Core|Withdrawal by Subject|4
2011571|NCT00237185|3578201|FG000|Core|Administrative problems|0
2011572|NCT00237185|3578202|FG001|Core|Administrative problems|1
2011573|NCT00237185|3578201|FG000|Core|Death|4
2011574|NCT00237185|3578202|FG001|Core|Death|0
2011575|NCT00237185|3578201|FG000|Core|Determined ineligible post randomization|1
2011576|NCT00237185|3578202|FG001|Core|Determined ineligible post randomization|0
2011577|NCT00237185|3578201|FG000|Extension|Adverse Event|1
2011578|NCT00237185|3578202|FG001|Extension|Adverse Event|0
2011579|NCT00237185|3578201|FG000|Extension|Abnormal laboratory value|0
2011580|NCT00237185|3578202|FG001|Extension|Abnormal laboratory value|1
2011581|NCT00237185|3578201|FG000|Extension|Lack of Efficacy|9
2011582|NCT00237185|3578202|FG001|Extension|Lack of Efficacy|14
2011583|NCT00237185|3578201|FG000|Extension|Condition no longer required study drug|0
2011584|NCT00237185|3578202|FG001|Extension|Condition no longer required study drug|1
2011585|NCT00237185|3578201|FG000|Extension|Withdrawal by Subject|3
2011586|NCT00237185|3578202|FG001|Extension|Withdrawal by Subject|2
2011587|NCT00237185|3578201|FG000|Extension|Lost to Follow-up|1
2011588|NCT00237185|3578202|FG001|Extension|Lost to Follow-up|0
2011589|NCT00237185|3578201|FG000|Extension|Administrative problems|1
2011590|NCT00237185|3578202|FG001|Extension|Administrative problems|0
2011591|NCT00237185|3578201|FG000|Extension|Death|1
2011592|NCT00237185|3578202|FG001|Extension|Death|1
2011593|NCT00237458|3578208|FG000|Overall Study|Lack of Efficacy|1
2011594|NCT00237458|3578208|FG000|Overall Study|Adverse Event|1
2011595|NCT00237458|3578208|FG000|Overall Study|Withdrawal by Subject|1
2011596|NCT00237692|3578220|FG000|Overall Study|Lost to Follow-up|9
2011597|NCT00237692|3578221|FG001|Overall Study|Lost to Follow-up|3
2011598|NCT00237692|3578222|FG002|Overall Study|Lost to Follow-up|5
2011599|NCT00237692|3578223|FG003|Overall Study|Lost to Follow-up|3
2011600|NCT00237692|3578220|FG000|Overall Study|Death|1
2011601|NCT00237692|3578221|FG001|Overall Study|Death|2
2011602|NCT00237692|3578222|FG002|Overall Study|Death|2
2011603|NCT00237692|3578223|FG003|Overall Study|Death|3
2011604|NCT00237692|3578220|FG000|Overall Study|Excluded - did not meet criteria|4
2011605|NCT00237692|3578221|FG001|Overall Study|Excluded - did not meet criteria|3
2011606|NCT00237692|3578222|FG002|Overall Study|Excluded - did not meet criteria|5
2011607|NCT00237692|3578223|FG003|Overall Study|Excluded - did not meet criteria|9
2011608|NCT00237692|3578220|FG000|Overall Study|Withdrawal by Subject|4
2011609|NCT00237692|3578221|FG001|Overall Study|Withdrawal by Subject|6
2011610|NCT00237692|3578222|FG002|Overall Study|Withdrawal by Subject|10
2011611|NCT00237692|3578223|FG003|Overall Study|Withdrawal by Subject|4
2011612|NCT00237744|3578245|FG000|Overall Study|Withdrawal by Subject|3
2011613|NCT00237744|3578246|FG001|Overall Study|Withdrawal by Subject|1
2011614|NCT00237744|3578247|FG002|Overall Study|Withdrawal by Subject|0
2011615|NCT00237796|3578273|FG000|Overall Study|Baseline and one other ILSS required|10
2011616|NCT00237796|3578274|FG001|Overall Study|Baseline and one other ILSS required|5
2011617|NCT00237809|3578285|FG000|Overall Study|Lost to Follow-up|11
2011618|NCT00237809|3578286|FG001|Overall Study|Lost to Follow-up|10
2011619|NCT00237809|3578287|FG002|Overall Study|Lost to Follow-up|9
2011620|NCT00237809|3578288|FG003|Overall Study|Lost to Follow-up|9
2011621|NCT00238121|3578309|FG000|Overall Study|Withdrawal by Subject|1
2011622|NCT00238121|3578310|FG001|Overall Study|Withdrawal by Subject|1
2011623|NCT00238121|3578309|FG000|Overall Study|Adverse Event|2
2011624|NCT00238121|3578310|FG001|Overall Study|Adverse Event|1
2011625|NCT00238238|3578318|FG000|Overall Study|Withdrawal by Subject|0
2011626|NCT00238238|3578319|FG001|Overall Study|Withdrawal by Subject|3
2011627|NCT00238238|3578320|FG002|Overall Study|Withdrawal by Subject|0
2011628|NCT00238264|3578328|FG000|Overall Study|Death|7
2011629|NCT00238264|3578328|FG000|Overall Study|Lost to Follow-up|18
2011630|NCT00238264|3578328|FG000|Overall Study|Withdrawal by Subject|4
2011631|NCT00238264|3578328|FG000|Overall Study|Ineligible|7
2011632|NCT00238303|3578335|FG000|Overall Study|Withdrawal by Subject|11
2011633|NCT00238303|3578336|FG001|Overall Study|Withdrawal by Subject|1
2011634|NCT00238303|3578337|FG002|Overall Study|Withdrawal by Subject|2
2011635|NCT00238303|3578335|FG000|Overall Study|Death|1
2011636|NCT00238303|3578336|FG001|Overall Study|Death|0
2011637|NCT00238303|3578337|FG002|Overall Study|Death|1
2011638|NCT00238303|3578335|FG000|Overall Study|Other Medical Problems|2
2011639|NCT00238303|3578336|FG001|Overall Study|Other Medical Problems|0
2011640|NCT00238303|3578337|FG002|Overall Study|Other Medical Problems|2
2011641|NCT00238303|3578335|FG000|Overall Study|Poor tolerance of study treatment|1
2011642|NCT00238303|3578336|FG001|Overall Study|Poor tolerance of study treatment|0
2011643|NCT00238303|3578337|FG002|Overall Study|Poor tolerance of study treatment|1
2011644|NCT00238303|3578335|FG000|Overall Study|Adverse Event|0
2011645|NCT00238303|3578336|FG001|Overall Study|Adverse Event|1
2011646|NCT00238303|3578337|FG002|Overall Study|Adverse Event|3
2011647|NCT00238433|3578350|FG000|Overall Study|Screen failure|1
2011648|NCT00238433|3578350|FG000|Overall Study|Lost to Follow-up|1
2011649|NCT00238433|3578350|FG000|Overall Study|Death|1
2011650|NCT00239005|3578363|FG000|Overall Study|Adverse Event|6
2011651|NCT00239005|3578364|FG001|Overall Study|Adverse Event|6
2011652|NCT00239005|3578363|FG000|Overall Study|Withdrawal by Subject|3
2011653|NCT00239005|3578364|FG001|Overall Study|Withdrawal by Subject|4
2011654|NCT00239005|3578363|FG000|Overall Study|Unsatisfactory Therapeutic effect|2
2011655|NCT00239005|3578364|FG001|Overall Study|Unsatisfactory Therapeutic effect|0
2011656|NCT00239005|3578363|FG000|Overall Study|Protocol Violation|1
2011657|NCT00239005|3578364|FG001|Overall Study|Protocol Violation|0
2011658|NCT00239005|3578363|FG000|Overall Study|Subj. cond. no longer needs study drug|0
2011659|NCT00239005|3578364|FG001|Overall Study|Subj. cond. no longer needs study drug|1
2011660|NCT00239005|3578363|FG000|Overall Study|Lost to Follow-up|0
2011661|NCT00239005|3578364|FG001|Overall Study|Lost to Follow-up|1
2011662|NCT00239226|3578374|FG000|Overall Study|permAF during stabilization period|0
2011663|NCT00239226|3578375|FG001|Overall Study|permAF during stabilization period|0
2011664|NCT00239226|3578376|FG002|Overall Study|permAF during stabilization period|0
2011665|NCT00239226|3578377|FG003|Overall Study|permAF during stabilization period|3
2011666|NCT00239226|3578374|FG000|Overall Study|Lost to Follow-up|1
2011667|NCT00239226|3578375|FG001|Overall Study|Lost to Follow-up|0
2011668|NCT00239226|3578376|FG002|Overall Study|Lost to Follow-up|1
2011669|NCT00239226|3578377|FG003|Overall Study|Lost to Follow-up|0
2011670|NCT00239356|3578389|FG000|Overall Study|Lack of Efficacy|1
2011671|NCT00239356|3578390|FG001|Overall Study|Lack of Efficacy|0
2011672|NCT00239356|3578389|FG000|Overall Study|Adverse Event|6
2011673|NCT00239356|3578390|FG001|Overall Study|Adverse Event|0
2011674|NCT00239356|3578389|FG000|Overall Study|Withdrawal by Subject|15
2011675|NCT00239356|3578390|FG001|Overall Study|Withdrawal by Subject|6
2011676|NCT00239356|3578389|FG000|Overall Study|Lost to Follow-up|3
2011677|NCT00239356|3578390|FG001|Overall Study|Lost to Follow-up|0
2011678|NCT00239356|3578389|FG000|Overall Study|poor/non-compliance|2
2011679|NCT00239356|3578390|FG001|Overall Study|poor/non-compliance|0
2011680|NCT00239356|3578389|FG000|Overall Study|Pregnancy|1
2011681|NCT00239356|3578390|FG001|Overall Study|Pregnancy|0
2011682|NCT00239356|3578389|FG000|Overall Study|Administrative reason|0
2011683|NCT00239356|3578390|FG001|Overall Study|Administrative reason|1
2011684|NCT00239356|3578389|FG000|Overall Study|Drug available on market|11
2011685|NCT00239356|3578390|FG001|Overall Study|Drug available on market|2
2011686|NCT00239577|3578400|FG000|Primary Phase|Adverse Event|0
2011687|NCT00239577|3578401|FG001|Primary Phase|Adverse Event|0
2011688|NCT00239577|3578402|FG002|Primary Phase|Adverse Event|1
2011689|NCT00239577|3578403|FG003|Primary Phase|Adverse Event|0
2011690|NCT00239577|3578400|FG000|Primary Phase|Other|5
2011691|NCT00239577|3578401|FG001|Primary Phase|Other|3
2011692|NCT00239577|3578402|FG002|Primary Phase|Other|2
2011693|NCT00239577|3578403|FG003|Primary Phase|Other|0
2011694|NCT00239590|3578415|FG000|Randomized|Lost to Follow-up|0
2011695|NCT00239590|3578416|FG001|Randomized|Lost to Follow-up|1
2011696|NCT00239590|3578415|FG000|Randomized|Withdrawal by Subject|0
2011697|NCT00239590|3578416|FG001|Randomized|Withdrawal by Subject|1
2011698|NCT00239590|3578415|FG000|Completed Study Protocol|Adverse Event|1
2011699|NCT00239590|3578416|FG001|Completed Study Protocol|Adverse Event|1
2011700|NCT00239590|3578415|FG000|Completed Study Protocol|Withdrawal by Subject|0
2011701|NCT00239590|3578416|FG001|Completed Study Protocol|Withdrawal by Subject|1
2011702|NCT00239681|3578439|FG000|Overall Study|Adverse Event|100
2011703|NCT00239681|3578440|FG001|Overall Study|Adverse Event|99
2011704|NCT00239681|3578439|FG000|Overall Study|Withdrawal by Subject|458
2011705|NCT00239681|3578440|FG001|Overall Study|Withdrawal by Subject|489
2011706|NCT00239681|3578439|FG000|Overall Study|Lost to Follow-up|28
2011707|NCT00239681|3578440|FG001|Overall Study|Lost to Follow-up|22
2011708|NCT00239681|3578439|FG000|Overall Study|Protocol Violation|4
2011709|NCT00239681|3578440|FG001|Overall Study|Protocol Violation|4
2011710|NCT00239681|3578439|FG000|Overall Study|Physician Decision|13
2011711|NCT00239681|3578440|FG001|Overall Study|Physician Decision|17
2011712|NCT00239681|3578439|FG000|Overall Study|No information chacked on CaseReportForm|90
2011713|NCT00239681|3578440|FG001|Overall Study|No information chacked on CaseReportForm|84
2011714|NCT00239837|3578452|FG000|Overall Study|Lost to Follow-up|3
2011715|NCT00239837|3578453|FG001|Overall Study|Lost to Follow-up|7
2011716|NCT00239928|3578461|FG000|Overall Study|Lack of Efficacy|1
2011717|NCT00239928|3578461|FG000|Overall Study|Adverse Event|4
2011718|NCT00239928|3578461|FG000|Overall Study|Not need to continue study|3
2011719|NCT00239928|3578461|FG000|Overall Study|Withdrawal by Subject|2
2011720|NCT00240071|3578465|FG000|Overall Study|Withdrawal by Subject|3
2011721|NCT00240097|3578470|FG000|Part I|Adverse Event|1
2011722|NCT00240097|3578470|FG000|Part I|Death|1
2011723|NCT00240097|3578470|FG000|Part I|histology|1
2011724|NCT00240097|3578470|FG000|Part I|unevaluable|1
2011725|NCT00240097|3578470|FG000|Part II|did not continue from Part I|23
2011726|NCT00240110|3578480|FG000|Overall Study|Lost to Follow-up|6
2011727|NCT00240110|3578481|FG001|Overall Study|Lost to Follow-up|7
2011728|NCT00240331|3578495|FG000|Overall Study|Withdrawal by Subject|125
2011729|NCT00240331|3578496|FG001|Overall Study|Withdrawal by Subject|132
2011730|NCT00240331|3578495|FG000|Overall Study|Option selected by investigator|1
2011731|NCT00240331|3578496|FG001|Overall Study|Option selected by investigator|2
2025541|NCT00346398|3594452|FG000|Overall Study|Withdrawal by Subject|0
2025542|NCT00346398|3594453|FG001|Overall Study|Withdrawal by Subject|2
2025543|NCT00346632|3594465|FG000|Overall Study|Progressive Disease|2
2025544|NCT00346632|3594466|FG001|Overall Study|Progressive Disease|2
2025545|NCT00346632|3594467|FG002|Overall Study|Progressive Disease|4
2025546|NCT00346632|3594468|FG003|Overall Study|Progressive Disease|3
2011732|NCT00240994|3578559|FG000|Overall Study|Lost to Follow-up|1
2011733|NCT00240994|3578559|FG000|Overall Study|Protocol Violation|1
2011734|NCT00240994|3578559|FG000|Overall Study|Graft failure|1
2011735|NCT00241280|3578570|FG000|Overall Study|Adverse Event|2
2011736|NCT00241280|3578571|FG001|Overall Study|Adverse Event|6
2011737|NCT00241280|3578570|FG000|Overall Study|Discomfort|11
2011738|NCT00241280|3578571|FG001|Overall Study|Discomfort|16
2011739|NCT00241280|3578570|FG000|Overall Study|Pregnancy|1
2011740|NCT00241280|3578571|FG001|Overall Study|Pregnancy|5
2011741|NCT00241280|3578570|FG000|Overall Study|Lost to Follow-up|5
2011742|NCT00241280|3578571|FG001|Overall Study|Lost to Follow-up|8
2011743|NCT00241280|3578570|FG000|Overall Study|Withdrawal by Subject|7
2011744|NCT00241280|3578571|FG001|Overall Study|Withdrawal by Subject|4
2011745|NCT00241280|3578570|FG000|Overall Study|Protocol Violation|4
2011746|NCT00241280|3578571|FG001|Overall Study|Protocol Violation|10
2011747|NCT00241280|3578570|FG000|Overall Study|Relocation|4
2011748|NCT00241280|3578571|FG001|Overall Study|Relocation|4
2011749|NCT00241280|3578570|FG000|Overall Study|Unsatisfactory Physiological Response|1
2011750|NCT00241280|3578571|FG001|Overall Study|Unsatisfactory Physiological Response|1
2011751|NCT00241280|3578570|FG000|Overall Study|Unsatisfactory Visual Response|1
2011752|NCT00241280|3578571|FG001|Overall Study|Unsatisfactory Visual Response|1
2011753|NCT00241280|3578570|FG000|Overall Study|Diabetic|1
2011754|NCT00241280|3578571|FG001|Overall Study|Diabetic|0
2011755|NCT00241280|3578570|FG000|Overall Study|Subject Ineligible/Dispensed|9
2011756|NCT00241280|3578571|FG001|Overall Study|Subject Ineligible/Dispensed|6
2011757|NCT00241280|3578570|FG000|Overall Study|Dispensed incorrect test article|1
2011758|NCT00241280|3578571|FG001|Overall Study|Dispensed incorrect test article|2
2011759|NCT00241280|3578570|FG000|Overall Study|Unacceptable Fit|0
2011760|NCT00241280|3578571|FG001|Overall Study|Unacceptable Fit|1
2011761|NCT00241280|3578570|FG000|Overall Study|Scheduling Conflict|0
2011762|NCT00241280|3578571|FG001|Overall Study|Scheduling Conflict|2
2011763|NCT00241280|3578570|FG000|Overall Study|History of Ocular Surgery|0
2011764|NCT00241280|3578571|FG001|Overall Study|History of Ocular Surgery|1
2011765|NCT00241280|3578570|FG000|Overall Study|Coating on Lens|1
2011766|NCT00241280|3578571|FG001|Overall Study|Coating on Lens|0
2011767|NCT00241280|3578570|FG000|Overall Study|Excessive Dryness|0
2011768|NCT00241280|3578571|FG001|Overall Study|Excessive Dryness|1
2011769|NCT00241358|3578581|FG000|Overall Study|Determined to be not ineligible|0
2011770|NCT00241358|3578582|FG001|Overall Study|Determined to be not ineligible|1
2011771|NCT00241358|3578583|FG002|Overall Study|Determined to be not ineligible|1
2011772|NCT00241631|3578592|FG000|Run in (2 Weeks)|Physician Decision|3
2011773|NCT00241631|3578593|FG001|Run in (2 Weeks)|Physician Decision|3
2011774|NCT00241631|3578592|FG000|Phase 1 (4 Weeks)|sore throat|1
2011775|NCT00241631|3578593|FG001|Phase 1 (4 Weeks)|sore throat|0
2011776|NCT00241631|3578592|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4
2011777|NCT00241631|3578593|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4
2011778|NCT00241631|3578592|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3
2011779|NCT00241631|3578593|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0
2011780|NCT00241631|3578592|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0
2011781|NCT00241631|3578593|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1
2011782|NCT00241644|3578603|FG000|First Efficacy Period (Year 1)|Adverse Event|46
2011783|NCT00241644|3578604|FG001|First Efficacy Period (Year 1)|Adverse Event|45
2011784|NCT00241644|3578605|FG002|First Efficacy Period (Year 1)|Adverse Event|45
2011785|NCT00241644|3578606|FG003|First Efficacy Period (Year 1)|Adverse Event|91
2011786|NCT00241644|3578603|FG000|First Efficacy Period (Year 1)|Protocol Violation|3
2011787|NCT00241644|3578604|FG001|First Efficacy Period (Year 1)|Protocol Violation|5
2011788|NCT00241644|3578605|FG002|First Efficacy Period (Year 1)|Protocol Violation|4
2011789|NCT00241644|3578606|FG003|First Efficacy Period (Year 1)|Protocol Violation|8
2011790|NCT00241644|3578603|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59
2011791|NCT00241644|3578604|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74
2011792|NCT00241644|3578605|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81
2011793|NCT00241644|3578606|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133
2011794|NCT00241644|3578603|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116
2011795|NCT00241644|3578604|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142
2011796|NCT00241644|3578605|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116
2011797|NCT00241644|3578606|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258
2011798|NCT00241644|3578603|FG000|First Efficacy Period (Year 1)|Non-compliance|2
2011799|NCT00241644|3578604|FG001|First Efficacy Period (Year 1)|Non-compliance|1
2011800|NCT00241644|3578605|FG002|First Efficacy Period (Year 1)|Non-compliance|2
2011801|NCT00241644|3578606|FG003|First Efficacy Period (Year 1)|Non-compliance|3
2011802|NCT00241644|3578603|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1
2011803|NCT00241644|3578604|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0
2011804|NCT00241644|3578605|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0
2011805|NCT00241644|3578606|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1
2011806|NCT00241644|3578603|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
2011807|NCT00241644|3578604|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
2011808|NCT00241644|3578605|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
2011809|NCT00241644|3578606|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
2011810|NCT00241644|3578603|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0
2011811|NCT00241644|3578604|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1
2011812|NCT00241644|3578605|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0
2011813|NCT00241644|3578606|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1
2011814|NCT00241644|3578603|FG000|Second Efficacy Period (Year 2)|Adverse Event|11
2011815|NCT00241644|3578604|FG001|Second Efficacy Period (Year 2)|Adverse Event|9
2011816|NCT00241644|3578605|FG002|Second Efficacy Period (Year 2)|Adverse Event|12
2011817|NCT00241644|3578606|FG003|Second Efficacy Period (Year 2)|Adverse Event|20
2011818|NCT00241644|3578603|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2
2011819|NCT00241644|3578604|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1
2011820|NCT00241644|3578605|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2
2011821|NCT00241644|3578606|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3
2011822|NCT00241644|3578603|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
2011823|NCT00241644|3578604|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
2011824|NCT00241644|3578605|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
2011825|NCT00241644|3578606|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
2011826|NCT00241644|3578603|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43
2011827|NCT00241644|3578604|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43
2011828|NCT00241644|3578605|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46
2011829|NCT00241644|3578606|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86
2011830|NCT00241644|3578603|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1
2011831|NCT00241644|3578604|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1
2011832|NCT00241644|3578605|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2
2011833|NCT00241644|3578606|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2
2011834|NCT00241839|3578618|FG000|Overall Study|Withdrawal by Subject|18
2011835|NCT00241839|3578619|FG001|Overall Study|Withdrawal by Subject|17
2011836|NCT00241839|3578618|FG000|Overall Study|Adverse Event|1
2011837|NCT00241839|3578619|FG001|Overall Study|Adverse Event|1
2011838|NCT00242216|3578646|FG000|Overall Study|Lost to Follow-up|12
2011839|NCT00242216|3578647|FG001|Overall Study|Lost to Follow-up|17
2011840|NCT00242216|3578646|FG000|Overall Study|Death|4
2011841|NCT00242216|3578647|FG001|Overall Study|Death|2
2011842|NCT00242216|3578646|FG000|Overall Study|Lack of Efficacy|1
2011843|NCT00242216|3578647|FG001|Overall Study|Lack of Efficacy|2
2011844|NCT00242216|3578646|FG000|Overall Study|no medicaiton dispensed|1
2011845|NCT00242216|3578647|FG001|Overall Study|no medicaiton dispensed|1
2011846|NCT00242567|3578666|FG000|Overall Study|Adverse Event|70
2011847|NCT00242567|3578667|FG001|Overall Study|Adverse Event|43
2011848|NCT00242567|3578666|FG000|Overall Study|Disease Progression|17
2011849|NCT00242567|3578667|FG001|Overall Study|Disease Progression|22
2011850|NCT00242567|3578666|FG000|Overall Study|Symptomatic deterioration|9
2011851|NCT00242567|3578667|FG001|Overall Study|Symptomatic deterioration|3
2011852|NCT00242567|3578666|FG000|Overall Study|Lack of Efficacy|2
2011853|NCT00242567|3578667|FG001|Overall Study|Lack of Efficacy|2
2011854|NCT00242567|3578666|FG000|Overall Study|Lost to Follow-up|9
2011855|NCT00242567|3578667|FG001|Overall Study|Lost to Follow-up|19
2011856|NCT00242567|3578666|FG000|Overall Study|Withdrawal by Subject|33
2011857|NCT00242567|3578667|FG001|Overall Study|Withdrawal by Subject|28
2011858|NCT00242567|3578666|FG000|Overall Study|Protocol Violation|12
2011859|NCT00242567|3578667|FG001|Overall Study|Protocol Violation|12
2011860|NCT00242567|3578666|FG000|Overall Study|Use of an inhibitor of bone resorption|0
2011861|NCT00242567|3578667|FG001|Overall Study|Use of an inhibitor of bone resorption|2
2011862|NCT00242567|3578666|FG000|Overall Study|Other|14
2011863|NCT00242567|3578667|FG001|Overall Study|Other|9
2011864|NCT00242580|3578678|FG000|Overall Study|Adverse Event|3
2011865|NCT00242580|3578679|FG001|Overall Study|Adverse Event|0
2011866|NCT00242580|3578680|FG002|Overall Study|Adverse Event|2
2011867|NCT00242580|3578678|FG000|Overall Study|Unsatisfactory therapeutic effect|4
2011868|NCT00242580|3578679|FG001|Overall Study|Unsatisfactory therapeutic effect|5
2011869|NCT00242580|3578680|FG002|Overall Study|Unsatisfactory therapeutic effect|5
2011870|NCT00242580|3578678|FG000|Overall Study|Protocol Violation|0
2011871|NCT00242580|3578679|FG001|Overall Study|Protocol Violation|0
2011872|NCT00242580|3578680|FG002|Overall Study|Protocol Violation|1
2011873|NCT00242580|3578678|FG000|Overall Study|Subject withdrew consent|2
2011874|NCT00242580|3578679|FG001|Overall Study|Subject withdrew consent|2
2011875|NCT00242580|3578680|FG002|Overall Study|Subject withdrew consent|5
2011876|NCT00242580|3578678|FG000|Overall Study|Lost to Follow-up|0
2011877|NCT00242580|3578679|FG001|Overall Study|Lost to Follow-up|3
2011878|NCT00242580|3578680|FG002|Overall Study|Lost to Follow-up|0
2011879|NCT00242580|3578678|FG000|Overall Study|Death|1
2011880|NCT00242580|3578679|FG001|Overall Study|Death|2
2011881|NCT00242580|3578680|FG002|Overall Study|Death|1
2011882|NCT00242658|3578709|FG000|Overall Study|Lost to Follow-up|22
2214436|NCT01687283|3856701|FG001|Overall Study|protocol defined stopping criteria|10
2011883|NCT00242658|3578710|FG001|Overall Study|Lost to Follow-up|19
2011884|NCT00242710|3578724|FG000|Core Study (up to Year 1)|Adverse Event|30
2011885|NCT00242710|3578725|FG001|Core Study (up to Year 1)|Adverse Event|25
2011886|NCT00242710|3578726|FG002|Core Study (up to Year 1)|Adverse Event|23
2011887|NCT00242710|3578727|FG003|Core Study (up to Year 1)|Adverse Event|14
2011888|NCT00242710|3578724|FG000|Core Study (up to Year 1)|Death|0
2011889|NCT00242710|3578725|FG001|Core Study (up to Year 1)|Death|0
2313262|NCT02787304|4020570|FG001|Overall Study|Adverse Event|3
2313263|NCT02787304|4020571|FG002|Overall Study|Adverse Event|8
2011890|NCT00242710|3578726|FG002|Core Study (up to Year 1)|Death|1
2011891|NCT00242710|3578727|FG003|Core Study (up to Year 1)|Death|0
2011892|NCT00242710|3578724|FG000|Core Study (up to Year 1)|Physician Decision|0
2011893|NCT00242710|3578725|FG001|Core Study (up to Year 1)|Physician Decision|1
2011894|NCT00242710|3578726|FG002|Core Study (up to Year 1)|Physician Decision|0
2011895|NCT00242710|3578727|FG003|Core Study (up to Year 1)|Physician Decision|1
2011896|NCT00242710|3578724|FG000|Core Study (up to Year 1)|Lost to Follow-up|8
2011897|NCT00242710|3578725|FG001|Core Study (up to Year 1)|Lost to Follow-up|8
2011898|NCT00242710|3578726|FG002|Core Study (up to Year 1)|Lost to Follow-up|7
2011899|NCT00242710|3578727|FG003|Core Study (up to Year 1)|Lost to Follow-up|3
2011900|NCT00242710|3578724|FG000|Core Study (up to Year 1)|Other|6
2011901|NCT00242710|3578725|FG001|Core Study (up to Year 1)|Other|1
2011902|NCT00242710|3578726|FG002|Core Study (up to Year 1)|Other|0
2011903|NCT00242710|3578727|FG003|Core Study (up to Year 1)|Other|2
2011904|NCT00242710|3578724|FG000|Core Study (up to Year 1)|Protocol Violation|2
2011905|NCT00242710|3578725|FG001|Core Study (up to Year 1)|Protocol Violation|9
2011906|NCT00242710|3578726|FG002|Core Study (up to Year 1)|Protocol Violation|1
2011907|NCT00242710|3578727|FG003|Core Study (up to Year 1)|Protocol Violation|3
2011908|NCT00242710|3578724|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27
2011909|NCT00242710|3578725|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16
2011910|NCT00242710|3578726|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15
2011911|NCT00242710|3578727|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6
2011912|NCT00242710|3578724|FG000|Core Study (up to Year 1)|Lack of Efficacy|1
2011913|NCT00242710|3578725|FG001|Core Study (up to Year 1)|Lack of Efficacy|0
2011914|NCT00242710|3578726|FG002|Core Study (up to Year 1)|Lack of Efficacy|0
2011915|NCT00242710|3578727|FG003|Core Study (up to Year 1)|Lack of Efficacy|0
2011916|NCT00242710|3578724|FG000|Core Study (up to Year 1)|Randomized but not Treated|12
2011917|NCT00242710|3578725|FG001|Core Study (up to Year 1)|Randomized but not Treated|4
2011918|NCT00242710|3578726|FG002|Core Study (up to Year 1)|Randomized but not Treated|4
2011919|NCT00242710|3578727|FG003|Core Study (up to Year 1)|Randomized but not Treated|2
2011920|NCT00242710|3578724|FG000|Period Between Core Study and Extension|Adverse Event|2
2011921|NCT00242710|3578725|FG001|Period Between Core Study and Extension|Adverse Event|3
2011922|NCT00242710|3578726|FG002|Period Between Core Study and Extension|Adverse Event|5
2011923|NCT00242710|3578727|FG003|Period Between Core Study and Extension|Adverse Event|2
2011924|NCT00242710|3578724|FG000|Period Between Core Study and Extension|Physician Decision|1
2011925|NCT00242710|3578725|FG001|Period Between Core Study and Extension|Physician Decision|1
2011926|NCT00242710|3578726|FG002|Period Between Core Study and Extension|Physician Decision|0
2011927|NCT00242710|3578727|FG003|Period Between Core Study and Extension|Physician Decision|0
2011928|NCT00242710|3578724|FG000|Period Between Core Study and Extension|Other|24
2011929|NCT00242710|3578725|FG001|Period Between Core Study and Extension|Other|24
2011930|NCT00242710|3578726|FG002|Period Between Core Study and Extension|Other|9
2011931|NCT00242710|3578727|FG003|Period Between Core Study and Extension|Other|11
2011932|NCT00242710|3578724|FG000|Period Between Core Study and Extension|Extension not Available|17
2011933|NCT00242710|3578725|FG001|Period Between Core Study and Extension|Extension not Available|21
2011934|NCT00242710|3578726|FG002|Period Between Core Study and Extension|Extension not Available|8
2011935|NCT00242710|3578727|FG003|Period Between Core Study and Extension|Extension not Available|7
2011936|NCT00242710|3578724|FG000|Period Between Core Study and Extension|Protocol Violation|0
2011937|NCT00242710|3578725|FG001|Period Between Core Study and Extension|Protocol Violation|0
2011938|NCT00242710|3578726|FG002|Period Between Core Study and Extension|Protocol Violation|2
2011939|NCT00242710|3578727|FG003|Period Between Core Study and Extension|Protocol Violation|1
2011940|NCT00242710|3578724|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75
2011941|NCT00242710|3578725|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63
2011942|NCT00242710|3578726|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24
2011943|NCT00242710|3578727|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28
2011944|NCT00242710|3578724|FG000|Study Extension (up to Year 2)|Adverse Event|7
2011945|NCT00242710|3578725|FG001|Study Extension (up to Year 2)|Adverse Event|9
2011946|NCT00242710|3578726|FG002|Study Extension (up to Year 2)|Adverse Event|2
2011947|NCT00242710|3578727|FG003|Study Extension (up to Year 2)|Adverse Event|4
2011948|NCT00242710|3578724|FG000|Study Extension (up to Year 2)|Death|0
2011949|NCT00242710|3578725|FG001|Study Extension (up to Year 2)|Death|0
2011950|NCT00242710|3578726|FG002|Study Extension (up to Year 2)|Death|0
2011951|NCT00242710|3578727|FG003|Study Extension (up to Year 2)|Death|1
2011952|NCT00242710|3578724|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7
2011953|NCT00242710|3578725|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7
2011954|NCT00242710|3578726|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5
2011955|NCT00242710|3578727|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0
2011956|NCT00242710|3578724|FG000|Study Extension (up to Year 2)|Other|3
2011957|NCT00242710|3578725|FG001|Study Extension (up to Year 2)|Other|5
2011958|NCT00242710|3578726|FG002|Study Extension (up to Year 2)|Other|4
2011959|NCT00242710|3578727|FG003|Study Extension (up to Year 2)|Other|3
2025547|NCT00346632|3594469|FG004|Overall Study|Progressive Disease|3
2313264|NCT02787304|4020572|FG003|Overall Study|Adverse Event|1
2011960|NCT00242710|3578724|FG000|Study Extension (up to Year 2)|Protocol Violation|0
2011961|NCT00242710|3578725|FG001|Study Extension (up to Year 2)|Protocol Violation|2
2011962|NCT00242710|3578726|FG002|Study Extension (up to Year 2)|Protocol Violation|0
2011963|NCT00242710|3578727|FG003|Study Extension (up to Year 2)|Protocol Violation|1
2011964|NCT00242710|3578724|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10
2011965|NCT00242710|3578725|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6
2011966|NCT00242710|3578726|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4
2011967|NCT00242710|3578727|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1
2011968|NCT00243022|3578739|FG000|Overall Study|Withdrawal by Subject|1
2011969|NCT00243022|3578740|FG001|Overall Study|Withdrawal by Subject|0
2011970|NCT00243022|3578739|FG000|Overall Study|Death|1
2011971|NCT00243022|3578740|FG001|Overall Study|Death|0
2011972|NCT00243022|3578739|FG000|Overall Study|Difficult Travel Distance|0
2011973|NCT00243022|3578740|FG001|Overall Study|Difficult Travel Distance|1
2011974|NCT00243074|3578752|FG000|Overall Study|Ineligible|6
2011975|NCT00243074|3578752|FG000|Overall Study|Adverse Event|6
2011976|NCT00243074|3578752|FG000|Overall Study|Withdrawal by Subject|2
2011977|NCT00243074|3578752|FG000|Overall Study|Lack of Efficacy|36
2011978|NCT00243074|3578752|FG000|Overall Study|Death|2
2011979|NCT00243074|3578752|FG000|Overall Study|not protocol specified|1
2011980|NCT00243074|3578752|FG000|Overall Study|Did not receive any treatment|1
2011981|NCT00243230|3578772|FG000|Double-Blind Period|Adverse Event|0
2011982|NCT00243230|3578773|FG001|Double-Blind Period|Adverse Event|2
2011983|NCT00243230|3578774|FG002|Double-Blind Period|Adverse Event|2
2011984|NCT00243230|3578775|FG003|Double-Blind Period|Adverse Event|0
2011985|NCT00243230|3578772|FG000|Double-Blind Period|Withdrawal by Subject|1
2011986|NCT00243230|3578773|FG001|Double-Blind Period|Withdrawal by Subject|0
2011987|NCT00243230|3578774|FG002|Double-Blind Period|Withdrawal by Subject|0
2011988|NCT00243230|3578775|FG003|Double-Blind Period|Withdrawal by Subject|0
2011989|NCT00243230|3578772|FG000|Double-Blind Period|Protocol Violation|0
2011990|NCT00243230|3578773|FG001|Double-Blind Period|Protocol Violation|0
2011991|NCT00243230|3578774|FG002|Double-Blind Period|Protocol Violation|1
2011992|NCT00243230|3578775|FG003|Double-Blind Period|Protocol Violation|0
2011993|NCT00243230|3578772|FG000|Double-Blind Period|Randomized but Not Treated|0
2011994|NCT00243230|3578773|FG001|Double-Blind Period|Randomized but Not Treated|0
2011995|NCT00243230|3578774|FG002|Double-Blind Period|Randomized but Not Treated|2
2011996|NCT00243230|3578775|FG003|Double-Blind Period|Randomized but Not Treated|0
2011997|NCT00243230|3578772|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5
2011998|NCT00243230|3578773|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3
2011999|NCT00243230|3578774|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14
2012000|NCT00243230|3578775|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0
2012001|NCT00243230|3578772|FG000|Open Label Period|Adverse Event|0
2012002|NCT00243230|3578773|FG001|Open Label Period|Adverse Event|0
2012003|NCT00243230|3578774|FG002|Open Label Period|Adverse Event|0
2012004|NCT00243230|3578775|FG003|Open Label Period|Adverse Event|2
2012005|NCT00243230|3578772|FG000|Open Label Period|Treatment Failure - Virologic Failure|0
2012006|NCT00243230|3578773|FG001|Open Label Period|Treatment Failure - Virologic Failure|0
2012007|NCT00243230|3578774|FG002|Open Label Period|Treatment Failure - Virologic Failure|0
2012008|NCT00243230|3578775|FG003|Open Label Period|Treatment Failure - Virologic Failure|13
2012009|NCT00243230|3578772|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0
2012010|NCT00243230|3578773|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0
2012011|NCT00243230|3578774|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0
2012012|NCT00243230|3578775|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1
2012013|NCT00243230|3578772|FG000|Open Label Period|Lost to Follow-up|0
2012014|NCT00243230|3578773|FG001|Open Label Period|Lost to Follow-up|0
2012015|NCT00243230|3578774|FG002|Open Label Period|Lost to Follow-up|0
2012016|NCT00243230|3578775|FG003|Open Label Period|Lost to Follow-up|2
2012017|NCT00243230|3578772|FG000|Open Label Period|Withdrawal by Subject|0
2012018|NCT00243230|3578773|FG001|Open Label Period|Withdrawal by Subject|0
2012019|NCT00243230|3578774|FG002|Open Label Period|Withdrawal by Subject|0
2012020|NCT00243230|3578775|FG003|Open Label Period|Withdrawal by Subject|2
2012021|NCT00243230|3578772|FG000|Open Label Period|Protocol Violation|0
2012022|NCT00243230|3578773|FG001|Open Label Period|Protocol Violation|0
2012023|NCT00243230|3578774|FG002|Open Label Period|Protocol Violation|0
2012024|NCT00243230|3578775|FG003|Open Label Period|Protocol Violation|2
2012025|NCT00243230|3578772|FG000|Open Label Period|Administrative Reason|0
2012026|NCT00243230|3578773|FG001|Open Label Period|Administrative Reason|0
2012027|NCT00243230|3578774|FG002|Open Label Period|Administrative Reason|0
2012028|NCT00243230|3578775|FG003|Open Label Period|Administrative Reason|63
2012029|NCT00243269|3578798|FG000|Overall Study|Protocol Violation|2
2012030|NCT00243269|3578799|FG001|Overall Study|Protocol Violation|1
2012031|NCT00243269|3578800|FG002|Overall Study|Protocol Violation|0
2012032|NCT00243269|3578801|FG003|Overall Study|Protocol Violation|1
2012033|NCT00243269|3578798|FG000|Overall Study|Lost to Follow-up|1
2012034|NCT00243269|3578799|FG001|Overall Study|Lost to Follow-up|0
2012035|NCT00243269|3578800|FG002|Overall Study|Lost to Follow-up|1
2012036|NCT00243269|3578801|FG003|Overall Study|Lost to Follow-up|3
2012037|NCT00243347|3578811|FG000|Overall Study|Lack of Efficacy|4
2012038|NCT00243347|3578811|FG000|Overall Study|Adverse Event|2
2012039|NCT00243347|3578811|FG000|Overall Study|Death|1
2012040|NCT00243347|3578811|FG000|Overall Study|Withdrawal by Subject|5
2012041|NCT00243347|3578811|FG000|Overall Study|Condition worsened|7
2012042|NCT00243386|3578815|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
2012043|NCT00243386|3578816|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
2012044|NCT00243386|3578817|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
2012045|NCT00243386|3578815|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
2012046|NCT00243386|3578816|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
2012047|NCT00243386|3578817|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
2012048|NCT00243386|3578815|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2
2012049|NCT00243386|3578816|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0
2012050|NCT00243386|3578817|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0
2012051|NCT00243386|3578815|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
2012052|NCT00243386|3578816|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
2012053|NCT00243386|3578817|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
2012054|NCT00243386|3578815|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
2012055|NCT00243386|3578816|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
2012056|NCT00243386|3578817|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
2012057|NCT00243386|3578815|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
2012058|NCT00243386|3578816|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
2012059|NCT00243386|3578817|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
2012060|NCT00243386|3578815|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
2012061|NCT00243386|3578816|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
2012062|NCT00243386|3578817|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
2012063|NCT00243386|3578815|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
2012064|NCT00243386|3578816|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
2012065|NCT00243386|3578817|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
2012066|NCT00243412|3578855|FG000|Overall Study|Death|0
2012067|NCT00243412|3578856|FG001|Overall Study|Death|1
2012068|NCT00243412|3578855|FG000|Overall Study|Adverse Event|4
2012069|NCT00243412|3578856|FG001|Overall Study|Adverse Event|2
2012070|NCT00243412|3578855|FG000|Overall Study|Lost to Follow-up|0
2012071|NCT00243412|3578856|FG001|Overall Study|Lost to Follow-up|1
2012072|NCT00243412|3578855|FG000|Overall Study|Physician Decision|1
2012073|NCT00243412|3578856|FG001|Overall Study|Physician Decision|1
2012074|NCT00243412|3578855|FG000|Overall Study|Withdrawal by Subject|4
2012075|NCT00243412|3578856|FG001|Overall Study|Withdrawal by Subject|5
2012076|NCT00243412|3578855|FG000|Overall Study|Other|1
2012077|NCT00243412|3578856|FG001|Overall Study|Other|1
2012078|NCT00243503|3578862|FG000|Overall Study|Adverse Event|11
2012079|NCT00243503|3578862|FG000|Overall Study|Withdrawal by Subject|1
2012080|NCT00243503|3578862|FG000|Overall Study|Lack of Efficacy|44
2012081|NCT00243503|3578862|FG000|Overall Study|Death|1
2012082|NCT00243503|3578862|FG000|Overall Study|Other|1
2012083|NCT00243659|3578869|FG000|Overall Study|Withdrawal by Subject|1
2012084|NCT00243659|3578870|FG001|Overall Study|Withdrawal by Subject|1
2012085|NCT00243659|3578869|FG000|Overall Study|Protocol Violation|1
2012086|NCT00243659|3578870|FG001|Overall Study|Protocol Violation|2
2012087|NCT00243841|3578879|FG000|Overall Study|Physician Decision|0
2012088|NCT00243841|3578880|FG001|Overall Study|Physician Decision|0
2012089|NCT00243841|3578881|FG002|Overall Study|Physician Decision|1
2012090|NCT00243841|3578882|FG003|Overall Study|Physician Decision|0
2012091|NCT00243841|3578883|FG004|Overall Study|Physician Decision|0
2012092|NCT00243841|3578884|FG005|Overall Study|Physician Decision|2
2012093|NCT00243919|3578903|FG000|Overall Study|Death|3
2012094|NCT00243919|3578904|FG001|Overall Study|Death|4
2012095|NCT00243919|3578905|FG002|Overall Study|Death|6
2012096|NCT00243919|3578903|FG000|Overall Study|Withdrawal by Subject|6
2012097|NCT00243919|3578904|FG001|Overall Study|Withdrawal by Subject|6
2012098|NCT00243919|3578905|FG002|Overall Study|Withdrawal by Subject|2
2012099|NCT00243919|3578903|FG000|Overall Study|Lost to Follow-up|6
2012100|NCT00243919|3578904|FG001|Overall Study|Lost to Follow-up|7
2012101|NCT00243919|3578905|FG002|Overall Study|Lost to Follow-up|3
2012102|NCT00243919|3578903|FG000|Overall Study|Administrative Error|1
2012103|NCT00243919|3578904|FG001|Overall Study|Administrative Error|0
2012104|NCT00243919|3578905|FG002|Overall Study|Administrative Error|0
2012105|NCT00243919|3578903|FG000|Overall Study|Physician Decision|1
2012106|NCT00243919|3578904|FG001|Overall Study|Physician Decision|1
2012107|NCT00243919|3578905|FG002|Overall Study|Physician Decision|0
2012108|NCT00243932|3578916|FG000|Stage 1: Dose Selection|Lost to Follow-up|2
2012109|NCT00243932|3578917|FG001|Stage 1: Dose Selection|Lost to Follow-up|0
2012110|NCT00243932|3578918|FG002|Stage 1: Dose Selection|Lost to Follow-up|0
2012111|NCT00244374|3578948|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
2012112|NCT00244374|3578949|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
2012113|NCT00244374|3578950|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
2012114|NCT00244374|3578951|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
2012115|NCT00244374|3578952|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
2025548|NCT00346632|3594470|FG005|Overall Study|Progressive Disease|1
2012116|NCT00244374|3578948|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
2012117|NCT00244374|3578949|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
2012118|NCT00244374|3578950|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
2012119|NCT00244374|3578951|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
2012120|NCT00244374|3578952|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
2012121|NCT00244374|3578948|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
2012122|NCT00244374|3578949|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
2012123|NCT00244374|3578950|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
2012124|NCT00244374|3578951|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
2012125|NCT00244374|3578952|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
2012126|NCT00244374|3578948|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
2012127|NCT00244374|3578949|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
2012128|NCT00244374|3578950|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
2012129|NCT00244374|3578951|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
2012130|NCT00244374|3578952|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
2012131|NCT00244374|3578948|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
2012132|NCT00244374|3578949|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
2012133|NCT00244374|3578950|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
2012134|NCT00244374|3578951|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
2012135|NCT00244374|3578952|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
2012136|NCT00244374|3578948|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
2012137|NCT00244374|3578949|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
2012138|NCT00244374|3578950|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
2012139|NCT00244374|3578951|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
2012140|NCT00244374|3578952|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
2012141|NCT00244374|3578948|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
2012142|NCT00244374|3578949|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
2012143|NCT00244374|3578950|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
2012144|NCT00244374|3578951|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
2012145|NCT00244374|3578952|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
2012146|NCT00244374|3578948|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
2012147|NCT00244374|3578949|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
2012148|NCT00244374|3578950|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
2012149|NCT00244374|3578951|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
2012150|NCT00244374|3578952|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
2012151|NCT00244374|3578948|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
2012152|NCT00244374|3578949|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
2012153|NCT00244374|3578950|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
2012154|NCT00244374|3578951|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
2012155|NCT00244374|3578952|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
2012156|NCT00244621|3578971|FG000|Double-blind Treatment Period|Lost to Follow-up|0
2012157|NCT00244621|3578972|FG001|Double-blind Treatment Period|Lost to Follow-up|0
2012158|NCT00244621|3578973|FG002|Double-blind Treatment Period|Lost to Follow-up|1
2012159|NCT00244621|3578971|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
2012160|NCT00244621|3578972|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
2012161|NCT00244621|3578973|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
2012162|NCT00244621|3578971|FG000|Double-blind Treatment Period|Lack of Efficacy|0
2012163|NCT00244621|3578972|FG001|Double-blind Treatment Period|Lack of Efficacy|1
2012164|NCT00244621|3578973|FG002|Double-blind Treatment Period|Lack of Efficacy|0
2012165|NCT00244621|3578971|FG000|Double-blind Treatment Period|Multiple Reasons|2
2012166|NCT00244621|3578972|FG001|Double-blind Treatment Period|Multiple Reasons|1
2012167|NCT00244621|3578973|FG002|Double-blind Treatment Period|Multiple Reasons|1
2012168|NCT00244621|3578971|FG000|Open-label Treatment Period|Lost to Follow-up|0
2012169|NCT00244621|3578972|FG001|Open-label Treatment Period|Lost to Follow-up|1
2012170|NCT00244621|3578973|FG002|Open-label Treatment Period|Lost to Follow-up|0
2012171|NCT00244621|3578971|FG000|Open-label Treatment Period|Withdrawal by Subject|1
2012172|NCT00244621|3578972|FG001|Open-label Treatment Period|Withdrawal by Subject|0
2012173|NCT00244621|3578973|FG002|Open-label Treatment Period|Withdrawal by Subject|0
2012174|NCT00244621|3578971|FG000|Open-label Treatment Period|Adverse Event|0
2012175|NCT00244621|3578972|FG001|Open-label Treatment Period|Adverse Event|0
2012176|NCT00244621|3578973|FG002|Open-label Treatment Period|Adverse Event|1
2012177|NCT00244621|3578971|FG000|Open-label Treatment Period|Moved abroad|0
2012178|NCT00244621|3578972|FG001|Open-label Treatment Period|Moved abroad|0
2012179|NCT00244621|3578973|FG002|Open-label Treatment Period|Moved abroad|1
2012180|NCT00244712|3578983|FG000|Overall Study|Adverse Event|20
2012181|NCT00244712|3578984|FG001|Overall Study|Adverse Event|21
2012182|NCT00244712|3578983|FG000|Overall Study|Protocol-Defined Virologic Failure|8
2012183|NCT00244712|3578984|FG001|Overall Study|Protocol-Defined Virologic Failure|6
2012184|NCT00244712|3578983|FG000|Overall Study|Lack of Compliance|10
2012185|NCT00244712|3578984|FG001|Overall Study|Lack of Compliance|11
2012186|NCT00244712|3578983|FG000|Overall Study|Lost to Follow-up|45
2012187|NCT00244712|3578984|FG001|Overall Study|Lost to Follow-up|52
2012188|NCT00244712|3578983|FG000|Overall Study|Withdrawal by Subject|13
2012189|NCT00244712|3578984|FG001|Overall Study|Withdrawal by Subject|23
2012190|NCT00244712|3578983|FG000|Overall Study|Protocol Violation, disease progression|13
2012191|NCT00244712|3578984|FG001|Overall Study|Protocol Violation, disease progression|11
2012192|NCT00244725|3578994|FG000|Overall Study|Lost to Follow-up|3
2012193|NCT00244725|3578995|FG001|Overall Study|Lost to Follow-up|4
2012194|NCT00244725|3578996|FG002|Overall Study|Lost to Follow-up|9
2012195|NCT00244725|3578997|FG003|Overall Study|Lost to Follow-up|2
2012196|NCT00244725|3578994|FG000|Overall Study|Withdrawal by Subject|9
2012197|NCT00244725|3578995|FG001|Overall Study|Withdrawal by Subject|7
2012198|NCT00244725|3578996|FG002|Overall Study|Withdrawal by Subject|7
2012199|NCT00244725|3578997|FG003|Overall Study|Withdrawal by Subject|8
2012200|NCT00244725|3578994|FG000|Overall Study|Not meet treatment eligibility criteria|1
2012201|NCT00244725|3578995|FG001|Overall Study|Not meet treatment eligibility criteria|2
2012202|NCT00244725|3578996|FG002|Overall Study|Not meet treatment eligibility criteria|0
2012203|NCT00244725|3578997|FG003|Overall Study|Not meet treatment eligibility criteria|0
2012204|NCT00244725|3578994|FG000|Overall Study|Physician Decision|3
2012205|NCT00244725|3578995|FG001|Overall Study|Physician Decision|0
2012206|NCT00244725|3578996|FG002|Overall Study|Physician Decision|1
2012207|NCT00244725|3578997|FG003|Overall Study|Physician Decision|2
2012208|NCT00244725|3578994|FG000|Overall Study|Adverse Events|3
2012209|NCT00244725|3578995|FG001|Overall Study|Adverse Events|1
2012210|NCT00244725|3578996|FG002|Overall Study|Adverse Events|4
2012211|NCT00244725|3578997|FG003|Overall Study|Adverse Events|4
2012212|NCT00244725|3578994|FG000|Overall Study|Withdrwal by participant|1
2012213|NCT00244725|3578995|FG001|Overall Study|Withdrwal by participant|0
2012214|NCT00244725|3578996|FG002|Overall Study|Withdrwal by participant|0
2012215|NCT00244725|3578997|FG003|Overall Study|Withdrwal by participant|1
2012216|NCT00244725|3578994|FG000|Overall Study|Liver function test abnormality|2
2012217|NCT00244725|3578995|FG001|Overall Study|Liver function test abnormality|0
2012218|NCT00244725|3578996|FG002|Overall Study|Liver function test abnormality|0
2012219|NCT00244725|3578997|FG003|Overall Study|Liver function test abnormality|1
2012220|NCT00244725|3578994|FG000|Overall Study|Sponsor withdrew the participant|1
2012221|NCT00244725|3578995|FG001|Overall Study|Sponsor withdrew the participant|0
2012222|NCT00244725|3578996|FG002|Overall Study|Sponsor withdrew the participant|0
2012223|NCT00244725|3578997|FG003|Overall Study|Sponsor withdrew the participant|1
2012224|NCT00244725|3578994|FG000|Overall Study|Mediciation Error|0
2012225|NCT00244725|3578995|FG001|Overall Study|Mediciation Error|1
2012226|NCT00244725|3578996|FG002|Overall Study|Mediciation Error|0
2012227|NCT00244725|3578997|FG003|Overall Study|Mediciation Error|0
2012228|NCT00244725|3578994|FG000|Overall Study|Rehab Refused to allow participantion|0
2012229|NCT00244725|3578995|FG001|Overall Study|Rehab Refused to allow participantion|1
2012230|NCT00244725|3578996|FG002|Overall Study|Rehab Refused to allow participantion|0
2012231|NCT00244725|3578997|FG003|Overall Study|Rehab Refused to allow participantion|0
2012232|NCT00244725|3578994|FG000|Overall Study|Headache|0
2012233|NCT00244725|3578995|FG001|Overall Study|Headache|1
2012234|NCT00244725|3578996|FG002|Overall Study|Headache|0
2012235|NCT00244725|3578997|FG003|Overall Study|Headache|0
2012236|NCT00244725|3578994|FG000|Overall Study|Received prohibited medication|0
2012237|NCT00244725|3578995|FG001|Overall Study|Received prohibited medication|1
2012238|NCT00244725|3578996|FG002|Overall Study|Received prohibited medication|0
2012239|NCT00244725|3578997|FG003|Overall Study|Received prohibited medication|1
2012240|NCT00244725|3578994|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0
2012241|NCT00244725|3578995|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1
2012242|NCT00244725|3578996|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0
2012243|NCT00244725|3578997|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0
2012244|NCT00244725|3578994|FG000|Overall Study|Administrative reason|0
2012245|NCT00244725|3578995|FG001|Overall Study|Administrative reason|0
2012246|NCT00244725|3578996|FG002|Overall Study|Administrative reason|1
2012247|NCT00244725|3578997|FG003|Overall Study|Administrative reason|0
2012248|NCT00244725|3578994|FG000|Overall Study|Vomit|0
2012249|NCT00244725|3578995|FG001|Overall Study|Vomit|0
2012250|NCT00244725|3578996|FG002|Overall Study|Vomit|1
2012251|NCT00244725|3578997|FG003|Overall Study|Vomit|0
2012252|NCT00244725|3578994|FG000|Overall Study|Failed to follow-up|0
2012253|NCT00244725|3578995|FG001|Overall Study|Failed to follow-up|0
2012254|NCT00244725|3578996|FG002|Overall Study|Failed to follow-up|1
2012255|NCT00244725|3578997|FG003|Overall Study|Failed to follow-up|1
2012256|NCT00244751|3579010|FG000|Overall Study|Adverse Event|7
2012257|NCT00244751|3579011|FG001|Overall Study|Adverse Event|7
2012258|NCT00244751|3579012|FG002|Overall Study|Adverse Event|5
2012259|NCT00244751|3579010|FG000|Overall Study|Lost to Follow-up|0
2012260|NCT00244751|3579011|FG001|Overall Study|Lost to Follow-up|1
2012261|NCT00244751|3579012|FG002|Overall Study|Lost to Follow-up|0
2012262|NCT00244751|3579010|FG000|Overall Study|Protocol Violation|1
2012263|NCT00244751|3579011|FG001|Overall Study|Protocol Violation|0
2012264|NCT00244751|3579012|FG002|Overall Study|Protocol Violation|1
2012265|NCT00244751|3579010|FG000|Overall Study|Withdrawal by Subject|7
2012266|NCT00244751|3579011|FG001|Overall Study|Withdrawal by Subject|5
2012267|NCT00244751|3579012|FG002|Overall Study|Withdrawal by Subject|3
2012268|NCT00244751|3579010|FG000|Overall Study|Elevated liver enzymes|1
2012269|NCT00244751|3579011|FG001|Overall Study|Elevated liver enzymes|0
2012270|NCT00244751|3579012|FG002|Overall Study|Elevated liver enzymes|0
2012271|NCT00244751|3579010|FG000|Overall Study|Lack of compliance with protocol|0
2012272|NCT00244751|3579011|FG001|Overall Study|Lack of compliance with protocol|1
2012273|NCT00244751|3579012|FG002|Overall Study|Lack of compliance with protocol|0
2012274|NCT00244751|3579010|FG000|Overall Study|Safety reasons|0
2012275|NCT00244751|3579011|FG001|Overall Study|Safety reasons|1
2012276|NCT00244751|3579012|FG002|Overall Study|Safety reasons|0
2012277|NCT00244751|3579010|FG000|Overall Study|Participant randomized by mistake|0
2012278|NCT00244751|3579011|FG001|Overall Study|Participant randomized by mistake|0
2012279|NCT00244751|3579012|FG002|Overall Study|Participant randomized by mistake|1
2012280|NCT00244764|3579029|FG000|Overall Study|Adverse Event|37
2012281|NCT00244764|3579029|FG000|Overall Study|Lost to Follow-up|23
2012282|NCT00244764|3579029|FG000|Overall Study|Withdrawal by Subject|12
2012283|NCT00244764|3579029|FG000|Overall Study|Disease Progression|13
2012284|NCT00244764|3579029|FG000|Overall Study|Protocol Violation|2
2012285|NCT00244764|3579029|FG000|Overall Study|Death|1
2012286|NCT00244764|3579029|FG000|Overall Study|Off Study Medication for >21 Days|1
2012287|NCT00244764|3579029|FG000|Overall Study|Declining Performance Status|1
2012288|NCT00244764|3579029|FG000|Overall Study|Participant was Hospitalized until Death|1
2214437|NCT01687283|3856700|FG000|Overall Study|Lost to Follow-up|1
2214438|NCT01687283|3856701|FG001|Overall Study|Lost to Follow-up|1
2214439|NCT01687283|3856700|FG000|Overall Study|Investigator discretion|2
2214440|NCT01687283|3856701|FG001|Overall Study|Investigator discretion|0
2012289|NCT00244764|3579029|FG000|Overall Study|Primary Investigator Discretion|2
2012290|NCT00244764|3579029|FG000|Overall Study|Sponsor Terminated Study|2
2012291|NCT00244764|3579029|FG000|Overall Study|Developed Secondary Malignancy|1
2012292|NCT00244855|3579036|FG000|Overall Study|Withdrawal by Subject|0
2012293|NCT00244855|3579037|FG001|Overall Study|Withdrawal by Subject|1
2012294|NCT00244881|3579045|FG000|Overall Study|Withdrawal by Subject|3
2012295|NCT00244933|3579049|FG000|Overall Study|Not response evaluable|2
2012296|NCT00245011|3579057|FG000|Overall Study|Lack of Efficacy|1
2313265|NCT02787304|4020569|FG000|Overall Study|Withdrawal by Subject|1
2313266|NCT02787304|4020570|FG001|Overall Study|Withdrawal by Subject|4
2313267|NCT02787304|4020571|FG002|Overall Study|Withdrawal by Subject|0
2313268|NCT02787304|4020572|FG003|Overall Study|Withdrawal by Subject|0
2313269|NCT02787304|4020569|FG000|Overall Study|Lost to Follow-up|1
2313270|NCT02787304|4020570|FG001|Overall Study|Lost to Follow-up|0
2313271|NCT02787304|4020571|FG002|Overall Study|Lost to Follow-up|0
2012297|NCT00245037|3579061|FG000|Overall Study|Death|17
2012298|NCT00245050|3579067|FG000|Overall Study|Adverse Event|3
2012299|NCT00245050|3579068|FG001|Overall Study|Adverse Event|2
2012300|NCT00245063|3579076|FG000|Overall Study|Adverse Event|6
2012301|NCT00245063|3579077|FG001|Overall Study|Adverse Event|5
2012302|NCT00245063|3579076|FG000|Overall Study|Death|1
2012303|NCT00245063|3579077|FG001|Overall Study|Death|0
2012304|NCT00245102|3579089|FG000|Overall Study|Not Treated|1
2012305|NCT00245102|3579090|FG001|Overall Study|Not Treated|0
2012306|NCT00245102|3579091|FG002|Overall Study|Not Treated|1
2012307|NCT00245102|3579092|FG003|Overall Study|Not Treated|0
2012308|NCT00245102|3579093|FG004|Overall Study|Not Treated|0
2012309|NCT00245102|3579094|FG005|Overall Study|Not Treated|0
2012310|NCT00245102|3579089|FG000|Overall Study|Protocol Violation|1
2012311|NCT00245102|3579090|FG001|Overall Study|Protocol Violation|0
2012312|NCT00245102|3579091|FG002|Overall Study|Protocol Violation|0
2012313|NCT00245102|3579092|FG003|Overall Study|Protocol Violation|0
2012314|NCT00245102|3579093|FG004|Overall Study|Protocol Violation|0
2012315|NCT00245102|3579094|FG005|Overall Study|Protocol Violation|0
2012316|NCT00245102|3579089|FG000|Overall Study|Death|0
2012317|NCT00245102|3579090|FG001|Overall Study|Death|0
2012318|NCT00245102|3579091|FG002|Overall Study|Death|0
2012319|NCT00245102|3579092|FG003|Overall Study|Death|1
2012320|NCT00245102|3579093|FG004|Overall Study|Death|0
2012321|NCT00245102|3579094|FG005|Overall Study|Death|0
2012322|NCT00245102|3579089|FG000|Overall Study|Adverse Event|4
2012323|NCT00245102|3579090|FG001|Overall Study|Adverse Event|2
2012324|NCT00245102|3579091|FG002|Overall Study|Adverse Event|5
2012325|NCT00245102|3579092|FG003|Overall Study|Adverse Event|1
2012326|NCT00245102|3579093|FG004|Overall Study|Adverse Event|0
2012327|NCT00245102|3579094|FG005|Overall Study|Adverse Event|2
2012328|NCT00245102|3579089|FG000|Overall Study|Decline in performance|0
2012329|NCT00245102|3579090|FG001|Overall Study|Decline in performance|2
2012330|NCT00245102|3579091|FG002|Overall Study|Decline in performance|0
2012331|NCT00245102|3579092|FG003|Overall Study|Decline in performance|1
2313272|NCT02787304|4020572|FG003|Overall Study|Lost to Follow-up|1
2313273|NCT02787304|4020569|FG000|Overall Study|Noncompliance with study drug|0
2012332|NCT00245102|3579093|FG004|Overall Study|Decline in performance|0
2012333|NCT00245102|3579094|FG005|Overall Study|Decline in performance|2
2012334|NCT00245102|3579089|FG000|Overall Study|Participant needed surgery|0
2012335|NCT00245102|3579090|FG001|Overall Study|Participant needed surgery|0
2012336|NCT00245102|3579091|FG002|Overall Study|Participant needed surgery|1
2012337|NCT00245102|3579092|FG003|Overall Study|Participant needed surgery|0
2012338|NCT00245102|3579093|FG004|Overall Study|Participant needed surgery|0
2012339|NCT00245102|3579094|FG005|Overall Study|Participant needed surgery|0
2012340|NCT00245102|3579089|FG000|Overall Study|Clinical progression|1
2012341|NCT00245102|3579090|FG001|Overall Study|Clinical progression|0
2012342|NCT00245102|3579091|FG002|Overall Study|Clinical progression|0
2012343|NCT00245102|3579092|FG003|Overall Study|Clinical progression|0
2012344|NCT00245102|3579093|FG004|Overall Study|Clinical progression|0
2012345|NCT00245102|3579094|FG005|Overall Study|Clinical progression|0
2012346|NCT00245466|3579124|FG000|Overall Study|Adverse Event|2
2012347|NCT00245466|3579125|FG001|Overall Study|Adverse Event|8
2012348|NCT00245466|3579126|FG002|Overall Study|Adverse Event|4
2214441|NCT01687283|3856700|FG000|Overall Study|Withdrawal by Subject|9
2214442|NCT01687283|3856701|FG001|Overall Study|Withdrawal by Subject|8
2214443|NCT01687296|3856709|FG000|Overall Study|Lack of Efficacy|1
2214444|NCT01687296|3856710|FG001|Overall Study|Lack of Efficacy|1
2214445|NCT01687296|3856709|FG000|Overall Study|Protocol Violation|0
2214446|NCT01687296|3856710|FG001|Overall Study|Protocol Violation|1
2214447|NCT01687296|3856709|FG000|Overall Study|Withdrawal by Subject|6
2214448|NCT01687296|3856710|FG001|Overall Study|Withdrawal by Subject|3
2214449|NCT01687413|3856740|FG000|Overall Study|Withdrawal by Subject|0
2214450|NCT01687413|3856741|FG001|Overall Study|Withdrawal by Subject|2
2214451|NCT01687413|3856740|FG000|Overall Study|Not eligible|0
2214452|NCT01687413|3856741|FG001|Overall Study|Not eligible|2
2177484|NCT01374516|3801670|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
2177485|NCT01374516|3801671|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
2177486|NCT01374516|3801670|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
2177487|NCT01374516|3801671|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
2177488|NCT01374516|3801670|FG000|Surveillance Expansion Period|Protocol Violation|386
2177489|NCT01374516|3801671|FG001|Surveillance Expansion Period|Protocol Violation|217
2177490|NCT01374516|3801670|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870
2177491|NCT01374516|3801671|FG001|Surveillance Expansion Period|Withdrawal by Subject|986
2177492|NCT01374516|3801670|FG000|Surveillance Expansion Period|Lost to Follow-up|73
2177493|NCT01374516|3801671|FG001|Surveillance Expansion Period|Lost to Follow-up|45
2177494|NCT01374516|3801670|FG000|Surveillance Expansion Period|Serious adverse event|20
2177495|NCT01374516|3801671|FG001|Surveillance Expansion Period|Serious adverse event|5
2214453|NCT01687413|3856740|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1
2012349|NCT00245466|3579124|FG000|Overall Study|Low prostate specific antigen suppr|16
2012350|NCT00245466|3579125|FG001|Overall Study|Low prostate specific antigen suppr|14
2012351|NCT00245466|3579126|FG002|Overall Study|Low prostate specific antigen suppr|5
2012352|NCT00245466|3579124|FG000|Overall Study|Insufficient testosterone suppr|12
2012353|NCT00245466|3579125|FG001|Overall Study|Insufficient testosterone suppr|12
2012354|NCT00245466|3579126|FG002|Overall Study|Insufficient testosterone suppr|21
2012355|NCT00245466|3579124|FG000|Overall Study|Insufficient PSA and testosterone suppr|0
2012356|NCT00245466|3579125|FG001|Overall Study|Insufficient PSA and testosterone suppr|0
2012357|NCT00245466|3579126|FG002|Overall Study|Insufficient PSA and testosterone suppr|3
2012358|NCT00245466|3579124|FG000|Overall Study|Withdrawal by Subject|2
2012359|NCT00245466|3579125|FG001|Overall Study|Withdrawal by Subject|2
2012360|NCT00245466|3579126|FG002|Overall Study|Withdrawal by Subject|1
2012361|NCT00245466|3579124|FG000|Overall Study|Lost to Follow-up|3
2012362|NCT00245466|3579125|FG001|Overall Study|Lost to Follow-up|0
2012363|NCT00245466|3579126|FG002|Overall Study|Lost to Follow-up|0
2012364|NCT00245466|3579124|FG000|Overall Study|Disease progression|0
2012365|NCT00245466|3579125|FG001|Overall Study|Disease progression|3
2012366|NCT00245466|3579126|FG002|Overall Study|Disease progression|1
2012367|NCT00245466|3579124|FG000|Overall Study|Protocol Violation|1
2012368|NCT00245466|3579125|FG001|Overall Study|Protocol Violation|2
2012369|NCT00245466|3579126|FG002|Overall Study|Protocol Violation|2
2012370|NCT00245466|3579124|FG000|Overall Study|Death|0
2012371|NCT00245466|3579125|FG001|Overall Study|Death|2
2012372|NCT00245466|3579126|FG002|Overall Study|Death|0
2012373|NCT00245466|3579124|FG000|Overall Study|Administrative reasons|0
2012374|NCT00245466|3579125|FG001|Overall Study|Administrative reasons|1
2012375|NCT00245466|3579126|FG002|Overall Study|Administrative reasons|0
2012376|NCT00245583|3579155|FG000|Overall Study|Lost to Follow-up|1
2012377|NCT00245583|3579156|FG001|Overall Study|Lost to Follow-up|5
2012378|NCT00245583|3579155|FG000|Overall Study|Adverse Event|2
2012379|NCT00245583|3579156|FG001|Overall Study|Adverse Event|1
2012380|NCT00245583|3579155|FG000|Overall Study|Lack of Efficacy|1
2012381|NCT00245583|3579156|FG001|Overall Study|Lack of Efficacy|0
2012382|NCT00245583|3579155|FG000|Overall Study|Withdrawal by Subject|2
2012383|NCT00245583|3579156|FG001|Overall Study|Withdrawal by Subject|3
2012384|NCT00245765|3579174|FG000|Overall Study|Adverse Event|1
2012385|NCT00245765|3579175|FG001|Overall Study|Adverse Event|1
2012386|NCT00245765|3579176|FG002|Overall Study|Adverse Event|0
2012387|NCT00245765|3579174|FG000|Overall Study|Lack of Efficacy|14
2012388|NCT00245765|3579175|FG001|Overall Study|Lack of Efficacy|7
2012389|NCT00245765|3579176|FG002|Overall Study|Lack of Efficacy|0
2012390|NCT00245765|3579174|FG000|Overall Study|Lost to Follow-up|1
2012391|NCT00245765|3579175|FG001|Overall Study|Lost to Follow-up|2
2012392|NCT00245765|3579176|FG002|Overall Study|Lost to Follow-up|0
2012393|NCT00245765|3579174|FG000|Overall Study|Withdrawal by Subject|1
2012394|NCT00245765|3579175|FG001|Overall Study|Withdrawal by Subject|0
2012395|NCT00245765|3579176|FG002|Overall Study|Withdrawal by Subject|3
2012396|NCT00245765|3579174|FG000|Overall Study|Other reason|2
2012397|NCT00245765|3579175|FG001|Overall Study|Other reason|0
2012398|NCT00245765|3579176|FG002|Overall Study|Other reason|1
2012399|NCT00245765|3579174|FG000|Overall Study|Other|13
2012400|NCT00245765|3579175|FG001|Overall Study|Other|4
2012401|NCT00245765|3579176|FG002|Overall Study|Other|4
2012402|NCT00245856|3579184|FG000|Period Two|Withdrawal by Subject|0
2012403|NCT00245856|3579185|FG001|Period Two|Withdrawal by Subject|1
2012404|NCT00246012|3579201|FG000|Overall Study|Adverse Event|0
2012405|NCT00246012|3579202|FG001|Overall Study|Adverse Event|0
2012406|NCT00246012|3579203|FG002|Overall Study|Adverse Event|0
2012407|NCT00246012|3579204|FG003|Overall Study|Adverse Event|0
2012408|NCT00246012|3579205|FG004|Overall Study|Adverse Event|0
2012409|NCT00246012|3579206|FG005|Overall Study|Adverse Event|1
2012410|NCT00246012|3579207|FG006|Overall Study|Adverse Event|0
2012411|NCT00246012|3579208|FG007|Overall Study|Adverse Event|0
2012412|NCT00246012|3579209|FG008|Overall Study|Adverse Event|2
2012413|NCT00246012|3579201|FG000|Overall Study|Withdrawal by Subject|0
2012414|NCT00246012|3579202|FG001|Overall Study|Withdrawal by Subject|0
2012415|NCT00246012|3579203|FG002|Overall Study|Withdrawal by Subject|0
2012416|NCT00246012|3579204|FG003|Overall Study|Withdrawal by Subject|0
2012417|NCT00246012|3579205|FG004|Overall Study|Withdrawal by Subject|0
2012418|NCT00246012|3579206|FG005|Overall Study|Withdrawal by Subject|1
2012419|NCT00246012|3579207|FG006|Overall Study|Withdrawal by Subject|0
2012420|NCT00246012|3579208|FG007|Overall Study|Withdrawal by Subject|0
2012421|NCT00246012|3579209|FG008|Overall Study|Withdrawal by Subject|0
2012422|NCT00246012|3579201|FG000|Overall Study|Disease progression|3
2012423|NCT00246012|3579202|FG001|Overall Study|Disease progression|1
2012424|NCT00246012|3579203|FG002|Overall Study|Disease progression|2
2012425|NCT00246012|3579204|FG003|Overall Study|Disease progression|3
2012426|NCT00246012|3579205|FG004|Overall Study|Disease progression|3
2012427|NCT00246012|3579206|FG005|Overall Study|Disease progression|25
2012428|NCT00246012|3579207|FG006|Overall Study|Disease progression|30
2012429|NCT00246012|3579208|FG007|Overall Study|Disease progression|27
2012430|NCT00246012|3579209|FG008|Overall Study|Disease progression|26
2012431|NCT00246012|3579201|FG000|Overall Study|Other|0
2012432|NCT00246012|3579202|FG001|Overall Study|Other|0
2012433|NCT00246012|3579203|FG002|Overall Study|Other|0
2012434|NCT00246012|3579204|FG003|Overall Study|Other|0
2012435|NCT00246012|3579205|FG004|Overall Study|Other|0
2012436|NCT00246012|3579206|FG005|Overall Study|Other|0
2012437|NCT00246012|3579207|FG006|Overall Study|Other|0
2012438|NCT00246012|3579208|FG007|Overall Study|Other|1
2012439|NCT00246012|3579209|FG008|Overall Study|Other|0
2012440|NCT00246012|3579201|FG000|Overall Study|Randomly assigned but not treated|0
2012441|NCT00246012|3579202|FG001|Overall Study|Randomly assigned but not treated|0
2012442|NCT00246012|3579203|FG002|Overall Study|Randomly assigned but not treated|0
2012443|NCT00246012|3579204|FG003|Overall Study|Randomly assigned but not treated|0
2012444|NCT00246012|3579205|FG004|Overall Study|Randomly assigned but not treated|0
2012445|NCT00246012|3579206|FG005|Overall Study|Randomly assigned but not treated|1
2012446|NCT00246012|3579207|FG006|Overall Study|Randomly assigned but not treated|1
2012447|NCT00246012|3579208|FG007|Overall Study|Randomly assigned but not treated|0
2012448|NCT00246012|3579209|FG008|Overall Study|Randomly assigned but not treated|0
2012449|NCT00246025|3579235|FG000|Overall Study|Adverse Event|7
2012450|NCT00246025|3579236|FG001|Overall Study|Adverse Event|9
2012451|NCT00246025|3579237|FG002|Overall Study|Adverse Event|9
2012452|NCT00246025|3579238|FG003|Overall Study|Adverse Event|10
2012453|NCT00246025|3579235|FG000|Overall Study|Withdrawal by Subject|3
2012454|NCT00246025|3579236|FG001|Overall Study|Withdrawal by Subject|0
2012455|NCT00246025|3579237|FG002|Overall Study|Withdrawal by Subject|1
2012456|NCT00246025|3579238|FG003|Overall Study|Withdrawal by Subject|2
2012457|NCT00246025|3579235|FG000|Overall Study|unsuitable medical history was found|0
2012458|NCT00246025|3579236|FG001|Overall Study|unsuitable medical history was found|0
2012459|NCT00246025|3579237|FG002|Overall Study|unsuitable medical history was found|0
2012460|NCT00246025|3579238|FG003|Overall Study|unsuitable medical history was found|1
2012461|NCT00246090|3579248|FG000|Overall Study|Adverse Event|25
2012462|NCT00246090|3579248|FG000|Overall Study|Withdrawal by Subject|7
2012463|NCT00246090|3579248|FG000|Overall Study|Progressive Disease|212
2012464|NCT00246090|3579248|FG000|Overall Study|Clinical Progression|30
2012465|NCT00246090|3579248|FG000|Overall Study|Physician Decision|11
2012466|NCT00246090|3579248|FG000|Overall Study|Not Otherwise Specified|10
2012467|NCT00246129|3579254|FG000|Overall Study|Lost to Follow-up|1
2012468|NCT00246129|3579255|FG001|Overall Study|Lost to Follow-up|0
2012469|NCT00246129|3579254|FG000|Overall Study|Death|2
2012470|NCT00246129|3579255|FG001|Overall Study|Death|1
2012471|NCT00246129|3579254|FG000|Overall Study|suffered primary non-function|1
2012472|NCT00246129|3579255|FG001|Overall Study|suffered primary non-function|0
2012473|NCT00246129|3579254|FG000|Overall Study|grafts failed|3
2012474|NCT00246129|3579255|FG001|Overall Study|grafts failed|1
2012475|NCT00246259|3579266|FG000|Overall Study|Other|3
2012476|NCT00246259|3579267|FG001|Overall Study|Other|3
2012477|NCT00246259|3579266|FG000|Overall Study|Not stable by Week 18|2
2012478|NCT00246259|3579267|FG001|Overall Study|Not stable by Week 18|1
2012479|NCT00246259|3579266|FG000|Overall Study|Participant non-compliant|4
2012480|NCT00246259|3579267|FG001|Overall Study|Participant non-compliant|9
2012481|NCT00246259|3579266|FG000|Overall Study|Lack of Efficacy|2
2012482|NCT00246259|3579267|FG001|Overall Study|Lack of Efficacy|2
2012483|NCT00246259|3579266|FG000|Overall Study|Investigator withdrew participant|2
2012484|NCT00246259|3579267|FG001|Overall Study|Investigator withdrew participant|0
2012485|NCT00246259|3579266|FG000|Overall Study|Adverse Event|5
2012486|NCT00246259|3579267|FG001|Overall Study|Adverse Event|0
2012487|NCT00246259|3579266|FG000|Overall Study|Lost to Follow-up|3
2012488|NCT00246259|3579267|FG001|Overall Study|Lost to Follow-up|4
2012489|NCT00246259|3579266|FG000|Overall Study|Withdrawal by Subject|5
2012490|NCT00246259|3579267|FG001|Overall Study|Withdrawal by Subject|1
2012491|NCT00246259|3579266|FG000|Overall Study|randomly assigned, not eligible for ITT|2
2012492|NCT00246259|3579267|FG001|Overall Study|randomly assigned, not eligible for ITT|6
2012493|NCT00246324|3579273|FG000|Overall Study|Withdrawal by Subject|1
2012494|NCT00246337|3579286|FG000|Overall Study|Lost to Follow-up|3
2012495|NCT00246337|3579287|FG001|Overall Study|Lost to Follow-up|0
2012496|NCT00246337|3579288|FG002|Overall Study|Lost to Follow-up|0
2012497|NCT00246337|3579289|FG003|Overall Study|Lost to Follow-up|0
2012498|NCT00246337|3579290|FG004|Overall Study|Lost to Follow-up|2
2012499|NCT00246337|3579291|FG005|Overall Study|Lost to Follow-up|2
2012500|NCT00246337|3579292|FG006|Overall Study|Lost to Follow-up|1
2012501|NCT00246337|3579293|FG007|Overall Study|Lost to Follow-up|2
2012502|NCT00246337|3579294|FG008|Overall Study|Lost to Follow-up|0
2012503|NCT00246337|3579286|FG000|Overall Study|Protocol Violation|1
2012504|NCT00246337|3579287|FG001|Overall Study|Protocol Violation|0
2012505|NCT00246337|3579288|FG002|Overall Study|Protocol Violation|0
2012506|NCT00246337|3579289|FG003|Overall Study|Protocol Violation|0
2012507|NCT00246337|3579290|FG004|Overall Study|Protocol Violation|1
2012508|NCT00246337|3579291|FG005|Overall Study|Protocol Violation|0
2012509|NCT00246337|3579292|FG006|Overall Study|Protocol Violation|1
2012510|NCT00246337|3579293|FG007|Overall Study|Protocol Violation|1
2012511|NCT00246337|3579294|FG008|Overall Study|Protocol Violation|0
2012512|NCT00246337|3579286|FG000|Overall Study|Withdrawal by Subject|2
2012513|NCT00246337|3579287|FG001|Overall Study|Withdrawal by Subject|0
2012514|NCT00246337|3579288|FG002|Overall Study|Withdrawal by Subject|0
2012515|NCT00246337|3579289|FG003|Overall Study|Withdrawal by Subject|0
2012516|NCT00246337|3579290|FG004|Overall Study|Withdrawal by Subject|0
2012517|NCT00246337|3579291|FG005|Overall Study|Withdrawal by Subject|0
2012518|NCT00246337|3579292|FG006|Overall Study|Withdrawal by Subject|1
2012519|NCT00246337|3579293|FG007|Overall Study|Withdrawal by Subject|1
2012520|NCT00246337|3579294|FG008|Overall Study|Withdrawal by Subject|0
2012521|NCT00246337|3579286|FG000|Overall Study|Lack of Qualifying Event|8
2012522|NCT00246337|3579287|FG001|Overall Study|Lack of Qualifying Event|2
2012523|NCT00246337|3579288|FG002|Overall Study|Lack of Qualifying Event|1
2012524|NCT00246337|3579289|FG003|Overall Study|Lack of Qualifying Event|1
2012525|NCT00246337|3579290|FG004|Overall Study|Lack of Qualifying Event|1
2012526|NCT00246337|3579291|FG005|Overall Study|Lack of Qualifying Event|3
2012527|NCT00246337|3579292|FG006|Overall Study|Lack of Qualifying Event|3
2012528|NCT00246337|3579293|FG007|Overall Study|Lack of Qualifying Event|2
2012529|NCT00246337|3579294|FG008|Overall Study|Lack of Qualifying Event|5
2012530|NCT00246337|3579286|FG000|Overall Study|Site Terminated|10
2012531|NCT00246337|3579287|FG001|Overall Study|Site Terminated|0
2012532|NCT00246337|3579288|FG002|Overall Study|Site Terminated|0
2012533|NCT00246337|3579289|FG003|Overall Study|Site Terminated|0
2012534|NCT00246337|3579290|FG004|Overall Study|Site Terminated|0
2012535|NCT00246337|3579291|FG005|Overall Study|Site Terminated|7
2012536|NCT00246337|3579292|FG006|Overall Study|Site Terminated|1
2012537|NCT00246337|3579293|FG007|Overall Study|Site Terminated|6
2012538|NCT00246337|3579294|FG008|Overall Study|Site Terminated|2
2012539|NCT00246337|3579286|FG000|Overall Study|Abnormal baseline lab values|7
2012540|NCT00246337|3579287|FG001|Overall Study|Abnormal baseline lab values|0
2012541|NCT00246337|3579288|FG002|Overall Study|Abnormal baseline lab values|2
2012542|NCT00246337|3579289|FG003|Overall Study|Abnormal baseline lab values|0
2012543|NCT00246337|3579290|FG004|Overall Study|Abnormal baseline lab values|0
2012544|NCT00246337|3579291|FG005|Overall Study|Abnormal baseline lab values|2
2012545|NCT00246337|3579292|FG006|Overall Study|Abnormal baseline lab values|2
2012546|NCT00246337|3579293|FG007|Overall Study|Abnormal baseline lab values|0
2012547|NCT00246337|3579294|FG008|Overall Study|Abnormal baseline lab values|4
2012548|NCT00246337|3579286|FG000|Overall Study|Overwhelmed|0
2012549|NCT00246337|3579287|FG001|Overall Study|Overwhelmed|0
2012550|NCT00246337|3579288|FG002|Overall Study|Overwhelmed|0
2012551|NCT00246337|3579289|FG003|Overall Study|Overwhelmed|0
2012552|NCT00246337|3579290|FG004|Overall Study|Overwhelmed|0
2012553|NCT00246337|3579291|FG005|Overall Study|Overwhelmed|1
2012554|NCT00246337|3579292|FG006|Overall Study|Overwhelmed|0
2012555|NCT00246337|3579293|FG007|Overall Study|Overwhelmed|0
2012556|NCT00246337|3579294|FG008|Overall Study|Overwhelmed|0
2012557|NCT00246337|3579286|FG000|Overall Study|Protocol Violator|1
2012558|NCT00246337|3579287|FG001|Overall Study|Protocol Violator|0
2012559|NCT00246337|3579288|FG002|Overall Study|Protocol Violator|0
2012560|NCT00246337|3579289|FG003|Overall Study|Protocol Violator|0
2012561|NCT00246337|3579290|FG004|Overall Study|Protocol Violator|0
2012562|NCT00246337|3579291|FG005|Overall Study|Protocol Violator|0
2012563|NCT00246337|3579292|FG006|Overall Study|Protocol Violator|0
2012564|NCT00246337|3579293|FG007|Overall Study|Protocol Violator|0
2012565|NCT00246337|3579294|FG008|Overall Study|Protocol Violator|0
2012566|NCT00246337|3579286|FG000|Overall Study|Reported as completing trial in error|0
2012567|NCT00246337|3579287|FG001|Overall Study|Reported as completing trial in error|0
2012568|NCT00246337|3579288|FG002|Overall Study|Reported as completing trial in error|0
2012569|NCT00246337|3579289|FG003|Overall Study|Reported as completing trial in error|0
2012570|NCT00246337|3579290|FG004|Overall Study|Reported as completing trial in error|0
2012571|NCT00246337|3579291|FG005|Overall Study|Reported as completing trial in error|0
2012572|NCT00246337|3579292|FG006|Overall Study|Reported as completing trial in error|0
2012573|NCT00246337|3579293|FG007|Overall Study|Reported as completing trial in error|1
2012574|NCT00246337|3579294|FG008|Overall Study|Reported as completing trial in error|0
2012575|NCT00246376|3579319|FG000|Overall Study|Dropped/withdrew during dietary run-in|11
2012576|NCT00246376|3579320|FG001|Overall Study|Dropped/withdrew during dietary run-in|5
2012577|NCT00246376|3579321|FG002|Overall Study|Dropped/withdrew during dietary run-in|4
2012578|NCT00246376|3579322|FG003|Overall Study|Dropped/withdrew during dietary run-in|7
2012579|NCT00246376|3579323|FG004|Overall Study|Dropped/withdrew during dietary run-in|3
2012580|NCT00246376|3579319|FG000|Overall Study|Adverse Event|2
2012581|NCT00246376|3579320|FG001|Overall Study|Adverse Event|3
2012582|NCT00246376|3579321|FG002|Overall Study|Adverse Event|1
2012583|NCT00246376|3579322|FG003|Overall Study|Adverse Event|3
2012584|NCT00246376|3579323|FG004|Overall Study|Adverse Event|1
2012585|NCT00246376|3579319|FG000|Overall Study|Lost to Follow-up|2
2012586|NCT00246376|3579320|FG001|Overall Study|Lost to Follow-up|11
2012587|NCT00246376|3579321|FG002|Overall Study|Lost to Follow-up|11
2012588|NCT00246376|3579322|FG003|Overall Study|Lost to Follow-up|16
2012589|NCT00246376|3579323|FG004|Overall Study|Lost to Follow-up|13
2012590|NCT00246571|3579361|FG000|Overall Study|Adverse Event|7
2012591|NCT00246571|3579362|FG001|Overall Study|Adverse Event|0
2012592|NCT00246571|3579361|FG000|Overall Study|Protocol Violation|0
2012593|NCT00246571|3579362|FG001|Overall Study|Protocol Violation|1
2012594|NCT00246571|3579361|FG000|Overall Study|Withdrawal by Subject|2
2012595|NCT00246571|3579362|FG001|Overall Study|Withdrawal by Subject|3
2012596|NCT00246571|3579361|FG000|Overall Study|Lack of Efficacy|84
2012597|NCT00246571|3579362|FG001|Overall Study|Lack of Efficacy|21
2012598|NCT00246571|3579361|FG000|Overall Study|Death|17
2012599|NCT00246571|3579362|FG001|Overall Study|Death|3
2012600|NCT00246571|3579361|FG000|Overall Study|Sponsor|0
2012601|NCT00246571|3579362|FG001|Overall Study|Sponsor|1
2012602|NCT00246571|3579361|FG000|Overall Study|Did not meet entrance criteria|2
2012603|NCT00246571|3579362|FG001|Overall Study|Did not meet entrance criteria|1
2012604|NCT00246571|3579361|FG000|Overall Study|Laboratory abnormalities|1
2214454|NCT01687413|3856741|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0
2214455|NCT01687478|3856767|FG000|Overall Study|Adverse Event|3
2012605|NCT00246571|3579362|FG001|Overall Study|Laboratory abnormalities|0
2012606|NCT00246571|3579361|FG000|Overall Study|Crossover participants|0
2012607|NCT00246571|3579362|FG001|Overall Study|Crossover participants|74
2012608|NCT00246740|3579370|FG000|Initial Enrollment|Death|1
2012609|NCT00246740|3579371|FG001|Initial Enrollment|Death|0
2012610|NCT00246740|3579370|FG000|Initial Enrollment|Additional surgery scheduled|0
2012611|NCT00246740|3579371|FG001|Initial Enrollment|Additional surgery scheduled|2
2012612|NCT00246740|3579370|FG000|Initial Enrollment|Surgery schedule change|4
2012613|NCT00246740|3579371|FG001|Initial Enrollment|Surgery schedule change|4
2012614|NCT00246740|3579370|FG000|Initial Enrollment|Other|1
2012615|NCT00246740|3579371|FG001|Initial Enrollment|Other|2
2012616|NCT00246753|3579377|FG000|Overall Study|Withdrawal by Subject|2
2012617|NCT00246753|3579377|FG000|Overall Study|Physician Decision|2
2012618|NCT00246753|3579377|FG000|Overall Study|Adverse Event|2
2012619|NCT00246753|3579377|FG000|Overall Study|Unacceptable toxicity|2
2012620|NCT00246805|3579383|FG000|Phase 1|Lost to Follow-up|1
2012621|NCT00246805|3579384|FG001|Phase 1|Lost to Follow-up|0
2012622|NCT00247273|3579392|FG000|Overall Study|Adverse Event|85
2012623|NCT00247273|3579393|FG001|Overall Study|Adverse Event|80
2012624|NCT00247273|3579392|FG000|Overall Study|Physician Decision|6
2012625|NCT00247273|3579393|FG001|Overall Study|Physician Decision|3
2012626|NCT00247273|3579392|FG000|Overall Study|Lost to Follow-up|7
2012627|NCT00247273|3579393|FG001|Overall Study|Lost to Follow-up|7
2012628|NCT00247273|3579392|FG000|Overall Study|Withdrawal by Subject|46
2012629|NCT00247273|3579393|FG001|Overall Study|Withdrawal by Subject|47
2012630|NCT00247273|3579392|FG000|Overall Study|Did not take any study drug|2
2012631|NCT00247273|3579393|FG001|Overall Study|Did not take any study drug|0
2012632|NCT00247416|3579410|FG000|Overall Study|3 patients were found to be ineligible|1
2012633|NCT00247416|3579411|FG001|Overall Study|3 patients were found to be ineligible|2
2012634|NCT00247611|3579421|FG000|Baselined|Completed baseline, never placed on ARVs|8
2012635|NCT00247611|3579422|FG001|Baselined|Completed baseline, never placed on ARVs|5
2012636|NCT00247611|3579421|FG000|Baselined|Completed baseline only|9
2012637|NCT00247611|3579422|FG001|Baselined|Completed baseline only|8
2012638|NCT00247676|3579443|FG000|Overall Study|Death|5
2012639|NCT00247676|3579443|FG000|Overall Study|Adverse Event|11
2012640|NCT00247676|3579443|FG000|Overall Study|Lack of Efficacy|15
2012641|NCT00247676|3579443|FG000|Overall Study|Other|3
2012642|NCT00247676|3579443|FG000|Overall Study|Withdrawal by Subject|2
2012643|NCT00247962|3579464|FG000|Overall Study|Adverse Event|15
2012644|NCT00247962|3579465|FG001|Overall Study|Adverse Event|12
2012645|NCT00247962|3579464|FG000|Overall Study|Lost to Follow-up|3
2012646|NCT00247962|3579465|FG001|Overall Study|Lost to Follow-up|1
2012647|NCT00247962|3579464|FG000|Overall Study|Physician Decision|0
2012648|NCT00247962|3579465|FG001|Overall Study|Physician Decision|1
2012649|NCT00247962|3579464|FG000|Overall Study|Protocol Violation|1
2012650|NCT00247962|3579465|FG001|Overall Study|Protocol Violation|1
2012651|NCT00247962|3579464|FG000|Overall Study|Withdrawal by Subject|3
2012652|NCT00247962|3579465|FG001|Overall Study|Withdrawal by Subject|2
2012653|NCT00247962|3579464|FG000|Overall Study|Lack of Efficacy|4
2012654|NCT00247962|3579465|FG001|Overall Study|Lack of Efficacy|2
2012655|NCT00248040|3579474|FG000|Overall Study|transplantectomy|2
2012656|NCT00248040|3579475|FG001|Overall Study|transplantectomy|1
2012657|NCT00248040|3579476|FG002|Overall Study|transplantectomy|3
2012658|NCT00248040|3579474|FG000|Overall Study|transplant cancelled post treat start|1
2012659|NCT00248040|3579475|FG001|Overall Study|transplant cancelled post treat start|0
2012660|NCT00248040|3579476|FG002|Overall Study|transplant cancelled post treat start|0
2012661|NCT00248040|3579474|FG000|Overall Study|Death|0
2012662|NCT00248040|3579475|FG001|Overall Study|Death|0
2012663|NCT00248040|3579476|FG002|Overall Study|Death|1
2012664|NCT00248170|3579487|FG000|Overall Study|Withdrawal by Subject|71
2012665|NCT00248170|3579488|FG001|Overall Study|Withdrawal by Subject|79
2012666|NCT00248170|3579487|FG000|Overall Study|Protocol Violation|35
2012667|NCT00248170|3579488|FG001|Overall Study|Protocol Violation|30
2012668|NCT00248170|3579487|FG000|Overall Study|Lost to Follow-up|28
2012669|NCT00248170|3579488|FG001|Overall Study|Lost to Follow-up|35
2012670|NCT00248170|3579487|FG000|Overall Study|Disease progression|196
2012671|NCT00248170|3579488|FG001|Overall Study|Disease progression|216
2012672|NCT00248170|3579487|FG000|Overall Study|Death|28
2012673|NCT00248170|3579488|FG001|Overall Study|Death|47
2012674|NCT00248170|3579487|FG000|Overall Study|Adverse Event|311
2012675|NCT00248170|3579488|FG001|Overall Study|Adverse Event|296
2012676|NCT00248170|3579487|FG000|Overall Study|Administrative problems|22
2012677|NCT00248170|3579488|FG001|Overall Study|Administrative problems|25
2012678|NCT00248170|3579487|FG000|Overall Study|Abnormal test procedure(s) result|49
2012679|NCT00248170|3579488|FG001|Overall Study|Abnormal test procedure(s) result|61
2012680|NCT00248170|3579487|FG000|Overall Study|Abnormal laboratory values|4
2012681|NCT00248170|3579488|FG001|Overall Study|Abnormal laboratory values|0
2012682|NCT00248170|3579487|FG000|Overall Study|Protocol deviation|17
2012683|NCT00248170|3579488|FG001|Overall Study|Protocol deviation|19
2012684|NCT00248495|3579494|FG000|Overall Study|Withdrawal by Subject|1
2012685|NCT00248625|3579537|FG000|Overall Study|Withdrawal by Subject|0
2012686|NCT00248625|3579538|FG001|Overall Study|Withdrawal by Subject|2
2012687|NCT00248651|3579558|FG000|Overall Study|Withdrawal by Subject|28
2012688|NCT00248651|3579559|FG001|Overall Study|Withdrawal by Subject|40
2012689|NCT00248651|3579560|FG002|Overall Study|Withdrawal by Subject|32
2012690|NCT00248794|3579580|FG000|Overall Study|Lost to Follow-up|6
2012691|NCT00248794|3579581|FG001|Overall Study|Lost to Follow-up|8
2012692|NCT00248794|3579582|FG002|Overall Study|Lost to Follow-up|3
2012693|NCT00248833|3579614|FG000|Overall Study|Adverse Event|2
2313274|NCT02787304|4020570|FG001|Overall Study|Noncompliance with study drug|0
2313275|NCT02787304|4020571|FG002|Overall Study|Noncompliance with study drug|1
2313276|NCT02787304|4020572|FG003|Overall Study|Noncompliance with study drug|0
2313277|NCT02787304|4020569|FG000|Overall Study|Physician Decision|0
2313278|NCT02787304|4020570|FG001|Overall Study|Physician Decision|0
2313279|NCT02787304|4020571|FG002|Overall Study|Physician Decision|1
2313280|NCT02787304|4020572|FG003|Overall Study|Physician Decision|0
2313281|NCT02787304|4020569|FG000|Overall Study|Study terminated by sponsor|25
2313282|NCT02787304|4020570|FG001|Overall Study|Study terminated by sponsor|31
2313283|NCT02787304|4020571|FG002|Overall Study|Study terminated by sponsor|31
2313284|NCT02787304|4020572|FG003|Overall Study|Study terminated by sponsor|32
2313285|NCT02787551|4020584|FG000|Core Period: 26 Weeks|Adverse Event|10
2313286|NCT02787551|4020585|FG001|Core Period: 26 Weeks|Adverse Event|0
2313287|NCT02787551|4020584|FG000|Core Period: 26 Weeks|Lack of Efficacy|1
2313288|NCT02787551|4020585|FG001|Core Period: 26 Weeks|Lack of Efficacy|0
2313289|NCT02787551|4020584|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2
2313290|NCT02787551|4020585|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0
2313291|NCT02787551|4020584|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9
2313292|NCT02787551|4020585|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9
2313293|NCT02787551|4020584|FG000|Core Period: 26 Weeks|Randomized but not treated|2
2313294|NCT02787551|4020585|FG001|Core Period: 26 Weeks|Randomized but not treated|1
2313295|NCT02787551|4020584|FG000|Core Period: 26 Weeks|Other than specified|3
2313296|NCT02787551|4020585|FG001|Core Period: 26 Weeks|Other than specified|1
2321993|NCT02966353|4036678|FG000|Overall Study|Withdrawal by Subject|7
2012694|NCT00248833|3579615|FG001|Overall Study|Adverse Event|0
2012695|NCT00248833|3579616|FG002|Overall Study|Adverse Event|0
2012696|NCT00248833|3579614|FG000|Overall Study|Withdrawal by Subject|0
2012697|NCT00248833|3579615|FG001|Overall Study|Withdrawal by Subject|1
2012698|NCT00248833|3579616|FG002|Overall Study|Withdrawal by Subject|1
2012699|NCT00248833|3579614|FG000|Overall Study|Lost to Follow-up|1
2012700|NCT00248833|3579615|FG001|Overall Study|Lost to Follow-up|1
2012701|NCT00248833|3579616|FG002|Overall Study|Lost to Follow-up|1
2012702|NCT00248833|3579614|FG000|Overall Study|Other|0
2012703|NCT00248833|3579615|FG001|Overall Study|Other|1
2012704|NCT00248833|3579616|FG002|Overall Study|Other|0
2012705|NCT00249002|3579626|FG000|Overall Study|Adverse Event|2
2012706|NCT00249002|3579626|FG000|Overall Study|Study cancellation|3
2012707|NCT00249002|3579626|FG000|Overall Study|Other|2
2012708|NCT00249288|3579649|FG000|Overall Study|Lost to Follow-up|3
2012709|NCT00249288|3579650|FG001|Overall Study|Lost to Follow-up|3
2012710|NCT00249288|3579649|FG000|Overall Study|Withdrawal by Subject|2
2012711|NCT00249288|3579650|FG001|Overall Study|Withdrawal by Subject|2
2025549|NCT00346632|3594471|FG006|Overall Study|Progressive Disease|2
2025550|NCT00346632|3594472|FG007|Overall Study|Progressive Disease|2
2025551|NCT00346632|3594473|FG008|Overall Study|Progressive Disease|2
2025552|NCT00346632|3594474|FG009|Overall Study|Progressive Disease|2
2025553|NCT00346632|3594465|FG000|Overall Study|Adverse Event|0
2025554|NCT00346632|3594466|FG001|Overall Study|Adverse Event|0
2025555|NCT00346632|3594467|FG002|Overall Study|Adverse Event|0
2025556|NCT00346632|3594468|FG003|Overall Study|Adverse Event|0
2025557|NCT00346632|3594469|FG004|Overall Study|Adverse Event|1
2025558|NCT00346632|3594470|FG005|Overall Study|Adverse Event|1
2025559|NCT00346632|3594471|FG006|Overall Study|Adverse Event|1
2025560|NCT00346632|3594472|FG007|Overall Study|Adverse Event|0
2025561|NCT00346632|3594473|FG008|Overall Study|Adverse Event|0
2025562|NCT00346632|3594474|FG009|Overall Study|Adverse Event|0
2025563|NCT00346632|3594465|FG000|Overall Study|Death|0
2025564|NCT00346632|3594466|FG001|Overall Study|Death|0
2025565|NCT00346632|3594467|FG002|Overall Study|Death|1
2025566|NCT00346632|3594468|FG003|Overall Study|Death|0
2025567|NCT00346632|3594469|FG004|Overall Study|Death|0
2025568|NCT00346632|3594470|FG005|Overall Study|Death|0
2025569|NCT00346632|3594471|FG006|Overall Study|Death|0
2025570|NCT00346632|3594472|FG007|Overall Study|Death|0
2025571|NCT00346632|3594473|FG008|Overall Study|Death|0
2025572|NCT00346632|3594474|FG009|Overall Study|Death|0
2025573|NCT00346632|3594465|FG000|Overall Study|Protocol Violation|0
2025574|NCT00346632|3594466|FG001|Overall Study|Protocol Violation|0
2025575|NCT00346632|3594467|FG002|Overall Study|Protocol Violation|0
2025576|NCT00346632|3594468|FG003|Overall Study|Protocol Violation|0
2025577|NCT00346632|3594469|FG004|Overall Study|Protocol Violation|0
2025578|NCT00346632|3594470|FG005|Overall Study|Protocol Violation|0
2025579|NCT00346632|3594471|FG006|Overall Study|Protocol Violation|1
2025580|NCT00346632|3594472|FG007|Overall Study|Protocol Violation|0
2025581|NCT00346632|3594473|FG008|Overall Study|Protocol Violation|0
2025582|NCT00346632|3594474|FG009|Overall Study|Protocol Violation|0
2025583|NCT00346632|3594465|FG000|Overall Study|Withdrawal by Subject|0
2025584|NCT00346632|3594466|FG001|Overall Study|Withdrawal by Subject|0
2025585|NCT00346632|3594467|FG002|Overall Study|Withdrawal by Subject|0
2025586|NCT00346632|3594468|FG003|Overall Study|Withdrawal by Subject|0
2025587|NCT00346632|3594469|FG004|Overall Study|Withdrawal by Subject|0
2025588|NCT00346632|3594470|FG005|Overall Study|Withdrawal by Subject|0
2025589|NCT00346632|3594471|FG006|Overall Study|Withdrawal by Subject|1
2025590|NCT00346632|3594472|FG007|Overall Study|Withdrawal by Subject|0
2025591|NCT00346632|3594473|FG008|Overall Study|Withdrawal by Subject|0
2025592|NCT00346632|3594474|FG009|Overall Study|Withdrawal by Subject|0
2025593|NCT00346632|3594465|FG000|Overall Study|Switched to alternative treatment|0
2025594|NCT00346632|3594466|FG001|Overall Study|Switched to alternative treatment|0
2025595|NCT00346632|3594467|FG002|Overall Study|Switched to alternative treatment|1
2025596|NCT00346632|3594468|FG003|Overall Study|Switched to alternative treatment|0
2025597|NCT00346632|3594469|FG004|Overall Study|Switched to alternative treatment|0
2025598|NCT00346632|3594470|FG005|Overall Study|Switched to alternative treatment|0
2025599|NCT00346632|3594471|FG006|Overall Study|Switched to alternative treatment|0
2025600|NCT00346632|3594472|FG007|Overall Study|Switched to alternative treatment|0
2025601|NCT00346632|3594473|FG008|Overall Study|Switched to alternative treatment|0
2025602|NCT00346632|3594474|FG009|Overall Study|Switched to alternative treatment|0
2025603|NCT00346632|3594465|FG000|Overall Study|Not Stated|1
2025604|NCT00346632|3594466|FG001|Overall Study|Not Stated|1
2025605|NCT00346632|3594467|FG002|Overall Study|Not Stated|0
2025606|NCT00346632|3594468|FG003|Overall Study|Not Stated|0
2025607|NCT00346632|3594469|FG004|Overall Study|Not Stated|0
2025608|NCT00346632|3594470|FG005|Overall Study|Not Stated|0
2025609|NCT00346632|3594471|FG006|Overall Study|Not Stated|0
2025610|NCT00346632|3594472|FG007|Overall Study|Not Stated|2
2025611|NCT00346632|3594473|FG008|Overall Study|Not Stated|2
2025612|NCT00346632|3594474|FG009|Overall Study|Not Stated|1
2025613|NCT00346697|3594538|FG000|Overall Study|Lost to Follow-up|0
2025614|NCT00346697|3594539|FG001|Overall Study|Lost to Follow-up|1
2025615|NCT00346775|3594547|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1
2025616|NCT00346775|3594548|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1
2025617|NCT00346775|3594547|FG000|Period 1: Intervention Period 1|Protocol Violation|3
2025618|NCT00346775|3594548|FG001|Period 1: Intervention Period 1|Protocol Violation|2
2025619|NCT00346775|3594547|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
2012712|NCT00249444|3579675|FG000|Overall Study|Lost to Follow-up|2
2012713|NCT00249444|3579676|FG001|Overall Study|Lost to Follow-up|2
2012714|NCT00249444|3579675|FG000|Overall Study|non-compliant|9
2012715|NCT00249444|3579676|FG001|Overall Study|non-compliant|11
2012716|NCT00249444|3579675|FG000|Overall Study|Adverse Event|1
2012717|NCT00249444|3579676|FG001|Overall Study|Adverse Event|1
2012718|NCT00249444|3579675|FG000|Overall Study|life event|0
2012719|NCT00249444|3579676|FG001|Overall Study|life event|1
2012720|NCT00249613|3579704|FG000|12 Month Follow-up|Death|1
2012721|NCT00249613|3579705|FG001|12 Month Follow-up|Death|1
2012722|NCT00249613|3579704|FG000|12 Month Follow-up|Withdrawal by Subject|6
2012723|NCT00249613|3579705|FG001|12 Month Follow-up|Withdrawal by Subject|6
2012724|NCT00249613|3579704|FG000|12 Month Follow-up|Lost to Follow-up|10
2012725|NCT00249613|3579705|FG001|12 Month Follow-up|Lost to Follow-up|8
2012726|NCT00249769|3579717|FG000|Overall Study|Withdrawal by Subject|1
2012727|NCT00249769|3579718|FG001|Overall Study|Withdrawal by Subject|10
2012728|NCT00249769|3579719|FG002|Overall Study|Withdrawal by Subject|6
2012729|NCT00249769|3579717|FG000|Overall Study|Migration from Study Area|1
2012730|NCT00249769|3579718|FG001|Overall Study|Migration from Study Area|3
2012731|NCT00249769|3579719|FG002|Overall Study|Migration from Study Area|14
2012732|NCT00249769|3579717|FG000|Overall Study|Miscellaneous|0
2012733|NCT00249769|3579718|FG001|Overall Study|Miscellaneous|2
2012734|NCT00249769|3579719|FG002|Overall Study|Miscellaneous|2
2012735|NCT00249769|3579717|FG000|Overall Study|Adverse Event|0
2012736|NCT00249769|3579718|FG001|Overall Study|Adverse Event|0
2012737|NCT00249769|3579719|FG002|Overall Study|Adverse Event|1
2012738|NCT00249769|3579717|FG000|Overall Study|Physician Decision|0
2012739|NCT00249769|3579718|FG001|Overall Study|Physician Decision|0
2012740|NCT00249769|3579719|FG002|Overall Study|Physician Decision|2
2012741|NCT00249769|3579717|FG000|Overall Study|Lost to Follow-up|0
2012742|NCT00249769|3579718|FG001|Overall Study|Lost to Follow-up|0
2012743|NCT00249769|3579719|FG002|Overall Study|Lost to Follow-up|3
2012744|NCT00249795|3579729|FG000|Overall Study|Not treated|16
2012745|NCT00249795|3579730|FG001|Overall Study|Not treated|14
2012746|NCT00249795|3579729|FG000|Overall Study|Symptomatic hypotension|127
2012747|NCT00249795|3579730|FG001|Overall Study|Symptomatic hypotension|64
2012748|NCT00249795|3579729|FG000|Overall Study|Other Serious Adverse Event|84
2012749|NCT00249795|3579730|FG001|Overall Study|Other Serious Adverse Event|93
2012750|NCT00249795|3579729|FG000|Overall Study|Qualifying condition not present|26
2012751|NCT00249795|3579730|FG001|Overall Study|Qualifying condition not present|29
2012752|NCT00249795|3579729|FG000|Overall Study|Withdrawal by Subject|678
2012753|NCT00249795|3579730|FG001|Overall Study|Withdrawal by Subject|742
2012754|NCT00249795|3579729|FG000|Overall Study|Thromboembolic / outcome event|39
2012755|NCT00249795|3579730|FG001|Overall Study|Thromboembolic / outcome event|45
2012756|NCT00249795|3579729|FG000|Overall Study|Oral anticoagulant required|2
2012757|NCT00249795|3579730|FG001|Overall Study|Oral anticoagulant required|0
2012758|NCT00249795|3579729|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
2012759|NCT00249795|3579730|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
2012760|NCT00249795|3579729|FG000|Overall Study|Non-compliance|71
2012761|NCT00249795|3579730|FG001|Overall Study|Non-compliance|69
2012762|NCT00249795|3579729|FG000|Overall Study|Study drug intolerance|3
2012763|NCT00249795|3579730|FG001|Overall Study|Study drug intolerance|3
2012764|NCT00249795|3579729|FG000|Overall Study|Other adverse events (non-serious)|188
2012765|NCT00249795|3579730|FG001|Overall Study|Other adverse events (non-serious)|159
2012766|NCT00249795|3579729|FG000|Overall Study|Physician withdrew consent|71
2012767|NCT00249795|3579730|FG001|Overall Study|Physician withdrew consent|63
2012768|NCT00249795|3579729|FG000|Overall Study|Surgery / procedure|4
2012769|NCT00249795|3579730|FG001|Overall Study|Surgery / procedure|5
2012770|NCT00249795|3579729|FG000|Overall Study|Angiotensin II receptor blocker required|35
2012771|NCT00249795|3579730|FG001|Overall Study|Angiotensin II receptor blocker required|58
2012772|NCT00249795|3579729|FG000|Overall Study|Lightheadedness / dizziness|15
2012773|NCT00249795|3579730|FG001|Overall Study|Lightheadedness / dizziness|11
2012774|NCT00249795|3579729|FG000|Overall Study|Hypotension (non-symptomatic)|5
2012775|NCT00249795|3579730|FG001|Overall Study|Hypotension (non-symptomatic)|5
2012776|NCT00249795|3579729|FG000|Overall Study|Other contraindicated medication|1
2012777|NCT00249795|3579730|FG001|Overall Study|Other contraindicated medication|1
2012778|NCT00249795|3579729|FG000|Overall Study|Event related to cardiac condition|17
2012779|NCT00249795|3579730|FG001|Overall Study|Event related to cardiac condition|16
2012780|NCT00249795|3579729|FG000|Overall Study|Patient not wish to continue after May08|4
2012781|NCT00249795|3579730|FG001|Overall Study|Patient not wish to continue after May08|6
2012782|NCT00249795|3579729|FG000|Overall Study|Site not agree to continue after May08|1
2012783|NCT00249795|3579730|FG001|Overall Study|Site not agree to continue after May08|1
2012784|NCT00249795|3579729|FG000|Overall Study|Lost to Follow-up|0
2012785|NCT00249795|3579730|FG001|Overall Study|Lost to Follow-up|2
2012786|NCT00249795|3579729|FG000|Overall Study|Missing|0
2012787|NCT00249795|3579730|FG001|Overall Study|Missing|1
2012788|NCT00249808|3579736|FG000|Overall Study|Other|27
2012789|NCT00249808|3579736|FG000|Overall Study|Protocol Violation|3
2012790|NCT00249808|3579736|FG000|Overall Study|Lost to Follow-up|8
2012791|NCT00249808|3579736|FG000|Overall Study|Adverse Event|81
2012792|NCT00249808|3579736|FG000|Overall Study|Lack of Efficacy|52
2012793|NCT00249808|3579736|FG000|Overall Study|Did Not Provide Post-Baseline Data|11
2012794|NCT00249821|3579742|FG000|Overall Study|Technical problem|0
2012795|NCT00249821|3579743|FG001|Overall Study|Technical problem|1
2012796|NCT00249834|3579757|FG000|Overall Study|Ovarian stimulation failed|1
2012797|NCT00249834|3579758|FG001|Overall Study|Ovarian stimulation failed|0
2012798|NCT00249834|3579759|FG002|Overall Study|Ovarian stimulation failed|0
2012799|NCT00249834|3579760|FG003|Overall Study|Ovarian stimulation failed|0
2012800|NCT00249834|3579761|FG004|Overall Study|Ovarian stimulation failed|0
2012801|NCT00249834|3579762|FG005|Overall Study|Ovarian stimulation failed|0
2012802|NCT00249834|3579763|FG006|Overall Study|Ovarian stimulation failed|0
2012803|NCT00249834|3579764|FG007|Overall Study|Ovarian stimulation failed|0
2012804|NCT00249834|3579757|FG000|Overall Study|Failure of down-regulation|0
2012805|NCT00249834|3579758|FG001|Overall Study|Failure of down-regulation|0
2012806|NCT00249834|3579759|FG002|Overall Study|Failure of down-regulation|0
2012807|NCT00249834|3579760|FG003|Overall Study|Failure of down-regulation|0
2012808|NCT00249834|3579761|FG004|Overall Study|Failure of down-regulation|0
2012809|NCT00249834|3579762|FG005|Overall Study|Failure of down-regulation|0
2012810|NCT00249834|3579763|FG006|Overall Study|Failure of down-regulation|1
2012811|NCT00249834|3579764|FG007|Overall Study|Failure of down-regulation|0
2012812|NCT00249834|3579757|FG000|Overall Study|Protocol Violation|0
2012813|NCT00249834|3579758|FG001|Overall Study|Protocol Violation|19
2012814|NCT00249834|3579759|FG002|Overall Study|Protocol Violation|14
2012815|NCT00249834|3579760|FG003|Overall Study|Protocol Violation|8
2012816|NCT00249834|3579761|FG004|Overall Study|Protocol Violation|5
2012817|NCT00249834|3579762|FG005|Overall Study|Protocol Violation|2
2012818|NCT00249834|3579763|FG006|Overall Study|Protocol Violation|0
2012819|NCT00249834|3579764|FG007|Overall Study|Protocol Violation|0
2012820|NCT00249873|3579778|FG000|Overall Study|Not treated|7
2012821|NCT00249873|3579779|FG001|Overall Study|Not treated|8
2012822|NCT00249873|3579778|FG000|Overall Study|Significant thrombocytopenia|9
2012823|NCT00249873|3579779|FG001|Overall Study|Significant thrombocytopenia|8
2012824|NCT00249873|3579778|FG000|Overall Study|Severe allergic reaction|8
2012825|NCT00249873|3579779|FG001|Overall Study|Severe allergic reaction|1
2012826|NCT00249873|3579778|FG000|Overall Study|Serious haemorrhagic Adverse Event|74
2012827|NCT00249873|3579779|FG001|Overall Study|Serious haemorrhagic Adverse Event|30
2012828|NCT00249873|3579778|FG000|Overall Study|Other Serious Adverse Event|86
2012829|NCT00249873|3579779|FG001|Overall Study|Other Serious Adverse Event|97
2012830|NCT00249873|3579778|FG000|Overall Study|Qualifying condition not present|20
2012831|NCT00249873|3579779|FG001|Overall Study|Qualifying condition not present|23
2012832|NCT00249873|3579778|FG000|Overall Study|Contraindication to oral anticoagulant|4
2012833|NCT00249873|3579779|FG001|Overall Study|Contraindication to oral anticoagulant|8
2012834|NCT00249873|3579778|FG000|Overall Study|Withdrawal by Subject|504
2012835|NCT00249873|3579779|FG001|Overall Study|Withdrawal by Subject|466
2012836|NCT00249873|3579778|FG000|Overall Study|Lost to Follow-up|4
2012837|NCT00249873|3579779|FG001|Overall Study|Lost to Follow-up|7
2012838|NCT00249873|3579778|FG000|Overall Study|Minor bleeding|99
2012839|NCT00249873|3579779|FG001|Overall Study|Minor bleeding|37
2012840|NCT00249873|3579778|FG000|Overall Study|Non-compliance|41
2012841|NCT00249873|3579779|FG001|Overall Study|Non-compliance|46
2012842|NCT00249873|3579778|FG000|Overall Study|Other non serious Adverse Event|112
2012843|NCT00249873|3579779|FG001|Overall Study|Other non serious Adverse Event|108
2012844|NCT00249873|3579778|FG000|Overall Study|Other contraindicated medication|1
2012845|NCT00249873|3579779|FG001|Overall Study|Other contraindicated medication|0
2012846|NCT00249873|3579778|FG000|Overall Study|Patient not wish to continue after May08|3
2012847|NCT00249873|3579779|FG001|Overall Study|Patient not wish to continue after May08|4
2012848|NCT00249873|3579778|FG000|Overall Study|Physician withdrew consent|59
2012849|NCT00249873|3579779|FG001|Overall Study|Physician withdrew consent|60
2012850|NCT00249873|3579778|FG000|Overall Study|Open label clopidogrel required|31
2012851|NCT00249873|3579779|FG001|Overall Study|Open label clopidogrel required|42
2012852|NCT00249873|3579778|FG000|Overall Study|Angiotensin II receptor blocker required|1
2012853|NCT00249873|3579779|FG001|Overall Study|Angiotensin II receptor blocker required|0
2012854|NCT00249873|3579778|FG000|Overall Study|Oral anticoagulant required|159
2012855|NCT00249873|3579779|FG001|Overall Study|Oral anticoagulant required|157
2012856|NCT00249873|3579778|FG000|Overall Study|Study drug intolerance|5
2012857|NCT00249873|3579779|FG001|Overall Study|Study drug intolerance|0
2012858|NCT00249873|3579778|FG000|Overall Study|Surgery/ procedure|9
2012859|NCT00249873|3579779|FG001|Overall Study|Surgery/ procedure|9
2012860|NCT00249873|3579778|FG000|Overall Study|Event related to cardiac condition|12
2012861|NCT00249873|3579779|FG001|Overall Study|Event related to cardiac condition|21
2012862|NCT00249873|3579778|FG000|Overall Study|Thromboembolic/outcome event|82
2012863|NCT00249873|3579779|FG001|Overall Study|Thromboembolic/outcome event|122
2012864|NCT00250276|3579789|FG000|Overall Study|Serious Adverse Event|0
2012865|NCT00250276|3579790|FG001|Overall Study|Serious Adverse Event|0
2012866|NCT00250276|3579791|FG002|Overall Study|Serious Adverse Event|1
2012867|NCT00250276|3579792|FG003|Overall Study|Serious Adverse Event|0
2012868|NCT00250276|3579789|FG000|Overall Study|Non-serious Adverse Event|2
2012869|NCT00250276|3579790|FG001|Overall Study|Non-serious Adverse Event|0
2012870|NCT00250276|3579791|FG002|Overall Study|Non-serious Adverse Event|0
2012871|NCT00250276|3579792|FG003|Overall Study|Non-serious Adverse Event|2
2012872|NCT00250276|3579789|FG000|Overall Study|Protocol Violation|0
2012873|NCT00250276|3579790|FG001|Overall Study|Protocol Violation|1
2012874|NCT00250276|3579791|FG002|Overall Study|Protocol Violation|0
2012875|NCT00250276|3579792|FG003|Overall Study|Protocol Violation|0
2012876|NCT00250276|3579789|FG000|Overall Study|Withdrawal by Subject|1
2012877|NCT00250276|3579790|FG001|Overall Study|Withdrawal by Subject|2
2012878|NCT00250276|3579791|FG002|Overall Study|Withdrawal by Subject|3
2012879|NCT00250276|3579792|FG003|Overall Study|Withdrawal by Subject|2
2012880|NCT00250276|3579789|FG000|Overall Study|Migrated/moved from study area|3
2012881|NCT00250276|3579790|FG001|Overall Study|Migrated/moved from study area|0
2012882|NCT00250276|3579791|FG002|Overall Study|Migrated/moved from study area|2
2012883|NCT00250276|3579792|FG003|Overall Study|Migrated/moved from study area|7
2012884|NCT00250276|3579789|FG000|Overall Study|Lost to Follow-up|11
2012885|NCT00250276|3579790|FG001|Overall Study|Lost to Follow-up|18
2012886|NCT00250276|3579791|FG002|Overall Study|Lost to Follow-up|13
2012887|NCT00250276|3579792|FG003|Overall Study|Lost to Follow-up|8
2012888|NCT00250432|3579809|FG000|Overall Study|Adverse Event|25
2012889|NCT00250432|3579810|FG001|Overall Study|Adverse Event|29
2012890|NCT00250432|3579809|FG000|Overall Study|Lack of Efficacy|2
2012891|NCT00250432|3579810|FG001|Overall Study|Lack of Efficacy|1
2012892|NCT00250432|3579809|FG000|Overall Study|Lost to Follow-up|6
2012893|NCT00250432|3579810|FG001|Overall Study|Lost to Follow-up|5
2012894|NCT00250432|3579809|FG000|Overall Study|Patient Moved|0
2012895|NCT00250432|3579810|FG001|Overall Study|Patient Moved|1
2012896|NCT00250432|3579809|FG000|Overall Study|Protocol Violation|0
2012897|NCT00250432|3579810|FG001|Overall Study|Protocol Violation|3
2012898|NCT00250432|3579809|FG000|Overall Study|Withdrawal by Subject|6
2012899|NCT00250432|3579810|FG001|Overall Study|Withdrawal by Subject|2
2012900|NCT00250432|3579809|FG000|Overall Study|Pt died out of posttherapy report period|6
2012901|NCT00250432|3579810|FG001|Overall Study|Pt died out of posttherapy report period|5
2012902|NCT00250432|3579809|FG000|Overall Study|Pt was considered untreatable|0
2012903|NCT00250432|3579810|FG001|Overall Study|Pt was considered untreatable|1
2012904|NCT00250588|3579837|FG000|Overall Study|Withdrawal by Subject|3
2012905|NCT00250588|3579838|FG001|Overall Study|Withdrawal by Subject|6
2012906|NCT00250588|3579839|FG002|Overall Study|Withdrawal by Subject|0
2012907|NCT00250588|3579837|FG000|Overall Study|Lost to Follow-up|6
2012908|NCT00250588|3579838|FG001|Overall Study|Lost to Follow-up|13
2012909|NCT00250588|3579839|FG002|Overall Study|Lost to Follow-up|13
2012910|NCT00250679|3579850|FG000|Overall Study|Adverse Event|12
2012911|NCT00250679|3579851|FG001|Overall Study|Adverse Event|15
2012912|NCT00250679|3579852|FG002|Overall Study|Adverse Event|16
2012913|NCT00250679|3579850|FG000|Overall Study|Protocol Violation|2
2012914|NCT00250679|3579851|FG001|Overall Study|Protocol Violation|4
2012915|NCT00250679|3579852|FG002|Overall Study|Protocol Violation|3
2012916|NCT00250679|3579850|FG000|Overall Study|Withdrawal by Subject|15
2012917|NCT00250679|3579851|FG001|Overall Study|Withdrawal by Subject|18
2012918|NCT00250679|3579852|FG002|Overall Study|Withdrawal by Subject|15
2012919|NCT00250679|3579850|FG000|Overall Study|Lost to Follow-up|3
2012920|NCT00250679|3579851|FG001|Overall Study|Lost to Follow-up|4
2012921|NCT00250679|3579852|FG002|Overall Study|Lost to Follow-up|2
2012922|NCT00250679|3579850|FG000|Overall Study|Does Not Meet Entry Criteria|1
2012923|NCT00250679|3579851|FG001|Overall Study|Does Not Meet Entry Criteria|4
2012924|NCT00250679|3579852|FG002|Overall Study|Does Not Meet Entry Criteria|2
2012925|NCT00250679|3579850|FG000|Overall Study|Lack of Efficacy|0
2012926|NCT00250679|3579851|FG001|Overall Study|Lack of Efficacy|1
2012927|NCT00250679|3579852|FG002|Overall Study|Lack of Efficacy|3
2012928|NCT00250679|3579850|FG000|Overall Study|Technical Holter issues|1
2012929|NCT00250679|3579851|FG001|Overall Study|Technical Holter issues|0
2012930|NCT00250679|3579852|FG002|Overall Study|Technical Holter issues|2
2012931|NCT00250679|3579850|FG000|Overall Study|Moved|1
2012932|NCT00250679|3579851|FG001|Overall Study|Moved|1
2012933|NCT00250679|3579852|FG002|Overall Study|Moved|0
2012934|NCT00250679|3579850|FG000|Overall Study|Non-compliance|1
2012935|NCT00250679|3579851|FG001|Overall Study|Non-compliance|1
2012936|NCT00250679|3579852|FG002|Overall Study|Non-compliance|0
2012937|NCT00250679|3579850|FG000|Overall Study|various single events: hip surgery,diary|3
2012938|NCT00250679|3579851|FG001|Overall Study|various single events: hip surgery,diary|1
2012939|NCT00250679|3579852|FG002|Overall Study|various single events: hip surgery,diary|1
2012940|NCT00250705|3579860|FG000|Overall Study|Lack of Efficacy|2
2012941|NCT00250835|3579866|FG000|Overall Study|Withdrawal by Subject|1
2012942|NCT00251004|3579878|FG000|Overall Study|Withdrawal by Subject|23
2012943|NCT00251004|3579879|FG001|Overall Study|Withdrawal by Subject|16
2012944|NCT00251004|3579880|FG002|Overall Study|Withdrawal by Subject|14
2012945|NCT00251004|3579878|FG000|Overall Study|Death|9
2012946|NCT00251004|3579879|FG001|Overall Study|Death|10
2012947|NCT00251004|3579880|FG002|Overall Study|Death|8
2012948|NCT00251004|3579878|FG000|Overall Study|Lost to Follow-up|1
2012949|NCT00251004|3579879|FG001|Overall Study|Lost to Follow-up|2
2012950|NCT00251004|3579880|FG002|Overall Study|Lost to Follow-up|1
2012951|NCT00251004|3579878|FG000|Overall Study|Graft Loss|12
2012952|NCT00251004|3579879|FG001|Overall Study|Graft Loss|13
2012953|NCT00251004|3579880|FG002|Overall Study|Graft Loss|8
2012954|NCT00251316|3579914|FG000|Overall Study|Physician Decision|2
2012955|NCT00251316|3579915|FG001|Overall Study|Physician Decision|3
2012956|NCT00251589|3579925|FG000|Overall Study|Adverse Event|5
2012957|NCT00251589|3579926|FG001|Overall Study|Adverse Event|1
2012958|NCT00251589|3579927|FG002|Overall Study|Adverse Event|2
2012959|NCT00251589|3579928|FG003|Overall Study|Adverse Event|1
2012960|NCT00251589|3579925|FG000|Overall Study|Withdrawal by Subject|1
2012961|NCT00251589|3579926|FG001|Overall Study|Withdrawal by Subject|1
2012962|NCT00251589|3579927|FG002|Overall Study|Withdrawal by Subject|0
2012963|NCT00251589|3579928|FG003|Overall Study|Withdrawal by Subject|0
2012964|NCT00251589|3579925|FG000|Overall Study|Discontinued due to progressive disease|9
2012965|NCT00251589|3579926|FG001|Overall Study|Discontinued due to progressive disease|1
2012966|NCT00251589|3579927|FG002|Overall Study|Discontinued due to progressive disease|0
2012967|NCT00251589|3579928|FG003|Overall Study|Discontinued due to progressive disease|1
2012968|NCT00251641|3579940|FG000|Overall Study|Adverse Event|80
2012969|NCT00251641|3579941|FG001|Overall Study|Adverse Event|8
2012970|NCT00251641|3579940|FG000|Overall Study|Lack of Efficacy|2
2012971|NCT00251641|3579941|FG001|Overall Study|Lack of Efficacy|1
2012972|NCT00251641|3579940|FG000|Overall Study|Progression of Disease|0
2012973|NCT00251641|3579941|FG001|Overall Study|Progression of Disease|2
2012974|NCT00251641|3579940|FG000|Overall Study|Lost to Follow-up|3
2012975|NCT00251641|3579941|FG001|Overall Study|Lost to Follow-up|3
2012976|NCT00251641|3579940|FG000|Overall Study|Withdrawal by Subject|6
2012977|NCT00251641|3579941|FG001|Overall Study|Withdrawal by Subject|8
2012978|NCT00251641|3579940|FG000|Overall Study|Protocol Violation|10
2012979|NCT00251641|3579941|FG001|Overall Study|Protocol Violation|2
2012980|NCT00251641|3579940|FG000|Overall Study|Did not Meet protocol Eligibility|2
2012981|NCT00251641|3579941|FG001|Overall Study|Did not Meet protocol Eligibility|1
2012982|NCT00251641|3579940|FG000|Overall Study|Switched Treatment|9
2012983|NCT00251641|3579941|FG001|Overall Study|Switched Treatment|63
2012984|NCT00251693|3579952|FG000|Overall Study|Adverse Event|17
2012985|NCT00251693|3579953|FG001|Overall Study|Adverse Event|9
2012986|NCT00251693|3579954|FG002|Overall Study|Adverse Event|9
2012987|NCT00251693|3579952|FG000|Overall Study|Protocol Violation|2
2012988|NCT00251693|3579953|FG001|Overall Study|Protocol Violation|0
2012989|NCT00251693|3579954|FG002|Overall Study|Protocol Violation|2
2012990|NCT00251693|3579952|FG000|Overall Study|Lost to Follow-up|12
2012991|NCT00251693|3579953|FG001|Overall Study|Lost to Follow-up|7
2012992|NCT00251693|3579954|FG002|Overall Study|Lost to Follow-up|8
2012993|NCT00251693|3579952|FG000|Overall Study|Withdrawal by Subject|11
2012994|NCT00251693|3579953|FG001|Overall Study|Withdrawal by Subject|17
2012995|NCT00251693|3579954|FG002|Overall Study|Withdrawal by Subject|14
2012996|NCT00251693|3579952|FG000|Overall Study|Lack of Efficacy|0
2012997|NCT00251693|3579953|FG001|Overall Study|Lack of Efficacy|1
2012998|NCT00251693|3579954|FG002|Overall Study|Lack of Efficacy|0
2012999|NCT00251693|3579952|FG000|Overall Study|Inclusion/exclusion criteria not met|5
2013000|NCT00251693|3579953|FG001|Overall Study|Inclusion/exclusion criteria not met|3
2013001|NCT00251693|3579954|FG002|Overall Study|Inclusion/exclusion criteria not met|8
2013002|NCT00251693|3579952|FG000|Overall Study|Noncompliant|0
2013003|NCT00251693|3579953|FG001|Overall Study|Noncompliant|0
2013004|NCT00251693|3579954|FG002|Overall Study|Noncompliant|2
2013005|NCT00251693|3579952|FG000|Overall Study|Possible Barrett's esophagus|3
2013006|NCT00251693|3579953|FG001|Overall Study|Possible Barrett's esophagus|5
2013007|NCT00251693|3579954|FG002|Overall Study|Possible Barrett's esophagus|2
2013008|NCT00251693|3579952|FG000|Overall Study|Subject request/subject unavailable|1
2013009|NCT00251693|3579953|FG001|Overall Study|Subject request/subject unavailable|2
2013010|NCT00251693|3579954|FG002|Overall Study|Subject request/subject unavailable|0
2013011|NCT00251693|3579952|FG000|Overall Study|Abnormal laboratory findings|0
2013012|NCT00251693|3579953|FG001|Overall Study|Abnormal laboratory findings|0
2013013|NCT00251693|3579954|FG002|Overall Study|Abnormal laboratory findings|1
2013014|NCT00251719|3579965|FG000|Overall Study|Adverse Event|14
2013015|NCT00251719|3579966|FG001|Overall Study|Adverse Event|8
2013016|NCT00251719|3579967|FG002|Overall Study|Adverse Event|7
2013017|NCT00251719|3579965|FG000|Overall Study|Protocol Violation|1
2013018|NCT00251719|3579966|FG001|Overall Study|Protocol Violation|1
2013019|NCT00251719|3579967|FG002|Overall Study|Protocol Violation|1
2013020|NCT00251719|3579965|FG000|Overall Study|Lost to Follow-up|5
2013021|NCT00251719|3579966|FG001|Overall Study|Lost to Follow-up|11
2013022|NCT00251719|3579967|FG002|Overall Study|Lost to Follow-up|8
2013023|NCT00251719|3579965|FG000|Overall Study|Withdrawal by Subject|14
2013024|NCT00251719|3579966|FG001|Overall Study|Withdrawal by Subject|12
2013025|NCT00251719|3579967|FG002|Overall Study|Withdrawal by Subject|11
2013026|NCT00251719|3579965|FG000|Overall Study|Lack of Efficacy|2
2013027|NCT00251719|3579966|FG001|Overall Study|Lack of Efficacy|1
2013028|NCT00251719|3579967|FG002|Overall Study|Lack of Efficacy|0
2013029|NCT00251719|3579965|FG000|Overall Study|Inclusion/exclusion criteria not met|12
2013030|NCT00251719|3579966|FG001|Overall Study|Inclusion/exclusion criteria not met|6
2013031|NCT00251719|3579967|FG002|Overall Study|Inclusion/exclusion criteria not met|2
2013032|NCT00251719|3579965|FG000|Overall Study|Investigator decision|1
2013033|NCT00251719|3579966|FG001|Overall Study|Investigator decision|1
2013034|NCT00251719|3579967|FG002|Overall Study|Investigator decision|0
2013035|NCT00251719|3579965|FG000|Overall Study|Noncompliance|2
2013036|NCT00251719|3579966|FG001|Overall Study|Noncompliance|3
2013037|NCT00251719|3579967|FG002|Overall Study|Noncompliance|1
2013038|NCT00251719|3579965|FG000|Overall Study|Barrett's esophagus|2
2013039|NCT00251719|3579966|FG001|Overall Study|Barrett's esophagus|2
2013040|NCT00251719|3579967|FG002|Overall Study|Barrett's esophagus|0
2013041|NCT00251745|3579978|FG000|Overall Study|Adverse Event|7
2013042|NCT00251745|3579979|FG001|Overall Study|Adverse Event|9
2013043|NCT00251745|3579980|FG002|Overall Study|Adverse Event|11
2013044|NCT00251745|3579978|FG000|Overall Study|Lost to Follow-up|4
2013045|NCT00251745|3579979|FG001|Overall Study|Lost to Follow-up|2
2013046|NCT00251745|3579980|FG002|Overall Study|Lost to Follow-up|5
2013047|NCT00251745|3579978|FG000|Overall Study|Withdrawal by Subject|13
2013048|NCT00251745|3579979|FG001|Overall Study|Withdrawal by Subject|7
2013049|NCT00251745|3579980|FG002|Overall Study|Withdrawal by Subject|3
2013050|NCT00251745|3579978|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
2013051|NCT00251745|3579979|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
2013052|NCT00251745|3579980|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
2013053|NCT00251745|3579978|FG000|Overall Study|Lack of Efficacy|3
2013054|NCT00251745|3579979|FG001|Overall Study|Lack of Efficacy|0
2013055|NCT00251745|3579980|FG002|Overall Study|Lack of Efficacy|0
2013056|NCT00251745|3579978|FG000|Overall Study|Noncompliant|0
2013057|NCT00251745|3579979|FG001|Overall Study|Noncompliant|2
2013058|NCT00251745|3579980|FG002|Overall Study|Noncompliant|2
2013059|NCT00251745|3579978|FG000|Overall Study|Pregnancy|0
2013060|NCT00251745|3579979|FG001|Overall Study|Pregnancy|1
2013061|NCT00251745|3579980|FG002|Overall Study|Pregnancy|0
2013062|NCT00251745|3579978|FG000|Overall Study|Per Subject Request|0
2013063|NCT00251745|3579979|FG001|Overall Study|Per Subject Request|0
2013064|NCT00251745|3579980|FG002|Overall Study|Per Subject Request|1
2013065|NCT00251745|3579978|FG000|Overall Study|Per Investigator Request|1
2013066|NCT00251745|3579979|FG001|Overall Study|Per Investigator Request|0
2013067|NCT00251745|3579980|FG002|Overall Study|Per Investigator Request|0
2013068|NCT00251758|3579991|FG000|Overall Study|Adverse Event|7
2013069|NCT00251758|3579992|FG001|Overall Study|Adverse Event|9
2013070|NCT00251758|3579993|FG002|Overall Study|Adverse Event|11
2013071|NCT00251758|3579991|FG000|Overall Study|Lost to Follow-up|4
2013072|NCT00251758|3579992|FG001|Overall Study|Lost to Follow-up|2
2013073|NCT00251758|3579993|FG002|Overall Study|Lost to Follow-up|5
2013074|NCT00251758|3579991|FG000|Overall Study|Withdrawal by Subject|13
2013075|NCT00251758|3579992|FG001|Overall Study|Withdrawal by Subject|7
2013076|NCT00251758|3579993|FG002|Overall Study|Withdrawal by Subject|3
2013077|NCT00251758|3579991|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
2013078|NCT00251758|3579992|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
2013079|NCT00251758|3579993|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
2013080|NCT00251758|3579991|FG000|Overall Study|Lack of Efficacy|3
2013081|NCT00251758|3579992|FG001|Overall Study|Lack of Efficacy|0
2214456|NCT01687478|3856768|FG001|Overall Study|Adverse Event|10
2214457|NCT01687478|3856767|FG000|Overall Study|Lost to Follow-up|1
2214458|NCT01687478|3856768|FG001|Overall Study|Lost to Follow-up|3
2214459|NCT01687478|3856767|FG000|Overall Study|Protocol Violation|0
2214460|NCT01687478|3856768|FG001|Overall Study|Protocol Violation|2
2214461|NCT01687478|3856767|FG000|Overall Study|Withdrawal by Subject|21
2013082|NCT00251758|3579993|FG002|Overall Study|Lack of Efficacy|0
2013083|NCT00251758|3579991|FG000|Overall Study|Noncompliant|0
2013084|NCT00251758|3579992|FG001|Overall Study|Noncompliant|2
2013085|NCT00251758|3579993|FG002|Overall Study|Noncompliant|2
2013086|NCT00251758|3579991|FG000|Overall Study|Pregnancy|0
2013087|NCT00251758|3579992|FG001|Overall Study|Pregnancy|1
2013088|NCT00251758|3579993|FG002|Overall Study|Pregnancy|0
2013089|NCT00251758|3579991|FG000|Overall Study|Per Subject Request|0
2013090|NCT00251758|3579992|FG001|Overall Study|Per Subject Request|0
2013091|NCT00251758|3579993|FG002|Overall Study|Per Subject Request|1
2013092|NCT00251758|3579991|FG000|Overall Study|Per Investigator Request|1
2013093|NCT00251758|3579992|FG001|Overall Study|Per Investigator Request|0
2013094|NCT00251758|3579993|FG002|Overall Study|Per Investigator Request|0
2013095|NCT00251927|3580016|FG000|Overall Study|Adverse Event|3
2013096|NCT00251927|3580017|FG001|Overall Study|Adverse Event|15
2013097|NCT00251927|3580016|FG000|Overall Study|Lack of Efficacy|22
2013098|NCT00251927|3580017|FG001|Overall Study|Lack of Efficacy|16
2013099|NCT00251927|3580016|FG000|Overall Study|Lost to Follow-up|22
2013100|NCT00251927|3580017|FG001|Overall Study|Lost to Follow-up|8
2013101|NCT00251927|3580016|FG000|Overall Study|Protocol Violation|1
2013102|NCT00251927|3580017|FG001|Overall Study|Protocol Violation|2
2013103|NCT00251927|3580016|FG000|Overall Study|Pregnancy|2
2214462|NCT01687478|3856768|FG001|Overall Study|Withdrawal by Subject|19
2214463|NCT01687478|3856767|FG000|Overall Study|Physician Decision|1
2214464|NCT01687478|3856768|FG001|Overall Study|Physician Decision|3
2214465|NCT01687478|3856767|FG000|Overall Study|Entry Criteria Not Met|6
2214466|NCT01687478|3856768|FG001|Overall Study|Entry Criteria Not Met|2
2214467|NCT01687595|3856776|FG000|Overall Study|Withdrawal by Subject|8
2214468|NCT01687595|3856777|FG001|Overall Study|Withdrawal by Subject|0
2214469|NCT01687595|3856776|FG000|Overall Study|Lost to Follow-up|3
2013104|NCT00251927|3580017|FG001|Overall Study|Pregnancy|0
2013105|NCT00251927|3580016|FG000|Overall Study|Withdrawal by Subject|40
2013106|NCT00251927|3580017|FG001|Overall Study|Withdrawal by Subject|25
2013107|NCT00251927|3580016|FG000|Overall Study|Study-specific discont. achieved|13
2013108|NCT00251927|3580017|FG001|Overall Study|Study-specific discont. achieved|2
2013109|NCT00251927|3580016|FG000|Overall Study|Study procedure non-compliance|5
2013110|NCT00251927|3580017|FG001|Overall Study|Study procedure non-compliance|6
2013111|NCT00251979|3580026|FG000|Overall Study|Protocol Violation|3
2013112|NCT00251979|3580027|FG001|Overall Study|Protocol Violation|5
2013113|NCT00251979|3580026|FG000|Overall Study|Adverse Event|11
2013114|NCT00251979|3580027|FG001|Overall Study|Adverse Event|17
2013115|NCT00251979|3580026|FG000|Overall Study|Withdrawal by Subject|13
2013116|NCT00251979|3580027|FG001|Overall Study|Withdrawal by Subject|7
2013117|NCT00251979|3580026|FG000|Overall Study|Lost to Follow-up|8
2013118|NCT00251979|3580027|FG001|Overall Study|Lost to Follow-up|6
2013119|NCT00251979|3580026|FG000|Overall Study|Death|3
2013120|NCT00251979|3580027|FG001|Overall Study|Death|5
2013121|NCT00252057|3580035|FG000|Overall Study|Withdrawal by Subject|2
2013122|NCT00252057|3580036|FG001|Overall Study|Withdrawal by Subject|5
2013123|NCT00252057|3580035|FG000|Overall Study|Death|1
2013124|NCT00252057|3580036|FG001|Overall Study|Death|2
2013125|NCT00252057|3580035|FG000|Overall Study|Participant previously enrolled|0
2013126|NCT00252057|3580036|FG001|Overall Study|Participant previously enrolled|1
2013127|NCT00252187|3580044|FG000|Overall Study|Adverse Event|3
2013128|NCT00252187|3580045|FG001|Overall Study|Adverse Event|1
2013129|NCT00252187|3580044|FG000|Overall Study|Withdrawal by Subject|1
2013130|NCT00252187|3580045|FG001|Overall Study|Withdrawal by Subject|0
2013131|NCT00252239|3580055|FG000|Overall Study|Withdrawal by Subject|1
2013132|NCT00252239|3580056|FG001|Overall Study|Withdrawal by Subject|0
2013133|NCT00252239|3580057|FG002|Overall Study|Withdrawal by Subject|0
2013134|NCT00252239|3580058|FG003|Overall Study|Withdrawal by Subject|1
2013135|NCT00252239|3580055|FG000|Overall Study|Lost to Follow-up|0
2013136|NCT00252239|3580056|FG001|Overall Study|Lost to Follow-up|0
2013137|NCT00252239|3580057|FG002|Overall Study|Lost to Follow-up|2
2013138|NCT00252239|3580058|FG003|Overall Study|Lost to Follow-up|0
2013139|NCT00252499|3580075|FG000|Overall Study|Lost to Follow-up|1
2013140|NCT00252499|3580076|FG001|Overall Study|Lost to Follow-up|0
2013141|NCT00252499|3580077|FG002|Overall Study|Lost to Follow-up|0
2013142|NCT00252564|3580102|FG000|Overall Study|Adverse Event|17
2013143|NCT00252564|3580103|FG001|Overall Study|Adverse Event|13
2013144|NCT00252564|3580102|FG000|Overall Study|Unrelated Complication|2
2013145|NCT00252564|3580103|FG001|Overall Study|Unrelated Complication|1
2013146|NCT00252564|3580102|FG000|Overall Study|Disease Progression|14
2013147|NCT00252564|3580103|FG001|Overall Study|Disease Progression|20
2013148|NCT00252564|3580102|FG000|Overall Study|Death|0
2013149|NCT00252564|3580103|FG001|Overall Study|Death|3
2013150|NCT00252564|3580102|FG000|Overall Study|Physician Decision|1
2013151|NCT00252564|3580103|FG001|Overall Study|Physician Decision|0
2013152|NCT00252564|3580102|FG000|Overall Study|Lost to Follow-up|1
2013153|NCT00252564|3580103|FG001|Overall Study|Lost to Follow-up|0
2013154|NCT00252564|3580102|FG000|Overall Study|Patient Request|4
2013155|NCT00252564|3580103|FG001|Overall Study|Patient Request|5
2013156|NCT00252564|3580102|FG000|Overall Study|Withdrawal by Subject|0
2013157|NCT00252564|3580103|FG001|Overall Study|Withdrawal by Subject|2
2013158|NCT00252577|3580109|FG000|Overall Study|Lost to Follow-up|20
2013159|NCT00252694|3580146|FG000|Overall Study|Withdrawal by Subject|83
2013160|NCT00252694|3580147|FG001|Overall Study|Withdrawal by Subject|91
2013161|NCT00252694|3580146|FG000|Overall Study|Death|36
2013162|NCT00252694|3580147|FG001|Overall Study|Death|34
2013163|NCT00252694|3580146|FG000|Overall Study|Mostly Lost to Follow Up|8
2013164|NCT00252694|3580147|FG001|Overall Study|Mostly Lost to Follow Up|13
2013165|NCT00252694|3580146|FG000|Overall Study|Patient Moving|17
2013166|NCT00252694|3580147|FG001|Overall Study|Patient Moving|16
2013167|NCT00252720|3580155|FG000|Overall Study|Withdrawal by Subject|95
2013168|NCT00252720|3580156|FG001|Overall Study|Withdrawal by Subject|97
2013169|NCT00252720|3580155|FG000|Overall Study|Death|7
2013170|NCT00252720|3580156|FG001|Overall Study|Death|8
2013171|NCT00252720|3580155|FG000|Overall Study|Moving|23
2013172|NCT00252720|3580156|FG001|Overall Study|Moving|42
2013173|NCT00252720|3580155|FG000|Overall Study|Mainly patients lost to follow-up|7
2013174|NCT00252720|3580156|FG001|Overall Study|Mainly patients lost to follow-up|18
2013175|NCT00252733|3580164|FG000|Overall Study|Withdrawal by Subject|73
2013176|NCT00252733|3580165|FG001|Overall Study|Withdrawal by Subject|67
2013177|NCT00252733|3580164|FG000|Overall Study|Death|7
2013178|NCT00252733|3580165|FG001|Overall Study|Death|5
2013179|NCT00252733|3580164|FG000|Overall Study|Lost to Follow-up|12
2013180|NCT00252733|3580165|FG001|Overall Study|Lost to Follow-up|6
2013181|NCT00252733|3580164|FG000|Overall Study|Multiple Reasons|14
2013182|NCT00252733|3580165|FG001|Overall Study|Multiple Reasons|14
2013183|NCT00253370|3580193|FG000|Overall Study|Adverse Event|18
2013184|NCT00253370|3580193|FG000|Overall Study|Disease progression|13
2013185|NCT00253370|3580193|FG000|Overall Study|Death|2
2013186|NCT00253370|3580193|FG000|Overall Study|Withdrawal by Subject|6
2013187|NCT00253370|3580193|FG000|Overall Study|Non-protocol therapy|1
2013188|NCT00253370|3580193|FG000|Overall Study|Physician Decision|1
2013189|NCT00253370|3580193|FG000|Overall Study|Protocol Violation|1
2013190|NCT00253370|3580193|FG000|Overall Study|Abdominal pain due to disease|1
2013191|NCT00253448|3580207|FG000|Overall Study|Withdrawal by Subject|1
2013192|NCT00253630|3580215|FG000|Overall Study|ineligible|2
2013193|NCT00253643|3580223|FG000|Overall Study|Withdrawal by Subject|0
2013194|NCT00253643|3580224|FG001|Overall Study|Withdrawal by Subject|0
2013195|NCT00253643|3580225|FG002|Overall Study|Withdrawal by Subject|1
2013196|NCT00253643|3580226|FG003|Overall Study|Withdrawal by Subject|1
2013197|NCT00253643|3580223|FG000|Overall Study|Non-Compliance|0
2013198|NCT00253643|3580224|FG001|Overall Study|Non-Compliance|0
2013199|NCT00253643|3580225|FG002|Overall Study|Non-Compliance|0
2013200|NCT00253643|3580226|FG003|Overall Study|Non-Compliance|2
2013201|NCT00253747|3580251|FG000|Overall Study|Lost to Follow-up|13
2013202|NCT00253747|3580252|FG001|Overall Study|Lost to Follow-up|14
2013203|NCT00253747|3580251|FG000|Overall Study|Withdrawal by Subject|10
2013204|NCT00253747|3580252|FG001|Overall Study|Withdrawal by Subject|11
2013205|NCT00253747|3580251|FG000|Overall Study|Administrative Discharge (1), Other (2)|1
2013206|NCT00253747|3580252|FG001|Overall Study|Administrative Discharge (1), Other (2)|2
2013207|NCT00254163|3580288|FG000|Overall Study|Adverse Event|29
2013208|NCT00254163|3580289|FG001|Overall Study|Adverse Event|26
2013209|NCT00254163|3580288|FG000|Overall Study|Patient request/withdrew consent|6
2013210|NCT00254163|3580289|FG001|Overall Study|Patient request/withdrew consent|4
2013211|NCT00254163|3580288|FG000|Overall Study|Investigator request|1
2013212|NCT00254163|3580289|FG001|Overall Study|Investigator request|3
2013213|NCT00254163|3580288|FG000|Overall Study|Failed entry|1
2013214|NCT00254163|3580289|FG001|Overall Study|Failed entry|3
2013215|NCT00254163|3580288|FG000|Overall Study|Progressive disease|0
2013216|NCT00254163|3580289|FG001|Overall Study|Progressive disease|1
2013217|NCT00254163|3580288|FG000|Overall Study|Death|0
2013218|NCT00254163|3580289|FG001|Overall Study|Death|1
2013219|NCT00254163|3580288|FG000|Overall Study|Other|8
2013220|NCT00254163|3580289|FG001|Overall Study|Other|8
2013221|NCT00254293|3580301|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0
2013222|NCT00254293|3580302|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1
2013223|NCT00254293|3580303|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0
2313297|NCT02787551|4020584|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
2313298|NCT02787551|4020585|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
2013224|NCT00254293|3580304|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1
2013225|NCT00254293|3580305|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0
2013226|NCT00254293|3580306|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0
2013227|NCT00254293|3580307|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0
2013228|NCT00254293|3580301|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2013229|NCT00254293|3580302|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2013230|NCT00254293|3580303|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
2013231|NCT00254293|3580304|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2013232|NCT00254293|3580305|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2013233|NCT00254293|3580306|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2013234|NCT00254293|3580307|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2013235|NCT00254293|3580301|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2013236|NCT00254293|3580302|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2013237|NCT00254293|3580303|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
2013238|NCT00254293|3580304|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2013239|NCT00254293|3580305|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2013240|NCT00254293|3580306|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2013241|NCT00254293|3580307|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2013242|NCT00254293|3580301|FG000|LTE Open Label Variable SC Dosing|Death|0
2013243|NCT00254293|3580302|FG001|LTE Open Label Variable SC Dosing|Death|0
2013244|NCT00254293|3580303|FG002|LTE Open Label Variable SC Dosing|Death|1
2013245|NCT00254293|3580304|FG003|LTE Open Label Variable SC Dosing|Death|0
2013246|NCT00254293|3580305|FG004|LTE Open Label Variable SC Dosing|Death|0
2013247|NCT00254293|3580306|FG005|LTE Open Label Variable SC Dosing|Death|0
2013248|NCT00254293|3580307|FG006|LTE Open Label Variable SC Dosing|Death|0
2013249|NCT00254293|3580301|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1
2013250|NCT00254293|3580302|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0
2013251|NCT00254293|3580303|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2
2013252|NCT00254293|3580304|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0
2013253|NCT00254293|3580305|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1
2013254|NCT00254293|3580306|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0
2013255|NCT00254293|3580307|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0
2013256|NCT00254293|3580301|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
2013257|NCT00254293|3580302|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
2013258|NCT00254293|3580303|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
2013259|NCT00254293|3580304|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
2013260|NCT00254293|3580305|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
2013261|NCT00254293|3580306|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
2013262|NCT00254293|3580307|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
2013263|NCT00254293|3580301|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2013264|NCT00254293|3580302|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2013265|NCT00254293|3580303|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
2013266|NCT00254293|3580304|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2013267|NCT00254293|3580305|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2013268|NCT00254293|3580306|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2013269|NCT00254293|3580307|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2026046|NCT00348283|3594714|FG000|Double Blind|Lack of Efficacy|2
2013270|NCT00254293|3580301|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2013271|NCT00254293|3580302|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2013272|NCT00254293|3580303|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
2013273|NCT00254293|3580304|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2013274|NCT00254293|3580305|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2013275|NCT00254293|3580306|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2013276|NCT00254293|3580307|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2013277|NCT00254293|3580301|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2013278|NCT00254293|3580302|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2013279|NCT00254293|3580303|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
2013280|NCT00254293|3580304|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2013281|NCT00254293|3580305|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2013282|NCT00254293|3580306|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2013283|NCT00254293|3580307|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2013284|NCT00254293|3580301|FG000|LTE Open Label Variable SC Dosing|Other|0
2013285|NCT00254293|3580302|FG001|LTE Open Label Variable SC Dosing|Other|0
2013286|NCT00254293|3580303|FG002|LTE Open Label Variable SC Dosing|Other|2
2013287|NCT00254293|3580304|FG003|LTE Open Label Variable SC Dosing|Other|0
2214470|NCT01687595|3856777|FG001|Overall Study|Lost to Follow-up|1
2214471|NCT01687595|3856776|FG000|Overall Study|Investigator's decision|1
2214472|NCT01687595|3856777|FG001|Overall Study|Investigator's decision|0
2214473|NCT01687595|3856776|FG000|Overall Study|Sponsor's decision|1
2214474|NCT01687595|3856777|FG001|Overall Study|Sponsor's decision|0
2214475|NCT01687595|3856776|FG000|Overall Study|Noncompliance|1
2214476|NCT01687595|3856777|FG001|Overall Study|Noncompliance|2
2214477|NCT01687595|3856776|FG000|Overall Study|Other than specified|56
2214478|NCT01687595|3856777|FG001|Overall Study|Other than specified|7
2214479|NCT01687673|3856783|FG000|Overall Study|Physician Decision|1
2214480|NCT01687712|3856789|FG000|Cycle 1|Not Biochemically Pregnant|386
2214481|NCT01687712|3856790|FG001|Cycle 1|Not Biochemically Pregnant|348
2214482|NCT01687712|3856789|FG000|Cycle 1|Early Pregnancy Loss|43
2214483|NCT01687712|3856790|FG001|Cycle 1|Early Pregnancy Loss|60
2214484|NCT01687712|3856789|FG000|Cycle 1|Ectopic Pregnancy|5
2214485|NCT01687712|3856790|FG001|Cycle 1|Ectopic Pregnancy|5
2214486|NCT01687712|3856789|FG000|Cycle 1|Heterotropic Pregnancy|1
2214487|NCT01687712|3856790|FG001|Cycle 1|Heterotropic Pregnancy|0
2214488|NCT01687712|3856789|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9
2214489|NCT01687712|3856790|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14
2214490|NCT01687712|3856789|FG000|Cycle 1|Abortion|3
2214491|NCT01687712|3856790|FG001|Cycle 1|Abortion|0
2214492|NCT01687712|3856789|FG000|Cycle 1|Intrauterine Fetal Death|0
2214493|NCT01687712|3856790|FG001|Cycle 1|Intrauterine Fetal Death|1
2013288|NCT00254293|3580305|FG004|LTE Open Label Variable SC Dosing|Other|0
2013289|NCT00254293|3580306|FG005|LTE Open Label Variable SC Dosing|Other|0
2013290|NCT00254293|3580307|FG006|LTE Open Label Variable SC Dosing|Other|0
2013291|NCT00254293|3580301|FG000|LTE Open Label Fixed Dosing|Death|0
2013292|NCT00254293|3580302|FG001|LTE Open Label Fixed Dosing|Death|0
2013293|NCT00254293|3580303|FG002|LTE Open Label Fixed Dosing|Death|0
2013294|NCT00254293|3580304|FG003|LTE Open Label Fixed Dosing|Death|0
2013295|NCT00254293|3580305|FG004|LTE Open Label Fixed Dosing|Death|0
2013296|NCT00254293|3580306|FG005|LTE Open Label Fixed Dosing|Death|0
2013297|NCT00254293|3580307|FG006|LTE Open Label Fixed Dosing|Death|3
2013298|NCT00254293|3580301|FG000|LTE Open Label Fixed Dosing|Adverse Event|0
2013299|NCT00254293|3580302|FG001|LTE Open Label Fixed Dosing|Adverse Event|0
2013300|NCT00254293|3580303|FG002|LTE Open Label Fixed Dosing|Adverse Event|0
2013301|NCT00254293|3580304|FG003|LTE Open Label Fixed Dosing|Adverse Event|0
2013302|NCT00254293|3580305|FG004|LTE Open Label Fixed Dosing|Adverse Event|0
2013303|NCT00254293|3580306|FG005|LTE Open Label Fixed Dosing|Adverse Event|0
2013304|NCT00254293|3580307|FG006|LTE Open Label Fixed Dosing|Adverse Event|1
2013305|NCT00254293|3580301|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2013306|NCT00254293|3580302|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2013307|NCT00254293|3580303|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2013308|NCT00254293|3580304|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2013309|NCT00254293|3580305|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2013310|NCT00254293|3580306|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2013311|NCT00254293|3580307|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3
2013312|NCT00254293|3580301|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2013313|NCT00254293|3580302|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2013314|NCT00254293|3580303|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2013315|NCT00254293|3580304|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2013316|NCT00254293|3580305|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2013317|NCT00254293|3580306|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2013318|NCT00254293|3580307|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1
2013319|NCT00254293|3580301|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2013320|NCT00254293|3580302|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2214494|NCT01687712|3856789|FG000|Cycle 1|Lost to Follow-up|1
2214495|NCT01687712|3856790|FG001|Cycle 1|Lost to Follow-up|1
2214496|NCT01687712|3856789|FG000|Cycle 2|Not Biochemically Pregnant|74
2214497|NCT01687712|3856790|FG001|Cycle 2|Not Biochemically Pregnant|77
2214498|NCT01687712|3856789|FG000|Cycle 2|Early Pregnancy Loss|18
2013321|NCT00254293|3580303|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2013322|NCT00254293|3580304|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2013323|NCT00254293|3580305|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2013324|NCT00254293|3580306|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2013325|NCT00254293|3580307|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
2013326|NCT00254293|3580301|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2013327|NCT00254293|3580302|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2013328|NCT00254293|3580303|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2013329|NCT00254293|3580304|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2013330|NCT00254293|3580305|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2013331|NCT00254293|3580306|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2013332|NCT00254293|3580307|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1
2013333|NCT00254293|3580301|FG000|LTE Open Label Fixed Dosing|Other|0
2013334|NCT00254293|3580302|FG001|LTE Open Label Fixed Dosing|Other|0
2013335|NCT00254293|3580303|FG002|LTE Open Label Fixed Dosing|Other|0
2013336|NCT00254293|3580304|FG003|LTE Open Label Fixed Dosing|Other|0
2013337|NCT00254293|3580305|FG004|LTE Open Label Fixed Dosing|Other|0
2013338|NCT00254293|3580306|FG005|LTE Open Label Fixed Dosing|Other|0
2013339|NCT00254293|3580307|FG006|LTE Open Label Fixed Dosing|Other|1
2013340|NCT00254397|3580354|FG000|Overall Study|Disease Progression|4
2013341|NCT00254397|3580355|FG001|Overall Study|Disease Progression|1
2013342|NCT00254397|3580356|FG002|Overall Study|Disease Progression|16
2013343|NCT00254397|3580357|FG003|Overall Study|Disease Progression|23
2013344|NCT00254397|3580354|FG000|Overall Study|Non-Compliant|0
2013345|NCT00254397|3580355|FG001|Overall Study|Non-Compliant|0
2013346|NCT00254397|3580356|FG002|Overall Study|Non-Compliant|0
2013347|NCT00254397|3580357|FG003|Overall Study|Non-Compliant|1
2013348|NCT00254397|3580354|FG000|Overall Study|Adverse Event|2
2013349|NCT00254397|3580355|FG001|Overall Study|Adverse Event|0
2013350|NCT00254397|3580356|FG002|Overall Study|Adverse Event|3
2013351|NCT00254397|3580357|FG003|Overall Study|Adverse Event|1
2013352|NCT00254501|3580392|FG000|Overall Study|Lost to Follow-up|1
2013353|NCT00254501|3580393|FG001|Overall Study|Lost to Follow-up|1
2013354|NCT00254540|3580403|FG000|Overall Study|Adverse Event|6
2013355|NCT00254540|3580404|FG001|Overall Study|Adverse Event|7
2013356|NCT00254540|3580403|FG000|Overall Study|Lack of Efficacy|13
2013357|NCT00254540|3580404|FG001|Overall Study|Lack of Efficacy|13
2013358|NCT00254540|3580403|FG000|Overall Study|Death|0
2013359|NCT00254540|3580404|FG001|Overall Study|Death|1
2013360|NCT00254540|3580403|FG000|Overall Study|Laboratory Test Abnormality|0
2013361|NCT00254540|3580404|FG001|Overall Study|Laboratory Test Abnormality|1
2013362|NCT00254566|3580413|FG000|Overall Study|Death|1
2013363|NCT00254566|3580414|FG001|Overall Study|Death|0
2013364|NCT00254566|3580413|FG000|Overall Study|Adverse Event|5
2013365|NCT00254566|3580414|FG001|Overall Study|Adverse Event|4
2013366|NCT00254566|3580413|FG000|Overall Study|Lack of Efficacy|12
2013367|NCT00254566|3580414|FG001|Overall Study|Lack of Efficacy|9
2013368|NCT00254566|3580413|FG000|Overall Study|Other|1
2013369|NCT00254566|3580414|FG001|Overall Study|Other|5
2013370|NCT00254566|3580413|FG000|Overall Study|Withdrawal by Subject|5
2013371|NCT00254566|3580414|FG001|Overall Study|Withdrawal by Subject|6
2013372|NCT00254566|3580413|FG000|Overall Study|Lost to Follow-up|7
2013373|NCT00254566|3580414|FG001|Overall Study|Lost to Follow-up|2
2013374|NCT00254982|3580426|FG000|Overall Study|Other|2
2013375|NCT00254982|3580427|FG001|Overall Study|Other|1
2013376|NCT00254982|3580426|FG000|Overall Study|Lack of Efficacy|5
2013377|NCT00254982|3580427|FG001|Overall Study|Lack of Efficacy|3
2013378|NCT00254982|3580426|FG000|Overall Study|Lost to Follow-up|5
2013379|NCT00254982|3580427|FG001|Overall Study|Lost to Follow-up|3
2013380|NCT00254982|3580426|FG000|Overall Study|Adverse Event|18
2013381|NCT00254982|3580427|FG001|Overall Study|Adverse Event|16
2013382|NCT00254982|3580426|FG000|Overall Study|Withdrawal by Subject|1
2013383|NCT00254982|3580427|FG001|Overall Study|Withdrawal by Subject|1
2013384|NCT00254982|3580426|FG000|Overall Study|Inclusion/exclusion criteria violation|0
2013385|NCT00254982|3580427|FG001|Overall Study|Inclusion/exclusion criteria violation|2
2013386|NCT00254982|3580426|FG000|Overall Study|Protocol deviation|1
2013387|NCT00254982|3580427|FG001|Overall Study|Protocol deviation|1
2013388|NCT00254982|3580426|FG000|Overall Study|Diagnosis of Tuberculosis|1
2013389|NCT00254982|3580427|FG001|Overall Study|Diagnosis of Tuberculosis|1
2013390|NCT00254982|3580426|FG000|Overall Study|Malignancy|0
2013391|NCT00254982|3580427|FG001|Overall Study|Malignancy|2
2013392|NCT00254982|3580426|FG000|Overall Study|Opportunistic infection|1
2013393|NCT00254982|3580427|FG001|Overall Study|Opportunistic infection|0
2013394|NCT00254982|3580426|FG000|Overall Study|Abnormal liver function tests|2
2013395|NCT00254982|3580427|FG001|Overall Study|Abnormal liver function tests|1
2013396|NCT00255008|3580448|FG000|Overall Study|Adverse Event|1
2013397|NCT00255008|3580449|FG001|Overall Study|Adverse Event|1
2013398|NCT00255008|3580450|FG002|Overall Study|Adverse Event|2
2013399|NCT00255008|3580451|FG003|Overall Study|Adverse Event|0
2013400|NCT00255008|3580448|FG000|Overall Study|Lost to Follow-up|1
2013401|NCT00255008|3580449|FG001|Overall Study|Lost to Follow-up|0
2013402|NCT00255008|3580450|FG002|Overall Study|Lost to Follow-up|1
2013403|NCT00255008|3580451|FG003|Overall Study|Lost to Follow-up|2
2013404|NCT00255008|3580448|FG000|Overall Study|Did not meet viral reduction criteria|4
2013405|NCT00255008|3580449|FG001|Overall Study|Did not meet viral reduction criteria|5
2013406|NCT00255008|3580450|FG002|Overall Study|Did not meet viral reduction criteria|0
2013407|NCT00255008|3580451|FG003|Overall Study|Did not meet viral reduction criteria|1
2013408|NCT00255008|3580448|FG000|Overall Study|Withdrew consent|0
2013409|NCT00255008|3580449|FG001|Overall Study|Withdrew consent|0
2013410|NCT00255008|3580450|FG002|Overall Study|Withdrew consent|2
2013411|NCT00255008|3580451|FG003|Overall Study|Withdrew consent|0
2013412|NCT00255008|3580448|FG000|Overall Study|Sponsor request|18
2013413|NCT00255008|3580449|FG001|Overall Study|Sponsor request|3
2013414|NCT00255008|3580450|FG002|Overall Study|Sponsor request|8
2013415|NCT00255008|3580451|FG003|Overall Study|Sponsor request|17
2013416|NCT00255008|3580448|FG000|Overall Study|Adverse lab experience|1
2013417|NCT00255008|3580449|FG001|Overall Study|Adverse lab experience|0
2013418|NCT00255008|3580450|FG002|Overall Study|Adverse lab experience|0
2013419|NCT00255008|3580451|FG003|Overall Study|Adverse lab experience|0
2013420|NCT00255008|3580448|FG000|Overall Study|Other|7
2013421|NCT00255008|3580449|FG001|Overall Study|Other|0
2013422|NCT00255008|3580450|FG002|Overall Study|Other|3
2013423|NCT00255008|3580451|FG003|Overall Study|Other|2
2013424|NCT00255034|3580463|FG000|Overall Study|Withdrawal by Subject|15
2013425|NCT00255034|3580464|FG001|Overall Study|Withdrawal by Subject|38
2013426|NCT00255047|3580474|FG000|Overall Study|Serious Adverse Events|2
2013427|NCT00255047|3580475|FG001|Overall Study|Serious Adverse Events|1
2013428|NCT00255047|3580476|FG002|Overall Study|Serious Adverse Events|2
2013429|NCT00255047|3580477|FG003|Overall Study|Serious Adverse Events|1
2013430|NCT00255047|3580474|FG000|Overall Study|Adverse Event|0
2013431|NCT00255047|3580475|FG001|Overall Study|Adverse Event|3
2013432|NCT00255047|3580476|FG002|Overall Study|Adverse Event|2
2013433|NCT00255047|3580477|FG003|Overall Study|Adverse Event|1
2013434|NCT00255047|3580474|FG000|Overall Study|Protocol Violation|13
2013435|NCT00255047|3580475|FG001|Overall Study|Protocol Violation|13
2013436|NCT00255047|3580476|FG002|Overall Study|Protocol Violation|16
2013437|NCT00255047|3580477|FG003|Overall Study|Protocol Violation|20
2013438|NCT00255047|3580474|FG000|Overall Study|Lost to Follow-up|9
2013439|NCT00255047|3580475|FG001|Overall Study|Lost to Follow-up|8
2013440|NCT00255047|3580476|FG002|Overall Study|Lost to Follow-up|5
2013441|NCT00255047|3580477|FG003|Overall Study|Lost to Follow-up|6
2013442|NCT00255047|3580474|FG000|Overall Study|Withdrawal by Subject|24
2013443|NCT00255047|3580475|FG001|Overall Study|Withdrawal by Subject|23
2013444|NCT00255047|3580476|FG002|Overall Study|Withdrawal by Subject|25
2013445|NCT00255047|3580477|FG003|Overall Study|Withdrawal by Subject|18
2013446|NCT00255086|3580489|FG000|Overall Study|Adverse Event|1
2013447|NCT00255086|3580490|FG001|Overall Study|Adverse Event|1
2013448|NCT00255086|3580489|FG000|Overall Study|Protocol Violation|1
2013449|NCT00255086|3580490|FG001|Overall Study|Protocol Violation|1
2013450|NCT00255151|3580511|FG000|Overall Study|Adverse Event|10
2013451|NCT00255151|3580512|FG001|Overall Study|Adverse Event|6
2013452|NCT00255151|3580513|FG002|Overall Study|Adverse Event|9
2013453|NCT00255151|3580511|FG000|Overall Study|Lost to Follow-up|4
2013454|NCT00255151|3580512|FG001|Overall Study|Lost to Follow-up|3
2013455|NCT00255151|3580513|FG002|Overall Study|Lost to Follow-up|4
2013456|NCT00255151|3580511|FG000|Overall Study|Withdrawal by Subject|18
2013457|NCT00255151|3580512|FG001|Overall Study|Withdrawal by Subject|17
2013458|NCT00255151|3580513|FG002|Overall Study|Withdrawal by Subject|8
2013459|NCT00255151|3580511|FG000|Overall Study|Noncompliance|0
2013460|NCT00255151|3580512|FG001|Overall Study|Noncompliance|1
2013461|NCT00255151|3580513|FG002|Overall Study|Noncompliance|2
2013462|NCT00255151|3580511|FG000|Overall Study|Subject Request/Subject Unavailable|1
2013463|NCT00255151|3580512|FG001|Overall Study|Subject Request/Subject Unavailable|1
2013464|NCT00255151|3580513|FG002|Overall Study|Subject Request/Subject Unavailable|2
2013465|NCT00255151|3580511|FG000|Overall Study|Relapse of Erosive Esophagitis|78
2013466|NCT00255151|3580512|FG001|Overall Study|Relapse of Erosive Esophagitis|16
2013467|NCT00255151|3580513|FG002|Overall Study|Relapse of Erosive Esophagitis|12
2013468|NCT00255151|3580511|FG000|Overall Study|Possible Barrett's Esophagus|1
2013469|NCT00255151|3580512|FG001|Overall Study|Possible Barrett's Esophagus|3
2013470|NCT00255151|3580513|FG002|Overall Study|Possible Barrett's Esophagus|8
2013471|NCT00255151|3580511|FG000|Overall Study|Esophageal Stricture|0
2013472|NCT00255151|3580512|FG001|Overall Study|Esophageal Stricture|0
2013473|NCT00255151|3580513|FG002|Overall Study|Esophageal Stricture|1
2013474|NCT00255151|3580511|FG000|Overall Study|Therapeutic Failure|11
2013475|NCT00255151|3580512|FG001|Overall Study|Therapeutic Failure|2
2214499|NCT01687712|3856790|FG001|Cycle 2|Early Pregnancy Loss|16
2214500|NCT01687712|3856789|FG000|Cycle 2|Ectopic Pregnancy|0
2214501|NCT01687712|3856790|FG001|Cycle 2|Ectopic Pregnancy|1
2214502|NCT01687712|3856789|FG000|Cycle 2|Still Birth|1
2214503|NCT01687712|3856790|FG001|Cycle 2|Still Birth|0
2214504|NCT01687712|3856789|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0
2214505|NCT01687712|3856790|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1
2013476|NCT00255151|3580513|FG002|Overall Study|Therapeutic Failure|3
2013477|NCT00255164|3580524|FG000|Overall Study|Adverse Event|10
2013478|NCT00255164|3580525|FG001|Overall Study|Adverse Event|6
2013479|NCT00255164|3580526|FG002|Overall Study|Adverse Event|9
2013480|NCT00255164|3580524|FG000|Overall Study|Lost to Follow-up|4
2013481|NCT00255164|3580525|FG001|Overall Study|Lost to Follow-up|3
2214506|NCT01687712|3856789|FG000|Cycle 3|Not Biochemically Pregnant|21
2214507|NCT01687712|3856790|FG001|Cycle 3|Not Biochemically Pregnant|22
2214508|NCT01687712|3856789|FG000|Cycle 3|Early Pregnancy Loss|1
2214509|NCT01687712|3856790|FG001|Cycle 3|Early Pregnancy Loss|2
2214510|NCT01687712|3856789|FG000|Cycle 3|Ectopic Pregnancy|1
2214511|NCT01687712|3856790|FG001|Cycle 3|Ectopic Pregnancy|0
2013482|NCT00255164|3580526|FG002|Overall Study|Lost to Follow-up|4
2013483|NCT00255164|3580524|FG000|Overall Study|Withdrawal by Subject|18
2013484|NCT00255164|3580525|FG001|Overall Study|Withdrawal by Subject|17
2013485|NCT00255164|3580526|FG002|Overall Study|Withdrawal by Subject|8
2013486|NCT00255164|3580524|FG000|Overall Study|Noncompliance|0
2013487|NCT00255164|3580525|FG001|Overall Study|Noncompliance|1
2013488|NCT00255164|3580526|FG002|Overall Study|Noncompliance|2
2013489|NCT00255164|3580524|FG000|Overall Study|Subject Request/Subject Unavailable|1
2013490|NCT00255164|3580525|FG001|Overall Study|Subject Request/Subject Unavailable|1
2013491|NCT00255164|3580526|FG002|Overall Study|Subject Request/Subject Unavailable|2
2013492|NCT00255164|3580524|FG000|Overall Study|Relapse of Erosive Esophagitis|78
2013493|NCT00255164|3580525|FG001|Overall Study|Relapse of Erosive Esophagitis|16
2013494|NCT00255164|3580526|FG002|Overall Study|Relapse of Erosive Esophagitis|12
2013495|NCT00255164|3580524|FG000|Overall Study|Possible Barrett's Esophagus|1
2013496|NCT00255164|3580525|FG001|Overall Study|Possible Barrett's Esophagus|3
2013497|NCT00255164|3580526|FG002|Overall Study|Possible Barrett's Esophagus|8
2013498|NCT00255164|3580524|FG000|Overall Study|Esophageal Stricture|0
2013499|NCT00255164|3580525|FG001|Overall Study|Esophageal Stricture|0
2013500|NCT00255164|3580526|FG002|Overall Study|Esophageal Stricture|1
2013501|NCT00255164|3580524|FG000|Overall Study|Therapeutic Failure|11
2013502|NCT00255164|3580525|FG001|Overall Study|Therapeutic Failure|2
2013503|NCT00255164|3580526|FG002|Overall Study|Therapeutic Failure|3
2013504|NCT00255190|3580553|FG000|Overall Study|Adverse Event|17
2013505|NCT00255190|3580554|FG001|Overall Study|Adverse Event|36
2013506|NCT00255190|3580553|FG000|Overall Study|Protocol Violation|2
2013507|NCT00255190|3580554|FG001|Overall Study|Protocol Violation|2
2013508|NCT00255190|3580553|FG000|Overall Study|Lost to Follow-up|10
2013509|NCT00255190|3580554|FG001|Overall Study|Lost to Follow-up|27
2013510|NCT00255190|3580553|FG000|Overall Study|Withdrew Consent|17
2013511|NCT00255190|3580554|FG001|Overall Study|Withdrew Consent|48
2013512|NCT00255190|3580553|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
2013513|NCT00255190|3580554|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
2013514|NCT00255190|3580553|FG000|Overall Study|Erosive esophagitis not healed|0
2013515|NCT00255190|3580554|FG001|Overall Study|Erosive esophagitis not healed|20
2013516|NCT00255190|3580553|FG000|Overall Study|Various|4
2013517|NCT00255190|3580554|FG001|Overall Study|Various|23
2013518|NCT00255346|3580565|FG000|Overall Study|Adverse Event|1
2013519|NCT00255346|3580566|FG001|Overall Study|Adverse Event|0
2013520|NCT00255346|3580567|FG002|Overall Study|Adverse Event|0
2013521|NCT00255346|3580568|FG003|Overall Study|Adverse Event|0
2013522|NCT00255346|3580569|FG004|Overall Study|Adverse Event|0
2013523|NCT00255723|3580583|FG000|Overall Study|Adverse Event|1
2013524|NCT00255723|3580584|FG001|Overall Study|Adverse Event|1
2013525|NCT00255723|3580583|FG000|Overall Study|Death|0
2013526|NCT00255723|3580584|FG001|Overall Study|Death|1
2013527|NCT00255723|3580583|FG000|Overall Study|Response Data Not Available|1
2013528|NCT00255723|3580584|FG001|Overall Study|Response Data Not Available|0
2013529|NCT00255840|3580596|FG000|Overall Study|Lost to Follow-up|10
2013530|NCT00255840|3580597|FG001|Overall Study|Lost to Follow-up|14
2013531|NCT00255840|3580596|FG000|Overall Study|Discontinued intervention|53
2013532|NCT00255840|3580597|FG001|Overall Study|Discontinued intervention|56
2013533|NCT00255944|3580605|FG000|Overall Study|Lost to Follow-up|797
2013534|NCT00255944|3580606|FG001|Overall Study|Lost to Follow-up|834
2013535|NCT00256126|3580623|FG000|Overall Study|Adverse Event|1
2013536|NCT00256126|3580624|FG001|Overall Study|Adverse Event|0
2013537|NCT00256126|3580623|FG000|Overall Study|Other|1
2013538|NCT00256126|3580624|FG001|Overall Study|Other|2
2013539|NCT00256204|3580634|FG000|Overall Study|Adverse Event|10
2013540|NCT00256204|3580635|FG001|Overall Study|Adverse Event|14
2013541|NCT00256204|3580636|FG002|Overall Study|Adverse Event|16
2013542|NCT00256204|3580637|FG003|Overall Study|Adverse Event|14
2013543|NCT00256204|3580634|FG000|Overall Study|Death|0
2013544|NCT00256204|3580635|FG001|Overall Study|Death|1
2013545|NCT00256204|3580636|FG002|Overall Study|Death|0
2013546|NCT00256204|3580637|FG003|Overall Study|Death|0
2013547|NCT00256204|3580634|FG000|Overall Study|Lost to Follow-up|1
2013548|NCT00256204|3580635|FG001|Overall Study|Lost to Follow-up|1
2013549|NCT00256204|3580636|FG002|Overall Study|Lost to Follow-up|1
2013550|NCT00256204|3580637|FG003|Overall Study|Lost to Follow-up|2
2013551|NCT00256204|3580634|FG000|Overall Study|Protocol Violation|1
2013552|NCT00256204|3580635|FG001|Overall Study|Protocol Violation|0
2013553|NCT00256204|3580636|FG002|Overall Study|Protocol Violation|2
2013554|NCT00256204|3580637|FG003|Overall Study|Protocol Violation|1
2013555|NCT00256204|3580634|FG000|Overall Study|Physician Decision|0
2013556|NCT00256204|3580635|FG001|Overall Study|Physician Decision|0
2013557|NCT00256204|3580636|FG002|Overall Study|Physician Decision|1
2013558|NCT00256204|3580637|FG003|Overall Study|Physician Decision|2
2013559|NCT00256204|3580634|FG000|Overall Study|Withdrawal by Subject|17
2013560|NCT00256204|3580635|FG001|Overall Study|Withdrawal by Subject|6
2013561|NCT00256204|3580636|FG002|Overall Study|Withdrawal by Subject|7
2013562|NCT00256204|3580637|FG003|Overall Study|Withdrawal by Subject|5
2013563|NCT00256204|3580634|FG000|Overall Study|Need for additional prohibited treatment|38
2013564|NCT00256204|3580635|FG001|Overall Study|Need for additional prohibited treatment|28
2013565|NCT00256204|3580636|FG002|Overall Study|Need for additional prohibited treatment|27
2013566|NCT00256204|3580637|FG003|Overall Study|Need for additional prohibited treatment|25
2013567|NCT00256243|3580654|FG000|Overall Study|Lost to Follow-up|2
2013568|NCT00256243|3580654|FG000|Overall Study|Death|7
2013569|NCT00256243|3580654|FG000|Overall Study|Not treated|1
2013570|NCT00256282|3580659|FG000|Overall Study|Disease progression, relapse during acti|12
2013571|NCT00256282|3580659|FG000|Overall Study|Adverse Event|3
2013572|NCT00256282|3580659|FG000|Overall Study|Physician Decision|1
2013573|NCT00256308|3580663|FG000|Overall Study|Death|2
2013574|NCT00256698|3580682|FG000|Overall Study|Withdrawal by Subject|7
2013575|NCT00256698|3580683|FG001|Overall Study|Withdrawal by Subject|7
2013576|NCT00256698|3580682|FG000|Overall Study|Adverse Event|13
2013577|NCT00256698|3580683|FG001|Overall Study|Adverse Event|6
2013578|NCT00256698|3580682|FG000|Overall Study|Protocol Violation|6
2013579|NCT00256698|3580683|FG001|Overall Study|Protocol Violation|5
2013580|NCT00256698|3580682|FG000|Overall Study|Lost to Follow-up|1
2013581|NCT00256698|3580683|FG001|Overall Study|Lost to Follow-up|3
2013582|NCT00256698|3580682|FG000|Overall Study|disease progression|97
2013583|NCT00256698|3580683|FG001|Overall Study|disease progression|105
2214512|NCT01687712|3856789|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1
2013584|NCT00256698|3580682|FG000|Overall Study|still ongoing at data cut-off|41
2013585|NCT00256698|3580683|FG001|Overall Study|still ongoing at data cut-off|46
2013586|NCT00256698|3580682|FG000|Overall Study|withdrawn due to osteoporosis|1
2013587|NCT00256698|3580683|FG001|Overall Study|withdrawn due to osteoporosis|0
2013588|NCT00256698|3580682|FG000|Overall Study|Prematurely Discontinued|1
2013589|NCT00256698|3580683|FG001|Overall Study|Prematurely Discontinued|0
2013590|NCT00256724|3580691|FG000|Overall Study|Physician Decision|2
2013591|NCT00256724|3580692|FG001|Overall Study|Physician Decision|5
2013592|NCT00256724|3580691|FG000|Overall Study|Protocol Violation|3
2013593|NCT00256724|3580692|FG001|Overall Study|Protocol Violation|3
2013594|NCT00256750|3580701|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3
2013595|NCT00256750|3580702|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0
2013596|NCT00256750|3580703|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0
2013597|NCT00256750|3580701|FG000|Transplanted Pre-Treatment|Other|2
2013598|NCT00256750|3580702|FG001|Transplanted Pre-Treatment|Other|0
2013599|NCT00256750|3580703|FG002|Transplanted Pre-Treatment|Other|0
2013600|NCT00256750|3580701|FG000|Transplanted Pre-Treatment|Death|1
2013601|NCT00256750|3580702|FG001|Transplanted Pre-Treatment|Death|0
2013602|NCT00256750|3580703|FG002|Transplanted Pre-Treatment|Death|0
2013603|NCT00256750|3580701|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20
2013604|NCT00256750|3580702|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12
2013605|NCT00256750|3580703|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8
2013606|NCT00256750|3580701|FG000|Post-Transplant Treated (12 Months)|Death|3
2013607|NCT00256750|3580702|FG001|Post-Transplant Treated (12 Months)|Death|2
2013608|NCT00256750|3580703|FG002|Post-Transplant Treated (12 Months)|Death|4
2013609|NCT00256750|3580701|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
2013610|NCT00256750|3580702|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
2013611|NCT00256750|3580703|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
2013612|NCT00256750|3580701|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
2013613|NCT00256750|3580702|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
2013614|NCT00256750|3580703|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
2013615|NCT00256750|3580701|FG000|Post-Transplant Treated (12 Months)|Other|5
2013616|NCT00256750|3580702|FG001|Post-Transplant Treated (12 Months)|Other|4
2013617|NCT00256750|3580703|FG002|Post-Transplant Treated (12 Months)|Other|2
2013618|NCT00256750|3580701|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
2013619|NCT00256750|3580702|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
2013620|NCT00256750|3580703|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
2013621|NCT00256750|3580701|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2
2013622|NCT00256750|3580702|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0
2013623|NCT00256750|3580703|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0
2013624|NCT00256750|3580701|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7
2013625|NCT00256750|3580702|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3
2013626|NCT00256750|3580703|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6
2013627|NCT00256750|3580701|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
2013628|NCT00256750|3580702|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
2013629|NCT00256750|3580703|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
2013630|NCT00256750|3580701|FG000|Post-Transplant Treated (24 Months)|Death|3
2013631|NCT00256750|3580702|FG001|Post-Transplant Treated (24 Months)|Death|0
2013632|NCT00256750|3580703|FG002|Post-Transplant Treated (24 Months)|Death|0
2013633|NCT00256750|3580701|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
2013634|NCT00256750|3580702|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
2013635|NCT00256750|3580703|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
2013636|NCT00256750|3580701|FG000|Post-Transplant Treated (24 Months)|Other|2
2013637|NCT00256750|3580702|FG001|Post-Transplant Treated (24 Months)|Other|0
2013638|NCT00256750|3580703|FG002|Post-Transplant Treated (24 Months)|Other|1
2013639|NCT00256750|3580701|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5
2013640|NCT00256750|3580702|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1
2013641|NCT00256750|3580703|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2
2013642|NCT00256750|3580701|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
2013643|NCT00256750|3580702|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
2013644|NCT00256750|3580703|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
2013645|NCT00256750|3580701|FG000|Post-Transplant Treated (36 Months)|Death|0
2013646|NCT00256750|3580702|FG001|Post-Transplant Treated (36 Months)|Death|2
2013647|NCT00256750|3580703|FG002|Post-Transplant Treated (36 Months)|Death|1
2013648|NCT00256750|3580701|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
2013649|NCT00256750|3580702|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
2013650|NCT00256750|3580703|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
2013651|NCT00256750|3580701|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
2013652|NCT00256750|3580702|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
2013653|NCT00256750|3580703|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
2013654|NCT00256750|3580701|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0
2013655|NCT00256750|3580702|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1
2013656|NCT00256750|3580703|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0
2013657|NCT00256750|3580701|FG000|Post-Transplant Treated (36 Months)|Other|0
2013658|NCT00256750|3580702|FG001|Post-Transplant Treated (36 Months)|Other|1
2013659|NCT00256750|3580703|FG002|Post-Transplant Treated (36 Months)|Other|1
2013660|NCT00256750|3580701|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13
2013661|NCT00256750|3580702|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11
2013662|NCT00256750|3580703|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14
2013663|NCT00256750|3580701|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
2013664|NCT00256750|3580702|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
2013665|NCT00256750|3580703|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
2013666|NCT00256750|3580701|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
2013667|NCT00256750|3580702|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
2013668|NCT00256750|3580703|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
2013669|NCT00256750|3580701|FG000|Long Term Extension (LTE; 84 Months)|Death|9
2013670|NCT00256750|3580702|FG001|Long Term Extension (LTE; 84 Months)|Death|4
2013671|NCT00256750|3580703|FG002|Long Term Extension (LTE; 84 Months)|Death|4
2013672|NCT00256750|3580701|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
2013673|NCT00256750|3580702|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
2013674|NCT00256750|3580703|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
2013675|NCT00256750|3580701|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
2013676|NCT00256750|3580702|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
2013677|NCT00256750|3580703|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
2013678|NCT00256750|3580701|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0
2013679|NCT00256750|3580702|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1
2013680|NCT00256750|3580703|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2
2013681|NCT00256750|3580701|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
2013682|NCT00256750|3580702|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
2013683|NCT00256750|3580703|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
2013684|NCT00256750|3580701|FG000|Long Term Extension (LTE; 84 Months)|Other|5
2013685|NCT00256750|3580702|FG001|Long Term Extension (LTE; 84 Months)|Other|4
2013686|NCT00256750|3580703|FG002|Long Term Extension (LTE; 84 Months)|Other|5
2013687|NCT00256854|3580729|FG000|Overall Study|Withdrawal by Subject|2
2013688|NCT00256854|3580730|FG001|Overall Study|Withdrawal by Subject|3
2013689|NCT00256854|3580731|FG002|Overall Study|Withdrawal by Subject|0
2013690|NCT00256854|3580732|FG003|Overall Study|Withdrawal by Subject|0
2013691|NCT00256854|3580733|FG004|Overall Study|Withdrawal by Subject|0
2013692|NCT00256854|3580734|FG005|Overall Study|Withdrawal by Subject|0
2013693|NCT00256854|3580729|FG000|Overall Study|Lack of Efficacy|1
2013694|NCT00256854|3580730|FG001|Overall Study|Lack of Efficacy|0
2013695|NCT00256854|3580731|FG002|Overall Study|Lack of Efficacy|0
2013696|NCT00256854|3580732|FG003|Overall Study|Lack of Efficacy|0
2013697|NCT00256854|3580733|FG004|Overall Study|Lack of Efficacy|0
2013698|NCT00256854|3580734|FG005|Overall Study|Lack of Efficacy|0
2013699|NCT00256854|3580729|FG000|Overall Study|Protocol Violation|0
2013700|NCT00256854|3580730|FG001|Overall Study|Protocol Violation|1
2013701|NCT00256854|3580731|FG002|Overall Study|Protocol Violation|1
2013702|NCT00256854|3580732|FG003|Overall Study|Protocol Violation|1
2013703|NCT00256854|3580733|FG004|Overall Study|Protocol Violation|0
2013704|NCT00256854|3580734|FG005|Overall Study|Protocol Violation|0
2013705|NCT00256854|3580729|FG000|Overall Study|Adverse Event|0
2013706|NCT00256854|3580730|FG001|Overall Study|Adverse Event|0
2013707|NCT00256854|3580731|FG002|Overall Study|Adverse Event|2
2013708|NCT00256854|3580732|FG003|Overall Study|Adverse Event|2
2013709|NCT00256854|3580733|FG004|Overall Study|Adverse Event|0
2013710|NCT00256854|3580734|FG005|Overall Study|Adverse Event|1
2013711|NCT00256854|3580729|FG000|Overall Study|Not compliant with the study drug|0
2013712|NCT00256854|3580730|FG001|Overall Study|Not compliant with the study drug|0
2013713|NCT00256854|3580731|FG002|Overall Study|Not compliant with the study drug|0
2013714|NCT00256854|3580732|FG003|Overall Study|Not compliant with the study drug|0
2013715|NCT00256854|3580733|FG004|Overall Study|Not compliant with the study drug|1
2013716|NCT00256854|3580734|FG005|Overall Study|Not compliant with the study drug|0
2025620|NCT00346775|3594548|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
2025621|NCT00347009|3594562|FG000|Overall Study|Death|1
2025622|NCT00347009|3594562|FG000|Overall Study|Adverse Event|6
2025623|NCT00347009|3594562|FG000|Overall Study|Withdrawal by Subject|3
2025624|NCT00347009|3594562|FG000|Overall Study|Physician Decision|5
2025625|NCT00347009|3594562|FG000|Overall Study|Lost to Follow-up|4
2025626|NCT00347009|3594562|FG000|Overall Study|Protocol Violation|2
2025627|NCT00347009|3594562|FG000|Overall Study|Adverse Laboratory Experience|1
2025628|NCT00347009|3594562|FG000|Overall Study|Insufficient Viral Suppression|3
2025629|NCT00347009|3594562|FG000|Overall Study|Increased ALT/HBV DNA|1
2025630|NCT00347009|3594562|FG000|Overall Study|Serious Adverse Event|1
2025631|NCT00347269|3594577|FG000|Overall Study|Lost to Follow-up|74
2025632|NCT00347269|3594578|FG001|Overall Study|Lost to Follow-up|65
2025633|NCT00347269|3594577|FG000|Overall Study|Withdrawal by Subject|18
2025634|NCT00347269|3594578|FG001|Overall Study|Withdrawal by Subject|38
2025635|NCT00347269|3594577|FG000|Overall Study|Death|2
2025636|NCT00347269|3594578|FG001|Overall Study|Death|3
2025637|NCT00347360|3594603|FG000|Overall Study|Adverse Event|1
2025638|NCT00347360|3594604|FG001|Overall Study|Adverse Event|2
2025639|NCT00347360|3594605|FG002|Overall Study|Adverse Event|0
2025640|NCT00347360|3594606|FG003|Overall Study|Adverse Event|4
2025641|NCT00347360|3594607|FG004|Overall Study|Adverse Event|1
2025642|NCT00347360|3594608|FG005|Overall Study|Adverse Event|2
2025643|NCT00347360|3594609|FG006|Overall Study|Adverse Event|2
2025644|NCT00347360|3594610|FG007|Overall Study|Adverse Event|0
2025645|NCT00347360|3594611|FG008|Overall Study|Adverse Event|2
2025646|NCT00347360|3594612|FG009|Overall Study|Adverse Event|3
2025647|NCT00347360|3594613|FG010|Overall Study|Adverse Event|3
2025648|NCT00347360|3594614|FG011|Overall Study|Adverse Event|1
2025649|NCT00347360|3594615|FG012|Overall Study|Adverse Event|3
2025650|NCT00347360|3594616|FG013|Overall Study|Adverse Event|2
2025651|NCT00347360|3594617|FG014|Overall Study|Adverse Event|2
2025652|NCT00347360|3594603|FG000|Overall Study|Lost to Follow-up|0
2025653|NCT00347360|3594604|FG001|Overall Study|Lost to Follow-up|0
2025654|NCT00347360|3594605|FG002|Overall Study|Lost to Follow-up|0
2025655|NCT00347360|3594606|FG003|Overall Study|Lost to Follow-up|2
2025656|NCT00347360|3594607|FG004|Overall Study|Lost to Follow-up|1
2025657|NCT00347360|3594608|FG005|Overall Study|Lost to Follow-up|1
2025658|NCT00347360|3594609|FG006|Overall Study|Lost to Follow-up|0
2025659|NCT00347360|3594610|FG007|Overall Study|Lost to Follow-up|1
2025660|NCT00347360|3594611|FG008|Overall Study|Lost to Follow-up|1
2025661|NCT00347360|3594612|FG009|Overall Study|Lost to Follow-up|2
2025662|NCT00347360|3594613|FG010|Overall Study|Lost to Follow-up|0
2025663|NCT00347360|3594614|FG011|Overall Study|Lost to Follow-up|0
2025664|NCT00347360|3594615|FG012|Overall Study|Lost to Follow-up|1
2025665|NCT00347360|3594616|FG013|Overall Study|Lost to Follow-up|0
2025666|NCT00347360|3594617|FG014|Overall Study|Lost to Follow-up|0
2025667|NCT00347360|3594603|FG000|Overall Study|Protocol Violation|2
2025668|NCT00347360|3594604|FG001|Overall Study|Protocol Violation|3
2025669|NCT00347360|3594605|FG002|Overall Study|Protocol Violation|1
2025670|NCT00347360|3594606|FG003|Overall Study|Protocol Violation|2
2025671|NCT00347360|3594607|FG004|Overall Study|Protocol Violation|1
2025672|NCT00347360|3594608|FG005|Overall Study|Protocol Violation|2
2025673|NCT00347360|3594609|FG006|Overall Study|Protocol Violation|0
2025674|NCT00347360|3594610|FG007|Overall Study|Protocol Violation|0
2025675|NCT00347360|3594611|FG008|Overall Study|Protocol Violation|1
2025676|NCT00347360|3594612|FG009|Overall Study|Protocol Violation|2
2025677|NCT00347360|3594613|FG010|Overall Study|Protocol Violation|0
2025678|NCT00347360|3594614|FG011|Overall Study|Protocol Violation|0
2025679|NCT00347360|3594615|FG012|Overall Study|Protocol Violation|0
2025680|NCT00347360|3594616|FG013|Overall Study|Protocol Violation|1
2025681|NCT00347360|3594617|FG014|Overall Study|Protocol Violation|0
2025682|NCT00347360|3594603|FG000|Overall Study|Withdrawal by Subject|0
2025683|NCT00347360|3594604|FG001|Overall Study|Withdrawal by Subject|1
2025684|NCT00347360|3594605|FG002|Overall Study|Withdrawal by Subject|2
2025685|NCT00347360|3594606|FG003|Overall Study|Withdrawal by Subject|4
2025686|NCT00347360|3594607|FG004|Overall Study|Withdrawal by Subject|1
2025687|NCT00347360|3594608|FG005|Overall Study|Withdrawal by Subject|2
2025688|NCT00347360|3594609|FG006|Overall Study|Withdrawal by Subject|1
2025689|NCT00347360|3594610|FG007|Overall Study|Withdrawal by Subject|1
2025690|NCT00347360|3594611|FG008|Overall Study|Withdrawal by Subject|1
2025691|NCT00347360|3594612|FG009|Overall Study|Withdrawal by Subject|1
2025692|NCT00347360|3594613|FG010|Overall Study|Withdrawal by Subject|0
2025693|NCT00347360|3594614|FG011|Overall Study|Withdrawal by Subject|3
2025694|NCT00347360|3594615|FG012|Overall Study|Withdrawal by Subject|4
2025695|NCT00347360|3594616|FG013|Overall Study|Withdrawal by Subject|2
2025696|NCT00347360|3594617|FG014|Overall Study|Withdrawal by Subject|1
2025697|NCT00347360|3594603|FG000|Overall Study|Lack of Efficacy|1
2025698|NCT00347360|3594604|FG001|Overall Study|Lack of Efficacy|1
2025699|NCT00347360|3594605|FG002|Overall Study|Lack of Efficacy|3
2025700|NCT00347360|3594606|FG003|Overall Study|Lack of Efficacy|1
2025701|NCT00347360|3594607|FG004|Overall Study|Lack of Efficacy|0
2025702|NCT00347360|3594608|FG005|Overall Study|Lack of Efficacy|1
2025703|NCT00347360|3594609|FG006|Overall Study|Lack of Efficacy|0
2013717|NCT00256867|3580757|FG000|Overall Study|Adverse Event|0
2013718|NCT00256867|3580758|FG001|Overall Study|Adverse Event|1
2013719|NCT00256867|3580759|FG002|Overall Study|Adverse Event|1
2013720|NCT00256867|3580760|FG003|Overall Study|Adverse Event|1
2013721|NCT00256867|3580761|FG004|Overall Study|Adverse Event|2
2013722|NCT00256867|3580762|FG005|Overall Study|Adverse Event|2
2013723|NCT00256867|3580763|FG006|Overall Study|Adverse Event|1
2013724|NCT00256867|3580764|FG007|Overall Study|Adverse Event|4
2013725|NCT00256867|3580757|FG000|Overall Study|Lost to Follow-up|2
2013726|NCT00256867|3580758|FG001|Overall Study|Lost to Follow-up|2
2013727|NCT00256867|3580759|FG002|Overall Study|Lost to Follow-up|2
2013728|NCT00256867|3580760|FG003|Overall Study|Lost to Follow-up|3
2013729|NCT00256867|3580761|FG004|Overall Study|Lost to Follow-up|2
2013730|NCT00256867|3580762|FG005|Overall Study|Lost to Follow-up|0
2013731|NCT00256867|3580763|FG006|Overall Study|Lost to Follow-up|1
2013732|NCT00256867|3580764|FG007|Overall Study|Lost to Follow-up|2
2013733|NCT00256867|3580757|FG000|Overall Study|Protocol Violation|0
2013734|NCT00256867|3580758|FG001|Overall Study|Protocol Violation|0
2013735|NCT00256867|3580759|FG002|Overall Study|Protocol Violation|0
2013736|NCT00256867|3580760|FG003|Overall Study|Protocol Violation|1
2013737|NCT00256867|3580761|FG004|Overall Study|Protocol Violation|0
2013738|NCT00256867|3580762|FG005|Overall Study|Protocol Violation|1
2013739|NCT00256867|3580763|FG006|Overall Study|Protocol Violation|0
2013740|NCT00256867|3580764|FG007|Overall Study|Protocol Violation|1
2013741|NCT00256867|3580757|FG000|Overall Study|Withdrawal by Subject|0
2013742|NCT00256867|3580758|FG001|Overall Study|Withdrawal by Subject|0
2013743|NCT00256867|3580759|FG002|Overall Study|Withdrawal by Subject|1
2013744|NCT00256867|3580760|FG003|Overall Study|Withdrawal by Subject|1
2013745|NCT00256867|3580761|FG004|Overall Study|Withdrawal by Subject|2
2013746|NCT00256867|3580762|FG005|Overall Study|Withdrawal by Subject|2
2013747|NCT00256867|3580763|FG006|Overall Study|Withdrawal by Subject|3
2013748|NCT00256867|3580764|FG007|Overall Study|Withdrawal by Subject|2
2013749|NCT00256867|3580757|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0
2013750|NCT00256867|3580758|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1
2013751|NCT00256867|3580759|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0
2013752|NCT00256867|3580760|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0
2013753|NCT00256867|3580761|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0
2013754|NCT00256867|3580762|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0
2013755|NCT00256867|3580763|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0
2013756|NCT00256867|3580764|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0
2013757|NCT00256867|3580757|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0
2013758|NCT00256867|3580758|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0
2013759|NCT00256867|3580759|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0
2013760|NCT00256867|3580760|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0
2013761|NCT00256867|3580761|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0
2013762|NCT00256867|3580762|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0
2013763|NCT00256867|3580763|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0
2013764|NCT00256867|3580764|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1
2013765|NCT00256867|3580757|FG000|Overall Study|Investigator's Decision|0
2013766|NCT00256867|3580758|FG001|Overall Study|Investigator's Decision|0
2013767|NCT00256867|3580759|FG002|Overall Study|Investigator's Decision|0
2013768|NCT00256867|3580760|FG003|Overall Study|Investigator's Decision|0
2013769|NCT00256867|3580761|FG004|Overall Study|Investigator's Decision|1
2013770|NCT00256867|3580762|FG005|Overall Study|Investigator's Decision|0
2013771|NCT00256867|3580763|FG006|Overall Study|Investigator's Decision|0
2013772|NCT00256867|3580764|FG007|Overall Study|Investigator's Decision|0
2013773|NCT00256867|3580757|FG000|Overall Study|Non-compliance with study medication|0
2013774|NCT00256867|3580758|FG001|Overall Study|Non-compliance with study medication|0
2013775|NCT00256867|3580759|FG002|Overall Study|Non-compliance with study medication|0
2013776|NCT00256867|3580760|FG003|Overall Study|Non-compliance with study medication|0
2013777|NCT00256867|3580761|FG004|Overall Study|Non-compliance with study medication|0
2013778|NCT00256867|3580762|FG005|Overall Study|Non-compliance with study medication|0
2013779|NCT00256867|3580763|FG006|Overall Study|Non-compliance with study medication|0
2013780|NCT00256867|3580764|FG007|Overall Study|Non-compliance with study medication|1
2013781|NCT00256867|3580757|FG000|Overall Study|Participant travelled Overseas|0
2013782|NCT00256867|3580758|FG001|Overall Study|Participant travelled Overseas|1
2013783|NCT00256867|3580759|FG002|Overall Study|Participant travelled Overseas|0
2013784|NCT00256867|3580760|FG003|Overall Study|Participant travelled Overseas|0
2013785|NCT00256867|3580761|FG004|Overall Study|Participant travelled Overseas|0
2013786|NCT00256867|3580762|FG005|Overall Study|Participant travelled Overseas|0
2013787|NCT00256867|3580763|FG006|Overall Study|Participant travelled Overseas|0
2013788|NCT00256867|3580764|FG007|Overall Study|Participant travelled Overseas|0
2013789|NCT00256867|3580757|FG000|Overall Study|Participant out of assessment window|0
2013790|NCT00256867|3580758|FG001|Overall Study|Participant out of assessment window|0
2013791|NCT00256867|3580759|FG002|Overall Study|Participant out of assessment window|1
2013792|NCT00256867|3580760|FG003|Overall Study|Participant out of assessment window|0
2013793|NCT00256867|3580761|FG004|Overall Study|Participant out of assessment window|0
2013794|NCT00256867|3580762|FG005|Overall Study|Participant out of assessment window|0
2013795|NCT00256867|3580763|FG006|Overall Study|Participant out of assessment window|0
2013796|NCT00256867|3580764|FG007|Overall Study|Participant out of assessment window|0
2013797|NCT00256867|3580757|FG000|Overall Study|Withdrawal by participant|0
2013798|NCT00256867|3580758|FG001|Overall Study|Withdrawal by participant|0
2013799|NCT00256867|3580759|FG002|Overall Study|Withdrawal by participant|0
2013800|NCT00256867|3580760|FG003|Overall Study|Withdrawal by participant|0
2013801|NCT00256867|3580761|FG004|Overall Study|Withdrawal by participant|0
2013802|NCT00256867|3580762|FG005|Overall Study|Withdrawal by participant|1
2013803|NCT00256867|3580763|FG006|Overall Study|Withdrawal by participant|0
2013804|NCT00256867|3580764|FG007|Overall Study|Withdrawal by participant|0
2013805|NCT00256997|3580793|FG000|Overall Study|Protocol Violation|1
2013806|NCT00256997|3580794|FG001|Overall Study|Protocol Violation|4
2013807|NCT00256997|3580793|FG000|Overall Study|Lack of Efficacy|1
2013808|NCT00256997|3580794|FG001|Overall Study|Lack of Efficacy|4
2013809|NCT00256997|3580793|FG000|Overall Study|Death|2
2013810|NCT00256997|3580794|FG001|Overall Study|Death|0
2013811|NCT00256997|3580793|FG000|Overall Study|Adverse Event|4
2013812|NCT00256997|3580794|FG001|Overall Study|Adverse Event|0
2013813|NCT00256997|3580793|FG000|Overall Study|Lost to Follow-up|3
2013814|NCT00256997|3580794|FG001|Overall Study|Lost to Follow-up|5
2013815|NCT00256997|3580793|FG000|Overall Study|Withdrawal by Subject|13
2013816|NCT00256997|3580794|FG001|Overall Study|Withdrawal by Subject|3
2013817|NCT00256997|3580793|FG000|Overall Study|Started but not treated|2
2013818|NCT00256997|3580794|FG001|Overall Study|Started but not treated|0
2013819|NCT00256997|3580793|FG000|Overall Study|Other|5
2013820|NCT00256997|3580794|FG001|Overall Study|Other|8
2013821|NCT00256997|3580793|FG000|Overall Study|End of Study (As Per Sponsor)|12
2013822|NCT00256997|3580794|FG001|Overall Study|End of Study (As Per Sponsor)|24
2013823|NCT00256997|3580793|FG000|Overall Study|Participant Non-compliant|3
2013824|NCT00256997|3580794|FG001|Overall Study|Participant Non-compliant|6
2013825|NCT00256997|3580793|FG000|Overall Study|Investigator Withdrew Participant|2
2013826|NCT00256997|3580794|FG001|Overall Study|Investigator Withdrew Participant|1
2013827|NCT00257010|3580801|FG000|Overall Study|Lack of Efficacy|11
2013828|NCT00257010|3580801|FG000|Overall Study|Lost to Follow-up|53
2013829|NCT00257010|3580801|FG000|Overall Study|Withdrawal by Subject|34
2013830|NCT00257010|3580801|FG000|Overall Study|Adverse Event|10
2013831|NCT00257010|3580801|FG000|Overall Study|various|11
2013832|NCT00257010|3580801|FG000|Overall Study|no headache reported|9
2013833|NCT00257166|3580807|FG000|Overall Study|Adverse Event|18
2013834|NCT00257166|3580808|FG001|Overall Study|Adverse Event|13
2013835|NCT00257166|3580807|FG000|Overall Study|Laboratory abnormality|1
2013836|NCT00257166|3580808|FG001|Overall Study|Laboratory abnormality|0
2013837|NCT00257166|3580807|FG000|Overall Study|Lost to Follow-up|8
2013838|NCT00257166|3580808|FG001|Overall Study|Lost to Follow-up|1
2013839|NCT00257166|3580807|FG000|Overall Study|Withdrawal by Subject|9
2013840|NCT00257166|3580808|FG001|Overall Study|Withdrawal by Subject|2
2013841|NCT00257166|3580807|FG000|Overall Study|Other|16
2013842|NCT00257166|3580808|FG001|Overall Study|Other|21
2013843|NCT00257166|3580807|FG000|Overall Study|Randomized, but not treated|1
2013844|NCT00257166|3580808|FG001|Overall Study|Randomized, but not treated|0
2013845|NCT00257192|3580816|FG000|Overall Study|Adverse Event|21
2013846|NCT00257192|3580817|FG001|Overall Study|Adverse Event|10
2013847|NCT00257192|3580816|FG000|Overall Study|Laboratory abnormality|1
2013848|NCT00257192|3580817|FG001|Overall Study|Laboratory abnormality|1
2013849|NCT00257192|3580816|FG000|Overall Study|Lost to Follow-up|3
2013850|NCT00257192|3580817|FG001|Overall Study|Lost to Follow-up|3
2013851|NCT00257192|3580816|FG000|Overall Study|Insufficient clinical response|18
2013852|NCT00257192|3580817|FG001|Overall Study|Insufficient clinical response|18
2013853|NCT00257192|3580816|FG000|Overall Study|Withdrawal by Subject|14
2013854|NCT00257192|3580817|FG001|Overall Study|Withdrawal by Subject|2
2013855|NCT00257192|3580816|FG000|Overall Study|Randomized but not treated|0
2013856|NCT00257192|3580817|FG001|Overall Study|Randomized but not treated|1
2013857|NCT00257192|3580816|FG000|Overall Study|Study terminated by sponsor|1
2013858|NCT00257192|3580817|FG001|Overall Study|Study terminated by sponsor|0
2013859|NCT00257192|3580816|FG000|Overall Study|Miscellaneous|0
2013860|NCT00257192|3580817|FG001|Overall Study|Miscellaneous|4
2013861|NCT00257556|3580838|FG000|Overall Study|Adverse Event|1
2013862|NCT00257556|3580839|FG001|Overall Study|Adverse Event|4
2013863|NCT00257556|3580838|FG000|Overall Study|Physician Decision|6
2013864|NCT00257556|3580839|FG001|Overall Study|Physician Decision|0
2013865|NCT00257556|3580838|FG000|Overall Study|Did not meet hCG criterion|3
2013866|NCT00257556|3580839|FG001|Overall Study|Did not meet hCG criterion|0
2013867|NCT00257556|3580838|FG000|Overall Study|other reason|4
2013868|NCT00257556|3580839|FG001|Overall Study|other reason|6
2013869|NCT00257608|3580847|FG000|Chemotherapy Phase|Adverse Event|138
2013870|NCT00257608|3580848|FG001|Chemotherapy Phase|Adverse Event|0
2013871|NCT00257608|3580849|FG002|Chemotherapy Phase|Adverse Event|0
2013872|NCT00257608|3580847|FG000|Chemotherapy Phase|Disease progression|139
2013873|NCT00257608|3580848|FG001|Chemotherapy Phase|Disease progression|0
2013874|NCT00257608|3580849|FG002|Chemotherapy Phase|Disease progression|0
2013875|NCT00257608|3580847|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6
2013876|NCT00257608|3580848|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0
2013877|NCT00257608|3580849|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0
2013878|NCT00257608|3580847|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
2013879|NCT00257608|3580848|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
2013880|NCT00257608|3580849|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
2013881|NCT00257608|3580847|FG000|Chemotherapy Phase|Patient's decision to discontinue|35
2013882|NCT00257608|3580848|FG001|Chemotherapy Phase|Patient's decision to discontinue|0
2013883|NCT00257608|3580849|FG002|Chemotherapy Phase|Patient's decision to discontinue|0
2013884|NCT00257608|3580847|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3
2013885|NCT00257608|3580848|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0
2013886|NCT00257608|3580849|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0
2013887|NCT00257608|3580847|FG000|Chemotherapy Phase|Physician Decision|28
2013888|NCT00257608|3580848|FG001|Chemotherapy Phase|Physician Decision|0
2013889|NCT00257608|3580849|FG002|Chemotherapy Phase|Physician Decision|0
2013890|NCT00257608|3580847|FG000|Post Chemotherapy Phase|Adverse Event|0
2013891|NCT00257608|3580848|FG001|Post Chemotherapy Phase|Adverse Event|34
2013892|NCT00257608|3580849|FG002|Post Chemotherapy Phase|Adverse Event|38
2013893|NCT00257608|3580847|FG000|Post Chemotherapy Phase|Disease progression|0
2013894|NCT00257608|3580848|FG001|Post Chemotherapy Phase|Disease progression|204
2013895|NCT00257608|3580849|FG002|Post Chemotherapy Phase|Disease progression|168
2013896|NCT00257608|3580847|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0
2013897|NCT00257608|3580848|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4
2013898|NCT00257608|3580849|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5
2013899|NCT00257608|3580847|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
2013900|NCT00257608|3580848|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
2013901|NCT00257608|3580849|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
2013902|NCT00257608|3580847|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0
2013903|NCT00257608|3580848|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4
2013904|NCT00257608|3580849|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8
2013905|NCT00257608|3580847|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0
2013906|NCT00257608|3580848|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0
2013907|NCT00257608|3580849|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1
2013908|NCT00257608|3580847|FG000|Post Chemotherapy Phase|Lost to Follow-up|0
2013909|NCT00257608|3580848|FG001|Post Chemotherapy Phase|Lost to Follow-up|0
2013910|NCT00257608|3580849|FG002|Post Chemotherapy Phase|Lost to Follow-up|1
2013911|NCT00257608|3580847|FG000|Post Chemotherapy Phase|Physician Decision|0
2013912|NCT00257608|3580848|FG001|Post Chemotherapy Phase|Physician Decision|8
2013913|NCT00257608|3580849|FG002|Post Chemotherapy Phase|Physician Decision|11
2013914|NCT00257608|3580847|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
2013915|NCT00257608|3580848|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
2013916|NCT00257608|3580849|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
2013917|NCT00257608|3580847|FG000|Post Chemotherapy Phase|Not treated|0
2013918|NCT00257608|3580848|FG001|Post Chemotherapy Phase|Not treated|4
2013919|NCT00257608|3580849|FG002|Post Chemotherapy Phase|Not treated|7
2013920|NCT00257660|3580864|FG000|Overall Study|Lack of Efficacy|5
2013921|NCT00257660|3580865|FG001|Overall Study|Lack of Efficacy|23
2013922|NCT00257660|3580864|FG000|Overall Study|Withdrawal by Subject|2
2013923|NCT00257660|3580865|FG001|Overall Study|Withdrawal by Subject|0
2013924|NCT00257660|3580864|FG000|Overall Study|Lost to Follow-up|1
2013925|NCT00257660|3580865|FG001|Overall Study|Lost to Follow-up|0
2013926|NCT00257660|3580864|FG000|Overall Study|PI & Subject Schedule Conflicts|1
2013927|NCT00257660|3580865|FG001|Overall Study|PI & Subject Schedule Conflicts|0
2013928|NCT00257660|3580864|FG000|Overall Study|No longer wanted to do blood draws|1
2013929|NCT00257660|3580865|FG001|Overall Study|No longer wanted to do blood draws|0
2013930|NCT00257725|3580896|FG000|Overall Study|Adverse Event|3
2013931|NCT00257920|3580912|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0
2013932|NCT00257920|3580913|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1
2013933|NCT00257920|3580912|FG000|Period: Second Intervention|Other|2
2013934|NCT00257920|3580913|FG001|Period: Second Intervention|Other|1
2013935|NCT00258154|3580946|FG000|Overall Study|Adverse Event|1
2013936|NCT00258154|3580947|FG001|Overall Study|Adverse Event|0
2013937|NCT00258154|3580946|FG000|Overall Study|Lost to Follow-up|0
2013938|NCT00258154|3580947|FG001|Overall Study|Lost to Follow-up|1
2013939|NCT00258154|3580946|FG000|Overall Study|Protocol Violation|2
2013940|NCT00258154|3580947|FG001|Overall Study|Protocol Violation|1
2013941|NCT00258154|3580946|FG000|Overall Study|Withdrawal by Subject|3
2013942|NCT00258154|3580947|FG001|Overall Study|Withdrawal by Subject|4
2013943|NCT00258154|3580946|FG000|Overall Study|Patient Moved|3
2013944|NCT00258154|3580947|FG001|Overall Study|Patient Moved|1
2013945|NCT00258440|3580980|FG000|Overall Study|Withdrawal by Subject|0
2013946|NCT00258440|3580981|FG001|Overall Study|Withdrawal by Subject|0
2013947|NCT00258440|3580982|FG002|Overall Study|Withdrawal by Subject|1
2013948|NCT00258674|3580993|FG000|Overall Study|Death|32
2013949|NCT00258674|3580994|FG001|Overall Study|Death|53
2013950|NCT00258674|3580995|FG002|Overall Study|Death|34
2013951|NCT00258856|3581025|FG000|Overall Study|Lost to Follow-up|1
2013952|NCT00258856|3581026|FG001|Overall Study|Lost to Follow-up|0
2013953|NCT00258856|3581027|FG002|Overall Study|Lost to Follow-up|2
2013954|NCT00258856|3581028|FG003|Overall Study|Lost to Follow-up|0
2013955|NCT00258856|3581025|FG000|Overall Study|Non-compliance|2
2013956|NCT00258856|3581026|FG001|Overall Study|Non-compliance|0
2013957|NCT00258856|3581027|FG002|Overall Study|Non-compliance|0
2013958|NCT00258856|3581028|FG003|Overall Study|Non-compliance|1
2013959|NCT00258895|3581051|FG000|Overall Study|Lost to Follow-up|3
2013960|NCT00258895|3581052|FG001|Overall Study|Lost to Follow-up|1
2013961|NCT00258895|3581051|FG000|Overall Study|Protocol Violation|6
2013962|NCT00258895|3581052|FG001|Overall Study|Protocol Violation|2
2013963|NCT00258895|3581051|FG000|Overall Study|Withdrawal by Subject|1
2013964|NCT00258895|3581052|FG001|Overall Study|Withdrawal by Subject|0
2013965|NCT00258960|3581062|FG000|Overall Study|Death|2
2013966|NCT00258960|3581062|FG000|Overall Study|Disease Progression|7
2013967|NCT00258960|3581062|FG000|Overall Study|Adverse Event|4
2013968|NCT00258960|3581062|FG000|Overall Study|Physician Decision|1
2013969|NCT00258960|3581062|FG000|Overall Study|Withdrawal by Subject|1
2013970|NCT00258960|3581062|FG000|Overall Study|Mistake|2
2013971|NCT00259012|3581068|FG000|Overall Study|Adverse Event|0
2013972|NCT00259012|3581069|FG001|Overall Study|Adverse Event|1
2013973|NCT00259012|3581068|FG000|Overall Study|Withdrawal by Subject|1
2013974|NCT00259012|3581069|FG001|Overall Study|Withdrawal by Subject|0
2013975|NCT00259012|3581068|FG000|Overall Study|Physician Decision|0
2013976|NCT00259012|3581069|FG001|Overall Study|Physician Decision|1
2013977|NCT00259012|3581068|FG000|Overall Study|Lost to Follow-up|0
2013978|NCT00259012|3581069|FG001|Overall Study|Lost to Follow-up|1
2013979|NCT00259012|3581068|FG000|Overall Study|Protocol Violation|1
2013980|NCT00259012|3581069|FG001|Overall Study|Protocol Violation|1
2013981|NCT00259272|3581092|FG000|Overall Study|Adverse Event|2
2013982|NCT00259272|3581093|FG001|Overall Study|Adverse Event|1
2013983|NCT00259272|3581094|FG002|Overall Study|Adverse Event|0
2013984|NCT00259272|3581095|FG003|Overall Study|Adverse Event|3
2013985|NCT00259272|3581092|FG000|Overall Study|Lack of Efficacy|5
2013986|NCT00259272|3581093|FG001|Overall Study|Lack of Efficacy|1
2013987|NCT00259272|3581094|FG002|Overall Study|Lack of Efficacy|2
2013988|NCT00259272|3581095|FG003|Overall Study|Lack of Efficacy|6
2013989|NCT00259272|3581092|FG000|Overall Study|Physician Decision|1
2013990|NCT00259272|3581093|FG001|Overall Study|Physician Decision|2
2013991|NCT00259272|3581094|FG002|Overall Study|Physician Decision|1
2013992|NCT00259272|3581095|FG003|Overall Study|Physician Decision|3
2013993|NCT00259272|3581092|FG000|Overall Study|Protocol Violation|2
2013994|NCT00259272|3581093|FG001|Overall Study|Protocol Violation|0
2013995|NCT00259272|3581094|FG002|Overall Study|Protocol Violation|0
2013996|NCT00259272|3581095|FG003|Overall Study|Protocol Violation|1
2013997|NCT00259272|3581092|FG000|Overall Study|Sponsor Decision|0
2013998|NCT00259272|3581093|FG001|Overall Study|Sponsor Decision|1
2013999|NCT00259272|3581094|FG002|Overall Study|Sponsor Decision|0
2014000|NCT00259272|3581095|FG003|Overall Study|Sponsor Decision|0
2014001|NCT00259272|3581092|FG000|Overall Study|Withdrawal by Subject|4
2014002|NCT00259272|3581093|FG001|Overall Study|Withdrawal by Subject|2
2014003|NCT00259272|3581094|FG002|Overall Study|Withdrawal by Subject|2
2014004|NCT00259272|3581095|FG003|Overall Study|Withdrawal by Subject|7
2014005|NCT00259272|3581092|FG000|Overall Study|Lost to Follow-up|1
2014006|NCT00259272|3581093|FG001|Overall Study|Lost to Follow-up|0
2014007|NCT00259272|3581094|FG002|Overall Study|Lost to Follow-up|0
2014008|NCT00259272|3581095|FG003|Overall Study|Lost to Follow-up|1
2014009|NCT00259298|3581114|FG000|Overall Study|Withdrawal by Subject|1
2014010|NCT00259298|3581114|FG000|Overall Study|Physician Decision|2
2014011|NCT00259610|3581122|FG000|Overall Study|Withdrawal by Subject|33
2014012|NCT00259610|3581123|FG001|Overall Study|Withdrawal by Subject|25
2014013|NCT00259610|3581124|FG002|Overall Study|Withdrawal by Subject|29
2014014|NCT00259610|3581125|FG003|Overall Study|Withdrawal by Subject|19
2014015|NCT00259610|3581122|FG000|Overall Study|Lost to Follow-up|19
2014016|NCT00259610|3581123|FG001|Overall Study|Lost to Follow-up|8
2014017|NCT00259610|3581124|FG002|Overall Study|Lost to Follow-up|18
2014018|NCT00259610|3581125|FG003|Overall Study|Lost to Follow-up|15
2214513|NCT01687712|3856790|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0
2214514|NCT01687998|3856816|FG000|Overall Study|Withdrawal by Subject|49
2214515|NCT01687998|3856817|FG001|Overall Study|Withdrawal by Subject|51
2214516|NCT01687998|3856816|FG000|Overall Study|Known to be Alive at Study End|54
2214517|NCT01687998|3856817|FG001|Overall Study|Known to be Alive at Study End|62
2214518|NCT01687998|3856816|FG000|Overall Study|Lost to Follow-up|9
2214519|NCT01687998|3856817|FG001|Overall Study|Lost to Follow-up|7
2214520|NCT01688037|3856826|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1
2014019|NCT00259610|3581122|FG000|Overall Study|Physician Decision|6
2014020|NCT00259610|3581123|FG001|Overall Study|Physician Decision|4
2014021|NCT00259610|3581124|FG002|Overall Study|Physician Decision|7
2014022|NCT00259610|3581125|FG003|Overall Study|Physician Decision|2
2014023|NCT00259610|3581122|FG000|Overall Study|Death|1
2014024|NCT00259610|3581123|FG001|Overall Study|Death|1
2014025|NCT00259610|3581124|FG002|Overall Study|Death|2
2014026|NCT00259610|3581125|FG003|Overall Study|Death|0
2014027|NCT00259610|3581122|FG000|Overall Study|non medical reason|6
2014028|NCT00259610|3581123|FG001|Overall Study|non medical reason|2
2014029|NCT00259610|3581124|FG002|Overall Study|non medical reason|10
2014030|NCT00259610|3581125|FG003|Overall Study|non medical reason|3
2014031|NCT00259610|3581122|FG000|Overall Study|Adverse Event|3
2014032|NCT00259610|3581123|FG001|Overall Study|Adverse Event|4
2014033|NCT00259610|3581124|FG002|Overall Study|Adverse Event|5
2313299|NCT02787551|4020584|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
2313300|NCT02787551|4020585|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
2313301|NCT02787551|4020584|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
2313302|NCT02787551|4020585|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
2313303|NCT02787863|4020628|FG000|Overall Study|Death|1
2313304|NCT02787863|4020629|FG001|Overall Study|Death|0
2313305|NCT02787863|4020630|FG002|Overall Study|Death|1
2313306|NCT02787863|4020631|FG003|Overall Study|Death|0
2313307|NCT02787863|4020632|FG004|Overall Study|Death|0
2313308|NCT02787863|4020633|FG005|Overall Study|Death|0
2313309|NCT02787863|4020634|FG006|Overall Study|Death|0
2313310|NCT02787863|4020635|FG007|Overall Study|Death|0
2313311|NCT02787863|4020628|FG000|Overall Study|Withdrawal by Subject|0
2313312|NCT02787863|4020629|FG001|Overall Study|Withdrawal by Subject|1
2313313|NCT02787863|4020630|FG002|Overall Study|Withdrawal by Subject|1
2313314|NCT02787863|4020631|FG003|Overall Study|Withdrawal by Subject|0
2313315|NCT02787863|4020632|FG004|Overall Study|Withdrawal by Subject|0
2313316|NCT02787863|4020633|FG005|Overall Study|Withdrawal by Subject|0
2313317|NCT02787863|4020634|FG006|Overall Study|Withdrawal by Subject|0
2313318|NCT02787863|4020635|FG007|Overall Study|Withdrawal by Subject|0
2313319|NCT02788175|4020694|FG000|Overall Study|Protocol Violation|3
2313320|NCT02788175|4020694|FG000|Overall Study|Withdrawal by Subject|4
2313321|NCT02788175|4020694|FG000|Overall Study|Ineligible prior to study agent|6
2313322|NCT02788201|4020733|FG000|Overall Study|Death|1
2313323|NCT02788201|4020734|FG001|Overall Study|Death|1
2313324|NCT02788201|4020735|FG002|Overall Study|Death|1
2313325|NCT02788201|4020736|FG003|Overall Study|Death|1
2313326|NCT02788201|4020737|FG004|Overall Study|Death|0
2313327|NCT02788201|4020738|FG005|Overall Study|Death|1
2313328|NCT02788201|4020733|FG000|Overall Study|Ineligible|0
2313329|NCT02788201|4020734|FG001|Overall Study|Ineligible|0
2014034|NCT00259610|3581125|FG003|Overall Study|Adverse Event|2
2014035|NCT00259610|3581122|FG000|Overall Study|Serious Adverse Event|8
2014036|NCT00259610|3581123|FG001|Overall Study|Serious Adverse Event|2
2014037|NCT00259610|3581124|FG002|Overall Study|Serious Adverse Event|2
2014038|NCT00259610|3581125|FG003|Overall Study|Serious Adverse Event|2
2014039|NCT00259649|3581135|FG000|Overall Study|Lost to Follow-up|7
2014040|NCT00259649|3581135|FG000|Overall Study|irregular menses|3
2014041|NCT00259740|3581141|FG000|Overall Study|Physician Decision|1
2014042|NCT00259740|3581142|FG001|Overall Study|Physician Decision|1
2014043|NCT00259740|3581141|FG000|Overall Study|Adverse Event|0
2014044|NCT00259740|3581142|FG001|Overall Study|Adverse Event|2
2014045|NCT00259740|3581141|FG000|Overall Study|Withdrawal by Subject|2
2014046|NCT00259740|3581142|FG001|Overall Study|Withdrawal by Subject|6
2014047|NCT00259740|3581141|FG000|Overall Study|Death|1
2014048|NCT00259740|3581142|FG001|Overall Study|Death|1
2014049|NCT00259740|3581141|FG000|Overall Study|Disease progression|19
2014050|NCT00259740|3581142|FG001|Overall Study|Disease progression|36
2014051|NCT00259740|3581141|FG000|Overall Study|Ongoing|17
2014052|NCT00259740|3581142|FG001|Overall Study|Ongoing|3
2014053|NCT00259740|3581141|FG000|Overall Study|Other|3
2014054|NCT00259740|3581142|FG001|Overall Study|Other|0
2014055|NCT00259740|3581141|FG000|Overall Study|Requirement for alternative therapy|0
2014056|NCT00259740|3581142|FG001|Overall Study|Requirement for alternative therapy|4
2014057|NCT00259857|3581150|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
2014058|NCT00259857|3581151|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
2014059|NCT00259857|3581150|FG000|24 Months Treatment|Lost to Follow-up|0
2014060|NCT00259857|3581151|FG001|24 Months Treatment|Lost to Follow-up|3
2014061|NCT00260065|3581157|FG000|Overall Study|Progressive Disease|22
2014062|NCT00260065|3581157|FG000|Overall Study|Adverse Event|17
2014063|NCT00260065|3581157|FG000|Overall Study|Death|13
2014064|NCT00260065|3581157|FG000|Overall Study|Withdrawal by Subject|13
2014065|NCT00260065|3581157|FG000|Overall Study|Physician Decision|19
2014066|NCT00260065|3581157|FG000|Overall Study|Not otherwise specified|8
2014067|NCT00260065|3581157|FG000|Overall Study|Medication Noncompliance|1
2014068|NCT00260208|3581173|FG000|Overall Study|Subject withdrew consent|11
2014069|NCT00260208|3581174|FG001|Overall Study|Subject withdrew consent|7
2014070|NCT00260208|3581173|FG000|Overall Study|Lost to Follow-up|6
2014071|NCT00260208|3581174|FG001|Overall Study|Lost to Follow-up|1
2014072|NCT00260208|3581173|FG000|Overall Study|Death|12
2014073|NCT00260208|3581174|FG001|Overall Study|Death|10
2014074|NCT00260208|3581173|FG000|Overall Study|Missing|18
2014075|NCT00260208|3581174|FG001|Overall Study|Missing|16
2014076|NCT00260429|3581182|FG000|Overall Study|failure to follow appointments|1
2014077|NCT00260429|3581183|FG001|Overall Study|failure to follow appointments|0
2014078|NCT00260429|3581182|FG000|Overall Study|scheduled hand surgery|1
2313330|NCT02788201|4020735|FG002|Overall Study|Ineligible|0
2313331|NCT02788201|4020736|FG003|Overall Study|Ineligible|0
2313332|NCT02788201|4020737|FG004|Overall Study|Ineligible|0
2313333|NCT02788201|4020738|FG005|Overall Study|Ineligible|1
2014079|NCT00260429|3581183|FG001|Overall Study|scheduled hand surgery|0
2014080|NCT00260533|3581191|FG000|Overall Study|Other|3
2014081|NCT00260533|3581192|FG001|Overall Study|Other|3
2014082|NCT00260832|3581213|FG000|Overall Study|Adverse Event|26
2014083|NCT00260832|3581214|FG001|Overall Study|Adverse Event|19
2313334|NCT02788201|4020733|FG000|Overall Study|Withdrawal by Subject|0
2014084|NCT00260832|3581213|FG000|Overall Study|Progression|116
2014085|NCT00260832|3581214|FG001|Overall Study|Progression|96
2014086|NCT00260832|3581213|FG000|Overall Study|Withdrawal by Subject|15
2014087|NCT00260832|3581214|FG001|Overall Study|Withdrawal by Subject|17
2014088|NCT00260832|3581213|FG000|Overall Study|Physician Decision|15
2014089|NCT00260832|3581214|FG001|Overall Study|Physician Decision|9
2014090|NCT00260832|3581213|FG000|Overall Study|Death|43
2014091|NCT00260832|3581214|FG001|Overall Study|Death|62
2014092|NCT00260832|3581213|FG000|Overall Study|Other|10
2014093|NCT00260832|3581214|FG001|Overall Study|Other|7
2014094|NCT00260832|3581213|FG000|Overall Study|Protocol Violation|3
2014095|NCT00260832|3581214|FG001|Overall Study|Protocol Violation|1
2014096|NCT00261443|3581240|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33
2014097|NCT00261443|3581241|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0
2014098|NCT00261443|3581242|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0
2014099|NCT00261443|3581240|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
2014100|NCT00261443|3581241|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
2014101|NCT00261443|3581242|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
2014102|NCT00261443|3581240|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
2014103|NCT00261443|3581241|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
2014104|NCT00261443|3581242|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
2014105|NCT00261443|3581240|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
2014106|NCT00261443|3581241|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
2014107|NCT00261443|3581242|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
2014108|NCT00261443|3581240|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1
2014109|NCT00261443|3581241|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0
2014110|NCT00261443|3581242|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0
2014111|NCT00261443|3581240|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
2014112|NCT00261443|3581241|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
2014113|NCT00261443|3581242|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
2014114|NCT00261443|3581240|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16
2014115|NCT00261443|3581241|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0
2014116|NCT00261443|3581242|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0
2014117|NCT00261443|3581240|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43
2014118|NCT00261443|3581241|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0
2014119|NCT00261443|3581242|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0
2014120|NCT00261443|3581240|FG000|2: Stability & Maintenance of Stability|Adverse Event|93
2014121|NCT00261443|3581241|FG001|2: Stability & Maintenance of Stability|Adverse Event|0
2014122|NCT00261443|3581242|FG002|2: Stability & Maintenance of Stability|Adverse Event|0
2014123|NCT00261443|3581240|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
2014124|NCT00261443|3581241|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
2014125|NCT00261443|3581242|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
2014126|NCT00261443|3581240|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59
2014127|NCT00261443|3581241|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0
2014128|NCT00261443|3581242|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0
2014129|NCT00261443|3581240|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
2014130|NCT00261443|3581241|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
2014131|NCT00261443|3581242|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
2014132|NCT00261443|3581240|FG000|2: Stability & Maintenance of Stability|Pregnancy|1
2014133|NCT00261443|3581241|FG001|2: Stability & Maintenance of Stability|Pregnancy|0
2014134|NCT00261443|3581242|FG002|2: Stability & Maintenance of Stability|Pregnancy|0
2014135|NCT00261443|3581240|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
2014136|NCT00261443|3581241|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
2014137|NCT00261443|3581242|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
2014138|NCT00261443|3581240|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
2014139|NCT00261443|3581241|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
2014140|NCT00261443|3581242|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
2014141|NCT00261443|3581240|FG000|2: Stability & Maintenance of Stability|Other Reasons|13
2014142|NCT00261443|3581241|FG001|2: Stability & Maintenance of Stability|Other Reasons|0
2014143|NCT00261443|3581242|FG002|2: Stability & Maintenance of Stability|Other Reasons|0
2014144|NCT00261443|3581240|FG000|3: Assessment of Relapse|Lack of Efficacy|0
2014145|NCT00261443|3581241|FG001|3: Assessment of Relapse|Lack of Efficacy|31
2014146|NCT00261443|3581242|FG002|3: Assessment of Relapse|Lack of Efficacy|14
2014147|NCT00261443|3581240|FG000|3: Assessment of Relapse|Adverse Event|0
2014148|NCT00261443|3581241|FG001|3: Assessment of Relapse|Adverse Event|15
2014149|NCT00261443|3581242|FG002|3: Assessment of Relapse|Adverse Event|19
2214521|NCT01688037|3856827|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
2214522|NCT01688037|3856828|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1
2214523|NCT01688037|3856826|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1
2214524|NCT01688037|3856827|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
2214525|NCT01688037|3856828|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3
2014150|NCT00261443|3581240|FG000|3: Assessment of Relapse|Withdrawal by Subject|0
2014151|NCT00261443|3581241|FG001|3: Assessment of Relapse|Withdrawal by Subject|14
2014152|NCT00261443|3581242|FG002|3: Assessment of Relapse|Withdrawal by Subject|15
2014153|NCT00261443|3581240|FG000|3: Assessment of Relapse|Death|0
2014154|NCT00261443|3581241|FG001|3: Assessment of Relapse|Death|0
2014155|NCT00261443|3581242|FG002|3: Assessment of Relapse|Death|1
2014156|NCT00261443|3581240|FG000|3: Assessment of Relapse|Lost to Follow-up|0
2014157|NCT00261443|3581241|FG001|3: Assessment of Relapse|Lost to Follow-up|7
2014158|NCT00261443|3581242|FG002|3: Assessment of Relapse|Lost to Follow-up|6
2014159|NCT00261443|3581240|FG000|3: Assessment of Relapse|Poor/Noncompliance|0
2014160|NCT00261443|3581241|FG001|3: Assessment of Relapse|Poor/Noncompliance|5
2014161|NCT00261443|3581242|FG002|3: Assessment of Relapse|Poor/Noncompliance|3
2014162|NCT00261443|3581240|FG000|3: Assessment of Relapse|Pregnancy|0
2014163|NCT00261443|3581241|FG001|3: Assessment of Relapse|Pregnancy|2
2014164|NCT00261443|3581242|FG002|3: Assessment of Relapse|Pregnancy|1
2014165|NCT00261443|3581240|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
2014166|NCT00261443|3581241|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
2014167|NCT00261443|3581242|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
2014168|NCT00261443|3581240|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0
2014169|NCT00261443|3581241|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0
2014170|NCT00261443|3581242|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2
2014171|NCT00261443|3581240|FG000|3: Assessment of Relapse|Other Reasons|0
2014172|NCT00261443|3581241|FG001|3: Assessment of Relapse|Other Reasons|4
2014173|NCT00261443|3581242|FG002|3: Assessment of Relapse|Other Reasons|3
2014174|NCT00261443|3581240|FG000|4: Extension Phase|Adverse Event|0
2014175|NCT00261443|3581241|FG001|4: Extension Phase|Adverse Event|1
2014176|NCT00261443|3581242|FG002|4: Extension Phase|Adverse Event|0
2014177|NCT00261443|3581240|FG000|4: Extension Phase|Withdrawal by Subject|0
2014178|NCT00261443|3581241|FG001|4: Extension Phase|Withdrawal by Subject|1
2014179|NCT00261443|3581242|FG002|4: Extension Phase|Withdrawal by Subject|2
2014180|NCT00261443|3581240|FG000|4: Extension Phase|Lost to Follow-up|0
2014181|NCT00261443|3581241|FG001|4: Extension Phase|Lost to Follow-up|1
2014182|NCT00261443|3581242|FG002|4: Extension Phase|Lost to Follow-up|0
2014183|NCT00261495|3581255|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28
2014184|NCT00261495|3581256|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36
2014185|NCT00261495|3581255|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
2014186|NCT00261495|3581256|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
2014187|NCT00261495|3581255|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
2014188|NCT00261495|3581256|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
2014189|NCT00261495|3581255|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3
2014190|NCT00261495|3581256|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1
2014191|NCT00261495|3581255|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2
2014192|NCT00261495|3581256|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5
2014193|NCT00261495|3581255|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
2014194|NCT00261495|3581256|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
2014195|NCT00261495|3581255|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
2014196|NCT00261495|3581256|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
2014197|NCT00261495|3581255|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
2014198|NCT00261495|3581256|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
2014199|NCT00261495|3581255|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
2014200|NCT00261495|3581256|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
2014201|NCT00261495|3581255|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
2014202|NCT00261495|3581256|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
2014203|NCT00261495|3581255|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
2014204|NCT00261495|3581256|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
2014205|NCT00261495|3581255|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6
2014206|NCT00261495|3581256|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5
2014207|NCT00261495|3581255|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
2014208|NCT00261495|3581256|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
2014209|NCT00261495|3581255|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
2014210|NCT00261495|3581256|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
2014211|NCT00261495|3581255|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
2014212|NCT00261495|3581256|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
2014213|NCT00261495|3581255|FG000|Extension Phase (Weeks 24 to 52)|Other|4
2014214|NCT00261495|3581256|FG001|Extension Phase (Weeks 24 to 52)|Other|2
2014215|NCT00261495|3581255|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4
2014216|NCT00261495|3581256|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2014217|NCT00261495|3581255|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
2014218|NCT00261495|3581256|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
2014219|NCT00261495|3581255|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2014220|NCT00261495|3581256|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
2014221|NCT00261495|3581255|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1
2014222|NCT00261495|3581256|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0
2014223|NCT00261495|3581255|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
2014224|NCT00261495|3581256|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2014225|NCT00261716|3581264|FG000|Overall Study|Withdrawal by Subject|6
2014226|NCT00261716|3581265|FG001|Overall Study|Withdrawal by Subject|8
2014227|NCT00261716|3581264|FG000|Overall Study|Lost to Follow-up|0
2014228|NCT00261716|3581265|FG001|Overall Study|Lost to Follow-up|2
2014229|NCT00261833|3581277|FG000|Overall Study|Death|1
2014230|NCT00261833|3581278|FG001|Overall Study|Death|3
2014231|NCT00261833|3581277|FG000|Overall Study|Adverse Event|1
2014232|NCT00261833|3581278|FG001|Overall Study|Adverse Event|4
2014233|NCT00261833|3581277|FG000|Overall Study|Withdrawal by Subject|5
2014234|NCT00261833|3581278|FG001|Overall Study|Withdrawal by Subject|7
2014235|NCT00261833|3581277|FG000|Overall Study|Protocol Violation|0
2014236|NCT00261833|3581278|FG001|Overall Study|Protocol Violation|1
2014237|NCT00261833|3581277|FG000|Overall Study|Suspicion of pulmonary cancer|0
2014238|NCT00261833|3581278|FG001|Overall Study|Suspicion of pulmonary cancer|1
2014239|NCT00261833|3581277|FG000|Overall Study|Lung transplantation|1
2014240|NCT00261833|3581278|FG001|Overall Study|Lung transplantation|1
2014241|NCT00261833|3581277|FG000|Overall Study|Missing reason|1
2014242|NCT00261833|3581278|FG001|Overall Study|Missing reason|0
2014243|NCT00261833|3581277|FG000|Overall Study|Not interested in being participant|0
2014244|NCT00261833|3581278|FG001|Overall Study|Not interested in being participant|1
2014245|NCT00261846|3581294|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
2014246|NCT00261846|3581295|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
2014247|NCT00261846|3581296|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
2014248|NCT00261846|3581297|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2014249|NCT00261846|3581298|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2014250|NCT00261846|3581299|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2014251|NCT00261846|3581300|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2014252|NCT00261846|3581301|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2014253|NCT00261846|3581302|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2014254|NCT00261846|3581303|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2014255|NCT00261846|3581304|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2014256|NCT00261846|3581305|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2014257|NCT00261846|3581294|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2014258|NCT00261846|3581295|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2014259|NCT00261846|3581296|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2014260|NCT00261846|3581297|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
2014261|NCT00261846|3581298|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2014262|NCT00261846|3581299|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2014263|NCT00261846|3581300|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2014264|NCT00261846|3581301|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2014265|NCT00261846|3581302|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
2014266|NCT00261846|3581303|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2014267|NCT00261846|3581304|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2014268|NCT00261846|3581305|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2014269|NCT00261846|3581294|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2014270|NCT00261846|3581295|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2014271|NCT00261846|3581296|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2014272|NCT00261846|3581297|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
2014273|NCT00261846|3581298|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
2014274|NCT00261846|3581299|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
2014275|NCT00261846|3581300|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
2014276|NCT00261846|3581301|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
2014277|NCT00261846|3581302|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2014278|NCT00261846|3581303|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
2014279|NCT00261846|3581304|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2014280|NCT00261846|3581305|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2014281|NCT00261846|3581294|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2014282|NCT00261846|3581295|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2014283|NCT00261846|3581296|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2014284|NCT00261846|3581297|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
2014285|NCT00261846|3581298|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
2014286|NCT00261846|3581299|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2014287|NCT00261846|3581300|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
2014288|NCT00261846|3581301|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2014289|NCT00261846|3581302|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
2014290|NCT00261846|3581303|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
2014291|NCT00261846|3581304|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
2014292|NCT00261846|3581305|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2014293|NCT00261846|3581294|FG000|Period 2: Part 2 (Efficacy)|Other|0
2014294|NCT00261846|3581295|FG001|Period 2: Part 2 (Efficacy)|Other|0
2014295|NCT00261846|3581296|FG002|Period 2: Part 2 (Efficacy)|Other|0
2014296|NCT00261846|3581297|FG003|Period 2: Part 2 (Efficacy)|Other|15
2014297|NCT00261846|3581298|FG004|Period 2: Part 2 (Efficacy)|Other|4
2014298|NCT00261846|3581299|FG005|Period 2: Part 2 (Efficacy)|Other|0
2014299|NCT00261846|3581300|FG006|Period 2: Part 2 (Efficacy)|Other|1
2014300|NCT00261846|3581301|FG007|Period 2: Part 2 (Efficacy)|Other|5
2014301|NCT00261846|3581302|FG008|Period 2: Part 2 (Efficacy)|Other|4
2014302|NCT00261846|3581303|FG009|Period 2: Part 2 (Efficacy)|Other|4
2014303|NCT00261846|3581304|FG010|Period 2: Part 2 (Efficacy)|Other|0
2014304|NCT00261846|3581305|FG011|Period 2: Part 2 (Efficacy)|Other|0
2014305|NCT00261846|3581294|FG000|Period 2: Part 2 (Efficacy)|Death|0
2014306|NCT00261846|3581295|FG001|Period 2: Part 2 (Efficacy)|Death|0
2014307|NCT00261846|3581296|FG002|Period 2: Part 2 (Efficacy)|Death|0
2014308|NCT00261846|3581297|FG003|Period 2: Part 2 (Efficacy)|Death|37
2014309|NCT00261846|3581298|FG004|Period 2: Part 2 (Efficacy)|Death|7
2014310|NCT00261846|3581299|FG005|Period 2: Part 2 (Efficacy)|Death|1
2014311|NCT00261846|3581300|FG006|Period 2: Part 2 (Efficacy)|Death|10
2014312|NCT00261846|3581301|FG007|Period 2: Part 2 (Efficacy)|Death|12
2014313|NCT00261846|3581302|FG008|Period 2: Part 2 (Efficacy)|Death|3
2014314|NCT00261846|3581303|FG009|Period 2: Part 2 (Efficacy)|Death|30
2014315|NCT00261846|3581304|FG010|Period 2: Part 2 (Efficacy)|Death|44
2014316|NCT00261846|3581305|FG011|Period 2: Part 2 (Efficacy)|Death|22
2014317|NCT00261846|3581294|FG000|Period 2: Part 2 (Efficacy)|Extension study|0
2014318|NCT00261846|3581295|FG001|Period 2: Part 2 (Efficacy)|Extension study|0
2014319|NCT00261846|3581296|FG002|Period 2: Part 2 (Efficacy)|Extension study|0
2014320|NCT00261846|3581297|FG003|Period 2: Part 2 (Efficacy)|Extension study|61
2014321|NCT00261846|3581298|FG004|Period 2: Part 2 (Efficacy)|Extension study|27
2014322|NCT00261846|3581299|FG005|Period 2: Part 2 (Efficacy)|Extension study|0
2014323|NCT00261846|3581300|FG006|Period 2: Part 2 (Efficacy)|Extension study|4
2014324|NCT00261846|3581301|FG007|Period 2: Part 2 (Efficacy)|Extension study|9
2014325|NCT00261846|3581302|FG008|Period 2: Part 2 (Efficacy)|Extension study|5
2014326|NCT00261846|3581303|FG009|Period 2: Part 2 (Efficacy)|Extension study|9
2014327|NCT00261846|3581304|FG010|Period 2: Part 2 (Efficacy)|Extension study|1
2014328|NCT00261846|3581305|FG011|Period 2: Part 2 (Efficacy)|Extension study|1
2014329|NCT00261950|3581344|FG000|Overall Study|Lost to Follow-up|2
2014330|NCT00261950|3581344|FG000|Overall Study|Death|6
2014331|NCT00261950|3581344|FG000|Overall Study|Withdrawal by Subject|5
2014332|NCT00261950|3581344|FG000|Overall Study|Other|1
2014333|NCT00261950|3581344|FG000|Overall Study|Physician Decision|1
2014334|NCT00261950|3581344|FG000|Overall Study|Protocol specified Criteria|11
2014335|NCT00262002|3581355|FG000|Overall Study|Adverse Event|2
2014336|NCT00262002|3581356|FG001|Overall Study|Adverse Event|1
2014337|NCT00262002|3581357|FG002|Overall Study|Adverse Event|0
2014338|NCT00262002|3581358|FG003|Overall Study|Adverse Event|0
2014339|NCT00262002|3581359|FG004|Overall Study|Adverse Event|0
2014340|NCT00262002|3581360|FG005|Overall Study|Adverse Event|1
2014341|NCT00262002|3581361|FG006|Overall Study|Adverse Event|0
2014342|NCT00262002|3581355|FG000|Overall Study|Withdrawal by Subject|4
2014343|NCT00262002|3581356|FG001|Overall Study|Withdrawal by Subject|2
2014344|NCT00262002|3581357|FG002|Overall Study|Withdrawal by Subject|0
2014345|NCT00262002|3581358|FG003|Overall Study|Withdrawal by Subject|1
2014346|NCT00262002|3581359|FG004|Overall Study|Withdrawal by Subject|2
2014347|NCT00262002|3581360|FG005|Overall Study|Withdrawal by Subject|2
2014348|NCT00262002|3581361|FG006|Overall Study|Withdrawal by Subject|2
2014349|NCT00262002|3581355|FG000|Overall Study|Lost to Follow-up|2
2014350|NCT00262002|3581356|FG001|Overall Study|Lost to Follow-up|0
2014351|NCT00262002|3581357|FG002|Overall Study|Lost to Follow-up|0
2014352|NCT00262002|3581358|FG003|Overall Study|Lost to Follow-up|2
2014353|NCT00262002|3581359|FG004|Overall Study|Lost to Follow-up|0
2014354|NCT00262002|3581360|FG005|Overall Study|Lost to Follow-up|1
2014355|NCT00262002|3581361|FG006|Overall Study|Lost to Follow-up|0
2014356|NCT00262002|3581355|FG000|Overall Study|Inapropriate enrollment|0
2014357|NCT00262002|3581356|FG001|Overall Study|Inapropriate enrollment|1
2014358|NCT00262002|3581357|FG002|Overall Study|Inapropriate enrollment|0
2014359|NCT00262002|3581358|FG003|Overall Study|Inapropriate enrollment|0
2014360|NCT00262002|3581359|FG004|Overall Study|Inapropriate enrollment|0
2014361|NCT00262002|3581360|FG005|Overall Study|Inapropriate enrollment|0
2014362|NCT00262002|3581361|FG006|Overall Study|Inapropriate enrollment|0
2014363|NCT00262002|3581355|FG000|Overall Study|Protocol Violation|3
2014364|NCT00262002|3581356|FG001|Overall Study|Protocol Violation|2
2014365|NCT00262002|3581357|FG002|Overall Study|Protocol Violation|0
2014366|NCT00262002|3581358|FG003|Overall Study|Protocol Violation|2
2014367|NCT00262002|3581359|FG004|Overall Study|Protocol Violation|5
2014368|NCT00262002|3581360|FG005|Overall Study|Protocol Violation|3
2014369|NCT00262002|3581361|FG006|Overall Study|Protocol Violation|2
2014370|NCT00262002|3581355|FG000|Overall Study|Unable to classify|0
2014371|NCT00262002|3581356|FG001|Overall Study|Unable to classify|0
2014372|NCT00262002|3581357|FG002|Overall Study|Unable to classify|0
2014373|NCT00262002|3581358|FG003|Overall Study|Unable to classify|0
2014374|NCT00262002|3581359|FG004|Overall Study|Unable to classify|0
2014375|NCT00262002|3581360|FG005|Overall Study|Unable to classify|0
2014376|NCT00262002|3581361|FG006|Overall Study|Unable to classify|2
2014377|NCT00262028|3581435|FG000|Overall Study|Withdrawal by Subject|6
2014378|NCT00262028|3581436|FG001|Overall Study|Withdrawal by Subject|3
2014379|NCT00262028|3581437|FG002|Overall Study|Withdrawal by Subject|6
2014380|NCT00262028|3581438|FG003|Overall Study|Withdrawal by Subject|5
2014381|NCT00262028|3581439|FG004|Overall Study|Withdrawal by Subject|2
2014382|NCT00262028|3581440|FG005|Overall Study|Withdrawal by Subject|3
2014383|NCT00262028|3581441|FG006|Overall Study|Withdrawal by Subject|5
2014384|NCT00262028|3581442|FG007|Overall Study|Withdrawal by Subject|7
2014385|NCT00262028|3581443|FG008|Overall Study|Withdrawal by Subject|2
2014386|NCT00262028|3581435|FG000|Overall Study|Lost to Follow-up|7
2014387|NCT00262028|3581436|FG001|Overall Study|Lost to Follow-up|7
2014388|NCT00262028|3581437|FG002|Overall Study|Lost to Follow-up|5
2014389|NCT00262028|3581438|FG003|Overall Study|Lost to Follow-up|5
2014390|NCT00262028|3581439|FG004|Overall Study|Lost to Follow-up|4
2014391|NCT00262028|3581440|FG005|Overall Study|Lost to Follow-up|3
2014392|NCT00262028|3581441|FG006|Overall Study|Lost to Follow-up|3
2014393|NCT00262028|3581442|FG007|Overall Study|Lost to Follow-up|5
2014394|NCT00262028|3581443|FG008|Overall Study|Lost to Follow-up|6
2014395|NCT00262028|3581435|FG000|Overall Study|Administrative Reason|11
2014396|NCT00262028|3581436|FG001|Overall Study|Administrative Reason|14
2014397|NCT00262028|3581437|FG002|Overall Study|Administrative Reason|9
2014398|NCT00262028|3581438|FG003|Overall Study|Administrative Reason|12
2014399|NCT00262028|3581439|FG004|Overall Study|Administrative Reason|6
2014400|NCT00262028|3581440|FG005|Overall Study|Administrative Reason|7
2014401|NCT00262028|3581441|FG006|Overall Study|Administrative Reason|4
2014402|NCT00262028|3581442|FG007|Overall Study|Administrative Reason|6
2014403|NCT00262028|3581443|FG008|Overall Study|Administrative Reason|10
2014404|NCT00262028|3581435|FG000|Overall Study|Protocol Violation|0
2014405|NCT00262028|3581436|FG001|Overall Study|Protocol Violation|0
2014406|NCT00262028|3581437|FG002|Overall Study|Protocol Violation|0
2014407|NCT00262028|3581438|FG003|Overall Study|Protocol Violation|1
2014408|NCT00262028|3581439|FG004|Overall Study|Protocol Violation|0
2014409|NCT00262028|3581440|FG005|Overall Study|Protocol Violation|0
2014410|NCT00262028|3581441|FG006|Overall Study|Protocol Violation|0
2014411|NCT00262028|3581442|FG007|Overall Study|Protocol Violation|0
2014412|NCT00262028|3581443|FG008|Overall Study|Protocol Violation|0
2014413|NCT00262028|3581435|FG000|Overall Study|Unable to classify|0
2014414|NCT00262028|3581436|FG001|Overall Study|Unable to classify|3
2014415|NCT00262028|3581437|FG002|Overall Study|Unable to classify|0
2014416|NCT00262028|3581438|FG003|Overall Study|Unable to classify|0
2214526|NCT01688037|3856826|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
2014417|NCT00262028|3581439|FG004|Overall Study|Unable to classify|0
2014418|NCT00262028|3581440|FG005|Overall Study|Unable to classify|0
2014419|NCT00262028|3581441|FG006|Overall Study|Unable to classify|0
2313335|NCT02788201|4020734|FG001|Overall Study|Withdrawal by Subject|0
2313336|NCT02788201|4020735|FG002|Overall Study|Withdrawal by Subject|0
2313337|NCT02788201|4020736|FG003|Overall Study|Withdrawal by Subject|0
2313338|NCT02788201|4020737|FG004|Overall Study|Withdrawal by Subject|0
2313339|NCT02788201|4020738|FG005|Overall Study|Withdrawal by Subject|1
2313340|NCT02788279|4020757|FG000|Overall Study|Death|62
2313341|NCT02788279|4020758|FG001|Overall Study|Death|136
2313342|NCT02788279|4020759|FG002|Overall Study|Death|72
2313343|NCT02788279|4020757|FG000|Overall Study|Withdrawal by Subject|10
2313344|NCT02788279|4020758|FG001|Overall Study|Withdrawal by Subject|15
2313345|NCT02788279|4020759|FG002|Overall Study|Withdrawal by Subject|5
2313346|NCT02788279|4020757|FG000|Overall Study|Lost to Follow-up|0
2313347|NCT02788279|4020758|FG001|Overall Study|Lost to Follow-up|3
2313348|NCT02788279|4020759|FG002|Overall Study|Lost to Follow-up|2
2313349|NCT02788279|4020757|FG000|Overall Study|Sponsor decision|18
2313350|NCT02788279|4020758|FG001|Overall Study|Sponsor decision|29
2313351|NCT02788279|4020759|FG002|Overall Study|Sponsor decision|11
2313352|NCT02788357|4020772|FG000|Overall Study|Lost to Follow-up|3
2313353|NCT02788357|4020773|FG001|Overall Study|Lost to Follow-up|0
2313354|NCT02788474|4020781|FG000|Double Blind Treatment Period|Not treated|1
2313355|NCT02788474|4020782|FG001|Double Blind Treatment Period|Not treated|0
2313356|NCT02788474|4020781|FG000|Double Blind Treatment Period|Patient's refusal|3
2313357|NCT02788474|4020782|FG001|Double Blind Treatment Period|Patient's refusal|0
2014420|NCT00262028|3581442|FG007|Overall Study|Unable to classify|0
2014421|NCT00262028|3581443|FG008|Overall Study|Unable to classify|1
2014422|NCT00262041|3581489|FG000|Overall Study|Withdrawal by Subject|0
2014423|NCT00262041|3581490|FG001|Overall Study|Withdrawal by Subject|3
2014424|NCT00262041|3581491|FG002|Overall Study|Withdrawal by Subject|1
2014425|NCT00262041|3581489|FG000|Overall Study|Lost to Follow-up|1
2014426|NCT00262041|3581490|FG001|Overall Study|Lost to Follow-up|1
2014427|NCT00262041|3581491|FG002|Overall Study|Lost to Follow-up|5
2014428|NCT00262041|3581489|FG000|Overall Study|Unable to classify|1
2014429|NCT00262041|3581490|FG001|Overall Study|Unable to classify|0
2014430|NCT00262041|3581491|FG002|Overall Study|Unable to classify|0
2313358|NCT02788474|4020781|FG000|Double Blind Treatment Period|Adverse Event|6
2014431|NCT00262067|3581509|FG000|Overall Study|Death|190
2014432|NCT00262067|3581510|FG001|Overall Study|Death|89
2014433|NCT00262067|3581511|FG002|Overall Study|Death|186
2014434|NCT00262067|3581512|FG003|Overall Study|Death|99
2014435|NCT00262067|3581509|FG000|Overall Study|Lost to Follow-up|5
2014436|NCT00262067|3581510|FG001|Overall Study|Lost to Follow-up|4
2014437|NCT00262067|3581511|FG002|Overall Study|Lost to Follow-up|7
2014438|NCT00262067|3581512|FG003|Overall Study|Lost to Follow-up|5
2014439|NCT00262067|3581509|FG000|Overall Study|Sponsor's Decision to Terminate Study|1
2014440|NCT00262067|3581510|FG001|Overall Study|Sponsor's Decision to Terminate Study|0
2014441|NCT00262067|3581511|FG002|Overall Study|Sponsor's Decision to Terminate Study|0
2025704|NCT00347360|3594610|FG007|Overall Study|Lack of Efficacy|1
2313359|NCT02788474|4020782|FG001|Double Blind Treatment Period|Adverse Event|4
2313360|NCT02788474|4020781|FG000|Open Label Treatment Period|Adverse Event|29
2313361|NCT02788474|4020782|FG001|Open Label Treatment Period|Adverse Event|9
2313362|NCT02788474|4020781|FG000|Open Label Treatment Period|Other than reason specified|1
2313363|NCT02788474|4020782|FG001|Open Label Treatment Period|Other than reason specified|0
2313364|NCT02788474|4020781|FG000|Open Label Treatment Period|Patient's refusal|1
2313365|NCT02788474|4020782|FG001|Open Label Treatment Period|Patient's refusal|3
2313366|NCT02788474|4020781|FG000|Open Label Treatment Period|Non-compliance|1
2313367|NCT02788474|4020782|FG001|Open Label Treatment Period|Non-compliance|0
2313368|NCT02788513|4020794|FG000|Overall Study|Withdrawal by Subject|3
2313369|NCT02788513|4020795|FG001|Overall Study|Withdrawal by Subject|0
2313370|NCT02788513|4020796|FG002|Overall Study|Withdrawal by Subject|2
2313371|NCT02788513|4020797|FG003|Overall Study|Withdrawal by Subject|3
2313372|NCT02788513|4020798|FG004|Overall Study|Withdrawal by Subject|1
2313373|NCT02788513|4020794|FG000|Overall Study|Lost to Follow-up|1
2313374|NCT02788513|4020795|FG001|Overall Study|Lost to Follow-up|0
2313375|NCT02788513|4020796|FG002|Overall Study|Lost to Follow-up|0
2313376|NCT02788513|4020797|FG003|Overall Study|Lost to Follow-up|0
2313377|NCT02788513|4020798|FG004|Overall Study|Lost to Follow-up|1
2313378|NCT02788513|4020794|FG000|Overall Study|Adverse Event|5
2313379|NCT02788513|4020795|FG001|Overall Study|Adverse Event|8
2313380|NCT02788513|4020796|FG002|Overall Study|Adverse Event|4
2313381|NCT02788513|4020797|FG003|Overall Study|Adverse Event|2
2313382|NCT02788513|4020798|FG004|Overall Study|Adverse Event|2
2313383|NCT02788513|4020794|FG000|Overall Study|Protocol Violation|0
2313384|NCT02788513|4020795|FG001|Overall Study|Protocol Violation|0
2313385|NCT02788513|4020796|FG002|Overall Study|Protocol Violation|1
2313386|NCT02788513|4020797|FG003|Overall Study|Protocol Violation|1
2313387|NCT02788513|4020798|FG004|Overall Study|Protocol Violation|0
2313388|NCT02788513|4020794|FG000|Overall Study|Subject decided to stop taking treatment|0
2313389|NCT02788513|4020795|FG001|Overall Study|Subject decided to stop taking treatment|0
2313390|NCT02788513|4020796|FG002|Overall Study|Subject decided to stop taking treatment|1
2313391|NCT02788513|4020797|FG003|Overall Study|Subject decided to stop taking treatment|0
2313392|NCT02788513|4020798|FG004|Overall Study|Subject decided to stop taking treatment|0
2313393|NCT02788513|4020794|FG000|Overall Study|Decision by the study team|0
2313394|NCT02788513|4020795|FG001|Overall Study|Decision by the study team|0
2313395|NCT02788513|4020796|FG002|Overall Study|Decision by the study team|0
2313396|NCT02788513|4020797|FG003|Overall Study|Decision by the study team|0
2014442|NCT00262067|3581512|FG003|Overall Study|Sponsor's Decision to Terminate Study|0
2014443|NCT00262067|3581509|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23
2014444|NCT00262067|3581510|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7
2014445|NCT00262067|3581511|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23
2014446|NCT00262067|3581512|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9
2014447|NCT00262080|3581525|FG000|Double Blind Treatment Period|Lost to Follow-up|1
2014448|NCT00262080|3581526|FG001|Double Blind Treatment Period|Lost to Follow-up|0
2014449|NCT00262080|3581527|FG002|Double Blind Treatment Period|Lost to Follow-up|0
2014450|NCT00262080|3581525|FG000|Repeat Dose Treatment Period|Adverse Event|1
2014451|NCT00262080|3581526|FG001|Repeat Dose Treatment Period|Adverse Event|0
2014452|NCT00262080|3581527|FG002|Repeat Dose Treatment Period|Adverse Event|0
2014453|NCT00262080|3581525|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0
2014454|NCT00262080|3581526|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1
2014455|NCT00262080|3581527|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1
2014456|NCT00262080|3581525|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2
2014457|NCT00262080|3581526|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0
2014458|NCT00262080|3581527|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2
2014459|NCT00262080|3581525|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0
2014460|NCT00262080|3581526|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0
2014461|NCT00262080|3581527|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2
2014462|NCT00262080|3581525|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1
2014463|NCT00262080|3581526|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0
2014464|NCT00262080|3581527|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0
2014465|NCT00262119|3581538|FG000|Overall Study|Lost to Follow-up|38
2014466|NCT00262119|3581539|FG001|Overall Study|Lost to Follow-up|51
2014467|NCT00262119|3581540|FG002|Overall Study|Lost to Follow-up|42
2014468|NCT00262119|3581538|FG000|Overall Study|Death|20
2014469|NCT00262119|3581539|FG001|Overall Study|Death|19
2014470|NCT00262119|3581540|FG002|Overall Study|Death|16
2313397|NCT02788513|4020798|FG004|Overall Study|Decision by the study team|1
2313398|NCT02788656|4020812|FG000|Overall Study|Withdrawal by Subject|1
2313399|NCT02788656|4020813|FG001|Overall Study|Withdrawal by Subject|0
2313400|NCT02788747|4020822|FG000|Overall Study|Adverse Event|1
2014471|NCT00262223|3581550|FG000|Treatment Phase|Withdrawal by Subject|3
2014472|NCT00262223|3581551|FG001|Treatment Phase|Withdrawal by Subject|6
2014473|NCT00262223|3581550|FG000|Treatment Phase|Adverse Event|1
2014474|NCT00262223|3581551|FG001|Treatment Phase|Adverse Event|2
2014475|NCT00262223|3581550|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4
2014476|NCT00262223|3581551|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4
2014477|NCT00262223|3581550|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6
2014478|NCT00262223|3581551|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1
2014479|NCT00262223|3581550|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7
2014480|NCT00262223|3581551|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7
2014481|NCT00262301|3581561|FG000|Double-blind Phase|Lost to Follow-up|1
2014482|NCT00262301|3581562|FG001|Double-blind Phase|Lost to Follow-up|0
2014483|NCT00262301|3581563|FG002|Double-blind Phase|Lost to Follow-up|0
2014484|NCT00262301|3581561|FG000|Double-blind Phase|"worsening of HAE symptoms"|0
2014485|NCT00262301|3581562|FG001|Double-blind Phase|"worsening of HAE symptoms"|1
2014486|NCT00262301|3581563|FG002|Double-blind Phase|"worsening of HAE symptoms"|0
2014487|NCT00262314|3581571|FG000|Overall Study|Changing physicians|38
2014488|NCT00262314|3581571|FG000|Overall Study|Death|12
2014489|NCT00262314|3581571|FG000|Overall Study|Patient's decision|92
2014490|NCT00262314|3581571|FG000|Overall Study|Other|95
2014491|NCT00262314|3581571|FG000|Overall Study|Lost to Follow-up|70
2014492|NCT00262314|3581571|FG000|Overall Study|Administrative withdrawal|30
2014493|NCT00262522|3581588|FG000|Study Start Through 8 Weeks|Adverse Event|1
2014494|NCT00262522|3581589|FG001|Study Start Through 8 Weeks|Adverse Event|2
2014495|NCT00262522|3581590|FG002|Study Start Through 8 Weeks|Adverse Event|3
2014496|NCT00262522|3581591|FG003|Study Start Through 8 Weeks|Adverse Event|1
2014497|NCT00262522|3581588|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1
2014498|NCT00262522|3581589|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1
2014499|NCT00262522|3581590|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3
2014500|NCT00262522|3581591|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0
2014501|NCT00262522|3581588|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1
2014502|NCT00262522|3581589|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2
2014503|NCT00262522|3581590|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3
2014504|NCT00262522|3581591|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2
2014505|NCT00262522|3581588|FG000|Study Start Through 8 Weeks|Noncompliance|0
2014506|NCT00262522|3581589|FG001|Study Start Through 8 Weeks|Noncompliance|0
2014507|NCT00262522|3581590|FG002|Study Start Through 8 Weeks|Noncompliance|2
2014508|NCT00262522|3581591|FG003|Study Start Through 8 Weeks|Noncompliance|2
2014509|NCT00262522|3581588|FG000|Study Start Through 8 Weeks|Death|1
2014510|NCT00262522|3581589|FG001|Study Start Through 8 Weeks|Death|0
2014511|NCT00262522|3581590|FG002|Study Start Through 8 Weeks|Death|0
2014512|NCT00262522|3581591|FG003|Study Start Through 8 Weeks|Death|0
2014513|NCT00262522|3581588|FG000|Study Start Through 48 Weeks|Adverse Event|16
2014514|NCT00262522|3581589|FG001|Study Start Through 48 Weeks|Adverse Event|0
2014515|NCT00262522|3581590|FG002|Study Start Through 48 Weeks|Adverse Event|10
2014516|NCT00262522|3581591|FG003|Study Start Through 48 Weeks|Adverse Event|0
2014517|NCT00262522|3581588|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10
2014518|NCT00262522|3581589|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0
2014519|NCT00262522|3581590|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11
2014520|NCT00262522|3581591|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0
2014521|NCT00262522|3581588|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8
2014522|NCT00262522|3581589|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0
2014523|NCT00262522|3581590|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14
2014524|NCT00262522|3581591|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0
2014525|NCT00262522|3581588|FG000|Study Start Through 48 Weeks|Noncompliance|3
2014526|NCT00262522|3581589|FG001|Study Start Through 48 Weeks|Noncompliance|0
2014527|NCT00262522|3581590|FG002|Study Start Through 48 Weeks|Noncompliance|8
2014528|NCT00262522|3581591|FG003|Study Start Through 48 Weeks|Noncompliance|0
2014529|NCT00262522|3581588|FG000|Study Start Through 48 Weeks|Death|2
2014530|NCT00262522|3581589|FG001|Study Start Through 48 Weeks|Death|0
2014531|NCT00262522|3581590|FG002|Study Start Through 48 Weeks|Death|1
2014532|NCT00262522|3581591|FG003|Study Start Through 48 Weeks|Death|0
2014533|NCT00262522|3581588|FG000|Study Start Through 48 Weeks|Virologic failure|2
2014534|NCT00262522|3581589|FG001|Study Start Through 48 Weeks|Virologic failure|0
2014535|NCT00262522|3581590|FG002|Study Start Through 48 Weeks|Virologic failure|4
2014536|NCT00262522|3581591|FG003|Study Start Through 48 Weeks|Virologic failure|0
2014537|NCT00262522|3581588|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
2014538|NCT00262522|3581589|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
2014539|NCT00262522|3581590|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
2014540|NCT00262522|3581591|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
2014541|NCT00262522|3581588|FG000|Study Start Through 96 Weeks|Adverse Event|20
2014542|NCT00262522|3581589|FG001|Study Start Through 96 Weeks|Adverse Event|0
2014543|NCT00262522|3581590|FG002|Study Start Through 96 Weeks|Adverse Event|16
2014544|NCT00262522|3581591|FG003|Study Start Through 96 Weeks|Adverse Event|0
2014545|NCT00262522|3581588|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15
2014546|NCT00262522|3581589|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0
2014547|NCT00262522|3581590|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13
2014548|NCT00262522|3581591|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0
2014549|NCT00262522|3581588|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19
2014550|NCT00262522|3581589|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0
2014551|NCT00262522|3581590|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18
2014552|NCT00262522|3581591|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0
2014553|NCT00262522|3581588|FG000|Study Start Through 96 Weeks|Noncompliance|6
2014554|NCT00262522|3581589|FG001|Study Start Through 96 Weeks|Noncompliance|0
2014555|NCT00262522|3581590|FG002|Study Start Through 96 Weeks|Noncompliance|11
2014556|NCT00262522|3581591|FG003|Study Start Through 96 Weeks|Noncompliance|0
2014557|NCT00262522|3581588|FG000|Study Start Through 96 Weeks|Death|2
2014558|NCT00262522|3581589|FG001|Study Start Through 96 Weeks|Death|0
2014559|NCT00262522|3581590|FG002|Study Start Through 96 Weeks|Death|2
2014560|NCT00262522|3581591|FG003|Study Start Through 96 Weeks|Death|0
2014561|NCT00262522|3581588|FG000|Study Start Through 96 Weeks|Virologic failure|5
2014562|NCT00262522|3581589|FG001|Study Start Through 96 Weeks|Virologic failure|0
2014563|NCT00262522|3581590|FG002|Study Start Through 96 Weeks|Virologic failure|8
2014564|NCT00262522|3581591|FG003|Study Start Through 96 Weeks|Virologic failure|0
2014565|NCT00262522|3581588|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
2014566|NCT00262522|3581589|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
2014567|NCT00262522|3581590|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
2014568|NCT00262522|3581591|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
2014569|NCT00262600|3581602|FG000|Overall Study|Lost to Follow-up|17
2014570|NCT00262600|3581603|FG001|Overall Study|Lost to Follow-up|31
2014571|NCT00262600|3581604|FG002|Overall Study|Lost to Follow-up|41
2014572|NCT00262600|3581602|FG000|Overall Study|Withdrawal by Subject|128
2014573|NCT00262600|3581603|FG001|Overall Study|Withdrawal by Subject|145
2014574|NCT00262600|3581604|FG002|Overall Study|Withdrawal by Subject|139
2014575|NCT00262600|3581602|FG000|Overall Study|Not Treated|32
2014576|NCT00262600|3581603|FG001|Overall Study|Not Treated|17
2014577|NCT00262600|3581604|FG002|Overall Study|Not Treated|24
2014578|NCT00262600|3581602|FG000|Overall Study|Other|58
2014579|NCT00262600|3581603|FG001|Overall Study|Other|59
2014580|NCT00262600|3581604|FG002|Overall Study|Other|62
2014581|NCT00262743|3581635|FG000|Overall Study|Adverse Event|0
2014582|NCT00262743|3581636|FG001|Overall Study|Adverse Event|9
2014583|NCT00262743|3581635|FG000|Overall Study|Disease progression|0
2014584|NCT00262743|3581636|FG001|Overall Study|Disease progression|3
2014585|NCT00262821|3581642|FG000|Overall Study|Ineligible - wrong stage|0
2014586|NCT00262821|3581643|FG001|Overall Study|Ineligible - wrong stage|3
2014587|NCT00262821|3581642|FG000|Overall Study|Ineligible - wrong cell type|2
2014588|NCT00262821|3581643|FG001|Overall Study|Ineligible - wrong cell type|2
2014589|NCT00262821|3581642|FG000|Overall Study|Ineligible - wrong primary|0
2014590|NCT00262821|3581643|FG001|Overall Study|Ineligible - wrong primary|1
2014591|NCT00262821|3581642|FG000|Overall Study|Ineligible - inadequate pathology|1
2014592|NCT00262821|3581643|FG001|Overall Study|Ineligible - inadequate pathology|3
2014593|NCT00262821|3581642|FG000|Overall Study|Ineligible - elevated creatinine|0
2014594|NCT00262821|3581643|FG001|Overall Study|Ineligible - elevated creatinine|2
2014595|NCT00262821|3581642|FG000|Overall Study|Ineligible - required test not done|1
2014596|NCT00262821|3581643|FG001|Overall Study|Ineligible - required test not done|4
2014597|NCT00262821|3581642|FG000|Overall Study|Inevaluable - inadequate data|0
2014598|NCT00262821|3581643|FG001|Overall Study|Inevaluable - inadequate data|4
2014599|NCT00262834|3581651|FG000|Overall Study|Surgery delayed/tissue not collected|1
2014600|NCT00262834|3581652|FG001|Overall Study|Surgery delayed/tissue not collected|4
2014601|NCT00262847|3581661|FG000|Overall Study|Disease Progression|309
2014602|NCT00262847|3581662|FG001|Overall Study|Disease Progression|274
2014603|NCT00262847|3581663|FG002|Overall Study|Disease Progression|195
2014604|NCT00262847|3581661|FG000|Overall Study|Patient Refusal|41
2014605|NCT00262847|3581662|FG001|Overall Study|Patient Refusal|52
2014606|NCT00262847|3581663|FG002|Overall Study|Patient Refusal|47
2014607|NCT00262847|3581661|FG000|Overall Study|Adverse Event|74
2014608|NCT00262847|3581662|FG001|Overall Study|Adverse Event|88
2014609|NCT00262847|3581663|FG002|Overall Study|Adverse Event|108
2014610|NCT00262847|3581661|FG000|Overall Study|Death|8
2014611|NCT00262847|3581662|FG001|Overall Study|Death|8
2014612|NCT00262847|3581663|FG002|Overall Study|Death|11
2014613|NCT00262847|3581661|FG000|Overall Study|Concomitant disease|3
2014614|NCT00262847|3581662|FG001|Overall Study|Concomitant disease|2
2014615|NCT00262847|3581663|FG002|Overall Study|Concomitant disease|4
2014616|NCT00262847|3581661|FG000|Overall Study|Other Reasons|79
2014617|NCT00262847|3581662|FG001|Overall Study|Other Reasons|88
2014618|NCT00262847|3581663|FG002|Overall Study|Other Reasons|27
2014619|NCT00262847|3581661|FG000|Overall Study|Did not receive study treatment|4
2014620|NCT00262847|3581662|FG001|Overall Study|Did not receive study treatment|1
2014621|NCT00262847|3581663|FG002|Overall Study|Did not receive study treatment|4
2014622|NCT00262860|3581674|FG000|Overall Study|Adverse Event|2
2014623|NCT00262873|3581678|FG000|Overall Study|Adverse Event|3
2014624|NCT00262873|3581678|FG000|Overall Study|Withdrawal by Subject|5
2014625|NCT00262925|3581682|FG000|Overall Study|Lack of Efficacy|3
2014626|NCT00262925|3581682|FG000|Overall Study|Adverse Event|4
2014627|NCT00262925|3581682|FG000|Overall Study|Death|2
2014628|NCT00262925|3581682|FG000|Overall Study|alternative therapy|1
2014629|NCT00262925|3581682|FG000|Overall Study|Other|1
2014630|NCT00262951|3581688|FG000|Overall Study|Progressive disease/relapse|3
2014631|NCT00262951|3581688|FG000|Overall Study|Adverse Event|7
2014632|NCT00262951|3581688|FG000|Overall Study|Death|1
2014633|NCT00262951|3581688|FG000|Overall Study|Withdrawal by Subject|1
2014634|NCT00262951|3581688|FG000|Overall Study|Alternative treatment|3
2014635|NCT00262951|3581688|FG000|Overall Study|Off treatment for other disease|1
2014636|NCT00263211|3581721|FG000|Overall Study|Death|1
2014637|NCT00263211|3581722|FG001|Overall Study|Death|0
2014638|NCT00263211|3581721|FG000|Overall Study|Withdrawal by Subject|3
2014639|NCT00263211|3581722|FG001|Overall Study|Withdrawal by Subject|0
2014640|NCT00263211|3581721|FG000|Overall Study|Protocol Violation|1
2014641|NCT00263211|3581722|FG001|Overall Study|Protocol Violation|0
2014642|NCT00263211|3581721|FG000|Overall Study|Disease Progression|0
2014643|NCT00263211|3581722|FG001|Overall Study|Disease Progression|1
2014644|NCT00263328|3581734|FG000|Overall Study|Death|0
2014645|NCT00263328|3581735|FG001|Overall Study|Death|0
2014646|NCT00263328|3581736|FG002|Overall Study|Death|1
2014647|NCT00263328|3581734|FG000|Overall Study|Lost to Follow-up|1
2014648|NCT00263328|3581735|FG001|Overall Study|Lost to Follow-up|1
2014649|NCT00263328|3581736|FG002|Overall Study|Lost to Follow-up|0
2014650|NCT00263328|3581734|FG000|Overall Study|Withdrawal by Subject|3
2014651|NCT00263328|3581735|FG001|Overall Study|Withdrawal by Subject|0
2014652|NCT00263328|3581736|FG002|Overall Study|Withdrawal by Subject|1
2014653|NCT00263328|3581734|FG000|Overall Study|Other|3
2014654|NCT00263328|3581735|FG001|Overall Study|Other|0
2014655|NCT00263328|3581736|FG002|Overall Study|Other|1
2014656|NCT00263328|3581734|FG000|Overall Study|Adverse Event|1
2014657|NCT00263328|3581735|FG001|Overall Study|Adverse Event|1
2014658|NCT00263328|3581736|FG002|Overall Study|Adverse Event|4
2014659|NCT00263562|3581748|FG000|Overall Study|Protocol Violation|3
2014660|NCT00263562|3581749|FG001|Overall Study|Protocol Violation|0
2014661|NCT00263575|3581757|FG000|Titration Period|Adverse Event|14
2014662|NCT00263575|3581757|FG000|Titration Period|Withdrawal by Subject|10
2014663|NCT00263575|3581757|FG000|Titration Period|Protocol Violation|9
2014664|NCT00263575|3581757|FG000|Titration Period|Sponsor Decision|2
2014665|NCT00263575|3581757|FG000|Titration Period|Other|2
2014666|NCT00263575|3581757|FG000|Titration Period|Lack of Efficacy|6
2014667|NCT00263575|3581757|FG000|Maintence Period|Adverse Event|23
2014668|NCT00263575|3581757|FG000|Maintence Period|Withdrawal by Subject|8
2014669|NCT00263575|3581757|FG000|Maintence Period|Protocol Violation|4
2014670|NCT00263575|3581757|FG000|Maintence Period|Lack of Efficacy|4
2014671|NCT00263575|3581757|FG000|Maintence Period|Physician Decision|6
2014672|NCT00263575|3581757|FG000|Maintence Period|Lost to Follow-up|1
2014673|NCT00263575|3581757|FG000|Maintence Period|Sponsor Decision|24
2014674|NCT00263575|3581757|FG000|Maintence Period|Other|7
2014675|NCT00263588|3581765|FG000|Overall Study|Death|54
2014676|NCT00263588|3581766|FG001|Overall Study|Death|90
2014677|NCT00263588|3581765|FG000|Overall Study|disease progression, coma, 1 unknown|10
2014678|NCT00263588|3581766|FG001|Overall Study|disease progression, coma, 1 unknown|11
2014679|NCT00263588|3581765|FG000|Overall Study|Lost to Follow-up|7
2014680|NCT00263588|3581766|FG001|Overall Study|Lost to Follow-up|10
2014681|NCT00263588|3581765|FG000|Overall Study|Withdrawal by Subject|3
2014682|NCT00263588|3581766|FG001|Overall Study|Withdrawal by Subject|4
2014683|NCT00263588|3581765|FG000|Overall Study|Protocol Violation|0
2014684|NCT00263588|3581766|FG001|Overall Study|Protocol Violation|1
2014685|NCT00263588|3581765|FG000|Overall Study|Investigator decision|7
2014686|NCT00263588|3581766|FG001|Overall Study|Investigator decision|15
2014687|NCT00263588|3581765|FG000|Overall Study|Sponsor terminated study|0
2014688|NCT00263588|3581766|FG001|Overall Study|Sponsor terminated study|1
2014689|NCT00263666|3581775|FG000|Overall Study|Adverse Event|6
2014690|NCT00263666|3581776|FG001|Overall Study|Adverse Event|8
2014691|NCT00263666|3581775|FG000|Overall Study|Lost to Follow-up|1
2014692|NCT00263666|3581776|FG001|Overall Study|Lost to Follow-up|2
2014693|NCT00263666|3581775|FG000|Overall Study|Withdrawal by Subject|0
2014694|NCT00263666|3581776|FG001|Overall Study|Withdrawal by Subject|1
2014695|NCT00263757|3581784|FG000|Overall Study|Withdrawal by Subject|5
2014696|NCT00263757|3581785|FG001|Overall Study|Withdrawal by Subject|4
2014697|NCT00263757|3581784|FG000|Overall Study|Screen failure|0
2014698|NCT00263757|3581785|FG001|Overall Study|Screen failure|1
2014699|NCT00263757|3581784|FG000|Overall Study|Adverse Event|3
2014700|NCT00263757|3581785|FG001|Overall Study|Adverse Event|3
2014701|NCT00263887|3581793|FG000|Overall Study|Withdrawal by Subject|1
2014702|NCT00263887|3581794|FG001|Overall Study|Withdrawal by Subject|1
2014703|NCT00263887|3581793|FG000|Overall Study|Lung transplantation|1
2014704|NCT00263887|3581794|FG001|Overall Study|Lung transplantation|2
2014705|NCT00263887|3581793|FG000|Overall Study|Too ill to attend visit|1
2014706|NCT00263887|3581794|FG001|Overall Study|Too ill to attend visit|0
2014707|NCT00263887|3581793|FG000|Overall Study|Adverse Event|0
2014708|NCT00263887|3581794|FG001|Overall Study|Adverse Event|2
2014709|NCT00263887|3581793|FG000|Overall Study|Disease progression|0
2014710|NCT00263887|3581794|FG001|Overall Study|Disease progression|1
2014711|NCT00263887|3581793|FG000|Overall Study|Lack of Efficacy|0
2014712|NCT00263887|3581794|FG001|Overall Study|Lack of Efficacy|1
2014713|NCT00264004|3581804|FG000|Overall Study|Adverse Event|2
2014714|NCT00264004|3581805|FG001|Overall Study|Adverse Event|3
2014715|NCT00264004|3581806|FG002|Overall Study|Adverse Event|6
2014716|NCT00264004|3581807|FG003|Overall Study|Adverse Event|4
2014717|NCT00264004|3581804|FG000|Overall Study|Withdrawal by Subject|0
2014718|NCT00264004|3581805|FG001|Overall Study|Withdrawal by Subject|1
2014719|NCT00264004|3581806|FG002|Overall Study|Withdrawal by Subject|2
2014720|NCT00264004|3581807|FG003|Overall Study|Withdrawal by Subject|2
2014721|NCT00264004|3581804|FG000|Overall Study|Other|2
2014722|NCT00264004|3581805|FG001|Overall Study|Other|2
2014723|NCT00264004|3581806|FG002|Overall Study|Other|0
2014724|NCT00264004|3581807|FG003|Overall Study|Other|3
2014725|NCT00264004|3581804|FG000|Overall Study|Development study specific disc. crit.|1
2014726|NCT00264004|3581805|FG001|Overall Study|Development study specific disc. crit.|0
2014727|NCT00264004|3581806|FG002|Overall Study|Development study specific disc. crit.|1
2014728|NCT00264004|3581807|FG003|Overall Study|Development study specific disc. crit.|0
2014729|NCT00264004|3581804|FG000|Overall Study|Cond. under inv. worsened|9
2014730|NCT00264004|3581805|FG001|Overall Study|Cond. under inv. worsened|5
2014731|NCT00264004|3581806|FG002|Overall Study|Cond. under inv. worsened|3
2014732|NCT00264004|3581807|FG003|Overall Study|Cond. under inv. worsened|4
2014733|NCT00264004|3581804|FG000|Overall Study|Not treated|3
2014734|NCT00264004|3581805|FG001|Overall Study|Not treated|0
2014735|NCT00264004|3581806|FG002|Overall Study|Not treated|2
2014736|NCT00264004|3581807|FG003|Overall Study|Not treated|2
2014737|NCT00264238|3581817|FG000|Overall Study|Protocol Violation|1
2014738|NCT00264290|3581825|FG000|Intervention (8 Weeks)|Adverse Event|1
2014739|NCT00264290|3581826|FG001|Intervention (8 Weeks)|Adverse Event|0
2014740|NCT00264303|3581838|FG000|Overall Study|Adverse Event|4
2014741|NCT00264303|3581839|FG001|Overall Study|Adverse Event|3
2014742|NCT00264303|3581838|FG000|Overall Study|Lack of Efficacy|10
2014743|NCT00264303|3581839|FG001|Overall Study|Lack of Efficacy|13
2014744|NCT00264303|3581838|FG000|Overall Study|Lost to Follow-up|3
2014745|NCT00264303|3581839|FG001|Overall Study|Lost to Follow-up|3
2014746|NCT00264303|3581838|FG000|Overall Study|Withdrawal by Subject|2
2014747|NCT00264303|3581839|FG001|Overall Study|Withdrawal by Subject|3
2014748|NCT00264303|3581838|FG000|Overall Study|Various reasons listed in study report|6
2014749|NCT00264303|3581839|FG001|Overall Study|Various reasons listed in study report|7
2014750|NCT00264498|3581856|FG000|Randomized Treatment|Death|0
2014751|NCT00264498|3581857|FG001|Randomized Treatment|Death|3
2014752|NCT00264498|3581856|FG000|Randomized Treatment|Withdrawal by Subject|0
2014753|NCT00264498|3581857|FG001|Randomized Treatment|Withdrawal by Subject|1
2014754|NCT00264498|3581856|FG000|Randomized Treatment|Objective disease Progression|13
2014755|NCT00264498|3581857|FG001|Randomized Treatment|Objective disease Progression|14
2014756|NCT00264498|3581856|FG000|Randomized Treatment|Physician Decision|1
2014757|NCT00264498|3581857|FG001|Randomized Treatment|Physician Decision|0
2014758|NCT00264498|3581856|FG000|Randomized Treatment|Incorrectly randomized|1
2014759|NCT00264498|3581857|FG001|Randomized Treatment|Incorrectly randomized|0
2014760|NCT00264498|3581856|FG000|Randomized Treatment|Study Closure|1
2014761|NCT00264498|3581857|FG001|Randomized Treatment|Study Closure|0
2014762|NCT00264498|3581856|FG000|Randomized Treatment|Protocol Violation|1
2014763|NCT00264498|3581857|FG001|Randomized Treatment|Protocol Violation|0
2014764|NCT00264498|3581856|FG000|Crossover Treatment|Death|1
2014765|NCT00264498|3581857|FG001|Crossover Treatment|Death|3
2014766|NCT00264498|3581856|FG000|Crossover Treatment|Objective disease progression|4
2014767|NCT00264498|3581857|FG001|Crossover Treatment|Objective disease progression|5
2014768|NCT00264498|3581856|FG000|Crossover Treatment|Study closure|0
2014769|NCT00264498|3581857|FG001|Crossover Treatment|Study closure|1
2014770|NCT00264498|3581856|FG000|Crossover Treatment|Withdrawal by Subject|1
2014771|NCT00264498|3581857|FG001|Crossover Treatment|Withdrawal by Subject|0
2014772|NCT00264537|3581867|FG000|Overall Study|Death|0
2014773|NCT00264537|3581868|FG001|Overall Study|Death|3
2014774|NCT00264537|3581869|FG002|Overall Study|Death|3
2014775|NCT00264537|3581870|FG003|Overall Study|Death|2
2014776|NCT00264537|3581867|FG000|Overall Study|Lost to Follow-up|3
2014777|NCT00264537|3581868|FG001|Overall Study|Lost to Follow-up|4
2014778|NCT00264537|3581869|FG002|Overall Study|Lost to Follow-up|7
2014779|NCT00264537|3581870|FG003|Overall Study|Lost to Follow-up|6
2014780|NCT00264537|3581867|FG000|Overall Study|Adverse Event|21
2014781|NCT00264537|3581868|FG001|Overall Study|Adverse Event|32
2014782|NCT00264537|3581869|FG002|Overall Study|Adverse Event|24
2014783|NCT00264537|3581870|FG003|Overall Study|Adverse Event|34
2014784|NCT00264537|3581867|FG000|Overall Study|Unsatisfactory therapeutic effect|5
2014785|NCT00264537|3581868|FG001|Overall Study|Unsatisfactory therapeutic effect|6
2014786|NCT00264537|3581869|FG002|Overall Study|Unsatisfactory therapeutic effect|5
2014787|NCT00264537|3581870|FG003|Overall Study|Unsatisfactory therapeutic effect|7
2014788|NCT00264537|3581867|FG000|Overall Study|Other|21
2014789|NCT00264537|3581868|FG001|Overall Study|Other|11
2014790|NCT00264537|3581869|FG002|Overall Study|Other|10
2014791|NCT00264537|3581870|FG003|Overall Study|Other|11
2014792|NCT00264537|3581867|FG000|Overall Study|Not treated|0
2014793|NCT00264537|3581868|FG001|Overall Study|Not treated|2
2014794|NCT00264537|3581869|FG002|Overall Study|Not treated|1
2014795|NCT00264537|3581870|FG003|Overall Study|Not treated|0
2014796|NCT00264550|3581886|FG000|Overall Study|Death|0
2014797|NCT00264550|3581887|FG001|Overall Study|Death|3
2014798|NCT00264550|3581888|FG002|Overall Study|Death|0
2014799|NCT00264550|3581889|FG003|Overall Study|Death|0
2014800|NCT00264550|3581886|FG000|Overall Study|Lost to Follow-up|3
2014801|NCT00264550|3581887|FG001|Overall Study|Lost to Follow-up|1
2014802|NCT00264550|3581888|FG002|Overall Study|Lost to Follow-up|1
2014803|NCT00264550|3581889|FG003|Overall Study|Lost to Follow-up|1
2014804|NCT00264550|3581886|FG000|Overall Study|Adverse Event|23
2014805|NCT00264550|3581887|FG001|Overall Study|Adverse Event|18
2014806|NCT00264550|3581888|FG002|Overall Study|Adverse Event|9
2014807|NCT00264550|3581889|FG003|Overall Study|Adverse Event|14
2014808|NCT00264550|3581886|FG000|Overall Study|Unsatisfactory therapeutic effect|4
2014809|NCT00264550|3581887|FG001|Overall Study|Unsatisfactory therapeutic effect|11
2014810|NCT00264550|3581888|FG002|Overall Study|Unsatisfactory therapeutic effect|4
2014811|NCT00264550|3581889|FG003|Overall Study|Unsatisfactory therapeutic effect|6
2014812|NCT00264550|3581886|FG000|Overall Study|Discontinued oral study agent|0
2014813|NCT00264550|3581887|FG001|Overall Study|Discontinued oral study agent|1
2014814|NCT00264550|3581888|FG002|Overall Study|Discontinued oral study agent|0
2014815|NCT00264550|3581889|FG003|Overall Study|Discontinued oral study agent|0
2014816|NCT00264550|3581886|FG000|Overall Study|Other|13
2014817|NCT00264550|3581887|FG001|Overall Study|Other|7
2014818|NCT00264550|3581888|FG002|Overall Study|Other|3
2014819|NCT00264550|3581889|FG003|Overall Study|Other|9
2014820|NCT00264576|3581901|FG000|Overall Study|Lost to Follow-up|1
2014821|NCT00264576|3581902|FG001|Overall Study|Lost to Follow-up|1
2014822|NCT00264797|3581919|FG000|Overall Study|Withdrawal by Subject|11
2014823|NCT00264797|3581920|FG001|Overall Study|Withdrawal by Subject|11
2014824|NCT00264797|3581919|FG000|Overall Study|Lost to Follow-up|9
2014825|NCT00264797|3581920|FG001|Overall Study|Lost to Follow-up|17
2014826|NCT00264797|3581919|FG000|Overall Study|Moved from area|3
2014827|NCT00264797|3581920|FG001|Overall Study|Moved from area|1
2014828|NCT00264797|3581919|FG000|Overall Study|Practical Problems|2
2014829|NCT00264797|3581920|FG001|Overall Study|Practical Problems|3
2014830|NCT00264797|3581919|FG000|Overall Study|Incarceration|4
2014831|NCT00264797|3581920|FG001|Overall Study|Incarceration|5
2014832|NCT00264797|3581919|FG000|Overall Study|Pressure/advice from Outsiders|1
2014833|NCT00264797|3581920|FG001|Overall Study|Pressure/advice from Outsiders|1
2014834|NCT00264797|3581919|FG000|Overall Study|Feels treatment not necessary, not worki|0
2014835|NCT00264797|3581920|FG001|Overall Study|Feels treatment not necessary, not worki|1
2014836|NCT00264797|3581919|FG000|Overall Study|Other|3
2014837|NCT00264797|3581920|FG001|Overall Study|Other|4
2014838|NCT00264810|3581928|FG000|Baseline|Withdrawal by Subject|10
2014839|NCT00264810|3581929|FG001|Baseline|Withdrawal by Subject|10
2014840|NCT00264810|3581928|FG000|Baseline|Physician Decision|7
2014841|NCT00264810|3581929|FG001|Baseline|Physician Decision|8
2014842|NCT00264810|3581928|FG000|Baseline|Subject Compliance Failure|3
2014843|NCT00264810|3581929|FG001|Baseline|Subject Compliance Failure|3
2014844|NCT00264810|3581928|FG000|Baseline|Insufficient Seizure Frequency|2
2014845|NCT00264810|3581929|FG001|Baseline|Insufficient Seizure Frequency|2
2014846|NCT00264810|3581928|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1
2014847|NCT00264810|3581929|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2
2014848|NCT00264810|3581928|FG000|Baseline|Other|0
2014849|NCT00264810|3581929|FG001|Baseline|Other|1
2014850|NCT00264810|3581928|FG000|Stimulation Optimization Period|Withdrawal by Subject|1
2014851|NCT00264810|3581929|FG001|Stimulation Optimization Period|Withdrawal by Subject|0
2014852|NCT00264810|3581928|FG000|Stimulation Optimization Period|Death|0
2014853|NCT00264810|3581929|FG001|Stimulation Optimization Period|Death|1
2014854|NCT00264810|3581928|FG000|Blinded Evaluation Period|Explant due to infection|1
2014855|NCT00264810|3581929|FG001|Blinded Evaluation Period|Explant due to infection|1
2014856|NCT00264810|3581928|FG000|Open Label Evaluation Period|Explant due to infection|1
2014857|NCT00264810|3581929|FG001|Open Label Evaluation Period|Explant due to infection|1
2014858|NCT00264810|3581928|FG000|Open Label Evaluation Period|Death|3
2014859|NCT00264810|3581929|FG001|Open Label Evaluation Period|Death|2
2014860|NCT00264810|3581928|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2
2014861|NCT00264810|3581929|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3
2025705|NCT00347360|3594611|FG008|Overall Study|Lack of Efficacy|1
2025706|NCT00347360|3594612|FG009|Overall Study|Lack of Efficacy|0
2025707|NCT00347360|3594613|FG010|Overall Study|Lack of Efficacy|0
2025708|NCT00347360|3594614|FG011|Overall Study|Lack of Efficacy|0
2025709|NCT00347360|3594615|FG012|Overall Study|Lack of Efficacy|0
2025710|NCT00347360|3594616|FG013|Overall Study|Lack of Efficacy|0
2025711|NCT00347360|3594617|FG014|Overall Study|Lack of Efficacy|0
2025712|NCT00347360|3594603|FG000|Overall Study|Reason not listed/blank|1
2025713|NCT00347360|3594604|FG001|Overall Study|Reason not listed/blank|0
2025714|NCT00347360|3594605|FG002|Overall Study|Reason not listed/blank|0
2025715|NCT00347360|3594606|FG003|Overall Study|Reason not listed/blank|0
2025716|NCT00347360|3594607|FG004|Overall Study|Reason not listed/blank|0
2025717|NCT00347360|3594608|FG005|Overall Study|Reason not listed/blank|0
2025718|NCT00347360|3594609|FG006|Overall Study|Reason not listed/blank|1
2025719|NCT00347360|3594610|FG007|Overall Study|Reason not listed/blank|0
2025720|NCT00347360|3594611|FG008|Overall Study|Reason not listed/blank|0
2025721|NCT00347360|3594612|FG009|Overall Study|Reason not listed/blank|0
2025722|NCT00347360|3594613|FG010|Overall Study|Reason not listed/blank|0
2025723|NCT00347360|3594614|FG011|Overall Study|Reason not listed/blank|0
2025724|NCT00347360|3594615|FG012|Overall Study|Reason not listed/blank|0
2025725|NCT00347360|3594616|FG013|Overall Study|Reason not listed/blank|1
2025726|NCT00347360|3594617|FG014|Overall Study|Reason not listed/blank|0
2025727|NCT00347360|3594603|FG000|Overall Study|Per sponsors instruction|0
2025728|NCT00347360|3594604|FG001|Overall Study|Per sponsors instruction|1
2025729|NCT00347360|3594605|FG002|Overall Study|Per sponsors instruction|0
2025730|NCT00347360|3594606|FG003|Overall Study|Per sponsors instruction|0
2025731|NCT00347360|3594607|FG004|Overall Study|Per sponsors instruction|0
2014862|NCT00264849|3581939|FG000|Overall Study|Adverse Event|7
2014863|NCT00264849|3581940|FG001|Overall Study|Adverse Event|2
2014864|NCT00264849|3581939|FG000|Overall Study|Withdrawal by Subject|7
2014865|NCT00264849|3581940|FG001|Overall Study|Withdrawal by Subject|11
2014866|NCT00264849|3581939|FG000|Overall Study|Protocol Violation|5
2014867|NCT00264849|3581940|FG001|Overall Study|Protocol Violation|3
2014868|NCT00264849|3581939|FG000|Overall Study|Lack of Efficacy|1
2014869|NCT00264849|3581940|FG001|Overall Study|Lack of Efficacy|6
2014870|NCT00264849|3581939|FG000|Overall Study|Lost to Follow-up|0
2014871|NCT00264849|3581940|FG001|Overall Study|Lost to Follow-up|2
2014872|NCT00264849|3581939|FG000|Overall Study|Death|0
2014873|NCT00264849|3581940|FG001|Overall Study|Death|1
2014874|NCT00264849|3581939|FG000|Overall Study|Administrative Problems|2
2014875|NCT00264849|3581940|FG001|Overall Study|Administrative Problems|0
2014876|NCT00264875|3581946|FG000|Overall Study|Adverse Event|6
2014877|NCT00264875|3581946|FG000|Overall Study|Lost to Follow-up|6
2014878|NCT00264875|3581946|FG000|Overall Study|Protocol Violation|11
2014879|NCT00264875|3581946|FG000|Overall Study|Withdrawal by Subject|7
2313401|NCT02788747|4020823|FG001|Overall Study|Adverse Event|0
2014880|NCT00265083|3581953|FG000|Overall Study|Adverse Event|5
2014881|NCT00265083|3581954|FG001|Overall Study|Adverse Event|13
2014882|NCT00265083|3581955|FG002|Overall Study|Adverse Event|15
2014883|NCT00265083|3581953|FG000|Overall Study|Lost to Follow-up|3
2014884|NCT00265083|3581954|FG001|Overall Study|Lost to Follow-up|4
2014885|NCT00265083|3581955|FG002|Overall Study|Lost to Follow-up|4
2014886|NCT00265083|3581953|FG000|Overall Study|Unsatisfactory therapeutic effect|8
2014887|NCT00265083|3581954|FG001|Overall Study|Unsatisfactory therapeutic effect|13
2014888|NCT00265083|3581955|FG002|Overall Study|Unsatisfactory therapeutic effect|14
2014889|NCT00265083|3581953|FG000|Overall Study|Other|1
2014890|NCT00265083|3581954|FG001|Overall Study|Other|12
2014891|NCT00265083|3581955|FG002|Overall Study|Other|9
2014892|NCT00265096|3581967|FG000|Overall Study|Adverse Event|14
2014893|NCT00265096|3581968|FG001|Overall Study|Adverse Event|18
2014894|NCT00265096|3581969|FG002|Overall Study|Adverse Event|18
2014895|NCT00265096|3581967|FG000|Overall Study|Lost to Follow-up|2
2014896|NCT00265096|3581968|FG001|Overall Study|Lost to Follow-up|5
2014897|NCT00265096|3581969|FG002|Overall Study|Lost to Follow-up|3
2014898|NCT00265096|3581967|FG000|Overall Study|Death|0
2014899|NCT00265096|3581968|FG001|Overall Study|Death|1
2014900|NCT00265096|3581969|FG002|Overall Study|Death|2
2014901|NCT00265096|3581967|FG000|Overall Study|Unsatisfactory therapeutic effect|9
2014902|NCT00265096|3581968|FG001|Overall Study|Unsatisfactory therapeutic effect|8
2014903|NCT00265096|3581969|FG002|Overall Study|Unsatisfactory therapeutic effect|6
2014904|NCT00265096|3581967|FG000|Overall Study|Other|11
2014905|NCT00265096|3581968|FG001|Overall Study|Other|19
2014906|NCT00265096|3581969|FG002|Overall Study|Other|10
2014907|NCT00265109|3581979|FG000|Overall Study|Withdrawal by Subject|5
2014908|NCT00265109|3581979|FG000|Overall Study|Adverse Event|1
2014909|NCT00265122|3581990|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
2014910|NCT00265122|3581991|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
2014911|NCT00265122|3581992|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
2014912|NCT00265122|3581993|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
2014913|NCT00265122|3581994|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
2014914|NCT00265122|3581995|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
2214527|NCT01688037|3856827|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
2014915|NCT00265122|3581990|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
2014916|NCT00265122|3581991|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
2014917|NCT00265122|3581992|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
2014918|NCT00265122|3581993|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
2014919|NCT00265122|3581994|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
2014920|NCT00265122|3581995|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
2014921|NCT00265122|3581990|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0
2014922|NCT00265122|3581991|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1
2014923|NCT00265122|3581992|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2
2014924|NCT00265122|3581993|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1
2014925|NCT00265122|3581994|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0
2014926|NCT00265122|3581995|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0
2014927|NCT00265122|3581990|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
2014928|NCT00265122|3581991|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
2014929|NCT00265122|3581992|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
2014930|NCT00265122|3581993|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
2014931|NCT00265122|3581994|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
2014932|NCT00265122|3581995|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
2214528|NCT01688037|3856828|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
2214529|NCT01688037|3856826|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
2214530|NCT01688037|3856827|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
2214531|NCT01688037|3856828|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
2014933|NCT00265122|3581990|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
2014934|NCT00265122|3581991|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
2014935|NCT00265122|3581992|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
2014936|NCT00265122|3581993|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
2014937|NCT00265122|3581994|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
2014938|NCT00265122|3581995|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
2014939|NCT00265122|3581990|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4
2014940|NCT00265122|3581991|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0
2014941|NCT00265122|3581992|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1
2014942|NCT00265122|3581993|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1
2014943|NCT00265122|3581994|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0
2014944|NCT00265122|3581995|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0
2014945|NCT00265148|3582016|FG000|Overall Study|Adverse Event|2
2014946|NCT00265148|3582017|FG001|Overall Study|Adverse Event|2
2014947|NCT00265148|3582016|FG000|Overall Study|Lack of Efficacy|0
2014948|NCT00265148|3582017|FG001|Overall Study|Lack of Efficacy|2
2014949|NCT00265148|3582016|FG000|Overall Study|Protocol Violation|3
2014950|NCT00265148|3582017|FG001|Overall Study|Protocol Violation|2
2014951|NCT00265148|3582016|FG000|Overall Study|Lost to Follow-up|0
2014952|NCT00265148|3582017|FG001|Overall Study|Lost to Follow-up|1
2014953|NCT00265148|3582016|FG000|Overall Study|Withdrawal by Subject|2
2014954|NCT00265148|3582017|FG001|Overall Study|Withdrawal by Subject|1
2014955|NCT00265148|3582016|FG000|Overall Study|Physician Decision|1
2014956|NCT00265148|3582017|FG001|Overall Study|Physician Decision|0
2014957|NCT00265148|3582016|FG000|Overall Study|Increasing frailty|0
2014958|NCT00265148|3582017|FG001|Overall Study|Increasing frailty|1
2014959|NCT00265148|3582016|FG000|Overall Study|Subject chose to change of the dose|1
2014960|NCT00265148|3582017|FG001|Overall Study|Subject chose to change of the dose|0
2014961|NCT00265239|3582030|FG000|Overall Study|Adverse Event|2
2014962|NCT00265239|3582031|FG001|Overall Study|Adverse Event|1
2014963|NCT00265317|3582041|FG000|Lead-In|Objective progression or relapse|6
2014964|NCT00265317|3582042|FG001|Lead-In|Objective progression or relapse|11
2014965|NCT00265317|3582043|FG002|Lead-In|Objective progression or relapse|0
2014966|NCT00265317|3582044|FG003|Lead-In|Objective progression or relapse|0
2014967|NCT00265317|3582041|FG000|Lead-In|Adverse Event|2
2014968|NCT00265317|3582042|FG001|Lead-In|Adverse Event|1
2014969|NCT00265317|3582043|FG002|Lead-In|Adverse Event|0
2014970|NCT00265317|3582044|FG003|Lead-In|Adverse Event|0
2014971|NCT00265317|3582041|FG000|Lead-In|Death|3
2014972|NCT00265317|3582042|FG001|Lead-In|Death|5
2014973|NCT00265317|3582043|FG002|Lead-In|Death|0
2014974|NCT00265317|3582044|FG003|Lead-In|Death|0
2014975|NCT00265317|3582041|FG000|Lead-In|Withdrawal/other than adverse event|1
2014976|NCT00265317|3582042|FG001|Lead-In|Withdrawal/other than adverse event|0
2014977|NCT00265317|3582043|FG002|Lead-In|Withdrawal/other than adverse event|0
2014978|NCT00265317|3582044|FG003|Lead-In|Withdrawal/other than adverse event|0
2014979|NCT00265317|3582041|FG000|Phase 2|Objective progression or relapse|0
2014980|NCT00265317|3582042|FG001|Phase 2|Objective progression or relapse|0
2014981|NCT00265317|3582043|FG002|Phase 2|Objective progression or relapse|37
2014982|NCT00265317|3582044|FG003|Phase 2|Objective progression or relapse|38
2014983|NCT00265317|3582041|FG000|Phase 2|Global deterioration of health status|0
2014984|NCT00265317|3582042|FG001|Phase 2|Global deterioration of health status|0
2014985|NCT00265317|3582043|FG002|Phase 2|Global deterioration of health status|3
2014986|NCT00265317|3582044|FG003|Phase 2|Global deterioration of health status|0
2014987|NCT00265317|3582041|FG000|Phase 2|Adverse Event|0
2014988|NCT00265317|3582042|FG001|Phase 2|Adverse Event|0
2014989|NCT00265317|3582043|FG002|Phase 2|Adverse Event|7
2014990|NCT00265317|3582044|FG003|Phase 2|Adverse Event|5
2014991|NCT00265317|3582041|FG000|Phase 2|Death|0
2014992|NCT00265317|3582042|FG001|Phase 2|Death|0
2014993|NCT00265317|3582043|FG002|Phase 2|Death|12
2014994|NCT00265317|3582044|FG003|Phase 2|Death|15
2014995|NCT00265317|3582041|FG000|Phase 2|Protocol Violation|0
2014996|NCT00265317|3582042|FG001|Phase 2|Protocol Violation|0
2014997|NCT00265317|3582043|FG002|Phase 2|Protocol Violation|1
2014998|NCT00265317|3582044|FG003|Phase 2|Protocol Violation|4
2014999|NCT00265317|3582041|FG000|Phase 2|Lost to Follow-up|0
2015000|NCT00265317|3582042|FG001|Phase 2|Lost to Follow-up|0
2015001|NCT00265317|3582043|FG002|Phase 2|Lost to Follow-up|0
2015002|NCT00265317|3582044|FG003|Phase 2|Lost to Follow-up|1
2015003|NCT00265317|3582041|FG000|Phase 2|Withdrawal/other than adverse event|0
2015004|NCT00265317|3582042|FG001|Phase 2|Withdrawal/other than adverse event|0
2015005|NCT00265317|3582043|FG002|Phase 2|Withdrawal/other than adverse event|2
2015006|NCT00265317|3582044|FG003|Phase 2|Withdrawal/other than adverse event|1
2015007|NCT00265317|3582041|FG000|Phase 2|Study terminated by sponsor|0
2015008|NCT00265317|3582042|FG001|Phase 2|Study terminated by sponsor|0
2015009|NCT00265317|3582043|FG002|Phase 2|Study terminated by sponsor|1
2015010|NCT00265317|3582044|FG003|Phase 2|Study terminated by sponsor|0
2015011|NCT00265317|3582041|FG000|Phase 2|Other|0
2015012|NCT00265317|3582042|FG001|Phase 2|Other|0
2015013|NCT00265317|3582043|FG002|Phase 2|Other|1
2015014|NCT00265317|3582044|FG003|Phase 2|Other|1
2015015|NCT00265330|3582063|FG000|Overall Study|Adverse Event|41
2015016|NCT00265330|3582063|FG000|Overall Study|Lost to Follow-up|8
2015017|NCT00265330|3582063|FG000|Overall Study|Withdrawal by Subject|34
2015018|NCT00265330|3582063|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1
2015019|NCT00265330|3582063|FG000|Overall Study|Lack of Efficacy|4
2015020|NCT00265330|3582063|FG000|Overall Study|Family Scheduling Conflicts|1
2015021|NCT00265330|3582063|FG000|Overall Study|Began Taking Formulary Geodon|1
2015022|NCT00265330|3582063|FG000|Overall Study|Discharged from Unit for Long Term Care|1
2015023|NCT00265330|3582063|FG000|Overall Study|Site Closed by Sponsor|1
2015024|NCT00265330|3582063|FG000|Overall Study|Principal Investigators Request|1
2015025|NCT00265330|3582063|FG000|Overall Study|Withdrew Consent|1
2015026|NCT00265330|3582063|FG000|Overall Study|Protocol Violation|1
2015027|NCT00265382|3582067|FG000|Overall Study|Adverse Event|21
2015028|NCT00265382|3582067|FG000|Overall Study|Laboratory Abnormality|1
2015029|NCT00265382|3582067|FG000|Overall Study|Lost to Follow-up|3
2015030|NCT00265382|3582067|FG000|Overall Study|Lack of Efficacy|6
2015031|NCT00265382|3582067|FG000|Overall Study|Miscellaneous|6
2015032|NCT00265382|3582067|FG000|Overall Study|Withdrawal by Subject|13
2015033|NCT00265382|3582067|FG000|Overall Study|Study terminated by sponsor|94
2015034|NCT00265382|3582067|FG000|Overall Study|Death|1
2015035|NCT00265395|3582073|FG000|Overall Study|Adverse Event|3
2015036|NCT00265395|3582074|FG001|Overall Study|Adverse Event|6
2015037|NCT00265395|3582073|FG000|Overall Study|Lost to Follow-up|2
2015038|NCT00265395|3582074|FG001|Overall Study|Lost to Follow-up|1
2015039|NCT00265395|3582073|FG000|Overall Study|Withdrawal by Subject|1
2015040|NCT00265395|3582074|FG001|Overall Study|Withdrawal by Subject|6
2015041|NCT00265395|3582073|FG000|Overall Study|Protocol Violation|2
2015042|NCT00265395|3582074|FG001|Overall Study|Protocol Violation|2
2015043|NCT00265395|3582073|FG000|Overall Study|Lack of Efficacy|0
2015044|NCT00265395|3582074|FG001|Overall Study|Lack of Efficacy|1
2015045|NCT00265395|3582073|FG000|Overall Study|Administrative|0
2015046|NCT00265395|3582074|FG001|Overall Study|Administrative|1
2015047|NCT00265564|3582112|FG000|Overall Study|Lost to Follow-up|5
2015048|NCT00265564|3582113|FG001|Overall Study|Lost to Follow-up|7
2015049|NCT00265564|3582112|FG000|Overall Study|met exclusion criteria|5
2015050|NCT00265564|3582113|FG001|Overall Study|met exclusion criteria|2
2015051|NCT00265759|3582134|FG000|Overall Study|Withdrawal by Subject|0
2015052|NCT00265759|3582135|FG001|Overall Study|Withdrawal by Subject|1
2015053|NCT00265759|3582136|FG002|Overall Study|Withdrawal by Subject|2
2015054|NCT00265759|3582137|FG003|Overall Study|Withdrawal by Subject|2
2015055|NCT00265759|3582134|FG000|Overall Study|Cancel|0
2015056|NCT00265759|3582135|FG001|Overall Study|Cancel|0
2015057|NCT00265759|3582136|FG002|Overall Study|Cancel|0
2015058|NCT00265759|3582137|FG003|Overall Study|Cancel|3
2015059|NCT00265759|3582134|FG000|Overall Study|Ineligible|0
2015060|NCT00265759|3582135|FG001|Overall Study|Ineligible|0
2015061|NCT00265759|3582136|FG002|Overall Study|Ineligible|0
2015062|NCT00265759|3582137|FG003|Overall Study|Ineligible|1
2015063|NCT00265759|3582134|FG000|Overall Study|Bilateral disease|0
2015064|NCT00265759|3582135|FG001|Overall Study|Bilateral disease|0
2015065|NCT00265759|3582136|FG002|Overall Study|Bilateral disease|0
2015066|NCT00265759|3582137|FG003|Overall Study|Bilateral disease|2
2015067|NCT00265759|3582134|FG000|Overall Study|Discontinued due to intolerability|0
2015068|NCT00265759|3582135|FG001|Overall Study|Discontinued due to intolerability|0
2015069|NCT00265759|3582136|FG002|Overall Study|Discontinued due to intolerability|0
2015070|NCT00265759|3582137|FG003|Overall Study|Discontinued due to intolerability|1
2015071|NCT00265785|3582148|FG000|Overall Study|Adverse Event|4
2015072|NCT00265785|3582148|FG000|Overall Study|Withdrawal by Subject|3
2015073|NCT00265785|3582148|FG000|Overall Study|Progression/Relapse|15
2015074|NCT00265785|3582148|FG000|Overall Study|Not protocol specified|2
2015075|NCT00265785|3582148|FG000|Overall Study|Ineligible|1
2015076|NCT00265785|3582148|FG000|Overall Study|Did not receive protocol treatment|2
2015077|NCT00265889|3582168|FG000|Overall Study|Physician Decision|1
2015078|NCT00265889|3582168|FG000|Overall Study|Protocol Violation|1
2015079|NCT00265889|3582168|FG000|Overall Study|Insurance denied the request|3
2015080|NCT00265941|3582174|FG000|Overall Study|Protocol Violation|22
2015081|NCT00265941|3582175|FG001|Overall Study|Protocol Violation|25
2015082|NCT00265941|3582174|FG000|Overall Study|Lost to Follow-up|1
2015083|NCT00265941|3582175|FG001|Overall Study|Lost to Follow-up|1
2015084|NCT00266032|3582196|FG000|Treatment|Adverse Event|42
2015085|NCT00266032|3582197|FG001|Treatment|Adverse Event|26
2015086|NCT00266032|3582198|FG002|Treatment|Adverse Event|10
2015087|NCT00266032|3582196|FG000|Treatment|Lost to Follow-up|19
2015088|NCT00266032|3582197|FG001|Treatment|Lost to Follow-up|4
2015089|NCT00266032|3582198|FG002|Treatment|Lost to Follow-up|2
2015090|NCT00266032|3582196|FG000|Treatment|Pregnancy|3
2015091|NCT00266032|3582197|FG001|Treatment|Pregnancy|2
2015092|NCT00266032|3582198|FG002|Treatment|Pregnancy|2
2015093|NCT00266032|3582196|FG000|Treatment|Protocol Violation|6
2015094|NCT00266032|3582197|FG001|Treatment|Protocol Violation|14
2015095|NCT00266032|3582198|FG002|Treatment|Protocol Violation|13
2015096|NCT00266032|3582196|FG000|Treatment|Withdrawal by Subject|28
2015097|NCT00266032|3582197|FG001|Treatment|Withdrawal by Subject|13
2015098|NCT00266032|3582198|FG002|Treatment|Withdrawal by Subject|12
2015099|NCT00266032|3582196|FG000|Treatment|patient moved/wish for pregnancy/no need|13
2015100|NCT00266032|3582197|FG001|Treatment|patient moved/wish for pregnancy/no need|5
2015101|NCT00266032|3582198|FG002|Treatment|patient moved/wish for pregnancy/no need|8
2015102|NCT00266032|3582196|FG000|Open-label Safety Extension|Adverse Event|5
2015103|NCT00266032|3582197|FG001|Open-label Safety Extension|Adverse Event|0
2015104|NCT00266032|3582198|FG002|Open-label Safety Extension|Adverse Event|4
2015105|NCT00266032|3582196|FG000|Open-label Safety Extension|Lost to Follow-up|2
2015106|NCT00266032|3582197|FG001|Open-label Safety Extension|Lost to Follow-up|5
2015107|NCT00266032|3582198|FG002|Open-label Safety Extension|Lost to Follow-up|4
2015108|NCT00266032|3582196|FG000|Open-label Safety Extension|Pregnancy|4
2015109|NCT00266032|3582197|FG001|Open-label Safety Extension|Pregnancy|1
2015110|NCT00266032|3582198|FG002|Open-label Safety Extension|Pregnancy|2
2015111|NCT00266032|3582196|FG000|Open-label Safety Extension|Protocol Violation|1
2015112|NCT00266032|3582197|FG001|Open-label Safety Extension|Protocol Violation|3
2015113|NCT00266032|3582198|FG002|Open-label Safety Extension|Protocol Violation|2
2015114|NCT00266032|3582196|FG000|Open-label Safety Extension|Withdrawal by Subject|19
2015115|NCT00266032|3582197|FG001|Open-label Safety Extension|Withdrawal by Subject|3
2015116|NCT00266032|3582198|FG002|Open-label Safety Extension|Withdrawal by Subject|12
2015117|NCT00266032|3582196|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
2015118|NCT00266032|3582197|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
2015119|NCT00266032|3582198|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
2015120|NCT00266227|3582213|FG000|Initial Treatment|Adverse Event|0
2015121|NCT00266227|3582214|FG001|Initial Treatment|Adverse Event|0
2015122|NCT00266227|3582215|FG002|Initial Treatment|Adverse Event|13
2015123|NCT00266227|3582213|FG000|Initial Treatment|Lost to Follow-up|0
2015124|NCT00266227|3582214|FG001|Initial Treatment|Lost to Follow-up|0
2015125|NCT00266227|3582215|FG002|Initial Treatment|Lost to Follow-up|6
2015126|NCT00266227|3582213|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0
2015127|NCT00266227|3582214|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0
2015128|NCT00266227|3582215|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45
2015129|NCT00266227|3582213|FG000|Initial Treatment|Physician decision to withdraw|0
2015130|NCT00266227|3582214|FG001|Initial Treatment|Physician decision to withdraw|0
2015131|NCT00266227|3582215|FG002|Initial Treatment|Physician decision to withdraw|12
2015132|NCT00266227|3582213|FG000|Initial Treatment|Pregnancy|0
2015133|NCT00266227|3582214|FG001|Initial Treatment|Pregnancy|0
2015134|NCT00266227|3582215|FG002|Initial Treatment|Pregnancy|1
2015135|NCT00266227|3582213|FG000|Retreatment: Up to Week 48|Death|1
2015136|NCT00266227|3582214|FG001|Retreatment: Up to Week 48|Death|0
2015137|NCT00266227|3582215|FG002|Retreatment: Up to Week 48|Death|0
2015138|NCT00266227|3582213|FG000|Retreatment: Up to Week 48|Adverse Event|7
2015139|NCT00266227|3582214|FG001|Retreatment: Up to Week 48|Adverse Event|7
2015140|NCT00266227|3582215|FG002|Retreatment: Up to Week 48|Adverse Event|0
2015141|NCT00266227|3582213|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3
2015142|NCT00266227|3582214|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0
2015143|NCT00266227|3582215|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0
2015144|NCT00266227|3582213|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
2015145|NCT00266227|3582214|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
2015146|NCT00266227|3582215|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
2015147|NCT00266227|3582213|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
2015148|NCT00266227|3582214|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
2015149|NCT00266227|3582215|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
2015150|NCT00266227|3582213|FG000|Retreatment: Up to Week 48|Pregnancy|1
2015151|NCT00266227|3582214|FG001|Retreatment: Up to Week 48|Pregnancy|0
2015152|NCT00266227|3582215|FG002|Retreatment: Up to Week 48|Pregnancy|0
2015153|NCT00266227|3582213|FG000|Retreatment: Week 48 to Week 72|Death|1
2015154|NCT00266227|3582214|FG001|Retreatment: Week 48 to Week 72|Death|1
2015155|NCT00266227|3582215|FG002|Retreatment: Week 48 to Week 72|Death|0
2015156|NCT00266227|3582213|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6
2015157|NCT00266227|3582214|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2
2015158|NCT00266227|3582215|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0
2015159|NCT00266227|3582213|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
2015160|NCT00266227|3582214|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
2015161|NCT00266227|3582215|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
2015162|NCT00266227|3582213|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
2015163|NCT00266227|3582214|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
2015164|NCT00266227|3582215|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
2015165|NCT00266227|3582213|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
2015166|NCT00266227|3582214|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
2015167|NCT00266227|3582215|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
2015168|NCT00266409|3582233|FG000|Overall Study|Lack of Efficacy|2
2015169|NCT00266409|3582234|FG001|Overall Study|Lack of Efficacy|6
2015170|NCT00266409|3582235|FG002|Overall Study|Lack of Efficacy|1
2015171|NCT00266409|3582236|FG003|Overall Study|Lack of Efficacy|2
2015172|NCT00266409|3582233|FG000|Overall Study|Adverse Event|7
2015173|NCT00266409|3582234|FG001|Overall Study|Adverse Event|2
2015174|NCT00266409|3582235|FG002|Overall Study|Adverse Event|1
2015175|NCT00266409|3582236|FG003|Overall Study|Adverse Event|1
2015176|NCT00266409|3582233|FG000|Overall Study|Lost to Follow-up|18
2015177|NCT00266409|3582234|FG001|Overall Study|Lost to Follow-up|21
2015178|NCT00266409|3582235|FG002|Overall Study|Lost to Follow-up|6
2015179|NCT00266409|3582236|FG003|Overall Study|Lost to Follow-up|8
2015180|NCT00266409|3582233|FG000|Overall Study|Withdrawal by Subject|6
2015181|NCT00266409|3582234|FG001|Overall Study|Withdrawal by Subject|10
2015182|NCT00266409|3582235|FG002|Overall Study|Withdrawal by Subject|3
2015183|NCT00266409|3582236|FG003|Overall Study|Withdrawal by Subject|9
2015184|NCT00266409|3582233|FG000|Overall Study|Protocol Violation|5
2015185|NCT00266409|3582234|FG001|Overall Study|Protocol Violation|3
2015186|NCT00266409|3582235|FG002|Overall Study|Protocol Violation|4
2015187|NCT00266409|3582236|FG003|Overall Study|Protocol Violation|2
2015188|NCT00266409|3582233|FG000|Overall Study|Other|7
2015189|NCT00266409|3582234|FG001|Overall Study|Other|4
2015190|NCT00266409|3582235|FG002|Overall Study|Other|2
2015191|NCT00266409|3582236|FG003|Overall Study|Other|0
2015192|NCT00266630|3582248|FG000|Overall Study|Adverse Event|8
2015193|NCT00266630|3582249|FG001|Overall Study|Adverse Event|6
2015194|NCT00266630|3582248|FG000|Overall Study|Lack of Efficacy|1
2015195|NCT00266630|3582249|FG001|Overall Study|Lack of Efficacy|4
2015196|NCT00266630|3582248|FG000|Overall Study|Entry Criteria not met|1
2015197|NCT00266630|3582249|FG001|Overall Study|Entry Criteria not met|0
2015198|NCT00266630|3582248|FG000|Overall Study|Protocol Violation|1
2015199|NCT00266630|3582249|FG001|Overall Study|Protocol Violation|3
2015200|NCT00266630|3582248|FG000|Overall Study|Physician Decision|1
2015201|NCT00266630|3582249|FG001|Overall Study|Physician Decision|2
2015202|NCT00266630|3582248|FG000|Overall Study|Withdrawal by Subject|10
2015203|NCT00266630|3582249|FG001|Overall Study|Withdrawal by Subject|2
2015204|NCT00266630|3582248|FG000|Overall Study|Lost to Follow-up|1
2015205|NCT00266630|3582249|FG001|Overall Study|Lost to Follow-up|0
2015206|NCT00266630|3582248|FG000|Overall Study|Other|19
2015207|NCT00266630|3582249|FG001|Overall Study|Other|11
2015208|NCT00266656|3582259|FG000|Overall Study|Death|1
2015209|NCT00266656|3582260|FG001|Overall Study|Death|0
2015210|NCT00266656|3582259|FG000|Overall Study|Lost to Follow-up|4
2015211|NCT00266656|3582260|FG001|Overall Study|Lost to Follow-up|1
2015212|NCT00266656|3582259|FG000|Overall Study|Withdrawal by Subject|4
2015213|NCT00266656|3582260|FG001|Overall Study|Withdrawal by Subject|2
2015214|NCT00266656|3582259|FG000|Overall Study|Did Not Reach Final Height|4
2015215|NCT00266656|3582260|FG001|Overall Study|Did Not Reach Final Height|8
2015216|NCT00266656|3582259|FG000|Overall Study|Parent/Caregiver Decision|1
2015217|NCT00266656|3582260|FG001|Overall Study|Parent/Caregiver Decision|2
2015218|NCT00266695|3582266|FG000|Overall Study|Adverse Event|1
2015219|NCT00266695|3582266|FG000|Overall Study|Death|9
2015220|NCT00266695|3582266|FG000|Overall Study|Physician Decision|1
2015221|NCT00266695|3582266|FG000|Overall Study|Lost to Follow-up|3
2015222|NCT00266695|3582266|FG000|Overall Study|Withdrawal by Subject|15
2015223|NCT00266708|3582272|FG000|Overall Study|No renal function|1
2015224|NCT00266708|3582273|FG001|Overall Study|No renal function|1
2015225|NCT00266708|3582272|FG000|Overall Study|Refused biopsy|3
2015226|NCT00266708|3582273|FG001|Overall Study|Refused biopsy|6
2015227|NCT00266708|3582272|FG000|Overall Study|Asthma|0
2015228|NCT00266708|3582273|FG001|Overall Study|Asthma|2
2015229|NCT00266812|3582290|FG000|Overall Study|Disease Progression|9
2015230|NCT00266812|3582291|FG001|Overall Study|Disease Progression|3
2015231|NCT00266812|3582290|FG000|Overall Study|Death|5
2015232|NCT00266812|3582291|FG001|Overall Study|Death|4
2015233|NCT00266812|3582290|FG000|Overall Study|Adverse Event|3
2015234|NCT00266812|3582291|FG001|Overall Study|Adverse Event|1
2015235|NCT00266812|3582290|FG000|Overall Study|Protocol Violation|0
2015236|NCT00266812|3582291|FG001|Overall Study|Protocol Violation|1
2015237|NCT00266812|3582290|FG000|Overall Study|Withdrawal by Subject|0
2015238|NCT00266812|3582291|FG001|Overall Study|Withdrawal by Subject|2
2015239|NCT00266812|3582290|FG000|Overall Study|Discontinued before starting study drug|4
2015240|NCT00266812|3582291|FG001|Overall Study|Discontinued before starting study drug|0
2015241|NCT00266825|3582299|FG000|Completed Follow-Up|Lost to Follow-up|14
2015242|NCT00266825|3582300|FG001|Completed Follow-Up|Lost to Follow-up|19
2015243|NCT00266825|3582299|FG000|Completed Follow-Up|Withdrawal by Subject|11
2015244|NCT00266825|3582300|FG001|Completed Follow-Up|Withdrawal by Subject|5
2015245|NCT00266864|3582327|FG000|Overall Study|Lost to Follow-up|4
2015246|NCT00266864|3582328|FG001|Overall Study|Lost to Follow-up|1
2015247|NCT00266864|3582327|FG000|Overall Study|Withdrawal by Subject|1
2015248|NCT00266864|3582328|FG001|Overall Study|Withdrawal by Subject|1
2015249|NCT00266877|3582337|FG000|Overall Study|Death|1
2015250|NCT00266877|3582338|FG001|Overall Study|Death|1
2015251|NCT00266877|3582339|FG002|Overall Study|Death|1
2015252|NCT00266877|3582337|FG000|Overall Study|Adverse Event|6
2015253|NCT00266877|3582338|FG001|Overall Study|Adverse Event|4
2015254|NCT00266877|3582339|FG002|Overall Study|Adverse Event|1
2015255|NCT00266877|3582337|FG000|Overall Study|Physician Decision|2
2015256|NCT00266877|3582338|FG001|Overall Study|Physician Decision|1
2015257|NCT00266877|3582339|FG002|Overall Study|Physician Decision|1
2015258|NCT00266877|3582337|FG000|Overall Study|Withdrawal by Subject|3
2015259|NCT00266877|3582338|FG001|Overall Study|Withdrawal by Subject|1
2015260|NCT00266877|3582339|FG002|Overall Study|Withdrawal by Subject|1
2015261|NCT00266877|3582337|FG000|Overall Study|Disease Progression|72
2015262|NCT00266877|3582338|FG001|Overall Study|Disease Progression|37
2015263|NCT00266877|3582339|FG002|Overall Study|Disease Progression|23
2015264|NCT00266877|3582337|FG000|Overall Study|Symptomatic Deterioration|6
2015265|NCT00266877|3582338|FG001|Overall Study|Symptomatic Deterioration|3
2015266|NCT00266877|3582339|FG002|Overall Study|Symptomatic Deterioration|1
2015267|NCT00266877|3582337|FG000|Overall Study|Hospitalization|1
2015268|NCT00266877|3582338|FG001|Overall Study|Hospitalization|0
2015269|NCT00266877|3582339|FG002|Overall Study|Hospitalization|0
2015270|NCT00266877|3582337|FG000|Overall Study|Concomitant Radiotherapy|0
2015271|NCT00266877|3582338|FG001|Overall Study|Concomitant Radiotherapy|1
2015272|NCT00266877|3582339|FG002|Overall Study|Concomitant Radiotherapy|0
2015273|NCT00267007|3582349|FG000|Overall Study|Withdrawal by Subject|6
2015274|NCT00267007|3582350|FG001|Overall Study|Withdrawal by Subject|0
2015275|NCT00267007|3582349|FG000|Overall Study|Lost to Follow-up|1
2015276|NCT00267007|3582350|FG001|Overall Study|Lost to Follow-up|0
2015277|NCT00267007|3582349|FG000|Overall Study|Non-compliance|0
2015278|NCT00267007|3582350|FG001|Overall Study|Non-compliance|1
2015279|NCT00267007|3582349|FG000|Overall Study|Adverse Event|1
2015280|NCT00267007|3582350|FG001|Overall Study|Adverse Event|0
2015281|NCT00267020|3582358|FG000|Overall Study|Adverse Event|22
2015282|NCT00267020|3582359|FG001|Overall Study|Adverse Event|5
2015283|NCT00267020|3582358|FG000|Overall Study|Death|2
2015284|NCT00267020|3582359|FG001|Overall Study|Death|1
2015285|NCT00267020|3582358|FG000|Overall Study|Withdrawal by Subject|17
2015286|NCT00267020|3582359|FG001|Overall Study|Withdrawal by Subject|7
2015287|NCT00267020|3582358|FG000|Overall Study|Physician Decision|3
2015288|NCT00267020|3582359|FG001|Overall Study|Physician Decision|2
2015289|NCT00267020|3582358|FG000|Overall Study|Disease Progression|39
2015290|NCT00267020|3582359|FG001|Overall Study|Disease Progression|25
2015291|NCT00267020|3582358|FG000|Overall Study|Unrelated Complication|1
2015292|NCT00267020|3582359|FG001|Overall Study|Unrelated Complication|1
2015293|NCT00267020|3582358|FG000|Overall Study|Sponsor Request|1
2015294|NCT00267020|3582359|FG001|Overall Study|Sponsor Request|0
2015295|NCT00267020|3582358|FG000|Overall Study|Other|1
2015296|NCT00267020|3582359|FG001|Overall Study|Other|2
2015297|NCT00267046|3582367|FG000|Overall Study|Disease progression|4
2015298|NCT00267046|3582368|FG001|Overall Study|Disease progression|2
2015299|NCT00267046|3582367|FG000|Overall Study|Chemotoxicity|2
2015300|NCT00267046|3582368|FG001|Overall Study|Chemotoxicity|0
2015301|NCT00267046|3582367|FG000|Overall Study|Open-label palifermin|2
2015302|NCT00267046|3582368|FG001|Overall Study|Open-label palifermin|7
2015303|NCT00267046|3582367|FG000|Overall Study|Surgery|3
2015304|NCT00267046|3582368|FG001|Overall Study|Surgery|1
2015305|NCT00267046|3582367|FG000|Overall Study|Withdrawal by Subject|1
2015306|NCT00267046|3582368|FG001|Overall Study|Withdrawal by Subject|0
2015307|NCT00267046|3582367|FG000|Overall Study|Radiation|0
2015308|NCT00267046|3582368|FG001|Overall Study|Radiation|1
2015309|NCT00267098|3582390|FG000|Overall Study|Death|0
2015310|NCT00267098|3582391|FG001|Overall Study|Death|0
2015311|NCT00267098|3582392|FG002|Overall Study|Death|57
2015312|NCT00267098|3582393|FG003|Overall Study|Death|66
2015313|NCT00267098|3582394|FG004|Overall Study|Death|14
2015314|NCT00267098|3582395|FG005|Overall Study|Death|23
2015315|NCT00267098|3582396|FG006|Overall Study|Death|28
2015316|NCT00267098|3582397|FG007|Overall Study|Death|9
2015317|NCT00267098|3582390|FG000|Overall Study|Lost to Follow-up|0
2015318|NCT00267098|3582391|FG001|Overall Study|Lost to Follow-up|0
2015319|NCT00267098|3582392|FG002|Overall Study|Lost to Follow-up|6
2015320|NCT00267098|3582393|FG003|Overall Study|Lost to Follow-up|5
2015321|NCT00267098|3582394|FG004|Overall Study|Lost to Follow-up|2
2015322|NCT00267098|3582395|FG005|Overall Study|Lost to Follow-up|3
2015323|NCT00267098|3582396|FG006|Overall Study|Lost to Follow-up|1
2015324|NCT00267098|3582397|FG007|Overall Study|Lost to Follow-up|1
2015325|NCT00267098|3582390|FG000|Overall Study|Withdrawal by Subject|8
2015326|NCT00267098|3582391|FG001|Overall Study|Withdrawal by Subject|0
2015327|NCT00267098|3582392|FG002|Overall Study|Withdrawal by Subject|24
2015328|NCT00267098|3582393|FG003|Overall Study|Withdrawal by Subject|21
2015329|NCT00267098|3582394|FG004|Overall Study|Withdrawal by Subject|12
2015330|NCT00267098|3582395|FG005|Overall Study|Withdrawal by Subject|9
2015331|NCT00267098|3582396|FG006|Overall Study|Withdrawal by Subject|12
2015332|NCT00267098|3582397|FG007|Overall Study|Withdrawal by Subject|5
2015333|NCT00267098|3582390|FG000|Overall Study|Physician Decision|5
2015334|NCT00267098|3582391|FG001|Overall Study|Physician Decision|0
2015335|NCT00267098|3582392|FG002|Overall Study|Physician Decision|7
2015336|NCT00267098|3582393|FG003|Overall Study|Physician Decision|11
2015337|NCT00267098|3582394|FG004|Overall Study|Physician Decision|5
2015338|NCT00267098|3582395|FG005|Overall Study|Physician Decision|4
2015339|NCT00267098|3582396|FG006|Overall Study|Physician Decision|3
2015340|NCT00267098|3582397|FG007|Overall Study|Physician Decision|0
2015341|NCT00267098|3582390|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96
2015342|NCT00267098|3582391|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2015343|NCT00267098|3582392|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2015344|NCT00267098|3582393|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2015345|NCT00267098|3582394|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2
2015346|NCT00267098|3582395|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2015347|NCT00267098|3582396|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2015348|NCT00267098|3582397|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2015349|NCT00267098|3582390|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2015350|NCT00267098|3582391|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51
2015351|NCT00267098|3582392|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2015352|NCT00267098|3582393|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2015353|NCT00267098|3582394|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2015354|NCT00267098|3582395|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2015355|NCT00267098|3582396|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2015356|NCT00267098|3582397|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2015357|NCT00267098|3582390|FG000|Overall Study|Site closure|0
2015358|NCT00267098|3582391|FG001|Overall Study|Site closure|0
2015359|NCT00267098|3582392|FG002|Overall Study|Site closure|0
2015360|NCT00267098|3582393|FG003|Overall Study|Site closure|1
2015361|NCT00267098|3582394|FG004|Overall Study|Site closure|0
2015362|NCT00267098|3582395|FG005|Overall Study|Site closure|1
2015363|NCT00267098|3582396|FG006|Overall Study|Site closure|1
2015364|NCT00267098|3582397|FG007|Overall Study|Site closure|0
2015365|NCT00267098|3582390|FG000|Overall Study|Explanted Medtronic device|0
2015366|NCT00267098|3582391|FG001|Overall Study|Explanted Medtronic device|0
2015367|NCT00267098|3582392|FG002|Overall Study|Explanted Medtronic device|0
2015368|NCT00267098|3582393|FG003|Overall Study|Explanted Medtronic device|1
2015369|NCT00267098|3582394|FG004|Overall Study|Explanted Medtronic device|0
2015370|NCT00267098|3582395|FG005|Overall Study|Explanted Medtronic device|0
2015371|NCT00267098|3582396|FG006|Overall Study|Explanted Medtronic device|0
2015372|NCT00267098|3582397|FG007|Overall Study|Explanted Medtronic device|0
2015373|NCT00267098|3582390|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0
2015374|NCT00267098|3582391|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0
2015375|NCT00267098|3582392|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0
2015376|NCT00267098|3582393|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0
2015377|NCT00267098|3582394|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2
2015378|NCT00267098|3582395|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0
2015379|NCT00267098|3582396|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0
2015380|NCT00267098|3582397|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0
2015381|NCT00267098|3582390|FG000|Overall Study|Subject listed for heart transplant|0
2015382|NCT00267098|3582391|FG001|Overall Study|Subject listed for heart transplant|0
2015383|NCT00267098|3582392|FG002|Overall Study|Subject listed for heart transplant|0
2015384|NCT00267098|3582393|FG003|Overall Study|Subject listed for heart transplant|0
2015385|NCT00267098|3582394|FG004|Overall Study|Subject listed for heart transplant|0
2015386|NCT00267098|3582395|FG005|Overall Study|Subject listed for heart transplant|0
2015387|NCT00267098|3582396|FG006|Overall Study|Subject listed for heart transplant|1
2015388|NCT00267098|3582397|FG007|Overall Study|Subject listed for heart transplant|0
2015389|NCT00267098|3582390|FG000|Overall Study|Sponsor withdrew subject|0
2015390|NCT00267098|3582391|FG001|Overall Study|Sponsor withdrew subject|0
2015391|NCT00267098|3582392|FG002|Overall Study|Sponsor withdrew subject|0
2015392|NCT00267098|3582393|FG003|Overall Study|Sponsor withdrew subject|1
2015393|NCT00267098|3582394|FG004|Overall Study|Sponsor withdrew subject|0
2015394|NCT00267098|3582395|FG005|Overall Study|Sponsor withdrew subject|0
2015395|NCT00267098|3582396|FG006|Overall Study|Sponsor withdrew subject|0
2015396|NCT00267098|3582397|FG007|Overall Study|Sponsor withdrew subject|0
2015397|NCT00267150|3582430|FG000|Overall Study|Adverse Event|1
2015398|NCT00267189|3582436|FG000|Overall Study|Patient withdrew consent|1
2015399|NCT00267189|3582437|FG001|Overall Study|Patient withdrew consent|1
2015400|NCT00267189|3582436|FG000|Overall Study|Death|1
2015401|NCT00267189|3582437|FG001|Overall Study|Death|0
2015402|NCT00267189|3582436|FG000|Overall Study|Missing|3
2015403|NCT00267189|3582437|FG001|Overall Study|Missing|0
2015404|NCT00267202|3582445|FG000|Overall Study|Unsatisfactory therapeutic effect|21
2015405|NCT00267202|3582446|FG001|Overall Study|Unsatisfactory therapeutic effect|8
2015406|NCT00267202|3582445|FG000|Overall Study|Withdrawal by Subject|12
2015407|NCT00267202|3582446|FG001|Overall Study|Withdrawal by Subject|15
2015408|NCT00267202|3582445|FG000|Overall Study|Adverse Event|13
2015409|NCT00267202|3582446|FG001|Overall Study|Adverse Event|7
2015410|NCT00267202|3582445|FG000|Overall Study|Protocol Violation|2
2015411|NCT00267202|3582446|FG001|Overall Study|Protocol Violation|3
2015412|NCT00267202|3582445|FG000|Overall Study|Administrative problems|2
2015413|NCT00267202|3582446|FG001|Overall Study|Administrative problems|1
2015414|NCT00267202|3582445|FG000|Overall Study|Lost to Follow-up|3
2015415|NCT00267202|3582446|FG001|Overall Study|Lost to Follow-up|0
2015416|NCT00267488|3582466|FG000|Overall Study|Sponsor Terminated Study|9
2015417|NCT00267488|3582466|FG000|Overall Study|Protocol Violation|1
2015418|NCT00267488|3582466|FG000|Overall Study|Other (Disease Progression)|1
2015419|NCT00267748|3582507|FG000|Non-randomized Period|Progressive disease|10
2015420|NCT00267748|3582508|FG001|Non-randomized Period|Progressive disease|0
2015421|NCT00267748|3582509|FG002|Non-randomized Period|Progressive disease|0
2015422|NCT00267748|3582507|FG000|Non-randomized Period|Adverse Event|8
2015423|NCT00267748|3582508|FG001|Non-randomized Period|Adverse Event|0
2015424|NCT00267748|3582509|FG002|Non-randomized Period|Adverse Event|0
2015425|NCT00267748|3582507|FG000|Non-randomized Period|Death|1
2015426|NCT00267748|3582508|FG001|Non-randomized Period|Death|0
2015427|NCT00267748|3582509|FG002|Non-randomized Period|Death|0
2015428|NCT00267748|3582507|FG000|Non-randomized Period|Participant not willing to participate|1
2015429|NCT00267748|3582508|FG001|Non-randomized Period|Participant not willing to participate|0
2015430|NCT00267748|3582509|FG002|Non-randomized Period|Participant not willing to participate|0
2015431|NCT00267748|3582507|FG000|Non-randomized Period|Other|3
2015432|NCT00267748|3582508|FG001|Non-randomized Period|Other|0
2015433|NCT00267748|3582509|FG002|Non-randomized Period|Other|0
2015434|NCT00267748|3582507|FG000|Randomized Period|Death|0
2015435|NCT00267748|3582508|FG001|Randomized Period|Death|2
2015436|NCT00267748|3582509|FG002|Randomized Period|Death|3
2015437|NCT00267748|3582507|FG000|Randomized Period|Adverse Event|0
2015438|NCT00267748|3582508|FG001|Randomized Period|Adverse Event|23
2015439|NCT00267748|3582509|FG002|Randomized Period|Adverse Event|25
2015440|NCT00267748|3582507|FG000|Randomized Period|Global deterioration of health status|0
2015441|NCT00267748|3582508|FG001|Randomized Period|Global deterioration of health status|6
2015442|NCT00267748|3582509|FG002|Randomized Period|Global deterioration of health status|7
2015443|NCT00267748|3582507|FG000|Randomized Period|Lost to Follow-up|0
2015444|NCT00267748|3582508|FG001|Randomized Period|Lost to Follow-up|1
2015445|NCT00267748|3582509|FG002|Randomized Period|Lost to Follow-up|0
2015446|NCT00267748|3582507|FG000|Randomized Period|Objective progression or relapse|0
2015447|NCT00267748|3582508|FG001|Randomized Period|Objective progression or relapse|77
2015448|NCT00267748|3582509|FG002|Randomized Period|Objective progression or relapse|86
2015449|NCT00267748|3582507|FG000|Randomized Period|Withdrawal by Subject|0
2015450|NCT00267748|3582508|FG001|Randomized Period|Withdrawal by Subject|9
2015451|NCT00267748|3582509|FG002|Randomized Period|Withdrawal by Subject|2
2015452|NCT00267748|3582507|FG000|Randomized Period|Other|0
2015453|NCT00267748|3582508|FG001|Randomized Period|Other|9
2015454|NCT00267748|3582509|FG002|Randomized Period|Other|6
2015455|NCT00267748|3582507|FG000|Randomized Period|randomized but not treated|0
2015456|NCT00267748|3582508|FG001|Randomized Period|randomized but not treated|0
2015457|NCT00267748|3582509|FG002|Randomized Period|randomized but not treated|3
2015458|NCT00267865|3582525|FG000|Induction Treatment|Died before completing.|2
2015459|NCT00267865|3582525|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
2015460|NCT00267956|3582531|FG000|Controlled Period|Adverse Event|4
2015461|NCT00267956|3582532|FG001|Controlled Period|Adverse Event|1
2015462|NCT00267956|3582533|FG002|Controlled Period|Adverse Event|0
2015463|NCT00267956|3582534|FG003|Controlled Period|Adverse Event|0
2015464|NCT00267956|3582531|FG000|Controlled Period|Lack of Efficacy|4
2015465|NCT00267956|3582532|FG001|Controlled Period|Lack of Efficacy|2
2015466|NCT00267956|3582533|FG002|Controlled Period|Lack of Efficacy|0
2015467|NCT00267956|3582534|FG003|Controlled Period|Lack of Efficacy|0
2015468|NCT00267956|3582531|FG000|Controlled Period|Lost to Follow-up|2
2015469|NCT00267956|3582532|FG001|Controlled Period|Lost to Follow-up|0
2015470|NCT00267956|3582533|FG002|Controlled Period|Lost to Follow-up|0
2015471|NCT00267956|3582534|FG003|Controlled Period|Lost to Follow-up|0
2015472|NCT00267956|3582531|FG000|Controlled Period|Withdrew consent|3
2015473|NCT00267956|3582532|FG001|Controlled Period|Withdrew consent|1
2015474|NCT00267956|3582533|FG002|Controlled Period|Withdrew consent|0
2015475|NCT00267956|3582534|FG003|Controlled Period|Withdrew consent|0
2015476|NCT00267956|3582531|FG000|After Controlled Period|Adverse Event|0
2015477|NCT00267956|3582532|FG001|After Controlled Period|Adverse Event|0
2015478|NCT00267956|3582533|FG002|After Controlled Period|Adverse Event|2
2015479|NCT00267956|3582534|FG003|After Controlled Period|Adverse Event|1
2015480|NCT00267956|3582531|FG000|After Controlled Period|Lack of Efficacy|0
2015481|NCT00267956|3582532|FG001|After Controlled Period|Lack of Efficacy|0
2015482|NCT00267956|3582533|FG002|After Controlled Period|Lack of Efficacy|1
2015483|NCT00267956|3582534|FG003|After Controlled Period|Lack of Efficacy|1
2015484|NCT00267956|3582531|FG000|After Controlled Period|Lost to Follow-up|0
2015485|NCT00267956|3582532|FG001|After Controlled Period|Lost to Follow-up|0
2015486|NCT00267956|3582533|FG002|After Controlled Period|Lost to Follow-up|1
2015487|NCT00267956|3582534|FG003|After Controlled Period|Lost to Follow-up|0
2015488|NCT00267956|3582531|FG000|After Controlled Period|Withdrew consent|0
2015489|NCT00267956|3582532|FG001|After Controlled Period|Withdrew consent|0
2015490|NCT00267956|3582533|FG002|After Controlled Period|Withdrew consent|1
2015491|NCT00267956|3582534|FG003|After Controlled Period|Withdrew consent|0
2015492|NCT00267969|3582545|FG000|Controlled Period|Adverse Event|6
2015493|NCT00267969|3582546|FG001|Controlled Period|Adverse Event|0
2015494|NCT00267969|3582547|FG002|Controlled Period|Adverse Event|2
2015495|NCT00267969|3582548|FG003|Controlled Period|Adverse Event|0
2015496|NCT00267969|3582549|FG004|Controlled Period|Adverse Event|0
2015497|NCT00267969|3582550|FG005|Controlled Period|Adverse Event|0
2015498|NCT00267969|3582551|FG006|Controlled Period|Adverse Event|0
2015499|NCT00267969|3582545|FG000|Controlled Period|Lack of Efficacy|3
2015500|NCT00267969|3582546|FG001|Controlled Period|Lack of Efficacy|0
2015501|NCT00267969|3582547|FG002|Controlled Period|Lack of Efficacy|1
2015502|NCT00267969|3582548|FG003|Controlled Period|Lack of Efficacy|0
2015503|NCT00267969|3582549|FG004|Controlled Period|Lack of Efficacy|0
2015504|NCT00267969|3582550|FG005|Controlled Period|Lack of Efficacy|0
2015505|NCT00267969|3582551|FG006|Controlled Period|Lack of Efficacy|0
2015506|NCT00267969|3582545|FG000|Controlled Period|Lost to Follow-up|1
2015507|NCT00267969|3582546|FG001|Controlled Period|Lost to Follow-up|0
2015508|NCT00267969|3582547|FG002|Controlled Period|Lost to Follow-up|1
2015509|NCT00267969|3582548|FG003|Controlled Period|Lost to Follow-up|0
2015510|NCT00267969|3582549|FG004|Controlled Period|Lost to Follow-up|0
2015511|NCT00267969|3582550|FG005|Controlled Period|Lost to Follow-up|0
2015512|NCT00267969|3582551|FG006|Controlled Period|Lost to Follow-up|0
2015513|NCT00267969|3582545|FG000|Controlled Period|Randomized but not treated|0
2015514|NCT00267969|3582546|FG001|Controlled Period|Randomized but not treated|0
2025732|NCT00347360|3594608|FG005|Overall Study|Per sponsors instruction|0
2015515|NCT00267969|3582547|FG002|Controlled Period|Randomized but not treated|1
2015516|NCT00267969|3582548|FG003|Controlled Period|Randomized but not treated|0
2015517|NCT00267969|3582549|FG004|Controlled Period|Randomized but not treated|0
2015518|NCT00267969|3582550|FG005|Controlled Period|Randomized but not treated|0
2015519|NCT00267969|3582551|FG006|Controlled Period|Randomized but not treated|0
2015520|NCT00267969|3582545|FG000|Controlled Period|Other|2
2015521|NCT00267969|3582546|FG001|Controlled Period|Other|1
2015522|NCT00267969|3582547|FG002|Controlled Period|Other|6
2015523|NCT00267969|3582548|FG003|Controlled Period|Other|0
2015524|NCT00267969|3582549|FG004|Controlled Period|Other|0
2015525|NCT00267969|3582550|FG005|Controlled Period|Other|0
2015526|NCT00267969|3582551|FG006|Controlled Period|Other|0
2015527|NCT00267969|3582545|FG000|After Controlled Period|Adverse Event|0
2015528|NCT00267969|3582546|FG001|After Controlled Period|Adverse Event|0
2015529|NCT00267969|3582547|FG002|After Controlled Period|Adverse Event|0
2015530|NCT00267969|3582548|FG003|After Controlled Period|Adverse Event|7
2015531|NCT00267969|3582549|FG004|After Controlled Period|Adverse Event|8
2015532|NCT00267969|3582550|FG005|After Controlled Period|Adverse Event|23
2015533|NCT00267969|3582551|FG006|After Controlled Period|Adverse Event|21
2015534|NCT00267969|3582545|FG000|After Controlled Period|Death|0
2015535|NCT00267969|3582546|FG001|After Controlled Period|Death|0
2015536|NCT00267969|3582547|FG002|After Controlled Period|Death|0
2015537|NCT00267969|3582548|FG003|After Controlled Period|Death|1
2015538|NCT00267969|3582549|FG004|After Controlled Period|Death|2
2015539|NCT00267969|3582550|FG005|After Controlled Period|Death|0
2015540|NCT00267969|3582551|FG006|After Controlled Period|Death|1
2015541|NCT00267969|3582545|FG000|After Controlled Period|Lack of Efficacy|0
2015542|NCT00267969|3582546|FG001|After Controlled Period|Lack of Efficacy|0
2015543|NCT00267969|3582547|FG002|After Controlled Period|Lack of Efficacy|0
2015544|NCT00267969|3582548|FG003|After Controlled Period|Lack of Efficacy|10
2015545|NCT00267969|3582549|FG004|After Controlled Period|Lack of Efficacy|6
2015546|NCT00267969|3582550|FG005|After Controlled Period|Lack of Efficacy|28
2015547|NCT00267969|3582551|FG006|After Controlled Period|Lack of Efficacy|15
2015548|NCT00267969|3582545|FG000|After Controlled Period|Lost to Follow-up|0
2015549|NCT00267969|3582546|FG001|After Controlled Period|Lost to Follow-up|0
2015550|NCT00267969|3582547|FG002|After Controlled Period|Lost to Follow-up|0
2015551|NCT00267969|3582548|FG003|After Controlled Period|Lost to Follow-up|5
2015552|NCT00267969|3582549|FG004|After Controlled Period|Lost to Follow-up|8
2015553|NCT00267969|3582550|FG005|After Controlled Period|Lost to Follow-up|9
2015554|NCT00267969|3582551|FG006|After Controlled Period|Lost to Follow-up|10
2015555|NCT00267969|3582545|FG000|After Controlled Period|Other|0
2015556|NCT00267969|3582546|FG001|After Controlled Period|Other|0
2015557|NCT00267969|3582547|FG002|After Controlled Period|Other|0
2015558|NCT00267969|3582548|FG003|After Controlled Period|Other|13
2015559|NCT00267969|3582549|FG004|After Controlled Period|Other|11
2015560|NCT00267969|3582550|FG005|After Controlled Period|Other|22
2015561|NCT00267969|3582551|FG006|After Controlled Period|Other|25
2015562|NCT00268203|3582569|FG000|Overall Study|Lost to Follow-up|92
2015563|NCT00268203|3582569|FG000|Overall Study|Withdrawal by Subject|9
2015564|NCT00268203|3582569|FG000|Overall Study|Received Other NHL Therapy|7
2015565|NCT00268203|3582569|FG000|Overall Study|Progressive Disease|359
2015566|NCT00268203|3582569|FG000|Overall Study|Death|84
2015567|NCT00268203|3582569|FG000|Overall Study|Reason Not Specified|34
2015568|NCT00268203|3582569|FG000|Overall Study|Completed 2 Years of Follow-up|62
2015569|NCT00268242|3582573|FG000|Overall Study|Death|1
2015570|NCT00268346|3582579|FG000|Overall Study|Adverse Event|0
2015571|NCT00268346|3582580|FG001|Overall Study|Adverse Event|1
2015572|NCT00268346|3582579|FG000|Overall Study|Death|0
2015573|NCT00268346|3582580|FG001|Overall Study|Death|1
2015574|NCT00268346|3582579|FG000|Overall Study|Withdrawal by Subject|0
2015575|NCT00268346|3582580|FG001|Overall Study|Withdrawal by Subject|1
2015576|NCT00268437|3582586|FG000|Overall Study|Ineligible|1
2015577|NCT00268892|3582598|FG000|Overall Study|Adverse Event|14
2015578|NCT00268892|3582599|FG001|Overall Study|Adverse Event|17
2015579|NCT00268892|3582600|FG002|Overall Study|Adverse Event|20
2015580|NCT00268892|3582598|FG000|Overall Study|Lack of Efficacy|1
2015581|NCT00268892|3582599|FG001|Overall Study|Lack of Efficacy|3
2015582|NCT00268892|3582600|FG002|Overall Study|Lack of Efficacy|0
2015583|NCT00268892|3582598|FG000|Overall Study|Withdrawal by Subject|14
2015584|NCT00268892|3582599|FG001|Overall Study|Withdrawal by Subject|15
2015585|NCT00268892|3582600|FG002|Overall Study|Withdrawal by Subject|13
2015586|NCT00268892|3582598|FG000|Overall Study|Physician Decision|0
2015587|NCT00268892|3582599|FG001|Overall Study|Physician Decision|1
2015588|NCT00268892|3582600|FG002|Overall Study|Physician Decision|0
2015589|NCT00268892|3582598|FG000|Overall Study|Lost to Follow-up|5
2015590|NCT00268892|3582599|FG001|Overall Study|Lost to Follow-up|2
2015591|NCT00268892|3582600|FG002|Overall Study|Lost to Follow-up|4
2015592|NCT00268892|3582598|FG000|Overall Study|Protocol Violation|0
2015593|NCT00268892|3582599|FG001|Overall Study|Protocol Violation|1
2015594|NCT00268892|3582600|FG002|Overall Study|Protocol Violation|0
2015595|NCT00268892|3582598|FG000|Overall Study|Disease Progression|1
2015596|NCT00268892|3582599|FG001|Overall Study|Disease Progression|1
2015597|NCT00268892|3582600|FG002|Overall Study|Disease Progression|0
2015598|NCT00268892|3582598|FG000|Overall Study|Trial Site Closed|4
2015599|NCT00268892|3582599|FG001|Overall Study|Trial Site Closed|2
2015600|NCT00268892|3582600|FG002|Overall Study|Trial Site Closed|2
2015601|NCT00268905|3582611|FG000|Overall Study|Adverse Event|3
2015602|NCT00268905|3582612|FG001|Overall Study|Adverse Event|0
2015603|NCT00268905|3582613|FG002|Overall Study|Adverse Event|4
2015604|NCT00268905|3582611|FG000|Overall Study|Lost to Follow-up|0
2015605|NCT00268905|3582612|FG001|Overall Study|Lost to Follow-up|1
2015606|NCT00268905|3582613|FG002|Overall Study|Lost to Follow-up|0
2015607|NCT00268905|3582611|FG000|Overall Study|Withdrawal by Subject|0
2015608|NCT00268905|3582612|FG001|Overall Study|Withdrawal by Subject|0
2015609|NCT00268905|3582613|FG002|Overall Study|Withdrawal by Subject|3
2015610|NCT00268905|3582611|FG000|Overall Study|Progressive Disease|28
2015611|NCT00268905|3582612|FG001|Overall Study|Progressive Disease|4
2015612|NCT00268905|3582613|FG002|Overall Study|Progressive Disease|3
2015613|NCT00268905|3582611|FG000|Overall Study|Physician Decision|3
2015614|NCT00268905|3582612|FG001|Overall Study|Physician Decision|0
2015615|NCT00268905|3582613|FG002|Overall Study|Physician Decision|1
2015616|NCT00268905|3582611|FG000|Overall Study|Clinical Progression|9
2015617|NCT00268905|3582612|FG001|Overall Study|Clinical Progression|4
2015618|NCT00268905|3582613|FG002|Overall Study|Clinical Progression|1
2015619|NCT00268983|3582623|FG000|Overall Study|Death|3
2015620|NCT00268983|3582624|FG001|Overall Study|Death|0
2015621|NCT00268996|3582632|FG000|Overall Study|Adverse Event|11
2015622|NCT00268996|3582633|FG001|Overall Study|Adverse Event|7
2015623|NCT00268996|3582632|FG000|Overall Study|Lost to Follow-up|3
2015624|NCT00268996|3582633|FG001|Overall Study|Lost to Follow-up|1
2015625|NCT00268996|3582632|FG000|Overall Study|Withdrawal by Subject|5
2015626|NCT00268996|3582633|FG001|Overall Study|Withdrawal by Subject|11
2015627|NCT00268996|3582632|FG000|Overall Study|Non-compliance|1
2015628|NCT00268996|3582633|FG001|Overall Study|Non-compliance|0
2015629|NCT00268996|3582632|FG000|Overall Study|Other|1
2015630|NCT00268996|3582633|FG001|Overall Study|Other|1
2015631|NCT00269087|3582641|FG000|Overall Study|Adverse Event|20
2015632|NCT00269087|3582641|FG000|Overall Study|Withdrawal by Subject|1
2015633|NCT00269087|3582641|FG000|Overall Study|Exacerbation of COPD|13
2015634|NCT00269113|3582647|FG000|Overall Study|Adverse Event|14
2015635|NCT00269113|3582648|FG001|Overall Study|Adverse Event|7
2015636|NCT00269113|3582647|FG000|Overall Study|Lack of Efficacy|35
2015637|NCT00269113|3582648|FG001|Overall Study|Lack of Efficacy|18
2015638|NCT00269113|3582647|FG000|Overall Study|Early Improvement|2
2015639|NCT00269113|3582648|FG001|Overall Study|Early Improvement|0
2015640|NCT00269113|3582647|FG000|Overall Study|Withdrawal by Subject|0
2015641|NCT00269113|3582648|FG001|Overall Study|Withdrawal by Subject|2
2015642|NCT00269113|3582647|FG000|Overall Study|Death|6
2015643|NCT00269113|3582648|FG001|Overall Study|Death|2
2015644|NCT00269113|3582647|FG000|Overall Study|Lost to Follow-up|2
2015645|NCT00269113|3582648|FG001|Overall Study|Lost to Follow-up|1
2015646|NCT00269113|3582647|FG000|Overall Study|Protocol Violation|15
2015647|NCT00269113|3582648|FG001|Overall Study|Protocol Violation|5
2015648|NCT00269113|3582647|FG000|Overall Study|Other|0
2015649|NCT00269113|3582648|FG001|Overall Study|Other|2
2015650|NCT00269152|3582656|FG000|Overall Study|Adverse Event|9
2015651|NCT00269152|3582657|FG001|Overall Study|Adverse Event|3
2015652|NCT00269152|3582656|FG000|Overall Study|Withdrawal by Subject|7
2015653|NCT00269152|3582657|FG001|Overall Study|Withdrawal by Subject|3
2015654|NCT00269152|3582656|FG000|Overall Study|Physician Decision|2
2015655|NCT00269152|3582657|FG001|Overall Study|Physician Decision|3
2015656|NCT00269152|3582656|FG000|Overall Study|Protocol Violation|0
2015657|NCT00269152|3582657|FG001|Overall Study|Protocol Violation|1
2015658|NCT00269399|3582665|FG000|Overall Study|Lack of Efficacy|27
2015659|NCT00269399|3582666|FG001|Overall Study|Lack of Efficacy|10
2015660|NCT00269399|3582665|FG000|Overall Study|Adverse Event|10
2015661|NCT00269399|3582666|FG001|Overall Study|Adverse Event|4
2015662|NCT00269399|3582665|FG000|Overall Study|Withdrawal by Subject|2
2015663|NCT00269399|3582666|FG001|Overall Study|Withdrawal by Subject|5
2015664|NCT00269399|3582665|FG000|Overall Study|Negative Lab Result for C. difficile|2
2015665|NCT00269399|3582666|FG001|Overall Study|Negative Lab Result for C. difficile|3
2015666|NCT00269399|3582665|FG000|Overall Study|Other|0
2015667|NCT00269399|3582666|FG001|Overall Study|Other|4
2015668|NCT00269399|3582665|FG000|Overall Study|Development of exclusion criteria|0
2015669|NCT00269399|3582666|FG001|Overall Study|Development of exclusion criteria|1
2015670|NCT00269477|3582676|FG000|Overall Study|Protocol Violation|5
2015671|NCT00269477|3582677|FG001|Overall Study|Protocol Violation|5
2015672|NCT00269477|3582678|FG002|Overall Study|Protocol Violation|1
2015673|NCT00269477|3582679|FG003|Overall Study|Protocol Violation|0
2015674|NCT00269477|3582676|FG000|Overall Study|Missed post-vaccination blood draw|0
2015675|NCT00269477|3582677|FG001|Overall Study|Missed post-vaccination blood draw|1
2015676|NCT00269477|3582678|FG002|Overall Study|Missed post-vaccination blood draw|0
2015677|NCT00269477|3582679|FG003|Overall Study|Missed post-vaccination blood draw|0
2015678|NCT00269633|3582691|FG000|Overall Study|Withdrawal by Subject|1
2015679|NCT00269633|3582692|FG001|Overall Study|Withdrawal by Subject|0
2015680|NCT00269919|3582698|FG000|Overall Study|Other|26
2015681|NCT00269919|3582698|FG000|Overall Study|Started but not treated|1
2015682|NCT00270205|3582707|FG000|Overall Study|Lost to Follow-up|1
2015683|NCT00270205|3582708|FG001|Overall Study|Lost to Follow-up|0
2015684|NCT00270205|3582709|FG002|Overall Study|Lost to Follow-up|0
2015685|NCT00270205|3582710|FG003|Overall Study|Lost to Follow-up|1
2015686|NCT00270231|3582720|FG000|First Intervention|Lost to Follow-up|1
2015687|NCT00270231|3582721|FG001|First Intervention|Lost to Follow-up|1
2015688|NCT00270231|3582720|FG000|Washout Period|Lost to Follow-up|1
2015689|NCT00270231|3582721|FG001|Washout Period|Lost to Follow-up|0
2015690|NCT00270231|3582720|FG000|Second Intervention|Lost to Follow-up|0
2015691|NCT00270231|3582721|FG001|Second Intervention|Lost to Follow-up|1
2015692|NCT00270257|3582729|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
2015693|NCT00270257|3582730|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
2015694|NCT00270855|3582791|FG000|Overall Study|Withdrawal by Subject|8
2015695|NCT00270855|3582792|FG001|Overall Study|Withdrawal by Subject|8
2015696|NCT00270894|3582800|FG000|Overall Study|Adverse Event|1
2015697|NCT00270894|3582800|FG000|Overall Study|Withdrawal by Subject|1
2015698|NCT00270998|3582807|FG000|3 Month Follow-up|Adverse Event|1
2015699|NCT00270998|3582808|FG001|3 Month Follow-up|Adverse Event|0
2015700|NCT00270998|3582809|FG002|3 Month Follow-up|Adverse Event|0
2015701|NCT00270998|3582807|FG000|3 Month Follow-up|Lack of Efficacy|1
2015702|NCT00270998|3582808|FG001|3 Month Follow-up|Lack of Efficacy|2
2015703|NCT00270998|3582809|FG002|3 Month Follow-up|Lack of Efficacy|1
2015704|NCT00270998|3582807|FG000|3 Month Follow-up|Withdrawal by Subject|11
2015705|NCT00270998|3582808|FG001|3 Month Follow-up|Withdrawal by Subject|14
2015706|NCT00270998|3582809|FG002|3 Month Follow-up|Withdrawal by Subject|15
2015707|NCT00270998|3582807|FG000|3 Month Follow-up|Pessary did not fit|12
2015708|NCT00270998|3582808|FG001|3 Month Follow-up|Pessary did not fit|0
2015709|NCT00270998|3582809|FG002|3 Month Follow-up|Pessary did not fit|0
2015710|NCT00270998|3582807|FG000|3 Month Follow-up|Personal/family health|1
2015711|NCT00270998|3582808|FG001|3 Month Follow-up|Personal/family health|1
2015712|NCT00270998|3582809|FG002|3 Month Follow-up|Personal/family health|0
2015713|NCT00270998|3582807|FG000|3 Month Follow-up|Received/desired alternate treatment|13
2015714|NCT00270998|3582808|FG001|3 Month Follow-up|Received/desired alternate treatment|5
2015715|NCT00270998|3582809|FG002|3 Month Follow-up|Received/desired alternate treatment|2
2015716|NCT00270998|3582807|FG000|12 Month Follow-up|Lack of Efficacy|5
2015717|NCT00270998|3582808|FG001|12 Month Follow-up|Lack of Efficacy|4
2015718|NCT00270998|3582809|FG002|12 Month Follow-up|Lack of Efficacy|3
2015719|NCT00270998|3582807|FG000|12 Month Follow-up|Withdrawal by Subject|7
2015720|NCT00270998|3582808|FG001|12 Month Follow-up|Withdrawal by Subject|12
2015721|NCT00270998|3582809|FG002|12 Month Follow-up|Withdrawal by Subject|16
2015722|NCT00270998|3582807|FG000|12 Month Follow-up|Pessary did not fit|1
2015723|NCT00270998|3582808|FG001|12 Month Follow-up|Pessary did not fit|0
2015724|NCT00270998|3582809|FG002|12 Month Follow-up|Pessary did not fit|0
2015725|NCT00270998|3582807|FG000|12 Month Follow-up|Personal/family health|0
2015726|NCT00270998|3582808|FG001|12 Month Follow-up|Personal/family health|5
2015727|NCT00270998|3582809|FG002|12 Month Follow-up|Personal/family health|1
2015728|NCT00270998|3582807|FG000|12 Month Follow-up|Received/desired alternate treatment|1
2015729|NCT00270998|3582808|FG001|12 Month Follow-up|Received/desired alternate treatment|4
2015730|NCT00270998|3582809|FG002|12 Month Follow-up|Received/desired alternate treatment|1
2015731|NCT00271024|3582823|FG000|Overall Study|Lost Interest|3
2015732|NCT00271024|3582824|FG001|Overall Study|Lost Interest|4
2015733|NCT00271024|3582825|FG002|Overall Study|Lost Interest|2
2015734|NCT00271024|3582826|FG003|Overall Study|Lost Interest|3
2015735|NCT00271024|3582823|FG000|Overall Study|Unknown/Unspecified|11
2015736|NCT00271024|3582824|FG001|Overall Study|Unknown/Unspecified|11
2015737|NCT00271024|3582825|FG002|Overall Study|Unknown/Unspecified|8
2015738|NCT00271024|3582826|FG003|Overall Study|Unknown/Unspecified|4
2015739|NCT00271024|3582823|FG000|Overall Study|Protocol Violation|1
2015740|NCT00271024|3582824|FG001|Overall Study|Protocol Violation|6
2015741|NCT00271024|3582825|FG002|Overall Study|Protocol Violation|5
2015742|NCT00271024|3582826|FG003|Overall Study|Protocol Violation|11
2015743|NCT00271024|3582823|FG000|Overall Study|Unpleasant Reaction To Tablet|1
2015744|NCT00271024|3582824|FG001|Overall Study|Unpleasant Reaction To Tablet|3
2015745|NCT00271024|3582825|FG002|Overall Study|Unpleasant Reaction To Tablet|4
2015746|NCT00271024|3582826|FG003|Overall Study|Unpleasant Reaction To Tablet|2
2015747|NCT00271024|3582823|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6
2015748|NCT00271024|3582824|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2
2015749|NCT00271024|3582825|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4
2015750|NCT00271024|3582826|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4
2015751|NCT00271505|3582873|FG000|Overall Study|Screen Failure|3
2015752|NCT00271505|3582873|FG000|Overall Study|Adverse Event|1
2015753|NCT00271505|3582873|FG000|Overall Study|Death|1
2015754|NCT00271596|3582889|FG000|Overall Study|Protocol Violation|1
2015755|NCT00271596|3582890|FG001|Overall Study|Protocol Violation|0
2015756|NCT00271596|3582889|FG000|Overall Study|Withdrawal by Subject|0
2015757|NCT00271596|3582890|FG001|Overall Study|Withdrawal by Subject|1
2015758|NCT00271609|3582898|FG000|Overall Study|Adverse Event|11
2015759|NCT00271609|3582899|FG001|Overall Study|Adverse Event|3
2015760|NCT00271609|3582898|FG000|Overall Study|Withdrawal by Subject|2
2015761|NCT00271609|3582899|FG001|Overall Study|Withdrawal by Subject|0
2015762|NCT00271856|3582916|FG000|Overall Study|Withdrawal by Subject|1
2015763|NCT00271856|3582917|FG001|Overall Study|Withdrawal by Subject|7
2015764|NCT00271856|3582916|FG000|Overall Study|Lost to Follow-up|10
2015765|NCT00271856|3582917|FG001|Overall Study|Lost to Follow-up|11
2015766|NCT00272038|3582923|FG000|Overall Study|withdrew before they received 2 cycles|7
2015767|NCT00272779|3582981|FG000|Baseline Through Week 48|Adverse event before Week 48|10
2015768|NCT00272779|3582982|FG001|Baseline Through Week 48|Adverse event before Week 48|14
2015769|NCT00272779|3582981|FG000|Baseline Through Week 48|Death before Week 48|4
2015770|NCT00272779|3582982|FG001|Baseline Through Week 48|Death before Week 48|4
2015771|NCT00272779|3582981|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5
2015772|NCT00272779|3582982|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8
2015773|NCT00272779|3582981|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6
2015774|NCT00272779|3582982|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6
2015775|NCT00272779|3582981|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1
2015776|NCT00272779|3582982|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0
2015777|NCT00272779|3582981|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6
2015778|NCT00272779|3582982|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9
2015779|NCT00272779|3582981|FG000|Baseline Through Week 48|Pregnancy before Week 48|2
2015780|NCT00272779|3582982|FG001|Baseline Through Week 48|Pregnancy before Week 48|2
2015781|NCT00272779|3582981|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1
2015782|NCT00272779|3582982|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0
2015783|NCT00272779|3582981|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4
2015784|NCT00272779|3582982|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13
2015785|NCT00272779|3582981|FG000|Baseline Through Week 48|Participant's decision before wk 48|0
2015786|NCT00272779|3582982|FG001|Baseline Through Week 48|Participant's decision before wk 48|1
2015787|NCT00272779|3582981|FG000|Baseline Through Week 48|Chose different site before wk 48|0
2015788|NCT00272779|3582982|FG001|Baseline Through Week 48|Chose different site before wk 48|1
2015789|NCT00272779|3582981|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1
2015790|NCT00272779|3582982|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1
2015791|NCT00272779|3582981|FG000|Baseline Through Week 48|Death on/after Week 48|1
2015792|NCT00272779|3582982|FG001|Baseline Through Week 48|Death on/after Week 48|1
2015793|NCT00272779|3582981|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
2015794|NCT00272779|3582982|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
2015795|NCT00272779|3582981|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2
2015796|NCT00272779|3582982|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2
2015797|NCT00272779|3582981|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
2015798|NCT00272779|3582982|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
2015799|NCT00272779|3582981|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1
2015800|NCT00272779|3582982|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2
2015801|NCT00272779|3582981|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0
2015802|NCT00272779|3582982|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2
2015803|NCT00272779|3582981|FG000|Baseline Through Week 48|Continuing treatment|385
2015804|NCT00272779|3582982|FG001|Baseline Through Week 48|Continuing treatment|368
2015805|NCT00272779|3582981|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
2015806|NCT00272779|3582982|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
2015807|NCT00272779|3582981|FG000|Baseline Through Week 48|Never treated|2
2015808|NCT00272779|3582982|FG001|Baseline Through Week 48|Never treated|3
2015809|NCT00272779|3582981|FG000|Baseline Through Week 96|Adverse event before Week 96|13
2015810|NCT00272779|3582982|FG001|Baseline Through Week 96|Adverse event before Week 96|22
2015811|NCT00272779|3582981|FG000|Baseline Through Week 96|Death before Week 96|6
2015812|NCT00272779|3582982|FG001|Baseline Through Week 96|Death before Week 96|5
2015813|NCT00272779|3582981|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16
2015814|NCT00272779|3582982|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10
2015815|NCT00272779|3582981|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10
2015816|NCT00272779|3582982|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13
2015817|NCT00272779|3582981|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1
2015818|NCT00272779|3582982|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0
2015819|NCT00272779|3582981|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12
2015820|NCT00272779|3582982|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16
2015821|NCT00272779|3582981|FG000|Baseline Through Week 96|Pregnancy before Week 96|5
2015822|NCT00272779|3582982|FG001|Baseline Through Week 96|Pregnancy before Week 96|7
2015823|NCT00272779|3582981|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4
2015824|NCT00272779|3582982|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3
2015825|NCT00272779|3582981|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5
2015826|NCT00272779|3582982|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18
2015827|NCT00272779|3582981|FG000|Baseline Through Week 96|Changed address before Week 96|0
2015828|NCT00272779|3582982|FG001|Baseline Through Week 96|Changed address before Week 96|1
2015829|NCT00272779|3582981|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1
2015830|NCT00272779|3582982|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0
2015831|NCT00272779|3582981|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2
2015832|NCT00272779|3582982|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0
2015833|NCT00272779|3582981|FG000|Baseline Through Week 96|Pregnancy at Week 96|1
2015834|NCT00272779|3582982|FG001|Baseline Through Week 96|Pregnancy at Week 96|0
2015835|NCT00272779|3582981|FG000|Baseline Through Week 96|Never treated|2
2015836|NCT00272779|3582982|FG001|Baseline Through Week 96|Never treated|3
2015837|NCT00272779|3582981|FG000|Baseline Through Week 96|Continuing on treatment|61
2015838|NCT00272779|3582982|FG001|Baseline Through Week 96|Continuing on treatment|38
2015839|NCT00272792|3582991|FG000|Part 1: Responsiveness|Lost to Follow-up|1
2015840|NCT00272792|3582992|FG001|Part 1: Responsiveness|Lost to Follow-up|0
2015841|NCT00272792|3582991|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
2015842|NCT00272792|3582992|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
2015843|NCT00272792|3582991|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
2015844|NCT00272792|3582992|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
2015845|NCT00272792|3582991|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
2015846|NCT00272792|3582992|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
2015847|NCT00272844|3582998|FG000|Overall Study|Withdrawal by Subject|5
2015848|NCT00272961|3583007|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
2015849|NCT00272961|3583008|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
2015850|NCT00272961|3583009|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
2015851|NCT00272961|3583010|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
2015852|NCT00272961|3583011|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
2015853|NCT00272961|3583007|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
2015854|NCT00272961|3583008|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
2015855|NCT00272961|3583009|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
2015856|NCT00272961|3583010|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
2015857|NCT00272961|3583011|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
2015858|NCT00272961|3583007|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
2015859|NCT00272961|3583008|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
2015860|NCT00272961|3583009|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
2015861|NCT00272961|3583010|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
2015862|NCT00272961|3583011|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
2015863|NCT00272961|3583007|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
2015864|NCT00272961|3583008|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
2015865|NCT00272961|3583009|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
2015866|NCT00272961|3583010|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
2015867|NCT00272961|3583011|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
2015868|NCT00272961|3583007|FG000|Placebo Run-in Phase: Up to Week 2|Other|2
2015869|NCT00272961|3583008|FG001|Placebo Run-in Phase: Up to Week 2|Other|0
2015870|NCT00272961|3583009|FG002|Placebo Run-in Phase: Up to Week 2|Other|0
2015871|NCT00272961|3583010|FG003|Placebo Run-in Phase: Up to Week 2|Other|0
2015872|NCT00272961|3583011|FG004|Placebo Run-in Phase: Up to Week 2|Other|0
2015873|NCT00272961|3583007|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
2015874|NCT00272961|3583008|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
2015875|NCT00272961|3583009|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
2015876|NCT00272961|3583010|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
2015877|NCT00272961|3583011|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
2015878|NCT00272961|3583007|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
2015879|NCT00272961|3583008|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
2015880|NCT00272961|3583009|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
2015881|NCT00272961|3583010|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
2015882|NCT00272961|3583011|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
2015883|NCT00272961|3583007|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1
2015884|NCT00272961|3583008|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3
2015885|NCT00272961|3583009|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3
2015886|NCT00272961|3583010|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2
2015887|NCT00272961|3583011|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2
2015888|NCT00272987|3583026|FG000|Overall Study|Adverse Event|1
2015889|NCT00272987|3583027|FG001|Overall Study|Adverse Event|0
2015890|NCT00272987|3583028|FG002|Overall Study|Adverse Event|0
2015891|NCT00272987|3583026|FG000|Overall Study|Lost to Follow-up|3
2015892|NCT00272987|3583027|FG001|Overall Study|Lost to Follow-up|1
2015893|NCT00272987|3583028|FG002|Overall Study|Lost to Follow-up|1
2015894|NCT00272987|3583026|FG000|Overall Study|Withdrawal by Subject|1
2015895|NCT00272987|3583027|FG001|Overall Study|Withdrawal by Subject|0
2015896|NCT00272987|3583028|FG002|Overall Study|Withdrawal by Subject|3
2015897|NCT00272987|3583026|FG000|Overall Study|Sponsor Terminated study|0
2015898|NCT00272987|3583027|FG001|Overall Study|Sponsor Terminated study|1
2015899|NCT00272987|3583028|FG002|Overall Study|Sponsor Terminated study|1
2015900|NCT00272987|3583026|FG000|Overall Study|Disease progression|1
2015901|NCT00272987|3583027|FG001|Overall Study|Disease progression|1
2015902|NCT00272987|3583028|FG002|Overall Study|Disease progression|2
2015903|NCT00272987|3583026|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2
2015904|NCT00272987|3583027|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1
2015905|NCT00272987|3583028|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4
2015906|NCT00272987|3583026|FG000|Overall Study|Death|1
2015907|NCT00272987|3583027|FG001|Overall Study|Death|0
2015908|NCT00272987|3583028|FG002|Overall Study|Death|0
2015909|NCT00273052|3583038|FG000|Overall Study|Withdrawal by Subject|16
2015910|NCT00273052|3583039|FG001|Overall Study|Withdrawal by Subject|19
2015911|NCT00273052|3583038|FG000|Overall Study|Adverse Event|21
2214532|NCT01688037|3856826|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0
2214533|NCT01688037|3856827|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1
2214534|NCT01688037|3856828|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0
2214535|NCT01688037|3856826|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4
2015912|NCT00273052|3583039|FG001|Overall Study|Adverse Event|19
2015913|NCT00273052|3583038|FG000|Overall Study|Protocol Violation|14
2015914|NCT00273052|3583039|FG001|Overall Study|Protocol Violation|18
2015915|NCT00273052|3583038|FG000|Overall Study|Lost to Follow-up|7
2015916|NCT00273052|3583039|FG001|Overall Study|Lost to Follow-up|25
2015917|NCT00273052|3583038|FG000|Overall Study|Lack of Efficacy|6
2015918|NCT00273052|3583039|FG001|Overall Study|Lack of Efficacy|4
2015919|NCT00273052|3583038|FG000|Overall Study|Non-Compliance|3
2015920|NCT00273052|3583039|FG001|Overall Study|Non-Compliance|1
2015921|NCT00273052|3583038|FG000|Overall Study|Other|2
2015922|NCT00273052|3583039|FG001|Overall Study|Other|0
2015923|NCT00273052|3583038|FG000|Overall Study|Worsening serum lipid levels|0
2015924|NCT00273052|3583039|FG001|Overall Study|Worsening serum lipid levels|2
2015925|NCT00273182|3583045|FG000|Overall Study|Death|450
2015926|NCT00273182|3583045|FG000|Overall Study|Lost to Follow-up|88
2015927|NCT00273182|3583045|FG000|Overall Study|Withdrawal by Subject|257
2015928|NCT00273182|3583045|FG000|Overall Study|Device/System Explant|154
2015929|NCT00273182|3583045|FG000|Overall Study|Site exit, system change, 36 m FU missed|36
2015930|NCT00273858|3583093|FG000|Overall Study|Not completed 24 month observation time|334
2015931|NCT00273858|3583093|FG000|Overall Study|Lost to Follow-up|101
2015932|NCT00273858|3583093|FG000|Overall Study|Withdrawal by Subject|21
2015933|NCT00273858|3583093|FG000|Overall Study|Adverse Event|81
2015934|NCT00274261|3583124|FG000|Overall Study|Adverse Event|19
2015935|NCT00274261|3583125|FG001|Overall Study|Adverse Event|11
2015936|NCT00274261|3583124|FG000|Overall Study|Pregnancy|114
2015937|NCT00274261|3583125|FG001|Overall Study|Pregnancy|83
2015938|NCT00274261|3583124|FG000|Overall Study|Withdrawal by Subject|179
2015939|NCT00274261|3583125|FG001|Overall Study|Withdrawal by Subject|126
2015940|NCT00274261|3583124|FG000|Overall Study|Protocol Violation|71
2015941|NCT00274261|3583125|FG001|Overall Study|Protocol Violation|42
2015942|NCT00274261|3583124|FG000|Overall Study|Lost to Follow-up|106
2015943|NCT00274261|3583125|FG001|Overall Study|Lost to Follow-up|75
2015944|NCT00274287|3583133|FG000|Overall Study|Withdrawal by Subject|1
2015945|NCT00274287|3583133|FG000|Overall Study|subject non-compliance|1
2015946|NCT00274456|3583142|FG000|Overall Study|Still on treatment|2
2015947|NCT00274456|3583143|FG001|Overall Study|Still on treatment|3
2015948|NCT00274456|3583144|FG002|Overall Study|Still on treatment|5
2015949|NCT00274456|3583145|FG003|Overall Study|Still on treatment|1
2015950|NCT00274456|3583142|FG000|Overall Study|Unacceptable toxicity|10
2015951|NCT00274456|3583143|FG001|Overall Study|Unacceptable toxicity|5
2015952|NCT00274456|3583144|FG002|Overall Study|Unacceptable toxicity|12
2015953|NCT00274456|3583145|FG003|Overall Study|Unacceptable toxicity|16
2015954|NCT00274456|3583142|FG000|Overall Study|Adverse Event|0
2015955|NCT00274456|3583143|FG001|Overall Study|Adverse Event|1
2015956|NCT00274456|3583144|FG002|Overall Study|Adverse Event|2
2015957|NCT00274456|3583145|FG003|Overall Study|Adverse Event|2
2015958|NCT00274456|3583142|FG000|Overall Study|Physician Decision|7
2015959|NCT00274456|3583143|FG001|Overall Study|Physician Decision|5
2015960|NCT00274456|3583144|FG002|Overall Study|Physician Decision|6
2015961|NCT00274456|3583145|FG003|Overall Study|Physician Decision|13
2015962|NCT00274456|3583142|FG000|Overall Study|Lost to Follow-up|0
2015963|NCT00274456|3583143|FG001|Overall Study|Lost to Follow-up|0
2015964|NCT00274456|3583144|FG002|Overall Study|Lost to Follow-up|1
2015965|NCT00274456|3583145|FG003|Overall Study|Lost to Follow-up|0
2015966|NCT00274456|3583142|FG000|Overall Study|Withdrawal by Subject|18
2015967|NCT00274456|3583143|FG001|Overall Study|Withdrawal by Subject|13
2015968|NCT00274456|3583144|FG002|Overall Study|Withdrawal by Subject|9
2015969|NCT00274456|3583145|FG003|Overall Study|Withdrawal by Subject|13
2015970|NCT00274469|3583157|FG000|Overall Study|Death|63
2015971|NCT00274469|3583158|FG001|Overall Study|Death|74
2015972|NCT00274469|3583157|FG000|Overall Study|Did not consent to OS follow-up|16
2015973|NCT00274469|3583158|FG001|Overall Study|Did not consent to OS follow-up|19
2015974|NCT00274625|3583166|FG000|Overall Study|Lost to Follow-up|46
2015975|NCT00274625|3583167|FG001|Overall Study|Lost to Follow-up|54
2015976|NCT00274625|3583166|FG000|Overall Study|Excluded from analysis|14
2015977|NCT00274625|3583167|FG001|Overall Study|Excluded from analysis|8
2015978|NCT00274651|3583175|FG000|Overall Study|Adverse Event|6
2015979|NCT00274651|3583176|FG001|Overall Study|Adverse Event|3
2015980|NCT00274651|3583175|FG000|Overall Study|Lack of Efficacy|13
2015981|NCT00274651|3583176|FG001|Overall Study|Lack of Efficacy|6
2015982|NCT00274651|3583175|FG000|Overall Study|Death|1
2015983|NCT00274651|3583176|FG001|Overall Study|Death|3
2015984|NCT00274651|3583175|FG000|Overall Study|Withdrawal by Subject|0
2015985|NCT00274651|3583176|FG001|Overall Study|Withdrawal by Subject|1
2015986|NCT00274651|3583175|FG000|Overall Study|Physician Decision|8
2015987|NCT00274651|3583176|FG001|Overall Study|Physician Decision|7
2015988|NCT00274716|3583189|FG000|Phase A|Other non-reported reason|4
2015989|NCT00274716|3583190|FG001|Phase A|Other non-reported reason|2
2015990|NCT00274716|3583191|FG002|Phase A|Other non-reported reason|1
2015991|NCT00274716|3583192|FG003|Phase A|Other non-reported reason|2
2015992|NCT00274716|3583193|FG004|Phase A|Other non-reported reason|0
2015993|NCT00274716|3583194|FG005|Phase A|Other non-reported reason|1
2015994|NCT00274716|3583189|FG000|Phase A|Participant moved|0
2015995|NCT00274716|3583190|FG001|Phase A|Participant moved|0
2015996|NCT00274716|3583191|FG002|Phase A|Participant moved|1
2015997|NCT00274716|3583192|FG003|Phase A|Participant moved|0
2015998|NCT00274716|3583193|FG004|Phase A|Participant moved|0
2015999|NCT00274716|3583194|FG005|Phase A|Participant moved|1
2016000|NCT00274716|3583189|FG000|Phase A|Site Terminated|0
2016001|NCT00274716|3583190|FG001|Phase A|Site Terminated|0
2016002|NCT00274716|3583191|FG002|Phase A|Site Terminated|0
2016003|NCT00274716|3583192|FG003|Phase A|Site Terminated|1
2016004|NCT00274716|3583193|FG004|Phase A|Site Terminated|0
2016005|NCT00274716|3583194|FG005|Phase A|Site Terminated|0
2016006|NCT00274716|3583189|FG000|Phase A|Protocol Violation|1
2016007|NCT00274716|3583190|FG001|Phase A|Protocol Violation|0
2016008|NCT00274716|3583191|FG002|Phase A|Protocol Violation|0
2016009|NCT00274716|3583192|FG003|Phase A|Protocol Violation|1
2016010|NCT00274716|3583193|FG004|Phase A|Protocol Violation|0
2016011|NCT00274716|3583194|FG005|Phase A|Protocol Violation|0
2016012|NCT00274716|3583189|FG000|Phase A|Met criteria for discontinuation|1
2016013|NCT00274716|3583190|FG001|Phase A|Met criteria for discontinuation|1
2016014|NCT00274716|3583191|FG002|Phase A|Met criteria for discontinuation|0
2016015|NCT00274716|3583192|FG003|Phase A|Met criteria for discontinuation|0
2016016|NCT00274716|3583193|FG004|Phase A|Met criteria for discontinuation|0
2016017|NCT00274716|3583194|FG005|Phase A|Met criteria for discontinuation|0
2016018|NCT00274716|3583189|FG000|Phase A|Withdrawal by Subject|2
2016019|NCT00274716|3583190|FG001|Phase A|Withdrawal by Subject|2
2016020|NCT00274716|3583191|FG002|Phase A|Withdrawal by Subject|1
2016021|NCT00274716|3583192|FG003|Phase A|Withdrawal by Subject|3
2016022|NCT00274716|3583193|FG004|Phase A|Withdrawal by Subject|0
2016023|NCT00274716|3583194|FG005|Phase A|Withdrawal by Subject|1
2016024|NCT00274716|3583189|FG000|Phase A|Adverse Event|2
2016025|NCT00274716|3583190|FG001|Phase A|Adverse Event|3
2016026|NCT00274716|3583191|FG002|Phase A|Adverse Event|3
2016027|NCT00274716|3583192|FG003|Phase A|Adverse Event|0
2016028|NCT00274716|3583193|FG004|Phase A|Adverse Event|2
2016029|NCT00274716|3583194|FG005|Phase A|Adverse Event|0
2016030|NCT00274716|3583189|FG000|Phase A|Completed but did not enter Phase B|1
2016031|NCT00274716|3583190|FG001|Phase A|Completed but did not enter Phase B|2
2016032|NCT00274716|3583191|FG002|Phase A|Completed but did not enter Phase B|2
2016033|NCT00274716|3583192|FG003|Phase A|Completed but did not enter Phase B|2
2016034|NCT00274716|3583193|FG004|Phase A|Completed but did not enter Phase B|1
2016035|NCT00274716|3583194|FG005|Phase A|Completed but did not enter Phase B|1
2016036|NCT00274716|3583189|FG000|Phase B|Adverse Event|0
2016037|NCT00274716|3583190|FG001|Phase B|Adverse Event|0
2016038|NCT00274716|3583191|FG002|Phase B|Adverse Event|2
2016039|NCT00274716|3583192|FG003|Phase B|Adverse Event|0
2016040|NCT00274716|3583193|FG004|Phase B|Adverse Event|0
2016041|NCT00274716|3583194|FG005|Phase B|Adverse Event|1
2016042|NCT00274716|3583189|FG000|Phase B|Protocol Violation|0
2016043|NCT00274716|3583190|FG001|Phase B|Protocol Violation|2
2016044|NCT00274716|3583191|FG002|Phase B|Protocol Violation|0
2016045|NCT00274716|3583192|FG003|Phase B|Protocol Violation|0
2016046|NCT00274716|3583193|FG004|Phase B|Protocol Violation|0
2016047|NCT00274716|3583194|FG005|Phase B|Protocol Violation|0
2016048|NCT00274716|3583189|FG000|Phase B|Withdrawal by Subject|0
2016049|NCT00274716|3583190|FG001|Phase B|Withdrawal by Subject|1
2016050|NCT00274716|3583191|FG002|Phase B|Withdrawal by Subject|0
2016051|NCT00274716|3583192|FG003|Phase B|Withdrawal by Subject|0
2016052|NCT00274716|3583193|FG004|Phase B|Withdrawal by Subject|0
2016053|NCT00274716|3583194|FG005|Phase B|Withdrawal by Subject|0
2016054|NCT00274716|3583189|FG000|Phase B|Participant moved|1
2016055|NCT00274716|3583190|FG001|Phase B|Participant moved|0
2016056|NCT00274716|3583191|FG002|Phase B|Participant moved|0
2016057|NCT00274716|3583192|FG003|Phase B|Participant moved|0
2016058|NCT00274716|3583193|FG004|Phase B|Participant moved|0
2016059|NCT00274716|3583194|FG005|Phase B|Participant moved|0
2016060|NCT00274716|3583189|FG000|Phase B|Other non-reported reason|0
2016061|NCT00274716|3583190|FG001|Phase B|Other non-reported reason|0
2016062|NCT00274716|3583191|FG002|Phase B|Other non-reported reason|1
2016063|NCT00274716|3583192|FG003|Phase B|Other non-reported reason|1
2016064|NCT00274716|3583193|FG004|Phase B|Other non-reported reason|0
2016065|NCT00274716|3583194|FG005|Phase B|Other non-reported reason|0
2016066|NCT00274716|3583189|FG000|Phase B|Lost to Follow-up|0
2016067|NCT00274716|3583190|FG001|Phase B|Lost to Follow-up|1
2016068|NCT00274716|3583191|FG002|Phase B|Lost to Follow-up|0
2016069|NCT00274716|3583192|FG003|Phase B|Lost to Follow-up|0
2016070|NCT00274716|3583193|FG004|Phase B|Lost to Follow-up|0
2016071|NCT00274716|3583194|FG005|Phase B|Lost to Follow-up|0
2016072|NCT00274742|3583218|FG000|Overall Study|Adverse Event|0
2016073|NCT00274742|3583219|FG001|Overall Study|Adverse Event|4
2016074|NCT00274742|3583220|FG002|Overall Study|Adverse Event|1
2016075|NCT00274742|3583221|FG003|Overall Study|Adverse Event|4
2016076|NCT00274742|3583222|FG004|Overall Study|Adverse Event|12
2016077|NCT00274742|3583223|FG005|Overall Study|Adverse Event|3
2016078|NCT00274742|3583218|FG000|Overall Study|Lost to Follow-up|0
2016079|NCT00274742|3583219|FG001|Overall Study|Lost to Follow-up|0
2016080|NCT00274742|3583220|FG002|Overall Study|Lost to Follow-up|0
2016081|NCT00274742|3583221|FG003|Overall Study|Lost to Follow-up|0
2016082|NCT00274742|3583222|FG004|Overall Study|Lost to Follow-up|1
2016083|NCT00274742|3583223|FG005|Overall Study|Lost to Follow-up|0
2016084|NCT00274742|3583218|FG000|Overall Study|End of Study|0
2016085|NCT00274742|3583219|FG001|Overall Study|End of Study|0
2016086|NCT00274742|3583220|FG002|Overall Study|End of Study|0
2214536|NCT01688037|3856827|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1
2214537|NCT01688037|3856828|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1
2214538|NCT01688037|3856826|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0
2214539|NCT01688037|3856827|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0
2214540|NCT01688037|3856828|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2
2214541|NCT01688037|3856826|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
2016087|NCT00274742|3583221|FG003|Overall Study|End of Study|1
2016088|NCT00274742|3583222|FG004|Overall Study|End of Study|0
2016089|NCT00274742|3583223|FG005|Overall Study|End of Study|0
2016090|NCT00274742|3583218|FG000|Overall Study|Disease Progression|0
2016091|NCT00274742|3583219|FG001|Overall Study|Disease Progression|1
2016092|NCT00274742|3583220|FG002|Overall Study|Disease Progression|1
2016093|NCT00274742|3583221|FG003|Overall Study|Disease Progression|0
2016094|NCT00274742|3583222|FG004|Overall Study|Disease Progression|1
2016095|NCT00274742|3583223|FG005|Overall Study|Disease Progression|0
2016096|NCT00274742|3583218|FG000|Overall Study|Other|0
2016097|NCT00274742|3583219|FG001|Overall Study|Other|3
2016098|NCT00274742|3583220|FG002|Overall Study|Other|0
2016099|NCT00274742|3583221|FG003|Overall Study|Other|0
2016100|NCT00274742|3583222|FG004|Overall Study|Other|2
2016101|NCT00274742|3583223|FG005|Overall Study|Other|0
2016102|NCT00274846|3583252|FG000|Overall Study|Did not receive adequate NK cells|1
2016103|NCT00274924|3583260|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
2016104|NCT00274924|3583261|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
2016105|NCT00274924|3583262|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
2016106|NCT00274924|3583260|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
2016107|NCT00274924|3583261|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
2016108|NCT00274924|3583262|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
2016109|NCT00274924|3583260|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
2016110|NCT00274924|3583261|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
2016111|NCT00274924|3583262|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
2016112|NCT00274924|3583260|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
2016113|NCT00274924|3583261|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
2016114|NCT00274924|3583262|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
2016115|NCT00274924|3583260|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
2016116|NCT00274924|3583261|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
2016117|NCT00274924|3583262|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
2016118|NCT00274924|3583260|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
2016119|NCT00274924|3583261|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
2016120|NCT00274924|3583262|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
2016121|NCT00274924|3583260|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
2016122|NCT00274924|3583261|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
2016123|NCT00274924|3583262|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
2016124|NCT00274924|3583260|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
2016125|NCT00274924|3583261|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
2016126|NCT00274924|3583262|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
2016127|NCT00274924|3583260|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
2016128|NCT00274924|3583261|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
2016129|NCT00274924|3583262|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
2016130|NCT00274924|3583260|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
2016131|NCT00274924|3583261|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
2016132|NCT00274924|3583262|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
2016133|NCT00274924|3583260|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0
2016134|NCT00274924|3583261|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1
2016135|NCT00274924|3583262|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0
2016136|NCT00274924|3583260|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
2016137|NCT00274924|3583261|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
2016138|NCT00274924|3583262|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
2016139|NCT00274924|3583260|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
2016140|NCT00274924|3583261|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
2016141|NCT00274924|3583262|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
2016142|NCT00274937|3583269|FG000|Overall Study|Physician Decision|10
2016143|NCT00274937|3583269|FG000|Overall Study|Withdrawal by Subject|6
2016144|NCT00274937|3583269|FG000|Overall Study|Progressive Disease|4
2016145|NCT00275002|3583275|FG000|Overall Study|Death|1
2016146|NCT00275002|3583276|FG001|Overall Study|Death|0
2016147|NCT00275002|3583275|FG000|Overall Study|Disease progression|21
2016148|NCT00275002|3583276|FG001|Overall Study|Disease progression|15
2016149|NCT00275002|3583275|FG000|Overall Study|Adverse Event|0
2016150|NCT00275002|3583276|FG001|Overall Study|Adverse Event|1
2016151|NCT00275028|3583282|FG000|Overall Study|Withdrew consent before treatment began|1
2016152|NCT00275028|3583282|FG000|Overall Study|Withdrawal by Subject|5
2016153|NCT00275028|3583282|FG000|Overall Study|Adverse Event|9
2016154|NCT00275028|3583282|FG000|Overall Study|Progressive Disease|30
2016155|NCT00275028|3583282|FG000|Overall Study|Physician Decision|2
2016156|NCT00275262|3583288|FG000|Overall Study|Adverse Event|2
2016157|NCT00275262|3583289|FG001|Overall Study|Adverse Event|0
2016158|NCT00275262|3583288|FG000|Overall Study|Disease progression|2
2016159|NCT00275262|3583289|FG001|Overall Study|Disease progression|5
2016160|NCT00275262|3583288|FG000|Overall Study|Lost to Follow-up|0
2016161|NCT00275262|3583289|FG001|Overall Study|Lost to Follow-up|2
2016162|NCT00275262|3583288|FG000|Overall Study|Protocol Violation|0
2016163|NCT00275262|3583289|FG001|Overall Study|Protocol Violation|2
2016164|NCT00275262|3583288|FG000|Overall Study|Death|1
2016165|NCT00275262|3583289|FG001|Overall Study|Death|0
2016166|NCT00275262|3583288|FG000|Overall Study|Started Chemotherapy|1
2016167|NCT00275262|3583289|FG001|Overall Study|Started Chemotherapy|0
2016168|NCT00275301|3583308|FG000|Overall Study|Adverse Event|5
2016169|NCT00275509|3583323|FG000|Overall Study|graft thrombosis, post-operative day #8|0
2016170|NCT00275509|3583324|FG001|Overall Study|graft thrombosis, post-operative day #8|1
2016171|NCT00275561|3583332|FG000|Overall Study|Withdrawal by Subject|0
2016172|NCT00275561|3583333|FG001|Overall Study|Withdrawal by Subject|1
2016173|NCT00275561|3583332|FG000|Overall Study|Travel|1
2016174|NCT00275561|3583333|FG001|Overall Study|Travel|1
2016175|NCT00275561|3583332|FG000|Overall Study|Scheduling|1
2016176|NCT00275561|3583333|FG001|Overall Study|Scheduling|2
2016177|NCT00275561|3583332|FG000|Overall Study|Family Issues|0
2016178|NCT00275561|3583333|FG001|Overall Study|Family Issues|2
2016179|NCT00275821|3583342|FG000|Overall Study|Adverse Event|4
2016180|NCT00275821|3583343|FG001|Overall Study|Adverse Event|12
2016181|NCT00275821|3583344|FG002|Overall Study|Adverse Event|5
2016182|NCT00275821|3583342|FG000|Overall Study|Administrative problems|3
2016183|NCT00275821|3583343|FG001|Overall Study|Administrative problems|4
2016184|NCT00275821|3583344|FG002|Overall Study|Administrative problems|4
2016185|NCT00275821|3583342|FG000|Overall Study|Withdrawal by Subject|0
2016186|NCT00275821|3583343|FG001|Overall Study|Withdrawal by Subject|2
2016187|NCT00275821|3583344|FG002|Overall Study|Withdrawal by Subject|1
2016188|NCT00275821|3583342|FG000|Overall Study|Lost to Follow-up|0
2016189|NCT00275821|3583343|FG001|Overall Study|Lost to Follow-up|1
2016190|NCT00275821|3583344|FG002|Overall Study|Lost to Follow-up|1
2016191|NCT00275821|3583342|FG000|Overall Study|Death|0
2016192|NCT00275821|3583343|FG001|Overall Study|Death|2
2016193|NCT00275821|3583344|FG002|Overall Study|Death|1
2016194|NCT00275821|3583342|FG000|Overall Study|Lack of Efficacy|2
2016195|NCT00275821|3583343|FG001|Overall Study|Lack of Efficacy|1
2016196|NCT00275821|3583344|FG002|Overall Study|Lack of Efficacy|0
2016197|NCT00275821|3583342|FG000|Overall Study|Protocol Violation|5
2016198|NCT00275821|3583343|FG001|Overall Study|Protocol Violation|1
2016199|NCT00275821|3583344|FG002|Overall Study|Protocol Violation|0
2016200|NCT00276094|3583370|FG000|Overall Study|Adverse Event|15
2016201|NCT00276094|3583371|FG001|Overall Study|Adverse Event|13
2016202|NCT00276094|3583372|FG002|Overall Study|Adverse Event|11
2016203|NCT00276094|3583370|FG000|Overall Study|Withdrawal by Subject|14
2016204|NCT00276094|3583371|FG001|Overall Study|Withdrawal by Subject|14
2016205|NCT00276094|3583372|FG002|Overall Study|Withdrawal by Subject|12
2016206|NCT00276094|3583370|FG000|Overall Study|Protocol Violation|16
2016207|NCT00276094|3583371|FG001|Overall Study|Protocol Violation|7
2016208|NCT00276094|3583372|FG002|Overall Study|Protocol Violation|10
2016209|NCT00276094|3583370|FG000|Overall Study|Lost to Follow-up|8
2016210|NCT00276094|3583371|FG001|Overall Study|Lost to Follow-up|6
2016211|NCT00276094|3583372|FG002|Overall Study|Lost to Follow-up|4
2016212|NCT00276094|3583370|FG000|Overall Study|Other-Subject moved out of country|1
2016213|NCT00276094|3583371|FG001|Overall Study|Other-Subject moved out of country|0
2016214|NCT00276094|3583372|FG002|Overall Study|Other-Subject moved out of country|0
2016215|NCT00276094|3583370|FG000|Overall Study|Other-Scheduled gastroplasty|1
2016216|NCT00276094|3583371|FG001|Overall Study|Other-Scheduled gastroplasty|0
2016217|NCT00276094|3583372|FG002|Overall Study|Other-Scheduled gastroplasty|0
2016218|NCT00276094|3583370|FG000|Overall Study|Other-Lack of efficacy|1
2016219|NCT00276094|3583371|FG001|Overall Study|Other-Lack of efficacy|0
2016220|NCT00276094|3583372|FG002|Overall Study|Other-Lack of efficacy|0
2016221|NCT00276094|3583370|FG000|Overall Study|Other-Refused follow-up visit|1
2016222|NCT00276094|3583371|FG001|Overall Study|Other-Refused follow-up visit|0
2016223|NCT00276094|3583372|FG002|Overall Study|Other-Refused follow-up visit|0
2016224|NCT00276094|3583370|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0
2016225|NCT00276094|3583371|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1
2016226|NCT00276094|3583372|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0
2016227|NCT00276094|3583370|FG000|Overall Study|Other-Relocation|0
2016228|NCT00276094|3583371|FG001|Overall Study|Other-Relocation|1
2016229|NCT00276094|3583372|FG002|Overall Study|Other-Relocation|0
2016230|NCT00276094|3583370|FG000|Overall Study|Other-Study medication lost|0
2016231|NCT00276094|3583371|FG001|Overall Study|Other-Study medication lost|0
2016232|NCT00276094|3583372|FG002|Overall Study|Other-Study medication lost|1
2016233|NCT00276159|3583380|FG000|Overall Study|Did not receive all 24 doses of 852A|6
2016234|NCT00276380|3583399|FG000|Overall Study|Adverse Event|5
2016235|NCT00276380|3583400|FG001|Overall Study|Adverse Event|3
2016236|NCT00276380|3583399|FG000|Overall Study|Lost to Follow-up|1
2016237|NCT00276380|3583400|FG001|Overall Study|Lost to Follow-up|1
2016238|NCT00276380|3583399|FG000|Overall Study|Withdrawal by Subject|3
2016239|NCT00276380|3583400|FG001|Overall Study|Withdrawal by Subject|6
2016240|NCT00276380|3583399|FG000|Overall Study|Death|5
2016241|NCT00276380|3583400|FG001|Overall Study|Death|3
2016242|NCT00276380|3583399|FG000|Overall Study|Abnormal aPPT Levels|0
2016243|NCT00276380|3583400|FG001|Overall Study|Abnormal aPPT Levels|1
2016244|NCT00276614|3583420|FG000|Overall Study|Progression of disease under study|3
2016245|NCT00276744|3583424|FG000|PART A|Reason unknown|98
2016246|NCT00277095|3583433|FG000|Overall Study|Death|2
2016247|NCT00277095|3583433|FG000|Overall Study|Explanted|7
2016248|NCT00277095|3583433|FG000|Overall Study|Lost to Follow-up|2
2016249|NCT00277095|3583433|FG000|Overall Study|Missed Follow-up|9
2016250|NCT00277095|3583433|FG000|Overall Study|Physician Decision|1
2016251|NCT00277212|3583437|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
2016252|NCT00277212|3583438|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
2016253|NCT00277212|3583439|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
2016254|NCT00277212|3583437|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93
2016255|NCT00277212|3583438|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0
2016256|NCT00277212|3583439|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0
2016257|NCT00277212|3583437|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
2016258|NCT00277212|3583438|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
2016259|NCT00277212|3583439|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
2016260|NCT00277212|3583437|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
2016261|NCT00277212|3583438|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
2016262|NCT00277212|3583439|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
2016263|NCT00277212|3583437|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
2016264|NCT00277212|3583438|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
2016265|NCT00277212|3583439|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
2016266|NCT00277212|3583437|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6
2016267|NCT00277212|3583438|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0
2016268|NCT00277212|3583439|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0
2016269|NCT00277212|3583437|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
2016270|NCT00277212|3583438|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
2016271|NCT00277212|3583439|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
2016272|NCT00277212|3583437|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
2016273|NCT00277212|3583438|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
2016274|NCT00277212|3583439|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
2016275|NCT00277212|3583437|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12
2016276|NCT00277212|3583438|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0
2016277|NCT00277212|3583439|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0
2016278|NCT00277212|3583437|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
2016279|NCT00277212|3583438|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
2016280|NCT00277212|3583439|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
2016281|NCT00277212|3583437|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0
2016282|NCT00277212|3583438|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10
2016283|NCT00277212|3583439|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16
2016284|NCT00277212|3583437|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
2016285|NCT00277212|3583438|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
2016286|NCT00277212|3583439|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
2016287|NCT00277212|3583437|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
2016288|NCT00277212|3583438|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
2016289|NCT00277212|3583439|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
2016290|NCT00277212|3583437|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
2016291|NCT00277212|3583438|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
2016292|NCT00277212|3583439|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
2016293|NCT00277212|3583437|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0
2016294|NCT00277212|3583438|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2
2016295|NCT00277212|3583439|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2
2016296|NCT00277212|3583437|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
2016297|NCT00277212|3583438|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
2016298|NCT00277212|3583439|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
2016299|NCT00277212|3583437|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
2016300|NCT00277212|3583438|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
2016301|NCT00277212|3583439|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
2016302|NCT00277212|3583437|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0
2016303|NCT00277212|3583438|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7
2016304|NCT00277212|3583439|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5
2214542|NCT01688037|3856827|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
2214543|NCT01688037|3856828|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
2214544|NCT01688037|3856826|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
2016305|NCT00277355|3583449|FG000|Overall Study|Withdrawal by Subject|3
2016306|NCT00277355|3583450|FG001|Overall Study|Withdrawal by Subject|3
2016307|NCT00277355|3583449|FG000|Overall Study|Lost to Follow-up|2
2016308|NCT00277355|3583450|FG001|Overall Study|Lost to Follow-up|2
2016309|NCT00277355|3583449|FG000|Overall Study|Adverse Event|5
2016310|NCT00277355|3583450|FG001|Overall Study|Adverse Event|0
2016311|NCT00277355|3583449|FG000|Overall Study|Death|3
2016312|NCT00277355|3583450|FG001|Overall Study|Death|0
2016313|NCT00277355|3583449|FG000|Overall Study|Physician Decision|1
2016314|NCT00277355|3583450|FG001|Overall Study|Physician Decision|0
2016315|NCT00278109|3583491|FG000|Overall Study|Adverse Event|3
2016316|NCT00278109|3583491|FG000|Overall Study|social circumstances|1
2016317|NCT00278148|3583495|FG000|Phase II - Expansion Phase|Disease progression|0
2016318|NCT00278148|3583496|FG001|Phase II - Expansion Phase|Disease progression|0
2016319|NCT00278148|3583497|FG002|Phase II - Expansion Phase|Disease progression|4
2016320|NCT00278148|3583495|FG000|Phase II - Expansion Phase|Adverse Event|0
2016321|NCT00278148|3583496|FG001|Phase II - Expansion Phase|Adverse Event|0
2016322|NCT00278148|3583497|FG002|Phase II - Expansion Phase|Adverse Event|2
2016323|NCT00278161|3583504|FG000|Overall Study|Death|11
2016324|NCT00278200|3583510|FG000|Overall Study|Death|1
2016325|NCT00278200|3583511|FG001|Overall Study|Death|3
2016326|NCT00278200|3583510|FG000|Overall Study|Physician Decision|0
2016327|NCT00278200|3583511|FG001|Overall Study|Physician Decision|1
2016328|NCT00278395|3583517|FG000|Overall Study|Adverse Event|2
2016329|NCT00278395|3583517|FG000|Overall Study|Nonevaluable|1
2016330|NCT00278473|3583526|FG000|Overall Study|drop out|4
2016331|NCT00278473|3583527|FG001|Overall Study|drop out|3
2016332|NCT00278512|3583535|FG000|Overall Study|Death|1
2016333|NCT00278512|3583536|FG001|Overall Study|Death|0
2016334|NCT00278564|3583555|FG000|Overall Study|Lack of Efficacy|4
2016335|NCT00278629|3583559|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14
2016336|NCT00278889|3583585|FG000|Overall Study|Withdrawal by Subject|0
2016337|NCT00278889|3583586|FG001|Overall Study|Withdrawal by Subject|5
2016338|NCT00278889|3583587|FG002|Overall Study|Withdrawal by Subject|3
2016339|NCT00278889|3583585|FG000|Overall Study|Lost to Follow-up|1
2016340|NCT00278889|3583586|FG001|Overall Study|Lost to Follow-up|1
2016341|NCT00278889|3583587|FG002|Overall Study|Lost to Follow-up|0
2016342|NCT00278889|3583585|FG000|Overall Study|Death|24
2016343|NCT00278889|3583586|FG001|Overall Study|Death|21
2016344|NCT00278889|3583587|FG002|Overall Study|Death|17
2016346|NCT00278954|3583599|FG000|Overall Study|Adverse Event|3
2016347|NCT00278954|3583599|FG000|Overall Study|Lost to Follow-up|1
2016348|NCT00278954|3583599|FG000|Overall Study|Withdrawal by Subject|1
2016349|NCT00278993|3583603|FG000|Overall Study|Adverse Event|24
2016350|NCT00278993|3583603|FG000|Overall Study|Withdrawal by Subject|5
2016351|NCT00278993|3583603|FG000|Overall Study|Progressive Disease|65
2016352|NCT00278993|3583603|FG000|Overall Study|Physician Decision|9
2016353|NCT00278993|3583603|FG000|Overall Study|Not Otherwise Specified|4
2016354|NCT00279201|3583609|FG000|Initiation|Death|1
2016355|NCT00279201|3583610|FG001|Initiation|Death|5
2016356|NCT00279201|3583611|FG002|Initiation|Death|0
2016357|NCT00279201|3583612|FG003|Initiation|Death|0
2016358|NCT00279201|3583613|FG004|Initiation|Death|0
2016359|NCT00279201|3583614|FG005|Initiation|Death|0
2016360|NCT00279201|3583609|FG000|Initiation|Adverse Event|6
2016361|NCT00279201|3583610|FG001|Initiation|Adverse Event|15
2016362|NCT00279201|3583611|FG002|Initiation|Adverse Event|0
2016363|NCT00279201|3583612|FG003|Initiation|Adverse Event|0
2016364|NCT00279201|3583613|FG004|Initiation|Adverse Event|0
2016365|NCT00279201|3583614|FG005|Initiation|Adverse Event|0
2016366|NCT00279201|3583609|FG000|Initiation|Lost to Follow-up|42
2016367|NCT00279201|3583610|FG001|Initiation|Lost to Follow-up|41
2016368|NCT00279201|3583611|FG002|Initiation|Lost to Follow-up|0
2016369|NCT00279201|3583612|FG003|Initiation|Lost to Follow-up|0
2016370|NCT00279201|3583613|FG004|Initiation|Lost to Follow-up|0
2016371|NCT00279201|3583614|FG005|Initiation|Lost to Follow-up|0
2016372|NCT00279201|3583609|FG000|Initiation|Entry Criteria Exclusion|7
2016373|NCT00279201|3583610|FG001|Initiation|Entry Criteria Exclusion|9
2016374|NCT00279201|3583611|FG002|Initiation|Entry Criteria Exclusion|0
2016375|NCT00279201|3583612|FG003|Initiation|Entry Criteria Exclusion|0
2016376|NCT00279201|3583613|FG004|Initiation|Entry Criteria Exclusion|0
2016377|NCT00279201|3583614|FG005|Initiation|Entry Criteria Exclusion|0
2016378|NCT00279201|3583609|FG000|Initiation|Protocol Violation|9
2016379|NCT00279201|3583610|FG001|Initiation|Protocol Violation|10
2016380|NCT00279201|3583611|FG002|Initiation|Protocol Violation|0
2016381|NCT00279201|3583612|FG003|Initiation|Protocol Violation|0
2016382|NCT00279201|3583613|FG004|Initiation|Protocol Violation|0
2016383|NCT00279201|3583614|FG005|Initiation|Protocol Violation|0
2016384|NCT00279201|3583609|FG000|Initiation|Withdrawal by Subject|35
2016385|NCT00279201|3583610|FG001|Initiation|Withdrawal by Subject|41
2016386|NCT00279201|3583611|FG002|Initiation|Withdrawal by Subject|0
2016387|NCT00279201|3583612|FG003|Initiation|Withdrawal by Subject|0
2016388|NCT00279201|3583613|FG004|Initiation|Withdrawal by Subject|0
2016389|NCT00279201|3583614|FG005|Initiation|Withdrawal by Subject|0
2016390|NCT00279201|3583609|FG000|Initiation|Physician Decision|15
2016391|NCT00279201|3583610|FG001|Initiation|Physician Decision|18
2016392|NCT00279201|3583611|FG002|Initiation|Physician Decision|0
2016393|NCT00279201|3583612|FG003|Initiation|Physician Decision|0
2016394|NCT00279201|3583613|FG004|Initiation|Physician Decision|0
2016395|NCT00279201|3583614|FG005|Initiation|Physician Decision|0
2016396|NCT00279201|3583609|FG000|Initiation|Sponsor Decision|13
2016397|NCT00279201|3583610|FG001|Initiation|Sponsor Decision|5
2016398|NCT00279201|3583611|FG002|Initiation|Sponsor Decision|0
2016399|NCT00279201|3583612|FG003|Initiation|Sponsor Decision|0
2016400|NCT00279201|3583613|FG004|Initiation|Sponsor Decision|0
2016401|NCT00279201|3583614|FG005|Initiation|Sponsor Decision|0
2016402|NCT00279201|3583609|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0
2016403|NCT00279201|3583610|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1
2016404|NCT00279201|3583611|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0
2016405|NCT00279201|3583612|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0
2016406|NCT00279201|3583613|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0
2016407|NCT00279201|3583614|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0
2016408|NCT00279201|3583609|FG000|Maintenance|Lack of Efficacy|32
2016409|NCT00279201|3583610|FG001|Maintenance|Lack of Efficacy|30
2016410|NCT00279201|3583611|FG002|Maintenance|Lack of Efficacy|0
2016411|NCT00279201|3583612|FG003|Maintenance|Lack of Efficacy|0
2016412|NCT00279201|3583613|FG004|Maintenance|Lack of Efficacy|0
2016413|NCT00279201|3583614|FG005|Maintenance|Lack of Efficacy|0
2016414|NCT00279201|3583609|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3
2016415|NCT00279201|3583610|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2
2016416|NCT00279201|3583611|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0
2016417|NCT00279201|3583612|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0
2016418|NCT00279201|3583613|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0
2016419|NCT00279201|3583614|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0
2016420|NCT00279201|3583609|FG000|Maintenance|Adverse Event|4
2016421|NCT00279201|3583610|FG001|Maintenance|Adverse Event|4
2016422|NCT00279201|3583611|FG002|Maintenance|Adverse Event|0
2016423|NCT00279201|3583612|FG003|Maintenance|Adverse Event|0
2016424|NCT00279201|3583613|FG004|Maintenance|Adverse Event|0
2016425|NCT00279201|3583614|FG005|Maintenance|Adverse Event|0
2016426|NCT00279201|3583609|FG000|Maintenance|Death|4
2016427|NCT00279201|3583610|FG001|Maintenance|Death|4
2016428|NCT00279201|3583611|FG002|Maintenance|Death|0
2016429|NCT00279201|3583612|FG003|Maintenance|Death|0
2016430|NCT00279201|3583613|FG004|Maintenance|Death|0
2016431|NCT00279201|3583614|FG005|Maintenance|Death|0
2016432|NCT00279201|3583609|FG000|Maintenance|Lost to Follow-up|17
2016433|NCT00279201|3583610|FG001|Maintenance|Lost to Follow-up|13
2016434|NCT00279201|3583611|FG002|Maintenance|Lost to Follow-up|0
2016435|NCT00279201|3583612|FG003|Maintenance|Lost to Follow-up|0
2016436|NCT00279201|3583613|FG004|Maintenance|Lost to Follow-up|0
2016437|NCT00279201|3583614|FG005|Maintenance|Lost to Follow-up|0
2016438|NCT00279201|3583609|FG000|Maintenance|Entry Criteria Exclusion|1
2016439|NCT00279201|3583610|FG001|Maintenance|Entry Criteria Exclusion|4
2016440|NCT00279201|3583611|FG002|Maintenance|Entry Criteria Exclusion|0
2016441|NCT00279201|3583612|FG003|Maintenance|Entry Criteria Exclusion|0
2016442|NCT00279201|3583613|FG004|Maintenance|Entry Criteria Exclusion|0
2016443|NCT00279201|3583614|FG005|Maintenance|Entry Criteria Exclusion|0
2016444|NCT00279201|3583609|FG000|Maintenance|Protocol Violation|16
2016445|NCT00279201|3583610|FG001|Maintenance|Protocol Violation|24
2016446|NCT00279201|3583611|FG002|Maintenance|Protocol Violation|0
2016447|NCT00279201|3583612|FG003|Maintenance|Protocol Violation|0
2016448|NCT00279201|3583613|FG004|Maintenance|Protocol Violation|0
2016449|NCT00279201|3583614|FG005|Maintenance|Protocol Violation|0
2016450|NCT00279201|3583609|FG000|Maintenance|Withdrawal by Subject|18
2016451|NCT00279201|3583610|FG001|Maintenance|Withdrawal by Subject|18
2016452|NCT00279201|3583611|FG002|Maintenance|Withdrawal by Subject|0
2016453|NCT00279201|3583612|FG003|Maintenance|Withdrawal by Subject|0
2016454|NCT00279201|3583613|FG004|Maintenance|Withdrawal by Subject|0
2016455|NCT00279201|3583614|FG005|Maintenance|Withdrawal by Subject|0
2016456|NCT00279201|3583609|FG000|Maintenance|Physician Decision|9
2016457|NCT00279201|3583610|FG001|Maintenance|Physician Decision|9
2016458|NCT00279201|3583611|FG002|Maintenance|Physician Decision|0
2016459|NCT00279201|3583612|FG003|Maintenance|Physician Decision|0
2016460|NCT00279201|3583613|FG004|Maintenance|Physician Decision|0
2016461|NCT00279201|3583614|FG005|Maintenance|Physician Decision|0
2016462|NCT00279201|3583609|FG000|Maintenance|Sponsor Decision|4
2016463|NCT00279201|3583610|FG001|Maintenance|Sponsor Decision|0
2016464|NCT00279201|3583611|FG002|Maintenance|Sponsor Decision|0
2016465|NCT00279201|3583612|FG003|Maintenance|Sponsor Decision|0
2016466|NCT00279201|3583613|FG004|Maintenance|Sponsor Decision|0
2016467|NCT00279201|3583614|FG005|Maintenance|Sponsor Decision|0
2016468|NCT00279201|3583609|FG000|Maintenance|HbA1c>7.5%|123
2016469|NCT00279201|3583610|FG001|Maintenance|HbA1c>7.5%|126
2016470|NCT00279201|3583611|FG002|Maintenance|HbA1c>7.5%|0
2016471|NCT00279201|3583612|FG003|Maintenance|HbA1c>7.5%|0
2016472|NCT00279201|3583613|FG004|Maintenance|HbA1c>7.5%|0
2016473|NCT00279201|3583614|FG005|Maintenance|HbA1c>7.5%|0
2016474|NCT00279201|3583609|FG000|Intensification Addendum|Withdrawal by Subject|0
2016475|NCT00279201|3583610|FG001|Intensification Addendum|Withdrawal by Subject|0
2016476|NCT00279201|3583611|FG002|Intensification Addendum|Withdrawal by Subject|12
2016477|NCT00279201|3583612|FG003|Intensification Addendum|Withdrawal by Subject|14
2016478|NCT00279201|3583613|FG004|Intensification Addendum|Withdrawal by Subject|9
2016479|NCT00279201|3583614|FG005|Intensification Addendum|Withdrawal by Subject|18
2016480|NCT00279201|3583609|FG000|Intensification Addendum|Lost to Follow-up|0
2016481|NCT00279201|3583610|FG001|Intensification Addendum|Lost to Follow-up|0
2016482|NCT00279201|3583611|FG002|Intensification Addendum|Lost to Follow-up|4
2016483|NCT00279201|3583612|FG003|Intensification Addendum|Lost to Follow-up|6
2016484|NCT00279201|3583613|FG004|Intensification Addendum|Lost to Follow-up|7
2016485|NCT00279201|3583614|FG005|Intensification Addendum|Lost to Follow-up|7
2016486|NCT00279201|3583609|FG000|Intensification Addendum|Protocol Violation|0
2016487|NCT00279201|3583610|FG001|Intensification Addendum|Protocol Violation|0
2016488|NCT00279201|3583611|FG002|Intensification Addendum|Protocol Violation|2
2016489|NCT00279201|3583612|FG003|Intensification Addendum|Protocol Violation|2
2016490|NCT00279201|3583613|FG004|Intensification Addendum|Protocol Violation|6
2016491|NCT00279201|3583614|FG005|Intensification Addendum|Protocol Violation|6
2016492|NCT00279201|3583609|FG000|Intensification Addendum|Adverse Event|0
2016493|NCT00279201|3583610|FG001|Intensification Addendum|Adverse Event|0
2016494|NCT00279201|3583611|FG002|Intensification Addendum|Adverse Event|0
2016495|NCT00279201|3583612|FG003|Intensification Addendum|Adverse Event|4
2016496|NCT00279201|3583613|FG004|Intensification Addendum|Adverse Event|1
2016497|NCT00279201|3583614|FG005|Intensification Addendum|Adverse Event|3
2016498|NCT00279201|3583609|FG000|Intensification Addendum|Physician Decision|0
2016499|NCT00279201|3583610|FG001|Intensification Addendum|Physician Decision|0
2016500|NCT00279201|3583611|FG002|Intensification Addendum|Physician Decision|4
2016501|NCT00279201|3583612|FG003|Intensification Addendum|Physician Decision|1
2016502|NCT00279201|3583613|FG004|Intensification Addendum|Physician Decision|3
2016503|NCT00279201|3583614|FG005|Intensification Addendum|Physician Decision|2
2016504|NCT00279201|3583609|FG000|Intensification Addendum|Sponsor Decision|0
2016505|NCT00279201|3583610|FG001|Intensification Addendum|Sponsor Decision|0
2016506|NCT00279201|3583611|FG002|Intensification Addendum|Sponsor Decision|0
2016507|NCT00279201|3583612|FG003|Intensification Addendum|Sponsor Decision|0
2016508|NCT00279201|3583613|FG004|Intensification Addendum|Sponsor Decision|1
2016509|NCT00279201|3583614|FG005|Intensification Addendum|Sponsor Decision|1
2016510|NCT00279201|3583609|FG000|Intensification Addendum|Entry Criteria Exclusion|0
2016511|NCT00279201|3583610|FG001|Intensification Addendum|Entry Criteria Exclusion|0
2016512|NCT00279201|3583611|FG002|Intensification Addendum|Entry Criteria Exclusion|1
2016513|NCT00279201|3583612|FG003|Intensification Addendum|Entry Criteria Exclusion|0
2016514|NCT00279201|3583613|FG004|Intensification Addendum|Entry Criteria Exclusion|0
2016515|NCT00279201|3583614|FG005|Intensification Addendum|Entry Criteria Exclusion|0
2016516|NCT00279201|3583609|FG000|Intensification Addendum|Lack of Efficacy|0
2016517|NCT00279201|3583610|FG001|Intensification Addendum|Lack of Efficacy|0
2016518|NCT00279201|3583611|FG002|Intensification Addendum|Lack of Efficacy|0
2016519|NCT00279201|3583612|FG003|Intensification Addendum|Lack of Efficacy|1
2016520|NCT00279201|3583613|FG004|Intensification Addendum|Lack of Efficacy|1
2016521|NCT00279201|3583614|FG005|Intensification Addendum|Lack of Efficacy|0
2016522|NCT00279201|3583609|FG000|Intensification Addendum|Death|0
2016523|NCT00279201|3583610|FG001|Intensification Addendum|Death|0
2016524|NCT00279201|3583611|FG002|Intensification Addendum|Death|0
2016525|NCT00279201|3583612|FG003|Intensification Addendum|Death|0
2016526|NCT00279201|3583613|FG004|Intensification Addendum|Death|1
2016527|NCT00279201|3583614|FG005|Intensification Addendum|Death|0
2016528|NCT00279214|3583649|FG000|Overall Study|Physician Decision|3
2016529|NCT00279214|3583650|FG001|Overall Study|Physician Decision|2
2016530|NCT00279305|3583658|FG000|Overall Study|Pregnancy|1
2016531|NCT00279305|3583659|FG001|Overall Study|Pregnancy|0
2016532|NCT00279305|3583658|FG000|Overall Study|Withdrawal by Subject|2
2016533|NCT00279305|3583659|FG001|Overall Study|Withdrawal by Subject|0
2016534|NCT00279305|3583658|FG000|Overall Study|Dificulting establishing IV|1
2016535|NCT00279305|3583659|FG001|Overall Study|Dificulting establishing IV|0
2016536|NCT00279305|3583658|FG000|Overall Study|FDA Safety Alert|4
2016537|NCT00279305|3583659|FG001|Overall Study|FDA Safety Alert|1
2016538|NCT00279708|3583682|FG000|Overall Study|Withdrawal by Subject|2
2016539|NCT00279708|3583683|FG001|Overall Study|Withdrawal by Subject|3
2016540|NCT00279708|3583682|FG000|Overall Study|Adverse Event|1
2016541|NCT00279708|3583683|FG001|Overall Study|Adverse Event|1
2016542|NCT00279812|3583695|FG000|Overall Study|Protocol Violation|1
2016543|NCT00279812|3583696|FG001|Overall Study|Protocol Violation|1
2016544|NCT00279812|3583697|FG002|Overall Study|Protocol Violation|0
2016545|NCT00279812|3583698|FG003|Overall Study|Protocol Violation|0
2016546|NCT00279812|3583699|FG004|Overall Study|Protocol Violation|1
2016547|NCT00279812|3583700|FG005|Overall Study|Protocol Violation|0
2016548|NCT00279812|3583695|FG000|Overall Study|Withdrawal by Subject|0
2214545|NCT01688037|3856827|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
2214546|NCT01688037|3856828|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
2214547|NCT01688037|3856826|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
2214548|NCT01688037|3856827|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
2214549|NCT01688037|3856828|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
2214550|NCT01688050|3856840|FG000|Overall Study|Death|7
2214551|NCT01688050|3856840|FG000|Overall Study|Conversion to open repair|1
2214552|NCT01688050|3856840|FG000|Overall Study|Lost to Follow-up|13
2214553|NCT01688050|3856840|FG000|Overall Study|Withdrawal by Subject|10
2214554|NCT01688466|3856880|FG000|Overall Study|Withdrawal by Subject|2
2016549|NCT00279812|3583696|FG001|Overall Study|Withdrawal by Subject|4
2016550|NCT00279812|3583697|FG002|Overall Study|Withdrawal by Subject|2
2016551|NCT00279812|3583698|FG003|Overall Study|Withdrawal by Subject|0
2016552|NCT00279812|3583699|FG004|Overall Study|Withdrawal by Subject|0
2016553|NCT00279812|3583700|FG005|Overall Study|Withdrawal by Subject|0
2016554|NCT00279812|3583695|FG000|Overall Study|Adverse Event|0
2016555|NCT00279812|3583696|FG001|Overall Study|Adverse Event|1
2016556|NCT00279812|3583697|FG002|Overall Study|Adverse Event|1
2016557|NCT00279812|3583698|FG003|Overall Study|Adverse Event|0
2016558|NCT00279812|3583699|FG004|Overall Study|Adverse Event|2
2016559|NCT00279812|3583700|FG005|Overall Study|Adverse Event|1
2016560|NCT00279916|3583716|FG000|Overall Study|Withdrawal by Subject|4
2016561|NCT00279916|3583717|FG001|Overall Study|Withdrawal by Subject|3
2016562|NCT00279916|3583716|FG000|Overall Study|Lost to Follow-up|3
2016563|NCT00279916|3583717|FG001|Overall Study|Lost to Follow-up|2
2016564|NCT00280059|3583737|FG000|Efficacy Assessment Phase|Death|2
2016565|NCT00280059|3583738|FG001|Efficacy Assessment Phase|Death|0
2016566|NCT00280059|3583737|FG000|Efficacy Assessment Phase|Adverse Event|33
2016567|NCT00280059|3583738|FG001|Efficacy Assessment Phase|Adverse Event|31
2016568|NCT00280059|3583737|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1
2016569|NCT00280059|3583738|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0
2016570|NCT00280059|3583737|FG000|Efficacy Assessment Phase|Lack of Efficacy|19
2016571|NCT00280059|3583738|FG001|Efficacy Assessment Phase|Lack of Efficacy|3
2016572|NCT00280059|3583737|FG000|Efficacy Assessment Phase|Lost to Follow-up|6
2016573|NCT00280059|3583738|FG001|Efficacy Assessment Phase|Lost to Follow-up|13
2016574|NCT00280059|3583737|FG000|Efficacy Assessment Phase|Other|7
2016575|NCT00280059|3583738|FG001|Efficacy Assessment Phase|Other|8
2016576|NCT00280059|3583737|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26
2016577|NCT00280059|3583738|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25
2016578|NCT00280150|3583756|FG000|Overall Study|Adverse Event|0
2016579|NCT00280150|3583757|FG001|Overall Study|Adverse Event|1
2016580|NCT00280150|3583758|FG002|Overall Study|Adverse Event|2
2016581|NCT00280150|3583759|FG003|Overall Study|Adverse Event|3
2016582|NCT00280150|3583756|FG000|Overall Study|Lack of Efficacy|0
2016583|NCT00280150|3583757|FG001|Overall Study|Lack of Efficacy|0
2016584|NCT00280150|3583758|FG002|Overall Study|Lack of Efficacy|0
2016585|NCT00280150|3583759|FG003|Overall Study|Lack of Efficacy|3
2016586|NCT00280150|3583756|FG000|Overall Study|Physician Decision|0
2016587|NCT00280150|3583757|FG001|Overall Study|Physician Decision|0
2016588|NCT00280150|3583758|FG002|Overall Study|Physician Decision|0
2016589|NCT00280150|3583759|FG003|Overall Study|Physician Decision|1
2016590|NCT00280150|3583756|FG000|Overall Study|Protocol Violation|0
2016591|NCT00280150|3583757|FG001|Overall Study|Protocol Violation|0
2016592|NCT00280150|3583758|FG002|Overall Study|Protocol Violation|0
2016593|NCT00280150|3583759|FG003|Overall Study|Protocol Violation|1
2016594|NCT00280150|3583756|FG000|Overall Study|Withdrawal by Subject|0
2016595|NCT00280150|3583757|FG001|Overall Study|Withdrawal by Subject|0
2016596|NCT00280150|3583758|FG002|Overall Study|Withdrawal by Subject|0
2016597|NCT00280150|3583759|FG003|Overall Study|Withdrawal by Subject|1
2016598|NCT00280150|3583756|FG000|Overall Study|Did not get consolidation therapy|3
2016599|NCT00280150|3583757|FG001|Overall Study|Did not get consolidation therapy|0
2016600|NCT00280150|3583758|FG002|Overall Study|Did not get consolidation therapy|3
2016601|NCT00280150|3583759|FG003|Overall Study|Did not get consolidation therapy|0
2016602|NCT00280150|3583756|FG000|Overall Study|Declining Performance Status|0
2016603|NCT00280150|3583757|FG001|Overall Study|Declining Performance Status|0
2016604|NCT00280150|3583758|FG002|Overall Study|Declining Performance Status|0
2016605|NCT00280150|3583759|FG003|Overall Study|Declining Performance Status|1
2016606|NCT00280293|3583776|FG000|Overall Study|Protocol Violation|3
2016607|NCT00280293|3583777|FG001|Overall Study|Protocol Violation|0
2016608|NCT00280293|3583776|FG000|Overall Study|Physician Decision|5
2016609|NCT00280293|3583777|FG001|Overall Study|Physician Decision|4
2016610|NCT00280293|3583776|FG000|Overall Study|Lost to Follow-up|14
2016611|NCT00280293|3583777|FG001|Overall Study|Lost to Follow-up|12
2016612|NCT00280293|3583776|FG000|Overall Study|Withdrawal by Subject|3
2016613|NCT00280293|3583777|FG001|Overall Study|Withdrawal by Subject|5
2016614|NCT00280293|3583776|FG000|Overall Study|Incarceration/Legal Reasons|1
2016615|NCT00280293|3583777|FG001|Overall Study|Incarceration/Legal Reasons|1
2016616|NCT00280293|3583776|FG000|Overall Study|Adverse Event|0
2016617|NCT00280293|3583777|FG001|Overall Study|Adverse Event|1
2016618|NCT00280397|3583816|FG000|Overall Study|Adverse Event|1
2016619|NCT00280566|3583824|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
2016620|NCT00280566|3583825|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
2016621|NCT00280566|3583826|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
2016622|NCT00280566|3583824|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
2016623|NCT00280566|3583825|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
2016624|NCT00280566|3583826|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
2016625|NCT00280566|3583824|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148
2016626|NCT00280566|3583825|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0
2016627|NCT00280566|3583826|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0
2016628|NCT00280566|3583824|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
2025733|NCT00347360|3594609|FG006|Overall Study|Per sponsors instruction|0
2016629|NCT00280566|3583825|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
2016630|NCT00280566|3583826|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
2016631|NCT00280566|3583824|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
2016632|NCT00280566|3583825|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
2016633|NCT00280566|3583826|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
2016634|NCT00280566|3583824|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50
2016635|NCT00280566|3583825|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0
2016636|NCT00280566|3583826|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0
2016637|NCT00280566|3583824|FG000|Period 2 Double Blind|Lack of Efficacy|0
2016638|NCT00280566|3583825|FG001|Period 2 Double Blind|Lack of Efficacy|9
2016639|NCT00280566|3583826|FG002|Period 2 Double Blind|Lack of Efficacy|22
2016640|NCT00280566|3583824|FG000|Period 2 Double Blind|Laboratory Abnormality|0
2016641|NCT00280566|3583825|FG001|Period 2 Double Blind|Laboratory Abnormality|1
2016642|NCT00280566|3583826|FG002|Period 2 Double Blind|Laboratory Abnormality|0
2016643|NCT00280566|3583824|FG000|Period 2 Double Blind|Adverse Event|0
2016644|NCT00280566|3583825|FG001|Period 2 Double Blind|Adverse Event|11
2016645|NCT00280566|3583826|FG002|Period 2 Double Blind|Adverse Event|15
2016646|NCT00280566|3583824|FG000|Period 2 Double Blind|Lost to Follow-up|0
2016647|NCT00280566|3583825|FG001|Period 2 Double Blind|Lost to Follow-up|3
2016648|NCT00280566|3583826|FG002|Period 2 Double Blind|Lost to Follow-up|6
2016649|NCT00280566|3583824|FG000|Period 2 Double Blind|Withdrawal by Subject|0
2016650|NCT00280566|3583825|FG001|Period 2 Double Blind|Withdrawal by Subject|9
2016651|NCT00280566|3583826|FG002|Period 2 Double Blind|Withdrawal by Subject|9
2016652|NCT00280566|3583824|FG000|Period 2 Double Blind|miscellaneous|0
2016653|NCT00280566|3583825|FG001|Period 2 Double Blind|miscellaneous|10
2016654|NCT00280566|3583826|FG002|Period 2 Double Blind|miscellaneous|5
2016655|NCT00280683|3583835|FG000|Overall Study|Withdrawal by Subject|1
2016656|NCT00280683|3583836|FG001|Overall Study|Withdrawal by Subject|2
2016657|NCT00280683|3583835|FG000|Overall Study|Adverse Event|1
2016658|NCT00280683|3583836|FG001|Overall Study|Adverse Event|1
2016659|NCT00280735|3583844|FG000|Overall Study|Adverse Event|5
2016660|NCT00280735|3583844|FG000|Overall Study|Lack of Efficacy|3
2016661|NCT00280735|3583844|FG000|Overall Study|Withdrawal by Subject|8
2016662|NCT00280735|3583844|FG000|Overall Study|Intercurrent Illness|2
2016663|NCT00280748|3583852|FG000|Overall Study|Decline in performance|3
2016664|NCT00280748|3583852|FG000|Overall Study|Extra-cranial disease progression|1
2016665|NCT00280917|3583869|FG000|Overall Study|Adverse Event|1
2016666|NCT00280917|3583870|FG001|Overall Study|Adverse Event|1
2016667|NCT00280917|3583871|FG002|Overall Study|Adverse Event|4
2016668|NCT00280917|3583872|FG003|Overall Study|Adverse Event|1
2016669|NCT00280917|3583869|FG000|Overall Study|Change Therapy|1
2016670|NCT00280917|3583870|FG001|Overall Study|Change Therapy|2
2016671|NCT00280917|3583871|FG002|Overall Study|Change Therapy|0
2016672|NCT00280917|3583872|FG003|Overall Study|Change Therapy|0
2016673|NCT00280917|3583869|FG000|Overall Study|Withdrawal by Subject|0
2016674|NCT00280917|3583870|FG001|Overall Study|Withdrawal by Subject|2
2016675|NCT00280917|3583871|FG002|Overall Study|Withdrawal by Subject|0
2016676|NCT00280917|3583872|FG003|Overall Study|Withdrawal by Subject|1
2016677|NCT00280917|3583869|FG000|Overall Study|Noncompliance|0
2016678|NCT00280917|3583870|FG001|Overall Study|Noncompliance|1
2016679|NCT00280917|3583871|FG002|Overall Study|Noncompliance|2
2016680|NCT00280917|3583872|FG003|Overall Study|Noncompliance|0
2016681|NCT00281099|3583888|FG000|Overall Study|Death|46
2016682|NCT00281099|3583889|FG001|Overall Study|Death|57
2016683|NCT00281099|3583888|FG000|Overall Study|Lost to Follow-up|10
2016684|NCT00281099|3583889|FG001|Overall Study|Lost to Follow-up|19
2016685|NCT00281099|3583888|FG000|Overall Study|Withdrawal by Subject|65
2016686|NCT00281099|3583889|FG001|Overall Study|Withdrawal by Subject|70
2016687|NCT00281099|3583888|FG000|Overall Study|Physician Decision|79
2016688|NCT00281099|3583889|FG001|Overall Study|Physician Decision|72
2016689|NCT00281099|3583888|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5
2016690|NCT00281099|3583889|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4
2016691|NCT00281528|3583903|FG000|Overall Study|Progressive Disease|28
2016692|NCT00281528|3583904|FG001|Overall Study|Progressive Disease|18
2016693|NCT00281528|3583905|FG002|Overall Study|Progressive Disease|27
2016694|NCT00281528|3583903|FG000|Overall Study|Unacceptable Toxicity-related to trt|21
2016695|NCT00281528|3583904|FG001|Overall Study|Unacceptable Toxicity-related to trt|24
2016696|NCT00281528|3583905|FG002|Overall Study|Unacceptable Toxicity-related to trt|32
2016697|NCT00281528|3583903|FG000|Overall Study|Adverse Event-unrelated to treatment|3
2016698|NCT00281528|3583904|FG001|Overall Study|Adverse Event-unrelated to treatment|0
2016699|NCT00281528|3583905|FG002|Overall Study|Adverse Event-unrelated to treatment|2
2016700|NCT00281528|3583903|FG000|Overall Study|Physician Decision|11
2016701|NCT00281528|3583904|FG001|Overall Study|Physician Decision|4
2016702|NCT00281528|3583905|FG002|Overall Study|Physician Decision|5
2016703|NCT00281528|3583903|FG000|Overall Study|Protocol Violation|1
2016704|NCT00281528|3583904|FG001|Overall Study|Protocol Violation|0
2016705|NCT00281528|3583905|FG002|Overall Study|Protocol Violation|1
2016706|NCT00281528|3583903|FG000|Overall Study|Withdrawal by Subject|5
2016707|NCT00281528|3583904|FG001|Overall Study|Withdrawal by Subject|5
2016708|NCT00281528|3583905|FG002|Overall Study|Withdrawal by Subject|7
2016709|NCT00281528|3583903|FG000|Overall Study|Other|6
2016710|NCT00281528|3583904|FG001|Overall Study|Other|3
2016711|NCT00281528|3583905|FG002|Overall Study|Other|5
2016712|NCT00281580|3583929|FG000|Overall Study|Adverse Event|2
2016713|NCT00281580|3583930|FG001|Overall Study|Adverse Event|0
2016714|NCT00281580|3583931|FG002|Overall Study|Adverse Event|2
2016715|NCT00281580|3583932|FG003|Overall Study|Adverse Event|4
2016716|NCT00281580|3583933|FG004|Overall Study|Adverse Event|1
2016717|NCT00281580|3583934|FG005|Overall Study|Adverse Event|0
2016718|NCT00281580|3583935|FG006|Overall Study|Adverse Event|1
2016719|NCT00281580|3583936|FG007|Overall Study|Adverse Event|0
2016720|NCT00281580|3583937|FG008|Overall Study|Adverse Event|1
2016721|NCT00281580|3583938|FG009|Overall Study|Adverse Event|6
2016722|NCT00281580|3583939|FG010|Overall Study|Adverse Event|0
2016723|NCT00281580|3583940|FG011|Overall Study|Adverse Event|5
2016724|NCT00281580|3583941|FG012|Overall Study|Adverse Event|8
2016725|NCT00281580|3583942|FG013|Overall Study|Adverse Event|2
2016726|NCT00281580|3583943|FG014|Overall Study|Adverse Event|3
2016727|NCT00281580|3583944|FG015|Overall Study|Adverse Event|3
2016728|NCT00281580|3583929|FG000|Overall Study|Protocol Violation|0
2016729|NCT00281580|3583930|FG001|Overall Study|Protocol Violation|0
2016730|NCT00281580|3583931|FG002|Overall Study|Protocol Violation|1
2016731|NCT00281580|3583932|FG003|Overall Study|Protocol Violation|1
2016732|NCT00281580|3583933|FG004|Overall Study|Protocol Violation|0
2016733|NCT00281580|3583934|FG005|Overall Study|Protocol Violation|0
2016734|NCT00281580|3583935|FG006|Overall Study|Protocol Violation|1
2016735|NCT00281580|3583936|FG007|Overall Study|Protocol Violation|0
2016736|NCT00281580|3583937|FG008|Overall Study|Protocol Violation|2
2016737|NCT00281580|3583938|FG009|Overall Study|Protocol Violation|0
2016738|NCT00281580|3583939|FG010|Overall Study|Protocol Violation|1
2016739|NCT00281580|3583940|FG011|Overall Study|Protocol Violation|2
2016740|NCT00281580|3583941|FG012|Overall Study|Protocol Violation|0
2016741|NCT00281580|3583942|FG013|Overall Study|Protocol Violation|1
2016742|NCT00281580|3583943|FG014|Overall Study|Protocol Violation|1
2016743|NCT00281580|3583944|FG015|Overall Study|Protocol Violation|3
2016744|NCT00281580|3583929|FG000|Overall Study|Withdrawal by Subject|3
2016745|NCT00281580|3583930|FG001|Overall Study|Withdrawal by Subject|0
2016746|NCT00281580|3583931|FG002|Overall Study|Withdrawal by Subject|1
2016747|NCT00281580|3583932|FG003|Overall Study|Withdrawal by Subject|1
2016748|NCT00281580|3583933|FG004|Overall Study|Withdrawal by Subject|1
2016749|NCT00281580|3583934|FG005|Overall Study|Withdrawal by Subject|2
2016750|NCT00281580|3583935|FG006|Overall Study|Withdrawal by Subject|2
2016751|NCT00281580|3583936|FG007|Overall Study|Withdrawal by Subject|0
2016752|NCT00281580|3583937|FG008|Overall Study|Withdrawal by Subject|1
2016753|NCT00281580|3583938|FG009|Overall Study|Withdrawal by Subject|4
2016754|NCT00281580|3583939|FG010|Overall Study|Withdrawal by Subject|1
2016755|NCT00281580|3583940|FG011|Overall Study|Withdrawal by Subject|1
2016756|NCT00281580|3583941|FG012|Overall Study|Withdrawal by Subject|2
2016757|NCT00281580|3583942|FG013|Overall Study|Withdrawal by Subject|2
2016758|NCT00281580|3583943|FG014|Overall Study|Withdrawal by Subject|1
2016759|NCT00281580|3583944|FG015|Overall Study|Withdrawal by Subject|5
2016760|NCT00281580|3583929|FG000|Overall Study|Lack of Efficacy|2
2016761|NCT00281580|3583930|FG001|Overall Study|Lack of Efficacy|1
2016762|NCT00281580|3583931|FG002|Overall Study|Lack of Efficacy|1
2016763|NCT00281580|3583932|FG003|Overall Study|Lack of Efficacy|6
2016764|NCT00281580|3583933|FG004|Overall Study|Lack of Efficacy|2
2016765|NCT00281580|3583934|FG005|Overall Study|Lack of Efficacy|0
2016766|NCT00281580|3583935|FG006|Overall Study|Lack of Efficacy|0
2016767|NCT00281580|3583936|FG007|Overall Study|Lack of Efficacy|0
2016768|NCT00281580|3583937|FG008|Overall Study|Lack of Efficacy|0
2016769|NCT00281580|3583938|FG009|Overall Study|Lack of Efficacy|0
2016770|NCT00281580|3583939|FG010|Overall Study|Lack of Efficacy|0
2016771|NCT00281580|3583940|FG011|Overall Study|Lack of Efficacy|1
2016772|NCT00281580|3583941|FG012|Overall Study|Lack of Efficacy|0
2016773|NCT00281580|3583942|FG013|Overall Study|Lack of Efficacy|2
2016774|NCT00281580|3583943|FG014|Overall Study|Lack of Efficacy|1
2016775|NCT00281580|3583944|FG015|Overall Study|Lack of Efficacy|0
2016776|NCT00281580|3583929|FG000|Overall Study|Lost to Follow-up|0
2016777|NCT00281580|3583930|FG001|Overall Study|Lost to Follow-up|0
2016778|NCT00281580|3583931|FG002|Overall Study|Lost to Follow-up|0
2016779|NCT00281580|3583932|FG003|Overall Study|Lost to Follow-up|3
2214555|NCT01688466|3856881|FG001|Overall Study|Withdrawal by Subject|1
2016780|NCT00281580|3583933|FG004|Overall Study|Lost to Follow-up|0
2016781|NCT00281580|3583934|FG005|Overall Study|Lost to Follow-up|1
2016782|NCT00281580|3583935|FG006|Overall Study|Lost to Follow-up|0
2016783|NCT00281580|3583936|FG007|Overall Study|Lost to Follow-up|1
2016784|NCT00281580|3583937|FG008|Overall Study|Lost to Follow-up|2
2016785|NCT00281580|3583938|FG009|Overall Study|Lost to Follow-up|1
2016786|NCT00281580|3583939|FG010|Overall Study|Lost to Follow-up|1
2016787|NCT00281580|3583940|FG011|Overall Study|Lost to Follow-up|0
2016788|NCT00281580|3583941|FG012|Overall Study|Lost to Follow-up|1
2016789|NCT00281580|3583942|FG013|Overall Study|Lost to Follow-up|0
2016790|NCT00281580|3583943|FG014|Overall Study|Lost to Follow-up|0
2016791|NCT00281580|3583944|FG015|Overall Study|Lost to Follow-up|0
2016792|NCT00281580|3583929|FG000|Overall Study|Randomised in error; pregnancy; moving|0
2016793|NCT00281580|3583930|FG001|Overall Study|Randomised in error; pregnancy; moving|0
2016794|NCT00281580|3583931|FG002|Overall Study|Randomised in error; pregnancy; moving|0
2016795|NCT00281580|3583932|FG003|Overall Study|Randomised in error; pregnancy; moving|2
2016796|NCT00281580|3583933|FG004|Overall Study|Randomised in error; pregnancy; moving|0
2016797|NCT00281580|3583934|FG005|Overall Study|Randomised in error; pregnancy; moving|0
2016798|NCT00281580|3583935|FG006|Overall Study|Randomised in error; pregnancy; moving|1
2016799|NCT00281580|3583936|FG007|Overall Study|Randomised in error; pregnancy; moving|0
2016800|NCT00281580|3583937|FG008|Overall Study|Randomised in error; pregnancy; moving|2
2016801|NCT00281580|3583938|FG009|Overall Study|Randomised in error; pregnancy; moving|1
2016802|NCT00281580|3583939|FG010|Overall Study|Randomised in error; pregnancy; moving|1
2016803|NCT00281580|3583940|FG011|Overall Study|Randomised in error; pregnancy; moving|1
2016804|NCT00281580|3583941|FG012|Overall Study|Randomised in error; pregnancy; moving|2
2016805|NCT00281580|3583942|FG013|Overall Study|Randomised in error; pregnancy; moving|0
2016806|NCT00281580|3583943|FG014|Overall Study|Randomised in error; pregnancy; moving|1
2016807|NCT00281580|3583944|FG015|Overall Study|Randomised in error; pregnancy; moving|2
2016808|NCT00281632|3584013|FG000|Overall Study|Adverse Event|7
2016809|NCT00281632|3584013|FG000|Overall Study|Withdrawal by Subject|2
2016810|NCT00281632|3584013|FG000|Overall Study|Disease Progression|22
2016811|NCT00281632|3584013|FG000|Overall Study|Death|1
2016812|NCT00281632|3584013|FG000|Overall Study|Physician Decision|1
2016813|NCT00281632|3584013|FG000|Overall Study|Ongoing|3
2016814|NCT00281684|3584039|FG000|Overall Study|Lost to Follow-up|0
2016815|NCT00281684|3584040|FG001|Overall Study|Lost to Follow-up|0
2016816|NCT00281684|3584041|FG002|Overall Study|Lost to Follow-up|1
2016817|NCT00281684|3584042|FG003|Overall Study|Lost to Follow-up|0
2016818|NCT00281684|3584039|FG000|Overall Study|Withdrawal by Subject|1
2016819|NCT00281684|3584040|FG001|Overall Study|Withdrawal by Subject|0
2016820|NCT00281684|3584041|FG002|Overall Study|Withdrawal by Subject|0
2016821|NCT00281684|3584042|FG003|Overall Study|Withdrawal by Subject|0
2016822|NCT00281697|3584056|FG000|Overall Study|> 60 days since last dose of study drug|4
2016823|NCT00281697|3584057|FG001|Overall Study|> 60 days since last dose of study drug|4
2016824|NCT00281697|3584056|FG000|Overall Study|Adverse Event|54
2016825|NCT00281697|3584057|FG001|Overall Study|Adverse Event|15
2016826|NCT00281697|3584056|FG000|Overall Study|Death|8
2016827|NCT00281697|3584057|FG001|Overall Study|Death|3
2016828|NCT00281697|3584056|FG000|Overall Study|Disease progression|279
2016829|NCT00281697|3584057|FG001|Overall Study|Disease progression|149
2016830|NCT00281697|3584056|FG000|Overall Study|Other|5
2016831|NCT00281697|3584057|FG001|Overall Study|Other|6
2016832|NCT00281697|3584056|FG000|Overall Study|Physician's decision to withdraw|15
2016833|NCT00281697|3584057|FG001|Overall Study|Physician's decision to withdraw|12
2016834|NCT00281697|3584056|FG000|Overall Study|Subject/guardian's decision to withdraw|33
2016835|NCT00281697|3584057|FG001|Overall Study|Subject/guardian's decision to withdraw|6
2016836|NCT00281697|3584056|FG000|Overall Study|Did not receive study drug|3
2016837|NCT00281697|3584057|FG001|Overall Study|Did not receive study drug|2
2025734|NCT00347360|3594610|FG007|Overall Study|Per sponsors instruction|0
2025735|NCT00347360|3594611|FG008|Overall Study|Per sponsors instruction|0
2025736|NCT00347360|3594612|FG009|Overall Study|Per sponsors instruction|0
2025737|NCT00347360|3594613|FG010|Overall Study|Per sponsors instruction|0
2025738|NCT00347360|3594614|FG011|Overall Study|Per sponsors instruction|0
2025739|NCT00347360|3594615|FG012|Overall Study|Per sponsors instruction|0
2214556|NCT01688466|3856880|FG000|Overall Study|Death|0
2214557|NCT01688466|3856881|FG001|Overall Study|Death|1
2214558|NCT01688466|3856880|FG000|Overall Study|Adverse Event|0
2025740|NCT00347360|3594616|FG013|Overall Study|Per sponsors instruction|0
2025741|NCT00347360|3594617|FG014|Overall Study|Per sponsors instruction|0
2025742|NCT00347360|3594603|FG000|Overall Study|P.I. recommended due to blood pressure|0
2025743|NCT00347360|3594604|FG001|Overall Study|P.I. recommended due to blood pressure|0
2025744|NCT00347360|3594605|FG002|Overall Study|P.I. recommended due to blood pressure|0
2025745|NCT00347360|3594606|FG003|Overall Study|P.I. recommended due to blood pressure|0
2025746|NCT00347360|3594607|FG004|Overall Study|P.I. recommended due to blood pressure|1
2025747|NCT00347360|3594608|FG005|Overall Study|P.I. recommended due to blood pressure|0
2025748|NCT00347360|3594609|FG006|Overall Study|P.I. recommended due to blood pressure|0
2025749|NCT00347360|3594610|FG007|Overall Study|P.I. recommended due to blood pressure|0
2025750|NCT00347360|3594611|FG008|Overall Study|P.I. recommended due to blood pressure|0
2025751|NCT00347360|3594612|FG009|Overall Study|P.I. recommended due to blood pressure|0
2025752|NCT00347360|3594613|FG010|Overall Study|P.I. recommended due to blood pressure|0
2214559|NCT01688466|3856881|FG001|Overall Study|Adverse Event|4
2214560|NCT01688466|3856880|FG000|Overall Study|Not evaluable|0
2214561|NCT01688466|3856881|FG001|Overall Study|Not evaluable|1
2025753|NCT00347360|3594614|FG011|Overall Study|P.I. recommended due to blood pressure|0
2025754|NCT00347360|3594615|FG012|Overall Study|P.I. recommended due to blood pressure|0
2025755|NCT00347360|3594616|FG013|Overall Study|P.I. recommended due to blood pressure|0
2025756|NCT00347360|3594617|FG014|Overall Study|P.I. recommended due to blood pressure|0
2025757|NCT00347360|3594603|FG000|Overall Study|Subject did not meet end of study ABPM|0
2025758|NCT00347360|3594604|FG001|Overall Study|Subject did not meet end of study ABPM|0
2025759|NCT00347360|3594605|FG002|Overall Study|Subject did not meet end of study ABPM|0
2025760|NCT00347360|3594606|FG003|Overall Study|Subject did not meet end of study ABPM|0
2214562|NCT01688635|3856900|FG000|Washout 1|Withdrawal by Subject|1
2214563|NCT01688635|3856901|FG001|Washout 1|Withdrawal by Subject|0
2016838|NCT00281840|3584069|FG000|Overall Study|Adverse Event|12
2016839|NCT00281840|3584069|FG000|Overall Study|Physician Decision|6
2016840|NCT00281840|3584069|FG000|Overall Study|Withdrawal by Subject|3
2016841|NCT00281840|3584069|FG000|Overall Study|Disease Progression|2
2016842|NCT00281840|3584069|FG000|Overall Study|exceed maximum delay in treatment|1
2016843|NCT00281840|3584069|FG000|Overall Study|Complicating Disease|1
2016844|NCT00281957|3584085|FG000|Overall Study|Adverse Event|7
2016845|NCT00281957|3584086|FG001|Overall Study|Adverse Event|2
2016846|NCT00281957|3584085|FG000|Overall Study|Death|1
2016847|NCT00281957|3584086|FG001|Overall Study|Death|0
2016848|NCT00281957|3584085|FG000|Overall Study|Progression/relapse|47
2016849|NCT00281957|3584086|FG001|Overall Study|Progression/relapse|35
2016850|NCT00281957|3584085|FG000|Overall Study|Not protocol specified|8
2016851|NCT00281957|3584086|FG001|Overall Study|Not protocol specified|1
2016852|NCT00281957|3584085|FG000|Overall Study|Not eligible|1
2016853|NCT00281957|3584086|FG001|Overall Study|Not eligible|2
2016854|NCT00281957|3584085|FG000|Overall Study|Did not start treatment|3
2016855|NCT00281957|3584086|FG001|Overall Study|Did not start treatment|1
2016856|NCT00281957|3584085|FG000|Overall Study|Refusal unrelated to adverse events|0
2016857|NCT00281957|3584086|FG001|Overall Study|Refusal unrelated to adverse events|1
2016858|NCT00282048|3584094|FG000|Overall Study|Lack of Efficacy|30
2016859|NCT00282048|3584094|FG000|Overall Study|Adverse Event|22
2016860|NCT00282048|3584094|FG000|Overall Study|Withdrawal by Subject|1
2016861|NCT00282048|3584094|FG000|Overall Study|Other|8
2016862|NCT00282048|3584094|FG000|Overall Study|Ongoing|1
2016863|NCT00282087|3584098|FG000|Overall Study|Death|1
2016864|NCT00282113|3584106|FG000|Overall Study|Removed at parents request|1
2016865|NCT00282113|3584107|FG001|Overall Study|Removed at parents request|0
2016866|NCT00282113|3584108|FG002|Overall Study|Removed at parents request|0
2016867|NCT00282152|3584118|FG000|Overall Study|Withdrawal by Subject|1
2016868|NCT00282152|3584119|FG001|Overall Study|Withdrawal by Subject|0
2016869|NCT00282243|3584126|FG000|Pharmacokinetic Treatment Period|Adverse Event|3
2016870|NCT00282243|3584126|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
2016871|NCT00282243|3584126|FG000|Extension Treatment Period|Adverse Event|15
2016872|NCT00282243|3584126|FG000|Extension Treatment Period|Withdrawal by Subject|4
2016873|NCT00282243|3584126|FG000|Extension Treatment Period|Non-compliance|2
2016874|NCT00282243|3584126|FG000|Extension Treatment Period|Physician Decision|1
2016875|NCT00282256|3584130|FG000|Pharmacokinetic Treatment Period|Poor venous access|1
2016876|NCT00282256|3584130|FG000|Extension Treatment Period|Adverse Event|2
2016877|NCT00282295|3584142|FG000|Overall Study|Adverse Event|0
2016878|NCT00282295|3584143|FG001|Overall Study|Adverse Event|1
2016879|NCT00282295|3584144|FG002|Overall Study|Adverse Event|0
2016880|NCT00282295|3584142|FG000|Overall Study|Serious Adverse Events|0
2016881|NCT00282295|3584143|FG001|Overall Study|Serious Adverse Events|0
2016882|NCT00282295|3584144|FG002|Overall Study|Serious Adverse Events|1
2016883|NCT00282295|3584142|FG000|Overall Study|Protocol Violation|0
2016884|NCT00282295|3584143|FG001|Overall Study|Protocol Violation|2
2016885|NCT00282295|3584144|FG002|Overall Study|Protocol Violation|1
2016886|NCT00282295|3584142|FG000|Overall Study|Withdrawal by Subject|2
2016887|NCT00282295|3584143|FG001|Overall Study|Withdrawal by Subject|6
2016888|NCT00282295|3584144|FG002|Overall Study|Withdrawal by Subject|4
2016889|NCT00282295|3584142|FG000|Overall Study|Lost to Follow-up|1
2016890|NCT00282295|3584143|FG001|Overall Study|Lost to Follow-up|7
2016891|NCT00282295|3584144|FG002|Overall Study|Lost to Follow-up|2
2016892|NCT00282295|3584142|FG000|Overall Study|Other|0
2016893|NCT00282295|3584143|FG001|Overall Study|Other|1
2016894|NCT00282295|3584144|FG002|Overall Study|Other|0
2016895|NCT00282308|3584159|FG000|Treatment Period|Lost to Follow-up|1
2016896|NCT00282308|3584160|FG001|Treatment Period|Lost to Follow-up|0
2016897|NCT00282308|3584161|FG002|Treatment Period|Lost to Follow-up|0
2016898|NCT00282308|3584159|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2
2016899|NCT00282308|3584160|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4
2016900|NCT00282308|3584161|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0
2016901|NCT00282308|3584159|FG000|Treatment Period|Adverse Event|0
2016902|NCT00282308|3584160|FG001|Treatment Period|Adverse Event|2
2016903|NCT00282308|3584161|FG002|Treatment Period|Adverse Event|0
2016904|NCT00282308|3584159|FG000|Treatment Period|Not Treated with Study Drug|1
2016905|NCT00282308|3584160|FG001|Treatment Period|Not Treated with Study Drug|0
2016906|NCT00282308|3584161|FG002|Treatment Period|Not Treated with Study Drug|0
2016907|NCT00282308|3584159|FG000|Optional Extension Re-treatment Period|Adverse Event|0
2016908|NCT00282308|3584160|FG001|Optional Extension Re-treatment Period|Adverse Event|0
2016909|NCT00282308|3584161|FG002|Optional Extension Re-treatment Period|Adverse Event|4
2016910|NCT00282308|3584159|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
2016911|NCT00282308|3584160|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
2016912|NCT00282308|3584161|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
2016913|NCT00282308|3584159|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
2016914|NCT00282308|3584160|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
2016915|NCT00282308|3584161|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
2016916|NCT00282308|3584159|FG000|Safety Follow-up Period|Adverse Event|0
2016917|NCT00282308|3584160|FG001|Safety Follow-up Period|Adverse Event|0
2016918|NCT00282308|3584161|FG002|Safety Follow-up Period|Adverse Event|1
2016919|NCT00282308|3584159|FG000|Safety Follow-up Period|Lost to Follow-up|0
2016920|NCT00282308|3584160|FG001|Safety Follow-up Period|Lost to Follow-up|0
2016921|NCT00282308|3584161|FG002|Safety Follow-up Period|Lost to Follow-up|5
2016922|NCT00282308|3584159|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0
2016923|NCT00282308|3584160|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0
2016924|NCT00282308|3584161|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1
2016925|NCT00282308|3584159|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
2016926|NCT00282308|3584160|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
2016927|NCT00282308|3584161|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
2016928|NCT00282334|3584173|FG000|Overall Study|Withdrawal by Subject|8
2016929|NCT00282334|3584174|FG001|Overall Study|Withdrawal by Subject|5
2016930|NCT00282347|3584182|FG000|Treatment Period|Death|2
2016931|NCT00282347|3584183|FG001|Treatment Period|Death|0
2016932|NCT00282347|3584182|FG000|Treatment Period|Lost to Follow-up|2
2016933|NCT00282347|3584183|FG001|Treatment Period|Lost to Follow-up|5
2016934|NCT00282347|3584182|FG000|Treatment Period|Withdrawal by Subject|1
2016935|NCT00282347|3584183|FG001|Treatment Period|Withdrawal by Subject|3
2016936|NCT00282347|3584182|FG000|Treatment Period|Physician Decision|0
2016937|NCT00282347|3584183|FG001|Treatment Period|Physician Decision|1
2016938|NCT00282347|3584182|FG000|Safety Follow-up Period|Lost to Follow-up|0
2016939|NCT00282347|3584183|FG001|Safety Follow-up Period|Lost to Follow-up|2
2016940|NCT00282347|3584182|FG000|Safety Follow-up Period|Withdrawal by Subject|2
2016941|NCT00282347|3584183|FG001|Safety Follow-up Period|Withdrawal by Subject|1
2016942|NCT00282347|3584182|FG000|Safety Follow-up Period|Physician Decision|1
2016943|NCT00282347|3584183|FG001|Safety Follow-up Period|Physician Decision|1
2016944|NCT00282347|3584182|FG000|Safety Follow-up Period|Protocol Deviation|0
2016945|NCT00282347|3584183|FG001|Safety Follow-up Period|Protocol Deviation|2
2016946|NCT00282347|3584182|FG000|B Cell Follow-up Period|Withdrawal by Subject|2
2016947|NCT00282347|3584183|FG001|B Cell Follow-up Period|Withdrawal by Subject|0
2016948|NCT00282347|3584182|FG000|B Cell Follow-up Period|Physician Decision|1
2016949|NCT00282347|3584183|FG001|B Cell Follow-up Period|Physician Decision|0
2016950|NCT00282347|3584182|FG000|B Cell Follow-up Period|Reason Not Specified|2
2016951|NCT00282347|3584183|FG001|B Cell Follow-up Period|Reason Not Specified|0
2016952|NCT00282412|3584191|FG000|Overall Study|Death|2
2016953|NCT00282438|3584197|FG000|Overall Study|Lack of Efficacy|1
2016954|NCT00282438|3584198|FG001|Overall Study|Lack of Efficacy|0
2016955|NCT00282438|3584197|FG000|Overall Study|Death|0
2016956|NCT00282438|3584198|FG001|Overall Study|Death|1
2016957|NCT00282464|3584206|FG000|Overall Study|Adverse Event|26
2016958|NCT00282464|3584207|FG001|Overall Study|Adverse Event|20
2016959|NCT00282464|3584206|FG000|Overall Study|Lack of Efficacy|8
2016960|NCT00282464|3584207|FG001|Overall Study|Lack of Efficacy|8
2016961|NCT00282464|3584206|FG000|Overall Study|Lost to Follow-up|10
2016962|NCT00282464|3584207|FG001|Overall Study|Lost to Follow-up|10
2016963|NCT00282464|3584206|FG000|Overall Study|Withdrawal by Subject|24
2016964|NCT00282464|3584207|FG001|Overall Study|Withdrawal by Subject|10
2016965|NCT00282464|3584206|FG000|Overall Study|laboratory abnormality|1
2016966|NCT00282464|3584207|FG001|Overall Study|laboratory abnormality|2
2016967|NCT00282464|3584206|FG000|Overall Study|Protocol Violation|0
2016968|NCT00282464|3584207|FG001|Overall Study|Protocol Violation|7
2016969|NCT00282464|3584206|FG000|Overall Study|Patient moved|1
2016970|NCT00282464|3584207|FG001|Overall Study|Patient moved|0
2016971|NCT00282464|3584206|FG000|Overall Study|patient non-compliant|3
2016972|NCT00282464|3584207|FG001|Overall Study|patient non-compliant|0
2016973|NCT00282464|3584206|FG000|Overall Study|patient no show|0
2016974|NCT00282464|3584207|FG001|Overall Study|patient no show|1
2016975|NCT00282464|3584206|FG000|Overall Study|patient incarcerated|0
2016976|NCT00282464|3584207|FG001|Overall Study|patient incarcerated|1
2016977|NCT00282464|3584206|FG000|Overall Study|family crisis|0
2016978|NCT00282464|3584207|FG001|Overall Study|family crisis|1
2016979|NCT00282464|3584206|FG000|Overall Study|dispensed wrong kit|0
2016980|NCT00282464|3584207|FG001|Overall Study|dispensed wrong kit|1
2016981|NCT00282464|3584206|FG000|Overall Study|dropped due to missed visits|0
2016982|NCT00282464|3584207|FG001|Overall Study|dropped due to missed visits|1
2016983|NCT00282568|3584213|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
2016984|NCT00282568|3584213|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1
2016985|NCT00282568|3584213|FG000|Extended Treatment Period|Adverse Event|17
2016986|NCT00282568|3584213|FG000|Extended Treatment Period|Non-compliance|4
2016987|NCT00282568|3584213|FG000|Extended Treatment Period|Physician Decision|1
2016988|NCT00282568|3584213|FG000|Extended Treatment Period|Lost to Follow-up|2
2016989|NCT00282919|3584288|FG000|Overall Study|Lack of Efficacy|4
2016990|NCT00282919|3584288|FG000|Overall Study|Withdrawal by Subject|1
2016991|NCT00282919|3584288|FG000|Overall Study|Asymptomatic Parasitemia|2
2016992|NCT00282984|3584303|FG000|Overall Study|Death|2
2016993|NCT00282984|3584304|FG001|Overall Study|Death|5
2016994|NCT00282984|3584303|FG000|Overall Study|Adverse Event|8
2016995|NCT00282984|3584304|FG001|Overall Study|Adverse Event|5
2016996|NCT00282984|3584303|FG000|Overall Study|Lack of Efficacy|0
2016997|NCT00282984|3584304|FG001|Overall Study|Lack of Efficacy|2
2016998|NCT00282984|3584303|FG000|Overall Study|Lost to Follow-up|14
2016999|NCT00282984|3584304|FG001|Overall Study|Lost to Follow-up|10
2017000|NCT00282984|3584303|FG000|Overall Study|Withdrawal by Participant|22
2017001|NCT00282984|3584304|FG001|Overall Study|Withdrawal by Participant|34
2017002|NCT00282984|3584303|FG000|Overall Study|Participant stopped study medication|2
2017003|NCT00282984|3584304|FG001|Overall Study|Participant stopped study medication|2
2017004|NCT00282984|3584303|FG000|Overall Study|Participant only allowed phone follow-up|0
2017005|NCT00282984|3584304|FG001|Overall Study|Participant only allowed phone follow-up|1
2017006|NCT00282984|3584303|FG000|Overall Study|Participant used antipsychosis meds|0
2017007|NCT00282984|3584304|FG001|Overall Study|Participant used antipsychosis meds|1
2017008|NCT00282984|3584303|FG000|Overall Study|lack of motivation|1
2017009|NCT00282984|3584304|FG001|Overall Study|lack of motivation|0
2017010|NCT00282984|3584303|FG000|Overall Study|in prison|0
2017011|NCT00282984|3584304|FG001|Overall Study|in prison|1
2017012|NCT00282984|3584303|FG000|Overall Study|Protocol Violation|2
2017013|NCT00282984|3584304|FG001|Overall Study|Protocol Violation|0
2017014|NCT00283049|3584313|FG000|Overall Study|Adverse Event|6
2017015|NCT00283049|3584314|FG001|Overall Study|Adverse Event|1
2017016|NCT00283049|3584315|FG002|Overall Study|Adverse Event|4
2017017|NCT00283049|3584313|FG000|Overall Study|Protocol Violation|3
2017018|NCT00283049|3584314|FG001|Overall Study|Protocol Violation|0
2017019|NCT00283049|3584315|FG002|Overall Study|Protocol Violation|3
2017020|NCT00283049|3584313|FG000|Overall Study|Death|1
2017021|NCT00283049|3584314|FG001|Overall Study|Death|1
2214564|NCT01688635|3856900|FG000|Washout 1|Adverse Event|0
2214565|NCT01688635|3856901|FG001|Washout 1|Adverse Event|1
2214566|NCT01688635|3856900|FG000|Washout 1|Physician Decision|0
2017022|NCT00283049|3584315|FG002|Overall Study|Death|1
2017023|NCT00283049|3584313|FG000|Overall Study|Lack of Efficacy|0
2017024|NCT00283049|3584314|FG001|Overall Study|Lack of Efficacy|1
2017025|NCT00283049|3584315|FG002|Overall Study|Lack of Efficacy|1
2017026|NCT00283049|3584313|FG000|Overall Study|Lost to Follow-up|4
2017027|NCT00283049|3584314|FG001|Overall Study|Lost to Follow-up|2
2017028|NCT00283049|3584315|FG002|Overall Study|Lost to Follow-up|5
2017029|NCT00283049|3584313|FG000|Overall Study|Withdrawal by Subject|26
2017030|NCT00283049|3584314|FG001|Overall Study|Withdrawal by Subject|24
2017031|NCT00283049|3584315|FG002|Overall Study|Withdrawal by Subject|19
2017032|NCT00283049|3584313|FG000|Overall Study|Discontinuation of Study|18
2017033|NCT00283049|3584314|FG001|Overall Study|Discontinuation of Study|16
2017034|NCT00283049|3584315|FG002|Overall Study|Discontinuation of Study|20
2017035|NCT00283049|3584313|FG000|Overall Study|No longer requires study treatment|0
2017036|NCT00283049|3584314|FG001|Overall Study|No longer requires study treatment|0
2017037|NCT00283049|3584315|FG002|Overall Study|No longer requires study treatment|1
2017038|NCT00283062|3584327|FG000|Overall Study|Did not receive any study medication|5
2017039|NCT00283062|3584328|FG001|Overall Study|Did not receive any study medication|4
2017040|NCT00283062|3584329|FG002|Overall Study|Did not receive any study medication|36
2017041|NCT00283062|3584330|FG003|Overall Study|Did not receive any study medication|45
2017042|NCT00283062|3584327|FG000|Overall Study|Adverse Event|2
2017043|NCT00283062|3584328|FG001|Overall Study|Adverse Event|0
2017044|NCT00283062|3584329|FG002|Overall Study|Adverse Event|1
2017045|NCT00283062|3584330|FG003|Overall Study|Adverse Event|0
2017046|NCT00283062|3584327|FG000|Overall Study|Lost to Follow-up|1
2017047|NCT00283062|3584328|FG001|Overall Study|Lost to Follow-up|0
2017048|NCT00283062|3584329|FG002|Overall Study|Lost to Follow-up|1
2017049|NCT00283062|3584330|FG003|Overall Study|Lost to Follow-up|0
2017050|NCT00283062|3584327|FG000|Overall Study|Progressive disease|0
2017051|NCT00283062|3584328|FG001|Overall Study|Progressive disease|0
2017052|NCT00283062|3584329|FG002|Overall Study|Progressive disease|1
2017053|NCT00283062|3584330|FG003|Overall Study|Progressive disease|0
2017054|NCT00283062|3584327|FG000|Overall Study|Participant did not wish to continue|3
2017055|NCT00283062|3584328|FG001|Overall Study|Participant did not wish to continue|2
2017056|NCT00283062|3584329|FG002|Overall Study|Participant did not wish to continue|1
2017057|NCT00283062|3584330|FG003|Overall Study|Participant did not wish to continue|0
2017058|NCT00283062|3584327|FG000|Overall Study|Undefined|0
2017059|NCT00283062|3584328|FG001|Overall Study|Undefined|1
2017060|NCT00283062|3584329|FG002|Overall Study|Undefined|1
2017061|NCT00283062|3584330|FG003|Overall Study|Undefined|4
2017062|NCT00283062|3584327|FG000|Overall Study|chemotherapy not completed (cycle 6)|1
2017063|NCT00283062|3584328|FG001|Overall Study|chemotherapy not completed (cycle 6)|0
2017064|NCT00283062|3584329|FG002|Overall Study|chemotherapy not completed (cycle 6)|0
2017065|NCT00283062|3584330|FG003|Overall Study|chemotherapy not completed (cycle 6)|0
2017066|NCT00283244|3584355|FG000|Overall Study|Adverse Event|0
2017067|NCT00283244|3584356|FG001|Overall Study|Adverse Event|8
2017068|NCT00283244|3584357|FG002|Overall Study|Adverse Event|11
2017069|NCT00283244|3584355|FG000|Overall Study|Death|4
2017070|NCT00283244|3584356|FG001|Overall Study|Death|3
2017071|NCT00283244|3584357|FG002|Overall Study|Death|2
2017072|NCT00283244|3584355|FG000|Overall Study|Lack of Efficacy|8
2017073|NCT00283244|3584356|FG001|Overall Study|Lack of Efficacy|32
2017074|NCT00283244|3584357|FG002|Overall Study|Lack of Efficacy|26
2017075|NCT00283244|3584355|FG000|Overall Study|Withdrawal by Subject|1
2017076|NCT00283244|3584356|FG001|Overall Study|Withdrawal by Subject|2
2017077|NCT00283244|3584357|FG002|Overall Study|Withdrawal by Subject|2
2214567|NCT01688635|3856901|FG001|Washout 1|Physician Decision|1
2017078|NCT00283244|3584355|FG000|Overall Study|Physician Decision|0
2017079|NCT00283244|3584356|FG001|Overall Study|Physician Decision|0
2017080|NCT00283244|3584357|FG002|Overall Study|Physician Decision|1
2017081|NCT00283244|3584355|FG000|Overall Study|Medical illness (other complicating dz)|4
2017082|NCT00283244|3584356|FG001|Overall Study|Medical illness (other complicating dz)|3
2017083|NCT00283244|3584357|FG002|Overall Study|Medical illness (other complicating dz)|6
2017084|NCT00283244|3584355|FG000|Overall Study|Clinical deterioration|1
2017085|NCT00283244|3584356|FG001|Overall Study|Clinical deterioration|3
2214568|NCT01688635|3856900|FG000|Washout 2|Physician Decision|1
2214569|NCT01688635|3856901|FG001|Washout 2|Physician Decision|0
2214570|NCT01688635|3856900|FG000|Washout 2|Withdrawal by Subject|1
2214571|NCT01688635|3856901|FG001|Washout 2|Withdrawal by Subject|0
2214572|NCT01688635|3856900|FG000|Washout 2|Sponsor Decision|1
2214573|NCT01688635|3856901|FG001|Washout 2|Sponsor Decision|2
2214574|NCT01688635|3856900|FG000|Washout 3|Withdrawal by Subject|1
2214575|NCT01688635|3856901|FG001|Washout 3|Withdrawal by Subject|0
2214576|NCT01688726|3856910|FG000|Overall Study|Adverse Event|1
2214577|NCT01688726|3856911|FG001|Overall Study|Adverse Event|0
2214578|NCT01688726|3856910|FG000|Overall Study|Relocated abroad|0
2214579|NCT01688726|3856911|FG001|Overall Study|Relocated abroad|1
2017086|NCT00283244|3584357|FG002|Overall Study|Clinical deterioration|3
2017087|NCT00283296|3584388|FG000|Overall Study|in-home trial not completed|5
2017088|NCT00283387|3584393|FG000|First Intervention|Subject non-compliant|1
2017089|NCT00283387|3584394|FG001|First Intervention|Subject non-compliant|1
2017090|NCT00283387|3584393|FG000|First Intervention|Withdrawal by Subject|0
2017091|NCT00283387|3584394|FG001|First Intervention|Withdrawal by Subject|1
2017092|NCT00283400|3584404|FG000|Overall Study|Withdrawal by Subject|1
2017093|NCT00283400|3584405|FG001|Overall Study|Withdrawal by Subject|1
2017094|NCT00283400|3584406|FG002|Overall Study|Withdrawal by Subject|0
2017095|NCT00283400|3584407|FG003|Overall Study|Withdrawal by Subject|0
2017096|NCT00283400|3584404|FG000|Overall Study|Death|1
2017097|NCT00283400|3584405|FG001|Overall Study|Death|0
2017098|NCT00283400|3584406|FG002|Overall Study|Death|1
2017099|NCT00283400|3584407|FG003|Overall Study|Death|0
2017100|NCT00283439|3584421|FG000|Overall Study|Adverse Event|0
2017101|NCT00283439|3584422|FG001|Overall Study|Adverse Event|0
2017102|NCT00283439|3584423|FG002|Overall Study|Adverse Event|0
2017103|NCT00283439|3584424|FG003|Overall Study|Adverse Event|1
2017104|NCT00283439|3584421|FG000|Overall Study|Death|0
2017105|NCT00283439|3584422|FG001|Overall Study|Death|0
2017106|NCT00283439|3584423|FG002|Overall Study|Death|1
2017107|NCT00283439|3584424|FG003|Overall Study|Death|0
2017108|NCT00283439|3584421|FG000|Overall Study|Disease progression|0
2017109|NCT00283439|3584422|FG001|Overall Study|Disease progression|1
2017110|NCT00283439|3584423|FG002|Overall Study|Disease progression|0
2017111|NCT00283439|3584424|FG003|Overall Study|Disease progression|0
2017112|NCT00283439|3584421|FG000|Overall Study|Requirement for alternative therapy|1
2017113|NCT00283439|3584422|FG001|Overall Study|Requirement for alternative therapy|2
2017114|NCT00283439|3584423|FG002|Overall Study|Requirement for alternative therapy|5
2017115|NCT00283439|3584424|FG003|Overall Study|Requirement for alternative therapy|2
2017116|NCT00283439|3584421|FG000|Overall Study|Stem cell transplant|6
2017117|NCT00283439|3584422|FG001|Overall Study|Stem cell transplant|6
2017118|NCT00283439|3584423|FG002|Overall Study|Stem cell transplant|4
2017119|NCT00283439|3584424|FG003|Overall Study|Stem cell transplant|3
2017120|NCT00283439|3584421|FG000|Overall Study|Treatment discontinued|0
2017121|NCT00283439|3584422|FG001|Overall Study|Treatment discontinued|2
2017122|NCT00283439|3584423|FG002|Overall Study|Treatment discontinued|1
2017123|NCT00283439|3584424|FG003|Overall Study|Treatment discontinued|3
2017124|NCT00283439|3584421|FG000|Overall Study|Other|1
2017125|NCT00283439|3584422|FG001|Overall Study|Other|0
2017126|NCT00283439|3584423|FG002|Overall Study|Other|0
2017127|NCT00283439|3584424|FG003|Overall Study|Other|0
2017128|NCT00283595|3584447|FG000|Overall Study|Withdrawal by Subject|1
2017129|NCT00283595|3584448|FG001|Overall Study|Withdrawal by Subject|2
2017130|NCT00283686|3584458|FG000|Overall Study|Death|1
2017131|NCT00283686|3584459|FG001|Overall Study|Death|1
2017132|NCT00283686|3584460|FG002|Overall Study|Death|1
2017133|NCT00283686|3584461|FG003|Overall Study|Death|0
2017134|NCT00283686|3584458|FG000|Overall Study|Lost to Follow-up|21
2017135|NCT00283686|3584459|FG001|Overall Study|Lost to Follow-up|31
2017136|NCT00283686|3584460|FG002|Overall Study|Lost to Follow-up|26
2017137|NCT00283686|3584461|FG003|Overall Study|Lost to Follow-up|20
2017138|NCT00283686|3584458|FG000|Overall Study|Less than full participation|7
2017139|NCT00283686|3584459|FG001|Overall Study|Less than full participation|9
2017140|NCT00283686|3584460|FG002|Overall Study|Less than full participation|6
2017141|NCT00283686|3584461|FG003|Overall Study|Less than full participation|12
2214580|NCT01688739|3856931|FG000|Overall Study|Administrative Decision|1
2214581|NCT01688739|3856932|FG001|Overall Study|Administrative Decision|0
2214582|NCT01688739|3856933|FG002|Overall Study|Administrative Decision|0
2017142|NCT00283712|3584473|FG000|Overall Study|Death|0
2017143|NCT00283712|3584474|FG001|Overall Study|Death|1
2017144|NCT00283803|3584480|FG000|Overall Study|Physician Decision|9
2017145|NCT00283803|3584480|FG000|Overall Study|Withdrawal by Subject|4
2017146|NCT00283842|3584500|FG000|Overall Study|Adverse Event|8
2017147|NCT00283842|3584501|FG001|Overall Study|Adverse Event|7
2017148|NCT00283842|3584502|FG002|Overall Study|Adverse Event|21
2017149|NCT00283842|3584503|FG003|Overall Study|Adverse Event|21
2017150|NCT00283842|3584504|FG004|Overall Study|Adverse Event|5
2017151|NCT00283842|3584500|FG000|Overall Study|Protocol Violation|1
2017152|NCT00283842|3584501|FG001|Overall Study|Protocol Violation|5
2017153|NCT00283842|3584502|FG002|Overall Study|Protocol Violation|4
2017154|NCT00283842|3584503|FG003|Overall Study|Protocol Violation|0
2017155|NCT00283842|3584504|FG004|Overall Study|Protocol Violation|0
2017156|NCT00283842|3584500|FG000|Overall Study|Protocol deviation|0
2017157|NCT00283842|3584501|FG001|Overall Study|Protocol deviation|0
2017158|NCT00283842|3584502|FG002|Overall Study|Protocol deviation|0
2017159|NCT00283842|3584503|FG003|Overall Study|Protocol deviation|0
2017160|NCT00283842|3584504|FG004|Overall Study|Protocol deviation|2
2017161|NCT00283842|3584500|FG000|Overall Study|Withdrawal by Subject|2
2017162|NCT00283842|3584501|FG001|Overall Study|Withdrawal by Subject|1
2017163|NCT00283842|3584502|FG002|Overall Study|Withdrawal by Subject|1
2017164|NCT00283842|3584503|FG003|Overall Study|Withdrawal by Subject|5
2017165|NCT00283842|3584504|FG004|Overall Study|Withdrawal by Subject|4
2017166|NCT00283842|3584500|FG000|Overall Study|Lack of Efficacy|1
2017167|NCT00283842|3584501|FG001|Overall Study|Lack of Efficacy|3
2017168|NCT00283842|3584502|FG002|Overall Study|Lack of Efficacy|1
2017169|NCT00283842|3584503|FG003|Overall Study|Lack of Efficacy|0
2017170|NCT00283842|3584504|FG004|Overall Study|Lack of Efficacy|3
2017171|NCT00283842|3584500|FG000|Overall Study|Lost to Follow-up|0
2017172|NCT00283842|3584501|FG001|Overall Study|Lost to Follow-up|2
2017173|NCT00283842|3584502|FG002|Overall Study|Lost to Follow-up|4
2017174|NCT00283842|3584503|FG003|Overall Study|Lost to Follow-up|1
2017175|NCT00283842|3584504|FG004|Overall Study|Lost to Follow-up|1
2017176|NCT00284050|3584523|FG000|Overall Study|Adverse Event|1
2017177|NCT00284050|3584524|FG001|Overall Study|Adverse Event|1
2017178|NCT00284050|3584525|FG002|Overall Study|Adverse Event|1
2017179|NCT00284050|3584523|FG000|Overall Study|Lack of Efficacy|0
2017180|NCT00284050|3584524|FG001|Overall Study|Lack of Efficacy|1
2017181|NCT00284050|3584525|FG002|Overall Study|Lack of Efficacy|3
2017182|NCT00284050|3584523|FG000|Overall Study|Protocol Violation|0
2017183|NCT00284050|3584524|FG001|Overall Study|Protocol Violation|1
2017184|NCT00284050|3584525|FG002|Overall Study|Protocol Violation|2
2017185|NCT00284050|3584523|FG000|Overall Study|Withdrawal by Subject|2
2017186|NCT00284050|3584524|FG001|Overall Study|Withdrawal by Subject|2
2017187|NCT00284050|3584525|FG002|Overall Study|Withdrawal by Subject|2
2017188|NCT00284050|3584523|FG000|Overall Study|Lost to Follow-up|1
2017189|NCT00284050|3584524|FG001|Overall Study|Lost to Follow-up|0
2017190|NCT00284050|3584525|FG002|Overall Study|Lost to Follow-up|1
2017191|NCT00284050|3584523|FG000|Overall Study|Death|1
2017192|NCT00284050|3584524|FG001|Overall Study|Death|0
2017193|NCT00284050|3584525|FG002|Overall Study|Death|0
2017194|NCT00284089|3584537|FG000|Multiple Dose Phase|Adverse Event|1
2017195|NCT00284089|3584538|FG001|Multiple Dose Phase|Adverse Event|0
2017196|NCT00284089|3584539|FG002|Multiple Dose Phase|Adverse Event|1
2017197|NCT00284089|3584540|FG003|Multiple Dose Phase|Adverse Event|1
2017198|NCT00284089|3584537|FG000|Multiple Dose Phase|Protocol Violation|0
2017199|NCT00284089|3584538|FG001|Multiple Dose Phase|Protocol Violation|0
2017200|NCT00284089|3584539|FG002|Multiple Dose Phase|Protocol Violation|1
2017201|NCT00284089|3584540|FG003|Multiple Dose Phase|Protocol Violation|0
2017202|NCT00284089|3584537|FG000|Multiple Dose Phase|Withdrawal by Subject|0
2017203|NCT00284089|3584538|FG001|Multiple Dose Phase|Withdrawal by Subject|0
2017204|NCT00284089|3584539|FG002|Multiple Dose Phase|Withdrawal by Subject|1
2017205|NCT00284089|3584540|FG003|Multiple Dose Phase|Withdrawal by Subject|2
2017206|NCT00284089|3584537|FG000|Multiple Dose Phase|Death|0
2017207|NCT00284089|3584538|FG001|Multiple Dose Phase|Death|0
2017208|NCT00284089|3584539|FG002|Multiple Dose Phase|Death|1
2017209|NCT00284089|3584540|FG003|Multiple Dose Phase|Death|1
2017210|NCT00284089|3584537|FG000|Extension Phase|Adverse Event|0
2017211|NCT00284089|3584538|FG001|Extension Phase|Adverse Event|0
2017212|NCT00284089|3584539|FG002|Extension Phase|Adverse Event|2
2017213|NCT00284089|3584540|FG003|Extension Phase|Adverse Event|2
2017214|NCT00284089|3584537|FG000|Extension Phase|condition no longer requires study drug|2
2017215|NCT00284089|3584538|FG001|Extension Phase|condition no longer requires study drug|0
2017216|NCT00284089|3584539|FG002|Extension Phase|condition no longer requires study drug|2
2017217|NCT00284089|3584540|FG003|Extension Phase|condition no longer requires study drug|7
2017218|NCT00284089|3584537|FG000|Extension Phase|Protocol Violation|0
2017219|NCT00284089|3584538|FG001|Extension Phase|Protocol Violation|0
2017220|NCT00284089|3584539|FG002|Extension Phase|Protocol Violation|1
2017221|NCT00284089|3584540|FG003|Extension Phase|Protocol Violation|0
2017222|NCT00284089|3584537|FG000|Extension Phase|Withdrawal by Subject|0
2017223|NCT00284089|3584538|FG001|Extension Phase|Withdrawal by Subject|0
2017224|NCT00284089|3584539|FG002|Extension Phase|Withdrawal by Subject|1
2017225|NCT00284089|3584540|FG003|Extension Phase|Withdrawal by Subject|3
2017226|NCT00284141|3584550|FG000|Overall Study|Disease Progression / Lack of efficacy|51
2017227|NCT00284141|3584550|FG000|Overall Study|Adverse Event|19
2017228|NCT00284141|3584550|FG000|Overall Study|Participant's request|9
2017229|NCT00284141|3584550|FG000|Overall Study|Symptomatic / Clinical Progression|11
2017230|NCT00284141|3584550|FG000|Overall Study|Clinical deterioration / death|2
2017231|NCT00284141|3584550|FG000|Overall Study|General decline|1
2017232|NCT00284141|3584550|FG000|Overall Study|Pneumonia|1
2017233|NCT00284141|3584550|FG000|Overall Study|Did not take study medication|2
2017234|NCT00284141|3584550|FG000|Overall Study|Ongoing treatment|2
2017235|NCT00284934|3584606|FG000|Overall Study|Adverse Event|1
2017236|NCT00284934|3584607|FG001|Overall Study|Adverse Event|2
2017237|NCT00284934|3584606|FG000|Overall Study|Other reasons|3
2017238|NCT00284934|3584607|FG001|Overall Study|Other reasons|1
2017239|NCT00285012|3584615|FG000|Assigned to Study Treatment (Tx)|Other|2
2017240|NCT00285012|3584616|FG001|Assigned to Study Treatment (Tx)|Other|3
2017241|NCT00285012|3584615|FG000|Received Study Tx|Death|2
2017242|NCT00285012|3584616|FG001|Received Study Tx|Death|1
2017243|NCT00285012|3584615|FG000|Received Study Tx|Adverse Event|5
2017244|NCT00285012|3584616|FG001|Received Study Tx|Adverse Event|11
2017245|NCT00285012|3584615|FG000|Received Study Tx|Lack of Efficacy|0
2017246|NCT00285012|3584616|FG001|Received Study Tx|Lack of Efficacy|3
2017247|NCT00285012|3584615|FG000|Received Study Tx|Lost to Follow-up|29
2017248|NCT00285012|3584616|FG001|Received Study Tx|Lost to Follow-up|31
2017249|NCT00285012|3584615|FG000|Received Study Tx|Withdrawal by Subject|31
2017250|NCT00285012|3584616|FG001|Received Study Tx|Withdrawal by Subject|43
2017251|NCT00285012|3584615|FG000|Received Study Tx|Other|5
2017252|NCT00285012|3584616|FG001|Received Study Tx|Other|5
2017253|NCT00285207|3584624|FG000|Overall Study|Lost to Follow-up|3
2017254|NCT00285207|3584625|FG001|Overall Study|Lost to Follow-up|2
2017255|NCT00285207|3584624|FG000|Overall Study|Withdrawal by Subject|5
2017256|NCT00285207|3584625|FG001|Overall Study|Withdrawal by Subject|2
2017257|NCT00285207|3584624|FG000|Overall Study|Pregnancy|1
2017258|NCT00285207|3584625|FG001|Overall Study|Pregnancy|1
2017259|NCT00285207|3584624|FG000|Overall Study|non-compliance|0
2017260|NCT00285207|3584625|FG001|Overall Study|non-compliance|1
2017261|NCT00285584|3584646|FG000|Month 3|Lost to Follow-up|3
2017262|NCT00285584|3584647|FG001|Month 3|Lost to Follow-up|3
2017263|NCT00285584|3584646|FG000|Month 3|Withdrawal by Subject|1
2017264|NCT00285584|3584647|FG001|Month 3|Withdrawal by Subject|0
2017265|NCT00285584|3584646|FG000|Month 6|Lost to Follow-up|0
2017266|NCT00285584|3584647|FG001|Month 6|Lost to Follow-up|1
2017267|NCT00285649|3584660|FG000|Overall Study|Lost to Follow-up|6
2017268|NCT00285649|3584661|FG001|Overall Study|Lost to Follow-up|4
2017269|NCT00285649|3584662|FG002|Overall Study|Lost to Follow-up|4
2017270|NCT00285649|3584660|FG000|Overall Study|Withdrawal by Subject|3
2017271|NCT00285649|3584661|FG001|Overall Study|Withdrawal by Subject|2
2017272|NCT00285649|3584662|FG002|Overall Study|Withdrawal by Subject|2
2017273|NCT00285818|3584681|FG000|Overall Study|Withdrawal by Subject|3
2017274|NCT00285818|3584682|FG001|Overall Study|Withdrawal by Subject|2
2017275|NCT00285818|3584681|FG000|Overall Study|Lost to Follow-up|1
2017276|NCT00285818|3584682|FG001|Overall Study|Lost to Follow-up|0
2017277|NCT00285857|3584688|FG000|Overall Study|Withdrawal by Subject|2
2017278|NCT00285857|3584688|FG000|Overall Study|Inadequate initial breast cytology|1
2017279|NCT00285857|3584688|FG000|Overall Study|Adverse Event|1
2017280|NCT00286091|3584708|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103
2017281|NCT00286091|3584709|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113
2017282|NCT00286091|3584708|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307
2017283|NCT00286091|3584709|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269
2017284|NCT00286091|3584708|FG000|Double-blind Treatment Phase|Death|58
2017285|NCT00286091|3584709|FG001|Double-blind Treatment Phase|Death|65
2017286|NCT00286091|3584708|FG000|Double-blind Treatment Phase|Adverse Event|28
2017287|NCT00286091|3584709|FG001|Double-blind Treatment Phase|Adverse Event|40
2017288|NCT00286091|3584708|FG000|Double-blind Treatment Phase|Disease Progression|22
2017289|NCT00286091|3584709|FG001|Double-blind Treatment Phase|Disease Progression|35
2017290|NCT00286091|3584708|FG000|Double-blind Treatment Phase|Other|25
2017291|NCT00286091|3584709|FG001|Double-blind Treatment Phase|Other|33
2017292|NCT00286091|3584708|FG000|Double-blind Treatment Phase|Administrative Decision|20
2017293|NCT00286091|3584709|FG001|Double-blind Treatment Phase|Administrative Decision|21
2017294|NCT00286091|3584708|FG000|Double-blind Treatment Phase|Noncompliance|8
2017295|NCT00286091|3584709|FG001|Double-blind Treatment Phase|Noncompliance|8
2017296|NCT00286091|3584708|FG000|Double-blind Treatment Phase|Lost to Follow-up|11
2017297|NCT00286091|3584709|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
2017298|NCT00286091|3584708|FG000|Double-blind Treatment Phase|Protocol Deviation|1
2017299|NCT00286091|3584709|FG001|Double-blind Treatment Phase|Protocol Deviation|3
2017300|NCT00286091|3584708|FG000|Double-blind Treatment Phase|Ineligibility Determined|1
2017301|NCT00286091|3584709|FG001|Double-blind Treatment Phase|Ineligibility Determined|2
2017302|NCT00286091|3584708|FG000|Open-label Treatment Phase|Physician Decision|24
2017303|NCT00286091|3584709|FG001|Open-label Treatment Phase|Physician Decision|21
2017304|NCT00286091|3584708|FG000|Open-label Treatment Phase|Adverse Event|5
2017305|NCT00286091|3584709|FG001|Open-label Treatment Phase|Adverse Event|16
2017306|NCT00286091|3584708|FG000|Open-label Treatment Phase|Other|11
2017307|NCT00286091|3584709|FG001|Open-label Treatment Phase|Other|11
2177496|NCT01374568|3801686|FG000|Overall Study|Lab unable to analyze BTM|0
2017308|NCT00286091|3584708|FG000|Open-label Treatment Phase|Withdrawal by Subject|14
2017309|NCT00286091|3584709|FG001|Open-label Treatment Phase|Withdrawal by Subject|10
2017310|NCT00286091|3584708|FG000|Open-label Treatment Phase|Death|10
2017311|NCT00286091|3584709|FG001|Open-label Treatment Phase|Death|7
2017312|NCT00286091|3584708|FG000|Open-label Treatment Phase|Disease Progression|9
2017313|NCT00286091|3584709|FG001|Open-label Treatment Phase|Disease Progression|3
2017314|NCT00286091|3584708|FG000|Open-label Treatment Phase|Noncompliance|3
2017315|NCT00286091|3584709|FG001|Open-label Treatment Phase|Noncompliance|1
2017316|NCT00286091|3584708|FG000|Open-label Treatment Phase|Lost to Follow-up|0
2017317|NCT00286091|3584709|FG001|Open-label Treatment Phase|Lost to Follow-up|1
2017318|NCT00286091|3584708|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1
2017319|NCT00286091|3584709|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0
2017320|NCT00286091|3584708|FG000|Open-label Treatment Phase|Missing End of Study Information|0
2017321|NCT00286091|3584709|FG001|Open-label Treatment Phase|Missing End of Study Information|1
2017322|NCT00286156|3584720|FG000|Overall Study|Missed 12 month visit|0
2017323|NCT00286156|3584721|FG001|Overall Study|Missed 12 month visit|0
2017324|NCT00286156|3584722|FG002|Overall Study|Missed 12 month visit|1
2017325|NCT00286156|3584720|FG000|Overall Study|AE: pulmonary embolus|0
2017326|NCT00286156|3584721|FG001|Overall Study|AE: pulmonary embolus|1
2017327|NCT00286156|3584722|FG002|Overall Study|AE: pulmonary embolus|0
2017328|NCT00286156|3584720|FG000|Overall Study|AE: nephrotic-range proteinuruia|1
2017329|NCT00286156|3584721|FG001|Overall Study|AE: nephrotic-range proteinuruia|0
2017330|NCT00286156|3584722|FG002|Overall Study|AE: nephrotic-range proteinuruia|0
2017331|NCT00286156|3584720|FG000|Overall Study|AE: pneumonia|1
2017332|NCT00286156|3584721|FG001|Overall Study|AE: pneumonia|0
2017333|NCT00286156|3584722|FG002|Overall Study|AE: pneumonia|0
2017334|NCT00286221|3584743|FG000|Overall Study|Protocol Violation|2
2017335|NCT00286221|3584744|FG001|Overall Study|Protocol Violation|1
2017336|NCT00286221|3584745|FG002|Overall Study|Protocol Violation|6
2017337|NCT00286221|3584746|FG003|Overall Study|Protocol Violation|4
2017338|NCT00286221|3584743|FG000|Overall Study|Unanticipated Neurosurgical Complication|6
2017339|NCT00286221|3584744|FG001|Overall Study|Unanticipated Neurosurgical Complication|3
2017340|NCT00286221|3584745|FG002|Overall Study|Unanticipated Neurosurgical Complication|3
2017341|NCT00286221|3584746|FG003|Overall Study|Unanticipated Neurosurgical Complication|2
2017342|NCT00286221|3584743|FG000|Overall Study|Inability to trigger PCA|2
2017343|NCT00286221|3584744|FG001|Overall Study|Inability to trigger PCA|0
2017344|NCT00286221|3584745|FG002|Overall Study|Inability to trigger PCA|0
2017345|NCT00286221|3584746|FG003|Overall Study|Inability to trigger PCA|0
2017346|NCT00286221|3584743|FG000|Overall Study|Unrecognized exclusion criteria met|0
2017347|NCT00286221|3584744|FG001|Overall Study|Unrecognized exclusion criteria met|1
2017348|NCT00286221|3584745|FG002|Overall Study|Unrecognized exclusion criteria met|0
2017349|NCT00286221|3584746|FG003|Overall Study|Unrecognized exclusion criteria met|0
2017350|NCT00286234|3584760|FG000|Overall Study|Protocol Violation|1
2017351|NCT00286234|3584761|FG001|Overall Study|Protocol Violation|2
2017352|NCT00286234|3584762|FG002|Overall Study|Protocol Violation|0
2017353|NCT00286234|3584763|FG003|Overall Study|Protocol Violation|1
2017354|NCT00286234|3584760|FG000|Overall Study|Physician Decision|1
2017355|NCT00286234|3584761|FG001|Overall Study|Physician Decision|0
2017356|NCT00286234|3584762|FG002|Overall Study|Physician Decision|0
2017357|NCT00286234|3584763|FG003|Overall Study|Physician Decision|1
2017358|NCT00286234|3584760|FG000|Overall Study|Adverse Event|0
2017359|NCT00286234|3584761|FG001|Overall Study|Adverse Event|0
2017360|NCT00286234|3584762|FG002|Overall Study|Adverse Event|0
2017361|NCT00286234|3584763|FG003|Overall Study|Adverse Event|1
2017362|NCT00286234|3584760|FG000|Overall Study|Adverse Event|0
2017363|NCT00286234|3584761|FG001|Overall Study|Adverse Event|0
2017364|NCT00286234|3584762|FG002|Overall Study|Adverse Event|0
2017365|NCT00286234|3584763|FG003|Overall Study|Adverse Event|1
2017366|NCT00286429|3584780|FG000|Overall Study|Adverse Event|4
2017367|NCT00286429|3584781|FG001|Overall Study|Adverse Event|1
2017368|NCT00286429|3584782|FG002|Overall Study|Adverse Event|6
2017369|NCT00286429|3584780|FG000|Overall Study|Lack of Efficacy|52
2017370|NCT00286429|3584781|FG001|Overall Study|Lack of Efficacy|27
2017371|NCT00286429|3584782|FG002|Overall Study|Lack of Efficacy|25
2017372|NCT00286429|3584780|FG000|Overall Study|Lost to Follow-up|2
2017373|NCT00286429|3584781|FG001|Overall Study|Lost to Follow-up|4
2017374|NCT00286429|3584782|FG002|Overall Study|Lost to Follow-up|3
2017375|NCT00286429|3584780|FG000|Overall Study|Physician Decision|10
2214583|NCT01688739|3856934|FG003|Overall Study|Administrative Decision|0
2214584|NCT01688739|3856935|FG004|Overall Study|Administrative Decision|0
2214585|NCT01688739|3856936|FG005|Overall Study|Administrative Decision|0
2214586|NCT01688739|3856937|FG006|Overall Study|Administrative Decision|0
2214587|NCT01688739|3856938|FG007|Overall Study|Administrative Decision|0
2214588|NCT01688739|3856939|FG008|Overall Study|Administrative Decision|0
2214589|NCT01688739|3856940|FG009|Overall Study|Administrative Decision|0
2214590|NCT01688830|3856991|FG000|Overall Study|Lost to Follow-up|0
2214591|NCT01688830|3856992|FG001|Overall Study|Lost to Follow-up|0
2214592|NCT01688830|3856993|FG002|Overall Study|Lost to Follow-up|0
2214593|NCT01688830|3856994|FG003|Overall Study|Lost to Follow-up|0
2214594|NCT01688830|3856995|FG004|Overall Study|Lost to Follow-up|0
2214595|NCT01688830|3856996|FG005|Overall Study|Lost to Follow-up|0
2214596|NCT01688830|3856997|FG006|Overall Study|Lost to Follow-up|0
2214597|NCT01688830|3856998|FG007|Overall Study|Lost to Follow-up|0
2214598|NCT01688830|3856999|FG008|Overall Study|Lost to Follow-up|0
2214599|NCT01688830|3857000|FG009|Overall Study|Lost to Follow-up|0
2214600|NCT01688830|3857001|FG010|Overall Study|Lost to Follow-up|1
2214601|NCT01688830|3857002|FG011|Overall Study|Lost to Follow-up|0
2214602|NCT01688830|3857003|FG012|Overall Study|Lost to Follow-up|0
2214603|NCT01688830|3857004|FG013|Overall Study|Lost to Follow-up|0
2214604|NCT01688830|3857005|FG014|Overall Study|Lost to Follow-up|0
2214605|NCT01688830|3857006|FG015|Overall Study|Lost to Follow-up|0
2214606|NCT01688830|3857007|FG016|Overall Study|Lost to Follow-up|0
2214607|NCT01688830|3857008|FG017|Overall Study|Lost to Follow-up|0
2214608|NCT01688830|3857009|FG018|Overall Study|Lost to Follow-up|0
2214609|NCT01688830|3857010|FG019|Overall Study|Lost to Follow-up|0
2214610|NCT01688830|3857011|FG020|Overall Study|Lost to Follow-up|0
2214611|NCT01688882|3857116|FG000|Overall Study|Adverse Event|1
2214612|NCT01688882|3857117|FG001|Overall Study|Adverse Event|0
2214613|NCT01688882|3857116|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2214614|NCT01688882|3857117|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2214615|NCT01688882|3857116|FG000|Overall Study|Administrative problems|1
2214616|NCT01688882|3857117|FG001|Overall Study|Administrative problems|0
2214617|NCT01688921|3857133|FG000|Overall Study|Lost to Follow-up|7
2214618|NCT01688921|3857134|FG001|Overall Study|Lost to Follow-up|13
2214619|NCT01688921|3857133|FG000|Overall Study|Physician Decision|6
2214620|NCT01688921|3857134|FG001|Overall Study|Physician Decision|1
2214621|NCT01688921|3857133|FG000|Overall Study|Protocol Violation|0
2214622|NCT01688921|3857134|FG001|Overall Study|Protocol Violation|1
2017376|NCT00286429|3584781|FG001|Overall Study|Physician Decision|7
2017377|NCT00286429|3584782|FG002|Overall Study|Physician Decision|7
2017378|NCT00286429|3584780|FG000|Overall Study|Protocol Violation|3
2017379|NCT00286429|3584781|FG001|Overall Study|Protocol Violation|5
2017380|NCT00286429|3584782|FG002|Overall Study|Protocol Violation|4
2017381|NCT00286429|3584780|FG000|Overall Study|Withdrawal by Subject|3
2017382|NCT00286429|3584781|FG001|Overall Study|Withdrawal by Subject|2
2017383|NCT00286429|3584782|FG002|Overall Study|Withdrawal by Subject|6
2017384|NCT00286429|3584780|FG000|Overall Study|Administrative Error|1
2017385|NCT00286429|3584781|FG001|Overall Study|Administrative Error|1
2017386|NCT00286429|3584782|FG002|Overall Study|Administrative Error|1
2017387|NCT00286429|3584780|FG000|Overall Study|Administrative Decision|0
2017388|NCT00286429|3584781|FG001|Overall Study|Administrative Decision|1
2017389|NCT00286429|3584782|FG002|Overall Study|Administrative Decision|0
2017390|NCT00286442|3584793|FG000|Overall Study|Hyperglycemic Rescue|19
2017391|NCT00286442|3584794|FG001|Overall Study|Hyperglycemic Rescue|17
2017392|NCT00286442|3584795|FG002|Overall Study|Hyperglycemic Rescue|25
2017393|NCT00286442|3584793|FG000|Overall Study|Adverse Event|7
2017394|NCT00286442|3584794|FG001|Overall Study|Adverse Event|6
2017395|NCT00286442|3584795|FG002|Overall Study|Adverse Event|1
2017396|NCT00286442|3584793|FG000|Overall Study|Protocol Violation|2
2017397|NCT00286442|3584794|FG001|Overall Study|Protocol Violation|4
2017398|NCT00286442|3584795|FG002|Overall Study|Protocol Violation|2
2017399|NCT00286442|3584793|FG000|Overall Study|Lost to Follow-up|5
2017400|NCT00286442|3584794|FG001|Overall Study|Lost to Follow-up|2
2017401|NCT00286442|3584795|FG002|Overall Study|Lost to Follow-up|1
2017402|NCT00286442|3584793|FG000|Overall Study|Physician Decision|1
2017403|NCT00286442|3584794|FG001|Overall Study|Physician Decision|1
2017404|NCT00286442|3584795|FG002|Overall Study|Physician Decision|1
2017405|NCT00286442|3584793|FG000|Overall Study|Administrative Error|1
2017406|NCT00286442|3584794|FG001|Overall Study|Administrative Error|1
2017407|NCT00286442|3584795|FG002|Overall Study|Administrative Error|0
2017408|NCT00286442|3584793|FG000|Overall Study|Withdrawal by Subject|2
2017409|NCT00286442|3584794|FG001|Overall Study|Withdrawal by Subject|14
2017410|NCT00286442|3584795|FG002|Overall Study|Withdrawal by Subject|2
2017411|NCT00286455|3584806|FG000|Overall Study|Hyperglycemia rescue|19
2017412|NCT00286455|3584807|FG001|Overall Study|Hyperglycemia rescue|13
2017413|NCT00286455|3584808|FG002|Overall Study|Hyperglycemia rescue|10
2017414|NCT00286455|3584806|FG000|Overall Study|Adverse Event|1
2017415|NCT00286455|3584807|FG001|Overall Study|Adverse Event|3
2017416|NCT00286455|3584808|FG002|Overall Study|Adverse Event|2
2017417|NCT00286455|3584806|FG000|Overall Study|Lost to Follow-up|0
2017418|NCT00286455|3584807|FG001|Overall Study|Lost to Follow-up|3
2017419|NCT00286455|3584808|FG002|Overall Study|Lost to Follow-up|3
2017420|NCT00286455|3584806|FG000|Overall Study|Physician Decision|3
2017421|NCT00286455|3584807|FG001|Overall Study|Physician Decision|0
2017422|NCT00286455|3584808|FG002|Overall Study|Physician Decision|2
2017423|NCT00286455|3584806|FG000|Overall Study|Protocol Violation|1
2017424|NCT00286455|3584807|FG001|Overall Study|Protocol Violation|1
2017425|NCT00286455|3584808|FG002|Overall Study|Protocol Violation|0
2017426|NCT00286455|3584806|FG000|Overall Study|Participant Non-compliance|1
2017427|NCT00286455|3584807|FG001|Overall Study|Participant Non-compliance|0
2017428|NCT00286455|3584808|FG002|Overall Study|Participant Non-compliance|0
2017429|NCT00286455|3584806|FG000|Overall Study|Withdrawal by Subject|0
2017430|NCT00286455|3584807|FG001|Overall Study|Withdrawal by Subject|8
2017431|NCT00286455|3584808|FG002|Overall Study|Withdrawal by Subject|7
2017432|NCT00286468|3584819|FG000|Overall Study|Hyperglycemic Rescue|28
2017433|NCT00286468|3584820|FG001|Overall Study|Hyperglycemic Rescue|30
2017434|NCT00286468|3584821|FG002|Overall Study|Hyperglycemic Rescue|31
2017435|NCT00286468|3584819|FG000|Overall Study|Adverse Event|2
2017436|NCT00286468|3584820|FG001|Overall Study|Adverse Event|6
2214623|NCT01688921|3857133|FG000|Overall Study|informed consent|3
2017437|NCT00286468|3584821|FG002|Overall Study|Adverse Event|4
2214624|NCT01688921|3857134|FG001|Overall Study|informed consent|0
2214625|NCT01688973|3857143|FG000|Overall Study|Ineligible|2
2214626|NCT01688973|3857144|FG001|Overall Study|Ineligible|3
2017438|NCT00286468|3584819|FG000|Overall Study|Protocol Violation|0
2017439|NCT00286468|3584820|FG001|Overall Study|Protocol Violation|3
2017440|NCT00286468|3584821|FG002|Overall Study|Protocol Violation|1
2017441|NCT00286468|3584819|FG000|Overall Study|Lost to Follow-up|1
2017442|NCT00286468|3584820|FG001|Overall Study|Lost to Follow-up|1
2017443|NCT00286468|3584821|FG002|Overall Study|Lost to Follow-up|2
2017444|NCT00286468|3584819|FG000|Overall Study|Withdrawal by Subject|3
2017445|NCT00286468|3584820|FG001|Overall Study|Withdrawal by Subject|8
2017446|NCT00286468|3584821|FG002|Overall Study|Withdrawal by Subject|11
2017447|NCT00286468|3584819|FG000|Overall Study|Physician Decision|3
2017448|NCT00286468|3584820|FG001|Overall Study|Physician Decision|2
2017449|NCT00286468|3584821|FG002|Overall Study|Physician Decision|1
2017450|NCT00286494|3584832|FG000|Overall Study|Hyperglycemic rescue|12
2017451|NCT00286494|3584833|FG001|Overall Study|Hyperglycemic rescue|19
2017452|NCT00286494|3584834|FG002|Overall Study|Hyperglycemic rescue|18
2017453|NCT00286494|3584832|FG000|Overall Study|Withdrawal by Subject|2
2017454|NCT00286494|3584833|FG001|Overall Study|Withdrawal by Subject|10
2017455|NCT00286494|3584834|FG002|Overall Study|Withdrawal by Subject|9
2017456|NCT00286494|3584832|FG000|Overall Study|Adverse Event|3
2017457|NCT00286494|3584833|FG001|Overall Study|Adverse Event|8
2214627|NCT01688999|3857154|FG000|Overall Study|Withdrawal by Subject|5
2214628|NCT01688999|3857155|FG001|Overall Study|Withdrawal by Subject|1
2214629|NCT01688999|3857156|FG002|Overall Study|Withdrawal by Subject|1
2214630|NCT01688999|3857154|FG000|Overall Study|Adverse Event|2
2214631|NCT01688999|3857155|FG001|Overall Study|Adverse Event|0
2214632|NCT01688999|3857156|FG002|Overall Study|Adverse Event|2
2214633|NCT01688999|3857154|FG000|Overall Study|Ineligible/Not treated|1
2214634|NCT01688999|3857155|FG001|Overall Study|Ineligible/Not treated|0
2214635|NCT01688999|3857156|FG002|Overall Study|Ineligible/Not treated|0
2214636|NCT01689207|3857179|FG000|Overall Study|Adverse Event|0
2017458|NCT00286494|3584834|FG002|Overall Study|Adverse Event|6
2017459|NCT00286494|3584832|FG000|Overall Study|Physician Decision|5
2017460|NCT00286494|3584833|FG001|Overall Study|Physician Decision|5
2017461|NCT00286494|3584834|FG002|Overall Study|Physician Decision|1
2017462|NCT00286494|3584832|FG000|Overall Study|Lost to Follow-up|3
2017463|NCT00286494|3584833|FG001|Overall Study|Lost to Follow-up|1
2017464|NCT00286494|3584834|FG002|Overall Study|Lost to Follow-up|3
2017465|NCT00286494|3584832|FG000|Overall Study|Protocol Violation|1
2017466|NCT00286494|3584833|FG001|Overall Study|Protocol Violation|1
2017467|NCT00286494|3584834|FG002|Overall Study|Protocol Violation|2
2017468|NCT00286754|3584866|FG000|Overall Study|Adverse Event|2
2017469|NCT00286754|3584867|FG001|Overall Study|Adverse Event|2
2017470|NCT00286754|3584868|FG002|Overall Study|Adverse Event|3
2017471|NCT00286754|3584866|FG000|Overall Study|Withdrawal by Subject|6
2017472|NCT00286754|3584867|FG001|Overall Study|Withdrawal by Subject|2
2017473|NCT00286754|3584868|FG002|Overall Study|Withdrawal by Subject|0
2017474|NCT00286754|3584866|FG000|Overall Study|Lost to Follow-up|12
2017475|NCT00286754|3584867|FG001|Overall Study|Lost to Follow-up|14
2017476|NCT00286754|3584868|FG002|Overall Study|Lost to Follow-up|6
2017477|NCT00286754|3584866|FG000|Overall Study|Moved out of state|0
2017478|NCT00286754|3584867|FG001|Overall Study|Moved out of state|0
2017479|NCT00286754|3584868|FG002|Overall Study|Moved out of state|1
2017480|NCT00287079|3584899|FG000|Overall Study|Qualifying relapse|12
2017481|NCT00287079|3584900|FG001|Overall Study|Qualifying relapse|1
2017482|NCT00287079|3584899|FG000|Overall Study|Non-qualifying relapse|1
2017483|NCT00287079|3584900|FG001|Overall Study|Non-qualifying relapse|0
2017484|NCT00287079|3584899|FG000|Overall Study|Adverse Event|5
2017485|NCT00287079|3584900|FG001|Overall Study|Adverse Event|0
2017486|NCT00287079|3584899|FG000|Overall Study|Protocol Violation|1
2017487|NCT00287079|3584900|FG001|Overall Study|Protocol Violation|0
2017488|NCT00287079|3584899|FG000|Overall Study|Other|3
2017489|NCT00287079|3584900|FG001|Overall Study|Other|0
2017490|NCT00287118|3584906|FG000|Overall Study|Adverse Event|30
2017491|NCT00287118|3584906|FG000|Overall Study|Death|1
2017492|NCT00287118|3584906|FG000|Overall Study|Lack of Efficacy|11
2017493|NCT00287118|3584906|FG000|Overall Study|Lost to Follow-up|1
2017494|NCT00287118|3584906|FG000|Overall Study|Protocol Violation|2
2017495|NCT00287118|3584906|FG000|Overall Study|Other|7
2017496|NCT00287365|3584927|FG000|Overall Study|sample not acquired|13
2017497|NCT00287469|3584934|FG000|Overall Study|serious adverse event|1
2017498|NCT00287469|3584935|FG001|Overall Study|serious adverse event|6
2017499|NCT00287469|3584934|FG000|Overall Study|Adverse Event|1
2017500|NCT00287469|3584935|FG001|Overall Study|Adverse Event|1
2017501|NCT00287469|3584934|FG000|Overall Study|moved from area|144
2017502|NCT00287469|3584935|FG001|Overall Study|moved from area|138
2017503|NCT00287469|3584934|FG000|Overall Study|Lost to Follow-up|74
2017504|NCT00287469|3584935|FG001|Overall Study|Lost to Follow-up|69
2017505|NCT00287586|3584945|FG000|Overall Study|Withdrew Consent|19
2017506|NCT00287586|3584946|FG001|Overall Study|Withdrew Consent|30
2017507|NCT00287586|3584945|FG000|Overall Study|Lost to Follow-up|5
2017508|NCT00287586|3584946|FG001|Overall Study|Lost to Follow-up|4
2017509|NCT00287586|3584945|FG000|Overall Study|Death|2
2017510|NCT00287586|3584946|FG001|Overall Study|Death|3
2214637|NCT01689207|3857180|FG001|Overall Study|Adverse Event|1
2214638|NCT01689207|3857181|FG002|Overall Study|Adverse Event|0
2017511|NCT00287586|3584945|FG000|Overall Study|Elevated Hematocrit|3
2017512|NCT00287586|3584946|FG001|Overall Study|Elevated Hematocrit|0
2017513|NCT00287586|3584945|FG000|Overall Study|Rash|3
2017514|NCT00287586|3584946|FG001|Overall Study|Rash|0
2017515|NCT00287586|3584945|FG000|Overall Study|Elevated Prostate Specific Antigen|2
2017516|NCT00287586|3584946|FG001|Overall Study|Elevated Prostate Specific Antigen|0
2017517|NCT00287586|3584945|FG000|Overall Study|Stroke|2
2017518|NCT00287586|3584946|FG001|Overall Study|Stroke|0
2017519|NCT00287586|3584945|FG000|Overall Study|Myocardial Infarction|1
2017520|NCT00287586|3584946|FG001|Overall Study|Myocardial Infarction|0
2017521|NCT00287586|3584945|FG000|Overall Study|Lower Urinary Tract Symptoms|1
2017522|NCT00287586|3584946|FG001|Overall Study|Lower Urinary Tract Symptoms|0
2017523|NCT00287586|3584945|FG000|Overall Study|Cognitive Impairment|1
2017524|NCT00287586|3584946|FG001|Overall Study|Cognitive Impairment|0
2017525|NCT00287586|3584945|FG000|Overall Study|Pancreatic Cancer|1
2017526|NCT00287586|3584946|FG001|Overall Study|Pancreatic Cancer|3
2017527|NCT00287586|3584945|FG000|Overall Study|Sleep Apnea|1
2017528|NCT00287586|3584946|FG001|Overall Study|Sleep Apnea|0
2017529|NCT00287586|3584945|FG000|Overall Study|Shoulder Pain|1
2017530|NCT00287586|3584946|FG001|Overall Study|Shoulder Pain|0
2017531|NCT00287586|3584945|FG000|Overall Study|Inappropriate Behaviour with Staff|1
2017532|NCT00287586|3584946|FG001|Overall Study|Inappropriate Behaviour with Staff|0
2017533|NCT00287586|3584945|FG000|Overall Study|Nonadherence|1
2017534|NCT00287586|3584946|FG001|Overall Study|Nonadherence|1
2017535|NCT00287586|3584945|FG000|Overall Study|Enrolled in Another Study|1
2017536|NCT00287586|3584946|FG001|Overall Study|Enrolled in Another Study|0
2017537|NCT00287586|3584945|FG000|Overall Study|Major Depression|0
2017538|NCT00287586|3584946|FG001|Overall Study|Major Depression|2
2017539|NCT00287586|3584945|FG000|Overall Study|Lung Cancer|0
2017540|NCT00287586|3584946|FG001|Overall Study|Lung Cancer|2
2017541|NCT00287586|3584945|FG000|Overall Study|Elevated IPSS Score|0
2017542|NCT00287586|3584946|FG001|Overall Study|Elevated IPSS Score|1
2017543|NCT00287586|3584945|FG000|Overall Study|Retroperitoneal Cancer|0
2017544|NCT00287586|3584946|FG001|Overall Study|Retroperitoneal Cancer|1
2017545|NCT00287586|3584945|FG000|Overall Study|Mastodynia and Gynecomastia|0
2017546|NCT00287586|3584946|FG001|Overall Study|Mastodynia and Gynecomastia|1
2017547|NCT00287586|3584945|FG000|Overall Study|Mood Swings and Irritability|0
2017548|NCT00287586|3584946|FG001|Overall Study|Mood Swings and Irritability|1
2017549|NCT00287586|3584945|FG000|Overall Study|Bradycardia|0
2017550|NCT00287586|3584946|FG001|Overall Study|Bradycardia|1
2017551|NCT00287586|3584945|FG000|Overall Study|Itchy Swollen Eyes|0
2017552|NCT00287586|3584946|FG001|Overall Study|Itchy Swollen Eyes|1
2017553|NCT00287586|3584945|FG000|Overall Study|Recurrent Melanoma|0
2017554|NCT00287586|3584946|FG001|Overall Study|Recurrent Melanoma|1
2017555|NCT00287690|3584954|FG000|Overall Study|Protocol Violation|20
2017556|NCT00287690|3584955|FG001|Overall Study|Protocol Violation|26
2017557|NCT00288015|3585001|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
2017558|NCT00288015|3585001|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
2017559|NCT00288015|3585001|FG000|First Response Assessment|Withdrawal by Subject|1
2017560|NCT00288015|3585001|FG000|First Response Assessment|Death|1
2017561|NCT00288015|3585001|FG000|First Response Assessment|Physician Decision|2
2017562|NCT00288015|3585001|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7
2017563|NCT00288015|3585001|FG000|Follow up for Survival x 2 Years|Death|13
2017564|NCT00288015|3585001|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4
2017565|NCT00288015|3585001|FG000|Follow up for Survival x 2 Years|Other|9
2017566|NCT00288054|3585005|FG000|Overall Study|Protocol Violation|2
2017567|NCT00288054|3585005|FG000|Overall Study|Lack of Efficacy|16
2017568|NCT00288054|3585005|FG000|Overall Study|Adverse Event|3
2017569|NCT00288054|3585005|FG000|Overall Study|Withdrawal by Subject|1
2017570|NCT00288054|3585005|FG000|Overall Study|Not protocol specified|2
2017571|NCT00288509|3585026|FG000|Treatment Cycle 1|Adverse Event|1
2017572|NCT00288509|3585026|FG000|Treatment Cycle 1|Lack of Efficacy|1
2017573|NCT00288509|3585026|FG000|Treatment Cycle 1|Withdrawal by Subject|1
2017574|NCT00288509|3585026|FG000|Treatment Cycle 1|Lost to Follow-up|2
2017575|NCT00288509|3585026|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1
2017576|NCT00288509|3585026|FG000|Treatment Cycle 2|Lack of Efficacy|1
2017577|NCT00288509|3585026|FG000|Treatment Cycle 2|Withdrawal by Subject|2
2017578|NCT00288509|3585026|FG000|Treatment Cycle 3|Lack of Efficacy|1
2017579|NCT00288509|3585026|FG000|Treatment Cycle 3|Withdrawal by Subject|1
2017580|NCT00288509|3585026|FG000|Treatment Cycle 3|Lost to Follow-up|2
2017581|NCT00288509|3585026|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1
2017582|NCT00288509|3585026|FG000|Treatment Cycle 4|Withdrawal by Subject|3
2017583|NCT00288509|3585026|FG000|Treatment Cycle 4|Physician Decision|4
2017584|NCT00288509|3585026|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1
2017585|NCT00288587|3585044|FG000|Overall Study|Death|4
2017586|NCT00288587|3585045|FG001|Overall Study|Death|4
2017587|NCT00288587|3585044|FG000|Overall Study|Transplant|0
2017588|NCT00288587|3585045|FG001|Overall Study|Transplant|3
2017589|NCT00288587|3585044|FG000|Overall Study|Adverse Event|0
2017590|NCT00288587|3585045|FG001|Overall Study|Adverse Event|1
2017591|NCT00288587|3585044|FG000|Overall Study|Physician Decision|0
2017592|NCT00288587|3585045|FG001|Overall Study|Physician Decision|2
2017593|NCT00288587|3585044|FG000|Overall Study|Severe Aortic Stenosis|1
2017594|NCT00288587|3585045|FG001|Overall Study|Severe Aortic Stenosis|0
2017595|NCT00288626|3585060|FG000|Overall Study|Death|3
2017596|NCT00288626|3585060|FG000|Overall Study|Withdrawal by Subject|4
2025761|NCT00347360|3594607|FG004|Overall Study|Subject did not meet end of study ABPM|0
2025762|NCT00347360|3594608|FG005|Overall Study|Subject did not meet end of study ABPM|0
2025763|NCT00347360|3594609|FG006|Overall Study|Subject did not meet end of study ABPM|1
2025764|NCT00347360|3594610|FG007|Overall Study|Subject did not meet end of study ABPM|0
2025765|NCT00347360|3594611|FG008|Overall Study|Subject did not meet end of study ABPM|0
2025766|NCT00347360|3594612|FG009|Overall Study|Subject did not meet end of study ABPM|0
2025767|NCT00347360|3594613|FG010|Overall Study|Subject did not meet end of study ABPM|1
2025768|NCT00347360|3594614|FG011|Overall Study|Subject did not meet end of study ABPM|0
2025769|NCT00347360|3594615|FG012|Overall Study|Subject did not meet end of study ABPM|1
2025770|NCT00347360|3594616|FG013|Overall Study|Subject did not meet end of study ABPM|1
2025771|NCT00347360|3594617|FG014|Overall Study|Subject did not meet end of study ABPM|0
2025772|NCT00347360|3594603|FG000|Overall Study|Abnormal lab values|0
2025773|NCT00347360|3594604|FG001|Overall Study|Abnormal lab values|0
2214639|NCT01689207|3857182|FG003|Overall Study|Adverse Event|0
2214640|NCT01689207|3857183|FG004|Overall Study|Adverse Event|2
2214641|NCT01689207|3857184|FG005|Overall Study|Adverse Event|1
2214642|NCT01689207|3857185|FG006|Overall Study|Adverse Event|0
2214643|NCT01689207|3857186|FG007|Overall Study|Adverse Event|0
2214644|NCT01689207|3857187|FG008|Overall Study|Adverse Event|1
2214645|NCT01689207|3857188|FG009|Overall Study|Adverse Event|0
2214646|NCT01689207|3857189|FG010|Overall Study|Adverse Event|0
2214647|NCT01689337|3857223|FG000|Overall Study|Study Discontinuation|1
2214648|NCT01689363|3857238|FG000|Overall Study|Protocol Violation|0
2214649|NCT01689363|3857239|FG001|Overall Study|Protocol Violation|1
2214650|NCT01689363|3857240|FG002|Overall Study|Protocol Violation|0
2214651|NCT01689363|3857241|FG003|Overall Study|Protocol Violation|0
2214652|NCT01689363|3857242|FG004|Overall Study|Protocol Violation|0
2214653|NCT01689363|3857243|FG005|Overall Study|Protocol Violation|0
2214654|NCT01689363|3857244|FG006|Overall Study|Protocol Violation|0
2214655|NCT01689363|3857245|FG007|Overall Study|Protocol Violation|0
2214656|NCT01689519|3857267|FG000|Intent to Treat|Death|157
2214657|NCT01689519|3857268|FG001|Intent to Treat|Death|167
2214658|NCT01689519|3857267|FG000|Intent to Treat|Lost to Follow-up|4
2214659|NCT01689519|3857268|FG001|Intent to Treat|Lost to Follow-up|8
2214660|NCT01689519|3857267|FG000|Intent to Treat|Other|2
2214661|NCT01689519|3857268|FG001|Intent to Treat|Other|4
2214662|NCT01689519|3857267|FG000|Intent to Treat|Physician Decision|4
2214663|NCT01689519|3857268|FG001|Intent to Treat|Physician Decision|1
2214664|NCT01689519|3857267|FG000|Intent to Treat|Study terminated by Spon6sor|59
2214665|NCT01689519|3857268|FG001|Intent to Treat|Study terminated by Spon6sor|48
2025774|NCT00347360|3594605|FG002|Overall Study|Abnormal lab values|0
2025775|NCT00347360|3594606|FG003|Overall Study|Abnormal lab values|0
2025776|NCT00347360|3594607|FG004|Overall Study|Abnormal lab values|0
2025777|NCT00347360|3594608|FG005|Overall Study|Abnormal lab values|0
2025778|NCT00347360|3594609|FG006|Overall Study|Abnormal lab values|1
2025779|NCT00347360|3594610|FG007|Overall Study|Abnormal lab values|0
2025780|NCT00347360|3594611|FG008|Overall Study|Abnormal lab values|0
2025781|NCT00347360|3594612|FG009|Overall Study|Abnormal lab values|0
2025782|NCT00347360|3594613|FG010|Overall Study|Abnormal lab values|0
2025783|NCT00347360|3594614|FG011|Overall Study|Abnormal lab values|0
2025784|NCT00347360|3594615|FG012|Overall Study|Abnormal lab values|0
2025785|NCT00347360|3594616|FG013|Overall Study|Abnormal lab values|0
2025786|NCT00347360|3594617|FG014|Overall Study|Abnormal lab values|0
2025787|NCT00347360|3594603|FG000|Overall Study|PI recommended early withdrawal|0
2025788|NCT00347360|3594604|FG001|Overall Study|PI recommended early withdrawal|0
2025789|NCT00347360|3594605|FG002|Overall Study|PI recommended early withdrawal|0
2025790|NCT00347360|3594606|FG003|Overall Study|PI recommended early withdrawal|0
2025791|NCT00347360|3594607|FG004|Overall Study|PI recommended early withdrawal|0
2025792|NCT00347360|3594608|FG005|Overall Study|PI recommended early withdrawal|0
2025793|NCT00347360|3594609|FG006|Overall Study|PI recommended early withdrawal|0
2025794|NCT00347360|3594610|FG007|Overall Study|PI recommended early withdrawal|0
2025795|NCT00347360|3594611|FG008|Overall Study|PI recommended early withdrawal|0
2025796|NCT00347360|3594612|FG009|Overall Study|PI recommended early withdrawal|1
2025797|NCT00347360|3594613|FG010|Overall Study|PI recommended early withdrawal|0
2025798|NCT00347360|3594614|FG011|Overall Study|PI recommended early withdrawal|0
2025799|NCT00347360|3594615|FG012|Overall Study|PI recommended early withdrawal|0
2025800|NCT00347360|3594616|FG013|Overall Study|PI recommended early withdrawal|0
2025801|NCT00347360|3594617|FG014|Overall Study|PI recommended early withdrawal|0
2025802|NCT00347360|3594603|FG000|Overall Study|Did not meet criteria before ABPM|0
2025803|NCT00347360|3594604|FG001|Overall Study|Did not meet criteria before ABPM|0
2025804|NCT00347360|3594605|FG002|Overall Study|Did not meet criteria before ABPM|0
2025805|NCT00347360|3594606|FG003|Overall Study|Did not meet criteria before ABPM|0
2025806|NCT00347360|3594607|FG004|Overall Study|Did not meet criteria before ABPM|0
2025807|NCT00347360|3594608|FG005|Overall Study|Did not meet criteria before ABPM|0
2025808|NCT00347360|3594609|FG006|Overall Study|Did not meet criteria before ABPM|0
2025809|NCT00347360|3594610|FG007|Overall Study|Did not meet criteria before ABPM|0
2025810|NCT00347360|3594611|FG008|Overall Study|Did not meet criteria before ABPM|0
2025811|NCT00347360|3594612|FG009|Overall Study|Did not meet criteria before ABPM|0
2025812|NCT00347360|3594613|FG010|Overall Study|Did not meet criteria before ABPM|1
2017597|NCT00288639|3585066|FG000|Overall Study|Adverse Event|5
2017598|NCT00288639|3585066|FG000|Overall Study|Lack of Efficacy|4
2017599|NCT00288639|3585066|FG000|Overall Study|Withdrawal by Subject|2
2017600|NCT00288639|3585066|FG000|Overall Study|Other|1
2017601|NCT00288704|3585073|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
2017602|NCT00288704|3585074|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
2017603|NCT00288704|3585075|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
2017604|NCT00288704|3585073|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
2017605|NCT00288704|3585074|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
2017606|NCT00288704|3585075|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
2017607|NCT00288704|3585073|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
2017608|NCT00288704|3585074|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
2017609|NCT00288704|3585075|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
2017610|NCT00288704|3585073|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
2017611|NCT00288704|3585074|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
2017612|NCT00288704|3585075|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
2017613|NCT00288704|3585073|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0
2017614|NCT00288704|3585074|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0
2017615|NCT00288704|3585075|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2
2017616|NCT00288704|3585073|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
2017617|NCT00288704|3585074|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
2017618|NCT00288704|3585075|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
2017619|NCT00288704|3585073|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
2017620|NCT00288704|3585074|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
2017621|NCT00288704|3585075|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
2017622|NCT00288860|3585084|FG000|Overall Study|Did not complete intake|4
2017623|NCT00288860|3585085|FG001|Overall Study|Did not complete intake|8
2017624|NCT00288860|3585084|FG000|Overall Study|Death|4
2017625|NCT00288860|3585085|FG001|Overall Study|Death|3
2017626|NCT00288860|3585084|FG000|Overall Study|Withdrawal by Subject|20
2017627|NCT00288860|3585085|FG001|Overall Study|Withdrawal by Subject|15
2017628|NCT00288860|3585084|FG000|Overall Study|Lost to Follow-up|74
2017629|NCT00288860|3585085|FG001|Overall Study|Lost to Follow-up|71
2017630|NCT00288912|3585106|FG000|Overall Study|Developed exclusion criterion|4
2017631|NCT00288912|3585107|FG001|Overall Study|Developed exclusion criterion|6
2017632|NCT00288912|3585108|FG002|Overall Study|Developed exclusion criterion|7
2017633|NCT00288912|3585106|FG000|Overall Study|Lost to Follow-up|9
2017634|NCT00288912|3585107|FG001|Overall Study|Lost to Follow-up|6
2017635|NCT00288912|3585108|FG002|Overall Study|Lost to Follow-up|9
2017636|NCT00288912|3585106|FG000|Overall Study|Withdrawal by Subject|4
2017637|NCT00288912|3585107|FG001|Overall Study|Withdrawal by Subject|5
2017638|NCT00288912|3585108|FG002|Overall Study|Withdrawal by Subject|12
2017639|NCT00289016|3585116|FG000|Overall Study|Disease Progression|29
2017640|NCT00289016|3585116|FG000|Overall Study|Death|2
2017641|NCT00289016|3585116|FG000|Overall Study|Unrelated Medical Condition or Accident|2
2017642|NCT00289016|3585116|FG000|Overall Study|Withdrawal by Subject|2
2017643|NCT00289016|3585116|FG000|Overall Study|Adverse Event|1
2017644|NCT00289016|3585116|FG000|Overall Study|Other|1
2017645|NCT00289133|3585148|FG000|Overall Study|Non-study device implanted|12
2017646|NCT00289133|3585149|FG001|Overall Study|Non-study device implanted|0
2017647|NCT00289133|3585148|FG000|Overall Study|Protocol Violation|32
2017648|NCT00289133|3585149|FG001|Overall Study|Protocol Violation|38
2017649|NCT00289133|3585148|FG000|Overall Study|Withdrawal by Subject|9
2017650|NCT00289133|3585149|FG001|Overall Study|Withdrawal by Subject|10
2017651|NCT00289133|3585148|FG000|Overall Study|Death|5
2017652|NCT00289133|3585149|FG001|Overall Study|Death|10
2017653|NCT00289133|3585148|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73
2017654|NCT00289133|3585149|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74
2017655|NCT00289133|3585148|FG000|Overall Study|Physician Decision|41
2017656|NCT00289133|3585149|FG001|Overall Study|Physician Decision|45
2017657|NCT00289133|3585148|FG000|Overall Study|Revision|8
2017658|NCT00289133|3585149|FG001|Overall Study|Revision|6
2017659|NCT00289133|3585148|FG000|Overall Study|Lost to Follow-up|92
2017660|NCT00289133|3585149|FG001|Overall Study|Lost to Follow-up|115
2017661|NCT00289185|3585161|FG000|Overall Study|Withdrawal by Subject|4
2017662|NCT00289185|3585162|FG001|Overall Study|Withdrawal by Subject|8
2017663|NCT00289185|3585161|FG000|Overall Study|Lost to Follow-up|23
2017664|NCT00289185|3585162|FG001|Overall Study|Lost to Follow-up|17
2017665|NCT00289185|3585161|FG000|Overall Study|Death|1
2017666|NCT00289185|3585162|FG001|Overall Study|Death|1
2017667|NCT00289198|3585171|FG000|Overall Study|Adverse Event|0
2017668|NCT00289198|3585172|FG001|Overall Study|Adverse Event|2
2017669|NCT00289198|3585171|FG000|Overall Study|Protocol Violation|2
2017670|NCT00289198|3585172|FG001|Overall Study|Protocol Violation|1
2017671|NCT00289198|3585171|FG000|Overall Study|Withdrawal by Subject|4
2017672|NCT00289198|3585172|FG001|Overall Study|Withdrawal by Subject|1
2017673|NCT00289198|3585171|FG000|Overall Study|Lack of Efficacy|2
2017674|NCT00289198|3585172|FG001|Overall Study|Lack of Efficacy|0
2017675|NCT00289198|3585171|FG000|Overall Study|Other: Low compliance|0
2017676|NCT00289198|3585172|FG001|Overall Study|Other: Low compliance|1
2017677|NCT00289198|3585171|FG000|Overall Study|Other: Physician's decision|0
2017678|NCT00289198|3585172|FG001|Overall Study|Other: Physician's decision|1
2017679|NCT00289198|3585171|FG000|Overall Study|Other: Unable to attend on schedule|2
2017680|NCT00289198|3585172|FG001|Overall Study|Other: Unable to attend on schedule|1
2017681|NCT00289198|3585171|FG000|Overall Study|Other: Miscalculation of the visit date|21
2017682|NCT00289198|3585172|FG001|Overall Study|Other: Miscalculation of the visit date|22
2017683|NCT00289198|3585171|FG000|Overall Study|Other: Impossible to come on visit|0
2017684|NCT00289198|3585172|FG001|Overall Study|Other: Impossible to come on visit|1
2017685|NCT00289276|3585192|FG000|Second Part of FAST Study (Expansion)|Death|0
2017686|NCT00289276|3585193|FG001|Second Part of FAST Study (Expansion)|Death|2
2017687|NCT00289276|3585192|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
2017688|NCT00289276|3585193|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
2017689|NCT00289289|3585202|FG000|Overall Study|Withdrawal by Subject|5
2017690|NCT00289289|3585203|FG001|Overall Study|Withdrawal by Subject|3
2017691|NCT00289289|3585204|FG002|Overall Study|Withdrawal by Subject|15
2017692|NCT00289289|3585202|FG000|Overall Study|Lost to Follow-up|1
2017693|NCT00289289|3585203|FG001|Overall Study|Lost to Follow-up|0
2017694|NCT00289289|3585204|FG002|Overall Study|Lost to Follow-up|1
2017695|NCT00289289|3585202|FG000|Overall Study|Death|4
2017696|NCT00289289|3585203|FG001|Overall Study|Death|2
2017697|NCT00289289|3585204|FG002|Overall Study|Death|5
2017698|NCT00289289|3585202|FG000|Overall Study|No implant attempted|0
2017699|NCT00289289|3585203|FG001|Overall Study|No implant attempted|0
2017700|NCT00289289|3585204|FG002|Overall Study|No implant attempted|1
2017701|NCT00289289|3585202|FG000|Overall Study|Physician Decision|1
2017702|NCT00289289|3585203|FG001|Overall Study|Physician Decision|0
2017703|NCT00289289|3585204|FG002|Overall Study|Physician Decision|6
2017704|NCT00289289|3585202|FG000|Overall Study|Non-study device implanted|2
2017705|NCT00289289|3585203|FG001|Overall Study|Non-study device implanted|1
2017706|NCT00289289|3585204|FG002|Overall Study|Non-study device implanted|3
2017707|NCT00289289|3585202|FG000|Overall Study|Did not meet inclusion/exclusion|0
2017708|NCT00289289|3585203|FG001|Overall Study|Did not meet inclusion/exclusion|0
2017709|NCT00289289|3585204|FG002|Overall Study|Did not meet inclusion/exclusion|6
2017710|NCT00289289|3585202|FG000|Overall Study|Other Exit Reason|6
2017711|NCT00289289|3585203|FG001|Overall Study|Other Exit Reason|4
2017712|NCT00289289|3585204|FG002|Overall Study|Other Exit Reason|12
2017713|NCT00289458|3585240|FG000|Overall Study|Death|1
2017714|NCT00289458|3585241|FG001|Overall Study|Death|0
2017715|NCT00289458|3585242|FG002|Overall Study|Death|0
2017716|NCT00289458|3585240|FG000|Overall Study|Physician Decision|3
2017717|NCT00289458|3585241|FG001|Overall Study|Physician Decision|4
2017718|NCT00289458|3585242|FG002|Overall Study|Physician Decision|2
2017719|NCT00289458|3585240|FG000|Overall Study|Withdrawal by Subject|2
2017720|NCT00289458|3585241|FG001|Overall Study|Withdrawal by Subject|2
2017721|NCT00289458|3585242|FG002|Overall Study|Withdrawal by Subject|4
2017722|NCT00289536|3585254|FG000|Period 3|Lost to Follow-up|0
2017723|NCT00289536|3585255|FG001|Period 3|Lost to Follow-up|0
2017724|NCT00289536|3585256|FG002|Period 3|Lost to Follow-up|1
2017725|NCT00289731|3585279|FG000|Overall Study|Adverse Event|1
2017726|NCT00289731|3585280|FG001|Overall Study|Adverse Event|2
2017727|NCT00289731|3585281|FG002|Overall Study|Adverse Event|2
2017728|NCT00289731|3585279|FG000|Overall Study|Other|1
2017729|NCT00289731|3585280|FG001|Overall Study|Other|0
2017730|NCT00289731|3585281|FG002|Overall Study|Other|0
2017731|NCT00289770|3585305|FG000|Year 15|Withdrawal by Subject|1
2017732|NCT00289783|3585311|FG000|Primary Phase|Adverse Event|10
2017733|NCT00289783|3585312|FG001|Primary Phase|Adverse Event|1
2017734|NCT00289783|3585311|FG000|Primary Phase|Protocol Violation|27
2017735|NCT00289783|3585312|FG001|Primary Phase|Protocol Violation|6
2017736|NCT00289783|3585311|FG000|Primary Phase|Withdrawal by Subject|93
2017737|NCT00289783|3585312|FG001|Primary Phase|Withdrawal by Subject|40
2017738|NCT00289783|3585311|FG000|Primary Phase|Lost to Follow-up|60
2017739|NCT00289783|3585312|FG001|Primary Phase|Lost to Follow-up|14
2017740|NCT00289783|3585311|FG000|Primary Phase|Migration from the study area|26
2017741|NCT00289783|3585312|FG001|Primary Phase|Migration from the study area|10
2017742|NCT00289783|3585311|FG000|Primary Phase|Other|32
2017743|NCT00289783|3585312|FG001|Primary Phase|Other|12
2017744|NCT00289783|3585311|FG000|Fourth Dose Phase|Adverse Event|1
2017745|NCT00289783|3585312|FG001|Fourth Dose Phase|Adverse Event|0
2017746|NCT00289783|3585311|FG000|Fourth Dose Phase|Withdrawal by Subject|10
2017747|NCT00289783|3585312|FG001|Fourth Dose Phase|Withdrawal by Subject|1
2017748|NCT00289783|3585311|FG000|Fourth Dose Phase|Lost to Follow-up|53
2017749|NCT00289783|3585312|FG001|Fourth Dose Phase|Lost to Follow-up|12
2017750|NCT00289783|3585311|FG000|Fourth Dose Phase|Migration from the study area|1
2017751|NCT00289783|3585312|FG001|Fourth Dose Phase|Migration from the study area|1
2017752|NCT00289783|3585311|FG000|Fourth Dose Phase|Other|22
2017753|NCT00289783|3585312|FG001|Fourth Dose Phase|Other|10
2017754|NCT00289848|3585328|FG000|Overall Study|Adverse Event|6
2017755|NCT00289848|3585329|FG001|Overall Study|Adverse Event|4
2017756|NCT00289848|3585328|FG000|Overall Study|Death|1
2017757|NCT00289848|3585329|FG001|Overall Study|Death|0
2017758|NCT00289848|3585328|FG000|Overall Study|Lack of Efficacy|20
2017759|NCT00289848|3585329|FG001|Overall Study|Lack of Efficacy|24
2017760|NCT00289848|3585328|FG000|Overall Study|Lost to Follow-up|3
2017761|NCT00289848|3585329|FG001|Overall Study|Lost to Follow-up|1
2017762|NCT00289848|3585328|FG000|Overall Study|Protocol Violation|5
2017763|NCT00289848|3585329|FG001|Overall Study|Protocol Violation|2
2017764|NCT00289848|3585328|FG000|Overall Study|Withdrawal by Subject|5
2017765|NCT00289848|3585329|FG001|Overall Study|Withdrawal by Subject|11
2017766|NCT00289848|3585328|FG000|Overall Study|Patient Moved|6
2017767|NCT00289848|3585329|FG001|Overall Study|Patient Moved|2
2017768|NCT00289848|3585328|FG000|Overall Study|Open-Label AHA Treatment Requested|0
2017769|NCT00289848|3585329|FG001|Overall Study|Open-Label AHA Treatment Requested|1
2017770|NCT00289900|3585341|FG000|Overall Study|Adverse Event|28
2017771|NCT00289900|3585342|FG001|Overall Study|Adverse Event|40
2017772|NCT00289900|3585343|FG002|Overall Study|Adverse Event|13
2017773|NCT00289900|3585344|FG003|Overall Study|Adverse Event|19
2017774|NCT00289900|3585345|FG004|Overall Study|Adverse Event|20
2017775|NCT00289900|3585346|FG005|Overall Study|Adverse Event|33
2017776|NCT00289900|3585341|FG000|Overall Study|Lost to Follow-up|7
2017777|NCT00289900|3585342|FG001|Overall Study|Lost to Follow-up|7
2017778|NCT00289900|3585343|FG002|Overall Study|Lost to Follow-up|8
2017779|NCT00289900|3585344|FG003|Overall Study|Lost to Follow-up|8
2017780|NCT00289900|3585345|FG004|Overall Study|Lost to Follow-up|4
2017781|NCT00289900|3585346|FG005|Overall Study|Lost to Follow-up|8
2017782|NCT00289900|3585341|FG000|Overall Study|Participant had flushing|18
2017783|NCT00289900|3585342|FG001|Overall Study|Participant had flushing|42
2017784|NCT00289900|3585343|FG002|Overall Study|Participant had flushing|1
2017785|NCT00289900|3585344|FG003|Overall Study|Participant had flushing|2
2017786|NCT00289900|3585345|FG004|Overall Study|Participant had flushing|0
2017787|NCT00289900|3585346|FG005|Overall Study|Participant had flushing|4
2017788|NCT00289900|3585341|FG000|Overall Study|Other|0
2017789|NCT00289900|3585342|FG001|Overall Study|Other|0
2017790|NCT00289900|3585343|FG002|Overall Study|Other|0
2017791|NCT00289900|3585344|FG003|Overall Study|Other|5
2017792|NCT00289900|3585345|FG004|Overall Study|Other|1
2017793|NCT00289900|3585346|FG005|Overall Study|Other|0
2017794|NCT00289900|3585341|FG000|Overall Study|Participant moved|1
2017795|NCT00289900|3585342|FG001|Overall Study|Participant moved|0
2017796|NCT00289900|3585343|FG002|Overall Study|Participant moved|0
2017797|NCT00289900|3585344|FG003|Overall Study|Participant moved|1
2017798|NCT00289900|3585345|FG004|Overall Study|Participant moved|1
2017799|NCT00289900|3585346|FG005|Overall Study|Participant moved|1
2017800|NCT00289900|3585341|FG000|Overall Study|Withdrawal by Subject|10
2017801|NCT00289900|3585342|FG001|Overall Study|Withdrawal by Subject|21
2017802|NCT00289900|3585343|FG002|Overall Study|Withdrawal by Subject|8
2017803|NCT00289900|3585344|FG003|Overall Study|Withdrawal by Subject|18
2017804|NCT00289900|3585345|FG004|Overall Study|Withdrawal by Subject|12
2017805|NCT00289900|3585346|FG005|Overall Study|Withdrawal by Subject|11
2017806|NCT00289900|3585341|FG000|Overall Study|Protocol Violation|3
2017807|NCT00289900|3585342|FG001|Overall Study|Protocol Violation|9
2017808|NCT00289900|3585343|FG002|Overall Study|Protocol Violation|2
2017809|NCT00289900|3585344|FG003|Overall Study|Protocol Violation|6
2017810|NCT00289900|3585345|FG004|Overall Study|Protocol Violation|7
2017811|NCT00289900|3585346|FG005|Overall Study|Protocol Violation|4
2017812|NCT00289900|3585341|FG000|Overall Study|site terminated|1
2017813|NCT00289900|3585342|FG001|Overall Study|site terminated|0
2017814|NCT00289900|3585343|FG002|Overall Study|site terminated|1
2017815|NCT00289900|3585344|FG003|Overall Study|site terminated|0
2017816|NCT00289900|3585345|FG004|Overall Study|site terminated|0
2017817|NCT00289900|3585346|FG005|Overall Study|site terminated|0
2017818|NCT00289900|3585341|FG000|Overall Study|Not treated|0
2017819|NCT00289900|3585342|FG001|Overall Study|Not treated|1
2017820|NCT00289900|3585343|FG002|Overall Study|Not treated|0
2017821|NCT00289900|3585344|FG003|Overall Study|Not treated|0
2017822|NCT00289900|3585345|FG004|Overall Study|Not treated|0
2017823|NCT00289900|3585346|FG005|Overall Study|Not treated|0
2017824|NCT00289913|3585368|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017825|NCT00289913|3585369|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
2017826|NCT00289913|3585370|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017827|NCT00289913|3585371|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017828|NCT00289913|3585372|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017829|NCT00289913|3585368|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
2017830|NCT00289913|3585369|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
2017831|NCT00289913|3585370|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
2017832|NCT00289913|3585371|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
2017833|NCT00289913|3585372|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
2017834|NCT00289913|3585368|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
2017835|NCT00289913|3585369|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
2017836|NCT00289913|3585370|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2017837|NCT00289913|3585371|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
2017838|NCT00289913|3585372|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
2017839|NCT00289913|3585368|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
2214666|NCT01689519|3857267|FG000|Intent to Treat|Withdrawal by Subject|21
2017840|NCT00289913|3585369|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
2017841|NCT00289913|3585370|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
2017842|NCT00289913|3585371|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
2017843|NCT00289913|3585372|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
2017844|NCT00289913|3585368|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
2017845|NCT00289913|3585369|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
2017846|NCT00289913|3585370|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
2017847|NCT00289913|3585371|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
2017848|NCT00289913|3585372|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
2017849|NCT00289913|3585368|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
2017850|NCT00289913|3585369|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
2017851|NCT00289913|3585370|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
2017852|NCT00289913|3585371|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
2017853|NCT00289913|3585372|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
2017854|NCT00289913|3585368|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
2017855|NCT00289913|3585369|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
2017856|NCT00289913|3585370|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
2017857|NCT00289913|3585371|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
2017858|NCT00289913|3585372|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
2017859|NCT00289913|3585368|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
2017860|NCT00289913|3585369|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
2017861|NCT00289913|3585370|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
2017862|NCT00289913|3585371|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
2017863|NCT00289913|3585372|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
2017864|NCT00289913|3585368|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
2017865|NCT00289913|3585369|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
2017866|NCT00289913|3585370|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
2017867|NCT00289913|3585371|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
2017868|NCT00289913|3585372|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
2017869|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017870|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017871|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
2017872|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017873|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017874|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
2017875|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
2017876|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
2017877|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
2017878|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
2017879|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
2017880|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
2017881|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
2017882|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
2017883|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
2017884|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
2017885|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
2017886|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
2017887|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2017888|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2017889|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
2017890|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
2017891|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
2017892|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
2017893|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
2017894|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
2017895|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
2017896|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
2017897|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
2017898|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
2017899|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
2017900|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
2017901|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
2017902|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
2017903|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
2017904|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
2017905|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
2017906|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
2017907|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
2017908|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
2017909|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
2017910|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
2017911|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
2017912|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
2017913|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
2017914|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
2017915|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
2017916|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
2017917|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
2017918|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
2017919|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
2017920|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
2017921|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
2017922|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
2017923|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
2017924|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
2017925|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
2017926|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
2017927|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
2017928|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
2017929|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
2017930|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
2017931|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
2017932|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
2017933|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
2017934|NCT00289913|3585368|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
2017935|NCT00289913|3585369|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
2017936|NCT00289913|3585370|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
2017937|NCT00289913|3585371|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
2017938|NCT00289913|3585372|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
2017939|NCT00289913|3585368|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017940|NCT00289913|3585369|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
2017941|NCT00289913|3585370|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017942|NCT00289913|3585371|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017943|NCT00289913|3585372|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2017944|NCT00289913|3585368|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
2017945|NCT00289913|3585369|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
2017946|NCT00289913|3585370|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
2017947|NCT00289913|3585371|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
2017948|NCT00289913|3585372|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
2017949|NCT00289913|3585368|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2017950|NCT00289913|3585369|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2017951|NCT00289913|3585370|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2017952|NCT00289913|3585371|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
2017953|NCT00289913|3585372|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2017954|NCT00289913|3585368|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
2017955|NCT00289913|3585369|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
2017956|NCT00289913|3585370|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
2017957|NCT00289913|3585371|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
2017958|NCT00289913|3585372|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
2017959|NCT00289913|3585368|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
2017960|NCT00289913|3585369|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
2017961|NCT00289913|3585370|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
2017962|NCT00289913|3585371|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
2017963|NCT00289913|3585372|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
2017964|NCT00289913|3585368|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
2017965|NCT00289913|3585369|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
2017966|NCT00289913|3585370|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
2017967|NCT00289913|3585371|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
2017968|NCT00289913|3585372|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
2017969|NCT00289913|3585368|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
2017970|NCT00289913|3585369|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
2017971|NCT00289913|3585370|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
2017972|NCT00289913|3585371|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
2017973|NCT00289913|3585372|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
2017974|NCT00289913|3585368|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
2017975|NCT00289913|3585369|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
2017976|NCT00289913|3585370|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
2017977|NCT00289913|3585371|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
2017978|NCT00289913|3585372|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
2017979|NCT00289978|3585390|FG000|Overall Study|Withdrawal by Subject|31
2017980|NCT00289978|3585391|FG001|Overall Study|Withdrawal by Subject|17
2017981|NCT00289978|3585392|FG002|Overall Study|Withdrawal by Subject|28
2017982|NCT00289978|3585390|FG000|Overall Study|Adverse Event|22
2017983|NCT00289978|3585391|FG001|Overall Study|Adverse Event|13
2017984|NCT00289978|3585392|FG002|Overall Study|Adverse Event|18
2017985|NCT00289978|3585390|FG000|Overall Study|Lack of Efficacy|13
2017986|NCT00289978|3585391|FG001|Overall Study|Lack of Efficacy|6
2017987|NCT00289978|3585392|FG002|Overall Study|Lack of Efficacy|25
2017988|NCT00289978|3585390|FG000|Overall Study|Abnormal laboratory value(s)|20
2017989|NCT00289978|3585391|FG001|Overall Study|Abnormal laboratory value(s)|9
2017990|NCT00289978|3585392|FG002|Overall Study|Abnormal laboratory value(s)|1
2017991|NCT00289978|3585390|FG000|Overall Study|Lost to Follow-up|3
2017992|NCT00289978|3585391|FG001|Overall Study|Lost to Follow-up|5
2017993|NCT00289978|3585392|FG002|Overall Study|Lost to Follow-up|7
2017994|NCT00289978|3585390|FG000|Overall Study|Protocol Violation|5
2017995|NCT00289978|3585391|FG001|Overall Study|Protocol Violation|5
2017996|NCT00289978|3585392|FG002|Overall Study|Protocol Violation|4
2017997|NCT00289978|3585390|FG000|Overall Study|Abnormal test procedure result(s)|2
2017998|NCT00289978|3585391|FG001|Overall Study|Abnormal test procedure result(s)|1
2017999|NCT00289978|3585392|FG002|Overall Study|Abnormal test procedure result(s)|1
2018000|NCT00289978|3585390|FG000|Overall Study|Death|1
2018001|NCT00289978|3585391|FG001|Overall Study|Death|0
2018002|NCT00289978|3585392|FG002|Overall Study|Death|2
2018003|NCT00289991|3585402|FG000|Overall Study|Death|35
2018004|NCT00289991|3585403|FG001|Overall Study|Death|38
2018005|NCT00289991|3585402|FG000|Overall Study|Adverse Event|15
2018006|NCT00289991|3585403|FG001|Overall Study|Adverse Event|13
2018007|NCT00289991|3585402|FG000|Overall Study|Failure of prophylaxis|1
2018008|NCT00289991|3585403|FG001|Overall Study|Failure of prophylaxis|1
2018009|NCT00289991|3585402|FG000|Overall Study|Fungal breakthrough infection|0
2018010|NCT00289991|3585403|FG001|Overall Study|Fungal breakthrough infection|1
2018011|NCT00289991|3585402|FG000|Overall Study|Lost to Follow-up|0
2018012|NCT00289991|3585403|FG001|Overall Study|Lost to Follow-up|1
2018013|NCT00289991|3585402|FG000|Overall Study|Withdrawal by Subject|2
2018014|NCT00289991|3585403|FG001|Overall Study|Withdrawal by Subject|12
2018015|NCT00289991|3585402|FG000|Overall Study|Other|5
2018016|NCT00289991|3585403|FG001|Overall Study|Other|14
2018017|NCT00290186|3585420|FG000|Overall Study|Adverse Event|1
2018018|NCT00290186|3585421|FG001|Overall Study|Adverse Event|1
2018019|NCT00290186|3585420|FG000|Overall Study|Lost to Follow-up|3
2018020|NCT00290186|3585421|FG001|Overall Study|Lost to Follow-up|2
2018021|NCT00290186|3585420|FG000|Overall Study|Study was terminated prior to 3-month te|1
2018022|NCT00290186|3585421|FG001|Overall Study|Study was terminated prior to 3-month te|1
2018023|NCT00290186|3585420|FG000|Overall Study|Withdrawal by Subject|0
2018024|NCT00290186|3585421|FG001|Overall Study|Withdrawal by Subject|1
2018025|NCT00290238|3585442|FG000|Overall Study|Study terminated|27
2018026|NCT00290238|3585443|FG001|Overall Study|Study terminated|27
2018027|NCT00290238|3585442|FG000|Overall Study|Lost to Follow-up|0
2018028|NCT00290238|3585443|FG001|Overall Study|Lost to Follow-up|1
2018029|NCT00290238|3585442|FG000|Overall Study|Withdrawal by Subject|15
2018030|NCT00290238|3585443|FG001|Overall Study|Withdrawal by Subject|13
2018031|NCT00290251|3585449|FG000|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
2018032|NCT00290251|3585450|FG001|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
2018033|NCT00290251|3585451|FG002|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
2018034|NCT00290251|3585449|FG000|Treatment 1 (Months 1 - 3)|headache|0
2018035|NCT00290251|3585450|FG001|Treatment 1 (Months 1 - 3)|headache|1
2018036|NCT00290251|3585451|FG002|Treatment 1 (Months 1 - 3)|headache|0
2018037|NCT00290251|3585449|FG000|Treatment 1 (Months 1 - 3)|Out of body experience|1
2018038|NCT00290251|3585450|FG001|Treatment 1 (Months 1 - 3)|Out of body experience|0
2018039|NCT00290251|3585451|FG002|Treatment 1 (Months 1 - 3)|Out of body experience|0
2018040|NCT00290251|3585449|FG000|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
2018041|NCT00290251|3585450|FG001|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
2018042|NCT00290251|3585451|FG002|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
2018043|NCT00290290|3585463|FG000|Overall Study|Death|3
2018044|NCT00290290|3585464|FG001|Overall Study|Death|4
2018045|NCT00290290|3585463|FG000|Overall Study|Withdrawal by Subject|2
2018046|NCT00290290|3585464|FG001|Overall Study|Withdrawal by Subject|2
2018047|NCT00290290|3585463|FG000|Overall Study|Underwent clean surgical procedure|13
2018048|NCT00290290|3585464|FG001|Overall Study|Underwent clean surgical procedure|12
2018049|NCT00290342|3585487|FG000|Overall Study|Other|0
2018050|NCT00290342|3585488|FG001|Overall Study|Other|1
2018051|NCT00290342|3585487|FG000|Overall Study|Withdrawal by Subject|6
2018052|NCT00290342|3585488|FG001|Overall Study|Withdrawal by Subject|4
2018053|NCT00290342|3585487|FG000|Overall Study|Lost to Follow-up|1
2018054|NCT00290342|3585488|FG001|Overall Study|Lost to Follow-up|0
2018055|NCT00290355|3585496|FG000|Overall Study|Serious adverse event|7
2018056|NCT00290355|3585497|FG001|Overall Study|Serious adverse event|4
2018057|NCT00290355|3585496|FG000|Overall Study|Study product reactogenicity|1
2018058|NCT00290355|3585497|FG001|Overall Study|Study product reactogenicity|0
2018059|NCT00290355|3585496|FG000|Overall Study|Protocol Violation|1
2018060|NCT00290355|3585497|FG001|Overall Study|Protocol Violation|0
2018061|NCT00290355|3585496|FG000|Overall Study|Withdrawal by Subject|2
2018062|NCT00290355|3585497|FG001|Overall Study|Withdrawal by Subject|0
2018063|NCT00290355|3585496|FG000|Overall Study|Migrated / moved from the study area|1
2018064|NCT00290355|3585497|FG001|Overall Study|Migrated / moved from the study area|0
2018065|NCT00290355|3585496|FG000|Overall Study|Lost to Follow-up|3
2018066|NCT00290355|3585497|FG001|Overall Study|Lost to Follow-up|1
2018067|NCT00290355|3585496|FG000|Overall Study|Other|2
2018068|NCT00290355|3585497|FG001|Overall Study|Other|0
2018069|NCT00290433|3585503|FG000|Overall Study|Disease Progression|13
2018070|NCT00290433|3585503|FG000|Overall Study|Adverse Event|14
2018071|NCT00290433|3585503|FG000|Overall Study|Withdrawal by Subject|1
2018072|NCT00290433|3585503|FG000|Overall Study|Non-Compliance|1
2018073|NCT00290433|3585503|FG000|Overall Study|Congestive Heart Failure|1
2018074|NCT00290433|3585503|FG000|Overall Study|Transplant in CR|5
2018075|NCT00290433|3585503|FG000|Overall Study|Unrelated Infection/Death|1
2018076|NCT00290498|3585520|FG000|Overall Study|Death|2
2018077|NCT00290498|3585521|FG001|Overall Study|Death|0
2018078|NCT00290498|3585520|FG000|Overall Study|Physician Decision|1
2018079|NCT00290498|3585521|FG001|Overall Study|Physician Decision|0
2018080|NCT00290498|3585520|FG000|Overall Study|Withdrawal by Subject|1
2018081|NCT00290498|3585521|FG001|Overall Study|Withdrawal by Subject|0
2018082|NCT00290498|3585520|FG000|Overall Study|Ineligible|3
2018083|NCT00290498|3585521|FG001|Overall Study|Ineligible|0
2018084|NCT00290498|3585520|FG000|Overall Study|Non-Compliance|1
2018085|NCT00290498|3585521|FG001|Overall Study|Non-Compliance|0
2018086|NCT00290589|3585536|FG000|Overall Study|Lost to Follow-up|2
2018087|NCT00290589|3585537|FG001|Overall Study|Lost to Follow-up|2
2018088|NCT00290693|3585551|FG000|Overall Study|Withdrawal by Subject|2
2018089|NCT00290706|3585560|FG000|Overall Study|Withdrawal by Subject|2
2018090|NCT00290706|3585561|FG001|Overall Study|Withdrawal by Subject|0
2018091|NCT00290706|3585562|FG002|Overall Study|Withdrawal by Subject|0
2018092|NCT00290706|3585563|FG003|Overall Study|Withdrawal by Subject|0
2018093|NCT00290706|3585560|FG000|Overall Study|Progressive Disease|3
2018094|NCT00290706|3585561|FG001|Overall Study|Progressive Disease|5
2018095|NCT00290706|3585562|FG002|Overall Study|Progressive Disease|4
2018096|NCT00290706|3585563|FG003|Overall Study|Progressive Disease|10
2018097|NCT00290706|3585560|FG000|Overall Study|Adverse Event|0
2018098|NCT00290706|3585561|FG001|Overall Study|Adverse Event|1
2018099|NCT00290706|3585562|FG002|Overall Study|Adverse Event|2
2018100|NCT00290706|3585563|FG003|Overall Study|Adverse Event|0
2018101|NCT00290706|3585560|FG000|Overall Study|Receive auto transplant or radiation|0
2018102|NCT00290706|3585561|FG001|Overall Study|Receive auto transplant or radiation|0
2018103|NCT00290706|3585562|FG002|Overall Study|Receive auto transplant or radiation|0
2018104|NCT00290706|3585563|FG003|Overall Study|Receive auto transplant or radiation|1
2018105|NCT00290706|3585560|FG000|Overall Study|Physician Decision|0
2018106|NCT00290706|3585561|FG001|Overall Study|Physician Decision|0
2018107|NCT00290706|3585562|FG002|Overall Study|Physician Decision|0
2018108|NCT00290706|3585563|FG003|Overall Study|Physician Decision|1
2018109|NCT00290732|3585576|FG000|Overall Study|Inability to instill drug intraductally.|0
2018110|NCT00290732|3585577|FG001|Overall Study|Inability to instill drug intraductally.|1
2313402|NCT02788747|4020824|FG002|Overall Study|Adverse Event|0
2321994|NCT02966353|4036678|FG000|Overall Study|Adverse Event|4
2321995|NCT02966353|4036678|FG000|Overall Study|Death|4
2321996|NCT02966353|4036678|FG000|Overall Study|Physician Decision|3
2321997|NCT02966353|4036678|FG000|Overall Study|Progressive disease|2
2321998|NCT02966353|4036678|FG000|Overall Study|Protocol deviation|2
2321999|NCT02966509|4036684|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2
2322000|NCT02966509|4036685|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3
2322001|NCT02966509|4036684|FG000|Baseline Satisfaction Survey|Death|0
2322002|NCT02966509|4036685|FG001|Baseline Satisfaction Survey|Death|1
2322003|NCT02966509|4036684|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1
2322004|NCT02966509|4036685|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1
2322005|NCT02966509|4036684|FG000|Baseline Satisfaction Survey|Refused to Answer|1
2322006|NCT02966509|4036685|FG001|Baseline Satisfaction Survey|Refused to Answer|2
2322007|NCT02966509|4036684|FG000|6 Month Satisfaction Decision Survey|Death|22
2322008|NCT02966509|4036685|FG001|6 Month Satisfaction Decision Survey|Death|25
2018111|NCT00290732|3585578|FG002|Overall Study|Inability to instill drug intraductally.|1
2018112|NCT00290732|3585579|FG003|Overall Study|Inability to instill drug intraductally.|0
2018113|NCT00290732|3585580|FG004|Overall Study|Inability to instill drug intraductally.|0
2018114|NCT00290745|3585593|FG000|Overall Study|Withdrawal by Subject|4
2018115|NCT00290745|3585593|FG000|Overall Study|Physician Decision|2
2018116|NCT00290745|3585593|FG000|Overall Study|Surgery after 3 months for progression|3
2018117|NCT00290745|3585593|FG000|Overall Study|Baseline MRI not available|3
2018118|NCT00290771|3585599|FG000|Overall Study|Disease progression|95
2018119|NCT00290771|3585600|FG001|Overall Study|Disease progression|73
2018120|NCT00290771|3585599|FG000|Overall Study|Death|11
2018121|NCT00290771|3585600|FG001|Overall Study|Death|10
2018122|NCT00290771|3585599|FG000|Overall Study|Adverse Event|12
2018123|NCT00290771|3585600|FG001|Overall Study|Adverse Event|6
2018124|NCT00290771|3585599|FG000|Overall Study|Withdrawal by Subject|5
2018125|NCT00290771|3585600|FG001|Overall Study|Withdrawal by Subject|6
2018126|NCT00290771|3585599|FG000|Overall Study|Administrative problems|2
2018127|NCT00290771|3585600|FG001|Overall Study|Administrative problems|1
2018128|NCT00290771|3585599|FG000|Overall Study|Protocol Violation|2
2018129|NCT00290771|3585600|FG001|Overall Study|Protocol Violation|0
2018130|NCT00290771|3585599|FG000|Overall Study|Lost to Follow-up|0
2018131|NCT00290771|3585600|FG001|Overall Study|Lost to Follow-up|1
2018132|NCT00290888|3585613|FG000|Overall Study|Physician Decision|3
2018133|NCT00290888|3585614|FG001|Overall Study|Physician Decision|1
2018134|NCT00291018|3585624|FG000|Overall Study|Not Consented or Declined PAS|12
2018135|NCT00291018|3585625|FG001|Overall Study|Not Consented or Declined PAS|15
2018136|NCT00291018|3585626|FG002|Overall Study|Not Consented or Declined PAS|15
2018137|NCT00291018|3585624|FG000|Overall Study|Death|3
2018138|NCT00291018|3585625|FG001|Overall Study|Death|3
2018139|NCT00291018|3585626|FG002|Overall Study|Death|4
2018140|NCT00291018|3585624|FG000|Overall Study|Withdrawal by Subject|2
2018141|NCT00291018|3585625|FG001|Overall Study|Withdrawal by Subject|8
2018142|NCT00291018|3585626|FG002|Overall Study|Withdrawal by Subject|1
2018143|NCT00291018|3585624|FG000|Overall Study|Failures|5
2018144|NCT00291018|3585625|FG001|Overall Study|Failures|12
2018145|NCT00291018|3585626|FG002|Overall Study|Failures|5
2018146|NCT00291018|3585624|FG000|Overall Study|Lost to Follow-up|3
2018147|NCT00291018|3585625|FG001|Overall Study|Lost to Follow-up|4
2018148|NCT00291018|3585626|FG002|Overall Study|Lost to Follow-up|18
2018149|NCT00291187|3585660|FG000|Overall Study|Protocol Violation- No Drug Administered|0
2018150|NCT00291187|3585661|FG001|Overall Study|Protocol Violation- No Drug Administered|0
2018151|NCT00291187|3585662|FG002|Overall Study|Protocol Violation- No Drug Administered|1
2018152|NCT00291187|3585663|FG003|Overall Study|Protocol Violation- No Drug Administered|0
2018153|NCT00291330|3585693|FG000|Overall Study|Adverse Event|47
2018154|NCT00291330|3585694|FG001|Overall Study|Adverse Event|40
2018155|NCT00291330|3585693|FG000|Overall Study|Protocol Violation|13
2018156|NCT00291330|3585694|FG001|Overall Study|Protocol Violation|20
2018157|NCT00291330|3585693|FG000|Overall Study|Lost to Follow-up|16
2018158|NCT00291330|3585694|FG001|Overall Study|Lost to Follow-up|11
2018159|NCT00291330|3585693|FG000|Overall Study|Withdrawal by Subject|22
2018160|NCT00291330|3585694|FG001|Overall Study|Withdrawal by Subject|25
2018161|NCT00291330|3585693|FG000|Overall Study|Other|3
2018162|NCT00291330|3585694|FG001|Overall Study|Other|1
2018163|NCT00291499|3585729|FG000|Overall Study|Adverse Event|3
2018164|NCT00291499|3585730|FG001|Overall Study|Adverse Event|8
2018165|NCT00291499|3585729|FG000|Overall Study|Change to other therapy|2
2018166|NCT00291499|3585730|FG001|Overall Study|Change to other therapy|1
2018167|NCT00291499|3585729|FG000|Overall Study|Intercurrent illness|1
2018168|NCT00291499|3585730|FG001|Overall Study|Intercurrent illness|0
2018169|NCT00291499|3585729|FG000|Overall Study|Protocol Violation|2
2018170|NCT00291499|3585730|FG001|Overall Study|Protocol Violation|2
2018171|NCT00291499|3585729|FG000|Overall Study|Other reasons|1
2018172|NCT00291499|3585730|FG001|Overall Study|Other reasons|4
2018173|NCT00291551|3585736|FG000|Overall Study|Death|7
2018174|NCT00291551|3585736|FG000|Overall Study|Withdrawal by Subject|6
2018175|NCT00291577|3585741|FG000|Overall Study|Adverse Event|1
2018176|NCT00291577|3585741|FG000|Overall Study|Other|4
2018177|NCT00291577|3585741|FG000|Overall Study|Withdrawal by Subject|2
2018178|NCT00291577|3585741|FG000|Overall Study|Lack of Efficacy|14
2018179|NCT00291642|3585750|FG000|Overall Study|Adverse Event|1
2018180|NCT00291642|3585751|FG001|Overall Study|Adverse Event|0
2018181|NCT00291642|3585752|FG002|Overall Study|Adverse Event|1
2018182|NCT00291642|3585753|FG003|Overall Study|Adverse Event|0
2018183|NCT00291642|3585754|FG004|Overall Study|Adverse Event|1
2018184|NCT00291642|3585750|FG000|Overall Study|Patient missed visit|0
2018185|NCT00291642|3585751|FG001|Overall Study|Patient missed visit|0
2018186|NCT00291642|3585752|FG002|Overall Study|Patient missed visit|1
2018187|NCT00291642|3585753|FG003|Overall Study|Patient missed visit|0
2018188|NCT00291642|3585754|FG004|Overall Study|Patient missed visit|0
2018189|NCT00291642|3585750|FG000|Overall Study|Intake of prohibited medication|1
2018190|NCT00291642|3585751|FG001|Overall Study|Intake of prohibited medication|0
2018191|NCT00291642|3585752|FG002|Overall Study|Intake of prohibited medication|0
2018192|NCT00291642|3585753|FG003|Overall Study|Intake of prohibited medication|0
2018193|NCT00291642|3585754|FG004|Overall Study|Intake of prohibited medication|0
2018194|NCT00291668|3585773|FG000|Overall Study|Lack of Efficacy|1
2018195|NCT00291668|3585774|FG001|Overall Study|Lack of Efficacy|0
2018196|NCT00291668|3585775|FG002|Overall Study|Lack of Efficacy|0
2018197|NCT00291668|3585773|FG000|Overall Study|SAE, non-fatal|1
2018198|NCT00291668|3585774|FG001|Overall Study|SAE, non-fatal|1
2018199|NCT00291668|3585775|FG002|Overall Study|SAE, non-fatal|1
2018200|NCT00291668|3585773|FG000|Overall Study|AE, non-serious non-fatal|1
2018201|NCT00291668|3585774|FG001|Overall Study|AE, non-serious non-fatal|0
2018202|NCT00291668|3585775|FG002|Overall Study|AE, non-serious non-fatal|0
2018203|NCT00291668|3585773|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2018204|NCT00291668|3585774|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2018205|NCT00291668|3585775|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2018206|NCT00292045|3585798|FG000|Core Study (Through Week 13)|Adverse Event|1
2018207|NCT00292045|3585798|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1
2018208|NCT00292188|3585813|FG000|Single-Blind|Adverse Event|14
2018209|NCT00292188|3585814|FG001|Single-Blind|Adverse Event|0
2018210|NCT00292188|3585815|FG002|Single-Blind|Adverse Event|0
2018211|NCT00292188|3585813|FG000|Single-Blind|Lack of Efficacy|2
2018212|NCT00292188|3585814|FG001|Single-Blind|Lack of Efficacy|0
2018213|NCT00292188|3585815|FG002|Single-Blind|Lack of Efficacy|0
2018214|NCT00292188|3585813|FG000|Single-Blind|Laboratory Abnormality|5
2018215|NCT00292188|3585814|FG001|Single-Blind|Laboratory Abnormality|0
2018216|NCT00292188|3585815|FG002|Single-Blind|Laboratory Abnormality|0
2018217|NCT00292188|3585813|FG000|Single-Blind|Lost to Follow-up|3
2018218|NCT00292188|3585814|FG001|Single-Blind|Lost to Follow-up|0
2018219|NCT00292188|3585815|FG002|Single-Blind|Lost to Follow-up|0
2018220|NCT00292188|3585813|FG000|Single-Blind|Other|77
2018221|NCT00292188|3585814|FG001|Single-Blind|Other|0
2018222|NCT00292188|3585815|FG002|Single-Blind|Other|0
2018223|NCT00292188|3585813|FG000|Single-Blind|Withdrawal by Subject|12
2018224|NCT00292188|3585814|FG001|Single-Blind|Withdrawal by Subject|0
2018225|NCT00292188|3585815|FG002|Single-Blind|Withdrawal by Subject|0
2018226|NCT00292188|3585813|FG000|Single-Blind|Did not receive treatment|1
2018227|NCT00292188|3585814|FG001|Single-Blind|Did not receive treatment|0
2018228|NCT00292188|3585815|FG002|Single-Blind|Did not receive treatment|0
2018229|NCT00292188|3585813|FG000|Double-Blind|Adverse Event|0
2018230|NCT00292188|3585814|FG001|Double-Blind|Adverse Event|25
2018231|NCT00292188|3585815|FG002|Double-Blind|Adverse Event|9
2018232|NCT00292188|3585813|FG000|Double-Blind|Lack of Efficacy|0
2018233|NCT00292188|3585814|FG001|Double-Blind|Lack of Efficacy|2
2018234|NCT00292188|3585815|FG002|Double-Blind|Lack of Efficacy|12
2018235|NCT00292188|3585813|FG000|Double-Blind|Lost to Follow-up|0
2018236|NCT00292188|3585814|FG001|Double-Blind|Lost to Follow-up|1
2018237|NCT00292188|3585815|FG002|Double-Blind|Lost to Follow-up|0
2018238|NCT00292188|3585813|FG000|Double-Blind|Other|0
2018239|NCT00292188|3585814|FG001|Double-Blind|Other|3
2018240|NCT00292188|3585815|FG002|Double-Blind|Other|4
2018241|NCT00292188|3585813|FG000|Double-Blind|Withdrawal by Subject|0
2018242|NCT00292188|3585814|FG001|Double-Blind|Withdrawal by Subject|0
2018243|NCT00292188|3585815|FG002|Double-Blind|Withdrawal by Subject|3
2018244|NCT00292188|3585813|FG000|Double-Blind|Laboratory Abnormality|0
2018245|NCT00292188|3585814|FG001|Double-Blind|Laboratory Abnormality|0
2018246|NCT00292188|3585815|FG002|Double-Blind|Laboratory Abnormality|1
2018247|NCT00292227|3585824|FG000|Patch Period|Adverse Event|1
2018248|NCT00292227|3585825|FG001|Patch Period|Adverse Event|0
2018249|NCT00292227|3585826|FG002|Patch Period|Adverse Event|2
2018250|NCT00292227|3585824|FG000|Patch Period|Withdrawal by Subject|0
2018251|NCT00292227|3585825|FG001|Patch Period|Withdrawal by Subject|0
2018252|NCT00292227|3585826|FG002|Patch Period|Withdrawal by Subject|1
2018253|NCT00292318|3585836|FG000|Overall Study|Study terminated by officials|2
2018254|NCT00292318|3585837|FG001|Overall Study|Study terminated by officials|1
2018255|NCT00292370|3585846|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
2018256|NCT00292370|3585847|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
2018257|NCT00292370|3585848|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
2018258|NCT00292370|3585846|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
2018259|NCT00292370|3585847|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
2018260|NCT00292370|3585848|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
2018261|NCT00292370|3585846|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
2018262|NCT00292370|3585847|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
2018263|NCT00292370|3585848|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
2018264|NCT00292370|3585846|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
2018265|NCT00292370|3585847|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
2018266|NCT00292370|3585848|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
2018267|NCT00292370|3585846|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
2018268|NCT00292370|3585847|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
2018269|NCT00292370|3585848|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
2018270|NCT00292370|3585846|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
2018271|NCT00292370|3585847|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
2018272|NCT00292370|3585848|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
2018273|NCT00292461|3585857|FG000|Overall Study|Adverse Event|4
2018274|NCT00292461|3585858|FG001|Overall Study|Adverse Event|2
2018275|NCT00292461|3585857|FG000|Overall Study|Lack of Efficacy|1
2018276|NCT00292461|3585858|FG001|Overall Study|Lack of Efficacy|0
2018277|NCT00292461|3585857|FG000|Overall Study|Withdrawal by Subject|0
2018278|NCT00292461|3585858|FG001|Overall Study|Withdrawal by Subject|1
2018279|NCT00292461|3585857|FG000|Overall Study|Protocol Violation|4
2018280|NCT00292461|3585858|FG001|Overall Study|Protocol Violation|3
2018281|NCT00292461|3585857|FG000|Overall Study|Lost to Follow-up|1
2018282|NCT00292461|3585858|FG001|Overall Study|Lost to Follow-up|0
2018283|NCT00292942|3585881|FG000|Overall Study|Withdrawal by Subject|0
2018284|NCT00292942|3585882|FG001|Overall Study|Withdrawal by Subject|0
2018285|NCT00292942|3585883|FG002|Overall Study|Withdrawal by Subject|1
2018286|NCT00292942|3585884|FG003|Overall Study|Withdrawal by Subject|0
2018287|NCT00292942|3585881|FG000|Overall Study|Adverse Event|0
2018288|NCT00292942|3585882|FG001|Overall Study|Adverse Event|0
2018289|NCT00292942|3585883|FG002|Overall Study|Adverse Event|0
2018290|NCT00292942|3585884|FG003|Overall Study|Adverse Event|1
2018291|NCT00292981|3585897|FG000|Overall Study|Adverse Event|1
2018292|NCT00292981|3585897|FG000|Overall Study|Lost to Follow-up|13
2018293|NCT00292981|3585897|FG000|Overall Study|Withdrawal by Subject|22
2018294|NCT00292981|3585897|FG000|Overall Study|Other|3
2018295|NCT00293020|3585901|FG000|Overall Study|Withdrawal by Subject|34
2018296|NCT00293020|3585901|FG000|Overall Study|Adverse Event|30
2018297|NCT00293020|3585901|FG000|Overall Study|Death|32
2018298|NCT00293020|3585901|FG000|Overall Study|Lack of Efficacy|12
2018299|NCT00293020|3585901|FG000|Overall Study|Lost to Follow-up|4
2018300|NCT00293020|3585901|FG000|Overall Study|Protocol Violation|6
2018301|NCT00293020|3585901|FG000|Overall Study|Physician Decision|21
2018302|NCT00293020|3585901|FG000|Overall Study|Other Reason|22
2018303|NCT00293020|3585901|FG000|Overall Study|No dose taken|1
2018304|NCT00293033|3585905|FG000|Open-label Titration Period|Adverse Event|10
2018305|NCT00293033|3585905|FG000|Open-label Titration Period|Death|3
2018306|NCT00293033|3585905|FG000|Open-label Titration Period|Lack of Efficacy|5
2018307|NCT00293033|3585905|FG000|Open-label Titration Period|Protocol Violation|2
2018308|NCT00293033|3585905|FG000|Open-label Titration Period|Withdrawal by Subject|22
2018309|NCT00293033|3585905|FG000|Open-label Titration Period|Noncompliance and other|27
2018310|NCT00293033|3585905|FG000|Double-blind Treatment Period|Adverse Event|3
2018311|NCT00293033|3585905|FG000|Double-blind Treatment Period|Lack of Efficacy|1
2018312|NCT00293033|3585905|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
2018313|NCT00293033|3585905|FG000|Double-blind Treatment Period|Noncompliance|4
2018314|NCT00293059|3585915|FG000|Overall Study|Adverse Event|12
2018315|NCT00293059|3585916|FG001|Overall Study|Adverse Event|4
2018316|NCT00293059|3585915|FG000|Overall Study|Lack of Efficacy|2
2018317|NCT00293059|3585916|FG001|Overall Study|Lack of Efficacy|0
2018318|NCT00293059|3585915|FG000|Overall Study|Lost to Follow-up|2
2018319|NCT00293059|3585916|FG001|Overall Study|Lost to Follow-up|3
2018320|NCT00293059|3585915|FG000|Overall Study|Pregnancy|1
2018321|NCT00293059|3585916|FG001|Overall Study|Pregnancy|1
2018322|NCT00293059|3585915|FG000|Overall Study|Protocol Violation|2
2018323|NCT00293059|3585916|FG001|Overall Study|Protocol Violation|0
2018324|NCT00293059|3585915|FG000|Overall Study|Withdrawal by Subject|11
2018325|NCT00293059|3585916|FG001|Overall Study|Withdrawal by Subject|5
2018326|NCT00293059|3585915|FG000|Overall Study|Participant moved out of state|1
2018327|NCT00293059|3585916|FG001|Overall Study|Participant moved out of state|0
2018328|NCT00293059|3585915|FG000|Overall Study|Participant stopped study drug|1
2018329|NCT00293059|3585916|FG001|Overall Study|Participant stopped study drug|0
2018330|NCT00293059|3585915|FG000|Overall Study|Noncompliant - sanitary pads collection|0
2018331|NCT00293059|3585916|FG001|Overall Study|Noncompliant - sanitary pads collection|1
2018332|NCT00293059|3585915|FG000|Overall Study|missing|3
2018333|NCT00293059|3585916|FG001|Overall Study|missing|5
2018334|NCT00293202|3585924|FG000|Overall Study|Withdrawal by Subject|1
2018335|NCT00293202|3585925|FG001|Overall Study|Withdrawal by Subject|2
2018336|NCT00293202|3585924|FG000|Overall Study|positive ANA (antinuclear antibody)|1
2018337|NCT00293202|3585925|FG001|Overall Study|positive ANA (antinuclear antibody)|0
2018338|NCT00293202|3585924|FG000|Overall Study|on-hold due to fistula maturation time|1
2018339|NCT00293202|3585925|FG001|Overall Study|on-hold due to fistula maturation time|0
2313403|NCT02789111|4020865|FG000|Overall Study|Withdrawal by Subject|1
2313404|NCT02789111|4020866|FG001|Overall Study|Withdrawal by Subject|4
2313405|NCT02789137|4020874|FG000|Overall Study|Dropped out/Died|58
2358386|NCT01915498|4118881|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
2358387|NCT01915498|4118882|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
2358388|NCT01915498|4118883|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
2358389|NCT01915498|4118884|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
2358390|NCT01915498|4118885|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
2358391|NCT01915498|4118886|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6
2018340|NCT00293215|3585937|FG000|Overall Study|Progressive disease|3
2018341|NCT00293215|3585938|FG001|Overall Study|Progressive disease|1
2018342|NCT00293215|3585937|FG000|Overall Study|Adverse Event|2
2018343|NCT00293215|3585938|FG001|Overall Study|Adverse Event|2
2018344|NCT00293241|3585946|FG000|Overall Study|Lost to Follow-up|9
2018345|NCT00293241|3585947|FG001|Overall Study|Lost to Follow-up|16
2018346|NCT00293241|3585946|FG000|Overall Study|Physician Decision|23
2018347|NCT00293241|3585947|FG001|Overall Study|Physician Decision|17
2018348|NCT00293241|3585946|FG000|Overall Study|Withdrawal by Subject|4
2018349|NCT00293241|3585947|FG001|Overall Study|Withdrawal by Subject|8
2018350|NCT00293254|3585958|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
2313406|NCT02789176|4020883|FG000|Overall Study|Death|0
2313407|NCT02789176|4020884|FG001|Overall Study|Death|0
2313408|NCT02789176|4020885|FG002|Overall Study|Death|3
2313409|NCT02789176|4020886|FG003|Overall Study|Death|0
2313410|NCT02789176|4020883|FG000|Overall Study|Withdrawal by Subject|0
2313411|NCT02789176|4020884|FG001|Overall Study|Withdrawal by Subject|0
2313412|NCT02789176|4020885|FG002|Overall Study|Withdrawal by Subject|1
2018351|NCT00293254|3585959|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
2018352|NCT00293254|3585958|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2
2018353|NCT00293254|3585959|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
2018354|NCT00293254|3585958|FG000|Primary Study - Double-Blind Week 0-48|Death|5
2018355|NCT00293254|3585959|FG001|Primary Study - Double-Blind Week 0-48|Death|2
2018356|NCT00293254|3585958|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
2018357|NCT00293254|3585959|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
2018358|NCT00293254|3585958|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
2018359|NCT00293254|3585959|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
2018360|NCT00293254|3585958|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
2018361|NCT00293254|3585959|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
2018362|NCT00293254|3585958|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
2018363|NCT00293254|3585959|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
2018364|NCT00293254|3585958|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
2018365|NCT00293254|3585959|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
2018366|NCT00293254|3585958|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4
2018367|NCT00293254|3585959|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1
2018368|NCT00293254|3585958|FG000|Extension - Double-Blind Week 49-156|Death|4
2018369|NCT00293254|3585959|FG001|Extension - Double-Blind Week 49-156|Death|1
2018370|NCT00293254|3585958|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
2018371|NCT00293254|3585959|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
2018372|NCT00293254|3585958|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
2018373|NCT00293254|3585959|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
2018374|NCT00293254|3585958|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
2018375|NCT00293254|3585959|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
2018376|NCT00293254|3585958|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
2018377|NCT00293254|3585959|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
2018378|NCT00293254|3585958|FG000|Extension - Double-Blind Week 49-156|Other Reason|10
2313413|NCT02789176|4020886|FG003|Overall Study|Withdrawal by Subject|0
2313414|NCT02789176|4020883|FG000|Overall Study|Lost to Follow-up|8
2313415|NCT02789176|4020884|FG001|Overall Study|Lost to Follow-up|2
2313416|NCT02789176|4020885|FG002|Overall Study|Lost to Follow-up|6
2018379|NCT00293254|3585959|FG001|Extension - Double-Blind Week 49-156|Other Reason|2
2018380|NCT00293254|3585958|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
2018381|NCT00293254|3585959|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
2018382|NCT00293254|3585958|FG000|Extension - Open-Label Week 157-240|Adverse Event|2
2018383|NCT00293254|3585959|FG001|Extension - Open-Label Week 157-240|Adverse Event|1
2018384|NCT00293254|3585958|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1
2018385|NCT00293254|3585959|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
2018386|NCT00293254|3585958|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
2018387|NCT00293254|3585959|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
2018388|NCT00293254|3585958|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2
2018389|NCT00293254|3585959|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
2018390|NCT00293254|3585958|FG000|Extension - Open-Label Week 157-240|Other Reason|4
2102437|NCT00838903|3694189|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
2214667|NCT01689519|3857268|FG001|Intent to Treat|Withdrawal by Subject|20
2214668|NCT01689519|3857267|FG000|Safety Population|Death|158
2214669|NCT01689519|3857268|FG001|Safety Population|Death|165
2214670|NCT01689519|3857267|FG000|Safety Population|Lost to Follow-up|4
2214671|NCT01689519|3857268|FG001|Safety Population|Lost to Follow-up|8
2214672|NCT01689519|3857267|FG000|Safety Population|Other|2
2214673|NCT01689519|3857268|FG001|Safety Population|Other|4
2214674|NCT01689519|3857267|FG000|Safety Population|Physician Decision|4
2214675|NCT01689519|3857268|FG001|Safety Population|Physician Decision|1
2214676|NCT01689519|3857267|FG000|Safety Population|Study Terminated By Sponsor|60
2214677|NCT01689519|3857268|FG001|Safety Population|Study Terminated By Sponsor|47
2313417|NCT02789176|4020886|FG003|Overall Study|Lost to Follow-up|1
2313418|NCT02790073|4020905|FG000|Overall Study|Death|1
2313419|NCT02790073|4020905|FG000|Overall Study|Withdrawal from HD|1
2313420|NCT02790073|4020905|FG000|Overall Study|Withdrawal by Subject|1
2313421|NCT02790437|4020915|FG000|Overall Study|Patient graft failure - nephrectomy|1
2313422|NCT02790437|4020916|FG001|Overall Study|Patient graft failure - nephrectomy|0
2313423|NCT02790437|4020915|FG000|Overall Study|Adverse Event|1
2313424|NCT02790437|4020916|FG001|Overall Study|Adverse Event|0
2313425|NCT02790437|4020915|FG000|Overall Study|Withdrawal by Subject|1
2018391|NCT00293254|3585959|FG001|Extension - Open-Label Week 157-240|Other Reason|0
2018392|NCT00293254|3585958|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4
2214678|NCT01689519|3857267|FG000|Safety Population|Withdrawal by Subject|20
2214679|NCT01689519|3857268|FG001|Safety Population|Withdrawal by Subject|20
2214680|NCT01689532|3857276|FG000|Overall Study|Adverse Event|9
2214681|NCT01689532|3857277|FG001|Overall Study|Adverse Event|5
2214682|NCT01689532|3857276|FG000|Overall Study|Lack of Efficacy|2
2214683|NCT01689532|3857277|FG001|Overall Study|Lack of Efficacy|2
2214684|NCT01689532|3857276|FG000|Overall Study|Withdrawal by Subject|1
2313426|NCT02790437|4020916|FG001|Overall Study|Withdrawal by Subject|0
2018393|NCT00293254|3585959|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7
2018394|NCT00293254|3585958|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
2018395|NCT00293254|3585959|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
2018396|NCT00293254|3585958|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
2018397|NCT00293254|3585959|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
2018398|NCT00293254|3585958|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
2018399|NCT00293254|3585959|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
2018400|NCT00293254|3585958|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
2018401|NCT00293254|3585959|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
2018402|NCT00293254|3585958|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1
2018403|NCT00293254|3585959|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2
2018404|NCT00293267|3585969|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
2018405|NCT00293267|3585970|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
2018406|NCT00293267|3585969|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1
2018407|NCT00293267|3585970|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
2018408|NCT00293267|3585969|FG000|Primary Study - Double-Blind Week 0-48|Death|3
2018409|NCT00293267|3585970|FG001|Primary Study - Double-Blind Week 0-48|Death|3
2018410|NCT00293267|3585969|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
2018411|NCT00293267|3585970|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
2018412|NCT00293267|3585969|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
2018413|NCT00293267|3585970|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
2018414|NCT00293267|3585969|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
2018415|NCT00293267|3585970|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
2018416|NCT00293267|3585969|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
2018417|NCT00293267|3585970|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
2018418|NCT00293267|3585969|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1
2018419|NCT00293267|3585970|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4
2018420|NCT00293267|3585969|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
2018421|NCT00293267|3585970|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
2018422|NCT00293267|3585969|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
2018423|NCT00293267|3585970|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
2018424|NCT00293267|3585969|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
2018425|NCT00293267|3585970|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
2018426|NCT00293267|3585969|FG000|Extension - Double-Blind Week 49-156|Death|3
2018427|NCT00293267|3585970|FG001|Extension - Double-Blind Week 49-156|Death|0
2018428|NCT00293267|3585969|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
2018429|NCT00293267|3585970|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
2018430|NCT00293267|3585969|FG000|Extension - Double-Blind Week 49-156|Other Reason|7
2018431|NCT00293267|3585970|FG001|Extension - Double-Blind Week 49-156|Other Reason|0
2018432|NCT00293267|3585969|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
2018433|NCT00293267|3585970|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
2018434|NCT00293267|3585969|FG000|Extension - Open-Label Week 157-240|Adverse Event|5
2018435|NCT00293267|3585970|FG001|Extension - Open-Label Week 157-240|Adverse Event|0
2018436|NCT00293267|3585969|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7
2018437|NCT00293267|3585970|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
2018438|NCT00293267|3585969|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1
2018439|NCT00293267|3585970|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
2018440|NCT00293267|3585969|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
2018441|NCT00293267|3585970|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
2018442|NCT00293267|3585969|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
2018443|NCT00293267|3585970|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
2018444|NCT00293267|3585969|FG000|Extension - Open-Label Week 157-240|Other Reason|3
2018445|NCT00293267|3585970|FG001|Extension - Open-Label Week 157-240|Other Reason|1
2018446|NCT00293267|3585969|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2
2018447|NCT00293267|3585970|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3
2018448|NCT00293267|3585969|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
2018449|NCT00293267|3585970|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
2018450|NCT00293267|3585969|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
2018451|NCT00293267|3585970|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
2018452|NCT00293267|3585969|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
2018453|NCT00293267|3585970|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
2018454|NCT00293267|3585969|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
2018455|NCT00293267|3585970|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
2018456|NCT00293267|3585969|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
2018457|NCT00293267|3585970|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
2018458|NCT00293267|3585969|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4
2018459|NCT00293267|3585970|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5
2018460|NCT00293293|3585980|FG000|Overall Study|Withdrawal by Subject|1
2018461|NCT00293293|3585981|FG001|Overall Study|Withdrawal by Subject|1
2018462|NCT00293293|3585980|FG000|Overall Study|"Patient too anxious to complete trial"|1
2018463|NCT00293293|3585981|FG001|Overall Study|"Patient too anxious to complete trial"|0
2018464|NCT00293293|3585980|FG000|Overall Study|Patient discontinued chemotherapy|0
2018465|NCT00293293|3585981|FG001|Overall Study|Patient discontinued chemotherapy|1
2018466|NCT00293384|3585988|FG000|Overall Study|Non-compliance|2
2018467|NCT00293384|3585988|FG000|Overall Study|Missed dosage/study drug|1
2018468|NCT00293384|3585988|FG000|Overall Study|Ineligible|2
2018469|NCT00293397|3585992|FG000|Overall Study|Death|2
2018470|NCT00293423|3585999|FG000|Surgical Resection|Less than a 90% extent of resection|0
2018471|NCT00293423|3586000|FG001|Surgical Resection|Less than a 90% extent of resection|1
2018472|NCT00293423|3585999|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0
2018473|NCT00293423|3586000|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4
2018474|NCT00293423|3585999|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9
2018475|NCT00293423|3586000|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13
2018476|NCT00293423|3585999|FG000|Surgical Resection|disease progression prior to initial vaccination|2
2018477|NCT00293423|3586000|FG001|Surgical Resection|disease progression prior to initial vaccination|9
2018478|NCT00293423|3585999|FG000|Surgical Resection|processing error during surgical resection|1
2018479|NCT00293423|3586000|FG001|Surgical Resection|processing error during surgical resection|0
2018480|NCT00293423|3585999|FG000|Surgical Resection|Withdrawal by Subject|4
2018481|NCT00293423|3586000|FG001|Surgical Resection|Withdrawal by Subject|0
2018482|NCT00293423|3585999|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0
2018483|NCT00293423|3586000|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3
2018484|NCT00293462|3586009|FG000|Overall Study|Withdrawal by Subject|4
2018485|NCT00293462|3586010|FG001|Overall Study|Withdrawal by Subject|3
2018486|NCT00293462|3586011|FG002|Overall Study|Withdrawal by Subject|8
2018487|NCT00293462|3586009|FG000|Overall Study|Death|1
2018488|NCT00293462|3586010|FG001|Overall Study|Death|0
2018489|NCT00293462|3586011|FG002|Overall Study|Death|0
2018490|NCT00293462|3586009|FG000|Overall Study|Lost to Follow-up|0
2018491|NCT00293462|3586010|FG001|Overall Study|Lost to Follow-up|1
2018492|NCT00293462|3586011|FG002|Overall Study|Lost to Follow-up|0
2018493|NCT00293462|3586009|FG000|Overall Study|Change Treatment Regimen (ineligible)|1
2018494|NCT00293462|3586010|FG001|Overall Study|Change Treatment Regimen (ineligible)|0
2018495|NCT00293462|3586011|FG002|Overall Study|Change Treatment Regimen (ineligible)|0
2018496|NCT00293462|3586009|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
2018497|NCT00293462|3586010|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
2018498|NCT00293462|3586011|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
2018499|NCT00293462|3586009|FG000|Overall Study|Refuse Radiation Treatment|1
2018500|NCT00293462|3586010|FG001|Overall Study|Refuse Radiation Treatment|0
2018501|NCT00293462|3586011|FG002|Overall Study|Refuse Radiation Treatment|0
2018502|NCT00293462|3586009|FG000|Overall Study|No Show|0
2018503|NCT00293462|3586010|FG001|Overall Study|No Show|0
2018504|NCT00293462|3586011|FG002|Overall Study|No Show|1
2018505|NCT00293462|3586009|FG000|Overall Study|Went back to his home country|0
2018506|NCT00293462|3586010|FG001|Overall Study|Went back to his home country|0
2018507|NCT00293462|3586011|FG002|Overall Study|Went back to his home country|1
2018508|NCT00293462|3586009|FG000|Overall Study|Blood clot after chemotherapy|0
2018509|NCT00293462|3586010|FG001|Overall Study|Blood clot after chemotherapy|0
2018510|NCT00293462|3586011|FG002|Overall Study|Blood clot after chemotherapy|1
2018511|NCT00293462|3586009|FG000|Overall Study|Ischemic stroke after chemotherapy|0
2018512|NCT00293462|3586010|FG001|Overall Study|Ischemic stroke after chemotherapy|0
2018513|NCT00293462|3586011|FG002|Overall Study|Ischemic stroke after chemotherapy|1
2018514|NCT00293462|3586009|FG000|Overall Study|Possible Tracheostomy leakage|0
2018515|NCT00293462|3586010|FG001|Overall Study|Possible Tracheostomy leakage|1
2018516|NCT00293462|3586011|FG002|Overall Study|Possible Tracheostomy leakage|0
2018517|NCT00293462|3586009|FG000|Overall Study|Low radiation dose in oral cavity|0
2018518|NCT00293462|3586010|FG001|Overall Study|Low radiation dose in oral cavity|1
2018519|NCT00293462|3586011|FG002|Overall Study|Low radiation dose in oral cavity|0
2018520|NCT00293462|3586009|FG000|Overall Study|Physician Decision|0
2018521|NCT00293462|3586010|FG001|Overall Study|Physician Decision|1
2018522|NCT00293462|3586011|FG002|Overall Study|Physician Decision|0
2018523|NCT00293579|3586028|FG000|Overall Study|Withdrawal by Subject|1
2018524|NCT00293709|3586033|FG000|Overall Study|Other|47
2018525|NCT00293722|3586037|FG000|Overall Study|Other|427
2018526|NCT00293813|3586044|FG000|Overall Study|Physician Decision|0
2018527|NCT00293813|3586045|FG001|Overall Study|Physician Decision|1
2018528|NCT00293813|3586046|FG002|Overall Study|Physician Decision|0
2018529|NCT00293813|3586044|FG000|Overall Study|Adverse Event|3
2018530|NCT00293813|3586045|FG001|Overall Study|Adverse Event|1
2018531|NCT00293813|3586046|FG002|Overall Study|Adverse Event|1
2018532|NCT00293813|3586044|FG000|Overall Study|Withdrawal by Subject|7
2018533|NCT00293813|3586045|FG001|Overall Study|Withdrawal by Subject|4
2018534|NCT00293813|3586046|FG002|Overall Study|Withdrawal by Subject|4
2018535|NCT00293813|3586044|FG000|Overall Study|Lost to Follow-up|3
2018536|NCT00293813|3586045|FG001|Overall Study|Lost to Follow-up|2
2018537|NCT00293813|3586046|FG002|Overall Study|Lost to Follow-up|3
2018538|NCT00293813|3586044|FG000|Overall Study|Noncompliance|0
2018539|NCT00293813|3586045|FG001|Overall Study|Noncompliance|1
2018540|NCT00293813|3586046|FG002|Overall Study|Noncompliance|0
2025813|NCT00347360|3594614|FG011|Overall Study|Did not meet criteria before ABPM|0
2025814|NCT00347360|3594615|FG012|Overall Study|Did not meet criteria before ABPM|0
2025815|NCT00347360|3594616|FG013|Overall Study|Did not meet criteria before ABPM|0
2025816|NCT00347360|3594617|FG014|Overall Study|Did not meet criteria before ABPM|0
2025817|NCT00347360|3594603|FG000|Overall Study|Randomized in error|0
2025818|NCT00347360|3594604|FG001|Overall Study|Randomized in error|0
2025819|NCT00347360|3594605|FG002|Overall Study|Randomized in error|0
2025820|NCT00347360|3594606|FG003|Overall Study|Randomized in error|0
2025821|NCT00347360|3594607|FG004|Overall Study|Randomized in error|0
2025822|NCT00347360|3594608|FG005|Overall Study|Randomized in error|0
2025823|NCT00347360|3594609|FG006|Overall Study|Randomized in error|0
2025824|NCT00347360|3594610|FG007|Overall Study|Randomized in error|0
2025825|NCT00347360|3594611|FG008|Overall Study|Randomized in error|0
2025826|NCT00347360|3594612|FG009|Overall Study|Randomized in error|0
2025827|NCT00347360|3594613|FG010|Overall Study|Randomized in error|0
2025828|NCT00347360|3594614|FG011|Overall Study|Randomized in error|1
2025829|NCT00347360|3594615|FG012|Overall Study|Randomized in error|0
2025830|NCT00347360|3594616|FG013|Overall Study|Randomized in error|0
2025831|NCT00347360|3594617|FG014|Overall Study|Randomized in error|0
2025832|NCT00347360|3594603|FG000|Overall Study|Failed inclusion criteria #4|0
2025833|NCT00347360|3594604|FG001|Overall Study|Failed inclusion criteria #4|0
2025834|NCT00347360|3594605|FG002|Overall Study|Failed inclusion criteria #4|0
2025835|NCT00347360|3594606|FG003|Overall Study|Failed inclusion criteria #4|0
2025836|NCT00347360|3594607|FG004|Overall Study|Failed inclusion criteria #4|0
2025837|NCT00347360|3594608|FG005|Overall Study|Failed inclusion criteria #4|0
2025838|NCT00347360|3594609|FG006|Overall Study|Failed inclusion criteria #4|0
2025839|NCT00347360|3594610|FG007|Overall Study|Failed inclusion criteria #4|0
2025840|NCT00347360|3594611|FG008|Overall Study|Failed inclusion criteria #4|0
2025841|NCT00347360|3594612|FG009|Overall Study|Failed inclusion criteria #4|0
2025842|NCT00347360|3594613|FG010|Overall Study|Failed inclusion criteria #4|0
2025843|NCT00347360|3594614|FG011|Overall Study|Failed inclusion criteria #4|1
2025844|NCT00347360|3594615|FG012|Overall Study|Failed inclusion criteria #4|0
2025845|NCT00347360|3594616|FG013|Overall Study|Failed inclusion criteria #4|0
2025846|NCT00347360|3594617|FG014|Overall Study|Failed inclusion criteria #4|0
2025847|NCT00347360|3594603|FG000|Overall Study|Prolonged duration between visits|0
2025848|NCT00347360|3594604|FG001|Overall Study|Prolonged duration between visits|0
2025849|NCT00347360|3594605|FG002|Overall Study|Prolonged duration between visits|0
2025850|NCT00347360|3594606|FG003|Overall Study|Prolonged duration between visits|0
2025851|NCT00347360|3594607|FG004|Overall Study|Prolonged duration between visits|0
2025852|NCT00347360|3594608|FG005|Overall Study|Prolonged duration between visits|0
2025853|NCT00347360|3594609|FG006|Overall Study|Prolonged duration between visits|0
2025854|NCT00347360|3594610|FG007|Overall Study|Prolonged duration between visits|0
2025855|NCT00347360|3594611|FG008|Overall Study|Prolonged duration between visits|0
2025856|NCT00347360|3594612|FG009|Overall Study|Prolonged duration between visits|0
2025857|NCT00347360|3594613|FG010|Overall Study|Prolonged duration between visits|0
2025858|NCT00347360|3594614|FG011|Overall Study|Prolonged duration between visits|0
2025859|NCT00347360|3594615|FG012|Overall Study|Prolonged duration between visits|1
2025860|NCT00347360|3594616|FG013|Overall Study|Prolonged duration between visits|0
2025861|NCT00347360|3594617|FG014|Overall Study|Prolonged duration between visits|0
2025862|NCT00347360|3594603|FG000|Overall Study|Subject left town, ran out of study drug|0
2025863|NCT00347360|3594604|FG001|Overall Study|Subject left town, ran out of study drug|0
2025864|NCT00347360|3594605|FG002|Overall Study|Subject left town, ran out of study drug|0
2025865|NCT00347360|3594606|FG003|Overall Study|Subject left town, ran out of study drug|0
2025866|NCT00347360|3594607|FG004|Overall Study|Subject left town, ran out of study drug|0
2025867|NCT00347360|3594608|FG005|Overall Study|Subject left town, ran out of study drug|0
2025868|NCT00347360|3594609|FG006|Overall Study|Subject left town, ran out of study drug|0
2025869|NCT00347360|3594610|FG007|Overall Study|Subject left town, ran out of study drug|0
2025870|NCT00347360|3594611|FG008|Overall Study|Subject left town, ran out of study drug|0
2025871|NCT00347360|3594612|FG009|Overall Study|Subject left town, ran out of study drug|0
2025872|NCT00347360|3594613|FG010|Overall Study|Subject left town, ran out of study drug|0
2025873|NCT00347360|3594614|FG011|Overall Study|Subject left town, ran out of study drug|0
2025874|NCT00347360|3594615|FG012|Overall Study|Subject left town, ran out of study drug|0
2025875|NCT00347360|3594616|FG013|Overall Study|Subject left town, ran out of study drug|1
2025876|NCT00347360|3594617|FG014|Overall Study|Subject left town, ran out of study drug|0
2025877|NCT00347360|3594603|FG000|Overall Study|Subject refuse to sign updated consent|0
2025878|NCT00347360|3594604|FG001|Overall Study|Subject refuse to sign updated consent|0
2025879|NCT00347360|3594605|FG002|Overall Study|Subject refuse to sign updated consent|0
2025880|NCT00347360|3594606|FG003|Overall Study|Subject refuse to sign updated consent|0
2025881|NCT00347360|3594607|FG004|Overall Study|Subject refuse to sign updated consent|0
2025882|NCT00347360|3594608|FG005|Overall Study|Subject refuse to sign updated consent|0
2025883|NCT00347360|3594609|FG006|Overall Study|Subject refuse to sign updated consent|0
2025884|NCT00347360|3594610|FG007|Overall Study|Subject refuse to sign updated consent|0
2025885|NCT00347360|3594611|FG008|Overall Study|Subject refuse to sign updated consent|0
2018541|NCT00294047|3586056|FG000|Month 48|Adverse Event|28
2018542|NCT00294047|3586057|FG001|Month 48|Adverse Event|13
2018543|NCT00294047|3586056|FG000|Month 48|Protocol Violation|4
2018544|NCT00294047|3586057|FG001|Month 48|Protocol Violation|4
2018545|NCT00294047|3586056|FG000|Month 48|Withdrawal by Subject|111
2018546|NCT00294047|3586057|FG001|Month 48|Withdrawal by Subject|115
2018547|NCT00294047|3586056|FG000|Month 48|Lost to Follow-up|272
2018548|NCT00294047|3586057|FG001|Month 48|Lost to Follow-up|287
2018549|NCT00294047|3586056|FG000|Month 48|Other|10
2018550|NCT00294047|3586057|FG001|Month 48|Other|14
2018551|NCT00294047|3586056|FG000|Month 84|Adverse Event|4
2018552|NCT00294047|3586057|FG001|Month 84|Adverse Event|2
2018553|NCT00294047|3586056|FG000|Month 84|Protocol Violation|1
2018554|NCT00294047|3586057|FG001|Month 84|Protocol Violation|1
2018555|NCT00294047|3586056|FG000|Month 84|Withdrawal by Subject|33
2018556|NCT00294047|3586057|FG001|Month 84|Withdrawal by Subject|31
2018557|NCT00294047|3586056|FG000|Month 84|Lost to Follow-up|187
2018558|NCT00294047|3586057|FG001|Month 84|Lost to Follow-up|190
2018559|NCT00294047|3586056|FG000|Month 84|Absent Cervix|2
2018560|NCT00294047|3586057|FG001|Month 84|Absent Cervix|0
2018561|NCT00294047|3586056|FG000|Month 84|Work related reasons|4
2018562|NCT00294047|3586057|FG001|Month 84|Work related reasons|2
2018563|NCT00294047|3586056|FG000|Month 84|Center closed, subject did not transfer|1
2018564|NCT00294047|3586057|FG001|Month 84|Center closed, subject did not transfer|0
2018565|NCT00294047|3586056|FG000|Month 84|Family problems|2
2018566|NCT00294047|3586057|FG001|Month 84|Family problems|2
2018567|NCT00294047|3586056|FG000|Month 84|Lack of time|3
2018568|NCT00294047|3586057|FG001|Month 84|Lack of time|1
2018569|NCT00294047|3586056|FG000|Month 84|Personal reason|2
2018570|NCT00294047|3586057|FG001|Month 84|Personal reason|4
2018571|NCT00294047|3586056|FG000|Month 84|Subject does not want male physician|1
2018572|NCT00294047|3586057|FG001|Month 84|Subject does not want male physician|0
2018573|NCT00294047|3586056|FG000|Month 84|Transport reimbursement delayed|0
2018574|NCT00294047|3586057|FG001|Month 84|Transport reimbursement delayed|1
2018575|NCT00294047|3586056|FG000|Month 84|Unable to reach study site|1
2018576|NCT00294047|3586057|FG001|Month 84|Unable to reach study site|0
2018577|NCT00294047|3586056|FG000|Month 84|Under investigation locally|1
2018578|NCT00294047|3586057|FG001|Month 84|Under investigation locally|0
2018579|NCT00294047|3586056|FG000|Month 84|Visit missed|0
2018580|NCT00294047|3586057|FG001|Month 84|Visit missed|1
2018581|NCT00294047|3586056|FG000|Month 84|No consent for Month 84 Follow-up|731
2018582|NCT00294047|3586057|FG001|Month 84|No consent for Month 84 Follow-up|754
2018583|NCT00294060|3586064|FG000|Overall Study|Death|225
2018584|NCT00294060|3586064|FG000|Overall Study|Other|59
2018585|NCT00294060|3586064|FG000|Overall Study|Lost to Follow-up|55
2018586|NCT00294060|3586064|FG000|Overall Study|Withdrawal by Subject|11
2018587|NCT00294060|3586064|FG000|Overall Study|Physician Decision|797
2018588|NCT00294060|3586064|FG000|Overall Study|Medical condition|3
2018589|NCT00294060|3586064|FG000|Overall Study|Device explanted/not replaced|23
2018590|NCT00294398|3586070|FG000|Overall Study|Lost to Follow-up|21
2018591|NCT00294398|3586071|FG001|Overall Study|Lost to Follow-up|26
2018592|NCT00294554|3586088|FG000|Overall Study|Lack of Efficacy|0
2018593|NCT00294554|3586089|FG001|Overall Study|Lack of Efficacy|1
2018594|NCT00294554|3586088|FG000|Overall Study|Physician Decision|0
2018595|NCT00294554|3586089|FG001|Overall Study|Physician Decision|1
2018596|NCT00294645|3586107|FG000|Overall Study|Death|10
2018597|NCT00294645|3586108|FG001|Overall Study|Death|18
2018598|NCT00294645|3586107|FG000|Overall Study|Lost to Follow-up|1
2018599|NCT00294645|3586108|FG001|Overall Study|Lost to Follow-up|10
2018600|NCT00294645|3586107|FG000|Overall Study|Withdrawal by Subject|18
2018601|NCT00294645|3586108|FG001|Overall Study|Withdrawal by Subject|34
2018602|NCT00294645|3586107|FG000|Overall Study|Physician Decision|15
2018603|NCT00294645|3586108|FG001|Overall Study|Physician Decision|20
2018604|NCT00294645|3586107|FG000|Overall Study|Other|4
2018605|NCT00294645|3586108|FG001|Overall Study|Other|10
2018606|NCT00294658|3586116|FG000|Overall Study|Death|0
2018607|NCT00294658|3586117|FG001|Overall Study|Death|1
2018608|NCT00294658|3586116|FG000|Overall Study|Lost to Follow-up|4
2018609|NCT00294658|3586117|FG001|Overall Study|Lost to Follow-up|0
2018610|NCT00294658|3586116|FG000|Overall Study|Physician Decision|1
2018611|NCT00294658|3586117|FG001|Overall Study|Physician Decision|2
2018612|NCT00294658|3586116|FG000|Overall Study|Pregnancy|0
2018613|NCT00294658|3586117|FG001|Overall Study|Pregnancy|1
2018614|NCT00294658|3586116|FG000|Overall Study|Withdrawal by Subject|0
2018615|NCT00294658|3586117|FG001|Overall Study|Withdrawal by Subject|4
2018616|NCT00294658|3586116|FG000|Overall Study|Found to have invasive thymoma|1
2018617|NCT00294658|3586117|FG001|Overall Study|Found to have invasive thymoma|0
2018618|NCT00294658|3586116|FG000|Overall Study|Patient and family were not satisfied|0
2018619|NCT00294658|3586117|FG001|Overall Study|Patient and family were not satisfied|1
2018620|NCT00294671|3586125|FG000|Overall Study|Lack of Efficacy|11
2018621|NCT00294671|3586126|FG001|Overall Study|Lack of Efficacy|23
2018622|NCT00294671|3586125|FG000|Overall Study|Liver transplant|7
2018623|NCT00294671|3586126|FG001|Overall Study|Liver transplant|9
2018624|NCT00294671|3586125|FG000|Overall Study|Drug related adverse event (AE)|4
2018625|NCT00294671|3586126|FG001|Overall Study|Drug related adverse event (AE)|2
2018626|NCT00294671|3586125|FG000|Overall Study|Non-drug related AE|3
2018627|NCT00294671|3586126|FG001|Overall Study|Non-drug related AE|2
2018628|NCT00294671|3586125|FG000|Overall Study|Lost to Follow-up|1
2018629|NCT00294671|3586126|FG001|Overall Study|Lost to Follow-up|3
2018630|NCT00294671|3586125|FG000|Overall Study|Non-compliance|1
2018631|NCT00294671|3586126|FG001|Overall Study|Non-compliance|0
2018632|NCT00294671|3586125|FG000|Overall Study|Death|0
2018633|NCT00294671|3586126|FG001|Overall Study|Death|1
2018634|NCT00294684|3586134|FG000|Overall Study|Lost to Follow-up|5
2018635|NCT00294684|3586135|FG001|Overall Study|Lost to Follow-up|8
2018636|NCT00294723|3586144|FG000|Double-Blind Period 52 Weeks|Adverse Event|18
2018637|NCT00294723|3586145|FG001|Double-Blind Period 52 Weeks|Adverse Event|25
2018638|NCT00294723|3586146|FG002|Double-Blind Period 52 Weeks|Adverse Event|15
2018639|NCT00294723|3586144|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9
2018640|NCT00294723|3586145|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15
2018641|NCT00294723|3586146|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25
2018642|NCT00294723|3586144|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11
2018643|NCT00294723|3586145|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11
2018644|NCT00294723|3586146|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5
2018645|NCT00294723|3586144|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36
2018646|NCT00294723|3586145|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38
2018647|NCT00294723|3586146|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51
2018648|NCT00294723|3586144|FG000|Open-Label Extension 52 Weeks|Adverse Event|5
2018649|NCT00294723|3586145|FG001|Open-Label Extension 52 Weeks|Adverse Event|5
2018650|NCT00294723|3586146|FG002|Open-Label Extension 52 Weeks|Adverse Event|2
2018651|NCT00294723|3586144|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12
2018652|NCT00294723|3586145|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15
2018653|NCT00294723|3586146|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21
2018654|NCT00294723|3586144|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4
2018655|NCT00294723|3586145|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3
2018656|NCT00294723|3586146|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3
2018657|NCT00294723|3586144|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19
2018658|NCT00294723|3586145|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16
2018659|NCT00294723|3586146|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14
2018660|NCT00294723|3586144|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1
2018661|NCT00294723|3586145|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1
2018662|NCT00294723|3586146|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0
2018663|NCT00294723|3586144|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
2018664|NCT00294723|3586145|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
2018665|NCT00294723|3586146|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
2018666|NCT00294723|3586144|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
2018667|NCT00294723|3586145|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
2018668|NCT00294723|3586146|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
2018669|NCT00294723|3586144|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
2018670|NCT00294723|3586145|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
2018671|NCT00294723|3586146|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
2018672|NCT00294762|3586159|FG000|Overall Study|Did not receive study treatment|3
2018673|NCT00294762|3586160|FG001|Overall Study|Did not receive study treatment|3
2018674|NCT00295022|3586194|FG000|Overall Study|Adverse Event|1
2018675|NCT00295022|3586195|FG001|Overall Study|Adverse Event|1
2018676|NCT00295022|3586196|FG002|Overall Study|Adverse Event|2
2018677|NCT00295022|3586194|FG000|Overall Study|Lost to Follow-up|0
2018678|NCT00295022|3586195|FG001|Overall Study|Lost to Follow-up|0
2018679|NCT00295022|3586196|FG002|Overall Study|Lost to Follow-up|1
2018680|NCT00295022|3586194|FG000|Overall Study|Withdrawal by Subject|0
2018681|NCT00295022|3586195|FG001|Overall Study|Withdrawal by Subject|0
2018682|NCT00295022|3586196|FG002|Overall Study|Withdrawal by Subject|2
2018683|NCT00295620|3586222|FG000|Overall Study|Lost to Follow-up|9
2018684|NCT00295620|3586223|FG001|Overall Study|Lost to Follow-up|5
2018685|NCT00295620|3586222|FG000|Overall Study|Withdrawal by Subject|37
2018686|NCT00295620|3586223|FG001|Overall Study|Withdrawal by Subject|50
2018687|NCT00295620|3586222|FG000|Overall Study|Death|206
2018688|NCT00295620|3586223|FG001|Overall Study|Death|207
2018689|NCT00295620|3586222|FG000|Overall Study|Other reasons|10
2018690|NCT00295620|3586223|FG001|Overall Study|Other reasons|9
2018691|NCT00295620|3586222|FG000|Overall Study|Discontinuation by sponsor|580
2018692|NCT00295620|3586223|FG001|Overall Study|Discontinuation by sponsor|593
2018693|NCT00295620|3586222|FG000|Overall Study|Protocol Violation|30
2018694|NCT00295620|3586223|FG001|Overall Study|Protocol Violation|32
2018695|NCT00295633|3586232|FG000|Overall Study|Lack of Efficacy|19
2018696|NCT00295633|3586233|FG001|Overall Study|Lack of Efficacy|7
2018697|NCT00295633|3586234|FG002|Overall Study|Lack of Efficacy|16
2018698|NCT00295633|3586232|FG000|Overall Study|Withdrawal of consent by subject|16
2018699|NCT00295633|3586233|FG001|Overall Study|Withdrawal of consent by subject|16
2018700|NCT00295633|3586234|FG002|Overall Study|Withdrawal of consent by subject|26
2018701|NCT00295633|3586232|FG000|Overall Study|Adverse Event|9
2018702|NCT00295633|3586233|FG001|Overall Study|Adverse Event|17
2018703|NCT00295633|3586234|FG002|Overall Study|Adverse Event|9
2018704|NCT00295633|3586232|FG000|Overall Study|Lost to Follow-up|6
2018705|NCT00295633|3586233|FG001|Overall Study|Lost to Follow-up|11
2018706|NCT00295633|3586234|FG002|Overall Study|Lost to Follow-up|7
2018707|NCT00295633|3586232|FG000|Overall Study|Physician Decision|9
2018708|NCT00295633|3586233|FG001|Overall Study|Physician Decision|10
2018709|NCT00295633|3586234|FG002|Overall Study|Physician Decision|8
2018710|NCT00295633|3586232|FG000|Overall Study|Poor/Noncompliance|2
2018711|NCT00295633|3586233|FG001|Overall Study|Poor/Noncompliance|2
2018712|NCT00295633|3586234|FG002|Overall Study|Poor/Noncompliance|6
2018713|NCT00295633|3586232|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
2018714|NCT00295633|3586233|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
2018715|NCT00295633|3586234|FG002|Overall Study|Subject No Longer Meets Study Criteria|3
2018716|NCT00295633|3586232|FG000|Overall Study|Death|1
2018717|NCT00295633|3586233|FG001|Overall Study|Death|1
2018718|NCT00295633|3586234|FG002|Overall Study|Death|0
2018719|NCT00295633|3586232|FG000|Overall Study|Administrative reason by sponsor|0
2018720|NCT00295633|3586233|FG001|Overall Study|Administrative reason by sponsor|0
2018721|NCT00295633|3586234|FG002|Overall Study|Administrative reason by sponsor|1
2018722|NCT00295750|3586245|FG000|Overall Study|Adverse Event|19
2018723|NCT00295750|3586246|FG001|Overall Study|Adverse Event|15
2018724|NCT00295750|3586247|FG002|Overall Study|Adverse Event|12
2018725|NCT00295750|3586245|FG000|Overall Study|Lack of Efficacy|1
2018726|NCT00295750|3586246|FG001|Overall Study|Lack of Efficacy|1
2018727|NCT00295750|3586247|FG002|Overall Study|Lack of Efficacy|0
2018728|NCT00295750|3586245|FG000|Overall Study|Lost to Follow-up|1
2018729|NCT00295750|3586246|FG001|Overall Study|Lost to Follow-up|4
2018730|NCT00295750|3586247|FG002|Overall Study|Lost to Follow-up|1
2018731|NCT00295750|3586245|FG000|Overall Study|Taking prohibited therapy|2
2018732|NCT00295750|3586246|FG001|Overall Study|Taking prohibited therapy|3
2018733|NCT00295750|3586247|FG002|Overall Study|Taking prohibited therapy|2
2018734|NCT00295750|3586245|FG000|Overall Study|Administrative errors|2
2018735|NCT00295750|3586246|FG001|Overall Study|Administrative errors|4
2018736|NCT00295750|3586247|FG002|Overall Study|Administrative errors|5
2018737|NCT00295750|3586245|FG000|Overall Study|Trial drug errors|1
2018738|NCT00295750|3586246|FG001|Overall Study|Trial drug errors|1
2018739|NCT00295750|3586247|FG002|Overall Study|Trial drug errors|0
2018740|NCT00295750|3586245|FG000|Overall Study|Disease progression|2
2018741|NCT00295750|3586246|FG001|Overall Study|Disease progression|1
2018742|NCT00295750|3586247|FG002|Overall Study|Disease progression|0
2018743|NCT00295750|3586245|FG000|Overall Study|Personal reasons|0
2018744|NCT00295750|3586246|FG001|Overall Study|Personal reasons|1
2018745|NCT00295750|3586247|FG002|Overall Study|Personal reasons|0
2018746|NCT00295750|3586245|FG000|Overall Study|Randomized but never received trial drug|4
2018747|NCT00295750|3586246|FG001|Overall Study|Randomized but never received trial drug|3
2018748|NCT00295750|3586247|FG002|Overall Study|Randomized but never received trial drug|3
2018749|NCT00295750|3586245|FG000|Overall Study|Withdrawal by Subject|9
2018750|NCT00295750|3586246|FG001|Overall Study|Withdrawal by Subject|4
2018751|NCT00295750|3586247|FG002|Overall Study|Withdrawal by Subject|7
2018752|NCT00295750|3586245|FG000|Overall Study|Protocol Violation|2
2018753|NCT00295750|3586246|FG001|Overall Study|Protocol Violation|4
2018754|NCT00295750|3586247|FG002|Overall Study|Protocol Violation|2
2018755|NCT00295854|3586258|FG000|Overall Study|Adverse Event|7
2018756|NCT00295854|3586259|FG001|Overall Study|Adverse Event|7
2018757|NCT00295854|3586260|FG002|Overall Study|Adverse Event|6
2018758|NCT00295854|3586258|FG000|Overall Study|Protocol Violation|1
2018759|NCT00295854|3586259|FG001|Overall Study|Protocol Violation|1
2018760|NCT00295854|3586260|FG002|Overall Study|Protocol Violation|1
2018761|NCT00295854|3586258|FG000|Overall Study|Lost to Follow-up|2
2018762|NCT00295854|3586259|FG001|Overall Study|Lost to Follow-up|0
2018763|NCT00295854|3586260|FG002|Overall Study|Lost to Follow-up|1
2018764|NCT00295854|3586258|FG000|Overall Study|Withdrawal by Subject|3
2018765|NCT00295854|3586259|FG001|Overall Study|Withdrawal by Subject|7
2018766|NCT00295854|3586260|FG002|Overall Study|Withdrawal by Subject|4
2018767|NCT00295854|3586258|FG000|Overall Study|did not continue to meet criteria|1
2018768|NCT00295854|3586259|FG001|Overall Study|did not continue to meet criteria|1
2018769|NCT00295854|3586260|FG002|Overall Study|did not continue to meet criteria|2
2018770|NCT00295854|3586258|FG000|Overall Study|required a prohibited medication|1
2018771|NCT00295854|3586259|FG001|Overall Study|required a prohibited medication|0
2018772|NCT00295854|3586260|FG002|Overall Study|required a prohibited medication|0
2018773|NCT00295854|3586258|FG000|Overall Study|Other|3
2018774|NCT00295854|3586259|FG001|Overall Study|Other|5
2018775|NCT00295854|3586260|FG002|Overall Study|Other|1
2018776|NCT00295880|3586272|FG000|Overall Study|IBMI unit could not be volume reduced|1
2018777|NCT00295880|3586272|FG000|Overall Study|Unit randomization did not occur|1
2018778|NCT00295932|3586287|FG000|Overall Study|Not Treated|0
2018779|NCT00295932|3586288|FG001|Overall Study|Not Treated|0
2018780|NCT00295932|3586289|FG002|Overall Study|Not Treated|0
2018781|NCT00295932|3586290|FG003|Overall Study|Not Treated|0
2018782|NCT00295932|3586291|FG004|Overall Study|Not Treated|0
2018783|NCT00295932|3586292|FG005|Overall Study|Not Treated|0
2018784|NCT00295932|3586293|FG006|Overall Study|Not Treated|0
2018785|NCT00295932|3586294|FG007|Overall Study|Not Treated|0
2018786|NCT00295932|3586295|FG008|Overall Study|Not Treated|0
2018787|NCT00295932|3586296|FG009|Overall Study|Not Treated|0
2018788|NCT00295932|3586297|FG010|Overall Study|Not Treated|1
2018789|NCT00296036|3586325|FG000|Overall Study|Withdrawal by Subject|1
2018790|NCT00296036|3586326|FG001|Overall Study|Withdrawal by Subject|0
2018791|NCT00296036|3586327|FG002|Overall Study|Withdrawal by Subject|2
2018792|NCT00296036|3586328|FG003|Overall Study|Withdrawal by Subject|1
2018793|NCT00296036|3586329|FG004|Overall Study|Withdrawal by Subject|2
2018794|NCT00296036|3586330|FG005|Overall Study|Withdrawal by Subject|1
2018795|NCT00296036|3586325|FG000|Overall Study|Protocol Violation|0
2018796|NCT00296036|3586326|FG001|Overall Study|Protocol Violation|0
2018797|NCT00296036|3586327|FG002|Overall Study|Protocol Violation|0
2018798|NCT00296036|3586328|FG003|Overall Study|Protocol Violation|0
2018799|NCT00296036|3586329|FG004|Overall Study|Protocol Violation|0
2018800|NCT00296036|3586330|FG005|Overall Study|Protocol Violation|3
2018801|NCT00296140|3586349|FG000|Overall Study|Lost to Follow-up|1
2018802|NCT00296140|3586350|FG001|Overall Study|Lost to Follow-up|0
2018803|NCT00296140|3586349|FG000|Overall Study|Withdrawal by Subject|1
2018804|NCT00296140|3586350|FG001|Overall Study|Withdrawal by Subject|0
2018805|NCT00296140|3586349|FG000|Overall Study|Discharge to Nursing Home|1
2018806|NCT00296140|3586350|FG001|Overall Study|Discharge to Nursing Home|0
2018807|NCT00296244|3586383|FG000|Overall Study|Underwent retransplant|0
2018808|NCT00296244|3586384|FG001|Overall Study|Underwent retransplant|1
2018809|NCT00296335|3586415|FG000|Overall Study|Recurrence|3
2018810|NCT00296335|3586416|FG001|Overall Study|Recurrence|51
2018811|NCT00296335|3586415|FG000|Overall Study|Adverse Event|17
2018812|NCT00296335|3586416|FG001|Overall Study|Adverse Event|27
2018813|NCT00296335|3586415|FG000|Overall Study|Lost to Follow-up|7
2018814|NCT00296335|3586416|FG001|Overall Study|Lost to Follow-up|33
2018815|NCT00296335|3586415|FG000|Overall Study|Physician Decision|3
2018816|NCT00296335|3586416|FG001|Overall Study|Physician Decision|11
2018817|NCT00296374|3586427|FG000|Overall Study|Adverse Event|14
2018818|NCT00296374|3586428|FG001|Overall Study|Adverse Event|10
2018819|NCT00296374|3586429|FG002|Overall Study|Adverse Event|7
2018820|NCT00296374|3586427|FG000|Overall Study|Withdrawal by Subject|3
2018821|NCT00296374|3586428|FG001|Overall Study|Withdrawal by Subject|5
2018822|NCT00296374|3586429|FG002|Overall Study|Withdrawal by Subject|11
2018823|NCT00296374|3586427|FG000|Overall Study|Incorrect enrollment|3
2018824|NCT00296374|3586428|FG001|Overall Study|Incorrect enrollment|3
2018825|NCT00296374|3586429|FG002|Overall Study|Incorrect enrollment|4
2018826|NCT00296374|3586427|FG000|Overall Study|Protocol Violation|1
2018827|NCT00296374|3586428|FG001|Overall Study|Protocol Violation|2
2018828|NCT00296374|3586429|FG002|Overall Study|Protocol Violation|3
2018829|NCT00296374|3586427|FG000|Overall Study|Lost to Follow-up|3
2214685|NCT01689532|3857277|FG001|Overall Study|Withdrawal by Subject|2
2214686|NCT01689532|3857276|FG000|Overall Study|Physician Decision|2
2214687|NCT01689532|3857277|FG001|Overall Study|Physician Decision|0
2214688|NCT01689649|3857283|FG000|Overall Study|Lack of Efficacy|3
2214689|NCT01689649|3857283|FG000|Overall Study|Non-compliance|11
2214690|NCT01689649|3857283|FG000|Overall Study|Protocol Violation|3
2214691|NCT01689649|3857283|FG000|Overall Study|Lost to Follow-up|5
2214692|NCT01689857|3857307|FG000|Overall Study|Lost to Follow-up|5
2214693|NCT01689857|3857308|FG001|Overall Study|Lost to Follow-up|2
2214694|NCT01690052|3857323|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
2018830|NCT00296374|3586428|FG001|Overall Study|Lost to Follow-up|1
2018831|NCT00296374|3586429|FG002|Overall Study|Lost to Follow-up|1
2018832|NCT00296374|3586427|FG000|Overall Study|Relocated to another state|1
2018833|NCT00296374|3586428|FG001|Overall Study|Relocated to another state|0
2018834|NCT00296374|3586429|FG002|Overall Study|Relocated to another state|0
2018835|NCT00296374|3586427|FG000|Overall Study|Stopped drug before end of study visit|0
2018836|NCT00296374|3586428|FG001|Overall Study|Stopped drug before end of study visit|1
2018837|NCT00296374|3586429|FG002|Overall Study|Stopped drug before end of study visit|0
2018838|NCT00296374|3586427|FG000|Overall Study|Nephrologist introduced ACE|0
2018839|NCT00296374|3586428|FG001|Overall Study|Nephrologist introduced ACE|1
2018840|NCT00296374|3586429|FG002|Overall Study|Nephrologist introduced ACE|0
2018841|NCT00296374|3586427|FG000|Overall Study|Pregnancy|0
2018842|NCT00296374|3586428|FG001|Overall Study|Pregnancy|0
2018843|NCT00296374|3586429|FG002|Overall Study|Pregnancy|2
2018844|NCT00296374|3586427|FG000|Overall Study|Other|0
2018845|NCT00296374|3586428|FG001|Overall Study|Other|0
2018846|NCT00296374|3586429|FG002|Overall Study|Other|1
2018847|NCT00296400|3586446|FG000|Overall Study|Adverse Event|7
2018848|NCT00296400|3586447|FG001|Overall Study|Adverse Event|7
2018849|NCT00296400|3586448|FG002|Overall Study|Adverse Event|7
2018850|NCT00296400|3586446|FG000|Overall Study|Withdrawal by Subject|5
2018851|NCT00296400|3586447|FG001|Overall Study|Withdrawal by Subject|6
2018852|NCT00296400|3586448|FG002|Overall Study|Withdrawal by Subject|2
2018853|NCT00296400|3586446|FG000|Overall Study|Incorrect enrollment|2
2018854|NCT00296400|3586447|FG001|Overall Study|Incorrect enrollment|0
2018855|NCT00296400|3586448|FG002|Overall Study|Incorrect enrollment|0
2018856|NCT00296400|3586446|FG000|Overall Study|Protocol Violation|1
2018857|NCT00296400|3586447|FG001|Overall Study|Protocol Violation|1
2018858|NCT00296400|3586448|FG002|Overall Study|Protocol Violation|1
2018859|NCT00296400|3586446|FG000|Overall Study|Lost to Follow-up|1
2018860|NCT00296400|3586447|FG001|Overall Study|Lost to Follow-up|1
2018861|NCT00296400|3586448|FG002|Overall Study|Lost to Follow-up|2
2018862|NCT00296400|3586446|FG000|Overall Study|Study specific discontinuation criteria|0
2018863|NCT00296400|3586447|FG001|Overall Study|Study specific discontinuation criteria|0
2018864|NCT00296400|3586448|FG002|Overall Study|Study specific discontinuation criteria|1
2018865|NCT00296400|3586446|FG000|Overall Study|Visit 10 was performed earlier|0
2018866|NCT00296400|3586447|FG001|Overall Study|Visit 10 was performed earlier|1
2018867|NCT00296400|3586448|FG002|Overall Study|Visit 10 was performed earlier|0
2018868|NCT00296400|3586446|FG000|Overall Study|Pregnancy|1
2018869|NCT00296400|3586447|FG001|Overall Study|Pregnancy|2
2018870|NCT00296400|3586448|FG002|Overall Study|Pregnancy|0
2018871|NCT00296491|3586463|FG000|Overall Study|Low Pollen Counts|18
2018872|NCT00296491|3586464|FG001|Overall Study|Low Pollen Counts|26
2018873|NCT00296491|3586465|FG002|Overall Study|Low Pollen Counts|25
2018874|NCT00296491|3586466|FG003|Overall Study|Low Pollen Counts|16
2018875|NCT00296491|3586463|FG000|Overall Study|Protocol Violation|4
2018876|NCT00296491|3586464|FG001|Overall Study|Protocol Violation|6
2018877|NCT00296491|3586465|FG002|Overall Study|Protocol Violation|2
2018878|NCT00296491|3586466|FG003|Overall Study|Protocol Violation|3
2018879|NCT00296491|3586463|FG000|Overall Study|Adverse Event|1
2018880|NCT00296491|3586464|FG001|Overall Study|Adverse Event|3
2018881|NCT00296491|3586465|FG002|Overall Study|Adverse Event|1
2018882|NCT00296491|3586466|FG003|Overall Study|Adverse Event|4
2018883|NCT00296491|3586463|FG000|Overall Study|Withdrawn due to Asthma|0
2018884|NCT00296491|3586464|FG001|Overall Study|Withdrawn due to Asthma|0
2018885|NCT00296491|3586465|FG002|Overall Study|Withdrawn due to Asthma|0
2018886|NCT00296491|3586466|FG003|Overall Study|Withdrawn due to Asthma|4
2018887|NCT00296491|3586463|FG000|Overall Study|Withdrawal by Subject|7
2018888|NCT00296491|3586464|FG001|Overall Study|Withdrawal by Subject|3
2018889|NCT00296491|3586465|FG002|Overall Study|Withdrawal by Subject|3
2018890|NCT00296491|3586466|FG003|Overall Study|Withdrawal by Subject|2
2018891|NCT00296491|3586463|FG000|Overall Study|Non-Compliance|12
2018892|NCT00296491|3586464|FG001|Overall Study|Non-Compliance|13
2018893|NCT00296491|3586465|FG002|Overall Study|Non-Compliance|10
2018894|NCT00296491|3586466|FG003|Overall Study|Non-Compliance|14
2018895|NCT00296491|3586463|FG000|Overall Study|Lost to Follow-up|0
2018896|NCT00296491|3586464|FG001|Overall Study|Lost to Follow-up|2
2018897|NCT00296491|3586465|FG002|Overall Study|Lost to Follow-up|2
2018898|NCT00296491|3586466|FG003|Overall Study|Lost to Follow-up|0
2018899|NCT00296504|3586491|FG000|Interim Analysis|Withdrawal by Subject|8
2018900|NCT00296504|3586492|FG001|Interim Analysis|Withdrawal by Subject|0
2018901|NCT00296504|3586493|FG002|Interim Analysis|Withdrawal by Subject|12
2018902|NCT00296504|3586494|FG003|Interim Analysis|Withdrawal by Subject|0
2018903|NCT00296504|3586495|FG004|Interim Analysis|Withdrawal by Subject|5
2018904|NCT00296504|3586496|FG005|Interim Analysis|Withdrawal by Subject|5
2018905|NCT00296504|3586497|FG006|Interim Analysis|Withdrawal by Subject|9
2018906|NCT00296504|3586498|FG007|Interim Analysis|Withdrawal by Subject|3
2018907|NCT00296504|3586499|FG008|Interim Analysis|Withdrawal by Subject|0
2018908|NCT00296504|3586491|FG000|Interim Analysis|Lost to Follow-up|13
2018909|NCT00296504|3586492|FG001|Interim Analysis|Lost to Follow-up|3
2018910|NCT00296504|3586493|FG002|Interim Analysis|Lost to Follow-up|26
2018911|NCT00296504|3586494|FG003|Interim Analysis|Lost to Follow-up|8
2018912|NCT00296504|3586495|FG004|Interim Analysis|Lost to Follow-up|14
2018913|NCT00296504|3586496|FG005|Interim Analysis|Lost to Follow-up|4
2018914|NCT00296504|3586497|FG006|Interim Analysis|Lost to Follow-up|11
2018915|NCT00296504|3586498|FG007|Interim Analysis|Lost to Follow-up|4
2018916|NCT00296504|3586499|FG008|Interim Analysis|Lost to Follow-up|0
2018917|NCT00296504|3586491|FG000|Interim Analysis|Clinical Progression|1
2018918|NCT00296504|3586492|FG001|Interim Analysis|Clinical Progression|0
2018919|NCT00296504|3586493|FG002|Interim Analysis|Clinical Progression|1
2018920|NCT00296504|3586494|FG003|Interim Analysis|Clinical Progression|1
2018921|NCT00296504|3586495|FG004|Interim Analysis|Clinical Progression|0
2018922|NCT00296504|3586496|FG005|Interim Analysis|Clinical Progression|2
2018923|NCT00296504|3586497|FG006|Interim Analysis|Clinical Progression|1
2018924|NCT00296504|3586498|FG007|Interim Analysis|Clinical Progression|2
2018925|NCT00296504|3586499|FG008|Interim Analysis|Clinical Progression|0
2018926|NCT00296504|3586491|FG000|Interim Analysis|Insufficient Viral Load Response|5
2018927|NCT00296504|3586492|FG001|Interim Analysis|Insufficient Viral Load Response|1
2018928|NCT00296504|3586493|FG002|Interim Analysis|Insufficient Viral Load Response|12
2018929|NCT00296504|3586494|FG003|Interim Analysis|Insufficient Viral Load Response|2
2018930|NCT00296504|3586495|FG004|Interim Analysis|Insufficient Viral Load Response|7
2018931|NCT00296504|3586496|FG005|Interim Analysis|Insufficient Viral Load Response|9
2018932|NCT00296504|3586497|FG006|Interim Analysis|Insufficient Viral Load Response|2
2018933|NCT00296504|3586498|FG007|Interim Analysis|Insufficient Viral Load Response|24
2018934|NCT00296504|3586499|FG008|Interim Analysis|Insufficient Viral Load Response|0
2018935|NCT00296504|3586491|FG000|Interim Analysis|Adverse Event|0
2018936|NCT00296504|3586492|FG001|Interim Analysis|Adverse Event|0
2018937|NCT00296504|3586493|FG002|Interim Analysis|Adverse Event|13
2018938|NCT00296504|3586494|FG003|Interim Analysis|Adverse Event|4
2018939|NCT00296504|3586495|FG004|Interim Analysis|Adverse Event|6
2018940|NCT00296504|3586496|FG005|Interim Analysis|Adverse Event|3
2018941|NCT00296504|3586497|FG006|Interim Analysis|Adverse Event|4
2018942|NCT00296504|3586498|FG007|Interim Analysis|Adverse Event|5
2018943|NCT00296504|3586499|FG008|Interim Analysis|Adverse Event|0
2018944|NCT00296504|3586491|FG000|Interim Analysis|Protocol Violation|0
2018945|NCT00296504|3586492|FG001|Interim Analysis|Protocol Violation|0
2018946|NCT00296504|3586493|FG002|Interim Analysis|Protocol Violation|2
2018947|NCT00296504|3586494|FG003|Interim Analysis|Protocol Violation|0
2018948|NCT00296504|3586495|FG004|Interim Analysis|Protocol Violation|1
2018949|NCT00296504|3586496|FG005|Interim Analysis|Protocol Violation|0
2018950|NCT00296504|3586497|FG006|Interim Analysis|Protocol Violation|0
2018951|NCT00296504|3586498|FG007|Interim Analysis|Protocol Violation|1
2018952|NCT00296504|3586499|FG008|Interim Analysis|Protocol Violation|0
2018953|NCT00296504|3586491|FG000|Interim Analysis|Insufficient CD4 Response|0
2018954|NCT00296504|3586492|FG001|Interim Analysis|Insufficient CD4 Response|0
2018955|NCT00296504|3586493|FG002|Interim Analysis|Insufficient CD4 Response|0
2018956|NCT00296504|3586494|FG003|Interim Analysis|Insufficient CD4 Response|0
2018957|NCT00296504|3586495|FG004|Interim Analysis|Insufficient CD4 Response|1
2018958|NCT00296504|3586496|FG005|Interim Analysis|Insufficient CD4 Response|1
2018959|NCT00296504|3586497|FG006|Interim Analysis|Insufficient CD4 Response|0
2018960|NCT00296504|3586498|FG007|Interim Analysis|Insufficient CD4 Response|0
2018961|NCT00296504|3586499|FG008|Interim Analysis|Insufficient CD4 Response|0
2018962|NCT00296504|3586491|FG000|Interim Analysis|Switched to Commercially Available Drug|2
2018963|NCT00296504|3586492|FG001|Interim Analysis|Switched to Commercially Available Drug|0
2018964|NCT00296504|3586493|FG002|Interim Analysis|Switched to Commercially Available Drug|4
2018965|NCT00296504|3586494|FG003|Interim Analysis|Switched to Commercially Available Drug|1
2018966|NCT00296504|3586495|FG004|Interim Analysis|Switched to Commercially Available Drug|0
2018967|NCT00296504|3586496|FG005|Interim Analysis|Switched to Commercially Available Drug|5
2018968|NCT00296504|3586497|FG006|Interim Analysis|Switched to Commercially Available Drug|3
2018969|NCT00296504|3586498|FG007|Interim Analysis|Switched to Commercially Available Drug|4
2018970|NCT00296504|3586499|FG008|Interim Analysis|Switched to Commercially Available Drug|0
2018971|NCT00296504|3586491|FG000|Interim Analysis|Pregnancy|4
2018972|NCT00296504|3586492|FG001|Interim Analysis|Pregnancy|1
2018973|NCT00296504|3586493|FG002|Interim Analysis|Pregnancy|4
2018974|NCT00296504|3586494|FG003|Interim Analysis|Pregnancy|2
2018975|NCT00296504|3586495|FG004|Interim Analysis|Pregnancy|0
2018976|NCT00296504|3586496|FG005|Interim Analysis|Pregnancy|1
2018977|NCT00296504|3586497|FG006|Interim Analysis|Pregnancy|1
2018978|NCT00296504|3586498|FG007|Interim Analysis|Pregnancy|1
2018979|NCT00296504|3586499|FG008|Interim Analysis|Pregnancy|0
2018980|NCT00296504|3586491|FG000|Interim Analysis|Death|1
2018981|NCT00296504|3586492|FG001|Interim Analysis|Death|0
2018982|NCT00296504|3586493|FG002|Interim Analysis|Death|3
2018983|NCT00296504|3586494|FG003|Interim Analysis|Death|0
2102438|NCT00838903|3694190|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
2102439|NCT00838903|3694187|FG000|Follow-up Period (8 Weeks)|Adverse Event|0
2102440|NCT00838903|3694188|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
2102441|NCT00838903|3694189|FG002|Follow-up Period (8 Weeks)|Adverse Event|3
2102442|NCT00838903|3694190|FG003|Follow-up Period (8 Weeks)|Adverse Event|1
2102443|NCT00838903|3694187|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
2102444|NCT00838903|3694188|FG001|Follow-up Period (8 Weeks)|Noncompliance|8
2102445|NCT00838903|3694189|FG002|Follow-up Period (8 Weeks)|Noncompliance|5
2102446|NCT00838903|3694190|FG003|Follow-up Period (8 Weeks)|Noncompliance|5
2102447|NCT00838903|3694187|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6
2102448|NCT00838903|3694188|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28
2102449|NCT00838903|3694189|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22
2102450|NCT00838903|3694190|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24
2102451|NCT00838903|3694187|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
2102452|NCT00838903|3694188|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
2102453|NCT00838903|3694189|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
2102454|NCT00838903|3694190|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
2102455|NCT00838903|3694187|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
2102456|NCT00838903|3694188|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
2102457|NCT00838903|3694189|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
2102458|NCT00838903|3694190|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
2102459|NCT00838903|3694187|FG000|Follow-up Period (8 Weeks)|Physician Decision|1
2102460|NCT00838903|3694188|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
2102461|NCT00838903|3694189|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
2102462|NCT00838903|3694190|FG003|Follow-up Period (8 Weeks)|Physician Decision|1
2102463|NCT00838903|3694187|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
2102464|NCT00838903|3694188|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
2102465|NCT00838903|3694189|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
2102466|NCT00838903|3694190|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
2102467|NCT00838903|3694187|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0
2102468|NCT00838903|3694188|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1
2102469|NCT00838903|3694189|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0
2102470|NCT00838903|3694190|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0
2102471|NCT00838903|3694187|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
2102472|NCT00838903|3694188|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
2102473|NCT00838903|3694189|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
2102474|NCT00838903|3694190|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
2102475|NCT00838903|3694187|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
2102476|NCT00838903|3694188|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
2102477|NCT00838903|3694189|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
2102478|NCT00838903|3694190|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
2102479|NCT00838903|3694187|FG000|Follow-up Period (8 Weeks)|Missing|1
2102480|NCT00838903|3694188|FG001|Follow-up Period (8 Weeks)|Missing|2
2102481|NCT00838903|3694189|FG002|Follow-up Period (8 Weeks)|Missing|1
2102482|NCT00838903|3694190|FG003|Follow-up Period (8 Weeks)|Missing|1
2102483|NCT00838916|3694202|FG000|Treatment Period (156 Weeks)|Adverse Event|50
2102484|NCT00838916|3694203|FG001|Treatment Period (156 Weeks)|Adverse Event|11
2102485|NCT00838916|3694202|FG000|Treatment Period (156 Weeks)|Protocol Violation|12
2102486|NCT00838916|3694203|FG001|Treatment Period (156 Weeks)|Protocol Violation|3
2102487|NCT00838916|3694202|FG000|Treatment Period (156 Weeks)|Noncompliance|21
2102488|NCT00838916|3694203|FG001|Treatment Period (156 Weeks)|Noncompliance|14
2102489|NCT00838916|3694202|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
2102490|NCT00838916|3694203|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
2102491|NCT00838916|3694202|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19
2102492|NCT00838916|3694203|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18
2102493|NCT00838916|3694202|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81
2102494|NCT00838916|3694203|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29
2102495|NCT00838916|3694202|FG000|Treatment Period (156 Weeks)|Physician Decision|6
2102496|NCT00838916|3694203|FG001|Treatment Period (156 Weeks)|Physician Decision|1
2102497|NCT00838916|3694202|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
2102498|NCT00838916|3694203|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
2102499|NCT00838916|3694202|FG000|Treatment Period (156 Weeks)|Missing|3
2102500|NCT00838916|3694203|FG001|Treatment Period (156 Weeks)|Missing|1
2102501|NCT00838916|3694202|FG000|Treatment Period (156 Weeks)|Pregnancy|2
2102502|NCT00838916|3694203|FG001|Treatment Period (156 Weeks)|Pregnancy|0
2102503|NCT00838916|3694202|FG000|Follow-up Period (8 Weeks)|Adverse Event|10
2102504|NCT00838916|3694203|FG001|Follow-up Period (8 Weeks)|Adverse Event|5
2102505|NCT00838916|3694202|FG000|Follow-up Period (8 Weeks)|Noncompliance|6
2102506|NCT00838916|3694203|FG001|Follow-up Period (8 Weeks)|Noncompliance|5
2102507|NCT00838916|3694202|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38
2102508|NCT00838916|3694203|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22
2102509|NCT00838916|3694202|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
2102510|NCT00838916|3694203|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
2102511|NCT00838916|3694202|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
2102512|NCT00838916|3694203|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
2102513|NCT00838916|3694202|FG000|Follow-up Period (8 Weeks)|Physician Decision|2
2102514|NCT00838916|3694203|FG001|Follow-up Period (8 Weeks)|Physician Decision|0
2102515|NCT00838916|3694202|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
2102516|NCT00838916|3694203|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
2102517|NCT00838916|3694202|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
2102518|NCT00838916|3694203|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
2102519|NCT00838916|3694202|FG000|Follow-up Period (8 Weeks)|Missing|3
2102520|NCT00838916|3694203|FG001|Follow-up Period (8 Weeks)|Missing|0
2102521|NCT00838929|3694212|FG000|Overall Study|Protocol Violation|0
2102522|NCT00838929|3694213|FG001|Overall Study|Protocol Violation|1
2102523|NCT00838929|3694214|FG002|Overall Study|Protocol Violation|0
2102524|NCT00838929|3694212|FG000|Overall Study|Disease progression|0
2102525|NCT00838929|3694213|FG001|Overall Study|Disease progression|2
2102526|NCT00838929|3694214|FG002|Overall Study|Disease progression|1
2102527|NCT00839072|3694220|FG000|First Intervention Period|Withdrawal by Subject|1
2214695|NCT01690052|3857324|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
2102528|NCT00839072|3694221|FG001|First Intervention Period|Withdrawal by Subject|0
2102529|NCT00839072|3694220|FG000|First Intervention Period|Adverse Event|1
2102530|NCT00839072|3694221|FG001|First Intervention Period|Adverse Event|1
2102531|NCT00839072|3694220|FG000|Second Intervention Period|Withdrawal by Subject|1
2102532|NCT00839072|3694221|FG001|Second Intervention Period|Withdrawal by Subject|0
2214696|NCT01690130|3857343|FG000|Overall Study|Subject have cancelled visit.|1
2214697|NCT01690130|3857344|FG001|Overall Study|Subject have cancelled visit.|0
2214698|NCT01690143|3857350|FG000|Overall Study|Withdrawal by Subject|1
2214699|NCT01690299|3857375|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
2214700|NCT01690299|3857376|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
2214701|NCT01690299|3857377|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
2214702|NCT01690299|3857378|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
2214703|NCT01690299|3857379|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
2214704|NCT01690299|3857380|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
2214705|NCT01690299|3857375|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
2214706|NCT01690299|3857376|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2214707|NCT01690299|3857377|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2214708|NCT01690299|3857378|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2102533|NCT00839098|3694230|FG000|Overall Study|Withdrawal by Subject|2
2102534|NCT00839098|3694231|FG001|Overall Study|Withdrawal by Subject|1
2102535|NCT00839098|3694232|FG002|Overall Study|Withdrawal by Subject|7
2102536|NCT00839254|3694257|FG000|Overall Study|Protocol Violation|0
2102537|NCT00839254|3694258|FG001|Overall Study|Protocol Violation|1
2102538|NCT00839254|3694259|FG002|Overall Study|Protocol Violation|1
2102539|NCT00839254|3694260|FG003|Overall Study|Protocol Violation|1
2102540|NCT00839254|3694261|FG004|Overall Study|Protocol Violation|0
2102541|NCT00839254|3694262|FG005|Overall Study|Protocol Violation|0
2102542|NCT00839254|3694263|FG006|Overall Study|Protocol Violation|1
2102543|NCT00839254|3694264|FG007|Overall Study|Protocol Violation|2
2102544|NCT00839254|3694257|FG000|Overall Study|Physician Decision|0
2102545|NCT00839254|3694258|FG001|Overall Study|Physician Decision|1
2102546|NCT00839254|3694259|FG002|Overall Study|Physician Decision|0
2102547|NCT00839254|3694260|FG003|Overall Study|Physician Decision|0
2102548|NCT00839254|3694261|FG004|Overall Study|Physician Decision|0
2102549|NCT00839254|3694262|FG005|Overall Study|Physician Decision|0
2102550|NCT00839254|3694263|FG006|Overall Study|Physician Decision|0
2102551|NCT00839254|3694264|FG007|Overall Study|Physician Decision|1
2102552|NCT00839254|3694257|FG000|Overall Study|Wrong treatment number allocation|0
2102553|NCT00839254|3694258|FG001|Overall Study|Wrong treatment number allocation|1
2102554|NCT00839254|3694259|FG002|Overall Study|Wrong treatment number allocation|0
2102555|NCT00839254|3694260|FG003|Overall Study|Wrong treatment number allocation|0
2102556|NCT00839254|3694261|FG004|Overall Study|Wrong treatment number allocation|0
2102557|NCT00839254|3694262|FG005|Overall Study|Wrong treatment number allocation|1
2102558|NCT00839254|3694263|FG006|Overall Study|Wrong treatment number allocation|0
2102559|NCT00839254|3694264|FG007|Overall Study|Wrong treatment number allocation|0
2102560|NCT00839254|3694257|FG000|Overall Study|Adverse Event|12
2102561|NCT00839254|3694258|FG001|Overall Study|Adverse Event|6
2102562|NCT00839254|3694259|FG002|Overall Study|Adverse Event|3
2102563|NCT00839254|3694260|FG003|Overall Study|Adverse Event|5
2102564|NCT00839254|3694261|FG004|Overall Study|Adverse Event|2
2102565|NCT00839254|3694262|FG005|Overall Study|Adverse Event|1
2102566|NCT00839254|3694263|FG006|Overall Study|Adverse Event|0
2102567|NCT00839254|3694264|FG007|Overall Study|Adverse Event|1
2102568|NCT00839254|3694257|FG000|Overall Study|Withdrawal by Subject|87
2102569|NCT00839254|3694258|FG001|Overall Study|Withdrawal by Subject|53
2102570|NCT00839254|3694259|FG002|Overall Study|Withdrawal by Subject|54
2102571|NCT00839254|3694260|FG003|Overall Study|Withdrawal by Subject|32
2102572|NCT00839254|3694261|FG004|Overall Study|Withdrawal by Subject|27
2102573|NCT00839254|3694262|FG005|Overall Study|Withdrawal by Subject|15
2102574|NCT00839254|3694263|FG006|Overall Study|Withdrawal by Subject|22
2102575|NCT00839254|3694264|FG007|Overall Study|Withdrawal by Subject|9
2102576|NCT00839254|3694257|FG000|Overall Study|Wrong group allocation|0
2102577|NCT00839254|3694258|FG001|Overall Study|Wrong group allocation|0
2102578|NCT00839254|3694259|FG002|Overall Study|Wrong group allocation|0
2102579|NCT00839254|3694260|FG003|Overall Study|Wrong group allocation|0
2102580|NCT00839254|3694261|FG004|Overall Study|Wrong group allocation|0
2102581|NCT00839254|3694262|FG005|Overall Study|Wrong group allocation|0
2102582|NCT00839254|3694263|FG006|Overall Study|Wrong group allocation|1
2102583|NCT00839254|3694264|FG007|Overall Study|Wrong group allocation|0
2102584|NCT00839254|3694257|FG000|Overall Study|Parents wanted pneumococcal vaccine|1
2102585|NCT00839254|3694258|FG001|Overall Study|Parents wanted pneumococcal vaccine|0
2102586|NCT00839254|3694259|FG002|Overall Study|Parents wanted pneumococcal vaccine|0
2102587|NCT00839254|3694260|FG003|Overall Study|Parents wanted pneumococcal vaccine|0
2102588|NCT00839254|3694261|FG004|Overall Study|Parents wanted pneumococcal vaccine|0
2102589|NCT00839254|3694262|FG005|Overall Study|Parents wanted pneumococcal vaccine|1
2102590|NCT00839254|3694263|FG006|Overall Study|Parents wanted pneumococcal vaccine|0
2102591|NCT00839254|3694264|FG007|Overall Study|Parents wanted pneumococcal vaccine|0
2102592|NCT00839254|3694257|FG000|Overall Study|Withdrawn due to non-compliance|2
2102593|NCT00839254|3694258|FG001|Overall Study|Withdrawn due to non-compliance|0
2102594|NCT00839254|3694259|FG002|Overall Study|Withdrawn due to non-compliance|0
2102595|NCT00839254|3694260|FG003|Overall Study|Withdrawn due to non-compliance|0
2102596|NCT00839254|3694261|FG004|Overall Study|Withdrawn due to non-compliance|0
2102597|NCT00839254|3694262|FG005|Overall Study|Withdrawn due to non-compliance|0
2102598|NCT00839254|3694263|FG006|Overall Study|Withdrawn due to non-compliance|0
2102599|NCT00839254|3694264|FG007|Overall Study|Withdrawn due to non-compliance|0
2102600|NCT00839254|3694257|FG000|Overall Study|Lost to Follow-up|51
2102601|NCT00839254|3694258|FG001|Overall Study|Lost to Follow-up|30
2102602|NCT00839254|3694259|FG002|Overall Study|Lost to Follow-up|32
2102603|NCT00839254|3694260|FG003|Overall Study|Lost to Follow-up|24
2102604|NCT00839254|3694261|FG004|Overall Study|Lost to Follow-up|8
2102605|NCT00839254|3694262|FG005|Overall Study|Lost to Follow-up|8
2102606|NCT00839254|3694263|FG006|Overall Study|Lost to Follow-up|4
2102607|NCT00839254|3694264|FG007|Overall Study|Lost to Follow-up|2
2102608|NCT00839306|3694315|FG000|Overall Study|Adverse Event|3
2102609|NCT00839306|3694316|FG001|Overall Study|Adverse Event|5
2102610|NCT00839306|3694315|FG000|Overall Study|Lost to Follow-up|6
2102611|NCT00839306|3694316|FG001|Overall Study|Lost to Follow-up|9
2102612|NCT00839306|3694315|FG000|Overall Study|Withdrawal by Subject|5
2102613|NCT00839306|3694316|FG001|Overall Study|Withdrawal by Subject|7
2102614|NCT00839306|3694315|FG000|Overall Study|Lack of Efficacy|5
2102615|NCT00839306|3694316|FG001|Overall Study|Lack of Efficacy|4
2102616|NCT00839306|3694315|FG000|Overall Study|Other|6
2102617|NCT00839306|3694316|FG001|Overall Study|Other|18
2102618|NCT00839332|3694347|FG000|Phase 1|Disease Progression|38
2102619|NCT00839332|3694348|FG001|Phase 1|Disease Progression|0
2102620|NCT00839332|3694349|FG002|Phase 1|Disease Progression|0
2102621|NCT00839332|3694347|FG000|Phase 1|Adverse Event|6
2102622|NCT00839332|3694348|FG001|Phase 1|Adverse Event|0
2102623|NCT00839332|3694349|FG002|Phase 1|Adverse Event|0
2102624|NCT00839332|3694347|FG000|Phase 1|Withdrawal by Subject|4
2102625|NCT00839332|3694348|FG001|Phase 1|Withdrawal by Subject|0
2102626|NCT00839332|3694349|FG002|Phase 1|Withdrawal by Subject|0
2102627|NCT00839332|3694347|FG000|Phase 1|Physician Decision|2
2102628|NCT00839332|3694348|FG001|Phase 1|Physician Decision|0
2102629|NCT00839332|3694349|FG002|Phase 1|Physician Decision|0
2102630|NCT00839332|3694347|FG000|Phase 2|Protocol Violation|0
2102631|NCT00839332|3694348|FG001|Phase 2|Protocol Violation|1
2102632|NCT00839332|3694349|FG002|Phase 2|Protocol Violation|0
2102633|NCT00839332|3694347|FG000|Phase 2|Disease Progression|0
2102634|NCT00839332|3694348|FG001|Phase 2|Disease Progression|46
2102635|NCT00839332|3694349|FG002|Phase 2|Disease Progression|21
2102636|NCT00839332|3694347|FG000|Phase 2|Adverse Event|0
2102637|NCT00839332|3694348|FG001|Phase 2|Adverse Event|8
2102638|NCT00839332|3694349|FG002|Phase 2|Adverse Event|6
2102639|NCT00839332|3694347|FG000|Phase 2|Death|0
2102640|NCT00839332|3694348|FG001|Phase 2|Death|4
2102641|NCT00839332|3694349|FG002|Phase 2|Death|2
2102642|NCT00839332|3694347|FG000|Phase 2|Withdrawal by Subject|0
2102643|NCT00839332|3694348|FG001|Phase 2|Withdrawal by Subject|5
2102644|NCT00839332|3694349|FG002|Phase 2|Withdrawal by Subject|8
2102645|NCT00839332|3694347|FG000|Phase 2|Physician Decision|0
2102646|NCT00839332|3694348|FG001|Phase 2|Physician Decision|4
2102647|NCT00839332|3694349|FG002|Phase 2|Physician Decision|1
2102648|NCT00839332|3694347|FG000|Phase 2|Lost to Follow-up|0
2102649|NCT00839332|3694348|FG001|Phase 2|Lost to Follow-up|0
2102650|NCT00839332|3694349|FG002|Phase 2|Lost to Follow-up|1
2102651|NCT00839423|3694362|FG000|Overall Study|Adverse Event|4
2102652|NCT00839423|3694363|FG001|Overall Study|Adverse Event|3
2102653|NCT00839423|3694364|FG002|Overall Study|Adverse Event|7
2102654|NCT00839423|3694365|FG003|Overall Study|Adverse Event|16
2102655|NCT00839423|3694362|FG000|Overall Study|Lack of Efficacy|6
2102656|NCT00839423|3694363|FG001|Overall Study|Lack of Efficacy|6
2102657|NCT00839423|3694364|FG002|Overall Study|Lack of Efficacy|3
2102658|NCT00839423|3694365|FG003|Overall Study|Lack of Efficacy|2
2102659|NCT00839423|3694362|FG000|Overall Study|Non-compliance|0
2102660|NCT00839423|3694363|FG001|Overall Study|Non-compliance|0
2102661|NCT00839423|3694364|FG002|Overall Study|Non-compliance|0
2102662|NCT00839423|3694365|FG003|Overall Study|Non-compliance|1
2102663|NCT00839423|3694362|FG000|Overall Study|Protocol Violation|0
2102664|NCT00839423|3694363|FG001|Overall Study|Protocol Violation|1
2102665|NCT00839423|3694364|FG002|Overall Study|Protocol Violation|2
2102666|NCT00839423|3694365|FG003|Overall Study|Protocol Violation|0
2102667|NCT00839423|3694362|FG000|Overall Study|Withdrawal of consent|4
2102668|NCT00839423|3694363|FG001|Overall Study|Withdrawal of consent|0
2102669|NCT00839423|3694364|FG002|Overall Study|Withdrawal of consent|4
2102670|NCT00839423|3694365|FG003|Overall Study|Withdrawal of consent|1
2102671|NCT00839423|3694362|FG000|Overall Study|Lost to Follow-up|1
2102672|NCT00839423|3694363|FG001|Overall Study|Lost to Follow-up|0
2102673|NCT00839423|3694364|FG002|Overall Study|Lost to Follow-up|1
2102674|NCT00839423|3694365|FG003|Overall Study|Lost to Follow-up|0
2214709|NCT01690299|3857379|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2214710|NCT01690299|3857380|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2214711|NCT01690299|3857375|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
2214712|NCT01690299|3857376|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
2214713|NCT01690299|3857377|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2214714|NCT01690299|3857378|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2214715|NCT01690299|3857379|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2214716|NCT01690299|3857380|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2214717|NCT01690299|3857375|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2
2214718|NCT01690299|3857376|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1
2214719|NCT01690299|3857377|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1
2214720|NCT01690299|3857378|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0
2214721|NCT01690299|3857379|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0
2214722|NCT01690299|3857380|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0
2214723|NCT01690299|3857375|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
2214724|NCT01690299|3857376|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
2214725|NCT01690299|3857377|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
2214726|NCT01690299|3857378|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
2214727|NCT01690299|3857379|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
2214728|NCT01690299|3857380|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
2214729|NCT01690299|3857375|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
2214730|NCT01690299|3857376|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
2214731|NCT01690299|3857377|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
2214732|NCT01690299|3857378|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
2214733|NCT01690299|3857379|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
2214734|NCT01690299|3857380|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
2102675|NCT00839423|3694362|FG000|Overall Study|Administrative or other reasons|3
2102676|NCT00839423|3694363|FG001|Overall Study|Administrative or other reasons|0
2102677|NCT00839423|3694364|FG002|Overall Study|Administrative or other reasons|1
2102678|NCT00839423|3694365|FG003|Overall Study|Administrative or other reasons|0
2102679|NCT00839436|3694378|FG000|Overall Study|Developed exclusionary condition|1
2102680|NCT00839436|3694379|FG001|Overall Study|Developed exclusionary condition|0
2102681|NCT00839436|3694380|FG002|Overall Study|Developed exclusionary condition|0
2102682|NCT00839436|3694378|FG000|Overall Study|Withdrawal by Subject|0
2102683|NCT00839436|3694379|FG001|Overall Study|Withdrawal by Subject|1
2102684|NCT00839436|3694380|FG002|Overall Study|Withdrawal by Subject|0
2102685|NCT00839436|3694378|FG000|Overall Study|Study drug no longer available|0
2102686|NCT00839436|3694379|FG001|Overall Study|Study drug no longer available|0
2102687|NCT00839436|3694380|FG002|Overall Study|Study drug no longer available|1
2102688|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11
2102689|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29
2102690|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22
2102691|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
2102692|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
2102693|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
2102694|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5
2102695|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6
2102696|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16
2102697|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
2102698|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
2102699|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
2102700|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
2102701|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
2102702|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
2102703|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1
2102704|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6
2102705|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1
2102706|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
2102707|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
2102708|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
2102709|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Missing|0
2102710|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Missing|1
2102711|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Missing|0
2102712|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
2102713|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
2102714|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
2102715|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0
2102716|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1
2102717|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1
2102718|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1
2102719|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2
2102720|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0
2102721|NCT00839527|3694391|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
2102722|NCT00839527|3694392|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
2102723|NCT00839527|3694393|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
2102724|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
2102725|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
2102726|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
2102727|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
2102728|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
2214735|NCT01690299|3857375|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2214736|NCT01690299|3857376|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2214737|NCT01690299|3857377|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2214738|NCT01690299|3857378|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2214739|NCT01690299|3857379|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
2214740|NCT01690299|3857380|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
2214741|NCT01690299|3857375|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
2214742|NCT01690299|3857376|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
2102729|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
2102730|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
2102731|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
2102732|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
2102733|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
2102734|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
2102735|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
2102736|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
2102737|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
2102738|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
2102739|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
2102740|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
2102741|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
2102742|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
2102743|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
2102744|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
2102745|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
2102746|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
2102747|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
2102748|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
2102749|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
2102750|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
2102751|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
2102752|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
2102753|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
2102754|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
2102755|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
2102756|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
2102757|NCT00839527|3694391|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
2102758|NCT00839527|3694392|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
2102759|NCT00839527|3694393|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
2108041|NCT00877799|3701846|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
2108042|NCT00877799|3701847|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
2108043|NCT00877799|3701848|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
2108044|NCT00877799|3701849|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
2108045|NCT00877799|3701850|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
2108046|NCT00877799|3701846|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
2108047|NCT00877799|3701847|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
2108048|NCT00877799|3701848|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
2108049|NCT00877799|3701849|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
2108050|NCT00877799|3701850|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
2108051|NCT00877890|3701872|FG000|Overall Study|Adverse Event|6
2108052|NCT00877890|3701873|FG001|Overall Study|Adverse Event|6
2108053|NCT00877890|3701872|FG000|Overall Study|Lost to Follow-up|5
2108054|NCT00877890|3701873|FG001|Overall Study|Lost to Follow-up|5
2108055|NCT00877890|3701872|FG000|Overall Study|Protocol Violation|0
2108056|NCT00877890|3701873|FG001|Overall Study|Protocol Violation|1
2108057|NCT00877890|3701872|FG000|Overall Study|Withdrawal of Consent|6
2108058|NCT00877890|3701873|FG001|Overall Study|Withdrawal of Consent|12
2108059|NCT00877890|3701872|FG000|Overall Study|Investigator Decision|0
2108060|NCT00877890|3701873|FG001|Overall Study|Investigator Decision|2
2108061|NCT00877890|3701872|FG000|Overall Study|Loss of Glucose Control|3
2108062|NCT00877890|3701873|FG001|Overall Study|Loss of Glucose Control|4
2108063|NCT00877929|3701885|FG000|Overall Study|Adverse Event|11
2108064|NCT00877929|3701886|FG001|Overall Study|Adverse Event|20
2108065|NCT00877929|3701885|FG000|Overall Study|Protocol Violation|3
2108066|NCT00877929|3701886|FG001|Overall Study|Protocol Violation|3
2108067|NCT00877929|3701885|FG000|Overall Study|Lost to Follow-up|0
2108068|NCT00877929|3701886|FG001|Overall Study|Lost to Follow-up|1
2108069|NCT00877929|3701885|FG000|Overall Study|Withdrawal by Subject|4
2108070|NCT00877929|3701886|FG001|Overall Study|Withdrawal by Subject|4
2108071|NCT00877929|3701885|FG000|Overall Study|Lack of Efficacy|0
2108072|NCT00877929|3701886|FG001|Overall Study|Lack of Efficacy|1
2108073|NCT00877929|3701885|FG000|Overall Study|Other reason (not specified)|2
2108074|NCT00877929|3701886|FG001|Overall Study|Other reason (not specified)|6
2108075|NCT00878072|3701896|FG000|Overall Study|Withdrew consent|2
2108076|NCT00878189|3701907|FG000|Overall Study|Death|0
2108077|NCT00878189|3701908|FG001|Overall Study|Death|1
2108078|NCT00878189|3701909|FG002|Overall Study|Death|0
2108079|NCT00878189|3701910|FG003|Overall Study|Death|1
2108080|NCT00878189|3701911|FG004|Overall Study|Death|0
2108081|NCT00878189|3701912|FG005|Overall Study|Death|0
2108082|NCT00878189|3701913|FG006|Overall Study|Death|0
2108083|NCT00878189|3701914|FG007|Overall Study|Death|0
2108084|NCT00878189|3701915|FG008|Overall Study|Death|1
2108085|NCT00878189|3701907|FG000|Overall Study|Participant Refused to Follow-up|0
2108086|NCT00878189|3701908|FG001|Overall Study|Participant Refused to Follow-up|0
2108087|NCT00878189|3701909|FG002|Overall Study|Participant Refused to Follow-up|0
2108088|NCT00878189|3701910|FG003|Overall Study|Participant Refused to Follow-up|0
2108089|NCT00878189|3701911|FG004|Overall Study|Participant Refused to Follow-up|0
2108090|NCT00878189|3701912|FG005|Overall Study|Participant Refused to Follow-up|4
2108091|NCT00878189|3701913|FG006|Overall Study|Participant Refused to Follow-up|0
2108092|NCT00878189|3701914|FG007|Overall Study|Participant Refused to Follow-up|0
2108093|NCT00878189|3701915|FG008|Overall Study|Participant Refused to Follow-up|0
2108094|NCT00878189|3701907|FG000|Overall Study|Other|3
2108095|NCT00878189|3701908|FG001|Overall Study|Other|2
2108096|NCT00878189|3701909|FG002|Overall Study|Other|4
2108097|NCT00878189|3701910|FG003|Overall Study|Other|7
2102760|NCT00839800|3694418|FG000|Overall Study|Adverse Event|8
2102761|NCT00839800|3694419|FG001|Overall Study|Adverse Event|12
2102762|NCT00839800|3694418|FG000|Overall Study|Lost to Follow-up|31
2102763|NCT00839800|3694419|FG001|Overall Study|Lost to Follow-up|26
2102764|NCT00839800|3694418|FG000|Overall Study|Withdrawal by Subject|28
2102765|NCT00839800|3694419|FG001|Overall Study|Withdrawal by Subject|34
2102766|NCT00839800|3694418|FG000|Overall Study|Incorrect Enrolment|3
2102767|NCT00839800|3694419|FG001|Overall Study|Incorrect Enrolment|3
2102768|NCT00839800|3694418|FG000|Overall Study|Study-Specific Discontinuation Criteria|6
2102769|NCT00839800|3694419|FG001|Overall Study|Study-Specific Discontinuation Criteria|13
2102770|NCT00839800|3694418|FG000|Overall Study|Safety Reasons|2
2102771|NCT00839800|3694419|FG001|Overall Study|Safety Reasons|1
2102772|NCT00839800|3694418|FG000|Overall Study|Other|8
2102773|NCT00839800|3694419|FG001|Overall Study|Other|14
2102774|NCT00839800|3694418|FG000|Overall Study|Severe Non-Compliance to Protocol|7
2102775|NCT00839800|3694419|FG001|Overall Study|Severe Non-Compliance to Protocol|7
2102776|NCT00839852|3694425|FG000|Overall Study|Adverse Event|10
2102777|NCT00839852|3694425|FG000|Overall Study|Insufficient Therapeutic Response|3
2102778|NCT00839852|3694425|FG000|Overall Study|Protocol Violation|9
2102779|NCT00839852|3694425|FG000|Overall Study|Withdrawal of Consent|16
2102780|NCT00839852|3694425|FG000|Overall Study|Lost to Follow-up|7
2102781|NCT00839852|3694425|FG000|Overall Study|Lack of Compliance While in Jail|1
2102782|NCT00839852|3694425|FG000|Overall Study|Pregnancy|1
2102783|NCT00839917|3694431|FG000|Overall Study|Lost to Follow-up|1
2102784|NCT00839917|3694432|FG001|Overall Study|Lost to Follow-up|0
2102785|NCT00839917|3694431|FG000|Overall Study|Did not receive vaccine|0
2102786|NCT00839917|3694432|FG001|Overall Study|Did not receive vaccine|1
2102787|NCT00839956|3694438|FG000|Overall Study|Adverse Event|2
2102788|NCT00839956|3694438|FG000|Overall Study|Lack of Efficacy|6
2102789|NCT00839956|3694438|FG000|Overall Study|Physician Decision|1
2102790|NCT00839956|3694438|FG000|Overall Study|Withdrawal by Subject|3
2102791|NCT00840034|3694455|FG000|Acute Treatment Phase|Adverse Event|6
2102792|NCT00840034|3694456|FG001|Acute Treatment Phase|Adverse Event|8
2102793|NCT00840034|3694455|FG000|Acute Treatment Phase|Lack of Efficacy|2
2102794|NCT00840034|3694456|FG001|Acute Treatment Phase|Lack of Efficacy|0
2102795|NCT00840034|3694455|FG000|Acute Treatment Phase|Lost to Follow-up|5
2102796|NCT00840034|3694456|FG001|Acute Treatment Phase|Lost to Follow-up|12
2102797|NCT00840034|3694455|FG000|Acute Treatment Phase|Physician Decision|0
2102798|NCT00840034|3694456|FG001|Acute Treatment Phase|Physician Decision|1
2102799|NCT00840034|3694455|FG000|Acute Treatment Phase|Protocol Violation|2
2102800|NCT00840034|3694456|FG001|Acute Treatment Phase|Protocol Violation|4
2102801|NCT00840034|3694455|FG000|Acute Treatment Phase|Withdrawal by Subject|6
2102802|NCT00840034|3694456|FG001|Acute Treatment Phase|Withdrawal by Subject|11
2102803|NCT00840034|3694455|FG000|Taper Phase|Adverse Event|1
2102804|NCT00840034|3694456|FG001|Taper Phase|Adverse Event|0
2102805|NCT00840034|3694455|FG000|Taper Phase|Lost to Follow-up|1
2102806|NCT00840034|3694456|FG001|Taper Phase|Lost to Follow-up|1
2102807|NCT00840034|3694455|FG000|Taper Phase|Withdrawal by Subject|1
2102808|NCT00840034|3694456|FG001|Taper Phase|Withdrawal by Subject|1
2102809|NCT00840060|3694466|FG000|Overall Study|Withdrawal by Subject|1
2102810|NCT00840060|3694467|FG001|Overall Study|Withdrawal by Subject|0
2102811|NCT00840060|3694466|FG000|Overall Study|Change in emotional/behavioral status|0
2102812|NCT00840060|3694467|FG001|Overall Study|Change in emotional/behavioral status|1
2102813|NCT00840086|3694473|FG000|Overall Study|Adverse Event|1
2102814|NCT00840086|3694473|FG000|Overall Study|Protocol Violation|2
2102815|NCT00840086|3694473|FG000|Overall Study|Lost to Follow-up|1
2102816|NCT00840294|3694482|FG000|Overall Study|Withdrawal by Subject|2
2102817|NCT00840294|3694483|FG001|Overall Study|Withdrawal by Subject|1
2102818|NCT00840294|3694482|FG000|Overall Study|Protocol Violation|1
2102819|NCT00840294|3694483|FG001|Overall Study|Protocol Violation|3
2102820|NCT00840294|3694482|FG000|Overall Study|Illness|0
2102821|NCT00840294|3694483|FG001|Overall Study|Illness|1
2102822|NCT00840450|3694493|FG000|Overall Study|Adverse Event|1
2102823|NCT00840450|3694493|FG000|Overall Study|Lack of Efficacy|2
2102824|NCT00840463|3694499|FG000|Overall Study|Adverse Event|1
2102825|NCT00840463|3694500|FG001|Overall Study|Adverse Event|0
2102826|NCT00840658|3694510|FG000|Overall Study|Death|2
2102827|NCT00840658|3694511|FG001|Overall Study|Death|2
2102828|NCT00840658|3694512|FG002|Overall Study|Death|3
2102829|NCT00840658|3694513|FG003|Overall Study|Death|3
2102830|NCT00840658|3694510|FG000|Overall Study|Lost to Follow-up|3
2102831|NCT00840658|3694511|FG001|Overall Study|Lost to Follow-up|1
2102832|NCT00840658|3694512|FG002|Overall Study|Lost to Follow-up|2
2102833|NCT00840658|3694513|FG003|Overall Study|Lost to Follow-up|1
2102834|NCT00840749|3694529|FG000|Overall Study|Death|1
2102835|NCT00840749|3694530|FG001|Overall Study|Death|2
2102836|NCT00840749|3694529|FG000|Overall Study|not treated on study arm|11
2102837|NCT00840749|3694530|FG001|Overall Study|not treated on study arm|11
2102838|NCT00840749|3694529|FG000|Overall Study|study closed|19
2102839|NCT00840749|3694530|FG001|Overall Study|study closed|14
2102840|NCT00840970|3694536|FG000|Overall Study|Adverse Event|0
2102841|NCT00840970|3694537|FG001|Overall Study|Adverse Event|0
2102842|NCT00840970|3694538|FG002|Overall Study|Adverse Event|1
2102843|NCT00840996|3694550|FG000|Overall Study|Withdrawal by Subject|1
2102844|NCT00840996|3694551|FG001|Overall Study|Withdrawal by Subject|0
2102845|NCT00841100|3694566|FG000|Phase 1 (28 Days)|Adverse Event|1
2102846|NCT00841100|3694566|FG000|Phase 1 (28 Days)|Participant non-compliance|2
2102847|NCT00841321|3694591|FG000|Overall Study|Lost to Follow-up|1
2102848|NCT00841321|3694592|FG001|Overall Study|Lost to Follow-up|1
2102849|NCT00841321|3694591|FG000|Overall Study|Adverse Event|0
2102850|NCT00841321|3694592|FG001|Overall Study|Adverse Event|2
2102851|NCT00841568|3694616|FG000|Overall Study|Adverse Event|1
2102852|NCT00841568|3694616|FG000|Overall Study|Death|1
2102853|NCT00841568|3694616|FG000|Overall Study|Withdrawal by Subject|2
2102854|NCT00841568|3694616|FG000|Overall Study|Creatinine over the withdrawal criteria|1
2102855|NCT00841672|3694626|FG000|Overall Study|Adverse Event|7
2102856|NCT00841672|3694627|FG001|Overall Study|Adverse Event|16
2102857|NCT00841672|3694626|FG000|Overall Study|Abnormal test procedure result(s)|0
2102858|NCT00841672|3694627|FG001|Overall Study|Abnormal test procedure result(s)|1
2102859|NCT00841672|3694626|FG000|Overall Study|Subject withdrew consent|2
2102860|NCT00841672|3694627|FG001|Overall Study|Subject withdrew consent|4
2102861|NCT00841672|3694626|FG000|Overall Study|Lost to Follow-up|1
2102862|NCT00841672|3694627|FG001|Overall Study|Lost to Follow-up|1
2102863|NCT00841672|3694626|FG000|Overall Study|Administrative problems|9
2102864|NCT00841672|3694627|FG001|Overall Study|Administrative problems|9
2102865|NCT00841672|3694626|FG000|Overall Study|Misrandomized|1
2102866|NCT00841672|3694627|FG001|Overall Study|Misrandomized|0
2102867|NCT00841672|3694626|FG000|Overall Study|Protocol Deviation|0
2102868|NCT00841672|3694627|FG001|Overall Study|Protocol Deviation|1
2102869|NCT00841763|3694635|FG000|Overall Study|Withdrawal by Subject|60
2102870|NCT00841763|3694636|FG001|Overall Study|Withdrawal by Subject|17
2102871|NCT00841763|3694637|FG002|Overall Study|Withdrawal by Subject|4
2102872|NCT00841763|3694638|FG003|Overall Study|Withdrawal by Subject|1
2102873|NCT00841763|3694635|FG000|Overall Study|Adverse Event|9
2102874|NCT00841763|3694636|FG001|Overall Study|Adverse Event|10
2102875|NCT00841763|3694637|FG002|Overall Study|Adverse Event|3
2102876|NCT00841763|3694638|FG003|Overall Study|Adverse Event|2
2102877|NCT00841763|3694635|FG000|Overall Study|Lost to Follow-up|63
2102878|NCT00841763|3694636|FG001|Overall Study|Lost to Follow-up|25
2102879|NCT00841763|3694637|FG002|Overall Study|Lost to Follow-up|0
2102880|NCT00841763|3694638|FG003|Overall Study|Lost to Follow-up|0
2102881|NCT00841763|3694635|FG000|Overall Study|Protocol Violation|20
2102882|NCT00841763|3694636|FG001|Overall Study|Protocol Violation|3
2102883|NCT00841763|3694637|FG002|Overall Study|Protocol Violation|1
2102884|NCT00841763|3694638|FG003|Overall Study|Protocol Violation|0
2102885|NCT00841763|3694635|FG000|Overall Study|Administrative Reasons|3
2102886|NCT00841763|3694636|FG001|Overall Study|Administrative Reasons|1
2102887|NCT00841763|3694637|FG002|Overall Study|Administrative Reasons|0
2102888|NCT00841763|3694638|FG003|Overall Study|Administrative Reasons|0
2102889|NCT00841763|3694635|FG000|Overall Study|Unable to Classify|7
2102890|NCT00841763|3694636|FG001|Overall Study|Unable to Classify|1
2102891|NCT00841763|3694637|FG002|Overall Study|Unable to Classify|0
2102892|NCT00841763|3694638|FG003|Overall Study|Unable to Classify|0
2102893|NCT00841776|3694685|FG000|Overall Study|Lack of Efficacy|0
2102894|NCT00841776|3694686|FG001|Overall Study|Lack of Efficacy|1
2102895|NCT00841776|3694685|FG000|Overall Study|Lost to Follow-up|2
2102896|NCT00841776|3694686|FG001|Overall Study|Lost to Follow-up|1
2102897|NCT00841776|3694685|FG000|Overall Study|Withdrawal by Subject|0
2214743|NCT01690299|3857377|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
2214744|NCT01690299|3857378|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
2214745|NCT01690299|3857379|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
2214746|NCT01690299|3857380|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
2214747|NCT01690299|3857375|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
2214748|NCT01690299|3857376|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
2214749|NCT01690299|3857377|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
2214750|NCT01690299|3857378|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
2214751|NCT01690299|3857379|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
2214752|NCT01690299|3857380|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
2177497|NCT01374568|3801687|FG001|Overall Study|Lab unable to analyze BTM|2
2177498|NCT01374906|3801701|FG000|Overall Study|Abnormal laboratory value(s)|0
2313427|NCT02790606|4020938|FG000|Overall Study|Death|27
2313428|NCT02790606|4020938|FG000|Overall Study|Lost to Follow-up|4
2313429|NCT02790606|4020938|FG000|Overall Study|Physician Decision|3
2313430|NCT02790606|4020938|FG000|Overall Study|Withdrawal by Subject|1
2102898|NCT00841776|3694686|FG001|Overall Study|Withdrawal by Subject|1
2177499|NCT01374906|3801702|FG001|Overall Study|Abnormal laboratory value(s)|3
2177500|NCT01374906|3801701|FG000|Overall Study|Administrative problems|2
2177501|NCT01374906|3801702|FG001|Overall Study|Administrative problems|2
2177502|NCT01374906|3801701|FG000|Overall Study|Adverse Event|10
2177503|NCT01374906|3801702|FG001|Overall Study|Adverse Event|11
2177504|NCT01374906|3801701|FG000|Overall Study|Death|0
2177505|NCT01374906|3801702|FG001|Overall Study|Death|2
2214753|NCT01690299|3857375|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2214754|NCT01690299|3857376|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2214755|NCT01690299|3857377|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2313431|NCT02791191|4020965|FG000|Overall Study|Adverse Event|2
2102899|NCT00841906|3694705|FG000|Overall Study|Withdrawal by Subject|2
2102900|NCT00841906|3694706|FG001|Overall Study|Withdrawal by Subject|0
2102901|NCT00842153|3694746|FG000|Overall Study|Adverse Event|0
2102902|NCT00842153|3694747|FG001|Overall Study|Adverse Event|1
2102903|NCT00842153|3694746|FG000|Overall Study|Lost to Follow-up|1
2102904|NCT00842153|3694747|FG001|Overall Study|Lost to Follow-up|2
2102905|NCT00842244|3694757|FG000|Overall Study|Death|3
2102906|NCT00842244|3694757|FG000|Overall Study|Withdrawal by Subject|1
2102907|NCT00842244|3694757|FG000|Overall Study|Other|17
2102908|NCT00842257|3694764|FG000|Overall Study|Adverse Event|1
2102909|NCT00842309|3694774|FG000|Overall Study|Withdrawal by Subject|3
2102910|NCT00842309|3694775|FG001|Overall Study|Withdrawal by Subject|1
2102911|NCT00842348|3694789|FG000|Patients Randomised in Study 726|Did not enter Study 729|59
2102912|NCT00842348|3694790|FG001|Patients Randomised in Study 726|Did not enter Study 729|56
2102913|NCT00842348|3694789|FG000|Study 729|Disease progression/death|19
2102914|NCT00842348|3694790|FG001|Study 729|Disease progression/death|30
2102915|NCT00842348|3694789|FG000|Study 729|Adverse Event|1
2102916|NCT00842348|3694790|FG001|Study 729|Adverse Event|1
2102917|NCT00842348|3694789|FG000|Study 729|Protocol Violation|1
2102918|NCT00842348|3694790|FG001|Study 729|Protocol Violation|1
2102919|NCT00842348|3694789|FG000|Study 729|Withdrawal by Subject|2
2102920|NCT00842348|3694790|FG001|Study 729|Withdrawal by Subject|4
2102921|NCT00842348|3694789|FG000|Study 729|Due to Sponsor stopping the study|1
2102922|NCT00842348|3694790|FG001|Study 729|Due to Sponsor stopping the study|1
2102923|NCT00842348|3694789|FG000|Study 729|Due to non-availability of IP|0
2102924|NCT00842348|3694790|FG001|Study 729|Due to non-availability of IP|1
2102925|NCT00842348|3694789|FG000|Study 729|Sponsor's decision|1
2102926|NCT00842348|3694790|FG001|Study 729|Sponsor's decision|0
2102927|NCT00842348|3694789|FG000|Study 729|Surgical resection|1
2102928|NCT00842348|3694790|FG001|Study 729|Surgical resection|0
2102929|NCT00842361|3694802|FG000|Overall Study|Protocol Violation|1
2102930|NCT00842361|3694803|FG001|Overall Study|Protocol Violation|0
2102931|NCT00842361|3694802|FG000|Overall Study|Unclassified|0
2102932|NCT00842361|3694803|FG001|Overall Study|Unclassified|2
2102933|NCT00842530|3694811|FG000|Overall Study|Serious adverse event|0
2102934|NCT00842530|3694812|FG001|Overall Study|Serious adverse event|6
2102935|NCT00842530|3694811|FG000|Overall Study|Other adverse event|6
2102936|NCT00842530|3694812|FG001|Overall Study|Other adverse event|1
2102937|NCT00842530|3694811|FG000|Overall Study|Protocol Violation|32
2102938|NCT00842530|3694812|FG001|Overall Study|Protocol Violation|14
2102939|NCT00842530|3694811|FG000|Overall Study|Lost to Follow-up|6
2102940|NCT00842530|3694812|FG001|Overall Study|Lost to Follow-up|8
2102941|NCT00842530|3694811|FG000|Overall Study|Withdrawal by Subject|73
2102942|NCT00842530|3694812|FG001|Overall Study|Withdrawal by Subject|28
2102943|NCT00842543|3694823|FG000|Overall Study|Withdrawal by Subject|2
2102944|NCT00842543|3694824|FG001|Overall Study|Withdrawal by Subject|0
2102945|NCT00842543|3694825|FG002|Overall Study|Withdrawal by Subject|3
2102946|NCT00842543|3694826|FG003|Overall Study|Withdrawal by Subject|4
2102947|NCT00842712|3694862|FG000|Safety Run-in Part|Adverse Event|0
2102948|NCT00842712|3694863|FG001|Safety Run-in Part|Adverse Event|1
2102949|NCT00842712|3694864|FG002|Safety Run-in Part|Adverse Event|0
2102950|NCT00842712|3694865|FG003|Safety Run-in Part|Adverse Event|0
2102951|NCT00842712|3694866|FG004|Safety Run-in Part|Adverse Event|0
2102952|NCT00842712|3694867|FG005|Safety Run-in Part|Adverse Event|0
2102953|NCT00842712|3694868|FG006|Safety Run-in Part|Adverse Event|0
2102954|NCT00842712|3694862|FG000|Safety Run-in Part|Progressive disease|3
2102955|NCT00842712|3694863|FG001|Safety Run-in Part|Progressive disease|1
2102956|NCT00842712|3694864|FG002|Safety Run-in Part|Progressive disease|0
2102957|NCT00842712|3694865|FG003|Safety Run-in Part|Progressive disease|1
2102958|NCT00842712|3694866|FG004|Safety Run-in Part|Progressive disease|0
2102959|NCT00842712|3694867|FG005|Safety Run-in Part|Progressive disease|0
2102960|NCT00842712|3694868|FG006|Safety Run-in Part|Progressive disease|0
2102961|NCT00842712|3694862|FG000|Randomized Part|Randomized but not treated|0
2102962|NCT00842712|3694863|FG001|Randomized Part|Randomized but not treated|0
2102963|NCT00842712|3694864|FG002|Randomized Part|Randomized but not treated|0
2102964|NCT00842712|3694865|FG003|Randomized Part|Randomized but not treated|0
2102965|NCT00842712|3694866|FG004|Randomized Part|Randomized but not treated|0
2102966|NCT00842712|3694867|FG005|Randomized Part|Randomized but not treated|1
2102967|NCT00842712|3694868|FG006|Randomized Part|Randomized but not treated|4
2102968|NCT00842712|3694862|FG000|Randomized Part|Ongoing at cut-off date|0
2102969|NCT00842712|3694863|FG001|Randomized Part|Ongoing at cut-off date|0
2102970|NCT00842712|3694864|FG002|Randomized Part|Ongoing at cut-off date|0
2102971|NCT00842712|3694865|FG003|Randomized Part|Ongoing at cut-off date|0
2102972|NCT00842712|3694866|FG004|Randomized Part|Ongoing at cut-off date|0
2102973|NCT00842712|3694867|FG005|Randomized Part|Ongoing at cut-off date|0
2102974|NCT00842712|3694868|FG006|Randomized Part|Ongoing at cut-off date|2
2102975|NCT00842829|3694903|FG000|Dose Titration Period|Adverse Event|11
2102976|NCT00842829|3694904|FG001|Dose Titration Period|Adverse Event|10
2102977|NCT00842829|3694905|FG002|Dose Titration Period|Adverse Event|0
2102978|NCT00842829|3694903|FG000|Dose Titration Period|Lack of Efficacy|4
2102979|NCT00842829|3694904|FG001|Dose Titration Period|Lack of Efficacy|1
2102980|NCT00842829|3694905|FG002|Dose Titration Period|Lack of Efficacy|0
2102981|NCT00842829|3694903|FG000|Dose Titration Period|Unstable persistent cancer pain|1
2102982|NCT00842829|3694904|FG001|Dose Titration Period|Unstable persistent cancer pain|0
2102983|NCT00842829|3694905|FG002|Dose Titration Period|Unstable persistent cancer pain|0
2102984|NCT00842829|3694903|FG000|Dose Titration Period|Withdrawal by Subject|2
2102985|NCT00842829|3694904|FG001|Dose Titration Period|Withdrawal by Subject|6
2102986|NCT00842829|3694905|FG002|Dose Titration Period|Withdrawal by Subject|0
2102987|NCT00842829|3694903|FG000|Dose Titration Period|Other|5
2102988|NCT00842829|3694904|FG001|Dose Titration Period|Other|4
2102989|NCT00842829|3694905|FG002|Dose Titration Period|Other|0
2102990|NCT00842829|3694903|FG000|Dose Titration Period|Non-compliance to study procedures|1
2102991|NCT00842829|3694904|FG001|Dose Titration Period|Non-compliance to study procedures|1
2102992|NCT00842829|3694905|FG002|Dose Titration Period|Non-compliance to study procedures|0
2102993|NCT00842829|3694903|FG000|Dose Titration Period|Non-compliance to study drug|2
2102994|NCT00842829|3694904|FG001|Dose Titration Period|Non-compliance to study drug|1
2102995|NCT00842829|3694905|FG002|Dose Titration Period|Non-compliance to study drug|0
2102996|NCT00842829|3694903|FG000|Treatment Period|Adverse Event|0
2102997|NCT00842829|3694904|FG001|Treatment Period|Adverse Event|0
2102998|NCT00842829|3694905|FG002|Treatment Period|Adverse Event|15
2102999|NCT00842829|3694903|FG000|Treatment Period|Lack of Efficacy|0
2103000|NCT00842829|3694904|FG001|Treatment Period|Lack of Efficacy|0
2103001|NCT00842829|3694905|FG002|Treatment Period|Lack of Efficacy|6
2103002|NCT00842829|3694903|FG000|Treatment Period|Unstable persistent cancer pain|0
2103003|NCT00842829|3694904|FG001|Treatment Period|Unstable persistent cancer pain|0
2103004|NCT00842829|3694905|FG002|Treatment Period|Unstable persistent cancer pain|5
2103005|NCT00842829|3694903|FG000|Treatment Period|Withdrawal by Subject|0
2103006|NCT00842829|3694904|FG001|Treatment Period|Withdrawal by Subject|0
2103007|NCT00842829|3694905|FG002|Treatment Period|Withdrawal by Subject|11
2103008|NCT00842829|3694903|FG000|Treatment Period|Consistently >4 BTP episodes daily|0
2103009|NCT00842829|3694904|FG001|Treatment Period|Consistently >4 BTP episodes daily|0
2103010|NCT00842829|3694905|FG002|Treatment Period|Consistently >4 BTP episodes daily|1
2103011|NCT00842829|3694903|FG000|Treatment Period|Protocol Violation|0
2103012|NCT00842829|3694904|FG001|Treatment Period|Protocol Violation|0
2103013|NCT00842829|3694905|FG002|Treatment Period|Protocol Violation|2
2103014|NCT00842829|3694903|FG000|Treatment Period|Other|0
2103015|NCT00842829|3694904|FG001|Treatment Period|Other|0
2103016|NCT00842829|3694905|FG002|Treatment Period|Other|18
2103017|NCT00842829|3694903|FG000|Treatment Period|Non-compliance to study procedures|0
2103018|NCT00842829|3694904|FG001|Treatment Period|Non-compliance to study procedures|0
2103019|NCT00842829|3694905|FG002|Treatment Period|Non-compliance to study procedures|4
2103020|NCT00842829|3694903|FG000|Treatment Period|Unclear completion status|0
2214756|NCT01690299|3857378|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2214757|NCT01690299|3857379|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2214758|NCT01690299|3857380|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
2214759|NCT01690520|3857403|FG000|Overall Study|Death|25
2214760|NCT01690520|3857404|FG001|Overall Study|Death|21
2214761|NCT01690520|3857403|FG000|Overall Study|Lost to Follow-up|2
2214762|NCT01690520|3857404|FG001|Overall Study|Lost to Follow-up|3
2214763|NCT01690520|3857403|FG000|Overall Study|Withdrawal by Subject|2
2214764|NCT01690520|3857404|FG001|Overall Study|Withdrawal by Subject|0
2214765|NCT01690520|3857403|FG000|Overall Study|Relapse|0
2214766|NCT01690520|3857404|FG001|Overall Study|Relapse|1
2214767|NCT01690520|3857403|FG000|Overall Study|Other|0
2214768|NCT01690520|3857404|FG001|Overall Study|Other|1
2214769|NCT01690520|3857403|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22
2214770|NCT01690520|3857404|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21
2214771|NCT01690988|3857439|FG000|Overall Study|Withdrawal by Subject|2
2214772|NCT01690988|3857440|FG001|Overall Study|Withdrawal by Subject|2
2214773|NCT01690988|3857441|FG002|Overall Study|Withdrawal by Subject|3
2214774|NCT01690988|3857439|FG000|Overall Study|Physician Decision|0
2214775|NCT01690988|3857440|FG001|Overall Study|Physician Decision|0
2214776|NCT01690988|3857441|FG002|Overall Study|Physician Decision|1
2214777|NCT01690988|3857439|FG000|Overall Study|Operation Cancelled|1
2214778|NCT01690988|3857440|FG001|Overall Study|Operation Cancelled|1
2214779|NCT01690988|3857441|FG002|Overall Study|Operation Cancelled|0
2214780|NCT01690988|3857439|FG000|Overall Study|Determined ineligible|1
2313432|NCT02791191|4020966|FG001|Overall Study|Adverse Event|4
2313433|NCT02791191|4020967|FG002|Overall Study|Adverse Event|5
2313434|NCT02791191|4020965|FG000|Overall Study|Lack of Efficacy|0
2313435|NCT02791191|4020966|FG001|Overall Study|Lack of Efficacy|1
2313436|NCT02791191|4020967|FG002|Overall Study|Lack of Efficacy|0
2313437|NCT02791191|4020965|FG000|Overall Study|Study Drug Non-Compliance|0
2313438|NCT02791191|4020966|FG001|Overall Study|Study Drug Non-Compliance|2
2313439|NCT02791191|4020967|FG002|Overall Study|Study Drug Non-Compliance|0
2313440|NCT02791191|4020965|FG000|Overall Study|Site Closed by Sponsor|1
2313441|NCT02791191|4020966|FG001|Overall Study|Site Closed by Sponsor|1
2313442|NCT02791191|4020967|FG002|Overall Study|Site Closed by Sponsor|3
2313443|NCT02791191|4020965|FG000|Overall Study|Progressive Disease|1
2313444|NCT02791191|4020966|FG001|Overall Study|Progressive Disease|0
2313445|NCT02791191|4020967|FG002|Overall Study|Progressive Disease|0
2313446|NCT02791191|4020965|FG000|Overall Study|Study Terminated by Sponsor|29
2103021|NCT00842829|3694904|FG001|Treatment Period|Unclear completion status|0
2103022|NCT00842829|3694905|FG002|Treatment Period|Unclear completion status|1
2103023|NCT00842829|3694903|FG000|Continuation Period|Adverse Event|0
2103024|NCT00842829|3694904|FG001|Continuation Period|Adverse Event|0
2103025|NCT00842829|3694905|FG002|Continuation Period|Adverse Event|32
2103026|NCT00842829|3694903|FG000|Continuation Period|Lack of Efficacy|0
2103027|NCT00842829|3694904|FG001|Continuation Period|Lack of Efficacy|0
2103028|NCT00842829|3694905|FG002|Continuation Period|Lack of Efficacy|6
2103029|NCT00842829|3694903|FG000|Continuation Period|Unstable persistent cancer pain|0
2103030|NCT00842829|3694904|FG001|Continuation Period|Unstable persistent cancer pain|0
2103031|NCT00842829|3694905|FG002|Continuation Period|Unstable persistent cancer pain|3
2103032|NCT00842829|3694903|FG000|Continuation Period|Withdrawal by Subject|0
2103033|NCT00842829|3694904|FG001|Continuation Period|Withdrawal by Subject|0
2103034|NCT00842829|3694905|FG002|Continuation Period|Withdrawal by Subject|10
2103035|NCT00842829|3694903|FG000|Continuation Period|Other|0
2103036|NCT00842829|3694904|FG001|Continuation Period|Other|0
2103037|NCT00842829|3694905|FG002|Continuation Period|Other|7
2103038|NCT00842829|3694903|FG000|Continuation Period|Non-compliance to study procedures|0
2103039|NCT00842829|3694904|FG001|Continuation Period|Non-compliance to study procedures|0
2103040|NCT00842829|3694905|FG002|Continuation Period|Non-compliance to study procedures|2
2103041|NCT00842829|3694903|FG000|Continuation Period|Non-compliance to study drug|0
2103042|NCT00842829|3694904|FG001|Continuation Period|Non-compliance to study drug|0
2103043|NCT00842829|3694905|FG002|Continuation Period|Non-compliance to study drug|1
2103044|NCT00842985|3694926|FG000|Screening|Did not meet entrance requirements|27
2103045|NCT00842985|3694926|FG000|First Intervention|Withdrawal by Subject|3
2103046|NCT00842985|3694926|FG000|First Intervention|Protocol Violation|3
2103047|NCT00842985|3694926|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
2103048|NCT00842985|3694926|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
2103049|NCT00843024|3694937|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
2103050|NCT00843024|3694938|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
2103051|NCT00843024|3694939|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
2103052|NCT00843024|3694940|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
2103053|NCT00843024|3694941|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
2103054|NCT00843024|3694942|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
2103055|NCT00843024|3694937|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
2103056|NCT00843024|3694938|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
2103057|NCT00843024|3694939|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
2103058|NCT00843024|3694940|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
2103059|NCT00843024|3694941|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
2103060|NCT00843024|3694942|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
2103061|NCT00843024|3694937|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
2103062|NCT00843024|3694938|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
2103063|NCT00843024|3694939|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
2103064|NCT00843024|3694940|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
2103065|NCT00843024|3694941|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
2103066|NCT00843024|3694942|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
2103067|NCT00843024|3694937|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4
2103068|NCT00843024|3694938|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5
2103069|NCT00843024|3694939|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0
2103070|NCT00843024|3694940|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0
2103071|NCT00843024|3694941|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0
2214781|NCT01690988|3857440|FG001|Overall Study|Determined ineligible|0
2214782|NCT01690988|3857441|FG002|Overall Study|Determined ineligible|0
2313447|NCT02791191|4020966|FG001|Overall Study|Study Terminated by Sponsor|101
2313448|NCT02791191|4020967|FG002|Overall Study|Study Terminated by Sponsor|109
2313449|NCT02791191|4020965|FG000|Overall Study|Withdrawal by Subject|3
2313450|NCT02791191|4020966|FG001|Overall Study|Withdrawal by Subject|1
2313451|NCT02791191|4020967|FG002|Overall Study|Withdrawal by Subject|3
2313452|NCT02791191|4020965|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2
2313453|NCT02791191|4020966|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1
2313454|NCT02791191|4020967|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0
2313455|NCT02791269|4020977|FG000|Overall Study|Lost to Follow-up|0
2313456|NCT02791269|4020978|FG001|Overall Study|Lost to Follow-up|1
2313457|NCT02791438|4021010|FG000|Treatment Period|Adverse Event|1
2313458|NCT02791438|4021011|FG001|Treatment Period|Adverse Event|0
2313459|NCT02791438|4021010|FG000|Treatment Period|Withdrawal by Subject|0
2313460|NCT02791438|4021011|FG001|Treatment Period|Withdrawal by Subject|1
2313461|NCT02791438|4021010|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
2313462|NCT02791438|4021011|FG001|Treatment Period|Withdrawal by Parent/Guardian|0
2313463|NCT02791490|4021019|FG000|Overall Study|Lost to Follow-up|1
2313464|NCT02791490|4021020|FG001|Overall Study|Lost to Follow-up|2
2313465|NCT02791490|4021019|FG000|Overall Study|Withdrawal by Subject|2
2313466|NCT02791490|4021020|FG001|Overall Study|Withdrawal by Subject|6
2313467|NCT02791516|4021028|FG000|Overall Study|Withdrawal by Subject|1
2313468|NCT02791516|4021029|FG001|Overall Study|Withdrawal by Subject|1
2103072|NCT00843024|3694942|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0
2103073|NCT00843024|3694937|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2
2103074|NCT00843024|3694938|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6
2103075|NCT00843024|3694939|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0
2103076|NCT00843024|3694940|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0
2103077|NCT00843024|3694941|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0
2103078|NCT00843024|3694942|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0
2103079|NCT00843024|3694937|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0
2103080|NCT00843024|3694938|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1
2103081|NCT00843024|3694939|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0
2103082|NCT00843024|3694940|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0
2103083|NCT00843024|3694941|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0
2103084|NCT00843024|3694942|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0
2103085|NCT00843024|3694937|FG000|Single-blind Placebo Run-In Phase|Other|0
2103086|NCT00843024|3694938|FG001|Single-blind Placebo Run-In Phase|Other|1
2103087|NCT00843024|3694939|FG002|Single-blind Placebo Run-In Phase|Other|0
2103088|NCT00843024|3694940|FG003|Single-blind Placebo Run-In Phase|Other|0
2103089|NCT00843024|3694941|FG004|Single-blind Placebo Run-In Phase|Other|0
2103090|NCT00843024|3694942|FG005|Single-blind Placebo Run-In Phase|Other|0
2103091|NCT00843024|3694937|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0
2214783|NCT01690988|3857439|FG000|Overall Study|Death|1
2214784|NCT01690988|3857440|FG001|Overall Study|Death|1
2214785|NCT01690988|3857441|FG002|Overall Study|Death|1
2214786|NCT01690988|3857439|FG000|Overall Study|Sedated|1
2214787|NCT01690988|3857440|FG001|Overall Study|Sedated|1
2214788|NCT01690988|3857441|FG002|Overall Study|Sedated|2
2214789|NCT01691014|3857456|FG000|Overall Study|Premature Termination|1
2214790|NCT01691014|3857457|FG001|Overall Study|Premature Termination|6
2214791|NCT01691014|3857458|FG002|Overall Study|Premature Termination|0
2214792|NCT01691014|3857459|FG003|Overall Study|Premature Termination|3
2214793|NCT01691014|3857456|FG000|Overall Study|Other|0
2214794|NCT01691014|3857457|FG001|Overall Study|Other|0
2214795|NCT01691014|3857458|FG002|Overall Study|Other|2
2214796|NCT01691014|3857459|FG003|Overall Study|Other|0
2214797|NCT01691014|3857456|FG000|Overall Study|Withdrawal by Subject|0
2214798|NCT01691014|3857457|FG001|Overall Study|Withdrawal by Subject|1
2214799|NCT01691014|3857458|FG002|Overall Study|Withdrawal by Subject|1
2313469|NCT02791659|4021037|FG000|Overall Study|Protocol Violation|0
2313470|NCT02791659|4021038|FG001|Overall Study|Protocol Violation|1
2313471|NCT02791763|4021047|FG000|Overall Study|Protocol Violation|0
2103092|NCT00843024|3694938|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0
2103093|NCT00843024|3694939|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20
2103094|NCT00843024|3694940|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10
2103095|NCT00843024|3694941|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13
2103096|NCT00843024|3694942|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14
2103097|NCT00843024|3694937|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
2103098|NCT00843024|3694938|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
2103099|NCT00843024|3694939|FG002|Double-blind Treatment Phase|Lost to Follow-up|8
2103100|NCT00843024|3694940|FG003|Double-blind Treatment Phase|Lost to Follow-up|4
2103101|NCT00843024|3694941|FG004|Double-blind Treatment Phase|Lost to Follow-up|4
2103102|NCT00843024|3694942|FG005|Double-blind Treatment Phase|Lost to Follow-up|4
2103103|NCT00843024|3694937|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
2103104|NCT00843024|3694938|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0
2103105|NCT00843024|3694939|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
2103106|NCT00843024|3694940|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6
2103107|NCT00843024|3694941|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
2103108|NCT00843024|3694942|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2
2103109|NCT00843024|3694937|FG000|Double-blind Treatment Phase|Protocol Violation|0
2103110|NCT00843024|3694938|FG001|Double-blind Treatment Phase|Protocol Violation|0
2103111|NCT00843024|3694939|FG002|Double-blind Treatment Phase|Protocol Violation|3
2103112|NCT00843024|3694940|FG003|Double-blind Treatment Phase|Protocol Violation|0
2103113|NCT00843024|3694941|FG004|Double-blind Treatment Phase|Protocol Violation|0
2103114|NCT00843024|3694942|FG005|Double-blind Treatment Phase|Protocol Violation|3
2214800|NCT01691014|3857459|FG003|Overall Study|Withdrawal by Subject|1
2214801|NCT01691014|3857456|FG000|Overall Study|Adverse Event|0
2214802|NCT01691014|3857457|FG001|Overall Study|Adverse Event|5
2214803|NCT01691014|3857458|FG002|Overall Study|Adverse Event|1
2313472|NCT02791763|4021048|FG001|Overall Study|Protocol Violation|0
2313473|NCT02791763|4021049|FG002|Overall Study|Protocol Violation|1
2313474|NCT02791763|4021047|FG000|Overall Study|Withdrawal by Subject|5
2313475|NCT02791763|4021048|FG001|Overall Study|Withdrawal by Subject|1
2313476|NCT02791763|4021049|FG002|Overall Study|Withdrawal by Subject|0
2313477|NCT02791763|4021047|FG000|Overall Study|Physician Decision|0
2313478|NCT02791763|4021048|FG001|Overall Study|Physician Decision|1
2313479|NCT02791763|4021049|FG002|Overall Study|Physician Decision|0
2313480|NCT02791763|4021047|FG000|Overall Study|Needs maintenance/changes in dialysis|16
2313481|NCT02791763|4021048|FG001|Overall Study|Needs maintenance/changes in dialysis|19
2313482|NCT02791763|4021049|FG002|Overall Study|Needs maintenance/changes in dialysis|5
2103115|NCT00843024|3694937|FG000|Double-blind Treatment Phase|Physician Decision|0
2103116|NCT00843024|3694938|FG001|Double-blind Treatment Phase|Physician Decision|0
2103117|NCT00843024|3694939|FG002|Double-blind Treatment Phase|Physician Decision|0
2103118|NCT00843024|3694940|FG003|Double-blind Treatment Phase|Physician Decision|3
2103119|NCT00843024|3694941|FG004|Double-blind Treatment Phase|Physician Decision|1
2103120|NCT00843024|3694942|FG005|Double-blind Treatment Phase|Physician Decision|1
2103121|NCT00843024|3694937|FG000|Double-blind Treatment Phase|Adverse Event|0
2103122|NCT00843024|3694938|FG001|Double-blind Treatment Phase|Adverse Event|0
2103123|NCT00843024|3694939|FG002|Double-blind Treatment Phase|Adverse Event|0
2103124|NCT00843024|3694940|FG003|Double-blind Treatment Phase|Adverse Event|0
2103125|NCT00843024|3694941|FG004|Double-blind Treatment Phase|Adverse Event|1
2103126|NCT00843024|3694942|FG005|Double-blind Treatment Phase|Adverse Event|1
2103127|NCT00843024|3694937|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
2103128|NCT00843024|3694938|FG001|Double-blind Treatment Phase|Lack of Efficacy|0
2103129|NCT00843024|3694939|FG002|Double-blind Treatment Phase|Lack of Efficacy|0
2103130|NCT00843024|3694940|FG003|Double-blind Treatment Phase|Lack of Efficacy|0
2103131|NCT00843024|3694941|FG004|Double-blind Treatment Phase|Lack of Efficacy|1
2103132|NCT00843024|3694942|FG005|Double-blind Treatment Phase|Lack of Efficacy|0
2103133|NCT00843115|3694955|FG000|Overall Study|Death|4
2103134|NCT00843115|3694955|FG000|Overall Study|Adverse Event|30
2103135|NCT00843115|3694955|FG000|Overall Study|Lost to Follow-up|4
2103136|NCT00843115|3694955|FG000|Overall Study|Withdrawal by Subject|17
2103137|NCT00843115|3694955|FG000|Overall Study|Family wanted meds stopped|1
2103138|NCT00843115|3694955|FG000|Overall Study|Family does not want continuation|1
2103139|NCT00843115|3694955|FG000|Overall Study|Patient forgot to take meds|1
2103140|NCT00843115|3694955|FG000|Overall Study|Does not meet entrance criteria|1
2103141|NCT00843115|3694955|FG000|Overall Study|Physician Decision|1
2103142|NCT00843115|3694955|FG000|Overall Study|Family discontinued meds|1
2103143|NCT00843115|3694955|FG000|Overall Study|patient took for 2 days then stopped|1
2103144|NCT00843115|3694955|FG000|Overall Study|patient never took the medication|1
2103145|NCT00843115|3694955|FG000|Overall Study|hospitalized due to deterioration|1
2103146|NCT00843115|3694955|FG000|Overall Study|week 12 not done|1
2103147|NCT00843115|3694955|FG000|Overall Study|Syndrome De Glissement|1
2103148|NCT00843167|3694961|FG000|Treatment Period|Adverse Event|1
2103149|NCT00843167|3694962|FG001|Treatment Period|Adverse Event|5
2103150|NCT00843167|3694961|FG000|Treatment Period|Withdrawal by Subject|2
2103151|NCT00843167|3694962|FG001|Treatment Period|Withdrawal by Subject|3
2103152|NCT00843193|3694983|FG000|Overall Study|Adverse Event|2
2103153|NCT00843193|3694984|FG001|Overall Study|Adverse Event|4
2103154|NCT00843193|3694983|FG000|Overall Study|Lack of Efficacy|1
2103155|NCT00843193|3694984|FG001|Overall Study|Lack of Efficacy|1
2103156|NCT00843193|3694983|FG000|Overall Study|Protocol Violation|1
2103157|NCT00843193|3694984|FG001|Overall Study|Protocol Violation|2
2103158|NCT00843193|3694983|FG000|Overall Study|Lost to Follow-up|1
2103159|NCT00843193|3694984|FG001|Overall Study|Lost to Follow-up|0
2103160|NCT00843193|3694983|FG000|Overall Study|Physician Decision|0
2103161|NCT00843193|3694984|FG001|Overall Study|Physician Decision|1
2103162|NCT00843193|3694983|FG000|Overall Study|Withdrawal by Subject|3
2103163|NCT00843193|3694984|FG001|Overall Study|Withdrawal by Subject|3
2103164|NCT00843284|3694991|FG000|Overall Study|Adverse Event|39
2103165|NCT00843284|3694991|FG000|Overall Study|Lack of Efficacy|5
2103166|NCT00843284|3694991|FG000|Overall Study|Lost to Follow-up|11
2103167|NCT00843284|3694991|FG000|Overall Study|Other|10
2103168|NCT00843284|3694991|FG000|Overall Study|Withdrawal by Subject|4
2103169|NCT00843284|3694991|FG000|Overall Study|Death|3
2313483|NCT02791763|4021047|FG000|Overall Study|Cancer event|1
2313484|NCT02791763|4021048|FG001|Overall Study|Cancer event|3
2313485|NCT02791763|4021049|FG002|Overall Study|Cancer event|0
2313486|NCT02791763|4021047|FG000|Overall Study|Participant had renal transplant|3
2313487|NCT02791763|4021048|FG001|Overall Study|Participant had renal transplant|0
2313488|NCT02791763|4021049|FG002|Overall Study|Participant had renal transplant|0
2313489|NCT02791763|4021047|FG000|Overall Study|Met hemoglobin stopping criteria|1
2358392|NCT01915498|4118887|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5
2358393|NCT01915498|4118888|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
2358394|NCT01915498|4118889|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
2358395|NCT01915498|4118890|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9
2358396|NCT01915498|4118891|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
2103170|NCT00843492|3695034|FG000|Overall Study|Adverse Event|0
2103171|NCT00843492|3695035|FG001|Overall Study|Adverse Event|3
2103172|NCT00843492|3695034|FG000|Overall Study|Lost to Follow-up|4
2103173|NCT00843492|3695035|FG001|Overall Study|Lost to Follow-up|4
2103174|NCT00843492|3695034|FG000|Overall Study|Withdrawal by Subject|0
2103175|NCT00843492|3695035|FG001|Overall Study|Withdrawal by Subject|4
2103176|NCT00843492|3695034|FG000|Overall Study|Immobilization Stopped|1
2103177|NCT00843492|3695035|FG001|Overall Study|Immobilization Stopped|0
2103178|NCT00843492|3695034|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1
2103179|NCT00843492|3695035|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1
2103180|NCT00843492|3695034|FG000|Overall Study|Orthopedic Surgery|0
2103181|NCT00843492|3695035|FG001|Overall Study|Orthopedic Surgery|2
2103182|NCT00843492|3695034|FG000|Overall Study|Visit Not Performed|1
2103183|NCT00843492|3695035|FG001|Overall Study|Visit Not Performed|0
2103184|NCT00843492|3695034|FG000|Overall Study|Deep-vein Thrombosis|1
2103185|NCT00843492|3695035|FG001|Overall Study|Deep-vein Thrombosis|0
2103186|NCT00843518|3695043|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5
2103187|NCT00843518|3695044|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3
2103188|NCT00843518|3695043|FG000|Period 2 (Double-blind Treatment)|Death|0
2103189|NCT00843518|3695044|FG001|Period 2 (Double-blind Treatment)|Death|1
2103190|NCT00843518|3695043|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
2103191|NCT00843518|3695044|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
2103192|NCT00843518|3695043|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2
2103193|NCT00843518|3695044|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1
2103194|NCT00843518|3695043|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2
2103195|NCT00843518|3695044|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5
2103196|NCT00843518|3695043|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
2103197|NCT00843518|3695044|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
2103198|NCT00843518|3695043|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7
2103199|NCT00843518|3695044|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7
2103200|NCT00843635|3695074|FG000|Overall Study|Adverse Event|2
2103201|NCT00843635|3695075|FG001|Overall Study|Adverse Event|2
2313490|NCT02791763|4021048|FG001|Overall Study|Met hemoglobin stopping criteria|0
2313491|NCT02791763|4021049|FG002|Overall Study|Met hemoglobin stopping criteria|0
2313492|NCT02791763|4021047|FG000|Overall Study|Adverse Event|12
2313493|NCT02791763|4021048|FG001|Overall Study|Adverse Event|13
2103202|NCT00843635|3695076|FG002|Overall Study|Adverse Event|0
2103203|NCT00843726|3695099|FG000|Overall Study|Death|1
2103204|NCT00843726|3695100|FG001|Overall Study|Death|0
2103205|NCT00843726|3695099|FG000|Overall Study|Withdrawal by Subject|0
2103206|NCT00843726|3695100|FG001|Overall Study|Withdrawal by Subject|1
2103207|NCT00843778|3695107|FG000|Overall Study|Adverse Event|15
2103208|NCT00843778|3695107|FG000|Overall Study|Lack of Efficacy|14
2103209|NCT00843778|3695107|FG000|Overall Study|Loss of efficacy|2
2103210|NCT00843778|3695107|FG000|Overall Study|Withdrawal by Subject|4
2103211|NCT00843843|3695113|FG000|Overall Study|Physician Decision|1
2103212|NCT00843843|3695114|FG001|Overall Study|Physician Decision|1
2103213|NCT00843843|3695113|FG000|Overall Study|Protocol Violation|1
2103214|NCT00843843|3695114|FG001|Overall Study|Protocol Violation|1
2103215|NCT00843856|3695122|FG000|Overall Study|Lost to Follow-up|1
2103216|NCT00843856|3695123|FG001|Overall Study|Lost to Follow-up|2
2103217|NCT00844194|3695149|FG000|Overall Study|Adverse Event|17
2103218|NCT00844194|3695150|FG001|Overall Study|Adverse Event|5
2103219|NCT00844194|3695149|FG000|Overall Study|Protocol Violation|1
2103220|NCT00844194|3695150|FG001|Overall Study|Protocol Violation|1
2103221|NCT00844194|3695149|FG000|Overall Study|Lost to Follow-up|1
2103222|NCT00844194|3695150|FG001|Overall Study|Lost to Follow-up|1
2103223|NCT00844194|3695149|FG000|Overall Study|Withdrawal by Subject|2
2103224|NCT00844194|3695150|FG001|Overall Study|Withdrawal by Subject|1
2103225|NCT00844194|3695149|FG000|Overall Study|Lack of Efficacy|3
2103226|NCT00844194|3695150|FG001|Overall Study|Lack of Efficacy|0
2103227|NCT00844194|3695149|FG000|Overall Study|Other reason (not specified)|1
2103228|NCT00844194|3695150|FG001|Overall Study|Other reason (not specified)|0
2103229|NCT00844376|3695164|FG000|Period 1: First Intervention|Withdrawal by Subject|1
2103230|NCT00844376|3695165|FG001|Period 1: First Intervention|Withdrawal by Subject|0
2103231|NCT00844415|3695171|FG000|Overall Study|Withdrawal by Subject|1
2103232|NCT00844428|3695176|FG000|Screening Period|Screen Failure|3
2103233|NCT00844428|3695176|FG000|Extension Treatment Period|Death|1
2103234|NCT00844428|3695176|FG000|Post Treatment Period (Patients Who Disc|Death|1
2313494|NCT02791763|4021049|FG002|Overall Study|Adverse Event|7
2313495|NCT02791893|4021068|FG000|Blinded Phase|Lost to Follow-up|2
2313496|NCT02791893|4021069|FG001|Blinded Phase|Lost to Follow-up|2
2313497|NCT02791893|4021068|FG000|Blinded Phase|Withdrawal by Subject|1
2313498|NCT02791893|4021069|FG001|Blinded Phase|Withdrawal by Subject|2
2313499|NCT02791893|4021068|FG000|Open Label Phase|Lost to Follow-up|3
2313500|NCT02791893|4021069|FG001|Open Label Phase|Lost to Follow-up|0
2313501|NCT02791893|4021068|FG000|Open Label Phase|Withdrawal by Subject|0
2313502|NCT02791893|4021069|FG001|Open Label Phase|Withdrawal by Subject|2
2313503|NCT02792062|4021112|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
2313504|NCT02792062|4021113|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2313505|NCT02792062|4021114|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2313506|NCT02792062|4021115|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2313507|NCT02792062|4021116|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2313508|NCT02792062|4021117|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2313509|NCT02792192|4021129|FG000|Overall Study|Death|1
2313510|NCT02792192|4021130|FG001|Overall Study|Death|0
2313511|NCT02792192|4021131|FG002|Overall Study|Death|0
2313512|NCT02792192|4021132|FG003|Overall Study|Death|0
2313513|NCT02792192|4021129|FG000|Overall Study|Informed Consent Withdrawn|4
2103235|NCT00844519|3695182|FG000|Overall Study|Withdrawal by Subject|1
2103236|NCT00844519|3695183|FG001|Overall Study|Withdrawal by Subject|1
2103237|NCT00844519|3695182|FG000|Overall Study|Adverse Event|1
2103238|NCT00844519|3695183|FG001|Overall Study|Adverse Event|0
2103239|NCT00844532|3695189|FG000|Overall Study|Death|16
2103240|NCT00844532|3695189|FG000|Overall Study|Withdrawal by Subject|16
2103241|NCT00844532|3695189|FG000|Overall Study|Lost to Follow-up|7
2103242|NCT00844545|3695193|FG000|Treatment Period (26 Weeks)|Adverse Event|1
2103243|NCT00844545|3695193|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
2103244|NCT00844545|3695193|FG000|Extension Treatment Period|Adverse Event|2
2103245|NCT00844545|3695193|FG000|Post Treatment Period|Withdrawal by Subject|1
2103246|NCT00844558|3695200|FG000|Overall Study|Withdrawal by Subject|9
2103247|NCT00844558|3695201|FG001|Overall Study|Withdrawal by Subject|2
2103248|NCT00844558|3695200|FG000|Overall Study|Death|1
2103249|NCT00844558|3695201|FG001|Overall Study|Death|0
2103250|NCT00844558|3695200|FG000|Overall Study|Protocol Violation|1
2103251|NCT00844558|3695201|FG001|Overall Study|Protocol Violation|1
2103252|NCT00844558|3695200|FG000|Overall Study|Lost to Follow-up|0
2103253|NCT00844558|3695201|FG001|Overall Study|Lost to Follow-up|1
2103254|NCT00844558|3695200|FG000|Overall Study|Physician Decision|1
2103255|NCT00844558|3695201|FG001|Overall Study|Physician Decision|0
2103256|NCT00844597|3695218|FG000|Overall Study|Adverse Event|0
2103257|NCT00844597|3695219|FG001|Overall Study|Adverse Event|0
2103258|NCT00844597|3695220|FG002|Overall Study|Adverse Event|0
2103259|NCT00844597|3695221|FG003|Overall Study|Adverse Event|1
2103260|NCT00844597|3695222|FG004|Overall Study|Adverse Event|0
2103261|NCT00844597|3695223|FG005|Overall Study|Adverse Event|0
2103262|NCT00844649|3695241|FG000|Overall Study|Progressive Disease|196
2103263|NCT00844649|3695242|FG001|Overall Study|Progressive Disease|245
2313514|NCT02792192|4021130|FG001|Overall Study|Informed Consent Withdrawn|0
2313515|NCT02792192|4021131|FG002|Overall Study|Informed Consent Withdrawn|0
2313516|NCT02792192|4021132|FG003|Overall Study|Informed Consent Withdrawn|0
2313517|NCT02792192|4021129|FG000|Overall Study|Physician Decision|1
2313518|NCT02792192|4021130|FG001|Overall Study|Physician Decision|0
2313519|NCT02792192|4021131|FG002|Overall Study|Physician Decision|0
2313520|NCT02792192|4021132|FG003|Overall Study|Physician Decision|0
2313521|NCT02792192|4021129|FG000|Overall Study|Progressive Disease|0
2313522|NCT02792192|4021130|FG001|Overall Study|Progressive Disease|1
2313523|NCT02792192|4021131|FG002|Overall Study|Progressive Disease|0
2313524|NCT02792192|4021132|FG003|Overall Study|Progressive Disease|0
2313525|NCT02792192|4021129|FG000|Overall Study|Study Terminated By Sponsor|6
2313526|NCT02792192|4021130|FG001|Overall Study|Study Terminated By Sponsor|10
2313527|NCT02792192|4021131|FG002|Overall Study|Study Terminated By Sponsor|0
2313528|NCT02792192|4021132|FG003|Overall Study|Study Terminated By Sponsor|0
2313529|NCT02792218|4021145|FG000|Overall Study|Patient/guardian decision|15
2313530|NCT02792218|4021146|FG001|Overall Study|Patient/guardian decision|42
2313531|NCT02792218|4021145|FG000|Overall Study|Adverse Event|15
2313532|NCT02792218|4021146|FG001|Overall Study|Adverse Event|14
2313533|NCT02792218|4021145|FG000|Overall Study|Lost to Follow-up|10
2313534|NCT02792218|4021146|FG001|Overall Study|Lost to Follow-up|5
2313535|NCT02792218|4021145|FG000|Overall Study|Lack of Efficacy|1
2313536|NCT02792218|4021146|FG001|Overall Study|Lack of Efficacy|12
2313537|NCT02792218|4021145|FG000|Overall Study|Physician Decision|4
2313538|NCT02792218|4021146|FG001|Overall Study|Physician Decision|4
2313539|NCT02792218|4021145|FG000|Overall Study|Protocol deviation|3
2313540|NCT02792218|4021146|FG001|Overall Study|Protocol deviation|2
2313541|NCT02792218|4021145|FG000|Overall Study|New therapy for study indication|0
2313542|NCT02792218|4021146|FG001|Overall Study|New therapy for study indication|1
2313543|NCT02792218|4021145|FG000|Overall Study|Non-compliance with study treatment|0
2313544|NCT02792218|4021146|FG001|Overall Study|Non-compliance with study treatment|1
2313545|NCT02792218|4021145|FG000|Overall Study|Pregnancy|1
2313546|NCT02792218|4021146|FG001|Overall Study|Pregnancy|0
2313547|NCT02792231|4021154|FG000|Overall Study|Patient/guardian decision|32
2313548|NCT02792231|4021155|FG001|Overall Study|Patient/guardian decision|42
2313549|NCT02792231|4021154|FG000|Overall Study|Adverse Event|15
2313550|NCT02792231|4021155|FG001|Overall Study|Adverse Event|11
2313551|NCT02792231|4021154|FG000|Overall Study|Physician Decision|14
2313552|NCT02792231|4021155|FG001|Overall Study|Physician Decision|12
2313553|NCT02792231|4021154|FG000|Overall Study|Lack of Efficacy|7
2313554|NCT02792231|4021155|FG001|Overall Study|Lack of Efficacy|9
2313555|NCT02792231|4021154|FG000|Overall Study|Lost to Follow-up|9
2313556|NCT02792231|4021155|FG001|Overall Study|Lost to Follow-up|5
2313557|NCT02792231|4021154|FG000|Overall Study|Pregnancy|1
2313558|NCT02792231|4021155|FG001|Overall Study|Pregnancy|3
2313559|NCT02792231|4021154|FG000|Overall Study|Non-compliance with study treatment|2
2313560|NCT02792231|4021155|FG001|Overall Study|Non-compliance with study treatment|1
2313561|NCT02792231|4021154|FG000|Overall Study|Protocol deviation|2
2313562|NCT02792231|4021155|FG001|Overall Study|Protocol deviation|0
2313563|NCT02792231|4021154|FG000|Overall Study|Technical problems|0
2313564|NCT02792231|4021155|FG001|Overall Study|Technical problems|1
2313565|NCT02792504|4021161|FG000|Overall Study|Lost to Follow-up|24
2313566|NCT02792504|4021161|FG000|Overall Study|Violated inclusion/exclusion criteria|6
2103264|NCT00844649|3695241|FG000|Overall Study|Adverse Event|128
2103265|NCT00844649|3695242|FG001|Overall Study|Adverse Event|73
2103266|NCT00844649|3695241|FG000|Overall Study|Physician Decision|25
2103267|NCT00844649|3695242|FG001|Overall Study|Physician Decision|18
2103268|NCT00844649|3695241|FG000|Overall Study|Protocol Violation|10
2103269|NCT00844649|3695242|FG001|Overall Study|Protocol Violation|6
2103270|NCT00844649|3695241|FG000|Overall Study|Withdrawal by Subject|28
2103271|NCT00844649|3695242|FG001|Overall Study|Withdrawal by Subject|39
2103272|NCT00844649|3695241|FG000|Overall Study|Other|7
2103273|NCT00844649|3695242|FG001|Overall Study|Other|10
2103274|NCT00844649|3695241|FG000|Overall Study|Withdrew prior to starting treatment|11
2103275|NCT00844649|3695242|FG001|Overall Study|Withdrew prior to starting treatment|27
2103276|NCT00844753|3695258|FG000|Overall Study|Lack of Efficacy|1
2103277|NCT00844753|3695259|FG001|Overall Study|Lack of Efficacy|0
2103278|NCT00844753|3695260|FG002|Overall Study|Lack of Efficacy|2
2103279|NCT00844753|3695261|FG003|Overall Study|Lack of Efficacy|2
2103280|NCT00844753|3695258|FG000|Overall Study|Adverse Event|3
2103281|NCT00844753|3695259|FG001|Overall Study|Adverse Event|2
2103282|NCT00844753|3695260|FG002|Overall Study|Adverse Event|5
2103283|NCT00844753|3695261|FG003|Overall Study|Adverse Event|5
2103284|NCT00844753|3695258|FG000|Overall Study|Lost to Follow-up|1
2103285|NCT00844753|3695259|FG001|Overall Study|Lost to Follow-up|1
2103286|NCT00844753|3695260|FG002|Overall Study|Lost to Follow-up|0
2103287|NCT00844753|3695261|FG003|Overall Study|Lost to Follow-up|1
2103288|NCT00844753|3695258|FG000|Overall Study|could not swallow medication|2
2103289|NCT00844753|3695259|FG001|Overall Study|could not swallow medication|0
2103290|NCT00844753|3695260|FG002|Overall Study|could not swallow medication|0
2103291|NCT00844753|3695261|FG003|Overall Study|could not swallow medication|0
2103292|NCT00844753|3695258|FG000|Overall Study|Withdrawal by Subject|1
2103293|NCT00844753|3695259|FG001|Overall Study|Withdrawal by Subject|0
2103294|NCT00844753|3695260|FG002|Overall Study|Withdrawal by Subject|0
2103295|NCT00844753|3695261|FG003|Overall Study|Withdrawal by Subject|3
2103296|NCT00844805|3695271|FG000|Treatment Phase|Adverse Event|5
2103297|NCT00844805|3695272|FG001|Treatment Phase|Adverse Event|1
2103298|NCT00844805|3695273|FG002|Treatment Phase|Adverse Event|0
2103299|NCT00844805|3695274|FG003|Treatment Phase|Adverse Event|0
2103300|NCT00844805|3695271|FG000|Treatment Phase|Withdrawal by Subject|3
2103301|NCT00844805|3695272|FG001|Treatment Phase|Withdrawal by Subject|4
2103302|NCT00844805|3695273|FG002|Treatment Phase|Withdrawal by Subject|0
2103303|NCT00844805|3695274|FG003|Treatment Phase|Withdrawal by Subject|0
2103304|NCT00844805|3695271|FG000|Treatment Phase|Noncompliance With Protocol|1
2103305|NCT00844805|3695272|FG001|Treatment Phase|Noncompliance With Protocol|0
2103306|NCT00844805|3695273|FG002|Treatment Phase|Noncompliance With Protocol|0
2103307|NCT00844805|3695274|FG003|Treatment Phase|Noncompliance With Protocol|0
2103308|NCT00844805|3695271|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1
2103309|NCT00844805|3695272|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2
2103310|NCT00844805|3695273|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0
2103311|NCT00844805|3695274|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0
2103312|NCT00844805|3695271|FG000|Follow-Up Phase|Adverse Event|0
2103313|NCT00844805|3695272|FG001|Follow-Up Phase|Adverse Event|0
2103314|NCT00844805|3695273|FG002|Follow-Up Phase|Adverse Event|1
2103315|NCT00844805|3695274|FG003|Follow-Up Phase|Adverse Event|0
2103316|NCT00844805|3695271|FG000|Follow-Up Phase|Withdrawal by Subject|0
2103317|NCT00844805|3695272|FG001|Follow-Up Phase|Withdrawal by Subject|0
2103318|NCT00844805|3695273|FG002|Follow-Up Phase|Withdrawal by Subject|6
2103319|NCT00844805|3695274|FG003|Follow-Up Phase|Withdrawal by Subject|3
2103320|NCT00844805|3695271|FG000|Follow-Up Phase|Noncompliance With Protocol|0
2103321|NCT00844805|3695272|FG001|Follow-Up Phase|Noncompliance With Protocol|0
2103322|NCT00844805|3695273|FG002|Follow-Up Phase|Noncompliance With Protocol|0
2103323|NCT00844805|3695274|FG003|Follow-Up Phase|Noncompliance With Protocol|1
2103324|NCT00844805|3695271|FG000|Follow-Up Phase|Relapse/Recurrence|0
2103325|NCT00844805|3695272|FG001|Follow-Up Phase|Relapse/Recurrence|0
2103326|NCT00844805|3695273|FG002|Follow-Up Phase|Relapse/Recurrence|2
2103327|NCT00844805|3695274|FG003|Follow-Up Phase|Relapse/Recurrence|4
2103328|NCT00844805|3695271|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
2103329|NCT00844805|3695272|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
2103330|NCT00844805|3695273|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
2103331|NCT00844805|3695274|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
2103332|NCT00844831|3695285|FG000|Overall Study|Withdrawal by Subject|4
2103333|NCT00844831|3695285|FG000|Overall Study|Adverse Event|1
2103334|NCT00844831|3695285|FG000|Overall Study|Physician Decision|1
2103335|NCT00844844|3695293|FG000|Treatment Period (26 Weeks)|Adverse Event|1
2103336|NCT00844844|3695293|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
2103337|NCT00844844|3695293|FG000|Extension Treatment Period|Adverse Event|2
2103338|NCT00844844|3695293|FG000|Post Treatment Period|Withdrawal by Subject|1
2103339|NCT00844857|3695299|FG000|Overall Study|Adverse Event|24
2103340|NCT00844857|3695300|FG001|Overall Study|Adverse Event|5
2103341|NCT00844857|3695299|FG000|Overall Study|Sponsor Decision|1
2103342|NCT00844857|3695300|FG001|Overall Study|Sponsor Decision|1
2103343|NCT00844857|3695299|FG000|Overall Study|Physician Decision|2
2103344|NCT00844857|3695300|FG001|Overall Study|Physician Decision|0
2103345|NCT00844857|3695299|FG000|Overall Study|Parent/Caregiver Decision|6
2103346|NCT00844857|3695300|FG001|Overall Study|Parent/Caregiver Decision|2
2103347|NCT00844857|3695299|FG000|Overall Study|Withdrawal by Subject|8
2103348|NCT00844857|3695300|FG001|Overall Study|Withdrawal by Subject|7
2103349|NCT00844857|3695299|FG000|Overall Study|Protocol Violation|6
2103350|NCT00844857|3695300|FG001|Overall Study|Protocol Violation|0
2103351|NCT00844857|3695299|FG000|Overall Study|Lack of Efficacy|5
2103352|NCT00844857|3695300|FG001|Overall Study|Lack of Efficacy|5
2103353|NCT00844857|3695299|FG000|Overall Study|Clinical Relapse|0
2103354|NCT00844857|3695300|FG001|Overall Study|Clinical Relapse|1
2103355|NCT00844857|3695299|FG000|Overall Study|Entry Criteria Not Met|0
2103356|NCT00844857|3695300|FG001|Overall Study|Entry Criteria Not Met|1
2103357|NCT00844857|3695299|FG000|Overall Study|Lost to Follow-up|2
2103358|NCT00844857|3695300|FG001|Overall Study|Lost to Follow-up|3
2103359|NCT00844857|3695299|FG000|Overall Study|Did Not Take Study Drug|3
2103360|NCT00844857|3695300|FG001|Overall Study|Did Not Take Study Drug|1
2103361|NCT00844857|3695299|FG000|Overall Study|Good Clinical Practice Violations|21
2103362|NCT00844857|3695300|FG001|Overall Study|Good Clinical Practice Violations|11
2103363|NCT00844883|3695309|FG000|Overall Study|Bridged to liver transplant|3
2103364|NCT00844883|3695309|FG000|Overall Study|Bridged to resection|1
2103365|NCT00844896|3695315|FG000|Overall Study|Lost to Follow-up|12
2103366|NCT00844896|3695316|FG001|Overall Study|Lost to Follow-up|16
2103367|NCT00844896|3695315|FG000|Overall Study|Parents did not have time to complete|0
2103368|NCT00844896|3695316|FG001|Overall Study|Parents did not have time to complete|1
2103369|NCT00845065|3695355|FG000|Overall Study|Adverse Event|3
2103370|NCT00845065|3695356|FG001|Overall Study|Adverse Event|23
2103371|NCT00845065|3695355|FG000|Overall Study|Lack of Efficacy|43
2103372|NCT00845065|3695356|FG001|Overall Study|Lack of Efficacy|21
2103373|NCT00845065|3695355|FG000|Overall Study|Non-Medical Reasons|1
2313567|NCT02792517|4021165|FG000|Overall Study|Withdrawal by Subject|10
2313568|NCT02792517|4021165|FG000|Overall Study|Decision by Sponsor|7
2313569|NCT02792517|4021165|FG000|Overall Study|Lost to Follow-up|3
2313570|NCT02792699|4021172|FG000|Overall Study|Adverse Event|1
2313571|NCT02792699|4021173|FG001|Overall Study|Adverse Event|2
2313572|NCT02792699|4021174|FG002|Overall Study|Adverse Event|4
2313573|NCT02792699|4021172|FG000|Overall Study|Withdrawal by Subject|4
2313574|NCT02792699|4021173|FG001|Overall Study|Withdrawal by Subject|4
2313575|NCT02792699|4021174|FG002|Overall Study|Withdrawal by Subject|3
2313576|NCT02792699|4021172|FG000|Overall Study|Lost to Follow-up|0
2313577|NCT02792699|4021173|FG001|Overall Study|Lost to Follow-up|1
2313578|NCT02792699|4021174|FG002|Overall Study|Lost to Follow-up|2
2313579|NCT02792699|4021172|FG000|Overall Study|Physician Decision|2
2313580|NCT02792699|4021173|FG001|Overall Study|Physician Decision|0
2313581|NCT02792699|4021174|FG002|Overall Study|Physician Decision|0
2313582|NCT02792699|4021172|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1
2313583|NCT02792699|4021173|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3
2313584|NCT02792699|4021174|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1
2313585|NCT02792699|4021172|FG000|Overall Study|Other|1
2313586|NCT02792699|4021173|FG001|Overall Study|Other|0
2313587|NCT02792699|4021174|FG002|Overall Study|Other|0
2313588|NCT02792777|4021191|FG000|Overall Study|Withdrawal by Subject|2
2313589|NCT02792777|4021192|FG001|Overall Study|Withdrawal by Subject|0
2313590|NCT02792777|4021191|FG000|Overall Study|Recording malfunction|2
2313591|NCT02792777|4021192|FG001|Overall Study|Recording malfunction|0
2313592|NCT02792777|4021191|FG000|Overall Study|Later determined to be ineligible|2
2313593|NCT02792777|4021192|FG001|Overall Study|Later determined to be ineligible|0
2313594|NCT02792777|4021191|FG000|Overall Study|Participant interviewed twice|1
2313595|NCT02792777|4021192|FG001|Overall Study|Participant interviewed twice|0
2313596|NCT02792829|4021207|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0
2313597|NCT02792829|4021208|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1
2313598|NCT02792829|4021209|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0
2313599|NCT02792829|4021210|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0
2313600|NCT02792829|4021211|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0
2313601|NCT02792829|4021212|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0
2313602|NCT02792829|4021213|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0
2313603|NCT02792829|4021214|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0
2313604|NCT02792829|4021207|FG000|Treatment Period 2|Adverse Event|0
2313605|NCT02792829|4021208|FG001|Treatment Period 2|Adverse Event|0
2313606|NCT02792829|4021209|FG002|Treatment Period 2|Adverse Event|0
2313607|NCT02792829|4021210|FG003|Treatment Period 2|Adverse Event|0
2313608|NCT02792829|4021211|FG004|Treatment Period 2|Adverse Event|1
2313609|NCT02792829|4021212|FG005|Treatment Period 2|Adverse Event|0
2313610|NCT02792829|4021213|FG006|Treatment Period 2|Adverse Event|1
2313611|NCT02792829|4021214|FG007|Treatment Period 2|Adverse Event|1
2313612|NCT02792829|4021207|FG000|Treatment Period 2|Use of proscribed medications|0
2313613|NCT02792829|4021208|FG001|Treatment Period 2|Use of proscribed medications|0
2313614|NCT02792829|4021209|FG002|Treatment Period 2|Use of proscribed medications|0
2313615|NCT02792829|4021210|FG003|Treatment Period 2|Use of proscribed medications|0
2313616|NCT02792829|4021211|FG004|Treatment Period 2|Use of proscribed medications|0
2313617|NCT02792829|4021212|FG005|Treatment Period 2|Use of proscribed medications|0
2313618|NCT02792829|4021213|FG006|Treatment Period 2|Use of proscribed medications|0
2313619|NCT02792829|4021214|FG007|Treatment Period 2|Use of proscribed medications|1
2313620|NCT02792959|4021240|FG000|Overall Study|Protocol Violation|1
2313621|NCT02793128|4021244|FG000|Overall Study|Death|4
2313622|NCT02793128|4021244|FG000|Overall Study|Withdrawal by Subject|2
2313623|NCT02793128|4021244|FG000|Overall Study|Physician Decision|1
2313624|NCT02793128|4021244|FG000|Overall Study|Comorbid conditions and noncompliance|1
2313625|NCT02793128|4021244|FG000|Overall Study|Patient elected nephroureterectomy|1
2313626|NCT02793232|4021278|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2103374|NCT00845065|3695356|FG001|Overall Study|Non-Medical Reasons|11
2103375|NCT00845182|3695376|FG000|Overall Study|Lost to Follow-up|3
2103376|NCT00845182|3695377|FG001|Overall Study|Lost to Follow-up|3
2103377|NCT00845182|3695378|FG002|Overall Study|Lost to Follow-up|4
2103378|NCT00845182|3695376|FG000|Overall Study|Adverse Event|0
2103379|NCT00845182|3695377|FG001|Overall Study|Adverse Event|1
2103380|NCT00845182|3695378|FG002|Overall Study|Adverse Event|1
2103381|NCT00845182|3695376|FG000|Overall Study|Physician Decision|0
2103382|NCT00845182|3695377|FG001|Overall Study|Physician Decision|0
2103383|NCT00845182|3695378|FG002|Overall Study|Physician Decision|1
2103384|NCT00845429|3695402|FG000|Overall Study|Protocol Violation|5
2103385|NCT00845429|3695403|FG001|Overall Study|Protocol Violation|4
2103386|NCT00845429|3695404|FG002|Overall Study|Protocol Violation|7
2103387|NCT00845429|3695402|FG000|Overall Study|Lost to Follow-up|7
2103388|NCT00845429|3695403|FG001|Overall Study|Lost to Follow-up|9
2103389|NCT00845429|3695404|FG002|Overall Study|Lost to Follow-up|10
2103390|NCT00845429|3695402|FG000|Overall Study|Withdrawal by Subject|2
2103391|NCT00845429|3695403|FG001|Overall Study|Withdrawal by Subject|2
2103392|NCT00845429|3695404|FG002|Overall Study|Withdrawal by Subject|2
2103393|NCT00845429|3695402|FG000|Overall Study|Serious adverse event|0
2103394|NCT00845429|3695403|FG001|Overall Study|Serious adverse event|0
2103395|NCT00845429|3695404|FG002|Overall Study|Serious adverse event|1
2103396|NCT00845520|3695433|FG000|Overall Study|Death|1
2103397|NCT00845520|3695434|FG001|Overall Study|Death|2
2103398|NCT00845520|3695435|FG002|Overall Study|Death|0
2103399|NCT00845520|3695433|FG000|Overall Study|Lost to Follow-up|1
2103400|NCT00845520|3695434|FG001|Overall Study|Lost to Follow-up|0
2103401|NCT00845520|3695435|FG002|Overall Study|Lost to Follow-up|0
2103402|NCT00845520|3695433|FG000|Overall Study|Adverse Event|0
2103403|NCT00845520|3695434|FG001|Overall Study|Adverse Event|0
2103404|NCT00845520|3695435|FG002|Overall Study|Adverse Event|1
2108098|NCT00878189|3701911|FG004|Overall Study|Other|4
2108099|NCT00878189|3701912|FG005|Overall Study|Other|18
2108100|NCT00878189|3701913|FG006|Overall Study|Other|15
2108101|NCT00878189|3701914|FG007|Overall Study|Other|3
2108102|NCT00878189|3701915|FG008|Overall Study|Other|4
2108103|NCT00878189|3701907|FG000|Overall Study|Lost to Follow-up|0
2108104|NCT00878189|3701908|FG001|Overall Study|Lost to Follow-up|0
2108105|NCT00878189|3701909|FG002|Overall Study|Lost to Follow-up|0
2108106|NCT00878189|3701910|FG003|Overall Study|Lost to Follow-up|0
2108107|NCT00878189|3701911|FG004|Overall Study|Lost to Follow-up|0
2108108|NCT00878189|3701912|FG005|Overall Study|Lost to Follow-up|1
2108109|NCT00878189|3701913|FG006|Overall Study|Lost to Follow-up|1
2108110|NCT00878189|3701914|FG007|Overall Study|Lost to Follow-up|0
2108111|NCT00878189|3701915|FG008|Overall Study|Lost to Follow-up|0
2108112|NCT00878189|3701907|FG000|Overall Study|Objection Progression or Relapse|0
2108113|NCT00878189|3701908|FG001|Overall Study|Objection Progression or Relapse|0
2108114|NCT00878189|3701909|FG002|Overall Study|Objection Progression or Relapse|0
2108115|NCT00878189|3701910|FG003|Overall Study|Objection Progression or Relapse|0
2108116|NCT00878189|3701911|FG004|Overall Study|Objection Progression or Relapse|0
2108117|NCT00878189|3701912|FG005|Overall Study|Objection Progression or Relapse|0
2108118|NCT00878189|3701913|FG006|Overall Study|Objection Progression or Relapse|0
2108119|NCT00878189|3701914|FG007|Overall Study|Objection Progression or Relapse|0
2108120|NCT00878189|3701915|FG008|Overall Study|Objection Progression or Relapse|3
2108223|NCT00878800|3702085|FG003|Overall Study|Adverse Event|0
2108224|NCT00878800|3702086|FG004|Overall Study|Adverse Event|1
2108225|NCT00878800|3702082|FG000|Overall Study|Progressive disease|1
2108226|NCT00878800|3702083|FG001|Overall Study|Progressive disease|5
2108227|NCT00878800|3702084|FG002|Overall Study|Progressive disease|6
2108228|NCT00878800|3702085|FG003|Overall Study|Progressive disease|5
2108229|NCT00878800|3702086|FG004|Overall Study|Progressive disease|13
2108230|NCT00878800|3702082|FG000|Overall Study|Withdrew consent|1
2108231|NCT00878800|3702083|FG001|Overall Study|Withdrew consent|1
2108232|NCT00878800|3702084|FG002|Overall Study|Withdrew consent|0
2108233|NCT00878800|3702085|FG003|Overall Study|Withdrew consent|1
2108234|NCT00878800|3702086|FG004|Overall Study|Withdrew consent|1
2108235|NCT00878800|3702082|FG000|Overall Study|Death|0
2108236|NCT00878800|3702083|FG001|Overall Study|Death|0
2108237|NCT00878800|3702084|FG002|Overall Study|Death|1
2108238|NCT00878800|3702085|FG003|Overall Study|Death|0
2108239|NCT00878800|3702086|FG004|Overall Study|Death|0
2108240|NCT00878800|3702082|FG000|Overall Study|Other|1
2108241|NCT00878800|3702083|FG001|Overall Study|Other|1
2108242|NCT00878800|3702084|FG002|Overall Study|Other|0
2108243|NCT00878800|3702085|FG003|Overall Study|Other|0
2108244|NCT00878800|3702086|FG004|Overall Study|Other|1
2108245|NCT00878995|3702123|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0
2108246|NCT00878995|3702124|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2
2108247|NCT00879229|3702157|FG000|Overall Study|Study terminated by Sponsor|13
2313627|NCT02793232|4021279|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2313628|NCT02793232|4021280|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2313629|NCT02793232|4021281|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2313630|NCT02793232|4021282|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
2108248|NCT00879229|3702158|FG001|Overall Study|Study terminated by Sponsor|12
2108249|NCT00879229|3702157|FG000|Overall Study|Death|4
2108250|NCT00879229|3702158|FG001|Overall Study|Death|2
2103405|NCT00845650|3695455|FG000|Overall Study|Withdrawal by Subject|0
2103406|NCT00845650|3695456|FG001|Overall Study|Withdrawal by Subject|0
2103407|NCT00845650|3695457|FG002|Overall Study|Withdrawal by Subject|0
2103408|NCT00845650|3695458|FG003|Overall Study|Withdrawal by Subject|0
2103409|NCT00845650|3695459|FG004|Overall Study|Withdrawal by Subject|2
2103410|NCT00845650|3695460|FG005|Overall Study|Withdrawal by Subject|0
2103411|NCT00845650|3695455|FG000|Overall Study|Lost to Follow-up|0
2103412|NCT00845650|3695456|FG001|Overall Study|Lost to Follow-up|0
2103413|NCT00845650|3695457|FG002|Overall Study|Lost to Follow-up|3
2103414|NCT00845650|3695458|FG003|Overall Study|Lost to Follow-up|1
2103415|NCT00845650|3695459|FG004|Overall Study|Lost to Follow-up|0
2103416|NCT00845650|3695460|FG005|Overall Study|Lost to Follow-up|1
2103417|NCT00845650|3695455|FG000|Overall Study|Sponsor hold on dosing|0
2103418|NCT00845650|3695456|FG001|Overall Study|Sponsor hold on dosing|0
2103419|NCT00845650|3695457|FG002|Overall Study|Sponsor hold on dosing|0
2103420|NCT00845650|3695458|FG003|Overall Study|Sponsor hold on dosing|0
2103421|NCT00845650|3695459|FG004|Overall Study|Sponsor hold on dosing|1
2103422|NCT00845650|3695460|FG005|Overall Study|Sponsor hold on dosing|1
2103423|NCT00845650|3695455|FG000|Overall Study|Unable to access IV line|1
2103424|NCT00845650|3695456|FG001|Overall Study|Unable to access IV line|0
2103425|NCT00845650|3695457|FG002|Overall Study|Unable to access IV line|0
2103426|NCT00845650|3695458|FG003|Overall Study|Unable to access IV line|0
2103427|NCT00845650|3695459|FG004|Overall Study|Unable to access IV line|0
2103428|NCT00845650|3695460|FG005|Overall Study|Unable to access IV line|0
2103429|NCT00845676|3695485|FG000|Overall Study|Virologic breakthrough at week 20|1
2103430|NCT00845676|3695485|FG000|Overall Study|Adverse Event|1
2103431|NCT00845728|3695492|FG000|Overall Study|Abnormal laboratory value (s)|2
2103432|NCT00845728|3695493|FG001|Overall Study|Abnormal laboratory value (s)|2
2103433|NCT00845728|3695492|FG000|Overall Study|Patient's inability to use the device|4
2103434|NCT00845728|3695493|FG001|Overall Study|Patient's inability to use the device|6
2103435|NCT00845728|3695492|FG000|Overall Study|Abnormal test procedure result (s)|7
2103436|NCT00845728|3695493|FG001|Overall Study|Abnormal test procedure result (s)|2
2103437|NCT00845728|3695492|FG000|Overall Study|Lost to Follow-up|22
2103438|NCT00845728|3695493|FG001|Overall Study|Lost to Follow-up|13
2103439|NCT00845728|3695492|FG000|Overall Study|Death|24
2103440|NCT00845728|3695493|FG001|Overall Study|Death|26
2103441|NCT00845728|3695492|FG000|Overall Study|Administrative Problems|34
2103442|NCT00845728|3695493|FG001|Overall Study|Administrative Problems|26
2103443|NCT00845728|3695492|FG000|Overall Study|Protocol Violation|36
2103444|NCT00845728|3695493|FG001|Overall Study|Protocol Violation|24
2103445|NCT00845728|3695492|FG000|Overall Study|Lack of Efficacy|51
2103446|NCT00845728|3695493|FG001|Overall Study|Lack of Efficacy|39
2103447|NCT00845728|3695492|FG000|Overall Study|Adverse Event|101
2103448|NCT00845728|3695493|FG001|Overall Study|Adverse Event|96
2103449|NCT00845728|3695492|FG000|Overall Study|Withdrawal by Subject|105
2103450|NCT00845728|3695493|FG001|Overall Study|Withdrawal by Subject|108
2103451|NCT00845832|3695502|FG000|Treatment Period|Adverse Event|0
2103452|NCT00845832|3695503|FG001|Treatment Period|Adverse Event|2
2103453|NCT00845832|3695504|FG002|Treatment Period|Adverse Event|0
2103454|NCT00845832|3695502|FG000|Treatment Period|Protocol Violation|1
2103455|NCT00845832|3695503|FG001|Treatment Period|Protocol Violation|1
2103456|NCT00845832|3695504|FG002|Treatment Period|Protocol Violation|0
2103457|NCT00845832|3695502|FG000|Safety Follow-Up|Withdrawal by Subject|1
2103458|NCT00845832|3695503|FG001|Safety Follow-Up|Withdrawal by Subject|0
2103459|NCT00845832|3695504|FG002|Safety Follow-Up|Withdrawal by Subject|0
2103460|NCT00845832|3695502|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0
2103461|NCT00845832|3695503|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0
2103462|NCT00845832|3695504|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7
2103463|NCT00845858|3695515|FG000|Overall Study|Withdrawal by Subject|5
2103464|NCT00845858|3695516|FG001|Overall Study|Withdrawal by Subject|1
2103465|NCT00845858|3695517|FG002|Overall Study|Withdrawal by Subject|1
2103466|NCT00845858|3695515|FG000|Overall Study|Adverse Event|3
2103467|NCT00845858|3695516|FG001|Overall Study|Adverse Event|8
2103468|NCT00845858|3695517|FG002|Overall Study|Adverse Event|4
2103469|NCT00845858|3695515|FG000|Overall Study|Protocol Violation|0
2103470|NCT00845858|3695516|FG001|Overall Study|Protocol Violation|0
2103471|NCT00845858|3695517|FG002|Overall Study|Protocol Violation|1
2103472|NCT00845858|3695515|FG000|Overall Study|not eligible|0
2103473|NCT00845858|3695516|FG001|Overall Study|not eligible|3
2103474|NCT00845858|3695517|FG002|Overall Study|not eligible|2
2103475|NCT00845871|3695528|FG000|Assessment Period|Adverse Event|2
2103476|NCT00845871|3695528|FG000|Assessment Period|Abnormal laboratory values|1
2103477|NCT00845871|3695528|FG000|Assessment Period|Abnormal test procedure results|1
2103478|NCT00845871|3695528|FG000|Assessment Period|Patient withdrew consent|3
2103479|NCT00845897|3695555|FG000|Overall Study|Lost to Follow-up|1
2103480|NCT00845897|3695556|FG001|Overall Study|Lost to Follow-up|1
2103481|NCT00845897|3695557|FG002|Overall Study|Lost to Follow-up|0
2103482|NCT00845897|3695555|FG000|Overall Study|Withdrawal by Subject|0
2103483|NCT00845897|3695556|FG001|Overall Study|Withdrawal by Subject|3
2103484|NCT00845897|3695557|FG002|Overall Study|Withdrawal by Subject|2
2103485|NCT00845897|3695555|FG000|Overall Study|Ulcer did not heal|1
2103486|NCT00845897|3695556|FG001|Overall Study|Ulcer did not heal|0
2103487|NCT00845897|3695557|FG002|Overall Study|Ulcer did not heal|1
2103488|NCT00845897|3695555|FG000|Overall Study|Too ill to participate|0
2103489|NCT00845897|3695556|FG001|Overall Study|Too ill to participate|1
2103490|NCT00845897|3695557|FG002|Overall Study|Too ill to participate|0
2103491|NCT00846027|3695574|FG000|Overall Study|Death|3
2103492|NCT00846027|3695574|FG000|Overall Study|Disease Progression|30
2103493|NCT00846027|3695574|FG000|Overall Study|Toxicity|12
2103494|NCT00846027|3695574|FG000|Overall Study|Patient Decision|7
2103495|NCT00846027|3695574|FG000|Overall Study|Investigator Discretion|29
2103496|NCT00846027|3695574|FG000|Overall Study|Protocol Violation|2
2103497|NCT00846027|3695574|FG000|Overall Study|Subject Not Treated|7
2103498|NCT00846040|3695581|FG000|Baseline: Days 1-5|Withdrawal by Subject|1
2103499|NCT00846040|3695582|FG001|Baseline: Days 1-5|Withdrawal by Subject|0
2103500|NCT00846040|3695583|FG002|Baseline: Days 1-5|Withdrawal by Subject|0
2103501|NCT00846040|3695581|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
2103502|NCT00846040|3695582|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2
2103503|NCT00846040|3695583|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
2103504|NCT00846053|3695594|FG000|Overall Study|Physician Decision|3
2103505|NCT00846053|3695595|FG001|Overall Study|Physician Decision|0
2103506|NCT00846365|3695625|FG000|Overall Study|Adverse Event|20
2103507|NCT00846365|3695626|FG001|Overall Study|Adverse Event|30
2103508|NCT00846365|3695627|FG002|Overall Study|Adverse Event|11
2103509|NCT00846365|3695625|FG000|Overall Study|Protocol Violation|5
2103510|NCT00846365|3695626|FG001|Overall Study|Protocol Violation|4
2103511|NCT00846365|3695627|FG002|Overall Study|Protocol Violation|0
2103512|NCT00846365|3695625|FG000|Overall Study|Lost to Follow-up|8
2103513|NCT00846365|3695626|FG001|Overall Study|Lost to Follow-up|2
2103514|NCT00846365|3695627|FG002|Overall Study|Lost to Follow-up|5
2103515|NCT00846365|3695625|FG000|Overall Study|Withdrawal by Subject|11
2103516|NCT00846365|3695626|FG001|Overall Study|Withdrawal by Subject|11
2103517|NCT00846365|3695627|FG002|Overall Study|Withdrawal by Subject|9
2103518|NCT00846365|3695625|FG000|Overall Study|Pregnancy|1
2103519|NCT00846365|3695626|FG001|Overall Study|Pregnancy|0
2103520|NCT00846365|3695627|FG002|Overall Study|Pregnancy|0
2103521|NCT00846365|3695625|FG000|Overall Study|Lack of Efficacy|1
2103522|NCT00846365|3695626|FG001|Overall Study|Lack of Efficacy|1
2103523|NCT00846365|3695627|FG002|Overall Study|Lack of Efficacy|2
2103524|NCT00846365|3695625|FG000|Overall Study|Other|9
2103525|NCT00846365|3695626|FG001|Overall Study|Other|1
2103526|NCT00846365|3695627|FG002|Overall Study|Other|6
2103527|NCT00846391|3695638|FG000|Overall Study|Physician Decision|0
2103528|NCT00846391|3695639|FG001|Overall Study|Physician Decision|0
2103529|NCT00846391|3695640|FG002|Overall Study|Physician Decision|1
2103530|NCT00846391|3695638|FG000|Overall Study|Study Terminated by Sponsor|1
2103531|NCT00846391|3695639|FG001|Overall Study|Study Terminated by Sponsor|2
2103532|NCT00846391|3695640|FG002|Overall Study|Study Terminated by Sponsor|2
2103533|NCT00846495|3695655|FG000|Overall Study|Lost to Follow-up|1
2103534|NCT00846495|3695656|FG001|Overall Study|Lost to Follow-up|0
2103535|NCT00846495|3695655|FG000|Overall Study|Adverse Event|5
2103536|NCT00846495|3695656|FG001|Overall Study|Adverse Event|1
2103537|NCT00846495|3695655|FG000|Overall Study|Lack of Efficacy|1
2103538|NCT00846495|3695656|FG001|Overall Study|Lack of Efficacy|2
2103539|NCT00846495|3695655|FG000|Overall Study|Physician Decision|1
2103540|NCT00846495|3695656|FG001|Overall Study|Physician Decision|0
2103541|NCT00846521|3695662|FG000|Overall Study|Withdrawal by Subject|5
2103542|NCT00846521|3695662|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5
2103543|NCT00846521|3695662|FG000|Overall Study|Protocol Violation|1
2103544|NCT00846586|3695686|FG000|Overall Study|Adverse Event|20
2103545|NCT00846586|3695687|FG001|Overall Study|Adverse Event|10
2103546|NCT00846586|3695686|FG000|Overall Study|Subject withdrew consent|8
2103547|NCT00846586|3695687|FG001|Overall Study|Subject withdrew consent|10
2103548|NCT00846586|3695686|FG000|Overall Study|Administrative problems|5
2103549|NCT00846586|3695687|FG001|Overall Study|Administrative problems|4
2103550|NCT00846586|3695686|FG000|Overall Study|Death|2
2103551|NCT00846586|3695687|FG001|Overall Study|Death|0
2103552|NCT00846586|3695686|FG000|Overall Study|Protocol deviation|2
2103553|NCT00846586|3695687|FG001|Overall Study|Protocol deviation|6
2103554|NCT00846586|3695686|FG000|Overall Study|Abnormal test procedure result(s)|1
2103555|NCT00846586|3695687|FG001|Overall Study|Abnormal test procedure result(s)|0
2103556|NCT00846586|3695686|FG000|Overall Study|Lost to Follow-up|1
2103557|NCT00846586|3695687|FG001|Overall Study|Lost to Follow-up|4
2103558|NCT00846586|3695686|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2103559|NCT00846586|3695687|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2103560|NCT00846742|3695704|FG000|Overall Study|Withdrawal by Subject|1
2103561|NCT00846768|3695709|FG000|Overall Study|Adverse Event|0
2103562|NCT00846768|3695710|FG001|Overall Study|Adverse Event|1
2103563|NCT00846768|3695711|FG002|Overall Study|Adverse Event|0
2103564|NCT00846768|3695712|FG003|Overall Study|Adverse Event|0
2103565|NCT00846807|3695722|FG000|Overall Study|Adverse Event|270
2103566|NCT00846807|3695722|FG000|Overall Study|Lost to Follow-up|94
2103567|NCT00846807|3695722|FG000|Overall Study|Withdrawal by Subject|56
2103568|NCT00846807|3695722|FG000|Overall Study|Non compliant with European label|7
2103569|NCT00846807|3695722|FG000|Overall Study|Switch to other anticoagulants|89
2103570|NCT00846807|3695722|FG000|Overall Study|No prescription after hospital discharge|56
2103571|NCT00846807|3695722|FG000|Overall Study|Other|60
2103572|NCT00846846|3695726|FG000|Overall Study|Death|56
2103573|NCT00846846|3695726|FG000|Overall Study|Withdrawal by Subject|19
2103574|NCT00847015|3695730|FG000|Overall Study|Withdrawal by Subject|1
2103575|NCT00847015|3695730|FG000|Overall Study|declined any surgery|1
2103576|NCT00847015|3695730|FG000|Overall Study|partial cystectomy vs radical cystectomy|1
2103577|NCT00847132|3695736|FG000|Overall Study|Death|1
2103578|NCT00847132|3695737|FG001|Overall Study|Death|1
2103579|NCT00847145|3695751|FG000|Overall Study|AE or Death|0
2103580|NCT00847145|3695752|FG001|Overall Study|AE or Death|1
2103581|NCT00847145|3695753|FG002|Overall Study|AE or Death|1
2103582|NCT00847145|3695754|FG003|Overall Study|AE or Death|0
2103583|NCT00847145|3695755|FG004|Overall Study|AE or Death|0
2103584|NCT00847145|3695756|FG005|Overall Study|AE or Death|0
2103585|NCT00847145|3695757|FG006|Overall Study|AE or Death|0
2103586|NCT00847145|3695758|FG007|Overall Study|AE or Death|0
2103587|NCT00847145|3695751|FG000|Overall Study|Withdrawal by Subject|3
2103588|NCT00847145|3695752|FG001|Overall Study|Withdrawal by Subject|4
2103589|NCT00847145|3695753|FG002|Overall Study|Withdrawal by Subject|6
2103590|NCT00847145|3695754|FG003|Overall Study|Withdrawal by Subject|1
2103591|NCT00847145|3695755|FG004|Overall Study|Withdrawal by Subject|0
2103592|NCT00847145|3695756|FG005|Overall Study|Withdrawal by Subject|0
2103593|NCT00847145|3695757|FG006|Overall Study|Withdrawal by Subject|1
2103594|NCT00847145|3695758|FG007|Overall Study|Withdrawal by Subject|1
2103595|NCT00847145|3695751|FG000|Overall Study|Lost to Follow-up|3
2103596|NCT00847145|3695752|FG001|Overall Study|Lost to Follow-up|1
2103597|NCT00847145|3695753|FG002|Overall Study|Lost to Follow-up|1
2103598|NCT00847145|3695754|FG003|Overall Study|Lost to Follow-up|0
2103599|NCT00847145|3695755|FG004|Overall Study|Lost to Follow-up|4
2103600|NCT00847145|3695756|FG005|Overall Study|Lost to Follow-up|4
2103601|NCT00847145|3695757|FG006|Overall Study|Lost to Follow-up|8
2103602|NCT00847145|3695758|FG007|Overall Study|Lost to Follow-up|2
2103603|NCT00847145|3695751|FG000|Overall Study|Inappropriate enrollment|0
2103604|NCT00847145|3695752|FG001|Overall Study|Inappropriate enrollment|0
2103605|NCT00847145|3695753|FG002|Overall Study|Inappropriate enrollment|0
2103606|NCT00847145|3695754|FG003|Overall Study|Inappropriate enrollment|0
2103607|NCT00847145|3695755|FG004|Overall Study|Inappropriate enrollment|1
2103608|NCT00847145|3695756|FG005|Overall Study|Inappropriate enrollment|0
2103609|NCT00847145|3695757|FG006|Overall Study|Inappropriate enrollment|0
2103610|NCT00847145|3695758|FG007|Overall Study|Inappropriate enrollment|0
2103611|NCT00847145|3695751|FG000|Overall Study|Protocol Violation|0
2103612|NCT00847145|3695752|FG001|Overall Study|Protocol Violation|0
2103613|NCT00847145|3695753|FG002|Overall Study|Protocol Violation|3
2103614|NCT00847145|3695754|FG003|Overall Study|Protocol Violation|0
2103615|NCT00847145|3695755|FG004|Overall Study|Protocol Violation|1
2103616|NCT00847145|3695756|FG005|Overall Study|Protocol Violation|0
2103617|NCT00847145|3695757|FG006|Overall Study|Protocol Violation|0
2313631|NCT02793232|4021283|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2313632|NCT02793232|4021284|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
2313633|NCT02793232|4021285|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2313634|NCT02793232|4021286|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2313635|NCT02793622|4021322|FG000|Overall Study|Lost to Follow-up|31
2313636|NCT02793622|4021323|FG001|Overall Study|Lost to Follow-up|19
2313637|NCT02793622|4021322|FG000|Overall Study|Withdrawal by Subject|21
2313638|NCT02793622|4021323|FG001|Overall Study|Withdrawal by Subject|17
2313639|NCT02793622|4021322|FG000|Overall Study|Adverse Event|0
2313640|NCT02793622|4021323|FG001|Overall Study|Adverse Event|1
2313641|NCT02793622|4021322|FG000|Overall Study|Protocol Violation|1
2313642|NCT02793622|4021323|FG001|Overall Study|Protocol Violation|5
2313643|NCT02793947|4021400|FG000|Overall Study|Death|1
2313644|NCT02793947|4021401|FG001|Overall Study|Death|0
2313645|NCT02793947|4021400|FG000|Overall Study|Physician Decision|1
2313646|NCT02793947|4021401|FG001|Overall Study|Physician Decision|5
2313647|NCT02794103|4021407|FG000|Overall Study|Loss to follow up due to high sedation|3
2313648|NCT02794246|4021419|FG000|Overall Study|Withdrawal by Subject|2
2313649|NCT02794246|4021419|FG000|Overall Study|Physician Decision|4
2313650|NCT02794480|4021434|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
2313651|NCT02794480|4021435|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
2313652|NCT02794480|4021436|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
2313653|NCT02794480|4021437|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
2313654|NCT02794480|4021434|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
2313655|NCT02794480|4021435|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
2313656|NCT02794480|4021436|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
2313657|NCT02794480|4021437|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
2313658|NCT02794480|4021434|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
2313659|NCT02794480|4021435|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
2313660|NCT02794480|4021436|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
2313661|NCT02794480|4021437|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
2313662|NCT02794480|4021434|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2103618|NCT00847145|3695758|FG007|Overall Study|Protocol Violation|1
2103619|NCT00847197|3695792|FG000|Overall Study|Adverse Event|21
2103620|NCT00847197|3695793|FG001|Overall Study|Adverse Event|3
2103621|NCT00847197|3695792|FG000|Overall Study|Protocol Violation|0
2103622|NCT00847197|3695793|FG001|Overall Study|Protocol Violation|1
2103623|NCT00847197|3695792|FG000|Overall Study|Withdrawal by Subject|3
2103624|NCT00847197|3695793|FG001|Overall Study|Withdrawal by Subject|1
2214804|NCT01691014|3857459|FG003|Overall Study|Adverse Event|1
2214805|NCT01691014|3857456|FG000|Overall Study|Lack of Efficacy|2
2214806|NCT01691014|3857457|FG001|Overall Study|Lack of Efficacy|3
2214807|NCT01691014|3857458|FG002|Overall Study|Lack of Efficacy|7
2214808|NCT01691014|3857459|FG003|Overall Study|Lack of Efficacy|0
2214809|NCT01691092|3857474|FG000|Overall Study|Lost to Follow-up|10
2214810|NCT01691092|3857474|FG000|Overall Study|Physician Decision|4
2214811|NCT01691092|3857474|FG000|Overall Study|Withdrawal by Subject|3
2214812|NCT01691092|3857474|FG000|Overall Study|non-compliance|3
2214813|NCT01691092|3857474|FG000|Overall Study|used for different study|2
2313663|NCT02794480|4021435|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
2313664|NCT02794480|4021436|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2313665|NCT02794480|4021437|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2313666|NCT02794480|4021434|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
2313667|NCT02794480|4021435|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2358397|NCT01915498|4118873|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358398|NCT01915498|4118874|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358399|NCT01915498|4118875|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358400|NCT01915498|4118876|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358401|NCT01915498|4118877|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358402|NCT01915498|4118878|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358403|NCT01915498|4118879|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358404|NCT01915498|4118880|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358405|NCT01915498|4118881|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358406|NCT01915498|4118882|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358407|NCT01915498|4118883|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
2358408|NCT01915498|4118884|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358409|NCT01915498|4118885|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358410|NCT01915498|4118886|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
2358411|NCT01915498|4118887|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358412|NCT01915498|4118888|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358413|NCT01915498|4118889|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
2358414|NCT01915498|4118890|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
2358415|NCT01915498|4118891|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
2358416|NCT01915498|4118873|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
2358417|NCT01915498|4118874|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358418|NCT01915498|4118875|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358419|NCT01915498|4118876|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358420|NCT01915498|4118877|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358421|NCT01915498|4118878|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
2358422|NCT01915498|4118879|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358423|NCT01915498|4118880|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358424|NCT01915498|4118881|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358425|NCT01915498|4118882|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358426|NCT01915498|4118883|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358427|NCT01915498|4118884|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358428|NCT01915498|4118885|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358429|NCT01915498|4118886|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358430|NCT01915498|4118887|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
2358431|NCT01915498|4118888|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358432|NCT01915498|4118889|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358433|NCT01915498|4118890|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2
2358434|NCT01915498|4118891|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
2358435|NCT01915498|4118873|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2358436|NCT01915498|4118874|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2358437|NCT01915498|4118875|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2358438|NCT01915498|4118876|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2358439|NCT01915498|4118877|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2214814|NCT01691092|3857474|FG000|Overall Study|screen fail|19
2214815|NCT01691105|3857480|FG000|1 Month Follow-up|Lost to Follow-up|41
2214816|NCT01691105|3857481|FG001|1 Month Follow-up|Lost to Follow-up|38
2313668|NCT02794480|4021436|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2313669|NCT02794480|4021437|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
2103625|NCT00847301|3695817|FG000|Overall Study|Adverse Event|35
2103626|NCT00847301|3695817|FG000|Overall Study|Switch to other anticoagulants|16
2103627|NCT00847301|3695817|FG000|Overall Study|Lost to Follow-up|1
2103628|NCT00847301|3695817|FG000|Overall Study|No prescription after hospital discharge|1
2103629|NCT00847301|3695817|FG000|Overall Study|Other reason not defined above|1
2103630|NCT00847379|3695824|FG000|Overall Study|Study terminated by Sponsor|59
2103631|NCT00847379|3695825|FG001|Overall Study|Study terminated by Sponsor|57
2103632|NCT00847379|3695826|FG002|Overall Study|Study terminated by Sponsor|57
2103633|NCT00847535|3695840|FG000|Overall Study|Withdrawal by Subject|2
2103634|NCT00847535|3695841|FG001|Overall Study|Withdrawal by Subject|1
2103635|NCT00847535|3695842|FG002|Overall Study|Withdrawal by Subject|1
2103636|NCT00847535|3695840|FG000|Overall Study|Lost to Follow-up|0
2103637|NCT00847535|3695841|FG001|Overall Study|Lost to Follow-up|1
2103638|NCT00847535|3695842|FG002|Overall Study|Lost to Follow-up|0
2103639|NCT00847561|3695849|FG000|Overall Study|Withdrawal by Subject|4
2103640|NCT00847561|3695850|FG001|Overall Study|Withdrawal by Subject|3
2103641|NCT00847561|3695849|FG000|Overall Study|Unable to schedule|9
2103642|NCT00847561|3695850|FG001|Overall Study|Unable to schedule|1
2103643|NCT00847613|3695869|FG000|Overall Study|Ongoing at cut-off date|250
2103644|NCT00847613|3695870|FG001|Overall Study|Ongoing at cut-off date|265
2103645|NCT00847613|3695871|FG002|Overall Study|Ongoing at cut-off date|64
2103646|NCT00847613|3695872|FG003|Overall Study|Ongoing at cut-off date|64
2103647|NCT00847613|3695869|FG000|Overall Study|Death|1
2103648|NCT00847613|3695870|FG001|Overall Study|Death|1
2103649|NCT00847613|3695871|FG002|Overall Study|Death|0
2103650|NCT00847613|3695872|FG003|Overall Study|Death|0
2103651|NCT00847613|3695869|FG000|Overall Study|Adverse Event|36
2103652|NCT00847613|3695870|FG001|Overall Study|Adverse Event|26
2103653|NCT00847613|3695871|FG002|Overall Study|Adverse Event|5
2103654|NCT00847613|3695872|FG003|Overall Study|Adverse Event|6
2103655|NCT00847613|3695869|FG000|Overall Study|Lack of Efficacy|7
2103656|NCT00847613|3695870|FG001|Overall Study|Lack of Efficacy|3
2103657|NCT00847613|3695871|FG002|Overall Study|Lack of Efficacy|3
2103658|NCT00847613|3695872|FG003|Overall Study|Lack of Efficacy|1
2103659|NCT00847613|3695869|FG000|Overall Study|Study terminated by Sponsor|1
2103660|NCT00847613|3695870|FG001|Overall Study|Study terminated by Sponsor|0
2103661|NCT00847613|3695871|FG002|Overall Study|Study terminated by Sponsor|2
2103662|NCT00847613|3695872|FG003|Overall Study|Study terminated by Sponsor|1
2103663|NCT00847613|3695869|FG000|Overall Study|Lost to Follow-up|5
2103664|NCT00847613|3695870|FG001|Overall Study|Lost to Follow-up|0
2103665|NCT00847613|3695871|FG002|Overall Study|Lost to Follow-up|0
2103666|NCT00847613|3695872|FG003|Overall Study|Lost to Follow-up|3
2103667|NCT00847613|3695869|FG000|Overall Study|Protocol Violation|6
2103668|NCT00847613|3695870|FG001|Overall Study|Protocol Violation|6
2103669|NCT00847613|3695871|FG002|Overall Study|Protocol Violation|3
2103670|NCT00847613|3695872|FG003|Overall Study|Protocol Violation|1
2103671|NCT00847613|3695869|FG000|Overall Study|Pregnancy|1
2103672|NCT00847613|3695870|FG001|Overall Study|Pregnancy|1
2103673|NCT00847613|3695871|FG002|Overall Study|Pregnancy|0
2103674|NCT00847613|3695872|FG003|Overall Study|Pregnancy|0
2103675|NCT00847613|3695869|FG000|Overall Study|Site closure|1
2103676|NCT00847613|3695870|FG001|Overall Study|Site closure|0
2103677|NCT00847613|3695871|FG002|Overall Study|Site closure|0
2103678|NCT00847613|3695872|FG003|Overall Study|Site closure|1
2103679|NCT00847613|3695869|FG000|Overall Study|Withdrawal by Subject|8
2103680|NCT00847613|3695870|FG001|Overall Study|Withdrawal by Subject|11
2103681|NCT00847613|3695871|FG002|Overall Study|Withdrawal by Subject|2
2103682|NCT00847613|3695872|FG003|Overall Study|Withdrawal by Subject|2
2103683|NCT00847613|3695869|FG000|Overall Study|Participant moved|4
2103684|NCT00847613|3695870|FG001|Overall Study|Participant moved|1
2103685|NCT00847613|3695871|FG002|Overall Study|Participant moved|0
2103686|NCT00847613|3695872|FG003|Overall Study|Participant moved|0
2103687|NCT00847613|3695869|FG000|Overall Study|Sponsor request|0
2313670|NCT02794870|4021485|FG000|Overall Study|Withdrawal by Subject|2
2313671|NCT02794870|4021486|FG001|Overall Study|Withdrawal by Subject|0
2313672|NCT02794974|4021494|FG000|Overall Study|Physician Decision|0
2313673|NCT02794974|4021495|FG001|Overall Study|Physician Decision|1
2313674|NCT02795767|4021517|FG000|Overall Study|Received Commercial Emicizumab|1
2313675|NCT02795767|4021518|FG001|Overall Study|Received Commercial Emicizumab|0
2313676|NCT02795767|4021519|FG002|Overall Study|Received Commercial Emicizumab|0
2313677|NCT02795832|4021564|FG000|Overall Study|Adverse Event|0
2313678|NCT02795832|4021565|FG001|Overall Study|Adverse Event|0
2313679|NCT02795832|4021566|FG002|Overall Study|Adverse Event|0
2313680|NCT02795832|4021567|FG003|Overall Study|Adverse Event|0
2313681|NCT02795832|4021568|FG004|Overall Study|Adverse Event|0
2313682|NCT02795832|4021569|FG005|Overall Study|Adverse Event|3
2313683|NCT02796560|4021634|FG000|Overall Study|Adverse Event|2
2313684|NCT02796560|4021635|FG001|Overall Study|Adverse Event|0
2313685|NCT02796560|4021634|FG000|Overall Study|Withdrawal by Subject|2
2313686|NCT02796560|4021635|FG001|Overall Study|Withdrawal by Subject|2
2313687|NCT02796651|4021645|FG000|Overall Study|Adverse Event|6
2103688|NCT00847613|3695870|FG001|Overall Study|Sponsor request|1
2103689|NCT00847613|3695871|FG002|Overall Study|Sponsor request|0
2103690|NCT00847613|3695872|FG003|Overall Study|Sponsor request|0
2313688|NCT02796651|4021645|FG000|Overall Study|Lost to Follow-up|1
2313689|NCT02796651|4021645|FG000|Overall Study|Withdrawal by Subject|4
2103691|NCT00847613|3695869|FG000|Overall Study|Randomized, but not treated|0
2103692|NCT00847613|3695870|FG001|Overall Study|Randomized, but not treated|3
2103693|NCT00847613|3695871|FG002|Overall Study|Randomized, but not treated|0
2103694|NCT00847613|3695872|FG003|Overall Study|Randomized, but not treated|0
2103695|NCT00847613|3695869|FG000|Overall Study|Other|1
2103696|NCT00847613|3695870|FG001|Overall Study|Other|1
2103697|NCT00847613|3695871|FG002|Overall Study|Other|2
2103698|NCT00847613|3695872|FG003|Overall Study|Other|0
2103699|NCT00847626|3695900|FG000|Overall Study|Adverse Event|10
2103700|NCT00847626|3695901|FG001|Overall Study|Adverse Event|10
2103701|NCT00847626|3695902|FG002|Overall Study|Adverse Event|6
2103702|NCT00847626|3695903|FG003|Overall Study|Adverse Event|19
2103703|NCT00847626|3695904|FG004|Overall Study|Adverse Event|11
2103704|NCT00847626|3695905|FG005|Overall Study|Adverse Event|22
2103705|NCT00847626|3695906|FG006|Overall Study|Adverse Event|4
2103706|NCT00847626|3695907|FG007|Overall Study|Adverse Event|6
2103707|NCT00847626|3695908|FG008|Overall Study|Adverse Event|3
2103708|NCT00847626|3695909|FG009|Overall Study|Adverse Event|6
2103709|NCT00847626|3695910|FG010|Overall Study|Adverse Event|6
2103710|NCT00847626|3695900|FG000|Overall Study|Protocol Violation|2
2103711|NCT00847626|3695901|FG001|Overall Study|Protocol Violation|1
2103712|NCT00847626|3695902|FG002|Overall Study|Protocol Violation|2
2103713|NCT00847626|3695903|FG003|Overall Study|Protocol Violation|1
2103714|NCT00847626|3695904|FG004|Overall Study|Protocol Violation|1
2103715|NCT00847626|3695905|FG005|Overall Study|Protocol Violation|1
2103716|NCT00847626|3695906|FG006|Overall Study|Protocol Violation|1
2103717|NCT00847626|3695907|FG007|Overall Study|Protocol Violation|1
2103718|NCT00847626|3695908|FG008|Overall Study|Protocol Violation|0
2313690|NCT02796651|4021645|FG000|Overall Study|Protocol Violation|4
2313691|NCT02796651|4021645|FG000|Overall Study|Lack of Efficacy|1
2313692|NCT02796651|4021645|FG000|Overall Study|Other|10
2313693|NCT02796664|4021662|FG000|Overall Study|Withdrawal by Subject|0
2313694|NCT02796664|4021663|FG001|Overall Study|Withdrawal by Subject|3
2313695|NCT02796664|4021662|FG000|Overall Study|Noncompliance|1
2313696|NCT02796664|4021663|FG001|Overall Study|Noncompliance|1
2313697|NCT02796664|4021662|FG000|Overall Study|Death|0
2358440|NCT01915498|4118878|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
2358441|NCT01915498|4118879|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2358442|NCT01915498|4118880|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2358443|NCT01915498|4118881|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2358444|NCT01915498|4118882|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
2358445|NCT01915498|4118883|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2358446|NCT01915498|4118884|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2358447|NCT01915498|4118885|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2358448|NCT01915498|4118886|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
2358449|NCT01915498|4118887|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
2358450|NCT01915498|4118888|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
2358451|NCT01915498|4118889|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
2358452|NCT01915498|4118890|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
2358453|NCT01915498|4118891|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
2358454|NCT01915498|4118873|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358455|NCT01915498|4118874|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358456|NCT01915498|4118875|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358457|NCT01915498|4118876|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358458|NCT01915498|4118877|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358459|NCT01915498|4118878|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358460|NCT01915498|4118879|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358461|NCT01915498|4118880|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358462|NCT01915498|4118881|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358463|NCT01915498|4118882|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358464|NCT01915498|4118883|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358465|NCT01915498|4118884|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358466|NCT01915498|4118885|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358467|NCT01915498|4118886|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358468|NCT01915498|4118887|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358469|NCT01915498|4118888|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358470|NCT01915498|4118889|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358471|NCT01915498|4118890|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
2358472|NCT01915498|4118891|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2
2103719|NCT00847626|3695909|FG009|Overall Study|Protocol Violation|1
2103720|NCT00847626|3695910|FG010|Overall Study|Protocol Violation|1
2103721|NCT00847626|3695900|FG000|Overall Study|Lost to Follow-up|0
2313698|NCT02796664|4021663|FG001|Overall Study|Death|1
2313699|NCT02796677|4021675|FG000|Overall Study|Adverse Event|11
2103722|NCT00847626|3695901|FG001|Overall Study|Lost to Follow-up|1
2103723|NCT00847626|3695902|FG002|Overall Study|Lost to Follow-up|1
2103724|NCT00847626|3695903|FG003|Overall Study|Lost to Follow-up|1
2103725|NCT00847626|3695904|FG004|Overall Study|Lost to Follow-up|0
2103726|NCT00847626|3695905|FG005|Overall Study|Lost to Follow-up|3
2214817|NCT01691105|3857480|FG000|1 Month Follow-up|Death|2
2103727|NCT00847626|3695906|FG006|Overall Study|Lost to Follow-up|1
2103728|NCT00847626|3695907|FG007|Overall Study|Lost to Follow-up|3
2103729|NCT00847626|3695908|FG008|Overall Study|Lost to Follow-up|1
2103730|NCT00847626|3695909|FG009|Overall Study|Lost to Follow-up|0
2103731|NCT00847626|3695910|FG010|Overall Study|Lost to Follow-up|1
2103732|NCT00847626|3695900|FG000|Overall Study|Withdrawal by Subject|5
2313700|NCT02796677|4021676|FG001|Overall Study|Adverse Event|22
2313701|NCT02796677|4021677|FG002|Overall Study|Adverse Event|14
2313702|NCT02796677|4021678|FG003|Overall Study|Adverse Event|14
2313703|NCT02796677|4021675|FG000|Overall Study|Protocol Violation|7
2313704|NCT02796677|4021676|FG001|Overall Study|Protocol Violation|5
2313705|NCT02796677|4021677|FG002|Overall Study|Protocol Violation|4
2313706|NCT02796677|4021678|FG003|Overall Study|Protocol Violation|8
2313707|NCT02796677|4021675|FG000|Overall Study|Lost to Follow-up|1
2313708|NCT02796677|4021676|FG001|Overall Study|Lost to Follow-up|5
2313709|NCT02796677|4021677|FG002|Overall Study|Lost to Follow-up|2
2313710|NCT02796677|4021678|FG003|Overall Study|Lost to Follow-up|2
2313711|NCT02796677|4021675|FG000|Overall Study|Lack of Efficacy|7
2313712|NCT02796677|4021676|FG001|Overall Study|Lack of Efficacy|9
2313713|NCT02796677|4021677|FG002|Overall Study|Lack of Efficacy|14
2313714|NCT02796677|4021678|FG003|Overall Study|Lack of Efficacy|20
2313715|NCT02796677|4021675|FG000|Overall Study|Withdrawal by Subject|4
2313716|NCT02796677|4021676|FG001|Overall Study|Withdrawal by Subject|14
2313717|NCT02796677|4021677|FG002|Overall Study|Withdrawal by Subject|6
2313718|NCT02796677|4021678|FG003|Overall Study|Withdrawal by Subject|7
2313719|NCT02796677|4021675|FG000|Overall Study|Progressive disease|6
2313720|NCT02796677|4021676|FG001|Overall Study|Progressive disease|15
2313721|NCT02796677|4021677|FG002|Overall Study|Progressive disease|13
2313722|NCT02796677|4021678|FG003|Overall Study|Progressive disease|18
2313723|NCT02796677|4021675|FG000|Overall Study|Reason not mentioned|2
2313724|NCT02796677|4021676|FG001|Overall Study|Reason not mentioned|3
2313725|NCT02796677|4021677|FG002|Overall Study|Reason not mentioned|0
2313726|NCT02796677|4021678|FG003|Overall Study|Reason not mentioned|5
2313727|NCT02796755|4021692|FG000|Overall Study|Adverse Event|2
2313728|NCT02796755|4021693|FG001|Overall Study|Adverse Event|0
2313729|NCT02796963|4021707|FG000|Overall Study|Lost to Follow-up|89
2313730|NCT02796963|4021708|FG001|Overall Study|Lost to Follow-up|76
2313731|NCT02796963|4021709|FG002|Overall Study|Lost to Follow-up|69
2313732|NCT02796963|4021710|FG003|Overall Study|Lost to Follow-up|72
2313733|NCT02797080|4021733|FG000|Overall Study|Lost to Follow-up|1
2313734|NCT02797080|4021733|FG000|Overall Study|Withdrawal by Subject|1
2313735|NCT02797132|4021737|FG000|Part A (15 Days)|Adverse Event|1
2313736|NCT02797132|4021737|FG000|Part B (24 Weeks)|Adverse Event|3
2313737|NCT02797171|4021756|FG000|Overall Study|Lost to Follow-up|2
2313738|NCT02797171|4021757|FG001|Overall Study|Lost to Follow-up|0
2313739|NCT02797171|4021758|FG002|Overall Study|Lost to Follow-up|2
2313740|NCT02797171|4021759|FG003|Overall Study|Lost to Follow-up|1
2313741|NCT02797171|4021760|FG004|Overall Study|Lost to Follow-up|2
2313742|NCT02797171|4021761|FG005|Overall Study|Lost to Follow-up|0
2313743|NCT02797171|4021756|FG000|Overall Study|Withdrawal by Subject|1
2313744|NCT02797171|4021757|FG001|Overall Study|Withdrawal by Subject|1
2313745|NCT02797171|4021758|FG002|Overall Study|Withdrawal by Subject|0
2313746|NCT02797171|4021759|FG003|Overall Study|Withdrawal by Subject|0
2313747|NCT02797171|4021760|FG004|Overall Study|Withdrawal by Subject|0
2313748|NCT02797171|4021761|FG005|Overall Study|Withdrawal by Subject|0
2313749|NCT02797171|4021756|FG000|Overall Study|Protocol Violation|1
2313750|NCT02797171|4021757|FG001|Overall Study|Protocol Violation|0
2313751|NCT02797171|4021758|FG002|Overall Study|Protocol Violation|0
2313752|NCT02797171|4021759|FG003|Overall Study|Protocol Violation|0
2313753|NCT02797171|4021760|FG004|Overall Study|Protocol Violation|0
2313754|NCT02797171|4021761|FG005|Overall Study|Protocol Violation|0
2313755|NCT02797171|4021756|FG000|Overall Study|Participant unable to adhere|0
2313756|NCT02797171|4021757|FG001|Overall Study|Participant unable to adhere|1
2313757|NCT02797171|4021758|FG002|Overall Study|Participant unable to adhere|0
2313758|NCT02797171|4021759|FG003|Overall Study|Participant unable to adhere|0
2313759|NCT02797171|4021760|FG004|Overall Study|Participant unable to adhere|0
2313760|NCT02797171|4021761|FG005|Overall Study|Participant unable to adhere|0
2313761|NCT02797171|4021756|FG000|Overall Study|Not Randomized|0
2313762|NCT02797171|4021757|FG001|Overall Study|Not Randomized|0
2313763|NCT02797171|4021758|FG002|Overall Study|Not Randomized|0
2313764|NCT02797171|4021759|FG003|Overall Study|Not Randomized|0
2313765|NCT02797171|4021760|FG004|Overall Study|Not Randomized|0
2313766|NCT02797171|4021761|FG005|Overall Study|Not Randomized|1
2313767|NCT02797522|4021786|FG000|Overall Study|Study Terminated by Sponsor|0
2313768|NCT02797522|4021787|FG001|Overall Study|Study Terminated by Sponsor|0
2313769|NCT02797522|4021788|FG002|Overall Study|Study Terminated by Sponsor|0
2313770|NCT02797522|4021789|FG003|Overall Study|Study Terminated by Sponsor|0
2313771|NCT02797522|4021790|FG004|Overall Study|Study Terminated by Sponsor|0
2313772|NCT02797522|4021791|FG005|Overall Study|Study Terminated by Sponsor|0
2103733|NCT00847626|3695901|FG001|Overall Study|Withdrawal by Subject|5
2103734|NCT00847626|3695902|FG002|Overall Study|Withdrawal by Subject|3
2103735|NCT00847626|3695903|FG003|Overall Study|Withdrawal by Subject|8
2103736|NCT00847626|3695904|FG004|Overall Study|Withdrawal by Subject|12
2103737|NCT00847626|3695905|FG005|Overall Study|Withdrawal by Subject|9
2103738|NCT00847626|3695906|FG006|Overall Study|Withdrawal by Subject|8
2103739|NCT00847626|3695907|FG007|Overall Study|Withdrawal by Subject|4
2103740|NCT00847626|3695908|FG008|Overall Study|Withdrawal by Subject|4
2103741|NCT00847626|3695909|FG009|Overall Study|Withdrawal by Subject|5
2103742|NCT00847626|3695910|FG010|Overall Study|Withdrawal by Subject|2
2103743|NCT00847626|3695900|FG000|Overall Study|Lack of Efficacy|3
2103744|NCT00847626|3695901|FG001|Overall Study|Lack of Efficacy|1
2103745|NCT00847626|3695902|FG002|Overall Study|Lack of Efficacy|0
2103746|NCT00847626|3695903|FG003|Overall Study|Lack of Efficacy|1
2103747|NCT00847626|3695904|FG004|Overall Study|Lack of Efficacy|2
2103748|NCT00847626|3695905|FG005|Overall Study|Lack of Efficacy|0
2103749|NCT00847626|3695906|FG006|Overall Study|Lack of Efficacy|6
2103750|NCT00847626|3695907|FG007|Overall Study|Lack of Efficacy|2
2103751|NCT00847626|3695908|FG008|Overall Study|Lack of Efficacy|5
2103752|NCT00847626|3695909|FG009|Overall Study|Lack of Efficacy|1
2103753|NCT00847626|3695910|FG010|Overall Study|Lack of Efficacy|7
2103754|NCT00847626|3695900|FG000|Overall Study|Other|1
2103755|NCT00847626|3695901|FG001|Overall Study|Other|5
2103756|NCT00847626|3695902|FG002|Overall Study|Other|4
2103757|NCT00847626|3695903|FG003|Overall Study|Other|1
2103758|NCT00847626|3695904|FG004|Overall Study|Other|2
2103759|NCT00847626|3695905|FG005|Overall Study|Other|2
2103760|NCT00847626|3695906|FG006|Overall Study|Other|2
2103761|NCT00847626|3695907|FG007|Overall Study|Other|3
2103762|NCT00847626|3695908|FG008|Overall Study|Other|1
2103763|NCT00847626|3695909|FG009|Overall Study|Other|1
2103764|NCT00847626|3695910|FG010|Overall Study|Other|3
2103765|NCT00847665|3695939|FG000|Overall Study|Withdrawal by Subject|1
2103766|NCT00847665|3695940|FG001|Overall Study|Withdrawal by Subject|0
2103767|NCT00847704|3695946|FG000|Overall Study|Withdrawal by Subject|1
2103768|NCT00847730|3695950|FG000|Overall Study|Multiple interruptions in therapy|8
2103769|NCT00847808|3695954|FG000|Overall Study|Adverse Event|7
2103770|NCT00847808|3695954|FG000|Overall Study|Protocol Violation|1
2103771|NCT00847808|3695954|FG000|Overall Study|Lost to Follow-up|1
2103772|NCT00847808|3695954|FG000|Overall Study|Withdrawal by Subject|4
2103773|NCT00847808|3695954|FG000|Overall Study|Participant Reported Lack of Efficacy|1
2103774|NCT00847808|3695954|FG000|Overall Study|Participant Took Excluded Medication|1
2103775|NCT00847886|3695960|FG000|Overall Study|Adverse Event|0
2103776|NCT00847886|3695961|FG001|Overall Study|Adverse Event|1
2103777|NCT00847912|3695969|FG000|Overall Study|Protocol Violation|6
2103778|NCT00847912|3695970|FG001|Overall Study|Protocol Violation|7
2103779|NCT00847912|3695969|FG000|Overall Study|Withdrawal by Subject|3
2103780|NCT00847912|3695970|FG001|Overall Study|Withdrawal by Subject|6
2103781|NCT00848042|3696001|FG000|Overall Study|Death|1
2103782|NCT00848042|3696002|FG001|Overall Study|Death|2
2103783|NCT00848042|3696003|FG002|Overall Study|Death|0
2103784|NCT00848042|3696001|FG000|Overall Study|Other Therapy|3
2103785|NCT00848042|3696002|FG001|Overall Study|Other Therapy|0
2103786|NCT00848042|3696003|FG002|Overall Study|Other Therapy|0
2103787|NCT00848081|3696013|FG000|Overall Study|Adverse Event|6
2103788|NCT00848081|3696014|FG001|Overall Study|Adverse Event|7
2103789|NCT00848081|3696013|FG000|Overall Study|Protocol Violation|8
2103790|NCT00848081|3696014|FG001|Overall Study|Protocol Violation|5
2103791|NCT00848081|3696013|FG000|Overall Study|Lost to Follow-up|1
2103792|NCT00848081|3696014|FG001|Overall Study|Lost to Follow-up|0
2103793|NCT00848081|3696013|FG000|Overall Study|Physician Decision|0
2103794|NCT00848081|3696014|FG001|Overall Study|Physician Decision|3
2103795|NCT00848081|3696013|FG000|Overall Study|Withdrawal by Subject|5
2103796|NCT00848081|3696014|FG001|Overall Study|Withdrawal by Subject|3
2103797|NCT00848107|3696020|FG000|Overall Study|Lost to Follow-up|2
2103798|NCT00848107|3696020|FG000|Overall Study|Withdrawal by Subject|8
2103799|NCT00848107|3696020|FG000|Overall Study|Adverse Event|9
2103800|NCT00848107|3696020|FG000|Overall Study|Death|1
2103801|NCT00848107|3696020|FG000|Overall Study|Pregnancy|1
2103802|NCT00848120|3696024|FG000|Overall Study|Adverse Event|1
2103803|NCT00848198|3696053|FG000|Overall Study|Incomplete Case Report Forms|15
2103804|NCT00848211|3696065|FG000|Overall Study|Protocol Violation|0
2103805|NCT00848211|3696066|FG001|Overall Study|Protocol Violation|1
2103806|NCT00848211|3696067|FG002|Overall Study|Protocol Violation|1
2103807|NCT00848211|3696068|FG003|Overall Study|Protocol Violation|0
2103808|NCT00848211|3696065|FG000|Overall Study|Adverse Event|0
2103809|NCT00848211|3696066|FG001|Overall Study|Adverse Event|0
2103810|NCT00848211|3696067|FG002|Overall Study|Adverse Event|0
2103811|NCT00848211|3696068|FG003|Overall Study|Adverse Event|0
2103812|NCT00848250|3696084|FG000|Overall Study|surgery was completed without cardiopulm|0
2103813|NCT00848250|3696085|FG001|Overall Study|surgery was completed without cardiopulm|1
2103814|NCT00848354|3696094|FG000|Phase 1|Adverse Event|5
2103815|NCT00848354|3696095|FG001|Phase 1|Adverse Event|4
2103816|NCT00848354|3696094|FG000|Phase 1|Discontinuation of study by sponsor|2
2103817|NCT00848354|3696095|FG001|Phase 1|Discontinuation of study by sponsor|1
2103818|NCT00848354|3696094|FG000|Phase 1|Failed to return|0
2103819|NCT00848354|3696095|FG001|Phase 1|Failed to return|1
2103820|NCT00848354|3696094|FG000|Phase 1|Lost to Follow-up|1
2103821|NCT00848354|3696095|FG001|Phase 1|Lost to Follow-up|1
2103822|NCT00848354|3696094|FG000|Phase 1|Unspecified Reason|1
2103823|NCT00848354|3696095|FG001|Phase 1|Unspecified Reason|1
2103824|NCT00848354|3696094|FG000|Phase 1|Protocol Violation|1
2103825|NCT00848354|3696095|FG001|Phase 1|Protocol Violation|1
2103826|NCT00848354|3696094|FG000|Phase 1|Withdrawal by Subject|2
2103827|NCT00848354|3696095|FG001|Phase 1|Withdrawal by Subject|4
2103828|NCT00848354|3696094|FG000|Phase 1|Lack of Efficacy|0
2103829|NCT00848354|3696095|FG001|Phase 1|Lack of Efficacy|1
2103830|NCT00848354|3696094|FG000|Phase 2 Year 1|Adverse Event|7
2103831|NCT00848354|3696095|FG001|Phase 2 Year 1|Adverse Event|2
2103832|NCT00848354|3696094|FG000|Phase 2 Year 1|Death|1
2103833|NCT00848354|3696095|FG001|Phase 2 Year 1|Death|0
2103834|NCT00848354|3696094|FG000|Phase 2 Year 1|Failed to Return|1
2103835|NCT00848354|3696095|FG001|Phase 2 Year 1|Failed to Return|1
2103836|NCT00848354|3696094|FG000|Phase 2 Year 1|Lost to Follow-up|1
2103837|NCT00848354|3696095|FG001|Phase 2 Year 1|Lost to Follow-up|0
2103838|NCT00848354|3696094|FG000|Phase 2 Year 1|Unspecified Reason|3
2103839|NCT00848354|3696095|FG001|Phase 2 Year 1|Unspecified Reason|0
2103840|NCT00848354|3696094|FG000|Phase 2 Year 1|Protocol Violation|4
2103841|NCT00848354|3696095|FG001|Phase 2 Year 1|Protocol Violation|1
2103842|NCT00848354|3696094|FG000|Phase 2 Year 1|Subject Request|1
2103843|NCT00848354|3696095|FG001|Phase 2 Year 1|Subject Request|2
2103844|NCT00848354|3696094|FG000|Phase 2 Year 2|Adverse Event|12
2103845|NCT00848354|3696095|FG001|Phase 2 Year 2|Adverse Event|2
2103846|NCT00848354|3696094|FG000|Phase 2 Year 2|Death|2
2103847|NCT00848354|3696095|FG001|Phase 2 Year 2|Death|0
2103848|NCT00848354|3696094|FG000|Phase 2 Year 2|Failed to return|3
2103849|NCT00848354|3696095|FG001|Phase 2 Year 2|Failed to return|0
2103850|NCT00848354|3696094|FG000|Phase 2 Year 2|Lost to Follow-up|1
2103851|NCT00848354|3696095|FG001|Phase 2 Year 2|Lost to Follow-up|3
2103852|NCT00848354|3696094|FG000|Phase 2 Year 2|Unspecified Reason|1
2103853|NCT00848354|3696095|FG001|Phase 2 Year 2|Unspecified Reason|0
2103854|NCT00848354|3696094|FG000|Phase 2 Year 2|Protocol Violation|1
2103855|NCT00848354|3696095|FG001|Phase 2 Year 2|Protocol Violation|1
2103856|NCT00848354|3696094|FG000|Phase 2 Year 2|Subject Request|1
2103857|NCT00848354|3696095|FG001|Phase 2 Year 2|Subject Request|1
2103858|NCT00848354|3696094|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
2103859|NCT00848354|3696095|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
2103860|NCT00848393|3696119|FG000|Overall Study|Protocol Violation|0
2103861|NCT00848393|3696120|FG001|Overall Study|Protocol Violation|0
2103862|NCT00848393|3696121|FG002|Overall Study|Protocol Violation|1
2103863|NCT00848393|3696119|FG000|Overall Study|surgical complications unrelated to stud|0
2103864|NCT00848393|3696120|FG001|Overall Study|surgical complications unrelated to stud|0
2103865|NCT00848393|3696121|FG002|Overall Study|surgical complications unrelated to stud|2
2313773|NCT02797522|4021792|FG006|Overall Study|Study Terminated by Sponsor|0
2313774|NCT02797522|4021793|FG007|Overall Study|Study Terminated by Sponsor|4
2313775|NCT02797522|4021794|FG008|Overall Study|Study Terminated by Sponsor|2
2313776|NCT02797522|4021795|FG009|Overall Study|Study Terminated by Sponsor|4
2358473|NCT01917318|4118981|FG000|First Treatment|Withdrawal by Subject|0
2358474|NCT01917318|4118982|FG001|First Treatment|Withdrawal by Subject|1
2103866|NCT00848484|3696135|FG000|First Intervention (Treatment Period 1)|Adverse Event|2
2103867|NCT00848484|3696136|FG001|First Intervention (Treatment Period 1)|Adverse Event|1
2103868|NCT00848484|3696135|FG000|First Intervention (Treatment Period 1)|Physician Decision|0
2103869|NCT00848484|3696136|FG001|First Intervention (Treatment Period 1)|Physician Decision|1
2103870|NCT00848484|3696135|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
2103871|NCT00848484|3696136|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
2103872|NCT00848484|3696135|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0
2103873|NCT00848484|3696136|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3
2103874|NCT00848484|3696135|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
2103875|NCT00848484|3696136|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
2103876|NCT00848497|3696144|FG000|Overall Study|Screen failure|2
2103877|NCT00848497|3696145|FG001|Overall Study|Screen failure|0
2103878|NCT00848497|3696144|FG000|Overall Study|Withdrawal by Subject|0
2103879|NCT00848497|3696145|FG001|Overall Study|Withdrawal by Subject|1
2103880|NCT00848536|3696172|FG000|Overall Study|Adverse Event|2
2103881|NCT00848536|3696173|FG001|Overall Study|Adverse Event|2
2103882|NCT00848536|3696172|FG000|Overall Study|Withdrawal by Subject|0
2103883|NCT00848536|3696173|FG001|Overall Study|Withdrawal by Subject|1
2103884|NCT00848536|3696172|FG000|Overall Study|Protocol Violation|0
2103885|NCT00848536|3696173|FG001|Overall Study|Protocol Violation|1
2103886|NCT00848536|3696172|FG000|Overall Study|Noncompliance|1
2103887|NCT00848536|3696173|FG001|Overall Study|Noncompliance|0
2103888|NCT00848536|3696172|FG000|Overall Study|Inadequate Control of IOP|1
2103889|NCT00848536|3696173|FG001|Overall Study|Inadequate Control of IOP|1
2103890|NCT00848536|3696172|FG000|Overall Study|Patient Moved|0
2103891|NCT00848536|3696173|FG001|Overall Study|Patient Moved|2
2103892|NCT00848549|3696181|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
2103893|NCT00848549|3696182|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
2103894|NCT00848549|3696181|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
2103895|NCT00848549|3696182|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
2103896|NCT00848549|3696181|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
2103897|NCT00848549|3696182|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
2103898|NCT00848549|3696181|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
2103899|NCT00848549|3696182|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
2103900|NCT00848549|3696181|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
2103901|NCT00848549|3696182|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
2103902|NCT00848549|3696181|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
2103903|NCT00848549|3696182|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
2103904|NCT00848549|3696181|FG000|E2090-E044-310 (Base Study) Disposition|Other|4
2103905|NCT00848549|3696182|FG001|E2090-E044-310 (Base Study) Disposition|Other|3
2103906|NCT00848549|3696181|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
2103907|NCT00848549|3696182|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
2103908|NCT00848549|3696181|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2
2103909|NCT00848549|3696182|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1
2103910|NCT00848549|3696181|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1
2103911|NCT00848549|3696182|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2
2103912|NCT00848549|3696181|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
2103913|NCT00848549|3696182|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
2103914|NCT00848549|3696181|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
2177506|NCT01374906|3801701|FG000|Overall Study|Protocol Violation|2
2177507|NCT01374906|3801702|FG001|Overall Study|Protocol Violation|2
2313777|NCT02797522|4021796|FG010|Overall Study|Study Terminated by Sponsor|1
2313778|NCT02797678|4021833|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25
2313779|NCT02797678|4021834|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0
2313780|NCT02797678|4021835|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0
2313781|NCT02797678|4021836|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0
2313782|NCT02797678|4021833|FG000|First Intervention (5 Nights)|study/device use non-compliance|0
2313783|NCT02797678|4021834|FG001|First Intervention (5 Nights)|study/device use non-compliance|1
2313784|NCT02797678|4021835|FG002|First Intervention (5 Nights)|study/device use non-compliance|0
2313785|NCT02797678|4021836|FG003|First Intervention (5 Nights)|study/device use non-compliance|0
2313786|NCT02797678|4021833|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0
2313787|NCT02797678|4021834|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0
2313788|NCT02797678|4021835|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1
2313789|NCT02797678|4021836|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0
2313790|NCT02797808|4021851|FG000|Overall Study|Withdrawal by Subject|1
2313791|NCT02797808|4021852|FG001|Overall Study|Withdrawal by Subject|1
2313792|NCT02797808|4021851|FG000|Overall Study|Physician Decision|6
2313793|NCT02797808|4021852|FG001|Overall Study|Physician Decision|2
2313794|NCT02798211|4021874|FG000|Period 1|Adverse Event|1
2313795|NCT02798211|4021875|FG001|Period 1|Adverse Event|1
2313796|NCT02798211|4021876|FG002|Period 1|Adverse Event|0
2313797|NCT02798211|4021877|FG003|Period 1|Adverse Event|0
2313798|NCT02798211|4021878|FG004|Period 1|Adverse Event|0
2313799|NCT02798211|4021879|FG005|Period 1|Adverse Event|0
2313800|NCT02798211|4021874|FG000|Period 1|Lost to Follow-up|2
2313801|NCT02798211|4021875|FG001|Period 1|Lost to Follow-up|1
2313802|NCT02798211|4021876|FG002|Period 1|Lost to Follow-up|0
2313803|NCT02798211|4021877|FG003|Period 1|Lost to Follow-up|0
2313804|NCT02798211|4021878|FG004|Period 1|Lost to Follow-up|0
2313805|NCT02798211|4021879|FG005|Period 1|Lost to Follow-up|0
2313806|NCT02798211|4021874|FG000|Period 1|Protocol Violation|0
2313807|NCT02798211|4021875|FG001|Period 1|Protocol Violation|0
2313808|NCT02798211|4021876|FG002|Period 1|Protocol Violation|2
2103915|NCT00848549|3696182|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
2103916|NCT00848549|3696181|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0
2103917|NCT00848549|3696182|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2
2103918|NCT00848549|3696181|FG000|E2090-E044-314 (Extension Study)|Other|5
2103919|NCT00848549|3696182|FG001|E2090-E044-314 (Extension Study)|Other|6
2103920|NCT00848718|3696203|FG000|Overall Study|Adverse Event|2
2103921|NCT00848718|3696204|FG001|Overall Study|Adverse Event|2
2103922|NCT00848718|3696205|FG002|Overall Study|Adverse Event|1
2103923|NCT00848718|3696206|FG003|Overall Study|Adverse Event|1
2103924|NCT00848718|3696207|FG004|Overall Study|Adverse Event|1
2103925|NCT00848718|3696208|FG005|Overall Study|Adverse Event|0
2103926|NCT00848718|3696209|FG006|Overall Study|Adverse Event|0
2103927|NCT00848718|3696210|FG007|Overall Study|Adverse Event|1
2103928|NCT00848718|3696211|FG008|Overall Study|Adverse Event|1
2103929|NCT00848718|3696212|FG009|Overall Study|Adverse Event|0
2103930|NCT00848718|3696213|FG010|Overall Study|Adverse Event|0
2103931|NCT00848718|3696214|FG011|Overall Study|Adverse Event|0
2103932|NCT00848718|3696215|FG012|Overall Study|Adverse Event|2
2103933|NCT00848718|3696203|FG000|Overall Study|Lack of Efficacy|0
2103934|NCT00848718|3696204|FG001|Overall Study|Lack of Efficacy|0
2103935|NCT00848718|3696205|FG002|Overall Study|Lack of Efficacy|1
2103936|NCT00848718|3696206|FG003|Overall Study|Lack of Efficacy|0
2103937|NCT00848718|3696207|FG004|Overall Study|Lack of Efficacy|0
2103938|NCT00848718|3696208|FG005|Overall Study|Lack of Efficacy|0
2103939|NCT00848718|3696209|FG006|Overall Study|Lack of Efficacy|1
2103940|NCT00848718|3696210|FG007|Overall Study|Lack of Efficacy|0
2103941|NCT00848718|3696211|FG008|Overall Study|Lack of Efficacy|0
2103942|NCT00848718|3696212|FG009|Overall Study|Lack of Efficacy|0
2103943|NCT00848718|3696213|FG010|Overall Study|Lack of Efficacy|0
2103944|NCT00848718|3696214|FG011|Overall Study|Lack of Efficacy|0
2103945|NCT00848718|3696215|FG012|Overall Study|Lack of Efficacy|0
2103946|NCT00848718|3696203|FG000|Overall Study|Physician Decision|0
2103947|NCT00848718|3696204|FG001|Overall Study|Physician Decision|1
2103948|NCT00848718|3696205|FG002|Overall Study|Physician Decision|0
2103949|NCT00848718|3696206|FG003|Overall Study|Physician Decision|0
2103950|NCT00848718|3696207|FG004|Overall Study|Physician Decision|1
2103951|NCT00848718|3696208|FG005|Overall Study|Physician Decision|1
2103952|NCT00848718|3696209|FG006|Overall Study|Physician Decision|0
2103953|NCT00848718|3696210|FG007|Overall Study|Physician Decision|0
2103954|NCT00848718|3696211|FG008|Overall Study|Physician Decision|1
2103955|NCT00848718|3696212|FG009|Overall Study|Physician Decision|2
2103956|NCT00848718|3696213|FG010|Overall Study|Physician Decision|0
2103957|NCT00848718|3696214|FG011|Overall Study|Physician Decision|0
2103958|NCT00848718|3696215|FG012|Overall Study|Physician Decision|1
2103959|NCT00848718|3696203|FG000|Overall Study|Progressive disease before treatment|1
2103960|NCT00848718|3696204|FG001|Overall Study|Progressive disease before treatment|5
2103961|NCT00848718|3696205|FG002|Overall Study|Progressive disease before treatment|1
2103962|NCT00848718|3696206|FG003|Overall Study|Progressive disease before treatment|3
2103963|NCT00848718|3696207|FG004|Overall Study|Progressive disease before treatment|4
2103964|NCT00848718|3696208|FG005|Overall Study|Progressive disease before treatment|4
2103965|NCT00848718|3696209|FG006|Overall Study|Progressive disease before treatment|2
2103966|NCT00848718|3696210|FG007|Overall Study|Progressive disease before treatment|1
2103967|NCT00848718|3696211|FG008|Overall Study|Progressive disease before treatment|2
2103968|NCT00848718|3696212|FG009|Overall Study|Progressive disease before treatment|7
2103969|NCT00848718|3696213|FG010|Overall Study|Progressive disease before treatment|3
2103970|NCT00848718|3696214|FG011|Overall Study|Progressive disease before treatment|6
2103971|NCT00848718|3696215|FG012|Overall Study|Progressive disease before treatment|2
2103972|NCT00848718|3696203|FG000|Overall Study|Protocol Violation|0
2103973|NCT00848718|3696204|FG001|Overall Study|Protocol Violation|1
2103974|NCT00848718|3696205|FG002|Overall Study|Protocol Violation|0
2103975|NCT00848718|3696206|FG003|Overall Study|Protocol Violation|0
2103976|NCT00848718|3696207|FG004|Overall Study|Protocol Violation|0
2313809|NCT02798211|4021877|FG003|Period 1|Protocol Violation|0
2313810|NCT02798211|4021878|FG004|Period 1|Protocol Violation|0
2313811|NCT02798211|4021879|FG005|Period 1|Protocol Violation|0
2313812|NCT02798211|4021874|FG000|Period 1|Withdrawal by Subject|1
2313813|NCT02798211|4021875|FG001|Period 1|Withdrawal by Subject|1
2313814|NCT02798211|4021876|FG002|Period 1|Withdrawal by Subject|0
2313815|NCT02798211|4021877|FG003|Period 1|Withdrawal by Subject|0
2313816|NCT02798211|4021878|FG004|Period 1|Withdrawal by Subject|0
2313817|NCT02798211|4021879|FG005|Period 1|Withdrawal by Subject|0
2313818|NCT02798211|4021874|FG000|Period 1|Death|0
2313819|NCT02798211|4021875|FG001|Period 1|Death|0
2313820|NCT02798211|4021876|FG002|Period 1|Death|1
2313821|NCT02798211|4021877|FG003|Period 1|Death|0
2313822|NCT02798211|4021878|FG004|Period 1|Death|0
2313823|NCT02798211|4021879|FG005|Period 1|Death|0
2313824|NCT02798211|4021874|FG000|Period 1|Withdrawal of Informed Consent|2
2313825|NCT02798211|4021875|FG001|Period 1|Withdrawal of Informed Consent|7
2313826|NCT02798211|4021876|FG002|Period 1|Withdrawal of Informed Consent|3
2103977|NCT00848718|3696208|FG005|Overall Study|Protocol Violation|0
2103978|NCT00848718|3696209|FG006|Overall Study|Protocol Violation|0
2177508|NCT01374906|3801701|FG000|Overall Study|Withdrawal by Subject|15
2313827|NCT02798211|4021877|FG003|Period 1|Withdrawal of Informed Consent|0
2103979|NCT00848718|3696210|FG007|Overall Study|Protocol Violation|1
2103980|NCT00848718|3696211|FG008|Overall Study|Protocol Violation|0
2103981|NCT00848718|3696212|FG009|Overall Study|Protocol Violation|0
2103982|NCT00848718|3696213|FG010|Overall Study|Protocol Violation|0
2103983|NCT00848718|3696214|FG011|Overall Study|Protocol Violation|0
2103984|NCT00848718|3696215|FG012|Overall Study|Protocol Violation|1
2103985|NCT00848718|3696203|FG000|Overall Study|Withdrawal by Subject|1
2103986|NCT00848718|3696204|FG001|Overall Study|Withdrawal by Subject|0
2103987|NCT00848718|3696205|FG002|Overall Study|Withdrawal by Subject|0
2103988|NCT00848718|3696206|FG003|Overall Study|Withdrawal by Subject|1
2103989|NCT00848718|3696207|FG004|Overall Study|Withdrawal by Subject|0
2103990|NCT00848718|3696208|FG005|Overall Study|Withdrawal by Subject|0
2103991|NCT00848718|3696209|FG006|Overall Study|Withdrawal by Subject|0
2103992|NCT00848718|3696210|FG007|Overall Study|Withdrawal by Subject|0
2103993|NCT00848718|3696211|FG008|Overall Study|Withdrawal by Subject|0
2103994|NCT00848718|3696212|FG009|Overall Study|Withdrawal by Subject|0
2313828|NCT02798211|4021878|FG004|Period 1|Withdrawal of Informed Consent|0
2358475|NCT01921218|4118990|FG000|Overall Study|Death|2
2358476|NCT01921218|4118991|FG001|Overall Study|Death|1
2358477|NCT01921218|4118990|FG000|Overall Study|Withdrawal by Subject|0
2358478|NCT01921218|4118991|FG001|Overall Study|Withdrawal by Subject|2
2358479|NCT01921218|4118990|FG000|Overall Study|Kidney transplant|1
2358480|NCT01921218|4118991|FG001|Overall Study|Kidney transplant|1
2358507|NCT01945021|4119041|FG000|Overall Study|Adverse Event|1
2358508|NCT01945021|4119041|FG000|Overall Study|Withdrawal of consent|12
2358509|NCT01945021|4119041|FG000|Overall Study|Lost to Follow-up|5
2358510|NCT01945021|4119041|FG000|Overall Study|Death|65
2358511|NCT01956669|4119052|FG000|Overall Study|Disease Progression|12
2358512|NCT01956669|4119053|FG001|Overall Study|Disease Progression|7
2358513|NCT01956669|4119054|FG002|Overall Study|Disease Progression|7
2358514|NCT01956669|4119055|FG003|Overall Study|Disease Progression|8
2358515|NCT01956669|4119056|FG004|Overall Study|Disease Progression|4
2358516|NCT01956669|4119057|FG005|Overall Study|Disease Progression|3
2358517|NCT01956669|4119058|FG006|Overall Study|Disease Progression|5
2358518|NCT01956669|4119052|FG000|Overall Study|Adverse Event|0
2358519|NCT01956669|4119053|FG001|Overall Study|Adverse Event|2
2358520|NCT01956669|4119054|FG002|Overall Study|Adverse Event|2
2358521|NCT01956669|4119055|FG003|Overall Study|Adverse Event|1
2358522|NCT01956669|4119056|FG004|Overall Study|Adverse Event|0
2358523|NCT01956669|4119057|FG005|Overall Study|Adverse Event|0
2358524|NCT01956669|4119058|FG006|Overall Study|Adverse Event|0
2358525|NCT01956669|4119052|FG000|Overall Study|Physician Decision|0
2358526|NCT01956669|4119053|FG001|Overall Study|Physician Decision|2
2358527|NCT01956669|4119054|FG002|Overall Study|Physician Decision|0
2358528|NCT01956669|4119055|FG003|Overall Study|Physician Decision|0
2358529|NCT01956669|4119056|FG004|Overall Study|Physician Decision|0
2358530|NCT01956669|4119057|FG005|Overall Study|Physician Decision|1
2358531|NCT01956669|4119058|FG006|Overall Study|Physician Decision|0
2358532|NCT01956669|4119052|FG000|Overall Study|Withdrawal by Subject|0
2358533|NCT01956669|4119053|FG001|Overall Study|Withdrawal by Subject|0
2358534|NCT01956669|4119054|FG002|Overall Study|Withdrawal by Subject|1
2358535|NCT01956669|4119055|FG003|Overall Study|Withdrawal by Subject|1
2358536|NCT01956669|4119056|FG004|Overall Study|Withdrawal by Subject|0
2358537|NCT01956669|4119057|FG005|Overall Study|Withdrawal by Subject|0
2358538|NCT01956669|4119058|FG006|Overall Study|Withdrawal by Subject|1
2358539|NCT01967823|4119083|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1
2358540|NCT01989676|4119093|FG000|Overall Study|Death|52
2358541|NCT01989676|4119094|FG001|Overall Study|Death|60
2358542|NCT01989676|4119093|FG000|Overall Study|Protocol Violation|2
2358543|NCT01989676|4119094|FG001|Overall Study|Protocol Violation|1
2358544|NCT01989676|4119093|FG000|Overall Study|Lost to Follow-up|8
2358545|NCT01989676|4119094|FG001|Overall Study|Lost to Follow-up|18
2358546|NCT01989676|4119093|FG000|Overall Study|No longer willing to participate in study|26
2358547|NCT01989676|4119094|FG001|Overall Study|No longer willing to participate in study|26
2358548|NCT01989676|4119093|FG000|Overall Study|Participants terminated from study by Sponsor|26
2358549|NCT01989676|4119094|FG001|Overall Study|Participants terminated from study by Sponsor|30
2358550|NCT01989676|4119093|FG000|Overall Study|Other|4
2358551|NCT01989676|4119094|FG001|Overall Study|Other|3
2103995|NCT00848718|3696213|FG010|Overall Study|Withdrawal by Subject|1
2103996|NCT00848718|3696214|FG011|Overall Study|Withdrawal by Subject|0
2103997|NCT00848718|3696215|FG012|Overall Study|Withdrawal by Subject|0
2103998|NCT00848718|3696203|FG000|Overall Study|Progressive disease during treatment|3
2103999|NCT00848718|3696204|FG001|Overall Study|Progressive disease during treatment|0
2104000|NCT00848718|3696205|FG002|Overall Study|Progressive disease during treatment|3
2104001|NCT00848718|3696206|FG003|Overall Study|Progressive disease during treatment|0
2104002|NCT00848718|3696207|FG004|Overall Study|Progressive disease during treatment|0
2104003|NCT00848718|3696208|FG005|Overall Study|Progressive disease during treatment|0
2104004|NCT00848718|3696209|FG006|Overall Study|Progressive disease during treatment|0
2104005|NCT00848718|3696210|FG007|Overall Study|Progressive disease during treatment|2
2104006|NCT00848718|3696211|FG008|Overall Study|Progressive disease during treatment|0
2104007|NCT00848718|3696212|FG009|Overall Study|Progressive disease during treatment|0
2104008|NCT00848718|3696213|FG010|Overall Study|Progressive disease during treatment|0
2104009|NCT00848718|3696214|FG011|Overall Study|Progressive disease during treatment|0
2104010|NCT00848718|3696215|FG012|Overall Study|Progressive disease during treatment|2
2104011|NCT00848926|3696266|FG000|Treatment Period|Progressive disease|45
2104012|NCT00848926|3696266|FG000|Treatment Period|Adverse Event|20
2104013|NCT00848926|3696266|FG000|Treatment Period|Physician Decision|12
2104014|NCT00848926|3696266|FG000|Treatment Period|Withdrawal by Subject|7
2104015|NCT00848926|3696266|FG000|Follow-up Period|Lost to Follow-up|7
2104016|NCT00848926|3696266|FG000|Follow-up Period|Withdrawal by Subject|3
2104017|NCT00848926|3696266|FG000|Follow-up Period|Other|2
2104018|NCT00848965|3696270|FG000|Overall Study|Adverse Event|1
2104019|NCT00848965|3696270|FG000|Overall Study|Withdrawal by Subject|1
2104020|NCT00849017|3696285|FG000|Treatment Period (156 Weeks)|Adverse Event|5
2104021|NCT00849017|3696286|FG001|Treatment Period (156 Weeks)|Adverse Event|6
2104022|NCT00849017|3696287|FG002|Treatment Period (156 Weeks)|Adverse Event|15
2104023|NCT00849017|3696285|FG000|Treatment Period (156 Weeks)|Noncompliance|3
2104024|NCT00849017|3696286|FG001|Treatment Period (156 Weeks)|Noncompliance|3
2104025|NCT00849017|3696287|FG002|Treatment Period (156 Weeks)|Noncompliance|4
2104026|NCT00849017|3696285|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10
2104027|NCT00849017|3696286|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7
2104028|NCT00849017|3696287|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8
2104029|NCT00849017|3696285|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18
2104030|NCT00849017|3696286|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14
2104031|NCT00849017|3696287|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11
2104032|NCT00849017|3696285|FG000|Treatment Period (156 Weeks)|Physician Decision|0
2104033|NCT00849017|3696286|FG001|Treatment Period (156 Weeks)|Physician Decision|2
2104034|NCT00849017|3696287|FG002|Treatment Period (156 Weeks)|Physician Decision|1
2104035|NCT00849017|3696285|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
2104036|NCT00849017|3696286|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
2104037|NCT00849017|3696287|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
2104038|NCT00849017|3696285|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1
2104039|NCT00849017|3696286|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0
2104040|NCT00849017|3696287|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0
2104041|NCT00849017|3696285|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
2104042|NCT00849017|3696286|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
2104043|NCT00849017|3696287|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
2104044|NCT00849017|3696285|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1
2104045|NCT00849017|3696286|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0
2104046|NCT00849017|3696287|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0
2104047|NCT00849017|3696285|FG000|Treatment Period (156 Weeks)|Pregnancy|1
2104048|NCT00849017|3696286|FG001|Treatment Period (156 Weeks)|Pregnancy|0
2104049|NCT00849017|3696287|FG002|Treatment Period (156 Weeks)|Pregnancy|1
2104050|NCT00849017|3696285|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
2104051|NCT00849017|3696286|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
2104052|NCT00849017|3696287|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
2104053|NCT00849017|3696285|FG000|Follow-up Period (8 Weeks)|Adverse Event|1
2104054|NCT00849017|3696286|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
2104055|NCT00849017|3696287|FG002|Follow-up Period (8 Weeks)|Adverse Event|0
2104056|NCT00849017|3696285|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
2104057|NCT00849017|3696286|FG001|Follow-up Period (8 Weeks)|Noncompliance|1
2104058|NCT00849017|3696287|FG002|Follow-up Period (8 Weeks)|Noncompliance|0
2104059|NCT00849017|3696285|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13
2104060|NCT00849017|3696286|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
2104061|NCT00849017|3696287|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16
2104062|NCT00849017|3696285|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
2104063|NCT00849017|3696286|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
2104064|NCT00849017|3696287|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
2104065|NCT00849017|3696285|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
2104066|NCT00849017|3696286|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
2104067|NCT00849017|3696287|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
2104068|NCT00849017|3696285|FG000|Follow-up Period (8 Weeks)|Physician Decision|0
2104069|NCT00849017|3696286|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
2104070|NCT00849017|3696287|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
2104071|NCT00849017|3696285|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
2104072|NCT00849017|3696286|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
2104073|NCT00849017|3696287|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
2104074|NCT00849017|3696285|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
2104075|NCT00849017|3696286|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
2104076|NCT00849017|3696287|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
2104077|NCT00849056|3696301|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13
2104078|NCT00849056|3696302|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11
2104079|NCT00849056|3696301|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
2104080|NCT00849056|3696302|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
2104081|NCT00849056|3696301|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3
2104082|NCT00849056|3696302|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3
2104083|NCT00849056|3696301|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
2104084|NCT00849056|3696302|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
2104085|NCT00849056|3696301|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
2104086|NCT00849056|3696302|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
2104087|NCT00849056|3696301|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3
2104088|NCT00849056|3696302|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3
2104089|NCT00849056|3696301|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
2104090|NCT00849056|3696302|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
2104091|NCT00849056|3696301|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
2104092|NCT00849056|3696302|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
2104093|NCT00849056|3696301|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1
2104094|NCT00849056|3696302|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0
2104095|NCT00849056|3696301|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
2104096|NCT00849056|3696302|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
2104097|NCT00849056|3696301|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
2104098|NCT00849056|3696302|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
2104099|NCT00849056|3696301|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
2104100|NCT00849056|3696302|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
2104101|NCT00849056|3696301|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
2104102|NCT00849056|3696302|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
2104103|NCT00849056|3696301|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
2104104|NCT00849056|3696302|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
2104105|NCT00849056|3696301|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
2104106|NCT00849056|3696302|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
2313829|NCT02798211|4021879|FG005|Period 1|Withdrawal of Informed Consent|0
2313830|NCT02798211|4021874|FG000|Period 2|Withdrawal by Subject|2
2313831|NCT02798211|4021875|FG001|Period 2|Withdrawal by Subject|0
2313832|NCT02798211|4021876|FG002|Period 2|Withdrawal by Subject|0
2313833|NCT02798211|4021877|FG003|Period 2|Withdrawal by Subject|0
2313834|NCT02798211|4021878|FG004|Period 2|Withdrawal by Subject|2
2313835|NCT02798211|4021879|FG005|Period 2|Withdrawal by Subject|2
2313836|NCT02798211|4021874|FG000|Period 2|Adverse Event|5
2313837|NCT02798211|4021875|FG001|Period 2|Adverse Event|0
2313838|NCT02798211|4021876|FG002|Period 2|Adverse Event|0
2313839|NCT02798211|4021877|FG003|Period 2|Adverse Event|0
2313840|NCT02798211|4021878|FG004|Period 2|Adverse Event|1
2313841|NCT02798211|4021879|FG005|Period 2|Adverse Event|0
2313842|NCT02798211|4021874|FG000|Period 2|Lack of Efficacy|1
2358481|NCT01923168|4119000|FG000|Overall Study|Protocol Violation|1
2358482|NCT01923168|4119001|FG001|Overall Study|Protocol Violation|1
2358483|NCT01923168|4119002|FG002|Overall Study|Protocol Violation|0
2358484|NCT01923168|4119000|FG000|Overall Study|Subject/guardian decision|14
2358485|NCT01923168|4119001|FG001|Overall Study|Subject/guardian decision|14
2358486|NCT01923168|4119002|FG002|Overall Study|Subject/guardian decision|4
2358487|NCT01923168|4119000|FG000|Overall Study|Adverse Event|12
2358488|NCT01923168|4119001|FG001|Overall Study|Adverse Event|12
2358489|NCT01923168|4119002|FG002|Overall Study|Adverse Event|0
2358490|NCT01923168|4119000|FG000|Overall Study|Physician Decision|6
2358491|NCT01923168|4119001|FG001|Overall Study|Physician Decision|9
2358492|NCT01923168|4119002|FG002|Overall Study|Physician Decision|5
2358493|NCT01923168|4119000|FG000|Overall Study|Progressive disease|4
2358494|NCT01923168|4119001|FG001|Overall Study|Progressive disease|3
2358495|NCT01923168|4119002|FG002|Overall Study|Progressive disease|7
2358496|NCT01923168|4119000|FG000|Overall Study|Death|0
2358497|NCT01923168|4119001|FG001|Overall Study|Death|0
2358498|NCT01923168|4119002|FG002|Overall Study|Death|1
2358552|NCT01992653|4119109|FG000|Overall Study|Death|0
2358553|NCT01992653|4119110|FG001|Overall Study|Death|0
2358554|NCT01992653|4119111|FG002|Overall Study|Death|1
2358555|NCT01992653|4119112|FG003|Overall Study|Death|0
2358556|NCT01992653|4119113|FG004|Overall Study|Death|1
2358557|NCT01992653|4119114|FG005|Overall Study|Death|0
2358558|NCT01992653|4119115|FG006|Overall Study|Death|4
2358559|NCT01992653|4119116|FG007|Overall Study|Death|2
2104107|NCT00849056|3696301|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
2104108|NCT00849056|3696302|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
2104109|NCT00849108|3696311|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
2104110|NCT00849108|3696312|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
2104111|NCT00849108|3696311|FG000|Cohort 2 Efficacy|Adverse Event|0
2104112|NCT00849108|3696312|FG001|Cohort 2 Efficacy|Adverse Event|1
2104113|NCT00849108|3696311|FG000|Cohort 2 Efficacy|Other|0
2104114|NCT00849108|3696312|FG001|Cohort 2 Efficacy|Other|9
2104115|NCT00849147|3696329|FG000|Overall Study|Withdrawal by Subject|1
2313843|NCT02798211|4021875|FG001|Period 2|Lack of Efficacy|0
2313844|NCT02798211|4021876|FG002|Period 2|Lack of Efficacy|0
2313845|NCT02798211|4021877|FG003|Period 2|Lack of Efficacy|1
2313846|NCT02798211|4021878|FG004|Period 2|Lack of Efficacy|0
2313847|NCT02798211|4021879|FG005|Period 2|Lack of Efficacy|1
2313848|NCT02798211|4021874|FG000|Period 2|Lost to Follow-up|3
2313849|NCT02798211|4021875|FG001|Period 2|Lost to Follow-up|0
2313850|NCT02798211|4021876|FG002|Period 2|Lost to Follow-up|0
2313851|NCT02798211|4021877|FG003|Period 2|Lost to Follow-up|0
2313852|NCT02798211|4021878|FG004|Period 2|Lost to Follow-up|2
2313853|NCT02798211|4021879|FG005|Period 2|Lost to Follow-up|0
2313854|NCT02798211|4021874|FG000|Period 2|Physician Decision|1
2313855|NCT02798211|4021875|FG001|Period 2|Physician Decision|0
2313856|NCT02798211|4021876|FG002|Period 2|Physician Decision|0
2313857|NCT02798211|4021877|FG003|Period 2|Physician Decision|1
2313858|NCT02798211|4021878|FG004|Period 2|Physician Decision|1
2313859|NCT02798211|4021879|FG005|Period 2|Physician Decision|0
2313860|NCT02798211|4021874|FG000|Period 2|Pregnancy|0
2313861|NCT02798211|4021875|FG001|Period 2|Pregnancy|0
2313862|NCT02798211|4021876|FG002|Period 2|Pregnancy|0
2313863|NCT02798211|4021877|FG003|Period 2|Pregnancy|2
2313864|NCT02798211|4021878|FG004|Period 2|Pregnancy|0
2313865|NCT02798211|4021879|FG005|Period 2|Pregnancy|0
2313866|NCT02798211|4021874|FG000|Period 2|Technical problems|1
2313867|NCT02798211|4021875|FG001|Period 2|Technical problems|0
2313868|NCT02798211|4021876|FG002|Period 2|Technical problems|0
2313869|NCT02798211|4021877|FG003|Period 2|Technical problems|1
2313870|NCT02798211|4021878|FG004|Period 2|Technical problems|0
2313871|NCT02798211|4021879|FG005|Period 2|Technical problems|0
2313872|NCT02798211|4021874|FG000|Period 2|Withdrawal of Informed Consent|1
2313873|NCT02798211|4021875|FG001|Period 2|Withdrawal of Informed Consent|0
2313874|NCT02798211|4021876|FG002|Period 2|Withdrawal of Informed Consent|0
2313875|NCT02798211|4021877|FG003|Period 2|Withdrawal of Informed Consent|2
2313876|NCT02798211|4021878|FG004|Period 2|Withdrawal of Informed Consent|2
2313877|NCT02798211|4021879|FG005|Period 2|Withdrawal of Informed Consent|3
2313878|NCT02798315|4021895|FG000|Overall Study|Failure to return|1
2313879|NCT02798835|4021934|FG000|Overall Study|Protocol Violation|0
2313880|NCT02798835|4021935|FG001|Overall Study|Protocol Violation|0
2313881|NCT02798835|4021936|FG002|Overall Study|Protocol Violation|3
2313882|NCT02798861|4021944|FG000|Overall Study|Lost to Follow-up|22
2313883|NCT02798861|4021944|FG000|Overall Study|Withdrawal by Subject|1
2313884|NCT02799069|4021990|FG000|Overall Study|Adverse Event|0
2313885|NCT02799069|4021991|FG001|Overall Study|Adverse Event|2
2313886|NCT02799069|4021992|FG002|Overall Study|Adverse Event|2
2313887|NCT02799069|4021990|FG000|Overall Study|Lack of Efficacy|2
2313888|NCT02799069|4021991|FG001|Overall Study|Lack of Efficacy|0
2313889|NCT02799069|4021992|FG002|Overall Study|Lack of Efficacy|0
2313890|NCT02799069|4021990|FG000|Overall Study|Lost to Follow-up|1
2313891|NCT02799069|4021991|FG001|Overall Study|Lost to Follow-up|1
2313892|NCT02799069|4021992|FG002|Overall Study|Lost to Follow-up|0
2313893|NCT02799069|4021990|FG000|Overall Study|Withdrawal by Subject|4
2313894|NCT02799069|4021991|FG001|Overall Study|Withdrawal by Subject|4
2313895|NCT02799069|4021992|FG002|Overall Study|Withdrawal by Subject|3
2313896|NCT02799069|4021990|FG000|Overall Study|Protocol Violation|1
2313897|NCT02799069|4021991|FG001|Overall Study|Protocol Violation|0
2313898|NCT02799069|4021992|FG002|Overall Study|Protocol Violation|2
2313899|NCT02799082|4022002|FG000|Overall Study|Refused second PDT or withdraw consent|4
2313900|NCT02799082|4022003|FG001|Overall Study|Refused second PDT or withdraw consent|3
2313901|NCT02799082|4022002|FG000|Overall Study|Protocol Violation|0
2313902|NCT02799082|4022003|FG001|Overall Study|Protocol Violation|1
2313903|NCT02799381|4022028|FG000|Overall Study|Withdrew consent|3
2313904|NCT02799381|4022029|FG001|Overall Study|Withdrew consent|2
2313905|NCT02799381|4022028|FG000|Overall Study|Adverse Event|0
2313906|NCT02799381|4022029|FG001|Overall Study|Adverse Event|1
2313907|NCT02799381|4022028|FG000|Overall Study|Participant did not take any study drug|1
2313908|NCT02799381|4022029|FG001|Overall Study|Participant did not take any study drug|0
2313909|NCT02799472|4022037|FG000|Overall Study|Withdrawal by Subject|2
2313910|NCT02799472|4022038|FG001|Overall Study|Withdrawal by Subject|4
2313911|NCT02799472|4022037|FG000|Overall Study|Lack of Efficacy|2
2313912|NCT02799472|4022038|FG001|Overall Study|Lack of Efficacy|0
2313913|NCT02799472|4022037|FG000|Overall Study|Lost to Follow-up|0
2313914|NCT02799472|4022038|FG001|Overall Study|Lost to Follow-up|1
2313915|NCT02799745|4022055|FG000|Overall Study|Participant moved out of state|1
2313916|NCT02799745|4022056|FG001|Overall Study|Participant moved out of state|0
2313917|NCT02799745|4022055|FG000|Overall Study|Discontinued due to planned surgery|1
2313918|NCT02799745|4022056|FG001|Overall Study|Discontinued due to planned surgery|0
2104116|NCT00849147|3696329|FG000|Overall Study|Protocol Violation|2
2104117|NCT00849147|3696329|FG000|Overall Study|Disease Relapse/Progression|2
2104118|NCT00849186|3696333|FG000|Overall Study|Adverse Event|2
2104119|NCT00849186|3696333|FG000|Overall Study|Withdrawal by Subject|1
2104120|NCT00849186|3696333|FG000|Overall Study|not treated|6
2104121|NCT00849186|3696333|FG000|Overall Study|Other|1
2104122|NCT00849212|3696338|FG000|Overall Study|Lack of Efficacy|1
2313919|NCT02799745|4022055|FG000|Overall Study|Withdrawal by Subject|16
2313920|NCT02799745|4022056|FG001|Overall Study|Withdrawal by Subject|25
2313921|NCT02799745|4022055|FG000|Overall Study|Protocol Deviation|4
2313922|NCT02799745|4022056|FG001|Overall Study|Protocol Deviation|5
2313923|NCT02799745|4022055|FG000|Overall Study|Progressive Disease|28
2313924|NCT02799745|4022056|FG001|Overall Study|Progressive Disease|38
2313925|NCT02799745|4022055|FG000|Overall Study|Lost to Follow-up|3
2313926|NCT02799745|4022056|FG001|Overall Study|Lost to Follow-up|2
2313927|NCT02799745|4022055|FG000|Overall Study|Death|3
2313928|NCT02799745|4022056|FG001|Overall Study|Death|0
2313929|NCT02799745|4022055|FG000|Overall Study|Adverse Event|0
2313930|NCT02799745|4022056|FG001|Overall Study|Adverse Event|1
2313931|NCT02799784|4022062|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
2313932|NCT02799784|4022063|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
2313933|NCT02799784|4022062|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
2313934|NCT02799784|4022063|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
2313935|NCT02799784|4022062|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
2313936|NCT02799784|4022063|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
2313937|NCT02799784|4022062|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
2313938|NCT02799784|4022063|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
2313939|NCT02799784|4022062|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
2313940|NCT02799784|4022063|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
2313941|NCT02799784|4022062|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
2313942|NCT02799784|4022063|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
2322009|NCT02966509|4036684|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
2322010|NCT02966509|4036685|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
2322011|NCT02966509|4036684|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
2322012|NCT02966509|4036685|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
2322013|NCT02966509|4036684|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0
2322014|NCT02966509|4036685|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2
2322015|NCT02966509|4036684|FG000|6 Month Satisfaction Survey|Death|36
2322016|NCT02966509|4036685|FG001|6 Month Satisfaction Survey|Death|33
2322017|NCT02966509|4036684|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2
2322018|NCT02966509|4036685|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3
2322019|NCT02966509|4036684|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1
2322020|NCT02966509|4036685|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1
2322021|NCT02966509|4036684|FG000|6 Month Satisfaction Survey|Refused to Answer|8
2322022|NCT02966509|4036685|FG001|6 Month Satisfaction Survey|Refused to Answer|11
2322023|NCT02966509|4036684|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
2322024|NCT02966509|4036685|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
2322025|NCT02966509|4036684|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45
2322026|NCT02966509|4036685|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48
2322027|NCT02966795|4036693|FG000|Overall Study|Patient Left the Country|0
2322028|NCT02966795|4036694|FG001|Overall Study|Patient Left the Country|1
2322029|NCT02966834|4036705|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0
2322030|NCT02966834|4036706|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0
2322031|NCT02966834|4036707|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0
2322032|NCT02966834|4036708|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0
2322033|NCT02966834|4036709|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1
2322034|NCT02966834|4036710|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0
2322035|NCT02966834|4036705|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1
2322036|NCT02966834|4036706|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
2322037|NCT02966834|4036707|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
2322038|NCT02966834|4036708|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
2322039|NCT02966834|4036709|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
2322040|NCT02966834|4036710|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
2322041|NCT02966834|4036705|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
2322042|NCT02966834|4036706|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
2322043|NCT02966834|4036707|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4
2322044|NCT02966834|4036708|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8
2322045|NCT02966834|4036709|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
2322046|NCT02966834|4036710|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5
2322047|NCT02966834|4036705|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0
2322048|NCT02966834|4036706|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0
2322049|NCT02966834|4036707|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1
2104123|NCT00849212|3696338|FG000|Overall Study|Withdrawal by Subject|3
2104124|NCT00849212|3696338|FG000|Overall Study|Adverse Event|2
2104125|NCT00849212|3696338|FG000|Overall Study|Miscellaneous|1
2104126|NCT00849290|3696349|FG000|Overall Study|Adverse Event|3
2104127|NCT00849290|3696349|FG000|Overall Study|Death|14
2104128|NCT00849290|3696349|FG000|Overall Study|Withdrawal by Subject|11
2104129|NCT00849290|3696349|FG000|Overall Study|Lost to Follow-up|2
2104130|NCT00849290|3696349|FG000|Overall Study|Protocol Violation|5
2104131|NCT00849290|3696349|FG000|Overall Study|Disease Progression|20
2104132|NCT00849381|3696353|FG000|Overall Study|Adverse Event|1
2104133|NCT00849381|3696353|FG000|Overall Study|Lost to Follow-up|129
2104134|NCT00849381|3696353|FG000|Overall Study|Protocol Violation|5
2104135|NCT00849381|3696353|FG000|Overall Study|Withdrawal by Subject|6
2104136|NCT00849381|3696353|FG000|Overall Study|Other|4
2104137|NCT00849472|3696357|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
2104138|NCT00849472|3696357|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
2104139|NCT00849472|3696357|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
2104140|NCT00849472|3696357|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
2104141|NCT00849472|3696357|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
2104142|NCT00849472|3696357|FG000|Weekly Paclitaxel|Disease Progression|1
2104143|NCT00849472|3696357|FG000|Weekly Paclitaxel|Adverse Event|11
2104144|NCT00849472|3696357|FG000|Weekly Paclitaxel|Withdrawal by Subject|1
2104145|NCT00849472|3696357|FG000|Weekly Paclitaxel|Physician Decision|3
2104146|NCT00849472|3696357|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
2104147|NCT00849472|3696357|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
2104148|NCT00849472|3696357|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
2104149|NCT00849472|3696357|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
2104150|NCT00849472|3696357|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19
2214818|NCT01691105|3857481|FG001|1 Month Follow-up|Death|3
2214819|NCT01691105|3857480|FG000|6 Month Follow-up|Lost to Follow-up|39
2214820|NCT01691105|3857481|FG001|6 Month Follow-up|Lost to Follow-up|58
2214821|NCT01691105|3857480|FG000|6 Month Follow-up|Death|13
2214822|NCT01691105|3857481|FG001|6 Month Follow-up|Death|13
2313943|NCT02800642|4022095|FG000|Overall Study|Death|3
2313944|NCT02800642|4022095|FG000|Overall Study|Other|10
2313945|NCT02800642|4022095|FG000|Overall Study|Physician Decision|2
2313946|NCT02800642|4022095|FG000|Overall Study|Adverse Event|6
2313947|NCT02800642|4022095|FG000|Overall Study|Withdrawal by Subject|3
2313948|NCT02800642|4022095|FG000|Overall Study|Lost to Follow-up|1
2313949|NCT02800928|4022099|FG000|Overall Study|Withdrawal by Subject|1
2313950|NCT02800928|4022100|FG001|Overall Study|Withdrawal by Subject|1
2313951|NCT02800928|4022099|FG000|Overall Study|Protocol Violation|1
2313952|NCT02800928|4022100|FG001|Overall Study|Protocol Violation|1
2313953|NCT02801396|4022125|FG000|Period 1|Withdrawal by Subject|0
2313954|NCT02801396|4022126|FG001|Period 1|Withdrawal by Subject|0
2313955|NCT02801396|4022127|FG002|Period 1|Withdrawal by Subject|0
2313956|NCT02801396|4022128|FG003|Period 1|Withdrawal by Subject|0
2313957|NCT02801396|4022129|FG004|Period 1|Withdrawal by Subject|1
2313958|NCT02801396|4022130|FG005|Period 1|Withdrawal by Subject|0
2313959|NCT02801578|4022138|FG000|Overall Study|Adverse Event|2
2313960|NCT02801617|4022144|FG000|Overall Study|Protocol Violation|2
2313961|NCT02801617|4022145|FG001|Overall Study|Protocol Violation|6
2313962|NCT02801669|4022157|FG000|Overall Study|Death|66
2313963|NCT02801669|4022158|FG001|Overall Study|Death|69
2313964|NCT02801669|4022157|FG000|Overall Study|Withdrawal by Subject|81
2313965|NCT02801669|4022158|FG001|Overall Study|Withdrawal by Subject|77
2313966|NCT02801669|4022157|FG000|Overall Study|Other|4
2313967|NCT02801669|4022158|FG001|Overall Study|Other|6
2313968|NCT02801877|4022168|FG000|Overall Study|Lost to Follow-up|1
2313969|NCT02801877|4022169|FG001|Overall Study|Lost to Follow-up|1
2313970|NCT02801877|4022170|FG002|Overall Study|Lost to Follow-up|2
2313971|NCT02801877|4022171|FG003|Overall Study|Lost to Follow-up|0
2313972|NCT02801877|4022168|FG000|Overall Study|Never Started Treatment|2
2313973|NCT02801877|4022169|FG001|Overall Study|Never Started Treatment|0
2313974|NCT02801877|4022170|FG002|Overall Study|Never Started Treatment|4
2313975|NCT02801877|4022171|FG003|Overall Study|Never Started Treatment|0
2313976|NCT02802319|4022218|FG000|Overall Study|Physician Decision|2
2313977|NCT02802319|4022219|FG001|Overall Study|Physician Decision|1
2313978|NCT02802319|4022218|FG000|Overall Study|Lost to Follow-up|0
2313979|NCT02802319|4022219|FG001|Overall Study|Lost to Follow-up|4
2313980|NCT02802345|4022227|FG000|Overall Study|Not Treated|0
2313981|NCT02802345|4022228|FG001|Overall Study|Not Treated|1
2313982|NCT02802345|4022227|FG000|Overall Study|Adverse Event|28
2313983|NCT02802345|4022228|FG001|Overall Study|Adverse Event|20
2313984|NCT02802345|4022227|FG000|Overall Study|Withdrawal by Subject|3
2313985|NCT02802345|4022228|FG001|Overall Study|Withdrawal by Subject|3
2313986|NCT02802345|4022227|FG000|Overall Study|Protocol Violation|0
2313987|NCT02802345|4022228|FG001|Overall Study|Protocol Violation|1
2313988|NCT02802345|4022227|FG000|Overall Study|Other than listed|1
2313989|NCT02802345|4022228|FG001|Overall Study|Other than listed|5
2313990|NCT02802735|4022280|FG000|Overall Study|Withdrawal by Subject|0
2313991|NCT02802735|4022281|FG001|Overall Study|Withdrawal by Subject|1
2313992|NCT02802735|4022282|FG002|Overall Study|Withdrawal by Subject|0
2313993|NCT02802735|4022283|FG003|Overall Study|Withdrawal by Subject|0
2313994|NCT02802735|4022284|FG004|Overall Study|Withdrawal by Subject|0
2104151|NCT00849472|3696357|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
2104152|NCT00849472|3696357|FG000|Pazopanib Postsurgery Treatment|Moved|1
2104153|NCT00849472|3696357|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
2104154|NCT00849680|3696370|FG000|Overall Study|Adverse Event|0
2104155|NCT00849680|3696371|FG001|Overall Study|Adverse Event|0
2104156|NCT00849680|3696372|FG002|Overall Study|Adverse Event|0
2104157|NCT00849680|3696373|FG003|Overall Study|Adverse Event|0
2104158|NCT00849680|3696374|FG004|Overall Study|Adverse Event|0
2104159|NCT00849680|3696375|FG005|Overall Study|Adverse Event|0
2104160|NCT00849680|3696376|FG006|Overall Study|Adverse Event|2
2313995|NCT02802865|4022301|FG000|Overall Study|Pregnancy|1
2313996|NCT02802865|4022302|FG001|Overall Study|Pregnancy|1
2313997|NCT02802865|4022301|FG000|Overall Study|Ineliegible due to tuberculosis|0
2313998|NCT02802865|4022302|FG001|Overall Study|Ineliegible due to tuberculosis|1
2313999|NCT02802878|4022310|FG000|Overall Study|Withdrawal by Subject|3
2314000|NCT02802878|4022311|FG001|Overall Study|Withdrawal by Subject|3
2314001|NCT02802878|4022310|FG000|Overall Study|Protocol Violation|1
2314002|NCT02802878|4022311|FG001|Overall Study|Protocol Violation|0
2314003|NCT02803138|4022317|FG000|Overall Study|Failure to return|38
2314004|NCT02803138|4022317|FG000|Overall Study|Insufficient virological response|2
2358499|NCT01931098|4119032|FG000|Overall Study|Withdrawal by Subject|0
2358500|NCT01931098|4119033|FG001|Overall Study|Withdrawal by Subject|1
2358501|NCT01931098|4119032|FG000|Overall Study|Enrolled in different protocol|0
2358502|NCT01931098|4119033|FG001|Overall Study|Enrolled in different protocol|1
2358503|NCT01931098|4119032|FG000|Overall Study|Unable to begin trmt:active infection|0
2358504|NCT01931098|4119033|FG001|Overall Study|Unable to begin trmt:active infection|1
2358505|NCT01931098|4119032|FG000|Overall Study|Refused further treatment|0
2358506|NCT01931098|4119033|FG001|Overall Study|Refused further treatment|1
2358560|NCT01992653|4119109|FG000|Overall Study|Lost to Follow-up|0
2358561|NCT01992653|4119110|FG001|Overall Study|Lost to Follow-up|0
2358562|NCT01992653|4119111|FG002|Overall Study|Lost to Follow-up|0
2358563|NCT01992653|4119112|FG003|Overall Study|Lost to Follow-up|0
2358564|NCT01992653|4119113|FG004|Overall Study|Lost to Follow-up|0
2358565|NCT01992653|4119114|FG005|Overall Study|Lost to Follow-up|0
2358566|NCT01992653|4119115|FG006|Overall Study|Lost to Follow-up|0
2358567|NCT01992653|4119116|FG007|Overall Study|Lost to Follow-up|1
2358568|NCT01992653|4119109|FG000|Overall Study|Study Completed|0
2358569|NCT01992653|4119110|FG001|Overall Study|Study Completed|0
2358570|NCT01992653|4119111|FG002|Overall Study|Study Completed|0
2358571|NCT01992653|4119112|FG003|Overall Study|Study Completed|0
2358572|NCT01992653|4119113|FG004|Overall Study|Study Completed|0
2314005|NCT02803138|4022317|FG000|Overall Study|Withdrawn consent|1
2314006|NCT02803138|4022317|FG000|Overall Study|Death|1
2314007|NCT02803138|4022317|FG000|Overall Study|Other, not specified|28
2314008|NCT02803580|4022343|FG000|Overall Study|Death|13
2314009|NCT02803580|4022343|FG000|Overall Study|Lost to Follow-up|19
2314010|NCT02803580|4022343|FG000|Overall Study|Withdrawal by Subject|3
2314011|NCT02803580|4022343|FG000|Overall Study|Inclusion in clinical trial|1
2314012|NCT02804178|4022356|FG000|Overall Study|Adverse Event|1
2314013|NCT02804399|4022360|FG000|Period 2|Adverse Event|0
2314014|NCT02804399|4022361|FG001|Period 2|Adverse Event|1
2314015|NCT02804750|4022381|FG000|Period 1|Adverse Event|0
2314016|NCT02804750|4022382|FG001|Period 1|Adverse Event|2
2314017|NCT02804750|4022381|FG000|Period 1|Withdrawal by Subject|0
2314018|NCT02804750|4022382|FG001|Period 1|Withdrawal by Subject|1
2314019|NCT02804750|4022381|FG000|Period 2|Adverse Event|1
2314020|NCT02804750|4022382|FG001|Period 2|Adverse Event|0
2314021|NCT02804750|4022381|FG000|Period 3|Adverse Event|0
2314022|NCT02804750|4022382|FG001|Period 3|Adverse Event|2
2314023|NCT02804750|4022381|FG000|Period 4|Adverse Event|0
2314024|NCT02804750|4022382|FG001|Period 4|Adverse Event|5
2314025|NCT02804763|4022394|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1
2314026|NCT02804763|4022395|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
2314027|NCT02804763|4022396|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
2314028|NCT02804763|4022397|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
2314029|NCT02804763|4022394|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
2314030|NCT02804763|4022395|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
2314031|NCT02804763|4022396|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1
2314032|NCT02804763|4022397|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2
2314033|NCT02804763|4022394|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
2314034|NCT02804763|4022395|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1
2314035|NCT02804763|4022396|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
2314036|NCT02804763|4022397|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
2314037|NCT02804763|4022394|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2
2314038|NCT02804763|4022395|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0
2314039|NCT02804763|4022396|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
2314040|NCT02804763|4022397|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
2314041|NCT02804763|4022394|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4
2358573|NCT01992653|4119114|FG005|Overall Study|Study Completed|0
2104161|NCT00849680|3696377|FG007|Overall Study|Adverse Event|0
2104162|NCT00849680|3696370|FG000|Overall Study|Lost to Follow-up|7
2104163|NCT00849680|3696371|FG001|Overall Study|Lost to Follow-up|3
2104164|NCT00849680|3696372|FG002|Overall Study|Lost to Follow-up|12
2104165|NCT00849680|3696373|FG003|Overall Study|Lost to Follow-up|11
2104166|NCT00849680|3696374|FG004|Overall Study|Lost to Follow-up|8
2104167|NCT00849680|3696375|FG005|Overall Study|Lost to Follow-up|11
2104168|NCT00849680|3696376|FG006|Overall Study|Lost to Follow-up|12
2104169|NCT00849680|3696377|FG007|Overall Study|Lost to Follow-up|5
2104170|NCT00849680|3696370|FG000|Overall Study|Subject moved|1
2104171|NCT00849680|3696371|FG001|Overall Study|Subject moved|0
2104172|NCT00849680|3696372|FG002|Overall Study|Subject moved|3
2104173|NCT00849680|3696373|FG003|Overall Study|Subject moved|1
2104174|NCT00849680|3696374|FG004|Overall Study|Subject moved|0
2104175|NCT00849680|3696375|FG005|Overall Study|Subject moved|2
2104176|NCT00849680|3696376|FG006|Overall Study|Subject moved|2
2104177|NCT00849680|3696377|FG007|Overall Study|Subject moved|2
2104178|NCT00849680|3696370|FG000|Overall Study|Withdrawal by Subject|2
2104179|NCT00849680|3696371|FG001|Overall Study|Withdrawal by Subject|0
2104180|NCT00849680|3696372|FG002|Overall Study|Withdrawal by Subject|0
2104181|NCT00849680|3696373|FG003|Overall Study|Withdrawal by Subject|2
2104182|NCT00849680|3696374|FG004|Overall Study|Withdrawal by Subject|2
2104183|NCT00849680|3696375|FG005|Overall Study|Withdrawal by Subject|2
2104184|NCT00849680|3696376|FG006|Overall Study|Withdrawal by Subject|1
2104185|NCT00849680|3696377|FG007|Overall Study|Withdrawal by Subject|1
2104186|NCT00849680|3696370|FG000|Overall Study|Subject unable to comply with protocol|1
2104187|NCT00849680|3696371|FG001|Overall Study|Subject unable to comply with protocol|0
2104188|NCT00849680|3696372|FG002|Overall Study|Subject unable to comply with protocol|0
2104189|NCT00849680|3696373|FG003|Overall Study|Subject unable to comply with protocol|0
2104190|NCT00849680|3696374|FG004|Overall Study|Subject unable to comply with protocol|0
2104191|NCT00849680|3696375|FG005|Overall Study|Subject unable to comply with protocol|0
2104192|NCT00849680|3696376|FG006|Overall Study|Subject unable to comply with protocol|0
2104193|NCT00849680|3696377|FG007|Overall Study|Subject unable to comply with protocol|0
2104194|NCT00849693|3696399|FG000|Acute Treatment Phase|Adverse Event|12
2104195|NCT00849693|3696400|FG001|Acute Treatment Phase|Adverse Event|7
2104196|NCT00849693|3696401|FG002|Acute Treatment Phase|Adverse Event|6
2104197|NCT00849693|3696402|FG003|Acute Treatment Phase|Adverse Event|4
2104198|NCT00849693|3696399|FG000|Acute Treatment Phase|Lost to Follow-up|5
2104199|NCT00849693|3696400|FG001|Acute Treatment Phase|Lost to Follow-up|8
2104200|NCT00849693|3696401|FG002|Acute Treatment Phase|Lost to Follow-up|11
2104201|NCT00849693|3696402|FG003|Acute Treatment Phase|Lost to Follow-up|9
2104202|NCT00849693|3696399|FG000|Acute Treatment Phase|Protocol Violation|1
2104203|NCT00849693|3696400|FG001|Acute Treatment Phase|Protocol Violation|5
2104204|NCT00849693|3696401|FG002|Acute Treatment Phase|Protocol Violation|2
2104205|NCT00849693|3696402|FG003|Acute Treatment Phase|Protocol Violation|6
2104206|NCT00849693|3696399|FG000|Acute Treatment Phase|Withdrawal by Subject|5
2104207|NCT00849693|3696400|FG001|Acute Treatment Phase|Withdrawal by Subject|5
2104208|NCT00849693|3696401|FG002|Acute Treatment Phase|Withdrawal by Subject|3
2104209|NCT00849693|3696402|FG003|Acute Treatment Phase|Withdrawal by Subject|8
2104210|NCT00849693|3696399|FG000|Acute Treatment Phase|Parent or caregiver decision|7
2104211|NCT00849693|3696400|FG001|Acute Treatment Phase|Parent or caregiver decision|6
2104212|NCT00849693|3696401|FG002|Acute Treatment Phase|Parent or caregiver decision|7
2104213|NCT00849693|3696402|FG003|Acute Treatment Phase|Parent or caregiver decision|7
2104214|NCT00849693|3696399|FG000|Acute Treatment Phase|Physician Decision|2
2104215|NCT00849693|3696400|FG001|Acute Treatment Phase|Physician Decision|1
2104216|NCT00849693|3696401|FG002|Acute Treatment Phase|Physician Decision|2
2104217|NCT00849693|3696402|FG003|Acute Treatment Phase|Physician Decision|1
2104218|NCT00849693|3696399|FG000|Acute Treatment Phase|Sponsor decision|0
2104219|NCT00849693|3696400|FG001|Acute Treatment Phase|Sponsor decision|0
2104220|NCT00849693|3696401|FG002|Acute Treatment Phase|Sponsor decision|1
2104221|NCT00849693|3696402|FG003|Acute Treatment Phase|Sponsor decision|0
2104222|NCT00849693|3696399|FG000|Acute Treatment Phase|Lack of Efficacy|1
2104223|NCT00849693|3696400|FG001|Acute Treatment Phase|Lack of Efficacy|3
2104224|NCT00849693|3696401|FG002|Acute Treatment Phase|Lack of Efficacy|1
2104225|NCT00849693|3696402|FG003|Acute Treatment Phase|Lack of Efficacy|2
2104226|NCT00849693|3696399|FG000|Extension Phase|Adverse Event|4
2104227|NCT00849693|3696400|FG001|Extension Phase|Adverse Event|6
2104228|NCT00849693|3696401|FG002|Extension Phase|Adverse Event|3
2104229|NCT00849693|3696402|FG003|Extension Phase|Adverse Event|7
2104230|NCT00849693|3696399|FG000|Extension Phase|Lost to Follow-up|7
2104231|NCT00849693|3696400|FG001|Extension Phase|Lost to Follow-up|5
2104232|NCT00849693|3696401|FG002|Extension Phase|Lost to Follow-up|6
2104233|NCT00849693|3696402|FG003|Extension Phase|Lost to Follow-up|6
2104234|NCT00849693|3696399|FG000|Extension Phase|Protocol Violation|0
2104235|NCT00849693|3696400|FG001|Extension Phase|Protocol Violation|3
2104236|NCT00849693|3696401|FG002|Extension Phase|Protocol Violation|2
2104237|NCT00849693|3696402|FG003|Extension Phase|Protocol Violation|3
2104238|NCT00849693|3696399|FG000|Extension Phase|Withdrawal by Subject|6
2104239|NCT00849693|3696400|FG001|Extension Phase|Withdrawal by Subject|9
2104240|NCT00849693|3696401|FG002|Extension Phase|Withdrawal by Subject|10
2104241|NCT00849693|3696402|FG003|Extension Phase|Withdrawal by Subject|15
2104242|NCT00849693|3696399|FG000|Extension Phase|Parent or caregiver decision|9
2104243|NCT00849693|3696400|FG001|Extension Phase|Parent or caregiver decision|4
2104244|NCT00849693|3696401|FG002|Extension Phase|Parent or caregiver decision|10
2104245|NCT00849693|3696402|FG003|Extension Phase|Parent or caregiver decision|5
2104246|NCT00849693|3696399|FG000|Extension Phase|Physician Decision|1
2104247|NCT00849693|3696400|FG001|Extension Phase|Physician Decision|1
2104248|NCT00849693|3696401|FG002|Extension Phase|Physician Decision|2
2104249|NCT00849693|3696402|FG003|Extension Phase|Physician Decision|0
2104250|NCT00849693|3696399|FG000|Extension Phase|Sponsor decision|1
2104251|NCT00849693|3696400|FG001|Extension Phase|Sponsor decision|0
2104252|NCT00849693|3696401|FG002|Extension Phase|Sponsor decision|0
2104253|NCT00849693|3696402|FG003|Extension Phase|Sponsor decision|1
2104254|NCT00849693|3696399|FG000|Extension Phase|Lack of Efficacy|2
2314042|NCT02804763|4022395|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0
2314043|NCT02804763|4022396|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
2314044|NCT02804763|4022397|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
2314045|NCT02804763|4022394|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
2314046|NCT02804763|4022395|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1
2314047|NCT02804763|4022396|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
2314048|NCT02804763|4022397|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
2314049|NCT02805309|4022418|FG000|Overall Study|Lost to Follow-up|2
2314050|NCT02805309|4022419|FG001|Overall Study|Lost to Follow-up|2
2104255|NCT00849693|3696400|FG001|Extension Phase|Lack of Efficacy|2
2104256|NCT00849693|3696401|FG002|Extension Phase|Lack of Efficacy|2
2314051|NCT02805309|4022420|FG002|Overall Study|Lost to Follow-up|2
2314052|NCT02805309|4022418|FG000|Overall Study|Post-Randomization Exclusion|0
2314053|NCT02805309|4022419|FG001|Overall Study|Post-Randomization Exclusion|2
2314054|NCT02805309|4022420|FG002|Overall Study|Post-Randomization Exclusion|1
2314055|NCT02805660|4022444|FG000|Overall Study|Death|5
2314056|NCT02805660|4022445|FG001|Overall Study|Death|2
2314057|NCT02805660|4022446|FG002|Overall Study|Death|9
2314058|NCT02805660|4022447|FG003|Overall Study|Death|5
2314059|NCT02805660|4022448|FG004|Overall Study|Death|0
2314060|NCT02805660|4022449|FG005|Overall Study|Death|14
2314061|NCT02805660|4022450|FG006|Overall Study|Death|12
2314062|NCT02805660|4022444|FG000|Overall Study|Lost to Follow-up|0
2314063|NCT02805660|4022445|FG001|Overall Study|Lost to Follow-up|1
2314064|NCT02805660|4022446|FG002|Overall Study|Lost to Follow-up|1
2314065|NCT02805660|4022447|FG003|Overall Study|Lost to Follow-up|2
2314066|NCT02805660|4022448|FG004|Overall Study|Lost to Follow-up|0
2314067|NCT02805660|4022449|FG005|Overall Study|Lost to Follow-up|0
2314068|NCT02805660|4022450|FG006|Overall Study|Lost to Follow-up|0
2314069|NCT02805660|4022444|FG000|Overall Study|Withdrawal by Subject|0
2314070|NCT02805660|4022445|FG001|Overall Study|Withdrawal by Subject|0
2314071|NCT02805660|4022446|FG002|Overall Study|Withdrawal by Subject|0
2314072|NCT02805660|4022447|FG003|Overall Study|Withdrawal by Subject|3
2314073|NCT02805660|4022448|FG004|Overall Study|Withdrawal by Subject|1
2314074|NCT02805660|4022449|FG005|Overall Study|Withdrawal by Subject|0
2314075|NCT02805660|4022450|FG006|Overall Study|Withdrawal by Subject|2
2314076|NCT02805660|4022444|FG000|Overall Study|Study terminated by Sponsor|0
2314077|NCT02805660|4022445|FG001|Overall Study|Study terminated by Sponsor|0
2314078|NCT02805660|4022446|FG002|Overall Study|Study terminated by Sponsor|1
2314079|NCT02805660|4022447|FG003|Overall Study|Study terminated by Sponsor|4
2314080|NCT02805660|4022448|FG004|Overall Study|Study terminated by Sponsor|2
2314081|NCT02805660|4022449|FG005|Overall Study|Study terminated by Sponsor|3
2314082|NCT02805660|4022450|FG006|Overall Study|Study terminated by Sponsor|1
2314083|NCT02805660|4022444|FG000|Overall Study|Miscellaneous|0
2314084|NCT02805660|4022445|FG001|Overall Study|Miscellaneous|1
2314085|NCT02805660|4022446|FG002|Overall Study|Miscellaneous|0
2314086|NCT02805660|4022447|FG003|Overall Study|Miscellaneous|4
2314087|NCT02805660|4022448|FG004|Overall Study|Miscellaneous|0
2314088|NCT02805660|4022449|FG005|Overall Study|Miscellaneous|6
2314089|NCT02805660|4022450|FG006|Overall Study|Miscellaneous|4
2314090|NCT02805790|4022481|FG000|Second Intervention (4 Weeks)|Physician Decision|0
2314091|NCT02805790|4022482|FG001|Second Intervention (4 Weeks)|Physician Decision|1
2314092|NCT02805907|4022490|FG000|Overall Study|Lost to Follow-up|3
2314093|NCT02805907|4022491|FG001|Overall Study|Lost to Follow-up|3
2314094|NCT02805972|4022499|FG000|Washout Period|Lost to Follow-up|3
2314095|NCT02805972|4022500|FG001|Washout Period|Lost to Follow-up|0
2314096|NCT02806024|4022518|FG000|Overall Study|Night Delivery|1
2314097|NCT02806024|4022519|FG001|Overall Study|Night Delivery|1
2314098|NCT02806024|4022518|FG000|Overall Study|DVT during antepartum admission|0
2314099|NCT02806024|4022519|FG001|Overall Study|DVT during antepartum admission|1
2314100|NCT02806232|4022534|FG000|Overall Study|Lost to Follow-up|1
2314101|NCT02806232|4022535|FG001|Overall Study|Lost to Follow-up|2
2314102|NCT02806232|4022536|FG002|Overall Study|Lost to Follow-up|1
2314103|NCT02806232|4022537|FG003|Overall Study|Lost to Follow-up|0
2314104|NCT02806232|4022538|FG004|Overall Study|Lost to Follow-up|0
2314105|NCT02806232|4022539|FG005|Overall Study|Lost to Follow-up|1
2314106|NCT02806232|4022540|FG006|Overall Study|Lost to Follow-up|0
2314107|NCT02806232|4022541|FG007|Overall Study|Lost to Follow-up|0
2104257|NCT00849693|3696402|FG003|Extension Phase|Lack of Efficacy|1
2104258|NCT00849875|3696431|FG000|Overall Study|Death|28
2314108|NCT02806232|4022542|FG008|Overall Study|Lost to Follow-up|0
2314109|NCT02806232|4022534|FG000|Overall Study|Withdrawal by Subject|0
2314110|NCT02806232|4022535|FG001|Overall Study|Withdrawal by Subject|2
2314111|NCT02806232|4022536|FG002|Overall Study|Withdrawal by Subject|0
2314112|NCT02806232|4022537|FG003|Overall Study|Withdrawal by Subject|0
2314113|NCT02806232|4022538|FG004|Overall Study|Withdrawal by Subject|2
2314114|NCT02806232|4022539|FG005|Overall Study|Withdrawal by Subject|1
2314115|NCT02806232|4022540|FG006|Overall Study|Withdrawal by Subject|0
2314116|NCT02806232|4022541|FG007|Overall Study|Withdrawal by Subject|0
2314117|NCT02806232|4022542|FG008|Overall Study|Withdrawal by Subject|0
2314118|NCT02806414|4022562|FG000|Overall Study|Lost to Follow-up|2
2314119|NCT02806505|4022568|FG000|Overall Study|Adverse event/intercurrent illness|1
2314120|NCT02806505|4022569|FG001|Overall Study|Adverse event/intercurrent illness|3
2314121|NCT02806505|4022568|FG000|Overall Study|Death|4
2314122|NCT02806505|4022569|FG001|Overall Study|Death|0
2314123|NCT02806505|4022568|FG000|Overall Study|Did not cooperate/refused treatment|3
2314124|NCT02806505|4022569|FG001|Overall Study|Did not cooperate/refused treatment|3
2314125|NCT02806505|4022568|FG000|Overall Study|Failure to return|0
2314126|NCT02806505|4022569|FG001|Overall Study|Failure to return|1
2314127|NCT02806505|4022568|FG000|Overall Study|Insufficient therapeutic response|2
2314128|NCT02806505|4022569|FG001|Overall Study|Insufficient therapeutic response|4
2314129|NCT02806713|4022581|FG000|Overall Study|Urethral injury during procedure|1
2314130|NCT02806713|4022582|FG001|Overall Study|Urethral injury during procedure|0
2314131|NCT02806713|4022581|FG000|Overall Study|cancelled surgery|1
2314132|NCT02806713|4022582|FG001|Overall Study|cancelled surgery|2
2314133|NCT02806726|4022588|FG000|Overall Study|Lost to Follow-up|1
2314134|NCT02806947|4022624|FG000|Overall Study|Withdrawal by Subject|5
2314135|NCT02806947|4022625|FG001|Overall Study|Withdrawal by Subject|1
2314136|NCT02806973|4022631|FG000|Period 1|Withdrawal by Subject|0
2314137|NCT02806973|4022632|FG001|Period 1|Withdrawal by Subject|2
2314138|NCT02806973|4022633|FG002|Period 1|Withdrawal by Subject|1
2314139|NCT02806973|4022634|FG003|Period 1|Withdrawal by Subject|1
2314140|NCT02806973|4022631|FG000|Period 1|Adverse Event|0
2314141|NCT02806973|4022632|FG001|Period 1|Adverse Event|0
2314142|NCT02806973|4022633|FG002|Period 1|Adverse Event|0
2314143|NCT02806973|4022634|FG003|Period 1|Adverse Event|1
2314144|NCT02806973|4022631|FG000|Period 3|Withdrawal by Subject|0
2314145|NCT02806973|4022632|FG001|Period 3|Withdrawal by Subject|0
2314146|NCT02806973|4022633|FG002|Period 3|Withdrawal by Subject|0
2314147|NCT02806973|4022634|FG003|Period 3|Withdrawal by Subject|3
2314148|NCT02806973|4022631|FG000|Period 3|Adverse Event|0
2314149|NCT02806973|4022632|FG001|Period 3|Adverse Event|0
2314150|NCT02806973|4022633|FG002|Period 3|Adverse Event|1
2314151|NCT02806973|4022634|FG003|Period 3|Adverse Event|0
2314152|NCT02806986|4022644|FG000|Treatment Stage 1|Adverse Event|1
2314153|NCT02806986|4022644|FG000|Treatment Stage 2|Adverse Event|3
2314154|NCT02806986|4022644|FG000|Treatment Stage 2|Withdrawal by Subject|2
2314155|NCT02807259|4022654|FG000|Baseline (3 Months)|migration, refusal, not available|77
2314156|NCT02807259|4022655|FG001|Baseline (3 Months)|migration, refusal, not available|112
2314157|NCT02807259|4022654|FG000|Midline (3 Months)|migration, refusal, not available|30
2314158|NCT02807259|4022655|FG001|Midline (3 Months)|migration, refusal, not available|34
2314159|NCT02807259|4022654|FG000|Endline (3 Months)|migration, refusal, not available|35
2314160|NCT02807259|4022655|FG001|Endline (3 Months)|migration, refusal, not available|87
2314161|NCT02807376|4022665|FG000|Overall Study|Intra-operative exclusion criteria|3
2314162|NCT02807376|4022666|FG001|Overall Study|Intra-operative exclusion criteria|0
2314163|NCT02807376|4022665|FG000|Overall Study|Lost to Follow-up|0
2314164|NCT02807376|4022666|FG001|Overall Study|Lost to Follow-up|1
2314165|NCT02807402|4022672|FG000|Overall Study|Failure to Return|1
2314166|NCT02807402|4022672|FG000|Overall Study|Death|3
2314167|NCT02807402|4022672|FG000|Overall Study|Other|2
2314168|NCT02807623|4022687|FG000|Overall Study|Lost to Follow-up|23
2314169|NCT02807623|4022688|FG001|Overall Study|Lost to Follow-up|18
2314170|NCT02807623|4022689|FG002|Overall Study|Lost to Follow-up|22
2358574|NCT01992653|4119115|FG006|Overall Study|Study Completed|0
2358575|NCT01992653|4119116|FG007|Overall Study|Study Completed|1
2358576|NCT01992653|4119109|FG000|Overall Study|Disease Progression|0
2358577|NCT01992653|4119110|FG001|Overall Study|Disease Progression|0
2358578|NCT01992653|4119111|FG002|Overall Study|Disease Progression|0
2358579|NCT01992653|4119112|FG003|Overall Study|Disease Progression|0
2358580|NCT01992653|4119113|FG004|Overall Study|Disease Progression|0
2358581|NCT01992653|4119114|FG005|Overall Study|Disease Progression|0
2314171|NCT02807623|4022687|FG000|Overall Study|Drug intolerance|0
2314172|NCT02807623|4022688|FG001|Overall Study|Drug intolerance|1
2314173|NCT02807623|4022689|FG002|Overall Study|Drug intolerance|0
2314174|NCT02807623|4022687|FG000|Overall Study|incomplete blood draw|0
2314175|NCT02807623|4022688|FG001|Overall Study|incomplete blood draw|2
2314176|NCT02807623|4022689|FG002|Overall Study|incomplete blood draw|1
2314177|NCT02807844|4022716|FG000|Overall Study|Physician Decision|0
2314178|NCT02807844|4022717|FG001|Overall Study|Physician Decision|0
2314179|NCT02807844|4022718|FG002|Overall Study|Physician Decision|0
2104259|NCT00849875|3696431|FG000|Overall Study|Ongoing (unknown completion status)|11
2358582|NCT01992653|4119115|FG006|Overall Study|Disease Progression|4
2314180|NCT02807844|4022719|FG003|Overall Study|Physician Decision|0
2314181|NCT02807844|4022720|FG004|Overall Study|Physician Decision|0
2314182|NCT02807844|4022721|FG005|Overall Study|Physician Decision|0
2314183|NCT02807844|4022722|FG006|Overall Study|Physician Decision|3
2314184|NCT02807844|4022723|FG007|Overall Study|Physician Decision|0
2314185|NCT02807844|4022724|FG008|Overall Study|Physician Decision|1
2314186|NCT02807844|4022725|FG009|Overall Study|Physician Decision|2
2314187|NCT02807844|4022716|FG000|Overall Study|Death|0
2314188|NCT02807844|4022717|FG001|Overall Study|Death|0
2314189|NCT02807844|4022718|FG002|Overall Study|Death|2
2314190|NCT02807844|4022719|FG003|Overall Study|Death|4
2314191|NCT02807844|4022720|FG004|Overall Study|Death|1
2314192|NCT02807844|4022721|FG005|Overall Study|Death|2
2314193|NCT02807844|4022722|FG006|Overall Study|Death|1
2314194|NCT02807844|4022723|FG007|Overall Study|Death|2
2314195|NCT02807844|4022724|FG008|Overall Study|Death|0
2314196|NCT02807844|4022725|FG009|Overall Study|Death|1
2314197|NCT02807844|4022716|FG000|Overall Study|Withdrawal by Subject|0
2314198|NCT02807844|4022717|FG001|Overall Study|Withdrawal by Subject|0
2314199|NCT02807844|4022718|FG002|Overall Study|Withdrawal by Subject|2
2314200|NCT02807844|4022719|FG003|Overall Study|Withdrawal by Subject|1
2314201|NCT02807844|4022720|FG004|Overall Study|Withdrawal by Subject|1
2314202|NCT02807844|4022721|FG005|Overall Study|Withdrawal by Subject|0
2314203|NCT02807844|4022722|FG006|Overall Study|Withdrawal by Subject|1
2314204|NCT02807844|4022723|FG007|Overall Study|Withdrawal by Subject|0
2314205|NCT02807844|4022724|FG008|Overall Study|Withdrawal by Subject|0
2314206|NCT02807844|4022725|FG009|Overall Study|Withdrawal by Subject|0
2314207|NCT02807844|4022716|FG000|Overall Study|Progressive disease|5
2314208|NCT02807844|4022717|FG001|Overall Study|Progressive disease|12
2314209|NCT02807844|4022718|FG002|Overall Study|Progressive disease|8
2314210|NCT02807844|4022719|FG003|Overall Study|Progressive disease|8
2314211|NCT02807844|4022720|FG004|Overall Study|Progressive disease|3
2314212|NCT02807844|4022721|FG005|Overall Study|Progressive disease|8
2314213|NCT02807844|4022722|FG006|Overall Study|Progressive disease|14
2314214|NCT02807844|4022723|FG007|Overall Study|Progressive disease|17
2314215|NCT02807844|4022724|FG008|Overall Study|Progressive disease|19
2314216|NCT02807844|4022725|FG009|Overall Study|Progressive disease|15
2314217|NCT02807844|4022716|FG000|Overall Study|Adverse Event|1
2314218|NCT02807844|4022717|FG001|Overall Study|Adverse Event|0
2314219|NCT02807844|4022718|FG002|Overall Study|Adverse Event|0
2314220|NCT02807844|4022719|FG003|Overall Study|Adverse Event|0
2314221|NCT02807844|4022720|FG004|Overall Study|Adverse Event|1
2314222|NCT02807844|4022721|FG005|Overall Study|Adverse Event|1
2314223|NCT02807844|4022722|FG006|Overall Study|Adverse Event|1
2314224|NCT02807844|4022723|FG007|Overall Study|Adverse Event|1
2314225|NCT02807844|4022724|FG008|Overall Study|Adverse Event|1
2314226|NCT02807844|4022725|FG009|Overall Study|Adverse Event|2
2314227|NCT02807857|4022751|FG000|Enrolled Set|Patients not suitable for follow-up.|551
2314228|NCT02807857|4022751|FG000|Follow-Up Set|Study Terminated By Sponsor|131
2314229|NCT02807857|4022751|FG000|Follow-Up Set|Withdrawal by Subject|8
2314230|NCT02807857|4022751|FG000|Follow-Up Set|Lost to Follow-up|7
2314231|NCT02807857|4022751|FG000|Follow-Up Set|Physician Decision|6
2314232|NCT02807857|4022751|FG000|Follow-Up Set|Adverse Event|3
2314233|NCT02807857|4022751|FG000|Follow-Up Set|Death|27
2314234|NCT02807857|4022751|FG000|Follow-Up Set|Relocation|2
2314235|NCT02807948|4022761|FG000|Overall Study|Physician Decision|1
2314236|NCT02807948|4022762|FG001|Overall Study|Physician Decision|0
2314237|NCT02808312|4022813|FG000|Overall Study|Enrolled but Never Treated|0
2314238|NCT02808312|4022814|FG001|Overall Study|Enrolled but Never Treated|0
2314239|NCT02808312|4022815|FG002|Overall Study|Enrolled but Never Treated|1
2314240|NCT02808312|4022816|FG003|Overall Study|Enrolled but Never Treated|0
2314241|NCT02808312|4022817|FG004|Overall Study|Enrolled but Never Treated|0
2314242|NCT02808338|4022834|FG000|Screening|Screen Failure|10
2314243|NCT02808338|4022834|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1
2314244|NCT02808338|4022834|FG000|Overnight In-lab Polysomonography|Reason not given|1
2314245|NCT02808429|4022848|FG000|Overall Study|Lost to Follow-up|1
2314246|NCT02808429|4022849|FG001|Overall Study|Lost to Follow-up|0
2314247|NCT02808429|4022850|FG002|Overall Study|Lost to Follow-up|0
2314248|NCT02808429|4022848|FG000|Overall Study|Protocol Violation|0
2314249|NCT02808429|4022849|FG001|Overall Study|Protocol Violation|1
2314250|NCT02808429|4022850|FG002|Overall Study|Protocol Violation|0
2314251|NCT02808429|4022848|FG000|Overall Study|Premature study termination by sponsor|2
2314252|NCT02808429|4022849|FG001|Overall Study|Premature study termination by sponsor|0
2314253|NCT02808429|4022850|FG002|Overall Study|Premature study termination by sponsor|1
2314254|NCT02808429|4022848|FG000|Overall Study|Relocation|0
2314255|NCT02808429|4022849|FG001|Overall Study|Relocation|0
2314256|NCT02808429|4022850|FG002|Overall Study|Relocation|1
2314257|NCT02808819|4022860|FG000|Overall Study|eg. no treatment efficacy on asthma|5
2314258|NCT02808819|4022861|FG001|Overall Study|eg. no treatment efficacy on asthma|4
2314259|NCT02808819|4022860|FG000|Overall Study|Withdrawal by Subject|10
2314260|NCT02808819|4022861|FG001|Overall Study|Withdrawal by Subject|13
2314261|NCT02808819|4022860|FG000|Overall Study|Site terminated by sponsor|2
2314262|NCT02808819|4022861|FG001|Overall Study|Site terminated by sponsor|0
2314263|NCT02808819|4022860|FG000|Overall Study|Pregnancy|1
2314264|NCT02808819|4022861|FG001|Overall Study|Pregnancy|0
2314265|NCT02808819|4022860|FG000|Overall Study|Lost to Follow-up|1
2104260|NCT00849875|3696431|FG000|Overall Study|Others|6
2104261|NCT00849875|3696431|FG000|Overall Study|Lost to Follow-up|2
2104262|NCT00849901|3696445|FG000|Acute Treatment Phase|Adverse Event|9
2104263|NCT00849901|3696446|FG001|Acute Treatment Phase|Adverse Event|1
2104264|NCT00849901|3696447|FG002|Acute Treatment Phase|Adverse Event|3
2104265|NCT00849901|3696445|FG000|Acute Treatment Phase|Lost to Follow-up|2
2104266|NCT00849901|3696446|FG001|Acute Treatment Phase|Lost to Follow-up|4
2104267|NCT00849901|3696447|FG002|Acute Treatment Phase|Lost to Follow-up|1
2104268|NCT00849901|3696445|FG000|Acute Treatment Phase|Protocol Violation|0
2104269|NCT00849901|3696446|FG001|Acute Treatment Phase|Protocol Violation|2
2104270|NCT00849901|3696447|FG002|Acute Treatment Phase|Protocol Violation|1
2104271|NCT00849901|3696445|FG000|Acute Treatment Phase|Withdrawal by Subject|4
2104272|NCT00849901|3696446|FG001|Acute Treatment Phase|Withdrawal by Subject|10
2104273|NCT00849901|3696447|FG002|Acute Treatment Phase|Withdrawal by Subject|4
2104274|NCT00849901|3696445|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11
2104275|NCT00849901|3696446|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5
2104276|NCT00849901|3696447|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4
2104277|NCT00849901|3696445|FG000|Acute Treatment Phase|Physician Decision|1
2314266|NCT02808819|4022861|FG001|Overall Study|Lost to Follow-up|6
2314267|NCT02808819|4022860|FG000|Overall Study|Protocol Violation|0
2314268|NCT02808819|4022861|FG001|Overall Study|Protocol Violation|1
2314269|NCT02808819|4022860|FG000|Overall Study|Development of study-specific withdrawal criteria|8
2314270|NCT02808819|4022861|FG001|Overall Study|Development of study-specific withdrawal criteria|3
2314271|NCT02808819|4022860|FG000|Overall Study|Death|1
2314272|NCT02808819|4022861|FG001|Overall Study|Death|0
2314273|NCT02808819|4022860|FG000|Overall Study|Adverse Event|3
2314274|NCT02808819|4022861|FG001|Overall Study|Adverse Event|4
2314275|NCT02808975|4022870|FG000|Overall Study|Adverse Event|3
2314276|NCT02808975|4022871|FG001|Overall Study|Adverse Event|4
2314277|NCT02808975|4022870|FG000|Overall Study|Withdrew consent|9
2314278|NCT02808975|4022871|FG001|Overall Study|Withdrew consent|8
2314279|NCT02808975|4022870|FG000|Overall Study|Lost to Follow-up|4
2314280|NCT02808975|4022871|FG001|Overall Study|Lost to Follow-up|6
2314281|NCT02808975|4022870|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1
2314282|NCT02808975|4022871|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0
2314283|NCT02808975|4022870|FG000|Overall Study|Other, not specified|5
2314284|NCT02808975|4022871|FG001|Overall Study|Other, not specified|1
2314285|NCT02809053|4022879|FG000|Overall Study|Death|0
2314286|NCT02809053|4022880|FG001|Overall Study|Death|1
2314287|NCT02809053|4022879|FG000|Overall Study|Lost to Follow-up|3
2314288|NCT02809053|4022880|FG001|Overall Study|Lost to Follow-up|1
2314289|NCT02809053|4022879|FG000|Overall Study|Withdrawal by Subject|2
2314290|NCT02809053|4022880|FG001|Overall Study|Withdrawal by Subject|3
2314291|NCT02809053|4022879|FG000|Overall Study|Disease Progression|2
2314292|NCT02809053|4022880|FG001|Overall Study|Disease Progression|1
2314293|NCT02809833|4022920|FG000|Overall Study|Death|3
2314294|NCT02809833|4022920|FG000|Overall Study|Intolerance|54
2314295|NCT02809833|4022920|FG000|Overall Study|Lack of Efficacy|89
2314296|NCT02809833|4022920|FG000|Overall Study|Remission/Treatment No Longer Needed|3
2314297|NCT02809833|4022920|FG000|Overall Study|Noncompliance|1
2314298|NCT02809833|4022920|FG000|Overall Study|Withdrawal by Subject|34
2314299|NCT02809833|4022920|FG000|Overall Study|Lost to Follow-up|35
2314300|NCT02809833|4022920|FG000|Overall Study|Adverse Event (AE)|24
2314301|NCT02809833|4022920|FG000|Overall Study|Other|5
2314302|NCT02809833|4022920|FG000|Overall Study|Missing Information|52
2314303|NCT02809976|4022946|FG000|Overall Study|Lost to Follow-up|1
2314304|NCT02809976|4022946|FG000|Overall Study|Withdrawal by Subject|1
2314305|NCT02810340|4022962|FG000|Overall Study|Withdrawal by Subject|1
2314306|NCT02810340|4022963|FG001|Overall Study|Withdrawal by Subject|0
2314307|NCT02810340|4022964|FG002|Overall Study|Withdrawal by Subject|0
2314308|NCT02810340|4022962|FG000|Overall Study|Incarceration|0
2314309|NCT02810340|4022963|FG001|Overall Study|Incarceration|1
2358583|NCT01992653|4119116|FG007|Overall Study|Disease Progression|0
2104278|NCT00849901|3696446|FG001|Acute Treatment Phase|Physician Decision|1
2104279|NCT00849901|3696447|FG002|Acute Treatment Phase|Physician Decision|1
2104280|NCT00849901|3696445|FG000|Acute Treatment Phase|Sponsor Decision|1
2104281|NCT00849901|3696446|FG001|Acute Treatment Phase|Sponsor Decision|0
2104282|NCT00849901|3696447|FG002|Acute Treatment Phase|Sponsor Decision|0
2104283|NCT00849901|3696445|FG000|Acute Treatment Phase|Lack of Efficacy|2
2104284|NCT00849901|3696446|FG001|Acute Treatment Phase|Lack of Efficacy|3
2104285|NCT00849901|3696447|FG002|Acute Treatment Phase|Lack of Efficacy|2
2104286|NCT00849901|3696445|FG000|Extension Phase|Adverse Event|2
2104287|NCT00849901|3696446|FG001|Extension Phase|Adverse Event|8
2104288|NCT00849901|3696447|FG002|Extension Phase|Adverse Event|4
2104289|NCT00849901|3696445|FG000|Extension Phase|Lost to Follow-up|3
2104290|NCT00849901|3696446|FG001|Extension Phase|Lost to Follow-up|0
2104291|NCT00849901|3696447|FG002|Extension Phase|Lost to Follow-up|1
2104292|NCT00849901|3696445|FG000|Extension Phase|Protocol Violation|2
2104293|NCT00849901|3696446|FG001|Extension Phase|Protocol Violation|2
2104294|NCT00849901|3696447|FG002|Extension Phase|Protocol Violation|4
2104295|NCT00849901|3696445|FG000|Extension Phase|Withdrawal by Subject|7
2104296|NCT00849901|3696446|FG001|Extension Phase|Withdrawal by Subject|6
2104297|NCT00849901|3696447|FG002|Extension Phase|Withdrawal by Subject|3
2104298|NCT00849901|3696445|FG000|Extension Phase|Parent or Caregiver Decision|10
2104299|NCT00849901|3696446|FG001|Extension Phase|Parent or Caregiver Decision|4
2104300|NCT00849901|3696447|FG002|Extension Phase|Parent or Caregiver Decision|4
2104301|NCT00849901|3696445|FG000|Extension Phase|Physician Decision|1
2104302|NCT00849901|3696446|FG001|Extension Phase|Physician Decision|2
2104303|NCT00849901|3696447|FG002|Extension Phase|Physician Decision|0
2104304|NCT00849901|3696445|FG000|Extension Phase|Lack of Efficacy|2
2104305|NCT00849901|3696446|FG001|Extension Phase|Lack of Efficacy|4
2104306|NCT00849901|3696447|FG002|Extension Phase|Lack of Efficacy|1
2104307|NCT00849940|3696461|FG000|Overall Study|Physician Decision|4
2104308|NCT00850070|3696471|FG000|Overall Study|Lack of Efficacy|1
2104309|NCT00850070|3696472|FG001|Overall Study|Lack of Efficacy|1
2104310|NCT00850070|3696471|FG000|Overall Study|Adverse Event|2
2104311|NCT00850070|3696472|FG001|Overall Study|Adverse Event|0
2104312|NCT00850135|3696492|FG000|Overall Study|Physician Decision|1
2104313|NCT00850200|3696498|FG000|Overall Study|Physician Decision|2
2104314|NCT00850200|3696498|FG000|Overall Study|Did not recieve treatment|2
2104315|NCT00850200|3696498|FG000|Overall Study|Withdrawal by Subject|1
2104316|NCT00850343|3696509|FG000|Overall Study|Withdrawal by Subject|11
2104317|NCT00850343|3696510|FG001|Overall Study|Withdrawal by Subject|0
2104318|NCT00850343|3696511|FG002|Overall Study|Withdrawal by Subject|3
2104319|NCT00850343|3696512|FG003|Overall Study|Withdrawal by Subject|2
2104320|NCT00850343|3696509|FG000|Overall Study|Adverse Event|15
2104321|NCT00850343|3696510|FG001|Overall Study|Adverse Event|2
2104322|NCT00850343|3696511|FG002|Overall Study|Adverse Event|6
2104323|NCT00850343|3696512|FG003|Overall Study|Adverse Event|6
2104324|NCT00850343|3696509|FG000|Overall Study|Pregnancy|0
2104325|NCT00850343|3696510|FG001|Overall Study|Pregnancy|0
2104326|NCT00850343|3696511|FG002|Overall Study|Pregnancy|0
2104327|NCT00850343|3696512|FG003|Overall Study|Pregnancy|1
2104328|NCT00850343|3696509|FG000|Overall Study|Lack of Efficacy|17
2104329|NCT00850343|3696510|FG001|Overall Study|Lack of Efficacy|0
2104330|NCT00850343|3696511|FG002|Overall Study|Lack of Efficacy|3
2104331|NCT00850343|3696512|FG003|Overall Study|Lack of Efficacy|2
2104332|NCT00850343|3696509|FG000|Overall Study|Non-compliance with Study Procedures|1
2104333|NCT00850343|3696510|FG001|Overall Study|Non-compliance with Study Procedures|0
2104334|NCT00850343|3696511|FG002|Overall Study|Non-compliance with Study Procedures|1
2104335|NCT00850343|3696512|FG003|Overall Study|Non-compliance with Study Procedures|1
2104336|NCT00850343|3696509|FG000|Overall Study|Physician Decision|2
2104337|NCT00850343|3696510|FG001|Overall Study|Physician Decision|1
2104338|NCT00850343|3696511|FG002|Overall Study|Physician Decision|1
2104339|NCT00850343|3696512|FG003|Overall Study|Physician Decision|1
2104340|NCT00850395|3696522|FG000|Overall Study|Death|1
2104341|NCT00850395|3696522|FG000|Overall Study|Adverse Event|1
2104342|NCT00850395|3696522|FG000|Overall Study|Insufficient clinical response|3
2104343|NCT00850395|3696522|FG000|Overall Study|Other|5
2104344|NCT00850460|3696528|FG000|Overall Study|Lost to Follow-up|4
2104345|NCT00850460|3696529|FG001|Overall Study|Lost to Follow-up|4
2104346|NCT00850499|3696541|FG000|Overall Study|Adverse Event|3
2104347|NCT00850499|3696542|FG001|Overall Study|Adverse Event|1
2104348|NCT00850499|3696541|FG000|Overall Study|Lack of Efficacy|0
2104349|NCT00850499|3696542|FG001|Overall Study|Lack of Efficacy|1
2108121|NCT00878215|3701953|FG000|Overall Study|Determined to be ineligible|0
2108122|NCT00878215|3701954|FG001|Overall Study|Determined to be ineligible|10
2108123|NCT00878215|3701955|FG002|Overall Study|Determined to be ineligible|0
2108124|NCT00878215|3701956|FG003|Overall Study|Determined to be ineligible|0
2108125|NCT00878501|3701987|FG000|Overall Study|Adverse Event|11
2108126|NCT00878501|3701988|FG001|Overall Study|Adverse Event|3
2108127|NCT00878501|3701989|FG002|Overall Study|Adverse Event|3
2108128|NCT00878501|3701987|FG000|Overall Study|Lack of Efficacy|2
2108129|NCT00878501|3701988|FG001|Overall Study|Lack of Efficacy|1
2108130|NCT00878501|3701989|FG002|Overall Study|Lack of Efficacy|0
2177509|NCT01374906|3801702|FG001|Overall Study|Withdrawal by Subject|9
2108131|NCT00878501|3701987|FG000|Overall Study|Withdrawal by Subject|2
2108132|NCT00878501|3701988|FG001|Overall Study|Withdrawal by Subject|1
2104350|NCT00850538|3696548|FG000|Overall Study|unable/unwilling to complete MRI|13
2104351|NCT00850538|3696548|FG000|Overall Study|specimen missed due to scheduling error|14
2104352|NCT00850538|3696548|FG000|Overall Study|specimen unusable|7
2104353|NCT00850538|3696548|FG000|Overall Study|Withdrawal by Subject|3
2104354|NCT00850538|3696548|FG000|Overall Study|radiology error|2
2104355|NCT00850538|3696548|FG000|Overall Study|Protocol Violation|2
2104356|NCT00850564|3696552|FG000|Overall Study|Withdrawal by Subject|2
2104357|NCT00850759|3696595|FG000|Overall Study|Lost to Follow-up|7
2104358|NCT00850759|3696596|FG001|Overall Study|Lost to Follow-up|5
2104359|NCT00850759|3696597|FG002|Overall Study|Lost to Follow-up|5
2104360|NCT00850759|3696598|FG003|Overall Study|Lost to Follow-up|3
2104361|NCT00850993|3696619|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1
2104362|NCT00850993|3696620|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0
2104363|NCT00850993|3696621|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0
2104364|NCT00850993|3696622|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1
2104365|NCT00851084|3696642|FG000|Overall Study|Randomized but not treated|1
2104366|NCT00851084|3696643|FG001|Overall Study|Randomized but not treated|0
2104367|NCT00851084|3696642|FG000|Overall Study|Adverse Event|26
2104368|NCT00851084|3696643|FG001|Overall Study|Adverse Event|36
2104369|NCT00851084|3696642|FG000|Overall Study|Disease progression|52
2104370|NCT00851084|3696643|FG001|Overall Study|Disease progression|47
2104371|NCT00851084|3696642|FG000|Overall Study|Poor compliance to protocol|1
2104372|NCT00851084|3696643|FG001|Overall Study|Poor compliance to protocol|1
2104373|NCT00851084|3696642|FG000|Overall Study|Physician Decision|13
2104374|NCT00851084|3696643|FG001|Overall Study|Physician Decision|14
2104375|NCT00851084|3696642|FG000|Overall Study|Consent withdrawn|0
2104376|NCT00851084|3696643|FG001|Overall Study|Consent withdrawn|2
2104377|NCT00851084|3696642|FG000|Overall Study|Withdrawal by Subject|11
2104378|NCT00851084|3696643|FG001|Overall Study|Withdrawal by Subject|12
2104379|NCT00851084|3696642|FG000|Overall Study|Metastatic surgery|6
2104380|NCT00851084|3696643|FG001|Overall Study|Metastatic surgery|6
2104381|NCT00851084|3696642|FG000|Overall Study|Other|7
2104382|NCT00851084|3696643|FG001|Overall Study|Other|1
2104383|NCT00851253|3696653|FG000|Overall Study|Disease Progression|1
2104384|NCT00851253|3696654|FG001|Overall Study|Disease Progression|0
2104385|NCT00851318|3696668|FG000|Overall Study|Withdrawal by Subject|7
2104386|NCT00851318|3696669|FG001|Overall Study|Withdrawal by Subject|1
2104387|NCT00851318|3696670|FG002|Overall Study|Withdrawal by Subject|5
2104388|NCT00851318|3696671|FG003|Overall Study|Withdrawal by Subject|3
2104389|NCT00851318|3696668|FG000|Overall Study|Adverse Event|13
2104390|NCT00851318|3696669|FG001|Overall Study|Adverse Event|2
2104391|NCT00851318|3696670|FG002|Overall Study|Adverse Event|9
2104392|NCT00851318|3696671|FG003|Overall Study|Adverse Event|12
2104393|NCT00851318|3696668|FG000|Overall Study|Pregnancy|0
2104394|NCT00851318|3696669|FG001|Overall Study|Pregnancy|0
2104395|NCT00851318|3696670|FG002|Overall Study|Pregnancy|1
2104396|NCT00851318|3696671|FG003|Overall Study|Pregnancy|1
2104397|NCT00851318|3696668|FG000|Overall Study|Lack of Efficacy|8
2104398|NCT00851318|3696669|FG001|Overall Study|Lack of Efficacy|2
2104399|NCT00851318|3696670|FG002|Overall Study|Lack of Efficacy|4
2104400|NCT00851318|3696671|FG003|Overall Study|Lack of Efficacy|2
2104401|NCT00851318|3696668|FG000|Overall Study|Non-compliance with Study Procedures|2
2104402|NCT00851318|3696669|FG001|Overall Study|Non-compliance with Study Procedures|0
2104403|NCT00851318|3696670|FG002|Overall Study|Non-compliance with Study Procedures|1
2104404|NCT00851318|3696671|FG003|Overall Study|Non-compliance with Study Procedures|0
2104405|NCT00851318|3696668|FG000|Overall Study|Physician Decision|0
2104406|NCT00851318|3696669|FG001|Overall Study|Physician Decision|0
2104407|NCT00851318|3696670|FG002|Overall Study|Physician Decision|1
2104408|NCT00851318|3696671|FG003|Overall Study|Physician Decision|1
2104409|NCT00851630|3696701|FG000|Overall Study|Death|2
2104410|NCT00851630|3696702|FG001|Overall Study|Death|1
2104411|NCT00851630|3696701|FG000|Overall Study|Clinical failure|0
2104412|NCT00851630|3696702|FG001|Overall Study|Clinical failure|1
2104413|NCT00851643|3696714|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1
2104414|NCT00851643|3696715|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0
2104415|NCT00851643|3696716|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0
2104416|NCT00851643|3696717|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0
2104417|NCT00851643|3696718|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0
2104418|NCT00851643|3696719|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0
2180068|NCT01397825|3805930|FG003|Overall Study|Symptomatic Deterioration|0
2104419|NCT00851643|3696714|FG000|Base Study (Up to 12 Months)|Other|0
2104420|NCT00851643|3696715|FG001|Base Study (Up to 12 Months)|Other|0
2104421|NCT00851643|3696716|FG002|Base Study (Up to 12 Months)|Other|0
2104422|NCT00851643|3696717|FG003|Base Study (Up to 12 Months)|Other|0
2104423|NCT00851643|3696718|FG004|Base Study (Up to 12 Months)|Other|0
2104424|NCT00851643|3696719|FG005|Base Study (Up to 12 Months)|Other|1
2104425|NCT00851643|3696714|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4
2104426|NCT00851643|3696715|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2
2104427|NCT00851643|3696716|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4
2104428|NCT00851643|3696717|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1
2104429|NCT00851643|3696718|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2
2104430|NCT00851643|3696719|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0
2104431|NCT00851643|3696714|FG000|Extension Study (Up to 36 Months)|Moved|0
2104432|NCT00851643|3696715|FG001|Extension Study (Up to 36 Months)|Moved|2
2104433|NCT00851643|3696716|FG002|Extension Study (Up to 36 Months)|Moved|1
2104434|NCT00851643|3696717|FG003|Extension Study (Up to 36 Months)|Moved|1
2104435|NCT00851643|3696718|FG004|Extension Study (Up to 36 Months)|Moved|0
2104436|NCT00851643|3696719|FG005|Extension Study (Up to 36 Months)|Moved|1
2104437|NCT00851721|3696734|FG000|Overall Study|planned surgery|1
2104438|NCT00851721|3696735|FG001|Overall Study|planned surgery|0
2104439|NCT00851721|3696734|FG000|Overall Study|Death|1
2104440|NCT00851721|3696735|FG001|Overall Study|Death|0
2104441|NCT00851721|3696734|FG000|Overall Study|Adverse Event|0
2104442|NCT00851721|3696735|FG001|Overall Study|Adverse Event|1
2104443|NCT00851786|3696749|FG000|Overall Study|Withdrawal by Subject|0
2104444|NCT00851786|3696750|FG001|Overall Study|Withdrawal by Subject|1
2104445|NCT00851786|3696749|FG000|Overall Study|Protocol Violation|0
2104446|NCT00851786|3696750|FG001|Overall Study|Protocol Violation|1
2104447|NCT00851786|3696749|FG000|Overall Study|Lost to Follow-up|1
2104448|NCT00851786|3696750|FG001|Overall Study|Lost to Follow-up|0
2104449|NCT00851786|3696749|FG000|Overall Study|Incarceration|1
2104450|NCT00851786|3696750|FG001|Overall Study|Incarceration|0
2104451|NCT00851786|3696749|FG000|Overall Study|Site Closure|1
2104452|NCT00851786|3696750|FG001|Overall Study|Site Closure|0
2104453|NCT00851786|3696749|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2
2104454|NCT00851786|3696750|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0
2104455|NCT00851799|3696759|FG000|Overall Study|Death|1
2104456|NCT00851799|3696760|FG001|Overall Study|Death|0
2104457|NCT00851799|3696761|FG002|Overall Study|Death|1
2104458|NCT00851799|3696759|FG000|Overall Study|Lost to Follow-up|5
2104459|NCT00851799|3696760|FG001|Overall Study|Lost to Follow-up|3
2104460|NCT00851799|3696761|FG002|Overall Study|Lost to Follow-up|10
2104461|NCT00851799|3696759|FG000|Overall Study|Not able to get to clinic|8
2104462|NCT00851799|3696760|FG001|Overall Study|Not able to get to clinic|5
2104463|NCT00851799|3696761|FG002|Overall Study|Not able to get to clinic|9
2104464|NCT00851799|3696759|FG000|Overall Study|Not willing to adhere to requirements|1
2104465|NCT00851799|3696760|FG001|Overall Study|Not willing to adhere to requirements|2
2104466|NCT00851799|3696761|FG002|Overall Study|Not willing to adhere to requirements|2
2104467|NCT00851799|3696759|FG000|Overall Study|Withdrew consent prior study completion|1
2104468|NCT00851799|3696760|FG001|Overall Study|Withdrew consent prior study completion|2
2104469|NCT00851799|3696761|FG002|Overall Study|Withdrew consent prior study completion|1
2104470|NCT00851799|3696759|FG000|Overall Study|Severe Debilitation|0
2104471|NCT00851799|3696760|FG001|Overall Study|Severe Debilitation|1
2104472|NCT00851799|3696761|FG002|Overall Study|Severe Debilitation|0
2104473|NCT00851799|3696759|FG000|Overall Study|Completed protocol due to pregnancy|0
2104474|NCT00851799|3696760|FG001|Overall Study|Completed protocol due to pregnancy|0
2104475|NCT00851799|3696761|FG002|Overall Study|Completed protocol due to pregnancy|1
2104476|NCT00851877|3696769|FG000|Phase I-1|Death|1
2104477|NCT00851877|3696770|FG001|Phase I-1|Death|0
2104478|NCT00851877|3696771|FG002|Phase I-1|Death|0
2104479|NCT00851877|3696769|FG000|Phase II|Withdrawal by Subject|0
2104480|NCT00851877|3696770|FG001|Phase II|Withdrawal by Subject|0
2104481|NCT00851877|3696771|FG002|Phase II|Withdrawal by Subject|3
2104482|NCT00851890|3696781|FG000|Overall Study|Lost to Follow-up|0
2104483|NCT00851890|3696782|FG001|Overall Study|Lost to Follow-up|1
2104484|NCT00851890|3696783|FG002|Overall Study|Lost to Follow-up|0
2104485|NCT00851890|3696784|FG003|Overall Study|Lost to Follow-up|1
2104486|NCT00851903|3696794|FG000|Overall Study|Withdrawal by Subject|2
2104487|NCT00852202|3696810|FG000|Overall Study|Adverse Event|2
2104488|NCT00852202|3696811|FG001|Overall Study|Adverse Event|3
2104489|NCT00852202|3696812|FG002|Overall Study|Adverse Event|7
2104490|NCT00852202|3696810|FG000|Overall Study|Lack of Efficacy|4
2104491|NCT00852202|3696811|FG001|Overall Study|Lack of Efficacy|1
2104492|NCT00852202|3696812|FG002|Overall Study|Lack of Efficacy|2
2104493|NCT00852202|3696810|FG000|Overall Study|Protocol Violation|2
2104494|NCT00852202|3696811|FG001|Overall Study|Protocol Violation|2
2104495|NCT00852202|3696812|FG002|Overall Study|Protocol Violation|7
2104496|NCT00852202|3696810|FG000|Overall Study|Withdrawal by Subject|3
2104497|NCT00852202|3696811|FG001|Overall Study|Withdrawal by Subject|1
2104498|NCT00852202|3696812|FG002|Overall Study|Withdrawal by Subject|2
2104499|NCT00852202|3696810|FG000|Overall Study|Lost to Follow-up|5
2104500|NCT00852202|3696811|FG001|Overall Study|Lost to Follow-up|5
2104501|NCT00852202|3696812|FG002|Overall Study|Lost to Follow-up|6
2104502|NCT00852202|3696810|FG000|Overall Study|pregnancy,moving away and surgery|1
2104503|NCT00852202|3696811|FG001|Overall Study|pregnancy,moving away and surgery|0
2104504|NCT00852202|3696812|FG002|Overall Study|pregnancy,moving away and surgery|2
2104505|NCT00852397|3696824|FG000|Overall Study|Adverse Event|4
2104506|NCT00852397|3696825|FG001|Overall Study|Adverse Event|6
2104507|NCT00852397|3696826|FG002|Overall Study|Adverse Event|4
2104508|NCT00852397|3696824|FG000|Overall Study|Death|0
2104509|NCT00852397|3696825|FG001|Overall Study|Death|0
2104510|NCT00852397|3696826|FG002|Overall Study|Death|1
2104511|NCT00852397|3696824|FG000|Overall Study|Withdrawal by Subject|4
2104512|NCT00852397|3696825|FG001|Overall Study|Withdrawal by Subject|1
2104513|NCT00852397|3696826|FG002|Overall Study|Withdrawal by Subject|2
2104514|NCT00852397|3696824|FG000|Overall Study|Study terminated by sponsor|2
2104515|NCT00852397|3696825|FG001|Overall Study|Study terminated by sponsor|1
2104516|NCT00852397|3696826|FG002|Overall Study|Study terminated by sponsor|6
2104517|NCT00852397|3696824|FG000|Overall Study|Difficulty in study site visit|1
2104518|NCT00852397|3696825|FG001|Overall Study|Difficulty in study site visit|0
2104519|NCT00852397|3696826|FG002|Overall Study|Difficulty in study site visit|0
2104520|NCT00852397|3696824|FG000|Overall Study|Protocol Violation|0
2104521|NCT00852397|3696825|FG001|Overall Study|Protocol Violation|0
2104522|NCT00852397|3696826|FG002|Overall Study|Protocol Violation|1
2104523|NCT00852475|3696836|FG000|Overall Study|Lost to Follow-up|3
2104524|NCT00852475|3696837|FG001|Overall Study|Lost to Follow-up|4
2104525|NCT00852540|3696853|FG000|Overall Study|Adverse Event|10
2104526|NCT00852540|3696854|FG001|Overall Study|Adverse Event|3
2104527|NCT00852540|3696853|FG000|Overall Study|Lack of Efficacy|15
2104528|NCT00852540|3696854|FG001|Overall Study|Lack of Efficacy|3
2104529|NCT00852540|3696853|FG000|Overall Study|Protocol Violation|1
2104530|NCT00852540|3696854|FG001|Overall Study|Protocol Violation|2
2104531|NCT00852540|3696853|FG000|Overall Study|Lost to Follow-up|2
2104532|NCT00852540|3696854|FG001|Overall Study|Lost to Follow-up|3
2104533|NCT00852540|3696853|FG000|Overall Study|Investigator Discretion|2
2104534|NCT00852540|3696854|FG001|Overall Study|Investigator Discretion|3
2104535|NCT00852540|3696853|FG000|Overall Study|Withdrawal by Subject|3
2104536|NCT00852540|3696854|FG001|Overall Study|Withdrawal by Subject|1
2104537|NCT00852540|3696853|FG000|Overall Study|Did Not Receive Study Drug|3
2104538|NCT00852540|3696854|FG001|Overall Study|Did Not Receive Study Drug|3
2104539|NCT00852917|3696907|FG000|Overall Study|Adverse Event|13
2104540|NCT00852917|3696908|FG001|Overall Study|Adverse Event|20
2104541|NCT00852917|3696909|FG002|Overall Study|Adverse Event|35
2104542|NCT00852917|3696910|FG003|Overall Study|Adverse Event|17
2104543|NCT00852917|3696907|FG000|Overall Study|Lack of Efficacy|21
2104544|NCT00852917|3696908|FG001|Overall Study|Lack of Efficacy|11
2104545|NCT00852917|3696909|FG002|Overall Study|Lack of Efficacy|11
2104546|NCT00852917|3696910|FG003|Overall Study|Lack of Efficacy|47
2104547|NCT00852917|3696907|FG000|Overall Study|Withdrawal by Subject|4
2104548|NCT00852917|3696908|FG001|Overall Study|Withdrawal by Subject|8
2104549|NCT00852917|3696909|FG002|Overall Study|Withdrawal by Subject|10
2104550|NCT00852917|3696910|FG003|Overall Study|Withdrawal by Subject|9
2104551|NCT00852917|3696907|FG000|Overall Study|Physician Decision|6
2104552|NCT00852917|3696908|FG001|Overall Study|Physician Decision|7
2104553|NCT00852917|3696909|FG002|Overall Study|Physician Decision|2
2104554|NCT00852917|3696910|FG003|Overall Study|Physician Decision|19
2104555|NCT00852917|3696907|FG000|Overall Study|Death|0
2104556|NCT00852917|3696908|FG001|Overall Study|Death|0
2104557|NCT00852917|3696909|FG002|Overall Study|Death|0
2104558|NCT00852917|3696910|FG003|Overall Study|Death|1
2104559|NCT00852930|3696923|FG000|Overall Study|Withdrawal by Subject|1
2104560|NCT00852930|3696924|FG001|Overall Study|Withdrawal by Subject|1
2104561|NCT00852930|3696925|FG002|Overall Study|Withdrawal by Subject|1
2104562|NCT00852930|3696923|FG000|Overall Study|Physician Decision|0
2104563|NCT00852930|3696924|FG001|Overall Study|Physician Decision|0
2104564|NCT00852930|3696925|FG002|Overall Study|Physician Decision|1
2104565|NCT00852969|3696936|FG000|Overall Study|Adverse Event|0
2104566|NCT00852969|3696937|FG001|Overall Study|Adverse Event|1
2104567|NCT00852969|3696936|FG000|Overall Study|Lost to Follow-up|0
2104568|NCT00852969|3696937|FG001|Overall Study|Lost to Follow-up|1
2104569|NCT00852995|3696948|FG000|Overall Study|Adverse Event|1
2104570|NCT00852995|3696949|FG001|Overall Study|Adverse Event|0
2104571|NCT00852995|3696950|FG002|Overall Study|Adverse Event|4
2104572|NCT00852995|3696951|FG003|Overall Study|Adverse Event|0
2104573|NCT00852995|3696952|FG004|Overall Study|Adverse Event|0
2104574|NCT00852995|3696948|FG000|Overall Study|Lost to Follow-up|0
2104575|NCT00852995|3696949|FG001|Overall Study|Lost to Follow-up|1
2104576|NCT00852995|3696950|FG002|Overall Study|Lost to Follow-up|1
2104577|NCT00852995|3696951|FG003|Overall Study|Lost to Follow-up|0
2104578|NCT00852995|3696952|FG004|Overall Study|Lost to Follow-up|0
2104579|NCT00852995|3696948|FG000|Overall Study|Withdrawal by Subject|4
2104580|NCT00852995|3696949|FG001|Overall Study|Withdrawal by Subject|0
2104581|NCT00852995|3696950|FG002|Overall Study|Withdrawal by Subject|0
2104582|NCT00852995|3696951|FG003|Overall Study|Withdrawal by Subject|1
2104583|NCT00852995|3696952|FG004|Overall Study|Withdrawal by Subject|2
2177510|NCT01374906|3801701|FG000|Overall Study|Unsatisfactory therapeutic effect|11
2104584|NCT00852995|3696948|FG000|Overall Study|Non-Compliance|0
2104585|NCT00852995|3696949|FG001|Overall Study|Non-Compliance|0
2104586|NCT00852995|3696950|FG002|Overall Study|Non-Compliance|0
2104587|NCT00852995|3696951|FG003|Overall Study|Non-Compliance|2
2104588|NCT00852995|3696952|FG004|Overall Study|Non-Compliance|0
2104589|NCT00852995|3696948|FG000|Overall Study|Progressive Disease|1
2104590|NCT00852995|3696949|FG001|Overall Study|Progressive Disease|0
2104591|NCT00852995|3696950|FG002|Overall Study|Progressive Disease|0
2104592|NCT00852995|3696951|FG003|Overall Study|Progressive Disease|2
2104593|NCT00852995|3696952|FG004|Overall Study|Progressive Disease|1
2104594|NCT00852995|3696948|FG000|Overall Study|Physician Decision|1
2104595|NCT00852995|3696949|FG001|Overall Study|Physician Decision|0
2104596|NCT00852995|3696950|FG002|Overall Study|Physician Decision|0
2104597|NCT00852995|3696951|FG003|Overall Study|Physician Decision|0
2104598|NCT00852995|3696952|FG004|Overall Study|Physician Decision|0
2104599|NCT00852995|3696948|FG000|Overall Study|Protocol Violation|0
2104600|NCT00852995|3696949|FG001|Overall Study|Protocol Violation|0
2104601|NCT00852995|3696950|FG002|Overall Study|Protocol Violation|0
2104602|NCT00852995|3696951|FG003|Overall Study|Protocol Violation|0
2104603|NCT00852995|3696952|FG004|Overall Study|Protocol Violation|1
2104604|NCT00852995|3696948|FG000|Overall Study|Moved Out of Area|1
2104605|NCT00852995|3696949|FG001|Overall Study|Moved Out of Area|0
2104606|NCT00852995|3696950|FG002|Overall Study|Moved Out of Area|0
2104607|NCT00852995|3696951|FG003|Overall Study|Moved Out of Area|0
2104608|NCT00852995|3696952|FG004|Overall Study|Moved Out of Area|0
2104609|NCT00853021|3696969|FG000|Overall Study|Adverse Event|2
2314310|NCT02810340|4022964|FG002|Overall Study|Incarceration|0
2314311|NCT02810340|4022962|FG000|Overall Study|Lost to Follow-up|0
2314312|NCT02810340|4022963|FG001|Overall Study|Lost to Follow-up|0
2314313|NCT02810340|4022964|FG002|Overall Study|Lost to Follow-up|1
2314314|NCT02810392|4022974|FG000|Overall Study|Subject too ill to continue|1
2314315|NCT02810392|4022975|FG001|Overall Study|Subject too ill to continue|0
2314316|NCT02810392|4022974|FG000|Overall Study|COVID 19 research restrictions|0
2314317|NCT02810392|4022975|FG001|Overall Study|COVID 19 research restrictions|1
2314318|NCT02810457|4022983|FG000|Overall Study|Randomised but no treatment received|2
2314319|NCT02810457|4022984|FG001|Overall Study|Randomised but no treatment received|1
2314320|NCT02810457|4022983|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191
2314321|NCT02810457|4022984|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199
2358584|NCT02001974|4119137|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2
2358585|NCT02001974|4119138|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3
2358586|NCT02001974|4119139|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14
2358587|NCT02001974|4119137|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1
2358588|NCT02001974|4119138|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0
2358589|NCT02001974|4119139|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4
2358590|NCT02001974|4119137|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1
2358591|NCT02001974|4119138|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0
2358592|NCT02001974|4119139|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6
2358593|NCT02001974|4119137|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
2358594|NCT02001974|4119138|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
2358595|NCT02001974|4119139|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2
2358596|NCT02014558|4119160|FG000|Overall Study|Never Received Study Drug|0
2358597|NCT02014558|4119161|FG001|Overall Study|Never Received Study Drug|0
2358598|NCT02014558|4119162|FG002|Overall Study|Never Received Study Drug|0
2358599|NCT02014558|4119163|FG003|Overall Study|Never Received Study Drug|0
2358600|NCT02014558|4119164|FG004|Overall Study|Never Received Study Drug|1
2358601|NCT02014558|4119165|FG005|Overall Study|Never Received Study Drug|0
2358602|NCT02014558|4119166|FG006|Overall Study|Never Received Study Drug|1
2358603|NCT02014558|4119167|FG007|Overall Study|Never Received Study Drug|0
2358604|NCT02014558|4119168|FG008|Overall Study|Never Received Study Drug|2
2358605|NCT02014558|4119169|FG009|Overall Study|Never Received Study Drug|0
2358606|NCT02014558|4119170|FG010|Overall Study|Never Received Study Drug|2
2358607|NCT02014558|4119171|FG011|Overall Study|Never Received Study Drug|2
2358608|NCT02014558|4119172|FG012|Overall Study|Never Received Study Drug|0
2358609|NCT02014558|4119160|FG000|Overall Study|Adverse Event|0
2358610|NCT02014558|4119161|FG001|Overall Study|Adverse Event|0
2358611|NCT02014558|4119162|FG002|Overall Study|Adverse Event|0
2358612|NCT02014558|4119163|FG003|Overall Study|Adverse Event|0
2358613|NCT02014558|4119164|FG004|Overall Study|Adverse Event|1
2358614|NCT02014558|4119165|FG005|Overall Study|Adverse Event|0
2358615|NCT02014558|4119166|FG006|Overall Study|Adverse Event|0
2358616|NCT02014558|4119167|FG007|Overall Study|Adverse Event|0
2358617|NCT02014558|4119168|FG008|Overall Study|Adverse Event|2
2358618|NCT02014558|4119169|FG009|Overall Study|Adverse Event|2
2358619|NCT02014558|4119170|FG010|Overall Study|Adverse Event|5
2358620|NCT02014558|4119171|FG011|Overall Study|Adverse Event|21
2358621|NCT02014558|4119172|FG012|Overall Study|Adverse Event|3
2358622|NCT02014558|4119160|FG000|Overall Study|Death|1
2358623|NCT02014558|4119161|FG001|Overall Study|Death|0
2358624|NCT02014558|4119162|FG002|Overall Study|Death|0
2358625|NCT02014558|4119163|FG003|Overall Study|Death|0
2358626|NCT02014558|4119164|FG004|Overall Study|Death|0
2358627|NCT02014558|4119165|FG005|Overall Study|Death|0
2358628|NCT02014558|4119166|FG006|Overall Study|Death|1
2358629|NCT02014558|4119167|FG007|Overall Study|Death|1
2358630|NCT02014558|4119168|FG008|Overall Study|Death|2
2358631|NCT02014558|4119169|FG009|Overall Study|Death|5
2358632|NCT02014558|4119170|FG010|Overall Study|Death|5
2358633|NCT02014558|4119171|FG011|Overall Study|Death|19
2358634|NCT02014558|4119172|FG012|Overall Study|Death|2
2358635|NCT02014558|4119160|FG000|Overall Study|Lack of Efficacy|1
2358636|NCT02014558|4119161|FG001|Overall Study|Lack of Efficacy|2
2358637|NCT02014558|4119162|FG002|Overall Study|Lack of Efficacy|1
2358638|NCT02014558|4119163|FG003|Overall Study|Lack of Efficacy|1
2358639|NCT02014558|4119164|FG004|Overall Study|Lack of Efficacy|0
2358640|NCT02014558|4119165|FG005|Overall Study|Lack of Efficacy|0
2104610|NCT00853021|3696969|FG000|Overall Study|Withdrawal by Subject|2
2104611|NCT00853021|3696969|FG000|Overall Study|Death|1
2104612|NCT00853047|3696978|FG000|Core Phase|Participant Request|0
2104613|NCT00853047|3696979|FG001|Core Phase|Participant Request|0
2314322|NCT02810457|4022983|FG000|Overall Study|Adverse Event|37
2314323|NCT02810457|4022984|FG001|Overall Study|Adverse Event|43
2314324|NCT02810457|4022983|FG000|Overall Study|Patient decision|31
2314325|NCT02810457|4022984|FG001|Overall Study|Patient decision|35
2314326|NCT02810457|4022983|FG000|Overall Study|Patient lost to follow-up|2
2314327|NCT02810457|4022984|FG001|Overall Study|Patient lost to follow-up|2
2314328|NCT02810457|4022983|FG000|Overall Study|Death|39
2314329|NCT02810457|4022984|FG001|Overall Study|Death|28
2314330|NCT02810457|4022983|FG000|Overall Study|Ongoing at data cutoff and discontinued|3
2314331|NCT02810457|4022984|FG001|Overall Study|Ongoing at data cutoff and discontinued|2
2314332|NCT02810457|4022983|FG000|Overall Study|Clinical progression|15
2314333|NCT02810457|4022984|FG001|Overall Study|Clinical progression|16
2314334|NCT02810457|4022983|FG000|Overall Study|Investigator decision|3
2314335|NCT02810457|4022984|FG001|Overall Study|Investigator decision|2
2314336|NCT02810457|4022983|FG000|Overall Study|Patient ineligibility|3
2314337|NCT02810457|4022984|FG001|Overall Study|Patient ineligibility|0
2314338|NCT02810457|4022983|FG000|Overall Study|Miscalculated PD|1
2314339|NCT02810457|4022984|FG001|Overall Study|Miscalculated PD|0
2314340|NCT02810457|4022983|FG000|Overall Study|Physician Decision|0
2314341|NCT02810457|4022984|FG001|Overall Study|Physician Decision|1
2314342|NCT02810951|4023011|FG000|Overall Study|Adverse Event|1
2314343|NCT02810964|4023019|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1
2314344|NCT02810964|4023020|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2
2314345|NCT02810964|4023019|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1
2314346|NCT02810964|4023020|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0
2314347|NCT02810964|4023019|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0
2314348|NCT02810964|4023020|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1
2314349|NCT02810964|4023019|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1
2314350|NCT02810964|4023020|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0
2314351|NCT02811159|4023026|FG000|Treatment Course 1|Lost to Follow-up|1
2314352|NCT02811640|4023053|FG000|Overall Study|Technology malfunction|2
2314353|NCT02811861|4023060|FG000|Overall Study|Radiological Disease Progression|123
2314354|NCT02811861|4023061|FG001|Overall Study|Radiological Disease Progression|97
2314355|NCT02811861|4023062|FG002|Overall Study|Radiological Disease Progression|174
2314356|NCT02811861|4023060|FG000|Overall Study|Clinical Disease Progression|20
2314357|NCT02811861|4023061|FG001|Overall Study|Clinical Disease Progression|19
2314358|NCT02811861|4023062|FG002|Overall Study|Clinical Disease Progression|22
2314359|NCT02811861|4023060|FG000|Overall Study|Adverse Event|63
2314360|NCT02811861|4023061|FG001|Overall Study|Adverse Event|60
2314361|NCT02811861|4023062|FG002|Overall Study|Adverse Event|41
2314362|NCT02811861|4023060|FG000|Overall Study|Lost to Follow-up|0
2314363|NCT02811861|4023061|FG001|Overall Study|Lost to Follow-up|0
2314364|NCT02811861|4023062|FG002|Overall Study|Lost to Follow-up|1
2314365|NCT02811861|4023060|FG000|Overall Study|Subject Choice|29
2314366|NCT02811861|4023061|FG001|Overall Study|Subject Choice|17
2314367|NCT02811861|4023062|FG002|Overall Study|Subject Choice|23
2314368|NCT02811861|4023060|FG000|Overall Study|Withdrawal by Subject|4
2314369|NCT02811861|4023061|FG001|Overall Study|Withdrawal by Subject|4
2314370|NCT02811861|4023062|FG002|Overall Study|Withdrawal by Subject|9
2314371|NCT02811861|4023060|FG000|Overall Study|Other|4
2314372|NCT02811861|4023061|FG001|Overall Study|Other|13
2314373|NCT02811861|4023062|FG002|Overall Study|Other|3
2314374|NCT02811861|4023060|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112
2314375|NCT02811861|4023061|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142
2314376|NCT02811861|4023062|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67
2314377|NCT02811861|4023060|FG000|Overall Study|Randomized but not treated|2
2314378|NCT02811861|4023061|FG001|Overall Study|Randomized but not treated|3
2314379|NCT02811861|4023062|FG002|Overall Study|Randomized but not treated|17
2314380|NCT02812186|4023106|FG000|Period 1|Post randomization screen failure|5
2314381|NCT02812186|4023107|FG001|Period 1|Post randomization screen failure|9
2314382|NCT02812186|4023106|FG000|Period 1|nonevaluable data sets|6
2314383|NCT02812186|4023107|FG001|Period 1|nonevaluable data sets|6
2314384|NCT02813421|4023154|FG000|Overall Study|Withdrawal by Subject|1
2314385|NCT02813421|4023155|FG001|Overall Study|Withdrawal by Subject|2
2314386|NCT02813421|4023154|FG000|Overall Study|Lost to Follow-up|1
2314387|NCT02813421|4023155|FG001|Overall Study|Lost to Follow-up|1
2314388|NCT02813577|4023174|FG000|Overall Study|Study terminated|4
2322050|NCT02966834|4036708|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2
2322051|NCT02966834|4036709|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0
2322052|NCT02966834|4036710|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1
2322053|NCT02966834|4036705|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
2322054|NCT02966834|4036706|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
2322055|NCT02966834|4036707|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
2322056|NCT02966834|4036708|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2
2322057|NCT02966834|4036709|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
2322058|NCT02966834|4036710|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
2322059|NCT02966834|4036705|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0
2322060|NCT02966834|4036706|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0
2322061|NCT02966834|4036707|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0
2322062|NCT02966834|4036708|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1
2314389|NCT02813681|4023181|FG000|Overall Study|Physician Decision|5
2314390|NCT02813681|4023182|FG001|Overall Study|Physician Decision|5
2314391|NCT02813681|4023183|FG002|Overall Study|Physician Decision|0
2314392|NCT02813681|4023181|FG000|Overall Study|Lost to Follow-up|0
2314393|NCT02813681|4023182|FG001|Overall Study|Lost to Follow-up|1
2314394|NCT02813681|4023183|FG002|Overall Study|Lost to Follow-up|0
2314395|NCT02813694|4023195|FG000|Overall Study|Physician Decision|0
2314396|NCT02813694|4023196|FG001|Overall Study|Physician Decision|1
2314397|NCT02813694|4023195|FG000|Overall Study|Withdrawal by Subject|10
2314398|NCT02813694|4023196|FG001|Overall Study|Withdrawal by Subject|9
2314399|NCT02813694|4023195|FG000|Overall Study|Lost to Follow-up|1
2314400|NCT02813694|4023196|FG001|Overall Study|Lost to Follow-up|1
2314401|NCT02813694|4023195|FG000|Overall Study|Death|3
2314402|NCT02813694|4023196|FG001|Overall Study|Death|3
2314403|NCT02813694|4023195|FG000|Overall Study|Randomized- did not receive study drug|2
2314404|NCT02813694|4023196|FG001|Overall Study|Randomized- did not receive study drug|0
2314405|NCT02813694|4023195|FG000|Overall Study|Patient hospitalized|1
2314406|NCT02813694|4023196|FG001|Overall Study|Patient hospitalized|0
2314407|NCT02814175|4023204|FG000|Part 1|Adverse Event|2
2314408|NCT02814175|4023205|FG001|Part 1|Adverse Event|3
2314409|NCT02814175|4023206|FG002|Part 1|Adverse Event|0
2358641|NCT02014558|4119166|FG006|Overall Study|Lack of Efficacy|1
2358642|NCT02014558|4119167|FG007|Overall Study|Lack of Efficacy|3
2358643|NCT02014558|4119168|FG008|Overall Study|Lack of Efficacy|3
2358644|NCT02014558|4119169|FG009|Overall Study|Lack of Efficacy|3
2358645|NCT02014558|4119170|FG010|Overall Study|Lack of Efficacy|16
2358646|NCT02014558|4119171|FG011|Overall Study|Lack of Efficacy|8
2358647|NCT02014558|4119172|FG012|Overall Study|Lack of Efficacy|5
2358648|NCT02014558|4119160|FG000|Overall Study|Lost to Follow-up|0
2358649|NCT02014558|4119161|FG001|Overall Study|Lost to Follow-up|0
2358650|NCT02014558|4119162|FG002|Overall Study|Lost to Follow-up|0
2358651|NCT02014558|4119163|FG003|Overall Study|Lost to Follow-up|0
2358652|NCT02014558|4119164|FG004|Overall Study|Lost to Follow-up|0
2358653|NCT02014558|4119165|FG005|Overall Study|Lost to Follow-up|0
2358654|NCT02014558|4119166|FG006|Overall Study|Lost to Follow-up|0
2358655|NCT02014558|4119167|FG007|Overall Study|Lost to Follow-up|0
2358656|NCT02014558|4119168|FG008|Overall Study|Lost to Follow-up|0
2358657|NCT02014558|4119169|FG009|Overall Study|Lost to Follow-up|0
2358658|NCT02014558|4119170|FG010|Overall Study|Lost to Follow-up|1
2358659|NCT02014558|4119171|FG011|Overall Study|Lost to Follow-up|0
2358660|NCT02014558|4119172|FG012|Overall Study|Lost to Follow-up|0
2358661|NCT02014558|4119160|FG000|Overall Study|Progressive Disease|1
2358662|NCT02014558|4119161|FG001|Overall Study|Progressive Disease|0
2358663|NCT02014558|4119162|FG002|Overall Study|Progressive Disease|1
2358664|NCT02014558|4119163|FG003|Overall Study|Progressive Disease|1
2358665|NCT02014558|4119164|FG004|Overall Study|Progressive Disease|1
2358666|NCT02014558|4119165|FG005|Overall Study|Progressive Disease|2
2358667|NCT02014558|4119166|FG006|Overall Study|Progressive Disease|1
2314410|NCT02814175|4023207|FG003|Part 1|Adverse Event|0
2314411|NCT02814175|4023208|FG004|Part 1|Adverse Event|0
2314412|NCT02814175|4023209|FG005|Part 1|Adverse Event|0
2314413|NCT02814175|4023204|FG000|Part 1|Withdrawal Consent|8
2314414|NCT02814175|4023205|FG001|Part 1|Withdrawal Consent|1
2314415|NCT02814175|4023206|FG002|Part 1|Withdrawal Consent|0
2314416|NCT02814175|4023207|FG003|Part 1|Withdrawal Consent|0
2314417|NCT02814175|4023208|FG004|Part 1|Withdrawal Consent|0
2314418|NCT02814175|4023209|FG005|Part 1|Withdrawal Consent|0
2314419|NCT02814175|4023204|FG000|Part 1|Lost to Follow-up|1
2314420|NCT02814175|4023205|FG001|Part 1|Lost to Follow-up|0
2314421|NCT02814175|4023206|FG002|Part 1|Lost to Follow-up|0
2314422|NCT02814175|4023207|FG003|Part 1|Lost to Follow-up|0
2314423|NCT02814175|4023208|FG004|Part 1|Lost to Follow-up|0
2314424|NCT02814175|4023209|FG005|Part 1|Lost to Follow-up|0
2314425|NCT02814175|4023204|FG000|Part 1|Lack of Efficacy|1
2314426|NCT02814175|4023205|FG001|Part 1|Lack of Efficacy|2
2314427|NCT02814175|4023206|FG002|Part 1|Lack of Efficacy|0
2314428|NCT02814175|4023207|FG003|Part 1|Lack of Efficacy|0
2314429|NCT02814175|4023208|FG004|Part 1|Lack of Efficacy|0
2314430|NCT02814175|4023209|FG005|Part 1|Lack of Efficacy|0
2314431|NCT02814175|4023204|FG000|Part 2|Adverse Event|0
2314432|NCT02814175|4023205|FG001|Part 2|Adverse Event|0
2314433|NCT02814175|4023206|FG002|Part 2|Adverse Event|0
2314434|NCT02814175|4023207|FG003|Part 2|Adverse Event|1
2314435|NCT02814175|4023208|FG004|Part 2|Adverse Event|1
2314436|NCT02814175|4023209|FG005|Part 2|Adverse Event|2
2314437|NCT02814175|4023204|FG000|Part 2|Withdrawal Consent|0
2314438|NCT02814175|4023205|FG001|Part 2|Withdrawal Consent|0
2314439|NCT02814175|4023206|FG002|Part 2|Withdrawal Consent|0
2314440|NCT02814175|4023207|FG003|Part 2|Withdrawal Consent|2
2314441|NCT02814175|4023208|FG004|Part 2|Withdrawal Consent|1
2314442|NCT02814175|4023209|FG005|Part 2|Withdrawal Consent|1
2314443|NCT02814175|4023204|FG000|Part 2|Lost to Follow-up|0
2314444|NCT02814175|4023205|FG001|Part 2|Lost to Follow-up|0
2314445|NCT02814175|4023206|FG002|Part 2|Lost to Follow-up|0
2314446|NCT02814175|4023207|FG003|Part 2|Lost to Follow-up|1
2358668|NCT02014558|4119167|FG007|Overall Study|Progressive Disease|6
2358669|NCT02014558|4119168|FG008|Overall Study|Progressive Disease|5
2358670|NCT02014558|4119169|FG009|Overall Study|Progressive Disease|6
2358671|NCT02014558|4119170|FG010|Overall Study|Progressive Disease|22
2358672|NCT02014558|4119171|FG011|Overall Study|Progressive Disease|31
2358673|NCT02014558|4119172|FG012|Overall Study|Progressive Disease|6
2314447|NCT02814175|4023208|FG004|Part 2|Lost to Follow-up|0
2314448|NCT02814175|4023209|FG005|Part 2|Lost to Follow-up|0
2314449|NCT02814175|4023204|FG000|Part 2|Lack of Efficacy|0
2314450|NCT02814175|4023205|FG001|Part 2|Lack of Efficacy|0
2314451|NCT02814175|4023206|FG002|Part 2|Lack of Efficacy|0
2314452|NCT02814175|4023207|FG003|Part 2|Lack of Efficacy|0
2314453|NCT02814175|4023208|FG004|Part 2|Lack of Efficacy|0
2314454|NCT02814175|4023209|FG005|Part 2|Lack of Efficacy|3
2314455|NCT02814565|4023259|FG000|Overall Study|Lack of Efficacy|0
2314456|NCT02814565|4023260|FG001|Overall Study|Lack of Efficacy|1
2314457|NCT02814565|4023259|FG000|Overall Study|Subject decision, caused by AE Influenza|1
2314458|NCT02814565|4023260|FG001|Overall Study|Subject decision, caused by AE Influenza|1
2314459|NCT02814643|4023268|FG000|Overall Study|Lost to Follow-up|0
2314460|NCT02814643|4023269|FG001|Overall Study|Lost to Follow-up|1
2314461|NCT02814643|4023268|FG000|Overall Study|Withdrawal by Subject|1
2314462|NCT02814643|4023269|FG001|Overall Study|Withdrawal by Subject|2
2314463|NCT02814838|4023294|FG000|Overall Study|3 agreed dates for the final visit missed|1
2314464|NCT02814838|4023295|FG001|Overall Study|3 agreed dates for the final visit missed|0
2314465|NCT02814838|4023294|FG000|Overall Study|Consent withdrawal|1
2314466|NCT02814838|4023295|FG001|Overall Study|Consent withdrawal|1
2314467|NCT02815293|4023319|FG000|Overall Study|Study termination by sponsor|10
2314468|NCT02815293|4023320|FG001|Overall Study|Study termination by sponsor|7
2314469|NCT02815293|4023321|FG002|Overall Study|Study termination by sponsor|0
2314470|NCT02815293|4023319|FG000|Overall Study|Participants not randomized|0
2314471|NCT02815293|4023320|FG001|Overall Study|Participants not randomized|0
2314472|NCT02815293|4023321|FG002|Overall Study|Participants not randomized|18
2314473|NCT02815293|4023319|FG000|Overall Study|Adverse Event|0
2314474|NCT02815293|4023320|FG001|Overall Study|Adverse Event|1
2314475|NCT02815293|4023321|FG002|Overall Study|Adverse Event|0
2314476|NCT02815670|4023336|FG000|Overall Study|Prematurely discontinued of the trial|1
2314477|NCT02815735|4023362|FG000|First Intervention (4 Weeks)|Discomfort|1
2314478|NCT02815735|4023363|FG001|First Intervention (4 Weeks)|Discomfort|0
2314479|NCT02815735|4023362|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1
2314480|NCT02815735|4023363|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
2314481|NCT02815735|4023362|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0
2314482|NCT02815735|4023363|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1
2314483|NCT02815735|4023362|FG000|Second Intervention (4 Weeks)|Protocol Violation|1
2314484|NCT02815735|4023363|FG001|Second Intervention (4 Weeks)|Protocol Violation|0
2314485|NCT02816138|4023397|FG000|Overall Study|Adverse Event|1
2314486|NCT02816398|4023422|FG000|Overall Study|Death|5
2314487|NCT02816398|4023422|FG000|Overall Study|Lack of Efficacy|8
2314488|NCT02816398|4023422|FG000|Overall Study|Lost to Follow-up|1
2314489|NCT02817087|4023453|FG000|Overall Study|Withdrawal by Subject|2
2314490|NCT02817087|4023454|FG001|Overall Study|Withdrawal by Subject|0
2314491|NCT02817516|4023464|FG000|Overall Study|Other|0
2314492|NCT02817516|4023465|FG001|Overall Study|Other|0
2314493|NCT02817516|4023466|FG002|Overall Study|Other|1
2314494|NCT02817516|4023467|FG003|Overall Study|Other|0
2314495|NCT02817555|4023482|FG000|Overall Study|Death|1
2314496|NCT02817555|4023483|FG001|Overall Study|Death|3
2314497|NCT02817555|4023482|FG000|Overall Study|moved away|1
2314498|NCT02817555|4023483|FG001|Overall Study|moved away|0
2314499|NCT02817555|4023482|FG000|Overall Study|transplant|1
2314500|NCT02817555|4023483|FG001|Overall Study|transplant|1
2314501|NCT02817555|4023482|FG000|Overall Study|changed to Peritoneal Dialysis|0
2314502|NCT02817555|4023483|FG001|Overall Study|changed to Peritoneal Dialysis|1
2314503|NCT02817594|4023489|FG000|Overall Study|Withdrawal by Subject|1
2314504|NCT02817594|4023489|FG000|Overall Study|Other|1
2314505|NCT02817594|4023489|FG000|Overall Study|Did Not Receive Treatment|1
2314506|NCT02817776|4023506|FG000|Overall Study|Excluded|33
2314507|NCT02817776|4023506|FG000|Overall Study|Lost to Follow-up|20
2314508|NCT02817776|4023506|FG000|Overall Study|Withdrawal by Subject|33
2314509|NCT02817776|4023506|FG000|Overall Study|Death|2
2314510|NCT02817828|4023510|FG000|Overall Study|Lost to Follow-up|41
2314511|NCT02817828|4023510|FG000|Overall Study|Adverse event not related to bleeding|104
2358674|NCT02014558|4119160|FG000|Overall Study|Withdrawal by Subject|0
2358675|NCT02014558|4119161|FG001|Overall Study|Withdrawal by Subject|0
2358676|NCT02014558|4119162|FG002|Overall Study|Withdrawal by Subject|0
2358677|NCT02014558|4119163|FG003|Overall Study|Withdrawal by Subject|0
2358678|NCT02014558|4119164|FG004|Overall Study|Withdrawal by Subject|1
2358679|NCT02014558|4119165|FG005|Overall Study|Withdrawal by Subject|0
2358680|NCT02014558|4119166|FG006|Overall Study|Withdrawal by Subject|0
2358681|NCT02014558|4119167|FG007|Overall Study|Withdrawal by Subject|0
2358682|NCT02014558|4119168|FG008|Overall Study|Withdrawal by Subject|0
2358683|NCT02014558|4119169|FG009|Overall Study|Withdrawal by Subject|2
2358684|NCT02014558|4119170|FG010|Overall Study|Withdrawal by Subject|6
2358685|NCT02014558|4119171|FG011|Overall Study|Withdrawal by Subject|10
2358686|NCT02014558|4119172|FG012|Overall Study|Withdrawal by Subject|0
2358687|NCT02014558|4119160|FG000|Overall Study|Miscellaneous|2
2358688|NCT02014558|4119161|FG001|Overall Study|Miscellaneous|1
2358689|NCT02014558|4119162|FG002|Overall Study|Miscellaneous|1
2358690|NCT02014558|4119163|FG003|Overall Study|Miscellaneous|1
2358691|NCT02014558|4119164|FG004|Overall Study|Miscellaneous|0
2358692|NCT02014558|4119165|FG005|Overall Study|Miscellaneous|1
2314512|NCT02817828|4023510|FG000|Overall Study|Adverse event related to bleeding|53
2314513|NCT02817828|4023510|FG000|Overall Study|Protocol Violation|11
2314514|NCT02817828|4023510|FG000|Overall Study|Pregnancy|7
2314515|NCT02817828|4023510|FG000|Overall Study|Pregnancy wish|15
2314516|NCT02817828|4023510|FG000|Overall Study|Withdrawal by Subject|78
2314517|NCT02817828|4023510|FG000|Overall Study|Other|26
2314518|NCT02817841|4023519|FG000|Overall Study|Lost to Follow-up|287
2314519|NCT02817841|4023519|FG000|Overall Study|Withdrawal by Subject|183
2358693|NCT02014558|4119166|FG006|Overall Study|Miscellaneous|0
2358694|NCT02014558|4119167|FG007|Overall Study|Miscellaneous|1
2358695|NCT02014558|4119168|FG008|Overall Study|Miscellaneous|1
2358696|NCT02014558|4119169|FG009|Overall Study|Miscellaneous|3
2358697|NCT02014558|4119170|FG010|Overall Study|Miscellaneous|12
2358698|NCT02014558|4119171|FG011|Overall Study|Miscellaneous|11
2358699|NCT02014558|4119172|FG012|Overall Study|Miscellaneous|1
2314520|NCT02817841|4023519|FG000|Overall Study|Adverse event not related to bleeding|131
2314521|NCT02817841|4023519|FG000|Overall Study|Adverse event related to bleeding|51
2314522|NCT02817841|4023519|FG000|Overall Study|Pregnancy|32
2314523|NCT02817841|4023519|FG000|Overall Study|Pregnancy wish|17
2314524|NCT02817841|4023519|FG000|Overall Study|Other reasons|53
2314525|NCT02817841|4023519|FG000|Overall Study|Protocol Violation|94
2314526|NCT02817906|4023529|FG000|Overall Study|Adverse Event|3
2314527|NCT02817906|4023530|FG001|Overall Study|Adverse Event|0
2314528|NCT02817906|4023529|FG000|Overall Study|Lack of Efficacy|1
2314529|NCT02817906|4023530|FG001|Overall Study|Lack of Efficacy|0
2314530|NCT02817906|4023529|FG000|Overall Study|Protocol Violation|1
2314531|NCT02817906|4023530|FG001|Overall Study|Protocol Violation|1
2314532|NCT02817906|4023529|FG000|Overall Study|Study Terminated by Sponsor|2
2314533|NCT02817906|4023530|FG001|Overall Study|Study Terminated by Sponsor|2
2314534|NCT02817906|4023529|FG000|Overall Study|Withdrawal by Subject|7
2314535|NCT02817906|4023530|FG001|Overall Study|Withdrawal by Subject|0
2314536|NCT02817906|4023529|FG000|Overall Study|Other|2
2314537|NCT02817906|4023530|FG001|Overall Study|Other|2
2314538|NCT02818036|4023538|FG000|Overall Study|head did not fit in fMRI scanner headres|1
2314539|NCT02818036|4023539|FG001|Overall Study|head did not fit in fMRI scanner headres|0
2314540|NCT02818036|4023538|FG000|Overall Study|Withdrawal by Subject|1
2314541|NCT02818036|4023539|FG001|Overall Study|Withdrawal by Subject|0
2314542|NCT02818777|4023577|FG000|Overall Study|Adverse Event|3
2314543|NCT02818998|4023590|FG000|Overall Study|Adverse Event|3
2314544|NCT02818998|4023591|FG001|Overall Study|Adverse Event|2
2314545|NCT02818998|4023592|FG002|Overall Study|Adverse Event|1
2314546|NCT02818998|4023590|FG000|Overall Study|Lost to Follow-up|4
2314547|NCT02818998|4023591|FG001|Overall Study|Lost to Follow-up|1
2314548|NCT02818998|4023592|FG002|Overall Study|Lost to Follow-up|2
2314549|NCT02818998|4023590|FG000|Overall Study|Withdrawal by sponsor|0
2314550|NCT02818998|4023591|FG001|Overall Study|Withdrawal by sponsor|1
2314551|NCT02818998|4023592|FG002|Overall Study|Withdrawal by sponsor|1
2314552|NCT02818998|4023590|FG000|Overall Study|Death|3
2314553|NCT02818998|4023591|FG001|Overall Study|Death|6
2314554|NCT02818998|4023592|FG002|Overall Study|Death|8
2314555|NCT02818998|4023590|FG000|Overall Study|Withdrawal by Subject|7
2314556|NCT02818998|4023591|FG001|Overall Study|Withdrawal by Subject|6
2314557|NCT02818998|4023592|FG002|Overall Study|Withdrawal by Subject|6
2314558|NCT02818998|4023590|FG000|Overall Study|Physician Decision|1
2314559|NCT02818998|4023591|FG001|Overall Study|Physician Decision|0
2314560|NCT02818998|4023592|FG002|Overall Study|Physician Decision|0
2104614|NCT00853047|3696980|FG002|Core Phase|Participant Request|0
2314561|NCT02819297|4023621|FG000|Overall Study|Withdrawal by Subject|25
2314562|NCT02819297|4023622|FG001|Overall Study|Withdrawal by Subject|13
2314563|NCT02819297|4023621|FG000|Overall Study|Lost to Follow-up|12
2314564|NCT02819297|4023622|FG001|Overall Study|Lost to Follow-up|14
2314565|NCT02819297|4023621|FG000|Overall Study|Adverse Event|12
2314566|NCT02819297|4023622|FG001|Overall Study|Adverse Event|10
2314567|NCT02819297|4023621|FG000|Overall Study|Physician Decision|5
2314568|NCT02819297|4023622|FG001|Overall Study|Physician Decision|5
2314569|NCT02819297|4023621|FG000|Overall Study|Lack of Efficacy|5
2314570|NCT02819297|4023622|FG001|Overall Study|Lack of Efficacy|8
2314571|NCT02819297|4023621|FG000|Overall Study|Protocol Violation|1
2314572|NCT02819297|4023622|FG001|Overall Study|Protocol Violation|2
2314573|NCT02819310|4023628|FG000|Overall Study|Withdrawal by Subject|37
2314574|NCT02819310|4023628|FG000|Overall Study|Lost to Follow-up|16
2314575|NCT02819310|4023628|FG000|Overall Study|Adverse Event|13
2314576|NCT02819310|4023628|FG000|Overall Study|Lack of Efficacy|5
2314577|NCT02819310|4023628|FG000|Overall Study|Physician Decision|8
2314578|NCT02819310|4023628|FG000|Overall Study|Protocol Violation|30
2314579|NCT02819479|4023645|FG000|Overall Study|Adverse Event|2
2314580|NCT02819726|4023657|FG000|Part A (All Participants)|Lost to Follow-up|0
2314581|NCT02819726|4023658|FG001|Part A (All Participants)|Lost to Follow-up|1
2314582|NCT02819726|4023659|FG002|Part A (All Participants)|Lost to Follow-up|0
2314583|NCT02819726|4023660|FG003|Part A (All Participants)|Lost to Follow-up|0
2314584|NCT02819726|4023657|FG000|Part A (All Participants)|Withdrawal by Subject|3
2314585|NCT02819726|4023658|FG001|Part A (All Participants)|Withdrawal by Subject|5
2314586|NCT02819726|4023659|FG002|Part A (All Participants)|Withdrawal by Subject|6
2314587|NCT02819726|4023660|FG003|Part A (All Participants)|Withdrawal by Subject|0
2314588|NCT02819726|4023657|FG000|Part A (All Participants)|Protocol non-compliance|3
2314589|NCT02819726|4023658|FG001|Part A (All Participants)|Protocol non-compliance|4
2314590|NCT02819726|4023659|FG002|Part A (All Participants)|Protocol non-compliance|5
2314591|NCT02819726|4023660|FG003|Part A (All Participants)|Protocol non-compliance|0
2314592|NCT02819726|4023657|FG000|Part B (All Participants)|Lost to Follow-up|1
2314593|NCT02819726|4023658|FG001|Part B (All Participants)|Lost to Follow-up|1
2314594|NCT02819726|4023659|FG002|Part B (All Participants)|Lost to Follow-up|2
2314595|NCT02819726|4023660|FG003|Part B (All Participants)|Lost to Follow-up|2
2314596|NCT02819726|4023657|FG000|Part B (All Participants)|Withdrawal by Subject|2
2314597|NCT02819726|4023658|FG001|Part B (All Participants)|Withdrawal by Subject|1
2314598|NCT02819726|4023659|FG002|Part B (All Participants)|Withdrawal by Subject|1
2314599|NCT02819726|4023660|FG003|Part B (All Participants)|Withdrawal by Subject|0
2314600|NCT02819726|4023657|FG000|Part B (All Participants)|Protocol non-compliance|0
2314601|NCT02819726|4023658|FG001|Part B (All Participants)|Protocol non-compliance|0
2314602|NCT02819726|4023659|FG002|Part B (All Participants)|Protocol non-compliance|1
2314603|NCT02819726|4023660|FG003|Part B (All Participants)|Protocol non-compliance|0
2314604|NCT02820038|4023691|FG000|Overall Study|Lost to Follow-up|7
2314605|NCT02820038|4023692|FG001|Overall Study|Lost to Follow-up|11
2314606|NCT02820038|4023693|FG002|Overall Study|Lost to Follow-up|2
2314607|NCT02820038|4023694|FG003|Overall Study|Lost to Follow-up|9
2314608|NCT02820038|4023691|FG000|Overall Study|Withdrawal by Subject|3
2314609|NCT02820038|4023692|FG001|Overall Study|Withdrawal by Subject|14
2314610|NCT02820038|4023693|FG002|Overall Study|Withdrawal by Subject|3
2314611|NCT02820038|4023694|FG003|Overall Study|Withdrawal by Subject|13
2314612|NCT02820298|4023716|FG000|Overall Study|Withdrawal by Subject|0
2314613|NCT02820298|4023717|FG001|Overall Study|Withdrawal by Subject|1
2314614|NCT02820298|4023716|FG000|Overall Study|Physician Decision|1
2314615|NCT02820298|4023717|FG001|Overall Study|Physician Decision|0
2314616|NCT02820298|4023716|FG000|Overall Study|Protocol Violation|0
2314617|NCT02820298|4023717|FG001|Overall Study|Protocol Violation|1
2314618|NCT02820597|4023750|FG000|Overall Study|Lost to Follow-up|12
2314619|NCT02820844|4023756|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
2314620|NCT02820844|4023757|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
2314621|NCT02820844|4023758|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2314622|NCT02820844|4023759|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2314623|NCT02820844|4023760|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2314624|NCT02820844|4023761|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2314625|NCT02820844|4023756|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
2314626|NCT02820844|4023757|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
2314627|NCT02820844|4023758|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2314628|NCT02820844|4023759|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2314629|NCT02820844|4023760|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2314630|NCT02820844|4023761|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2314631|NCT02820844|4023756|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2314632|NCT02820844|4023757|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
2314633|NCT02820844|4023758|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2314634|NCT02820844|4023759|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2314635|NCT02820844|4023760|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2314636|NCT02820844|4023761|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2314637|NCT02820844|4023756|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2
2314638|NCT02820844|4023757|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1
2314639|NCT02820844|4023758|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2314640|NCT02820844|4023759|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2314641|NCT02820844|4023760|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2314642|NCT02820844|4023761|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2314643|NCT02820844|4023756|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
2314644|NCT02820844|4023757|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2314645|NCT02820844|4023758|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2314646|NCT02820844|4023759|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2358700|NCT02024555|4119227|FG000|Overall Study|Lost to Follow-up|1
2358701|NCT02024555|4119228|FG001|Overall Study|Lost to Follow-up|1
2358702|NCT02024555|4119227|FG000|Overall Study|Withdrawal by Subject|5
2358703|NCT02024555|4119228|FG001|Overall Study|Withdrawal by Subject|1
2358704|NCT02034123|4119252|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358705|NCT02034123|4119253|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358706|NCT02034123|4119254|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358707|NCT02034123|4119255|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358708|NCT02034123|4119256|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
2358709|NCT02034123|4119257|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358710|NCT02034123|4119258|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358711|NCT02034123|4119259|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
2358712|NCT02034123|4119260|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
2358713|NCT02034123|4119261|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358714|NCT02034123|4119262|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358715|NCT02034123|4119263|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358716|NCT02034123|4119264|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358717|NCT02034123|4119265|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358718|NCT02034123|4119266|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358719|NCT02034123|4119267|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358720|NCT02034123|4119268|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358721|NCT02034123|4119269|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2358722|NCT02034123|4119252|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358723|NCT02034123|4119253|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358724|NCT02034123|4119254|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358725|NCT02034123|4119255|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
2358726|NCT02034123|4119256|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358727|NCT02034123|4119257|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358728|NCT02034123|4119258|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358729|NCT02034123|4119259|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358730|NCT02034123|4119260|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358731|NCT02034123|4119261|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358732|NCT02034123|4119262|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358733|NCT02034123|4119263|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358734|NCT02034123|4119264|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358735|NCT02034123|4119265|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358736|NCT02034123|4119266|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358737|NCT02034123|4119267|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358738|NCT02034123|4119268|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358739|NCT02034123|4119269|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2358740|NCT02034123|4119252|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2314647|NCT02820844|4023760|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2314648|NCT02820844|4023761|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2314649|NCT02820844|4023756|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2314650|NCT02820844|4023757|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2314651|NCT02820844|4023758|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
2314652|NCT02820844|4023759|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
2314653|NCT02820844|4023760|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2314654|NCT02820844|4023761|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2314655|NCT02820844|4023756|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2314656|NCT02820844|4023757|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2314657|NCT02820844|4023758|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
2314658|NCT02820844|4023759|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2314659|NCT02820844|4023760|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2314660|NCT02820844|4023761|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2314661|NCT02820844|4023756|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2314662|NCT02820844|4023757|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2314663|NCT02820844|4023758|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
2314664|NCT02820844|4023759|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
2314665|NCT02820844|4023760|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2314666|NCT02820844|4023761|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2314667|NCT02820844|4023756|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2314668|NCT02820844|4023757|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2314669|NCT02820844|4023758|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2314670|NCT02820844|4023759|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2314671|NCT02820844|4023760|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
2314672|NCT02820844|4023761|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2314673|NCT02820844|4023756|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2314674|NCT02820844|4023757|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2314675|NCT02820844|4023758|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2314676|NCT02820844|4023759|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2314677|NCT02820844|4023760|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2314678|NCT02820844|4023761|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
2314679|NCT02821416|4023820|FG000|Overall Study|Adverse Event|0
2314680|NCT02821416|4023821|FG001|Overall Study|Adverse Event|1
2314681|NCT02821416|4023820|FG000|Overall Study|Withdrawal by Subject|2
2314682|NCT02821416|4023821|FG001|Overall Study|Withdrawal by Subject|0
2314683|NCT02821416|4023820|FG000|Overall Study|Lost to Follow-up|1
2314684|NCT02821416|4023821|FG001|Overall Study|Lost to Follow-up|0
2314685|NCT02821715|4023832|FG000|Overall Study|Protocol Violation|1
2314686|NCT02821715|4023833|FG001|Overall Study|Protocol Violation|0
2314687|NCT02821715|4023834|FG002|Overall Study|Protocol Violation|0
2358741|NCT02034123|4119253|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358742|NCT02034123|4119254|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358743|NCT02034123|4119255|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358744|NCT02034123|4119256|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358745|NCT02034123|4119257|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358746|NCT02034123|4119258|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358747|NCT02034123|4119259|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358748|NCT02034123|4119260|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
2358749|NCT02034123|4119261|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358750|NCT02034123|4119262|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2314688|NCT02821715|4023835|FG003|Overall Study|Protocol Violation|0
2314689|NCT02821715|4023836|FG004|Overall Study|Protocol Violation|0
2314690|NCT02821715|4023837|FG005|Overall Study|Protocol Violation|0
2314691|NCT02821819|4023845|FG000|Overall Study|Protocol Violation|1
2314692|NCT02821910|4023855|FG000|Overall Study|Withdrawal by Subject|0
2314693|NCT02821910|4023856|FG001|Overall Study|Withdrawal by Subject|0
2314694|NCT02821910|4023857|FG002|Overall Study|Withdrawal by Subject|1
2314695|NCT02821910|4023858|FG003|Overall Study|Withdrawal by Subject|0
2314696|NCT02821910|4023859|FG004|Overall Study|Withdrawal by Subject|0
2314697|NCT02821910|4023860|FG005|Overall Study|Withdrawal by Subject|1
2314698|NCT02821910|4023855|FG000|Overall Study|Other than specified|1
2314699|NCT02821910|4023856|FG001|Overall Study|Other than specified|0
2314700|NCT02821910|4023857|FG002|Overall Study|Other than specified|1
2314701|NCT02821910|4023858|FG003|Overall Study|Other than specified|0
2314702|NCT02821910|4023859|FG004|Overall Study|Other than specified|0
2314703|NCT02821910|4023860|FG005|Overall Study|Other than specified|0
2314704|NCT02821962|4023876|FG000|Overall Study|Lost to Follow-up|2
2314705|NCT02821962|4023877|FG001|Overall Study|Lost to Follow-up|0
2314706|NCT02822222|4023885|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1
2314707|NCT02822222|4023886|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0
2314708|NCT02822235|4023894|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
2314709|NCT02822235|4023895|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
2314710|NCT02822235|4023894|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2
2314711|NCT02822235|4023895|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0
2214823|NCT01691105|3857480|FG000|12 Month Follow-up|Lost to Follow-up|50
2214824|NCT01691105|3857481|FG001|12 Month Follow-up|Lost to Follow-up|71
2214825|NCT01691105|3857480|FG000|12 Month Follow-up|Death|22
2214826|NCT01691105|3857481|FG001|12 Month Follow-up|Death|30
2214827|NCT01691105|3857480|FG000|12 Month Biochemical Verification|Death|22
2214828|NCT01691105|3857481|FG001|12 Month Biochemical Verification|Death|30
2214829|NCT01691105|3857480|FG000|12 Month Biochemical Verification|Lost to Follow-up|50
2214830|NCT01691105|3857481|FG001|12 Month Biochemical Verification|Lost to Follow-up|71
2214831|NCT01691105|3857480|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352
2214832|NCT01691105|3857481|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401
2217568|NCT01709084|3860882|FG001|Overall Study|Participant Reached a Virologic Endpoint|1
2217569|NCT01709084|3860881|FG000|Overall Study|Not Treated|0
2217570|NCT01709084|3860882|FG001|Overall Study|Not Treated|2
2217571|NCT01709110|3860890|FG000|Overall Study|Adverse Event|56
2217572|NCT01709110|3860891|FG001|Overall Study|Adverse Event|48
2217573|NCT01709110|3860890|FG000|Overall Study|Death|14
2314712|NCT02822235|4023894|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
2314713|NCT02822235|4023895|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
2314714|NCT02822235|4023894|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
2314715|NCT02822235|4023895|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
2314716|NCT02822235|4023894|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1
2314717|NCT02822235|4023895|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0
2314718|NCT02822235|4023894|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
2314719|NCT02822235|4023895|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
2314720|NCT02822794|4023946|FG000|Overall Study|Withdrew Consent|1
2314721|NCT02822794|4023947|FG001|Overall Study|Withdrew Consent|0
2314722|NCT02823470|4023989|FG000|Overall Study|Adverse Event|1
2314723|NCT02823470|4023990|FG001|Overall Study|Adverse Event|0
2314724|NCT02823470|4023989|FG000|Overall Study|Study terminated by sponsor|8
2314725|NCT02823470|4023990|FG001|Overall Study|Study terminated by sponsor|15
2314726|NCT02823964|4024005|FG000|Overall Study|Adverse Event|2
2314727|NCT02823964|4024005|FG000|Overall Study|Physician Decision|1
2314728|NCT02823964|4024005|FG000|Overall Study|Lack of Efficacy|1
2314729|NCT02823964|4024005|FG000|Overall Study|Withdrawal by Subject|1
2314730|NCT02824198|4024011|FG000|Overall Study|Non-compliance with the protocol|5
2314731|NCT02824198|4024012|FG001|Overall Study|Non-compliance with the protocol|1
2314732|NCT02824198|4024011|FG000|Overall Study|Lost to Follow-up|5
2314733|NCT02824198|4024012|FG001|Overall Study|Lost to Follow-up|2
2314734|NCT02824198|4024011|FG000|Overall Study|Withdrawal by Subject|5
2314735|NCT02824198|4024012|FG001|Overall Study|Withdrawal by Subject|0
2314736|NCT02824224|4024022|FG000|Overall Study|Discontinued, IUS expulsion|0
2314737|NCT02824224|4024023|FG001|Overall Study|Discontinued, IUS expulsion|1
2314738|NCT02824224|4024022|FG000|Overall Study|Did not show up for allocation visit|2
2314739|NCT02824224|4024023|FG001|Overall Study|Did not show up for allocation visit|0
2314740|NCT02824432|4024031|FG000|Overall Study|Major Protocol Deviation|1
2314741|NCT02824432|4024032|FG001|Overall Study|Major Protocol Deviation|0
2314742|NCT02824562|4024040|FG000|Overall Study|Lost to Follow-up|3
2314743|NCT02824562|4024041|FG001|Overall Study|Lost to Follow-up|4
2314744|NCT02824562|4024040|FG000|Overall Study|Death|0
2314745|NCT02824562|4024041|FG001|Overall Study|Death|1
2314746|NCT02825251|4024064|FG000|Overall Study|Adverse Event|0
2314747|NCT02825251|4024065|FG001|Overall Study|Adverse Event|1
2314748|NCT02825251|4024064|FG000|Overall Study|Lost to Follow-up|0
2314749|NCT02825251|4024065|FG001|Overall Study|Lost to Follow-up|1
2314750|NCT02825251|4024064|FG000|Overall Study|Withdrawal by Subject|1
2314751|NCT02825251|4024065|FG001|Overall Study|Withdrawal by Subject|4
2314752|NCT02825251|4024064|FG000|Overall Study|Unclassified|2
2314753|NCT02825251|4024065|FG001|Overall Study|Unclassified|0
2314754|NCT02825420|4024073|FG000|Overall Study|Death|30
2314755|NCT02825420|4024074|FG001|Overall Study|Death|12
2314756|NCT02825420|4024073|FG000|Overall Study|Progressive disease|6
2314757|NCT02825420|4024074|FG001|Overall Study|Progressive disease|1
2314758|NCT02825420|4024073|FG000|Overall Study|Lost to Follow-up|2
2314759|NCT02825420|4024074|FG001|Overall Study|Lost to Follow-up|2
2314760|NCT02825420|4024073|FG000|Overall Study|Withdrawal by Subject|1
2314761|NCT02825420|4024074|FG001|Overall Study|Withdrawal by Subject|1
2314762|NCT02825420|4024073|FG000|Overall Study|Protocol amendment not signed|1
2314763|NCT02825420|4024074|FG001|Overall Study|Protocol amendment not signed|1
2314764|NCT02825420|4024073|FG000|Overall Study|Physician Decision|1
2314765|NCT02825420|4024074|FG001|Overall Study|Physician Decision|0
2314766|NCT02825420|4024073|FG000|Overall Study|Did not receive PLD|2
2358751|NCT02034123|4119263|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358752|NCT02034123|4119264|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358753|NCT02034123|4119265|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2314767|NCT02825420|4024074|FG001|Overall Study|Did not receive PLD|0
2314768|NCT02825550|4024085|FG000|Overall Study|Physician Decision|1
2314769|NCT02825992|4024116|FG000|Overall Study|Withdrawal by Subject|4
2314770|NCT02825992|4024116|FG000|Overall Study|Lost to Follow-up|2
2314771|NCT02825992|4024116|FG000|Overall Study|Procedure terminated|2
2314772|NCT02826421|4024130|FG000|Overall Study|Adverse Event|1
2314773|NCT02826421|4024131|FG001|Overall Study|Adverse Event|0
2314774|NCT02826421|4024132|FG002|Overall Study|Adverse Event|0
2314775|NCT02826421|4024133|FG003|Overall Study|Adverse Event|1
2314776|NCT02826421|4024130|FG000|Overall Study|Withdrawal by Subject|1
2314777|NCT02826421|4024131|FG001|Overall Study|Withdrawal by Subject|3
2314778|NCT02826421|4024132|FG002|Overall Study|Withdrawal by Subject|1
2314779|NCT02826421|4024133|FG003|Overall Study|Withdrawal by Subject|1
2314780|NCT02826421|4024130|FG000|Overall Study|Reason not given|1
2314781|NCT02826421|4024131|FG001|Overall Study|Reason not given|0
2314782|NCT02826421|4024132|FG002|Overall Study|Reason not given|1
2314783|NCT02826421|4024133|FG003|Overall Study|Reason not given|0
2314784|NCT02826603|4024146|FG000|Overall Study|Adverse Event|17
2314785|NCT02826603|4024147|FG001|Overall Study|Adverse Event|9
2314786|NCT02826603|4024146|FG000|Overall Study|Lack of Efficacy|4
2314787|NCT02826603|4024147|FG001|Overall Study|Lack of Efficacy|9
2314788|NCT02826603|4024146|FG000|Overall Study|Lost to Follow-up|13
2314789|NCT02826603|4024147|FG001|Overall Study|Lost to Follow-up|12
2314790|NCT02826603|4024146|FG000|Overall Study|Noncompliance with treatment|0
2314791|NCT02826603|4024147|FG001|Overall Study|Noncompliance with treatment|2
2314792|NCT02826603|4024146|FG000|Overall Study|Physician Decision|1
2314793|NCT02826603|4024147|FG001|Overall Study|Physician Decision|7
2358754|NCT02034123|4119266|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358755|NCT02034123|4119267|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358756|NCT02034123|4119268|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358757|NCT02034123|4119269|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2358758|NCT02034123|4119252|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358759|NCT02034123|4119253|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358760|NCT02034123|4119254|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358761|NCT02034123|4119255|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
2358762|NCT02034123|4119256|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
2358763|NCT02034123|4119257|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358764|NCT02034123|4119258|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358765|NCT02034123|4119259|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358766|NCT02034123|4119260|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358767|NCT02034123|4119261|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358768|NCT02034123|4119262|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358769|NCT02034123|4119263|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358770|NCT02034123|4119264|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358771|NCT02034123|4119265|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358772|NCT02034123|4119266|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358773|NCT02034123|4119267|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358774|NCT02034123|4119268|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2358775|NCT02034123|4119269|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2314794|NCT02826603|4024146|FG000|Overall Study|Pregnancy|1
2314795|NCT02826603|4024147|FG001|Overall Study|Pregnancy|2
2314796|NCT02826603|4024146|FG000|Overall Study|Protocol Violation|3
2314797|NCT02826603|4024147|FG001|Overall Study|Protocol Violation|3
2314798|NCT02826603|4024146|FG000|Overall Study|Withdrawal by Subject|20
2314799|NCT02826603|4024147|FG001|Overall Study|Withdrawal by Subject|19
2314800|NCT02826603|4024146|FG000|Overall Study|Death|2
2314801|NCT02826603|4024147|FG001|Overall Study|Death|0
2314802|NCT02826603|4024146|FG000|Overall Study|New therapy for study indication|0
2314803|NCT02826603|4024147|FG001|Overall Study|New therapy for study indication|1
2314804|NCT02826798|4024170|FG000|Overall Study|Withdrawal by Subject|0
2314805|NCT02826798|4024171|FG001|Overall Study|Withdrawal by Subject|1
2314806|NCT02826798|4024172|FG002|Overall Study|Withdrawal by Subject|0
2314807|NCT02826798|4024173|FG003|Overall Study|Withdrawal by Subject|1
2314808|NCT02826798|4024174|FG004|Overall Study|Withdrawal by Subject|0
2314809|NCT02827500|4024188|FG000|Overall Study|Death|7
2314810|NCT02827500|4024189|FG001|Overall Study|Death|3
2314811|NCT02827500|4024188|FG000|Overall Study|Lost to Follow-up|1
2314812|NCT02827500|4024189|FG001|Overall Study|Lost to Follow-up|1
2314813|NCT02827500|4024188|FG000|Overall Study|Withdrawal by Subject|3
2314814|NCT02827500|4024189|FG001|Overall Study|Withdrawal by Subject|1
2314815|NCT02827500|4024188|FG000|Overall Study|Missing primary endpoint data|3
2314816|NCT02827500|4024189|FG001|Overall Study|Missing primary endpoint data|1
2314817|NCT02827500|4024188|FG000|Overall Study|Other|5
2314818|NCT02827500|4024189|FG001|Overall Study|Other|1
2314819|NCT02827708|4024197|FG000|Overall Study|Lost to Follow-up|3
2314820|NCT02827708|4024198|FG001|Overall Study|Lost to Follow-up|1
2314821|NCT02827708|4024197|FG000|Overall Study|Withdrawal by Subject|1
2314822|NCT02827708|4024198|FG001|Overall Study|Withdrawal by Subject|2
2314823|NCT02827708|4024197|FG000|Overall Study|Death|1
2314824|NCT02827708|4024198|FG001|Overall Study|Death|2
2314825|NCT02828020|4024207|FG000|Treatment Period|Adverse Event|3
2314826|NCT02828020|4024208|FG001|Treatment Period|Adverse Event|1
2314827|NCT02828020|4024209|FG002|Treatment Period|Adverse Event|1
2314828|NCT02828020|4024207|FG000|Treatment Period|Withdrawal of Consent|10
2314829|NCT02828020|4024208|FG001|Treatment Period|Withdrawal of Consent|14
2314830|NCT02828020|4024209|FG002|Treatment Period|Withdrawal of Consent|9
2314831|NCT02828020|4024207|FG000|Treatment Period|Lost to Follow-up|21
2314832|NCT02828020|4024208|FG001|Treatment Period|Lost to Follow-up|24
2314833|NCT02828020|4024209|FG002|Treatment Period|Lost to Follow-up|18
2314834|NCT02828020|4024207|FG000|Treatment Period|Lack of Qualifying Event|44
2314835|NCT02828020|4024208|FG001|Treatment Period|Lack of Qualifying Event|53
2314836|NCT02828020|4024209|FG002|Treatment Period|Lack of Qualifying Event|43
2314837|NCT02828020|4024207|FG000|Treatment Period|Pregnancy|0
2314838|NCT02828020|4024208|FG001|Treatment Period|Pregnancy|2
2314839|NCT02828020|4024209|FG002|Treatment Period|Pregnancy|0
2314840|NCT02828020|4024207|FG000|Treatment Period|Protocol Violation|2
2314841|NCT02828020|4024208|FG001|Treatment Period|Protocol Violation|4
2314842|NCT02828020|4024209|FG002|Treatment Period|Protocol Violation|7
2314843|NCT02828020|4024207|FG000|Treatment Period|Other Miscellaneous Reasons|0
2314844|NCT02828020|4024208|FG001|Treatment Period|Other Miscellaneous Reasons|1
2314845|NCT02828020|4024209|FG002|Treatment Period|Other Miscellaneous Reasons|0
2314846|NCT02828020|4024207|FG000|Safety Follow-up Period|Withdrawal of Consent|10
2314847|NCT02828020|4024208|FG001|Safety Follow-up Period|Withdrawal of Consent|8
2314848|NCT02828020|4024209|FG002|Safety Follow-up Period|Withdrawal of Consent|7
2314849|NCT02828020|4024207|FG000|Safety Follow-up Period|Lost to Follow-up|9
2314850|NCT02828020|4024208|FG001|Safety Follow-up Period|Lost to Follow-up|8
2314851|NCT02828020|4024209|FG002|Safety Follow-up Period|Lost to Follow-up|11
2314852|NCT02828020|4024207|FG000|Safety Follow-up Period|Protocol Violation|0
2314853|NCT02828020|4024208|FG001|Safety Follow-up Period|Protocol Violation|2
2314854|NCT02828020|4024209|FG002|Safety Follow-up Period|Protocol Violation|1
2314855|NCT02828020|4024207|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1
2314856|NCT02828020|4024208|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0
2314857|NCT02828020|4024209|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
2314858|NCT02828111|4024222|FG000|Overall Study|Withdrawal by Subject|0
2314859|NCT02828111|4024223|FG001|Overall Study|Withdrawal by Subject|0
2314860|NCT02828111|4024224|FG002|Overall Study|Withdrawal by Subject|2
2314861|NCT02828111|4024225|FG003|Overall Study|Withdrawal by Subject|0
2314862|NCT02828111|4024226|FG004|Overall Study|Withdrawal by Subject|0
2314863|NCT02828111|4024222|FG000|Overall Study|Lost to Follow-up|0
2314864|NCT02828111|4024223|FG001|Overall Study|Lost to Follow-up|0
2314865|NCT02828111|4024224|FG002|Overall Study|Lost to Follow-up|0
2314866|NCT02828111|4024225|FG003|Overall Study|Lost to Follow-up|1
2314867|NCT02828111|4024226|FG004|Overall Study|Lost to Follow-up|1
2314868|NCT02828241|4024262|FG000|Overall Study|Adverse Event|7
2314869|NCT02828241|4024263|FG001|Overall Study|Adverse Event|2
2314870|NCT02828241|4024262|FG000|Overall Study|Protocol Violation|1
2314871|NCT02828241|4024263|FG001|Overall Study|Protocol Violation|0
2314872|NCT02828358|4024291|FG000|Overall Study|Physician Decision|7
2314873|NCT02828358|4024292|FG001|Overall Study|Physician Decision|1
2314874|NCT02828358|4024291|FG000|Overall Study|Treatment Failure|6
2314875|NCT02828358|4024292|FG001|Overall Study|Treatment Failure|0
2314876|NCT02828358|4024291|FG000|Overall Study|Patients without KMT2A rearrangement|0
2314877|NCT02828358|4024292|FG001|Overall Study|Patients without KMT2A rearrangement|21
2314878|NCT02828358|4024291|FG000|Overall Study|Refusal of further protocol therapy|2
2314879|NCT02828358|4024292|FG001|Overall Study|Refusal of further protocol therapy|0
2314880|NCT02828358|4024291|FG000|Overall Study|Relapse|25
2314881|NCT02828358|4024292|FG001|Overall Study|Relapse|0
2314882|NCT02828358|4024291|FG000|Overall Study|Still on therapy|5
2314883|NCT02828358|4024292|FG001|Overall Study|Still on therapy|0
2322063|NCT02966834|4036709|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0
2322064|NCT02966834|4036710|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0
2322065|NCT02967055|4036768|FG000|Overall Study|Excluded|40
2322066|NCT02967055|4036768|FG000|Overall Study|Screen fail|3
2322067|NCT02967055|4036768|FG000|Overall Study|Lost to Follow-up|2
2322068|NCT02967055|4036768|FG000|Overall Study|Stopped due to side effects|3
2322069|NCT02967055|4036768|FG000|Overall Study|Stopped due to drug cost|1
2322396|NCT02971683|4037414|FG000|Overall Study|Participant withdrew consent|1
2322397|NCT02971683|4037415|FG001|Overall Study|Participant withdrew consent|1
2322398|NCT02971683|4037414|FG000|Overall Study|Participant request to discontinue study treatment|1
2322399|NCT02971683|4037415|FG001|Overall Study|Participant request to discontinue study treatment|1
2322400|NCT02971683|4037414|FG000|Overall Study|Adverse Event|1
2322401|NCT02971683|4037415|FG001|Overall Study|Adverse Event|2
2322402|NCT02971683|4037414|FG000|Overall Study|Lack of Efficacy|2
2322403|NCT02971683|4037415|FG001|Overall Study|Lack of Efficacy|2
2322404|NCT02971800|4037430|FG000|Overall Study|Protocol Violation|1
2322405|NCT02971800|4037430|FG000|Overall Study|Withdrawal by Subject|1
2322406|NCT02971800|4037430|FG000|Overall Study|Exclusion criteria prior intervention|1
2314884|NCT02828436|4024297|FG000|Period 1|Did Not Meet Inclusion Criteria|0
2314885|NCT02828436|4024298|FG001|Period 1|Did Not Meet Inclusion Criteria|3
2314886|NCT02828436|4024297|FG000|Period 1|Lost to Follow-up|0
2314887|NCT02828436|4024298|FG001|Period 1|Lost to Follow-up|1
2314888|NCT02828436|4024297|FG000|Period 2|Withdrawal by Subject|4
2314889|NCT02828436|4024298|FG001|Period 2|Withdrawal by Subject|0
2314890|NCT02828436|4024297|FG000|Period 2|Did Not Meet Inclusion Criteria|3
2314891|NCT02828436|4024298|FG001|Period 2|Did Not Meet Inclusion Criteria|0
2314892|NCT02828436|4024297|FG000|Period 2|Lost to Follow-up|1
2314893|NCT02828436|4024298|FG001|Period 2|Lost to Follow-up|0
2314894|NCT02828644|4024306|FG000|Overall Study|Lost to Follow-up|23
2314895|NCT02828644|4024307|FG001|Overall Study|Lost to Follow-up|22
2314896|NCT02829138|4024329|FG000|Overall Study|Withdrawal by Subject|1
2314897|NCT02829138|4024330|FG001|Overall Study|Withdrawal by Subject|0
2314898|NCT02829775|4024366|FG000|Overall Study|Death|1
2314899|NCT02829775|4024366|FG000|Overall Study|Withdrawal by Subject|3
2314900|NCT02829775|4024366|FG000|Overall Study|Disease remission|1
2314905|NCT02829944|4024377|FG000|Overall Study|Physician Decision|0
2314906|NCT02829944|4024378|FG001|Overall Study|Physician Decision|1
2314907|NCT02829944|4024377|FG000|Overall Study|Screen Failure|2
2314908|NCT02829944|4024378|FG001|Overall Study|Screen Failure|2
2314909|NCT02829944|4024377|FG000|Overall Study|Inadequate Neuraxial Block|1
2314910|NCT02829944|4024378|FG001|Overall Study|Inadequate Neuraxial Block|1
2314911|NCT02829944|4024377|FG000|Overall Study|Withdrawal by Subject|2
2314912|NCT02829944|4024378|FG001|Overall Study|Withdrawal by Subject|1
2314913|NCT02829944|4024377|FG000|Overall Study|Catheter Displacement|1
2314914|NCT02829944|4024378|FG001|Overall Study|Catheter Displacement|0
2314915|NCT02829944|4024377|FG000|Overall Study|Catheter broke|0
2314916|NCT02829944|4024378|FG001|Overall Study|Catheter broke|1
2314917|NCT02829944|4024377|FG000|Overall Study|Staff unavailable|0
2314918|NCT02829944|4024378|FG001|Overall Study|Staff unavailable|1
2314919|NCT02829996|4024398|FG000|Overall Study|Withdrawal by Subject|1
2314920|NCT02829996|4024399|FG001|Overall Study|Withdrawal by Subject|0
2314921|NCT02829996|4024400|FG002|Overall Study|Withdrawal by Subject|0
2314922|NCT02829996|4024401|FG003|Overall Study|Withdrawal by Subject|0
2314923|NCT02829996|4024402|FG004|Overall Study|Withdrawal by Subject|0
2314924|NCT02830087|4024430|FG000|Overall Study|No study staff to follow-up patients|4
2314925|NCT02830087|4024431|FG001|Overall Study|No study staff to follow-up patients|4
2314926|NCT02830087|4024432|FG002|Overall Study|No study staff to follow-up patients|4
2314927|NCT02830087|4024433|FG003|Overall Study|No study staff to follow-up patients|3
2314928|NCT02830087|4024434|FG004|Overall Study|No study staff to follow-up patients|3
2314929|NCT02830087|4024435|FG005|Overall Study|No study staff to follow-up patients|3
2314930|NCT02830776|4024453|FG000|Overall Study|Lost to Follow-up|1
2314931|NCT02830880|4024458|FG000|Overall Study|Adverse reaction to chemotherapy|1
2314932|NCT02830880|4024458|FG000|Overall Study|Death|1
2314933|NCT02830880|4024458|FG000|Overall Study|Physician Decision|1
2314934|NCT02830893|4024464|FG000|Overall Study|Relocation to out of the country|1
2314935|NCT02830893|4024465|FG001|Overall Study|Relocation to out of the country|0
2314936|NCT02830893|4024464|FG000|Overall Study|Lost to Follow-up|0
2314937|NCT02830893|4024465|FG001|Overall Study|Lost to Follow-up|2
2314938|NCT02830893|4024464|FG000|Overall Study|Discharged to SNF, no transportation.|0
2314939|NCT02830893|4024465|FG001|Overall Study|Discharged to SNF, no transportation.|1
2314940|NCT02831257|4024471|FG000|Overall Study|Lack of Efficacy|3
2314941|NCT02831257|4024471|FG000|Overall Study|Adverse Event|2
2314942|NCT02831257|4024471|FG000|Overall Study|Physician Decision|1
2314943|NCT02831257|4024471|FG000|Overall Study|Withdrawal by Subject|6
2314944|NCT02831387|4024477|FG000|Overall Study|Withdrawal by Subject|1
2314945|NCT02831387|4024478|FG001|Overall Study|Withdrawal by Subject|1
2314946|NCT02831387|4024477|FG000|Overall Study|Discontinued due to stock recovery|0
2314947|NCT02831387|4024478|FG001|Overall Study|Discontinued due to stock recovery|1
2314948|NCT02831855|4024503|FG000|Open Label Phase (24 Weeks)|Adverse Event|39
2314949|NCT02831855|4024504|FG001|Open Label Phase (24 Weeks)|Adverse Event|0
2314950|NCT02831855|4024505|FG002|Open Label Phase (24 Weeks)|Adverse Event|0
2314951|NCT02831855|4024503|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8
2314952|NCT02831855|4024504|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0
2314953|NCT02831855|4024505|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0
2314954|NCT02831855|4024503|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
2314955|NCT02831855|4024504|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
2314956|NCT02831855|4024505|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
2314957|NCT02831855|4024503|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
2314958|NCT02831855|4024504|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
2314959|NCT02831855|4024505|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
2314960|NCT02831855|4024503|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5
2314961|NCT02831855|4024504|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0
2314962|NCT02831855|4024505|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0
2314963|NCT02831855|4024503|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
2314964|NCT02831855|4024504|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
2314965|NCT02831855|4024505|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
2314966|NCT02831855|4024503|FG000|Open Label Phase (24 Weeks)|Other|4
2314967|NCT02831855|4024504|FG001|Open Label Phase (24 Weeks)|Other|0
2314968|NCT02831855|4024505|FG002|Open Label Phase (24 Weeks)|Other|0
2314969|NCT02831855|4024503|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0
2314970|NCT02831855|4024504|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6
2314971|NCT02831855|4024505|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6
2314972|NCT02831855|4024503|FG000|Double Blind Phase (24 Weeks)|Death|0
2314973|NCT02831855|4024504|FG001|Double Blind Phase (24 Weeks)|Death|0
2314974|NCT02831855|4024505|FG002|Double Blind Phase (24 Weeks)|Death|2
2314975|NCT02831855|4024503|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
2314976|NCT02831855|4024504|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
2314977|NCT02831855|4024505|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
2314978|NCT02831855|4024503|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0
2314979|NCT02831855|4024504|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1
2314980|NCT02831855|4024505|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0
2314981|NCT02831855|4024503|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
2314982|NCT02831855|4024504|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
2314983|NCT02831855|4024505|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
2314984|NCT02831855|4024503|FG000|Double Blind Phase (24 Weeks)|Other|0
2314985|NCT02831855|4024504|FG001|Double Blind Phase (24 Weeks)|Other|2
2314986|NCT02831855|4024505|FG002|Double Blind Phase (24 Weeks)|Other|5
2314987|NCT02831855|4024503|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
2314988|NCT02831855|4024504|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
2314989|NCT02831855|4024505|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
2314990|NCT02831855|4024503|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0
2314991|NCT02831855|4024504|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5
2314992|NCT02831855|4024505|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2
2314993|NCT02831855|4024503|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
2314994|NCT02831855|4024504|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
2314995|NCT02831855|4024505|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
2314996|NCT02832037|4024531|FG000|Overall Study|Administrative reasons|0
2314997|NCT02832037|4024532|FG001|Overall Study|Administrative reasons|0
2314998|NCT02832037|4024533|FG002|Overall Study|Administrative reasons|1
2314999|NCT02832037|4024534|FG003|Overall Study|Administrative reasons|0
2315000|NCT02832037|4024535|FG004|Overall Study|Administrative reasons|0
2315001|NCT02832037|4024531|FG000|Overall Study|Protocol Violation|3
2315002|NCT02832037|4024532|FG001|Overall Study|Protocol Violation|0
2315003|NCT02832037|4024533|FG002|Overall Study|Protocol Violation|4
2315004|NCT02832037|4024534|FG003|Overall Study|Protocol Violation|1
2315005|NCT02832037|4024535|FG004|Overall Study|Protocol Violation|2
2315006|NCT02832037|4024531|FG000|Overall Study|Lost to Follow-up|2
2315007|NCT02832037|4024532|FG001|Overall Study|Lost to Follow-up|0
2315008|NCT02832037|4024533|FG002|Overall Study|Lost to Follow-up|3
2315009|NCT02832037|4024534|FG003|Overall Study|Lost to Follow-up|0
2315010|NCT02832037|4024535|FG004|Overall Study|Lost to Follow-up|5
2315011|NCT02832037|4024531|FG000|Overall Study|Withdrawal by Subject|9
2315012|NCT02832037|4024532|FG001|Overall Study|Withdrawal by Subject|8
2315013|NCT02832037|4024533|FG002|Overall Study|Withdrawal by Subject|0
2315014|NCT02832037|4024534|FG003|Overall Study|Withdrawal by Subject|4
2315015|NCT02832037|4024535|FG004|Overall Study|Withdrawal by Subject|8
2315016|NCT02832037|4024531|FG000|Overall Study|Adverse Event|5
2315017|NCT02832037|4024532|FG001|Overall Study|Adverse Event|4
2358776|NCT02040584|4119314|FG000|Overall Study|Adverse Event|13
2358777|NCT02040584|4119315|FG001|Overall Study|Adverse Event|6
2358778|NCT02040584|4119314|FG000|Overall Study|Protocol Violation|9
2358779|NCT02040584|4119315|FG001|Overall Study|Protocol Violation|11
2358780|NCT02040584|4119314|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2358781|NCT02040584|4119315|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2315018|NCT02832037|4024533|FG002|Overall Study|Adverse Event|0
2315019|NCT02832037|4024534|FG003|Overall Study|Adverse Event|2
2315020|NCT02832037|4024535|FG004|Overall Study|Adverse Event|4
2315021|NCT02832167|4024560|FG000|Treatment Period 1|Disease progression|92
2315022|NCT02832167|4024560|FG000|Treatment Period 1|Adverse event unrelated to study drug|11
2315023|NCT02832167|4024560|FG000|Treatment Period 1|Death|1
2315024|NCT02832167|4024560|FG000|Treatment Period 1|Study Drug Toxicity|6
2315025|NCT02832167|4024560|FG000|Treatment Period 1|Participant request to discontinue|9
2315026|NCT02832167|4024560|FG000|Treatment Period 1|No longer meet study criteria|1
2315027|NCT02832167|4024560|FG000|Treatment Period 1|Participant withdrew consent|3
2315028|NCT02832167|4024560|FG000|Treatment Period 1|Other reasons|6
2315029|NCT02832167|4024560|FG000|Transition From Period 1 to Period 2|Other reasons|1
2315030|NCT02832167|4024560|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1
2322070|NCT02967562|4036837|FG000|Overall Study|Consent not obtained|1
2358782|NCT02040584|4119314|FG000|Overall Study|Death|6
2358783|NCT02040584|4119315|FG001|Overall Study|Death|3
2358784|NCT02040584|4119314|FG000|Overall Study|Transplant rejection/retransplant|0
2358785|NCT02040584|4119315|FG001|Overall Study|Transplant rejection/retransplant|1
2358786|NCT02040584|4119314|FG000|Overall Study|Immunosuppressant/prohibited med use|7
2315031|NCT02832167|4024560|FG000|Transition From Period 1 to Period 2|Death|2
2315032|NCT02832167|4024560|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3
2315033|NCT02832167|4024560|FG000|Treatment Period 2|Disease progression|68
2315034|NCT02832167|4024560|FG000|Treatment Period 2|Adverse event unrelated to study drug|1
2315035|NCT02832167|4024560|FG000|Treatment Period 2|Maximum clinical benefit|1
2315036|NCT02832167|4024560|FG000|Treatment Period 2|Study Drug Toxicity|5
2315037|NCT02832167|4024560|FG000|Treatment Period 2|Participant request to discontinue|2
2315038|NCT02832167|4024560|FG000|Treatment Period 2|Participant withdrew consent|3
2315039|NCT02832167|4024560|FG000|Treatment Period 2|Other reasons|3
2315040|NCT02832375|4024570|FG000|Overall Study|Lost to Follow-up|1
2315041|NCT02832375|4024571|FG001|Overall Study|Lost to Follow-up|0
2315042|NCT02832375|4024570|FG000|Overall Study|Withdrawal of Consent|1
2315043|NCT02832375|4024571|FG001|Overall Study|Withdrawal of Consent|0
2315044|NCT02832622|4024578|FG000|Overall Study|MPP not programmed|1259
2315045|NCT02832622|4024578|FG000|Overall Study|Withdrawal by Subject|123
2315046|NCT02832622|4024578|FG000|Overall Study|Death|119
2315047|NCT02832622|4024578|FG000|Overall Study|Unsuccessful CRT implant|93
2315048|NCT02832622|4024578|FG000|Overall Study|Lost to Follow-up|45
2315049|NCT02832622|4024578|FG000|Overall Study|Patient non-compliance|42
2315050|NCT02832622|4024578|FG000|Overall Study|Withdrawal by other reasons|25
2315051|NCT02832622|4024578|FG000|Overall Study|System explant|24
2315052|NCT02832622|4024578|FG000|Overall Study|Physician Decision|6
2315053|NCT02833077|4024589|FG000|Overall Study|Adverse Event|1
2315054|NCT02833077|4024590|FG001|Overall Study|Adverse Event|2
2315055|NCT02833077|4024589|FG000|Overall Study|Lost to Follow-up|10
2315056|NCT02833077|4024590|FG001|Overall Study|Lost to Follow-up|1
2315057|NCT02833077|4024589|FG000|Overall Study|Personal Reasons|6
2315058|NCT02833077|4024590|FG001|Overall Study|Personal Reasons|4
2315059|NCT02833077|4024589|FG000|Overall Study|Protocol Deviation|0
2315060|NCT02833077|4024590|FG001|Overall Study|Protocol Deviation|1
2315061|NCT02833350|4024608|FG000|Overall Study|Adverse Event|0
2315062|NCT02833350|4024609|FG001|Overall Study|Adverse Event|3
2315063|NCT02833350|4024610|FG002|Overall Study|Adverse Event|4
2315064|NCT02833350|4024611|FG003|Overall Study|Adverse Event|4
2315065|NCT02833350|4024612|FG004|Overall Study|Adverse Event|1
2315066|NCT02833350|4024613|FG005|Overall Study|Adverse Event|0
2315067|NCT02833350|4024614|FG006|Overall Study|Adverse Event|1
2315068|NCT02833350|4024608|FG000|Overall Study|Death|0
2315069|NCT02833350|4024609|FG001|Overall Study|Death|0
2315070|NCT02833350|4024610|FG002|Overall Study|Death|1
2315071|NCT02833350|4024611|FG003|Overall Study|Death|0
2315072|NCT02833350|4024612|FG004|Overall Study|Death|0
2315073|NCT02833350|4024613|FG005|Overall Study|Death|0
2315074|NCT02833350|4024614|FG006|Overall Study|Death|0
2315075|NCT02833350|4024608|FG000|Overall Study|Lack of Efficacy|0
2315076|NCT02833350|4024609|FG001|Overall Study|Lack of Efficacy|2
2315077|NCT02833350|4024610|FG002|Overall Study|Lack of Efficacy|1
2315078|NCT02833350|4024611|FG003|Overall Study|Lack of Efficacy|4
2315079|NCT02833350|4024612|FG004|Overall Study|Lack of Efficacy|0
2315080|NCT02833350|4024613|FG005|Overall Study|Lack of Efficacy|1
2315081|NCT02833350|4024614|FG006|Overall Study|Lack of Efficacy|1
2315082|NCT02833350|4024608|FG000|Overall Study|Lost to Follow-up|0
2315083|NCT02833350|4024609|FG001|Overall Study|Lost to Follow-up|1
2315084|NCT02833350|4024610|FG002|Overall Study|Lost to Follow-up|0
2315085|NCT02833350|4024611|FG003|Overall Study|Lost to Follow-up|0
2315086|NCT02833350|4024612|FG004|Overall Study|Lost to Follow-up|0
2315087|NCT02833350|4024613|FG005|Overall Study|Lost to Follow-up|0
2315088|NCT02833350|4024614|FG006|Overall Study|Lost to Follow-up|1
2315089|NCT02833350|4024608|FG000|Overall Study|Withdrawal by Subject|3
2315090|NCT02833350|4024609|FG001|Overall Study|Withdrawal by Subject|3
2315091|NCT02833350|4024610|FG002|Overall Study|Withdrawal by Subject|2
2315092|NCT02833350|4024611|FG003|Overall Study|Withdrawal by Subject|0
2315093|NCT02833350|4024612|FG004|Overall Study|Withdrawal by Subject|2
2315094|NCT02833350|4024613|FG005|Overall Study|Withdrawal by Subject|0
2315095|NCT02833350|4024614|FG006|Overall Study|Withdrawal by Subject|2
2315096|NCT02833844|4024644|FG000|Double-Blind Period|Withdrawal by Subject|2
2315097|NCT02833844|4024645|FG001|Double-Blind Period|Withdrawal by Subject|3
2315098|NCT02833844|4024644|FG000|Double-Blind Period|Protocol Violation|0
2315099|NCT02833844|4024645|FG001|Double-Blind Period|Protocol Violation|4
2315100|NCT02833844|4024644|FG000|Open-Label Period|Death|0
2315101|NCT02833844|4024645|FG001|Open-Label Period|Death|2
2315102|NCT02833844|4024644|FG000|Open-Label Period|Lost to Follow-up|1
2315103|NCT02833844|4024645|FG001|Open-Label Period|Lost to Follow-up|0
2315104|NCT02833844|4024644|FG000|Open-Label Period|Withdrawal by Subject|1
2315105|NCT02833844|4024645|FG001|Open-Label Period|Withdrawal by Subject|0
2315106|NCT02833948|4024663|FG000|Overall Study|Death|2
2315107|NCT02833948|4024664|FG001|Overall Study|Death|3
2315108|NCT02833948|4024663|FG000|Overall Study|were not scanned|8
2315109|NCT02833948|4024664|FG001|Overall Study|were not scanned|13
2315110|NCT02833948|4024663|FG000|Overall Study|scans could not be evaluated|5
2315111|NCT02833948|4024664|FG001|Overall Study|scans could not be evaluated|2
2315112|NCT02833974|4024676|FG000|Overall Study|Lost to Follow-up|1
2315113|NCT02833974|4024677|FG001|Overall Study|Lost to Follow-up|0
2315114|NCT02833974|4024676|FG000|Overall Study|Adverse Event|0
2315115|NCT02833974|4024677|FG001|Overall Study|Adverse Event|3
2322071|NCT02967562|4036838|FG001|Overall Study|Consent not obtained|0
2315116|NCT02834247|4024687|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1
2315117|NCT02834247|4024688|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2
2315118|NCT02834247|4024689|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0
2315119|NCT02834247|4024690|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0
2315120|NCT02834247|4024687|FG000|Dose Escalation Phase|Death|5
2315121|NCT02834247|4024688|FG001|Dose Escalation Phase|Death|6
2315122|NCT02834247|4024689|FG002|Dose Escalation Phase|Death|5
2315123|NCT02834247|4024690|FG003|Dose Escalation Phase|Death|0
2315124|NCT02834247|4024687|FG000|Dose Escalation Phase|Lost to Follow-up|0
2315125|NCT02834247|4024688|FG001|Dose Escalation Phase|Lost to Follow-up|1
2315126|NCT02834247|4024689|FG002|Dose Escalation Phase|Lost to Follow-up|0
2315127|NCT02834247|4024690|FG003|Dose Escalation Phase|Lost to Follow-up|0
2315128|NCT02834247|4024687|FG000|Dose Escalation Phase|Withdrawal by Subject|2
2315129|NCT02834247|4024688|FG001|Dose Escalation Phase|Withdrawal by Subject|2
2315130|NCT02834247|4024689|FG002|Dose Escalation Phase|Withdrawal by Subject|0
2315131|NCT02834247|4024690|FG003|Dose Escalation Phase|Withdrawal by Subject|0
2315132|NCT02834247|4024687|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0
2315133|NCT02834247|4024688|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0
2315134|NCT02834247|4024689|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0
2315135|NCT02834247|4024690|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7
2315136|NCT02834247|4024687|FG000|Dose Expansion Phase|Death|0
2315137|NCT02834247|4024688|FG001|Dose Expansion Phase|Death|0
2315138|NCT02834247|4024689|FG002|Dose Expansion Phase|Death|0
2315139|NCT02834247|4024690|FG003|Dose Expansion Phase|Death|8
2315140|NCT02834247|4024687|FG000|Dose Expansion Phase|Lost to Follow-up|0
2315141|NCT02834247|4024688|FG001|Dose Expansion Phase|Lost to Follow-up|0
2315142|NCT02834247|4024689|FG002|Dose Expansion Phase|Lost to Follow-up|0
2315143|NCT02834247|4024690|FG003|Dose Expansion Phase|Lost to Follow-up|1
2315144|NCT02834247|4024687|FG000|Dose Expansion Phase|Withdrawal by Subject|0
2315145|NCT02834247|4024688|FG001|Dose Expansion Phase|Withdrawal by Subject|0
2315146|NCT02834247|4024689|FG002|Dose Expansion Phase|Withdrawal by Subject|0
2315147|NCT02834247|4024690|FG003|Dose Expansion Phase|Withdrawal by Subject|1
2315148|NCT02834390|4024704|FG000|Induction Phase|Progressive disease|0
2315149|NCT02834390|4024705|FG001|Induction Phase|Progressive disease|1
2315150|NCT02834390|4024704|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2
2315151|NCT02834390|4024705|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0
2315152|NCT02834390|4024704|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0
2315153|NCT02834390|4024705|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1
2315154|NCT02834390|4024704|FG000|Consolidation Phase|Physician Decision|1
2315155|NCT02834390|4024705|FG001|Consolidation Phase|Physician Decision|1
2315156|NCT02834819|4024745|FG000|Overall Study|Did not complete 7 day follow up call.|5
2315157|NCT02834819|4024746|FG001|Overall Study|Did not complete 7 day follow up call.|0
2315158|NCT02835092|4024755|FG000|Overall Study|Withdrawal by Subject|3
2315159|NCT02835092|4024756|FG001|Overall Study|Withdrawal by Subject|6
2315160|NCT02835092|4024757|FG002|Overall Study|Withdrawal by Subject|3
2315161|NCT02835092|4024755|FG000|Overall Study|Lost to Follow-up|0
2315162|NCT02835092|4024756|FG001|Overall Study|Lost to Follow-up|2
2315163|NCT02835092|4024757|FG002|Overall Study|Lost to Follow-up|0
2315164|NCT02835339|4024776|FG000|Overall Study|Did not receive allocated intervention|13
2315165|NCT02835339|4024777|FG001|Overall Study|Did not receive allocated intervention|16
2315166|NCT02835495|4024785|FG000|Overall Study|Cancer diagnosis prior intervention|1
2315167|NCT02835495|4024786|FG001|Overall Study|Cancer diagnosis prior intervention|0
2315168|NCT02835495|4024785|FG000|Overall Study|Declined in-person follow-up visit|4
2315169|NCT02835495|4024786|FG001|Overall Study|Declined in-person follow-up visit|2
2315170|NCT02835820|4024810|FG000|Overall Study|Baseline Screen Failure|0
2315171|NCT02835820|4024811|FG001|Overall Study|Baseline Screen Failure|3
2315172|NCT02836249|4024823|FG000|Overall Study|Randomized but Never Treated|0
2315173|NCT02836249|4024824|FG001|Overall Study|Randomized but Never Treated|1
2315174|NCT02836249|4024823|FG000|Overall Study|Pregnancy|2
2315175|NCT02836249|4024824|FG001|Overall Study|Pregnancy|0
2315176|NCT02836249|4024823|FG000|Overall Study|Withdrew Consent|0
2315177|NCT02836249|4024824|FG001|Overall Study|Withdrew Consent|1
2315178|NCT02836249|4024823|FG000|Overall Study|Lost to Follow-up|0
2315179|NCT02836249|4024824|FG001|Overall Study|Lost to Follow-up|1
2315180|NCT02836249|4024823|FG000|Overall Study|Still on Study|121
2315181|NCT02836249|4024824|FG001|Overall Study|Still on Study|55
2315182|NCT02836496|4024832|FG000|Overall Study|Adverse Event|2
2315183|NCT02836496|4024833|FG001|Overall Study|Adverse Event|1
2315184|NCT02836496|4024832|FG000|Overall Study|Withdrawal by Subject|0
2315185|NCT02836496|4024833|FG001|Overall Study|Withdrawal by Subject|1
2315186|NCT02836613|4024841|FG000|Overall Study|Accidental drowning|1
2315187|NCT02836613|4024842|FG001|Overall Study|Accidental drowning|0
2315188|NCT02836613|4024841|FG000|Overall Study|Lost to Follow-up|0
2315189|NCT02836613|4024842|FG001|Overall Study|Lost to Follow-up|1
2315190|NCT02836613|4024841|FG000|Overall Study|Withdrawal by Subject|0
2315191|NCT02836613|4024842|FG001|Overall Study|Withdrawal by Subject|2
2315192|NCT02836652|4024850|FG000|Overall Study|Death|3
2315193|NCT02836652|4024851|FG001|Overall Study|Death|3
2315194|NCT02836652|4024850|FG000|Overall Study|Transplant/Explant|3
2315195|NCT02836652|4024851|FG001|Overall Study|Transplant/Explant|4
2315196|NCT02836652|4024850|FG000|Overall Study|Withdrawn|9
2315197|NCT02836652|4024851|FG001|Overall Study|Withdrawn|9
2315198|NCT02836652|4024850|FG000|Overall Study|Not on treatment regimen post-op day 15|3
2315199|NCT02836652|4024851|FG001|Overall Study|Not on treatment regimen post-op day 15|3
2315200|NCT02836769|4024857|FG000|Overall Study|Lost to Follow-up|10
2315201|NCT02836769|4024857|FG000|Overall Study|Medical withdrawal|2
2315202|NCT02836769|4024857|FG000|Overall Study|Withdrawal by Subject|3
2315203|NCT02836873|4024863|FG000|Overall Study|Protocol Violation|0
2315204|NCT02836873|4024864|FG001|Overall Study|Protocol Violation|1
2315205|NCT02836873|4024863|FG000|Overall Study|Adverse Event|1
2315206|NCT02836873|4024864|FG001|Overall Study|Adverse Event|4
2315207|NCT02836873|4024863|FG000|Overall Study|Withdrawal by Subject|2
2315208|NCT02836873|4024864|FG001|Overall Study|Withdrawal by Subject|2
2315209|NCT02836873|4024863|FG000|Overall Study|Lost to Follow-up|1
2177511|NCT01374906|3801702|FG001|Overall Study|Unsatisfactory therapeutic effect|19
2177512|NCT01374919|3801712|FG000|Overall Study|Withdrawal by Subject|2
2315210|NCT02836873|4024864|FG001|Overall Study|Lost to Follow-up|3
2315211|NCT02836873|4024863|FG000|Overall Study|Physician Decision|0
2315212|NCT02836873|4024864|FG001|Overall Study|Physician Decision|1
2315213|NCT02836873|4024863|FG000|Overall Study|Other|1
2315214|NCT02836873|4024864|FG001|Overall Study|Other|0
2315215|NCT02837731|4024896|FG000|Allocation|Admitted to General Floor|3
2315216|NCT02837731|4024897|FG001|Allocation|Admitted to General Floor|4
2315217|NCT02837731|4024896|FG000|Allocation|Immediate surgery/withdrew|2
2315218|NCT02837731|4024897|FG001|Allocation|Immediate surgery/withdrew|0
2315219|NCT02837731|4024896|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1
2315220|NCT02837731|4024897|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0
2315221|NCT02837731|4024896|FG000|Allocation|Withdrawal by Subject|2
2315222|NCT02837731|4024897|FG001|Allocation|Withdrawal by Subject|0
2315223|NCT02837731|4024896|FG000|Allocation|Device not available|1
2315224|NCT02837731|4024897|FG001|Allocation|Device not available|0
2315225|NCT02837731|4024896|FG000|Allocation|Protocol not implemented|7
2315226|NCT02837731|4024897|FG001|Allocation|Protocol not implemented|0
2315227|NCT02837731|4024896|FG000|Allocation|Moribund/Do not resuscitate|2
2315228|NCT02837731|4024897|FG001|Allocation|Moribund/Do not resuscitate|0
2315229|NCT02837731|4024896|FG000|Allocation|Did not meet sepsis criteria|1
2315230|NCT02837731|4024897|FG001|Allocation|Did not meet sepsis criteria|2
2315231|NCT02837731|4024896|FG000|Allocation|Known aortic abnormalities|0
2315232|NCT02837731|4024897|FG001|Allocation|Known aortic abnormalities|1
2315233|NCT02837952|4024918|FG000|Overall Study|Adverse Event|0
2315234|NCT02837952|4024919|FG001|Overall Study|Adverse Event|1
2315235|NCT02837952|4024918|FG000|Overall Study|Withdrawal by Subject|4
2315236|NCT02837952|4024919|FG001|Overall Study|Withdrawal by Subject|5
2315237|NCT02837952|4024918|FG000|Overall Study|Medication Error|1
2315238|NCT02837952|4024919|FG001|Overall Study|Medication Error|0
2315239|NCT02838017|4024927|FG000|Overall Study|Lost to Follow-up|14
2315240|NCT02838017|4024928|FG001|Overall Study|Lost to Follow-up|11
2315241|NCT02838134|4024936|FG000|Overall Study|Lost to Follow-up|1
2315242|NCT02838134|4024937|FG001|Overall Study|Lost to Follow-up|2
2315243|NCT02838134|4024936|FG000|Overall Study|logistic problems|1
2315244|NCT02838134|4024937|FG001|Overall Study|logistic problems|1
2315245|NCT02838420|4024949|FG000|Overall Study|Ongoing in Study|113
2315246|NCT02838420|4024950|FG001|Overall Study|Ongoing in Study|45
2315247|NCT02838420|4024949|FG000|Overall Study|Lost to Follow-up|1
2315248|NCT02838420|4024950|FG001|Overall Study|Lost to Follow-up|0
2315249|NCT02838420|4024949|FG000|Overall Study|Withdrawal by Subject|3
2315250|NCT02838420|4024950|FG001|Overall Study|Withdrawal by Subject|4
2315251|NCT02838420|4024949|FG000|Overall Study|Death|8
2315252|NCT02838420|4024950|FG001|Overall Study|Death|13
2315253|NCT02838628|4024958|FG000|Recurrence Follow-up Period|AK Recurrence|18
2315254|NCT02838628|4024959|FG001|Recurrence Follow-up Period|AK Recurrence|13
2315255|NCT02838628|4024958|FG000|Recurrence Follow-up Period|Adverse Event|1
2315256|NCT02838628|4024959|FG001|Recurrence Follow-up Period|Adverse Event|0
2315257|NCT02838628|4024958|FG000|Recurrence Follow-up Period|Non-compliance|0
2315258|NCT02838628|4024959|FG001|Recurrence Follow-up Period|Non-compliance|1
2315259|NCT02838628|4024958|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
2315260|NCT02838628|4024959|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2
2315261|NCT02838628|4024958|FG000|Recurrence Follow-up Period|Other un-specified|1
2315262|NCT02838628|4024959|FG001|Recurrence Follow-up Period|Other un-specified|1
2315263|NCT02838901|4024968|FG000|Overall Study|Withdrawal by Subject|1
2315264|NCT02838901|4024969|FG001|Overall Study|Withdrawal by Subject|1
2315265|NCT02838901|4024968|FG000|Overall Study|Lost to Follow-up|1
2177513|NCT01374971|3801716|FG000|Overall Study|Withdrawal by Subject|1
2177514|NCT01375010|3801722|FG000|Overall Study|Lost to Follow-up|8
2315266|NCT02838901|4024969|FG001|Overall Study|Lost to Follow-up|1
2315267|NCT02839200|4024983|FG000|Overall Study|Withdrawal by Subject|2
2315268|NCT02839200|4024984|FG001|Overall Study|Withdrawal by Subject|0
2315269|NCT02839200|4024985|FG002|Overall Study|Withdrawal by Subject|1
2315270|NCT02839200|4024986|FG003|Overall Study|Withdrawal by Subject|0
2177515|NCT01375010|3801723|FG001|Overall Study|Lost to Follow-up|2
2315271|NCT02839200|4024987|FG004|Overall Study|Withdrawal by Subject|0
2315272|NCT02839200|4024988|FG005|Overall Study|Withdrawal by Subject|1
2315273|NCT02839200|4024983|FG000|Overall Study|Lost to Follow-up|2
2315274|NCT02839200|4024984|FG001|Overall Study|Lost to Follow-up|0
2315275|NCT02839200|4024985|FG002|Overall Study|Lost to Follow-up|0
2315276|NCT02839200|4024986|FG003|Overall Study|Lost to Follow-up|0
2315277|NCT02839200|4024987|FG004|Overall Study|Lost to Follow-up|1
2315278|NCT02839200|4024988|FG005|Overall Study|Lost to Follow-up|0
2315279|NCT02839200|4024983|FG000|Overall Study|Adverse Event|0
2315280|NCT02839200|4024984|FG001|Overall Study|Adverse Event|0
2315281|NCT02839200|4024985|FG002|Overall Study|Adverse Event|0
2315282|NCT02839200|4024986|FG003|Overall Study|Adverse Event|0
2315283|NCT02839200|4024987|FG004|Overall Study|Adverse Event|1
2315284|NCT02839200|4024988|FG005|Overall Study|Adverse Event|0
2315285|NCT02839200|4024983|FG000|Overall Study|Randomized in error|0
2315286|NCT02839200|4024984|FG001|Overall Study|Randomized in error|1
2315287|NCT02839200|4024985|FG002|Overall Study|Randomized in error|0
2315288|NCT02839200|4024986|FG003|Overall Study|Randomized in error|0
2315289|NCT02839200|4024987|FG004|Overall Study|Randomized in error|0
2315290|NCT02839200|4024988|FG005|Overall Study|Randomized in error|0
2315291|NCT02839330|4025006|FG000|Overall Study|Adverse Event|0
2315292|NCT02839330|4025007|FG001|Overall Study|Adverse Event|1
2315293|NCT02839330|4025008|FG002|Overall Study|Adverse Event|2
2315294|NCT02839330|4025009|FG003|Overall Study|Adverse Event|2
2315295|NCT02839330|4025006|FG000|Overall Study|Death|4
2315296|NCT02839330|4025007|FG001|Overall Study|Death|6
2315297|NCT02839330|4025008|FG002|Overall Study|Death|1
2315298|NCT02839330|4025009|FG003|Overall Study|Death|1
2315299|NCT02839330|4025006|FG000|Overall Study|Withdrawal by Subject|27
2315300|NCT02839330|4025007|FG001|Overall Study|Withdrawal by Subject|19
2315301|NCT02839330|4025008|FG002|Overall Study|Withdrawal by Subject|11
2315302|NCT02839330|4025009|FG003|Overall Study|Withdrawal by Subject|13
2315303|NCT02839330|4025006|FG000|Overall Study|Lost to Follow-up|22
2315304|NCT02839330|4025007|FG001|Overall Study|Lost to Follow-up|27
2315305|NCT02839330|4025008|FG002|Overall Study|Lost to Follow-up|29
2315306|NCT02839330|4025009|FG003|Overall Study|Lost to Follow-up|25
2315307|NCT02839330|4025006|FG000|Overall Study|Administrative Reason|0
2315308|NCT02839330|4025007|FG001|Overall Study|Administrative Reason|0
2315309|NCT02839330|4025008|FG002|Overall Study|Administrative Reason|0
2315310|NCT02839330|4025009|FG003|Overall Study|Administrative Reason|1
2315311|NCT02839330|4025006|FG000|Overall Study|Protocol Violation|1
2315312|NCT02839330|4025007|FG001|Overall Study|Protocol Violation|2
2315313|NCT02839330|4025008|FG002|Overall Study|Protocol Violation|2
2315314|NCT02839330|4025009|FG003|Overall Study|Protocol Violation|3
2315315|NCT02839330|4025006|FG000|Overall Study|Other reason, not specified|4
2315316|NCT02839330|4025007|FG001|Overall Study|Other reason, not specified|3
2315317|NCT02839330|4025008|FG002|Overall Study|Other reason, not specified|3
2315318|NCT02839330|4025009|FG003|Overall Study|Other reason, not specified|6
2315319|NCT02839681|4025020|FG000|Overall Study|Death|2
2315320|NCT02839746|4025024|FG000|Overall Study|Not met selection criteria|12
2315321|NCT02839798|4025051|FG000|Overall Study|Withdrawal by Subject|2
2315322|NCT02839876|4025057|FG000|Overall Study|Protocol Violation|10
2315323|NCT02839876|4025058|FG001|Overall Study|Protocol Violation|11
2315324|NCT02840253|4025098|FG000|Overall Study|Unsuccessful block|4
2315325|NCT02840461|4025105|FG000|Overall Study|Adverse Event|1
2315326|NCT02840461|4025106|FG001|Overall Study|Adverse Event|5
2315327|NCT02840461|4025107|FG002|Overall Study|Adverse Event|3
2315328|NCT02840461|4025105|FG000|Overall Study|Lost to Follow-up|10
2315329|NCT02840461|4025106|FG001|Overall Study|Lost to Follow-up|7
2315330|NCT02840461|4025107|FG002|Overall Study|Lost to Follow-up|6
2315331|NCT02840461|4025105|FG000|Overall Study|Non-Comliance with Dosing Requirements|0
2315332|NCT02840461|4025106|FG001|Overall Study|Non-Comliance with Dosing Requirements|1
2315333|NCT02840461|4025107|FG002|Overall Study|Non-Comliance with Dosing Requirements|0
2315334|NCT02840461|4025105|FG000|Overall Study|Protocol Violation|2
2315335|NCT02840461|4025106|FG001|Overall Study|Protocol Violation|3
2315336|NCT02840461|4025107|FG002|Overall Study|Protocol Violation|1
2315337|NCT02840461|4025105|FG000|Overall Study|Withdrawal by Subject|10
2315338|NCT02840461|4025106|FG001|Overall Study|Withdrawal by Subject|6
2315339|NCT02840461|4025107|FG002|Overall Study|Withdrawal by Subject|2
2315340|NCT02840461|4025105|FG000|Overall Study|Worsening of Symptom & Kit Error|0
2315341|NCT02840461|4025106|FG001|Overall Study|Worsening of Symptom & Kit Error|0
2315342|NCT02840461|4025107|FG002|Overall Study|Worsening of Symptom & Kit Error|2
2315343|NCT02840474|4025118|FG000|Overall Study|Lost to Follow-up|1
2315344|NCT02840474|4025119|FG001|Overall Study|Lost to Follow-up|0
2315345|NCT02840721|4025125|FG000|Treatment Period|Adverse Event|1
2315346|NCT02840721|4025125|FG000|Follow-Up|Lack of Efficacy|1
2315347|NCT02840721|4025125|FG000|Follow-Up|Withdrawal by Subject|4
2315348|NCT02840721|4025125|FG000|Follow-Up|Withdrawal of Consent|2
2315349|NCT02841709|4025193|FG000|5th Intervention|Adverse Event|2
2315350|NCT02841709|4025194|FG001|5th Intervention|Adverse Event|0
2315351|NCT02841709|4025195|FG002|5th Intervention|Adverse Event|0
2315352|NCT02841709|4025196|FG003|5th Intervention|Adverse Event|0
2315353|NCT02841709|4025197|FG004|5th Intervention|Adverse Event|2
2322072|NCT02967562|4036837|FG000|Overall Study|High leak precluding analysis|1
2322073|NCT02967562|4036838|FG001|Overall Study|High leak precluding analysis|1
2322074|NCT02967679|4036844|FG000|Overall Study|Adverse Event|1
2322075|NCT02968004|4036861|FG000|Overall Study|Adverse Event|1
2322076|NCT02968004|4036862|FG001|Overall Study|Adverse Event|0
2322077|NCT02968004|4036861|FG000|Overall Study|Withdrawal by Subject|0
2322078|NCT02968004|4036862|FG001|Overall Study|Withdrawal by Subject|1
2315354|NCT02841787|4025213|FG000|Overall Study|Lost to Follow-up|1
2315355|NCT02841787|4025214|FG001|Overall Study|Lost to Follow-up|0
2315356|NCT02841787|4025215|FG002|Overall Study|Lost to Follow-up|0
2315357|NCT02841787|4025213|FG000|Overall Study|Symptoms dropped below threshold|1
2315358|NCT02841787|4025214|FG001|Overall Study|Symptoms dropped below threshold|0
2315359|NCT02841787|4025215|FG002|Overall Study|Symptoms dropped below threshold|0
2315360|NCT02841787|4025213|FG000|Overall Study|Withdrawal by Subject|1
2315361|NCT02841787|4025214|FG001|Overall Study|Withdrawal by Subject|4
2315362|NCT02841787|4025215|FG002|Overall Study|Withdrawal by Subject|0
2315363|NCT02842073|4025232|FG000|Overall Study|Withdrawal by Subject|1
2315364|NCT02842086|4025238|FG000|Overall Study|Randomized but Never Treated|6
2315365|NCT02842086|4025239|FG001|Overall Study|Randomized but Never Treated|6
2315366|NCT02842086|4025238|FG000|Overall Study|Still in Double-Blind Phase|7
2315367|NCT02842086|4025239|FG001|Overall Study|Still in Double-Blind Phase|3
2315368|NCT02842086|4025238|FG000|Overall Study|Adverse Event|18
2315369|NCT02842086|4025239|FG001|Overall Study|Adverse Event|20
2315370|NCT02842086|4025238|FG000|Overall Study|Death|3
2315371|NCT02842086|4025239|FG001|Overall Study|Death|3
2315372|NCT02842086|4025238|FG000|Overall Study|Investigator's Discretion|9
2315373|NCT02842086|4025239|FG001|Overall Study|Investigator's Discretion|13
2315374|NCT02842086|4025238|FG000|Overall Study|Non-Compliance with Study Drug|9
2315375|NCT02842086|4025239|FG001|Overall Study|Non-Compliance with Study Drug|8
2315376|NCT02842086|4025238|FG000|Overall Study|Protocol Violation|8
2315377|NCT02842086|4025239|FG001|Overall Study|Protocol Violation|4
2315378|NCT02842086|4025238|FG000|Overall Study|Withdrew Consent|205
2315379|NCT02842086|4025239|FG001|Overall Study|Withdrew Consent|194
2315380|NCT02842086|4025238|FG000|Overall Study|Lost to Follow-up|274
2315381|NCT02842086|4025239|FG001|Overall Study|Lost to Follow-up|236
2315382|NCT02842086|4025238|FG000|Overall Study|HIV-1 Infection|5
2315383|NCT02842086|4025239|FG001|Overall Study|HIV-1 Infection|6
2315384|NCT02842151|4025245|FG000|Overall Study|Adverse Event|1
2315385|NCT02842151|4025245|FG000|Overall Study|Subject moved too far away|1
2315386|NCT02842736|4025260|FG000|Overall Study|Lost to Follow-up|13
2315387|NCT02842736|4025260|FG000|Overall Study|Intervention for menstrual bleeding|17
2315388|NCT02842736|4025260|FG000|Overall Study|Withdrawal by Subject|4
2315389|NCT02842736|4025260|FG000|Overall Study|Pregnancy|3
2315390|NCT02842736|4025260|FG000|Overall Study|Hysterectomy for fibroids|2
2315391|NCT02842736|4025260|FG000|Overall Study|Hysterectomy for uterine prolapse|1
2315392|NCT02842736|4025260|FG000|Overall Study|IUD: Mirena|1
2315393|NCT02842853|4025268|FG000|Overall Study|Non-compliance with the protocol|3
2315394|NCT02842853|4025269|FG001|Overall Study|Non-compliance with the protocol|7
2315395|NCT02842853|4025270|FG002|Overall Study|Non-compliance with the protocol|2
2315396|NCT02842853|4025271|FG003|Overall Study|Non-compliance with the protocol|5
2315397|NCT02842853|4025268|FG000|Overall Study|Subject met exclusion criteria|0
2315398|NCT02842853|4025269|FG001|Overall Study|Subject met exclusion criteria|1
2315399|NCT02842853|4025270|FG002|Overall Study|Subject met exclusion criteria|0
2315400|NCT02842853|4025271|FG003|Overall Study|Subject met exclusion criteria|0
2315401|NCT02842853|4025268|FG000|Overall Study|Withdrawal by Subject|11
2315402|NCT02842853|4025269|FG001|Overall Study|Withdrawal by Subject|13
2315403|NCT02842853|4025270|FG002|Overall Study|Withdrawal by Subject|9
2315404|NCT02842853|4025271|FG003|Overall Study|Withdrawal by Subject|8
2315405|NCT02842853|4025268|FG000|Overall Study|Lost to Follow-up|9
2315406|NCT02842853|4025269|FG001|Overall Study|Lost to Follow-up|13
2315407|NCT02842853|4025270|FG002|Overall Study|Lost to Follow-up|10
2315408|NCT02842853|4025271|FG003|Overall Study|Lost to Follow-up|11
2315409|NCT02842866|4025285|FG000|Overall Study|Serious Adverse Event|0
2315410|NCT02842866|4025286|FG001|Overall Study|Serious Adverse Event|1
2315411|NCT02842866|4025285|FG000|Overall Study|Protocol Violation|4
2315412|NCT02842866|4025286|FG001|Overall Study|Protocol Violation|2
2315413|NCT02842866|4025285|FG000|Overall Study|Lost to Follow-up|2
2315414|NCT02842866|4025286|FG001|Overall Study|Lost to Follow-up|0
2315415|NCT02842866|4025285|FG000|Overall Study|Withdrawal by Subject|1
2315416|NCT02842866|4025286|FG001|Overall Study|Withdrawal by Subject|0
2315417|NCT02843178|4025296|FG000|Overall Study|Lost to Follow-up|8
2315418|NCT02843178|4025297|FG001|Overall Study|Lost to Follow-up|8
2315419|NCT02843178|4025298|FG002|Overall Study|Lost to Follow-up|6
2315420|NCT02843178|4025299|FG003|Overall Study|Lost to Follow-up|3
2315421|NCT02843178|4025296|FG000|Overall Study|Withdrawal by Subject|0
2315422|NCT02843178|4025297|FG001|Overall Study|Withdrawal by Subject|0
2315423|NCT02843178|4025298|FG002|Overall Study|Withdrawal by Subject|1
2315424|NCT02843178|4025299|FG003|Overall Study|Withdrawal by Subject|1
2315425|NCT02843659|4025321|FG000|Overall Study|Subject Withdrew Consent|0
2315426|NCT02843659|4025322|FG001|Overall Study|Subject Withdrew Consent|0
2315427|NCT02843659|4025323|FG002|Overall Study|Subject Withdrew Consent|1
2315428|NCT02843659|4025321|FG000|Overall Study|Administrative Reason by Sponsor|4
2315429|NCT02843659|4025322|FG001|Overall Study|Administrative Reason by Sponsor|5
2315430|NCT02843659|4025323|FG002|Overall Study|Administrative Reason by Sponsor|4
2315431|NCT02843659|4025321|FG000|Overall Study|Adverse Event|0
2315432|NCT02843659|4025322|FG001|Overall Study|Adverse Event|1
2315433|NCT02843659|4025323|FG002|Overall Study|Adverse Event|0
2315434|NCT02844439|4025331|FG000|Overall Study|Withdrawal by Subject|1
2315435|NCT02844439|4025331|FG000|Overall Study|Lost to Follow-up|2
2315436|NCT02844439|4025331|FG000|Overall Study|Termination by Sponsor|4
2315437|NCT02844439|4025331|FG000|Overall Study|Death|28
2315438|NCT02844439|4025331|FG000|Overall Study|Other|5
2315439|NCT02844543|4025342|FG000|Overall Study|Withdrawal by Subject|4
2315440|NCT02844543|4025342|FG000|Overall Study|Did not meet eligibility criteria|1
2315441|NCT02844920|4025359|FG000|Overall Study|Lost to Follow-up|2
2315442|NCT02845336|4025378|FG000|Overall Study|Lost to Follow-up|3
2315443|NCT02845336|4025379|FG001|Overall Study|Lost to Follow-up|1
2315444|NCT02845336|4025378|FG000|Overall Study|Inability to get medication|2
2315445|NCT02845336|4025379|FG001|Overall Study|Inability to get medication|0
2315446|NCT02845375|4025388|FG000|Overall Study|upper airway obstruction|1
2315447|NCT02845375|4025389|FG001|Overall Study|upper airway obstruction|2
2315448|NCT02845375|4025390|FG002|Overall Study|upper airway obstruction|1
2315449|NCT02846324|4025438|FG000|Overall Study|Other|1
2315450|NCT02846324|4025439|FG001|Overall Study|Other|0
2315451|NCT02846324|4025440|FG002|Overall Study|Other|0
2315452|NCT02846324|4025441|FG003|Overall Study|Other|0
2315453|NCT02846324|4025438|FG000|Overall Study|Withdrawal by Subject|1
2315454|NCT02846324|4025439|FG001|Overall Study|Withdrawal by Subject|0
2315455|NCT02846324|4025440|FG002|Overall Study|Withdrawal by Subject|4
2315456|NCT02846324|4025441|FG003|Overall Study|Withdrawal by Subject|0
2315457|NCT02846415|4025462|FG000|Overall Study|Lost to Follow-up|2
2315458|NCT02846415|4025463|FG001|Overall Study|Lost to Follow-up|0
2315459|NCT02846415|4025462|FG000|Overall Study|Withdrawal by Subject|1
2315460|NCT02846415|4025463|FG001|Overall Study|Withdrawal by Subject|1
2315461|NCT02846558|4025473|FG000|Overall Study|Adverse Event|1
2315462|NCT02846558|4025474|FG001|Overall Study|Adverse Event|0
2315463|NCT02846558|4025475|FG002|Overall Study|Adverse Event|0
2315464|NCT02846558|4025476|FG003|Overall Study|Adverse Event|0
2315465|NCT02846558|4025473|FG000|Overall Study|Withdrawal by Subject|5
2315466|NCT02846558|4025474|FG001|Overall Study|Withdrawal by Subject|4
2315467|NCT02846558|4025475|FG002|Overall Study|Withdrawal by Subject|2
2315468|NCT02846558|4025476|FG003|Overall Study|Withdrawal by Subject|2
2315469|NCT02846558|4025473|FG000|Overall Study|Lost to Follow-up|2
2358787|NCT02040584|4119315|FG001|Overall Study|Immunosuppressant/prohibited med use|10
2315470|NCT02846558|4025474|FG001|Overall Study|Lost to Follow-up|0
2315471|NCT02846558|4025475|FG002|Overall Study|Lost to Follow-up|0
2315472|NCT02846558|4025476|FG003|Overall Study|Lost to Follow-up|0
2315473|NCT02846779|4025509|FG000|Overall Study|Lost Enrollment|83
2315474|NCT02846779|4025510|FG001|Overall Study|Lost Enrollment|82
2315475|NCT02846779|4025511|FG002|Overall Study|Lost Enrollment|86
2315476|NCT02846779|4025509|FG000|Overall Study|Less than 31 days of follow-up|56
2315477|NCT02846779|4025510|FG001|Overall Study|Less than 31 days of follow-up|45
2315478|NCT02846779|4025511|FG002|Overall Study|Less than 31 days of follow-up|52
2315479|NCT02847182|4025547|FG000|Overall Study|Withdrawal by Subject|0
2315480|NCT02847182|4025548|FG001|Overall Study|Withdrawal by Subject|1
2315481|NCT02847260|4025560|FG000|Overall Study|Adverse Event|3
2315482|NCT02847260|4025560|FG000|Overall Study|Withdrawal by Subject|2
2315483|NCT02847260|4025560|FG000|Overall Study|Clinical Deterioration|1
2315484|NCT02847260|4025560|FG000|Overall Study|Physician Decision|1
2315485|NCT02847494|4025566|FG000|Overall Study|Lost to Follow-up|8
2315486|NCT02847494|4025567|FG001|Overall Study|Lost to Follow-up|5
2315487|NCT02847650|4025575|FG000|Overall Study|Adverse Event|2
2315488|NCT02847650|4025576|FG001|Overall Study|Adverse Event|4
2315489|NCT02847650|4025575|FG000|Overall Study|Lost to Follow-up|1
2315490|NCT02847650|4025576|FG001|Overall Study|Lost to Follow-up|0
2315491|NCT02847650|4025575|FG000|Overall Study|Protocol Violation|0
2315492|NCT02847650|4025576|FG001|Overall Study|Protocol Violation|1
2315493|NCT02847650|4025575|FG000|Overall Study|Withdrawal by Subject|1
2315494|NCT02847650|4025576|FG001|Overall Study|Withdrawal by Subject|1
2315495|NCT02847858|4025584|FG000|Overall Study|Lost to Follow-up|401
2315496|NCT02847858|4025585|FG001|Overall Study|Lost to Follow-up|269
2315497|NCT02848313|4025615|FG000|Overall Study|Adverse Event|1
2315498|NCT02848313|4025616|FG001|Overall Study|Adverse Event|2
2315499|NCT02848313|4025615|FG000|Overall Study|Lack of Efficacy|0
2315500|NCT02848313|4025616|FG001|Overall Study|Lack of Efficacy|1
2315501|NCT02848313|4025615|FG000|Overall Study|Withdrawal by Subject|1
2315502|NCT02848313|4025616|FG001|Overall Study|Withdrawal by Subject|1
2315503|NCT02848313|4025615|FG000|Overall Study|Lost to follow up|1
2315504|NCT02848313|4025616|FG001|Overall Study|Lost to follow up|0
2315505|NCT02848326|4025628|FG000|Treatment Period|Adverse Event|5
2315506|NCT02848326|4025629|FG001|Treatment Period|Adverse Event|4
2315507|NCT02848326|4025630|FG002|Treatment Period|Adverse Event|11
2315508|NCT02848326|4025631|FG003|Treatment Period|Adverse Event|6
2214833|NCT01691248|3857489|FG000|Overall Study|Protocol Violation|43
2214834|NCT01691248|3857490|FG001|Overall Study|Protocol Violation|27
2214835|NCT01691248|3857489|FG000|Overall Study|Adverse Event|24
2315509|NCT02848326|4025632|FG004|Treatment Period|Adverse Event|5
2315510|NCT02848326|4025633|FG005|Treatment Period|Adverse Event|7
2315511|NCT02848326|4025628|FG000|Treatment Period|Withdrawal of Consent|20
2315512|NCT02848326|4025629|FG001|Treatment Period|Withdrawal of Consent|6
2315513|NCT02848326|4025630|FG002|Treatment Period|Withdrawal of Consent|9
2315514|NCT02848326|4025631|FG003|Treatment Period|Withdrawal of Consent|6
2315515|NCT02848326|4025632|FG004|Treatment Period|Withdrawal of Consent|9
2315516|NCT02848326|4025633|FG005|Treatment Period|Withdrawal of Consent|6
2315517|NCT02848326|4025628|FG000|Treatment Period|Lost to Follow-up|5
2315518|NCT02848326|4025629|FG001|Treatment Period|Lost to Follow-up|1
2315519|NCT02848326|4025630|FG002|Treatment Period|Lost to Follow-up|11
2315520|NCT02848326|4025631|FG003|Treatment Period|Lost to Follow-up|7
2315521|NCT02848326|4025632|FG004|Treatment Period|Lost to Follow-up|2
2315522|NCT02848326|4025633|FG005|Treatment Period|Lost to Follow-up|3
2315523|NCT02848326|4025628|FG000|Treatment Period|Pregnancy|0
2315524|NCT02848326|4025629|FG001|Treatment Period|Pregnancy|0
2315525|NCT02848326|4025630|FG002|Treatment Period|Pregnancy|1
2315526|NCT02848326|4025631|FG003|Treatment Period|Pregnancy|1
2315527|NCT02848326|4025632|FG004|Treatment Period|Pregnancy|0
2315528|NCT02848326|4025633|FG005|Treatment Period|Pregnancy|1
2315529|NCT02848326|4025628|FG000|Treatment Period|Protocol Violation|4
2315530|NCT02848326|4025629|FG001|Treatment Period|Protocol Violation|3
2315531|NCT02848326|4025630|FG002|Treatment Period|Protocol Violation|4
2315532|NCT02848326|4025631|FG003|Treatment Period|Protocol Violation|2
2315533|NCT02848326|4025632|FG004|Treatment Period|Protocol Violation|3
2315534|NCT02848326|4025633|FG005|Treatment Period|Protocol Violation|3
2315535|NCT02848326|4025628|FG000|Treatment Period|Non-compliance with Study Drug|4
2315536|NCT02848326|4025629|FG001|Treatment Period|Non-compliance with Study Drug|0
2315537|NCT02848326|4025630|FG002|Treatment Period|Non-compliance with Study Drug|0
2315538|NCT02848326|4025631|FG003|Treatment Period|Non-compliance with Study Drug|1
2315539|NCT02848326|4025632|FG004|Treatment Period|Non-compliance with Study Drug|0
2315540|NCT02848326|4025633|FG005|Treatment Period|Non-compliance with Study Drug|0
2315541|NCT02848326|4025628|FG000|Safety Follow-up Period|Withdrawal of Consent|0
2315542|NCT02848326|4025629|FG001|Safety Follow-up Period|Withdrawal of Consent|1
2315543|NCT02848326|4025630|FG002|Safety Follow-up Period|Withdrawal of Consent|1
2315544|NCT02848326|4025631|FG003|Safety Follow-up Period|Withdrawal of Consent|0
2315545|NCT02848326|4025632|FG004|Safety Follow-up Period|Withdrawal of Consent|0
2315546|NCT02848326|4025633|FG005|Safety Follow-up Period|Withdrawal of Consent|2
2315547|NCT02848326|4025628|FG000|Safety Follow-up Period|Lost to Follow-up|4
2315548|NCT02848326|4025629|FG001|Safety Follow-up Period|Lost to Follow-up|0
2315549|NCT02848326|4025630|FG002|Safety Follow-up Period|Lost to Follow-up|2
2315550|NCT02848326|4025631|FG003|Safety Follow-up Period|Lost to Follow-up|0
2315551|NCT02848326|4025632|FG004|Safety Follow-up Period|Lost to Follow-up|1
2315552|NCT02848326|4025633|FG005|Safety Follow-up Period|Lost to Follow-up|3
2315553|NCT02848599|4025649|FG000|Overall Study|Protocol Violation|7
2315554|NCT02848599|4025650|FG001|Overall Study|Protocol Violation|9
2315555|NCT02848651|4025658|FG000|Overall Study|Death|85
2315556|NCT02848651|4025658|FG000|Overall Study|Lost to Follow-up|1
2315557|NCT02848651|4025658|FG000|Overall Study|Non-Compliance|1
2315558|NCT02848651|4025658|FG000|Overall Study|Symptomatic Deterioration|1
2315559|NCT02848651|4025658|FG000|Overall Study|Physician Decision|4
2315560|NCT02848651|4025658|FG000|Overall Study|Withdrawal by Subject|14
2315561|NCT02848664|4025678|FG000|Overall Study|Withdrawal by Subject|2
2315562|NCT02848664|4025678|FG000|Overall Study|Adverse Event|1
2315563|NCT02848664|4025678|FG000|Overall Study|no assistance for device training|1
2315564|NCT02848729|4025688|FG000|Overall Study|Withdrawal by Subject|1
2315565|NCT02848729|4025689|FG001|Overall Study|Withdrawal by Subject|0
2315566|NCT02848729|4025688|FG000|Overall Study|Emesis|15
2315567|NCT02848729|4025689|FG001|Overall Study|Emesis|11
2315568|NCT02848833|4025702|FG000|Overall Study|subject who are duplicated|1
2315569|NCT02848833|4025702|FG000|Overall Study|have not taken the study drug|11
2315570|NCT02848833|4025702|FG000|Overall Study|follow-up failure|6
2315571|NCT02848833|4025702|FG000|Overall Study|Protocol Violation|119
2315572|NCT02849080|4025708|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
2358788|NCT02045797|4119334|FG000|Overall Study|Adverse Event|3
2315573|NCT02849080|4025709|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
2315574|NCT02849080|4025710|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
2315575|NCT02849080|4025711|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
2315576|NCT02849080|4025708|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
2315577|NCT02849080|4025709|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
2315578|NCT02849080|4025710|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
2315579|NCT02849080|4025711|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
2315580|NCT02849080|4025708|FG000|Main Phase: 0 - 52 Weeks|Death|0
2315581|NCT02849080|4025709|FG001|Main Phase: 0 - 52 Weeks|Death|2
2315582|NCT02849080|4025710|FG002|Main Phase: 0 - 52 Weeks|Death|0
2315583|NCT02849080|4025711|FG003|Main Phase: 0 - 52 Weeks|Death|0
2315584|NCT02849080|4025708|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
2315585|NCT02849080|4025709|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
2315586|NCT02849080|4025710|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
2315587|NCT02849080|4025711|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
2315588|NCT02849080|4025708|FG000|Extension Phase: 53 - 104 Weeks|Other|0
2315589|NCT02849080|4025709|FG001|Extension Phase: 53 - 104 Weeks|Other|0
2315590|NCT02849080|4025710|FG002|Extension Phase: 53 - 104 Weeks|Other|1
2315591|NCT02849080|4025711|FG003|Extension Phase: 53 - 104 Weeks|Other|0
2315592|NCT02849080|4025708|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
2315593|NCT02849080|4025709|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
2315594|NCT02849080|4025710|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
2315595|NCT02849080|4025711|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
2315596|NCT02849509|4025758|FG000|Overall Study|Worsening of disease under study|1
2315597|NCT02849509|4025759|FG001|Overall Study|Worsening of disease under study|1
2315598|NCT02849509|4025760|FG002|Overall Study|Worsening of disease under study|1
2315599|NCT02849509|4025758|FG000|Overall Study|Worsening of other pre-existing disease|0
2315600|NCT02849509|4025759|FG001|Overall Study|Worsening of other pre-existing disease|1
2315601|NCT02849509|4025760|FG002|Overall Study|Worsening of other pre-existing disease|2
2315602|NCT02849509|4025758|FG000|Overall Study|Other adverse event|36
2315603|NCT02849509|4025759|FG001|Overall Study|Other adverse event|41
2315604|NCT02849509|4025760|FG002|Overall Study|Other adverse event|8
2315605|NCT02849509|4025758|FG000|Overall Study|Withdrawal by Subject|6
2315606|NCT02849509|4025759|FG001|Overall Study|Withdrawal by Subject|17
2315607|NCT02849509|4025760|FG002|Overall Study|Withdrawal by Subject|12
2315608|NCT02849509|4025758|FG000|Overall Study|Lost to Follow-up|27
2315609|NCT02849509|4025759|FG001|Overall Study|Lost to Follow-up|67
2315610|NCT02849509|4025760|FG002|Overall Study|Lost to Follow-up|36
2315611|NCT02849509|4025758|FG000|Overall Study|Other, reason not specified|14
2315612|NCT02849509|4025759|FG001|Overall Study|Other, reason not specified|29
2315613|NCT02849509|4025760|FG002|Overall Study|Other, reason not specified|25
2315614|NCT02849509|4025758|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6
2315615|NCT02849509|4025759|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10
2315616|NCT02849509|4025760|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1
2315617|NCT02849678|4025772|FG000|Overall Study|Protocol Violation|3
2315618|NCT02849678|4025773|FG001|Overall Study|Protocol Violation|6
2315619|NCT02849704|4025781|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
2315620|NCT02849704|4025782|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
2315621|NCT02849704|4025781|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
2315622|NCT02849704|4025782|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
2315623|NCT02849704|4025781|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
2315624|NCT02849704|4025782|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
2315625|NCT02850276|4025814|FG000|Overall Study|screen failure|43
2315626|NCT02850276|4025814|FG000|Overall Study|Withdrawal by Subject|14
2315627|NCT02850276|4025814|FG000|Overall Study|Physician Decision|2
2315628|NCT02850276|4025814|FG000|Overall Study|Lost to Follow-up|2
2315629|NCT02850965|4025830|FG000|Overall Study|Other than listed|3
2315630|NCT02850965|4025831|FG001|Overall Study|Other than listed|4
2315631|NCT02850965|4025830|FG000|Overall Study|Protocol Violation|0
2315632|NCT02850965|4025831|FG001|Overall Study|Protocol Violation|2
2315633|NCT02850965|4025830|FG000|Overall Study|Lost to Follow-up|5
2315634|NCT02850965|4025831|FG001|Overall Study|Lost to Follow-up|3
2315635|NCT02850965|4025830|FG000|Overall Study|Lack of Efficacy|4
2315636|NCT02850965|4025831|FG001|Overall Study|Lack of Efficacy|8
2315637|NCT02850965|4025830|FG000|Overall Study|Adverse Event|3
2315638|NCT02850965|4025831|FG001|Overall Study|Adverse Event|2
2315639|NCT02850965|4025830|FG000|Overall Study|Withdrawal by Subject|3
2315640|NCT02850965|4025831|FG001|Overall Study|Withdrawal by Subject|4
2315641|NCT02850965|4025830|FG000|Overall Study|Physician Decision|0
2315642|NCT02850965|4025831|FG001|Overall Study|Physician Decision|1
2315643|NCT02850965|4025830|FG000|Overall Study|Randomized but not treated|0
2315644|NCT02850965|4025831|FG001|Overall Study|Randomized but not treated|1
2315645|NCT02850978|4025837|FG000|Overall Study|Uncollectable CRF|27
2315646|NCT02850978|4025837|FG000|Overall Study|No visit since the first visit|35
2315647|NCT02850978|4025837|FG000|Overall Study|Adverse Event|81
2315648|NCT02850978|4025837|FG000|Overall Study|Lack of Efficacy|40
2315649|NCT02850978|4025837|FG000|Overall Study|Improvement in condition|34
2315650|NCT02850978|4025837|FG000|Overall Study|Lost to Follow-up|121
2315651|NCT02850978|4025837|FG000|Overall Study|Reason not listed|88
2315652|NCT02851069|4025841|FG000|Overall Study|Failure to Return|3
2315653|NCT02851069|4025841|FG000|Overall Study|Other|3
2315654|NCT02851615|4025857|FG000|Overall Study|Cognitive Issue|1
2315655|NCT02851615|4025858|FG001|Overall Study|Cognitive Issue|0
2315656|NCT02851615|4025857|FG000|Overall Study|Lost to Follow-up|0
2315657|NCT02851615|4025858|FG001|Overall Study|Lost to Follow-up|4
2315658|NCT02852005|4025876|FG000|Overall Study|Lost to Follow-up|0
2315659|NCT02852005|4025877|FG001|Overall Study|Lost to Follow-up|0
2214836|NCT01691248|3857490|FG001|Overall Study|Adverse Event|22
2214837|NCT01691248|3857489|FG000|Overall Study|Withdrawal by Subject|20
2315660|NCT02852005|4025878|FG002|Overall Study|Lost to Follow-up|0
2315661|NCT02852005|4025879|FG003|Overall Study|Lost to Follow-up|0
2315662|NCT02852005|4025880|FG004|Overall Study|Lost to Follow-up|1
2315663|NCT02852005|4025876|FG000|Overall Study|Withdrawal by Subject|1
2315664|NCT02852005|4025877|FG001|Overall Study|Withdrawal by Subject|0
2315665|NCT02852005|4025878|FG002|Overall Study|Withdrawal by Subject|0
2315666|NCT02852005|4025879|FG003|Overall Study|Withdrawal by Subject|0
2315667|NCT02852005|4025880|FG004|Overall Study|Withdrawal by Subject|0
2315668|NCT02852265|4025896|FG000|3-month Follow-up|Lost to Follow-up|1
2315669|NCT02852265|4025897|FG001|3-month Follow-up|Lost to Follow-up|1
2315670|NCT02852434|4025913|FG000|Overall Study|Withdrawal by Subject|0
2315671|NCT02852434|4025914|FG001|Overall Study|Withdrawal by Subject|1
2315672|NCT02852434|4025913|FG000|Overall Study|Unsuccessful Dilator Procedure|2
2315673|NCT02852434|4025914|FG001|Overall Study|Unsuccessful Dilator Procedure|0
2315674|NCT02852967|4025925|FG000|Overall Study|Adverse Event|3
2315675|NCT02852967|4025926|FG001|Overall Study|Adverse Event|1
2315676|NCT02852967|4025927|FG002|Overall Study|Adverse Event|0
2315677|NCT02852967|4025928|FG003|Overall Study|Adverse Event|1
2315678|NCT02852967|4025929|FG004|Overall Study|Adverse Event|0
2315679|NCT02852967|4025925|FG000|Overall Study|Death|1
2315680|NCT02852967|4025926|FG001|Overall Study|Death|0
2315681|NCT02852967|4025927|FG002|Overall Study|Death|0
2315682|NCT02852967|4025928|FG003|Overall Study|Death|0
2315683|NCT02852967|4025929|FG004|Overall Study|Death|0
2315684|NCT02852967|4025925|FG000|Overall Study|Lost to Follow-up|1
2315685|NCT02852967|4025926|FG001|Overall Study|Lost to Follow-up|2
2315686|NCT02852967|4025927|FG002|Overall Study|Lost to Follow-up|3
2315687|NCT02852967|4025928|FG003|Overall Study|Lost to Follow-up|4
2315688|NCT02852967|4025929|FG004|Overall Study|Lost to Follow-up|4
2315689|NCT02852967|4025925|FG000|Overall Study|Withdrawal by Subject|6
2315690|NCT02852967|4025926|FG001|Overall Study|Withdrawal by Subject|12
2315691|NCT02852967|4025927|FG002|Overall Study|Withdrawal by Subject|7
2315692|NCT02852967|4025928|FG003|Overall Study|Withdrawal by Subject|10
2315693|NCT02852967|4025929|FG004|Overall Study|Withdrawal by Subject|10
2315694|NCT02852967|4025925|FG000|Overall Study|SAE|0
2315695|NCT02852967|4025926|FG001|Overall Study|SAE|0
2315696|NCT02852967|4025927|FG002|Overall Study|SAE|0
2315697|NCT02852967|4025928|FG003|Overall Study|SAE|3
2315698|NCT02852967|4025929|FG004|Overall Study|SAE|0
2315699|NCT02852967|4025925|FG000|Overall Study|Elevated Liver Enzymes|2
2315700|NCT02852967|4025926|FG001|Overall Study|Elevated Liver Enzymes|0
2315701|NCT02852967|4025927|FG002|Overall Study|Elevated Liver Enzymes|0
2315702|NCT02852967|4025928|FG003|Overall Study|Elevated Liver Enzymes|2
2315703|NCT02852967|4025929|FG004|Overall Study|Elevated Liver Enzymes|2
2315704|NCT02852967|4025925|FG000|Overall Study|Physician Decision|0
2315705|NCT02852967|4025926|FG001|Overall Study|Physician Decision|0
2315706|NCT02852967|4025927|FG002|Overall Study|Physician Decision|0
2315707|NCT02852967|4025928|FG003|Overall Study|Physician Decision|1
2315708|NCT02852967|4025929|FG004|Overall Study|Physician Decision|0
2315709|NCT02852967|4025925|FG000|Overall Study|Lack of Efficacy|0
2315710|NCT02852967|4025926|FG001|Overall Study|Lack of Efficacy|1
2315711|NCT02852967|4025927|FG002|Overall Study|Lack of Efficacy|0
2315712|NCT02852967|4025928|FG003|Overall Study|Lack of Efficacy|0
2315713|NCT02852967|4025929|FG004|Overall Study|Lack of Efficacy|0
2315714|NCT02852967|4025925|FG000|Overall Study|Non-compliance|0
2315715|NCT02852967|4025926|FG001|Overall Study|Non-compliance|0
2214838|NCT01691248|3857490|FG001|Overall Study|Withdrawal by Subject|18
2214839|NCT01691248|3857489|FG000|Overall Study|Confirmed CDAD|14
2214840|NCT01691248|3857490|FG001|Overall Study|Confirmed CDAD|31
2214841|NCT01691248|3857489|FG000|Overall Study|Lost to Follow-up|2
2315716|NCT02852967|4025927|FG002|Overall Study|Non-compliance|1
2315717|NCT02852967|4025928|FG003|Overall Study|Non-compliance|1
2315718|NCT02852967|4025929|FG004|Overall Study|Non-compliance|0
2315719|NCT02852967|4025925|FG000|Overall Study|Dispensing Drug Violation|0
2315720|NCT02852967|4025926|FG001|Overall Study|Dispensing Drug Violation|0
2315721|NCT02852967|4025927|FG002|Overall Study|Dispensing Drug Violation|1
2315722|NCT02852967|4025928|FG003|Overall Study|Dispensing Drug Violation|0
2315723|NCT02852967|4025929|FG004|Overall Study|Dispensing Drug Violation|0
2315724|NCT02852967|4025925|FG000|Overall Study|Inclusion/Exclusion Violation|1
2322079|NCT02968173|4036872|FG000|Overall Study|Withdrawal by Subject|1
2315725|NCT02852967|4025926|FG001|Overall Study|Inclusion/Exclusion Violation|0
2315726|NCT02852967|4025927|FG002|Overall Study|Inclusion/Exclusion Violation|0
2315727|NCT02852967|4025928|FG003|Overall Study|Inclusion/Exclusion Violation|0
2315728|NCT02852967|4025929|FG004|Overall Study|Inclusion/Exclusion Violation|0
2315729|NCT02853032|4025951|FG000|Overall Study|Adverse Event|4
2315730|NCT02853032|4025952|FG001|Overall Study|Adverse Event|0
2315731|NCT02853032|4025951|FG000|Overall Study|Withdrawal by Subject|3
2315732|NCT02853032|4025952|FG001|Overall Study|Withdrawal by Subject|1
2315733|NCT02853032|4025951|FG000|Overall Study|Requested to withdraw from all treatment|2
2315734|NCT02853032|4025952|FG001|Overall Study|Requested to withdraw from all treatment|2
2315735|NCT02853123|4025960|FG000|Treatment Period 1|Adverse Event|0
2315736|NCT02853123|4025961|FG001|Treatment Period 1|Adverse Event|3
2315737|NCT02853123|4025960|FG000|Washout Period|Worsening of COPD|0
2315738|NCT02853123|4025961|FG001|Washout Period|Worsening of COPD|3
2315739|NCT02853123|4025960|FG000|Washout Period|Adverse Event|1
2315740|NCT02853123|4025961|FG001|Washout Period|Adverse Event|0
2315741|NCT02853305|4025971|FG000|Overall Study|Death|244
2315742|NCT02853305|4025972|FG001|Overall Study|Death|207
2315743|NCT02853305|4025973|FG002|Overall Study|Death|263
2315744|NCT02853305|4025971|FG000|Overall Study|Withdrawal by Subject|2
2315745|NCT02853305|4025972|FG001|Overall Study|Withdrawal by Subject|4
2315746|NCT02853305|4025973|FG002|Overall Study|Withdrawal by Subject|2
2315747|NCT02853305|4025971|FG000|Overall Study|Ongoing in Trial|105
2315748|NCT02853305|4025972|FG001|Overall Study|Ongoing in Trial|96
2315749|NCT02853305|4025973|FG002|Overall Study|Ongoing in Trial|87
2315750|NCT02853318|4025981|FG000|Overall Study|Withdrawal by Subject|1
2315751|NCT02853435|4025988|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2315752|NCT02853435|4025989|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2315753|NCT02853435|4025990|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2315754|NCT02853435|4025991|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2315755|NCT02853435|4025992|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
2315756|NCT02853435|4025993|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2315757|NCT02853760|4026023|FG000|Washout (1 Week)|acute illness (not connected with the study)|0
2315758|NCT02853760|4026024|FG001|Washout (1 Week)|acute illness (not connected with the study)|0
2315759|NCT02853760|4026025|FG002|Washout (1 Week)|acute illness (not connected with the study)|1
2315760|NCT02853760|4026026|FG003|Washout (1 Week)|acute illness (not connected with the study)|2
2315761|NCT02853760|4026027|FG004|Washout (1 Week)|acute illness (not connected with the study)|0
2315762|NCT02853760|4026028|FG005|Washout (1 Week)|acute illness (not connected with the study)|2
2315763|NCT02853929|4026038|FG000|Overall Study|Lost to Follow-up|3
2315764|NCT02853929|4026039|FG001|Overall Study|Lost to Follow-up|0
2315765|NCT02853929|4026038|FG000|Overall Study|Withdrawal by Subject|1
2315766|NCT02853929|4026039|FG001|Overall Study|Withdrawal by Subject|0
2315767|NCT02853929|4026038|FG000|Overall Study|Subjects enrolled but not vaccinated|7
2315768|NCT02853929|4026039|FG001|Overall Study|Subjects enrolled but not vaccinated|4
2315769|NCT02854527|4026064|FG000|Overall Study|Adverse Event|0
2315770|NCT02854527|4026065|FG001|Overall Study|Adverse Event|0
2315771|NCT02854527|4026066|FG002|Overall Study|Adverse Event|0
2315772|NCT02854527|4026067|FG003|Overall Study|Adverse Event|0
2315773|NCT02854527|4026068|FG004|Overall Study|Adverse Event|1
2315774|NCT02854527|4026069|FG005|Overall Study|Adverse Event|0
2315775|NCT02854527|4026070|FG006|Overall Study|Adverse Event|0
2315776|NCT02854527|4026071|FG007|Overall Study|Adverse Event|0
2315777|NCT02854527|4026072|FG008|Overall Study|Adverse Event|0
2315778|NCT02854527|4026073|FG009|Overall Study|Adverse Event|0
2315779|NCT02854527|4026064|FG000|Overall Study|Lost to Follow-up|0
2315780|NCT02854527|4026065|FG001|Overall Study|Lost to Follow-up|0
2315781|NCT02854527|4026066|FG002|Overall Study|Lost to Follow-up|0
2315782|NCT02854527|4026067|FG003|Overall Study|Lost to Follow-up|1
2315783|NCT02854527|4026068|FG004|Overall Study|Lost to Follow-up|0
2315784|NCT02854527|4026069|FG005|Overall Study|Lost to Follow-up|0
2315785|NCT02854527|4026070|FG006|Overall Study|Lost to Follow-up|0
2315786|NCT02854527|4026071|FG007|Overall Study|Lost to Follow-up|0
2315787|NCT02854527|4026072|FG008|Overall Study|Lost to Follow-up|0
2315788|NCT02854527|4026073|FG009|Overall Study|Lost to Follow-up|0
2315789|NCT02854605|4026094|FG000|Overall Study|Adverse Event|1
2315790|NCT02854605|4026095|FG001|Overall Study|Adverse Event|5
2315791|NCT02854605|4026096|FG002|Overall Study|Adverse Event|2
2315792|NCT02854605|4026094|FG000|Overall Study|Lost to Follow-up|0
2315793|NCT02854605|4026095|FG001|Overall Study|Lost to Follow-up|2
2315794|NCT02854605|4026096|FG002|Overall Study|Lost to Follow-up|0
2315795|NCT02854605|4026094|FG000|Overall Study|Withdrew Consent|1
2315796|NCT02854605|4026095|FG001|Overall Study|Withdrew Consent|0
2315797|NCT02854605|4026096|FG002|Overall Study|Withdrew Consent|1
2315798|NCT02854605|4026094|FG000|Overall Study|Investigator's Discretion|1
2315799|NCT02854605|4026095|FG001|Overall Study|Investigator's Discretion|0
2315800|NCT02854605|4026096|FG002|Overall Study|Investigator's Discretion|0
2315801|NCT02854605|4026094|FG000|Overall Study|Protocol Violation|0
2315802|NCT02854605|4026095|FG001|Overall Study|Protocol Violation|0
2315803|NCT02854605|4026096|FG002|Overall Study|Protocol Violation|1
2315804|NCT02854631|4026106|FG000|Overall Study|Adverse Event|1
2315805|NCT02854631|4026107|FG001|Overall Study|Adverse Event|2
2315806|NCT02854631|4026106|FG000|Overall Study|Withdrew Consent|3
2315807|NCT02854631|4026107|FG001|Overall Study|Withdrew Consent|2
2315808|NCT02854631|4026106|FG000|Overall Study|Investigator's Discretion|2
2315809|NCT02854631|4026107|FG001|Overall Study|Investigator's Discretion|0
2315810|NCT02854631|4026106|FG000|Overall Study|Death|12
2315811|NCT02854631|4026107|FG001|Overall Study|Death|8
2315812|NCT02854631|4026106|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
2315813|NCT02854631|4026107|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
2315814|NCT02854631|4026106|FG000|Overall Study|Protocol Violation|0
2315815|NCT02854631|4026107|FG001|Overall Study|Protocol Violation|1
2315816|NCT02854631|4026106|FG000|Overall Study|Subjects Randomized but Never Treated|2
2315817|NCT02854631|4026107|FG001|Overall Study|Subjects Randomized but Never Treated|0
2315818|NCT02854631|4026106|FG000|Overall Study|Lost to Follow-up|4
2315819|NCT02854631|4026107|FG001|Overall Study|Lost to Follow-up|2
2315820|NCT02854800|4026116|FG000|Overall Study|Protocol Violation|16
2315821|NCT02854800|4026117|FG001|Overall Study|Protocol Violation|11
2315822|NCT02854800|4026118|FG002|Overall Study|Protocol Violation|3
2315823|NCT02854800|4026116|FG000|Overall Study|Withdrawal by Subject|4
2315824|NCT02854800|4026117|FG001|Overall Study|Withdrawal by Subject|2
2315825|NCT02854800|4026118|FG002|Overall Study|Withdrawal by Subject|3
2315826|NCT02855164|4026155|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0
2315827|NCT02855164|4026156|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0
2315828|NCT02855164|4026157|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1
2315829|NCT02855164|4026158|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2
2315830|NCT02855164|4026159|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1
2315831|NCT02855164|4026160|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0
2315832|NCT02855164|4026161|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0
2315833|NCT02855164|4026162|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0
2315834|NCT02855164|4026155|FG000|Parts A + B (Randomized Set)|Physician Decision|0
2315835|NCT02855164|4026156|FG001|Parts A + B (Randomized Set)|Physician Decision|0
2315836|NCT02855164|4026157|FG002|Parts A + B (Randomized Set)|Physician Decision|0
2315837|NCT02855164|4026158|FG003|Parts A + B (Randomized Set)|Physician Decision|2
2315838|NCT02855164|4026159|FG004|Parts A + B (Randomized Set)|Physician Decision|0
2315839|NCT02855164|4026160|FG005|Parts A + B (Randomized Set)|Physician Decision|0
2315840|NCT02855164|4026161|FG006|Parts A + B (Randomized Set)|Physician Decision|0
2315841|NCT02855164|4026162|FG007|Parts A + B (Randomized Set)|Physician Decision|0
2315842|NCT02855164|4026155|FG000|Parts A + B (Randomized Set)|Adverse Event|0
2315843|NCT02855164|4026156|FG001|Parts A + B (Randomized Set)|Adverse Event|0
2315844|NCT02855164|4026157|FG002|Parts A + B (Randomized Set)|Adverse Event|0
2315845|NCT02855164|4026158|FG003|Parts A + B (Randomized Set)|Adverse Event|4
2315846|NCT02855164|4026159|FG004|Parts A + B (Randomized Set)|Adverse Event|0
2315847|NCT02855164|4026160|FG005|Parts A + B (Randomized Set)|Adverse Event|0
2315848|NCT02855164|4026161|FG006|Parts A + B (Randomized Set)|Adverse Event|0
2315849|NCT02855164|4026162|FG007|Parts A + B (Randomized Set)|Adverse Event|0
2315850|NCT02855164|4026155|FG000|Part C (Randomized Set)|Adverse Event|0
2315851|NCT02855164|4026156|FG001|Part C (Randomized Set)|Adverse Event|0
2315852|NCT02855164|4026157|FG002|Part C (Randomized Set)|Adverse Event|0
2315853|NCT02855164|4026158|FG003|Part C (Randomized Set)|Adverse Event|0
2315854|NCT02855164|4026159|FG004|Part C (Randomized Set)|Adverse Event|0
2315855|NCT02855164|4026160|FG005|Part C (Randomized Set)|Adverse Event|5
2315856|NCT02855164|4026161|FG006|Part C (Randomized Set)|Adverse Event|9
2315857|NCT02855164|4026162|FG007|Part C (Randomized Set)|Adverse Event|2
2315858|NCT02855164|4026155|FG000|Part C (Randomized Set)|Lost to Follow-up|0
2315859|NCT02855164|4026156|FG001|Part C (Randomized Set)|Lost to Follow-up|0
2315860|NCT02855164|4026157|FG002|Part C (Randomized Set)|Lost to Follow-up|0
2315861|NCT02855164|4026158|FG003|Part C (Randomized Set)|Lost to Follow-up|0
2315862|NCT02855164|4026159|FG004|Part C (Randomized Set)|Lost to Follow-up|0
2315863|NCT02855164|4026160|FG005|Part C (Randomized Set)|Lost to Follow-up|1
2315864|NCT02855164|4026161|FG006|Part C (Randomized Set)|Lost to Follow-up|1
2315865|NCT02855164|4026162|FG007|Part C (Randomized Set)|Lost to Follow-up|1
2315866|NCT02855164|4026155|FG000|Part C (Randomized Set)|Physician Decision|0
2315867|NCT02855164|4026156|FG001|Part C (Randomized Set)|Physician Decision|0
2315868|NCT02855164|4026157|FG002|Part C (Randomized Set)|Physician Decision|0
2315869|NCT02855164|4026158|FG003|Part C (Randomized Set)|Physician Decision|0
2315870|NCT02855164|4026159|FG004|Part C (Randomized Set)|Physician Decision|0
2315871|NCT02855164|4026160|FG005|Part C (Randomized Set)|Physician Decision|1
2315872|NCT02855164|4026161|FG006|Part C (Randomized Set)|Physician Decision|0
2315873|NCT02855164|4026162|FG007|Part C (Randomized Set)|Physician Decision|1
2315874|NCT02855164|4026155|FG000|Part C (Randomized Set)|Withdrawal by Subject|0
2315875|NCT02855164|4026156|FG001|Part C (Randomized Set)|Withdrawal by Subject|0
2315876|NCT02855164|4026157|FG002|Part C (Randomized Set)|Withdrawal by Subject|0
2315877|NCT02855164|4026158|FG003|Part C (Randomized Set)|Withdrawal by Subject|0
2315878|NCT02855164|4026159|FG004|Part C (Randomized Set)|Withdrawal by Subject|0
2315879|NCT02855164|4026160|FG005|Part C (Randomized Set)|Withdrawal by Subject|5
2315880|NCT02855164|4026161|FG006|Part C (Randomized Set)|Withdrawal by Subject|4
2315881|NCT02855164|4026162|FG007|Part C (Randomized Set)|Withdrawal by Subject|3
2315882|NCT02855359|4026210|FG000|Overall Study|Death|2
2315883|NCT02855359|4026211|FG001|Overall Study|Death|2
2315884|NCT02855359|4026212|FG002|Overall Study|Death|0
2177516|NCT01375010|3801722|FG000|Overall Study|Withdrawal by Subject|4
2315885|NCT02855359|4026213|FG003|Overall Study|Death|0
2315886|NCT02855359|4026210|FG000|Overall Study|Study Termination by Sponsor|9
2315887|NCT02855359|4026211|FG001|Overall Study|Study Termination by Sponsor|11
2315888|NCT02855359|4026212|FG002|Overall Study|Study Termination by Sponsor|0
2315889|NCT02855359|4026213|FG003|Overall Study|Study Termination by Sponsor|0
2315890|NCT02855450|4026231|FG000|Overall Study|Adverse Event|1
2315891|NCT02855450|4026232|FG001|Overall Study|Adverse Event|0
2315892|NCT02855450|4026231|FG000|Overall Study|Lost to Follow-up|4
2315893|NCT02855450|4026232|FG001|Overall Study|Lost to Follow-up|0
2315894|NCT02855541|4026238|FG000|Overall Study|Change in health status|2
2315895|NCT02855541|4026238|FG000|Overall Study|Withdrawal by Subject|2
2315896|NCT02856282|4026255|FG000|Overall Study|Withdrawal by Subject|1
2315897|NCT02856555|4026275|FG000|Overall Study|Adverse Event|1
2315898|NCT02856555|4026276|FG001|Overall Study|Adverse Event|0
2315899|NCT02856555|4026277|FG002|Overall Study|Adverse Event|0
2315900|NCT02856555|4026275|FG000|Overall Study|Lost to Follow-up|1
2315901|NCT02856555|4026276|FG001|Overall Study|Lost to Follow-up|3
2315902|NCT02856555|4026277|FG002|Overall Study|Lost to Follow-up|0
2315903|NCT02856555|4026275|FG000|Overall Study|Withdrawal by Subject|3
2315904|NCT02856555|4026276|FG001|Overall Study|Withdrawal by Subject|0
2315905|NCT02856555|4026277|FG002|Overall Study|Withdrawal by Subject|0
2315906|NCT02856555|4026275|FG000|Overall Study|Randomized but Never Treated|0
2315907|NCT02856555|4026276|FG001|Overall Study|Randomized but Never Treated|1
2315908|NCT02856555|4026277|FG002|Overall Study|Randomized but Never Treated|0
2315909|NCT02856802|4026287|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
2315910|NCT02856802|4026288|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2
2315911|NCT02856802|4026287|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1
2315912|NCT02856802|4026288|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0
2315913|NCT02856802|4026287|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
2315914|NCT02856802|4026288|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
2315915|NCT02856802|4026287|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1
2315916|NCT02856802|4026288|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0
2315917|NCT02856802|4026287|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0
2315918|NCT02856802|4026288|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2
2315919|NCT02856802|4026287|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1
2315920|NCT02856802|4026288|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0
2315921|NCT02856880|4026315|FG000|Overall Study|Withdrawal of consent|1
2315922|NCT02857283|4026336|FG000|First Exposure|Withdrawal by Subject|1
2315923|NCT02857283|4026337|FG001|First Exposure|Withdrawal by Subject|0
2315924|NCT02857816|4026344|FG000|Overall Study|Screen Failure|33
2315925|NCT02857816|4026344|FG000|Overall Study|Withdrawal by Subject|4
2315926|NCT02857816|4026344|FG000|Overall Study|Lost to Follow-up|1
2322080|NCT02968433|4036918|FG000|Overall Study|Withdrawal by Subject|1
2322081|NCT02968576|4036928|FG000|Overall Study|Pregnancy|0
2322082|NCT02968576|4036929|FG001|Overall Study|Pregnancy|1
2322083|NCT02968979|4036950|FG000|Overall Study|Protocol Violation|7
2322084|NCT02968979|4036950|FG000|Overall Study|Withdrawal by Subject|1
2322085|NCT02969018|4037017|FG000|Overall Study|Adverse Event|2
2322086|NCT02969018|4037018|FG001|Overall Study|Adverse Event|4
2322087|NCT02969018|4037019|FG002|Overall Study|Adverse Event|1
2322088|NCT02969018|4037020|FG003|Overall Study|Adverse Event|2
2322089|NCT02969018|4037021|FG004|Overall Study|Adverse Event|0
2322090|NCT02969018|4037022|FG005|Overall Study|Adverse Event|1
2322091|NCT02969018|4037023|FG006|Overall Study|Adverse Event|2
2322092|NCT02969018|4037024|FG007|Overall Study|Adverse Event|0
2322093|NCT02969018|4037017|FG000|Overall Study|Lack of Efficacy|0
2322094|NCT02969018|4037018|FG001|Overall Study|Lack of Efficacy|1
2322095|NCT02969018|4037019|FG002|Overall Study|Lack of Efficacy|0
2322096|NCT02969018|4037020|FG003|Overall Study|Lack of Efficacy|0
2322097|NCT02969018|4037021|FG004|Overall Study|Lack of Efficacy|1
2322098|NCT02969018|4037022|FG005|Overall Study|Lack of Efficacy|1
2322099|NCT02969018|4037023|FG006|Overall Study|Lack of Efficacy|1
2322100|NCT02969018|4037024|FG007|Overall Study|Lack of Efficacy|1
2322101|NCT02969018|4037017|FG000|Overall Study|Lost to Follow-up|1
2322102|NCT02969018|4037018|FG001|Overall Study|Lost to Follow-up|2
2322103|NCT02969018|4037019|FG002|Overall Study|Lost to Follow-up|2
2322104|NCT02969018|4037020|FG003|Overall Study|Lost to Follow-up|0
2322105|NCT02969018|4037021|FG004|Overall Study|Lost to Follow-up|1
2322106|NCT02969018|4037022|FG005|Overall Study|Lost to Follow-up|1
2322107|NCT02969018|4037023|FG006|Overall Study|Lost to Follow-up|0
2322108|NCT02969018|4037024|FG007|Overall Study|Lost to Follow-up|1
2322109|NCT02969018|4037017|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
2322110|NCT02969018|4037018|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
2322111|NCT02969018|4037019|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
2322112|NCT02969018|4037020|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
2322113|NCT02969018|4037021|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
2322114|NCT02969018|4037022|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
2322115|NCT02969018|4037023|FG006|Overall Study|No Longer Meets Eligibility Criteria|1
2322116|NCT02969018|4037024|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
2322117|NCT02969018|4037017|FG000|Overall Study|Non-Compliance With Study Drug|1
2315927|NCT02858076|4026360|FG000|Overall Study|Death|6
2315928|NCT02858076|4026361|FG001|Overall Study|Death|3
2315929|NCT02858076|4026360|FG000|Overall Study|Withdrawal by Subject|1
2315930|NCT02858076|4026361|FG001|Overall Study|Withdrawal by Subject|5
2315931|NCT02858076|4026360|FG000|Overall Study|Lost to Follow-up|2
2315932|NCT02858076|4026361|FG001|Overall Study|Lost to Follow-up|7
2315933|NCT02858076|4026360|FG000|Overall Study|Completed Out of Window|1
2315934|NCT02858076|4026361|FG001|Overall Study|Completed Out of Window|3
2315935|NCT02858180|4026376|FG000|Overall Study|Lost to Follow-up|0
2315936|NCT02858180|4026377|FG001|Overall Study|Lost to Follow-up|2
2315937|NCT02858362|4026390|FG000|Overall Study|Protocol Violation|0
2315938|NCT02858362|4026391|FG001|Overall Study|Protocol Violation|1
2315939|NCT02858362|4026392|FG002|Overall Study|Protocol Violation|0
2315940|NCT02858362|4026390|FG000|Overall Study|Withdrawal by Subject|1
2315941|NCT02858362|4026391|FG001|Overall Study|Withdrawal by Subject|0
2315942|NCT02858362|4026392|FG002|Overall Study|Withdrawal by Subject|0
2315943|NCT02858362|4026390|FG000|Overall Study|Early Study Termination|0
2315944|NCT02858362|4026391|FG001|Overall Study|Early Study Termination|0
2315945|NCT02858362|4026392|FG002|Overall Study|Early Study Termination|3
2315946|NCT02858362|4026390|FG000|Overall Study|Lost to Follow-up|1
2315947|NCT02858362|4026391|FG001|Overall Study|Lost to Follow-up|0
2315948|NCT02858362|4026392|FG002|Overall Study|Lost to Follow-up|0
2315949|NCT02858401|4026412|FG000|Overall Study|Withdrew Consent|0
2315950|NCT02858401|4026413|FG001|Overall Study|Withdrew Consent|0
2315951|NCT02858401|4026414|FG002|Overall Study|Withdrew Consent|0
2315952|NCT02858401|4026415|FG003|Overall Study|Withdrew Consent|0
2315953|NCT02858401|4026416|FG004|Overall Study|Withdrew Consent|0
2315954|NCT02858401|4026417|FG005|Overall Study|Withdrew Consent|1
2315955|NCT02858401|4026418|FG006|Overall Study|Withdrew Consent|0
2315956|NCT02858401|4026412|FG000|Overall Study|Lost to Follow-up|0
2315957|NCT02858401|4026413|FG001|Overall Study|Lost to Follow-up|1
2315958|NCT02858401|4026414|FG002|Overall Study|Lost to Follow-up|0
2315959|NCT02858401|4026415|FG003|Overall Study|Lost to Follow-up|0
2315960|NCT02858401|4026416|FG004|Overall Study|Lost to Follow-up|0
2315961|NCT02858401|4026417|FG005|Overall Study|Lost to Follow-up|0
2315962|NCT02858401|4026418|FG006|Overall Study|Lost to Follow-up|0
2315963|NCT02858440|4026443|FG000|Overall Study|Lost to Follow-up|3
2315964|NCT02858440|4026443|FG000|Overall Study|Protocol Violation|2
2315965|NCT02858440|4026443|FG000|Overall Study|Consent withdrawal|3
2315966|NCT02858440|4026443|FG000|Overall Study|Migrated/moved from study area|4
2315967|NCT02858492|4026451|FG000|Overall Study|Withdrawal by Subject|0
2315968|NCT02858492|4026452|FG001|Overall Study|Withdrawal by Subject|1
2315969|NCT02858492|4026453|FG002|Overall Study|Withdrawal by Subject|0
2315970|NCT02858492|4026454|FG003|Overall Study|Withdrawal by Subject|1
2315971|NCT02858492|4026451|FG000|Overall Study|Adverse Event|0
2315972|NCT02858492|4026452|FG001|Overall Study|Adverse Event|0
2315973|NCT02858492|4026453|FG002|Overall Study|Adverse Event|0
2315974|NCT02858492|4026454|FG003|Overall Study|Adverse Event|3
2315975|NCT02858492|4026451|FG000|Overall Study|Lack of Efficacy|0
2315976|NCT02858492|4026452|FG001|Overall Study|Lack of Efficacy|0
2315977|NCT02858492|4026453|FG002|Overall Study|Lack of Efficacy|0
2315978|NCT02858492|4026454|FG003|Overall Study|Lack of Efficacy|1
2315979|NCT02858492|4026451|FG000|Overall Study|Protocol defined stopping criteria|0
2315980|NCT02858492|4026452|FG001|Overall Study|Protocol defined stopping criteria|0
2315981|NCT02858492|4026453|FG002|Overall Study|Protocol defined stopping criteria|0
2315982|NCT02858492|4026454|FG003|Overall Study|Protocol defined stopping criteria|1
2315983|NCT02858726|4026483|FG000|Overall Study|Adverse Event|4
2315984|NCT02858726|4026484|FG001|Overall Study|Adverse Event|4
2315985|NCT02858726|4026485|FG002|Overall Study|Adverse Event|9
2315986|NCT02858726|4026486|FG003|Overall Study|Adverse Event|1
2315987|NCT02858726|4026483|FG000|Overall Study|Physician Decision|0
2315988|NCT02858726|4026484|FG001|Overall Study|Physician Decision|0
2315989|NCT02858726|4026485|FG002|Overall Study|Physician Decision|1
2315990|NCT02858726|4026486|FG003|Overall Study|Physician Decision|0
2315991|NCT02858726|4026483|FG000|Overall Study|Protocol Violation|0
2315992|NCT02858726|4026484|FG001|Overall Study|Protocol Violation|0
2315993|NCT02858726|4026485|FG002|Overall Study|Protocol Violation|0
2315994|NCT02858726|4026486|FG003|Overall Study|Protocol Violation|1
2315995|NCT02858726|4026483|FG000|Overall Study|Study Terminated by Sponsor|0
2315996|NCT02858726|4026484|FG001|Overall Study|Study Terminated by Sponsor|0
2315997|NCT02858726|4026485|FG002|Overall Study|Study Terminated by Sponsor|0
2315998|NCT02858726|4026486|FG003|Overall Study|Study Terminated by Sponsor|1
2315999|NCT02858726|4026483|FG000|Overall Study|Withdrawal by Subject|1
2316000|NCT02858726|4026484|FG001|Overall Study|Withdrawal by Subject|2
2316001|NCT02858726|4026485|FG002|Overall Study|Withdrawal by Subject|1
2316002|NCT02858726|4026486|FG003|Overall Study|Withdrawal by Subject|0
2316003|NCT02858726|4026483|FG000|Overall Study|Noncompliance|0
2316004|NCT02858726|4026484|FG001|Overall Study|Noncompliance|1
2316005|NCT02858726|4026485|FG002|Overall Study|Noncompliance|0
2316006|NCT02858726|4026486|FG003|Overall Study|Noncompliance|0
2316007|NCT02859142|4026502|FG000|Overall Study|Adverse Event|1
2316008|NCT02859142|4026503|FG001|Overall Study|Adverse Event|2
2316009|NCT02859142|4026502|FG000|Overall Study|Lost to Follow-up|1
2316010|NCT02859142|4026503|FG001|Overall Study|Lost to Follow-up|4
2316011|NCT02859142|4026502|FG000|Overall Study|Withdrawal by Subject|2
2316012|NCT02859142|4026503|FG001|Overall Study|Withdrawal by Subject|0
2316013|NCT02859142|4026502|FG000|Overall Study|Scheduling difficulties|0
2316014|NCT02859142|4026503|FG001|Overall Study|Scheduling difficulties|3
2316015|NCT02859246|4026509|FG000|Overall Study|Screen fails|3
2358789|NCT02045797|4119335|FG001|Overall Study|Adverse Event|1
2358790|NCT02045797|4119336|FG002|Overall Study|Adverse Event|0
2358791|NCT02045797|4119334|FG000|Overall Study|Lack of Efficacy|1
2358792|NCT02045797|4119335|FG001|Overall Study|Lack of Efficacy|0
2358793|NCT02045797|4119336|FG002|Overall Study|Lack of Efficacy|0
2358794|NCT02045797|4119334|FG000|Overall Study|Lost to Follow-up|2
2358795|NCT02045797|4119335|FG001|Overall Study|Lost to Follow-up|3
2358796|NCT02045797|4119336|FG002|Overall Study|Lost to Follow-up|1
2358797|NCT02045797|4119334|FG000|Overall Study|Physician Decision|0
2358798|NCT02045797|4119335|FG001|Overall Study|Physician Decision|1
2358799|NCT02045797|4119336|FG002|Overall Study|Physician Decision|0
2358800|NCT02045797|4119334|FG000|Overall Study|Withdrawal by Subject|1
2358801|NCT02045797|4119335|FG001|Overall Study|Withdrawal by Subject|2
2358802|NCT02045797|4119336|FG002|Overall Study|Withdrawal by Subject|0
2316016|NCT02859246|4026509|FG000|Overall Study|Adverse Event|1
2316017|NCT02859246|4026509|FG000|Overall Study|Withdrawal by Subject|1
2316018|NCT02859324|4026517|FG000|Overall Study|Death|4
2316019|NCT02859324|4026518|FG001|Overall Study|Death|6
2316020|NCT02859324|4026519|FG002|Overall Study|Death|5
2316021|NCT02859324|4026517|FG000|Overall Study|Other reasons|3
2316022|NCT02859324|4026518|FG001|Overall Study|Other reasons|3
2316023|NCT02859324|4026519|FG002|Overall Study|Other reasons|0
2316024|NCT02859454|4026548|FG000|Overall Study|PI discretion/off study prior to trtmt|1
2316025|NCT02860130|4026568|FG000|Overall Study|Adverse Event|2
2316026|NCT02860130|4026569|FG001|Overall Study|Adverse Event|3
2316027|NCT02860130|4026568|FG000|Overall Study|Protocol Violation|1
2316028|NCT02860130|4026569|FG001|Overall Study|Protocol Violation|1
2316029|NCT02860130|4026568|FG000|Overall Study|Withdrawal by Subject|0
2316030|NCT02860130|4026569|FG001|Overall Study|Withdrawal by Subject|2
2316031|NCT02860130|4026568|FG000|Overall Study|Physician Decision|2
2316032|NCT02860130|4026569|FG001|Overall Study|Physician Decision|2
2316033|NCT02860130|4026568|FG000|Overall Study|Other|2
2316034|NCT02860130|4026569|FG001|Overall Study|Other|1
2316035|NCT02860546|4026602|FG000|Overall Study|Clinical Progression|6
2316036|NCT02860546|4026602|FG000|Overall Study|Radiological Progression|12
2316037|NCT02861534|4026650|FG000|Overall Study|Death|541
2316038|NCT02861534|4026651|FG001|Overall Study|Death|552
2316039|NCT02861534|4026650|FG000|Overall Study|Lost to Follow-up|14
2316040|NCT02861534|4026651|FG001|Overall Study|Lost to Follow-up|14
2316041|NCT02861534|4026650|FG000|Overall Study|Site Terminated by Sponsor|4
2316042|NCT02861534|4026651|FG001|Overall Study|Site Terminated by Sponsor|3
2316043|NCT02861534|4026650|FG000|Overall Study|Withdrawal by Subject|15
2316044|NCT02861534|4026651|FG001|Overall Study|Withdrawal by Subject|18
2316045|NCT02861586|4026665|FG000|Overall Study|Withdrawal by Subject|1
2316046|NCT02861586|4026666|FG001|Overall Study|Withdrawal by Subject|2
2316047|NCT02861586|4026667|FG002|Overall Study|Withdrawal by Subject|0
2316048|NCT02861586|4026668|FG003|Overall Study|Withdrawal by Subject|0
2316049|NCT02861586|4026669|FG004|Overall Study|Withdrawal by Subject|0
2316050|NCT02861586|4026670|FG005|Overall Study|Withdrawal by Subject|1
2316051|NCT02861586|4026671|FG006|Overall Study|Withdrawal by Subject|1
2316052|NCT02861586|4026672|FG007|Overall Study|Withdrawal by Subject|0
2316053|NCT02861586|4026665|FG000|Overall Study|Lost to Follow-up|3
2316054|NCT02861586|4026666|FG001|Overall Study|Lost to Follow-up|1
2316055|NCT02861586|4026667|FG002|Overall Study|Lost to Follow-up|1
2316056|NCT02861586|4026668|FG003|Overall Study|Lost to Follow-up|0
2316057|NCT02861586|4026669|FG004|Overall Study|Lost to Follow-up|0
2316058|NCT02861586|4026670|FG005|Overall Study|Lost to Follow-up|3
2316059|NCT02861586|4026671|FG006|Overall Study|Lost to Follow-up|0
2316060|NCT02861586|4026672|FG007|Overall Study|Lost to Follow-up|0
2316061|NCT02861586|4026665|FG000|Overall Study|Adverse Event|0
2316062|NCT02861586|4026666|FG001|Overall Study|Adverse Event|0
2316063|NCT02861586|4026667|FG002|Overall Study|Adverse Event|0
2316064|NCT02861586|4026668|FG003|Overall Study|Adverse Event|0
2316065|NCT02861586|4026669|FG004|Overall Study|Adverse Event|0
2316066|NCT02861586|4026670|FG005|Overall Study|Adverse Event|1
2316067|NCT02861586|4026671|FG006|Overall Study|Adverse Event|0
2358803|NCT02049710|4119346|FG000|Overall Study|Lost to Follow-up|319
2358804|NCT02049710|4119347|FG001|Overall Study|Lost to Follow-up|324
2358805|NCT02055547|4119353|FG000|Overall Study|Protocol Violation|0
2358806|NCT02055547|4119354|FG001|Overall Study|Protocol Violation|0
2358807|NCT02055547|4119355|FG002|Overall Study|Protocol Violation|1
2358808|NCT02055547|4119356|FG003|Overall Study|Protocol Violation|0
2358809|NCT02055547|4119357|FG004|Overall Study|Protocol Violation|0
2358810|NCT02055547|4119358|FG005|Overall Study|Protocol Violation|0
2358811|NCT02055547|4119359|FG006|Overall Study|Protocol Violation|1
2358812|NCT02055547|4119360|FG007|Overall Study|Protocol Violation|0
2358813|NCT02055547|4119361|FG008|Overall Study|Protocol Violation|0
2358814|NCT02055547|4119362|FG009|Overall Study|Protocol Violation|0
2358815|NCT02055547|4119363|FG010|Overall Study|Protocol Violation|0
2358816|NCT02055547|4119364|FG011|Overall Study|Protocol Violation|0
2358817|NCT02055547|4119365|FG012|Overall Study|Protocol Violation|0
2358818|NCT02055547|4119366|FG013|Overall Study|Protocol Violation|0
2358819|NCT02055547|4119367|FG014|Overall Study|Protocol Violation|0
2358820|NCT02055547|4119368|FG015|Overall Study|Protocol Violation|0
2358821|NCT02055547|4119369|FG016|Overall Study|Protocol Violation|0
2358822|NCT02055547|4119370|FG017|Overall Study|Protocol Violation|0
2358823|NCT02055547|4119371|FG018|Overall Study|Protocol Violation|0
2358824|NCT02055547|4119353|FG000|Overall Study|Physician Decision|0
2358825|NCT02055547|4119354|FG001|Overall Study|Physician Decision|1
2358826|NCT02055547|4119355|FG002|Overall Study|Physician Decision|1
2358827|NCT02055547|4119356|FG003|Overall Study|Physician Decision|0
2358828|NCT02055547|4119357|FG004|Overall Study|Physician Decision|1
2358829|NCT02055547|4119358|FG005|Overall Study|Physician Decision|0
2358830|NCT02055547|4119359|FG006|Overall Study|Physician Decision|0
2358831|NCT02055547|4119360|FG007|Overall Study|Physician Decision|0
2358832|NCT02055547|4119361|FG008|Overall Study|Physician Decision|0
2358833|NCT02055547|4119362|FG009|Overall Study|Physician Decision|1
2358834|NCT02055547|4119363|FG010|Overall Study|Physician Decision|1
2358835|NCT02055547|4119364|FG011|Overall Study|Physician Decision|0
2358836|NCT02055547|4119365|FG012|Overall Study|Physician Decision|0
2358837|NCT02055547|4119366|FG013|Overall Study|Physician Decision|0
2358838|NCT02055547|4119367|FG014|Overall Study|Physician Decision|0
2358839|NCT02055547|4119368|FG015|Overall Study|Physician Decision|0
2358840|NCT02055547|4119369|FG016|Overall Study|Physician Decision|0
2358841|NCT02055547|4119370|FG017|Overall Study|Physician Decision|0
2358842|NCT02055547|4119371|FG018|Overall Study|Physician Decision|0
2358843|NCT02055547|4119353|FG000|Overall Study|Adverse Event|0
2358844|NCT02055547|4119354|FG001|Overall Study|Adverse Event|0
2358845|NCT02055547|4119355|FG002|Overall Study|Adverse Event|0
2358846|NCT02055547|4119356|FG003|Overall Study|Adverse Event|0
2358847|NCT02055547|4119357|FG004|Overall Study|Adverse Event|0
2358848|NCT02055547|4119358|FG005|Overall Study|Adverse Event|0
2358849|NCT02055547|4119359|FG006|Overall Study|Adverse Event|1
2358850|NCT02055547|4119360|FG007|Overall Study|Adverse Event|0
2358851|NCT02055547|4119361|FG008|Overall Study|Adverse Event|1
2358852|NCT02055547|4119362|FG009|Overall Study|Adverse Event|0
2358853|NCT02055547|4119363|FG010|Overall Study|Adverse Event|0
2316068|NCT02861586|4026672|FG007|Overall Study|Adverse Event|0
2358854|NCT02055547|4119364|FG011|Overall Study|Adverse Event|0
2358855|NCT02055547|4119365|FG012|Overall Study|Adverse Event|0
2358856|NCT02055547|4119366|FG013|Overall Study|Adverse Event|0
2358857|NCT02055547|4119367|FG014|Overall Study|Adverse Event|0
2358858|NCT02055547|4119368|FG015|Overall Study|Adverse Event|0
2358859|NCT02055547|4119369|FG016|Overall Study|Adverse Event|0
2358860|NCT02055547|4119370|FG017|Overall Study|Adverse Event|0
2358861|NCT02055547|4119371|FG018|Overall Study|Adverse Event|0
2316069|NCT02861664|4026697|FG000|Overall Study|Withdrawal of Consent|0
2316070|NCT02861664|4026698|FG001|Overall Study|Withdrawal of Consent|1
2316071|NCT02861807|4026706|FG000|Overall Study|Lost to Follow-up|7
2316072|NCT02861807|4026707|FG001|Overall Study|Lost to Follow-up|6
2316073|NCT02861807|4026706|FG000|Overall Study|Withdrawal by Subject|5
2316074|NCT02861807|4026707|FG001|Overall Study|Withdrawal by Subject|8
2316075|NCT02862106|4026748|FG000|Overall Study|Adverse Event|4
2316076|NCT02862106|4026749|FG001|Overall Study|Adverse Event|0
2316077|NCT02862106|4026748|FG000|Overall Study|Protocol Violation|16
2316078|NCT02862106|4026749|FG001|Overall Study|Protocol Violation|1
2316079|NCT02862106|4026748|FG000|Overall Study|Lost to Follow-up|15
2316080|NCT02862106|4026749|FG001|Overall Study|Lost to Follow-up|5
2316081|NCT02862106|4026748|FG000|Overall Study|Withdrawal by Subject|2
2316082|NCT02862106|4026749|FG001|Overall Study|Withdrawal by Subject|0
2316083|NCT02862106|4026748|FG000|Overall Study|Subjects moved to other city|1
2316084|NCT02862106|4026749|FG001|Overall Study|Subjects moved to other city|0
2316085|NCT02862535|4026765|FG000|Overall Study|Death|7
2316086|NCT02862535|4026766|FG001|Overall Study|Death|3
2316087|NCT02862535|4026767|FG002|Overall Study|Death|2
2316088|NCT02862535|4026768|FG003|Overall Study|Death|5
2316089|NCT02862535|4026765|FG000|Overall Study|Study Terminated by Sponsor|1
2316090|NCT02862535|4026766|FG001|Overall Study|Study Terminated by Sponsor|3
2316091|NCT02862535|4026767|FG002|Overall Study|Study Terminated by Sponsor|8
2316092|NCT02862535|4026768|FG003|Overall Study|Study Terminated by Sponsor|5
2316093|NCT02862535|4026765|FG000|Overall Study|Enrolled, not Treated|1
2316094|NCT02862535|4026766|FG001|Overall Study|Enrolled, not Treated|0
2316095|NCT02862535|4026767|FG002|Overall Study|Enrolled, not Treated|0
2316096|NCT02862535|4026768|FG003|Overall Study|Enrolled, not Treated|1
2316097|NCT02862548|4026780|FG000|Open-Label Phase|Death|0
2316098|NCT02862548|4026781|FG001|Open-Label Phase|Death|1
2316099|NCT02862548|4026780|FG000|Open-Label Extension Phase|Still on Study|26
2316100|NCT02862548|4026781|FG001|Open-Label Extension Phase|Still on Study|24
2316101|NCT02862574|4026790|FG000|Double-Blind Treatment Period|Adverse Event|0
2316102|NCT02862574|4026791|FG001|Double-Blind Treatment Period|Adverse Event|1
2316103|NCT02862574|4026792|FG002|Double-Blind Treatment Period|Adverse Event|0
2316104|NCT02862574|4026790|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3
2316105|NCT02862574|4026791|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1
2316106|NCT02862574|4026792|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4
2316107|NCT02862574|4026790|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2
2316108|NCT02862574|4026791|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3
2316109|NCT02862574|4026792|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1
2316110|NCT02862600|4026801|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
2316111|NCT02862600|4026801|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3
2316112|NCT02862600|4026801|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
2316113|NCT02862600|4026801|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
2316114|NCT02862730|4026807|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2316115|NCT02862730|4026808|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2316116|NCT02862730|4026809|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
2316117|NCT02862730|4026810|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2316118|NCT02862730|4026811|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2316119|NCT02862730|4026812|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2316120|NCT02862730|4026813|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2316121|NCT02862730|4026807|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1
2316122|NCT02862730|4026808|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0
2316123|NCT02862730|4026809|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0
2316124|NCT02862730|4026810|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0
2316125|NCT02862730|4026811|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0
2316126|NCT02862730|4026812|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0
2316127|NCT02862730|4026813|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0
2316128|NCT02862730|4026807|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2316129|NCT02862730|4026808|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2316130|NCT02862730|4026809|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
2316131|NCT02862730|4026810|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2316132|NCT02862730|4026811|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
2316133|NCT02862730|4026812|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2316134|NCT02862730|4026813|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2316135|NCT02862730|4026807|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2316136|NCT02862730|4026808|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2316137|NCT02862730|4026809|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2316138|NCT02862730|4026810|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
2316139|NCT02862730|4026811|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2316140|NCT02862730|4026812|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2316141|NCT02862730|4026813|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2316142|NCT02863328|4026864|FG000|Overall Study|Lost to Follow-up|4
2316143|NCT02863328|4026865|FG001|Overall Study|Lost to Follow-up|10
2316144|NCT02863328|4026864|FG000|Overall Study|Withdrawal by Subject|7
2316145|NCT02863328|4026865|FG001|Overall Study|Withdrawal by Subject|12
2316146|NCT02863328|4026864|FG000|Overall Study|Died|0
2316147|NCT02863328|4026865|FG001|Overall Study|Died|1
2316148|NCT02863354|4026873|FG000|Year 1|Lost to Follow-up|1
2316149|NCT02863354|4026874|FG001|Year 1|Lost to Follow-up|1
2316150|NCT02863354|4026873|FG000|Year 1|Withdrawal by Subject|3
2316151|NCT02863354|4026874|FG001|Year 1|Withdrawal by Subject|0
2316152|NCT02863354|4026873|FG000|Year 1|Death|0
2316153|NCT02863354|4026874|FG001|Year 1|Death|1
2316154|NCT02863354|4026873|FG000|Year 2|Lost to Follow-up|2
2316155|NCT02863354|4026874|FG001|Year 2|Lost to Follow-up|2
2316156|NCT02863419|4026883|FG000|Overall Study|Lost to Follow-up|0
2316157|NCT02863419|4026884|FG001|Overall Study|Lost to Follow-up|1
2316158|NCT02863419|4026885|FG002|Overall Study|Lost to Follow-up|4
2316159|NCT02863419|4026883|FG000|Overall Study|Withdrawal by Subject|5
2316160|NCT02863419|4026884|FG001|Overall Study|Withdrawal by Subject|5
2316161|NCT02863419|4026885|FG002|Overall Study|Withdrawal by Subject|3
2316162|NCT02863419|4026883|FG000|Overall Study|Died|3
2316163|NCT02863419|4026884|FG001|Overall Study|Died|4
2316164|NCT02863419|4026885|FG002|Overall Study|Died|1
2358862|NCT02055547|4119353|FG000|Overall Study|Withdrawal by Subject|0
2358863|NCT02055547|4119354|FG001|Overall Study|Withdrawal by Subject|0
2358864|NCT02055547|4119355|FG002|Overall Study|Withdrawal by Subject|0
2358865|NCT02055547|4119356|FG003|Overall Study|Withdrawal by Subject|0
2358866|NCT02055547|4119357|FG004|Overall Study|Withdrawal by Subject|0
2358867|NCT02055547|4119358|FG005|Overall Study|Withdrawal by Subject|1
2358868|NCT02055547|4119359|FG006|Overall Study|Withdrawal by Subject|0
2358869|NCT02055547|4119360|FG007|Overall Study|Withdrawal by Subject|0
2358870|NCT02055547|4119361|FG008|Overall Study|Withdrawal by Subject|1
2358871|NCT02055547|4119362|FG009|Overall Study|Withdrawal by Subject|0
2358872|NCT02055547|4119363|FG010|Overall Study|Withdrawal by Subject|0
2358873|NCT02055547|4119364|FG011|Overall Study|Withdrawal by Subject|0
2358874|NCT02055547|4119365|FG012|Overall Study|Withdrawal by Subject|0
2358875|NCT02055547|4119366|FG013|Overall Study|Withdrawal by Subject|1
2358876|NCT02055547|4119367|FG014|Overall Study|Withdrawal by Subject|0
2358877|NCT02055547|4119368|FG015|Overall Study|Withdrawal by Subject|1
2358878|NCT02055547|4119369|FG016|Overall Study|Withdrawal by Subject|0
2358879|NCT02055547|4119370|FG017|Overall Study|Withdrawal by Subject|0
2358880|NCT02055547|4119371|FG018|Overall Study|Withdrawal by Subject|0
2358881|NCT02055547|4119353|FG000|Overall Study|Lost to Follow-up|0
2358882|NCT02055547|4119354|FG001|Overall Study|Lost to Follow-up|0
2358883|NCT02055547|4119355|FG002|Overall Study|Lost to Follow-up|1
2358884|NCT02055547|4119356|FG003|Overall Study|Lost to Follow-up|0
2358885|NCT02055547|4119357|FG004|Overall Study|Lost to Follow-up|0
2358886|NCT02055547|4119358|FG005|Overall Study|Lost to Follow-up|0
2358887|NCT02055547|4119359|FG006|Overall Study|Lost to Follow-up|0
2358888|NCT02055547|4119360|FG007|Overall Study|Lost to Follow-up|0
2358889|NCT02055547|4119361|FG008|Overall Study|Lost to Follow-up|0
2358890|NCT02055547|4119362|FG009|Overall Study|Lost to Follow-up|0
2358891|NCT02055547|4119363|FG010|Overall Study|Lost to Follow-up|0
2358892|NCT02055547|4119364|FG011|Overall Study|Lost to Follow-up|0
2358893|NCT02055547|4119365|FG012|Overall Study|Lost to Follow-up|0
2358894|NCT02055547|4119366|FG013|Overall Study|Lost to Follow-up|0
2358895|NCT02055547|4119367|FG014|Overall Study|Lost to Follow-up|0
2358896|NCT02055547|4119368|FG015|Overall Study|Lost to Follow-up|0
2358897|NCT02055547|4119369|FG016|Overall Study|Lost to Follow-up|0
2358898|NCT02055547|4119370|FG017|Overall Study|Lost to Follow-up|0
2358899|NCT02055547|4119371|FG018|Overall Study|Lost to Follow-up|0
2214842|NCT01691248|3857490|FG001|Overall Study|Lost to Follow-up|5
2316165|NCT02863575|4026896|FG000|Overall Study|Participants Unable To Swallow Capsule|1
2316166|NCT02863575|4026897|FG001|Overall Study|Participants Unable To Swallow Capsule|0
2316167|NCT02863575|4026898|FG002|Overall Study|Participants Unable To Swallow Capsule|0
2316168|NCT02863575|4026896|FG000|Overall Study|Withdrawal by Subject|0
2316169|NCT02863575|4026897|FG001|Overall Study|Withdrawal by Subject|1
2316170|NCT02863575|4026898|FG002|Overall Study|Withdrawal by Subject|1
2316171|NCT02863575|4026896|FG000|Overall Study|Adverse Event|0
2316172|NCT02863575|4026897|FG001|Overall Study|Adverse Event|1
2316173|NCT02863575|4026898|FG002|Overall Study|Adverse Event|0
2316174|NCT02864082|4026921|FG000|Overall Study|Adverse Event|1
2316175|NCT02864082|4026922|FG001|Overall Study|Adverse Event|1
2316176|NCT02864082|4026921|FG000|Overall Study|Lost to Follow-up|0
2316177|NCT02864082|4026922|FG001|Overall Study|Lost to Follow-up|1
2316178|NCT02864082|4026921|FG000|Overall Study|Withdrawal by Subject|2
2316179|NCT02864082|4026922|FG001|Overall Study|Withdrawal by Subject|2
2316180|NCT02864316|4026944|FG000|Overall Study|Progressive Disease|2
2316181|NCT02864316|4026945|FG001|Overall Study|Progressive Disease|1
2358900|NCT02064387|4119417|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0
2358901|NCT02064387|4119418|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0
2358902|NCT02064387|4119419|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0
2358903|NCT02064387|4119420|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0
2358904|NCT02064387|4119421|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0
2358905|NCT02064387|4119422|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0
2358906|NCT02064387|4119423|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0
2358907|NCT02064387|4119424|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1
2358908|NCT02064387|4119425|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0
2358909|NCT02064387|4119426|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1
2358910|NCT02064387|4119427|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0
2358911|NCT02064387|4119428|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0
2358912|NCT02064387|4119417|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
2358913|NCT02064387|4119418|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
2358914|NCT02064387|4119419|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
2358915|NCT02064387|4119420|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
2358916|NCT02064387|4119421|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
2358917|NCT02064387|4119422|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
2358918|NCT02064387|4119423|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
2358919|NCT02064387|4119424|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1
2358920|NCT02064387|4119425|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
2358921|NCT02064387|4119426|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
2358922|NCT02064387|4119427|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
2358923|NCT02064387|4119428|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
2358924|NCT02064387|4119417|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
2358925|NCT02064387|4119418|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
2358926|NCT02064387|4119419|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
2358927|NCT02064387|4119420|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
2358928|NCT02064387|4119421|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
2358929|NCT02064387|4119422|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
2358930|NCT02064387|4119423|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
2358931|NCT02064387|4119424|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
2358932|NCT02064387|4119425|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1
2358933|NCT02064387|4119426|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
2358934|NCT02064387|4119427|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
2358935|NCT02064387|4119428|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
2358936|NCT02064387|4119417|FG000|Part 2 Max 35 Months Followup Duration|Death|0
2358937|NCT02064387|4119418|FG001|Part 2 Max 35 Months Followup Duration|Death|0
2358938|NCT02064387|4119419|FG002|Part 2 Max 35 Months Followup Duration|Death|0
2358939|NCT02064387|4119420|FG003|Part 2 Max 35 Months Followup Duration|Death|0
2358940|NCT02064387|4119421|FG004|Part 2 Max 35 Months Followup Duration|Death|0
2358941|NCT02064387|4119422|FG005|Part 2 Max 35 Months Followup Duration|Death|0
2358942|NCT02064387|4119423|FG006|Part 2 Max 35 Months Followup Duration|Death|0
2358943|NCT02064387|4119424|FG007|Part 2 Max 35 Months Followup Duration|Death|0
2358944|NCT02064387|4119425|FG008|Part 2 Max 35 Months Followup Duration|Death|0
2358945|NCT02064387|4119426|FG009|Part 2 Max 35 Months Followup Duration|Death|0
2358946|NCT02064387|4119427|FG010|Part 2 Max 35 Months Followup Duration|Death|5
2358947|NCT02064387|4119428|FG011|Part 2 Max 35 Months Followup Duration|Death|3
2358948|NCT02064387|4119417|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
2358949|NCT02064387|4119418|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
2358950|NCT02064387|4119419|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
2358951|NCT02064387|4119420|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
2358952|NCT02064387|4119421|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
2358953|NCT02064387|4119422|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
2358954|NCT02064387|4119423|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
2358955|NCT02064387|4119424|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
2316182|NCT02864316|4026944|FG000|Overall Study|Adverse Event|0
2316183|NCT02864316|4026945|FG001|Overall Study|Adverse Event|1
2316184|NCT02864342|4026953|FG000|Overall Study|Eligibility Criteria Deviation|2
2316185|NCT02864342|4026954|FG001|Overall Study|Eligibility Criteria Deviation|3
2316186|NCT02864342|4026953|FG000|Overall Study|Withdrawal by Subject|4
2316187|NCT02864342|4026954|FG001|Overall Study|Withdrawal by Subject|2
2316188|NCT02864342|4026953|FG000|Overall Study|Device Technology Issue|6
2316189|NCT02864342|4026954|FG001|Overall Study|Device Technology Issue|7
2316190|NCT02864342|4026953|FG000|Overall Study|Death|0
2316191|NCT02864342|4026954|FG001|Overall Study|Death|1
2316192|NCT02864342|4026953|FG000|Overall Study|Did Not Start Treatment with Symbicort|0
2316193|NCT02864342|4026954|FG001|Overall Study|Did Not Start Treatment with Symbicort|1
2316194|NCT02864342|4026953|FG000|Overall Study|Lost to Follow-up|1
2316195|NCT02864342|4026954|FG001|Overall Study|Lost to Follow-up|5
2316196|NCT02864342|4026953|FG000|Overall Study|Lost Device|1
2316197|NCT02864342|4026954|FG001|Overall Study|Lost Device|0
2316198|NCT02864342|4026953|FG000|Overall Study|Adverse Event|1
2316199|NCT02864342|4026954|FG001|Overall Study|Adverse Event|0
2316200|NCT02864381|4026998|FG000|Overall Study|Death|58
2316201|NCT02864381|4026999|FG001|Overall Study|Death|61
2316202|NCT02864381|4026998|FG000|Overall Study|Withdrew Consent|5
2316203|NCT02864381|4026999|FG001|Overall Study|Withdrew Consent|6
2316204|NCT02864381|4026998|FG000|Overall Study|Reason Unknown|7
2316205|NCT02864381|4026999|FG001|Overall Study|Reason Unknown|3
2316206|NCT02864381|4026998|FG000|Overall Study|Lost to Follow-up|1
2316207|NCT02864381|4026999|FG001|Overall Study|Lost to Follow-up|1
2316208|NCT02864381|4026998|FG000|Overall Study|Investigator's Discretion|1
2316209|NCT02864381|4026999|FG001|Overall Study|Investigator's Discretion|0
2316210|NCT02864381|4026998|FG000|Overall Study|Protocol Violation|0
2316211|NCT02864381|4026999|FG001|Overall Study|Protocol Violation|1
2316212|NCT02864394|4027007|FG000|Overall Study|Death|135
2316213|NCT02864394|4027008|FG001|Overall Study|Death|150
2316214|NCT02864394|4027007|FG000|Overall Study|Withdrawal by Subject|1
2316215|NCT02864394|4027008|FG001|Overall Study|Withdrawal by Subject|9
2316216|NCT02864394|4027007|FG000|Overall Study|Ongoing In Study|77
2316217|NCT02864394|4027008|FG001|Overall Study|Ongoing In Study|53
2316218|NCT02865187|4027035|FG000|Overall Study|Lost to Follow-up|12
2316219|NCT02865187|4027036|FG001|Overall Study|Lost to Follow-up|7
2316220|NCT02865187|4027035|FG000|Overall Study|Adverse Event|1
2358956|NCT02064387|4119425|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
2358957|NCT02064387|4119426|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
2358958|NCT02064387|4119427|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1
2358959|NCT02064387|4119428|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
2316221|NCT02865187|4027036|FG001|Overall Study|Adverse Event|0
2316222|NCT02865499|4027104|FG000|Baseline|Adverse Event|1
2316223|NCT02865499|4027104|FG000|Baseline|Withdrawal by Subject|1
2316224|NCT02865538|4027113|FG000|Overall Study|Withdrawal by Subject|0
2316225|NCT02865538|4027114|FG001|Overall Study|Withdrawal by Subject|0
2316226|NCT02865538|4027115|FG002|Overall Study|Withdrawal by Subject|1
2316227|NCT02865538|4027116|FG003|Overall Study|Withdrawal by Subject|0
2316228|NCT02865538|4027117|FG004|Overall Study|Withdrawal by Subject|0
2316229|NCT02865538|4027113|FG000|Overall Study|Lost to Follow-up|1
2316230|NCT02865538|4027114|FG001|Overall Study|Lost to Follow-up|0
2316231|NCT02865538|4027115|FG002|Overall Study|Lost to Follow-up|0
2316232|NCT02865538|4027116|FG003|Overall Study|Lost to Follow-up|0
2316233|NCT02865538|4027117|FG004|Overall Study|Lost to Follow-up|0
2316234|NCT02866175|4027153|FG000|Overall Study|Adverse Event|56
2316235|NCT02866175|4027154|FG001|Overall Study|Adverse Event|54
2316236|NCT02866175|4027153|FG000|Overall Study|Withdrawal by Subject|31
2316237|NCT02866175|4027154|FG001|Overall Study|Withdrawal by Subject|52
2316238|NCT02866175|4027153|FG000|Overall Study|Death|30
2316239|NCT02866175|4027154|FG001|Overall Study|Death|23
2316240|NCT02866175|4027153|FG000|Overall Study|Other|7
2316241|NCT02866175|4027154|FG001|Overall Study|Other|14
2316242|NCT02866175|4027153|FG000|Overall Study|Progressive disease|1
2316243|NCT02866175|4027154|FG001|Overall Study|Progressive disease|1
2316244|NCT02866175|4027153|FG000|Overall Study|Lost to Follow-up|2
2316245|NCT02866175|4027154|FG001|Overall Study|Lost to Follow-up|0
2316246|NCT02866175|4027153|FG000|Overall Study|Lack of Efficacy|0
2316247|NCT02866175|4027154|FG001|Overall Study|Lack of Efficacy|1
2316248|NCT02866175|4027153|FG000|Overall Study|Physician Decision|3
2316249|NCT02866175|4027154|FG001|Overall Study|Physician Decision|15
2316250|NCT02866175|4027153|FG000|Overall Study|Did not receive treatment|5
2316251|NCT02866175|4027154|FG001|Overall Study|Did not receive treatment|15
2316252|NCT02866695|4027170|FG000|Overall Study|Adverse Event|1
2316253|NCT02866695|4027170|FG000|Overall Study|Lost to Follow-up|1
2316254|NCT02866942|4027174|FG000|Overall Study|Invalid consent|1
2316255|NCT02867709|4027228|FG000|Treatment Period|Adverse Event|1
2316256|NCT02867709|4027229|FG001|Treatment Period|Adverse Event|1
2316257|NCT02867709|4027230|FG002|Treatment Period|Adverse Event|2
2316258|NCT02867709|4027228|FG000|Treatment Period|Withdrawal of Consent|7
2316259|NCT02867709|4027229|FG001|Treatment Period|Withdrawal of Consent|9
2316260|NCT02867709|4027230|FG002|Treatment Period|Withdrawal of Consent|8
2316261|NCT02867709|4027228|FG000|Treatment Period|Lost to Follow-up|17
2316262|NCT02867709|4027229|FG001|Treatment Period|Lost to Follow-up|20
2316263|NCT02867709|4027230|FG002|Treatment Period|Lost to Follow-up|20
2316264|NCT02867709|4027228|FG000|Treatment Period|Lack of Qualifying Event|42
2316265|NCT02867709|4027229|FG001|Treatment Period|Lack of Qualifying Event|55
2316266|NCT02867709|4027230|FG002|Treatment Period|Lack of Qualifying Event|42
2316267|NCT02867709|4027228|FG000|Treatment Period|Protocol Violation|3
2316268|NCT02867709|4027229|FG001|Treatment Period|Protocol Violation|2
2316269|NCT02867709|4027230|FG002|Treatment Period|Protocol Violation|3
2316270|NCT02867709|4027228|FG000|Safety Follow-up Period|Withdrawal of Consent|1
2316271|NCT02867709|4027229|FG001|Safety Follow-up Period|Withdrawal of Consent|8
2316272|NCT02867709|4027230|FG002|Safety Follow-up Period|Withdrawal of Consent|6
2316273|NCT02867709|4027228|FG000|Safety Follow-up Period|Lost to Follow-up|10
2316274|NCT02867709|4027229|FG001|Safety Follow-up Period|Lost to Follow-up|5
2316275|NCT02867709|4027230|FG002|Safety Follow-up Period|Lost to Follow-up|7
2316276|NCT02867709|4027228|FG000|Safety Follow-up Period|Pregnancy|0
2316277|NCT02867709|4027229|FG001|Safety Follow-up Period|Pregnancy|1
2316278|NCT02867709|4027230|FG002|Safety Follow-up Period|Pregnancy|0
2316279|NCT02867709|4027228|FG000|Safety Follow-up Period|Protocol Violation|0
2316280|NCT02867709|4027229|FG001|Safety Follow-up Period|Protocol Violation|1
2316281|NCT02867709|4027230|FG002|Safety Follow-up Period|Protocol Violation|1
2316282|NCT02867995|4027240|FG000|Overall Study|Withdrawal by Subject|0
2316283|NCT02867995|4027241|FG001|Overall Study|Withdrawal by Subject|1
2316284|NCT02867995|4027240|FG000|Overall Study|Lost to Follow-up|0
2316285|NCT02867995|4027241|FG001|Overall Study|Lost to Follow-up|2
2316286|NCT02868216|4027253|FG000|Overall Study|Death|0
2316287|NCT02868216|4027254|FG001|Overall Study|Death|1
2316288|NCT02868216|4027253|FG000|Overall Study|coronary artery bypass|1
2316289|NCT02868216|4027254|FG001|Overall Study|coronary artery bypass|0
2316290|NCT02868216|4027253|FG000|Overall Study|Withdrawal by Subject|7
2316291|NCT02868216|4027254|FG001|Overall Study|Withdrawal by Subject|5
2316292|NCT02868229|4027264|FG000|Overall Study|Adverse Event|1
2316293|NCT02868229|4027265|FG001|Overall Study|Adverse Event|0
2316294|NCT02868229|4027266|FG002|Overall Study|Adverse Event|0
2316295|NCT02868229|4027267|FG003|Overall Study|Adverse Event|1
2316296|NCT02868229|4027264|FG000|Overall Study|Death|0
2316297|NCT02868229|4027265|FG001|Overall Study|Death|0
2316298|NCT02868229|4027266|FG002|Overall Study|Death|1
2316299|NCT02868229|4027267|FG003|Overall Study|Death|1
2316300|NCT02868229|4027264|FG000|Overall Study|Missed dose|0
2316301|NCT02868229|4027265|FG001|Overall Study|Missed dose|0
2316302|NCT02868229|4027266|FG002|Overall Study|Missed dose|0
2316303|NCT02868229|4027267|FG003|Overall Study|Missed dose|3
2316304|NCT02868281|4027290|FG000|Overall Study|Adverse Event|2
2316305|NCT02868281|4027291|FG001|Overall Study|Adverse Event|2
2316306|NCT02868281|4027290|FG000|Overall Study|Protocol Violation|13
2316307|NCT02868281|4027291|FG001|Overall Study|Protocol Violation|10
2316308|NCT02868281|4027290|FG000|Overall Study|Lost to Follow-up|3
2316309|NCT02868281|4027291|FG001|Overall Study|Lost to Follow-up|6
2316310|NCT02868281|4027290|FG000|Overall Study|Withdrawal by Subject|11
2316311|NCT02868281|4027291|FG001|Overall Study|Withdrawal by Subject|15
2316312|NCT02868281|4027290|FG000|Overall Study|Physician Decision|2
2316313|NCT02868281|4027291|FG001|Overall Study|Physician Decision|0
2316314|NCT02868281|4027290|FG000|Overall Study|Had protocol-defined asthma exacerbation|8
2316315|NCT02868281|4027291|FG001|Overall Study|Had protocol-defined asthma exacerbation|8
2316316|NCT02868281|4027290|FG000|Overall Study|Inclusion/exclusion criteria violation|3
2316317|NCT02868281|4027291|FG001|Overall Study|Inclusion/exclusion criteria violation|2
2316318|NCT02868281|4027290|FG000|Overall Study|Long journey/moving away|1
2316319|NCT02868281|4027291|FG001|Overall Study|Long journey/moving away|1
2316320|NCT02868554|4027300|FG000|Overall Study|Lost to Follow-up|3
2316321|NCT02868554|4027301|FG001|Overall Study|Lost to Follow-up|0
2316322|NCT02868554|4027302|FG002|Overall Study|Lost to Follow-up|1
2316323|NCT02869438|4027342|FG000|Overall Study|Lost to Follow-up|1
2316324|NCT02869438|4027343|FG001|Overall Study|Lost to Follow-up|0
2316325|NCT02869438|4027342|FG000|Overall Study|Adverse Event|1
2316326|NCT02869438|4027343|FG001|Overall Study|Adverse Event|0
2316327|NCT02869438|4027342|FG000|Overall Study|Withdrawal by Subject|1
2316328|NCT02869438|4027343|FG001|Overall Study|Withdrawal by Subject|2
2316329|NCT02869893|4027353|FG000|Overall Study|participant aversion to IV|5
2316330|NCT02869893|4027353|FG000|Overall Study|participant fear of MRI scanner|2
2316331|NCT02870933|4027418|FG000|Overall Study|Death|2
2316332|NCT02870933|4027419|FG001|Overall Study|Death|1
2316333|NCT02870933|4027418|FG000|Overall Study|Withdrawal by Subject|0
2316334|NCT02870933|4027419|FG001|Overall Study|Withdrawal by Subject|1
2316335|NCT02870972|4027431|FG000|Overall Study|Adverse Event|1
2316336|NCT02870972|4027432|FG001|Overall Study|Adverse Event|0
2316337|NCT02870972|4027433|FG002|Overall Study|Adverse Event|0
2316338|NCT02870972|4027434|FG003|Overall Study|Adverse Event|0
2316339|NCT02870972|4027435|FG004|Overall Study|Adverse Event|0
2316340|NCT02871375|4027471|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
2316341|NCT02871375|4027472|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
2316342|NCT02871492|4027512|FG000|Overall Study|Lost to Follow-up|6
2316343|NCT02871492|4027513|FG001|Overall Study|Lost to Follow-up|3
2316344|NCT02871492|4027514|FG002|Overall Study|Lost to Follow-up|5
2316345|NCT02871492|4027512|FG000|Overall Study|Withdrawal by Subject|0
2316346|NCT02871492|4027513|FG001|Overall Study|Withdrawal by Subject|0
2316347|NCT02871492|4027514|FG002|Overall Study|Withdrawal by Subject|1
2316348|NCT02871635|4027533|FG000|Overall Study|Primary lack of efficacy|4
2358960|NCT02076178|4119469|FG000|Oral Phase|Adverse Event|0
2358961|NCT02076178|4119470|FG001|Oral Phase|Adverse Event|7
2358962|NCT02076178|4119469|FG000|Oral Phase|Withdrawal by Subject|0
2358963|NCT02076178|4119470|FG001|Oral Phase|Withdrawal by Subject|4
2358964|NCT02076178|4119469|FG000|Oral Phase|Physician Decision|0
2358965|NCT02076178|4119470|FG001|Oral Phase|Physician Decision|1
2358966|NCT02076178|4119469|FG000|Injection Phase|Protocol defined stopping criteria|1
2358967|NCT02076178|4119470|FG001|Injection Phase|Protocol defined stopping criteria|0
2358968|NCT02076178|4119469|FG000|Injection Phase|Withdrawal by Subject|0
2358969|NCT02076178|4119470|FG001|Injection Phase|Withdrawal by Subject|3
2358970|NCT02076178|4119469|FG000|Injection Phase|Physician Decision|0
2358971|NCT02076178|4119470|FG001|Injection Phase|Physician Decision|3
2358972|NCT02076178|4119469|FG000|Injection Phase|Lost to Follow-up|0
2358973|NCT02076178|4119470|FG001|Injection Phase|Lost to Follow-up|1
2358974|NCT02079766|4119480|FG000|Overall Study|Physician Decision|1
2358975|NCT02079766|4119481|FG001|Overall Study|Physician Decision|0
2358976|NCT02079766|4119480|FG000|Overall Study|Withdrawal by Subject|1
2358977|NCT02079766|4119481|FG001|Overall Study|Withdrawal by Subject|0
2316349|NCT02871635|4027534|FG001|Overall Study|Primary lack of efficacy|4
2316350|NCT02871635|4027533|FG000|Overall Study|Protocol Violation|3
2316351|NCT02871635|4027534|FG001|Overall Study|Protocol Violation|1
2316352|NCT02871635|4027533|FG000|Overall Study|Lost to Follow-up|1
2316353|NCT02871635|4027534|FG001|Overall Study|Lost to Follow-up|2
2316354|NCT02871635|4027533|FG000|Overall Study|Pregnancy|0
2316355|NCT02871635|4027534|FG001|Overall Study|Pregnancy|2
2316356|NCT02871635|4027533|FG000|Overall Study|Physician Decision|1
2316357|NCT02871635|4027534|FG001|Overall Study|Physician Decision|1
2316358|NCT02871635|4027533|FG000|Overall Study|Withdrawal by Subject|3
2316359|NCT02871635|4027534|FG001|Overall Study|Withdrawal by Subject|4
2316360|NCT02871635|4027533|FG000|Overall Study|Adverse Event|4
2316361|NCT02871635|4027534|FG001|Overall Study|Adverse Event|4
2316362|NCT02871635|4027533|FG000|Overall Study|Secondary lack of efficacy|2
2316363|NCT02871635|4027534|FG001|Overall Study|Secondary lack of efficacy|1
2316364|NCT02871739|4027546|FG000|Overall Study|Lost to Follow-up|3
2316365|NCT02871739|4027547|FG001|Overall Study|Lost to Follow-up|2
2316366|NCT02871739|4027548|FG002|Overall Study|Lost to Follow-up|0
2316367|NCT02871739|4027549|FG003|Overall Study|Lost to Follow-up|2
2322118|NCT02969018|4037018|FG001|Overall Study|Non-Compliance With Study Drug|0
2322119|NCT02969018|4037019|FG002|Overall Study|Non-Compliance With Study Drug|0
2322120|NCT02969018|4037020|FG003|Overall Study|Non-Compliance With Study Drug|0
2322121|NCT02969018|4037021|FG004|Overall Study|Non-Compliance With Study Drug|0
2322122|NCT02969018|4037022|FG005|Overall Study|Non-Compliance With Study Drug|0
2322123|NCT02969018|4037023|FG006|Overall Study|Non-Compliance With Study Drug|0
2322124|NCT02969018|4037024|FG007|Overall Study|Non-Compliance With Study Drug|0
2322125|NCT02969018|4037017|FG000|Overall Study|Other|0
2322126|NCT02969018|4037018|FG001|Overall Study|Other|0
2322127|NCT02969018|4037019|FG002|Overall Study|Other|0
2322128|NCT02969018|4037020|FG003|Overall Study|Other|1
2322129|NCT02969018|4037021|FG004|Overall Study|Other|0
2322130|NCT02969018|4037022|FG005|Overall Study|Other|0
2322131|NCT02969018|4037023|FG006|Overall Study|Other|0
2322132|NCT02969018|4037024|FG007|Overall Study|Other|2
2322133|NCT02969018|4037017|FG000|Overall Study|Pregnancy|0
2322134|NCT02969018|4037018|FG001|Overall Study|Pregnancy|0
2322135|NCT02969018|4037019|FG002|Overall Study|Pregnancy|0
2322136|NCT02969018|4037020|FG003|Overall Study|Pregnancy|0
2214843|NCT01691248|3857489|FG000|Overall Study|Reason not provided|4
2214844|NCT01691248|3857490|FG001|Overall Study|Reason not provided|4
2214845|NCT01691248|3857489|FG000|Overall Study|Not Treated|4
2214846|NCT01691248|3857490|FG001|Overall Study|Not Treated|7
2214847|NCT01691378|3857543|FG000|Overall Study|Withdrawal by Subject|2
2214848|NCT01691378|3857544|FG001|Overall Study|Withdrawal by Subject|0
2214849|NCT01691378|3857543|FG000|Overall Study|Lost to Follow-up|5
2214850|NCT01691378|3857544|FG001|Overall Study|Lost to Follow-up|2
2214851|NCT01691430|3857552|FG000|Overall Study|Death|17
2214852|NCT01691430|3857553|FG001|Overall Study|Death|16
2322137|NCT02969018|4037021|FG004|Overall Study|Pregnancy|0
2322138|NCT02969018|4037022|FG005|Overall Study|Pregnancy|1
2322139|NCT02969018|4037023|FG006|Overall Study|Pregnancy|0
2322140|NCT02969018|4037024|FG007|Overall Study|Pregnancy|0
2322141|NCT02969018|4037017|FG000|Overall Study|Protocol Violation|0
2322142|NCT02969018|4037018|FG001|Overall Study|Protocol Violation|0
2322143|NCT02969018|4037019|FG002|Overall Study|Protocol Violation|1
2322144|NCT02969018|4037020|FG003|Overall Study|Protocol Violation|1
2322145|NCT02969018|4037021|FG004|Overall Study|Protocol Violation|0
2322146|NCT02969018|4037022|FG005|Overall Study|Protocol Violation|0
2322147|NCT02969018|4037023|FG006|Overall Study|Protocol Violation|0
2322148|NCT02969018|4037024|FG007|Overall Study|Protocol Violation|0
2322149|NCT02969018|4037017|FG000|Overall Study|Withdrawal by Subject|0
2322150|NCT02969018|4037018|FG001|Overall Study|Withdrawal by Subject|1
2322151|NCT02969018|4037019|FG002|Overall Study|Withdrawal by Subject|2
2322152|NCT02969018|4037020|FG003|Overall Study|Withdrawal by Subject|1
2322153|NCT02969018|4037021|FG004|Overall Study|Withdrawal by Subject|0
2322154|NCT02969018|4037022|FG005|Overall Study|Withdrawal by Subject|4
2322155|NCT02969018|4037023|FG006|Overall Study|Withdrawal by Subject|4
2322156|NCT02969018|4037024|FG007|Overall Study|Withdrawal by Subject|3
2358978|NCT02081391|4119491|FG000|12-hour Treatment|Withdrawal by Subject|3
2358979|NCT02081391|4119492|FG001|12-hour Treatment|Withdrawal by Subject|2
2358980|NCT02081391|4119493|FG002|12-hour Treatment|Withdrawal by Subject|0
2358981|NCT02081391|4119494|FG003|12-hour Treatment|Withdrawal by Subject|0
2358982|NCT02081391|4119491|FG000|12-hour Treatment|Physician Decision|4
2358983|NCT02081391|4119492|FG001|12-hour Treatment|Physician Decision|1
2358984|NCT02081391|4119493|FG002|12-hour Treatment|Physician Decision|0
2358985|NCT02081391|4119494|FG003|12-hour Treatment|Physician Decision|0
2358986|NCT02081391|4119491|FG000|12-hour Treatment|Lack of Efficacy|3
2358987|NCT02081391|4119492|FG001|12-hour Treatment|Lack of Efficacy|0
2358988|NCT02081391|4119493|FG002|12-hour Treatment|Lack of Efficacy|0
2358989|NCT02081391|4119494|FG003|12-hour Treatment|Lack of Efficacy|0
2358990|NCT02081391|4119491|FG000|12-hour Treatment|Adverse Event|4
2358991|NCT02081391|4119492|FG001|12-hour Treatment|Adverse Event|2
2322157|NCT02969044|4037056|FG000|Overall Study|Withdrawal by Subject|2
2322158|NCT02969044|4037057|FG001|Overall Study|Withdrawal by Subject|6
2214853|NCT01691430|3857552|FG000|Overall Study|Withdrawal by Subject|5
2358992|NCT02081391|4119493|FG002|12-hour Treatment|Adverse Event|0
2316368|NCT02872012|4027564|FG000|Overall Study|Withdrawal by Subject|1
2316369|NCT02872012|4027565|FG001|Overall Study|Withdrawal by Subject|0
2316370|NCT02872012|4027566|FG002|Overall Study|Withdrawal by Subject|0
2316371|NCT02872012|4027567|FG003|Overall Study|Withdrawal by Subject|0
2316372|NCT02872012|4027568|FG004|Overall Study|Withdrawal by Subject|0
2316373|NCT02872142|4027593|FG000|Overall Study|Adverse Event|2
2316374|NCT02872142|4027593|FG000|Overall Study|Death|1
2316375|NCT02872142|4027593|FG000|Overall Study|Participant Decision|3
2316376|NCT02872285|4027599|FG000|Overall Study|Withdrawal by Subject|2
2316377|NCT02872285|4027600|FG001|Overall Study|Withdrawal by Subject|0
2316378|NCT02872285|4027599|FG000|Overall Study|Lost to Follow-up|2
2316379|NCT02872285|4027600|FG001|Overall Study|Lost to Follow-up|2
2316380|NCT02872285|4027599|FG000|Overall Study|Discontinued due to back surgery|1
2316381|NCT02872285|4027600|FG001|Overall Study|Discontinued due to back surgery|0
2316382|NCT02872311|4027611|FG000|Overall Study|Death|2
2316383|NCT02872311|4027612|FG001|Overall Study|Death|0
2316384|NCT02872311|4027613|FG002|Overall Study|Death|0
2316385|NCT02872311|4027614|FG003|Overall Study|Death|0
2316386|NCT02872311|4027615|FG004|Overall Study|Death|0
2316387|NCT02872311|4027611|FG000|Overall Study|Lost to Follow-up|2
2316388|NCT02872311|4027612|FG001|Overall Study|Lost to Follow-up|0
2316389|NCT02872311|4027613|FG002|Overall Study|Lost to Follow-up|0
2316390|NCT02872311|4027614|FG003|Overall Study|Lost to Follow-up|0
2316391|NCT02872311|4027615|FG004|Overall Study|Lost to Follow-up|0
2316392|NCT02872311|4027611|FG000|Overall Study|Protocol Violation|0
2316393|NCT02872311|4027612|FG001|Overall Study|Protocol Violation|2
2316394|NCT02872311|4027613|FG002|Overall Study|Protocol Violation|1
2316395|NCT02872311|4027614|FG003|Overall Study|Protocol Violation|0
2316396|NCT02872311|4027615|FG004|Overall Study|Protocol Violation|0
2316397|NCT02872935|4027665|FG000|Overall Study|Other|0
2316398|NCT02872935|4027666|FG001|Overall Study|Other|1
2316399|NCT02873208|4027681|FG000|Overall Study|Withdrawal by Subject|36
2316400|NCT02873208|4027681|FG000|Overall Study|Lost to Follow-up|22
2316401|NCT02873208|4027681|FG000|Overall Study|Adverse Event|15
2316402|NCT02873208|4027681|FG000|Overall Study|Non-compliance with study drug|12
2316403|NCT02873208|4027681|FG000|Overall Study|Protocol Violation|8
2316404|NCT02873208|4027681|FG000|Overall Study|Pregnancy|2
2316405|NCT02873208|4027681|FG000|Overall Study|Incarceration|1
2316406|NCT02873208|4027681|FG000|Overall Study|Lack of Efficacy|1
2316407|NCT02873208|4027681|FG000|Overall Study|Physician Decision|1
2316408|NCT02873221|4027688|FG000|Treatment Period|Other Miscellaneous Reasons|0
2316409|NCT02873221|4027689|FG001|Treatment Period|Other Miscellaneous Reasons|2
2316410|NCT02873221|4027690|FG002|Treatment Period|Other Miscellaneous Reasons|1
2316411|NCT02873221|4027688|FG000|Treatment Period|Non-Compliance with Study Drug|0
2316412|NCT02873221|4027689|FG001|Treatment Period|Non-Compliance with Study Drug|3
2316413|NCT02873221|4027690|FG002|Treatment Period|Non-Compliance with Study Drug|2
2316414|NCT02873221|4027688|FG000|Treatment Period|Protocol Violation|2
2316415|NCT02873221|4027689|FG001|Treatment Period|Protocol Violation|5
2316416|NCT02873221|4027690|FG002|Treatment Period|Protocol Violation|8
2316417|NCT02873221|4027688|FG000|Treatment Period|Pregnancy|4
2316418|NCT02873221|4027689|FG001|Treatment Period|Pregnancy|6
2316419|NCT02873221|4027690|FG002|Treatment Period|Pregnancy|3
2316420|NCT02873221|4027688|FG000|Treatment Period|Lack of Qualifying Event|0
2316421|NCT02873221|4027689|FG001|Treatment Period|Lack of Qualifying Event|3
2316422|NCT02873221|4027690|FG002|Treatment Period|Lack of Qualifying Event|1
2316423|NCT02873221|4027688|FG000|Treatment Period|Withdrawal of Consent|52
2316424|NCT02873221|4027689|FG001|Treatment Period|Withdrawal of Consent|51
2316425|NCT02873221|4027690|FG002|Treatment Period|Withdrawal of Consent|41
2316426|NCT02873221|4027688|FG000|Treatment Period|Lack of Efficacy|0
2316427|NCT02873221|4027689|FG001|Treatment Period|Lack of Efficacy|17
2316428|NCT02873221|4027690|FG002|Treatment Period|Lack of Efficacy|12
2316429|NCT02873221|4027688|FG000|Treatment Period|Adverse Event|4
2316430|NCT02873221|4027689|FG001|Treatment Period|Adverse Event|9
2358993|NCT02081391|4119494|FG003|12-hour Treatment|Adverse Event|0
2358994|NCT02081391|4119491|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2
2358995|NCT02081391|4119492|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0
2358996|NCT02081391|4119493|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1
2358997|NCT02081391|4119494|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0
2358998|NCT02081391|4119491|FG000|12-hour Treatment|Further reasons|2
2358999|NCT02081391|4119492|FG001|12-hour Treatment|Further reasons|1
2359000|NCT02081391|4119493|FG002|12-hour Treatment|Further reasons|0
2359001|NCT02081391|4119494|FG003|12-hour Treatment|Further reasons|0
2359002|NCT02081391|4119491|FG000|24-hour Treatment and Trial Completion|Physician Decision|10
2359003|NCT02081391|4119492|FG001|24-hour Treatment and Trial Completion|Physician Decision|5
2359004|NCT02081391|4119493|FG002|24-hour Treatment and Trial Completion|Physician Decision|0
2359005|NCT02081391|4119494|FG003|24-hour Treatment and Trial Completion|Physician Decision|0
2359006|NCT02081391|4119491|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1
2359007|NCT02081391|4119492|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3
2359008|NCT02081391|4119493|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0
2316431|NCT02873221|4027690|FG002|Treatment Period|Adverse Event|11
2316432|NCT02873221|4027688|FG000|Treatment Period|Lost to Follow-up|26
2316433|NCT02873221|4027689|FG001|Treatment Period|Lost to Follow-up|30
2316434|NCT02873221|4027690|FG002|Treatment Period|Lost to Follow-up|26
2316435|NCT02873221|4027688|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0
2316436|NCT02873221|4027689|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2
2316437|NCT02873221|4027690|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
2316438|NCT02873221|4027688|FG000|Safety Follow-up Period|Protocol Violation|0
2316439|NCT02873221|4027689|FG001|Safety Follow-up Period|Protocol Violation|0
2316440|NCT02873221|4027690|FG002|Safety Follow-up Period|Protocol Violation|1
2214854|NCT01691430|3857553|FG001|Overall Study|Withdrawal by Subject|1
2214855|NCT01691430|3857552|FG000|Overall Study|Lost to Follow-up|0
2214856|NCT01691430|3857553|FG001|Overall Study|Lost to Follow-up|3
2214857|NCT01691482|3857559|FG000|Treatment Period 2|Adverse Event|0
2214858|NCT01691482|3857560|FG001|Treatment Period 2|Adverse Event|1
2214859|NCT01691482|3857559|FG000|Treatment Period 2|Protocol Violation|1
2214860|NCT01691482|3857560|FG001|Treatment Period 2|Protocol Violation|1
2214861|NCT01691508|3857569|FG000|Overall Study|Adverse Event|3
2214862|NCT01691508|3857570|FG001|Overall Study|Adverse Event|3
2214863|NCT01691508|3857569|FG000|Overall Study|Withdrawal by Subject|1
2214864|NCT01691508|3857570|FG001|Overall Study|Withdrawal by Subject|0
2214865|NCT01691521|3857579|FG000|Overall Study|Adverse Event|4
2214866|NCT01691521|3857580|FG001|Overall Study|Adverse Event|0
2214867|NCT01691521|3857581|FG002|Overall Study|Adverse Event|1
2214868|NCT01691521|3857579|FG000|Overall Study|Lack of Efficacy|1
2214869|NCT01691521|3857580|FG001|Overall Study|Lack of Efficacy|1
2214870|NCT01691521|3857581|FG002|Overall Study|Lack of Efficacy|2
2214871|NCT01691521|3857579|FG000|Overall Study|Protocol Violation|0
2214872|NCT01691521|3857580|FG001|Overall Study|Protocol Violation|3
2214873|NCT01691521|3857581|FG002|Overall Study|Protocol Violation|0
2214874|NCT01691521|3857579|FG000|Overall Study|Lost to Follow-up|0
2214875|NCT01691521|3857580|FG001|Overall Study|Lost to Follow-up|2
2316441|NCT02873221|4027688|FG000|Safety Follow-up Period|Lost to Follow-up|3
2316442|NCT02873221|4027689|FG001|Safety Follow-up Period|Lost to Follow-up|5
2316443|NCT02873221|4027690|FG002|Safety Follow-up Period|Lost to Follow-up|5
2316444|NCT02873221|4027688|FG000|Safety Follow-up Period|Withdrawal of Consent|4
2359009|NCT02081391|4119494|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0
2359010|NCT02081391|4119491|FG000|24-hour Treatment and Trial Completion|Adverse Event|1
2359011|NCT02081391|4119492|FG001|24-hour Treatment and Trial Completion|Adverse Event|0
2359012|NCT02081391|4119493|FG002|24-hour Treatment and Trial Completion|Adverse Event|0
2359013|NCT02081391|4119494|FG003|24-hour Treatment and Trial Completion|Adverse Event|0
2359014|NCT02081391|4119491|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
2359015|NCT02081391|4119492|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
2359016|NCT02081391|4119493|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
2359017|NCT02081391|4119494|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
2359018|NCT02081391|4119491|FG000|24-hour Treatment and Trial Completion|Technical Problems|1
2359019|NCT02081391|4119492|FG001|24-hour Treatment and Trial Completion|Technical Problems|1
2359020|NCT02081391|4119493|FG002|24-hour Treatment and Trial Completion|Technical Problems|0
2359021|NCT02081391|4119494|FG003|24-hour Treatment and Trial Completion|Technical Problems|0
2359022|NCT02081391|4119491|FG000|24-hour Treatment and Trial Completion|Further reasons|3
2359023|NCT02081391|4119492|FG001|24-hour Treatment and Trial Completion|Further reasons|4
2359024|NCT02081391|4119493|FG002|24-hour Treatment and Trial Completion|Further reasons|0
2359025|NCT02081391|4119494|FG003|24-hour Treatment and Trial Completion|Further reasons|0
2214876|NCT01691521|3857581|FG002|Overall Study|Lost to Follow-up|2
2214877|NCT01691521|3857579|FG000|Overall Study|Physician Decision|2
2214878|NCT01691521|3857580|FG001|Overall Study|Physician Decision|1
2214879|NCT01691521|3857581|FG002|Overall Study|Physician Decision|0
2214880|NCT01691521|3857579|FG000|Overall Study|Withdrawal by Subject|5
2214881|NCT01691521|3857580|FG001|Overall Study|Withdrawal by Subject|9
2316445|NCT02873221|4027689|FG001|Safety Follow-up Period|Withdrawal of Consent|10
2316446|NCT02873221|4027690|FG002|Safety Follow-up Period|Withdrawal of Consent|8
2316447|NCT02873338|4027722|FG000|Overall Study|Adverse Event|0
2316448|NCT02873338|4027723|FG001|Overall Study|Adverse Event|2
2316449|NCT02873338|4027724|FG002|Overall Study|Adverse Event|1
2316450|NCT02873338|4027722|FG000|Overall Study|Death|2
2316451|NCT02873338|4027723|FG001|Overall Study|Death|1
2316452|NCT02873338|4027724|FG002|Overall Study|Death|1
2316453|NCT02873338|4027722|FG000|Overall Study|Withdrawal by Subject|2
2316454|NCT02873338|4027723|FG001|Overall Study|Withdrawal by Subject|1
2316455|NCT02873338|4027724|FG002|Overall Study|Withdrawal by Subject|3
2316456|NCT02873338|4027722|FG000|Overall Study|Lack of Efficacy|0
2316457|NCT02873338|4027723|FG001|Overall Study|Lack of Efficacy|2
2316458|NCT02873338|4027724|FG002|Overall Study|Lack of Efficacy|0
2316459|NCT02873338|4027722|FG000|Overall Study|Other or Missing|14
2316460|NCT02873338|4027723|FG001|Overall Study|Other or Missing|15
2316461|NCT02873338|4027724|FG002|Overall Study|Other or Missing|13
2316462|NCT02873377|4027734|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
2316463|NCT02873377|4027735|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
2316464|NCT02873377|4027734|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
2316465|NCT02873377|4027735|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
2316466|NCT02873429|4027744|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
2316467|NCT02873429|4027745|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
2316468|NCT02873429|4027744|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2
2316469|NCT02873429|4027745|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2
2316470|NCT02873429|4027744|FG000|16 Weeks|Lost to Follow-up|3
2316471|NCT02873429|4027745|FG001|16 Weeks|Lost to Follow-up|0
2316472|NCT02873689|4027770|FG000|Overall Study|Lack of Efficacy|1
2316473|NCT02873689|4027771|FG001|Overall Study|Lack of Efficacy|0
2316474|NCT02873689|4027770|FG000|Overall Study|Withdrawal by Subject|2
2316475|NCT02873689|4027771|FG001|Overall Study|Withdrawal by Subject|2
2316476|NCT02873689|4027770|FG000|Overall Study|Protocol Violation|1
2316477|NCT02873689|4027771|FG001|Overall Study|Protocol Violation|0
2316478|NCT02873689|4027770|FG000|Overall Study|Adverse Event|2
2316479|NCT02873689|4027771|FG001|Overall Study|Adverse Event|2
2316480|NCT02873689|4027770|FG000|Overall Study|Randomized but not Treated|1
2316481|NCT02873689|4027771|FG001|Overall Study|Randomized but not Treated|1
2316482|NCT02873702|4027779|FG000|Healing Period (up to Week 8)|Adverse Event|1
2316483|NCT02873702|4027780|FG001|Healing Period (up to Week 8)|Adverse Event|0
2316484|NCT02873702|4027781|FG002|Healing Period (up to Week 8)|Adverse Event|0
2316485|NCT02873702|4027782|FG003|Healing Period (up to Week 8)|Adverse Event|0
2316486|NCT02873702|4027779|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0
2316487|NCT02873702|4027780|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1
2316488|NCT02873702|4027781|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0
2316489|NCT02873702|4027782|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0
2316490|NCT02873702|4027779|FG000|Maintenance Period (up to Month 6)|Adverse Event|0
2316491|NCT02873702|4027780|FG001|Maintenance Period (up to Month 6)|Adverse Event|0
2316492|NCT02873702|4027781|FG002|Maintenance Period (up to Month 6)|Adverse Event|1
2316493|NCT02873702|4027782|FG003|Maintenance Period (up to Month 6)|Adverse Event|0
2316494|NCT02873702|4027779|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0
2316495|NCT02873702|4027780|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0
2316496|NCT02873702|4027781|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4
2316497|NCT02873702|4027782|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1
2316498|NCT02873702|4027779|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
2316499|NCT02873702|4027780|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
2316500|NCT02873702|4027781|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
2316501|NCT02873702|4027782|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
2316502|NCT02873754|4027792|FG000|Overall Study|Lost to Follow-up|5
2316503|NCT02873754|4027792|FG000|Overall Study|Couldn't complete study procedures|1
2316504|NCT02873936|4027803|FG000|Overall Study|Withdrew Consent|4
2316505|NCT02873936|4027804|FG001|Overall Study|Withdrew Consent|11
2316506|NCT02873936|4027805|FG002|Overall Study|Withdrew Consent|20
2316507|NCT02873936|4027803|FG000|Overall Study|Investigator's Discretion|3
2316508|NCT02873936|4027804|FG001|Overall Study|Investigator's Discretion|5
2316509|NCT02873936|4027805|FG002|Overall Study|Investigator's Discretion|4
2316510|NCT02873936|4027803|FG000|Overall Study|Adverse Event|3
2316511|NCT02873936|4027804|FG001|Overall Study|Adverse Event|5
2316512|NCT02873936|4027805|FG002|Overall Study|Adverse Event|3
2316513|NCT02873936|4027803|FG000|Overall Study|Protocol Violation|0
2316514|NCT02873936|4027804|FG001|Overall Study|Protocol Violation|1
2316515|NCT02873936|4027805|FG002|Overall Study|Protocol Violation|3
2316516|NCT02873936|4027803|FG000|Overall Study|Lost to Follow-up|1
2359026|NCT02087189|4119514|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2
2359027|NCT02112916|4119522|FG000|Overall Study|Adverse Event|6
2359028|NCT02112916|4119523|FG001|Overall Study|Adverse Event|9
2359029|NCT02112916|4119524|FG002|Overall Study|Adverse Event|3
2359030|NCT02112916|4119525|FG003|Overall Study|Adverse Event|2
2359031|NCT02112916|4119522|FG000|Overall Study|Death|9
2359032|NCT02112916|4119523|FG001|Overall Study|Death|9
2359033|NCT02112916|4119524|FG002|Overall Study|Death|3
2359034|NCT02112916|4119525|FG003|Overall Study|Death|4
2316517|NCT02873936|4027804|FG001|Overall Study|Lost to Follow-up|1
2316518|NCT02873936|4027805|FG002|Overall Study|Lost to Follow-up|1
2316519|NCT02873936|4027803|FG000|Overall Study|Non-compliance With Study Drug|1
2316520|NCT02873936|4027804|FG001|Overall Study|Non-compliance With Study Drug|0
2316521|NCT02873936|4027805|FG002|Overall Study|Non-compliance With Study Drug|1
2316522|NCT02873936|4027803|FG000|Overall Study|Randomized but not Dosed|1
2316523|NCT02873936|4027804|FG001|Overall Study|Randomized but not Dosed|0
2316524|NCT02873936|4027805|FG002|Overall Study|Randomized but not Dosed|0
2316525|NCT02874534|4027832|FG000|Overall Study|Withdrawal by Subject|5
2316526|NCT02874534|4027833|FG001|Overall Study|Withdrawal by Subject|8
2316527|NCT02874534|4027832|FG000|Overall Study|Lost to Follow-up|2
2316528|NCT02874534|4027833|FG001|Overall Study|Lost to Follow-up|2
2316529|NCT02874534|4027832|FG000|Overall Study|Ongoing in study|1
2316530|NCT02874534|4027833|FG001|Overall Study|Ongoing in study|1
2316531|NCT02874794|4027841|FG000|Overall Study|Physician Decision|3
2316532|NCT02874794|4027842|FG001|Overall Study|Physician Decision|2
2316533|NCT02874794|4027841|FG000|Overall Study|Withdrawal by Subject|2
2316534|NCT02874794|4027842|FG001|Overall Study|Withdrawal by Subject|8
2316535|NCT02874794|4027841|FG000|Overall Study|Death|2
2316536|NCT02874794|4027842|FG001|Overall Study|Death|1
2316537|NCT02874924|4027864|FG000|Overall Study|Adverse Event|2
2316538|NCT02874924|4027865|FG001|Overall Study|Adverse Event|0
2316539|NCT02874924|4027866|FG002|Overall Study|Adverse Event|0
2316540|NCT02874924|4027864|FG000|Overall Study|Withdrawal by Subject|1
2316541|NCT02874924|4027865|FG001|Overall Study|Withdrawal by Subject|0
2316542|NCT02874924|4027866|FG002|Overall Study|Withdrawal by Subject|0
2316543|NCT02875028|4027876|FG000|Washout Period|Withdrawal by Subject|0
2316544|NCT02875028|4027877|FG001|Washout Period|Withdrawal by Subject|1
2316545|NCT02875080|4027888|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2
2316546|NCT02875080|4027889|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
2316547|NCT02875080|4027890|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
2316548|NCT02875340|4027898|FG000|Overall Study|Death|2
2316549|NCT02875340|4027898|FG000|Overall Study|Withdrawal by Subject|2
2316550|NCT02875340|4027898|FG000|Overall Study|Physician Decision|3
2316551|NCT02875340|4027898|FG000|Overall Study|Adverse Event|1
2316552|NCT02875366|4027910|FG000|Overall Study|Adverse Event|0
2316553|NCT02875366|4027911|FG001|Overall Study|Adverse Event|2
2316554|NCT02875366|4027910|FG000|Overall Study|Noncompliance|0
2316555|NCT02875366|4027911|FG001|Overall Study|Noncompliance|1
2316556|NCT02875392|4027919|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7
2316557|NCT02875392|4027920|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8
2316558|NCT02875613|4027926|FG000|Overall Study|Withdrawal by Subject|1
2316559|NCT02875834|4027934|FG000|Open-label Phase|Withdrawal by Subject|3
2316560|NCT02875834|4027935|FG001|Open-label Phase|Withdrawal by Subject|0
2316561|NCT02875834|4027936|FG002|Open-label Phase|Withdrawal by Subject|0
2316562|NCT02875834|4027937|FG003|Open-label Phase|Withdrawal by Subject|0
2316563|NCT02875834|4027934|FG000|Open-label Phase|(Not collected)|4
2316564|NCT02875834|4027935|FG001|Open-label Phase|(Not collected)|0
2316565|NCT02875834|4027936|FG002|Open-label Phase|(Not collected)|0
2316566|NCT02875834|4027937|FG003|Open-label Phase|(Not collected)|0
2316567|NCT02875834|4027934|FG000|Randomized Treatment Phase|Withdrawal by Subject|0
2316568|NCT02875834|4027935|FG001|Randomized Treatment Phase|Withdrawal by Subject|3
2316569|NCT02875834|4027936|FG002|Randomized Treatment Phase|Withdrawal by Subject|1
2316570|NCT02875834|4027937|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
2316571|NCT02875834|4027934|FG000|Randomized Treatment Phase|Protocol Violation|0
2316572|NCT02875834|4027935|FG001|Randomized Treatment Phase|Protocol Violation|2
2316573|NCT02875834|4027936|FG002|Randomized Treatment Phase|Protocol Violation|0
2359035|NCT02112916|4119522|FG000|Overall Study|Lost to Follow-up|1
2359036|NCT02112916|4119523|FG001|Overall Study|Lost to Follow-up|0
2359037|NCT02112916|4119524|FG002|Overall Study|Lost to Follow-up|0
2359038|NCT02112916|4119525|FG003|Overall Study|Lost to Follow-up|0
2359039|NCT02112916|4119522|FG000|Overall Study|Physician Decision|94
2359040|NCT02112916|4119523|FG001|Overall Study|Physician Decision|72
2359041|NCT02112916|4119524|FG002|Overall Study|Physician Decision|24
2359042|NCT02112916|4119525|FG003|Overall Study|Physician Decision|15
2359043|NCT02112916|4119522|FG000|Overall Study|Withdrawal by Subject|5
2359044|NCT02112916|4119523|FG001|Overall Study|Withdrawal by Subject|3
2359045|NCT02112916|4119524|FG002|Overall Study|Withdrawal by Subject|1
2359046|NCT02112916|4119525|FG003|Overall Study|Withdrawal by Subject|1
2359047|NCT02112916|4119522|FG000|Overall Study|Ineligible|4
2359048|NCT02112916|4119523|FG001|Overall Study|Ineligible|8
2359049|NCT02112916|4119524|FG002|Overall Study|Ineligible|3
2359050|NCT02112916|4119525|FG003|Overall Study|Ineligible|8
2359051|NCT02112916|4119522|FG000|Overall Study|Inevaluable|6
2359052|NCT02112916|4119523|FG001|Overall Study|Inevaluable|4
2359053|NCT02112916|4119524|FG002|Overall Study|Inevaluable|5
2359054|NCT02112916|4119525|FG003|Overall Study|Inevaluable|5
2359055|NCT02112916|4119522|FG000|Overall Study|Refusal of further protocol therapy|19
2359056|NCT02112916|4119523|FG001|Overall Study|Refusal of further protocol therapy|16
2359057|NCT02112916|4119524|FG002|Overall Study|Refusal of further protocol therapy|1
2359058|NCT02112916|4119525|FG003|Overall Study|Refusal of further protocol therapy|7
2359059|NCT02112916|4119522|FG000|Overall Study|Development of SMN|1
2316574|NCT02875834|4027937|FG003|Randomized Treatment Phase|Protocol Violation|0
2316575|NCT02875834|4027934|FG000|Randomized Treatment Phase|(Not collected)|0
2316576|NCT02875834|4027935|FG001|Randomized Treatment Phase|(Not collected)|9
2316577|NCT02875834|4027936|FG002|Randomized Treatment Phase|(Not collected)|10
2316578|NCT02875834|4027937|FG003|Randomized Treatment Phase|(Not collected)|9
2316579|NCT02875977|4027949|FG000|Overall Study|Lost to Follow-up|42
2316580|NCT02875977|4027950|FG001|Overall Study|Lost to Follow-up|29
2316581|NCT02876601|4027990|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
2316582|NCT02876601|4027991|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
2316583|NCT02876601|4027992|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
2316584|NCT02876601|4027993|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
2214882|NCT01691521|3857581|FG002|Overall Study|Withdrawal by Subject|4
2316585|NCT02877004|4028085|FG000|Overall Study|Pregnancy|0
2316586|NCT02877004|4028086|FG001|Overall Study|Pregnancy|0
2316587|NCT02877004|4028087|FG002|Overall Study|Pregnancy|1
2316588|NCT02877082|4028095|FG000|Overall Study|Trial was closed early|5
2316589|NCT02877680|4028120|FG000|Overall Study|Lost to Follow-up|1
2316590|NCT02877680|4028121|FG001|Overall Study|Lost to Follow-up|1
2316591|NCT02877927|4028133|FG000|Overall Study|Adverse Event|1
2359060|NCT02112916|4119523|FG001|Overall Study|Development of SMN|0
2359061|NCT02112916|4119524|FG002|Overall Study|Development of SMN|0
2359062|NCT02112916|4119525|FG003|Overall Study|Development of SMN|1
2359063|NCT02112916|4119522|FG000|Overall Study|Relapse/Progression|10
2359064|NCT02112916|4119523|FG001|Overall Study|Relapse/Progression|18
2359065|NCT02112916|4119524|FG002|Overall Study|Relapse/Progression|15
2359066|NCT02112916|4119525|FG003|Overall Study|Relapse/Progression|2
2359067|NCT02112916|4119522|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5
2359068|NCT02112916|4119523|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5
2359069|NCT02112916|4119524|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0
2359070|NCT02112916|4119525|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0
2359071|NCT02112916|4119522|FG000|Overall Study|Still on Therapy|44
2359072|NCT02112916|4119523|FG001|Overall Study|Still on Therapy|47
2359073|NCT02112916|4119524|FG002|Overall Study|Still on Therapy|3
2359074|NCT02112916|4119525|FG003|Overall Study|Still on Therapy|2
2359075|NCT02112916|4119522|FG000|Overall Study|Identified to have Ph+ T-ALL|0
2359076|NCT02112916|4119523|FG001|Overall Study|Identified to have Ph+ T-ALL|1
2359077|NCT02112916|4119524|FG002|Overall Study|Identified to have Ph+ T-ALL|0
2359078|NCT02112916|4119525|FG003|Overall Study|Identified to have Ph+ T-ALL|0
2359079|NCT02112916|4119522|FG000|Overall Study|Identified to have Ph+ T-Lly|0
2359080|NCT02112916|4119523|FG001|Overall Study|Identified to have Ph+ T-Lly|0
2359081|NCT02112916|4119524|FG002|Overall Study|Identified to have Ph+ T-Lly|1
2359082|NCT02112916|4119525|FG003|Overall Study|Identified to have Ph+ T-Lly|0
2316592|NCT02877927|4028134|FG001|Overall Study|Adverse Event|0
2316593|NCT02877927|4028133|FG000|Overall Study|Lost to Follow-up|37
2316594|NCT02877927|4028134|FG001|Overall Study|Lost to Follow-up|38
2316595|NCT02877927|4028133|FG000|Overall Study|Withdrawal by Subject|11
2316596|NCT02877927|4028134|FG001|Overall Study|Withdrawal by Subject|12
2316597|NCT02877927|4028133|FG000|Overall Study|Physician Decision|0
2316598|NCT02877927|4028134|FG001|Overall Study|Physician Decision|1
2316599|NCT02877927|4028133|FG000|Overall Study|Missed EOT/PTE Visit|5
2316600|NCT02877927|4028134|FG001|Overall Study|Missed EOT/PTE Visit|6
2316601|NCT02878213|4028144|FG000|Overall Study|Withdrawal by Subject|2
2316602|NCT02878213|4028144|FG000|Overall Study|Adverse Event|1
2316603|NCT02878330|4028151|FG000|Overall Study|Death|3
2316604|NCT02878330|4028152|FG001|Overall Study|Death|2
2316605|NCT02878330|4028151|FG000|Overall Study|Lost to Follow-up|11
2316606|NCT02878330|4028152|FG001|Overall Study|Lost to Follow-up|26
2316607|NCT02878330|4028151|FG000|Overall Study|Withdrawal by Subject|11
2316608|NCT02878330|4028152|FG001|Overall Study|Withdrawal by Subject|21
2316609|NCT02878330|4028151|FG000|Overall Study|Other|4
2316610|NCT02878330|4028152|FG001|Overall Study|Other|7
2316611|NCT02878590|4028177|FG000|Overall Study|Withdrawal by Subject|2
2316612|NCT02878603|4028183|FG000|Overall Study|Lost to Follow-up|4
2316613|NCT02878603|4028184|FG001|Overall Study|Lost to Follow-up|1
2316614|NCT02878603|4028183|FG000|Overall Study|Withdrawal by Subject|1
2316615|NCT02878603|4028184|FG001|Overall Study|Withdrawal by Subject|1
2316616|NCT02878603|4028183|FG000|Overall Study|Death|1
2316617|NCT02878603|4028184|FG001|Overall Study|Death|0
2316618|NCT02878603|4028183|FG000|Overall Study|Physician Decision|0
2316619|NCT02878603|4028184|FG001|Overall Study|Physician Decision|3
2316620|NCT02879383|4028209|FG000|First 24 Weeks|Physician Decision|0
2316621|NCT02879383|4028210|FG001|First 24 Weeks|Physician Decision|1
2316622|NCT02879383|4028211|FG002|First 24 Weeks|Physician Decision|0
2316623|NCT02879383|4028212|FG003|First 24 Weeks|Physician Decision|0
2316624|NCT02879578|4028227|FG000|Overall Study|Adverse Event|1
2316625|NCT02879578|4028228|FG001|Overall Study|Adverse Event|2
2316626|NCT02879578|4028229|FG002|Overall Study|Adverse Event|14
2316627|NCT02879578|4028227|FG000|Overall Study|Protocol Violation|0
2316628|NCT02879578|4028228|FG001|Overall Study|Protocol Violation|1
2316629|NCT02879578|4028229|FG002|Overall Study|Protocol Violation|1
2316630|NCT02879578|4028227|FG000|Overall Study|Withdrawal by Subject|8
2316631|NCT02879578|4028228|FG001|Overall Study|Withdrawal by Subject|6
2316632|NCT02879578|4028229|FG002|Overall Study|Withdrawal by Subject|9
2316633|NCT02879578|4028227|FG000|Overall Study|Lost to Follow-up|1
2316634|NCT02879578|4028228|FG001|Overall Study|Lost to Follow-up|0
2316635|NCT02879578|4028229|FG002|Overall Study|Lost to Follow-up|4
2316636|NCT02879578|4028227|FG000|Overall Study|Physician Decision|0
2316637|NCT02879578|4028228|FG001|Overall Study|Physician Decision|0
2316638|NCT02879578|4028229|FG002|Overall Study|Physician Decision|4
2316639|NCT02879994|4028268|FG000|Overall Study|off treatment early|7
2316640|NCT02879994|4028268|FG000|Overall Study|Adverse Event|2
2316641|NCT02879994|4028268|FG000|Overall Study|Death|2
2316642|NCT02880761|4028323|FG000|Overall Study|Death|6
2316643|NCT02880761|4028324|FG001|Overall Study|Death|8
2316644|NCT02880761|4028323|FG000|Overall Study|Withdrawal by Subject|3
2316645|NCT02880761|4028324|FG001|Overall Study|Withdrawal by Subject|6
2316646|NCT02880761|4028323|FG000|Overall Study|Protocol Violation|4
2316647|NCT02880761|4028324|FG001|Overall Study|Protocol Violation|3
2316648|NCT02880761|4028323|FG000|Overall Study|Lost to Follow-up|3
2316649|NCT02880761|4028324|FG001|Overall Study|Lost to Follow-up|4
2316650|NCT02880865|4028336|FG000|Overall Study|Adverse Event|1
2316651|NCT02880865|4028337|FG001|Overall Study|Adverse Event|0
2316652|NCT02880865|4028336|FG000|Overall Study|Withdrawal by Subject|0
2316653|NCT02880865|4028337|FG001|Overall Study|Withdrawal by Subject|2
2214883|NCT01691612|3857637|FG000|Overall Study|deemed ineligible after 1st visit|6
2214884|NCT01691612|3857637|FG000|Overall Study|Adverse Event|1
2214885|NCT01691768|3857655|FG000|Overall Study|Death|0
2214886|NCT01691768|3857656|FG001|Overall Study|Death|2
2316654|NCT02880865|4028336|FG000|Overall Study|Physician Decision|0
2316655|NCT02880865|4028337|FG001|Overall Study|Physician Decision|1
2316656|NCT02881047|4028392|FG000|Overall Study|Adverse Event|1
2316657|NCT02881047|4028392|FG000|Overall Study|Withdrawal by Subject|1
2316658|NCT02881567|4028400|FG000|Overall Study|Adverse Event|1
2316659|NCT02881567|4028400|FG000|Overall Study|Lost to Follow-up|3
2316660|NCT02881567|4028400|FG000|Overall Study|Consent withdrawn|1
2316661|NCT02881567|4028400|FG000|Overall Study|Investigator decision|1
2316662|NCT02881567|4028400|FG000|Overall Study|Study terminated by sponsor|9
2316663|NCT02881567|4028400|FG000|Overall Study|Reason not Specified|3
2316664|NCT02881957|4028428|FG000|Overall Study|Comfort care|0
2316665|NCT02881957|4028429|FG001|Overall Study|Comfort care|1
2316666|NCT02881957|4028428|FG000|Overall Study|Concurrent trial enrollment|0
2316667|NCT02881957|4028429|FG001|Overall Study|Concurrent trial enrollment|1
2316668|NCT02881957|4028428|FG000|Overall Study|Discharged within 48 hours|0
2316669|NCT02881957|4028429|FG001|Overall Study|Discharged within 48 hours|1
2316670|NCT02881957|4028428|FG000|Overall Study|Withdrawal by Subject|2
2316671|NCT02881957|4028429|FG001|Overall Study|Withdrawal by Subject|1
2316672|NCT02881957|4028428|FG000|Overall Study|Protocol Violation|1
2316673|NCT02881957|4028429|FG001|Overall Study|Protocol Violation|0
2316674|NCT02882152|4028446|FG000|Overall Study|Lost to Follow-up|1
2316675|NCT02882152|4028447|FG001|Overall Study|Lost to Follow-up|0
2316676|NCT02882854|4028472|FG000|Overall Study|Lost to Follow-up|1
2316677|NCT02882854|4028473|FG001|Overall Study|Lost to Follow-up|2
2316678|NCT02882854|4028472|FG000|Overall Study|Physician Decision|0
2316679|NCT02882854|4028473|FG001|Overall Study|Physician Decision|1
2316680|NCT02883244|4028481|FG000|Overall Study|Lost to Follow-up|0
2316681|NCT02883244|4028482|FG001|Overall Study|Lost to Follow-up|1
2316682|NCT02883452|4028503|FG000|Overall Study|Withdrawal by Subject|1
2316683|NCT02883452|4028504|FG001|Overall Study|Withdrawal by Subject|1
2316684|NCT02883452|4028505|FG002|Overall Study|Withdrawal by Subject|3
2316685|NCT02883452|4028506|FG003|Overall Study|Withdrawal by Subject|0
2316686|NCT02883452|4028507|FG004|Overall Study|Withdrawal by Subject|2
2316687|NCT02883452|4028508|FG005|Overall Study|Withdrawal by Subject|5
2316688|NCT02883452|4028503|FG000|Overall Study|Disease progression|1
2316689|NCT02883452|4028504|FG001|Overall Study|Disease progression|0
2316690|NCT02883452|4028505|FG002|Overall Study|Disease progression|0
2316691|NCT02883452|4028506|FG003|Overall Study|Disease progression|1
2316692|NCT02883452|4028507|FG004|Overall Study|Disease progression|4
2359083|NCT02114697|4119542|FG000|Overall Study|Study terminated|5
2359084|NCT02114697|4119543|FG001|Overall Study|Study terminated|4
2316693|NCT02883452|4028508|FG005|Overall Study|Disease progression|5
2316694|NCT02883452|4028503|FG000|Overall Study|Adverse Event|2
2316695|NCT02883452|4028504|FG001|Overall Study|Adverse Event|1
2316696|NCT02883452|4028505|FG002|Overall Study|Adverse Event|1
2316697|NCT02883452|4028506|FG003|Overall Study|Adverse Event|1
2316698|NCT02883452|4028507|FG004|Overall Study|Adverse Event|1
2316699|NCT02883452|4028508|FG005|Overall Study|Adverse Event|3
2316700|NCT02883452|4028503|FG000|Overall Study|Physician Decision|0
2316701|NCT02883452|4028504|FG001|Overall Study|Physician Decision|0
2316702|NCT02883452|4028505|FG002|Overall Study|Physician Decision|0
2316703|NCT02883452|4028506|FG003|Overall Study|Physician Decision|0
2316704|NCT02883452|4028507|FG004|Overall Study|Physician Decision|4
2316705|NCT02883452|4028508|FG005|Overall Study|Physician Decision|1
2316706|NCT02883452|4028503|FG000|Overall Study|Death|1
2316707|NCT02883452|4028504|FG001|Overall Study|Death|0
2316708|NCT02883452|4028505|FG002|Overall Study|Death|1
2316709|NCT02883452|4028506|FG003|Overall Study|Death|0
2316710|NCT02883452|4028507|FG004|Overall Study|Death|0
2316711|NCT02883452|4028508|FG005|Overall Study|Death|0
2316712|NCT02883452|4028503|FG000|Overall Study|Other|0
2316713|NCT02883452|4028504|FG001|Overall Study|Other|0
2316714|NCT02883452|4028505|FG002|Overall Study|Other|0
2316715|NCT02883452|4028506|FG003|Overall Study|Other|0
2316716|NCT02883452|4028507|FG004|Overall Study|Other|0
2316717|NCT02883452|4028508|FG005|Overall Study|Other|1
2316718|NCT02884089|4028523|FG000|Period 1|Dosing error|2
2316719|NCT02884089|4028524|FG001|Period 1|Dosing error|2
2316720|NCT02884089|4028525|FG002|Period 1|Dosing error|0
2316721|NCT02884089|4028526|FG003|Period 1|Dosing error|0
2316722|NCT02884089|4028523|FG000|Washout Period 1|Lost to Follow-up|0
2316723|NCT02884089|4028524|FG001|Washout Period 1|Lost to Follow-up|1
2316724|NCT02884089|4028525|FG002|Washout Period 1|Lost to Follow-up|0
2316725|NCT02884089|4028526|FG003|Washout Period 1|Lost to Follow-up|1
2316726|NCT02884089|4028523|FG000|Washout Period 1|Withdrawal by Subject|0
2316727|NCT02884089|4028524|FG001|Washout Period 1|Withdrawal by Subject|1
2316728|NCT02884089|4028525|FG002|Washout Period 1|Withdrawal by Subject|0
2316729|NCT02884089|4028526|FG003|Washout Period 1|Withdrawal by Subject|0
2316730|NCT02884089|4028523|FG000|Period 2|Adverse Event|1
2316731|NCT02884089|4028524|FG001|Period 2|Adverse Event|0
2316732|NCT02884089|4028525|FG002|Period 2|Adverse Event|0
2316733|NCT02884089|4028526|FG003|Period 2|Adverse Event|0
2316734|NCT02884089|4028523|FG000|Period 3|Withdrawal by Subject|0
2316735|NCT02884089|4028524|FG001|Period 3|Withdrawal by Subject|0
2316736|NCT02884089|4028525|FG002|Period 3|Withdrawal by Subject|1
2316737|NCT02884089|4028526|FG003|Period 3|Withdrawal by Subject|0
2316738|NCT02884089|4028523|FG000|Washout Period 3|Withdrawal by Subject|0
2316739|NCT02884089|4028524|FG001|Washout Period 3|Withdrawal by Subject|0
2316740|NCT02884089|4028525|FG002|Washout Period 3|Withdrawal by Subject|1
2316741|NCT02884089|4028526|FG003|Washout Period 3|Withdrawal by Subject|0
2316742|NCT02884089|4028523|FG000|Washout Period 3|Lost to Follow-up|0
2316743|NCT02884089|4028524|FG001|Washout Period 3|Lost to Follow-up|0
2316744|NCT02884089|4028525|FG002|Washout Period 3|Lost to Follow-up|0
2316745|NCT02884089|4028526|FG003|Washout Period 3|Lost to Follow-up|1
2316746|NCT02884089|4028523|FG000|Period 4|Withdrawal by Subject|0
2316747|NCT02884089|4028524|FG001|Period 4|Withdrawal by Subject|1
2316748|NCT02884089|4028525|FG002|Period 4|Withdrawal by Subject|0
2316749|NCT02884089|4028526|FG003|Period 4|Withdrawal by Subject|0
2316750|NCT02884089|4028523|FG000|Period 4|Lost to Follow-up|1
2359085|NCT02135029|4119556|FG000|Overall Study|Adverse Event|2
2359086|NCT02135029|4119557|FG001|Overall Study|Adverse Event|2
2359087|NCT02135029|4119558|FG002|Overall Study|Adverse Event|2
2359088|NCT02135029|4119556|FG000|Overall Study|Lost to Follow-up|0
2359089|NCT02135029|4119557|FG001|Overall Study|Lost to Follow-up|1
2359090|NCT02135029|4119558|FG002|Overall Study|Lost to Follow-up|0
2359091|NCT02135029|4119556|FG000|Overall Study|Withdrawal by Subject|2
2359092|NCT02135029|4119557|FG001|Overall Study|Withdrawal by Subject|0
2359093|NCT02135029|4119558|FG002|Overall Study|Withdrawal by Subject|1
2359094|NCT02135029|4119556|FG000|Overall Study|Other|0
2359095|NCT02135029|4119557|FG001|Overall Study|Other|1
2359096|NCT02135029|4119558|FG002|Overall Study|Other|0
2359097|NCT02135029|4119556|FG000|Overall Study|Death|0
2359098|NCT02135029|4119557|FG001|Overall Study|Death|1
2359099|NCT02135029|4119558|FG002|Overall Study|Death|0
2359106|NCT02148133|4119576|FG000|Overall Study|Investigator discretion|1
2359107|NCT02148133|4119576|FG000|Overall Study|Lack of Efficacy|1
2359108|NCT02148133|4119576|FG000|Overall Study|Protocol deviation|1
2359109|NCT02148133|4119576|FG000|Overall Study|Protocol-defined stopping criteria|2
2316751|NCT02884089|4028524|FG001|Period 4|Lost to Follow-up|0
2316752|NCT02884089|4028525|FG002|Period 4|Lost to Follow-up|0
2316753|NCT02884089|4028526|FG003|Period 4|Lost to Follow-up|0
2316754|NCT02884089|4028523|FG000|Follow-up Visit|Withdrawal by Subject|1
2316755|NCT02884089|4028524|FG001|Follow-up Visit|Withdrawal by Subject|0
2316756|NCT02884089|4028525|FG002|Follow-up Visit|Withdrawal by Subject|0
2316757|NCT02884089|4028526|FG003|Follow-up Visit|Withdrawal by Subject|1
2316758|NCT02885181|4028596|FG000|Overall Study|Investigator's Discretion|0
2359110|NCT02165215|4119596|FG000|Induction Phase|Adverse Event|1
2359111|NCT02165215|4119597|FG001|Induction Phase|Adverse Event|0
2359112|NCT02165215|4119598|FG002|Induction Phase|Adverse Event|0
2359113|NCT02165215|4119596|FG000|Induction Phase|Withdrawal by Subject|10
2316759|NCT02885181|4028597|FG001|Overall Study|Investigator's Discretion|1
2316760|NCT02885181|4028598|FG002|Overall Study|Investigator's Discretion|0
2316761|NCT02885181|4028599|FG003|Overall Study|Investigator's Discretion|1
2316762|NCT02885181|4028596|FG000|Overall Study|Adverse Event|0
2316763|NCT02885181|4028597|FG001|Overall Study|Adverse Event|0
2316764|NCT02885181|4028598|FG002|Overall Study|Adverse Event|0
2316765|NCT02885181|4028599|FG003|Overall Study|Adverse Event|1
2316766|NCT02885181|4028596|FG000|Overall Study|Withdrawal by Subject|0
2316767|NCT02885181|4028597|FG001|Overall Study|Withdrawal by Subject|0
2316768|NCT02885181|4028598|FG002|Overall Study|Withdrawal by Subject|0
2316769|NCT02885181|4028599|FG003|Overall Study|Withdrawal by Subject|1
2322159|NCT02969044|4037056|FG000|Overall Study|Adverse Event|3
2322160|NCT02969044|4037057|FG001|Overall Study|Adverse Event|0
2322161|NCT02969187|4037065|FG000|Overall Study|Physician Decision|12
2322162|NCT02969187|4037066|FG001|Overall Study|Physician Decision|13
2322163|NCT02969356|4037079|FG000|Overall Study|Adverse Event|7
2322164|NCT02969356|4037079|FG000|Overall Study|Consent withdrawn|2
2322165|NCT02969356|4037079|FG000|Overall Study|Lost to Follow-up|3
2322166|NCT02969356|4037079|FG000|Overall Study|Did not need to be reinjected|6
2322167|NCT02969356|4037079|FG000|Overall Study|Personal reasons|5
2322168|NCT02969382|4037085|FG000|Overall Study|Adverse Event|8
2322169|NCT02969382|4037086|FG001|Overall Study|Adverse Event|10
2322170|NCT02969382|4037085|FG000|Overall Study|Lack of Efficacy|4
2322171|NCT02969382|4037086|FG001|Overall Study|Lack of Efficacy|5
2322172|NCT02969382|4037085|FG000|Overall Study|Death|0
2322173|NCT02969382|4037086|FG001|Overall Study|Death|1
2322174|NCT02969382|4037085|FG000|Overall Study|PROTOCOL DEVIATION|0
2322175|NCT02969382|4037086|FG001|Overall Study|PROTOCOL DEVIATION|1
2322176|NCT02969382|4037085|FG000|Overall Study|Withdrawal by Subject|14
2322177|NCT02969382|4037086|FG001|Overall Study|Withdrawal by Subject|9
2322178|NCT02969408|4037092|FG000|Overall Study|Adverse Event|2
2322179|NCT02969408|4037092|FG000|Overall Study|Withdrawal by Subject|8
2322180|NCT02969408|4037092|FG000|Overall Study|Lost to Follow-up|4
2322181|NCT02969408|4037092|FG000|Overall Study|Protocol Violation|1
2322182|NCT02969408|4037092|FG000|Overall Study|Other than specified|1
2322183|NCT02969525|4037114|FG000|Double-Blind Period|Adverse Event|0
2322184|NCT02969525|4037115|FG001|Double-Blind Period|Adverse Event|0
2322185|NCT02969525|4037116|FG002|Double-Blind Period|Adverse Event|1
2322186|NCT02969525|4037117|FG003|Double-Blind Period|Adverse Event|1
2322187|NCT02969525|4037118|FG004|Double-Blind Period|Adverse Event|0
2322188|NCT02969525|4037119|FG005|Double-Blind Period|Adverse Event|0
2322189|NCT02969525|4037120|FG006|Double-Blind Period|Adverse Event|0
2322190|NCT02969525|4037121|FG007|Double-Blind Period|Adverse Event|0
2322191|NCT02969525|4037122|FG008|Double-Blind Period|Adverse Event|0
2322192|NCT02969525|4037123|FG009|Double-Blind Period|Adverse Event|0
2214887|NCT01691768|3857655|FG000|Overall Study|Lost to Follow-up|4
2214888|NCT01691768|3857656|FG001|Overall Study|Lost to Follow-up|3
2322193|NCT02969525|4037124|FG010|Double-Blind Period|Adverse Event|0
2322194|NCT02969525|4037125|FG011|Double-Blind Period|Adverse Event|0
2322195|NCT02969525|4037114|FG000|Double-Blind Period|LOW EGFR|0
2322196|NCT02969525|4037115|FG001|Double-Blind Period|LOW EGFR|0
2322197|NCT02969525|4037116|FG002|Double-Blind Period|LOW EGFR|0
2322198|NCT02969525|4037117|FG003|Double-Blind Period|LOW EGFR|1
2322199|NCT02969525|4037118|FG004|Double-Blind Period|LOW EGFR|0
2322200|NCT02969525|4037119|FG005|Double-Blind Period|LOW EGFR|0
2322201|NCT02969525|4037120|FG006|Double-Blind Period|LOW EGFR|0
2322202|NCT02969525|4037121|FG007|Double-Blind Period|LOW EGFR|0
2322203|NCT02969525|4037122|FG008|Double-Blind Period|LOW EGFR|0
2322204|NCT02969525|4037123|FG009|Double-Blind Period|LOW EGFR|0
2322205|NCT02969525|4037124|FG010|Double-Blind Period|LOW EGFR|0
2322206|NCT02969525|4037125|FG011|Double-Blind Period|LOW EGFR|0
2322207|NCT02969525|4037114|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2
2322208|NCT02969525|4037115|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0
2322209|NCT02969525|4037116|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0
2322210|NCT02969525|4037117|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2
2322211|NCT02969525|4037118|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0
2322212|NCT02969525|4037119|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0
2322213|NCT02969525|4037120|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0
2322214|NCT02969525|4037121|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0
2322215|NCT02969525|4037122|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0
2322216|NCT02969525|4037123|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0
2322217|NCT02969525|4037124|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0
2322218|NCT02969525|4037125|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0
2322219|NCT02969525|4037114|FG000|Dose-Blind Period|Adverse Event|0
2322220|NCT02969525|4037115|FG001|Dose-Blind Period|Adverse Event|0
2322221|NCT02969525|4037116|FG002|Dose-Blind Period|Adverse Event|0
2322222|NCT02969525|4037117|FG003|Dose-Blind Period|Adverse Event|0
2322223|NCT02969525|4037118|FG004|Dose-Blind Period|Adverse Event|0
2322224|NCT02969525|4037119|FG005|Dose-Blind Period|Adverse Event|0
2322225|NCT02969525|4037120|FG006|Dose-Blind Period|Adverse Event|0
2322226|NCT02969525|4037121|FG007|Dose-Blind Period|Adverse Event|0
2322227|NCT02969525|4037122|FG008|Dose-Blind Period|Adverse Event|0
2316770|NCT02886338|4028695|FG000|Overall Study|Withdrawal by Subject|1
2316771|NCT02886494|4028701|FG000|Overall Study|Adverse Event|1
2316772|NCT02886494|4028702|FG001|Overall Study|Adverse Event|0
2316773|NCT02886494|4028701|FG000|Overall Study|Withdrawal by Subject|12
2316774|NCT02886494|4028702|FG001|Overall Study|Withdrawal by Subject|3
2316775|NCT02886494|4028701|FG000|Overall Study|Protocol Violation|4
2316776|NCT02886494|4028702|FG001|Overall Study|Protocol Violation|1
2316777|NCT02886624|4028711|FG000|12-week Post Treatment Follow-up|Death|1
2316778|NCT02886624|4028711|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1
2316779|NCT02886702|4028718|FG000|Overall Study|Other|4
2316780|NCT02886702|4028719|FG001|Overall Study|Other|3
2316781|NCT02886702|4028720|FG002|Overall Study|Other|9
2316782|NCT02886702|4028718|FG000|Overall Study|Withdrawal by Subject|24
2316783|NCT02886702|4028719|FG001|Overall Study|Withdrawal by Subject|18
2316784|NCT02886702|4028720|FG002|Overall Study|Withdrawal by Subject|22
2316785|NCT02886702|4028718|FG000|Overall Study|Significant Worsening of Condition|0
2316786|NCT02886702|4028719|FG001|Overall Study|Significant Worsening of Condition|1
2316787|NCT02886702|4028720|FG002|Overall Study|Significant Worsening of Condition|0
2316788|NCT02886702|4028718|FG000|Overall Study|Protocol Violation|2
2316789|NCT02886702|4028719|FG001|Overall Study|Protocol Violation|2
2316790|NCT02886702|4028720|FG002|Overall Study|Protocol Violation|1
2359100|NCT02137239|4119569|FG000|Overall Study|Discontinued Study Treatment|0
2359101|NCT02137239|4119570|FG001|Overall Study|Discontinued Study Treatment|3
2359102|NCT02137239|4119569|FG000|Overall Study|Withdrew Consent|1
2359103|NCT02137239|4119570|FG001|Overall Study|Withdrew Consent|1
2359104|NCT02137239|4119569|FG000|Overall Study|Adverse Event|2
2359105|NCT02137239|4119570|FG001|Overall Study|Adverse Event|2
2359114|NCT02165215|4119597|FG001|Induction Phase|Withdrawal by Subject|0
2359115|NCT02165215|4119598|FG002|Induction Phase|Withdrawal by Subject|0
2359116|NCT02165215|4119596|FG000|Induction Phase|Protocol Violation|1
2359117|NCT02165215|4119597|FG001|Induction Phase|Protocol Violation|0
2359118|NCT02165215|4119598|FG002|Induction Phase|Protocol Violation|0
2359119|NCT02165215|4119596|FG000|Induction Phase|Physician Decision|1
2359120|NCT02165215|4119597|FG001|Induction Phase|Physician Decision|0
2359121|NCT02165215|4119598|FG002|Induction Phase|Physician Decision|0
2359122|NCT02165215|4119596|FG000|Induction Phase|Lack of Efficacy|2
2359123|NCT02165215|4119597|FG001|Induction Phase|Lack of Efficacy|0
2359124|NCT02165215|4119598|FG002|Induction Phase|Lack of Efficacy|0
2359125|NCT02165215|4119596|FG000|Induction Phase|Non-Compliance|2
2359126|NCT02165215|4119597|FG001|Induction Phase|Non-Compliance|0
2359127|NCT02165215|4119598|FG002|Induction Phase|Non-Compliance|0
2359128|NCT02165215|4119596|FG000|Induction Phase|Lost to Follow-up|6
2359129|NCT02165215|4119597|FG001|Induction Phase|Lost to Follow-up|0
2359130|NCT02165215|4119598|FG002|Induction Phase|Lost to Follow-up|0
2359131|NCT02165215|4119596|FG000|Maintenance Phase|Withdrawal by Subject|0
2359132|NCT02165215|4119597|FG001|Maintenance Phase|Withdrawal by Subject|7
2359133|NCT02165215|4119598|FG002|Maintenance Phase|Withdrawal by Subject|3
2359134|NCT02165215|4119596|FG000|Maintenance Phase|Multiple reasons|0
2359135|NCT02165215|4119597|FG001|Maintenance Phase|Multiple reasons|2
2359136|NCT02165215|4119598|FG002|Maintenance Phase|Multiple reasons|1
2359137|NCT02165215|4119596|FG000|Maintenance Phase|Lost to Follow-up|0
2359138|NCT02165215|4119597|FG001|Maintenance Phase|Lost to Follow-up|2
2359139|NCT02165215|4119598|FG002|Maintenance Phase|Lost to Follow-up|0
2359140|NCT02165215|4119596|FG000|Maintenance Phase|Adverse Event|0
2359141|NCT02165215|4119597|FG001|Maintenance Phase|Adverse Event|1
2359142|NCT02165215|4119598|FG002|Maintenance Phase|Adverse Event|1
2214889|NCT01691768|3857655|FG000|Overall Study|Withdrawal by Subject|10
2214890|NCT01691768|3857656|FG001|Overall Study|Withdrawal by Subject|9
2316791|NCT02886702|4028718|FG000|Overall Study|Non-Compliance With Study Drug|0
2316792|NCT02886702|4028719|FG001|Overall Study|Non-Compliance With Study Drug|1
2316793|NCT02886702|4028720|FG002|Overall Study|Non-Compliance With Study Drug|4
2316794|NCT02886702|4028718|FG000|Overall Study|Lost to Follow-up|11
2316795|NCT02886702|4028719|FG001|Overall Study|Lost to Follow-up|13
2316796|NCT02886702|4028720|FG002|Overall Study|Lost to Follow-up|8
2316797|NCT02886702|4028718|FG000|Overall Study|Lack of Efficacy|3
2316798|NCT02886702|4028719|FG001|Overall Study|Lack of Efficacy|4
2316799|NCT02886702|4028720|FG002|Overall Study|Lack of Efficacy|5
2316800|NCT02886702|4028718|FG000|Overall Study|Adverse Event|4
2316801|NCT02886702|4028719|FG001|Overall Study|Adverse Event|9
2316802|NCT02886702|4028720|FG002|Overall Study|Adverse Event|3
2316803|NCT02886702|4028718|FG000|Overall Study|Administrative Reasons|0
2316804|NCT02886702|4028719|FG001|Overall Study|Administrative Reasons|0
2316805|NCT02886702|4028720|FG002|Overall Study|Administrative Reasons|1
2316806|NCT02886715|4028731|FG000|Overall Study|Non-Compliance With Study Drug|0
2316807|NCT02886715|4028732|FG001|Overall Study|Non-Compliance With Study Drug|2
2316808|NCT02886715|4028733|FG002|Overall Study|Non-Compliance With Study Drug|0
2316809|NCT02886715|4028731|FG000|Overall Study|Adverse Event|4
2316810|NCT02886715|4028732|FG001|Overall Study|Adverse Event|2
2316811|NCT02886715|4028733|FG002|Overall Study|Adverse Event|0
2316812|NCT02886715|4028731|FG000|Overall Study|Lack of Efficacy|0
2316813|NCT02886715|4028732|FG001|Overall Study|Lack of Efficacy|2
2316814|NCT02886715|4028733|FG002|Overall Study|Lack of Efficacy|1
2316815|NCT02886715|4028731|FG000|Overall Study|Lost to Follow-up|29
2316816|NCT02886715|4028732|FG001|Overall Study|Lost to Follow-up|26
2316817|NCT02886715|4028733|FG002|Overall Study|Lost to Follow-up|10
2316818|NCT02886715|4028731|FG000|Overall Study|Pregnancy|1
2316819|NCT02886715|4028732|FG001|Overall Study|Pregnancy|1
2316820|NCT02886715|4028733|FG002|Overall Study|Pregnancy|1
2316821|NCT02886715|4028731|FG000|Overall Study|Protocol Violation|3
2316822|NCT02886715|4028732|FG001|Overall Study|Protocol Violation|2
2316823|NCT02886715|4028733|FG002|Overall Study|Protocol Violation|1
2316824|NCT02886715|4028731|FG000|Overall Study|Withdrawal by Subject|20
2316825|NCT02886715|4028732|FG001|Overall Study|Withdrawal by Subject|18
2316826|NCT02886715|4028733|FG002|Overall Study|Withdrawal by Subject|5
2316827|NCT02886715|4028731|FG000|Overall Study|missing|7
2316828|NCT02886715|4028732|FG001|Overall Study|missing|2
2316829|NCT02886715|4028733|FG002|Overall Study|missing|2
2316830|NCT02886728|4028745|FG000|Overall Study|Withdrew Consent|31
2316831|NCT02886728|4028746|FG001|Overall Study|Withdrew Consent|13
2316832|NCT02886728|4028747|FG002|Overall Study|Withdrew Consent|11
2316833|NCT02886728|4028748|FG003|Overall Study|Withdrew Consent|47
2316834|NCT02886728|4028745|FG000|Overall Study|Lost to Follow-up|12
2316835|NCT02886728|4028746|FG001|Overall Study|Lost to Follow-up|6
2316836|NCT02886728|4028747|FG002|Overall Study|Lost to Follow-up|13
2316837|NCT02886728|4028748|FG003|Overall Study|Lost to Follow-up|12
2316838|NCT02886728|4028745|FG000|Overall Study|Adverse Event|13
2316839|NCT02886728|4028746|FG001|Overall Study|Adverse Event|5
2316840|NCT02886728|4028747|FG002|Overall Study|Adverse Event|5
2316841|NCT02886728|4028748|FG003|Overall Study|Adverse Event|11
2316842|NCT02886728|4028745|FG000|Overall Study|Investigator's Discretion|11
2316843|NCT02886728|4028746|FG001|Overall Study|Investigator's Discretion|7
2316844|NCT02886728|4028747|FG002|Overall Study|Investigator's Discretion|5
2316845|NCT02886728|4028748|FG003|Overall Study|Investigator's Discretion|11
2316846|NCT02886728|4028745|FG000|Overall Study|Death|3
2316847|NCT02886728|4028746|FG001|Overall Study|Death|1
2359143|NCT02180217|4119612|FG000|Overall Study|Adverse Event|3
2359144|NCT02180217|4119613|FG001|Overall Study|Adverse Event|2
2359145|NCT02180217|4119614|FG002|Overall Study|Adverse Event|22
2359146|NCT02180217|4119612|FG000|Overall Study|Death|1
2359147|NCT02180217|4119613|FG001|Overall Study|Death|1
2359148|NCT02180217|4119614|FG002|Overall Study|Death|0
2359149|NCT02180217|4119612|FG000|Overall Study|Withdrawal by Subject|1
2359150|NCT02180217|4119613|FG001|Overall Study|Withdrawal by Subject|1
2359151|NCT02180217|4119614|FG002|Overall Study|Withdrawal by Subject|4
2359152|NCT02180217|4119612|FG000|Overall Study|Subject/Guardian decision|5
2359153|NCT02180217|4119613|FG001|Overall Study|Subject/Guardian decision|3
2359154|NCT02180217|4119614|FG002|Overall Study|Subject/Guardian decision|6
2359155|NCT02180217|4119612|FG000|Overall Study|Physician Decision|1
2359156|NCT02180217|4119613|FG001|Overall Study|Physician Decision|1
2359157|NCT02180217|4119614|FG002|Overall Study|Physician Decision|6
2359158|NCT02180217|4119612|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2359159|NCT02180217|4119613|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2359160|NCT02180217|4119614|FG002|Overall Study|Unsatisfactory therapeutic effect|0
2359161|NCT02193867|4119638|FG000|Overall Study|Death|2
2359162|NCT02193867|4119638|FG000|Overall Study|Sponsor Study Termination|2
2359163|NCT02215096|4119645|FG000|Run-In Period (Up to Week 2)|Adverse Event|1
2359164|NCT02215096|4119646|FG001|Run-In Period (Up to Week 2)|Adverse Event|0
2359165|NCT02215096|4119647|FG002|Run-In Period (Up to Week 2)|Adverse Event|0
2359166|NCT02215096|4119648|FG003|Run-In Period (Up to Week 2)|Adverse Event|0
2316848|NCT02886728|4028747|FG002|Overall Study|Death|0
2316849|NCT02886728|4028748|FG003|Overall Study|Death|0
2316850|NCT02886728|4028745|FG000|Overall Study|Protocol Violation|0
2316851|NCT02886728|4028746|FG001|Overall Study|Protocol Violation|0
2316852|NCT02886728|4028747|FG002|Overall Study|Protocol Violation|0
2316853|NCT02886728|4028748|FG003|Overall Study|Protocol Violation|4
2316854|NCT02886728|4028745|FG000|Overall Study|Non-Compliance with Study Drug|1
2316855|NCT02886728|4028746|FG001|Overall Study|Non-Compliance with Study Drug|0
2316856|NCT02886728|4028747|FG002|Overall Study|Non-Compliance with Study Drug|1
2316857|NCT02886728|4028748|FG003|Overall Study|Non-Compliance with Study Drug|0
2316858|NCT02886728|4028745|FG000|Overall Study|Pregnancy|0
2316859|NCT02886728|4028746|FG001|Overall Study|Pregnancy|0
2316860|NCT02886728|4028747|FG002|Overall Study|Pregnancy|1
2316861|NCT02886728|4028748|FG003|Overall Study|Pregnancy|0
2316862|NCT02886728|4028745|FG000|Overall Study|Randomized but Not Dosed|1
2316863|NCT02886728|4028746|FG001|Overall Study|Randomized but Not Dosed|0
2316864|NCT02886728|4028747|FG002|Overall Study|Randomized but Not Dosed|0
2316865|NCT02886728|4028748|FG003|Overall Study|Randomized but Not Dosed|2
2316866|NCT02887183|4028765|FG000|Overall Study|Adverse Event|44
2316867|NCT02887183|4028765|FG000|Overall Study|Death|30
2316868|NCT02887183|4028765|FG000|Overall Study|Pregnancy|1
2316869|NCT02887183|4028765|FG000|Overall Study|Protocol Violation|6
2316870|NCT02887183|4028765|FG000|Overall Study|Technical Problems|2
2316871|NCT02887183|4028765|FG000|Overall Study|Lost to Follow-up|13
2359167|NCT02215096|4119649|FG004|Run-In Period (Up to Week 2)|Adverse Event|0
2359168|NCT02215096|4119645|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
2359169|NCT02215096|4119646|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
2359170|NCT02215096|4119647|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
2359171|NCT02215096|4119648|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
2359172|NCT02215096|4119649|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1
2359173|NCT02215096|4119645|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
2359174|NCT02215096|4119646|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
2359175|NCT02215096|4119647|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
2359176|NCT02215096|4119648|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1
2359177|NCT02215096|4119649|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
2359178|NCT02215096|4119645|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
2359179|NCT02215096|4119646|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2
2359180|NCT02215096|4119647|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
2359181|NCT02215096|4119648|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
2359182|NCT02215096|4119649|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
2214891|NCT01691768|3857655|FG000|Overall Study|Relocated|0
2316872|NCT02887183|4028765|FG000|Overall Study|Physician Decision|10
2316873|NCT02887183|4028765|FG000|Overall Study|Withdrawal by Subject|35
2316874|NCT02887521|4028781|FG000|Overall Study|Withdrawal by Subject|0
2316875|NCT02887521|4028782|FG001|Overall Study|Withdrawal by Subject|3
2316876|NCT02887989|4028790|FG000|Overall Study|Withdrawal by Subject|8
2316877|NCT02887989|4028791|FG001|Overall Study|Withdrawal by Subject|11
2316878|NCT02887989|4028790|FG000|Overall Study|Death|1
2316879|NCT02887989|4028791|FG001|Overall Study|Death|0
2316880|NCT02888080|4028799|FG000|Overall Study|Subject / Guardian decision|1
2316881|NCT02888080|4028800|FG001|Overall Study|Subject / Guardian decision|3
2316882|NCT02888080|4028799|FG000|Overall Study|New Therapy for study indication|1
2316883|NCT02888080|4028800|FG001|Overall Study|New Therapy for study indication|0
2316884|NCT02888080|4028799|FG000|Overall Study|Lack of Efficacy|0
2316885|NCT02888080|4028800|FG001|Overall Study|Lack of Efficacy|1
2316886|NCT02888080|4028799|FG000|Overall Study|Adverse Event|0
2316887|NCT02888080|4028800|FG001|Overall Study|Adverse Event|1
2316888|NCT02888106|4028823|FG000|Overall Study|Withdrawal by Subject|1
2316889|NCT02888106|4028824|FG001|Overall Study|Withdrawal by Subject|2
2316890|NCT02888106|4028825|FG002|Overall Study|Withdrawal by Subject|0
2316891|NCT02888106|4028826|FG003|Overall Study|Withdrawal by Subject|1
2316892|NCT02888106|4028827|FG004|Overall Study|Withdrawal by Subject|0
2316893|NCT02888106|4028828|FG005|Overall Study|Withdrawal by Subject|0
2316894|NCT02888106|4028823|FG000|Overall Study|Lost to Follow-up|1
2316895|NCT02888106|4028824|FG001|Overall Study|Lost to Follow-up|0
2316896|NCT02888106|4028825|FG002|Overall Study|Lost to Follow-up|0
2316897|NCT02888106|4028826|FG003|Overall Study|Lost to Follow-up|1
2316898|NCT02888106|4028827|FG004|Overall Study|Lost to Follow-up|0
2316899|NCT02888106|4028828|FG005|Overall Study|Lost to Follow-up|1
2316900|NCT02888106|4028823|FG000|Overall Study|Adverse Event|2
2316901|NCT02888106|4028824|FG001|Overall Study|Adverse Event|0
2316902|NCT02888106|4028825|FG002|Overall Study|Adverse Event|0
2316903|NCT02888106|4028826|FG003|Overall Study|Adverse Event|0
2316904|NCT02888106|4028827|FG004|Overall Study|Adverse Event|0
2316905|NCT02888106|4028828|FG005|Overall Study|Adverse Event|0
2316906|NCT02888106|4028823|FG000|Overall Study|Withdrawal of consent|0
2316907|NCT02888106|4028824|FG001|Overall Study|Withdrawal of consent|0
2316908|NCT02888106|4028825|FG002|Overall Study|Withdrawal of consent|0
2316909|NCT02888106|4028826|FG003|Overall Study|Withdrawal of consent|0
2316910|NCT02888106|4028827|FG004|Overall Study|Withdrawal of consent|1
2316911|NCT02888106|4028828|FG005|Overall Study|Withdrawal of consent|0
2316912|NCT02888106|4028823|FG000|Overall Study|Pregnancy|1
2316913|NCT02888106|4028824|FG001|Overall Study|Pregnancy|0
2316914|NCT02888106|4028825|FG002|Overall Study|Pregnancy|0
2316915|NCT02888106|4028826|FG003|Overall Study|Pregnancy|0
2316916|NCT02888106|4028827|FG004|Overall Study|Pregnancy|0
2316917|NCT02888106|4028828|FG005|Overall Study|Pregnancy|0
2316918|NCT02888171|4028850|FG000|Overall Study|Lost to Follow-up|2
2316919|NCT02888171|4028851|FG001|Overall Study|Lost to Follow-up|1
2316920|NCT02888171|4028850|FG000|Overall Study|Withdrawal by Subject|3
2316921|NCT02888171|4028851|FG001|Overall Study|Withdrawal by Subject|2
2316922|NCT02888171|4028850|FG000|Overall Study|Adverse Event|0
2316923|NCT02888171|4028851|FG001|Overall Study|Adverse Event|1
2316924|NCT02888756|4028881|FG000|Analytical Treatment Interruption|Physician Decision|10
2316925|NCT02888756|4028882|FG001|Analytical Treatment Interruption|Physician Decision|6
2316926|NCT02888756|4028883|FG002|Analytical Treatment Interruption|Physician Decision|5
2316927|NCT02889562|4028914|FG000|Overall Study|Physician Decision|0
2316928|NCT02889562|4028915|FG001|Overall Study|Physician Decision|1
2316929|NCT02889562|4028914|FG000|Overall Study|Withdrawal by Subject|0
2316930|NCT02889562|4028915|FG001|Overall Study|Withdrawal by Subject|1
2316931|NCT02889796|4028925|FG000|Overall Study|Withdrew Consent|18
2316932|NCT02889796|4028926|FG001|Overall Study|Withdrew Consent|29
2316933|NCT02889796|4028927|FG002|Overall Study|Withdrew Consent|20
2316934|NCT02889796|4028928|FG003|Overall Study|Withdrew Consent|1
2316935|NCT02889796|4028929|FG004|Overall Study|Withdrew Consent|2
2316936|NCT02889796|4028930|FG005|Overall Study|Withdrew Consent|35
2316937|NCT02889796|4028925|FG000|Overall Study|Investigator's Discretion|10
2316938|NCT02889796|4028926|FG001|Overall Study|Investigator's Discretion|9
2316939|NCT02889796|4028927|FG002|Overall Study|Investigator's Discretion|10
2316940|NCT02889796|4028928|FG003|Overall Study|Investigator's Discretion|3
2316941|NCT02889796|4028929|FG004|Overall Study|Investigator's Discretion|0
2316942|NCT02889796|4028930|FG005|Overall Study|Investigator's Discretion|15
2316943|NCT02889796|4028925|FG000|Overall Study|Adverse Event|17
2316944|NCT02889796|4028926|FG001|Overall Study|Adverse Event|8
2316945|NCT02889796|4028927|FG002|Overall Study|Adverse Event|8
2316946|NCT02889796|4028928|FG003|Overall Study|Adverse Event|4
2316947|NCT02889796|4028929|FG004|Overall Study|Adverse Event|1
2316948|NCT02889796|4028930|FG005|Overall Study|Adverse Event|7
2316949|NCT02889796|4028925|FG000|Overall Study|Lost to Follow-up|5
2316950|NCT02889796|4028926|FG001|Overall Study|Lost to Follow-up|7
2316951|NCT02889796|4028927|FG002|Overall Study|Lost to Follow-up|2
2316952|NCT02889796|4028928|FG003|Overall Study|Lost to Follow-up|0
2316953|NCT02889796|4028929|FG004|Overall Study|Lost to Follow-up|2
2316954|NCT02889796|4028930|FG005|Overall Study|Lost to Follow-up|6
2316955|NCT02889796|4028925|FG000|Overall Study|Protocol Violation|0
2316956|NCT02889796|4028926|FG001|Overall Study|Protocol Violation|1
2316957|NCT02889796|4028927|FG002|Overall Study|Protocol Violation|3
2316958|NCT02889796|4028928|FG003|Overall Study|Protocol Violation|0
2316959|NCT02889796|4028929|FG004|Overall Study|Protocol Violation|0
2316960|NCT02889796|4028930|FG005|Overall Study|Protocol Violation|4
2316961|NCT02889796|4028925|FG000|Overall Study|Non-compliance With Study Drug|0
2316962|NCT02889796|4028926|FG001|Overall Study|Non-compliance With Study Drug|2
2316963|NCT02889796|4028927|FG002|Overall Study|Non-compliance With Study Drug|0
2359183|NCT02218697|4119667|FG000|Overall Study|Adverse Event|0
2359184|NCT02218697|4119668|FG001|Overall Study|Adverse Event|2
2359185|NCT02218697|4119667|FG000|Overall Study|Unwilling to be vaccinated in left arm|0
2359186|NCT02218697|4119668|FG001|Overall Study|Unwilling to be vaccinated in left arm|1
2359187|NCT02218697|4119667|FG000|Overall Study|Withdrawal by Subject|2
2359188|NCT02218697|4119668|FG001|Overall Study|Withdrawal by Subject|3
2359189|NCT02221037|4119678|FG000|Overall Study|Physician Decision|0
2359190|NCT02221037|4119679|FG001|Overall Study|Physician Decision|0
2359191|NCT02221037|4119680|FG002|Overall Study|Physician Decision|1
2359192|NCT02221037|4119681|FG003|Overall Study|Physician Decision|0
2359201|NCT02231762|4119699|FG000|Combination Phase|Adverse Event|10
2359202|NCT02231762|4119700|FG001|Combination Phase|Adverse Event|0
2359203|NCT02231762|4119701|FG002|Combination Phase|Adverse Event|0
2359204|NCT02231762|4119702|FG003|Combination Phase|Adverse Event|0
2359205|NCT02231762|4119699|FG000|Combination Phase|Withdrawal by Subject|2
2359206|NCT02231762|4119700|FG001|Combination Phase|Withdrawal by Subject|0
2359207|NCT02231762|4119701|FG002|Combination Phase|Withdrawal by Subject|0
2214892|NCT01691768|3857656|FG001|Overall Study|Relocated|1
2214893|NCT01691768|3857655|FG000|Overall Study|Investigator decision|1
2214894|NCT01691768|3857656|FG001|Overall Study|Investigator decision|1
2214895|NCT01691781|3857665|FG000|Overall Study|Withdrawal by Subject|4
2214896|NCT01691781|3857666|FG001|Overall Study|Withdrawal by Subject|3
2214897|NCT01691781|3857665|FG000|Overall Study|Physician Decision|1
2214898|NCT01691781|3857666|FG001|Overall Study|Physician Decision|1
2214899|NCT01691781|3857665|FG000|Overall Study|Protocol Violation|2
2316964|NCT02889796|4028928|FG003|Overall Study|Non-compliance With Study Drug|0
2316965|NCT02889796|4028929|FG004|Overall Study|Non-compliance With Study Drug|1
2316966|NCT02889796|4028930|FG005|Overall Study|Non-compliance With Study Drug|2
2316967|NCT02889796|4028925|FG000|Overall Study|Death|1
2316968|NCT02889796|4028926|FG001|Overall Study|Death|1
2316969|NCT02889796|4028927|FG002|Overall Study|Death|0
2316970|NCT02889796|4028928|FG003|Overall Study|Death|1
2316971|NCT02889796|4028929|FG004|Overall Study|Death|0
2316972|NCT02889796|4028930|FG005|Overall Study|Death|1
2316973|NCT02889796|4028925|FG000|Overall Study|Pregnancy|0
2316974|NCT02889796|4028926|FG001|Overall Study|Pregnancy|1
2316975|NCT02889796|4028927|FG002|Overall Study|Pregnancy|1
2316976|NCT02889796|4028928|FG003|Overall Study|Pregnancy|0
2316977|NCT02889796|4028929|FG004|Overall Study|Pregnancy|0
2316978|NCT02889796|4028930|FG005|Overall Study|Pregnancy|0
2316979|NCT02889796|4028925|FG000|Overall Study|Randomized but not Dosed|2
2316980|NCT02889796|4028926|FG001|Overall Study|Randomized but not Dosed|0
2316981|NCT02889796|4028927|FG002|Overall Study|Randomized but not Dosed|0
2316982|NCT02889796|4028928|FG003|Overall Study|Randomized but not Dosed|0
2316983|NCT02889796|4028929|FG004|Overall Study|Randomized but not Dosed|0
2316984|NCT02889796|4028930|FG005|Overall Study|Randomized but not Dosed|2
2316985|NCT02889861|4028953|FG000|Overall Study|Ongoing in Survival Follow-up|2
2316986|NCT02889900|4028962|FG000|Overall Study|Adverse Event|11
2316987|NCT02889900|4028962|FG000|Overall Study|Condition under investigation worsened|32
2316988|NCT02889900|4028962|FG000|Overall Study|Other|5
2316989|NCT02889900|4028962|FG000|Overall Study|Withdrawal by Subject|7
2316990|NCT02889900|4028962|FG000|Overall Study|Not treated|2
2316991|NCT02890992|4028987|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0
2316992|NCT02890992|4028988|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1
2316993|NCT02890992|4028989|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0
2316994|NCT02890992|4028990|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0
2316995|NCT02890992|4028991|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0
2316996|NCT02890992|4028992|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0
2316997|NCT02890992|4028993|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0
2316998|NCT02890992|4028994|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0
2316999|NCT02890992|4028987|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0
2317000|NCT02890992|4028988|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0
2317001|NCT02890992|4028989|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0
2317002|NCT02890992|4028990|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0
2317003|NCT02890992|4028991|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0
2317004|NCT02890992|4028992|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0
2317005|NCT02890992|4028993|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1
2317006|NCT02890992|4028994|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1
2317007|NCT02890992|4028987|FG000|130 Weeks Open-Label Extension Period|Other than specified|0
2317008|NCT02890992|4028988|FG001|130 Weeks Open-Label Extension Period|Other than specified|2
2317009|NCT02890992|4028989|FG002|130 Weeks Open-Label Extension Period|Other than specified|0
2317010|NCT02890992|4028990|FG003|130 Weeks Open-Label Extension Period|Other than specified|0
2317011|NCT02890992|4028991|FG004|130 Weeks Open-Label Extension Period|Other than specified|0
2317012|NCT02890992|4028992|FG005|130 Weeks Open-Label Extension Period|Other than specified|0
2317013|NCT02890992|4028993|FG006|130 Weeks Open-Label Extension Period|Other than specified|0
2317014|NCT02890992|4028994|FG007|130 Weeks Open-Label Extension Period|Other than specified|0
2317015|NCT02891070|4029021|FG000|Overall Study|Adverse Event|1
2317016|NCT02891070|4029022|FG001|Overall Study|Adverse Event|0
2317017|NCT02891070|4029021|FG000|Overall Study|Physician Decision|0
2317018|NCT02891070|4029022|FG001|Overall Study|Physician Decision|1
2317019|NCT02891070|4029021|FG000|Overall Study|Lost to Follow-up|4
2317020|NCT02891070|4029022|FG001|Overall Study|Lost to Follow-up|4
2317021|NCT02891070|4029021|FG000|Overall Study|Other|1
2317022|NCT02891070|4029022|FG001|Overall Study|Other|0
2317023|NCT02891070|4029021|FG000|Overall Study|Protocol Violation|0
2317024|NCT02891070|4029022|FG001|Overall Study|Protocol Violation|1
2317025|NCT02891070|4029021|FG000|Overall Study|Withdrawal by Subject|1
2317026|NCT02891070|4029022|FG001|Overall Study|Withdrawal by Subject|2
2317027|NCT02891070|4029021|FG000|Overall Study|Death|3
2317028|NCT02891070|4029022|FG001|Overall Study|Death|0
2317029|NCT02891174|4029030|FG000|First Intervention (24 Hours)|Declined any study medication|1
2317030|NCT02891174|4029031|FG001|First Intervention (24 Hours)|Declined any study medication|5
2317031|NCT02891174|4029030|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0
2317032|NCT02891174|4029031|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2
2317033|NCT02891174|4029030|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2
2317034|NCT02891174|4029031|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6
2317035|NCT02891174|4029030|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1
2317036|NCT02891174|4029031|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0
2317037|NCT02891174|4029030|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3
2317038|NCT02891174|4029031|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5
2317039|NCT02891174|4029030|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
2317040|NCT02891174|4029031|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
2317041|NCT02891174|4029030|FG000|Second Intervention (24 Hours)|Protocol Violation|0
2317042|NCT02891174|4029031|FG001|Second Intervention (24 Hours)|Protocol Violation|1
2317043|NCT02891200|4029043|FG000|Overall Study|Lost to Follow-up|31
2317044|NCT02891200|4029044|FG001|Overall Study|Lost to Follow-up|36
2317045|NCT02891200|4029043|FG000|Overall Study|Death|10
2317046|NCT02891200|4029044|FG001|Overall Study|Death|9
2317047|NCT02891200|4029043|FG000|Overall Study|Withdrawal by Subject|1
2317048|NCT02891200|4029044|FG001|Overall Study|Withdrawal by Subject|4
2317049|NCT02891408|4029057|FG000|Overall Study|Lost to Follow-up|0
2317050|NCT02891408|4029058|FG001|Overall Study|Lost to Follow-up|0
2317051|NCT02891408|4029059|FG002|Overall Study|Lost to Follow-up|1
2317052|NCT02891408|4029060|FG003|Overall Study|Lost to Follow-up|0
2317053|NCT02891408|4029061|FG004|Overall Study|Lost to Follow-up|0
2317054|NCT02891408|4029062|FG005|Overall Study|Lost to Follow-up|0
2317055|NCT02891408|4029063|FG006|Overall Study|Lost to Follow-up|0
2317056|NCT02891681|4029101|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
2317057|NCT02891681|4029102|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
2317058|NCT02891681|4029103|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1
2317059|NCT02891681|4029101|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2
2317060|NCT02891681|4029102|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
2317061|NCT02891681|4029103|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
2317062|NCT02891681|4029101|FG000|Overall Study|Taken off study after first imaging appointment|1
2317063|NCT02891681|4029102|FG001|Overall Study|Taken off study after first imaging appointment|0
2317064|NCT02891681|4029103|FG002|Overall Study|Taken off study after first imaging appointment|0
2317065|NCT02891850|4029113|FG000|Overall Study|Adverse Event|3
2317066|NCT02891850|4029114|FG001|Overall Study|Adverse Event|0
2317067|NCT02891850|4029113|FG000|Overall Study|Death|0
2317068|NCT02891850|4029114|FG001|Overall Study|Death|4
2317069|NCT02891850|4029113|FG000|Overall Study|Physician Decision|1
2317070|NCT02891850|4029114|FG001|Overall Study|Physician Decision|0
2317071|NCT02891850|4029113|FG000|Overall Study|Pregnancy|1
2317072|NCT02891850|4029114|FG001|Overall Study|Pregnancy|0
2317073|NCT02891850|4029113|FG000|Overall Study|Withdrawal by Subject|2
2317074|NCT02891850|4029114|FG001|Overall Study|Withdrawal by Subject|3
2317075|NCT02891915|4029126|FG000|Overall Study|Enrolled but Treatment Not Administered|6
2317076|NCT02891915|4029127|FG001|Overall Study|Enrolled but Treatment Not Administered|4
2317077|NCT02891915|4029126|FG000|Overall Study|Withdrawal by Subject|3
2317078|NCT02891915|4029127|FG001|Overall Study|Withdrawal by Subject|3
2317079|NCT02891915|4029126|FG000|Overall Study|Became Ineligible After Enrollment|2
2317080|NCT02891915|4029127|FG001|Overall Study|Became Ineligible After Enrollment|1
2317081|NCT02891915|4029126|FG000|Overall Study|Lost to Follow-up|1
2317082|NCT02891915|4029127|FG001|Overall Study|Lost to Follow-up|4
2317083|NCT02891915|4029126|FG000|Overall Study|Physician Decision|1
2317084|NCT02891915|4029127|FG001|Overall Study|Physician Decision|0
2317085|NCT02892019|4029135|FG000|Overall Study|randomized but not treated|0
2317086|NCT02892019|4029136|FG001|Overall Study|randomized but not treated|1
2317087|NCT02892019|4029135|FG000|Overall Study|Withdrawal by Subject|0
2317088|NCT02892019|4029136|FG001|Overall Study|Withdrawal by Subject|1
2317089|NCT02892019|4029135|FG000|Overall Study|Adverse Event|1
2317090|NCT02892019|4029136|FG001|Overall Study|Adverse Event|1
2317091|NCT02892344|4029153|FG000|Overall Study|Protocol deviation|3
2317092|NCT02892344|4029154|FG001|Overall Study|Protocol deviation|4
2317093|NCT02892344|4029153|FG000|Overall Study|Adverse Event|1
2317094|NCT02892344|4029154|FG001|Overall Study|Adverse Event|8
2317095|NCT02892344|4029153|FG000|Overall Study|Lost to Follow-up|0
2317096|NCT02892344|4029154|FG001|Overall Study|Lost to Follow-up|1
2317097|NCT02892344|4029153|FG000|Overall Study|Non-compliance with study treatment|0
2317098|NCT02892344|4029154|FG001|Overall Study|Non-compliance with study treatment|1
2317099|NCT02892344|4029153|FG000|Overall Study|Physician Decision|0
2317100|NCT02892344|4029154|FG001|Overall Study|Physician Decision|2
2317101|NCT02892344|4029153|FG000|Overall Study|Subject/guardian decision|0
2317102|NCT02892344|4029154|FG001|Overall Study|Subject/guardian decision|4
2317103|NCT02892344|4029153|FG000|Overall Study|Technical problems|0
2317104|NCT02892344|4029154|FG001|Overall Study|Technical problems|1
2317105|NCT02892409|4029162|FG000|Overall Study|Adverse Event|1
2317106|NCT02892409|4029163|FG001|Overall Study|Adverse Event|0
2317107|NCT02892409|4029162|FG000|Overall Study|Withdrawal by Subject|2
2317108|NCT02892409|4029163|FG001|Overall Study|Withdrawal by Subject|1
2317109|NCT02892422|4029169|FG000|Overall Study|Enrolled not treated|4
2317110|NCT02892422|4029169|FG000|Overall Study|Adverse Event|38
2317111|NCT02892422|4029169|FG000|Overall Study|Lack of Efficacy|32
2317112|NCT02892422|4029169|FG000|Overall Study|Non-compliance with study drug|11
2317113|NCT02892422|4029169|FG000|Overall Study|Protocol Violation|4
2317114|NCT02892422|4029169|FG000|Overall Study|Withdrawal by Subject|56
2317115|NCT02892422|4029169|FG000|Overall Study|Lost to Follow-up|5
2317116|NCT02892422|4029169|FG000|Overall Study|sponsor information 16159A results|21
2317117|NCT02892422|4029169|FG000|Overall Study|withdrawal of consent|13
2317118|NCT02892422|4029169|FG000|Overall Study|exclusion criteria met|3
2317119|NCT02892422|4029169|FG000|Overall Study|moving elsewhere|4
2317120|NCT02892422|4029169|FG000|Overall Study|non-compliance|10
2317121|NCT02892422|4029169|FG000|Overall Study|patient legally incapable|1
2317122|NCT02892422|4029169|FG000|Overall Study|patient decision|7
2317123|NCT02892422|4029169|FG000|Overall Study|Investigator decision|1
2317124|NCT02892448|4029176|FG000|Overall Study|Screening failure|2
2317125|NCT02892448|4029177|FG001|Overall Study|Screening failure|2
2317126|NCT02892448|4029178|FG002|Overall Study|Screening failure|1
2317127|NCT02892513|4029188|FG000|Overall Study|Withdrawal by Subject|0
2317128|NCT02892513|4029189|FG001|Overall Study|Withdrawal by Subject|1
2317129|NCT02892734|4029195|FG000|Treatment on Study|Progressive Disease|2
2317130|NCT02892734|4029195|FG000|Follow up for 2 Years|Death|2
2317131|NCT02892734|4029195|FG000|Follow up for 2 Years|Study closed early|1
2317132|NCT02892760|4029199|FG000|Overall Study|Withdrawal by Subject|3
2317133|NCT02894502|4029222|FG000|Baseline|Withdrawal by Subject|24
2317134|NCT02894502|4029223|FG001|Baseline|Withdrawal by Subject|31
2317135|NCT02894502|4029224|FG002|Baseline|Withdrawal by Subject|36
2317136|NCT02894502|4029222|FG000|Baseline|Death|3
2359193|NCT02224456|4119695|FG000|Overall Study|Lack of Efficacy|1
2359194|NCT02224456|4119695|FG000|Overall Study|Lost to Follow-up|15
2359195|NCT02224456|4119695|FG000|Overall Study|Withdrawal by Subject|9
2359196|NCT02224456|4119695|FG000|Overall Study|Physician Decision|3
2359197|NCT02224456|4119695|FG000|Overall Study|Death|2
2359198|NCT02224456|4119695|FG000|Overall Study|Pregnancy|4
2359199|NCT02224456|4119695|FG000|Overall Study|Protocol Violation|1
2359200|NCT02224456|4119695|FG000|Overall Study|Treatment Interruptions of ≥28 days|1
2359208|NCT02231762|4119702|FG003|Combination Phase|Withdrawal by Subject|0
2359209|NCT02231762|4119699|FG000|Combination Phase|Disease Progression|6
2359210|NCT02231762|4119700|FG001|Combination Phase|Disease Progression|0
2359211|NCT02231762|4119701|FG002|Combination Phase|Disease Progression|0
2359212|NCT02231762|4119702|FG003|Combination Phase|Disease Progression|0
2359213|NCT02231762|4119699|FG000|Combination Phase|Did not meet inclusion criteria|1
2359214|NCT02231762|4119700|FG001|Combination Phase|Did not meet inclusion criteria|0
2359215|NCT02231762|4119701|FG002|Combination Phase|Did not meet inclusion criteria|0
2359216|NCT02231762|4119702|FG003|Combination Phase|Did not meet inclusion criteria|0
2359217|NCT02231762|4119699|FG000|Combination Phase|Protocol Violation|1
2359218|NCT02231762|4119700|FG001|Combination Phase|Protocol Violation|0
2359219|NCT02231762|4119701|FG002|Combination Phase|Protocol Violation|0
2359220|NCT02231762|4119702|FG003|Combination Phase|Protocol Violation|0
2359221|NCT02231762|4119699|FG000|Maintenance Phase|Disease progression|0
2359222|NCT02231762|4119700|FG001|Maintenance Phase|Disease progression|3
2359223|NCT02231762|4119701|FG002|Maintenance Phase|Disease progression|4
2359224|NCT02231762|4119702|FG003|Maintenance Phase|Disease progression|3
2359225|NCT02231762|4119699|FG000|Maintenance Phase|Adverse Event|0
2359226|NCT02231762|4119700|FG001|Maintenance Phase|Adverse Event|0
2359227|NCT02231762|4119701|FG002|Maintenance Phase|Adverse Event|1
2359228|NCT02231762|4119702|FG003|Maintenance Phase|Adverse Event|2
2317137|NCT02894502|4029223|FG001|Baseline|Death|1
2317138|NCT02894502|4029224|FG002|Baseline|Death|9
2317139|NCT02894502|4029222|FG000|First Follow up|Withdrawal by Subject|32
2317140|NCT02894502|4029223|FG001|First Follow up|Withdrawal by Subject|29
2317141|NCT02894502|4029224|FG002|First Follow up|Withdrawal by Subject|37
2317142|NCT02894502|4029222|FG000|First Follow up|Death|2
2317143|NCT02894502|4029223|FG001|First Follow up|Death|2
2317144|NCT02894502|4029224|FG002|First Follow up|Death|3
2317145|NCT02894502|4029222|FG000|Second Follow up|Withdrawal by Subject|13
2317146|NCT02894502|4029223|FG001|Second Follow up|Withdrawal by Subject|15
2317147|NCT02894502|4029224|FG002|Second Follow up|Withdrawal by Subject|13
2317148|NCT02894502|4029222|FG000|Second Follow up|Death|2
2317149|NCT02894502|4029223|FG001|Second Follow up|Death|3
2317150|NCT02894502|4029224|FG002|Second Follow up|Death|1
2317151|NCT02894502|4029222|FG000|Third Follow up|Withdrawal by Subject|5
2317152|NCT02894502|4029223|FG001|Third Follow up|Withdrawal by Subject|6
2317153|NCT02894502|4029224|FG002|Third Follow up|Withdrawal by Subject|3
2317154|NCT02894502|4029222|FG000|Third Follow up|Death|1
2317155|NCT02894502|4029223|FG001|Third Follow up|Death|1
2317156|NCT02894502|4029224|FG002|Third Follow up|Death|0
2317157|NCT02894840|4029239|FG000|Overall Study|Lost to Follow-up|1
2317158|NCT02894840|4029240|FG001|Overall Study|Lost to Follow-up|0
2317159|NCT02894840|4029241|FG002|Overall Study|Lost to Follow-up|3
2317160|NCT02894840|4029242|FG003|Overall Study|Lost to Follow-up|0
2317161|NCT02895295|4029284|FG000|Overall Study|Survey Non-response|71
2317162|NCT02895295|4029285|FG001|Overall Study|Survey Non-response|94
2317163|NCT02895295|4029286|FG002|Overall Study|Survey Non-response|92
2317164|NCT02895347|4029296|FG000|Overall Study|Withdrawal by Subject|3
2317165|NCT02895347|4029297|FG001|Overall Study|Withdrawal by Subject|1
2317166|NCT02895360|4029310|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4
2317167|NCT02895360|4029311|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
2317168|NCT02895360|4029312|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
2317169|NCT02895360|4029313|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
2317170|NCT02895360|4029314|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
2317171|NCT02895360|4029315|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
2317172|NCT02895360|4029310|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
2317173|NCT02895360|4029311|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3
2317174|NCT02895360|4029312|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
2317175|NCT02895360|4029313|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
2317176|NCT02895360|4029314|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
2317177|NCT02895360|4029315|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
2317178|NCT02895360|4029310|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
2317179|NCT02895360|4029311|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
2317180|NCT02895360|4029312|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2
2317181|NCT02895360|4029313|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
2317182|NCT02895360|4029314|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
2317183|NCT02895360|4029315|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
2317184|NCT02895360|4029310|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
2317185|NCT02895360|4029311|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
2317186|NCT02895360|4029312|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7
2317187|NCT02895360|4029313|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
2317188|NCT02895360|4029314|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
2317189|NCT02895360|4029315|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
2317190|NCT02895360|4029310|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
2317191|NCT02895360|4029311|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
2317192|NCT02895360|4029312|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
2317193|NCT02895360|4029313|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4
2317194|NCT02895360|4029314|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
2317195|NCT02895360|4029315|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
2317196|NCT02895360|4029310|FG000|Phase 2a|Adverse Event|0
2317197|NCT02895360|4029311|FG001|Phase 2a|Adverse Event|0
2317198|NCT02895360|4029312|FG002|Phase 2a|Adverse Event|0
2317199|NCT02895360|4029313|FG003|Phase 2a|Adverse Event|0
2317200|NCT02895360|4029314|FG004|Phase 2a|Adverse Event|0
2317201|NCT02895360|4029315|FG005|Phase 2a|Adverse Event|1
2317202|NCT02895360|4029310|FG000|Phase 2a|Progressive disease|0
2317203|NCT02895360|4029311|FG001|Phase 2a|Progressive disease|0
2317204|NCT02895360|4029312|FG002|Phase 2a|Progressive disease|0
2317205|NCT02895360|4029313|FG003|Phase 2a|Progressive disease|0
2317206|NCT02895360|4029314|FG004|Phase 2a|Progressive disease|11
2317207|NCT02895360|4029315|FG005|Phase 2a|Progressive disease|11
2317208|NCT02895945|4029349|FG000|Overall Study|Physician Decision|2
2317209|NCT02895945|4029350|FG001|Overall Study|Physician Decision|1
2317210|NCT02896127|4029365|FG000|COMPLETED WEEK 52|Adverse Event|9
2317211|NCT02896127|4029366|FG001|COMPLETED WEEK 52|Adverse Event|2
2317212|NCT02896127|4029365|FG000|COMPLETED WEEK 52|Lack of Efficacy|2
2317213|NCT02896127|4029366|FG001|COMPLETED WEEK 52|Lack of Efficacy|3
2317214|NCT02896127|4029365|FG000|COMPLETED WEEK 52|Lost to Follow-up|0
2317215|NCT02896127|4029366|FG001|COMPLETED WEEK 52|Lost to Follow-up|1
2317216|NCT02896127|4029365|FG000|COMPLETED WEEK 52|Physician Decision|1
2317217|NCT02896127|4029366|FG001|COMPLETED WEEK 52|Physician Decision|1
2317218|NCT02896127|4029365|FG000|COMPLETED WEEK 52|Pregnancy|2
2317219|NCT02896127|4029366|FG001|COMPLETED WEEK 52|Pregnancy|0
2317220|NCT02896127|4029365|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12
2317221|NCT02896127|4029366|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4
2317222|NCT02896127|4029365|FG000|COMPLETED WEEK 52|Technical problems|1
2317223|NCT02896127|4029366|FG001|COMPLETED WEEK 52|Technical problems|0
2317224|NCT02896127|4029365|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2
2317225|NCT02896127|4029366|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3
2317226|NCT02896127|4029365|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0
2317227|NCT02896127|4029366|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1
2317228|NCT02896127|4029365|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1
2317229|NCT02896127|4029366|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0
2317230|NCT02896127|4029365|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1
2317231|NCT02896127|4029366|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0
2317232|NCT02896127|4029365|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0
2317233|NCT02896127|4029366|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1
2317234|NCT02896296|4029372|FG000|Overall Study|Adverse Event|1
2317235|NCT02896296|4029372|FG000|Overall Study|Lost to Follow-up|19
2317236|NCT02896296|4029372|FG000|Overall Study|Pregnancy|1
2317237|NCT02896296|4029372|FG000|Overall Study|Physician Decision|2
2317238|NCT02896296|4029372|FG000|Overall Study|Withdrawal by Subject|10
2317239|NCT02896296|4029372|FG000|Overall Study|Site closing|7
2317240|NCT02896296|4029372|FG000|Overall Study|Incarceration|1
2317241|NCT02896296|4029372|FG000|Overall Study|Relocation|1
2317242|NCT02896361|4029376|FG000|Third Intervention (2 Weeks)|Protocol Violation|1
2317243|NCT02896361|4029377|FG001|Third Intervention (2 Weeks)|Protocol Violation|0
2317244|NCT02896361|4029378|FG002|Third Intervention (2 Weeks)|Protocol Violation|0
2317245|NCT02896361|4029376|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
2317246|NCT02896361|4029377|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
2317247|NCT02896361|4029378|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
2317248|NCT02896400|4029406|FG000|1 Month Follow-up|Lost to Follow-up|7
2317249|NCT02896400|4029407|FG001|1 Month Follow-up|Lost to Follow-up|7
2317250|NCT02896400|4029408|FG002|1 Month Follow-up|Lost to Follow-up|5
2317251|NCT02896400|4029409|FG003|1 Month Follow-up|Lost to Follow-up|8
2317252|NCT02896400|4029410|FG004|1 Month Follow-up|Lost to Follow-up|9
2317253|NCT02896400|4029411|FG005|1 Month Follow-up|Lost to Follow-up|6
2359229|NCT02234843|4119726|FG000|Overall Study|Death|1
2359230|NCT02234843|4119727|FG001|Overall Study|Death|0
2214900|NCT01691781|3857666|FG001|Overall Study|Protocol Violation|2
2214901|NCT01691781|3857665|FG000|Overall Study|Adverse Event|0
2214902|NCT01691781|3857666|FG001|Overall Study|Adverse Event|1
2214903|NCT01691794|3857675|FG000|Overall Study|Poor/Non-Compliance|1
2214904|NCT01691794|3857676|FG001|Overall Study|Poor/Non-Compliance|4
2214905|NCT01691794|3857677|FG002|Overall Study|Poor/Non-Compliance|1
2214906|NCT01691794|3857675|FG000|Overall Study|Death|0
2214907|NCT01691794|3857676|FG001|Overall Study|Death|0
2359231|NCT02234843|4119728|FG002|Overall Study|Death|0
2359232|NCT02234843|4119729|FG003|Overall Study|Death|0
2359233|NCT02234843|4119730|FG004|Overall Study|Death|0
2359234|NCT02234843|4119731|FG005|Overall Study|Death|0
2359235|NCT02234843|4119732|FG006|Overall Study|Death|0
2359236|NCT02234843|4119733|FG007|Overall Study|Death|0
2359237|NCT02234843|4119734|FG008|Overall Study|Death|0
2359238|NCT02234843|4119735|FG009|Overall Study|Death|0
2359239|NCT02234843|4119726|FG000|Overall Study|Protocol Violation|1
2359240|NCT02234843|4119727|FG001|Overall Study|Protocol Violation|0
2359241|NCT02234843|4119728|FG002|Overall Study|Protocol Violation|1
2359242|NCT02234843|4119729|FG003|Overall Study|Protocol Violation|0
2359243|NCT02234843|4119730|FG004|Overall Study|Protocol Violation|0
2359244|NCT02234843|4119731|FG005|Overall Study|Protocol Violation|0
2359245|NCT02234843|4119732|FG006|Overall Study|Protocol Violation|0
2359246|NCT02234843|4119733|FG007|Overall Study|Protocol Violation|0
2359247|NCT02234843|4119734|FG008|Overall Study|Protocol Violation|0
2359248|NCT02234843|4119735|FG009|Overall Study|Protocol Violation|0
2359249|NCT02234843|4119726|FG000|Overall Study|Efficacy outcome reached|2
2359250|NCT02234843|4119727|FG001|Overall Study|Efficacy outcome reached|0
2359251|NCT02234843|4119728|FG002|Overall Study|Efficacy outcome reached|0
2359252|NCT02234843|4119729|FG003|Overall Study|Efficacy outcome reached|0
2359253|NCT02234843|4119730|FG004|Overall Study|Efficacy outcome reached|0
2359254|NCT02234843|4119731|FG005|Overall Study|Efficacy outcome reached|2
2359255|NCT02234843|4119732|FG006|Overall Study|Efficacy outcome reached|0
2359256|NCT02234843|4119733|FG007|Overall Study|Efficacy outcome reached|0
2359257|NCT02234843|4119734|FG008|Overall Study|Efficacy outcome reached|0
2359258|NCT02234843|4119735|FG009|Overall Study|Efficacy outcome reached|0
2359259|NCT02234843|4119726|FG000|Overall Study|Patient convenience|2
2359260|NCT02234843|4119727|FG001|Overall Study|Patient convenience|0
2359261|NCT02234843|4119728|FG002|Overall Study|Patient convenience|0
2359262|NCT02234843|4119729|FG003|Overall Study|Patient convenience|0
2359263|NCT02234843|4119730|FG004|Overall Study|Patient convenience|0
2359264|NCT02234843|4119731|FG005|Overall Study|Patient convenience|1
2359265|NCT02234843|4119732|FG006|Overall Study|Patient convenience|0
2359266|NCT02234843|4119733|FG007|Overall Study|Patient convenience|0
2359267|NCT02234843|4119734|FG008|Overall Study|Patient convenience|0
2359268|NCT02234843|4119735|FG009|Overall Study|Patient convenience|0
2214908|NCT01691794|3857677|FG002|Overall Study|Death|1
2317254|NCT02896400|4029412|FG006|1 Month Follow-up|Lost to Follow-up|5
2317255|NCT02896400|4029413|FG007|1 Month Follow-up|Lost to Follow-up|6
2317256|NCT02896400|4029414|FG008|1 Month Follow-up|Lost to Follow-up|4
2317257|NCT02896400|4029415|FG009|1 Month Follow-up|Lost to Follow-up|7
2317258|NCT02896400|4029416|FG010|1 Month Follow-up|Lost to Follow-up|5
2317259|NCT02896400|4029417|FG011|1 Month Follow-up|Lost to Follow-up|5
2317260|NCT02896400|4029418|FG012|1 Month Follow-up|Lost to Follow-up|3
2317261|NCT02896400|4029419|FG013|1 Month Follow-up|Lost to Follow-up|4
2317262|NCT02896400|4029420|FG014|1 Month Follow-up|Lost to Follow-up|1
2317263|NCT02896400|4029421|FG015|1 Month Follow-up|Lost to Follow-up|2
2317264|NCT02896400|4029406|FG000|1 Month Follow-up|Death|0
2317265|NCT02896400|4029407|FG001|1 Month Follow-up|Death|0
2317266|NCT02896400|4029408|FG002|1 Month Follow-up|Death|0
2317267|NCT02896400|4029409|FG003|1 Month Follow-up|Death|0
2317268|NCT02896400|4029410|FG004|1 Month Follow-up|Death|0
2317269|NCT02896400|4029411|FG005|1 Month Follow-up|Death|0
2317270|NCT02896400|4029412|FG006|1 Month Follow-up|Death|0
2317271|NCT02896400|4029413|FG007|1 Month Follow-up|Death|0
2317272|NCT02896400|4029414|FG008|1 Month Follow-up|Death|0
2317273|NCT02896400|4029415|FG009|1 Month Follow-up|Death|0
2317274|NCT02896400|4029416|FG010|1 Month Follow-up|Death|0
2317275|NCT02896400|4029417|FG011|1 Month Follow-up|Death|0
2317276|NCT02896400|4029418|FG012|1 Month Follow-up|Death|0
2317277|NCT02896400|4029419|FG013|1 Month Follow-up|Death|0
2317278|NCT02896400|4029420|FG014|1 Month Follow-up|Death|0
2317279|NCT02896400|4029421|FG015|1 Month Follow-up|Death|1
2317280|NCT02896400|4029406|FG000|3 Month Follow-up|Lost to Follow-up|6
2317281|NCT02896400|4029407|FG001|3 Month Follow-up|Lost to Follow-up|3
2317282|NCT02896400|4029408|FG002|3 Month Follow-up|Lost to Follow-up|6
2317283|NCT02896400|4029409|FG003|3 Month Follow-up|Lost to Follow-up|11
2317284|NCT02896400|4029410|FG004|3 Month Follow-up|Lost to Follow-up|12
2317285|NCT02896400|4029411|FG005|3 Month Follow-up|Lost to Follow-up|6
2317286|NCT02896400|4029412|FG006|3 Month Follow-up|Lost to Follow-up|4
2317287|NCT02896400|4029413|FG007|3 Month Follow-up|Lost to Follow-up|3
2317288|NCT02896400|4029414|FG008|3 Month Follow-up|Lost to Follow-up|6
2317289|NCT02896400|4029415|FG009|3 Month Follow-up|Lost to Follow-up|5
2317290|NCT02896400|4029416|FG010|3 Month Follow-up|Lost to Follow-up|6
2317291|NCT02896400|4029417|FG011|3 Month Follow-up|Lost to Follow-up|6
2317292|NCT02896400|4029418|FG012|3 Month Follow-up|Lost to Follow-up|3
2317293|NCT02896400|4029419|FG013|3 Month Follow-up|Lost to Follow-up|5
2317294|NCT02896400|4029420|FG014|3 Month Follow-up|Lost to Follow-up|3
2317295|NCT02896400|4029421|FG015|3 Month Follow-up|Lost to Follow-up|2
2317296|NCT02896400|4029406|FG000|3 Month Follow-up|Death|0
2317297|NCT02896400|4029407|FG001|3 Month Follow-up|Death|0
2317298|NCT02896400|4029408|FG002|3 Month Follow-up|Death|0
2317299|NCT02896400|4029409|FG003|3 Month Follow-up|Death|0
2317300|NCT02896400|4029410|FG004|3 Month Follow-up|Death|0
2317301|NCT02896400|4029411|FG005|3 Month Follow-up|Death|0
2317302|NCT02896400|4029412|FG006|3 Month Follow-up|Death|0
2317303|NCT02896400|4029413|FG007|3 Month Follow-up|Death|0
2317304|NCT02896400|4029414|FG008|3 Month Follow-up|Death|0
2317305|NCT02896400|4029415|FG009|3 Month Follow-up|Death|0
2317306|NCT02896400|4029416|FG010|3 Month Follow-up|Death|0
2317307|NCT02896400|4029417|FG011|3 Month Follow-up|Death|0
2317308|NCT02896400|4029418|FG012|3 Month Follow-up|Death|0
2317309|NCT02896400|4029419|FG013|3 Month Follow-up|Death|1
2317310|NCT02896400|4029420|FG014|3 Month Follow-up|Death|1
2317311|NCT02896400|4029421|FG015|3 Month Follow-up|Death|0
2317312|NCT02896400|4029406|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1
2317313|NCT02896400|4029407|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0
2317314|NCT02896400|4029408|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1
2317315|NCT02896400|4029409|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1
2317316|NCT02896400|4029410|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0
2317317|NCT02896400|4029411|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1
2317318|NCT02896400|4029412|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3
2317319|NCT02896400|4029413|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2
2317320|NCT02896400|4029414|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1
2317321|NCT02896400|4029415|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1
2317322|NCT02896400|4029416|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0
2317323|NCT02896400|4029417|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0
2317324|NCT02896400|4029418|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1
2317325|NCT02896400|4029419|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0
2317326|NCT02896400|4029420|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3
2317327|NCT02896400|4029421|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1
2317328|NCT02896400|4029406|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
2317329|NCT02896400|4029407|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
2317330|NCT02896400|4029408|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46
2317331|NCT02896400|4029409|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40
2317332|NCT02896400|4029410|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
2317333|NCT02896400|4029411|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
2322228|NCT02969525|4037123|FG009|Dose-Blind Period|Adverse Event|1
2317334|NCT02896400|4029412|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
2317335|NCT02896400|4029413|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47
2317336|NCT02896400|4029414|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44
2317337|NCT02896400|4029415|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
2317338|NCT02896400|4029416|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55
2359269|NCT02234843|4119726|FG000|Overall Study|Withdrawal by Subject|5
2359270|NCT02234843|4119727|FG001|Overall Study|Withdrawal by Subject|1
2359271|NCT02234843|4119728|FG002|Overall Study|Withdrawal by Subject|1
2359272|NCT02234843|4119729|FG003|Overall Study|Withdrawal by Subject|0
2359273|NCT02234843|4119730|FG004|Overall Study|Withdrawal by Subject|0
2359274|NCT02234843|4119731|FG005|Overall Study|Withdrawal by Subject|7
2359275|NCT02234843|4119732|FG006|Overall Study|Withdrawal by Subject|0
2359276|NCT02234843|4119733|FG007|Overall Study|Withdrawal by Subject|0
2359277|NCT02234843|4119734|FG008|Overall Study|Withdrawal by Subject|0
2359278|NCT02234843|4119735|FG009|Overall Study|Withdrawal by Subject|0
2359279|NCT02234843|4119726|FG000|Overall Study|Recovery|1
2359280|NCT02234843|4119727|FG001|Overall Study|Recovery|0
2359281|NCT02234843|4119728|FG002|Overall Study|Recovery|0
2359282|NCT02234843|4119729|FG003|Overall Study|Recovery|0
2359283|NCT02234843|4119730|FG004|Overall Study|Recovery|0
2359284|NCT02234843|4119731|FG005|Overall Study|Recovery|0
2359285|NCT02234843|4119732|FG006|Overall Study|Recovery|0
2359286|NCT02234843|4119733|FG007|Overall Study|Recovery|0
2359287|NCT02234843|4119734|FG008|Overall Study|Recovery|0
2359288|NCT02234843|4119735|FG009|Overall Study|Recovery|0
2359289|NCT02234843|4119726|FG000|Overall Study|Other|0
2359290|NCT02234843|4119727|FG001|Overall Study|Other|2
2359291|NCT02234843|4119728|FG002|Overall Study|Other|0
2359292|NCT02234843|4119729|FG003|Overall Study|Other|1
2359293|NCT02234843|4119730|FG004|Overall Study|Other|0
2359294|NCT02234843|4119731|FG005|Overall Study|Other|1
2359295|NCT02234843|4119732|FG006|Overall Study|Other|0
2359296|NCT02234843|4119733|FG007|Overall Study|Other|1
2359297|NCT02234843|4119734|FG008|Overall Study|Other|0
2359298|NCT02234843|4119735|FG009|Overall Study|Other|0
2359299|NCT02234843|4119726|FG000|Overall Study|Physician Decision|4
2359300|NCT02234843|4119727|FG001|Overall Study|Physician Decision|1
2359301|NCT02234843|4119728|FG002|Overall Study|Physician Decision|0
2359302|NCT02234843|4119729|FG003|Overall Study|Physician Decision|1
2359303|NCT02234843|4119730|FG004|Overall Study|Physician Decision|0
2359304|NCT02234843|4119731|FG005|Overall Study|Physician Decision|0
2359305|NCT02234843|4119732|FG006|Overall Study|Physician Decision|0
2359306|NCT02234843|4119733|FG007|Overall Study|Physician Decision|1
2359307|NCT02234843|4119734|FG008|Overall Study|Physician Decision|0
2359308|NCT02234843|4119735|FG009|Overall Study|Physician Decision|0
2359309|NCT02234843|4119726|FG000|Overall Study|Adverse Event|5
2359310|NCT02234843|4119727|FG001|Overall Study|Adverse Event|1
2359311|NCT02234843|4119728|FG002|Overall Study|Adverse Event|1
2359312|NCT02234843|4119729|FG003|Overall Study|Adverse Event|3
2359313|NCT02234843|4119730|FG004|Overall Study|Adverse Event|2
2359314|NCT02234843|4119731|FG005|Overall Study|Adverse Event|1
2359315|NCT02234843|4119732|FG006|Overall Study|Adverse Event|0
2359316|NCT02234843|4119733|FG007|Overall Study|Adverse Event|0
2359317|NCT02234843|4119734|FG008|Overall Study|Adverse Event|1
2359318|NCT02234843|4119735|FG009|Overall Study|Adverse Event|0
2359319|NCT02234843|4119726|FG000|Overall Study|Non-compliance with study drug|1
2359320|NCT02234843|4119727|FG001|Overall Study|Non-compliance with study drug|0
2359321|NCT02234843|4119728|FG002|Overall Study|Non-compliance with study drug|0
2359322|NCT02234843|4119729|FG003|Overall Study|Non-compliance with study drug|0
2359323|NCT02234843|4119730|FG004|Overall Study|Non-compliance with study drug|0
2359324|NCT02234843|4119731|FG005|Overall Study|Non-compliance with study drug|1
2359325|NCT02234843|4119732|FG006|Overall Study|Non-compliance with study drug|1
2214909|NCT01691794|3857675|FG000|Overall Study|Lack of Efficacy|0
2214910|NCT01691794|3857676|FG001|Overall Study|Lack of Efficacy|7
2359326|NCT02234843|4119733|FG007|Overall Study|Non-compliance with study drug|0
2359327|NCT02234843|4119734|FG008|Overall Study|Non-compliance with study drug|0
2359328|NCT02234843|4119735|FG009|Overall Study|Non-compliance with study drug|0
2359329|NCT02234843|4119726|FG000|Overall Study|Lost to Follow-up|0
2359330|NCT02234843|4119727|FG001|Overall Study|Lost to Follow-up|1
2359331|NCT02234843|4119728|FG002|Overall Study|Lost to Follow-up|0
2359332|NCT02234843|4119729|FG003|Overall Study|Lost to Follow-up|0
2359333|NCT02234843|4119730|FG004|Overall Study|Lost to Follow-up|0
2359334|NCT02234843|4119731|FG005|Overall Study|Lost to Follow-up|0
2359335|NCT02234843|4119732|FG006|Overall Study|Lost to Follow-up|1
2214911|NCT01691794|3857677|FG002|Overall Study|Lack of Efficacy|1
2317339|NCT02896400|4029417|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41
2359336|NCT02234843|4119733|FG007|Overall Study|Lost to Follow-up|0
2359337|NCT02234843|4119734|FG008|Overall Study|Lost to Follow-up|0
2359338|NCT02234843|4119735|FG009|Overall Study|Lost to Follow-up|0
2359339|NCT02243306|4119770|FG000|Overall Study|Adverse Event|0
2359340|NCT02243306|4119771|FG001|Overall Study|Adverse Event|1
2359341|NCT02243306|4119770|FG000|Overall Study|Other: Reached stopping criteria|0
2359342|NCT02243306|4119771|FG001|Overall Study|Other: Reached stopping criteria|1
2359343|NCT02243306|4119770|FG000|Overall Study|Physician Decision|0
2359344|NCT02243306|4119771|FG001|Overall Study|Physician Decision|1
2359345|NCT02246621|4119780|FG000|Overall Study|Withdrawal by Subject|28
2359346|NCT02246621|4119781|FG001|Overall Study|Withdrawal by Subject|16
2359347|NCT02246621|4119780|FG000|Overall Study|Lost to Follow-up|1
2359348|NCT02246621|4119781|FG001|Overall Study|Lost to Follow-up|0
2359349|NCT02246621|4119780|FG000|Overall Study|On Study Treatment/ Follow Up|236
2359350|NCT02246621|4119781|FG001|Overall Study|On Study Treatment/ Follow Up|119
2359351|NCT02257918|4119790|FG000|Overall Study|Lost to Follow-up|4
2359352|NCT02257918|4119791|FG001|Overall Study|Lost to Follow-up|1
2359353|NCT02257918|4119792|FG002|Overall Study|Lost to Follow-up|0
2359354|NCT02257918|4119790|FG000|Overall Study|Withdrawal by Subject|0
2359355|NCT02257918|4119791|FG001|Overall Study|Withdrawal by Subject|0
2359356|NCT02257918|4119792|FG002|Overall Study|Withdrawal by Subject|1
2359357|NCT02257918|4119790|FG000|Overall Study|Pregnancy|0
2359358|NCT02257918|4119791|FG001|Overall Study|Pregnancy|0
2359359|NCT02257918|4119792|FG002|Overall Study|Pregnancy|1
2359392|NCT02290431|4119835|FG000|Overall Study|Adverse Event|20
2359393|NCT02290431|4119835|FG000|Overall Study|Progressive disease|4
2359394|NCT02290431|4119835|FG000|Overall Study|Study terminated by Sponsor|1
2359395|NCT02290431|4119835|FG000|Overall Study|Physician Decision|2
2359396|NCT02314923|4119849|FG000|Overall Study|Death|0
2359397|NCT02314923|4119850|FG001|Overall Study|Death|0
2359398|NCT02314923|4119851|FG002|Overall Study|Death|0
2359399|NCT02314923|4119852|FG003|Overall Study|Death|1
2359400|NCT02314923|4119853|FG004|Overall Study|Death|0
2359401|NCT02314923|4119854|FG005|Overall Study|Death|0
2359402|NCT02314923|4119855|FG006|Overall Study|Death|0
2359403|NCT02314923|4119856|FG007|Overall Study|Death|0
2359404|NCT02314923|4119857|FG008|Overall Study|Death|0
2359405|NCT02314923|4119858|FG009|Overall Study|Death|0
2359406|NCT02314923|4119849|FG000|Overall Study|Lost to Follow-up|2
2359407|NCT02314923|4119850|FG001|Overall Study|Lost to Follow-up|3
2359408|NCT02314923|4119851|FG002|Overall Study|Lost to Follow-up|1
2359409|NCT02314923|4119852|FG003|Overall Study|Lost to Follow-up|0
2359410|NCT02314923|4119853|FG004|Overall Study|Lost to Follow-up|0
2359411|NCT02314923|4119854|FG005|Overall Study|Lost to Follow-up|0
2359412|NCT02314923|4119855|FG006|Overall Study|Lost to Follow-up|3
2359413|NCT02314923|4119856|FG007|Overall Study|Lost to Follow-up|4
2359414|NCT02314923|4119857|FG008|Overall Study|Lost to Follow-up|2
2359415|NCT02314923|4119858|FG009|Overall Study|Lost to Follow-up|0
2359416|NCT02314923|4119849|FG000|Overall Study|Withdrawal by Subject|0
2359417|NCT02314923|4119850|FG001|Overall Study|Withdrawal by Subject|0
2359418|NCT02314923|4119851|FG002|Overall Study|Withdrawal by Subject|1
2359419|NCT02314923|4119852|FG003|Overall Study|Withdrawal by Subject|0
2359420|NCT02314923|4119853|FG004|Overall Study|Withdrawal by Subject|1
2359421|NCT02314923|4119854|FG005|Overall Study|Withdrawal by Subject|0
2359422|NCT02314923|4119855|FG006|Overall Study|Withdrawal by Subject|1
2359423|NCT02314923|4119856|FG007|Overall Study|Withdrawal by Subject|0
2359424|NCT02314923|4119857|FG008|Overall Study|Withdrawal by Subject|0
2359425|NCT02314923|4119858|FG009|Overall Study|Withdrawal by Subject|0
2359426|NCT02314923|4119849|FG000|Overall Study|Physician Decision|0
2359427|NCT02314923|4119850|FG001|Overall Study|Physician Decision|1
2359428|NCT02314923|4119851|FG002|Overall Study|Physician Decision|0
2359429|NCT02314923|4119852|FG003|Overall Study|Physician Decision|0
2359430|NCT02314923|4119853|FG004|Overall Study|Physician Decision|0
2359431|NCT02314923|4119854|FG005|Overall Study|Physician Decision|0
2359432|NCT02314923|4119855|FG006|Overall Study|Physician Decision|0
2359433|NCT02314923|4119856|FG007|Overall Study|Physician Decision|0
2359434|NCT02314923|4119857|FG008|Overall Study|Physician Decision|0
2359435|NCT02314923|4119858|FG009|Overall Study|Physician Decision|0
2359436|NCT02314923|4119849|FG000|Overall Study|Participant unavailable|0
2359437|NCT02314923|4119850|FG001|Overall Study|Participant unavailable|0
2359438|NCT02314923|4119851|FG002|Overall Study|Participant unavailable|0
2359439|NCT02314923|4119852|FG003|Overall Study|Participant unavailable|0
2359440|NCT02314923|4119853|FG004|Overall Study|Participant unavailable|0
2359441|NCT02314923|4119854|FG005|Overall Study|Participant unavailable|1
2359442|NCT02314923|4119855|FG006|Overall Study|Participant unavailable|0
2359443|NCT02314923|4119856|FG007|Overall Study|Participant unavailable|0
2359444|NCT02314923|4119857|FG008|Overall Study|Participant unavailable|0
2359445|NCT02314923|4119858|FG009|Overall Study|Participant unavailable|0
2359446|NCT02314923|4119849|FG000|Overall Study|Screen failure|0
2359447|NCT02314923|4119850|FG001|Overall Study|Screen failure|0
2359448|NCT02314923|4119851|FG002|Overall Study|Screen failure|0
2359449|NCT02314923|4119852|FG003|Overall Study|Screen failure|0
2359450|NCT02314923|4119853|FG004|Overall Study|Screen failure|0
2359451|NCT02314923|4119854|FG005|Overall Study|Screen failure|0
2359452|NCT02314923|4119855|FG006|Overall Study|Screen failure|1
2359453|NCT02314923|4119856|FG007|Overall Study|Screen failure|0
2359454|NCT02314923|4119857|FG008|Overall Study|Screen failure|0
2359455|NCT02314923|4119858|FG009|Overall Study|Screen failure|0
2359456|NCT02314923|4119849|FG000|Overall Study|Participant relocation|1
2359360|NCT02258542|4119804|FG000|Overall Study|eg. not made to the visit|7
2359361|NCT02258542|4119805|FG001|Overall Study|eg. not made to the visit|4
2359362|NCT02258542|4119806|FG002|Overall Study|eg. not made to the visit|0
2359363|NCT02258542|4119807|FG003|Overall Study|eg. not made to the visit|1
2359364|NCT02258542|4119804|FG000|Overall Study|study specific discount. criteria|1
2359365|NCT02258542|4119805|FG001|Overall Study|study specific discount. criteria|1
2359366|NCT02258542|4119806|FG002|Overall Study|study specific discount. criteria|0
2359367|NCT02258542|4119807|FG003|Overall Study|study specific discount. criteria|0
2359368|NCT02258542|4119804|FG000|Overall Study|Withdrawal by Subject|20
2359369|NCT02258542|4119805|FG001|Overall Study|Withdrawal by Subject|20
2359370|NCT02258542|4119806|FG002|Overall Study|Withdrawal by Subject|7
2359371|NCT02258542|4119807|FG003|Overall Study|Withdrawal by Subject|1
2359372|NCT02258542|4119804|FG000|Overall Study|Lost to Follow-up|5
2359373|NCT02258542|4119805|FG001|Overall Study|Lost to Follow-up|12
2359374|NCT02258542|4119806|FG002|Overall Study|Lost to Follow-up|1
2359375|NCT02258542|4119807|FG003|Overall Study|Lost to Follow-up|2
2359376|NCT02258542|4119804|FG000|Overall Study|Death|5
2359377|NCT02258542|4119805|FG001|Overall Study|Death|4
2359378|NCT02258542|4119806|FG002|Overall Study|Death|0
2359379|NCT02258542|4119807|FG003|Overall Study|Death|1
2359380|NCT02258542|4119804|FG000|Overall Study|Adverse Event|3
2359381|NCT02258542|4119805|FG001|Overall Study|Adverse Event|4
2359382|NCT02258542|4119806|FG002|Overall Study|Adverse Event|0
2359383|NCT02258542|4119807|FG003|Overall Study|Adverse Event|0
2359384|NCT02258542|4119804|FG000|Overall Study|Protocol Violation|1
2359385|NCT02258542|4119805|FG001|Overall Study|Protocol Violation|2
2359386|NCT02258542|4119806|FG002|Overall Study|Protocol Violation|0
2359387|NCT02258542|4119807|FG003|Overall Study|Protocol Violation|0
2359388|NCT02258542|4119804|FG000|Overall Study|Eligibility criteria not fulfilled|0
2359389|NCT02258542|4119805|FG001|Overall Study|Eligibility criteria not fulfilled|2
2359390|NCT02258542|4119806|FG002|Overall Study|Eligibility criteria not fulfilled|0
2359391|NCT02258542|4119807|FG003|Overall Study|Eligibility criteria not fulfilled|0
2359457|NCT02314923|4119850|FG001|Overall Study|Participant relocation|0
2359458|NCT02314923|4119851|FG002|Overall Study|Participant relocation|0
2359459|NCT02314923|4119852|FG003|Overall Study|Participant relocation|0
2359460|NCT02314923|4119853|FG004|Overall Study|Participant relocation|0
2359461|NCT02314923|4119854|FG005|Overall Study|Participant relocation|0
2359462|NCT02314923|4119855|FG006|Overall Study|Participant relocation|0
2359463|NCT02314923|4119856|FG007|Overall Study|Participant relocation|1
2359464|NCT02314923|4119857|FG008|Overall Study|Participant relocation|0
2359465|NCT02314923|4119858|FG009|Overall Study|Participant relocation|0
2359466|NCT04524507|4119899|FG000|Overall Study|Lost to Follow-up|2
2359467|NCT04524507|4119900|FG001|Overall Study|Lost to Follow-up|4
2359468|NCT04524507|4119899|FG000|Overall Study|Withdrawal by Subject|2
2359469|NCT04524507|4119900|FG001|Overall Study|Withdrawal by Subject|9
2359470|NCT04524507|4119899|FG000|Overall Study|Death|2
2359471|NCT04524507|4119900|FG001|Overall Study|Death|10
2359472|NCT04382924|4119909|FG000|Overall Study|Death|2
2359473|NCT04382924|4119910|FG001|Overall Study|Death|5
2359474|NCT04382924|4119911|FG002|Overall Study|Death|4
2359475|NCT04382924|4119909|FG000|Overall Study|Protocol Violation|0
2359476|NCT04382924|4119910|FG001|Overall Study|Protocol Violation|1
2359477|NCT04382924|4119911|FG002|Overall Study|Protocol Violation|1
2359478|NCT04382924|4119909|FG000|Overall Study|Transferred to other hospital/declined in person visits|0
2359479|NCT04382924|4119910|FG001|Overall Study|Transferred to other hospital/declined in person visits|1
2359480|NCT04382924|4119911|FG002|Overall Study|Transferred to other hospital/declined in person visits|1
2359481|NCT04382924|4119909|FG000|Overall Study|Withdrawal by Subject|6
2359482|NCT04382924|4119910|FG001|Overall Study|Withdrawal by Subject|3
2359483|NCT04382924|4119911|FG002|Overall Study|Withdrawal by Subject|6
2359484|NCT03842436|4119942|FG000|Overall Study|Lost to Follow-up|1
2359485|NCT03462030|4119963|FG000|Overall Study|Withdrawal by Subject|1
2359486|NCT03462030|4119964|FG001|Overall Study|Withdrawal by Subject|1
2359487|NCT03446768|4119972|FG000|Overall Study|Withdrawal by Subject|0
2359488|NCT03446768|4119973|FG001|Overall Study|Withdrawal by Subject|1
2359489|NCT03253393|4120041|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6
2359490|NCT03253393|4120042|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7
2359491|NCT03253393|4120043|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0
2359492|NCT03188822|4120057|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6
2359493|NCT03188822|4120057|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1
2359494|NCT03128671|4120063|FG000|Allocation|ICU discharge prior to intervention initiation|4
2359495|NCT03128671|4120064|FG001|Allocation|ICU discharge prior to intervention initiation|0
2359496|NCT03128671|4120063|FG000|Allocation|Death|1
2359497|NCT03128671|4120064|FG001|Allocation|Death|0
2359498|NCT03128671|4120063|FG000|Allocation|Withdrawal by Subject|4
2359499|NCT03128671|4120064|FG001|Allocation|Withdrawal by Subject|0
2359500|NCT03128671|4120063|FG000|Intervention|Withdrawal by Subject|11
2359501|NCT03128671|4120064|FG001|Intervention|Withdrawal by Subject|10
2359502|NCT03128671|4120063|FG000|Intervention|Palliative/hospice care initiated|9
2359503|NCT03128671|4120064|FG001|Intervention|Palliative/hospice care initiated|10
2359504|NCT03128671|4120063|FG000|Intervention|Death|13
2359505|NCT03128671|4120064|FG001|Intervention|Death|11
2359506|NCT03128671|4120063|FG000|Intervention|Interrupted by hurricane|1
2359507|NCT03128671|4120064|FG001|Intervention|Interrupted by hurricane|0
2359508|NCT03128671|4120063|FG000|Intervention|Physician Decision|2
2359509|NCT03128671|4120064|FG001|Intervention|Physician Decision|3
2359510|NCT03111732|4120070|FG000|Overall Study|Enrolled in different study|1
2359511|NCT03111732|4120070|FG000|Overall Study|Progressive disease|3
2359512|NCT03111732|4120070|FG000|Overall Study|Withdrawal by Subject|1
2359513|NCT03065244|4120081|FG000|Overall Study|Lost to Follow-up|1
2359514|NCT03065244|4120082|FG001|Overall Study|Lost to Follow-up|1
2359515|NCT03065244|4120081|FG000|Overall Study|Diagnosed with a different disease|1
2359516|NCT03065244|4120082|FG001|Overall Study|Diagnosed with a different disease|1
2359517|NCT03065244|4120081|FG000|Overall Study|Protocol Violation|0
2359518|NCT03065244|4120082|FG001|Overall Study|Protocol Violation|1
2359519|NCT03065244|4120081|FG000|Overall Study|Withdrawal by Subject|1
2359520|NCT03065244|4120082|FG001|Overall Study|Withdrawal by Subject|1
2359521|NCT02879305|4120090|FG000|Overall Study|Investigator Site Closed|55
2359522|NCT02879305|4120091|FG001|Overall Study|Investigator Site Closed|57
2359523|NCT02879305|4120090|FG000|Overall Study|Withdrawal by Subject|44
2359524|NCT02879305|4120091|FG001|Overall Study|Withdrawal by Subject|42
2359525|NCT02879305|4120090|FG000|Overall Study|Lost to Follow-up|17
2359526|NCT02879305|4120091|FG001|Overall Study|Lost to Follow-up|12
2359527|NCT02879305|4120090|FG000|Overall Study|Other|1
2359528|NCT02879305|4120091|FG001|Overall Study|Other|0
2359529|NCT02787850|4120108|FG000|Overall Study|Withdrawal by Subject|0
2359530|NCT02787850|4120109|FG001|Overall Study|Withdrawal by Subject|1
2359531|NCT02676284|4120128|FG000|Overall Study|Withdrawal by Subject|1
2214912|NCT01691794|3857675|FG000|Overall Study|Participant request to discontinue|0
2214913|NCT01691794|3857676|FG001|Overall Study|Participant request to discontinue|1
2214914|NCT01691794|3857677|FG002|Overall Study|Participant request to discontinue|0
2359532|NCT02632409|4120134|FG000|Randomized|AE unrelated to study Drug|0
2359533|NCT02632409|4120135|FG001|Randomized|AE unrelated to study Drug|1
2359534|NCT02632409|4120134|FG000|Randomized|Participant withdrew consent|2
2359535|NCT02632409|4120135|FG001|Randomized|Participant withdrew consent|1
2359536|NCT02632409|4120134|FG000|Randomized|No Longer meets study criteria|5
2359537|NCT02632409|4120135|FG001|Randomized|No Longer meets study criteria|0
2359538|NCT02632409|4120134|FG000|Randomized|other reasons|1
2359539|NCT02632409|4120135|FG001|Randomized|other reasons|0
2359540|NCT02632409|4120134|FG000|Treatment Period|Ongoing Treatment|20
2359541|NCT02632409|4120135|FG001|Treatment Period|Ongoing Treatment|21
2359542|NCT02632409|4120134|FG000|Treatment Period|Disease Recurrence|147
2359543|NCT02632409|4120135|FG001|Treatment Period|Disease Recurrence|90
2359544|NCT02632409|4120134|FG000|Treatment Period|Study Drug Toxicity|8
2359545|NCT02632409|4120135|FG001|Treatment Period|Study Drug Toxicity|49
2359546|NCT02632409|4120134|FG000|Treatment Period|Death|1
2359547|NCT02632409|4120135|FG001|Treatment Period|Death|0
2359548|NCT02632409|4120134|FG000|Treatment Period|AE unrelated to study drug|15
2359549|NCT02632409|4120135|FG001|Treatment Period|AE unrelated to study drug|16
2359550|NCT02632409|4120134|FG000|Treatment Period|Request to discontinue treatment|4
2359551|NCT02632409|4120135|FG001|Treatment Period|Request to discontinue treatment|19
2359552|NCT02632409|4120134|FG000|Treatment Period|Participant withdrew consent|7
2359553|NCT02632409|4120135|FG001|Treatment Period|Participant withdrew consent|5
2359554|NCT02632409|4120134|FG000|Treatment Period|Lost to Follow-up|0
2359555|NCT02632409|4120135|FG001|Treatment Period|Lost to Follow-up|1
2359556|NCT02632409|4120134|FG000|Treatment Period|Maximum clinical benefit|1
2359557|NCT02632409|4120135|FG001|Treatment Period|Maximum clinical benefit|0
2359558|NCT02632409|4120134|FG000|Treatment Period|No longer meets study criteria|3
2359559|NCT02632409|4120135|FG001|Treatment Period|No longer meets study criteria|0
2359560|NCT02632409|4120134|FG000|Treatment Period|Administrative Reason by sponsor|0
2359561|NCT02632409|4120135|FG001|Treatment Period|Administrative Reason by sponsor|1
2359562|NCT02632409|4120134|FG000|Treatment Period|Other Reasons|10
2359563|NCT02632409|4120135|FG001|Treatment Period|Other Reasons|6
2359564|NCT02516241|4120144|FG000|Overall Study|Death|255
2359565|NCT02516241|4120145|FG001|Overall Study|Death|262
2359566|NCT02516241|4120146|FG002|Overall Study|Death|270
2359567|NCT02516241|4120144|FG000|Overall Study|Lost to Follow-up|1
2359568|NCT02516241|4120145|FG001|Overall Study|Lost to Follow-up|1
2359569|NCT02516241|4120146|FG002|Overall Study|Lost to Follow-up|3
2359570|NCT02516241|4120144|FG000|Overall Study|Withdrawal by Subject|2
2359571|NCT02516241|4120145|FG001|Overall Study|Withdrawal by Subject|7
2359572|NCT02516241|4120146|FG002|Overall Study|Withdrawal by Subject|12
2359573|NCT02516241|4120144|FG000|Overall Study|participants ongoing at data cut-off|84
2359574|NCT02516241|4120145|FG001|Overall Study|participants ongoing at data cut-off|76
2359575|NCT02516241|4120146|FG002|Overall Study|participants ongoing at data cut-off|59
2359576|NCT02431702|4120159|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7
2359577|NCT02431702|4120160|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
2359578|NCT02431702|4120161|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
2359579|NCT02431702|4120162|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
2359580|NCT02431702|4120163|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
2359581|NCT02431702|4120164|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
2359582|NCT02431702|4120165|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
2359583|NCT02431702|4120159|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11
2359584|NCT02431702|4120160|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
2359585|NCT02431702|4120161|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
2359586|NCT02431702|4120162|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
2359587|NCT02431702|4120163|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
2359588|NCT02431702|4120164|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
2359589|NCT02431702|4120165|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23
2359590|NCT02431702|4120159|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9
2359591|NCT02431702|4120160|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
2359592|NCT02431702|4120161|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
2359593|NCT02431702|4120162|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
2359594|NCT02431702|4120163|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
2359595|NCT02431702|4120164|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
2359596|NCT02431702|4120165|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6
2359597|NCT02431702|4120159|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5
2359598|NCT02431702|4120160|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0
2359599|NCT02431702|4120161|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0
2359600|NCT02431702|4120162|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0
2359601|NCT02431702|4120163|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0
2359602|NCT02431702|4120164|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0
2359603|NCT02431702|4120165|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3
2359604|NCT02431702|4120159|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2
2359605|NCT02431702|4120160|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
2359606|NCT02431702|4120161|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
2359607|NCT02431702|4120162|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
2359608|NCT02431702|4120163|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
2359609|NCT02431702|4120164|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
2359610|NCT02431702|4120165|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
2359611|NCT02431702|4120159|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0
2359612|NCT02431702|4120160|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5
2359613|NCT02431702|4120161|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1
2359614|NCT02431702|4120162|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0
2359615|NCT02431702|4120163|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0
2359616|NCT02431702|4120164|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0
2359617|NCT02431702|4120165|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0
2359618|NCT02431702|4120159|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
2359619|NCT02431702|4120160|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6
2359620|NCT02431702|4120161|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13
2359621|NCT02431702|4120162|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
2359622|NCT02431702|4120163|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
2359623|NCT02431702|4120164|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
2359624|NCT02431702|4120165|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
2359625|NCT02431702|4120159|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
2359626|NCT02431702|4120160|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11
2359627|NCT02431702|4120161|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8
2359628|NCT02431702|4120162|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
2359629|NCT02431702|4120163|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
2359630|NCT02431702|4120164|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
2359631|NCT02431702|4120165|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
2359632|NCT02431702|4120159|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
2359633|NCT02431702|4120160|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2
2359634|NCT02431702|4120161|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
2359635|NCT02431702|4120162|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
2359636|NCT02431702|4120163|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
2359637|NCT02431702|4120164|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
2359638|NCT02431702|4120165|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
2359639|NCT02431702|4120159|FG000|Part 2: 9Month Disease Progression Phase|Other|0
2359640|NCT02431702|4120160|FG001|Part 2: 9Month Disease Progression Phase|Other|2
2359641|NCT02431702|4120161|FG002|Part 2: 9Month Disease Progression Phase|Other|2
2359642|NCT02431702|4120162|FG003|Part 2: 9Month Disease Progression Phase|Other|0
2359643|NCT02431702|4120163|FG004|Part 2: 9Month Disease Progression Phase|Other|0
2359644|NCT02431702|4120164|FG005|Part 2: 9Month Disease Progression Phase|Other|0
2359645|NCT02431702|4120165|FG006|Part 2: 9Month Disease Progression Phase|Other|0
2359646|NCT02431702|4120159|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
2359647|NCT02431702|4120160|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
2359648|NCT02431702|4120161|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5
2359649|NCT02431702|4120162|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
2359650|NCT02431702|4120163|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
2359651|NCT02431702|4120164|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
2359652|NCT02431702|4120165|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
2359653|NCT02431702|4120159|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0
2359654|NCT02431702|4120160|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0
2359655|NCT02431702|4120161|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0
2359656|NCT02431702|4120162|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2
2359657|NCT02431702|4120163|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3
2359658|NCT02431702|4120164|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0
2359659|NCT02431702|4120165|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0
2359660|NCT02431702|4120159|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
2359661|NCT02431702|4120160|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
2359662|NCT02431702|4120161|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
2359663|NCT02431702|4120162|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1
2359664|NCT02431702|4120163|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
2359665|NCT02431702|4120164|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5
2359666|NCT02431702|4120165|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
2359667|NCT02431702|4120159|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
2359668|NCT02431702|4120160|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
2359669|NCT02431702|4120161|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
2359670|NCT02431702|4120162|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5
2359671|NCT02431702|4120163|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
2359672|NCT02431702|4120164|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
2359673|NCT02431702|4120165|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
2359674|NCT02431702|4120159|FG000|Part 3: 9 Month of Additional Treatment|Other|0
2359675|NCT02431702|4120160|FG001|Part 3: 9 Month of Additional Treatment|Other|0
2359676|NCT02431702|4120161|FG002|Part 3: 9 Month of Additional Treatment|Other|0
2359677|NCT02431702|4120162|FG003|Part 3: 9 Month of Additional Treatment|Other|1
2359678|NCT02431702|4120163|FG004|Part 3: 9 Month of Additional Treatment|Other|1
2214915|NCT01691794|3857675|FG000|Overall Study|Adverse Event|0
2214916|NCT01691794|3857676|FG001|Overall Study|Adverse Event|1
2359679|NCT02431702|4120164|FG005|Part 3: 9 Month of Additional Treatment|Other|6
2359680|NCT02431702|4120165|FG006|Part 3: 9 Month of Additional Treatment|Other|0
2359681|NCT02200770|4120202|FG000|Randomized-controlled Period (RCP)|Adverse Event|0
2359682|NCT02200770|4120203|FG001|Randomized-controlled Period (RCP)|Adverse Event|2
2359683|NCT02200770|4120202|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
2359684|NCT02200770|4120203|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
2359685|NCT02200770|4120202|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0
2359686|NCT02200770|4120203|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1
2359687|NCT02200770|4120202|FG000|Randomized-controlled Period (RCP)|Other|1
2359688|NCT02200770|4120203|FG001|Randomized-controlled Period (RCP)|Other|2
2359689|NCT02200770|4120202|FG000|Open-label Period (OLP)|Adverse Event|1
2359690|NCT02200770|4120203|FG001|Open-label Period (OLP)|Adverse Event|2
2359691|NCT02200770|4120202|FG000|Open-label Period (OLP)|Death|1
2359692|NCT02200770|4120203|FG001|Open-label Period (OLP)|Death|2
2359693|NCT02200770|4120202|FG000|Open-label Period (OLP)|Lost to Follow-up|0
2359694|NCT02200770|4120203|FG001|Open-label Period (OLP)|Lost to Follow-up|1
2359695|NCT02200770|4120202|FG000|Open-label Period (OLP)|Withdrawal by Subject|0
2359696|NCT02200770|4120203|FG001|Open-label Period (OLP)|Withdrawal by Subject|14
2359697|NCT02200770|4120202|FG000|Open-label Period (OLP)|Other|6
2359698|NCT02200770|4120203|FG001|Open-label Period (OLP)|Other|15
2359699|NCT02136069|4120213|FG000|Overall Study|UC flare-up|1
2359700|NCT02136069|4120214|FG001|Overall Study|UC flare-up|0
2359701|NCT02136069|4120213|FG000|Overall Study|Adverse Event|6
2359702|NCT02136069|4120214|FG001|Overall Study|Adverse Event|8
2359703|NCT02136069|4120213|FG000|Overall Study|Death|0
2359704|NCT02136069|4120214|FG001|Overall Study|Death|1
2359705|NCT02136069|4120213|FG000|Overall Study|Lack of Efficacy|10
2359706|NCT02136069|4120214|FG001|Overall Study|Lack of Efficacy|4
2359707|NCT02136069|4120213|FG000|Overall Study|Lost to Follow-up|1
2359708|NCT02136069|4120214|FG001|Overall Study|Lost to Follow-up|0
2359709|NCT02136069|4120213|FG000|Overall Study|Non-Compliance|1
2359710|NCT02136069|4120214|FG001|Overall Study|Non-Compliance|0
2359711|NCT02136069|4120213|FG000|Overall Study|Physician Decision|5
2359712|NCT02136069|4120214|FG001|Overall Study|Physician Decision|4
2359713|NCT02136069|4120213|FG000|Overall Study|Withdrawal by Subject|10
2359714|NCT02136069|4120214|FG001|Overall Study|Withdrawal by Subject|11
2214917|NCT01691794|3857677|FG002|Overall Study|Adverse Event|1
2359715|NCT02086552|4120220|FG000|Overall Study|Withdrawal by Subject|1
2359716|NCT01209767|4120238|FG000|Overall Study|Withdrawal by Subject|1
2359717|NCT01209767|4120238|FG000|Overall Study|Lost to Follow-up|3
2359718|NCT01186848|4120246|FG000|Overall Study|Lost to Follow-up|4
2359719|NCT01186848|4120246|FG000|Overall Study|Withdrawal by Subject|2
2359720|NCT01186848|4120246|FG000|Overall Study|Adverse Event|2
2359721|NCT01024608|4120263|FG000|Overall Study|Adverse Event|1
2359722|NCT01024608|4120264|FG001|Overall Study|Adverse Event|0
2359723|NCT01024608|4120263|FG000|Overall Study|Withdrawal by Subject|1
2359724|NCT01024608|4120264|FG001|Overall Study|Withdrawal by Subject|0
2359725|NCT01024608|4120263|FG000|Overall Study|Lost to Follow-up|0
2359726|NCT01024608|4120264|FG001|Overall Study|Lost to Follow-up|1
2359727|NCT01024608|4120263|FG000|Overall Study|Protocol Violation|0
2359728|NCT01024608|4120264|FG001|Overall Study|Protocol Violation|3
2359729|NCT01024608|4120263|FG000|Overall Study|Never received study treatment|2
2359730|NCT01024608|4120264|FG001|Overall Study|Never received study treatment|0
2359731|NCT00988247|4120272|FG000|Overall Study|Adverse Event|17
2359732|NCT00988247|4120273|FG001|Overall Study|Adverse Event|3
2359733|NCT00988247|4120272|FG000|Overall Study|Withdrawal by Subject|44
2359734|NCT00988247|4120273|FG001|Overall Study|Withdrawal by Subject|13
2359735|NCT00988247|4120272|FG000|Overall Study|Pregnancy|1
2359736|NCT00988247|4120273|FG001|Overall Study|Pregnancy|2
2359737|NCT00988247|4120272|FG000|Overall Study|Lost to Follow-up|11
2359738|NCT00988247|4120273|FG001|Overall Study|Lost to Follow-up|2
2359739|NCT00988247|4120272|FG000|Overall Study|Protocol Violation|4
2359740|NCT00988247|4120273|FG001|Overall Study|Protocol Violation|5
2359741|NCT00988247|4120272|FG000|Overall Study|Sponsor requested withdrawal|3
2359742|NCT00988247|4120273|FG001|Overall Study|Sponsor requested withdrawal|1
2359743|NCT00988247|4120272|FG000|Overall Study|Other|3
2359744|NCT00988247|4120273|FG001|Overall Study|Other|0
2359745|NCT00730639|4120305|FG000|Overall Study|Adverse Event|3
2359746|NCT00730639|4120306|FG001|Overall Study|Adverse Event|0
2359747|NCT00730639|4120307|FG002|Overall Study|Adverse Event|9
2359748|NCT00730639|4120308|FG003|Overall Study|Adverse Event|8
2359749|NCT00730639|4120309|FG004|Overall Study|Adverse Event|23
2359750|NCT00730639|4120305|FG000|Overall Study|Complete Response|0
2359751|NCT00730639|4120306|FG001|Overall Study|Complete Response|0
2359752|NCT00730639|4120307|FG002|Overall Study|Complete Response|2
2359753|NCT00730639|4120308|FG003|Overall Study|Complete Response|2
2359754|NCT00730639|4120309|FG004|Overall Study|Complete Response|1
2359755|NCT00730639|4120305|FG000|Overall Study|Completed Maximum Cycles|0
2359756|NCT00730639|4120306|FG001|Overall Study|Completed Maximum Cycles|0
2359757|NCT00730639|4120307|FG002|Overall Study|Completed Maximum Cycles|11
2359758|NCT00730639|4120308|FG003|Overall Study|Completed Maximum Cycles|3
2359759|NCT00730639|4120309|FG004|Overall Study|Completed Maximum Cycles|6
2214918|NCT01691794|3857675|FG000|Overall Study|Completed Only first 24 weeks of study|0
2359760|NCT00730639|4120305|FG000|Overall Study|Death|0
2359761|NCT00730639|4120306|FG001|Overall Study|Death|0
2359762|NCT00730639|4120307|FG002|Overall Study|Death|0
2359763|NCT00730639|4120308|FG003|Overall Study|Death|0
2359764|NCT00730639|4120309|FG004|Overall Study|Death|2
2359765|NCT00730639|4120305|FG000|Overall Study|Disease Progression|12
2359766|NCT00730639|4120306|FG001|Overall Study|Disease Progression|13
2359767|NCT00730639|4120307|FG002|Overall Study|Disease Progression|48
2359768|NCT00730639|4120308|FG003|Overall Study|Disease Progression|32
2359769|NCT00730639|4120309|FG004|Overall Study|Disease Progression|88
2359770|NCT00730639|4120305|FG000|Overall Study|non-specified|0
2214919|NCT01691794|3857676|FG001|Overall Study|Completed Only first 24 weeks of study|2
2214920|NCT01691794|3857677|FG002|Overall Study|Completed Only first 24 weeks of study|3
2359771|NCT00730639|4120306|FG001|Overall Study|non-specified|0
2359772|NCT00730639|4120307|FG002|Overall Study|non-specified|4
2359773|NCT00730639|4120308|FG003|Overall Study|non-specified|2
2359774|NCT00730639|4120309|FG004|Overall Study|non-specified|3
2359775|NCT00730639|4120305|FG000|Overall Study|Protocol Violation|0
2359776|NCT00730639|4120306|FG001|Overall Study|Protocol Violation|0
2359777|NCT00730639|4120307|FG002|Overall Study|Protocol Violation|1
2359778|NCT00730639|4120308|FG003|Overall Study|Protocol Violation|0
2359779|NCT00730639|4120309|FG004|Overall Study|Protocol Violation|0
2359780|NCT00730639|4120305|FG000|Overall Study|Withdrawal by Subject|0
2359781|NCT00730639|4120306|FG001|Overall Study|Withdrawal by Subject|0
2359782|NCT00730639|4120307|FG002|Overall Study|Withdrawal by Subject|6
2359783|NCT00730639|4120308|FG003|Overall Study|Withdrawal by Subject|3
2359784|NCT00730639|4120309|FG004|Overall Study|Withdrawal by Subject|4
2359785|NCT00730639|4120305|FG000|Overall Study|Treatment on-going|2
2359786|NCT00730639|4120306|FG001|Overall Study|Treatment on-going|5
2359787|NCT00730639|4120307|FG002|Overall Study|Treatment on-going|5
2359788|NCT00730639|4120308|FG003|Overall Study|Treatment on-going|4
2359789|NCT00730639|4120309|FG004|Overall Study|Treatment on-going|4
2359790|NCT04834362|4120347|FG000|Overall Study|Death|1
2359791|NCT04834362|4120348|FG001|Overall Study|Death|2
2359792|NCT04611789|4120374|FG000|Overall Study|Lost to Follow-up|1
2359793|NCT04611789|4120375|FG001|Overall Study|Lost to Follow-up|0
2359794|NCT04611789|4120376|FG002|Overall Study|Lost to Follow-up|0
2359795|NCT04254809|4120450|FG000|Overall Study|Lost to Follow-up|5
2359796|NCT04254809|4120451|FG001|Overall Study|Lost to Follow-up|10
2359797|NCT04230122|4120459|FG000|Overall Study|Lost to Follow-up|1
2359798|NCT04230122|4120460|FG001|Overall Study|Lost to Follow-up|0
2359799|NCT04033068|4120489|FG000|Overall Study|Withdrawal by Subject|0
2359800|NCT04033068|4120490|FG001|Overall Study|Withdrawal by Subject|0
2359801|NCT04033068|4120491|FG002|Overall Study|Withdrawal by Subject|1
2359802|NCT04033068|4120492|FG003|Overall Study|Withdrawal by Subject|0
2359803|NCT04033068|4120489|FG000|Overall Study|Lost to Follow-up|0
2359804|NCT04033068|4120490|FG001|Overall Study|Lost to Follow-up|1
2359805|NCT04033068|4120491|FG002|Overall Study|Lost to Follow-up|0
2359806|NCT04033068|4120492|FG003|Overall Study|Lost to Follow-up|0
2359807|NCT04033068|4120489|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0
2359808|NCT04033068|4120490|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0
2359809|NCT04033068|4120491|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0
2359810|NCT04033068|4120492|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1
2359811|NCT03561597|4120502|FG000|Overall Study|Lost to Follow-up|20
2359812|NCT03446573|4120508|FG000|Overall Study|Withdrawal by Subject|7
2359813|NCT03446573|4120509|FG001|Overall Study|Withdrawal by Subject|16
2359814|NCT03446573|4120508|FG000|Overall Study|Physician Decision|1
2359815|NCT03446573|4120509|FG001|Overall Study|Physician Decision|1
2359816|NCT03446573|4120508|FG000|Overall Study|Lost to Follow-up|3
2359817|NCT03446573|4120509|FG001|Overall Study|Lost to Follow-up|5
2359818|NCT03446573|4120508|FG000|Overall Study|Protocol Violation|3
2359819|NCT03446573|4120509|FG001|Overall Study|Protocol Violation|2
2359820|NCT03446573|4120508|FG000|Overall Study|Lack of Efficacy|0
2359821|NCT03446573|4120509|FG001|Overall Study|Lack of Efficacy|3
2359822|NCT03446573|4120508|FG000|Overall Study|Adverse Event|13
2359823|NCT03446573|4120509|FG001|Overall Study|Adverse Event|2
2359824|NCT03446573|4120508|FG000|Overall Study|Ongoing at the time of interim analysis|342
2359825|NCT03446573|4120509|FG001|Overall Study|Ongoing at the time of interim analysis|343
2359826|NCT03350984|4120529|FG000|Overall Study|Death|1
2359827|NCT03350984|4120530|FG001|Overall Study|Death|0
2359828|NCT03350984|4120529|FG000|Overall Study|Lost to Follow-up|5
2359829|NCT03350984|4120530|FG001|Overall Study|Lost to Follow-up|6
2359830|NCT03350984|4120529|FG000|Overall Study|Protocol Violation|1
2359831|NCT03350984|4120530|FG001|Overall Study|Protocol Violation|2
2359832|NCT03350984|4120529|FG000|Overall Study|Physician Decision|1
2359833|NCT03350984|4120530|FG001|Overall Study|Physician Decision|0
2359834|NCT03277261|4120538|FG000|Overall Study|Adverse Event|17
2214921|NCT01691794|3857675|FG000|Overall Study|Did not complete first 24 weeks of study|0
2214922|NCT01691794|3857676|FG001|Overall Study|Did not complete first 24 weeks of study|3
2214923|NCT01691794|3857677|FG002|Overall Study|Did not complete first 24 weeks of study|3
2214924|NCT01691820|3857687|FG000|Overall Study|Consent withdrawal (not due to an AE)|9
2214925|NCT01691820|3857688|FG001|Overall Study|Consent withdrawal (not due to an AE)|15
2214926|NCT01691820|3857687|FG000|Overall Study|Migrated/moved from study area|7
2214927|NCT01691820|3857688|FG001|Overall Study|Migrated/moved from study area|4
2214928|NCT01691820|3857687|FG000|Overall Study|Lost to Follow-up|6
2214929|NCT01691820|3857688|FG001|Overall Study|Lost to Follow-up|17
2214930|NCT01691820|3857687|FG000|Overall Study|Other (unspecified)|4
2214931|NCT01691820|3857688|FG001|Overall Study|Other (unspecified)|1
2214932|NCT01691859|3857711|FG000|Overall Study|Adverse Event|19
2214933|NCT01691859|3857711|FG000|Overall Study|Lack of Efficacy|11
2214934|NCT01691859|3857711|FG000|Overall Study|Protocol Violation|4
2214935|NCT01691859|3857711|FG000|Overall Study|Product commercially available|221
2214936|NCT01691859|3857711|FG000|Overall Study|Study closed/terminated|50
2214937|NCT01691859|3857711|FG000|Overall Study|Lost to Follow-up|5
2214938|NCT01691859|3857711|FG000|Overall Study|Physician Decision|6
2214939|NCT01691859|3857711|FG000|Overall Study|Withdrawal by Subject|31
2214940|NCT01691885|3857715|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1
2214941|NCT01691885|3857716|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1
2214942|NCT01691885|3857715|FG000|Washout Period (7-9 Days)|Adverse Event|0
2214943|NCT01691885|3857716|FG001|Washout Period (7-9 Days)|Adverse Event|1
2214944|NCT01691898|3857728|FG000|Overall Study|Death|34
2214945|NCT01691898|3857729|FG001|Overall Study|Death|32
2214946|NCT01691898|3857730|FG002|Overall Study|Death|6
2214947|NCT01691898|3857731|FG003|Overall Study|Death|3
2359835|NCT03277261|4120539|FG001|Overall Study|Adverse Event|1
2359836|NCT03277261|4120538|FG000|Overall Study|Participant Withdrawal of Consent|6
2359837|NCT03277261|4120539|FG001|Overall Study|Participant Withdrawal of Consent|15
2359838|NCT03277261|4120538|FG000|Overall Study|Investigator / Sponsor Decision|4
2359839|NCT03277261|4120539|FG001|Overall Study|Investigator / Sponsor Decision|2
2214948|NCT01691898|3857732|FG004|Overall Study|Death|8
2359840|NCT03277261|4120538|FG000|Overall Study|Pregnancy|2
2359841|NCT03277261|4120539|FG001|Overall Study|Pregnancy|0
2359842|NCT03277261|4120538|FG000|Overall Study|Lost to Follow-up|2
2359843|NCT03277261|4120539|FG001|Overall Study|Lost to Follow-up|2
2214949|NCT01691898|3857733|FG005|Overall Study|Death|31
2359844|NCT03277261|4120538|FG000|Overall Study|Lack of Efficacy|2
2359845|NCT03277261|4120539|FG001|Overall Study|Lack of Efficacy|2
2359846|NCT03277261|4120538|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
2359847|NCT03277261|4120539|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
2359848|NCT03277248|4120548|FG000|Overall Study|Adverse Event|3
2359849|NCT03277248|4120549|FG001|Overall Study|Adverse Event|1
2359850|NCT03277248|4120548|FG000|Overall Study|Subject Withdrawal of Consent|6
2359851|NCT03277248|4120549|FG001|Overall Study|Subject Withdrawal of Consent|23
2359852|NCT03277248|4120548|FG000|Overall Study|Investigator/Sponsor Decision|2
2359853|NCT03277248|4120549|FG001|Overall Study|Investigator/Sponsor Decision|2
2359854|NCT03277248|4120548|FG000|Overall Study|Pregnancy|4
2359855|NCT03277248|4120549|FG001|Overall Study|Pregnancy|1
2359856|NCT03277248|4120548|FG000|Overall Study|Lost to Follow-up|0
2359857|NCT03277248|4120549|FG001|Overall Study|Lost to Follow-up|2
2359858|NCT03277248|4120548|FG000|Overall Study|Lack of Efficacy|0
2359859|NCT03277248|4120549|FG001|Overall Study|Lack of Efficacy|2
2359860|NCT03277248|4120548|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
2359861|NCT03277248|4120549|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
2359862|NCT03179462|4120558|FG000|Overall Study|screening failure|1
2359863|NCT03179462|4120559|FG001|Overall Study|screening failure|2
2359864|NCT03179462|4120560|FG002|Overall Study|screening failure|0
2359865|NCT03099707|4120570|FG000|Overall Study|Withdrawal by Subject|0
2359866|NCT03099707|4120571|FG001|Overall Study|Withdrawal by Subject|3
2359867|NCT03099707|4120570|FG000|Overall Study|Lost to Follow-up|0
2359868|NCT03099707|4120571|FG001|Overall Study|Lost to Follow-up|1
2359869|NCT03064763|4120577|FG000|Overall Study|Ongoing in study|10
2359870|NCT03064763|4120577|FG000|Overall Study|Death|8
2359871|NCT02928224|4120593|FG000|Overall Study|Randomized, Not Treated|0
2359872|NCT02928224|4120594|FG001|Overall Study|Randomized, Not Treated|2
2359873|NCT02928224|4120595|FG002|Overall Study|Randomized, Not Treated|4
2359874|NCT02928224|4120596|FG003|Overall Study|Randomized, Not Treated|28
2359875|NCT02928224|4120593|FG000|Overall Study|Treatment Ongoing|6
2359876|NCT02928224|4120594|FG001|Overall Study|Treatment Ongoing|78
2359877|NCT02928224|4120595|FG002|Overall Study|Treatment Ongoing|78
2359878|NCT02928224|4120596|FG003|Overall Study|Treatment Ongoing|37
2359879|NCT02928224|4120593|FG000|Overall Study|Progressive Disease|23
2359880|NCT02928224|4120594|FG001|Overall Study|Progressive Disease|104
2359881|NCT02928224|4120595|FG002|Overall Study|Progressive Disease|101
2359882|NCT02928224|4120596|FG003|Overall Study|Progressive Disease|103
2359883|NCT02928224|4120593|FG000|Overall Study|Adverse Event|2
2359884|NCT02928224|4120594|FG001|Overall Study|Adverse Event|11
2359885|NCT02928224|4120595|FG002|Overall Study|Adverse Event|11
2359886|NCT02928224|4120596|FG003|Overall Study|Adverse Event|10
2359887|NCT02928224|4120593|FG000|Overall Study|Changes in Patient's Condition|3
2359888|NCT02928224|4120594|FG001|Overall Study|Changes in Patient's Condition|9
2359889|NCT02928224|4120595|FG002|Overall Study|Changes in Patient's Condition|9
2359890|NCT02928224|4120596|FG003|Overall Study|Changes in Patient's Condition|13
2359891|NCT02928224|4120593|FG000|Overall Study|Death|1
2359892|NCT02928224|4120594|FG001|Overall Study|Death|7
2359893|NCT02928224|4120595|FG002|Overall Study|Death|5
2359894|NCT02928224|4120596|FG003|Overall Study|Death|11
2359895|NCT02928224|4120593|FG000|Overall Study|Withdrawal by Subject|1
2359896|NCT02928224|4120594|FG001|Overall Study|Withdrawal by Subject|4
2359897|NCT02928224|4120595|FG002|Overall Study|Withdrawal by Subject|3
2359898|NCT02928224|4120596|FG003|Overall Study|Withdrawal by Subject|9
2359899|NCT02928224|4120593|FG000|Overall Study|Dose Interruptions>28|1
2359900|NCT02928224|4120594|FG001|Overall Study|Dose Interruptions>28|2
2359901|NCT02928224|4120595|FG002|Overall Study|Dose Interruptions>28|2
2359902|NCT02928224|4120596|FG003|Overall Study|Dose Interruptions>28|4
2359903|NCT02928224|4120593|FG000|Overall Study|Patient Decision to Discontinue Drug|0
2359904|NCT02928224|4120594|FG001|Overall Study|Patient Decision to Discontinue Drug|2
2359905|NCT02928224|4120595|FG002|Overall Study|Patient Decision to Discontinue Drug|2
2359906|NCT02928224|4120596|FG003|Overall Study|Patient Decision to Discontinue Drug|4
2359907|NCT02928224|4120593|FG000|Overall Study|Physician Decision|0
2359908|NCT02928224|4120594|FG001|Overall Study|Physician Decision|2
2359909|NCT02928224|4120595|FG002|Overall Study|Physician Decision|4
2359910|NCT02928224|4120596|FG003|Overall Study|Physician Decision|2
2359911|NCT02928224|4120593|FG000|Overall Study|not listed|0
2359912|NCT02928224|4120594|FG001|Overall Study|not listed|3
2359913|NCT02928224|4120595|FG002|Overall Study|not listed|1
2359914|NCT02928224|4120596|FG003|Overall Study|not listed|0
2359915|NCT02906033|4120624|FG000|Baseline|Protocol Violation|37
2359916|NCT02906033|4120625|FG001|Baseline|Protocol Violation|33
2359917|NCT02906033|4120624|FG000|Follow-up|Lost to Follow-up|46
2359918|NCT02906033|4120625|FG001|Follow-up|Lost to Follow-up|62
2359919|NCT02837783|4120633|FG000|Overall Study|Adverse Event|1
2359920|NCT02837783|4120634|FG001|Overall Study|Adverse Event|0
2359921|NCT02837783|4120633|FG000|Overall Study|Other, Not Specified|1
2359922|NCT02837783|4120634|FG001|Overall Study|Other, Not Specified|2
2359923|NCT02786537|4120646|FG000|As Randomized|Adverse Event|0
2359924|NCT02786537|4120647|FG001|As Randomized|Adverse Event|11
2359925|NCT02786537|4120648|FG002|As Randomized|Adverse Event|0
2359926|NCT02786537|4120649|FG003|As Randomized|Adverse Event|4
2359927|NCT02786537|4120650|FG004|As Randomized|Adverse Event|6
2359928|NCT02786537|4120651|FG005|As Randomized|Adverse Event|2
2359929|NCT02786537|4120646|FG000|As Randomized|Lack of Efficacy|0
2359930|NCT02786537|4120647|FG001|As Randomized|Lack of Efficacy|0
2359931|NCT02786537|4120648|FG002|As Randomized|Lack of Efficacy|0
2359932|NCT02786537|4120649|FG003|As Randomized|Lack of Efficacy|1
2359933|NCT02786537|4120650|FG004|As Randomized|Lack of Efficacy|0
2359934|NCT02786537|4120651|FG005|As Randomized|Lack of Efficacy|0
2359935|NCT02786537|4120646|FG000|As Randomized|Withdrawal by Subject|1
2359936|NCT02786537|4120647|FG001|As Randomized|Withdrawal by Subject|2
2359937|NCT02786537|4120648|FG002|As Randomized|Withdrawal by Subject|0
2359938|NCT02786537|4120649|FG003|As Randomized|Withdrawal by Subject|1
2359939|NCT02786537|4120650|FG004|As Randomized|Withdrawal by Subject|1
2359940|NCT02786537|4120651|FG005|As Randomized|Withdrawal by Subject|0
2359941|NCT02786537|4120646|FG000|As Randomized|Death|0
2359942|NCT02786537|4120647|FG001|As Randomized|Death|2
2359943|NCT02786537|4120648|FG002|As Randomized|Death|0
2359944|NCT02786537|4120649|FG003|As Randomized|Death|3
2359945|NCT02786537|4120650|FG004|As Randomized|Death|1
2359946|NCT02786537|4120651|FG005|As Randomized|Death|0
2359947|NCT02786537|4120646|FG000|As Randomized|Non-compliance with study drug|1
2359948|NCT02786537|4120647|FG001|As Randomized|Non-compliance with study drug|11
2359949|NCT02786537|4120648|FG002|As Randomized|Non-compliance with study drug|0
2359950|NCT02786537|4120649|FG003|As Randomized|Non-compliance with study drug|1
2359951|NCT02786537|4120650|FG004|As Randomized|Non-compliance with study drug|0
2359952|NCT02786537|4120651|FG005|As Randomized|Non-compliance with study drug|1
2359953|NCT02786537|4120646|FG000|As Randomized|Lost to treatment follow-up|4
2359954|NCT02786537|4120647|FG001|As Randomized|Lost to treatment follow-up|32
2359955|NCT02786537|4120648|FG002|As Randomized|Lost to treatment follow-up|0
2359956|NCT02786537|4120649|FG003|As Randomized|Lost to treatment follow-up|24
2359957|NCT02786537|4120650|FG004|As Randomized|Lost to treatment follow-up|4
2359958|NCT02786537|4120651|FG005|As Randomized|Lost to treatment follow-up|4
2359959|NCT02786537|4120646|FG000|As Randomized|Incarceration|0
2359960|NCT02786537|4120647|FG001|As Randomized|Incarceration|1
2359961|NCT02786537|4120648|FG002|As Randomized|Incarceration|0
2359962|NCT02786537|4120649|FG003|As Randomized|Incarceration|0
2359963|NCT02786537|4120650|FG004|As Randomized|Incarceration|0
2359964|NCT02786537|4120651|FG005|As Randomized|Incarceration|0
2359965|NCT02786537|4120646|FG000|As Randomized|Opiate Dependency Relapse|0
2359966|NCT02786537|4120647|FG001|As Randomized|Opiate Dependency Relapse|1
2359967|NCT02786537|4120648|FG002|As Randomized|Opiate Dependency Relapse|0
2359968|NCT02786537|4120649|FG003|As Randomized|Opiate Dependency Relapse|0
2359969|NCT02786537|4120650|FG004|As Randomized|Opiate Dependency Relapse|0
2359970|NCT02786537|4120651|FG005|As Randomized|Opiate Dependency Relapse|0
2359971|NCT02786537|4120646|FG000|As Randomized|HCV drugs stolen from pt|0
2359972|NCT02786537|4120647|FG001|As Randomized|HCV drugs stolen from pt|1
2359973|NCT02786537|4120648|FG002|As Randomized|HCV drugs stolen from pt|0
2359974|NCT02786537|4120649|FG003|As Randomized|HCV drugs stolen from pt|0
2359975|NCT02786537|4120650|FG004|As Randomized|HCV drugs stolen from pt|0
2359976|NCT02786537|4120651|FG005|As Randomized|HCV drugs stolen from pt|0
2359977|NCT02786537|4120646|FG000|As Randomized|Advised to stop after lapse in dosing|0
2359978|NCT02786537|4120647|FG001|As Randomized|Advised to stop after lapse in dosing|1
2359979|NCT02786537|4120648|FG002|As Randomized|Advised to stop after lapse in dosing|0
2359980|NCT02786537|4120649|FG003|As Randomized|Advised to stop after lapse in dosing|0
2359981|NCT02786537|4120650|FG004|As Randomized|Advised to stop after lapse in dosing|0
2359982|NCT02786537|4120651|FG005|As Randomized|Advised to stop after lapse in dosing|0
2359983|NCT02786537|4120646|FG000|As Randomized|Subject lost insurance|0
2359984|NCT02786537|4120647|FG001|As Randomized|Subject lost insurance|0
2359985|NCT02786537|4120648|FG002|As Randomized|Subject lost insurance|0
2359986|NCT02786537|4120649|FG003|As Randomized|Subject lost insurance|1
2359987|NCT02786537|4120650|FG004|As Randomized|Subject lost insurance|0
2359988|NCT02786537|4120651|FG005|As Randomized|Subject lost insurance|0
2359989|NCT02786537|4120646|FG000|As Treated|Adverse Event|0
2359990|NCT02786537|4120647|FG001|As Treated|Adverse Event|11
2359991|NCT02786537|4120648|FG002|As Treated|Adverse Event|0
2359992|NCT02786537|4120649|FG003|As Treated|Adverse Event|4
2359993|NCT02786537|4120650|FG004|As Treated|Adverse Event|6
2359994|NCT02786537|4120651|FG005|As Treated|Adverse Event|2
2359995|NCT02786537|4120646|FG000|As Treated|Death|0
2359996|NCT02786537|4120647|FG001|As Treated|Death|2
2359997|NCT02786537|4120648|FG002|As Treated|Death|0
2359998|NCT02786537|4120649|FG003|As Treated|Death|3
2359999|NCT02786537|4120650|FG004|As Treated|Death|1
2360000|NCT02786537|4120651|FG005|As Treated|Death|0
2360001|NCT02786537|4120646|FG000|As Treated|Lack of Efficacy|0
2360002|NCT02786537|4120647|FG001|As Treated|Lack of Efficacy|0
2360003|NCT02786537|4120648|FG002|As Treated|Lack of Efficacy|0
2360004|NCT02786537|4120649|FG003|As Treated|Lack of Efficacy|1
2360005|NCT02786537|4120650|FG004|As Treated|Lack of Efficacy|0
2360006|NCT02786537|4120651|FG005|As Treated|Lack of Efficacy|0
2360007|NCT02786537|4120646|FG000|As Treated|Lost to Follow-up|4
2360008|NCT02786537|4120647|FG001|As Treated|Lost to Follow-up|32
2360009|NCT02786537|4120648|FG002|As Treated|Lost to Follow-up|0
2360010|NCT02786537|4120649|FG003|As Treated|Lost to Follow-up|25
2360011|NCT02786537|4120650|FG004|As Treated|Lost to Follow-up|4
2360012|NCT02786537|4120651|FG005|As Treated|Lost to Follow-up|4
2360013|NCT02786537|4120646|FG000|As Treated|Non-compliance with study drug|1
2360014|NCT02786537|4120647|FG001|As Treated|Non-compliance with study drug|11
2360015|NCT02786537|4120648|FG002|As Treated|Non-compliance with study drug|0
2360016|NCT02786537|4120649|FG003|As Treated|Non-compliance with study drug|1
2360017|NCT02786537|4120650|FG004|As Treated|Non-compliance with study drug|0
2360018|NCT02786537|4120651|FG005|As Treated|Non-compliance with study drug|1
2360019|NCT02786537|4120646|FG000|As Treated|Lost insurance|0
2360020|NCT02786537|4120647|FG001|As Treated|Lost insurance|0
2360021|NCT02786537|4120648|FG002|As Treated|Lost insurance|0
2360022|NCT02786537|4120649|FG003|As Treated|Lost insurance|1
2360023|NCT02786537|4120650|FG004|As Treated|Lost insurance|0
2360024|NCT02786537|4120651|FG005|As Treated|Lost insurance|0
2360025|NCT02786537|4120646|FG000|As Treated|Withdrawal by Subject|1
2360026|NCT02786537|4120647|FG001|As Treated|Withdrawal by Subject|2
2360027|NCT02786537|4120648|FG002|As Treated|Withdrawal by Subject|0
2360028|NCT02786537|4120649|FG003|As Treated|Withdrawal by Subject|0
2360029|NCT02786537|4120650|FG004|As Treated|Withdrawal by Subject|1
2360030|NCT02786537|4120651|FG005|As Treated|Withdrawal by Subject|0
2360031|NCT02786537|4120646|FG000|As Treated|Incarceration|0
2360032|NCT02786537|4120647|FG001|As Treated|Incarceration|1
2360033|NCT02786537|4120648|FG002|As Treated|Incarceration|0
2360034|NCT02786537|4120649|FG003|As Treated|Incarceration|0
2360035|NCT02786537|4120650|FG004|As Treated|Incarceration|0
2360036|NCT02786537|4120651|FG005|As Treated|Incarceration|0
2360037|NCT02786537|4120646|FG000|As Treated|Opiate dependency relapse|0
2360038|NCT02786537|4120647|FG001|As Treated|Opiate dependency relapse|1
2360039|NCT02786537|4120648|FG002|As Treated|Opiate dependency relapse|0
2360040|NCT02786537|4120649|FG003|As Treated|Opiate dependency relapse|0
2360041|NCT02786537|4120650|FG004|As Treated|Opiate dependency relapse|0
2360042|NCT02786537|4120651|FG005|As Treated|Opiate dependency relapse|0
2360043|NCT02786537|4120646|FG000|As Treated|Drugs stolen from patient|0
2360044|NCT02786537|4120647|FG001|As Treated|Drugs stolen from patient|1
2360045|NCT02786537|4120648|FG002|As Treated|Drugs stolen from patient|0
2360046|NCT02786537|4120649|FG003|As Treated|Drugs stolen from patient|0
2360047|NCT02786537|4120650|FG004|As Treated|Drugs stolen from patient|0
2360048|NCT02786537|4120651|FG005|As Treated|Drugs stolen from patient|0
2360049|NCT02786537|4120646|FG000|As Treated|Advised to stop tx after loss of meds|0
2360050|NCT02786537|4120647|FG001|As Treated|Advised to stop tx after loss of meds|1
2360051|NCT02786537|4120648|FG002|As Treated|Advised to stop tx after loss of meds|0
2360052|NCT02786537|4120649|FG003|As Treated|Advised to stop tx after loss of meds|0
2360053|NCT02786537|4120650|FG004|As Treated|Advised to stop tx after loss of meds|0
2360054|NCT02786537|4120651|FG005|As Treated|Advised to stop tx after loss of meds|0
2360055|NCT02740231|4120761|FG000|Overall Study|Withdrawal by Subject|1
2360056|NCT02740231|4120762|FG001|Overall Study|Withdrawal by Subject|1
2360057|NCT02740231|4120763|FG002|Overall Study|Withdrawal by Subject|1
2360058|NCT02740231|4120764|FG003|Overall Study|Withdrawal by Subject|0
2360059|NCT02740231|4120761|FG000|Overall Study|Lack of Efficacy|0
2360060|NCT02740231|4120762|FG001|Overall Study|Lack of Efficacy|1
2360061|NCT02740231|4120763|FG002|Overall Study|Lack of Efficacy|0
2360062|NCT02740231|4120764|FG003|Overall Study|Lack of Efficacy|4
2360063|NCT02740231|4120761|FG000|Overall Study|Lost to Follow-up|1
2360064|NCT02740231|4120762|FG001|Overall Study|Lost to Follow-up|3
2360065|NCT02740231|4120763|FG002|Overall Study|Lost to Follow-up|0
2360066|NCT02740231|4120764|FG003|Overall Study|Lost to Follow-up|3
2360067|NCT02740231|4120761|FG000|Overall Study|Adverse Event|0
2360068|NCT02740231|4120762|FG001|Overall Study|Adverse Event|1
2360069|NCT02740231|4120763|FG002|Overall Study|Adverse Event|0
2360070|NCT02740231|4120764|FG003|Overall Study|Adverse Event|1
2360071|NCT02710084|4120776|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3
2360072|NCT02710084|4120777|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1
2360073|NCT02660034|4120798|FG000|Overall Study|Progressive Disease (Radiographic)|3
2360074|NCT02660034|4120799|FG001|Overall Study|Progressive Disease (Radiographic)|1
2214950|NCT01691898|3857728|FG000|Overall Study|Adverse Event|0
2214951|NCT01691898|3857729|FG001|Overall Study|Adverse Event|1
2214952|NCT01691898|3857730|FG002|Overall Study|Adverse Event|0
2214953|NCT01691898|3857731|FG003|Overall Study|Adverse Event|1
2317340|NCT02896400|4029418|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
2317341|NCT02896400|4029419|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
2317342|NCT02896400|4029420|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
2317343|NCT02896400|4029421|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56
2317344|NCT02896569|4029449|FG000|Overall Study|Lost to Follow-up|2
2317345|NCT02896569|4029450|FG001|Overall Study|Lost to Follow-up|1
2317346|NCT02896569|4029449|FG000|Overall Study|Physician Decision|1
2317347|NCT02896569|4029450|FG001|Overall Study|Physician Decision|3
2317348|NCT02896569|4029449|FG000|Overall Study|Adverse Event|0
2317349|NCT02896569|4029450|FG001|Overall Study|Adverse Event|1
2360075|NCT02660034|4120800|FG002|Overall Study|Progressive Disease (Radiographic)|0
2360076|NCT02660034|4120801|FG003|Overall Study|Progressive Disease (Radiographic)|1
2360077|NCT02660034|4120802|FG004|Overall Study|Progressive Disease (Radiographic)|0
2360078|NCT02660034|4120803|FG005|Overall Study|Progressive Disease (Radiographic)|0
2360079|NCT02660034|4120804|FG006|Overall Study|Progressive Disease (Radiographic)|0
2360080|NCT02660034|4120805|FG007|Overall Study|Progressive Disease (Radiographic)|0
2360081|NCT02660034|4120806|FG008|Overall Study|Progressive Disease (Radiographic)|0
2360082|NCT02660034|4120807|FG009|Overall Study|Progressive Disease (Radiographic)|0
2360083|NCT02660034|4120808|FG010|Overall Study|Progressive Disease (Radiographic)|0
2360084|NCT02660034|4120809|FG011|Overall Study|Progressive Disease (Radiographic)|0
2360085|NCT02660034|4120810|FG012|Overall Study|Progressive Disease (Radiographic)|0
2360086|NCT02660034|4120811|FG013|Overall Study|Progressive Disease (Radiographic)|0
2360087|NCT02660034|4120798|FG000|Overall Study|Progressive Disease (Clinical)|7
2360088|NCT02660034|4120799|FG001|Overall Study|Progressive Disease (Clinical)|8
2360089|NCT02660034|4120800|FG002|Overall Study|Progressive Disease (Clinical)|3
2360090|NCT02660034|4120801|FG003|Overall Study|Progressive Disease (Clinical)|9
2360091|NCT02660034|4120802|FG004|Overall Study|Progressive Disease (Clinical)|3
2360092|NCT02660034|4120803|FG005|Overall Study|Progressive Disease (Clinical)|0
2360093|NCT02660034|4120804|FG006|Overall Study|Progressive Disease (Clinical)|0
2360094|NCT02660034|4120805|FG007|Overall Study|Progressive Disease (Clinical)|0
2360095|NCT02660034|4120806|FG008|Overall Study|Progressive Disease (Clinical)|0
2360096|NCT02660034|4120807|FG009|Overall Study|Progressive Disease (Clinical)|0
2360097|NCT02660034|4120808|FG010|Overall Study|Progressive Disease (Clinical)|0
2360098|NCT02660034|4120809|FG011|Overall Study|Progressive Disease (Clinical)|0
2360099|NCT02660034|4120810|FG012|Overall Study|Progressive Disease (Clinical)|0
2360100|NCT02660034|4120811|FG013|Overall Study|Progressive Disease (Clinical)|0
2360101|NCT02660034|4120798|FG000|Overall Study|Lost to Follow-up|0
2360102|NCT02660034|4120799|FG001|Overall Study|Lost to Follow-up|0
2360103|NCT02660034|4120800|FG002|Overall Study|Lost to Follow-up|1
2360104|NCT02660034|4120801|FG003|Overall Study|Lost to Follow-up|1
2360105|NCT02660034|4120802|FG004|Overall Study|Lost to Follow-up|0
2360106|NCT02660034|4120803|FG005|Overall Study|Lost to Follow-up|0
2360107|NCT02660034|4120804|FG006|Overall Study|Lost to Follow-up|0
2360108|NCT02660034|4120805|FG007|Overall Study|Lost to Follow-up|0
2360109|NCT02660034|4120806|FG008|Overall Study|Lost to Follow-up|0
2360110|NCT02660034|4120807|FG009|Overall Study|Lost to Follow-up|1
2360111|NCT02660034|4120808|FG010|Overall Study|Lost to Follow-up|1
2360112|NCT02660034|4120809|FG011|Overall Study|Lost to Follow-up|1
2360113|NCT02660034|4120810|FG012|Overall Study|Lost to Follow-up|0
2360114|NCT02660034|4120811|FG013|Overall Study|Lost to Follow-up|0
2360115|NCT02660034|4120798|FG000|Overall Study|Participant moved into special access scheme|1
2360116|NCT02660034|4120799|FG001|Overall Study|Participant moved into special access scheme|2
2360117|NCT02660034|4120800|FG002|Overall Study|Participant moved into special access scheme|0
2360118|NCT02660034|4120801|FG003|Overall Study|Participant moved into special access scheme|0
2360119|NCT02660034|4120802|FG004|Overall Study|Participant moved into special access scheme|0
2360120|NCT02660034|4120803|FG005|Overall Study|Participant moved into special access scheme|0
2360121|NCT02660034|4120804|FG006|Overall Study|Participant moved into special access scheme|0
2360122|NCT02660034|4120805|FG007|Overall Study|Participant moved into special access scheme|0
2360123|NCT02660034|4120806|FG008|Overall Study|Participant moved into special access scheme|0
2360124|NCT02660034|4120807|FG009|Overall Study|Participant moved into special access scheme|0
2360125|NCT02660034|4120808|FG010|Overall Study|Participant moved into special access scheme|0
2360126|NCT02660034|4120809|FG011|Overall Study|Participant moved into special access scheme|0
2360127|NCT02660034|4120810|FG012|Overall Study|Participant moved into special access scheme|0
2360128|NCT02660034|4120811|FG013|Overall Study|Participant moved into special access scheme|0
2360129|NCT02660034|4120798|FG000|Overall Study|Adverse Event|1
2360130|NCT02660034|4120799|FG001|Overall Study|Adverse Event|0
2360131|NCT02660034|4120800|FG002|Overall Study|Adverse Event|0
2360132|NCT02660034|4120801|FG003|Overall Study|Adverse Event|0
2360133|NCT02660034|4120802|FG004|Overall Study|Adverse Event|0
2360134|NCT02660034|4120803|FG005|Overall Study|Adverse Event|0
2360135|NCT02660034|4120804|FG006|Overall Study|Adverse Event|0
2360136|NCT02660034|4120805|FG007|Overall Study|Adverse Event|0
2360137|NCT02660034|4120806|FG008|Overall Study|Adverse Event|0
2360138|NCT02660034|4120807|FG009|Overall Study|Adverse Event|0
2360139|NCT02660034|4120808|FG010|Overall Study|Adverse Event|0
2360140|NCT02660034|4120809|FG011|Overall Study|Adverse Event|0
2360141|NCT02660034|4120810|FG012|Overall Study|Adverse Event|0
2360142|NCT02660034|4120811|FG013|Overall Study|Adverse Event|0
2360143|NCT02660034|4120798|FG000|Overall Study|Sponsor Decision|0
2360144|NCT02660034|4120799|FG001|Overall Study|Sponsor Decision|1
2360145|NCT02660034|4120800|FG002|Overall Study|Sponsor Decision|2
2360146|NCT02660034|4120801|FG003|Overall Study|Sponsor Decision|2
2360147|NCT02660034|4120802|FG004|Overall Study|Sponsor Decision|3
2360148|NCT02660034|4120803|FG005|Overall Study|Sponsor Decision|0
2360149|NCT02660034|4120804|FG006|Overall Study|Sponsor Decision|0
2360150|NCT02660034|4120805|FG007|Overall Study|Sponsor Decision|0
2360151|NCT02660034|4120806|FG008|Overall Study|Sponsor Decision|0
2360152|NCT02660034|4120807|FG009|Overall Study|Sponsor Decision|0
2360153|NCT02660034|4120808|FG010|Overall Study|Sponsor Decision|0
2360154|NCT02660034|4120809|FG011|Overall Study|Sponsor Decision|0
2360155|NCT02660034|4120810|FG012|Overall Study|Sponsor Decision|0
2360156|NCT02660034|4120811|FG013|Overall Study|Sponsor Decision|1
2360157|NCT02660034|4120798|FG000|Overall Study|Withdrawal by Subject|0
2360158|NCT02660034|4120799|FG001|Overall Study|Withdrawal by Subject|0
2360159|NCT02660034|4120800|FG002|Overall Study|Withdrawal by Subject|0
2360160|NCT02660034|4120801|FG003|Overall Study|Withdrawal by Subject|0
2360161|NCT02660034|4120802|FG004|Overall Study|Withdrawal by Subject|0
2360162|NCT02660034|4120803|FG005|Overall Study|Withdrawal by Subject|0
2360163|NCT02660034|4120804|FG006|Overall Study|Withdrawal by Subject|1
2360164|NCT02660034|4120805|FG007|Overall Study|Withdrawal by Subject|1
2360165|NCT02660034|4120806|FG008|Overall Study|Withdrawal by Subject|1
2360166|NCT02660034|4120807|FG009|Overall Study|Withdrawal by Subject|0
2360167|NCT02660034|4120808|FG010|Overall Study|Withdrawal by Subject|0
2360168|NCT02660034|4120809|FG011|Overall Study|Withdrawal by Subject|1
2360169|NCT02660034|4120810|FG012|Overall Study|Withdrawal by Subject|2
2360170|NCT02660034|4120811|FG013|Overall Study|Withdrawal by Subject|0
2360171|NCT02660034|4120798|FG000|Overall Study|Death|0
2360172|NCT02660034|4120799|FG001|Overall Study|Death|0
2360173|NCT02660034|4120800|FG002|Overall Study|Death|0
2360174|NCT02660034|4120801|FG003|Overall Study|Death|0
2360175|NCT02660034|4120802|FG004|Overall Study|Death|0
2360176|NCT02660034|4120803|FG005|Overall Study|Death|13
2360177|NCT02660034|4120804|FG006|Overall Study|Death|14
2360178|NCT02660034|4120805|FG007|Overall Study|Death|10
2360179|NCT02660034|4120806|FG008|Overall Study|Death|9
2360180|NCT02660034|4120807|FG009|Overall Study|Death|21
2360181|NCT02660034|4120808|FG010|Overall Study|Death|17
2360182|NCT02660034|4120809|FG011|Overall Study|Death|15
2360183|NCT02660034|4120810|FG012|Overall Study|Death|18
2360184|NCT02660034|4120811|FG013|Overall Study|Death|7
2360185|NCT02660034|4120798|FG000|Overall Study|Physician Decision|0
2360186|NCT02660034|4120799|FG001|Overall Study|Physician Decision|0
2360187|NCT02660034|4120800|FG002|Overall Study|Physician Decision|0
2360188|NCT02660034|4120801|FG003|Overall Study|Physician Decision|0
2360189|NCT02660034|4120802|FG004|Overall Study|Physician Decision|0
2360190|NCT02660034|4120803|FG005|Overall Study|Physician Decision|0
2360191|NCT02660034|4120804|FG006|Overall Study|Physician Decision|0
2360192|NCT02660034|4120805|FG007|Overall Study|Physician Decision|0
2360193|NCT02660034|4120806|FG008|Overall Study|Physician Decision|0
2360194|NCT02660034|4120807|FG009|Overall Study|Physician Decision|0
2360195|NCT02660034|4120808|FG010|Overall Study|Physician Decision|0
2360196|NCT02660034|4120809|FG011|Overall Study|Physician Decision|0
2360197|NCT02660034|4120810|FG012|Overall Study|Physician Decision|0
2360198|NCT02660034|4120811|FG013|Overall Study|Physician Decision|1
2360199|NCT02660034|4120798|FG000|Overall Study|Participants transferred to LTE|0
2360200|NCT02660034|4120799|FG001|Overall Study|Participants transferred to LTE|0
2360201|NCT02660034|4120800|FG002|Overall Study|Participants transferred to LTE|0
2360202|NCT02660034|4120801|FG003|Overall Study|Participants transferred to LTE|0
2360203|NCT02660034|4120802|FG004|Overall Study|Participants transferred to LTE|0
2360204|NCT02660034|4120803|FG005|Overall Study|Participants transferred to LTE|10
2360205|NCT02660034|4120804|FG006|Overall Study|Participants transferred to LTE|8
2360206|NCT02660034|4120805|FG007|Overall Study|Participants transferred to LTE|8
2360207|NCT02660034|4120806|FG008|Overall Study|Participants transferred to LTE|10
2360208|NCT02660034|4120807|FG009|Overall Study|Participants transferred to LTE|1
2360209|NCT02660034|4120808|FG010|Overall Study|Participants transferred to LTE|2
2360210|NCT02660034|4120809|FG011|Overall Study|Participants transferred to LTE|4
2360211|NCT02660034|4120810|FG012|Overall Study|Participants transferred to LTE|1
2360212|NCT02660034|4120811|FG013|Overall Study|Participants transferred to LTE|1
2360213|NCT02640625|4120845|FG000|Overall Study|Adverse Event|1
2360214|NCT02561962|4120859|FG000|Overall Study|Ongoing in study|1
2360215|NCT02561962|4120860|FG001|Overall Study|Ongoing in study|0
2360216|NCT02561962|4120861|FG002|Overall Study|Ongoing in study|0
2360217|NCT02561962|4120862|FG003|Overall Study|Ongoing in study|1
2360218|NCT02561962|4120863|FG004|Overall Study|Ongoing in study|0
2360219|NCT02561962|4120864|FG005|Overall Study|Ongoing in study|1
2360220|NCT02561962|4120865|FG006|Overall Study|Ongoing in study|0
2360221|NCT02561962|4120866|FG007|Overall Study|Ongoing in study|4
2360222|NCT02561962|4120867|FG008|Overall Study|Ongoing in study|1
2360223|NCT02561962|4120859|FG000|Overall Study|Withdrawal by Subject|1
2360224|NCT02561962|4120860|FG001|Overall Study|Withdrawal by Subject|0
2360225|NCT02561962|4120861|FG002|Overall Study|Withdrawal by Subject|0
2360226|NCT02561962|4120862|FG003|Overall Study|Withdrawal by Subject|0
2360227|NCT02561962|4120863|FG004|Overall Study|Withdrawal by Subject|1
2360228|NCT02561962|4120864|FG005|Overall Study|Withdrawal by Subject|1
2360229|NCT02561962|4120865|FG006|Overall Study|Withdrawal by Subject|2
2360230|NCT02561962|4120866|FG007|Overall Study|Withdrawal by Subject|1
2360231|NCT02561962|4120867|FG008|Overall Study|Withdrawal by Subject|0
2360232|NCT02561962|4120859|FG000|Overall Study|Decision by sponsor|0
2360233|NCT02561962|4120860|FG001|Overall Study|Decision by sponsor|0
2360234|NCT02561962|4120861|FG002|Overall Study|Decision by sponsor|0
2360235|NCT02561962|4120862|FG003|Overall Study|Decision by sponsor|0
2360236|NCT02561962|4120863|FG004|Overall Study|Decision by sponsor|1
2360237|NCT02561962|4120864|FG005|Overall Study|Decision by sponsor|1
2360238|NCT02561962|4120865|FG006|Overall Study|Decision by sponsor|0
2360239|NCT02561962|4120866|FG007|Overall Study|Decision by sponsor|3
2360240|NCT02561962|4120867|FG008|Overall Study|Decision by sponsor|0
2360241|NCT02561962|4120859|FG000|Overall Study|Lost to Follow-up|0
2360242|NCT02561962|4120860|FG001|Overall Study|Lost to Follow-up|0
2360243|NCT02561962|4120861|FG002|Overall Study|Lost to Follow-up|0
2360244|NCT02561962|4120862|FG003|Overall Study|Lost to Follow-up|0
2360245|NCT02561962|4120863|FG004|Overall Study|Lost to Follow-up|0
2360246|NCT02561962|4120864|FG005|Overall Study|Lost to Follow-up|1
2360247|NCT02561962|4120865|FG006|Overall Study|Lost to Follow-up|0
2360248|NCT02561962|4120866|FG007|Overall Study|Lost to Follow-up|0
2360249|NCT02561962|4120867|FG008|Overall Study|Lost to Follow-up|0
2360250|NCT02519348|4120896|FG000|Overall Study|Death|31
2360251|NCT02519348|4120897|FG001|Overall Study|Death|74
2360252|NCT02519348|4120898|FG002|Overall Study|Death|47
2360253|NCT02519348|4120899|FG003|Overall Study|Death|54
2360254|NCT02519348|4120900|FG004|Overall Study|Death|63
2360255|NCT02519348|4120901|FG005|Overall Study|Death|18
2360256|NCT02519348|4120902|FG006|Overall Study|Death|2
2360257|NCT02519348|4120903|FG007|Overall Study|Death|5
2360258|NCT02519348|4120904|FG008|Overall Study|Death|5
2360259|NCT02519348|4120896|FG000|Overall Study|Withdrawal by Subject|4
2360260|NCT02519348|4120897|FG001|Overall Study|Withdrawal by Subject|7
2360261|NCT02519348|4120898|FG002|Overall Study|Withdrawal by Subject|4
2360262|NCT02519348|4120899|FG003|Overall Study|Withdrawal by Subject|3
2360263|NCT02519348|4120900|FG004|Overall Study|Withdrawal by Subject|3
2360264|NCT02519348|4120901|FG005|Overall Study|Withdrawal by Subject|2
2360265|NCT02519348|4120902|FG006|Overall Study|Withdrawal by Subject|0
2360266|NCT02519348|4120903|FG007|Overall Study|Withdrawal by Subject|0
2360267|NCT02519348|4120904|FG008|Overall Study|Withdrawal by Subject|1
2360268|NCT02519348|4120896|FG000|Overall Study|Lost to Follow-up|0
2360269|NCT02519348|4120897|FG001|Overall Study|Lost to Follow-up|0
2360270|NCT02519348|4120898|FG002|Overall Study|Lost to Follow-up|1
2360271|NCT02519348|4120899|FG003|Overall Study|Lost to Follow-up|0
2360272|NCT02519348|4120900|FG004|Overall Study|Lost to Follow-up|2
2360273|NCT02519348|4120901|FG005|Overall Study|Lost to Follow-up|1
2360274|NCT02519348|4120902|FG006|Overall Study|Lost to Follow-up|1
2360275|NCT02519348|4120903|FG007|Overall Study|Lost to Follow-up|0
2360276|NCT02519348|4120904|FG008|Overall Study|Lost to Follow-up|0
2360277|NCT02519348|4120896|FG000|Overall Study|Other|0
2360278|NCT02519348|4120897|FG001|Overall Study|Other|3
2360279|NCT02519348|4120898|FG002|Overall Study|Other|0
2360280|NCT02519348|4120899|FG003|Overall Study|Other|0
2360281|NCT02519348|4120900|FG004|Overall Study|Other|1
2360282|NCT02519348|4120901|FG005|Overall Study|Other|0
2360283|NCT02519348|4120902|FG006|Overall Study|Other|0
2360284|NCT02519348|4120903|FG007|Overall Study|Other|0
2360285|NCT02519348|4120904|FG008|Overall Study|Other|0
2360286|NCT02519348|4120896|FG000|Overall Study|Ongoing at the time of data cut-off date|5
2360287|NCT02519348|4120897|FG001|Overall Study|Ongoing at the time of data cut-off date|20
2360288|NCT02519348|4120898|FG002|Overall Study|Ongoing at the time of data cut-off date|23
2360289|NCT02519348|4120899|FG003|Overall Study|Ongoing at the time of data cut-off date|12
2360290|NCT02519348|4120900|FG004|Overall Study|Ongoing at the time of data cut-off date|15
2360291|NCT02519348|4120901|FG005|Overall Study|Ongoing at the time of data cut-off date|26
2360292|NCT02519348|4120902|FG006|Overall Study|Ongoing at the time of data cut-off date|0
2360293|NCT02519348|4120903|FG007|Overall Study|Ongoing at the time of data cut-off date|0
2360294|NCT02519348|4120904|FG008|Overall Study|Ongoing at the time of data cut-off date|0
2360295|NCT02500589|4120927|FG000|Overall Study|Withdrawal by Subject|11
2360296|NCT02500589|4120928|FG001|Overall Study|Withdrawal by Subject|14
2360297|NCT02500589|4120927|FG000|Overall Study|Lost to Follow-up|10
2360298|NCT02500589|4120928|FG001|Overall Study|Lost to Follow-up|12
2360299|NCT02500589|4120927|FG000|Overall Study|Excluded post rand: cognitive impairment|0
2360300|NCT02500589|4120928|FG001|Overall Study|Excluded post rand: cognitive impairment|1
2360301|NCT02500589|4120927|FG000|Overall Study|Death|7
2360302|NCT02500589|4120928|FG001|Overall Study|Death|5
2360303|NCT02474329|4120938|FG000|Overall Study|Withdraw or did not contribute data.|13
2360304|NCT02471339|4120945|FG000|Overall Study|Did not provide follow-up data|2
2360305|NCT02471339|4120946|FG001|Overall Study|Did not provide follow-up data|0
2360306|NCT02384993|4120954|FG000|Overall Study|Adverse Event|0
2360307|NCT02384993|4120955|FG001|Overall Study|Adverse Event|1
2360308|NCT01388491|4120987|FG000|Overall Study|Adverse Event|10
2360309|NCT01388491|4120988|FG001|Overall Study|Adverse Event|9
2360310|NCT01388491|4120987|FG000|Overall Study|Sponsor Request|9
2360311|NCT01388491|4120988|FG001|Overall Study|Sponsor Request|7
2360312|NCT01388491|4120987|FG000|Overall Study|Withdrawal by Subject|6
2360313|NCT01388491|4120988|FG001|Overall Study|Withdrawal by Subject|10
2360314|NCT01388491|4120987|FG000|Overall Study|Lost to Follow-up|4
2360315|NCT01388491|4120988|FG001|Overall Study|Lost to Follow-up|3
2360316|NCT01388491|4120987|FG000|Overall Study|Protocol Violation|2
2360317|NCT01388491|4120988|FG001|Overall Study|Protocol Violation|0
2360318|NCT01388491|4120987|FG000|Overall Study|Noncompliance|2
2360319|NCT01388491|4120988|FG001|Overall Study|Noncompliance|0
2360320|NCT01388491|4120987|FG000|Overall Study|Pregnancy|1
2360321|NCT01388491|4120988|FG001|Overall Study|Pregnancy|0
2360322|NCT01373151|4121001|FG000|Period 1|Lack of Efficacy|3
2360323|NCT01373151|4121002|FG001|Period 1|Lack of Efficacy|0
2360324|NCT01373151|4121003|FG002|Period 1|Lack of Efficacy|0
2360325|NCT01373151|4121004|FG003|Period 1|Lack of Efficacy|0
2360326|NCT01373151|4121005|FG004|Period 1|Lack of Efficacy|1
2360327|NCT01373151|4121006|FG005|Period 1|Lack of Efficacy|0
2360328|NCT01373151|4121007|FG006|Period 1|Lack of Efficacy|0
2360329|NCT01373151|4121001|FG000|Period 1|Adverse Event|0
2360330|NCT01373151|4121002|FG001|Period 1|Adverse Event|0
2360331|NCT01373151|4121003|FG002|Period 1|Adverse Event|1
2360332|NCT01373151|4121004|FG003|Period 1|Adverse Event|0
2360333|NCT01373151|4121005|FG004|Period 1|Adverse Event|4
2360334|NCT01373151|4121006|FG005|Period 1|Adverse Event|3
2360335|NCT01373151|4121007|FG006|Period 1|Adverse Event|0
2360336|NCT01373151|4121001|FG000|Period 1|Withdrawal by Subject|2
2360337|NCT01373151|4121002|FG001|Period 1|Withdrawal by Subject|0
2360338|NCT01373151|4121003|FG002|Period 1|Withdrawal by Subject|3
2360339|NCT01373151|4121004|FG003|Period 1|Withdrawal by Subject|1
2360340|NCT01373151|4121005|FG004|Period 1|Withdrawal by Subject|0
2360341|NCT01373151|4121006|FG005|Period 1|Withdrawal by Subject|1
2360342|NCT01373151|4121007|FG006|Period 1|Withdrawal by Subject|0
2360343|NCT01373151|4121001|FG000|Period 2|Lack of Efficacy|9
2360344|NCT01373151|4121002|FG001|Period 2|Lack of Efficacy|0
2360345|NCT01373151|4121003|FG002|Period 2|Lack of Efficacy|0
2360346|NCT01373151|4121004|FG003|Period 2|Lack of Efficacy|1
2360347|NCT01373151|4121005|FG004|Period 2|Lack of Efficacy|2
2360348|NCT01373151|4121006|FG005|Period 2|Lack of Efficacy|0
2360349|NCT01373151|4121007|FG006|Period 2|Lack of Efficacy|3
2360350|NCT01373151|4121001|FG000|Period 2|Adverse Event|0
2360351|NCT01373151|4121002|FG001|Period 2|Adverse Event|0
2360352|NCT01373151|4121003|FG002|Period 2|Adverse Event|3
2360353|NCT01373151|4121004|FG003|Period 2|Adverse Event|3
2360354|NCT01373151|4121005|FG004|Period 2|Adverse Event|0
2360355|NCT01373151|4121006|FG005|Period 2|Adverse Event|0
2360356|NCT01373151|4121007|FG006|Period 2|Adverse Event|1
2360357|NCT01373151|4121001|FG000|Period 2|subject request to discontinue|0
2360358|NCT01373151|4121002|FG001|Period 2|subject request to discontinue|1
2360359|NCT01373151|4121003|FG002|Period 2|subject request to discontinue|0
2360360|NCT01373151|4121004|FG003|Period 2|subject request to discontinue|0
2360361|NCT01373151|4121005|FG004|Period 2|subject request to discontinue|0
2360362|NCT01373151|4121006|FG005|Period 2|subject request to discontinue|0
2360363|NCT01373151|4121007|FG006|Period 2|subject request to discontinue|0
2360364|NCT01373151|4121001|FG000|Period 2|Withdrawal by Subject|0
2360365|NCT01373151|4121002|FG001|Period 2|Withdrawal by Subject|0
2360366|NCT01373151|4121003|FG002|Period 2|Withdrawal by Subject|0
2360367|NCT01373151|4121004|FG003|Period 2|Withdrawal by Subject|1
2360368|NCT01373151|4121005|FG004|Period 2|Withdrawal by Subject|0
2360369|NCT01373151|4121006|FG005|Period 2|Withdrawal by Subject|0
2360370|NCT01373151|4121007|FG006|Period 2|Withdrawal by Subject|0
2360371|NCT01373151|4121001|FG000|Period 2|Other|0
2360372|NCT01373151|4121002|FG001|Period 2|Other|0
2360373|NCT01373151|4121003|FG002|Period 2|Other|1
2360374|NCT01373151|4121004|FG003|Period 2|Other|0
2360375|NCT01373151|4121005|FG004|Period 2|Other|0
2360376|NCT01373151|4121006|FG005|Period 2|Other|0
2360377|NCT01373151|4121007|FG006|Period 2|Other|1
2360378|NCT01281644|4121036|FG000|Overall Study|Lost to Follow-up|3
2360379|NCT01281644|4121036|FG000|Overall Study|Withdrawal by Subject|2
2360380|NCT00960297|4121048|FG000|Overall Study|Physician Decision|1
2360381|NCT00960297|4121048|FG000|Overall Study|Venous port infection|1
2360382|NCT00960297|4121048|FG000|Overall Study|Disease progression|1
2360383|NCT00910650|4121052|FG000|Overall Study|Death|2
2360384|NCT00703326|4121062|FG000|Overall Study|Lost to Follow-up|47
2360385|NCT00703326|4121063|FG001|Overall Study|Lost to Follow-up|18
2360386|NCT00703326|4121062|FG000|Overall Study|Withdrawal by Subject|54
2360387|NCT00703326|4121063|FG001|Overall Study|Withdrawal by Subject|20
2360388|NCT00703326|4121062|FG000|Overall Study|Adverse Event|1
2360389|NCT00703326|4121063|FG001|Overall Study|Adverse Event|0
2360390|NCT00602667|4121073|FG000|Overall Study|Still on Therapy|0
2360391|NCT00602667|4121074|FG001|Overall Study|Still on Therapy|2
2360392|NCT00602667|4121075|FG002|Overall Study|Still on Therapy|2
2360393|NCT00602667|4121073|FG000|Overall Study|Death|0
2360394|NCT00602667|4121074|FG001|Overall Study|Death|1
2360395|NCT00602667|4121075|FG002|Overall Study|Death|1
2360396|NCT00602667|4121073|FG000|Overall Study|Family request|3
2360397|NCT00602667|4121074|FG001|Overall Study|Family request|25
2360398|NCT00602667|4121075|FG002|Overall Study|Family request|6
2360399|NCT00602667|4121073|FG000|Overall Study|Excessive toxicity|1
2360400|NCT00602667|4121074|FG001|Overall Study|Excessive toxicity|1
2360401|NCT00602667|4121075|FG002|Overall Study|Excessive toxicity|0
2360402|NCT00602667|4121073|FG000|Overall Study|Second malignancy|0
2360403|NCT00602667|4121074|FG001|Overall Study|Second malignancy|1
2360404|NCT00602667|4121075|FG002|Overall Study|Second malignancy|0
2360405|NCT00602667|4121073|FG000|Overall Study|Physician Decision|2
2360406|NCT00602667|4121074|FG001|Overall Study|Physician Decision|3
2360407|NCT00602667|4121075|FG002|Overall Study|Physician Decision|8
2360408|NCT00602667|4121073|FG000|Overall Study|Progressive disease|13
2360409|NCT00602667|4121074|FG001|Overall Study|Progressive disease|48
2360410|NCT00602667|4121075|FG002|Overall Study|Progressive disease|45
2360411|NCT00602667|4121073|FG000|Overall Study|Progressive disease prior to therapy|0
2360412|NCT00602667|4121074|FG001|Overall Study|Progressive disease prior to therapy|0
2360413|NCT00602667|4121075|FG002|Overall Study|Progressive disease prior to therapy|1
2360414|NCT00472186|4121116|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1
2360415|NCT00472186|4121117|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0
2360416|NCT03996876|4121127|FG000|Overall Study|Incomplete Data|2
2360417|NCT03996876|4121128|FG001|Overall Study|Incomplete Data|4
2360464|NCT02662985|4121278|FG000|Treatment Period 1|Adverse Event|0
2360465|NCT02662985|4121279|FG001|Treatment Period 1|Adverse Event|2
2360466|NCT02662985|4121278|FG000|Treatment Period 1|Protocol Violation|0
2360467|NCT02662985|4121279|FG001|Treatment Period 1|Protocol Violation|1
2360468|NCT02662985|4121278|FG000|Treatment Period 1|Physician Decision|1
2360469|NCT02662985|4121279|FG001|Treatment Period 1|Physician Decision|0
2360470|NCT02662985|4121278|FG000|Treatment Period 1|Withdrawal by Subject|0
2360471|NCT02662985|4121279|FG001|Treatment Period 1|Withdrawal by Subject|1
2360472|NCT02662985|4121278|FG000|Treatment Period 2|Lack of Efficacy|0
2360473|NCT02662985|4121279|FG001|Treatment Period 2|Lack of Efficacy|1
2360474|NCT02662985|4121278|FG000|Treatment Period 2|Lost to Follow-up|1
2360475|NCT02662985|4121279|FG001|Treatment Period 2|Lost to Follow-up|0
2360476|NCT02662985|4121278|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
2360477|NCT02662985|4121279|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
2360478|NCT02662985|4121278|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1
2360479|NCT02662985|4121279|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1
2360480|NCT02662985|4121278|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0
2360481|NCT02662985|4121279|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1
2360482|NCT02662985|4121278|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1
2360483|NCT02662985|4121279|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2
2360484|NCT02662985|4121278|FG000|Treatment Period 3 (Extension Period)|Death|0
2360485|NCT02662985|4121279|FG001|Treatment Period 3 (Extension Period)|Death|1
2360486|NCT02606461|4121289|FG000|Overall Study|Withdrawal by Subject|3
2360487|NCT02606461|4121290|FG001|Overall Study|Withdrawal by Subject|2
2360488|NCT02606461|4121291|FG002|Overall Study|Withdrawal by Subject|14
2360489|NCT02606461|4121292|FG003|Overall Study|Withdrawal by Subject|11
2360490|NCT02606461|4121289|FG000|Overall Study|Death|16
2360491|NCT02606461|4121290|FG001|Overall Study|Death|25
2360492|NCT02606461|4121291|FG002|Overall Study|Death|105
2360493|NCT02606461|4121292|FG003|Overall Study|Death|58
2360494|NCT02606461|4121289|FG000|Overall Study|Lost to Follow-up|2
2360495|NCT02606461|4121290|FG001|Overall Study|Lost to Follow-up|2
2360496|NCT02606461|4121291|FG002|Overall Study|Lost to Follow-up|4
2360497|NCT02606461|4121292|FG003|Overall Study|Lost to Follow-up|1
2360498|NCT02606461|4121289|FG000|Overall Study|Physician Decision|0
2360499|NCT02606461|4121290|FG001|Overall Study|Physician Decision|0
2360500|NCT02606461|4121291|FG002|Overall Study|Physician Decision|1
2360501|NCT02606461|4121292|FG003|Overall Study|Physician Decision|1
2360502|NCT02606461|4121289|FG000|Overall Study|Disease Progression|1
2360503|NCT02606461|4121290|FG001|Overall Study|Disease Progression|0
2360504|NCT02606461|4121291|FG002|Overall Study|Disease Progression|0
2360505|NCT02606461|4121292|FG003|Overall Study|Disease Progression|0
2360506|NCT02606461|4121289|FG000|Overall Study|No treatment|0
2360507|NCT02606461|4121290|FG001|Overall Study|No treatment|0
2360508|NCT02606461|4121291|FG002|Overall Study|No treatment|1
2360509|NCT02606461|4121292|FG003|Overall Study|No treatment|0
2360510|NCT02606461|4121289|FG000|Overall Study|Ongoing|5
2360511|NCT02606461|4121290|FG001|Overall Study|Ongoing|1
2360512|NCT02606461|4121291|FG002|Overall Study|Ongoing|63
2360513|NCT02606461|4121292|FG003|Overall Study|Ongoing|26
2360514|NCT02536339|4121305|FG000|Overall Study|Death|20
2360515|NCT02536339|4121305|FG000|Overall Study|Withdrawal by Subject|3
2360516|NCT02536339|4121305|FG000|Overall Study|Lost to Follow-up|2
2360517|NCT02536339|4121305|FG000|Overall Study|Treatment discontinued|2
2360518|NCT02536339|4121305|FG000|Overall Study|Physician Decision|1
2360519|NCT02514083|4121309|FG000|Overall Study|Adverse Event|1
2360520|NCT02323295|4121315|FG000|Overall Study|Adverse Event|0
2360521|NCT02323295|4121316|FG001|Overall Study|Adverse Event|1
2360522|NCT02323295|4121315|FG000|Overall Study|Withdrawal by Subject|0
2360523|NCT02323295|4121316|FG001|Overall Study|Withdrawal by Subject|1
2360524|NCT02323295|4121315|FG000|Overall Study|Patient did not have surgery as planned.|0
2360525|NCT02323295|4121316|FG001|Overall Study|Patient did not have surgery as planned.|1
2360526|NCT02180724|4121324|FG000|Overall Study|Death|12
2360527|NCT02180724|4121325|FG001|Overall Study|Death|1
2360528|NCT02180724|4121324|FG000|Overall Study|Lost to Follow-up|1
2360529|NCT02180724|4121325|FG001|Overall Study|Lost to Follow-up|0
2360530|NCT02180724|4121324|FG000|Overall Study|Withdrawal by Subject|1
2360531|NCT02180724|4121325|FG001|Overall Study|Withdrawal by Subject|2
2360532|NCT02180724|4121324|FG000|Overall Study|Ongoing Study|78
2360533|NCT02180724|4121325|FG001|Overall Study|Ongoing Study|11
2360534|NCT02108964|4121339|FG000|Overall Study|Progressive disease|12
2360535|NCT02108964|4121340|FG001|Overall Study|Progressive disease|25
2360536|NCT02108964|4121341|FG002|Overall Study|Progressive disease|50
2360537|NCT02108964|4121342|FG003|Overall Study|Progressive disease|6
2360538|NCT02108964|4121343|FG004|Overall Study|Progressive disease|18
2360539|NCT02108964|4121344|FG005|Overall Study|Progressive disease|5
2360540|NCT02108964|4121345|FG006|Overall Study|Progressive disease|7
2360541|NCT02108964|4121346|FG007|Overall Study|Progressive disease|9
2360542|NCT02108964|4121339|FG000|Overall Study|Physician Decision|1
2360543|NCT02108964|4121340|FG001|Overall Study|Physician Decision|5
2360544|NCT02108964|4121341|FG002|Overall Study|Physician Decision|6
2360545|NCT02108964|4121342|FG003|Overall Study|Physician Decision|0
2360418|NCT03589976|4121137|FG000|Overall Study|Death|5
2360419|NCT03589976|4121138|FG001|Overall Study|Death|1
2360420|NCT03589976|4121137|FG000|Overall Study|Adverse Event|5
2360421|NCT03589976|4121138|FG001|Overall Study|Adverse Event|1
2360422|NCT03589976|4121137|FG000|Overall Study|Withdrawal by Subject|4
2360423|NCT03589976|4121138|FG001|Overall Study|Withdrawal by Subject|1
2360424|NCT03589976|4121137|FG000|Overall Study|Lost to Follow-up|1
2360425|NCT03589976|4121138|FG001|Overall Study|Lost to Follow-up|0
2360426|NCT03589976|4121137|FG000|Overall Study|Other|4
2360427|NCT03589976|4121138|FG001|Overall Study|Other|3
2360428|NCT03517449|4121146|FG000|Overall Study|Death|184
2360429|NCT03517449|4121147|FG001|Overall Study|Death|236
2360430|NCT03517449|4121146|FG000|Overall Study|Lost to Follow-up|0
2360431|NCT03517449|4121147|FG001|Overall Study|Lost to Follow-up|2
2360432|NCT03517449|4121146|FG000|Overall Study|Withdrawal by Subject|7
2360433|NCT03517449|4121147|FG001|Overall Study|Withdrawal by Subject|26
2360434|NCT03517449|4121146|FG000|Overall Study|Participants Ongoing|220
2360435|NCT03517449|4121147|FG001|Overall Study|Participants Ongoing|152
2360436|NCT03135262|4121194|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1
2360437|NCT03135262|4121195|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0
2360438|NCT03135262|4121196|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0
2360439|NCT03135262|4121197|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0
2360440|NCT03135262|4121198|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0
2360441|NCT03135262|4121194|FG000|Overall Study|Progression of disease|0
2360442|NCT03135262|4121195|FG001|Overall Study|Progression of disease|0
2360443|NCT03135262|4121196|FG002|Overall Study|Progression of disease|0
2360444|NCT03135262|4121197|FG003|Overall Study|Progression of disease|1
2360445|NCT03135262|4121198|FG004|Overall Study|Progression of disease|0
2360446|NCT03135262|4121194|FG000|Overall Study|Death|6
2360447|NCT03135262|4121195|FG001|Overall Study|Death|2
2360448|NCT03135262|4121196|FG002|Overall Study|Death|2
2360449|NCT03135262|4121197|FG003|Overall Study|Death|2
2360450|NCT03135262|4121198|FG004|Overall Study|Death|0
2360451|NCT03135262|4121194|FG000|Overall Study|Withdrawal by Subject|0
2360452|NCT03135262|4121195|FG001|Overall Study|Withdrawal by Subject|0
2360453|NCT03135262|4121196|FG002|Overall Study|Withdrawal by Subject|1
2360454|NCT03135262|4121197|FG003|Overall Study|Withdrawal by Subject|0
2360455|NCT03135262|4121198|FG004|Overall Study|Withdrawal by Subject|1
2360456|NCT03135262|4121194|FG000|Overall Study|Study terminated by sponsor|2
2360457|NCT03135262|4121195|FG001|Overall Study|Study terminated by sponsor|4
2360458|NCT03135262|4121196|FG002|Overall Study|Study terminated by sponsor|4
2360459|NCT03135262|4121197|FG003|Overall Study|Study terminated by sponsor|3
2360460|NCT03135262|4121198|FG004|Overall Study|Study terminated by sponsor|0
2360461|NCT03104075|4121230|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1
2360462|NCT03104075|4121231|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0
2360463|NCT03038087|4121238|FG000|Overall Study|lost data|1
2360546|NCT02108964|4121343|FG004|Overall Study|Physician Decision|1
2360547|NCT02108964|4121344|FG005|Overall Study|Physician Decision|0
2214954|NCT01691898|3857732|FG004|Overall Study|Adverse Event|1
2214955|NCT01691898|3857733|FG005|Overall Study|Adverse Event|0
2214956|NCT01691898|3857728|FG000|Overall Study|Progression of Disease|1
2214957|NCT01691898|3857729|FG001|Overall Study|Progression of Disease|2
2214958|NCT01691898|3857730|FG002|Overall Study|Progression of Disease|1
2214959|NCT01691898|3857731|FG003|Overall Study|Progression of Disease|0
2214960|NCT01691898|3857732|FG004|Overall Study|Progression of Disease|0
2214961|NCT01691898|3857733|FG005|Overall Study|Progression of Disease|1
2360548|NCT02108964|4121345|FG006|Overall Study|Physician Decision|0
2360549|NCT02108964|4121346|FG007|Overall Study|Physician Decision|0
2360550|NCT02108964|4121339|FG000|Overall Study|Adverse Event|0
2360551|NCT02108964|4121340|FG001|Overall Study|Adverse Event|0
2360552|NCT02108964|4121341|FG002|Overall Study|Adverse Event|4
2360553|NCT02108964|4121342|FG003|Overall Study|Adverse Event|0
2360554|NCT02108964|4121343|FG004|Overall Study|Adverse Event|1
2360555|NCT02108964|4121344|FG005|Overall Study|Adverse Event|0
2360556|NCT02108964|4121345|FG006|Overall Study|Adverse Event|3
2360557|NCT02108964|4121346|FG007|Overall Study|Adverse Event|1
2360558|NCT02108964|4121339|FG000|Overall Study|Death|1
2360559|NCT02108964|4121340|FG001|Overall Study|Death|1
2360560|NCT02108964|4121341|FG002|Overall Study|Death|2
2360561|NCT02108964|4121342|FG003|Overall Study|Death|0
2360562|NCT02108964|4121343|FG004|Overall Study|Death|3
2360563|NCT02108964|4121344|FG005|Overall Study|Death|0
2360564|NCT02108964|4121345|FG006|Overall Study|Death|0
2360565|NCT02108964|4121346|FG007|Overall Study|Death|1
2360566|NCT02108964|4121339|FG000|Overall Study|Subject/Guardian decision|0
2360567|NCT02108964|4121340|FG001|Overall Study|Subject/Guardian decision|1
2360568|NCT02108964|4121341|FG002|Overall Study|Subject/Guardian decision|3
2214962|NCT01691898|3857728|FG000|Overall Study|Lost to Follow-up|3
2360569|NCT02108964|4121342|FG003|Overall Study|Subject/Guardian decision|0
2360570|NCT02108964|4121343|FG004|Overall Study|Subject/Guardian decision|2
2360571|NCT02108964|4121344|FG005|Overall Study|Subject/Guardian decision|0
2360572|NCT02108964|4121345|FG006|Overall Study|Subject/Guardian decision|1
2360573|NCT02108964|4121346|FG007|Overall Study|Subject/Guardian decision|1
2360574|NCT02036970|4121389|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0
2360575|NCT02036970|4121390|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0
2360576|NCT02036970|4121391|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3
2360577|NCT02036970|4121392|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2
2360578|NCT02036970|4121393|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0
2360579|NCT02036970|4121394|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1
2360580|NCT02036970|4121395|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0
2360581|NCT02036970|4121396|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1
2360582|NCT02036970|4121397|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3
2360583|NCT02036970|4121398|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1
2360584|NCT02036970|4121389|FG000|Part 1: Day 1 Through Week 16|Death|0
2360585|NCT02036970|4121390|FG001|Part 1: Day 1 Through Week 16|Death|0
2360586|NCT02036970|4121391|FG002|Part 1: Day 1 Through Week 16|Death|0
2360587|NCT02036970|4121392|FG003|Part 1: Day 1 Through Week 16|Death|0
2360588|NCT02036970|4121393|FG004|Part 1: Day 1 Through Week 16|Death|0
2360589|NCT02036970|4121394|FG005|Part 1: Day 1 Through Week 16|Death|0
2360590|NCT02036970|4121395|FG006|Part 1: Day 1 Through Week 16|Death|0
2360591|NCT02036970|4121396|FG007|Part 1: Day 1 Through Week 16|Death|0
2360592|NCT02036970|4121397|FG008|Part 1: Day 1 Through Week 16|Death|1
2360593|NCT02036970|4121398|FG009|Part 1: Day 1 Through Week 16|Death|0
2360594|NCT02036970|4121389|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1
2360595|NCT02036970|4121390|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0
2360596|NCT02036970|4121391|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1
2360597|NCT02036970|4121392|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0
2360598|NCT02036970|4121393|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0
2360599|NCT02036970|4121394|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0
2360600|NCT02036970|4121395|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0
2360601|NCT02036970|4121396|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0
2360602|NCT02036970|4121397|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2
2360603|NCT02036970|4121398|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0
2360604|NCT02036970|4121389|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
2360605|NCT02036970|4121390|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
2360606|NCT02036970|4121391|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
2360607|NCT02036970|4121392|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
2360608|NCT02036970|4121393|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1
2360609|NCT02036970|4121394|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
2360610|NCT02036970|4121395|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
2360611|NCT02036970|4121396|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
2360612|NCT02036970|4121397|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2
2360613|NCT02036970|4121398|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4
2360614|NCT02036970|4121389|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0
2360615|NCT02036970|4121390|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0
2360616|NCT02036970|4121391|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0
2360617|NCT02036970|4121392|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1
2360618|NCT02036970|4121393|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0
2360619|NCT02036970|4121394|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0
2360620|NCT02036970|4121395|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0
2360621|NCT02036970|4121396|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0
2360622|NCT02036970|4121397|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0
2360623|NCT02036970|4121398|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0
2360624|NCT02036970|4121389|FG000|Part 2: Week 16 Onwards|Adverse Event|0
2360625|NCT02036970|4121390|FG001|Part 2: Week 16 Onwards|Adverse Event|2
2360626|NCT02036970|4121391|FG002|Part 2: Week 16 Onwards|Adverse Event|1
2360627|NCT02036970|4121392|FG003|Part 2: Week 16 Onwards|Adverse Event|1
2360628|NCT02036970|4121393|FG004|Part 2: Week 16 Onwards|Adverse Event|1
2360629|NCT02036970|4121394|FG005|Part 2: Week 16 Onwards|Adverse Event|0
2360630|NCT02036970|4121395|FG006|Part 2: Week 16 Onwards|Adverse Event|1
2360631|NCT02036970|4121396|FG007|Part 2: Week 16 Onwards|Adverse Event|0
2360632|NCT02036970|4121397|FG008|Part 2: Week 16 Onwards|Adverse Event|6
2360633|NCT02036970|4121398|FG009|Part 2: Week 16 Onwards|Adverse Event|3
2360634|NCT02036970|4121389|FG000|Part 2: Week 16 Onwards|Protocol Violation|0
2360635|NCT02036970|4121390|FG001|Part 2: Week 16 Onwards|Protocol Violation|0
2360636|NCT02036970|4121391|FG002|Part 2: Week 16 Onwards|Protocol Violation|0
2360637|NCT02036970|4121392|FG003|Part 2: Week 16 Onwards|Protocol Violation|0
2360638|NCT02036970|4121393|FG004|Part 2: Week 16 Onwards|Protocol Violation|0
2360639|NCT02036970|4121394|FG005|Part 2: Week 16 Onwards|Protocol Violation|0
2360640|NCT02036970|4121395|FG006|Part 2: Week 16 Onwards|Protocol Violation|0
2360641|NCT02036970|4121396|FG007|Part 2: Week 16 Onwards|Protocol Violation|1
2360642|NCT02036970|4121397|FG008|Part 2: Week 16 Onwards|Protocol Violation|0
2360643|NCT02036970|4121398|FG009|Part 2: Week 16 Onwards|Protocol Violation|0
2360644|NCT02036970|4121389|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0
2360645|NCT02036970|4121390|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1
2360646|NCT02036970|4121391|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1
2360647|NCT02036970|4121392|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0
2360648|NCT02036970|4121393|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0
2360649|NCT02036970|4121394|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0
2360650|NCT02036970|4121395|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0
2360651|NCT02036970|4121396|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0
2360652|NCT02036970|4121397|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3
2360653|NCT02036970|4121398|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0
2360654|NCT02036970|4121389|FG000|Part 2: Week 16 Onwards|Progressive Disease|0
2360655|NCT02036970|4121390|FG001|Part 2: Week 16 Onwards|Progressive Disease|2
2360656|NCT02036970|4121391|FG002|Part 2: Week 16 Onwards|Progressive Disease|1
2360657|NCT02036970|4121392|FG003|Part 2: Week 16 Onwards|Progressive Disease|1
2360658|NCT02036970|4121393|FG004|Part 2: Week 16 Onwards|Progressive Disease|0
2360659|NCT02036970|4121394|FG005|Part 2: Week 16 Onwards|Progressive Disease|0
2360660|NCT02036970|4121395|FG006|Part 2: Week 16 Onwards|Progressive Disease|0
2360661|NCT02036970|4121396|FG007|Part 2: Week 16 Onwards|Progressive Disease|0
2360662|NCT02036970|4121397|FG008|Part 2: Week 16 Onwards|Progressive Disease|0
2360663|NCT02036970|4121398|FG009|Part 2: Week 16 Onwards|Progressive Disease|2
2360664|NCT01958021|4121432|FG000|Overall Study|Progressive disease|87
2360665|NCT01958021|4121433|FG001|Overall Study|Progressive disease|146
2360666|NCT01958021|4121432|FG000|Overall Study|Adverse Event|25
2360667|NCT01958021|4121433|FG001|Overall Study|Adverse Event|7
2360668|NCT01958021|4121432|FG000|Overall Study|Subject/guardian decision|12
2360669|NCT01958021|4121433|FG001|Overall Study|Subject/guardian decision|13
2360670|NCT01958021|4121432|FG000|Overall Study|Physician Decision|10
2360671|NCT01958021|4121433|FG001|Overall Study|Physician Decision|13
2360672|NCT01958021|4121432|FG000|Overall Study|Protocol Violation|3
2360673|NCT01958021|4121433|FG001|Overall Study|Protocol Violation|1
2360674|NCT01958021|4121432|FG000|Overall Study|Death|2
2360675|NCT01958021|4121433|FG001|Overall Study|Death|0
2360676|NCT01941719|4121441|FG000|Overall Study|Lost to Follow-up|20
2360677|NCT01941719|4121442|FG001|Overall Study|Lost to Follow-up|19
2360678|NCT01828099|4121451|FG000|Overall Study|Adverse Event|15
2360679|NCT01828099|4121452|FG001|Overall Study|Adverse Event|18
2360680|NCT01828099|4121451|FG000|Overall Study|Death|9
2360681|NCT01828099|4121452|FG001|Overall Study|Death|11
2360682|NCT01828099|4121451|FG000|Overall Study|Lost to Follow-up|2
2360683|NCT01828099|4121452|FG001|Overall Study|Lost to Follow-up|0
2360684|NCT01828099|4121451|FG000|Overall Study|Non-compliance with study treatment|2
2360685|NCT01828099|4121452|FG001|Overall Study|Non-compliance with study treatment|0
2360686|NCT01828099|4121451|FG000|Overall Study|Physician Decision|7
2360687|NCT01828099|4121452|FG001|Overall Study|Physician Decision|11
2360688|NCT01828099|4121451|FG000|Overall Study|Progressive disease|51
2360689|NCT01828099|4121452|FG001|Overall Study|Progressive disease|94
2360690|NCT01828099|4121451|FG000|Overall Study|Protocol Violation|1
2360691|NCT01828099|4121452|FG001|Overall Study|Protocol Violation|0
2360692|NCT01828099|4121451|FG000|Overall Study|Subject/guardian decision|7
2360693|NCT01828099|4121452|FG001|Overall Study|Subject/guardian decision|23
2360694|NCT01593254|4121460|FG000|Treatment Period|Treatment Failure|1
2360695|NCT01593254|4121461|FG001|Treatment Period|Treatment Failure|2
2360696|NCT01593254|4121460|FG000|Treatment Period|Pregnancy|0
2360697|NCT01593254|4121461|FG001|Treatment Period|Pregnancy|1
2360698|NCT01593254|4121460|FG000|Treatment Period|Poor/Non-Compliance|2
2360699|NCT01593254|4121461|FG001|Treatment Period|Poor/Non-Compliance|1
2360700|NCT01593254|4121460|FG000|Treatment Period|Maximum clinical benefit|1
2360701|NCT01593254|4121461|FG001|Treatment Period|Maximum clinical benefit|0
2360702|NCT01593254|4121460|FG000|Treatment Period|Subject withdrew consent|0
2360703|NCT01593254|4121461|FG001|Treatment Period|Subject withdrew consent|5
2360704|NCT01593254|4121460|FG000|Treatment Period|Subject Request to Discontinue|1
2360705|NCT01593254|4121461|FG001|Treatment Period|Subject Request to Discontinue|1
2360706|NCT01593254|4121460|FG000|Treatment Period|AE unrelated to Study Drug|0
2360707|NCT01593254|4121461|FG001|Treatment Period|AE unrelated to Study Drug|1
2360708|NCT01593254|4121460|FG000|Treatment Period|Death|2
2360709|NCT01593254|4121461|FG001|Treatment Period|Death|1
2360710|NCT01593254|4121460|FG000|Treatment Period|Study Drug Toxicity|3
2360711|NCT01593254|4121461|FG001|Treatment Period|Study Drug Toxicity|9
2360712|NCT01593254|4121460|FG000|Treatment Period|Disease Progression|1
2360713|NCT01593254|4121461|FG001|Treatment Period|Disease Progression|6
2360714|NCT01593254|4121460|FG000|Treatment Period|Did Not Achieve RCC|0
2360715|NCT01593254|4121461|FG001|Treatment Period|Did Not Achieve RCC|1
2360716|NCT01593254|4121460|FG000|Treatment Period|Patient Refused to Return|0
2360717|NCT01593254|4121461|FG001|Treatment Period|Patient Refused to Return|1
2360718|NCT01593254|4121460|FG000|Treatment Period|No Response|1
2360719|NCT01593254|4121461|FG001|Treatment Period|No Response|0
2360720|NCT01593254|4121460|FG000|Treatment Period|T315I MUTATION|0
2360721|NCT01593254|4121461|FG001|Treatment Period|T315I MUTATION|1
2360722|NCT01593254|4121460|FG000|Treatment Period|Investigator Decision|2
2360723|NCT01593254|4121461|FG001|Treatment Period|Investigator Decision|1
2360724|NCT01593254|4121460|FG000|Follow-Up Period|Withdrawal by Subject|0
2360725|NCT01593254|4121461|FG001|Follow-Up Period|Withdrawal by Subject|2
2360726|NCT01593254|4121460|FG000|Follow-Up Period|Non-Compliance|1
2360727|NCT01593254|4121461|FG001|Follow-Up Period|Non-Compliance|0
2360728|NCT01593254|4121460|FG000|Follow-Up Period|Death|2
2360729|NCT01593254|4121461|FG001|Follow-Up Period|Death|2
2360730|NCT01593254|4121460|FG000|Follow-Up Period|Subject request to Discontinue|0
2360731|NCT01593254|4121461|FG001|Follow-Up Period|Subject request to Discontinue|1
2360732|NCT01593254|4121460|FG000|Follow-Up Period|Pregnancy|0
2360733|NCT01593254|4121461|FG001|Follow-Up Period|Pregnancy|1
2360734|NCT01593254|4121460|FG000|Follow-Up Period|Study Drug Toxicity|0
2360735|NCT01593254|4121461|FG001|Follow-Up Period|Study Drug Toxicity|1
2360736|NCT01593254|4121460|FG000|Follow-Up Period|Patient refused to return|0
2360737|NCT01593254|4121461|FG001|Follow-Up Period|Patient refused to return|1
2360738|NCT01593254|4121460|FG000|Follow-Up Period|Fundus Hemorrhage|0
2360739|NCT01593254|4121461|FG001|Follow-Up Period|Fundus Hemorrhage|1
2360740|NCT01593254|4121460|FG000|Follow-Up Period|Disease Progression|0
2360741|NCT01593254|4121461|FG001|Follow-Up Period|Disease Progression|1
2360742|NCT01593254|4121460|FG000|Follow-Up Period|Study Drug Side Effects|0
2360743|NCT01593254|4121461|FG001|Follow-Up Period|Study Drug Side Effects|1
2360744|NCT00943618|4121487|FG000|Overall Study|Lost to Follow-up|38
2360745|NCT00943618|4121488|FG001|Overall Study|Lost to Follow-up|48
2360746|NCT00943618|4121489|FG002|Overall Study|Lost to Follow-up|20
2360747|NCT00943618|4121487|FG000|Overall Study|Discontinued Medication|17
2360748|NCT00943618|4121488|FG001|Overall Study|Discontinued Medication|29
2360749|NCT00943618|4121489|FG002|Overall Study|Discontinued Medication|11
2360750|NCT00529763|4121500|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1
2360751|NCT00529763|4121501|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
2360752|NCT00529763|4121502|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1
2360753|NCT00529763|4121500|FG000|Overall Study|Death|0
2360754|NCT00529763|4121501|FG001|Overall Study|Death|1
2360755|NCT00529763|4121502|FG002|Overall Study|Death|1
2360756|NCT00529763|4121500|FG000|Overall Study|Disease Progression|6
2360757|NCT00529763|4121501|FG001|Overall Study|Disease Progression|16
2360758|NCT00529763|4121502|FG002|Overall Study|Disease Progression|1
2360759|NCT00529763|4121500|FG000|Overall Study|Lost to Follow-up|0
2360760|NCT00529763|4121501|FG001|Overall Study|Lost to Follow-up|1
2360761|NCT00529763|4121502|FG002|Overall Study|Lost to Follow-up|1
2360762|NCT00529763|4121500|FG000|Overall Study|Stem Cell Transplant|0
2360763|NCT00529763|4121501|FG001|Overall Study|Stem Cell Transplant|3
2360764|NCT00529763|4121502|FG002|Overall Study|Stem Cell Transplant|0
2360765|NCT00529763|4121500|FG000|Overall Study|Study Drug Toxicity|1
2360766|NCT00529763|4121501|FG001|Overall Study|Study Drug Toxicity|6
2360767|NCT00529763|4121502|FG002|Overall Study|Study Drug Toxicity|1
2360768|NCT00529763|4121500|FG000|Overall Study|Patient Withdrew Consent|2
2360769|NCT00529763|4121501|FG001|Overall Study|Patient Withdrew Consent|3
2360770|NCT00529763|4121502|FG002|Overall Study|Patient Withdrew Consent|2
2360771|NCT03938272|4121519|FG000|Overall Study|Withdrawal by Subject|1
2360772|NCT03938272|4121520|FG001|Overall Study|Withdrawal by Subject|0
2360773|NCT03938272|4121519|FG000|Overall Study|Physician Decision|0
2360774|NCT03938272|4121520|FG001|Overall Study|Physician Decision|2
2360775|NCT03938272|4121519|FG000|Overall Study|Study termination by sponsor|10
2360776|NCT03938272|4121520|FG001|Overall Study|Study termination by sponsor|8
2360777|NCT03641339|4121532|FG000|Overall Study|Physician Decision|1
2360778|NCT03641339|4121533|FG001|Overall Study|Physician Decision|0
2360779|NCT03641339|4121534|FG002|Overall Study|Physician Decision|0
2360780|NCT03641339|4121535|FG003|Overall Study|Physician Decision|0
2360781|NCT03641339|4121536|FG004|Overall Study|Physician Decision|0
2360782|NCT03641339|4121537|FG005|Overall Study|Physician Decision|0
2360783|NCT03641339|4121532|FG000|Overall Study|Withdrawal by Subject|0
2360784|NCT03641339|4121533|FG001|Overall Study|Withdrawal by Subject|2
2360785|NCT03641339|4121534|FG002|Overall Study|Withdrawal by Subject|0
2360786|NCT03641339|4121535|FG003|Overall Study|Withdrawal by Subject|2
2360787|NCT03641339|4121536|FG004|Overall Study|Withdrawal by Subject|0
2360788|NCT03641339|4121537|FG005|Overall Study|Withdrawal by Subject|1
2360789|NCT03625466|4121553|FG000|Overall Study|Adverse Event|0
2360790|NCT03625466|4121554|FG001|Overall Study|Adverse Event|1
2360791|NCT03625466|4121553|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
2360792|NCT03625466|4121554|FG001|Overall Study|Withdrawal of Consent (not due to AE)|1
2360793|NCT03476239|4121560|FG000|Overall Study|Continuing study|43
2360794|NCT03476239|4121560|FG000|Overall Study|Withdrawal by Subject|6
2360795|NCT03476239|4121560|FG000|Overall Study|Death|39
2360796|NCT03476239|4121560|FG000|Overall Study|Lost to Follow-up|2
2360797|NCT03476239|4121560|FG000|Overall Study|Data Not Available|15
2360798|NCT03476239|4121560|FG000|Overall Study|Did not receive study drug|1
2360799|NCT03427411|4121566|FG000|Overall Study|Screen failure - platelets too low|0
2360800|NCT03427411|4121567|FG001|Overall Study|Screen failure - platelets too low|1
2360801|NCT03317795|4121575|FG000|Overall Study|IUD Expulsion|1
2360802|NCT03317795|4121576|FG001|Overall Study|IUD Expulsion|0
2360803|NCT03317795|4121575|FG000|Overall Study|Lost to Follow-up|1
2360804|NCT03317795|4121576|FG001|Overall Study|Lost to Follow-up|3
2360805|NCT03317795|4121575|FG000|Overall Study|Treatment change|0
2360806|NCT03317795|4121576|FG001|Overall Study|Treatment change|3
2360807|NCT03317795|4121575|FG000|Overall Study|Intolerance of medication|0
2360808|NCT03317795|4121576|FG001|Overall Study|Intolerance of medication|1
2360809|NCT03287245|4121586|FG000|Overall Study|Study terminated by sponsor|3
2360810|NCT03287245|4121587|FG001|Overall Study|Study terminated by sponsor|0
2360811|NCT03287245|4121588|FG002|Overall Study|Study terminated by sponsor|3
2360812|NCT03287245|4121589|FG003|Overall Study|Study terminated by sponsor|1
2360813|NCT03287245|4121586|FG000|Overall Study|Adverse Event|1
2360814|NCT03287245|4121587|FG001|Overall Study|Adverse Event|0
2360815|NCT03287245|4121588|FG002|Overall Study|Adverse Event|0
2360816|NCT03287245|4121589|FG003|Overall Study|Adverse Event|0
2360817|NCT03287245|4121586|FG000|Overall Study|Withdrawal by Subject|8
2360818|NCT03287245|4121587|FG001|Overall Study|Withdrawal by Subject|3
2360819|NCT03287245|4121588|FG002|Overall Study|Withdrawal by Subject|3
2360820|NCT03287245|4121589|FG003|Overall Study|Withdrawal by Subject|0
2104615|NCT00853047|3696981|FG003|Core Phase|Participant Request|1
2104616|NCT00853047|3696982|FG004|Core Phase|Participant Request|0
2104617|NCT00853047|3696983|FG005|Core Phase|Participant Request|0
2104618|NCT00853047|3696978|FG000|Open-Label Extension Phase|Participant Request|0
2104619|NCT00853047|3696979|FG001|Open-Label Extension Phase|Participant Request|0
2104620|NCT00853047|3696980|FG002|Open-Label Extension Phase|Participant Request|0
2104621|NCT00853047|3696981|FG003|Open-Label Extension Phase|Participant Request|0
2360821|NCT03287245|4121586|FG000|Overall Study|Physician Decision|3
2360822|NCT03287245|4121587|FG001|Overall Study|Physician Decision|2
2360823|NCT03287245|4121588|FG002|Overall Study|Physician Decision|0
2360824|NCT03287245|4121589|FG003|Overall Study|Physician Decision|0
2360825|NCT03092219|4121630|FG000|Overall Study|Protocol Violation|7
2360826|NCT03092219|4121631|FG001|Overall Study|Protocol Violation|4
2360827|NCT03033069|4121644|FG000|Overall Study|Adverse Event|6
2360828|NCT03033069|4121645|FG001|Overall Study|Adverse Event|7
2360829|NCT03033069|4121646|FG002|Overall Study|Adverse Event|4
2360830|NCT03033069|4121647|FG003|Overall Study|Adverse Event|6
2360831|NCT03033069|4121644|FG000|Overall Study|Lack of Efficacy|0
2360832|NCT03033069|4121645|FG001|Overall Study|Lack of Efficacy|0
2360833|NCT03033069|4121646|FG002|Overall Study|Lack of Efficacy|1
2360834|NCT03033069|4121647|FG003|Overall Study|Lack of Efficacy|0
2360835|NCT03033069|4121644|FG000|Overall Study|Lost to Follow-up|6
2360836|NCT03033069|4121645|FG001|Overall Study|Lost to Follow-up|5
2360837|NCT03033069|4121646|FG002|Overall Study|Lost to Follow-up|5
2360838|NCT03033069|4121647|FG003|Overall Study|Lost to Follow-up|6
2360839|NCT03033069|4121644|FG000|Overall Study|Non-Compliance With Study Drug|1
2360840|NCT03033069|4121645|FG001|Overall Study|Non-Compliance With Study Drug|1
2360841|NCT03033069|4121646|FG002|Overall Study|Non-Compliance With Study Drug|1
2360842|NCT03033069|4121647|FG003|Overall Study|Non-Compliance With Study Drug|0
2360843|NCT03033069|4121644|FG000|Overall Study|Protocol Deviation|0
2360844|NCT03033069|4121645|FG001|Overall Study|Protocol Deviation|1
2360845|NCT03033069|4121646|FG002|Overall Study|Protocol Deviation|0
2360846|NCT03033069|4121647|FG003|Overall Study|Protocol Deviation|0
2360847|NCT03033069|4121644|FG000|Overall Study|Withdrawal by Subject|10
2360848|NCT03033069|4121645|FG001|Overall Study|Withdrawal by Subject|10
2360849|NCT03033069|4121646|FG002|Overall Study|Withdrawal by Subject|11
2360850|NCT03033069|4121647|FG003|Overall Study|Withdrawal by Subject|6
2360851|NCT03033069|4121644|FG000|Overall Study|Withdrawal By Caregiver|1
2360852|NCT03033069|4121645|FG001|Overall Study|Withdrawal By Caregiver|0
2360853|NCT03033069|4121646|FG002|Overall Study|Withdrawal By Caregiver|0
2360854|NCT03033069|4121647|FG003|Overall Study|Withdrawal By Caregiver|0
2360855|NCT03033069|4121644|FG000|Overall Study|Reason not Specified|0
2360856|NCT03033069|4121645|FG001|Overall Study|Reason not Specified|1
2360857|NCT03033069|4121646|FG002|Overall Study|Reason not Specified|0
2360858|NCT03033069|4121647|FG003|Overall Study|Reason not Specified|1
2360859|NCT02663622|4121676|FG000|Overall Study|Ongoing in study|0
2360860|NCT02663622|4121677|FG001|Overall Study|Ongoing in study|0
2360861|NCT02663622|4121678|FG002|Overall Study|Ongoing in study|0
2360862|NCT02663622|4121679|FG003|Overall Study|Ongoing in study|6
2360863|NCT02663622|4121676|FG000|Overall Study|Death|3
2360864|NCT02663622|4121677|FG001|Overall Study|Death|1
2360865|NCT02663622|4121678|FG002|Overall Study|Death|1
2360866|NCT02663622|4121679|FG003|Overall Study|Death|8
2360867|NCT02663622|4121676|FG000|Overall Study|Protocol Violation|0
2360868|NCT02663622|4121677|FG001|Overall Study|Protocol Violation|0
2360869|NCT02663622|4121678|FG002|Overall Study|Protocol Violation|0
2360870|NCT02663622|4121679|FG003|Overall Study|Protocol Violation|1
2360871|NCT02609503|4121690|FG000|Overall Study|Adverse Event|1
2360872|NCT02609503|4121690|FG000|Overall Study|Death|1
2360873|NCT02609503|4121690|FG000|Overall Study|Withdrawal by Subject|1
2360874|NCT02609503|4121690|FG000|Overall Study|Disease progression|1
2360875|NCT02587598|4121708|FG000|Overall Study|Death|4
2360876|NCT02587598|4121709|FG001|Overall Study|Death|8
2360877|NCT02587598|4121710|FG002|Overall Study|Death|4
2360878|NCT02587598|4121711|FG003|Overall Study|Death|16
2360879|NCT02587598|4121712|FG004|Overall Study|Death|9
2360880|NCT02587598|4121713|FG005|Overall Study|Death|4
2360881|NCT02587598|4121714|FG006|Overall Study|Death|6
2360882|NCT02587598|4121715|FG007|Overall Study|Death|7
2360883|NCT02587598|4121716|FG008|Overall Study|Death|9
2360884|NCT02587598|4121717|FG009|Overall Study|Death|1
2360885|NCT02587598|4121718|FG010|Overall Study|Death|3
2360886|NCT02587598|4121708|FG000|Overall Study|Study Terminated by the Sponsor|0
2360887|NCT02587598|4121709|FG001|Overall Study|Study Terminated by the Sponsor|1
2360888|NCT02587598|4121710|FG002|Overall Study|Study Terminated by the Sponsor|0
2360889|NCT02587598|4121711|FG003|Overall Study|Study Terminated by the Sponsor|3
2360890|NCT02587598|4121712|FG004|Overall Study|Study Terminated by the Sponsor|0
2360891|NCT02587598|4121713|FG005|Overall Study|Study Terminated by the Sponsor|1
2360892|NCT02587598|4121714|FG006|Overall Study|Study Terminated by the Sponsor|0
2360893|NCT02587598|4121715|FG007|Overall Study|Study Terminated by the Sponsor|0
2360894|NCT02587598|4121716|FG008|Overall Study|Study Terminated by the Sponsor|0
2360895|NCT02587598|4121717|FG009|Overall Study|Study Terminated by the Sponsor|1
2360896|NCT02587598|4121718|FG010|Overall Study|Study Terminated by the Sponsor|6
2360897|NCT02587598|4121708|FG000|Overall Study|Reason for study withdrawal not specified|0
2360898|NCT02587598|4121709|FG001|Overall Study|Reason for study withdrawal not specified|1
2360899|NCT02587598|4121710|FG002|Overall Study|Reason for study withdrawal not specified|0
2360900|NCT02587598|4121711|FG003|Overall Study|Reason for study withdrawal not specified|0
2360901|NCT02587598|4121712|FG004|Overall Study|Reason for study withdrawal not specified|0
2360902|NCT02587598|4121713|FG005|Overall Study|Reason for study withdrawal not specified|0
2360903|NCT02587598|4121714|FG006|Overall Study|Reason for study withdrawal not specified|0
2360904|NCT02587598|4121715|FG007|Overall Study|Reason for study withdrawal not specified|0
2360905|NCT02587598|4121716|FG008|Overall Study|Reason for study withdrawal not specified|0
2360906|NCT02587598|4121717|FG009|Overall Study|Reason for study withdrawal not specified|0
2360907|NCT02587598|4121718|FG010|Overall Study|Reason for study withdrawal not specified|0
2360908|NCT02587598|4121708|FG000|Overall Study|Withdrawal by Subject|0
2360909|NCT02587598|4121709|FG001|Overall Study|Withdrawal by Subject|1
2360910|NCT02587598|4121710|FG002|Overall Study|Withdrawal by Subject|0
2360911|NCT02587598|4121711|FG003|Overall Study|Withdrawal by Subject|2
2360912|NCT02587598|4121712|FG004|Overall Study|Withdrawal by Subject|3
2360913|NCT02587598|4121713|FG005|Overall Study|Withdrawal by Subject|1
2360914|NCT02587598|4121714|FG006|Overall Study|Withdrawal by Subject|0
2360915|NCT02587598|4121715|FG007|Overall Study|Withdrawal by Subject|0
2360916|NCT02587598|4121716|FG008|Overall Study|Withdrawal by Subject|0
2360917|NCT02587598|4121717|FG009|Overall Study|Withdrawal by Subject|1
2360918|NCT02587598|4121718|FG010|Overall Study|Withdrawal by Subject|2
2360919|NCT02587598|4121708|FG000|Overall Study|Physician Decision|0
2360920|NCT02587598|4121709|FG001|Overall Study|Physician Decision|0
2360921|NCT02587598|4121710|FG002|Overall Study|Physician Decision|0
2360922|NCT02587598|4121711|FG003|Overall Study|Physician Decision|0
2360923|NCT02587598|4121712|FG004|Overall Study|Physician Decision|0
2360924|NCT02587598|4121713|FG005|Overall Study|Physician Decision|0
2360925|NCT02587598|4121714|FG006|Overall Study|Physician Decision|0
2360926|NCT02587598|4121715|FG007|Overall Study|Physician Decision|0
2360927|NCT02587598|4121716|FG008|Overall Study|Physician Decision|0
2360928|NCT02587598|4121717|FG009|Overall Study|Physician Decision|0
2360929|NCT02587598|4121718|FG010|Overall Study|Physician Decision|3
2360930|NCT02485574|4121754|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4
2360931|NCT02214160|4121766|FG000|Overall Study|Withdrawal by Subject|1
2360932|NCT02214160|4121767|FG001|Overall Study|Withdrawal by Subject|0
2360933|NCT02214160|4121768|FG002|Overall Study|Withdrawal by Subject|6
2360934|NCT02214160|4121766|FG000|Overall Study|Death|2
2360935|NCT02214160|4121767|FG001|Overall Study|Death|2
2360936|NCT02214160|4121768|FG002|Overall Study|Death|1
2360937|NCT02214160|4121766|FG000|Overall Study|Subject Non-Compliance|0
2360938|NCT02214160|4121767|FG001|Overall Study|Subject Non-Compliance|3
2360939|NCT02214160|4121768|FG002|Overall Study|Subject Non-Compliance|1
2360940|NCT02214160|4121766|FG000|Overall Study|Adverse Event|0
2360941|NCT02214160|4121767|FG001|Overall Study|Adverse Event|1
2360942|NCT02214160|4121768|FG002|Overall Study|Adverse Event|1
2360943|NCT02214160|4121766|FG000|Overall Study|Sponsor Decision|0
2360944|NCT02214160|4121767|FG001|Overall Study|Sponsor Decision|2
2360945|NCT02214160|4121768|FG002|Overall Study|Sponsor Decision|0
2360946|NCT02214160|4121766|FG000|Overall Study|Protocol Violation|1
2360947|NCT02214160|4121767|FG001|Overall Study|Protocol Violation|0
2360948|NCT02214160|4121768|FG002|Overall Study|Protocol Violation|0
2360949|NCT02214160|4121766|FG000|Overall Study|Physician Decision|0
2360950|NCT02214160|4121767|FG001|Overall Study|Physician Decision|0
2360951|NCT02214160|4121768|FG002|Overall Study|Physician Decision|1
2360952|NCT02032823|4121782|FG000|Overall Study|Death|59
2360953|NCT02032823|4121783|FG001|Overall Study|Death|86
2360954|NCT02032823|4121782|FG000|Overall Study|Lost to Follow-up|12
2360955|NCT02032823|4121783|FG001|Overall Study|Lost to Follow-up|15
2360956|NCT02032823|4121782|FG000|Overall Study|Withdrawal by Subject|65
2360957|NCT02032823|4121783|FG001|Overall Study|Withdrawal by Subject|49
2360958|NCT02032823|4121782|FG000|Overall Study|Ongoing study at data cut-off|782
2360959|NCT02032823|4121783|FG001|Overall Study|Ongoing study at data cut-off|760
2360960|NCT02032823|4121782|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3
2360961|NCT02032823|4121783|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5
2360962|NCT01460160|4121804|FG000|Treatment Phase|Lack of Efficacy|3
2360963|NCT01460160|4121804|FG000|Treatment Phase|Study Drug Toxicity|2
2360964|NCT01460160|4121804|FG000|Treatment Phase|Adverse Event|8
2360965|NCT01460160|4121804|FG000|Treatment Phase|Withdrawal by Subject|4
2360966|NCT01460160|4121804|FG000|Treatment Phase|Death|2
2360967|NCT01460160|4121804|FG000|Treatment Phase|Other reasons|9
2360968|NCT01460160|4121804|FG000|Follow-up Phase|Withdrawal by Subject|4
2360969|NCT01460160|4121804|FG000|Follow-up Phase|Death|14
2360970|NCT01460160|4121804|FG000|Follow-up Phase|Lost to Follow-up|7
2360971|NCT01460160|4121804|FG000|Follow-up Phase|Follow-up no longer required per protocol|70
2360972|NCT01460160|4121804|FG000|Follow-up Phase|Other and not reported reasons|5
2360973|NCT01170702|4121821|FG000|Overall Study|Exclusion criteria met after consent|1
2360974|NCT01170702|4121822|FG001|Overall Study|Exclusion criteria met after consent|2
2360975|NCT01170702|4121823|FG002|Overall Study|Exclusion criteria met after consent|0
2360976|NCT01170702|4121824|FG003|Overall Study|Exclusion criteria met after consent|2
2360977|NCT01018563|4121834|FG000|Overall Study|Termination of the study by Sponsor|2
2360978|NCT01018563|4121835|FG001|Overall Study|Termination of the study by Sponsor|1
2360979|NCT00805961|4121845|FG000|Modality Therapy|Withdrawal by Subject|1
2360980|NCT00805961|4121845|FG000|Modality Therapy|Adverse Event|1
2360981|NCT00805961|4121845|FG000|Modality Therapy|Disease Progression|2
2360982|NCT00805961|4121845|FG000|Treatment-Free Interval|Adverse Event|3
2360983|NCT00805961|4121845|FG000|Treatment-Free Interval|Intercurrent Illness|2
2360984|NCT00805961|4121845|FG000|Treatment-Free Interval|Physician Decision|1
2360985|NCT00805961|4121845|FG000|Treatment-Free Interval|Lack of Efficacy|1
2360986|NCT00805961|4121845|FG000|Maintenance Treatment|Lack of Efficacy|13
2360987|NCT00805961|4121845|FG000|Maintenance Treatment|Intercurrent Illness|7
2360988|NCT00805961|4121845|FG000|Maintenance Treatment|Adverse Event|6
2360989|NCT00805961|4121845|FG000|Maintenance Treatment|Withdrawal by Subject|5
2360990|NCT00805961|4121845|FG000|Maintenance Treatment|Symptomatic Deterioration|2
2360991|NCT00805961|4121845|FG000|Maintenance Treatment|Withdrawn Consent|1
2360992|NCT03921424|4121866|FG000|Overall Study|Lost to Follow-up|0
2360993|NCT03921424|4121867|FG001|Overall Study|Lost to Follow-up|1
2360994|NCT03921424|4121866|FG000|Overall Study|Withdrawal By Parent/Guardian|0
2360995|NCT03921424|4121867|FG001|Overall Study|Withdrawal By Parent/Guardian|2
2317350|NCT02896569|4029449|FG000|Overall Study|Withdrawal by Subject|1
2317351|NCT02896569|4029450|FG001|Overall Study|Withdrawal by Subject|0
2317352|NCT02897115|4029471|FG000|Overall Study|Early termination of study by sponsor|11
2317353|NCT02897115|4029472|FG001|Overall Study|Early termination of study by sponsor|8
2317354|NCT02897349|4029500|FG000|Overall Study|Lost to Follow-up|2
2317355|NCT02897349|4029501|FG001|Overall Study|Lost to Follow-up|2
2317356|NCT02897349|4029500|FG000|Overall Study|Adverse Event|3
2317357|NCT02897349|4029501|FG001|Overall Study|Adverse Event|3
2317358|NCT02897349|4029500|FG000|Overall Study|Other than listed above|0
2317359|NCT02897349|4029501|FG001|Overall Study|Other than listed above|1
2317360|NCT02898077|4029509|FG000|Overall Study|Adverse Event|21
2317361|NCT02898077|4029510|FG001|Overall Study|Adverse Event|7
2317362|NCT02898077|4029509|FG000|Overall Study|Withdrawal by Subject|51
2317363|NCT02898077|4029510|FG001|Overall Study|Withdrawal by Subject|14
2317364|NCT02898077|4029509|FG000|Overall Study|Physician Decision|12
2317365|NCT02898077|4029510|FG001|Overall Study|Physician Decision|4
2317366|NCT02898077|4029509|FG000|Overall Study|Non-compliance With Study Drug|3
2317367|NCT02898077|4029510|FG001|Overall Study|Non-compliance With Study Drug|2
2317368|NCT02898077|4029509|FG000|Overall Study|Protocol Deviation|3
2317369|NCT02898077|4029510|FG001|Overall Study|Protocol Deviation|0
2317370|NCT02898077|4029509|FG000|Overall Study|On Study Treatment|5
2317371|NCT02898077|4029510|FG001|Overall Study|On Study Treatment|3
2317372|NCT02898116|4029529|FG000|Overall Study|Adverse Event|1
2317373|NCT02898116|4029529|FG000|Overall Study|Progressive disease|1
2317374|NCT02898259|4029538|FG000|Overall Study|Adverse Event|0
2317375|NCT02898259|4029539|FG001|Overall Study|Adverse Event|0
2317376|NCT02898259|4029540|FG002|Overall Study|Adverse Event|1
2317377|NCT02898259|4029541|FG003|Overall Study|Adverse Event|0
2317378|NCT02898259|4029542|FG004|Overall Study|Adverse Event|0
2317379|NCT02898259|4029538|FG000|Overall Study|Lack of Efficacy|1
2317380|NCT02898259|4029539|FG001|Overall Study|Lack of Efficacy|1
2317381|NCT02898259|4029540|FG002|Overall Study|Lack of Efficacy|3
2317382|NCT02898259|4029541|FG003|Overall Study|Lack of Efficacy|0
2317383|NCT02898259|4029542|FG004|Overall Study|Lack of Efficacy|0
2317384|NCT02898259|4029538|FG000|Overall Study|Lost to Follow-up|0
2317385|NCT02898259|4029539|FG001|Overall Study|Lost to Follow-up|0
2317386|NCT02898259|4029540|FG002|Overall Study|Lost to Follow-up|1
2317387|NCT02898259|4029541|FG003|Overall Study|Lost to Follow-up|0
2317388|NCT02898259|4029542|FG004|Overall Study|Lost to Follow-up|0
2317389|NCT02898259|4029538|FG000|Overall Study|Transformation before study began|0
2317390|NCT02898259|4029539|FG001|Overall Study|Transformation before study began|0
2317391|NCT02898259|4029540|FG002|Overall Study|Transformation before study began|0
2317392|NCT02898259|4029541|FG003|Overall Study|Transformation before study began|1
2317393|NCT02898259|4029542|FG004|Overall Study|Transformation before study began|0
2317394|NCT02898454|4029553|FG000|Overall Study|Adverse Event|4
2317395|NCT02898454|4029554|FG001|Overall Study|Adverse Event|1
2317396|NCT02898454|4029555|FG002|Overall Study|Adverse Event|2
2317397|NCT02898454|4029553|FG000|Overall Study|Protocol Violation|1
2317398|NCT02898454|4029554|FG001|Overall Study|Protocol Violation|0
2317399|NCT02898454|4029555|FG002|Overall Study|Protocol Violation|1
2317400|NCT02898454|4029553|FG000|Overall Study|Lack of Efficacy|4
2317401|NCT02898454|4029554|FG001|Overall Study|Lack of Efficacy|1
2317402|NCT02898454|4029555|FG002|Overall Study|Lack of Efficacy|0
2317403|NCT02898454|4029553|FG000|Overall Study|Withdrawal by Subject|6
2360996|NCT03598777|4121880|FG000|Overall Study|Study Terminated by Sponsor|3
2360997|NCT03598777|4121881|FG001|Overall Study|Study Terminated by Sponsor|0
2360998|NCT03598777|4121882|FG002|Overall Study|Study Terminated by Sponsor|0
2360999|NCT03598777|4121883|FG003|Overall Study|Study Terminated by Sponsor|0
2361000|NCT03598777|4121884|FG004|Overall Study|Study Terminated by Sponsor|15
2361001|NCT03598777|4121880|FG000|Overall Study|Withdrawal by Subject|1
2361002|NCT03598777|4121881|FG001|Overall Study|Withdrawal by Subject|1
2361003|NCT03598777|4121882|FG002|Overall Study|Withdrawal by Subject|0
2361004|NCT03598777|4121883|FG003|Overall Study|Withdrawal by Subject|0
2361005|NCT03598777|4121884|FG004|Overall Study|Withdrawal by Subject|0
2361006|NCT03598777|4121880|FG000|Overall Study|Adverse Event|1
2361007|NCT03598777|4121881|FG001|Overall Study|Adverse Event|0
2361008|NCT03598777|4121882|FG002|Overall Study|Adverse Event|0
2361009|NCT03598777|4121883|FG003|Overall Study|Adverse Event|0
2361010|NCT03598777|4121884|FG004|Overall Study|Adverse Event|0
2361011|NCT03598777|4121880|FG000|Overall Study|Lost to Follow-up|1
2361012|NCT03598777|4121881|FG001|Overall Study|Lost to Follow-up|0
2361013|NCT03598777|4121882|FG002|Overall Study|Lost to Follow-up|0
2361014|NCT03598777|4121883|FG003|Overall Study|Lost to Follow-up|0
2361015|NCT03598777|4121884|FG004|Overall Study|Lost to Follow-up|0
2361016|NCT03406078|4121901|FG000|Overall Study|Death|1
2361017|NCT03406078|4121902|FG001|Overall Study|Death|0
2361018|NCT03406078|4121901|FG000|Overall Study|Lost to Follow-up|0
2361019|NCT03406078|4121902|FG001|Overall Study|Lost to Follow-up|1
2361020|NCT03406078|4121901|FG000|Overall Study|Withdrawal by Subject|5
2361021|NCT03406078|4121902|FG001|Overall Study|Withdrawal by Subject|2
2361022|NCT03345342|4121924|FG000|Open-Label Phase|Adverse Event|30
2361023|NCT03345342|4121925|FG001|Open-Label Phase|Adverse Event|0
2361024|NCT03345342|4121926|FG002|Open-Label Phase|Adverse Event|0
2361025|NCT03345342|4121927|FG003|Open-Label Phase|Adverse Event|0
2361026|NCT03345342|4121928|FG004|Open-Label Phase|Adverse Event|0
2361027|NCT03345342|4121924|FG000|Open-Label Phase|Death|1
2361028|NCT03345342|4121925|FG001|Open-Label Phase|Death|0
2361029|NCT03345342|4121926|FG002|Open-Label Phase|Death|0
2361030|NCT03345342|4121927|FG003|Open-Label Phase|Death|0
2361031|NCT03345342|4121928|FG004|Open-Label Phase|Death|0
2361032|NCT03345342|4121924|FG000|Open-Label Phase|Initiated Prohibited Medication|2
2361033|NCT03345342|4121925|FG001|Open-Label Phase|Initiated Prohibited Medication|0
2361034|NCT03345342|4121926|FG002|Open-Label Phase|Initiated Prohibited Medication|0
2361035|NCT03345342|4121927|FG003|Open-Label Phase|Initiated Prohibited Medication|0
2361036|NCT03345342|4121928|FG004|Open-Label Phase|Initiated Prohibited Medication|0
2361037|NCT03345342|4121924|FG000|Open-Label Phase|Lack of Efficacy|6
2361038|NCT03345342|4121925|FG001|Open-Label Phase|Lack of Efficacy|0
2361039|NCT03345342|4121926|FG002|Open-Label Phase|Lack of Efficacy|0
2361040|NCT03345342|4121927|FG003|Open-Label Phase|Lack of Efficacy|0
2361041|NCT03345342|4121928|FG004|Open-Label Phase|Lack of Efficacy|0
2361042|NCT03345342|4121924|FG000|Open-Label Phase|Lost to Follow-up|9
2361043|NCT03345342|4121925|FG001|Open-Label Phase|Lost to Follow-up|0
2361044|NCT03345342|4121926|FG002|Open-Label Phase|Lost to Follow-up|0
2361045|NCT03345342|4121927|FG003|Open-Label Phase|Lost to Follow-up|0
2361046|NCT03345342|4121928|FG004|Open-Label Phase|Lost to Follow-up|0
2361047|NCT03345342|4121924|FG000|Open-Label Phase|Non-Compliance with Study Drug|4
2361048|NCT03345342|4121925|FG001|Open-Label Phase|Non-Compliance with Study Drug|0
2361049|NCT03345342|4121926|FG002|Open-Label Phase|Non-Compliance with Study Drug|0
2361050|NCT03345342|4121927|FG003|Open-Label Phase|Non-Compliance with Study Drug|0
2361051|NCT03345342|4121928|FG004|Open-Label Phase|Non-Compliance with Study Drug|0
2361052|NCT03345342|4121924|FG000|Open-Label Phase|Physician Decision|4
2361053|NCT03345342|4121925|FG001|Open-Label Phase|Physician Decision|0
2361054|NCT03345342|4121926|FG002|Open-Label Phase|Physician Decision|0
2361055|NCT03345342|4121927|FG003|Open-Label Phase|Physician Decision|0
2361056|NCT03345342|4121928|FG004|Open-Label Phase|Physician Decision|0
2361057|NCT03345342|4121924|FG000|Open-Label Phase|Protocol Violation|8
2361058|NCT03345342|4121925|FG001|Open-Label Phase|Protocol Violation|0
2361059|NCT03345342|4121926|FG002|Open-Label Phase|Protocol Violation|0
2361060|NCT03345342|4121927|FG003|Open-Label Phase|Protocol Violation|0
2361061|NCT03345342|4121928|FG004|Open-Label Phase|Protocol Violation|0
2361062|NCT03345342|4121924|FG000|Open-Label Phase|Withdrawal by Subject|57
2361063|NCT03345342|4121925|FG001|Open-Label Phase|Withdrawal by Subject|0
2361064|NCT03345342|4121926|FG002|Open-Label Phase|Withdrawal by Subject|0
2361065|NCT03345342|4121927|FG003|Open-Label Phase|Withdrawal by Subject|0
2361066|NCT03345342|4121928|FG004|Open-Label Phase|Withdrawal by Subject|0
2361067|NCT03345342|4121924|FG000|Open-Label Phase|Other|15
2361068|NCT03345342|4121925|FG001|Open-Label Phase|Other|0
2361069|NCT03345342|4121926|FG002|Open-Label Phase|Other|0
2361070|NCT03345342|4121927|FG003|Open-Label Phase|Other|0
2361071|NCT03345342|4121928|FG004|Open-Label Phase|Other|0
2361072|NCT03345342|4121924|FG000|Double-Blind Phase|Adverse Event|0
2361073|NCT03345342|4121925|FG001|Double-Blind Phase|Adverse Event|1
2104622|NCT00853047|3696982|FG004|Open-Label Extension Phase|Participant Request|0
2108133|NCT00878501|3701989|FG002|Overall Study|Withdrawal by Subject|2
2361074|NCT03345342|4121926|FG002|Double-Blind Phase|Adverse Event|6
2361075|NCT03345342|4121927|FG003|Double-Blind Phase|Adverse Event|0
2361076|NCT03345342|4121928|FG004|Double-Blind Phase|Adverse Event|0
2361077|NCT03345342|4121924|FG000|Double-Blind Phase|Death|0
2361078|NCT03345342|4121925|FG001|Double-Blind Phase|Death|2
2361079|NCT03345342|4121926|FG002|Double-Blind Phase|Death|1
2361080|NCT03345342|4121927|FG003|Double-Blind Phase|Death|0
2361081|NCT03345342|4121928|FG004|Double-Blind Phase|Death|0
2361082|NCT03345342|4121924|FG000|Double-Blind Phase|Initiated Prohibited Medication|0
2361083|NCT03345342|4121925|FG001|Double-Blind Phase|Initiated Prohibited Medication|0
2361084|NCT03345342|4121926|FG002|Double-Blind Phase|Initiated Prohibited Medication|2
2361085|NCT03345342|4121927|FG003|Double-Blind Phase|Initiated Prohibited Medication|0
2361086|NCT03345342|4121928|FG004|Double-Blind Phase|Initiated Prohibited Medication|0
2361087|NCT03345342|4121924|FG000|Double-Blind Phase|Lost to Follow-up|0
2361088|NCT03345342|4121925|FG001|Double-Blind Phase|Lost to Follow-up|1
2361089|NCT03345342|4121926|FG002|Double-Blind Phase|Lost to Follow-up|7
2361090|NCT03345342|4121927|FG003|Double-Blind Phase|Lost to Follow-up|0
2361091|NCT03345342|4121928|FG004|Double-Blind Phase|Lost to Follow-up|0
2361092|NCT03345342|4121924|FG000|Double-Blind Phase|Physician Decision|0
2361093|NCT03345342|4121925|FG001|Double-Blind Phase|Physician Decision|1
2361094|NCT03345342|4121926|FG002|Double-Blind Phase|Physician Decision|4
2361095|NCT03345342|4121927|FG003|Double-Blind Phase|Physician Decision|0
2361096|NCT03345342|4121928|FG004|Double-Blind Phase|Physician Decision|0
2361097|NCT03345342|4121924|FG000|Double-Blind Phase|Protocol Violation|0
2361098|NCT03345342|4121925|FG001|Double-Blind Phase|Protocol Violation|0
2361099|NCT03345342|4121926|FG002|Double-Blind Phase|Protocol Violation|1
2361100|NCT03345342|4121927|FG003|Double-Blind Phase|Protocol Violation|0
2361101|NCT03345342|4121928|FG004|Double-Blind Phase|Protocol Violation|0
2361102|NCT03345342|4121924|FG000|Double-Blind Phase|Withdrawal by Subject|0
2361103|NCT03345342|4121925|FG001|Double-Blind Phase|Withdrawal by Subject|16
2361104|NCT03345342|4121926|FG002|Double-Blind Phase|Withdrawal by Subject|38
2361105|NCT03345342|4121927|FG003|Double-Blind Phase|Withdrawal by Subject|0
2361106|NCT03345342|4121928|FG004|Double-Blind Phase|Withdrawal by Subject|0
2361107|NCT03345342|4121924|FG000|Double-Blind Phase|Other|0
2214963|NCT01691898|3857729|FG001|Overall Study|Lost to Follow-up|1
2214964|NCT01691898|3857730|FG002|Overall Study|Lost to Follow-up|0
2361108|NCT03345342|4121925|FG001|Double-Blind Phase|Other|1
2361109|NCT03345342|4121926|FG002|Double-Blind Phase|Other|3
2361110|NCT03345342|4121927|FG003|Double-Blind Phase|Other|0
2361111|NCT03345342|4121928|FG004|Double-Blind Phase|Other|0
2361112|NCT03345342|4121924|FG000|Follow-Up Phase|Adverse Event|0
2361113|NCT03345342|4121925|FG001|Follow-Up Phase|Adverse Event|0
2361114|NCT03345342|4121926|FG002|Follow-Up Phase|Adverse Event|0
2361115|NCT03345342|4121927|FG003|Follow-Up Phase|Adverse Event|0
2361116|NCT03345342|4121928|FG004|Follow-Up Phase|Adverse Event|4
2361117|NCT03345342|4121924|FG000|Follow-Up Phase|Lost to Follow-up|0
2361118|NCT03345342|4121925|FG001|Follow-Up Phase|Lost to Follow-up|0
2361119|NCT03345342|4121926|FG002|Follow-Up Phase|Lost to Follow-up|0
2361120|NCT03345342|4121927|FG003|Follow-Up Phase|Lost to Follow-up|0
2361121|NCT03345342|4121928|FG004|Follow-Up Phase|Lost to Follow-up|6
2361122|NCT03345342|4121924|FG000|Follow-Up Phase|Physician Decision|0
2361123|NCT03345342|4121925|FG001|Follow-Up Phase|Physician Decision|0
2361124|NCT03345342|4121926|FG002|Follow-Up Phase|Physician Decision|0
2361125|NCT03345342|4121927|FG003|Follow-Up Phase|Physician Decision|0
2361126|NCT03345342|4121928|FG004|Follow-Up Phase|Physician Decision|5
2361127|NCT03345342|4121924|FG000|Follow-Up Phase|Withdrawal by Subject|0
2361128|NCT03345342|4121925|FG001|Follow-Up Phase|Withdrawal by Subject|0
2361129|NCT03345342|4121926|FG002|Follow-Up Phase|Withdrawal by Subject|0
2361130|NCT03345342|4121927|FG003|Follow-Up Phase|Withdrawal by Subject|5
2361131|NCT03345342|4121928|FG004|Follow-Up Phase|Withdrawal by Subject|15
2361132|NCT03345342|4121924|FG000|Follow-Up Phase|Other|0
2361133|NCT03345342|4121925|FG001|Follow-Up Phase|Other|0
2361134|NCT03345342|4121926|FG002|Follow-Up Phase|Other|0
2361135|NCT03345342|4121927|FG003|Follow-Up Phase|Other|3
2361136|NCT03345342|4121928|FG004|Follow-Up Phase|Other|1
2361137|NCT03265145|4121942|FG000|Overall Study|Protocol Violation|2
2361138|NCT03265145|4121943|FG001|Overall Study|Protocol Violation|0
2361139|NCT03265145|4121942|FG000|Overall Study|Adverse Event|1
2361140|NCT03265145|4121943|FG001|Overall Study|Adverse Event|0
2361141|NCT03265145|4121942|FG000|Overall Study|Withdrawal by Subject|23
2361142|NCT03265145|4121943|FG001|Overall Study|Withdrawal by Subject|19
2361143|NCT03265145|4121942|FG000|Overall Study|Death|12
2361144|NCT03265145|4121943|FG001|Overall Study|Death|12
2361145|NCT03265145|4121942|FG000|Overall Study|Lost to Follow-up|13
2361146|NCT03265145|4121943|FG001|Overall Study|Lost to Follow-up|9
2361147|NCT03265145|4121942|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0
2361148|NCT03265145|4121943|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1
2361149|NCT03265145|4121942|FG000|Overall Study|Switched back to previous medication|1
2361150|NCT03265145|4121943|FG001|Overall Study|Switched back to previous medication|0
2361151|NCT03265145|4121942|FG000|Overall Study|Did not want to take medication|1
2361152|NCT03265145|4121943|FG001|Overall Study|Did not want to take medication|0
2361153|NCT03265145|4121942|FG000|Overall Study|Subject could not afford medication|0
2361154|NCT03265145|4121943|FG001|Overall Study|Subject could not afford medication|1
2361155|NCT03265145|4121942|FG000|Overall Study|Site closed|2
2361156|NCT03265145|4121943|FG001|Overall Study|Site closed|3
2361157|NCT03265145|4121942|FG000|Overall Study|Incorrectly randomized|16
2361158|NCT03265145|4121943|FG001|Overall Study|Incorrectly randomized|6
2361159|NCT03265145|4121942|FG000|Overall Study|Entered into Electronic Data Capture in error|0
2361160|NCT03265145|4121943|FG001|Overall Study|Entered into Electronic Data Capture in error|1
2361161|NCT03265145|4121942|FG000|Overall Study|Physician Decision|0
2361162|NCT03265145|4121943|FG001|Overall Study|Physician Decision|3
2361163|NCT03265145|4121942|FG000|Overall Study|Subject transferred to another facility|0
2361164|NCT03265145|4121943|FG001|Overall Study|Subject transferred to another facility|1
2361165|NCT03197935|4121958|FG000|Overall Study|Death due to any cause|9
2361166|NCT03197935|4121959|FG001|Overall Study|Death due to any cause|7
2361167|NCT03197935|4121958|FG000|Overall Study|Lost to Follow-up|0
2361168|NCT03197935|4121959|FG001|Overall Study|Lost to Follow-up|3
2361169|NCT03197935|4121958|FG000|Overall Study|Physician Decision|0
2361170|NCT03197935|4121959|FG001|Overall Study|Physician Decision|1
2361171|NCT03197935|4121958|FG000|Overall Study|Withdrawal by Subject|11
2361172|NCT03197935|4121959|FG001|Overall Study|Withdrawal by Subject|7
2361173|NCT03197935|4121958|FG000|Overall Study|On-Going in Study|147
2361174|NCT03197935|4121959|FG001|Overall Study|On-Going in Study|146
2361175|NCT03197935|4121958|FG000|Overall Study|Did not receive any study treatment|1
2361176|NCT03197935|4121959|FG001|Overall Study|Did not receive any study treatment|1
2361177|NCT02880241|4121981|FG000|Overall Study|Lack of Efficacy|1
2361178|NCT02880241|4121982|FG001|Overall Study|Lack of Efficacy|0
2361179|NCT02880241|4121983|FG002|Overall Study|Lack of Efficacy|0
2361180|NCT02880241|4121984|FG003|Overall Study|Lack of Efficacy|0
2361181|NCT02880241|4121985|FG004|Overall Study|Lack of Efficacy|0
2361182|NCT02880241|4121986|FG005|Overall Study|Lack of Efficacy|0
2361183|NCT02832687|4122004|FG000|Overall Study|Adverse Event|0
2361184|NCT02832687|4122005|FG001|Overall Study|Adverse Event|2
2361185|NCT02499900|4122017|FG000|Core Study Period|Other|1
2361186|NCT02499900|4122018|FG001|Core Study Period|Other|4
2361187|NCT02499900|4122017|FG000|Core Study Period|Lost to Follow-up|1
2361188|NCT02499900|4122018|FG001|Core Study Period|Lost to Follow-up|2
2361189|NCT02499900|4122017|FG000|Core Study Period|Per sponsor request|0
2361190|NCT02499900|4122018|FG001|Core Study Period|Per sponsor request|1
2361191|NCT02499900|4122017|FG000|Core Study Period|Pregnancy|1
2361192|NCT02499900|4122018|FG001|Core Study Period|Pregnancy|0
2361193|NCT02499900|4122017|FG000|Core Study Period|Protocol Violation|3
2361194|NCT02499900|4122018|FG001|Core Study Period|Protocol Violation|0
2361195|NCT02499900|4122017|FG000|Core Study Period|Withdrawal by Subject|11
2361196|NCT02499900|4122018|FG001|Core Study Period|Withdrawal by Subject|10
2361197|NCT02499900|4122017|FG000|Core Study Period|Adverse Event|18
2361198|NCT02499900|4122018|FG001|Core Study Period|Adverse Event|14
2361199|NCT02499900|4122017|FG000|Core Study Period|Death|0
2361200|NCT02499900|4122018|FG001|Core Study Period|Death|1
2361201|NCT02499900|4122017|FG000|Completed Core, Continued Into Extension|Physician Decision|1
2361202|NCT02499900|4122018|FG001|Completed Core, Continued Into Extension|Physician Decision|0
2361203|NCT02499900|4122017|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0
2361204|NCT02499900|4122018|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2
2361205|NCT02499900|4122017|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
2361206|NCT02499900|4122018|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
2361207|NCT02499900|4122017|FG000|Completed Core, Continued Into Extension|Personal motivation|1
2361208|NCT02499900|4122018|FG001|Completed Core, Continued Into Extension|Personal motivation|0
2361209|NCT02499900|4122017|FG000|Extension Study Period|Adverse Event|2
2361210|NCT02499900|4122018|FG001|Extension Study Period|Adverse Event|4
2361211|NCT02499900|4122017|FG000|Extension Study Period|Withdrawal by Subject|5
2361212|NCT02499900|4122018|FG001|Extension Study Period|Withdrawal by Subject|2
2361213|NCT02499900|4122017|FG000|Extension Study Period|Physician Decision|2
2361214|NCT02499900|4122018|FG001|Extension Study Period|Physician Decision|5
2361215|NCT02499900|4122017|FG000|Extension Study Period|Pregnancy|1
2361216|NCT02499900|4122018|FG001|Extension Study Period|Pregnancy|2
2361217|NCT02499900|4122017|FG000|Extension Study Period|Lost to Follow-up|2
2361218|NCT02499900|4122018|FG001|Extension Study Period|Lost to Follow-up|5
2361219|NCT02499900|4122017|FG000|Extension Study Period|Other|0
2361220|NCT02499900|4122018|FG001|Extension Study Period|Other|2
2361221|NCT02269917|4122045|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25
2361222|NCT02269917|4122046|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7
2361223|NCT02269917|4122047|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0
2361224|NCT02269917|4122045|FG000|BL to EOE-Test and BL to Switch-Control|Other|19
2361225|NCT02269917|4122046|FG001|BL to EOE-Test and BL to Switch-Control|Other|4
2361226|NCT02269917|4122047|FG002|BL to EOE-Test and BL to Switch-Control|Other|0
2361227|NCT02269917|4122045|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32
2361228|NCT02269917|4122046|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10
2361229|NCT02269917|4122047|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0
2361230|NCT02269917|4122045|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24
2361231|NCT02269917|4122046|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4
2361232|NCT02269917|4122047|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0
2361233|NCT02269917|4122045|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4
2361234|NCT02269917|4122046|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
2361235|NCT02269917|4122047|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
2361236|NCT02269917|4122045|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4
2361237|NCT02269917|4122046|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
2361238|NCT02269917|4122047|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
2361239|NCT02269917|4122045|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2
2361240|NCT02269917|4122046|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1
2361241|NCT02269917|4122047|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0
2361242|NCT02269917|4122045|FG000|BL to EOE-Test and BL to Switch-Control|Death|4
2361243|NCT02269917|4122046|FG001|BL to EOE-Test and BL to Switch-Control|Death|0
2361244|NCT02269917|4122047|FG002|BL to EOE-Test and BL to Switch-Control|Death|0
2361245|NCT02269917|4122045|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3
2361246|NCT02269917|4122046|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5
2361247|NCT02269917|4122047|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0
2361248|NCT02269917|4122045|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
2361249|NCT02269917|4122046|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
2361250|NCT02269917|4122047|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
2361251|NCT02269917|4122045|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
2361252|NCT02269917|4122046|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
2361253|NCT02269917|4122047|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10
2361254|NCT02269917|4122045|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
2361255|NCT02269917|4122046|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
2361256|NCT02269917|4122047|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11
2361257|NCT02269917|4122045|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
2361258|NCT02269917|4122046|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
2361259|NCT02269917|4122047|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
2361260|NCT02269917|4122045|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
2361261|NCT02269917|4122046|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
2361262|NCT02269917|4122047|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2
2361263|NCT02269917|4122045|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
2361264|NCT02269917|4122046|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
2361265|NCT02269917|4122047|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5
2361266|NCT02269917|4122045|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
2361267|NCT02269917|4122046|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
2361268|NCT02269917|4122047|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8
2361269|NCT02225366|4122058|FG000|Overall Study|Lack of Efficacy|1
2361270|NCT02225366|4122059|FG001|Overall Study|Lack of Efficacy|0
2361271|NCT02021773|4122068|FG000|Overall Study|Adverse Event|1
2361272|NCT02021773|4122069|FG001|Overall Study|Adverse Event|4
2361273|NCT02021773|4122070|FG002|Overall Study|Adverse Event|3
2361274|NCT02021773|4122068|FG000|Overall Study|Lack of Efficacy|2
2361275|NCT02021773|4122069|FG001|Overall Study|Lack of Efficacy|2
2361276|NCT02021773|4122070|FG002|Overall Study|Lack of Efficacy|2
2361277|NCT02021773|4122068|FG000|Overall Study|Protocol Violation|2
2361278|NCT02021773|4122069|FG001|Overall Study|Protocol Violation|3
2361279|NCT02021773|4122070|FG002|Overall Study|Protocol Violation|1
2361280|NCT02021773|4122068|FG000|Overall Study|Withdrawal by Subject|3
2361281|NCT02021773|4122069|FG001|Overall Study|Withdrawal by Subject|4
2361282|NCT02021773|4122070|FG002|Overall Study|Withdrawal by Subject|5
2361283|NCT02021773|4122068|FG000|Overall Study|Lost to Follow-up|1
2361284|NCT02021773|4122069|FG001|Overall Study|Lost to Follow-up|3
2361285|NCT02021773|4122070|FG002|Overall Study|Lost to Follow-up|0
2361286|NCT02021773|4122068|FG000|Overall Study|Reason not specified|3
2361287|NCT02021773|4122069|FG001|Overall Study|Reason not specified|0
2361288|NCT02021773|4122070|FG002|Overall Study|Reason not specified|0
2361289|NCT01530997|4122078|FG000|Overall Study|Physician Decision|1
2361290|NCT01530997|4122078|FG000|Overall Study|Withdrawal by Subject|1
2361291|NCT01067521|4122104|FG000|Double-Blind Placebo-Controlled Period|Death|0
2361292|NCT01067521|4122105|FG001|Double-Blind Placebo-Controlled Period|Death|1
2361293|NCT01067521|4122104|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29
2361294|NCT01067521|4122105|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6
2361295|NCT01067521|4122104|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
2361296|NCT01067521|4122105|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
2361297|NCT01067521|4122104|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1
2361298|NCT01067521|4122105|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1
2361299|NCT01067521|4122104|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
2361300|NCT01067521|4122105|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
2361301|NCT01067521|4122104|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
2361302|NCT01067521|4122105|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
2361303|NCT01067521|4122104|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2
2361304|NCT01067521|4122105|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
2361305|NCT01067521|4122104|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7
2361306|NCT01067521|4122105|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4
2361307|NCT01067521|4122104|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
2361308|NCT01067521|4122105|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
2361309|NCT01067521|4122104|FG000|Open-Label Period|Death|3
2361310|NCT01067521|4122105|FG001|Open-Label Period|Death|1
2361311|NCT01067521|4122104|FG000|Open-Label Period|Adverse Event|30
2361312|NCT01067521|4122105|FG001|Open-Label Period|Adverse Event|28
2361313|NCT01067521|4122104|FG000|Open-Label Period|Withdrawal by Subject|160
2361314|NCT01067521|4122105|FG001|Open-Label Period|Withdrawal by Subject|88
2361315|NCT01067521|4122104|FG000|Open-Label Period|Physician Decision|13
2361316|NCT01067521|4122105|FG001|Open-Label Period|Physician Decision|11
2361317|NCT01067521|4122104|FG000|Open-Label Period|Non-compliance with study drug|5
2361318|NCT01067521|4122105|FG001|Open-Label Period|Non-compliance with study drug|0
2361319|NCT01067521|4122104|FG000|Open-Label Period|Protocol Violation|3
2361320|NCT01067521|4122105|FG001|Open-Label Period|Protocol Violation|0
2361321|NCT01067521|4122104|FG000|Open-Label Period|Pregnancy|14
2361322|NCT01067521|4122105|FG001|Open-Label Period|Pregnancy|8
2361323|NCT01067521|4122104|FG000|Open-Label Period|Teva requested subject to be withdrawn|5
2361324|NCT01067521|4122105|FG001|Open-Label Period|Teva requested subject to be withdrawn|2
2361325|NCT01067521|4122104|FG000|Open-Label Period|Lost to Follow-up|21
2361326|NCT01067521|4122105|FG001|Open-Label Period|Lost to Follow-up|20
2214965|NCT01691898|3857731|FG003|Overall Study|Lost to Follow-up|0
2214966|NCT01691898|3857732|FG004|Overall Study|Lost to Follow-up|1
2214967|NCT01691898|3857733|FG005|Overall Study|Lost to Follow-up|0
2214968|NCT01691898|3857728|FG000|Overall Study|Withdrawal by Subject|9
2214969|NCT01691898|3857729|FG001|Overall Study|Withdrawal by Subject|8
2214970|NCT01691898|3857730|FG002|Overall Study|Withdrawal by Subject|2
2317404|NCT02898454|4029554|FG001|Overall Study|Withdrawal by Subject|3
2214971|NCT01691898|3857731|FG003|Overall Study|Withdrawal by Subject|1
2317405|NCT02898454|4029555|FG002|Overall Study|Withdrawal by Subject|3
2317406|NCT02898454|4029553|FG000|Overall Study|Lost to Follow-up|1
2317407|NCT02898454|4029554|FG001|Overall Study|Lost to Follow-up|0
2317408|NCT02898454|4029555|FG002|Overall Study|Lost to Follow-up|0
2317409|NCT02898454|4029553|FG000|Overall Study|Did Not Met Eligibility Criteria|1
2317410|NCT02898454|4029554|FG001|Overall Study|Did Not Met Eligibility Criteria|0
2317411|NCT02898454|4029555|FG002|Overall Study|Did Not Met Eligibility Criteria|0
2317412|NCT02898597|4029570|FG000|Overall Study|Protocol Violation|4
2317413|NCT02898597|4029571|FG001|Overall Study|Protocol Violation|2
2317414|NCT02898597|4029570|FG000|Overall Study|Lost to Follow-up|0
2317415|NCT02898597|4029571|FG001|Overall Study|Lost to Follow-up|9
2317416|NCT02898597|4029570|FG000|Overall Study|Death|0
2317417|NCT02898597|4029571|FG001|Overall Study|Death|1
2317418|NCT02898662|4029579|FG000|Overall Study|Adverse Event|1
2317419|NCT02898662|4029580|FG001|Overall Study|Adverse Event|0
2317420|NCT02898662|4029579|FG000|Overall Study|Loss of asthma control|23
2361327|NCT01047319|4122119|FG000|Overall Study|Teva requested participant withdrawal|3
2361328|NCT01047319|4122120|FG001|Overall Study|Teva requested participant withdrawal|0
2361329|NCT01047319|4122121|FG002|Overall Study|Teva requested participant withdrawal|1
2361330|NCT01047319|4122119|FG000|Overall Study|Protocol Violation|3
2361331|NCT01047319|4122120|FG001|Overall Study|Protocol Violation|2
2361332|NCT01047319|4122121|FG002|Overall Study|Protocol Violation|4
2361333|NCT01047319|4122119|FG000|Overall Study|Lack of Efficacy|4
2361334|NCT01047319|4122120|FG001|Overall Study|Lack of Efficacy|3
2361335|NCT01047319|4122121|FG002|Overall Study|Lack of Efficacy|3
2361336|NCT01047319|4122119|FG000|Overall Study|Death|5
2361337|NCT01047319|4122120|FG001|Overall Study|Death|1
2361338|NCT01047319|4122121|FG002|Overall Study|Death|5
2361339|NCT01047319|4122119|FG000|Overall Study|Pregnancy|13
2361340|NCT01047319|4122120|FG001|Overall Study|Pregnancy|8
2361341|NCT01047319|4122121|FG002|Overall Study|Pregnancy|8
2361342|NCT01047319|4122119|FG000|Overall Study|Physician Decision|12
2361343|NCT01047319|4122120|FG001|Overall Study|Physician Decision|9
2361344|NCT01047319|4122121|FG002|Overall Study|Physician Decision|10
2361345|NCT01047319|4122119|FG000|Overall Study|Lost to Follow-up|14
2361346|NCT01047319|4122120|FG001|Overall Study|Lost to Follow-up|10
2361347|NCT01047319|4122121|FG002|Overall Study|Lost to Follow-up|10
2361348|NCT01047319|4122119|FG000|Overall Study|Adverse Event|16
2361349|NCT01047319|4122120|FG001|Overall Study|Adverse Event|27
2361350|NCT01047319|4122121|FG002|Overall Study|Adverse Event|21
2361351|NCT01047319|4122119|FG000|Overall Study|Withdrawal by Subject|77
2361352|NCT01047319|4122120|FG001|Overall Study|Withdrawal by Subject|75
2361353|NCT01047319|4122121|FG002|Overall Study|Withdrawal by Subject|87
2361354|NCT01047319|4122119|FG000|Overall Study|Study terminated by Sponsor|198
2361355|NCT01047319|4122120|FG001|Overall Study|Study terminated by Sponsor|215
2361356|NCT01047319|4122121|FG002|Overall Study|Study terminated by Sponsor|203
2361357|NCT00988052|4122131|FG000|Overall Study|Missing|1
2361358|NCT00988052|4122132|FG001|Overall Study|Missing|0
2361359|NCT00988052|4122131|FG000|Overall Study|Teva requested subject withdrawal|3
2361360|NCT00988052|4122132|FG001|Overall Study|Teva requested subject withdrawal|1
2361361|NCT00988052|4122131|FG000|Overall Study|Death|1
2361362|NCT00988052|4122132|FG001|Overall Study|Death|3
2361363|NCT00988052|4122131|FG000|Overall Study|Protocol Violation|6
2361364|NCT00988052|4122132|FG001|Overall Study|Protocol Violation|5
2361365|NCT00988052|4122131|FG000|Overall Study|Pregnancy|6
2361366|NCT00988052|4122132|FG001|Overall Study|Pregnancy|6
2361367|NCT00988052|4122131|FG000|Overall Study|Lack of Efficacy|8
2361368|NCT00988052|4122132|FG001|Overall Study|Lack of Efficacy|7
2361369|NCT00988052|4122131|FG000|Overall Study|Lost to Follow-up|6
2361370|NCT00988052|4122132|FG001|Overall Study|Lost to Follow-up|11
2361371|NCT00988052|4122131|FG000|Overall Study|Physician Decision|27
2361372|NCT00988052|4122132|FG001|Overall Study|Physician Decision|28
2361373|NCT00988052|4122131|FG000|Overall Study|Adverse Event|35
2361374|NCT00988052|4122132|FG001|Overall Study|Adverse Event|28
2361375|NCT00988052|4122131|FG000|Overall Study|Withdrawal by Subject|90
2361376|NCT00988052|4122132|FG001|Overall Study|Withdrawal by Subject|91
2361377|NCT00988052|4122131|FG000|Overall Study|Study terminated by sponsor|240
2361378|NCT00988052|4122132|FG001|Overall Study|Study terminated by sponsor|236
2361379|NCT00861705|4122142|FG000|Overall Study|Never Began Treatment|7
2361380|NCT00861705|4122143|FG001|Overall Study|Never Began Treatment|3
2361381|NCT00861705|4122144|FG002|Overall Study|Never Began Treatment|0
2361382|NCT00861705|4122145|FG003|Overall Study|Never Began Treatment|1
2317421|NCT02898662|4029580|FG001|Overall Study|Loss of asthma control|24
2317422|NCT02898662|4029579|FG000|Overall Study|Withdrawal by Subject|4
2317423|NCT02898662|4029580|FG001|Overall Study|Withdrawal by Subject|1
2317424|NCT02898662|4029579|FG000|Overall Study|Technical issue|0
2317425|NCT02898662|4029580|FG001|Overall Study|Technical issue|1
2317426|NCT02898662|4029579|FG000|Overall Study|Randomized in error|0
2317427|NCT02898662|4029580|FG001|Overall Study|Randomized in error|1
2317428|NCT02898662|4029579|FG000|Overall Study|Subject decision|1
2317429|NCT02898662|4029580|FG001|Overall Study|Subject decision|0
2317430|NCT02898662|4029579|FG000|Overall Study|Other|0
2317431|NCT02898662|4029580|FG001|Overall Study|Other|1
2317432|NCT02899156|4029606|FG000|Overall Study|Death|1
2317433|NCT02899156|4029607|FG001|Overall Study|Death|0
2317434|NCT02899156|4029606|FG000|Overall Study|Physician Decision|0
2317435|NCT02899156|4029607|FG001|Overall Study|Physician Decision|1
2361383|NCT04553406|4122179|FG000|Overall Study|Study Discontinuation|0
2361384|NCT04553406|4122180|FG001|Overall Study|Study Discontinuation|1
2361385|NCT04325906|4122188|FG000|Overall Study|Withdrawal by Subject|2
2361386|NCT04325906|4122189|FG001|Overall Study|Withdrawal by Subject|0
2361387|NCT04056299|4122197|FG000|Overall Study|Sponsor discontinued study|3
2361388|NCT04056299|4122198|FG001|Overall Study|Sponsor discontinued study|3
2361389|NCT04046939|4122208|FG000|Primary Assessment Period|Adverse Event|1
2361390|NCT04046939|4122209|FG001|Primary Assessment Period|Adverse Event|0
2361391|NCT04046939|4122210|FG002|Primary Assessment Period|Adverse Event|0
2361392|NCT04046939|4122211|FG003|Primary Assessment Period|Adverse Event|0
2361393|NCT04046939|4122208|FG000|Primary Assessment Period|Withdrawal by Subject|1
2361394|NCT04046939|4122209|FG001|Primary Assessment Period|Withdrawal by Subject|0
2361395|NCT04046939|4122210|FG002|Primary Assessment Period|Withdrawal by Subject|1
2361396|NCT04046939|4122211|FG003|Primary Assessment Period|Withdrawal by Subject|0
2361397|NCT04046939|4122208|FG000|Primary Assessment Period|Physician Decision|0
2361398|NCT04046939|4122209|FG001|Primary Assessment Period|Physician Decision|0
2361399|NCT04046939|4122210|FG002|Primary Assessment Period|Physician Decision|1
2361400|NCT04046939|4122211|FG003|Primary Assessment Period|Physician Decision|0
2361401|NCT04046939|4122208|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1
2361402|NCT04046939|4122209|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0
2361403|NCT04046939|4122210|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0
2361404|NCT04046939|4122211|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1
2361405|NCT03792750|4122227|FG000|Overall Study|Death|3
2361406|NCT03739138|4122248|FG000|Overall Study|Death|0
2361407|NCT03739138|4122249|FG001|Overall Study|Death|7
2361408|NCT03739138|4122250|FG002|Overall Study|Death|4
2361409|NCT03739138|4122251|FG003|Overall Study|Death|13
2361410|NCT03739138|4122252|FG004|Overall Study|Death|0
2361411|NCT03739138|4122248|FG000|Overall Study|Lost to Follow-up|0
2361412|NCT03739138|4122249|FG001|Overall Study|Lost to Follow-up|0
2361413|NCT03739138|4122250|FG002|Overall Study|Lost to Follow-up|1
2361414|NCT03739138|4122251|FG003|Overall Study|Lost to Follow-up|0
2361415|NCT03739138|4122252|FG004|Overall Study|Lost to Follow-up|0
2361416|NCT03739138|4122248|FG000|Overall Study|Study Terminated By Sponsor|0
2361417|NCT03739138|4122249|FG001|Overall Study|Study Terminated By Sponsor|0
2361418|NCT03739138|4122250|FG002|Overall Study|Study Terminated By Sponsor|0
2361419|NCT03739138|4122251|FG003|Overall Study|Study Terminated By Sponsor|4
2361420|NCT03739138|4122252|FG004|Overall Study|Study Terminated By Sponsor|0
2361421|NCT03739138|4122248|FG000|Overall Study|Withdrawal by Subject|0
2361422|NCT03739138|4122249|FG001|Overall Study|Withdrawal by Subject|0
2361423|NCT03739138|4122250|FG002|Overall Study|Withdrawal by Subject|0
2361424|NCT03739138|4122251|FG003|Overall Study|Withdrawal by Subject|1
2361425|NCT03739138|4122252|FG004|Overall Study|Withdrawal by Subject|0
2361426|NCT03688555|4122262|FG000|Overall Study|Adverse Event|0
2361427|NCT03688555|4122263|FG001|Overall Study|Adverse Event|1
2361428|NCT03518086|4122271|FG000|Overall Study|Adverse Event|23
2361429|NCT03518086|4122272|FG001|Overall Study|Adverse Event|15
2361430|NCT03518086|4122273|FG002|Overall Study|Adverse Event|0
2361431|NCT03518086|4122274|FG003|Overall Study|Adverse Event|0
2361432|NCT03518086|4122271|FG000|Overall Study|Withdrawal by Subject|8
2361433|NCT03518086|4122272|FG001|Overall Study|Withdrawal by Subject|5
2361434|NCT03518086|4122273|FG002|Overall Study|Withdrawal by Subject|0
2361435|NCT03518086|4122274|FG003|Overall Study|Withdrawal by Subject|0
2361436|NCT03518086|4122271|FG000|Overall Study|Lack of Efficacy|5
2361437|NCT03518086|4122272|FG001|Overall Study|Lack of Efficacy|5
2361438|NCT03518086|4122273|FG002|Overall Study|Lack of Efficacy|0
2361439|NCT03518086|4122274|FG003|Overall Study|Lack of Efficacy|0
2361440|NCT03518086|4122271|FG000|Overall Study|Protocol Violation|1
2361441|NCT03518086|4122272|FG001|Overall Study|Protocol Violation|5
2361442|NCT03518086|4122273|FG002|Overall Study|Protocol Violation|0
2361443|NCT03518086|4122274|FG003|Overall Study|Protocol Violation|0
2361444|NCT03518086|4122271|FG000|Overall Study|Lost to Follow-up|0
2361445|NCT03518086|4122272|FG001|Overall Study|Lost to Follow-up|3
2361446|NCT03518086|4122273|FG002|Overall Study|Lost to Follow-up|0
2361447|NCT03518086|4122274|FG003|Overall Study|Lost to Follow-up|0
2361448|NCT03518086|4122271|FG000|Overall Study|Insufficient Diary Data|0
2361449|NCT03518086|4122272|FG001|Overall Study|Insufficient Diary Data|2
2361450|NCT03518086|4122273|FG002|Overall Study|Insufficient Diary Data|0
2361451|NCT03518086|4122274|FG003|Overall Study|Insufficient Diary Data|0
2361452|NCT03518086|4122271|FG000|Overall Study|Non- compliance to Protocol|0
2361453|NCT03518086|4122272|FG001|Overall Study|Non- compliance to Protocol|1
2361454|NCT03518086|4122273|FG002|Overall Study|Non- compliance to Protocol|0
2361455|NCT03518086|4122274|FG003|Overall Study|Non- compliance to Protocol|0
2361456|NCT03518086|4122271|FG000|Overall Study|COVID-19 Related Study Disruption|0
2361457|NCT03518086|4122272|FG001|Overall Study|COVID-19 Related Study Disruption|2
2361458|NCT03518086|4122273|FG002|Overall Study|COVID-19 Related Study Disruption|0
2361459|NCT03518086|4122274|FG003|Overall Study|COVID-19 Related Study Disruption|0
2361460|NCT03518086|4122271|FG000|Overall Study|Site Terminated by Sponsor|0
2361461|NCT03518086|4122272|FG001|Overall Study|Site Terminated by Sponsor|1
2361462|NCT03518086|4122273|FG002|Overall Study|Site Terminated by Sponsor|0
2361463|NCT03518086|4122274|FG003|Overall Study|Site Terminated by Sponsor|0
2361464|NCT03468309|4122281|FG000|Overall Study|Lost to Follow-up|4
2361465|NCT03468309|4122281|FG000|Overall Study|Withdrawal by Subject|2
2361466|NCT03347123|4122291|FG000|Overall Study|Death|1
2361467|NCT03347123|4122292|FG001|Overall Study|Death|2
2361468|NCT03347123|4122293|FG002|Overall Study|Death|0
2361469|NCT03347123|4122294|FG003|Overall Study|Death|0
2361470|NCT03347123|4122295|FG004|Overall Study|Death|0
2361471|NCT03347123|4122296|FG005|Overall Study|Death|0
2361472|NCT03347123|4122297|FG006|Overall Study|Death|0
2361473|NCT03347123|4122291|FG000|Overall Study|Withdrawal by Subject|1
2361474|NCT03347123|4122292|FG001|Overall Study|Withdrawal by Subject|0
2361475|NCT03347123|4122293|FG002|Overall Study|Withdrawal by Subject|0
2361476|NCT03347123|4122294|FG003|Overall Study|Withdrawal by Subject|0
2361477|NCT03347123|4122295|FG004|Overall Study|Withdrawal by Subject|0
2361478|NCT03347123|4122296|FG005|Overall Study|Withdrawal by Subject|0
2361479|NCT03347123|4122297|FG006|Overall Study|Withdrawal by Subject|0
2361480|NCT03347123|4122291|FG000|Overall Study|Reason not Specified|3
2361481|NCT03347123|4122292|FG001|Overall Study|Reason not Specified|4
2361482|NCT03347123|4122293|FG002|Overall Study|Reason not Specified|0
2361483|NCT03347123|4122294|FG003|Overall Study|Reason not Specified|0
2361484|NCT03347123|4122295|FG004|Overall Study|Reason not Specified|0
2361485|NCT03347123|4122296|FG005|Overall Study|Reason not Specified|0
2361486|NCT03347123|4122297|FG006|Overall Study|Reason not Specified|0
2361487|NCT03318523|4122312|FG000|PC Period: Up to Year 1|Adverse Event|1
2361488|NCT03318523|4122313|FG001|PC Period: Up to Year 1|Adverse Event|0
2361489|NCT03318523|4122314|FG002|PC Period: Up to Year 1|Adverse Event|2
2361490|NCT03318523|4122315|FG003|PC Period: Up to Year 1|Adverse Event|0
2361491|NCT03318523|4122316|FG004|PC Period: Up to Year 1|Adverse Event|0
2361492|NCT03318523|4122317|FG005|PC Period: Up to Year 1|Adverse Event|0
2361493|NCT03318523|4122318|FG006|PC Period: Up to Year 1|Adverse Event|0
2361494|NCT03318523|4122319|FG007|PC Period: Up to Year 1|Adverse Event|0
2361495|NCT03318523|4122320|FG008|PC Period: Up to Year 1|Adverse Event|0
2361496|NCT03318523|4122321|FG009|PC Period: Up to Year 1|Adverse Event|0
2361497|NCT03318523|4122312|FG000|PC Period: Up to Year 1|Consent Withdrawn|3
2361498|NCT03318523|4122313|FG001|PC Period: Up to Year 1|Consent Withdrawn|2
2361499|NCT03318523|4122314|FG002|PC Period: Up to Year 1|Consent Withdrawn|0
2361500|NCT03318523|4122315|FG003|PC Period: Up to Year 1|Consent Withdrawn|4
2361501|NCT03318523|4122316|FG004|PC Period: Up to Year 1|Consent Withdrawn|0
2361502|NCT03318523|4122317|FG005|PC Period: Up to Year 1|Consent Withdrawn|0
2361503|NCT03318523|4122318|FG006|PC Period: Up to Year 1|Consent Withdrawn|0
2361504|NCT03318523|4122319|FG007|PC Period: Up to Year 1|Consent Withdrawn|0
2361505|NCT03318523|4122320|FG008|PC Period: Up to Year 1|Consent Withdrawn|0
2361506|NCT03318523|4122321|FG009|PC Period: Up to Year 1|Consent Withdrawn|0
2361507|NCT03318523|4122312|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
2361508|NCT03318523|4122313|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
2361509|NCT03318523|4122314|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
2361510|NCT03318523|4122315|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
2361511|NCT03318523|4122316|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
2361512|NCT03318523|4122317|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
2361513|NCT03318523|4122318|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
2361514|NCT03318523|4122319|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
2361515|NCT03318523|4122320|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
2361516|NCT03318523|4122321|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2
2361517|NCT03318523|4122312|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
2361518|NCT03318523|4122313|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
2361519|NCT03318523|4122314|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
2361520|NCT03318523|4122315|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
2361521|NCT03318523|4122316|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
2361522|NCT03318523|4122317|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
2361523|NCT03318523|4122318|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
2361524|NCT03318523|4122319|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
2361525|NCT03318523|4122320|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3
2361526|NCT03318523|4122321|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2
2361527|NCT03318523|4122312|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
2361528|NCT03318523|4122313|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
2361529|NCT03318523|4122314|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
2361530|NCT03318523|4122315|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
2361531|NCT03318523|4122316|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
2104623|NCT00853047|3696983|FG005|Open-Label Extension Phase|Participant Request|7
2317436|NCT02899195|4029613|FG000|Concurrent Durvalumab|Adverse Event|4
2317437|NCT02899195|4029613|FG000|Concurrent Durvalumab|Physician Decision|1
2317438|NCT02899195|4029613|FG000|Concurrent Durvalumab|Withdrawal by Subject|1
2317439|NCT02899195|4029613|FG000|Concurrent Durvalumab|Progressive Disease|5
2317440|NCT02899195|4029613|FG000|Maintenance Durvalumab|Adverse Event|1
2317441|NCT02899195|4029613|FG000|Maintenance Durvalumab|Physician Decision|1
2317442|NCT02899195|4029613|FG000|Maintenance Durvalumab|Withdrawal by Subject|1
2317443|NCT02899195|4029613|FG000|Maintenance Durvalumab|Progressive Disease|31
2317476|NCT02899338|4029628|FG000|Overall Study|Adverse Event|1
2317477|NCT02899338|4029629|FG001|Overall Study|Adverse Event|2
2317478|NCT02899338|4029628|FG000|Overall Study|Withdrawal by Subject|2
2317479|NCT02899338|4029629|FG001|Overall Study|Withdrawal by Subject|0
2317480|NCT02899377|4029637|FG000|Overall Study|Adverse Event|1
2317481|NCT02899377|4029638|FG001|Overall Study|Adverse Event|0
2317482|NCT02899962|4029674|FG000|Open-label Phase|Adverse Event|2
2317483|NCT02899962|4029675|FG001|Open-label Phase|Adverse Event|0
2317484|NCT02899962|4029676|FG002|Open-label Phase|Adverse Event|0
2317485|NCT02899962|4029674|FG000|Open-label Phase|Lost to Follow-up|9
2317486|NCT02899962|4029675|FG001|Open-label Phase|Lost to Follow-up|0
2317487|NCT02899962|4029676|FG002|Open-label Phase|Lost to Follow-up|0
2317488|NCT02899962|4029674|FG000|Open-label Phase|Other reasons|9
2317489|NCT02899962|4029675|FG001|Open-label Phase|Other reasons|0
2317490|NCT02899962|4029676|FG002|Open-label Phase|Other reasons|0
2317491|NCT02899962|4029674|FG000|Open-label Phase|Withdrawal by Subject|7
2317492|NCT02899962|4029675|FG001|Open-label Phase|Withdrawal by Subject|0
2317493|NCT02899962|4029676|FG002|Open-label Phase|Withdrawal by Subject|0
2317494|NCT02899962|4029674|FG000|Maintenance Phase|Adverse Event|0
2317495|NCT02899962|4029675|FG001|Maintenance Phase|Adverse Event|2
2317496|NCT02899962|4029676|FG002|Maintenance Phase|Adverse Event|1
2317497|NCT02899962|4029674|FG000|Maintenance Phase|Death|0
2317498|NCT02899962|4029675|FG001|Maintenance Phase|Death|0
2317499|NCT02899962|4029676|FG002|Maintenance Phase|Death|1
2317500|NCT02899962|4029674|FG000|Maintenance Phase|Lack of Efficacy|0
2317501|NCT02899962|4029675|FG001|Maintenance Phase|Lack of Efficacy|20
2317502|NCT02899962|4029676|FG002|Maintenance Phase|Lack of Efficacy|16
2317503|NCT02899962|4029674|FG000|Maintenance Phase|Lost to Follow-up|0
2361532|NCT03318523|4122317|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1
2361533|NCT03318523|4122318|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
2361534|NCT03318523|4122319|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
2361535|NCT03318523|4122320|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
2361536|NCT03318523|4122321|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
2361537|NCT03318523|4122312|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
2361538|NCT03318523|4122313|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
2361539|NCT03318523|4122314|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
2361540|NCT03318523|4122315|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
2317504|NCT02899962|4029675|FG001|Maintenance Phase|Lost to Follow-up|12
2317505|NCT02899962|4029676|FG002|Maintenance Phase|Lost to Follow-up|14
2317506|NCT02899962|4029674|FG000|Maintenance Phase|Other reasons|0
2317507|NCT02899962|4029675|FG001|Maintenance Phase|Other reasons|9
2317508|NCT02899962|4029676|FG002|Maintenance Phase|Other reasons|13
2317509|NCT02899962|4029674|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0
2317510|NCT02899962|4029675|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3
2317511|NCT02899962|4029676|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2
2317512|NCT02899962|4029674|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0
2317513|NCT02899962|4029675|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65
2361541|NCT03318523|4122316|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
2361542|NCT03318523|4122317|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
2361543|NCT03318523|4122318|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
2361544|NCT03318523|4122319|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
2361545|NCT03318523|4122320|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
2361546|NCT03318523|4122321|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1
2361547|NCT03318523|4122312|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
2361548|NCT03318523|4122313|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
2361549|NCT03318523|4122314|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
2361550|NCT03318523|4122315|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
2361551|NCT03318523|4122316|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17
2361552|NCT03318523|4122317|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36
2317514|NCT02899962|4029676|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70
2317515|NCT02899962|4029674|FG000|Maintenance Phase|Withdrawal by Subject|0
2317516|NCT02899962|4029675|FG001|Maintenance Phase|Withdrawal by Subject|30
2317517|NCT02899962|4029676|FG002|Maintenance Phase|Withdrawal by Subject|36
2361553|NCT03318523|4122318|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39
2361554|NCT03318523|4122319|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48
2361555|NCT03318523|4122320|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94
2361556|NCT03318523|4122321|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91
2361557|NCT03318523|4122312|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
2361558|NCT03318523|4122313|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
2361559|NCT03318523|4122314|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
2361560|NCT03318523|4122315|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
2361561|NCT03318523|4122316|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1
2361562|NCT03318523|4122317|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
2361563|NCT03318523|4122318|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
2361564|NCT03318523|4122319|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2
2361565|NCT03318523|4122320|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3
2361566|NCT03318523|4122321|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
2361567|NCT03260894|4122347|FG000|Overall Study|Death|6
2361568|NCT03260894|4122348|FG001|Overall Study|Death|8
2361569|NCT03260894|4122347|FG000|Overall Study|Withdrawal by Subject|4
2361570|NCT03260894|4122348|FG001|Overall Study|Withdrawal by Subject|11
2361571|NCT03260894|4122347|FG000|Overall Study|On-going at clinical cut off date|36
2361572|NCT03260894|4122348|FG001|Overall Study|On-going at clinical cut off date|31
2361573|NCT03125902|4122356|FG000|Overall Study|Death|52
2361574|NCT03125902|4122357|FG001|Overall Study|Death|123
2361575|NCT03125902|4122356|FG000|Overall Study|Lost to Follow-up|1
2361576|NCT03125902|4122357|FG001|Overall Study|Lost to Follow-up|0
2361577|NCT03125902|4122356|FG000|Overall Study|Mastectomy|0
2361578|NCT03125902|4122357|FG001|Overall Study|Mastectomy|1
2361579|NCT03125902|4122356|FG000|Overall Study|Physician Decision|1
2361580|NCT03125902|4122357|FG001|Overall Study|Physician Decision|0
2361581|NCT03125902|4122356|FG000|Overall Study|Withdrawal by Subject|13
2361582|NCT03125902|4122357|FG001|Overall Study|Withdrawal by Subject|25
2361583|NCT03125902|4122356|FG000|Overall Study|Study is ongoing|153
2361584|NCT03125902|4122357|FG001|Overall Study|Study is ongoing|282
2361585|NCT02906020|4122374|FG000|Part 1: Dose Escalation Period|Adverse Event|0
2361586|NCT02906020|4122375|FG001|Part 1: Dose Escalation Period|Adverse Event|1
2361587|NCT02906020|4122376|FG002|Part 1: Dose Escalation Period|Adverse Event|0
2361588|NCT02906020|4122377|FG003|Part 1: Dose Escalation Period|Adverse Event|1
2361589|NCT02906020|4122378|FG004|Part 1: Dose Escalation Period|Adverse Event|0
2361590|NCT02906020|4122379|FG005|Part 1: Dose Escalation Period|Adverse Event|0
2361591|NCT02906020|4122380|FG006|Part 1: Dose Escalation Period|Adverse Event|0
2361592|NCT02906020|4122381|FG007|Part 1: Dose Escalation Period|Adverse Event|0
2361593|NCT02906020|4122382|FG008|Part 1: Dose Escalation Period|Adverse Event|0
2361594|NCT02906020|4122383|FG009|Part 1: Dose Escalation Period|Adverse Event|0
2361595|NCT02906020|4122384|FG010|Part 1: Dose Escalation Period|Adverse Event|0
2361596|NCT02906020|4122385|FG011|Part 1: Dose Escalation Period|Adverse Event|0
2361597|NCT02906020|4122386|FG012|Part 1: Dose Escalation Period|Adverse Event|0
2317518|NCT02899988|4029687|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
2317519|NCT02899988|4029688|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1
2317520|NCT02899988|4029689|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
2317521|NCT02899988|4029690|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
2317522|NCT02899988|4029691|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
2317523|NCT02899988|4029692|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
2317524|NCT02899988|4029693|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
2322229|NCT02969525|4037124|FG010|Dose-Blind Period|Adverse Event|1
2361598|NCT02906020|4122387|FG013|Part 1: Dose Escalation Period|Adverse Event|0
2361599|NCT02906020|4122388|FG014|Part 1: Dose Escalation Period|Adverse Event|0
2361600|NCT02906020|4122389|FG015|Part 1: Dose Escalation Period|Adverse Event|0
2361601|NCT02906020|4122374|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0
2361602|NCT02906020|4122375|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0
2361603|NCT02906020|4122376|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0
2361604|NCT02906020|4122377|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0
2361605|NCT02906020|4122378|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0
2361606|NCT02906020|4122379|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0
2361607|NCT02906020|4122380|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0
2361608|NCT02906020|4122381|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0
2361609|NCT02906020|4122382|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6
2361610|NCT02906020|4122383|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15
2361611|NCT02906020|4122384|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0
2361612|NCT02906020|4122385|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0
2361613|NCT02906020|4122386|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0
2361614|NCT02906020|4122387|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0
2361615|NCT02906020|4122388|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0
2361616|NCT02906020|4122389|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0
2361617|NCT02906020|4122374|FG000|Part 2: Double-blind Treatment Period|Other|0
2361618|NCT02906020|4122375|FG001|Part 2: Double-blind Treatment Period|Other|0
2361619|NCT02906020|4122376|FG002|Part 2: Double-blind Treatment Period|Other|0
2361620|NCT02906020|4122377|FG003|Part 2: Double-blind Treatment Period|Other|0
2361621|NCT02906020|4122378|FG004|Part 2: Double-blind Treatment Period|Other|0
2361622|NCT02906020|4122379|FG005|Part 2: Double-blind Treatment Period|Other|0
2361623|NCT02906020|4122380|FG006|Part 2: Double-blind Treatment Period|Other|0
2361624|NCT02906020|4122381|FG007|Part 2: Double-blind Treatment Period|Other|0
2361625|NCT02906020|4122382|FG008|Part 2: Double-blind Treatment Period|Other|6
2361626|NCT02906020|4122383|FG009|Part 2: Double-blind Treatment Period|Other|10
2361627|NCT02906020|4122384|FG010|Part 2: Double-blind Treatment Period|Other|0
2361628|NCT02906020|4122385|FG011|Part 2: Double-blind Treatment Period|Other|0
2361629|NCT02906020|4122386|FG012|Part 2: Double-blind Treatment Period|Other|0
2361630|NCT02906020|4122387|FG013|Part 2: Double-blind Treatment Period|Other|0
2361631|NCT02906020|4122388|FG014|Part 2: Double-blind Treatment Period|Other|0
2361632|NCT02906020|4122389|FG015|Part 2: Double-blind Treatment Period|Other|0
2361633|NCT02906020|4122374|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0
2361634|NCT02906020|4122375|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0
2361635|NCT02906020|4122376|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0
2361636|NCT02906020|4122377|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0
2361637|NCT02906020|4122378|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0
2361638|NCT02906020|4122379|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0
2361639|NCT02906020|4122380|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0
2361640|NCT02906020|4122381|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0
2361641|NCT02906020|4122382|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0
2361642|NCT02906020|4122383|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0
2361643|NCT02906020|4122384|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0
2361644|NCT02906020|4122385|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0
2361645|NCT02906020|4122386|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10
2361646|NCT02906020|4122387|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4
2361647|NCT02906020|4122388|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0
2361648|NCT02906020|4122389|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0
2361649|NCT02906020|4122374|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361650|NCT02906020|4122375|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361651|NCT02906020|4122376|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361652|NCT02906020|4122377|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361653|NCT02906020|4122378|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361654|NCT02906020|4122379|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361655|NCT02906020|4122380|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361656|NCT02906020|4122381|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361657|NCT02906020|4122382|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361658|NCT02906020|4122383|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361659|NCT02906020|4122384|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361660|NCT02906020|4122385|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361661|NCT02906020|4122386|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7
2361662|NCT02906020|4122387|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4
2361663|NCT02906020|4122388|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0
2361664|NCT02906020|4122389|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1
2361665|NCT02906020|4122374|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361666|NCT02906020|4122375|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361667|NCT02906020|4122376|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2214972|NCT01691898|3857732|FG004|Overall Study|Withdrawal by Subject|3
2214973|NCT01691898|3857733|FG005|Overall Study|Withdrawal by Subject|3
2361668|NCT02906020|4122377|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361669|NCT02906020|4122378|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361670|NCT02906020|4122379|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361671|NCT02906020|4122380|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2214974|NCT01691898|3857728|FG000|Overall Study|Non-Compliance|0
2214975|NCT01691898|3857729|FG001|Overall Study|Non-Compliance|0
2361672|NCT02906020|4122381|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361673|NCT02906020|4122382|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361674|NCT02906020|4122383|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361675|NCT02906020|4122384|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361676|NCT02906020|4122385|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361677|NCT02906020|4122386|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1
2361678|NCT02906020|4122387|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1
2361679|NCT02906020|4122388|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361680|NCT02906020|4122389|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
2361681|NCT02906020|4122374|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361682|NCT02906020|4122375|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361683|NCT02906020|4122376|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361684|NCT02906020|4122377|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361685|NCT02906020|4122378|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361686|NCT02906020|4122379|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361687|NCT02906020|4122380|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361688|NCT02906020|4122381|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361689|NCT02906020|4122382|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361690|NCT02906020|4122383|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361691|NCT02906020|4122384|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361692|NCT02906020|4122385|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361693|NCT02906020|4122386|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1
2361694|NCT02906020|4122387|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4
2361695|NCT02906020|4122388|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361696|NCT02906020|4122389|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
2361697|NCT02906020|4122374|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361698|NCT02906020|4122375|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361699|NCT02906020|4122376|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361700|NCT02906020|4122377|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361701|NCT02906020|4122378|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361702|NCT02906020|4122379|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361703|NCT02906020|4122380|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361704|NCT02906020|4122381|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361705|NCT02906020|4122382|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361706|NCT02906020|4122383|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361707|NCT02906020|4122384|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361708|NCT02906020|4122385|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
2361709|NCT02906020|4122386|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67
2361710|NCT02906020|4122387|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64
2361711|NCT02906020|4122388|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7
2361712|NCT02906020|4122389|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8
2361713|NCT02906020|4122374|FG000|Part 2: Long-term Follow-up Period|Other|0
2361714|NCT02906020|4122375|FG001|Part 2: Long-term Follow-up Period|Other|0
2361715|NCT02906020|4122376|FG002|Part 2: Long-term Follow-up Period|Other|0
2361716|NCT02906020|4122377|FG003|Part 2: Long-term Follow-up Period|Other|0
2361717|NCT02906020|4122378|FG004|Part 2: Long-term Follow-up Period|Other|0
2361718|NCT02906020|4122379|FG005|Part 2: Long-term Follow-up Period|Other|0
2361719|NCT02906020|4122380|FG006|Part 2: Long-term Follow-up Period|Other|0
2361720|NCT02906020|4122381|FG007|Part 2: Long-term Follow-up Period|Other|0
2361721|NCT02906020|4122382|FG008|Part 2: Long-term Follow-up Period|Other|0
2361722|NCT02906020|4122383|FG009|Part 2: Long-term Follow-up Period|Other|0
2361723|NCT02906020|4122384|FG010|Part 2: Long-term Follow-up Period|Other|0
2361724|NCT02906020|4122385|FG011|Part 2: Long-term Follow-up Period|Other|0
2361725|NCT02906020|4122386|FG012|Part 2: Long-term Follow-up Period|Other|13
2361726|NCT02906020|4122387|FG013|Part 2: Long-term Follow-up Period|Other|8
2361727|NCT02906020|4122388|FG014|Part 2: Long-term Follow-up Period|Other|3
2361728|NCT02906020|4122389|FG015|Part 2: Long-term Follow-up Period|Other|2
2361729|NCT02899299|4122419|FG000|Pre-treatment|Participant request to discontinue study treatment|0
2361730|NCT02899299|4122420|FG001|Pre-treatment|Participant request to discontinue study treatment|3
2361731|NCT02899299|4122419|FG000|Pre-treatment|Participant withdrew consent|1
2361732|NCT02899299|4122420|FG001|Pre-treatment|Participant withdrew consent|11
2214976|NCT01691898|3857730|FG002|Overall Study|Non-Compliance|0
2214977|NCT01691898|3857731|FG003|Overall Study|Non-Compliance|0
2214978|NCT01691898|3857732|FG004|Overall Study|Non-Compliance|1
2214979|NCT01691898|3857733|FG005|Overall Study|Non-Compliance|0
2214980|NCT01692119|3857776|FG000|Overall Study|Protocol Violation|3
2214981|NCT01692119|3857777|FG001|Overall Study|Protocol Violation|1
2214982|NCT01692119|3857776|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17
2214983|NCT01692119|3857777|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0
2361733|NCT02899299|4122419|FG000|Pre-treatment|Participant no longer meets study criteria|2
2361734|NCT02899299|4122420|FG001|Pre-treatment|Participant no longer meets study criteria|3
2361735|NCT02899299|4122419|FG000|Pre-treatment|Not reported|0
2361736|NCT02899299|4122420|FG001|Pre-treatment|Not reported|1
2361737|NCT02899299|4122419|FG000|Treatment|Disease Progression|182
2361738|NCT02899299|4122420|FG001|Treatment|Disease Progression|44
2361739|NCT02899299|4122419|FG000|Treatment|Study Drug Toxicity|59
2361740|NCT02899299|4122420|FG001|Treatment|Study Drug Toxicity|24
2361741|NCT02899299|4122419|FG000|Treatment|Adverse Event unrelated to Study Drug|12
2361742|NCT02899299|4122420|FG001|Treatment|Adverse Event unrelated to Study Drug|9
2361743|NCT02899299|4122419|FG000|Treatment|Participant request to discontinue Study treatment|4
2361744|NCT02899299|4122420|FG001|Treatment|Participant request to discontinue Study treatment|10
2361745|NCT02899299|4122419|FG000|Treatment|Participant withdrew consent|6
2361746|NCT02899299|4122420|FG001|Treatment|Participant withdrew consent|3
2361747|NCT02899299|4122419|FG000|Treatment|Lost to Follow-up|0
2361748|NCT02899299|4122420|FG001|Treatment|Lost to Follow-up|1
2361749|NCT02899299|4122419|FG000|Treatment|Maximum Clinical Benefit|10
2361750|NCT02899299|4122420|FG001|Treatment|Maximum Clinical Benefit|2
2361751|NCT02899299|4122419|FG000|Treatment|Poor/Non-compliance|1
2361752|NCT02899299|4122420|FG001|Treatment|Poor/Non-compliance|0
2361753|NCT02899299|4122419|FG000|Treatment|Participant no longer meets Study criteria|4
2361754|NCT02899299|4122420|FG001|Treatment|Participant no longer meets Study criteria|0
2361755|NCT02899299|4122419|FG000|Treatment|Administrative reason by Sponsor|2
2361756|NCT02899299|4122420|FG001|Treatment|Administrative reason by Sponsor|0
2361757|NCT02899299|4122419|FG000|Treatment|Other reasons|11
2361758|NCT02899299|4122420|FG001|Treatment|Other reasons|2
2361759|NCT02899299|4122419|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4
2361760|NCT02899299|4122420|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189
2361761|NCT02891226|4122430|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4
2361762|NCT02891226|4122431|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1
2361763|NCT02891226|4122432|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3
2361764|NCT02891226|4122433|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361765|NCT02891226|4122434|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361766|NCT02891226|4122435|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361767|NCT02891226|4122436|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361768|NCT02891226|4122437|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361769|NCT02891226|4122438|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361770|NCT02891226|4122439|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361771|NCT02891226|4122440|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361772|NCT02891226|4122441|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361773|NCT02891226|4122442|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361774|NCT02891226|4122443|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361775|NCT02891226|4122444|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361776|NCT02891226|4122445|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0
2361777|NCT02891226|4122430|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
2361778|NCT02891226|4122431|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
2361779|NCT02891226|4122432|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361780|NCT02891226|4122433|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361781|NCT02891226|4122434|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361782|NCT02891226|4122435|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361783|NCT02891226|4122436|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361784|NCT02891226|4122437|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361785|NCT02891226|4122438|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361786|NCT02891226|4122439|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361787|NCT02891226|4122440|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361788|NCT02891226|4122441|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361789|NCT02891226|4122442|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361790|NCT02891226|4122443|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361791|NCT02891226|4122444|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361792|NCT02891226|4122445|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2361793|NCT02891226|4122430|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361794|NCT02891226|4122431|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361795|NCT02891226|4122432|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361796|NCT02891226|4122433|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2
2361797|NCT02891226|4122434|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361798|NCT02891226|4122435|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361799|NCT02891226|4122436|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361800|NCT02891226|4122437|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361801|NCT02891226|4122438|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361802|NCT02891226|4122439|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361803|NCT02891226|4122440|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361804|NCT02891226|4122441|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361805|NCT02891226|4122442|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361806|NCT02891226|4122443|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361807|NCT02891226|4122444|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361808|NCT02891226|4122445|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2361809|NCT02891226|4122430|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361810|NCT02891226|4122431|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361811|NCT02891226|4122432|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1
2361812|NCT02891226|4122433|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361813|NCT02891226|4122434|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361814|NCT02891226|4122435|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361815|NCT02891226|4122436|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361816|NCT02891226|4122437|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361817|NCT02891226|4122438|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361818|NCT02891226|4122439|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361819|NCT02891226|4122440|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361820|NCT02891226|4122441|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361821|NCT02891226|4122442|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361822|NCT02891226|4122443|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361823|NCT02891226|4122444|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361824|NCT02891226|4122445|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
2361825|NCT02891226|4122430|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361826|NCT02891226|4122431|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361827|NCT02891226|4122432|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361828|NCT02891226|4122433|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1
2361829|NCT02891226|4122434|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361830|NCT02891226|4122435|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361831|NCT02891226|4122436|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361832|NCT02891226|4122437|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361833|NCT02891226|4122438|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361834|NCT02891226|4122439|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361835|NCT02891226|4122440|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361836|NCT02891226|4122441|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361837|NCT02891226|4122442|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361838|NCT02891226|4122443|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361839|NCT02891226|4122444|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361840|NCT02891226|4122445|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
2361841|NCT02891226|4122430|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361842|NCT02891226|4122431|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361843|NCT02891226|4122432|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361844|NCT02891226|4122433|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1
2361845|NCT02891226|4122434|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361846|NCT02891226|4122435|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361847|NCT02891226|4122436|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361848|NCT02891226|4122437|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361849|NCT02891226|4122438|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361850|NCT02891226|4122439|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361851|NCT02891226|4122440|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361852|NCT02891226|4122441|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361853|NCT02891226|4122442|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361854|NCT02891226|4122443|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361855|NCT02891226|4122444|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361856|NCT02891226|4122445|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
2361857|NCT02891226|4122430|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361858|NCT02891226|4122431|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361859|NCT02891226|4122432|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361860|NCT02891226|4122433|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361861|NCT02891226|4122434|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361862|NCT02891226|4122435|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361863|NCT02891226|4122436|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1
2361864|NCT02891226|4122437|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1
2361865|NCT02891226|4122438|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3
2361866|NCT02891226|4122439|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7
2361867|NCT02891226|4122440|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361868|NCT02891226|4122441|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361869|NCT02891226|4122442|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361870|NCT02891226|4122443|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361871|NCT02891226|4122444|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361872|NCT02891226|4122445|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0
2361873|NCT02891226|4122430|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361874|NCT02891226|4122431|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361875|NCT02891226|4122432|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361876|NCT02891226|4122433|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361877|NCT02891226|4122434|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361878|NCT02891226|4122435|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1
2361879|NCT02891226|4122436|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361880|NCT02891226|4122437|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361881|NCT02891226|4122438|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361882|NCT02891226|4122439|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1
2361883|NCT02891226|4122440|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361884|NCT02891226|4122441|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361885|NCT02891226|4122442|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361886|NCT02891226|4122443|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361887|NCT02891226|4122444|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361888|NCT02891226|4122445|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
2361889|NCT02891226|4122430|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2361890|NCT02891226|4122431|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2361891|NCT02891226|4122432|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2361892|NCT02891226|4122433|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2214984|NCT01692197|3857783|FG000|Overall Study|Failed Screening|3
2214985|NCT01692275|3857794|FG000|Overall Study|Lost to Follow-up|57
2214986|NCT01692275|3857795|FG001|Overall Study|Lost to Follow-up|48
2214987|NCT01692275|3857794|FG000|Overall Study|Withdrawal by Subject|9
2214988|NCT01692275|3857795|FG001|Overall Study|Withdrawal by Subject|11
2214989|NCT01692301|3857815|FG000|Overall Study|Adverse Event|15
2214990|NCT01692301|3857816|FG001|Overall Study|Adverse Event|12
2214991|NCT01692301|3857815|FG000|Overall Study|Death|1
2214992|NCT01692301|3857816|FG001|Overall Study|Death|2
2214993|NCT01692301|3857815|FG000|Overall Study|Lack of Efficacy|0
2214994|NCT01692301|3857816|FG001|Overall Study|Lack of Efficacy|5
2214995|NCT01692301|3857815|FG000|Overall Study|Non-compliance with study treatment|1
2214996|NCT01692301|3857816|FG001|Overall Study|Non-compliance with study treatment|2
2214997|NCT01692301|3857815|FG000|Overall Study|Protocol deviation|9
2214998|NCT01692301|3857816|FG001|Overall Study|Protocol deviation|2
2214999|NCT01692301|3857815|FG000|Overall Study|Patient/guardian decision|16
2215000|NCT01692301|3857816|FG001|Overall Study|Patient/guardian decision|15
2215001|NCT01692301|3857815|FG000|Overall Study|Technical problems|0
2215002|NCT01692301|3857816|FG001|Overall Study|Technical problems|1
2215003|NCT01692301|3857815|FG000|Overall Study|Physician Decision|2
2215004|NCT01692301|3857816|FG001|Overall Study|Physician Decision|2
2215005|NCT01692301|3857815|FG000|Overall Study|Lost to Follow-up|1
2215006|NCT01692301|3857816|FG001|Overall Study|Lost to Follow-up|1
2215007|NCT01692626|3857840|FG000|Overall Study|Death|0
2215008|NCT01692626|3857841|FG001|Overall Study|Death|1
2215009|NCT01692626|3857840|FG000|Overall Study|Adverse Event|2
2215010|NCT01692626|3857841|FG001|Overall Study|Adverse Event|3
2215011|NCT01692626|3857840|FG000|Overall Study|Protocol Violation|1
2215012|NCT01692626|3857841|FG001|Overall Study|Protocol Violation|2
2215013|NCT01692626|3857840|FG000|Overall Study|Withdrawal by Subject|1
2215014|NCT01692626|3857841|FG001|Overall Study|Withdrawal by Subject|0
2215015|NCT01692730|3857848|FG000|Overall Study|Lost to Follow-up|225
2215016|NCT01692730|3857849|FG001|Overall Study|Lost to Follow-up|227
2215017|NCT01692782|3857888|FG000|Overall Study|Adverse Event|12
2215018|NCT01692782|3857889|FG001|Overall Study|Adverse Event|32
2215019|NCT01692782|3857890|FG002|Overall Study|Adverse Event|2
2215020|NCT01692782|3857888|FG000|Overall Study|Lack of Efficacy|1
2215021|NCT01692782|3857889|FG001|Overall Study|Lack of Efficacy|2
2215022|NCT01692782|3857890|FG002|Overall Study|Lack of Efficacy|0
2215023|NCT01692782|3857888|FG000|Overall Study|Lost to Follow-up|2
2215024|NCT01692782|3857889|FG001|Overall Study|Lost to Follow-up|7
2215025|NCT01692782|3857890|FG002|Overall Study|Lost to Follow-up|1
2215026|NCT01692782|3857888|FG000|Overall Study|Pregnancy|1
2215027|NCT01692782|3857889|FG001|Overall Study|Pregnancy|0
2215028|NCT01692782|3857890|FG002|Overall Study|Pregnancy|0
2215029|NCT01692782|3857888|FG000|Overall Study|Protocol Violation|1
2361893|NCT02891226|4122434|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2361894|NCT02891226|4122435|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2361895|NCT02891226|4122436|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1
2361896|NCT02891226|4122437|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2
2361897|NCT02891226|4122438|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1
2361898|NCT02891226|4122439|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6
2361899|NCT02891226|4122440|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2361900|NCT02891226|4122441|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2361901|NCT02891226|4122442|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2361902|NCT02891226|4122443|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2361903|NCT02891226|4122444|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2361904|NCT02891226|4122445|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
2361905|NCT02891226|4122430|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361906|NCT02891226|4122431|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361907|NCT02891226|4122432|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361908|NCT02891226|4122433|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361909|NCT02891226|4122434|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1
2361910|NCT02891226|4122435|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361911|NCT02891226|4122436|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361912|NCT02891226|4122437|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361913|NCT02891226|4122438|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361914|NCT02891226|4122439|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361915|NCT02891226|4122440|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2215030|NCT01692782|3857889|FG001|Overall Study|Protocol Violation|0
2215031|NCT01692782|3857890|FG002|Overall Study|Protocol Violation|2
2215032|NCT01692782|3857888|FG000|Overall Study|Non-complance with study drug|0
2215033|NCT01692782|3857889|FG001|Overall Study|Non-complance with study drug|4
2215034|NCT01692782|3857890|FG002|Overall Study|Non-complance with study drug|1
2215035|NCT01692782|3857888|FG000|Overall Study|Non-compliant with study visits|0
2361916|NCT02891226|4122441|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361917|NCT02891226|4122442|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361918|NCT02891226|4122443|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361919|NCT02891226|4122444|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361920|NCT02891226|4122445|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
2361921|NCT02891226|4122430|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361922|NCT02891226|4122431|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361923|NCT02891226|4122432|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361924|NCT02891226|4122433|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361925|NCT02891226|4122434|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361926|NCT02891226|4122435|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361927|NCT02891226|4122436|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1
2361928|NCT02891226|4122437|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361929|NCT02891226|4122438|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361930|NCT02891226|4122439|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361931|NCT02891226|4122440|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361932|NCT02891226|4122441|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361933|NCT02891226|4122442|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361934|NCT02891226|4122443|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361935|NCT02891226|4122444|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361936|NCT02891226|4122445|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
2361937|NCT02891226|4122430|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361938|NCT02891226|4122431|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361939|NCT02891226|4122432|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361940|NCT02891226|4122433|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361941|NCT02891226|4122434|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361942|NCT02891226|4122435|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361943|NCT02891226|4122436|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361944|NCT02891226|4122437|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
2361945|NCT02891226|4122438|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
2361946|NCT02891226|4122439|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
2361947|NCT02891226|4122440|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361948|NCT02891226|4122441|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361949|NCT02891226|4122442|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361950|NCT02891226|4122443|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361951|NCT02891226|4122444|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2215036|NCT01692782|3857889|FG001|Overall Study|Non-compliant with study visits|0
2215037|NCT01692782|3857890|FG002|Overall Study|Non-compliant with study visits|1
2215038|NCT01692782|3857888|FG000|Overall Study|SAE not related to study drug|0
2215039|NCT01692782|3857889|FG001|Overall Study|SAE not related to study drug|1
2215040|NCT01692782|3857890|FG002|Overall Study|SAE not related to study drug|0
2215041|NCT01692782|3857888|FG000|Overall Study|Withdrawal by Subject|3
2215042|NCT01692782|3857889|FG001|Overall Study|Withdrawal by Subject|10
2215043|NCT01692782|3857890|FG002|Overall Study|Withdrawal by Subject|3
2215044|NCT01692938|3857900|FG000|Overall Study|Protocol Deviation|1
2215045|NCT01692938|3857901|FG001|Overall Study|Protocol Deviation|1
2215046|NCT01692938|3857900|FG000|Overall Study|Study completed prior to site completion|3
2215047|NCT01692938|3857901|FG001|Overall Study|Study completed prior to site completion|3
2215048|NCT01693029|3857931|FG000|Overall Study|Withdrawal by Subject|15
2215049|NCT01693029|3857932|FG001|Overall Study|Withdrawal by Subject|22
2215050|NCT01693029|3857931|FG000|Overall Study|Kidney transplantation|7
2215051|NCT01693029|3857932|FG001|Overall Study|Kidney transplantation|7
2215052|NCT01693029|3857931|FG000|Overall Study|Bindinging anti-EPO antibodies|6
2215053|NCT01693029|3857932|FG001|Overall Study|Bindinging anti-EPO antibodies|2
2215054|NCT01693029|3857931|FG000|Overall Study|Protocol Violation|6
2215055|NCT01693029|3857932|FG001|Overall Study|Protocol Violation|7
2215056|NCT01693029|3857931|FG000|Overall Study|Change in dialysis modality|2
2215057|NCT01693029|3857932|FG001|Overall Study|Change in dialysis modality|1
2215058|NCT01693029|3857931|FG000|Overall Study|Physician Decision|0
2215059|NCT01693029|3857932|FG001|Overall Study|Physician Decision|2
2215060|NCT01693029|3857931|FG000|Overall Study|Lost to Follow-up|0
2215061|NCT01693029|3857932|FG001|Overall Study|Lost to Follow-up|1
2215062|NCT01693029|3857931|FG000|Overall Study|Adverse Event|1
2215063|NCT01693029|3857932|FG001|Overall Study|Adverse Event|6
2215064|NCT01693029|3857931|FG000|Overall Study|Death|5
2215065|NCT01693029|3857932|FG001|Overall Study|Death|8
2215066|NCT01693029|3857931|FG000|Overall Study|Non-compliance|2
2215067|NCT01693029|3857932|FG001|Overall Study|Non-compliance|1
2215068|NCT01693068|3857940|FG000|Randomization Period|On-study|2
2215069|NCT01693068|3857941|FG001|Randomization Period|On-study|5
2215070|NCT01693068|3857942|FG002|Randomization Period|On-study|0
2215071|NCT01693068|3857940|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0
2215072|NCT01693068|3857941|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0
2215073|NCT01693068|3857942|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1
2215074|NCT01693120|3857950|FG000|Enrollment|Lost to Follow-up|1
2215075|NCT01693120|3857950|FG000|Enrollment|Withdrawal by Subject|10
2215076|NCT01693120|3857950|FG000|Enrollment|Protocol Violation|46
2215077|NCT01693120|3857950|FG000|Enrollment|Physician Decision|3
2361952|NCT02891226|4122445|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
2361953|NCT02891226|4122430|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361954|NCT02891226|4122431|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361955|NCT02891226|4122432|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2215078|NCT01693120|3857950|FG000|Enrollment|Adverse Event|1
2215079|NCT01693120|3857950|FG000|Enrollment|Study closed|8
2215080|NCT01693120|3857950|FG000|Enrollment|Other|1
2215081|NCT01693120|3857950|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
2215082|NCT01693120|3857950|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
2215083|NCT01693120|3857950|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3
2361956|NCT02891226|4122433|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361957|NCT02891226|4122434|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361958|NCT02891226|4122435|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361959|NCT02891226|4122436|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361960|NCT02891226|4122437|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1
2361961|NCT02891226|4122438|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361962|NCT02891226|4122439|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361963|NCT02891226|4122440|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361964|NCT02891226|4122441|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361965|NCT02891226|4122442|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361966|NCT02891226|4122443|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361967|NCT02891226|4122444|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361968|NCT02891226|4122445|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
2361969|NCT02891226|4122430|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361970|NCT02891226|4122431|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361971|NCT02891226|4122432|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361972|NCT02891226|4122433|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361973|NCT02891226|4122434|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361974|NCT02891226|4122435|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361975|NCT02891226|4122436|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361976|NCT02891226|4122437|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361977|NCT02891226|4122438|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1
2361978|NCT02891226|4122439|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361979|NCT02891226|4122440|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361980|NCT02891226|4122441|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361981|NCT02891226|4122442|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361982|NCT02891226|4122443|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361983|NCT02891226|4122444|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361984|NCT02891226|4122445|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
2361985|NCT02891226|4122430|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361986|NCT02891226|4122431|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361987|NCT02891226|4122432|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361988|NCT02891226|4122433|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361989|NCT02891226|4122434|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361990|NCT02891226|4122435|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361991|NCT02891226|4122436|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361992|NCT02891226|4122437|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361993|NCT02891226|4122438|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361994|NCT02891226|4122439|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1
2361995|NCT02891226|4122440|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361996|NCT02891226|4122441|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361997|NCT02891226|4122442|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361998|NCT02891226|4122443|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2361999|NCT02891226|4122444|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2362000|NCT02891226|4122445|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
2362001|NCT02891226|4122430|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362002|NCT02891226|4122431|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362003|NCT02891226|4122432|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362004|NCT02891226|4122433|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362005|NCT02891226|4122434|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362006|NCT02891226|4122435|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362007|NCT02891226|4122436|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362008|NCT02891226|4122437|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362009|NCT02891226|4122438|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362010|NCT02891226|4122439|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1
2362011|NCT02891226|4122440|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362012|NCT02891226|4122441|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362013|NCT02891226|4122442|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362014|NCT02891226|4122443|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362015|NCT02891226|4122444|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362016|NCT02891226|4122445|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
2362017|NCT02891226|4122430|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362018|NCT02891226|4122431|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362019|NCT02891226|4122432|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362020|NCT02891226|4122433|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362021|NCT02891226|4122434|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362022|NCT02891226|4122435|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362023|NCT02891226|4122436|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362024|NCT02891226|4122437|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362025|NCT02891226|4122438|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362026|NCT02891226|4122439|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362027|NCT02891226|4122440|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5
2362028|NCT02891226|4122441|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362029|NCT02891226|4122442|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362030|NCT02891226|4122443|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362031|NCT02891226|4122444|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362032|NCT02891226|4122445|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0
2362033|NCT02891226|4122430|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362034|NCT02891226|4122431|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362035|NCT02891226|4122432|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362036|NCT02891226|4122433|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362037|NCT02891226|4122434|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362038|NCT02891226|4122435|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362039|NCT02891226|4122436|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362040|NCT02891226|4122437|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362041|NCT02891226|4122438|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362042|NCT02891226|4122439|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362043|NCT02891226|4122440|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1
2362044|NCT02891226|4122441|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362045|NCT02891226|4122442|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362046|NCT02891226|4122443|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362047|NCT02891226|4122444|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362048|NCT02891226|4122445|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
2362049|NCT02891226|4122430|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362050|NCT02891226|4122431|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362051|NCT02891226|4122432|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362052|NCT02891226|4122433|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362053|NCT02891226|4122434|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362054|NCT02891226|4122435|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362055|NCT02891226|4122436|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362056|NCT02891226|4122437|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362057|NCT02891226|4122438|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362058|NCT02891226|4122439|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362059|NCT02891226|4122440|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14
2362060|NCT02891226|4122441|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362061|NCT02891226|4122442|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362062|NCT02891226|4122443|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362063|NCT02891226|4122444|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362064|NCT02891226|4122445|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
2362065|NCT02891226|4122430|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362066|NCT02891226|4122431|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362067|NCT02891226|4122432|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362068|NCT02891226|4122433|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362069|NCT02891226|4122434|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362070|NCT02891226|4122435|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362071|NCT02891226|4122436|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362072|NCT02891226|4122437|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362073|NCT02891226|4122438|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362074|NCT02891226|4122439|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362075|NCT02891226|4122440|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108
2362076|NCT02891226|4122441|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362077|NCT02891226|4122442|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362078|NCT02891226|4122443|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362079|NCT02891226|4122444|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362080|NCT02891226|4122445|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
2362081|NCT02891226|4122430|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362082|NCT02891226|4122431|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362083|NCT02891226|4122432|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362084|NCT02891226|4122433|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362085|NCT02891226|4122434|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362086|NCT02891226|4122435|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362087|NCT02891226|4122436|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362088|NCT02891226|4122437|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362089|NCT02891226|4122438|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362090|NCT02891226|4122439|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362091|NCT02891226|4122440|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2
2362092|NCT02891226|4122441|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362093|NCT02891226|4122442|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362094|NCT02891226|4122443|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362095|NCT02891226|4122444|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362096|NCT02891226|4122445|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
2362097|NCT02891226|4122430|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362098|NCT02891226|4122431|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362099|NCT02891226|4122432|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362100|NCT02891226|4122433|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362101|NCT02891226|4122434|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362102|NCT02891226|4122435|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362103|NCT02891226|4122436|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362104|NCT02891226|4122437|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362105|NCT02891226|4122438|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362106|NCT02891226|4122439|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362107|NCT02891226|4122440|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3
2362108|NCT02891226|4122441|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362109|NCT02891226|4122442|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362110|NCT02891226|4122443|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362111|NCT02891226|4122444|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362112|NCT02891226|4122445|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
2362113|NCT02891226|4122430|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362114|NCT02891226|4122431|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362115|NCT02891226|4122432|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362116|NCT02891226|4122433|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362117|NCT02891226|4122434|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362118|NCT02891226|4122435|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362119|NCT02891226|4122436|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362120|NCT02891226|4122437|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362121|NCT02891226|4122438|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362122|NCT02891226|4122439|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362123|NCT02891226|4122440|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2
2362124|NCT02891226|4122441|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362125|NCT02891226|4122442|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362126|NCT02891226|4122443|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362127|NCT02891226|4122444|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362128|NCT02891226|4122445|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
2362129|NCT02891226|4122430|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362130|NCT02891226|4122431|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362131|NCT02891226|4122432|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362132|NCT02891226|4122433|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362133|NCT02891226|4122434|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362134|NCT02891226|4122435|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362135|NCT02891226|4122436|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362136|NCT02891226|4122437|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362137|NCT02891226|4122438|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362138|NCT02891226|4122439|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362139|NCT02891226|4122440|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2
2362140|NCT02891226|4122441|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362141|NCT02891226|4122442|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362142|NCT02891226|4122443|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362143|NCT02891226|4122444|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362144|NCT02891226|4122445|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
2362145|NCT02891226|4122430|FG000|Follow-up Period|Withdrawal by Subject|0
2362146|NCT02891226|4122431|FG001|Follow-up Period|Withdrawal by Subject|0
2362147|NCT02891226|4122432|FG002|Follow-up Period|Withdrawal by Subject|0
2362148|NCT02891226|4122433|FG003|Follow-up Period|Withdrawal by Subject|0
2362149|NCT02891226|4122434|FG004|Follow-up Period|Withdrawal by Subject|0
2362150|NCT02891226|4122435|FG005|Follow-up Period|Withdrawal by Subject|0
2362151|NCT02891226|4122436|FG006|Follow-up Period|Withdrawal by Subject|0
2362152|NCT02891226|4122437|FG007|Follow-up Period|Withdrawal by Subject|0
2362153|NCT02891226|4122438|FG008|Follow-up Period|Withdrawal by Subject|0
2362154|NCT02891226|4122439|FG009|Follow-up Period|Withdrawal by Subject|0
2362155|NCT02891226|4122440|FG010|Follow-up Period|Withdrawal by Subject|0
2362156|NCT02891226|4122441|FG011|Follow-up Period|Withdrawal by Subject|1
2362157|NCT02891226|4122442|FG012|Follow-up Period|Withdrawal by Subject|0
2362158|NCT02891226|4122443|FG013|Follow-up Period|Withdrawal by Subject|0
2362159|NCT02891226|4122444|FG014|Follow-up Period|Withdrawal by Subject|1
2362160|NCT02891226|4122445|FG015|Follow-up Period|Withdrawal by Subject|1
2362161|NCT02829918|4122469|FG000|Overall Study|Death|2
2362162|NCT02829918|4122469|FG000|Overall Study|Withdrawal by Subject|4
2362163|NCT02829918|4122469|FG000|Overall Study|Adverse Event|1
2362164|NCT02829918|4122469|FG000|Overall Study|Progression|1
2362165|NCT02549092|4122482|FG000|Treatment Period|Adverse Event|2
2362166|NCT02549092|4122483|FG001|Treatment Period|Adverse Event|2
2362167|NCT02549092|4122482|FG000|Treatment Period|Withdrawal by Subject|1
2362168|NCT02549092|4122483|FG001|Treatment Period|Withdrawal by Subject|3
2362169|NCT02549092|4122482|FG000|Treatment Period|Lack of Efficacy|0
2362170|NCT02549092|4122483|FG001|Treatment Period|Lack of Efficacy|2
2362171|NCT02549092|4122482|FG000|Extension/Transition Period|Still in Extension/Transition Period|4
2362172|NCT02549092|4122483|FG001|Extension/Transition Period|Still in Extension/Transition Period|8
2362173|NCT02549092|4122482|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
2362174|NCT02549092|4122483|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
2362175|NCT02323126|4122504|FG000|Overall Study|Patient / guardian decision|0
2362176|NCT02323126|4122505|FG001|Overall Study|Patient / guardian decision|1
2362177|NCT02323126|4122506|FG002|Overall Study|Patient / guardian decision|2
2362178|NCT02323126|4122504|FG000|Overall Study|Progressive disease|14
2362179|NCT02323126|4122505|FG001|Overall Study|Progressive disease|8
2362180|NCT02323126|4122506|FG002|Overall Study|Progressive disease|14
2215084|NCT01693120|3857950|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1
2215085|NCT01693120|3857950|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7
2215086|NCT01693185|3857956|FG000|Overall Study|diagnostic procedure after colonoscopy|0
2215087|NCT01693185|3857957|FG001|Overall Study|diagnostic procedure after colonoscopy|6
2362181|NCT02323126|4122504|FG000|Overall Study|Physician Decision|0
2362182|NCT02323126|4122505|FG001|Overall Study|Physician Decision|1
2362183|NCT02323126|4122506|FG002|Overall Study|Physician Decision|3
2362184|NCT02323126|4122504|FG000|Overall Study|Death|1
2362185|NCT02323126|4122505|FG001|Overall Study|Death|1
2362186|NCT02323126|4122506|FG002|Overall Study|Death|4
2362187|NCT02323126|4122504|FG000|Overall Study|Adverse Event|3
2362188|NCT02323126|4122505|FG001|Overall Study|Adverse Event|5
2362189|NCT02323126|4122506|FG002|Overall Study|Adverse Event|7
2362190|NCT01902290|4122519|FG000|Overall Study|Withdrawal by Subject|19
2362191|NCT01902290|4122520|FG001|Overall Study|Withdrawal by Subject|27
2362192|NCT01902290|4122519|FG000|Overall Study|Lost to Follow-up|2
2362193|NCT01902290|4122520|FG001|Overall Study|Lost to Follow-up|2
2362194|NCT01902290|4122519|FG000|Overall Study|Death|1
2362195|NCT01902290|4122520|FG001|Overall Study|Death|0
2362196|NCT01902290|4122519|FG000|Overall Study|Sponsor Decision|26
2362197|NCT01902290|4122520|FG001|Overall Study|Sponsor Decision|24
2362198|NCT01619085|4122527|FG000|Overall Study|Adverse Event|231
2362199|NCT01619085|4122527|FG000|Overall Study|Protocol Violation|4
2362200|NCT01619085|4122527|FG000|Overall Study|Lost to Follow-up|3
2362201|NCT01619085|4122527|FG000|Overall Study|Withdrawal by Subject|45
2362202|NCT01619085|4122527|FG000|Overall Study|Other than specified|96
2362203|NCT01619085|4122527|FG000|Overall Study|Not treated|1
2362204|NCT01619085|4122527|FG000|Overall Study|Death|145
2362205|NCT01126749|4122542|FG000|Phase 1b|Other|0
2362206|NCT01126749|4122543|FG001|Phase 1b|Other|1
2362207|NCT01126749|4122544|FG002|Phase 1b|Other|0
2362208|NCT01126749|4122545|FG003|Phase 1b|Other|0
2362209|NCT01126749|4122542|FG000|Phase 1b|Withdrawal by Subject|0
2362210|NCT01126749|4122543|FG001|Phase 1b|Withdrawal by Subject|1
2362211|NCT01126749|4122544|FG002|Phase 1b|Withdrawal by Subject|0
2362212|NCT01126749|4122545|FG003|Phase 1b|Withdrawal by Subject|0
2362213|NCT01126749|4122542|FG000|Phase 1b|Death|3
2362214|NCT01126749|4122543|FG001|Phase 1b|Death|4
2362215|NCT01126749|4122544|FG002|Phase 1b|Death|0
2362216|NCT01126749|4122545|FG003|Phase 1b|Death|0
2362217|NCT01126749|4122542|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0
2362218|NCT01126749|4122543|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0
2362219|NCT01126749|4122544|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4
2362220|NCT01126749|4122545|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7
2362221|NCT01126749|4122542|FG000|Phase 2|Study Termination by Sponsor|0
2362222|NCT01126749|4122543|FG001|Phase 2|Study Termination by Sponsor|0
2362223|NCT01126749|4122544|FG002|Phase 2|Study Termination by Sponsor|12
2362224|NCT01126749|4122545|FG003|Phase 2|Study Termination by Sponsor|6
2215088|NCT01693250|3857965|FG000|Overall Study|Lost to Follow-up|2
2215089|NCT01693250|3857966|FG001|Overall Study|Lost to Follow-up|2
2215090|NCT01693523|3857977|FG000|Overall Study|Adverse Event|2
2215091|NCT01693523|3857978|FG001|Overall Study|Adverse Event|1
2215092|NCT01693523|3857979|FG002|Overall Study|Adverse Event|0
2215093|NCT01693523|3857977|FG000|Overall Study|Death|0
2215094|NCT01693523|3857978|FG001|Overall Study|Death|1
2215095|NCT01693523|3857979|FG002|Overall Study|Death|1
2215096|NCT01693523|3857977|FG000|Overall Study|Lost to Follow-up|0
2215097|NCT01693523|3857978|FG001|Overall Study|Lost to Follow-up|0
2215098|NCT01693523|3857979|FG002|Overall Study|Lost to Follow-up|4
2215099|NCT01693523|3857977|FG000|Overall Study|Physician Decision|0
2215100|NCT01693523|3857978|FG001|Overall Study|Physician Decision|0
2215101|NCT01693523|3857979|FG002|Overall Study|Physician Decision|1
2215102|NCT01693523|3857977|FG000|Overall Study|Withdrawal by Subject|1
2215103|NCT01693523|3857978|FG001|Overall Study|Withdrawal by Subject|2
2215104|NCT01693523|3857979|FG002|Overall Study|Withdrawal by Subject|2
2215105|NCT01693523|3857977|FG000|Overall Study|Lack of compliance study medication|1
2215106|NCT01693523|3857978|FG001|Overall Study|Lack of compliance study medication|2
2215107|NCT01693523|3857979|FG002|Overall Study|Lack of compliance study medication|0
2215108|NCT01693523|3857977|FG000|Overall Study|Chemotherapy was held|1
2215109|NCT01693523|3857978|FG001|Overall Study|Chemotherapy was held|2
2215110|NCT01693523|3857979|FG002|Overall Study|Chemotherapy was held|0
2215111|NCT01693562|3858009|FG000|Escalation Phase|Withdrawal by Subject|0
2215112|NCT01693562|3858010|FG001|Escalation Phase|Withdrawal by Subject|1
2215113|NCT01693562|3858011|FG002|Escalation Phase|Withdrawal by Subject|0
2215114|NCT01693562|3858012|FG003|Escalation Phase|Withdrawal by Subject|0
2215115|NCT01693562|3858013|FG004|Escalation Phase|Withdrawal by Subject|0
2215116|NCT01693562|3858014|FG005|Escalation Phase|Withdrawal by Subject|2
2215117|NCT01693562|3858015|FG006|Escalation Phase|Withdrawal by Subject|0
2215118|NCT01693562|3858016|FG007|Escalation Phase|Withdrawal by Subject|0
2215119|NCT01693562|3858017|FG008|Escalation Phase|Withdrawal by Subject|0
2215120|NCT01693562|3858018|FG009|Escalation Phase|Withdrawal by Subject|0
2215121|NCT01693562|3858019|FG010|Escalation Phase|Withdrawal by Subject|0
2215122|NCT01693562|3858020|FG011|Escalation Phase|Withdrawal by Subject|0
2362225|NCT01126749|4122542|FG000|Phase 2|Other|0
2362226|NCT01126749|4122543|FG001|Phase 2|Other|0
2362227|NCT01126749|4122544|FG002|Phase 2|Other|4
2362228|NCT01126749|4122545|FG003|Phase 2|Other|2
2362229|NCT01126749|4122542|FG000|Phase 2|Withdrawal by Subject|0
2362230|NCT01126749|4122543|FG001|Phase 2|Withdrawal by Subject|0
2362231|NCT01126749|4122544|FG002|Phase 2|Withdrawal by Subject|0
2362232|NCT01126749|4122545|FG003|Phase 2|Withdrawal by Subject|2
2362233|NCT01126749|4122542|FG000|Phase 2|Lost to Follow-up|0
2362234|NCT01126749|4122543|FG001|Phase 2|Lost to Follow-up|0
2362235|NCT01126749|4122544|FG002|Phase 2|Lost to Follow-up|0
2362236|NCT01126749|4122545|FG003|Phase 2|Lost to Follow-up|1
2362237|NCT01126749|4122542|FG000|Phase 2|Death|0
2362238|NCT01126749|4122543|FG001|Phase 2|Death|0
2362239|NCT01126749|4122544|FG002|Phase 2|Death|22
2362240|NCT01126749|4122545|FG003|Phase 2|Death|22
2362241|NCT01126749|4122542|FG000|Phase 2|Adverse Event|0
2362242|NCT01126749|4122543|FG001|Phase 2|Adverse Event|0
2362243|NCT01126749|4122544|FG002|Phase 2|Adverse Event|0
2362244|NCT01126749|4122545|FG003|Phase 2|Adverse Event|1
2362245|NCT01059448|4122568|FG000|Overall Study|Adverse Event|1
2362246|NCT01059448|4122569|FG001|Overall Study|Adverse Event|3
2362247|NCT01059448|4122570|FG002|Overall Study|Adverse Event|0
2362248|NCT01059448|4122571|FG003|Overall Study|Adverse Event|1
2362249|NCT01059448|4122568|FG000|Overall Study|Withdrawal by Subject|2
2362250|NCT01059448|4122569|FG001|Overall Study|Withdrawal by Subject|0
2362251|NCT01059448|4122570|FG002|Overall Study|Withdrawal by Subject|2
2362252|NCT01059448|4122571|FG003|Overall Study|Withdrawal by Subject|4
2362253|NCT01059448|4122568|FG000|Overall Study|Disease Progression|2
2362254|NCT01059448|4122569|FG001|Overall Study|Disease Progression|1
2362255|NCT01059448|4122570|FG002|Overall Study|Disease Progression|4
2362256|NCT01059448|4122571|FG003|Overall Study|Disease Progression|2
2362257|NCT01059448|4122568|FG000|Overall Study|Administrative Decision|43
2362258|NCT01059448|4122569|FG001|Overall Study|Administrative Decision|49
2362259|NCT01059448|4122570|FG002|Overall Study|Administrative Decision|45
2362260|NCT01059448|4122571|FG003|Overall Study|Administrative Decision|46
2362261|NCT01059448|4122568|FG000|Overall Study|Lost to Follow-up|0
2362262|NCT01059448|4122569|FG001|Overall Study|Lost to Follow-up|0
2362263|NCT01059448|4122570|FG002|Overall Study|Lost to Follow-up|2
2362264|NCT01059448|4122571|FG003|Overall Study|Lost to Follow-up|0
2215123|NCT01693562|3858021|FG012|Escalation Phase|Withdrawal by Subject|0
2362265|NCT01059448|4122568|FG000|Overall Study|Death|0
2362266|NCT01059448|4122569|FG001|Overall Study|Death|1
2362267|NCT01059448|4122570|FG002|Overall Study|Death|0
2362268|NCT01059448|4122571|FG003|Overall Study|Death|0
2362269|NCT01059448|4122568|FG000|Overall Study|Other|1
2215124|NCT01693562|3858022|FG013|Escalation Phase|Withdrawal by Subject|0
2215125|NCT01693562|3858023|FG014|Escalation Phase|Withdrawal by Subject|0
2215126|NCT01693562|3858024|FG015|Escalation Phase|Withdrawal by Subject|0
2362270|NCT01059448|4122569|FG001|Overall Study|Other|1
2362271|NCT01059448|4122570|FG002|Overall Study|Other|0
2362272|NCT01059448|4122571|FG003|Overall Study|Other|1
2362273|NCT00821587|4122592|FG000|Overall Study|Physician Decision|0
2362274|NCT00821587|4122593|FG001|Overall Study|Physician Decision|1
2362275|NCT00585195|4122620|FG000|Overall Study|Adverse Event|0
2362276|NCT00585195|4122621|FG001|Overall Study|Adverse Event|0
2362277|NCT00585195|4122622|FG002|Overall Study|Adverse Event|0
2362278|NCT00585195|4122623|FG003|Overall Study|Adverse Event|0
2362279|NCT00585195|4122624|FG004|Overall Study|Adverse Event|2
2362280|NCT00585195|4122625|FG005|Overall Study|Adverse Event|1
2362281|NCT00585195|4122626|FG006|Overall Study|Adverse Event|0
2362282|NCT00585195|4122627|FG007|Overall Study|Adverse Event|1
2362283|NCT00585195|4122628|FG008|Overall Study|Adverse Event|0
2362284|NCT00585195|4122629|FG009|Overall Study|Adverse Event|0
2362285|NCT00585195|4122630|FG010|Overall Study|Adverse Event|3
2362286|NCT00585195|4122631|FG011|Overall Study|Adverse Event|0
2362287|NCT00585195|4122632|FG012|Overall Study|Adverse Event|8
2362288|NCT00585195|4122633|FG013|Overall Study|Adverse Event|6
2362289|NCT00585195|4122634|FG014|Overall Study|Adverse Event|4
2362290|NCT00585195|4122635|FG015|Overall Study|Adverse Event|1
2362291|NCT00585195|4122636|FG016|Overall Study|Adverse Event|14
2362292|NCT00585195|4122637|FG017|Overall Study|Adverse Event|9
2362293|NCT00585195|4122638|FG018|Overall Study|Adverse Event|2
2362294|NCT00585195|4122639|FG019|Overall Study|Adverse Event|3
2362295|NCT00585195|4122640|FG020|Overall Study|Adverse Event|1
2362296|NCT00585195|4122620|FG000|Overall Study|Progressive Disease|2
2362297|NCT00585195|4122621|FG001|Overall Study|Progressive Disease|2
2362298|NCT00585195|4122622|FG002|Overall Study|Progressive Disease|5
2362299|NCT00585195|4122623|FG003|Overall Study|Progressive Disease|4
2362300|NCT00585195|4122624|FG004|Overall Study|Progressive Disease|6
2362301|NCT00585195|4122625|FG005|Overall Study|Progressive Disease|4
2362302|NCT00585195|4122626|FG006|Overall Study|Progressive Disease|6
2362303|NCT00585195|4122627|FG007|Overall Study|Progressive Disease|3
2362304|NCT00585195|4122628|FG008|Overall Study|Progressive Disease|0
2362305|NCT00585195|4122629|FG009|Overall Study|Progressive Disease|5
2362306|NCT00585195|4122630|FG010|Overall Study|Progressive Disease|2
2362307|NCT00585195|4122631|FG011|Overall Study|Progressive Disease|25
2362308|NCT00585195|4122632|FG012|Overall Study|Progressive Disease|29
2362309|NCT00585195|4122633|FG013|Overall Study|Progressive Disease|26
2362310|NCT00585195|4122634|FG014|Overall Study|Progressive Disease|21
2362311|NCT00585195|4122635|FG015|Overall Study|Progressive Disease|12
2362312|NCT00585195|4122636|FG016|Overall Study|Progressive Disease|94
2362313|NCT00585195|4122637|FG017|Overall Study|Progressive Disease|42
2362314|NCT00585195|4122638|FG018|Overall Study|Progressive Disease|4
2362315|NCT00585195|4122639|FG019|Overall Study|Progressive Disease|9
2362316|NCT00585195|4122640|FG020|Overall Study|Progressive Disease|8
2362317|NCT00585195|4122620|FG000|Overall Study|Withdrawal by Subject|1
2362318|NCT00585195|4122621|FG001|Overall Study|Withdrawal by Subject|1
2362319|NCT00585195|4122622|FG002|Overall Study|Withdrawal by Subject|2
2362320|NCT00585195|4122623|FG003|Overall Study|Withdrawal by Subject|2
2362321|NCT00585195|4122624|FG004|Overall Study|Withdrawal by Subject|0
2362322|NCT00585195|4122625|FG005|Overall Study|Withdrawal by Subject|0
2362323|NCT00585195|4122626|FG006|Overall Study|Withdrawal by Subject|0
2362324|NCT00585195|4122627|FG007|Overall Study|Withdrawal by Subject|1
2362325|NCT00585195|4122628|FG008|Overall Study|Withdrawal by Subject|0
2362326|NCT00585195|4122629|FG009|Overall Study|Withdrawal by Subject|0
2362327|NCT00585195|4122630|FG010|Overall Study|Withdrawal by Subject|3
2362328|NCT00585195|4122631|FG011|Overall Study|Withdrawal by Subject|8
2362329|NCT00585195|4122632|FG012|Overall Study|Withdrawal by Subject|15
2362330|NCT00585195|4122633|FG013|Overall Study|Withdrawal by Subject|0
2362331|NCT00585195|4122634|FG014|Overall Study|Withdrawal by Subject|3
2362332|NCT00585195|4122635|FG015|Overall Study|Withdrawal by Subject|0
2362333|NCT00585195|4122636|FG016|Overall Study|Withdrawal by Subject|7
2362334|NCT00585195|4122637|FG017|Overall Study|Withdrawal by Subject|1
2362335|NCT00585195|4122638|FG018|Overall Study|Withdrawal by Subject|2
2362336|NCT00585195|4122639|FG019|Overall Study|Withdrawal by Subject|2
2362337|NCT00585195|4122640|FG020|Overall Study|Withdrawal by Subject|0
2362338|NCT00585195|4122620|FG000|Overall Study|Other|0
2362339|NCT00585195|4122621|FG001|Overall Study|Other|1
2362340|NCT00585195|4122622|FG002|Overall Study|Other|1
2362341|NCT00585195|4122623|FG003|Overall Study|Other|1
2362342|NCT00585195|4122624|FG004|Overall Study|Other|0
2362343|NCT00585195|4122625|FG005|Overall Study|Other|1
2362344|NCT00585195|4122626|FG006|Overall Study|Other|0
2362345|NCT00585195|4122627|FG007|Overall Study|Other|0
2362346|NCT00585195|4122628|FG008|Overall Study|Other|2
2362347|NCT00585195|4122629|FG009|Overall Study|Other|1
2362348|NCT00585195|4122630|FG010|Overall Study|Other|0
2362349|NCT00585195|4122631|FG011|Overall Study|Other|19
2362350|NCT00585195|4122632|FG012|Overall Study|Other|23
2362351|NCT00585195|4122633|FG013|Overall Study|Other|7
2362352|NCT00585195|4122634|FG014|Overall Study|Other|11
2362353|NCT00585195|4122635|FG015|Overall Study|Other|3
2362354|NCT00585195|4122636|FG016|Overall Study|Other|28
2362355|NCT00585195|4122637|FG017|Overall Study|Other|12
2362356|NCT00585195|4122638|FG018|Overall Study|Other|10
2362357|NCT00585195|4122639|FG019|Overall Study|Other|4
2362358|NCT00585195|4122640|FG020|Overall Study|Other|2
2362359|NCT00585195|4122620|FG000|Overall Study|Randomized not treated|0
2362360|NCT00585195|4122621|FG001|Overall Study|Randomized not treated|0
2362361|NCT00585195|4122622|FG002|Overall Study|Randomized not treated|1
2362362|NCT00585195|4122623|FG003|Overall Study|Randomized not treated|0
2362363|NCT00585195|4122624|FG004|Overall Study|Randomized not treated|1
2362364|NCT00585195|4122625|FG005|Overall Study|Randomized not treated|0
2362365|NCT00585195|4122626|FG006|Overall Study|Randomized not treated|1
2362366|NCT00585195|4122627|FG007|Overall Study|Randomized not treated|0
2362367|NCT00585195|4122628|FG008|Overall Study|Randomized not treated|0
2362368|NCT00585195|4122629|FG009|Overall Study|Randomized not treated|0
2362369|NCT00585195|4122630|FG010|Overall Study|Randomized not treated|2
2362370|NCT00585195|4122631|FG011|Overall Study|Randomized not treated|0
2362371|NCT00585195|4122632|FG012|Overall Study|Randomized not treated|0
2362372|NCT00585195|4122633|FG013|Overall Study|Randomized not treated|0
2362373|NCT00585195|4122634|FG014|Overall Study|Randomized not treated|0
2362374|NCT00585195|4122635|FG015|Overall Study|Randomized not treated|1
2362375|NCT00585195|4122636|FG016|Overall Study|Randomized not treated|0
2362376|NCT00585195|4122637|FG017|Overall Study|Randomized not treated|1
2362377|NCT00585195|4122638|FG018|Overall Study|Randomized not treated|3
2362378|NCT00585195|4122639|FG019|Overall Study|Randomized not treated|0
2362379|NCT00585195|4122640|FG020|Overall Study|Randomized not treated|2
2362380|NCT00585195|4122620|FG000|Overall Study|Death|0
2362381|NCT00585195|4122621|FG001|Overall Study|Death|0
2362382|NCT00585195|4122622|FG002|Overall Study|Death|0
2362383|NCT00585195|4122623|FG003|Overall Study|Death|0
2362384|NCT00585195|4122624|FG004|Overall Study|Death|0
2362385|NCT00585195|4122625|FG005|Overall Study|Death|0
2362386|NCT00585195|4122626|FG006|Overall Study|Death|0
2362387|NCT00585195|4122627|FG007|Overall Study|Death|0
2362388|NCT00585195|4122628|FG008|Overall Study|Death|1
2362389|NCT00585195|4122629|FG009|Overall Study|Death|0
2362390|NCT00585195|4122630|FG010|Overall Study|Death|1
2362391|NCT00585195|4122631|FG011|Overall Study|Death|1
2362392|NCT00585195|4122632|FG012|Overall Study|Death|7
2362393|NCT00585195|4122633|FG013|Overall Study|Death|2
2362394|NCT00585195|4122634|FG014|Overall Study|Death|8
2362395|NCT00585195|4122635|FG015|Overall Study|Death|2
2362396|NCT00585195|4122636|FG016|Overall Study|Death|11
2362397|NCT00585195|4122637|FG017|Overall Study|Death|0
2362398|NCT00585195|4122638|FG018|Overall Study|Death|0
2362399|NCT00585195|4122639|FG019|Overall Study|Death|0
2362400|NCT00585195|4122640|FG020|Overall Study|Death|1
2362401|NCT00585195|4122620|FG000|Overall Study|Lost to Follow-up|0
2362402|NCT00585195|4122621|FG001|Overall Study|Lost to Follow-up|0
2362403|NCT00585195|4122622|FG002|Overall Study|Lost to Follow-up|0
2362404|NCT00585195|4122623|FG003|Overall Study|Lost to Follow-up|0
2362405|NCT00585195|4122624|FG004|Overall Study|Lost to Follow-up|0
2362406|NCT00585195|4122625|FG005|Overall Study|Lost to Follow-up|0
2362407|NCT00585195|4122626|FG006|Overall Study|Lost to Follow-up|0
2362408|NCT00585195|4122627|FG007|Overall Study|Lost to Follow-up|0
2362409|NCT00585195|4122628|FG008|Overall Study|Lost to Follow-up|0
2362410|NCT00585195|4122629|FG009|Overall Study|Lost to Follow-up|0
2362411|NCT00585195|4122630|FG010|Overall Study|Lost to Follow-up|0
2317525|NCT02899988|4029694|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
2317526|NCT02899988|4029695|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
2362412|NCT00585195|4122631|FG011|Overall Study|Lost to Follow-up|0
2362413|NCT00585195|4122632|FG012|Overall Study|Lost to Follow-up|1
2362414|NCT00585195|4122633|FG013|Overall Study|Lost to Follow-up|0
2362415|NCT00585195|4122634|FG014|Overall Study|Lost to Follow-up|0
2362416|NCT00585195|4122635|FG015|Overall Study|Lost to Follow-up|0
2362417|NCT00585195|4122636|FG016|Overall Study|Lost to Follow-up|0
2362418|NCT00585195|4122637|FG017|Overall Study|Lost to Follow-up|2
2362419|NCT00585195|4122638|FG018|Overall Study|Lost to Follow-up|0
2362420|NCT00585195|4122639|FG019|Overall Study|Lost to Follow-up|0
2362421|NCT00585195|4122640|FG020|Overall Study|Lost to Follow-up|0
2362422|NCT00585195|4122620|FG000|Overall Study|Ongoing|0
2362423|NCT00585195|4122621|FG001|Overall Study|Ongoing|0
2362424|NCT00585195|4122622|FG002|Overall Study|Ongoing|0
2362425|NCT00585195|4122623|FG003|Overall Study|Ongoing|0
2362426|NCT00585195|4122624|FG004|Overall Study|Ongoing|0
2362427|NCT00585195|4122625|FG005|Overall Study|Ongoing|0
2362428|NCT00585195|4122626|FG006|Overall Study|Ongoing|0
2362429|NCT00585195|4122627|FG007|Overall Study|Ongoing|0
2362430|NCT00585195|4122628|FG008|Overall Study|Ongoing|0
2317527|NCT02899988|4029696|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
2317528|NCT02899988|4029697|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
2317529|NCT02899988|4029687|FG000|Induction Period (16 Weeks)|Adverse Event|0
2317530|NCT02899988|4029688|FG001|Induction Period (16 Weeks)|Adverse Event|0
2317531|NCT02899988|4029689|FG002|Induction Period (16 Weeks)|Adverse Event|0
2317532|NCT02899988|4029690|FG003|Induction Period (16 Weeks)|Adverse Event|2
2317533|NCT02899988|4029691|FG004|Induction Period (16 Weeks)|Adverse Event|0
2317534|NCT02899988|4029692|FG005|Induction Period (16 Weeks)|Adverse Event|0
2317535|NCT02899988|4029693|FG006|Induction Period (16 Weeks)|Adverse Event|0
2362431|NCT00585195|4122629|FG009|Overall Study|Ongoing|0
2362432|NCT00585195|4122630|FG010|Overall Study|Ongoing|0
2362433|NCT00585195|4122631|FG011|Overall Study|Ongoing|0
2362434|NCT00585195|4122632|FG012|Overall Study|Ongoing|2
2362435|NCT00585195|4122633|FG013|Overall Study|Ongoing|0
2362436|NCT00585195|4122634|FG014|Overall Study|Ongoing|0
2362437|NCT00585195|4122635|FG015|Overall Study|Ongoing|0
2362438|NCT00585195|4122636|FG016|Overall Study|Ongoing|0
2362439|NCT00585195|4122637|FG017|Overall Study|Ongoing|0
2215127|NCT01693562|3858025|FG016|Escalation Phase|Withdrawal by Subject|0
2215128|NCT01693562|3858026|FG017|Escalation Phase|Withdrawal by Subject|0
2362440|NCT00585195|4122638|FG018|Overall Study|Ongoing|0
2362441|NCT00585195|4122639|FG019|Overall Study|Ongoing|0
2362442|NCT00585195|4122640|FG020|Overall Study|Ongoing|0
2362443|NCT00585195|4122620|FG000|Overall Study|Withdrawn Due to Pregnancy|0
2362444|NCT00585195|4122621|FG001|Overall Study|Withdrawn Due to Pregnancy|0
2362445|NCT00585195|4122622|FG002|Overall Study|Withdrawn Due to Pregnancy|0
2362446|NCT00585195|4122623|FG003|Overall Study|Withdrawn Due to Pregnancy|0
2362447|NCT00585195|4122624|FG004|Overall Study|Withdrawn Due to Pregnancy|0
2362448|NCT00585195|4122625|FG005|Overall Study|Withdrawn Due to Pregnancy|0
2362449|NCT00585195|4122626|FG006|Overall Study|Withdrawn Due to Pregnancy|0
2362450|NCT00585195|4122627|FG007|Overall Study|Withdrawn Due to Pregnancy|0
2362451|NCT00585195|4122628|FG008|Overall Study|Withdrawn Due to Pregnancy|0
2362452|NCT00585195|4122629|FG009|Overall Study|Withdrawn Due to Pregnancy|0
2362453|NCT00585195|4122630|FG010|Overall Study|Withdrawn Due to Pregnancy|0
2362454|NCT00585195|4122631|FG011|Overall Study|Withdrawn Due to Pregnancy|0
2362455|NCT00585195|4122632|FG012|Overall Study|Withdrawn Due to Pregnancy|0
2362456|NCT00585195|4122633|FG013|Overall Study|Withdrawn Due to Pregnancy|0
2362457|NCT00585195|4122634|FG014|Overall Study|Withdrawn Due to Pregnancy|1
2362458|NCT00585195|4122635|FG015|Overall Study|Withdrawn Due to Pregnancy|0
2362459|NCT00585195|4122636|FG016|Overall Study|Withdrawn Due to Pregnancy|0
2362460|NCT00585195|4122637|FG017|Overall Study|Withdrawn Due to Pregnancy|0
2362461|NCT00585195|4122638|FG018|Overall Study|Withdrawn Due to Pregnancy|0
2362462|NCT00585195|4122639|FG019|Overall Study|Withdrawn Due to Pregnancy|0
2362463|NCT00585195|4122640|FG020|Overall Study|Withdrawn Due to Pregnancy|0
2362464|NCT00278915|4122723|FG000|Overall Study|Lack of Efficacy|1
2215129|NCT01693562|3858027|FG018|Escalation Phase|Withdrawal by Subject|0
2215130|NCT01693562|3858028|FG019|Escalation Phase|Withdrawal by Subject|0
2215131|NCT01693562|3858029|FG020|Escalation Phase|Withdrawal by Subject|0
2215132|NCT01693562|3858030|FG021|Escalation Phase|Withdrawal by Subject|0
2215133|NCT01693562|3858031|FG022|Escalation Phase|Withdrawal by Subject|0
2215134|NCT01693562|3858009|FG000|Escalation Phase|Death|4
2215135|NCT01693562|3858010|FG001|Escalation Phase|Death|2
2215136|NCT01693562|3858011|FG002|Escalation Phase|Death|0
2215137|NCT01693562|3858012|FG003|Escalation Phase|Death|3
2215138|NCT01693562|3858013|FG004|Escalation Phase|Death|6
2215139|NCT01693562|3858014|FG005|Escalation Phase|Death|4
2177517|NCT01375010|3801723|FG001|Overall Study|Withdrawal by Subject|2
2177518|NCT01375049|3801729|FG000|Overall Study|Adverse Event|2
2177519|NCT01375049|3801729|FG000|Overall Study|Lost to Follow-up|1
2215140|NCT01693562|3858015|FG006|Escalation Phase|Death|0
2215141|NCT01693562|3858016|FG007|Escalation Phase|Death|0
2215142|NCT01693562|3858017|FG008|Escalation Phase|Death|0
2177520|NCT01375049|3801729|FG000|Overall Study|Withdrawal by Subject|2
2177521|NCT01375049|3801729|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45
2177522|NCT01375075|3801743|FG000|Overall Study|Adverse Event|0
2177523|NCT01375075|3801744|FG001|Overall Study|Adverse Event|0
2177524|NCT01375075|3801745|FG002|Overall Study|Adverse Event|3
2177525|NCT01375075|3801746|FG003|Overall Study|Adverse Event|1
2177526|NCT01375075|3801747|FG004|Overall Study|Adverse Event|0
2177527|NCT01375075|3801748|FG005|Overall Study|Adverse Event|1
2177528|NCT01375075|3801743|FG000|Overall Study|Entry Criterion Not Met|1
2177529|NCT01375075|3801744|FG001|Overall Study|Entry Criterion Not Met|0
2177530|NCT01375075|3801745|FG002|Overall Study|Entry Criterion Not Met|0
2177531|NCT01375075|3801746|FG003|Overall Study|Entry Criterion Not Met|0
2177532|NCT01375075|3801747|FG004|Overall Study|Entry Criterion Not Met|0
2177533|NCT01375075|3801748|FG005|Overall Study|Entry Criterion Not Met|1
2215143|NCT01693562|3858018|FG009|Escalation Phase|Death|0
2215144|NCT01693562|3858019|FG010|Escalation Phase|Death|0
2215145|NCT01693562|3858020|FG011|Escalation Phase|Death|0
2215146|NCT01693562|3858021|FG012|Escalation Phase|Death|0
2177534|NCT01375075|3801743|FG000|Overall Study|Withdrawal by Subject|0
2215147|NCT01693562|3858022|FG013|Escalation Phase|Death|0
2215148|NCT01693562|3858023|FG014|Escalation Phase|Death|0
2215149|NCT01693562|3858024|FG015|Escalation Phase|Death|0
2215150|NCT01693562|3858025|FG016|Escalation Phase|Death|0
2215151|NCT01693562|3858026|FG017|Escalation Phase|Death|0
2215152|NCT01693562|3858027|FG018|Escalation Phase|Death|0
2215153|NCT01693562|3858028|FG019|Escalation Phase|Death|0
2317536|NCT02899988|4029694|FG007|Induction Period (16 Weeks)|Adverse Event|0
2317537|NCT02899988|4029695|FG008|Induction Period (16 Weeks)|Adverse Event|0
2317538|NCT02899988|4029696|FG009|Induction Period (16 Weeks)|Adverse Event|0
2317539|NCT02899988|4029697|FG010|Induction Period (16 Weeks)|Adverse Event|0
2317540|NCT02899988|4029687|FG000|Induction Period (16 Weeks)|Physician Decision|0
2317541|NCT02899988|4029688|FG001|Induction Period (16 Weeks)|Physician Decision|1
2317542|NCT02899988|4029689|FG002|Induction Period (16 Weeks)|Physician Decision|0
2317543|NCT02899988|4029690|FG003|Induction Period (16 Weeks)|Physician Decision|0
2317544|NCT02899988|4029691|FG004|Induction Period (16 Weeks)|Physician Decision|0
2177535|NCT01375075|3801744|FG001|Overall Study|Withdrawal by Subject|1
2104624|NCT00853047|3696978|FG000|Open-Label Extension Phase|Lost to Follow-up|0
2177536|NCT01375075|3801745|FG002|Overall Study|Withdrawal by Subject|0
2177537|NCT01375075|3801746|FG003|Overall Study|Withdrawal by Subject|0
2177538|NCT01375075|3801747|FG004|Overall Study|Withdrawal by Subject|0
2177539|NCT01375075|3801748|FG005|Overall Study|Withdrawal by Subject|1
2177540|NCT01375205|3801797|FG000|Overall Study|Lost to Follow-up|15
2177541|NCT01375205|3801798|FG001|Overall Study|Lost to Follow-up|12
2177542|NCT01375205|3801797|FG000|Overall Study|Withdrawal by Subject|6
2177543|NCT01375205|3801798|FG001|Overall Study|Withdrawal by Subject|1
2215154|NCT01693562|3858029|FG020|Escalation Phase|Death|0
2215155|NCT01693562|3858030|FG021|Escalation Phase|Death|0
2104625|NCT00853047|3696979|FG001|Open-Label Extension Phase|Lost to Follow-up|0
2104626|NCT00853047|3696980|FG002|Open-Label Extension Phase|Lost to Follow-up|0
2104627|NCT00853047|3696981|FG003|Open-Label Extension Phase|Lost to Follow-up|0
2215156|NCT01693562|3858031|FG022|Escalation Phase|Death|0
2215157|NCT01693562|3858009|FG000|Escalation Phase|Lost to Follow-up|0
2215158|NCT01693562|3858010|FG001|Escalation Phase|Lost to Follow-up|1
2215159|NCT01693562|3858011|FG002|Escalation Phase|Lost to Follow-up|1
2215160|NCT01693562|3858012|FG003|Escalation Phase|Lost to Follow-up|0
2215161|NCT01693562|3858013|FG004|Escalation Phase|Lost to Follow-up|0
2317545|NCT02899988|4029692|FG005|Induction Period (16 Weeks)|Physician Decision|0
2317546|NCT02899988|4029693|FG006|Induction Period (16 Weeks)|Physician Decision|0
2317547|NCT02899988|4029694|FG007|Induction Period (16 Weeks)|Physician Decision|0
2317548|NCT02899988|4029695|FG008|Induction Period (16 Weeks)|Physician Decision|0
2317549|NCT02899988|4029696|FG009|Induction Period (16 Weeks)|Physician Decision|0
2317550|NCT02899988|4029697|FG010|Induction Period (16 Weeks)|Physician Decision|0
2317551|NCT02899988|4029687|FG000|Maintenance Period (88 Weeks)|Adverse Event|0
2317552|NCT02899988|4029688|FG001|Maintenance Period (88 Weeks)|Adverse Event|0
2317553|NCT02899988|4029689|FG002|Maintenance Period (88 Weeks)|Adverse Event|0
2317554|NCT02899988|4029690|FG003|Maintenance Period (88 Weeks)|Adverse Event|0
2317555|NCT02899988|4029691|FG004|Maintenance Period (88 Weeks)|Adverse Event|1
2317556|NCT02899988|4029692|FG005|Maintenance Period (88 Weeks)|Adverse Event|2
2317557|NCT02899988|4029693|FG006|Maintenance Period (88 Weeks)|Adverse Event|1
2317558|NCT02899988|4029694|FG007|Maintenance Period (88 Weeks)|Adverse Event|2
2317559|NCT02899988|4029695|FG008|Maintenance Period (88 Weeks)|Adverse Event|2
2322230|NCT02969525|4037125|FG011|Dose-Blind Period|Adverse Event|1
2215162|NCT01693562|3858014|FG005|Escalation Phase|Lost to Follow-up|0
2215163|NCT01693562|3858015|FG006|Escalation Phase|Lost to Follow-up|0
2215164|NCT01693562|3858016|FG007|Escalation Phase|Lost to Follow-up|0
2317560|NCT02899988|4029696|FG009|Maintenance Period (88 Weeks)|Adverse Event|2
2317561|NCT02899988|4029697|FG010|Maintenance Period (88 Weeks)|Adverse Event|1
2317562|NCT02899988|4029687|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0
2317563|NCT02899988|4029688|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0
2317564|NCT02899988|4029689|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0
2317565|NCT02899988|4029690|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0
2317566|NCT02899988|4029691|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0
2317567|NCT02899988|4029692|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1
2317568|NCT02899988|4029693|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0
2317569|NCT02899988|4029694|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1
2317570|NCT02899988|4029695|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0
2317571|NCT02899988|4029696|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0
2317572|NCT02899988|4029697|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0
2317573|NCT02899988|4029687|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
2317574|NCT02899988|4029688|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
2215165|NCT01693562|3858017|FG008|Escalation Phase|Lost to Follow-up|0
2215166|NCT01693562|3858018|FG009|Escalation Phase|Lost to Follow-up|0
2215167|NCT01693562|3858019|FG010|Escalation Phase|Lost to Follow-up|0
2104628|NCT00853047|3696982|FG004|Open-Label Extension Phase|Lost to Follow-up|0
2215168|NCT01693562|3858020|FG011|Escalation Phase|Lost to Follow-up|0
2215169|NCT01693562|3858021|FG012|Escalation Phase|Lost to Follow-up|0
2215170|NCT01693562|3858022|FG013|Escalation Phase|Lost to Follow-up|0
2215171|NCT01693562|3858023|FG014|Escalation Phase|Lost to Follow-up|0
2215172|NCT01693562|3858024|FG015|Escalation Phase|Lost to Follow-up|0
2215173|NCT01693562|3858025|FG016|Escalation Phase|Lost to Follow-up|0
2215174|NCT01693562|3858026|FG017|Escalation Phase|Lost to Follow-up|0
2215175|NCT01693562|3858027|FG018|Escalation Phase|Lost to Follow-up|0
2215176|NCT01693562|3858028|FG019|Escalation Phase|Lost to Follow-up|0
2215177|NCT01693562|3858029|FG020|Escalation Phase|Lost to Follow-up|0
2215178|NCT01693562|3858030|FG021|Escalation Phase|Lost to Follow-up|0
2215179|NCT01693562|3858031|FG022|Escalation Phase|Lost to Follow-up|0
2215180|NCT01693562|3858009|FG000|Escalation Phase|Other|0
2215181|NCT01693562|3858010|FG001|Escalation Phase|Other|0
2215182|NCT01693562|3858011|FG002|Escalation Phase|Other|2
2215183|NCT01693562|3858012|FG003|Escalation Phase|Other|0
2215184|NCT01693562|3858013|FG004|Escalation Phase|Other|0
2215185|NCT01693562|3858014|FG005|Escalation Phase|Other|1
2215186|NCT01693562|3858015|FG006|Escalation Phase|Other|0
2215187|NCT01693562|3858016|FG007|Escalation Phase|Other|0
2215188|NCT01693562|3858017|FG008|Escalation Phase|Other|0
2215189|NCT01693562|3858018|FG009|Escalation Phase|Other|0
2215190|NCT01693562|3858019|FG010|Escalation Phase|Other|0
2215191|NCT01693562|3858020|FG011|Escalation Phase|Other|0
2215192|NCT01693562|3858021|FG012|Escalation Phase|Other|0
2215193|NCT01693562|3858022|FG013|Escalation Phase|Other|0
2215194|NCT01693562|3858023|FG014|Escalation Phase|Other|0
2215195|NCT01693562|3858024|FG015|Escalation Phase|Other|0
2215196|NCT01693562|3858025|FG016|Escalation Phase|Other|0
2215197|NCT01693562|3858026|FG017|Escalation Phase|Other|0
2215198|NCT01693562|3858027|FG018|Escalation Phase|Other|0
2215199|NCT01693562|3858028|FG019|Escalation Phase|Other|0
2215200|NCT01693562|3858029|FG020|Escalation Phase|Other|0
2215201|NCT01693562|3858030|FG021|Escalation Phase|Other|0
2215202|NCT01693562|3858031|FG022|Escalation Phase|Other|0
2215203|NCT01693562|3858009|FG000|Exploration Phase|Withdrawal by Subject|0
2215204|NCT01693562|3858010|FG001|Exploration Phase|Withdrawal by Subject|0
2215205|NCT01693562|3858011|FG002|Exploration Phase|Withdrawal by Subject|0
2215206|NCT01693562|3858012|FG003|Exploration Phase|Withdrawal by Subject|0
2104629|NCT00853047|3696983|FG005|Open-Label Extension Phase|Lost to Follow-up|1
2104630|NCT00853047|3696978|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0
2104631|NCT00853047|3696979|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0
2104632|NCT00853047|3696980|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0
2104633|NCT00853047|3696981|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0
2104634|NCT00853047|3696982|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0
2104635|NCT00853047|3696983|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2
2104636|NCT00853047|3696978|FG000|Open-Label Extension Phase|Investigator Decision|0
2215207|NCT01693562|3858013|FG004|Exploration Phase|Withdrawal by Subject|0
2215208|NCT01693562|3858014|FG005|Exploration Phase|Withdrawal by Subject|0
2215209|NCT01693562|3858015|FG006|Exploration Phase|Withdrawal by Subject|2
2215210|NCT01693562|3858016|FG007|Exploration Phase|Withdrawal by Subject|0
2215211|NCT01693562|3858017|FG008|Exploration Phase|Withdrawal by Subject|0
2215212|NCT01693562|3858018|FG009|Exploration Phase|Withdrawal by Subject|0
2215213|NCT01693562|3858019|FG010|Exploration Phase|Withdrawal by Subject|0
2215214|NCT01693562|3858020|FG011|Exploration Phase|Withdrawal by Subject|0
2215215|NCT01693562|3858021|FG012|Exploration Phase|Withdrawal by Subject|0
2215216|NCT01693562|3858022|FG013|Exploration Phase|Withdrawal by Subject|0
2215217|NCT01693562|3858023|FG014|Exploration Phase|Withdrawal by Subject|0
2215218|NCT01693562|3858024|FG015|Exploration Phase|Withdrawal by Subject|0
2215219|NCT01693562|3858025|FG016|Exploration Phase|Withdrawal by Subject|0
2215220|NCT01693562|3858026|FG017|Exploration Phase|Withdrawal by Subject|0
2215221|NCT01693562|3858027|FG018|Exploration Phase|Withdrawal by Subject|0
2215222|NCT01693562|3858028|FG019|Exploration Phase|Withdrawal by Subject|0
2215223|NCT01693562|3858029|FG020|Exploration Phase|Withdrawal by Subject|0
2215224|NCT01693562|3858030|FG021|Exploration Phase|Withdrawal by Subject|0
2215225|NCT01693562|3858031|FG022|Exploration Phase|Withdrawal by Subject|0
2215226|NCT01693562|3858009|FG000|Exploration Phase|Death|0
2215227|NCT01693562|3858010|FG001|Exploration Phase|Death|0
2215228|NCT01693562|3858011|FG002|Exploration Phase|Death|0
2215229|NCT01693562|3858012|FG003|Exploration Phase|Death|0
2215230|NCT01693562|3858013|FG004|Exploration Phase|Death|0
2317575|NCT02899988|4029689|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
2317576|NCT02899988|4029690|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
2317577|NCT02899988|4029691|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
2317578|NCT02899988|4029692|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
2317579|NCT02899988|4029693|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3
2317580|NCT02899988|4029694|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
2317581|NCT02899988|4029695|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
2317582|NCT02899988|4029696|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
2317583|NCT02899988|4029697|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
2317584|NCT02900092|4029729|FG000|Overall Study|Adverse Event|1
2104637|NCT00853047|3696979|FG001|Open-Label Extension Phase|Investigator Decision|0
2104638|NCT00853047|3696980|FG002|Open-Label Extension Phase|Investigator Decision|0
2104639|NCT00853047|3696981|FG003|Open-Label Extension Phase|Investigator Decision|0
2104640|NCT00853047|3696982|FG004|Open-Label Extension Phase|Investigator Decision|0
2104641|NCT00853047|3696983|FG005|Open-Label Extension Phase|Investigator Decision|1
2104642|NCT00853047|3696978|FG000|Open-Label Extension Phase|Reason Not Specified|0
2104643|NCT00853047|3696979|FG001|Open-Label Extension Phase|Reason Not Specified|0
2104644|NCT00853047|3696980|FG002|Open-Label Extension Phase|Reason Not Specified|0
2104645|NCT00853047|3696981|FG003|Open-Label Extension Phase|Reason Not Specified|0
2104646|NCT00853047|3696982|FG004|Open-Label Extension Phase|Reason Not Specified|0
2104647|NCT00853047|3696983|FG005|Open-Label Extension Phase|Reason Not Specified|6
2104648|NCT00853073|3697000|FG000|Overall Study|Withdrawal by Subject|3
2104649|NCT00853073|3697001|FG001|Overall Study|Withdrawal by Subject|2
2104650|NCT00853099|3697010|FG000|Double-blind Period|Adverse Event|7
2104651|NCT00853099|3697011|FG001|Double-blind Period|Adverse Event|9
2104652|NCT00853099|3697012|FG002|Double-blind Period|Adverse Event|13
2104653|NCT00853099|3697013|FG003|Double-blind Period|Adverse Event|0
2104654|NCT00853099|3697010|FG000|Double-blind Period|Withdrawal by Subject|2
2104655|NCT00853099|3697011|FG001|Double-blind Period|Withdrawal by Subject|3
2104656|NCT00853099|3697012|FG002|Double-blind Period|Withdrawal by Subject|0
2104657|NCT00853099|3697013|FG003|Double-blind Period|Withdrawal by Subject|0
2104658|NCT00853099|3697010|FG000|Double-blind Period|Lack of Efficacy|14
2104659|NCT00853099|3697011|FG001|Double-blind Period|Lack of Efficacy|17
2104660|NCT00853099|3697012|FG002|Double-blind Period|Lack of Efficacy|16
2104661|NCT00853099|3697013|FG003|Double-blind Period|Lack of Efficacy|0
2104662|NCT00853099|3697010|FG000|Double-blind Period|Other|0
2104663|NCT00853099|3697011|FG001|Double-blind Period|Other|0
2104664|NCT00853099|3697012|FG002|Double-blind Period|Other|1
2104665|NCT00853099|3697013|FG003|Double-blind Period|Other|0
2104666|NCT00853099|3697010|FG000|Double-blind Period|Mistreated with rescue study drug|0
2104667|NCT00853099|3697011|FG001|Double-blind Period|Mistreated with rescue study drug|0
2104668|NCT00853099|3697012|FG002|Double-blind Period|Mistreated with rescue study drug|1
2104669|NCT00853099|3697013|FG003|Double-blind Period|Mistreated with rescue study drug|0
2104670|NCT00853099|3697010|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0
2104671|NCT00853099|3697011|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0
2104672|NCT00853099|3697012|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0
2104673|NCT00853099|3697013|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74
2104674|NCT00853099|3697010|FG000|Double-blind + Open-label Periods|Adverse Event|0
2104675|NCT00853099|3697011|FG001|Double-blind + Open-label Periods|Adverse Event|0
2104676|NCT00853099|3697012|FG002|Double-blind + Open-label Periods|Adverse Event|0
2104677|NCT00853099|3697013|FG003|Double-blind + Open-label Periods|Adverse Event|47
2104678|NCT00853099|3697010|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0
2104679|NCT00853099|3697011|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0
2104680|NCT00853099|3697012|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0
2104681|NCT00853099|3697013|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20
2104682|NCT00853099|3697010|FG000|Double-blind + Open-label Periods|Other|0
2104683|NCT00853099|3697011|FG001|Double-blind + Open-label Periods|Other|0
2104684|NCT00853099|3697012|FG002|Double-blind + Open-label Periods|Other|0
2215231|NCT01693562|3858014|FG005|Exploration Phase|Death|0
2215232|NCT01693562|3858015|FG006|Exploration Phase|Death|17
2215233|NCT01693562|3858016|FG007|Exploration Phase|Death|0
2215234|NCT01693562|3858017|FG008|Exploration Phase|Death|0
2317585|NCT02900170|4029733|FG000|Overall Study|Lost to Follow-up|8
2317586|NCT02900378|4029739|FG000|Randomization (Visit 2)|Adverse Event|14
2317587|NCT02900378|4029740|FG001|Randomization (Visit 2)|Adverse Event|11
2317588|NCT02900378|4029739|FG000|Randomization (Visit 2)|Death|1
2317589|NCT02900378|4029740|FG001|Randomization (Visit 2)|Death|4
2317590|NCT02900378|4029739|FG000|Randomization (Visit 2)|Lost to Follow-up|1
2317591|NCT02900378|4029740|FG001|Randomization (Visit 2)|Lost to Follow-up|0
2317592|NCT02900378|4029739|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1
2317593|NCT02900378|4029740|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1
2317594|NCT02900378|4029739|FG000|Randomization (Visit 2)|Protocol Deviation|1
2317595|NCT02900378|4029740|FG001|Randomization (Visit 2)|Protocol Deviation|7
2317596|NCT02900378|4029739|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
2317597|NCT02900378|4029740|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
2317598|NCT02900378|4029739|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0
2317599|NCT02900378|4029740|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2
2317600|NCT02901054|4029746|FG000|Overall Study|Physician Decision|1
2317601|NCT02901054|4029746|FG000|Overall Study|Withdrawal by Subject|3
2317602|NCT02901431|4029780|FG000|PK Part|Adverse Event|0
2317603|NCT02901431|4029781|FG001|PK Part|Adverse Event|1
2317604|NCT02901431|4029782|FG002|PK Part|Adverse Event|0
2317605|NCT02901431|4029783|FG003|PK Part|Adverse Event|0
2317606|NCT02901431|4029784|FG004|PK Part|Adverse Event|0
2317607|NCT02901431|4029785|FG005|PK Part|Adverse Event|0
2317608|NCT02901431|4029786|FG006|PK Part|Adverse Event|0
2317609|NCT02901431|4029787|FG007|PK Part|Adverse Event|0
2215235|NCT01693562|3858018|FG009|Exploration Phase|Death|0
2215236|NCT01693562|3858019|FG010|Exploration Phase|Death|0
2215237|NCT01693562|3858020|FG011|Exploration Phase|Death|0
2215238|NCT01693562|3858021|FG012|Exploration Phase|Death|0
2215239|NCT01693562|3858022|FG013|Exploration Phase|Death|0
2215240|NCT01693562|3858023|FG014|Exploration Phase|Death|0
2215241|NCT01693562|3858024|FG015|Exploration Phase|Death|0
2215242|NCT01693562|3858025|FG016|Exploration Phase|Death|0
2215243|NCT01693562|3858026|FG017|Exploration Phase|Death|0
2215244|NCT01693562|3858027|FG018|Exploration Phase|Death|0
2317610|NCT02901431|4029788|FG008|PK Part|Adverse Event|0
2317611|NCT02901431|4029789|FG009|PK Part|Adverse Event|0
2317612|NCT02901431|4029790|FG010|PK Part|Adverse Event|0
2317613|NCT02901431|4029791|FG011|PK Part|Adverse Event|0
2317614|NCT02901431|4029792|FG012|PK Part|Adverse Event|0
2317615|NCT02901431|4029780|FG000|PK Part|Lost to Follow-up|0
2317616|NCT02901431|4029781|FG001|PK Part|Lost to Follow-up|0
2317617|NCT02901431|4029782|FG002|PK Part|Lost to Follow-up|1
2317618|NCT02901431|4029783|FG003|PK Part|Lost to Follow-up|0
2317619|NCT02901431|4029784|FG004|PK Part|Lost to Follow-up|0
2317620|NCT02901431|4029785|FG005|PK Part|Lost to Follow-up|0
2215245|NCT01693562|3858028|FG019|Exploration Phase|Death|0
2215246|NCT01693562|3858029|FG020|Exploration Phase|Death|0
2215247|NCT01693562|3858030|FG021|Exploration Phase|Death|0
2215248|NCT01693562|3858031|FG022|Exploration Phase|Death|0
2215249|NCT01693562|3858009|FG000|Exploration Phase|Other|0
2215250|NCT01693562|3858010|FG001|Exploration Phase|Other|0
2215251|NCT01693562|3858011|FG002|Exploration Phase|Other|0
2215252|NCT01693562|3858012|FG003|Exploration Phase|Other|0
2215253|NCT01693562|3858013|FG004|Exploration Phase|Other|0
2215254|NCT01693562|3858014|FG005|Exploration Phase|Other|0
2215255|NCT01693562|3858015|FG006|Exploration Phase|Other|2
2215256|NCT01693562|3858016|FG007|Exploration Phase|Other|0
2215257|NCT01693562|3858017|FG008|Exploration Phase|Other|0
2215258|NCT01693562|3858018|FG009|Exploration Phase|Other|0
2215259|NCT01693562|3858019|FG010|Exploration Phase|Other|0
2215260|NCT01693562|3858020|FG011|Exploration Phase|Other|0
2215261|NCT01693562|3858021|FG012|Exploration Phase|Other|0
2215262|NCT01693562|3858022|FG013|Exploration Phase|Other|0
2215263|NCT01693562|3858023|FG014|Exploration Phase|Other|0
2215264|NCT01693562|3858024|FG015|Exploration Phase|Other|0
2215265|NCT01693562|3858025|FG016|Exploration Phase|Other|0
2215266|NCT01693562|3858026|FG017|Exploration Phase|Other|0
2215267|NCT01693562|3858027|FG018|Exploration Phase|Other|0
2215268|NCT01693562|3858028|FG019|Exploration Phase|Other|0
2215269|NCT01693562|3858029|FG020|Exploration Phase|Other|0
2215270|NCT01693562|3858030|FG021|Exploration Phase|Other|0
2215271|NCT01693562|3858031|FG022|Exploration Phase|Other|0
2215272|NCT01693562|3858009|FG000|Expansion Phase|Withdrawal by Subject|0
2215273|NCT01693562|3858010|FG001|Expansion Phase|Withdrawal by Subject|0
2104685|NCT00853099|3697013|FG003|Double-blind + Open-label Periods|Other|6
2104686|NCT00853112|3697030|FG000|Overall Study|Randomized but not treated|0
2104687|NCT00853112|3697031|FG001|Overall Study|Randomized but not treated|1
2104688|NCT00853112|3697032|FG002|Overall Study|Randomized but not treated|0
2104689|NCT00853112|3697033|FG003|Overall Study|Randomized but not treated|2
2104690|NCT00853112|3697034|FG004|Overall Study|Randomized but not treated|0
2104691|NCT00853112|3697035|FG005|Overall Study|Randomized but not treated|0
2104692|NCT00853112|3697036|FG006|Overall Study|Randomized but not treated|1
2104693|NCT00853125|3697052|FG000|Overall Study|Study participant's donor was CMV +|1
2104694|NCT00853151|3697061|FG000|Overall Study|Adverse Event|1
2104695|NCT00853151|3697062|FG001|Overall Study|Adverse Event|4
2104696|NCT00853151|3697063|FG002|Overall Study|Adverse Event|2
2104697|NCT00853151|3697064|FG003|Overall Study|Adverse Event|0
2104698|NCT00853151|3697061|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
2317621|NCT02901431|4029786|FG006|PK Part|Lost to Follow-up|0
2317622|NCT02901431|4029787|FG007|PK Part|Lost to Follow-up|0
2317623|NCT02901431|4029788|FG008|PK Part|Lost to Follow-up|0
2317624|NCT02901431|4029789|FG009|PK Part|Lost to Follow-up|0
2317625|NCT02901431|4029790|FG010|PK Part|Lost to Follow-up|0
2317626|NCT02901431|4029791|FG011|PK Part|Lost to Follow-up|0
2317627|NCT02901431|4029792|FG012|PK Part|Lost to Follow-up|0
2317628|NCT02901431|4029780|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2
2317629|NCT02901431|4029781|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0
2317630|NCT02901431|4029782|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0
2317631|NCT02901431|4029783|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0
2317632|NCT02901431|4029784|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0
2317633|NCT02901431|4029785|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0
2317634|NCT02901431|4029786|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0
2317635|NCT02901431|4029787|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0
2317636|NCT02901431|4029788|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0
2317637|NCT02901431|4029789|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0
2317638|NCT02901431|4029790|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0
2317639|NCT02901431|4029791|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0
2317640|NCT02901431|4029792|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0
2317641|NCT02901431|4029780|FG000|PK Part|Pending dose confirmation|0
2317642|NCT02901431|4029781|FG001|PK Part|Pending dose confirmation|1
2317643|NCT02901431|4029782|FG002|PK Part|Pending dose confirmation|0
2317644|NCT02901431|4029783|FG003|PK Part|Pending dose confirmation|0
2317645|NCT02901431|4029784|FG004|PK Part|Pending dose confirmation|0
2317646|NCT02901431|4029785|FG005|PK Part|Pending dose confirmation|0
2317647|NCT02901431|4029786|FG006|PK Part|Pending dose confirmation|0
2317648|NCT02901431|4029787|FG007|PK Part|Pending dose confirmation|0
2317649|NCT02901431|4029788|FG008|PK Part|Pending dose confirmation|0
2317650|NCT02901431|4029789|FG009|PK Part|Pending dose confirmation|0
2317651|NCT02901431|4029790|FG010|PK Part|Pending dose confirmation|0
2317652|NCT02901431|4029791|FG011|PK Part|Pending dose confirmation|0
2317653|NCT02901431|4029792|FG012|PK Part|Pending dose confirmation|0
2317654|NCT02901431|4029780|FG000|PK Part|8 weeks of treatment ran out|2
2317655|NCT02901431|4029781|FG001|PK Part|8 weeks of treatment ran out|0
2317656|NCT02901431|4029782|FG002|PK Part|8 weeks of treatment ran out|0
2317657|NCT02901431|4029783|FG003|PK Part|8 weeks of treatment ran out|0
2317658|NCT02901431|4029784|FG004|PK Part|8 weeks of treatment ran out|0
2317659|NCT02901431|4029785|FG005|PK Part|8 weeks of treatment ran out|0
2215274|NCT01693562|3858011|FG002|Expansion Phase|Withdrawal by Subject|0
2215275|NCT01693562|3858012|FG003|Expansion Phase|Withdrawal by Subject|0
2215276|NCT01693562|3858013|FG004|Expansion Phase|Withdrawal by Subject|0
2215277|NCT01693562|3858014|FG005|Expansion Phase|Withdrawal by Subject|0
2215278|NCT01693562|3858015|FG006|Expansion Phase|Withdrawal by Subject|0
2215279|NCT01693562|3858016|FG007|Expansion Phase|Withdrawal by Subject|16
2215280|NCT01693562|3858017|FG008|Expansion Phase|Withdrawal by Subject|2
2215281|NCT01693562|3858018|FG009|Expansion Phase|Withdrawal by Subject|54
2215282|NCT01693562|3858019|FG010|Expansion Phase|Withdrawal by Subject|2
2215283|NCT01693562|3858020|FG011|Expansion Phase|Withdrawal by Subject|2
2317660|NCT02901431|4029786|FG006|PK Part|8 weeks of treatment ran out|0
2317661|NCT02901431|4029787|FG007|PK Part|8 weeks of treatment ran out|0
2317662|NCT02901431|4029788|FG008|PK Part|8 weeks of treatment ran out|0
2317663|NCT02901431|4029789|FG009|PK Part|8 weeks of treatment ran out|0
2317664|NCT02901431|4029790|FG010|PK Part|8 weeks of treatment ran out|0
2317665|NCT02901431|4029791|FG011|PK Part|8 weeks of treatment ran out|0
2317666|NCT02901431|4029792|FG012|PK Part|8 weeks of treatment ran out|0
2317667|NCT02901431|4029780|FG000|PK Part|Stopped treatment after 8 weeks|1
2317668|NCT02901431|4029781|FG001|PK Part|Stopped treatment after 8 weeks|0
2317669|NCT02901431|4029782|FG002|PK Part|Stopped treatment after 8 weeks|1
2317670|NCT02901431|4029783|FG003|PK Part|Stopped treatment after 8 weeks|0
2317671|NCT02901431|4029784|FG004|PK Part|Stopped treatment after 8 weeks|0
2215284|NCT01693562|3858021|FG012|Expansion Phase|Withdrawal by Subject|3
2215285|NCT01693562|3858022|FG013|Expansion Phase|Withdrawal by Subject|5
2215286|NCT01693562|3858023|FG014|Expansion Phase|Withdrawal by Subject|16
2317672|NCT02901431|4029785|FG005|PK Part|Stopped treatment after 8 weeks|0
2317673|NCT02901431|4029786|FG006|PK Part|Stopped treatment after 8 weeks|0
2317674|NCT02901431|4029787|FG007|PK Part|Stopped treatment after 8 weeks|0
2317675|NCT02901431|4029788|FG008|PK Part|Stopped treatment after 8 weeks|0
2317676|NCT02901431|4029789|FG009|PK Part|Stopped treatment after 8 weeks|0
2317677|NCT02901431|4029790|FG010|PK Part|Stopped treatment after 8 weeks|0
2317678|NCT02901431|4029791|FG011|PK Part|Stopped treatment after 8 weeks|0
2317679|NCT02901431|4029792|FG012|PK Part|Stopped treatment after 8 weeks|0
2317680|NCT02901431|4029780|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1
2317681|NCT02901431|4029781|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
2317682|NCT02901431|4029782|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4
2317683|NCT02901431|4029783|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
2317684|NCT02901431|4029784|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
2215287|NCT01693562|3858024|FG015|Expansion Phase|Withdrawal by Subject|7
2215288|NCT01693562|3858025|FG016|Expansion Phase|Withdrawal by Subject|40
2215289|NCT01693562|3858026|FG017|Expansion Phase|Withdrawal by Subject|4
2215290|NCT01693562|3858027|FG018|Expansion Phase|Withdrawal by Subject|8
2215291|NCT01693562|3858028|FG019|Expansion Phase|Withdrawal by Subject|3
2215292|NCT01693562|3858029|FG020|Expansion Phase|Withdrawal by Subject|1
2215293|NCT01693562|3858030|FG021|Expansion Phase|Withdrawal by Subject|8
2215294|NCT01693562|3858031|FG022|Expansion Phase|Withdrawal by Subject|1
2215295|NCT01693562|3858009|FG000|Expansion Phase|Death|0
2215296|NCT01693562|3858010|FG001|Expansion Phase|Death|0
2215297|NCT01693562|3858011|FG002|Expansion Phase|Death|0
2215298|NCT01693562|3858012|FG003|Expansion Phase|Death|0
2215299|NCT01693562|3858013|FG004|Expansion Phase|Death|0
2215300|NCT01693562|3858014|FG005|Expansion Phase|Death|0
2215301|NCT01693562|3858015|FG006|Expansion Phase|Death|0
2215302|NCT01693562|3858016|FG007|Expansion Phase|Death|42
2215303|NCT01693562|3858017|FG008|Expansion Phase|Death|17
2215304|NCT01693562|3858018|FG009|Expansion Phase|Death|208
2215305|NCT01693562|3858019|FG010|Expansion Phase|Death|30
2215306|NCT01693562|3858020|FG011|Expansion Phase|Death|8
2215307|NCT01693562|3858021|FG012|Expansion Phase|Death|19
2215308|NCT01693562|3858022|FG013|Expansion Phase|Death|42
2215309|NCT01693562|3858023|FG014|Expansion Phase|Death|23
2215310|NCT01693562|3858024|FG015|Expansion Phase|Death|23
2215311|NCT01693562|3858025|FG016|Expansion Phase|Death|128
2215312|NCT01693562|3858026|FG017|Expansion Phase|Death|16
2215313|NCT01693562|3858027|FG018|Expansion Phase|Death|36
2215314|NCT01693562|3858028|FG019|Expansion Phase|Death|16
2215315|NCT01693562|3858029|FG020|Expansion Phase|Death|17
2215316|NCT01693562|3858030|FG021|Expansion Phase|Death|35
2215317|NCT01693562|3858031|FG022|Expansion Phase|Death|7
2215318|NCT01693562|3858009|FG000|Expansion Phase|Lost to Follow-up|0
2215319|NCT01693562|3858010|FG001|Expansion Phase|Lost to Follow-up|0
2215320|NCT01693562|3858011|FG002|Expansion Phase|Lost to Follow-up|0
2215321|NCT01693562|3858012|FG003|Expansion Phase|Lost to Follow-up|0
2215322|NCT01693562|3858013|FG004|Expansion Phase|Lost to Follow-up|0
2215323|NCT01693562|3858014|FG005|Expansion Phase|Lost to Follow-up|0
2215324|NCT01693562|3858015|FG006|Expansion Phase|Lost to Follow-up|0
2215325|NCT01693562|3858016|FG007|Expansion Phase|Lost to Follow-up|1
2215326|NCT01693562|3858017|FG008|Expansion Phase|Lost to Follow-up|2
2215327|NCT01693562|3858018|FG009|Expansion Phase|Lost to Follow-up|10
2215328|NCT01693562|3858019|FG010|Expansion Phase|Lost to Follow-up|4
2215329|NCT01693562|3858020|FG011|Expansion Phase|Lost to Follow-up|4
2215330|NCT01693562|3858021|FG012|Expansion Phase|Lost to Follow-up|1
2215331|NCT01693562|3858022|FG013|Expansion Phase|Lost to Follow-up|3
2215332|NCT01693562|3858023|FG014|Expansion Phase|Lost to Follow-up|0
2215333|NCT01693562|3858024|FG015|Expansion Phase|Lost to Follow-up|1
2215334|NCT01693562|3858025|FG016|Expansion Phase|Lost to Follow-up|1
2215335|NCT01693562|3858026|FG017|Expansion Phase|Lost to Follow-up|0
2215336|NCT01693562|3858027|FG018|Expansion Phase|Lost to Follow-up|2
2215337|NCT01693562|3858028|FG019|Expansion Phase|Lost to Follow-up|1
2104699|NCT00853151|3697062|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2104700|NCT00853151|3697063|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2104701|NCT00853151|3697064|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2104702|NCT00853151|3697061|FG000|Overall Study|Lost to Follow-up|2
2215338|NCT01693562|3858029|FG020|Expansion Phase|Lost to Follow-up|2
2215339|NCT01693562|3858030|FG021|Expansion Phase|Lost to Follow-up|2
2215340|NCT01693562|3858031|FG022|Expansion Phase|Lost to Follow-up|1
2215341|NCT01693562|3858009|FG000|Expansion Phase|Other|0
2215342|NCT01693562|3858010|FG001|Expansion Phase|Other|0
2215343|NCT01693562|3858011|FG002|Expansion Phase|Other|0
2215344|NCT01693562|3858012|FG003|Expansion Phase|Other|0
2215345|NCT01693562|3858013|FG004|Expansion Phase|Other|0
2215346|NCT01693562|3858014|FG005|Expansion Phase|Other|0
2215347|NCT01693562|3858015|FG006|Expansion Phase|Other|0
2215348|NCT01693562|3858016|FG007|Expansion Phase|Other|3
2215349|NCT01693562|3858017|FG008|Expansion Phase|Other|1
2215350|NCT01693562|3858018|FG009|Expansion Phase|Other|28
2215351|NCT01693562|3858019|FG010|Expansion Phase|Other|4
2215352|NCT01693562|3858020|FG011|Expansion Phase|Other|7
2215353|NCT01693562|3858021|FG012|Expansion Phase|Other|0
2317685|NCT02901431|4029785|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
2317686|NCT02901431|4029786|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
2317687|NCT02901431|4029787|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
2317688|NCT02901431|4029788|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
2317689|NCT02901431|4029789|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
2317690|NCT02901431|4029790|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
2317691|NCT02901431|4029791|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
2317692|NCT02901431|4029792|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
2317693|NCT02901431|4029780|FG000|PK Part|Discontinued per Sponsor|0
2317694|NCT02901431|4029781|FG001|PK Part|Discontinued per Sponsor|3
2317695|NCT02901431|4029782|FG002|PK Part|Discontinued per Sponsor|0
2317696|NCT02901431|4029783|FG003|PK Part|Discontinued per Sponsor|0
2317697|NCT02901431|4029784|FG004|PK Part|Discontinued per Sponsor|0
2317698|NCT02901431|4029785|FG005|PK Part|Discontinued per Sponsor|0
2317699|NCT02901431|4029786|FG006|PK Part|Discontinued per Sponsor|0
2317700|NCT02901431|4029787|FG007|PK Part|Discontinued per Sponsor|0
2317701|NCT02901431|4029788|FG008|PK Part|Discontinued per Sponsor|0
2317702|NCT02901431|4029789|FG009|PK Part|Discontinued per Sponsor|0
2317703|NCT02901431|4029790|FG010|PK Part|Discontinued per Sponsor|0
2317704|NCT02901431|4029791|FG011|PK Part|Discontinued per Sponsor|0
2317705|NCT02901431|4029792|FG012|PK Part|Discontinued per Sponsor|0
2317706|NCT02901431|4029780|FG000|PK Part|Withdrawal by Subject|1
2317707|NCT02901431|4029781|FG001|PK Part|Withdrawal by Subject|1
2215354|NCT01693562|3858022|FG013|Expansion Phase|Other|1
2215355|NCT01693562|3858023|FG014|Expansion Phase|Other|1
2215356|NCT01693562|3858024|FG015|Expansion Phase|Other|0
2215357|NCT01693562|3858025|FG016|Expansion Phase|Other|28
2215358|NCT01693562|3858026|FG017|Expansion Phase|Other|0
2215359|NCT01693562|3858027|FG018|Expansion Phase|Other|1
2215360|NCT01693562|3858028|FG019|Expansion Phase|Other|0
2215361|NCT01693562|3858029|FG020|Expansion Phase|Other|1
2215362|NCT01693562|3858030|FG021|Expansion Phase|Other|17
2215363|NCT01693562|3858031|FG022|Expansion Phase|Other|1
2215364|NCT01693614|3858117|FG000|Overall Study|Adverse Event|7
2215365|NCT01693614|3858118|FG001|Overall Study|Adverse Event|11
2215366|NCT01693614|3858119|FG002|Overall Study|Adverse Event|5
2215367|NCT01693614|3858117|FG000|Overall Study|Disease progression|11
2215368|NCT01693614|3858118|FG001|Overall Study|Disease progression|8
2215369|NCT01693614|3858119|FG002|Overall Study|Disease progression|7
2215370|NCT01693614|3858117|FG000|Overall Study|Protocol Violation|5
2215371|NCT01693614|3858118|FG001|Overall Study|Protocol Violation|2
2215372|NCT01693614|3858119|FG002|Overall Study|Protocol Violation|1
2215373|NCT01693614|3858117|FG000|Overall Study|Death|1
2215374|NCT01693614|3858118|FG001|Overall Study|Death|0
2215375|NCT01693614|3858119|FG002|Overall Study|Death|0
2215376|NCT01693614|3858117|FG000|Overall Study|Physician Decision|1
2215377|NCT01693614|3858118|FG001|Overall Study|Physician Decision|1
2215378|NCT01693614|3858119|FG002|Overall Study|Physician Decision|4
2215379|NCT01693614|3858117|FG000|Overall Study|Withdrawal by subject/guardian|0
2215380|NCT01693614|3858118|FG001|Overall Study|Withdrawal by subject/guardian|0
2215381|NCT01693614|3858119|FG002|Overall Study|Withdrawal by subject/guardian|2
2215382|NCT01693614|3858117|FG000|Overall Study|Withdrawal by Subject|1
2215383|NCT01693614|3858118|FG001|Overall Study|Withdrawal by Subject|0
2215384|NCT01693614|3858119|FG002|Overall Study|Withdrawal by Subject|5
2215385|NCT01694121|3858155|FG000|Overall Study|Participant used false ID, was withdrawn|1
2215386|NCT01694121|3858156|FG001|Overall Study|Participant used false ID, was withdrawn|0
2215387|NCT01694420|3858180|FG000|Overall Study|Lost to Follow-up|3
2215388|NCT01694433|3858186|FG000|Overall Study|Adverse Event|7
2215389|NCT01694433|3858187|FG001|Overall Study|Adverse Event|0
2215390|NCT01694433|3858186|FG000|Overall Study|Physician Decision|1
2215391|NCT01694433|3858187|FG001|Overall Study|Physician Decision|0
2215392|NCT01694433|3858186|FG000|Overall Study|Withdrawal by Subject|3
2215393|NCT01694433|3858187|FG001|Overall Study|Withdrawal by Subject|4
2215394|NCT01694485|3858198|FG000|Overall Study|Withdrawal by Subject|20
2215395|NCT01694485|3858199|FG001|Overall Study|Withdrawal by Subject|6
2215396|NCT01694485|3858200|FG002|Overall Study|Withdrawal by Subject|7
2215397|NCT01694485|3858201|FG003|Overall Study|Withdrawal by Subject|25
2215398|NCT01694485|3858202|FG004|Overall Study|Withdrawal by Subject|18
2215399|NCT01694485|3858198|FG000|Overall Study|Sponsor Decision|3
2215400|NCT01694485|3858199|FG001|Overall Study|Sponsor Decision|0
2215401|NCT01694485|3858200|FG002|Overall Study|Sponsor Decision|0
2215402|NCT01694485|3858201|FG003|Overall Study|Sponsor Decision|2
2215403|NCT01694485|3858202|FG004|Overall Study|Sponsor Decision|0
2215404|NCT01694485|3858198|FG000|Overall Study|Lost to Follow-up|9
2215405|NCT01694485|3858199|FG001|Overall Study|Lost to Follow-up|1
2215406|NCT01694485|3858200|FG002|Overall Study|Lost to Follow-up|6
2215407|NCT01694485|3858201|FG003|Overall Study|Lost to Follow-up|10
2215408|NCT01694485|3858202|FG004|Overall Study|Lost to Follow-up|7
2215409|NCT01694485|3858198|FG000|Overall Study|Death|1
2215410|NCT01694485|3858199|FG001|Overall Study|Death|0
2215411|NCT01694485|3858200|FG002|Overall Study|Death|0
2215412|NCT01694485|3858201|FG003|Overall Study|Death|1
2215413|NCT01694485|3858202|FG004|Overall Study|Death|0
2215414|NCT01694706|3858245|FG000|Overall Study|Adverse Event|0
2215415|NCT01694706|3858246|FG001|Overall Study|Adverse Event|1
2215416|NCT01694706|3858247|FG002|Overall Study|Adverse Event|0
2215417|NCT01694706|3858245|FG000|Overall Study|other reason not defined above|1
2215418|NCT01694706|3858246|FG001|Overall Study|other reason not defined above|0
2215419|NCT01694706|3858247|FG002|Overall Study|other reason not defined above|0
2215420|NCT01694771|3858258|FG000|Overall Study|Adverse Event|18
2215421|NCT01694771|3858259|FG001|Overall Study|Adverse Event|16
2215422|NCT01694771|3858258|FG000|Overall Study|Lack of Efficacy|1
2215423|NCT01694771|3858259|FG001|Overall Study|Lack of Efficacy|0
2215424|NCT01694771|3858258|FG000|Overall Study|Non compliance protocol|7
2215425|NCT01694771|3858259|FG001|Overall Study|Non compliance protocol|6
2317708|NCT02901431|4029782|FG002|PK Part|Withdrawal by Subject|3
2317709|NCT02901431|4029783|FG003|PK Part|Withdrawal by Subject|0
2317710|NCT02901431|4029784|FG004|PK Part|Withdrawal by Subject|0
2317711|NCT02901431|4029785|FG005|PK Part|Withdrawal by Subject|0
2317712|NCT02901431|4029786|FG006|PK Part|Withdrawal by Subject|0
2317713|NCT02901431|4029787|FG007|PK Part|Withdrawal by Subject|0
2317714|NCT02901431|4029788|FG008|PK Part|Withdrawal by Subject|0
2317715|NCT02901431|4029789|FG009|PK Part|Withdrawal by Subject|0
2317716|NCT02901431|4029790|FG010|PK Part|Withdrawal by Subject|0
2317717|NCT02901431|4029791|FG011|PK Part|Withdrawal by Subject|0
2317718|NCT02901431|4029792|FG012|PK Part|Withdrawal by Subject|0
2317719|NCT02901431|4029780|FG000|Main Treatment Part|Adverse Event|0
2317720|NCT02901431|4029781|FG001|Main Treatment Part|Adverse Event|0
2317721|NCT02901431|4029782|FG002|Main Treatment Part|Adverse Event|0
2215426|NCT01694771|3858258|FG000|Overall Study|Lost to Follow-up|2
2317722|NCT02901431|4029783|FG003|Main Treatment Part|Adverse Event|3
2317723|NCT02901431|4029784|FG004|Main Treatment Part|Adverse Event|3
2317724|NCT02901431|4029785|FG005|Main Treatment Part|Adverse Event|4
2317725|NCT02901431|4029786|FG006|Main Treatment Part|Adverse Event|1
2215427|NCT01694771|3858259|FG001|Overall Study|Lost to Follow-up|3
2215428|NCT01694771|3858258|FG000|Overall Study|Consent withdrawn|7
2215429|NCT01694771|3858259|FG001|Overall Study|Consent withdrawn|9
2215430|NCT01694771|3858258|FG000|Overall Study|Other reasons|5
2215431|NCT01694771|3858259|FG001|Overall Study|Other reasons|6
2215432|NCT01695135|3858290|FG000|Double-blind Treatment Phase|Progressive disease|50
2215433|NCT01695135|3858291|FG001|Double-blind Treatment Phase|Progressive disease|110
2215434|NCT01695135|3858292|FG002|Double-blind Treatment Phase|Progressive disease|0
2317726|NCT02901431|4029787|FG007|Main Treatment Part|Adverse Event|0
2317727|NCT02901431|4029788|FG008|Main Treatment Part|Adverse Event|0
2215435|NCT01695135|3858293|FG003|Double-blind Treatment Phase|Progressive disease|0
2215436|NCT01695135|3858290|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6
2215437|NCT01695135|3858291|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14
2215438|NCT01695135|3858292|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
2317728|NCT02901431|4029789|FG009|Main Treatment Part|Adverse Event|0
2317729|NCT02901431|4029790|FG010|Main Treatment Part|Adverse Event|0
2317730|NCT02901431|4029791|FG011|Main Treatment Part|Adverse Event|0
2317731|NCT02901431|4029792|FG012|Main Treatment Part|Adverse Event|0
2317732|NCT02901431|4029780|FG000|Main Treatment Part|Lack of Efficacy|0
2317733|NCT02901431|4029781|FG001|Main Treatment Part|Lack of Efficacy|0
2317734|NCT02901431|4029782|FG002|Main Treatment Part|Lack of Efficacy|0
2317735|NCT02901431|4029783|FG003|Main Treatment Part|Lack of Efficacy|1
2317736|NCT02901431|4029784|FG004|Main Treatment Part|Lack of Efficacy|0
2317737|NCT02901431|4029785|FG005|Main Treatment Part|Lack of Efficacy|0
2217574|NCT01709110|3860891|FG001|Overall Study|Death|6
2104703|NCT00853151|3697062|FG001|Overall Study|Lost to Follow-up|0
2104704|NCT00853151|3697063|FG002|Overall Study|Lost to Follow-up|3
2104705|NCT00853151|3697064|FG003|Overall Study|Lost to Follow-up|0
2104706|NCT00853151|3697061|FG000|Overall Study|Death|1
2104707|NCT00853151|3697062|FG001|Overall Study|Death|0
2104708|NCT00853151|3697063|FG002|Overall Study|Death|0
2104709|NCT00853151|3697064|FG003|Overall Study|Death|1
2104710|NCT00853151|3697061|FG000|Overall Study|Protocol Violation|0
2104711|NCT00853151|3697062|FG001|Overall Study|Protocol Violation|0
2104712|NCT00853151|3697063|FG002|Overall Study|Protocol Violation|0
2104713|NCT00853151|3697064|FG003|Overall Study|Protocol Violation|1
2104714|NCT00853151|3697061|FG000|Overall Study|Withdrawal by Subject|5
2317738|NCT02901431|4029786|FG006|Main Treatment Part|Lack of Efficacy|0
2317739|NCT02901431|4029787|FG007|Main Treatment Part|Lack of Efficacy|0
2104715|NCT00853151|3697062|FG001|Overall Study|Withdrawal by Subject|4
2104716|NCT00853151|3697063|FG002|Overall Study|Withdrawal by Subject|2
2104717|NCT00853151|3697064|FG003|Overall Study|Withdrawal by Subject|1
2104718|NCT00853151|3697061|FG000|Overall Study|Physician Decision|0
2104719|NCT00853151|3697062|FG001|Overall Study|Physician Decision|2
2104720|NCT00853151|3697063|FG002|Overall Study|Physician Decision|1
2104721|NCT00853151|3697064|FG003|Overall Study|Physician Decision|0
2104722|NCT00853151|3697061|FG000|Overall Study|Sponsor Decision|0
2104723|NCT00853151|3697062|FG001|Overall Study|Sponsor Decision|3
2104724|NCT00853151|3697063|FG002|Overall Study|Sponsor Decision|0
2104725|NCT00853151|3697064|FG003|Overall Study|Sponsor Decision|0
2104726|NCT00853242|3697084|FG000|Overall Study|Adverse Event|0
2104727|NCT00853242|3697085|FG001|Overall Study|Adverse Event|1
2104728|NCT00853242|3697086|FG002|Overall Study|Adverse Event|1
2104729|NCT00853242|3697087|FG003|Overall Study|Adverse Event|0
2104730|NCT00853242|3697088|FG004|Overall Study|Adverse Event|3
2104731|NCT00853242|3697089|FG005|Overall Study|Adverse Event|1
2104732|NCT00853242|3697090|FG006|Overall Study|Adverse Event|1
2104733|NCT00853242|3697084|FG000|Overall Study|Noncompliant|0
2104734|NCT00853242|3697085|FG001|Overall Study|Noncompliant|0
2104735|NCT00853242|3697086|FG002|Overall Study|Noncompliant|0
2104736|NCT00853242|3697087|FG003|Overall Study|Noncompliant|0
2104737|NCT00853242|3697088|FG004|Overall Study|Noncompliant|1
2104738|NCT00853242|3697089|FG005|Overall Study|Noncompliant|0
2104739|NCT00853242|3697090|FG006|Overall Study|Noncompliant|0
2104740|NCT00853242|3697084|FG000|Overall Study|Withdrawal by Subject|1
2104741|NCT00853242|3697085|FG001|Overall Study|Withdrawal by Subject|2
2104742|NCT00853242|3697086|FG002|Overall Study|Withdrawal by Subject|0
2104743|NCT00853242|3697087|FG003|Overall Study|Withdrawal by Subject|4
2104744|NCT00853242|3697088|FG004|Overall Study|Withdrawal by Subject|0
2104745|NCT00853242|3697089|FG005|Overall Study|Withdrawal by Subject|0
2104746|NCT00853242|3697090|FG006|Overall Study|Withdrawal by Subject|2
2104747|NCT00853242|3697084|FG000|Overall Study|Other|2
2317740|NCT02901431|4029788|FG008|Main Treatment Part|Lack of Efficacy|0
2317741|NCT02901431|4029789|FG009|Main Treatment Part|Lack of Efficacy|0
2317742|NCT02901431|4029790|FG010|Main Treatment Part|Lack of Efficacy|0
2317743|NCT02901431|4029791|FG011|Main Treatment Part|Lack of Efficacy|0
2317744|NCT02901431|4029792|FG012|Main Treatment Part|Lack of Efficacy|0
2317745|NCT02901431|4029780|FG000|Main Treatment Part|Lost to Follow-up|0
2317746|NCT02901431|4029781|FG001|Main Treatment Part|Lost to Follow-up|0
2317747|NCT02901431|4029782|FG002|Main Treatment Part|Lost to Follow-up|0
2317748|NCT02901431|4029783|FG003|Main Treatment Part|Lost to Follow-up|3
2317749|NCT02901431|4029784|FG004|Main Treatment Part|Lost to Follow-up|1
2317750|NCT02901431|4029785|FG005|Main Treatment Part|Lost to Follow-up|2
2317751|NCT02901431|4029786|FG006|Main Treatment Part|Lost to Follow-up|3
2317752|NCT02901431|4029787|FG007|Main Treatment Part|Lost to Follow-up|0
2317753|NCT02901431|4029788|FG008|Main Treatment Part|Lost to Follow-up|0
2317754|NCT02901431|4029789|FG009|Main Treatment Part|Lost to Follow-up|0
2104748|NCT00853242|3697085|FG001|Overall Study|Other|0
2104749|NCT00853242|3697086|FG002|Overall Study|Other|2
2104750|NCT00853242|3697087|FG003|Overall Study|Other|0
2104751|NCT00853242|3697088|FG004|Overall Study|Other|0
2104752|NCT00853242|3697089|FG005|Overall Study|Other|1
2104753|NCT00853242|3697090|FG006|Overall Study|Other|2
2104754|NCT00853307|3697114|FG000|Overall Study|Adverse Event|1
2104755|NCT00853307|3697115|FG001|Overall Study|Adverse Event|2
2104756|NCT00853307|3697114|FG000|Overall Study|Withdrawal by Subject|1
2104757|NCT00853307|3697115|FG001|Overall Study|Withdrawal by Subject|2
2104758|NCT00853307|3697114|FG000|Overall Study|Reason Not Specified|0
2104759|NCT00853307|3697115|FG001|Overall Study|Reason Not Specified|1
2104760|NCT00853372|3697136|FG000|Overall Study|Death|30
2104761|NCT00853372|3697137|FG001|Overall Study|Death|26
2104762|NCT00853372|3697136|FG000|Overall Study|Lost to Follow-up|1
2104763|NCT00853372|3697137|FG001|Overall Study|Lost to Follow-up|2
2104764|NCT00853372|3697136|FG000|Overall Study|Full Consent Withdrawn|1
2104765|NCT00853372|3697137|FG001|Overall Study|Full Consent Withdrawn|1
2104766|NCT00853385|3697148|FG000|Overall Study|Death|0
2104767|NCT00853385|3697149|FG001|Overall Study|Death|0
2104768|NCT00853385|3697150|FG002|Overall Study|Death|0
2104769|NCT00853385|3697151|FG003|Overall Study|Death|0
2104770|NCT00853385|3697152|FG004|Overall Study|Death|1
2104771|NCT00853385|3697148|FG000|Overall Study|Adverse Event|24
2104772|NCT00853385|3697149|FG001|Overall Study|Adverse Event|24
2104773|NCT00853385|3697150|FG002|Overall Study|Adverse Event|2
2104774|NCT00853385|3697151|FG003|Overall Study|Adverse Event|5
2104775|NCT00853385|3697152|FG004|Overall Study|Adverse Event|22
2104776|NCT00853385|3697148|FG000|Overall Study|Lack of Efficacy|6
2104777|NCT00853385|3697149|FG001|Overall Study|Lack of Efficacy|7
2104778|NCT00853385|3697150|FG002|Overall Study|Lack of Efficacy|3
2104779|NCT00853385|3697151|FG003|Overall Study|Lack of Efficacy|3
2104780|NCT00853385|3697152|FG004|Overall Study|Lack of Efficacy|6
2104781|NCT00853385|3697148|FG000|Overall Study|Lost to Follow-up|2
2104782|NCT00853385|3697149|FG001|Overall Study|Lost to Follow-up|1
2104783|NCT00853385|3697150|FG002|Overall Study|Lost to Follow-up|0
2104784|NCT00853385|3697151|FG003|Overall Study|Lost to Follow-up|0
2104785|NCT00853385|3697152|FG004|Overall Study|Lost to Follow-up|0
2104786|NCT00853385|3697148|FG000|Overall Study|Withdrawal by Subject|4
2104787|NCT00853385|3697149|FG001|Overall Study|Withdrawal by Subject|2
2104788|NCT00853385|3697150|FG002|Overall Study|Withdrawal by Subject|0
2104789|NCT00853385|3697151|FG003|Overall Study|Withdrawal by Subject|1
2104790|NCT00853385|3697152|FG004|Overall Study|Withdrawal by Subject|1
2104791|NCT00853385|3697148|FG000|Overall Study|Other|18
2104792|NCT00853385|3697149|FG001|Overall Study|Other|9
2104793|NCT00853385|3697150|FG002|Overall Study|Other|4
2104794|NCT00853385|3697151|FG003|Overall Study|Other|4
2104795|NCT00853385|3697152|FG004|Overall Study|Other|12
2104796|NCT00853489|3697176|FG000|Overall Study|Lost to Follow-up|5
2104797|NCT00853489|3697177|FG001|Overall Study|Lost to Follow-up|2
2104798|NCT00853580|3697185|FG000|Overall Study|Lost to Follow-up|3
2104799|NCT00853580|3697186|FG001|Overall Study|Lost to Follow-up|5
2104800|NCT00853580|3697185|FG000|Overall Study|Protocol Violation|2
2104801|NCT00853580|3697186|FG001|Overall Study|Protocol Violation|1
2104802|NCT00853580|3697185|FG000|Overall Study|Withdrawal by Subject|2
2104803|NCT00853580|3697186|FG001|Overall Study|Withdrawal by Subject|8
2215439|NCT01695135|3858293|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0
2215440|NCT01695135|3858290|FG000|Double-blind Treatment Phase|Adverse Event|7
2215441|NCT01695135|3858291|FG001|Double-blind Treatment Phase|Adverse Event|7
2215442|NCT01695135|3858292|FG002|Double-blind Treatment Phase|Adverse Event|0
2215443|NCT01695135|3858293|FG003|Double-blind Treatment Phase|Adverse Event|0
2215444|NCT01695135|3858290|FG000|Double-blind Treatment Phase|Other|1
2215445|NCT01695135|3858291|FG001|Double-blind Treatment Phase|Other|3
2215446|NCT01695135|3858292|FG002|Double-blind Treatment Phase|Other|0
2215447|NCT01695135|3858293|FG003|Double-blind Treatment Phase|Other|0
2215448|NCT01695135|3858290|FG000|Double-blind Treatment Phase|Physician Decision|6
2215449|NCT01695135|3858291|FG001|Double-blind Treatment Phase|Physician Decision|3
2215450|NCT01695135|3858292|FG002|Double-blind Treatment Phase|Physician Decision|0
2215451|NCT01695135|3858293|FG003|Double-blind Treatment Phase|Physician Decision|0
2317755|NCT02901431|4029790|FG010|Main Treatment Part|Lost to Follow-up|0
2317756|NCT02901431|4029791|FG011|Main Treatment Part|Lost to Follow-up|0
2317757|NCT02901431|4029792|FG012|Main Treatment Part|Lost to Follow-up|0
2104804|NCT00853580|3697185|FG000|Overall Study|Commenced contraindicated therapy|0
2104805|NCT00853580|3697186|FG001|Overall Study|Commenced contraindicated therapy|2
2104806|NCT00853593|3697192|FG000|Overall Study|Subjects did not receive a 4396 lead|12
2104807|NCT00853593|3697192|FG000|Overall Study|Model 4396 lead not attempted|29
2104808|NCT00853593|3697192|FG000|Overall Study|Implant not attempted|4
2104809|NCT00853658|3697224|FG000|Overall Study|Death|713
2104810|NCT00853658|3697225|FG001|Overall Study|Death|768
2104811|NCT00853658|3697226|FG002|Overall Study|Death|753
2317758|NCT02901431|4029780|FG000|Main Treatment Part|Withdrawal by Caregiver|0
2317759|NCT02901431|4029781|FG001|Main Treatment Part|Withdrawal by Caregiver|0
2317760|NCT02901431|4029782|FG002|Main Treatment Part|Withdrawal by Caregiver|0
2322231|NCT02969525|4037114|FG000|Dose-Blind Period|Withdrawal by Subject|0
2104812|NCT00853658|3697224|FG000|Overall Study|Lost to Follow-up|11
2104813|NCT00853658|3697225|FG001|Overall Study|Lost to Follow-up|6
2104814|NCT00853658|3697226|FG002|Overall Study|Lost to Follow-up|11
2104815|NCT00853658|3697224|FG000|Overall Study|H.A. Request|26
2104816|NCT00853658|3697225|FG001|Overall Study|H.A. Request|23
2104817|NCT00853658|3697226|FG002|Overall Study|H.A. Request|19
2215452|NCT01695135|3858290|FG000|Double-blind Treatment Phase|Death|1
2104818|NCT00853658|3697224|FG000|Overall Study|IRB request|0
2104819|NCT00853658|3697225|FG001|Overall Study|IRB request|0
2104820|NCT00853658|3697226|FG002|Overall Study|IRB request|2
2104821|NCT00853658|3697224|FG000|Overall Study|Vital Status known (alive) at study end|2
2104822|NCT00853658|3697225|FG001|Overall Study|Vital Status known (alive) at study end|3
2104823|NCT00853658|3697226|FG002|Overall Study|Vital Status known (alive) at study end|3
2104824|NCT00853658|3697224|FG000|Overall Study|Vital Status unknown at study end|1
2104825|NCT00853658|3697225|FG001|Overall Study|Vital Status unknown at study end|1
2215453|NCT01695135|3858291|FG001|Double-blind Treatment Phase|Death|1
2215454|NCT01695135|3858292|FG002|Double-blind Treatment Phase|Death|0
2215455|NCT01695135|3858293|FG003|Double-blind Treatment Phase|Death|0
2104826|NCT00853658|3697226|FG002|Overall Study|Vital Status unknown at study end|0
2104827|NCT00853658|3697224|FG000|Overall Study|Vital Status at study end N/A|8
2104828|NCT00853658|3697225|FG001|Overall Study|Vital Status at study end N/A|10
2104829|NCT00853658|3697226|FG002|Overall Study|Vital Status at study end N/A|10
2104830|NCT00853658|3697224|FG000|Overall Study|Patient's request|21
2104831|NCT00853658|3697225|FG001|Overall Study|Patient's request|17
2104832|NCT00853658|3697226|FG002|Overall Study|Patient's request|11
2104833|NCT00853658|3697224|FG000|Overall Study|Missing study completion information|5
2104834|NCT00853658|3697225|FG001|Overall Study|Missing study completion information|4
2104835|NCT00853658|3697226|FG002|Overall Study|Missing study completion information|6
2104836|NCT00853723|3697241|FG000|Overall Study|Adverse Event|3
2104837|NCT00853723|3697242|FG001|Overall Study|Adverse Event|4
2104838|NCT00853723|3697243|FG002|Overall Study|Adverse Event|1
2104839|NCT00853723|3697241|FG000|Overall Study|Withdrawal by Subject|2
2104840|NCT00853723|3697242|FG001|Overall Study|Withdrawal by Subject|1
2104841|NCT00853723|3697243|FG002|Overall Study|Withdrawal by Subject|0
2104842|NCT00853723|3697241|FG000|Overall Study|Protocol Violation|1
2104843|NCT00853723|3697242|FG001|Overall Study|Protocol Violation|2
2104844|NCT00853723|3697243|FG002|Overall Study|Protocol Violation|1
2104845|NCT00853749|3697256|FG000|Overall Study|Lost to Follow-up|0
2104846|NCT00853749|3697257|FG001|Overall Study|Lost to Follow-up|1
2104847|NCT00853762|3697267|FG000|Overall Study|Premature Termination|16
2104848|NCT00853762|3697268|FG001|Overall Study|Premature Termination|15
2104849|NCT00853762|3697269|FG002|Overall Study|Premature Termination|14
2104850|NCT00853762|3697270|FG003|Overall Study|Premature Termination|21
2104851|NCT00853762|3697267|FG000|Overall Study|Protocol Violation|0
2104852|NCT00853762|3697268|FG001|Overall Study|Protocol Violation|0
2104853|NCT00853762|3697269|FG002|Overall Study|Protocol Violation|0
2104854|NCT00853762|3697270|FG003|Overall Study|Protocol Violation|1
2104855|NCT00853762|3697267|FG000|Overall Study|Withdrawal by Subject|0
2104856|NCT00853762|3697268|FG001|Overall Study|Withdrawal by Subject|0
2104857|NCT00853762|3697269|FG002|Overall Study|Withdrawal by Subject|1
2104858|NCT00853762|3697270|FG003|Overall Study|Withdrawal by Subject|0
2104859|NCT00853762|3697267|FG000|Overall Study|Other|0
2104860|NCT00853762|3697268|FG001|Overall Study|Other|2
2104861|NCT00853762|3697269|FG002|Overall Study|Other|0
2104862|NCT00853762|3697270|FG003|Overall Study|Other|0
2104863|NCT00853762|3697267|FG000|Overall Study|Randomised but not Treated|0
2104864|NCT00853762|3697268|FG001|Overall Study|Randomised but not Treated|2
2104865|NCT00853762|3697269|FG002|Overall Study|Randomised but not Treated|2
2104866|NCT00853762|3697270|FG003|Overall Study|Randomised but not Treated|0
2104867|NCT00853827|3697282|FG000|Single Blind Period (1 Week)|Other|4
2104868|NCT00853827|3697283|FG001|Single Blind Period (1 Week)|Other|0
2104869|NCT00853827|3697282|FG000|Single Blind Period (1 Week)|Adverse Event|9
2104870|NCT00853827|3697283|FG001|Single Blind Period (1 Week)|Adverse Event|0
2104871|NCT00853827|3697282|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3
2104872|NCT00853827|3697283|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0
2217575|NCT01709110|3860890|FG000|Overall Study|Lost to Follow-up|7
2317761|NCT02901431|4029783|FG003|Main Treatment Part|Withdrawal by Caregiver|0
2317762|NCT02901431|4029784|FG004|Main Treatment Part|Withdrawal by Caregiver|0
2317763|NCT02901431|4029785|FG005|Main Treatment Part|Withdrawal by Caregiver|1
2317764|NCT02901431|4029786|FG006|Main Treatment Part|Withdrawal by Caregiver|0
2317765|NCT02901431|4029787|FG007|Main Treatment Part|Withdrawal by Caregiver|0
2317766|NCT02901431|4029788|FG008|Main Treatment Part|Withdrawal by Caregiver|0
2317767|NCT02901431|4029789|FG009|Main Treatment Part|Withdrawal by Caregiver|0
2317768|NCT02901431|4029790|FG010|Main Treatment Part|Withdrawal by Caregiver|0
2317769|NCT02901431|4029791|FG011|Main Treatment Part|Withdrawal by Caregiver|0
2317770|NCT02901431|4029792|FG012|Main Treatment Part|Withdrawal by Caregiver|0
2215456|NCT01695135|3858290|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0
2215457|NCT01695135|3858291|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1
2215458|NCT01695135|3858292|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0
2215459|NCT01695135|3858293|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0
2215460|NCT01695135|3858290|FG000|Open Label Extension Treatment Phase|Progressive disease|0
2317771|NCT02901431|4029780|FG000|Main Treatment Part|Physician Decision|0
2317772|NCT02901431|4029781|FG001|Main Treatment Part|Physician Decision|0
2317773|NCT02901431|4029782|FG002|Main Treatment Part|Physician Decision|0
2317774|NCT02901431|4029783|FG003|Main Treatment Part|Physician Decision|1
2317775|NCT02901431|4029784|FG004|Main Treatment Part|Physician Decision|0
2317776|NCT02901431|4029785|FG005|Main Treatment Part|Physician Decision|0
2317777|NCT02901431|4029786|FG006|Main Treatment Part|Physician Decision|1
2317778|NCT02901431|4029787|FG007|Main Treatment Part|Physician Decision|0
2317779|NCT02901431|4029788|FG008|Main Treatment Part|Physician Decision|0
2317780|NCT02901431|4029789|FG009|Main Treatment Part|Physician Decision|0
2317781|NCT02901431|4029790|FG010|Main Treatment Part|Physician Decision|0
2317782|NCT02901431|4029791|FG011|Main Treatment Part|Physician Decision|0
2317783|NCT02901431|4029792|FG012|Main Treatment Part|Physician Decision|0
2317784|NCT02901431|4029780|FG000|Main Treatment Part|Withdrawal by Subject|0
2317785|NCT02901431|4029781|FG001|Main Treatment Part|Withdrawal by Subject|0
2317786|NCT02901431|4029782|FG002|Main Treatment Part|Withdrawal by Subject|0
2317787|NCT02901431|4029783|FG003|Main Treatment Part|Withdrawal by Subject|18
2317788|NCT02901431|4029784|FG004|Main Treatment Part|Withdrawal by Subject|3
2317789|NCT02901431|4029785|FG005|Main Treatment Part|Withdrawal by Subject|5
2317790|NCT02901431|4029786|FG006|Main Treatment Part|Withdrawal by Subject|6
2317791|NCT02901431|4029787|FG007|Main Treatment Part|Withdrawal by Subject|0
2317792|NCT02901431|4029788|FG008|Main Treatment Part|Withdrawal by Subject|0
2215461|NCT01695135|3858291|FG001|Open Label Extension Treatment Phase|Progressive disease|0
2215462|NCT01695135|3858292|FG002|Open Label Extension Treatment Phase|Progressive disease|13
2215463|NCT01695135|3858293|FG003|Open Label Extension Treatment Phase|Progressive disease|22
2215464|NCT01695135|3858290|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0
2215465|NCT01695135|3858291|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0
2215466|NCT01695135|3858292|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6
2215467|NCT01695135|3858293|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16
2215468|NCT01695135|3858290|FG000|Open Label Extension Treatment Phase|Adverse Event|0
2215469|NCT01695135|3858291|FG001|Open Label Extension Treatment Phase|Adverse Event|0
2215470|NCT01695135|3858292|FG002|Open Label Extension Treatment Phase|Adverse Event|11
2215471|NCT01695135|3858293|FG003|Open Label Extension Treatment Phase|Adverse Event|16
2215472|NCT01695135|3858290|FG000|Open Label Extension Treatment Phase|Other|0
2215473|NCT01695135|3858291|FG001|Open Label Extension Treatment Phase|Other|0
2215474|NCT01695135|3858292|FG002|Open Label Extension Treatment Phase|Other|4
2215475|NCT01695135|3858293|FG003|Open Label Extension Treatment Phase|Other|7
2317793|NCT02901431|4029789|FG009|Main Treatment Part|Withdrawal by Subject|0
2317794|NCT02901431|4029790|FG010|Main Treatment Part|Withdrawal by Subject|0
2317795|NCT02901431|4029791|FG011|Main Treatment Part|Withdrawal by Subject|0
2317796|NCT02901431|4029792|FG012|Main Treatment Part|Withdrawal by Subject|0
2317797|NCT02901431|4029780|FG000|Open Label Part|Adverse Event|0
2317798|NCT02901431|4029781|FG001|Open Label Part|Adverse Event|0
2317799|NCT02901431|4029782|FG002|Open Label Part|Adverse Event|0
2317800|NCT02901431|4029783|FG003|Open Label Part|Adverse Event|0
2317801|NCT02901431|4029784|FG004|Open Label Part|Adverse Event|0
2317802|NCT02901431|4029785|FG005|Open Label Part|Adverse Event|0
2317803|NCT02901431|4029786|FG006|Open Label Part|Adverse Event|0
2317804|NCT02901431|4029787|FG007|Open Label Part|Adverse Event|0
2317805|NCT02901431|4029788|FG008|Open Label Part|Adverse Event|4
2317806|NCT02901431|4029789|FG009|Open Label Part|Adverse Event|4
2317807|NCT02901431|4029790|FG010|Open Label Part|Adverse Event|0
2317808|NCT02901431|4029791|FG011|Open Label Part|Adverse Event|4
2317809|NCT02901431|4029792|FG012|Open Label Part|Adverse Event|1
2317810|NCT02901431|4029780|FG000|Open Label Part|Lost to Follow-up|0
2317811|NCT02901431|4029781|FG001|Open Label Part|Lost to Follow-up|0
2317812|NCT02901431|4029782|FG002|Open Label Part|Lost to Follow-up|0
2317813|NCT02901431|4029783|FG003|Open Label Part|Lost to Follow-up|0
2317814|NCT02901431|4029784|FG004|Open Label Part|Lost to Follow-up|0
2317815|NCT02901431|4029785|FG005|Open Label Part|Lost to Follow-up|0
2317816|NCT02901431|4029786|FG006|Open Label Part|Lost to Follow-up|0
2215476|NCT01695135|3858290|FG000|Open Label Extension Treatment Phase|Physician Decision|0
2215477|NCT01695135|3858291|FG001|Open Label Extension Treatment Phase|Physician Decision|0
2317817|NCT02901431|4029787|FG007|Open Label Part|Lost to Follow-up|0
2317818|NCT02901431|4029788|FG008|Open Label Part|Lost to Follow-up|2
2317819|NCT02901431|4029789|FG009|Open Label Part|Lost to Follow-up|2
2317820|NCT02901431|4029790|FG010|Open Label Part|Lost to Follow-up|1
2317821|NCT02901431|4029791|FG011|Open Label Part|Lost to Follow-up|1
2317822|NCT02901431|4029792|FG012|Open Label Part|Lost to Follow-up|1
2317823|NCT02901431|4029780|FG000|Open Label Part|Physician Decision|0
2317824|NCT02901431|4029781|FG001|Open Label Part|Physician Decision|0
2317825|NCT02901431|4029782|FG002|Open Label Part|Physician Decision|0
2317826|NCT02901431|4029783|FG003|Open Label Part|Physician Decision|0
2317827|NCT02901431|4029784|FG004|Open Label Part|Physician Decision|0
2317828|NCT02901431|4029785|FG005|Open Label Part|Physician Decision|0
2317829|NCT02901431|4029786|FG006|Open Label Part|Physician Decision|0
2317830|NCT02901431|4029787|FG007|Open Label Part|Physician Decision|0
2317831|NCT02901431|4029788|FG008|Open Label Part|Physician Decision|1
2317832|NCT02901431|4029789|FG009|Open Label Part|Physician Decision|1
2317833|NCT02901431|4029790|FG010|Open Label Part|Physician Decision|0
2317834|NCT02901431|4029791|FG011|Open Label Part|Physician Decision|0
2317835|NCT02901431|4029792|FG012|Open Label Part|Physician Decision|0
2317836|NCT02901431|4029780|FG000|Open Label Part|Study Terminated By Sponsor|0
2317837|NCT02901431|4029781|FG001|Open Label Part|Study Terminated By Sponsor|0
2317838|NCT02901431|4029782|FG002|Open Label Part|Study Terminated By Sponsor|0
2317839|NCT02901431|4029783|FG003|Open Label Part|Study Terminated By Sponsor|0
2317840|NCT02901431|4029784|FG004|Open Label Part|Study Terminated By Sponsor|0
2317841|NCT02901431|4029785|FG005|Open Label Part|Study Terminated By Sponsor|0
2317842|NCT02901431|4029786|FG006|Open Label Part|Study Terminated By Sponsor|0
2317843|NCT02901431|4029787|FG007|Open Label Part|Study Terminated By Sponsor|0
2317844|NCT02901431|4029788|FG008|Open Label Part|Study Terminated By Sponsor|35
2317845|NCT02901431|4029789|FG009|Open Label Part|Study Terminated By Sponsor|12
2317846|NCT02901431|4029790|FG010|Open Label Part|Study Terminated By Sponsor|21
2317847|NCT02901431|4029791|FG011|Open Label Part|Study Terminated By Sponsor|31
2317848|NCT02901431|4029792|FG012|Open Label Part|Study Terminated By Sponsor|0
2317849|NCT02901431|4029780|FG000|Open Label Part|Withdrawal by Subject|0
2317850|NCT02901431|4029781|FG001|Open Label Part|Withdrawal by Subject|0
2317851|NCT02901431|4029782|FG002|Open Label Part|Withdrawal by Subject|0
2317852|NCT02901431|4029783|FG003|Open Label Part|Withdrawal by Subject|0
2317853|NCT02901431|4029784|FG004|Open Label Part|Withdrawal by Subject|0
2317854|NCT02901431|4029785|FG005|Open Label Part|Withdrawal by Subject|0
2317855|NCT02901431|4029786|FG006|Open Label Part|Withdrawal by Subject|0
2317856|NCT02901431|4029787|FG007|Open Label Part|Withdrawal by Subject|0
2317857|NCT02901431|4029788|FG008|Open Label Part|Withdrawal by Subject|6
2317858|NCT02901431|4029789|FG009|Open Label Part|Withdrawal by Subject|5
2317859|NCT02901431|4029790|FG010|Open Label Part|Withdrawal by Subject|7
2317860|NCT02901431|4029791|FG011|Open Label Part|Withdrawal by Subject|3
2317861|NCT02901431|4029792|FG012|Open Label Part|Withdrawal by Subject|1
2322232|NCT02969525|4037115|FG001|Dose-Blind Period|Withdrawal by Subject|0
2322233|NCT02969525|4037116|FG002|Dose-Blind Period|Withdrawal by Subject|0
2322234|NCT02969525|4037117|FG003|Dose-Blind Period|Withdrawal by Subject|0
2322235|NCT02969525|4037118|FG004|Dose-Blind Period|Withdrawal by Subject|0
2322236|NCT02969525|4037119|FG005|Dose-Blind Period|Withdrawal by Subject|0
2322237|NCT02969525|4037120|FG006|Dose-Blind Period|Withdrawal by Subject|2
2322238|NCT02969525|4037121|FG007|Dose-Blind Period|Withdrawal by Subject|0
2322239|NCT02969525|4037122|FG008|Dose-Blind Period|Withdrawal by Subject|1
2322240|NCT02969525|4037123|FG009|Dose-Blind Period|Withdrawal by Subject|2
2322241|NCT02969525|4037124|FG010|Dose-Blind Period|Withdrawal by Subject|0
2322242|NCT02969525|4037125|FG011|Dose-Blind Period|Withdrawal by Subject|0
2322243|NCT02969525|4037114|FG000|Dose-Blind Period|Non-cooperating patient|0
2322244|NCT02969525|4037115|FG001|Dose-Blind Period|Non-cooperating patient|0
2322245|NCT02969525|4037116|FG002|Dose-Blind Period|Non-cooperating patient|0
2322246|NCT02969525|4037117|FG003|Dose-Blind Period|Non-cooperating patient|0
2317862|NCT02902809|4029876|FG000|Overall Study|Discontinuation of asthma program|28
2317863|NCT02902965|4029888|FG000|Overall Study|Withdrawal by Subject|10
2317864|NCT02903030|4029895|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
2317865|NCT02903030|4029896|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
2317866|NCT02903238|4029914|FG000|Overall Study|Lost to Follow-up|4
2317867|NCT02903368|4029921|FG000|Overall Study|Not sprcified|4
2317868|NCT02903368|4029922|FG001|Overall Study|Not sprcified|0
2317869|NCT02903420|4029950|FG000|Overall Study|Death|3
2317870|NCT02903511|4029965|FG000|Overall Study|Withdrawal by Subject|1
2317871|NCT02903511|4029966|FG001|Overall Study|Withdrawal by Subject|0
2317872|NCT02903511|4029965|FG000|Overall Study|Lost to Follow-up|3
2317873|NCT02903511|4029966|FG001|Overall Study|Lost to Follow-up|2
2317874|NCT02903966|4029987|FG000|Part A (Day 1 to 43)|Adverse Event|1
2317875|NCT02903966|4029988|FG001|Part A (Day 1 to 43)|Adverse Event|0
2317876|NCT02903966|4029987|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0
2317877|NCT02903966|4029988|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1
2317878|NCT02903966|4029987|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0
2317879|NCT02903966|4029988|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1
2317880|NCT02904096|4030011|FG000|Overall Study|Adverse Event|1
2317881|NCT02904096|4030012|FG001|Overall Study|Adverse Event|0
2317882|NCT02904096|4030011|FG000|Overall Study|Withdrawal by Subject|4
2317883|NCT02904096|4030012|FG001|Overall Study|Withdrawal by Subject|3
2317884|NCT02904096|4030011|FG000|Overall Study|Lost to Follow-up|10
2317885|NCT02904096|4030012|FG001|Overall Study|Lost to Follow-up|17
2317886|NCT02904096|4030011|FG000|Overall Study|Non-compliant|3
2317887|NCT02904096|4030012|FG001|Overall Study|Non-compliant|1
2317888|NCT02904096|4030011|FG000|Overall Study|Sponsor instructed|1
2317889|NCT02904096|4030012|FG001|Overall Study|Sponsor instructed|0
2317890|NCT02904200|4030018|FG000|Overall Study|Withdrawal by Subject|1
2317891|NCT02904200|4030019|FG001|Overall Study|Withdrawal by Subject|0
2317892|NCT02904265|4030056|FG000|Overall Study|Physician Decision|1
2215478|NCT01695135|3858292|FG002|Open Label Extension Treatment Phase|Physician Decision|4
2215479|NCT01695135|3858293|FG003|Open Label Extension Treatment Phase|Physician Decision|1
2215480|NCT01695135|3858290|FG000|Open Label Extension Treatment Phase|Death|0
2215481|NCT01695135|3858291|FG001|Open Label Extension Treatment Phase|Death|0
2215482|NCT01695135|3858292|FG002|Open Label Extension Treatment Phase|Death|2
2317893|NCT02904265|4030057|FG001|Overall Study|Physician Decision|2
2317894|NCT02904512|4030065|FG000|Overall Study|Withdrawal by Subject|1
2317895|NCT02904512|4030066|FG001|Overall Study|Withdrawal by Subject|0
2317896|NCT02904512|4030065|FG000|Overall Study|Transferred to ICU|1
2317897|NCT02904512|4030066|FG001|Overall Study|Transferred to ICU|0
2317898|NCT02904512|4030065|FG000|Overall Study|Minor Bleeding at site of device insertion|1
2317899|NCT02904512|4030066|FG001|Overall Study|Minor Bleeding at site of device insertion|0
2317900|NCT02904902|4030072|FG000|Overall Study|Withdrawal by Subject|1
2317901|NCT02904954|4030087|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1
2317902|NCT02904954|4030088|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1
2317903|NCT02904954|4030087|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1
2317904|NCT02904954|4030088|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0
2317905|NCT02904954|4030087|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2
2317906|NCT02904954|4030088|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3
2317907|NCT02904954|4030087|FG000|Adjuvant Durvalumab|Recurrence|2
2317908|NCT02904954|4030088|FG001|Adjuvant Durvalumab|Recurrence|0
2317909|NCT02904954|4030087|FG000|Adjuvant Durvalumab|Adverse Event|2
2317910|NCT02904954|4030088|FG001|Adjuvant Durvalumab|Adverse Event|6
2317911|NCT02904954|4030087|FG000|Adjuvant Durvalumab|Participant wishes|12
2317912|NCT02904954|4030088|FG001|Adjuvant Durvalumab|Participant wishes|5
2317913|NCT02904954|4030087|FG000|Adjuvant Durvalumab|Physician Decision|2
2317914|NCT02904954|4030088|FG001|Adjuvant Durvalumab|Physician Decision|1
2317915|NCT02904954|4030087|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1
2317916|NCT02904954|4030088|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0
2317917|NCT02904954|4030087|FG000|Adjuvant Durvalumab|Death|0
2317918|NCT02904954|4030088|FG001|Adjuvant Durvalumab|Death|1
2317919|NCT02904954|4030087|FG000|Adjuvant Durvalumab|Prostate cancer|1
2317920|NCT02904954|4030088|FG001|Adjuvant Durvalumab|Prostate cancer|0
2317921|NCT02904954|4030087|FG000|Adjuvant Durvalumab|Currently on treatment|1
2317922|NCT02904954|4030088|FG001|Adjuvant Durvalumab|Currently on treatment|3
2317923|NCT02905006|4030102|FG000|Overall Study|Adverse Event|1
2317924|NCT02905006|4030103|FG001|Overall Study|Adverse Event|1
2317925|NCT02905006|4030104|FG002|Overall Study|Adverse Event|1
2317926|NCT02905006|4030105|FG003|Overall Study|Adverse Event|1
2317927|NCT02905006|4030106|FG004|Overall Study|Adverse Event|0
2317928|NCT02905006|4030107|FG005|Overall Study|Adverse Event|1
2317929|NCT02905006|4030102|FG000|Overall Study|Lack of Efficacy|1
2317930|NCT02905006|4030103|FG001|Overall Study|Lack of Efficacy|0
2317931|NCT02905006|4030104|FG002|Overall Study|Lack of Efficacy|0
2317932|NCT02905006|4030105|FG003|Overall Study|Lack of Efficacy|0
2317933|NCT02905006|4030106|FG004|Overall Study|Lack of Efficacy|0
2317934|NCT02905006|4030107|FG005|Overall Study|Lack of Efficacy|0
2317935|NCT02905006|4030102|FG000|Overall Study|Protocol Violation|2
2317936|NCT02905006|4030103|FG001|Overall Study|Protocol Violation|0
2317937|NCT02905006|4030104|FG002|Overall Study|Protocol Violation|0
2317938|NCT02905006|4030105|FG003|Overall Study|Protocol Violation|0
2317939|NCT02905006|4030106|FG004|Overall Study|Protocol Violation|0
2317940|NCT02905006|4030107|FG005|Overall Study|Protocol Violation|0
2317941|NCT02905006|4030102|FG000|Overall Study|Lost to Follow-up|0
2317942|NCT02905006|4030103|FG001|Overall Study|Lost to Follow-up|0
2317943|NCT02905006|4030104|FG002|Overall Study|Lost to Follow-up|0
2317944|NCT02905006|4030105|FG003|Overall Study|Lost to Follow-up|1
2317945|NCT02905006|4030106|FG004|Overall Study|Lost to Follow-up|1
2317946|NCT02905006|4030107|FG005|Overall Study|Lost to Follow-up|0
2317947|NCT02905006|4030102|FG000|Overall Study|Withdrawal by Subject|0
2317948|NCT02905006|4030103|FG001|Overall Study|Withdrawal by Subject|0
2317949|NCT02905006|4030104|FG002|Overall Study|Withdrawal by Subject|1
2317950|NCT02905006|4030105|FG003|Overall Study|Withdrawal by Subject|1
2317951|NCT02905006|4030106|FG004|Overall Study|Withdrawal by Subject|0
2317952|NCT02905006|4030107|FG005|Overall Study|Withdrawal by Subject|1
2317953|NCT02905006|4030102|FG000|Overall Study|Screening exclusion criteria met|1
2317954|NCT02905006|4030103|FG001|Overall Study|Screening exclusion criteria met|0
2317955|NCT02905006|4030104|FG002|Overall Study|Screening exclusion criteria met|0
2317956|NCT02905006|4030105|FG003|Overall Study|Screening exclusion criteria met|0
2317957|NCT02905006|4030106|FG004|Overall Study|Screening exclusion criteria met|0
2317958|NCT02905006|4030107|FG005|Overall Study|Screening exclusion criteria met|0
2317959|NCT02905006|4030102|FG000|Overall Study|Lab withdrawal criterion met|0
2317960|NCT02905006|4030103|FG001|Overall Study|Lab withdrawal criterion met|1
2317961|NCT02905006|4030104|FG002|Overall Study|Lab withdrawal criterion met|2
2317962|NCT02905006|4030105|FG003|Overall Study|Lab withdrawal criterion met|2
2317963|NCT02905006|4030106|FG004|Overall Study|Lab withdrawal criterion met|2
2317964|NCT02905006|4030107|FG005|Overall Study|Lab withdrawal criterion met|1
2317965|NCT02905006|4030102|FG000|Overall Study|Positive for Tuberculosis|0
2317966|NCT02905006|4030103|FG001|Overall Study|Positive for Tuberculosis|1
2317967|NCT02905006|4030104|FG002|Overall Study|Positive for Tuberculosis|0
2317968|NCT02905006|4030105|FG003|Overall Study|Positive for Tuberculosis|0
2317969|NCT02905006|4030106|FG004|Overall Study|Positive for Tuberculosis|0
2317970|NCT02905006|4030107|FG005|Overall Study|Positive for Tuberculosis|0
2317971|NCT02905006|4030102|FG000|Overall Study|Subject positive for Hep B|0
2317972|NCT02905006|4030103|FG001|Overall Study|Subject positive for Hep B|0
2317973|NCT02905006|4030104|FG002|Overall Study|Subject positive for Hep B|1
2317974|NCT02905006|4030105|FG003|Overall Study|Subject positive for Hep B|0
2317975|NCT02905006|4030106|FG004|Overall Study|Subject positive for Hep B|0
2317976|NCT02905006|4030107|FG005|Overall Study|Subject positive for Hep B|0
2317977|NCT02905006|4030102|FG000|Overall Study|Patient moved abroad|0
2317978|NCT02905006|4030103|FG001|Overall Study|Patient moved abroad|0
2317979|NCT02905006|4030104|FG002|Overall Study|Patient moved abroad|0
2317980|NCT02905006|4030105|FG003|Overall Study|Patient moved abroad|1
2317981|NCT02905006|4030106|FG004|Overall Study|Patient moved abroad|0
2317982|NCT02905006|4030107|FG005|Overall Study|Patient moved abroad|0
2317983|NCT02905006|4030102|FG000|Overall Study|Patient randomized by mistake|0
2317984|NCT02905006|4030103|FG001|Overall Study|Patient randomized by mistake|0
2317985|NCT02905006|4030104|FG002|Overall Study|Patient randomized by mistake|0
2317986|NCT02905006|4030105|FG003|Overall Study|Patient randomized by mistake|0
2317987|NCT02905006|4030106|FG004|Overall Study|Patient randomized by mistake|0
2317988|NCT02905006|4030107|FG005|Overall Study|Patient randomized by mistake|1
2317989|NCT02905149|4030147|FG000|Overall Study|Lost to Follow-up|2
2317990|NCT02905149|4030148|FG001|Overall Study|Lost to Follow-up|0
2317991|NCT02905266|4030156|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1
2217576|NCT01709110|3860891|FG001|Overall Study|Lost to Follow-up|5
2317992|NCT02905266|4030157|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0
2317993|NCT02905266|4030156|FG000|Treatment Phase Part 1|Disease Progression|6
2317994|NCT02905266|4030157|FG001|Treatment Phase Part 1|Disease Progression|7
2317995|NCT02905266|4030156|FG000|Treatment Phase Part 1|Study Drug Toxicity|22
2317996|NCT02905266|4030157|FG001|Treatment Phase Part 1|Study Drug Toxicity|16
2317997|NCT02905266|4030156|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1
2317998|NCT02905266|4030157|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0
2317999|NCT02905266|4030156|FG000|Transition From Part 1 to Part 2|Disease progression|2
2318000|NCT02905266|4030157|FG001|Transition From Part 1 to Part 2|Disease progression|1
2318001|NCT02905266|4030156|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0
2318002|NCT02905266|4030157|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4
2318003|NCT02905266|4030156|FG000|Transition From Part 1 to Part 2|Death|0
2318004|NCT02905266|4030157|FG001|Transition From Part 1 to Part 2|Death|1
2318005|NCT02905266|4030156|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0
2318006|NCT02905266|4030157|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1
2318007|NCT02905266|4030156|FG000|Transition From Part 1 to Part 2|Adverse Event|1
2318008|NCT02905266|4030157|FG001|Transition From Part 1 to Part 2|Adverse Event|1
2318009|NCT02905266|4030156|FG000|Maintenance Phase Part 2|Disease Progression|9
2318010|NCT02905266|4030157|FG001|Maintenance Phase Part 2|Disease Progression|2
2318011|NCT02905266|4030156|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3
2318012|NCT02905266|4030157|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4
2318013|NCT02905266|4030156|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0
2318014|NCT02905266|4030157|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2
2318015|NCT02905331|4030165|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
2318016|NCT02905331|4030166|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
2318017|NCT02905331|4030167|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
2318018|NCT02905331|4030165|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
2318019|NCT02905331|4030166|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
2318020|NCT02905331|4030167|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
2318021|NCT02905331|4030165|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
2318022|NCT02905331|4030166|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
2318023|NCT02905331|4030167|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
2318024|NCT02905331|4030165|FG000|Active Treatment and Follow up (wk16-40)|Other|0
2318025|NCT02905331|4030166|FG001|Active Treatment and Follow up (wk16-40)|Other|6
2318026|NCT02905331|4030167|FG002|Active Treatment and Follow up (wk16-40)|Other|0
2318027|NCT02905331|4030165|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
2318028|NCT02905331|4030166|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
2318029|NCT02905331|4030167|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
2318030|NCT02905435|4030175|FG000|Overall Study|Death|2
2318031|NCT02905435|4030175|FG000|Overall Study|Physician Decision|1
2318032|NCT02905435|4030175|FG000|Overall Study|Lost to Follow-up|4
2318033|NCT02905825|4030180|FG000|Overall Study|Protocol Violation|11
2318034|NCT02905825|4030180|FG000|Overall Study|Device Malfunction|1
2318035|NCT02906358|4030190|FG000|Overall Study|Withdrawal by Subject|10
2318036|NCT02906358|4030191|FG001|Overall Study|Withdrawal by Subject|7
2318037|NCT02906358|4030190|FG000|Overall Study|Lost to Follow-up|12
2318038|NCT02906358|4030191|FG001|Overall Study|Lost to Follow-up|15
2318039|NCT02906579|4030208|FG000|Overall Study|Adverse Event|1
2318040|NCT02906579|4030208|FG000|Overall Study|Physician Decision|1
2318041|NCT02906644|4030230|FG000|First 2 Weeks|Withdrawal by Subject|0
2318042|NCT02906644|4030231|FG001|First 2 Weeks|Withdrawal by Subject|2
2318043|NCT02906644|4030230|FG000|First 2 Weeks|Physician Decision|1
2318044|NCT02906644|4030231|FG001|First 2 Weeks|Physician Decision|1
2318045|NCT02906644|4030230|FG000|Weeks 3 to 14|Withdrawal by Subject|13
2318046|NCT02906644|4030231|FG001|Weeks 3 to 14|Withdrawal by Subject|7
2318047|NCT02906644|4030230|FG000|Weeks 3 to 14|Lost to Follow-up|3
2318048|NCT02906644|4030231|FG001|Weeks 3 to 14|Lost to Follow-up|4
2318049|NCT02906670|4030248|FG000|Cohort 1, QW|Radiological Progression|1
2318050|NCT02906670|4030249|FG001|Cohort 1, QW|Radiological Progression|0
2318051|NCT02906670|4030250|FG002|Cohort 1, QW|Radiological Progression|0
2318052|NCT02906670|4030251|FG003|Cohort 1, QW|Radiological Progression|0
2318053|NCT02906670|4030252|FG004|Cohort 1, QW|Radiological Progression|0
2318054|NCT02906670|4030253|FG005|Cohort 1, QW|Radiological Progression|0
2318055|NCT02906670|4030254|FG006|Cohort 1, QW|Radiological Progression|0
2318056|NCT02906670|4030255|FG007|Cohort 1, QW|Radiological Progression|0
2318057|NCT02906670|4030256|FG008|Cohort 1, QW|Radiological Progression|0
2318058|NCT02906670|4030257|FG009|Cohort 1, QW|Radiological Progression|0
2318059|NCT02906670|4030248|FG000|Cohort 2, QW|Radiological Progression|0
2318060|NCT02906670|4030249|FG001|Cohort 2, QW|Radiological Progression|1
2318061|NCT02906670|4030250|FG002|Cohort 2, QW|Radiological Progression|0
2318062|NCT02906670|4030251|FG003|Cohort 2, QW|Radiological Progression|0
2318063|NCT02906670|4030252|FG004|Cohort 2, QW|Radiological Progression|0
2318064|NCT02906670|4030253|FG005|Cohort 2, QW|Radiological Progression|0
2318065|NCT02906670|4030254|FG006|Cohort 2, QW|Radiological Progression|0
2318066|NCT02906670|4030255|FG007|Cohort 2, QW|Radiological Progression|0
2318067|NCT02906670|4030256|FG008|Cohort 2, QW|Radiological Progression|0
2318068|NCT02906670|4030257|FG009|Cohort 2, QW|Radiological Progression|0
2318069|NCT02906670|4030248|FG000|Cohort 3, QW|Radiological Progression|0
2318070|NCT02906670|4030249|FG001|Cohort 3, QW|Radiological Progression|0
2318071|NCT02906670|4030250|FG002|Cohort 3, QW|Radiological Progression|2
2318072|NCT02906670|4030251|FG003|Cohort 3, QW|Radiological Progression|0
2318073|NCT02906670|4030252|FG004|Cohort 3, QW|Radiological Progression|0
2318074|NCT02906670|4030253|FG005|Cohort 3, QW|Radiological Progression|0
2318075|NCT02906670|4030254|FG006|Cohort 3, QW|Radiological Progression|0
2318076|NCT02906670|4030255|FG007|Cohort 3, QW|Radiological Progression|0
2318077|NCT02906670|4030256|FG008|Cohort 3, QW|Radiological Progression|0
2318078|NCT02906670|4030257|FG009|Cohort 3, QW|Radiological Progression|0
2318079|NCT02906670|4030248|FG000|Cohort 3, QW|Lack of Clinical Benefit|0
2318080|NCT02906670|4030249|FG001|Cohort 3, QW|Lack of Clinical Benefit|0
2318081|NCT02906670|4030250|FG002|Cohort 3, QW|Lack of Clinical Benefit|2
2318082|NCT02906670|4030251|FG003|Cohort 3, QW|Lack of Clinical Benefit|0
2318083|NCT02906670|4030252|FG004|Cohort 3, QW|Lack of Clinical Benefit|0
2318084|NCT02906670|4030253|FG005|Cohort 3, QW|Lack of Clinical Benefit|0
2318085|NCT02906670|4030254|FG006|Cohort 3, QW|Lack of Clinical Benefit|0
2318086|NCT02906670|4030255|FG007|Cohort 3, QW|Lack of Clinical Benefit|0
2318087|NCT02906670|4030256|FG008|Cohort 3, QW|Lack of Clinical Benefit|0
2318088|NCT02906670|4030257|FG009|Cohort 3, QW|Lack of Clinical Benefit|0
2318089|NCT02906670|4030248|FG000|Cohort 4, Q2W|Radiological Progression|0
2318090|NCT02906670|4030249|FG001|Cohort 4, Q2W|Radiological Progression|0
2318091|NCT02906670|4030250|FG002|Cohort 4, Q2W|Radiological Progression|0
2318092|NCT02906670|4030251|FG003|Cohort 4, Q2W|Radiological Progression|0
2318093|NCT02906670|4030252|FG004|Cohort 4, Q2W|Radiological Progression|0
2318094|NCT02906670|4030253|FG005|Cohort 4, Q2W|Radiological Progression|1
2318095|NCT02906670|4030254|FG006|Cohort 4, Q2W|Radiological Progression|0
2318096|NCT02906670|4030255|FG007|Cohort 4, Q2W|Radiological Progression|0
2318097|NCT02906670|4030256|FG008|Cohort 4, Q2W|Radiological Progression|0
2318098|NCT02906670|4030257|FG009|Cohort 4, Q2W|Radiological Progression|0
2318099|NCT02906670|4030248|FG000|Cohort 4, Q2W|Clinical Progression|0
2318100|NCT02906670|4030249|FG001|Cohort 4, Q2W|Clinical Progression|0
2318101|NCT02906670|4030250|FG002|Cohort 4, Q2W|Clinical Progression|0
2318102|NCT02906670|4030251|FG003|Cohort 4, Q2W|Clinical Progression|0
2318103|NCT02906670|4030252|FG004|Cohort 4, Q2W|Clinical Progression|0
2318104|NCT02906670|4030253|FG005|Cohort 4, Q2W|Clinical Progression|2
2318105|NCT02906670|4030254|FG006|Cohort 4, Q2W|Clinical Progression|0
2318106|NCT02906670|4030255|FG007|Cohort 4, Q2W|Clinical Progression|0
2318107|NCT02906670|4030256|FG008|Cohort 4, Q2W|Clinical Progression|0
2318108|NCT02906670|4030257|FG009|Cohort 4, Q2W|Clinical Progression|0
2318109|NCT02906670|4030248|FG000|Cohort 5, Q2W|Radiological Progression|0
2318110|NCT02906670|4030249|FG001|Cohort 5, Q2W|Radiological Progression|0
2318111|NCT02906670|4030250|FG002|Cohort 5, Q2W|Radiological Progression|0
2318112|NCT02906670|4030251|FG003|Cohort 5, Q2W|Radiological Progression|0
2318113|NCT02906670|4030252|FG004|Cohort 5, Q2W|Radiological Progression|0
2318114|NCT02906670|4030253|FG005|Cohort 5, Q2W|Radiological Progression|0
2318115|NCT02906670|4030254|FG006|Cohort 5, Q2W|Radiological Progression|4
2318116|NCT02906670|4030255|FG007|Cohort 5, Q2W|Radiological Progression|0
2318117|NCT02906670|4030256|FG008|Cohort 5, Q2W|Radiological Progression|0
2318118|NCT02906670|4030257|FG009|Cohort 5, Q2W|Radiological Progression|0
2318119|NCT02906670|4030248|FG000|Cohort 5, Q2W|Clinical Progression|0
2318120|NCT02906670|4030249|FG001|Cohort 5, Q2W|Clinical Progression|0
2318121|NCT02906670|4030250|FG002|Cohort 5, Q2W|Clinical Progression|0
2318122|NCT02906670|4030251|FG003|Cohort 5, Q2W|Clinical Progression|0
2318123|NCT02906670|4030252|FG004|Cohort 5, Q2W|Clinical Progression|0
2318124|NCT02906670|4030253|FG005|Cohort 5, Q2W|Clinical Progression|0
2318125|NCT02906670|4030254|FG006|Cohort 5, Q2W|Clinical Progression|1
2318126|NCT02906670|4030255|FG007|Cohort 5, Q2W|Clinical Progression|0
2318127|NCT02906670|4030256|FG008|Cohort 5, Q2W|Clinical Progression|0
2318128|NCT02906670|4030257|FG009|Cohort 5, Q2W|Clinical Progression|0
2318129|NCT02906670|4030248|FG000|Cohort 5, Q2W|Adverse Event|0
2318130|NCT02906670|4030249|FG001|Cohort 5, Q2W|Adverse Event|0
2318131|NCT02906670|4030250|FG002|Cohort 5, Q2W|Adverse Event|0
2318132|NCT02906670|4030251|FG003|Cohort 5, Q2W|Adverse Event|0
2318133|NCT02906670|4030252|FG004|Cohort 5, Q2W|Adverse Event|0
2318134|NCT02906670|4030253|FG005|Cohort 5, Q2W|Adverse Event|0
2318135|NCT02906670|4030254|FG006|Cohort 5, Q2W|Adverse Event|1
2318136|NCT02906670|4030255|FG007|Cohort 5, Q2W|Adverse Event|0
2318137|NCT02906670|4030256|FG008|Cohort 5, Q2W|Adverse Event|0
2318138|NCT02906670|4030257|FG009|Cohort 5, Q2W|Adverse Event|0
2215483|NCT01695135|3858293|FG003|Open Label Extension Treatment Phase|Death|7
2217577|NCT01709110|3860890|FG000|Overall Study|Protocol Violation|4
2318139|NCT02906670|4030248|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0
2318140|NCT02906670|4030249|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0
2318141|NCT02906670|4030250|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0
2318142|NCT02906670|4030251|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0
2318143|NCT02906670|4030252|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0
2318144|NCT02906670|4030253|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0
2318145|NCT02906670|4030254|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1
2318146|NCT02906670|4030255|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0
2318147|NCT02906670|4030256|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0
2318148|NCT02906670|4030257|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0
2318149|NCT02906670|4030248|FG000|Cohort 5P, Q2W|Radiological Progression|0
2318150|NCT02906670|4030249|FG001|Cohort 5P, Q2W|Radiological Progression|0
2318151|NCT02906670|4030250|FG002|Cohort 5P, Q2W|Radiological Progression|0
2318152|NCT02906670|4030251|FG003|Cohort 5P, Q2W|Radiological Progression|0
2318153|NCT02906670|4030252|FG004|Cohort 5P, Q2W|Radiological Progression|0
2318154|NCT02906670|4030253|FG005|Cohort 5P, Q2W|Radiological Progression|0
2318155|NCT02906670|4030254|FG006|Cohort 5P, Q2W|Radiological Progression|0
2318156|NCT02906670|4030255|FG007|Cohort 5P, Q2W|Radiological Progression|2
2318157|NCT02906670|4030256|FG008|Cohort 5P, Q2W|Radiological Progression|0
2318158|NCT02906670|4030257|FG009|Cohort 5P, Q2W|Radiological Progression|0
2318159|NCT02906670|4030248|FG000|Cohort 5P, Q2W|Adverse Event|0
2318160|NCT02906670|4030249|FG001|Cohort 5P, Q2W|Adverse Event|0
2318161|NCT02906670|4030250|FG002|Cohort 5P, Q2W|Adverse Event|0
2318162|NCT02906670|4030251|FG003|Cohort 5P, Q2W|Adverse Event|0
2318163|NCT02906670|4030252|FG004|Cohort 5P, Q2W|Adverse Event|0
2318164|NCT02906670|4030253|FG005|Cohort 5P, Q2W|Adverse Event|0
2318165|NCT02906670|4030254|FG006|Cohort 5P, Q2W|Adverse Event|0
2318166|NCT02906670|4030255|FG007|Cohort 5P, Q2W|Adverse Event|1
2318167|NCT02906670|4030256|FG008|Cohort 5P, Q2W|Adverse Event|0
2318168|NCT02906670|4030257|FG009|Cohort 5P, Q2W|Adverse Event|0
2318169|NCT02906670|4030248|FG000|Cohort 6P, Q2W|Radiological Progression|0
2318170|NCT02906670|4030249|FG001|Cohort 6P, Q2W|Radiological Progression|0
2318171|NCT02906670|4030250|FG002|Cohort 6P, Q2W|Radiological Progression|0
2318172|NCT02906670|4030251|FG003|Cohort 6P, Q2W|Radiological Progression|0
2318173|NCT02906670|4030252|FG004|Cohort 6P, Q2W|Radiological Progression|0
2318174|NCT02906670|4030253|FG005|Cohort 6P, Q2W|Radiological Progression|0
2318175|NCT02906670|4030254|FG006|Cohort 6P, Q2W|Radiological Progression|0
2318176|NCT02906670|4030255|FG007|Cohort 6P, Q2W|Radiological Progression|0
2318177|NCT02906670|4030256|FG008|Cohort 6P, Q2W|Radiological Progression|1
2318178|NCT02906670|4030257|FG009|Cohort 6P, Q2W|Radiological Progression|0
2318179|NCT02906670|4030248|FG000|Cohort 6P, Q2W|Clinical Progression|0
2318180|NCT02906670|4030249|FG001|Cohort 6P, Q2W|Clinical Progression|0
2318181|NCT02906670|4030250|FG002|Cohort 6P, Q2W|Clinical Progression|0
2318182|NCT02906670|4030251|FG003|Cohort 6P, Q2W|Clinical Progression|0
2318183|NCT02906670|4030252|FG004|Cohort 6P, Q2W|Clinical Progression|0
2318184|NCT02906670|4030253|FG005|Cohort 6P, Q2W|Clinical Progression|0
2318185|NCT02906670|4030254|FG006|Cohort 6P, Q2W|Clinical Progression|0
2318186|NCT02906670|4030255|FG007|Cohort 6P, Q2W|Clinical Progression|0
2318187|NCT02906670|4030256|FG008|Cohort 6P, Q2W|Clinical Progression|3
2318188|NCT02906670|4030257|FG009|Cohort 6P, Q2W|Clinical Progression|0
2318189|NCT02906670|4030248|FG000|Cohort 4P, QW|Radiological Progression|0
2318190|NCT02906670|4030249|FG001|Cohort 4P, QW|Radiological Progression|0
2318191|NCT02906670|4030250|FG002|Cohort 4P, QW|Radiological Progression|0
2318192|NCT02906670|4030251|FG003|Cohort 4P, QW|Radiological Progression|3
2318193|NCT02906670|4030252|FG004|Cohort 4P, QW|Radiological Progression|0
2318194|NCT02906670|4030253|FG005|Cohort 4P, QW|Radiological Progression|0
2318195|NCT02906670|4030254|FG006|Cohort 4P, QW|Radiological Progression|0
2318196|NCT02906670|4030255|FG007|Cohort 4P, QW|Radiological Progression|0
2318197|NCT02906670|4030256|FG008|Cohort 4P, QW|Radiological Progression|0
2318198|NCT02906670|4030257|FG009|Cohort 4P, QW|Radiological Progression|0
2318199|NCT02906670|4030248|FG000|Cohort 7P, Q2W|Adverse Event|0
2318200|NCT02906670|4030249|FG001|Cohort 7P, Q2W|Adverse Event|0
2318201|NCT02906670|4030250|FG002|Cohort 7P, Q2W|Adverse Event|0
2318202|NCT02906670|4030251|FG003|Cohort 7P, Q2W|Adverse Event|0
2318203|NCT02906670|4030252|FG004|Cohort 7P, Q2W|Adverse Event|0
2318204|NCT02906670|4030253|FG005|Cohort 7P, Q2W|Adverse Event|0
2318205|NCT02906670|4030254|FG006|Cohort 7P, Q2W|Adverse Event|0
2318206|NCT02906670|4030255|FG007|Cohort 7P, Q2W|Adverse Event|0
2318207|NCT02906670|4030256|FG008|Cohort 7P, Q2W|Adverse Event|0
2318208|NCT02906670|4030257|FG009|Cohort 7P, Q2W|Adverse Event|1
2318209|NCT02906670|4030248|FG000|Cohort 7P, Q2W|Physician Decision|0
2318210|NCT02906670|4030249|FG001|Cohort 7P, Q2W|Physician Decision|0
2318211|NCT02906670|4030250|FG002|Cohort 7P, Q2W|Physician Decision|0
2318212|NCT02906670|4030251|FG003|Cohort 7P, Q2W|Physician Decision|0
2318213|NCT02906670|4030252|FG004|Cohort 7P, Q2W|Physician Decision|0
2318214|NCT02906670|4030253|FG005|Cohort 7P, Q2W|Physician Decision|0
2318215|NCT02906670|4030254|FG006|Cohort 7P, Q2W|Physician Decision|0
2318216|NCT02906670|4030255|FG007|Cohort 7P, Q2W|Physician Decision|0
2318217|NCT02906670|4030256|FG008|Cohort 7P, Q2W|Physician Decision|0
2318218|NCT02906670|4030257|FG009|Cohort 7P, Q2W|Physician Decision|1
2318219|NCT02906670|4030248|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
2318220|NCT02906670|4030249|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
2318221|NCT02906670|4030250|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
2318222|NCT02906670|4030251|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
2318223|NCT02906670|4030252|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
2318224|NCT02906670|4030253|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
2318225|NCT02906670|4030254|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
2318226|NCT02906670|4030255|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
2318227|NCT02906670|4030256|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
2318228|NCT02906670|4030257|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1
2318229|NCT02906670|4030248|FG000|Cohort 5P, QW|Radiological Progression|0
2318230|NCT02906670|4030249|FG001|Cohort 5P, QW|Radiological Progression|0
2318231|NCT02906670|4030250|FG002|Cohort 5P, QW|Radiological Progression|0
2318232|NCT02906670|4030251|FG003|Cohort 5P, QW|Radiological Progression|0
2318233|NCT02906670|4030252|FG004|Cohort 5P, QW|Radiological Progression|3
2318234|NCT02906670|4030253|FG005|Cohort 5P, QW|Radiological Progression|0
2318235|NCT02906670|4030254|FG006|Cohort 5P, QW|Radiological Progression|0
2318236|NCT02906670|4030255|FG007|Cohort 5P, QW|Radiological Progression|0
2318237|NCT02906670|4030256|FG008|Cohort 5P, QW|Radiological Progression|0
2318238|NCT02906670|4030257|FG009|Cohort 5P, QW|Radiological Progression|0
2318239|NCT02906709|4030313|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1
2318240|NCT02906709|4030314|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2
2318241|NCT02906709|4030313|FG000|Phase A (Week 0 to Week 16)|Death|0
2318242|NCT02906709|4030314|FG001|Phase A (Week 0 to Week 16)|Death|1
2318243|NCT02906709|4030313|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
2318244|NCT02906709|4030314|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
2318245|NCT02906709|4030313|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
2318246|NCT02906709|4030314|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
2318247|NCT02906917|4030341|FG000|Initiation Period (Week 0-26)|Unclassified|1
2318248|NCT02906917|4030342|FG001|Initiation Period (Week 0-26)|Unclassified|3
2318249|NCT02906917|4030341|FG000|Initiation Period (Week 0-26)|Adverse Event|1
2318250|NCT02906917|4030342|FG001|Initiation Period (Week 0-26)|Adverse Event|0
2318251|NCT02906917|4030341|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1
2318252|NCT02906917|4030342|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4
2318253|NCT02906917|4030341|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3
2318254|NCT02906917|4030342|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4
2318255|NCT02906917|4030341|FG000|Intensification Period (Week 26-38)|Unclassified|3
2318256|NCT02906917|4030342|FG001|Intensification Period (Week 26-38)|Unclassified|2
2318257|NCT02906917|4030341|FG000|Intensification Period (Week 26-38)|Adverse Event|0
2318258|NCT02906917|4030342|FG001|Intensification Period (Week 26-38)|Adverse Event|2
2318259|NCT02906917|4030341|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3
2318260|NCT02906917|4030342|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1
2318261|NCT02906917|4030341|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3
2318262|NCT02906917|4030342|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2
2318263|NCT02906930|4030352|FG000|Overall Study|Withdrawal by Subject|0
2318264|NCT02906930|4030353|FG001|Overall Study|Withdrawal by Subject|5
2318265|NCT02906930|4030354|FG002|Overall Study|Withdrawal by Subject|5
2318266|NCT02906930|4030355|FG003|Overall Study|Withdrawal by Subject|4
2318267|NCT02906930|4030352|FG000|Overall Study|Lost to Follow-up|5
2318268|NCT02906930|4030353|FG001|Overall Study|Lost to Follow-up|7
2318269|NCT02906930|4030354|FG002|Overall Study|Lost to Follow-up|5
2318270|NCT02906930|4030355|FG003|Overall Study|Lost to Follow-up|2
2318271|NCT02906930|4030352|FG000|Overall Study|Death|0
2318272|NCT02906930|4030353|FG001|Overall Study|Death|0
2318273|NCT02906930|4030354|FG002|Overall Study|Death|1
2318274|NCT02906930|4030355|FG003|Overall Study|Death|0
2318275|NCT02906930|4030352|FG000|Overall Study|Other|1
2318276|NCT02906930|4030353|FG001|Overall Study|Other|2
2318277|NCT02906930|4030354|FG002|Overall Study|Other|1
2318278|NCT02906930|4030355|FG003|Overall Study|Other|2
2318279|NCT02907177|4030380|FG000|Overall Study|Death|0
2318280|NCT02907177|4030381|FG001|Overall Study|Death|1
2318281|NCT02907177|4030380|FG000|Overall Study|Physician Decision|3
2318282|NCT02907177|4030381|FG001|Overall Study|Physician Decision|3
2318283|NCT02907177|4030380|FG000|Overall Study|Withdrawal by Subject|15
2318284|NCT02907177|4030381|FG001|Overall Study|Withdrawal by Subject|7
2318285|NCT02907177|4030380|FG000|Overall Study|Sponsor's Decision|50
2318286|NCT02907177|4030381|FG001|Overall Study|Sponsor's Decision|57
2318287|NCT02907216|4030389|FG000|Overall Study|No benefit to be obtained by continuing|0
2318288|NCT02907216|4030390|FG001|Overall Study|No benefit to be obtained by continuing|1
2318289|NCT02907216|4030389|FG000|Overall Study|Withdrawal by Subject|1
2318290|NCT02907216|4030390|FG001|Overall Study|Withdrawal by Subject|0
2318291|NCT02907463|4030404|FG000|Overall Study|Lost to Follow-up|17
2318292|NCT02907463|4030404|FG000|Overall Study|Death|10
2318293|NCT02907463|4030404|FG000|Overall Study|Withdrawal by Subject|4
2318294|NCT02907463|4030404|FG000|Overall Study|MIS Approach was not used|2
2318295|NCT02907463|4030404|FG000|Overall Study|Not Implanted with Study Device|2
2318296|NCT02907463|4030404|FG000|Overall Study|Device Explanted|1
2318297|NCT02907463|4030404|FG000|Overall Study|Missing Exit Form|1
2318298|NCT02907619|4030428|FG000|Overall Study|Study terminated by sponsor|18
2318299|NCT02907619|4030429|FG001|Overall Study|Study terminated by sponsor|18
2318300|NCT02907619|4030430|FG002|Overall Study|Study terminated by sponsor|19
2318301|NCT02907619|4030428|FG000|Overall Study|Death|0
2318302|NCT02907619|4030429|FG001|Overall Study|Death|0
2318303|NCT02907619|4030430|FG002|Overall Study|Death|1
2318304|NCT02907619|4030428|FG000|Overall Study|Withdrawal by Subject|1
2318305|NCT02907619|4030429|FG001|Overall Study|Withdrawal by Subject|1
2318306|NCT02907619|4030430|FG002|Overall Study|Withdrawal by Subject|0
2318307|NCT02907619|4030428|FG000|Overall Study|Other|0
2318308|NCT02907619|4030429|FG001|Overall Study|Other|1
2318309|NCT02907619|4030430|FG002|Overall Study|Other|0
2318310|NCT02907892|4030451|FG000|Overall Study|Lost to Follow-up|27
2318311|NCT02907892|4030452|FG001|Overall Study|Lost to Follow-up|40
2318312|NCT02908100|4030468|FG000|Overall Study|Adverse Event|7
2318313|NCT02908100|4030469|FG001|Overall Study|Adverse Event|6
2318314|NCT02908100|4030470|FG002|Overall Study|Adverse Event|9
2318315|NCT02908100|4030468|FG000|Overall Study|Death|2
2318316|NCT02908100|4030469|FG001|Overall Study|Death|0
2318317|NCT02908100|4030470|FG002|Overall Study|Death|0
2318318|NCT02908100|4030468|FG000|Overall Study|Lack of Efficacy|2
2318319|NCT02908100|4030469|FG001|Overall Study|Lack of Efficacy|3
2318320|NCT02908100|4030470|FG002|Overall Study|Lack of Efficacy|3
2318321|NCT02908100|4030468|FG000|Overall Study|Lost to Follow-up|0
2318322|NCT02908100|4030469|FG001|Overall Study|Lost to Follow-up|1
2318323|NCT02908100|4030470|FG002|Overall Study|Lost to Follow-up|2
2318324|NCT02908100|4030468|FG000|Overall Study|Non-Compliance With Study Drug|1
2318325|NCT02908100|4030469|FG001|Overall Study|Non-Compliance With Study Drug|1
2318326|NCT02908100|4030470|FG002|Overall Study|Non-Compliance With Study Drug|2
2318327|NCT02908100|4030468|FG000|Overall Study|Non-Compliance With Contraceptive Method|1
2318328|NCT02908100|4030469|FG001|Overall Study|Non-Compliance With Contraceptive Method|0
2318329|NCT02908100|4030470|FG002|Overall Study|Non-Compliance With Contraceptive Method|0
2318330|NCT02908100|4030468|FG000|Overall Study|Physician Decision|0
2318331|NCT02908100|4030469|FG001|Overall Study|Physician Decision|1
2318332|NCT02908100|4030470|FG002|Overall Study|Physician Decision|0
2318333|NCT02908100|4030468|FG000|Overall Study|Pregnancy|1
2318334|NCT02908100|4030469|FG001|Overall Study|Pregnancy|2
2318335|NCT02908100|4030470|FG002|Overall Study|Pregnancy|0
2318336|NCT02908100|4030468|FG000|Overall Study|Withdrawal by Subject|8
2318337|NCT02908100|4030469|FG001|Overall Study|Withdrawal by Subject|7
2318338|NCT02908100|4030470|FG002|Overall Study|Withdrawal by Subject|5
2318339|NCT02908100|4030468|FG000|Overall Study|Randomised in Error|1
2318340|NCT02908100|4030469|FG001|Overall Study|Randomised in Error|0
2318341|NCT02908100|4030470|FG002|Overall Study|Randomised in Error|0
2318342|NCT02908347|4030512|FG000|Overall Study|Adverse Event|0
2318343|NCT02908347|4030513|FG001|Overall Study|Adverse Event|1
2318344|NCT02908347|4030512|FG000|Overall Study|Lost to Follow-up|1
2318345|NCT02908347|4030513|FG001|Overall Study|Lost to Follow-up|0
2318346|NCT02908464|4030535|FG000|Overall Study|Withdrawal by Subject|2
2318347|NCT02908464|4030536|FG001|Overall Study|Withdrawal by Subject|1
2318348|NCT02908464|4030535|FG000|Overall Study|Found ineligible after randomization|0
2318349|NCT02908464|4030536|FG001|Overall Study|Found ineligible after randomization|2
2318350|NCT02908529|4030552|FG000|Overall Study|Lost to Follow-up|0
2318351|NCT02908529|4030553|FG001|Overall Study|Lost to Follow-up|2
2318352|NCT02908841|4030584|FG000|Overall Study|Physician Decision|4
2318353|NCT02908841|4030585|FG001|Overall Study|Physician Decision|0
2318354|NCT02908880|4030591|FG000|Overall Study|Lost to Follow-up|4
2318355|NCT02908880|4030591|FG000|Overall Study|Explantation of the device|1
2318356|NCT02908880|4030591|FG000|Overall Study|Withdrawal by Subject|17
2318357|NCT02908880|4030591|FG000|Overall Study|Death|5
2318358|NCT02909101|4030597|FG000|Overall Study|Lost to Follow-up|1
2318359|NCT02909101|4030598|FG001|Overall Study|Lost to Follow-up|1
2318360|NCT02909153|4030622|FG000|Overall Study|Withdrawal by Subject|0
2318361|NCT02909153|4030623|FG001|Overall Study|Withdrawal by Subject|1
2318362|NCT02909153|4030624|FG002|Overall Study|Withdrawal by Subject|0
2318363|NCT02909153|4030625|FG003|Overall Study|Withdrawal by Subject|0
2318364|NCT02909153|4030626|FG004|Overall Study|Withdrawal by Subject|0
2318365|NCT02909504|4030647|FG000|Overall Study|Adverse Event|2
2318366|NCT02909504|4030647|FG000|Overall Study|Lack of Efficacy|3
2318367|NCT02909504|4030647|FG000|Overall Study|Withdrawal by Subject|4
2318368|NCT02909504|4030647|FG000|Overall Study|Pregnancy|1
2318369|NCT02909504|4030647|FG000|Overall Study|Subject moved|1
2318370|NCT02909504|4030647|FG000|Overall Study|Lost to Follow-up|1
2318371|NCT02909907|4030666|FG000|Overall Study|Withdrawal by Subject|0
2318372|NCT02909907|4030667|FG001|Overall Study|Withdrawal by Subject|1
2318373|NCT02910011|4030682|FG000|Overall Study|Physician Decision|2
2318374|NCT02910037|4030688|FG000|Overall Study|Withdrawal by Subject|4
2318375|NCT02910037|4030688|FG000|Overall Study|Lost to Follow-up|6
2318376|NCT02910063|4030708|FG000|Phase 2|Withdrawal by Subject|3
2318377|NCT02910063|4030709|FG001|Phase 2|Withdrawal by Subject|0
2318378|NCT02910063|4030710|FG002|Phase 2|Withdrawal by Subject|0
2318379|NCT02910063|4030708|FG000|Phase 2|Lost to Follow-up|1
2318380|NCT02910063|4030709|FG001|Phase 2|Lost to Follow-up|0
2318381|NCT02910063|4030710|FG002|Phase 2|Lost to Follow-up|0
2318382|NCT02910063|4030708|FG000|Phase 2|Death|24
2318383|NCT02910063|4030709|FG001|Phase 2|Death|0
2318384|NCT02910063|4030710|FG002|Phase 2|Death|0
2318385|NCT02910089|4030721|FG000|Overall Study|Lost insurance eligibility|22
2318386|NCT02910089|4030722|FG001|Overall Study|Lost insurance eligibility|16
2318387|NCT02910167|4030742|FG000|Overall Study|Adverse Event|1
2318388|NCT02910167|4030742|FG000|Overall Study|Lost to Follow-up|18
2318389|NCT02910466|4030755|FG000|Overall Study|Adverse Event|1
2318390|NCT02910466|4030755|FG000|Overall Study|Withdrawal by Subject|3
2318391|NCT02910466|4030755|FG000|Overall Study|Lost to Follow-up|5
2318392|NCT02910466|4030755|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29
2318393|NCT02910466|4030755|FG000|Overall Study|Participant didn't meet inclusion criteria|1
2318394|NCT02910713|4030764|FG000|Overall Study|Protocol Violation|2
2318395|NCT02910713|4030764|FG000|Overall Study|Subject Choice|4
2318396|NCT02910713|4030764|FG000|Overall Study|Received One Application|10
2318397|NCT02910713|4030764|FG000|Overall Study|Received Neither Application|18
2318398|NCT02910713|4030764|FG000|Overall Study|Enrollment cap|7
2318399|NCT02910713|4030764|FG000|Overall Study|Investigator Discretion|1
2318400|NCT02910739|4030771|FG000|Overall Study|Adverse Event|1
2318401|NCT02910739|4030772|FG001|Overall Study|Adverse Event|0
2318402|NCT02910739|4030773|FG002|Overall Study|Adverse Event|0
2318403|NCT02910739|4030774|FG003|Overall Study|Adverse Event|0
2318404|NCT02911025|4030780|FG000|Overall Study|Lost to Follow-up|3
2318405|NCT02911116|4030786|FG000|Overall Study|Insufficient Therapeutic Response|1
2318406|NCT02911116|4030787|FG001|Overall Study|Insufficient Therapeutic Response|0
2318407|NCT02911116|4030786|FG000|Overall Study|Lost to Follow-up|0
2318408|NCT02911116|4030787|FG001|Overall Study|Lost to Follow-up|1
2318409|NCT02911285|4030795|FG000|Overall Study|Lost to Follow-up|8
2318410|NCT02911285|4030796|FG001|Overall Study|Lost to Follow-up|5
2318411|NCT02911285|4030795|FG000|Overall Study|Participant got a job and no longer had time to participate.|1
2318412|NCT02911285|4030796|FG001|Overall Study|Participant got a job and no longer had time to participate.|0
2318413|NCT02911519|4030818|FG000|Overall Study|Lost to Follow-up|2
2318414|NCT02911519|4030819|FG001|Overall Study|Lost to Follow-up|2
2318415|NCT02911519|4030818|FG000|Overall Study|Death|0
2318416|NCT02911519|4030819|FG001|Overall Study|Death|2
2318417|NCT02911688|4030827|FG000|Washout|Lost to Follow-up|1
2318418|NCT02911688|4030828|FG001|Washout|Lost to Follow-up|1
2318419|NCT02911688|4030827|FG000|Washout|Withdrawal by Subject|0
2318420|NCT02911688|4030828|FG001|Washout|Withdrawal by Subject|1
2318421|NCT02911948|4030927|FG000|Overall Study|Protocol Violation|0
2318422|NCT02911948|4030928|FG001|Overall Study|Protocol Violation|1
2318423|NCT02911948|4030927|FG000|Overall Study|Withdrawal by Subject|0
2318424|NCT02911948|4030928|FG001|Overall Study|Withdrawal by Subject|2
2318425|NCT02911948|4030927|FG000|Overall Study|Lack of Efficacy|0
2318426|NCT02911948|4030928|FG001|Overall Study|Lack of Efficacy|1
2318427|NCT02911948|4030927|FG000|Overall Study|Unclassified|0
2318428|NCT02911948|4030928|FG001|Overall Study|Unclassified|3
2318429|NCT02912455|4030955|FG000|Overall Study|Withdrawal by Subject|0
2318430|NCT02912455|4030956|FG001|Overall Study|Withdrawal by Subject|1
2318431|NCT02912455|4030955|FG000|Overall Study|Lack of Efficacy|0
2318432|NCT02912455|4030956|FG001|Overall Study|Lack of Efficacy|1
2318433|NCT02912455|4030955|FG000|Overall Study|Lost to Follow-up|2
2318434|NCT02912455|4030956|FG001|Overall Study|Lost to Follow-up|1
2318435|NCT02912468|4030964|FG000|Overall Study|Adverse Event|3
2318436|NCT02912468|4030965|FG001|Overall Study|Adverse Event|2
2318437|NCT02912468|4030964|FG000|Overall Study|Withdrawal by Subject|6
2318438|NCT02912468|4030965|FG001|Overall Study|Withdrawal by Subject|2
2318439|NCT02912468|4030964|FG000|Overall Study|Randomized and not treated|0
2318440|NCT02912468|4030965|FG001|Overall Study|Randomized and not treated|1
2322247|NCT02969525|4037118|FG004|Dose-Blind Period|Non-cooperating patient|0
2322248|NCT02969525|4037119|FG005|Dose-Blind Period|Non-cooperating patient|0
2322249|NCT02969525|4037120|FG006|Dose-Blind Period|Non-cooperating patient|0
2322250|NCT02969525|4037121|FG007|Dose-Blind Period|Non-cooperating patient|0
2322251|NCT02969525|4037122|FG008|Dose-Blind Period|Non-cooperating patient|0
2322252|NCT02969525|4037123|FG009|Dose-Blind Period|Non-cooperating patient|0
2322253|NCT02969525|4037124|FG010|Dose-Blind Period|Non-cooperating patient|0
2322254|NCT02969525|4037125|FG011|Dose-Blind Period|Non-cooperating patient|1
2322255|NCT02969525|4037114|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
2322256|NCT02969525|4037115|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
2322257|NCT02969525|4037116|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
2322258|NCT02969525|4037117|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
2322259|NCT02969525|4037118|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
2322260|NCT02969525|4037119|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
2322261|NCT02969525|4037120|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
2322262|NCT02969525|4037121|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
2322263|NCT02969525|4037122|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
2322264|NCT02969525|4037123|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
2322265|NCT02969525|4037124|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1
2322266|NCT02969525|4037125|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
2322267|NCT02969590|4037147|FG000|Screening Period|Hormones not suppressed post Lupron|1
2322268|NCT02969590|4037148|FG001|Screening Period|Hormones not suppressed post Lupron|0
2322269|NCT02969590|4037149|FG002|Screening Period|Hormones not suppressed post Lupron|0
2322270|NCT02969655|4037161|FG000|Overall Study|Withdrawal by Subject|3
2322271|NCT02969655|4037162|FG001|Overall Study|Withdrawal by Subject|2
2322272|NCT02969655|4037161|FG000|Overall Study|Physician Decision|4
2322273|NCT02969655|4037162|FG001|Overall Study|Physician Decision|3
2322274|NCT02969655|4037161|FG000|Overall Study|Protocol-specified withdrawal criteria|4
2322275|NCT02969655|4037162|FG001|Overall Study|Protocol-specified withdrawal criteria|2
2322276|NCT02969655|4037161|FG000|Overall Study|Adverse Event|10
2322277|NCT02969655|4037162|FG001|Overall Study|Adverse Event|8
2322278|NCT02969707|4037171|FG000|Overall Study|Adverse Event|1
2322279|NCT02969707|4037172|FG001|Overall Study|Adverse Event|2
2322280|NCT02969707|4037171|FG000|Overall Study|Lost to Follow-up|3
2322281|NCT02969707|4037172|FG001|Overall Study|Lost to Follow-up|0
2322282|NCT02969707|4037171|FG000|Overall Study|Physician Decision|0
2322283|NCT02969707|4037172|FG001|Overall Study|Physician Decision|1
2322284|NCT02969707|4037171|FG000|Overall Study|Protocol Violation|1
2322285|NCT02969707|4037172|FG001|Overall Study|Protocol Violation|1
2322286|NCT02969707|4037171|FG000|Overall Study|Withdrawal by Subject|3
2322287|NCT02969707|4037172|FG001|Overall Study|Withdrawal by Subject|4
2322288|NCT02969863|4037183|FG000|Overall Study|Physician Decision|1
2322289|NCT02969863|4037184|FG001|Overall Study|Physician Decision|0
2322290|NCT02969863|4037185|FG002|Overall Study|Physician Decision|0
2322291|NCT02969863|4037186|FG003|Overall Study|Physician Decision|0
2322292|NCT02969863|4037187|FG004|Overall Study|Physician Decision|0
2322293|NCT02969863|4037188|FG005|Overall Study|Physician Decision|0
2322294|NCT02970292|4037227|FG000|Overall Study|Physician Decision|1
2322295|NCT02970292|4037228|FG001|Overall Study|Physician Decision|1
2322296|NCT02970292|4037227|FG000|Overall Study|Withdrawal by Subject|11
2322297|NCT02970292|4037228|FG001|Overall Study|Withdrawal by Subject|5
2322298|NCT02970292|4037227|FG000|Overall Study|Noncompliance with study drug|2
2322299|NCT02970292|4037228|FG001|Overall Study|Noncompliance with study drug|2
2322300|NCT02970292|4037227|FG000|Overall Study|Adverse Event|5
2318441|NCT02912650|4030976|FG000|Overall Study|Withdrawal by Subject|1
2318442|NCT02912650|4030977|FG001|Overall Study|Withdrawal by Subject|0
2318443|NCT02912650|4030978|FG002|Overall Study|Withdrawal by Subject|1
2318444|NCT02912650|4030979|FG003|Overall Study|Withdrawal by Subject|5
2318445|NCT02912650|4030976|FG000|Overall Study|Adverse Event|0
2318446|NCT02912650|4030977|FG001|Overall Study|Adverse Event|0
2318447|NCT02912650|4030978|FG002|Overall Study|Adverse Event|1
2318448|NCT02912650|4030979|FG003|Overall Study|Adverse Event|0
2318449|NCT02913105|4030992|FG000|Overall Study|Adverse Event|11
2318450|NCT02913105|4030993|FG001|Overall Study|Adverse Event|0
2318451|NCT02913105|4030994|FG002|Overall Study|Adverse Event|4
2318452|NCT02913105|4030992|FG000|Overall Study|Non-Compliance With Study Drug|0
2318453|NCT02913105|4030993|FG001|Overall Study|Non-Compliance With Study Drug|0
2318454|NCT02913105|4030994|FG002|Overall Study|Non-Compliance With Study Drug|1
2318455|NCT02913105|4030992|FG000|Overall Study|Reason Not Specified|3
2318456|NCT02913105|4030993|FG001|Overall Study|Reason Not Specified|1
2318457|NCT02913105|4030994|FG002|Overall Study|Reason Not Specified|1
2318458|NCT02913105|4030992|FG000|Overall Study|Physician Decision|1
2318459|NCT02913105|4030993|FG001|Overall Study|Physician Decision|1
2318460|NCT02913105|4030994|FG002|Overall Study|Physician Decision|0
2318461|NCT02913105|4030992|FG000|Overall Study|Withdrawal by Subject|0
2318462|NCT02913105|4030993|FG001|Overall Study|Withdrawal by Subject|3
2318463|NCT02913105|4030994|FG002|Overall Study|Withdrawal by Subject|1
2318464|NCT02913326|4031014|FG000|Overall Study|Reason not listed|0
2318465|NCT02913326|4031015|FG001|Overall Study|Reason not listed|1
2318466|NCT02913326|4031014|FG000|Overall Study|Lost to Follow-up|0
2318467|NCT02913326|4031015|FG001|Overall Study|Lost to Follow-up|1
2318468|NCT02913326|4031014|FG000|Overall Study|Adverse Event|1
2318469|NCT02913326|4031015|FG001|Overall Study|Adverse Event|0
2318470|NCT02914184|4031055|FG000|Overall Study|Lost to Follow-up|7
2318471|NCT02914184|4031056|FG001|Overall Study|Lost to Follow-up|10
2318472|NCT02914184|4031057|FG002|Overall Study|Lost to Follow-up|8
2318473|NCT02914184|4031058|FG003|Overall Study|Lost to Follow-up|7
2318474|NCT02914184|4031055|FG000|Overall Study|Withdrawal by Subject|4
2318475|NCT02914184|4031056|FG001|Overall Study|Withdrawal by Subject|2
2318476|NCT02914184|4031057|FG002|Overall Study|Withdrawal by Subject|7
2318477|NCT02914184|4031058|FG003|Overall Study|Withdrawal by Subject|3
2318478|NCT02914184|4031055|FG000|Overall Study|Other|1
2318479|NCT02914184|4031056|FG001|Overall Study|Other|0
2318480|NCT02914184|4031057|FG002|Overall Study|Other|0
2318481|NCT02914184|4031058|FG003|Overall Study|Other|0
2318482|NCT02914184|4031055|FG000|Overall Study|Migrated/moved from the study area|2
2318483|NCT02914184|4031056|FG001|Overall Study|Migrated/moved from the study area|1
2318484|NCT02914184|4031057|FG002|Overall Study|Migrated/moved from the study area|2
2318485|NCT02914184|4031058|FG003|Overall Study|Migrated/moved from the study area|1
2318486|NCT02914236|4031079|FG000|Overall Study|Lost to Follow-up|1
2318487|NCT02914275|4031085|FG000|Overall Study|Lost to Follow-up|84
2318488|NCT02914275|4031086|FG001|Overall Study|Lost to Follow-up|29
2318489|NCT02914275|4031085|FG000|Overall Study|Withdrawal by Subject|26
2318490|NCT02914275|4031086|FG001|Overall Study|Withdrawal by Subject|10
2318491|NCT02914275|4031085|FG000|Overall Study|Protocol Violation|1
2318492|NCT02914275|4031086|FG001|Overall Study|Protocol Violation|1
2318493|NCT02914275|4031085|FG000|Overall Study|Physician Decision|3
2318494|NCT02914275|4031086|FG001|Overall Study|Physician Decision|1
2318495|NCT02914275|4031085|FG000|Overall Study|Other|4
2318496|NCT02914275|4031086|FG001|Overall Study|Other|1
2318497|NCT02914275|4031085|FG000|Overall Study|Excluded due to invalid informed consent|3
2318498|NCT02914275|4031086|FG001|Overall Study|Excluded due to invalid informed consent|0
2318499|NCT02914457|4031096|FG000|Overall Study|Withdrawal by Subject|1
2318500|NCT02914457|4031096|FG000|Overall Study|Physician Decision|1
2318501|NCT02914457|4031096|FG000|Overall Study|No veins available for lead placement|1
2318502|NCT02914457|4031096|FG000|Overall Study|Electrical instability of patient|1
2318503|NCT02914457|4031096|FG000|Overall Study|ECG acquisition error due to sweating|1
2318504|NCT02914457|4031096|FG000|Overall Study|Protocol Violation|1
2318505|NCT02914522|4031117|FG000|Induction Study: Up to Week 11|Adverse Event|5
2318506|NCT02914522|4031118|FG001|Induction Study: Up to Week 11|Adverse Event|6
2318507|NCT02914522|4031119|FG002|Induction Study: Up to Week 11|Adverse Event|4
2318508|NCT02914522|4031120|FG003|Induction Study: Up to Week 11|Adverse Event|18
2318509|NCT02914522|4031121|FG004|Induction Study: Up to Week 11|Adverse Event|14
2318510|NCT02914522|4031122|FG005|Induction Study: Up to Week 11|Adverse Event|10
2318511|NCT02914522|4031123|FG006|Induction Study: Up to Week 11|Adverse Event|0
2318512|NCT02914522|4031124|FG007|Induction Study: Up to Week 11|Adverse Event|0
2318513|NCT02914522|4031125|FG008|Induction Study: Up to Week 11|Adverse Event|0
2318514|NCT02914522|4031126|FG009|Induction Study: Up to Week 11|Adverse Event|0
2318515|NCT02914522|4031127|FG010|Induction Study: Up to Week 11|Adverse Event|0
2318516|NCT02914522|4031117|FG000|Induction Study: Up to Week 11|Withdrew Consent|4
2318517|NCT02914522|4031118|FG001|Induction Study: Up to Week 11|Withdrew Consent|11
2318518|NCT02914522|4031119|FG002|Induction Study: Up to Week 11|Withdrew Consent|4
2318519|NCT02914522|4031120|FG003|Induction Study: Up to Week 11|Withdrew Consent|6
2318520|NCT02914522|4031121|FG004|Induction Study: Up to Week 11|Withdrew Consent|3
2318521|NCT02914522|4031122|FG005|Induction Study: Up to Week 11|Withdrew Consent|3
2318522|NCT02914522|4031123|FG006|Induction Study: Up to Week 11|Withdrew Consent|0
2318523|NCT02914522|4031124|FG007|Induction Study: Up to Week 11|Withdrew Consent|0
2318524|NCT02914522|4031125|FG008|Induction Study: Up to Week 11|Withdrew Consent|0
2318525|NCT02914522|4031126|FG009|Induction Study: Up to Week 11|Withdrew Consent|0
2318526|NCT02914522|4031127|FG010|Induction Study: Up to Week 11|Withdrew Consent|0
2318527|NCT02914522|4031117|FG000|Induction Study: Up to Week 11|Protocol Violation|0
2318528|NCT02914522|4031118|FG001|Induction Study: Up to Week 11|Protocol Violation|2
2318529|NCT02914522|4031119|FG002|Induction Study: Up to Week 11|Protocol Violation|1
2318530|NCT02914522|4031120|FG003|Induction Study: Up to Week 11|Protocol Violation|3
2318531|NCT02914522|4031121|FG004|Induction Study: Up to Week 11|Protocol Violation|4
2318532|NCT02914522|4031122|FG005|Induction Study: Up to Week 11|Protocol Violation|2
2318533|NCT02914522|4031123|FG006|Induction Study: Up to Week 11|Protocol Violation|0
2318534|NCT02914522|4031124|FG007|Induction Study: Up to Week 11|Protocol Violation|0
2318535|NCT02914522|4031125|FG008|Induction Study: Up to Week 11|Protocol Violation|0
2318536|NCT02914522|4031126|FG009|Induction Study: Up to Week 11|Protocol Violation|0
2318537|NCT02914522|4031127|FG010|Induction Study: Up to Week 11|Protocol Violation|0
2318538|NCT02914522|4031117|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0
2318539|NCT02914522|4031118|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2
2318540|NCT02914522|4031119|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1
2318541|NCT02914522|4031120|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1
2318542|NCT02914522|4031121|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0
2318543|NCT02914522|4031122|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0
2318544|NCT02914522|4031123|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0
2318545|NCT02914522|4031124|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0
2318546|NCT02914522|4031125|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0
2318547|NCT02914522|4031126|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0
2318548|NCT02914522|4031127|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0
2318549|NCT02914522|4031117|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0
2318550|NCT02914522|4031118|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0
2318551|NCT02914522|4031119|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0
2318552|NCT02914522|4031120|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0
2318553|NCT02914522|4031121|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1
2318554|NCT02914522|4031122|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0
2318555|NCT02914522|4031123|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0
2318556|NCT02914522|4031124|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0
2318557|NCT02914522|4031125|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0
2318558|NCT02914522|4031126|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0
2318559|NCT02914522|4031127|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0
2318560|NCT02914522|4031117|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1
2318561|NCT02914522|4031118|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
2318562|NCT02914522|4031119|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
2318563|NCT02914522|4031120|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
2318564|NCT02914522|4031121|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
2318565|NCT02914522|4031122|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
2318566|NCT02914522|4031123|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
2318567|NCT02914522|4031124|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
2318568|NCT02914522|4031125|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
2318569|NCT02914522|4031126|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
2318570|NCT02914522|4031127|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
2318571|NCT02914522|4031117|FG000|Induction Study: Up to Week 11|Pregnancy|0
2318572|NCT02914522|4031118|FG001|Induction Study: Up to Week 11|Pregnancy|0
2318573|NCT02914522|4031119|FG002|Induction Study: Up to Week 11|Pregnancy|0
2318574|NCT02914522|4031120|FG003|Induction Study: Up to Week 11|Pregnancy|0
2318575|NCT02914522|4031121|FG004|Induction Study: Up to Week 11|Pregnancy|1
2318576|NCT02914522|4031122|FG005|Induction Study: Up to Week 11|Pregnancy|0
2318577|NCT02914522|4031123|FG006|Induction Study: Up to Week 11|Pregnancy|0
2318578|NCT02914522|4031124|FG007|Induction Study: Up to Week 11|Pregnancy|0
2318579|NCT02914522|4031125|FG008|Induction Study: Up to Week 11|Pregnancy|0
2318580|NCT02914522|4031126|FG009|Induction Study: Up to Week 11|Pregnancy|0
2318581|NCT02914522|4031127|FG010|Induction Study: Up to Week 11|Pregnancy|0
2318582|NCT02914522|4031117|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0
2318583|NCT02914522|4031118|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1
2318584|NCT02914522|4031119|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0
2318585|NCT02914522|4031120|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0
2318586|NCT02914522|4031121|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1
2318587|NCT02914522|4031122|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1
2318588|NCT02914522|4031123|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0
2318589|NCT02914522|4031124|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0
2318590|NCT02914522|4031125|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0
2318591|NCT02914522|4031126|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0
2318592|NCT02914522|4031127|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0
2318593|NCT02914522|4031117|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
2318594|NCT02914522|4031118|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
2318595|NCT02914522|4031119|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
2318596|NCT02914522|4031120|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
2318597|NCT02914522|4031121|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
2318598|NCT02914522|4031122|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
2318599|NCT02914522|4031123|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34
2318600|NCT02914522|4031124|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49
2318601|NCT02914522|4031125|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53
2318602|NCT02914522|4031126|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39
2318603|NCT02914522|4031127|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21
2318604|NCT02914522|4031117|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0
2318605|NCT02914522|4031118|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0
2318606|NCT02914522|4031119|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0
2318607|NCT02914522|4031120|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0
2215484|NCT01695135|3858290|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0
2215485|NCT01695135|3858291|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0
2215486|NCT01695135|3858292|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0
2318608|NCT02914522|4031121|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0
2318609|NCT02914522|4031122|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0
2318610|NCT02914522|4031123|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7
2318611|NCT02914522|4031124|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2
2318612|NCT02914522|4031125|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10
2318613|NCT02914522|4031126|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4
2318614|NCT02914522|4031127|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3
2318615|NCT02914522|4031117|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
2318616|NCT02914522|4031118|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
2318617|NCT02914522|4031119|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
2318618|NCT02914522|4031120|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
2318619|NCT02914522|4031121|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
2318620|NCT02914522|4031122|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
2318621|NCT02914522|4031123|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
2318622|NCT02914522|4031124|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
2318623|NCT02914522|4031125|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3
2318624|NCT02914522|4031126|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
2318625|NCT02914522|4031127|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1
2318626|NCT02914522|4031117|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
2318627|NCT02914522|4031118|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
2318628|NCT02914522|4031119|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
2318629|NCT02914522|4031120|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
2318630|NCT02914522|4031121|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
2318631|NCT02914522|4031122|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
2318632|NCT02914522|4031123|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
2318633|NCT02914522|4031124|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1
2318634|NCT02914522|4031125|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6
2318635|NCT02914522|4031126|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3
2318636|NCT02914522|4031127|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
2318637|NCT02914522|4031117|FG000|Maintenance Study: Week 11 to Week 58|Death|0
2318638|NCT02914522|4031118|FG001|Maintenance Study: Week 11 to Week 58|Death|0
2318639|NCT02914522|4031119|FG002|Maintenance Study: Week 11 to Week 58|Death|0
2318640|NCT02914522|4031120|FG003|Maintenance Study: Week 11 to Week 58|Death|0
2318641|NCT02914522|4031121|FG004|Maintenance Study: Week 11 to Week 58|Death|0
2318642|NCT02914522|4031122|FG005|Maintenance Study: Week 11 to Week 58|Death|0
2318643|NCT02914522|4031123|FG006|Maintenance Study: Week 11 to Week 58|Death|2
2318644|NCT02914522|4031124|FG007|Maintenance Study: Week 11 to Week 58|Death|0
2318645|NCT02914522|4031125|FG008|Maintenance Study: Week 11 to Week 58|Death|0
2318646|NCT02914522|4031126|FG009|Maintenance Study: Week 11 to Week 58|Death|0
2318647|NCT02914522|4031127|FG010|Maintenance Study: Week 11 to Week 58|Death|0
2318648|NCT02914522|4031117|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
2318649|NCT02914522|4031118|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
2318650|NCT02914522|4031119|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
2318651|NCT02914522|4031120|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
2318652|NCT02914522|4031121|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
2318653|NCT02914522|4031122|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
2318654|NCT02914522|4031123|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
2318655|NCT02914522|4031124|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1
2318656|NCT02914522|4031125|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2
2318657|NCT02914522|4031126|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
2318658|NCT02914522|4031127|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
2318659|NCT02914522|4031117|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0
2318660|NCT02914522|4031118|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0
2318661|NCT02914522|4031119|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0
2318662|NCT02914522|4031120|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0
2215487|NCT01695135|3858293|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1
2215488|NCT01695239|3858305|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
2215489|NCT01695239|3858306|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
2215490|NCT01695239|3858307|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
2215491|NCT01695239|3858308|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
2215492|NCT01695239|3858309|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2215493|NCT01695239|3858310|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2215494|NCT01695239|3858311|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2215495|NCT01695239|3858312|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2215496|NCT01695239|3858313|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2215497|NCT01695239|3858314|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2215498|NCT01695239|3858315|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2215499|NCT01695239|3858316|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2215500|NCT01695239|3858317|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2215501|NCT01695239|3858318|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2215502|NCT01695239|3858305|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2
2215503|NCT01695239|3858306|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2
2215504|NCT01695239|3858307|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2
2215505|NCT01695239|3858308|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3
2215506|NCT01695239|3858309|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0
2215507|NCT01695239|3858310|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0
2215508|NCT01695239|3858311|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0
2217578|NCT01709110|3860891|FG001|Overall Study|Protocol Violation|6
2318663|NCT02914522|4031121|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0
2318664|NCT02914522|4031122|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0
2318665|NCT02914522|4031123|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0
2318666|NCT02914522|4031124|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0
2318667|NCT02914522|4031125|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1
2318668|NCT02914522|4031126|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2
2318669|NCT02914522|4031127|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0
2318670|NCT02914522|4031117|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
2318671|NCT02914522|4031118|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
2318672|NCT02914522|4031119|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
2318673|NCT02914522|4031120|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
2318674|NCT02914522|4031121|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
2318675|NCT02914522|4031122|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
2318676|NCT02914522|4031123|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
2318677|NCT02914522|4031124|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
2318678|NCT02914522|4031125|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
2318679|NCT02914522|4031126|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1
2318680|NCT02914522|4031127|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
2318681|NCT02914548|4031157|FG000|Overall Study|Adverse Event|15
2318682|NCT02914548|4031158|FG001|Overall Study|Adverse Event|7
2318683|NCT02914548|4031159|FG002|Overall Study|Adverse Event|15
2318684|NCT02914548|4031157|FG000|Overall Study|Physician Decision|2
2318685|NCT02914548|4031158|FG001|Overall Study|Physician Decision|2
2318686|NCT02914548|4031159|FG002|Overall Study|Physician Decision|0
2318687|NCT02914548|4031157|FG000|Overall Study|Protocol Violation|1
2318688|NCT02914548|4031158|FG001|Overall Study|Protocol Violation|0
2318689|NCT02914548|4031159|FG002|Overall Study|Protocol Violation|0
2318690|NCT02914548|4031157|FG000|Overall Study|Withdrawal by Subject|3
2318691|NCT02914548|4031158|FG001|Overall Study|Withdrawal by Subject|4
2318692|NCT02914548|4031159|FG002|Overall Study|Withdrawal by Subject|4
2318693|NCT02914548|4031157|FG000|Overall Study|>40% of body surface area|0
2318694|NCT02914548|4031158|FG001|Overall Study|>40% of body surface area|1
2318695|NCT02914548|4031159|FG002|Overall Study|>40% of body surface area|1
2318696|NCT02914834|4031180|FG000|Overall Study|Study halted due to COVID|1
2318697|NCT02914834|4031181|FG001|Overall Study|Study halted due to COVID|1
2318698|NCT02914834|4031180|FG000|Overall Study|1 subject withdrew|0
2318699|NCT02914834|4031181|FG001|Overall Study|1 subject withdrew|1
2318700|NCT02915016|4031195|FG000|Overall Study|Lost to Follow-up|4
2318701|NCT02915016|4031196|FG001|Overall Study|Lost to Follow-up|2
2318702|NCT02915016|4031197|FG002|Overall Study|Lost to Follow-up|5
2318703|NCT02915016|4031198|FG003|Overall Study|Lost to Follow-up|3
2318704|NCT02915016|4031199|FG004|Overall Study|Lost to Follow-up|5
2318705|NCT02915016|4031200|FG005|Overall Study|Lost to Follow-up|2
2318706|NCT02915016|4031201|FG006|Overall Study|Lost to Follow-up|8
2318707|NCT02915016|4031202|FG007|Overall Study|Lost to Follow-up|2
2318708|NCT02915016|4031195|FG000|Overall Study|Physician Decision|0
2318709|NCT02915016|4031196|FG001|Overall Study|Physician Decision|0
2318710|NCT02915016|4031197|FG002|Overall Study|Physician Decision|1
2318711|NCT02915016|4031198|FG003|Overall Study|Physician Decision|0
2318712|NCT02915016|4031199|FG004|Overall Study|Physician Decision|0
2318713|NCT02915016|4031200|FG005|Overall Study|Physician Decision|1
2318714|NCT02915016|4031201|FG006|Overall Study|Physician Decision|2
2318715|NCT02915016|4031202|FG007|Overall Study|Physician Decision|0
2318716|NCT02915016|4031195|FG000|Overall Study|Withdrawal by Subject|2
2318717|NCT02915016|4031196|FG001|Overall Study|Withdrawal by Subject|0
2318718|NCT02915016|4031197|FG002|Overall Study|Withdrawal by Subject|1
2318719|NCT02915016|4031198|FG003|Overall Study|Withdrawal by Subject|0
2318720|NCT02915016|4031199|FG004|Overall Study|Withdrawal by Subject|1
2318721|NCT02915016|4031200|FG005|Overall Study|Withdrawal by Subject|3
2318722|NCT02915016|4031201|FG006|Overall Study|Withdrawal by Subject|1
2318723|NCT02915016|4031202|FG007|Overall Study|Withdrawal by Subject|1
2318724|NCT02915016|4031195|FG000|Overall Study|Elected not to continue|0
2318725|NCT02915016|4031196|FG001|Overall Study|Elected not to continue|0
2318726|NCT02915016|4031197|FG002|Overall Study|Elected not to continue|0
2318727|NCT02915016|4031198|FG003|Overall Study|Elected not to continue|1
2318728|NCT02915016|4031199|FG004|Overall Study|Elected not to continue|0
2318729|NCT02915016|4031200|FG005|Overall Study|Elected not to continue|0
2318730|NCT02915016|4031201|FG006|Overall Study|Elected not to continue|1
2318731|NCT02915016|4031202|FG007|Overall Study|Elected not to continue|0
2318732|NCT02915016|4031195|FG000|Overall Study|HIV infection|1
2318733|NCT02915016|4031196|FG001|Overall Study|HIV infection|1
2318734|NCT02915016|4031197|FG002|Overall Study|HIV infection|1
2318735|NCT02915016|4031198|FG003|Overall Study|HIV infection|0
2318736|NCT02915016|4031199|FG004|Overall Study|HIV infection|1
2318737|NCT02915016|4031200|FG005|Overall Study|HIV infection|0
2318738|NCT02915016|4031201|FG006|Overall Study|HIV infection|0
2318739|NCT02915016|4031202|FG007|Overall Study|HIV infection|0
2318740|NCT02915016|4031195|FG000|Overall Study|Participant unable to adhere|0
2318741|NCT02915016|4031196|FG001|Overall Study|Participant unable to adhere|0
2318742|NCT02915016|4031197|FG002|Overall Study|Participant unable to adhere|0
2318743|NCT02915016|4031198|FG003|Overall Study|Participant unable to adhere|0
2318744|NCT02915016|4031199|FG004|Overall Study|Participant unable to adhere|0
2318745|NCT02915016|4031200|FG005|Overall Study|Participant unable to adhere|0
2318746|NCT02915016|4031201|FG006|Overall Study|Participant unable to adhere|0
2318747|NCT02915016|4031202|FG007|Overall Study|Participant unable to adhere|1
2318748|NCT02915159|4031231|FG000|Overall Study|Participant no longer meets criteria|2
2318749|NCT02915159|4031232|FG001|Overall Study|Participant no longer meets criteria|0
2318750|NCT02915159|4031231|FG000|Overall Study|poor/non-compliance|1
2318751|NCT02915159|4031232|FG001|Overall Study|poor/non-compliance|0
2318752|NCT02915159|4031231|FG000|Overall Study|Participant withdrew consent|5
2318753|NCT02915159|4031232|FG001|Overall Study|Participant withdrew consent|1
2318754|NCT02915159|4031231|FG000|Overall Study|Request to discontinue treatment|1
2318755|NCT02915159|4031232|FG001|Overall Study|Request to discontinue treatment|2
2318756|NCT02915159|4031231|FG000|Overall Study|Adverse Event|2
2318757|NCT02915159|4031232|FG001|Overall Study|Adverse Event|2
2318758|NCT02915159|4031231|FG000|Overall Study|Lack of Efficacy|0
2318759|NCT02915159|4031232|FG001|Overall Study|Lack of Efficacy|3
2318760|NCT02915302|4031244|FG000|Overall Study|Adverse Event|3
2318761|NCT02915302|4031245|FG001|Overall Study|Adverse Event|0
2318762|NCT02915302|4031244|FG000|Overall Study|Protocol Violation|20
2318763|NCT02915302|4031245|FG001|Overall Study|Protocol Violation|27
2318764|NCT02915302|4031244|FG000|Overall Study|Lost to Follow-up|19
2318765|NCT02915302|4031245|FG001|Overall Study|Lost to Follow-up|22
2318766|NCT02915302|4031244|FG000|Overall Study|Withdrawal by Subject|22
2318767|NCT02915302|4031245|FG001|Overall Study|Withdrawal by Subject|29
2318768|NCT02915302|4031244|FG000|Overall Study|Other|1
2318769|NCT02915302|4031245|FG001|Overall Study|Other|0
2318770|NCT02915835|4031276|FG000|Overall Study|Physician Decision|1
2318771|NCT02915835|4031277|FG001|Overall Study|Physician Decision|0
2318772|NCT02915835|4031276|FG000|Overall Study|Withdrawal by Subject|0
2318773|NCT02915835|4031277|FG001|Overall Study|Withdrawal by Subject|1
2318774|NCT02915874|4031285|FG000|Overall Study|Lost to Follow-up|5
2318775|NCT02915874|4031286|FG001|Overall Study|Lost to Follow-up|4
2318776|NCT02915874|4031285|FG000|Overall Study|Withdrawal by Subject|1
2318777|NCT02915874|4031286|FG001|Overall Study|Withdrawal by Subject|1
2318778|NCT02915874|4031285|FG000|Overall Study|Started New Anxiety Medication|0
2318779|NCT02915874|4031286|FG001|Overall Study|Started New Anxiety Medication|1
2318780|NCT02915978|4031295|FG000|Overall Study|Adverse Event|2
2318781|NCT02915978|4031296|FG001|Overall Study|Adverse Event|1
2318782|NCT02915978|4031297|FG002|Overall Study|Adverse Event|0
2318783|NCT02916056|4031305|FG000|Overall Study|Adverse Event|6
2318784|NCT02916056|4031305|FG000|Overall Study|Lost to Follow-up|1
2318785|NCT02916056|4031305|FG000|Overall Study|Other|12
2318786|NCT02916056|4031305|FG000|Overall Study|Protocol Violation|1
2318787|NCT02916056|4031305|FG000|Overall Study|Withdrawal by Subject|8
2318788|NCT02916056|4031305|FG000|Overall Study|Study Terminated by Sponsor|269
2318789|NCT02916433|4031320|FG000|Overall Study|Withdrawal by Subject|1
2318790|NCT02916433|4031321|FG001|Overall Study|Withdrawal by Subject|0
2318791|NCT02916433|4031320|FG000|Overall Study|Physician Decision|1
2318792|NCT02916433|4031321|FG001|Overall Study|Physician Decision|0
2318793|NCT02916693|4031343|FG000|Overall Study|Lost to Follow-up|7
2318794|NCT02916927|4031357|FG000|Overall Study|Discharged prior to study drug receipt|0
2318795|NCT02916927|4031358|FG001|Overall Study|Discharged prior to study drug receipt|2
2318796|NCT02916927|4031357|FG000|Overall Study|At radiology for 45 & 60 min time points|0
2318797|NCT02916927|4031358|FG001|Overall Study|At radiology for 45 & 60 min time points|1
2318798|NCT02916927|4031357|FG000|Overall Study|Withdrawal before first time point|1
2318799|NCT02916927|4031358|FG001|Overall Study|Withdrawal before first time point|0
2318800|NCT02917031|4031367|FG000|Overall Study|Reason not specified|7
2318801|NCT02917031|4031368|FG001|Overall Study|Reason not specified|5
2318802|NCT02917031|4031369|FG002|Overall Study|Reason not specified|6
2318803|NCT02917031|4031367|FG000|Overall Study|Development of study-specific withdrawal criteria|1
2318804|NCT02917031|4031368|FG001|Overall Study|Development of study-specific withdrawal criteria|1
2318805|NCT02917031|4031369|FG002|Overall Study|Development of study-specific withdrawal criteria|0
2318806|NCT02917031|4031367|FG000|Overall Study|Withdrawal by Subject|3
2318807|NCT02917031|4031368|FG001|Overall Study|Withdrawal by Subject|3
2318808|NCT02917031|4031369|FG002|Overall Study|Withdrawal by Subject|0
2318809|NCT02917031|4031367|FG000|Overall Study|Physician Decision|1
2318810|NCT02917031|4031368|FG001|Overall Study|Physician Decision|0
2318811|NCT02917031|4031369|FG002|Overall Study|Physician Decision|0
2318812|NCT02917031|4031367|FG000|Overall Study|Adverse Event|4
2318813|NCT02917031|4031368|FG001|Overall Study|Adverse Event|1
2318814|NCT02917031|4031369|FG002|Overall Study|Adverse Event|5
2318815|NCT02917031|4031367|FG000|Overall Study|Death|2
2318816|NCT02917031|4031368|FG001|Overall Study|Death|3
2318817|NCT02917031|4031369|FG002|Overall Study|Death|4
2318818|NCT02917265|4031389|FG000|Overall Study|Physician Decision|1
2318819|NCT02917265|4031390|FG001|Overall Study|Physician Decision|0
2318820|NCT02917265|4031389|FG000|Overall Study|Withdrawal by Subject|1
2318821|NCT02917265|4031390|FG001|Overall Study|Withdrawal by Subject|0
2318822|NCT02917941|4031435|FG000|Treatment Period|Adverse Event|11
2318823|NCT02917941|4031435|FG000|Treatment Period|Progressive Disease|11
2318824|NCT02917941|4031435|FG000|Treatment Period|Reason not Specified|2
2318825|NCT02917941|4031435|FG000|Survival Follow-up Period|Lost to Follow-up|1
2318826|NCT02917941|4031435|FG000|Survival Follow-up Period|Withdrawal by Subject|4
2318827|NCT02918071|4031439|FG000|Overall Study|Withdrawal by Subject|2
2318828|NCT02918071|4031439|FG000|Overall Study|Lost to Follow-up|1
2318829|NCT02918266|4031458|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0
2318830|NCT02918266|4031459|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2318831|NCT02918266|4031460|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2318832|NCT02918266|4031461|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2318833|NCT02918266|4031462|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2318834|NCT02918266|4031463|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2318835|NCT02918266|4031464|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2
2318836|NCT02918266|4031465|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2318837|NCT02918266|4031466|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2
2318838|NCT02918266|4031467|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2318839|NCT02918266|4031468|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2318840|NCT02918279|4031490|FG000|Overall Study|Lost to Follow-up|3
2318841|NCT02918279|4031491|FG001|Overall Study|Lost to Follow-up|6
2318842|NCT02918279|4031490|FG000|Overall Study|Withdrawal by Subject|5
2318843|NCT02918279|4031491|FG001|Overall Study|Withdrawal by Subject|15
2318844|NCT02918279|4031490|FG000|Overall Study|Withdrawal by parent/guardian|2
2318845|NCT02918279|4031491|FG001|Overall Study|Withdrawal by parent/guardian|1
2318846|NCT02918279|4031490|FG000|Overall Study|Other|3
2318847|NCT02918279|4031491|FG001|Overall Study|Other|1
2318848|NCT02918318|4031501|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1
2318849|NCT02918318|4031502|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4
2318850|NCT02918318|4031503|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2
2318851|NCT02918318|4031504|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3
2318852|NCT02918318|4031505|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0
2318853|NCT02918318|4031501|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
2318854|NCT02918318|4031502|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
2318855|NCT02918318|4031503|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
2318856|NCT02918318|4031504|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2
2318857|NCT02918318|4031505|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
2318858|NCT02918318|4031501|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
2318859|NCT02918318|4031502|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
2318860|NCT02918318|4031503|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
2318861|NCT02918318|4031504|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1
2318862|NCT02918318|4031505|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
2318863|NCT02918318|4031501|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
2318864|NCT02918318|4031502|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
2318865|NCT02918318|4031503|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
2318866|NCT02918318|4031504|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
2318867|NCT02918318|4031505|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
2318868|NCT02918318|4031501|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
2318869|NCT02918318|4031502|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
2318870|NCT02918318|4031503|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
2318871|NCT02918318|4031504|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1
2318872|NCT02918318|4031505|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
2318873|NCT02918318|4031501|FG000|Double-blind Induction Phase: 4 Weeks|Other|0
2318874|NCT02918318|4031502|FG001|Double-blind Induction Phase: 4 Weeks|Other|2
2318875|NCT02918318|4031503|FG002|Double-blind Induction Phase: 4 Weeks|Other|0
2318876|NCT02918318|4031504|FG003|Double-blind Induction Phase: 4 Weeks|Other|1
2318877|NCT02918318|4031505|FG004|Double-blind Induction Phase: 4 Weeks|Other|0
2318878|NCT02918318|4031501|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
2318879|NCT02918318|4031502|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
2318880|NCT02918318|4031503|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
2318881|NCT02918318|4031504|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2
2318882|NCT02918318|4031505|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
2318883|NCT02918318|4031501|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
2318884|NCT02918318|4031502|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
2318885|NCT02918318|4031503|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
2318886|NCT02918318|4031504|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
2318887|NCT02918318|4031505|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
2318888|NCT02918318|4031501|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
2318889|NCT02918318|4031502|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
2318890|NCT02918318|4031503|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
2318891|NCT02918318|4031504|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
2318892|NCT02918318|4031505|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
2318893|NCT02918318|4031501|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0
2318894|NCT02918318|4031502|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3
2318895|NCT02918318|4031503|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1
2318896|NCT02918318|4031504|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1
2318897|NCT02918318|4031505|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0
2318898|NCT02918318|4031501|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
2318899|NCT02918318|4031502|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
2318900|NCT02918318|4031503|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
2318901|NCT02918318|4031504|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
2318902|NCT02918318|4031505|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1
2318903|NCT02918318|4031501|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
2318904|NCT02918318|4031502|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
2318905|NCT02918318|4031503|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
2318906|NCT02918318|4031504|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
2318907|NCT02918318|4031505|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1
2318908|NCT02918552|4031563|FG000|Overall Study|Failed Pharmacokinetics|1
2318909|NCT02918552|4031564|FG001|Overall Study|Failed Pharmacokinetics|0
2318910|NCT02918552|4031563|FG000|Overall Study|Withdrawal by Subject|0
2318911|NCT02918552|4031564|FG001|Overall Study|Withdrawal by Subject|1
2318912|NCT02918552|4031563|FG000|Overall Study|Lost to Follow-up|0
2318913|NCT02918552|4031564|FG001|Overall Study|Lost to Follow-up|1
2318914|NCT02918877|4031663|FG000|Overall Study|Withdrawal by Subject|2
2318915|NCT02918877|4031664|FG001|Overall Study|Withdrawal by Subject|2
2318916|NCT02918877|4031663|FG000|Overall Study|Surgery cancelled|1
2318917|NCT02918877|4031664|FG001|Overall Study|Surgery cancelled|0
2318918|NCT02918877|4031663|FG000|Overall Study|Physician Decision|1
2318919|NCT02918877|4031664|FG001|Overall Study|Physician Decision|0
2318920|NCT02918877|4031663|FG000|Overall Study|Received intraoperative steroids|1
2318921|NCT02918877|4031664|FG001|Overall Study|Received intraoperative steroids|0
2318922|NCT02918877|4031663|FG000|Overall Study|Unable to obtain lab samples|1
2318923|NCT02918877|4031664|FG001|Overall Study|Unable to obtain lab samples|0
2318924|NCT02918877|4031663|FG000|Overall Study|Unsafe to perform BAL|0
2318925|NCT02918877|4031664|FG001|Overall Study|Unsafe to perform BAL|1
2318926|NCT02918968|4031672|FG000|1st Line AAT|Progressive disease|9
2318927|NCT02918968|4031673|FG001|1st Line AAT|Progressive disease|4
2318928|NCT02918968|4031672|FG000|1st Line AAT|Adverse Event|12
2318929|NCT02918968|4031673|FG001|1st Line AAT|Adverse Event|3
2318930|NCT02918968|4031672|FG000|1st Line AAT|Physician Decision|4
2318931|NCT02918968|4031673|FG001|1st Line AAT|Physician Decision|2
2318932|NCT02918968|4031672|FG000|1st Line AAT|Withdrawal by Subject|2
2318933|NCT02918968|4031673|FG001|1st Line AAT|Withdrawal by Subject|1
2318934|NCT02918968|4031672|FG000|1st Line AAT|Lost to Follow-up|0
2318935|NCT02918968|4031673|FG001|1st Line AAT|Lost to Follow-up|1
2318936|NCT02918968|4031672|FG000|1st Line AAT|Death|1
2318937|NCT02918968|4031673|FG001|1st Line AAT|Death|0
2318938|NCT02918968|4031672|FG000|1st Line AAT|Miscellaneous|1
2318939|NCT02918968|4031673|FG001|1st Line AAT|Miscellaneous|0
2318940|NCT02918968|4031672|FG000|2nd Line AAT|Progressive disease|21
2318941|NCT02918968|4031673|FG001|2nd Line AAT|Progressive disease|3
2318942|NCT02918968|4031672|FG000|2nd Line AAT|Adverse Event|2
2318943|NCT02918968|4031673|FG001|2nd Line AAT|Adverse Event|5
2318944|NCT02918968|4031672|FG000|2nd Line AAT|Physician Decision|0
2318945|NCT02918968|4031673|FG001|2nd Line AAT|Physician Decision|1
2318946|NCT02918968|4031672|FG000|2nd Line AAT|Withdrawal by Subject|2
2318947|NCT02918968|4031673|FG001|2nd Line AAT|Withdrawal by Subject|2
2318948|NCT02918968|4031672|FG000|2nd Line AAT|Death|0
2318949|NCT02918968|4031673|FG001|2nd Line AAT|Death|1
2318950|NCT02919267|4031693|FG000|Overall Study|Protocol Violation|0
2318951|NCT02919267|4031694|FG001|Overall Study|Protocol Violation|3
2318952|NCT02919267|4031695|FG002|Overall Study|Protocol Violation|3
2318953|NCT02919267|4031696|FG003|Overall Study|Protocol Violation|4
2318954|NCT02919475|4031720|FG000|Overall Study|Adverse Event|3
2318955|NCT02919475|4031721|FG001|Overall Study|Adverse Event|3
2318956|NCT02919475|4031722|FG002|Overall Study|Adverse Event|3
2318957|NCT02919475|4031723|FG003|Overall Study|Adverse Event|9
2318958|NCT02919475|4031724|FG004|Overall Study|Adverse Event|2
2318959|NCT02919475|4031720|FG000|Overall Study|Death|0
2318960|NCT02919475|4031721|FG001|Overall Study|Death|1
2318961|NCT02919475|4031722|FG002|Overall Study|Death|0
2318962|NCT02919475|4031723|FG003|Overall Study|Death|0
2318963|NCT02919475|4031724|FG004|Overall Study|Death|0
2318964|NCT02919475|4031720|FG000|Overall Study|Lost to Follow-up|0
2318965|NCT02919475|4031721|FG001|Overall Study|Lost to Follow-up|0
2318966|NCT02919475|4031722|FG002|Overall Study|Lost to Follow-up|0
2318967|NCT02919475|4031723|FG003|Overall Study|Lost to Follow-up|1
2318968|NCT02919475|4031724|FG004|Overall Study|Lost to Follow-up|0
2318969|NCT02919475|4031720|FG000|Overall Study|Withdrawal by Subject|2
2318970|NCT02919475|4031721|FG001|Overall Study|Withdrawal by Subject|3
2318971|NCT02919475|4031722|FG002|Overall Study|Withdrawal by Subject|1
2318972|NCT02919475|4031723|FG003|Overall Study|Withdrawal by Subject|2
2318973|NCT02919475|4031724|FG004|Overall Study|Withdrawal by Subject|2
2318974|NCT02919475|4031720|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
2318975|NCT02919475|4031721|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1
2318976|NCT02919475|4031722|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1
2322301|NCT02970292|4037228|FG001|Overall Study|Adverse Event|0
2215509|NCT01695239|3858312|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0
2215510|NCT01695239|3858313|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0
2215511|NCT01695239|3858314|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0
2215512|NCT01695239|3858315|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0
2215513|NCT01695239|3858316|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0
2215514|NCT01695239|3858317|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0
2215515|NCT01695239|3858318|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0
2215516|NCT01695239|3858305|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
2215517|NCT01695239|3858306|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2215518|NCT01695239|3858307|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
2215519|NCT01695239|3858308|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2215520|NCT01695239|3858309|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2215521|NCT01695239|3858310|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2215522|NCT01695239|3858311|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2215523|NCT01695239|3858312|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2215524|NCT01695239|3858313|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2215525|NCT01695239|3858314|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2215526|NCT01695239|3858315|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2215527|NCT01695239|3858316|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2215528|NCT01695239|3858317|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2217579|NCT01709110|3860890|FG000|Overall Study|Withdrawal by Subject|96
2215529|NCT01695239|3858318|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2215530|NCT01695239|3858305|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
2215531|NCT01695239|3858306|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
2215532|NCT01695239|3858307|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
2215533|NCT01695239|3858308|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2215534|NCT01695239|3858309|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2215535|NCT01695239|3858310|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2215536|NCT01695239|3858311|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2215537|NCT01695239|3858312|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2215538|NCT01695239|3858313|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2215539|NCT01695239|3858314|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2215540|NCT01695239|3858315|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2215541|NCT01695239|3858316|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2215542|NCT01695239|3858317|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2215543|NCT01695239|3858318|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2215544|NCT01695239|3858305|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3
2215545|NCT01695239|3858306|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215546|NCT01695239|3858307|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1
2215547|NCT01695239|3858308|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215548|NCT01695239|3858309|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215549|NCT01695239|3858310|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215550|NCT01695239|3858311|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215551|NCT01695239|3858312|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215552|NCT01695239|3858313|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215553|NCT01695239|3858314|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215554|NCT01695239|3858315|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215555|NCT01695239|3858316|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215556|NCT01695239|3858317|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215557|NCT01695239|3858318|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2215558|NCT01695239|3858305|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2215559|NCT01695239|3858306|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215560|NCT01695239|3858307|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2215561|NCT01695239|3858308|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215562|NCT01695239|3858309|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215563|NCT01695239|3858310|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215564|NCT01695239|3858311|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215565|NCT01695239|3858312|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215566|NCT01695239|3858313|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215567|NCT01695239|3858314|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215568|NCT01695239|3858315|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215569|NCT01695239|3858316|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215570|NCT01695239|3858317|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215571|NCT01695239|3858318|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2215572|NCT01695239|3858305|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1
2215573|NCT01695239|3858306|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215574|NCT01695239|3858307|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215575|NCT01695239|3858308|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215576|NCT01695239|3858309|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215577|NCT01695239|3858310|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215578|NCT01695239|3858311|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215579|NCT01695239|3858312|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0
2217580|NCT01709110|3860891|FG001|Overall Study|Withdrawal by Subject|89
2215580|NCT01695239|3858313|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215581|NCT01695239|3858314|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215582|NCT01695239|3858315|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215583|NCT01695239|3858316|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215584|NCT01695239|3858317|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215585|NCT01695239|3858318|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0
2215586|NCT01695239|3858305|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215587|NCT01695239|3858306|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215588|NCT01695239|3858307|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215589|NCT01695239|3858308|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215590|NCT01695239|3858309|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215591|NCT01695239|3858310|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215592|NCT01695239|3858311|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215593|NCT01695239|3858312|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
2215594|NCT01695239|3858313|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215595|NCT01695239|3858314|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215596|NCT01695239|3858315|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215597|NCT01695239|3858316|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215598|NCT01695239|3858317|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215599|NCT01695239|3858318|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2215600|NCT01695239|3858305|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2215601|NCT01695239|3858306|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2215602|NCT01695239|3858307|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2215603|NCT01695239|3858308|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2215604|NCT01695239|3858309|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2215605|NCT01695239|3858310|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2215606|NCT01695239|3858311|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2215607|NCT01695239|3858312|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
2215608|NCT01695239|3858313|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2215609|NCT01695239|3858314|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2318977|NCT02919475|4031723|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1
2318978|NCT02919475|4031724|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2318979|NCT02919696|4031745|FG000|Overall Study|Adverse Event|1
2318980|NCT02919696|4031746|FG001|Overall Study|Adverse Event|2
2215610|NCT01695239|3858315|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2215611|NCT01695239|3858316|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2215612|NCT01695239|3858317|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2217581|NCT01709110|3860890|FG000|Overall Study|Physician Decision|4
2318981|NCT02919696|4031745|FG000|Overall Study|Withdrawal by Subject|2
2318982|NCT02919696|4031746|FG001|Overall Study|Withdrawal by Subject|1
2318983|NCT02919696|4031745|FG000|Overall Study|Sponsor Decision|1
2318984|NCT02919696|4031746|FG001|Overall Study|Sponsor Decision|1
2318985|NCT02919696|4031745|FG000|Overall Study|Never Treated|0
2318986|NCT02919696|4031746|FG001|Overall Study|Never Treated|1
2318987|NCT02919761|4031758|FG000|Part 1: Open Label|Withdrawal by Subject|12
2318988|NCT02919761|4031759|FG001|Part 1: Open Label|Withdrawal by Subject|0
2318989|NCT02919761|4031760|FG002|Part 1: Open Label|Withdrawal by Subject|0
2318990|NCT02919761|4031758|FG000|Part 1: Open Label|Adverse Event|1
2215613|NCT01695239|3858318|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2215614|NCT01695239|3858305|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2215615|NCT01695239|3858306|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2318991|NCT02919761|4031759|FG001|Part 1: Open Label|Adverse Event|0
2318992|NCT02919761|4031760|FG002|Part 1: Open Label|Adverse Event|0
2318993|NCT02919761|4031758|FG000|Part 1: Open Label|Lost to Follow-up|1
2318994|NCT02919761|4031759|FG001|Part 1: Open Label|Lost to Follow-up|0
2318995|NCT02919761|4031760|FG002|Part 1: Open Label|Lost to Follow-up|0
2318996|NCT02919761|4031758|FG000|Part 1: Open Label|Met withdrawal criteria|5
2318997|NCT02919761|4031759|FG001|Part 1: Open Label|Met withdrawal criteria|0
2318998|NCT02919761|4031760|FG002|Part 1: Open Label|Met withdrawal criteria|0
2318999|NCT02919761|4031758|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
2319000|NCT02919761|4031759|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
2215616|NCT01695239|3858307|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2215617|NCT01695239|3858308|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2217582|NCT01709110|3860891|FG001|Overall Study|Physician Decision|10
2319001|NCT02919761|4031760|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
2319002|NCT02919761|4031758|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1
2319003|NCT02919761|4031759|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0
2319004|NCT02919761|4031760|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0
2319005|NCT02919761|4031758|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1
2319006|NCT02919761|4031759|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0
2319007|NCT02919761|4031760|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0
2319008|NCT02919761|4031758|FG000|Part 1: Open Label|Termination by Sponsor|1
2319009|NCT02919761|4031759|FG001|Part 1: Open Label|Termination by Sponsor|0
2319010|NCT02919761|4031760|FG002|Part 1: Open Label|Termination by Sponsor|0
2319011|NCT02919761|4031758|FG000|Part 2: Double-blind|Withdrawal by Subject|0
2319012|NCT02919761|4031759|FG001|Part 2: Double-blind|Withdrawal by Subject|0
2319013|NCT02919761|4031760|FG002|Part 2: Double-blind|Withdrawal by Subject|2
2319014|NCT02919761|4031758|FG000|Part 2: Double-blind|Adverse Event|0
2319015|NCT02919761|4031759|FG001|Part 2: Double-blind|Adverse Event|1
2319016|NCT02919761|4031760|FG002|Part 2: Double-blind|Adverse Event|0
2319017|NCT02919761|4031758|FG000|Part 2: Double-blind|Lost to Follow-up|0
2319018|NCT02919761|4031759|FG001|Part 2: Double-blind|Lost to Follow-up|0
2215618|NCT01695239|3858309|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2215619|NCT01695239|3858310|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2215620|NCT01695239|3858311|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2215621|NCT01695239|3858312|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
2215622|NCT01695239|3858313|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2215623|NCT01695239|3858314|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2215624|NCT01695239|3858315|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2215625|NCT01695239|3858316|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2215626|NCT01695239|3858317|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2215627|NCT01695239|3858318|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2215628|NCT01695239|3858305|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215629|NCT01695239|3858306|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215630|NCT01695239|3858307|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215631|NCT01695239|3858308|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215632|NCT01695239|3858309|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215633|NCT01695239|3858310|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215634|NCT01695239|3858311|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215635|NCT01695239|3858312|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215636|NCT01695239|3858313|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37
2215637|NCT01695239|3858314|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31
2215638|NCT01695239|3858315|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215639|NCT01695239|3858316|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215640|NCT01695239|3858317|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215641|NCT01695239|3858318|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0
2215642|NCT01695239|3858305|FG000|Extension Long-Term Extension Periods|Adverse Event|0
2215643|NCT01695239|3858306|FG001|Extension Long-Term Extension Periods|Adverse Event|0
2215644|NCT01695239|3858307|FG002|Extension Long-Term Extension Periods|Adverse Event|0
2215645|NCT01695239|3858308|FG003|Extension Long-Term Extension Periods|Adverse Event|0
2215646|NCT01695239|3858309|FG004|Extension Long-Term Extension Periods|Adverse Event|0
2215647|NCT01695239|3858310|FG005|Extension Long-Term Extension Periods|Adverse Event|0
2215648|NCT01695239|3858311|FG006|Extension Long-Term Extension Periods|Adverse Event|0
2215649|NCT01695239|3858312|FG007|Extension Long-Term Extension Periods|Adverse Event|0
2215650|NCT01695239|3858313|FG008|Extension Long-Term Extension Periods|Adverse Event|15
2215651|NCT01695239|3858314|FG009|Extension Long-Term Extension Periods|Adverse Event|21
2215652|NCT01695239|3858315|FG010|Extension Long-Term Extension Periods|Adverse Event|0
2215653|NCT01695239|3858316|FG011|Extension Long-Term Extension Periods|Adverse Event|0
2215654|NCT01695239|3858317|FG012|Extension Long-Term Extension Periods|Adverse Event|0
2215655|NCT01695239|3858318|FG013|Extension Long-Term Extension Periods|Adverse Event|0
2215656|NCT01695239|3858305|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215657|NCT01695239|3858306|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215658|NCT01695239|3858307|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215659|NCT01695239|3858308|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215660|NCT01695239|3858309|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215661|NCT01695239|3858310|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215662|NCT01695239|3858311|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215663|NCT01695239|3858312|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215664|NCT01695239|3858313|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6
2215665|NCT01695239|3858314|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7
2215666|NCT01695239|3858315|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215667|NCT01695239|3858316|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215668|NCT01695239|3858317|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215669|NCT01695239|3858318|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2215670|NCT01695239|3858305|FG000|Extension Long-Term Extension Periods|Physician Decision|0
2215671|NCT01695239|3858306|FG001|Extension Long-Term Extension Periods|Physician Decision|0
2215672|NCT01695239|3858307|FG002|Extension Long-Term Extension Periods|Physician Decision|0
2215673|NCT01695239|3858308|FG003|Extension Long-Term Extension Periods|Physician Decision|0
2215674|NCT01695239|3858309|FG004|Extension Long-Term Extension Periods|Physician Decision|0
2215675|NCT01695239|3858310|FG005|Extension Long-Term Extension Periods|Physician Decision|0
2215676|NCT01695239|3858311|FG006|Extension Long-Term Extension Periods|Physician Decision|0
2215677|NCT01695239|3858312|FG007|Extension Long-Term Extension Periods|Physician Decision|0
2215678|NCT01695239|3858313|FG008|Extension Long-Term Extension Periods|Physician Decision|3
2215679|NCT01695239|3858314|FG009|Extension Long-Term Extension Periods|Physician Decision|0
2215680|NCT01695239|3858315|FG010|Extension Long-Term Extension Periods|Physician Decision|0
2215681|NCT01695239|3858316|FG011|Extension Long-Term Extension Periods|Physician Decision|0
2215682|NCT01695239|3858317|FG012|Extension Long-Term Extension Periods|Physician Decision|0
2215683|NCT01695239|3858318|FG013|Extension Long-Term Extension Periods|Physician Decision|0
2215684|NCT01695239|3858305|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215685|NCT01695239|3858306|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215686|NCT01695239|3858307|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215687|NCT01695239|3858308|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215688|NCT01695239|3858309|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215689|NCT01695239|3858310|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215690|NCT01695239|3858311|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215691|NCT01695239|3858312|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215692|NCT01695239|3858313|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2
2215693|NCT01695239|3858314|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1
2215694|NCT01695239|3858315|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215695|NCT01695239|3858316|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215696|NCT01695239|3858317|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215697|NCT01695239|3858318|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0
2215698|NCT01695239|3858305|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0
2215699|NCT01695239|3858306|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0
2215700|NCT01695239|3858307|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0
2215701|NCT01695239|3858308|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0
2215702|NCT01695239|3858309|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0
2215703|NCT01695239|3858310|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0
2215704|NCT01695239|3858311|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0
2215705|NCT01695239|3858312|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0
2215706|NCT01695239|3858313|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2
2215707|NCT01695239|3858314|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1
2215708|NCT01695239|3858315|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0
2215709|NCT01695239|3858316|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0
2215710|NCT01695239|3858317|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0
2215711|NCT01695239|3858318|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0
2215712|NCT01695239|3858305|FG000|Extension Long-Term Extension Periods|Death|0
2215713|NCT01695239|3858306|FG001|Extension Long-Term Extension Periods|Death|0
2215714|NCT01695239|3858307|FG002|Extension Long-Term Extension Periods|Death|0
2215715|NCT01695239|3858308|FG003|Extension Long-Term Extension Periods|Death|0
2215716|NCT01695239|3858309|FG004|Extension Long-Term Extension Periods|Death|0
2215717|NCT01695239|3858310|FG005|Extension Long-Term Extension Periods|Death|0
2215718|NCT01695239|3858311|FG006|Extension Long-Term Extension Periods|Death|0
2215719|NCT01695239|3858312|FG007|Extension Long-Term Extension Periods|Death|0
2215720|NCT01695239|3858313|FG008|Extension Long-Term Extension Periods|Death|1
2215721|NCT01695239|3858314|FG009|Extension Long-Term Extension Periods|Death|0
2215722|NCT01695239|3858315|FG010|Extension Long-Term Extension Periods|Death|0
2215723|NCT01695239|3858316|FG011|Extension Long-Term Extension Periods|Death|0
2215724|NCT01695239|3858317|FG012|Extension Long-Term Extension Periods|Death|0
2215725|NCT01695239|3858318|FG013|Extension Long-Term Extension Periods|Death|0
2215726|NCT01695239|3858305|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2215727|NCT01695239|3858306|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2215728|NCT01695239|3858307|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2215729|NCT01695239|3858308|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2215730|NCT01695239|3858309|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2215731|NCT01695239|3858310|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2215732|NCT01695239|3858311|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2215733|NCT01695239|3858312|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2215734|NCT01695239|3858313|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2215735|NCT01695239|3858314|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2215736|NCT01695239|3858315|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2215737|NCT01695239|3858316|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
2215738|NCT01695239|3858317|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
2215739|NCT01695239|3858318|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
2215740|NCT01695239|3858305|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215741|NCT01695239|3858306|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215742|NCT01695239|3858307|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215743|NCT01695239|3858308|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215744|NCT01695239|3858309|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215745|NCT01695239|3858310|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215746|NCT01695239|3858311|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215747|NCT01695239|3858312|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215748|NCT01695239|3858313|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215749|NCT01695239|3858314|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215750|NCT01695239|3858315|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215751|NCT01695239|3858316|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2215752|NCT01695239|3858317|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1
2215753|NCT01695239|3858318|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
2215754|NCT01695239|3858305|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
2215755|NCT01695239|3858306|FG001|Post-Treatment Follow-Up Period|Physician Decision|0
2215756|NCT01695239|3858307|FG002|Post-Treatment Follow-Up Period|Physician Decision|0
2215757|NCT01695239|3858308|FG003|Post-Treatment Follow-Up Period|Physician Decision|0
2215758|NCT01695239|3858309|FG004|Post-Treatment Follow-Up Period|Physician Decision|0
2215759|NCT01695239|3858310|FG005|Post-Treatment Follow-Up Period|Physician Decision|0
2215760|NCT01695239|3858311|FG006|Post-Treatment Follow-Up Period|Physician Decision|0
2215761|NCT01695239|3858312|FG007|Post-Treatment Follow-Up Period|Physician Decision|0
2215762|NCT01695239|3858313|FG008|Post-Treatment Follow-Up Period|Physician Decision|0
2215763|NCT01695239|3858314|FG009|Post-Treatment Follow-Up Period|Physician Decision|0
2215764|NCT01695239|3858315|FG010|Post-Treatment Follow-Up Period|Physician Decision|0
2215765|NCT01695239|3858316|FG011|Post-Treatment Follow-Up Period|Physician Decision|0
2215766|NCT01695239|3858317|FG012|Post-Treatment Follow-Up Period|Physician Decision|2
2215767|NCT01695239|3858318|FG013|Post-Treatment Follow-Up Period|Physician Decision|0
2215768|NCT01695239|3858305|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
2215769|NCT01695239|3858306|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
2215770|NCT01695239|3858307|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
2215771|NCT01695239|3858308|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
2215772|NCT01695239|3858309|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
2215773|NCT01695239|3858310|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
2319019|NCT02919761|4031760|FG002|Part 2: Double-blind|Lost to Follow-up|3
2319020|NCT02919761|4031758|FG000|Part 2: Double-blind|Met withdrawal criteria|0
2319021|NCT02919761|4031759|FG001|Part 2: Double-blind|Met withdrawal criteria|1
2319022|NCT02919761|4031760|FG002|Part 2: Double-blind|Met withdrawal criteria|2
2319023|NCT02919761|4031758|FG000|Part 2: Double-blind|Worsening of disease activity|0
2319024|NCT02919761|4031759|FG001|Part 2: Double-blind|Worsening of disease activity|4
2319025|NCT02919761|4031760|FG002|Part 2: Double-blind|Worsening of disease activity|10
2215774|NCT01695239|3858311|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
2319026|NCT02919761|4031758|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0
2319027|NCT02919761|4031759|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0
2319028|NCT02919761|4031760|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1
2319029|NCT02919761|4031758|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0
2319030|NCT02919761|4031759|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0
2319031|NCT02919761|4031760|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1
2319032|NCT02919761|4031758|FG000|Part 2: Double-blind|Discontinued exclusion 16|0
2319033|NCT02919761|4031759|FG001|Part 2: Double-blind|Discontinued exclusion 16|0
2319034|NCT02919761|4031760|FG002|Part 2: Double-blind|Discontinued exclusion 16|2
2319035|NCT02919995|4031797|FG000|Overall Study|Adverse Event|0
2319036|NCT02919995|4031798|FG001|Overall Study|Adverse Event|0
2319037|NCT02919995|4031799|FG002|Overall Study|Adverse Event|0
2319038|NCT02919995|4031800|FG003|Overall Study|Adverse Event|0
2319039|NCT02919995|4031801|FG004|Overall Study|Adverse Event|0
2319040|NCT02919995|4031802|FG005|Overall Study|Adverse Event|1
2319041|NCT02920528|4031817|FG000|Overall Study|Incomplete Data|1
2319042|NCT02920528|4031818|FG001|Overall Study|Incomplete Data|1
2319043|NCT02920528|4031819|FG002|Overall Study|Incomplete Data|1
2319044|NCT02920528|4031817|FG000|Overall Study|Adverse Event|0
2319045|NCT02920528|4031818|FG001|Overall Study|Adverse Event|0
2319046|NCT02920528|4031819|FG002|Overall Study|Adverse Event|3
2319047|NCT02920528|4031817|FG000|Overall Study|Did not meet inclusion criteria|2
2319048|NCT02920528|4031818|FG001|Overall Study|Did not meet inclusion criteria|0
2319049|NCT02920528|4031819|FG002|Overall Study|Did not meet inclusion criteria|1
2319050|NCT02920957|4031857|FG000|First Intervention : 1 Month|Withdrawal by Subject|2
2319051|NCT02920957|4031858|FG001|First Intervention : 1 Month|Withdrawal by Subject|0
2319052|NCT02920957|4031857|FG000|First Intervention : 1 Month|Lost to Follow-up|1
2319053|NCT02920957|4031858|FG001|First Intervention : 1 Month|Lost to Follow-up|0
2319054|NCT02920957|4031857|FG000|First Intervention : 1 Month|Adverse Event|1
2319055|NCT02920957|4031858|FG001|First Intervention : 1 Month|Adverse Event|0
2319056|NCT02920957|4031857|FG000|Second Intervention: 1 Month|Lost to Follow-up|0
2319057|NCT02920957|4031858|FG001|Second Intervention: 1 Month|Lost to Follow-up|1
2319058|NCT02920970|4031875|FG000|First Intervention|Protocol Violation|0
2319059|NCT02920970|4031876|FG001|First Intervention|Protocol Violation|1
2319060|NCT02920970|4031875|FG000|First Intervention|Adverse Event|0
2319061|NCT02920970|4031876|FG001|First Intervention|Adverse Event|1
2319062|NCT02920970|4031875|FG000|Second Intervention|Poor Lens Fit|1
2319063|NCT02920970|4031876|FG001|Second Intervention|Poor Lens Fit|0
2319064|NCT02920983|4031884|FG000|Dispense 1|Unacceptable Lens Fit|0
2319065|NCT02920983|4031885|FG001|Dispense 1|Unacceptable Lens Fit|0
2217583|NCT01709110|3860890|FG000|Overall Study|Sponsor Decision|2
2215775|NCT01695239|3858312|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
2215776|NCT01695239|3858313|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
2215777|NCT01695239|3858314|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
2217584|NCT01709110|3860891|FG001|Overall Study|Sponsor Decision|2
2215778|NCT01695239|3858315|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
2215779|NCT01695239|3858316|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
2217585|NCT01709110|3860890|FG000|Overall Study|Lack of Efficacy|1
2215780|NCT01695239|3858317|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
2215781|NCT01695239|3858318|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
2215782|NCT01695746|3858385|FG000|Overall Study|Adverse Event|1
2215783|NCT01695746|3858385|FG000|Overall Study|Non-compliance by the participant|3
2215784|NCT01695746|3858385|FG000|Overall Study|Protocol Violation|5
2215785|NCT01695746|3858385|FG000|Overall Study|Participant not willing to participate|3
2215786|NCT01695772|3858390|FG000|Overall Study|Withdrawal by Subject|18
2215787|NCT01695772|3858390|FG000|Overall Study|Progressive Disease|8
2215788|NCT01695772|3858390|FG000|Overall Study|Investigator Decision|5
2215789|NCT01695772|3858390|FG000|Overall Study|Lost to Follow-up|4
2215790|NCT01695772|3858390|FG000|Overall Study|Protocol Violation|2
2215791|NCT01695772|3858390|FG000|Overall Study|Unspecified Reason|1
2215792|NCT01695954|3858396|FG000|Overall Study|Withdrawal by Subject|4
2215793|NCT01695954|3858397|FG001|Overall Study|Withdrawal by Subject|0
2215794|NCT01695954|3858396|FG000|Overall Study|Adverse Event|0
2215795|NCT01695954|3858397|FG001|Overall Study|Adverse Event|2
2319066|NCT02920983|4031886|FG002|Dispense 1|Unacceptable Lens Fit|0
2319067|NCT02920983|4031887|FG003|Dispense 1|Unacceptable Lens Fit|0
2319068|NCT02920983|4031888|FG004|Dispense 1|Unacceptable Lens Fit|1
2319069|NCT02920983|4031889|FG005|Dispense 1|Unacceptable Lens Fit|0
2319070|NCT02920983|4031884|FG000|Dispense 2|Unscceptable lens fit|1
2319071|NCT02920983|4031885|FG001|Dispense 2|Unscceptable lens fit|0
2319072|NCT02920983|4031886|FG002|Dispense 2|Unscceptable lens fit|0
2319073|NCT02920983|4031887|FG003|Dispense 2|Unscceptable lens fit|0
2319074|NCT02920983|4031888|FG004|Dispense 2|Unscceptable lens fit|1
2319075|NCT02920983|4031889|FG005|Dispense 2|Unscceptable lens fit|0
2319076|NCT02920983|4031884|FG000|Dispense 3|Unacceptable Lens Fit|1
2319077|NCT02920983|4031885|FG001|Dispense 3|Unacceptable Lens Fit|1
2319078|NCT02920983|4031886|FG002|Dispense 3|Unacceptable Lens Fit|0
2319079|NCT02920983|4031887|FG003|Dispense 3|Unacceptable Lens Fit|0
2319080|NCT02920983|4031888|FG004|Dispense 3|Unacceptable Lens Fit|1
2319081|NCT02920983|4031889|FG005|Dispense 3|Unacceptable Lens Fit|0
2215796|NCT01695993|3858408|FG000|Overall Study|Lost to Follow-up|2
2319082|NCT02921087|4031903|FG000|Overall Study|Withdrawal by Subject|0
2319083|NCT02921087|4031904|FG001|Overall Study|Withdrawal by Subject|1
2319084|NCT02921425|4031948|FG000|Overall Study|Protocol Violation|9
2319085|NCT02921750|4031962|FG000|Overall Study|Adverse Event|1
2215797|NCT01695993|3858409|FG001|Overall Study|Lost to Follow-up|1
2215798|NCT01695993|3858410|FG002|Overall Study|Lost to Follow-up|3
2215799|NCT01695993|3858408|FG000|Overall Study|Withdrawal by Subject|2
2215800|NCT01695993|3858409|FG001|Overall Study|Withdrawal by Subject|2
2215801|NCT01695993|3858410|FG002|Overall Study|Withdrawal by Subject|2
2215802|NCT01695993|3858408|FG000|Overall Study|To ill to continue|1
2215803|NCT01695993|3858409|FG001|Overall Study|To ill to continue|2
2215804|NCT01695993|3858410|FG002|Overall Study|To ill to continue|0
2215805|NCT01695993|3858408|FG000|Overall Study|Changed Medical Facility|0
2215806|NCT01695993|3858409|FG001|Overall Study|Changed Medical Facility|0
2215807|NCT01695993|3858410|FG002|Overall Study|Changed Medical Facility|1
2215808|NCT01696032|3858422|FG000|Overall Study|Withdrawal by Subject|0
2215809|NCT01696032|3858423|FG001|Overall Study|Withdrawal by Subject|0
2215810|NCT01696032|3858424|FG002|Overall Study|Withdrawal by Subject|1
2215811|NCT01696032|3858425|FG003|Overall Study|Withdrawal by Subject|2
2215812|NCT01696032|3858422|FG000|Overall Study|Death|14
2215813|NCT01696032|3858423|FG001|Overall Study|Death|4
2215814|NCT01696032|3858424|FG002|Overall Study|Death|43
2215815|NCT01696032|3858425|FG003|Overall Study|Death|18
2215816|NCT01696032|3858422|FG000|Overall Study|Lost to Follow-up|0
2215817|NCT01696032|3858423|FG001|Overall Study|Lost to Follow-up|1
2215818|NCT01696032|3858424|FG002|Overall Study|Lost to Follow-up|0
2215819|NCT01696032|3858425|FG003|Overall Study|Lost to Follow-up|0
2215820|NCT01696032|3858422|FG000|Overall Study|Database lock|0
2215821|NCT01696032|3858423|FG001|Overall Study|Database lock|1
2215822|NCT01696032|3858424|FG002|Overall Study|Database lock|7
2215823|NCT01696032|3858425|FG003|Overall Study|Database lock|2
2215824|NCT01696045|3858441|FG000|Overall Study|Study drug toxicity|1
2319086|NCT02921750|4031963|FG001|Overall Study|Adverse Event|2
2319087|NCT02921750|4031962|FG000|Overall Study|Withdrawal by Subject|1
2319088|NCT02921750|4031963|FG001|Overall Study|Withdrawal by Subject|1
2319089|NCT02921750|4031962|FG000|Overall Study|Lost to Follow-up|3
2319090|NCT02921750|4031963|FG001|Overall Study|Lost to Follow-up|3
2319091|NCT02921750|4031962|FG000|Overall Study|Wound healed|3
2319092|NCT02921750|4031963|FG001|Overall Study|Wound healed|3
2319093|NCT02921750|4031962|FG000|Overall Study|Serious Adverse Event|1
2319094|NCT02921750|4031963|FG001|Overall Study|Serious Adverse Event|2
2319095|NCT02922153|4031983|FG000|Overall Study|Death|8
2319096|NCT02922153|4031984|FG001|Overall Study|Death|1
2319097|NCT02922153|4031983|FG000|Overall Study|Lost to Follow-up|1
2319098|NCT02922153|4031984|FG001|Overall Study|Lost to Follow-up|0
2319099|NCT02922153|4031983|FG000|Overall Study|Physician Decision|1
2319100|NCT02922153|4031984|FG001|Overall Study|Physician Decision|1
2319101|NCT02922634|4032007|FG000|Overall Study|Withdrawal by Subject|5
2215825|NCT01696045|3858442|FG001|Overall Study|Study drug toxicity|5
2215826|NCT01696045|3858441|FG000|Overall Study|Disease progression|2
2215827|NCT01696045|3858442|FG001|Overall Study|Disease progression|2
2215828|NCT01696058|3858450|FG000|Overall Study|Adverse Event|21
2215829|NCT01696058|3858451|FG001|Overall Study|Adverse Event|11
2215830|NCT01696058|3858450|FG000|Overall Study|Lack of Efficacy|2
2215831|NCT01696058|3858451|FG001|Overall Study|Lack of Efficacy|3
2319102|NCT02922634|4032007|FG000|Overall Study|Did not have their surgery|5
2319103|NCT02923115|4032053|FG000|Overall Study|Lost to Follow-up|0
2319104|NCT02923115|4032054|FG001|Overall Study|Lost to Follow-up|0
2319105|NCT02923115|4032055|FG002|Overall Study|Lost to Follow-up|0
2319106|NCT02923115|4032056|FG003|Overall Study|Lost to Follow-up|1
2319107|NCT02923115|4032057|FG004|Overall Study|Lost to Follow-up|0
2319108|NCT02923115|4032058|FG005|Overall Study|Lost to Follow-up|0
2319109|NCT02923115|4032053|FG000|Overall Study|Withdrawal by Subject|0
2319110|NCT02923115|4032054|FG001|Overall Study|Withdrawal by Subject|1
2319111|NCT02923115|4032055|FG002|Overall Study|Withdrawal by Subject|0
2319112|NCT02923115|4032056|FG003|Overall Study|Withdrawal by Subject|0
2215832|NCT01696058|3858450|FG000|Overall Study|Protocol Violation|9
2215833|NCT01696058|3858451|FG001|Overall Study|Protocol Violation|3
2215834|NCT01696058|3858450|FG000|Overall Study|Lost to Follow-up|2
2215835|NCT01696058|3858451|FG001|Overall Study|Lost to Follow-up|5
2215836|NCT01696058|3858450|FG000|Overall Study|Withdrawal by Subject|4
2215837|NCT01696058|3858451|FG001|Overall Study|Withdrawal by Subject|6
2215838|NCT01696058|3858450|FG000|Overall Study|Other reason prematurely discontinued|5
2215839|NCT01696058|3858451|FG001|Overall Study|Other reason prematurely discontinued|3
2215840|NCT01696071|3858457|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1
2215841|NCT01696071|3858458|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0
2215842|NCT01696188|3858476|FG000|Overall Study|Protocol Violation|1
2215843|NCT01696188|3858477|FG001|Overall Study|Protocol Violation|1
2215844|NCT01696214|3858487|FG000|Overall Study|Lost to Follow-up|1
2215845|NCT01696214|3858488|FG001|Overall Study|Lost to Follow-up|0
2215846|NCT01696214|3858489|FG002|Overall Study|Lost to Follow-up|0
2215847|NCT01696214|3858490|FG003|Overall Study|Lost to Follow-up|0
2215848|NCT01696279|3858508|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
2215849|NCT01696279|3858509|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
2215850|NCT01696279|3858510|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
2215851|NCT01696279|3858511|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
2215852|NCT01696279|3858508|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
2215853|NCT01696279|3858509|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
2215854|NCT01696279|3858510|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
2215855|NCT01696279|3858511|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
2215856|NCT01696279|3858508|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
2215857|NCT01696279|3858509|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
2215858|NCT01696279|3858510|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
2215859|NCT01696279|3858511|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
2215860|NCT01696279|3858508|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
2215861|NCT01696279|3858509|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
2215862|NCT01696279|3858510|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
2104873|NCT00853827|3697282|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1
2104874|NCT00853827|3697283|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0
2104875|NCT00853827|3697282|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9
2104876|NCT00853827|3697283|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0
2104877|NCT00853827|3697282|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1
2104878|NCT00853827|3697283|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0
2104879|NCT00853827|3697282|FG000|Single Blind Period (1 Week)|Protocol Violation|12
2104880|NCT00853827|3697283|FG001|Single Blind Period (1 Week)|Protocol Violation|0
2104881|NCT00853827|3697282|FG000|Double Blind Period (103 Weeks)|Adverse Event|25
2104882|NCT00853827|3697283|FG001|Double Blind Period (103 Weeks)|Adverse Event|14
2104883|NCT00853827|3697282|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
2104884|NCT00853827|3697283|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
2104885|NCT00853827|3697282|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1
2104886|NCT00853827|3697283|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0
2104887|NCT00853827|3697282|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3
2104888|NCT00853827|3697283|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1
2104889|NCT00853827|3697282|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2
2104890|NCT00853827|3697283|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1
2104891|NCT00853827|3697282|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
2104892|NCT00853827|3697283|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
2104893|NCT00853827|3697282|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8
2104894|NCT00853827|3697283|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10
2104895|NCT00853827|3697282|FG000|Double Blind Period (103 Weeks)|Administrative problems|45
2104896|NCT00853827|3697283|FG001|Double Blind Period (103 Weeks)|Administrative problems|56
2104897|NCT00853827|3697282|FG000|Double Blind Period (103 Weeks)|Death|1
2104898|NCT00853827|3697283|FG001|Double Blind Period (103 Weeks)|Death|6
2104899|NCT00853905|3697299|FG000|Overall Study|Lost to Follow-up|1
2104900|NCT00853905|3697300|FG001|Overall Study|Lost to Follow-up|3
2104901|NCT00853905|3697299|FG000|Overall Study|Withdrawal by Subject|0
2104902|NCT00853905|3697300|FG001|Overall Study|Withdrawal by Subject|1
2215863|NCT01696279|3858511|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
2215864|NCT01696279|3858508|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
2215865|NCT01696279|3858509|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
2215866|NCT01696279|3858510|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
2215867|NCT01696279|3858511|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
2215868|NCT01696279|3858508|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
2215869|NCT01696279|3858509|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
2215870|NCT01696279|3858510|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
2215871|NCT01696279|3858511|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
2215872|NCT01696279|3858508|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
2215873|NCT01696279|3858509|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
2215874|NCT01696279|3858510|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
2215875|NCT01696279|3858511|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
2215876|NCT01696279|3858508|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
2215877|NCT01696279|3858509|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
2215878|NCT01696279|3858510|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
2215879|NCT01696279|3858511|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
2215880|NCT01696279|3858508|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
2215881|NCT01696279|3858509|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
2215882|NCT01696279|3858510|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
2215883|NCT01696279|3858511|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
2215884|NCT01696279|3858508|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
2215885|NCT01696279|3858509|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
2215886|NCT01696279|3858510|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
2215887|NCT01696279|3858511|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
2215888|NCT01696279|3858508|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
2215889|NCT01696279|3858509|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
2215890|NCT01696279|3858510|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
2215891|NCT01696279|3858511|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
2215892|NCT01696396|3858533|FG000|Overall Study|Withdrawal by Subject|19
2215893|NCT01696396|3858534|FG001|Overall Study|Withdrawal by Subject|5
2215894|NCT01696396|3858535|FG002|Overall Study|Withdrawal by Subject|19
2215895|NCT01696396|3858536|FG003|Overall Study|Withdrawal by Subject|11
2215896|NCT01696396|3858533|FG000|Overall Study|Decision by Sponsor|3
2215897|NCT01696396|3858534|FG001|Overall Study|Decision by Sponsor|1
2215898|NCT01696396|3858535|FG002|Overall Study|Decision by Sponsor|2
2215899|NCT01696396|3858536|FG003|Overall Study|Decision by Sponsor|2
2215900|NCT01696396|3858533|FG000|Overall Study|Lost to Follow-up|9
2215901|NCT01696396|3858534|FG001|Overall Study|Lost to Follow-up|1
2215902|NCT01696396|3858535|FG002|Overall Study|Lost to Follow-up|4
2215903|NCT01696396|3858536|FG003|Overall Study|Lost to Follow-up|1
2215904|NCT01696396|3858533|FG000|Overall Study|Death|0
2215905|NCT01696396|3858534|FG001|Overall Study|Death|0
2215906|NCT01696396|3858535|FG002|Overall Study|Death|1
2215907|NCT01696396|3858536|FG003|Overall Study|Death|0
2215908|NCT01696643|3858552|FG000|Overall Study|Adverse Event|15
2215909|NCT01696643|3858553|FG001|Overall Study|Adverse Event|7
2215910|NCT01696643|3858552|FG000|Overall Study|Death|1
2215911|NCT01696643|3858553|FG001|Overall Study|Death|2
2215912|NCT01696643|3858552|FG000|Overall Study|Lack of Efficacy|3
2215913|NCT01696643|3858553|FG001|Overall Study|Lack of Efficacy|0
2215914|NCT01696643|3858552|FG000|Overall Study|Lost to Follow-up|67
2215915|NCT01696643|3858553|FG001|Overall Study|Lost to Follow-up|67
2215916|NCT01696643|3858552|FG000|Overall Study|Physician Decision|3
2215917|NCT01696643|3858553|FG001|Overall Study|Physician Decision|2
2215918|NCT01696643|3858552|FG000|Overall Study|Pregnancy|0
2215919|NCT01696643|3858553|FG001|Overall Study|Pregnancy|1
2215920|NCT01696643|3858552|FG000|Overall Study|Protocol Violation|7
2215921|NCT01696643|3858553|FG001|Overall Study|Protocol Violation|7
2215922|NCT01696643|3858552|FG000|Overall Study|Study Terminated by Sponsor|286
2215923|NCT01696643|3858553|FG001|Overall Study|Study Terminated by Sponsor|294
2215924|NCT01696643|3858552|FG000|Overall Study|Withdrawal by Subject|142
2215925|NCT01696643|3858553|FG001|Overall Study|Withdrawal by Subject|149
2215926|NCT01696643|3858552|FG000|Overall Study|Participant on Restricted Bed Rest|1
2215927|NCT01696643|3858553|FG001|Overall Study|Participant on Restricted Bed Rest|0
2215928|NCT01696643|3858552|FG000|Overall Study|Site Error|2
2215929|NCT01696643|3858553|FG001|Overall Study|Site Error|1
2215930|NCT01696643|3858552|FG000|Overall Study|Participant Incarcerated|0
2215931|NCT01696643|3858553|FG001|Overall Study|Participant Incarcerated|1
2215932|NCT01696643|3858552|FG000|Overall Study|Medical Monitor Decision|0
2215933|NCT01696643|3858553|FG001|Overall Study|Medical Monitor Decision|2
2215934|NCT01696643|3858552|FG000|Overall Study|Participant Did Not Receive Study Drug|2
2215935|NCT01696643|3858553|FG001|Overall Study|Participant Did Not Receive Study Drug|2
2215936|NCT01696695|3858559|FG000|Overall Study|Disease progression|373
2215937|NCT01696695|3858559|FG000|Overall Study|Death|29
2215938|NCT01696695|3858559|FG000|Overall Study|Adverse Event|74
2215939|NCT01696695|3858559|FG000|Overall Study|Withdrawal by Subject|92
2215940|NCT01696695|3858559|FG000|Overall Study|Lost to Follow-up|48
2215941|NCT01696695|3858559|FG000|Overall Study|Other|74
2215942|NCT01696695|3858559|FG000|Overall Study|Major Protocol Violation|192
2215943|NCT01696773|3858574|FG000|Days 15-27, Washout|Adverse Event|1
2215944|NCT01696773|3858575|FG001|Days 15-27, Washout|Adverse Event|0
2215945|NCT01696877|3858583|FG000|Overall Study|Adverse Event|0
2215946|NCT01696877|3858584|FG001|Overall Study|Adverse Event|1
2215947|NCT01696929|3858592|FG000|Overall Study|Physician Decision|1
2215948|NCT01696942|3858598|FG000|Overall Study|Withdrawal by Subject|1
2215949|NCT01696942|3858599|FG001|Overall Study|Withdrawal by Subject|0
2215950|NCT01696942|3858598|FG000|Overall Study|Protocol Violation|1
2215951|NCT01696942|3858599|FG001|Overall Study|Protocol Violation|2
2215952|NCT01696942|3858598|FG000|Overall Study|screen failure|0
2215953|NCT01696942|3858599|FG001|Overall Study|screen failure|1
2215954|NCT01696955|3858607|FG000|Main Study|Protocol Violation|1
2215955|NCT01696955|3858608|FG001|Main Study|Protocol Violation|0
2104903|NCT00853905|3697299|FG000|Overall Study|never had surgery|1
2104904|NCT00853905|3697300|FG001|Overall Study|never had surgery|0
2104905|NCT00853957|3697311|FG000|Overall Study|Adverse Event|9
2104906|NCT00853957|3697312|FG001|Overall Study|Adverse Event|3
2104907|NCT00853957|3697311|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2104908|NCT00853957|3697312|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2104909|NCT00853957|3697311|FG000|Overall Study|Subject withdrew consent|4
2104910|NCT00853957|3697312|FG001|Overall Study|Subject withdrew consent|5
2104911|NCT00853957|3697311|FG000|Overall Study|Lost to Follow-up|1
2215956|NCT01696955|3858607|FG000|Main Study|Withdrawal by Subject|1
2215957|NCT01696955|3858608|FG001|Main Study|Withdrawal by Subject|1
2215958|NCT01696968|3858623|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0
2215959|NCT01696968|3858624|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8
2215960|NCT01696968|3858623|FG000|Overall Study|Died Before Randomization|3
2215961|NCT01696968|3858624|FG001|Overall Study|Died Before Randomization|8
2215962|NCT01696968|3858623|FG000|Overall Study|Died Before ASU (Control)|278
2215963|NCT01696968|3858624|FG001|Overall Study|Died Before ASU (Control)|0
2215964|NCT01696968|3858623|FG000|Overall Study|Refused ASU (Control)|920
2215965|NCT01696968|3858624|FG001|Overall Study|Refused ASU (Control)|0
2215966|NCT01696968|3858623|FG000|Overall Study|Refused Screen (Lung Screening)|0
2215967|NCT01696968|3858624|FG001|Overall Study|Refused Screen (Lung Screening)|6796
2215968|NCT01696981|3858633|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0
2215969|NCT01696981|3858634|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20
2215970|NCT01696981|3858633|FG000|Overall Study|Died Before Randomization|3
2215971|NCT01696981|3858634|FG001|Overall Study|Died Before Randomization|8
2215972|NCT01696981|3858633|FG000|Overall Study|Died Before ASU (Control)|278
2215973|NCT01696981|3858634|FG001|Overall Study|Died Before ASU (Control)|0
2215974|NCT01696981|3858633|FG000|Overall Study|Refused ASU (Control)|920
2215975|NCT01696981|3858634|FG001|Overall Study|Refused ASU (Control)|0
2215976|NCT01696981|3858633|FG000|Overall Study|Refused Screen (Colorectal Screening)|0
2215977|NCT01696981|3858634|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346
2215978|NCT01696994|3858642|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
2215979|NCT01696994|3858643|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
2215980|NCT01696994|3858642|FG000|Overall Study|Died Before Randomization|1
2215981|NCT01696994|3858643|FG001|Overall Study|Died Before Randomization|2
2215982|NCT01696994|3858642|FG000|Overall Study|Died Before ASU (Control)|73
2215983|NCT01696994|3858643|FG001|Overall Study|Died Before ASU (Control)|0
2215984|NCT01696994|3858642|FG000|Overall Study|No Ovaries at Baseline|4807
2215985|NCT01696994|3858643|FG001|Overall Study|No Ovaries at Baseline|4851
2215986|NCT01696994|3858642|FG000|Overall Study|Refused ASU (Control)|311
2215987|NCT01696994|3858643|FG001|Overall Study|Refused ASU (Control)|0
2215988|NCT01696994|3858642|FG000|Overall Study|Refused Screen (Ovarian Screening)|0
2215989|NCT01696994|3858643|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582
2215990|NCT01697319|3858651|FG000|Primary Phase|Withdrawal by Subject|1
2215991|NCT01697319|3858651|FG000|Extension Phase|Terminated by Sponsor|15
2215992|NCT01697345|3858655|FG000|Overall Study|Withdrawal by Subject|1
2215993|NCT01697358|3858676|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6
2319113|NCT02923115|4032057|FG004|Overall Study|Withdrawal by Subject|0
2319114|NCT02923115|4032058|FG005|Overall Study|Withdrawal by Subject|0
2319115|NCT02923115|4032053|FG000|Overall Study|Randomized, but not dosed|0
2319116|NCT02923115|4032054|FG001|Overall Study|Randomized, but not dosed|0
2319117|NCT02923115|4032055|FG002|Overall Study|Randomized, but not dosed|3
2319118|NCT02923115|4032056|FG003|Overall Study|Randomized, but not dosed|1
2319119|NCT02923115|4032057|FG004|Overall Study|Randomized, but not dosed|5
2319120|NCT02923115|4032058|FG005|Overall Study|Randomized, but not dosed|0
2319121|NCT02923180|4032077|FG000|Overall Study|Off Study Due to Detectable PSA|13
2319122|NCT02923180|4032077|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13
2319123|NCT02923245|4032083|FG000|Overall Study|ultrasound order was cancelled|2
2322302|NCT02970292|4037227|FG000|Overall Study|Lack of Efficacy|1
2215994|NCT01697358|3858677|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0
2217586|NCT01709110|3860891|FG001|Overall Study|Lack of Efficacy|1
2215995|NCT01697358|3858676|FG000|Period I: Randomization to 6 Months|Physician Decision|4
2215996|NCT01697358|3858677|FG001|Period I: Randomization to 6 Months|Physician Decision|0
2215997|NCT01697358|3858676|FG000|Period I: Randomization to 6 Months|Adverse Event|1
2215998|NCT01697358|3858677|FG001|Period I: Randomization to 6 Months|Adverse Event|1
2215999|NCT01697358|3858676|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2
2216000|NCT01697358|3858677|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0
2319124|NCT02923245|4032084|FG001|Overall Study|ultrasound order was cancelled|1
2319125|NCT02923349|4032107|FG000|Overall Study|Other|1
2319126|NCT02923349|4032108|FG001|Overall Study|Other|2
2319127|NCT02923349|4032109|FG002|Overall Study|Other|4
2319128|NCT02923349|4032110|FG003|Overall Study|Other|1
2319129|NCT02923349|4032111|FG004|Overall Study|Other|3
2216001|NCT01697358|3858676|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3
2216002|NCT01697358|3858677|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12
2216003|NCT01697358|3858676|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
2216004|NCT01697358|3858677|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
2216005|NCT01697358|3858676|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
2216006|NCT01697358|3858677|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
2216007|NCT01697358|3858676|FG000|Period II: 6-24M Long-term Follow-up|Death|1
2216008|NCT01697358|3858677|FG001|Period II: 6-24M Long-term Follow-up|Death|1
2216009|NCT01697358|3858676|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0
2216010|NCT01697358|3858677|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3
2216011|NCT01697358|3858676|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
2216012|NCT01697358|3858677|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
2216013|NCT01697449|3858683|FG000|Overall Study|Disease progression|47
2319130|NCT02923349|4032112|FG005|Overall Study|Other|0
2319131|NCT02923349|4032113|FG006|Overall Study|Other|1
2319132|NCT02923349|4032107|FG000|Overall Study|Withdrawal by Subject|2
2319133|NCT02923349|4032108|FG001|Overall Study|Withdrawal by Subject|2
2319134|NCT02923349|4032109|FG002|Overall Study|Withdrawal by Subject|8
2319135|NCT02923349|4032110|FG003|Overall Study|Withdrawal by Subject|10
2319136|NCT02923349|4032111|FG004|Overall Study|Withdrawal by Subject|12
2319137|NCT02923349|4032112|FG005|Overall Study|Withdrawal by Subject|3
2319138|NCT02923349|4032113|FG006|Overall Study|Withdrawal by Subject|0
2319139|NCT02923349|4032107|FG000|Overall Study|Physician Decision|0
2319140|NCT02923349|4032108|FG001|Overall Study|Physician Decision|0
2319141|NCT02923349|4032109|FG002|Overall Study|Physician Decision|0
2319142|NCT02923349|4032110|FG003|Overall Study|Physician Decision|1
2319143|NCT02923349|4032111|FG004|Overall Study|Physician Decision|1
2319144|NCT02923349|4032112|FG005|Overall Study|Physician Decision|0
2319145|NCT02923349|4032113|FG006|Overall Study|Physician Decision|2
2319146|NCT02923349|4032107|FG000|Overall Study|Lost to Follow-up|0
2319147|NCT02923349|4032108|FG001|Overall Study|Lost to Follow-up|0
2216014|NCT01697449|3858683|FG000|Overall Study|Adverse Event|7
2216015|NCT01697449|3858683|FG000|Overall Study|Lost to Follow-up|5
2216016|NCT01697449|3858683|FG000|Overall Study|Withdrawal by Subject|2
2216017|NCT01697449|3858683|FG000|Overall Study|Physician Decision|1
2216018|NCT01697449|3858683|FG000|Overall Study|Death|2
2216019|NCT01697449|3858683|FG000|Overall Study|Other|1
2216020|NCT01697449|3858683|FG000|Overall Study|Missing|25
2216021|NCT01697462|3858690|FG000|Overall Study|Disease Progression|1
2216022|NCT01697462|3858690|FG000|Overall Study|Adverse Event|6
2216023|NCT01697462|3858690|FG000|Overall Study|Lost to Follow-up|21
2216024|NCT01697462|3858690|FG000|Overall Study|Withdrawal by Subject|12
2216025|NCT01697462|3858690|FG000|Overall Study|Investigator Decision|21
2216026|NCT01697462|3858690|FG000|Overall Study|Death|1
2216027|NCT01697462|3858690|FG000|Overall Study|Other|10
2216028|NCT01697462|3858690|FG000|Overall Study|Missing|5
2216029|NCT01697501|3858694|FG000|Overall Study|Protocol Violation|2
2216030|NCT01697579|3858712|FG000|Base Study-Cycle 1|Adverse Event|1
2216031|NCT01697579|3858713|FG001|Base Study-Cycle 1|Adverse Event|0
2216032|NCT01697579|3858714|FG002|Base Study-Cycle 1|Adverse Event|0
2216033|NCT01697579|3858715|FG003|Base Study-Cycle 1|Adverse Event|0
2216034|NCT01697579|3858716|FG004|Base Study-Cycle 1|Adverse Event|0
2216035|NCT01697579|3858717|FG005|Base Study-Cycle 1|Adverse Event|0
2216036|NCT01697579|3858718|FG006|Base Study-Cycle 1|Adverse Event|0
2216037|NCT01697579|3858712|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
2216038|NCT01697579|3858713|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2216039|NCT01697579|3858714|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2216040|NCT01697579|3858715|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2216041|NCT01697579|3858716|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2216042|NCT01697579|3858717|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2216043|NCT01697579|3858718|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2216044|NCT01697579|3858712|FG000|Base Study-Cycle 1|Protocol Violation|0
2216045|NCT01697579|3858713|FG001|Base Study-Cycle 1|Protocol Violation|0
2216046|NCT01697579|3858714|FG002|Base Study-Cycle 1|Protocol Violation|0
2216047|NCT01697579|3858715|FG003|Base Study-Cycle 1|Protocol Violation|0
2216048|NCT01697579|3858716|FG004|Base Study-Cycle 1|Protocol Violation|3
2216049|NCT01697579|3858717|FG005|Base Study-Cycle 1|Protocol Violation|0
2216050|NCT01697579|3858718|FG006|Base Study-Cycle 1|Protocol Violation|0
2216051|NCT01697579|3858712|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2216052|NCT01697579|3858713|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1
2216053|NCT01697579|3858714|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2216054|NCT01697579|3858715|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2216055|NCT01697579|3858716|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2216056|NCT01697579|3858717|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2216057|NCT01697579|3858718|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2216058|NCT01697579|3858712|FG000|Base Study-Cycle 1|Technical Problems|0
2216059|NCT01697579|3858713|FG001|Base Study-Cycle 1|Technical Problems|0
2216060|NCT01697579|3858714|FG002|Base Study-Cycle 1|Technical Problems|1
2216061|NCT01697579|3858715|FG003|Base Study-Cycle 1|Technical Problems|1
2216062|NCT01697579|3858716|FG004|Base Study-Cycle 1|Technical Problems|0
2216063|NCT01697579|3858717|FG005|Base Study-Cycle 1|Technical Problems|0
2216064|NCT01697579|3858718|FG006|Base Study-Cycle 1|Technical Problems|0
2216065|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Death|0
2216066|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Death|0
2216067|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Death|0
2216068|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Death|0
2319148|NCT02923349|4032109|FG002|Overall Study|Lost to Follow-up|3
2319149|NCT02923349|4032110|FG003|Overall Study|Lost to Follow-up|0
2319150|NCT02923349|4032111|FG004|Overall Study|Lost to Follow-up|1
2319151|NCT02923349|4032112|FG005|Overall Study|Lost to Follow-up|1
2319152|NCT02923349|4032113|FG006|Overall Study|Lost to Follow-up|0
2319153|NCT02923349|4032107|FG000|Overall Study|Death|1
2319154|NCT02923349|4032108|FG001|Overall Study|Death|0
2319155|NCT02923349|4032109|FG002|Overall Study|Death|2
2319156|NCT02923349|4032110|FG003|Overall Study|Death|4
2319157|NCT02923349|4032111|FG004|Overall Study|Death|2
2319158|NCT02923349|4032112|FG005|Overall Study|Death|3
2319159|NCT02923349|4032113|FG006|Overall Study|Death|0
2322303|NCT02970292|4037228|FG001|Overall Study|Lack of Efficacy|0
2322304|NCT02970292|4037227|FG000|Overall Study|Lost to Follow-up|1
2322305|NCT02970292|4037228|FG001|Overall Study|Lost to Follow-up|0
2216069|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Death|0
2216070|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Death|0
2322306|NCT02970292|4037227|FG000|Overall Study|Protocol Violation|2
2216071|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Death|2
2216072|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2216073|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2216074|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2104912|NCT00853957|3697312|FG001|Overall Study|Lost to Follow-up|6
2104913|NCT00853957|3697311|FG000|Overall Study|Protocol deviation|0
2104914|NCT00853957|3697312|FG001|Overall Study|Protocol deviation|3
2104915|NCT00853970|3697320|FG000|Overall Study|Withdrawal by Subject|2
2104916|NCT00853970|3697321|FG001|Overall Study|Withdrawal by Subject|1
2104917|NCT00853970|3697320|FG000|Overall Study|Cancelled surgery|4
2104918|NCT00853970|3697321|FG001|Overall Study|Cancelled surgery|2
2104919|NCT00854100|3697349|FG000|Overall Study|Inability to complete the study visits|0
2104920|NCT00854100|3697350|FG001|Overall Study|Inability to complete the study visits|0
2104921|NCT00854100|3697351|FG002|Overall Study|Inability to complete the study visits|1
2104922|NCT00854100|3697349|FG000|Overall Study|Lost to Follow-up|2
2104923|NCT00854100|3697350|FG001|Overall Study|Lost to Follow-up|0
2319160|NCT02923427|4032131|FG000|Overall Study|convert to laparatomy|2
2319161|NCT02923427|4032132|FG001|Overall Study|convert to laparatomy|2
2319162|NCT02923427|4032131|FG000|Overall Study|destaturation|1
2319163|NCT02923427|4032132|FG001|Overall Study|destaturation|0
2319164|NCT02923427|4032131|FG000|Overall Study|can not replace LMA|1
2319165|NCT02923427|4032132|FG001|Overall Study|can not replace LMA|0
2319166|NCT02923921|4032149|FG000|Overall Study|Sponsor Decision|39
2319167|NCT02923921|4032150|FG001|Overall Study|Sponsor Decision|38
2319168|NCT02923921|4032149|FG000|Overall Study|Lost to Follow-up|1
2319169|NCT02923921|4032150|FG001|Overall Study|Lost to Follow-up|0
2319170|NCT02923921|4032149|FG000|Overall Study|Withdrawal by Subject|6
2319171|NCT02923921|4032150|FG001|Overall Study|Withdrawal by Subject|13
2319172|NCT02923921|4032149|FG000|Overall Study|Unknown, Not Collected|7
2319173|NCT02923921|4032150|FG001|Overall Study|Unknown, Not Collected|6
2319174|NCT02924051|4032158|FG000|Overall Study|Withdrawal by Subject|1
2319175|NCT02924051|4032159|FG001|Overall Study|Withdrawal by Subject|9
2319176|NCT02924129|4032169|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2
2319177|NCT02924129|4032170|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1
2319178|NCT02924129|4032169|FG000|Overall Study|Withdrawal by Subject|2
2319179|NCT02924129|4032170|FG001|Overall Study|Withdrawal by Subject|2
2319180|NCT02924129|4032169|FG000|Overall Study|Physician Decision|1
2319181|NCT02924129|4032170|FG001|Overall Study|Physician Decision|0
2319182|NCT02924129|4032169|FG000|Overall Study|Missed Visit|0
2319183|NCT02924129|4032170|FG001|Overall Study|Missed Visit|1
2319184|NCT02924428|4032187|FG000|Overall Study|Adverse Event|1
2319185|NCT02924428|4032188|FG001|Overall Study|Adverse Event|0
2216075|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2216076|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2216077|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
2216078|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
2216079|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Physician Decision|0
2216080|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Physician Decision|0
2216081|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Physician Decision|0
2216082|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Physician Decision|0
2217587|NCT01709110|3860890|FG000|Overall Study|Caregiver Decision|1
2216083|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Physician Decision|0
2216084|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Physician Decision|7
2216085|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Physician Decision|11
2216086|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0
2216087|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0
2216088|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0
2217588|NCT01709110|3860891|FG001|Overall Study|Caregiver Decision|1
2216089|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0
2216090|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0
2216091|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0
2216092|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4
2216093|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0
2216094|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0
2216095|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0
2216096|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0
2216097|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0
2216098|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1
2216099|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2
2216100|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2216101|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2216102|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2216103|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2216104|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2216105|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
2216106|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2216107|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2216108|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2217589|NCT01709149|3860900|FG000|Open-label Lead-in Phase|Adverse Event|109
2216109|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2216110|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2217590|NCT01709149|3860901|FG001|Open-label Lead-in Phase|Adverse Event|0
2319186|NCT02924428|4032187|FG000|Overall Study|Physician Decision|1
2319187|NCT02924428|4032188|FG001|Overall Study|Physician Decision|0
2319188|NCT02924428|4032187|FG000|Overall Study|Lost to Follow-up|2
2319189|NCT02924428|4032188|FG001|Overall Study|Lost to Follow-up|4
2319190|NCT02924428|4032187|FG000|Overall Study|Pregnancy|0
2319191|NCT02924428|4032188|FG001|Overall Study|Pregnancy|1
2319192|NCT02924688|4032200|FG000|Overall Study|Adverse Event|9
2319193|NCT02924688|4032201|FG001|Overall Study|Adverse Event|3
2319194|NCT02924688|4032202|FG002|Overall Study|Adverse Event|2
2319195|NCT02924688|4032203|FG003|Overall Study|Adverse Event|2
2319196|NCT02924688|4032204|FG004|Overall Study|Adverse Event|3
2319197|NCT02924688|4032205|FG005|Overall Study|Adverse Event|2
2319198|NCT02924688|4032200|FG000|Overall Study|Lack of Efficacy|2
2319199|NCT02924688|4032201|FG001|Overall Study|Lack of Efficacy|3
2319200|NCT02924688|4032202|FG002|Overall Study|Lack of Efficacy|4
2216111|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2216112|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
2319201|NCT02924688|4032203|FG003|Overall Study|Lack of Efficacy|2
2319202|NCT02924688|4032204|FG004|Overall Study|Lack of Efficacy|1
2319203|NCT02924688|4032205|FG005|Overall Study|Lack of Efficacy|1
2319204|NCT02924688|4032200|FG000|Overall Study|Protocol Violation|3
2319205|NCT02924688|4032201|FG001|Overall Study|Protocol Violation|7
2319206|NCT02924688|4032202|FG002|Overall Study|Protocol Violation|5
2319207|NCT02924688|4032203|FG003|Overall Study|Protocol Violation|6
2319208|NCT02924688|4032204|FG004|Overall Study|Protocol Violation|2
2319209|NCT02924688|4032205|FG005|Overall Study|Protocol Violation|2
2319210|NCT02924688|4032200|FG000|Overall Study|Protocol defined withdrawal criteria met|1
2319211|NCT02924688|4032201|FG001|Overall Study|Protocol defined withdrawal criteria met|0
2319212|NCT02924688|4032202|FG002|Overall Study|Protocol defined withdrawal criteria met|1
2319213|NCT02924688|4032203|FG003|Overall Study|Protocol defined withdrawal criteria met|1
2319214|NCT02924688|4032204|FG004|Overall Study|Protocol defined withdrawal criteria met|1
2319215|NCT02924688|4032205|FG005|Overall Study|Protocol defined withdrawal criteria met|0
2319216|NCT02924688|4032200|FG000|Overall Study|Lost to Follow-up|2
2319217|NCT02924688|4032201|FG001|Overall Study|Lost to Follow-up|4
2319218|NCT02924688|4032202|FG002|Overall Study|Lost to Follow-up|2
2319219|NCT02924688|4032203|FG003|Overall Study|Lost to Follow-up|4
2319220|NCT02924688|4032204|FG004|Overall Study|Lost to Follow-up|2
2319221|NCT02924688|4032205|FG005|Overall Study|Lost to Follow-up|4
2319222|NCT02924688|4032200|FG000|Overall Study|Physician Decision|2
2319223|NCT02924688|4032201|FG001|Overall Study|Physician Decision|1
2217591|NCT01709149|3860902|FG002|Open-label Lead-in Phase|Adverse Event|0
2216113|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
2216114|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2216115|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2216116|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2217691|NCT01709305|3860931|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0
2216117|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2216118|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2217692|NCT01709305|3860932|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2
2216119|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
2216120|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
2216121|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2216122|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2216123|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2216124|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2216125|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2216126|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2216127|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
2216128|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Technical Problems|0
2216129|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Technical Problems|0
2216130|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Technical Problems|0
2216131|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Technical Problems|0
2216132|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Technical Problems|0
2216133|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Technical Problems|0
2216134|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Technical Problems|1
2216135|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Participant Moved|0
2216136|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Participant Moved|0
2216137|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Participant Moved|0
2216138|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Participant Moved|0
2216139|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Participant Moved|0
2216140|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Participant Moved|0
2216141|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Participant Moved|2
2216142|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2217693|NCT01709305|3860928|FG000|Phase 2|Laboratory Adverse Event|0
2319224|NCT02924688|4032202|FG002|Overall Study|Physician Decision|0
2319225|NCT02924688|4032203|FG003|Overall Study|Physician Decision|1
2319226|NCT02924688|4032204|FG004|Overall Study|Physician Decision|1
2319227|NCT02924688|4032205|FG005|Overall Study|Physician Decision|1
2319228|NCT02924688|4032200|FG000|Overall Study|Withdrawal by Subject|14
2319229|NCT02924688|4032201|FG001|Overall Study|Withdrawal by Subject|13
2319230|NCT02924688|4032202|FG002|Overall Study|Withdrawal by Subject|9
2319231|NCT02924688|4032203|FG003|Overall Study|Withdrawal by Subject|12
2319232|NCT02924688|4032204|FG004|Overall Study|Withdrawal by Subject|13
2319233|NCT02924688|4032205|FG005|Overall Study|Withdrawal by Subject|14
2319234|NCT02924883|4032224|FG000|Overall Study|Death|39
2319235|NCT02924883|4032225|FG001|Overall Study|Death|20
2319236|NCT02924883|4032224|FG000|Overall Study|Lost to Follow-up|1
2319237|NCT02924883|4032225|FG001|Overall Study|Lost to Follow-up|0
2319238|NCT02924883|4032224|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0
2319239|NCT02924883|4032225|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1
2319240|NCT02924883|4032224|FG000|Overall Study|Protocol Violation|1
2319241|NCT02924883|4032225|FG001|Overall Study|Protocol Violation|0
2216143|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2319242|NCT02924883|4032224|FG000|Overall Study|Withdrawal by Subject|22
2319243|NCT02924883|4032225|FG001|Overall Study|Withdrawal by Subject|16
2319244|NCT02924883|4032224|FG000|Overall Study|Progressive Disease|1
2319245|NCT02924883|4032225|FG001|Overall Study|Progressive Disease|0
2319246|NCT02924883|4032224|FG000|Overall Study|Study Terminated by Sponsor|69
2319247|NCT02924883|4032225|FG001|Overall Study|Study Terminated by Sponsor|32
2319248|NCT02925117|4032246|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1
2319249|NCT02925117|4032247|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3
2319250|NCT02925117|4032248|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1
2319251|NCT02925117|4032249|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2
2104924|NCT00854100|3697351|FG002|Overall Study|Lost to Follow-up|3
2104925|NCT00854100|3697349|FG000|Overall Study|Withdrawal by Subject|3
2104926|NCT00854100|3697350|FG001|Overall Study|Withdrawal by Subject|1
2104927|NCT00854100|3697351|FG002|Overall Study|Withdrawal by Subject|2
2319252|NCT02925117|4032250|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0
2319253|NCT02925117|4032251|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0
2319254|NCT02925117|4032252|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0
2319255|NCT02925117|4032253|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0
2319256|NCT02925117|4032254|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0
2319257|NCT02925117|4032255|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0
2319258|NCT02925117|4032256|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0
2319259|NCT02925117|4032257|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0
2319260|NCT02925117|4032246|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10
2319261|NCT02925117|4032247|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
2319262|NCT02925117|4032248|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
2319263|NCT02925117|4032249|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
2319264|NCT02925117|4032250|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
2319265|NCT02925117|4032251|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
2319266|NCT02925117|4032252|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
2104928|NCT00854100|3697349|FG000|Overall Study|Protocol Violation|2
2104929|NCT00854100|3697350|FG001|Overall Study|Protocol Violation|4
2104930|NCT00854100|3697351|FG002|Overall Study|Protocol Violation|3
2104931|NCT00854100|3697349|FG000|Overall Study|Adverse Event|2
2104932|NCT00854100|3697350|FG001|Overall Study|Adverse Event|1
2216144|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2216145|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2216146|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2216147|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
2216148|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
2216149|NCT01697579|3858712|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2216150|NCT01697579|3858713|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2216151|NCT01697579|3858714|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2216152|NCT01697579|3858715|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2104933|NCT00854100|3697351|FG002|Overall Study|Adverse Event|2
2216153|NCT01697579|3858716|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2216154|NCT01697579|3858717|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2216155|NCT01697579|3858718|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1
2216156|NCT01697592|3858756|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
2216157|NCT01697592|3858757|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2216158|NCT01697592|3858758|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2104934|NCT00854113|3697371|FG000|Overall Study|Adverse Event|0
2104935|NCT00854113|3697372|FG001|Overall Study|Adverse Event|0
2104936|NCT00854113|3697373|FG002|Overall Study|Adverse Event|0
2104937|NCT00854113|3697374|FG003|Overall Study|Adverse Event|0
2104938|NCT00854113|3697375|FG004|Overall Study|Adverse Event|0
2104939|NCT00854113|3697376|FG005|Overall Study|Adverse Event|0
2104940|NCT00854113|3697377|FG006|Overall Study|Adverse Event|0
2104941|NCT00854113|3697378|FG007|Overall Study|Adverse Event|2
2104942|NCT00854113|3697379|FG008|Overall Study|Adverse Event|0
2104943|NCT00854113|3697380|FG009|Overall Study|Adverse Event|0
2104944|NCT00854113|3697381|FG010|Overall Study|Adverse Event|0
2104945|NCT00854113|3697371|FG000|Overall Study|Withdrawal by Subject|0
2104946|NCT00854113|3697372|FG001|Overall Study|Withdrawal by Subject|0
2104947|NCT00854113|3697373|FG002|Overall Study|Withdrawal by Subject|0
2216159|NCT01697592|3858759|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2216160|NCT01697592|3858760|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2216161|NCT01697592|3858761|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2216162|NCT01697592|3858762|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2216163|NCT01697592|3858763|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2216164|NCT01697592|3858764|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2216165|NCT01697592|3858765|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2216166|NCT01697592|3858756|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0
2216167|NCT01697592|3858757|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
2216168|NCT01697592|3858758|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
2216169|NCT01697592|3858759|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0
2216170|NCT01697592|3858760|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0
2216171|NCT01697592|3858761|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1
2216172|NCT01697592|3858762|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0
2216173|NCT01697592|3858763|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0
2216174|NCT01697592|3858764|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0
2319267|NCT02925117|4032253|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
2319268|NCT02925117|4032254|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
2319269|NCT02925117|4032255|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
2319270|NCT02925117|4032256|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
2319271|NCT02925117|4032257|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
2319272|NCT02925117|4032246|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2
2319273|NCT02925117|4032247|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1
2319274|NCT02925117|4032248|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
2319275|NCT02925117|4032249|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
2319276|NCT02925117|4032250|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
2319277|NCT02925117|4032251|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
2319278|NCT02925117|4032252|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
2319279|NCT02925117|4032253|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
2319280|NCT02925117|4032254|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
2319281|NCT02925117|4032255|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
2319282|NCT02925117|4032256|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
2319283|NCT02925117|4032257|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
2319284|NCT02925117|4032246|FG000|Period 1 (Weeks 0 - 16)|Other|5
2319285|NCT02925117|4032247|FG001|Period 1 (Weeks 0 - 16)|Other|4
2319286|NCT02925117|4032248|FG002|Period 1 (Weeks 0 - 16)|Other|1
2319287|NCT02925117|4032249|FG003|Period 1 (Weeks 0 - 16)|Other|1
2319288|NCT02925117|4032250|FG004|Period 1 (Weeks 0 - 16)|Other|0
2319289|NCT02925117|4032251|FG005|Period 1 (Weeks 0 - 16)|Other|0
2319290|NCT02925117|4032252|FG006|Period 1 (Weeks 0 - 16)|Other|0
2319291|NCT02925117|4032253|FG007|Period 1 (Weeks 0 - 16)|Other|0
2216175|NCT01697592|3858765|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0
2216176|NCT01697592|3858756|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1
2216177|NCT01697592|3858757|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
2216178|NCT01697592|3858758|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0
2216179|NCT01697592|3858759|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0
2216180|NCT01697592|3858760|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0
2216181|NCT01697592|3858761|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0
2216182|NCT01697592|3858762|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0
2216183|NCT01697592|3858763|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0
2216184|NCT01697592|3858764|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0
2216185|NCT01697592|3858765|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0
2216186|NCT01697592|3858756|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2216187|NCT01697592|3858757|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2216188|NCT01697592|3858758|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2216189|NCT01697592|3858759|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2216190|NCT01697592|3858760|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2216191|NCT01697592|3858761|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2216192|NCT01697592|3858762|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2216193|NCT01697592|3858763|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2216194|NCT01697592|3858764|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2216195|NCT01697592|3858765|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2216196|NCT01697592|3858756|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0
2216197|NCT01697592|3858757|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2
2216198|NCT01697592|3858758|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1
2216199|NCT01697592|3858759|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2
2216200|NCT01697592|3858760|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0
2216201|NCT01697592|3858761|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0
2216202|NCT01697592|3858762|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1
2319292|NCT02925117|4032254|FG008|Period 1 (Weeks 0 - 16)|Other|0
2319293|NCT02925117|4032255|FG009|Period 1 (Weeks 0 - 16)|Other|0
2319294|NCT02925117|4032256|FG010|Period 1 (Weeks 0 - 16)|Other|0
2319295|NCT02925117|4032257|FG011|Period 1 (Weeks 0 - 16)|Other|0
2319296|NCT02925117|4032246|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0
2319297|NCT02925117|4032247|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0
2319298|NCT02925117|4032248|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0
2319299|NCT02925117|4032249|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0
2319300|NCT02925117|4032250|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0
2319301|NCT02925117|4032251|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1
2319302|NCT02925117|4032252|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0
2319303|NCT02925117|4032253|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0
2216203|NCT01697592|3858763|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0
2216204|NCT01697592|3858764|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0
2216205|NCT01697592|3858765|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1
2216206|NCT01697592|3858756|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1
2216207|NCT01697592|3858757|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0
2216208|NCT01697592|3858758|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0
2216209|NCT01697592|3858759|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1
2216210|NCT01697592|3858760|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0
2216211|NCT01697592|3858761|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0
2216212|NCT01697592|3858762|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0
2216213|NCT01697592|3858763|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0
2216214|NCT01697592|3858764|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0
2216215|NCT01697592|3858765|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0
2216216|NCT01697592|3858756|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
2216217|NCT01697592|3858757|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2216218|NCT01697592|3858758|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2216219|NCT01697592|3858759|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2216220|NCT01697592|3858760|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2216221|NCT01697592|3858761|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
2216222|NCT01697592|3858762|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2216223|NCT01697592|3858763|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
2216224|NCT01697592|3858764|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2216225|NCT01697592|3858765|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2216226|NCT01697592|3858756|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2
2216227|NCT01697592|3858757|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1
2216228|NCT01697592|3858758|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1
2216229|NCT01697592|3858759|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2
2216230|NCT01697592|3858760|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0
2216231|NCT01697592|3858761|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1
2216232|NCT01697592|3858762|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1
2216233|NCT01697592|3858763|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0
2216234|NCT01697592|3858764|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2
2216235|NCT01697592|3858765|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0
2217592|NCT01709149|3860900|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2
2217593|NCT01709149|3860901|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0
2217594|NCT01709149|3860902|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0
2217595|NCT01709149|3860900|FG000|Open-label Lead-in Phase|Death|1
2217596|NCT01709149|3860901|FG001|Open-label Lead-in Phase|Death|0
2217597|NCT01709149|3860902|FG002|Open-label Lead-in Phase|Death|0
2217598|NCT01709149|3860900|FG000|Open-label Lead-in Phase|Protocol Violation|3
2217599|NCT01709149|3860901|FG001|Open-label Lead-in Phase|Protocol Violation|0
2217600|NCT01709149|3860902|FG002|Open-label Lead-in Phase|Protocol Violation|0
2217601|NCT01709149|3860900|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
2217602|NCT01709149|3860901|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12
2217603|NCT01709149|3860902|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78
2217604|NCT01709149|3860900|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2217605|NCT01709149|3860901|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
2217606|NCT01709149|3860902|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
2217607|NCT01709149|3860900|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
2217608|NCT01709149|3860901|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2
2217609|NCT01709149|3860902|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5
2217610|NCT01709149|3860900|FG000|Double-blind, Placebo-controlled Phase|Death|0
2217611|NCT01709149|3860901|FG001|Double-blind, Placebo-controlled Phase|Death|2
2217612|NCT01709149|3860902|FG002|Double-blind, Placebo-controlled Phase|Death|0
2217613|NCT01709149|3860900|FG000|Double-blind, Placebo-controlled Phase|not defined|0
2217614|NCT01709149|3860901|FG001|Double-blind, Placebo-controlled Phase|not defined|1
2217615|NCT01709149|3860902|FG002|Double-blind, Placebo-controlled Phase|not defined|2
2217616|NCT01709149|3860900|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2217617|NCT01709149|3860901|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
2217618|NCT01709149|3860902|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2217619|NCT01709162|3860911|FG000|Overall Study|Disease progression|3
2319304|NCT02925117|4032254|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0
2319305|NCT02925117|4032255|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0
2216236|NCT01697696|3858803|FG000|Overall Study|Study terminated by sponsor|0
2216237|NCT01697696|3858804|FG001|Overall Study|Study terminated by sponsor|3
2216238|NCT01697696|3858803|FG000|Overall Study|Protocol deviation|1
2216239|NCT01697696|3858804|FG001|Overall Study|Protocol deviation|0
2216240|NCT01697696|3858803|FG000|Overall Study|Physician Decision|1
2216241|NCT01697696|3858804|FG001|Overall Study|Physician Decision|0
2216242|NCT01697696|3858803|FG000|Overall Study|Death|4
2216243|NCT01697696|3858804|FG001|Overall Study|Death|2
2216244|NCT01697696|3858803|FG000|Overall Study|Lost to Follow-up|10
2216245|NCT01697696|3858804|FG001|Overall Study|Lost to Follow-up|7
2216246|NCT01697696|3858803|FG000|Overall Study|Subject/guardian decision|31
2216247|NCT01697696|3858804|FG001|Overall Study|Subject/guardian decision|35
2216248|NCT01697748|3858821|FG000|Overall Study|ineligible skin incision|1
2216249|NCT01697748|3858822|FG001|Overall Study|ineligible skin incision|2
2216250|NCT01697748|3858821|FG000|Overall Study|ineligible uterine incision|4
2216251|NCT01697748|3858822|FG001|Overall Study|ineligible uterine incision|1
2216252|NCT01697748|3858821|FG000|Overall Study|Lost to Follow-up|53
2216253|NCT01697748|3858822|FG001|Overall Study|Lost to Follow-up|65
2216254|NCT01697956|3858830|FG000|Overall Study|Protocol Violation|1
2216255|NCT01697956|3858831|FG001|Overall Study|Protocol Violation|1
2216256|NCT01697969|3858843|FG000|Overall Study|Did not meet inc/exc criteria|3
2216257|NCT01698008|3858850|FG000|Overall Study|Withdrawal by Subject|1
2216258|NCT01698008|3858851|FG001|Overall Study|Withdrawal by Subject|2
2216259|NCT01698268|3858859|FG000|Overall Study|Physician Decision|2
2216260|NCT01698268|3858860|FG001|Overall Study|Physician Decision|1
2216261|NCT01698320|3858868|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
2216262|NCT01698320|3858869|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
2216263|NCT01698320|3858870|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
2216264|NCT01698320|3858868|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
2216265|NCT01698320|3858869|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
2216266|NCT01698320|3858870|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
2216267|NCT01698320|3858868|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
2216268|NCT01698320|3858869|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
2216269|NCT01698320|3858870|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
2216270|NCT01698320|3858868|FG000|Run-In Period (Week -1 to Day 0)|Other|1
2216271|NCT01698320|3858869|FG001|Run-In Period (Week -1 to Day 0)|Other|0
2216272|NCT01698320|3858870|FG002|Run-In Period (Week -1 to Day 0)|Other|0
2216273|NCT01698320|3858868|FG000|12-Week Double-Blind Period|Adverse Event|0
2216274|NCT01698320|3858869|FG001|12-Week Double-Blind Period|Adverse Event|1
2216275|NCT01698320|3858870|FG002|12-Week Double-Blind Period|Adverse Event|1
2216276|NCT01698320|3858868|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0
2216277|NCT01698320|3858869|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2
2216278|NCT01698320|3858870|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2
2216279|NCT01698320|3858868|FG000|12-Week Double-Blind Period|Protocol Violation|0
2216280|NCT01698320|3858869|FG001|12-Week Double-Blind Period|Protocol Violation|0
2216281|NCT01698320|3858870|FG002|12-Week Double-Blind Period|Protocol Violation|2
2216282|NCT01698320|3858868|FG000|12-Week Double-Blind Period|Pregnancy|0
2216283|NCT01698320|3858869|FG001|12-Week Double-Blind Period|Pregnancy|1
2216284|NCT01698320|3858870|FG002|12-Week Double-Blind Period|Pregnancy|1
2216285|NCT01698320|3858868|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
2216286|NCT01698320|3858869|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
2216287|NCT01698320|3858870|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
2216288|NCT01698320|3858868|FG000|12-Week Double-Blind Period|Lost to Follow-up|0
2216289|NCT01698320|3858869|FG001|12-Week Double-Blind Period|Lost to Follow-up|0
2216290|NCT01698320|3858870|FG002|12-Week Double-Blind Period|Lost to Follow-up|4
2216291|NCT01698320|3858868|FG000|40-Week Open-Label Period|Adverse Event|0
2216292|NCT01698320|3858869|FG001|40-Week Open-Label Period|Adverse Event|3
2216293|NCT01698320|3858870|FG002|40-Week Open-Label Period|Adverse Event|2
2216294|NCT01698320|3858868|FG000|40-Week Open-Label Period|Withdrawal by Subject|0
2216295|NCT01698320|3858869|FG001|40-Week Open-Label Period|Withdrawal by Subject|11
2216296|NCT01698320|3858870|FG002|40-Week Open-Label Period|Withdrawal by Subject|7
2216297|NCT01698320|3858868|FG000|40-Week Open-Label Period|Pregnancy|0
2216298|NCT01698320|3858869|FG001|40-Week Open-Label Period|Pregnancy|2
2216299|NCT01698320|3858870|FG002|40-Week Open-Label Period|Pregnancy|1
2216300|NCT01698320|3858868|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
2216301|NCT01698320|3858869|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
2216302|NCT01698320|3858870|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
2216303|NCT01698320|3858868|FG000|40-Week Open-Label Period|Lost to Follow-up|0
2216304|NCT01698320|3858869|FG001|40-Week Open-Label Period|Lost to Follow-up|2
2216305|NCT01698320|3858870|FG002|40-Week Open-Label Period|Lost to Follow-up|0
2216306|NCT01698554|3858908|FG000|Overall Study|Adverse Event|2
2216307|NCT01698554|3858909|FG001|Overall Study|Adverse Event|5
2216308|NCT01698554|3858910|FG002|Overall Study|Adverse Event|0
2216309|NCT01698554|3858911|FG003|Overall Study|Adverse Event|1
2216310|NCT01698554|3858908|FG000|Overall Study|Lost to Follow-up|1
2216311|NCT01698554|3858909|FG001|Overall Study|Lost to Follow-up|0
2216312|NCT01698554|3858910|FG002|Overall Study|Lost to Follow-up|0
2216313|NCT01698554|3858911|FG003|Overall Study|Lost to Follow-up|0
2216314|NCT01698554|3858908|FG000|Overall Study|Personal Reasons|0
2216315|NCT01698554|3858909|FG001|Overall Study|Personal Reasons|5
2216316|NCT01698554|3858910|FG002|Overall Study|Personal Reasons|1
2216317|NCT01698554|3858911|FG003|Overall Study|Personal Reasons|1
2216318|NCT01698554|3858908|FG000|Overall Study|Protocol Violation|2
2216319|NCT01698554|3858909|FG001|Overall Study|Protocol Violation|0
2216320|NCT01698554|3858910|FG002|Overall Study|Protocol Violation|1
2216321|NCT01698554|3858911|FG003|Overall Study|Protocol Violation|0
2319306|NCT02925117|4032256|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3
2216322|NCT01698554|3858908|FG000|Overall Study|Other Miscellaneous Reasons|1
2216323|NCT01698554|3858909|FG001|Overall Study|Other Miscellaneous Reasons|0
2216324|NCT01698554|3858910|FG002|Overall Study|Other Miscellaneous Reasons|0
2319307|NCT02925117|4032257|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2
2319308|NCT02925117|4032246|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
2319309|NCT02925117|4032247|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
2319310|NCT02925117|4032248|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
2319311|NCT02925117|4032249|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
2319312|NCT02925117|4032250|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
2319313|NCT02925117|4032251|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1
2319314|NCT02925117|4032252|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4
2319315|NCT02925117|4032253|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3
2319316|NCT02925117|4032254|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
2319317|NCT02925117|4032255|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
2319318|NCT02925117|4032256|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
2319319|NCT02925117|4032257|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
2319320|NCT02925117|4032246|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
2319321|NCT02925117|4032247|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
2319322|NCT02925117|4032248|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
2216325|NCT01698554|3858911|FG003|Overall Study|Other Miscellaneous Reasons|0
2216326|NCT01698775|3858940|FG000|Phase A|Adverse Event|2
2216327|NCT01698775|3858941|FG001|Phase A|Adverse Event|1
2216328|NCT01698775|3858940|FG000|Phase A|Death|1
2216329|NCT01698775|3858941|FG001|Phase A|Death|1
2216330|NCT01698775|3858940|FG000|Phase A|Lack of Efficacy|1
2216331|NCT01698775|3858941|FG001|Phase A|Lack of Efficacy|0
2216332|NCT01698775|3858940|FG000|Phase A|Lost to Follow-up|1
2216333|NCT01698775|3858941|FG001|Phase A|Lost to Follow-up|2
2216334|NCT01698775|3858940|FG000|Phase A|Protocol Violation|1
2216335|NCT01698775|3858941|FG001|Phase A|Protocol Violation|0
2216336|NCT01698775|3858940|FG000|Phase A|Withdrawal by Subject|3
2216337|NCT01698775|3858941|FG001|Phase A|Withdrawal by Subject|4
2216338|NCT01698775|3858940|FG000|Phase A|Kidney [transplant]|0
2216339|NCT01698775|3858941|FG001|Phase A|Kidney [transplant]|1
2216340|NCT01698775|3858940|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0
2216341|NCT01698775|3858941|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1
2216342|NCT01698775|3858940|FG000|Phase B|Adverse Event|6
2216343|NCT01698775|3858941|FG001|Phase B|Adverse Event|3
2216344|NCT01698775|3858940|FG000|Phase B|Death|0
2216345|NCT01698775|3858941|FG001|Phase B|Death|1
2216346|NCT01698775|3858940|FG000|Phase B|Lack of Efficacy|0
2216347|NCT01698775|3858941|FG001|Phase B|Lack of Efficacy|1
2216348|NCT01698775|3858940|FG000|Phase B|Lost to Follow-up|0
2216349|NCT01698775|3858941|FG001|Phase B|Lost to Follow-up|1
2216350|NCT01698775|3858940|FG000|Phase B|Physician Decision|1
2216351|NCT01698775|3858941|FG001|Phase B|Physician Decision|1
2216352|NCT01698775|3858940|FG000|Phase B|Protocol Violation|1
2216353|NCT01698775|3858941|FG001|Phase B|Protocol Violation|1
2216354|NCT01698775|3858940|FG000|Phase B|Withdrawal by Subject|6
2216355|NCT01698775|3858941|FG001|Phase B|Withdrawal by Subject|2
2216356|NCT01698801|3858951|FG000|Treatment Phase|Adverse Event|4
2216357|NCT01698801|3858951|FG000|Treatment Phase|Protocol Violation|1
2216358|NCT01698801|3858951|FG000|Treatment Phase|Other|4
2216359|NCT01698801|3858951|FG000|Treatment Phase|Withdrawal by Subject|1
2216360|NCT01698801|3858951|FG000|Treatment Phase|Disease progression|1
2216361|NCT01698801|3858951|FG000|Follow Up Phase|Withdrawal by Subject|1
2216362|NCT01698801|3858951|FG000|Follow Up Phase|Death|4
2216363|NCT01698814|3858958|FG000|Overall Study|Adverse Event|0
2216364|NCT01698814|3858959|FG001|Overall Study|Adverse Event|2
2216365|NCT01698814|3858958|FG000|Overall Study|Lost to Follow-up|0
2216366|NCT01698814|3858959|FG001|Overall Study|Lost to Follow-up|1
2216367|NCT01698814|3858958|FG000|Overall Study|Pregnancy|1
2319323|NCT02925117|4032249|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
2319324|NCT02925117|4032250|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
2319325|NCT02925117|4032251|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2
2319326|NCT02925117|4032252|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
2319327|NCT02925117|4032253|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
2319328|NCT02925117|4032254|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
2319329|NCT02925117|4032255|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
2319330|NCT02925117|4032256|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
2319331|NCT02925117|4032257|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
2319332|NCT02925117|4032246|FG000|Period 2 (Weeks 16 - 88)|Other|0
2319333|NCT02925117|4032247|FG001|Period 2 (Weeks 16 - 88)|Other|0
2319334|NCT02925117|4032248|FG002|Period 2 (Weeks 16 - 88)|Other|0
2319335|NCT02925117|4032249|FG003|Period 2 (Weeks 16 - 88)|Other|0
2319336|NCT02925117|4032250|FG004|Period 2 (Weeks 16 - 88)|Other|1
2319337|NCT02925117|4032251|FG005|Period 2 (Weeks 16 - 88)|Other|1
2319338|NCT02925117|4032252|FG006|Period 2 (Weeks 16 - 88)|Other|1
2319339|NCT02925117|4032253|FG007|Period 2 (Weeks 16 - 88)|Other|1
2319340|NCT02925117|4032254|FG008|Period 2 (Weeks 16 - 88)|Other|3
2319341|NCT02925117|4032255|FG009|Period 2 (Weeks 16 - 88)|Other|4
2319342|NCT02925117|4032256|FG010|Period 2 (Weeks 16 - 88)|Other|3
2319343|NCT02925117|4032257|FG011|Period 2 (Weeks 16 - 88)|Other|0
2319344|NCT02925312|4032285|FG000|Overall Study|Lost to Follow-up|25
2319345|NCT02925312|4032286|FG001|Overall Study|Lost to Follow-up|0
2319346|NCT02925312|4032285|FG000|Overall Study|Adverse Event|2
2319347|NCT02925312|4032286|FG001|Overall Study|Adverse Event|0
2319348|NCT02925403|4032294|FG000|Overall Study|Lost to Follow-up|0
2319349|NCT02925403|4032295|FG001|Overall Study|Lost to Follow-up|1
2319350|NCT02925455|4032303|FG000|Overall Study|Withdrawal by Subject|2
2319351|NCT02925455|4032304|FG001|Overall Study|Withdrawal by Subject|0
2319352|NCT02925494|4032314|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
2319353|NCT02925494|4032315|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
2319354|NCT02925494|4032316|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
2319355|NCT02925494|4032317|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23
2319356|NCT02925494|4032314|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
2319357|NCT02925494|4032315|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
2216368|NCT01698814|3858959|FG001|Overall Study|Pregnancy|0
2319358|NCT02925494|4032316|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9
2319359|NCT02925494|4032317|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10
2319360|NCT02925494|4032314|FG000|Post-Treatment Follow-Up Period|Other|1
2319361|NCT02925494|4032315|FG001|Post-Treatment Follow-Up Period|Other|4
2319362|NCT02925494|4032316|FG002|Post-Treatment Follow-Up Period|Other|3
2319363|NCT02925494|4032317|FG003|Post-Treatment Follow-Up Period|Other|6
2319364|NCT02925494|4032314|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1
2319365|NCT02925494|4032315|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
2319366|NCT02925494|4032316|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
2319367|NCT02925494|4032317|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6
2319368|NCT02925494|4032314|FG000|Post-Treatment Follow-Up Period|Pregnancy|1
2319369|NCT02925494|4032315|FG001|Post-Treatment Follow-Up Period|Pregnancy|0
2319370|NCT02925494|4032316|FG002|Post-Treatment Follow-Up Period|Pregnancy|1
2319371|NCT02925494|4032317|FG003|Post-Treatment Follow-Up Period|Pregnancy|2
2319372|NCT02925494|4032314|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
2319373|NCT02925494|4032315|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
2319374|NCT02925494|4032316|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
2319375|NCT02925494|4032317|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2
2319376|NCT02925494|4032314|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
2319377|NCT02925494|4032315|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
2319378|NCT02925494|4032316|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
2319379|NCT02925494|4032317|FG003|Post-Treatment Follow-Up Period|Adverse Event|1
2319380|NCT02925741|4032339|FG000|Overall Study|Withdrawal by Subject|11
2319381|NCT02925741|4032340|FG001|Overall Study|Withdrawal by Subject|0
2319382|NCT02925923|4032360|FG000|Overall Study|blood samples hemolyzed|0
2319383|NCT02925923|4032361|FG001|Overall Study|blood samples hemolyzed|2
2319384|NCT02926209|4032376|FG000|Study Cohort|Poor Bowel Preparation|1
2319385|NCT02926209|4032377|FG001|Study Cohort|Poor Bowel Preparation|0
2319386|NCT02926573|4032386|FG000|Overall Study|Nausea|1
2319387|NCT02926573|4032387|FG001|Overall Study|Nausea|0
2319388|NCT02926573|4032386|FG000|Overall Study|Remain intubated|2
2319389|NCT02926573|4032387|FG001|Overall Study|Remain intubated|2
2319390|NCT02926573|4032386|FG000|Overall Study|Change in surgery plan|3
2319391|NCT02926573|4032387|FG001|Overall Study|Change in surgery plan|1
2319392|NCT02926573|4032386|FG000|Overall Study|Change to outpatient status|5
2319393|NCT02926573|4032387|FG001|Overall Study|Change to outpatient status|1
2319394|NCT02926573|4032386|FG000|Overall Study|Withdrawal by Subject|0
2319395|NCT02926573|4032387|FG001|Overall Study|Withdrawal by Subject|2
2319396|NCT02926573|4032386|FG000|Overall Study|Return to operating room|0
2319397|NCT02926573|4032387|FG001|Overall Study|Return to operating room|2
2319398|NCT02926573|4032386|FG000|Overall Study|Delirium|0
2319399|NCT02926573|4032387|FG001|Overall Study|Delirium|1
2319400|NCT02926937|4032410|FG000|Overall Study|Adverse Event|0
2319401|NCT02926937|4032411|FG001|Overall Study|Adverse Event|1
2319402|NCT02926937|4032412|FG002|Overall Study|Adverse Event|1
2319403|NCT02926937|4032410|FG000|Overall Study|Poor Compliance to Protocol|1
2319404|NCT02926937|4032411|FG001|Overall Study|Poor Compliance to Protocol|0
2319405|NCT02926937|4032412|FG002|Overall Study|Poor Compliance to Protocol|0
2319406|NCT02926937|4032410|FG000|Overall Study|Lost to Follow-up|4
2319407|NCT02926937|4032411|FG001|Overall Study|Lost to Follow-up|5
2319408|NCT02926937|4032412|FG002|Overall Study|Lost to Follow-up|0
2319409|NCT02926937|4032410|FG000|Overall Study|At the Participant's own Request|11
2319410|NCT02926937|4032411|FG001|Overall Study|At the Participant's own Request|5
2319411|NCT02926937|4032412|FG002|Overall Study|At the Participant's own Request|8
2319412|NCT02926937|4032410|FG000|Overall Study|Reason not Specified|3
2319413|NCT02926937|4032411|FG001|Overall Study|Reason not Specified|4
2319414|NCT02926937|4032412|FG002|Overall Study|Reason not Specified|2
2319415|NCT02926950|4032423|FG000|Overall Study|Adverse Event|4
2319416|NCT02926950|4032424|FG001|Overall Study|Adverse Event|6
2319417|NCT02926950|4032423|FG000|Overall Study|At the participant's own request|21
2319418|NCT02926950|4032424|FG001|Overall Study|At the participant's own request|25
2319419|NCT02926950|4032423|FG000|Overall Study|Reason not Specified|17
2319420|NCT02926950|4032424|FG001|Overall Study|Reason not Specified|9
2319421|NCT02926950|4032423|FG000|Overall Study|Lost to Follow-up|7
2319422|NCT02926950|4032424|FG001|Overall Study|Lost to Follow-up|8
2319423|NCT02927080|4032441|FG000|Overall Study|Withdrawal by Subject|0
2319424|NCT02927080|4032442|FG001|Overall Study|Withdrawal by Subject|0
2319425|NCT02927080|4032443|FG002|Overall Study|Withdrawal by Subject|0
2319426|NCT02927080|4032444|FG003|Overall Study|Withdrawal by Subject|0
2319427|NCT02927080|4032445|FG004|Overall Study|Withdrawal by Subject|1
2319428|NCT02927080|4032446|FG005|Overall Study|Withdrawal by Subject|0
2319429|NCT02927080|4032447|FG006|Overall Study|Withdrawal by Subject|1
2319430|NCT02927080|4032448|FG007|Overall Study|Withdrawal by Subject|1
2319431|NCT02927080|4032449|FG008|Overall Study|Withdrawal by Subject|0
2319432|NCT02927080|4032450|FG009|Overall Study|Withdrawal by Subject|2
2319433|NCT02927080|4032441|FG000|Overall Study|Willingness to comply with protocol|0
2319434|NCT02927080|4032442|FG001|Overall Study|Willingness to comply with protocol|0
2319435|NCT02927080|4032443|FG002|Overall Study|Willingness to comply with protocol|0
2319436|NCT02927080|4032444|FG003|Overall Study|Willingness to comply with protocol|0
2319437|NCT02927080|4032445|FG004|Overall Study|Willingness to comply with protocol|0
2319438|NCT02927080|4032446|FG005|Overall Study|Willingness to comply with protocol|0
2319439|NCT02927080|4032447|FG006|Overall Study|Willingness to comply with protocol|0
2319440|NCT02927080|4032448|FG007|Overall Study|Willingness to comply with protocol|0
2319441|NCT02927080|4032449|FG008|Overall Study|Willingness to comply with protocol|0
2319442|NCT02927080|4032450|FG009|Overall Study|Willingness to comply with protocol|1
2319443|NCT02927080|4032441|FG000|Overall Study|Study terminated by Sponsor|0
2319444|NCT02927080|4032442|FG001|Overall Study|Study terminated by Sponsor|0
2319445|NCT02927080|4032443|FG002|Overall Study|Study terminated by Sponsor|0
2319446|NCT02927080|4032444|FG003|Overall Study|Study terminated by Sponsor|0
2319447|NCT02927080|4032445|FG004|Overall Study|Study terminated by Sponsor|0
2319448|NCT02927080|4032446|FG005|Overall Study|Study terminated by Sponsor|0
2319449|NCT02927080|4032447|FG006|Overall Study|Study terminated by Sponsor|6
2319450|NCT02927080|4032448|FG007|Overall Study|Study terminated by Sponsor|7
2319451|NCT02927080|4032449|FG008|Overall Study|Study terminated by Sponsor|2
2319452|NCT02927080|4032450|FG009|Overall Study|Study terminated by Sponsor|3
2319453|NCT02927080|4032441|FG000|Overall Study|Adverse Event|0
2319454|NCT02927080|4032442|FG001|Overall Study|Adverse Event|1
2319455|NCT02927080|4032443|FG002|Overall Study|Adverse Event|0
2319456|NCT02927080|4032444|FG003|Overall Study|Adverse Event|0
2319457|NCT02927080|4032445|FG004|Overall Study|Adverse Event|0
2319458|NCT02927080|4032446|FG005|Overall Study|Adverse Event|0
2319459|NCT02927080|4032447|FG006|Overall Study|Adverse Event|0
2319460|NCT02927080|4032448|FG007|Overall Study|Adverse Event|1
2319461|NCT02927080|4032449|FG008|Overall Study|Adverse Event|0
2319462|NCT02927080|4032450|FG009|Overall Study|Adverse Event|1
2319463|NCT02927080|4032441|FG000|Overall Study|Other|0
2319464|NCT02927080|4032442|FG001|Overall Study|Other|0
2319465|NCT02927080|4032443|FG002|Overall Study|Other|0
2319466|NCT02927080|4032444|FG003|Overall Study|Other|0
2319467|NCT02927080|4032445|FG004|Overall Study|Other|0
2319468|NCT02927080|4032446|FG005|Overall Study|Other|0
2319469|NCT02927080|4032447|FG006|Overall Study|Other|1
2319470|NCT02927080|4032448|FG007|Overall Study|Other|0
2319471|NCT02927080|4032449|FG008|Overall Study|Other|1
2319472|NCT02927080|4032450|FG009|Overall Study|Other|0
2319473|NCT02927171|4032497|FG000|Overall Study|Lost to Follow-up|0
2319474|NCT02927171|4032498|FG001|Overall Study|Lost to Follow-up|1
2319475|NCT02927301|4032510|FG000|Overall Study|Adverse Event|7
2319476|NCT02927301|4032510|FG000|Overall Study|Withdrawal by Subject|1
2319477|NCT02927301|4032510|FG000|Overall Study|Physician Decision|2
2319478|NCT02927366|4032525|FG000|Overall Study|Adverse Event|1
2319479|NCT02927366|4032526|FG001|Overall Study|Adverse Event|0
2319480|NCT02927366|4032525|FG000|Overall Study|Patient schedule|1
2319481|NCT02927366|4032526|FG001|Overall Study|Patient schedule|0
2319482|NCT02927431|4032535|FG000|Overall Study|Withdrawal by Subject|0
2319483|NCT02927431|4032536|FG001|Overall Study|Withdrawal by Subject|0
2319484|NCT02927431|4032537|FG002|Overall Study|Withdrawal by Subject|1
2319485|NCT02927795|4032569|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19
2319486|NCT02927795|4032569|FG000|Overall Study|Not Treated|4
2319487|NCT02927834|4032576|FG000|Overall Study|Lost to Follow-up|1
2319488|NCT02927834|4032577|FG001|Overall Study|Lost to Follow-up|2
2319489|NCT02927834|4032578|FG002|Overall Study|Lost to Follow-up|2
2319490|NCT02927873|4032592|FG000|Overall Study|Lost to Follow-up|0
2319491|NCT02927873|4032593|FG001|Overall Study|Lost to Follow-up|1
2319492|NCT02927873|4032594|FG002|Overall Study|Lost to Follow-up|0
2319493|NCT02927873|4032595|FG003|Overall Study|Lost to Follow-up|0
2319494|NCT02927873|4032596|FG004|Overall Study|Lost to Follow-up|0
2319495|NCT02927873|4032597|FG005|Overall Study|Lost to Follow-up|0
2319496|NCT02927873|4032592|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
2319497|NCT02927873|4032593|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
2319498|NCT02927873|4032594|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
2319499|NCT02927873|4032595|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
2319500|NCT02927873|4032596|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
2319501|NCT02927873|4032597|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
2319502|NCT02927873|4032592|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2319503|NCT02927873|4032593|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2319504|NCT02927873|4032594|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2319505|NCT02927873|4032595|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2319506|NCT02927873|4032596|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2319507|NCT02927873|4032597|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
2319508|NCT02927873|4032592|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
2319509|NCT02927873|4032593|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1
2319510|NCT02927873|4032594|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
2319511|NCT02927873|4032595|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
2319512|NCT02927873|4032596|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
2319513|NCT02927873|4032597|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
2319514|NCT02927873|4032592|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1
2319515|NCT02927873|4032593|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
2319516|NCT02927873|4032594|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
2319517|NCT02927873|4032595|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
2319518|NCT02927873|4032596|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
2319519|NCT02927873|4032597|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
2319520|NCT02927873|4032592|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1
2319521|NCT02927873|4032593|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
2319522|NCT02927873|4032594|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
2319523|NCT02927873|4032595|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
2319524|NCT02927873|4032596|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
2319525|NCT02927873|4032597|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
2319526|NCT02927925|4032611|FG000|Overall Study|Death|16
2319527|NCT02927925|4032611|FG000|Overall Study|Physician Decision|1
2319528|NCT02927925|4032611|FG000|Overall Study|Withdrawal by Subject|11
2319529|NCT02927925|4032611|FG000|Overall Study|Other|3
2319530|NCT02927925|4032611|FG000|Overall Study|Disease progression at clinical cutoff|1
2319531|NCT02927938|4032619|FG000|Overall Study|Death|0
2319532|NCT02927938|4032620|FG001|Overall Study|Death|1
2319533|NCT02927938|4032621|FG002|Overall Study|Death|0
2319534|NCT02927938|4032622|FG003|Overall Study|Death|4
2319535|NCT02927938|4032619|FG000|Overall Study|Early Study Termination|1
2319536|NCT02927938|4032620|FG001|Overall Study|Early Study Termination|5
2319537|NCT02927938|4032621|FG002|Overall Study|Early Study Termination|4
2319538|NCT02927938|4032622|FG003|Overall Study|Early Study Termination|3
2319539|NCT02928029|4032632|FG000|Overall Study|Withdrawal by Subject|0
2319540|NCT02928029|4032633|FG001|Overall Study|Withdrawal by Subject|1
2319541|NCT02928029|4032632|FG000|Overall Study|Radiological progression|1
2319542|NCT02928029|4032633|FG001|Overall Study|Radiological progression|0
2319543|NCT02928029|4032632|FG000|Overall Study|Clinical progression|1
2319544|NCT02928029|4032633|FG001|Overall Study|Clinical progression|2
2319545|NCT02928029|4032632|FG000|Overall Study|AE not related to clinical progression|1
2319546|NCT02928029|4032633|FG001|Overall Study|AE not related to clinical progression|1
2319547|NCT02928770|4032672|FG000|Overall Study|Withdrawal by Subject|2
2319548|NCT02928848|4032678|FG000|Arm 2|Withdrawal by Subject|1
2319549|NCT02928848|4032679|FG001|Arm 2|Withdrawal by Subject|0
2319550|NCT02928952|4032689|FG000|Overall Study|Lost to Follow-up|5
2319551|NCT02928952|4032690|FG001|Overall Study|Lost to Follow-up|5
2319552|NCT02928952|4032689|FG000|Overall Study|Withdrawal by Subject|5
2319553|NCT02928952|4032690|FG001|Overall Study|Withdrawal by Subject|1
2319554|NCT02928952|4032689|FG000|Overall Study|Physician Decision|0
2319555|NCT02928952|4032690|FG001|Overall Study|Physician Decision|1
2319556|NCT02929329|4032698|FG000|Overall Study|Withdrawal by Subject|24
2319557|NCT02929329|4032699|FG001|Overall Study|Withdrawal by Subject|21
2319558|NCT02929329|4032698|FG000|Overall Study|Lost to Follow-up|26
2319559|NCT02929329|4032699|FG001|Overall Study|Lost to Follow-up|20
2177544|NCT01375374|3801804|FG000|Overall Study|Adverse Event|1
2177545|NCT01375608|3801824|FG000|Overall Study|Withdrawal by Subject|2
2177546|NCT01375673|3801840|FG000|Overall Study|Withdrawal by Subject|0
2177547|NCT01375673|3801841|FG001|Overall Study|Withdrawal by Subject|1
2177548|NCT01375751|3801850|FG000|Overall Study|Other|0
2177549|NCT01375751|3801851|FG001|Overall Study|Other|1
2177550|NCT01375751|3801852|FG002|Overall Study|Other|0
2177551|NCT01375764|3801865|FG000|Overall Study|Lost to Follow-up|0
2177552|NCT01375764|3801866|FG001|Overall Study|Lost to Follow-up|1
2177553|NCT01375764|3801867|FG002|Overall Study|Lost to Follow-up|0
2177554|NCT01375764|3801868|FG003|Overall Study|Lost to Follow-up|0
2177555|NCT01375764|3801869|FG004|Overall Study|Lost to Follow-up|0
2177556|NCT01375764|3801865|FG000|Overall Study|Withdrawal by Subject|2
2177557|NCT01375764|3801866|FG001|Overall Study|Withdrawal by Subject|0
2177558|NCT01375764|3801867|FG002|Overall Study|Withdrawal by Subject|0
2177559|NCT01375764|3801868|FG003|Overall Study|Withdrawal by Subject|0
2177560|NCT01375764|3801869|FG004|Overall Study|Withdrawal by Subject|1
2177561|NCT01375764|3801865|FG000|Overall Study|Other|0
2177562|NCT01375764|3801866|FG001|Overall Study|Other|0
2177563|NCT01375764|3801867|FG002|Overall Study|Other|0
2177564|NCT01375764|3801868|FG003|Overall Study|Other|1
2177565|NCT01375764|3801869|FG004|Overall Study|Other|0
2177566|NCT01375777|3801890|FG000|Overall Study|Withdrawal by Subject|0
2177567|NCT01375777|3801891|FG001|Overall Study|Withdrawal by Subject|2
2177568|NCT01375777|3801892|FG002|Overall Study|Withdrawal by Subject|1
2177569|NCT01375777|3801893|FG003|Overall Study|Withdrawal by Subject|0
2177570|NCT01375777|3801894|FG004|Overall Study|Withdrawal by Subject|1
2177571|NCT01375777|3801895|FG005|Overall Study|Withdrawal by Subject|1
2177572|NCT01375777|3801896|FG006|Overall Study|Withdrawal by Subject|1
2177573|NCT01375777|3801897|FG007|Overall Study|Withdrawal by Subject|2
2177574|NCT01375777|3801898|FG008|Overall Study|Withdrawal by Subject|1
2177575|NCT01375777|3801890|FG000|Overall Study|Lost to Follow-up|1
2177576|NCT01375777|3801891|FG001|Overall Study|Lost to Follow-up|0
2177577|NCT01375777|3801892|FG002|Overall Study|Lost to Follow-up|0
2177578|NCT01375777|3801893|FG003|Overall Study|Lost to Follow-up|0
2177579|NCT01375777|3801894|FG004|Overall Study|Lost to Follow-up|0
2177580|NCT01375777|3801895|FG005|Overall Study|Lost to Follow-up|0
2177581|NCT01375777|3801896|FG006|Overall Study|Lost to Follow-up|1
2177582|NCT01375777|3801897|FG007|Overall Study|Lost to Follow-up|0
2177583|NCT01375777|3801898|FG008|Overall Study|Lost to Follow-up|0
2177584|NCT01375777|3801890|FG000|Overall Study|Other|1
2177585|NCT01375777|3801891|FG001|Overall Study|Other|1
2177586|NCT01375777|3801892|FG002|Overall Study|Other|0
2177587|NCT01375777|3801893|FG003|Overall Study|Other|0
2177588|NCT01375777|3801894|FG004|Overall Study|Other|0
2177589|NCT01375777|3801895|FG005|Overall Study|Other|0
2177590|NCT01375777|3801896|FG006|Overall Study|Other|0
2177591|NCT01375777|3801897|FG007|Overall Study|Other|0
2177592|NCT01375777|3801898|FG008|Overall Study|Other|1
2177593|NCT01376037|3801929|FG000|Overall Study|Lost to Follow-up|0
2177594|NCT01376037|3801930|FG001|Overall Study|Lost to Follow-up|2
2177595|NCT01376089|3801947|FG000|Overall Study|Patient received no contrast media|3
2177596|NCT01376089|3801948|FG001|Overall Study|Patient received no contrast media|4
2177597|NCT01376167|3801961|FG000|Overall Study|Lost to Follow-up|2
2177598|NCT01376167|3801962|FG001|Overall Study|Lost to Follow-up|4
2177599|NCT01376167|3801963|FG002|Overall Study|Lost to Follow-up|2
2177600|NCT01376167|3801961|FG000|Overall Study|Physician Decision|1
2177601|NCT01376167|3801962|FG001|Overall Study|Physician Decision|1
2177602|NCT01376167|3801963|FG002|Overall Study|Physician Decision|0
2177603|NCT01376167|3801961|FG000|Overall Study|Withdrawal by Subject|1
2177604|NCT01376167|3801962|FG001|Overall Study|Withdrawal by Subject|5
2177605|NCT01376167|3801963|FG002|Overall Study|Withdrawal by Subject|4
2177606|NCT01376245|3801978|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
2177607|NCT01376245|3801979|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2177608|NCT01376245|3801980|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2177609|NCT01376245|3801981|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2177610|NCT01376245|3801982|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2177611|NCT01376245|3801978|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
2177612|NCT01376245|3801979|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2177613|NCT01376245|3801980|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2177614|NCT01376245|3801981|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2177615|NCT01376245|3801982|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2177616|NCT01376245|3801978|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
2177617|NCT01376245|3801979|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2177618|NCT01376245|3801980|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2177619|NCT01376245|3801981|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2177620|NCT01376245|3801982|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2177621|NCT01376245|3801978|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
2319560|NCT02929329|4032698|FG000|Overall Study|Death|1054
2319561|NCT02929329|4032699|FG001|Overall Study|Death|1051
2319562|NCT02929407|4032709|FG000|Overall Study|Adverse Event|1
2319563|NCT02929498|4032716|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
2319564|NCT02929498|4032717|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
2319565|NCT02929498|4032718|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
2319566|NCT02929498|4032716|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
2319567|NCT02929498|4032717|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
2319568|NCT02929498|4032718|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
2319569|NCT02930005|4032760|FG000|Overall Study|Lost to Follow-up|1
2319570|NCT02930005|4032761|FG001|Overall Study|Lost to Follow-up|5
2319571|NCT02930018|4032769|FG000|Overall Study|Lost to Follow-up|1
2319572|NCT02930018|4032770|FG001|Overall Study|Lost to Follow-up|1
2319573|NCT02930018|4032769|FG000|Overall Study|Withdrawal by Subject|5
2319574|NCT02930018|4032770|FG001|Overall Study|Withdrawal by Subject|2
2319575|NCT02930226|4032793|FG000|Overall Study|Technical Problems: Leak in plasma bag|0
2319576|NCT02930226|4032794|FG001|Overall Study|Technical Problems: Leak in plasma bag|0
2319577|NCT02930226|4032795|FG002|Overall Study|Technical Problems: Leak in plasma bag|0
2319578|NCT02930226|4032796|FG003|Overall Study|Technical Problems: Leak in plasma bag|0
2319579|NCT02930226|4032797|FG004|Overall Study|Technical Problems: Leak in plasma bag|1
2319580|NCT02930226|4032798|FG005|Overall Study|Technical Problems: Leak in plasma bag|0
2319581|NCT02930343|4032816|FG000|Overall Study|Lost to Follow-up|9
2319582|NCT02930343|4032817|FG001|Overall Study|Lost to Follow-up|7
2319583|NCT02930837|4032861|FG000|Overall Study|Adverse Event|6
2319584|NCT02930837|4032861|FG000|Overall Study|Lost to Follow-up|5
2319585|NCT02930837|4032861|FG000|Overall Study|Withdrawal by Subject|1
2319586|NCT02930941|4032867|FG000|Overall Study|Lost to Follow-up|1
2319587|NCT02930941|4032868|FG001|Overall Study|Lost to Follow-up|2
2319588|NCT02931396|4032902|FG000|Overall Study|Lost to Follow-up|3
2319589|NCT02931396|4032903|FG001|Overall Study|Lost to Follow-up|0
2319590|NCT02931396|4032902|FG000|Overall Study|Withdrawal by Subject|2
2319591|NCT02931396|4032903|FG001|Overall Study|Withdrawal by Subject|0
2319592|NCT02931539|4032911|FG000|Period 1: Treatment Phase|Investigator discretion|1
2319593|NCT02931539|4032912|FG001|Period 1: Treatment Phase|Investigator discretion|1
2319594|NCT02931539|4032913|FG002|Period 1: Treatment Phase|Investigator discretion|0
2319595|NCT02931539|4032911|FG000|Period 1: Treatment Phase|Adverse Event|5
2319596|NCT02931539|4032912|FG001|Period 1: Treatment Phase|Adverse Event|1
2319597|NCT02931539|4032913|FG002|Period 1: Treatment Phase|Adverse Event|0
2319598|NCT02931539|4032911|FG000|Period 1: Treatment Phase|Lost to Follow-up|1
2319599|NCT02931539|4032912|FG001|Period 1: Treatment Phase|Lost to Follow-up|2
2319600|NCT02931539|4032913|FG002|Period 1: Treatment Phase|Lost to Follow-up|0
2319601|NCT02931539|4032911|FG000|Period 1: Treatment Phase|Death|8
2319602|NCT02931539|4032912|FG001|Period 1: Treatment Phase|Death|24
2319603|NCT02931539|4032913|FG002|Period 1: Treatment Phase|Death|0
2319604|NCT02931539|4032911|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16
2319605|NCT02931539|4032912|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8
2319606|NCT02931539|4032913|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0
2319607|NCT02931539|4032911|FG000|Period 1: Treatment Phase|Protocol Violation|6
2319608|NCT02931539|4032912|FG001|Period 1: Treatment Phase|Protocol Violation|0
2319609|NCT02931539|4032913|FG002|Period 1: Treatment Phase|Protocol Violation|0
2319610|NCT02931539|4032911|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22
2319611|NCT02931539|4032912|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
2319612|NCT02931539|4032913|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
2319613|NCT02931539|4032911|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
2319614|NCT02931539|4032912|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
2319615|NCT02931539|4032913|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2
2319616|NCT02931838|4032942|FG000|Overall Study|Reason not provided by investigator|1
2319617|NCT02931838|4032943|FG001|Overall Study|Reason not provided by investigator|0
2319618|NCT02931838|4032944|FG002|Overall Study|Reason not provided by investigator|1
2319619|NCT02931838|4032945|FG003|Overall Study|Reason not provided by investigator|0
2319620|NCT02931838|4032946|FG004|Overall Study|Reason not provided by investigator|0
2319621|NCT02931838|4032947|FG005|Overall Study|Reason not provided by investigator|0
2319622|NCT02931838|4032942|FG000|Overall Study|Poor/non-compliance|0
2319623|NCT02931838|4032943|FG001|Overall Study|Poor/non-compliance|0
2319624|NCT02931838|4032944|FG002|Overall Study|Poor/non-compliance|1
2319625|NCT02931838|4032945|FG003|Overall Study|Poor/non-compliance|0
2319626|NCT02931838|4032946|FG004|Overall Study|Poor/non-compliance|0
2319627|NCT02931838|4032947|FG005|Overall Study|Poor/non-compliance|0
2319628|NCT02931838|4032942|FG000|Overall Study|Lack of Efficacy|5
2319629|NCT02931838|4032943|FG001|Overall Study|Lack of Efficacy|4
2319630|NCT02931838|4032944|FG002|Overall Study|Lack of Efficacy|0
2319631|NCT02931838|4032945|FG003|Overall Study|Lack of Efficacy|0
2319632|NCT02931838|4032946|FG004|Overall Study|Lack of Efficacy|0
2319633|NCT02931838|4032947|FG005|Overall Study|Lack of Efficacy|1
2319634|NCT02931838|4032942|FG000|Overall Study|Lost to Follow-up|1
2319635|NCT02931838|4032943|FG001|Overall Study|Lost to Follow-up|0
2319636|NCT02931838|4032944|FG002|Overall Study|Lost to Follow-up|1
2319637|NCT02931838|4032945|FG003|Overall Study|Lost to Follow-up|1
2319638|NCT02931838|4032946|FG004|Overall Study|Lost to Follow-up|2
2319639|NCT02931838|4032947|FG005|Overall Study|Lost to Follow-up|0
2319640|NCT02931838|4032942|FG000|Overall Study|Subject request to discontinue treatment|4
2319641|NCT02931838|4032943|FG001|Overall Study|Subject request to discontinue treatment|3
2319642|NCT02931838|4032944|FG002|Overall Study|Subject request to discontinue treatment|3
2319643|NCT02931838|4032945|FG003|Overall Study|Subject request to discontinue treatment|0
2319644|NCT02931838|4032946|FG004|Overall Study|Subject request to discontinue treatment|1
2319645|NCT02931838|4032947|FG005|Overall Study|Subject request to discontinue treatment|0
2319646|NCT02931838|4032942|FG000|Overall Study|Withdrawal by Subject|1
2319647|NCT02931838|4032943|FG001|Overall Study|Withdrawal by Subject|2
2319648|NCT02931838|4032944|FG002|Overall Study|Withdrawal by Subject|0
2319649|NCT02931838|4032945|FG003|Overall Study|Withdrawal by Subject|1
2319650|NCT02931838|4032946|FG004|Overall Study|Withdrawal by Subject|0
2319651|NCT02931838|4032947|FG005|Overall Study|Withdrawal by Subject|0
2319652|NCT02931838|4032942|FG000|Overall Study|Adverse Event|2
2319653|NCT02931838|4032943|FG001|Overall Study|Adverse Event|1
2319654|NCT02931838|4032944|FG002|Overall Study|Adverse Event|2
2319655|NCT02931838|4032945|FG003|Overall Study|Adverse Event|1
2319656|NCT02931838|4032946|FG004|Overall Study|Adverse Event|3
2319657|NCT02931838|4032947|FG005|Overall Study|Adverse Event|1
2319658|NCT02932228|4032968|FG000|Overall Study|Death|8
2319659|NCT02932228|4032969|FG001|Overall Study|Death|23
2319660|NCT02932228|4032968|FG000|Overall Study|not eligible upon chart review|2
2319661|NCT02932228|4032969|FG001|Overall Study|not eligible upon chart review|5
2319662|NCT02932267|4032977|FG000|Overall Study|Withdrawal by Subject|3
2319663|NCT02932267|4032977|FG000|Overall Study|Lost to Follow-up|4
2319664|NCT02932267|4032977|FG000|Overall Study|Pregnancy|1
2319665|NCT02932306|4032983|FG000|Overall Study|Withdrawal by Subject|16
2319666|NCT02932306|4032984|FG001|Overall Study|Withdrawal by Subject|25
2319667|NCT02932306|4032983|FG000|Overall Study|Adverse Event|3
2319668|NCT02932306|4032984|FG001|Overall Study|Adverse Event|0
2319669|NCT02932306|4032983|FG000|Overall Study|Pregnancy|2
2319670|NCT02932306|4032984|FG001|Overall Study|Pregnancy|0
2319671|NCT02932306|4032983|FG000|Overall Study|Protocol Violation|1
2319672|NCT02932306|4032984|FG001|Overall Study|Protocol Violation|1
2319673|NCT02932306|4032983|FG000|Overall Study|Noncompliance with Study Drug|1
2319674|NCT02932306|4032984|FG001|Overall Study|Noncompliance with Study Drug|1
2319675|NCT02932306|4032983|FG000|Overall Study|Lost to Follow-up|36
2319676|NCT02932306|4032984|FG001|Overall Study|Lost to Follow-up|40
2319677|NCT02932306|4032983|FG000|Overall Study|Withdrawal by Parent or Guardian|6
2319678|NCT02932306|4032984|FG001|Overall Study|Withdrawal by Parent or Guardian|8
2319679|NCT02932306|4032983|FG000|Overall Study|Lack of Efficacy|0
2319680|NCT02932306|4032984|FG001|Overall Study|Lack of Efficacy|2
2319681|NCT02932306|4032983|FG000|Overall Study|Worsening condition|2
2319682|NCT02932306|4032984|FG001|Overall Study|Worsening condition|0
2319683|NCT02932306|4032983|FG000|Overall Study|Withdrew due to burning,itching,stinging|1
2319684|NCT02932306|4032984|FG001|Overall Study|Withdrew due to burning,itching,stinging|0
2319685|NCT02932332|4032994|FG000|Overall Study|Withdrawal by Subject|1
2319686|NCT02932332|4032995|FG001|Overall Study|Withdrawal by Subject|1
2319687|NCT02932332|4032996|FG002|Overall Study|Withdrawal by Subject|0
2319688|NCT02932332|4032997|FG003|Overall Study|Withdrawal by Subject|1
2319689|NCT02932332|4032994|FG000|Overall Study|Chest pain|0
2319690|NCT02932332|4032995|FG001|Overall Study|Chest pain|0
2319691|NCT02932332|4032996|FG002|Overall Study|Chest pain|0
2319692|NCT02932332|4032997|FG003|Overall Study|Chest pain|1
2319693|NCT02932332|4032994|FG000|Overall Study|Not Dyspneic cough|1
2319694|NCT02932332|4032995|FG001|Overall Study|Not Dyspneic cough|2
2319695|NCT02932332|4032996|FG002|Overall Study|Not Dyspneic cough|1
2319696|NCT02932332|4032997|FG003|Overall Study|Not Dyspneic cough|0
2319697|NCT02932462|4033009|FG000|Overall Study|Adverse Event|1
2216369|NCT01698814|3858958|FG000|Overall Study|Randomized in error|1
2216370|NCT01698814|3858959|FG001|Overall Study|Randomized in error|0
2216371|NCT01698879|3858968|FG000|Overall Study|Withdrawal by Subject|1
2216372|NCT01698879|3858969|FG001|Overall Study|Withdrawal by Subject|0
2319698|NCT02932462|4033010|FG001|Overall Study|Adverse Event|2
2319699|NCT02932462|4033009|FG000|Overall Study|Lost to Follow-up|4
2319700|NCT02932462|4033010|FG001|Overall Study|Lost to Follow-up|1
2319701|NCT02932462|4033009|FG000|Overall Study|Protocol Violation|0
2319702|NCT02932462|4033010|FG001|Overall Study|Protocol Violation|5
2319703|NCT02932462|4033009|FG000|Overall Study|Withdrawal by Subject|1
2319704|NCT02932462|4033010|FG001|Overall Study|Withdrawal by Subject|4
2319705|NCT02932462|4033009|FG000|Overall Study|Non-Compliance With Study Drug|0
2319706|NCT02932462|4033010|FG001|Overall Study|Non-Compliance With Study Drug|1
2319707|NCT02932462|4033009|FG000|Overall Study|Progressive Disease|1
2319708|NCT02932462|4033010|FG001|Overall Study|Progressive Disease|0
2319709|NCT02932878|4033030|FG000|Overall Study|Due to Lab Results|2
2319710|NCT02932878|4033031|FG001|Overall Study|Due to Lab Results|1
2319711|NCT02932891|4033037|FG000|Overall Study|Lost to Follow-up|2
2319712|NCT02932891|4033037|FG000|Overall Study|HPA Suppress|2
2319713|NCT02932904|4033045|FG000|Overall Study|Reason not Specified|1
2319714|NCT02932904|4033046|FG001|Overall Study|Reason not Specified|0
2319715|NCT02932904|4033047|FG002|Overall Study|Reason not Specified|2
2319716|NCT02932904|4033048|FG003|Overall Study|Reason not Specified|2
2319717|NCT02932904|4033045|FG000|Overall Study|Noncompliance with Study Drug|2
2319718|NCT02932904|4033046|FG001|Overall Study|Noncompliance with Study Drug|3
2319719|NCT02932904|4033047|FG002|Overall Study|Noncompliance with Study Drug|3
2319720|NCT02932904|4033048|FG003|Overall Study|Noncompliance with Study Drug|4
2319721|NCT02932904|4033045|FG000|Overall Study|Pregnancy|0
2319722|NCT02932904|4033046|FG001|Overall Study|Pregnancy|1
2319723|NCT02932904|4033047|FG002|Overall Study|Pregnancy|1
2319724|NCT02932904|4033048|FG003|Overall Study|Pregnancy|0
2319725|NCT02932904|4033045|FG000|Overall Study|Study Termination|0
2319726|NCT02932904|4033046|FG001|Overall Study|Study Termination|1
2319727|NCT02932904|4033047|FG002|Overall Study|Study Termination|0
2319728|NCT02932904|4033048|FG003|Overall Study|Study Termination|0
2319729|NCT02932904|4033045|FG000|Overall Study|Voluntary Withdrawal|2
2319730|NCT02932904|4033046|FG001|Overall Study|Voluntary Withdrawal|1
2319731|NCT02932904|4033047|FG002|Overall Study|Voluntary Withdrawal|4
2319732|NCT02932904|4033048|FG003|Overall Study|Voluntary Withdrawal|2
2319733|NCT02932904|4033045|FG000|Overall Study|Lost to Follow-up|5
2319734|NCT02932904|4033046|FG001|Overall Study|Lost to Follow-up|3
2319735|NCT02932904|4033047|FG002|Overall Study|Lost to Follow-up|6
2216373|NCT01698879|3858970|FG002|Overall Study|Withdrawal by Subject|0
2216374|NCT01698905|3858984|FG000|Overall Study|Adverse Event|4
2216375|NCT01698905|3858984|FG000|Overall Study|Physician Decision|2
2216376|NCT01698905|3858984|FG000|Overall Study|Pregnancy|1
2319736|NCT02932904|4033048|FG003|Overall Study|Lost to Follow-up|0
2319737|NCT02932904|4033045|FG000|Overall Study|Significant Protocol Deviation|2
2319738|NCT02932904|4033046|FG001|Overall Study|Significant Protocol Deviation|3
2319739|NCT02932904|4033047|FG002|Overall Study|Significant Protocol Deviation|6
2319740|NCT02932904|4033048|FG003|Overall Study|Significant Protocol Deviation|1
2319741|NCT02932904|4033045|FG000|Overall Study|Pretreatment Event/Adverse Event|3
2319742|NCT02932904|4033046|FG001|Overall Study|Pretreatment Event/Adverse Event|5
2319743|NCT02932904|4033047|FG002|Overall Study|Pretreatment Event/Adverse Event|1
2319744|NCT02932904|4033048|FG003|Overall Study|Pretreatment Event/Adverse Event|3
2319745|NCT02932904|4033045|FG000|Overall Study|Randomized But Not Treated|1
2319746|NCT02932904|4033046|FG001|Overall Study|Randomized But Not Treated|1
2319747|NCT02932904|4033047|FG002|Overall Study|Randomized But Not Treated|0
2319748|NCT02932904|4033048|FG003|Overall Study|Randomized But Not Treated|2
2319749|NCT02932943|4033063|FG000|Overall Study|Lost to Follow-up|0
2319750|NCT02932943|4033064|FG001|Overall Study|Lost to Follow-up|2
2216377|NCT01698905|3858984|FG000|Overall Study|Protocol Violation|1
2216378|NCT01698905|3858984|FG000|Overall Study|Subject/guardian decision|2
2216379|NCT01698905|3858984|FG000|Overall Study|Death|1
2216380|NCT01699022|3858995|FG000|Overall Study|Early discontinuation from the study|3
2216381|NCT01699087|3859000|FG000|Overall Study|Lost to Follow-up|7
2216382|NCT01699087|3859000|FG000|Overall Study|Screen failure (prior to treatment)|15
2216383|NCT01699087|3859000|FG000|Overall Study|Unable to make future visits|2
2216384|NCT01699178|3859007|FG000|Overall Study|Adverse Event|1
2216385|NCT01699178|3859008|FG001|Overall Study|Adverse Event|5
2216386|NCT01699178|3859007|FG000|Overall Study|Lost to Follow-up|1
2216387|NCT01699178|3859008|FG001|Overall Study|Lost to Follow-up|6
2216388|NCT01699178|3859007|FG000|Overall Study|Non-compliance with Study Drug|3
2216389|NCT01699178|3859008|FG001|Overall Study|Non-compliance with Study Drug|1
2216390|NCT01699178|3859007|FG000|Overall Study|Physician Decision|1
2319751|NCT02932943|4033063|FG000|Overall Study|Adverse Event|2
2319752|NCT02932943|4033064|FG001|Overall Study|Adverse Event|2
2319753|NCT02932943|4033063|FG000|Overall Study|Withdrawal by Subject|3
2319754|NCT02932943|4033064|FG001|Overall Study|Withdrawal by Subject|3
2319755|NCT02933060|4033076|FG000|Overall Study|Withdrawal by Subject|0
2319756|NCT02933060|4033077|FG001|Overall Study|Withdrawal by Subject|1
2319757|NCT02933489|4033124|FG000|Overall Study|Ineligible|3
2319758|NCT02933489|4033125|FG001|Overall Study|Ineligible|3
2319759|NCT02933489|4033124|FG000|Overall Study|Withdrawal by Subject|27
2319760|NCT02933489|4033125|FG001|Overall Study|Withdrawal by Subject|18
2319761|NCT02933489|4033124|FG000|Overall Study|Unable to complete exams (other)|14
2319762|NCT02933489|4033125|FG001|Overall Study|Unable to complete exams (other)|7
2319763|NCT02933528|4033140|FG000|Overall Study|Lost to Follow-up|2
2319764|NCT02934178|4033170|FG000|Received Vaccination 2|Death|0
2319765|NCT02934178|4033171|FG001|Received Vaccination 2|Death|1
2319766|NCT02934178|4033170|FG000|Received Vaccination 3|Withdrawal by Subject|1
2319767|NCT02934178|4033171|FG001|Received Vaccination 3|Withdrawal by Subject|0
2319768|NCT02935192|4033253|FG000|Overall Study|Withdrawal by Subject|8
2319769|NCT02935192|4033254|FG001|Overall Study|Withdrawal by Subject|4
2322307|NCT02970292|4037228|FG001|Overall Study|Protocol Violation|0
2322308|NCT02970292|4037227|FG000|Overall Study|Other|1
2322309|NCT02970292|4037228|FG001|Overall Study|Other|0
2322310|NCT02970305|4037236|FG000|Overall Study|Adverse Event|10
2322311|NCT02970305|4037237|FG001|Overall Study|Adverse Event|6
2322312|NCT02970305|4037236|FG000|Overall Study|Lack of Efficacy|1
2322313|NCT02970305|4037237|FG001|Overall Study|Lack of Efficacy|1
2322314|NCT02970305|4037236|FG000|Overall Study|Noncompliance with study drug|2
2322315|NCT02970305|4037237|FG001|Overall Study|Noncompliance with study drug|4
2322316|NCT02970305|4037236|FG000|Overall Study|Protocol Violation|2
2322317|NCT02970305|4037237|FG001|Overall Study|Protocol Violation|2
2322318|NCT02970305|4037236|FG000|Overall Study|Withdrawal by Subject|12
2322319|NCT02970305|4037237|FG001|Overall Study|Withdrawal by Subject|11
2322320|NCT02970305|4037236|FG000|Overall Study|Not further specified|1
2322321|NCT02970305|4037237|FG001|Overall Study|Not further specified|2
2322322|NCT02970305|4037236|FG000|Overall Study|Lost to Follow-up|1
2322323|NCT02970305|4037237|FG001|Overall Study|Lost to Follow-up|2
2322324|NCT02970669|4037281|FG000|Double-blind Period|Adverse Event|4
2322325|NCT02970669|4037282|FG001|Double-blind Period|Adverse Event|0
2322326|NCT02970669|4037281|FG000|Double-blind Period|Death|1
2322327|NCT02970669|4037282|FG001|Double-blind Period|Death|0
2322328|NCT02970669|4037281|FG000|Double-blind Period|Study terminated by sponsor|1
2322329|NCT02970669|4037282|FG001|Double-blind Period|Study terminated by sponsor|2
2322330|NCT02970669|4037281|FG000|Double-blind Period|Physician Decision|0
2322331|NCT02970669|4037282|FG001|Double-blind Period|Physician Decision|2
2322332|NCT02970669|4037281|FG000|Double-blind Period|Withdrawal by Subject|2
2322333|NCT02970669|4037282|FG001|Double-blind Period|Withdrawal by Subject|2
2322334|NCT02970669|4037281|FG000|Open-label Period|Withdrawal by Subject|2
2322335|NCT02970669|4037282|FG001|Open-label Period|Withdrawal by Subject|2
2322336|NCT02970669|4037281|FG000|Open-label Period|Adverse Event|1
2322337|NCT02970669|4037282|FG001|Open-label Period|Adverse Event|0
2322338|NCT02970669|4037281|FG000|Open-label Period|Physician Decision|1
2216391|NCT01699178|3859008|FG001|Overall Study|Physician Decision|0
2216392|NCT01699178|3859007|FG000|Overall Study|Withdrawal by Subject|4
2216393|NCT01699178|3859008|FG001|Overall Study|Withdrawal by Subject|12
2216394|NCT01699178|3859007|FG000|Overall Study|Hematocrit >54%|1
2216395|NCT01699178|3859008|FG001|Overall Study|Hematocrit >54%|1
2216396|NCT01699178|3859007|FG000|Overall Study|PSA increase of >1.4 ng/mL|4
2216397|NCT01699178|3859008|FG001|Overall Study|PSA increase of >1.4 ng/mL|3
2216398|NCT01699178|3859007|FG000|Overall Study|ineligible/noncompliant/ subject reason|4
2216399|NCT01699178|3859008|FG001|Overall Study|ineligible/noncompliant/ subject reason|4
2319770|NCT02935452|4033262|FG000|Overall Study|work and life commintment|3
2319771|NCT02935452|4033263|FG001|Overall Study|work and life commintment|1
2319772|NCT02935673|4033276|FG000|Overall Study|Adverse Event|0
2319773|NCT02935673|4033277|FG001|Overall Study|Adverse Event|1
2319774|NCT02935673|4033278|FG002|Overall Study|Adverse Event|0
2319775|NCT02935673|4033276|FG000|Overall Study|Withdrawal by Subject|1
2319776|NCT02935673|4033277|FG001|Overall Study|Withdrawal by Subject|2
2319777|NCT02935673|4033278|FG002|Overall Study|Withdrawal by Subject|0
2319778|NCT02935842|4033318|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2
2319779|NCT02935842|4033319|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0
2319780|NCT02935842|4033320|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0
2319781|NCT02935842|4033321|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0
2319782|NCT02935842|4033318|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1
2319783|NCT02935842|4033319|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
2319784|NCT02935842|4033320|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
2319785|NCT02935842|4033321|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0
2319786|NCT02935842|4033318|FG000|Testing and Therapy Period 3|Accident prior to treatment|2
2319787|NCT02935842|4033319|FG001|Testing and Therapy Period 3|Accident prior to treatment|2
2319788|NCT02935842|4033320|FG002|Testing and Therapy Period 3|Accident prior to treatment|0
2319789|NCT02935842|4033321|FG003|Testing and Therapy Period 3|Accident prior to treatment|0
2216400|NCT01699503|3859025|FG000|Overall Study|Death|31
2319790|NCT02935842|4033318|FG000|Testing and Therapy Period 3|Lost to Follow-up|0
2319791|NCT02935842|4033319|FG001|Testing and Therapy Period 3|Lost to Follow-up|0
2319792|NCT02935842|4033320|FG002|Testing and Therapy Period 3|Lost to Follow-up|0
2319793|NCT02935842|4033321|FG003|Testing and Therapy Period 3|Lost to Follow-up|1
2319794|NCT02935842|4033318|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0
2319795|NCT02935842|4033319|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0
2319796|NCT02935842|4033320|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3
2319797|NCT02935842|4033321|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0
2319798|NCT02935894|4033338|FG000|Overall Study|Subject dismissed|1
2319799|NCT02936037|4033344|FG000|Double-Blind Treatment Period|Protocol Violation|1
2319800|NCT02936037|4033345|FG001|Double-Blind Treatment Period|Protocol Violation|4
2319801|NCT02936037|4033344|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2
2319802|NCT02936037|4033345|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8
2319803|NCT02936037|4033344|FG000|Double-Blind Treatment Period|Lack of Efficacy|4
2319804|NCT02936037|4033345|FG001|Double-Blind Treatment Period|Lack of Efficacy|12
2319805|NCT02936037|4033344|FG000|Double-Blind Treatment Period|Death|0
2319806|NCT02936037|4033345|FG001|Double-Blind Treatment Period|Death|1
2319807|NCT02936037|4033344|FG000|Double-Blind Treatment Period|Adverse Event|11
2319808|NCT02936037|4033345|FG001|Double-Blind Treatment Period|Adverse Event|11
2319809|NCT02936037|4033344|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31
2319810|NCT02936037|4033345|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28
2319811|NCT02936037|4033344|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
2319812|NCT02936037|4033345|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
2319813|NCT02936037|4033344|FG000|Open Label Extension|Adverse Event|0
2319814|NCT02936037|4033345|FG001|Open Label Extension|Adverse Event|3
2319815|NCT02936037|4033344|FG000|Open Label Extension|Other|0
2319816|NCT02936037|4033345|FG001|Open Label Extension|Other|3
2319817|NCT02936037|4033344|FG000|Open Label Extension|Withdrawal by Subject|0
2319818|NCT02936037|4033345|FG001|Open Label Extension|Withdrawal by Subject|4
2319819|NCT02936635|4033366|FG000|Overall Study|Adverse Event|43
2319820|NCT02936635|4033367|FG001|Overall Study|Adverse Event|25
2319821|NCT02936635|4033366|FG000|Overall Study|Progressive Disease|10
2319822|NCT02936635|4033367|FG001|Overall Study|Progressive Disease|18
2319823|NCT02936635|4033366|FG000|Overall Study|Sponsor Discretion|10
2319824|NCT02936635|4033367|FG001|Overall Study|Sponsor Discretion|16
2319825|NCT02936635|4033366|FG000|Overall Study|Death|9
2319826|NCT02936635|4033367|FG001|Overall Study|Death|15
2319827|NCT02936635|4033366|FG000|Overall Study|Withdrawal by Subject|8
2319828|NCT02936635|4033367|FG001|Overall Study|Withdrawal by Subject|15
2319829|NCT02936635|4033366|FG000|Overall Study|Physician Decision|2
2319830|NCT02936635|4033367|FG001|Overall Study|Physician Decision|9
2319831|NCT02936635|4033366|FG000|Overall Study|Lost to Follow-up|1
2319832|NCT02936635|4033367|FG001|Overall Study|Lost to Follow-up|2
2319833|NCT02936635|4033366|FG000|Overall Study|Protocol Violation|1
2319834|NCT02936635|4033367|FG001|Overall Study|Protocol Violation|0
2319835|NCT02936635|4033366|FG000|Overall Study|Lack of effect/Entry into other study|31
2319836|NCT02936635|4033367|FG001|Overall Study|Lack of effect/Entry into other study|65
2319837|NCT02936869|4033379|FG000|Overall Study|Lost to Follow-up|1
2319838|NCT02936869|4033380|FG001|Overall Study|Lost to Follow-up|3
2319839|NCT02936869|4033379|FG000|Overall Study|Death|0
2319840|NCT02936869|4033380|FG001|Overall Study|Death|1
2319841|NCT02936869|4033379|FG000|Overall Study|Legal Case|0
2319842|NCT02936869|4033380|FG001|Overall Study|Legal Case|1
2319843|NCT02936869|4033379|FG000|Overall Study|Protocol Violation|1
2319844|NCT02936869|4033380|FG001|Overall Study|Protocol Violation|0
2319845|NCT02937350|4033456|FG000|Overall Study|Withdrawal by Subject|0
2319846|NCT02937350|4033457|FG001|Overall Study|Withdrawal by Subject|1
2319847|NCT02937350|4033458|FG002|Overall Study|Withdrawal by Subject|0
2319848|NCT02937454|4033466|FG000|Overall Study|Adverse Event|0
2319849|NCT02937454|4033467|FG001|Overall Study|Adverse Event|1
2319850|NCT02937454|4033466|FG000|Overall Study|Death|98
2319851|NCT02937454|4033467|FG001|Overall Study|Death|95
2319852|NCT02937454|4033466|FG000|Overall Study|Lost to Follow-up|1
2319853|NCT02937454|4033467|FG001|Overall Study|Lost to Follow-up|1
2319854|NCT02937454|4033466|FG000|Overall Study|Physician Decision|0
2319855|NCT02937454|4033467|FG001|Overall Study|Physician Decision|1
2319856|NCT02937454|4033466|FG000|Overall Study|Protocol Violation|6
2319857|NCT02937454|4033467|FG001|Overall Study|Protocol Violation|10
2319858|NCT02937454|4033466|FG000|Overall Study|Withdrawal by Subject|27
2319859|NCT02937454|4033467|FG001|Overall Study|Withdrawal by Subject|15
2319860|NCT02937454|4033466|FG000|Overall Study|Other|8
2319861|NCT02937454|4033467|FG001|Overall Study|Other|5
2319862|NCT02937545|4033485|FG000|Overall Study|Withdrawal by Subject|1
2319863|NCT02937545|4033486|FG001|Overall Study|Withdrawal by Subject|2
2319864|NCT02937545|4033487|FG002|Overall Study|Withdrawal by Subject|6
2319865|NCT02937545|4033488|FG003|Overall Study|Withdrawal by Subject|7
2319866|NCT02937545|4033485|FG000|Overall Study|Lost to Follow-up|1
2319867|NCT02937545|4033486|FG001|Overall Study|Lost to Follow-up|0
2319868|NCT02937545|4033487|FG002|Overall Study|Lost to Follow-up|0
2319869|NCT02937545|4033488|FG003|Overall Study|Lost to Follow-up|0
2319870|NCT02937584|4033509|FG000|Period 1|Adverse Event|1
2319871|NCT02937584|4033510|FG001|Period 1|Adverse Event|2
2319872|NCT02937584|4033509|FG000|Washout|Adverse Event|0
2319873|NCT02937584|4033510|FG001|Washout|Adverse Event|1
2319874|NCT02937636|4033527|FG000|Overall Study|Other (Not specified)|3
2319875|NCT02937636|4033528|FG001|Overall Study|Other (Not specified)|2
2319876|NCT02937701|4033537|FG000|Day 1 to Week 22|Adverse Event|11
2319877|NCT02937701|4033538|FG001|Day 1 to Week 22|Adverse Event|14
2319878|NCT02937701|4033539|FG002|Day 1 to Week 22|Adverse Event|0
2319879|NCT02937701|4033540|FG003|Day 1 to Week 22|Adverse Event|0
2319880|NCT02937701|4033541|FG004|Day 1 to Week 22|Adverse Event|0
2319881|NCT02937701|4033537|FG000|Day 1 to Week 22|Protocol Specified Criteria|7
2319882|NCT02937701|4033538|FG001|Day 1 to Week 22|Protocol Specified Criteria|7
2319883|NCT02937701|4033539|FG002|Day 1 to Week 22|Protocol Specified Criteria|0
2319884|NCT02937701|4033540|FG003|Day 1 to Week 22|Protocol Specified Criteria|0
2319885|NCT02937701|4033541|FG004|Day 1 to Week 22|Protocol Specified Criteria|0
2319886|NCT02937701|4033537|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
2319887|NCT02937701|4033538|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
2319888|NCT02937701|4033539|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
2319889|NCT02937701|4033540|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
2319890|NCT02937701|4033541|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
2319891|NCT02937701|4033537|FG000|Day 1 to Week 22|Withdrawal by Subject|6
2319892|NCT02937701|4033538|FG001|Day 1 to Week 22|Withdrawal by Subject|6
2319893|NCT02937701|4033539|FG002|Day 1 to Week 22|Withdrawal by Subject|0
2319894|NCT02937701|4033540|FG003|Day 1 to Week 22|Withdrawal by Subject|0
2319895|NCT02937701|4033541|FG004|Day 1 to Week 22|Withdrawal by Subject|0
2319896|NCT02937701|4033537|FG000|Day 1 to Week 22|Death|1
2319897|NCT02937701|4033538|FG001|Day 1 to Week 22|Death|1
2319898|NCT02937701|4033539|FG002|Day 1 to Week 22|Death|0
2319899|NCT02937701|4033540|FG003|Day 1 to Week 22|Death|0
2319900|NCT02937701|4033541|FG004|Day 1 to Week 22|Death|0
2319901|NCT02937701|4033537|FG000|Day 1 to Week 22|Protocol Violation|1
2319902|NCT02937701|4033538|FG001|Day 1 to Week 22|Protocol Violation|1
2319903|NCT02937701|4033539|FG002|Day 1 to Week 22|Protocol Violation|0
2319904|NCT02937701|4033540|FG003|Day 1 to Week 22|Protocol Violation|0
2319905|NCT02937701|4033541|FG004|Day 1 to Week 22|Protocol Violation|0
2319906|NCT02937701|4033537|FG000|Day 1 to Week 22|Lost to Follow-up|1
2319907|NCT02937701|4033538|FG001|Day 1 to Week 22|Lost to Follow-up|1
2319908|NCT02937701|4033539|FG002|Day 1 to Week 22|Lost to Follow-up|0
2319909|NCT02937701|4033540|FG003|Day 1 to Week 22|Lost to Follow-up|0
2319910|NCT02937701|4033541|FG004|Day 1 to Week 22|Lost to Follow-up|0
2319911|NCT02937701|4033537|FG000|Day 1 to Week 22|Physician Decision|2
2319912|NCT02937701|4033538|FG001|Day 1 to Week 22|Physician Decision|0
2319913|NCT02937701|4033539|FG002|Day 1 to Week 22|Physician Decision|0
2319914|NCT02937701|4033540|FG003|Day 1 to Week 22|Physician Decision|0
2319915|NCT02937701|4033541|FG004|Day 1 to Week 22|Physician Decision|0
2319916|NCT02937701|4033537|FG000|Day 1 to Week 22|Other|1
2319917|NCT02937701|4033538|FG001|Day 1 to Week 22|Other|0
2319918|NCT02937701|4033539|FG002|Day 1 to Week 22|Other|0
2319919|NCT02937701|4033540|FG003|Day 1 to Week 22|Other|0
2319920|NCT02937701|4033541|FG004|Day 1 to Week 22|Other|0
2319921|NCT02937701|4033537|FG000|Week 22 to Week 50|Adverse Event|0
2319922|NCT02937701|4033538|FG001|Week 22 to Week 50|Adverse Event|0
2319923|NCT02937701|4033539|FG002|Week 22 to Week 50|Adverse Event|10
2319924|NCT02937701|4033540|FG003|Week 22 to Week 50|Adverse Event|3
2319925|NCT02937701|4033541|FG004|Week 22 to Week 50|Adverse Event|3
2319926|NCT02937701|4033537|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
2319927|NCT02937701|4033538|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
2319928|NCT02937701|4033539|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
2319929|NCT02937701|4033540|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
2319930|NCT02937701|4033541|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
2319931|NCT02937701|4033537|FG000|Week 22 to Week 50|Withdrawal by Subject|0
2319932|NCT02937701|4033538|FG001|Week 22 to Week 50|Withdrawal by Subject|0
2319933|NCT02937701|4033539|FG002|Week 22 to Week 50|Withdrawal by Subject|8
2319934|NCT02937701|4033540|FG003|Week 22 to Week 50|Withdrawal by Subject|2
2319935|NCT02937701|4033541|FG004|Week 22 to Week 50|Withdrawal by Subject|1
2319936|NCT02937701|4033537|FG000|Week 22 to Week 50|Lost to Follow-up|0
2319937|NCT02937701|4033538|FG001|Week 22 to Week 50|Lost to Follow-up|0
2319938|NCT02937701|4033539|FG002|Week 22 to Week 50|Lost to Follow-up|2
2319939|NCT02937701|4033540|FG003|Week 22 to Week 50|Lost to Follow-up|0
2319940|NCT02937701|4033541|FG004|Week 22 to Week 50|Lost to Follow-up|1
2319941|NCT02937701|4033537|FG000|Week 22 to Week 50|Physician Decision|0
2319942|NCT02937701|4033538|FG001|Week 22 to Week 50|Physician Decision|0
2319943|NCT02937701|4033539|FG002|Week 22 to Week 50|Physician Decision|2
2319944|NCT02937701|4033540|FG003|Week 22 to Week 50|Physician Decision|0
2319945|NCT02937701|4033541|FG004|Week 22 to Week 50|Physician Decision|1
2319946|NCT02937701|4033537|FG000|Week 22 to Week 50|Other|0
2319947|NCT02937701|4033538|FG001|Week 22 to Week 50|Other|0
2319948|NCT02937701|4033539|FG002|Week 22 to Week 50|Other|0
2319949|NCT02937701|4033540|FG003|Week 22 to Week 50|Other|0
2319950|NCT02937701|4033541|FG004|Week 22 to Week 50|Other|1
2319951|NCT02937740|4033555|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
2319952|NCT02937740|4033556|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
2319953|NCT02937740|4033555|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0
2319954|NCT02937740|4033556|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10
2319955|NCT02937740|4033555|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
2319956|NCT02937740|4033556|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
2322339|NCT02970669|4037282|FG001|Open-label Period|Physician Decision|0
2319957|NCT02937740|4033555|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
2319958|NCT02937740|4033556|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
2319959|NCT02937740|4033555|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
2319960|NCT02937740|4033556|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
2319961|NCT02937740|4033555|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
2319962|NCT02937740|4033556|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
2319963|NCT02937870|4033577|FG000|Overall Study|Adverse Event|1
2319964|NCT02937870|4033577|FG000|Overall Study|Protocol Deviation|2
2319965|NCT02938520|4033638|FG000|Overall Study|On-going at the time of analysis|258
2319966|NCT02938520|4033639|FG001|Overall Study|On-going at the time of analysis|261
2319967|NCT02938520|4033638|FG000|Overall Study|Physician Decision|2
2319968|NCT02938520|4033639|FG001|Overall Study|Physician Decision|5
2319969|NCT02938520|4033638|FG000|Overall Study|Lost to Follow-up|2
2319970|NCT02938520|4033639|FG001|Overall Study|Lost to Follow-up|2
2319971|NCT02938520|4033638|FG000|Overall Study|Withdrawal by Subject|7
2319972|NCT02938520|4033639|FG001|Overall Study|Withdrawal by Subject|7
2319973|NCT02938520|4033638|FG000|Overall Study|Protocol Violation|0
2319974|NCT02938520|4033639|FG001|Overall Study|Protocol Violation|1
2319975|NCT02938520|4033638|FG000|Overall Study|Lack of Efficacy|5
2319976|NCT02938520|4033639|FG001|Overall Study|Lack of Efficacy|3
2319977|NCT02938520|4033638|FG000|Overall Study|Adverse Event|9
2319978|NCT02938520|4033639|FG001|Overall Study|Adverse Event|4
2319979|NCT02938585|4033652|FG000|Overall Study|Withdrawal by parent or guardian|0
2319980|NCT02938585|4033653|FG001|Overall Study|Withdrawal by parent or guardian|1
2319981|NCT02938585|4033654|FG002|Overall Study|Withdrawal by parent or guardian|0
2319982|NCT02938585|4033655|FG003|Overall Study|Withdrawal by parent or guardian|0
2319983|NCT02938585|4033652|FG000|Overall Study|Withdrawal by Subject|0
2319984|NCT02938585|4033653|FG001|Overall Study|Withdrawal by Subject|0
2319985|NCT02938585|4033654|FG002|Overall Study|Withdrawal by Subject|0
2319986|NCT02938585|4033655|FG003|Overall Study|Withdrawal by Subject|5
2319987|NCT02939014|4033690|FG000|Overall Study|Lost to Follow-up|1
2319988|NCT02939014|4033691|FG001|Overall Study|Lost to Follow-up|0
2319989|NCT02939014|4033690|FG000|Overall Study|Death|4
2319990|NCT02939014|4033691|FG001|Overall Study|Death|3
2319991|NCT02939079|4033700|FG000|Overall Study|Adverse Event|2
2319992|NCT02939079|4033701|FG001|Overall Study|Adverse Event|1
2319993|NCT02939079|4033700|FG000|Overall Study|Lost to Follow-up|0
2319994|NCT02939079|4033701|FG001|Overall Study|Lost to Follow-up|2
2319995|NCT02939079|4033700|FG000|Overall Study|Protocol Violation|1
2319996|NCT02939079|4033701|FG001|Overall Study|Protocol Violation|0
2319997|NCT02939079|4033700|FG000|Overall Study|Withdrawal by Subject|0
2319998|NCT02939079|4033701|FG001|Overall Study|Withdrawal by Subject|1
2319999|NCT02939079|4033700|FG000|Overall Study|relapse during the study|1
2320000|NCT02939079|4033701|FG001|Overall Study|relapse during the study|1
2320001|NCT02939131|4033714|FG000|Overall Study|Unable to get to clinic|6
2320002|NCT02939131|4033715|FG001|Overall Study|Unable to get to clinic|4
2320003|NCT02939131|4033714|FG000|Overall Study|Lost to Follow-up|2
2320004|NCT02939131|4033715|FG001|Overall Study|Lost to Follow-up|4
2320005|NCT02939131|4033714|FG000|Overall Study|severe debilitation|1
2320006|NCT02939131|4033715|FG001|Overall Study|severe debilitation|0
2320007|NCT02939131|4033714|FG000|Overall Study|Other|0
2320008|NCT02939131|4033715|FG001|Overall Study|Other|1
2320009|NCT02939131|4033714|FG000|Overall Study|not willing to adhere to protocol|2
2320010|NCT02939131|4033715|FG001|Overall Study|not willing to adhere to protocol|0
2320011|NCT02939560|4033765|FG000|Overall Study|Withdrawal by Subject|2
2320012|NCT02939560|4033765|FG000|Overall Study|Protocol Violation|1
2320013|NCT02939599|4033771|FG000|Overall Study|Adverse Event|1
2320014|NCT02939599|4033772|FG001|Overall Study|Adverse Event|0
2320015|NCT02939599|4033771|FG000|Overall Study|Study Terminated By Sponsor|2
2320016|NCT02939599|4033772|FG001|Overall Study|Study Terminated By Sponsor|2
2320017|NCT02939716|4033783|FG000|Overall Study|scanner failure|0
2320018|NCT02939716|4033784|FG001|Overall Study|scanner failure|0
2320019|NCT02939716|4033785|FG002|Overall Study|scanner failure|0
2320020|NCT02939716|4033786|FG003|Overall Study|scanner failure|1
2320021|NCT02939716|4033787|FG004|Overall Study|scanner failure|1
2320022|NCT02939716|4033788|FG005|Overall Study|scanner failure|1
2320023|NCT02939781|4033805|FG000|Overall Study|Protocol Violation|8
2320024|NCT02939781|4033805|FG000|Overall Study|Withdrawal by Subject|1
2320025|NCT02939937|4033812|FG000|Overall Study|Adverse Event|5
2320026|NCT02939937|4033813|FG001|Overall Study|Adverse Event|0
2320027|NCT02939937|4033812|FG000|Overall Study|Lost to Follow-up|1
2320028|NCT02939937|4033813|FG001|Overall Study|Lost to Follow-up|3
2320029|NCT02939950|4033821|FG000|Overall Study|Lost to Follow-up|13
2216401|NCT01699503|3859026|FG001|Overall Study|Death|40
2216402|NCT01699503|3859025|FG000|Overall Study|Withdrawal by Subject|65
2216403|NCT01699503|3859026|FG001|Overall Study|Withdrawal by Subject|57
2216404|NCT01699503|3859025|FG000|Overall Study|Lost to Follow-up|121
2216405|NCT01699503|3859026|FG001|Overall Study|Lost to Follow-up|117
2216406|NCT01699503|3859025|FG000|Overall Study|Excluded due to quality|783
2216407|NCT01699503|3859026|FG001|Overall Study|Excluded due to quality|791
2216408|NCT01699685|3859051|FG000|Period 1|Adverse Event|1
2216409|NCT01699685|3859052|FG001|Period 1|Adverse Event|1
2216410|NCT01699685|3859051|FG000|Period 1|Medical or ethical, noncompliance|2
2320030|NCT02939950|4033822|FG001|Overall Study|Lost to Follow-up|16
2320031|NCT02939950|4033821|FG000|Overall Study|Positive slit lamp findings|0
2320032|NCT02939950|4033822|FG001|Overall Study|Positive slit lamp findings|1
2216411|NCT01699685|3859052|FG001|Period 1|Medical or ethical, noncompliance|0
2320033|NCT02939950|4033821|FG000|Overall Study|Chalazion upper lid|0
2320034|NCT02939950|4033822|FG001|Overall Study|Chalazion upper lid|1
2320035|NCT02939950|4033821|FG000|Overall Study|Lack of motivation|0
2320036|NCT02939950|4033822|FG001|Overall Study|Lack of motivation|2
2320037|NCT02939950|4033821|FG000|Overall Study|Unacceptable distance lens visual acuity|1
2320038|NCT02939950|4033822|FG001|Overall Study|Unacceptable distance lens visual acuity|1
2320039|NCT02939950|4033821|FG000|Overall Study|Military orders|1
2320040|NCT02939950|4033822|FG001|Overall Study|Military orders|0
2320041|NCT02939950|4033821|FG000|Overall Study|Participant Relocated|5
2320042|NCT02939950|4033822|FG001|Overall Study|Participant Relocated|3
2320043|NCT02939950|4033821|FG000|Overall Study|Study related symptoms|8
2320044|NCT02939950|4033822|FG001|Overall Study|Study related symptoms|8
2320045|NCT02939950|4033821|FG000|Overall Study|Unacceptable lens movement|2
2320046|NCT02939950|4033822|FG001|Overall Study|Unacceptable lens movement|0
2320047|NCT02939950|4033821|FG000|Overall Study|Protocol Violation|6
2320048|NCT02939950|4033822|FG001|Overall Study|Protocol Violation|3
2320049|NCT02939950|4033821|FG000|Overall Study|Physician Decision|2
2320050|NCT02939950|4033822|FG001|Overall Study|Physician Decision|0
2320051|NCT02939950|4033821|FG000|Overall Study|Pregnancy|6
2320052|NCT02939950|4033822|FG001|Overall Study|Pregnancy|7
2320053|NCT02939950|4033821|FG000|Overall Study|Withdrawal by Subject|12
2320054|NCT02939950|4033822|FG001|Overall Study|Withdrawal by Subject|28
2320055|NCT02939950|4033821|FG000|Overall Study|Adverse Event|7
2320056|NCT02939950|4033822|FG001|Overall Study|Adverse Event|3
2320057|NCT02939950|4033821|FG000|Overall Study|Randomized, not dispensed|1
2320058|NCT02939950|4033822|FG001|Overall Study|Randomized, not dispensed|0
2320059|NCT02939950|4033821|FG000|Overall Study|Ineligible at Baseline|2
2320060|NCT02939950|4033822|FG001|Overall Study|Ineligible at Baseline|8
2320061|NCT02940392|4033843|FG000|Overall Study|Lost to Follow-up|3
2320062|NCT02940392|4033843|FG000|Overall Study|Retreatment|3
2320063|NCT02940392|4033843|FG000|Overall Study|Death|2
2320064|NCT02940522|4033849|FG000|Overall Study|Lost to Follow-up|1
2320065|NCT02940522|4033850|FG001|Overall Study|Lost to Follow-up|2
2320066|NCT02940522|4033849|FG000|Overall Study|Withdrawal by Subject|1
2320067|NCT02940522|4033850|FG001|Overall Study|Withdrawal by Subject|0
2320068|NCT02940574|4033858|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
2320069|NCT02940574|4033859|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
2320070|NCT02940574|4033858|FG000|1-year Follow-up|Lost to Follow-up|3
2320071|NCT02940574|4033859|FG001|1-year Follow-up|Lost to Follow-up|4
2320072|NCT02940626|4033871|FG000|Overall Study|Death|40
2320073|NCT02940626|4033872|FG001|Overall Study|Death|32
2320074|NCT02940626|4033871|FG000|Overall Study|Lost to Follow-up|5
2320075|NCT02940626|4033872|FG001|Overall Study|Lost to Follow-up|2
2320076|NCT02940626|4033871|FG000|Overall Study|Withdrawal by Subject|1
2320077|NCT02940626|4033872|FG001|Overall Study|Withdrawal by Subject|0
2320078|NCT02940626|4033871|FG000|Overall Study|Transfer to Hospice Care|1
2320079|NCT02940626|4033872|FG001|Overall Study|Transfer to Hospice Care|0
2320080|NCT02940626|4033871|FG000|Overall Study|Prohibited Concomitant Medication|0
2320081|NCT02940626|4033872|FG001|Overall Study|Prohibited Concomitant Medication|1
2320082|NCT02940691|4033880|FG000|Overall Study|Lost to Follow-up|5
2320083|NCT02940691|4033880|FG000|Overall Study|Incarceration|1
2320084|NCT02940730|4033887|FG000|Intervention 2|Physician Decision|7
2216412|NCT01699685|3859051|FG000|Period 1|Other|0
2320085|NCT02940730|4033888|FG001|Intervention 2|Physician Decision|0
2320086|NCT02940860|4033896|FG000|Overall Study|Non-serious AE|1
2320087|NCT02940860|4033897|FG001|Overall Study|Non-serious AE|2
2320088|NCT02940860|4033896|FG000|Overall Study|Serious AE|7
2320089|NCT02940860|4033897|FG001|Overall Study|Serious AE|3
2320090|NCT02940860|4033896|FG000|Overall Study|Withdrawal by Subject|19
2320091|NCT02940860|4033897|FG001|Overall Study|Withdrawal by Subject|9
2320092|NCT02940860|4033896|FG000|Overall Study|Lost to Follow-up|13
2320093|NCT02940860|4033897|FG001|Overall Study|Lost to Follow-up|7
2320094|NCT02940860|4033896|FG000|Overall Study|Physician Decision|5
2320095|NCT02940860|4033897|FG001|Overall Study|Physician Decision|3
2320096|NCT02940860|4033896|FG000|Overall Study|Sponsor Decision|0
2320097|NCT02940860|4033897|FG001|Overall Study|Sponsor Decision|1
2320098|NCT02940860|4033896|FG000|Overall Study|Protocol Violation|0
2320099|NCT02940860|4033897|FG001|Overall Study|Protocol Violation|2
2320100|NCT02940860|4033896|FG000|Overall Study|Death|3
2320101|NCT02940860|4033897|FG001|Overall Study|Death|2
2320102|NCT02940860|4033896|FG000|Overall Study|Moved, poor venous access, transport|6
2320103|NCT02940860|4033897|FG001|Overall Study|Moved, poor venous access, transport|4
2320104|NCT02940860|4033896|FG000|Overall Study|Not treated|2
2320105|NCT02940860|4033897|FG001|Overall Study|Not treated|2
2320106|NCT02940886|4033907|FG000|Overall Study|Adverse Event|7
2320107|NCT02940886|4033908|FG001|Overall Study|Adverse Event|3
2320108|NCT02940886|4033907|FG000|Overall Study|Protocol Violation|0
2320109|NCT02940886|4033908|FG001|Overall Study|Protocol Violation|2
2320110|NCT02940886|4033907|FG000|Overall Study|Withdrawal by Subject|28
2320111|NCT02940886|4033908|FG001|Overall Study|Withdrawal by Subject|20
2320112|NCT02940886|4033907|FG000|Overall Study|Death|1
2320113|NCT02940886|4033908|FG001|Overall Study|Death|0
2320114|NCT02940886|4033907|FG000|Overall Study|Lack of Efficacy|1
2320115|NCT02940886|4033908|FG001|Overall Study|Lack of Efficacy|0
2320116|NCT02940886|4033907|FG000|Overall Study|Lost to Follow-up|49
2320117|NCT02940886|4033908|FG001|Overall Study|Lost to Follow-up|21
2320118|NCT02940886|4033907|FG000|Overall Study|Physician Decision|9
2320119|NCT02940886|4033908|FG001|Overall Study|Physician Decision|4
2320120|NCT02940886|4033907|FG000|Overall Study|Sponsor decision|0
2320121|NCT02940886|4033908|FG001|Overall Study|Sponsor decision|1
2320122|NCT02940886|4033907|FG000|Overall Study|No treatment|7
2320123|NCT02940886|4033908|FG001|Overall Study|No treatment|2
2320124|NCT02940886|4033907|FG000|Overall Study|Enrolment error|0
2320125|NCT02940886|4033908|FG001|Overall Study|Enrolment error|1
2320126|NCT02941523|4033918|FG000|Monotherapy|Withdrawal by Subject|0
2320127|NCT02941523|4033919|FG001|Monotherapy|Withdrawal by Subject|1
2320128|NCT02941523|4033918|FG000|Carboplatin Combination Therapy|Adverse Event|0
2320129|NCT02941523|4033919|FG001|Carboplatin Combination Therapy|Adverse Event|1
2320130|NCT02941523|4033918|FG000|Carboplatin Combination Therapy|Death|1
2320131|NCT02941523|4033919|FG001|Carboplatin Combination Therapy|Death|2
2320132|NCT02941523|4033918|FG000|Carboplatin Combination Therapy|Disease progression|2
2320133|NCT02941523|4033919|FG001|Carboplatin Combination Therapy|Disease progression|0
2320134|NCT02941523|4033918|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2
2320135|NCT02941523|4033919|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1
2320136|NCT02941627|4033944|FG000|Overall Study|Death|1
2320137|NCT02941627|4033944|FG000|Overall Study|Surgical failure|1
2320138|NCT02941627|4033944|FG000|Overall Study|cholesteatoma prevented implantation|1
2320139|NCT02942264|4033997|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0
2320140|NCT02942264|4033998|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1
2320141|NCT02942264|4033999|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0
2320142|NCT02942264|4034000|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0
2320143|NCT02942264|4034001|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0
2320144|NCT02942264|4034002|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0
2320145|NCT02942264|4034003|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1
2320146|NCT02942264|4034004|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0
2320147|NCT02942264|4034005|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0
2320148|NCT02942264|4033997|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
2320149|NCT02942264|4033998|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
2320150|NCT02942264|4033999|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
2320151|NCT02942264|4034000|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
2320152|NCT02942264|4034001|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
2320153|NCT02942264|4034002|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
2320154|NCT02942264|4034003|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
2320155|NCT02942264|4034004|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
2320156|NCT02942264|4034005|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1
2320157|NCT02942407|4034032|FG000|Overall Study|Lost to Follow-up|3
2320158|NCT02942407|4034033|FG001|Overall Study|Lost to Follow-up|2
2320159|NCT02942407|4034032|FG000|Overall Study|Withdrawal by Subject|7
2320160|NCT02942407|4034033|FG001|Overall Study|Withdrawal by Subject|9
2320161|NCT02942407|4034032|FG000|Overall Study|Death|16
2320162|NCT02942407|4034033|FG001|Overall Study|Death|13
2320163|NCT02942485|4034049|FG000|Overall Study|Lost to Follow-up|1
2320164|NCT02942485|4034050|FG001|Overall Study|Lost to Follow-up|0
2320165|NCT02942576|4034058|FG000|Overall Study|Adverse Event|28
2320166|NCT02942576|4034059|FG001|Overall Study|Adverse Event|6
2320167|NCT02942576|4034058|FG000|Overall Study|Withdrawal by Subject|7
2320168|NCT02942576|4034059|FG001|Overall Study|Withdrawal by Subject|5
2320169|NCT02942576|4034058|FG000|Overall Study|Physician Decision|1
2320170|NCT02942576|4034059|FG001|Overall Study|Physician Decision|4
2320171|NCT02942576|4034058|FG000|Overall Study|Other|10
2320172|NCT02942576|4034059|FG001|Overall Study|Other|8
2320173|NCT02942771|4034077|FG000|Overall Study|Adverse Event|1
2320174|NCT02942771|4034078|FG001|Overall Study|Adverse Event|0
2320175|NCT02942771|4034079|FG002|Overall Study|Adverse Event|0
2320176|NCT02942771|4034080|FG003|Overall Study|Adverse Event|0
2320177|NCT02942771|4034081|FG004|Overall Study|Adverse Event|2
2320178|NCT02942771|4034077|FG000|Overall Study|Lost to Follow-up|1
2320179|NCT02942771|4034078|FG001|Overall Study|Lost to Follow-up|0
2320180|NCT02942771|4034079|FG002|Overall Study|Lost to Follow-up|0
2320181|NCT02942771|4034080|FG003|Overall Study|Lost to Follow-up|0
2320182|NCT02942771|4034081|FG004|Overall Study|Lost to Follow-up|0
2320183|NCT02942771|4034077|FG000|Overall Study|Withdrawal by Subject|1
2320184|NCT02942771|4034078|FG001|Overall Study|Withdrawal by Subject|0
2320185|NCT02942771|4034079|FG002|Overall Study|Withdrawal by Subject|0
2320186|NCT02942771|4034080|FG003|Overall Study|Withdrawal by Subject|0
2320187|NCT02942771|4034081|FG004|Overall Study|Withdrawal by Subject|2
2320188|NCT02943070|4034102|FG000|Overall Study|Physician Decision|1
2320189|NCT02943070|4034102|FG000|Overall Study|Adverse Event|2
2320190|NCT02943070|4034102|FG000|Overall Study|Death|2
2320191|NCT02943070|4034102|FG000|Overall Study|Withdrawal by Subject|3
2320192|NCT02943070|4034102|FG000|Overall Study|Lost to Follow-up|4
2320193|NCT02943070|4034102|FG000|Overall Study|Retreatment or TURP|13
2320194|NCT02943070|4034102|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18
2320195|NCT02943096|4034115|FG000|Overall Study|Lack of Efficacy|0
2320196|NCT02943096|4034116|FG001|Overall Study|Lack of Efficacy|1
2320197|NCT02943447|4034140|FG000|Blinded Study Phase|Withdrew Consent|1
2320198|NCT02943447|4034141|FG001|Blinded Study Phase|Withdrew Consent|2
2320199|NCT02943447|4034142|FG002|Blinded Study Phase|Withdrew Consent|1
2320200|NCT02943447|4034140|FG000|Blinded Study Phase|Adverse Event|3
2320201|NCT02943447|4034141|FG001|Blinded Study Phase|Adverse Event|0
2320202|NCT02943447|4034142|FG002|Blinded Study Phase|Adverse Event|0
2320203|NCT02943447|4034140|FG000|Blinded Study Phase|Investigator's discretion|1
2320204|NCT02943447|4034141|FG001|Blinded Study Phase|Investigator's discretion|0
2320205|NCT02943447|4034142|FG002|Blinded Study Phase|Investigator's discretion|0
2320206|NCT02943447|4034140|FG000|Open-Label Extension Phase|Study terminated by sponsor|10
2320207|NCT02943447|4034141|FG001|Open-Label Extension Phase|Study terminated by sponsor|12
2320208|NCT02943447|4034142|FG002|Open-Label Extension Phase|Study terminated by sponsor|6
2216413|NCT01699685|3859052|FG001|Period 1|Other|1
2216414|NCT01699685|3859051|FG000|Period 1|Patient request|0
2216415|NCT01699685|3859052|FG001|Period 1|Patient request|1
2216416|NCT01699685|3859051|FG000|Period 2|Lost to Follow-up|1
2216417|NCT01699685|3859052|FG001|Period 2|Lost to Follow-up|0
2216418|NCT01699750|3859070|FG000|Overall Study|Withdrew Consent|0
2216419|NCT01699750|3859071|FG001|Overall Study|Withdrew Consent|1
2216420|NCT01699750|3859070|FG000|Overall Study|Other|0
2216421|NCT01699750|3859071|FG001|Overall Study|Other|2
2216422|NCT01699789|3859087|FG000|Overall Study|Withdrawal by Subject|18
2216423|NCT01699789|3859088|FG001|Overall Study|Withdrawal by Subject|23
2216424|NCT01699789|3859087|FG000|Overall Study|Death|1
2216425|NCT01699789|3859088|FG001|Overall Study|Death|2
2216426|NCT01699789|3859087|FG000|Overall Study|Lost to Follow-up|83
2216427|NCT01699789|3859088|FG001|Overall Study|Lost to Follow-up|101
2216428|NCT01699815|3859098|FG000|Overall Study|Protocol Violation|4
2216429|NCT01699815|3859099|FG001|Overall Study|Protocol Violation|7
2216430|NCT01699815|3859098|FG000|Overall Study|record could not be located|1
2216431|NCT01699815|3859099|FG001|Overall Study|record could not be located|0
2216432|NCT01699815|3859098|FG000|Overall Study|Adverse Event|0
2216433|NCT01699815|3859099|FG001|Overall Study|Adverse Event|1
2320209|NCT02943447|4034140|FG000|Open-Label Extension Phase|Adverse Event|4
2320210|NCT02943447|4034141|FG001|Open-Label Extension Phase|Adverse Event|7
2320211|NCT02943447|4034142|FG002|Open-Label Extension Phase|Adverse Event|3
2320212|NCT02943447|4034140|FG000|Open-Label Extension Phase|Lack of Efficacy|3
2320213|NCT02943447|4034141|FG001|Open-Label Extension Phase|Lack of Efficacy|4
2320214|NCT02943447|4034142|FG002|Open-Label Extension Phase|Lack of Efficacy|0
2320215|NCT02943447|4034140|FG000|Open-Label Extension Phase|Withdrew consent|1
2320216|NCT02943447|4034141|FG001|Open-Label Extension Phase|Withdrew consent|1
2320217|NCT02943447|4034142|FG002|Open-Label Extension Phase|Withdrew consent|1
2320218|NCT02943447|4034140|FG000|Open-Label Extension Phase|Lost to Follow-up|0
2320219|NCT02943447|4034141|FG001|Open-Label Extension Phase|Lost to Follow-up|1
2320220|NCT02943447|4034142|FG002|Open-Label Extension Phase|Lost to Follow-up|0
2320221|NCT02943460|4034162|FG000|Blinded Study Phase|Adverse Event|3
2320222|NCT02943460|4034163|FG001|Blinded Study Phase|Adverse Event|0
2320223|NCT02943460|4034164|FG002|Blinded Study Phase|Adverse Event|0
2320224|NCT02943460|4034162|FG000|Blinded Study Phase|Withdrew Consent|0
2320225|NCT02943460|4034163|FG001|Blinded Study Phase|Withdrew Consent|1
2320226|NCT02943460|4034164|FG002|Blinded Study Phase|Withdrew Consent|0
2320227|NCT02943460|4034162|FG000|Open Label Extension (OLE) Phase|Adverse Event|2
2320228|NCT02943460|4034163|FG001|Open Label Extension (OLE) Phase|Adverse Event|5
2320229|NCT02943460|4034164|FG002|Open Label Extension (OLE) Phase|Adverse Event|2
2320230|NCT02943460|4034162|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2
2320231|NCT02943460|4034163|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1
2320232|NCT02943460|4034164|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0
2320233|NCT02943460|4034162|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1
2320234|NCT02943460|4034163|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1
2320235|NCT02943460|4034164|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0
2320236|NCT02943473|4034173|FG000|Overall Study|enrolled but not dosed|1
2320237|NCT02943473|4034173|FG000|Overall Study|screen failure|1
2320238|NCT02943473|4034173|FG000|Overall Study|Physician Decision|4
2320239|NCT02943564|4034189|FG000|Overall Study|Miscellaneous Reasons|0
2320240|NCT02943564|4034190|FG001|Overall Study|Miscellaneous Reasons|0
2320241|NCT02943564|4034191|FG002|Overall Study|Miscellaneous Reasons|3
2320242|NCT02943564|4034189|FG000|Overall Study|Site terminated by sponsor|0
2320243|NCT02943564|4034190|FG001|Overall Study|Site terminated by sponsor|1
2320244|NCT02943564|4034191|FG002|Overall Study|Site terminated by sponsor|0
2320245|NCT02943564|4034189|FG000|Overall Study|Non-compliance with study drug|0
2320246|NCT02943564|4034190|FG001|Overall Study|Non-compliance with study drug|1
2320247|NCT02943564|4034191|FG002|Overall Study|Non-compliance with study drug|0
2320248|NCT02943564|4034189|FG000|Overall Study|Pregnancy|0
2320249|NCT02943564|4034190|FG001|Overall Study|Pregnancy|1
2320250|NCT02943564|4034191|FG002|Overall Study|Pregnancy|1
2320251|NCT02943564|4034189|FG000|Overall Study|Protocol Violation|2
2320252|NCT02943564|4034190|FG001|Overall Study|Protocol Violation|2
2320253|NCT02943564|4034191|FG002|Overall Study|Protocol Violation|2
2320254|NCT02943564|4034189|FG000|Overall Study|Lost to Follow-up|1
2320255|NCT02943564|4034190|FG001|Overall Study|Lost to Follow-up|0
2320256|NCT02943564|4034191|FG002|Overall Study|Lost to Follow-up|0
2320257|NCT02943564|4034189|FG000|Overall Study|Withdrawal by Subject|6
2320258|NCT02943564|4034190|FG001|Overall Study|Withdrawal by Subject|5
2320259|NCT02943564|4034191|FG002|Overall Study|Withdrawal by Subject|2
2320260|NCT02943564|4034189|FG000|Overall Study|Adverse Event|1
2320261|NCT02943564|4034190|FG001|Overall Study|Adverse Event|2
2320262|NCT02943564|4034191|FG002|Overall Study|Adverse Event|1
2320263|NCT02943564|4034189|FG000|Overall Study|Lack of Efficacy|0
2320264|NCT02943564|4034190|FG001|Overall Study|Lack of Efficacy|1
2320265|NCT02943564|4034191|FG002|Overall Study|Lack of Efficacy|0
2320266|NCT02943577|4034201|FG000|Overall Study|Protocol Violation|0
2320267|NCT02943577|4034202|FG001|Overall Study|Protocol Violation|1
2320268|NCT02943577|4034201|FG000|Overall Study|Adverse Event|3
2320269|NCT02943577|4034202|FG001|Overall Study|Adverse Event|2
2320270|NCT02943577|4034201|FG000|Overall Study|Lost to Follow-up|0
2320271|NCT02943577|4034202|FG001|Overall Study|Lost to Follow-up|1
2320272|NCT02943577|4034201|FG000|Overall Study|Withdrawal by Subject|1
2320273|NCT02943577|4034202|FG001|Overall Study|Withdrawal by Subject|1
2320274|NCT02943577|4034201|FG000|Overall Study|Pregnancy|1
2320275|NCT02943577|4034202|FG001|Overall Study|Pregnancy|0
2320276|NCT02943668|4034208|FG000|Overall Study|Disease Progression|1
2320277|NCT02944383|4034223|FG000|Overall Study|Lost to Follow-up|0
2320278|NCT02944383|4034224|FG001|Overall Study|Lost to Follow-up|0
2320279|NCT02944383|4034225|FG002|Overall Study|Lost to Follow-up|1
2320280|NCT02944383|4034223|FG000|Overall Study|Withdrawal by Subject|1
2320281|NCT02944383|4034224|FG001|Overall Study|Withdrawal by Subject|0
2320282|NCT02944383|4034225|FG002|Overall Study|Withdrawal by Subject|0
2320283|NCT02944448|4034237|FG000|Overall Study|Adverse Event|37
2320284|NCT02944448|4034238|FG001|Overall Study|Adverse Event|6
2320285|NCT02944448|4034237|FG000|Overall Study|Lack of Efficacy|8
2320286|NCT02944448|4034238|FG001|Overall Study|Lack of Efficacy|5
2320287|NCT02944448|4034237|FG000|Overall Study|Lost to Follow-up|3
2320288|NCT02944448|4034238|FG001|Overall Study|Lost to Follow-up|1
2320289|NCT02944448|4034237|FG000|Overall Study|Protocol Violation|25
2320290|NCT02944448|4034238|FG001|Overall Study|Protocol Violation|7
2320291|NCT02944448|4034237|FG000|Overall Study|Withdrawal by Subject|14
2320292|NCT02944448|4034238|FG001|Overall Study|Withdrawal by Subject|4
2320293|NCT02944448|4034237|FG000|Overall Study|Sponsor did not supply drug in time|0
2320294|NCT02944448|4034238|FG001|Overall Study|Sponsor did not supply drug in time|1
2320295|NCT02944448|4034237|FG000|Overall Study|Noncompliant with dosing|1
2320296|NCT02944448|4034238|FG001|Overall Study|Noncompliant with dosing|0
2320297|NCT02944448|4034237|FG000|Overall Study|Abnormal laboratory values|1
2320298|NCT02944448|4034238|FG001|Overall Study|Abnormal laboratory values|0
2320299|NCT02944513|4034251|FG000|Overall Study|Withdrawal by Subject|4
2320300|NCT02944513|4034252|FG001|Overall Study|Withdrawal by Subject|1
2320301|NCT02944656|4034265|FG000|Overall Study|No longer eligible|3
2320302|NCT02944656|4034266|FG001|Overall Study|No longer eligible|0
2320303|NCT02944656|4034265|FG000|Overall Study|Lost to Follow-up|7
2320304|NCT02944656|4034266|FG001|Overall Study|Lost to Follow-up|10
2320305|NCT02944968|4034272|FG000|Overall Study|Subject excluded before study procedure|1
2320306|NCT02944968|4034272|FG000|Overall Study|Subject didn't meet eligibility criteria|2
2320307|NCT02945046|4034279|FG000|Overall Study|Adverse Event|1
2320308|NCT02945046|4034280|FG001|Overall Study|Adverse Event|0
2320309|NCT02945046|4034281|FG002|Overall Study|Adverse Event|2
2320310|NCT02945046|4034279|FG000|Overall Study|Withdrawal by Subject|3
2320311|NCT02945046|4034280|FG001|Overall Study|Withdrawal by Subject|3
2320312|NCT02945046|4034281|FG002|Overall Study|Withdrawal by Subject|3
2320313|NCT02945046|4034279|FG000|Overall Study|Protocol Violation|2
2320314|NCT02945046|4034280|FG001|Overall Study|Protocol Violation|3
2320315|NCT02945046|4034281|FG002|Overall Study|Protocol Violation|2
2320316|NCT02945046|4034279|FG000|Overall Study|Lost to Follow-up|1
2320317|NCT02945046|4034280|FG001|Overall Study|Lost to Follow-up|1
2320318|NCT02945046|4034281|FG002|Overall Study|Lost to Follow-up|0
2320319|NCT02945046|4034279|FG000|Overall Study|Lack of Efficacy|1
2320320|NCT02945046|4034280|FG001|Overall Study|Lack of Efficacy|2
2320321|NCT02945046|4034281|FG002|Overall Study|Lack of Efficacy|1
2320322|NCT02945046|4034279|FG000|Overall Study|Other than specified|5
2320323|NCT02945046|4034280|FG001|Overall Study|Other than specified|4
2320324|NCT02945046|4034281|FG002|Overall Study|Other than specified|7
2320325|NCT02945254|4034295|FG000|Overall Study|Lost to Follow-up|1
2320326|NCT02945254|4034296|FG001|Overall Study|Lost to Follow-up|0
2320327|NCT02945254|4034295|FG000|Overall Study|Withdrawal by Subject|1
2320328|NCT02945254|4034296|FG001|Overall Study|Withdrawal by Subject|0
2322340|NCT02970942|4037303|FG000|Overall Study|Death|0
2322341|NCT02970942|4037304|FG001|Overall Study|Death|1
2322342|NCT02970942|4037305|FG002|Overall Study|Death|0
2322343|NCT02970942|4037306|FG003|Overall Study|Death|0
2322344|NCT02970942|4037303|FG000|Overall Study|Lost to Follow-up|1
2322345|NCT02970942|4037304|FG001|Overall Study|Lost to Follow-up|0
2322346|NCT02970942|4037305|FG002|Overall Study|Lost to Follow-up|2
2322347|NCT02970942|4037306|FG003|Overall Study|Lost to Follow-up|1
2322348|NCT02970942|4037303|FG000|Overall Study|Withdrawal by Subject|3
2322349|NCT02970942|4037304|FG001|Overall Study|Withdrawal by Subject|5
2322350|NCT02970942|4037305|FG002|Overall Study|Withdrawal by Subject|3
2322351|NCT02970942|4037306|FG003|Overall Study|Withdrawal by Subject|2
2322352|NCT02971007|4037319|FG000|Overall Study|Adverse Event|1
2322353|NCT02971007|4037320|FG001|Overall Study|Adverse Event|0
2322354|NCT02971007|4037321|FG002|Overall Study|Adverse Event|0
2322355|NCT02971007|4037319|FG000|Overall Study|Lost to Follow-up|0
2322356|NCT02971007|4037320|FG001|Overall Study|Lost to Follow-up|1
2322357|NCT02971007|4037321|FG002|Overall Study|Lost to Follow-up|1
2322358|NCT02971007|4037319|FG000|Overall Study|Withdrawal by Subject|0
2322359|NCT02971007|4037320|FG001|Overall Study|Withdrawal by Subject|1
2322360|NCT02971007|4037321|FG002|Overall Study|Withdrawal by Subject|0
2322361|NCT02971007|4037319|FG000|Overall Study|Patient had yeast at Day 5 visit|1
2322362|NCT02971007|4037320|FG001|Overall Study|Patient had yeast at Day 5 visit|0
2322363|NCT02971007|4037321|FG002|Overall Study|Patient had yeast at Day 5 visit|0
2322364|NCT02971007|4037319|FG000|Overall Study|Patient discontinued study drug|0
2322365|NCT02971007|4037320|FG001|Overall Study|Patient discontinued study drug|1
2320329|NCT02945410|4034308|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
2320330|NCT02945410|4034309|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3
2320331|NCT02945410|4034310|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0
2320332|NCT02945410|4034311|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0
2320333|NCT02945410|4034312|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0
2320334|NCT02945410|4034313|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0
2320335|NCT02945410|4034308|FG000|Intervention 1 (5 Days)|Adverse Event|1
2320336|NCT02945410|4034309|FG001|Intervention 1 (5 Days)|Adverse Event|0
2320337|NCT02945410|4034310|FG002|Intervention 1 (5 Days)|Adverse Event|0
2320338|NCT02945410|4034311|FG003|Intervention 1 (5 Days)|Adverse Event|0
2320339|NCT02945410|4034312|FG004|Intervention 1 (5 Days)|Adverse Event|0
2320340|NCT02945410|4034313|FG005|Intervention 1 (5 Days)|Adverse Event|1
2320341|NCT02945410|4034308|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0
2320342|NCT02945410|4034309|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0
2320343|NCT02945410|4034310|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2
2320344|NCT02945410|4034311|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0
2320345|NCT02945410|4034312|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1
2320346|NCT02945410|4034313|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0
2320347|NCT02945657|4034334|FG000|Overall Study|Adverse Event|1
2320348|NCT02945657|4034334|FG000|Overall Study|Withdrawal by Parent/Guardian|3
2320349|NCT02946385|4034390|FG000|Overall Study|Lost to Follow-up|0
2320350|NCT02946385|4034391|FG001|Overall Study|Lost to Follow-up|0
2320351|NCT02946385|4034392|FG002|Overall Study|Lost to Follow-up|3
2320352|NCT02946385|4034393|FG003|Overall Study|Lost to Follow-up|0
2320353|NCT02946385|4034394|FG004|Overall Study|Lost to Follow-up|2
2320354|NCT02946385|4034395|FG005|Overall Study|Lost to Follow-up|1
2322366|NCT02971007|4037321|FG002|Overall Study|Patient discontinued study drug|0
2322367|NCT02971163|4037331|FG000|Overall Study|Lost to Follow-up|4
2322368|NCT02971163|4037332|FG001|Overall Study|Lost to Follow-up|2
2322369|NCT02971202|4037341|FG000|Overall Study|Pregnancy|1
2322370|NCT02971202|4037342|FG001|Overall Study|Pregnancy|0
2322371|NCT02971202|4037343|FG002|Overall Study|Pregnancy|0
2322372|NCT02971202|4037341|FG000|Overall Study|screen fail after consent|1
2322373|NCT02971202|4037342|FG001|Overall Study|screen fail after consent|0
2322374|NCT02971202|4037343|FG002|Overall Study|screen fail after consent|1
2322375|NCT02971228|4037351|FG000|Overall Study|Withdrawal by Subject|1
2322376|NCT02971228|4037352|FG001|Overall Study|Withdrawal by Subject|1
2322377|NCT02971228|4037353|FG002|Overall Study|Withdrawal by Subject|0
2322378|NCT02971228|4037354|FG003|Overall Study|Withdrawal by Subject|0
2322379|NCT02971228|4037355|FG004|Overall Study|Withdrawal by Subject|0
2322380|NCT02971228|4037351|FG000|Overall Study|Logistical challenges|0
2322381|NCT02971228|4037352|FG001|Overall Study|Logistical challenges|1
2322382|NCT02971228|4037353|FG002|Overall Study|Logistical challenges|0
2322383|NCT02971228|4037354|FG003|Overall Study|Logistical challenges|0
2216434|NCT01699867|3859105|FG000|Overall Study|Screening Failure|3
2216435|NCT01700049|3859113|FG000|Overall Study|Withdrawal by Subject|1
2216436|NCT01700140|3859121|FG000|Overall Study|Use of rescue drugs|3
2320355|NCT02946463|4034417|FG000|Primary Evaluation Period|Physician Decision|0
2320356|NCT02946463|4034418|FG001|Primary Evaluation Period|Physician Decision|1
2320357|NCT02946463|4034417|FG000|Primary Evaluation Period|Withdrawal by Subject|0
2320358|NCT02946463|4034418|FG001|Primary Evaluation Period|Withdrawal by Subject|1
2216437|NCT01700140|3859122|FG001|Overall Study|Use of rescue drugs|3
2216438|NCT01700140|3859123|FG002|Overall Study|Use of rescue drugs|1
2320359|NCT02946515|4034430|FG000|Overall Study|Lost to Follow-up|2
2320360|NCT02946515|4034431|FG001|Overall Study|Lost to Follow-up|1
2320361|NCT02946580|4034439|FG000|Overall Study|Withdrawal by Subject|1
2320362|NCT02946580|4034440|FG001|Overall Study|Withdrawal by Subject|2
2320363|NCT02946580|4034439|FG000|Overall Study|Adverse Event|0
2320364|NCT02946580|4034440|FG001|Overall Study|Adverse Event|2
2320365|NCT02946580|4034439|FG000|Overall Study|Did not undergo posterior spinal fusion|0
2320366|NCT02946580|4034440|FG001|Overall Study|Did not undergo posterior spinal fusion|1
2320367|NCT02946918|4034455|FG000|Overall Study|Patient unblinded himself|1
2320368|NCT02946918|4034456|FG001|Overall Study|Patient unblinded himself|0
2320369|NCT02946918|4034455|FG000|Overall Study|Physician Decision|0
2320370|NCT02946918|4034456|FG001|Overall Study|Physician Decision|2
2217620|NCT01709162|3860912|FG001|Overall Study|Disease progression|3
2216439|NCT01700140|3859121|FG000|Overall Study|Discontinuation of radiotherapy|1
2216440|NCT01700140|3859122|FG001|Overall Study|Discontinuation of radiotherapy|0
2216441|NCT01700140|3859123|FG002|Overall Study|Discontinuation of radiotherapy|0
2216442|NCT01700140|3859121|FG000|Overall Study|Use of chemotherapy or surgical therapy|0
2216443|NCT01700140|3859122|FG001|Overall Study|Use of chemotherapy or surgical therapy|1
2216444|NCT01700140|3859123|FG002|Overall Study|Use of chemotherapy or surgical therapy|0
2216445|NCT01700140|3859121|FG000|Overall Study|Aggravation of symptoms|1
2216446|NCT01700140|3859122|FG001|Overall Study|Aggravation of symptoms|0
2216447|NCT01700140|3859123|FG002|Overall Study|Aggravation of symptoms|0
2216448|NCT01700140|3859121|FG000|Overall Study|Adverse Event|0
2216449|NCT01700140|3859122|FG001|Overall Study|Adverse Event|1
2216450|NCT01700140|3859123|FG002|Overall Study|Adverse Event|0
2216451|NCT01700140|3859121|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
2216452|NCT01700140|3859122|FG001|Overall Study|Inclusion/exclusion criteria deviation|4
2216453|NCT01700140|3859123|FG002|Overall Study|Inclusion/exclusion criteria deviation|0
2216454|NCT01700179|3859134|FG000|Overall Study|Physician Decision|2
2216455|NCT01700192|3859140|FG000|Overall Study|Adverse Event|73
2216456|NCT01700192|3859141|FG001|Overall Study|Adverse Event|18
2216457|NCT01700192|3859140|FG000|Overall Study|Lack of Efficacy|1
2216458|NCT01700192|3859141|FG001|Overall Study|Lack of Efficacy|0
2216459|NCT01700192|3859140|FG000|Overall Study|Lost to Follow-up|42
2216460|NCT01700192|3859141|FG001|Overall Study|Lost to Follow-up|29
2216461|NCT01700192|3859140|FG000|Overall Study|Noncompliance with study drug|0
2216462|NCT01700192|3859141|FG001|Overall Study|Noncompliance with study drug|5
2216463|NCT01700192|3859140|FG000|Overall Study|Physician Decision|2
2216464|NCT01700192|3859141|FG001|Overall Study|Physician Decision|3
2216465|NCT01700192|3859140|FG000|Overall Study|Pregnancy|1
2216466|NCT01700192|3859141|FG001|Overall Study|Pregnancy|4
2216467|NCT01700192|3859140|FG000|Overall Study|Progressive disease|1
2216468|NCT01700192|3859141|FG001|Overall Study|Progressive disease|0
2320371|NCT02946918|4034455|FG000|Overall Study|Ran out of study medication|0
2320372|NCT02946918|4034456|FG001|Overall Study|Ran out of study medication|1
2320373|NCT02948582|4034498|FG000|Washout Period 1|Adverse Event|0
2320374|NCT02948582|4034499|FG001|Washout Period 1|Adverse Event|2
2320375|NCT02948582|4034500|FG002|Washout Period 1|Adverse Event|0
2320376|NCT02948582|4034501|FG003|Washout Period 1|Adverse Event|0
2320377|NCT02948582|4034502|FG004|Washout Period 1|Adverse Event|0
2320378|NCT02948582|4034503|FG005|Washout Period 1|Adverse Event|0
2320379|NCT02948582|4034498|FG000|Washout Period 1|Protocol Violation|0
2320380|NCT02948582|4034499|FG001|Washout Period 1|Protocol Violation|0
2216469|NCT01700192|3859140|FG000|Overall Study|Protocol Violation|3
2216470|NCT01700192|3859141|FG001|Overall Study|Protocol Violation|4
2216471|NCT01700192|3859140|FG000|Overall Study|Technical problems|0
2216472|NCT01700192|3859141|FG001|Overall Study|Technical problems|1
2216473|NCT01700192|3859140|FG000|Overall Study|Withdrawal by Subject|56
2216474|NCT01700192|3859141|FG001|Overall Study|Withdrawal by Subject|64
2216475|NCT01700192|3859140|FG000|Overall Study|Never received study drug|1
2216476|NCT01700192|3859141|FG001|Overall Study|Never received study drug|0
2216477|NCT01700205|3859149|FG000|Overall Study|Withdrawal by Subject|13
2216478|NCT01700205|3859150|FG001|Overall Study|Withdrawal by Subject|13
2216479|NCT01700205|3859149|FG000|Overall Study|Protocol Violation|2
2216480|NCT01700205|3859150|FG001|Overall Study|Protocol Violation|2
2216481|NCT01700387|3859166|FG000|Overall Study|Withdrawal by Subject|1
2216482|NCT01700387|3859167|FG001|Overall Study|Withdrawal by Subject|2
2216483|NCT01700387|3859166|FG000|Overall Study|Adverse Event|1
2216484|NCT01700387|3859167|FG001|Overall Study|Adverse Event|1
2216485|NCT01700387|3859166|FG000|Overall Study|Lost to Follow-up|2
2216486|NCT01700387|3859167|FG001|Overall Study|Lost to Follow-up|1
2216487|NCT01700530|3859198|FG000|Overall Study|Withdrawal by Subject|0
2216488|NCT01700530|3859199|FG001|Overall Study|Withdrawal by Subject|3
2216489|NCT01700530|3859200|FG002|Overall Study|Withdrawal by Subject|1
2216490|NCT01700621|3859210|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7
2216491|NCT01700621|3859211|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4
2216492|NCT01700621|3859210|FG000|Analyzed for Immunogenicity|Protocol Violation|5
2216493|NCT01700621|3859211|FG001|Analyzed for Immunogenicity|Protocol Violation|1
2216494|NCT01700621|3859210|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1
2216495|NCT01700621|3859211|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2
2216496|NCT01700829|3859256|FG000|Overall Study|Withdrawal by Subject|1
2216497|NCT01700829|3859257|FG001|Overall Study|Withdrawal by Subject|1
2216498|NCT01700959|3859278|FG000|Overall Study|Adverse Event|0
2216499|NCT01700959|3859279|FG001|Overall Study|Adverse Event|1
2216500|NCT01700959|3859280|FG002|Overall Study|Adverse Event|1
2216501|NCT01700959|3859281|FG003|Overall Study|Adverse Event|2
2216502|NCT01700959|3859282|FG004|Overall Study|Adverse Event|0
2216503|NCT01700959|3859283|FG005|Overall Study|Adverse Event|2
2216504|NCT01700959|3859278|FG000|Overall Study|Withdrawal by Subject|15
2216505|NCT01700959|3859279|FG001|Overall Study|Withdrawal by Subject|9
2216506|NCT01700959|3859280|FG002|Overall Study|Withdrawal by Subject|12
2216507|NCT01700959|3859281|FG003|Overall Study|Withdrawal by Subject|11
2216508|NCT01700959|3859282|FG004|Overall Study|Withdrawal by Subject|8
2216509|NCT01700959|3859283|FG005|Overall Study|Withdrawal by Subject|12
2216510|NCT01700959|3859278|FG000|Overall Study|Ineligible|2
2216511|NCT01700959|3859279|FG001|Overall Study|Ineligible|1
2216512|NCT01700959|3859280|FG002|Overall Study|Ineligible|2
2216513|NCT01700959|3859281|FG003|Overall Study|Ineligible|0
2216514|NCT01700959|3859282|FG004|Overall Study|Ineligible|0
2216515|NCT01700959|3859283|FG005|Overall Study|Ineligible|1
2216516|NCT01700959|3859278|FG000|Overall Study|Noncompliant|9
2216517|NCT01700959|3859279|FG001|Overall Study|Noncompliant|9
2216518|NCT01700959|3859280|FG002|Overall Study|Noncompliant|17
2216519|NCT01700959|3859281|FG003|Overall Study|Noncompliant|18
2216520|NCT01700959|3859282|FG004|Overall Study|Noncompliant|15
2216521|NCT01700959|3859283|FG005|Overall Study|Noncompliant|9
2216522|NCT01700959|3859278|FG000|Overall Study|Side effects|1
2216523|NCT01700959|3859279|FG001|Overall Study|Side effects|4
2216524|NCT01700959|3859280|FG002|Overall Study|Side effects|8
2216525|NCT01700959|3859281|FG003|Overall Study|Side effects|4
2216526|NCT01700959|3859282|FG004|Overall Study|Side effects|4
2216527|NCT01700959|3859283|FG005|Overall Study|Side effects|1
2216528|NCT01700985|3859301|FG000|Overall Study|Incarcerated|0
2216529|NCT01700985|3859302|FG001|Overall Study|Incarcerated|1
2216530|NCT01701063|3859339|FG000|Overall Study|Lost to Follow-up|0
2216531|NCT01701063|3859340|FG001|Overall Study|Lost to Follow-up|1
2216532|NCT01701063|3859341|FG002|Overall Study|Lost to Follow-up|0
2216533|NCT01701063|3859339|FG000|Overall Study|Withdrawal by Subject|0
2216534|NCT01701063|3859340|FG001|Overall Study|Withdrawal by Subject|0
2216535|NCT01701063|3859341|FG002|Overall Study|Withdrawal by Subject|1
2216536|NCT01701063|3859339|FG000|Overall Study|Other|0
2216537|NCT01701063|3859340|FG001|Overall Study|Other|0
2216538|NCT01701063|3859341|FG002|Overall Study|Other|1
2216539|NCT01701193|3859380|FG000|Overall Study|Withdrawal by Subject|2
2216540|NCT01701193|3859381|FG001|Overall Study|Withdrawal by Subject|2
2216541|NCT01701193|3859382|FG002|Overall Study|Withdrawal by Subject|1
2216542|NCT01701193|3859383|FG003|Overall Study|Withdrawal by Subject|2
2216543|NCT01701193|3859380|FG000|Overall Study|Adverse Event|1
2216544|NCT01701193|3859381|FG001|Overall Study|Adverse Event|0
2216545|NCT01701193|3859382|FG002|Overall Study|Adverse Event|0
2216546|NCT01701193|3859383|FG003|Overall Study|Adverse Event|0
2216547|NCT01701245|3859398|FG000|Overall Study|Protocol Violation|1
2216548|NCT01701245|3859399|FG001|Overall Study|Protocol Violation|3
2216549|NCT01701245|3859398|FG000|Overall Study|Did not complete the open label period|11
2216550|NCT01701245|3859399|FG001|Overall Study|Did not complete the open label period|12
2216551|NCT01701258|3859409|FG000|Assessment and Scheduling|Found to be Ineligible|57
2216552|NCT01701258|3859410|FG001|Assessment and Scheduling|Found to be Ineligible|0
2216553|NCT01701258|3859411|FG002|Assessment and Scheduling|Found to be Ineligible|0
2216554|NCT01701258|3859412|FG003|Assessment and Scheduling|Found to be Ineligible|0
2216555|NCT01701258|3859413|FG004|Assessment and Scheduling|Found to be Ineligible|0
2216556|NCT01701258|3859414|FG005|Assessment and Scheduling|Found to be Ineligible|0
2216557|NCT01701258|3859415|FG006|Assessment and Scheduling|Found to be Ineligible|0
2216558|NCT01701258|3859416|FG007|Assessment and Scheduling|Found to be Ineligible|0
2216559|NCT01701258|3859417|FG008|Assessment and Scheduling|Found to be Ineligible|0
2216560|NCT01701258|3859418|FG009|Assessment and Scheduling|Found to be Ineligible|0
2216561|NCT01701258|3859419|FG010|Assessment and Scheduling|Found to be Ineligible|0
2216562|NCT01701258|3859420|FG011|Assessment and Scheduling|Found to be Ineligible|0
2216563|NCT01701258|3859421|FG012|Assessment and Scheduling|Found to be Ineligible|0
2216564|NCT01701258|3859409|FG000|Assessment and Scheduling|Lost to Follow-up|10
2216565|NCT01701258|3859410|FG001|Assessment and Scheduling|Lost to Follow-up|0
2216566|NCT01701258|3859411|FG002|Assessment and Scheduling|Lost to Follow-up|0
2216567|NCT01701258|3859412|FG003|Assessment and Scheduling|Lost to Follow-up|0
2216568|NCT01701258|3859413|FG004|Assessment and Scheduling|Lost to Follow-up|0
2216569|NCT01701258|3859414|FG005|Assessment and Scheduling|Lost to Follow-up|0
2216570|NCT01701258|3859415|FG006|Assessment and Scheduling|Lost to Follow-up|0
2216571|NCT01701258|3859416|FG007|Assessment and Scheduling|Lost to Follow-up|0
2216572|NCT01701258|3859417|FG008|Assessment and Scheduling|Lost to Follow-up|0
2216573|NCT01701258|3859418|FG009|Assessment and Scheduling|Lost to Follow-up|0
2216574|NCT01701258|3859419|FG010|Assessment and Scheduling|Lost to Follow-up|0
2216575|NCT01701258|3859420|FG011|Assessment and Scheduling|Lost to Follow-up|0
2216576|NCT01701258|3859421|FG012|Assessment and Scheduling|Lost to Follow-up|0
2216577|NCT01701258|3859409|FG000|Assessment and Scheduling|Withdrawal by Subject|14
2216578|NCT01701258|3859410|FG001|Assessment and Scheduling|Withdrawal by Subject|0
2216579|NCT01701258|3859411|FG002|Assessment and Scheduling|Withdrawal by Subject|0
2216580|NCT01701258|3859412|FG003|Assessment and Scheduling|Withdrawal by Subject|0
2217621|NCT01709162|3860911|FG000|Overall Study|Study drug toxicity|2
2216581|NCT01701258|3859413|FG004|Assessment and Scheduling|Withdrawal by Subject|0
2216582|NCT01701258|3859414|FG005|Assessment and Scheduling|Withdrawal by Subject|0
2216583|NCT01701258|3859415|FG006|Assessment and Scheduling|Withdrawal by Subject|0
2216584|NCT01701258|3859416|FG007|Assessment and Scheduling|Withdrawal by Subject|0
2217622|NCT01709162|3860912|FG001|Overall Study|Study drug toxicity|0
2216585|NCT01701258|3859417|FG008|Assessment and Scheduling|Withdrawal by Subject|0
2216586|NCT01701258|3859418|FG009|Assessment and Scheduling|Withdrawal by Subject|0
2216587|NCT01701258|3859419|FG010|Assessment and Scheduling|Withdrawal by Subject|0
2216588|NCT01701258|3859420|FG011|Assessment and Scheduling|Withdrawal by Subject|0
2216589|NCT01701258|3859421|FG012|Assessment and Scheduling|Withdrawal by Subject|0
2216590|NCT01701258|3859409|FG000|Assessment and Scheduling|Investigator Terminated|2
2216591|NCT01701258|3859410|FG001|Assessment and Scheduling|Investigator Terminated|0
2216592|NCT01701258|3859411|FG002|Assessment and Scheduling|Investigator Terminated|0
2216593|NCT01701258|3859412|FG003|Assessment and Scheduling|Investigator Terminated|0
2216594|NCT01701258|3859413|FG004|Assessment and Scheduling|Investigator Terminated|0
2216595|NCT01701258|3859414|FG005|Assessment and Scheduling|Investigator Terminated|0
2216596|NCT01701258|3859415|FG006|Assessment and Scheduling|Investigator Terminated|0
2216597|NCT01701258|3859416|FG007|Assessment and Scheduling|Investigator Terminated|0
2216598|NCT01701258|3859417|FG008|Assessment and Scheduling|Investigator Terminated|0
2216599|NCT01701258|3859418|FG009|Assessment and Scheduling|Investigator Terminated|0
2216600|NCT01701258|3859419|FG010|Assessment and Scheduling|Investigator Terminated|0
2216601|NCT01701258|3859420|FG011|Assessment and Scheduling|Investigator Terminated|0
2216602|NCT01701258|3859421|FG012|Assessment and Scheduling|Investigator Terminated|0
2216603|NCT01701362|3859456|FG000|Overall Study|Adverse events not related to study drug|1
2216604|NCT01701362|3859457|FG001|Overall Study|Adverse events not related to study drug|6
2216605|NCT01701362|3859456|FG000|Overall Study|Adverse events related to study drug|12
2216606|NCT01701362|3859457|FG001|Overall Study|Adverse events related to study drug|10
2216607|NCT01701362|3859456|FG000|Overall Study|Protocol Violation|5
2216608|NCT01701362|3859457|FG001|Overall Study|Protocol Violation|3
2216609|NCT01701362|3859456|FG000|Overall Study|No longer willing to participate|8
2216610|NCT01701362|3859457|FG001|Overall Study|No longer willing to participate|14
2216611|NCT01701362|3859456|FG000|Overall Study|Lost to Follow-up|6
2216612|NCT01701362|3859457|FG001|Overall Study|Lost to Follow-up|9
2216613|NCT01701362|3859456|FG000|Overall Study|Insufficient clinical response|6
2216614|NCT01701362|3859457|FG001|Overall Study|Insufficient clinical response|6
2216615|NCT01701362|3859456|FG000|Overall Study|Death|0
2216616|NCT01701362|3859457|FG001|Overall Study|Death|1
2216617|NCT01701362|3859456|FG000|Overall Study|Randomized but not treated|1
2216618|NCT01701362|3859457|FG001|Overall Study|Randomized but not treated|2
2216619|NCT01701362|3859456|FG000|Overall Study|Reasons other than those mentioned above|3
2216620|NCT01701362|3859457|FG001|Overall Study|Reasons other than those mentioned above|5
2216621|NCT01701401|3859471|FG000|Overall Study|Randomized But Not Treated|3
2216622|NCT01701401|3859472|FG001|Overall Study|Randomized But Not Treated|1
2216623|NCT01701401|3859473|FG002|Overall Study|Randomized But Not Treated|0
2216624|NCT01701401|3859474|FG003|Overall Study|Randomized But Not Treated|1
2216625|NCT01701401|3859471|FG000|Overall Study|Lost to Follow-up|5
2216626|NCT01701401|3859472|FG001|Overall Study|Lost to Follow-up|5
2216627|NCT01701401|3859473|FG002|Overall Study|Lost to Follow-up|1
2216628|NCT01701401|3859474|FG003|Overall Study|Lost to Follow-up|3
2216629|NCT01701401|3859471|FG000|Overall Study|Withdrew Consent|0
2216630|NCT01701401|3859472|FG001|Overall Study|Withdrew Consent|3
2216631|NCT01701401|3859473|FG002|Overall Study|Withdrew Consent|1
2216632|NCT01701401|3859474|FG003|Overall Study|Withdrew Consent|2
2216633|NCT01701401|3859471|FG000|Overall Study|Lack of Efficacy|1
2216634|NCT01701401|3859472|FG001|Overall Study|Lack of Efficacy|0
2216635|NCT01701401|3859473|FG002|Overall Study|Lack of Efficacy|2
2216636|NCT01701401|3859474|FG003|Overall Study|Lack of Efficacy|0
2216637|NCT01701401|3859471|FG000|Overall Study|Adverse Event|1
2216638|NCT01701401|3859472|FG001|Overall Study|Adverse Event|0
2216639|NCT01701401|3859473|FG002|Overall Study|Adverse Event|0
2216640|NCT01701401|3859474|FG003|Overall Study|Adverse Event|0
2216641|NCT01701401|3859471|FG000|Overall Study|Protocol Violation|0
2216642|NCT01701401|3859472|FG001|Overall Study|Protocol Violation|0
2216643|NCT01701401|3859473|FG002|Overall Study|Protocol Violation|1
2216644|NCT01701401|3859474|FG003|Overall Study|Protocol Violation|0
2216645|NCT01701973|3859521|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0
2216646|NCT01701973|3859522|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1
2216647|NCT01701973|3859523|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0
2216648|NCT01701973|3859524|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0
2216649|NCT01701973|3859525|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0
2216650|NCT01701973|3859526|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0
2216651|NCT01701973|3859527|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0
2216652|NCT01701973|3859528|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0
2216653|NCT01702025|3859581|FG000|Overall Study|Equipment failure|1
2216654|NCT01702025|3859582|FG001|Overall Study|Equipment failure|0
2216655|NCT01702025|3859583|FG002|Overall Study|Equipment failure|0
2216656|NCT01702025|3859584|FG003|Overall Study|Equipment failure|0
2216657|NCT01702025|3859581|FG000|Overall Study|Adverse Event|1
2216658|NCT01702025|3859582|FG001|Overall Study|Adverse Event|1
2216659|NCT01702025|3859583|FG002|Overall Study|Adverse Event|1
2216660|NCT01702025|3859584|FG003|Overall Study|Adverse Event|0
2216661|NCT01702246|3859612|FG000|Overall Study|Lost to Follow-up|2
2216662|NCT01702246|3859612|FG000|Overall Study|Withdrawal by Subject|2
2216663|NCT01702246|3859612|FG000|Overall Study|Physician Decision|1
2216664|NCT01702298|3859628|FG000|Overall Study|Withdrawal by Subject|1
2216665|NCT01702311|3859634|FG000|Overall Study|Withdrawal by Subject|3
2216666|NCT01702311|3859635|FG001|Overall Study|Withdrawal by Subject|2
2216667|NCT01702311|3859634|FG000|Overall Study|Discharge less than 24 hours|10
2216668|NCT01702311|3859635|FG001|Overall Study|Discharge less than 24 hours|7
2216669|NCT01702311|3859634|FG000|Overall Study|Physician Decision|3
2216670|NCT01702311|3859635|FG001|Overall Study|Physician Decision|4
2216671|NCT01702363|3859644|FG000|Overall Study|Adverse Event|14
2216672|NCT01702363|3859644|FG000|Overall Study|Lack of Efficacy|4
2216673|NCT01702363|3859644|FG000|Overall Study|Withdrawal by Subject|2
2216674|NCT01702428|3859653|FG000|Overall Study|Adverse Event|2
2216675|NCT01702428|3859654|FG001|Overall Study|Adverse Event|0
2216676|NCT01702428|3859655|FG002|Overall Study|Adverse Event|0
2320381|NCT02948582|4034500|FG002|Washout Period 1|Protocol Violation|0
2320382|NCT02948582|4034501|FG003|Washout Period 1|Protocol Violation|0
2320383|NCT02948582|4034502|FG004|Washout Period 1|Protocol Violation|0
2320384|NCT02948582|4034503|FG005|Washout Period 1|Protocol Violation|1
2320385|NCT02948582|4034498|FG000|Washout Period 2|Adverse Event|0
2320386|NCT02948582|4034499|FG001|Washout Period 2|Adverse Event|1
2320387|NCT02948582|4034500|FG002|Washout Period 2|Adverse Event|0
2320388|NCT02948582|4034501|FG003|Washout Period 2|Adverse Event|0
2320389|NCT02948582|4034502|FG004|Washout Period 2|Adverse Event|0
2320390|NCT02948582|4034503|FG005|Washout Period 2|Adverse Event|0
2320391|NCT02948582|4034498|FG000|Washout Period 2|personal reasons|0
2320392|NCT02948582|4034499|FG001|Washout Period 2|personal reasons|0
2320393|NCT02948582|4034500|FG002|Washout Period 2|personal reasons|0
2320394|NCT02948582|4034501|FG003|Washout Period 2|personal reasons|1
2320395|NCT02948582|4034502|FG004|Washout Period 2|personal reasons|0
2320396|NCT02948582|4034503|FG005|Washout Period 2|personal reasons|0
2320397|NCT02948582|4034498|FG000|Washout Period 4|Adverse Event|1
2320398|NCT02948582|4034499|FG001|Washout Period 4|Adverse Event|0
2320399|NCT02948582|4034500|FG002|Washout Period 4|Adverse Event|1
2216677|NCT01702428|3859656|FG003|Overall Study|Adverse Event|0
2216678|NCT01702428|3859653|FG000|Overall Study|Lost to Follow-up|33
2320400|NCT02948582|4034501|FG003|Washout Period 4|Adverse Event|0
2320401|NCT02948582|4034502|FG004|Washout Period 4|Adverse Event|0
2320402|NCT02948582|4034503|FG005|Washout Period 4|Adverse Event|0
2320403|NCT02948634|4034519|FG000|Overall Study|Lack of efficacy and study suspended|10
2320404|NCT02948634|4034520|FG001|Overall Study|Lack of efficacy and study suspended|2
2320405|NCT02948777|4034526|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1
2320406|NCT02948829|4034531|FG000|Overall Study|Withdrawal by Subject|4
2320407|NCT02948829|4034531|FG000|Overall Study|Ongoing (at data cut-off date: 29 May 2018)|195
2320408|NCT02948829|4034531|FG000|Overall Study|Non-Compliance with Study Procedures|1
2320409|NCT02948959|4034552|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0
2320410|NCT02948959|4034553|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2
2320411|NCT02948959|4034552|FG000|52 Weeks Treatment Period|Adverse Event|2
2320412|NCT02948959|4034553|FG001|52 Weeks Treatment Period|Adverse Event|5
2320413|NCT02948959|4034552|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2
2320414|NCT02948959|4034553|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2
2320415|NCT02948959|4034552|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1
2320416|NCT02948959|4034553|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6
2320417|NCT02948959|4034552|FG000|52 Weeks Treatment Period|Randomized by error|0
2320418|NCT02948959|4034553|FG001|52 Weeks Treatment Period|Randomized by error|5
2320419|NCT02948959|4034552|FG000|52 Weeks Treatment Period|Randomized and not treated|0
2320420|NCT02948959|4034553|FG001|52 Weeks Treatment Period|Randomized and not treated|3
2320421|NCT02948959|4034552|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0
2320422|NCT02948959|4034553|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1
2320423|NCT02948959|4034552|FG000|52 Weeks Treatment Period|Change of residence location|0
2320424|NCT02948959|4034553|FG001|52 Weeks Treatment Period|Change of residence location|1
2320425|NCT02948959|4034552|FG000|12 Weeks Follow-up Period|Adverse Event|0
2320426|NCT02948959|4034553|FG001|12 Weeks Follow-up Period|Adverse Event|2
2320427|NCT02948959|4034552|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1
2320428|NCT02948959|4034553|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2
2320429|NCT02948959|4034552|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3
2216679|NCT01702428|3859654|FG001|Overall Study|Lost to Follow-up|41
2216680|NCT01702428|3859655|FG002|Overall Study|Lost to Follow-up|37
2216681|NCT01702428|3859656|FG003|Overall Study|Lost to Follow-up|44
2216682|NCT01702428|3859653|FG000|Overall Study|Parents cannot assist to site|1
2216683|NCT01702428|3859654|FG001|Overall Study|Parents cannot assist to site|0
2216684|NCT01702428|3859655|FG002|Overall Study|Parents cannot assist to site|1
2216685|NCT01702428|3859656|FG003|Overall Study|Parents cannot assist to site|0
2216686|NCT01702428|3859653|FG000|Overall Study|Lost Coverage|0
2216687|NCT01702428|3859654|FG001|Overall Study|Lost Coverage|0
2216688|NCT01702428|3859655|FG002|Overall Study|Lost Coverage|0
2216689|NCT01702428|3859656|FG003|Overall Study|Lost Coverage|1
2216690|NCT01702428|3859653|FG000|Overall Study|Lost Health Plan|3
2216691|NCT01702428|3859654|FG001|Overall Study|Lost Health Plan|5
2216692|NCT01702428|3859655|FG002|Overall Study|Lost Health Plan|0
2216693|NCT01702428|3859656|FG003|Overall Study|Lost Health Plan|2
2216694|NCT01702428|3859653|FG000|Overall Study|Mother transferred care|0
2216695|NCT01702428|3859654|FG001|Overall Study|Mother transferred care|1
2216696|NCT01702428|3859655|FG002|Overall Study|Mother transferred care|0
2216697|NCT01702428|3859656|FG003|Overall Study|Mother transferred care|0
2216698|NCT01702428|3859653|FG000|Overall Study|Parents too busy|1
2320430|NCT02948959|4034553|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3
2320431|NCT02948959|4034552|FG000|12 Weeks Follow-up Period|Randomized by error|0
2320432|NCT02948959|4034553|FG001|12 Weeks Follow-up Period|Randomized by error|3
2320433|NCT02948959|4034552|FG000|12 Weeks Follow-up Period|Change of residence location|0
2320434|NCT02948959|4034553|FG001|12 Weeks Follow-up Period|Change of residence location|2
2320435|NCT02948959|4034552|FG000|12 Weeks Follow-up Period|Study site closure|1
2320436|NCT02948959|4034553|FG001|12 Weeks Follow-up Period|Study site closure|0
2320437|NCT02949011|4034570|FG000|Overall Study|Adverse Event|6
2320438|NCT02949011|4034571|FG001|Overall Study|Adverse Event|7
2216699|NCT01702428|3859654|FG001|Overall Study|Parents too busy|0
2216700|NCT01702428|3859655|FG002|Overall Study|Parents too busy|0
2216701|NCT01702428|3859656|FG003|Overall Study|Parents too busy|0
2216702|NCT01702428|3859653|FG000|Overall Study|Protocol Violation|3
2216703|NCT01702428|3859654|FG001|Overall Study|Protocol Violation|0
2216704|NCT01702428|3859655|FG002|Overall Study|Protocol Violation|1
2216705|NCT01702428|3859656|FG003|Overall Study|Protocol Violation|0
2216706|NCT01702428|3859653|FG000|Overall Study|Withdrawal by Subject|21
2216707|NCT01702428|3859654|FG001|Overall Study|Withdrawal by Subject|23
2216708|NCT01702428|3859655|FG002|Overall Study|Withdrawal by Subject|14
2216709|NCT01702428|3859656|FG003|Overall Study|Withdrawal by Subject|10
2216710|NCT01702454|3859675|FG000|Overall Study|Consent withdrawal|0
2216711|NCT01702454|3859676|FG001|Overall Study|Consent withdrawal|1
2216712|NCT01702454|3859675|FG000|Overall Study|Migrated/moved from study area|0
2216713|NCT01702454|3859676|FG001|Overall Study|Migrated/moved from study area|1
2216714|NCT01702454|3859675|FG000|Overall Study|Lost to Follow-up|3
2216715|NCT01702454|3859676|FG001|Overall Study|Lost to Follow-up|6
2216716|NCT01702519|3859687|FG000|Washout Period|Lost to Follow-up|1
2216717|NCT01702519|3859688|FG001|Washout Period|Lost to Follow-up|0
2216718|NCT01702519|3859687|FG000|Washout Period|Withdrawal by Subject|0
2216719|NCT01702519|3859688|FG001|Washout Period|Withdrawal by Subject|2
2216720|NCT01702532|3859700|FG000|Overall Study|Adverse Event|0
2216721|NCT01702532|3859701|FG001|Overall Study|Adverse Event|1
2216722|NCT01702558|3859713|FG000|Overall Study|Withdrawal by Subject|0
2216723|NCT01702558|3859714|FG001|Overall Study|Withdrawal by Subject|0
2216724|NCT01702558|3859715|FG002|Overall Study|Withdrawal by Subject|0
2216725|NCT01702558|3859716|FG003|Overall Study|Withdrawal by Subject|12
2216726|NCT01702558|3859717|FG004|Overall Study|Withdrawal by Subject|4
2216727|NCT01702558|3859713|FG000|Overall Study|Lost to Follow-up|0
2216728|NCT01702558|3859714|FG001|Overall Study|Lost to Follow-up|0
2216729|NCT01702558|3859715|FG002|Overall Study|Lost to Follow-up|0
2216730|NCT01702558|3859716|FG003|Overall Study|Lost to Follow-up|3
2216731|NCT01702558|3859717|FG004|Overall Study|Lost to Follow-up|0
2320439|NCT02949011|4034572|FG002|Overall Study|Adverse Event|3
2320440|NCT02949011|4034570|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
2320441|NCT02949011|4034571|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0
2320442|NCT02949011|4034572|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3
2320443|NCT02949011|4034570|FG000|Overall Study|Protocol Deviation|5
2320444|NCT02949011|4034571|FG001|Overall Study|Protocol Deviation|3
2320445|NCT02949011|4034572|FG002|Overall Study|Protocol Deviation|3
2320446|NCT02949011|4034570|FG000|Overall Study|Lack of Efficacy|0
2320447|NCT02949011|4034571|FG001|Overall Study|Lack of Efficacy|2
2320448|NCT02949011|4034572|FG002|Overall Study|Lack of Efficacy|0
2320449|NCT02949011|4034570|FG000|Overall Study|Withdrawal by Subject|13
2320450|NCT02949011|4034571|FG001|Overall Study|Withdrawal by Subject|13
2320451|NCT02949011|4034572|FG002|Overall Study|Withdrawal by Subject|21
2320452|NCT02949011|4034570|FG000|Overall Study|Lost to Follow-up|7
2320453|NCT02949011|4034571|FG001|Overall Study|Lost to Follow-up|5
2320454|NCT02949011|4034572|FG002|Overall Study|Lost to Follow-up|5
2216732|NCT01702558|3859713|FG000|Overall Study|Death|4
2320455|NCT02949011|4034570|FG000|Overall Study|Death|0
2320456|NCT02949011|4034571|FG001|Overall Study|Death|0
2320457|NCT02949011|4034572|FG002|Overall Study|Death|1
2320458|NCT02949011|4034570|FG000|Overall Study|Miscellaneous|2
2320459|NCT02949011|4034571|FG001|Overall Study|Miscellaneous|4
2320460|NCT02949011|4034572|FG002|Overall Study|Miscellaneous|6
2320461|NCT02949024|4034582|FG000|Overall Study|Withdrawal by Subject|0
2320462|NCT02949024|4034583|FG001|Overall Study|Withdrawal by Subject|1
2320463|NCT02949128|4034591|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
2320464|NCT02949128|4034591|FG000|Initial Evaluation Period|Adverse Event|3
2320465|NCT02949128|4034591|FG000|Initial Evaluation Period|Death|2
2320466|NCT02949128|4034591|FG000|Initial Evaluation Period|Physician Decision|1
2320467|NCT02949128|4034591|FG000|Initial Evaluation Period|Protocol Violation|1
2320468|NCT02949128|4034591|FG000|Extension Period|Physician Decision|1
2320469|NCT02949128|4034591|FG000|Extension Period|Withdrawal by Subject|1
2320470|NCT02949219|4034602|FG000|Overall Study|Withdrawal by Subject|1
2320471|NCT02949271|4034608|FG000|Overall Study|Lack of Efficacy|5
2320472|NCT02949271|4034609|FG001|Overall Study|Lack of Efficacy|4
2320473|NCT02949271|4034608|FG000|Overall Study|Lost to Follow-up|3
2320474|NCT02949271|4034609|FG001|Overall Study|Lost to Follow-up|6
2320475|NCT02949271|4034608|FG000|Overall Study|Physician Decision|5
2320476|NCT02949271|4034609|FG001|Overall Study|Physician Decision|5
2320477|NCT02949271|4034608|FG000|Overall Study|Protocol Violation|6
2216733|NCT01702558|3859714|FG001|Overall Study|Death|3
2216734|NCT01702558|3859715|FG002|Overall Study|Death|3
2320478|NCT02949271|4034609|FG001|Overall Study|Protocol Violation|3
2320479|NCT02949271|4034608|FG000|Overall Study|Withdrawal by Subject|1
2320480|NCT02949271|4034609|FG001|Overall Study|Withdrawal by Subject|0
2320481|NCT02949271|4034608|FG000|Overall Study|Delivered prior to intervention|7
2320482|NCT02949271|4034609|FG001|Overall Study|Delivered prior to intervention|9
2320483|NCT02949271|4034608|FG000|Overall Study|Outside the window for cervical dilation|2
2320484|NCT02949271|4034609|FG001|Overall Study|Outside the window for cervical dilation|3
2320485|NCT02949362|4034617|FG000|Retrospective Period|Inform consent not signed by participant|4
2320486|NCT02949362|4034618|FG001|Retrospective Period|Inform consent not signed by participant|1
2320487|NCT02949362|4034619|FG002|Retrospective Period|Inform consent not signed by participant|0
2320488|NCT02949362|4034620|FG003|Retrospective Period|Inform consent not signed by participant|0
2320489|NCT02949362|4034617|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
2320490|NCT02949362|4034618|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
2216735|NCT01702558|3859716|FG003|Overall Study|Death|16
2216736|NCT01702558|3859717|FG004|Overall Study|Death|20
2216737|NCT01702558|3859713|FG000|Overall Study|Safety Follow-Up less than 3 Months|0
2216738|NCT01702558|3859714|FG001|Overall Study|Safety Follow-Up less than 3 Months|0
2216739|NCT01702558|3859715|FG002|Overall Study|Safety Follow-Up less than 3 Months|2
2216740|NCT01702558|3859716|FG003|Overall Study|Safety Follow-Up less than 3 Months|0
2216741|NCT01702558|3859717|FG004|Overall Study|Safety Follow-Up less than 3 Months|0
2216742|NCT01702558|3859713|FG000|Overall Study|Study Terminated by Sponsor|0
2216743|NCT01702558|3859714|FG001|Overall Study|Study Terminated by Sponsor|1
2216744|NCT01702558|3859715|FG002|Overall Study|Study Terminated by Sponsor|0
2216745|NCT01702558|3859716|FG003|Overall Study|Study Terminated by Sponsor|0
2216746|NCT01702558|3859717|FG004|Overall Study|Study Terminated by Sponsor|1
2216747|NCT01702558|3859713|FG000|Overall Study|Other|0
2216748|NCT01702558|3859714|FG001|Overall Study|Other|0
2216749|NCT01702558|3859715|FG002|Overall Study|Other|0
2216750|NCT01702558|3859716|FG003|Overall Study|Other|16
2216751|NCT01702558|3859717|FG004|Overall Study|Other|17
2216752|NCT01702571|3859732|FG000|Overall Study|Death|1067
2216753|NCT01702571|3859733|FG001|Overall Study|Death|76
2216754|NCT01702571|3859732|FG000|Overall Study|Lost to Follow-up|144
2216755|NCT01702571|3859733|FG001|Overall Study|Lost to Follow-up|10
2216756|NCT01702571|3859732|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4
2216757|NCT01702571|3859733|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0
2216758|NCT01702571|3859732|FG000|Overall Study|Investigator Decision|5
2216759|NCT01702571|3859733|FG001|Overall Study|Investigator Decision|0
2216760|NCT01702571|3859732|FG000|Overall Study|Not Classifiable|1
2320491|NCT02949362|4034619|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1
2320492|NCT02949362|4034620|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
2320493|NCT02949362|4034617|FG000|Prospective Period|Other|0
2320494|NCT02949362|4034618|FG001|Prospective Period|Other|0
2320495|NCT02949362|4034619|FG002|Prospective Period|Other|0
2320496|NCT02949362|4034620|FG003|Prospective Period|Other|4
2320497|NCT02949908|4034656|FG000|Overall Study|Study termination|2
2320498|NCT02949973|4034669|FG000|Overall Study|Physician Decision|1
2320499|NCT02950545|4034692|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0
2320500|NCT02950545|4034693|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0
2320501|NCT02950545|4034694|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0
2320502|NCT02950545|4034695|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0
2320503|NCT02950545|4034696|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0
2320504|NCT02950545|4034697|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1
2320505|NCT02950545|4034692|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1
2320506|NCT02950545|4034693|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0
2320507|NCT02950545|4034694|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0
2320508|NCT02950545|4034695|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1
2320509|NCT02950545|4034696|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0
2320510|NCT02950545|4034697|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1
2320511|NCT02950545|4034692|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0
2320512|NCT02950545|4034693|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0
2320513|NCT02950545|4034694|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0
2320514|NCT02950545|4034695|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0
2320515|NCT02950545|4034696|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1
2320516|NCT02950545|4034697|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0
2320517|NCT02950545|4034692|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1
2320518|NCT02950545|4034693|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2216761|NCT01702571|3859733|FG001|Overall Study|Not Classifiable|0
2216762|NCT01702571|3859732|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93
2216763|NCT01702571|3859733|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0
2216764|NCT01702571|3859732|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0
2216765|NCT01702571|3859733|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1
2320519|NCT02950545|4034694|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2320520|NCT02950545|4034695|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2320521|NCT02950545|4034696|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2320522|NCT02950545|4034697|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2216766|NCT01702571|3859732|FG000|Overall Study|Progressive Disease|3
2216767|NCT01702571|3859733|FG001|Overall Study|Progressive Disease|0
2216768|NCT01702571|3859732|FG000|Overall Study|Protocol Violation|2
2216769|NCT01702571|3859733|FG001|Overall Study|Protocol Violation|0
2216770|NCT01702571|3859732|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9
2216771|NCT01702571|3859733|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1
2320523|NCT02950545|4034692|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0
2320524|NCT02950545|4034693|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0
2320525|NCT02950545|4034694|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0
2320526|NCT02950545|4034695|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0
2320527|NCT02950545|4034696|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0
2320528|NCT02950545|4034697|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1
2320529|NCT02950558|4034705|FG000|Overall Study|Lost to Follow-up|2
2320530|NCT02950558|4034706|FG001|Overall Study|Lost to Follow-up|0
2320531|NCT02950831|4034722|FG000|Overall Study|Lost to Follow-up|1
2320532|NCT02950831|4034722|FG000|Overall Study|Withdrawal by Subject|3
2320533|NCT02950831|4034722|FG000|Overall Study|stimulation trail failure|5
2320534|NCT02951156|4034754|FG000|Overall Study|Death|3
2320535|NCT02951156|4034755|FG001|Overall Study|Death|8
2320536|NCT02951156|4034756|FG002|Overall Study|Death|5
2216772|NCT01702571|3859732|FG000|Overall Study|Termination By Sponsor|4
2216773|NCT01702571|3859733|FG001|Overall Study|Termination By Sponsor|0
2216774|NCT01702571|3859732|FG000|Overall Study|Withdrawal by Subject|177
2216775|NCT01702571|3859733|FG001|Overall Study|Withdrawal by Subject|29
2216776|NCT01702844|3859739|FG000|Overall Study|Adverse Event|9
2216777|NCT01702844|3859739|FG000|Overall Study|Death|1
2216778|NCT01702844|3859739|FG000|Overall Study|Withdrawal by Subject|3
2216779|NCT01702844|3859739|FG000|Overall Study|Physician Decision|6
2216780|NCT01702961|3859743|FG000|Overall Study|Additional treatment|3
2216781|NCT01702961|3859743|FG000|Overall Study|Progressive disease|5
2216782|NCT01702961|3859743|FG000|Overall Study|Relapse|20
2216783|NCT01702961|3859743|FG000|Overall Study|Death|6
2216784|NCT01702961|3859743|FG000|Overall Study|Lost to Follow-up|2
2320537|NCT02951156|4034754|FG000|Overall Study|Progressive disease|1
2320538|NCT02951156|4034755|FG001|Overall Study|Progressive disease|0
2320539|NCT02951156|4034756|FG002|Overall Study|Progressive disease|1
2320540|NCT02951156|4034754|FG000|Overall Study|Withdrawal by Subject|0
2320541|NCT02951156|4034755|FG001|Overall Study|Withdrawal by Subject|0
2320542|NCT02951156|4034756|FG002|Overall Study|Withdrawal by Subject|1
2320543|NCT02951156|4034754|FG000|Overall Study|Study terminated by sponsor|0
2320544|NCT02951156|4034755|FG001|Overall Study|Study terminated by sponsor|0
2320545|NCT02951156|4034756|FG002|Overall Study|Study terminated by sponsor|1
2320546|NCT02951156|4034754|FG000|Overall Study|Other|5
2320547|NCT02951156|4034755|FG001|Overall Study|Other|1
2320548|NCT02951156|4034756|FG002|Overall Study|Other|2
2320549|NCT02951429|4034881|FG000|Overall Study|Adverse Event|3
2320550|NCT02951429|4034882|FG001|Overall Study|Adverse Event|7
2320551|NCT02951429|4034881|FG000|Overall Study|Death|28
2320552|NCT02951429|4034882|FG001|Overall Study|Death|36
2320553|NCT02951429|4034881|FG000|Overall Study|Lack of Efficacy|0
2320554|NCT02951429|4034882|FG001|Overall Study|Lack of Efficacy|1
2320555|NCT02951429|4034881|FG000|Overall Study|Lost to Follow-up|0
2216785|NCT01702961|3859743|FG000|Overall Study|Ongoing|11
2320556|NCT02951429|4034882|FG001|Overall Study|Lost to Follow-up|1
2320557|NCT02951429|4034881|FG000|Overall Study|Lung Transplantation|9
2180069|NCT01397825|3805931|FG004|Overall Study|Symptomatic Deterioration|0
2216786|NCT01702987|3859749|FG000|Overall Study|Withdrawal by Subject|1
2216787|NCT01702987|3859750|FG001|Overall Study|Withdrawal by Subject|0
2216788|NCT01703000|3859756|FG000|Overall Study|Death|1
2216789|NCT01703065|3859773|FG000|Overall Study|Lack of Efficacy|1
2216790|NCT01703065|3859774|FG001|Overall Study|Lack of Efficacy|0
2216791|NCT01703091|3859783|FG000|Overall Study|Adverse Event|5
2216792|NCT01703091|3859784|FG001|Overall Study|Adverse Event|3
2216793|NCT01703091|3859783|FG000|Overall Study|Physician Decision|2
2216794|NCT01703091|3859784|FG001|Overall Study|Physician Decision|1
2216795|NCT01703091|3859783|FG000|Overall Study|Withdrawal by Subject|1
2216796|NCT01703091|3859784|FG001|Overall Study|Withdrawal by Subject|0
2216797|NCT01703091|3859783|FG000|Overall Study|Sponsor Decision|1
2216798|NCT01703091|3859784|FG001|Overall Study|Sponsor Decision|0
2180070|NCT01397825|3805927|FG000|Overall Study|Adverse Event|0
2216799|NCT01703117|3859792|FG000|Overall Study|Adverse Event|4
2216800|NCT01703117|3859793|FG001|Overall Study|Adverse Event|3
2216801|NCT01703117|3859792|FG000|Overall Study|Withdrawal by Subject|0
2216802|NCT01703117|3859793|FG001|Overall Study|Withdrawal by Subject|1
2216803|NCT01703208|3859807|FG000|Overall Study|Death|61
2216804|NCT01703208|3859808|FG001|Overall Study|Death|48
2216805|NCT01703208|3859807|FG000|Overall Study|Lack of Efficacy|1
2216806|NCT01703208|3859808|FG001|Overall Study|Lack of Efficacy|2
2216807|NCT01703208|3859807|FG000|Overall Study|Lost to Follow-up|68
2216808|NCT01703208|3859808|FG001|Overall Study|Lost to Follow-up|62
2216809|NCT01703208|3859807|FG000|Overall Study|Non-Compliance with Study Drug|1
2216810|NCT01703208|3859808|FG001|Overall Study|Non-Compliance with Study Drug|0
2216811|NCT01703208|3859807|FG000|Overall Study|Excluded Medication|1
2216812|NCT01703208|3859808|FG001|Overall Study|Excluded Medication|2
2216813|NCT01703208|3859807|FG000|Overall Study|Site Discontinued Study Participation|23
2216814|NCT01703208|3859808|FG001|Overall Study|Site Discontinued Study Participation|27
2216815|NCT01703208|3859807|FG000|Overall Study|Physician Decision|11
2216816|NCT01703208|3859808|FG001|Overall Study|Physician Decision|13
2216817|NCT01703208|3859807|FG000|Overall Study|Progressive disease|2
2216818|NCT01703208|3859808|FG001|Overall Study|Progressive disease|2
2216819|NCT01703208|3859807|FG000|Overall Study|Protocol Violation|1
2216820|NCT01703208|3859808|FG001|Overall Study|Protocol Violation|1
2216821|NCT01703208|3859807|FG000|Overall Study|Study Terminated by Sponsor|1710
2216822|NCT01703208|3859808|FG001|Overall Study|Study Terminated by Sponsor|1716
2216823|NCT01703208|3859807|FG000|Overall Study|Withdrawal by Subject|205
2216824|NCT01703208|3859808|FG001|Overall Study|Withdrawal by Subject|209
2216825|NCT01703208|3859807|FG000|Overall Study|Adverse Event|14
2216826|NCT01703208|3859808|FG001|Overall Study|Adverse Event|19
2216827|NCT01703208|3859807|FG000|Overall Study|Technical Problems|0
2216828|NCT01703208|3859808|FG001|Overall Study|Technical Problems|1
2216829|NCT01703208|3859807|FG000|Overall Study|Protocol Deviation|2
2216830|NCT01703208|3859808|FG001|Overall Study|Protocol Deviation|0
2216831|NCT01703221|3859817|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2
2216832|NCT01703221|3859818|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4
2216833|NCT01703221|3859819|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0
2216834|NCT01703221|3859817|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
2216835|NCT01703221|3859818|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
2216836|NCT01703221|3859819|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
2216837|NCT01703221|3859817|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1
2216838|NCT01703221|3859818|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
2216839|NCT01703221|3859819|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
2216840|NCT01703221|3859817|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
2216841|NCT01703221|3859818|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2216842|NCT01703221|3859819|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2216843|NCT01703221|3859817|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0
2216844|NCT01703221|3859818|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
2216845|NCT01703221|3859819|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1
2216846|NCT01703221|3859817|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
2216847|NCT01703221|3859818|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
2216848|NCT01703221|3859819|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
2320558|NCT02951429|4034882|FG001|Overall Study|Lung Transplantation|6
2320559|NCT02951429|4034881|FG000|Overall Study|Other|1
2320560|NCT02951429|4034882|FG001|Overall Study|Other|3
2320561|NCT02951429|4034881|FG000|Overall Study|Progressive Disease|1
2320562|NCT02951429|4034882|FG001|Overall Study|Progressive Disease|1
2320563|NCT02951429|4034881|FG000|Overall Study|Withdrawal by Subject|7
2320564|NCT02951429|4034882|FG001|Overall Study|Withdrawal by Subject|11
2320565|NCT02951429|4034881|FG000|Overall Study|Participant ongoing in the study|23
2320566|NCT02951429|4034882|FG001|Overall Study|Participant ongoing in the study|17
2216849|NCT01703221|3859817|FG000|Phase B - (Week 25 to 52)|Adverse Event|2
2216850|NCT01703221|3859818|FG001|Phase B - (Week 25 to 52)|Adverse Event|3
2216851|NCT01703221|3859819|FG002|Phase B - (Week 25 to 52)|Adverse Event|2
2216852|NCT01703221|3859817|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12
2216853|NCT01703221|3859818|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10
2216854|NCT01703221|3859819|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3
2216855|NCT01703260|3859836|FG000|Overall Study|Adverse Event|1
2216856|NCT01703260|3859837|FG001|Overall Study|Adverse Event|2
2216857|NCT01703260|3859838|FG002|Overall Study|Adverse Event|2
2216858|NCT01703260|3859836|FG000|Overall Study|Lost to Follow-up|1
2216859|NCT01703260|3859837|FG001|Overall Study|Lost to Follow-up|0
2216860|NCT01703260|3859838|FG002|Overall Study|Lost to Follow-up|0
2177622|NCT01376245|3801979|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2177623|NCT01376245|3801980|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2177624|NCT01376245|3801981|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2177625|NCT01376245|3801982|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2177626|NCT01376245|3801978|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
2177627|NCT01376245|3801979|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2177628|NCT01376245|3801980|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2177629|NCT01376245|3801981|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2177630|NCT01376245|3801982|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2177631|NCT01376245|3801978|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
2177632|NCT01376245|3801979|FG001|24-week, Double-blind Treatment Period|Adverse Event|16
2177633|NCT01376245|3801980|FG002|24-week, Double-blind Treatment Period|Adverse Event|7
2177634|NCT01376245|3801981|FG003|24-week, Double-blind Treatment Period|Adverse Event|8
2177635|NCT01376245|3801982|FG004|24-week, Double-blind Treatment Period|Adverse Event|18
2177636|NCT01376245|3801978|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0
2177637|NCT01376245|3801979|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4
2177638|NCT01376245|3801980|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5
2177639|NCT01376245|3801981|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4
2177640|NCT01376245|3801982|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3
2217694|NCT01709305|3860929|FG001|Phase 2|Laboratory Adverse Event|1
2217695|NCT01709305|3860930|FG002|Phase 2|Laboratory Adverse Event|0
2217696|NCT01709305|3860931|FG003|Phase 2|Laboratory Adverse Event|1
2217697|NCT01709305|3860932|FG004|Phase 2|Laboratory Adverse Event|1
2217698|NCT01709305|3860928|FG000|Phase 2|Lost to Follow-up|0
2217699|NCT01709305|3860929|FG001|Phase 2|Lost to Follow-up|10
2217700|NCT01709305|3860930|FG002|Phase 2|Lost to Follow-up|6
2217701|NCT01709305|3860931|FG003|Phase 2|Lost to Follow-up|9
2217702|NCT01709305|3860932|FG004|Phase 2|Lost to Follow-up|5
2026068|NCT00348309|3594726|FG002|Overall Study|Adverse Event|63
2026069|NCT00348309|3594724|FG000|Overall Study|Lost to Follow-up|6
2026070|NCT00348309|3594725|FG001|Overall Study|Lost to Follow-up|7
2026071|NCT00348309|3594726|FG002|Overall Study|Lost to Follow-up|4
2026072|NCT00348309|3594724|FG000|Overall Study|Protocol Violation|7
2026073|NCT00348309|3594725|FG001|Overall Study|Protocol Violation|12
2026074|NCT00348309|3594726|FG002|Overall Study|Protocol Violation|7
2026075|NCT00348309|3594724|FG000|Overall Study|Withdrawal by Subject|33
2026076|NCT00348309|3594725|FG001|Overall Study|Withdrawal by Subject|37
2026077|NCT00348309|3594726|FG002|Overall Study|Withdrawal by Subject|40
2026078|NCT00348309|3594724|FG000|Overall Study|Non-compliance|8
2026079|NCT00348309|3594725|FG001|Overall Study|Non-compliance|6
2026080|NCT00348309|3594726|FG002|Overall Study|Non-compliance|8
2026081|NCT00348309|3594724|FG000|Overall Study|Death of caregiver|1
2026082|NCT00348309|3594725|FG001|Overall Study|Death of caregiver|0
2026083|NCT00348309|3594726|FG002|Overall Study|Death of caregiver|1
2026084|NCT00348309|3594724|FG000|Overall Study|Lack of insight, dementia|1
2026085|NCT00348309|3594725|FG001|Overall Study|Lack of insight, dementia|0
2026086|NCT00348309|3594726|FG002|Overall Study|Lack of insight, dementia|0
2026087|NCT00348309|3594724|FG000|Overall Study|Wrong bottle allocated|1
2026088|NCT00348309|3594725|FG001|Overall Study|Wrong bottle allocated|0
2026089|NCT00348309|3594726|FG002|Overall Study|Wrong bottle allocated|0
2026090|NCT00348309|3594724|FG000|Overall Study|Caregiver sick|1
2026091|NCT00348309|3594725|FG001|Overall Study|Caregiver sick|0
2026092|NCT00348309|3594726|FG002|Overall Study|Caregiver sick|0
2026093|NCT00348309|3594724|FG000|Overall Study|Use of prohibited medication|5
2026094|NCT00348309|3594725|FG001|Overall Study|Use of prohibited medication|2
2026095|NCT00348309|3594726|FG002|Overall Study|Use of prohibited medication|2
2026096|NCT00348309|3594724|FG000|Overall Study|Caregiver withdrawal|3
2026097|NCT00348309|3594725|FG001|Overall Study|Caregiver withdrawal|0
2026098|NCT00348309|3594726|FG002|Overall Study|Caregiver withdrawal|7
2026099|NCT00348309|3594724|FG000|Overall Study|Unable to complete ET visit|1
2026100|NCT00348309|3594725|FG001|Overall Study|Unable to complete ET visit|0
2026101|NCT00348309|3594726|FG002|Overall Study|Unable to complete ET visit|0
2026102|NCT00348309|3594724|FG000|Overall Study|PI closing medical practice|1
2026103|NCT00348309|3594725|FG001|Overall Study|PI closing medical practice|0
2026104|NCT00348309|3594726|FG002|Overall Study|PI closing medical practice|0
2026105|NCT00348309|3594724|FG000|Overall Study|Principal investigator's decision|1
2026106|NCT00348309|3594725|FG001|Overall Study|Principal investigator's decision|0
2026107|NCT00348309|3594726|FG002|Overall Study|Principal investigator's decision|0
2026108|NCT00348309|3594724|FG000|Overall Study|No disponibility of medication|1
2026109|NCT00348309|3594725|FG001|Overall Study|No disponibility of medication|0
2026110|NCT00348309|3594726|FG002|Overall Study|No disponibility of medication|0
2026111|NCT00348309|3594724|FG000|Overall Study|Worsened neurodegenerative disease|1
2026112|NCT00348309|3594725|FG001|Overall Study|Worsened neurodegenerative disease|0
2026113|NCT00348309|3594726|FG002|Overall Study|Worsened neurodegenerative disease|0
2026114|NCT00348309|3594724|FG000|Overall Study|Cognitive and behaviour worsening|2
2026115|NCT00348309|3594725|FG001|Overall Study|Cognitive and behaviour worsening|0
2026116|NCT00348309|3594726|FG002|Overall Study|Cognitive and behaviour worsening|0
2026117|NCT00348309|3594724|FG000|Overall Study|Worsening of alzheimer|1
2026118|NCT00348309|3594725|FG001|Overall Study|Worsening of alzheimer|0
2026119|NCT00348309|3594726|FG002|Overall Study|Worsening of alzheimer|1
2026120|NCT00348309|3594724|FG000|Overall Study|Did not appear in time for Visit 3|1
2026121|NCT00348309|3594725|FG001|Overall Study|Did not appear in time for Visit 3|0
2026122|NCT00348309|3594726|FG002|Overall Study|Did not appear in time for Visit 3|0
2026123|NCT00348309|3594724|FG000|Overall Study|Participant died|2
2180159|NCT01399372|3806137|FG001|Overall Study|Protocol Violation|1
2026124|NCT00348309|3594725|FG001|Overall Study|Participant died|1
2026125|NCT00348309|3594726|FG002|Overall Study|Participant died|1
2026126|NCT00348309|3594724|FG000|Overall Study|Decision of sponsor|1
2217703|NCT01709305|3860928|FG000|Phase 2|Travel, moving, etc.|0
2217704|NCT01709305|3860929|FG001|Phase 2|Travel, moving, etc.|2
2217705|NCT01709305|3860930|FG002|Phase 2|Travel, moving, etc.|3
2026127|NCT00348309|3594725|FG001|Overall Study|Decision of sponsor|0
2026128|NCT00348309|3594726|FG002|Overall Study|Decision of sponsor|0
2026129|NCT00348309|3594724|FG000|Overall Study|Ineffectiveness of treatment|0
2026130|NCT00348309|3594725|FG001|Overall Study|Ineffectiveness of treatment|1
2026131|NCT00348309|3594726|FG002|Overall Study|Ineffectiveness of treatment|0
2026132|NCT00348309|3594724|FG000|Overall Study|A foul of exclusion criteria|0
2026133|NCT00348309|3594725|FG001|Overall Study|A foul of exclusion criteria|1
2026134|NCT00348309|3594726|FG002|Overall Study|A foul of exclusion criteria|0
2108251|NCT00879229|3702157|FG000|Overall Study|Adverse Event|2
2108252|NCT00879229|3702158|FG001|Overall Study|Adverse Event|0
2108253|NCT00879229|3702157|FG000|Overall Study|Withdrawal by Subject|1
2108254|NCT00879229|3702158|FG001|Overall Study|Withdrawal by Subject|0
2108255|NCT00879229|3702157|FG000|Overall Study|Clinical status did not improve|1
2108256|NCT00879229|3702158|FG001|Overall Study|Clinical status did not improve|0
2108257|NCT00879229|3702157|FG000|Overall Study|Other|1
2108258|NCT00879229|3702158|FG001|Overall Study|Other|0
2108259|NCT00879333|3702175|FG000|Overall Study|Adverse Event|94
2108260|NCT00879333|3702176|FG001|Overall Study|Adverse Event|34
2108261|NCT00879333|3702175|FG000|Overall Study|Abnormal Laboratory Value|1
2108262|NCT00879333|3702176|FG001|Overall Study|Abnormal Laboratory Value|0
2108263|NCT00879333|3702175|FG000|Overall Study|Withdrawal by Subject|20
2108264|NCT00879333|3702176|FG001|Overall Study|Withdrawal by Subject|7
2108265|NCT00879333|3702175|FG000|Overall Study|Lost to Follow-up|2
2108266|NCT00879333|3702176|FG001|Overall Study|Lost to Follow-up|1
2026135|NCT00348309|3594724|FG000|Overall Study|Participant was hospitalized|0
2026136|NCT00348309|3594725|FG001|Overall Study|Participant was hospitalized|1
2026137|NCT00348309|3594726|FG002|Overall Study|Participant was hospitalized|0
2026138|NCT00348309|3594724|FG000|Overall Study|Sponsor refuseal|0
2026139|NCT00348309|3594725|FG001|Overall Study|Sponsor refuseal|1
2026140|NCT00348309|3594726|FG002|Overall Study|Sponsor refuseal|1
2026141|NCT00348309|3594724|FG000|Overall Study|Forgot often medication|0
2026142|NCT00348309|3594725|FG001|Overall Study|Forgot often medication|1
2108267|NCT00879333|3702175|FG000|Overall Study|Administrative Problems|2
2108268|NCT00879333|3702176|FG001|Overall Study|Administrative Problems|0
2108269|NCT00879333|3702175|FG000|Overall Study|Death|16
2108270|NCT00879333|3702176|FG001|Overall Study|Death|5
2108271|NCT00879333|3702175|FG000|Overall Study|Disease Progression|292
2108272|NCT00879333|3702176|FG001|Overall Study|Disease Progression|169
2108273|NCT00879333|3702175|FG000|Overall Study|Protocol Violation|1
2108274|NCT00879333|3702176|FG001|Overall Study|Protocol Violation|1
2108275|NCT00879398|3702189|FG000|Overall Study|Visit Stop|399
2108276|NCT00879398|3702189|FG000|Overall Study|Lack of Efficacy|64
2108277|NCT00879398|3702189|FG000|Overall Study|Adverse Event|41
2108278|NCT00879398|3702189|FG000|Overall Study|Other Reasons|171
2108279|NCT00879411|3702193|FG000|Overall Study|lost to follow-up (non-AE)|162
2108280|NCT00879437|3702197|FG000|Overall Study|Protocol Violation|0
2108281|NCT00879437|3702198|FG001|Overall Study|Protocol Violation|1
2108282|NCT00879437|3702197|FG000|Overall Study|Death|1
2108283|NCT00879437|3702198|FG001|Overall Study|Death|0
2108284|NCT00879645|3702210|FG000|Overall Study|Adverse Event|1
2108285|NCT00879645|3702211|FG001|Overall Study|Adverse Event|0
2108286|NCT00879645|3702212|FG002|Overall Study|Adverse Event|0
2108287|NCT00879645|3702213|FG003|Overall Study|Adverse Event|0
2108288|NCT00879658|3702230|FG000|Overall Study|Abnormal laboratory value(s)|3
2108289|NCT00879658|3702231|FG001|Overall Study|Abnormal laboratory value(s)|0
2108290|NCT00879658|3702232|FG002|Overall Study|Abnormal laboratory value(s)|0
2108291|NCT00879658|3702233|FG003|Overall Study|Abnormal laboratory value(s)|1
2108292|NCT00879658|3702234|FG004|Overall Study|Abnormal laboratory value(s)|0
2108293|NCT00879658|3702235|FG005|Overall Study|Abnormal laboratory value(s)|0
2108294|NCT00879658|3702236|FG006|Overall Study|Abnormal laboratory value(s)|0
2108295|NCT00879658|3702230|FG000|Overall Study|Administrative problems|2
2108296|NCT00879658|3702231|FG001|Overall Study|Administrative problems|1
2108297|NCT00879658|3702232|FG002|Overall Study|Administrative problems|0
2108298|NCT00879658|3702233|FG003|Overall Study|Administrative problems|1
2108299|NCT00879658|3702234|FG004|Overall Study|Administrative problems|0
2026143|NCT00348309|3594726|FG002|Overall Study|Forgot often medication|0
2026144|NCT00348309|3594724|FG000|Overall Study|Medical Monitor decision|0
2026145|NCT00348309|3594725|FG001|Overall Study|Medical Monitor decision|0
2026146|NCT00348309|3594726|FG002|Overall Study|Medical Monitor decision|1
2026147|NCT00348309|3594724|FG000|Overall Study|Increased dose of Aricept|0
2026148|NCT00348309|3594725|FG001|Overall Study|Increased dose of Aricept|0
2026149|NCT00348309|3594726|FG002|Overall Study|Increased dose of Aricept|1
2026150|NCT00348309|3594724|FG000|Overall Study|Site closure|0
2026151|NCT00348309|3594725|FG001|Overall Study|Site closure|0
2026152|NCT00348309|3594726|FG002|Overall Study|Site closure|1
2026153|NCT00348309|3594724|FG000|Overall Study|Adverse event not attended|0
2026154|NCT00348309|3594725|FG001|Overall Study|Adverse event not attended|0
2026155|NCT00348309|3594726|FG002|Overall Study|Adverse event not attended|1
2026156|NCT00348309|3594724|FG000|Overall Study|ECG abnormal|0
2026157|NCT00348309|3594725|FG001|Overall Study|ECG abnormal|0
2108300|NCT00879658|3702235|FG005|Overall Study|Administrative problems|0
2108301|NCT00879658|3702236|FG006|Overall Study|Administrative problems|0
2108302|NCT00879658|3702230|FG000|Overall Study|Adverse Event|6
2108303|NCT00879658|3702231|FG001|Overall Study|Adverse Event|4
2108304|NCT00879658|3702232|FG002|Overall Study|Adverse Event|3
2108305|NCT00879658|3702233|FG003|Overall Study|Adverse Event|1
2108306|NCT00879658|3702234|FG004|Overall Study|Adverse Event|2
2108307|NCT00879658|3702235|FG005|Overall Study|Adverse Event|0
2108308|NCT00879658|3702236|FG006|Overall Study|Adverse Event|0
2108309|NCT00879658|3702230|FG000|Overall Study|Protocol Violation|1
2108310|NCT00879658|3702231|FG001|Overall Study|Protocol Violation|0
2108311|NCT00879658|3702232|FG002|Overall Study|Protocol Violation|0
2108312|NCT00879658|3702233|FG003|Overall Study|Protocol Violation|0
2108313|NCT00879658|3702234|FG004|Overall Study|Protocol Violation|0
2108314|NCT00879658|3702235|FG005|Overall Study|Protocol Violation|0
2108315|NCT00879658|3702236|FG006|Overall Study|Protocol Violation|0
2108316|NCT00879658|3702230|FG000|Overall Study|Withdrawal by Subject|3
2108317|NCT00879658|3702231|FG001|Overall Study|Withdrawal by Subject|0
2108318|NCT00879658|3702232|FG002|Overall Study|Withdrawal by Subject|2
2108319|NCT00879658|3702233|FG003|Overall Study|Withdrawal by Subject|0
2108320|NCT00879658|3702234|FG004|Overall Study|Withdrawal by Subject|0
2108321|NCT00879658|3702235|FG005|Overall Study|Withdrawal by Subject|1
2108322|NCT00879658|3702236|FG006|Overall Study|Withdrawal by Subject|0
2108323|NCT00879658|3702230|FG000|Overall Study|Lack of Efficacy|0
2108324|NCT00879658|3702231|FG001|Overall Study|Lack of Efficacy|0
2108325|NCT00879658|3702232|FG002|Overall Study|Lack of Efficacy|2
2108326|NCT00879658|3702233|FG003|Overall Study|Lack of Efficacy|0
2108327|NCT00879658|3702234|FG004|Overall Study|Lack of Efficacy|0
2026158|NCT00348309|3594726|FG002|Overall Study|ECG abnormal|2
2026159|NCT00348309|3594724|FG000|Overall Study|Cardiologist recommendations|0
2026160|NCT00348309|3594725|FG001|Overall Study|Cardiologist recommendations|0
2026161|NCT00348309|3594726|FG002|Overall Study|Cardiologist recommendations|1
2026162|NCT00348309|3594724|FG000|Overall Study|HCV career|0
2026163|NCT00348309|3594725|FG001|Overall Study|HCV career|0
2026164|NCT00348309|3594726|FG002|Overall Study|HCV career|1
2026165|NCT00348348|3594737|FG000|Overall Study|Adverse event - unrelated to study drug|0
2026166|NCT00348348|3594738|FG001|Overall Study|Adverse event - unrelated to study drug|1
2026167|NCT00348348|3594737|FG000|Overall Study|Lack of Efficacy|1
2026168|NCT00348348|3594738|FG001|Overall Study|Lack of Efficacy|1
2026169|NCT00348348|3594737|FG000|Overall Study|Lost to Follow-up|8
2026170|NCT00348348|3594738|FG001|Overall Study|Lost to Follow-up|10
2026171|NCT00348348|3594737|FG000|Overall Study|Withdrawal by Subject|4
2217706|NCT01709305|3860931|FG003|Phase 2|Travel, moving, etc.|3
2026172|NCT00348348|3594738|FG001|Overall Study|Withdrawal by Subject|1
2026173|NCT00348348|3594737|FG000|Overall Study|Other|7
2026174|NCT00348348|3594738|FG001|Overall Study|Other|4
2026175|NCT00348348|3594737|FG000|Overall Study|Dissallowed Meds - unrelated to study|1
2026176|NCT00348348|3594738|FG001|Overall Study|Dissallowed Meds - unrelated to study|3
2026177|NCT00348348|3594737|FG000|Overall Study|Dissallowed Meds - unlikley related|1
2026178|NCT00348348|3594738|FG001|Overall Study|Dissallowed Meds - unlikley related|1
2026179|NCT00348348|3594737|FG000|Overall Study|Dissallowed Meds - possibly releated|1
2026180|NCT00348348|3594738|FG001|Overall Study|Dissallowed Meds - possibly releated|1
2026181|NCT00348348|3594737|FG000|Overall Study|Worsening of BC - Unrelated to study|0
2026182|NCT00348348|3594738|FG001|Overall Study|Worsening of BC - Unrelated to study|3
2026183|NCT00348348|3594737|FG000|Overall Study|Worsening of BC - Unlikely related|1
2026184|NCT00348348|3594738|FG001|Overall Study|Worsening of BC - Unlikely related|2
2026185|NCT00348348|3594737|FG000|Overall Study|Adverse event probably related to study|1
2026186|NCT00348348|3594738|FG001|Overall Study|Adverse event probably related to study|0
2026187|NCT00348374|3594746|FG000|Overall Study|Adverse Event|1
2026188|NCT00348374|3594747|FG001|Overall Study|Adverse Event|4
2026189|NCT00348374|3594746|FG000|Overall Study|Lost to Follow-up|1
2026190|NCT00348374|3594747|FG001|Overall Study|Lost to Follow-up|3
2026191|NCT00348374|3594746|FG000|Overall Study|Withdrawal by Subject|5
2026192|NCT00348374|3594747|FG001|Overall Study|Withdrawal by Subject|5
2026193|NCT00348374|3594746|FG000|Overall Study|Other|11
2026194|NCT00348374|3594747|FG001|Overall Study|Other|12
2026195|NCT00348374|3594746|FG000|Overall Study|ongoing at date of cutoff|1
2026196|NCT00348374|3594747|FG001|Overall Study|ongoing at date of cutoff|1
2026197|NCT00348374|3594746|FG000|Overall Study|randomized but did not receive treatment|0
2026198|NCT00348374|3594747|FG001|Overall Study|randomized but did not receive treatment|7
2026199|NCT00348595|3594756|FG000|Overall Study|Adverse Event|5
2026200|NCT00348595|3594757|FG001|Overall Study|Adverse Event|8
2026201|NCT00348673|3594771|FG000|Stage 1|Randomized but not Treated|0
2026202|NCT00348673|3594772|FG001|Stage 1|Randomized but not Treated|0
2026203|NCT00348673|3594773|FG002|Stage 1|Randomized but not Treated|1
2026204|NCT00348673|3594774|FG003|Stage 1|Randomized but not Treated|0
2026205|NCT00348673|3594775|FG004|Stage 1|Randomized but not Treated|0
2026206|NCT00348673|3594776|FG005|Stage 1|Randomized but not Treated|0
2026207|NCT00348673|3594777|FG006|Stage 1|Randomized but not Treated|0
2026208|NCT00348673|3594778|FG007|Stage 1|Randomized but not Treated|0
2026209|NCT00348673|3594779|FG008|Stage 1|Randomized but not Treated|0
2026210|NCT00348686|3594797|FG000|Overall Study|Withdrawal by Subject|45
2026211|NCT00348686|3594797|FG000|Overall Study|Adverse Event|5
2026212|NCT00348686|3594797|FG000|Overall Study|Protocol Violation|6
2026213|NCT00348686|3594797|FG000|Overall Study|Lost to Follow-up|2
2026214|NCT00348686|3594797|FG000|Overall Study|Multiple Reasons|8
2026215|NCT00348790|3594801|FG000|Completed Treatment|Withdrawal by Subject|4
2026216|NCT00348790|3594801|FG000|Completed Treatment|Disease progression|14
2026217|NCT00348790|3594801|FG000|Completed Treatment|Adverse Event|4
2026218|NCT00348790|3594801|FG000|Completed Treatment|Required surgery|2
2026219|NCT00348790|3594801|FG000|Completed Treatment|Unable to travel to study site|1
2026220|NCT00348816|3594806|FG000|Overall Study|Noncompliance with radiation treatment|1
2026221|NCT00348881|3594814|FG000|Overall Study|Lost to Follow-up|12
2026222|NCT00348881|3594815|FG001|Overall Study|Lost to Follow-up|6
2026223|NCT00348881|3594814|FG000|Overall Study|Withdrawal by Subject|3
2026224|NCT00348881|3594815|FG001|Overall Study|Withdrawal by Subject|4
2026225|NCT00348881|3594814|FG000|Overall Study|Adverse Event|2
2026226|NCT00348881|3594815|FG001|Overall Study|Adverse Event|0
2026227|NCT00348881|3594814|FG000|Overall Study|Serious Adverse Event|0
2026228|NCT00348881|3594815|FG001|Overall Study|Serious Adverse Event|2
2026229|NCT00348933|3594825|FG000|Overall Study|Withdrawal by Subject|10
2026230|NCT00348933|3594825|FG000|Overall Study|Lost to Follow-up|6
2026231|NCT00348933|3594825|FG000|Overall Study|Protocol Violation|2
2108328|NCT00879658|3702235|FG005|Overall Study|Lack of Efficacy|0
2108329|NCT00879658|3702236|FG006|Overall Study|Lack of Efficacy|0
2108330|NCT00879658|3702230|FG000|Overall Study|misrandomized (never received study med)|0
2108331|NCT00879658|3702231|FG001|Overall Study|misrandomized (never received study med)|0
2108332|NCT00879658|3702232|FG002|Overall Study|misrandomized (never received study med)|0
2108333|NCT00879658|3702233|FG003|Overall Study|misrandomized (never received study med)|1
2108334|NCT00879658|3702234|FG004|Overall Study|misrandomized (never received study med)|0
2108335|NCT00879658|3702235|FG005|Overall Study|misrandomized (never received study med)|0
2108336|NCT00879658|3702236|FG006|Overall Study|misrandomized (never received study med)|0
2108337|NCT00879684|3702258|FG000|Stage 1: Dose Escalation|Adverse Event|1
2108338|NCT00879684|3702259|FG001|Stage 1: Dose Escalation|Adverse Event|0
2108339|NCT00879684|3702260|FG002|Stage 1: Dose Escalation|Adverse Event|0
2108340|NCT00879684|3702261|FG003|Stage 1: Dose Escalation|Adverse Event|0
2108341|NCT00879684|3702262|FG004|Stage 1: Dose Escalation|Adverse Event|0
2108342|NCT00879684|3702263|FG005|Stage 1: Dose Escalation|Adverse Event|0
2108343|NCT00879684|3702264|FG006|Stage 1: Dose Escalation|Adverse Event|0
2108344|NCT00879684|3702258|FG000|Stage 1: Dose Escalation|Progressive Disease|2
2108345|NCT00879684|3702259|FG001|Stage 1: Dose Escalation|Progressive Disease|3
2108346|NCT00879684|3702260|FG002|Stage 1: Dose Escalation|Progressive Disease|0
2108347|NCT00879684|3702261|FG003|Stage 1: Dose Escalation|Progressive Disease|4
2108348|NCT00879684|3702262|FG004|Stage 1: Dose Escalation|Progressive Disease|3
2108349|NCT00879684|3702263|FG005|Stage 1: Dose Escalation|Progressive Disease|3
2108350|NCT00879684|3702264|FG006|Stage 1: Dose Escalation|Progressive Disease|0
2108351|NCT00879684|3702258|FG000|Stage 1: Dose Escalation|Investigator declined participation|0
2108352|NCT00879684|3702259|FG001|Stage 1: Dose Escalation|Investigator declined participation|0
2108353|NCT00879684|3702260|FG002|Stage 1: Dose Escalation|Investigator declined participation|2
2108354|NCT00879684|3702261|FG003|Stage 1: Dose Escalation|Investigator declined participation|2
2108355|NCT00879684|3702262|FG004|Stage 1: Dose Escalation|Investigator declined participation|0
2108356|NCT00879684|3702263|FG005|Stage 1: Dose Escalation|Investigator declined participation|0
2108357|NCT00879684|3702264|FG006|Stage 1: Dose Escalation|Investigator declined participation|0
2108358|NCT00879684|3702258|FG000|Stage 1: Dose Escalation|Death|0
2108359|NCT00879684|3702259|FG001|Stage 1: Dose Escalation|Death|0
2108360|NCT00879684|3702260|FG002|Stage 1: Dose Escalation|Death|1
2108361|NCT00879684|3702261|FG003|Stage 1: Dose Escalation|Death|0
2108362|NCT00879684|3702262|FG004|Stage 1: Dose Escalation|Death|0
2026232|NCT00348933|3594825|FG000|Overall Study|Adverse Event|7
2026233|NCT00349349|3594853|FG000|Overall Study|Adverse Event|5
2026234|NCT00349349|3594854|FG001|Overall Study|Adverse Event|6
2026235|NCT00349349|3594855|FG002|Overall Study|Adverse Event|2
2026236|NCT00349349|3594853|FG000|Overall Study|Withdrawal by Subject|5
2026237|NCT00349349|3594854|FG001|Overall Study|Withdrawal by Subject|2
2026238|NCT00349349|3594855|FG002|Overall Study|Withdrawal by Subject|1
2026239|NCT00349349|3594853|FG000|Overall Study|Withdrawn due to Disease Progression|27
2026240|NCT00349349|3594854|FG001|Overall Study|Withdrawn due to Disease Progression|37
2026241|NCT00349349|3594855|FG002|Overall Study|Withdrawn due to Disease Progression|1
2026242|NCT00349349|3594853|FG000|Overall Study|Death|13
2026243|NCT00349349|3594854|FG001|Overall Study|Death|10
2026244|NCT00349349|3594855|FG002|Overall Study|Death|1
2026245|NCT00349349|3594853|FG000|Overall Study|Other Treatment Selected|2
2026246|NCT00349349|3594854|FG001|Overall Study|Other Treatment Selected|0
2026247|NCT00349349|3594855|FG002|Overall Study|Other Treatment Selected|0
2026248|NCT00349349|3594853|FG000|Overall Study|Participant Reduced General Condition|0
2026249|NCT00349349|3594854|FG001|Overall Study|Participant Reduced General Condition|1
2026250|NCT00349349|3594855|FG002|Overall Study|Participant Reduced General Condition|0
2026251|NCT00349349|3594853|FG000|Overall Study|Physician Decision|1
2026252|NCT00349349|3594854|FG001|Overall Study|Physician Decision|2
2026253|NCT00349349|3594855|FG002|Overall Study|Physician Decision|1
2026254|NCT00349349|3594853|FG000|Overall Study|No Response|0
2026255|NCT00349349|3594854|FG001|Overall Study|No Response|3
2026256|NCT00349349|3594855|FG002|Overall Study|No Response|0
2026257|NCT00349349|3594853|FG000|Overall Study|New Malignancy (Bladder Cancer)|0
2026258|NCT00349349|3594854|FG001|Overall Study|New Malignancy (Bladder Cancer)|1
2026259|NCT00349349|3594855|FG002|Overall Study|New Malignancy (Bladder Cancer)|0
2026260|NCT00349622|3594885|FG000|Overall Study|Death|168
2026261|NCT00349622|3594886|FG001|Overall Study|Death|86
2026262|NCT00349622|3594885|FG000|Overall Study|Lost to Follow-up|5
2026263|NCT00349622|3594886|FG001|Overall Study|Lost to Follow-up|1
2026264|NCT00349622|3594885|FG000|Overall Study|Withdrawal by Subject|5
2026265|NCT00349622|3594886|FG001|Overall Study|Withdrawal by Subject|9
2026266|NCT00349752|3594907|FG000|Overall Study|Adverse Event|8
2026267|NCT00349752|3594908|FG001|Overall Study|Adverse Event|12
2026268|NCT00349752|3594907|FG000|Overall Study|Lack of Efficacy|37
2026269|NCT00349752|3594908|FG001|Overall Study|Lack of Efficacy|42
2108363|NCT00879684|3702263|FG005|Stage 1: Dose Escalation|Death|0
2108364|NCT00879684|3702264|FG006|Stage 1: Dose Escalation|Death|0
2108365|NCT00879684|3702258|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0
2108366|NCT00879684|3702259|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0
2108367|NCT00879684|3702260|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0
2108368|NCT00879684|3702261|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0
2108369|NCT00879684|3702262|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0
2108370|NCT00879684|3702263|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0
2108371|NCT00879684|3702264|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1
2026270|NCT00349752|3594907|FG000|Overall Study|Lost to Follow-up|4
2026271|NCT00349752|3594908|FG001|Overall Study|Lost to Follow-up|2
2026272|NCT00349752|3594907|FG000|Overall Study|Personal reasons|6
2026273|NCT00349752|3594908|FG001|Overall Study|Personal reasons|5
2026274|NCT00349752|3594907|FG000|Overall Study|Other: Required exclusionary medication|0
2026275|NCT00349752|3594908|FG001|Overall Study|Other: Required exclusionary medication|1
2026276|NCT00349752|3594907|FG000|Overall Study|Other: Non compliance|0
2026277|NCT00349752|3594908|FG001|Overall Study|Other: Non compliance|1
2026278|NCT00349752|3594907|FG000|Overall Study|Other: Patient stopped steroids|0
2026279|NCT00349752|3594908|FG001|Overall Study|Other: Patient stopped steroids|1
2026280|NCT00349752|3594907|FG000|Overall Study|Other: Patient's steroid use|1
2026281|NCT00349752|3594908|FG001|Overall Study|Other: Patient's steroid use|0
2026282|NCT00349752|3594907|FG000|Overall Study|Other: Ineligible|1
2026283|NCT00349752|3594908|FG001|Overall Study|Other: Ineligible|0
2026284|NCT00349752|3594907|FG000|Overall Study|Other: Inadvertently unblinded|1
2026285|NCT00349752|3594908|FG001|Overall Study|Other: Inadvertently unblinded|0
2026286|NCT00349752|3594907|FG000|Overall Study|Other:History of squamous cell carcinoma|1
2026287|NCT00349752|3594908|FG001|Overall Study|Other:History of squamous cell carcinoma|0
2026288|NCT00349908|3594920|FG000|Overall Study|Withdrawal by Subject|0
2026289|NCT00349908|3594921|FG001|Overall Study|Withdrawal by Subject|4
2026290|NCT00349921|3594932|FG000|First Spinal Injection|Physician Decision|1
2026291|NCT00349921|3594933|FG001|First Spinal Injection|Physician Decision|0
2026292|NCT00349921|3594934|FG002|First Spinal Injection|Physician Decision|0
2026293|NCT00349921|3594935|FG003|First Spinal Injection|Physician Decision|0
2026294|NCT00349921|3594932|FG000|First Spinal Injection|Adverse Event|0
2026295|NCT00349921|3594933|FG001|First Spinal Injection|Adverse Event|0
2217707|NCT01709305|3860932|FG004|Phase 2|Travel, moving, etc.|5
2026296|NCT00349921|3594934|FG002|First Spinal Injection|Adverse Event|1
2026297|NCT00349921|3594935|FG003|First Spinal Injection|Adverse Event|0
2026298|NCT00349973|3594946|FG000|Overall Study|Adverse Event|3
2026299|NCT00349973|3594947|FG001|Overall Study|Adverse Event|3
2026300|NCT00349973|3594946|FG000|Overall Study|Withdrawal by Subject|1
2026301|NCT00349973|3594947|FG001|Overall Study|Withdrawal by Subject|0
2026302|NCT00350207|3594970|FG000|Overall Study|Adverse Event|5
2026303|NCT00350207|3594971|FG001|Overall Study|Adverse Event|2
2026304|NCT00350207|3594972|FG002|Overall Study|Adverse Event|2
2026305|NCT00350207|3594970|FG000|Overall Study|Lack of Efficacy|1
2026306|NCT00350207|3594971|FG001|Overall Study|Lack of Efficacy|0
2026307|NCT00350207|3594972|FG002|Overall Study|Lack of Efficacy|2
2026308|NCT00350207|3594970|FG000|Overall Study|Lost to Follow-up|1
2026309|NCT00350207|3594971|FG001|Overall Study|Lost to Follow-up|0
2026310|NCT00350207|3594972|FG002|Overall Study|Lost to Follow-up|1
2026311|NCT00350207|3594970|FG000|Overall Study|Withdrawal by Subject|0
2026312|NCT00350207|3594971|FG001|Overall Study|Withdrawal by Subject|1
2026313|NCT00350207|3594972|FG002|Overall Study|Withdrawal by Subject|1
2026314|NCT00350207|3594970|FG000|Overall Study|Other|1
2026315|NCT00350207|3594971|FG001|Overall Study|Other|3
2026316|NCT00350207|3594972|FG002|Overall Study|Other|1
2026317|NCT00350272|3594991|FG000|Blinded 12 Week Treatment|Adverse Event|1
2026318|NCT00350272|3594992|FG001|Blinded 12 Week Treatment|Adverse Event|0
2026319|NCT00350272|3594991|FG000|Blinded 12 Week Treatment|Death|1
2026320|NCT00350272|3594992|FG001|Blinded 12 Week Treatment|Death|0
2026321|NCT00350272|3594991|FG000|Blinded 12 Week Treatment|Lost to Follow-up|2
2026322|NCT00350272|3594992|FG001|Blinded 12 Week Treatment|Lost to Follow-up|0
2026323|NCT00350272|3594991|FG000|Blinded 12 Week Treatment|Withdrawal by Subject|3
2026324|NCT00350272|3594992|FG001|Blinded 12 Week Treatment|Withdrawal by Subject|0
2026325|NCT00350272|3594991|FG000|Blinded 12 Week Treatment|Physician Decision|2
2026326|NCT00350272|3594992|FG001|Blinded 12 Week Treatment|Physician Decision|1
2026327|NCT00350272|3594991|FG000|Blinded 12 Week Treatment|Sponsor decision|0
2026328|NCT00350272|3594992|FG001|Blinded 12 Week Treatment|Sponsor decision|1
2026329|NCT00350272|3594991|FG000|Open-Label 84 Week Treatment|Adverse Event|2
2026330|NCT00350272|3594992|FG001|Open-Label 84 Week Treatment|Adverse Event|1
2026331|NCT00350272|3594991|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3
2026332|NCT00350272|3594992|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2
2217708|NCT01709305|3860928|FG000|Phase 2|Physician Decision|0
2217709|NCT01709305|3860929|FG001|Phase 2|Physician Decision|2
2217710|NCT01709305|3860930|FG002|Phase 2|Physician Decision|0
2217711|NCT01709305|3860931|FG003|Phase 2|Physician Decision|1
2217712|NCT01709305|3860932|FG004|Phase 2|Physician Decision|2
2217713|NCT01709305|3860928|FG000|Phase 2|Protocol Violation|0
2217714|NCT01709305|3860929|FG001|Phase 2|Protocol Violation|19
2217715|NCT01709305|3860930|FG002|Phase 2|Protocol Violation|19
2217716|NCT01709305|3860931|FG003|Phase 2|Protocol Violation|13
2217717|NCT01709305|3860932|FG004|Phase 2|Protocol Violation|9
2217718|NCT01709305|3860928|FG000|Phase 2|Withdrawal by Subject|0
2026333|NCT00350272|3594991|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1
2026334|NCT00350272|3594992|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2
2026335|NCT00350272|3594991|FG000|Open-Label 84 Week Treatment|Physician Decision|1
2026336|NCT00350272|3594992|FG001|Open-Label 84 Week Treatment|Physician Decision|2
2026337|NCT00350272|3594991|FG000|Open-Label 84 Week Treatment|Sponsor decision|2
2026338|NCT00350272|3594992|FG001|Open-Label 84 Week Treatment|Sponsor decision|1
2026339|NCT00350298|3595002|FG000|Overall Study|Death|7
2026340|NCT00350298|3595003|FG001|Overall Study|Death|8
2026341|NCT00350298|3595002|FG000|Overall Study|Lost to Follow-up|1
2026342|NCT00350298|3595003|FG001|Overall Study|Lost to Follow-up|2
2026343|NCT00350298|3595002|FG000|Overall Study|Withdrawal by Subject|1
2026344|NCT00350298|3595003|FG001|Overall Study|Withdrawal by Subject|3
2026345|NCT00350402|3595033|FG000|Overall Study|Lost to Follow-up|1
2026346|NCT00350402|3595034|FG001|Overall Study|Lost to Follow-up|1
2108372|NCT00879684|3702258|FG000|Stage 2: Expanded Cohort|Progressive Disease|0
2108373|NCT00879684|3702259|FG001|Stage 2: Expanded Cohort|Progressive Disease|0
2108374|NCT00879684|3702260|FG002|Stage 2: Expanded Cohort|Progressive Disease|0
2108375|NCT00879684|3702261|FG003|Stage 2: Expanded Cohort|Progressive Disease|0
2108376|NCT00879684|3702262|FG004|Stage 2: Expanded Cohort|Progressive Disease|0
2108377|NCT00879684|3702263|FG005|Stage 2: Expanded Cohort|Progressive Disease|0
2108378|NCT00879684|3702264|FG006|Stage 2: Expanded Cohort|Progressive Disease|11
2108379|NCT00879684|3702258|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0
2108380|NCT00879684|3702259|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0
2108381|NCT00879684|3702260|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0
2108382|NCT00879684|3702261|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0
2108383|NCT00879684|3702262|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0
2108384|NCT00879684|3702263|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0
2108385|NCT00879684|3702264|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1
2108386|NCT00879697|3702285|FG000|Overall Study|Physician Decision|2
2108387|NCT00879697|3702286|FG001|Overall Study|Physician Decision|2
2108388|NCT00879710|3702294|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2
2108389|NCT00879710|3702295|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3
2108390|NCT00879710|3702296|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1
2108391|NCT00879710|3702297|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4
2108392|NCT00879710|3702294|FG000|Phase 1 - 6 Weeks|Adverse Event|0
2108393|NCT00879710|3702295|FG001|Phase 1 - 6 Weeks|Adverse Event|0
2108394|NCT00879710|3702296|FG002|Phase 1 - 6 Weeks|Adverse Event|1
2108395|NCT00879710|3702297|FG003|Phase 1 - 6 Weeks|Adverse Event|0
2217719|NCT01709305|3860929|FG001|Phase 2|Withdrawal by Subject|8
2217720|NCT01709305|3860930|FG002|Phase 2|Withdrawal by Subject|6
2026347|NCT00350519|3595048|FG000|Overall Study|Death|0
2026348|NCT00350519|3595049|FG001|Overall Study|Death|1
2026349|NCT00350519|3595048|FG000|Overall Study|Physician Decision|0
2026350|NCT00350519|3595049|FG001|Overall Study|Physician Decision|1
2026351|NCT00350519|3595048|FG000|Overall Study|Protocol Violation|1
2026352|NCT00350519|3595049|FG001|Overall Study|Protocol Violation|2
2026353|NCT00350519|3595048|FG000|Overall Study|Withdrawal by Subject|3
2026354|NCT00350519|3595049|FG001|Overall Study|Withdrawal by Subject|2
2026355|NCT00350545|3595064|FG000|Overall Study|Withdrawal by Subject|2
2026356|NCT00350636|3595070|FG000|Overall Study|Adverse Event|19
2026357|NCT00350636|3595071|FG001|Overall Study|Adverse Event|13
2026358|NCT00350636|3595070|FG000|Overall Study|Protocol Violation|1
2026359|NCT00350636|3595071|FG001|Overall Study|Protocol Violation|3
2026360|NCT00350636|3595070|FG000|Overall Study|Withdrawal by Subject|13
2026361|NCT00350636|3595071|FG001|Overall Study|Withdrawal by Subject|17
2026362|NCT00350636|3595070|FG000|Overall Study|Lost to Follow-up|9
2026363|NCT00350636|3595071|FG001|Overall Study|Lost to Follow-up|8
2026364|NCT00350636|3595070|FG000|Overall Study|Physician Decision|0
2026365|NCT00350636|3595071|FG001|Overall Study|Physician Decision|2
2026366|NCT00350636|3595070|FG000|Overall Study|Other|1
2026367|NCT00350636|3595071|FG001|Overall Study|Other|2
2026368|NCT00350727|3595080|FG000|Phase I: Dose Escalation|Adverse Event|4
2026369|NCT00350727|3595081|FG001|Phase I: Dose Escalation|Adverse Event|0
2026370|NCT00350727|3595082|FG002|Phase I: Dose Escalation|Adverse Event|0
2026371|NCT00350727|3595080|FG000|Phase I: Dose Escalation|Lack of Efficacy|25
2026372|NCT00350727|3595081|FG001|Phase I: Dose Escalation|Lack of Efficacy|0
2026373|NCT00350727|3595082|FG002|Phase I: Dose Escalation|Lack of Efficacy|0
2026374|NCT00350727|3595080|FG000|Phase I: Dose Escalation|Death|1
2026375|NCT00350727|3595081|FG001|Phase I: Dose Escalation|Death|0
2026376|NCT00350727|3595082|FG002|Phase I: Dose Escalation|Death|0
2026377|NCT00350727|3595080|FG000|Phase I: Dose Escalation|Physician Decision|1
2026378|NCT00350727|3595081|FG001|Phase I: Dose Escalation|Physician Decision|0
2026379|NCT00350727|3595082|FG002|Phase I: Dose Escalation|Physician Decision|0
2026380|NCT00350727|3595080|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3
2026381|NCT00350727|3595081|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0
2026382|NCT00350727|3595082|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0
2026383|NCT00350727|3595080|FG000|Phase II|Disease Progression|0
2026384|NCT00350727|3595081|FG001|Phase II|Disease Progression|15
2026385|NCT00350727|3595082|FG002|Phase II|Disease Progression|16
2026386|NCT00350727|3595080|FG000|Phase II|Clinical Deterioration|0
2026387|NCT00350727|3595081|FG001|Phase II|Clinical Deterioration|1
2026388|NCT00350727|3595082|FG002|Phase II|Clinical Deterioration|0
2026389|NCT00350727|3595080|FG000|Phase II|Withdrawal by Subject|0
2026390|NCT00350727|3595081|FG001|Phase II|Withdrawal by Subject|2
2026391|NCT00350727|3595082|FG002|Phase II|Withdrawal by Subject|1
2026392|NCT00350727|3595080|FG000|Phase II|Adverse Event|0
2026393|NCT00350727|3595081|FG001|Phase II|Adverse Event|1
2026394|NCT00350727|3595082|FG002|Phase II|Adverse Event|1
2026395|NCT00350727|3595080|FG000|Phase II|Death|0
2026396|NCT00350727|3595081|FG001|Phase II|Death|0
2026397|NCT00350727|3595082|FG002|Phase II|Death|2
2026398|NCT00350727|3595080|FG000|Phase II|Sponsor Terminated Study|0
2026399|NCT00350727|3595081|FG001|Phase II|Sponsor Terminated Study|0
2026400|NCT00350727|3595082|FG002|Phase II|Sponsor Terminated Study|1
2026401|NCT00350727|3595080|FG000|Phase II|Enrolled in Rollover Study|0
2026402|NCT00350727|3595081|FG001|Phase II|Enrolled in Rollover Study|0
2026403|NCT00350727|3595082|FG002|Phase II|Enrolled in Rollover Study|1
2026404|NCT00350779|3595103|FG000|Overall Study|Adverse Event|4
2026405|NCT00350779|3595104|FG001|Overall Study|Adverse Event|2
2026406|NCT00350779|3595103|FG000|Overall Study|Lack of Efficacy|0
2026407|NCT00350779|3595104|FG001|Overall Study|Lack of Efficacy|4
2026408|NCT00350779|3595103|FG000|Overall Study|Lost to Follow-up|2
2026409|NCT00350779|3595104|FG001|Overall Study|Lost to Follow-up|0
2026410|NCT00350779|3595103|FG000|Overall Study|Physician Decision|2
2026411|NCT00350779|3595104|FG001|Overall Study|Physician Decision|4
2026412|NCT00350779|3595103|FG000|Overall Study|Protocol Violation|3
2026413|NCT00350779|3595104|FG001|Overall Study|Protocol Violation|1
2026414|NCT00350779|3595103|FG000|Overall Study|Withdrawal by Subject|9
2026415|NCT00350779|3595104|FG001|Overall Study|Withdrawal by Subject|8
2026416|NCT00350779|3595103|FG000|Overall Study|Patient Moved|2
2026417|NCT00350779|3595104|FG001|Overall Study|Patient Moved|1
2026418|NCT00350779|3595103|FG000|Overall Study|Non-compliance with study procedures|0
2026419|NCT00350779|3595104|FG001|Overall Study|Non-compliance with study procedures|1
2026420|NCT00350792|3595112|FG000|Overall Study|Adverse Event|11
2026421|NCT00350792|3595112|FG000|Overall Study|Death from Study Disease|1
2026422|NCT00350792|3595112|FG000|Overall Study|Death from Study Drug Toxicity|1
2026423|NCT00350792|3595112|FG000|Overall Study|Death Not Study Drug Related|2
2026424|NCT00350792|3595112|FG000|Overall Study|Protocol Violation|1
2026425|NCT00350792|3595112|FG000|Overall Study|Withdrawal by Subject|4
2026426|NCT00350792|3595112|FG000|Overall Study|Physician Decision|2
2026427|NCT00350792|3595112|FG000|Overall Study|Lack of Efficacy|11
2026428|NCT00350870|3595120|FG000|Overall Study|Withdrawal by Subject|21
2026429|NCT00350870|3595121|FG001|Overall Study|Withdrawal by Subject|17
2026430|NCT00350870|3595122|FG002|Overall Study|Withdrawal by Subject|15
2026431|NCT00350870|3595123|FG003|Overall Study|Withdrawal by Subject|14
2026432|NCT00350870|3595120|FG000|Overall Study|Physician Decision|1
2026433|NCT00350870|3595121|FG001|Overall Study|Physician Decision|0
2026434|NCT00350870|3595122|FG002|Overall Study|Physician Decision|1
2026435|NCT00350870|3595123|FG003|Overall Study|Physician Decision|1
2026436|NCT00351273|3595148|FG000|Overall Study|Lost to Follow-up|1
2026437|NCT00351273|3595149|FG001|Overall Study|Lost to Follow-up|2
2026438|NCT00351273|3595150|FG002|Overall Study|Lost to Follow-up|5
2026439|NCT00351351|3595178|FG000|Overall Study|surgical access pbs; device issues|9
2026440|NCT00351351|3595179|FG001|Overall Study|surgical access pbs; device issues|4
2026441|NCT00351377|3595185|FG000|Overall Study|Adverse Event|5
2026442|NCT00351377|3595185|FG000|Overall Study|Death|1
2026443|NCT00351377|3595185|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2026444|NCT00351468|3595198|FG000|Overall Study|Adverse Event|42
2026445|NCT00351468|3595198|FG000|Overall Study|Withdrawal by Subject|39
2026446|NCT00351468|3595198|FG000|Overall Study|Various -follow up w clinical team|39
2026447|NCT00351468|3595198|FG000|Overall Study|Lack of Efficacy|32
2026448|NCT00351468|3595198|FG000|Overall Study|Non-compliance|8
2026449|NCT00351468|3595198|FG000|Overall Study|Lost to Follow-up|4
2026450|NCT00351468|3595198|FG000|Overall Study|Protocol Violation|3
2322407|NCT02971800|4037430|FG000|Overall Study|Number evaluable participant already reached|4
2322408|NCT02972242|4037436|FG000|Overall Study|Withdrawal by Subject|1
2322409|NCT02972242|4037437|FG001|Overall Study|Withdrawal by Subject|0
2322410|NCT02972359|4037443|FG000|Overall Study|Incl. criteria not met/Exclusion met|2
2322411|NCT02972359|4037443|FG000|Overall Study|Lack of Efficacy|1
2322412|NCT02972359|4037443|FG000|Overall Study|Adverse Event|4
2322413|NCT02972359|4037443|FG000|Overall Study|Death|1
2322414|NCT02972359|4037443|FG000|Overall Study|Withdrawal by Subject|30
2322415|NCT02972359|4037443|FG000|Overall Study|Protocol Violation|1
2322416|NCT02972359|4037443|FG000|Overall Study|Lost to Follow-up|26
2322417|NCT02972359|4037443|FG000|Overall Study|Other reasons|5
2322418|NCT02972359|4037443|FG000|Overall Study|Missing|1
2322419|NCT02972502|4037449|FG000|Overall Study|Lost to Follow-up|3
2322420|NCT02972502|4037450|FG001|Overall Study|Lost to Follow-up|1
2322421|NCT02972502|4037449|FG000|Overall Study|Withdrawal by Subject|1
2322422|NCT02972502|4037450|FG001|Overall Study|Withdrawal by Subject|1
2322423|NCT02972515|4037456|FG000|Overall Study|Lost to Follow-up|78
2322424|NCT02972632|4037469|FG000|Overall Study|Pretreatment Event/Adverse Event|3
2322425|NCT02972632|4037469|FG000|Overall Study|Lost to Follow-up|4
2322426|NCT02972632|4037469|FG000|Overall Study|Voluntary Withdrawal|10
2322427|NCT02972658|4037477|FG000|Overall Study|Adverse Event|0
2026451|NCT00351533|3595205|FG000|Overall Study|Extubated before first BAL|1
2026452|NCT00351533|3595206|FG001|Overall Study|Extubated before first BAL|0
2026453|NCT00351533|3595205|FG000|Overall Study|Lost to Follow-up|1
2026454|NCT00351533|3595206|FG001|Overall Study|Lost to Follow-up|3
2026455|NCT00351533|3595205|FG000|Overall Study|Physician Decision|0
2026456|NCT00351533|3595206|FG001|Overall Study|Physician Decision|1
2026457|NCT00351533|3595205|FG000|Overall Study|Withdrawal by Subject|0
2026458|NCT00351533|3595206|FG001|Overall Study|Withdrawal by Subject|1
2026459|NCT00351611|3595214|FG000|Overall Study|Adverse Event|11
2026460|NCT00351611|3595215|FG001|Overall Study|Adverse Event|3
2026461|NCT00351611|3595214|FG000|Overall Study|Death|1
2026462|NCT00351611|3595215|FG001|Overall Study|Death|0
2026463|NCT00351611|3595214|FG000|Overall Study|Lost to Follow-up|1
2026464|NCT00351611|3595215|FG001|Overall Study|Lost to Follow-up|0
2026465|NCT00351611|3595214|FG000|Overall Study|No Longer Willing to Participate in Study|0
2026466|NCT00351611|3595215|FG001|Overall Study|No Longer Willing to Participate in Study|5
2026467|NCT00351611|3595214|FG000|Overall Study|Other|1
2026468|NCT00351611|3595215|FG001|Overall Study|Other|0
2026469|NCT00351611|3595214|FG000|Overall Study|Protocol Violation|0
2026470|NCT00351611|3595215|FG001|Overall Study|Protocol Violation|2
2026471|NCT00351819|3595232|FG000|Overall Study|Lost to Follow-up|4
2026472|NCT00351819|3595233|FG001|Overall Study|Lost to Follow-up|4
2026473|NCT00351819|3595232|FG000|Overall Study|Withdrawal by Subject|0
2108396|NCT00879775|3702307|FG000|Overall Study|Lost to Follow-up|2
2108397|NCT00879775|3702308|FG001|Overall Study|Lost to Follow-up|1
2108398|NCT00879814|3702318|FG000|Overall Study|Adverse Event|0
2108399|NCT00879814|3702319|FG001|Overall Study|Adverse Event|1
2108400|NCT00879814|3702320|FG002|Overall Study|Adverse Event|0
2108401|NCT00879814|3702321|FG003|Overall Study|Adverse Event|0
2108402|NCT00879814|3702318|FG000|Overall Study|Lost to Follow-up|1
2108403|NCT00879814|3702319|FG001|Overall Study|Lost to Follow-up|0
2108404|NCT00879814|3702320|FG002|Overall Study|Lost to Follow-up|0
2322428|NCT02972658|4037478|FG001|Overall Study|Adverse Event|3
2322429|NCT02972658|4037479|FG002|Overall Study|Adverse Event|0
2108405|NCT00879814|3702321|FG003|Overall Study|Lost to Follow-up|2
2108406|NCT00879814|3702318|FG000|Overall Study|Participant Failed to Return|0
2108407|NCT00879814|3702319|FG001|Overall Study|Participant Failed to Return|0
2026474|NCT00351819|3595233|FG001|Overall Study|Withdrawal by Subject|4
2026475|NCT00351819|3595232|FG000|Overall Study|Elevated PSA|1
2026476|NCT00351819|3595233|FG001|Overall Study|Elevated PSA|1
2026477|NCT00351819|3595232|FG000|Overall Study|Traumatic ankle fracture|1
2322430|NCT02972658|4037480|FG003|Overall Study|Adverse Event|2
2026478|NCT00351819|3595233|FG001|Overall Study|Traumatic ankle fracture|0
2026479|NCT00351819|3595232|FG000|Overall Study|Unprofessional behavior|1
2026480|NCT00351819|3595233|FG001|Overall Study|Unprofessional behavior|0
2026481|NCT00351819|3595232|FG000|Overall Study|Non-compliance|0
2026482|NCT00351819|3595233|FG001|Overall Study|Non-compliance|1
2026483|NCT00351819|3595232|FG000|Overall Study|Incarcerated|0
2026484|NCT00351819|3595233|FG001|Overall Study|Incarcerated|1
2026485|NCT00351819|3595232|FG000|Overall Study|Enrolled in another trial|0
2026486|NCT00351819|3595233|FG001|Overall Study|Enrolled in another trial|1
2026487|NCT00352027|3595248|FG000|Overall Study|Progressive disease|3
2026488|NCT00352053|3595276|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14
2026489|NCT00352053|3595277|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10
2026490|NCT00352053|3595276|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2
2026491|NCT00352053|3595277|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2
2026492|NCT00352053|3595276|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1
2026493|NCT00352053|3595277|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0
2026494|NCT00352053|3595276|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
2026495|NCT00352053|3595277|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
2026496|NCT00352053|3595276|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
2026497|NCT00352053|3595277|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
2026498|NCT00352053|3595276|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9
2026499|NCT00352053|3595277|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13
2026500|NCT00352053|3595276|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
2026501|NCT00352053|3595277|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
2026502|NCT00352053|3595276|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1
2026503|NCT00352053|3595277|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0
2026504|NCT00352053|3595276|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
2026505|NCT00352053|3595277|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
2026506|NCT00352053|3595276|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4
2026507|NCT00352053|3595277|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4
2026508|NCT00352053|3595276|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
2026509|NCT00352053|3595277|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
2026510|NCT00352053|3595276|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
2026511|NCT00352053|3595277|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
2026512|NCT00352053|3595276|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
2026513|NCT00352053|3595277|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
2026514|NCT00352105|3595291|FG000|Overall Study|Death|5
2026515|NCT00352105|3595291|FG000|Overall Study|Withdrawal by Subject|5
2026516|NCT00352105|3595291|FG000|Overall Study|Lack of Efficacy|9
2026517|NCT00352105|3595291|FG000|Overall Study|Adverse Event|19
2026518|NCT00352105|3595291|FG000|Overall Study|Protocol Violation|2
2026519|NCT00352365|3595295|FG000|Induction Therapy|Adverse Event|7
2026520|NCT00352365|3595295|FG000|Induction Therapy|Progression/Relapse|8
2026521|NCT00352365|3595295|FG000|Induction Therapy|Death|7
2026522|NCT00352365|3595295|FG000|Induction Therapy|Not protocol specified|1
2026523|NCT00352365|3595295|FG000|Induction Therapy|Not eligible|3
2026524|NCT00352365|3595295|FG000|Induction Therapy|Death before starting protocol therapy|1
2026525|NCT00352365|3595295|FG000|Maintenance Therapy|Progression/Relapse|3
2026526|NCT00352365|3595295|FG000|Maintenance Therapy|Death|2
2026527|NCT00352365|3595295|FG000|Maintenance Therapy|Not protocol specified|3
2026528|NCT00352365|3595295|FG000|Maintenance Therapy|Not eligible|4
2026529|NCT00352417|3595305|FG000|Overall Study|Adverse Event|1
2026530|NCT00352417|3595306|FG001|Overall Study|Adverse Event|0
2026531|NCT00352417|3595305|FG000|Overall Study|Protocol Violation|0
2026532|NCT00352417|3595306|FG001|Overall Study|Protocol Violation|2
2026533|NCT00352417|3595305|FG000|Overall Study|Withdrawal by Subject|1
2026534|NCT00352417|3595306|FG001|Overall Study|Withdrawal by Subject|2
2026535|NCT00352417|3595305|FG000|Overall Study|Lost to Follow-up|1
2026536|NCT00352417|3595306|FG001|Overall Study|Lost to Follow-up|0
2026537|NCT00352417|3595305|FG000|Overall Study|Schedule Change|2
2026538|NCT00352417|3595306|FG001|Overall Study|Schedule Change|1
2026539|NCT00352664|3595323|FG000|Overall Study|Withdrawal by Subject|7
2026540|NCT00352664|3595324|FG001|Overall Study|Withdrawal by Subject|0
2026541|NCT00352690|3595332|FG000|Overall Study|Determined to be ineligible|2
2026542|NCT00352690|3595333|FG001|Overall Study|Determined to be ineligible|0
2026543|NCT00352755|3595339|FG000|Overall Study|Physician Decision|1
2026544|NCT00352755|3595339|FG000|Overall Study|Adverse Event|1
2026545|NCT00352846|3595353|FG000|Overall Study|Disease progression|0
2026546|NCT00352846|3595354|FG001|Overall Study|Disease progression|2
2026547|NCT00352846|3595353|FG000|Overall Study|Withdrawal by Subject|3
2322431|NCT02972658|4037477|FG000|Overall Study|Other-determined by Investigator|1
2322432|NCT02972658|4037478|FG001|Overall Study|Other-determined by Investigator|1
2322433|NCT02972658|4037479|FG002|Overall Study|Other-determined by Investigator|0
2322434|NCT02972658|4037480|FG003|Overall Study|Other-determined by Investigator|0
2322435|NCT02972658|4037477|FG000|Overall Study|Death|0
2322436|NCT02972658|4037478|FG001|Overall Study|Death|0
2322437|NCT02972658|4037479|FG002|Overall Study|Death|0
2322438|NCT02972658|4037480|FG003|Overall Study|Death|1
2322439|NCT02972658|4037477|FG000|Overall Study|Lost to Follow-up|0
2322440|NCT02972658|4037478|FG001|Overall Study|Lost to Follow-up|1
2322441|NCT02972658|4037479|FG002|Overall Study|Lost to Follow-up|1
2026548|NCT00352846|3595354|FG001|Overall Study|Withdrawal by Subject|8
2026549|NCT00352846|3595353|FG000|Overall Study|Ineligible|3
2026550|NCT00352846|3595354|FG001|Overall Study|Ineligible|2
2026551|NCT00352846|3595353|FG000|Overall Study|Non-compliance|2
2026552|NCT00352846|3595354|FG001|Overall Study|Non-compliance|0
2322442|NCT02972658|4037480|FG003|Overall Study|Lost to Follow-up|2
2322443|NCT02972658|4037477|FG000|Overall Study|Progressive Disease|0
2026553|NCT00352846|3595353|FG000|Overall Study|Death|0
2026554|NCT00352846|3595354|FG001|Overall Study|Death|1
2026555|NCT00352885|3595362|FG000|Overall Study|Withdrawal by Subject|0
2026556|NCT00352885|3595363|FG001|Overall Study|Withdrawal by Subject|3
2026557|NCT00352885|3595362|FG000|Overall Study|Development of major depression|0
2026558|NCT00352885|3595363|FG001|Overall Study|Development of major depression|1
2026559|NCT00352885|3595362|FG000|Overall Study|Progression of metastatic melanoma|5
2026560|NCT00352885|3595363|FG001|Overall Study|Progression of metastatic melanoma|3
2026561|NCT00352885|3595362|FG000|Overall Study|Side effects of IL-2 administration|1
2026562|NCT00352885|3595363|FG001|Overall Study|Side effects of IL-2 administration|0
2026563|NCT00353262|3595395|FG000|Overall Study|Adverse Event|8
2026564|NCT00353262|3595395|FG000|Overall Study|Withdrawal by Subject|2
2026565|NCT00353262|3595395|FG000|Overall Study|Insufficient Therapeutic Response|13
2026566|NCT00353262|3595395|FG000|Overall Study|Progression|1
2026567|NCT00353262|3595395|FG000|Overall Study|Surgery|4
2026568|NCT00353262|3595395|FG000|Overall Study|Break from Chemotherapy|1
2026569|NCT00353366|3595403|FG000|Overall Study|Adverse Event|8
2026570|NCT00353366|3595403|FG000|Overall Study|Protocol Violation|12
2026571|NCT00353366|3595403|FG000|Overall Study|Withdrawal by Subject|12
2026572|NCT00353366|3595403|FG000|Overall Study|Lost to Follow-up|92
2026573|NCT00353366|3595403|FG000|Overall Study|Other|19
2026574|NCT00353496|3595427|FG000|Overall Study|Adverse Event|1
2026575|NCT00353496|3595428|FG001|Overall Study|Adverse Event|0
2026576|NCT00353496|3595427|FG000|Overall Study|Protocol Violation|2
2026577|NCT00353496|3595428|FG001|Overall Study|Protocol Violation|2
2026578|NCT00353496|3595427|FG000|Overall Study|Withdrawal by Subject|3
2026579|NCT00353496|3595428|FG001|Overall Study|Withdrawal by Subject|4
2026580|NCT00353496|3595427|FG000|Overall Study|Physician Decision|6
2026581|NCT00353496|3595428|FG001|Overall Study|Physician Decision|9
2026582|NCT00353496|3595427|FG000|Overall Study|Not otherwise specified|4
2026583|NCT00353496|3595428|FG001|Overall Study|Not otherwise specified|2
2026584|NCT00353704|3595470|FG000|Overall Study|Protocol Violation|3
2026585|NCT00353704|3595471|FG001|Overall Study|Protocol Violation|1
2217721|NCT01709305|3860931|FG003|Phase 2|Withdrawal by Subject|15
2026586|NCT00353873|3595492|FG000|Overall Study|Protocol Violation|1
2026587|NCT00353873|3595493|FG001|Overall Study|Protocol Violation|2
2026588|NCT00353873|3595492|FG000|Overall Study|Exacerbation|1
2026589|NCT00353873|3595493|FG001|Overall Study|Exacerbation|0
2026590|NCT00353873|3595492|FG000|Overall Study|Adverse Event|1
2026591|NCT00353873|3595493|FG001|Overall Study|Adverse Event|0
2026592|NCT00353873|3595492|FG000|Overall Study|Physician Decision|2
2026593|NCT00353873|3595493|FG001|Overall Study|Physician Decision|0
2026594|NCT00353873|3595492|FG000|Overall Study|Withdrawal by Subject|1
2026595|NCT00353873|3595493|FG001|Overall Study|Withdrawal by Subject|1
2026596|NCT00354029|3595505|FG000|Overall Study|Protocol Violation|4
2026597|NCT00354029|3595506|FG001|Overall Study|Protocol Violation|2
2026598|NCT00354107|3595512|FG000|Overall Study|Adverse Event|2
2026599|NCT00354107|3595512|FG000|Overall Study|Physician Decision|2
2026600|NCT00354107|3595512|FG000|Overall Study|Withdrawal by Subject|1
2026601|NCT00354159|3595518|FG000|Randomized Study Period|Withdrawal by Subject|5
2026602|NCT00354159|3595519|FG001|Randomized Study Period|Withdrawal by Subject|3
2026603|NCT00354159|3595518|FG000|Randomized Study Period|Physician Decision|6
2026604|NCT00354159|3595519|FG001|Randomized Study Period|Physician Decision|10
2026605|NCT00354159|3595518|FG000|Randomized Study Period|Lost to Follow-up|4
2026606|NCT00354159|3595519|FG001|Randomized Study Period|Lost to Follow-up|0
2026607|NCT00354159|3595518|FG000|Randomized Study Period|Death|7
2026608|NCT00354159|3595519|FG001|Randomized Study Period|Death|9
2026609|NCT00354159|3595518|FG000|Long-term Follow-up|Withdrawal by Subject|9
2026610|NCT00354159|3595519|FG001|Long-term Follow-up|Withdrawal by Subject|9
2026611|NCT00354159|3595518|FG000|Long-term Follow-up|Physician Decision|127
2026612|NCT00354159|3595519|FG001|Long-term Follow-up|Physician Decision|122
2026613|NCT00354159|3595518|FG000|Long-term Follow-up|Lost to Follow-up|1
2026614|NCT00354159|3595519|FG001|Long-term Follow-up|Lost to Follow-up|0
2026615|NCT00354159|3595518|FG000|Long-term Follow-up|Death|14
2026616|NCT00354159|3595519|FG001|Long-term Follow-up|Death|11
2026617|NCT00354159|3595518|FG000|Long-term Follow-up|Study Closed|29
2026618|NCT00354159|3595519|FG001|Long-term Follow-up|Study Closed|34
2026619|NCT00354172|3595532|FG000|Overall Study|Did not receive transplant|1
2026620|NCT00354341|3595542|FG000|Overall Study|Adverse Event|1
2026621|NCT00354341|3595543|FG001|Overall Study|Adverse Event|0
2026622|NCT00354341|3595542|FG000|Overall Study|Death|0
2026623|NCT00354341|3595543|FG001|Overall Study|Death|2
2026624|NCT00354341|3595542|FG000|Overall Study|Refused treatment|1
2026625|NCT00354341|3595543|FG001|Overall Study|Refused treatment|2
2026626|NCT00354341|3595542|FG000|Overall Study|Failure to return|0
2026627|NCT00354341|3595543|FG001|Overall Study|Failure to return|1
2026628|NCT00354341|3595542|FG000|Overall Study|Other|1
2026629|NCT00354341|3595543|FG001|Overall Study|Other|2
2026630|NCT00354432|3595553|FG000|Overall Study|Adverse Event|3
2026631|NCT00354432|3595554|FG001|Overall Study|Adverse Event|1
2026632|NCT00354432|3595555|FG002|Overall Study|Adverse Event|5
2026633|NCT00354432|3595556|FG003|Overall Study|Adverse Event|5
2026634|NCT00354432|3595553|FG000|Overall Study|Off/Toxicity|3
2026635|NCT00354432|3595554|FG001|Overall Study|Off/Toxicity|7
2026636|NCT00354432|3595555|FG002|Overall Study|Off/Toxicity|5
2026637|NCT00354432|3595556|FG003|Overall Study|Off/Toxicity|5
2026638|NCT00354601|3595575|FG000|Overall Study|Protocol Violation|1
2026639|NCT00354601|3595575|FG000|Overall Study|progression|1
2026640|NCT00354614|3595579|FG000|Overall Study|Lack of Efficacy|28
2026641|NCT00354679|3595587|FG000|Overall Study|Patient Not Treated|1
2026642|NCT00354744|3595591|FG000|Overall Study|Adverse Event|2
2026643|NCT00354744|3595591|FG000|Overall Study|Death|2
2026644|NCT00354744|3595591|FG000|Overall Study|Lack of Efficacy|11
2026645|NCT00354744|3595591|FG000|Overall Study|Lost to Follow-up|2
2026646|NCT00354744|3595591|FG000|Overall Study|Physician Decision|11
2026647|NCT00354744|3595591|FG000|Overall Study|Withdrawal by Subject|14
2026648|NCT00355030|3595620|FG000|Study Period 1 Treatment|Adverse Event|1
2026649|NCT00355030|3595621|FG001|Study Period 1 Treatment|Adverse Event|1
2026650|NCT00355030|3595620|FG000|Study Period 1 Treatment|Lost to Follow-up|3
2026651|NCT00355030|3595621|FG001|Study Period 1 Treatment|Lost to Follow-up|0
2026652|NCT00355030|3595620|FG000|Study Period 1 Treatment|Withdrawal by Subject|4
2026653|NCT00355030|3595621|FG001|Study Period 1 Treatment|Withdrawal by Subject|1
2026654|NCT00355030|3595620|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1
2026655|NCT00355030|3595621|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2
2026656|NCT00355030|3595620|FG000|Study Period 1 Treatment|Physician Decision|0
2026657|NCT00355030|3595621|FG001|Study Period 1 Treatment|Physician Decision|1
2026658|NCT00355030|3595620|FG000|Study Period 1 Treatment|Sponsor Decision|34
2026659|NCT00355030|3595621|FG001|Study Period 1 Treatment|Sponsor Decision|32
2026660|NCT00355030|3595620|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
2026661|NCT00355030|3595621|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
2026662|NCT00355030|3595620|FG000|Study Period 1 Treatment|Other|2
2026663|NCT00355030|3595621|FG001|Study Period 1 Treatment|Other|6
2026664|NCT00355030|3595620|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
2026665|NCT00355030|3595621|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
2026666|NCT00355030|3595620|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
2026667|NCT00355030|3595621|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
2026668|NCT00355056|3595629|FG000|Randomization Period|Early Termination|4
2026669|NCT00355056|3595630|FG001|Randomization Period|Early Termination|6
2026670|NCT00355082|3595646|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4
2026671|NCT00355082|3595647|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10
2026672|NCT00355082|3595648|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0
2026673|NCT00355082|3595646|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
2108408|NCT00879814|3702320|FG002|Overall Study|Participant Failed to Return|0
2108409|NCT00879814|3702321|FG003|Overall Study|Participant Failed to Return|1
2108410|NCT00879814|3702318|FG000|Overall Study|Withdrawal by Subject|3
2108411|NCT00879814|3702319|FG001|Overall Study|Withdrawal by Subject|1
2108412|NCT00879814|3702320|FG002|Overall Study|Withdrawal by Subject|1
2108413|NCT00879814|3702321|FG003|Overall Study|Withdrawal by Subject|2
2108414|NCT00879814|3702318|FG000|Overall Study|Physician Decision|0
2108415|NCT00879814|3702319|FG001|Overall Study|Physician Decision|0
2108416|NCT00879814|3702320|FG002|Overall Study|Physician Decision|1
2108417|NCT00879814|3702321|FG003|Overall Study|Physician Decision|0
2108418|NCT00879814|3702318|FG000|Overall Study|Other|0
2108419|NCT00879814|3702319|FG001|Overall Study|Other|0
2108420|NCT00879814|3702320|FG002|Overall Study|Other|1
2108421|NCT00879814|3702321|FG003|Overall Study|Other|0
2108422|NCT00879879|3702331|FG000|Overall Study|Death|1
2108423|NCT00879879|3702331|FG000|Overall Study|Withdrawal by Subject|1
2108424|NCT00879879|3702331|FG000|Overall Study|Physician Decision|1
2108425|NCT00879970|3702340|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3
2108426|NCT00879970|3702341|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3
2108427|NCT00879970|3702342|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4
2108428|NCT00879970|3702343|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0
2108429|NCT00879970|3702344|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0
2108430|NCT00879970|3702340|FG000|Period 1 TZD Randomization|Lost to Follow-up|1
2108431|NCT00879970|3702341|FG001|Period 1 TZD Randomization|Lost to Follow-up|0
2108432|NCT00879970|3702342|FG002|Period 1 TZD Randomization|Lost to Follow-up|1
2108433|NCT00879970|3702343|FG003|Period 1 TZD Randomization|Lost to Follow-up|0
2108434|NCT00879970|3702344|FG004|Period 1 TZD Randomization|Lost to Follow-up|0
2108435|NCT00879970|3702340|FG000|Period 1 TZD Randomization|Death|2
2108436|NCT00879970|3702341|FG001|Period 1 TZD Randomization|Death|1
2108437|NCT00879970|3702342|FG002|Period 1 TZD Randomization|Death|0
2108438|NCT00879970|3702343|FG003|Period 1 TZD Randomization|Death|0
2108439|NCT00879970|3702344|FG004|Period 1 TZD Randomization|Death|0
2108440|NCT00879970|3702340|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
2108441|NCT00879970|3702341|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
2108442|NCT00879970|3702342|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
2108443|NCT00879970|3702343|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
2108444|NCT00879970|3702344|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
2108445|NCT00879970|3702340|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
2108446|NCT00879970|3702341|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
2108447|NCT00879970|3702342|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
2108448|NCT00879970|3702343|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
2108449|NCT00879970|3702344|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
2108450|NCT00879970|3702340|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0
2108451|NCT00879970|3702341|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0
2108452|NCT00879970|3702342|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0
2108453|NCT00879970|3702343|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0
2026674|NCT00355082|3595647|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
2026675|NCT00355082|3595648|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
2026676|NCT00355082|3595646|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
2026677|NCT00355082|3595647|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
2026678|NCT00355082|3595648|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
2026679|NCT00355082|3595646|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
2026680|NCT00355082|3595647|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
2026681|NCT00355082|3595648|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
2026682|NCT00355082|3595646|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0
2026683|NCT00355082|3595647|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4
2026684|NCT00355082|3595648|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0
2026685|NCT00355082|3595646|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0
2026686|NCT00355082|3595647|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1
2026687|NCT00355082|3595648|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0
2026688|NCT00355082|3595646|FG000|Continuation Phase|Adverse Event|2
2026689|NCT00355082|3595647|FG001|Continuation Phase|Adverse Event|0
2026690|NCT00355082|3595648|FG002|Continuation Phase|Adverse Event|1
2026691|NCT00355082|3595646|FG000|Continuation Phase|Lost to Follow-up|2
2026692|NCT00355082|3595647|FG001|Continuation Phase|Lost to Follow-up|0
2026693|NCT00355082|3595648|FG002|Continuation Phase|Lost to Follow-up|1
2026694|NCT00355082|3595646|FG000|Continuation Phase|Protocol Violation|1
2026695|NCT00355082|3595647|FG001|Continuation Phase|Protocol Violation|0
2026696|NCT00355082|3595648|FG002|Continuation Phase|Protocol Violation|1
2026697|NCT00355082|3595646|FG000|Continuation Phase|Withdrawal by Subject|4
2026698|NCT00355082|3595647|FG001|Continuation Phase|Withdrawal by Subject|0
2026699|NCT00355082|3595648|FG002|Continuation Phase|Withdrawal by Subject|0
2026700|NCT00355082|3595646|FG000|Continuation Phase|Lack of Efficacy|5
2026701|NCT00355082|3595647|FG001|Continuation Phase|Lack of Efficacy|0
2026702|NCT00355082|3595648|FG002|Continuation Phase|Lack of Efficacy|0
2026703|NCT00355082|3595646|FG000|Continuation Phase|Site Closed by Sponsor|8
2026704|NCT00355082|3595647|FG001|Continuation Phase|Site Closed by Sponsor|0
2026705|NCT00355082|3595648|FG002|Continuation Phase|Site Closed by Sponsor|0
2026706|NCT00355082|3595646|FG000|Continuation Phase|Scheduling Error|1
2026707|NCT00355082|3595647|FG001|Continuation Phase|Scheduling Error|0
2026708|NCT00355082|3595648|FG002|Continuation Phase|Scheduling Error|0
2026709|NCT00355082|3595646|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1
2026710|NCT00355082|3595647|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0
2026711|NCT00355082|3595648|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0
2026712|NCT00355121|3595662|FG000|Overall Study|Did not receive study vaccine|1
2026713|NCT00355121|3595663|FG001|Overall Study|Did not receive study vaccine|0
2026714|NCT00355121|3595664|FG002|Overall Study|Did not receive study vaccine|1
2026715|NCT00355121|3595662|FG000|Overall Study|Adverse Event|0
2026716|NCT00355121|3595663|FG001|Overall Study|Adverse Event|1
2026717|NCT00355121|3595664|FG002|Overall Study|Adverse Event|0
2026718|NCT00355121|3595662|FG000|Overall Study|Protocol Violation|7
2026719|NCT00355121|3595663|FG001|Overall Study|Protocol Violation|9
2026720|NCT00355121|3595664|FG002|Overall Study|Protocol Violation|1
2026721|NCT00355121|3595662|FG000|Overall Study|Lost to Follow-up|4
2026722|NCT00355121|3595663|FG001|Overall Study|Lost to Follow-up|7
2026723|NCT00355121|3595664|FG002|Overall Study|Lost to Follow-up|1
2026724|NCT00355121|3595662|FG000|Overall Study|Withdrawal by Subject|9
2026725|NCT00355121|3595663|FG001|Overall Study|Withdrawal by Subject|10
2026726|NCT00355121|3595664|FG002|Overall Study|Withdrawal by Subject|2
2026727|NCT00355121|3595662|FG000|Overall Study|Serious adverse events|0
2026728|NCT00355121|3595663|FG001|Overall Study|Serious adverse events|2
2026729|NCT00355121|3595664|FG002|Overall Study|Serious adverse events|0
2108454|NCT00879970|3702344|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1
2108455|NCT00879970|3702340|FG000|Period 2 Vitamin D Randomization|Death|0
2108456|NCT00879970|3702341|FG001|Period 2 Vitamin D Randomization|Death|0
2108457|NCT00879970|3702342|FG002|Period 2 Vitamin D Randomization|Death|0
2108458|NCT00879970|3702343|FG003|Period 2 Vitamin D Randomization|Death|2
2108459|NCT00879970|3702344|FG004|Period 2 Vitamin D Randomization|Death|0
2108460|NCT00879996|3702364|FG000|Overall Study|Lost to Follow-up|7
2108461|NCT00879996|3702365|FG001|Overall Study|Lost to Follow-up|6
2108462|NCT00879996|3702364|FG000|Overall Study|non-compliance|6
2108463|NCT00879996|3702365|FG001|Overall Study|non-compliance|4
2108464|NCT00879996|3702364|FG000|Overall Study|Physician Decision|1
2108465|NCT00879996|3702365|FG001|Overall Study|Physician Decision|2
2108466|NCT00879996|3702364|FG000|Overall Study|psychiatric problem|0
2108467|NCT00879996|3702365|FG001|Overall Study|psychiatric problem|1
2108468|NCT00879996|3702364|FG000|Overall Study|put on parole|1
2108469|NCT00879996|3702365|FG001|Overall Study|put on parole|0
2108470|NCT00880009|3702373|FG000|Overall Study|Study terminated by sponsor|14
2108471|NCT00880009|3702373|FG000|Overall Study|Withdrawal by Subject|1
2108472|NCT00880009|3702373|FG000|Overall Study|Protocol Violation|1
2108473|NCT00880048|3702394|FG000|Overall Study|Adverse Event|2
2108474|NCT00880048|3702395|FG001|Overall Study|Adverse Event|3
2108475|NCT00880048|3702396|FG002|Overall Study|Adverse Event|5
2108476|NCT00880048|3702394|FG000|Overall Study|Lack of Efficacy|1
2108477|NCT00880048|3702395|FG001|Overall Study|Lack of Efficacy|2
2108478|NCT00880048|3702396|FG002|Overall Study|Lack of Efficacy|2
2108479|NCT00880048|3702394|FG000|Overall Study|Protocol Violation|4
2026730|NCT00355134|3595680|FG000|Core Phase|Withdrawal by Subject|35
2026731|NCT00355134|3595681|FG001|Core Phase|Withdrawal by Subject|24
2026732|NCT00355134|3595682|FG002|Core Phase|Withdrawal by Subject|35
2026733|NCT00355134|3595683|FG003|Core Phase|Withdrawal by Subject|0
2026734|NCT00355134|3595684|FG004|Core Phase|Withdrawal by Subject|0
2026735|NCT00355134|3595680|FG000|Core Phase|Adverse Event|28
2026736|NCT00355134|3595681|FG001|Core Phase|Adverse Event|22
2026737|NCT00355134|3595682|FG002|Core Phase|Adverse Event|16
2026738|NCT00355134|3595683|FG003|Core Phase|Adverse Event|0
2026739|NCT00355134|3595684|FG004|Core Phase|Adverse Event|0
2026740|NCT00355134|3595680|FG000|Core Phase|Lost to Follow-up|17
2026741|NCT00355134|3595681|FG001|Core Phase|Lost to Follow-up|13
2026742|NCT00355134|3595682|FG002|Core Phase|Lost to Follow-up|21
2026743|NCT00355134|3595683|FG003|Core Phase|Lost to Follow-up|0
2026744|NCT00355134|3595684|FG004|Core Phase|Lost to Follow-up|0
2026745|NCT00355134|3595680|FG000|Core Phase|Abnormal laboratory value(s)|19
2026746|NCT00355134|3595681|FG001|Core Phase|Abnormal laboratory value(s)|14
2026747|NCT00355134|3595682|FG002|Core Phase|Abnormal laboratory value(s)|2
2026748|NCT00355134|3595683|FG003|Core Phase|Abnormal laboratory value(s)|0
2026749|NCT00355134|3595684|FG004|Core Phase|Abnormal laboratory value(s)|0
2026750|NCT00355134|3595680|FG000|Core Phase|Unsatisfactory therapeutic effect|10
2026751|NCT00355134|3595681|FG001|Core Phase|Unsatisfactory therapeutic effect|6
2026752|NCT00355134|3595682|FG002|Core Phase|Unsatisfactory therapeutic effect|17
2026753|NCT00355134|3595683|FG003|Core Phase|Unsatisfactory therapeutic effect|0
2026754|NCT00355134|3595684|FG004|Core Phase|Unsatisfactory therapeutic effect|0
2026755|NCT00355134|3595680|FG000|Core Phase|Administrative problems|5
2026756|NCT00355134|3595681|FG001|Core Phase|Administrative problems|3
2026757|NCT00355134|3595682|FG002|Core Phase|Administrative problems|5
2026758|NCT00355134|3595683|FG003|Core Phase|Administrative problems|0
2026759|NCT00355134|3595684|FG004|Core Phase|Administrative problems|0
2026760|NCT00355134|3595680|FG000|Core Phase|Protocol Violation|3
2026761|NCT00355134|3595681|FG001|Core Phase|Protocol Violation|2
2026762|NCT00355134|3595682|FG002|Core Phase|Protocol Violation|2
2026763|NCT00355134|3595683|FG003|Core Phase|Protocol Violation|0
2026764|NCT00355134|3595684|FG004|Core Phase|Protocol Violation|0
2026765|NCT00355134|3595680|FG000|Core Phase|Abnormal test procedure result(s)|1
2026766|NCT00355134|3595681|FG001|Core Phase|Abnormal test procedure result(s)|2
2026767|NCT00355134|3595682|FG002|Core Phase|Abnormal test procedure result(s)|1
2026768|NCT00355134|3595683|FG003|Core Phase|Abnormal test procedure result(s)|0
2026769|NCT00355134|3595684|FG004|Core Phase|Abnormal test procedure result(s)|0
2026770|NCT00355134|3595680|FG000|Core Phase|Condition no longer requires study drug|1
2026771|NCT00355134|3595681|FG001|Core Phase|Condition no longer requires study drug|0
2026772|NCT00355134|3595682|FG002|Core Phase|Condition no longer requires study drug|1
2026773|NCT00355134|3595683|FG003|Core Phase|Condition no longer requires study drug|0
2026774|NCT00355134|3595684|FG004|Core Phase|Condition no longer requires study drug|0
2026775|NCT00355134|3595680|FG000|Extension Phase|Withdrawal by Subject|7
2026776|NCT00355134|3595681|FG001|Extension Phase|Withdrawal by Subject|11
2026777|NCT00355134|3595682|FG002|Extension Phase|Withdrawal by Subject|0
2026778|NCT00355134|3595683|FG003|Extension Phase|Withdrawal by Subject|7
2026779|NCT00355134|3595684|FG004|Extension Phase|Withdrawal by Subject|5
2026780|NCT00355134|3595680|FG000|Extension Phase|Adverse Event|13
2026781|NCT00355134|3595681|FG001|Extension Phase|Adverse Event|9
2026782|NCT00355134|3595682|FG002|Extension Phase|Adverse Event|0
2026783|NCT00355134|3595683|FG003|Extension Phase|Adverse Event|3
2026784|NCT00355134|3595684|FG004|Extension Phase|Adverse Event|5
2026785|NCT00355134|3595680|FG000|Extension Phase|Lost to Follow-up|2
2026786|NCT00355134|3595681|FG001|Extension Phase|Lost to Follow-up|6
2026787|NCT00355134|3595682|FG002|Extension Phase|Lost to Follow-up|0
2026788|NCT00355134|3595683|FG003|Extension Phase|Lost to Follow-up|2
2026789|NCT00355134|3595684|FG004|Extension Phase|Lost to Follow-up|4
2026790|NCT00355134|3595680|FG000|Extension Phase|Abnormal laboratory value(s)|4
2026791|NCT00355134|3595681|FG001|Extension Phase|Abnormal laboratory value(s)|2
2026792|NCT00355134|3595682|FG002|Extension Phase|Abnormal laboratory value(s)|0
2026793|NCT00355134|3595683|FG003|Extension Phase|Abnormal laboratory value(s)|2
2026794|NCT00355134|3595684|FG004|Extension Phase|Abnormal laboratory value(s)|2
2026795|NCT00355134|3595680|FG000|Extension Phase|Administrative problems|2
2026796|NCT00355134|3595681|FG001|Extension Phase|Administrative problems|4
2026797|NCT00355134|3595682|FG002|Extension Phase|Administrative problems|0
2108480|NCT00880048|3702395|FG001|Overall Study|Protocol Violation|6
2108481|NCT00880048|3702396|FG002|Overall Study|Protocol Violation|5
2108482|NCT00880048|3702394|FG000|Overall Study|Lost to Follow-up|6
2108483|NCT00880048|3702395|FG001|Overall Study|Lost to Follow-up|6
2108484|NCT00880048|3702396|FG002|Overall Study|Lost to Follow-up|5
2108485|NCT00880048|3702394|FG000|Overall Study|Physician Decision|1
2108486|NCT00880048|3702395|FG001|Overall Study|Physician Decision|1
2108487|NCT00880048|3702396|FG002|Overall Study|Physician Decision|7
2108488|NCT00880048|3702394|FG000|Overall Study|Withdrawal by Subject|5
2108489|NCT00880048|3702395|FG001|Overall Study|Withdrawal by Subject|8
2108490|NCT00880048|3702396|FG002|Overall Study|Withdrawal by Subject|5
2108491|NCT00880048|3702394|FG000|Overall Study|Study closed/terminated|9
2108492|NCT00880048|3702395|FG001|Overall Study|Study closed/terminated|7
2180160|NCT01399593|3806145|FG000|Overall Study|Physician Decision|1
2026798|NCT00355134|3595683|FG003|Extension Phase|Administrative problems|1
2026799|NCT00355134|3595684|FG004|Extension Phase|Administrative problems|1
2026800|NCT00355134|3595680|FG000|Extension Phase|Unsatisfactory therapeutic effect|3
2026801|NCT00355134|3595681|FG001|Extension Phase|Unsatisfactory therapeutic effect|4
2026802|NCT00355134|3595682|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
2026803|NCT00355134|3595683|FG003|Extension Phase|Unsatisfactory therapeutic effect|0
2026804|NCT00355134|3595684|FG004|Extension Phase|Unsatisfactory therapeutic effect|1
2026805|NCT00355134|3595680|FG000|Extension Phase|Abnormal test procedure result(s)|0
2026806|NCT00355134|3595681|FG001|Extension Phase|Abnormal test procedure result(s)|1
2026807|NCT00355134|3595682|FG002|Extension Phase|Abnormal test procedure result(s)|0
2026808|NCT00355134|3595683|FG003|Extension Phase|Abnormal test procedure result(s)|0
2026809|NCT00355134|3595684|FG004|Extension Phase|Abnormal test procedure result(s)|1
2026810|NCT00355134|3595680|FG000|Extension Phase|Protocol Violation|0
2026811|NCT00355134|3595681|FG001|Extension Phase|Protocol Violation|0
2026812|NCT00355134|3595682|FG002|Extension Phase|Protocol Violation|0
2026813|NCT00355134|3595683|FG003|Extension Phase|Protocol Violation|1
2026814|NCT00355134|3595684|FG004|Extension Phase|Protocol Violation|0
2026815|NCT00355147|3595696|FG000|Overall Study|Lost to Follow-up|10
2026816|NCT00355147|3595697|FG001|Overall Study|Lost to Follow-up|8
2026817|NCT00355147|3595696|FG000|Overall Study|Withdrawal by Subject|8
2026818|NCT00355147|3595697|FG001|Overall Study|Withdrawal by Subject|12
2026819|NCT00355264|3595716|FG000|Extension (Variable Duration)|Adverse Event|1
2026820|NCT00355264|3595716|FG000|Extension (Variable Duration)|Withdrew Consent|1
2108493|NCT00880048|3702396|FG002|Overall Study|Study closed/terminated|6
2108494|NCT00880087|3702406|FG000|Overall Study|Lost to Follow-up|0
2108495|NCT00880087|3702407|FG001|Overall Study|Lost to Follow-up|2
2108496|NCT00880100|3702413|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
2108497|NCT00880100|3702413|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1
2108498|NCT00880100|3702413|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2
2108499|NCT00880165|3702419|FG000|Overall Study|Withdrawal by Subject|27
2108500|NCT00880165|3702420|FG001|Overall Study|Withdrawal by Subject|23
2108501|NCT00880165|3702419|FG000|Overall Study|Not diagnosed with OSA|14
2108502|NCT00880165|3702420|FG001|Overall Study|Not diagnosed with OSA|8
2180161|NCT01399593|3806146|FG001|Overall Study|Physician Decision|0
2180162|NCT01399593|3806145|FG000|Overall Study|Adverse Event|1
2180163|NCT01399593|3806146|FG001|Overall Study|Adverse Event|0
2180164|NCT01399593|3806145|FG000|Overall Study|Death|1
2180165|NCT01399593|3806146|FG001|Overall Study|Death|1
2180166|NCT01399593|3806145|FG000|Overall Study|Transplantectomy|0
2180167|NCT01399593|3806146|FG001|Overall Study|Transplantectomy|1
2180168|NCT01399619|3806154|FG000|Overall Study|Adverse Event|10
2180169|NCT01399619|3806155|FG001|Overall Study|Adverse Event|0
2180170|NCT01399619|3806156|FG002|Overall Study|Adverse Event|4
2180171|NCT01399619|3806157|FG003|Overall Study|Adverse Event|10
2180172|NCT01399619|3806154|FG000|Overall Study|Lack of Efficacy|9
2180173|NCT01399619|3806155|FG001|Overall Study|Lack of Efficacy|0
2180174|NCT01399619|3806156|FG002|Overall Study|Lack of Efficacy|5
2180175|NCT01399619|3806157|FG003|Overall Study|Lack of Efficacy|0
2180176|NCT01399619|3806154|FG000|Overall Study|Withdrawal by Subject|6
2180177|NCT01399619|3806155|FG001|Overall Study|Withdrawal by Subject|0
2180178|NCT01399619|3806156|FG002|Overall Study|Withdrawal by Subject|3
2180179|NCT01399619|3806157|FG003|Overall Study|Withdrawal by Subject|4
2180180|NCT01399619|3806154|FG000|Overall Study|Protocol Violation|0
2180181|NCT01399619|3806155|FG001|Overall Study|Protocol Violation|0
2180182|NCT01399619|3806156|FG002|Overall Study|Protocol Violation|0
2180183|NCT01399619|3806157|FG003|Overall Study|Protocol Violation|1
2180184|NCT01399619|3806154|FG000|Overall Study|Not treated|0
2180185|NCT01399619|3806155|FG001|Overall Study|Not treated|0
2180186|NCT01399619|3806156|FG002|Overall Study|Not treated|0
2180187|NCT01399619|3806157|FG003|Overall Study|Not treated|2
2180188|NCT01399697|3806175|FG000|Overall Study|Adverse Event|13
2180189|NCT01399697|3806176|FG001|Overall Study|Adverse Event|3
2180190|NCT01399697|3806177|FG002|Overall Study|Adverse Event|1
2180191|NCT01399697|3806175|FG000|Overall Study|Lost to Follow-up|2
2180192|NCT01399697|3806176|FG001|Overall Study|Lost to Follow-up|0
2180193|NCT01399697|3806177|FG002|Overall Study|Lost to Follow-up|0
2180194|NCT01399697|3806175|FG000|Overall Study|Withdrawal by Subject|8
2180195|NCT01399697|3806176|FG001|Overall Study|Withdrawal by Subject|0
2180196|NCT01399697|3806177|FG002|Overall Study|Withdrawal by Subject|0
2180197|NCT01399697|3806175|FG000|Overall Study|Investigator Decisión|1
2180198|NCT01399697|3806176|FG001|Overall Study|Investigator Decisión|0
2180199|NCT01399697|3806177|FG002|Overall Study|Investigator Decisión|2
2180200|NCT01399697|3806175|FG000|Overall Study|Lack of Efficacy|9
2180201|NCT01399697|3806176|FG001|Overall Study|Lack of Efficacy|0
2180202|NCT01399697|3806177|FG002|Overall Study|Lack of Efficacy|1
2180203|NCT01399697|3806175|FG000|Overall Study|Protocol Violation|2
2180204|NCT01399697|3806176|FG001|Overall Study|Protocol Violation|0
2180205|NCT01399697|3806177|FG002|Overall Study|Protocol Violation|0
2180206|NCT01399697|3806175|FG000|Overall Study|Non-Compliant|1
2180207|NCT01399697|3806176|FG001|Overall Study|Non-Compliant|0
2180208|NCT01399697|3806177|FG002|Overall Study|Non-Compliant|0
2180209|NCT01399697|3806175|FG000|Overall Study|Inclusion Error|2
2180210|NCT01399697|3806176|FG001|Overall Study|Inclusion Error|0
2180211|NCT01399697|3806177|FG002|Overall Study|Inclusion Error|0
2026821|NCT00355342|3595727|FG000|Overall Study|Adverse Event|13
2026822|NCT00355342|3595728|FG001|Overall Study|Adverse Event|15
2026823|NCT00355342|3595727|FG000|Overall Study|Lost to Follow-up|4
2026824|NCT00355342|3595728|FG001|Overall Study|Lost to Follow-up|2
2026825|NCT00355342|3595727|FG000|Overall Study|Withdrawal by Subject|14
2026826|NCT00355342|3595728|FG001|Overall Study|Withdrawal by Subject|11
2026827|NCT00355342|3595727|FG000|Overall Study|Sponsor terminated study|2
2026828|NCT00355342|3595728|FG001|Overall Study|Sponsor terminated study|2
2026829|NCT00355342|3595727|FG000|Overall Study|Overcompliant-PI discretion|1
2026830|NCT00355342|3595728|FG001|Overall Study|Overcompliant-PI discretion|0
2026831|NCT00355342|3595727|FG000|Overall Study|Use of prohibited medication|1
2217722|NCT01709305|3860932|FG004|Phase 2|Withdrawal by Subject|12
2026832|NCT00355342|3595728|FG001|Overall Study|Use of prohibited medication|0
2026833|NCT00355342|3595727|FG000|Overall Study|COPD exacerbation|1
2026834|NCT00355342|3595728|FG001|Overall Study|COPD exacerbation|1
2026835|NCT00355342|3595727|FG000|Overall Study|Dispensed wrong study drug kit|1
2026836|NCT00355342|3595728|FG001|Overall Study|Dispensed wrong study drug kit|0
2026837|NCT00355342|3595727|FG000|Overall Study|Non-compliance with Dexa scans|1
2026838|NCT00355342|3595728|FG001|Overall Study|Non-compliance with Dexa scans|0
2026839|NCT00355342|3595727|FG000|Overall Study|Withdrawal by participant and physician|1
2026840|NCT00355342|3595728|FG001|Overall Study|Withdrawal by participant and physician|0
2026841|NCT00355342|3595727|FG000|Overall Study|Participant relocated|0
2026842|NCT00355342|3595728|FG001|Overall Study|Participant relocated|1
2026843|NCT00355342|3595727|FG000|Overall Study|Participant discontinued study drug|0
2026844|NCT00355342|3595728|FG001|Overall Study|Participant discontinued study drug|1
2026845|NCT00355342|3595727|FG000|Overall Study|Study management|0
2026846|NCT00355342|3595728|FG001|Overall Study|Study management|1
2026847|NCT00355342|3595727|FG000|Overall Study|Protocol Violation|0
2026848|NCT00355342|3595728|FG001|Overall Study|Protocol Violation|1
2026849|NCT00355342|3595727|FG000|Overall Study|Use of protocol excluded medication|0
2026850|NCT00355342|3595728|FG001|Overall Study|Use of protocol excluded medication|1
2026851|NCT00355368|3595736|FG000|Overall Study|Protocol Violation|8
2026852|NCT00355368|3595737|FG001|Overall Study|Protocol Violation|7
2026853|NCT00355368|3595736|FG000|Overall Study|cardiac arrest prior to intubation|2
2026854|NCT00355368|3595737|FG001|Overall Study|cardiac arrest prior to intubation|2
2026855|NCT00355472|3595754|FG000|Overall Study|Physician Decision|1
2108503|NCT00880165|3702419|FG000|Overall Study|Required BIPAP or oxygen treatment|12
2108504|NCT00880165|3702420|FG001|Overall Study|Required BIPAP or oxygen treatment|4
2108505|NCT00880165|3702419|FG000|Overall Study|Lost to follow|9
2108506|NCT00880165|3702420|FG001|Overall Study|Lost to follow|15
2108507|NCT00880191|3702428|FG000|Overall Study|Refused further treatment|4
2108508|NCT00880191|3702429|FG001|Overall Study|Refused further treatment|1
2108509|NCT00880191|3702428|FG000|Overall Study|Adverse Event|8
2108510|NCT00880191|3702429|FG001|Overall Study|Adverse Event|6
2108511|NCT00880191|3702428|FG000|Overall Study|Hospitalization/efficacy|1
2108512|NCT00880191|3702429|FG001|Overall Study|Hospitalization/efficacy|1
2108513|NCT00880256|3702439|FG000|Overall Study|Lost to Follow-up|28
2108514|NCT00880269|3702445|FG000|Overall Study|Protocol Violation|1
2108515|NCT00880269|3702446|FG001|Overall Study|Protocol Violation|0
2108516|NCT00880269|3702445|FG000|Overall Study|Disease Progression|13
2108517|NCT00880269|3702446|FG001|Overall Study|Disease Progression|11
2108518|NCT00880269|3702445|FG000|Overall Study|New Cancer Therapy|1
2108519|NCT00880269|3702446|FG001|Overall Study|New Cancer Therapy|0
2108520|NCT00880269|3702445|FG000|Overall Study|Death|4
2108521|NCT00880269|3702446|FG001|Overall Study|Death|2
2108522|NCT00880269|3702445|FG000|Overall Study|Lost to Follow-up|0
2108523|NCT00880269|3702446|FG001|Overall Study|Lost to Follow-up|1
2108524|NCT00880269|3702445|FG000|Overall Study|Withdrawal by Subject|3
2108525|NCT00880269|3702446|FG001|Overall Study|Withdrawal by Subject|4
2108526|NCT00880269|3702445|FG000|Overall Study|Adverse Event|10
2108527|NCT00880269|3702446|FG001|Overall Study|Adverse Event|9
2108528|NCT00880334|3702454|FG000|Randomized Phase|Physician Decision|1
2108529|NCT00880334|3702455|FG001|Randomized Phase|Physician Decision|0
2108530|NCT00880334|3702454|FG000|Randomized Phase|Withdrawal by Subject|2
2108531|NCT00880334|3702455|FG001|Randomized Phase|Withdrawal by Subject|1
2108532|NCT00880334|3702454|FG000|Randomized Phase|Inadequate Labs|1
2108533|NCT00880334|3702455|FG001|Randomized Phase|Inadequate Labs|1
2108534|NCT00880334|3702454|FG000|Randomized Phase|Brain Metastasis|0
2108535|NCT00880334|3702455|FG001|Randomized Phase|Brain Metastasis|1
2108536|NCT00880334|3702454|FG000|Randomized Phase|Crossover Participants|0
2108537|NCT00880334|3702455|FG001|Randomized Phase|Crossover Participants|37
2108538|NCT00880399|3702473|FG000|Overall Study|Adverse Event|4
2108539|NCT00880399|3702474|FG001|Overall Study|Adverse Event|6
2108540|NCT00880399|3702475|FG002|Overall Study|Adverse Event|5
2108541|NCT00880399|3702473|FG000|Overall Study|Lack of Efficacy|1
2108542|NCT00880399|3702474|FG001|Overall Study|Lack of Efficacy|4
2108543|NCT00880399|3702475|FG002|Overall Study|Lack of Efficacy|2
2108544|NCT00880399|3702473|FG000|Overall Study|Protocol Violation|4
2108545|NCT00880399|3702474|FG001|Overall Study|Protocol Violation|4
2108546|NCT00880399|3702475|FG002|Overall Study|Protocol Violation|6
2108547|NCT00880399|3702473|FG000|Overall Study|Study closed/terminated|3
2108548|NCT00880399|3702474|FG001|Overall Study|Study closed/terminated|7
2108549|NCT00880399|3702475|FG002|Overall Study|Study closed/terminated|4
2026856|NCT00355615|3595770|FG000|Randomized Double Blind Period|Adverse Event|1
2026857|NCT00355615|3595771|FG001|Randomized Double Blind Period|Adverse Event|0
2026858|NCT00355615|3595772|FG002|Randomized Double Blind Period|Adverse Event|0
2026859|NCT00355615|3595773|FG003|Randomized Double Blind Period|Adverse Event|0
2026860|NCT00355615|3595774|FG004|Randomized Double Blind Period|Adverse Event|0
2026861|NCT00355615|3595770|FG000|Randomized Double Blind Period|Protocol Violation|0
2026862|NCT00355615|3595771|FG001|Randomized Double Blind Period|Protocol Violation|0
2026863|NCT00355615|3595772|FG002|Randomized Double Blind Period|Protocol Violation|1
2026864|NCT00355615|3595773|FG003|Randomized Double Blind Period|Protocol Violation|1
2026865|NCT00355615|3595774|FG004|Randomized Double Blind Period|Protocol Violation|0
2026866|NCT00355615|3595770|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0
2026867|NCT00355615|3595771|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0
2026868|NCT00355615|3595772|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0
2026869|NCT00355615|3595773|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0
2026870|NCT00355615|3595774|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4
2108550|NCT00880399|3702473|FG000|Overall Study|Lost to Follow-up|8
2108551|NCT00880399|3702474|FG001|Overall Study|Lost to Follow-up|5
2108552|NCT00880399|3702475|FG002|Overall Study|Lost to Follow-up|3
2108553|NCT00880399|3702473|FG000|Overall Study|Physician Decision|5
2108554|NCT00880399|3702474|FG001|Overall Study|Physician Decision|0
2108555|NCT00880399|3702475|FG002|Overall Study|Physician Decision|3
2108556|NCT00880399|3702473|FG000|Overall Study|Withdrawal by Subject|6
2108557|NCT00880399|3702474|FG001|Overall Study|Withdrawal by Subject|3
2108558|NCT00880399|3702475|FG002|Overall Study|Withdrawal by Subject|3
2108559|NCT00880555|3702497|FG000|Overall Study|Physician Decision|0
2108560|NCT00880555|3702498|FG001|Overall Study|Physician Decision|8
2108561|NCT00880555|3702499|FG002|Overall Study|Physician Decision|0
2108562|NCT00880555|3702500|FG003|Overall Study|Physician Decision|2
2108563|NCT00880555|3702501|FG004|Overall Study|Physician Decision|1
2108564|NCT00880555|3702502|FG005|Overall Study|Physician Decision|0
2108565|NCT00880555|3702497|FG000|Overall Study|Withdrawal by Subject|1
2108566|NCT00880555|3702498|FG001|Overall Study|Withdrawal by Subject|1
2108567|NCT00880555|3702499|FG002|Overall Study|Withdrawal by Subject|0
2108568|NCT00880555|3702500|FG003|Overall Study|Withdrawal by Subject|0
2108569|NCT00880555|3702501|FG004|Overall Study|Withdrawal by Subject|0
2108570|NCT00880555|3702502|FG005|Overall Study|Withdrawal by Subject|0
2108571|NCT00880555|3702497|FG000|Overall Study|Lack of resources (hired rater)|9
2108572|NCT00880555|3702498|FG001|Overall Study|Lack of resources (hired rater)|7
2108573|NCT00880555|3702499|FG002|Overall Study|Lack of resources (hired rater)|5
2108574|NCT00880555|3702500|FG003|Overall Study|Lack of resources (hired rater)|0
2108575|NCT00880555|3702501|FG004|Overall Study|Lack of resources (hired rater)|0
2108576|NCT00880555|3702502|FG005|Overall Study|Lack of resources (hired rater)|0
2108577|NCT00880555|3702497|FG000|Overall Study|Death|0
2108578|NCT00880555|3702498|FG001|Overall Study|Death|0
2108579|NCT00880555|3702499|FG002|Overall Study|Death|0
2108580|NCT00880555|3702500|FG003|Overall Study|Death|0
2108581|NCT00880555|3702501|FG004|Overall Study|Death|0
2108582|NCT00880555|3702502|FG005|Overall Study|Death|1
2108583|NCT00880555|3702497|FG000|Overall Study|Lost to Follow-up|0
2108584|NCT00880555|3702498|FG001|Overall Study|Lost to Follow-up|1
2108585|NCT00880555|3702499|FG002|Overall Study|Lost to Follow-up|0
2108586|NCT00880555|3702500|FG003|Overall Study|Lost to Follow-up|0
2108587|NCT00880555|3702501|FG004|Overall Study|Lost to Follow-up|0
2108588|NCT00880555|3702502|FG005|Overall Study|Lost to Follow-up|0
2108589|NCT00880568|3702522|FG000|Overall Study|Disease progression|3
2108590|NCT00880568|3702523|FG001|Overall Study|Disease progression|3
2108591|NCT00880568|3702524|FG002|Overall Study|Disease progression|3
2108592|NCT00880568|3702525|FG003|Overall Study|Disease progression|1
2108593|NCT00880568|3702526|FG004|Overall Study|Disease progression|3
2108594|NCT00880568|3702527|FG005|Overall Study|Disease progression|3
2108595|NCT00880568|3702528|FG006|Overall Study|Disease progression|5
2108596|NCT00880568|3702529|FG007|Overall Study|Disease progression|0
2108597|NCT00880568|3702530|FG008|Overall Study|Disease progression|3
2108598|NCT00880568|3702522|FG000|Overall Study|Adverse Event|0
2108599|NCT00880568|3702523|FG001|Overall Study|Adverse Event|0
2108600|NCT00880568|3702524|FG002|Overall Study|Adverse Event|0
2108601|NCT00880568|3702525|FG003|Overall Study|Adverse Event|0
2108602|NCT00880568|3702526|FG004|Overall Study|Adverse Event|0
2108603|NCT00880568|3702527|FG005|Overall Study|Adverse Event|0
2108604|NCT00880568|3702528|FG006|Overall Study|Adverse Event|1
2108605|NCT00880568|3702529|FG007|Overall Study|Adverse Event|1
2108606|NCT00880568|3702530|FG008|Overall Study|Adverse Event|0
2108607|NCT00880568|3702522|FG000|Overall Study|Withdrawal by Subject|0
2108608|NCT00880568|3702523|FG001|Overall Study|Withdrawal by Subject|0
2108609|NCT00880568|3702524|FG002|Overall Study|Withdrawal by Subject|0
2108610|NCT00880568|3702525|FG003|Overall Study|Withdrawal by Subject|0
2108611|NCT00880568|3702526|FG004|Overall Study|Withdrawal by Subject|0
2108612|NCT00880568|3702527|FG005|Overall Study|Withdrawal by Subject|0
2108613|NCT00880568|3702528|FG006|Overall Study|Withdrawal by Subject|0
2108614|NCT00880568|3702529|FG007|Overall Study|Withdrawal by Subject|1
2108615|NCT00880568|3702530|FG008|Overall Study|Withdrawal by Subject|0
2108616|NCT00880607|3702561|FG000|Overall Study|Physician Decision|2
2108617|NCT00880607|3702562|FG001|Overall Study|Physician Decision|2
2026871|NCT00355615|3595770|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0
2026872|NCT00355615|3595771|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0
2026873|NCT00355615|3595772|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0
2026874|NCT00355615|3595773|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0
2026875|NCT00355615|3595774|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1
2026876|NCT00355615|3595770|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
2026877|NCT00355615|3595771|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
2026878|NCT00355615|3595772|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
2026879|NCT00355615|3595773|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
2026880|NCT00355615|3595774|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
2026881|NCT00355615|3595770|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0
2026882|NCT00355615|3595771|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0
2026883|NCT00355615|3595772|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0
2026884|NCT00355615|3595773|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0
2026885|NCT00355615|3595774|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1
2026886|NCT00355784|3595799|FG000|Overall Study|Withdrawal by Subject|0
2026887|NCT00355784|3595800|FG001|Overall Study|Withdrawal by Subject|0
2026888|NCT00355784|3595801|FG002|Overall Study|Withdrawal by Subject|2
2026889|NCT00356122|3595857|FG000|TREATMENT|Lack of Efficacy|26
2026890|NCT00356122|3595857|FG000|TREATMENT|Adverse Event|10
2026891|NCT00356122|3595857|FG000|TREATMENT|Subject's request|4
2108618|NCT00880607|3702561|FG000|Overall Study|Protocol Violation|2
2108619|NCT00880607|3702562|FG001|Overall Study|Protocol Violation|1
2108620|NCT00880607|3702561|FG000|Overall Study|surgery did not extend past L1 level|3
2108621|NCT00880607|3702562|FG001|Overall Study|surgery did not extend past L1 level|0
2108622|NCT00880620|3702574|FG000|Overall Study|Adverse Event|4
2108623|NCT00880620|3702575|FG001|Overall Study|Adverse Event|5
2108624|NCT00880620|3702576|FG002|Overall Study|Adverse Event|15
2108625|NCT00880620|3702577|FG003|Overall Study|Adverse Event|15
2108626|NCT00880620|3702574|FG000|Overall Study|Death|0
2108627|NCT00880620|3702575|FG001|Overall Study|Death|0
2108628|NCT00880620|3702576|FG002|Overall Study|Death|1
2108629|NCT00880620|3702577|FG003|Overall Study|Death|0
2108630|NCT00880620|3702574|FG000|Overall Study|Lack of Efficacy|12
2108631|NCT00880620|3702575|FG001|Overall Study|Lack of Efficacy|4
2108632|NCT00880620|3702576|FG002|Overall Study|Lack of Efficacy|0
2108633|NCT00880620|3702577|FG003|Overall Study|Lack of Efficacy|1
2108634|NCT00880620|3702574|FG000|Overall Study|Lost to Follow-up|0
2108635|NCT00880620|3702575|FG001|Overall Study|Lost to Follow-up|1
2108636|NCT00880620|3702576|FG002|Overall Study|Lost to Follow-up|1
2108637|NCT00880620|3702577|FG003|Overall Study|Lost to Follow-up|0
2108638|NCT00880620|3702574|FG000|Overall Study|Protocol Violation|0
2108639|NCT00880620|3702575|FG001|Overall Study|Protocol Violation|1
2108640|NCT00880620|3702576|FG002|Overall Study|Protocol Violation|0
2108641|NCT00880620|3702577|FG003|Overall Study|Protocol Violation|2
2108642|NCT00880620|3702574|FG000|Overall Study|Withdrawal by Subject|4
2108643|NCT00880620|3702575|FG001|Overall Study|Withdrawal by Subject|3
2108644|NCT00880620|3702576|FG002|Overall Study|Withdrawal by Subject|1
2108645|NCT00880620|3702577|FG003|Overall Study|Withdrawal by Subject|3
2108646|NCT00880620|3702574|FG000|Overall Study|Noncompliance|0
2108647|NCT00880620|3702575|FG001|Overall Study|Noncompliance|0
2108648|NCT00880620|3702576|FG002|Overall Study|Noncompliance|1
2108649|NCT00880620|3702577|FG003|Overall Study|Noncompliance|1
2108650|NCT00880620|3702574|FG000|Overall Study|Other|1
2108651|NCT00880620|3702575|FG001|Overall Study|Other|1
2108652|NCT00880620|3702576|FG002|Overall Study|Other|2
2108653|NCT00880620|3702577|FG003|Overall Study|Other|2
2108654|NCT00880685|3702591|FG000|Memantine 10mg|Lost to Follow-up|2
2108655|NCT00880685|3702591|FG000|Memantine 20mg|Withdrawal by Subject|1
2108656|NCT00880698|3702602|FG000|Overall Study|Death|0
2108657|NCT00880698|3702603|FG001|Overall Study|Death|0
2108658|NCT00880698|3702604|FG002|Overall Study|Death|1
2108659|NCT00880698|3702605|FG003|Overall Study|Death|2
2108660|NCT00880698|3702602|FG000|Overall Study|Lost to Follow-up|1
2108661|NCT00880698|3702603|FG001|Overall Study|Lost to Follow-up|3
2108662|NCT00880698|3702604|FG002|Overall Study|Lost to Follow-up|0
2108663|NCT00880698|3702605|FG003|Overall Study|Lost to Follow-up|1
2108664|NCT00880750|3702619|FG000|First Intervention|Adverse Event|1
2108665|NCT00880750|3702620|FG001|First Intervention|Adverse Event|0
2108666|NCT00880750|3702619|FG000|First Intervention|Unable to collect urine|4
2108667|NCT00880750|3702620|FG001|First Intervention|Unable to collect urine|0
2108668|NCT00880750|3702619|FG000|First Intervention|Non-compliance with meals|0
2108669|NCT00880750|3702620|FG001|First Intervention|Non-compliance with meals|1
2108670|NCT00880750|3702619|FG000|First Intervention|Withdrawal by Subject|2
2108671|NCT00880750|3702620|FG001|First Intervention|Withdrawal by Subject|0
2108672|NCT00880750|3702619|FG000|First Intervention|Lost to Follow-up|2
2108673|NCT00880750|3702620|FG001|First Intervention|Lost to Follow-up|0
2108674|NCT00880750|3702619|FG000|Second Intervention|Withdrawal by Subject|2
2108675|NCT00880750|3702620|FG001|Second Intervention|Withdrawal by Subject|2
2108676|NCT00880750|3702619|FG000|Second Intervention|Protocol Violation|1
2108677|NCT00880750|3702620|FG001|Second Intervention|Protocol Violation|0
2026892|NCT00356122|3595857|FG000|TREATMENT|Other|4
2026893|NCT00356122|3595857|FG000|TREATMENT|Did not receive study medication|1
2026894|NCT00356122|3595857|FG000|FOLLOW-UP|Death|37
2026895|NCT00356122|3595857|FG000|FOLLOW-UP|Lost to Follow-up|2
2026896|NCT00356122|3595857|FG000|FOLLOW-UP|Other|2
2026897|NCT00356135|3595864|FG000|Overall Study|Protocol Violation|1
2026898|NCT00356135|3595865|FG001|Overall Study|Protocol Violation|0
2026899|NCT00356135|3595866|FG002|Overall Study|Protocol Violation|0
2026900|NCT00356135|3595864|FG000|Overall Study|Adverse Event|1
2026901|NCT00356135|3595865|FG001|Overall Study|Adverse Event|0
2026902|NCT00356135|3595866|FG002|Overall Study|Adverse Event|0
2026903|NCT00356135|3595864|FG000|Overall Study|Lost to Follow-up|0
2026904|NCT00356135|3595865|FG001|Overall Study|Lost to Follow-up|0
2026905|NCT00356135|3595866|FG002|Overall Study|Lost to Follow-up|1
2026906|NCT00356135|3595864|FG000|Overall Study|Physician Decision|1
2026907|NCT00356135|3595865|FG001|Overall Study|Physician Decision|1
2026908|NCT00356135|3595866|FG002|Overall Study|Physician Decision|1
2026909|NCT00356135|3595864|FG000|Overall Study|Subject non-compliance|1
2026910|NCT00356135|3595865|FG001|Overall Study|Subject non-compliance|1
2026911|NCT00356135|3595866|FG002|Overall Study|Subject non-compliance|3
2026912|NCT00356148|3595878|FG000|Overall Study|Reoperation within 30 days|2
2026913|NCT00356148|3595879|FG001|Overall Study|Reoperation within 30 days|1
2026914|NCT00356200|3595888|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1
2026915|NCT00356200|3595889|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0
2026916|NCT00356200|3595888|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
2026917|NCT00356200|3595889|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
2026918|NCT00356265|3595904|FG000|Overall Study|Withdrawal by Subject|0
2026919|NCT00356265|3595905|FG001|Overall Study|Withdrawal by Subject|0
2026920|NCT00356265|3595906|FG002|Overall Study|Withdrawal by Subject|1
2026921|NCT00356278|3595918|FG000|Overall Study|Withdrawal by Subject|25
2026922|NCT00356278|3595919|FG001|Overall Study|Withdrawal by Subject|15
2026923|NCT00356278|3595920|FG002|Overall Study|Withdrawal by Subject|19
2026924|NCT00356369|3595939|FG000|Active Phase|Withdrawal by Subject|2
2026925|NCT00356369|3595940|FG001|Active Phase|Withdrawal by Subject|1
2026926|NCT00356408|3595950|FG000|Overall Study|Adverse Event|9
2026927|NCT00356408|3595950|FG000|Overall Study|Lack of Efficacy|36
2026928|NCT00356408|3595950|FG000|Overall Study|Lost to Follow-up|2
2026929|NCT00356408|3595950|FG000|Overall Study|Withdrawal by Subject|6
2026930|NCT00356408|3595950|FG000|Overall Study|Other: Principal investigator discretion|3
2026931|NCT00356408|3595950|FG000|Overall Study|Other: Sponsor request|1
2026932|NCT00356408|3595950|FG000|Overall Study|Other: Azathioprine stopped|1
2026933|NCT00356408|3595950|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1
2026934|NCT00356408|3595950|FG000|Overall Study|Other: Subject chose commerical dosing|1
2026935|NCT00356525|3595975|FG000|Overall Study|Progressive Disease|8
2026936|NCT00356525|3595976|FG001|Overall Study|Progressive Disease|5
2026937|NCT00356525|3595977|FG002|Overall Study|Progressive Disease|4
2026938|NCT00356525|3595978|FG003|Overall Study|Progressive Disease|2
2108678|NCT00880750|3702619|FG000|Second Intervention|Unable to collect urine|1
2108679|NCT00880750|3702620|FG001|Second Intervention|Unable to collect urine|0
2108680|NCT00880763|3702630|FG000|Extension Period (Part 2)|Adverse Event|0
2108681|NCT00880763|3702631|FG001|Extension Period (Part 2)|Adverse Event|0
2108682|NCT00880763|3702632|FG002|Extension Period (Part 2)|Adverse Event|1
2108683|NCT00880763|3702633|FG003|Extension Period (Part 2)|Adverse Event|1
2108684|NCT00880763|3702630|FG000|Extension Period (Part 2)|Withdrawal by Subject|0
2108685|NCT00880763|3702631|FG001|Extension Period (Part 2)|Withdrawal by Subject|2
2108686|NCT00880763|3702632|FG002|Extension Period (Part 2)|Withdrawal by Subject|1
2108687|NCT00880763|3702633|FG003|Extension Period (Part 2)|Withdrawal by Subject|1
2108688|NCT00880763|3702630|FG000|Extension Period (Part 2)|Physician Decision|0
2108689|NCT00880763|3702631|FG001|Extension Period (Part 2)|Physician Decision|1
2108690|NCT00880763|3702632|FG002|Extension Period (Part 2)|Physician Decision|1
2108691|NCT00880763|3702633|FG003|Extension Period (Part 2)|Physician Decision|0
2108692|NCT00880763|3702630|FG000|Extension Period (Part 2)|Lack of Efficacy|0
2108693|NCT00880763|3702631|FG001|Extension Period (Part 2)|Lack of Efficacy|0
2108694|NCT00880763|3702632|FG002|Extension Period (Part 2)|Lack of Efficacy|0
2108695|NCT00880763|3702633|FG003|Extension Period (Part 2)|Lack of Efficacy|1
2217723|NCT01709383|3860949|FG000|Overall Study|Lost to Follow-up|1
2217724|NCT01709383|3860950|FG001|Overall Study|Lost to Follow-up|0
2217725|NCT01709409|3860960|FG000|Overall Study|Protocol Violation|1
2217726|NCT01709409|3860961|FG001|Overall Study|Protocol Violation|0
2217727|NCT01709500|3860989|FG000|Overall Study|Randomized but not treated|0
2217728|NCT01709500|3860990|FG001|Overall Study|Randomized but not treated|1
2026939|NCT00356525|3595975|FG000|Overall Study|Adverse Event|1
2108696|NCT00880893|3702645|FG000|Overall Study|Protocol Violation|13
2108697|NCT00880893|3702646|FG001|Overall Study|Protocol Violation|1
2108698|NCT00880893|3702645|FG000|Overall Study|Withdrawal by Subject|15
2108699|NCT00880893|3702646|FG001|Overall Study|Withdrawal by Subject|11
2108700|NCT00880893|3702645|FG000|Overall Study|Lost to Follow-up|76
2108701|NCT00880893|3702646|FG001|Overall Study|Lost to Follow-up|33
2108702|NCT00880893|3702645|FG000|Overall Study|Serious adverse event|3
2026940|NCT00356525|3595976|FG001|Overall Study|Adverse Event|3
2026941|NCT00356525|3595977|FG002|Overall Study|Adverse Event|1
2026942|NCT00356525|3595978|FG003|Overall Study|Adverse Event|1
2026943|NCT00356525|3595975|FG000|Overall Study|Lost to Follow-up|1
2026944|NCT00356525|3595976|FG001|Overall Study|Lost to Follow-up|0
2026945|NCT00356525|3595977|FG002|Overall Study|Lost to Follow-up|0
2026946|NCT00356525|3595978|FG003|Overall Study|Lost to Follow-up|0
2026947|NCT00356525|3595975|FG000|Overall Study|Physician Decision|2
2026948|NCT00356525|3595976|FG001|Overall Study|Physician Decision|2
2026949|NCT00356525|3595977|FG002|Overall Study|Physician Decision|2
2026950|NCT00356525|3595978|FG003|Overall Study|Physician Decision|1
2026951|NCT00356525|3595975|FG000|Overall Study|Protocol Entry Criteria Not Met|1
2026952|NCT00356525|3595976|FG001|Overall Study|Protocol Entry Criteria Not Met|0
2026953|NCT00356525|3595977|FG002|Overall Study|Protocol Entry Criteria Not Met|0
2026954|NCT00356525|3595978|FG003|Overall Study|Protocol Entry Criteria Not Met|0
2026955|NCT00356525|3595975|FG000|Overall Study|Withdrawal by Subject|1
2026956|NCT00356525|3595976|FG001|Overall Study|Withdrawal by Subject|1
2026957|NCT00356525|3595977|FG002|Overall Study|Withdrawal by Subject|0
2026958|NCT00356525|3595978|FG003|Overall Study|Withdrawal by Subject|3
2026959|NCT00356525|3595975|FG000|Overall Study|Death|0
2026960|NCT00356525|3595976|FG001|Overall Study|Death|0
2026961|NCT00356525|3595977|FG002|Overall Study|Death|0
2026962|NCT00356525|3595978|FG003|Overall Study|Death|1
2026963|NCT00356525|3595975|FG000|Overall Study|Sponsor Decision|0
2026964|NCT00356525|3595976|FG001|Overall Study|Sponsor Decision|0
2026965|NCT00356525|3595977|FG002|Overall Study|Sponsor Decision|0
2026966|NCT00356525|3595978|FG003|Overall Study|Sponsor Decision|1
2026967|NCT00356590|3595988|FG000|Overall Study|Adverse Event|54
2026968|NCT00356590|3595988|FG000|Overall Study|Death|10
2026969|NCT00356590|3595988|FG000|Overall Study|Lost to Follow-up|35
2026970|NCT00356590|3595988|FG000|Overall Study|Physician Decision|46
2026971|NCT00356590|3595988|FG000|Overall Study|Withdrawal by Subject|41
2026972|NCT00356590|3595988|FG000|Overall Study|Completed month 12 only|2
2026973|NCT00356590|3595988|FG000|Overall Study|Protocol issues|6
2026974|NCT00356590|3595988|FG000|Overall Study|Response status|28
2026975|NCT00356590|3595988|FG000|Overall Study|Other|52
2026976|NCT00356603|3595994|FG000|Overall Study|Other|6
2026977|NCT00356603|3595995|FG001|Overall Study|Other|3
2108703|NCT00880893|3702646|FG001|Overall Study|Serious adverse event|0
2108704|NCT00880906|3702654|FG000|Overall Study|Lost to Follow-up|0
2108705|NCT00880906|3702655|FG001|Overall Study|Lost to Follow-up|1
2108706|NCT00880906|3702654|FG000|Overall Study|Did not meet criteria following patholog|12
2108707|NCT00880906|3702655|FG001|Overall Study|Did not meet criteria following patholog|6
2108708|NCT00881335|3702692|FG000|Overall Study|Lost to Follow-up|3
2108709|NCT00881335|3702693|FG001|Overall Study|Lost to Follow-up|2
2108710|NCT00881361|3702701|FG000|Overall Study|Terminated prior to surgery|27
2108711|NCT00881361|3702702|FG001|Overall Study|Terminated prior to surgery|7
2108712|NCT00881361|3702703|FG002|Overall Study|Terminated prior to surgery|0
2108713|NCT00881361|3702701|FG000|Overall Study|Ineligible|17
2108714|NCT00881361|3702702|FG001|Overall Study|Ineligible|2
2108715|NCT00881361|3702703|FG002|Overall Study|Ineligible|2
2108716|NCT00881504|3702721|FG000|Overall Study|Withdrawal by Subject|1
2108717|NCT00881530|3702731|FG000|Overall Study|Adverse Event|5
2108718|NCT00881530|3702732|FG001|Overall Study|Adverse Event|1
2108719|NCT00881530|3702733|FG002|Overall Study|Adverse Event|1
2108720|NCT00881530|3702734|FG003|Overall Study|Adverse Event|4
2108721|NCT00881530|3702735|FG004|Overall Study|Adverse Event|10
2108722|NCT00881530|3702736|FG005|Overall Study|Adverse Event|2
2108723|NCT00881530|3702731|FG000|Overall Study|Lack of Efficacy|1
2108724|NCT00881530|3702732|FG001|Overall Study|Lack of Efficacy|0
2108725|NCT00881530|3702733|FG002|Overall Study|Lack of Efficacy|0
2108726|NCT00881530|3702734|FG003|Overall Study|Lack of Efficacy|0
2108727|NCT00881530|3702735|FG004|Overall Study|Lack of Efficacy|1
2108728|NCT00881530|3702736|FG005|Overall Study|Lack of Efficacy|1
2108729|NCT00881530|3702731|FG000|Overall Study|Not compliant with the protocol|0
2108730|NCT00881530|3702732|FG001|Overall Study|Not compliant with the protocol|0
2108731|NCT00881530|3702733|FG002|Overall Study|Not compliant with the protocol|0
2108732|NCT00881530|3702734|FG003|Overall Study|Not compliant with the protocol|0
2108733|NCT00881530|3702735|FG004|Overall Study|Not compliant with the protocol|2
2108734|NCT00881530|3702736|FG005|Overall Study|Not compliant with the protocol|0
2108735|NCT00881530|3702731|FG000|Overall Study|Lost to Follow-up|0
2108736|NCT00881530|3702732|FG001|Overall Study|Lost to Follow-up|1
2108737|NCT00881530|3702733|FG002|Overall Study|Lost to Follow-up|1
2108738|NCT00881530|3702734|FG003|Overall Study|Lost to Follow-up|3
2108739|NCT00881530|3702735|FG004|Overall Study|Lost to Follow-up|1
2108740|NCT00881530|3702736|FG005|Overall Study|Lost to Follow-up|0
2108741|NCT00881530|3702731|FG000|Overall Study|Refused to continue medication|7
2108742|NCT00881530|3702732|FG001|Overall Study|Refused to continue medication|2
2108743|NCT00881530|3702733|FG002|Overall Study|Refused to continue medication|1
2108744|NCT00881530|3702734|FG003|Overall Study|Refused to continue medication|2
2108745|NCT00881530|3702735|FG004|Overall Study|Refused to continue medication|0
2108746|NCT00881530|3702736|FG005|Overall Study|Refused to continue medication|0
2108747|NCT00881530|3702731|FG000|Overall Study|Other reason not defined above|1
2108748|NCT00881530|3702732|FG001|Overall Study|Other reason not defined above|1
2108749|NCT00881530|3702733|FG002|Overall Study|Other reason not defined above|2
2108750|NCT00881530|3702734|FG003|Overall Study|Other reason not defined above|0
2108751|NCT00881530|3702735|FG004|Overall Study|Other reason not defined above|0
2026978|NCT00356759|3596005|FG000|Overall Study|Death|5
2026979|NCT00356759|3596006|FG001|Overall Study|Death|2
2026980|NCT00356759|3596005|FG000|Overall Study|Withdrawal by Subject|2
2026981|NCT00356759|3596006|FG001|Overall Study|Withdrawal by Subject|2
2026982|NCT00356759|3596005|FG000|Overall Study|Adverse Event|1
2026983|NCT00356759|3596006|FG001|Overall Study|Adverse Event|3
2026984|NCT00356759|3596005|FG000|Overall Study|Lost to Follow-up|1
2026985|NCT00356759|3596006|FG001|Overall Study|Lost to Follow-up|1
2026986|NCT00356759|3596005|FG000|Overall Study|Intercurrent disease or persistent extre|5
2026987|NCT00356759|3596006|FG001|Overall Study|Intercurrent disease or persistent extre|2
2026988|NCT00356811|3596012|FG000|Overall Study|Death|35
2026989|NCT00356811|3596012|FG000|Overall Study|Lost to Follow-up|2
2026990|NCT00356811|3596012|FG000|Overall Study|Withdrawal by Subject|6
2026991|NCT00356811|3596012|FG000|Overall Study|Participant Could Not Make a Checkup|1
2026992|NCT00356811|3596012|FG000|Overall Study|Study Is Terminating|3
2026993|NCT00356811|3596012|FG000|Overall Study|Site Closed during Follow-up|2
2026994|NCT00356863|3596019|FG000|Overall Study|Death|16
2026995|NCT00356863|3596020|FG001|Overall Study|Death|32
2026996|NCT00356863|3596019|FG000|Overall Study|Lost to Follow-up|76
2026997|NCT00356863|3596020|FG001|Overall Study|Lost to Follow-up|43
2026998|NCT00356889|3596030|FG000|Overall Study|Protocol Violation|2
2026999|NCT00356889|3596030|FG000|Overall Study|Adverse Event|1
2027000|NCT00356915|3596038|FG000|Overall Study|Non compliance|1
2027001|NCT00356915|3596039|FG001|Overall Study|Non compliance|2
2027002|NCT00356915|3596040|FG002|Overall Study|Non compliance|1
2027003|NCT00356915|3596038|FG000|Overall Study|Protocol Violation|2
2027004|NCT00356915|3596039|FG001|Overall Study|Protocol Violation|3
2027005|NCT00356915|3596040|FG002|Overall Study|Protocol Violation|2
2027006|NCT00356915|3596038|FG000|Overall Study|Withdrawal by Subject|14
2027007|NCT00356915|3596039|FG001|Overall Study|Withdrawal by Subject|14
2027008|NCT00356915|3596040|FG002|Overall Study|Withdrawal by Subject|10
2027009|NCT00356915|3596038|FG000|Overall Study|Lack of Efficacy|0
2027010|NCT00356915|3596039|FG001|Overall Study|Lack of Efficacy|0
2027011|NCT00356915|3596040|FG002|Overall Study|Lack of Efficacy|3
2027012|NCT00356915|3596038|FG000|Overall Study|Lost to Follow-up|27
2027013|NCT00356915|3596039|FG001|Overall Study|Lost to Follow-up|34
2027014|NCT00356915|3596040|FG002|Overall Study|Lost to Follow-up|14
2027015|NCT00356915|3596038|FG000|Overall Study|Administrative Decision|0
2027016|NCT00356915|3596039|FG001|Overall Study|Administrative Decision|0
2027017|NCT00356915|3596040|FG002|Overall Study|Administrative Decision|1
2027018|NCT00356915|3596038|FG000|Overall Study|Physician Decision|0
2027019|NCT00356915|3596039|FG001|Overall Study|Physician Decision|2
2027020|NCT00356915|3596040|FG002|Overall Study|Physician Decision|0
2027021|NCT00356915|3596038|FG000|Overall Study|Adverse Event|21
2027022|NCT00356915|3596039|FG001|Overall Study|Adverse Event|31
2027023|NCT00356915|3596040|FG002|Overall Study|Adverse Event|8
2027024|NCT00356915|3596038|FG000|Overall Study|Miscellaneous reasons|11
2027025|NCT00356915|3596039|FG001|Overall Study|Miscellaneous reasons|8
2027026|NCT00356915|3596040|FG002|Overall Study|Miscellaneous reasons|3
2027027|NCT00357006|3596061|FG000|Overall Study|Lost to Follow-up|1
2027028|NCT00357006|3596062|FG001|Overall Study|Lost to Follow-up|2
2027029|NCT00357006|3596063|FG002|Overall Study|Lost to Follow-up|1
2027030|NCT00357006|3596061|FG000|Overall Study|Withdrawal by Subject|1
2027031|NCT00357006|3596062|FG001|Overall Study|Withdrawal by Subject|3
2027032|NCT00357006|3596063|FG002|Overall Study|Withdrawal by Subject|2
2027033|NCT00357097|3596077|FG000|Overall Study|Did not meet inclusion criteria|5
2027034|NCT00357097|3596078|FG001|Overall Study|Did not meet inclusion criteria|3
2027035|NCT00357097|3596077|FG000|Overall Study|Adverse Event|34
2027036|NCT00357097|3596078|FG001|Overall Study|Adverse Event|6
2027037|NCT00357097|3596077|FG000|Overall Study|Withdrawal by Subject|8
2027038|NCT00357097|3596078|FG001|Overall Study|Withdrawal by Subject|7
2027039|NCT00357097|3596077|FG000|Overall Study|Non-compliance|1
2027040|NCT00357097|3596078|FG001|Overall Study|Non-compliance|2
2027041|NCT00357097|3596077|FG000|Overall Study|Lack of Efficacy|2
2027042|NCT00357097|3596078|FG001|Overall Study|Lack of Efficacy|8
2027043|NCT00357097|3596077|FG000|Overall Study|Met Exclusion Criteria|3
2027044|NCT00357097|3596078|FG001|Overall Study|Met Exclusion Criteria|1
2027045|NCT00357097|3596077|FG000|Overall Study|Other|1
2027046|NCT00357097|3596078|FG001|Overall Study|Other|1
2027047|NCT00357097|3596077|FG000|Overall Study|Increase of RLS Symptoms|0
2180212|NCT01399697|3806175|FG000|Overall Study|Positive result for hepatitis B|1
2027048|NCT00357097|3596078|FG001|Overall Study|Increase of RLS Symptoms|1
2027049|NCT00357110|3596086|FG000|Overall Study|Early study termination|5
2027050|NCT00357110|3596087|FG001|Overall Study|Early study termination|5
2027051|NCT00357370|3596126|FG000|Cohort 2|Lack of Efficacy|0
2027052|NCT00357370|3596127|FG001|Cohort 2|Lack of Efficacy|2
2027053|NCT00357370|3596128|FG002|Cohort 2|Lack of Efficacy|1
2027054|NCT00357370|3596126|FG000|Cohort 2|Adverse Event|1
2027055|NCT00357370|3596127|FG001|Cohort 2|Adverse Event|1
2027056|NCT00357370|3596128|FG002|Cohort 2|Adverse Event|1
2027057|NCT00357370|3596126|FG000|Cohort 2|Lost to Follow-up|0
2027058|NCT00357370|3596127|FG001|Cohort 2|Lost to Follow-up|1
2027059|NCT00357370|3596128|FG002|Cohort 2|Lost to Follow-up|0
2027060|NCT00357370|3596126|FG000|Cohort 2|non-compliance, not met criteria, etc|1
2027061|NCT00357370|3596127|FG001|Cohort 2|non-compliance, not met criteria, etc|1
2027062|NCT00357370|3596128|FG002|Cohort 2|non-compliance, not met criteria, etc|0
2027063|NCT00357370|3596126|FG000|Cohort 2|Withdrawal by Subject|0
2027064|NCT00357370|3596127|FG001|Cohort 2|Withdrawal by Subject|2
2027065|NCT00357370|3596128|FG002|Cohort 2|Withdrawal by Subject|0
2027066|NCT00357396|3596138|FG000|Overall Study|Adverse Event|1
2027067|NCT00357396|3596139|FG001|Overall Study|Adverse Event|0
2027068|NCT00357500|3596144|FG000|Overall Study|Adverse Event|3
2027069|NCT00357500|3596144|FG000|Overall Study|Withdrawal by Subject|5
2027070|NCT00357500|3596144|FG000|Overall Study|Progressive Disease|65
2027071|NCT00357500|3596144|FG000|Overall Study|Not Started Protocol Therapy|4
2027072|NCT00357552|3596148|FG000|Screening|Did not meet eligibility criteria|84
2027073|NCT00357552|3596148|FG000|Weeks 0 to 24|Death|1
2027074|NCT00357552|3596148|FG000|Weeks 24 to 104|Death|3
2027075|NCT00357552|3596148|FG000|Weeks 24 to 104|Not able to get to clinic|2
2027076|NCT00357656|3596158|FG000|Overall Study|Other, No surgery performed|0
2027077|NCT00357656|3596159|FG001|Overall Study|Other, No surgery performed|3
2027078|NCT00357760|3596183|FG000|Overall Study|Disease progression|44
2027079|NCT00357760|3596184|FG001|Overall Study|Disease progression|17
2027080|NCT00357760|3596183|FG000|Overall Study|Adverse Event|10
2027081|NCT00357760|3596184|FG001|Overall Study|Adverse Event|7
2027082|NCT00357760|3596183|FG000|Overall Study|Death|0
2027083|NCT00357760|3596184|FG001|Overall Study|Death|3
2027084|NCT00357760|3596183|FG000|Overall Study|Alternative therapy|1
2027085|NCT00357760|3596184|FG001|Overall Study|Alternative therapy|0
2027086|NCT00357760|3596183|FG000|Overall Study|Withdrawal by Subject|0
2027087|NCT00357760|3596184|FG001|Overall Study|Withdrawal by Subject|2
2027088|NCT00357760|3596183|FG000|Overall Study|Never started treatment|2
2027089|NCT00357760|3596184|FG001|Overall Study|Never started treatment|1
2027090|NCT00357760|3596183|FG000|Overall Study|Ineligible|0
2108752|NCT00881530|3702736|FG005|Overall Study|Other reason not defined above|2
2108753|NCT00881569|3702752|FG000|Overall Study|Disease progression|1
2108754|NCT00881569|3702753|FG001|Overall Study|Disease progression|1
2108755|NCT00881621|3702759|FG000|Overall Study|Physician Decision|34
2108756|NCT00881712|3702775|FG000|Overall Study|Death|1
2108757|NCT00881712|3702776|FG001|Overall Study|Death|0
2108758|NCT00881712|3702777|FG002|Overall Study|Death|0
2108759|NCT00881712|3702775|FG000|Overall Study|Withdrawal by Subject|1
2108760|NCT00881712|3702776|FG001|Overall Study|Withdrawal by Subject|0
2108761|NCT00881712|3702777|FG002|Overall Study|Withdrawal by Subject|0
2108762|NCT00881751|3702787|FG000|Overall Study|Physician Decision|0
2108763|NCT00881751|3702788|FG001|Overall Study|Physician Decision|1
2108764|NCT00881751|3702787|FG000|Overall Study|Adverse Event|0
2108765|NCT00881751|3702788|FG001|Overall Study|Adverse Event|2
2108766|NCT00881751|3702787|FG000|Overall Study|Withdrawal by Subject|0
2108767|NCT00881751|3702788|FG001|Overall Study|Withdrawal by Subject|2
2108768|NCT00881868|3702796|FG000|Overall Study|Adverse Event|0
2108769|NCT00881868|3702797|FG001|Overall Study|Adverse Event|1
2108770|NCT00881868|3702796|FG000|Overall Study|Lost to Follow-up|2
2108771|NCT00881868|3702797|FG001|Overall Study|Lost to Follow-up|1
2108772|NCT00881868|3702796|FG000|Overall Study|Physician Decision|4
2108773|NCT00881868|3702797|FG001|Overall Study|Physician Decision|0
2108774|NCT00881868|3702796|FG000|Overall Study|Protocol Violation|2
2108775|NCT00881868|3702797|FG001|Overall Study|Protocol Violation|0
2108776|NCT00881894|3702805|FG000|Overall Study|Consent withdrawn|0
2108777|NCT00881894|3702806|FG001|Overall Study|Consent withdrawn|1
2108778|NCT00881894|3702805|FG000|Overall Study|Other reasons for premature termination|1
2108779|NCT00881894|3702806|FG001|Overall Study|Other reasons for premature termination|2
2108780|NCT00881959|3702814|FG000|Overall Study|Lost to Follow-up|2
2108781|NCT00881959|3702815|FG001|Overall Study|Lost to Follow-up|4
2108782|NCT00882115|3702825|FG000|Overall Study|Withdrawal by Subject|3
2108783|NCT00882115|3702825|FG000|Overall Study|did not respond to DEP challe|6
2108784|NCT00882362|3702836|FG000|Overall Study|Adverse Event|13
2108785|NCT00882362|3702837|FG001|Overall Study|Adverse Event|10
2108786|NCT00882362|3702836|FG000|Overall Study|Withdrawal by Subject|13
2108787|NCT00882362|3702837|FG001|Overall Study|Withdrawal by Subject|10
2108788|NCT00882362|3702836|FG000|Overall Study|Lack of Efficacy|3
2108789|NCT00882362|3702837|FG001|Overall Study|Lack of Efficacy|0
2108790|NCT00882362|3702836|FG000|Overall Study|Protocol Violation|7
2108791|NCT00882362|3702837|FG001|Overall Study|Protocol Violation|2
2108792|NCT00882362|3702836|FG000|Overall Study|Pregnancy|1
2108793|NCT00882362|3702837|FG001|Overall Study|Pregnancy|0
2108794|NCT00882362|3702836|FG000|Overall Study|Physician Decision|5
2108795|NCT00882362|3702837|FG001|Overall Study|Physician Decision|1
2108796|NCT00882362|3702836|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
2108797|NCT00882362|3702837|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
2108798|NCT00882362|3702836|FG000|Overall Study|change of residence or other commitments|5
2108799|NCT00882362|3702837|FG001|Overall Study|change of residence or other commitments|0
2108800|NCT00882518|3702845|FG000|Overall Study|Adverse Event|9
2108801|NCT00882518|3702846|FG001|Overall Study|Adverse Event|18
2108802|NCT00882518|3702845|FG000|Overall Study|Withdrawal by Subject|9
2108803|NCT00882518|3702846|FG001|Overall Study|Withdrawal by Subject|13
2108804|NCT00882518|3702845|FG000|Overall Study|Lack of Efficacy|12
2108805|NCT00882518|3702846|FG001|Overall Study|Lack of Efficacy|9
2027091|NCT00357760|3596184|FG001|Overall Study|Ineligible|2
2027092|NCT00357760|3596183|FG000|Overall Study|Physician Decision|2
2027093|NCT00357760|3596184|FG001|Overall Study|Physician Decision|1
2027094|NCT00357760|3596183|FG000|Overall Study|Protocol Violation|0
2027095|NCT00357760|3596184|FG001|Overall Study|Protocol Violation|1
2027096|NCT00357760|3596183|FG000|Overall Study|To receive hospice care|0
2027097|NCT00357760|3596184|FG001|Overall Study|To receive hospice care|1
2027098|NCT00357877|3596192|FG000|Overall Study|Death|2
2027099|NCT00357877|3596193|FG001|Overall Study|Death|1
2027100|NCT00357877|3596192|FG000|Overall Study|Lost to Follow-up|20
2027101|NCT00357877|3596193|FG001|Overall Study|Lost to Follow-up|23
2027102|NCT00357877|3596192|FG000|Overall Study|Withdrawal by Subject|3
2027103|NCT00357877|3596193|FG001|Overall Study|Withdrawal by Subject|3
2027104|NCT00357877|3596192|FG000|Overall Study|Administrative withdrawal|1
2027105|NCT00357877|3596193|FG001|Overall Study|Administrative withdrawal|1
2027106|NCT00357877|3596192|FG000|Overall Study|Other|0
2027107|NCT00357877|3596193|FG001|Overall Study|Other|2
2027108|NCT00357903|3596203|FG000|Overall Study|Adverse Event|87
2027109|NCT00357903|3596204|FG001|Overall Study|Adverse Event|4
2027110|NCT00357903|3596203|FG000|Overall Study|Death|33
2027111|NCT00357903|3596204|FG001|Overall Study|Death|0
2027112|NCT00357903|3596203|FG000|Overall Study|Lost to Follow-up|23
2027113|NCT00357903|3596204|FG001|Overall Study|Lost to Follow-up|4
2027114|NCT00357903|3596203|FG000|Overall Study|Physician Decision|39
2027115|NCT00357903|3596204|FG001|Overall Study|Physician Decision|5
2027116|NCT00357903|3596203|FG000|Overall Study|Withdrawal by Subject|57
2027117|NCT00357903|3596204|FG001|Overall Study|Withdrawal by Subject|7
2027118|NCT00357903|3596203|FG000|Overall Study|Completed month 12 only|0
2027119|NCT00357903|3596204|FG001|Overall Study|Completed month 12 only|1
2108806|NCT00882518|3702845|FG000|Overall Study|Severe non-compliance to protocol|3
2108807|NCT00882518|3702846|FG001|Overall Study|Severe non-compliance to protocol|1
2108808|NCT00882518|3702845|FG000|Overall Study|Incorrect enrolment|4
2108809|NCT00882518|3702846|FG001|Overall Study|Incorrect enrolment|2
2108810|NCT00882518|3702845|FG000|Overall Study|Central lab closure for National day|1
2108811|NCT00882518|3702846|FG001|Overall Study|Central lab closure for National day|0
2108812|NCT00882518|3702845|FG000|Overall Study|Allocating random number by mistake|0
2108813|NCT00882518|3702846|FG001|Overall Study|Allocating random number by mistake|1
2108814|NCT00882557|3702854|FG000|Overall Study|Withdrawal by Subject|1
2108815|NCT00882557|3702855|FG001|Overall Study|Withdrawal by Subject|0
2108816|NCT00882557|3702854|FG000|Overall Study|Trouble with Vein Access|1
2108817|NCT00882557|3702855|FG001|Overall Study|Trouble with Vein Access|0
2108818|NCT00882557|3702854|FG000|Overall Study|Randomized Not Treated|0
2108819|NCT00882557|3702855|FG001|Overall Study|Randomized Not Treated|1
2108820|NCT00882583|3702863|FG000|Overall Study|Physician Decision|1
2108821|NCT00882583|3702864|FG001|Overall Study|Physician Decision|0
2108822|NCT00882583|3702863|FG000|Overall Study|Adverse Event|0
2108823|NCT00882583|3702864|FG001|Overall Study|Adverse Event|1
2108824|NCT00882713|3702899|FG000|Overall Study|Adverse Event|2
2108825|NCT00882713|3702899|FG000|Overall Study|Death|3
2108826|NCT00882713|3702899|FG000|Overall Study|Administrative reasons|4
2108827|NCT00882713|3702899|FG000|Overall Study|refused treatment/withdrew consent|4
2108828|NCT00882713|3702899|FG000|Overall Study|Blood transfusion|2
2108829|NCT00882713|3702899|FG000|Overall Study|Insufficient therapeutic response|3
2108830|NCT00882713|3702899|FG000|Overall Study|Failure to return|2
2108831|NCT00882713|3702899|FG000|Overall Study|Other - Reasons|2
2108832|NCT00882908|3702913|FG000|Overall Study|Adverse Event|0
2108833|NCT00882908|3702914|FG001|Overall Study|Adverse Event|0
2108834|NCT00882908|3702915|FG002|Overall Study|Adverse Event|1
2108835|NCT00882908|3702916|FG003|Overall Study|Adverse Event|0
2108836|NCT00882908|3702917|FG004|Overall Study|Adverse Event|1
2108837|NCT00882908|3702913|FG000|Overall Study|Lost to Follow-up|3
2108838|NCT00882908|3702914|FG001|Overall Study|Lost to Follow-up|5
2108839|NCT00882908|3702915|FG002|Overall Study|Lost to Follow-up|3
2108840|NCT00882908|3702916|FG003|Overall Study|Lost to Follow-up|1
2108841|NCT00882908|3702917|FG004|Overall Study|Lost to Follow-up|2
2108842|NCT00882908|3702913|FG000|Overall Study|Protocol Violation|0
2108843|NCT00882908|3702914|FG001|Overall Study|Protocol Violation|1
2108844|NCT00882908|3702915|FG002|Overall Study|Protocol Violation|0
2108845|NCT00882908|3702916|FG003|Overall Study|Protocol Violation|0
2108846|NCT00882908|3702917|FG004|Overall Study|Protocol Violation|0
2217729|NCT01709500|3860989|FG000|Overall Study|Adverse Event|5
2217730|NCT01709500|3860990|FG001|Overall Study|Adverse Event|1
2108847|NCT00882908|3702913|FG000|Overall Study|Withdrawal by Subject|0
2108848|NCT00882908|3702914|FG001|Overall Study|Withdrawal by Subject|0
2108849|NCT00882908|3702915|FG002|Overall Study|Withdrawal by Subject|3
2108850|NCT00882908|3702916|FG003|Overall Study|Withdrawal by Subject|5
2108851|NCT00882908|3702917|FG004|Overall Study|Withdrawal by Subject|2
2108852|NCT00882908|3702913|FG000|Overall Study|Subject reached a virologic endpoint|0
2108853|NCT00882908|3702914|FG001|Overall Study|Subject reached a virologic endpoint|0
2108854|NCT00882908|3702915|FG002|Overall Study|Subject reached a virologic endpoint|0
2108855|NCT00882908|3702916|FG003|Overall Study|Subject reached a virologic endpoint|0
2108856|NCT00882908|3702917|FG004|Overall Study|Subject reached a virologic endpoint|1
2108857|NCT00882908|3702913|FG000|Overall Study|Study terminated in error|0
2108858|NCT00882908|3702914|FG001|Overall Study|Study terminated in error|0
2027120|NCT00357903|3596203|FG000|Overall Study|Protocol issues|14
2027121|NCT00357903|3596204|FG001|Overall Study|Protocol issues|3
2027122|NCT00357903|3596203|FG000|Overall Study|Response status|61
2027123|NCT00357903|3596204|FG001|Overall Study|Response status|9
2027124|NCT00357903|3596203|FG000|Overall Study|Other|49
2027125|NCT00357903|3596204|FG001|Overall Study|Other|10
2027126|NCT00357968|3596222|FG000|First Maintenance Dose Phase|Not a PCI patient|47
2027127|NCT00357968|3596223|FG001|First Maintenance Dose Phase|Not a PCI patient|42
2027128|NCT00357968|3596222|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1
2027129|NCT00357968|3596223|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2
2027130|NCT00357994|3596246|FG000|Overall Study|Adverse Event|1
2027131|NCT00357994|3596247|FG001|Overall Study|Adverse Event|2
2027132|NCT00357994|3596246|FG000|Overall Study|Lack of Efficacy|0
2027133|NCT00357994|3596247|FG001|Overall Study|Lack of Efficacy|1
2027134|NCT00357994|3596246|FG000|Overall Study|Protocol Violation|1
2027135|NCT00357994|3596247|FG001|Overall Study|Protocol Violation|0
2027136|NCT00358150|3596257|FG000|Overall Study|Adverse Event|3
2027137|NCT00358150|3596257|FG000|Overall Study|Withdrawal by Subject|1
2027138|NCT00358150|3596257|FG000|Overall Study|Undefined|3
2027139|NCT00358215|3596266|FG000|Overall Study|Ineligibility determined|4
2027140|NCT00358215|3596267|FG001|Overall Study|Ineligibility determined|3
2027141|NCT00358215|3596266|FG000|Overall Study|Adverse Event|83
2027142|NCT00358215|3596267|FG001|Overall Study|Adverse Event|65
2027143|NCT00358215|3596266|FG000|Overall Study|Withdrawal by Subject|111
2027144|NCT00358215|3596267|FG001|Overall Study|Withdrawal by Subject|102
2027145|NCT00358215|3596266|FG000|Overall Study|Participant request|65
2027146|NCT00358215|3596267|FG001|Overall Study|Participant request|64
2027147|NCT00358215|3596266|FG000|Overall Study|Physician Decision|47
2027148|NCT00358215|3596267|FG001|Overall Study|Physician Decision|39
2027149|NCT00358215|3596266|FG000|Overall Study|Lost to Follow-up|16
2027150|NCT00358215|3596267|FG001|Overall Study|Lost to Follow-up|22
2027151|NCT00358215|3596266|FG000|Overall Study|Death|265
2027152|NCT00358215|3596267|FG001|Overall Study|Death|281
2027153|NCT00358215|3596266|FG000|Overall Study|Protocol Violation|64
2108859|NCT00882908|3702915|FG002|Overall Study|Study terminated in error|0
2108860|NCT00882908|3702916|FG003|Overall Study|Study terminated in error|1
2108861|NCT00882908|3702917|FG004|Overall Study|Study terminated in error|0
2108862|NCT00882921|3702930|FG000|Overall Study|Death|2
2108863|NCT00882921|3702930|FG000|Overall Study|Other|3
2108864|NCT00882921|3702930|FG000|Overall Study|Lost to Follow-up|2
2108865|NCT00882921|3702930|FG000|Overall Study|Termination By Investigator|3
2108866|NCT00882921|3702930|FG000|Overall Study|Withdrawal Of Consent|1
2108867|NCT00882999|3702942|FG000|Overall Study|Adverse Event|0
2108868|NCT00882999|3702943|FG001|Overall Study|Adverse Event|0
2108869|NCT00882999|3702944|FG002|Overall Study|Adverse Event|0
2108870|NCT00882999|3702945|FG003|Overall Study|Adverse Event|0
2108871|NCT00882999|3702946|FG004|Overall Study|Adverse Event|1
2108872|NCT00882999|3702947|FG005|Overall Study|Adverse Event|0
2108873|NCT00882999|3702948|FG006|Overall Study|Adverse Event|0
2108874|NCT00882999|3702942|FG000|Overall Study|Death|0
2108875|NCT00882999|3702943|FG001|Overall Study|Death|1
2108876|NCT00882999|3702944|FG002|Overall Study|Death|0
2108877|NCT00882999|3702945|FG003|Overall Study|Death|0
2108878|NCT00882999|3702946|FG004|Overall Study|Death|0
2108879|NCT00882999|3702947|FG005|Overall Study|Death|0
2108880|NCT00882999|3702948|FG006|Overall Study|Death|0
2108881|NCT00882999|3702942|FG000|Overall Study|Withdrawal by Subject|7
2217731|NCT01709500|3860989|FG000|Overall Study|Poor compliance to protocol|2
2108882|NCT00882999|3702943|FG001|Overall Study|Withdrawal by Subject|6
2108883|NCT00882999|3702944|FG002|Overall Study|Withdrawal by Subject|3
2108884|NCT00882999|3702945|FG003|Overall Study|Withdrawal by Subject|3
2108885|NCT00882999|3702946|FG004|Overall Study|Withdrawal by Subject|6
2108886|NCT00882999|3702947|FG005|Overall Study|Withdrawal by Subject|5
2108887|NCT00882999|3702948|FG006|Overall Study|Withdrawal by Subject|5
2108888|NCT00882999|3702942|FG000|Overall Study|Lost to Follow-up|0
2108889|NCT00882999|3702943|FG001|Overall Study|Lost to Follow-up|1
2108890|NCT00882999|3702944|FG002|Overall Study|Lost to Follow-up|1
2108891|NCT00882999|3702945|FG003|Overall Study|Lost to Follow-up|2
2108892|NCT00882999|3702946|FG004|Overall Study|Lost to Follow-up|1
2108893|NCT00882999|3702947|FG005|Overall Study|Lost to Follow-up|1
2108894|NCT00882999|3702948|FG006|Overall Study|Lost to Follow-up|2
2108895|NCT00882999|3702942|FG000|Overall Study|Physician Decision|1
2108896|NCT00882999|3702943|FG001|Overall Study|Physician Decision|0
2108897|NCT00882999|3702944|FG002|Overall Study|Physician Decision|0
2108898|NCT00882999|3702945|FG003|Overall Study|Physician Decision|0
2108899|NCT00882999|3702946|FG004|Overall Study|Physician Decision|0
2108900|NCT00882999|3702947|FG005|Overall Study|Physician Decision|1
2108901|NCT00882999|3702948|FG006|Overall Study|Physician Decision|1
2108902|NCT00883051|3702976|FG000|Overall Study|Lost to Follow-up|0
2108903|NCT00883051|3702977|FG001|Overall Study|Lost to Follow-up|0
2108904|NCT00883051|3702978|FG002|Overall Study|Lost to Follow-up|0
2108905|NCT00883051|3702979|FG003|Overall Study|Lost to Follow-up|0
2108906|NCT00883051|3702980|FG004|Overall Study|Lost to Follow-up|1
2108907|NCT00883051|3702976|FG000|Overall Study|Did not use study medication|24
2108908|NCT00883051|3702977|FG001|Overall Study|Did not use study medication|22
2108909|NCT00883051|3702978|FG002|Overall Study|Did not use study medication|29
2108910|NCT00883051|3702979|FG003|Overall Study|Did not use study medication|29
2108911|NCT00883051|3702980|FG004|Overall Study|Did not use study medication|17
2027154|NCT00358215|3596267|FG001|Overall Study|Protocol Violation|59
2027155|NCT00358215|3596266|FG000|Overall Study|Pregnancy|1
2027156|NCT00358215|3596267|FG001|Overall Study|Pregnancy|0
2027157|NCT00358215|3596266|FG000|Overall Study|Other|21
2027158|NCT00358215|3596267|FG001|Overall Study|Other|14
2027159|NCT00358215|3596266|FG000|Overall Study|Did not receive investigational product|2
2027160|NCT00358215|3596267|FG001|Overall Study|Did not receive investigational product|3
2027161|NCT00358436|3596292|FG000|Overall Study|Adverse Event|29
2027162|NCT00358436|3596293|FG001|Overall Study|Adverse Event|13
2027163|NCT00358436|3596292|FG000|Overall Study|Lack of Efficacy|34
2027164|NCT00358436|3596293|FG001|Overall Study|Lack of Efficacy|36
2027165|NCT00358436|3596292|FG000|Overall Study|Lost to Follow-up|11
2027166|NCT00358436|3596293|FG001|Overall Study|Lost to Follow-up|6
2027167|NCT00358436|3596292|FG000|Overall Study|Protocol Violation|8
2027168|NCT00358436|3596293|FG001|Overall Study|Protocol Violation|3
2027169|NCT00358436|3596292|FG000|Overall Study|Withdrawal by Subject|40
2108912|NCT00883090|3702992|FG000|Overall Study|Sponsor's decision|1
2108913|NCT00883090|3702992|FG000|Overall Study|Withdrawal by Subject|1
2108914|NCT00883116|3703007|FG000|Overall Study|Adverse event unrelated to study drug|5
2108915|NCT00883116|3703008|FG001|Overall Study|Adverse event unrelated to study drug|10
2108916|NCT00883116|3703007|FG000|Overall Study|Death|6
2108917|NCT00883116|3703008|FG001|Overall Study|Death|2
2108918|NCT00883116|3703007|FG000|Overall Study|Disease progression|130
2108919|NCT00883116|3703008|FG001|Overall Study|Disease progression|128
2108920|NCT00883116|3703007|FG000|Overall Study|Lost to Follow-up|0
2108921|NCT00883116|3703008|FG001|Overall Study|Lost to Follow-up|1
2108922|NCT00883116|3703007|FG000|Overall Study|Maximum clinical benefit|13
2108923|NCT00883116|3703008|FG001|Overall Study|Maximum clinical benefit|46
2108924|NCT00883116|3703007|FG000|Overall Study|Not identified|3
2108925|NCT00883116|3703008|FG001|Overall Study|Not identified|6
2108926|NCT00883116|3703007|FG000|Overall Study|Study drug toxicity|36
2108927|NCT00883116|3703008|FG001|Overall Study|Study drug toxicity|16
2108928|NCT00883116|3703007|FG000|Overall Study|Withdrawal by Subject|14
2108929|NCT00883116|3703008|FG001|Overall Study|Withdrawal by Subject|8
2108930|NCT00883116|3703007|FG000|Overall Study|No longer meets study criteria|2
2108931|NCT00883116|3703008|FG001|Overall Study|No longer meets study criteria|2
2108932|NCT00883129|3703018|FG000|Overall Study|Adverse Event|7
2108933|NCT00883129|3703019|FG001|Overall Study|Adverse Event|15
2108934|NCT00883129|3703018|FG000|Overall Study|Withdrawal by Subject|8
2108935|NCT00883129|3703019|FG001|Overall Study|Withdrawal by Subject|9
2108936|NCT00883129|3703018|FG000|Overall Study|Non-compliance|3
2108937|NCT00883129|3703019|FG001|Overall Study|Non-compliance|6
2108938|NCT00883129|3703018|FG000|Overall Study|Lost to Follow-up|1
2108939|NCT00883129|3703019|FG001|Overall Study|Lost to Follow-up|2
2108940|NCT00883129|3703018|FG000|Overall Study|Death|1
2108941|NCT00883129|3703019|FG001|Overall Study|Death|2
2108942|NCT00883129|3703018|FG000|Overall Study|Defined Treatment Failure|0
2108943|NCT00883129|3703019|FG001|Overall Study|Defined Treatment Failure|2
2108944|NCT00883181|3703042|FG000|Overall Study|Hematological Adverse Event|26
2108945|NCT00883181|3703042|FG000|Overall Study|Non-hematological Adverse Event|55
2108946|NCT00883181|3703042|FG000|Overall Study|Disease Progression|94
2108947|NCT00883181|3703042|FG000|Overall Study|Administrative Reason|24
2108948|NCT00883181|3703042|FG000|Overall Study|Withdrawal by Subject|4
2108949|NCT00883181|3703042|FG000|Overall Study|Death|31
2108950|NCT00883181|3703042|FG000|Overall Study|Other|38
2108951|NCT00883181|3703042|FG000|Overall Study|Protocol Deviation|3
2108952|NCT00883181|3703042|FG000|Overall Study|Noncompliance|3
2108953|NCT00883337|3703089|FG000|Core Treatment Period|Adverse Event|9
2108954|NCT00883337|3703090|FG001|Core Treatment Period|Adverse Event|12
2108955|NCT00883337|3703091|FG002|Core Treatment Period|Adverse Event|22
2108956|NCT00883337|3703089|FG000|Core Treatment Period|Lack of Efficacy|7
2108957|NCT00883337|3703090|FG001|Core Treatment Period|Lack of Efficacy|4
2108958|NCT00883337|3703091|FG002|Core Treatment Period|Lack of Efficacy|2
2108959|NCT00883337|3703089|FG000|Core Treatment Period|Lost to Follow-up|1
2108960|NCT00883337|3703090|FG001|Core Treatment Period|Lost to Follow-up|1
2108961|NCT00883337|3703091|FG002|Core Treatment Period|Lost to Follow-up|0
2108962|NCT00883337|3703089|FG000|Core Treatment Period|Withdrawal by Subject|2
2108963|NCT00883337|3703090|FG001|Core Treatment Period|Withdrawal by Subject|2
2108964|NCT00883337|3703091|FG002|Core Treatment Period|Withdrawal by Subject|6
2108965|NCT00883337|3703089|FG000|Core Treatment Period|Wish to be pregnant|1
2108966|NCT00883337|3703090|FG001|Core Treatment Period|Wish to be pregnant|2
2108967|NCT00883337|3703091|FG002|Core Treatment Period|Wish to be pregnant|1
2108968|NCT00883337|3703089|FG000|Core Treatment Period|Poor compliance to protocol|0
2108969|NCT00883337|3703090|FG001|Core Treatment Period|Poor compliance to protocol|0
2108970|NCT00883337|3703091|FG002|Core Treatment Period|Poor compliance to protocol|1
2108971|NCT00883337|3703089|FG000|Core Treatment Period|Other than above|0
2108972|NCT00883337|3703090|FG001|Core Treatment Period|Other than above|1
2108973|NCT00883337|3703091|FG002|Core Treatment Period|Other than above|1
2108974|NCT00883337|3703089|FG000|Extension Treatment Period|Adverse Event|8
2108975|NCT00883337|3703090|FG001|Extension Treatment Period|Adverse Event|5
2108976|NCT00883337|3703091|FG002|Extension Treatment Period|Adverse Event|5
2108977|NCT00883337|3703089|FG000|Extension Treatment Period|Lack of Efficacy|8
2027170|NCT00358436|3596293|FG001|Overall Study|Withdrawal by Subject|17
2027171|NCT00358436|3596292|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4
2027172|NCT00358436|3596293|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0
2027173|NCT00358436|3596292|FG000|Overall Study|COPD exacerbation|22
2027174|NCT00358436|3596293|FG001|Overall Study|COPD exacerbation|10
2027175|NCT00358436|3596292|FG000|Overall Study|Other|6
2027176|NCT00358436|3596293|FG001|Overall Study|Other|1
2027177|NCT00358449|3596304|FG000|Overall Study|Adverse Event|1
2027178|NCT00358449|3596305|FG001|Overall Study|Adverse Event|0
2027179|NCT00358449|3596306|FG002|Overall Study|Adverse Event|1
2027180|NCT00358449|3596304|FG000|Overall Study|Lost to Follow-up|1
2027181|NCT00358449|3596305|FG001|Overall Study|Lost to Follow-up|0
2027182|NCT00358449|3596306|FG002|Overall Study|Lost to Follow-up|0
2027183|NCT00358449|3596304|FG000|Overall Study|Withdrawal by Subject|2
2027184|NCT00358449|3596305|FG001|Overall Study|Withdrawal by Subject|0
2027185|NCT00358449|3596306|FG002|Overall Study|Withdrawal by Subject|0
2027186|NCT00358449|3596304|FG000|Overall Study|Lack of Efficacy|0
2027187|NCT00358449|3596305|FG001|Overall Study|Lack of Efficacy|1
2027188|NCT00358449|3596306|FG002|Overall Study|Lack of Efficacy|0
2027189|NCT00358449|3596304|FG000|Overall Study|Steriod Inhaler was Increased|0
2027190|NCT00358449|3596305|FG001|Overall Study|Steriod Inhaler was Increased|0
2027191|NCT00358449|3596306|FG002|Overall Study|Steriod Inhaler was Increased|1
2027192|NCT00358644|3596354|FG000|Overall Study|Progressive Disease|21
2027193|NCT00358644|3596354|FG000|Overall Study|Adverse Event|7
2027194|NCT00358644|3596354|FG000|Overall Study|Death|11
2027195|NCT00358644|3596354|FG000|Overall Study|Withdrawal by Subject|4
2027196|NCT00358644|3596354|FG000|Overall Study|Physician Decision|6
2027197|NCT00358644|3596354|FG000|Overall Study|Patient not eligible for study|1
2027198|NCT00358670|3596364|FG000|Overall Study|Adverse Event|26
2027199|NCT00358670|3596365|FG001|Overall Study|Adverse Event|29
2027200|NCT00358670|3596364|FG000|Overall Study|Lack of Efficacy|20
2027201|NCT00358670|3596365|FG001|Overall Study|Lack of Efficacy|23
2027202|NCT00358670|3596364|FG000|Overall Study|Protocol Violation|6
2027203|NCT00358670|3596365|FG001|Overall Study|Protocol Violation|9
2027204|NCT00358670|3596364|FG000|Overall Study|Lost to Follow-up|4
2027205|NCT00358670|3596365|FG001|Overall Study|Lost to Follow-up|5
2027206|NCT00358670|3596364|FG000|Overall Study|Withdrawal by Subject|13
2027207|NCT00358670|3596365|FG001|Overall Study|Withdrawal by Subject|24
2027208|NCT00358670|3596364|FG000|Overall Study|Protocol Defined Clinical Event|0
2027209|NCT00358670|3596365|FG001|Overall Study|Protocol Defined Clinical Event|1
2027210|NCT00358670|3596364|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
2027211|NCT00358670|3596365|FG001|Overall Study|Did Not Meet Protocol Eligibility|3
2027212|NCT00358670|3596364|FG000|Overall Study|Administrative|153
2027213|NCT00358670|3596365|FG001|Overall Study|Administrative|125
2027214|NCT00358826|3596384|FG000|Core Study|Adverse Event|1
2027215|NCT00358826|3596385|FG001|Core Study|Adverse Event|3
2027216|NCT00358826|3596386|FG002|Core Study|Adverse Event|1
2027217|NCT00358826|3596387|FG003|Core Study|Adverse Event|1
2027218|NCT00358826|3596388|FG004|Core Study|Adverse Event|0
2027219|NCT00358826|3596389|FG005|Core Study|Adverse Event|0
2027220|NCT00358826|3596390|FG006|Core Study|Adverse Event|0
2027221|NCT00358826|3596391|FG007|Core Study|Adverse Event|0
2027222|NCT00358826|3596384|FG000|Core Study|Withdrawal by Subject|2
2027223|NCT00358826|3596385|FG001|Core Study|Withdrawal by Subject|2
2027224|NCT00358826|3596386|FG002|Core Study|Withdrawal by Subject|0
2027225|NCT00358826|3596387|FG003|Core Study|Withdrawal by Subject|0
2027226|NCT00358826|3596388|FG004|Core Study|Withdrawal by Subject|0
2027227|NCT00358826|3596389|FG005|Core Study|Withdrawal by Subject|0
2027228|NCT00358826|3596390|FG006|Core Study|Withdrawal by Subject|0
2027229|NCT00358826|3596391|FG007|Core Study|Withdrawal by Subject|0
2027230|NCT00358826|3596384|FG000|Core Study|Lost to Follow-up|0
2027231|NCT00358826|3596385|FG001|Core Study|Lost to Follow-up|0
2027232|NCT00358826|3596386|FG002|Core Study|Lost to Follow-up|0
2108978|NCT00883337|3703090|FG001|Extension Treatment Period|Lack of Efficacy|8
2108979|NCT00883337|3703091|FG002|Extension Treatment Period|Lack of Efficacy|8
2108980|NCT00883337|3703089|FG000|Extension Treatment Period|Poor compliance to protocol|1
2108981|NCT00883337|3703090|FG001|Extension Treatment Period|Poor compliance to protocol|1
2108982|NCT00883337|3703091|FG002|Extension Treatment Period|Poor compliance to protocol|1
2108983|NCT00883337|3703089|FG000|Extension Treatment Period|Lost to Follow-up|1
2108984|NCT00883337|3703090|FG001|Extension Treatment Period|Lost to Follow-up|0
2108985|NCT00883337|3703091|FG002|Extension Treatment Period|Lost to Follow-up|0
2108986|NCT00883337|3703089|FG000|Extension Treatment Period|Other than above|10
2108987|NCT00883337|3703090|FG001|Extension Treatment Period|Other than above|9
2108988|NCT00883337|3703091|FG002|Extension Treatment Period|Other than above|5
2108989|NCT00883493|3703115|FG000|Overall Study|Adverse Event|11
2027233|NCT00358826|3596387|FG003|Core Study|Lost to Follow-up|1
2027234|NCT00358826|3596388|FG004|Core Study|Lost to Follow-up|0
2027235|NCT00358826|3596389|FG005|Core Study|Lost to Follow-up|0
2027236|NCT00358826|3596390|FG006|Core Study|Lost to Follow-up|0
2027237|NCT00358826|3596391|FG007|Core Study|Lost to Follow-up|0
2027238|NCT00358826|3596384|FG000|Core Study|Physician Decision|0
2027239|NCT00358826|3596385|FG001|Core Study|Physician Decision|0
2027240|NCT00358826|3596386|FG002|Core Study|Physician Decision|1
2027241|NCT00358826|3596387|FG003|Core Study|Physician Decision|0
2027242|NCT00358826|3596388|FG004|Core Study|Physician Decision|0
2027243|NCT00358826|3596389|FG005|Core Study|Physician Decision|0
2027244|NCT00358826|3596390|FG006|Core Study|Physician Decision|0
2027245|NCT00358826|3596391|FG007|Core Study|Physician Decision|0
2027246|NCT00358826|3596384|FG000|MDCT Substudy|Adverse Event|0
2027247|NCT00358826|3596385|FG001|MDCT Substudy|Adverse Event|0
2027248|NCT00358826|3596386|FG002|MDCT Substudy|Adverse Event|0
2027249|NCT00358826|3596387|FG003|MDCT Substudy|Adverse Event|0
2027250|NCT00358826|3596388|FG004|MDCT Substudy|Adverse Event|1
2027251|NCT00358826|3596389|FG005|MDCT Substudy|Adverse Event|0
2027252|NCT00358826|3596390|FG006|MDCT Substudy|Adverse Event|0
2027253|NCT00358826|3596391|FG007|MDCT Substudy|Adverse Event|0
2027254|NCT00358826|3596384|FG000|MDCT Substudy|Lost to Follow-up|0
2027255|NCT00358826|3596385|FG001|MDCT Substudy|Lost to Follow-up|0
2027256|NCT00358826|3596386|FG002|MDCT Substudy|Lost to Follow-up|0
2027257|NCT00358826|3596387|FG003|MDCT Substudy|Lost to Follow-up|0
2027258|NCT00358826|3596388|FG004|MDCT Substudy|Lost to Follow-up|0
2027259|NCT00358826|3596389|FG005|MDCT Substudy|Lost to Follow-up|1
2027260|NCT00358826|3596390|FG006|MDCT Substudy|Lost to Follow-up|0
2027261|NCT00358826|3596391|FG007|MDCT Substudy|Lost to Follow-up|0
2027262|NCT00358826|3596384|FG000|MDCT Substudy|Withdrawal by Subject|0
2027263|NCT00358826|3596385|FG001|MDCT Substudy|Withdrawal by Subject|0
2027264|NCT00358826|3596386|FG002|MDCT Substudy|Withdrawal by Subject|0
2027265|NCT00358826|3596387|FG003|MDCT Substudy|Withdrawal by Subject|0
2027266|NCT00358826|3596388|FG004|MDCT Substudy|Withdrawal by Subject|0
2027267|NCT00358826|3596389|FG005|MDCT Substudy|Withdrawal by Subject|1
2027268|NCT00358826|3596390|FG006|MDCT Substudy|Withdrawal by Subject|0
2027269|NCT00358826|3596391|FG007|MDCT Substudy|Withdrawal by Subject|0
2027270|NCT00358917|3596407|FG000|Overall Study|Adverse Event|14
2027271|NCT00358917|3596408|FG001|Overall Study|Adverse Event|21
2027272|NCT00358917|3596407|FG000|Overall Study|Withdrawal by Subject|5
2027273|NCT00358917|3596408|FG001|Overall Study|Withdrawal by Subject|7
2027274|NCT00358917|3596407|FG000|Overall Study|Lost to Follow-up|20
2027275|NCT00358917|3596408|FG001|Overall Study|Lost to Follow-up|17
2027276|NCT00358917|3596407|FG000|Overall Study|Noncompliance|12
2027277|NCT00358917|3596408|FG001|Overall Study|Noncompliance|11
2027278|NCT00358917|3596407|FG000|Overall Study|Death|2
2027279|NCT00358917|3596408|FG001|Overall Study|Death|3
2027280|NCT00358917|3596407|FG000|Overall Study|Virologic failure|11
2027281|NCT00358917|3596408|FG001|Overall Study|Virologic failure|8
2027282|NCT00358917|3596407|FG000|Overall Study|Unable to Continue Participation|2
2027283|NCT00358917|3596408|FG001|Overall Study|Unable to Continue Participation|2
2027284|NCT00358956|3596416|FG000|Overall Study|Adverse Event|3
2027285|NCT00358956|3596416|FG000|Overall Study|condition under investigation worsened|4
2027286|NCT00358956|3596416|FG000|Overall Study|Withdrawal by Subject|1
2027287|NCT00359021|3596422|FG000|Overall Study|Adverse Event|26
2027288|NCT00359021|3596423|FG001|Overall Study|Adverse Event|8
2027289|NCT00359021|3596422|FG000|Overall Study|Subject Non-Compliant|1
2027290|NCT00359021|3596423|FG001|Overall Study|Subject Non-Compliant|2
2027291|NCT00359021|3596422|FG000|Overall Study|Subject Ineligible To Continue The Trial|1
2027292|NCT00359021|3596423|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
2027293|NCT00359021|3596422|FG000|Overall Study|Subject Reached A Virologic Endpoint|45
2027294|NCT00359021|3596423|FG001|Overall Study|Subject Reached A Virologic Endpoint|32
2027295|NCT00359021|3596422|FG000|Overall Study|Withdrawal by Subject|2
2027296|NCT00359021|3596423|FG001|Overall Study|Withdrawal by Subject|9
2108990|NCT00883493|3703116|FG001|Overall Study|Adverse Event|12
2108991|NCT00883493|3703115|FG000|Overall Study|Lack of Efficacy|4
2108992|NCT00883493|3703116|FG001|Overall Study|Lack of Efficacy|3
2108993|NCT00883493|3703115|FG000|Overall Study|Lost to Follow-up|7
2108994|NCT00883493|3703116|FG001|Overall Study|Lost to Follow-up|6
2108995|NCT00883493|3703115|FG000|Overall Study|Withdrawal by Subject|11
2108996|NCT00883493|3703116|FG001|Overall Study|Withdrawal by Subject|20
2108997|NCT00883493|3703115|FG000|Overall Study|Eligibility Criteria not fullfilled|6
2108998|NCT00883493|3703116|FG001|Overall Study|Eligibility Criteria not fullfilled|6
2108999|NCT00883493|3703115|FG000|Overall Study|Study specific disc. criteria|2
2109000|NCT00883493|3703116|FG001|Overall Study|Study specific disc. criteria|0
2109001|NCT00883493|3703115|FG000|Overall Study|Other|5
2109002|NCT00883493|3703116|FG001|Overall Study|Other|3
2180213|NCT01399697|3806176|FG001|Overall Study|Positive result for hepatitis B|0
2180214|NCT01399697|3806177|FG002|Overall Study|Positive result for hepatitis B|0
2180215|NCT01399697|3806175|FG000|Overall Study|Clinical RA remission|1
2180216|NCT01399697|3806176|FG001|Overall Study|Clinical RA remission|0
2180217|NCT01399697|3806177|FG002|Overall Study|Clinical RA remission|0
2180218|NCT01399697|3806175|FG000|Overall Study|Sponsor Decision|1
2180219|NCT01399697|3806176|FG001|Overall Study|Sponsor Decision|0
2180220|NCT01399697|3806177|FG002|Overall Study|Sponsor Decision|0
2180221|NCT01399723|3806190|FG000|Overall Study|Lost to Follow-up|0
2180222|NCT01399723|3806191|FG001|Overall Study|Lost to Follow-up|1
2180223|NCT01399736|3806200|FG000|Overall Study|Withdrawal by Subject|4
2180224|NCT01399736|3806201|FG001|Overall Study|Withdrawal by Subject|2
2180225|NCT01399736|3806200|FG000|Overall Study|Lost to Follow-up|0
2180226|NCT01399736|3806201|FG001|Overall Study|Lost to Follow-up|2
2180227|NCT01399788|3806215|FG000|First Intervention Period|Adverse Event|1
2027297|NCT00359021|3596422|FG000|Overall Study|Lost to Follow-up|1
2180228|NCT01399788|3806216|FG001|First Intervention Period|Adverse Event|0
2027298|NCT00359021|3596423|FG001|Overall Study|Lost to Follow-up|0
2027299|NCT00359021|3596422|FG000|Overall Study|Other|4
2027300|NCT00359021|3596423|FG001|Overall Study|Other|1
2027301|NCT00359021|3596422|FG000|Overall Study|Pregnancy|1
2027302|NCT00359021|3596423|FG001|Overall Study|Pregnancy|0
2027303|NCT00359073|3596433|FG000|Overall Study|Withdrawal by Subject|1
2027304|NCT00359073|3596434|FG001|Overall Study|Withdrawal by Subject|1
2027305|NCT00359073|3596433|FG000|Overall Study|Eligibility criteria no longer met|3
2027306|NCT00359073|3596434|FG001|Overall Study|Eligibility criteria no longer met|0
2027307|NCT00359073|3596433|FG000|Overall Study|developed RV16 antibody|0
2027308|NCT00359073|3596434|FG001|Overall Study|developed RV16 antibody|1
2027309|NCT00359281|3596460|FG000|Overall Study|Adverse Event|1
2027310|NCT00359281|3596461|FG001|Overall Study|Adverse Event|0
2027311|NCT00359281|3596462|FG002|Overall Study|Adverse Event|0
2027312|NCT00359281|3596463|FG003|Overall Study|Adverse Event|0
2027313|NCT00359281|3596464|FG004|Overall Study|Adverse Event|0
2027314|NCT00359281|3596465|FG005|Overall Study|Adverse Event|0
2027315|NCT00359281|3596466|FG006|Overall Study|Adverse Event|1
2027316|NCT00359281|3596467|FG007|Overall Study|Adverse Event|0
2027317|NCT00359281|3596468|FG008|Overall Study|Adverse Event|0
2027318|NCT00359281|3596460|FG000|Overall Study|Withdrawal by Subject|0
2027319|NCT00359281|3596461|FG001|Overall Study|Withdrawal by Subject|0
2027320|NCT00359281|3596462|FG002|Overall Study|Withdrawal by Subject|0
2027321|NCT00359281|3596463|FG003|Overall Study|Withdrawal by Subject|0
2027322|NCT00359281|3596464|FG004|Overall Study|Withdrawal by Subject|0
2027323|NCT00359281|3596465|FG005|Overall Study|Withdrawal by Subject|0
2027324|NCT00359281|3596466|FG006|Overall Study|Withdrawal by Subject|1
2027325|NCT00359281|3596467|FG007|Overall Study|Withdrawal by Subject|0
2027326|NCT00359281|3596468|FG008|Overall Study|Withdrawal by Subject|0
2027327|NCT00359294|3596500|FG000|Overall Study|Progressive disease|1
2027328|NCT00359294|3596501|FG001|Overall Study|Progressive disease|1
2027329|NCT00359294|3596502|FG002|Overall Study|Progressive disease|2
2027330|NCT00359294|3596503|FG003|Overall Study|Progressive disease|3
2027331|NCT00359294|3596504|FG004|Overall Study|Progressive disease|2
2027332|NCT00359294|3596500|FG000|Overall Study|Withdrawal by Subject|0
2027333|NCT00359294|3596501|FG001|Overall Study|Withdrawal by Subject|0
2027334|NCT00359294|3596502|FG002|Overall Study|Withdrawal by Subject|0
2027335|NCT00359294|3596503|FG003|Overall Study|Withdrawal by Subject|0
2027336|NCT00359294|3596504|FG004|Overall Study|Withdrawal by Subject|1
2027337|NCT00359294|3596500|FG000|Overall Study|Not treated|0
2027338|NCT00359294|3596501|FG001|Overall Study|Not treated|0
2027339|NCT00359294|3596502|FG002|Overall Study|Not treated|0
2027340|NCT00359294|3596503|FG003|Overall Study|Not treated|1
2027341|NCT00359294|3596504|FG004|Overall Study|Not treated|0
2027342|NCT00359294|3596500|FG000|Overall Study|Physician Decision|0
2027343|NCT00359294|3596501|FG001|Overall Study|Physician Decision|0
2027344|NCT00359294|3596502|FG002|Overall Study|Physician Decision|1
2027345|NCT00359294|3596503|FG003|Overall Study|Physician Decision|0
2217732|NCT01709500|3860990|FG001|Overall Study|Poor compliance to protocol|1
2027346|NCT00359294|3596504|FG004|Overall Study|Physician Decision|0
2027347|NCT00359424|3596514|FG000|Overall Study|Death|99
2027348|NCT00359424|3596515|FG001|Overall Study|Death|58
2027349|NCT00359424|3596514|FG000|Overall Study|Lost to Follow-up|19
2027350|NCT00359424|3596515|FG001|Overall Study|Lost to Follow-up|7
2027351|NCT00359424|3596514|FG000|Overall Study|Withdrawal by Subject|10
2027352|NCT00359424|3596515|FG001|Overall Study|Withdrawal by Subject|2
2027353|NCT00359424|3596514|FG000|Overall Study|follow up not conducted|2
2027354|NCT00359424|3596515|FG001|Overall Study|follow up not conducted|0
2027355|NCT00359619|3596528|FG000|Overall Study|Adverse Event|0
2027356|NCT00359619|3596529|FG001|Overall Study|Adverse Event|0
2027357|NCT00359619|3596530|FG002|Overall Study|Adverse Event|1
2027358|NCT00359619|3596531|FG003|Overall Study|Adverse Event|0
2027359|NCT00359619|3596532|FG004|Overall Study|Adverse Event|0
2027360|NCT00359619|3596533|FG005|Overall Study|Adverse Event|0
2027361|NCT00359619|3596534|FG006|Overall Study|Adverse Event|1
2027362|NCT00359619|3596528|FG000|Overall Study|Withdrawal by Subject|3
2027363|NCT00359619|3596529|FG001|Overall Study|Withdrawal by Subject|1
2027364|NCT00359619|3596530|FG002|Overall Study|Withdrawal by Subject|4
2027365|NCT00359619|3596531|FG003|Overall Study|Withdrawal by Subject|2
2027366|NCT00359619|3596532|FG004|Overall Study|Withdrawal by Subject|2
2027367|NCT00359619|3596533|FG005|Overall Study|Withdrawal by Subject|0
2027368|NCT00359619|3596534|FG006|Overall Study|Withdrawal by Subject|3
2027369|NCT00359619|3596528|FG000|Overall Study|Other|1
2027370|NCT00359619|3596529|FG001|Overall Study|Other|0
2027371|NCT00359619|3596530|FG002|Overall Study|Other|0
2027372|NCT00359619|3596531|FG003|Overall Study|Other|0
2027373|NCT00359619|3596532|FG004|Overall Study|Other|0
2027374|NCT00359619|3596533|FG005|Overall Study|Other|0
2027375|NCT00359619|3596534|FG006|Overall Study|Other|0
2027376|NCT00359619|3596528|FG000|Overall Study|Lost to Follow-up|4
2027377|NCT00359619|3596529|FG001|Overall Study|Lost to Follow-up|4
2027378|NCT00359619|3596530|FG002|Overall Study|Lost to Follow-up|2
2027379|NCT00359619|3596531|FG003|Overall Study|Lost to Follow-up|1
2027380|NCT00359619|3596532|FG004|Overall Study|Lost to Follow-up|1
2027381|NCT00359619|3596533|FG005|Overall Study|Lost to Follow-up|5
2027382|NCT00359619|3596534|FG006|Overall Study|Lost to Follow-up|0
2027383|NCT00359632|3596552|FG000|Overall Study|Death|2
2027384|NCT00359632|3596553|FG001|Overall Study|Death|0
2027385|NCT00359632|3596552|FG000|Overall Study|Adverse Event|1
2027386|NCT00359632|3596553|FG001|Overall Study|Adverse Event|0
2027387|NCT00359632|3596552|FG000|Overall Study|Non-compliance with visit schedule|1
2027388|NCT00359632|3596553|FG001|Overall Study|Non-compliance with visit schedule|0
2027389|NCT00359762|3596572|FG000|Period II|Adverse Event|17
2027390|NCT00359762|3596573|FG001|Period II|Adverse Event|0
2027391|NCT00359762|3596574|FG002|Period II|Adverse Event|0
2027392|NCT00359762|3596575|FG003|Period II|Adverse Event|0
2027393|NCT00359762|3596576|FG004|Period II|Adverse Event|49
2027394|NCT00359762|3596572|FG000|Period II|Protocol Violation|18
2027395|NCT00359762|3596573|FG001|Period II|Protocol Violation|0
2027396|NCT00359762|3596574|FG002|Period II|Protocol Violation|0
2027397|NCT00359762|3596575|FG003|Period II|Protocol Violation|0
2027398|NCT00359762|3596576|FG004|Period II|Protocol Violation|11
2027399|NCT00359762|3596572|FG000|Period II|Physician Decision|17
2027400|NCT00359762|3596573|FG001|Period II|Physician Decision|0
2027401|NCT00359762|3596574|FG002|Period II|Physician Decision|0
2027402|NCT00359762|3596575|FG003|Period II|Physician Decision|0
2027403|NCT00359762|3596576|FG004|Period II|Physician Decision|23
2027404|NCT00359762|3596572|FG000|Period II|Death|2
2027405|NCT00359762|3596573|FG001|Period II|Death|0
2027406|NCT00359762|3596574|FG002|Period II|Death|0
2027407|NCT00359762|3596575|FG003|Period II|Death|0
2027408|NCT00359762|3596576|FG004|Period II|Death|4
2027409|NCT00359762|3596572|FG000|Period II|Lack of Efficacy|11
2027410|NCT00359762|3596573|FG001|Period II|Lack of Efficacy|0
2027411|NCT00359762|3596574|FG002|Period II|Lack of Efficacy|0
2027412|NCT00359762|3596575|FG003|Period II|Lack of Efficacy|0
2027413|NCT00359762|3596576|FG004|Period II|Lack of Efficacy|8
2027414|NCT00359762|3596572|FG000|Period II|Lost to follow up|5
2027415|NCT00359762|3596573|FG001|Period II|Lost to follow up|0
2027416|NCT00359762|3596574|FG002|Period II|Lost to follow up|0
2027417|NCT00359762|3596575|FG003|Period II|Lost to follow up|0
2027418|NCT00359762|3596576|FG004|Period II|Lost to follow up|5
2027419|NCT00359762|3596572|FG000|Period II|Entry Criteria Not Met|8
2027420|NCT00359762|3596573|FG001|Period II|Entry Criteria Not Met|0
2027421|NCT00359762|3596574|FG002|Period II|Entry Criteria Not Met|0
2027422|NCT00359762|3596575|FG003|Period II|Entry Criteria Not Met|0
2027423|NCT00359762|3596576|FG004|Period II|Entry Criteria Not Met|4
2027424|NCT00359762|3596572|FG000|Period II|Subject Decision|50
2027425|NCT00359762|3596573|FG001|Period II|Subject Decision|0
2027426|NCT00359762|3596574|FG002|Period II|Subject Decision|0
2027427|NCT00359762|3596575|FG003|Period II|Subject Decision|0
2027428|NCT00359762|3596576|FG004|Period II|Subject Decision|70
2027429|NCT00359762|3596572|FG000|Period III|Protocol Violation|0
2027430|NCT00359762|3596573|FG001|Period III|Protocol Violation|5
2027431|NCT00359762|3596574|FG002|Period III|Protocol Violation|3
2027432|NCT00359762|3596575|FG003|Period III|Protocol Violation|8
2027433|NCT00359762|3596576|FG004|Period III|Protocol Violation|0
2027434|NCT00359762|3596572|FG000|Period III|Adverse Event|0
2027435|NCT00359762|3596573|FG001|Period III|Adverse Event|3
2027436|NCT00359762|3596574|FG002|Period III|Adverse Event|4
2027437|NCT00359762|3596575|FG003|Period III|Adverse Event|10
2027438|NCT00359762|3596576|FG004|Period III|Adverse Event|0
2027439|NCT00359762|3596572|FG000|Period III|Physician Decision|0
2027440|NCT00359762|3596573|FG001|Period III|Physician Decision|5
2027441|NCT00359762|3596574|FG002|Period III|Physician Decision|9
2027442|NCT00359762|3596575|FG003|Period III|Physician Decision|15
2027443|NCT00359762|3596576|FG004|Period III|Physician Decision|0
2027444|NCT00359762|3596572|FG000|Period III|Lack of Efficacy|0
2027445|NCT00359762|3596573|FG001|Period III|Lack of Efficacy|7
2027446|NCT00359762|3596574|FG002|Period III|Lack of Efficacy|5
2027447|NCT00359762|3596575|FG003|Period III|Lack of Efficacy|9
2027448|NCT00359762|3596576|FG004|Period III|Lack of Efficacy|0
2027449|NCT00359762|3596572|FG000|Period III|Lost to follow up|0
2027450|NCT00359762|3596573|FG001|Period III|Lost to follow up|1
2027451|NCT00359762|3596574|FG002|Period III|Lost to follow up|1
2027452|NCT00359762|3596575|FG003|Period III|Lost to follow up|2
2027453|NCT00359762|3596576|FG004|Period III|Lost to follow up|0
2027454|NCT00359762|3596572|FG000|Period III|Entry Criteria Not Met|0
2027455|NCT00359762|3596573|FG001|Period III|Entry Criteria Not Met|1
2027456|NCT00359762|3596574|FG002|Period III|Entry Criteria Not Met|0
2027457|NCT00359762|3596575|FG003|Period III|Entry Criteria Not Met|1
2027458|NCT00359762|3596576|FG004|Period III|Entry Criteria Not Met|0
2027459|NCT00359762|3596572|FG000|Period III|Subject Decision|0
2027460|NCT00359762|3596573|FG001|Period III|Subject Decision|7
2027461|NCT00359762|3596574|FG002|Period III|Subject Decision|8
2027462|NCT00359762|3596575|FG003|Period III|Subject Decision|20
2027463|NCT00359762|3596576|FG004|Period III|Subject Decision|0
2027464|NCT00359788|3596592|FG000|Overall Study|Adverse Event|11
2027465|NCT00359788|3596593|FG001|Overall Study|Adverse Event|10
2027466|NCT00359788|3596592|FG000|Overall Study|Lack of Efficacy|1
2027467|NCT00359788|3596593|FG001|Overall Study|Lack of Efficacy|2
2027468|NCT00359788|3596592|FG000|Overall Study|Lost to Follow-up|3
2027469|NCT00359788|3596593|FG001|Overall Study|Lost to Follow-up|2
2027470|NCT00359788|3596592|FG000|Overall Study|Withdrawal by Subject|4
2027471|NCT00359788|3596593|FG001|Overall Study|Withdrawal by Subject|1
2027472|NCT00359788|3596592|FG000|Overall Study|Protocol Violation|4
2027473|NCT00359788|3596593|FG001|Overall Study|Protocol Violation|2
2027474|NCT00359801|3596601|FG000|Overall Study|Lost to Follow-up|72
2027475|NCT00359801|3596602|FG001|Overall Study|Lost to Follow-up|58
2027476|NCT00359801|3596601|FG000|Overall Study|Withdrawal by Subject|143
2027477|NCT00359801|3596602|FG001|Overall Study|Withdrawal by Subject|96
2027478|NCT00359801|3596601|FG000|Overall Study|Other|66
2027479|NCT00359801|3596602|FG001|Overall Study|Other|46
2027480|NCT00359801|3596601|FG000|Overall Study|Final Status Unknown: missing data|7
2027481|NCT00359801|3596602|FG001|Overall Study|Final Status Unknown: missing data|4
2027482|NCT00359801|3596601|FG000|Overall Study|Sponsor Decision|17
2027483|NCT00359801|3596602|FG001|Overall Study|Sponsor Decision|16
2027484|NCT00360230|3596658|FG000|Overall Study|Withdrawal by Subject|1
2027485|NCT00360230|3596659|FG001|Overall Study|Withdrawal by Subject|1
2027486|NCT00360230|3596660|FG002|Overall Study|Withdrawal by Subject|0
2027487|NCT00360230|3596661|FG003|Overall Study|Withdrawal by Subject|1
2027488|NCT00360230|3596662|FG004|Overall Study|Withdrawal by Subject|1
2027489|NCT00360230|3596663|FG005|Overall Study|Withdrawal by Subject|1
2027490|NCT00360230|3596664|FG006|Overall Study|Withdrawal by Subject|0
2027491|NCT00360230|3596658|FG000|Overall Study|Migrated|4
2027492|NCT00360230|3596659|FG001|Overall Study|Migrated|1
2027493|NCT00360230|3596660|FG002|Overall Study|Migrated|3
2027494|NCT00360230|3596661|FG003|Overall Study|Migrated|1
2027495|NCT00360230|3596662|FG004|Overall Study|Migrated|4
2027496|NCT00360230|3596663|FG005|Overall Study|Migrated|1
2027497|NCT00360230|3596664|FG006|Overall Study|Migrated|1
2027498|NCT00360230|3596658|FG000|Overall Study|Other|1
2027499|NCT00360230|3596659|FG001|Overall Study|Other|0
2027500|NCT00360230|3596660|FG002|Overall Study|Other|0
2027501|NCT00360230|3596661|FG003|Overall Study|Other|0
2027502|NCT00360230|3596662|FG004|Overall Study|Other|0
2027503|NCT00360230|3596663|FG005|Overall Study|Other|0
2027504|NCT00360230|3596664|FG006|Overall Study|Other|0
2027505|NCT00360230|3596658|FG000|Overall Study|Protocol Violation|0
2027506|NCT00360230|3596659|FG001|Overall Study|Protocol Violation|0
2027507|NCT00360230|3596660|FG002|Overall Study|Protocol Violation|0
2027508|NCT00360230|3596661|FG003|Overall Study|Protocol Violation|0
2027509|NCT00360230|3596662|FG004|Overall Study|Protocol Violation|0
2027510|NCT00360230|3596663|FG005|Overall Study|Protocol Violation|1
2027511|NCT00360230|3596664|FG006|Overall Study|Protocol Violation|0
2027512|NCT00360230|3596658|FG000|Overall Study|Death|0
2027513|NCT00360230|3596659|FG001|Overall Study|Death|1
2027514|NCT00360230|3596660|FG002|Overall Study|Death|0
2027515|NCT00360230|3596661|FG003|Overall Study|Death|0
2027516|NCT00360230|3596662|FG004|Overall Study|Death|0
2027517|NCT00360230|3596663|FG005|Overall Study|Death|1
2027518|NCT00360230|3596664|FG006|Overall Study|Death|1
2027519|NCT00360269|3596701|FG000|Overall Study|Lost to Follow-up|7
2027520|NCT00360269|3596702|FG001|Overall Study|Lost to Follow-up|9
2027521|NCT00360269|3596701|FG000|Overall Study|Physician Decision|1
2027522|NCT00360269|3596702|FG001|Overall Study|Physician Decision|2
2027523|NCT00360269|3596701|FG000|Overall Study|Adverse Event|1
2027524|NCT00360269|3596702|FG001|Overall Study|Adverse Event|0
2027525|NCT00360269|3596701|FG000|Overall Study|Withdrawal by Subject|1
2027526|NCT00360269|3596702|FG001|Overall Study|Withdrawal by Subject|1
2027527|NCT00360282|3596708|FG000|Washout 1-3 Weeks|Lost to Follow-up|0
2027528|NCT00360282|3596709|FG001|Washout 1-3 Weeks|Lost to Follow-up|0
2027529|NCT00360282|3596710|FG002|Washout 1-3 Weeks|Lost to Follow-up|1
2027530|NCT00360282|3596711|FG003|Washout 1-3 Weeks|Lost to Follow-up|0
2027531|NCT00360282|3596708|FG000|Second Intervention|Adverse Event|0
2027532|NCT00360282|3596709|FG001|Second Intervention|Adverse Event|1
2027533|NCT00360282|3596710|FG002|Second Intervention|Adverse Event|0
2027534|NCT00360282|3596711|FG003|Second Intervention|Adverse Event|0
2027535|NCT00360308|3596722|FG000|Overall Study|Adverse Event|15
2027536|NCT00360308|3596723|FG001|Overall Study|Adverse Event|14
2027537|NCT00360308|3596724|FG002|Overall Study|Adverse Event|25
2027538|NCT00360308|3596722|FG000|Overall Study|Abnormal Laboratory Value(s)|0
2027539|NCT00360308|3596723|FG001|Overall Study|Abnormal Laboratory Value(s)|1
2027540|NCT00360308|3596724|FG002|Overall Study|Abnormal Laboratory Value(s)|0
2027541|NCT00360308|3596722|FG000|Overall Study|Protocol Violation|2
2027542|NCT00360308|3596723|FG001|Overall Study|Protocol Violation|1
2027543|NCT00360308|3596724|FG002|Overall Study|Protocol Violation|2
2027544|NCT00360308|3596722|FG000|Overall Study|Withdrawal by Subject|11
2027545|NCT00360308|3596723|FG001|Overall Study|Withdrawal by Subject|7
2027546|NCT00360308|3596724|FG002|Overall Study|Withdrawal by Subject|14
2027547|NCT00360308|3596722|FG000|Overall Study|Lack of Efficacy|3
2027548|NCT00360308|3596723|FG001|Overall Study|Lack of Efficacy|0
2027549|NCT00360308|3596724|FG002|Overall Study|Lack of Efficacy|2
2027550|NCT00360308|3596722|FG000|Overall Study|Other|2
2027551|NCT00360308|3596723|FG001|Overall Study|Other|1
2027552|NCT00360308|3596724|FG002|Overall Study|Other|1
2027553|NCT00360308|3596722|FG000|Overall Study|Study termination by sponsor|43
2027554|NCT00360308|3596723|FG001|Overall Study|Study termination by sponsor|55
2027555|NCT00360308|3596724|FG002|Overall Study|Study termination by sponsor|44
2027556|NCT00360334|3596738|FG000|Overall Study|Adverse Event|7
2027557|NCT00360334|3596739|FG001|Overall Study|Adverse Event|4
2027558|NCT00360334|3596738|FG000|Overall Study|Protocol Violation|1
2027559|NCT00360334|3596739|FG001|Overall Study|Protocol Violation|1
2027560|NCT00360334|3596738|FG000|Overall Study|Physician Decision|2
2027561|NCT00360334|3596739|FG001|Overall Study|Physician Decision|3
2027562|NCT00360334|3596738|FG000|Overall Study|Lack of Efficacy|0
2027563|NCT00360334|3596739|FG001|Overall Study|Lack of Efficacy|1
2027564|NCT00360334|3596738|FG000|Overall Study|Entry criterion not met|1
2027565|NCT00360334|3596739|FG001|Overall Study|Entry criterion not met|2
2027566|NCT00360334|3596738|FG000|Overall Study|Subject decision|8
2027567|NCT00360334|3596739|FG001|Overall Study|Subject decision|2
2027568|NCT00360412|3596764|FG000|Overall Study|Adverse Event|37
2027569|NCT00360412|3596765|FG001|Overall Study|Adverse Event|65
2027570|NCT00360412|3596764|FG000|Overall Study|Protocol Violation|2
2027571|NCT00360412|3596765|FG001|Overall Study|Protocol Violation|5
2027572|NCT00360412|3596764|FG000|Overall Study|Patient withdrew consent|27
2027573|NCT00360412|3596765|FG001|Overall Study|Patient withdrew consent|52
2027574|NCT00360412|3596764|FG000|Overall Study|Lack of therapeutic efficacy|46
2027575|NCT00360412|3596765|FG001|Overall Study|Lack of therapeutic efficacy|61
2027576|NCT00360412|3596764|FG000|Overall Study|Physician Decision|2
2027577|NCT00360412|3596765|FG001|Overall Study|Physician Decision|4
2027578|NCT00360412|3596764|FG000|Overall Study|Other|5
2027579|NCT00360412|3596765|FG001|Overall Study|Other|6
2027580|NCT00360412|3596764|FG000|Overall Study|Study termination by Sponsor|214
2027581|NCT00360412|3596765|FG001|Overall Study|Study termination by Sponsor|469
2027582|NCT00360490|3596773|FG000|Overall Study|Adverse Event|4
2027583|NCT00360490|3596774|FG001|Overall Study|Adverse Event|2
2027584|NCT00360490|3596773|FG000|Overall Study|Lost to Follow-up|2
2027585|NCT00360490|3596774|FG001|Overall Study|Lost to Follow-up|1
2027586|NCT00360490|3596773|FG000|Overall Study|Physician Decision|2
2027587|NCT00360490|3596774|FG001|Overall Study|Physician Decision|1
2027588|NCT00360490|3596773|FG000|Overall Study|Protocol Violation|0
2027589|NCT00360490|3596774|FG001|Overall Study|Protocol Violation|4
2027590|NCT00360490|3596773|FG000|Overall Study|Withdrawal by Subject|1
2027591|NCT00360490|3596774|FG001|Overall Study|Withdrawal by Subject|3
2027592|NCT00360529|3596783|FG000|Overall Study|Adverse Event|10
2027593|NCT00360529|3596784|FG001|Overall Study|Adverse Event|23
2027594|NCT00360529|3596785|FG002|Overall Study|Adverse Event|33
2027595|NCT00360529|3596783|FG000|Overall Study|Protocol Violation|3
2027596|NCT00360529|3596784|FG001|Overall Study|Protocol Violation|3
2027597|NCT00360529|3596785|FG002|Overall Study|Protocol Violation|11
2027598|NCT00360529|3596783|FG000|Overall Study|Lost to Follow-up|14
2027599|NCT00360529|3596784|FG001|Overall Study|Lost to Follow-up|10
2027600|NCT00360529|3596785|FG002|Overall Study|Lost to Follow-up|13
2027601|NCT00360529|3596783|FG000|Overall Study|Withdrawal by Subject|22
2027602|NCT00360529|3596784|FG001|Overall Study|Withdrawal by Subject|14
2027603|NCT00360529|3596785|FG002|Overall Study|Withdrawal by Subject|18
2027604|NCT00360529|3596783|FG000|Overall Study|Lack of Efficacy|8
2027605|NCT00360529|3596784|FG001|Overall Study|Lack of Efficacy|6
2027606|NCT00360529|3596785|FG002|Overall Study|Lack of Efficacy|5
2027607|NCT00360529|3596783|FG000|Overall Study|Reason discontinued not explained above|4
2027608|NCT00360529|3596784|FG001|Overall Study|Reason discontinued not explained above|9
2027609|NCT00360529|3596785|FG002|Overall Study|Reason discontinued not explained above|11
2027610|NCT00360568|3596812|FG000|Overall Study|Adverse Event|1
2027611|NCT00360568|3596813|FG001|Overall Study|Adverse Event|2
2027612|NCT00360568|3596812|FG000|Overall Study|Lack of Efficacy|1
2027613|NCT00360568|3596813|FG001|Overall Study|Lack of Efficacy|0
2027614|NCT00360568|3596812|FG000|Overall Study|Withdrawal by Subject|0
2027615|NCT00360568|3596813|FG001|Overall Study|Withdrawal by Subject|3
2027616|NCT00360698|3596837|FG000|Run-In|Physician Decision|0
2027617|NCT00360698|3596838|FG001|Run-In|Physician Decision|1
2027618|NCT00360698|3596837|FG000|Run-In|Withdrawal by Subject|0
2027619|NCT00360698|3596838|FG001|Run-In|Withdrawal by Subject|2
2027620|NCT00360698|3596837|FG000|Run-In|Non compliance with treatment procedure|0
2027621|NCT00360698|3596838|FG001|Run-In|Non compliance with treatment procedure|1
2027622|NCT00360698|3596837|FG000|Run-In|Sponsor request|0
2109003|NCT00883558|3703122|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
2109004|NCT00883558|3703123|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
2109005|NCT00883558|3703124|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
2109006|NCT00883558|3703122|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
2109007|NCT00883558|3703123|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
2109008|NCT00883558|3703124|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
2109009|NCT00883558|3703122|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
2109010|NCT00883558|3703123|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
2109011|NCT00883558|3703124|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
2109012|NCT00883558|3703122|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
2109013|NCT00883558|3703123|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
2109014|NCT00883558|3703124|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
2109015|NCT00883558|3703122|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
2109016|NCT00883558|3703123|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
2109017|NCT00883558|3703124|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
2109018|NCT00883688|3703134|FG000|Overall Study|Ineligible|2
2027623|NCT00360698|3596838|FG001|Run-In|Sponsor request|2
2027624|NCT00360698|3596837|FG000|Run-In|Patient did not meet inclusion criteria|0
2027625|NCT00360698|3596838|FG001|Run-In|Patient did not meet inclusion criteria|1
2027626|NCT00360698|3596837|FG000|Run-In|Patient personal reasons|0
2027627|NCT00360698|3596838|FG001|Run-In|Patient personal reasons|2
2027628|NCT00360698|3596837|FG000|Run-In|Need of insulin with meals|0
2027629|NCT00360698|3596838|FG001|Run-In|Need of insulin with meals|1
2027630|NCT00360698|3596837|FG000|Treatment Period|Non compliance with treatment procedure|1
2027631|NCT00360698|3596838|FG001|Treatment Period|Non compliance with treatment procedure|0
2027632|NCT00360698|3596837|FG000|Treatment Period|Early termination by error|0
2027633|NCT00360698|3596838|FG001|Treatment Period|Early termination by error|1
2027634|NCT00361218|3596882|FG000|Overall Study|Lost to Follow-up|11
2027635|NCT00361218|3596882|FG000|Overall Study|Personal Reasons|7
2027636|NCT00361218|3596882|FG000|Overall Study|terminated / withdrawn due to toxicity /|5
2027637|NCT00361231|3596886|FG000|Overall Study|Physician Decision|3
2027638|NCT00361231|3596886|FG000|Overall Study|Symptomatic deterioration|5
2027639|NCT00361231|3596886|FG000|Overall Study|Radiographic disease progression|16
2027640|NCT00361231|3596886|FG000|Overall Study|Withdrawal by Subject|4
2027641|NCT00361231|3596886|FG000|Overall Study|Adverse Event|6
2027642|NCT00361270|3596905|FG000|Overall Study|Death|0
2027643|NCT00361270|3596906|FG001|Overall Study|Death|0
2027644|NCT00361270|3596907|FG002|Overall Study|Death|0
2027645|NCT00361270|3596908|FG003|Overall Study|Death|2
2027646|NCT00361270|3596905|FG000|Overall Study|Lost to Follow-up|4
2027647|NCT00361270|3596906|FG001|Overall Study|Lost to Follow-up|1
2027648|NCT00361270|3596907|FG002|Overall Study|Lost to Follow-up|0
2027649|NCT00361270|3596908|FG003|Overall Study|Lost to Follow-up|0
2027650|NCT00361270|3596905|FG000|Overall Study|Physician Decision|0
2027651|NCT00361270|3596906|FG001|Overall Study|Physician Decision|0
2027652|NCT00361270|3596907|FG002|Overall Study|Physician Decision|1
2027653|NCT00361270|3596908|FG003|Overall Study|Physician Decision|0
2027654|NCT00361270|3596905|FG000|Overall Study|Protocol Violation|9
2027655|NCT00361270|3596906|FG001|Overall Study|Protocol Violation|4
2027656|NCT00361270|3596907|FG002|Overall Study|Protocol Violation|5
2027657|NCT00361270|3596908|FG003|Overall Study|Protocol Violation|4
2027658|NCT00361270|3596905|FG000|Overall Study|Withdrawal by Subject|6
2027659|NCT00361270|3596906|FG001|Overall Study|Withdrawal by Subject|6
2027660|NCT00361270|3596907|FG002|Overall Study|Withdrawal by Subject|3
2027661|NCT00361270|3596908|FG003|Overall Study|Withdrawal by Subject|7
2027662|NCT00361270|3596905|FG000|Overall Study|Afraid of Hypnosis|1
2027663|NCT00361270|3596906|FG001|Overall Study|Afraid of Hypnosis|2
2027664|NCT00361270|3596907|FG002|Overall Study|Afraid of Hypnosis|0
2027665|NCT00361270|3596908|FG003|Overall Study|Afraid of Hypnosis|0
2027666|NCT00361270|3596905|FG000|Overall Study|Problems with Transportation|4
2027667|NCT00361270|3596906|FG001|Overall Study|Problems with Transportation|0
2027668|NCT00361270|3596907|FG002|Overall Study|Problems with Transportation|0
2027669|NCT00361270|3596908|FG003|Overall Study|Problems with Transportation|0
2027670|NCT00361270|3596905|FG000|Overall Study|Adverse Event|0
2027671|NCT00361270|3596906|FG001|Overall Study|Adverse Event|1
2027672|NCT00361270|3596907|FG002|Overall Study|Adverse Event|1
2027673|NCT00361270|3596908|FG003|Overall Study|Adverse Event|0
2027674|NCT00361283|3596925|FG000|Overall Study|Lost to Follow-up|27
2027675|NCT00361296|3596929|FG000|Overall Study|Physician Decision|1
2027676|NCT00361296|3596929|FG000|Overall Study|Lack of Efficacy|2
2027677|NCT00361335|3596938|FG000|IV Period: Baseline to E0|Adverse Event|9
2027678|NCT00361335|3596939|FG001|IV Period: Baseline to E0|Adverse Event|4
2027679|NCT00361335|3596940|FG002|IV Period: Baseline to E0|Adverse Event|5
2027680|NCT00361335|3596941|FG003|IV Period: Baseline to E0|Adverse Event|9
2027681|NCT00361335|3596942|FG004|IV Period: Baseline to E0|Adverse Event|8
2027682|NCT00361335|3596943|FG005|IV Period: Baseline to E0|Adverse Event|0
2027683|NCT00361335|3596944|FG006|IV Period: Baseline to E0|Adverse Event|0
2027684|NCT00361335|3596938|FG000|IV Period: Baseline to E0|Lost to Follow-up|1
2027685|NCT00361335|3596939|FG001|IV Period: Baseline to E0|Lost to Follow-up|0
2027686|NCT00361335|3596940|FG002|IV Period: Baseline to E0|Lost to Follow-up|0
2027687|NCT00361335|3596941|FG003|IV Period: Baseline to E0|Lost to Follow-up|2
2027688|NCT00361335|3596942|FG004|IV Period: Baseline to E0|Lost to Follow-up|2
2027689|NCT00361335|3596943|FG005|IV Period: Baseline to E0|Lost to Follow-up|0
2027690|NCT00361335|3596944|FG006|IV Period: Baseline to E0|Lost to Follow-up|0
2027691|NCT00361335|3596938|FG000|IV Period: Baseline to E0|Death|1
2027692|NCT00361335|3596939|FG001|IV Period: Baseline to E0|Death|1
2027693|NCT00361335|3596940|FG002|IV Period: Baseline to E0|Death|1
2027694|NCT00361335|3596941|FG003|IV Period: Baseline to E0|Death|1
2027695|NCT00361335|3596942|FG004|IV Period: Baseline to E0|Death|0
2027696|NCT00361335|3596943|FG005|IV Period: Baseline to E0|Death|0
2027697|NCT00361335|3596944|FG006|IV Period: Baseline to E0|Death|0
2027698|NCT00361335|3596938|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2
2027699|NCT00361335|3596939|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1
2027700|NCT00361335|3596940|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1
2027701|NCT00361335|3596941|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1
2027702|NCT00361335|3596942|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2
2027703|NCT00361335|3596943|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0
2027704|NCT00361335|3596944|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0
2027705|NCT00361335|3596938|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0
2027706|NCT00361335|3596939|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0
2027707|NCT00361335|3596940|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1
2027708|NCT00361335|3596941|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0
2027709|NCT00361335|3596942|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0
2027710|NCT00361335|3596943|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0
2027711|NCT00361335|3596944|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0
2027712|NCT00361335|3596938|FG000|IV Period: Baseline to E0|Worsening of RA|0
2027713|NCT00361335|3596939|FG001|IV Period: Baseline to E0|Worsening of RA|5
2027714|NCT00361335|3596940|FG002|IV Period: Baseline to E0|Worsening of RA|1
2027715|NCT00361335|3596941|FG003|IV Period: Baseline to E0|Worsening of RA|4
2027716|NCT00361335|3596942|FG004|IV Period: Baseline to E0|Worsening of RA|2
2027717|NCT00361335|3596943|FG005|IV Period: Baseline to E0|Worsening of RA|0
2027718|NCT00361335|3596944|FG006|IV Period: Baseline to E0|Worsening of RA|0
2027719|NCT00361335|3596938|FG000|IV Period: Baseline to E0|Other|2
2027720|NCT00361335|3596939|FG001|IV Period: Baseline to E0|Other|9
2217733|NCT01709500|3860989|FG000|Overall Study|Other|3
2217734|NCT01709500|3860990|FG001|Overall Study|Other|1
2217735|NCT01709500|3860989|FG000|Overall Study|Related to IMP administration|1
2027721|NCT00361335|3596940|FG002|IV Period: Baseline to E0|Other|9
2027722|NCT00361335|3596941|FG003|IV Period: Baseline to E0|Other|3
2027723|NCT00361335|3596942|FG004|IV Period: Baseline to E0|Other|2
2027724|NCT00361335|3596943|FG005|IV Period: Baseline to E0|Other|0
2027725|NCT00361335|3596944|FG006|IV Period: Baseline to E0|Other|0
2027726|NCT00361335|3596938|FG000|IV Period: Baseline to E0|Lack of Efficacy|5
2027727|NCT00361335|3596939|FG001|IV Period: Baseline to E0|Lack of Efficacy|9
2027728|NCT00361335|3596940|FG002|IV Period: Baseline to E0|Lack of Efficacy|3
2027729|NCT00361335|3596941|FG003|IV Period: Baseline to E0|Lack of Efficacy|7
2027730|NCT00361335|3596942|FG004|IV Period: Baseline to E0|Lack of Efficacy|8
2027731|NCT00361335|3596943|FG005|IV Period: Baseline to E0|Lack of Efficacy|0
2027732|NCT00361335|3596944|FG006|IV Period: Baseline to E0|Lack of Efficacy|0
2027733|NCT00361335|3596938|FG000|SC Period: Week E0 to Week E24|Adverse Event|0
2027734|NCT00361335|3596939|FG001|SC Period: Week E0 to Week E24|Adverse Event|2
2027735|NCT00361335|3596940|FG002|SC Period: Week E0 to Week E24|Adverse Event|1
2027736|NCT00361335|3596941|FG003|SC Period: Week E0 to Week E24|Adverse Event|2
2027737|NCT00361335|3596942|FG004|SC Period: Week E0 to Week E24|Adverse Event|0
2027738|NCT00361335|3596943|FG005|SC Period: Week E0 to Week E24|Adverse Event|0
2027739|NCT00361335|3596944|FG006|SC Period: Week E0 to Week E24|Adverse Event|2
2027740|NCT00361335|3596938|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1
2027741|NCT00361335|3596939|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0
2027742|NCT00361335|3596940|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1
2027743|NCT00361335|3596941|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0
2109019|NCT00883740|3703138|FG000|First Intervention|Lost to Follow-up|1
2109020|NCT00883740|3703139|FG001|First Intervention|Lost to Follow-up|0
2109021|NCT00883740|3703138|FG000|First Intervention|No longer willing to participate|2
2109022|NCT00883740|3703139|FG001|First Intervention|No longer willing to participate|0
2109023|NCT00883740|3703138|FG000|First Intervention|Protocol Violation|3
2109024|NCT00883740|3703139|FG001|First Intervention|Protocol Violation|6
2109025|NCT00883740|3703138|FG000|First Intervention|Adverse Event|1
2109026|NCT00883740|3703139|FG001|First Intervention|Adverse Event|2
2109027|NCT00883740|3703138|FG000|Second Intervention|Protocol Violation|1
2109028|NCT00883740|3703139|FG001|Second Intervention|Protocol Violation|0
2109029|NCT00883740|3703138|FG000|Second Intervention|No longer willing to participate|0
2109030|NCT00883740|3703139|FG001|Second Intervention|No longer willing to participate|1
2109031|NCT00883753|3703145|FG000|Overall Study|Adverse Event|37
2109032|NCT00883753|3703145|FG000|Overall Study|Death|2
2109033|NCT00883753|3703145|FG000|Overall Study|Insufficient therapeutic response|16
2109034|NCT00883753|3703145|FG000|Overall Study|Lost to Follow-up|4
2109035|NCT00883753|3703145|FG000|Overall Study|Violation of selection criteria at entry|7
2109036|NCT00883753|3703145|FG000|Overall Study|Protocol Violation|2
2109037|NCT00883753|3703145|FG000|Overall Study|Refused treatment|4
2109038|NCT00883753|3703145|FG000|Overall Study|Withdrew consent|10
2109039|NCT00883753|3703145|FG000|Overall Study|Investigator's decision|17
2109040|NCT00883753|3703145|FG000|Overall Study|Administrative/Other|8
2109041|NCT00883779|3703154|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4
2109042|NCT00883779|3703155|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4
2109043|NCT00883779|3703154|FG000|Primary Study Treatment Phase|Disease progression|75
2109044|NCT00883779|3703155|FG001|Primary Study Treatment Phase|Disease progression|59
2109045|NCT00883779|3703154|FG000|Primary Study Treatment Phase|Adverse Event|16
2109046|NCT00883779|3703155|FG001|Primary Study Treatment Phase|Adverse Event|16
2109047|NCT00883779|3703154|FG000|Primary Study Treatment Phase|Death|2
2109048|NCT00883779|3703155|FG001|Primary Study Treatment Phase|Death|3
2109049|NCT00883779|3703154|FG000|Primary Study Treatment Phase|Refused Treatment|5
2109050|NCT00883779|3703155|FG001|Primary Study Treatment Phase|Refused Treatment|4
2109051|NCT00883779|3703154|FG000|Primary Study Treatment Phase|Other|3
2109052|NCT00883779|3703155|FG001|Primary Study Treatment Phase|Other|0
2109053|NCT00883779|3703154|FG000|Post-Study Treatment Phase|Adverse Event|2
2109054|NCT00883779|3703155|FG001|Post-Study Treatment Phase|Adverse Event|3
2109055|NCT00883779|3703154|FG000|Post-Study Treatment Phase|Death|1
2109056|NCT00883779|3703155|FG001|Post-Study Treatment Phase|Death|3
2109057|NCT00883779|3703154|FG000|Post-Study Treatment Phase|Protocol Violation|0
2027744|NCT00361335|3596942|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0
2027745|NCT00361335|3596943|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0
2027746|NCT00361335|3596944|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1
2027747|NCT00361335|3596938|FG000|SC Period: Week E0 to Week E24|Death|0
2027748|NCT00361335|3596939|FG001|SC Period: Week E0 to Week E24|Death|0
2027749|NCT00361335|3596940|FG002|SC Period: Week E0 to Week E24|Death|0
2027750|NCT00361335|3596941|FG003|SC Period: Week E0 to Week E24|Death|0
2027751|NCT00361335|3596942|FG004|SC Period: Week E0 to Week E24|Death|0
2027752|NCT00361335|3596943|FG005|SC Period: Week E0 to Week E24|Death|0
2027753|NCT00361335|3596944|FG006|SC Period: Week E0 to Week E24|Death|1
2027754|NCT00361335|3596938|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0
2027755|NCT00361335|3596939|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1
2027756|NCT00361335|3596940|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1
2027757|NCT00361335|3596941|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1
2027758|NCT00361335|3596942|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0
2027759|NCT00361335|3596943|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0
2027760|NCT00361335|3596944|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0
2027761|NCT00361335|3596938|FG000|SC Period: Week E0 to Week E24|Other|1
2027762|NCT00361335|3596939|FG001|SC Period: Week E0 to Week E24|Other|0
2027763|NCT00361335|3596940|FG002|SC Period: Week E0 to Week E24|Other|0
2027764|NCT00361335|3596941|FG003|SC Period: Week E0 to Week E24|Other|1
2027765|NCT00361335|3596942|FG004|SC Period: Week E0 to Week E24|Other|0
2027766|NCT00361335|3596943|FG005|SC Period: Week E0 to Week E24|Other|1
2027767|NCT00361335|3596944|FG006|SC Period: Week E0 to Week E24|Other|2
2027768|NCT00361335|3596938|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0
2027769|NCT00361335|3596939|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0
2217736|NCT01709500|3860990|FG001|Overall Study|Related to IMP administration|0
2027770|NCT00361335|3596940|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2
2027771|NCT00361335|3596941|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0
2027772|NCT00361335|3596942|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0
2027773|NCT00361335|3596943|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0
2027774|NCT00361335|3596944|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3
2027775|NCT00361504|3596984|FG000|Overall Study|Withdrawal by Subject|94
2027776|NCT00361504|3596985|FG001|Overall Study|Withdrawal by Subject|31
2027777|NCT00361504|3596984|FG000|Overall Study|Lost to Follow-up|40
2027778|NCT00361504|3596985|FG001|Overall Study|Lost to Follow-up|7
2027779|NCT00361504|3596984|FG000|Overall Study|Adverse Event|203
2027780|NCT00361504|3596985|FG001|Overall Study|Adverse Event|82
2027781|NCT00361504|3596984|FG000|Overall Study|Lack of Efficacy|72
2027782|NCT00361504|3596985|FG001|Overall Study|Lack of Efficacy|7
2027783|NCT00361504|3596984|FG000|Overall Study|Resolution of Pain|2
2027784|NCT00361504|3596985|FG001|Overall Study|Resolution of Pain|0
2027785|NCT00361504|3596984|FG000|Overall Study|Study medication non compliant|42
2027786|NCT00361504|3596985|FG001|Overall Study|Study medication non compliant|15
2027787|NCT00361504|3596984|FG000|Overall Study|All other|28
2027788|NCT00361504|3596985|FG001|Overall Study|All other|3
2027789|NCT00361569|3596995|FG000|Overall Study|Protocol Violation|3
2027790|NCT00361569|3596996|FG001|Overall Study|Protocol Violation|2
2027791|NCT00361569|3596997|FG002|Overall Study|Protocol Violation|4
2027792|NCT00361569|3596998|FG003|Overall Study|Protocol Violation|2
2027793|NCT00361569|3596995|FG000|Overall Study|Withdrawal by Subject|2
2027794|NCT00361569|3596996|FG001|Overall Study|Withdrawal by Subject|1
2027795|NCT00361569|3596997|FG002|Overall Study|Withdrawal by Subject|9
2027796|NCT00361569|3596998|FG003|Overall Study|Withdrawal by Subject|14
2027797|NCT00361569|3596995|FG000|Overall Study|Adverse Event|3
2027798|NCT00361569|3596996|FG001|Overall Study|Adverse Event|5
2027799|NCT00361569|3596997|FG002|Overall Study|Adverse Event|2
2027800|NCT00361569|3596998|FG003|Overall Study|Adverse Event|2
2027801|NCT00361569|3596995|FG000|Overall Study|Lost to Follow-up|2
2027802|NCT00361569|3596996|FG001|Overall Study|Lost to Follow-up|3
2027803|NCT00361569|3596997|FG002|Overall Study|Lost to Follow-up|3
2027804|NCT00361569|3596998|FG003|Overall Study|Lost to Follow-up|2
2109058|NCT00883779|3703155|FG001|Post-Study Treatment Phase|Protocol Violation|1
2109059|NCT00883779|3703154|FG000|Post-Study Treatment Phase|Refused Treatment|3
2109060|NCT00883779|3703155|FG001|Post-Study Treatment Phase|Refused Treatment|0
2109061|NCT00883779|3703154|FG000|Post-Study Treatment Phase|Disease progression|103
2109062|NCT00883779|3703155|FG001|Post-Study Treatment Phase|Disease progression|122
2109063|NCT00883779|3703154|FG000|Post-Study Treatment Phase|Other|3
2109064|NCT00883779|3703155|FG001|Post-Study Treatment Phase|Other|0
2109065|NCT00883779|3703154|FG000|Post-Study Treatment Phase|Ongoing in the study|0
2109066|NCT00883779|3703155|FG001|Post-Study Treatment Phase|Ongoing in the study|6
2109067|NCT00883779|3703154|FG000|Off-study Phase|Death|185
2109068|NCT00883779|3703155|FG001|Off-study Phase|Death|174
2109069|NCT00883779|3703154|FG000|Off-study Phase|Refused treatment|1
2109070|NCT00883779|3703155|FG001|Off-study Phase|Refused treatment|1
2109071|NCT00883779|3703154|FG000|Off-study Phase|Failure to return|5
2109072|NCT00883779|3703155|FG001|Off-study Phase|Failure to return|6
2109073|NCT00883779|3703154|FG000|Off-study Phase|Other|18
2109074|NCT00883779|3703155|FG001|Off-study Phase|Other|21
2109075|NCT00884039|3703163|FG000|Overall Study|Withdrawal by Subject|0
2109076|NCT00884039|3703164|FG001|Overall Study|Withdrawal by Subject|1
2109077|NCT00884039|3703163|FG000|Overall Study|Lack of Efficacy|2
2027805|NCT00361569|3596995|FG000|Overall Study|Not specified by investigator|2
2027806|NCT00361569|3596996|FG001|Overall Study|Not specified by investigator|0
2027807|NCT00361569|3596997|FG002|Overall Study|Not specified by investigator|0
2027808|NCT00361569|3596998|FG003|Overall Study|Not specified by investigator|1
2027809|NCT00361634|3597012|FG000|Overall Study|Lost to Follow-up|1
2027810|NCT00361634|3597012|FG000|Overall Study|Withdrawal by Subject|1
2027811|NCT00361842|3597027|FG000|Overall Study|Withdrawal by Subject|2
2027812|NCT00361842|3597028|FG001|Overall Study|Withdrawal by Subject|3
2027813|NCT00361842|3597027|FG000|Overall Study|Death|2
2027814|NCT00361842|3597028|FG001|Overall Study|Death|1
2027815|NCT00361842|3597027|FG000|Overall Study|Disease progression|19
2027816|NCT00361842|3597028|FG001|Overall Study|Disease progression|20
2027817|NCT00361842|3597027|FG000|Overall Study|Adverse Event|2
2027818|NCT00361842|3597028|FG001|Overall Study|Adverse Event|3
2027819|NCT00361842|3597027|FG000|Overall Study|Occurrence of unacceptable toxicity|1
2027820|NCT00361842|3597028|FG001|Overall Study|Occurrence of unacceptable toxicity|5
2027821|NCT00361842|3597027|FG000|Overall Study|Other|1
2027822|NCT00361842|3597028|FG001|Overall Study|Other|0
2027823|NCT00361842|3597027|FG000|Overall Study|Other|0
2027824|NCT00361842|3597028|FG001|Overall Study|Other|2
2027825|NCT00362115|3597053|FG000|Overall Study|Adverse Event|0
2027826|NCT00362115|3597054|FG001|Overall Study|Adverse Event|1
2027827|NCT00362115|3597055|FG002|Overall Study|Adverse Event|1
2027828|NCT00362115|3597056|FG003|Overall Study|Adverse Event|1
2217737|NCT01709500|3860989|FG000|Overall Study|Treatment ongoing|156
2217738|NCT01709500|3860990|FG001|Overall Study|Treatment ongoing|78
2027829|NCT00362115|3597057|FG004|Overall Study|Adverse Event|2
2273881|NCT02291289|3954589|FG006|Maintenance Treatment Phase|Lost to Follow-up|0
2273882|NCT02291289|3954590|FG007|Maintenance Treatment Phase|Lost to Follow-up|1
2273883|NCT02291289|3954591|FG008|Maintenance Treatment Phase|Lost to Follow-up|0
2273884|NCT02291289|3954592|FG009|Maintenance Treatment Phase|Lost to Follow-up|0
2273885|NCT02291289|3954593|FG010|Maintenance Treatment Phase|Lost to Follow-up|2
2273886|NCT02291289|3954594|FG011|Maintenance Treatment Phase|Lost to Follow-up|1
2273887|NCT02291289|3954583|FG000|Maintenance Treatment Phase|Other|0
2027830|NCT00362115|3597058|FG005|Overall Study|Adverse Event|2
2027831|NCT00362115|3597059|FG006|Overall Study|Adverse Event|1
2027832|NCT00362115|3597053|FG000|Overall Study|Protocol Violation|0
2027833|NCT00362115|3597054|FG001|Overall Study|Protocol Violation|0
2027834|NCT00362115|3597055|FG002|Overall Study|Protocol Violation|0
2027835|NCT00362115|3597056|FG003|Overall Study|Protocol Violation|0
2027836|NCT00362115|3597057|FG004|Overall Study|Protocol Violation|0
2027837|NCT00362115|3597058|FG005|Overall Study|Protocol Violation|1
2027838|NCT00362115|3597059|FG006|Overall Study|Protocol Violation|0
2027839|NCT00362115|3597053|FG000|Overall Study|Lost to Follow-up|0
2027840|NCT00362115|3597054|FG001|Overall Study|Lost to Follow-up|1
2027841|NCT00362115|3597055|FG002|Overall Study|Lost to Follow-up|0
2027842|NCT00362115|3597056|FG003|Overall Study|Lost to Follow-up|0
2027843|NCT00362115|3597057|FG004|Overall Study|Lost to Follow-up|2
2027844|NCT00362115|3597058|FG005|Overall Study|Lost to Follow-up|0
2027845|NCT00362115|3597059|FG006|Overall Study|Lost to Follow-up|1
2027846|NCT00362115|3597053|FG000|Overall Study|Withdrawal by Subject|1
2027847|NCT00362115|3597054|FG001|Overall Study|Withdrawal by Subject|3
2027848|NCT00362115|3597055|FG002|Overall Study|Withdrawal by Subject|1
2027849|NCT00362115|3597056|FG003|Overall Study|Withdrawal by Subject|0
2027850|NCT00362115|3597057|FG004|Overall Study|Withdrawal by Subject|1
2027851|NCT00362115|3597058|FG005|Overall Study|Withdrawal by Subject|3
2027852|NCT00362115|3597059|FG006|Overall Study|Withdrawal by Subject|4
2027853|NCT00362115|3597053|FG000|Overall Study|Lack of Efficacy|1
2027854|NCT00362115|3597054|FG001|Overall Study|Lack of Efficacy|0
2027855|NCT00362115|3597055|FG002|Overall Study|Lack of Efficacy|5
2027856|NCT00362115|3597056|FG003|Overall Study|Lack of Efficacy|2
2027857|NCT00362115|3597057|FG004|Overall Study|Lack of Efficacy|2
2027858|NCT00362115|3597058|FG005|Overall Study|Lack of Efficacy|0
2027859|NCT00362115|3597059|FG006|Overall Study|Lack of Efficacy|3
2027860|NCT00362115|3597053|FG000|Overall Study|Physician Decision|0
2027861|NCT00362115|3597054|FG001|Overall Study|Physician Decision|0
2027862|NCT00362115|3597055|FG002|Overall Study|Physician Decision|0
2027863|NCT00362115|3597056|FG003|Overall Study|Physician Decision|0
2027864|NCT00362115|3597057|FG004|Overall Study|Physician Decision|0
2027865|NCT00362115|3597058|FG005|Overall Study|Physician Decision|0
2027866|NCT00362115|3597059|FG006|Overall Study|Physician Decision|3
2027867|NCT00362115|3597053|FG000|Overall Study|Other|0
2027868|NCT00362115|3597054|FG001|Overall Study|Other|1
2027869|NCT00362115|3597055|FG002|Overall Study|Other|0
2027870|NCT00362115|3597056|FG003|Overall Study|Other|1
2027871|NCT00362115|3597057|FG004|Overall Study|Other|0
2027872|NCT00362115|3597058|FG005|Overall Study|Other|1
2027873|NCT00362115|3597059|FG006|Overall Study|Other|0
2027874|NCT00362180|3597088|FG000|Treated Period|Withdrawal by Subject|1
2027875|NCT00362180|3597089|FG001|Treated Period|Withdrawal by Subject|0
2109078|NCT00884039|3703164|FG001|Overall Study|Lack of Efficacy|0
2109079|NCT00884117|3703186|FG000|Overall Study|Adverse Event|2
2273888|NCT02291289|3954584|FG001|Maintenance Treatment Phase|Other|0
2027876|NCT00362180|3597090|FG002|Treated Period|Withdrawal by Subject|0
2027877|NCT00362180|3597091|FG003|Treated Period|Withdrawal by Subject|0
2027878|NCT00362180|3597092|FG004|Treated Period|Withdrawal by Subject|0
2027879|NCT00362180|3597093|FG005|Treated Period|Withdrawal by Subject|0
2027880|NCT00362180|3597094|FG006|Treated Period|Withdrawal by Subject|0
2027881|NCT00362180|3597095|FG007|Treated Period|Withdrawal by Subject|0
2027882|NCT00362180|3597096|FG008|Treated Period|Withdrawal by Subject|0
2027883|NCT00362180|3597088|FG000|Treated Period|Adverse Event|0
2027884|NCT00362180|3597089|FG001|Treated Period|Adverse Event|0
2027885|NCT00362180|3597090|FG002|Treated Period|Adverse Event|0
2027886|NCT00362180|3597091|FG003|Treated Period|Adverse Event|0
2027887|NCT00362180|3597092|FG004|Treated Period|Adverse Event|0
2027888|NCT00362180|3597093|FG005|Treated Period|Adverse Event|1
2217739|NCT01709513|3860999|FG000|Overall Study|Randomized but not treated|0
2217740|NCT01709513|3861000|FG001|Overall Study|Randomized but not treated|1
2027889|NCT00362180|3597094|FG006|Treated Period|Adverse Event|0
2027890|NCT00362180|3597095|FG007|Treated Period|Adverse Event|1
2027891|NCT00362180|3597096|FG008|Treated Period|Adverse Event|0
2027892|NCT00362232|3597116|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62
2027893|NCT00362232|3597117|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56
2027894|NCT00362232|3597116|FG000|Treatment (12 +/- 2 Days)|Death|1
2027895|NCT00362232|3597117|FG001|Treatment (12 +/- 2 Days)|Death|3
2027896|NCT00362232|3597116|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
2027897|NCT00362232|3597117|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
2027898|NCT00362232|3597116|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2
2027899|NCT00362232|3597117|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5
2027900|NCT00362232|3597116|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22
2027901|NCT00362232|3597117|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21
2027902|NCT00362232|3597116|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
2027903|NCT00362232|3597117|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
2027904|NCT00362232|3597116|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
2027905|NCT00362232|3597117|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
2027906|NCT00362232|3597116|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1
2027907|NCT00362232|3597117|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0
2027908|NCT00362232|3597116|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
2027909|NCT00362232|3597117|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
2027910|NCT00362232|3597116|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2
2027911|NCT00362232|3597117|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3
2027912|NCT00362232|3597116|FG000|Follow-up (30 (+ 5) Days)|Death|1
2027913|NCT00362232|3597117|FG001|Follow-up (30 (+ 5) Days)|Death|1
2027914|NCT00362232|3597116|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
2027915|NCT00362232|3597117|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
2027916|NCT00362232|3597116|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
2027917|NCT00362232|3597117|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
2027918|NCT00362297|3597125|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
2027919|NCT00362297|3597126|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
2027920|NCT00362336|3597135|FG000|Overall Study|Serious Adverse Event|1
2027921|NCT00362336|3597136|FG001|Overall Study|Serious Adverse Event|0
2027922|NCT00362336|3597137|FG002|Overall Study|Serious Adverse Event|1
2027923|NCT00362336|3597135|FG000|Overall Study|Protocol Violation|0
2027924|NCT00362336|3597136|FG001|Overall Study|Protocol Violation|0
2027925|NCT00362336|3597137|FG002|Overall Study|Protocol Violation|1
2027926|NCT00362336|3597135|FG000|Overall Study|Lost to Follow-up|6
2027927|NCT00362336|3597136|FG001|Overall Study|Lost to Follow-up|4
2027928|NCT00362336|3597137|FG002|Overall Study|Lost to Follow-up|0
2027929|NCT00362336|3597135|FG000|Overall Study|Withdrawal by Subject|3
2027930|NCT00362336|3597136|FG001|Overall Study|Withdrawal by Subject|3
2027931|NCT00362336|3597137|FG002|Overall Study|Withdrawal by Subject|1
2027932|NCT00362375|3597154|FG000|Overall Study|Lost to Follow-up|40
2027933|NCT00362375|3597155|FG001|Overall Study|Lost to Follow-up|35
2217741|NCT01709513|3861001|FG002|Overall Study|Randomized but not treated|0
2109080|NCT00884117|3703186|FG000|Overall Study|Withdrawal by Subject|89
2109081|NCT00884117|3703186|FG000|Overall Study|Death|3
2109082|NCT00884117|3703186|FG000|Overall Study|Lost to Follow-up|143
2109083|NCT00884117|3703186|FG000|Overall Study|Other|12
2109084|NCT00884221|3703205|FG000|Overall Study|Withdrawal by Subject|0
2109085|NCT00884221|3703206|FG001|Overall Study|Withdrawal by Subject|3
2109086|NCT00884221|3703205|FG000|Overall Study|Adverse Event|6
2109087|NCT00884221|3703206|FG001|Overall Study|Adverse Event|3
2109088|NCT00884221|3703205|FG000|Overall Study|Protocol Violation|16
2109089|NCT00884221|3703206|FG001|Overall Study|Protocol Violation|13
2109090|NCT00884221|3703205|FG000|Overall Study|Cancellation of Cycle and Other Reason|12
2109091|NCT00884221|3703206|FG001|Overall Study|Cancellation of Cycle and Other Reason|13
2109092|NCT00884273|3703216|FG000|Overall Study|Adverse Event|0
2109093|NCT00884273|3703217|FG001|Overall Study|Adverse Event|2
2109094|NCT00884273|3703216|FG000|Overall Study|Protocol Violation|1
2109095|NCT00884273|3703217|FG001|Overall Study|Protocol Violation|3
2109096|NCT00884273|3703216|FG000|Overall Study|Practical reasons|1
2109097|NCT00884273|3703217|FG001|Overall Study|Practical reasons|0
2109098|NCT00884286|3703225|FG000|Overall Study|Progressive disease|21
2109099|NCT00884286|3703226|FG001|Overall Study|Progressive disease|28
2109100|NCT00884286|3703225|FG000|Overall Study|Toxicity|4
2109101|NCT00884286|3703226|FG001|Overall Study|Toxicity|1
2109102|NCT00884286|3703225|FG000|Overall Study|Death|2
2109103|NCT00884286|3703226|FG001|Overall Study|Death|2
2027934|NCT00362414|3597161|FG000|Overall Study|Death|2
2027935|NCT00362414|3597161|FG000|Overall Study|Adverse Event|1
2027936|NCT00362609|3597197|FG000|Overall Study|Withdrawal by Subject|0
2027937|NCT00362609|3597198|FG001|Overall Study|Withdrawal by Subject|1
2027938|NCT00362609|3597197|FG000|Overall Study|Protocol Violation|0
2027939|NCT00362609|3597198|FG001|Overall Study|Protocol Violation|1
2027940|NCT00362648|3597208|FG000|Overall Study|Adverse Event|12
2027941|NCT00362648|3597209|FG001|Overall Study|Adverse Event|21
2027942|NCT00362648|3597210|FG002|Overall Study|Adverse Event|1
2027943|NCT00362648|3597211|FG003|Overall Study|Adverse Event|0
2027944|NCT00362648|3597208|FG000|Overall Study|Lost to Follow-up|62
2027945|NCT00362648|3597209|FG001|Overall Study|Lost to Follow-up|69
2027946|NCT00362648|3597210|FG002|Overall Study|Lost to Follow-up|4
2027947|NCT00362648|3597211|FG003|Overall Study|Lost to Follow-up|3
2027948|NCT00362648|3597208|FG000|Overall Study|Protocol Violation|4
2027949|NCT00362648|3597209|FG001|Overall Study|Protocol Violation|2
2027950|NCT00362648|3597210|FG002|Overall Study|Protocol Violation|2
2027951|NCT00362648|3597211|FG003|Overall Study|Protocol Violation|2
2027952|NCT00362648|3597208|FG000|Overall Study|Withdrawal by Subject|48
2027953|NCT00362648|3597209|FG001|Overall Study|Withdrawal by Subject|42
2027954|NCT00362648|3597210|FG002|Overall Study|Withdrawal by Subject|2
2027955|NCT00362648|3597211|FG003|Overall Study|Withdrawal by Subject|6
2027956|NCT00363051|3597241|FG000|Overall Study|Adminstrative problems|1
2027957|NCT00363051|3597242|FG001|Overall Study|Adminstrative problems|1
2027958|NCT00363051|3597241|FG000|Overall Study|Adverse Event|21
2027959|NCT00363051|3597242|FG001|Overall Study|Adverse Event|12
2027960|NCT00363051|3597241|FG000|Overall Study|New Cancer Therapy|2
2027961|NCT00363051|3597242|FG001|Overall Study|New Cancer Therapy|1
2027962|NCT00363051|3597241|FG000|Overall Study|Withdrawal by Subject|11
2109104|NCT00884286|3703225|FG000|Overall Study|Physician Decision|1
2109105|NCT00884286|3703226|FG001|Overall Study|Physician Decision|0
2109106|NCT00884286|3703225|FG000|Overall Study|Septic shock|1
2109107|NCT00884286|3703226|FG001|Overall Study|Septic shock|0
2109108|NCT00884286|3703225|FG000|Overall Study|Thrombus in right auricle|1
2109109|NCT00884286|3703226|FG001|Overall Study|Thrombus in right auricle|0
2109110|NCT00884286|3703225|FG000|Overall Study|Not treated|2
2109111|NCT00884286|3703226|FG001|Overall Study|Not treated|1
2109112|NCT00884286|3703225|FG000|Overall Study|Comprised lung carcinoma|0
2109113|NCT00884286|3703226|FG001|Overall Study|Comprised lung carcinoma|1
2109114|NCT00884312|3703235|FG000|Overall Study|Non-fatal Progressive Disease|0
2109115|NCT00884312|3703236|FG001|Overall Study|Non-fatal Progressive Disease|8
2109116|NCT00884312|3703235|FG000|Overall Study|Fatal Progressive Disease|0
2109117|NCT00884312|3703236|FG001|Overall Study|Fatal Progressive Disease|1
2109118|NCT00884312|3703235|FG000|Overall Study|Non-fatal Adverse Event|1
2109119|NCT00884312|3703236|FG001|Overall Study|Non-fatal Adverse Event|0
2109120|NCT00884312|3703235|FG000|Overall Study|Fatal Adverse Event|1
2109121|NCT00884312|3703236|FG001|Overall Study|Fatal Adverse Event|4
2109122|NCT00884312|3703235|FG000|Overall Study|Withdrawal by Subject|0
2109123|NCT00884312|3703236|FG001|Overall Study|Withdrawal by Subject|6
2109124|NCT00884312|3703235|FG000|Overall Study|Physician Decision|0
2109125|NCT00884312|3703236|FG001|Overall Study|Physician Decision|1
2109126|NCT00884312|3703235|FG000|Overall Study|Other|0
2109127|NCT00884312|3703236|FG001|Overall Study|Other|4
2109128|NCT00884312|3703235|FG000|Overall Study|Did Not Receive Study Drug|0
2109129|NCT00884312|3703236|FG001|Overall Study|Did Not Receive Study Drug|1
2109130|NCT00884325|3703244|FG000|Overall Study|Lost to Follow-up|1
2109131|NCT00884325|3703245|FG001|Overall Study|Lost to Follow-up|2
2109132|NCT00884325|3703244|FG000|Overall Study|Lack of Efficacy|0
2109133|NCT00884325|3703245|FG001|Overall Study|Lack of Efficacy|1
2109134|NCT00884325|3703244|FG000|Overall Study|Withdrawal by Subject|1
2109135|NCT00884325|3703245|FG001|Overall Study|Withdrawal by Subject|1
2109136|NCT00884325|3703244|FG000|Overall Study|Not provided|1
2109137|NCT00884325|3703245|FG001|Overall Study|Not provided|0
2109138|NCT00884377|3703253|FG000|Overall Study|Withdrawal by Subject|1
2109139|NCT00884377|3703254|FG001|Overall Study|Withdrawal by Subject|0
2109140|NCT00884377|3703253|FG000|Overall Study|Could not confirm diagnosis|1
2109141|NCT00884377|3703254|FG001|Overall Study|Could not confirm diagnosis|0
2109142|NCT00884377|3703253|FG000|Overall Study|Physician Decision|0
2109143|NCT00884377|3703254|FG001|Overall Study|Physician Decision|1
2109144|NCT00884390|3703268|FG000|Overall Study|Adverse Event|0
2109145|NCT00884390|3703269|FG001|Overall Study|Adverse Event|1
2109146|NCT00884390|3703268|FG000|Overall Study|Lost to Follow-up|0
2109147|NCT00884390|3703269|FG001|Overall Study|Lost to Follow-up|1
2109148|NCT00884390|3703268|FG000|Overall Study|Physician Decision|2
2109149|NCT00884390|3703269|FG001|Overall Study|Physician Decision|1
2109150|NCT00884390|3703268|FG000|Overall Study|Protocol Violation|4
2109151|NCT00884390|3703269|FG001|Overall Study|Protocol Violation|1
2109152|NCT00884390|3703268|FG000|Overall Study|Withdrawal by Subject|4
2109153|NCT00884390|3703269|FG001|Overall Study|Withdrawal by Subject|1
2109154|NCT00884390|3703268|FG000|Overall Study|Discontinuation of Study by Sponsor|2
2109155|NCT00884390|3703269|FG001|Overall Study|Discontinuation of Study by Sponsor|2
2109156|NCT00884390|3703268|FG000|Overall Study|Other|11
2109157|NCT00884390|3703269|FG001|Overall Study|Other|1
2027963|NCT00363051|3597242|FG001|Overall Study|Withdrawal by Subject|3
2109158|NCT00884650|3703304|FG000|Overall Study|Did not return complete pain diaries|7
2027964|NCT00363051|3597241|FG000|Overall Study|Lost to Follow-up|0
2027965|NCT00363051|3597242|FG001|Overall Study|Lost to Follow-up|1
2027966|NCT00363051|3597241|FG000|Overall Study|Protocol Violation|0
2027967|NCT00363051|3597242|FG001|Overall Study|Protocol Violation|2
2027968|NCT00363051|3597241|FG000|Overall Study|Death|3
2027969|NCT00363051|3597242|FG001|Overall Study|Death|2
2027970|NCT00363129|3597261|FG000|Overall Study|Withdrawal by Subject|11
2027971|NCT00363129|3597262|FG001|Overall Study|Withdrawal by Subject|18
2027972|NCT00363129|3597261|FG000|Overall Study|Adverse Event|8
2027973|NCT00363129|3597262|FG001|Overall Study|Adverse Event|3
2027974|NCT00363129|3597261|FG000|Overall Study|Alternate Treatment|2
2027975|NCT00363129|3597262|FG001|Overall Study|Alternate Treatment|4
2322444|NCT02972658|4037478|FG001|Overall Study|Progressive Disease|1
2027976|NCT00363129|3597261|FG000|Overall Study|Other Medical Problems|2
2027977|NCT00363129|3597262|FG001|Overall Study|Other Medical Problems|4
2027978|NCT00363129|3597261|FG000|Overall Study|Death|0
2027979|NCT00363129|3597262|FG001|Overall Study|Death|1
2027980|NCT00363129|3597261|FG000|Overall Study|Other Reasons|6
2027981|NCT00363129|3597262|FG001|Overall Study|Other Reasons|3
2027982|NCT00363142|3597270|FG000|Overall Study|Adverse Event|2
2027983|NCT00363142|3597271|FG001|Overall Study|Adverse Event|0
2027984|NCT00363142|3597270|FG000|Overall Study|Lack of Efficacy|0
2027985|NCT00363142|3597271|FG001|Overall Study|Lack of Efficacy|1
2109159|NCT00884650|3703305|FG001|Overall Study|Did not return complete pain diaries|7
2109160|NCT00884650|3703304|FG000|Overall Study|Admitted Post-Op|1
2109161|NCT00884650|3703305|FG001|Overall Study|Admitted Post-Op|0
2109162|NCT00884650|3703304|FG000|Overall Study|Femoral Stress Fracture|1
2109163|NCT00884650|3703305|FG001|Overall Study|Femoral Stress Fracture|0
2109164|NCT00884650|3703304|FG000|Overall Study|Pain Pump Complication|0
2109165|NCT00884650|3703305|FG001|Overall Study|Pain Pump Complication|1
2109166|NCT00884741|3703315|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157
2109167|NCT00884741|3703316|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0
2109168|NCT00884741|3703317|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0
2109169|NCT00884741|3703318|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0
2109170|NCT00884741|3703315|FG000|Step 1 Registration: Tissue Screening|Death|3
2109171|NCT00884741|3703316|FG001|Step 1 Registration: Tissue Screening|Death|0
2109172|NCT00884741|3703317|FG002|Step 1 Registration: Tissue Screening|Death|0
2109173|NCT00884741|3703318|FG003|Step 1 Registration: Tissue Screening|Death|0
2109174|NCT00884741|3703315|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3
2109175|NCT00884741|3703316|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0
2109176|NCT00884741|3703317|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0
2109177|NCT00884741|3703318|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0
2109178|NCT00884741|3703315|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105
2109179|NCT00884741|3703316|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0
2109180|NCT00884741|3703317|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0
2109181|NCT00884741|3703318|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0
2109182|NCT00884741|3703315|FG000|Step 1 Registration: Tissue Screening|Disease progression|12
2109183|NCT00884741|3703316|FG001|Step 1 Registration: Tissue Screening|Disease progression|0
2109184|NCT00884741|3703317|FG002|Step 1 Registration: Tissue Screening|Disease progression|0
2109185|NCT00884741|3703318|FG003|Step 1 Registration: Tissue Screening|Disease progression|0
2109186|NCT00884741|3703315|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32
2109187|NCT00884741|3703316|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0
2109188|NCT00884741|3703317|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0
2109189|NCT00884741|3703318|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0
2109190|NCT00884741|3703315|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0
2109191|NCT00884741|3703316|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15
2109192|NCT00884741|3703317|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0
2109193|NCT00884741|3703318|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0
2109194|NCT00884741|3703315|FG000|Step 2 Registration: Tissue Analysis|Death|0
2109195|NCT00884741|3703316|FG001|Step 2 Registration: Tissue Analysis|Death|1
2109196|NCT00884741|3703317|FG002|Step 2 Registration: Tissue Analysis|Death|0
2109197|NCT00884741|3703318|FG003|Step 2 Registration: Tissue Analysis|Death|0
2109198|NCT00884741|3703315|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0
2109199|NCT00884741|3703316|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2
2109200|NCT00884741|3703317|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0
2109201|NCT00884741|3703318|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0
2109202|NCT00884741|3703315|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0
2109203|NCT00884741|3703316|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7
2109204|NCT00884741|3703317|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0
2109205|NCT00884741|3703318|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0
2109206|NCT00884741|3703315|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0
2109207|NCT00884741|3703316|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4
2109208|NCT00884741|3703317|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0
2109209|NCT00884741|3703318|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0
2109210|NCT00884741|3703315|FG000|Randomization|Protocol Violation|0
2027986|NCT00363142|3597270|FG000|Overall Study|Lost to Follow-up|1
2027987|NCT00363142|3597271|FG001|Overall Study|Lost to Follow-up|0
2027988|NCT00363142|3597270|FG000|Overall Study|Non-compliance|1
2027989|NCT00363142|3597271|FG001|Overall Study|Non-compliance|1
2027990|NCT00363142|3597270|FG000|Overall Study|Withdrawal by Subject|3
2027991|NCT00363142|3597271|FG001|Overall Study|Withdrawal by Subject|1
2027992|NCT00363246|3597289|FG000|Overall Study|Death|40
2027993|NCT00363246|3597289|FG000|Overall Study|Withdrawal by Subject|19
2027994|NCT00363246|3597289|FG000|Overall Study|Lost to Follow-up|14
2027995|NCT00363246|3597289|FG000|Overall Study|Bad health|6
2027996|NCT00363246|3597289|FG000|Overall Study|Stopped using wheelchair|11
2027997|NCT00363246|3597289|FG000|Overall Study|Subject expressed security concerns|2
2027998|NCT00363246|3597289|FG000|Overall Study|Eligibility changed due to Hospice move|5
2027999|NCT00363298|3597296|FG000|First Study Week|Lack of Efficacy|6
2028000|NCT00363298|3597297|FG001|First Study Week|Lack of Efficacy|5
2028001|NCT00363298|3597296|FG000|4-week Study Continuation Phase|Lack of Efficacy|1
2028002|NCT00363298|3597297|FG001|4-week Study Continuation Phase|Lack of Efficacy|0
2028003|NCT00363311|3597306|FG000|Overall Study|Adverse Event|6
2028004|NCT00363311|3597307|FG001|Overall Study|Adverse Event|4
2028005|NCT00363311|3597306|FG000|Overall Study|Lost to Follow-up|3
2028006|NCT00363311|3597307|FG001|Overall Study|Lost to Follow-up|0
2028007|NCT00363311|3597306|FG000|Overall Study|Protocol Violation|1
2028008|NCT00363311|3597307|FG001|Overall Study|Protocol Violation|2
2028009|NCT00363311|3597306|FG000|Overall Study|Withdrawal by Subject|12
2028010|NCT00363311|3597307|FG001|Overall Study|Withdrawal by Subject|6
2028011|NCT00363311|3597306|FG000|Overall Study|Physician Decision|1
2028012|NCT00363311|3597307|FG001|Overall Study|Physician Decision|1
2028013|NCT00363311|3597306|FG000|Overall Study|Sponsor Terminated Study|2
2028014|NCT00363311|3597307|FG001|Overall Study|Sponsor Terminated Study|2
2028015|NCT00363311|3597306|FG000|Overall Study|Disease Progression|46
2028016|NCT00363311|3597307|FG001|Overall Study|Disease Progression|26
2028017|NCT00363311|3597306|FG000|Overall Study|Non-Compliance|1
2028018|NCT00363311|3597307|FG001|Overall Study|Non-Compliance|1
2028019|NCT00363311|3597306|FG000|Overall Study|Participant Refused Biopsy|1
2028020|NCT00363311|3597307|FG001|Overall Study|Participant Refused Biopsy|0
2028021|NCT00363311|3597306|FG000|Overall Study|Prostate Volume/PSA Doubled|1
2028022|NCT00363311|3597307|FG001|Overall Study|Prostate Volume/PSA Doubled|0
2028023|NCT00363311|3597306|FG000|Overall Study|Participant Opted for Treatment|1
2028024|NCT00363311|3597307|FG001|Overall Study|Participant Opted for Treatment|0
2028025|NCT00363311|3597306|FG000|Overall Study|Participant Moved to Another Country|1
2028026|NCT00363311|3597307|FG001|Overall Study|Participant Moved to Another Country|0
2028027|NCT00363311|3597306|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0
2028028|NCT00363311|3597307|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1
2028029|NCT00363311|3597306|FG000|Overall Study|Withdrawn per Instructions of Monitor|0
2028030|NCT00363311|3597307|FG001|Overall Study|Withdrawn per Instructions of Monitor|1
2028031|NCT00363311|3597306|FG000|Overall Study|Participant Moved to Louisiana|0
2028032|NCT00363311|3597307|FG001|Overall Study|Participant Moved to Louisiana|1
2028033|NCT00363415|3597315|FG000|Overall Study|Progressive Disease|196
2028034|NCT00363415|3597316|FG001|Overall Study|Progressive Disease|107
2028035|NCT00363415|3597315|FG000|Overall Study|Sponsor Decision|67
2028036|NCT00363415|3597316|FG001|Overall Study|Sponsor Decision|31
2028037|NCT00363415|3597315|FG000|Overall Study|Death|32
2028038|NCT00363415|3597316|FG001|Overall Study|Death|29
2028039|NCT00363415|3597315|FG000|Overall Study|Adverse Event|24
2028040|NCT00363415|3597316|FG001|Overall Study|Adverse Event|15
2028041|NCT00363415|3597315|FG000|Overall Study|Physician Decision|18
2028042|NCT00363415|3597316|FG001|Overall Study|Physician Decision|35
2028043|NCT00363415|3597315|FG000|Overall Study|Entry Criteria Not Met|11
2028044|NCT00363415|3597316|FG001|Overall Study|Entry Criteria Not Met|10
2028045|NCT00363415|3597315|FG000|Overall Study|Withdrawal by Subject|9
2028046|NCT00363415|3597316|FG001|Overall Study|Withdrawal by Subject|15
2028047|NCT00363415|3597315|FG000|Overall Study|Lost to Follow-up|3
2028048|NCT00363415|3597316|FG001|Overall Study|Lost to Follow-up|3
2028049|NCT00363415|3597315|FG000|Overall Study|Protocol Violation|1
2028050|NCT00363415|3597316|FG001|Overall Study|Protocol Violation|4
2028051|NCT00363467|3597322|FG000|Overall Study|Physician Decision|1
2028052|NCT00363480|3597326|FG000|Overall Study|Criteria for treatment period not fulfil|1
2028053|NCT00363480|3597326|FG000|Overall Study|Adverse Event|4
2028054|NCT00363480|3597326|FG000|Overall Study|Lost to Follow-up|5
2028055|NCT00363480|3597326|FG000|Overall Study|Withdrawal by Subject|5
2028056|NCT00363480|3597326|FG000|Overall Study|Non-compliance of subject|1
2028057|NCT00363480|3597326|FG000|Overall Study|Participant discontinued on its own|1
2028058|NCT00363545|3597332|FG000|Overall Study|Serious Adverse Event|0
2028059|NCT00363545|3597333|FG001|Overall Study|Serious Adverse Event|1
2028060|NCT00363545|3597332|FG000|Overall Study|Withdrawal by Subject|12
2028061|NCT00363545|3597333|FG001|Overall Study|Withdrawal by Subject|15
2028062|NCT00363545|3597332|FG000|Overall Study|Migrated/moved from study area|3
2028063|NCT00363545|3597333|FG001|Overall Study|Migrated/moved from study area|6
2028064|NCT00363545|3597332|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14
2028065|NCT00363545|3597333|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18
2028066|NCT00363545|3597332|FG000|Overall Study|Lost to follow-up (complete vaccination)|14
2028067|NCT00363545|3597333|FG001|Overall Study|Lost to follow-up (complete vaccination)|17
2028068|NCT00363545|3597332|FG000|Overall Study|Others|1
2028069|NCT00363545|3597333|FG001|Overall Study|Others|0
2028070|NCT00363649|3597341|FG000|Overall Study|Withdrawal by Subject|1
2028071|NCT00363649|3597342|FG001|Overall Study|Withdrawal by Subject|1
2028072|NCT00363649|3597341|FG000|Overall Study|Adverse Event|6
2028073|NCT00363649|3597342|FG001|Overall Study|Adverse Event|0
2028074|NCT00363766|3597355|FG000|Overall Study|Progressive Disease|15
2028075|NCT00363766|3597356|FG001|Overall Study|Progressive Disease|9
2028076|NCT00363766|3597355|FG000|Overall Study|Adverse Event|10
2028077|NCT00363766|3597356|FG001|Overall Study|Adverse Event|2
2028078|NCT00363766|3597355|FG000|Overall Study|Disease Related Death|1
2028079|NCT00363766|3597356|FG001|Overall Study|Disease Related Death|3
2028080|NCT00363766|3597355|FG000|Overall Study|Not Disease Related Death|3
2028081|NCT00363766|3597356|FG001|Overall Study|Not Disease Related Death|4
2028082|NCT00363766|3597355|FG000|Overall Study|Withdrawal by Subject|2
2028083|NCT00363766|3597356|FG001|Overall Study|Withdrawal by Subject|0
2028084|NCT00363766|3597355|FG000|Overall Study|Physician Decision|1
2028085|NCT00363766|3597356|FG001|Overall Study|Physician Decision|2
2028086|NCT00363896|3597386|FG000|Overall Study|Withdrawal by Subject|29
2028087|NCT00363896|3597387|FG001|Overall Study|Withdrawal by Subject|16
2028088|NCT00363896|3597386|FG000|Overall Study|Adverse Event|24
2028089|NCT00363896|3597387|FG001|Overall Study|Adverse Event|13
2109211|NCT00884741|3703316|FG001|Randomization|Protocol Violation|0
2109212|NCT00884741|3703317|FG002|Randomization|Protocol Violation|8
2109213|NCT00884741|3703318|FG003|Randomization|Protocol Violation|8
2109214|NCT00884793|3703334|FG000|Overall Study|Withdrawal by Subject|1
2109215|NCT00884832|3703344|FG000|Overall Study|Withdrawal by Subject|0
2109216|NCT00884832|3703345|FG001|Overall Study|Withdrawal by Subject|1
2109217|NCT00884949|3703364|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
2109218|NCT00884949|3703364|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
2109219|NCT00885105|3703397|FG000|Overall Study|Withdrawal by Subject|0
2109220|NCT00885105|3703398|FG001|Overall Study|Withdrawal by Subject|8
2109221|NCT00885105|3703397|FG000|Overall Study|Adverse Event|1
2109222|NCT00885105|3703398|FG001|Overall Study|Adverse Event|0
2109223|NCT00885105|3703397|FG000|Overall Study|Protocol Violation|0
2109224|NCT00885105|3703398|FG001|Overall Study|Protocol Violation|2
2109225|NCT00885118|3703409|FG000|Overall Study|Adverse Event|1
2109226|NCT00885118|3703410|FG001|Overall Study|Adverse Event|0
2109227|NCT00885118|3703411|FG002|Overall Study|Adverse Event|0
2109228|NCT00885118|3703412|FG003|Overall Study|Adverse Event|0
2109229|NCT00885118|3703413|FG004|Overall Study|Adverse Event|0
2109230|NCT00885118|3703409|FG000|Overall Study|Withdrawal by Subject|0
2109231|NCT00885118|3703410|FG001|Overall Study|Withdrawal by Subject|0
2109232|NCT00885118|3703411|FG002|Overall Study|Withdrawal by Subject|0
2109233|NCT00885118|3703412|FG003|Overall Study|Withdrawal by Subject|0
2109234|NCT00885118|3703413|FG004|Overall Study|Withdrawal by Subject|1
2109235|NCT00885118|3703409|FG000|Overall Study|Other reason not defined above|0
2109236|NCT00885118|3703410|FG001|Overall Study|Other reason not defined above|0
2109237|NCT00885118|3703411|FG002|Overall Study|Other reason not defined above|1
2109238|NCT00885118|3703412|FG003|Overall Study|Other reason not defined above|0
2109239|NCT00885118|3703413|FG004|Overall Study|Other reason not defined above|0
2109240|NCT00885170|3703431|FG000|Overall Study|Adverse Event|12
2109241|NCT00885170|3703432|FG001|Overall Study|Adverse Event|4
2322445|NCT02972658|4037479|FG002|Overall Study|Progressive Disease|0
2322446|NCT02972658|4037480|FG003|Overall Study|Progressive Disease|1
2322447|NCT02972658|4037477|FG000|Overall Study|Withdrawal by Subject|4
2322448|NCT02972658|4037478|FG001|Overall Study|Withdrawal by Subject|4
2322449|NCT02972658|4037479|FG002|Overall Study|Withdrawal by Subject|1
2028090|NCT00363896|3597386|FG000|Overall Study|COPD exacerbation|13
2028091|NCT00363896|3597387|FG001|Overall Study|COPD exacerbation|7
2028092|NCT00363896|3597386|FG000|Overall Study|Lack of Efficacy|12
2028093|NCT00363896|3597387|FG001|Overall Study|Lack of Efficacy|8
2109242|NCT00885170|3703431|FG000|Overall Study|Excessive bone loss|6
2109243|NCT00885170|3703432|FG001|Overall Study|Excessive bone loss|3
2109244|NCT00885170|3703431|FG000|Overall Study|Lost to Follow-up|2
2322450|NCT02972658|4037480|FG003|Overall Study|Withdrawal by Subject|6
2028094|NCT00363896|3597386|FG000|Overall Study|Protocol Violation|6
2028095|NCT00363896|3597387|FG001|Overall Study|Protocol Violation|1
2028096|NCT00363896|3597386|FG000|Overall Study|Lost to Follow-up|3
2028097|NCT00363896|3597387|FG001|Overall Study|Lost to Follow-up|0
2028098|NCT00363896|3597386|FG000|Overall Study|Non-fulfilment of entry criteria|1
2028099|NCT00363896|3597387|FG001|Overall Study|Non-fulfilment of entry criteria|0
2028100|NCT00363896|3597386|FG000|Overall Study|Other|1
2028101|NCT00363896|3597387|FG001|Overall Study|Other|2
2028102|NCT00364013|3597398|FG000|Overall Study|Ineligibility determined|4
2028103|NCT00364013|3597399|FG001|Overall Study|Ineligibility determined|2
2028104|NCT00364013|3597398|FG000|Overall Study|Adverse Event|4
2028105|NCT00364013|3597399|FG001|Overall Study|Adverse Event|3
2028106|NCT00364013|3597398|FG000|Overall Study|Withdrawal by Subject|13
2028107|NCT00364013|3597399|FG001|Overall Study|Withdrawal by Subject|18
2028108|NCT00364013|3597398|FG000|Overall Study|Physician Decision|3
2028109|NCT00364013|3597399|FG001|Overall Study|Physician Decision|3
2028110|NCT00364013|3597398|FG000|Overall Study|Lost to Follow-up|10
2028111|NCT00364013|3597399|FG001|Overall Study|Lost to Follow-up|3
2028112|NCT00364013|3597398|FG000|Overall Study|Protocol-specified criteria|6
2028113|NCT00364013|3597399|FG001|Overall Study|Protocol-specified criteria|6
2028114|NCT00364013|3597398|FG000|Overall Study|Other|41
2028115|NCT00364013|3597399|FG001|Overall Study|Other|47
2028116|NCT00364013|3597398|FG000|Overall Study|Ongoing|20
2028117|NCT00364013|3597399|FG001|Overall Study|Ongoing|13
2028118|NCT00364130|3597411|FG000|Intervention Period|Lost to Follow-up|4
2028119|NCT00364130|3597412|FG001|Intervention Period|Lost to Follow-up|3
2028120|NCT00364130|3597411|FG000|Intervention Period|Pregnancy|1
2028121|NCT00364130|3597412|FG001|Intervention Period|Pregnancy|0
2028122|NCT00364130|3597411|FG000|Intervention Period|Withdrawal by Subject|4
2028123|NCT00364130|3597412|FG001|Intervention Period|Withdrawal by Subject|5
2028124|NCT00364130|3597411|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5
2028125|NCT00364130|3597412|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11
2028126|NCT00364156|3597422|FG000|Overall Study|Withdrawal by Subject|73
2028127|NCT00364156|3597423|FG001|Overall Study|Withdrawal by Subject|80
2028128|NCT00364156|3597422|FG000|Overall Study|Protocol Violation|6
2028129|NCT00364156|3597423|FG001|Overall Study|Protocol Violation|1
2028130|NCT00364182|3597432|FG000|First Intervention|Secondary prophylaxis|1
2028131|NCT00364182|3597433|FG001|First Intervention|Secondary prophylaxis|0
2109245|NCT00885170|3703432|FG001|Overall Study|Lost to Follow-up|1
2109246|NCT00885170|3703431|FG000|Overall Study|Physician Decision|2
2109247|NCT00885170|3703432|FG001|Overall Study|Physician Decision|1
2109248|NCT00885170|3703431|FG000|Overall Study|Protocol Violation|3
2109249|NCT00885170|3703432|FG001|Overall Study|Protocol Violation|1
2109250|NCT00885170|3703431|FG000|Overall Study|Withdrawal by Subject|13
2109251|NCT00885170|3703432|FG001|Overall Study|Withdrawal by Subject|13
2109252|NCT00885352|3703440|FG000|Overall Study|Adverse Event|2
2109253|NCT00885352|3703441|FG001|Overall Study|Adverse Event|3
2109254|NCT00885352|3703440|FG000|Overall Study|Lost to Follow-up|2
2109255|NCT00885352|3703441|FG001|Overall Study|Lost to Follow-up|2
2109256|NCT00885352|3703440|FG000|Overall Study|Physician Decision|0
2109257|NCT00885352|3703441|FG001|Overall Study|Physician Decision|3
2109258|NCT00885352|3703440|FG000|Overall Study|Protocol Violation|0
2109259|NCT00885352|3703441|FG001|Overall Study|Protocol Violation|2
2109260|NCT00885352|3703440|FG000|Overall Study|Withdrawal by Subject|1
2109261|NCT00885352|3703441|FG001|Overall Study|Withdrawal by Subject|5
2109262|NCT00885352|3703440|FG000|Overall Study|Contradiction to study medication|0
2109263|NCT00885352|3703441|FG001|Overall Study|Contradiction to study medication|2
2109264|NCT00885352|3703440|FG000|Overall Study|Excluded medication|2
2109265|NCT00885352|3703441|FG001|Overall Study|Excluded medication|2
2109266|NCT00885352|3703440|FG000|Overall Study|Lab abnormalities|1
2109267|NCT00885352|3703441|FG001|Overall Study|Lab abnormalities|1
2109268|NCT00885365|3703449|FG000|4 Weeks ON Treatment|Adverse Event|2
2109269|NCT00885365|3703450|FG001|4 Weeks ON Treatment|Adverse Event|4
2109270|NCT00885365|3703449|FG000|4 Weeks ON Treatment|Protocol Violation|1
2109271|NCT00885365|3703450|FG001|4 Weeks ON Treatment|Protocol Violation|2
2109272|NCT00885365|3703449|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1
2109273|NCT00885365|3703450|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0
2109274|NCT00885378|3703458|FG000|Overall Study|Lack of Efficacy|2
2109275|NCT00885378|3703459|FG001|Overall Study|Lack of Efficacy|2
2109276|NCT00885378|3703458|FG000|Overall Study|Withdrawal by Subject|1
2109277|NCT00885378|3703459|FG001|Overall Study|Withdrawal by Subject|2
2109278|NCT00885378|3703458|FG000|Overall Study|Lost to Follow-up|1
2109279|NCT00885378|3703459|FG001|Overall Study|Lost to Follow-up|2
2109280|NCT00885378|3703458|FG000|Overall Study|Poor/Noncompliance|2
2109281|NCT00885378|3703459|FG001|Overall Study|Poor/Noncompliance|2
2109282|NCT00885378|3703458|FG000|Overall Study|Protocol Violation|2
2109283|NCT00885378|3703459|FG001|Overall Study|Protocol Violation|0
2109284|NCT00885482|3703465|FG000|Overall Study|Pregnancy|1
2109285|NCT00885482|3703465|FG000|Overall Study|Lack of Efficacy|1
2109286|NCT00885482|3703465|FG000|Overall Study|Death|1
2028132|NCT00364182|3597434|FG002|First Intervention|Secondary prophylaxis|0
2028133|NCT00364182|3597432|FG000|First Intervention|Withdrawal by Subject|2
2109287|NCT00885482|3703465|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1
2109288|NCT00885534|3703469|FG000|Overall Study|Patient deemed ineligible|1
2109289|NCT00885677|3703483|FG000|Overall Study|Death|40
2028134|NCT00364182|3597433|FG001|First Intervention|Withdrawal by Subject|0
2028135|NCT00364182|3597434|FG002|First Intervention|Withdrawal by Subject|0
2028136|NCT00364182|3597432|FG000|Second Intervention|non-compliance|0
2028137|NCT00364182|3597433|FG001|Second Intervention|non-compliance|1
2028138|NCT00364182|3597434|FG002|Second Intervention|non-compliance|1
2028139|NCT00364182|3597432|FG000|Second Intervention|Protocol Violation|0
2028140|NCT00364182|3597433|FG001|Second Intervention|Protocol Violation|1
2028141|NCT00364182|3597434|FG002|Second Intervention|Protocol Violation|0
2028142|NCT00364182|3597432|FG000|Second Intervention|Adverse Event|0
2028143|NCT00364182|3597433|FG001|Second Intervention|Adverse Event|0
2028144|NCT00364182|3597434|FG002|Second Intervention|Adverse Event|1
2028145|NCT00364182|3597432|FG000|Third Intervention|non-compliance|0
2028146|NCT00364182|3597433|FG001|Third Intervention|non-compliance|1
2028147|NCT00364182|3597434|FG002|Third Intervention|non-compliance|0
2028148|NCT00364182|3597432|FG000|Third Intervention|Lost to Follow-up|0
2028149|NCT00364182|3597433|FG001|Third Intervention|Lost to Follow-up|0
2028150|NCT00364182|3597434|FG002|Third Intervention|Lost to Follow-up|1
2028151|NCT00364286|3597444|FG000|Overall Study|Withdrawal by Subject|1
2028152|NCT00364286|3597444|FG000|Overall Study|Adverse Event|2
2028153|NCT00364351|3597450|FG000|Overall Study|Adverse Event|90
2028154|NCT00364351|3597451|FG001|Overall Study|Adverse Event|44
2028155|NCT00364351|3597450|FG000|Overall Study|Condition under investigation worsened|469
2028156|NCT00364351|3597451|FG001|Overall Study|Condition under investigation worsened|497
2028157|NCT00364351|3597450|FG000|Overall Study|Prohibited concomitant medication|0
2028158|NCT00364351|3597451|FG001|Overall Study|Prohibited concomitant medication|2
2028159|NCT00364351|3597450|FG000|Overall Study|Lost to Follow-up|1
2028160|NCT00364351|3597451|FG001|Overall Study|Lost to Follow-up|1
2028161|NCT00364351|3597450|FG000|Overall Study|Withdrawal by Subject|30
2028162|NCT00364351|3597451|FG001|Overall Study|Withdrawal by Subject|29
2028163|NCT00364351|3597450|FG000|Overall Study|Incorrect enrollment|1
2028164|NCT00364351|3597451|FG001|Overall Study|Incorrect enrollment|1
2028165|NCT00364351|3597450|FG000|Overall Study|Sponsor decision|1
2028166|NCT00364351|3597451|FG001|Overall Study|Sponsor decision|0
2028167|NCT00364351|3597450|FG000|Overall Study|Poor treatment compliance|0
2028168|NCT00364351|3597451|FG001|Overall Study|Poor treatment compliance|3
2028169|NCT00364351|3597450|FG000|Overall Study|Investigator error|0
2028170|NCT00364351|3597451|FG001|Overall Study|Investigator error|2
2322451|NCT02972658|4037477|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1
2322452|NCT02972658|4037478|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1
2322453|NCT02972658|4037479|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1
2322454|NCT02972658|4037480|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0
2028171|NCT00364351|3597450|FG000|Overall Study|Patient could not travel to site|0
2028172|NCT00364351|3597451|FG001|Overall Study|Patient could not travel to site|1
2028173|NCT00364351|3597450|FG000|Overall Study|Randomised treatment not started|0
2028174|NCT00364351|3597451|FG001|Overall Study|Randomised treatment not started|3
2028175|NCT00364533|3597471|FG000|Overall Study|Adverse Event|8
2028176|NCT00364533|3597472|FG001|Overall Study|Adverse Event|7
2028177|NCT00364533|3597473|FG002|Overall Study|Adverse Event|15
2028178|NCT00364533|3597474|FG003|Overall Study|Adverse Event|5
2028179|NCT00364533|3597475|FG004|Overall Study|Adverse Event|2
2028180|NCT00364533|3597471|FG000|Overall Study|Withdrawal by Subject|4
2028181|NCT00364533|3597472|FG001|Overall Study|Withdrawal by Subject|8
2028182|NCT00364533|3597473|FG002|Overall Study|Withdrawal by Subject|6
2028183|NCT00364533|3597474|FG003|Overall Study|Withdrawal by Subject|6
2028184|NCT00364533|3597475|FG004|Overall Study|Withdrawal by Subject|6
2028185|NCT00364533|3597471|FG000|Overall Study|Lack of Efficacy|22
2028186|NCT00364533|3597472|FG001|Overall Study|Lack of Efficacy|22
2028187|NCT00364533|3597473|FG002|Overall Study|Lack of Efficacy|21
2028188|NCT00364533|3597474|FG003|Overall Study|Lack of Efficacy|17
2217742|NCT01709513|3860999|FG000|Overall Study|Adverse Event|16
2217743|NCT01709513|3861000|FG001|Overall Study|Adverse Event|31
2217744|NCT01709513|3861001|FG002|Overall Study|Adverse Event|23
2322455|NCT02972658|4037477|FG000|Overall Study|Sponsor Decision|70
2028189|NCT00364533|3597475|FG004|Overall Study|Lack of Efficacy|42
2028190|NCT00364533|3597471|FG000|Overall Study|Subject discharged from hospital|4
2028191|NCT00364533|3597472|FG001|Overall Study|Subject discharged from hospital|1
2028192|NCT00364533|3597473|FG002|Overall Study|Subject discharged from hospital|2
2322456|NCT02972658|4037478|FG001|Overall Study|Sponsor Decision|127
2322457|NCT02972658|4037479|FG002|Overall Study|Sponsor Decision|72
2322458|NCT02972658|4037480|FG003|Overall Study|Sponsor Decision|119
2322459|NCT02973048|4037492|FG000|Overall Study|Epidural catheter insertion failure|1
2322460|NCT02973048|4037493|FG001|Overall Study|Epidural catheter insertion failure|0
2322461|NCT02973048|4037492|FG000|Overall Study|Withdrawal by Subject|0
2322462|NCT02973048|4037493|FG001|Overall Study|Withdrawal by Subject|3
2322463|NCT02973087|4037501|FG000|Overall Study|Withdrawal by Subject|2
2322464|NCT02973087|4037502|FG001|Overall Study|Withdrawal by Subject|1
2322465|NCT02973087|4037501|FG000|Overall Study|Adverse Event|1
2322466|NCT02973087|4037502|FG001|Overall Study|Adverse Event|0
2322467|NCT02973087|4037501|FG000|Overall Study|other|1
2028193|NCT00364533|3597474|FG003|Overall Study|Subject discharged from hospital|3
2217745|NCT01709513|3860999|FG000|Overall Study|Poor compliance to protocol|2
2028194|NCT00364533|3597475|FG004|Overall Study|Subject discharged from hospital|1
2028195|NCT00364533|3597471|FG000|Overall Study|Variations in drug compliance|2
2028196|NCT00364533|3597472|FG001|Overall Study|Variations in drug compliance|1
2028197|NCT00364533|3597473|FG002|Overall Study|Variations in drug compliance|1
2028198|NCT00364533|3597474|FG003|Overall Study|Variations in drug compliance|0
2028199|NCT00364533|3597475|FG004|Overall Study|Variations in drug compliance|0
2028200|NCT00364533|3597471|FG000|Overall Study|Non-compliance|1
2028201|NCT00364533|3597472|FG001|Overall Study|Non-compliance|0
2028202|NCT00364533|3597473|FG002|Overall Study|Non-compliance|0
2028203|NCT00364533|3597474|FG003|Overall Study|Non-compliance|0
2028204|NCT00364533|3597475|FG004|Overall Study|Non-compliance|0
2028205|NCT00364533|3597471|FG000|Overall Study|Protocol Violation|1
2028206|NCT00364533|3597472|FG001|Overall Study|Protocol Violation|1
2028207|NCT00364533|3597473|FG002|Overall Study|Protocol Violation|0
2028208|NCT00364533|3597474|FG003|Overall Study|Protocol Violation|0
2028209|NCT00364533|3597475|FG004|Overall Study|Protocol Violation|0
2028210|NCT00364611|3597489|FG000|Overall Study|Did not receive study medication|0
2028211|NCT00364611|3597490|FG001|Overall Study|Did not receive study medication|1
2028212|NCT00364611|3597489|FG000|Overall Study|Adverse Event|7
2028213|NCT00364611|3597490|FG001|Overall Study|Adverse Event|4
2109290|NCT00885677|3703484|FG001|Overall Study|Death|34
2217746|NCT01709513|3861000|FG001|Overall Study|Poor compliance to protocol|0
2217747|NCT01709513|3861001|FG002|Overall Study|Poor compliance to protocol|0
2217748|NCT01709513|3860999|FG000|Overall Study|Other|3
2217749|NCT01709513|3861000|FG001|Overall Study|Other|11
2217750|NCT01709513|3861001|FG002|Overall Study|Other|7
2217751|NCT01709578|3861015|FG000|Overall Study|Rescued and entered in long term safety|63
2217752|NCT01709578|3861016|FG001|Overall Study|Rescued and entered in long term safety|25
2217753|NCT01709578|3861017|FG002|Overall Study|Rescued and entered in long term safety|26
2217754|NCT01709578|3861015|FG000|Overall Study|Adverse Event|9
2217755|NCT01709578|3861016|FG001|Overall Study|Adverse Event|18
2217756|NCT01709578|3861017|FG002|Overall Study|Adverse Event|17
2217757|NCT01709578|3861015|FG000|Overall Study|Lack of Efficacy|5
2217758|NCT01709578|3861016|FG001|Overall Study|Lack of Efficacy|4
2217759|NCT01709578|3861017|FG002|Overall Study|Lack of Efficacy|2
2217760|NCT01709578|3861015|FG000|Overall Study|Poor compliance to protocol|1
2217761|NCT01709578|3861016|FG001|Overall Study|Poor compliance to protocol|2
2217762|NCT01709578|3861017|FG002|Overall Study|Poor compliance to protocol|1
2217763|NCT01709578|3861015|FG000|Overall Study|Other, not related to safety or efficacy|2
2217764|NCT01709578|3861016|FG001|Overall Study|Other, not related to safety or efficacy|7
2217765|NCT01709578|3861017|FG002|Overall Study|Other, not related to safety or efficacy|5
2217766|NCT01709695|3861027|FG000|Overall Study|Withdrawal by Subject|1
2217767|NCT01709695|3861028|FG001|Overall Study|Withdrawal by Subject|1
2217768|NCT01709708|3861036|FG000|Overall Study|Protocol Violation|1
2217769|NCT01709708|3861037|FG001|Overall Study|Protocol Violation|2
2217770|NCT01709721|3861047|FG000|Open Label Phase|Withdrawal by Subject|0
2217771|NCT01709721|3861048|FG001|Open Label Phase|Withdrawal by Subject|0
2217772|NCT01709721|3861049|FG002|Open Label Phase|Withdrawal by Subject|5
2217773|NCT01709721|3861047|FG000|Open Label Phase|Adverse Event|0
2217774|NCT01709721|3861048|FG001|Open Label Phase|Adverse Event|0
2217775|NCT01709721|3861049|FG002|Open Label Phase|Adverse Event|8
2217776|NCT01709721|3861047|FG000|Open Label Phase|Non-compliance With Study Drug|0
2217777|NCT01709721|3861048|FG001|Open Label Phase|Non-compliance With Study Drug|0
2217778|NCT01709721|3861049|FG002|Open Label Phase|Non-compliance With Study Drug|3
2217779|NCT01709721|3861047|FG000|Open Label Phase|Investigator Decision|0
2217780|NCT01709721|3861048|FG001|Open Label Phase|Investigator Decision|0
2217781|NCT01709721|3861049|FG002|Open Label Phase|Investigator Decision|1
2109291|NCT00885677|3703483|FG000|Overall Study|Lost to Follow-up|15
2109292|NCT00885677|3703484|FG001|Overall Study|Lost to Follow-up|13
2109293|NCT00885677|3703483|FG000|Overall Study|Protocol Violation|54
2109294|NCT00885677|3703484|FG001|Overall Study|Protocol Violation|54
2109295|NCT00885677|3703483|FG000|Overall Study|premature study closure|41
2109296|NCT00885677|3703484|FG001|Overall Study|premature study closure|44
2109297|NCT00885677|3703483|FG000|Overall Study|device/lead revision or replacement|7
2109298|NCT00885677|3703484|FG001|Overall Study|device/lead revision or replacement|6
2109299|NCT00885677|3703483|FG000|Overall Study|Heart transplantation|1
2109300|NCT00885677|3703484|FG001|Overall Study|Heart transplantation|0
2109301|NCT00885677|3703483|FG000|Overall Study|Inclusion/exclusion not met|25
2109302|NCT00885677|3703484|FG001|Overall Study|Inclusion/exclusion not met|27
2109303|NCT00885703|3703497|FG000|Overall Study|Death|9
2109304|NCT00885703|3703498|FG001|Overall Study|Death|7
2109305|NCT00885703|3703499|FG002|Overall Study|Death|8
2109306|NCT00885703|3703500|FG003|Overall Study|Death|7
2109307|NCT00885703|3703501|FG004|Overall Study|Death|7
2109308|NCT00885703|3703502|FG005|Overall Study|Death|8
2109309|NCT00885703|3703503|FG006|Overall Study|Death|4
2217782|NCT01709721|3861047|FG000|Open Label Phase|Sponsor Decision|0
2217783|NCT01709721|3861048|FG001|Open Label Phase|Sponsor Decision|0
2217784|NCT01709721|3861049|FG002|Open Label Phase|Sponsor Decision|2
2217785|NCT01709721|3861047|FG000|Open Label Phase|Protocol Violation|0
2217786|NCT01709721|3861048|FG001|Open Label Phase|Protocol Violation|0
2217787|NCT01709721|3861049|FG002|Open Label Phase|Protocol Violation|1
2273889|NCT02291289|3954585|FG002|Maintenance Treatment Phase|Other|1
2028214|NCT00364611|3597489|FG000|Overall Study|Participant's Request|3
2028215|NCT00364611|3597490|FG001|Overall Study|Participant's Request|4
2028216|NCT00364611|3597489|FG000|Overall Study|Disease Progression|38
2028217|NCT00364611|3597490|FG001|Overall Study|Disease Progression|8
2028218|NCT00364611|3597489|FG000|Overall Study|Investigator decision|2
2028219|NCT00364611|3597490|FG001|Overall Study|Investigator decision|2
2028220|NCT00364611|3597489|FG000|Overall Study|Found Ineligible|1
2028221|NCT00364611|3597490|FG001|Overall Study|Found Ineligible|0
2028222|NCT00364611|3597489|FG000|Overall Study|Presumed CR on Study|0
2028223|NCT00364611|3597490|FG001|Overall Study|Presumed CR on Study|1
2028224|NCT00364611|3597489|FG000|Overall Study|Receiving Liver Ablation|0
2028225|NCT00364611|3597490|FG001|Overall Study|Receiving Liver Ablation|1
2028226|NCT00364793|3597500|FG000|Overall Study|Adverse Event|2
2028227|NCT00364793|3597501|FG001|Overall Study|Adverse Event|0
2028228|NCT00364793|3597502|FG002|Overall Study|Adverse Event|0
2028229|NCT00364793|3597503|FG003|Overall Study|Adverse Event|0
2028230|NCT00364793|3597500|FG000|Overall Study|Death|1
2028231|NCT00364793|3597501|FG001|Overall Study|Death|0
2028232|NCT00364793|3597502|FG002|Overall Study|Death|1
2028233|NCT00364793|3597503|FG003|Overall Study|Death|0
2028234|NCT00364793|3597500|FG000|Overall Study|Lack of Efficacy|3
2028235|NCT00364793|3597501|FG001|Overall Study|Lack of Efficacy|3
2028236|NCT00364793|3597502|FG002|Overall Study|Lack of Efficacy|1
2028237|NCT00364793|3597503|FG003|Overall Study|Lack of Efficacy|1
2217788|NCT01709721|3861047|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
2217789|NCT01709721|3861048|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
2217790|NCT01709721|3861049|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1
2217791|NCT01709721|3861047|FG000|Open Label Phase|Inadequate Pain Control|0
2028238|NCT00364793|3597500|FG000|Overall Study|Lost to Follow-up|1
2028239|NCT00364793|3597501|FG001|Overall Study|Lost to Follow-up|0
2028240|NCT00364793|3597502|FG002|Overall Study|Lost to Follow-up|2
2028241|NCT00364793|3597503|FG003|Overall Study|Lost to Follow-up|0
2109310|NCT00885703|3703497|FG000|Overall Study|Lost to Follow-up|0
2109311|NCT00885703|3703498|FG001|Overall Study|Lost to Follow-up|0
2109312|NCT00885703|3703499|FG002|Overall Study|Lost to Follow-up|1
2109313|NCT00885703|3703500|FG003|Overall Study|Lost to Follow-up|0
2109314|NCT00885703|3703501|FG004|Overall Study|Lost to Follow-up|0
2109315|NCT00885703|3703502|FG005|Overall Study|Lost to Follow-up|1
2109316|NCT00885703|3703503|FG006|Overall Study|Lost to Follow-up|0
2109317|NCT00885703|3703497|FG000|Overall Study|Withdrawal by Subject|0
2109318|NCT00885703|3703498|FG001|Overall Study|Withdrawal by Subject|0
2109319|NCT00885703|3703499|FG002|Overall Study|Withdrawal by Subject|0
2109320|NCT00885703|3703500|FG003|Overall Study|Withdrawal by Subject|1
2109321|NCT00885703|3703501|FG004|Overall Study|Withdrawal by Subject|3
2109322|NCT00885703|3703502|FG005|Overall Study|Withdrawal by Subject|1
2109323|NCT00885703|3703503|FG006|Overall Study|Withdrawal by Subject|1
2109324|NCT00885703|3703497|FG000|Overall Study|Ineligible (no CM)|1
2109325|NCT00885703|3703498|FG001|Overall Study|Ineligible (no CM)|3
2109326|NCT00885703|3703499|FG002|Overall Study|Ineligible (no CM)|2
2109327|NCT00885703|3703500|FG003|Overall Study|Ineligible (no CM)|1
2109328|NCT00885703|3703501|FG004|Overall Study|Ineligible (no CM)|2
2109329|NCT00885703|3703502|FG005|Overall Study|Ineligible (no CM)|3
2109330|NCT00885703|3703503|FG006|Overall Study|Ineligible (no CM)|1
2109331|NCT00885755|3703530|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1
2109332|NCT00885755|3703531|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0
2109333|NCT00885755|3703532|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0
2109334|NCT00885755|3703530|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16
2109335|NCT00885755|3703531|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0
2109336|NCT00885755|3703532|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0
2109337|NCT00885755|3703530|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
2109338|NCT00885755|3703531|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
2217792|NCT01709721|3861048|FG001|Open Label Phase|Inadequate Pain Control|0
2217793|NCT01709721|3861049|FG002|Open Label Phase|Inadequate Pain Control|37
2217794|NCT01709721|3861047|FG000|Open Label Phase|Other, Specify in text field in database|0
2217795|NCT01709721|3861048|FG001|Open Label Phase|Other, Specify in text field in database|0
2217796|NCT01709721|3861049|FG002|Open Label Phase|Other, Specify in text field in database|14
2217797|NCT01709721|3861047|FG000|Randomized Phase|Adverse Event|0
2217798|NCT01709721|3861048|FG001|Randomized Phase|Adverse Event|1
2217799|NCT01709721|3861049|FG002|Randomized Phase|Adverse Event|0
2028242|NCT00364793|3597500|FG000|Overall Study|Poor or non-compliance|1
2109339|NCT00885755|3703532|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
2109340|NCT00885755|3703530|FG000|Part I: Trastuzumab+Taxane|Death|0
2109341|NCT00885755|3703531|FG001|Part I: Trastuzumab+Taxane|Death|0
2109342|NCT00885755|3703532|FG002|Part I: Trastuzumab+Taxane|Death|1
2109343|NCT00885755|3703530|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
2109344|NCT00885755|3703531|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
2109345|NCT00885755|3703532|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
2109346|NCT00885846|3703547|FG000|Overall Study|Withdrawal by Subject|2
2109347|NCT00885846|3703548|FG001|Overall Study|Withdrawal by Subject|5
2109348|NCT00885846|3703549|FG002|Overall Study|Withdrawal by Subject|2
2109349|NCT00886015|3703559|FG000|Overall Study|Death|0
2028243|NCT00364793|3597501|FG001|Overall Study|Poor or non-compliance|1
2028244|NCT00364793|3597502|FG002|Overall Study|Poor or non-compliance|0
2028245|NCT00364793|3597503|FG003|Overall Study|Poor or non-compliance|1
2028246|NCT00364793|3597500|FG000|Overall Study|No longer meets criteria|0
2028247|NCT00364793|3597501|FG001|Overall Study|No longer meets criteria|0
2028248|NCT00364793|3597502|FG002|Overall Study|No longer meets criteria|0
2028249|NCT00364793|3597503|FG003|Overall Study|No longer meets criteria|1
2028250|NCT00364793|3597500|FG000|Overall Study|Withdrawal by Subject|0
2028251|NCT00364793|3597501|FG001|Overall Study|Withdrawal by Subject|1
2028252|NCT00364793|3597502|FG002|Overall Study|Withdrawal by Subject|0
2028253|NCT00364793|3597503|FG003|Overall Study|Withdrawal by Subject|0
2028254|NCT00364832|3597529|FG000|Core Period|Early Withdrawals|2
2028255|NCT00364832|3597530|FG001|Core Period|Early Withdrawals|2
2028256|NCT00364832|3597531|FG002|Core Period|Early Withdrawals|1
2028257|NCT00364832|3597532|FG003|Core Period|Early Withdrawals|1
2028258|NCT00364832|3597533|FG004|Core Period|Early Withdrawals|0
2028259|NCT00364832|3597534|FG005|Core Period|Early Withdrawals|0
2028260|NCT00364832|3597535|FG006|Core Period|Early Withdrawals|4
2028261|NCT00364832|3597536|FG007|Core Period|Early Withdrawals|1
2028262|NCT00364832|3597537|FG008|Core Period|Early Withdrawals|0
2028263|NCT00364832|3597538|FG009|Core Period|Early Withdrawals|0
2028264|NCT00364832|3597539|FG010|Core Period|Early Withdrawals|0
2028265|NCT00364832|3597540|FG011|Core Period|Early Withdrawals|0
2028266|NCT00364832|3597529|FG000|Extension Year 1|Early Withdrawals|0
2028267|NCT00364832|3597530|FG001|Extension Year 1|Early Withdrawals|0
2028268|NCT00364832|3597531|FG002|Extension Year 1|Early Withdrawals|0
2028269|NCT00364832|3597532|FG003|Extension Year 1|Early Withdrawals|0
2028270|NCT00364832|3597533|FG004|Extension Year 1|Early Withdrawals|0
2028271|NCT00364832|3597534|FG005|Extension Year 1|Early Withdrawals|0
2028272|NCT00364832|3597535|FG006|Extension Year 1|Early Withdrawals|0
2028273|NCT00364832|3597536|FG007|Extension Year 1|Early Withdrawals|0
2028274|NCT00364832|3597537|FG008|Extension Year 1|Early Withdrawals|0
2028275|NCT00364832|3597538|FG009|Extension Year 1|Early Withdrawals|4
2028276|NCT00364832|3597539|FG010|Extension Year 1|Early Withdrawals|2
2028277|NCT00364832|3597540|FG011|Extension Year 1|Early Withdrawals|10
2028278|NCT00364832|3597529|FG000|Extension Year 2|Early Withdrawals|0
2028279|NCT00364832|3597530|FG001|Extension Year 2|Early Withdrawals|0
2028280|NCT00364832|3597531|FG002|Extension Year 2|Early Withdrawals|0
2028281|NCT00364832|3597532|FG003|Extension Year 2|Early Withdrawals|0
2028282|NCT00364832|3597533|FG004|Extension Year 2|Early Withdrawals|0
2028283|NCT00364832|3597534|FG005|Extension Year 2|Early Withdrawals|0
2028284|NCT00364832|3597535|FG006|Extension Year 2|Early Withdrawals|0
2028285|NCT00364832|3597536|FG007|Extension Year 2|Early Withdrawals|0
2028286|NCT00364832|3597537|FG008|Extension Year 2|Early Withdrawals|0
2028287|NCT00364832|3597538|FG009|Extension Year 2|Early Withdrawals|5
2028288|NCT00364832|3597539|FG010|Extension Year 2|Early Withdrawals|5
2028289|NCT00364832|3597540|FG011|Extension Year 2|Early Withdrawals|3
2028290|NCT00364845|3597559|FG000|Overall Study|Adverse Event|1
2028291|NCT00364845|3597560|FG001|Overall Study|Adverse Event|0
2028292|NCT00364845|3597559|FG000|Overall Study|Withdrawal by Subject|2
2028293|NCT00364845|3597560|FG001|Overall Study|Withdrawal by Subject|1
2028294|NCT00364845|3597559|FG000|Overall Study|Physician Decision|8
2028295|NCT00364845|3597560|FG001|Overall Study|Physician Decision|8
2028296|NCT00364845|3597559|FG000|Overall Study|Lost to Follow-up|0
2028297|NCT00364845|3597560|FG001|Overall Study|Lost to Follow-up|1
2028298|NCT00364845|3597559|FG000|Overall Study|Death|0
2028299|NCT00364845|3597560|FG001|Overall Study|Death|1
2028300|NCT00364858|3597568|FG000|Overall Study|Adverse Event|1
2028301|NCT00364858|3597569|FG001|Overall Study|Adverse Event|5
2028302|NCT00364858|3597568|FG000|Overall Study|Withdrawal by Subject|1
2028303|NCT00364858|3597569|FG001|Overall Study|Withdrawal by Subject|1
2028304|NCT00364858|3597568|FG000|Overall Study|Pregnancy|1
2028305|NCT00364858|3597569|FG001|Overall Study|Pregnancy|1
2028306|NCT00364858|3597568|FG000|Overall Study|Clinical failure|2
2028307|NCT00364858|3597569|FG001|Overall Study|Clinical failure|13
2028308|NCT00364858|3597568|FG000|Overall Study|Discontinuation at baseline|1
2028309|NCT00364858|3597569|FG001|Overall Study|Discontinuation at baseline|0
2028310|NCT00364858|3597568|FG000|Overall Study|Non-compliant|1
2028311|NCT00364858|3597569|FG001|Overall Study|Non-compliant|0
2028312|NCT00364858|3597568|FG000|Overall Study|Return to Q2 regimen|0
2028313|NCT00364858|3597569|FG001|Overall Study|Return to Q2 regimen|1
2028314|NCT00364858|3597568|FG000|Overall Study|Clinical baseline issue|0
2028315|NCT00364858|3597569|FG001|Overall Study|Clinical baseline issue|1
2028316|NCT00364923|3597576|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
2028317|NCT00364923|3597576|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
2028318|NCT00365105|3597595|FG000|Overall Study|Protocol Violation|5
2028319|NCT00365105|3597596|FG001|Overall Study|Protocol Violation|8
2028320|NCT00365300|3597629|FG000|Open-label Phase|Adverse Event|4
2028321|NCT00365300|3597630|FG001|Open-label Phase|Adverse Event|0
2028322|NCT00365300|3597629|FG000|Open-label Phase|Failed to Return|1
2028323|NCT00365300|3597630|FG001|Open-label Phase|Failed to Return|0
2028324|NCT00365300|3597629|FG000|Open-label Phase|Physician Decision|1
2028325|NCT00365300|3597630|FG001|Open-label Phase|Physician Decision|0
2028326|NCT00365300|3597629|FG000|Open-label Phase|Noncompliance|9
2028327|NCT00365300|3597630|FG001|Open-label Phase|Noncompliance|0
2028328|NCT00365300|3597629|FG000|Open-label Phase|Parent/Legal Guardian Request|4
2028329|NCT00365300|3597630|FG001|Open-label Phase|Parent/Legal Guardian Request|0
2028330|NCT00365300|3597629|FG000|Open-label Phase|Protocol Violation|1
2028331|NCT00365300|3597630|FG001|Open-label Phase|Protocol Violation|0
2028332|NCT00365300|3597629|FG000|Open-label Phase|Lack of Efficacy|1
2028333|NCT00365300|3597630|FG001|Open-label Phase|Lack of Efficacy|0
2028334|NCT00365300|3597629|FG000|Open-label Phase|Patient skipped open label phase|1
2028335|NCT00365300|3597630|FG001|Open-label Phase|Patient skipped open label phase|0
2028336|NCT00365300|3597629|FG000|Double-blind Phase|Failed to return|1
2028337|NCT00365300|3597630|FG001|Double-blind Phase|Failed to return|0
2028338|NCT00365300|3597629|FG000|Double-blind Phase|Noncompliance|1
2028339|NCT00365300|3597630|FG001|Double-blind Phase|Noncompliance|1
2028340|NCT00365300|3597629|FG000|Double-blind Phase|Withdrawal by Subject|0
2028341|NCT00365300|3597630|FG001|Double-blind Phase|Withdrawal by Subject|1
2028342|NCT00365300|3597629|FG000|Double-blind Phase|Protocol Violation|3
2028343|NCT00365300|3597630|FG001|Double-blind Phase|Protocol Violation|1
2028344|NCT00365300|3597629|FG000|Double-blind Phase|Lack of Efficacy|6
2028345|NCT00365300|3597630|FG001|Double-blind Phase|Lack of Efficacy|6
2028346|NCT00365352|3597642|FG000|Overall Study|Adverse Event|6
2109350|NCT00886015|3703560|FG001|Overall Study|Death|2
2109351|NCT00886119|3703566|FG000|Period 1|Did not meet inclusion criteria|1
2109352|NCT00886119|3703567|FG001|Period 1|Did not meet inclusion criteria|0
2109353|NCT00886288|3703603|FG000|Overall Study|no respect of the 12 weeks period|657
2109354|NCT00886288|3703604|FG001|Overall Study|no respect of the 12 weeks period|227
2109355|NCT00886288|3703603|FG000|Overall Study|Lost to Follow-up|86
2109356|NCT00886288|3703604|FG001|Overall Study|Lost to Follow-up|0
2109357|NCT00886340|3703614|FG000|Overall Study|Withdrawal by Subject|0
2109358|NCT00886340|3703615|FG001|Overall Study|Withdrawal by Subject|7
2109359|NCT00886379|3703626|FG000|Overall Study|Transferred Schools|0
2109360|NCT00886379|3703627|FG001|Overall Study|Transferred Schools|0
2109361|NCT00886379|3703628|FG002|Overall Study|Transferred Schools|2
2109362|NCT00886379|3703629|FG003|Overall Study|Transferred Schools|1
2109363|NCT00886379|3703630|FG004|Overall Study|Transferred Schools|1
2109364|NCT00886379|3703626|FG000|Overall Study|Final blood draw not obtained|3
2109365|NCT00886379|3703627|FG001|Overall Study|Final blood draw not obtained|3
2109366|NCT00886379|3703628|FG002|Overall Study|Final blood draw not obtained|4
2109367|NCT00886379|3703629|FG003|Overall Study|Final blood draw not obtained|2
2109368|NCT00886379|3703630|FG004|Overall Study|Final blood draw not obtained|2
2109369|NCT00886483|3703644|FG000|Overall Study|Lost to Follow-up|0
2109370|NCT00886483|3703645|FG001|Overall Study|Lost to Follow-up|1
2109371|NCT00886483|3703644|FG000|Overall Study|Pursue medications|1
2109372|NCT00886483|3703645|FG001|Overall Study|Pursue medications|2
2109373|NCT00886483|3703644|FG000|Overall Study|Distance to center, poor grades|1
2109374|NCT00886483|3703645|FG001|Overall Study|Distance to center, poor grades|0
2109375|NCT00886587|3703661|FG000|Overall Study|Adverse Event|2
2109376|NCT00886587|3703662|FG001|Overall Study|Adverse Event|1
2109377|NCT00886587|3703661|FG000|Overall Study|Protocol Violation|2
2109378|NCT00886587|3703662|FG001|Overall Study|Protocol Violation|0
2109379|NCT00886587|3703661|FG000|Overall Study|Withdrawal by Subject|0
2109380|NCT00886587|3703662|FG001|Overall Study|Withdrawal by Subject|1
2109381|NCT00886613|3703671|FG000|Overall Study|Protocol deviation (Part B)|1
2109382|NCT00886613|3703672|FG001|Overall Study|Protocol deviation (Part B)|0
2109383|NCT00886613|3703673|FG002|Overall Study|Protocol deviation (Part B)|0
2109384|NCT00886613|3703671|FG000|Overall Study|Lost to follow-up (Part B)|1
2109385|NCT00886613|3703672|FG001|Overall Study|Lost to follow-up (Part B)|0
2109386|NCT00886613|3703673|FG002|Overall Study|Lost to follow-up (Part B)|1
2109387|NCT00886613|3703671|FG000|Overall Study|Subject withdrew consent (Part A)|0
2109388|NCT00886613|3703672|FG001|Overall Study|Subject withdrew consent (Part A)|0
2109389|NCT00886613|3703673|FG002|Overall Study|Subject withdrew consent (Part A)|2
2109390|NCT00886639|3703691|FG000|Overall Study|acute exacerbation|14
2109391|NCT00886639|3703691|FG000|Overall Study|non-compliance|2
2109392|NCT00886743|3703706|FG000|Overall Study|Adverse Event|3
2109393|NCT00886743|3703706|FG000|Overall Study|Other|1
2109394|NCT00886769|3703712|FG000|Overall Study|Unsatisfactory therapeutic effect|6
2109395|NCT00886769|3703713|FG001|Overall Study|Unsatisfactory therapeutic effect|37
2109396|NCT00886795|3703719|FG000|Overall Study|Lack of Efficacy|1
2109397|NCT00886821|3703738|FG000|Stage 2|Adverse Event|0
2109398|NCT00886821|3703739|FG001|Stage 2|Adverse Event|0
2109399|NCT00886821|3703740|FG002|Stage 2|Adverse Event|0
2109400|NCT00886821|3703741|FG003|Stage 2|Adverse Event|0
2109401|NCT00886821|3703742|FG004|Stage 2|Adverse Event|0
2109402|NCT00886821|3703743|FG005|Stage 2|Adverse Event|0
2109403|NCT00886821|3703744|FG006|Stage 2|Adverse Event|0
2109404|NCT00886821|3703745|FG007|Stage 2|Adverse Event|0
2109405|NCT00886821|3703746|FG008|Stage 2|Adverse Event|0
2109406|NCT00886821|3703747|FG009|Stage 2|Adverse Event|0
2109407|NCT00886821|3703748|FG010|Stage 2|Adverse Event|0
2109408|NCT00886821|3703749|FG011|Stage 2|Adverse Event|1
2109409|NCT00886821|3703750|FG012|Stage 2|Adverse Event|3
2109410|NCT00886821|3703751|FG013|Stage 2|Adverse Event|0
2109411|NCT00886821|3703738|FG000|Stage 2|Lost to Follow-up|0
2109412|NCT00886821|3703739|FG001|Stage 2|Lost to Follow-up|0
2322468|NCT02973087|4037502|FG001|Overall Study|other|1
2028347|NCT00365352|3597643|FG001|Overall Study|Adverse Event|7
2028348|NCT00365352|3597644|FG002|Overall Study|Adverse Event|8
2028349|NCT00365352|3597642|FG000|Overall Study|Participant Withdrew Consent|8
2028350|NCT00365352|3597643|FG001|Overall Study|Participant Withdrew Consent|3
2028351|NCT00365352|3597644|FG002|Overall Study|Participant Withdrew Consent|4
2028352|NCT00365352|3597642|FG000|Overall Study|Lack of Efficacy|3
2028353|NCT00365352|3597643|FG001|Overall Study|Lack of Efficacy|0
2028354|NCT00365352|3597644|FG002|Overall Study|Lack of Efficacy|0
2028355|NCT00365352|3597642|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
2028356|NCT00365352|3597643|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
2028357|NCT00365352|3597644|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
2028358|NCT00365352|3597642|FG000|Overall Study|Non-Compliance (after Randomization)|1
2028359|NCT00365352|3597643|FG001|Overall Study|Non-Compliance (after Randomization)|0
2028360|NCT00365352|3597644|FG002|Overall Study|Non-Compliance (after Randomization)|1
2028361|NCT00365352|3597642|FG000|Overall Study|Lost to Follow-up|1
2028362|NCT00365352|3597643|FG001|Overall Study|Lost to Follow-up|1
2028363|NCT00365352|3597644|FG002|Overall Study|Lost to Follow-up|0
2028364|NCT00365352|3597642|FG000|Overall Study|Withdrawal of Participant by Sponsor|1
2028365|NCT00365352|3597643|FG001|Overall Study|Withdrawal of Participant by Sponsor|0
2028366|NCT00365352|3597644|FG002|Overall Study|Withdrawal of Participant by Sponsor|0
2028367|NCT00365365|3597658|FG000|Overall Study|Randomized but not treated|0
2028368|NCT00365365|3597659|FG001|Overall Study|Randomized but not treated|2
2028369|NCT00365365|3597660|FG002|Overall Study|Randomized but not treated|0
2028370|NCT00365365|3597658|FG000|Overall Study|Poor compliance to protocol|0
2028371|NCT00365365|3597659|FG001|Overall Study|Poor compliance to protocol|1
2028372|NCT00365365|3597660|FG002|Overall Study|Poor compliance to protocol|0
2028373|NCT00365365|3597658|FG000|Overall Study|Lost to Follow-up|3
2028374|NCT00365365|3597659|FG001|Overall Study|Lost to Follow-up|3
2028375|NCT00365365|3597660|FG002|Overall Study|Lost to Follow-up|3
2028376|NCT00365365|3597658|FG000|Overall Study|Death|1
2028377|NCT00365365|3597659|FG001|Overall Study|Death|3
2028378|NCT00365365|3597660|FG002|Overall Study|Death|0
2028379|NCT00365365|3597658|FG000|Overall Study|Subject's request|11
2028380|NCT00365365|3597659|FG001|Overall Study|Subject's request|13
2028381|NCT00365365|3597660|FG002|Overall Study|Subject's request|1
2028382|NCT00365365|3597658|FG000|Overall Study|Disease progression/relapse|9
2109413|NCT00886821|3703740|FG002|Stage 2|Lost to Follow-up|0
2109414|NCT00886821|3703741|FG003|Stage 2|Lost to Follow-up|0
2109415|NCT00886821|3703742|FG004|Stage 2|Lost to Follow-up|0
2109416|NCT00886821|3703743|FG005|Stage 2|Lost to Follow-up|0
2109417|NCT00886821|3703744|FG006|Stage 2|Lost to Follow-up|0
2109418|NCT00886821|3703745|FG007|Stage 2|Lost to Follow-up|0
2109419|NCT00886821|3703746|FG008|Stage 2|Lost to Follow-up|0
2109420|NCT00886821|3703747|FG009|Stage 2|Lost to Follow-up|0
2109421|NCT00886821|3703748|FG010|Stage 2|Lost to Follow-up|0
2109422|NCT00886821|3703749|FG011|Stage 2|Lost to Follow-up|0
2109423|NCT00886821|3703750|FG012|Stage 2|Lost to Follow-up|2
2109424|NCT00886821|3703751|FG013|Stage 2|Lost to Follow-up|1
2109425|NCT00886834|3703797|FG000|Overall Study|Protocol Violation|0
2109426|NCT00886834|3703798|FG001|Overall Study|Protocol Violation|3
2109427|NCT00886938|3703808|FG000|Overall Study|Adverse Event|1
2109428|NCT00886938|3703808|FG000|Overall Study|Withdrawal by Subject|1
2109429|NCT00887068|3703814|FG000|Overall Study|Withdrawal by Subject|2
2109430|NCT00887068|3703815|FG001|Overall Study|Withdrawal by Subject|0
2109431|NCT00887068|3703814|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4
2109432|NCT00887068|3703815|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0
2109433|NCT00887159|3703824|FG000|Overall Study|Disease progression|6
2109434|NCT00887159|3703825|FG001|Overall Study|Disease progression|39
2109435|NCT00887159|3703826|FG002|Overall Study|Disease progression|33
2109436|NCT00887159|3703824|FG000|Overall Study|Adverse Event|3
2109437|NCT00887159|3703825|FG001|Overall Study|Adverse Event|4
2109438|NCT00887159|3703826|FG002|Overall Study|Adverse Event|17
2109439|NCT00887159|3703824|FG000|Overall Study|Death|2
2109440|NCT00887159|3703825|FG001|Overall Study|Death|2
2109441|NCT00887159|3703826|FG002|Overall Study|Death|0
2109442|NCT00887159|3703824|FG000|Overall Study|Withdrawal by Subject|4
2109443|NCT00887159|3703825|FG001|Overall Study|Withdrawal by Subject|4
2180229|NCT01399905|3806242|FG000|Overall Study|Withdrawal by Subject|1
2180230|NCT01399905|3806243|FG001|Overall Study|Withdrawal by Subject|1
2180231|NCT01400113|3806256|FG000|Overall Study|Withdrawal by Subject|1
2180232|NCT01400113|3806257|FG001|Overall Study|Withdrawal by Subject|1
2180233|NCT01400139|3806263|FG000|HYD Core Study|Adverse Event|210
2180234|NCT01400139|3806263|FG000|HYD Core Study|Lack of Efficacy|59
2180235|NCT01400139|3806263|FG000|HYD Core Study|Withdrawal by Subject|114
2180236|NCT01400139|3806263|FG000|HYD Core Study|Lost to Follow-up|39
2180237|NCT01400139|3806263|FG000|HYD Core Study|Confirmed or suspected diversion|20
2180238|NCT01400139|3806263|FG000|HYD Core Study|Administrative|56
2180239|NCT01400139|3806263|FG000|HYD Core Study|Did not qualify for Maintenance Period|14
2180240|NCT01400139|3806263|FG000|HYD Extension Period|Adverse Event|8
2180241|NCT01400139|3806263|FG000|HYD Extension Period|Withdrawal by Subject|5
2109444|NCT00887159|3703826|FG002|Overall Study|Withdrawal by Subject|2
2109445|NCT00887159|3703824|FG000|Overall Study|Alternative therapy|2
2109446|NCT00887159|3703825|FG001|Overall Study|Alternative therapy|0
2109447|NCT00887159|3703826|FG002|Overall Study|Alternative therapy|0
2180242|NCT01400139|3806263|FG000|HYD Extension Period|Administrative|10
2028383|NCT00365365|3597659|FG001|Overall Study|Disease progression/relapse|6
2028384|NCT00365365|3597660|FG002|Overall Study|Disease progression/relapse|7
2028385|NCT00365365|3597658|FG000|Overall Study|Adverse Event|6
2028386|NCT00365365|3597659|FG001|Overall Study|Adverse Event|6
2028387|NCT00365365|3597660|FG002|Overall Study|Adverse Event|3
2028388|NCT00365365|3597658|FG000|Overall Study|Moved|2
2028389|NCT00365365|3597659|FG001|Overall Study|Moved|0
2028390|NCT00365365|3597660|FG002|Overall Study|Moved|0
2028391|NCT00365365|3597658|FG000|Overall Study|New cancer|1
2028392|NCT00365365|3597659|FG001|Overall Study|New cancer|0
2028393|NCT00365365|3597660|FG002|Overall Study|New cancer|0
2028394|NCT00365365|3597658|FG000|Overall Study|Withdrew consent|1
2028395|NCT00365365|3597659|FG001|Overall Study|Withdrew consent|1
2028396|NCT00365365|3597660|FG002|Overall Study|Withdrew consent|0
2028397|NCT00365365|3597658|FG000|Overall Study|Second malignancy|0
2028398|NCT00365365|3597659|FG001|Overall Study|Second malignancy|1
2028399|NCT00365365|3597660|FG002|Overall Study|Second malignancy|0
2028400|NCT00365365|3597658|FG000|Overall Study|Patient/physician decision|0
2028401|NCT00365365|3597659|FG001|Overall Study|Patient/physician decision|0
2028402|NCT00365365|3597660|FG002|Overall Study|Patient/physician decision|1
2028403|NCT00365378|3597670|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
2028404|NCT00365378|3597671|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
2028405|NCT00365378|3597672|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
2028406|NCT00365378|3597670|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4
2028407|NCT00365378|3597671|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5
2028408|NCT00365378|3597672|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0
2028409|NCT00365378|3597670|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
2028410|NCT00365378|3597671|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
2028411|NCT00365378|3597672|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
2028412|NCT00365378|3597670|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19
2028413|NCT00365378|3597671|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14
2028414|NCT00365378|3597672|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0
2028415|NCT00365378|3597670|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22
2028416|NCT00365378|3597671|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13
2028417|NCT00365378|3597672|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0
2028418|NCT00365378|3597670|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
2028419|NCT00365378|3597671|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
2028420|NCT00365378|3597672|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
2028421|NCT00365378|3597670|FG000|Vaccination (Day 1 to Month 7)|Other|17
2028422|NCT00365378|3597671|FG001|Vaccination (Day 1 to Month 7)|Other|9
2028423|NCT00365378|3597672|FG002|Vaccination (Day 1 to Month 7)|Other|0
2028424|NCT00365378|3597670|FG000|Follow-up (Month 7 Though Month 48)|Moved|6
2028425|NCT00365378|3597671|FG001|Follow-up (Month 7 Though Month 48)|Moved|5
2217800|NCT01709721|3861047|FG000|Randomized Phase|Lost to Follow-up|1
2028426|NCT00365378|3597672|FG002|Follow-up (Month 7 Though Month 48)|Moved|0
2028427|NCT00365378|3597670|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
2028428|NCT00365378|3597671|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
2028429|NCT00365378|3597672|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
2028430|NCT00365378|3597670|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0
2028431|NCT00365378|3597671|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1
2028432|NCT00365378|3597672|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0
2028433|NCT00365378|3597670|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
2109448|NCT00887159|3703824|FG000|Overall Study|Physician Decision|1
2109449|NCT00887159|3703825|FG001|Overall Study|Physician Decision|1
2109450|NCT00887159|3703826|FG002|Overall Study|Physician Decision|0
2109451|NCT00887159|3703824|FG000|Overall Study|Sympomatic deterioration|1
2109452|NCT00887159|3703825|FG001|Overall Study|Sympomatic deterioration|0
2109453|NCT00887159|3703826|FG002|Overall Study|Sympomatic deterioration|0
2109454|NCT00887159|3703824|FG000|Overall Study|Treatment delayed|1
2109455|NCT00887159|3703825|FG001|Overall Study|Treatment delayed|1
2109456|NCT00887159|3703826|FG002|Overall Study|Treatment delayed|0
2109457|NCT00887159|3703824|FG000|Overall Study|Pt had PD but was SD when re-measured|0
2109458|NCT00887159|3703825|FG001|Overall Study|Pt had PD but was SD when re-measured|1
2109459|NCT00887159|3703826|FG002|Overall Study|Pt had PD but was SD when re-measured|0
2109460|NCT00887159|3703824|FG000|Overall Study|Received more tx instead of observation|1
2109461|NCT00887159|3703825|FG001|Overall Study|Received more tx instead of observation|0
2109462|NCT00887159|3703826|FG002|Overall Study|Received more tx instead of observation|0
2109463|NCT00887159|3703824|FG000|Overall Study|Ineligible|5
2109464|NCT00887159|3703825|FG001|Overall Study|Ineligible|1
2109465|NCT00887159|3703826|FG002|Overall Study|Ineligible|0
2109466|NCT00887159|3703824|FG000|Overall Study|Never started assigned therapy|3
2109467|NCT00887159|3703825|FG001|Overall Study|Never started assigned therapy|3
2109468|NCT00887159|3703826|FG002|Overall Study|Never started assigned therapy|4
2109469|NCT00887198|3703838|FG000|Randomized Period|Ongoing|42
2109470|NCT00887198|3703839|FG001|Randomized Period|Ongoing|0
2109471|NCT00887198|3703840|FG002|Randomized Period|Ongoing|0
2109472|NCT00887198|3703838|FG000|Randomized Period|Adverse Event|50
2109473|NCT00887198|3703839|FG001|Randomized Period|Adverse Event|33
2109474|NCT00887198|3703840|FG002|Randomized Period|Adverse Event|0
2109475|NCT00887198|3703838|FG000|Randomized Period|Lost to Follow-up|1
2028434|NCT00365378|3597671|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
2028435|NCT00365378|3597672|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
2028436|NCT00365378|3597670|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
2028437|NCT00365378|3597671|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
2028438|NCT00365378|3597672|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
2028439|NCT00365378|3597670|FG000|Follow-up (Month 7 Though Month 48)|Other|11
2028440|NCT00365378|3597671|FG001|Follow-up (Month 7 Though Month 48)|Other|21
2028441|NCT00365378|3597672|FG002|Follow-up (Month 7 Though Month 48)|Other|0
2028442|NCT00365378|3597670|FG000|Extension|Adverse Event|0
2028443|NCT00365378|3597671|FG001|Extension|Adverse Event|0
2028444|NCT00365378|3597672|FG002|Extension|Adverse Event|1
2028445|NCT00365378|3597670|FG000|Extension|Moved|0
2028446|NCT00365378|3597671|FG001|Extension|Moved|0
2028447|NCT00365378|3597672|FG002|Extension|Moved|8
2028448|NCT00365378|3597670|FG000|Extension|Lost to Follow-up|0
2028449|NCT00365378|3597671|FG001|Extension|Lost to Follow-up|0
2028450|NCT00365378|3597672|FG002|Extension|Lost to Follow-up|57
2028451|NCT00365378|3597670|FG000|Extension|Protocol Violation|0
2028452|NCT00365378|3597671|FG001|Extension|Protocol Violation|0
2028453|NCT00365378|3597672|FG002|Extension|Protocol Violation|2
2028454|NCT00365378|3597670|FG000|Extension|Withdrawal by Subject|0
2028455|NCT00365378|3597671|FG001|Extension|Withdrawal by Subject|0
2028456|NCT00365378|3597672|FG002|Extension|Withdrawal by Subject|98
2028457|NCT00365378|3597670|FG000|Extension|Other|0
2028458|NCT00365378|3597671|FG001|Extension|Other|0
2028459|NCT00365378|3597672|FG002|Extension|Other|31
2028460|NCT00365456|3597688|FG000|Trial Period I (12 Months)|Adverse Event|84
2028461|NCT00365456|3597689|FG001|Trial Period I (12 Months)|Adverse Event|0
2028462|NCT00365456|3597688|FG000|Trial Period I (12 Months)|Non-compliance|3
2028463|NCT00365456|3597689|FG001|Trial Period I (12 Months)|Non-compliance|0
2028464|NCT00365456|3597688|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27
2028465|NCT00365456|3597689|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0
2028466|NCT00365456|3597688|FG000|Trial Period I (12 Months)|Other|11
2028467|NCT00365456|3597689|FG001|Trial Period I (12 Months)|Other|0
2028468|NCT00365456|3597688|FG000|Trial Period II (12 Months)|Adverse Event|0
2028469|NCT00365456|3597689|FG001|Trial Period II (12 Months)|Adverse Event|6
2028470|NCT00365456|3597688|FG000|Trial Period II (12 Months)|Non-compliance|0
2028471|NCT00365456|3597689|FG001|Trial Period II (12 Months)|Non-compliance|2
2028472|NCT00365456|3597688|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0
2028473|NCT00365456|3597689|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5
2028474|NCT00365456|3597688|FG000|Trial Period II (12 Months)|Other|0
2028475|NCT00365456|3597689|FG001|Trial Period II (12 Months)|Other|1
2028476|NCT00365456|3597688|FG000|Trial Period III (12 Months)|Adverse Event|13
2028477|NCT00365456|3597689|FG001|Trial Period III (12 Months)|Adverse Event|3
2028478|NCT00365456|3597688|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4
2028479|NCT00365456|3597689|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1
2028480|NCT00365456|3597688|FG000|Trial Period III (12 Months)|Other|1
2028481|NCT00365456|3597689|FG001|Trial Period III (12 Months)|Other|1
2028482|NCT00365508|3597697|FG000|Overall Study|Lost to Follow-up|139
2028483|NCT00365508|3597698|FG001|Overall Study|Lost to Follow-up|154
2028484|NCT00365547|3597704|FG000|Overall Study|Insurance did not cover Avastin|1
2028485|NCT00365547|3597704|FG000|Overall Study|Screen failure|1
2028486|NCT00365547|3597704|FG000|Overall Study|Withdrawal by Subject|1
2028487|NCT00365716|3597720|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
2028488|NCT00365716|3597721|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
2028489|NCT00365716|3597722|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
2028490|NCT00365716|3597723|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
2028491|NCT00365716|3597724|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
2028492|NCT00365716|3597725|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
2028493|NCT00365716|3597726|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
2028494|NCT00365716|3597720|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0
2028495|NCT00365716|3597721|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2
2028496|NCT00365716|3597722|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0
2028497|NCT00365716|3597723|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0
2028498|NCT00365716|3597724|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1
2028499|NCT00365716|3597725|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0
2028500|NCT00365716|3597726|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0
2028501|NCT00365716|3597720|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
2028502|NCT00365716|3597721|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
2028503|NCT00365716|3597722|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
2028504|NCT00365716|3597723|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
2028505|NCT00365716|3597724|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
2028506|NCT00365716|3597725|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
2028507|NCT00365716|3597726|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
2028508|NCT00365716|3597720|FG000|Base Study (Day 1 to Month 7)|Other|0
2028509|NCT00365716|3597721|FG001|Base Study (Day 1 to Month 7)|Other|1
2028510|NCT00365716|3597722|FG002|Base Study (Day 1 to Month 7)|Other|0
2028511|NCT00365716|3597723|FG003|Base Study (Day 1 to Month 7)|Other|0
2109476|NCT00887198|3703839|FG001|Randomized Period|Lost to Follow-up|0
2028512|NCT00365716|3597724|FG004|Base Study (Day 1 to Month 7)|Other|0
2028513|NCT00365716|3597725|FG005|Base Study (Day 1 to Month 7)|Other|0
2028514|NCT00365716|3597726|FG006|Base Study (Day 1 to Month 7)|Other|0
2028515|NCT00365716|3597720|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3
2028516|NCT00365716|3597721|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2
2028517|NCT00365716|3597722|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3
2028518|NCT00365716|3597723|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1
2109477|NCT00887198|3703840|FG002|Randomized Period|Lost to Follow-up|0
2109478|NCT00887198|3703838|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0
2109479|NCT00887198|3703839|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51
2109480|NCT00887198|3703840|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0
2109481|NCT00887198|3703838|FG000|Randomized Period|Withdrawal by Subject|41
2109482|NCT00887198|3703839|FG001|Randomized Period|Withdrawal by Subject|56
2109483|NCT00887198|3703840|FG002|Randomized Period|Withdrawal by Subject|0
2109484|NCT00887198|3703838|FG000|Randomized Period|Progressive disease|366
2109485|NCT00887198|3703839|FG001|Randomized Period|Progressive disease|370
2109486|NCT00887198|3703840|FG002|Randomized Period|Progressive disease|0
2109487|NCT00887198|3703838|FG000|Randomized Period|Other|42
2109488|NCT00887198|3703839|FG001|Randomized Period|Other|30
2109489|NCT00887198|3703840|FG002|Randomized Period|Other|0
2109490|NCT00887198|3703838|FG000|Randomized Period|Randomized, Not treated|4
2109491|NCT00887198|3703839|FG001|Randomized Period|Randomized, Not treated|2
2109492|NCT00887198|3703840|FG002|Randomized Period|Randomized, Not treated|0
2109493|NCT00887198|3703838|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
2109494|NCT00887198|3703839|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
2109495|NCT00887198|3703840|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
2109496|NCT00887198|3703838|FG000|Cross Over (Placebo to AA)|Ongoing|0
2217801|NCT01709721|3861048|FG001|Randomized Phase|Lost to Follow-up|0
2217802|NCT01709721|3861049|FG002|Randomized Phase|Lost to Follow-up|0
2217803|NCT01709721|3861047|FG000|Randomized Phase|Inadequate Pain Control|1
2217804|NCT01709721|3861048|FG001|Randomized Phase|Inadequate Pain Control|2
2217805|NCT01709721|3861049|FG002|Randomized Phase|Inadequate Pain Control|0
2217806|NCT01709721|3861047|FG000|Randomized Phase|Other, Specify text field in database|1
2217807|NCT01709721|3861048|FG001|Randomized Phase|Other, Specify text field in database|3
2217808|NCT01709721|3861049|FG002|Randomized Phase|Other, Specify text field in database|0
2217809|NCT01709838|3861081|FG000|Overall Study|Withdrawal by Subject|21
2217810|NCT01709838|3861081|FG000|Overall Study|Lost to Follow-up|16
2217811|NCT01709838|3861081|FG000|Overall Study|Pregnancy|10
2217812|NCT01709838|3861081|FG000|Overall Study|Subject/guardian decision|8
2217813|NCT01709838|3861081|FG000|Overall Study|Adverse Event|4
2217814|NCT01709838|3861081|FG000|Overall Study|Physician Decision|4
2217815|NCT01709838|3861081|FG000|Overall Study|Death|3
2217816|NCT01709838|3861081|FG000|Overall Study|Protocol Violation|1
2217817|NCT01709864|3861089|FG000|Overall Study|Physician Decision|0
2217818|NCT01709864|3861090|FG001|Overall Study|Physician Decision|1
2217819|NCT01709864|3861089|FG000|Overall Study|subject/guardian decision|5
2217820|NCT01709864|3861090|FG001|Overall Study|subject/guardian decision|6
2217821|NCT01709864|3861089|FG000|Overall Study|Lost to Follow-up|1
2217822|NCT01709864|3861090|FG001|Overall Study|Lost to Follow-up|0
2217823|NCT01709864|3861089|FG000|Overall Study|non-compliance with study treatment|1
2028519|NCT00365716|3597724|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1
2109497|NCT00887198|3703839|FG001|Cross Over (Placebo to AA)|Ongoing|0
2109498|NCT00887198|3703840|FG002|Cross Over (Placebo to AA)|Ongoing|35
2109499|NCT00887198|3703838|FG000|Cross Over (Placebo to AA)|Adverse Event|0
2109500|NCT00887198|3703839|FG001|Cross Over (Placebo to AA)|Adverse Event|0
2109501|NCT00887198|3703840|FG002|Cross Over (Placebo to AA)|Adverse Event|9
2109502|NCT00887198|3703838|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0
2109503|NCT00887198|3703839|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0
2109504|NCT00887198|3703840|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2
2109505|NCT00887198|3703838|FG000|Cross Over (Placebo to AA)|Progressive disease|0
2109506|NCT00887198|3703839|FG001|Cross Over (Placebo to AA)|Progressive disease|0
2109507|NCT00887198|3703840|FG002|Cross Over (Placebo to AA)|Progressive disease|20
2109508|NCT00887198|3703838|FG000|Cross Over (Placebo to AA)|Other|0
2109509|NCT00887198|3703839|FG001|Cross Over (Placebo to AA)|Other|0
2109510|NCT00887198|3703840|FG002|Cross Over (Placebo to AA)|Other|19
2109511|NCT00887224|3703851|FG000|Open-label Response (OLR) Phase|Adverse Event|46
2109512|NCT00887224|3703852|FG001|Open-label Response (OLR) Phase|Adverse Event|0
2109513|NCT00887224|3703853|FG002|Open-label Response (OLR) Phase|Adverse Event|0
2109514|NCT00887224|3703851|FG000|Open-label Response (OLR) Phase|Failed to return|6
2109515|NCT00887224|3703852|FG001|Open-label Response (OLR) Phase|Failed to return|0
2109516|NCT00887224|3703853|FG002|Open-label Response (OLR) Phase|Failed to return|0
2109517|NCT00887224|3703851|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26
2109518|NCT00887224|3703852|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0
2109519|NCT00887224|3703853|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0
2109520|NCT00887224|3703851|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16
2109521|NCT00887224|3703852|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0
2109522|NCT00887224|3703853|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0
2109523|NCT00887224|3703851|FG000|Open-label Response (OLR) Phase|Other|1
2217824|NCT01709864|3861090|FG001|Overall Study|non-compliance with study treatment|1
2217825|NCT01709864|3861089|FG000|Overall Study|Adverse Event|0
2028520|NCT00365716|3597725|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0
2028521|NCT00365716|3597726|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0
2028522|NCT00365716|3597720|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1
2028523|NCT00365716|3597721|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2
2028524|NCT00365716|3597722|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0
2028525|NCT00365716|3597723|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1
2028526|NCT00365716|3597724|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2
2028527|NCT00365716|3597725|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0
2028528|NCT00365716|3597726|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0
2028529|NCT00365716|3597720|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
2028530|NCT00365716|3597721|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
2028531|NCT00365716|3597722|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
2028532|NCT00365716|3597723|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
2028533|NCT00365716|3597724|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
2028534|NCT00365716|3597725|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
2028535|NCT00365716|3597726|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
2028536|NCT00365716|3597720|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
2028537|NCT00365716|3597721|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
2028538|NCT00365716|3597722|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
2028539|NCT00365716|3597723|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
2028540|NCT00365716|3597724|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
2028541|NCT00365716|3597725|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
2028542|NCT00365716|3597726|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
2028543|NCT00365716|3597720|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
2028544|NCT00365716|3597721|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
2028545|NCT00365716|3597722|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
2028546|NCT00365716|3597723|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
2028547|NCT00365716|3597724|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
2028548|NCT00365716|3597725|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
2109524|NCT00887224|3703852|FG001|Open-label Response (OLR) Phase|Other|0
2109525|NCT00887224|3703853|FG002|Open-label Response (OLR) Phase|Other|0
2109526|NCT00887224|3703851|FG000|Open-label Response (OLR) Phase|Protocol Violation|12
2109527|NCT00887224|3703852|FG001|Open-label Response (OLR) Phase|Protocol Violation|0
2109528|NCT00887224|3703853|FG002|Open-label Response (OLR) Phase|Protocol Violation|0
2109529|NCT00887224|3703851|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15
2109530|NCT00887224|3703852|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0
2109531|NCT00887224|3703853|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0
2109532|NCT00887224|3703851|FG000|Open-label Stability (OLS) Phase|Adverse Event|22
2109533|NCT00887224|3703852|FG001|Open-label Stability (OLS) Phase|Adverse Event|0
2109534|NCT00887224|3703853|FG002|Open-label Stability (OLS) Phase|Adverse Event|0
2109535|NCT00887224|3703851|FG000|Open-label Stability (OLS) Phase|Failed to return|3
2109536|NCT00887224|3703852|FG001|Open-label Stability (OLS) Phase|Failed to return|0
2109537|NCT00887224|3703853|FG002|Open-label Stability (OLS) Phase|Failed to return|0
2109538|NCT00887224|3703851|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16
2109539|NCT00887224|3703852|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0
2109540|NCT00887224|3703853|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0
2109541|NCT00887224|3703851|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9
2109542|NCT00887224|3703852|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0
2109543|NCT00887224|3703853|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0
2109544|NCT00887224|3703851|FG000|Open-label Stability (OLS) Phase|Other|1
2109545|NCT00887224|3703852|FG001|Open-label Stability (OLS) Phase|Other|0
2109546|NCT00887224|3703853|FG002|Open-label Stability (OLS) Phase|Other|0
2109547|NCT00887224|3703851|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13
2109548|NCT00887224|3703852|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0
2109549|NCT00887224|3703853|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0
2109550|NCT00887224|3703851|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
2109551|NCT00887224|3703852|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
2109552|NCT00887224|3703853|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
2109553|NCT00887224|3703851|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28
2109554|NCT00887224|3703852|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0
2109555|NCT00887224|3703853|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0
2109556|NCT00887224|3703851|FG000|OL Taper Phase / OL Follow Up|Failed to return|17
2109557|NCT00887224|3703852|FG001|OL Taper Phase / OL Follow Up|Failed to return|0
2109558|NCT00887224|3703853|FG002|OL Taper Phase / OL Follow Up|Failed to return|0
2109559|NCT00887224|3703851|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10
2109560|NCT00887224|3703852|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0
2109561|NCT00887224|3703853|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0
2109562|NCT00887224|3703851|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
2109563|NCT00887224|3703852|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
2109564|NCT00887224|3703853|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
2109565|NCT00887224|3703851|FG000|OL Taper Phase / OL Follow Up|Other|30
2180243|NCT01400243|3806271|FG000|Overall Study|Protocol Violation|8
2028549|NCT00365716|3597726|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
2028550|NCT00365716|3597720|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
2028551|NCT00365716|3597721|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
2028552|NCT00365716|3597722|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
2028553|NCT00365716|3597723|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
2028554|NCT00365716|3597724|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
2028555|NCT00365716|3597725|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
2028556|NCT00365716|3597726|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
2028557|NCT00365716|3597720|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2
2028558|NCT00365716|3597721|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0
2028559|NCT00365716|3597722|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0
2028560|NCT00365716|3597723|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0
2028561|NCT00365716|3597724|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1
2028562|NCT00365716|3597725|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0
2028563|NCT00365716|3597726|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0
2028564|NCT00365716|3597720|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
2028565|NCT00365716|3597721|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
2028566|NCT00365716|3597722|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
2028567|NCT00365716|3597723|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
2028568|NCT00365716|3597724|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
2028569|NCT00365716|3597725|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
2028570|NCT00365716|3597726|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
2028571|NCT00365716|3597720|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
2028572|NCT00365716|3597721|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
2028573|NCT00365716|3597722|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
2028574|NCT00365716|3597723|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
2028575|NCT00365716|3597724|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
2028576|NCT00365716|3597725|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
2028577|NCT00365716|3597726|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
2028578|NCT00365716|3597720|FG000|Extension 1|Lost to Follow-up|0
2028579|NCT00365716|3597721|FG001|Extension 1|Lost to Follow-up|0
2109566|NCT00887224|3703852|FG001|OL Taper Phase / OL Follow Up|Other|0
2109567|NCT00887224|3703853|FG002|OL Taper Phase / OL Follow Up|Other|0
2109568|NCT00887224|3703851|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3
2109569|NCT00887224|3703852|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0
2109570|NCT00887224|3703853|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0
2109571|NCT00887224|3703851|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
2109572|NCT00887224|3703852|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
2109573|NCT00887224|3703853|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
2109574|NCT00887224|3703851|FG000|Double-blind (DB) Phase|Adverse Event|0
2109575|NCT00887224|3703852|FG001|Double-blind (DB) Phase|Adverse Event|7
2109576|NCT00887224|3703853|FG002|Double-blind (DB) Phase|Adverse Event|2
2109577|NCT00887224|3703851|FG000|Double-blind (DB) Phase|Failed to return|0
2109578|NCT00887224|3703852|FG001|Double-blind (DB) Phase|Failed to return|2
2109579|NCT00887224|3703853|FG002|Double-blind (DB) Phase|Failed to return|2
2109580|NCT00887224|3703851|FG000|Double-blind (DB) Phase|Lack of Efficacy|0
2109581|NCT00887224|3703852|FG001|Double-blind (DB) Phase|Lack of Efficacy|67
2109582|NCT00887224|3703853|FG002|Double-blind (DB) Phase|Lack of Efficacy|33
2109583|NCT00887224|3703851|FG000|Double-blind (DB) Phase|Lost to Follow-up|0
2109584|NCT00887224|3703852|FG001|Double-blind (DB) Phase|Lost to Follow-up|8
2109585|NCT00887224|3703853|FG002|Double-blind (DB) Phase|Lost to Follow-up|8
2109586|NCT00887224|3703851|FG000|Double-blind (DB) Phase|Other|0
2109587|NCT00887224|3703852|FG001|Double-blind (DB) Phase|Other|2
2109588|NCT00887224|3703853|FG002|Double-blind (DB) Phase|Other|0
2109589|NCT00887224|3703851|FG000|Double-blind (DB) Phase|Protocol Violation|0
2109590|NCT00887224|3703852|FG001|Double-blind (DB) Phase|Protocol Violation|8
2109591|NCT00887224|3703853|FG002|Double-blind (DB) Phase|Protocol Violation|5
2109592|NCT00887224|3703851|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0
2109593|NCT00887224|3703852|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6
2109594|NCT00887224|3703853|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12
2109595|NCT00887224|3703851|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0
2109596|NCT00887224|3703852|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5
2109597|NCT00887224|3703853|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0
2109598|NCT00887224|3703851|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0
2109599|NCT00887224|3703852|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5
2109600|NCT00887224|3703853|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4
2109601|NCT00887224|3703851|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0
2109602|NCT00887224|3703852|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6
2109603|NCT00887224|3703853|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0
2109604|NCT00887224|3703851|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
2109605|NCT00887224|3703852|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
2109606|NCT00887224|3703853|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
2322469|NCT02973100|4037513|FG000|Overall Study|Adverse Event|1
2028580|NCT00365716|3597722|FG002|Extension 1|Lost to Follow-up|0
2028581|NCT00365716|3597723|FG003|Extension 1|Lost to Follow-up|0
2028582|NCT00365716|3597724|FG004|Extension 1|Lost to Follow-up|0
2028583|NCT00365716|3597725|FG005|Extension 1|Lost to Follow-up|1
2028584|NCT00365716|3597726|FG006|Extension 1|Lost to Follow-up|0
2028585|NCT00365716|3597720|FG000|Extension 1|Other|0
2028586|NCT00365716|3597721|FG001|Extension 1|Other|0
2028587|NCT00365716|3597722|FG002|Extension 1|Other|0
2028588|NCT00365716|3597723|FG003|Extension 1|Other|0
2028589|NCT00365716|3597724|FG004|Extension 1|Other|0
2028590|NCT00365716|3597725|FG005|Extension 1|Other|9
2028591|NCT00365716|3597726|FG006|Extension 1|Other|0
2028592|NCT00365716|3597720|FG000|Extension 1|Moved|0
2028593|NCT00365716|3597721|FG001|Extension 1|Moved|0
2028594|NCT00365716|3597722|FG002|Extension 1|Moved|0
2028595|NCT00365716|3597723|FG003|Extension 1|Moved|0
2028596|NCT00365716|3597724|FG004|Extension 1|Moved|0
2028597|NCT00365716|3597725|FG005|Extension 1|Moved|4
2028598|NCT00365716|3597726|FG006|Extension 1|Moved|0
2028599|NCT00365716|3597720|FG000|Extension 1|Withdrawal by Subject|0
2028600|NCT00365716|3597721|FG001|Extension 1|Withdrawal by Subject|0
2028601|NCT00365716|3597722|FG002|Extension 1|Withdrawal by Subject|0
2028602|NCT00365716|3597723|FG003|Extension 1|Withdrawal by Subject|0
2028603|NCT00365716|3597724|FG004|Extension 1|Withdrawal by Subject|0
2028604|NCT00365716|3597725|FG005|Extension 1|Withdrawal by Subject|3
2028605|NCT00365716|3597726|FG006|Extension 1|Withdrawal by Subject|0
2028606|NCT00365716|3597720|FG000|Extension 1|Pregnancy|0
2028607|NCT00365716|3597721|FG001|Extension 1|Pregnancy|0
2028608|NCT00365716|3597722|FG002|Extension 1|Pregnancy|0
2028609|NCT00365716|3597723|FG003|Extension 1|Pregnancy|0
2028610|NCT00365716|3597724|FG004|Extension 1|Pregnancy|0
2028611|NCT00365716|3597725|FG005|Extension 1|Pregnancy|4
2028612|NCT00365716|3597726|FG006|Extension 1|Pregnancy|0
2028613|NCT00365716|3597720|FG000|Extension 1|Protocol Violation|0
2028614|NCT00365716|3597721|FG001|Extension 1|Protocol Violation|0
2028615|NCT00365716|3597722|FG002|Extension 1|Protocol Violation|0
2028616|NCT00365716|3597723|FG003|Extension 1|Protocol Violation|0
2028617|NCT00365716|3597724|FG004|Extension 1|Protocol Violation|0
2028618|NCT00365716|3597725|FG005|Extension 1|Protocol Violation|1
2028619|NCT00365716|3597726|FG006|Extension 1|Protocol Violation|0
2028620|NCT00365716|3597720|FG000|Extension 2|Lost to Follow-up|0
2028621|NCT00365716|3597721|FG001|Extension 2|Lost to Follow-up|0
2028622|NCT00365716|3597722|FG002|Extension 2|Lost to Follow-up|0
2028623|NCT00365716|3597723|FG003|Extension 2|Lost to Follow-up|0
2028624|NCT00365716|3597724|FG004|Extension 2|Lost to Follow-up|0
2028625|NCT00365716|3597725|FG005|Extension 2|Lost to Follow-up|0
2028626|NCT00365716|3597726|FG006|Extension 2|Lost to Follow-up|2
2028627|NCT00365716|3597720|FG000|Extension 2|Other|0
2028628|NCT00365716|3597721|FG001|Extension 2|Other|0
2028629|NCT00365716|3597722|FG002|Extension 2|Other|0
2028630|NCT00365716|3597723|FG003|Extension 2|Other|0
2028631|NCT00365716|3597724|FG004|Extension 2|Other|0
2028632|NCT00365716|3597725|FG005|Extension 2|Other|0
2322470|NCT02973100|4037514|FG001|Overall Study|Adverse Event|2
2322471|NCT02973100|4037515|FG002|Overall Study|Adverse Event|1
2322472|NCT02973100|4037516|FG003|Overall Study|Adverse Event|2
2322473|NCT02973100|4037513|FG000|Overall Study|Lost to Follow-up|3
2322474|NCT02973100|4037514|FG001|Overall Study|Lost to Follow-up|1
2322475|NCT02973100|4037515|FG002|Overall Study|Lost to Follow-up|1
2322476|NCT02973100|4037516|FG003|Overall Study|Lost to Follow-up|0
2322477|NCT02973100|4037513|FG000|Overall Study|Withdrawal by Subject|3
2322478|NCT02973100|4037514|FG001|Overall Study|Withdrawal by Subject|5
2322479|NCT02973100|4037515|FG002|Overall Study|Withdrawal by Subject|1
2322480|NCT02973100|4037516|FG003|Overall Study|Withdrawal by Subject|4
2322481|NCT02973100|4037513|FG000|Overall Study|Notification of change in address|0
2322482|NCT02973100|4037514|FG001|Overall Study|Notification of change in address|0
2322483|NCT02973100|4037515|FG002|Overall Study|Notification of change in address|0
2322484|NCT02973100|4037516|FG003|Overall Study|Notification of change in address|1
2322485|NCT02973100|4037513|FG000|Overall Study|Failed to attend Safety followup period|0
2322486|NCT02973100|4037514|FG001|Overall Study|Failed to attend Safety followup period|0
2322487|NCT02973100|4037515|FG002|Overall Study|Failed to attend Safety followup period|1
2322488|NCT02973100|4037516|FG003|Overall Study|Failed to attend Safety followup period|0
2322489|NCT02973321|4037534|FG000|Overall Study|Other than specified|0
2322490|NCT02973321|4037535|FG001|Overall Study|Other than specified|5
2322491|NCT02973321|4037536|FG002|Overall Study|Other than specified|3
2322492|NCT02973321|4037537|FG003|Overall Study|Other than specified|3
2028633|NCT00365716|3597726|FG006|Extension 2|Other|3
2028634|NCT00365716|3597720|FG000|Extension 2|Withdrawal by Subject|0
2028635|NCT00365716|3597721|FG001|Extension 2|Withdrawal by Subject|0
2028636|NCT00365716|3597722|FG002|Extension 2|Withdrawal by Subject|0
2028637|NCT00365716|3597723|FG003|Extension 2|Withdrawal by Subject|0
2028638|NCT00365716|3597724|FG004|Extension 2|Withdrawal by Subject|0
2028639|NCT00365716|3597725|FG005|Extension 2|Withdrawal by Subject|0
2028640|NCT00365716|3597726|FG006|Extension 2|Withdrawal by Subject|5
2028641|NCT00365794|3597749|FG000|Overall Study|Withdrawal by Subject|2
2028642|NCT00365846|3597754|FG000|Overall Study|Lost to Follow-up|1
2028643|NCT00365976|3597789|FG000|Overall Study|Withdrawal by Subject|1
2028644|NCT00365976|3597790|FG001|Overall Study|Withdrawal by Subject|5
2028645|NCT00365989|3597796|FG000|Overall Study|Withdrawal by Subject|1
2028646|NCT00365989|3597796|FG000|Overall Study|Non-compliance|1
2028647|NCT00366249|3597818|FG000|Overall Study|Adverse Event|53
2028648|NCT00366249|3597819|FG001|Overall Study|Adverse Event|28
2028649|NCT00366249|3597818|FG000|Overall Study|Death|0
2028650|NCT00366249|3597819|FG001|Overall Study|Death|1
2028651|NCT00366249|3597818|FG000|Overall Study|Physician Decision|5
2028652|NCT00366249|3597819|FG001|Overall Study|Physician Decision|2
2028653|NCT00366249|3597818|FG000|Overall Study|Lost to Follow-up|2
2028654|NCT00366249|3597819|FG001|Overall Study|Lost to Follow-up|0
2028655|NCT00366249|3597818|FG000|Overall Study|Protocol Violation|1
2028656|NCT00366249|3597819|FG001|Overall Study|Protocol Violation|2
2028657|NCT00366249|3597818|FG000|Overall Study|Withdrawal by Subject|18
2028658|NCT00366249|3597819|FG001|Overall Study|Withdrawal by Subject|4
2028659|NCT00366249|3597818|FG000|Overall Study|Lack of Efficacy|21
2028660|NCT00366249|3597819|FG001|Overall Study|Lack of Efficacy|21
2028661|NCT00366249|3597818|FG000|Overall Study|Most due to osteomylitis status|31
2028662|NCT00366249|3597819|FG001|Overall Study|Most due to osteomylitis status|20
2028663|NCT00366301|3597833|FG000|Overall Study|Lost to Follow-up|4
2028664|NCT00366301|3597834|FG001|Overall Study|Lost to Follow-up|4
2028665|NCT00366301|3597835|FG002|Overall Study|Lost to Follow-up|3
2028666|NCT00366301|3597836|FG003|Overall Study|Lost to Follow-up|7
2028667|NCT00366301|3597833|FG000|Overall Study|Withdrawal by Subject|4
2028668|NCT00366301|3597834|FG001|Overall Study|Withdrawal by Subject|2
2028669|NCT00366301|3597835|FG002|Overall Study|Withdrawal by Subject|1
2028670|NCT00366301|3597836|FG003|Overall Study|Withdrawal by Subject|1
2028671|NCT00366340|3597848|FG000|Infant Series|Protocol Violation|3
2109607|NCT00887224|3703851|FG000|DB Taper Phase / Post Study Follow Up|Other|0
2109608|NCT00887224|3703852|FG001|DB Taper Phase / Post Study Follow Up|Other|11
2109609|NCT00887224|3703853|FG002|DB Taper Phase / Post Study Follow Up|Other|12
2109610|NCT00887224|3703851|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
2109611|NCT00887224|3703852|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
2109612|NCT00887224|3703853|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
2109613|NCT00887224|3703851|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
2109614|NCT00887224|3703852|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
2109615|NCT00887224|3703853|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
2109616|NCT00887289|3703865|FG000|Overall Study|Lack of Efficacy|14
2109617|NCT00887289|3703865|FG000|Overall Study|Adverse Event|27
2109618|NCT00887289|3703865|FG000|Overall Study|Withdrawal by Subject|26
2109619|NCT00887289|3703865|FG000|Overall Study|Lost to Follow-up|8
2109620|NCT00887289|3703865|FG000|Overall Study|Other|20
2109621|NCT00887341|3703871|FG000|Overall Study|Refused treatment|1
2109622|NCT00887341|3703872|FG001|Overall Study|Refused treatment|0
2109623|NCT00887341|3703871|FG000|Overall Study|Withdrawal by Subject|1
2109624|NCT00887341|3703872|FG001|Overall Study|Withdrawal by Subject|1
2109625|NCT00887341|3703871|FG000|Overall Study|Adverse Event|0
2109626|NCT00887341|3703872|FG001|Overall Study|Adverse Event|1
2109627|NCT00887341|3703871|FG000|Overall Study|Lost to Follow-up|0
2109628|NCT00887341|3703872|FG001|Overall Study|Lost to Follow-up|1
2109629|NCT00887354|3703880|FG000|Treatment Phase (Week 0 to Week 26)|Death|0
2109630|NCT00887354|3703881|FG001|Treatment Phase (Week 0 to Week 26)|Death|1
2109631|NCT00887354|3703880|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
2109632|NCT00887354|3703881|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
2109633|NCT00887354|3703880|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
2109634|NCT00887354|3703881|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
2109635|NCT00887354|3703880|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
2109636|NCT00887354|3703881|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
2109637|NCT00887354|3703880|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
2109638|NCT00887354|3703881|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
2109639|NCT00887354|3703880|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
2109640|NCT00887354|3703881|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
2322493|NCT02973321|4037538|FG004|Overall Study|Other than specified|1
2322494|NCT02973321|4037534|FG000|Overall Study|Lack of Efficacy|0
2322495|NCT02973321|4037535|FG001|Overall Study|Lack of Efficacy|0
2322496|NCT02973321|4037536|FG002|Overall Study|Lack of Efficacy|0
2322497|NCT02973321|4037537|FG003|Overall Study|Lack of Efficacy|0
2322498|NCT02973321|4037538|FG004|Overall Study|Lack of Efficacy|1
2322499|NCT02973321|4037534|FG000|Overall Study|Adverse Event|1
2322500|NCT02973321|4037535|FG001|Overall Study|Adverse Event|10
2322501|NCT02973321|4037536|FG002|Overall Study|Adverse Event|11
2322502|NCT02973321|4037537|FG003|Overall Study|Adverse Event|13
2322503|NCT02973321|4037538|FG004|Overall Study|Adverse Event|3
2322504|NCT02973477|4037571|FG000|First Intervention|Lost to Follow-up|0
2322505|NCT02973477|4037572|FG001|First Intervention|Lost to Follow-up|2
2322506|NCT02973477|4037571|FG000|Washout|Withdrawal by Subject|1
2322507|NCT02973477|4037572|FG001|Washout|Withdrawal by Subject|0
2322508|NCT02973477|4037571|FG000|Second Intervention|Lost to Follow-up|1
2322509|NCT02973477|4037572|FG001|Second Intervention|Lost to Follow-up|0
2322510|NCT02973802|4037602|FG000|Overall Study|Lost to Follow-up|1
2028672|NCT00366340|3597849|FG001|Infant Series|Protocol Violation|4
2028673|NCT00366340|3597848|FG000|Infant Series|Withdrawal by Subject|3
2028674|NCT00366340|3597849|FG001|Infant Series|Withdrawal by Subject|3
2028675|NCT00366340|3597848|FG000|Infant Series|Adverse Event|0
2028676|NCT00366340|3597849|FG001|Infant Series|Adverse Event|2
2028677|NCT00366340|3597848|FG000|Infant Series|Lost to Follow-up|1
2028678|NCT00366340|3597849|FG001|Infant Series|Lost to Follow-up|1
2028679|NCT00366340|3597848|FG000|Infant Series|Failure to return|1
2028680|NCT00366340|3597849|FG001|Infant Series|Failure to return|0
2028681|NCT00366340|3597848|FG000|After the Infant Series|Parent/legal guardian request|1
2028682|NCT00366340|3597849|FG001|After the Infant Series|Parent/legal guardian request|1
2028683|NCT00366340|3597848|FG000|After the Infant Series|Failed to return|0
2028684|NCT00366340|3597849|FG001|After the Infant Series|Failed to return|1
2028685|NCT00366340|3597848|FG000|After the Infant Series|Protocol Violation|2
2028686|NCT00366340|3597849|FG001|After the Infant Series|Protocol Violation|2
2028687|NCT00366340|3597848|FG000|After the Infant Series|Adverse Event|0
2028688|NCT00366340|3597849|FG001|After the Infant Series|Adverse Event|1
2028689|NCT00366340|3597848|FG000|After the Infant Series|Lost to Follow-up|0
2028690|NCT00366340|3597849|FG001|After the Infant Series|Lost to Follow-up|1
2028691|NCT00366340|3597848|FG000|Toddler Dose|Failed to return|1
2028692|NCT00366340|3597849|FG001|Toddler Dose|Failed to return|0
2028693|NCT00366340|3597848|FG000|Toddler Dose|Parent/legal guardian request|0
2028694|NCT00366340|3597849|FG001|Toddler Dose|Parent/legal guardian request|1
2028695|NCT00366444|3597881|FG000|Overall Study|Withdrawal by Subject|1
2028696|NCT00366444|3597882|FG001|Overall Study|Withdrawal by Subject|1
2028697|NCT00366444|3597881|FG000|Overall Study|Lack of Efficacy|0
2028698|NCT00366444|3597882|FG001|Overall Study|Lack of Efficacy|1
2028699|NCT00366457|3597888|FG000|Overall Study|never began study therapy|2
2028700|NCT00366535|3597894|FG000|First Phase: 12 Weeks|Adverse Event|1
2028701|NCT00366535|3597895|FG001|First Phase: 12 Weeks|Adverse Event|3
2028702|NCT00366535|3597894|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2
2028703|NCT00366535|3597895|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5
2028704|NCT00366535|3597894|FG000|Second Phase: 12 Weeks|Adverse Event|1
2028705|NCT00366535|3597895|FG001|Second Phase: 12 Weeks|Adverse Event|1
2028706|NCT00366535|3597894|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2
2028707|NCT00366535|3597895|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2
2028708|NCT00366548|3597911|FG000|Infant Series|Adverse Event|1
2028709|NCT00366548|3597912|FG001|Infant Series|Adverse Event|3
2028710|NCT00366548|3597911|FG000|Infant Series|Protocol Violation|0
2028711|NCT00366548|3597912|FG001|Infant Series|Protocol Violation|1
2028712|NCT00366548|3597911|FG000|Infant Series|Withdrawal by Subject|3
2028713|NCT00366548|3597912|FG001|Infant Series|Withdrawal by Subject|1
2028714|NCT00366548|3597911|FG000|After Infant Series|Withdrawal by Subject|3
2028715|NCT00366548|3597912|FG001|After Infant Series|Withdrawal by Subject|1
2028716|NCT00366548|3597911|FG000|After Infant Series|Adverse Event|2
2028717|NCT00366548|3597912|FG001|After Infant Series|Adverse Event|0
2028718|NCT00366548|3597911|FG000|After Infant Series|Lost to Follow-up|1
2028719|NCT00366548|3597912|FG001|After Infant Series|Lost to Follow-up|0
2028720|NCT00366678|3597949|FG000|Infant Series|Withdrawal by Subject|8
2028721|NCT00366678|3597950|FG001|Infant Series|Withdrawal by Subject|6
2028722|NCT00366678|3597951|FG002|Infant Series|Withdrawal by Subject|0
2028723|NCT00366678|3597949|FG000|Infant Series|Protocol Violation|4
2322511|NCT02973802|4037602|FG000|Overall Study|Withdrawal by Subject|1
2028724|NCT00366678|3597950|FG001|Infant Series|Protocol Violation|3
2028725|NCT00366678|3597951|FG002|Infant Series|Protocol Violation|0
2028726|NCT00366678|3597949|FG000|Infant Series|Failed to return|1
2028727|NCT00366678|3597950|FG001|Infant Series|Failed to return|1
2028728|NCT00366678|3597951|FG002|Infant Series|Failed to return|0
2028729|NCT00366678|3597949|FG000|Infant Series|Adverse Event|1
2028730|NCT00366678|3597950|FG001|Infant Series|Adverse Event|0
2028731|NCT00366678|3597951|FG002|Infant Series|Adverse Event|0
2028732|NCT00366678|3597949|FG000|After Infant|Withdrawal by Subject|8
2028733|NCT00366678|3597950|FG001|After Infant|Withdrawal by Subject|4
2028734|NCT00366678|3597951|FG002|After Infant|Withdrawal by Subject|0
2028735|NCT00366678|3597949|FG000|After Infant|Lost to Follow-up|2
2028736|NCT00366678|3597950|FG001|After Infant|Lost to Follow-up|1
2028737|NCT00366678|3597951|FG002|After Infant|Lost to Follow-up|0
2028738|NCT00366678|3597949|FG000|After Infant|Failed to return|5
2028739|NCT00366678|3597950|FG001|After Infant|Failed to return|5
2322512|NCT02974010|4037611|FG000|Overall Study|Lost to Follow-up|3
2322513|NCT02974010|4037612|FG001|Overall Study|Lost to Follow-up|1
2322514|NCT02974010|4037613|FG002|Overall Study|Lost to Follow-up|0
2322515|NCT02974010|4037614|FG003|Overall Study|Lost to Follow-up|0
2322516|NCT02974010|4037611|FG000|Overall Study|Withdrawal by Subject|2
2028740|NCT00366678|3597951|FG002|After Infant|Failed to return|0
2028741|NCT00366678|3597949|FG000|After Infant|Adverse Event|1
2028742|NCT00366678|3597950|FG001|After Infant|Adverse Event|0
2028743|NCT00366678|3597951|FG002|After Infant|Adverse Event|0
2028744|NCT00366678|3597949|FG000|After Infant|Protocol Violation|1
2028745|NCT00366678|3597950|FG001|After Infant|Protocol Violation|0
2028746|NCT00366678|3597951|FG002|After Infant|Protocol Violation|0
2028747|NCT00366678|3597949|FG000|Toddler Dose|Protocol Violation|2
2028748|NCT00366678|3597950|FG001|Toddler Dose|Protocol Violation|1
2028749|NCT00366678|3597951|FG002|Toddler Dose|Protocol Violation|0
2028750|NCT00366678|3597949|FG000|Toddler Dose|Failed to return|1
2028751|NCT00366678|3597950|FG001|Toddler Dose|Failed to return|0
2028752|NCT00366678|3597951|FG002|Toddler Dose|Failed to return|0
2028753|NCT00366678|3597949|FG000|Toddler Dose|Withdrawal by Subject|1
2028754|NCT00366678|3597950|FG001|Toddler Dose|Withdrawal by Subject|0
2028755|NCT00366678|3597951|FG002|Toddler Dose|Withdrawal by Subject|0
2028756|NCT00366678|3597949|FG000|Toddler Dose|protocol deviation|1
2028757|NCT00366678|3597950|FG001|Toddler Dose|protocol deviation|0
2028758|NCT00366678|3597951|FG002|Toddler Dose|protocol deviation|0
2028759|NCT00366899|3597998|FG000|Infant Series|Withdrawal by Subject|4
2028760|NCT00366899|3597999|FG001|Infant Series|Withdrawal by Subject|7
2028761|NCT00366899|3597998|FG000|Infant Series|Protocol Violation|2
2028762|NCT00366899|3597999|FG001|Infant Series|Protocol Violation|1
2028763|NCT00366899|3597998|FG000|Infant Series|Failed to return|1
2028764|NCT00366899|3597999|FG001|Infant Series|Failed to return|1
2028765|NCT00366899|3597998|FG000|Infant Series|Lost to Follow-up|0
2028766|NCT00366899|3597999|FG001|Infant Series|Lost to Follow-up|2
2028767|NCT00366899|3597998|FG000|Infant Series|Adverse Event|0
2028768|NCT00366899|3597999|FG001|Infant Series|Adverse Event|1
2028769|NCT00366899|3597998|FG000|Infant Series|Physician Decision|1
2028770|NCT00366899|3597999|FG001|Infant Series|Physician Decision|0
2028771|NCT00366899|3597998|FG000|Infant Series|Randomized but not consented|1
2028772|NCT00366899|3597999|FG001|Infant Series|Randomized but not consented|0
2028773|NCT00366899|3597998|FG000|After Infant Series|Lost to Follow-up|4
2028774|NCT00366899|3597999|FG001|After Infant Series|Lost to Follow-up|3
2028775|NCT00366899|3597998|FG000|After Infant Series|Withdrawal by Subject|1
2028776|NCT00366899|3597999|FG001|After Infant Series|Withdrawal by Subject|4
2028777|NCT00366899|3597998|FG000|After Infant Series|Adverse Event|1
2028778|NCT00366899|3597999|FG001|After Infant Series|Adverse Event|2
2028779|NCT00366899|3597998|FG000|After Infant Series|Protocol Violation|1
2028780|NCT00366899|3597999|FG001|After Infant Series|Protocol Violation|0
2028781|NCT00366899|3597998|FG000|Toddler Dose|Withdrawal by Subject|1
2028782|NCT00366899|3597999|FG001|Toddler Dose|Withdrawal by Subject|1
2028783|NCT00366899|3597998|FG000|Toddler Dose|Protocol Violation|1
2028784|NCT00366899|3597999|FG001|Toddler Dose|Protocol Violation|0
2028785|NCT00367055|3598048|FG000|Overall Study|Adverse Event|6
2028786|NCT00367055|3598049|FG001|Overall Study|Adverse Event|3
2028787|NCT00367055|3598048|FG000|Overall Study|Patient's Willing|3
2028788|NCT00367055|3598049|FG001|Overall Study|Patient's Willing|2
2028789|NCT00367055|3598048|FG000|Overall Study|Lack of Efficacy|1
2028790|NCT00367055|3598049|FG001|Overall Study|Lack of Efficacy|2
2028791|NCT00367055|3598048|FG000|Overall Study|Lost to Follow-up|1
2028792|NCT00367055|3598049|FG001|Overall Study|Lost to Follow-up|1
2028793|NCT00367055|3598048|FG000|Overall Study|Protocol Violation|0
2028794|NCT00367055|3598049|FG001|Overall Study|Protocol Violation|1
2028795|NCT00367055|3598048|FG000|Overall Study|Stopping Criterion Met|0
2028796|NCT00367055|3598049|FG001|Overall Study|Stopping Criterion Met|1
2028797|NCT00367055|3598048|FG000|Overall Study|Participant Living too Far from Hospital|0
2028798|NCT00367055|3598049|FG001|Overall Study|Participant Living too Far from Hospital|1
2028799|NCT00367133|3598058|FG000|2 Years|Death|20
2028800|NCT00367133|3598059|FG001|2 Years|Death|12
2028801|NCT00367133|3598060|FG002|2 Years|Death|12
2028802|NCT00367133|3598058|FG000|2 Years|Dropped|34
2028803|NCT00367133|3598059|FG001|2 Years|Dropped|19
2028804|NCT00367133|3598060|FG002|2 Years|Dropped|33
2028805|NCT00367133|3598058|FG000|2 Years|Missed visit|4
2028806|NCT00367133|3598059|FG001|2 Years|Missed visit|5
2028807|NCT00367133|3598060|FG002|2 Years|Missed visit|4
2028808|NCT00367237|3598070|FG000|Overall Study|Adverse Event|7
2028809|NCT00367237|3598071|FG001|Overall Study|Adverse Event|2
2028810|NCT00367237|3598070|FG000|Overall Study|Lost to Follow-up|1
2028811|NCT00367237|3598071|FG001|Overall Study|Lost to Follow-up|0
2028812|NCT00367237|3598070|FG000|Overall Study|Withdrawal by Subject|0
2028813|NCT00367237|3598071|FG001|Overall Study|Withdrawal by Subject|4
2028814|NCT00367237|3598070|FG000|Overall Study|Protocol Violation|2
2028815|NCT00367237|3598071|FG001|Overall Study|Protocol Violation|5
2028816|NCT00367341|3598079|FG000|Overall Study|Physician Decision|1
2217826|NCT01709864|3861090|FG001|Overall Study|Adverse Event|2
2217827|NCT01709864|3861089|FG000|Overall Study|Death|0
2028817|NCT00367341|3598080|FG001|Overall Study|Physician Decision|0
2028818|NCT00367341|3598079|FG000|Overall Study|Protocol Violation|1
2028819|NCT00367341|3598080|FG001|Overall Study|Protocol Violation|0
2028820|NCT00367432|3598099|FG000|First Period (16 Weeks)|Adverse Event|6
2028821|NCT00367432|3598100|FG001|First Period (16 Weeks)|Adverse Event|0
2028822|NCT00367432|3598099|FG000|First Period (16 Weeks)|Lack of Efficacy|24
2028823|NCT00367432|3598100|FG001|First Period (16 Weeks)|Lack of Efficacy|0
2217828|NCT01709864|3861090|FG001|Overall Study|Death|1
2028824|NCT00367432|3598099|FG000|First Period (16 Weeks)|Withdrawal by Subject|6
2028825|NCT00367432|3598100|FG001|First Period (16 Weeks)|Withdrawal by Subject|0
2028826|NCT00367432|3598099|FG000|First Period (16 Weeks)|Other Reason|2
2109641|NCT00887354|3703880|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
2109642|NCT00887354|3703881|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
2109643|NCT00887354|3703880|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
2109644|NCT00887354|3703881|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
2109645|NCT00887354|3703880|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
2109646|NCT00887354|3703881|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
2109647|NCT00887354|3703880|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5
2109648|NCT00887354|3703881|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3
2109649|NCT00887354|3703880|FG000|Open Label Phase (Week 26 to Week 78)|Death|0
2109650|NCT00887354|3703881|FG001|Open Label Phase (Week 26 to Week 78)|Death|2
2109651|NCT00887354|3703880|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
2109652|NCT00887354|3703881|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
2109653|NCT00887354|3703880|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
2109654|NCT00887354|3703881|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
2109655|NCT00887354|3703880|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
2217829|NCT01709903|3861098|FG000|Overall Study|administrative problems|2
2217830|NCT01709903|3861099|FG001|Overall Study|administrative problems|6
2109656|NCT00887354|3703881|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
2109657|NCT00887354|3703880|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
2109658|NCT00887354|3703881|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
2109659|NCT00887432|3703890|FG000|Overall Study|Start Excluded Therapy|3
2109660|NCT00887432|3703891|FG001|Overall Study|Start Excluded Therapy|0
2109661|NCT00887432|3703890|FG000|Overall Study|Did not complete treatment|6
2109662|NCT00887432|3703891|FG001|Overall Study|Did not complete treatment|8
2109663|NCT00887432|3703890|FG000|Overall Study|Protocol Violation|2
2109664|NCT00887432|3703891|FG001|Overall Study|Protocol Violation|3
2109665|NCT00887432|3703890|FG000|Overall Study|Withdrawal by Subject|3
2109666|NCT00887432|3703891|FG001|Overall Study|Withdrawal by Subject|2
2109667|NCT00887432|3703890|FG000|Overall Study|Lost to Follow-up|1
2109668|NCT00887432|3703891|FG001|Overall Study|Lost to Follow-up|0
2109669|NCT00887432|3703890|FG000|Overall Study|No reason provided|0
2109670|NCT00887432|3703891|FG001|Overall Study|No reason provided|1
2109671|NCT00887484|3703917|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
2109672|NCT00887484|3703917|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
2109673|NCT00887484|3703917|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
2109674|NCT00887549|3703935|FG000|Induction Therapy|Adverse Event|8
2109675|NCT00887549|3703935|FG000|Induction Therapy|Physician Decision|1
2109676|NCT00887549|3703935|FG000|Induction Therapy|Progressive Disease|13
2109677|NCT00887549|3703935|FG000|Induction Therapy|Death due to Study Disease|4
2109678|NCT00887549|3703935|FG000|Induction Therapy|Death due to Study Drug Toxicity|1
2109679|NCT00887549|3703935|FG000|Maintenance Therapy|Adverse Event|16
2109680|NCT00887549|3703935|FG000|Maintenance Therapy|Physician Decision|1
2109681|NCT00887549|3703935|FG000|Maintenance Therapy|Progressive Disease|25
2109682|NCT00887549|3703935|FG000|Maintenance Therapy|Death due to adverse event|1
2109683|NCT00887588|3703963|FG000|Core Period|Death|1
2109684|NCT00887588|3703964|FG001|Core Period|Death|1
2109685|NCT00887588|3703963|FG000|Core Period|Lost to Follow-up|3
2109686|NCT00887588|3703964|FG001|Core Period|Lost to Follow-up|1
2109687|NCT00887588|3703963|FG000|Core Period|Withdrawal by Subject|6
2109688|NCT00887588|3703964|FG001|Core Period|Withdrawal by Subject|8
2109689|NCT00887588|3703963|FG000|Core Period|Adverse Event|9
2109690|NCT00887588|3703964|FG001|Core Period|Adverse Event|11
2109691|NCT00887588|3703963|FG000|Extension Period|Adverse Event|4
2109692|NCT00887588|3703964|FG001|Extension Period|Adverse Event|4
2109693|NCT00887588|3703963|FG000|Extension Period|Death|0
2109694|NCT00887588|3703964|FG001|Extension Period|Death|1
2109695|NCT00887588|3703963|FG000|Extension Period|Protocol deviation|1
2109696|NCT00887588|3703964|FG001|Extension Period|Protocol deviation|0
2109697|NCT00887588|3703963|FG000|Extension Period|Lost to Follow-up|1
2109698|NCT00887588|3703964|FG001|Extension Period|Lost to Follow-up|0
2109699|NCT00887679|3703978|FG000|Overall Study|Withdrawal by Subject|1
2109700|NCT00887679|3703978|FG000|Overall Study|Lost to Follow-up|4
2109701|NCT00887679|3703978|FG000|Overall Study|Physician Decision|5
2109702|NCT00887744|3703983|FG000|Overall Study|Adverse Event|3
2109703|NCT00887744|3703983|FG000|Overall Study|Death|1
2109704|NCT00887744|3703983|FG000|Overall Study|Lost to Follow-up|3
2109705|NCT00887744|3703983|FG000|Overall Study|Withdrawal by Subject|18
2109706|NCT00887744|3703983|FG000|Overall Study|Various reasons|9
2109707|NCT00887809|3703998|FG000|Overall Study|Patient Not Treated|3
2109708|NCT00887809|3703999|FG001|Overall Study|Patient Not Treated|0
2109709|NCT00887809|3703998|FG000|Overall Study|Death|1
2109710|NCT00887809|3703999|FG001|Overall Study|Death|0
2109711|NCT00887822|3704007|FG000|Overall Study|Insufficient therapeutic response|53
2109712|NCT00887822|3704008|FG001|Overall Study|Insufficient therapeutic response|55
2109713|NCT00887822|3704007|FG000|Overall Study|Adverse Event|14
2109714|NCT00887822|3704008|FG001|Overall Study|Adverse Event|17
2109715|NCT00887822|3704007|FG000|Overall Study|Failure to return|11
2109716|NCT00887822|3704008|FG001|Overall Study|Failure to return|11
2028827|NCT00367432|3598100|FG001|First Period (16 Weeks)|Other Reason|0
2028828|NCT00367432|3598099|FG000|Second Period (up to 54 Months)|Adverse Event|14
2028829|NCT00367432|3598100|FG001|Second Period (up to 54 Months)|Adverse Event|3
2028830|NCT00367432|3598099|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59
2028831|NCT00367432|3598100|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5
2028832|NCT00367432|3598099|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0
2028833|NCT00367432|3598100|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1
2028834|NCT00367432|3598099|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8
2028835|NCT00367432|3598100|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5
2028836|NCT00367432|3598099|FG000|Second Period (up to 54 Months)|Other Reason|6
2028837|NCT00367432|3598100|FG001|Second Period (up to 54 Months)|Other Reason|2
2028838|NCT00367458|3598106|FG000|First Intervention - 8 Weeks|Adverse Event|2
2028839|NCT00367458|3598107|FG001|First Intervention - 8 Weeks|Adverse Event|0
2028840|NCT00367484|3598113|FG000|Overall Study|Adverse Event|7
2028841|NCT00367484|3598113|FG000|Overall Study|Withdrew informed consent|5
2028842|NCT00367484|3598113|FG000|Overall Study|Travel to USA|1
2028843|NCT00367484|3598113|FG000|Overall Study|Lost to Follow-up|1
2028844|NCT00367484|3598113|FG000|Overall Study|Protocol Violation|1
2028845|NCT00367484|3598113|FG000|Overall Study|The choice of the patient|1
2028846|NCT00367484|3598113|FG000|Overall Study|Lack of Efficacy|1
2028847|NCT00367640|3598126|FG000|Overall Study|Adverse Event|3
2028848|NCT00367640|3598127|FG001|Overall Study|Adverse Event|6
2028849|NCT00367640|3598128|FG002|Overall Study|Adverse Event|8
2028850|NCT00367640|3598129|FG003|Overall Study|Adverse Event|0
2028851|NCT00367640|3598126|FG000|Overall Study|Withdrawal by Subject|8
2028852|NCT00367640|3598127|FG001|Overall Study|Withdrawal by Subject|11
2028853|NCT00367640|3598128|FG002|Overall Study|Withdrawal by Subject|8
2028854|NCT00367640|3598129|FG003|Overall Study|Withdrawal by Subject|6
2028855|NCT00367640|3598126|FG000|Overall Study|Any other reason not above-mentioned|7
2028856|NCT00367640|3598127|FG001|Overall Study|Any other reason not above-mentioned|5
2109717|NCT00887822|3704007|FG000|Overall Study|Refused treatment/Did not cooperate|12
2109718|NCT00887822|3704008|FG001|Overall Study|Refused treatment/Did not cooperate|10
2109719|NCT00887822|3704007|FG000|Overall Study|Administrative/Other than specified|5
2109720|NCT00887822|3704008|FG001|Overall Study|Administrative/Other than specified|4
2109721|NCT00887822|3704007|FG000|Overall Study|Death|2
2109722|NCT00887822|3704008|FG001|Overall Study|Death|3
2109723|NCT00887822|3704007|FG000|Overall Study|Protocol Violation|0
2109724|NCT00887822|3704008|FG001|Overall Study|Protocol Violation|1
2109725|NCT00887822|3704007|FG000|Overall Study|Randomized but not treated|0
2109726|NCT00887822|3704008|FG001|Overall Study|Randomized but not treated|1
2109727|NCT00887913|3704014|FG000|Overall Study|Withdrawal by Subject|6
2109728|NCT00887926|3704022|FG000|Overall Study|Withdrawal by Subject|0
2109729|NCT00887926|3704023|FG001|Overall Study|Withdrawal by Subject|1
2109730|NCT00887926|3704024|FG002|Overall Study|Withdrawal by Subject|0
2109731|NCT00887926|3704025|FG003|Overall Study|Withdrawal by Subject|0
2109732|NCT00887978|3704043|FG000|Overall Study|Adverse Event|18
2109733|NCT00887978|3704044|FG001|Overall Study|Adverse Event|5
2109734|NCT00887978|3704043|FG000|Overall Study|Clinical Worsening|4
2109735|NCT00887978|3704044|FG001|Overall Study|Clinical Worsening|4
2109736|NCT00887978|3704043|FG000|Overall Study|Death|2
2109737|NCT00887978|3704044|FG001|Overall Study|Death|3
2109738|NCT00887978|3704043|FG000|Overall Study|Withdrawal by Subject|1
2109739|NCT00887978|3704044|FG001|Overall Study|Withdrawal by Subject|2
2109740|NCT00887978|3704043|FG000|Overall Study|Lost to Follow-up|0
2109741|NCT00887978|3704044|FG001|Overall Study|Lost to Follow-up|1
2109742|NCT00888134|3704050|FG000|Treatment With Study Drug|Withdrawal by Subject|1
2109743|NCT00888134|3704050|FG000|Follow-up|being followed for long-term survival|1
2109744|NCT00888173|3704055|FG000|Overall Study|Wrong Primary|1
2109745|NCT00888173|3704055|FG000|Overall Study|Ineligible: required test not done|1
2109746|NCT00888238|3704059|FG000|Washout Period After Period 2|Adverse Event|0
2109747|NCT00888238|3704060|FG001|Washout Period After Period 2|Adverse Event|0
2109748|NCT00888238|3704061|FG002|Washout Period After Period 2|Adverse Event|1
2109749|NCT00888329|3704069|FG000|Overall Study|Physician Decision|6
2109750|NCT00888329|3704070|FG001|Overall Study|Physician Decision|9
2109751|NCT00888381|3704078|FG000|Overall Study|Lost to Follow-up|0
2109752|NCT00888381|3704079|FG001|Overall Study|Lost to Follow-up|1
2109753|NCT00888433|3704087|FG000|Overall Study|Withdrawal by Subject|1
2109754|NCT00888433|3704088|FG001|Overall Study|Withdrawal by Subject|2
2109755|NCT00888433|3704087|FG000|Overall Study|Missed Visit|2
2109756|NCT00888433|3704088|FG001|Overall Study|Missed Visit|1
2180244|NCT01400243|3806272|FG001|Overall Study|Protocol Violation|11
2180245|NCT01400412|3806282|FG000|Overall Study|Lost to Follow-up|4
2180246|NCT01400412|3806283|FG001|Overall Study|Lost to Follow-up|7
2180247|NCT01400412|3806282|FG000|Overall Study|Withdrawal by Subject|3
2180248|NCT01400412|3806283|FG001|Overall Study|Withdrawal by Subject|4
2180249|NCT01400412|3806282|FG000|Overall Study|Unable to complete|3
2180250|NCT01400412|3806283|FG001|Overall Study|Unable to complete|3
2180251|NCT01400412|3806282|FG000|Overall Study|Never started study treatment|0
2180252|NCT01400412|3806283|FG001|Overall Study|Never started study treatment|3
2180253|NCT01400425|3806291|FG000|Overall Study|Withdrawal by Subject|10
2180254|NCT01400451|3806300|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2
2028857|NCT00367640|3598128|FG002|Overall Study|Any other reason not above-mentioned|3
2028858|NCT00367640|3598129|FG003|Overall Study|Any other reason not above-mentioned|4
2028859|NCT00367744|3598147|FG000|Overall Study|Lost to Follow-up|4
2028860|NCT00367744|3598148|FG001|Overall Study|Lost to Follow-up|5
2028861|NCT00367770|3598155|FG000|Overall Study|Adverse Event|1
2028862|NCT00367770|3598155|FG000|Overall Study|Withdrawal by Subject|1
2028863|NCT00367835|3598161|FG000|Overall Study|Adverse Event|14
2028864|NCT00367835|3598162|FG001|Overall Study|Adverse Event|1
2028865|NCT00367835|3598161|FG000|Overall Study|Protocol Violation|1
2028866|NCT00367835|3598162|FG001|Overall Study|Protocol Violation|7
2028867|NCT00367835|3598161|FG000|Overall Study|Withdrawal by Subject|7
2028868|NCT00367835|3598162|FG001|Overall Study|Withdrawal by Subject|6
2028869|NCT00367835|3598161|FG000|Overall Study|Lost to Follow-up|1
2028870|NCT00367835|3598162|FG001|Overall Study|Lost to Follow-up|4
2028871|NCT00367835|3598161|FG000|Overall Study|Lack of Efficacy|3
2028872|NCT00367835|3598162|FG001|Overall Study|Lack of Efficacy|12
2028873|NCT00367835|3598161|FG000|Overall Study|Subject in juvenile detention center|1
2028874|NCT00367835|3598162|FG001|Overall Study|Subject in juvenile detention center|0
2028875|NCT00367835|3598161|FG000|Overall Study|refused blood collection|1
2028876|NCT00367835|3598162|FG001|Overall Study|refused blood collection|0
2028877|NCT00367835|3598161|FG000|Overall Study|Did not respond to calls|1
2028878|NCT00367835|3598162|FG001|Overall Study|Did not respond to calls|0
2028879|NCT00367835|3598161|FG000|Overall Study|History of lead poisoning|0
2028880|NCT00367835|3598162|FG001|Overall Study|History of lead poisoning|1
2028881|NCT00367991|3598170|FG000|Overall Study|Withdrawal by Subject|1
2028882|NCT00367991|3598171|FG001|Overall Study|Withdrawal by Subject|1
2028883|NCT00367991|3598170|FG000|Overall Study|Adverse Event|1
2028884|NCT00367991|3598171|FG001|Overall Study|Adverse Event|1
2028885|NCT00368069|3598179|FG000|Overall Study|Adverse Event|5
2028886|NCT00368069|3598180|FG001|Overall Study|Adverse Event|2
2028887|NCT00368069|3598179|FG000|Overall Study|Lack of Efficacy|0
2028888|NCT00368069|3598180|FG001|Overall Study|Lack of Efficacy|1
2028889|NCT00368069|3598179|FG000|Overall Study|Lost to Follow-up|1
2028890|NCT00368069|3598180|FG001|Overall Study|Lost to Follow-up|0
2028891|NCT00368069|3598179|FG000|Overall Study|Protocol Violation|0
2028892|NCT00368069|3598180|FG001|Overall Study|Protocol Violation|2
2028893|NCT00368069|3598179|FG000|Overall Study|Withdrawal of Consent|2
2028894|NCT00368069|3598180|FG001|Overall Study|Withdrawal of Consent|1
2028895|NCT00368069|3598179|FG000|Overall Study|no blood sampling possible|0
2028896|NCT00368069|3598180|FG001|Overall Study|no blood sampling possible|1
2028897|NCT00368108|3598189|FG000|Overall Study|Adverse Event|38
2028898|NCT00368108|3598190|FG001|Overall Study|Adverse Event|26
2028899|NCT00368108|3598191|FG002|Overall Study|Adverse Event|44
2028900|NCT00368108|3598189|FG000|Overall Study|Abnormal Laboratory Value|0
2028901|NCT00368108|3598190|FG001|Overall Study|Abnormal Laboratory Value|0
2028902|NCT00368108|3598191|FG002|Overall Study|Abnormal Laboratory Value|3
2028903|NCT00368108|3598189|FG000|Overall Study|Protocol Violation|5
2028904|NCT00368108|3598190|FG001|Overall Study|Protocol Violation|9
2028905|NCT00368108|3598191|FG002|Overall Study|Protocol Violation|9
2028906|NCT00368108|3598189|FG000|Overall Study|Withdrawal by Subject|9
2028907|NCT00368108|3598190|FG001|Overall Study|Withdrawal by Subject|3
2028908|NCT00368108|3598191|FG002|Overall Study|Withdrawal by Subject|5
2028909|NCT00368108|3598189|FG000|Overall Study|Lack of Efficacy|7
2028910|NCT00368108|3598190|FG001|Overall Study|Lack of Efficacy|8
2028911|NCT00368108|3598191|FG002|Overall Study|Lack of Efficacy|5
2028912|NCT00368108|3598189|FG000|Overall Study|Physician Decision|2
2028913|NCT00368108|3598190|FG001|Overall Study|Physician Decision|0
2028914|NCT00368108|3598191|FG002|Overall Study|Physician Decision|1
2028915|NCT00368108|3598189|FG000|Overall Study|Other|3
2028916|NCT00368108|3598190|FG001|Overall Study|Other|7
2028917|NCT00368108|3598191|FG002|Overall Study|Other|1
2028918|NCT00368251|3598202|FG000|Overall Study|SAE, non-fatal|1
2028919|NCT00368251|3598203|FG001|Overall Study|SAE, non-fatal|0
2028920|NCT00368251|3598204|FG002|Overall Study|SAE, non-fatal|0
2028921|NCT00368251|3598202|FG000|Overall Study|AE, non-serious non-fatal|0
2028922|NCT00368251|3598203|FG001|Overall Study|AE, non-serious non-fatal|0
2028923|NCT00368251|3598204|FG002|Overall Study|AE, non-serious non-fatal|1
2109757|NCT00888615|3704107|FG000|Overall Study|No treatment|2
2109758|NCT00888654|3704115|FG000|Overall Study|Problems swallowing oral meds.|1
2109759|NCT00888654|3704115|FG000|Overall Study|Not enough oral meds before surgery|3
2109760|NCT00888654|3704115|FG000|Overall Study|Surgery aborted|2
2109761|NCT00888654|3704115|FG000|Overall Study|Withdrawal by Subject|1
2109762|NCT00888654|3704115|FG000|Overall Study|Inelig. due to contraindication of med|1
2109763|NCT00888654|3704115|FG000|Overall Study|Change in surg date|1
2109764|NCT00888654|3704115|FG000|Overall Study|Stopped meds due to headaches|1
2109765|NCT00888849|3704121|FG000|Overall Study|Death|4
2109766|NCT00888849|3704122|FG001|Overall Study|Death|7
2109767|NCT00888849|3704121|FG000|Overall Study|Lost to Follow-up|1
2109768|NCT00888849|3704122|FG001|Overall Study|Lost to Follow-up|2
2109769|NCT00888927|3704132|FG000|Overall Study|Adverse Event|0
2109770|NCT00888927|3704133|FG001|Overall Study|Adverse Event|0
2109771|NCT00888927|3704134|FG002|Overall Study|Adverse Event|0
2109772|NCT00888927|3704135|FG003|Overall Study|Adverse Event|1
2109773|NCT00888927|3704132|FG000|Overall Study|Withdrawal of consent|0
2028924|NCT00368277|3598214|FG000|Overall Study|Adverse Event|33
2028925|NCT00368277|3598215|FG001|Overall Study|Adverse Event|49
2028926|NCT00368277|3598214|FG000|Overall Study|Death|2
2028927|NCT00368277|3598215|FG001|Overall Study|Death|1
2028928|NCT00368277|3598214|FG000|Overall Study|Unsatisfactory therapeutic effect|31
2028929|NCT00368277|3598215|FG001|Overall Study|Unsatisfactory therapeutic effect|24
2028930|NCT00368277|3598214|FG000|Overall Study|Protocol deviation|7
2028931|NCT00368277|3598215|FG001|Overall Study|Protocol deviation|0
2028932|NCT00368277|3598214|FG000|Overall Study|Patient withdrew consent|32
2028933|NCT00368277|3598215|FG001|Overall Study|Patient withdrew consent|28
2028934|NCT00368277|3598214|FG000|Overall Study|Lost to Follow-up|8
2028935|NCT00368277|3598215|FG001|Overall Study|Lost to Follow-up|6
2028936|NCT00368355|3598241|FG000|Overall Study|Adverse Event|1
2028937|NCT00368355|3598242|FG001|Overall Study|Adverse Event|0
2028938|NCT00368355|3598241|FG000|Overall Study|Death|2
2028939|NCT00368355|3598242|FG001|Overall Study|Death|4
2028940|NCT00368355|3598241|FG000|Overall Study|Relapse|6
2028941|NCT00368355|3598242|FG001|Overall Study|Relapse|10
2028942|NCT00368355|3598241|FG000|Overall Study|Subsequent transplant|0
2028943|NCT00368355|3598242|FG001|Overall Study|Subsequent transplant|3
2028944|NCT00368355|3598241|FG000|Overall Study|Treatment - hematopoietic cell product|2
2028945|NCT00368355|3598242|FG001|Overall Study|Treatment - hematopoietic cell product|0
2028946|NCT00368472|3598257|FG000|Overall Study|Adverse Event|22
2028947|NCT00368472|3598257|FG000|Overall Study|Medication non-compliance|4
2028948|NCT00368472|3598257|FG000|Overall Study|Protocol Violation|2
2028949|NCT00368472|3598257|FG000|Overall Study|Request of Investigator or Sponsor|3
2028950|NCT00368472|3598257|FG000|Overall Study|Withdrawal by Subject|40
2028951|NCT00368472|3598257|FG000|Overall Study|Diary non-compliance|1
2028952|NCT00368472|3598257|FG000|Overall Study|Other|32
2028953|NCT00368472|3598257|FG000|Overall Study|Missing Final Disposition Date|1
2109774|NCT00888927|3704133|FG001|Overall Study|Withdrawal of consent|0
2109775|NCT00888927|3704134|FG002|Overall Study|Withdrawal of consent|0
2109776|NCT00888927|3704135|FG003|Overall Study|Withdrawal of consent|1
2109777|NCT00888940|3704147|FG000|Overall Study|Adverse Event|12
2109778|NCT00888940|3704148|FG001|Overall Study|Adverse Event|3
2109779|NCT00888940|3704147|FG000|Overall Study|Lost to Follow-up|5
2109780|NCT00888940|3704148|FG001|Overall Study|Lost to Follow-up|5
2109781|NCT00888940|3704147|FG000|Overall Study|Randomized Not Treated|11
2109782|NCT00888940|3704148|FG001|Overall Study|Randomized Not Treated|13
2109783|NCT00889005|3704160|FG000|Overall Study|Lost to Follow-up|4
2109784|NCT00889005|3704161|FG001|Overall Study|Lost to Follow-up|2
2109785|NCT00889005|3704160|FG000|Overall Study|Withdrawal by Subject|4
2109786|NCT00889005|3704161|FG001|Overall Study|Withdrawal by Subject|0
2109787|NCT00889252|3704195|FG000|Overall Study|Adverse Event|2
2109788|NCT00889252|3704196|FG001|Overall Study|Adverse Event|4
2109789|NCT00889252|3704195|FG000|Overall Study|Withdrawal by Subject|3
2109790|NCT00889252|3704196|FG001|Overall Study|Withdrawal by Subject|0
2109791|NCT00889252|3704195|FG000|Overall Study|Protocol Violation|2
2217831|NCT01709903|3861098|FG000|Overall Study|Abnormal test procedure results|1
2217832|NCT01709903|3861099|FG001|Overall Study|Abnormal test procedure results|0
2217833|NCT01709903|3861098|FG000|Overall Study|In ability to use device|1
2217834|NCT01709903|3861099|FG001|Overall Study|In ability to use device|1
2217835|NCT01709903|3861098|FG000|Overall Study|no longer needed study drug|0
2217836|NCT01709903|3861099|FG001|Overall Study|no longer needed study drug|1
2217837|NCT01709903|3861098|FG000|Overall Study|Lost to Follow-up|0
2217838|NCT01709903|3861099|FG001|Overall Study|Lost to Follow-up|2
2217839|NCT01709903|3861098|FG000|Overall Study|Death|2
2109792|NCT00889252|3704196|FG001|Overall Study|Protocol Violation|0
2109793|NCT00889265|3704202|FG000|Overall Study|Adverse Event|1
2109794|NCT00889265|3704202|FG000|Overall Study|Lost to Follow-up|5
2109795|NCT00889265|3704202|FG000|Overall Study|Protocol Violation|1
2109796|NCT00889603|3704224|FG000|Overall Study|Adverse Event|7
2109797|NCT00889603|3704224|FG000|Overall Study|Death|3
2109798|NCT00889603|3704224|FG000|Overall Study|Lost to Follow-up|19
2109799|NCT00889603|3704224|FG000|Overall Study|No longer willing to participant in stud|4
2109800|NCT00889603|3704224|FG000|Overall Study|Other|4
2109801|NCT00889681|3704228|FG000|Overall Study|Not meeting qualification Criteria|2
2109802|NCT00889681|3704228|FG000|Overall Study|Insurance disapproval|1
2109803|NCT00889707|3704234|FG000|Overall Study|Adverse Event|1
2109804|NCT00889707|3704235|FG001|Overall Study|Adverse Event|0
2109805|NCT00889707|3704234|FG000|Overall Study|Withdrawal by Subject|4
2109806|NCT00889707|3704235|FG001|Overall Study|Withdrawal by Subject|3
2109807|NCT00889707|3704234|FG000|Overall Study|Lost to Follow-up|0
2109808|NCT00889707|3704235|FG001|Overall Study|Lost to Follow-up|2
2109809|NCT00889707|3704234|FG000|Overall Study|Lack of Efficacy|2
2109810|NCT00889707|3704235|FG001|Overall Study|Lack of Efficacy|5
2109811|NCT00889720|3704241|FG000|Overall Study|Withdrawal by Subject|4
2217840|NCT01709903|3861099|FG001|Overall Study|Death|0
2217841|NCT01709903|3861098|FG000|Overall Study|Protocol Violation|3
2217842|NCT01709903|3861099|FG001|Overall Study|Protocol Violation|2
2217843|NCT01709903|3861098|FG000|Overall Study|Lack of Efficacy|3
2217844|NCT01709903|3861099|FG001|Overall Study|Lack of Efficacy|3
2109812|NCT00889720|3704241|FG000|Overall Study|Other|4
2109813|NCT00889863|3704249|FG000|Part I: Open Label|Death|1
2109814|NCT00889863|3704250|FG001|Part I: Open Label|Death|0
2028954|NCT00368537|3598263|FG000|Randomization|No study drug dosed|13
2028955|NCT00368537|3598264|FG001|Randomization|No study drug dosed|6
2028956|NCT00368537|3598263|FG000|Baseline Participants|Lost to Follow-up|16
2028957|NCT00368537|3598264|FG001|Baseline Participants|Lost to Follow-up|17
2028958|NCT00368537|3598263|FG000|Baseline Participants|Withdrawal by Subject|6
2028959|NCT00368537|3598264|FG001|Baseline Participants|Withdrawal by Subject|4
2028960|NCT00368537|3598263|FG000|Baseline Participants|Death|1
2028961|NCT00368537|3598264|FG001|Baseline Participants|Death|2
2028962|NCT00368537|3598263|FG000|Baseline Participants|No susceptibility|1
2028963|NCT00368537|3598264|FG001|Baseline Participants|No susceptibility|0
2028964|NCT00368537|3598263|FG000|Baseline Participants|Patient uncompliant|0
2028965|NCT00368537|3598264|FG001|Baseline Participants|Patient uncompliant|1
2028966|NCT00368550|3598272|FG000|Overall Study|Adverse Event|7
2028967|NCT00368550|3598273|FG001|Overall Study|Adverse Event|4
2028968|NCT00368550|3598272|FG000|Overall Study|Lack of Efficacy|4
2028969|NCT00368550|3598273|FG001|Overall Study|Lack of Efficacy|9
2028970|NCT00368550|3598272|FG000|Overall Study|Withdrawal by Subject|17
2028971|NCT00368550|3598273|FG001|Overall Study|Withdrawal by Subject|10
2028972|NCT00368641|3598281|FG000|Overall Study|Adverse Event|2
2028973|NCT00368641|3598282|FG001|Overall Study|Adverse Event|1
2028974|NCT00368641|3598281|FG000|Overall Study|Death|1
2028975|NCT00368641|3598282|FG001|Overall Study|Death|0
2028976|NCT00368641|3598281|FG000|Overall Study|Withdrawal by Subject|1
2028977|NCT00368641|3598282|FG001|Overall Study|Withdrawal by Subject|0
2028978|NCT00368641|3598281|FG000|Overall Study|Sponsor decision to terminate study|2
2028979|NCT00368641|3598282|FG001|Overall Study|Sponsor decision to terminate study|5
2028980|NCT00368745|3598290|FG000|Double-blind Treatment Period|Adverse Event|6
2028981|NCT00368745|3598291|FG001|Double-blind Treatment Period|Adverse Event|6
2028982|NCT00368745|3598290|FG000|Double-blind Treatment Period|Lack of Efficacy|7
2028983|NCT00368745|3598291|FG001|Double-blind Treatment Period|Lack of Efficacy|16
2028984|NCT00368745|3598290|FG000|Double-blind Treatment Period|Lost to Follow-up|1
2028985|NCT00368745|3598291|FG001|Double-blind Treatment Period|Lost to Follow-up|0
2028986|NCT00368745|3598290|FG000|Double-blind Treatment Period|Withdrawal by Subject|5
2028987|NCT00368745|3598291|FG001|Double-blind Treatment Period|Withdrawal by Subject|3
2028988|NCT00368745|3598290|FG000|Double-blind Treatment Period|Other|7
2028989|NCT00368745|3598291|FG001|Double-blind Treatment Period|Other|6
2028990|NCT00368836|3598299|FG000|Phase II|Screen Failure|1
2028991|NCT00368836|3598299|FG000|Phase II|Withdrawal by Subject|1
2028992|NCT00368836|3598299|FG000|Phase II|unable to collect blood and/or breath|17
2028993|NCT00368836|3598299|FG000|Phase II|Protocol Violation|2
2028994|NCT00368849|3598306|FG000|Overall Study|Withdrawal by Subject|0
2028995|NCT00368849|3598307|FG001|Overall Study|Withdrawal by Subject|1
2028996|NCT00368849|3598306|FG000|Overall Study|Physician Decision|0
2028997|NCT00368849|3598307|FG001|Overall Study|Physician Decision|1
2028998|NCT00368875|3598314|FG000|Overall Study|Adverse Event|0
2028999|NCT00368875|3598315|FG001|Overall Study|Adverse Event|12
2029000|NCT00368875|3598314|FG000|Overall Study|Progressive disease|3
2029001|NCT00368875|3598315|FG001|Overall Study|Progressive disease|27
2029002|NCT00368875|3598314|FG000|Overall Study|Withdrawal by Subject|2
2029003|NCT00368875|3598315|FG001|Overall Study|Withdrawal by Subject|6
2029004|NCT00368875|3598314|FG000|Overall Study|Other Reason|0
2029005|NCT00368875|3598315|FG001|Overall Study|Other Reason|2
2029006|NCT00368875|3598314|FG000|Overall Study|Alternative Therapy|1
2029007|NCT00368875|3598315|FG001|Overall Study|Alternative Therapy|1
2029008|NCT00368927|3598323|FG000|Overall Study|Lost to Follow-up|2
2029009|NCT00368927|3598324|FG001|Overall Study|Lost to Follow-up|0
2029010|NCT00368927|3598323|FG000|Overall Study|Adverse Event|1
2029011|NCT00368927|3598324|FG001|Overall Study|Adverse Event|1
2029012|NCT00368927|3598323|FG000|Overall Study|Withdrawal by Subject|1
2029013|NCT00368927|3598324|FG001|Overall Study|Withdrawal by Subject|2
2029014|NCT00368927|3598323|FG000|Overall Study|Physician Decision|1
2029015|NCT00368927|3598324|FG001|Overall Study|Physician Decision|0
2029016|NCT00368966|3598342|FG000|Infant Series|Withdrawal by Subject|11
2029017|NCT00368966|3598343|FG001|Infant Series|Withdrawal by Subject|6
2029018|NCT00368966|3598342|FG000|Infant Series|Protocol Violation|2
2029019|NCT00368966|3598343|FG001|Infant Series|Protocol Violation|1
2029020|NCT00368966|3598342|FG000|Infant Series|Lost to Follow-up|2
2029021|NCT00368966|3598343|FG001|Infant Series|Lost to Follow-up|0
2109815|NCT00889863|3704249|FG000|Part I: Open Label|Adverse Event|4
2109816|NCT00889863|3704250|FG001|Part I: Open Label|Adverse Event|0
2109817|NCT00889863|3704249|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72
2109818|NCT00889863|3704250|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0
2109819|NCT00889863|3704249|FG000|Part II: Randomized Double Blind|Adverse Event|0
2109820|NCT00889863|3704250|FG001|Part II: Randomized Double Blind|Adverse Event|4
2109821|NCT00889863|3704249|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
2109822|NCT00889863|3704250|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
2109823|NCT00889863|3704249|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0
2109824|NCT00889863|3704250|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1
2029022|NCT00368966|3598342|FG000|Infant Series|Randomization error|0
2029023|NCT00368966|3598343|FG001|Infant Series|Randomization error|1
2029024|NCT00368966|3598342|FG000|Infant Series|Failed to meet eligibility criteria|0
2029025|NCT00368966|3598343|FG001|Infant Series|Failed to meet eligibility criteria|1
2029026|NCT00368966|3598342|FG000|Infant Series|Adverse Event|0
2029027|NCT00368966|3598343|FG001|Infant Series|Adverse Event|1
2029028|NCT00368966|3598342|FG000|Infant Series|Failed to return|1
2029029|NCT00368966|3598343|FG001|Infant Series|Failed to return|0
2029030|NCT00368966|3598342|FG000|After Infant|Failed to return|3
2029031|NCT00368966|3598343|FG001|After Infant|Failed to return|1
2029032|NCT00368966|3598342|FG000|After Infant|Adverse Event|1
2029033|NCT00368966|3598343|FG001|After Infant|Adverse Event|2
2029034|NCT00368966|3598342|FG000|After Infant|Withdrawal by Subject|1
2029035|NCT00368966|3598343|FG001|After Infant|Withdrawal by Subject|1
2029036|NCT00368966|3598342|FG000|After Infant|Death|1
2029037|NCT00368966|3598343|FG001|After Infant|Death|0
2029038|NCT00368966|3598342|FG000|After Infant|Lost to Follow-up|0
2029039|NCT00368966|3598343|FG001|After Infant|Lost to Follow-up|1
2029040|NCT00368966|3598342|FG000|Toddler Dose|Withdrawal by Subject|1
2029041|NCT00368966|3598343|FG001|Toddler Dose|Withdrawal by Subject|1
2029042|NCT00368966|3598342|FG000|Toddler Dose|Lost to Follow-up|0
2029043|NCT00368966|3598343|FG001|Toddler Dose|Lost to Follow-up|2
2029044|NCT00368979|3598376|FG000|Overall Study|Adverse Event|9
2029045|NCT00368979|3598377|FG001|Overall Study|Adverse Event|16
2029046|NCT00368979|3598376|FG000|Overall Study|Lack of Efficacy|5
2029047|NCT00368979|3598377|FG001|Overall Study|Lack of Efficacy|3
2029048|NCT00368979|3598376|FG000|Overall Study|Other|3
2029049|NCT00368979|3598377|FG001|Overall Study|Other|1
2029050|NCT00368979|3598376|FG000|Overall Study|Lost to Follow-up|1
2029051|NCT00368979|3598377|FG001|Overall Study|Lost to Follow-up|0
2029052|NCT00368979|3598376|FG000|Overall Study|Protocol Violation|2
2029053|NCT00368979|3598377|FG001|Overall Study|Protocol Violation|1
2029054|NCT00368979|3598376|FG000|Overall Study|Withdrawal by Subject|5
2029055|NCT00368979|3598377|FG001|Overall Study|Withdrawal by Subject|9
2029056|NCT00368992|3598383|FG000|Overall Study|Ineligible|5
2029057|NCT00368992|3598383|FG000|Overall Study|Refused treatment|3
2029058|NCT00368992|3598383|FG000|Overall Study|Lack of Efficacy|63
2029059|NCT00368992|3598383|FG000|Overall Study|Adverse Event|26
2029060|NCT00368992|3598383|FG000|Overall Study|Death|4
2029061|NCT00368992|3598383|FG000|Overall Study|Other|9
2029062|NCT00369122|3598388|FG000|Overall Study|Ineligible|10
2029063|NCT00369122|3598388|FG000|Overall Study|No protocol treatment|1
2029064|NCT00369161|3598394|FG000|Overall Study|Adverse Event|15
2029065|NCT00369161|3598395|FG001|Overall Study|Adverse Event|13
2029066|NCT00369161|3598394|FG000|Overall Study|Abnormal laboratory value|0
2029067|NCT00369161|3598395|FG001|Overall Study|Abnormal laboratory value|1
2029068|NCT00369161|3598394|FG000|Overall Study|Lack of Efficacy|3
2029069|NCT00369161|3598395|FG001|Overall Study|Lack of Efficacy|1
2029070|NCT00369161|3598394|FG000|Overall Study|Protocol Violation|0
2029071|NCT00369161|3598395|FG001|Overall Study|Protocol Violation|2
2029072|NCT00369161|3598394|FG000|Overall Study|Withdrawal by Subject|2
2029073|NCT00369161|3598395|FG001|Overall Study|Withdrawal by Subject|3
2029074|NCT00369161|3598394|FG000|Overall Study|Death|1
2029075|NCT00369161|3598395|FG001|Overall Study|Death|2
2029076|NCT00369161|3598394|FG000|Overall Study|Graft loss|4
2029077|NCT00369161|3598395|FG001|Overall Study|Graft loss|0
2029078|NCT00369161|3598394|FG000|Overall Study|Administrative Problem|2
2029079|NCT00369161|3598395|FG001|Overall Study|Administrative Problem|2
2109825|NCT00889863|3704249|FG000|Part II: Randomized Double Blind|Protocol deviation|0
2109826|NCT00889863|3704250|FG001|Part II: Randomized Double Blind|Protocol deviation|1
2109827|NCT00890045|3704281|FG000|Overall Study|Death|0
2109828|NCT00890045|3704282|FG001|Overall Study|Death|1
2109829|NCT00890045|3704281|FG000|Overall Study|Did not receive HeRO Graft|0
2109830|NCT00890045|3704282|FG001|Overall Study|Did not receive HeRO Graft|2
2109831|NCT00890045|3704281|FG000|Overall Study|Lost to Follow-up|5
2109832|NCT00890045|3704282|FG001|Overall Study|Lost to Follow-up|7
2109833|NCT00890084|3704288|FG000|Overall Study|Adverse Event|16
2109834|NCT00890084|3704288|FG000|Overall Study|Lost to Follow-up|126
2109835|NCT00890097|3704295|FG000|Overall Study|Adverse Event|21
2109836|NCT00890097|3704296|FG001|Overall Study|Adverse Event|32
2109837|NCT00890097|3704297|FG002|Overall Study|Adverse Event|28
2109838|NCT00890097|3704295|FG000|Overall Study|Decision Unrelated to an Adverse Event|15
2109839|NCT00890097|3704296|FG001|Overall Study|Decision Unrelated to an Adverse Event|12
2109840|NCT00890097|3704297|FG002|Overall Study|Decision Unrelated to an Adverse Event|17
2109841|NCT00890097|3704295|FG000|Overall Study|Withdrew Consent|9
2109842|NCT00890097|3704296|FG001|Overall Study|Withdrew Consent|6
2109843|NCT00890097|3704297|FG002|Overall Study|Withdrew Consent|9
2109844|NCT00890097|3704295|FG000|Overall Study|Lost to Follow-up|5
2109845|NCT00890097|3704296|FG001|Overall Study|Lost to Follow-up|5
2109846|NCT00890097|3704297|FG002|Overall Study|Lost to Follow-up|5
2109847|NCT00890097|3704295|FG000|Overall Study|Noncompliance|0
2109848|NCT00890097|3704296|FG001|Overall Study|Noncompliance|4
2109849|NCT00890097|3704297|FG002|Overall Study|Noncompliance|4
2109850|NCT00890097|3704295|FG000|Overall Study|Sponsor Decision|7
2109851|NCT00890097|3704296|FG001|Overall Study|Sponsor Decision|11
2109852|NCT00890097|3704297|FG002|Overall Study|Sponsor Decision|7
2109853|NCT00890097|3704295|FG000|Overall Study|Did not attend final visit|2
2029080|NCT00369278|3598415|FG000|Overall Study|Adverse Event|14
2029081|NCT00369278|3598416|FG001|Overall Study|Adverse Event|11
2029082|NCT00369278|3598415|FG000|Overall Study|Unsatisfactory therapeutic effect|4
2029083|NCT00369278|3598416|FG001|Overall Study|Unsatisfactory therapeutic effect|5
2029084|NCT00369278|3598415|FG000|Overall Study|Protocol Violation|2
2029085|NCT00369278|3598416|FG001|Overall Study|Protocol Violation|1
2029086|NCT00369278|3598415|FG000|Overall Study|Withdrawal by Subject|2
2029087|NCT00369278|3598416|FG001|Overall Study|Withdrawal by Subject|2
2029088|NCT00369278|3598415|FG000|Overall Study|Lost to Follow-up|1
2029089|NCT00369278|3598416|FG001|Overall Study|Lost to Follow-up|0
2029090|NCT00369278|3598415|FG000|Overall Study|Graft loss|1
2029091|NCT00369278|3598416|FG001|Overall Study|Graft loss|2
2029092|NCT00369343|3598424|FG000|Double-blind Phase|Adverse Event|19
2029093|NCT00369343|3598425|FG001|Double-blind Phase|Adverse Event|4
2029094|NCT00369343|3598424|FG000|Double-blind Phase|Failed to return|2
2029095|NCT00369343|3598425|FG001|Double-blind Phase|Failed to return|0
2029096|NCT00369343|3598424|FG000|Double-blind Phase|Lost to Follow-up|9
2029097|NCT00369343|3598425|FG001|Double-blind Phase|Lost to Follow-up|2
2029098|NCT00369343|3598424|FG000|Double-blind Phase|Protocol Violation|2
2029099|NCT00369343|3598425|FG001|Double-blind Phase|Protocol Violation|0
2029100|NCT00369343|3598424|FG000|Double-blind Phase|Withdrawal by Subject|8
2029101|NCT00369343|3598425|FG001|Double-blind Phase|Withdrawal by Subject|6
2029102|NCT00369343|3598424|FG000|Double-blind Phase|Lack of Efficacy|0
2029103|NCT00369343|3598425|FG001|Double-blind Phase|Lack of Efficacy|4
2029104|NCT00369343|3598424|FG000|Double-blind Phase|Protocol deviation|4
2029105|NCT00369343|3598425|FG001|Double-blind Phase|Protocol deviation|0
2029106|NCT00369343|3598424|FG000|Open-label Phase|Adverse Event|19
2029107|NCT00369343|3598425|FG001|Open-label Phase|Adverse Event|7
2029108|NCT00369343|3598424|FG000|Open-label Phase|Failed to return|4
2029109|NCT00369343|3598425|FG001|Open-label Phase|Failed to return|0
2029110|NCT00369343|3598424|FG000|Open-label Phase|Physician Decision|2
2029111|NCT00369343|3598425|FG001|Open-label Phase|Physician Decision|0
2029112|NCT00369343|3598424|FG000|Open-label Phase|Lost to Follow-up|5
2029113|NCT00369343|3598425|FG001|Open-label Phase|Lost to Follow-up|3
2029114|NCT00369343|3598424|FG000|Open-label Phase|inadvertently reported study completers|3
2029115|NCT00369343|3598425|FG001|Open-label Phase|inadvertently reported study completers|2
2029116|NCT00369343|3598424|FG000|Open-label Phase|Protocol Violation|1
2029117|NCT00369343|3598425|FG001|Open-label Phase|Protocol Violation|3
2029118|NCT00369343|3598424|FG000|Open-label Phase|Withdrawal by Subject|15
2029119|NCT00369343|3598425|FG001|Open-label Phase|Withdrawal by Subject|6
2109854|NCT00890097|3704296|FG001|Overall Study|Did not attend final visit|3
2109855|NCT00890097|3704297|FG002|Overall Study|Did not attend final visit|0
2109856|NCT00890097|3704295|FG000|Overall Study|Subject Decision|3
2109857|NCT00890097|3704296|FG001|Overall Study|Subject Decision|2
2109858|NCT00890097|3704297|FG002|Overall Study|Subject Decision|6
2109859|NCT00890097|3704295|FG000|Overall Study|Randomization Error|2
2109860|NCT00890097|3704296|FG001|Overall Study|Randomization Error|0
2109861|NCT00890097|3704297|FG002|Overall Study|Randomization Error|0
2109862|NCT00890097|3704295|FG000|Overall Study|Failed inclusion criteria|3
2109863|NCT00890097|3704296|FG001|Overall Study|Failed inclusion criteria|4
2109864|NCT00890097|3704297|FG002|Overall Study|Failed inclusion criteria|0
2109865|NCT00890097|3704295|FG000|Overall Study|Transportation|0
2109866|NCT00890097|3704296|FG001|Overall Study|Transportation|2
2109867|NCT00890097|3704297|FG002|Overall Study|Transportation|0
2109868|NCT00890097|3704295|FG000|Overall Study|Subject Moved|0
2109869|NCT00890097|3704296|FG001|Overall Study|Subject Moved|4
2109870|NCT00890097|3704297|FG002|Overall Study|Subject Moved|0
2109871|NCT00890097|3704295|FG000|Overall Study|Protocol Deviation|1
2109872|NCT00890097|3704296|FG001|Overall Study|Protocol Deviation|1
2109873|NCT00890097|3704297|FG002|Overall Study|Protocol Deviation|1
2109874|NCT00890201|3704316|FG000|Overall Study|Protocol Violation|5
2109875|NCT00890201|3704317|FG001|Overall Study|Protocol Violation|56
2109876|NCT00890552|3704335|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1
2109877|NCT00890552|3704335|FG000|On-treatment|Early prog disease/ death|10
2109878|NCT00890695|3704358|FG000|Overall Study|Protocol Violation|1
2109879|NCT00890695|3704359|FG001|Overall Study|Protocol Violation|0
2109880|NCT00890825|3704376|FG000|Overall Study|Withdrawal by Subject|1
2109881|NCT00890825|3704377|FG001|Overall Study|Withdrawal by Subject|0
2109882|NCT00890825|3704376|FG000|Overall Study|Alive at data cut off (DCO)|13
2109883|NCT00890825|3704377|FG001|Overall Study|Alive at data cut off (DCO)|14
2109884|NCT00890929|3704387|FG000|Overall Study|Death before treatment|2
2109885|NCT00890929|3704387|FG000|Overall Study|Withdrawal by Subject|3
2109886|NCT00890929|3704387|FG000|Overall Study|Physician Decision|1
2109887|NCT00891020|3704403|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11
2109888|NCT00891020|3704404|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32
2109889|NCT00891020|3704405|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17
2109890|NCT00891020|3704403|FG000|24 Week Treatment Period|Death|0
2109891|NCT00891020|3704404|FG001|24 Week Treatment Period|Death|2
2109892|NCT00891020|3704405|FG002|24 Week Treatment Period|Death|0
2109893|NCT00891020|3704403|FG000|24 Week Treatment Period|Insufficient therapeutic response|6
2109894|NCT00891020|3704404|FG001|24 Week Treatment Period|Insufficient therapeutic response|9
2109895|NCT00891020|3704405|FG002|24 Week Treatment Period|Insufficient therapeutic response|15
2109896|NCT00891020|3704403|FG000|24 Week Treatment Period|Failure to return|4
2029120|NCT00369343|3598424|FG000|Open-label Phase|Lack of Efficacy|4
2029121|NCT00369343|3598425|FG001|Open-label Phase|Lack of Efficacy|3
2029122|NCT00369343|3598424|FG000|Open-label Phase|Lack of continuance tolerability|3
2029123|NCT00369343|3598425|FG001|Open-label Phase|Lack of continuance tolerability|4
2029124|NCT00369343|3598424|FG000|Open-label Phase|did not take study drug|1
2029125|NCT00369343|3598425|FG001|Open-label Phase|did not take study drug|2
2029126|NCT00369382|3598440|FG000|Overall Study|Death|0
2029127|NCT00369382|3598441|FG001|Overall Study|Death|2
2029128|NCT00369382|3598440|FG000|Overall Study|Physician Decision|2
2029129|NCT00369382|3598441|FG001|Overall Study|Physician Decision|1
2029130|NCT00369382|3598440|FG000|Overall Study|Withdrawal by Subject|5
2029131|NCT00369382|3598441|FG001|Overall Study|Withdrawal by Subject|0
2029132|NCT00369382|3598440|FG000|Overall Study|Randomized, not treated|2
2029133|NCT00369382|3598441|FG001|Overall Study|Randomized, not treated|0
2029134|NCT00369382|3598440|FG000|Overall Study|Other|1
2029135|NCT00369382|3598441|FG001|Overall Study|Other|0
2029136|NCT00369486|3598453|FG000|4-Week Visit|Missed visit|2
2029137|NCT00369486|3598454|FG001|4-Week Visit|Missed visit|2
2029138|NCT00369486|3598455|FG002|4-Week Visit|Missed visit|0
2029139|NCT00369486|3598456|FG003|4-Week Visit|Missed visit|2
2029140|NCT00369486|3598457|FG004|4-Week Visit|Missed visit|1
2029141|NCT00369486|3598453|FG000|4-Week Visit|Dropped|0
2029142|NCT00369486|3598454|FG001|4-Week Visit|Dropped|0
2029143|NCT00369486|3598455|FG002|4-Week Visit|Dropped|1
2029144|NCT00369486|3598456|FG003|4-Week Visit|Dropped|0
2029145|NCT00369486|3598457|FG004|4-Week Visit|Dropped|0
2029146|NCT00369486|3598453|FG000|8-Week Visit|Missed visit|0
2029147|NCT00369486|3598454|FG001|8-Week Visit|Missed visit|1
2029148|NCT00369486|3598455|FG002|8-Week Visit|Missed visit|0
2029149|NCT00369486|3598456|FG003|8-Week Visit|Missed visit|0
2029150|NCT00369486|3598457|FG004|8-Week Visit|Missed visit|1
2029151|NCT00369486|3598453|FG000|8-Week Visit|Dropped|0
2029152|NCT00369486|3598454|FG001|8-Week Visit|Dropped|0
2029153|NCT00369486|3598455|FG002|8-Week Visit|Dropped|0
2029154|NCT00369486|3598456|FG003|8-Week Visit|Dropped|1
2029155|NCT00369486|3598457|FG004|8-Week Visit|Dropped|0
2029156|NCT00369486|3598453|FG000|17-Week Visit|Missed visit|0
2029157|NCT00369486|3598454|FG001|17-Week Visit|Missed visit|0
2029158|NCT00369486|3598455|FG002|17-Week Visit|Missed visit|1
2029159|NCT00369486|3598456|FG003|17-Week Visit|Missed visit|1
2029160|NCT00369486|3598457|FG004|17-Week Visit|Missed visit|1
2029161|NCT00369486|3598453|FG000|34-Week Visit|Dropped|0
2029162|NCT00369486|3598454|FG001|34-Week Visit|Dropped|1
2029163|NCT00369486|3598455|FG002|34-Week Visit|Dropped|1
2029164|NCT00369486|3598456|FG003|34-Week Visit|Dropped|3
2029165|NCT00369486|3598457|FG004|34-Week Visit|Dropped|3
2029166|NCT00369577|3598489|FG000|Overall Study|Withdrawal by Subject|0
2029167|NCT00369577|3598490|FG001|Overall Study|Withdrawal by Subject|0
2029168|NCT00369577|3598491|FG002|Overall Study|Withdrawal by Subject|1
2029169|NCT00369629|3598507|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0
2029170|NCT00369629|3598508|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1
2109897|NCT00891020|3704404|FG001|24 Week Treatment Period|Failure to return|5
2109898|NCT00891020|3704405|FG002|24 Week Treatment Period|Failure to return|5
2109899|NCT00891020|3704403|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1
2109900|NCT00891020|3704404|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0
2109901|NCT00891020|3704405|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2
2109902|NCT00891020|3704403|FG000|24 Week Treatment Period|Other protocol violation|1
2109903|NCT00891020|3704404|FG001|24 Week Treatment Period|Other protocol violation|1
2109904|NCT00891020|3704405|FG002|24 Week Treatment Period|Other protocol violation|2
2109905|NCT00891020|3704403|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3
2109906|NCT00891020|3704404|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2
2109907|NCT00891020|3704405|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1
2109908|NCT00891020|3704403|FG000|24 Week Treatment Period|Withdrew consent|6
2109909|NCT00891020|3704404|FG001|24 Week Treatment Period|Withdrew consent|3
2109910|NCT00891020|3704405|FG002|24 Week Treatment Period|Withdrew consent|15
2109911|NCT00891020|3704403|FG000|24 Week Treatment Period|Administrative/Other|5
2109912|NCT00891020|3704404|FG001|24 Week Treatment Period|Administrative/Other|6
2109913|NCT00891020|3704405|FG002|24 Week Treatment Period|Administrative/Other|1
2109914|NCT00891020|3704403|FG000|Long-term Extension Period|Adverse Event|1
2109915|NCT00891020|3704404|FG001|Long-term Extension Period|Adverse Event|11
2109916|NCT00891020|3704405|FG002|Long-term Extension Period|Adverse Event|10
2322517|NCT02974010|4037612|FG001|Overall Study|Withdrawal by Subject|1
2322518|NCT02974010|4037613|FG002|Overall Study|Withdrawal by Subject|0
2322519|NCT02974010|4037614|FG003|Overall Study|Withdrawal by Subject|0
2322520|NCT02974010|4037611|FG000|Overall Study|Adverse Event|0
2322521|NCT02974010|4037612|FG001|Overall Study|Adverse Event|1
2322522|NCT02974010|4037613|FG002|Overall Study|Adverse Event|0
2322523|NCT02974010|4037614|FG003|Overall Study|Adverse Event|0
2322524|NCT02974010|4037611|FG000|Overall Study|Completed day 42 but did not return for day 70|1
2322525|NCT02974010|4037612|FG001|Overall Study|Completed day 42 but did not return for day 70|0
2322526|NCT02974010|4037613|FG002|Overall Study|Completed day 42 but did not return for day 70|1
2029171|NCT00369629|3598509|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1
2029172|NCT00369629|3598510|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0
2029173|NCT00369629|3598507|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0
2029174|NCT00369629|3598508|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0
2029175|NCT00369629|3598509|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1
2029176|NCT00369629|3598510|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0
2029177|NCT00369629|3598507|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2
2029178|NCT00369629|3598508|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0
2029179|NCT00369629|3598509|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0
2029180|NCT00369629|3598510|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0
2029181|NCT00369629|3598507|FG000|Moved on to 4 More Cycles|Progressive Disease|0
2029182|NCT00369629|3598508|FG001|Moved on to 4 More Cycles|Progressive Disease|0
2029183|NCT00369629|3598509|FG002|Moved on to 4 More Cycles|Progressive Disease|1
2029184|NCT00369629|3598510|FG003|Moved on to 4 More Cycles|Progressive Disease|0
2029185|NCT00369629|3598507|FG000|Completed 4 More Cycles|Withdrawal by Subject|2
2029186|NCT00369629|3598508|FG001|Completed 4 More Cycles|Withdrawal by Subject|1
2029187|NCT00369629|3598509|FG002|Completed 4 More Cycles|Withdrawal by Subject|0
2029188|NCT00369629|3598510|FG003|Completed 4 More Cycles|Withdrawal by Subject|0
2029189|NCT00369629|3598507|FG000|Completed 4 More Cycles|Progressive disease|2
2029190|NCT00369629|3598508|FG001|Completed 4 More Cycles|Progressive disease|1
2029191|NCT00369629|3598509|FG002|Completed 4 More Cycles|Progressive disease|2
2029192|NCT00369629|3598510|FG003|Completed 4 More Cycles|Progressive disease|0
2029193|NCT00369629|3598507|FG000|Follow up for 1 Year|Death|2
2109917|NCT00891020|3704403|FG000|Long-term Extension Period|Death|0
2109918|NCT00891020|3704404|FG001|Long-term Extension Period|Death|0
2109919|NCT00891020|3704405|FG002|Long-term Extension Period|Death|1
2109920|NCT00891020|3704403|FG000|Long-term Extension Period|Insufficient therapeutic response|3
2109921|NCT00891020|3704404|FG001|Long-term Extension Period|Insufficient therapeutic response|2
2109922|NCT00891020|3704405|FG002|Long-term Extension Period|Insufficient therapeutic response|2
2217845|NCT01709903|3861098|FG000|Overall Study|Withdrawal by Subject|6
2217846|NCT01709903|3861099|FG001|Overall Study|Withdrawal by Subject|6
2217847|NCT01709903|3861098|FG000|Overall Study|Adverse Event|11
2109923|NCT00891020|3704403|FG000|Long-term Extension Period|Protocol Violation|0
2109924|NCT00891020|3704404|FG001|Long-term Extension Period|Protocol Violation|1
2109925|NCT00891020|3704405|FG002|Long-term Extension Period|Protocol Violation|1
2109926|NCT00891020|3704403|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1
2109927|NCT00891020|3704404|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6
2109928|NCT00891020|3704405|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4
2109929|NCT00891020|3704403|FG000|Long-term Extension Period|Failure to return|0
2109930|NCT00891020|3704404|FG001|Long-term Extension Period|Failure to return|2
2109931|NCT00891020|3704405|FG002|Long-term Extension Period|Failure to return|3
2109932|NCT00891020|3704403|FG000|Long-term Extension Period|Administrative|1
2109933|NCT00891020|3704404|FG001|Long-term Extension Period|Administrative|2
2109934|NCT00891020|3704405|FG002|Long-term Extension Period|Administrative|2
2109935|NCT00891046|3704420|FG000|Overall Study|Protocol Violation|1
2109936|NCT00891046|3704421|FG001|Overall Study|Protocol Violation|1
2109937|NCT00891046|3704422|FG002|Overall Study|Protocol Violation|0
2109938|NCT00891046|3704423|FG003|Overall Study|Protocol Violation|0
2109939|NCT00891046|3704424|FG004|Overall Study|Protocol Violation|1
2109940|NCT00891046|3704420|FG000|Overall Study|Unsatisfactory therapeutic effect|5
2109941|NCT00891046|3704421|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2109942|NCT00891046|3704422|FG002|Overall Study|Unsatisfactory therapeutic effect|19
2109943|NCT00891046|3704423|FG003|Overall Study|Unsatisfactory therapeutic effect|2
2109944|NCT00891046|3704424|FG004|Overall Study|Unsatisfactory therapeutic effect|20
2109945|NCT00891046|3704420|FG000|Overall Study|Administrative problems|0
2109946|NCT00891046|3704421|FG001|Overall Study|Administrative problems|0
2109947|NCT00891046|3704422|FG002|Overall Study|Administrative problems|0
2109948|NCT00891046|3704423|FG003|Overall Study|Administrative problems|0
2109949|NCT00891046|3704424|FG004|Overall Study|Administrative problems|1
2109950|NCT00891046|3704420|FG000|Overall Study|Participant no longer required drug|0
2217848|NCT01709903|3861099|FG001|Overall Study|Adverse Event|18
2217849|NCT01710020|3861114|FG000|Period 1|Protocol Violation|1
2217850|NCT01710033|3861124|FG000|Stage 2|Adverse Event|0
2217851|NCT01710033|3861125|FG001|Stage 2|Adverse Event|0
2217852|NCT01710033|3861126|FG002|Stage 2|Adverse Event|0
2217853|NCT01710033|3861127|FG003|Stage 2|Adverse Event|0
2217854|NCT01710033|3861128|FG004|Stage 2|Adverse Event|1
2217855|NCT01710046|3861143|FG000|Overall Study|Lost to Follow-up|1
2217856|NCT01710046|3861144|FG001|Overall Study|Lost to Follow-up|0
2217857|NCT01710345|3861185|FG000|Overall Study|Adverse Event|0
2322527|NCT02974010|4037614|FG003|Overall Study|Completed day 42 but did not return for day 70|0
2322528|NCT02974010|4037611|FG000|Overall Study|Lack of Efficacy|0
2322529|NCT02974010|4037612|FG001|Overall Study|Lack of Efficacy|0
2322530|NCT02974010|4037613|FG002|Overall Study|Lack of Efficacy|1
2322531|NCT02974010|4037614|FG003|Overall Study|Lack of Efficacy|0
2322532|NCT02974088|4037626|FG000|Overall Study|Lost to Follow-up|0
2322533|NCT02974088|4037627|FG001|Overall Study|Lost to Follow-up|2
2322534|NCT02974088|4037626|FG000|Overall Study|Adverse Event|0
2322535|NCT02974088|4037627|FG001|Overall Study|Adverse Event|1
2322536|NCT02974114|4037636|FG000|Overall Study|Other (Not specified)|0
2322537|NCT02974114|4037637|FG001|Overall Study|Other (Not specified)|1
2217858|NCT01710345|3861186|FG001|Overall Study|Adverse Event|2
2217859|NCT01710345|3861187|FG002|Overall Study|Adverse Event|0
2217860|NCT01710345|3861185|FG000|Overall Study|Lack of Efficacy|2
2217861|NCT01710345|3861186|FG001|Overall Study|Lack of Efficacy|3
2217862|NCT01710345|3861187|FG002|Overall Study|Lack of Efficacy|1
2217863|NCT01710345|3861185|FG000|Overall Study|Drug Dosing Error|1
2217864|NCT01710345|3861186|FG001|Overall Study|Drug Dosing Error|0
2217865|NCT01710345|3861187|FG002|Overall Study|Drug Dosing Error|0
2217866|NCT01710358|3861198|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
2217867|NCT01710358|3861199|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
2217868|NCT01710358|3861200|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
2217869|NCT01710358|3861198|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0
2029194|NCT00369629|3598508|FG001|Follow up for 1 Year|Death|1
2029195|NCT00369629|3598509|FG002|Follow up for 1 Year|Death|1
2029196|NCT00369629|3598510|FG003|Follow up for 1 Year|Death|0
2029197|NCT00369629|3598507|FG000|Follow up for 1 Year|Lost to Follow-up|0
2029198|NCT00369629|3598508|FG001|Follow up for 1 Year|Lost to Follow-up|1
2029199|NCT00369629|3598509|FG002|Follow up for 1 Year|Lost to Follow-up|0
2029200|NCT00369629|3598510|FG003|Follow up for 1 Year|Lost to Follow-up|0
2029201|NCT00369629|3598507|FG000|Follow up for 1 Year|stopped being followed as study closed|0
2029202|NCT00369629|3598508|FG001|Follow up for 1 Year|stopped being followed as study closed|0
2029203|NCT00369629|3598509|FG002|Follow up for 1 Year|stopped being followed as study closed|2
2029204|NCT00369629|3598510|FG003|Follow up for 1 Year|stopped being followed as study closed|0
2029205|NCT00369655|3598520|FG000|Overall Study|Refusal of further treatment|2
2029206|NCT00369668|3598527|FG000|Overall Study|Lack of Efficacy|4
2029207|NCT00369668|3598528|FG001|Overall Study|Lack of Efficacy|5
2029208|NCT00369668|3598529|FG002|Overall Study|Lack of Efficacy|7
2029209|NCT00369681|3598540|FG000|Overall Study|Death|1
2029210|NCT00369707|3598544|FG000|Induction Part B (2 Cycles)|Adverse Event|3
2029211|NCT00369707|3598544|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2
2029212|NCT00369707|3598544|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
2029213|NCT00369707|3598544|FG000|Induction Part B (2 Cycles)|Progressive disease|1
2029214|NCT00369707|3598544|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
2029215|NCT00369707|3598544|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
2029216|NCT00369707|3598544|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4
2029217|NCT00369707|3598544|FG000|Follow up for 2 Years After Treatment|Death|1
2029218|NCT00369707|3598544|FG000|Follow up for 2 Years After Treatment|Other|2
2029219|NCT00369785|3598559|FG000|Overall Study|Physician Decision|3
2029220|NCT00369785|3598560|FG001|Overall Study|Physician Decision|2
2029221|NCT00369785|3598559|FG000|Overall Study|Death|1
2029222|NCT00369785|3598560|FG001|Overall Study|Death|2
2029223|NCT00369785|3598559|FG000|Overall Study|Withdrawal by Subject|7
2029224|NCT00369785|3598560|FG001|Overall Study|Withdrawal by Subject|6
2029225|NCT00369785|3598559|FG000|Overall Study|Toxicity|6
2029226|NCT00369785|3598560|FG001|Overall Study|Toxicity|4
2029227|NCT00369785|3598559|FG000|Overall Study|Never started|0
2029228|NCT00369785|3598560|FG001|Overall Study|Never started|2
2029229|NCT00369785|3598559|FG000|Overall Study|Progression|4
2029230|NCT00369785|3598560|FG001|Overall Study|Progression|4
2029231|NCT00369785|3598559|FG000|Overall Study|Multiple reasons|6
2029232|NCT00369785|3598560|FG001|Overall Study|Multiple reasons|5
2029233|NCT00369824|3598572|FG000|Overall Study|Adverse Event|0
2029234|NCT00369824|3598573|FG001|Overall Study|Adverse Event|2
2029235|NCT00369824|3598574|FG002|Overall Study|Adverse Event|0
2029236|NCT00369824|3598575|FG003|Overall Study|Adverse Event|0
2029237|NCT00369824|3598576|FG004|Overall Study|Adverse Event|1
2029238|NCT00369824|3598577|FG005|Overall Study|Adverse Event|0
2029239|NCT00369824|3598572|FG000|Overall Study|Protocol Violation|0
2029240|NCT00369824|3598573|FG001|Overall Study|Protocol Violation|1
2029241|NCT00369824|3598574|FG002|Overall Study|Protocol Violation|0
2029242|NCT00369824|3598575|FG003|Overall Study|Protocol Violation|1
2029243|NCT00369824|3598576|FG004|Overall Study|Protocol Violation|1
2029244|NCT00369824|3598577|FG005|Overall Study|Protocol Violation|0
2029245|NCT00369824|3598572|FG000|Overall Study|Withdrawal by Subject|9
2029246|NCT00369824|3598573|FG001|Overall Study|Withdrawal by Subject|5
2029247|NCT00369824|3598574|FG002|Overall Study|Withdrawal by Subject|5
2029248|NCT00369824|3598575|FG003|Overall Study|Withdrawal by Subject|4
2029249|NCT00369824|3598576|FG004|Overall Study|Withdrawal by Subject|6
2029250|NCT00369824|3598577|FG005|Overall Study|Withdrawal by Subject|2
2029251|NCT00369824|3598572|FG000|Overall Study|Lost to Follow-up|6
2029252|NCT00369824|3598573|FG001|Overall Study|Lost to Follow-up|11
2029253|NCT00369824|3598574|FG002|Overall Study|Lost to Follow-up|7
2029254|NCT00369824|3598575|FG003|Overall Study|Lost to Follow-up|8
2029255|NCT00369824|3598576|FG004|Overall Study|Lost to Follow-up|9
2029256|NCT00369824|3598577|FG005|Overall Study|Lost to Follow-up|6
2029257|NCT00369824|3598572|FG000|Overall Study|Other|0
2029258|NCT00369824|3598573|FG001|Overall Study|Other|0
2029259|NCT00369824|3598574|FG002|Overall Study|Other|0
2029260|NCT00369824|3598575|FG003|Overall Study|Other|2
2029261|NCT00369824|3598576|FG004|Overall Study|Other|1
2029262|NCT00369824|3598577|FG005|Overall Study|Other|3
2029263|NCT00369915|3598593|FG000|Overall Study|expected side effects|2
2029264|NCT00369915|3598594|FG001|Overall Study|expected side effects|1
2029265|NCT00369915|3598593|FG000|Overall Study|Withdrawal by Subject|4
2029266|NCT00369915|3598594|FG001|Overall Study|Withdrawal by Subject|1
2029267|NCT00369915|3598593|FG000|Overall Study|W/drawl by investigators|0
2029268|NCT00369915|3598594|FG001|Overall Study|W/drawl by investigators|1
2029269|NCT00369941|3598615|FG000|Overall Study|Never Treated|1
2029270|NCT00369941|3598616|FG001|Overall Study|Never Treated|2
2029271|NCT00369941|3598615|FG000|Overall Study|Adverse Event|14
2029272|NCT00369941|3598616|FG001|Overall Study|Adverse Event|28
2029273|NCT00369941|3598615|FG000|Overall Study|Lack of Efficacy|6
2029274|NCT00369941|3598616|FG001|Overall Study|Lack of Efficacy|10
2029275|NCT00369941|3598615|FG000|Overall Study|Lost to Follow-up|12
2029276|NCT00369941|3598616|FG001|Overall Study|Lost to Follow-up|22
2029277|NCT00369941|3598615|FG000|Overall Study|Protocol Violation|5
2029278|NCT00369941|3598616|FG001|Overall Study|Protocol Violation|3
2029279|NCT00369941|3598615|FG000|Overall Study|Withdrawal by Subject|5
2029280|NCT00369941|3598616|FG001|Overall Study|Withdrawal by Subject|18
2029281|NCT00369941|3598615|FG000|Overall Study|Pregnancy|4
2029282|NCT00369941|3598616|FG001|Overall Study|Pregnancy|2
2029283|NCT00369941|3598615|FG000|Overall Study|Completed, Did Not Enter Extension|5
2029284|NCT00369941|3598616|FG001|Overall Study|Completed, Did Not Enter Extension|6
2029285|NCT00369941|3598615|FG000|Overall Study|Moved|11
2029286|NCT00369941|3598616|FG001|Overall Study|Moved|5
2029287|NCT00369941|3598615|FG000|Overall Study|Treatment with Prohibited Medication|3
2029288|NCT00369941|3598616|FG001|Overall Study|Treatment with Prohibited Medication|1
2029289|NCT00369941|3598615|FG000|Overall Study|Employment Interfered with Study Visits|1
2029290|NCT00369941|3598616|FG001|Overall Study|Employment Interfered with Study Visits|0
2029291|NCT00369941|3598615|FG000|Overall Study|Study Site Terminated|2
2029292|NCT00369941|3598616|FG001|Overall Study|Study Site Terminated|0
2029293|NCT00369941|3598615|FG000|Overall Study|Miscellaneous|3
2029294|NCT00369941|3598616|FG001|Overall Study|Miscellaneous|3
2029295|NCT00369967|3598625|FG000|Overall Study|Lost to Follow-up|23
2029296|NCT00369967|3598626|FG001|Overall Study|Lost to Follow-up|12
2029297|NCT00370032|3598638|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
2029298|NCT00370032|3598639|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
2029299|NCT00370032|3598638|FG000|Washout Period|Withdrawal by Subject|0
2029300|NCT00370032|3598639|FG001|Washout Period|Withdrawal by Subject|1
2029301|NCT00370032|3598638|FG000|Washout Period|Lost to Follow-up|0
2029302|NCT00370032|3598639|FG001|Washout Period|Lost to Follow-up|1
2029303|NCT00370032|3598638|FG000|Washout Period|Adverse Event|1
2029304|NCT00370032|3598639|FG001|Washout Period|Adverse Event|0
2029305|NCT00370032|3598638|FG000|Follow-up Period|Withdrawal by Subject|1
2029306|NCT00370032|3598639|FG001|Follow-up Period|Withdrawal by Subject|0
2029307|NCT00370071|3598654|FG000|Overall Study|Withdrawal by Subject|2
2029308|NCT00370149|3598660|FG000|Overall Study|Physician Decision|16
2029309|NCT00370149|3598661|FG001|Overall Study|Physician Decision|16
2029310|NCT00370149|3598660|FG000|Overall Study|Protocol Violation|1
2029311|NCT00370149|3598661|FG001|Overall Study|Protocol Violation|0
2029312|NCT00370149|3598660|FG000|Overall Study|Catheter inserted in wrong vessel-|2
2029313|NCT00370149|3598661|FG001|Overall Study|Catheter inserted in wrong vessel-|1
2029314|NCT00370149|3598660|FG000|Overall Study|Pre-existing infection|0
2029315|NCT00370149|3598661|FG001|Overall Study|Pre-existing infection|1
2029316|NCT00370149|3598660|FG000|Overall Study|Antibiotic coated dressing placed|0
2029317|NCT00370149|3598661|FG001|Overall Study|Antibiotic coated dressing placed|1
2029318|NCT00370292|3598672|FG000|Overall Study|Disease Progression|4
2029319|NCT00370292|3598672|FG000|Overall Study|Adverse Event|7
2029320|NCT00370292|3598672|FG000|Overall Study|Physician Decision|2
2029321|NCT00370331|3598685|FG000|Overall Study|Adverse Event|4
2029322|NCT00370331|3598686|FG001|Overall Study|Adverse Event|13
2029323|NCT00370331|3598685|FG000|Overall Study|Withdrawal by Subject|2
2029324|NCT00370331|3598686|FG001|Overall Study|Withdrawal by Subject|4
2029325|NCT00370331|3598685|FG000|Overall Study|Lost to Follow-up|0
2029326|NCT00370331|3598686|FG001|Overall Study|Lost to Follow-up|3
2029327|NCT00370331|3598685|FG000|Overall Study|Lack of Efficacy|0
2029328|NCT00370331|3598686|FG001|Overall Study|Lack of Efficacy|1
2029329|NCT00370331|3598685|FG000|Overall Study|Non-compliance|0
2029330|NCT00370331|3598686|FG001|Overall Study|Non-compliance|1
2029331|NCT00370331|3598685|FG000|Overall Study|Protocol Violation|1
2029332|NCT00370331|3598686|FG001|Overall Study|Protocol Violation|1
2029333|NCT00370396|3598695|FG000|Overall Study|Withdrawal by Subject|0
2029334|NCT00370396|3598696|FG001|Overall Study|Withdrawal by Subject|0
2029335|NCT00370396|3598697|FG002|Overall Study|Withdrawal by Subject|1
2029336|NCT00370396|3598695|FG000|Overall Study|Lost to Follow-up|11
2029337|NCT00370396|3598696|FG001|Overall Study|Lost to Follow-up|1
2029338|NCT00370396|3598697|FG002|Overall Study|Lost to Follow-up|0
2029339|NCT00370552|3598708|FG000|Overall Study|Adverse Event|2
2029340|NCT00370552|3598709|FG001|Overall Study|Adverse Event|2
2029341|NCT00370552|3598710|FG002|Overall Study|Adverse Event|2
2029342|NCT00370552|3598708|FG000|Overall Study|Disease progression|23
2029343|NCT00370552|3598709|FG001|Overall Study|Disease progression|23
2029344|NCT00370552|3598710|FG002|Overall Study|Disease progression|15
2029345|NCT00370552|3598708|FG000|Overall Study|Maximum clinical benefit|3
2109951|NCT00891046|3704421|FG001|Overall Study|Participant no longer required drug|2
2109952|NCT00891046|3704422|FG002|Overall Study|Participant no longer required drug|0
2029346|NCT00370552|3598709|FG001|Overall Study|Maximum clinical benefit|5
2029347|NCT00370552|3598710|FG002|Overall Study|Maximum clinical benefit|5
2029348|NCT00370552|3598708|FG000|Overall Study|Poor or noncompliance|0
2029349|NCT00370552|3598709|FG001|Overall Study|Poor or noncompliance|0
2029350|NCT00370552|3598710|FG002|Overall Study|Poor or noncompliance|1
2029351|NCT00370552|3598708|FG000|Overall Study|Study drug toxicity|11
2029352|NCT00370552|3598709|FG001|Overall Study|Study drug toxicity|8
2029353|NCT00370552|3598710|FG002|Overall Study|Study drug toxicity|6
2029354|NCT00370552|3598708|FG000|Overall Study|Withdrawal by Subject|2
2029355|NCT00370552|3598709|FG001|Overall Study|Withdrawal by Subject|0
2029356|NCT00370552|3598710|FG002|Overall Study|Withdrawal by Subject|1
2029357|NCT00370552|3598708|FG000|Overall Study|Still on treatment|1
2029358|NCT00370552|3598709|FG001|Overall Study|Still on treatment|3
2029359|NCT00370552|3598710|FG002|Overall Study|Still on treatment|2
2029360|NCT00370552|3598708|FG000|Overall Study|Never treated|1
2029361|NCT00370552|3598709|FG001|Overall Study|Never treated|0
2029362|NCT00370552|3598710|FG002|Overall Study|Never treated|0
2029363|NCT00370552|3598708|FG000|Overall Study|Physician Decision|1
2029364|NCT00370552|3598709|FG001|Overall Study|Physician Decision|1
2029365|NCT00370552|3598710|FG002|Overall Study|Physician Decision|0
2029366|NCT00370552|3598708|FG000|Overall Study|Investigator decision|2
2029367|NCT00370552|3598709|FG001|Overall Study|Investigator decision|1
2029368|NCT00370552|3598710|FG002|Overall Study|Investigator decision|0
2029369|NCT00370552|3598708|FG000|Overall Study|High risk of allergic reaction|0
2029370|NCT00370552|3598709|FG001|Overall Study|High risk of allergic reaction|1
2029371|NCT00370552|3598710|FG002|Overall Study|High risk of allergic reaction|0
2029372|NCT00370552|3598708|FG000|Overall Study|Planned radiation for palliation|0
2029373|NCT00370552|3598709|FG001|Overall Study|Planned radiation for palliation|1
2029374|NCT00370552|3598710|FG002|Overall Study|Planned radiation for palliation|0
2029375|NCT00370682|3598721|FG000|Overall Study|Moved from area|0
2029376|NCT00370682|3598722|FG001|Overall Study|Moved from area|2
2029377|NCT00370682|3598723|FG002|Overall Study|Moved from area|0
2029378|NCT00370682|3598721|FG000|Overall Study|Lost to Follow-up|0
2029379|NCT00370682|3598722|FG001|Overall Study|Lost to Follow-up|1
2029380|NCT00370682|3598723|FG002|Overall Study|Lost to Follow-up|1
2029381|NCT00371137|3598756|FG000|Overall Study|Adverse Event|20
2029382|NCT00371137|3598757|FG001|Overall Study|Adverse Event|35
2029383|NCT00371137|3598758|FG002|Overall Study|Adverse Event|42
2029384|NCT00371137|3598756|FG000|Overall Study|Withdrawal by Subject|11
2029385|NCT00371137|3598757|FG001|Overall Study|Withdrawal by Subject|10
2029386|NCT00371137|3598758|FG002|Overall Study|Withdrawal by Subject|15
2029387|NCT00371137|3598756|FG000|Overall Study|Lost to Follow-up|6
2029388|NCT00371137|3598757|FG001|Overall Study|Lost to Follow-up|3
2029389|NCT00371137|3598758|FG002|Overall Study|Lost to Follow-up|5
2029390|NCT00371137|3598756|FG000|Overall Study|Lack of Efficacy|30
2029391|NCT00371137|3598757|FG001|Overall Study|Lack of Efficacy|12
2029392|NCT00371137|3598758|FG002|Overall Study|Lack of Efficacy|13
2029393|NCT00371137|3598756|FG000|Overall Study|Sponsor Decision|2
2322538|NCT02974114|4037638|FG002|Overall Study|Other (Not specified)|2
2322539|NCT02974140|4037648|FG000|Overall Study|Adverse Event|2
2322540|NCT02974140|4037648|FG000|Overall Study|Lost to Follow-up|1
2322541|NCT02974140|4037648|FG000|Overall Study|Study Terminated by Sponsor|36
2322542|NCT02974153|4037658|FG000|Overall Study|Adverse Event|6
2322543|NCT02974153|4037659|FG001|Overall Study|Adverse Event|0
2322544|NCT02974153|4037660|FG002|Overall Study|Adverse Event|1
2322545|NCT02974153|4037658|FG000|Overall Study|Lack of Efficacy|6
2322546|NCT02974153|4037659|FG001|Overall Study|Lack of Efficacy|5
2322547|NCT02974153|4037660|FG002|Overall Study|Lack of Efficacy|10
2322548|NCT02974153|4037658|FG000|Overall Study|Lost to Follow-up|9
2322549|NCT02974153|4037659|FG001|Overall Study|Lost to Follow-up|10
2029394|NCT00371137|3598757|FG001|Overall Study|Sponsor Decision|1
2029395|NCT00371137|3598758|FG002|Overall Study|Sponsor Decision|2
2029396|NCT00371137|3598756|FG000|Overall Study|Physician Decision|1
2029397|NCT00371137|3598757|FG001|Overall Study|Physician Decision|1
2029398|NCT00371137|3598758|FG002|Overall Study|Physician Decision|1
2029399|NCT00371137|3598756|FG000|Overall Study|Protocol Violation|2
2029400|NCT00371137|3598757|FG001|Overall Study|Protocol Violation|1
2029401|NCT00371137|3598758|FG002|Overall Study|Protocol Violation|1
2029402|NCT00371150|3598768|FG000|Overall Study|Lost to Follow-up|3
2029403|NCT00371150|3598769|FG001|Overall Study|Lost to Follow-up|2
2029404|NCT00371254|3598790|FG000|Overall Study|Disease progression|13
2029405|NCT00371254|3598791|FG001|Overall Study|Disease progression|13
2029406|NCT00371254|3598790|FG000|Overall Study|Study drug toxicity|3
2029407|NCT00371254|3598791|FG001|Overall Study|Study drug toxicity|5
2029408|NCT00371254|3598790|FG000|Overall Study|Subject request|5
2029409|NCT00371254|3598791|FG001|Overall Study|Subject request|0
2029410|NCT00371254|3598790|FG000|Overall Study|Investigator Decision|2
2029411|NCT00371254|3598791|FG001|Overall Study|Investigator Decision|0
2029412|NCT00371254|3598790|FG000|Overall Study|Adverse event unrelated to study drug|0
2029413|NCT00371254|3598791|FG001|Overall Study|Adverse event unrelated to study drug|1
2109953|NCT00891046|3704423|FG003|Overall Study|Participant no longer required drug|0
2109954|NCT00891046|3704424|FG004|Overall Study|Participant no longer required drug|1
2109955|NCT00891046|3704420|FG000|Overall Study|Adverse Event|4
2109956|NCT00891046|3704421|FG001|Overall Study|Adverse Event|3
2109957|NCT00891046|3704422|FG002|Overall Study|Adverse Event|2
2109958|NCT00891046|3704423|FG003|Overall Study|Adverse Event|0
2109959|NCT00891046|3704424|FG004|Overall Study|Adverse Event|14
2109960|NCT00891046|3704420|FG000|Overall Study|Withdrawal by Subject|2
2109961|NCT00891046|3704421|FG001|Overall Study|Withdrawal by Subject|1
2109962|NCT00891046|3704422|FG002|Overall Study|Withdrawal by Subject|2
2109963|NCT00891046|3704423|FG003|Overall Study|Withdrawal by Subject|1
2109964|NCT00891046|3704424|FG004|Overall Study|Withdrawal by Subject|1
2109965|NCT00891046|3704420|FG000|Overall Study|Lost to Follow-up|0
2109966|NCT00891046|3704421|FG001|Overall Study|Lost to Follow-up|0
2109967|NCT00891046|3704422|FG002|Overall Study|Lost to Follow-up|0
2109968|NCT00891046|3704423|FG003|Overall Study|Lost to Follow-up|0
2109969|NCT00891046|3704424|FG004|Overall Study|Lost to Follow-up|1
2109970|NCT00891202|3704476|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1
2109971|NCT00891202|3704477|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0
2109972|NCT00891202|3704478|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0
2109973|NCT00891202|3704479|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0
2109974|NCT00891202|3704476|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
2109975|NCT00891202|3704477|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
2109976|NCT00891202|3704478|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
2109977|NCT00891202|3704479|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
2109978|NCT00891202|3704476|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
2109979|NCT00891202|3704477|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
2109980|NCT00891202|3704478|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
2109981|NCT00891202|3704479|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
2109982|NCT00891202|3704476|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
2109983|NCT00891202|3704477|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
2109984|NCT00891202|3704478|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
2322550|NCT02974153|4037660|FG002|Overall Study|Lost to Follow-up|17
2322551|NCT02974153|4037658|FG000|Overall Study|Physician Decision|0
2322552|NCT02974153|4037659|FG001|Overall Study|Physician Decision|2
2322553|NCT02974153|4037660|FG002|Overall Study|Physician Decision|1
2322554|NCT02974153|4037658|FG000|Overall Study|Withdrawal by Subject|9
2322555|NCT02974153|4037659|FG001|Overall Study|Withdrawal by Subject|16
2322556|NCT02974153|4037660|FG002|Overall Study|Withdrawal by Subject|11
2322557|NCT02974153|4037658|FG000|Overall Study|Study Burden|8
2322558|NCT02974153|4037659|FG001|Overall Study|Study Burden|7
2273890|NCT02291289|3954586|FG003|Maintenance Treatment Phase|Other|0
2273891|NCT02291289|3954587|FG004|Maintenance Treatment Phase|Other|29
2273892|NCT02291289|3954588|FG005|Maintenance Treatment Phase|Other|8
2273893|NCT02291289|3954589|FG006|Maintenance Treatment Phase|Other|0
2273894|NCT02291289|3954590|FG007|Maintenance Treatment Phase|Other|0
2273895|NCT02291289|3954591|FG008|Maintenance Treatment Phase|Other|1
2273896|NCT02291289|3954592|FG009|Maintenance Treatment Phase|Other|0
2273897|NCT02291289|3954593|FG010|Maintenance Treatment Phase|Other|0
2273898|NCT02291289|3954594|FG011|Maintenance Treatment Phase|Other|0
2273899|NCT02291289|3954583|FG000|Maintenance Treatment Phase|Physician Decision|0
2273900|NCT02291289|3954584|FG001|Maintenance Treatment Phase|Physician Decision|0
2273901|NCT02291289|3954585|FG002|Maintenance Treatment Phase|Physician Decision|0
2273902|NCT02291289|3954586|FG003|Maintenance Treatment Phase|Physician Decision|0
2273903|NCT02291289|3954587|FG004|Maintenance Treatment Phase|Physician Decision|2
2273904|NCT02291289|3954588|FG005|Maintenance Treatment Phase|Physician Decision|0
2273905|NCT02291289|3954589|FG006|Maintenance Treatment Phase|Physician Decision|0
2273906|NCT02291289|3954590|FG007|Maintenance Treatment Phase|Physician Decision|0
2273907|NCT02291289|3954591|FG008|Maintenance Treatment Phase|Physician Decision|0
2273908|NCT02291289|3954592|FG009|Maintenance Treatment Phase|Physician Decision|0
2273909|NCT02291289|3954593|FG010|Maintenance Treatment Phase|Physician Decision|0
2273910|NCT02291289|3954594|FG011|Maintenance Treatment Phase|Physician Decision|1
2029414|NCT00371254|3598790|FG000|Overall Study|Lost to Follow-up|0
2029415|NCT00371254|3598791|FG001|Overall Study|Lost to Follow-up|1
2029416|NCT00371254|3598790|FG000|Overall Study|Withdrawal by Subject|0
2029417|NCT00371254|3598791|FG001|Overall Study|Withdrawal by Subject|1
2029418|NCT00371345|3598822|FG000|Overall Study|Disease Progression|21
2029419|NCT00371345|3598823|FG001|Overall Study|Disease Progression|35
2029420|NCT00371345|3598822|FG000|Overall Study|Study Drug Toxicity|1
2029421|NCT00371345|3598823|FG001|Overall Study|Study Drug Toxicity|7
2029422|NCT00371345|3598822|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1
2029423|NCT00371345|3598823|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2
2029424|NCT00371345|3598822|FG000|Overall Study|Participant Request|1
2029425|NCT00371345|3598823|FG001|Overall Study|Participant Request|1
2029426|NCT00371345|3598822|FG000|Overall Study|Participant Withdrew Consent|0
2029427|NCT00371345|3598823|FG001|Overall Study|Participant Withdrew Consent|1
2029428|NCT00371397|3598843|FG000|Session 1|Withdrawal by Subject|1
2029429|NCT00371397|3598844|FG001|Session 1|Withdrawal by Subject|0
2029430|NCT00371397|3598845|FG002|Session 1|Withdrawal by Subject|0
2029431|NCT00371397|3598846|FG003|Session 1|Withdrawal by Subject|0
2029432|NCT00371397|3598847|FG004|Session 1|Withdrawal by Subject|0
2029433|NCT00371397|3598848|FG005|Session 1|Withdrawal by Subject|0
2029434|NCT00371397|3598849|FG006|Session 1|Withdrawal by Subject|0
2029435|NCT00371397|3598850|FG007|Session 1|Withdrawal by Subject|1
2029436|NCT00371397|3598851|FG008|Session 1|Withdrawal by Subject|0
2029437|NCT00371397|3598852|FG009|Session 1|Withdrawal by Subject|0
2029438|NCT00371397|3598853|FG010|Session 1|Withdrawal by Subject|0
2029439|NCT00371397|3598854|FG011|Session 1|Withdrawal by Subject|0
2029440|NCT00371566|3598886|FG000|Treatment Phase|Withdrawal by Subject|0
2029441|NCT00371566|3598887|FG001|Treatment Phase|Withdrawal by Subject|1
2029442|NCT00371566|3598886|FG000|Treatment Phase|Adverse Event|0
2029443|NCT00371566|3598887|FG001|Treatment Phase|Adverse Event|1
2029444|NCT00371566|3598886|FG000|Treatment Phase|Protocol Violation|0
2029445|NCT00371566|3598887|FG001|Treatment Phase|Protocol Violation|1
2029446|NCT00371566|3598886|FG000|Chemoradiation Phase|Physician Decision|2
2029447|NCT00371566|3598887|FG001|Chemoradiation Phase|Physician Decision|0
2029448|NCT00371566|3598886|FG000|Chemoradiation Phase|Withdrawal by Subject|0
2029449|NCT00371566|3598887|FG001|Chemoradiation Phase|Withdrawal by Subject|1
2029450|NCT00371566|3598886|FG000|Chemoradiation Phase|Non compliant|0
2029451|NCT00371566|3598887|FG001|Chemoradiation Phase|Non compliant|1
2029452|NCT00371566|3598886|FG000|Chemoradiation Phase|Progressive Disease|1
2029453|NCT00371566|3598887|FG001|Chemoradiation Phase|Progressive Disease|1
2029454|NCT00371566|3598886|FG000|Chemoradiation Phase|Death|2
2029455|NCT00371566|3598887|FG001|Chemoradiation Phase|Death|0
2029456|NCT00371566|3598886|FG000|Follow Up Phase|Death|0
2029457|NCT00371566|3598887|FG001|Follow Up Phase|Death|5
2029458|NCT00371566|3598886|FG000|Follow Up Phase|Disease progression|1
2029459|NCT00371566|3598887|FG001|Follow Up Phase|Disease progression|0
2029460|NCT00371566|3598886|FG000|Follow Up Phase|Withdrawal by Subject|0
2029461|NCT00371566|3598887|FG001|Follow Up Phase|Withdrawal by Subject|1
2029462|NCT00371566|3598886|FG000|Follow Up Phase|Physician Decision|1
2029463|NCT00371566|3598887|FG001|Follow Up Phase|Physician Decision|1
2029464|NCT00371566|3598886|FG000|Follow Up Phase|Lost to Follow-up|1
2109985|NCT00891202|3704479|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
2109986|NCT00891228|3704490|FG000|Overall Study|Adverse Event|0
2109987|NCT00891228|3704491|FG001|Overall Study|Adverse Event|2
2109988|NCT00891228|3704492|FG002|Overall Study|Adverse Event|3
2109989|NCT00891228|3704490|FG000|Overall Study|Withdrawal by Subject|2
2109990|NCT00891228|3704491|FG001|Overall Study|Withdrawal by Subject|4
2109991|NCT00891228|3704492|FG002|Overall Study|Withdrawal by Subject|5
2109992|NCT00891228|3704490|FG000|Overall Study|Protocol Violation|3
2109993|NCT00891228|3704491|FG001|Overall Study|Protocol Violation|1
2109994|NCT00891228|3704492|FG002|Overall Study|Protocol Violation|2
2109995|NCT00891228|3704490|FG000|Overall Study|Physician Decision|2
2109996|NCT00891228|3704491|FG001|Overall Study|Physician Decision|1
2109997|NCT00891228|3704492|FG002|Overall Study|Physician Decision|0
2109998|NCT00891228|3704490|FG000|Overall Study|Lost to Follow-up|4
2109999|NCT00891228|3704491|FG001|Overall Study|Lost to Follow-up|4
2110000|NCT00891228|3704492|FG002|Overall Study|Lost to Follow-up|5
2110001|NCT00891228|3704490|FG000|Overall Study|Pregnancy|0
2110002|NCT00891228|3704491|FG001|Overall Study|Pregnancy|1
2110003|NCT00891228|3704492|FG002|Overall Study|Pregnancy|0
2110004|NCT00891293|3704500|FG000|Overall Study|Adverse Event|2
2110005|NCT00891293|3704500|FG000|Overall Study|Protocol Violation|2
2110006|NCT00891293|3704500|FG000|Overall Study|Laboratory abnormality|4
2110007|NCT00891293|3704500|FG000|Overall Study|Lost to Follow-up|7
2110008|NCT00891293|3704500|FG000|Overall Study|Subject withdrew consent|7
2110009|NCT00891293|3704500|FG000|Overall Study|Sponsor termination|62
2110010|NCT00891371|3704513|FG000|Pre-assignment|Inclusion/exclusion|5
2110011|NCT00891371|3704513|FG000|Pre-assignment|Consent withdrawal|1
2029465|NCT00371566|3598887|FG001|Follow Up Phase|Lost to Follow-up|0
2029466|NCT00371683|3598908|FG000|DB Treatment Period-Randomized Patients|Death|1
2110012|NCT00891371|3704513|FG000|Treatment|Lack of Efficacy|5
2110013|NCT00891371|3704513|FG000|Treatment|Adverse Event|2
2110014|NCT00891371|3704513|FG000|Treatment|Death|1
2110015|NCT00891371|3704513|FG000|Treatment|Lost to Follow-up|1
2110016|NCT00891462|3704529|FG000|Overall Study|Withdrawal by Subject|9
2029467|NCT00371683|3598909|FG001|DB Treatment Period-Randomized Patients|Death|1
2029468|NCT00371683|3598908|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60
2029469|NCT00371683|3598909|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58
2029470|NCT00371683|3598908|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
2029471|NCT00371683|3598909|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
2029472|NCT00371683|3598908|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
2029473|NCT00371683|3598909|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
2029474|NCT00371683|3598908|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
2029475|NCT00371683|3598909|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
2029476|NCT00371683|3598908|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
2029477|NCT00371683|3598909|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
2029478|NCT00371683|3598908|FG000|DB Treatment Period-Randomized Patients|non-specified|9
2029479|NCT00371683|3598909|FG001|DB Treatment Period-Randomized Patients|non-specified|8
2029480|NCT00371683|3598908|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
2029481|NCT00371683|3598909|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
2029482|NCT00371683|3598908|FG000|Follow-Up Period - Randomized Patients|Death|0
2029483|NCT00371683|3598909|FG001|Follow-Up Period - Randomized Patients|Death|2
2029484|NCT00371683|3598908|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
2029485|NCT00371683|3598909|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
2029486|NCT00371683|3598908|FG000|Follow-Up Period - Randomized Patients|non-specified|6
2029487|NCT00371683|3598909|FG001|Follow-Up Period - Randomized Patients|non-specified|12
2029488|NCT00371761|3598927|FG000|Overall Study|Adverse Event|1
2029489|NCT00371761|3598928|FG001|Overall Study|Adverse Event|1
2029490|NCT00371761|3598927|FG000|Overall Study|Withdrawal by Subject|1
2029491|NCT00371761|3598928|FG001|Overall Study|Withdrawal by Subject|3
2029492|NCT00371761|3598927|FG000|Overall Study|Investigator Judgment|2
2029493|NCT00371761|3598928|FG001|Overall Study|Investigator Judgment|3
2029494|NCT00371761|3598927|FG000|Overall Study|Study termination|4
2029495|NCT00371761|3598928|FG001|Overall Study|Study termination|3
2029496|NCT00371787|3598936|FG000|Overall Study|Withdrawal by Subject|3
2029497|NCT00371787|3598937|FG001|Overall Study|Withdrawal by Subject|1
2029498|NCT00371826|3598946|FG000|Core Phase (12 Months)|Adverse Event|15
2029499|NCT00371826|3598947|FG001|Core Phase (12 Months)|Adverse Event|4
2029500|NCT00371826|3598948|FG002|Core Phase (12 Months)|Adverse Event|9
2029501|NCT00371826|3598946|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1
2029502|NCT00371826|3598947|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0
2029503|NCT00371826|3598948|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1
2029504|NCT00371826|3598946|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
2029505|NCT00371826|3598947|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
2029506|NCT00371826|3598948|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
2029507|NCT00371826|3598946|FG000|Core Phase (12 Months)|Protocol Violation|1
2029508|NCT00371826|3598947|FG001|Core Phase (12 Months)|Protocol Violation|0
2029509|NCT00371826|3598948|FG002|Core Phase (12 Months)|Protocol Violation|1
2029510|NCT00371826|3598946|FG000|Core Phase (12 Months)|Subject withdrew consent|0
2029511|NCT00371826|3598947|FG001|Core Phase (12 Months)|Subject withdrew consent|0
2029512|NCT00371826|3598948|FG002|Core Phase (12 Months)|Subject withdrew consent|3
2029513|NCT00371826|3598946|FG000|Core Phase (12 Months)|Administrative problems|1
2029514|NCT00371826|3598947|FG001|Core Phase (12 Months)|Administrative problems|0
2029515|NCT00371826|3598948|FG002|Core Phase (12 Months)|Administrative problems|8
2029516|NCT00371826|3598946|FG000|Core Phase (12 Months)|Graft Loss|0
2029517|NCT00371826|3598947|FG001|Core Phase (12 Months)|Graft Loss|1
2110017|NCT00891462|3704530|FG001|Overall Study|Withdrawal by Subject|6
2110018|NCT00891462|3704531|FG002|Overall Study|Withdrawal by Subject|7
2110019|NCT00891462|3704529|FG000|Overall Study|Adverse Event|7
2110020|NCT00891462|3704530|FG001|Overall Study|Adverse Event|8
2110021|NCT00891462|3704531|FG002|Overall Study|Adverse Event|7
2110022|NCT00891462|3704529|FG000|Overall Study|Lack of Efficacy|10
2110023|NCT00891462|3704530|FG001|Overall Study|Lack of Efficacy|5
2110024|NCT00891462|3704531|FG002|Overall Study|Lack of Efficacy|1
2110025|NCT00891462|3704529|FG000|Overall Study|COPD exacerbation|7
2110026|NCT00891462|3704530|FG001|Overall Study|COPD exacerbation|4
2110027|NCT00891462|3704531|FG002|Overall Study|COPD exacerbation|1
2110028|NCT00891462|3704529|FG000|Overall Study|Other Reason|2
2110029|NCT00891462|3704530|FG001|Overall Study|Other Reason|5
2110030|NCT00891462|3704531|FG002|Overall Study|Other Reason|3
2110031|NCT00891462|3704529|FG000|Overall Study|Protocol Violation|2
2110032|NCT00891462|3704530|FG001|Overall Study|Protocol Violation|1
2110033|NCT00891462|3704531|FG002|Overall Study|Protocol Violation|3
2110034|NCT00891462|3704529|FG000|Overall Study|Inclusion/exclusion criteria|0
2110035|NCT00891462|3704530|FG001|Overall Study|Inclusion/exclusion criteria|2
2110036|NCT00891462|3704531|FG002|Overall Study|Inclusion/exclusion criteria|2
2110037|NCT00891462|3704529|FG000|Overall Study|Lost to Follow-up|0
2110038|NCT00891462|3704530|FG001|Overall Study|Lost to Follow-up|2
2110039|NCT00891462|3704531|FG002|Overall Study|Lost to Follow-up|0
2110040|NCT00891527|3704541|FG000|Overall Study|Withdrawal by Subject|2
2110041|NCT00891618|3704546|FG000|Overall Study|Withdrawal by Subject|1
2110042|NCT00891657|3704552|FG000|Overall Study|Withdrawal by Subject|1
2029518|NCT00371826|3598948|FG002|Core Phase (12 Months)|Graft Loss|0
2029519|NCT00371826|3598946|FG000|Extension Phase (24 Months)|Adverse Event|4
2029520|NCT00371826|3598947|FG001|Extension Phase (24 Months)|Adverse Event|5
2029521|NCT00371826|3598948|FG002|Extension Phase (24 Months)|Adverse Event|0
2029522|NCT00371826|3598946|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
2029523|NCT00371826|3598947|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
2029524|NCT00371826|3598948|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
2029525|NCT00371826|3598946|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
2029526|NCT00371826|3598947|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
2029527|NCT00371826|3598948|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
2029528|NCT00371826|3598946|FG000|Extension Phase (24 Months)|Subject withdrew consent|1
2029529|NCT00371826|3598947|FG001|Extension Phase (24 Months)|Subject withdrew consent|2
2029530|NCT00371826|3598948|FG002|Extension Phase (24 Months)|Subject withdrew consent|0
2029531|NCT00371826|3598946|FG000|Extension Phase (24 Months)|Administrative problems|0
2029532|NCT00371826|3598947|FG001|Extension Phase (24 Months)|Administrative problems|0
2029533|NCT00371826|3598948|FG002|Extension Phase (24 Months)|Administrative problems|2
2029534|NCT00371839|3598959|FG000|Overall Study|Death|4
2029535|NCT00371839|3598960|FG001|Overall Study|Death|0
2029536|NCT00371839|3598961|FG002|Overall Study|Death|0
2029537|NCT00371839|3598959|FG000|Overall Study|Withdrawal by Subject|7
2029538|NCT00371839|3598960|FG001|Overall Study|Withdrawal by Subject|4
2029539|NCT00371839|3598961|FG002|Overall Study|Withdrawal by Subject|0
2110043|NCT00891657|3704553|FG001|Overall Study|Withdrawal by Subject|1
2110044|NCT00891735|3704563|FG000|Overall Study|Adverse Event|2
2110045|NCT00891735|3704564|FG001|Overall Study|Adverse Event|0
2110046|NCT00891735|3704565|FG002|Overall Study|Adverse Event|2
2110047|NCT00891735|3704566|FG003|Overall Study|Adverse Event|0
2110048|NCT00891735|3704563|FG000|Overall Study|Death|8
2110049|NCT00891735|3704564|FG001|Overall Study|Death|5
2110050|NCT00891735|3704565|FG002|Overall Study|Death|4
2110051|NCT00891735|3704566|FG003|Overall Study|Death|5
2110052|NCT00891735|3704563|FG000|Overall Study|Lost to Follow-up|2
2110053|NCT00891735|3704564|FG001|Overall Study|Lost to Follow-up|2
2110054|NCT00891735|3704565|FG002|Overall Study|Lost to Follow-up|2
2110055|NCT00891735|3704566|FG003|Overall Study|Lost to Follow-up|2
2110056|NCT00891735|3704563|FG000|Overall Study|Physician's decision to withdraw patient|1
2110057|NCT00891735|3704564|FG001|Overall Study|Physician's decision to withdraw patient|0
2110058|NCT00891735|3704565|FG002|Overall Study|Physician's decision to withdraw patient|0
2110059|NCT00891735|3704566|FG003|Overall Study|Physician's decision to withdraw patient|0
2110060|NCT00891735|3704563|FG000|Overall Study|Patient's decision to withdraw|4
2110061|NCT00891735|3704564|FG001|Overall Study|Patient's decision to withdraw|9
2110062|NCT00891735|3704565|FG002|Overall Study|Patient's decision to withdraw|4
2110063|NCT00891735|3704566|FG003|Overall Study|Patient's decision to withdraw|8
2110064|NCT00891774|3704576|FG000|Overall Study|Lost to Follow-up|5
2110065|NCT00891774|3704576|FG000|Overall Study|Illness (Self/Mother)|3
2110066|NCT00891774|3704576|FG000|Overall Study|Withdrawal by Subject|2
2110067|NCT00891774|3704576|FG000|Overall Study|Protocol Violation|4
2110068|NCT00891813|3704580|FG000|Overall Study|Adverse Event|3
2110069|NCT00891813|3704580|FG000|Overall Study|Withdrawal by Subject|1
2110070|NCT00891813|3704580|FG000|Overall Study|Patient Noncompliance|6
2110071|NCT00891813|3704580|FG000|Overall Study|Protocol Violation|2
2110072|NCT00891839|3704584|FG000|Overall Study|Adverse Event|2
2110073|NCT00891839|3704584|FG000|Overall Study|Withdrawal by Subject|2
2110074|NCT00891839|3704584|FG000|Overall Study|Disease progression|3
2110075|NCT00891930|3704597|FG000|Part 1: Panitumumab +Irinotecan|Death|38
2110076|NCT00891930|3704597|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
2110077|NCT00891930|3704597|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
2110078|NCT00891930|3704597|FG000|Part 2: Panitumumab + Ganitumab|Death|30
2110079|NCT00891930|3704597|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
2110080|NCT00892008|3704623|FG000|Overall Study|Death|5
2110081|NCT00892008|3704623|FG000|Overall Study|Lack of Efficacy|3
2110082|NCT00892008|3704623|FG000|Overall Study|Lost to Follow-up|142
2110083|NCT00892008|3704623|FG000|Overall Study|Other|378
2110084|NCT00892008|3704623|FG000|Overall Study|Adverse Event|37
2110085|NCT00892047|3704629|FG000|Overall Study|Adverse Event|2
2110086|NCT00892047|3704630|FG001|Overall Study|Adverse Event|2
2110087|NCT00892047|3704629|FG000|Overall Study|subject burden|2
2110088|NCT00892047|3704630|FG001|Overall Study|subject burden|3
2110089|NCT00892047|3704629|FG000|Overall Study|Lack of Efficacy|0
2110090|NCT00892047|3704630|FG001|Overall Study|Lack of Efficacy|2
2110091|NCT00892099|3704641|FG000|Overall Study|Death|1
2110092|NCT00892099|3704642|FG001|Overall Study|Death|0
2110093|NCT00892099|3704643|FG002|Overall Study|Death|1
2110094|NCT00892099|3704641|FG000|Overall Study|Adverse Event|1
2110095|NCT00892099|3704642|FG001|Overall Study|Adverse Event|0
2110096|NCT00892099|3704643|FG002|Overall Study|Adverse Event|0
2110097|NCT00892099|3704641|FG000|Overall Study|replocated|1
2110098|NCT00892099|3704642|FG001|Overall Study|replocated|0
2110099|NCT00892099|3704643|FG002|Overall Study|replocated|2
2110100|NCT00892099|3704641|FG000|Overall Study|Prolonged hospitalization|1
2110101|NCT00892099|3704642|FG001|Overall Study|Prolonged hospitalization|0
2110102|NCT00892099|3704643|FG002|Overall Study|Prolonged hospitalization|1
2029540|NCT00371839|3598959|FG000|Overall Study|Lost to Follow-up|6
2029541|NCT00371839|3598960|FG001|Overall Study|Lost to Follow-up|3
2029542|NCT00371839|3598961|FG002|Overall Study|Lost to Follow-up|2
2029543|NCT00371865|3598969|FG000|Overall Study|Lack of Efficacy|0
2029544|NCT00371865|3598970|FG001|Overall Study|Lack of Efficacy|2
2029545|NCT00371865|3598969|FG000|Overall Study|Protocol Violation|3
2029546|NCT00371865|3598970|FG001|Overall Study|Protocol Violation|2
2029547|NCT00371865|3598969|FG000|Overall Study|Withdrawal by Subject|12
2029548|NCT00371865|3598970|FG001|Overall Study|Withdrawal by Subject|10
2029549|NCT00372060|3598978|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
2029550|NCT00372060|3598979|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
2029551|NCT00372060|3598978|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
2029552|NCT00372060|3598979|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
2029553|NCT00372060|3598978|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
2029554|NCT00372060|3598979|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
2029555|NCT00372060|3598978|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3
2029556|NCT00372060|3598979|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0
2029557|NCT00372060|3598978|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
2029558|NCT00372060|3598979|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
2029559|NCT00372060|3598978|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
2029560|NCT00372060|3598979|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
2029561|NCT00372112|3598992|FG000|Overall Study|Adverse Event|0
2029562|NCT00372112|3598993|FG001|Overall Study|Adverse Event|1
2029563|NCT00372112|3598994|FG002|Overall Study|Adverse Event|1
2029564|NCT00372112|3598995|FG003|Overall Study|Adverse Event|1
2029565|NCT00372112|3598992|FG000|Overall Study|Withdrawal by Subject|0
2029566|NCT00372112|3598993|FG001|Overall Study|Withdrawal by Subject|0
2029567|NCT00372112|3598994|FG002|Overall Study|Withdrawal by Subject|2
2029568|NCT00372112|3598995|FG003|Overall Study|Withdrawal by Subject|1
2029569|NCT00372112|3598992|FG000|Overall Study|Exacerbation|0
2029570|NCT00372112|3598993|FG001|Overall Study|Exacerbation|0
2029571|NCT00372112|3598994|FG002|Overall Study|Exacerbation|0
2029572|NCT00372112|3598995|FG003|Overall Study|Exacerbation|1
2029573|NCT00372112|3598992|FG000|Overall Study|PR >240 at Visit 3|0
2029574|NCT00372112|3598993|FG001|Overall Study|PR >240 at Visit 3|0
2029575|NCT00372112|3598994|FG002|Overall Study|PR >240 at Visit 3|0
2029576|NCT00372112|3598995|FG003|Overall Study|PR >240 at Visit 3|1
2029577|NCT00372112|3598992|FG000|Overall Study|Hepatitis B|1
2029578|NCT00372112|3598993|FG001|Overall Study|Hepatitis B|0
2029579|NCT00372112|3598994|FG002|Overall Study|Hepatitis B|0
2029580|NCT00372112|3598995|FG003|Overall Study|Hepatitis B|0
2029581|NCT00372112|3598992|FG000|Overall Study|Other-protocol violation|0
2029582|NCT00372112|3598993|FG001|Overall Study|Other-protocol violation|0
2029583|NCT00372112|3598994|FG002|Overall Study|Other-protocol violation|1
2029584|NCT00372112|3598995|FG003|Overall Study|Other-protocol violation|0
2029585|NCT00372190|3599010|FG000|Overall Study|Lost to Follow-up|3
2029586|NCT00372190|3599011|FG001|Overall Study|Lost to Follow-up|1
2029587|NCT00372255|3599021|FG000|Overall Study|Withdrawn for other reasons|2
2029588|NCT00372255|3599022|FG001|Overall Study|Withdrawn for other reasons|1
2029589|NCT00372385|3599033|FG000|Overall Study|Adverse Event|6
2110103|NCT00892099|3704641|FG000|Overall Study|no further details|1
2322559|NCT02974153|4037660|FG002|Overall Study|Study Burden|3
2322560|NCT02974153|4037658|FG000|Overall Study|Other|14
2322561|NCT02974153|4037659|FG001|Overall Study|Other|8
2322562|NCT02974153|4037660|FG002|Overall Study|Other|7
2322563|NCT02974543|4037679|FG000|Overall Study|Withdrawal by Subject|1
2322564|NCT02974543|4037680|FG001|Overall Study|Withdrawal by Subject|0
2322565|NCT02974634|4037696|FG000|Overall Study|Advanced disease|12
2322566|NCT02974634|4037697|FG001|Overall Study|Advanced disease|3
2322567|NCT02974634|4037696|FG000|Overall Study|Noncompliance|3
2322568|NCT02974634|4037697|FG001|Overall Study|Noncompliance|7
2322569|NCT02974634|4037696|FG000|Overall Study|intervention technology related issues|5
2322570|NCT02974634|4037697|FG001|Overall Study|intervention technology related issues|0
2322571|NCT02974634|4037696|FG000|Overall Study|Death|8
2322572|NCT02974634|4037697|FG001|Overall Study|Death|11
2322573|NCT02974842|4037704|FG000|Overall Study|Withdrawal by Subject|4
2322574|NCT02974842|4037704|FG000|Overall Study|Screen failures|4
2322575|NCT02974855|4037712|FG000|Overall Study|Adverse Event|0
2322576|NCT02974855|4037713|FG001|Overall Study|Adverse Event|1
2322577|NCT02974855|4037714|FG002|Overall Study|Adverse Event|0
2322578|NCT02974855|4037715|FG003|Overall Study|Adverse Event|1
2322579|NCT02974868|4037732|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1
2322580|NCT02974868|4037733|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1
2322581|NCT02974868|4037734|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2
2322582|NCT02974868|4037735|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4
2322583|NCT02974868|4037732|FG000|Initial 24-Week Treatment Period (TP)|others|3
2322584|NCT02974868|4037733|FG001|Initial 24-Week Treatment Period (TP)|others|8
2322585|NCT02974868|4037734|FG002|Initial 24-Week Treatment Period (TP)|others|1
2322586|NCT02974868|4037735|FG003|Initial 24-Week Treatment Period (TP)|others|8
2029590|NCT00372385|3599034|FG001|Overall Study|Adverse Event|11
2029591|NCT00372385|3599035|FG002|Overall Study|Adverse Event|9
2029592|NCT00372385|3599036|FG003|Overall Study|Adverse Event|7
2029593|NCT00372385|3599033|FG000|Overall Study|Noncompliance|0
2029594|NCT00372385|3599034|FG001|Overall Study|Noncompliance|1
2029595|NCT00372385|3599035|FG002|Overall Study|Noncompliance|1
2029596|NCT00372385|3599036|FG003|Overall Study|Noncompliance|1
2029597|NCT00372385|3599033|FG000|Overall Study|Physician Decision|1
2110104|NCT00892099|3704642|FG001|Overall Study|no further details|0
2110105|NCT00892099|3704643|FG002|Overall Study|no further details|1
2110106|NCT00892099|3704641|FG000|Overall Study|kidney function recovered|0
2110107|NCT00892099|3704642|FG001|Overall Study|kidney function recovered|1
2110108|NCT00892099|3704643|FG002|Overall Study|kidney function recovered|0
2110109|NCT00892099|3704641|FG000|Overall Study|investigator decision|0
2110110|NCT00892099|3704642|FG001|Overall Study|investigator decision|0
2110111|NCT00892099|3704643|FG002|Overall Study|investigator decision|1
2110112|NCT00892099|3704641|FG000|Overall Study|Lost to Follow-up|0
2110113|NCT00892099|3704642|FG001|Overall Study|Lost to Follow-up|0
2110114|NCT00892099|3704643|FG002|Overall Study|Lost to Follow-up|1
2110115|NCT00892151|3704651|FG000|Overall Study|Protocol Violation|1
2110116|NCT00892177|3704658|FG000|Phase II|Ineligible|0
2110117|NCT00892177|3704659|FG001|Phase II|Ineligible|0
2110118|NCT00892177|3704660|FG002|Phase II|Ineligible|0
2110119|NCT00892177|3704661|FG003|Phase II|Ineligible|0
2110120|NCT00892177|3704662|FG004|Phase II|Ineligible|1
2110121|NCT00892177|3704663|FG005|Phase II|Ineligible|1
2110122|NCT00892177|3704658|FG000|Phase II|Withdrawal by Subject|0
2110123|NCT00892177|3704659|FG001|Phase II|Withdrawal by Subject|0
2110124|NCT00892177|3704660|FG002|Phase II|Withdrawal by Subject|0
2110125|NCT00892177|3704661|FG003|Phase II|Withdrawal by Subject|0
2110126|NCT00892177|3704662|FG004|Phase II|Withdrawal by Subject|4
2110127|NCT00892177|3704663|FG005|Phase II|Withdrawal by Subject|1
2110128|NCT00892281|3704680|FG000|Overall Study|Adverse Event|65
2110129|NCT00892281|3704681|FG001|Overall Study|Adverse Event|8
2110130|NCT00892281|3704680|FG000|Overall Study|Lost to Follow-up|81
2110131|NCT00892281|3704681|FG001|Overall Study|Lost to Follow-up|8
2110132|NCT00892281|3704680|FG000|Overall Study|Pregnancy|1
2110133|NCT00892281|3704681|FG001|Overall Study|Pregnancy|0
2110134|NCT00892281|3704680|FG000|Overall Study|Protocol Violation|7
2110135|NCT00892281|3704681|FG001|Overall Study|Protocol Violation|2
2110136|NCT00892281|3704680|FG000|Overall Study|Withdrawal by Subject|86
2110137|NCT00892281|3704681|FG001|Overall Study|Withdrawal by Subject|14
2110138|NCT00892281|3704680|FG000|Overall Study|Subject failed to return for final visit|2
2110139|NCT00892281|3704681|FG001|Overall Study|Subject failed to return for final visit|0
2110140|NCT00892281|3704680|FG000|Overall Study|Subject unable to keep follow-up visits|1
2110141|NCT00892281|3704681|FG001|Overall Study|Subject unable to keep follow-up visits|0
2110142|NCT00892281|3704680|FG000|Overall Study|Final visit completed 4 weeks late|0
2110143|NCT00892281|3704681|FG001|Overall Study|Final visit completed 4 weeks late|1
2110144|NCT00892281|3704680|FG000|Overall Study|Subject completed day after study closed|1
2110145|NCT00892281|3704681|FG001|Overall Study|Subject completed day after study closed|0
2110146|NCT00892281|3704680|FG000|Overall Study|Family emergency|1
2110147|NCT00892281|3704681|FG001|Overall Study|Family emergency|0
2110148|NCT00892281|3704680|FG000|Overall Study|Last visit not done - death in family|1
2110149|NCT00892281|3704681|FG001|Overall Study|Last visit not done - death in family|0
2110150|NCT00892281|3704680|FG000|Overall Study|Did not meet incl/excl criteria|1
2110151|NCT00892281|3704681|FG001|Overall Study|Did not meet incl/excl criteria|0
2110152|NCT00892281|3704680|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1
2110153|NCT00892281|3704681|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0
2110154|NCT00892281|3704680|FG000|Overall Study|Unable to redeem the drug voucher|1
2110155|NCT00892281|3704681|FG001|Overall Study|Unable to redeem the drug voucher|0
2110156|NCT00892281|3704680|FG000|Overall Study|Subject not good candidate for study|1
2110157|NCT00892281|3704681|FG001|Overall Study|Subject not good candidate for study|0
2110158|NCT00892281|3704680|FG000|Overall Study|Subject did not return for any visits|1
2110159|NCT00892281|3704681|FG001|Overall Study|Subject did not return for any visits|0
2110160|NCT00892281|3704680|FG000|Overall Study|Subject missed several visits/lost meds|1
2110161|NCT00892281|3704681|FG001|Overall Study|Subject missed several visits/lost meds|0
2110162|NCT00892281|3704680|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1
2110163|NCT00892281|3704681|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1
2110164|NCT00892281|3704680|FG000|Overall Study|Scheduled for knee replacement|0
2110165|NCT00892281|3704681|FG001|Overall Study|Scheduled for knee replacement|1
2110166|NCT00892281|3704680|FG000|Overall Study|PI complained of inadequate compensation|3
2110167|NCT00892281|3704681|FG001|Overall Study|PI complained of inadequate compensation|0
2110168|NCT00892281|3704680|FG000|Overall Study|Subject lost interest in program|0
2110169|NCT00892281|3704681|FG001|Overall Study|Subject lost interest in program|1
2110170|NCT00892281|3704680|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0
2110171|NCT00892281|3704681|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1
2110172|NCT00892281|3704680|FG000|Overall Study|Death in family|1
2110173|NCT00892281|3704681|FG001|Overall Study|Death in family|0
2110174|NCT00892281|3704680|FG000|Overall Study|Lack of efficacy of study product|2
2352308|NCT03780959|4101232|FG002|Part 1|Adverse Event|0
2029598|NCT00372385|3599034|FG001|Overall Study|Physician Decision|0
2029599|NCT00372385|3599035|FG002|Overall Study|Physician Decision|0
2029600|NCT00372385|3599036|FG003|Overall Study|Physician Decision|0
2029601|NCT00372385|3599033|FG000|Overall Study|Lost to Follow-up|2
2029602|NCT00372385|3599034|FG001|Overall Study|Lost to Follow-up|0
2029603|NCT00372385|3599035|FG002|Overall Study|Lost to Follow-up|0
2029604|NCT00372385|3599036|FG003|Overall Study|Lost to Follow-up|0
2029605|NCT00372385|3599033|FG000|Overall Study|Withdrawal by Subject|2
2029606|NCT00372385|3599034|FG001|Overall Study|Withdrawal by Subject|1
2029607|NCT00372385|3599035|FG002|Overall Study|Withdrawal by Subject|0
2029608|NCT00372385|3599036|FG003|Overall Study|Withdrawal by Subject|0
2029609|NCT00372385|3599033|FG000|Overall Study|Refusal of Treatment|3
2029610|NCT00372385|3599034|FG001|Overall Study|Refusal of Treatment|6
2029611|NCT00372385|3599035|FG002|Overall Study|Refusal of Treatment|0
2029612|NCT00372385|3599036|FG003|Overall Study|Refusal of Treatment|0
2029613|NCT00372385|3599033|FG000|Overall Study|No Response|1
2029614|NCT00372385|3599034|FG001|Overall Study|No Response|1
2029615|NCT00372385|3599035|FG002|Overall Study|No Response|0
2029616|NCT00372385|3599036|FG003|Overall Study|No Response|0
2029617|NCT00372385|3599033|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1
2029618|NCT00372385|3599034|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0
2029619|NCT00372385|3599035|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0
2029620|NCT00372385|3599036|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0
2029621|NCT00372385|3599033|FG000|Overall Study|Virologic Stopping Rule|17
2029622|NCT00372385|3599034|FG001|Overall Study|Virologic Stopping Rule|0
2029623|NCT00372385|3599035|FG002|Overall Study|Virologic Stopping Rule|0
2029624|NCT00372385|3599036|FG003|Overall Study|Virologic Stopping Rule|0
2029625|NCT00372411|3599050|FG000|Overall Study|Withdrawal by Subject|3
2029626|NCT00372411|3599051|FG001|Overall Study|Withdrawal by Subject|4
2029627|NCT00372411|3599052|FG002|Overall Study|Withdrawal by Subject|1
2029628|NCT00372411|3599050|FG000|Overall Study|Death|0
2029629|NCT00372411|3599051|FG001|Overall Study|Death|2
2029630|NCT00372411|3599052|FG002|Overall Study|Death|1
2029631|NCT00372411|3599050|FG000|Overall Study|Lost to Follow-up|1
2029632|NCT00372411|3599051|FG001|Overall Study|Lost to Follow-up|1
2029633|NCT00372411|3599052|FG002|Overall Study|Lost to Follow-up|1
2029634|NCT00372411|3599050|FG000|Overall Study|Adverse Event|1
2029635|NCT00372411|3599051|FG001|Overall Study|Adverse Event|1
2029636|NCT00372411|3599052|FG002|Overall Study|Adverse Event|0
2029637|NCT00372424|3599060|FG000|Overall Study|Adverse Event|2
2029638|NCT00372424|3599060|FG000|Overall Study|Withdrawal by Subject|1
2029639|NCT00372424|3599060|FG000|Overall Study|Death|1
2029640|NCT00372424|3599060|FG000|Overall Study|Objective Progression or Relapse|14
2029641|NCT00372424|3599060|FG000|Overall Study|Other|7
2029642|NCT00372424|3599060|FG000|Overall Study|Enrolled, Not Treated|1
2029643|NCT00372489|3599064|FG000|Overall Study|Adverse Event|18
2029644|NCT00372489|3599064|FG000|Overall Study|Lack of Efficacy|1
2029645|NCT00372489|3599064|FG000|Overall Study|Lost to Follow-up|3
2029646|NCT00372489|3599064|FG000|Overall Study|Physician Decision|3
2029647|NCT00372489|3599064|FG000|Overall Study|Withdrawal by Subject|5
2029648|NCT00372489|3599064|FG000|Overall Study|Patient Relocation|2
2029649|NCT00372489|3599064|FG000|Overall Study|Renal transplant|6
2217870|NCT01710358|3861199|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2
2322587|NCT02974868|4037732|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
2322588|NCT02974868|4037733|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
2322589|NCT02974868|4037734|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
2322590|NCT02974868|4037735|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
2322591|NCT02974868|4037732|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
2322592|NCT02974868|4037733|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
2322593|NCT02974868|4037734|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
2322594|NCT02974868|4037735|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
2322595|NCT02975206|4037779|FG000|Overall Study|Withdrawal by Subject|14
2322596|NCT02975206|4037780|FG001|Overall Study|Withdrawal by Subject|11
2322597|NCT02975206|4037781|FG002|Overall Study|Withdrawal by Subject|11
2029650|NCT00372489|3599064|FG000|Overall Study|Sponsor Decision to Terminate Study|41
2029651|NCT00372528|3599068|FG000|Overall Study|Lack of Efficacy|1
2029652|NCT00372528|3599068|FG000|Overall Study|Adverse Event|1
2029653|NCT00372528|3599068|FG000|Overall Study|Study Terminated by Sponsor|18
2029654|NCT00372528|3599068|FG000|Overall Study|Other|1
2029655|NCT00372567|3599075|FG000|Phase 3 Study|Adverse Event|5
2029656|NCT00372567|3599076|FG001|Phase 3 Study|Adverse Event|1
2029657|NCT00372567|3599077|FG002|Phase 3 Study|Adverse Event|1
2029658|NCT00372567|3599075|FG000|Phase 3 Study|Death|1
2029659|NCT00372567|3599076|FG001|Phase 3 Study|Death|1
2029660|NCT00372567|3599077|FG002|Phase 3 Study|Death|0
2029661|NCT00372567|3599075|FG000|Phase 3 Study|Protocol Violation|0
2029662|NCT00372567|3599076|FG001|Phase 3 Study|Protocol Violation|0
2029663|NCT00372567|3599077|FG002|Phase 3 Study|Protocol Violation|1
2029664|NCT00372567|3599075|FG000|Phase 3 Study|Objective progression or relapse|10
2029665|NCT00372567|3599076|FG001|Phase 3 Study|Objective progression or relapse|13
2029666|NCT00372567|3599077|FG002|Phase 3 Study|Objective progression or relapse|4
2029667|NCT00372567|3599075|FG000|Phase 3 Study|Global deterioration of health status|0
2029668|NCT00372567|3599076|FG001|Phase 3 Study|Global deterioration of health status|1
2029669|NCT00372567|3599077|FG002|Phase 3 Study|Global deterioration of health status|0
2029670|NCT00372567|3599075|FG000|Phase 3 Study|Other|2
2029671|NCT00372567|3599076|FG001|Phase 3 Study|Other|2
2029672|NCT00372567|3599077|FG002|Phase 3 Study|Other|1
2029673|NCT00372567|3599075|FG000|Phase 3 Study|study terminated by sponsor|13
2029674|NCT00372567|3599076|FG001|Phase 3 Study|study terminated by sponsor|8
2029675|NCT00372567|3599077|FG002|Phase 3 Study|study terminated by sponsor|5
2029676|NCT00372593|3599088|FG000|Overall Study|Adverse Event|43
2029677|NCT00372593|3599089|FG001|Overall Study|Adverse Event|45
2029678|NCT00372593|3599090|FG002|Overall Study|Adverse Event|0
2029679|NCT00372593|3599088|FG000|Overall Study|Death|16
2029680|NCT00372593|3599089|FG001|Overall Study|Death|20
2029681|NCT00372593|3599090|FG002|Overall Study|Death|1
2029682|NCT00372593|3599088|FG000|Overall Study|Lack of Efficacy|82
2029683|NCT00372593|3599089|FG001|Overall Study|Lack of Efficacy|71
2029684|NCT00372593|3599090|FG002|Overall Study|Lack of Efficacy|2
2029685|NCT00372593|3599088|FG000|Overall Study|Lost to Follow-up|1
2029686|NCT00372593|3599089|FG001|Overall Study|Lost to Follow-up|0
2029687|NCT00372593|3599090|FG002|Overall Study|Lost to Follow-up|0
2029688|NCT00372593|3599088|FG000|Overall Study|Physician Decision|42
2029689|NCT00372593|3599089|FG001|Overall Study|Physician Decision|41
2029690|NCT00372593|3599090|FG002|Overall Study|Physician Decision|0
2029691|NCT00372593|3599088|FG000|Overall Study|Ineligible|20
2029692|NCT00372593|3599089|FG001|Overall Study|Ineligible|21
2029693|NCT00372593|3599090|FG002|Overall Study|Ineligible|1
2029694|NCT00372619|3599106|FG000|Overall Study|Ineligible|0
2029695|NCT00372619|3599107|FG001|Overall Study|Ineligible|0
2029696|NCT00372619|3599108|FG002|Overall Study|Ineligible|0
2029697|NCT00372619|3599109|FG003|Overall Study|Ineligible|0
2029698|NCT00372619|3599110|FG004|Overall Study|Ineligible|0
2110175|NCT00892281|3704681|FG001|Overall Study|Lack of efficacy of study product|0
2110176|NCT00892281|3704680|FG000|Overall Study|Subject not seen by PI at final visit|1
2110177|NCT00892281|3704681|FG001|Overall Study|Subject not seen by PI at final visit|0
2110178|NCT00892281|3704680|FG000|Overall Study|No show Visit 2; prescription not filled|1
2110179|NCT00892281|3704681|FG001|Overall Study|No show Visit 2; prescription not filled|0
2110180|NCT00892281|3704680|FG000|Overall Study|Missed multiple visits|1
2110181|NCT00892281|3704681|FG001|Overall Study|Missed multiple visits|0
2110182|NCT00892281|3704680|FG000|Overall Study|Missed visits rescheduled out of window|1
2110183|NCT00892281|3704681|FG001|Overall Study|Missed visits rescheduled out of window|0
2110184|NCT00892281|3704680|FG000|Overall Study|Non-compliant with visits as scheduled|1
2110185|NCT00892281|3704681|FG001|Overall Study|Non-compliant with visits as scheduled|0
2322598|NCT02975206|4037779|FG000|Overall Study|Other (e.g., lost to follow up)|13
2322599|NCT02975206|4037780|FG001|Overall Study|Other (e.g., lost to follow up)|6
2322600|NCT02975206|4037781|FG002|Overall Study|Other (e.g., lost to follow up)|6
2322601|NCT02975336|4037802|FG000|DBPC (52 Weeks)|Adverse Event|16
2322602|NCT02975336|4037803|FG001|DBPC (52 Weeks)|Adverse Event|17
2322603|NCT02975336|4037804|FG002|DBPC (52 Weeks)|Adverse Event|13
2322604|NCT02975336|4037805|FG003|DBPC (52 Weeks)|Adverse Event|18
2322605|NCT02975336|4037806|FG004|DBPC (52 Weeks)|Adverse Event|0
2322606|NCT02975336|4037807|FG005|DBPC (52 Weeks)|Adverse Event|0
2322607|NCT02975336|4037808|FG006|DBPC (52 Weeks)|Adverse Event|0
2322608|NCT02975336|4037809|FG007|DBPC (52 Weeks)|Adverse Event|0
2322609|NCT02975336|4037802|FG000|DBPC (52 Weeks)|Lost to Follow-up|2
2322610|NCT02975336|4037803|FG001|DBPC (52 Weeks)|Lost to Follow-up|1
2322611|NCT02975336|4037804|FG002|DBPC (52 Weeks)|Lost to Follow-up|2
2322612|NCT02975336|4037805|FG003|DBPC (52 Weeks)|Lost to Follow-up|4
2322613|NCT02975336|4037806|FG004|DBPC (52 Weeks)|Lost to Follow-up|0
2322614|NCT02975336|4037807|FG005|DBPC (52 Weeks)|Lost to Follow-up|0
2322615|NCT02975336|4037808|FG006|DBPC (52 Weeks)|Lost to Follow-up|0
2322616|NCT02975336|4037809|FG007|DBPC (52 Weeks)|Lost to Follow-up|0
2322617|NCT02975336|4037802|FG000|DBPC (52 Weeks)|Protocol Violation|4
2322618|NCT02975336|4037803|FG001|DBPC (52 Weeks)|Protocol Violation|1
2322619|NCT02975336|4037804|FG002|DBPC (52 Weeks)|Protocol Violation|3
2322620|NCT02975336|4037805|FG003|DBPC (52 Weeks)|Protocol Violation|1
2029699|NCT00372619|3599111|FG005|Overall Study|Ineligible|2
2029700|NCT00372619|3599112|FG006|Overall Study|Ineligible|0
2029701|NCT00372619|3599106|FG000|Overall Study|Inevaluable|0
2029702|NCT00372619|3599107|FG001|Overall Study|Inevaluable|0
2029703|NCT00372619|3599108|FG002|Overall Study|Inevaluable|0
2029704|NCT00372619|3599109|FG003|Overall Study|Inevaluable|0
2029705|NCT00372619|3599110|FG004|Overall Study|Inevaluable|0
2029706|NCT00372619|3599111|FG005|Overall Study|Inevaluable|1
2029707|NCT00372619|3599112|FG006|Overall Study|Inevaluable|0
2029708|NCT00372697|3599130|FG000|Overall Study|Protocol Violation|1
2029709|NCT00372697|3599131|FG001|Overall Study|Protocol Violation|1
2029710|NCT00372775|3599137|FG000|Overall Study|Adverse Event|8
2029711|NCT00372775|3599137|FG000|Overall Study|Death|15
2029712|NCT00372775|3599137|FG000|Overall Study|Objective progression or relapse|30
2029713|NCT00372775|3599137|FG000|Overall Study|Global deterioration of health status|6
2029714|NCT00372775|3599137|FG000|Overall Study|Withdrawal by Subject|1
2029715|NCT00372775|3599137|FG000|Overall Study|Other|1
2029716|NCT00372775|3599137|FG000|Overall Study|Not Treated|2
2029717|NCT00372905|3599141|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
2029718|NCT00372905|3599142|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
2029719|NCT00372905|3599143|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
2029720|NCT00372905|3599144|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
2029721|NCT00372905|3599141|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
2029722|NCT00372905|3599142|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
2029723|NCT00372905|3599143|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
2029724|NCT00372905|3599144|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
2029725|NCT00372905|3599141|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
2029726|NCT00372905|3599142|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
2029727|NCT00372905|3599143|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
2029728|NCT00372905|3599144|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
2029729|NCT00372905|3599141|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
2029730|NCT00372905|3599142|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
2029731|NCT00372905|3599143|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
2029732|NCT00372905|3599144|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
2029733|NCT00372905|3599141|FG000|Follow up Until Relapse or Progression|Study closed|0
2029734|NCT00372905|3599142|FG001|Follow up Until Relapse or Progression|Study closed|0
2029735|NCT00372905|3599143|FG002|Follow up Until Relapse or Progression|Study closed|0
2029736|NCT00372905|3599144|FG003|Follow up Until Relapse or Progression|Study closed|3
2029737|NCT00372905|3599141|FG000|Follow up Until Relapse or Progression|Other|0
2029738|NCT00372905|3599142|FG001|Follow up Until Relapse or Progression|Other|1
2029739|NCT00372905|3599143|FG002|Follow up Until Relapse or Progression|Other|0
2029740|NCT00372905|3599144|FG003|Follow up Until Relapse or Progression|Other|0
2029741|NCT00372996|3599180|FG000|Overall Study|Death|11
2029742|NCT00372996|3599181|FG001|Overall Study|Death|4
2029743|NCT00372996|3599182|FG002|Overall Study|Death|8
2029744|NCT00372996|3599183|FG003|Overall Study|Death|7
2029745|NCT00372996|3599180|FG000|Overall Study|Lost to Follow-up|0
2029746|NCT00372996|3599181|FG001|Overall Study|Lost to Follow-up|2
2029747|NCT00372996|3599182|FG002|Overall Study|Lost to Follow-up|0
2029748|NCT00372996|3599183|FG003|Overall Study|Lost to Follow-up|1
2029749|NCT00372996|3599180|FG000|Overall Study|Withdrawal by Subject|12
2029750|NCT00372996|3599181|FG001|Overall Study|Withdrawal by Subject|6
2029751|NCT00372996|3599182|FG002|Overall Study|Withdrawal by Subject|9
2029752|NCT00372996|3599183|FG003|Overall Study|Withdrawal by Subject|5
2029753|NCT00372996|3599180|FG000|Overall Study|Study Terminated by Sponsor|4
2029754|NCT00372996|3599181|FG001|Overall Study|Study Terminated by Sponsor|0
2029755|NCT00372996|3599182|FG002|Overall Study|Study Terminated by Sponsor|4
2029756|NCT00372996|3599183|FG003|Overall Study|Study Terminated by Sponsor|0
2029757|NCT00372996|3599180|FG000|Overall Study|Other|10
2029758|NCT00372996|3599181|FG001|Overall Study|Other|2
2029759|NCT00372996|3599182|FG002|Overall Study|Other|7
2029760|NCT00372996|3599183|FG003|Overall Study|Other|7
2029761|NCT00373113|3599195|FG000|Overall Study|Death|1
2029762|NCT00373113|3599196|FG001|Overall Study|Death|7
2029763|NCT00373113|3599195|FG000|Overall Study|Adverse Event|38
2029764|NCT00373113|3599196|FG001|Overall Study|Adverse Event|24
2029765|NCT00373113|3599195|FG000|Overall Study|Study terminated by sponsor|9
2029766|NCT00373113|3599196|FG001|Overall Study|Study terminated by sponsor|1
2029767|NCT00373113|3599195|FG000|Overall Study|Global deterioration of health status|10
2029768|NCT00373113|3599196|FG001|Overall Study|Global deterioration of health status|7
2029769|NCT00373113|3599195|FG000|Overall Study|Lost to Follow-up|1
2029770|NCT00373113|3599196|FG001|Overall Study|Lost to Follow-up|3
2029771|NCT00373113|3599195|FG000|Overall Study|Objective progression or relapse|150
2029772|NCT00373113|3599196|FG001|Overall Study|Objective progression or relapse|169
2029773|NCT00373113|3599195|FG000|Overall Study|Other|14
2029774|NCT00373113|3599196|FG001|Overall Study|Other|17
2029775|NCT00373113|3599195|FG000|Overall Study|Protocol Violation|5
2029776|NCT00373113|3599196|FG001|Overall Study|Protocol Violation|1
2029777|NCT00373113|3599195|FG000|Overall Study|Withdrawal by Subject|10
2029778|NCT00373113|3599196|FG001|Overall Study|Withdrawal by Subject|15
2029779|NCT00373256|3599204|FG000|Overall Study|Adverse Event (AE)|1
2029780|NCT00373256|3599205|FG001|Overall Study|Adverse Event (AE)|5
2029781|NCT00373256|3599204|FG000|Overall Study|Lost to Follow-up|2
2029782|NCT00373256|3599205|FG001|Overall Study|Lost to Follow-up|1
2029783|NCT00373256|3599204|FG000|Overall Study|Death|9
2029784|NCT00373256|3599205|FG001|Overall Study|Death|8
2029785|NCT00373256|3599204|FG000|Overall Study|Objective Progression or Relapse|111
2029786|NCT00373256|3599205|FG001|Overall Study|Objective Progression or Relapse|104
2029787|NCT00373256|3599204|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4
2029788|NCT00373256|3599205|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7
2029789|NCT00373256|3599204|FG000|Overall Study|Other|73
2029790|NCT00373256|3599205|FG001|Overall Study|Other|107
2029791|NCT00373256|3599204|FG000|Overall Study|Protocol Violation|0
2029792|NCT00373256|3599205|FG001|Overall Study|Protocol Violation|2
2029793|NCT00373256|3599204|FG000|Overall Study|Study Terminated by Sponsor|41
2029794|NCT00373256|3599205|FG001|Overall Study|Study Terminated by Sponsor|13
2029795|NCT00373295|3599220|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0
2029796|NCT00373295|3599221|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2
2029797|NCT00373295|3599222|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0
2029798|NCT00373295|3599223|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0
2029799|NCT00373295|3599224|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1
2029800|NCT00373295|3599225|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0
2029801|NCT00373425|3599274|FG000|Overall Study|Relapse of NSCLC|116
2029802|NCT00373425|3599275|FG001|Overall Study|Relapse of NSCLC|104
2029803|NCT00373425|3599276|FG002|Overall Study|Relapse of NSCLC|19
2029804|NCT00373425|3599277|FG003|Overall Study|Relapse of NSCLC|2
2029805|NCT00373425|3599278|FG004|Overall Study|Relapse of NSCLC|26
2029806|NCT00373425|3599274|FG000|Overall Study|Adverse Event|191
2029807|NCT00373425|3599275|FG001|Overall Study|Adverse Event|22
2029808|NCT00373425|3599276|FG002|Overall Study|Adverse Event|59
2029809|NCT00373425|3599277|FG003|Overall Study|Adverse Event|0
2029810|NCT00373425|3599278|FG004|Overall Study|Adverse Event|34
2029811|NCT00373425|3599274|FG000|Overall Study|Patient request|35
2029812|NCT00373425|3599275|FG001|Overall Study|Patient request|18
2029813|NCT00373425|3599276|FG002|Overall Study|Patient request|43
2029814|NCT00373425|3599277|FG003|Overall Study|Patient request|6
2029815|NCT00373425|3599278|FG004|Overall Study|Patient request|7
2029816|NCT00373425|3599274|FG000|Overall Study|Medical/ethical/noncompliance reason|21
2029817|NCT00373425|3599275|FG001|Overall Study|Medical/ethical/noncompliance reason|9
2029818|NCT00373425|3599276|FG002|Overall Study|Medical/ethical/noncompliance reason|10
2029819|NCT00373425|3599277|FG003|Overall Study|Medical/ethical/noncompliance reason|2
2029820|NCT00373425|3599278|FG004|Overall Study|Medical/ethical/noncompliance reason|5
2029821|NCT00373425|3599274|FG000|Overall Study|Death|7
2029822|NCT00373425|3599275|FG001|Overall Study|Death|0
2029823|NCT00373425|3599276|FG002|Overall Study|Death|3
2029824|NCT00373425|3599277|FG003|Overall Study|Death|1
2029825|NCT00373425|3599278|FG004|Overall Study|Death|0
2029826|NCT00373490|3599289|FG000|Overall Study|Adverse Event|0
2029827|NCT00373490|3599290|FG001|Overall Study|Adverse Event|1
2029828|NCT00373490|3599289|FG000|Overall Study|Lack of Efficacy|9
2322621|NCT02975336|4037806|FG004|DBPC (52 Weeks)|Protocol Violation|0
2322622|NCT02975336|4037807|FG005|DBPC (52 Weeks)|Protocol Violation|0
2322623|NCT02975336|4037808|FG006|DBPC (52 Weeks)|Protocol Violation|0
2322624|NCT02975336|4037809|FG007|DBPC (52 Weeks)|Protocol Violation|0
2322625|NCT02975336|4037802|FG000|DBPC (52 Weeks)|Lack of Efficacy|4
2029829|NCT00373490|3599290|FG001|Overall Study|Lack of Efficacy|4
2029830|NCT00373490|3599289|FG000|Overall Study|Withdrawal by Subject|0
2029831|NCT00373490|3599290|FG001|Overall Study|Withdrawal by Subject|1
2110186|NCT00892281|3704680|FG000|Overall Study|Subject had history of drug abuse|1
2110187|NCT00892281|3704681|FG001|Overall Study|Subject had history of drug abuse|0
2110188|NCT00892281|3704680|FG000|Overall Study|Rash on hand|1
2110189|NCT00892281|3704681|FG001|Overall Study|Rash on hand|0
2110190|NCT00892281|3704680|FG000|Overall Study|Visit 4 date out of window|1
2110191|NCT00892281|3704681|FG001|Overall Study|Visit 4 date out of window|0
2110192|NCT00892437|3704689|FG000|Randomized Phase|Randomized but not treated|6
2110193|NCT00892437|3704690|FG001|Randomized Phase|Randomized but not treated|0
2110194|NCT00892437|3704689|FG000|Randomized Phase|Adverse Event|2
2180255|NCT01400451|3806301|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1
2322626|NCT02975336|4037803|FG001|DBPC (52 Weeks)|Lack of Efficacy|4
2322627|NCT02975336|4037804|FG002|DBPC (52 Weeks)|Lack of Efficacy|2
2322628|NCT02975336|4037805|FG003|DBPC (52 Weeks)|Lack of Efficacy|3
2322629|NCT02975336|4037806|FG004|DBPC (52 Weeks)|Lack of Efficacy|0
2110195|NCT00892437|3704690|FG001|Randomized Phase|Adverse Event|2
2110196|NCT00892437|3704689|FG000|Randomized Phase|Lost to Follow-up|1
2110197|NCT00892437|3704690|FG001|Randomized Phase|Lost to Follow-up|3
2322630|NCT02975336|4037807|FG005|DBPC (52 Weeks)|Lack of Efficacy|0
2029832|NCT00373529|3599296|FG000|Overall Study|Physician Decision|19
2029833|NCT00373529|3599296|FG000|Overall Study|Withdrawal by Subject|7
2029834|NCT00373529|3599296|FG000|Overall Study|Adverse Event|7
2029835|NCT00373529|3599296|FG000|Overall Study|Treatment failure|36
2029836|NCT00373529|3599296|FG000|Overall Study|Disease recurrence|10
2029837|NCT00373529|3599296|FG000|Overall Study|Death|16
2029838|NCT00373529|3599296|FG000|Overall Study|Need for treatment prohibited by study|1
2029839|NCT00373529|3599296|FG000|Overall Study|Other|8
2029840|NCT00373529|3599296|FG000|Overall Study|Failed independent confirmation of AML|3
2029841|NCT00373529|3599296|FG000|Overall Study|Consent violation|1
2110198|NCT00892437|3704689|FG000|Randomized Phase|Investigator's Discretion|1
2110199|NCT00892437|3704690|FG001|Randomized Phase|Investigator's Discretion|0
2110200|NCT00892437|3704689|FG000|Randomized Phase|Withdrew Consent|1
2110201|NCT00892437|3704690|FG001|Randomized Phase|Withdrew Consent|0
2110202|NCT00892437|3704689|FG000|Open-Label Extension Phase|Adverse Event|4
2110203|NCT00892437|3704690|FG001|Open-Label Extension Phase|Adverse Event|2
2110204|NCT00892437|3704689|FG000|Open-Label Extension Phase|Lack of Efficacy|1
2110205|NCT00892437|3704690|FG001|Open-Label Extension Phase|Lack of Efficacy|0
2110206|NCT00892437|3704689|FG000|Open-Label Extension Phase|Lost to Follow-up|3
2110207|NCT00892437|3704690|FG001|Open-Label Extension Phase|Lost to Follow-up|1
2110208|NCT00892437|3704689|FG000|Open-Label Extension Phase|Investigator's Discretion|1
2110209|NCT00892437|3704690|FG001|Open-Label Extension Phase|Investigator's Discretion|0
2110210|NCT00892437|3704689|FG000|Open-Label Extension Phase|Withdrew Consent|3
2110211|NCT00892437|3704690|FG001|Open-Label Extension Phase|Withdrew Consent|1
2110212|NCT00892723|3704727|FG000|Overall Study|Lost to Follow-up|1
2110213|NCT00892723|3704728|FG001|Overall Study|Lost to Follow-up|3
2110214|NCT00892723|3704729|FG002|Overall Study|Lost to Follow-up|1
2110215|NCT00892723|3704727|FG000|Overall Study|Withdrawal by Subject|1
2110216|NCT00892723|3704728|FG001|Overall Study|Withdrawal by Subject|1
2110217|NCT00892723|3704729|FG002|Overall Study|Withdrawal by Subject|1
2110218|NCT00892775|3704772|FG000|Overall Study|Protocol Violation|1
2110219|NCT00892775|3704773|FG001|Overall Study|Protocol Violation|0
2110220|NCT00892775|3704772|FG000|Overall Study|Subject difficulties with blood drawing|1
2110221|NCT00892775|3704773|FG001|Overall Study|Subject difficulties with blood drawing|0
2110222|NCT00892775|3704772|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
2110223|NCT00892775|3704773|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
2110224|NCT00892775|3704772|FG000|Overall Study|Migrated/ moved from study area|1
2110225|NCT00892775|3704773|FG001|Overall Study|Migrated/ moved from study area|0
2110226|NCT00892775|3704772|FG000|Overall Study|Withdrawal by Subject|0
2110227|NCT00892775|3704773|FG001|Overall Study|Withdrawal by Subject|1
2110228|NCT00892775|3704772|FG000|Overall Study|Lost to Follow-up|1
2110229|NCT00892775|3704773|FG001|Overall Study|Lost to Follow-up|0
2110230|NCT00892957|3704781|FG000|Between Postoperative Day 1 and Day 14|Death|0
2110231|NCT00892957|3704782|FG001|Between Postoperative Day 1 and Day 14|Death|2
2110232|NCT00892957|3704781|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
2110233|NCT00892957|3704782|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
2110234|NCT00893113|3704819|FG000|Overall Study|Lost to Follow-up|4
2110235|NCT00893113|3704820|FG001|Overall Study|Lost to Follow-up|8
2322631|NCT02975336|4037808|FG006|DBPC (52 Weeks)|Lack of Efficacy|0
2322632|NCT02975336|4037809|FG007|DBPC (52 Weeks)|Lack of Efficacy|0
2322633|NCT02975336|4037802|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1
2322634|NCT02975336|4037803|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0
2322635|NCT02975336|4037804|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1
2322636|NCT02975336|4037805|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3
2322637|NCT02975336|4037806|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0
2322638|NCT02975336|4037807|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0
2322639|NCT02975336|4037808|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0
2322640|NCT02975336|4037809|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0
2322641|NCT02975336|4037802|FG000|DBPC (52 Weeks)|Premature termination of the study|5
2322642|NCT02975336|4037803|FG001|DBPC (52 Weeks)|Premature termination of the study|6
2322643|NCT02975336|4037804|FG002|DBPC (52 Weeks)|Premature termination of the study|6
2352309|NCT03780959|4101230|FG000|Part 1|Withdrawal by Subject|1
2352310|NCT03780959|4101231|FG001|Part 1|Withdrawal by Subject|0
2352311|NCT03780959|4101232|FG002|Part 1|Withdrawal by Subject|0
2352312|NCT03780959|4101230|FG000|Part 1|Withdrawal by Parent/Guardian|1
2352313|NCT03780959|4101231|FG001|Part 1|Withdrawal by Parent/Guardian|0
2352314|NCT03780959|4101232|FG002|Part 1|Withdrawal by Parent/Guardian|0
2352315|NCT03780959|4101230|FG000|Part 1|Response Status|2
2352316|NCT03780959|4101231|FG001|Part 1|Response Status|0
2352317|NCT03780959|4101232|FG002|Part 1|Response Status|0
2352318|NCT03780959|4101230|FG000|Part 2|Withdrawal by Parent/Guardian|0
2352319|NCT03780959|4101231|FG001|Part 2|Withdrawal by Parent/Guardian|1
2352320|NCT03780959|4101232|FG002|Part 2|Withdrawal by Parent/Guardian|0
2352321|NCT03780959|4101230|FG000|Part 2|Response Status|0
2352322|NCT03780959|4101231|FG001|Part 2|Response Status|18
2352323|NCT03780959|4101232|FG002|Part 2|Response Status|6
2352324|NCT03796676|4101261|FG000|Overall Study|Adverse Event|2
2352325|NCT03796676|4101262|FG001|Overall Study|Adverse Event|1
2352326|NCT03796676|4101263|FG002|Overall Study|Adverse Event|2
2029842|NCT00373685|3599302|FG000|Overall Study|Death|2
2029843|NCT00373685|3599303|FG001|Overall Study|Death|1
2029844|NCT00373685|3599302|FG000|Overall Study|Adverse Event|278
2029845|NCT00373685|3599303|FG001|Overall Study|Adverse Event|253
2029846|NCT00373685|3599302|FG000|Overall Study|Insufficient clinical response|169
2029847|NCT00373685|3599303|FG001|Overall Study|Insufficient clinical response|119
2029848|NCT00373685|3599302|FG000|Overall Study|Did not meet entrance criteria|167
2029849|NCT00373685|3599303|FG001|Overall Study|Did not meet entrance criteria|184
2029850|NCT00373685|3599302|FG000|Overall Study|Lost to follow up|83
2029851|NCT00373685|3599303|FG001|Overall Study|Lost to follow up|103
2029852|NCT00373685|3599302|FG000|Overall Study|No longer willing to participate|337
2029853|NCT00373685|3599303|FG001|Overall Study|No longer willing to participate|352
2029854|NCT00373685|3599302|FG000|Overall Study|Other|149
2029855|NCT00373685|3599303|FG001|Overall Study|Other|146
2029856|NCT00373685|3599302|FG000|Overall Study|Protocol Violation|191
2029857|NCT00373685|3599303|FG001|Overall Study|Protocol Violation|182
2029858|NCT00373685|3599302|FG000|Overall Study|Final Status Unknown|12
2029859|NCT00373685|3599303|FG001|Overall Study|Final Status Unknown|4
2029860|NCT00373685|3599302|FG000|Overall Study|Randomized, not treated|51
2029861|NCT00373685|3599303|FG001|Overall Study|Randomized, not treated|77
2029862|NCT00373880|3599320|FG000|Overall Study|Physician Decision|3
2029863|NCT00373880|3599320|FG000|Overall Study|Arrested|1
2029864|NCT00373880|3599320|FG000|Overall Study|Protocol Violation|14
2029865|NCT00373958|3599334|FG000|Infant Series|Withdrawal by Subject|13
2029866|NCT00373958|3599335|FG001|Infant Series|Withdrawal by Subject|15
2029867|NCT00373958|3599334|FG000|Infant Series|Failed to return|8
2029868|NCT00373958|3599335|FG001|Infant Series|Failed to return|13
2029869|NCT00373958|3599334|FG000|Infant Series|Lost to Follow-up|6
2029870|NCT00373958|3599335|FG001|Infant Series|Lost to Follow-up|5
2029871|NCT00373958|3599334|FG000|Infant Series|Protocol Violation|3
2322644|NCT02975336|4037805|FG003|DBPC (52 Weeks)|Premature termination of the study|4
2322645|NCT02975336|4037806|FG004|DBPC (52 Weeks)|Premature termination of the study|0
2322646|NCT02975336|4037807|FG005|DBPC (52 Weeks)|Premature termination of the study|0
2322647|NCT02975336|4037808|FG006|DBPC (52 Weeks)|Premature termination of the study|0
2322648|NCT02975336|4037809|FG007|DBPC (52 Weeks)|Premature termination of the study|0
2322649|NCT02975336|4037802|FG000|LTE (104 Weeks)|Adverse Event|0
2322650|NCT02975336|4037803|FG001|LTE (104 Weeks)|Adverse Event|0
2322651|NCT02975336|4037804|FG002|LTE (104 Weeks)|Adverse Event|0
2322652|NCT02975336|4037805|FG003|LTE (104 Weeks)|Adverse Event|0
2322653|NCT02975336|4037806|FG004|LTE (104 Weeks)|Adverse Event|7
2322654|NCT02975336|4037807|FG005|LTE (104 Weeks)|Adverse Event|4
2322655|NCT02975336|4037808|FG006|LTE (104 Weeks)|Adverse Event|2
2322656|NCT02975336|4037809|FG007|LTE (104 Weeks)|Adverse Event|0
2322657|NCT02975336|4037802|FG000|LTE (104 Weeks)|Lost to Follow-up|0
2322658|NCT02975336|4037803|FG001|LTE (104 Weeks)|Lost to Follow-up|0
2322659|NCT02975336|4037804|FG002|LTE (104 Weeks)|Lost to Follow-up|0
2322660|NCT02975336|4037805|FG003|LTE (104 Weeks)|Lost to Follow-up|0
2322661|NCT02975336|4037806|FG004|LTE (104 Weeks)|Lost to Follow-up|0
2322662|NCT02975336|4037807|FG005|LTE (104 Weeks)|Lost to Follow-up|1
2322663|NCT02975336|4037808|FG006|LTE (104 Weeks)|Lost to Follow-up|0
2322664|NCT02975336|4037809|FG007|LTE (104 Weeks)|Lost to Follow-up|0
2322665|NCT02975336|4037802|FG000|LTE (104 Weeks)|Lack of Efficacy|0
2322666|NCT02975336|4037803|FG001|LTE (104 Weeks)|Lack of Efficacy|0
2322667|NCT02975336|4037804|FG002|LTE (104 Weeks)|Lack of Efficacy|0
2322668|NCT02975336|4037805|FG003|LTE (104 Weeks)|Lack of Efficacy|0
2322669|NCT02975336|4037806|FG004|LTE (104 Weeks)|Lack of Efficacy|0
2322670|NCT02975336|4037807|FG005|LTE (104 Weeks)|Lack of Efficacy|1
2322671|NCT02975336|4037808|FG006|LTE (104 Weeks)|Lack of Efficacy|2
2322672|NCT02975336|4037809|FG007|LTE (104 Weeks)|Lack of Efficacy|0
2322673|NCT02975336|4037802|FG000|LTE (104 Weeks)|Other|0
2322674|NCT02975336|4037803|FG001|LTE (104 Weeks)|Other|0
2322675|NCT02975336|4037804|FG002|LTE (104 Weeks)|Other|0
2322676|NCT02975336|4037805|FG003|LTE (104 Weeks)|Other|0
2322677|NCT02975336|4037806|FG004|LTE (104 Weeks)|Other|55
2322678|NCT02975336|4037807|FG005|LTE (104 Weeks)|Other|63
2322679|NCT02975336|4037808|FG006|LTE (104 Weeks)|Other|76
2322680|NCT02975336|4037809|FG007|LTE (104 Weeks)|Other|72
2322681|NCT02975349|4037828|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
2322682|NCT02975349|4037829|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
2029872|NCT00373958|3599335|FG001|Infant Series|Protocol Violation|7
2029873|NCT00373958|3599334|FG000|Infant Series|Lost Kaiser coverage|4
2110236|NCT00893113|3704819|FG000|Overall Study|Early Termination|1
2110237|NCT00893113|3704820|FG001|Overall Study|Early Termination|1
2110238|NCT00893113|3704819|FG000|Overall Study|Withdrew Consent|8
2110239|NCT00893113|3704820|FG001|Overall Study|Withdrew Consent|7
2110240|NCT00893464|3704843|FG000|Overall Study|Did not complete therapy/experience PD|0
2110241|NCT00893464|3704844|FG001|Overall Study|Did not complete therapy/experience PD|0
2110242|NCT00893464|3704845|FG002|Overall Study|Did not complete therapy/experience PD|0
2110243|NCT00893464|3704846|FG003|Overall Study|Did not complete therapy/experience PD|0
2110244|NCT00893464|3704847|FG004|Overall Study|Did not complete therapy/experience PD|0
2110245|NCT00893464|3704848|FG005|Overall Study|Did not complete therapy/experience PD|0
2110246|NCT00893464|3704849|FG006|Overall Study|Did not complete therapy/experience PD|2
2110247|NCT00893464|3704850|FG007|Overall Study|Did not complete therapy/experience PD|2
2110248|NCT00893737|3704873|FG000|Overall Study|Adverse Event|4
2110249|NCT00893737|3704873|FG000|Overall Study|Withdrawal by Subject|2
2110250|NCT00893737|3704873|FG000|Overall Study|Lost to Follow-up|6
2110251|NCT00893763|3704879|FG000|Overall Study|extubated|110
2180256|NCT01400451|3806302|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1
2180257|NCT01400451|3806300|FG000|Combination Treatment (or Intended)|Drug Toxicity|0
2180258|NCT01400451|3806301|FG001|Combination Treatment (or Intended)|Drug Toxicity|1
2180259|NCT01400451|3806302|FG002|Combination Treatment (or Intended)|Drug Toxicity|0
2180260|NCT01400451|3806300|FG000|Combination Treatment (or Intended)|Adverse Event|1
2180261|NCT01400451|3806301|FG001|Combination Treatment (or Intended)|Adverse Event|0
2180262|NCT01400451|3806302|FG002|Combination Treatment (or Intended)|Adverse Event|0
2180263|NCT01400451|3806300|FG000|Combination Treatment (or Intended)|Disease Progression|3
2322683|NCT02975349|4037830|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
2322684|NCT02975349|4037831|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
2322685|NCT02975349|4037832|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
2322686|NCT02975349|4037833|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
2322687|NCT02975349|4037828|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1
2322688|NCT02975349|4037829|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
2322689|NCT02975349|4037830|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
2322690|NCT02975349|4037831|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
2322691|NCT02975349|4037832|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
2322692|NCT02975349|4037833|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
2322693|NCT02975349|4037828|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4
2322694|NCT02975349|4037829|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0
2322695|NCT02975349|4037830|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1
2322696|NCT02975349|4037831|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2
2322697|NCT02975349|4037832|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6
2322698|NCT02975349|4037833|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2
2322699|NCT02975349|4037828|FG000|Active Treatment Period (24 Weeks)|Un-specified|0
2322700|NCT02975349|4037829|FG001|Active Treatment Period (24 Weeks)|Un-specified|0
2322701|NCT02975349|4037830|FG002|Active Treatment Period (24 Weeks)|Un-specified|1
2029874|NCT00373958|3599335|FG001|Infant Series|Lost Kaiser coverage|0
2029875|NCT00373958|3599334|FG000|Infant Series|Child relocated|1
2029876|NCT00373958|3599335|FG001|Infant Series|Child relocated|0
2029877|NCT00373958|3599334|FG000|Infant Series|Consent was not received|1
2029878|NCT00373958|3599335|FG001|Infant Series|Consent was not received|0
2029879|NCT00373958|3599334|FG000|Infant Series|Adverse Event|3
2029880|NCT00373958|3599335|FG001|Infant Series|Adverse Event|1
2029881|NCT00373958|3599334|FG000|Infant Series|Physician Decision|1
2029882|NCT00373958|3599335|FG001|Infant Series|Physician Decision|1
2029883|NCT00373958|3599334|FG000|Toddler Dose|Lost to Follow-up|5
2029884|NCT00373958|3599335|FG001|Toddler Dose|Lost to Follow-up|8
2029885|NCT00373958|3599334|FG000|Toddler Dose|Withdrawal by Subject|2
2029886|NCT00373958|3599335|FG001|Toddler Dose|Withdrawal by Subject|2
2029887|NCT00373958|3599334|FG000|Toddler Dose|Failed to return|1
2029888|NCT00373958|3599335|FG001|Toddler Dose|Failed to return|2
2029889|NCT00373958|3599334|FG000|Toddler Dose|Protocol Violation|0
2029890|NCT00373958|3599335|FG001|Toddler Dose|Protocol Violation|1
2029891|NCT00373958|3599334|FG000|Toddler Dose|Withdrawn after infant series|22
2029892|NCT00373958|3599335|FG001|Toddler Dose|Withdrawn after infant series|25
2029893|NCT00374127|3599373|FG000|Overall Study|Did not inhale during smoking procedure.|3
2029894|NCT00374127|3599373|FG000|Overall Study|Blood could not be drawn.|2
2029895|NCT00374127|3599373|FG000|Overall Study|Protocol Violation|5
2029896|NCT00374127|3599373|FG000|Overall Study|Pregnancy|1
2029897|NCT00374140|3599383|FG000|Overall Study|Lost to Follow-up|1
2029898|NCT00374140|3599383|FG000|Overall Study|Protocol Violation|1
2029899|NCT00374322|3599403|FG000|Overall Study|Lost to Follow-up|92
2029900|NCT00374322|3599404|FG001|Overall Study|Lost to Follow-up|90
2029901|NCT00374322|3599403|FG000|Overall Study|Protocol Violation|8
2029902|NCT00374322|3599404|FG001|Overall Study|Protocol Violation|3
2029903|NCT00374322|3599403|FG000|Overall Study|Withdrawal by Subject|235
2029904|NCT00374322|3599404|FG001|Overall Study|Withdrawal by Subject|167
2029905|NCT00374322|3599403|FG000|Overall Study|Sponsor Terminated Study|866
2029906|NCT00374322|3599404|FG001|Overall Study|Sponsor Terminated Study|990
2029907|NCT00374322|3599403|FG000|Overall Study|Physician Decision|36
2322702|NCT02975349|4037831|FG003|Active Treatment Period (24 Weeks)|Un-specified|0
2322703|NCT02975349|4037832|FG004|Active Treatment Period (24 Weeks)|Un-specified|0
2322704|NCT02975349|4037833|FG005|Active Treatment Period (24 Weeks)|Un-specified|0
2322705|NCT02975349|4037828|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0
2322706|NCT02975349|4037829|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1
2322707|NCT02975349|4037830|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1
2322708|NCT02975349|4037831|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2
2322709|NCT02975349|4037832|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1
2322710|NCT02975349|4037833|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0
2322711|NCT02975349|4037828|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
2322712|NCT02975349|4037829|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5
2322713|NCT02975349|4037830|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2
2322714|NCT02975349|4037831|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
2322715|NCT02975349|4037832|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
2322716|NCT02975349|4037833|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
2322717|NCT02975349|4037828|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
2322718|NCT02975349|4037829|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
2322719|NCT02975349|4037830|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1
2322720|NCT02975349|4037831|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
2322721|NCT02975349|4037832|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
2322722|NCT02975349|4037833|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
2322723|NCT02975349|4037828|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0
2322724|NCT02975349|4037829|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1
2322725|NCT02975349|4037830|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0
2029908|NCT00374322|3599404|FG001|Overall Study|Physician Decision|32
2029909|NCT00374322|3599403|FG000|Overall Study|Par. Consented to Survival FU Only|3
2029910|NCT00374322|3599404|FG001|Overall Study|Par. Consented to Survival FU Only|1
2029911|NCT00374322|3599403|FG000|Overall Study|Sponsor Decision|2
2029912|NCT00374322|3599404|FG001|Overall Study|Sponsor Decision|3
2029913|NCT00374322|3599403|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2
2029914|NCT00374322|3599404|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3
2029915|NCT00374322|3599403|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1
2029916|NCT00374322|3599404|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0
2029917|NCT00374322|3599403|FG000|Overall Study|Severe Toxicity|1
2029918|NCT00374322|3599404|FG001|Overall Study|Severe Toxicity|0
2029919|NCT00374322|3599403|FG000|Overall Study|Site Closed|2
2029920|NCT00374322|3599404|FG001|Overall Study|Site Closed|2
2029921|NCT00374322|3599403|FG000|Overall Study|Participant Changed Physician|1
2029922|NCT00374322|3599404|FG001|Overall Study|Participant Changed Physician|0
2029923|NCT00374322|3599403|FG000|Overall Study|Started Another Chemotherapy Regimen|0
2029924|NCT00374322|3599404|FG001|Overall Study|Started Another Chemotherapy Regimen|1
2029925|NCT00374322|3599403|FG000|Overall Study|Noncompliance with Study Requirements|0
2029926|NCT00374322|3599404|FG001|Overall Study|Noncompliance with Study Requirements|1
2029927|NCT00374322|3599403|FG000|Overall Study|Withdrew Consent During Follow-up|0
2029928|NCT00374322|3599404|FG001|Overall Study|Withdrew Consent During Follow-up|5
2029929|NCT00374322|3599403|FG000|Overall Study|Did Not Receive Study Medication|8
2029930|NCT00374322|3599404|FG001|Overall Study|Did Not Receive Study Medication|6
2029931|NCT00374452|3599417|FG000|Overall Study|Left clinic before intervention started|4
2029932|NCT00374452|3599418|FG001|Overall Study|Left clinic before intervention started|1
2029933|NCT00374452|3599417|FG000|Overall Study|Change in job role before intervention|0
2029934|NCT00374452|3599418|FG001|Overall Study|Change in job role before intervention|1
2029935|NCT00374452|3599417|FG000|Overall Study|Left clinic after intervention started|1
2029936|NCT00374452|3599418|FG001|Overall Study|Left clinic after intervention started|1
2029937|NCT00374452|3599417|FG000|Overall Study|Withdrawal by Subject|0
2029938|NCT00374452|3599418|FG001|Overall Study|Withdrawal by Subject|2
2029939|NCT00374556|3599426|FG000|Overall Study|Lost to Follow-up|1
2029940|NCT00374556|3599427|FG001|Overall Study|Lost to Follow-up|0
2029941|NCT00374556|3599426|FG000|Overall Study|Removed at baseline due to medical cond|0
2029942|NCT00374556|3599427|FG001|Overall Study|Removed at baseline due to medical cond|1
2029943|NCT00374868|3599459|FG000|Overall Study|Adverse Event|12
2029944|NCT00374868|3599459|FG000|Overall Study|Progressive Disease|7
2322726|NCT02975349|4037831|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0
2322727|NCT02975349|4037832|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0
2322728|NCT02975349|4037833|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0
2322729|NCT02975349|4037828|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0
2322730|NCT02975349|4037829|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0
2322731|NCT02975349|4037830|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0
2322732|NCT02975349|4037831|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1
2322733|NCT02975349|4037832|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0
2322734|NCT02975349|4037833|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0
2322735|NCT02975700|4037865|FG000|Overall Study|Adverse Event|1
2322736|NCT02975700|4037865|FG000|Overall Study|Progressive disease|3
2322737|NCT02975700|4037865|FG000|Overall Study|Failed screening criteria|2
2322738|NCT02975973|4037882|FG000|Overall Study|Adverse Event|1
2322739|NCT02975973|4037883|FG001|Overall Study|Adverse Event|1
2322740|NCT02975973|4037884|FG002|Overall Study|Adverse Event|1
2322741|NCT02975973|4037885|FG003|Overall Study|Adverse Event|0
2322742|NCT02976103|4037897|FG000|Overall Study|Withdrawal by Subject|1
2322743|NCT02976103|4037898|FG001|Overall Study|Withdrawal by Subject|0
2322744|NCT02976103|4037897|FG000|Overall Study|Lost to Follow-up|12
2322745|NCT02976103|4037898|FG001|Overall Study|Lost to Follow-up|8
2322746|NCT02976519|4037917|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2322747|NCT02976519|4037918|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
2322748|NCT02976519|4037919|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2322749|NCT02976519|4037920|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2029945|NCT00374868|3599459|FG000|Overall Study|Physician Decision|13
2029946|NCT00374868|3599459|FG000|Overall Study|Lost to Follow-up|1
2029947|NCT00374868|3599459|FG000|Overall Study|Death|2
2029948|NCT00374868|3599459|FG000|Overall Study|Other - Not Specified|1
2029949|NCT00374907|3599465|FG000|12-Week Short-term Period|Subject Withdrew Consent|3
2029950|NCT00374907|3599466|FG001|12-Week Short-term Period|Subject Withdrew Consent|1
2029951|NCT00374907|3599465|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
2029952|NCT00374907|3599466|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
2029953|NCT00374907|3599465|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4
2029954|NCT00374907|3599466|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2
2322750|NCT02976519|4037921|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2322751|NCT02976519|4037922|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2029955|NCT00374907|3599465|FG000|116-Week Short-term + Long-term Period|Adverse Event|0
2029956|NCT00374907|3599466|FG001|116-Week Short-term + Long-term Period|Adverse Event|2
2029957|NCT00374907|3599465|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1
2029958|NCT00374907|3599466|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1
2029959|NCT00375219|3599488|FG000|Overall Study|Failure to achieve a response|16
2029960|NCT00375219|3599489|FG001|Overall Study|Failure to achieve a response|2
2029961|NCT00375219|3599490|FG002|Overall Study|Failure to achieve a response|0
2029962|NCT00375219|3599488|FG000|Overall Study|Adverse Event|8
2029963|NCT00375219|3599489|FG001|Overall Study|Adverse Event|2
2029964|NCT00375219|3599490|FG002|Overall Study|Adverse Event|1
2029965|NCT00375219|3599488|FG000|Overall Study|Protocol Violation|1
2029966|NCT00375219|3599489|FG001|Overall Study|Protocol Violation|0
2029967|NCT00375219|3599490|FG002|Overall Study|Protocol Violation|1
2029968|NCT00375219|3599488|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5
2029969|NCT00375219|3599489|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3
2029970|NCT00375219|3599490|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0
2029971|NCT00375219|3599488|FG000|Overall Study|Lost to Follow-up|1
2029972|NCT00375219|3599489|FG001|Overall Study|Lost to Follow-up|1
2029973|NCT00375219|3599490|FG002|Overall Study|Lost to Follow-up|0
2029974|NCT00375219|3599488|FG000|Overall Study|Disease progression|18
2029975|NCT00375219|3599489|FG001|Overall Study|Disease progression|9
2029976|NCT00375219|3599490|FG002|Overall Study|Disease progression|12
2029977|NCT00375219|3599488|FG000|Overall Study|Death|4
2029978|NCT00375219|3599489|FG001|Overall Study|Death|3
2029979|NCT00375219|3599490|FG002|Overall Study|Death|7
2029980|NCT00375219|3599488|FG000|Overall Study|Hematologic resistance|1
2029981|NCT00375219|3599489|FG001|Overall Study|Hematologic resistance|0
2029982|NCT00375219|3599490|FG002|Overall Study|Hematologic resistance|0
2180264|NCT01400451|3806301|FG001|Combination Treatment (or Intended)|Disease Progression|1
2322752|NCT02976519|4037923|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2322753|NCT02976519|4037917|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2322754|NCT02976519|4037918|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2322755|NCT02976519|4037919|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2322756|NCT02976519|4037920|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
2322757|NCT02976519|4037921|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2322758|NCT02976519|4037922|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2322759|NCT02976519|4037923|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2322760|NCT02976519|4037917|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0
2322761|NCT02976519|4037918|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0
2322762|NCT02976519|4037919|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0
2322763|NCT02976519|4037920|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0
2322764|NCT02976519|4037921|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0
2322765|NCT02976519|4037922|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0
2322766|NCT02976519|4037923|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1
2322767|NCT02976519|4037917|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2322768|NCT02976519|4037918|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2322769|NCT02976519|4037919|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2322770|NCT02976519|4037920|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2322771|NCT02976519|4037921|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2322772|NCT02976519|4037922|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2322773|NCT02976519|4037923|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
2322774|NCT02976519|4037917|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2322775|NCT02976519|4037918|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2322776|NCT02976519|4037919|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2322777|NCT02976519|4037920|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2322778|NCT02976519|4037921|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2322779|NCT02976519|4037922|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2322780|NCT02976519|4037923|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1
2322781|NCT02977507|4037943|FG000|Overall Study|Protocol Deviation|1
2322782|NCT02977507|4037944|FG001|Overall Study|Protocol Deviation|0
2322783|NCT02977507|4037943|FG000|Overall Study|Lost to Follow-up|1
2322784|NCT02977507|4037944|FG001|Overall Study|Lost to Follow-up|0
2322785|NCT02977572|4037953|FG000|Overall Study|Exclusion criterion|2
2322786|NCT02977572|4037954|FG001|Overall Study|Exclusion criterion|2
2322787|NCT02978417|4037988|FG000|Overall Study|Lost to Follow-up|2
2322788|NCT02978417|4037989|FG001|Overall Study|Lost to Follow-up|2
2352327|NCT03796676|4101261|FG000|Overall Study|Lost to Follow-up|2
2352328|NCT03796676|4101262|FG001|Overall Study|Lost to Follow-up|1
2352329|NCT03796676|4101263|FG002|Overall Study|Lost to Follow-up|0
2352330|NCT03796676|4101261|FG000|Overall Study|Protocol Violation|0
2352331|NCT03796676|4101262|FG001|Overall Study|Protocol Violation|0
2352332|NCT03796676|4101263|FG002|Overall Study|Protocol Violation|1
2352333|NCT03796676|4101261|FG000|Overall Study|Withdrawal by Subject|1
2352334|NCT03796676|4101262|FG001|Overall Study|Withdrawal by Subject|1
2352335|NCT03796676|4101263|FG002|Overall Study|Withdrawal by Subject|0
2352336|NCT03796676|4101261|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1
2352337|NCT03796676|4101262|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
2029983|NCT00375219|3599488|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1
2029984|NCT00375219|3599489|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0
2029985|NCT00375219|3599490|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0
2029986|NCT00375219|3599488|FG000|Overall Study|Allograft|2
2029987|NCT00375219|3599489|FG001|Overall Study|Allograft|0
2029988|NCT00375219|3599490|FG002|Overall Study|Allograft|0
2029989|NCT00375219|3599488|FG000|Overall Study|Cord blood transplantation|1
2029990|NCT00375219|3599489|FG001|Overall Study|Cord blood transplantation|0
2029991|NCT00375219|3599490|FG002|Overall Study|Cord blood transplantation|0
2029992|NCT00375219|3599488|FG000|Overall Study|Withdrawal by Subject|1
2029993|NCT00375219|3599489|FG001|Overall Study|Withdrawal by Subject|0
2029994|NCT00375219|3599490|FG002|Overall Study|Withdrawal by Subject|0
2029995|NCT00375427|3599499|FG000|Overall Study|Adverse Event|21
2029996|NCT00375427|3599500|FG001|Overall Study|Adverse Event|27
2029997|NCT00375427|3599499|FG000|Overall Study|Abnormal test procedure result(s)|0
2029998|NCT00375427|3599500|FG001|Overall Study|Abnormal test procedure result(s)|1
2029999|NCT00375427|3599499|FG000|Overall Study|Abnormal laboratory value(s)|1
2030000|NCT00375427|3599500|FG001|Overall Study|Abnormal laboratory value(s)|2
2030001|NCT00375427|3599499|FG000|Overall Study|Unsatisfactory therapeutic effect|4
2030002|NCT00375427|3599500|FG001|Overall Study|Unsatisfactory therapeutic effect|4
2030003|NCT00375427|3599499|FG000|Overall Study|Patient no longer requires study drug|3
2030004|NCT00375427|3599500|FG001|Overall Study|Patient no longer requires study drug|7
2030005|NCT00375427|3599499|FG000|Overall Study|Protocol Violation|10
2030006|NCT00375427|3599500|FG001|Overall Study|Protocol Violation|8
2030007|NCT00375427|3599499|FG000|Overall Study|Withdrawal by Subject|9
2030008|NCT00375427|3599500|FG001|Overall Study|Withdrawal by Subject|13
2030009|NCT00375427|3599499|FG000|Overall Study|Lost to Follow-up|1
2030010|NCT00375427|3599500|FG001|Overall Study|Lost to Follow-up|1
2030011|NCT00375427|3599499|FG000|Overall Study|Administrative reasons|0
2030012|NCT00375427|3599500|FG001|Overall Study|Administrative reasons|1
2030013|NCT00375427|3599499|FG000|Overall Study|Death|11
2030014|NCT00375427|3599500|FG001|Overall Study|Death|10
2030015|NCT00375492|3599508|FG000|Overall Study|Adverse Event|4
2030016|NCT00375492|3599509|FG001|Overall Study|Adverse Event|5
2030017|NCT00375492|3599508|FG000|Overall Study|Entry Criteria Not Met|0
2030018|NCT00375492|3599509|FG001|Overall Study|Entry Criteria Not Met|1
2030019|NCT00375492|3599508|FG000|Overall Study|Loss of Glucose Control|0
2217871|NCT01710358|3861200|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0
2217872|NCT01710358|3861198|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
2030020|NCT00375492|3599509|FG001|Overall Study|Loss of Glucose Control|1
2030021|NCT00375492|3599508|FG000|Overall Study|Lost to Follow-up|10
2030022|NCT00375492|3599509|FG001|Overall Study|Lost to Follow-up|5
2030023|NCT00375492|3599508|FG000|Overall Study|Physician Decision|0
2030024|NCT00375492|3599509|FG001|Overall Study|Physician Decision|4
2030025|NCT00375492|3599508|FG000|Overall Study|Protocol Violation|6
2030026|NCT00375492|3599509|FG001|Overall Study|Protocol Violation|3
2030027|NCT00375492|3599508|FG000|Overall Study|Sponsor Decision|0
2030028|NCT00375492|3599509|FG001|Overall Study|Sponsor Decision|1
2030029|NCT00375492|3599508|FG000|Overall Study|Withdrawal by Subject|6
2030030|NCT00375492|3599509|FG001|Overall Study|Withdrawal by Subject|6
2030031|NCT00375505|3599517|FG000|Overall Study|Adverse Event|1
2030032|NCT00375505|3599518|FG001|Overall Study|Adverse Event|2
2030033|NCT00375518|3599526|FG000|Overall Study|Withdrawal by Subject|2
2030034|NCT00375518|3599527|FG001|Overall Study|Withdrawal by Subject|10
2030035|NCT00375518|3599526|FG000|Overall Study|Patient Not Treated|6
2030036|NCT00375518|3599527|FG001|Overall Study|Patient Not Treated|6
2030037|NCT00375518|3599526|FG000|Overall Study|Death|0
2030038|NCT00375518|3599527|FG001|Overall Study|Death|1
2030039|NCT00375609|3599536|FG000|Overall Study|Did not receive treatment|1
2030040|NCT00375609|3599537|FG001|Overall Study|Did not receive treatment|0
2030041|NCT00375609|3599538|FG002|Overall Study|Did not receive treatment|0
2030042|NCT00375609|3599536|FG000|Overall Study|Adverse Event|0
2030043|NCT00375609|3599537|FG001|Overall Study|Adverse Event|3
2030044|NCT00375609|3599538|FG002|Overall Study|Adverse Event|0
2030045|NCT00375609|3599536|FG000|Overall Study|Lost to Follow-up|1
2030046|NCT00375609|3599537|FG001|Overall Study|Lost to Follow-up|0
2322789|NCT02979197|4038016|FG000|Overall Study|Adverse Event|4
2322790|NCT02979197|4038017|FG001|Overall Study|Adverse Event|2
2322791|NCT02979197|4038018|FG002|Overall Study|Adverse Event|0
2322792|NCT02979197|4038016|FG000|Overall Study|Protocol Violation|0
2322793|NCT02979197|4038017|FG001|Overall Study|Protocol Violation|1
2322794|NCT02979197|4038018|FG002|Overall Study|Protocol Violation|0
2322795|NCT02979197|4038016|FG000|Overall Study|Subject unable to commit to study dates|0
2322796|NCT02979197|4038017|FG001|Overall Study|Subject unable to commit to study dates|1
2322797|NCT02979197|4038018|FG002|Overall Study|Subject unable to commit to study dates|0
2322798|NCT02979249|4038026|FG000|Overall Study|Lost to Follow-up|2
2322799|NCT02979249|4038026|FG000|Overall Study|Withdrawal by Subject|4
2322800|NCT02979431|4038052|FG000|Overall Study|Parent/guardian withdrew consent|2
2322801|NCT02979431|4038053|FG001|Overall Study|Parent/guardian withdrew consent|1
2322802|NCT02979431|4038054|FG002|Overall Study|Parent/guardian withdrew consent|1
2322803|NCT02979431|4038055|FG003|Overall Study|Parent/guardian withdrew consent|1
2322804|NCT02979431|4038052|FG000|Overall Study|Randomized but received no study drug|1
2030047|NCT00375609|3599538|FG002|Overall Study|Lost to Follow-up|0
2030048|NCT00375609|3599536|FG000|Overall Study|Physician Decision|0
2030049|NCT00375609|3599537|FG001|Overall Study|Physician Decision|0
2030050|NCT00375609|3599538|FG002|Overall Study|Physician Decision|1
2030051|NCT00375609|3599536|FG000|Overall Study|Withdrawal by Subject|1
2030052|NCT00375609|3599537|FG001|Overall Study|Withdrawal by Subject|4
2030053|NCT00375609|3599538|FG002|Overall Study|Withdrawal by Subject|0
2030054|NCT00375609|3599536|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1
2322805|NCT02979431|4038053|FG001|Overall Study|Randomized but received no study drug|1
2322806|NCT02979431|4038054|FG002|Overall Study|Randomized but received no study drug|0
2322807|NCT02979431|4038055|FG003|Overall Study|Randomized but received no study drug|0
2322808|NCT02979431|4038052|FG000|Overall Study|Adverse Event|0
2322809|NCT02979431|4038053|FG001|Overall Study|Adverse Event|0
2322810|NCT02979431|4038054|FG002|Overall Study|Adverse Event|1
2322811|NCT02979431|4038055|FG003|Overall Study|Adverse Event|0
2322812|NCT02979431|4038052|FG000|Overall Study|Subject left country after Day14|1
2322813|NCT02979431|4038053|FG001|Overall Study|Subject left country after Day14|0
2322814|NCT02979431|4038054|FG002|Overall Study|Subject left country after Day14|0
2322815|NCT02979431|4038055|FG003|Overall Study|Subject left country after Day14|0
2322816|NCT02979535|4038089|FG000|Overall Study|Non compliance with the protocol|78
2322817|NCT02979535|4038090|FG001|Overall Study|Non compliance with the protocol|82
2322818|NCT02979535|4038089|FG000|Overall Study|Consent withdrawn by participant|11
2322819|NCT02979535|4038090|FG001|Overall Study|Consent withdrawn by participant|18
2322820|NCT02979535|4038089|FG000|Overall Study|Lost to Follow-up|6
2322821|NCT02979535|4038090|FG001|Overall Study|Lost to Follow-up|1
2322822|NCT02979613|4038098|FG000|Double-Blind Phase|Withdrew Consent|2
2322823|NCT02979613|4038099|FG001|Double-Blind Phase|Withdrew Consent|4
2322824|NCT02979613|4038098|FG000|Double-Blind Phase|Pregnancy|2
2322825|NCT02979613|4038099|FG001|Double-Blind Phase|Pregnancy|2
2322826|NCT02979613|4038098|FG000|Double-Blind Phase|Adverse Event|2
2322827|NCT02979613|4038099|FG001|Double-Blind Phase|Adverse Event|0
2322828|NCT02979613|4038098|FG000|Double-Blind Phase|Lost to Follow-up|1
2322829|NCT02979613|4038099|FG001|Double-Blind Phase|Lost to Follow-up|1
2322830|NCT02979613|4038098|FG000|Double-Blind Phase|Protocol Violation|1
2322831|NCT02979613|4038099|FG001|Double-Blind Phase|Protocol Violation|1
2322832|NCT02979613|4038098|FG000|Double-Blind Phase|Randomized but Never Treated|2
2322833|NCT02979613|4038099|FG001|Double-Blind Phase|Randomized but Never Treated|0
2322834|NCT02979613|4038098|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2
2322835|NCT02979613|4038099|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4
2322836|NCT02979613|4038098|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1
2322837|NCT02979613|4038099|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
2030055|NCT00375609|3599537|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0
2030056|NCT00375609|3599538|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0
2030057|NCT00375674|3599548|FG000|Overall Study|Other|26
2030058|NCT00375674|3599549|FG001|Overall Study|Other|18
2030059|NCT00375674|3599548|FG000|Overall Study|Death|67
2030060|NCT00375674|3599549|FG001|Overall Study|Death|76
2030061|NCT00375674|3599548|FG000|Overall Study|Participants refused further follow-up|31
2030062|NCT00375674|3599549|FG001|Overall Study|Participants refused further follow-up|30
2030063|NCT00375674|3599548|FG000|Overall Study|Lost to Follow-up|17
2030064|NCT00375674|3599549|FG001|Overall Study|Lost to Follow-up|15
2030065|NCT00375674|3599548|FG000|Overall Study|Enrolled but not treated|3
2030066|NCT00375674|3599549|FG001|Overall Study|Enrolled but not treated|2
2030067|NCT00375752|3599566|FG000|Overall Study|Lack of Efficacy|4
2030068|NCT00375752|3599567|FG001|Overall Study|Lack of Efficacy|4
2030069|NCT00375752|3599566|FG000|Overall Study|Adverse Event|1
2030070|NCT00375752|3599567|FG001|Overall Study|Adverse Event|6
2030071|NCT00375752|3599566|FG000|Overall Study|Withdrawal by Subject|6
2030072|NCT00375752|3599567|FG001|Overall Study|Withdrawal by Subject|1
2030073|NCT00375752|3599566|FG000|Overall Study|Abnormal Laboratory Value(s)|1
2030074|NCT00375752|3599567|FG001|Overall Study|Abnormal Laboratory Value(s)|1
2030075|NCT00375752|3599566|FG000|Overall Study|Protocol Violation|0
2030076|NCT00375752|3599567|FG001|Overall Study|Protocol Violation|2
2030077|NCT00375752|3599566|FG000|Overall Study|Administrative Problems|0
2030078|NCT00375752|3599567|FG001|Overall Study|Administrative Problems|1
2030079|NCT00375934|3599600|FG000|Overall Study|Adverse Event|1
2030080|NCT00375934|3599601|FG001|Overall Study|Adverse Event|1
2030081|NCT00375934|3599600|FG000|Overall Study|Withdrawal by Subject|2
2030082|NCT00375934|3599601|FG001|Overall Study|Withdrawal by Subject|2
2030083|NCT00375934|3599600|FG000|Overall Study|Lack of Efficacy|0
2030084|NCT00375934|3599601|FG001|Overall Study|Lack of Efficacy|2
2030085|NCT00375934|3599600|FG000|Overall Study|Physician Decision|0
2030086|NCT00375934|3599601|FG001|Overall Study|Physician Decision|1
2030087|NCT00376168|3599622|FG000|Overall Study|Adverse Event|1
2030088|NCT00376168|3599623|FG001|Overall Study|Adverse Event|1
2030089|NCT00376168|3599622|FG000|Overall Study|Pregnancy|1
2030090|NCT00376168|3599623|FG001|Overall Study|Pregnancy|0
2030091|NCT00376220|3599631|FG000|Overall Study|Lost to Follow-up|7
2030092|NCT00376220|3599632|FG001|Overall Study|Lost to Follow-up|10
2030093|NCT00376220|3599631|FG000|Overall Study|Withdrawal by Subject|3
2030094|NCT00376220|3599632|FG001|Overall Study|Withdrawal by Subject|2
2030095|NCT00376246|3599638|FG000|First Intervention (2 Weeks)|Adverse Event|2
2030096|NCT00376246|3599639|FG001|First Intervention (2 Weeks)|Adverse Event|0
2030097|NCT00376246|3599638|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1
2030098|NCT00376246|3599639|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2
2030099|NCT00376246|3599638|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1
2030100|NCT00376246|3599639|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
2030101|NCT00376259|3599649|FG000|Overall Study|Sponsor request - study termination|21
2030102|NCT00376259|3599650|FG001|Overall Study|Sponsor request - study termination|21
2030103|NCT00376259|3599649|FG000|Overall Study|Patient request|1
2030104|NCT00376259|3599650|FG001|Overall Study|Patient request|0
2030105|NCT00376506|3599667|FG000|Overall Study|Death|0
2030106|NCT00376506|3599668|FG001|Overall Study|Death|2
2030107|NCT00376532|3599679|FG000|Overall Study|Lack sufficient blood sample|6
2030108|NCT00376532|3599680|FG001|Overall Study|Lack sufficient blood sample|6
2030109|NCT00376675|3599709|FG000|Overall Study|Withdrawal by Subject|9
2030110|NCT00376675|3599710|FG001|Overall Study|Withdrawal by Subject|2
2322838|NCT02979613|4038098|FG000|Open-Label Extension (OLE) Phase|Death|0
2322839|NCT02979613|4038099|FG001|Open-Label Extension (OLE) Phase|Death|1
2322840|NCT02979613|4038098|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0
2322841|NCT02979613|4038099|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1
2322842|NCT02979639|4038116|FG000|Overall Study|Withdrawal based on medical judgement|1
2322843|NCT02979639|4038116|FG000|Overall Study|Lost to Follow-up|8
2322844|NCT02979639|4038116|FG000|Overall Study|Withdrawal by Subject|3
2322845|NCT02979639|4038116|FG000|Overall Study|Adverse Event|2
2322846|NCT02980042|4038140|FG000|Overall Study|Lost to Follow-up|5
2322847|NCT02980042|4038141|FG001|Overall Study|Lost to Follow-up|0
2322848|NCT02980042|4038140|FG000|Overall Study|Insurance issues/treatment plan changes|2
2322849|NCT02980042|4038141|FG001|Overall Study|Insurance issues/treatment plan changes|0
2322850|NCT02980107|4038161|FG000|Overall Study|Withdrawal by Subject|51
2322851|NCT02980107|4038162|FG001|Overall Study|Withdrawal by Subject|62
2322852|NCT02980133|4038172|FG000|Overall Study|Other than specified|1
2322853|NCT02980133|4038173|FG001|Overall Study|Other than specified|1
2322854|NCT02980133|4038174|FG002|Overall Study|Other than specified|2
2322855|NCT02980133|4038175|FG003|Overall Study|Other than specified|2
2322856|NCT02980133|4038172|FG000|Overall Study|Lost to Follow-up|0
2322857|NCT02980133|4038173|FG001|Overall Study|Lost to Follow-up|0
2322858|NCT02980133|4038174|FG002|Overall Study|Lost to Follow-up|1
2322859|NCT02980133|4038175|FG003|Overall Study|Lost to Follow-up|3
2030111|NCT00376675|3599709|FG000|Overall Study|Adverse Event|10
2030112|NCT00376675|3599710|FG001|Overall Study|Adverse Event|5
2030113|NCT00376675|3599709|FG000|Overall Study|Other Reason|1
2030114|NCT00376675|3599710|FG001|Overall Study|Other Reason|7
2030115|NCT00376688|3599716|FG000|Overall Study|Adverse Event|3
2030116|NCT00376688|3599716|FG000|Overall Study|Death|1
2030117|NCT00376961|3599745|FG000|Initial Registration|Adverse Event|1
2030118|NCT00376961|3599746|FG001|Initial Registration|Adverse Event|0
2030119|NCT00376961|3599745|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2
2030120|NCT00376961|3599746|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
2030121|NCT00376961|3599745|FG000|Initial Registration|Progression/relapse|1
2030122|NCT00376961|3599746|FG001|Initial Registration|Progression/relapse|0
2030123|NCT00376961|3599745|FG000|Initial Registration|Ineligible|3
2030124|NCT00376961|3599746|FG001|Initial Registration|Ineligible|0
2030125|NCT00376961|3599745|FG000|Maintenance|Adverse Event|0
2030126|NCT00376961|3599746|FG001|Maintenance|Adverse Event|1
2030127|NCT00376961|3599745|FG000|Maintenance|Refusal Unrelated to Adverse Event|0
2030128|NCT00376961|3599746|FG001|Maintenance|Refusal Unrelated to Adverse Event|1
2030129|NCT00376961|3599745|FG000|Maintenance|Progression/relapse|0
2030130|NCT00376961|3599746|FG001|Maintenance|Progression/relapse|18
2030131|NCT00376961|3599745|FG000|Maintenance|Ineligible|0
2030132|NCT00376961|3599746|FG001|Maintenance|Ineligible|3
2030133|NCT00377156|3599756|FG000|Overall Study|Death|23
2030134|NCT00377156|3599757|FG001|Overall Study|Death|19
2030135|NCT00377156|3599756|FG000|Overall Study|Withdrawal by Subject|16
2030136|NCT00377156|3599757|FG001|Overall Study|Withdrawal by Subject|24
2030137|NCT00377156|3599756|FG000|Overall Study|Had follow-up <90 d|3
2030138|NCT00377156|3599757|FG001|Overall Study|Had follow-up <90 d|6
2217873|NCT01710358|3861199|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
2217874|NCT01710358|3861200|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
2217875|NCT01710358|3861198|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
2322860|NCT02980133|4038172|FG000|Overall Study|Protocol Violation|0
2322861|NCT02980133|4038173|FG001|Overall Study|Protocol Violation|1
2322862|NCT02980133|4038174|FG002|Overall Study|Protocol Violation|0
2322863|NCT02980133|4038175|FG003|Overall Study|Protocol Violation|0
2322864|NCT02980133|4038172|FG000|Overall Study|Withdrawal by parent/guardian|6
2322865|NCT02980133|4038173|FG001|Overall Study|Withdrawal by parent/guardian|3
2322866|NCT02980133|4038174|FG002|Overall Study|Withdrawal by parent/guardian|3
2322867|NCT02980133|4038175|FG003|Overall Study|Withdrawal by parent/guardian|1
2322868|NCT02980133|4038172|FG000|Overall Study|Withdrawal by Subject|0
2322869|NCT02980133|4038173|FG001|Overall Study|Withdrawal by Subject|0
2322870|NCT02980133|4038174|FG002|Overall Study|Withdrawal by Subject|1
2322871|NCT02980133|4038175|FG003|Overall Study|Withdrawal by Subject|0
2322872|NCT02980224|4038194|FG000|Overall Study|Adverse Event|4
2322873|NCT02980224|4038195|FG001|Overall Study|Adverse Event|1
2322874|NCT02980224|4038194|FG000|Overall Study|Withdrawal by Subject|0
2322875|NCT02980224|4038195|FG001|Overall Study|Withdrawal by Subject|2
2322876|NCT02980523|4038206|FG000|Overall Study|Lost to Follow-up|1
2322877|NCT02980523|4038207|FG001|Overall Study|Lost to Follow-up|4
2322878|NCT02980523|4038208|FG002|Overall Study|Lost to Follow-up|1
2322879|NCT02980523|4038209|FG003|Overall Study|Lost to Follow-up|2
2322880|NCT02980523|4038210|FG004|Overall Study|Lost to Follow-up|1
2322881|NCT02980523|4038206|FG000|Overall Study|Excluded from analysis|1
2322882|NCT02980523|4038207|FG001|Overall Study|Excluded from analysis|3
2322883|NCT02980523|4038208|FG002|Overall Study|Excluded from analysis|1
2322884|NCT02980523|4038209|FG003|Overall Study|Excluded from analysis|1
2322885|NCT02980523|4038210|FG004|Overall Study|Excluded from analysis|1
2322886|NCT02980523|4038206|FG000|Overall Study|Lack of Efficacy|1
2322887|NCT02980523|4038207|FG001|Overall Study|Lack of Efficacy|4
2322888|NCT02980523|4038208|FG002|Overall Study|Lack of Efficacy|4
2322889|NCT02980523|4038209|FG003|Overall Study|Lack of Efficacy|5
2322890|NCT02980523|4038210|FG004|Overall Study|Lack of Efficacy|8
2322891|NCT02980523|4038206|FG000|Overall Study|Did not receive intervention|0
2322892|NCT02980523|4038207|FG001|Overall Study|Did not receive intervention|0
2322893|NCT02980523|4038208|FG002|Overall Study|Did not receive intervention|0
2322894|NCT02980523|4038209|FG003|Overall Study|Did not receive intervention|1
2322895|NCT02980523|4038210|FG004|Overall Study|Did not receive intervention|0
2322896|NCT02980601|4038227|FG000|Overall Study|Lost to Follow-up|2
2322897|NCT02980601|4038228|FG001|Overall Study|Lost to Follow-up|2
2322898|NCT02980601|4038227|FG000|Overall Study|Death|0
2322899|NCT02980601|4038228|FG001|Overall Study|Death|1
2322900|NCT02980601|4038227|FG000|Overall Study|Graft loss|1
2322901|NCT02980601|4038228|FG001|Overall Study|Graft loss|0
2322902|NCT02980601|4038227|FG000|Overall Study|Failed to sign consent|2
2322903|NCT02980601|4038228|FG001|Overall Study|Failed to sign consent|0
2322904|NCT02980692|4038239|FG000|Overall Study|Adverse Event|0
2322905|NCT02980692|4038240|FG001|Overall Study|Adverse Event|2
2322906|NCT02980692|4038241|FG002|Overall Study|Adverse Event|0
2322907|NCT02980692|4038242|FG003|Overall Study|Adverse Event|0
2322908|NCT02980692|4038243|FG004|Overall Study|Adverse Event|1
2030139|NCT00377156|3599756|FG000|Overall Study|Cancellation|1
2030140|NCT00377156|3599757|FG001|Overall Study|Cancellation|0
2110252|NCT00893763|3704880|FG001|Overall Study|extubated|110
2030141|NCT00377156|3599756|FG000|Overall Study|Refused testing|0
2322909|NCT02980692|4038239|FG000|Overall Study|Withdrawal by Subject|4
2322910|NCT02980692|4038240|FG001|Overall Study|Withdrawal by Subject|3
2322911|NCT02980692|4038241|FG002|Overall Study|Withdrawal by Subject|6
2322912|NCT02980692|4038242|FG003|Overall Study|Withdrawal by Subject|6
2030142|NCT00377156|3599757|FG001|Overall Study|Refused testing|1
2030143|NCT00377156|3599756|FG000|Overall Study|Ineligible|0
2030144|NCT00377156|3599757|FG001|Overall Study|Ineligible|1
2030145|NCT00377156|3599756|FG000|Overall Study|Disability or language problem|0
2030146|NCT00377156|3599757|FG001|Overall Study|Disability or language problem|1
2030147|NCT00377156|3599756|FG000|Overall Study|Other|5
2030148|NCT00377156|3599757|FG001|Overall Study|Other|2
2030149|NCT00377234|3599767|FG000|Overall Study|Adverse Event|14
2030150|NCT00377234|3599768|FG001|Overall Study|Adverse Event|17
2030151|NCT00377234|3599767|FG000|Overall Study|Withdrawal by Subject|11
2030152|NCT00377234|3599768|FG001|Overall Study|Withdrawal by Subject|9
2030153|NCT00377234|3599767|FG000|Overall Study|Lost to Follow-up|4
2030154|NCT00377234|3599768|FG001|Overall Study|Lost to Follow-up|2
2030155|NCT00377234|3599767|FG000|Overall Study|Administrative|2
2030156|NCT00377234|3599768|FG001|Overall Study|Administrative|1
2030157|NCT00377234|3599767|FG000|Overall Study|Not assigned|3
2217876|NCT01710358|3861199|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
2217877|NCT01710358|3861200|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
2217878|NCT01710358|3861198|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
2217879|NCT01710358|3861199|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
2322913|NCT02980692|4038243|FG004|Overall Study|Withdrawal by Subject|7
2322914|NCT02980692|4038239|FG000|Overall Study|Lost to Follow-up|3
2322915|NCT02980692|4038240|FG001|Overall Study|Lost to Follow-up|0
2322916|NCT02980692|4038241|FG002|Overall Study|Lost to Follow-up|4
2322917|NCT02980692|4038242|FG003|Overall Study|Lost to Follow-up|1
2322918|NCT02980692|4038243|FG004|Overall Study|Lost to Follow-up|1
2322919|NCT02980692|4038239|FG000|Overall Study|Death|1
2322920|NCT02980692|4038240|FG001|Overall Study|Death|0
2322921|NCT02980692|4038241|FG002|Overall Study|Death|0
2322922|NCT02980692|4038242|FG003|Overall Study|Death|0
2322923|NCT02980692|4038243|FG004|Overall Study|Death|0
2322924|NCT02980692|4038239|FG000|Overall Study|Physician Decision|0
2322925|NCT02980692|4038240|FG001|Overall Study|Physician Decision|0
2322926|NCT02980692|4038241|FG002|Overall Study|Physician Decision|1
2322927|NCT02980692|4038242|FG003|Overall Study|Physician Decision|1
2322928|NCT02980692|4038243|FG004|Overall Study|Physician Decision|0
2322929|NCT02980692|4038239|FG000|Overall Study|NON COMPLIANCE|1
2322930|NCT02980692|4038240|FG001|Overall Study|NON COMPLIANCE|0
2322931|NCT02980692|4038241|FG002|Overall Study|NON COMPLIANCE|0
2322932|NCT02980692|4038242|FG003|Overall Study|NON COMPLIANCE|0
2322933|NCT02980692|4038243|FG004|Overall Study|NON COMPLIANCE|0
2322934|NCT02980692|4038239|FG000|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
2322935|NCT02980692|4038240|FG001|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|1
2322936|NCT02980692|4038241|FG002|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
2322937|NCT02980692|4038242|FG003|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
2322938|NCT02980692|4038243|FG004|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
2322939|NCT02980692|4038239|FG000|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
2322940|NCT02980692|4038240|FG001|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
2322941|NCT02980692|4038241|FG002|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|1
2322942|NCT02980692|4038242|FG003|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
2030158|NCT00377234|3599768|FG001|Overall Study|Not assigned|2
2030159|NCT00377260|3599782|FG000|Overall Study|Lost to Follow-up|0
2030160|NCT00377260|3599783|FG001|Overall Study|Lost to Follow-up|1
2030161|NCT00377260|3599782|FG000|Overall Study|Withdrawal by Subject|2
2030162|NCT00377260|3599783|FG001|Overall Study|Withdrawal by Subject|4
2030163|NCT00377299|3599791|FG000|Overall Study|Lost to Follow-up|14
2030164|NCT00377299|3599792|FG001|Overall Study|Lost to Follow-up|19
2030165|NCT00377299|3599791|FG000|Overall Study|Adverse Event|0
2030166|NCT00377299|3599792|FG001|Overall Study|Adverse Event|1
2030167|NCT00377299|3599791|FG000|Overall Study|Withdrawal by Subject|5
2030168|NCT00377299|3599792|FG001|Overall Study|Withdrawal by Subject|4
2030169|NCT00377312|3599801|FG000|Overall Study|Adverse Event|1
2030170|NCT00377312|3599802|FG001|Overall Study|Adverse Event|1
2030171|NCT00377364|3599810|FG000|Overall Study|Lost to Follow-up|1
2030172|NCT00377364|3599811|FG001|Overall Study|Lost to Follow-up|0
2030173|NCT00377364|3599810|FG000|Overall Study|Withdrawal by Subject|1
2030174|NCT00377364|3599811|FG001|Overall Study|Withdrawal by Subject|0
2322943|NCT02980692|4038243|FG004|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
2322944|NCT02980692|4038239|FG000|Overall Study|Lack of Efficacy|0
2322945|NCT02980692|4038240|FG001|Overall Study|Lack of Efficacy|0
2322946|NCT02980692|4038241|FG002|Overall Study|Lack of Efficacy|0
2322947|NCT02980692|4038242|FG003|Overall Study|Lack of Efficacy|1
2322948|NCT02980692|4038243|FG004|Overall Study|Lack of Efficacy|0
2322949|NCT02980692|4038239|FG000|Overall Study|RELOCATION|0
2322950|NCT02980692|4038240|FG001|Overall Study|RELOCATION|0
2322951|NCT02980692|4038241|FG002|Overall Study|RELOCATION|0
2322952|NCT02980692|4038242|FG003|Overall Study|RELOCATION|0
2322953|NCT02980692|4038243|FG004|Overall Study|RELOCATION|1
2322954|NCT02980692|4038239|FG000|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
2322955|NCT02980692|4038240|FG001|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
2322956|NCT02980692|4038241|FG002|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
2322957|NCT02980692|4038242|FG003|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
2322958|NCT02980692|4038243|FG004|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|1
2322959|NCT02980705|4038258|FG000|Overall Study|Adverse Event|0
2322960|NCT02980705|4038259|FG001|Overall Study|Adverse Event|1
2322961|NCT02980705|4038258|FG000|Overall Study|Withdrawal by Subject|6
2322962|NCT02980705|4038259|FG001|Overall Study|Withdrawal by Subject|9
2322963|NCT02980705|4038258|FG000|Overall Study|withdrew participation|0
2322964|NCT02980705|4038259|FG001|Overall Study|withdrew participation|1
2322965|NCT02980705|4038258|FG000|Overall Study|Lost to Follow-up|2
2322966|NCT02980705|4038259|FG001|Overall Study|Lost to Follow-up|0
2322967|NCT02980783|4038266|FG000|Overall Study|Lost to Follow-up|1
2322968|NCT02980874|4038272|FG000|Overall Study|Adverse Event|2
2322969|NCT02980874|4038273|FG001|Overall Study|Adverse Event|7
2322970|NCT02980874|4038272|FG000|Overall Study|Withdrawal by Subject|7
2322971|NCT02980874|4038273|FG001|Overall Study|Withdrawal by Subject|2
2322972|NCT02980874|4038272|FG000|Overall Study|Lost to Follow-up|5
2322973|NCT02980874|4038273|FG001|Overall Study|Lost to Follow-up|5
2322974|NCT02980874|4038272|FG000|Overall Study|Includes premature discontinuation due to study termination.|88
2322975|NCT02980874|4038273|FG001|Overall Study|Includes premature discontinuation due to study termination.|88
2322976|NCT02980874|4038272|FG000|Overall Study|Unknown study completion status|1
2322977|NCT02980874|4038273|FG001|Overall Study|Unknown study completion status|0
2322978|NCT02981342|4038292|FG000|Overall Study|Adverse Event|0
2322979|NCT02981342|4038293|FG001|Overall Study|Adverse Event|0
2322980|NCT02981342|4038294|FG002|Overall Study|Adverse Event|0
2322981|NCT02981342|4038295|FG003|Overall Study|Adverse Event|1
2322982|NCT02981342|4038292|FG000|Overall Study|Death|0
2322983|NCT02981342|4038293|FG001|Overall Study|Death|9
2322984|NCT02981342|4038294|FG002|Overall Study|Death|9
2322985|NCT02981342|4038295|FG003|Overall Study|Death|4
2322986|NCT02981342|4038292|FG000|Overall Study|Withdrawal by Subject|0
2322987|NCT02981342|4038293|FG001|Overall Study|Withdrawal by Subject|0
2322988|NCT02981342|4038294|FG002|Overall Study|Withdrawal by Subject|3
2322989|NCT02981342|4038295|FG003|Overall Study|Withdrawal by Subject|1
2322990|NCT02981342|4038292|FG000|Overall Study|Study closed by sponsor|0
2322991|NCT02981342|4038293|FG001|Overall Study|Study closed by sponsor|0
2322992|NCT02981342|4038294|FG002|Overall Study|Study closed by sponsor|1
2322993|NCT02981342|4038295|FG003|Overall Study|Study closed by sponsor|1
2322994|NCT02981342|4038292|FG000|Overall Study|Randomized, Never Treated|0
2322995|NCT02981342|4038293|FG001|Overall Study|Randomized, Never Treated|1
2322996|NCT02981342|4038294|FG002|Overall Study|Randomized, Never Treated|0
2322997|NCT02981342|4038295|FG003|Overall Study|Randomized, Never Treated|7
2322998|NCT02981342|4038292|FG000|Overall Study|Lost to Follow-up|0
2322999|NCT02981342|4038293|FG001|Overall Study|Lost to Follow-up|1
2323000|NCT02981342|4038294|FG002|Overall Study|Lost to Follow-up|0
2323001|NCT02981342|4038295|FG003|Overall Study|Lost to Follow-up|0
2323002|NCT02981524|4038343|FG000|Overall Study|Progressive Disease|14
2323003|NCT02981524|4038343|FG000|Overall Study|Death (unrelated)|1
2323004|NCT02981524|4038343|FG000|Overall Study|Treatment Related Toxicity|1
2323005|NCT02981524|4038343|FG000|Overall Study|Withdrawal by Subject|1
2323006|NCT02981602|4038352|FG000|Overall Study|Adverse Event|0
2323007|NCT02981602|4038353|FG001|Overall Study|Adverse Event|0
2323008|NCT02981602|4038354|FG002|Overall Study|Adverse Event|0
2323009|NCT02981602|4038355|FG003|Overall Study|Adverse Event|1
2323010|NCT02981602|4038356|FG004|Overall Study|Adverse Event|0
2323011|NCT02981953|4038369|FG000|Overall Study|Death|9
2323012|NCT02981953|4038369|FG000|Overall Study|Withdrawal by Subject|1
2323013|NCT02981953|4038369|FG000|Overall Study|Withdrawal to non-compliance|1
2323014|NCT02982018|4038375|FG000|Overall Study|Incorrect Lens Dispensed|1
2323015|NCT02982018|4038376|FG001|Overall Study|Incorrect Lens Dispensed|0
2323016|NCT02982018|4038375|FG000|Overall Study|Protocol Violation|1
2030175|NCT00377403|3599821|FG000|Overall Study|Unable to contact for telephone intervie|4
2030176|NCT00377403|3599822|FG001|Overall Study|Unable to contact for telephone intervie|7
2030177|NCT00377429|3599828|FG000|Overall Study|Withdrawal by Subject|5
2030178|NCT00377429|3599828|FG000|Overall Study|Adverse Event|8
2030179|NCT00377429|3599828|FG000|Overall Study|Physician Decision|1
2030180|NCT00377429|3599828|FG000|Overall Study|Patient non-compliance|1
2030181|NCT00377520|3599832|FG000|Overall Study|Ineligible (Prior radiation)|1
2030182|NCT00377611|3599847|FG000|Overall Study|Adverse Event|2
2030183|NCT00377611|3599848|FG001|Overall Study|Adverse Event|9
2030184|NCT00377611|3599847|FG000|Overall Study|Protocol Violation|2
2030185|NCT00377611|3599848|FG001|Overall Study|Protocol Violation|0
2217880|NCT01710358|3861200|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
2217881|NCT01710358|3861198|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
2323017|NCT02982018|4038376|FG001|Overall Study|Protocol Violation|1
2323018|NCT02982018|4038375|FG000|Overall Study|Adverse Event|1
2323019|NCT02982018|4038376|FG001|Overall Study|Adverse Event|1
2323020|NCT02982018|4038375|FG000|Overall Study|Lens Discomfort|2
2323021|NCT02982018|4038376|FG001|Overall Study|Lens Discomfort|0
2323022|NCT02982018|4038375|FG000|Overall Study|Withdrawal by Subject|0
2323023|NCT02982018|4038376|FG001|Overall Study|Withdrawal by Subject|1
2323024|NCT02982187|4038384|FG000|Overall Study|Withdrawal by Subject|0
2323025|NCT02982187|4038385|FG001|Overall Study|Withdrawal by Subject|0
2323026|NCT02982187|4038386|FG002|Overall Study|Withdrawal by Subject|0
2323027|NCT02982187|4038387|FG003|Overall Study|Withdrawal by Subject|0
2323028|NCT02982187|4038388|FG004|Overall Study|Withdrawal by Subject|0
2323029|NCT02982187|4038389|FG005|Overall Study|Withdrawal by Subject|0
2323030|NCT02982187|4038390|FG006|Overall Study|Withdrawal by Subject|1
2323031|NCT02982187|4038391|FG007|Overall Study|Withdrawal by Subject|0
2323032|NCT02982213|4038403|FG000|Overall Study|Did not complete follow up questionnaire|5
2323033|NCT02982213|4038404|FG001|Overall Study|Did not complete follow up questionnaire|1
2323034|NCT02982239|4038412|FG000|Overall Study|Lost to Follow-up|3
2323035|NCT02982239|4038413|FG001|Overall Study|Lost to Follow-up|2
2323036|NCT02982590|4038422|FG000|Overall Study|Lost to Follow-up|0
2323037|NCT02982590|4038423|FG001|Overall Study|Lost to Follow-up|1
2323038|NCT02982590|4038422|FG000|Overall Study|Death|4
2323039|NCT02982590|4038423|FG001|Overall Study|Death|0
2323040|NCT02982772|4038431|FG000|Intervention|Lost to Follow-up|19
2323041|NCT02982772|4038432|FG001|Intervention|Lost to Follow-up|13
2323042|NCT02982772|4038431|FG000|1M Follow-Up|Lost to Follow-up|21
2323043|NCT02982772|4038432|FG001|1M Follow-Up|Lost to Follow-up|18
2323044|NCT02982772|4038431|FG000|3M Follow-Up|Lost to Follow-up|17
2323045|NCT02982772|4038432|FG001|3M Follow-Up|Lost to Follow-up|11
2323046|NCT02982772|4038431|FG000|6M Follow-Up|Lost to Follow-up|11
2323047|NCT02982772|4038432|FG001|6M Follow-Up|Lost to Follow-up|9
2323048|NCT02982772|4038431|FG000|12M Follow-Up|Lost to Follow-up|11
2323049|NCT02982772|4038432|FG001|12M Follow-Up|Lost to Follow-up|5
2323050|NCT02982863|4038445|FG000|Overall Study|Not eligible patients|809
2323051|NCT02982863|4038446|FG001|Overall Study|Not eligible patients|4261
2323052|NCT02982863|4038447|FG002|Overall Study|Not eligible patients|1852
2323053|NCT02982863|4038448|FG003|Overall Study|Not eligible patients|1400
2323054|NCT02982863|4038449|FG004|Overall Study|Not eligible patients|492
2323055|NCT02982954|4038473|FG000|Treatment Period|Disease progression|62
2323056|NCT02982954|4038474|FG001|Treatment Period|Disease progression|26
2323057|NCT02982954|4038475|FG002|Treatment Period|Disease progression|12
2323058|NCT02982954|4038476|FG003|Treatment Period|Disease progression|10
2323059|NCT02982954|4038473|FG000|Treatment Period|study drug toxicity|20
2323060|NCT02982954|4038474|FG001|Treatment Period|study drug toxicity|10
2323061|NCT02982954|4038475|FG002|Treatment Period|study drug toxicity|8
2323062|NCT02982954|4038476|FG003|Treatment Period|study drug toxicity|0
2323063|NCT02982954|4038473|FG000|Treatment Period|Death|1
2323064|NCT02982954|4038474|FG001|Treatment Period|Death|3
2217882|NCT01710358|3861199|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
2217883|NCT01710358|3861200|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
2217884|NCT01710358|3861198|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
2217885|NCT01710358|3861199|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
2217886|NCT01710358|3861200|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
2217887|NCT01710358|3861198|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
2217888|NCT01710358|3861199|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
2217889|NCT01710358|3861200|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
2217890|NCT01710358|3861198|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
2217891|NCT01710358|3861199|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
2323065|NCT02982954|4038475|FG002|Treatment Period|Death|2
2323066|NCT02982954|4038476|FG003|Treatment Period|Death|4
2323067|NCT02982954|4038473|FG000|Treatment Period|Adverse events unrelated to study drug|4
2323068|NCT02982954|4038474|FG001|Treatment Period|Adverse events unrelated to study drug|1
2323069|NCT02982954|4038475|FG002|Treatment Period|Adverse events unrelated to study drug|1
2323070|NCT02982954|4038476|FG003|Treatment Period|Adverse events unrelated to study drug|3
2323071|NCT02982954|4038473|FG000|Treatment Period|participant request to discontinue|2
2323072|NCT02982954|4038474|FG001|Treatment Period|participant request to discontinue|2
2030186|NCT00377611|3599847|FG000|Overall Study|Withdrawal by Subject|0
2030187|NCT00377611|3599848|FG001|Overall Study|Withdrawal by Subject|5
2030188|NCT00377611|3599847|FG000|Overall Study|Lost to Follow-up|18
2030189|NCT00377611|3599848|FG001|Overall Study|Lost to Follow-up|16
2030190|NCT00377611|3599847|FG000|Overall Study|Other|0
2030191|NCT00377611|3599848|FG001|Overall Study|Other|3
2030192|NCT00377637|3599859|FG000|Induction Phase|Adverse Event|12
2030193|NCT00377637|3599860|FG001|Induction Phase|Adverse Event|21
2030194|NCT00377637|3599861|FG002|Induction Phase|Adverse Event|0
2030195|NCT00377637|3599862|FG003|Induction Phase|Adverse Event|0
2030196|NCT00377637|3599859|FG000|Induction Phase|Deterioration/serum creatinine|2
2030197|NCT00377637|3599860|FG001|Induction Phase|Deterioration/serum creatinine|0
2030198|NCT00377637|3599861|FG002|Induction Phase|Deterioration/serum creatinine|0
2030199|NCT00377637|3599862|FG003|Induction Phase|Deterioration/serum creatinine|0
2030200|NCT00377637|3599859|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
2030201|NCT00377637|3599860|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
2030202|NCT00377637|3599861|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
2217892|NCT01710358|3861200|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
2217893|NCT01710358|3861198|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
2323073|NCT02982954|4038475|FG002|Treatment Period|participant request to discontinue|1
2323074|NCT02982954|4038476|FG003|Treatment Period|participant request to discontinue|2
2323075|NCT02982954|4038473|FG000|Treatment Period|participant withdrew consent|1
2323076|NCT02982954|4038474|FG001|Treatment Period|participant withdrew consent|1
2323077|NCT02982954|4038475|FG002|Treatment Period|participant withdrew consent|0
2323078|NCT02982954|4038476|FG003|Treatment Period|participant withdrew consent|1
2323079|NCT02982954|4038473|FG000|Treatment Period|maximum clinical benefit|1
2323080|NCT02982954|4038474|FG001|Treatment Period|maximum clinical benefit|0
2323081|NCT02982954|4038475|FG002|Treatment Period|maximum clinical benefit|0
2323082|NCT02982954|4038476|FG003|Treatment Period|maximum clinical benefit|0
2323083|NCT02982954|4038473|FG000|Treatment Period|no longer meets study criteria|0
2323084|NCT02982954|4038474|FG001|Treatment Period|no longer meets study criteria|1
2323085|NCT02982954|4038475|FG002|Treatment Period|no longer meets study criteria|0
2323086|NCT02982954|4038476|FG003|Treatment Period|no longer meets study criteria|0
2323087|NCT02982954|4038473|FG000|Treatment Period|Admin reason by sponsor|3
2323088|NCT02982954|4038474|FG001|Treatment Period|Admin reason by sponsor|0
2323089|NCT02982954|4038475|FG002|Treatment Period|Admin reason by sponsor|0
2323090|NCT02982954|4038476|FG003|Treatment Period|Admin reason by sponsor|0
2323091|NCT02982954|4038473|FG000|Treatment Period|other reasons|12
2323092|NCT02982954|4038474|FG001|Treatment Period|other reasons|8
2323093|NCT02982954|4038475|FG002|Treatment Period|other reasons|4
2323094|NCT02982954|4038476|FG003|Treatment Period|other reasons|5
2323095|NCT02982954|4038473|FG000|Continuing in Study|Death|44
2323096|NCT02982954|4038474|FG001|Continuing in Study|Death|27
2323097|NCT02982954|4038475|FG002|Continuing in Study|Death|10
2323098|NCT02982954|4038476|FG003|Continuing in Study|Death|17
2323099|NCT02982954|4038473|FG000|Continuing in Study|participant withdrew consent|9
2323100|NCT02982954|4038474|FG001|Continuing in Study|participant withdrew consent|5
2323101|NCT02982954|4038475|FG002|Continuing in Study|participant withdrew consent|1
2323102|NCT02982954|4038476|FG003|Continuing in Study|participant withdrew consent|1
2323103|NCT02982954|4038473|FG000|Continuing in Study|Lost to Follow-up|1
2323104|NCT02982954|4038474|FG001|Continuing in Study|Lost to Follow-up|0
2323105|NCT02982954|4038475|FG002|Continuing in Study|Lost to Follow-up|0
2323106|NCT02982954|4038476|FG003|Continuing in Study|Lost to Follow-up|0
2323107|NCT02982954|4038473|FG000|Continuing in Study|other reasons|0
2323108|NCT02982954|4038474|FG001|Continuing in Study|other reasons|1
2323109|NCT02982954|4038475|FG002|Continuing in Study|other reasons|0
2323110|NCT02982954|4038476|FG003|Continuing in Study|other reasons|0
2323111|NCT02983227|4038497|FG000|Overall Study|Adverse Event|21
2323112|NCT02983227|4038498|FG001|Overall Study|Adverse Event|3
2323113|NCT02983227|4038497|FG000|Overall Study|Death|3
2323114|NCT02983227|4038498|FG001|Overall Study|Death|0
2323115|NCT02983227|4038497|FG000|Overall Study|Lack of Efficacy|8
2323116|NCT02983227|4038498|FG001|Overall Study|Lack of Efficacy|1
2323117|NCT02983227|4038497|FG000|Overall Study|Lost to Follow-up|3
2323118|NCT02983227|4038498|FG001|Overall Study|Lost to Follow-up|0
2323119|NCT02983227|4038497|FG000|Overall Study|Multiple Reasons|2
2323120|NCT02983227|4038498|FG001|Overall Study|Multiple Reasons|1
2323121|NCT02983227|4038497|FG000|Overall Study|Physician Decision|3
2323122|NCT02983227|4038498|FG001|Overall Study|Physician Decision|1
2323123|NCT02983227|4038497|FG000|Overall Study|Withdrawal by Subject|19
2323124|NCT02983227|4038498|FG001|Overall Study|Withdrawal by Subject|8
2323125|NCT02983305|4038506|FG000|Overall Study|incomplete data|2
2323126|NCT02983305|4038507|FG001|Overall Study|incomplete data|0
2323127|NCT02983604|4038547|FG000|Overall Study|Enrolled but not Treated|0
2323128|NCT02983604|4038548|FG001|Overall Study|Enrolled but not Treated|0
2323129|NCT02983604|4038549|FG002|Overall Study|Enrolled but not Treated|1
2323130|NCT02983604|4038550|FG003|Overall Study|Enrolled but not Treated|0
2323131|NCT02984267|4038575|FG000|Overall Study|Protocol Violation|1
2323132|NCT02984267|4038576|FG001|Overall Study|Protocol Violation|0
2323133|NCT02984267|4038575|FG000|Overall Study|Withdrawal by Subject|0
2323134|NCT02984267|4038576|FG001|Overall Study|Withdrawal by Subject|1
2030203|NCT00377637|3599862|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
2030204|NCT00377637|3599859|FG000|Induction Phase|Lost to Follow-up|2
2030205|NCT00377637|3599860|FG001|Induction Phase|Lost to Follow-up|1
2030206|NCT00377637|3599861|FG002|Induction Phase|Lost to Follow-up|0
2030207|NCT00377637|3599862|FG003|Induction Phase|Lost to Follow-up|0
2030208|NCT00377637|3599859|FG000|Induction Phase|Death|1
2030209|NCT00377637|3599860|FG001|Induction Phase|Death|3
2030210|NCT00377637|3599861|FG002|Induction Phase|Death|0
2030211|NCT00377637|3599862|FG003|Induction Phase|Death|0
2030212|NCT00377637|3599859|FG000|Induction Phase|Withdrawal by Subject|5
2030213|NCT00377637|3599860|FG001|Induction Phase|Withdrawal by Subject|6
2030214|NCT00377637|3599861|FG002|Induction Phase|Withdrawal by Subject|0
2030215|NCT00377637|3599862|FG003|Induction Phase|Withdrawal by Subject|0
2030216|NCT00377637|3599859|FG000|Induction Phase|Physician Decision|3
2030217|NCT00377637|3599860|FG001|Induction Phase|Physician Decision|1
2030218|NCT00377637|3599861|FG002|Induction Phase|Physician Decision|0
2030219|NCT00377637|3599862|FG003|Induction Phase|Physician Decision|0
2030220|NCT00377637|3599859|FG000|Induction Phase|Sponsor decision|1
2030221|NCT00377637|3599860|FG001|Induction Phase|Sponsor decision|2
2030222|NCT00377637|3599861|FG002|Induction Phase|Sponsor decision|0
2030223|NCT00377637|3599862|FG003|Induction Phase|Sponsor decision|0
2030224|NCT00377637|3599859|FG000|Induction Phase|Non-Compliance|1
2030225|NCT00377637|3599860|FG001|Induction Phase|Non-Compliance|0
2030226|NCT00377637|3599861|FG002|Induction Phase|Non-Compliance|0
2030227|NCT00377637|3599862|FG003|Induction Phase|Non-Compliance|0
2217894|NCT01710358|3861199|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
2217895|NCT01710358|3861200|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
2323135|NCT02984683|4038614|FG000|Overall Study|Adverse Event|3
2323136|NCT02984683|4038615|FG001|Overall Study|Adverse Event|3
2323137|NCT02984683|4038614|FG000|Overall Study|Withdrawal by Subject|1
2323138|NCT02984683|4038615|FG001|Overall Study|Withdrawal by Subject|0
2323139|NCT02984683|4038614|FG000|Overall Study|Disease progression|7
2323140|NCT02984683|4038615|FG001|Overall Study|Disease progression|9
2323141|NCT02984943|4038644|FG000|Overall Study|Withdrawal by Subject|3
2323142|NCT02984943|4038644|FG000|Overall Study|Physician Decision|1
2323143|NCT02984982|4038650|FG000|Overall Study|Adverse Event|2
2323144|NCT02984982|4038651|FG001|Overall Study|Adverse Event|5
2323145|NCT02984982|4038650|FG000|Overall Study|Poor Compliance to Protocol|4
2323146|NCT02984982|4038651|FG001|Overall Study|Poor Compliance to Protocol|4
2323147|NCT02984982|4038650|FG000|Overall Study|Withdrawal by Subject|2
2323148|NCT02984982|4038651|FG001|Overall Study|Withdrawal by Subject|0
2323149|NCT02984982|4038650|FG000|Overall Study|Randomized but not treated|0
2323150|NCT02984982|4038651|FG001|Overall Study|Randomized but not treated|1
2323151|NCT02984995|4038660|FG000|Overall Study|Required stem cell transplant|13
2323152|NCT02984995|4038661|FG001|Overall Study|Required stem cell transplant|2
2323153|NCT02984995|4038660|FG000|Overall Study|Progressive disease|11
2323154|NCT02984995|4038661|FG001|Overall Study|Progressive disease|1
2323155|NCT02984995|4038660|FG000|Overall Study|Adverse Event|1
2323156|NCT02984995|4038661|FG001|Overall Study|Adverse Event|0
2323157|NCT02985021|4038673|FG000|Overall Study|Inability to comply with study procedures|1
2217896|NCT01710358|3861198|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1
2217897|NCT01710358|3861199|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0
2030228|NCT00377637|3599859|FG000|Induction Phase|Reason for withdrawal is not noted|2
2030229|NCT00377637|3599860|FG001|Induction Phase|Reason for withdrawal is not noted|0
2217898|NCT01710358|3861200|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1
2217899|NCT01710358|3861198|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
2217900|NCT01710358|3861199|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
2217901|NCT01710358|3861200|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
2217902|NCT01710358|3861198|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
2217903|NCT01710358|3861199|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
2217904|NCT01710358|3861200|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
2217905|NCT01710358|3861198|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
2217906|NCT01710358|3861199|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
2323158|NCT02985398|4038677|FG000|Overall Study|Adverse Event|1
2323159|NCT02985398|4038677|FG000|Overall Study|Lost to Follow-up|4
2323160|NCT02985398|4038677|FG000|Overall Study|Withdrawal by Subject|8
2030230|NCT00377637|3599861|FG002|Induction Phase|Reason for withdrawal is not noted|0
2030231|NCT00377637|3599862|FG003|Induction Phase|Reason for withdrawal is not noted|0
2030232|NCT00377637|3599859|FG000|Maintenance Phase|Adverse Event|0
2030233|NCT00377637|3599860|FG001|Maintenance Phase|Adverse Event|0
2030234|NCT00377637|3599861|FG002|Maintenance Phase|Adverse Event|29
2030235|NCT00377637|3599862|FG003|Maintenance Phase|Adverse Event|43
2030236|NCT00377637|3599859|FG000|Maintenance Phase|Physician Decision|0
2030237|NCT00377637|3599860|FG001|Maintenance Phase|Physician Decision|0
2030238|NCT00377637|3599861|FG002|Maintenance Phase|Physician Decision|5
2030239|NCT00377637|3599862|FG003|Maintenance Phase|Physician Decision|4
2030240|NCT00377637|3599859|FG000|Maintenance Phase|Lost to Follow-up|0
2030241|NCT00377637|3599860|FG001|Maintenance Phase|Lost to Follow-up|0
2030242|NCT00377637|3599861|FG002|Maintenance Phase|Lost to Follow-up|3
2030243|NCT00377637|3599862|FG003|Maintenance Phase|Lost to Follow-up|1
2030244|NCT00377637|3599859|FG000|Maintenance Phase|Withdrawal by Subject|0
2030245|NCT00377637|3599860|FG001|Maintenance Phase|Withdrawal by Subject|0
2030246|NCT00377637|3599861|FG002|Maintenance Phase|Withdrawal by Subject|3
2217907|NCT01710358|3861200|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
2217908|NCT01710358|3861198|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
2217909|NCT01710358|3861199|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
2217910|NCT01710358|3861200|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
2217911|NCT01710358|3861198|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
2217912|NCT01710358|3861199|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
2217913|NCT01710358|3861200|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
2217914|NCT01710358|3861198|FG000|Rescue Period|Adverse Event|0
2217915|NCT01710358|3861199|FG001|Rescue Period|Adverse Event|15
2217916|NCT01710358|3861200|FG002|Rescue Period|Adverse Event|0
2217917|NCT01710358|3861198|FG000|Rescue Period|Death|0
2217918|NCT01710358|3861199|FG001|Rescue Period|Death|1
2217919|NCT01710358|3861200|FG002|Rescue Period|Death|0
2217920|NCT01710358|3861198|FG000|Rescue Period|Lack of Efficacy|0
2217921|NCT01710358|3861199|FG001|Rescue Period|Lack of Efficacy|7
2217922|NCT01710358|3861200|FG002|Rescue Period|Lack of Efficacy|0
2217923|NCT01710358|3861198|FG000|Rescue Period|Withdrawal by Subject|0
2217924|NCT01710358|3861199|FG001|Rescue Period|Withdrawal by Subject|8
2217925|NCT01710358|3861200|FG002|Rescue Period|Withdrawal by Subject|0
2217926|NCT01710501|3861224|FG000|Overall Study|Lost to Follow-up|2
2217927|NCT01710501|3861225|FG001|Overall Study|Lost to Follow-up|0
2217928|NCT01710501|3861226|FG002|Overall Study|Lost to Follow-up|0
2217929|NCT01710514|3861236|FG000|Overall Study|Adverse Event|6
2217930|NCT01710514|3861237|FG001|Overall Study|Adverse Event|7
2217931|NCT01710514|3861236|FG000|Overall Study|Withdrawal by Subject|1
2217932|NCT01710514|3861237|FG001|Overall Study|Withdrawal by Subject|0
2217933|NCT01710527|3861246|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0
2217934|NCT01710527|3861247|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1
2217935|NCT01710657|3861256|FG000|Overall Study|Lost to Follow-up|2
2217936|NCT01710657|3861257|FG001|Overall Study|Lost to Follow-up|0
2217937|NCT01710657|3861258|FG002|Overall Study|Lost to Follow-up|1
2323161|NCT02985398|4038677|FG000|Overall Study|Study Burden|9
2323162|NCT02985450|4038681|FG000|Overall Study|Lost to Follow-up|7
2323163|NCT02985879|4038709|FG000|Overall Study|Adverse Event|7
2323164|NCT02985879|4038710|FG001|Overall Study|Adverse Event|9
2323165|NCT02985879|4038711|FG002|Overall Study|Adverse Event|7
2323166|NCT02985879|4038709|FG000|Overall Study|Withdrew consent|6
2323167|NCT02985879|4038710|FG001|Overall Study|Withdrew consent|8
2323168|NCT02985879|4038711|FG002|Overall Study|Withdrew consent|10
2323169|NCT02985879|4038709|FG000|Overall Study|Lost to Follow-up|1
2323170|NCT02985879|4038710|FG001|Overall Study|Lost to Follow-up|0
2323171|NCT02985879|4038711|FG002|Overall Study|Lost to Follow-up|2
2323172|NCT02985879|4038709|FG000|Overall Study|Other, not specified|62
2323173|NCT02985879|4038710|FG001|Overall Study|Other, not specified|58
2323174|NCT02985879|4038711|FG002|Overall Study|Other, not specified|58
2323175|NCT02985996|4038730|FG000|Overall Study|Withdrawal by Subject|0
2217938|NCT01710657|3861256|FG000|Overall Study|Protocol Violation|2
2217939|NCT01710657|3861257|FG001|Overall Study|Protocol Violation|2
2217940|NCT01710657|3861258|FG002|Overall Study|Protocol Violation|0
2217941|NCT01710657|3861256|FG000|Overall Study|Adverse Event|14
2217942|NCT01710657|3861257|FG001|Overall Study|Adverse Event|8
2323176|NCT02985996|4038731|FG001|Overall Study|Withdrawal by Subject|0
2030247|NCT00377637|3599862|FG003|Maintenance Phase|Withdrawal by Subject|3
2030248|NCT00377637|3599859|FG000|Maintenance Phase|Sponsor decision|0
2030249|NCT00377637|3599860|FG001|Maintenance Phase|Sponsor decision|0
2030250|NCT00377637|3599861|FG002|Maintenance Phase|Sponsor decision|2
2030251|NCT00377637|3599862|FG003|Maintenance Phase|Sponsor decision|3
2030252|NCT00377637|3599859|FG000|Maintenance Phase|Non-compliance|0
2030253|NCT00377637|3599860|FG001|Maintenance Phase|Non-compliance|0
2030254|NCT00377637|3599861|FG002|Maintenance Phase|Non-compliance|1
2030255|NCT00377637|3599862|FG003|Maintenance Phase|Non-compliance|1
2030256|NCT00377637|3599859|FG000|Maintenance Phase|Study medication stopped > 14 days|0
2030257|NCT00377637|3599860|FG001|Maintenance Phase|Study medication stopped > 14 days|0
2323177|NCT02985996|4038732|FG002|Overall Study|Withdrawal by Subject|1
2323178|NCT02985996|4038733|FG003|Overall Study|Withdrawal by Subject|0
2323179|NCT02985996|4038734|FG004|Overall Study|Withdrawal by Subject|0
2323180|NCT02985996|4038730|FG000|Overall Study|Protocol Violation|0
2323181|NCT02985996|4038731|FG001|Overall Study|Protocol Violation|1
2323182|NCT02985996|4038732|FG002|Overall Study|Protocol Violation|0
2323183|NCT02985996|4038733|FG003|Overall Study|Protocol Violation|0
2323184|NCT02985996|4038734|FG004|Overall Study|Protocol Violation|0
2323185|NCT02986074|4038750|FG000|First Trial Period|Adverse Event|1
2323186|NCT02986074|4038751|FG001|First Trial Period|Adverse Event|0
2323187|NCT02986074|4038752|FG002|First Trial Period|Adverse Event|0
2323188|NCT02986074|4038753|FG003|First Trial Period|Adverse Event|0
2323189|NCT02986074|4038750|FG000|Follow up Period|system explant|0
2323190|NCT02986074|4038751|FG001|Follow up Period|system explant|0
2323191|NCT02986074|4038752|FG002|Follow up Period|system explant|1
2323192|NCT02986074|4038753|FG003|Follow up Period|system explant|2
2323193|NCT02986074|4038750|FG000|Follow up Period|Physician Decision|0
2323194|NCT02986074|4038751|FG001|Follow up Period|Physician Decision|0
2323195|NCT02986074|4038752|FG002|Follow up Period|Physician Decision|0
2323196|NCT02986074|4038753|FG003|Follow up Period|Physician Decision|1
2323197|NCT02986139|4038760|FG000|Overall Study|Sponsor Decision|1
2323198|NCT02986139|4038761|FG001|Overall Study|Sponsor Decision|2
2323199|NCT02986139|4038760|FG000|Overall Study|Withdrawal by Subject|0
2323200|NCT02986139|4038761|FG001|Overall Study|Withdrawal by Subject|1
2323201|NCT02986139|4038760|FG000|Overall Study|Lost to Follow-up|0
2323202|NCT02986139|4038761|FG001|Overall Study|Lost to Follow-up|1
2323203|NCT02986373|4038775|FG000|Overall Study|Adverse Event|4
2323204|NCT02986373|4038775|FG000|Overall Study|Lost to Follow-up|1
2323205|NCT02986373|4038775|FG000|Overall Study|Withdrawal by Subject|10
2323206|NCT02986373|4038775|FG000|Overall Study|Other|24
2323207|NCT02986854|4038808|FG000|Overall Study|Withdrawal by Subject|0
2323208|NCT02986854|4038809|FG001|Overall Study|Withdrawal by Subject|1
2323209|NCT02986854|4038810|FG002|Overall Study|Withdrawal by Subject|1
2323210|NCT02986854|4038808|FG000|Overall Study|Lost to Follow-up|3
2323211|NCT02986854|4038809|FG001|Overall Study|Lost to Follow-up|11
2323212|NCT02986854|4038810|FG002|Overall Study|Lost to Follow-up|2
2323213|NCT02987205|4038829|FG000|Overall Study|Adverse Event|1
2323214|NCT02987205|4038829|FG000|Overall Study|Withdrawal by Subject|3
2323215|NCT02987543|4038852|FG000|Overall Study|Ongoing study at data cut off|49
2323216|NCT02987543|4038853|FG001|Overall Study|Ongoing study at data cut off|21
2323217|NCT02987543|4038854|FG002|Overall Study|Ongoing study at data cut off|19
2323218|NCT02987543|4038855|FG003|Overall Study|Ongoing study at data cut off|12
2323219|NCT02987543|4038852|FG000|Overall Study|Death|88
2323220|NCT02987543|4038853|FG001|Overall Study|Death|54
2323221|NCT02987543|4038854|FG002|Overall Study|Death|67
2323222|NCT02987543|4038855|FG003|Overall Study|Death|28
2323223|NCT02987543|4038852|FG000|Overall Study|Lost to Follow-up|3
2323224|NCT02987543|4038853|FG001|Overall Study|Lost to Follow-up|0
2323225|NCT02987543|4038854|FG002|Overall Study|Lost to Follow-up|1
2323226|NCT02987543|4038855|FG003|Overall Study|Lost to Follow-up|0
2323227|NCT02987543|4038852|FG000|Overall Study|Screen failure|0
2323228|NCT02987543|4038853|FG001|Overall Study|Screen failure|0
2323229|NCT02987543|4038854|FG002|Overall Study|Screen failure|0
2323230|NCT02987543|4038855|FG003|Overall Study|Screen failure|1
2323231|NCT02987543|4038852|FG000|Overall Study|Withdrawal by Subject|21
2323232|NCT02987543|4038853|FG001|Overall Study|Withdrawal by Subject|7
2323233|NCT02987543|4038854|FG002|Overall Study|Withdrawal by Subject|7
2323234|NCT02987543|4038855|FG003|Overall Study|Withdrawal by Subject|6
2323235|NCT02987543|4038852|FG000|Overall Study|Study terminated by sponsor|1
2323236|NCT02987543|4038853|FG001|Overall Study|Study terminated by sponsor|0
2323237|NCT02987543|4038854|FG002|Overall Study|Study terminated by sponsor|0
2323238|NCT02987543|4038855|FG003|Overall Study|Study terminated by sponsor|0
2323239|NCT02987543|4038852|FG000|Overall Study|Investigator decision|0
2323240|NCT02987543|4038853|FG001|Overall Study|Investigator decision|1
2323241|NCT02987543|4038854|FG002|Overall Study|Investigator decision|0
2323242|NCT02987543|4038855|FG003|Overall Study|Investigator decision|0
2323243|NCT02987543|4038852|FG000|Overall Study|Disease progression|0
2323244|NCT02987543|4038853|FG001|Overall Study|Disease progression|0
2323245|NCT02987543|4038854|FG002|Overall Study|Disease progression|0
2323246|NCT02987543|4038855|FG003|Overall Study|Disease progression|1
2110253|NCT00893971|3704888|FG000|Overall Study|Physician Decision|3
2323247|NCT02987660|4038872|FG000|Overall Study|Study terminated by sponsor|10
2323248|NCT02987660|4038873|FG001|Overall Study|Study terminated by sponsor|10
2030258|NCT00377637|3599861|FG002|Maintenance Phase|Study medication stopped > 14 days|0
2030259|NCT00377637|3599862|FG003|Maintenance Phase|Study medication stopped > 14 days|1
2030260|NCT00377637|3599859|FG000|Maintenance Phase|Death|0
2030261|NCT00377637|3599860|FG001|Maintenance Phase|Death|0
2110254|NCT00894166|3704921|FG000|Overall Study|Withdrew or Lost to Follow-Up|61
2110255|NCT00894166|3704922|FG001|Overall Study|Withdrew or Lost to Follow-Up|63
2110256|NCT00894166|3704923|FG002|Overall Study|Withdrew or Lost to Follow-Up|62
2110257|NCT00894166|3704924|FG003|Overall Study|Withdrew or Lost to Follow-Up|68
2110258|NCT00894166|3704925|FG004|Overall Study|Withdrew or Lost to Follow-Up|24
2110259|NCT00894166|3704926|FG005|Overall Study|Withdrew or Lost to Follow-Up|16
2110260|NCT00894166|3704927|FG006|Overall Study|Withdrew or Lost to Follow-Up|16
2110261|NCT00894166|3704928|FG007|Overall Study|Withdrew or Lost to Follow-Up|34
2110262|NCT00894166|3704921|FG000|Overall Study|Death|0
2110263|NCT00894166|3704922|FG001|Overall Study|Death|0
2323249|NCT02987959|4038914|FG000|Overall Study|Grantor stopped supply of drugs|6
2323250|NCT02987972|4038921|FG000|Overall Study|Adverse Event|1
2323251|NCT02987972|4038922|FG001|Overall Study|Adverse Event|1
2323252|NCT02987972|4038923|FG002|Overall Study|Adverse Event|0
2110264|NCT00894166|3704923|FG002|Overall Study|Death|0
2110265|NCT00894166|3704924|FG003|Overall Study|Death|1
2110266|NCT00894166|3704925|FG004|Overall Study|Death|0
2110267|NCT00894166|3704926|FG005|Overall Study|Death|0
2110268|NCT00894166|3704927|FG006|Overall Study|Death|0
2217943|NCT01710657|3861258|FG002|Overall Study|Adverse Event|28
2030262|NCT00377637|3599861|FG002|Maintenance Phase|Death|0
2030263|NCT00377637|3599862|FG003|Maintenance Phase|Death|1
2030264|NCT00377676|3599878|FG000|Overall Study|Adverse Event|498
2030265|NCT00377676|3599879|FG001|Overall Study|Adverse Event|107
2030266|NCT00377676|3599878|FG000|Overall Study|Protocol Violation|33
2030267|NCT00377676|3599879|FG001|Overall Study|Protocol Violation|27
2030268|NCT00377676|3599878|FG000|Overall Study|Death|5
2030269|NCT00377676|3599879|FG001|Overall Study|Death|2
2030270|NCT00377676|3599878|FG000|Overall Study|Withdrawal by Subject|187
2030271|NCT00377676|3599879|FG001|Overall Study|Withdrawal by Subject|72
2030272|NCT00377676|3599878|FG000|Overall Study|Lost to Follow-up|120
2030273|NCT00377676|3599879|FG001|Overall Study|Lost to Follow-up|56
2030274|NCT00377676|3599878|FG000|Overall Study|Other|118
2323253|NCT02987972|4038921|FG000|Overall Study|Death|1
2323254|NCT02987972|4038922|FG001|Overall Study|Death|0
2323255|NCT02987972|4038923|FG002|Overall Study|Death|0
2323256|NCT02987972|4038921|FG000|Overall Study|Lack of Efficacy|9
2323257|NCT02987972|4038922|FG001|Overall Study|Lack of Efficacy|12
2323258|NCT02987972|4038923|FG002|Overall Study|Lack of Efficacy|12
2323259|NCT02987972|4038921|FG000|Overall Study|Lost to Follow-up|7
2323260|NCT02987972|4038922|FG001|Overall Study|Lost to Follow-up|8
2323261|NCT02987972|4038923|FG002|Overall Study|Lost to Follow-up|4
2323262|NCT02987972|4038921|FG000|Overall Study|Physician Decision|1
2323263|NCT02987972|4038922|FG001|Overall Study|Physician Decision|6
2323264|NCT02987972|4038923|FG002|Overall Study|Physician Decision|0
2323265|NCT02987972|4038921|FG000|Overall Study|Protocol Violation|2
2323266|NCT02987972|4038922|FG001|Overall Study|Protocol Violation|1
2323267|NCT02987972|4038923|FG002|Overall Study|Protocol Violation|5
2323268|NCT02987972|4038921|FG000|Overall Study|Withdrawal by Subject|22
2323269|NCT02987972|4038922|FG001|Overall Study|Withdrawal by Subject|17
2323270|NCT02987972|4038923|FG002|Overall Study|Withdrawal by Subject|21
2323271|NCT02988115|4038942|FG000|Overall Study|Adverse Event|6
2323272|NCT02988115|4038943|FG001|Overall Study|Adverse Event|1
2323273|NCT02988115|4038942|FG000|Overall Study|Sponsor Decision|5
2323274|NCT02988115|4038943|FG001|Overall Study|Sponsor Decision|2
2323275|NCT02988115|4038942|FG000|Overall Study|Withdrawal by Subject|1
2323276|NCT02988115|4038943|FG001|Overall Study|Withdrawal by Subject|1
2323277|NCT02988115|4038942|FG000|Overall Study|Withdrawn by Mistake|1
2323278|NCT02988115|4038943|FG001|Overall Study|Withdrawn by Mistake|0
2323279|NCT02988115|4038942|FG000|Overall Study|Lost to Follow-up|1
2323280|NCT02988115|4038943|FG001|Overall Study|Lost to Follow-up|0
2323281|NCT02988219|4038960|FG000|Overall Study|Lack of Efficacy|1
2323282|NCT02988219|4038961|FG001|Overall Study|Lack of Efficacy|1
2323283|NCT02988219|4038960|FG000|Overall Study|Withdrawal by Subject|0
2323284|NCT02988219|4038961|FG001|Overall Study|Withdrawal by Subject|2
2323285|NCT02988622|4038976|FG000|Overall Study|Lost to Follow-up|17
2323286|NCT02989168|4039006|FG000|Overall Study|Withdrawal by Subject|2
2323287|NCT02989168|4039007|FG001|Overall Study|Withdrawal by Subject|0
2323288|NCT02989168|4039006|FG000|Overall Study|Physician Decision|0
2323289|NCT02989168|4039007|FG001|Overall Study|Physician Decision|1
2323290|NCT02989168|4039006|FG000|Overall Study|Adverse Event|1
2323291|NCT02989168|4039007|FG001|Overall Study|Adverse Event|2
2323292|NCT02989168|4039006|FG000|Overall Study|Sponsor stopped study.|1
2323293|NCT02989168|4039007|FG001|Overall Study|Sponsor stopped study.|0
2323294|NCT02989389|4039029|FG000|Period 1|Lost to Follow-up|0
2030275|NCT00377676|3599879|FG001|Overall Study|Other|58
2030276|NCT00377819|3599896|FG000|Overall Study|Adverse Event|2
2030277|NCT00377819|3599897|FG001|Overall Study|Adverse Event|3
2030278|NCT00377819|3599896|FG000|Overall Study|Withdrawal by Subject|10
2030279|NCT00377819|3599897|FG001|Overall Study|Withdrawal by Subject|4
2030280|NCT00377819|3599896|FG000|Overall Study|Death|0
2323295|NCT02989389|4039030|FG001|Period 1|Lost to Follow-up|1
2323296|NCT02989389|4039031|FG002|Period 1|Lost to Follow-up|0
2323297|NCT02989389|4039032|FG003|Period 1|Lost to Follow-up|0
2030281|NCT00377819|3599897|FG001|Overall Study|Death|1
2030282|NCT00377819|3599896|FG000|Overall Study|Lost to Follow-up|0
2030283|NCT00377819|3599897|FG001|Overall Study|Lost to Follow-up|1
2030284|NCT00377819|3599896|FG000|Overall Study|Protocol Violation|1
2030285|NCT00377819|3599897|FG001|Overall Study|Protocol Violation|1
2030286|NCT00377858|3599917|FG000|Overall Study|Withdrawal by Subject|12
2030287|NCT00377858|3599918|FG001|Overall Study|Withdrawal by Subject|11
2030288|NCT00377858|3599917|FG000|Overall Study|Lost to Follow-up|6
2030289|NCT00377858|3599918|FG001|Overall Study|Lost to Follow-up|1
2030290|NCT00377858|3599917|FG000|Overall Study|Physician Decision|5
2323298|NCT02989389|4039033|FG004|Period 1|Lost to Follow-up|0
2323299|NCT02989389|4039034|FG005|Period 1|Lost to Follow-up|0
2323300|NCT02989389|4039035|FG006|Period 1|Lost to Follow-up|0
2323301|NCT02989389|4039036|FG007|Period 1|Lost to Follow-up|0
2323302|NCT02989389|4039037|FG008|Period 1|Lost to Follow-up|0
2323303|NCT02989389|4039038|FG009|Period 1|Lost to Follow-up|0
2323304|NCT02989389|4039029|FG000|Period 1|Physician Decision|0
2323305|NCT02989389|4039030|FG001|Period 1|Physician Decision|0
2323306|NCT02989389|4039031|FG002|Period 1|Physician Decision|0
2323307|NCT02989389|4039032|FG003|Period 1|Physician Decision|0
2323308|NCT02989389|4039033|FG004|Period 1|Physician Decision|0
2323309|NCT02989389|4039034|FG005|Period 1|Physician Decision|0
2323310|NCT02989389|4039035|FG006|Period 1|Physician Decision|0
2323311|NCT02989389|4039036|FG007|Period 1|Physician Decision|0
2323312|NCT02989389|4039037|FG008|Period 1|Physician Decision|1
2323313|NCT02989389|4039038|FG009|Period 1|Physician Decision|0
2323314|NCT02989610|4039095|FG000|Overall Study|Withdrawal/Other reasons|39
2323315|NCT02989649|4039099|FG000|Overall Study|Patient/Investigator's Decision to Stop|403
2323316|NCT02989649|4039099|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1
2323317|NCT02989649|4039099|FG000|Overall Study|Lost For Observation During Study|3
2323318|NCT02989649|4039099|FG000|Overall Study|Reason Not Specified|13
2352338|NCT03796676|4101263|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
2352339|NCT03792477|4101288|FG000|Overall Study|Adverse Event|0
2352340|NCT03792477|4101289|FG001|Overall Study|Adverse Event|0
2352341|NCT03792477|4101290|FG002|Overall Study|Adverse Event|0
2352342|NCT03792477|4101291|FG003|Overall Study|Adverse Event|1
2352343|NCT03792477|4101292|FG004|Overall Study|Adverse Event|0
2352344|NCT03792477|4101288|FG000|Overall Study|Lost to Follow-up|0
2352345|NCT03792477|4101289|FG001|Overall Study|Lost to Follow-up|0
2352346|NCT03792477|4101290|FG002|Overall Study|Lost to Follow-up|2
2352347|NCT03792477|4101291|FG003|Overall Study|Lost to Follow-up|0
2352348|NCT03792477|4101292|FG004|Overall Study|Lost to Follow-up|0
2352349|NCT03792477|4101288|FG000|Overall Study|Other|0
2352350|NCT03792477|4101289|FG001|Overall Study|Other|0
2352351|NCT03792477|4101290|FG002|Overall Study|Other|0
2352352|NCT03792477|4101291|FG003|Overall Study|Other|0
2352353|NCT03792477|4101292|FG004|Overall Study|Other|1
2352354|NCT03783962|4101300|FG000|Overall Study|Lost to Follow-up|3
2352355|NCT03783962|4101301|FG001|Overall Study|Lost to Follow-up|6
2352356|NCT03783962|4101300|FG000|Overall Study|Protocol Violation|0
2323319|NCT02989805|4039125|FG000|Overall Study|invalid consent|6
2323320|NCT02989805|4039126|FG001|Overall Study|invalid consent|4
2323321|NCT02990000|4039134|FG000|Overall Study|Failed to provide data beyond baseline|36
2323322|NCT02990000|4039135|FG001|Overall Study|Failed to provide data beyond baseline|34
2323323|NCT02990338|4039143|FG000|Overall Study|Adverse Event|19
2323324|NCT02990338|4039144|FG001|Overall Study|Adverse Event|11
2323325|NCT02990338|4039143|FG000|Overall Study|Progressive disease|88
2030291|NCT00377858|3599918|FG001|Overall Study|Physician Decision|5
2030292|NCT00377858|3599917|FG000|Overall Study|Protocol Violation|3
2030293|NCT00377858|3599918|FG001|Overall Study|Protocol Violation|4
2030294|NCT00377858|3599917|FG000|Overall Study|Adverse Event|2
2030295|NCT00377858|3599918|FG001|Overall Study|Adverse Event|1
2030296|NCT00377858|3599917|FG000|Overall Study|Entry Criteria Not Met|2
2030297|NCT00377858|3599918|FG001|Overall Study|Entry Criteria Not Met|0
2030298|NCT00377858|3599917|FG000|Overall Study|Sponsor Decision|1
2030299|NCT00377858|3599918|FG001|Overall Study|Sponsor Decision|2
2030300|NCT00377858|3599917|FG000|Overall Study|Death|0
2030301|NCT00377858|3599918|FG001|Overall Study|Death|3
2030302|NCT00377962|3599926|FG000|Core Study: 0-12 Months|Adverse Event|18
2030303|NCT00377962|3599927|FG001|Core Study: 0-12 Months|Adverse Event|2
2030304|NCT00377962|3599926|FG000|Core Study: 0-12 Months|Death|3
2030305|NCT00377962|3599927|FG001|Core Study: 0-12 Months|Death|0
2030306|NCT00377962|3599926|FG000|Core Study: 0-12 Months|Withdrew Consent|5
2030307|NCT00377962|3599927|FG001|Core Study: 0-12 Months|Withdrew Consent|2
2030308|NCT00377962|3599926|FG000|Core Study: 0-12 Months|Administrative Reason|1
2030309|NCT00377962|3599927|FG001|Core Study: 0-12 Months|Administrative Reason|1
2030310|NCT00377962|3599926|FG000|Core Study: 0-12 Months|Unspecified reasons|1
2030311|NCT00377962|3599927|FG001|Core Study: 0-12 Months|Unspecified reasons|4
2030312|NCT00377962|3599926|FG000|Extension Study: 12-24 Months|Death|1
2030313|NCT00377962|3599927|FG001|Extension Study: 12-24 Months|Death|1
2030314|NCT00377962|3599926|FG000|Extension Study: 12-24 Months|Adverse Event|8
2030315|NCT00377962|3599927|FG001|Extension Study: 12-24 Months|Adverse Event|0
2030316|NCT00377962|3599926|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1
2110269|NCT00894166|3704928|FG007|Overall Study|Death|0
2323326|NCT02990338|4039144|FG001|Overall Study|Progressive disease|66
2323327|NCT02990338|4039143|FG000|Overall Study|Poor compliance to protocol|0
2323328|NCT02990338|4039144|FG001|Overall Study|Poor compliance to protocol|1
2323329|NCT02990338|4039143|FG000|Overall Study|Withdrawal by Subject|6
2323330|NCT02990338|4039144|FG001|Overall Study|Withdrawal by Subject|5
2323331|NCT02990338|4039143|FG000|Overall Study|Other|1
2323332|NCT02990338|4039144|FG001|Overall Study|Other|4
2323333|NCT02990338|4039143|FG000|Overall Study|Randomized but not treated|4
2323334|NCT02990338|4039144|FG001|Overall Study|Randomized but not treated|2
2323335|NCT02990910|4039153|FG000|Overall Study|Lack of Efficacy|6
2323336|NCT02990910|4039154|FG001|Overall Study|Lack of Efficacy|10
2323337|NCT02991040|4039160|FG000|Overall Study|Withdrawal by Subject|2
2323338|NCT02991040|4039160|FG000|Overall Study|Lost to Follow-up|2
2323339|NCT02991118|4039168|FG000|Overall Study|Death|3
2323340|NCT02991118|4039169|FG001|Overall Study|Death|8
2323341|NCT02991118|4039168|FG000|Overall Study|Protocol Violation|0
2323342|NCT02991118|4039169|FG001|Overall Study|Protocol Violation|3
2323343|NCT02991118|4039168|FG000|Overall Study|Physician Decision|0
2323344|NCT02991118|4039169|FG001|Overall Study|Physician Decision|1
2323345|NCT02991118|4039168|FG000|Overall Study|Moved out of the country|0
2323346|NCT02991118|4039169|FG001|Overall Study|Moved out of the country|1
2323347|NCT02991118|4039168|FG000|Overall Study|Adverse Event|2
2323348|NCT02991118|4039169|FG001|Overall Study|Adverse Event|2
2323349|NCT02991118|4039168|FG000|Overall Study|Withdrawal by Subject|1
2323350|NCT02991118|4039169|FG001|Overall Study|Withdrawal by Subject|7
2323351|NCT02991118|4039168|FG000|Overall Study|Could not attend study visits|0
2323352|NCT02991118|4039169|FG001|Overall Study|Could not attend study visits|1
2323353|NCT02991118|4039168|FG000|Overall Study|Lost to Follow-up|1
2323354|NCT02991118|4039169|FG001|Overall Study|Lost to Follow-up|9
2323355|NCT02991859|4039214|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323356|NCT02991859|4039215|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
2323357|NCT02991859|4039216|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323358|NCT02991859|4039217|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323359|NCT02991859|4039218|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
2323360|NCT02991859|4039219|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323361|NCT02991859|4039220|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323362|NCT02991859|4039221|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323363|NCT02991859|4039222|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323364|NCT02991859|4039223|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323365|NCT02991859|4039224|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323366|NCT02991859|4039225|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323367|NCT02991859|4039226|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323368|NCT02991859|4039227|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323369|NCT02991859|4039228|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323370|NCT02991859|4039229|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323371|NCT02991859|4039230|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2323372|NCT02991859|4039214|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323373|NCT02991859|4039215|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323374|NCT02991859|4039216|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323375|NCT02991859|4039217|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323376|NCT02991859|4039218|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323377|NCT02991859|4039219|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323378|NCT02991859|4039220|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323379|NCT02991859|4039221|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323380|NCT02991859|4039222|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323381|NCT02991859|4039223|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323382|NCT02991859|4039224|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323383|NCT02991859|4039225|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323384|NCT02991859|4039226|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
2323385|NCT02991859|4039227|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
2323386|NCT02991859|4039228|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323387|NCT02991859|4039229|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323388|NCT02991859|4039230|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2323389|NCT02991859|4039214|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323390|NCT02991859|4039215|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323391|NCT02991859|4039216|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323392|NCT02991859|4039217|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323393|NCT02991859|4039218|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323394|NCT02991859|4039219|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1
2323395|NCT02991859|4039220|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323396|NCT02991859|4039221|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323397|NCT02991859|4039222|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323398|NCT02991859|4039223|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323399|NCT02991859|4039224|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323400|NCT02991859|4039225|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323401|NCT02991859|4039226|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323402|NCT02991859|4039227|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323403|NCT02991859|4039228|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323404|NCT02991859|4039229|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323405|NCT02991859|4039230|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0
2323406|NCT02991859|4039214|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0
2323407|NCT02991859|4039215|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0
2323408|NCT02991859|4039216|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0
2323409|NCT02991859|4039217|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0
2323410|NCT02991859|4039218|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0
2323411|NCT02991859|4039219|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0
2323412|NCT02991859|4039220|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0
2323413|NCT02991859|4039221|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0
2323414|NCT02991859|4039222|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0
2323415|NCT02991859|4039223|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1
2323416|NCT02991859|4039224|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0
2323417|NCT02991859|4039225|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0
2323418|NCT02991859|4039226|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0
2323419|NCT02991859|4039227|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0
2323420|NCT02991859|4039228|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0
2323421|NCT02991859|4039229|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0
2323422|NCT02991859|4039230|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0
2323423|NCT02991859|4039214|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323424|NCT02991859|4039215|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323425|NCT02991859|4039216|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323426|NCT02991859|4039217|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323427|NCT02991859|4039218|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323428|NCT02991859|4039219|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323429|NCT02991859|4039220|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323430|NCT02991859|4039221|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323431|NCT02991859|4039222|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
2323432|NCT02991859|4039223|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323433|NCT02991859|4039224|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323434|NCT02991859|4039225|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323435|NCT02991859|4039226|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323436|NCT02991859|4039227|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323437|NCT02991859|4039228|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323438|NCT02991859|4039229|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323439|NCT02991859|4039230|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2323440|NCT02992132|4039346|FG000|Overall Study|Adverse Event|4
2323441|NCT02992132|4039347|FG001|Overall Study|Adverse Event|1
2323442|NCT02992132|4039348|FG002|Overall Study|Adverse Event|3
2323443|NCT02992132|4039346|FG000|Overall Study|Lack of Efficacy|2
2323444|NCT02992132|4039347|FG001|Overall Study|Lack of Efficacy|0
2323445|NCT02992132|4039348|FG002|Overall Study|Lack of Efficacy|0
2323446|NCT02992132|4039346|FG000|Overall Study|Non-compliance with study drug|2
2323447|NCT02992132|4039347|FG001|Overall Study|Non-compliance with study drug|0
2323448|NCT02992132|4039348|FG002|Overall Study|Non-compliance with study drug|0
2323449|NCT02992132|4039346|FG000|Overall Study|Progressive disease|1
2323450|NCT02992132|4039347|FG001|Overall Study|Progressive disease|0
2323451|NCT02992132|4039348|FG002|Overall Study|Progressive disease|0
2323452|NCT02992132|4039346|FG000|Overall Study|Protocol Violation|2
2323453|NCT02992132|4039347|FG001|Overall Study|Protocol Violation|2
2323454|NCT02992132|4039348|FG002|Overall Study|Protocol Violation|0
2323455|NCT02992132|4039346|FG000|Overall Study|Caregiver withdrew consent|2
2323456|NCT02992132|4039347|FG001|Overall Study|Caregiver withdrew consent|3
2323457|NCT02992132|4039348|FG002|Overall Study|Caregiver withdrew consent|2
2323458|NCT02992132|4039346|FG000|Overall Study|Withdrawal by Subject|0
2323459|NCT02992132|4039347|FG001|Overall Study|Withdrawal by Subject|2
2323460|NCT02992132|4039348|FG002|Overall Study|Withdrawal by Subject|1
2323461|NCT02992132|4039346|FG000|Overall Study|Physician Decision|0
2323462|NCT02992132|4039347|FG001|Overall Study|Physician Decision|0
2323463|NCT02992132|4039348|FG002|Overall Study|Physician Decision|1
2323464|NCT02992288|4039382|FG000|Overall Study|Adverse Event|8
2323465|NCT02992288|4039383|FG001|Overall Study|Adverse Event|2
2323466|NCT02992288|4039384|FG002|Overall Study|Adverse Event|2
2323467|NCT02992288|4039385|FG003|Overall Study|Adverse Event|2
2323468|NCT02992288|4039386|FG004|Overall Study|Adverse Event|2
2323469|NCT02992288|4039387|FG005|Overall Study|Adverse Event|7
2323470|NCT02992288|4039382|FG000|Overall Study|Non-compliance with study drug|0
2323471|NCT02992288|4039383|FG001|Overall Study|Non-compliance with study drug|1
2323472|NCT02992288|4039384|FG002|Overall Study|Non-compliance with study drug|1
2323473|NCT02992288|4039385|FG003|Overall Study|Non-compliance with study drug|0
2323474|NCT02992288|4039386|FG004|Overall Study|Non-compliance with study drug|1
2323475|NCT02992288|4039387|FG005|Overall Study|Non-compliance with study drug|0
2323476|NCT02992288|4039382|FG000|Overall Study|Physician Decision|3
2030317|NCT00377962|3599927|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0
2030318|NCT00377962|3599926|FG000|Extension Study: 12-24 Months|Unspecified reason|0
2030319|NCT00377962|3599927|FG001|Extension Study: 12-24 Months|Unspecified reason|3
2030320|NCT00378014|3599941|FG000|Core (Randomization to Month 11)|Adverse Event|1
2030321|NCT00378014|3599942|FG001|Core (Randomization to Month 11)|Adverse Event|0
2030322|NCT00378014|3599941|FG000|Core (Randomization to Month 11)|Graft loss|1
2030323|NCT00378014|3599942|FG001|Core (Randomization to Month 11)|Graft loss|2
2030324|NCT00378014|3599941|FG000|Core (Randomization to Month 11)|Death|5
2030325|NCT00378014|3599942|FG001|Core (Randomization to Month 11)|Death|3
2030326|NCT00378014|3599941|FG000|Core (Randomization to Month 11)|Administrative Problems|2
2030327|NCT00378014|3599942|FG001|Core (Randomization to Month 11)|Administrative Problems|2
2030328|NCT00378014|3599941|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0
2030329|NCT00378014|3599942|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1
2030330|NCT00378014|3599941|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5
2030331|NCT00378014|3599942|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2
2030332|NCT00378014|3599941|FG000|Core (Randomization to Month 11)|Protocol deviation|0
2030333|NCT00378014|3599942|FG001|Core (Randomization to Month 11)|Protocol deviation|1
2030334|NCT00378014|3599941|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0
2030335|NCT00378014|3599942|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1
2030336|NCT00378014|3599941|FG000|Extension (Month 12 to Month 59)|Adverse Event|8
2323477|NCT02992288|4039383|FG001|Overall Study|Physician Decision|0
2323478|NCT02992288|4039384|FG002|Overall Study|Physician Decision|1
2323479|NCT02992288|4039385|FG003|Overall Study|Physician Decision|0
2217944|NCT01710657|3861256|FG000|Overall Study|Withdrawal by Subject|0
2217945|NCT01710657|3861257|FG001|Overall Study|Withdrawal by Subject|1
2217946|NCT01710657|3861258|FG002|Overall Study|Withdrawal by Subject|2
2217947|NCT01710657|3861256|FG000|Overall Study|Lack of Efficacy|0
2323480|NCT02992288|4039386|FG004|Overall Study|Physician Decision|0
2323481|NCT02992288|4039387|FG005|Overall Study|Physician Decision|1
2323482|NCT02992288|4039382|FG000|Overall Study|Death|2
2323483|NCT02992288|4039383|FG001|Overall Study|Death|0
2323484|NCT02992288|4039384|FG002|Overall Study|Death|2
2323485|NCT02992288|4039385|FG003|Overall Study|Death|1
2323486|NCT02992288|4039386|FG004|Overall Study|Death|2
2323487|NCT02992288|4039387|FG005|Overall Study|Death|0
2323488|NCT02992288|4039382|FG000|Overall Study|Lost to Follow-up|0
2323489|NCT02992288|4039383|FG001|Overall Study|Lost to Follow-up|0
2323490|NCT02992288|4039384|FG002|Overall Study|Lost to Follow-up|0
2323491|NCT02992288|4039385|FG003|Overall Study|Lost to Follow-up|1
2323492|NCT02992288|4039386|FG004|Overall Study|Lost to Follow-up|0
2323493|NCT02992288|4039387|FG005|Overall Study|Lost to Follow-up|0
2323494|NCT02992288|4039382|FG000|Overall Study|Protocol Violation|0
2323495|NCT02992288|4039383|FG001|Overall Study|Protocol Violation|0
2323496|NCT02992288|4039384|FG002|Overall Study|Protocol Violation|0
2323497|NCT02992288|4039385|FG003|Overall Study|Protocol Violation|0
2323498|NCT02992288|4039386|FG004|Overall Study|Protocol Violation|0
2323499|NCT02992288|4039387|FG005|Overall Study|Protocol Violation|1
2323500|NCT02992288|4039382|FG000|Overall Study|Withdrawal by Subject|4
2323501|NCT02992288|4039383|FG001|Overall Study|Withdrawal by Subject|2
2323502|NCT02992288|4039384|FG002|Overall Study|Withdrawal by Subject|1
2323503|NCT02992288|4039385|FG003|Overall Study|Withdrawal by Subject|5
2323504|NCT02992288|4039386|FG004|Overall Study|Withdrawal by Subject|3
2323505|NCT02992288|4039387|FG005|Overall Study|Withdrawal by Subject|4
2323506|NCT02992418|4039403|FG000|Overall Study|Withdrawal by Subject|11
2323507|NCT02992418|4039404|FG001|Overall Study|Withdrawal by Subject|12
2323508|NCT02992418|4039403|FG000|Overall Study|Non-compliance with the protocol|308
2323509|NCT02992418|4039404|FG001|Overall Study|Non-compliance with the protocol|308
2323510|NCT02992418|4039403|FG000|Overall Study|Lost to Follow-up|27
2323511|NCT02992418|4039404|FG001|Overall Study|Lost to Follow-up|22
2323512|NCT02992691|4039410|FG000|Overall Study|Adverse Event|2
2323513|NCT02992691|4039410|FG000|Overall Study|Withdrawal by Subject|1
2323514|NCT02992899|4039427|FG000|Overall Study|Withdrawal by Subject|1
2323515|NCT02992899|4039428|FG001|Overall Study|Withdrawal by Subject|0
2323516|NCT02992899|4039427|FG000|Overall Study|Lost to Follow-up|1
2323517|NCT02992899|4039428|FG001|Overall Study|Lost to Follow-up|3
2323518|NCT02993224|4039434|FG000|Core Phase - Period 1|Adverse Event|4
2323519|NCT02993224|4039434|FG000|Core Phase - Period 1|Withdrawal by Subject|1
2323520|NCT02993224|4039434|FG000|Core Phase - Period 1|Lost to Follow-up|3
2323521|NCT02993224|4039434|FG000|Core Phase- Period 2|Adverse Event|1
2323522|NCT02993224|4039434|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2
2323523|NCT02993224|4039434|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1
2323524|NCT02993224|4039434|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1
2323525|NCT02993224|4039434|FG000|Extension Phase|Adverse Event|3
2323526|NCT02993224|4039434|FG000|Extension Phase|Withdrawal by Subject|3
2323527|NCT02993224|4039434|FG000|Extension Phase|Lost to Follow-up|2
2323528|NCT02993224|4039434|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27
2323529|NCT02993250|4039442|FG000|Overall Study|Lost to Follow-up|0
2323530|NCT02993250|4039443|FG001|Overall Study|Lost to Follow-up|1
2323531|NCT02993471|4039467|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
2323532|NCT02993471|4039467|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
2323533|NCT02993731|4039491|FG000|Overall Study|Study Termination|101
2323534|NCT02993731|4039492|FG001|Overall Study|Study Termination|105
2323535|NCT02993757|4039510|FG000|Overall Study|Non compliance with the protocol|155
2323536|NCT02993757|4039511|FG001|Overall Study|Non compliance with the protocol|170
2323537|NCT02993757|4039510|FG000|Overall Study|Lost to Follow-up|1
2323538|NCT02993757|4039511|FG001|Overall Study|Lost to Follow-up|0
2323539|NCT02993757|4039510|FG000|Overall Study|Voluntary withdraw not due adverse event|8
2323540|NCT02993757|4039511|FG001|Overall Study|Voluntary withdraw not due adverse event|8
2323541|NCT02993783|4039519|FG000|Overall Study|Reason not Specified|6
2323542|NCT02993783|4039520|FG001|Overall Study|Reason not Specified|9
2323543|NCT02993926|4039526|FG000|Enantone Treatment Phase|Adverse Event|1
2323544|NCT02993926|4039527|FG001|Enantone Treatment Phase|Adverse Event|0
2323545|NCT02993926|4039528|FG002|Enantone Treatment Phase|Adverse Event|0
2323546|NCT02993926|4039526|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
2323547|NCT02993926|4039527|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
2323548|NCT02993926|4039528|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
2323549|NCT02993926|4039526|FG000|Enantone Treatment Phase|Investigator Judgment|1
2323550|NCT02993926|4039527|FG001|Enantone Treatment Phase|Investigator Judgment|0
2217948|NCT01710657|3861257|FG001|Overall Study|Lack of Efficacy|1
2323551|NCT02993926|4039528|FG002|Enantone Treatment Phase|Investigator Judgment|0
2323552|NCT02993926|4039526|FG000|Enantone Treatment Phase|Reason Not Specified|4
2323553|NCT02993926|4039527|FG001|Enantone Treatment Phase|Reason Not Specified|0
2323554|NCT02993926|4039528|FG002|Enantone Treatment Phase|Reason Not Specified|0
2323555|NCT02994056|4039538|FG000|Overall Study|Death|8
2323556|NCT02994056|4039538|FG000|Overall Study|Withdrew Consent|1
2323557|NCT02994108|4039553|FG000|Intervention Messages|Withdrawal by Subject|2
2323558|NCT02994108|4039554|FG001|Intervention Messages|Withdrawal by Subject|0
2323559|NCT02994108|4039553|FG000|Phase 1 Assessment|Lost to Follow-up|5
2323560|NCT02994108|4039554|FG001|Phase 1 Assessment|Lost to Follow-up|3
2323561|NCT02994108|4039553|FG000|Phase 2 Assessment|Lost to Follow-up|8
2323562|NCT02994108|4039554|FG001|Phase 2 Assessment|Lost to Follow-up|7
2323563|NCT02994108|4039553|FG000|Phase 2 Assessment|Withdrawal by Subject|1
2323564|NCT02994108|4039554|FG001|Phase 2 Assessment|Withdrawal by Subject|0
2323565|NCT02994394|4039572|FG000|Period 1 (Days 1 to 3)|Adverse Event|0
2323566|NCT02994394|4039573|FG001|Period 1 (Days 1 to 3)|Adverse Event|0
2323567|NCT02994394|4039574|FG002|Period 1 (Days 1 to 3)|Adverse Event|1
2323568|NCT02994394|4039575|FG003|Period 1 (Days 1 to 3)|Adverse Event|0
2323569|NCT02994394|4039576|FG004|Period 1 (Days 1 to 3)|Adverse Event|0
2323570|NCT02994394|4039577|FG005|Period 1 (Days 1 to 3)|Adverse Event|0
2323571|NCT02994394|4039572|FG000|Period 2 (Days 4 to 6)|Adverse Event|0
2323572|NCT02994394|4039573|FG001|Period 2 (Days 4 to 6)|Adverse Event|1
2323573|NCT02994394|4039574|FG002|Period 2 (Days 4 to 6)|Adverse Event|0
2323574|NCT02994394|4039575|FG003|Period 2 (Days 4 to 6)|Adverse Event|0
2323575|NCT02994394|4039576|FG004|Period 2 (Days 4 to 6)|Adverse Event|1
2323576|NCT02994394|4039577|FG005|Period 2 (Days 4 to 6)|Adverse Event|0
2323577|NCT02994654|4039591|FG000|Overall Study|Lost to Follow-up|1
2323578|NCT02994940|4039603|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6
2323579|NCT02994940|4039604|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0
2323580|NCT02994940|4039603|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1
2323581|NCT02994940|4039604|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0
2323582|NCT02994940|4039603|FG000|Overall Study|Did not receive study medications: red dye allergy|0
2323583|NCT02994940|4039604|FG001|Overall Study|Did not receive study medications: red dye allergy|1
2323584|NCT02995980|4039628|FG000|Overall Study|Lost to Follow-up|14
2323585|NCT02996097|4039633|FG000|Overall Study|Lost to Follow-up|11
2323586|NCT02996097|4039634|FG001|Overall Study|Lost to Follow-up|11
2323587|NCT02996448|4039639|FG000|Overall Study|Study terminated due to adverse effects|3
2323588|NCT02996474|4039644|FG000|Overall Study|Physician Decision|5
2323589|NCT02996500|4039654|FG000|Overall Study|Adverse Event|1
2323590|NCT02996500|4039655|FG001|Overall Study|Adverse Event|1
2323591|NCT02996500|4039656|FG002|Overall Study|Adverse Event|4
2323592|NCT02996500|4039657|FG003|Overall Study|Adverse Event|3
2323593|NCT02996500|4039658|FG004|Overall Study|Adverse Event|1
2323594|NCT02996500|4039659|FG005|Overall Study|Adverse Event|2
2323595|NCT02996500|4039654|FG000|Overall Study|Lack of Efficacy|0
2323596|NCT02996500|4039655|FG001|Overall Study|Lack of Efficacy|0
2323597|NCT02996500|4039656|FG002|Overall Study|Lack of Efficacy|0
2323598|NCT02996500|4039657|FG003|Overall Study|Lack of Efficacy|0
2323599|NCT02996500|4039658|FG004|Overall Study|Lack of Efficacy|2
2323600|NCT02996500|4039659|FG005|Overall Study|Lack of Efficacy|0
2323601|NCT02996500|4039654|FG000|Overall Study|Lost to Follow-up|1
2323602|NCT02996500|4039655|FG001|Overall Study|Lost to Follow-up|0
2323603|NCT02996500|4039656|FG002|Overall Study|Lost to Follow-up|0
2323604|NCT02996500|4039657|FG003|Overall Study|Lost to Follow-up|0
2323605|NCT02996500|4039658|FG004|Overall Study|Lost to Follow-up|0
2323606|NCT02996500|4039659|FG005|Overall Study|Lost to Follow-up|1
2323607|NCT02996500|4039654|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
2323608|NCT02996500|4039655|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
2323609|NCT02996500|4039656|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
2323610|NCT02996500|4039657|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
2323611|NCT02996500|4039658|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
2323612|NCT02996500|4039659|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
2323613|NCT02996500|4039654|FG000|Overall Study|Non-Compliance With Study Drug|0
2323614|NCT02996500|4039655|FG001|Overall Study|Non-Compliance With Study Drug|0
2323615|NCT02996500|4039656|FG002|Overall Study|Non-Compliance With Study Drug|0
2323616|NCT02996500|4039657|FG003|Overall Study|Non-Compliance With Study Drug|0
2323617|NCT02996500|4039658|FG004|Overall Study|Non-Compliance With Study Drug|0
2323618|NCT02996500|4039659|FG005|Overall Study|Non-Compliance With Study Drug|1
2323619|NCT02996500|4039654|FG000|Overall Study|Progressive Disease|1
2323620|NCT02996500|4039655|FG001|Overall Study|Progressive Disease|0
2323621|NCT02996500|4039656|FG002|Overall Study|Progressive Disease|0
2030337|NCT00378014|3599942|FG001|Extension (Month 12 to Month 59)|Adverse Event|7
2030338|NCT00378014|3599941|FG000|Extension (Month 12 to Month 59)|Death|1
2030339|NCT00378014|3599942|FG001|Extension (Month 12 to Month 59)|Death|2
2030340|NCT00378014|3599941|FG000|Extension (Month 12 to Month 59)|Administrative problems|1
2323622|NCT02996500|4039657|FG003|Overall Study|Progressive Disease|0
2323623|NCT02996500|4039658|FG004|Overall Study|Progressive Disease|0
2323624|NCT02996500|4039659|FG005|Overall Study|Progressive Disease|0
2323625|NCT02996500|4039654|FG000|Overall Study|Other|2
2323626|NCT02996500|4039655|FG001|Overall Study|Other|0
2323627|NCT02996500|4039656|FG002|Overall Study|Other|2
2323628|NCT02996500|4039657|FG003|Overall Study|Other|0
2323629|NCT02996500|4039658|FG004|Overall Study|Other|0
2323630|NCT02996500|4039659|FG005|Overall Study|Other|0
2323631|NCT02996500|4039654|FG000|Overall Study|Protocol Violation|0
2323632|NCT02996500|4039655|FG001|Overall Study|Protocol Violation|0
2323633|NCT02996500|4039656|FG002|Overall Study|Protocol Violation|0
2323634|NCT02996500|4039657|FG003|Overall Study|Protocol Violation|1
2323635|NCT02996500|4039658|FG004|Overall Study|Protocol Violation|0
2323636|NCT02996500|4039659|FG005|Overall Study|Protocol Violation|0
2323637|NCT02996500|4039654|FG000|Overall Study|Withdrawal by Subject|3
2323638|NCT02996500|4039655|FG001|Overall Study|Withdrawal by Subject|0
2323639|NCT02996500|4039656|FG002|Overall Study|Withdrawal by Subject|3
2323640|NCT02996500|4039657|FG003|Overall Study|Withdrawal by Subject|0
2323641|NCT02996500|4039658|FG004|Overall Study|Withdrawal by Subject|2
2323642|NCT02996500|4039659|FG005|Overall Study|Withdrawal by Subject|0
2323643|NCT02996682|4039688|FG000|Overall Study|Death|0
2323644|NCT02996682|4039689|FG001|Overall Study|Death|3
2323645|NCT02996968|4039706|FG000|Overall Study|Withdrawal by Subject|1
2323646|NCT02996968|4039707|FG001|Overall Study|Withdrawal by Subject|0
2323647|NCT02997163|4039729|FG000|Overall Study|Adverse Event|1
2323648|NCT02997163|4039730|FG001|Overall Study|Adverse Event|0
2323649|NCT02997163|4039731|FG002|Overall Study|Adverse Event|0
2323650|NCT02997163|4039732|FG003|Overall Study|Adverse Event|1
2323651|NCT02997176|4039746|FG000|Overall Study|Adverse Event|0
2323652|NCT02997176|4039747|FG001|Overall Study|Adverse Event|0
2323653|NCT02997176|4039748|FG002|Overall Study|Adverse Event|0
2323654|NCT02997176|4039749|FG003|Overall Study|Adverse Event|8
2323655|NCT02997176|4039746|FG000|Overall Study|Progressive Disease|1
2323656|NCT02997176|4039747|FG001|Overall Study|Progressive Disease|0
2323657|NCT02997176|4039748|FG002|Overall Study|Progressive Disease|1
2323658|NCT02997176|4039749|FG003|Overall Study|Progressive Disease|1
2323659|NCT02997176|4039746|FG000|Overall Study|Death|0
2323660|NCT02997176|4039747|FG001|Overall Study|Death|0
2323661|NCT02997176|4039748|FG002|Overall Study|Death|1
2323662|NCT02997176|4039749|FG003|Overall Study|Death|1
2323663|NCT02997176|4039746|FG000|Overall Study|Withdrawal by Subject|0
2323664|NCT02997176|4039747|FG001|Overall Study|Withdrawal by Subject|2
2323665|NCT02997176|4039748|FG002|Overall Study|Withdrawal by Subject|0
2323666|NCT02997176|4039749|FG003|Overall Study|Withdrawal by Subject|1
2323667|NCT02998021|4039792|FG000|Overall Study|Withdrawal by Subject|3
2323668|NCT02998021|4039793|FG001|Overall Study|Withdrawal by Subject|1
2323669|NCT02998021|4039792|FG000|Overall Study|unsafe home|0
2323670|NCT02998021|4039793|FG001|Overall Study|unsafe home|1
2323671|NCT02998151|4039799|FG000|Overall Study|Withdrawal by Subject|3
2323672|NCT02998151|4039799|FG000|Overall Study|Participant declined to re-enroll for baclofen|8
2323673|NCT02998151|4039799|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13
2323674|NCT02998476|4039813|FG000|Overall Study|Ongoing in study|21
2323675|NCT02998476|4039814|FG001|Overall Study|Ongoing in study|1
2323676|NCT02998476|4039813|FG000|Overall Study|Disease Progression|1
2323677|NCT02998476|4039814|FG001|Overall Study|Disease Progression|0
2323678|NCT02998476|4039813|FG000|Overall Study|Withdrawal by Subject|1
2323679|NCT02998476|4039814|FG001|Overall Study|Withdrawal by Subject|2
2323680|NCT02998476|4039813|FG000|Overall Study|Death|32
2323681|NCT02998476|4039814|FG001|Overall Study|Death|2
2323682|NCT02998541|4039822|FG000|Overall Study|Adverse Event|4
2323683|NCT02998541|4039823|FG001|Overall Study|Adverse Event|5
2323684|NCT02998541|4039824|FG002|Overall Study|Adverse Event|1
2323685|NCT02998541|4039822|FG000|Overall Study|Protocol Violation|1
2323686|NCT02998541|4039823|FG001|Overall Study|Protocol Violation|0
2323687|NCT02998541|4039824|FG002|Overall Study|Protocol Violation|0
2323688|NCT02998541|4039822|FG000|Overall Study|Withdrawal by Subject|3
2323689|NCT02998541|4039823|FG001|Overall Study|Withdrawal by Subject|1
2323690|NCT02998541|4039824|FG002|Overall Study|Withdrawal by Subject|0
2323691|NCT02998541|4039822|FG000|Overall Study|Lost to Follow-up|0
2323692|NCT02998541|4039823|FG001|Overall Study|Lost to Follow-up|3
2323693|NCT02998541|4039824|FG002|Overall Study|Lost to Follow-up|1
2323694|NCT02998541|4039822|FG000|Overall Study|Physician Decision|0
2323695|NCT02998541|4039823|FG001|Overall Study|Physician Decision|0
2323696|NCT02998541|4039824|FG002|Overall Study|Physician Decision|3
2323697|NCT02998541|4039822|FG000|Overall Study|Withdrawal by Parent/Guardian|0
2323698|NCT02998541|4039823|FG001|Overall Study|Withdrawal by Parent/Guardian|0
2323699|NCT02998541|4039824|FG002|Overall Study|Withdrawal by Parent/Guardian|1
2323700|NCT02998554|4039834|FG000|Overall Study|Adverse Event|8
2323701|NCT02998554|4039835|FG001|Overall Study|Adverse Event|3
2323702|NCT02998554|4039834|FG000|Overall Study|Protocol deviation|1
2323703|NCT02998554|4039835|FG001|Overall Study|Protocol deviation|0
2323704|NCT02998554|4039834|FG000|Overall Study|Withdrawal by Subject|2
2323705|NCT02998554|4039835|FG001|Overall Study|Withdrawal by Subject|6
2323706|NCT02998554|4039834|FG000|Overall Study|Lost to Follow-up|0
2323707|NCT02998554|4039835|FG001|Overall Study|Lost to Follow-up|1
2323708|NCT02998554|4039834|FG000|Overall Study|Lack of Efficacy|0
2323709|NCT02998554|4039835|FG001|Overall Study|Lack of Efficacy|1
2323710|NCT02998671|4039848|FG000|Period 1|Study Terminated By Sponsor|2
2323711|NCT02998671|4039849|FG001|Period 1|Study Terminated By Sponsor|1
2323712|NCT02998671|4039850|FG002|Period 1|Study Terminated By Sponsor|0
2323713|NCT02998671|4039851|FG003|Period 1|Study Terminated By Sponsor|0
2323714|NCT02998671|4039852|FG004|Period 1|Study Terminated By Sponsor|1
2323715|NCT02998671|4039848|FG000|Period 1|Withdrawal by Subject|1
2323716|NCT02998671|4039849|FG001|Period 1|Withdrawal by Subject|2
2323717|NCT02998671|4039850|FG002|Period 1|Withdrawal by Subject|0
2323718|NCT02998671|4039851|FG003|Period 1|Withdrawal by Subject|0
2323719|NCT02998671|4039852|FG004|Period 1|Withdrawal by Subject|2
2323720|NCT02998671|4039848|FG000|Period 1|Pregnancy|1
2323721|NCT02998671|4039849|FG001|Period 1|Pregnancy|0
2323722|NCT02998671|4039850|FG002|Period 1|Pregnancy|0
2323723|NCT02998671|4039851|FG003|Period 1|Pregnancy|0
2323724|NCT02998671|4039852|FG004|Period 1|Pregnancy|0
2323725|NCT02998671|4039848|FG000|Period 1|Adverse Event|0
2323726|NCT02998671|4039849|FG001|Period 1|Adverse Event|0
2323727|NCT02998671|4039850|FG002|Period 1|Adverse Event|0
2323728|NCT02998671|4039851|FG003|Period 1|Adverse Event|0
2323729|NCT02998671|4039852|FG004|Period 1|Adverse Event|1
2323730|NCT02998671|4039848|FG000|Period 2|Adverse Event|0
2323731|NCT02998671|4039849|FG001|Period 2|Adverse Event|1
2323732|NCT02998671|4039850|FG002|Period 2|Adverse Event|0
2323733|NCT02998671|4039851|FG003|Period 2|Adverse Event|0
2323734|NCT02998671|4039852|FG004|Period 2|Adverse Event|0
2323735|NCT02998671|4039848|FG000|Period 2|Study Terminated By Sponsor|3
2323736|NCT02998671|4039849|FG001|Period 2|Study Terminated By Sponsor|5
2323737|NCT02998671|4039850|FG002|Period 2|Study Terminated By Sponsor|1
2323738|NCT02998671|4039851|FG003|Period 2|Study Terminated By Sponsor|3
2323739|NCT02998671|4039852|FG004|Period 2|Study Terminated By Sponsor|0
2323740|NCT02998671|4039848|FG000|Period 2|Withdrawal by Subject|0
2323741|NCT02998671|4039849|FG001|Period 2|Withdrawal by Subject|1
2323742|NCT02998671|4039850|FG002|Period 2|Withdrawal by Subject|0
2323743|NCT02998671|4039851|FG003|Period 2|Withdrawal by Subject|0
2323744|NCT02998671|4039852|FG004|Period 2|Withdrawal by Subject|0
2323745|NCT02998671|4039848|FG000|Period 2|Lost to Follow-up|0
2323746|NCT02998671|4039849|FG001|Period 2|Lost to Follow-up|0
2323747|NCT02998671|4039850|FG002|Period 2|Lost to Follow-up|0
2323748|NCT02998671|4039851|FG003|Period 2|Lost to Follow-up|1
2323749|NCT02998671|4039852|FG004|Period 2|Lost to Follow-up|0
2323750|NCT02998996|4039887|FG000|Overall Study|Lost to Follow-up|0
2323751|NCT02998996|4039888|FG001|Overall Study|Lost to Follow-up|0
2323752|NCT02998996|4039889|FG002|Overall Study|Lost to Follow-up|1
2323753|NCT02998996|4039890|FG003|Overall Study|Lost to Follow-up|0
2323754|NCT02998996|4039891|FG004|Overall Study|Lost to Follow-up|0
2323755|NCT02998996|4039892|FG005|Overall Study|Lost to Follow-up|0
2323756|NCT02998996|4039887|FG000|Overall Study|Pregnancy|0
2030341|NCT00378014|3599942|FG001|Extension (Month 12 to Month 59)|Administrative problems|0
2030342|NCT00378014|3599941|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1
2030343|NCT00378014|3599942|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1
2030344|NCT00378014|3599941|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
2030345|NCT00378014|3599942|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
2030346|NCT00378014|3599941|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3
2323757|NCT02998996|4039888|FG001|Overall Study|Pregnancy|1
2323758|NCT02998996|4039889|FG002|Overall Study|Pregnancy|0
2323759|NCT02998996|4039890|FG003|Overall Study|Pregnancy|0
2323760|NCT02998996|4039891|FG004|Overall Study|Pregnancy|0
2323761|NCT02998996|4039892|FG005|Overall Study|Pregnancy|0
2323762|NCT02998996|4039887|FG000|Overall Study|Family reasons|0
2323763|NCT02998996|4039888|FG001|Overall Study|Family reasons|0
2323764|NCT02998996|4039889|FG002|Overall Study|Family reasons|0
2323765|NCT02998996|4039890|FG003|Overall Study|Family reasons|0
2323766|NCT02998996|4039891|FG004|Overall Study|Family reasons|1
2323767|NCT02998996|4039892|FG005|Overall Study|Family reasons|0
2323768|NCT02999100|4039912|FG000|Part 1 (up to 15 Days)|Adverse Event|0
2323769|NCT02999100|4039913|FG001|Part 1 (up to 15 Days)|Adverse Event|1
2323770|NCT02999100|4039914|FG002|Part 1 (up to 15 Days)|Adverse Event|0
2323771|NCT02999100|4039915|FG003|Part 1 (up to 15 Days)|Adverse Event|0
2323772|NCT02999100|4039916|FG004|Part 1 (up to 15 Days)|Adverse Event|0
2323773|NCT02999100|4039917|FG005|Part 1 (up to 15 Days)|Adverse Event|0
2323774|NCT02999100|4039912|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2323775|NCT02999100|4039913|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2323776|NCT02999100|4039914|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2323777|NCT02999100|4039915|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2323778|NCT02999100|4039916|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2323779|NCT02999100|4039917|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
2323780|NCT02999100|4039912|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2323781|NCT02999100|4039913|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2323782|NCT02999100|4039914|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
2323783|NCT02999100|4039915|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2323784|NCT02999100|4039916|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2323785|NCT02999100|4039917|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2323786|NCT02999178|4039941|FG000|Overall Study|Adverse Event|85
2323787|NCT02999178|4039942|FG001|Overall Study|Adverse Event|62
2323788|NCT02999178|4039941|FG000|Overall Study|Protocol Violation|1
2323789|NCT02999178|4039942|FG001|Overall Study|Protocol Violation|2
2323790|NCT02999178|4039941|FG000|Overall Study|Lost to Follow-up|0
2323791|NCT02999178|4039942|FG001|Overall Study|Lost to Follow-up|2
2323792|NCT02999178|4039941|FG000|Overall Study|Withdrawal by Subject|21
2323793|NCT02999178|4039942|FG001|Overall Study|Withdrawal by Subject|21
2323794|NCT02999178|4039941|FG000|Overall Study|Other reason not defined above|7
2323795|NCT02999178|4039942|FG001|Overall Study|Other reason not defined above|13
2323796|NCT02999191|4039951|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0
2030347|NCT00378014|3599942|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1
2030348|NCT00378079|3599953|FG000|Overall Study|Lost to Follow-up|6
2030349|NCT00378079|3599954|FG001|Overall Study|Lost to Follow-up|1
2030350|NCT00378079|3599955|FG002|Overall Study|Lost to Follow-up|0
2030351|NCT00378105|3599965|FG000|Overall Study|Adverse Event|3
2030352|NCT00378105|3599966|FG001|Overall Study|Adverse Event|1
2030353|NCT00378105|3599965|FG000|Overall Study|Withdrawal by Subject|3
2030354|NCT00378105|3599966|FG001|Overall Study|Withdrawal by Subject|3
2030355|NCT00378105|3599965|FG000|Overall Study|Death|1
2030356|NCT00378105|3599966|FG001|Overall Study|Death|0
2030357|NCT00378105|3599965|FG000|Overall Study|Going to transplant|7
2030358|NCT00378105|3599966|FG001|Overall Study|Going to transplant|8
2030359|NCT00378105|3599965|FG000|Overall Study|Progressive disease|3
2030360|NCT00378105|3599966|FG001|Overall Study|Progressive disease|3
2030361|NCT00378105|3599965|FG000|Overall Study|remain on study|3
2030362|NCT00378105|3599966|FG001|Overall Study|remain on study|11
2030363|NCT00378105|3599965|FG000|Overall Study|Physician Decision|0
2030364|NCT00378105|3599966|FG001|Overall Study|Physician Decision|2
2323797|NCT02999191|4039952|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1
2323798|NCT02999191|4039953|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0
2323799|NCT02999633|4039961|FG000|Overall Study|Adverse Event|2
2323800|NCT02999633|4039961|FG000|Overall Study|Progressive disease|12
2323801|NCT02999672|4039967|FG000|Overall Study|Death|0
2323802|NCT02999672|4039968|FG001|Overall Study|Death|1
2323803|NCT02999672|4039967|FG000|Overall Study|Study Terminated by Sponsor|0
2323804|NCT02999672|4039968|FG001|Overall Study|Study Terminated by Sponsor|1
2323805|NCT02999672|4039967|FG000|Overall Study|Progressive Disease|9
2323806|NCT02999672|4039968|FG001|Overall Study|Progressive Disease|5
2323807|NCT02999672|4039967|FG000|Overall Study|Adverse Event|4
2323808|NCT02999672|4039968|FG001|Overall Study|Adverse Event|0
2323809|NCT03000075|4039990|FG000|Part A|Adverse Event|4
2323810|NCT03000075|4039991|FG001|Part A|Adverse Event|0
2323811|NCT03000075|4039992|FG002|Part A|Adverse Event|0
2323812|NCT03000075|4039993|FG003|Part A|Adverse Event|0
2323813|NCT03000075|4039994|FG004|Part A|Adverse Event|0
2323814|NCT03000075|4039995|FG005|Part A|Adverse Event|0
2323815|NCT03000075|4039996|FG006|Part A|Adverse Event|0
2323816|NCT03000075|4039990|FG000|Part B|Not dosed due to AE|0
2323817|NCT03000075|4039991|FG001|Part B|Not dosed due to AE|0
2323818|NCT03000075|4039992|FG002|Part B|Not dosed due to AE|0
2323819|NCT03000075|4039993|FG003|Part B|Not dosed due to AE|0
2323820|NCT03000075|4039994|FG004|Part B|Not dosed due to AE|0
2323821|NCT03000075|4039995|FG005|Part B|Not dosed due to AE|2
2323822|NCT03000075|4039996|FG006|Part B|Not dosed due to AE|1
2323823|NCT03000075|4039990|FG000|Part B|Adverse Event|0
2323824|NCT03000075|4039991|FG001|Part B|Adverse Event|0
2323825|NCT03000075|4039992|FG002|Part B|Adverse Event|0
2323826|NCT03000075|4039993|FG003|Part B|Adverse Event|0
2323827|NCT03000075|4039994|FG004|Part B|Adverse Event|1
2323828|NCT03000075|4039995|FG005|Part B|Adverse Event|0
2323829|NCT03000075|4039996|FG006|Part B|Adverse Event|0
2323830|NCT03000348|4040045|FG000|Overall Study|Adverse Event|1
2323831|NCT03000348|4040046|FG001|Overall Study|Adverse Event|1
2323832|NCT03000348|4040047|FG002|Overall Study|Adverse Event|1
2323833|NCT03000348|4040048|FG003|Overall Study|Adverse Event|1
2323834|NCT03000348|4040049|FG004|Overall Study|Adverse Event|1
2323835|NCT03000348|4040050|FG005|Overall Study|Adverse Event|1
2323836|NCT03000348|4040045|FG000|Overall Study|Lost to Follow-up|0
2323837|NCT03000348|4040046|FG001|Overall Study|Lost to Follow-up|0
2323838|NCT03000348|4040047|FG002|Overall Study|Lost to Follow-up|1
2323839|NCT03000348|4040048|FG003|Overall Study|Lost to Follow-up|0
2323840|NCT03000348|4040049|FG004|Overall Study|Lost to Follow-up|0
2323841|NCT03000348|4040050|FG005|Overall Study|Lost to Follow-up|0
2323842|NCT03000348|4040045|FG000|Overall Study|Withdrawal by Subject|0
2323843|NCT03000348|4040046|FG001|Overall Study|Withdrawal by Subject|1
2323844|NCT03000348|4040047|FG002|Overall Study|Withdrawal by Subject|0
2323845|NCT03000348|4040048|FG003|Overall Study|Withdrawal by Subject|0
2323846|NCT03000348|4040049|FG004|Overall Study|Withdrawal by Subject|0
2323847|NCT03000348|4040050|FG005|Overall Study|Withdrawal by Subject|0
2323848|NCT03000348|4040045|FG000|Overall Study|Consent|0
2323849|NCT03000348|4040046|FG001|Overall Study|Consent|0
2323850|NCT03000348|4040047|FG002|Overall Study|Consent|0
2323851|NCT03000348|4040048|FG003|Overall Study|Consent|0
2323852|NCT03000348|4040049|FG004|Overall Study|Consent|1
2323853|NCT03000348|4040050|FG005|Overall Study|Consent|0
2323854|NCT03000348|4040045|FG000|Overall Study|Failure to expectorate sputum|1
2323855|NCT03000348|4040046|FG001|Overall Study|Failure to expectorate sputum|0
2323856|NCT03000348|4040047|FG002|Overall Study|Failure to expectorate sputum|1
2323857|NCT03000348|4040048|FG003|Overall Study|Failure to expectorate sputum|0
2323858|NCT03000348|4040049|FG004|Overall Study|Failure to expectorate sputum|1
2323859|NCT03000348|4040050|FG005|Overall Study|Failure to expectorate sputum|0
2323860|NCT03000348|4040045|FG000|Overall Study|No gram negative|1
2323861|NCT03000348|4040046|FG001|Overall Study|No gram negative|2
2323862|NCT03000348|4040047|FG002|Overall Study|No gram negative|1
2323863|NCT03000348|4040048|FG003|Overall Study|No gram negative|1
2323864|NCT03000348|4040049|FG004|Overall Study|No gram negative|1
2323865|NCT03000348|4040050|FG005|Overall Study|No gram negative|1
2323866|NCT03000348|4040045|FG000|Overall Study|Patient had no transport|0
2323867|NCT03000348|4040046|FG001|Overall Study|Patient had no transport|0
2323868|NCT03000348|4040047|FG002|Overall Study|Patient had no transport|0
2323869|NCT03000348|4040048|FG003|Overall Study|Patient had no transport|1
2323870|NCT03000348|4040049|FG004|Overall Study|Patient had no transport|0
2323871|NCT03000348|4040050|FG005|Overall Study|Patient had no transport|0
2323872|NCT03000348|4040045|FG000|Overall Study|Dosing|0
2323873|NCT03000348|4040046|FG001|Overall Study|Dosing|0
2323874|NCT03000348|4040047|FG002|Overall Study|Dosing|0
2323875|NCT03000348|4040048|FG003|Overall Study|Dosing|0
2323876|NCT03000348|4040049|FG004|Overall Study|Dosing|1
2323877|NCT03000348|4040050|FG005|Overall Study|Dosing|0
2323878|NCT03000452|4040067|FG000|Treatment Period|Death|1
2323879|NCT03000452|4040067|FG000|Treatment Period|Progressive Disease (PD)|14
2323880|NCT03000452|4040067|FG000|Treatment Period|Physician Decision|1
2323881|NCT03000452|4040067|FG000|Treatment Period|Miscellaneous|2
2323882|NCT03000452|4040067|FG000|Follow-Up Period|Study Terminated by Sponsor|1
2323883|NCT03000452|4040067|FG000|Follow-Up Period|Death|3
2323884|NCT03000452|4040067|FG000|Follow-Up Period|Withdrawal by Subject|3
2323885|NCT03000673|4040084|FG000|Overall Study|Withdrawal by Subject|1
2323886|NCT03000673|4040085|FG001|Overall Study|Withdrawal by Subject|0
2323887|NCT03000673|4040086|FG002|Overall Study|Withdrawal by Subject|0
2323888|NCT03000673|4040087|FG003|Overall Study|Withdrawal by Subject|0
2030365|NCT00378105|3599965|FG000|Overall Study|Going non-protocol therapy|0
2030366|NCT00378105|3599966|FG001|Overall Study|Going non-protocol therapy|1
2030367|NCT00378105|3599965|FG000|Overall Study|necessity to increase lenalidomide dose|0
2030368|NCT00378105|3599966|FG001|Overall Study|necessity to increase lenalidomide dose|1
2030369|NCT00378209|3599973|FG000|Overall Study|Progressive disease|11
2030370|NCT00378209|3599973|FG000|Overall Study|Adverse Event|3
2030371|NCT00378209|3599973|FG000|Overall Study|Initiation of non-protocol therapy|3
2030372|NCT00378209|3599973|FG000|Overall Study|Physician Decision|3
2030373|NCT00378209|3599973|FG000|Overall Study|Death|1
2030374|NCT00378209|3599973|FG000|Overall Study|Treatment delay|1
2030375|NCT00378482|3599999|FG000|Overall Study|Lost to Follow-up|1
2030376|NCT00378482|3599999|FG000|Overall Study|Lack of Efficacy|8
2030377|NCT00378482|3599999|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9
2030378|NCT00378482|3599999|FG000|Overall Study|Withdrawal by Subject|4
2030379|NCT00378482|3599999|FG000|Overall Study|Adverse Event|9
2030380|NCT00378508|3600005|FG000|Overall Study|Withdrawal by Subject|1
2030381|NCT00378508|3600006|FG001|Overall Study|Withdrawal by Subject|3
2030382|NCT00378508|3600005|FG000|Overall Study|Lost to Follow-up|1
2030383|NCT00378508|3600006|FG001|Overall Study|Lost to Follow-up|0
2030384|NCT00378534|3600015|FG000|Overall Study|Participants did not receive transplant|3
2030385|NCT00378534|3600016|FG001|Overall Study|Participants did not receive transplant|0
2110270|NCT00894322|3704954|FG000|Overall Study|Withdrawal by Subject|1
2110271|NCT00894322|3704955|FG001|Overall Study|Withdrawal by Subject|0
2110272|NCT00894322|3704956|FG002|Overall Study|Withdrawal by Subject|0
2110273|NCT00894361|3704968|FG000|Overall Study|deaths and less than 2 years followup|24
2110274|NCT00894361|3704969|FG001|Overall Study|deaths and less than 2 years followup|64
2110275|NCT00894387|3704979|FG000|Overall Study|Adverse Event|44
2110276|NCT00894387|3704980|FG001|Overall Study|Adverse Event|45
2110277|NCT00894387|3704979|FG000|Overall Study|Abnormal Laboratory values|2
2110278|NCT00894387|3704980|FG001|Overall Study|Abnormal Laboratory values|2
2110279|NCT00894387|3704979|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2110280|NCT00894387|3704980|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2110281|NCT00894387|3704979|FG000|Overall Study|Lost to Follow-up|3
2110282|NCT00894387|3704980|FG001|Overall Study|Lost to Follow-up|5
2110283|NCT00894387|3704979|FG000|Overall Study|Administrative problems|2
2110284|NCT00894387|3704980|FG001|Overall Study|Administrative problems|2
2110285|NCT00894387|3704979|FG000|Overall Study|Death|77
2110286|NCT00894387|3704980|FG001|Overall Study|Death|76
2110287|NCT00894387|3704979|FG000|Overall Study|Protocol Deviation|4
2110288|NCT00894387|3704980|FG001|Overall Study|Protocol Deviation|0
2110289|NCT00894387|3704979|FG000|Overall Study|Patient's request|25
2110290|NCT00894387|3704980|FG001|Overall Study|Patient's request|30
2110291|NCT00894387|3704979|FG000|Overall Study|Other (Missing)|5
2323889|NCT03000686|4040100|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0
2323890|NCT03000686|4040101|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1
2323891|NCT03000686|4040102|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0
2323892|NCT03000686|4040103|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0
2323893|NCT03001011|4040117|FG000|Overall Study|Adverse Event|9
2323894|NCT03001011|4040118|FG001|Overall Study|Adverse Event|3
2323895|NCT03001011|4040117|FG000|Overall Study|Chronic kidney disease lead to dialysis|15
2323896|NCT03001011|4040118|FG001|Overall Study|Chronic kidney disease lead to dialysis|10
2323897|NCT03001011|4040117|FG000|Overall Study|Other than specified above|3
2323898|NCT03001011|4040118|FG001|Overall Study|Other than specified above|8
2323899|NCT03001076|4040127|FG000|Overall Study|Withdrawal by patient|2
2323900|NCT03001076|4040128|FG001|Overall Study|Withdrawal by patient|0
2323901|NCT03001076|4040127|FG000|Overall Study|Other|1
2323902|NCT03001076|4040128|FG001|Overall Study|Other|0
2323903|NCT03001076|4040127|FG000|Overall Study|Adverse Event|3
2323904|NCT03001076|4040128|FG001|Overall Study|Adverse Event|3
2323905|NCT03001076|4040127|FG000|Overall Study|Sponsor decision|1
2323906|NCT03001076|4040128|FG001|Overall Study|Sponsor decision|0
2323907|NCT03001076|4040127|FG000|Overall Study|Lost to Follow-up|0
2323908|NCT03001076|4040128|FG001|Overall Study|Lost to Follow-up|2
2030386|NCT00378560|3600023|FG000|Overall Study|Adverse Event|1
2030387|NCT00378560|3600024|FG001|Overall Study|Adverse Event|0
2030388|NCT00378560|3600023|FG000|Overall Study|Lost to Follow-up|24
2030389|NCT00378560|3600024|FG001|Overall Study|Lost to Follow-up|29
2030390|NCT00378560|3600023|FG000|Overall Study|Protocol Violation|2
2030391|NCT00378560|3600024|FG001|Overall Study|Protocol Violation|0
2030392|NCT00378560|3600023|FG000|Overall Study|Withdrawal by Subject|17
2030393|NCT00378560|3600024|FG001|Overall Study|Withdrawal by Subject|21
2030394|NCT00378560|3600023|FG000|Overall Study|Moved|4
2030395|NCT00378560|3600024|FG001|Overall Study|Moved|3
2030396|NCT00378560|3600023|FG000|Overall Study|Pregnancy|7
2030397|NCT00378560|3600024|FG001|Overall Study|Pregnancy|5
2323909|NCT03001219|4040136|FG000|Proof of Concept|Study Termination by Sponsor|0
2323910|NCT03001219|4040137|FG001|Proof of Concept|Study Termination by Sponsor|1
2323911|NCT03001219|4040136|FG000|Proof of Concept|Withdrawal by Subject|0
2323912|NCT03001219|4040137|FG001|Proof of Concept|Withdrawal by Subject|4
2323913|NCT03001219|4040136|FG000|Proof of Concept|Protocol Deviation|0
2323914|NCT03001219|4040137|FG001|Proof of Concept|Protocol Deviation|1
2323915|NCT03001219|4040136|FG000|Proof of Concept|Adverse Event|1
2323916|NCT03001219|4040137|FG001|Proof of Concept|Adverse Event|1
2323917|NCT03001219|4040136|FG000|Proof of Concept|Physician Decision|1
2323918|NCT03001219|4040137|FG001|Proof of Concept|Physician Decision|0
2323919|NCT03001219|4040136|FG000|Extension Period Analysis|Study Termination by Sponsor|0
2323920|NCT03001219|4040137|FG001|Extension Period Analysis|Study Termination by Sponsor|36
2323921|NCT03001219|4040136|FG000|Extension Period Analysis|Participant Non-Compliance|0
2323922|NCT03001219|4040137|FG001|Extension Period Analysis|Participant Non-Compliance|1
2323923|NCT03001219|4040136|FG000|Extension Period Analysis|Physician Decision|0
2323924|NCT03001219|4040137|FG001|Extension Period Analysis|Physician Decision|1
2323925|NCT03001219|4040136|FG000|Extension Period Analysis|Adverse Event|1
2323926|NCT03001219|4040137|FG001|Extension Period Analysis|Adverse Event|1
2323927|NCT03001219|4040136|FG000|Extension Period Analysis|Protocol Deviation|0
2323928|NCT03001219|4040137|FG001|Extension Period Analysis|Protocol Deviation|1
2323929|NCT03001219|4040136|FG000|Extension Period Analysis|Withdrawal by Subject|4
2323930|NCT03001219|4040137|FG001|Extension Period Analysis|Withdrawal by Subject|5
2323931|NCT03001557|4040175|FG000|Core Phase|Randomized but not treated|0
2323932|NCT03001557|4040176|FG001|Core Phase|Randomized but not treated|0
2323933|NCT03001557|4040177|FG002|Core Phase|Randomized but not treated|1
2030398|NCT00378560|3600023|FG000|Overall Study|Laboratory test values abnormal|1
2030399|NCT00378560|3600024|FG001|Overall Study|Laboratory test values abnormal|0
2030400|NCT00378573|3600030|FG000|Treatment Period|Adverse Event|9
2030401|NCT00378573|3600030|FG000|Treatment Period|Physician Decision|1
2030402|NCT00378573|3600030|FG000|Treatment Period|Withdrawal by Subject|2
2030403|NCT00378573|3600030|FG000|Treatment Period|Disease Progression|4
2110292|NCT00894387|3704980|FG001|Overall Study|Other (Missing)|3
2110293|NCT00894387|3704979|FG000|Overall Study|Mis-randomized|13
2110294|NCT00894387|3704980|FG001|Overall Study|Mis-randomized|9
2110295|NCT00894387|3704979|FG000|Overall Study|GCP non-compliance|0
2110296|NCT00894387|3704980|FG001|Overall Study|GCP non-compliance|2
2110297|NCT00894413|3704988|FG000|Overall Study|Physician Decision|0
2110298|NCT00894413|3704989|FG001|Overall Study|Physician Decision|2
2110299|NCT00894413|3704988|FG000|Overall Study|Adverse Event|0
2110300|NCT00894413|3704989|FG001|Overall Study|Adverse Event|2
2110301|NCT00894413|3704988|FG000|Overall Study|Withdrawal by Subject|0
2110302|NCT00894413|3704989|FG001|Overall Study|Withdrawal by Subject|4
2110303|NCT00894543|3705031|FG000|Baseline to Week 4|No diary or lost or withdrew|3
2110304|NCT00894543|3705032|FG001|Baseline to Week 4|No diary or lost or withdrew|2
2110305|NCT00894543|3705031|FG000|Week 4 to Week 8|No diary or lost or withdrew|4
2110306|NCT00894543|3705032|FG001|Week 4 to Week 8|No diary or lost or withdrew|2
2110307|NCT00894647|3705040|FG000|Overall Study|Adverse Event|5
2110308|NCT00894647|3705041|FG001|Overall Study|Adverse Event|4
2110309|NCT00894647|3705040|FG000|Overall Study|Withdrawal by Subject|4
2110310|NCT00894647|3705041|FG001|Overall Study|Withdrawal by Subject|4
2110311|NCT00894647|3705040|FG000|Overall Study|Lost to Follow-up|0
2110312|NCT00894647|3705041|FG001|Overall Study|Lost to Follow-up|2
2110313|NCT00894647|3705040|FG000|Overall Study|Non-compliance with study procedures|0
2110314|NCT00894647|3705041|FG001|Overall Study|Non-compliance with study procedures|2
2110315|NCT00894647|3705040|FG000|Overall Study|Other, not due to AE|1
2110316|NCT00894647|3705041|FG001|Overall Study|Other, not due to AE|2
2323934|NCT03001557|4040178|FG003|Core Phase|Randomized but not treated|0
2323935|NCT03001557|4040179|FG004|Core Phase|Randomized but not treated|0
2323936|NCT03001557|4040180|FG005|Core Phase|Randomized but not treated|0
2323937|NCT03001557|4040181|FG006|Core Phase|Randomized but not treated|0
2323938|NCT03001557|4040182|FG007|Core Phase|Randomized but not treated|0
2323939|NCT03001557|4040175|FG000|Extension Phase|Adverse Event|0
2323940|NCT03001557|4040176|FG001|Extension Phase|Adverse Event|0
2323941|NCT03001557|4040177|FG002|Extension Phase|Adverse Event|0
2323942|NCT03001557|4040178|FG003|Extension Phase|Adverse Event|0
2323943|NCT03001557|4040179|FG004|Extension Phase|Adverse Event|0
2323944|NCT03001557|4040180|FG005|Extension Phase|Adverse Event|2
2323945|NCT03001557|4040181|FG006|Extension Phase|Adverse Event|0
2323946|NCT03001557|4040182|FG007|Extension Phase|Adverse Event|0
2323947|NCT03001557|4040175|FG000|Extension Phase|Withdrawal by Subject|0
2323948|NCT03001557|4040176|FG001|Extension Phase|Withdrawal by Subject|0
2323949|NCT03001557|4040177|FG002|Extension Phase|Withdrawal by Subject|0
2323950|NCT03001557|4040178|FG003|Extension Phase|Withdrawal by Subject|0
2323951|NCT03001557|4040179|FG004|Extension Phase|Withdrawal by Subject|0
2323952|NCT03001557|4040180|FG005|Extension Phase|Withdrawal by Subject|1
2323953|NCT03001557|4040181|FG006|Extension Phase|Withdrawal by Subject|5
2323954|NCT03001557|4040182|FG007|Extension Phase|Withdrawal by Subject|2
2323955|NCT03001557|4040175|FG000|Extension Phase|Lost to Follow-up|0
2323956|NCT03001557|4040176|FG001|Extension Phase|Lost to Follow-up|0
2323957|NCT03001557|4040177|FG002|Extension Phase|Lost to Follow-up|0
2323958|NCT03001557|4040178|FG003|Extension Phase|Lost to Follow-up|0
2323959|NCT03001557|4040179|FG004|Extension Phase|Lost to Follow-up|0
2323960|NCT03001557|4040180|FG005|Extension Phase|Lost to Follow-up|0
2323961|NCT03001557|4040181|FG006|Extension Phase|Lost to Follow-up|2
2323962|NCT03001557|4040182|FG007|Extension Phase|Lost to Follow-up|1
2323963|NCT03001557|4040175|FG000|Extension Phase|Administrative Reason|0
2323964|NCT03001557|4040176|FG001|Extension Phase|Administrative Reason|0
2323965|NCT03001557|4040177|FG002|Extension Phase|Administrative Reason|0
2323966|NCT03001557|4040178|FG003|Extension Phase|Administrative Reason|0
2323967|NCT03001557|4040179|FG004|Extension Phase|Administrative Reason|0
2323968|NCT03001557|4040180|FG005|Extension Phase|Administrative Reason|1
2323969|NCT03001557|4040181|FG006|Extension Phase|Administrative Reason|3
2323970|NCT03001557|4040182|FG007|Extension Phase|Administrative Reason|3
2323971|NCT03001557|4040175|FG000|Extension Phase|Loss of caregiver|0
2323972|NCT03001557|4040176|FG001|Extension Phase|Loss of caregiver|0
2323973|NCT03001557|4040177|FG002|Extension Phase|Loss of caregiver|0
2323974|NCT03001557|4040178|FG003|Extension Phase|Loss of caregiver|0
2323975|NCT03001557|4040179|FG004|Extension Phase|Loss of caregiver|0
2323976|NCT03001557|4040180|FG005|Extension Phase|Loss of caregiver|0
2323977|NCT03001557|4040181|FG006|Extension Phase|Loss of caregiver|1
2323978|NCT03001557|4040182|FG007|Extension Phase|Loss of caregiver|0
2323979|NCT03001557|4040175|FG000|Extension Phase|Others|0
2323980|NCT03001557|4040176|FG001|Extension Phase|Others|0
2323981|NCT03001557|4040177|FG002|Extension Phase|Others|0
2323982|NCT03001557|4040178|FG003|Extension Phase|Others|0
2323983|NCT03001557|4040179|FG004|Extension Phase|Others|0
2323984|NCT03001557|4040180|FG005|Extension Phase|Others|1
2323985|NCT03001557|4040181|FG006|Extension Phase|Others|3
2323986|NCT03001557|4040182|FG007|Extension Phase|Others|0
2323987|NCT03002038|4040242|FG000|Overall Study|Adverse Event|3
2323988|NCT03002038|4040243|FG001|Overall Study|Adverse Event|1
2323989|NCT03002038|4040242|FG000|Overall Study|Withdrawal by Subject|8
2323990|NCT03002038|4040243|FG001|Overall Study|Withdrawal by Subject|4
2323991|NCT03002038|4040242|FG000|Overall Study|Immigration to another region|0
2323992|NCT03002038|4040243|FG001|Overall Study|Immigration to another region|2
2323993|NCT03002077|4040249|FG000|Overall Study|Non-compliance with Study Drug|4
2323994|NCT03002077|4040249|FG000|Overall Study|Non-compliance w/Background ADT|1
2323995|NCT03002077|4040249|FG000|Overall Study|Study Terminated by Sponsor|257
2323996|NCT03002077|4040249|FG000|Overall Study|Site Terminated by Sponsor|5
2323997|NCT03002077|4040249|FG000|Overall Study|Miscellaneous Reasons|10
2323998|NCT03002077|4040249|FG000|Overall Study|Adverse Event|23
2323999|NCT03002077|4040249|FG000|Overall Study|Lack of Efficacy|20
2324000|NCT03002077|4040249|FG000|Overall Study|Withdrawal by Subject|72
2324001|NCT03002077|4040249|FG000|Overall Study|Lost to Follow-up|21
2324002|NCT03002077|4040249|FG000|Overall Study|Pregnancy|4
2324003|NCT03002077|4040249|FG000|Overall Study|Protocol Violation|21
2324004|NCT03002194|4040253|FG000|Overall Study|Lost to Follow-up|6
2324005|NCT03002194|4040253|FG000|Overall Study|Adverse Event|1
2324006|NCT03002194|4040253|FG000|Overall Study|Lack of Efficacy|1
2324007|NCT03002194|4040253|FG000|Overall Study|Withdrawal by Subject|2
2324008|NCT03002311|4040259|FG000|Overall Study|Lost to Follow-up|13
2324009|NCT03002311|4040260|FG001|Overall Study|Lost to Follow-up|26
2324010|NCT03002311|4040259|FG000|Overall Study|Referral provider called to schedule app|3
2324011|NCT03002311|4040260|FG001|Overall Study|Referral provider called to schedule app|3
2324012|NCT03002311|4040259|FG000|Overall Study|Physician Decision|3
2324013|NCT03002311|4040260|FG001|Overall Study|Physician Decision|1
2324014|NCT03002610|4040278|FG000|Overall Study|Withdrawal by Subject|6
2324015|NCT03002610|4040279|FG001|Overall Study|Withdrawal by Subject|25
2324016|NCT03002610|4040280|FG002|Overall Study|Withdrawal by Subject|13
2324017|NCT03002623|4040290|FG000|Overall Study|Lost to Follow-up|1
2324018|NCT03002623|4040291|FG001|Overall Study|Lost to Follow-up|0
2324019|NCT03002623|4040290|FG000|Overall Study|Physician Decision|1
2324020|NCT03002623|4040291|FG001|Overall Study|Physician Decision|1
2324021|NCT03002818|4040311|FG000|Overall Study|Decision of the investigator|1
2352357|NCT03783962|4101301|FG001|Overall Study|Protocol Violation|1
2352358|NCT03793556|4101365|FG000|Overall Study|Withdrawal by Subject|12
2352359|NCT03793556|4101366|FG001|Overall Study|Withdrawal by Subject|1
2352360|NCT03793556|4101365|FG000|Overall Study|Lost to Follow-up|1
2352361|NCT03793556|4101366|FG001|Overall Study|Lost to Follow-up|1
2352362|NCT03785548|4101377|FG000|Overall Study|age > 80|1
2352363|NCT03785548|4101378|FG001|Overall Study|age > 80|0
2352364|NCT03785548|4101377|FG000|Overall Study|no Postop queries|1
2352365|NCT03785548|4101378|FG001|Overall Study|no Postop queries|0
2352366|NCT03773133|4101390|FG000|Overall Study|Screen Failure|8
2352367|NCT03792672|4101408|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1
2352368|NCT03792672|4101409|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0
2352369|NCT03792672|4101410|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0
2352370|NCT03792672|4101411|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2
2352371|NCT03792672|4101412|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0
2324022|NCT03003000|4040331|FG000|Overall Study|Adverse Event|1
2324023|NCT03003000|4040332|FG001|Overall Study|Adverse Event|2
2324024|NCT03003000|4040333|FG002|Overall Study|Adverse Event|3
2324025|NCT03003000|4040331|FG000|Overall Study|Lack of Efficacy|1
2324026|NCT03003000|4040332|FG001|Overall Study|Lack of Efficacy|0
2324027|NCT03003000|4040333|FG002|Overall Study|Lack of Efficacy|0
2324028|NCT03003000|4040331|FG000|Overall Study|Non-compliant with protocol|0
2324029|NCT03003000|4040332|FG001|Overall Study|Non-compliant with protocol|1
2324030|NCT03003000|4040333|FG002|Overall Study|Non-compliant with protocol|1
2324031|NCT03003000|4040331|FG000|Overall Study|Refused to continue medication|2
2324032|NCT03003000|4040332|FG001|Overall Study|Refused to continue medication|0
2324033|NCT03003000|4040333|FG002|Overall Study|Refused to continue medication|0
2324034|NCT03003000|4040331|FG000|Overall Study|Other than listed|1
2324035|NCT03003000|4040332|FG001|Overall Study|Other than listed|1
2324036|NCT03003000|4040333|FG002|Overall Study|Other than listed|1
2324037|NCT03003390|4040352|FG000|Overall Study|Physician Decision|2
2324038|NCT03003390|4040353|FG001|Overall Study|Physician Decision|0
2324039|NCT03003390|4040352|FG000|Overall Study|Parent refused intervention|2
2324040|NCT03003390|4040353|FG001|Overall Study|Parent refused intervention|0
2324041|NCT03003494|4040364|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28
2324042|NCT03003676|4040370|FG000|Overall Study|Lack of Efficacy|5
2324043|NCT03003676|4040371|FG001|Overall Study|Lack of Efficacy|7
2324044|NCT03003676|4040370|FG000|Overall Study|Withdrawal by Subject|0
2324045|NCT03003676|4040371|FG001|Overall Study|Withdrawal by Subject|1
2324046|NCT03003676|4040370|FG000|Overall Study|Hepatitis B infection|1
2324047|NCT03003676|4040371|FG001|Overall Study|Hepatitis B infection|0
2324048|NCT03004469|4040400|FG000|Overall Study|Adverse Event|6
2324049|NCT03004469|4040401|FG001|Overall Study|Adverse Event|4
2324050|NCT03004469|4040402|FG002|Overall Study|Adverse Event|6
2324051|NCT03004469|4040400|FG000|Overall Study|Lack of Efficacy|1
2324052|NCT03004469|4040401|FG001|Overall Study|Lack of Efficacy|0
2324053|NCT03004469|4040402|FG002|Overall Study|Lack of Efficacy|1
2324054|NCT03004469|4040400|FG000|Overall Study|Lost to Follow-up|23
2324055|NCT03004469|4040401|FG001|Overall Study|Lost to Follow-up|14
2324056|NCT03004469|4040402|FG002|Overall Study|Lost to Follow-up|6
2324057|NCT03004469|4040400|FG000|Overall Study|Non-Compliance with Study Drug|2
2324058|NCT03004469|4040401|FG001|Overall Study|Non-Compliance with Study Drug|0
2324059|NCT03004469|4040402|FG002|Overall Study|Non-Compliance with Study Drug|0
2324060|NCT03004469|4040400|FG000|Overall Study|Protocol Violation|0
2324061|NCT03004469|4040401|FG001|Overall Study|Protocol Violation|0
2030404|NCT00378573|3600030|FG000|Treatment Period|Sponsor decision to close study|1
2030405|NCT00378573|3600030|FG000|Follow-up|Death|12
2030406|NCT00378573|3600030|FG000|Follow-up|Lost to Follow-up|1
2030407|NCT00378573|3600030|FG000|Follow-up|Withdrawal by Subject|1
2030408|NCT00378599|3600034|FG000|Overall Study|Adverse Event|38
2030409|NCT00378599|3600034|FG000|Overall Study|Protocol Violation|2
2030410|NCT00378599|3600034|FG000|Overall Study|Treatment failure|7
2030411|NCT00378599|3600034|FG000|Overall Study|Withdrawal by Subject|5
2030412|NCT00378703|3600042|FG000|Overall Study|Disease progression|59
2030413|NCT00378703|3600043|FG001|Overall Study|Disease progression|43
2030414|NCT00378703|3600044|FG002|Overall Study|Disease progression|48
2030415|NCT00378703|3600045|FG003|Overall Study|Disease progression|49
2030416|NCT00378703|3600042|FG000|Overall Study|Adverse Event|11
2030417|NCT00378703|3600043|FG001|Overall Study|Adverse Event|17
2030418|NCT00378703|3600044|FG002|Overall Study|Adverse Event|20
2030419|NCT00378703|3600045|FG003|Overall Study|Adverse Event|18
2030420|NCT00378703|3600042|FG000|Overall Study|Death|2
2030421|NCT00378703|3600043|FG001|Overall Study|Death|2
2030422|NCT00378703|3600044|FG002|Overall Study|Death|4
2030423|NCT00378703|3600045|FG003|Overall Study|Death|3
2030424|NCT00378703|3600042|FG000|Overall Study|Withdrawal by Subject|4
2324062|NCT03004469|4040402|FG002|Overall Study|Protocol Violation|1
2324063|NCT03004469|4040400|FG000|Overall Study|Withdrawal by Subject|29
2324064|NCT03004469|4040401|FG001|Overall Study|Withdrawal by Subject|27
2324065|NCT03004469|4040402|FG002|Overall Study|Withdrawal by Subject|10
2324066|NCT03004469|4040400|FG000|Overall Study|Other unspecified reason|0
2324067|NCT03004469|4040401|FG001|Overall Study|Other unspecified reason|4
2324068|NCT03004469|4040402|FG002|Overall Study|Other unspecified reason|1
2324069|NCT03004924|4040470|FG000|Overall Study|Adverse Event|6
2324070|NCT03004924|4040471|FG001|Overall Study|Adverse Event|5
2324071|NCT03004924|4040472|FG002|Overall Study|Adverse Event|10
2324072|NCT03004924|4040470|FG000|Overall Study|Protocol Violation|4
2324073|NCT03004924|4040471|FG001|Overall Study|Protocol Violation|0
2324074|NCT03004924|4040472|FG002|Overall Study|Protocol Violation|1
2324075|NCT03004924|4040470|FG000|Overall Study|Withdrawal by Subject|5
2324076|NCT03004924|4040471|FG001|Overall Study|Withdrawal by Subject|3
2324077|NCT03004924|4040472|FG002|Overall Study|Withdrawal by Subject|5
2324078|NCT03004924|4040470|FG000|Overall Study|Lost to Follow-up|6
2324079|NCT03004924|4040471|FG001|Overall Study|Lost to Follow-up|1
2324080|NCT03004924|4040472|FG002|Overall Study|Lost to Follow-up|4
2324081|NCT03004924|4040470|FG000|Overall Study|Lack of Efficacy|2
2324082|NCT03004924|4040471|FG001|Overall Study|Lack of Efficacy|4
2324083|NCT03004924|4040472|FG002|Overall Study|Lack of Efficacy|2
2324084|NCT03004924|4040470|FG000|Overall Study|Physician Decision|1
2324085|NCT03004924|4040471|FG001|Overall Study|Physician Decision|0
2324086|NCT03004924|4040472|FG002|Overall Study|Physician Decision|1
2324087|NCT03004924|4040470|FG000|Overall Study|Withdrawal by parent/guardian|1
2324088|NCT03004924|4040471|FG001|Overall Study|Withdrawal by parent/guardian|0
2324089|NCT03004924|4040472|FG002|Overall Study|Withdrawal by parent/guardian|2
2324090|NCT03004924|4040470|FG000|Overall Study|Screen Failure|1
2324091|NCT03004924|4040471|FG001|Overall Study|Screen Failure|0
2030425|NCT00378703|3600043|FG001|Overall Study|Withdrawal by Subject|8
2030426|NCT00378703|3600044|FG002|Overall Study|Withdrawal by Subject|5
2030427|NCT00378703|3600045|FG003|Overall Study|Withdrawal by Subject|7
2030428|NCT00378703|3600042|FG000|Overall Study|Physician Decision|1
2030429|NCT00378703|3600043|FG001|Overall Study|Physician Decision|4
2030430|NCT00378703|3600044|FG002|Overall Study|Physician Decision|1
2030431|NCT00378703|3600045|FG003|Overall Study|Physician Decision|0
2030432|NCT00378703|3600042|FG000|Overall Study|Alternative therapy|4
2030433|NCT00378703|3600043|FG001|Overall Study|Alternative therapy|2
2030434|NCT00378703|3600044|FG002|Overall Study|Alternative therapy|0
2030435|NCT00378703|3600045|FG003|Overall Study|Alternative therapy|0
2030436|NCT00378703|3600042|FG000|Overall Study|Other complicated disease|0
2030437|NCT00378703|3600043|FG001|Overall Study|Other complicated disease|2
2030438|NCT00378703|3600044|FG002|Overall Study|Other complicated disease|2
2030439|NCT00378703|3600045|FG003|Overall Study|Other complicated disease|0
2030440|NCT00378703|3600042|FG000|Overall Study|Symptomatic deterioration|0
2030441|NCT00378703|3600043|FG001|Overall Study|Symptomatic deterioration|1
2030442|NCT00378703|3600044|FG002|Overall Study|Symptomatic deterioration|0
2030443|NCT00378703|3600045|FG003|Overall Study|Symptomatic deterioration|2
2030444|NCT00378703|3600042|FG000|Overall Study|Surgery|1
2030445|NCT00378703|3600043|FG001|Overall Study|Surgery|0
2030446|NCT00378703|3600044|FG002|Overall Study|Surgery|0
2030447|NCT00378703|3600045|FG003|Overall Study|Surgery|1
2030448|NCT00378703|3600042|FG000|Overall Study|Joint decision of physician and patient|1
2030449|NCT00378703|3600043|FG001|Overall Study|Joint decision of physician and patient|0
2030450|NCT00378703|3600044|FG002|Overall Study|Joint decision of physician and patient|0
2030451|NCT00378703|3600045|FG003|Overall Study|Joint decision of physician and patient|0
2030452|NCT00378703|3600042|FG000|Overall Study|Adverse events and progressive disease|0
2030453|NCT00378703|3600043|FG001|Overall Study|Adverse events and progressive disease|0
2030454|NCT00378703|3600044|FG002|Overall Study|Adverse events and progressive disease|0
2030455|NCT00378703|3600045|FG003|Overall Study|Adverse events and progressive disease|1
2030456|NCT00378703|3600042|FG000|Overall Study|Relocation|0
2030457|NCT00378703|3600043|FG001|Overall Study|Relocation|0
2030458|NCT00378703|3600044|FG002|Overall Study|Relocation|1
2030459|NCT00378703|3600045|FG003|Overall Study|Relocation|0
2030460|NCT00378703|3600042|FG000|Overall Study|Ineligible|4
2030461|NCT00378703|3600043|FG001|Overall Study|Ineligible|7
2030462|NCT00378703|3600044|FG002|Overall Study|Ineligible|7
2030463|NCT00378703|3600045|FG003|Overall Study|Ineligible|7
2324092|NCT03004924|4040472|FG002|Overall Study|Screen Failure|0
2030464|NCT00378703|3600042|FG000|Overall Study|Never started treatment|1
2324093|NCT03004924|4040470|FG000|Overall Study|Pregnancy|0
2324094|NCT03004924|4040471|FG001|Overall Study|Pregnancy|1
2324095|NCT03004924|4040472|FG002|Overall Study|Pregnancy|0
2324096|NCT03004924|4040470|FG000|Overall Study|Terminated by Sponsor|0
2324097|NCT03004924|4040471|FG001|Overall Study|Terminated by Sponsor|0
2324098|NCT03004924|4040472|FG002|Overall Study|Terminated by Sponsor|1
2324099|NCT03004924|4040470|FG000|Overall Study|Missed Study Visit|0
2324100|NCT03004924|4040471|FG001|Overall Study|Missed Study Visit|0
2324101|NCT03004924|4040472|FG002|Overall Study|Missed Study Visit|2
2324102|NCT03004924|4040470|FG000|Overall Study|HSV1 Positive|1
2324103|NCT03004924|4040471|FG001|Overall Study|HSV1 Positive|0
2324104|NCT03004924|4040472|FG002|Overall Study|HSV1 Positive|0
2324105|NCT03005067|4040494|FG000|Overall Study|Withdrawal by Subject|3
2324106|NCT03005067|4040495|FG001|Overall Study|Withdrawal by Subject|2
2324107|NCT03005067|4040494|FG000|Overall Study|Adverse Event|4
2324108|NCT03005067|4040495|FG001|Overall Study|Adverse Event|3
2324109|NCT03005067|4040494|FG000|Overall Study|Other (reason not specified)|3
2324110|NCT03005067|4040495|FG001|Overall Study|Other (reason not specified)|1
2324111|NCT03005067|4040494|FG000|Overall Study|Protocol Violation|0
2324112|NCT03005067|4040495|FG001|Overall Study|Protocol Violation|1
2324113|NCT03005106|4040501|FG000|Overall Study|Lost to Follow-up|16
2324114|NCT03005106|4040501|FG000|Overall Study|Adverse Event|1
2324115|NCT03005106|4040501|FG000|Overall Study|Physician Decision|1
2324116|NCT03005106|4040501|FG000|Overall Study|Death|2
2324117|NCT03005288|4040507|FG000|Overall Study|Withdrawal by Subject|7
2324118|NCT03005288|4040508|FG001|Overall Study|Withdrawal by Subject|5
2324119|NCT03005288|4040507|FG000|Overall Study|Lost to Follow-up|0
2324120|NCT03005288|4040508|FG001|Overall Study|Lost to Follow-up|1
2324121|NCT03005288|4040507|FG000|Overall Study|Adverse Event|5
2324122|NCT03005288|4040508|FG001|Overall Study|Adverse Event|0
2324123|NCT03005288|4040507|FG000|Overall Study|Protocol deviation|0
2324124|NCT03005288|4040508|FG001|Overall Study|Protocol deviation|1
2324125|NCT03005288|4040507|FG000|Overall Study|Physician Decision|0
2324126|NCT03005288|4040508|FG001|Overall Study|Physician Decision|1
2324127|NCT03006341|4040518|FG000|Overall Study|Not linked in the EMR|25069
2324128|NCT03006341|4040519|FG001|Overall Study|Not linked in the EMR|67505
2324129|NCT03006341|4040520|FG002|Overall Study|Not linked in the EMR|30993
2324130|NCT03006341|4040521|FG003|Overall Study|Not linked in the EMR|10685
2324131|NCT03006393|4040531|FG000|Overall Study|Withdrawal by Subject|1
2324132|NCT03006393|4040532|FG001|Overall Study|Withdrawal by Subject|1
2324133|NCT03006393|4040531|FG000|Overall Study|Pregnancy|0
2324134|NCT03006393|4040532|FG001|Overall Study|Pregnancy|1
2324135|NCT03006393|4040531|FG000|Overall Study|Lost to Follow-up|0
2324136|NCT03006393|4040532|FG001|Overall Study|Lost to Follow-up|1
2324137|NCT03006458|4040538|FG000|First Intervention|Unsatisfied Vision|0
2324138|NCT03006458|4040539|FG001|First Intervention|Unsatisfied Vision|3
2324139|NCT03006562|4040556|FG000|Overall Study|Lost to Follow-up|0
2217949|NCT01710657|3861258|FG002|Overall Study|Lack of Efficacy|1
2217950|NCT01710709|3861266|FG000|Overall Study|Lost to Follow-up|29
2217951|NCT01710709|3861266|FG000|Overall Study|Adverse Event|48
2217952|NCT01710709|3861266|FG000|Overall Study|Participant met withdrawal criteria|33
2324140|NCT03006562|4040557|FG001|Overall Study|Lost to Follow-up|1
2324141|NCT03006848|4040563|FG000|Overall Study|Adverse Event|1
2324142|NCT03006848|4040563|FG000|Overall Study|Physician Decision|1
2324143|NCT03006848|4040563|FG000|Overall Study|Lack of Efficacy|16
2324144|NCT03006887|4040574|FG000|Overall Study|Adverse Event|1
2324145|NCT03006926|4040580|FG000|Overall Study|Death|0
2324146|NCT03006926|4040581|FG001|Overall Study|Death|33
2324147|NCT03006926|4040580|FG000|Overall Study|Ongoing Survival Follow-up|0
2324148|NCT03006926|4040581|FG001|Overall Study|Ongoing Survival Follow-up|26
2324149|NCT03006926|4040580|FG000|Overall Study|Ongoing-on Treatment|0
2324150|NCT03006926|4040581|FG001|Overall Study|Ongoing-on Treatment|36
2324151|NCT03006926|4040580|FG000|Overall Study|Lost to Follow-up|0
2324152|NCT03006926|4040581|FG001|Overall Study|Lost to Follow-up|1
2324153|NCT03006926|4040580|FG000|Overall Study|Withdrawal by Subject|0
2324154|NCT03006926|4040581|FG001|Overall Study|Withdrawal by Subject|2
2324155|NCT03007472|4040607|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2
2324156|NCT03007472|4040607|FG000|Overall Study|Death|2
2324157|NCT03007472|4040607|FG000|Overall Study|Loss to Follow Up|1
2324158|NCT03007953|4040613|FG000|Overall Study|Withdrawal by Subject|5
2324159|NCT03007953|4040614|FG001|Overall Study|Withdrawal by Subject|2
2324160|NCT03007953|4040613|FG000|Overall Study|Death|5
2324161|NCT03007953|4040614|FG001|Overall Study|Death|7
2324162|NCT03007953|4040613|FG000|Overall Study|Lost to Follow-up|3
2324163|NCT03007953|4040614|FG001|Overall Study|Lost to Follow-up|2
2324164|NCT03007953|4040613|FG000|Overall Study|Enrolled in Hospice|3
2324165|NCT03007953|4040614|FG001|Overall Study|Enrolled in Hospice|2
2324166|NCT03007966|4040622|FG000|Overall Study|Did not meeting inclusion/exclusion|1
2324167|NCT03007966|4040623|FG001|Overall Study|Did not meeting inclusion/exclusion|0
2324168|NCT03007979|4040630|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1
2324169|NCT03008070|4040637|FG000|Overall Study|Adverse Event|3
2324170|NCT03008070|4040638|FG001|Overall Study|Adverse Event|3
2324171|NCT03008070|4040639|FG002|Overall Study|Adverse Event|3
2324172|NCT03008070|4040637|FG000|Overall Study|Lost to Follow-up|1
2324173|NCT03008070|4040638|FG001|Overall Study|Lost to Follow-up|1
2324174|NCT03008070|4040639|FG002|Overall Study|Lost to Follow-up|0
2324175|NCT03008070|4040637|FG000|Overall Study|Non compliance|0
2324176|NCT03008070|4040638|FG001|Overall Study|Non compliance|1
2324177|NCT03008070|4040639|FG002|Overall Study|Non compliance|1
2324178|NCT03008070|4040637|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0
2324179|NCT03008070|4040638|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1
2324180|NCT03008070|4040639|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0
2324181|NCT03008070|4040637|FG000|Overall Study|Withdrawal by Subject|2
2324182|NCT03008070|4040638|FG001|Overall Study|Withdrawal by Subject|0
2324183|NCT03008070|4040639|FG002|Overall Study|Withdrawal by Subject|1
2324184|NCT03008070|4040637|FG000|Overall Study|Use of prohibited drug|0
2324185|NCT03008070|4040638|FG001|Overall Study|Use of prohibited drug|0
2324186|NCT03008070|4040639|FG002|Overall Study|Use of prohibited drug|2
2324187|NCT03008460|4040664|FG000|Overall Study|Protocol deviation|0
2324188|NCT03008460|4040665|FG001|Overall Study|Protocol deviation|2
2324189|NCT03008460|4040664|FG000|Overall Study|Study drug not dispensed|0
2324190|NCT03008460|4040665|FG001|Overall Study|Study drug not dispensed|1
2324191|NCT03008460|4040664|FG000|Overall Study|Adverse Event|0
2324192|NCT03008460|4040665|FG001|Overall Study|Adverse Event|1
2324193|NCT03008460|4040664|FG000|Overall Study|Withdrawal by Subject|5
2324194|NCT03008460|4040665|FG001|Overall Study|Withdrawal by Subject|6
2324195|NCT03008460|4040664|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1
2324196|NCT03008460|4040665|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0
2324197|NCT03008460|4040664|FG000|Overall Study|End of study visit outside permitted time window|0
2324198|NCT03008460|4040665|FG001|Overall Study|End of study visit outside permitted time window|1
2324199|NCT03008460|4040664|FG000|Overall Study|Lost to Follow-up|1
2324200|NCT03008460|4040665|FG001|Overall Study|Lost to Follow-up|3
2324201|NCT03008915|4040711|FG000|Treatment 1|Withdrawal by Subject|0
2324202|NCT03008915|4040712|FG001|Treatment 1|Withdrawal by Subject|1
2324203|NCT03010254|4040747|FG000|Overall Study|Adverse Event|0
2324204|NCT03010254|4040748|FG001|Overall Study|Adverse Event|1
2324205|NCT03010254|4040747|FG000|Overall Study|Lost to Follow-up|4
2324206|NCT03010254|4040748|FG001|Overall Study|Lost to Follow-up|0
2324207|NCT03010254|4040747|FG000|Overall Study|Withdrawal by Subject|1
2324208|NCT03010254|4040748|FG001|Overall Study|Withdrawal by Subject|1
2324209|NCT03010254|4040747|FG000|Overall Study|Other|2
2324210|NCT03010254|4040748|FG001|Overall Study|Other|3
2324211|NCT03010462|4040763|FG000|Overall Study|Withdrawal by Subject|3
2324212|NCT03010462|4040764|FG001|Overall Study|Withdrawal by Subject|1
2324213|NCT03010501|4040779|FG000|Study Week 1|Withdrawal by Subject|2
2324214|NCT03010501|4040780|FG001|Study Week 1|Withdrawal by Subject|1
2324215|NCT03010501|4040781|FG002|Study Week 1|Withdrawal by Subject|0
2324216|NCT03010501|4040782|FG003|Study Week 1|Withdrawal by Subject|2
2324217|NCT03010501|4040783|FG004|Study Week 1|Withdrawal by Subject|0
2324218|NCT03010501|4040784|FG005|Study Week 1|Withdrawal by Subject|0
2324219|NCT03010501|4040779|FG000|Study Week 3|Withdrawal by Subject|0
2324220|NCT03010501|4040780|FG001|Study Week 3|Withdrawal by Subject|0
2324221|NCT03010501|4040781|FG002|Study Week 3|Withdrawal by Subject|0
2324222|NCT03010501|4040782|FG003|Study Week 3|Withdrawal by Subject|1
2324223|NCT03010501|4040783|FG004|Study Week 3|Withdrawal by Subject|0
2324224|NCT03010501|4040784|FG005|Study Week 3|Withdrawal by Subject|0
2324225|NCT03010527|4040795|FG000|Overall Study|Death|0
2324226|NCT03010527|4040796|FG001|Overall Study|Death|0
2324227|NCT03010527|4040797|FG002|Overall Study|Death|1
2324228|NCT03010527|4040795|FG000|Overall Study|Adverse Event|0
2324229|NCT03010527|4040796|FG001|Overall Study|Adverse Event|4
2324230|NCT03010527|4040797|FG002|Overall Study|Adverse Event|2
2324231|NCT03010527|4040795|FG000|Overall Study|Protocol Violation|0
2324232|NCT03010527|4040796|FG001|Overall Study|Protocol Violation|1
2324233|NCT03010527|4040797|FG002|Overall Study|Protocol Violation|0
2324234|NCT03010527|4040795|FG000|Overall Study|Lost to Follow-up|0
2324235|NCT03010527|4040796|FG001|Overall Study|Lost to Follow-up|2
2324236|NCT03010527|4040797|FG002|Overall Study|Lost to Follow-up|1
2324237|NCT03010527|4040795|FG000|Overall Study|Withdrawal by Subject|0
2324238|NCT03010527|4040796|FG001|Overall Study|Withdrawal by Subject|3
2324239|NCT03010527|4040797|FG002|Overall Study|Withdrawal by Subject|4
2324240|NCT03010527|4040795|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0
2324241|NCT03010527|4040796|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4
2324242|NCT03010527|4040797|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6
2324243|NCT03010527|4040795|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0
2324244|NCT03010527|4040796|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4
2324245|NCT03010527|4040797|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2
2324246|NCT03010527|4040795|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
2324247|NCT03010527|4040796|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1
2324248|NCT03010527|4040797|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
2324249|NCT03011099|4040855|FG000|Overall Study|Withdrawal by Subject|0
2324250|NCT03011099|4040856|FG001|Overall Study|Withdrawal by Subject|2
2324251|NCT03011333|4040871|FG000|Overall Study|Lost to Follow-up|0
2324252|NCT03011333|4040872|FG001|Overall Study|Lost to Follow-up|1
2324253|NCT03011333|4040873|FG002|Overall Study|Lost to Follow-up|0
2324254|NCT03011333|4040874|FG003|Overall Study|Lost to Follow-up|1
2324255|NCT03011333|4040875|FG004|Overall Study|Lost to Follow-up|4
2324256|NCT03011333|4040876|FG005|Overall Study|Lost to Follow-up|4
2324257|NCT03011333|4040877|FG006|Overall Study|Lost to Follow-up|5
2324258|NCT03011840|4040895|FG000|Overall Study|Not received PIL in post PIL phase|0
2324259|NCT03011840|4040896|FG001|Overall Study|Not received PIL in post PIL phase|21
2324260|NCT03011892|4040908|FG000|Double Blind (DB) Period|Adverse Event|0
2324261|NCT03011892|4040909|FG001|Double Blind (DB) Period|Adverse Event|1
2324262|NCT03011892|4040910|FG002|Double Blind (DB) Period|Adverse Event|1
2324263|NCT03011892|4040911|FG003|Double Blind (DB) Period|Adverse Event|0
2324264|NCT03011892|4040912|FG004|Double Blind (DB) Period|Adverse Event|0
2324265|NCT03011892|4040913|FG005|Double Blind (DB) Period|Adverse Event|0
2324266|NCT03011892|4040914|FG006|Double Blind (DB) Period|Adverse Event|0
2324267|NCT03011892|4040915|FG007|Double Blind (DB) Period|Adverse Event|0
2324268|NCT03011892|4040916|FG008|Double Blind (DB) Period|Adverse Event|0
2324269|NCT03011892|4040917|FG009|Double Blind (DB) Period|Adverse Event|0
2324270|NCT03011892|4040918|FG010|Double Blind (DB) Period|Adverse Event|0
2324271|NCT03011892|4040919|FG011|Double Blind (DB) Period|Adverse Event|0
2324272|NCT03011892|4040908|FG000|Double Blind (DB) Period|Lack of Efficacy|1
2217953|NCT01710709|3861266|FG000|Overall Study|Participant withdrawn by investigator|2
2324273|NCT03011892|4040909|FG001|Double Blind (DB) Period|Lack of Efficacy|0
2324274|NCT03011892|4040910|FG002|Double Blind (DB) Period|Lack of Efficacy|0
2324275|NCT03011892|4040911|FG003|Double Blind (DB) Period|Lack of Efficacy|0
2324276|NCT03011892|4040912|FG004|Double Blind (DB) Period|Lack of Efficacy|0
2324277|NCT03011892|4040913|FG005|Double Blind (DB) Period|Lack of Efficacy|0
2324278|NCT03011892|4040914|FG006|Double Blind (DB) Period|Lack of Efficacy|0
2324279|NCT03011892|4040915|FG007|Double Blind (DB) Period|Lack of Efficacy|0
2324280|NCT03011892|4040916|FG008|Double Blind (DB) Period|Lack of Efficacy|0
2324281|NCT03011892|4040917|FG009|Double Blind (DB) Period|Lack of Efficacy|0
2324282|NCT03011892|4040918|FG010|Double Blind (DB) Period|Lack of Efficacy|0
2324283|NCT03011892|4040919|FG011|Double Blind (DB) Period|Lack of Efficacy|0
2324284|NCT03011892|4040908|FG000|Double Blind (DB) Period|Lost to Follow-up|0
2324285|NCT03011892|4040909|FG001|Double Blind (DB) Period|Lost to Follow-up|3
2324286|NCT03011892|4040910|FG002|Double Blind (DB) Period|Lost to Follow-up|2
2324287|NCT03011892|4040911|FG003|Double Blind (DB) Period|Lost to Follow-up|5
2324288|NCT03011892|4040912|FG004|Double Blind (DB) Period|Lost to Follow-up|0
2324289|NCT03011892|4040913|FG005|Double Blind (DB) Period|Lost to Follow-up|2
2324290|NCT03011892|4040914|FG006|Double Blind (DB) Period|Lost to Follow-up|0
2324291|NCT03011892|4040915|FG007|Double Blind (DB) Period|Lost to Follow-up|0
2324292|NCT03011892|4040916|FG008|Double Blind (DB) Period|Lost to Follow-up|0
2324293|NCT03011892|4040917|FG009|Double Blind (DB) Period|Lost to Follow-up|0
2324294|NCT03011892|4040918|FG010|Double Blind (DB) Period|Lost to Follow-up|0
2324295|NCT03011892|4040919|FG011|Double Blind (DB) Period|Lost to Follow-up|0
2324296|NCT03011892|4040908|FG000|Double Blind (DB) Period|Other|1
2324297|NCT03011892|4040909|FG001|Double Blind (DB) Period|Other|1
2324298|NCT03011892|4040910|FG002|Double Blind (DB) Period|Other|1
2324299|NCT03011892|4040911|FG003|Double Blind (DB) Period|Other|0
2324300|NCT03011892|4040912|FG004|Double Blind (DB) Period|Other|1
2324301|NCT03011892|4040913|FG005|Double Blind (DB) Period|Other|0
2324302|NCT03011892|4040914|FG006|Double Blind (DB) Period|Other|0
2324303|NCT03011892|4040915|FG007|Double Blind (DB) Period|Other|0
2324304|NCT03011892|4040916|FG008|Double Blind (DB) Period|Other|0
2324305|NCT03011892|4040917|FG009|Double Blind (DB) Period|Other|0
2324306|NCT03011892|4040918|FG010|Double Blind (DB) Period|Other|0
2324307|NCT03011892|4040919|FG011|Double Blind (DB) Period|Other|0
2324308|NCT03011892|4040908|FG000|Double Blind (DB) Period|Physician Decision|1
2324309|NCT03011892|4040909|FG001|Double Blind (DB) Period|Physician Decision|0
2324310|NCT03011892|4040910|FG002|Double Blind (DB) Period|Physician Decision|1
2324311|NCT03011892|4040911|FG003|Double Blind (DB) Period|Physician Decision|0
2324312|NCT03011892|4040912|FG004|Double Blind (DB) Period|Physician Decision|0
2324313|NCT03011892|4040913|FG005|Double Blind (DB) Period|Physician Decision|0
2324314|NCT03011892|4040914|FG006|Double Blind (DB) Period|Physician Decision|0
2324315|NCT03011892|4040915|FG007|Double Blind (DB) Period|Physician Decision|0
2324316|NCT03011892|4040916|FG008|Double Blind (DB) Period|Physician Decision|0
2324317|NCT03011892|4040917|FG009|Double Blind (DB) Period|Physician Decision|0
2324318|NCT03011892|4040918|FG010|Double Blind (DB) Period|Physician Decision|0
2324319|NCT03011892|4040919|FG011|Double Blind (DB) Period|Physician Decision|0
2324320|NCT03011892|4040908|FG000|Double Blind (DB) Period|Pregnancy|0
2324321|NCT03011892|4040909|FG001|Double Blind (DB) Period|Pregnancy|0
2324322|NCT03011892|4040910|FG002|Double Blind (DB) Period|Pregnancy|0
2324323|NCT03011892|4040911|FG003|Double Blind (DB) Period|Pregnancy|0
2324324|NCT03011892|4040912|FG004|Double Blind (DB) Period|Pregnancy|1
2324325|NCT03011892|4040913|FG005|Double Blind (DB) Period|Pregnancy|0
2324326|NCT03011892|4040914|FG006|Double Blind (DB) Period|Pregnancy|0
2324327|NCT03011892|4040915|FG007|Double Blind (DB) Period|Pregnancy|0
2324328|NCT03011892|4040916|FG008|Double Blind (DB) Period|Pregnancy|0
2324329|NCT03011892|4040917|FG009|Double Blind (DB) Period|Pregnancy|0
2324330|NCT03011892|4040918|FG010|Double Blind (DB) Period|Pregnancy|0
2324331|NCT03011892|4040919|FG011|Double Blind (DB) Period|Pregnancy|0
2324332|NCT03011892|4040908|FG000|Double Blind (DB) Period|Protocol Violation|1
2324333|NCT03011892|4040909|FG001|Double Blind (DB) Period|Protocol Violation|0
2324334|NCT03011892|4040910|FG002|Double Blind (DB) Period|Protocol Violation|0
2324335|NCT03011892|4040911|FG003|Double Blind (DB) Period|Protocol Violation|0
2324336|NCT03011892|4040912|FG004|Double Blind (DB) Period|Protocol Violation|0
2324337|NCT03011892|4040913|FG005|Double Blind (DB) Period|Protocol Violation|0
2324338|NCT03011892|4040914|FG006|Double Blind (DB) Period|Protocol Violation|0
2324339|NCT03011892|4040915|FG007|Double Blind (DB) Period|Protocol Violation|0
2324340|NCT03011892|4040916|FG008|Double Blind (DB) Period|Protocol Violation|0
2324341|NCT03011892|4040917|FG009|Double Blind (DB) Period|Protocol Violation|0
2324342|NCT03011892|4040918|FG010|Double Blind (DB) Period|Protocol Violation|0
2324343|NCT03011892|4040919|FG011|Double Blind (DB) Period|Protocol Violation|0
2324344|NCT03011892|4040908|FG000|Double Blind (DB) Period|Withdrawal by Subject|7
2324345|NCT03011892|4040909|FG001|Double Blind (DB) Period|Withdrawal by Subject|5
2324346|NCT03011892|4040910|FG002|Double Blind (DB) Period|Withdrawal by Subject|1
2324347|NCT03011892|4040911|FG003|Double Blind (DB) Period|Withdrawal by Subject|2
2324348|NCT03011892|4040912|FG004|Double Blind (DB) Period|Withdrawal by Subject|4
2324349|NCT03011892|4040913|FG005|Double Blind (DB) Period|Withdrawal by Subject|3
2324350|NCT03011892|4040914|FG006|Double Blind (DB) Period|Withdrawal by Subject|0
2324351|NCT03011892|4040915|FG007|Double Blind (DB) Period|Withdrawal by Subject|0
2324352|NCT03011892|4040916|FG008|Double Blind (DB) Period|Withdrawal by Subject|0
2324353|NCT03011892|4040917|FG009|Double Blind (DB) Period|Withdrawal by Subject|0
2324354|NCT03011892|4040918|FG010|Double Blind (DB) Period|Withdrawal by Subject|0
2324355|NCT03011892|4040919|FG011|Double Blind (DB) Period|Withdrawal by Subject|0
2324356|NCT03011892|4040908|FG000|Double Blind (DB) Period|Randomized but not treated|0
2324357|NCT03011892|4040909|FG001|Double Blind (DB) Period|Randomized but not treated|0
2324358|NCT03011892|4040910|FG002|Double Blind (DB) Period|Randomized but not treated|0
2324359|NCT03011892|4040911|FG003|Double Blind (DB) Period|Randomized but not treated|0
2324360|NCT03011892|4040912|FG004|Double Blind (DB) Period|Randomized but not treated|1
2324361|NCT03011892|4040913|FG005|Double Blind (DB) Period|Randomized but not treated|0
2324362|NCT03011892|4040914|FG006|Double Blind (DB) Period|Randomized but not treated|0
2324363|NCT03011892|4040915|FG007|Double Blind (DB) Period|Randomized but not treated|0
2324364|NCT03011892|4040916|FG008|Double Blind (DB) Period|Randomized but not treated|0
2324365|NCT03011892|4040917|FG009|Double Blind (DB) Period|Randomized but not treated|0
2324366|NCT03011892|4040918|FG010|Double Blind (DB) Period|Randomized but not treated|0
2324367|NCT03011892|4040919|FG011|Double Blind (DB) Period|Randomized but not treated|0
2324368|NCT03011892|4040908|FG000|Open Label (OL) Period|Lost to Follow-up|0
2324369|NCT03011892|4040909|FG001|Open Label (OL) Period|Lost to Follow-up|0
2324370|NCT03011892|4040910|FG002|Open Label (OL) Period|Lost to Follow-up|0
2324371|NCT03011892|4040911|FG003|Open Label (OL) Period|Lost to Follow-up|0
2030465|NCT00378703|3600043|FG001|Overall Study|Never started treatment|4
2324372|NCT03011892|4040912|FG004|Open Label (OL) Period|Lost to Follow-up|0
2324373|NCT03011892|4040913|FG005|Open Label (OL) Period|Lost to Follow-up|0
2324374|NCT03011892|4040914|FG006|Open Label (OL) Period|Lost to Follow-up|4
2324375|NCT03011892|4040915|FG007|Open Label (OL) Period|Lost to Follow-up|2
2324376|NCT03011892|4040916|FG008|Open Label (OL) Period|Lost to Follow-up|1
2324377|NCT03011892|4040917|FG009|Open Label (OL) Period|Lost to Follow-up|0
2324378|NCT03011892|4040918|FG010|Open Label (OL) Period|Lost to Follow-up|1
2324379|NCT03011892|4040919|FG011|Open Label (OL) Period|Lost to Follow-up|1
2324380|NCT03011892|4040908|FG000|Open Label (OL) Period|Withdrawal by Subject|0
2324381|NCT03011892|4040909|FG001|Open Label (OL) Period|Withdrawal by Subject|0
2324382|NCT03011892|4040910|FG002|Open Label (OL) Period|Withdrawal by Subject|0
2324383|NCT03011892|4040911|FG003|Open Label (OL) Period|Withdrawal by Subject|0
2324384|NCT03011892|4040912|FG004|Open Label (OL) Period|Withdrawal by Subject|0
2324385|NCT03011892|4040913|FG005|Open Label (OL) Period|Withdrawal by Subject|0
2324386|NCT03011892|4040914|FG006|Open Label (OL) Period|Withdrawal by Subject|3
2324387|NCT03011892|4040915|FG007|Open Label (OL) Period|Withdrawal by Subject|0
2324388|NCT03011892|4040916|FG008|Open Label (OL) Period|Withdrawal by Subject|1
2324389|NCT03011892|4040917|FG009|Open Label (OL) Period|Withdrawal by Subject|0
2324390|NCT03011892|4040918|FG010|Open Label (OL) Period|Withdrawal by Subject|1
2324391|NCT03011892|4040919|FG011|Open Label (OL) Period|Withdrawal by Subject|2
2324392|NCT03011892|4040908|FG000|Open Label (OL) Period|Reason not specified|0
2324393|NCT03011892|4040909|FG001|Open Label (OL) Period|Reason not specified|0
2324394|NCT03011892|4040910|FG002|Open Label (OL) Period|Reason not specified|0
2324395|NCT03011892|4040911|FG003|Open Label (OL) Period|Reason not specified|0
2324396|NCT03011892|4040912|FG004|Open Label (OL) Period|Reason not specified|0
2324397|NCT03011892|4040913|FG005|Open Label (OL) Period|Reason not specified|0
2324398|NCT03011892|4040914|FG006|Open Label (OL) Period|Reason not specified|0
2324399|NCT03011892|4040915|FG007|Open Label (OL) Period|Reason not specified|1
2217954|NCT01710709|3861266|FG000|Overall Study|Withdrawal by Subject|53
2324400|NCT03011892|4040916|FG008|Open Label (OL) Period|Reason not specified|0
2324401|NCT03011892|4040917|FG009|Open Label (OL) Period|Reason not specified|0
2324402|NCT03011892|4040918|FG010|Open Label (OL) Period|Reason not specified|0
2324403|NCT03011892|4040919|FG011|Open Label (OL) Period|Reason not specified|0
2324404|NCT03012061|4040949|FG000|Overall Study|Withdrawal by Subject|1
2324405|NCT03012061|4040950|FG001|Overall Study|Withdrawal by Subject|5
2324406|NCT03012061|4040951|FG002|Overall Study|Withdrawal by Subject|4
2217955|NCT01710709|3861266|FG000|Overall Study|Protocol Violation|5
2217956|NCT01710709|3861266|FG000|Overall Study|Lack of Efficacy|3
2324407|NCT03012061|4040949|FG000|Overall Study|Investigator Site Closed|1
2324408|NCT03012061|4040950|FG001|Overall Study|Investigator Site Closed|2
2324409|NCT03012061|4040951|FG002|Overall Study|Investigator Site Closed|0
2324410|NCT03012061|4040949|FG000|Overall Study|Lost to Follow-up|2
2324411|NCT03012061|4040950|FG001|Overall Study|Lost to Follow-up|1
2324412|NCT03012061|4040951|FG002|Overall Study|Lost to Follow-up|0
2324413|NCT03012061|4040949|FG000|Overall Study|Study closed/ Terminated|0
2324414|NCT03012061|4040950|FG001|Overall Study|Study closed/ Terminated|0
2324415|NCT03012061|4040951|FG002|Overall Study|Study closed/ Terminated|1
2324416|NCT03012061|4040949|FG000|Overall Study|Met Protocol Withdrawal Criterion|0
2324417|NCT03012061|4040950|FG001|Overall Study|Met Protocol Withdrawal Criterion|0
2324418|NCT03012061|4040951|FG002|Overall Study|Met Protocol Withdrawal Criterion|1
2324419|NCT03012061|4040949|FG000|Overall Study|Protocol Violation|0
2324420|NCT03012061|4040950|FG001|Overall Study|Protocol Violation|0
2324421|NCT03012061|4040951|FG002|Overall Study|Protocol Violation|2
2324422|NCT03012061|4040949|FG000|Overall Study|Lack of Efficacy|0
2324423|NCT03012061|4040950|FG001|Overall Study|Lack of Efficacy|1
2324424|NCT03012061|4040951|FG002|Overall Study|Lack of Efficacy|0
2324425|NCT03012061|4040949|FG000|Overall Study|Adverse Event|2
2324426|NCT03012061|4040950|FG001|Overall Study|Adverse Event|0
2324427|NCT03012061|4040951|FG002|Overall Study|Adverse Event|0
2324428|NCT03012334|4040983|FG000|Period 1|Withdrawal by Subject|0
2324429|NCT03012334|4040984|FG001|Period 1|Withdrawal by Subject|0
2324430|NCT03012334|4040985|FG002|Period 1|Withdrawal by Subject|0
2324431|NCT03012334|4040986|FG003|Period 1|Withdrawal by Subject|0
2324432|NCT03012334|4040987|FG004|Period 1|Withdrawal by Subject|0
2324433|NCT03012334|4040988|FG005|Period 1|Withdrawal by Subject|0
2324434|NCT03012334|4040989|FG006|Period 1|Withdrawal by Subject|0
2324435|NCT03012334|4040990|FG007|Period 1|Withdrawal by Subject|0
2324436|NCT03012334|4040991|FG008|Period 1|Withdrawal by Subject|0
2324437|NCT03012334|4040992|FG009|Period 1|Withdrawal by Subject|1
2324438|NCT03012334|4040983|FG000|Period 2|Withdrawal by Subject|0
2324439|NCT03012334|4040984|FG001|Period 2|Withdrawal by Subject|1
2324440|NCT03012334|4040985|FG002|Period 2|Withdrawal by Subject|0
2324441|NCT03012334|4040986|FG003|Period 2|Withdrawal by Subject|0
2324442|NCT03012334|4040987|FG004|Period 2|Withdrawal by Subject|0
2324443|NCT03012334|4040988|FG005|Period 2|Withdrawal by Subject|0
2324444|NCT03012334|4040989|FG006|Period 2|Withdrawal by Subject|0
2324445|NCT03012334|4040990|FG007|Period 2|Withdrawal by Subject|0
2324446|NCT03012334|4040991|FG008|Period 2|Withdrawal by Subject|0
2324447|NCT03012334|4040992|FG009|Period 2|Withdrawal by Subject|0
2324448|NCT03012334|4040983|FG000|Period 2|Protocol Violation|0
2324449|NCT03012334|4040984|FG001|Period 2|Protocol Violation|0
2324450|NCT03012334|4040985|FG002|Period 2|Protocol Violation|1
2324451|NCT03012334|4040986|FG003|Period 2|Protocol Violation|0
2324452|NCT03012334|4040987|FG004|Period 2|Protocol Violation|0
2324453|NCT03012334|4040988|FG005|Period 2|Protocol Violation|0
2324454|NCT03012334|4040989|FG006|Period 2|Protocol Violation|0
2324455|NCT03012334|4040990|FG007|Period 2|Protocol Violation|1
2324456|NCT03012334|4040991|FG008|Period 2|Protocol Violation|0
2324457|NCT03012334|4040992|FG009|Period 2|Protocol Violation|0
2324458|NCT03012334|4040983|FG000|Period 4|Non-Compliance|0
2324459|NCT03012334|4040984|FG001|Period 4|Non-Compliance|0
2324460|NCT03012334|4040985|FG002|Period 4|Non-Compliance|0
2324461|NCT03012334|4040986|FG003|Period 4|Non-Compliance|0
2324462|NCT03012334|4040987|FG004|Period 4|Non-Compliance|0
2324463|NCT03012334|4040988|FG005|Period 4|Non-Compliance|0
2324464|NCT03012334|4040989|FG006|Period 4|Non-Compliance|1
2324465|NCT03012334|4040990|FG007|Period 4|Non-Compliance|0
2324466|NCT03012334|4040991|FG008|Period 4|Non-Compliance|0
2324467|NCT03012334|4040992|FG009|Period 4|Non-Compliance|0
2324468|NCT03012334|4040983|FG000|Period 4|Adverse Event|0
2324469|NCT03012334|4040984|FG001|Period 4|Adverse Event|0
2324470|NCT03012334|4040985|FG002|Period 4|Adverse Event|0
2324471|NCT03012334|4040986|FG003|Period 4|Adverse Event|0
2324472|NCT03012334|4040987|FG004|Period 4|Adverse Event|0
2324473|NCT03012334|4040988|FG005|Period 4|Adverse Event|0
2324474|NCT03012334|4040989|FG006|Period 4|Adverse Event|0
2324475|NCT03012334|4040990|FG007|Period 4|Adverse Event|0
2324476|NCT03012334|4040991|FG008|Period 4|Adverse Event|1
2324477|NCT03012334|4040992|FG009|Period 4|Adverse Event|0
2324478|NCT03012828|4041027|FG000|Overall Study|Lost to Follow-up|1
2324479|NCT03012828|4041028|FG001|Overall Study|Lost to Follow-up|0
2324480|NCT03012828|4041029|FG002|Overall Study|Lost to Follow-up|1
2324481|NCT03012828|4041030|FG003|Overall Study|Lost to Follow-up|0
2324482|NCT03012828|4041031|FG004|Overall Study|Lost to Follow-up|1
2324483|NCT03012828|4041032|FG005|Overall Study|Lost to Follow-up|0
2324484|NCT03012828|4041027|FG000|Overall Study|Withdrawal by Subject|0
2324485|NCT03012828|4041028|FG001|Overall Study|Withdrawal by Subject|0
2324486|NCT03012828|4041029|FG002|Overall Study|Withdrawal by Subject|1
2324487|NCT03012828|4041030|FG003|Overall Study|Withdrawal by Subject|0
2324488|NCT03012828|4041031|FG004|Overall Study|Withdrawal by Subject|0
2324489|NCT03012828|4041032|FG005|Overall Study|Withdrawal by Subject|1
2324490|NCT03012828|4041027|FG000|Overall Study|Non-compliance with protocol|0
2324491|NCT03012828|4041028|FG001|Overall Study|Non-compliance with protocol|0
2324492|NCT03012828|4041029|FG002|Overall Study|Non-compliance with protocol|0
2324493|NCT03012828|4041030|FG003|Overall Study|Non-compliance with protocol|0
2324494|NCT03012828|4041031|FG004|Overall Study|Non-compliance with protocol|1
2324495|NCT03012828|4041032|FG005|Overall Study|Non-compliance with protocol|0
2324496|NCT03012828|4041027|FG000|Overall Study|Delay to last visit would delay DBL|0
2324497|NCT03012828|4041028|FG001|Overall Study|Delay to last visit would delay DBL|0
2324498|NCT03012828|4041029|FG002|Overall Study|Delay to last visit would delay DBL|0
2324499|NCT03012828|4041030|FG003|Overall Study|Delay to last visit would delay DBL|0
2324500|NCT03012828|4041031|FG004|Overall Study|Delay to last visit would delay DBL|0
2324501|NCT03012828|4041032|FG005|Overall Study|Delay to last visit would delay DBL|1
2324502|NCT03012841|4041048|FG000|Overall Study|Protocol Violation|0
2324503|NCT03012841|4041049|FG001|Overall Study|Protocol Violation|10
2324504|NCT03012841|4041048|FG000|Overall Study|Lost to Follow-up|6
2324505|NCT03012841|4041049|FG001|Overall Study|Lost to Follow-up|1
2324506|NCT03012841|4041048|FG000|Overall Study|Withdrawal by Subject|6
2324507|NCT03012841|4041049|FG001|Overall Study|Withdrawal by Subject|0
2324508|NCT03012841|4041048|FG000|Overall Study|Unable to complete 12 month visit|6
2324509|NCT03012841|4041049|FG001|Overall Study|Unable to complete 12 month visit|0
2324510|NCT03012841|4041048|FG000|Overall Study|Subject relocation|1
2324511|NCT03012841|4041049|FG001|Overall Study|Subject relocation|0
2324512|NCT03012841|4041048|FG000|Overall Study|Seasonal winter travel|1
2324513|NCT03012841|4041049|FG001|Overall Study|Seasonal winter travel|0
2324514|NCT03012841|4041048|FG000|Overall Study|Physician Decision|0
2324515|NCT03012841|4041049|FG001|Overall Study|Physician Decision|2
2324516|NCT03012841|4041048|FG000|Overall Study|No ablation performed|0
2324517|NCT03012841|4041049|FG001|Overall Study|No ablation performed|2
2324518|NCT03012841|4041048|FG000|Overall Study|Study reached n=165 treated subject cap|0
2324519|NCT03012841|4041049|FG001|Overall Study|Study reached n=165 treated subject cap|5
2324520|NCT03012841|4041048|FG000|Overall Study|Insurance change|0
2324521|NCT03012841|4041049|FG001|Overall Study|Insurance change|1
2324522|NCT03013985|4041056|FG000|Overall Study|Protocol Violation|2
2324523|NCT03013985|4041057|FG001|Overall Study|Protocol Violation|2
2324524|NCT03013985|4041056|FG000|Overall Study|Withdrawal by Subject|14
2324525|NCT03013985|4041057|FG001|Overall Study|Withdrawal by Subject|17
2324526|NCT03014011|4041063|FG000|First Intervention|Withdrawal by Subject|1
2324527|NCT03014011|4041064|FG001|First Intervention|Withdrawal by Subject|0
2324528|NCT03014011|4041063|FG000|Washout|Withdrawal by Subject|1
2324529|NCT03014011|4041064|FG001|Washout|Withdrawal by Subject|0
2324530|NCT03014180|4041070|FG000|Overall Study|Protocol Violation|2
2324531|NCT03014206|4041078|FG000|Overall Study|Registration Violation|12
2324532|NCT03014453|4041082|FG000|Overall Study|Lost to Follow-up|12
2324533|NCT03014453|4041082|FG000|Overall Study|Discontinued GER|3
2324534|NCT03014453|4041082|FG000|Overall Study|Excluded|19
2324535|NCT03014453|4041082|FG000|Overall Study|Refused to take part in|37
2324536|NCT03014479|4041088|FG000|Overall Study|Adverse Event|0
2217957|NCT01710800|3861284|FG000|Overall Study|Withdrawal by Subject|21
2217958|NCT01710800|3861284|FG000|Overall Study|Protocol Violation|1
2324537|NCT03014479|4041089|FG001|Overall Study|Adverse Event|1
2324538|NCT03014479|4041088|FG000|Overall Study|Voluntary Withdrawal|0
2324539|NCT03014479|4041089|FG001|Overall Study|Voluntary Withdrawal|2
2324540|NCT03014479|4041088|FG000|Overall Study|Unacceptable Inability of Site Visit|0
2324541|NCT03014479|4041089|FG001|Overall Study|Unacceptable Inability of Site Visit|1
2324542|NCT03014674|4041107|FG000|Overall Study|Withdrawal by Subject|1
2324543|NCT03014674|4041108|FG001|Overall Study|Withdrawal by Subject|0
2324544|NCT03014674|4041109|FG002|Overall Study|Withdrawal by Subject|0
2324545|NCT03015116|4041129|FG000|Overall Study|Lost to Follow-up|3
2324546|NCT03015116|4041130|FG001|Overall Study|Lost to Follow-up|0
2324547|NCT03015116|4041131|FG002|Overall Study|Lost to Follow-up|2
2324548|NCT03015116|4041129|FG000|Overall Study|Withdrawal by Subject|3
2324549|NCT03015116|4041130|FG001|Overall Study|Withdrawal by Subject|1
2324550|NCT03015116|4041131|FG002|Overall Study|Withdrawal by Subject|0
2324551|NCT03015116|4041129|FG000|Overall Study|Subject has New Medical Status|1
2324552|NCT03015116|4041130|FG001|Overall Study|Subject has New Medical Status|0
2324553|NCT03015116|4041131|FG002|Overall Study|Subject has New Medical Status|0
2324554|NCT03015116|4041129|FG000|Overall Study|Physician Decision|0
2324555|NCT03015116|4041130|FG001|Overall Study|Physician Decision|1
2324556|NCT03015116|4041131|FG002|Overall Study|Physician Decision|0
2324557|NCT03015181|4041154|FG000|Overall Study|Enrolled, but product never administered|1
2324558|NCT03015181|4041155|FG001|Overall Study|Enrolled, but product never administered|0
2324559|NCT03015181|4041156|FG002|Overall Study|Enrolled, but product never administered|0
2324560|NCT03015181|4041157|FG003|Overall Study|Enrolled, but product never administered|0
2324561|NCT03015181|4041158|FG004|Overall Study|Enrolled, but product never administered|0
2324562|NCT03015181|4041159|FG005|Overall Study|Enrolled, but product never administered|0
2324563|NCT03015181|4041160|FG006|Overall Study|Enrolled, but product never administered|0
2324564|NCT03015181|4041154|FG000|Overall Study|Withdrawal by Subject|0
2324565|NCT03015181|4041155|FG001|Overall Study|Withdrawal by Subject|0
2324566|NCT03015181|4041156|FG002|Overall Study|Withdrawal by Subject|0
2324567|NCT03015181|4041157|FG003|Overall Study|Withdrawal by Subject|0
2324568|NCT03015181|4041158|FG004|Overall Study|Withdrawal by Subject|0
2324569|NCT03015181|4041159|FG005|Overall Study|Withdrawal by Subject|1
2324570|NCT03015181|4041160|FG006|Overall Study|Withdrawal by Subject|0
2324571|NCT03015181|4041154|FG000|Overall Study|Physician Decision|0
2324572|NCT03015181|4041155|FG001|Overall Study|Physician Decision|0
2324573|NCT03015181|4041156|FG002|Overall Study|Physician Decision|0
2324574|NCT03015181|4041157|FG003|Overall Study|Physician Decision|0
2324575|NCT03015181|4041158|FG004|Overall Study|Physician Decision|0
2324576|NCT03015181|4041159|FG005|Overall Study|Physician Decision|0
2324577|NCT03015181|4041160|FG006|Overall Study|Physician Decision|1
2324578|NCT03015194|4041196|FG000|Overall Study|Death|10
2324579|NCT03015194|4041196|FG000|Overall Study|Withdrawal by Subject|2
2324580|NCT03015220|4041205|FG000|Overall Study|Withdrawal by Subject|3
2324581|NCT03015220|4041206|FG001|Overall Study|Withdrawal by Subject|2
2324582|NCT03015220|4041207|FG002|Overall Study|Withdrawal by Subject|2
2324583|NCT03015220|4041208|FG003|Overall Study|Withdrawal by Subject|2
2324584|NCT03015220|4041205|FG000|Overall Study|Lost to Follow-up|0
2324585|NCT03015220|4041206|FG001|Overall Study|Lost to Follow-up|0
2324586|NCT03015220|4041207|FG002|Overall Study|Lost to Follow-up|1
2324587|NCT03015220|4041208|FG003|Overall Study|Lost to Follow-up|0
2324588|NCT03015363|4041218|FG000|Overall Study|Physician Decision|14
2324589|NCT03015363|4041218|FG000|Overall Study|Withdrawal by Subject|3
2324590|NCT03015532|4041230|FG000|Overall Study|Adverse Event|0
2324591|NCT03015532|4041231|FG001|Overall Study|Adverse Event|0
2324592|NCT03015532|4041232|FG002|Overall Study|Adverse Event|0
2324593|NCT03015532|4041233|FG003|Overall Study|Adverse Event|0
2324594|NCT03015532|4041234|FG004|Overall Study|Adverse Event|0
2324595|NCT03015532|4041235|FG005|Overall Study|Adverse Event|2
2324596|NCT03015532|4041236|FG006|Overall Study|Adverse Event|1
2324597|NCT03015532|4041237|FG007|Overall Study|Adverse Event|0
2324598|NCT03015532|4041230|FG000|Overall Study|Withdrawal by Subject|0
2324599|NCT03015532|4041231|FG001|Overall Study|Withdrawal by Subject|0
2324600|NCT03015532|4041232|FG002|Overall Study|Withdrawal by Subject|0
2324601|NCT03015532|4041233|FG003|Overall Study|Withdrawal by Subject|0
2324602|NCT03015532|4041234|FG004|Overall Study|Withdrawal by Subject|0
2324603|NCT03015532|4041235|FG005|Overall Study|Withdrawal by Subject|0
2324604|NCT03015532|4041236|FG006|Overall Study|Withdrawal by Subject|1
2324605|NCT03015532|4041237|FG007|Overall Study|Withdrawal by Subject|0
2217959|NCT01711216|3861321|FG000|Overall Study|Adverse Event|4
2324606|NCT03016078|4041270|FG000|Overall Study|Protocol Violation|1
2324607|NCT03016078|4041270|FG000|Overall Study|Protocol Violation|1
2324608|NCT03016325|4041282|FG000|Treatment Period|Participant withdrew consent|0
2324609|NCT03016325|4041283|FG001|Treatment Period|Participant withdrew consent|1
2324610|NCT03016325|4041284|FG002|Treatment Period|Participant withdrew consent|0
2324611|NCT03016325|4041285|FG003|Treatment Period|Participant withdrew consent|0
2324612|NCT03016325|4041286|FG004|Treatment Period|Participant withdrew consent|0
2324613|NCT03016325|4041287|FG005|Treatment Period|Participant withdrew consent|0
2324614|NCT03016325|4041288|FG006|Treatment Period|Participant withdrew consent|0
2324615|NCT03016325|4041289|FG007|Treatment Period|Participant withdrew consent|0
2324616|NCT03016325|4041282|FG000|Treatment Period|Death|0
2324617|NCT03016325|4041283|FG001|Treatment Period|Death|0
2324618|NCT03016325|4041284|FG002|Treatment Period|Death|0
2324619|NCT03016325|4041285|FG003|Treatment Period|Death|0
2324620|NCT03016325|4041286|FG004|Treatment Period|Death|2
2324621|NCT03016325|4041287|FG005|Treatment Period|Death|0
2324622|NCT03016325|4041288|FG006|Treatment Period|Death|0
2324623|NCT03016325|4041289|FG007|Treatment Period|Death|0
2324624|NCT03016325|4041282|FG000|Treatment Period|Participant refuses assessments|0
2324625|NCT03016325|4041283|FG001|Treatment Period|Participant refuses assessments|0
2324626|NCT03016325|4041284|FG002|Treatment Period|Participant refuses assessments|1
2324627|NCT03016325|4041285|FG003|Treatment Period|Participant refuses assessments|0
2324628|NCT03016325|4041286|FG004|Treatment Period|Participant refuses assessments|0
2324629|NCT03016325|4041287|FG005|Treatment Period|Participant refuses assessments|0
2324630|NCT03016325|4041288|FG006|Treatment Period|Participant refuses assessments|0
2324631|NCT03016325|4041289|FG007|Treatment Period|Participant refuses assessments|0
2324632|NCT03016325|4041282|FG000|32-Day Follow-Up Period|Death|2
2324633|NCT03016325|4041283|FG001|32-Day Follow-Up Period|Death|0
2324634|NCT03016325|4041284|FG002|32-Day Follow-Up Period|Death|5
2324635|NCT03016325|4041285|FG003|32-Day Follow-Up Period|Death|6
2324636|NCT03016325|4041286|FG004|32-Day Follow-Up Period|Death|3
2324637|NCT03016325|4041287|FG005|32-Day Follow-Up Period|Death|0
2324638|NCT03016325|4041288|FG006|32-Day Follow-Up Period|Death|0
2324639|NCT03016325|4041289|FG007|32-Day Follow-Up Period|Death|0
2324640|NCT03016325|4041282|FG000|32-Day Follow-Up Period|Lost to Follow-up|1
2324641|NCT03016325|4041283|FG001|32-Day Follow-Up Period|Lost to Follow-up|0
2324642|NCT03016325|4041284|FG002|32-Day Follow-Up Period|Lost to Follow-up|1
2324643|NCT03016325|4041285|FG003|32-Day Follow-Up Period|Lost to Follow-up|1
2324644|NCT03016325|4041286|FG004|32-Day Follow-Up Period|Lost to Follow-up|0
2324645|NCT03016325|4041287|FG005|32-Day Follow-Up Period|Lost to Follow-up|0
2324646|NCT03016325|4041288|FG006|32-Day Follow-Up Period|Lost to Follow-up|0
2324647|NCT03016325|4041289|FG007|32-Day Follow-Up Period|Lost to Follow-up|0
2324648|NCT03016325|4041282|FG000|32-Day Follow-Up Period|Poor/non-compliance|1
2324649|NCT03016325|4041283|FG001|32-Day Follow-Up Period|Poor/non-compliance|0
2324650|NCT03016325|4041284|FG002|32-Day Follow-Up Period|Poor/non-compliance|0
2324651|NCT03016325|4041285|FG003|32-Day Follow-Up Period|Poor/non-compliance|1
2324652|NCT03016325|4041286|FG004|32-Day Follow-Up Period|Poor/non-compliance|1
2324653|NCT03016325|4041287|FG005|32-Day Follow-Up Period|Poor/non-compliance|0
2324654|NCT03016325|4041288|FG006|32-Day Follow-Up Period|Poor/non-compliance|0
2324655|NCT03016325|4041289|FG007|32-Day Follow-Up Period|Poor/non-compliance|0
2324656|NCT03016325|4041282|FG000|32-Day Follow-Up Period|Participant refused to visit|0
2324657|NCT03016325|4041283|FG001|32-Day Follow-Up Period|Participant refused to visit|1
2324658|NCT03016325|4041284|FG002|32-Day Follow-Up Period|Participant refused to visit|2
2324659|NCT03016325|4041285|FG003|32-Day Follow-Up Period|Participant refused to visit|0
2324660|NCT03016325|4041286|FG004|32-Day Follow-Up Period|Participant refused to visit|2
2324661|NCT03016325|4041287|FG005|32-Day Follow-Up Period|Participant refused to visit|0
2324662|NCT03016325|4041288|FG006|32-Day Follow-Up Period|Participant refused to visit|0
2324663|NCT03016325|4041289|FG007|32-Day Follow-Up Period|Participant refused to visit|0
2324664|NCT03016325|4041282|FG000|32-Day Follow-Up Period|Participant withdrew consent|0
2324665|NCT03016325|4041283|FG001|32-Day Follow-Up Period|Participant withdrew consent|0
2324666|NCT03016325|4041284|FG002|32-Day Follow-Up Period|Participant withdrew consent|0
2324667|NCT03016325|4041285|FG003|32-Day Follow-Up Period|Participant withdrew consent|0
2324668|NCT03016325|4041286|FG004|32-Day Follow-Up Period|Participant withdrew consent|2
2324669|NCT03016325|4041287|FG005|32-Day Follow-Up Period|Participant withdrew consent|0
2324670|NCT03016325|4041288|FG006|32-Day Follow-Up Period|Participant withdrew consent|1
2324671|NCT03016325|4041289|FG007|32-Day Follow-Up Period|Participant withdrew consent|0
2324672|NCT03016325|4041282|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
2324673|NCT03016325|4041283|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
2324674|NCT03016325|4041284|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1
2324675|NCT03016325|4041285|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
2324676|NCT03016325|4041286|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
2324677|NCT03016325|4041287|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
2324678|NCT03016325|4041288|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
2324679|NCT03016325|4041289|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
2324680|NCT03016325|4041282|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
2324681|NCT03016325|4041283|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1
2324682|NCT03016325|4041284|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
2324683|NCT03016325|4041285|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
2324684|NCT03016325|4041286|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
2324685|NCT03016325|4041287|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
2324686|NCT03016325|4041288|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
2324687|NCT03016325|4041289|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
2324688|NCT03016325|4041282|FG000|182-Day Follow-Up Period|Death|3
2324689|NCT03016325|4041283|FG001|182-Day Follow-Up Period|Death|3
2324690|NCT03016325|4041284|FG002|182-Day Follow-Up Period|Death|11
2324691|NCT03016325|4041285|FG003|182-Day Follow-Up Period|Death|12
2324692|NCT03016325|4041286|FG004|182-Day Follow-Up Period|Death|9
2324693|NCT03016325|4041287|FG005|182-Day Follow-Up Period|Death|0
2324694|NCT03016325|4041288|FG006|182-Day Follow-Up Period|Death|0
2324695|NCT03016325|4041289|FG007|182-Day Follow-Up Period|Death|1
2324696|NCT03016325|4041282|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1
2324697|NCT03016325|4041283|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0
2324698|NCT03016325|4041284|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0
2324699|NCT03016325|4041285|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0
2324700|NCT03016325|4041286|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0
2324701|NCT03016325|4041287|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0
2324702|NCT03016325|4041288|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0
2324703|NCT03016325|4041289|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0
2324704|NCT03016325|4041282|FG000|182-Day Follow-Up Period|Participant withdrew consent|0
2324705|NCT03016325|4041283|FG001|182-Day Follow-Up Period|Participant withdrew consent|0
2324706|NCT03016325|4041284|FG002|182-Day Follow-Up Period|Participant withdrew consent|0
2217960|NCT01711216|3861321|FG000|Overall Study|Pregnancy|56
2217961|NCT01711216|3861321|FG000|Overall Study|Withdrawal by Subject|6
2217962|NCT01711216|3861321|FG000|Overall Study|Lost to Follow-up|46
2217963|NCT01711216|3861321|FG000|Overall Study|variety of other minor reasons|83
2217964|NCT01711216|3861321|FG000|Overall Study|no reason specified|22
2217965|NCT01711359|3861341|FG000|Treatment Period|Withdrawal by Subject|18
2217966|NCT01711359|3861342|FG001|Treatment Period|Withdrawal by Subject|7
2217967|NCT01711359|3861343|FG002|Treatment Period|Withdrawal by Subject|13
2217968|NCT01711359|3861341|FG000|Treatment Period|Lack of Efficacy|13
2217969|NCT01711359|3861342|FG001|Treatment Period|Lack of Efficacy|2
2217970|NCT01711359|3861343|FG002|Treatment Period|Lack of Efficacy|2
2217971|NCT01711359|3861341|FG000|Treatment Period|Adverse Event|8
2217972|NCT01711359|3861342|FG001|Treatment Period|Adverse Event|10
2217973|NCT01711359|3861343|FG002|Treatment Period|Adverse Event|24
2217974|NCT01711359|3861341|FG000|Treatment Period|Physician Decision|4
2217975|NCT01711359|3861342|FG001|Treatment Period|Physician Decision|3
2217976|NCT01711359|3861343|FG002|Treatment Period|Physician Decision|2
2217977|NCT01711359|3861341|FG000|Treatment Period|Death|3
2217978|NCT01711359|3861342|FG001|Treatment Period|Death|0
2324707|NCT03016325|4041285|FG003|182-Day Follow-Up Period|Participant withdrew consent|0
2324708|NCT03016325|4041286|FG004|182-Day Follow-Up Period|Participant withdrew consent|1
2324709|NCT03016325|4041287|FG005|182-Day Follow-Up Period|Participant withdrew consent|0
2324710|NCT03016325|4041288|FG006|182-Day Follow-Up Period|Participant withdrew consent|1
2324711|NCT03016325|4041289|FG007|182-Day Follow-Up Period|Participant withdrew consent|0
2324712|NCT03016325|4041282|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0
2324713|NCT03016325|4041283|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0
2324714|NCT03016325|4041284|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0
2324715|NCT03016325|4041285|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0
2217979|NCT01711359|3861343|FG002|Treatment Period|Death|0
2217980|NCT01711359|3861341|FG000|Treatment Period|Entry Criteria Not Met|1
2324716|NCT03016325|4041286|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1
2324717|NCT03016325|4041287|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0
2324718|NCT03016325|4041288|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0
2324719|NCT03016325|4041289|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0
2324720|NCT03016325|4041282|FG000|182-Day Follow-Up Period|Alive, per civil unit|0
2324721|NCT03016325|4041283|FG001|182-Day Follow-Up Period|Alive, per civil unit|0
2324722|NCT03016325|4041284|FG002|182-Day Follow-Up Period|Alive, per civil unit|0
2324723|NCT03016325|4041285|FG003|182-Day Follow-Up Period|Alive, per civil unit|0
2324724|NCT03016325|4041286|FG004|182-Day Follow-Up Period|Alive, per civil unit|1
2324725|NCT03016325|4041287|FG005|182-Day Follow-Up Period|Alive, per civil unit|0
2324726|NCT03016325|4041288|FG006|182-Day Follow-Up Period|Alive, per civil unit|0
2324727|NCT03016325|4041289|FG007|182-Day Follow-Up Period|Alive, per civil unit|0
2324728|NCT03016325|4041282|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0
2324729|NCT03016325|4041283|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0
2324730|NCT03016325|4041284|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0
2324731|NCT03016325|4041285|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1
2324732|NCT03016325|4041286|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0
2324733|NCT03016325|4041287|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0
2324734|NCT03016325|4041288|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0
2324735|NCT03016325|4041289|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0
2324736|NCT03016325|4041282|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
2324737|NCT03016325|4041283|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1
2324738|NCT03016325|4041284|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
2324739|NCT03016325|4041285|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
2324740|NCT03016325|4041286|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
2324741|NCT03016325|4041287|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
2324742|NCT03016325|4041288|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
2324743|NCT03016325|4041289|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
2324744|NCT03016325|4041282|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
2324745|NCT03016325|4041283|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
2324746|NCT03016325|4041284|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
2324747|NCT03016325|4041285|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
2324748|NCT03016325|4041286|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
2324749|NCT03016325|4041287|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5
2324750|NCT03016325|4041288|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3
2324751|NCT03016325|4041289|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4
2324752|NCT03016403|4041314|FG000|Baseline|Death|5
2324753|NCT03016403|4041315|FG001|Baseline|Death|8
2324754|NCT03016403|4041316|FG002|Baseline|Death|1
2324755|NCT03016403|4041317|FG003|Baseline|Death|0
2324756|NCT03016403|4041314|FG000|Baseline|Withdrawal by Subject|2
2324757|NCT03016403|4041315|FG001|Baseline|Withdrawal by Subject|8
2324758|NCT03016403|4041316|FG002|Baseline|Withdrawal by Subject|4
2324759|NCT03016403|4041317|FG003|Baseline|Withdrawal by Subject|10
2324760|NCT03016403|4041314|FG000|Baseline|Lost to Follow-up|9
2324761|NCT03016403|4041315|FG001|Baseline|Lost to Follow-up|11
2324762|NCT03016403|4041316|FG002|Baseline|Lost to Follow-up|6
2324763|NCT03016403|4041317|FG003|Baseline|Lost to Follow-up|24
2324764|NCT03016403|4041314|FG000|6-week Follow-up|Death|1
2324765|NCT03016403|4041315|FG001|6-week Follow-up|Death|4
2324766|NCT03016403|4041316|FG002|6-week Follow-up|Death|0
2324767|NCT03016403|4041317|FG003|6-week Follow-up|Death|0
2324768|NCT03016403|4041314|FG000|6-week Follow-up|Lost to Follow-up|2
2324769|NCT03016403|4041315|FG001|6-week Follow-up|Lost to Follow-up|7
2324770|NCT03016403|4041316|FG002|6-week Follow-up|Lost to Follow-up|4
2324771|NCT03016403|4041317|FG003|6-week Follow-up|Lost to Follow-up|8
2324772|NCT03016403|4041314|FG000|6-week Follow-up|Withdrawal by Subject|0
2324773|NCT03016403|4041315|FG001|6-week Follow-up|Withdrawal by Subject|2
2324774|NCT03016403|4041316|FG002|6-week Follow-up|Withdrawal by Subject|0
2324775|NCT03016403|4041317|FG003|6-week Follow-up|Withdrawal by Subject|1
2324776|NCT03016403|4041314|FG000|3-month Follow-up and 6-month Follow-up|Death|6
2324777|NCT03016403|4041315|FG001|3-month Follow-up and 6-month Follow-up|Death|4
2324778|NCT03016403|4041316|FG002|3-month Follow-up and 6-month Follow-up|Death|0
2324779|NCT03016403|4041317|FG003|3-month Follow-up and 6-month Follow-up|Death|0
2324780|NCT03016403|4041314|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
2324781|NCT03016403|4041315|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7
2324782|NCT03016403|4041316|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8
2324783|NCT03016403|4041317|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
2324784|NCT03016403|4041314|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
2324785|NCT03016403|4041315|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
2324786|NCT03016403|4041316|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
2324787|NCT03016403|4041317|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1
2324788|NCT03016598|4041331|FG000|Overall Study|Lost to Follow-up|0
2324789|NCT03016598|4041332|FG001|Overall Study|Lost to Follow-up|2
2324790|NCT03017079|4041340|FG000|Overall Study|Physician Decision|1
2324791|NCT03017079|4041341|FG001|Overall Study|Physician Decision|1
2324792|NCT03017079|4041340|FG000|Overall Study|Death|3
2324793|NCT03017079|4041341|FG001|Overall Study|Death|2
2324794|NCT03017079|4041340|FG000|Overall Study|Lack of Efficacy|2
2324795|NCT03017079|4041341|FG001|Overall Study|Lack of Efficacy|2
2324796|NCT03017079|4041340|FG000|Overall Study|Protocol Violation|0
2324797|NCT03017079|4041341|FG001|Overall Study|Protocol Violation|1
2324798|NCT03017235|4041356|FG000|Overall Study|Withdrawal by Subject|4
2324799|NCT03017235|4041357|FG001|Overall Study|Withdrawal by Subject|3
2324800|NCT03017235|4041356|FG000|Overall Study|Lost to Follow-up|2
2324801|NCT03017235|4041357|FG001|Overall Study|Lost to Follow-up|7
2030466|NCT00378703|3600044|FG002|Overall Study|Never started treatment|0
2030467|NCT00378703|3600045|FG003|Overall Study|Never started treatment|0
2110317|NCT00894686|3705047|FG000|Overall Study|Withdrawal by Subject|50
2110318|NCT00894686|3705047|FG000|Overall Study|Physician Decision|1
2110319|NCT00894686|3705047|FG000|Overall Study|Other|5
2110320|NCT00894803|3705071|FG000|Overall Study|Death|20
2110321|NCT00894803|3705072|FG001|Overall Study|Death|4
2110322|NCT00894803|3705071|FG000|Overall Study|Lost to Follow-up|0
2110323|NCT00894803|3705072|FG001|Overall Study|Lost to Follow-up|1
2110324|NCT00894933|3705078|FG000|Overall Study|Lost to Follow-up|2
2110325|NCT00894933|3705078|FG000|Overall Study|Cancelled Procedure|1
2110326|NCT00894933|3705078|FG000|Overall Study|Did not meeting incl/excl criteria|1
2110327|NCT00895011|3705085|FG000|Overall Study|Withdrawal by Subject|14
2110328|NCT00895011|3705086|FG001|Overall Study|Withdrawal by Subject|7
2110329|NCT00895011|3705087|FG002|Overall Study|Withdrawal by Subject|2
2110330|NCT00895011|3705085|FG000|Overall Study|Lost to Follow-up|5
2110331|NCT00895011|3705086|FG001|Overall Study|Lost to Follow-up|4
2110332|NCT00895011|3705087|FG002|Overall Study|Lost to Follow-up|1
2110333|NCT00895011|3705085|FG000|Overall Study|Protocol Violation|3
2110334|NCT00895011|3705086|FG001|Overall Study|Protocol Violation|1
2110335|NCT00895011|3705087|FG002|Overall Study|Protocol Violation|3
2110336|NCT00895011|3705085|FG000|Overall Study|Adverse Event|1
2110337|NCT00895011|3705086|FG001|Overall Study|Adverse Event|2
2110338|NCT00895011|3705087|FG002|Overall Study|Adverse Event|2
2110339|NCT00895011|3705085|FG000|Overall Study|schedule conflict|1
2110340|NCT00895011|3705086|FG001|Overall Study|schedule conflict|0
2110341|NCT00895011|3705087|FG002|Overall Study|schedule conflict|0
2180265|NCT01400451|3806302|FG002|Combination Treatment (or Intended)|Disease Progression|1
2180266|NCT01400451|3806300|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0
2180267|NCT01400451|3806301|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1
2180268|NCT01400451|3806302|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0
2180269|NCT01400503|3806324|FG000|Overall Study|Withdrawal by Subject|1
2180270|NCT01400503|3806324|FG000|Overall Study|Study Terminated by Sponsor|58
2180271|NCT01400503|3806324|FG000|Overall Study|Other|1
2180272|NCT01400516|3806330|FG000|Primary Trial|Withdrawal by Subject|0
2180273|NCT01400516|3806331|FG001|Primary Trial|Withdrawal by Subject|2
2180274|NCT01400698|3806341|FG000|Overall Study|Lost to Follow-up|2
2180275|NCT01400698|3806342|FG001|Overall Study|Lost to Follow-up|5
2180276|NCT01400698|3806343|FG002|Overall Study|Lost to Follow-up|2
2180277|NCT01400698|3806344|FG003|Overall Study|Lost to Follow-up|1
2180278|NCT01400698|3806345|FG004|Overall Study|Lost to Follow-up|4
2180279|NCT01400698|3806346|FG005|Overall Study|Lost to Follow-up|3
2180280|NCT01400698|3806341|FG000|Overall Study|Withdrawal by Subject|8
2180281|NCT01400698|3806342|FG001|Overall Study|Withdrawal by Subject|2
2180282|NCT01400698|3806343|FG002|Overall Study|Withdrawal by Subject|0
2180283|NCT01400698|3806344|FG003|Overall Study|Withdrawal by Subject|4
2180284|NCT01400698|3806345|FG004|Overall Study|Withdrawal by Subject|1
2180285|NCT01400698|3806346|FG005|Overall Study|Withdrawal by Subject|3
2180286|NCT01400698|3806341|FG000|Overall Study|Protocol Violation|0
2180287|NCT01400698|3806342|FG001|Overall Study|Protocol Violation|1
2180288|NCT01400698|3806343|FG002|Overall Study|Protocol Violation|0
2180289|NCT01400698|3806344|FG003|Overall Study|Protocol Violation|0
2180290|NCT01400698|3806345|FG004|Overall Study|Protocol Violation|1
2180291|NCT01400698|3806346|FG005|Overall Study|Protocol Violation|0
2180292|NCT01400698|3806341|FG000|Overall Study|Non-compliance|0
2180293|NCT01400698|3806342|FG001|Overall Study|Non-compliance|1
2180294|NCT01400698|3806343|FG002|Overall Study|Non-compliance|0
2180295|NCT01400698|3806344|FG003|Overall Study|Non-compliance|1
2180296|NCT01400698|3806345|FG004|Overall Study|Non-compliance|0
2180297|NCT01400698|3806346|FG005|Overall Study|Non-compliance|0
2180298|NCT01400698|3806341|FG000|Overall Study|Adverse Event|1
2180299|NCT01400698|3806342|FG001|Overall Study|Adverse Event|0
2180300|NCT01400698|3806343|FG002|Overall Study|Adverse Event|0
2180301|NCT01400698|3806344|FG003|Overall Study|Adverse Event|0
2180302|NCT01400698|3806345|FG004|Overall Study|Adverse Event|0
2180303|NCT01400698|3806346|FG005|Overall Study|Adverse Event|0
2180304|NCT01400698|3806341|FG000|Overall Study|Other|4
2180305|NCT01400698|3806342|FG001|Overall Study|Other|2
2180306|NCT01400698|3806343|FG002|Overall Study|Other|0
2324802|NCT03017235|4041356|FG000|Overall Study|Adverse Event|0
2324803|NCT03017235|4041357|FG001|Overall Study|Adverse Event|1
2324804|NCT03017235|4041356|FG000|Overall Study|Protocol Violation|2
2324805|NCT03017235|4041357|FG001|Overall Study|Protocol Violation|1
2324806|NCT03017235|4041356|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4
2324807|NCT03017235|4041357|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2
2324808|NCT03017612|4041376|FG000|Overall Study|Adverse Event|2
2324809|NCT03017846|4041380|FG000|Overall Study|Lost to Follow-up|3
2324810|NCT03017846|4041380|FG000|Overall Study|Adverse Event|2
2324811|NCT03018028|4041407|FG000|Overall Study|Withdrawal by Subject|3
2324812|NCT03018028|4041408|FG001|Overall Study|Withdrawal by Subject|0
2324813|NCT03018028|4041409|FG002|Overall Study|Withdrawal by Subject|1
2324814|NCT03018028|4041410|FG003|Overall Study|Withdrawal by Subject|2
2324815|NCT03018028|4041411|FG004|Overall Study|Withdrawal by Subject|0
2324816|NCT03018106|4041425|FG000|Overall Study|Lost to Follow-up|0
2324817|NCT03018106|4041426|FG001|Overall Study|Lost to Follow-up|1
2324818|NCT03018249|4041436|FG000|Overall Study|Withdrawal by Subject|2
2324819|NCT03018249|4041437|FG001|Overall Study|Withdrawal by Subject|2
2324820|NCT03018340|4041445|FG000|Overall Study|Adverse Event|1
2324821|NCT03018340|4041446|FG001|Overall Study|Adverse Event|2
2324822|NCT03018340|4041445|FG000|Overall Study|Withdrawal by Subject|0
2324823|NCT03018340|4041446|FG001|Overall Study|Withdrawal by Subject|8
2324824|NCT03018340|4041445|FG000|Overall Study|Lack of Efficacy|0
2324825|NCT03018340|4041446|FG001|Overall Study|Lack of Efficacy|1
2324826|NCT03018340|4041445|FG000|Overall Study|Non-compliance with study drug/procedure|3
2324827|NCT03018340|4041446|FG001|Overall Study|Non-compliance with study drug/procedure|4
2324828|NCT03018340|4041445|FG000|Overall Study|Lost to Follow-up|1
2324829|NCT03018340|4041446|FG001|Overall Study|Lost to Follow-up|7
2324830|NCT03018340|4041445|FG000|Overall Study|Protocol Violation|3
2324831|NCT03018340|4041446|FG001|Overall Study|Protocol Violation|7
2324832|NCT03018340|4041445|FG000|Overall Study|Not further specified|0
2324833|NCT03018340|4041446|FG001|Overall Study|Not further specified|1
2324834|NCT03018691|4041459|FG000|Overall Study|Adverse Event|1
2324835|NCT03018691|4041460|FG001|Overall Study|Adverse Event|1
2324836|NCT03018691|4041461|FG002|Overall Study|Adverse Event|4
2324837|NCT03018691|4041459|FG000|Overall Study|Lack of Efficacy|0
2324838|NCT03018691|4041460|FG001|Overall Study|Lack of Efficacy|0
2324839|NCT03018691|4041461|FG002|Overall Study|Lack of Efficacy|1
2324840|NCT03018691|4041459|FG000|Overall Study|Withdrawal by Subject|0
2324841|NCT03018691|4041460|FG001|Overall Study|Withdrawal by Subject|0
2324842|NCT03018691|4041461|FG002|Overall Study|Withdrawal by Subject|1
2324843|NCT03018691|4041459|FG000|Overall Study|Withdrawal by parent/guardian|1
2324844|NCT03018691|4041460|FG001|Overall Study|Withdrawal by parent/guardian|0
2324845|NCT03018691|4041461|FG002|Overall Study|Withdrawal by parent/guardian|1
2352372|NCT03792672|4101413|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0
2352373|NCT03792672|4101408|FG000|Washout Period 3 (10 Days)|Physician Decision|0
2352374|NCT03792672|4101409|FG001|Washout Period 3 (10 Days)|Physician Decision|0
2352375|NCT03792672|4101410|FG002|Washout Period 3 (10 Days)|Physician Decision|1
2352376|NCT03792672|4101411|FG003|Washout Period 3 (10 Days)|Physician Decision|0
2217981|NCT01711359|3861342|FG001|Treatment Period|Entry Criteria Not Met|0
2217982|NCT01711359|3861343|FG002|Treatment Period|Entry Criteria Not Met|0
2352377|NCT03792672|4101412|FG004|Washout Period 3 (10 Days)|Physician Decision|0
2352378|NCT03792672|4101413|FG005|Washout Period 3 (10 Days)|Physician Decision|0
2352379|NCT03792672|4101408|FG000|Treatment Period 4 (2 Days)|Other|1
2352380|NCT03792672|4101409|FG001|Treatment Period 4 (2 Days)|Other|0
2352381|NCT03792672|4101410|FG002|Treatment Period 4 (2 Days)|Other|0
2352382|NCT03792672|4101411|FG003|Treatment Period 4 (2 Days)|Other|0
2352383|NCT03792672|4101412|FG004|Treatment Period 4 (2 Days)|Other|0
2352384|NCT03792672|4101413|FG005|Treatment Period 4 (2 Days)|Other|0
2352385|NCT03787615|4101522|FG000|Overall Study|Withdrawal by Subject|2
2352386|NCT03787615|4101522|FG000|Overall Study|Lost to Follow-up|2
2352387|NCT03786718|4101527|FG000|Overall Study|Lost to Follow-up|3
2352388|NCT03786718|4101527|FG000|Overall Study|Withdrawal by Subject|1
2352389|NCT03786718|4101527|FG000|Overall Study|Did not use the intervention|2
2352390|NCT03786718|4101527|FG000|Overall Study|diagnosis changed from type 2 to type 1|1
2352391|NCT03784963|4101536|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12
2352392|NCT03784963|4101537|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10
2352393|NCT03784963|4101538|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1
2352394|NCT03784963|4101539|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0
2352395|NCT03787212|4101560|FG000|Period 1|Study Termination|2
2352396|NCT03787212|4101561|FG001|Period 1|Study Termination|2
2352397|NCT03783702|4101586|FG000|Overall Study|Lost to Follow-up|6
2352398|NCT03783702|4101587|FG001|Overall Study|Lost to Follow-up|8
2352399|NCT03783702|4101586|FG000|Overall Study|Protocol Violation|1
2352400|NCT03783702|4101587|FG001|Overall Study|Protocol Violation|3
2352401|NCT03783039|4101645|FG000|Overall Study|Death|2
2352402|NCT03783039|4101646|FG001|Overall Study|Death|1
2352403|NCT03776175|4101674|FG000|Treatment Period (42 Days)|Adverse Event|0
2352404|NCT03776175|4101675|FG001|Treatment Period (42 Days)|Adverse Event|1
2352405|NCT03776175|4101676|FG002|Treatment Period (42 Days)|Adverse Event|1
2352406|NCT03776175|4101677|FG003|Treatment Period (42 Days)|Adverse Event|0
2352407|NCT03776175|4101674|FG000|Treatment Period (42 Days)|Lost to Follow-up|0
2324846|NCT03018938|4041498|FG000|Overall Study|Death|0
2324847|NCT03018938|4041499|FG001|Overall Study|Death|1
2324848|NCT03018938|4041498|FG000|Overall Study|Lost to Follow-up|21
2324849|NCT03018938|4041499|FG001|Overall Study|Lost to Follow-up|32
2324850|NCT03018938|4041498|FG000|Overall Study|Withdrawal by Subject|38
2324851|NCT03018938|4041499|FG001|Overall Study|Withdrawal by Subject|45
2324852|NCT03018938|4041498|FG000|Overall Study|Physician Decision|3
2324853|NCT03018938|4041499|FG001|Overall Study|Physician Decision|2
2324854|NCT03018938|4041498|FG000|Overall Study|Sponsor Decision|0
2324855|NCT03018938|4041499|FG001|Overall Study|Sponsor Decision|1
2324856|NCT03018938|4041498|FG000|Overall Study|Screen failure-After randomization|4
2324857|NCT03018938|4041499|FG001|Overall Study|Screen failure-After randomization|2
2324858|NCT03018938|4041498|FG000|Overall Study|Not recorded|0
2324859|NCT03018938|4041499|FG001|Overall Study|Not recorded|2
2324860|NCT03019289|4041540|FG000|Overall Study|Adverse Event|1
2324861|NCT03019289|4041541|FG001|Overall Study|Adverse Event|0
2324862|NCT03019289|4041542|FG002|Overall Study|Adverse Event|0
2324863|NCT03019289|4041543|FG003|Overall Study|Adverse Event|0
2324864|NCT03019289|4041544|FG004|Overall Study|Adverse Event|0
2324865|NCT03019289|4041545|FG005|Overall Study|Adverse Event|0
2324866|NCT03019289|4041546|FG006|Overall Study|Adverse Event|0
2324867|NCT03019289|4041547|FG007|Overall Study|Adverse Event|0
2324868|NCT03019289|4041548|FG008|Overall Study|Adverse Event|1
2324869|NCT03019289|4041540|FG000|Overall Study|Other|1
2324870|NCT03019289|4041541|FG001|Overall Study|Other|0
2324871|NCT03019289|4041542|FG002|Overall Study|Other|0
2324872|NCT03019289|4041543|FG003|Overall Study|Other|0
2324873|NCT03019289|4041544|FG004|Overall Study|Other|0
2324874|NCT03019289|4041545|FG005|Overall Study|Other|0
2324875|NCT03019289|4041546|FG006|Overall Study|Other|0
2324876|NCT03019289|4041547|FG007|Overall Study|Other|0
2324877|NCT03019289|4041548|FG008|Overall Study|Other|0
2324878|NCT03019406|4041573|FG000|ETP: Ongoing From Week 26|Ongoing|6
2324879|NCT03019406|4041574|FG001|ETP: Ongoing From Week 26|Ongoing|5
2324880|NCT03019406|4041575|FG002|ETP: Ongoing From Week 26|Ongoing|5
2324881|NCT03019406|4041576|FG003|ETP: Ongoing From Week 26|Ongoing|3
2324882|NCT03019458|4041591|FG000|Overall Study|Death|0
2324883|NCT03019458|4041592|FG001|Overall Study|Death|1
2324884|NCT03019549|4041600|FG000|Washout|DId not meet genotype criteria|11
2324885|NCT03019549|4041600|FG000|Period 2|Adverse Event|2
2324886|NCT03019549|4041600|FG000|Period 2|Physician Decision|2
2324887|NCT03019549|4041600|FG000|Period 2|Withdrawal by Subject|1
2324888|NCT03019627|4041611|FG000|Overall Study|Adverse Event|8
2324889|NCT03019627|4041612|FG001|Overall Study|Adverse Event|0
2324890|NCT03019627|4041611|FG000|Overall Study|Unrelated to adverse event|1
2324891|NCT03019627|4041612|FG001|Overall Study|Unrelated to adverse event|3
2324892|NCT03019627|4041611|FG000|Overall Study|Lost to Follow-up|2
2324893|NCT03019627|4041612|FG001|Overall Study|Lost to Follow-up|1
2324894|NCT03019627|4041611|FG000|Overall Study|not compliance|2
2324895|NCT03019627|4041612|FG001|Overall Study|not compliance|2
2324896|NCT03019627|4041611|FG000|Overall Study|Other|2
2324897|NCT03019627|4041612|FG001|Overall Study|Other|2
2324898|NCT03019965|4041654|FG000|Overall Study|Withdrawal by Subject|1
2324899|NCT03019965|4041655|FG001|Overall Study|Withdrawal by Subject|0
2324900|NCT03019965|4041654|FG000|Overall Study|Protocol Violation|1
2324901|NCT03019965|4041655|FG001|Overall Study|Protocol Violation|3
2324902|NCT03019965|4041654|FG000|Overall Study|viral or fungal infection|3
2324903|NCT03019965|4041655|FG001|Overall Study|viral or fungal infection|4
2324904|NCT03019965|4041654|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4
2324905|NCT03019965|4041655|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5
2324906|NCT03019965|4041654|FG000|Overall Study|Physician Decision|1
2324907|NCT03019965|4041655|FG001|Overall Study|Physician Decision|1
2324908|NCT03020069|4041667|FG000|Overall Study|Lost to Follow-up|0
2324909|NCT03020069|4041668|FG001|Overall Study|Lost to Follow-up|1
2324910|NCT03020407|4041684|FG000|Overall Study|Withdrawal by Subject|2
2324911|NCT03020407|4041685|FG001|Overall Study|Withdrawal by Subject|1
2324912|NCT03020407|4041684|FG000|Overall Study|Lost to Follow-up|2
2324913|NCT03020407|4041685|FG001|Overall Study|Lost to Follow-up|3
2324914|NCT03020407|4041684|FG000|Overall Study|Protocol Violation|0
2324915|NCT03020407|4041685|FG001|Overall Study|Protocol Violation|1
2324916|NCT03020576|4041741|FG000|Overall Study|Withdrawal by Subject|1
2324917|NCT03020576|4041742|FG001|Overall Study|Withdrawal by Subject|2
2324918|NCT03020615|4041751|FG000|Overall Study|Physician Decision|3
2324919|NCT03020615|4041752|FG001|Overall Study|Physician Decision|1
2324920|NCT03020615|4041753|FG002|Overall Study|Physician Decision|2
2324921|NCT03020615|4041751|FG000|Overall Study|Parent/guardian/patient choice|3
2324922|NCT03020615|4041752|FG001|Overall Study|Parent/guardian/patient choice|0
2324923|NCT03020615|4041753|FG002|Overall Study|Parent/guardian/patient choice|4
2324924|NCT03020615|4041751|FG000|Overall Study|Screen failure|0
2324925|NCT03020615|4041752|FG001|Overall Study|Screen failure|0
2324926|NCT03020615|4041753|FG002|Overall Study|Screen failure|1
2324927|NCT03020615|4041751|FG000|Overall Study|Death|1
2324928|NCT03020615|4041752|FG001|Overall Study|Death|0
2324929|NCT03020615|4041753|FG002|Overall Study|Death|0
2324930|NCT03020615|4041751|FG000|Overall Study|Lost to Follow-up|0
2324931|NCT03020615|4041752|FG001|Overall Study|Lost to Follow-up|1
2324932|NCT03020615|4041753|FG002|Overall Study|Lost to Follow-up|0
2324933|NCT03020641|4041766|FG000|Overall Study|Lost to Follow-up|0
2324934|NCT03020641|4041767|FG001|Overall Study|Lost to Follow-up|1
2324935|NCT03020641|4041766|FG000|Overall Study|Converted to open surgery|2
2324936|NCT03020641|4041767|FG001|Overall Study|Converted to open surgery|1
2324937|NCT03020641|4041766|FG000|Overall Study|for surgery not performed|0
2324938|NCT03020641|4041767|FG001|Overall Study|for surgery not performed|1
2324939|NCT03020745|4041793|FG000|Part 2 (Up to 169 Days)|Adverse Event|0
2324940|NCT03020745|4041794|FG001|Part 2 (Up to 169 Days)|Adverse Event|0
2324941|NCT03020745|4041795|FG002|Part 2 (Up to 169 Days)|Adverse Event|0
2324942|NCT03020745|4041796|FG003|Part 2 (Up to 169 Days)|Adverse Event|0
2324943|NCT03020745|4041797|FG004|Part 2 (Up to 169 Days)|Adverse Event|0
2324944|NCT03020745|4041798|FG005|Part 2 (Up to 169 Days)|Adverse Event|0
2324945|NCT03020745|4041799|FG006|Part 2 (Up to 169 Days)|Adverse Event|0
2324946|NCT03020745|4041800|FG007|Part 2 (Up to 169 Days)|Adverse Event|0
2030468|NCT00378703|3600042|FG000|Overall Study|Other|1
2030469|NCT00378703|3600043|FG001|Overall Study|Other|1
2030470|NCT00378703|3600044|FG002|Overall Study|Other|2
2030471|NCT00378703|3600045|FG003|Overall Study|Other|3
2030472|NCT00378898|3600057|FG000|Overall Study|Withdrawal by Subject|10
2030473|NCT00378898|3600058|FG001|Overall Study|Withdrawal by Subject|5
2030474|NCT00378898|3600057|FG000|Overall Study|Protocol Violation|1
2030475|NCT00378898|3600058|FG001|Overall Study|Protocol Violation|1
2030476|NCT00379080|3600069|FG000|Overall Study|Withdrawal by Subject|0
2030477|NCT00379080|3600070|FG001|Overall Study|Withdrawal by Subject|4
2030478|NCT00379080|3600071|FG002|Overall Study|Withdrawal by Subject|0
2030479|NCT00379210|3600110|FG000|Overall Study|Withdrawal by Subject|10
2030480|NCT00379210|3600111|FG001|Overall Study|Withdrawal by Subject|7
2030481|NCT00379236|3600119|FG000|Double-blind|Adverse Event|11
2030482|NCT00379236|3600120|FG001|Double-blind|Adverse Event|6
2030483|NCT00379236|3600121|FG002|Double-blind|Adverse Event|0
2030484|NCT00379236|3600119|FG000|Double-blind|Protocol Violation|3
2030485|NCT00379236|3600120|FG001|Double-blind|Protocol Violation|3
2030486|NCT00379236|3600121|FG002|Double-blind|Protocol Violation|0
2030487|NCT00379236|3600119|FG000|Double-blind|Withdrawal by Subject|12
2030488|NCT00379236|3600120|FG001|Double-blind|Withdrawal by Subject|13
2030489|NCT00379236|3600121|FG002|Double-blind|Withdrawal by Subject|0
2030490|NCT00379236|3600119|FG000|Double-blind|Lost to Follow-up|4
2030491|NCT00379236|3600120|FG001|Double-blind|Lost to Follow-up|3
2030492|NCT00379236|3600121|FG002|Double-blind|Lost to Follow-up|0
2030493|NCT00379236|3600119|FG000|Double-blind|Use of exclusionary medication|1
2030494|NCT00379236|3600120|FG001|Double-blind|Use of exclusionary medication|2
2217983|NCT01711359|3861341|FG000|Treatment Period|Sponsor Decision|1
2217984|NCT01711359|3861342|FG001|Treatment Period|Sponsor Decision|0
2217985|NCT01711359|3861343|FG002|Treatment Period|Sponsor Decision|0
2217986|NCT01711359|3861341|FG000|Treatment Period|Lost to Follow-up|1
2217987|NCT01711359|3861342|FG001|Treatment Period|Lost to Follow-up|1
2217988|NCT01711359|3861343|FG002|Treatment Period|Lost to Follow-up|1
2217989|NCT01711359|3861341|FG000|Treatment Period|Randomized, Not Treated|3
2217990|NCT01711359|3861342|FG001|Treatment Period|Randomized, Not Treated|1
2217991|NCT01711359|3861343|FG002|Treatment Period|Randomized, Not Treated|0
2217992|NCT01711619|3861370|FG000|Overall Study|Early study termination|10
2217993|NCT01711619|3861371|FG001|Overall Study|Early study termination|14
2217994|NCT01711619|3861370|FG000|Overall Study|Withdrawal by Subject|3
2217995|NCT01711619|3861371|FG001|Overall Study|Withdrawal by Subject|7
2217996|NCT01711619|3861370|FG000|Overall Study|Protocol Violation|2
2324947|NCT03020745|4041801|FG008|Part 2 (Up to 169 Days)|Adverse Event|1
2217997|NCT01711619|3861371|FG001|Overall Study|Protocol Violation|3
2217998|NCT01711619|3861370|FG000|Overall Study|Adverse Event|2
2217999|NCT01711619|3861371|FG001|Overall Study|Adverse Event|0
2218000|NCT01711619|3861370|FG000|Overall Study|Lost to Follow-up|1
2218001|NCT01711619|3861371|FG001|Overall Study|Lost to Follow-up|0
2218002|NCT01711645|3861377|FG000|Overall Study|Withdrawal by Subject|8
2218003|NCT01711645|3861377|FG000|Overall Study|Lost to Follow-up|6
2218004|NCT01711645|3861377|FG000|Overall Study|Physician Decision|5
2218005|NCT01711736|3861392|FG000|Overall Study|Lost to Follow-up|4
2218006|NCT01711736|3861393|FG001|Overall Study|Lost to Follow-up|1
2218007|NCT01711736|3861392|FG000|Overall Study|Withdrawal by Subject|6
2218008|NCT01711736|3861393|FG001|Overall Study|Withdrawal by Subject|6
2218009|NCT01711736|3861392|FG000|Overall Study|Migrated/moved from study area|2
2218010|NCT01711736|3861393|FG001|Overall Study|Migrated/moved from study area|1
2218011|NCT01711853|3861400|FG000|Overall Study|Not treated|3
2218012|NCT01711866|3861404|FG000|Overall Study|Noncompliant|3
2218013|NCT01711866|3861404|FG000|Overall Study|Withdrawal by Subject|3
2218014|NCT01711866|3861404|FG000|Overall Study|Adverse Event|2
2218015|NCT01711879|3861410|FG000|Overall Study|Death|1
2218016|NCT01711879|3861411|FG001|Overall Study|Death|0
2218017|NCT01711983|3861423|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32
2218018|NCT01711983|3861423|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26
2218019|NCT01711983|3861423|FG000|36-Month Closure Evaluation|Test Device Removal|2
2218020|NCT01711983|3861423|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62
2218021|NCT01712009|3861430|FG000|Overall Study|Withdrawal by Subject|24
2218022|NCT01712009|3861431|FG001|Overall Study|Withdrawal by Subject|15
2218023|NCT01712009|3861432|FG002|Overall Study|Withdrawal by Subject|8
2218024|NCT01712009|3861430|FG000|Overall Study|Lost to Follow-up|2
2218025|NCT01712009|3861431|FG001|Overall Study|Lost to Follow-up|0
2218026|NCT01712009|3861432|FG002|Overall Study|Lost to Follow-up|1
2218027|NCT01712009|3861430|FG000|Overall Study|Decision by Sponsor|12
2218028|NCT01712009|3861431|FG001|Overall Study|Decision by Sponsor|14
2218029|NCT01712009|3861432|FG002|Overall Study|Decision by Sponsor|12
2218030|NCT01712061|3861442|FG000|Overall Study|Adverse Event|4
2218031|NCT01712061|3861443|FG001|Overall Study|Adverse Event|9
2218032|NCT01712061|3861444|FG002|Overall Study|Adverse Event|5
2218033|NCT01712061|3861442|FG000|Overall Study|Death|0
2218034|NCT01712061|3861443|FG001|Overall Study|Death|0
2324948|NCT03020745|4041802|FG009|Part 2 (Up to 169 Days)|Adverse Event|0
2324949|NCT03020745|4041793|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
2324950|NCT03020745|4041794|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
2324951|NCT03020745|4041795|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
2324952|NCT03020745|4041796|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
2324953|NCT03020745|4041797|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
2324954|NCT03020745|4041798|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
2324955|NCT03020745|4041799|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
2324956|NCT03020745|4041800|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1
2324957|NCT03020745|4041801|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
2324958|NCT03020745|4041802|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
2324959|NCT03020745|4041793|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
2324960|NCT03020745|4041794|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
2324961|NCT03020745|4041795|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
2324962|NCT03020745|4041796|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
2324963|NCT03020745|4041797|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
2324964|NCT03020745|4041798|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
2324965|NCT03020745|4041799|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
2324966|NCT03020745|4041800|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
2324967|NCT03020745|4041801|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
2324968|NCT03020745|4041802|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
2324969|NCT03020745|4041793|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
2324970|NCT03020745|4041794|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
2324971|NCT03020745|4041795|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
2324972|NCT03020745|4041796|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
2324973|NCT03020745|4041797|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
2324974|NCT03020745|4041798|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
2324975|NCT03020745|4041799|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
2324976|NCT03020745|4041800|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
2324977|NCT03020745|4041801|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2
2324978|NCT03020745|4041802|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
2324979|NCT03020888|4041826|FG000|Overall Study|Physician Decision|4
2324980|NCT03020888|4041826|FG000|Overall Study|Withdrawal by Subject|6
2324981|NCT03020888|4041826|FG000|Overall Study|Insurance coverage|2
2324982|NCT03020888|4041826|FG000|Overall Study|Lost to Follow-up|1
2218035|NCT01712061|3861444|FG002|Overall Study|Death|1
2218036|NCT01712061|3861442|FG000|Overall Study|Lost to Follow-up|1
2218037|NCT01712061|3861443|FG001|Overall Study|Lost to Follow-up|0
2324983|NCT03020966|4041832|FG000|Overall Study|Withdrawal by Subject|2
2324984|NCT03020966|4041833|FG001|Overall Study|Withdrawal by Subject|0
2324985|NCT03020992|4041839|FG000|Overall Study|Adverse Event|5
2324986|NCT03020992|4041839|FG000|Overall Study|Withdrawal by Subject|1
2324987|NCT03021005|4041846|FG000|Overall Study|Lost to Follow-up|39
2324988|NCT03021005|4041847|FG001|Overall Study|Lost to Follow-up|26
2324989|NCT03021018|4041856|FG000|Overall Study|Adverse Event|1
2324990|NCT03021018|4041857|FG001|Overall Study|Adverse Event|0
2324991|NCT03021018|4041858|FG002|Overall Study|Adverse Event|0
2324992|NCT03021018|4041856|FG000|Overall Study|Fall with subsequent nasal fracture|1
2324993|NCT03021018|4041857|FG001|Overall Study|Fall with subsequent nasal fracture|0
2324994|NCT03021018|4041858|FG002|Overall Study|Fall with subsequent nasal fracture|0
2324995|NCT03021187|4041870|FG000|Overall Study|Death|0
2324996|NCT03021187|4041871|FG001|Overall Study|Death|0
2324997|NCT03021187|4041872|FG002|Overall Study|Death|3
2324998|NCT03021187|4041873|FG003|Overall Study|Death|0
2324999|NCT03021187|4041870|FG000|Overall Study|Withdrawal by Subject|0
2325000|NCT03021187|4041871|FG001|Overall Study|Withdrawal by Subject|6
2325001|NCT03021187|4041872|FG002|Overall Study|Withdrawal by Subject|2
2325002|NCT03021187|4041873|FG003|Overall Study|Withdrawal by Subject|5
2325003|NCT03021187|4041870|FG000|Overall Study|Lost to Follow-up|10
2325004|NCT03021187|4041871|FG001|Overall Study|Lost to Follow-up|3
2325005|NCT03021187|4041872|FG002|Overall Study|Lost to Follow-up|1
2325006|NCT03021187|4041873|FG003|Overall Study|Lost to Follow-up|4
2325007|NCT03021265|4041883|FG000|Overall Study|Adverse Event|29
2325008|NCT03021265|4041883|FG000|Overall Study|Lack of Efficacy|3
2325009|NCT03021265|4041883|FG000|Overall Study|Improved|17
2325010|NCT03021265|4041883|FG000|Overall Study|Lost to Follow-up|67
2030495|NCT00379236|3600121|FG002|Double-blind|Use of exclusionary medication|0
2030496|NCT00379236|3600119|FG000|Double-blind|Other|3
2030497|NCT00379236|3600120|FG001|Double-blind|Other|7
2030498|NCT00379236|3600121|FG002|Double-blind|Other|0
2030499|NCT00379236|3600119|FG000|Double-blind|Data could not be retrieved|2
2030500|NCT00379236|3600120|FG001|Double-blind|Data could not be retrieved|2
2030501|NCT00379236|3600121|FG002|Double-blind|Data could not be retrieved|0
2030502|NCT00379236|3600119|FG000|Open-label Extension|Adverse Event|0
2030503|NCT00379236|3600120|FG001|Open-label Extension|Adverse Event|0
2030504|NCT00379236|3600121|FG002|Open-label Extension|Adverse Event|13
2030505|NCT00379236|3600119|FG000|Open-label Extension|Protocol Violation|0
2030506|NCT00379236|3600120|FG001|Open-label Extension|Protocol Violation|0
2030507|NCT00379236|3600121|FG002|Open-label Extension|Protocol Violation|7
2030508|NCT00379236|3600119|FG000|Open-label Extension|Withdrawal by Subject|0
2030509|NCT00379236|3600120|FG001|Open-label Extension|Withdrawal by Subject|0
2030510|NCT00379236|3600121|FG002|Open-label Extension|Withdrawal by Subject|13
2030511|NCT00379236|3600119|FG000|Open-label Extension|Lost to Follow-up|0
2030512|NCT00379236|3600120|FG001|Open-label Extension|Lost to Follow-up|0
2030513|NCT00379236|3600121|FG002|Open-label Extension|Lost to Follow-up|12
2030514|NCT00379236|3600119|FG000|Open-label Extension|Use of exclusionary medication|0
2030515|NCT00379236|3600120|FG001|Open-label Extension|Use of exclusionary medication|0
2030516|NCT00379236|3600121|FG002|Open-label Extension|Use of exclusionary medication|3
2030517|NCT00379236|3600119|FG000|Open-label Extension|Other|0
2030518|NCT00379236|3600120|FG001|Open-label Extension|Other|0
2325011|NCT03021265|4041883|FG000|Overall Study|No reason given|2
2325012|NCT03021265|4041883|FG000|Overall Study|No visit since the first visit|4
2325013|NCT03021304|4041887|FG000|Overall Study|Lack of Efficacy|1
2325014|NCT03021499|4041902|FG000|Overall Study|Adverse Event|1
2325015|NCT03021499|4041903|FG001|Overall Study|Adverse Event|0
2325016|NCT03021499|4041902|FG000|Overall Study|Death|1
2325017|NCT03021499|4041903|FG001|Overall Study|Death|5
2325018|NCT03021499|4041902|FG000|Overall Study|Lack of Efficacy|0
2325019|NCT03021499|4041903|FG001|Overall Study|Lack of Efficacy|1
2325020|NCT03021499|4041902|FG000|Overall Study|Lost to Follow-up|1
2325021|NCT03021499|4041903|FG001|Overall Study|Lost to Follow-up|3
2325022|NCT03021499|4041902|FG000|Overall Study|Physician Decision|2
2325023|NCT03021499|4041903|FG001|Overall Study|Physician Decision|3
2325024|NCT03021499|4041902|FG000|Overall Study|Pregnancy|1
2325025|NCT03021499|4041903|FG001|Overall Study|Pregnancy|0
2325026|NCT03021499|4041902|FG000|Overall Study|Withdrawal by Subject|7
2325027|NCT03021499|4041903|FG001|Overall Study|Withdrawal by Subject|14
2325028|NCT03021499|4041902|FG000|Overall Study|Prohibited medication required|1
2325029|NCT03021499|4041903|FG001|Overall Study|Prohibited medication required|0
2325030|NCT03021499|4041902|FG000|Overall Study|Protocol non-compliance|1
2325031|NCT03021499|4041903|FG001|Overall Study|Protocol non-compliance|1
2325032|NCT03021499|4041902|FG000|Overall Study|None of the above|0
2325033|NCT03021499|4041903|FG001|Overall Study|None of the above|4
2325034|NCT03021499|4041902|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1
2325035|NCT03021499|4041903|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0
2325036|NCT03021564|4041922|FG000|Overall Study|Death|84
2325037|NCT03021564|4041923|FG001|Overall Study|Death|466
2325038|NCT03021564|4041922|FG000|Overall Study|Lost to Follow-up|0
2325039|NCT03021564|4041923|FG001|Overall Study|Lost to Follow-up|2
2325040|NCT03021642|4041933|FG000|Washout Period (21 Days)|Adverse Event|1
2325041|NCT03021642|4041934|FG001|Washout Period (21 Days)|Adverse Event|1
2325042|NCT03021668|4041942|FG000|Overall Study|Physician Decision|0
2325043|NCT03021668|4041943|FG001|Overall Study|Physician Decision|1
2325044|NCT03022045|4041964|FG000|Overall Study|Adverse Event|0
2325045|NCT03022045|4041965|FG001|Overall Study|Adverse Event|1
2325046|NCT03022045|4041964|FG000|Overall Study|Withdrawal by Subject|1
2325047|NCT03022045|4041965|FG001|Overall Study|Withdrawal by Subject|1
2325048|NCT03022084|4041977|FG000|Overall Study|Lost to Follow-up|2
2325049|NCT03022084|4041978|FG001|Overall Study|Lost to Follow-up|3
2325050|NCT03022370|4041988|FG000|Overall Study|Death|6
2325051|NCT03022370|4041989|FG001|Overall Study|Death|12
2325052|NCT03022370|4041988|FG000|Overall Study|Lost to Follow-up|174
2325053|NCT03022370|4041989|FG001|Overall Study|Lost to Follow-up|109
2325054|NCT03022422|4042030|FG000|Overall Study|3 subjects consented but not vaccinated|0
2325055|NCT03022422|4042031|FG001|Overall Study|3 subjects consented but not vaccinated|0
2325056|NCT03022422|4042032|FG002|Overall Study|3 subjects consented but not vaccinated|3
2325057|NCT03022422|4042033|FG003|Overall Study|3 subjects consented but not vaccinated|0
2325058|NCT03022422|4042034|FG004|Overall Study|3 subjects consented but not vaccinated|0
2325059|NCT03022422|4042035|FG005|Overall Study|3 subjects consented but not vaccinated|0
2325060|NCT03022630|4042090|FG000|Overall Study|Death|9
2325061|NCT03022630|4042091|FG001|Overall Study|Death|7
2325062|NCT03022630|4042090|FG000|Overall Study|Withdrawal by Subject|0
2325063|NCT03022630|4042091|FG001|Overall Study|Withdrawal by Subject|5
2325064|NCT03022799|4042115|FG000|Overall Study|Adverse Event|0
2325065|NCT03022799|4042116|FG001|Overall Study|Adverse Event|0
2325066|NCT03022799|4042117|FG002|Overall Study|Adverse Event|0
2325067|NCT03022799|4042118|FG003|Overall Study|Adverse Event|0
2325068|NCT03022799|4042119|FG004|Overall Study|Adverse Event|0
2325069|NCT03022799|4042120|FG005|Overall Study|Adverse Event|0
2325070|NCT03022799|4042121|FG006|Overall Study|Adverse Event|0
2325071|NCT03022799|4042122|FG007|Overall Study|Adverse Event|0
2325072|NCT03022799|4042123|FG008|Overall Study|Adverse Event|0
2325073|NCT03022799|4042124|FG009|Overall Study|Adverse Event|1
2325074|NCT03022799|4042125|FG010|Overall Study|Adverse Event|1
2325075|NCT03022799|4042126|FG011|Overall Study|Adverse Event|0
2325076|NCT03022799|4042127|FG012|Overall Study|Adverse Event|0
2325077|NCT03022981|4042185|FG000|Overall Study|Adverse Event|0
2325078|NCT03022981|4042186|FG001|Overall Study|Adverse Event|1
2325079|NCT03022981|4042187|FG002|Overall Study|Adverse Event|0
2325080|NCT03022981|4042185|FG000|Overall Study|Investigator's Discretion|0
2325081|NCT03022981|4042186|FG001|Overall Study|Investigator's Discretion|1
2325082|NCT03022981|4042187|FG002|Overall Study|Investigator's Discretion|2
2325083|NCT03022981|4042185|FG000|Overall Study|Lost to Follow-up|6
2325084|NCT03022981|4042186|FG001|Overall Study|Lost to Follow-up|2
2325085|NCT03022981|4042187|FG002|Overall Study|Lost to Follow-up|1
2325086|NCT03022981|4042185|FG000|Overall Study|Non-Compliance With Study Drug|0
2325087|NCT03022981|4042186|FG001|Overall Study|Non-Compliance With Study Drug|0
2325088|NCT03022981|4042187|FG002|Overall Study|Non-Compliance With Study Drug|2
2325089|NCT03022981|4042185|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0
2325090|NCT03022981|4042186|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0
2325091|NCT03022981|4042187|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1
2325092|NCT03023137|4042207|FG000|Overall Study|Multiple pregnancy|2
2325093|NCT03023137|4042208|FG001|Overall Study|Multiple pregnancy|4
2325094|NCT03023137|4042207|FG000|Overall Study|Lost to Follow-up|1
2325095|NCT03023137|4042208|FG001|Overall Study|Lost to Follow-up|1
2325096|NCT03023137|4042207|FG000|Overall Study|Protocol Violation|0
2325097|NCT03023137|4042208|FG001|Overall Study|Protocol Violation|4
2325098|NCT03023137|4042207|FG000|Overall Study|Lost the baby in a car accident|1
2325099|NCT03023137|4042208|FG001|Overall Study|Lost the baby in a car accident|0
2325100|NCT03023397|4042222|FG000|Run-In|Failed screening allergen challenge|1
2325101|NCT03023397|4042223|FG001|Run-In|Failed screening allergen challenge|0
2325102|NCT03023397|4042224|FG002|Run-In|Failed screening allergen challenge|0
2325103|NCT03023397|4042222|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1
2325104|NCT03023397|4042223|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
2325105|NCT03023397|4042224|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
2325106|NCT03023423|4042236|FG000|Overall Study|Death|5
2325107|NCT03023423|4042237|FG001|Overall Study|Death|12
2325108|NCT03023423|4042238|FG002|Overall Study|Death|20
2325109|NCT03023423|4042236|FG000|Overall Study|Other|0
2325110|NCT03023423|4042237|FG001|Overall Study|Other|2
2325111|NCT03023423|4042238|FG002|Overall Study|Other|2
2325112|NCT03023423|4042236|FG000|Overall Study|Ongoing|2
2325113|NCT03023423|4042237|FG001|Overall Study|Ongoing|32
2325114|NCT03023423|4042238|FG002|Overall Study|Ongoing|24
2325115|NCT03023722|4042289|FG000|Overall Study|No follow-up assessment|4
2325116|NCT03023813|4042296|FG000|Overall Study|Lost to Follow-up|1
2325117|NCT03023813|4042297|FG001|Overall Study|Lost to Follow-up|2
2325118|NCT03023813|4042298|FG002|Overall Study|Lost to Follow-up|0
2325119|NCT03023826|4042306|FG000|Period 1|Withdrawal by Subject|0
2325120|NCT03023826|4042307|FG001|Period 1|Withdrawal by Subject|0
2325121|NCT03023826|4042308|FG002|Period 1|Withdrawal by Subject|0
2325122|NCT03023826|4042309|FG003|Period 1|Withdrawal by Subject|0
2325123|NCT03023826|4042310|FG004|Period 1|Withdrawal by Subject|1
2325124|NCT03023826|4042311|FG005|Period 1|Withdrawal by Subject|0
2325125|NCT03023878|4042319|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11
2325126|NCT03023878|4042319|FG000|Pre-Study Run-In Period|Death|1
2325127|NCT03023878|4042319|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5
2325128|NCT03023878|4042319|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2
2325129|NCT03023878|4042319|FG000|Treatment Period|Disease Progression|1
2325130|NCT03023878|4042319|FG000|Treatment Period|Withdrawal by Subject|1
2325131|NCT03023878|4042319|FG000|Treatment Period|Adverse Event|1
2325132|NCT03023878|4042319|FG000|Long Term Follow-Up Period|Death|2
2325133|NCT03024606|4042338|FG000|Overall Study|Withdrawal by Subject|9
2325134|NCT03024606|4042339|FG001|Overall Study|Withdrawal by Subject|10
2325135|NCT03024970|4042345|FG000|First Intervention|Adverse Event|1
2325136|NCT03024970|4042346|FG001|First Intervention|Adverse Event|0
2325137|NCT03024970|4042345|FG000|Second Intervention|Lost to Follow-up|1
2325138|NCT03024970|4042346|FG001|Second Intervention|Lost to Follow-up|0
2325139|NCT03025217|4042352|FG000|Overall Study|Pregnancy|1
2325140|NCT03025217|4042352|FG000|Overall Study|Lost to Follow-up|1
2325141|NCT03025217|4042352|FG000|Overall Study|Not eligible, poor English|2
2325142|NCT03026075|4042365|FG000|Overall Study|Physician Decision|1
2325143|NCT03026088|4042369|FG000|Overall Study|Study termination|20
2325144|NCT03026166|4042375|FG000|Overall Study|Death|22
2325145|NCT03026166|4042376|FG001|Overall Study|Death|7
2325146|NCT03026166|4042375|FG000|Overall Study|Physician Decision|2
2325147|NCT03026166|4042376|FG001|Overall Study|Physician Decision|0
2325148|NCT03026166|4042375|FG000|Overall Study|Withdrawal by Subject|1
2325149|NCT03026166|4042376|FG001|Overall Study|Withdrawal by Subject|2
2325150|NCT03026166|4042375|FG000|Overall Study|Lost to Follow-up|1
2325151|NCT03026166|4042376|FG001|Overall Study|Lost to Follow-up|0
2325152|NCT03026166|4042375|FG000|Overall Study|Study Terminated by Sponsor|3
2325153|NCT03026166|4042376|FG001|Overall Study|Study Terminated by Sponsor|3
2325154|NCT03026166|4042375|FG000|Overall Study|Other|1
2325155|NCT03026166|4042376|FG001|Overall Study|Other|0
2325156|NCT03026257|4042388|FG000|Overall Study|Adverse Event|3
2325157|NCT03026257|4042389|FG001|Overall Study|Adverse Event|0
2325158|NCT03026257|4042390|FG002|Overall Study|Adverse Event|0
2325159|NCT03026257|4042391|FG003|Overall Study|Adverse Event|0
2325160|NCT03026257|4042392|FG004|Overall Study|Adverse Event|0
2325161|NCT03026257|4042393|FG005|Overall Study|Adverse Event|0
2325162|NCT03026257|4042388|FG000|Overall Study|Lost to Follow-up|1
2325163|NCT03026257|4042389|FG001|Overall Study|Lost to Follow-up|0
2325164|NCT03026257|4042390|FG002|Overall Study|Lost to Follow-up|0
2030519|NCT00379236|3600121|FG002|Open-label Extension|Other|7
2030520|NCT00379340|3600138|FG000|Overall Study|Death|0
2030521|NCT00379340|3600139|FG001|Overall Study|Death|0
2030522|NCT00379340|3600140|FG002|Overall Study|Death|0
2030523|NCT00379340|3600141|FG003|Overall Study|Death|2
2030524|NCT00379340|3600142|FG004|Overall Study|Death|0
2030525|NCT00379340|3600138|FG000|Overall Study|Lack of Efficacy|6
2030526|NCT00379340|3600139|FG001|Overall Study|Lack of Efficacy|1
2030527|NCT00379340|3600140|FG002|Overall Study|Lack of Efficacy|0
2030528|NCT00379340|3600141|FG003|Overall Study|Lack of Efficacy|4
2030529|NCT00379340|3600142|FG004|Overall Study|Lack of Efficacy|3
2030530|NCT00379340|3600138|FG000|Overall Study|Physician Decision|6
2030531|NCT00379340|3600139|FG001|Overall Study|Physician Decision|2
2030532|NCT00379340|3600140|FG002|Overall Study|Physician Decision|1
2030533|NCT00379340|3600141|FG003|Overall Study|Physician Decision|2
2030534|NCT00379340|3600142|FG004|Overall Study|Physician Decision|3
2030535|NCT00379340|3600138|FG000|Overall Study|Withdrawal by Subject|0
2030536|NCT00379340|3600139|FG001|Overall Study|Withdrawal by Subject|0
2030537|NCT00379340|3600140|FG002|Overall Study|Withdrawal by Subject|0
2030538|NCT00379340|3600141|FG003|Overall Study|Withdrawal by Subject|1
2030539|NCT00379340|3600142|FG004|Overall Study|Withdrawal by Subject|0
2030540|NCT00379340|3600138|FG000|Overall Study|Refusal of further protocol therapy|1
2030541|NCT00379340|3600139|FG001|Overall Study|Refusal of further protocol therapy|0
2030542|NCT00379340|3600140|FG002|Overall Study|Refusal of further protocol therapy|1
2030543|NCT00379340|3600141|FG003|Overall Study|Refusal of further protocol therapy|1
2030544|NCT00379340|3600142|FG004|Overall Study|Refusal of further protocol therapy|7
2030545|NCT00379340|3600138|FG000|Overall Study|On more than 1 tumor therapeutic study|0
2110342|NCT00895037|3705099|FG000|Overall Study|Death|0
2110343|NCT00895037|3705100|FG001|Overall Study|Death|2
2110344|NCT00895037|3705101|FG002|Overall Study|Death|1
2110345|NCT00895154|3705111|FG000|Overall Study|Lost to Follow-up|1
2110346|NCT00895154|3705112|FG001|Overall Study|Lost to Follow-up|1
2110347|NCT00895154|3705111|FG000|Overall Study|Withdrawal by Subject|0
2110348|NCT00895154|3705112|FG001|Overall Study|Withdrawal by Subject|1
2110349|NCT00895245|3705159|FG000|Overall Study|Lack of Efficacy|6
2110350|NCT00895310|3705163|FG000|Overall Study|Withdrawal by Subject|1
2110351|NCT00895414|3705167|FG000|First Intervention (14 Days)|Withdrawal by Subject|1
2110352|NCT00895414|3705168|FG001|First Intervention (14 Days)|Withdrawal by Subject|0
2110353|NCT00895414|3705167|FG000|First Intervention (14 Days)|Physician Decision|0
2110354|NCT00895414|3705168|FG001|First Intervention (14 Days)|Physician Decision|1
2325165|NCT03026257|4042391|FG003|Overall Study|Lost to Follow-up|0
2325166|NCT03026257|4042392|FG004|Overall Study|Lost to Follow-up|0
2325167|NCT03026257|4042393|FG005|Overall Study|Lost to Follow-up|0
2325168|NCT03026257|4042388|FG000|Overall Study|Protocol Violation|1
2325169|NCT03026257|4042389|FG001|Overall Study|Protocol Violation|0
2325170|NCT03026257|4042390|FG002|Overall Study|Protocol Violation|0
2325171|NCT03026257|4042391|FG003|Overall Study|Protocol Violation|1
2325172|NCT03026257|4042392|FG004|Overall Study|Protocol Violation|1
2325173|NCT03026257|4042393|FG005|Overall Study|Protocol Violation|0
2325174|NCT03026257|4042388|FG000|Overall Study|Withdrawal by Subject|1
2325175|NCT03026257|4042389|FG001|Overall Study|Withdrawal by Subject|1
2325176|NCT03026257|4042390|FG002|Overall Study|Withdrawal by Subject|0
2325177|NCT03026257|4042391|FG003|Overall Study|Withdrawal by Subject|0
2325178|NCT03026257|4042392|FG004|Overall Study|Withdrawal by Subject|0
2325179|NCT03026257|4042393|FG005|Overall Study|Withdrawal by Subject|0
2325180|NCT03026283|4042407|FG000|CCTA Diagnosis|CCTA not performed as planned|9
2325181|NCT03026283|4042408|FG001|CCTA Diagnosis|CCTA not performed as planned|0
2325182|NCT03026283|4042409|FG002|CCTA Diagnosis|CCTA not performed as planned|0
2325183|NCT03026283|4042410|FG003|CCTA Diagnosis|CCTA not performed as planned|0
2325184|NCT03026283|4042411|FG004|CCTA Diagnosis|CCTA not performed as planned|0
2325185|NCT03026283|4042412|FG005|CCTA Diagnosis|CCTA not performed as planned|0
2325186|NCT03026283|4042413|FG006|CCTA Diagnosis|CCTA not performed as planned|0
2325187|NCT03026283|4042414|FG007|CCTA Diagnosis|CCTA not performed as planned|0
2325188|NCT03026283|4042407|FG000|CCTA Diagnosis|Withdrawal by Subject|5
2325189|NCT03026283|4042408|FG001|CCTA Diagnosis|Withdrawal by Subject|0
2325190|NCT03026283|4042409|FG002|CCTA Diagnosis|Withdrawal by Subject|0
2325191|NCT03026283|4042410|FG003|CCTA Diagnosis|Withdrawal by Subject|0
2325192|NCT03026283|4042411|FG004|CCTA Diagnosis|Withdrawal by Subject|0
2325193|NCT03026283|4042412|FG005|CCTA Diagnosis|Withdrawal by Subject|0
2325194|NCT03026283|4042413|FG006|CCTA Diagnosis|Withdrawal by Subject|0
2325195|NCT03026283|4042414|FG007|CCTA Diagnosis|Withdrawal by Subject|0
2325196|NCT03026283|4042407|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
2325197|NCT03026283|4042408|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3
2325198|NCT03026283|4042409|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
2325199|NCT03026283|4042410|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
2325200|NCT03026283|4042411|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
2325201|NCT03026283|4042412|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
2325202|NCT03026283|4042413|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
2325203|NCT03026283|4042414|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
2325204|NCT03026283|4042407|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
2325205|NCT03026283|4042408|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
2325206|NCT03026283|4042409|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15
2325207|NCT03026283|4042410|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
2325208|NCT03026283|4042411|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
2325209|NCT03026283|4042412|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
2325210|NCT03026283|4042413|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
2325211|NCT03026283|4042414|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
2325212|NCT03026283|4042407|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
2325213|NCT03026283|4042408|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
2325214|NCT03026283|4042409|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
2325215|NCT03026283|4042410|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8
2325216|NCT03026283|4042411|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11
2325217|NCT03026283|4042412|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
2325218|NCT03026283|4042413|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
2325219|NCT03026283|4042414|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
2325220|NCT03026283|4042407|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
2325221|NCT03026283|4042408|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
2325222|NCT03026283|4042409|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
2325223|NCT03026283|4042410|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9
2325224|NCT03026283|4042411|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
2325225|NCT03026283|4042412|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
2325226|NCT03026283|4042413|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
2325227|NCT03026283|4042414|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
2030546|NCT00379340|3600139|FG001|Overall Study|On more than 1 tumor therapeutic study|0
2030547|NCT00379340|3600140|FG002|Overall Study|On more than 1 tumor therapeutic study|0
2030548|NCT00379340|3600141|FG003|Overall Study|On more than 1 tumor therapeutic study|2
2030549|NCT00379340|3600142|FG004|Overall Study|On more than 1 tumor therapeutic study|0
2030550|NCT00379340|3600138|FG000|Overall Study|Delayed nephrectomy and anaplasia|0
2030551|NCT00379340|3600139|FG001|Overall Study|Delayed nephrectomy and anaplasia|0
2030552|NCT00379340|3600140|FG002|Overall Study|Delayed nephrectomy and anaplasia|0
2030553|NCT00379340|3600141|FG003|Overall Study|Delayed nephrectomy and anaplasia|1
2030554|NCT00379340|3600142|FG004|Overall Study|Delayed nephrectomy and anaplasia|1
2030555|NCT00379353|3600157|FG000|Overall Study|Hospitalization|3
2030556|NCT00379353|3600158|FG001|Overall Study|Hospitalization|3
2030557|NCT00379353|3600157|FG000|Overall Study|Withdrawal by Subject|5
2030558|NCT00379353|3600158|FG001|Overall Study|Withdrawal by Subject|2
2030559|NCT00379353|3600157|FG000|Overall Study|Death|1
2030560|NCT00379353|3600158|FG001|Overall Study|Death|0
2030561|NCT00379353|3600157|FG000|Overall Study|Cardiac Tamponade|1
2030562|NCT00379353|3600158|FG001|Overall Study|Cardiac Tamponade|0
2030563|NCT00379353|3600157|FG000|Overall Study|Non-compliance|1
2030564|NCT00379353|3600158|FG001|Overall Study|Non-compliance|0
2030565|NCT00379353|3600157|FG000|Overall Study|Conflicting drug treatment|0
2030566|NCT00379353|3600158|FG001|Overall Study|Conflicting drug treatment|1
2030567|NCT00379587|3600178|FG000|Overall Study|Lost to Follow-up|2
2030568|NCT00379639|3600187|FG000|Overall Study|Disease Progression|3
2030569|NCT00379639|3600188|FG001|Overall Study|Disease Progression|3
2030570|NCT00379639|3600189|FG002|Overall Study|Disease Progression|3
2030571|NCT00379639|3600190|FG003|Overall Study|Disease Progression|4
2030572|NCT00379639|3600191|FG004|Overall Study|Disease Progression|4
2030573|NCT00379639|3600187|FG000|Overall Study|Physician Decision|0
2030574|NCT00379639|3600188|FG001|Overall Study|Physician Decision|2
2030575|NCT00379639|3600189|FG002|Overall Study|Physician Decision|1
2030576|NCT00379639|3600190|FG003|Overall Study|Physician Decision|1
2030577|NCT00379639|3600191|FG004|Overall Study|Physician Decision|0
2030578|NCT00379639|3600187|FG000|Overall Study|Symptomatic Deterioration|0
2030579|NCT00379639|3600188|FG001|Overall Study|Symptomatic Deterioration|0
2030580|NCT00379639|3600189|FG002|Overall Study|Symptomatic Deterioration|1
2030581|NCT00379639|3600190|FG003|Overall Study|Symptomatic Deterioration|0
2030582|NCT00379639|3600191|FG004|Overall Study|Symptomatic Deterioration|1
2030583|NCT00379639|3600187|FG000|Overall Study|Adverse Event|0
2325228|NCT03026283|4042407|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
2325229|NCT03026283|4042408|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
2325230|NCT03026283|4042409|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
2325231|NCT03026283|4042410|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2
2325232|NCT03026283|4042411|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
2325233|NCT03026283|4042412|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7
2325234|NCT03026283|4042413|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
2325235|NCT03026283|4042414|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
2325236|NCT03026283|4042407|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
2325237|NCT03026283|4042408|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
2325238|NCT03026283|4042409|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
2325239|NCT03026283|4042410|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1
2325240|NCT03026283|4042411|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
2325241|NCT03026283|4042412|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
2325242|NCT03026283|4042413|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
2325243|NCT03026283|4042414|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
2325244|NCT03026283|4042407|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
2325245|NCT03026283|4042408|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
2325246|NCT03026283|4042409|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
2325247|NCT03026283|4042410|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
2325248|NCT03026283|4042411|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25
2325249|NCT03026283|4042412|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19
2325250|NCT03026283|4042413|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
2325251|NCT03026283|4042414|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
2325252|NCT03026530|4042429|FG000|Overall Study|Lost to Follow-up|19
2325253|NCT03026530|4042430|FG001|Overall Study|Lost to Follow-up|24
2325254|NCT03026530|4042429|FG000|Overall Study|Protocol Violation|2
2325255|NCT03026530|4042430|FG001|Overall Study|Protocol Violation|5
2325256|NCT03027466|4042467|FG000|Overall Study|Opting out of the app|1869
2325257|NCT03027466|4042468|FG001|Overall Study|Opting out of the app|1819
2325258|NCT03027466|4042469|FG002|Overall Study|Opting out of the app|1743
2325259|NCT03027466|4042470|FG003|Overall Study|Opting out of the app|1821
2325260|NCT03027557|4042483|FG000|Overall Study|Adverse Event|1
2325261|NCT03027557|4042484|FG001|Overall Study|Adverse Event|0
2325262|NCT03027557|4042485|FG002|Overall Study|Adverse Event|0
2325263|NCT03028012|4042505|FG000|Overall Study|Lost to Follow-up|2
2325264|NCT03028012|4042506|FG001|Overall Study|Lost to Follow-up|3
2325265|NCT03028012|4042507|FG002|Overall Study|Lost to Follow-up|3
2325266|NCT03028129|4042540|FG000|Overall Study|Adverse Event|13
2325267|NCT03028129|4042541|FG001|Overall Study|Adverse Event|2
2325268|NCT03028129|4042540|FG000|Overall Study|Lost to Follow-up|50
2325269|NCT03028129|4042541|FG001|Overall Study|Lost to Follow-up|38
2325270|NCT03028129|4042540|FG000|Overall Study|Physician Decision|0
2325271|NCT03028129|4042541|FG001|Overall Study|Physician Decision|1
2325272|NCT03028129|4042540|FG000|Overall Study|Protocol Violation|1
2325273|NCT03028129|4042541|FG001|Overall Study|Protocol Violation|1
2325274|NCT03028129|4042540|FG000|Overall Study|Withdrawal by Subject|62
2325275|NCT03028129|4042541|FG001|Overall Study|Withdrawal by Subject|45
2325276|NCT03028142|4042547|FG000|Overall Study|Adverse Event|1
2325277|NCT03028142|4042548|FG001|Overall Study|Adverse Event|1
2325278|NCT03028142|4042549|FG002|Overall Study|Adverse Event|0
2325279|NCT03028142|4042550|FG003|Overall Study|Adverse Event|0
2325280|NCT03028142|4042551|FG004|Overall Study|Adverse Event|0
2325281|NCT03028142|4042552|FG005|Overall Study|Adverse Event|1
2325282|NCT03028142|4042547|FG000|Overall Study|Withdrawal by Subject|0
2325283|NCT03028142|4042548|FG001|Overall Study|Withdrawal by Subject|0
2325284|NCT03028142|4042549|FG002|Overall Study|Withdrawal by Subject|0
2325285|NCT03028142|4042550|FG003|Overall Study|Withdrawal by Subject|0
2325286|NCT03028142|4042551|FG004|Overall Study|Withdrawal by Subject|1
2325287|NCT03028142|4042552|FG005|Overall Study|Withdrawal by Subject|0
2325288|NCT03028415|4042585|FG000|Overall Study|Lost to Follow-up|6
2325289|NCT03028415|4042586|FG001|Overall Study|Lost to Follow-up|3
2325290|NCT03028415|4042585|FG000|Overall Study|Withdrawal by Subject|1
2325291|NCT03028415|4042586|FG001|Overall Study|Withdrawal by Subject|0
2325292|NCT03028415|4042585|FG000|Overall Study|Discontinued due to COVID-19|1
2325293|NCT03028415|4042586|FG001|Overall Study|Discontinued due to COVID-19|0
2325294|NCT03028870|4042626|FG000|Overall Study|Adverse Event|7
2325295|NCT03028870|4042627|FG001|Overall Study|Adverse Event|4
2325296|NCT03028870|4042628|FG002|Overall Study|Adverse Event|3
2325297|NCT03028870|4042629|FG003|Overall Study|Adverse Event|3
2325298|NCT03028870|4042626|FG000|Overall Study|Withdrawal by Subject|1
2325299|NCT03028870|4042627|FG001|Overall Study|Withdrawal by Subject|1
2325300|NCT03028870|4042628|FG002|Overall Study|Withdrawal by Subject|1
2325301|NCT03028870|4042629|FG003|Overall Study|Withdrawal by Subject|2
2325302|NCT03028870|4042626|FG000|Overall Study|Lost to Follow-up|1
2325303|NCT03028870|4042627|FG001|Overall Study|Lost to Follow-up|0
2325304|NCT03028870|4042628|FG002|Overall Study|Lost to Follow-up|0
2325305|NCT03028870|4042629|FG003|Overall Study|Lost to Follow-up|0
2325306|NCT03028870|4042626|FG000|Overall Study|Lack of Efficacy|3
2325307|NCT03028870|4042627|FG001|Overall Study|Lack of Efficacy|0
2325308|NCT03028870|4042628|FG002|Overall Study|Lack of Efficacy|0
2325309|NCT03028870|4042629|FG003|Overall Study|Lack of Efficacy|0
2325310|NCT03028870|4042626|FG000|Overall Study|Administrative|5
2325311|NCT03028870|4042627|FG001|Overall Study|Administrative|5
2325312|NCT03028870|4042628|FG002|Overall Study|Administrative|12
2325313|NCT03028870|4042629|FG003|Overall Study|Administrative|4
2352408|NCT03776175|4101675|FG001|Treatment Period (42 Days)|Lost to Follow-up|0
2352409|NCT03776175|4101676|FG002|Treatment Period (42 Days)|Lost to Follow-up|0
2325314|NCT03029143|4042683|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8
2325315|NCT03029143|4042684|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
2325316|NCT03029143|4042685|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
2325317|NCT03029143|4042683|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12
2325318|NCT03029143|4042684|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
2325319|NCT03029143|4042685|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
2325320|NCT03029143|4042683|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1
2325321|NCT03029143|4042684|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0
2325322|NCT03029143|4042685|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0
2325323|NCT03029143|4042683|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6
2325324|NCT03029143|4042684|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
2325325|NCT03029143|4042685|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
2325326|NCT03029143|4042683|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142
2325327|NCT03029143|4042684|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0
2325328|NCT03029143|4042685|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0
2325329|NCT03029143|4042683|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0
2325330|NCT03029143|4042684|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3
2325331|NCT03029143|4042685|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9
2325332|NCT03029143|4042683|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0
2325333|NCT03029143|4042684|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1
2325334|NCT03029143|4042685|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3
2325335|NCT03029143|4042683|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0
2325336|NCT03029143|4042684|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1
2325337|NCT03029143|4042685|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3
2325338|NCT03029143|4042683|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0
2325339|NCT03029143|4042684|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10
2325340|NCT03029143|4042685|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1
2325341|NCT03029143|4042683|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0
2325342|NCT03029143|4042684|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6
2325343|NCT03029143|4042685|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7
2325344|NCT03029143|4042683|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0
2325345|NCT03029143|4042684|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2
2325346|NCT03029143|4042685|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1
2325347|NCT03029208|4042696|FG000|Overall Study|Withdrawal by Subject|2
2325348|NCT03029208|4042697|FG001|Overall Study|Withdrawal by Subject|3
2325349|NCT03029208|4042696|FG000|Overall Study|Lost to Follow-up|0
2325350|NCT03029208|4042697|FG001|Overall Study|Lost to Follow-up|1
2325351|NCT03029247|4042714|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3
2325352|NCT03029247|4042715|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0
2325353|NCT03029247|4042714|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
2325354|NCT03029247|4042715|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
2325355|NCT03029247|4042714|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7
2325356|NCT03029247|4042715|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4
2325357|NCT03029247|4042714|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
2325358|NCT03029247|4042715|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
2325359|NCT03029585|4042723|FG000|Overall Study|Death|1
2325360|NCT03029585|4042724|FG001|Overall Study|Death|1
2325361|NCT03029585|4042723|FG000|Overall Study|Withdrawal by Subject|1
2325362|NCT03029585|4042724|FG001|Overall Study|Withdrawal by Subject|0
2325363|NCT03029624|4042730|FG000|Overall Study|Adverse Event|1
2325364|NCT03029624|4042730|FG000|Overall Study|Withdrawal by Subject|1
2325365|NCT03029624|4042730|FG000|Overall Study|Lack of Efficacy|1
2325366|NCT03029624|4042730|FG000|Overall Study|MRI need|2
2325367|NCT03029650|4042736|FG000|Washout (1 Week)|Withdrawal by Subject|1
2325368|NCT03029650|4042737|FG001|Washout (1 Week)|Withdrawal by Subject|1
2325369|NCT03029650|4042736|FG000|Washout (1 Week)|Physician Decision|0
2325370|NCT03029650|4042737|FG001|Washout (1 Week)|Physician Decision|1
2325371|NCT03029780|4042758|FG000|Overall Study|Disease Progression|1
2325372|NCT03029780|4042759|FG001|Overall Study|Disease Progression|3
2325373|NCT03029780|4042758|FG000|Overall Study|Study Drug Toxicity|5
2325374|NCT03029780|4042759|FG001|Overall Study|Study Drug Toxicity|5
2030584|NCT00379639|3600188|FG001|Overall Study|Adverse Event|0
2030585|NCT00379639|3600189|FG002|Overall Study|Adverse Event|1
2030586|NCT00379639|3600190|FG003|Overall Study|Adverse Event|0
2030587|NCT00379639|3600191|FG004|Overall Study|Adverse Event|1
2030588|NCT00379639|3600187|FG000|Overall Study|Lost to Follow-up|0
2030589|NCT00379639|3600188|FG001|Overall Study|Lost to Follow-up|0
2030590|NCT00379639|3600189|FG002|Overall Study|Lost to Follow-up|0
2030591|NCT00379639|3600190|FG003|Overall Study|Lost to Follow-up|1
2030592|NCT00379639|3600191|FG004|Overall Study|Lost to Follow-up|0
2030593|NCT00379639|3600187|FG000|Overall Study|Other|0
2030594|NCT00379639|3600188|FG001|Overall Study|Other|0
2030595|NCT00379639|3600189|FG002|Overall Study|Other|3
2030596|NCT00379639|3600190|FG003|Overall Study|Other|0
2030597|NCT00379639|3600191|FG004|Overall Study|Other|0
2030598|NCT00379769|3600207|FG000|Main Study|Death|57
2030599|NCT00379769|3600208|FG001|Main Study|Death|67
2030600|NCT00379769|3600209|FG002|Main Study|Death|54
2030601|NCT00379769|3600210|FG003|Main Study|Death|72
2030602|NCT00379769|3600211|FG004|Main Study|Death|0
2030603|NCT00379769|3600212|FG005|Main Study|Death|0
2030604|NCT00379769|3600207|FG000|Main Study|Adverse Event|5
2030605|NCT00379769|3600208|FG001|Main Study|Adverse Event|8
2030606|NCT00379769|3600209|FG002|Main Study|Adverse Event|10
2030607|NCT00379769|3600210|FG003|Main Study|Adverse Event|11
2030608|NCT00379769|3600211|FG004|Main Study|Adverse Event|0
2030609|NCT00379769|3600212|FG005|Main Study|Adverse Event|0
2030610|NCT00379769|3600207|FG000|Main Study|Lost to Follow-up|29
2030611|NCT00379769|3600208|FG001|Main Study|Lost to Follow-up|29
2030612|NCT00379769|3600209|FG002|Main Study|Lost to Follow-up|25
2030613|NCT00379769|3600210|FG003|Main Study|Lost to Follow-up|26
2030614|NCT00379769|3600211|FG004|Main Study|Lost to Follow-up|0
2030615|NCT00379769|3600212|FG005|Main Study|Lost to Follow-up|0
2030616|NCT00379769|3600207|FG000|Main Study|Withdrawal by Subject|46
2030617|NCT00379769|3600208|FG001|Main Study|Withdrawal by Subject|56
2030618|NCT00379769|3600209|FG002|Main Study|Withdrawal by Subject|72
2030619|NCT00379769|3600210|FG003|Main Study|Withdrawal by Subject|70
2030620|NCT00379769|3600211|FG004|Main Study|Withdrawal by Subject|0
2030621|NCT00379769|3600212|FG005|Main Study|Withdrawal by Subject|0
2030622|NCT00379769|3600207|FG000|Main Study|Moved to survival status follow-up only|27
2030623|NCT00379769|3600208|FG001|Main Study|Moved to survival status follow-up only|25
2030624|NCT00379769|3600209|FG002|Main Study|Moved to survival status follow-up only|32
2030625|NCT00379769|3600210|FG003|Main Study|Moved to survival status follow-up only|36
2030626|NCT00379769|3600211|FG004|Main Study|Moved to survival status follow-up only|0
2030627|NCT00379769|3600212|FG005|Main Study|Moved to survival status follow-up only|0
2110355|NCT00895453|3705177|FG000|Overall Study|Lost to Follow-up|25
2110356|NCT00895453|3705178|FG001|Overall Study|Lost to Follow-up|25
2110357|NCT00895453|3705179|FG002|Overall Study|Lost to Follow-up|23
2110358|NCT00895583|3705198|FG000|Overall Study|Adverse Event|28
2110359|NCT00895583|3705199|FG001|Overall Study|Adverse Event|4
2110360|NCT00895583|3705198|FG000|Overall Study|Death|2
2110361|NCT00895583|3705199|FG001|Overall Study|Death|1
2110362|NCT00895583|3705198|FG000|Overall Study|Physician Decision|3
2110363|NCT00895583|3705199|FG001|Overall Study|Physician Decision|1
2110364|NCT00895583|3705198|FG000|Overall Study|Lost to Follow-up|1
2110365|NCT00895583|3705199|FG001|Overall Study|Lost to Follow-up|3
2325375|NCT03029780|4042758|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0
2325376|NCT03029780|4042759|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
2325377|NCT03029819|4042767|FG000|Overall Study|Lost to Follow-up|3
2325378|NCT03029819|4042768|FG001|Overall Study|Lost to Follow-up|5
2325379|NCT03029819|4042767|FG000|Overall Study|Removed due to disruptive behavior|0
2325380|NCT03029819|4042768|FG001|Overall Study|Removed due to disruptive behavior|1
2325381|NCT03030599|4042786|FG000|Open Label Treatment and Titration|Protocol deviation|8
2325382|NCT03030599|4042787|FG001|Open Label Treatment and Titration|Protocol deviation|0
2325383|NCT03030599|4042788|FG002|Open Label Treatment and Titration|Protocol deviation|0
2325384|NCT03030599|4042786|FG000|Open Label Treatment and Titration|Other|1
2325385|NCT03030599|4042787|FG001|Open Label Treatment and Titration|Other|0
2325386|NCT03030599|4042788|FG002|Open Label Treatment and Titration|Other|0
2325387|NCT03030599|4042786|FG000|Open Label Treatment and Titration|Physician Decision|3
2325388|NCT03030599|4042787|FG001|Open Label Treatment and Titration|Physician Decision|0
2325389|NCT03030599|4042788|FG002|Open Label Treatment and Titration|Physician Decision|0
2325390|NCT03030599|4042786|FG000|Open Label Treatment and Titration|Lack of Efficacy|1
2325391|NCT03030599|4042787|FG001|Open Label Treatment and Titration|Lack of Efficacy|0
2325392|NCT03030599|4042788|FG002|Open Label Treatment and Titration|Lack of Efficacy|0
2325393|NCT03030599|4042786|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4
2325394|NCT03030599|4042787|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
2325395|NCT03030599|4042788|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
2325396|NCT03030599|4042786|FG000|Open Label Treatment and Titration|Adverse Event|18
2325397|NCT03030599|4042787|FG001|Open Label Treatment and Titration|Adverse Event|0
2325398|NCT03030599|4042788|FG002|Open Label Treatment and Titration|Adverse Event|0
2325399|NCT03030599|4042786|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6
2325400|NCT03030599|4042787|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0
2325401|NCT03030599|4042788|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0
2325402|NCT03030599|4042786|FG000|Open Label Treatment and Titration|Sponsor decision|2
2325403|NCT03030599|4042787|FG001|Open Label Treatment and Titration|Sponsor decision|0
2325404|NCT03030599|4042788|FG002|Open Label Treatment and Titration|Sponsor decision|0
2325405|NCT03030599|4042786|FG000|Open Label Treatment and Titration|Lost to Follow-up|3
2325406|NCT03030599|4042787|FG001|Open Label Treatment and Titration|Lost to Follow-up|0
2325407|NCT03030599|4042788|FG002|Open Label Treatment and Titration|Lost to Follow-up|0
2325408|NCT03030599|4042786|FG000|Stable Dose|Protocol deviation|3
2325409|NCT03030599|4042787|FG001|Stable Dose|Protocol deviation|0
2325410|NCT03030599|4042788|FG002|Stable Dose|Protocol deviation|0
2325411|NCT03030599|4042786|FG000|Stable Dose|Adverse Event|1
2325412|NCT03030599|4042787|FG001|Stable Dose|Adverse Event|0
2218038|NCT01712061|3861444|FG002|Overall Study|Lost to Follow-up|1
2325413|NCT03030599|4042788|FG002|Stable Dose|Adverse Event|0
2325414|NCT03030599|4042786|FG000|Stable Dose|Lost to Follow-up|1
2325415|NCT03030599|4042787|FG001|Stable Dose|Lost to Follow-up|0
2325416|NCT03030599|4042788|FG002|Stable Dose|Lost to Follow-up|0
2325417|NCT03030599|4042786|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0
2325418|NCT03030599|4042787|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0
2325419|NCT03030599|4042788|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2
2325420|NCT03030599|4042786|FG000|Double Blind Randomized Withdrawal|Adverse Event|0
2325421|NCT03030599|4042787|FG001|Double Blind Randomized Withdrawal|Adverse Event|0
2218039|NCT01712061|3861442|FG000|Overall Study|Did Not Meet Entrance Criteria|4
2218040|NCT01712061|3861443|FG001|Overall Study|Did Not Meet Entrance Criteria|6
2218041|NCT01712061|3861444|FG002|Overall Study|Did Not Meet Entrance Criteria|3
2218042|NCT01712061|3861442|FG000|Overall Study|Medication Error Without Associated AE|0
2218043|NCT01712061|3861443|FG001|Overall Study|Medication Error Without Associated AE|1
2218044|NCT01712061|3861444|FG002|Overall Study|Medication Error Without Associated AE|0
2218045|NCT01712061|3861442|FG000|Overall Study|Withdrawal by Subject|1
2218046|NCT01712061|3861443|FG001|Overall Study|Withdrawal by Subject|7
2218047|NCT01712061|3861444|FG002|Overall Study|Withdrawal by Subject|1
2218048|NCT01712061|3861442|FG000|Overall Study|Other|0
2218049|NCT01712061|3861443|FG001|Overall Study|Other|3
2218050|NCT01712061|3861444|FG002|Overall Study|Other|0
2218051|NCT01712074|3861456|FG000|Placebo Run-in Period|Adverse Event|2
2218052|NCT01712074|3861457|FG001|Placebo Run-in Period|Adverse Event|0
2218053|NCT01712074|3861458|FG002|Placebo Run-in Period|Adverse Event|0
2218054|NCT01712074|3861456|FG000|Placebo Run-in Period|Lost to Follow-up|1
2218055|NCT01712074|3861457|FG001|Placebo Run-in Period|Lost to Follow-up|0
2218056|NCT01712074|3861458|FG002|Placebo Run-in Period|Lost to Follow-up|0
2218057|NCT01712074|3861456|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5
2218058|NCT01712074|3861457|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0
2218059|NCT01712074|3861458|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0
2218060|NCT01712074|3861456|FG000|Placebo Run-in Period|Other|1
2218061|NCT01712074|3861457|FG001|Placebo Run-in Period|Other|0
2218062|NCT01712074|3861458|FG002|Placebo Run-in Period|Other|0
2218063|NCT01712074|3861456|FG000|Placebo Run-in Period|No longer willing to participate|1
2218064|NCT01712074|3861457|FG001|Placebo Run-in Period|No longer willing to participate|0
2218065|NCT01712074|3861458|FG002|Placebo Run-in Period|No longer willing to participate|0
2218066|NCT01712074|3861456|FG000|Double Blind Period|Adverse Event|0
2325422|NCT03030599|4042788|FG002|Double Blind Randomized Withdrawal|Adverse Event|3
2325423|NCT03030599|4042786|FG000|Double Blind Randomized Withdrawal|Randomized in error|0
2325424|NCT03030599|4042787|FG001|Double Blind Randomized Withdrawal|Randomized in error|0
2325425|NCT03030599|4042788|FG002|Double Blind Randomized Withdrawal|Randomized in error|2
2325426|NCT03030599|4042786|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
2325427|NCT03030599|4042787|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
2325428|NCT03030599|4042788|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1
2325429|NCT03030599|4042786|FG000|Open-label Extension|Adverse Event|3
2325430|NCT03030599|4042787|FG001|Open-label Extension|Adverse Event|0
2325431|NCT03030599|4042788|FG002|Open-label Extension|Adverse Event|0
2325432|NCT03030599|4042786|FG000|Open-label Extension|Lost to Follow-up|2
2325433|NCT03030599|4042787|FG001|Open-label Extension|Lost to Follow-up|0
2325434|NCT03030599|4042788|FG002|Open-label Extension|Lost to Follow-up|0
2325435|NCT03030599|4042786|FG000|Open-label Extension|Lack of Efficacy|1
2325436|NCT03030599|4042787|FG001|Open-label Extension|Lack of Efficacy|0
2325437|NCT03030599|4042788|FG002|Open-label Extension|Lack of Efficacy|0
2325438|NCT03030599|4042786|FG000|Open-label Extension|Other Reason|1
2325439|NCT03030599|4042787|FG001|Open-label Extension|Other Reason|0
2325440|NCT03030599|4042788|FG002|Open-label Extension|Other Reason|0
2325441|NCT03030989|4042831|FG000|Overall Study|Fever|2
2325442|NCT03030989|4042832|FG001|Overall Study|Fever|2
2325443|NCT03030989|4042831|FG000|Overall Study|Rash|2
2325444|NCT03030989|4042832|FG001|Overall Study|Rash|1
2325445|NCT03030989|4042831|FG000|Overall Study|Fatigue/Overwhelmed|1
2325446|NCT03030989|4042832|FG001|Overall Study|Fatigue/Overwhelmed|5
2325447|NCT03030989|4042831|FG000|Overall Study|Positive Blood Cultures|2
2325448|NCT03030989|4042832|FG001|Overall Study|Positive Blood Cultures|1
2325449|NCT03030989|4042831|FG000|Overall Study|Line Removed|0
2325450|NCT03030989|4042832|FG001|Overall Study|Line Removed|2
2325451|NCT03030989|4042831|FG000|Overall Study|No longer interested|5
2325452|NCT03030989|4042832|FG001|Overall Study|No longer interested|3
2325453|NCT03031431|4042838|FG000|Overall Study|Infant removed by maternal request|1
2325454|NCT03031496|4042842|FG000|Period 1|Adverse Event|2
2325455|NCT03031496|4042843|FG001|Period 1|Adverse Event|0
2325456|NCT03031496|4042842|FG000|Period 1|Withdrawal by Subject|0
2325457|NCT03031496|4042843|FG001|Period 1|Withdrawal by Subject|2
2325458|NCT03031678|4042849|FG000|Overall Study|Study closed prior to completion|1
2325459|NCT03031899|4042866|FG000|Overall Study|Protocol Violation|1
2325460|NCT03031899|4042866|FG000|Overall Study|lesion disappeared after stopping habit|1
2325461|NCT03031938|4042876|FG000|Overall Study|Death|1
2325462|NCT03031938|4042877|FG001|Overall Study|Death|0
2325463|NCT03032380|4042894|FG000|Overall Study|Adverse Event|0
2325464|NCT03032380|4042895|FG001|Overall Study|Adverse Event|1
2325465|NCT03032380|4042894|FG000|Overall Study|Lack of Efficacy|1
2325466|NCT03032380|4042895|FG001|Overall Study|Lack of Efficacy|0
2325467|NCT03032380|4042894|FG000|Overall Study|Withdrawal by Subject|2
2325468|NCT03032380|4042895|FG001|Overall Study|Withdrawal by Subject|3
2325469|NCT03032380|4042894|FG000|Overall Study|Recovery|0
2325470|NCT03032380|4042895|FG001|Overall Study|Recovery|1
2325471|NCT03032380|4042894|FG000|Overall Study|Death|39
2325472|NCT03032380|4042895|FG001|Overall Study|Death|34
2325473|NCT03032380|4042894|FG000|Overall Study|Other - Miscellaneous|0
2325474|NCT03032380|4042895|FG001|Overall Study|Other - Miscellaneous|1
2325475|NCT03032523|4042912|FG000|Overall Study|Withdrawal by Subject|2
2325476|NCT03032523|4042913|FG001|Overall Study|Withdrawal by Subject|2
2325477|NCT03032523|4042912|FG000|Overall Study|Physician Decision|1
2325478|NCT03032523|4042913|FG001|Overall Study|Physician Decision|0
2325479|NCT03033394|4042953|FG000|Completed Pharmacokinetic Analysis|Missing data|1
2325480|NCT03033394|4042953|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3
2325481|NCT03033394|4042953|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1
2325482|NCT03033394|4042953|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1
2325483|NCT03033394|4042953|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1
2325484|NCT03033745|4042974|FG000|Overall Study|Protocol Violation|0
2325485|NCT03033745|4042975|FG001|Overall Study|Protocol Violation|0
2325486|NCT03033745|4042976|FG002|Overall Study|Protocol Violation|1
2325487|NCT03033745|4042974|FG000|Overall Study|Adverse Event|1
2325488|NCT03033745|4042975|FG001|Overall Study|Adverse Event|0
2325489|NCT03033745|4042976|FG002|Overall Study|Adverse Event|1
2325490|NCT03033745|4042974|FG000|Overall Study|Withdrawal by Subject|0
2325491|NCT03033745|4042975|FG001|Overall Study|Withdrawal by Subject|1
2325492|NCT03033745|4042976|FG002|Overall Study|Withdrawal by Subject|0
2325493|NCT03033784|4042993|FG000|Overall Study|Anxiety related to MRI scanner|0
2325494|NCT03033784|4042994|FG001|Overall Study|Anxiety related to MRI scanner|1
2325495|NCT03033784|4042995|FG002|Overall Study|Anxiety related to MRI scanner|0
2325496|NCT03033784|4042996|FG003|Overall Study|Anxiety related to MRI scanner|0
2325497|NCT03033784|4042997|FG004|Overall Study|Anxiety related to MRI scanner|0
2325498|NCT03033784|4042998|FG005|Overall Study|Anxiety related to MRI scanner|0
2325499|NCT03033784|4042999|FG006|Overall Study|Anxiety related to MRI scanner|0
2325500|NCT03033784|4043000|FG007|Overall Study|Anxiety related to MRI scanner|0
2325501|NCT03033784|4043001|FG008|Overall Study|Anxiety related to MRI scanner|0
2325502|NCT03033784|4043002|FG009|Overall Study|Anxiety related to MRI scanner|0
2325503|NCT03033784|4043003|FG010|Overall Study|Anxiety related to MRI scanner|0
2325504|NCT03033784|4043004|FG011|Overall Study|Anxiety related to MRI scanner|0
2325505|NCT03033784|4043005|FG012|Overall Study|Anxiety related to MRI scanner|0
2325506|NCT03033784|4042993|FG000|Overall Study|Withdrawal by Subject|0
2325507|NCT03033784|4042994|FG001|Overall Study|Withdrawal by Subject|0
2325508|NCT03033784|4042995|FG002|Overall Study|Withdrawal by Subject|0
2325509|NCT03033784|4042996|FG003|Overall Study|Withdrawal by Subject|0
2325510|NCT03033784|4042997|FG004|Overall Study|Withdrawal by Subject|0
2325511|NCT03033784|4042998|FG005|Overall Study|Withdrawal by Subject|0
2325512|NCT03033784|4042999|FG006|Overall Study|Withdrawal by Subject|0
2325513|NCT03033784|4043000|FG007|Overall Study|Withdrawal by Subject|0
2325514|NCT03033784|4043001|FG008|Overall Study|Withdrawal by Subject|0
2325515|NCT03033784|4043002|FG009|Overall Study|Withdrawal by Subject|0
2325516|NCT03033784|4043003|FG010|Overall Study|Withdrawal by Subject|0
2325517|NCT03033784|4043004|FG011|Overall Study|Withdrawal by Subject|0
2325518|NCT03033784|4043005|FG012|Overall Study|Withdrawal by Subject|2
2325519|NCT03034044|4043025|FG000|Overall Study|Enrolled, but not received Xyntha|1
2325520|NCT03034057|4043029|FG000|Overall Study|Withdrawal by Subject|10
2325521|NCT03034057|4043029|FG000|Overall Study|Protocol Violation|1
2325522|NCT03034057|4043029|FG000|Overall Study|Not defined|2
2325523|NCT03034057|4043029|FG000|Overall Study|Lost to Follow-up|19
2325524|NCT03034057|4043029|FG000|Overall Study|Adverse Event|22
2325525|NCT03034057|4043029|FG000|Overall Study|Medication error without associated AE|1
2325526|NCT03034135|4043033|FG000|Overall Study|Withdrawal by Subject|2
2325527|NCT03034460|4043039|FG000|Overall Study|Adverse Event|0
2325528|NCT03034460|4043040|FG001|Overall Study|Adverse Event|1
2325529|NCT03034460|4043039|FG000|Overall Study|Withdrawal by Subject|2
2325530|NCT03034460|4043040|FG001|Overall Study|Withdrawal by Subject|2
2325531|NCT03034460|4043039|FG000|Overall Study|Personal Reasons|1
2030628|NCT00379769|3600207|FG000|Main Study|Participant moved|3
2030629|NCT00379769|3600208|FG001|Main Study|Participant moved|2
2030630|NCT00379769|3600209|FG002|Main Study|Participant moved|3
2030631|NCT00379769|3600210|FG003|Main Study|Participant moved|3
2030632|NCT00379769|3600211|FG004|Main Study|Participant moved|0
2030633|NCT00379769|3600212|FG005|Main Study|Participant moved|0
2030634|NCT00379769|3600207|FG000|Main Study|Poor compliance|3
2030635|NCT00379769|3600208|FG001|Main Study|Poor compliance|2
2030636|NCT00379769|3600209|FG002|Main Study|Poor compliance|2
2030637|NCT00379769|3600210|FG003|Main Study|Poor compliance|1
2030638|NCT00379769|3600211|FG004|Main Study|Poor compliance|0
2030639|NCT00379769|3600212|FG005|Main Study|Poor compliance|0
2030640|NCT00379769|3600207|FG000|Main Study|Prohibited glucose lowering medication|0
2030641|NCT00379769|3600208|FG001|Main Study|Prohibited glucose lowering medication|3
2030642|NCT00379769|3600209|FG002|Main Study|Prohibited glucose lowering medication|0
2325532|NCT03034460|4043040|FG001|Overall Study|Personal Reasons|0
2325533|NCT03034577|4043052|FG000|Overall Study|Withdrawal by Subject|6
2325534|NCT03034577|4043053|FG001|Overall Study|Withdrawal by Subject|9
2325535|NCT03034577|4043052|FG000|Overall Study|Lost to Follow-up|25
2325536|NCT03034577|4043053|FG001|Overall Study|Lost to Follow-up|26
2325537|NCT03034772|4043063|FG000|Overall Study|Adverse Event|0
2325538|NCT03034772|4043064|FG001|Overall Study|Adverse Event|1
2325539|NCT03034772|4043063|FG000|Overall Study|Withdrawal by Subject|0
2325540|NCT03034772|4043064|FG001|Overall Study|Withdrawal by Subject|1
2325541|NCT03034915|4043073|FG000|Overall Study|Adverse Event|29
2325542|NCT03034915|4043074|FG001|Overall Study|Adverse Event|32
2325543|NCT03034915|4043075|FG002|Overall Study|Adverse Event|22
2325544|NCT03034915|4043073|FG000|Overall Study|Lost to Follow-up|5
2325545|NCT03034915|4043074|FG001|Overall Study|Lost to Follow-up|13
2325546|NCT03034915|4043075|FG002|Overall Study|Lost to Follow-up|3
2325547|NCT03034915|4043073|FG000|Overall Study|Withdrawal by Subject|29
2325548|NCT03034915|4043074|FG001|Overall Study|Withdrawal by Subject|46
2325549|NCT03034915|4043075|FG002|Overall Study|Withdrawal by Subject|41
2325550|NCT03034915|4043073|FG000|Overall Study|Protocol Deviation|2
2325551|NCT03034915|4043074|FG001|Overall Study|Protocol Deviation|14
2325552|NCT03034915|4043075|FG002|Overall Study|Protocol Deviation|7
2325553|NCT03034915|4043073|FG000|Overall Study|Lack of Efficacy|8
2325554|NCT03034915|4043074|FG001|Overall Study|Lack of Efficacy|16
2325555|NCT03034915|4043075|FG002|Overall Study|Lack of Efficacy|18
2325556|NCT03034915|4043073|FG000|Overall Study|Site closed|2
2325557|NCT03034915|4043074|FG001|Overall Study|Site closed|2
2325558|NCT03034915|4043075|FG002|Overall Study|Site closed|4
2325559|NCT03034915|4043073|FG000|Overall Study|Protocol-defined withdrawal criteria met|19
2325560|NCT03034915|4043074|FG001|Overall Study|Protocol-defined withdrawal criteria met|26
2325561|NCT03034915|4043075|FG002|Overall Study|Protocol-defined withdrawal criteria met|29
2325562|NCT03034915|4043073|FG000|Overall Study|Physician Decision|1
2325563|NCT03034915|4043074|FG001|Overall Study|Physician Decision|5
2325564|NCT03034915|4043075|FG002|Overall Study|Physician Decision|2
2325565|NCT03034954|4043097|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1
2325566|NCT03034954|4043098|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0
2325567|NCT03034967|4043110|FG000|Overall Study|Withdrawal by Subject|9
2325568|NCT03034967|4043111|FG001|Overall Study|Withdrawal by Subject|2
2325569|NCT03034967|4043112|FG002|Overall Study|Withdrawal by Subject|6
2325570|NCT03034967|4043113|FG003|Overall Study|Withdrawal by Subject|6
2325571|NCT03034967|4043114|FG004|Overall Study|Withdrawal by Subject|9
2325572|NCT03034967|4043115|FG005|Overall Study|Withdrawal by Subject|2
2325573|NCT03034967|4043110|FG000|Overall Study|Physician Decision|1
2325574|NCT03034967|4043111|FG001|Overall Study|Physician Decision|0
2325575|NCT03034967|4043112|FG002|Overall Study|Physician Decision|1
2325576|NCT03034967|4043113|FG003|Overall Study|Physician Decision|1
2325577|NCT03034967|4043114|FG004|Overall Study|Physician Decision|1
2325578|NCT03034967|4043115|FG005|Overall Study|Physician Decision|0
2325579|NCT03034967|4043110|FG000|Overall Study|Lost to Follow-up|0
2325580|NCT03034967|4043111|FG001|Overall Study|Lost to Follow-up|0
2325581|NCT03034967|4043112|FG002|Overall Study|Lost to Follow-up|0
2325582|NCT03034967|4043113|FG003|Overall Study|Lost to Follow-up|1
2325583|NCT03034967|4043114|FG004|Overall Study|Lost to Follow-up|0
2325584|NCT03034967|4043115|FG005|Overall Study|Lost to Follow-up|2
2325585|NCT03034967|4043110|FG000|Overall Study|Liver function test abnormality|0
2325586|NCT03034967|4043111|FG001|Overall Study|Liver function test abnormality|0
2325587|NCT03034967|4043112|FG002|Overall Study|Liver function test abnormality|1
2325588|NCT03034967|4043113|FG003|Overall Study|Liver function test abnormality|0
2325589|NCT03034967|4043114|FG004|Overall Study|Liver function test abnormality|0
2325590|NCT03034967|4043115|FG005|Overall Study|Liver function test abnormality|0
2325591|NCT03034967|4043110|FG000|Overall Study|Protocol Violation|1
2325592|NCT03034967|4043111|FG001|Overall Study|Protocol Violation|0
2325593|NCT03034967|4043112|FG002|Overall Study|Protocol Violation|0
2325594|NCT03034967|4043113|FG003|Overall Study|Protocol Violation|0
2325595|NCT03034967|4043114|FG004|Overall Study|Protocol Violation|0
2325596|NCT03034967|4043115|FG005|Overall Study|Protocol Violation|2
2325597|NCT03034967|4043110|FG000|Overall Study|Lack of Efficacy|0
2325598|NCT03034967|4043111|FG001|Overall Study|Lack of Efficacy|1
2325599|NCT03034967|4043112|FG002|Overall Study|Lack of Efficacy|2
2325600|NCT03034967|4043113|FG003|Overall Study|Lack of Efficacy|1
2325601|NCT03034967|4043114|FG004|Overall Study|Lack of Efficacy|1
2325602|NCT03034967|4043115|FG005|Overall Study|Lack of Efficacy|0
2325603|NCT03034967|4043110|FG000|Overall Study|Adverse Event, non-fatal|3
2325604|NCT03034967|4043111|FG001|Overall Study|Adverse Event, non-fatal|1
2325605|NCT03034967|4043112|FG002|Overall Study|Adverse Event, non-fatal|2
2325606|NCT03034967|4043113|FG003|Overall Study|Adverse Event, non-fatal|0
2325607|NCT03034967|4043114|FG004|Overall Study|Adverse Event, non-fatal|2
2325608|NCT03034967|4043115|FG005|Overall Study|Adverse Event, non-fatal|8
2325609|NCT03034967|4043110|FG000|Overall Study|Adverse Event, Serious Fatal|0
2325610|NCT03034967|4043111|FG001|Overall Study|Adverse Event, Serious Fatal|1
2325611|NCT03034967|4043112|FG002|Overall Study|Adverse Event, Serious Fatal|1
2325612|NCT03034967|4043113|FG003|Overall Study|Adverse Event, Serious Fatal|2
2325613|NCT03034967|4043114|FG004|Overall Study|Adverse Event, Serious Fatal|1
2325614|NCT03034967|4043115|FG005|Overall Study|Adverse Event, Serious Fatal|1
2325615|NCT03035032|4043134|FG000|Overall Study|Adverse Event|2
2325616|NCT03035032|4043134|FG000|Overall Study|Death|9
2325617|NCT03035032|4043134|FG000|Overall Study|Lost to Follow-up|1
2325618|NCT03035032|4043134|FG000|Overall Study|Progressive Disease|22
2325619|NCT03035032|4043134|FG000|Overall Study|Protocol Violation|2
2325620|NCT03035032|4043134|FG000|Overall Study|Withdrawal by Subject|2
2325621|NCT03035032|4043134|FG000|Overall Study|Physician Decision|5
2325622|NCT03035864|4043198|FG000|Treatment Period|Adverse Event|1
2325623|NCT03035864|4043199|FG001|Treatment Period|Adverse Event|0
2325624|NCT03035864|4043198|FG000|Treatment Period|Other|3
2325625|NCT03035864|4043199|FG001|Treatment Period|Other|1
2325626|NCT03035864|4043198|FG000|Follow-up Period|Adverse Event|1
2325627|NCT03035864|4043199|FG001|Follow-up Period|Adverse Event|0
2325628|NCT03035864|4043198|FG000|Follow-up Period|Lost to Follow-up|6
2325629|NCT03035864|4043199|FG001|Follow-up Period|Lost to Follow-up|2
2325630|NCT03035864|4043198|FG000|Follow-up Period|Physician Decision|1
2325631|NCT03035864|4043199|FG001|Follow-up Period|Physician Decision|0
2325632|NCT03035864|4043198|FG000|Follow-up Period|Other|3
2325633|NCT03035864|4043199|FG001|Follow-up Period|Other|2
2325634|NCT03035916|4043208|FG000|Overall Study|Puncture failed|0
2325635|NCT03035916|4043209|FG001|Overall Study|Puncture failed|2
2325636|NCT03035916|4043210|FG002|Overall Study|Puncture failed|0
2325637|NCT03035942|4043226|FG000|Overall Study|Adverse Event|8
2325638|NCT03035942|4043227|FG001|Overall Study|Adverse Event|4
2325639|NCT03035942|4043228|FG002|Overall Study|Adverse Event|5
2325640|NCT03036072|4043249|FG000|Overall Study|Death|0
2325641|NCT03036072|4043250|FG001|Overall Study|Death|1
2325642|NCT03036072|4043249|FG000|Overall Study|Withdrawal by Subject|0
2325643|NCT03036072|4043250|FG001|Overall Study|Withdrawal by Subject|1
2325644|NCT03036072|4043249|FG000|Overall Study|Physician Decision|0
2325645|NCT03036072|4043250|FG001|Overall Study|Physician Decision|1
2325646|NCT03036124|4043258|FG000|Overall Study|Lost to Follow-up|0
2325647|NCT03036124|4043259|FG001|Overall Study|Lost to Follow-up|2
2325648|NCT03036124|4043258|FG000|Overall Study|Withdrawal by Subject|5
2325649|NCT03036124|4043259|FG001|Overall Study|Withdrawal by Subject|4
2325650|NCT03036150|4043267|FG000|Overall Study|Withdrawal by Subject|8
2325651|NCT03036150|4043268|FG001|Overall Study|Withdrawal by Subject|3
2325652|NCT03036150|4043267|FG000|Overall Study|Lost to Follow-up|2
2325653|NCT03036150|4043268|FG001|Overall Study|Lost to Follow-up|2
2325654|NCT03036813|4043364|FG000|Overall Study|Adverse Event|6
2325655|NCT03036813|4043365|FG001|Overall Study|Adverse Event|11
2325656|NCT03036813|4043366|FG002|Overall Study|Adverse Event|6
2325657|NCT03036813|4043364|FG000|Overall Study|Withdrawal by Subject|12
2325658|NCT03036813|4043365|FG001|Overall Study|Withdrawal by Subject|6
2325659|NCT03036813|4043366|FG002|Overall Study|Withdrawal by Subject|10
2325660|NCT03036813|4043364|FG000|Overall Study|Lost to Follow-up|1
2325661|NCT03036813|4043365|FG001|Overall Study|Lost to Follow-up|1
2325662|NCT03036813|4043366|FG002|Overall Study|Lost to Follow-up|0
2325663|NCT03036813|4043364|FG000|Overall Study|Physician Decision|2
2325664|NCT03036813|4043365|FG001|Overall Study|Physician Decision|1
2325665|NCT03036813|4043366|FG002|Overall Study|Physician Decision|1
2325666|NCT03036813|4043364|FG000|Overall Study|Non-Compliance|1
2325667|NCT03036813|4043365|FG001|Overall Study|Non-Compliance|5
2325668|NCT03036813|4043366|FG002|Overall Study|Non-Compliance|3
2325669|NCT03036813|4043364|FG000|Overall Study|Pregnancy|0
2325670|NCT03036813|4043365|FG001|Overall Study|Pregnancy|0
2325671|NCT03036813|4043366|FG002|Overall Study|Pregnancy|1
2325672|NCT03036813|4043364|FG000|Overall Study|Other|0
2325673|NCT03036813|4043365|FG001|Overall Study|Other|3
2325674|NCT03036813|4043366|FG002|Overall Study|Other|5
2325675|NCT03036839|4043380|FG000|Overall Study|Adverse Event|0
2325676|NCT03036839|4043381|FG001|Overall Study|Adverse Event|0
2325677|NCT03036839|4043382|FG002|Overall Study|Adverse Event|1
2325678|NCT03036839|4043380|FG000|Overall Study|Death|3
2325679|NCT03036839|4043381|FG001|Overall Study|Death|0
2325680|NCT03036839|4043382|FG002|Overall Study|Death|3
2325681|NCT03036839|4043380|FG000|Overall Study|Withdrew Consent|0
2325682|NCT03036839|4043381|FG001|Overall Study|Withdrew Consent|0
2325683|NCT03036839|4043382|FG002|Overall Study|Withdrew Consent|1
2325684|NCT03036852|4043396|FG000|Overall Study|Death|2
2325685|NCT03036852|4043396|FG000|Overall Study|Lack of Efficacy|2
2325686|NCT03036852|4043396|FG000|Overall Study|Adverse Event|1
2325687|NCT03036852|4043396|FG000|Overall Study|Lost to Follow-up|1
2325688|NCT03037307|4043444|FG000|Period 1|Did Not Meet Study Criteria|0
2325689|NCT03037307|4043445|FG001|Period 1|Did Not Meet Study Criteria|0
2325690|NCT03037307|4043446|FG002|Period 1|Did Not Meet Study Criteria|0
2325691|NCT03037307|4043447|FG003|Period 1|Did Not Meet Study Criteria|1
2325692|NCT03037307|4043448|FG004|Period 1|Did Not Meet Study Criteria|0
2325693|NCT03037307|4043449|FG005|Period 1|Did Not Meet Study Criteria|0
2325694|NCT03037489|4043460|FG000|Overall Study|Adverse Event|4
2325695|NCT03037489|4043461|FG001|Overall Study|Adverse Event|0
2325696|NCT03037489|4043460|FG000|Overall Study|Withdrawal by Subject|3
2325697|NCT03037489|4043461|FG001|Overall Study|Withdrawal by Subject|0
2325698|NCT03037580|4043478|FG000|Overall Study|Withdrawal by Subject|3
2325699|NCT03037580|4043479|FG001|Overall Study|Withdrawal by Subject|0
2325700|NCT03037580|4043478|FG000|Overall Study|Adverse Event|1
2325701|NCT03037580|4043479|FG001|Overall Study|Adverse Event|0
2325702|NCT03037580|4043478|FG000|Overall Study|Study Terminated by Sponsor|12
2325703|NCT03037580|4043479|FG001|Overall Study|Study Terminated by Sponsor|15
2325704|NCT03037580|4043478|FG000|Overall Study|Death|0
2325705|NCT03037580|4043479|FG001|Overall Study|Death|1
2325706|NCT03037619|4043487|FG000|Overall Study|Lost to Follow-up|0
2325707|NCT03037619|4043488|FG001|Overall Study|Lost to Follow-up|1
2325708|NCT03038113|4043528|FG000|Overall Study|Withdrawal by Subject|0
2325709|NCT03038113|4043529|FG001|Overall Study|Withdrawal by Subject|0
2325710|NCT03038113|4043530|FG002|Overall Study|Withdrawal by Subject|1
2325711|NCT03038113|4043531|FG003|Overall Study|Withdrawal by Subject|0
2325712|NCT03038113|4043532|FG004|Overall Study|Withdrawal by Subject|0
2325713|NCT03038113|4043533|FG005|Overall Study|Withdrawal by Subject|0
2325714|NCT03038113|4043534|FG006|Overall Study|Withdrawal by Subject|0
2325715|NCT03038113|4043535|FG007|Overall Study|Withdrawal by Subject|0
2325716|NCT03038113|4043536|FG008|Overall Study|Withdrawal by Subject|0
2325717|NCT03038113|4043537|FG009|Overall Study|Withdrawal by Subject|0
2325718|NCT03038113|4043538|FG010|Overall Study|Withdrawal by Subject|0
2325719|NCT03038113|4043539|FG011|Overall Study|Withdrawal by Subject|0
2325720|NCT03038113|4043540|FG012|Overall Study|Withdrawal by Subject|0
2325721|NCT03038113|4043541|FG013|Overall Study|Withdrawal by Subject|1
2325722|NCT03038113|4043528|FG000|Overall Study|Lost to Follow-up|0
2325723|NCT03038113|4043529|FG001|Overall Study|Lost to Follow-up|0
2325724|NCT03038113|4043530|FG002|Overall Study|Lost to Follow-up|0
2325725|NCT03038113|4043531|FG003|Overall Study|Lost to Follow-up|0
2325726|NCT03038113|4043532|FG004|Overall Study|Lost to Follow-up|0
2325727|NCT03038113|4043533|FG005|Overall Study|Lost to Follow-up|0
2325728|NCT03038113|4043534|FG006|Overall Study|Lost to Follow-up|1
2325729|NCT03038113|4043535|FG007|Overall Study|Lost to Follow-up|0
2325730|NCT03038113|4043536|FG008|Overall Study|Lost to Follow-up|0
2325731|NCT03038113|4043537|FG009|Overall Study|Lost to Follow-up|0
2325732|NCT03038113|4043538|FG010|Overall Study|Lost to Follow-up|0
2325733|NCT03038113|4043539|FG011|Overall Study|Lost to Follow-up|0
2325734|NCT03038113|4043540|FG012|Overall Study|Lost to Follow-up|0
2325735|NCT03038113|4043541|FG013|Overall Study|Lost to Follow-up|0
2325736|NCT03038126|4043590|FG000|Overall Study|Death|1
2325737|NCT03038126|4043591|FG001|Overall Study|Death|1
2325738|NCT03038126|4043590|FG000|Overall Study|Withdrawal by Subject|5
2325739|NCT03038126|4043591|FG001|Overall Study|Withdrawal by Subject|0
2325740|NCT03038126|4043590|FG000|Overall Study|Lost to Follow-up|0
2325741|NCT03038126|4043591|FG001|Overall Study|Lost to Follow-up|1
2325742|NCT03038126|4043590|FG000|Overall Study|Long Term Hospitalization|2
2325743|NCT03038126|4043591|FG001|Overall Study|Long Term Hospitalization|0
2325744|NCT03038126|4043590|FG000|Overall Study|Too Ill to Participate|1
2325745|NCT03038126|4043591|FG001|Overall Study|Too Ill to Participate|2
2325746|NCT03038620|4043622|FG000|Overall Study|Lost to Follow-up|18
2325747|NCT03038620|4043623|FG001|Overall Study|Lost to Follow-up|23
2325748|NCT03038620|4043622|FG000|Overall Study|Withdrawal by Subject|0
2325749|NCT03038620|4043623|FG001|Overall Study|Withdrawal by Subject|15
2325750|NCT03038620|4043622|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1
2325751|NCT03038620|4043623|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0
2325752|NCT03038880|4043651|FG000|Overall Study|Death|1
2325753|NCT03038880|4043652|FG001|Overall Study|Death|2
2325754|NCT03038880|4043653|FG002|Overall Study|Death|0
2325755|NCT03038880|4043651|FG000|Overall Study|Physician Decision|2
2325756|NCT03038880|4043652|FG001|Overall Study|Physician Decision|1
2325757|NCT03038880|4043653|FG002|Overall Study|Physician Decision|0
2325758|NCT03039023|4043666|FG000|Overall Study|Withdrawal by Subject|1
2325759|NCT03039023|4043667|FG001|Overall Study|Withdrawal by Subject|0
2325760|NCT03039023|4043668|FG002|Overall Study|Withdrawal by Subject|1
2325761|NCT03039023|4043669|FG003|Overall Study|Withdrawal by Subject|1
2325762|NCT03039023|4043670|FG004|Overall Study|Withdrawal by Subject|0
2325763|NCT03039023|4043666|FG000|Overall Study|Physician Decision|0
2325764|NCT03039023|4043667|FG001|Overall Study|Physician Decision|0
2325765|NCT03039023|4043668|FG002|Overall Study|Physician Decision|0
2325766|NCT03039023|4043669|FG003|Overall Study|Physician Decision|1
2325767|NCT03039023|4043670|FG004|Overall Study|Physician Decision|0
2325768|NCT03039192|4043702|FG000|Overall Study|Lost to Follow-up|4
2325769|NCT03039192|4043703|FG001|Overall Study|Lost to Follow-up|4
2325770|NCT03039192|4043702|FG000|Overall Study|Adverse event, serious fatal|0
2030643|NCT00379769|3600210|FG003|Main Study|Prohibited glucose lowering medication|1
2030644|NCT00379769|3600211|FG004|Main Study|Prohibited glucose lowering medication|0
2030645|NCT00379769|3600212|FG005|Main Study|Prohibited glucose lowering medication|0
2030646|NCT00379769|3600207|FG000|Main Study|Site closed|4
2030647|NCT00379769|3600208|FG001|Main Study|Site closed|4
2030648|NCT00379769|3600209|FG002|Main Study|Site closed|4
2030649|NCT00379769|3600210|FG003|Main Study|Site closed|8
2180307|NCT01400698|3806344|FG003|Overall Study|Other|2
2180308|NCT01400698|3806345|FG004|Overall Study|Other|1
2030650|NCT00379769|3600211|FG004|Main Study|Site closed|0
2325771|NCT03039192|4043703|FG001|Overall Study|Adverse event, serious fatal|1
2325772|NCT03039192|4043702|FG000|Overall Study|Adverse event, non-fatal|0
2325773|NCT03039192|4043703|FG001|Overall Study|Adverse event, non-fatal|2
2325774|NCT03039192|4043702|FG000|Overall Study|Withdrawal by Subject|6
2325775|NCT03039192|4043703|FG001|Overall Study|Withdrawal by Subject|9
2325776|NCT03039192|4043702|FG000|Overall Study|Discontinued from treatment phase|19
2325777|NCT03039192|4043703|FG001|Overall Study|Discontinued from treatment phase|12
2325778|NCT03039192|4043702|FG000|Overall Study|Other|3
2325779|NCT03039192|4043703|FG001|Overall Study|Other|2
2325780|NCT03039283|4043709|FG000|Overall Study|Protocol Violation|2
2325781|NCT03039569|4043724|FG000|Overall Study|Lost to Follow-up|5
2325782|NCT03039569|4043725|FG001|Overall Study|Lost to Follow-up|4
2325783|NCT03039621|4043734|FG000|Overall Study|Violation of inclusion criteria|3
2325784|NCT03039621|4043735|FG001|Overall Study|Violation of inclusion criteria|2
2325785|NCT03039621|4043734|FG000|Overall Study|Non-compliance with protocol requirement|4
2325786|NCT03039621|4043735|FG001|Overall Study|Non-compliance with protocol requirement|5
2325787|NCT03039621|4043734|FG000|Overall Study|Necessity to use drugs forbidden by pro|4
2325788|NCT03039621|4043735|FG001|Overall Study|Necessity to use drugs forbidden by pro|7
2325789|NCT03039621|4043734|FG000|Overall Study|Violation of non-inclusion criteria|1
2325790|NCT03039621|4043735|FG001|Overall Study|Violation of non-inclusion criteria|2
2325791|NCT03039686|4043744|FG000|Double-blind Period|Administrative Reason by Sponsor|24
2325792|NCT03039686|4043745|FG001|Double-blind Period|Administrative Reason by Sponsor|25
2325793|NCT03039686|4043746|FG002|Double-blind Period|Administrative Reason by Sponsor|21
2325794|NCT03039686|4043744|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1
2325795|NCT03039686|4043745|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2
2325796|NCT03039686|4043746|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0
2325797|NCT03039686|4043744|FG000|Double-blind Period|Withdrawal by Subject|2
2325798|NCT03039686|4043745|FG001|Double-blind Period|Withdrawal by Subject|2
2325799|NCT03039686|4043746|FG002|Double-blind Period|Withdrawal by Subject|1
2325800|NCT03039686|4043744|FG000|Double-blind Period|Death|0
2325801|NCT03039686|4043745|FG001|Double-blind Period|Death|0
2325802|NCT03039686|4043746|FG002|Double-blind Period|Death|1
2325803|NCT03039686|4043744|FG000|Open Label Period|Administrative Reason by Sponsor|0
2325804|NCT03039686|4043745|FG001|Open Label Period|Administrative Reason by Sponsor|34
2325805|NCT03039686|4043746|FG002|Open Label Period|Administrative Reason by Sponsor|41
2325806|NCT03039686|4043744|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0
2325807|NCT03039686|4043745|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1
2325808|NCT03039686|4043746|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0
2325809|NCT03039686|4043744|FG000|Open Label Period|Withdrawal by Subject|0
2325810|NCT03039686|4043745|FG001|Open Label Period|Withdrawal by Subject|3
2325811|NCT03039686|4043746|FG002|Open Label Period|Withdrawal by Subject|1
2325812|NCT03039699|4043766|FG000|Overall Study|Incorrect inclusion|5
2325813|NCT03039699|4043767|FG001|Overall Study|Incorrect inclusion|4
2325814|NCT03039699|4043766|FG000|Overall Study|Lack of data to assess study endpoint|5
2325815|NCT03039699|4043767|FG001|Overall Study|Lack of data to assess study endpoint|3
2325816|NCT03039699|4043766|FG000|Overall Study|Bacterial infection|12
2325817|NCT03039699|4043767|FG001|Overall Study|Bacterial infection|28
2325818|NCT03039738|4043775|FG000|Overall Study|Incomplete data sets|54
2325819|NCT03039738|4043776|FG001|Overall Study|Incomplete data sets|0
2325820|NCT03040024|4043798|FG000|Overall Study|Adverse Event|0
2325821|NCT03040024|4043799|FG001|Overall Study|Adverse Event|1
2325822|NCT03040024|4043800|FG002|Overall Study|Adverse Event|0
2325823|NCT03040024|4043798|FG000|Overall Study|Death|0
2325824|NCT03040024|4043799|FG001|Overall Study|Death|1
2325825|NCT03040024|4043800|FG002|Overall Study|Death|0
2325826|NCT03040024|4043798|FG000|Overall Study|Physician Decision|0
2325827|NCT03040024|4043799|FG001|Overall Study|Physician Decision|0
2325828|NCT03040024|4043800|FG002|Overall Study|Physician Decision|1
2325829|NCT03040336|4043819|FG000|Overall Study|Death|1
2325830|NCT03040336|4043820|FG001|Overall Study|Death|0
2325831|NCT03040336|4043819|FG000|Overall Study|Withdrawal by Subject|2
2325832|NCT03040336|4043820|FG001|Overall Study|Withdrawal by Subject|3
2352410|NCT03776175|4101677|FG003|Treatment Period (42 Days)|Lost to Follow-up|2
2352411|NCT03776175|4101674|FG000|Treatment Period (42 Days)|Participants screened at other site|0
2352412|NCT03776175|4101675|FG001|Treatment Period (42 Days)|Participants screened at other site|2
2352413|NCT03776175|4101676|FG002|Treatment Period (42 Days)|Participants screened at other site|0
2352414|NCT03776175|4101677|FG003|Treatment Period (42 Days)|Participants screened at other site|0
2352415|NCT03776175|4101674|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1
2352416|NCT03776175|4101675|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2
2352417|NCT03776175|4101676|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3
2352418|NCT03776175|4101677|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0
2352419|NCT03776175|4101674|FG000|Treatment Period (42 Days)|Unable to attend study visits|0
2352420|NCT03776175|4101675|FG001|Treatment Period (42 Days)|Unable to attend study visits|2
2352421|NCT03776175|4101676|FG002|Treatment Period (42 Days)|Unable to attend study visits|0
2352422|NCT03776175|4101677|FG003|Treatment Period (42 Days)|Unable to attend study visits|0
2352423|NCT03776175|4101674|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0
2352424|NCT03776175|4101675|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0
2352425|NCT03776175|4101676|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0
2352426|NCT03776175|4101677|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2
2352427|NCT03771963|4101687|FG000|Overall Study|Lost to Follow-up|22
2352428|NCT03771963|4101687|FG000|Overall Study|Withdrawal of Consent|10
2352429|NCT03771352|4101691|FG000|Overall Study|Screen failure|2
2325833|NCT03040674|4043877|FG000|Overall Study|Lost to Follow-up|225
2325834|NCT03040674|4043877|FG000|Overall Study|Death|23
2325835|NCT03040687|4043885|FG000|Overall Study|Withdrawal by Subject|1
2325836|NCT03040687|4043886|FG001|Overall Study|Withdrawal by Subject|0
2325837|NCT03040687|4043887|FG002|Overall Study|Withdrawal by Subject|0
2325838|NCT03040713|4043895|FG000|Overall Study|Positive amyloid scan|3
2325839|NCT03040986|4043905|FG000|Overall Study|Hospice|1
2325840|NCT03040986|4043906|FG001|Overall Study|Hospice|0
2325841|NCT03040986|4043905|FG000|Overall Study|Adverse Event|2
2325842|NCT03040986|4043906|FG001|Overall Study|Adverse Event|1
2325843|NCT03040986|4043905|FG000|Overall Study|Disease progression on study|3
2325844|NCT03040986|4043906|FG001|Overall Study|Disease progression on study|1
2325845|NCT03041025|4043917|FG000|Overall Study|Adverse Event|0
2325846|NCT03041025|4043918|FG001|Overall Study|Adverse Event|0
2325847|NCT03041025|4043919|FG002|Overall Study|Adverse Event|1
2325848|NCT03041025|4043917|FG000|Overall Study|Lost to Follow-up|1
2325849|NCT03041025|4043918|FG001|Overall Study|Lost to Follow-up|0
2325850|NCT03041025|4043919|FG002|Overall Study|Lost to Follow-up|0
2325851|NCT03041025|4043917|FG000|Overall Study|Withdrawal by Subject|0
2325852|NCT03041025|4043918|FG001|Overall Study|Withdrawal by Subject|0
2325853|NCT03041025|4043919|FG002|Overall Study|Withdrawal by Subject|1
2325854|NCT03041038|4043932|FG000|Overall Study|Withdrawal by Subject|4
2325855|NCT03041038|4043933|FG001|Overall Study|Withdrawal by Subject|0
2325856|NCT03041038|4043932|FG000|Overall Study|Lost to Follow-up|1
2325857|NCT03041038|4043933|FG001|Overall Study|Lost to Follow-up|1
2325858|NCT03041038|4043932|FG000|Overall Study|Protocol Violation|1
2325859|NCT03041038|4043933|FG001|Overall Study|Protocol Violation|1
2325860|NCT03041090|4043943|FG000|Overall Study|technical error|0
2325861|NCT03041090|4043944|FG001|Overall Study|technical error|3
2325862|NCT03041116|4043952|FG000|Double-blind|Death|0
2325863|NCT03041116|4043953|FG001|Double-blind|Death|2
2325864|NCT03041116|4043952|FG000|Double-blind|Withdrawal by Subject|0
2325865|NCT03041116|4043953|FG001|Double-blind|Withdrawal by Subject|4
2325866|NCT03041116|4043952|FG000|Open-label|Death|1
2325867|NCT03041116|4043953|FG001|Open-label|Death|0
2325868|NCT03041116|4043952|FG000|Open-label|Termination of the study by Sponsor|39
2325869|NCT03041116|4043953|FG001|Open-label|Termination of the study by Sponsor|37
2325870|NCT03041116|4043952|FG000|Open-label|Withdrawal by Subject|1
2325871|NCT03041116|4043953|FG001|Open-label|Withdrawal by Subject|0
2325872|NCT03041181|4043965|FG000|Overall Study|Disease Progression|1
2325873|NCT03041181|4043966|FG001|Overall Study|Disease Progression|2
2325874|NCT03041792|4043998|FG000|Overall Study|Adverse Event|4
2325875|NCT03041792|4043999|FG001|Overall Study|Adverse Event|0
2325876|NCT03041792|4043998|FG000|Overall Study|Death in the family|0
2325877|NCT03041792|4043999|FG001|Overall Study|Death in the family|2
2325878|NCT03041792|4043998|FG000|Overall Study|Randomized but not treated|0
2325879|NCT03041792|4043999|FG001|Overall Study|Randomized but not treated|1
2325880|NCT03042312|4044050|FG000|Overall Study|Administrative Reason|1
2030651|NCT00379769|3600212|FG005|Main Study|Site closed|0
2030652|NCT00379769|3600207|FG000|Main Study|Entry criteria violation|0
2030653|NCT00379769|3600208|FG001|Main Study|Entry criteria violation|0
2030654|NCT00379769|3600209|FG002|Main Study|Entry criteria violation|1
2030655|NCT00379769|3600210|FG003|Main Study|Entry criteria violation|1
2030656|NCT00379769|3600211|FG004|Main Study|Entry criteria violation|0
2030657|NCT00379769|3600212|FG005|Main Study|Entry criteria violation|0
2030658|NCT00379769|3600207|FG000|Main Study|Participant did not take study drug|0
2325881|NCT03042312|4044051|FG001|Overall Study|Administrative Reason|1
2325882|NCT03042312|4044050|FG000|Overall Study|Adverse Event|0
2325883|NCT03042312|4044051|FG001|Overall Study|Adverse Event|1
2325884|NCT03042312|4044050|FG000|Overall Study|Lost to Follow-up|1
2325885|NCT03042312|4044051|FG001|Overall Study|Lost to Follow-up|3
2325886|NCT03042312|4044050|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4
2325887|NCT03042312|4044051|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2
2325888|NCT03042312|4044050|FG000|Overall Study|Withdrawal by Subject|4
2325889|NCT03042312|4044051|FG001|Overall Study|Withdrawal by Subject|5
2325890|NCT03042559|4044059|FG000|Overall Study|drop out|1
2325891|NCT03042559|4044060|FG001|Overall Study|drop out|1
2325892|NCT03042767|4044077|FG000|Overall Study|Lost to Follow-up|1
2325893|NCT03042767|4044078|FG001|Overall Study|Lost to Follow-up|2
2325894|NCT03042910|4044084|FG000|Overall Study|Adverse Event|1
2325895|NCT03042910|4044084|FG000|Overall Study|Disease Progression|2
2325896|NCT03042910|4044084|FG000|Overall Study|Withdrawal by Subject|3
2325897|NCT03042910|4044084|FG000|Overall Study|Enrolled but not treated|1
2325898|NCT03043365|4044117|FG000|Weeks 0 to Week 8|Adverse Event|1
2325899|NCT03043365|4044118|FG001|Weeks 0 to Week 8|Adverse Event|3
2325900|NCT03043365|4044117|FG000|Weeks 0 to Week 8|Lost to Follow-up|2
2325901|NCT03043365|4044118|FG001|Weeks 0 to Week 8|Lost to Follow-up|0
2325902|NCT03043365|4044117|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1
2325903|NCT03043365|4044118|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0
2325904|NCT03043560|4044137|FG000|Overall Study|Discontinued Intervention|1
2325905|NCT03043560|4044138|FG001|Overall Study|Discontinued Intervention|2
2325906|NCT03043560|4044137|FG000|Overall Study|Lost to Follow-up|0
2325907|NCT03043560|4044138|FG001|Overall Study|Lost to Follow-up|1
2325908|NCT03043651|4044144|FG000|Overall Study|Death|1
2325909|NCT03043651|4044144|FG000|Overall Study|Progressive Disease|2
2325910|NCT03043651|4044144|FG000|Overall Study|Adverse Event|2
2325911|NCT03043651|4044144|FG000|Overall Study|Withdrawal by Subject|4
2325912|NCT03043651|4044144|FG000|Overall Study|Study Terminated by Sponsor|39
2325913|NCT03043872|4044151|FG000|Overall Study|Withdrawal by Subject|6
2325914|NCT03043872|4044152|FG001|Overall Study|Withdrawal by Subject|4
2325915|NCT03043872|4044153|FG002|Overall Study|Withdrawal by Subject|12
2325916|NCT03043872|4044151|FG000|Overall Study|Lost to Follow-up|2
2325917|NCT03043872|4044152|FG001|Overall Study|Lost to Follow-up|1
2325918|NCT03043872|4044153|FG002|Overall Study|Lost to Follow-up|1
2325919|NCT03043872|4044151|FG000|Overall Study|Death|204
2325920|NCT03043872|4044152|FG001|Overall Study|Death|207
2325921|NCT03043872|4044153|FG002|Overall Study|Death|225
2325922|NCT03044106|4044194|FG000|Washout (1 Week)|Withdrawal by Subject|0
2325923|NCT03044106|4044195|FG001|Washout (1 Week)|Withdrawal by Subject|2
2325924|NCT03044197|4044210|FG000|Overall Study|Withdrawal by Subject|3
2325925|NCT03044197|4044211|FG001|Overall Study|Withdrawal by Subject|1
2325926|NCT03044249|4044219|FG000|Overall Study|Adverse Event|4
2325927|NCT03044249|4044220|FG001|Overall Study|Adverse Event|9
2325928|NCT03044249|4044219|FG000|Overall Study|Lost to Follow-up|1
2325929|NCT03044249|4044220|FG001|Overall Study|Lost to Follow-up|0
2325930|NCT03044249|4044219|FG000|Overall Study|Non-compliance with Study Drug|1
2325931|NCT03044249|4044220|FG001|Overall Study|Non-compliance with Study Drug|0
2325932|NCT03044249|4044219|FG000|Overall Study|Study Terminated by Sponsor|2
2325933|NCT03044249|4044220|FG001|Overall Study|Study Terminated by Sponsor|0
2325934|NCT03044249|4044219|FG000|Overall Study|Withdrawal by Subject|2
2325935|NCT03044249|4044220|FG001|Overall Study|Withdrawal by Subject|5
2325936|NCT03044353|4044234|FG000|Overall Study|Adverse Event|0
2325937|NCT03044353|4044235|FG001|Overall Study|Adverse Event|1
2325938|NCT03044353|4044236|FG002|Overall Study|Adverse Event|0
2325939|NCT03044431|4044247|FG000|Overall Study|Lost to Follow-up|59
2325940|NCT03044574|4044253|FG000|Overall Study|Lost to Follow-up|37
2325941|NCT03044574|4044254|FG001|Overall Study|Lost to Follow-up|45
2110366|NCT00895583|3705198|FG000|Overall Study|Protocol Violation|1
2325942|NCT03044730|4044269|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1
2325943|NCT03044730|4044269|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1
2325944|NCT03044730|4044269|FG000|3 Cycles of Pembro + Capecitab|Death|1
2325945|NCT03044730|4044269|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1
2325946|NCT03044730|4044269|FG000|Cycles 4 and Beyond|Progressive Disease|9
2325947|NCT03044730|4044269|FG000|Cycles 4 and Beyond|Adverse Event|1
2325948|NCT03044730|4044269|FG000|On Follow-up for 2 Years|Still in follow-up|7
2325949|NCT03044730|4044269|FG000|On Follow-up for 2 Years|Lost to Follow-up|1
2325950|NCT03044730|4044269|FG000|On Follow-up for 2 Years|Death|17
2325951|NCT03044886|4044277|FG000|Overall Study|Lost to Follow-up|15
2325952|NCT03044886|4044278|FG001|Overall Study|Lost to Follow-up|10
2325953|NCT03044886|4044279|FG002|Overall Study|Lost to Follow-up|12
2325954|NCT03045081|4044289|FG000|Overall Study|Withdrawal by Subject|6
2325955|NCT03045081|4044290|FG001|Overall Study|Withdrawal by Subject|11
2325956|NCT03045302|4044296|FG000|Overall Study|Pre-treatment adverse event|1
2325957|NCT03045328|4044300|FG000|Overall Study|Withdrawal by Subject|2
2325958|NCT03045887|4044342|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
2325959|NCT03045887|4044343|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2325960|NCT03045887|4044344|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2325961|NCT03045887|4044345|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2325962|NCT03045887|4044346|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2325963|NCT03045887|4044347|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2325964|NCT03045887|4044348|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2325965|NCT03045887|4044349|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2325966|NCT03045887|4044350|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2325967|NCT03045887|4044351|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2325968|NCT03045887|4044342|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2325969|NCT03045887|4044343|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2325970|NCT03045887|4044344|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2325971|NCT03045887|4044345|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
2325972|NCT03045887|4044346|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2325973|NCT03045887|4044347|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2325974|NCT03045887|4044348|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2325975|NCT03045887|4044349|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2325976|NCT03045887|4044350|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2325977|NCT03045887|4044351|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2325978|NCT03045887|4044342|FG000|Part A, Period 2 (1 Day)|Adverse Event|1
2325979|NCT03045887|4044343|FG001|Part A, Period 2 (1 Day)|Adverse Event|0
2325980|NCT03045887|4044344|FG002|Part A, Period 2 (1 Day)|Adverse Event|0
2325981|NCT03045887|4044345|FG003|Part A, Period 2 (1 Day)|Adverse Event|0
2325982|NCT03045887|4044346|FG004|Part A, Period 2 (1 Day)|Adverse Event|0
2325983|NCT03045887|4044347|FG005|Part A, Period 2 (1 Day)|Adverse Event|0
2325984|NCT03045887|4044348|FG006|Part A, Period 2 (1 Day)|Adverse Event|0
2325985|NCT03045887|4044349|FG007|Part A, Period 2 (1 Day)|Adverse Event|0
2325986|NCT03045887|4044350|FG008|Part A, Period 2 (1 Day)|Adverse Event|0
2325987|NCT03045887|4044351|FG009|Part A, Period 2 (1 Day)|Adverse Event|0
2325988|NCT03045887|4044342|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2325989|NCT03045887|4044343|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2325990|NCT03045887|4044344|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
2325991|NCT03045887|4044345|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
2325992|NCT03045887|4044346|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2325993|NCT03045887|4044347|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2325994|NCT03045887|4044348|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2325995|NCT03045887|4044349|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2325996|NCT03045887|4044350|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2325997|NCT03045887|4044351|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2325998|NCT03045887|4044342|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2325999|NCT03045887|4044343|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2326000|NCT03045887|4044344|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2326001|NCT03045887|4044345|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
2326002|NCT03045887|4044346|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2326003|NCT03045887|4044347|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2326004|NCT03045887|4044348|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2326005|NCT03045887|4044349|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2326006|NCT03045887|4044350|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2326007|NCT03045887|4044351|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2326008|NCT03046056|4044385|FG000|Overall Study|Non-responder at Week 10|6
2326009|NCT03046056|4044386|FG001|Overall Study|Non-responder at Week 10|6
2326010|NCT03046056|4044387|FG002|Overall Study|Non-responder at Week 10|4
2326011|NCT03046056|4044385|FG000|Overall Study|Protocol-specified Disease Worsening|3
2326012|NCT03046056|4044386|FG001|Overall Study|Protocol-specified Disease Worsening|3
2326013|NCT03046056|4044387|FG002|Overall Study|Protocol-specified Disease Worsening|1
2326014|NCT03046056|4044385|FG000|Overall Study|Adverse Event|1
2326015|NCT03046056|4044386|FG001|Overall Study|Adverse Event|5
2326016|NCT03046056|4044387|FG002|Overall Study|Adverse Event|0
2326017|NCT03046056|4044385|FG000|Overall Study|Non-compliance With Study Drug|0
2326018|NCT03046056|4044386|FG001|Overall Study|Non-compliance With Study Drug|0
2326019|NCT03046056|4044387|FG002|Overall Study|Non-compliance With Study Drug|2
2326020|NCT03046056|4044385|FG000|Overall Study|Protocol Violation|1
2326021|NCT03046056|4044386|FG001|Overall Study|Protocol Violation|1
2326022|NCT03046056|4044387|FG002|Overall Study|Protocol Violation|0
2326023|NCT03046056|4044385|FG000|Overall Study|Investigator's Discretion|0
2326024|NCT03046056|4044386|FG001|Overall Study|Investigator's Discretion|1
2326025|NCT03046056|4044387|FG002|Overall Study|Investigator's Discretion|0
2326026|NCT03046056|4044385|FG000|Overall Study|Withdrew Consent|1
2326027|NCT03046056|4044386|FG001|Overall Study|Withdrew Consent|0
2326028|NCT03046056|4044387|FG002|Overall Study|Withdrew Consent|0
2326029|NCT03046446|4044413|FG000|Overall Study|Lack of Efficacy|7
2326030|NCT03046446|4044413|FG000|Overall Study|Adverse Event|6
2326031|NCT03046446|4044413|FG000|Overall Study|Lost to Follow-up|3
2326032|NCT03046446|4044413|FG000|Overall Study|Withdrawal by Subject|14
2030659|NCT00379769|3600208|FG001|Main Study|Participant did not take study drug|0
2030660|NCT00379769|3600209|FG002|Main Study|Participant did not take study drug|1
2030661|NCT00379769|3600210|FG003|Main Study|Participant did not take study drug|0
2030662|NCT00379769|3600211|FG004|Main Study|Participant did not take study drug|0
2030663|NCT00379769|3600212|FG005|Main Study|Participant did not take study drug|0
2030664|NCT00379769|3600207|FG000|Main Study|Physician Decision|2
2030665|NCT00379769|3600208|FG001|Main Study|Physician Decision|2
2030666|NCT00379769|3600209|FG002|Main Study|Physician Decision|1
2030667|NCT00379769|3600210|FG003|Main Study|Physician Decision|1
2030668|NCT00379769|3600211|FG004|Main Study|Physician Decision|0
2030669|NCT00379769|3600212|FG005|Main Study|Physician Decision|0
2030670|NCT00379769|3600207|FG000|Main Study|Participant completed study at visit 27|1
2030671|NCT00379769|3600208|FG001|Main Study|Participant completed study at visit 27|0
2030672|NCT00379769|3600209|FG002|Main Study|Participant completed study at visit 27|0
2030673|NCT00379769|3600210|FG003|Main Study|Participant completed study at visit 27|0
2030674|NCT00379769|3600211|FG004|Main Study|Participant completed study at visit 27|0
2030675|NCT00379769|3600212|FG005|Main Study|Participant completed study at visit 27|0
2030676|NCT00379769|3600207|FG000|Main Study|Personal reasons|1
2030677|NCT00379769|3600208|FG001|Main Study|Personal reasons|0
2110367|NCT00895583|3705199|FG001|Overall Study|Protocol Violation|0
2110368|NCT00895583|3705198|FG000|Overall Study|Withdrawal by Subject|4
2110369|NCT00895583|3705199|FG001|Overall Study|Withdrawal by Subject|2
2110370|NCT00895583|3705198|FG000|Overall Study|Lack of Efficacy|5
2110371|NCT00895583|3705199|FG001|Overall Study|Lack of Efficacy|0
2110372|NCT00895583|3705198|FG000|Overall Study|Other|0
2110373|NCT00895583|3705199|FG001|Overall Study|Other|1
2110374|NCT00895622|3705208|FG000|Overall Study|Protocol Violation|5
2110375|NCT00895622|3705209|FG001|Overall Study|Protocol Violation|4
2110376|NCT00895622|3705210|FG002|Overall Study|Protocol Violation|4
2110377|NCT00895661|3705226|FG000|Overall Study|Death|1
2218067|NCT01712074|3861457|FG001|Double Blind Period|Adverse Event|2
2218068|NCT01712074|3861458|FG002|Double Blind Period|Adverse Event|1
2110378|NCT00895661|3705226|FG000|Overall Study|reason unknown|2
2110379|NCT00895843|3705268|FG000|Overall Study|Protocol Violation|12
2110380|NCT00895843|3705269|FG001|Overall Study|Protocol Violation|12
2110381|NCT00895895|3705280|FG000|Period 1|Adverse Event|7
2110382|NCT00895895|3705281|FG001|Period 1|Adverse Event|6
2110383|NCT00895895|3705282|FG002|Period 1|Adverse Event|4
2110384|NCT00895895|3705283|FG003|Period 1|Adverse Event|6
2110385|NCT00895895|3705284|FG004|Period 1|Adverse Event|7
2110386|NCT00895895|3705280|FG000|Period 1|Death|0
2110387|NCT00895895|3705281|FG001|Period 1|Death|0
2110388|NCT00895895|3705282|FG002|Period 1|Death|0
2110389|NCT00895895|3705283|FG003|Period 1|Death|0
2110390|NCT00895895|3705284|FG004|Period 1|Death|1
2110391|NCT00895895|3705280|FG000|Period 1|discontinued by sponsor|2
2110392|NCT00895895|3705281|FG001|Period 1|discontinued by sponsor|1
2352430|NCT03771352|4101691|FG000|Overall Study|Withdrawal by Subject|2
2326033|NCT03046446|4044413|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3
2326034|NCT03046446|4044413|FG000|Overall Study|Disease Progression (see caveats)|25
2326035|NCT03046446|4044413|FG000|Overall Study|Non OA related knee surgery|1
2326036|NCT03047551|4044476|FG000|Overall Study|Did not receive TAS|1
2326037|NCT03047551|4044477|FG001|Overall Study|Did not receive TAS|0
2326038|NCT03047551|4044476|FG000|Overall Study|Physician Decision|1
2326039|NCT03047551|4044477|FG001|Overall Study|Physician Decision|0
2326040|NCT03047551|4044476|FG000|Overall Study|Withdrawal by Subject|0
2326041|NCT03047551|4044477|FG001|Overall Study|Withdrawal by Subject|1
2326042|NCT03047551|4044476|FG000|Overall Study|Probe malfunction|0
2326043|NCT03047551|4044477|FG001|Overall Study|Probe malfunction|1
2326044|NCT03047551|4044476|FG000|Overall Study|Ineligible|0
2326045|NCT03047551|4044477|FG001|Overall Study|Ineligible|1
2326046|NCT03047720|4044485|FG000|First Intervention (6weeks)|Participant data entry insufficient|7
2326047|NCT03047720|4044486|FG001|First Intervention (6weeks)|Participant data entry insufficient|0
2326048|NCT03047980|4044492|FG000|Overall Study|Adverse Event|1
2326049|NCT03048058|4044502|FG000|Overall Study|Lost to Follow-up|4
2326050|NCT03048058|4044503|FG001|Overall Study|Lost to Follow-up|0
2326051|NCT03048058|4044502|FG000|Overall Study|Withdrawal by Subject|0
2326052|NCT03048058|4044503|FG001|Overall Study|Withdrawal by Subject|4
2326053|NCT03048500|4044522|FG000|2 Cycles of Treatment|Withdrawal by Subject|1
2326054|NCT03048500|4044522|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4
2326055|NCT03048500|4044522|FG000|Reached 1st Response/Continued Treatment|Death|1
2218069|NCT01712074|3861456|FG000|Double Blind Period|No longer willing to participate|0
2218070|NCT01712074|3861457|FG001|Double Blind Period|No longer willing to participate|2
2218071|NCT01712074|3861458|FG002|Double Blind Period|No longer willing to participate|4
2218072|NCT01712074|3861456|FG000|Double Blind Period|Death|0
2218073|NCT01712074|3861457|FG001|Double Blind Period|Death|1
2326056|NCT03048500|4044522|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1
2326057|NCT03048500|4044522|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1
2326058|NCT03048500|4044522|FG000|Follow up for 3 Years|Currently in Follow-up|4
2326059|NCT03048500|4044522|FG000|Follow up for 3 Years|Death|12
2326060|NCT03048747|4044526|FG000|Overall Study|Adverse Event|2
2326061|NCT03048747|4044526|FG000|Overall Study|Participant Met Withdrawal Criteria|2
2326062|NCT03048747|4044526|FG000|Overall Study|Physician Decision|1
2326063|NCT03049280|4044540|FG000|Overall Study|Physician Decision|1
2326064|NCT03049488|4044552|FG000|Overall Study|Lost to Follow-up|1
2326065|NCT03049488|4044553|FG001|Overall Study|Lost to Follow-up|1
2326066|NCT03049488|4044554|FG002|Overall Study|Lost to Follow-up|0
2326067|NCT03049488|4044555|FG003|Overall Study|Lost to Follow-up|0
2326068|NCT03049488|4044556|FG004|Overall Study|Lost to Follow-up|0
2326069|NCT03049488|4044557|FG005|Overall Study|Lost to Follow-up|0
2326070|NCT03049488|4044552|FG000|Overall Study|Moved from Area|1
2326071|NCT03049488|4044553|FG001|Overall Study|Moved from Area|0
2326072|NCT03049488|4044554|FG002|Overall Study|Moved from Area|0
2326073|NCT03049488|4044555|FG003|Overall Study|Moved from Area|1
2326074|NCT03049488|4044556|FG004|Overall Study|Moved from Area|1
2326075|NCT03049488|4044557|FG005|Overall Study|Moved from Area|0
2326076|NCT03049488|4044552|FG000|Overall Study|Physician Decision|0
2326077|NCT03049488|4044553|FG001|Overall Study|Physician Decision|1
2326078|NCT03049488|4044554|FG002|Overall Study|Physician Decision|0
2326079|NCT03049488|4044555|FG003|Overall Study|Physician Decision|0
2326080|NCT03049488|4044556|FG004|Overall Study|Physician Decision|0
2326081|NCT03049488|4044557|FG005|Overall Study|Physician Decision|0
2326082|NCT03049488|4044552|FG000|Overall Study|Withdrawal by Subject|0
2326083|NCT03049488|4044553|FG001|Overall Study|Withdrawal by Subject|0
2326084|NCT03049488|4044554|FG002|Overall Study|Withdrawal by Subject|0
2326085|NCT03049488|4044555|FG003|Overall Study|Withdrawal by Subject|1
2326086|NCT03049488|4044556|FG004|Overall Study|Withdrawal by Subject|1
2326087|NCT03049488|4044557|FG005|Overall Study|Withdrawal by Subject|0
2326088|NCT03049748|4044583|FG000|Overall Study|Lost to Follow-up|1
2218074|NCT01712074|3861458|FG002|Double Blind Period|Death|0
2218075|NCT01712074|3861456|FG000|Double Blind Period|Lost to Follow-up|0
2218076|NCT01712074|3861457|FG001|Double Blind Period|Lost to Follow-up|2
2218077|NCT01712074|3861458|FG002|Double Blind Period|Lost to Follow-up|1
2218078|NCT01712074|3861456|FG000|Double Blind Period|Other|0
2218079|NCT01712074|3861457|FG001|Double Blind Period|Other|4
2218080|NCT01712074|3861458|FG002|Double Blind Period|Other|1
2218081|NCT01712074|3861456|FG000|Double Blind Period|Protocol Violation|0
2218082|NCT01712074|3861457|FG001|Double Blind Period|Protocol Violation|0
2218083|NCT01712074|3861458|FG002|Double Blind Period|Protocol Violation|1
2218084|NCT01712074|3861456|FG000|Double Blind Period|No longer met eligibility criteria|0
2218085|NCT01712074|3861457|FG001|Double Blind Period|No longer met eligibility criteria|3
2218086|NCT01712074|3861458|FG002|Double Blind Period|No longer met eligibility criteria|0
2218087|NCT01712178|3861475|FG000|Overall Study|Withdrew consent due to an adverse event|1
2218088|NCT01712178|3861476|FG001|Overall Study|Withdrew consent due to an adverse event|1
2218089|NCT01712178|3861475|FG000|Overall Study|Serious adverse event/withdrew consent|0
2218090|NCT01712178|3861476|FG001|Overall Study|Serious adverse event/withdrew consent|1
2218091|NCT01712178|3861475|FG000|Overall Study|Lost to Follow-up|0
2326089|NCT03049748|4044584|FG001|Overall Study|Lost to Follow-up|0
2326090|NCT03049748|4044583|FG000|Overall Study|Death|3
2326091|NCT03049748|4044584|FG001|Overall Study|Death|0
2326092|NCT03049748|4044583|FG000|Overall Study|Withdrawal by Subject|0
2326093|NCT03049748|4044584|FG001|Overall Study|Withdrawal by Subject|3
2326094|NCT03049748|4044583|FG000|Overall Study|Protocol Violation|0
2326095|NCT03049748|4044584|FG001|Overall Study|Protocol Violation|2
2326096|NCT03049748|4044583|FG000|Overall Study|Moved out of state (relocation)|0
2326097|NCT03049748|4044584|FG001|Overall Study|Moved out of state (relocation)|1
2326098|NCT03049852|4044593|FG000|Overall Study|Lost to Follow-up|0
2326099|NCT03049852|4044594|FG001|Overall Study|Lost to Follow-up|1
2326100|NCT03049852|4044595|FG002|Overall Study|Lost to Follow-up|0
2326101|NCT03050307|4044680|FG000|Overall Study|Adverse Event|4
2326102|NCT03050307|4044681|FG001|Overall Study|Adverse Event|2
2326103|NCT03050307|4044680|FG000|Overall Study|Significant Protocol Deviation|0
2326104|NCT03050307|4044681|FG001|Overall Study|Significant Protocol Deviation|1
2326105|NCT03050307|4044680|FG000|Overall Study|Lost to Follow-up|0
2326106|NCT03050307|4044681|FG001|Overall Study|Lost to Follow-up|1
2326107|NCT03050307|4044680|FG000|Overall Study|Voluntary Withdrawal|3
2326108|NCT03050307|4044681|FG001|Overall Study|Voluntary Withdrawal|4
2326109|NCT03050307|4044680|FG000|Overall Study|Reason not Specified|1
2326110|NCT03050307|4044681|FG001|Overall Study|Reason not Specified|1
2326111|NCT03050359|4044700|FG000|Overall Study|Randomized But Not Treated|2
2326112|NCT03050359|4044701|FG001|Overall Study|Randomized But Not Treated|0
2326113|NCT03050359|4044700|FG000|Overall Study|Pretreatment Event/Adverse Event|5
2326114|NCT03050359|4044701|FG001|Overall Study|Pretreatment Event/Adverse Event|10
2326115|NCT03050359|4044700|FG000|Overall Study|Significant Protocol Deviation|2
2326116|NCT03050359|4044701|FG001|Overall Study|Significant Protocol Deviation|3
2326117|NCT03050359|4044700|FG000|Overall Study|Lost to Follow-up|2
2326118|NCT03050359|4044701|FG001|Overall Study|Lost to Follow-up|1
2326119|NCT03050359|4044700|FG000|Overall Study|Voluntary Withdrawal|4
2326120|NCT03050359|4044701|FG001|Overall Study|Voluntary Withdrawal|6
2326121|NCT03050359|4044700|FG000|Overall Study|Pregnancy|1
2326122|NCT03050359|4044701|FG001|Overall Study|Pregnancy|0
2326123|NCT03050359|4044700|FG000|Overall Study|Reason Not Specified|1
2326124|NCT03050359|4044701|FG001|Overall Study|Reason Not Specified|0
2326125|NCT03050372|4044709|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1
2326126|NCT03050372|4044710|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0
2326127|NCT03050372|4044709|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
2326128|NCT03050372|4044710|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
2326129|NCT03050450|4044720|FG000|Overall Study|Physician Decision|1
2326130|NCT03050450|4044721|FG001|Overall Study|Physician Decision|0
2326131|NCT03050450|4044722|FG002|Overall Study|Physician Decision|0
2326132|NCT03050450|4044723|FG003|Overall Study|Physician Decision|0
2326133|NCT03050450|4044724|FG004|Overall Study|Physician Decision|0
2326134|NCT03050801|4044805|FG000|Experiment 1|Lost to Follow-up|0
2326135|NCT03050801|4044806|FG001|Experiment 1|Lost to Follow-up|1
2326136|NCT03050801|4044807|FG002|Experiment 1|Lost to Follow-up|0
2326137|NCT03050801|4044808|FG003|Experiment 1|Lost to Follow-up|0
2326138|NCT03050801|4044809|FG004|Experiment 1|Lost to Follow-up|0
2326139|NCT03050801|4044810|FG005|Experiment 1|Lost to Follow-up|0
2326140|NCT03050801|4044805|FG000|Experiment 1|Physician Decision|0
2326141|NCT03050801|4044806|FG001|Experiment 1|Physician Decision|3
2326142|NCT03050801|4044807|FG002|Experiment 1|Physician Decision|0
2326143|NCT03050801|4044808|FG003|Experiment 1|Physician Decision|0
2326144|NCT03050801|4044809|FG004|Experiment 1|Physician Decision|0
2326145|NCT03050801|4044810|FG005|Experiment 1|Physician Decision|0
2326146|NCT03050801|4044805|FG000|Experiment 1|Change of experimental design|0
2326147|NCT03050801|4044806|FG001|Experiment 1|Change of experimental design|3
2326148|NCT03050801|4044807|FG002|Experiment 1|Change of experimental design|0
2326149|NCT03050801|4044808|FG003|Experiment 1|Change of experimental design|0
2326150|NCT03050801|4044809|FG004|Experiment 1|Change of experimental design|0
2326151|NCT03050801|4044810|FG005|Experiment 1|Change of experimental design|0
2326152|NCT03050801|4044805|FG000|Experiment 1|Unable to obtain critical rTMS measure|0
2326153|NCT03050801|4044806|FG001|Experiment 1|Unable to obtain critical rTMS measure|0
2326154|NCT03050801|4044807|FG002|Experiment 1|Unable to obtain critical rTMS measure|2
2326155|NCT03050801|4044808|FG003|Experiment 1|Unable to obtain critical rTMS measure|0
2326156|NCT03050801|4044809|FG004|Experiment 1|Unable to obtain critical rTMS measure|0
2326157|NCT03050801|4044810|FG005|Experiment 1|Unable to obtain critical rTMS measure|0
2326158|NCT03050801|4044805|FG000|Experiment 2|Lost to Follow-up|0
2326159|NCT03050801|4044806|FG001|Experiment 2|Lost to Follow-up|0
2326160|NCT03050801|4044807|FG002|Experiment 2|Lost to Follow-up|0
2326161|NCT03050801|4044808|FG003|Experiment 2|Lost to Follow-up|1
2326162|NCT03050801|4044809|FG004|Experiment 2|Lost to Follow-up|1
2326163|NCT03050801|4044810|FG005|Experiment 2|Lost to Follow-up|0
2326164|NCT03050801|4044805|FG000|Experiment 2|Physician Decision|0
2030678|NCT00379769|3600209|FG002|Main Study|Personal reasons|0
2030679|NCT00379769|3600210|FG003|Main Study|Personal reasons|0
2030680|NCT00379769|3600211|FG004|Main Study|Personal reasons|0
2030681|NCT00379769|3600212|FG005|Main Study|Personal reasons|0
2030682|NCT00379769|3600207|FG000|Main Study|Risk of heart failure|0
2030683|NCT00379769|3600208|FG001|Main Study|Risk of heart failure|1
2030684|NCT00379769|3600209|FG002|Main Study|Risk of heart failure|0
2030685|NCT00379769|3600210|FG003|Main Study|Risk of heart failure|0
2030686|NCT00379769|3600211|FG004|Main Study|Risk of heart failure|0
2030687|NCT00379769|3600212|FG005|Main Study|Risk of heart failure|0
2030688|NCT00379769|3600207|FG000|Main Study|Investigator refused to log temperature|0
2030689|NCT00379769|3600208|FG001|Main Study|Investigator refused to log temperature|0
2030690|NCT00379769|3600209|FG002|Main Study|Investigator refused to log temperature|1
2030691|NCT00379769|3600210|FG003|Main Study|Investigator refused to log temperature|0
2030692|NCT00379769|3600211|FG004|Main Study|Investigator refused to log temperature|0
2030693|NCT00379769|3600212|FG005|Main Study|Investigator refused to log temperature|0
2030694|NCT00379769|3600207|FG000|Main Study|Reason unspecified|0
2030695|NCT00379769|3600208|FG001|Main Study|Reason unspecified|0
2030696|NCT00379769|3600209|FG002|Main Study|Reason unspecified|1
2326165|NCT03050801|4044806|FG001|Experiment 2|Physician Decision|0
2326166|NCT03050801|4044807|FG002|Experiment 2|Physician Decision|0
2326167|NCT03050801|4044808|FG003|Experiment 2|Physician Decision|0
2326168|NCT03050801|4044809|FG004|Experiment 2|Physician Decision|1
2326169|NCT03050801|4044810|FG005|Experiment 2|Physician Decision|0
2326170|NCT03050801|4044805|FG000|Experiment 2|Pregnancy|0
2326171|NCT03050801|4044806|FG001|Experiment 2|Pregnancy|0
2326172|NCT03050801|4044807|FG002|Experiment 2|Pregnancy|0
2326173|NCT03050801|4044808|FG003|Experiment 2|Pregnancy|0
2326174|NCT03050801|4044809|FG004|Experiment 2|Pregnancy|1
2326175|NCT03050801|4044810|FG005|Experiment 2|Pregnancy|0
2326176|NCT03050801|4044805|FG000|Experiment 2|Withdrawal by Subject|0
2326177|NCT03050801|4044806|FG001|Experiment 2|Withdrawal by Subject|0
2326178|NCT03050801|4044807|FG002|Experiment 2|Withdrawal by Subject|0
2326179|NCT03050801|4044808|FG003|Experiment 2|Withdrawal by Subject|1
2326180|NCT03050801|4044809|FG004|Experiment 2|Withdrawal by Subject|0
2326181|NCT03050801|4044810|FG005|Experiment 2|Withdrawal by Subject|0
2326182|NCT03050801|4044805|FG000|Experiment 2|Poor data quality|0
2326183|NCT03050801|4044806|FG001|Experiment 2|Poor data quality|0
2326184|NCT03050801|4044807|FG002|Experiment 2|Poor data quality|0
2326185|NCT03050801|4044808|FG003|Experiment 2|Poor data quality|4
2326186|NCT03050801|4044809|FG004|Experiment 2|Poor data quality|1
2326187|NCT03050801|4044810|FG005|Experiment 2|Poor data quality|0
2326188|NCT03050801|4044805|FG000|Experiment 2|Discomfort during stimulation|0
2326189|NCT03050801|4044806|FG001|Experiment 2|Discomfort during stimulation|0
2326190|NCT03050801|4044807|FG002|Experiment 2|Discomfort during stimulation|0
2326191|NCT03050801|4044808|FG003|Experiment 2|Discomfort during stimulation|0
2326192|NCT03050801|4044809|FG004|Experiment 2|Discomfort during stimulation|0
2326193|NCT03050801|4044810|FG005|Experiment 2|Discomfort during stimulation|2
2326194|NCT03051100|4044838|FG000|Overall Study|Withdrawal by Subject|1
2326195|NCT03051100|4044839|FG001|Overall Study|Withdrawal by Subject|0
2326196|NCT03051165|4044845|FG000|Overall Study|Withdrawal by Subject|1
2326197|NCT03051165|4044845|FG000|Overall Study|Early termination of study|12
2326198|NCT03051607|4044863|FG000|Overall Study|Adverse Event|66
2326199|NCT03051620|4044867|FG000|Overall Study|Lost to Follow-up|6
2326200|NCT03051620|4044867|FG000|Overall Study|n=124 enrolled in extension (all completed)|12
2326201|NCT03052322|4044907|FG000|Overall Study|Other un-specified|1
2326202|NCT03052322|4044908|FG001|Overall Study|Other un-specified|2
2326203|NCT03052322|4044907|FG000|Overall Study|Withdrawal by Subject|10
2326204|NCT03052322|4044908|FG001|Overall Study|Withdrawal by Subject|9
2326205|NCT03052322|4044907|FG000|Overall Study|Death|0
2326206|NCT03052322|4044908|FG001|Overall Study|Death|2
2326207|NCT03052322|4044907|FG000|Overall Study|Lack of Efficacy|1
2326208|NCT03052322|4044908|FG001|Overall Study|Lack of Efficacy|2
2326209|NCT03052322|4044907|FG000|Overall Study|Protocol Violation|1
2326210|NCT03052322|4044908|FG001|Overall Study|Protocol Violation|0
2326211|NCT03052322|4044907|FG000|Overall Study|Lost to Follow-up|2
2326212|NCT03052322|4044908|FG001|Overall Study|Lost to Follow-up|4
2326213|NCT03052322|4044907|FG000|Overall Study|Adverse Event|6
2326214|NCT03052322|4044908|FG001|Overall Study|Adverse Event|13
2352431|NCT03773796|4101695|FG000|Overall Study|Adverse Event|1
2352432|NCT03773796|4101695|FG000|Overall Study|Withdrawal by Subject|1
2352433|NCT03773796|4101695|FG000|Overall Study|Lack of Efficacy|1
2352434|NCT03781375|4101712|FG000|Double-blind Phase|Adverse Event|0
2352435|NCT03781375|4101713|FG001|Double-blind Phase|Adverse Event|1
2352436|NCT03781375|4101712|FG000|Double-blind Phase|Lack of Response|6
2352437|NCT03781375|4101713|FG001|Double-blind Phase|Lack of Response|2
2352438|NCT03781375|4101712|FG000|Double-blind Phase|Other|1
2352439|NCT03781375|4101713|FG001|Double-blind Phase|Other|3
2352440|NCT03781375|4101712|FG000|Open-label Phase|Protocol Issues|0
2352441|NCT03781375|4101713|FG001|Open-label Phase|Protocol Issues|1
2352442|NCT03781375|4101712|FG000|Open-label Phase|Suboptimal Clinical Response|1
2352443|NCT03781375|4101713|FG001|Open-label Phase|Suboptimal Clinical Response|0
2352444|NCT03781375|4101712|FG000|Open-label Phase|Other|2
2352445|NCT03781375|4101713|FG001|Open-label Phase|Other|2
2352446|NCT03781336|4101722|FG000|Overall Study|Withdrawal by Subject|2
2352447|NCT03781336|4101723|FG001|Overall Study|Withdrawal by Subject|2
2352448|NCT03780400|4101729|FG000|Overall Study|Lost to Follow-up|5
2352449|NCT03780400|4101729|FG000|Overall Study|Withdrawal by Subject|2
2352450|NCT03779503|4101742|FG000|First Intervention|Adverse Event|0
2352451|NCT03779503|4101743|FG001|First Intervention|Adverse Event|1
2352452|NCT03779503|4101742|FG000|First Intervention|Withdrawal by Subject|1
2352453|NCT03779503|4101743|FG001|First Intervention|Withdrawal by Subject|0
2352454|NCT03777059|4101777|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6
2352455|NCT03777059|4101778|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9
2352456|NCT03777059|4101779|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4
2352457|NCT03777059|4101780|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6
2352458|NCT03777059|4101777|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
2352459|NCT03777059|4101778|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
2326215|NCT03052426|4044917|FG000|Overall Study|Withdrawal by Subject|0
2326216|NCT03052426|4044918|FG001|Overall Study|Withdrawal by Subject|1
2326217|NCT03052426|4044919|FG002|Overall Study|Withdrawal by Subject|0
2326218|NCT03052426|4044917|FG000|Overall Study|Lost to Follow-up|2
2326219|NCT03052426|4044918|FG001|Overall Study|Lost to Follow-up|0
2326220|NCT03052426|4044919|FG002|Overall Study|Lost to Follow-up|1
2326221|NCT03052517|4044935|FG000|Overall Study|Study Terminated By Sponsor|928
2326222|NCT03052517|4044936|FG001|Overall Study|Study Terminated By Sponsor|938
2326223|NCT03052517|4044937|FG002|Overall Study|Study Terminated By Sponsor|296
2326224|NCT03052517|4044935|FG000|Overall Study|Subject/Guardian Decision|50
2326225|NCT03052517|4044936|FG001|Overall Study|Subject/Guardian Decision|45
2326226|NCT03052517|4044937|FG002|Overall Study|Subject/Guardian Decision|22
2326227|NCT03052517|4044935|FG000|Overall Study|Lack of Efficacy|23
2326228|NCT03052517|4044936|FG001|Overall Study|Lack of Efficacy|14
2326229|NCT03052517|4044937|FG002|Overall Study|Lack of Efficacy|7
2326230|NCT03052517|4044935|FG000|Overall Study|Adverse Event|6
2326231|NCT03052517|4044936|FG001|Overall Study|Adverse Event|5
2326232|NCT03052517|4044937|FG002|Overall Study|Adverse Event|0
2326233|NCT03052517|4044935|FG000|Overall Study|Physician Decision|4
2326234|NCT03052517|4044936|FG001|Overall Study|Physician Decision|5
2326235|NCT03052517|4044937|FG002|Overall Study|Physician Decision|1
2326236|NCT03052517|4044935|FG000|Overall Study|Death|3
2326237|NCT03052517|4044936|FG001|Overall Study|Death|0
2326238|NCT03052517|4044937|FG002|Overall Study|Death|1
2326239|NCT03052517|4044935|FG000|Overall Study|Lost to Follow-up|2
2326240|NCT03052517|4044936|FG001|Overall Study|Lost to Follow-up|4
2326241|NCT03052517|4044937|FG002|Overall Study|Lost to Follow-up|0
2326242|NCT03052517|4044935|FG000|Overall Study|Pregnancy|1
2326243|NCT03052517|4044936|FG001|Overall Study|Pregnancy|0
2326244|NCT03052517|4044937|FG002|Overall Study|Pregnancy|1
2326245|NCT03052517|4044935|FG000|Overall Study|Non-Compliance With Study Treatment|0
2326246|NCT03052517|4044936|FG001|Overall Study|Non-Compliance With Study Treatment|2
2326247|NCT03052517|4044937|FG002|Overall Study|Non-Compliance With Study Treatment|0
2326248|NCT03052517|4044935|FG000|Overall Study|Technical Problems|0
2326249|NCT03052517|4044936|FG001|Overall Study|Technical Problems|1
2326250|NCT03052517|4044937|FG002|Overall Study|Technical Problems|0
2326251|NCT03052725|4044951|FG000|Overall Study|Adverse Event|2
2326252|NCT03052725|4044952|FG001|Overall Study|Adverse Event|0
2326253|NCT03052725|4044951|FG000|Overall Study|Withdrawal by Subject|3
2326254|NCT03052725|4044952|FG001|Overall Study|Withdrawal by Subject|4
2326255|NCT03052725|4044951|FG000|Overall Study|Pregnancy|0
2326256|NCT03052725|4044952|FG001|Overall Study|Pregnancy|1
2326257|NCT03052725|4044951|FG000|Overall Study|Site closure|0
2326258|NCT03052725|4044952|FG001|Overall Study|Site closure|1
2326259|NCT03052725|4044951|FG000|Overall Study|Study terminated by sponsor|143
2326260|NCT03052725|4044952|FG001|Overall Study|Study terminated by sponsor|144
2326261|NCT03052751|4044959|FG000|Dosing Period 1|Adverse Event|0
2326262|NCT03052751|4044960|FG001|Dosing Period 1|Adverse Event|1
2326263|NCT03052751|4044961|FG002|Dosing Period 1|Adverse Event|0
2326264|NCT03052751|4044962|FG003|Dosing Period 1|Adverse Event|0
2326265|NCT03052751|4044963|FG004|Dosing Period 1|Adverse Event|0
2326266|NCT03052751|4044964|FG005|Dosing Period 1|Adverse Event|0
2326267|NCT03052751|4044959|FG000|Dosing Period 2|Adverse Event|0
2326268|NCT03052751|4044960|FG001|Dosing Period 2|Adverse Event|0
2326269|NCT03052751|4044961|FG002|Dosing Period 2|Adverse Event|3
2326270|NCT03052751|4044962|FG003|Dosing Period 2|Adverse Event|0
2326271|NCT03052751|4044963|FG004|Dosing Period 2|Adverse Event|0
2326272|NCT03052751|4044964|FG005|Dosing Period 2|Adverse Event|0
2326273|NCT03052751|4044959|FG000|Observation Period|Adverse Event|0
2326274|NCT03052751|4044960|FG001|Observation Period|Adverse Event|0
2326275|NCT03052751|4044961|FG002|Observation Period|Adverse Event|0
2326276|NCT03052751|4044962|FG003|Observation Period|Adverse Event|0
2326277|NCT03052751|4044963|FG004|Observation Period|Adverse Event|1
2326278|NCT03052751|4044964|FG005|Observation Period|Adverse Event|0
2326279|NCT03052764|4044976|FG000|Double-Blind Treatment Period|Adverse Event|2
2326280|NCT03052764|4044977|FG001|Double-Blind Treatment Period|Adverse Event|0
2326281|NCT03052764|4044976|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
2326282|NCT03052764|4044977|FG001|Double-Blind Treatment Period|Lack of Efficacy|0
2326283|NCT03052764|4044976|FG000|Double-Blind Treatment Period|Protocol Violation|2
2326284|NCT03052764|4044977|FG001|Double-Blind Treatment Period|Protocol Violation|1
2326285|NCT03052764|4044976|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3
2326286|NCT03052764|4044977|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
2326287|NCT03052764|4044976|FG000|Double-Blind Treatment Period|Reason not Specified|2
2326288|NCT03052764|4044977|FG001|Double-Blind Treatment Period|Reason not Specified|1
2326289|NCT03052816|4044987|FG000|Overall Study|Withdrawal by Subject|1
2326290|NCT03052816|4044988|FG001|Overall Study|Withdrawal by Subject|0
2326291|NCT03052816|4044987|FG000|Overall Study|Desired opioids|2
2326292|NCT03052816|4044988|FG001|Overall Study|Desired opioids|0
2326293|NCT03052959|4044998|FG000|Overall Study|Lost to Follow-up|4
2326294|NCT03052959|4044999|FG001|Overall Study|Lost to Follow-up|5
2326295|NCT03053050|4045019|FG000|Randomized Phase|Study Terminated by Sponsor|259
2326296|NCT03053050|4045020|FG001|Randomized Phase|Study Terminated by Sponsor|260
2326297|NCT03053050|4045021|FG002|Randomized Phase|Study Terminated by Sponsor|128
2326298|NCT03053050|4045022|FG003|Randomized Phase|Study Terminated by Sponsor|0
2326299|NCT03053050|4045019|FG000|Randomized Phase|Withdrew Consent|16
2326300|NCT03053050|4045020|FG001|Randomized Phase|Withdrew Consent|8
2326301|NCT03053050|4045021|FG002|Randomized Phase|Withdrew Consent|9
2326302|NCT03053050|4045022|FG003|Randomized Phase|Withdrew Consent|0
2326303|NCT03053050|4045019|FG000|Randomized Phase|Investigator's Discretion|6
2326304|NCT03053050|4045020|FG001|Randomized Phase|Investigator's Discretion|6
2326305|NCT03053050|4045021|FG002|Randomized Phase|Investigator's Discretion|3
2326306|NCT03053050|4045022|FG003|Randomized Phase|Investigator's Discretion|0
2326307|NCT03053050|4045019|FG000|Randomized Phase|Lost to Follow-up|5
2326308|NCT03053050|4045020|FG001|Randomized Phase|Lost to Follow-up|1
2326309|NCT03053050|4045021|FG002|Randomized Phase|Lost to Follow-up|1
2326310|NCT03053050|4045022|FG003|Randomized Phase|Lost to Follow-up|0
2326311|NCT03053050|4045019|FG000|Randomized Phase|Adverse Event|0
2326312|NCT03053050|4045020|FG001|Randomized Phase|Adverse Event|1
2326313|NCT03053050|4045021|FG002|Randomized Phase|Adverse Event|0
2326314|NCT03053050|4045022|FG003|Randomized Phase|Adverse Event|0
2326315|NCT03053050|4045019|FG000|Randomized Phase|Randomized but Never Treated|2
2326316|NCT03053050|4045020|FG001|Randomized Phase|Randomized but Never Treated|2
2326317|NCT03053050|4045021|FG002|Randomized Phase|Randomized but Never Treated|2
2326318|NCT03053050|4045022|FG003|Randomized Phase|Randomized but Never Treated|0
2326319|NCT03053050|4045019|FG000|Randomized Phase|Entered the Open-Label Phase|36
2326320|NCT03053050|4045020|FG001|Randomized Phase|Entered the Open-Label Phase|45
2326321|NCT03053050|4045021|FG002|Randomized Phase|Entered the Open-Label Phase|18
2326322|NCT03053050|4045022|FG003|Randomized Phase|Entered the Open-Label Phase|0
2326323|NCT03053050|4045019|FG000|Open-label Phase|Study Terminated by Sponsor|0
2326324|NCT03053050|4045020|FG001|Open-label Phase|Study Terminated by Sponsor|0
2326325|NCT03053050|4045021|FG002|Open-label Phase|Study Terminated by Sponsor|0
2326326|NCT03053050|4045022|FG003|Open-label Phase|Study Terminated by Sponsor|89
2326327|NCT03053050|4045019|FG000|Open-label Phase|Withdrew Consent|0
2326328|NCT03053050|4045020|FG001|Open-label Phase|Withdrew Consent|0
2326329|NCT03053050|4045021|FG002|Open-label Phase|Withdrew Consent|0
2326330|NCT03053050|4045022|FG003|Open-label Phase|Withdrew Consent|6
2326331|NCT03053050|4045019|FG000|Open-label Phase|Investigator's Discretion|0
2326332|NCT03053050|4045020|FG001|Open-label Phase|Investigator's Discretion|0
2326333|NCT03053050|4045021|FG002|Open-label Phase|Investigator's Discretion|0
2326334|NCT03053050|4045022|FG003|Open-label Phase|Investigator's Discretion|4
2326335|NCT03053063|4045034|FG000|Randomized Phase|Study Terminated by Sponsor|326
2326336|NCT03053063|4045035|FG001|Randomized Phase|Study Terminated by Sponsor|317
2326337|NCT03053063|4045036|FG002|Randomized Phase|Study Terminated by Sponsor|161
2326338|NCT03053063|4045037|FG003|Randomized Phase|Study Terminated by Sponsor|0
2326339|NCT03053063|4045034|FG000|Randomized Phase|Withdrew consent|8
2326340|NCT03053063|4045035|FG001|Randomized Phase|Withdrew consent|11
2326341|NCT03053063|4045036|FG002|Randomized Phase|Withdrew consent|5
2326342|NCT03053063|4045037|FG003|Randomized Phase|Withdrew consent|0
2326343|NCT03053063|4045034|FG000|Randomized Phase|Investigator's Discretion|8
2326344|NCT03053063|4045035|FG001|Randomized Phase|Investigator's Discretion|6
2326345|NCT03053063|4045036|FG002|Randomized Phase|Investigator's Discretion|2
2326346|NCT03053063|4045037|FG003|Randomized Phase|Investigator's Discretion|0
2326347|NCT03053063|4045034|FG000|Randomized Phase|Lost to Follow-up|3
2326348|NCT03053063|4045035|FG001|Randomized Phase|Lost to Follow-up|5
2326349|NCT03053063|4045036|FG002|Randomized Phase|Lost to Follow-up|1
2326350|NCT03053063|4045037|FG003|Randomized Phase|Lost to Follow-up|0
2326351|NCT03053063|4045034|FG000|Randomized Phase|Adverse Event|0
2326352|NCT03053063|4045035|FG001|Randomized Phase|Adverse Event|1
2326353|NCT03053063|4045036|FG002|Randomized Phase|Adverse Event|0
2326354|NCT03053063|4045037|FG003|Randomized Phase|Adverse Event|0
2326355|NCT03053063|4045034|FG000|Randomized Phase|Randomized but Never Treated|1
2326356|NCT03053063|4045035|FG001|Randomized Phase|Randomized but Never Treated|3
2326357|NCT03053063|4045036|FG002|Randomized Phase|Randomized but Never Treated|2
2326358|NCT03053063|4045037|FG003|Randomized Phase|Randomized but Never Treated|0
2326359|NCT03053063|4045034|FG000|Randomized Phase|Entered the Open-Label Phase|9
2326360|NCT03053063|4045035|FG001|Randomized Phase|Entered the Open-Label Phase|11
2326361|NCT03053063|4045036|FG002|Randomized Phase|Entered the Open-Label Phase|3
2326362|NCT03053063|4045037|FG003|Randomized Phase|Entered the Open-Label Phase|0
2326363|NCT03053063|4045034|FG000|Open-Label Phase|Study Terminated by Sponsor|0
2326364|NCT03053063|4045035|FG001|Open-Label Phase|Study Terminated by Sponsor|0
2326365|NCT03053063|4045036|FG002|Open-Label Phase|Study Terminated by Sponsor|0
2326366|NCT03053063|4045037|FG003|Open-Label Phase|Study Terminated by Sponsor|19
2326367|NCT03053063|4045034|FG000|Open-Label Phase|Death|0
2326368|NCT03053063|4045035|FG001|Open-Label Phase|Death|0
2326369|NCT03053063|4045036|FG002|Open-Label Phase|Death|0
2326370|NCT03053063|4045037|FG003|Open-Label Phase|Death|2
2326371|NCT03053063|4045034|FG000|Open-Label Phase|Investigator's discretion|0
2326372|NCT03053063|4045035|FG001|Open-Label Phase|Investigator's discretion|0
2326373|NCT03053063|4045036|FG002|Open-Label Phase|Investigator's discretion|0
2326374|NCT03053063|4045037|FG003|Open-Label Phase|Investigator's discretion|2
2326375|NCT03053102|4045046|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1
2326376|NCT03053102|4045046|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1
2326377|NCT03053180|4045051|FG000|Overall Study|Failure to Return|1
2326378|NCT03053271|4045055|FG000|Overall Study|Did not meet randomization criteria|3
2326379|NCT03053271|4045055|FG000|Overall Study|Withdrawal by Subject|1
2326380|NCT03053427|4045071|FG000|Overall Study|Adverse Event|4
2326381|NCT03053427|4045072|FG001|Overall Study|Adverse Event|4
2326382|NCT03053427|4045071|FG000|Overall Study|Lack of Efficacy|1
2326383|NCT03053427|4045072|FG001|Overall Study|Lack of Efficacy|3
2326384|NCT03053427|4045071|FG000|Overall Study|Lost to Follow-up|2
2326385|NCT03053427|4045072|FG001|Overall Study|Lost to Follow-up|2
2326386|NCT03053427|4045071|FG000|Overall Study|Worsening of the target disease|0
2326387|NCT03053427|4045072|FG001|Overall Study|Worsening of the target disease|1
2326388|NCT03053427|4045071|FG000|Overall Study|Protocol Deviation|3
2326389|NCT03053427|4045072|FG001|Overall Study|Protocol Deviation|3
2030697|NCT00379769|3600210|FG003|Main Study|Reason unspecified|0
2030698|NCT00379769|3600211|FG004|Main Study|Reason unspecified|0
2030699|NCT00379769|3600212|FG005|Main Study|Reason unspecified|0
2030700|NCT00379769|3600207|FG000|Observational Follow-up|Death|0
2030701|NCT00379769|3600208|FG001|Observational Follow-up|Death|0
2030702|NCT00379769|3600209|FG002|Observational Follow-up|Death|0
2030703|NCT00379769|3600210|FG003|Observational Follow-up|Death|0
2030704|NCT00379769|3600211|FG004|Observational Follow-up|Death|78
2030705|NCT00379769|3600212|FG005|Observational Follow-up|Death|70
2030706|NCT00379769|3600207|FG000|Observational Follow-up|Adverse Event|0
2030707|NCT00379769|3600208|FG001|Observational Follow-up|Adverse Event|0
2030708|NCT00379769|3600209|FG002|Observational Follow-up|Adverse Event|0
2030709|NCT00379769|3600210|FG003|Observational Follow-up|Adverse Event|0
2030710|NCT00379769|3600211|FG004|Observational Follow-up|Adverse Event|1
2030711|NCT00379769|3600212|FG005|Observational Follow-up|Adverse Event|0
2030712|NCT00379769|3600207|FG000|Observational Follow-up|Lost to Follow-up|0
2218092|NCT01712178|3861476|FG001|Overall Study|Lost to Follow-up|1
2218093|NCT01712204|3861484|FG000|Overall Study|Adverse Event|3
2218094|NCT01712204|3861485|FG001|Overall Study|Adverse Event|1
2030713|NCT00379769|3600208|FG001|Observational Follow-up|Lost to Follow-up|0
2030714|NCT00379769|3600209|FG002|Observational Follow-up|Lost to Follow-up|0
2218095|NCT01712204|3861484|FG000|Overall Study|Withdrawal by Subject|3
2326390|NCT03053427|4045071|FG000|Overall Study|Withdrawal by Subject|3
2326391|NCT03053427|4045072|FG001|Overall Study|Withdrawal by Subject|2
2218096|NCT01712204|3861485|FG001|Overall Study|Withdrawal by Subject|3
2218097|NCT01712204|3861484|FG000|Overall Study|Lost to Follow-up|1
2218098|NCT01712204|3861485|FG001|Overall Study|Lost to Follow-up|0
2218099|NCT01712204|3861484|FG000|Overall Study|Protocol Violation|1
2326392|NCT03053427|4045071|FG000|Overall Study|Miscellaneous|0
2326393|NCT03053427|4045072|FG001|Overall Study|Miscellaneous|1
2326394|NCT03053492|4045080|FG000|Overall Study|Adverse Event|1
2326395|NCT03053492|4045081|FG001|Overall Study|Adverse Event|1
2326396|NCT03053492|4045080|FG000|Overall Study|Withdrawal by Subject|7
2326397|NCT03053492|4045081|FG001|Overall Study|Withdrawal by Subject|5
2326398|NCT03054064|4045098|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1
2326399|NCT03054064|4045098|FG000|Overall Study|Investigator Decision|2
2326400|NCT03054064|4045098|FG000|Overall Study|Bladder Issue|1
2326401|NCT03054064|4045098|FG000|Overall Study|High Blood Pressure|1
2326402|NCT03054064|4045098|FG000|Overall Study|Change in Status|1
2326403|NCT03054337|4045130|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1
2326404|NCT03054337|4045131|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2
2326405|NCT03054337|4045132|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1
2326406|NCT03054337|4045133|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0
2326407|NCT03054337|4045134|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0
2326408|NCT03054337|4045135|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1
2326409|NCT03054350|4045168|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
2326410|NCT03054350|4045169|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
2326411|NCT03054350|4045170|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1
2326412|NCT03054350|4045171|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
2326413|NCT03054350|4045172|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
2326414|NCT03054350|4045173|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3
2326415|NCT03054350|4045168|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
2326416|NCT03054350|4045169|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
2326417|NCT03054350|4045170|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1
2326418|NCT03054350|4045171|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
2326419|NCT03054350|4045172|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
2326420|NCT03054350|4045173|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
2326421|NCT03054350|4045168|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
2326422|NCT03054350|4045169|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
2326423|NCT03054350|4045170|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
2326424|NCT03054350|4045171|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
2326425|NCT03054350|4045172|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
2326426|NCT03054350|4045173|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
2326427|NCT03054350|4045168|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0
2326428|NCT03054350|4045169|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0
2326429|NCT03054350|4045170|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1
2326430|NCT03054350|4045171|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0
2326431|NCT03054350|4045172|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0
2326432|NCT03054350|4045173|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0
2326433|NCT03054428|4045207|FG000|Overall Study|Physician Decision|0
2326434|NCT03054428|4045208|FG001|Overall Study|Physician Decision|1
2326435|NCT03054428|4045209|FG002|Overall Study|Physician Decision|1
2326436|NCT03054428|4045207|FG000|Overall Study|Lack of Efficacy|3
2326437|NCT03054428|4045208|FG001|Overall Study|Lack of Efficacy|1
2326438|NCT03054428|4045209|FG002|Overall Study|Lack of Efficacy|0
2326439|NCT03054428|4045207|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0
2326440|NCT03054428|4045208|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0
2326441|NCT03054428|4045209|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1
2326442|NCT03054428|4045207|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1
2326443|NCT03054428|4045208|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0
2326444|NCT03054428|4045209|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0
2326445|NCT03054428|4045207|FG000|Overall Study|Transitioned to OLE study|76
2326446|NCT03054428|4045208|FG001|Overall Study|Transitioned to OLE study|76
2326447|NCT03054428|4045209|FG002|Overall Study|Transitioned to OLE study|73
2326448|NCT03054428|4045207|FG000|Overall Study|Withdrawal by Subject|3
2326449|NCT03054428|4045208|FG001|Overall Study|Withdrawal by Subject|2
2326450|NCT03054428|4045209|FG002|Overall Study|Withdrawal by Subject|3
2326451|NCT03054428|4045207|FG000|Overall Study|Lost to Follow-up|0
2326452|NCT03054428|4045208|FG001|Overall Study|Lost to Follow-up|0
2326453|NCT03054428|4045209|FG002|Overall Study|Lost to Follow-up|1
2326454|NCT03054870|4045304|FG000|Day of Ventilation Imaging|Protocol Violation|4
2326455|NCT03054870|4045304|FG000|Day of Ventilation Imaging|Lost to Follow-up|1
2326456|NCT03055195|4045356|FG000|Overall Study|Lack of Efficacy|1
2326457|NCT03055195|4045357|FG001|Overall Study|Lack of Efficacy|0
2326458|NCT03055195|4045356|FG000|Overall Study|Withdrawal by Subject|6
2326459|NCT03055195|4045357|FG001|Overall Study|Withdrawal by Subject|7
2326460|NCT03055195|4045356|FG000|Overall Study|Study Terminated by Sponsor|2
2326461|NCT03055195|4045357|FG001|Overall Study|Study Terminated by Sponsor|6
2326462|NCT03055195|4045356|FG000|Overall Study|Protocol Violation|2
2326463|NCT03055195|4045357|FG001|Overall Study|Protocol Violation|1
2326464|NCT03055195|4045356|FG000|Overall Study|Physician Decision|1
2326465|NCT03055195|4045357|FG001|Overall Study|Physician Decision|0
2326466|NCT03055221|4045363|FG000|Overall Study|Adverse Event|2
2326467|NCT03055221|4045363|FG000|Overall Study|Withdrawal by Subject|4
2326468|NCT03055221|4045363|FG000|Overall Study|Death|6
2326469|NCT03055221|4045363|FG000|Overall Study|Physician Decision|1
2326470|NCT03055221|4045363|FG000|Overall Study|Study terminated by Sponsor|3
2326471|NCT03055260|4045369|FG000|Overall Study|Withdrawal by Subject|1
2326472|NCT03055260|4045370|FG001|Overall Study|Withdrawal by Subject|0
2326473|NCT03055338|4045379|FG000|Overall Study|Lost to Follow-up|9
2326474|NCT03055338|4045380|FG001|Overall Study|Lost to Follow-up|2
2326475|NCT03055338|4045381|FG002|Overall Study|Lost to Follow-up|3
2326476|NCT03055338|4045379|FG000|Overall Study|No Post-treatment Protocol Contact|0
2326477|NCT03055338|4045380|FG001|Overall Study|No Post-treatment Protocol Contact|1
2326478|NCT03055338|4045381|FG002|Overall Study|No Post-treatment Protocol Contact|0
2326479|NCT03055338|4045379|FG000|Overall Study|Physician Decision|0
2326480|NCT03055338|4045380|FG001|Overall Study|Physician Decision|0
2326481|NCT03055338|4045381|FG002|Overall Study|Physician Decision|2
2326482|NCT03055338|4045379|FG000|Overall Study|Withdrawal by Subject|9
2326483|NCT03055338|4045380|FG001|Overall Study|Withdrawal by Subject|8
2326484|NCT03055338|4045381|FG002|Overall Study|Withdrawal by Subject|7
2326485|NCT03055494|4045391|FG000|Overall Study|Lost to Follow-up|6
2326486|NCT03055494|4045392|FG001|Overall Study|Lost to Follow-up|0
2326487|NCT03055494|4045391|FG000|Overall Study|Physician Decision|2
2326488|NCT03055494|4045392|FG001|Overall Study|Physician Decision|0
2326489|NCT03055494|4045391|FG000|Overall Study|Withdrawal by Subject|1
2326490|NCT03055494|4045392|FG001|Overall Study|Withdrawal by Subject|0
2326491|NCT03055494|4045391|FG000|Overall Study|Adverse Event|0
2326492|NCT03055494|4045392|FG001|Overall Study|Adverse Event|1
2326493|NCT03055494|4045391|FG000|Overall Study|Non-compliance with study treatment|1
2326494|NCT03055494|4045392|FG001|Overall Study|Non-compliance with study treatment|0
2326495|NCT03055624|4045399|FG000|Overall Study|Study closed|9
2326496|NCT03055806|4045411|FG000|Overall Study|Adverse Event|0
2326497|NCT03055806|4045412|FG001|Overall Study|Adverse Event|0
2326498|NCT03055806|4045413|FG002|Overall Study|Adverse Event|1
2326499|NCT03055806|4045414|FG003|Overall Study|Adverse Event|1
2326500|NCT03055806|4045411|FG000|Overall Study|Lost to Follow-up|0
2326501|NCT03055806|4045412|FG001|Overall Study|Lost to Follow-up|3
2326502|NCT03055806|4045413|FG002|Overall Study|Lost to Follow-up|6
2326503|NCT03055806|4045414|FG003|Overall Study|Lost to Follow-up|7
2326504|NCT03055806|4045411|FG000|Overall Study|Physician Decision|1
2326505|NCT03055806|4045412|FG001|Overall Study|Physician Decision|0
2326506|NCT03055806|4045413|FG002|Overall Study|Physician Decision|0
2326507|NCT03055806|4045414|FG003|Overall Study|Physician Decision|1
2326508|NCT03055806|4045411|FG000|Overall Study|Protocol Violation|1
2326509|NCT03055806|4045412|FG001|Overall Study|Protocol Violation|0
2326510|NCT03055806|4045413|FG002|Overall Study|Protocol Violation|0
2326511|NCT03055806|4045414|FG003|Overall Study|Protocol Violation|0
2326512|NCT03055806|4045411|FG000|Overall Study|Withdrawal of consent to continue drug|1
2326513|NCT03055806|4045412|FG001|Overall Study|Withdrawal of consent to continue drug|1
2326514|NCT03055806|4045413|FG002|Overall Study|Withdrawal of consent to continue drug|2
2326515|NCT03055806|4045414|FG003|Overall Study|Withdrawal of consent to continue drug|0
2326516|NCT03055806|4045411|FG000|Overall Study|Withdrawal of consent to continue study|2
2326517|NCT03055806|4045412|FG001|Overall Study|Withdrawal of consent to continue study|3
2326518|NCT03055806|4045413|FG002|Overall Study|Withdrawal of consent to continue study|4
2326519|NCT03055806|4045414|FG003|Overall Study|Withdrawal of consent to continue study|6
2326520|NCT03055806|4045411|FG000|Overall Study|Partner not willing to try intercourse|1
2326521|NCT03055806|4045412|FG001|Overall Study|Partner not willing to try intercourse|0
2326522|NCT03055806|4045413|FG002|Overall Study|Partner not willing to try intercourse|0
2326523|NCT03055806|4045414|FG003|Overall Study|Partner not willing to try intercourse|0
2326524|NCT03055832|4045426|FG000|Week 2|Withdrawal by Subject|1
2326525|NCT03055832|4045427|FG001|Week 2|Withdrawal by Subject|0
2326526|NCT03055858|4045447|FG000|Overall Study|Death|5
2326527|NCT03055858|4045447|FG000|Overall Study|Adverse Event|1
2326528|NCT03055936|4045459|FG000|Overall Study|Adverse Event|0
2326529|NCT03055936|4045460|FG001|Overall Study|Adverse Event|1
2326530|NCT03055936|4045461|FG002|Overall Study|Adverse Event|1
2326531|NCT03055936|4045462|FG003|Overall Study|Adverse Event|1
2326532|NCT03055936|4045459|FG000|Overall Study|Personal reason|2
2326533|NCT03055936|4045460|FG001|Overall Study|Personal reason|0
2326534|NCT03055936|4045461|FG002|Overall Study|Personal reason|1
2326535|NCT03055936|4045462|FG003|Overall Study|Personal reason|0
2326536|NCT03055988|4045496|FG000|Period 1|Adverse Event|0
2030715|NCT00379769|3600210|FG003|Observational Follow-up|Lost to Follow-up|0
2030716|NCT00379769|3600211|FG004|Observational Follow-up|Lost to Follow-up|25
2030717|NCT00379769|3600212|FG005|Observational Follow-up|Lost to Follow-up|27
2030718|NCT00379769|3600207|FG000|Observational Follow-up|Withdrawal by Subject|0
2030719|NCT00379769|3600208|FG001|Observational Follow-up|Withdrawal by Subject|0
2030720|NCT00379769|3600209|FG002|Observational Follow-up|Withdrawal by Subject|0
2030721|NCT00379769|3600210|FG003|Observational Follow-up|Withdrawal by Subject|0
2030722|NCT00379769|3600211|FG004|Observational Follow-up|Withdrawal by Subject|12
2030723|NCT00379769|3600212|FG005|Observational Follow-up|Withdrawal by Subject|12
2030724|NCT00379769|3600207|FG000|Observational Follow-up|Entered into Another Clinical Trial|0
2030725|NCT00379769|3600208|FG001|Observational Follow-up|Entered into Another Clinical Trial|0
2326537|NCT03055988|4045497|FG001|Period 1|Adverse Event|1
2326538|NCT03055988|4045496|FG000|Period 1|Lost to Follow-up|1
2326539|NCT03055988|4045497|FG001|Period 1|Lost to Follow-up|0
2326540|NCT03055988|4045496|FG000|Period 1|Withdrawal by Subject|0
2326541|NCT03055988|4045497|FG001|Period 1|Withdrawal by Subject|4
2326542|NCT03055988|4045496|FG000|Period 2|Adverse Event|0
2326543|NCT03055988|4045497|FG001|Period 2|Adverse Event|1
2326544|NCT03055988|4045496|FG000|Period 2|Other than listed|1
2326545|NCT03055988|4045497|FG001|Period 2|Other than listed|1
2326546|NCT03056040|4045505|FG000|Primary Evaluation Period|Withdrawal by Subject|1
2326547|NCT03056040|4045506|FG001|Primary Evaluation Period|Withdrawal by Subject|1
2326548|NCT03056040|4045505|FG000|Primary Evaluation Period|Lack of Efficacy|0
2326549|NCT03056040|4045506|FG001|Primary Evaluation Period|Lack of Efficacy|1
2326550|NCT03056040|4045505|FG000|Primary Evaluation Period|Pregnancy|0
2326551|NCT03056040|4045506|FG001|Primary Evaluation Period|Pregnancy|1
2326552|NCT03056300|4045516|FG000|Overall Study|Surgical reason per study protocol|3
2326553|NCT03056352|4045520|FG000|Overall Study|Lost to Follow-up|1
2326554|NCT03056573|4045542|FG000|Overall Study|Death|2
2326555|NCT03056573|4045543|FG001|Overall Study|Death|4
2326556|NCT03056573|4045542|FG000|Overall Study|Withdrawal by Subject|2
2326557|NCT03056573|4045543|FG001|Overall Study|Withdrawal by Subject|0
2326558|NCT03056573|4045542|FG000|Overall Study|Lost to Follow-up|1
2326559|NCT03056573|4045543|FG001|Overall Study|Lost to Follow-up|1
2326560|NCT03056690|4045551|FG000|Overall Study|Adverse Event|3
2326561|NCT03056690|4045552|FG001|Overall Study|Adverse Event|2
2326562|NCT03056690|4045551|FG000|Overall Study|Lack of Efficacy|1
2326563|NCT03056690|4045552|FG001|Overall Study|Lack of Efficacy|2
2326564|NCT03056690|4045551|FG000|Overall Study|Lost to Follow-up|3
2326565|NCT03056690|4045552|FG001|Overall Study|Lost to Follow-up|2
2326566|NCT03056690|4045551|FG000|Overall Study|Protocol Violation|2
2326567|NCT03056690|4045552|FG001|Overall Study|Protocol Violation|2
2326568|NCT03056690|4045551|FG000|Overall Study|Withdrawal by Subject|3
2326569|NCT03056690|4045552|FG001|Overall Study|Withdrawal by Subject|6
2326570|NCT03056690|4045551|FG000|Overall Study|Non-compliance with Study Drug|1
2326571|NCT03056690|4045552|FG001|Overall Study|Non-compliance with Study Drug|0
2326572|NCT03056690|4045551|FG000|Overall Study|Miscellaneous|1
2326573|NCT03056690|4045552|FG001|Overall Study|Miscellaneous|2
2326574|NCT03057496|4045575|FG000|Overall Study|Withdrawal by Subject|8
2326575|NCT03057496|4045575|FG000|Overall Study|Lost to Follow-up|5
2326576|NCT03057496|4045575|FG000|Overall Study|Did not use device during home trial|3
2326577|NCT03057496|4045575|FG000|Overall Study|Device failure|2
2326578|NCT03057977|4045596|FG000|Discontinuation From Treatment|Withdrawal by Subject|124
2326579|NCT03057977|4045597|FG001|Discontinuation From Treatment|Withdrawal by Subject|92
2326580|NCT03057977|4045596|FG000|Discontinuation From Treatment|Lost to Follow-up|11
2326581|NCT03057977|4045597|FG001|Discontinuation From Treatment|Lost to Follow-up|17
2326582|NCT03057977|4045596|FG000|Discontinuation From Treatment|Protocol Violation|6
2326583|NCT03057977|4045597|FG001|Discontinuation From Treatment|Protocol Violation|5
2326584|NCT03057977|4045596|FG000|Discontinuation From Treatment|Not treated|4
2326585|NCT03057977|4045597|FG001|Discontinuation From Treatment|Not treated|0
2326586|NCT03057977|4045596|FG000|Discontinuation From Treatment|Adverse Event|343
2326587|NCT03057977|4045597|FG001|Discontinuation From Treatment|Adverse Event|337
2326588|NCT03057977|4045596|FG000|Discontinuation From Treatment|Reason Unknown|0
2326589|NCT03057977|4045597|FG001|Discontinuation From Treatment|Reason Unknown|1
2326590|NCT03057977|4045596|FG000|Discontinuation From Treatment|Personal Reasons|1
2326591|NCT03057977|4045597|FG001|Discontinuation From Treatment|Personal Reasons|1
2326592|NCT03057977|4045596|FG000|Discontinuation From Treatment|Unblinded medication|1
2326593|NCT03057977|4045597|FG001|Discontinuation From Treatment|Unblinded medication|0
2326594|NCT03057977|4045596|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
2326595|NCT03057977|4045597|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
2326596|NCT03057977|4045596|FG000|Discontinuation From Treatment|Principle Investigator Decision|2
2326597|NCT03057977|4045597|FG001|Discontinuation From Treatment|Principle Investigator Decision|0
2326598|NCT03057977|4045596|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2
2326599|NCT03057977|4045597|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4
2326600|NCT03057977|4045596|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4
2326601|NCT03057977|4045597|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3
2326602|NCT03057977|4045596|FG000|Discontinuation From Treatment|Unable to continue treatment|4
2326603|NCT03057977|4045597|FG001|Discontinuation From Treatment|Unable to continue treatment|1
2326604|NCT03057977|4045596|FG000|Discontinuation From Treatment|Not attending study visit|3
2326605|NCT03057977|4045597|FG001|Discontinuation From Treatment|Not attending study visit|10
2326606|NCT03057977|4045596|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1
2326607|NCT03057977|4045597|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4
2326608|NCT03057977|4045596|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8
2326609|NCT03057977|4045597|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6
2326610|NCT03057977|4045596|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
2326611|NCT03057977|4045597|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
2326612|NCT03057977|4045596|FG000|Discontinuation From Trial|Limited follow-up agreed|2
2326613|NCT03057977|4045597|FG001|Discontinuation From Trial|Limited follow-up agreed|2
2326614|NCT03057977|4045596|FG000|Discontinuation From Trial|Withdrawal by Subject|9
2326615|NCT03057977|4045597|FG001|Discontinuation From Trial|Withdrawal by Subject|11
2030726|NCT00379769|3600209|FG002|Observational Follow-up|Entered into Another Clinical Trial|0
2030727|NCT00379769|3600210|FG003|Observational Follow-up|Entered into Another Clinical Trial|0
2030728|NCT00379769|3600211|FG004|Observational Follow-up|Entered into Another Clinical Trial|18
2030729|NCT00379769|3600212|FG005|Observational Follow-up|Entered into Another Clinical Trial|22
2030730|NCT00379769|3600207|FG000|Observational Follow-up|Physician Decision|0
2030731|NCT00379769|3600208|FG001|Observational Follow-up|Physician Decision|0
2030732|NCT00379769|3600209|FG002|Observational Follow-up|Physician Decision|0
2030733|NCT00379769|3600210|FG003|Observational Follow-up|Physician Decision|0
2030734|NCT00379769|3600211|FG004|Observational Follow-up|Physician Decision|8
2030735|NCT00379769|3600212|FG005|Observational Follow-up|Physician Decision|8
2030736|NCT00379769|3600207|FG000|Observational Follow-up|Site Closed Early|0
2030737|NCT00379769|3600208|FG001|Observational Follow-up|Site Closed Early|0
2030738|NCT00379769|3600209|FG002|Observational Follow-up|Site Closed Early|0
2030739|NCT00379769|3600210|FG003|Observational Follow-up|Site Closed Early|0
2030740|NCT00379769|3600211|FG004|Observational Follow-up|Site Closed Early|6
2030741|NCT00379769|3600212|FG005|Observational Follow-up|Site Closed Early|7
2030742|NCT00379769|3600207|FG000|Observational Follow-up|Participant Moved|0
2030743|NCT00379769|3600208|FG001|Observational Follow-up|Participant Moved|0
2030744|NCT00379769|3600209|FG002|Observational Follow-up|Participant Moved|0
2030745|NCT00379769|3600210|FG003|Observational Follow-up|Participant Moved|0
2030746|NCT00379769|3600211|FG004|Observational Follow-up|Participant Moved|0
2030747|NCT00379769|3600212|FG005|Observational Follow-up|Participant Moved|1
2030748|NCT00379769|3600207|FG000|Observational Follow-up|Unknown; Reason Not Provided|0
2030749|NCT00379769|3600208|FG001|Observational Follow-up|Unknown; Reason Not Provided|0
2030750|NCT00379769|3600209|FG002|Observational Follow-up|Unknown; Reason Not Provided|0
2030751|NCT00379769|3600210|FG003|Observational Follow-up|Unknown; Reason Not Provided|0
2030752|NCT00379769|3600211|FG004|Observational Follow-up|Unknown; Reason Not Provided|1
2030753|NCT00379769|3600212|FG005|Observational Follow-up|Unknown; Reason Not Provided|1
2030754|NCT00379795|3600244|FG000|Overall Study|Death|31
2030755|NCT00379795|3600245|FG001|Overall Study|Death|8
2030756|NCT00379795|3600246|FG002|Overall Study|Death|6
2030757|NCT00379795|3600247|FG003|Overall Study|Death|4
2030758|NCT00379795|3600248|FG004|Overall Study|Death|7
2030759|NCT00379795|3600244|FG000|Overall Study|Adverse Event|17
2030760|NCT00379795|3600245|FG001|Overall Study|Adverse Event|3
2030761|NCT00379795|3600246|FG002|Overall Study|Adverse Event|3
2030762|NCT00379795|3600247|FG003|Overall Study|Adverse Event|1
2030763|NCT00379795|3600248|FG004|Overall Study|Adverse Event|4
2030764|NCT00379795|3600244|FG000|Overall Study|Lost to Follow-up|8
2030765|NCT00379795|3600245|FG001|Overall Study|Lost to Follow-up|1
2030766|NCT00379795|3600246|FG002|Overall Study|Lost to Follow-up|2
2030767|NCT00379795|3600247|FG003|Overall Study|Lost to Follow-up|1
2030768|NCT00379795|3600248|FG004|Overall Study|Lost to Follow-up|4
2030769|NCT00379795|3600244|FG000|Overall Study|Physician Decision|25
2030770|NCT00379795|3600245|FG001|Overall Study|Physician Decision|0
2030771|NCT00379795|3600246|FG002|Overall Study|Physician Decision|2
2110393|NCT00895895|3705282|FG002|Period 1|discontinued by sponsor|2
2110394|NCT00895895|3705283|FG003|Period 1|discontinued by sponsor|1
2110395|NCT00895895|3705284|FG004|Period 1|discontinued by sponsor|1
2110396|NCT00895895|3705280|FG000|Period 1|failed to return|0
2110397|NCT00895895|3705281|FG001|Period 1|failed to return|0
2110398|NCT00895895|3705282|FG002|Period 1|failed to return|1
2326616|NCT03058679|4045605|FG000|Baseline to Week 6|Lost to Follow-up|3
2326617|NCT03058679|4045606|FG001|Baseline to Week 6|Lost to Follow-up|2
2326618|NCT03058679|4045605|FG000|Baseline to Week 6|Change in Crohn's disease medication|4
2326619|NCT03058679|4045606|FG001|Baseline to Week 6|Change in Crohn's disease medication|2
2326620|NCT03058679|4045605|FG000|Baseline to Week 6|Adverse Event|6
2326621|NCT03058679|4045606|FG001|Baseline to Week 6|Adverse Event|6
2326622|NCT03058679|4045605|FG000|Baseline to Week 6|Withdrawal by Subject|4
2326623|NCT03058679|4045606|FG001|Baseline to Week 6|Withdrawal by Subject|3
2326624|NCT03058679|4045605|FG000|Baseline to Week 6|Difficulty following the diet|0
2326625|NCT03058679|4045606|FG001|Baseline to Week 6|Difficulty following the diet|2
2326626|NCT03058679|4045605|FG000|Baseline to Week 6|Physician Decision|1
2326627|NCT03058679|4045606|FG001|Baseline to Week 6|Physician Decision|0
2326628|NCT03058679|4045605|FG000|Week 6 to Week 12|Change in medication|5
2326629|NCT03058679|4045606|FG001|Week 6 to Week 12|Change in medication|7
2326630|NCT03058679|4045605|FG000|Week 6 to Week 12|Adverse Event|4
2326631|NCT03058679|4045606|FG001|Week 6 to Week 12|Adverse Event|3
2326632|NCT03058679|4045605|FG000|Week 6 to Week 12|Withdrawal by Subject|9
2326633|NCT03058679|4045606|FG001|Week 6 to Week 12|Withdrawal by Subject|4
2326634|NCT03058679|4045605|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2
2326635|NCT03058679|4045606|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3
2326636|NCT03058692|4045614|FG000|Overall Study|Lost to Follow-up|2
2326637|NCT03058692|4045615|FG001|Overall Study|Lost to Follow-up|1
2326638|NCT03058692|4045614|FG000|Overall Study|Withdrawal by Subject|1
2326639|NCT03058692|4045615|FG001|Overall Study|Withdrawal by Subject|1
2326640|NCT03058991|4045625|FG000|Overall Study|Lost to Follow-up|17
2326641|NCT03058991|4045626|FG001|Overall Study|Lost to Follow-up|12
2326642|NCT03058991|4045627|FG002|Overall Study|Lost to Follow-up|12
2326643|NCT03058991|4045625|FG000|Overall Study|Withdrawal by Subject|1
2326644|NCT03058991|4045626|FG001|Overall Study|Withdrawal by Subject|0
2326645|NCT03058991|4045627|FG002|Overall Study|Withdrawal by Subject|0
2326646|NCT03060447|4045650|FG000|Overall Study|Withdrawal by Subject|2
2326647|NCT03060447|4045651|FG001|Overall Study|Withdrawal by Subject|0
2218100|NCT01712204|3861485|FG001|Overall Study|Protocol Violation|1
2218101|NCT01712256|3861504|FG000|Overall Study|Lost to Follow-up|1
2218102|NCT01712334|3861508|FG000|Treatment Period 1|Randomized in Error|0
2218103|NCT01712334|3861509|FG001|Treatment Period 1|Randomized in Error|2
2218104|NCT01712399|3861538|FG000|Overall Study|Lost to Follow-up|1
2218105|NCT01712399|3861538|FG000|Overall Study|Withdrawal by Subject|39
2218106|NCT01712399|3861538|FG000|Overall Study|Death|1
2218107|NCT01712399|3861538|FG000|Overall Study|Adverse Event|11
2218108|NCT01712399|3861538|FG000|Overall Study|Study closure|345
2218109|NCT01712438|3861542|FG000|Overall Study|Not treated with Human-cl rhFVIII|2
2218110|NCT01712438|3861542|FG000|Overall Study|Ongoing ITI treatment|6
2218111|NCT01712438|3861542|FG000|Overall Study|Violated inclusion & exclusion criteria|4
2218112|NCT01712438|3861542|FG000|Overall Study|Prematurely Discontinued|25
2218113|NCT01712516|3861555|FG000|Overall Study|Technical problems|0
2218114|NCT01712516|3861556|FG001|Overall Study|Technical problems|0
2218115|NCT01712516|3861557|FG002|Overall Study|Technical problems|0
2326648|NCT03060512|4045669|FG000|Overall Study|Adverse Event|4
2326649|NCT03060512|4045670|FG001|Overall Study|Adverse Event|6
2326650|NCT03060512|4045669|FG000|Overall Study|Lost to Follow-up|1
2326651|NCT03060512|4045670|FG001|Overall Study|Lost to Follow-up|1
2326652|NCT03060512|4045669|FG000|Overall Study|Withdrawal by Subject|1
2326653|NCT03060512|4045670|FG001|Overall Study|Withdrawal by Subject|0
2326654|NCT03060512|4045669|FG000|Overall Study|Non-compliance with study medication|1
2326655|NCT03060512|4045670|FG001|Overall Study|Non-compliance with study medication|2
2326656|NCT03060551|4045681|FG000|Overall Study|Withdrawal by Subject|1
2326657|NCT03060551|4045681|FG000|Overall Study|Adverse Event|1
2326658|NCT03061097|4045696|FG000|Overall Study|Withdrawal by Subject|0
2326659|NCT03061097|4045697|FG001|Overall Study|Withdrawal by Subject|3
2326660|NCT03061175|4045705|FG000|Baseline|Participant was deemed ineligible|1
2326661|NCT03061175|4045706|FG001|Baseline|Participant was deemed ineligible|0
2326662|NCT03061175|4045705|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6
2326663|NCT03061175|4045706|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2
2326664|NCT03061175|4045705|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0
2326665|NCT03061175|4045706|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1
2326666|NCT03061175|4045705|FG000|Followup 2 at 6 Months|Lost to Follow-up|4
2326667|NCT03061175|4045706|FG001|Followup 2 at 6 Months|Lost to Follow-up|7
2326668|NCT03061188|4045716|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0
2326669|NCT03061188|4045717|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0
2326670|NCT03061188|4045718|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1
2326671|NCT03061188|4045719|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1
2326672|NCT03061188|4045716|FG000|On Follow-up for 3 Years|Death|0
2326673|NCT03061188|4045717|FG001|On Follow-up for 3 Years|Death|3
2326674|NCT03061188|4045718|FG002|On Follow-up for 3 Years|Death|5
2326675|NCT03061188|4045719|FG003|On Follow-up for 3 Years|Death|2
2218116|NCT01712516|3861558|FG003|Overall Study|Technical problems|2
2218117|NCT01712516|3861555|FG000|Overall Study|Lost to Follow-up|0
2326676|NCT03061188|4045716|FG000|On Follow-up for 3 Years|Still in follow-up|0
2218118|NCT01712516|3861556|FG001|Overall Study|Lost to Follow-up|0
2326677|NCT03061188|4045717|FG001|On Follow-up for 3 Years|Still in follow-up|0
2326678|NCT03061188|4045718|FG002|On Follow-up for 3 Years|Still in follow-up|0
2326679|NCT03061188|4045719|FG003|On Follow-up for 3 Years|Still in follow-up|3
2326680|NCT03061214|4045737|FG000|Overall Study|Withdrawal by Subject|21
2326681|NCT03061214|4045738|FG001|Overall Study|Withdrawal by Subject|26
2326682|NCT03061214|4045739|FG002|Overall Study|Withdrawal by Subject|9
2326683|NCT03061214|4045737|FG000|Overall Study|Lost to Follow-up|3
2326684|NCT03061214|4045738|FG001|Overall Study|Lost to Follow-up|1
2326685|NCT03061214|4045739|FG002|Overall Study|Lost to Follow-up|1
2326686|NCT03061214|4045737|FG000|Overall Study|Death|1
2326687|NCT03061214|4045738|FG001|Overall Study|Death|1
2326688|NCT03061214|4045739|FG002|Overall Study|Death|0
2326689|NCT03061331|4045749|FG000|Washout Period (8 Weeks)|Adverse Event|2
2326690|NCT03061331|4045750|FG001|Washout Period (8 Weeks)|Adverse Event|1
2326691|NCT03062891|4045811|FG000|Overall Study|Withdrawal by Subject|2
2326692|NCT03062891|4045812|FG001|Overall Study|Withdrawal by Subject|0
2326693|NCT03062891|4045811|FG000|Overall Study|Lost to Follow-up|50
2326694|NCT03062891|4045812|FG001|Overall Study|Lost to Follow-up|38
2326695|NCT03063086|4045839|FG000|Overall Study|technical problems|1
2326696|NCT03063086|4045840|FG001|Overall Study|technical problems|0
2326697|NCT03063086|4045841|FG002|Overall Study|technical problems|0
2326698|NCT03063086|4045842|FG003|Overall Study|technical problems|0
2326699|NCT03063086|4045843|FG004|Overall Study|technical problems|0
2326700|NCT03063086|4045844|FG005|Overall Study|technical problems|0
2326701|NCT03063086|4045839|FG000|Overall Study|Adverse Event|1
2326702|NCT03063086|4045840|FG001|Overall Study|Adverse Event|1
2218119|NCT01712516|3861557|FG002|Overall Study|Lost to Follow-up|2
2218120|NCT01712516|3861558|FG003|Overall Study|Lost to Follow-up|1
2218121|NCT01712516|3861555|FG000|Overall Study|Death|0
2218122|NCT01712516|3861556|FG001|Overall Study|Death|1
2218123|NCT01712516|3861557|FG002|Overall Study|Death|0
2218124|NCT01712516|3861558|FG003|Overall Study|Death|0
2218125|NCT01712516|3861555|FG000|Overall Study|Protocol deviation|1
2218126|NCT01712516|3861556|FG001|Overall Study|Protocol deviation|0
2218127|NCT01712516|3861557|FG002|Overall Study|Protocol deviation|1
2218128|NCT01712516|3861558|FG003|Overall Study|Protocol deviation|0
2218129|NCT01712516|3861555|FG000|Overall Study|Physician Decision|2
2218130|NCT01712516|3861556|FG001|Overall Study|Physician Decision|0
2218131|NCT01712516|3861557|FG002|Overall Study|Physician Decision|0
2218132|NCT01712516|3861558|FG003|Overall Study|Physician Decision|1
2218133|NCT01712516|3861555|FG000|Overall Study|Withdrawal by Subject|3
2218134|NCT01712516|3861556|FG001|Overall Study|Withdrawal by Subject|9
2218135|NCT01712516|3861557|FG002|Overall Study|Withdrawal by Subject|3
2218136|NCT01712516|3861558|FG003|Overall Study|Withdrawal by Subject|9
2326703|NCT03063086|4045841|FG002|Overall Study|Adverse Event|1
2326704|NCT03063086|4045842|FG003|Overall Study|Adverse Event|1
2326705|NCT03063086|4045843|FG004|Overall Study|Adverse Event|0
2326706|NCT03063086|4045844|FG005|Overall Study|Adverse Event|0
2326707|NCT03063086|4045839|FG000|Overall Study|subject/guardian decision|1
2326708|NCT03063086|4045840|FG001|Overall Study|subject/guardian decision|0
2326709|NCT03063086|4045841|FG002|Overall Study|subject/guardian decision|0
2326710|NCT03063086|4045842|FG003|Overall Study|subject/guardian decision|0
2326711|NCT03063086|4045843|FG004|Overall Study|subject/guardian decision|0
2326712|NCT03063086|4045844|FG005|Overall Study|subject/guardian decision|0
2326713|NCT03063086|4045839|FG000|Overall Study|Non-compliance with study treatment|0
2326714|NCT03063086|4045840|FG001|Overall Study|Non-compliance with study treatment|0
2326715|NCT03063086|4045841|FG002|Overall Study|Non-compliance with study treatment|0
2326716|NCT03063086|4045842|FG003|Overall Study|Non-compliance with study treatment|1
2326717|NCT03063086|4045843|FG004|Overall Study|Non-compliance with study treatment|0
2326718|NCT03063086|4045844|FG005|Overall Study|Non-compliance with study treatment|1
2326719|NCT03063086|4045839|FG000|Overall Study|Physician Decision|0
2326720|NCT03063086|4045840|FG001|Overall Study|Physician Decision|0
2326721|NCT03063086|4045841|FG002|Overall Study|Physician Decision|0
2326722|NCT03063086|4045842|FG003|Overall Study|Physician Decision|1
2326723|NCT03063086|4045843|FG004|Overall Study|Physician Decision|0
2326724|NCT03063086|4045844|FG005|Overall Study|Physician Decision|0
2326725|NCT03064438|4045908|FG000|Overall Study|Lost to Follow-up|1
2326726|NCT03064438|4045909|FG001|Overall Study|Lost to Follow-up|0
2326727|NCT03064438|4045908|FG000|Overall Study|Withdrawal by Subject|0
2326728|NCT03064438|4045909|FG001|Overall Study|Withdrawal by Subject|1
2326729|NCT03064451|4045915|FG000|Overall Study|Lost to Follow-up|1
2326730|NCT03064451|4045915|FG000|Overall Study|Mapping Failure|4
2326731|NCT03064451|4045915|FG000|Overall Study|Exited prior to procedure|8
2326732|NCT03064451|4045915|FG000|Overall Study|Withdrew consent: 3-month FU visit|1
2326733|NCT03064841|4045919|FG000|Overall Study|Inclusion/exclusion criteria violation|4
2326734|NCT03064841|4045919|FG000|Overall Study|No glycated haemoglobinA1c measurement|11
2326735|NCT03064841|4045919|FG000|Overall Study|Screen failure|2
2326736|NCT03065023|4045927|FG000|Overall Study|Progressive Disease|0
2218137|NCT01712685|3861568|FG000|Overall Study|pt declined to participate before trmt|1
2218138|NCT01712984|3861593|FG000|Overall Study|Adverse Event|0
2218139|NCT01712984|3861594|FG001|Overall Study|Adverse Event|0
2218140|NCT01712984|3861595|FG002|Overall Study|Adverse Event|1
2218141|NCT01712984|3861593|FG000|Overall Study|Protocol Violation|2
2326737|NCT03065023|4045928|FG001|Overall Study|Progressive Disease|1
2326738|NCT03065023|4045929|FG002|Overall Study|Progressive Disease|0
2326739|NCT03065023|4045930|FG003|Overall Study|Progressive Disease|0
2326740|NCT03065023|4045931|FG004|Overall Study|Progressive Disease|0
2326741|NCT03065023|4045927|FG000|Overall Study|Death|2
2030772|NCT00379795|3600247|FG003|Overall Study|Physician Decision|2
2030773|NCT00379795|3600248|FG004|Overall Study|Physician Decision|2
2030774|NCT00379795|3600244|FG000|Overall Study|Withdrawal by Subject|94
2030775|NCT00379795|3600245|FG001|Overall Study|Withdrawal by Subject|11
2030776|NCT00379795|3600246|FG002|Overall Study|Withdrawal by Subject|19
2030777|NCT00379795|3600247|FG003|Overall Study|Withdrawal by Subject|7
2030778|NCT00379795|3600248|FG004|Overall Study|Withdrawal by Subject|14
2030779|NCT00379795|3600244|FG000|Overall Study|Subject non-compliance|7
2030780|NCT00379795|3600245|FG001|Overall Study|Subject non-compliance|2
2030781|NCT00379795|3600246|FG002|Overall Study|Subject non-compliance|0
2030782|NCT00379795|3600247|FG003|Overall Study|Subject non-compliance|0
2030783|NCT00379795|3600248|FG004|Overall Study|Subject non-compliance|1
2030784|NCT00379795|3600244|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3
2030785|NCT00379795|3600245|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0
2030786|NCT00379795|3600246|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0
2030787|NCT00379795|3600247|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1
2030788|NCT00379795|3600248|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0
2030789|NCT00379795|3600244|FG000|Overall Study|Subjects condition mandated intervention|34
2030790|NCT00379795|3600245|FG001|Overall Study|Subjects condition mandated intervention|9
2030791|NCT00379795|3600246|FG002|Overall Study|Subjects condition mandated intervention|7
2030792|NCT00379795|3600247|FG003|Overall Study|Subjects condition mandated intervention|5
2030793|NCT00379795|3600248|FG004|Overall Study|Subjects condition mandated intervention|7
2030794|NCT00379795|3600244|FG000|Overall Study|Sponsor's decision|257
2030795|NCT00379795|3600245|FG001|Overall Study|Sponsor's decision|17
2030796|NCT00379795|3600246|FG002|Overall Study|Sponsor's decision|54
2030797|NCT00379795|3600247|FG003|Overall Study|Sponsor's decision|47
2030798|NCT00379795|3600248|FG004|Overall Study|Sponsor's decision|10
2030799|NCT00379808|3600263|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
2030800|NCT00379808|3600264|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
2030801|NCT00379834|3600294|FG000|Overall Study|Time constraints|2
2030802|NCT00379899|3600300|FG000|Overall Study|Adverse Event|7
2030803|NCT00379899|3600301|FG001|Overall Study|Adverse Event|3
2030804|NCT00379899|3600300|FG000|Overall Study|Death|10
2030805|NCT00379899|3600301|FG001|Overall Study|Death|10
2030806|NCT00379899|3600300|FG000|Overall Study|Lost to Follow-up|2
2030807|NCT00379899|3600301|FG001|Overall Study|Lost to Follow-up|4
2030808|NCT00379899|3600300|FG000|Overall Study|Physician Decision|3
2030809|NCT00379899|3600301|FG001|Overall Study|Physician Decision|4
2030810|NCT00379899|3600300|FG000|Overall Study|Withdrawal by Subject|5
2030811|NCT00379899|3600301|FG001|Overall Study|Withdrawal by Subject|5
2030812|NCT00379899|3600300|FG000|Overall Study|Ineligibility determined|0
2030813|NCT00379899|3600301|FG001|Overall Study|Ineligibility determined|1
2030814|NCT00379899|3600300|FG000|Overall Study|Noncompliance|1
2030815|NCT00379899|3600301|FG001|Overall Study|Noncompliance|1
2030816|NCT00379899|3600300|FG000|Overall Study|Parathyroidectomy|0
2030817|NCT00379899|3600301|FG001|Overall Study|Parathyroidectomy|2
2030818|NCT00379899|3600300|FG000|Overall Study|Renal transplantation|5
2030819|NCT00379899|3600301|FG001|Overall Study|Renal transplantation|4
2030820|NCT00379899|3600300|FG000|Overall Study|Coronary artery bypass graft|1
2030821|NCT00379899|3600301|FG001|Overall Study|Coronary artery bypass graft|1
2030822|NCT00379899|3600300|FG000|Overall Study|Other protocol-specified criteria|3
2030823|NCT00379899|3600301|FG001|Overall Study|Other protocol-specified criteria|4
2030824|NCT00379899|3600300|FG000|Overall Study|Other|3
2326742|NCT03065023|4045928|FG001|Overall Study|Death|0
2326743|NCT03065023|4045929|FG002|Overall Study|Death|1
2326744|NCT03065023|4045930|FG003|Overall Study|Death|1
2326745|NCT03065023|4045931|FG004|Overall Study|Death|0
2326746|NCT03065023|4045927|FG000|Overall Study|Lost to Follow-up|0
2326747|NCT03065023|4045928|FG001|Overall Study|Lost to Follow-up|1
2326748|NCT03065023|4045929|FG002|Overall Study|Lost to Follow-up|0
2326749|NCT03065023|4045930|FG003|Overall Study|Lost to Follow-up|0
2326750|NCT03065023|4045931|FG004|Overall Study|Lost to Follow-up|0
2326751|NCT03065023|4045927|FG000|Overall Study|Participant Decision|0
2326752|NCT03065023|4045928|FG001|Overall Study|Participant Decision|0
2326753|NCT03065023|4045929|FG002|Overall Study|Participant Decision|0
2326754|NCT03065023|4045930|FG003|Overall Study|Participant Decision|1
2326755|NCT03065023|4045931|FG004|Overall Study|Participant Decision|0
2326756|NCT03065023|4045927|FG000|Overall Study|Withdrawal by Subject|0
2326757|NCT03065023|4045928|FG001|Overall Study|Withdrawal by Subject|0
2326758|NCT03065023|4045929|FG002|Overall Study|Withdrawal by Subject|0
2326759|NCT03065023|4045930|FG003|Overall Study|Withdrawal by Subject|1
2326760|NCT03065023|4045931|FG004|Overall Study|Withdrawal by Subject|0
2326761|NCT03065400|4045968|FG000|Overall Study|Adverse Event|1
2326762|NCT03065400|4045968|FG000|Overall Study|Physician Decision|3
2326763|NCT03065400|4045968|FG000|Overall Study|Withdrawal by Subject|1
2326764|NCT03065400|4045968|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5
2030825|NCT00379899|3600301|FG001|Overall Study|Other|1
2030826|NCT00379912|3600309|FG000|Overall Study|Lack of Efficacy|1
2030827|NCT00379912|3600310|FG001|Overall Study|Lack of Efficacy|0
2030828|NCT00380068|3600330|FG000|Overall Study|Adverse Event|40
2030829|NCT00380068|3600330|FG000|Overall Study|Withdrawal by Subject|10
2030830|NCT00380068|3600330|FG000|Overall Study|Not compliant|6
2030831|NCT00380068|3600330|FG000|Overall Study|Lost to Follow-up|1
2030832|NCT00380068|3600330|FG000|Overall Study|Addition of other PAH therapeutic agent|1
2030833|NCT00380068|3600330|FG000|Overall Study|Lung transplant|3
2030834|NCT00380068|3600330|FG000|Overall Study|Physician Decision|2
2030835|NCT00380068|3600330|FG000|Overall Study|Partipant moved away|1
2030836|NCT00380068|3600330|FG000|Overall Study|Lack of Efficacy|5
2030837|NCT00380081|3600340|FG000|Overall Study|Withdrawal by Subject|0
2030838|NCT00380081|3600341|FG001|Overall Study|Withdrawal by Subject|0
2030839|NCT00380081|3600342|FG002|Overall Study|Withdrawal by Subject|0
2030840|NCT00380081|3600343|FG003|Overall Study|Withdrawal by Subject|0
2030841|NCT00380081|3600344|FG004|Overall Study|Withdrawal by Subject|1
2030842|NCT00380081|3600345|FG005|Overall Study|Withdrawal by Subject|0
2030843|NCT00380081|3600340|FG000|Overall Study|Family Emergency|0
2030844|NCT00380081|3600341|FG001|Overall Study|Family Emergency|0
2030845|NCT00380081|3600342|FG002|Overall Study|Family Emergency|0
2110399|NCT00895895|3705283|FG003|Period 1|failed to return|0
2110400|NCT00895895|3705284|FG004|Period 1|failed to return|1
2110401|NCT00895895|3705280|FG000|Period 1|investigator request|0
2110402|NCT00895895|3705281|FG001|Period 1|investigator request|1
2110403|NCT00895895|3705282|FG002|Period 1|investigator request|0
2110404|NCT00895895|3705283|FG003|Period 1|investigator request|0
2110405|NCT00895895|3705284|FG004|Period 1|investigator request|0
2110406|NCT00895895|3705280|FG000|Period 1|Lost to Follow-up|2
2110407|NCT00895895|3705281|FG001|Period 1|Lost to Follow-up|1
2110408|NCT00895895|3705282|FG002|Period 1|Lost to Follow-up|3
2110409|NCT00895895|3705283|FG003|Period 1|Lost to Follow-up|2
2110410|NCT00895895|3705284|FG004|Period 1|Lost to Follow-up|3
2110411|NCT00895895|3705280|FG000|Period 1|Other|1
2110412|NCT00895895|3705281|FG001|Period 1|Other|2
2110413|NCT00895895|3705282|FG002|Period 1|Other|1
2110414|NCT00895895|3705283|FG003|Period 1|Other|1
2110415|NCT00895895|3705284|FG004|Period 1|Other|1
2110416|NCT00895895|3705280|FG000|Period 1|Protocol Violation|0
2110417|NCT00895895|3705281|FG001|Period 1|Protocol Violation|1
2110418|NCT00895895|3705282|FG002|Period 1|Protocol Violation|0
2110419|NCT00895895|3705283|FG003|Period 1|Protocol Violation|0
2110420|NCT00895895|3705284|FG004|Period 1|Protocol Violation|0
2110421|NCT00895895|3705280|FG000|Period 1|Withdrawal by Subject|6
2110422|NCT00895895|3705281|FG001|Period 1|Withdrawal by Subject|6
2180309|NCT01400698|3806346|FG005|Overall Study|Other|0
2110423|NCT00895895|3705282|FG002|Period 1|Withdrawal by Subject|8
2110424|NCT00895895|3705283|FG003|Period 1|Withdrawal by Subject|2
2110425|NCT00895895|3705284|FG004|Period 1|Withdrawal by Subject|4
2110426|NCT00895895|3705280|FG000|Period 1|unsatisfactory response-efficacy|2
2110427|NCT00895895|3705281|FG001|Period 1|unsatisfactory response-efficacy|0
2180310|NCT01400815|3806358|FG000|Overall Study|Adverse Event|3
2326765|NCT03065530|4045976|FG000|Overall Study|Lack of Efficacy|1
2326766|NCT03065530|4045977|FG001|Overall Study|Lack of Efficacy|1
2326767|NCT03065530|4045978|FG002|Overall Study|Lack of Efficacy|0
2326768|NCT03065530|4045979|FG003|Overall Study|Lack of Efficacy|1
2326769|NCT03065530|4045976|FG000|Overall Study|Protocol Violation|1
2326770|NCT03065530|4045977|FG001|Overall Study|Protocol Violation|0
2326771|NCT03065530|4045978|FG002|Overall Study|Protocol Violation|1
2326772|NCT03065530|4045979|FG003|Overall Study|Protocol Violation|1
2326773|NCT03066193|4046010|FG000|Overall Study|Withdrawal by Subject|1
2326774|NCT03066609|4046017|FG000|INDUCTION|Pregnancy|0
2326775|NCT03066609|4046018|FG001|INDUCTION|Pregnancy|0
2326776|NCT03066609|4046019|FG002|INDUCTION|Pregnancy|1
2326777|NCT03066609|4046020|FG003|INDUCTION|Pregnancy|0
2326778|NCT03066609|4046017|FG000|INDUCTION|Lack of Efficacy|0
2326779|NCT03066609|4046018|FG001|INDUCTION|Lack of Efficacy|0
2326780|NCT03066609|4046019|FG002|INDUCTION|Lack of Efficacy|1
2326781|NCT03066609|4046020|FG003|INDUCTION|Lack of Efficacy|0
2326782|NCT03066609|4046017|FG000|INDUCTION|Adverse Event|2
2326783|NCT03066609|4046018|FG001|INDUCTION|Adverse Event|2
2326784|NCT03066609|4046019|FG002|INDUCTION|Adverse Event|0
2030846|NCT00380081|3600343|FG003|Overall Study|Family Emergency|0
2030847|NCT00380081|3600344|FG004|Overall Study|Family Emergency|0
2030848|NCT00380081|3600345|FG005|Overall Study|Family Emergency|1
2030849|NCT00380250|3600355|FG000|Overall Study|Withdrawal by Subject|39
2030850|NCT00380250|3600356|FG001|Overall Study|Withdrawal by Subject|28
2030851|NCT00380250|3600355|FG000|Overall Study|Adverse Event|20
2030852|NCT00380250|3600356|FG001|Overall Study|Adverse Event|9
2030853|NCT00380250|3600355|FG000|Overall Study|Lack of Efficacy|10
2030854|NCT00380250|3600356|FG001|Overall Study|Lack of Efficacy|8
2110428|NCT00895895|3705282|FG002|Period 1|unsatisfactory response-efficacy|0
2110429|NCT00895895|3705283|FG003|Period 1|unsatisfactory response-efficacy|0
2110430|NCT00895895|3705284|FG004|Period 1|unsatisfactory response-efficacy|0
2110431|NCT00895895|3705280|FG000|Period 1|randomized and not treated|1
2110432|NCT00895895|3705281|FG001|Period 1|randomized and not treated|3
2110433|NCT00895895|3705282|FG002|Period 1|randomized and not treated|1
2110434|NCT00895895|3705283|FG003|Period 1|randomized and not treated|1
2110435|NCT00895895|3705284|FG004|Period 1|randomized and not treated|2
2326785|NCT03066609|4046020|FG003|INDUCTION|Adverse Event|0
2326786|NCT03066609|4046017|FG000|MAINTENANCE|Adverse Event|0
2326787|NCT03066609|4046018|FG001|MAINTENANCE|Adverse Event|0
2326788|NCT03066609|4046019|FG002|MAINTENANCE|Adverse Event|0
2326789|NCT03066609|4046020|FG003|MAINTENANCE|Adverse Event|1
2326790|NCT03066609|4046017|FG000|MAINTENANCE|Withdrawal by Subject|4
2326791|NCT03066609|4046018|FG001|MAINTENANCE|Withdrawal by Subject|2
2326792|NCT03066609|4046019|FG002|MAINTENANCE|Withdrawal by Subject|1
2326793|NCT03066609|4046020|FG003|MAINTENANCE|Withdrawal by Subject|1
2326794|NCT03066609|4046017|FG000|MAINTENANCE|Lost to Follow-up|0
2326795|NCT03066609|4046018|FG001|MAINTENANCE|Lost to Follow-up|1
2326796|NCT03066609|4046019|FG002|MAINTENANCE|Lost to Follow-up|1
2326797|NCT03066609|4046020|FG003|MAINTENANCE|Lost to Follow-up|0
2326798|NCT03066609|4046017|FG000|MAINTENANCE|Pregnancy|1
2326799|NCT03066609|4046018|FG001|MAINTENANCE|Pregnancy|0
2326800|NCT03066609|4046019|FG002|MAINTENANCE|Pregnancy|0
2326801|NCT03066609|4046020|FG003|MAINTENANCE|Pregnancy|0
2326802|NCT03066609|4046017|FG000|MAINTENANCE|Lack of Efficacy|2
2326803|NCT03066609|4046018|FG001|MAINTENANCE|Lack of Efficacy|1
2326804|NCT03066609|4046019|FG002|MAINTENANCE|Lack of Efficacy|0
2326805|NCT03066609|4046020|FG003|MAINTENANCE|Lack of Efficacy|1
2326806|NCT03066609|4046017|FG000|OVERALL STUDY|Adverse Event|2
2326807|NCT03066609|4046018|FG001|OVERALL STUDY|Adverse Event|2
2326808|NCT03066609|4046019|FG002|OVERALL STUDY|Adverse Event|0
2326809|NCT03066609|4046020|FG003|OVERALL STUDY|Adverse Event|1
2326810|NCT03066609|4046017|FG000|OVERALL STUDY|Withdrawal by Subject|4
2326811|NCT03066609|4046018|FG001|OVERALL STUDY|Withdrawal by Subject|2
2326812|NCT03066609|4046019|FG002|OVERALL STUDY|Withdrawal by Subject|1
2326813|NCT03066609|4046020|FG003|OVERALL STUDY|Withdrawal by Subject|2
2326814|NCT03066609|4046017|FG000|OVERALL STUDY|Lost to Follow-up|1
2326815|NCT03066609|4046018|FG001|OVERALL STUDY|Lost to Follow-up|1
2326816|NCT03066609|4046019|FG002|OVERALL STUDY|Lost to Follow-up|1
2326817|NCT03066609|4046020|FG003|OVERALL STUDY|Lost to Follow-up|1
2326818|NCT03066609|4046017|FG000|OVERALL STUDY|Pregnancy|1
2326819|NCT03066609|4046018|FG001|OVERALL STUDY|Pregnancy|0
2326820|NCT03066609|4046019|FG002|OVERALL STUDY|Pregnancy|1
2326821|NCT03066609|4046020|FG003|OVERALL STUDY|Pregnancy|0
2326822|NCT03066609|4046017|FG000|OVERALL STUDY|Lack of Efficacy|2
2326823|NCT03066609|4046018|FG001|OVERALL STUDY|Lack of Efficacy|1
2326824|NCT03066609|4046019|FG002|OVERALL STUDY|Lack of Efficacy|1
2326825|NCT03066609|4046020|FG003|OVERALL STUDY|Lack of Efficacy|1
2326826|NCT03066609|4046017|FG000|OVERALL STUDY|discontinued follow up|0
2326827|NCT03066609|4046018|FG001|OVERALL STUDY|discontinued follow up|2
2326828|NCT03066609|4046019|FG002|OVERALL STUDY|discontinued follow up|0
2326829|NCT03066609|4046020|FG003|OVERALL STUDY|discontinued follow up|0
2326830|NCT03066778|4046033|FG000|Overall Study|Death|167
2326831|NCT03066778|4046034|FG001|Overall Study|Death|183
2326832|NCT03066778|4046033|FG000|Overall Study|Withdrawal by Subject|4
2326833|NCT03066778|4046034|FG001|Overall Study|Withdrawal by Subject|5
2326834|NCT03066778|4046033|FG000|Overall Study|Ongoing in Study|57
2326835|NCT03066778|4046034|FG001|Overall Study|Ongoing in Study|37
2326836|NCT03066804|4046042|FG000|Overall Study|Physician Decision|0
2326837|NCT03066804|4046043|FG001|Overall Study|Physician Decision|4
2326838|NCT03066804|4046042|FG000|Overall Study|Death|23
2326839|NCT03066804|4046043|FG001|Overall Study|Death|17
2326840|NCT03066804|4046042|FG000|Overall Study|Withdrawal by Subject|19
2326841|NCT03066804|4046043|FG001|Overall Study|Withdrawal by Subject|25
2326842|NCT03066804|4046042|FG000|Overall Study|Lost to Follow-up|2
2326843|NCT03066804|4046043|FG001|Overall Study|Lost to Follow-up|0
2326844|NCT03066804|4046042|FG000|Overall Study|Adverse Event|2
2326845|NCT03066804|4046043|FG001|Overall Study|Adverse Event|3
2326846|NCT03066804|4046042|FG000|Overall Study|Technical problems|5
2326847|NCT03066804|4046043|FG001|Overall Study|Technical problems|1
2326848|NCT03066830|4046052|FG000|Overall Study|At the Participant's own Request|16
2326849|NCT03066830|4046053|FG001|Overall Study|At the Participant's own Request|17
2326850|NCT03066830|4046052|FG000|Overall Study|Other|3
2326851|NCT03066830|4046053|FG001|Overall Study|Other|0
2326852|NCT03066830|4046052|FG000|Overall Study|Poor Compliance to Protocol|1
2326853|NCT03066830|4046053|FG001|Overall Study|Poor Compliance to Protocol|0
2326854|NCT03066830|4046052|FG000|Overall Study|Adverse Event|2
2326855|NCT03066830|4046053|FG001|Overall Study|Adverse Event|2
2326856|NCT03066830|4046052|FG000|Overall Study|Lost to Follow-up|11
2326857|NCT03066830|4046053|FG001|Overall Study|Lost to Follow-up|3
2326858|NCT03066999|4046067|FG000|Overall Study|abnormal urethraBladder neck contracture|0
2326859|NCT03066999|4046068|FG001|Overall Study|abnormal urethraBladder neck contracture|2
2326860|NCT03067129|4046079|FG000|Overall Study|Ongoing|45
2326861|NCT03067129|4046080|FG001|Overall Study|Ongoing|28
2326862|NCT03067129|4046081|FG002|Overall Study|Ongoing|27
2326863|NCT03067129|4046082|FG003|Overall Study|Ongoing|23
2326864|NCT03067129|4046079|FG000|Overall Study|Partially dosed; refused to swallow entire dose|0
2326865|NCT03067129|4046080|FG001|Overall Study|Partially dosed; refused to swallow entire dose|0
2030855|NCT00380250|3600355|FG000|Overall Study|Protocol Violation|15
2030856|NCT00380250|3600356|FG001|Overall Study|Protocol Violation|5
2218142|NCT01712984|3861594|FG001|Overall Study|Protocol Violation|0
2218143|NCT01712984|3861595|FG002|Overall Study|Protocol Violation|1
2218144|NCT01712984|3861593|FG000|Overall Study|Lost to Follow-up|8
2218145|NCT01712984|3861594|FG001|Overall Study|Lost to Follow-up|10
2218146|NCT01712984|3861595|FG002|Overall Study|Lost to Follow-up|1
2218147|NCT01712984|3861593|FG000|Overall Study|Withdrawal by Subject|6
2218148|NCT01712984|3861594|FG001|Overall Study|Withdrawal by Subject|6
2030857|NCT00380250|3600355|FG000|Overall Study|Lost to Follow-up|14
2030858|NCT00380250|3600356|FG001|Overall Study|Lost to Follow-up|5
2030859|NCT00380250|3600355|FG000|Overall Study|Physician Decision|1
2030860|NCT00380250|3600356|FG001|Overall Study|Physician Decision|0
2030861|NCT00380367|3600362|FG000|Overall Study|Lost to Follow-up|1
2030862|NCT00380367|3600362|FG000|Overall Study|Withdrawal by Subject|1
2110436|NCT00895895|3705280|FG000|After Period 1, Prior to Period 2|Adverse Event|0
2110437|NCT00895895|3705281|FG001|After Period 1, Prior to Period 2|Adverse Event|0
2110438|NCT00895895|3705282|FG002|After Period 1, Prior to Period 2|Adverse Event|1
2110439|NCT00895895|3705283|FG003|After Period 1, Prior to Period 2|Adverse Event|0
2110440|NCT00895895|3705284|FG004|After Period 1, Prior to Period 2|Adverse Event|0
2110441|NCT00895895|3705280|FG000|After Period 1, Prior to Period 2|Other|0
2110442|NCT00895895|3705281|FG001|After Period 1, Prior to Period 2|Other|0
2110443|NCT00895895|3705282|FG002|After Period 1, Prior to Period 2|Other|1
2110444|NCT00895895|3705283|FG003|After Period 1, Prior to Period 2|Other|0
2110445|NCT00895895|3705284|FG004|After Period 1, Prior to Period 2|Other|0
2110446|NCT00895895|3705280|FG000|After Period 1, Prior to Period 2|Protocol Violation|0
2110447|NCT00895895|3705281|FG001|After Period 1, Prior to Period 2|Protocol Violation|0
2110448|NCT00895895|3705282|FG002|After Period 1, Prior to Period 2|Protocol Violation|0
2110449|NCT00895895|3705283|FG003|After Period 1, Prior to Period 2|Protocol Violation|0
2110450|NCT00895895|3705284|FG004|After Period 1, Prior to Period 2|Protocol Violation|1
2110451|NCT00895895|3705280|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0
2110452|NCT00895895|3705281|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0
2110453|NCT00895895|3705282|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0
2110454|NCT00895895|3705283|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0
2110455|NCT00895895|3705284|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1
2218149|NCT01712984|3861595|FG002|Overall Study|Withdrawal by Subject|7
2326866|NCT03067129|4046081|FG002|Overall Study|Partially dosed; refused to swallow entire dose|0
2326867|NCT03067129|4046082|FG003|Overall Study|Partially dosed; refused to swallow entire dose|1
2326868|NCT03067311|4046102|FG000|Overall Study|Lost to Follow-up|1
2326869|NCT03067311|4046103|FG001|Overall Study|Lost to Follow-up|1
2326870|NCT03067311|4046102|FG000|Overall Study|Moved away|1
2326871|NCT03067311|4046103|FG001|Overall Study|Moved away|1
2326872|NCT03067441|4046111|FG000|Overall Study|Withdrawal by Subject|16
2326873|NCT03067441|4046112|FG001|Overall Study|Withdrawal by Subject|34
2326874|NCT03067441|4046111|FG000|Overall Study|Lost to Follow-up|7
2326875|NCT03067441|4046112|FG001|Overall Study|Lost to Follow-up|5
2326876|NCT03067441|4046111|FG000|Overall Study|Adverse Event|7
2326877|NCT03067441|4046112|FG001|Overall Study|Adverse Event|14
2326878|NCT03067441|4046111|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1
2326879|NCT03067441|4046112|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0
2326880|NCT03067441|4046111|FG000|Overall Study|Physician Decision|1
2326881|NCT03067441|4046112|FG001|Overall Study|Physician Decision|3
2326882|NCT03067441|4046111|FG000|Overall Study|Other|1
2326883|NCT03067441|4046112|FG001|Overall Study|Other|1
2326884|NCT03067987|4046131|FG000|Overall Study|Lost to Follow-up|7
2326885|NCT03067987|4046132|FG001|Overall Study|Lost to Follow-up|10
2326886|NCT03067987|4046131|FG000|Overall Study|Protocol Violation|1
2326887|NCT03067987|4046132|FG001|Overall Study|Protocol Violation|2
2326888|NCT03067987|4046131|FG000|Overall Study|Withdrawal by Subject|2
2326889|NCT03067987|4046132|FG001|Overall Study|Withdrawal by Subject|1
2326890|NCT03068455|4046154|FG000|Pre-treatment Period|Disease progression|0
2326891|NCT03068455|4046155|FG001|Pre-treatment Period|Disease progression|1
2326892|NCT03068455|4046154|FG000|Pre-treatment Period|Participant withdrew consent|1
2326893|NCT03068455|4046155|FG001|Pre-treatment Period|Participant withdrew consent|1
2326894|NCT03068455|4046154|FG000|Pre-treatment Period|Poor/non-compliance|0
2326895|NCT03068455|4046155|FG001|Pre-treatment Period|Poor/non-compliance|1
2326896|NCT03068455|4046154|FG000|Pre-treatment Period|Participant no longer meets study criteria|1
2030863|NCT00380393|3600368|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
2030864|NCT00380393|3600369|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
2030865|NCT00380393|3600368|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
2030866|NCT00380393|3600369|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
2030867|NCT00380393|3600368|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
2030868|NCT00380393|3600369|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
2030869|NCT00380393|3600368|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
2030870|NCT00380393|3600369|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
2030871|NCT00380393|3600368|FG000|Month 8 (Cross-sectional Visit)|Others|5
2030872|NCT00380393|3600369|FG001|Month 8 (Cross-sectional Visit)|Others|4
2030873|NCT00380393|3600368|FG000|Month 14|Withdrawal by Subject|9
2030874|NCT00380393|3600369|FG001|Month 14|Withdrawal by Subject|7
2326897|NCT03068455|4046155|FG001|Pre-treatment Period|Participant no longer meets study criteria|3
2326898|NCT03068455|4046154|FG000|Pre-treatment Period|Not reported|2
2326899|NCT03068455|4046155|FG001|Pre-treatment Period|Not reported|1
2326900|NCT03068455|4046154|FG000|Treatment Period|Disease progression|166
2326901|NCT03068455|4046155|FG001|Treatment Period|Disease progression|208
2326902|NCT03068455|4046154|FG000|Treatment Period|Study drug toxicity|317
2326903|NCT03068455|4046155|FG001|Treatment Period|Study drug toxicity|104
2326904|NCT03068455|4046154|FG000|Treatment Period|Adverse Event unrelated to study drug|15
2326905|NCT03068455|4046155|FG001|Treatment Period|Adverse Event unrelated to study drug|7
2326906|NCT03068455|4046154|FG000|Treatment Period|Participant request to stop therapy|33
2326907|NCT03068455|4046155|FG001|Treatment Period|Participant request to stop therapy|20
2326908|NCT03068455|4046154|FG000|Treatment Period|Participant withdrew consent|5
2326909|NCT03068455|4046155|FG001|Treatment Period|Participant withdrew consent|10
2326910|NCT03068455|4046154|FG000|Treatment Period|Poor/non-compliance|3
2326911|NCT03068455|4046155|FG001|Treatment Period|Poor/non-compliance|0
2326912|NCT03068455|4046154|FG000|Treatment Period|Participant no longer meets study criteria|1
2326913|NCT03068455|4046155|FG001|Treatment Period|Participant no longer meets study criteria|3
2326914|NCT03068455|4046154|FG000|Treatment Period|Other reasons|12
2326915|NCT03068455|4046155|FG001|Treatment Period|Other reasons|4
2326916|NCT03068468|4046163|FG000|Placebo-Controlled Period|Randomized but not Treated|1
2326917|NCT03068468|4046164|FG001|Placebo-Controlled Period|Randomized but not Treated|3
2326918|NCT03068468|4046165|FG002|Placebo-Controlled Period|Randomized but not Treated|0
2326919|NCT03068468|4046166|FG003|Placebo-Controlled Period|Randomized but not Treated|0
2326920|NCT03068468|4046163|FG000|Placebo-Controlled Period|Lack of Efficacy|0
2326921|NCT03068468|4046164|FG001|Placebo-Controlled Period|Lack of Efficacy|1
2326922|NCT03068468|4046165|FG002|Placebo-Controlled Period|Lack of Efficacy|0
2326923|NCT03068468|4046166|FG003|Placebo-Controlled Period|Lack of Efficacy|0
2326924|NCT03068468|4046163|FG000|Placebo-Controlled Period|Adverse Event|16
2326925|NCT03068468|4046164|FG001|Placebo-Controlled Period|Adverse Event|21
2326926|NCT03068468|4046165|FG002|Placebo-Controlled Period|Adverse Event|0
2326927|NCT03068468|4046166|FG003|Placebo-Controlled Period|Adverse Event|0
2326928|NCT03068468|4046163|FG000|Placebo-Controlled Period|Withdrawal by Subject|3
2326929|NCT03068468|4046164|FG001|Placebo-Controlled Period|Withdrawal by Subject|11
2326930|NCT03068468|4046165|FG002|Placebo-Controlled Period|Withdrawal by Subject|0
2326931|NCT03068468|4046166|FG003|Placebo-Controlled Period|Withdrawal by Subject|0
2326932|NCT03068468|4046163|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
2326933|NCT03068468|4046164|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2
2326934|NCT03068468|4046165|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
2326935|NCT03068468|4046166|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
2326936|NCT03068468|4046163|FG000|Placebo-Controlled Period|Reason Not Specified|1
2326937|NCT03068468|4046164|FG001|Placebo-Controlled Period|Reason Not Specified|6
2326938|NCT03068468|4046165|FG002|Placebo-Controlled Period|Reason Not Specified|0
2326939|NCT03068468|4046166|FG003|Placebo-Controlled Period|Reason Not Specified|0
2326940|NCT03068468|4046163|FG000|Placebo-Controlled Period|Death|0
2326941|NCT03068468|4046164|FG001|Placebo-Controlled Period|Death|1
2326942|NCT03068468|4046165|FG002|Placebo-Controlled Period|Death|0
2326943|NCT03068468|4046166|FG003|Placebo-Controlled Period|Death|0
2326944|NCT03068468|4046163|FG000|Open-Label Extension Period|Lack of Efficacy|0
2326945|NCT03068468|4046164|FG001|Open-Label Extension Period|Lack of Efficacy|0
2326946|NCT03068468|4046165|FG002|Open-Label Extension Period|Lack of Efficacy|1
2326947|NCT03068468|4046166|FG003|Open-Label Extension Period|Lack of Efficacy|2
2326948|NCT03068468|4046163|FG000|Open-Label Extension Period|Adverse Event|0
2326949|NCT03068468|4046164|FG001|Open-Label Extension Period|Adverse Event|0
2326950|NCT03068468|4046165|FG002|Open-Label Extension Period|Adverse Event|13
2326951|NCT03068468|4046166|FG003|Open-Label Extension Period|Adverse Event|17
2326952|NCT03068468|4046163|FG000|Open-Label Extension Period|Withdrawal by Subject|0
2326953|NCT03068468|4046164|FG001|Open-Label Extension Period|Withdrawal by Subject|0
2326954|NCT03068468|4046165|FG002|Open-Label Extension Period|Withdrawal by Subject|7
2326955|NCT03068468|4046166|FG003|Open-Label Extension Period|Withdrawal by Subject|20
2326956|NCT03068468|4046163|FG000|Open-Label Extension Period|Death|0
2326957|NCT03068468|4046164|FG001|Open-Label Extension Period|Death|0
2326958|NCT03068468|4046165|FG002|Open-Label Extension Period|Death|0
2326959|NCT03068468|4046166|FG003|Open-Label Extension Period|Death|1
2326960|NCT03068468|4046163|FG000|Open-Label Extension Period|Lost to Follow-up|0
2326961|NCT03068468|4046164|FG001|Open-Label Extension Period|Lost to Follow-up|0
2326962|NCT03068468|4046165|FG002|Open-Label Extension Period|Lost to Follow-up|1
2326963|NCT03068468|4046166|FG003|Open-Label Extension Period|Lost to Follow-up|0
2326964|NCT03068468|4046163|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
2030875|NCT00380393|3600368|FG000|Month 14|Death|1
2326965|NCT03068468|4046164|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
2326966|NCT03068468|4046165|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2
2326967|NCT03068468|4046166|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
2326968|NCT03068468|4046163|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0
2326969|NCT03068468|4046164|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0
2326970|NCT03068468|4046165|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115
2326971|NCT03068468|4046166|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228
2326972|NCT03068468|4046163|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
2326973|NCT03068468|4046164|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
2326974|NCT03068468|4046165|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
2326975|NCT03068468|4046166|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4
2326976|NCT03068468|4046163|FG000|Open-Label Extension Period|Reason not Specified|0
2326977|NCT03068468|4046164|FG001|Open-Label Extension Period|Reason not Specified|0
2326978|NCT03068468|4046165|FG002|Open-Label Extension Period|Reason not Specified|1
2326979|NCT03068468|4046166|FG003|Open-Label Extension Period|Reason not Specified|4
2326980|NCT03068715|4046185|FG000|Overall Study|No longer met inclusion criteria|1
2326981|NCT03068715|4046186|FG001|Overall Study|No longer met inclusion criteria|0
2326982|NCT03068754|4046196|FG000|Randomized Treatment Period (RTP)|Adverse Event|1
2326983|NCT03068754|4046197|FG001|Randomized Treatment Period (RTP)|Adverse Event|3
2326984|NCT03068754|4046198|FG002|Randomized Treatment Period (RTP)|Adverse Event|0
2326985|NCT03068754|4046199|FG003|Randomized Treatment Period (RTP)|Adverse Event|0
2326986|NCT03068754|4046196|FG000|Randomized Treatment Period (RTP)|Death|2
2326987|NCT03068754|4046197|FG001|Randomized Treatment Period (RTP)|Death|2
2326988|NCT03068754|4046198|FG002|Randomized Treatment Period (RTP)|Death|0
2326989|NCT03068754|4046199|FG003|Randomized Treatment Period (RTP)|Death|0
2326990|NCT03068754|4046196|FG000|Randomized Treatment Period (RTP)|Disease progression|1
2326991|NCT03068754|4046197|FG001|Randomized Treatment Period (RTP)|Disease progression|2
2326992|NCT03068754|4046198|FG002|Randomized Treatment Period (RTP)|Disease progression|0
2326993|NCT03068754|4046199|FG003|Randomized Treatment Period (RTP)|Disease progression|0
2326994|NCT03068754|4046196|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1
2326995|NCT03068754|4046197|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0
2326996|NCT03068754|4046198|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0
2326997|NCT03068754|4046199|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0
2326998|NCT03068754|4046196|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6
2326999|NCT03068754|4046197|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2
2327000|NCT03068754|4046198|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
2327001|NCT03068754|4046199|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
2218150|NCT01713036|3861603|FG000|Overall Study|Death|1
2327002|NCT03068754|4046196|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1
2327003|NCT03068754|4046197|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0
2327004|NCT03068754|4046198|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0
2327005|NCT03068754|4046199|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0
2327006|NCT03068754|4046196|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
2030876|NCT00380393|3600369|FG001|Month 14|Death|0
2030877|NCT00380393|3600368|FG000|Month 14|Lost to Follow-up|0
2030878|NCT00380393|3600369|FG001|Month 14|Lost to Follow-up|1
2030879|NCT00380393|3600368|FG000|Month 14|Migrated/moved from study area|39
2030880|NCT00380393|3600369|FG001|Month 14|Migrated/moved from study area|42
2030881|NCT00380393|3600368|FG000|Month 14|Protocol Violation|2
2030882|NCT00380393|3600369|FG001|Month 14|Protocol Violation|0
2030883|NCT00380393|3600368|FG000|Month 14|Others|6
2030884|NCT00380393|3600369|FG001|Month 14|Others|6
2327007|NCT03068754|4046197|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1
2327008|NCT03068754|4046198|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
2327009|NCT03068754|4046199|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
2327010|NCT03068754|4046196|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55
2327011|NCT03068754|4046197|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29
2327012|NCT03068754|4046198|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
2327013|NCT03068754|4046199|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
2327014|NCT03068754|4046196|FG000|Open Label Extension Period (OLE)|Adverse Event|0
2327015|NCT03068754|4046197|FG001|Open Label Extension Period (OLE)|Adverse Event|0
2327016|NCT03068754|4046198|FG002|Open Label Extension Period (OLE)|Adverse Event|0
2327017|NCT03068754|4046199|FG003|Open Label Extension Period (OLE)|Adverse Event|1
2327018|NCT03068754|4046196|FG000|Open Label Extension Period (OLE)|Death|0
2327019|NCT03068754|4046197|FG001|Open Label Extension Period (OLE)|Death|0
2327020|NCT03068754|4046198|FG002|Open Label Extension Period (OLE)|Death|0
2327021|NCT03068754|4046199|FG003|Open Label Extension Period (OLE)|Death|1
2327022|NCT03068754|4046196|FG000|Open Label Extension Period (OLE)|Disease progression|0
2327023|NCT03068754|4046197|FG001|Open Label Extension Period (OLE)|Disease progression|0
2327024|NCT03068754|4046198|FG002|Open Label Extension Period (OLE)|Disease progression|3
2327025|NCT03068754|4046199|FG003|Open Label Extension Period (OLE)|Disease progression|1
2327026|NCT03068754|4046196|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0
2327027|NCT03068754|4046197|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0
2327028|NCT03068754|4046198|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5
2327029|NCT03068754|4046199|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0
2327030|NCT03068754|4046196|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
2327031|NCT03068754|4046197|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
2327032|NCT03068754|4046198|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1
2327033|NCT03068754|4046199|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
2327034|NCT03068754|4046196|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
2327035|NCT03068754|4046197|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
2327036|NCT03068754|4046198|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12
2327037|NCT03068754|4046199|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3
2327038|NCT03068767|4046211|FG000|Overall Study|Lost to Follow-up|7
2327039|NCT03068767|4046212|FG001|Overall Study|Lost to Follow-up|3
2327040|NCT03068767|4046211|FG000|Overall Study|Protocol Violation|3
2327041|NCT03068767|4046212|FG001|Overall Study|Protocol Violation|0
2327042|NCT03069313|4046252|FG000|Overall Study|Adverse Event|5
2327043|NCT03069352|4046258|FG000|Overall Study|Ongoing|12
2327044|NCT03069352|4046259|FG001|Overall Study|Ongoing|40
2327045|NCT03069365|4046265|FG000|Overall Study|Adverse Event|1
2327046|NCT03069482|4046271|FG000|Overall Study|Lost to Follow-up|0
2327047|NCT03069482|4046272|FG001|Overall Study|Lost to Follow-up|1
2327048|NCT03069482|4046271|FG000|Overall Study|Physician Decision|1
2327049|NCT03069482|4046272|FG001|Overall Study|Physician Decision|0
2327050|NCT03069716|4046292|FG000|Run-in Period (2 Weeks)|Adverse Event|1
2327051|NCT03069716|4046293|FG001|Run-in Period (2 Weeks)|Adverse Event|0
2327052|NCT03069716|4046294|FG002|Run-in Period (2 Weeks)|Adverse Event|0
2327053|NCT03069716|4046292|FG000|Run-in Period (2 Weeks)|Protocol Violation|1
2327054|NCT03069716|4046293|FG001|Run-in Period (2 Weeks)|Protocol Violation|0
2327055|NCT03069716|4046294|FG002|Run-in Period (2 Weeks)|Protocol Violation|0
2327056|NCT03069716|4046292|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5
2327057|NCT03069716|4046293|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0
2327058|NCT03069716|4046294|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0
2327059|NCT03069716|4046292|FG000|Randomized Treatment|Withdrawal by Subject|0
2327060|NCT03069716|4046293|FG001|Randomized Treatment|Withdrawal by Subject|2
2327061|NCT03069716|4046294|FG002|Randomized Treatment|Withdrawal by Subject|0
2327062|NCT03069989|4046303|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
2327063|NCT03069989|4046304|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
2327064|NCT03070171|4046313|FG000|Treatment Period 2 + Washout|Other Adverse Event|0
2327065|NCT03070171|4046314|FG001|Treatment Period 2 + Washout|Other Adverse Event|1
2327066|NCT03070171|4046313|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0
2327067|NCT03070171|4046314|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1
2327068|NCT03070392|4046329|FG000|Overall Study|Not Treated|7
2327069|NCT03070392|4046330|FG001|Overall Study|Not Treated|0
2327070|NCT03070392|4046331|FG002|Overall Study|Not Treated|3
2327071|NCT03070392|4046332|FG003|Overall Study|Not Treated|12
2327072|NCT03070392|4046329|FG000|Overall Study|Death|3
2327073|NCT03070392|4046330|FG001|Overall Study|Death|0
2327074|NCT03070392|4046331|FG002|Overall Study|Death|0
2327075|NCT03070392|4046332|FG003|Overall Study|Death|1
2327076|NCT03070392|4046329|FG000|Overall Study|Withdrawal by Subject|7
2218151|NCT01713283|3861617|FG000|Overall Study|Lack of Efficacy|10
2218152|NCT01713283|3861618|FG001|Overall Study|Lack of Efficacy|2
2218153|NCT01713283|3861617|FG000|Overall Study|Lost to Follow-up|1
2218154|NCT01713283|3861618|FG001|Overall Study|Lost to Follow-up|1
2218155|NCT01713348|3861632|FG000|Overall Study|Withdrawal by Subject|3
2218156|NCT01713348|3861633|FG001|Overall Study|Withdrawal by Subject|2
2327077|NCT03070392|4046330|FG001|Overall Study|Withdrawal by Subject|0
2327078|NCT03070392|4046331|FG002|Overall Study|Withdrawal by Subject|0
2327079|NCT03070392|4046332|FG003|Overall Study|Withdrawal by Subject|3
2180311|NCT01400815|3806359|FG001|Overall Study|Adverse Event|0
2180312|NCT01400815|3806358|FG000|Overall Study|Death|0
2180313|NCT01400815|3806359|FG001|Overall Study|Death|1
2180314|NCT01400815|3806358|FG000|Overall Study|Lost to Follow-up|18
2180315|NCT01400815|3806359|FG001|Overall Study|Lost to Follow-up|11
2180316|NCT01400815|3806358|FG000|Overall Study|Protocol Violation|0
2180317|NCT01400815|3806359|FG001|Overall Study|Protocol Violation|1
2180318|NCT01400815|3806358|FG000|Overall Study|Physician Decision|1
2180319|NCT01400815|3806359|FG001|Overall Study|Physician Decision|0
2180320|NCT01400815|3806358|FG000|Overall Study|Withdrawal by Subject|15
2180321|NCT01400815|3806359|FG001|Overall Study|Withdrawal by Subject|8
2180322|NCT01400815|3806358|FG000|Overall Study|Subject in jail|1
2180323|NCT01400815|3806359|FG001|Overall Study|Subject in jail|0
2180324|NCT01400841|3806365|FG000|Initial Study Phase (6 Months)|Death|1
2180325|NCT01400841|3806365|FG000|Extended Study Phase (2 Years)|Adverse Event|2
2180326|NCT01400893|3806375|FG000|Overall Study|Death|27
2180327|NCT01400893|3806376|FG001|Overall Study|Death|21
2180328|NCT01400893|3806375|FG000|Overall Study|Lost to Follow-up|0
2180329|NCT01400893|3806376|FG001|Overall Study|Lost to Follow-up|6
2180330|NCT01400919|3806397|FG000|Overall Study|Withdrawal by Subject|4
2180331|NCT01400919|3806397|FG000|Overall Study|Lost to Follow-up|2
2180332|NCT01400919|3806397|FG000|Overall Study|Missed visit|2
2180333|NCT01400932|3806403|FG000|Overall Study|Adverse Event|10
2180334|NCT01400932|3806404|FG001|Overall Study|Adverse Event|5
2180335|NCT01400932|3806403|FG000|Overall Study|Lack of Efficacy|0
2180336|NCT01400932|3806404|FG001|Overall Study|Lack of Efficacy|3
2180337|NCT01400932|3806403|FG000|Overall Study|Withdrawal by Subject|2
2180338|NCT01400932|3806404|FG001|Overall Study|Withdrawal by Subject|6
2180339|NCT01400932|3806403|FG000|Overall Study|Lost to Follow-up|1
2180340|NCT01400932|3806404|FG001|Overall Study|Lost to Follow-up|0
2180341|NCT01400932|3806403|FG000|Overall Study|Protocol Deviation|0
2180342|NCT01400932|3806404|FG001|Overall Study|Protocol Deviation|1
2180343|NCT01400932|3806403|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
2180344|NCT01400932|3806404|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
2180345|NCT01400958|3806412|FG000|Overall Study|Physician Decision|0
2180346|NCT01400958|3806413|FG001|Overall Study|Physician Decision|1
2180347|NCT01400958|3806412|FG000|Overall Study|Withdrawal by Subject|0
2180348|NCT01400958|3806413|FG001|Overall Study|Withdrawal by Subject|1
2180349|NCT01400958|3806412|FG000|Overall Study|Adverse Event|1
2180350|NCT01400958|3806413|FG001|Overall Study|Adverse Event|0
2180351|NCT01400971|3806419|FG000|Overall Study|Death|82
2180352|NCT01400971|3806419|FG000|Overall Study|Lost to Follow-up|196
2180353|NCT01400971|3806419|FG000|Overall Study|Lost to follow up + Subject Decision|2
2180354|NCT01400971|3806419|FG000|Overall Study|Physician Decision|57
2180355|NCT01400971|3806419|FG000|Overall Study|Withdrawal by Subject|158
2180356|NCT01400971|3806419|FG000|Overall Study|Other|422
2180357|NCT01401010|3806425|FG000|Overall Study|Could not interpret assay results|1
2180358|NCT01401010|3806426|FG001|Overall Study|Could not interpret assay results|0
2180359|NCT01401062|3806445|FG000|Overall Study|Death|9
2180360|NCT01401062|3806446|FG001|Overall Study|Death|7
2180361|NCT01401062|3806445|FG000|Overall Study|Physician Decision|1
2180362|NCT01401062|3806446|FG001|Overall Study|Physician Decision|0
2180363|NCT01401062|3806445|FG000|Overall Study|Withdrawal by Subject|1
2180364|NCT01401062|3806446|FG001|Overall Study|Withdrawal by Subject|1
2180365|NCT01401153|3806463|FG000|First Test Day|Learning disabilities; illness|1
2180366|NCT01401153|3806464|FG001|First Test Day|Learning disabilities; illness|10
2327080|NCT03070392|4046329|FG000|Overall Study|Physician Decision|1
2327081|NCT03070392|4046330|FG001|Overall Study|Physician Decision|0
2327082|NCT03070392|4046331|FG002|Overall Study|Physician Decision|0
2327083|NCT03070392|4046332|FG003|Overall Study|Physician Decision|2
2180367|NCT01401153|3806463|FG000|Second Test Day|illness|0
2180368|NCT01401153|3806464|FG001|Second Test Day|illness|5
2180369|NCT01401283|3806512|FG000|Overall Study|surgery cancelled|5
2180370|NCT01401283|3806513|FG001|Overall Study|surgery cancelled|8
2180371|NCT01401283|3806512|FG000|Overall Study|preoperative arrhythmia|5
2180372|NCT01401283|3806513|FG001|Overall Study|preoperative arrhythmia|0
2180373|NCT01401283|3806512|FG000|Overall Study|no central venous access|0
2180374|NCT01401283|3806513|FG001|Overall Study|no central venous access|1
2180375|NCT01401283|3806512|FG000|Overall Study|suspicion of malignant hyperthermia|0
2180376|NCT01401283|3806513|FG001|Overall Study|suspicion of malignant hyperthermia|1
2327084|NCT03070392|4046329|FG000|Overall Study|Progressive Disease|154
2327085|NCT03070392|4046330|FG001|Overall Study|Progressive Disease|6
2327086|NCT03070392|4046331|FG002|Overall Study|Progressive Disease|2
2327087|NCT03070392|4046332|FG003|Overall Study|Progressive Disease|70
2327088|NCT03070392|4046329|FG000|Overall Study|Adverse Event|6
2327089|NCT03070392|4046330|FG001|Overall Study|Adverse Event|1
2327090|NCT03070392|4046331|FG002|Overall Study|Adverse Event|1
2327091|NCT03070392|4046332|FG003|Overall Study|Adverse Event|3
2327092|NCT03070392|4046329|FG000|Overall Study|Alternate anticancer treatment|1
2327093|NCT03070392|4046330|FG001|Overall Study|Alternate anticancer treatment|0
2327094|NCT03070392|4046331|FG002|Overall Study|Alternate anticancer treatment|0
2327095|NCT03070392|4046332|FG003|Overall Study|Alternate anticancer treatment|1
2327096|NCT03070392|4046329|FG000|Overall Study|Ongoing|73
2327097|NCT03070392|4046330|FG001|Overall Study|Ongoing|0
2327098|NCT03070392|4046331|FG002|Overall Study|Ongoing|0
2327099|NCT03070392|4046332|FG003|Overall Study|Ongoing|11
2327100|NCT03070431|4046338|FG000|Overall Study|Withdrawal by Subject|2
2327101|NCT03070431|4046338|FG000|Overall Study|Lost to Follow-up|2
2327102|NCT03070483|4046374|FG000|Overall Study|Lost to Follow-up|2
2327103|NCT03070782|4046402|FG000|Overall Study|Adverse Event|3
2327104|NCT03070782|4046403|FG001|Overall Study|Adverse Event|0
2327105|NCT03070782|4046404|FG002|Overall Study|Adverse Event|3
2327106|NCT03070782|4046405|FG003|Overall Study|Adverse Event|1
2327107|NCT03070782|4046406|FG004|Overall Study|Adverse Event|6
2327108|NCT03070782|4046407|FG005|Overall Study|Adverse Event|2
2327109|NCT03070782|4046402|FG000|Overall Study|Withdrawal by Subject|2
2327110|NCT03070782|4046403|FG001|Overall Study|Withdrawal by Subject|1
2327111|NCT03070782|4046404|FG002|Overall Study|Withdrawal by Subject|1
2327112|NCT03070782|4046405|FG003|Overall Study|Withdrawal by Subject|0
2327113|NCT03070782|4046406|FG004|Overall Study|Withdrawal by Subject|4
2327114|NCT03070782|4046407|FG005|Overall Study|Withdrawal by Subject|3
2327115|NCT03070782|4046402|FG000|Overall Study|Reason Not Specified|2
2327116|NCT03070782|4046403|FG001|Overall Study|Reason Not Specified|0
2327117|NCT03070782|4046404|FG002|Overall Study|Reason Not Specified|0
2327118|NCT03070782|4046405|FG003|Overall Study|Reason Not Specified|1
2327119|NCT03070782|4046406|FG004|Overall Study|Reason Not Specified|2
2327120|NCT03070782|4046407|FG005|Overall Study|Reason Not Specified|1
2327121|NCT03070782|4046402|FG000|Overall Study|Ineligibility|0
2327122|NCT03070782|4046403|FG001|Overall Study|Ineligibility|0
2327123|NCT03070782|4046404|FG002|Overall Study|Ineligibility|0
2327124|NCT03070782|4046405|FG003|Overall Study|Ineligibility|1
2327125|NCT03070782|4046406|FG004|Overall Study|Ineligibility|0
2327126|NCT03070782|4046407|FG005|Overall Study|Ineligibility|1
2327127|NCT03070782|4046402|FG000|Overall Study|Pregnancy|0
2327128|NCT03070782|4046403|FG001|Overall Study|Pregnancy|0
2327129|NCT03070782|4046404|FG002|Overall Study|Pregnancy|0
2327130|NCT03070782|4046405|FG003|Overall Study|Pregnancy|1
2327131|NCT03070782|4046406|FG004|Overall Study|Pregnancy|0
2327132|NCT03070782|4046407|FG005|Overall Study|Pregnancy|0
2327133|NCT03070782|4046402|FG000|Overall Study|Investigator Judgement|0
2327134|NCT03070782|4046403|FG001|Overall Study|Investigator Judgement|0
2327135|NCT03070782|4046404|FG002|Overall Study|Investigator Judgement|0
2327136|NCT03070782|4046405|FG003|Overall Study|Investigator Judgement|1
2327137|NCT03070782|4046406|FG004|Overall Study|Investigator Judgement|0
2327138|NCT03070782|4046407|FG005|Overall Study|Investigator Judgement|0
2327139|NCT03070964|4046421|FG000|Overall Study|Progressive disease|8
2327140|NCT03070964|4046421|FG000|Overall Study|Treatment-unrelated adverse event|2
2327141|NCT03070964|4046421|FG000|Overall Study|Never treated|1
2327142|NCT03070964|4046421|FG000|Overall Study|Physician Decision|1
2327143|NCT03070964|4046421|FG000|Overall Study|Withdrawal by Subject|1
2327144|NCT03070964|4046421|FG000|Overall Study|Adverse Event|1
2327145|NCT03071094|4046427|FG000|Overall Study|Death|1
2327146|NCT03071094|4046428|FG001|Overall Study|Death|1
2327147|NCT03071094|4046427|FG000|Overall Study|Adverse Event|1
2327148|NCT03071094|4046428|FG001|Overall Study|Adverse Event|0
2327149|NCT03071263|4046436|FG000|Overall Study|Adverse Event|1
2327150|NCT03071263|4046437|FG001|Overall Study|Adverse Event|3
2327151|NCT03071263|4046436|FG000|Overall Study|Withdrawal by Subject|1
2327152|NCT03071263|4046437|FG001|Overall Study|Withdrawal by Subject|3
2327153|NCT03071263|4046436|FG000|Overall Study|Physician Decision|1
2327154|NCT03071263|4046437|FG001|Overall Study|Physician Decision|0
2327155|NCT03071263|4046436|FG000|Overall Study|Participant moved to another city|0
2327156|NCT03071263|4046437|FG001|Overall Study|Participant moved to another city|1
2327157|NCT03071276|4046443|FG000|Overall Study|Adverse Event|1
2327158|NCT03071276|4046443|FG000|Overall Study|Lack of Efficacy|14
2327159|NCT03072160|4046457|FG000|Overall Study|Adverse Event|3
2327160|NCT03072160|4046458|FG001|Overall Study|Adverse Event|1
2327161|NCT03072160|4046457|FG000|Overall Study|Refused further treatment|6
2327162|NCT03072160|4046458|FG001|Overall Study|Refused further treatment|1
2327163|NCT03072160|4046457|FG000|Overall Study|Physician Decision|1
2327164|NCT03072160|4046458|FG001|Overall Study|Physician Decision|0
2327165|NCT03072160|4046457|FG000|Overall Study|Disease progression on study|1
2327166|NCT03072160|4046458|FG001|Overall Study|Disease progression on study|1
2327167|NCT03072160|4046457|FG000|Overall Study|No contact|0
2327168|NCT03072160|4046458|FG001|Overall Study|No contact|1
2327169|NCT03072719|4046515|FG000|Overall Study|Adverse Event|1
2327170|NCT03072719|4046516|FG001|Overall Study|Adverse Event|1
2327171|NCT03072875|4046531|FG000|Overall Study|Lost to Follow-up|1
2327172|NCT03073005|4046544|FG000|Overall Study|Death|6
2327173|NCT03073005|4046545|FG001|Overall Study|Death|0
2327174|NCT03073005|4046546|FG002|Overall Study|Death|7
2327175|NCT03073005|4046547|FG003|Overall Study|Death|0
2327176|NCT03073005|4046544|FG000|Overall Study|caregiver withdrew bc of pt death|0
2327177|NCT03073005|4046545|FG001|Overall Study|caregiver withdrew bc of pt death|6
2327178|NCT03073005|4046546|FG002|Overall Study|caregiver withdrew bc of pt death|0
2327179|NCT03073005|4046547|FG003|Overall Study|caregiver withdrew bc of pt death|7
2327180|NCT03073005|4046544|FG000|Overall Study|Lost to Follow-up|2
2327181|NCT03073005|4046545|FG001|Overall Study|Lost to Follow-up|2
2327182|NCT03073005|4046546|FG002|Overall Study|Lost to Follow-up|1
2327183|NCT03073005|4046547|FG003|Overall Study|Lost to Follow-up|2
2327184|NCT03073005|4046544|FG000|Overall Study|Withdrawal by Subject|0
2327185|NCT03073005|4046545|FG001|Overall Study|Withdrawal by Subject|4
2327186|NCT03073005|4046546|FG002|Overall Study|Withdrawal by Subject|4
2327187|NCT03073005|4046547|FG003|Overall Study|Withdrawal by Subject|4
2327188|NCT03073109|4046562|FG000|Overall Study|Adverse Event|0
2327189|NCT03073109|4046563|FG001|Overall Study|Adverse Event|1
2327190|NCT03073109|4046562|FG000|Overall Study|Other|2
2327191|NCT03073109|4046563|FG001|Overall Study|Other|0
2327192|NCT03073109|4046562|FG000|Overall Study|Lost to Follow-up|8
2327193|NCT03073109|4046563|FG001|Overall Study|Lost to Follow-up|1
2327194|NCT03073200|4046598|FG000|Double Blind Treatment Period|Protocol Violation|1
2327195|NCT03073200|4046599|FG001|Double Blind Treatment Period|Protocol Violation|0
2327196|NCT03073200|4046600|FG002|Double Blind Treatment Period|Protocol Violation|0
2327197|NCT03073200|4046601|FG003|Double Blind Treatment Period|Protocol Violation|0
2327198|NCT03073200|4046602|FG004|Double Blind Treatment Period|Protocol Violation|0
2327199|NCT03073200|4046603|FG005|Double Blind Treatment Period|Protocol Violation|0
2327200|NCT03073200|4046604|FG006|Double Blind Treatment Period|Protocol Violation|0
2327201|NCT03073200|4046605|FG007|Double Blind Treatment Period|Protocol Violation|0
2327202|NCT03073200|4046606|FG008|Double Blind Treatment Period|Protocol Violation|0
2327203|NCT03073200|4046607|FG009|Double Blind Treatment Period|Protocol Violation|0
2327204|NCT03073200|4046608|FG010|Double Blind Treatment Period|Protocol Violation|0
2327205|NCT03073200|4046609|FG011|Double Blind Treatment Period|Protocol Violation|0
2327206|NCT03073200|4046610|FG012|Double Blind Treatment Period|Protocol Violation|0
2327207|NCT03073200|4046611|FG013|Double Blind Treatment Period|Protocol Violation|0
2327208|NCT03073200|4046612|FG014|Double Blind Treatment Period|Protocol Violation|0
2327209|NCT03073200|4046598|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327210|NCT03073200|4046599|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1
2327211|NCT03073200|4046600|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327212|NCT03073200|4046601|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327213|NCT03073200|4046602|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327214|NCT03073200|4046603|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327215|NCT03073200|4046604|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327216|NCT03073200|4046605|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327217|NCT03073200|4046606|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327218|NCT03073200|4046607|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327219|NCT03073200|4046608|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327220|NCT03073200|4046609|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327221|NCT03073200|4046610|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327222|NCT03073200|4046611|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327223|NCT03073200|4046612|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
2327224|NCT03073200|4046598|FG000|Double Blind Treatment Period|Withdrawal by Subject|1
2327225|NCT03073200|4046599|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
2327226|NCT03073200|4046600|FG002|Double Blind Treatment Period|Withdrawal by Subject|0
2327227|NCT03073200|4046601|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
2327228|NCT03073200|4046602|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
2327229|NCT03073200|4046603|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
2327230|NCT03073200|4046604|FG006|Double Blind Treatment Period|Withdrawal by Subject|0
2327231|NCT03073200|4046605|FG007|Double Blind Treatment Period|Withdrawal by Subject|0
2327232|NCT03073200|4046606|FG008|Double Blind Treatment Period|Withdrawal by Subject|0
2327233|NCT03073200|4046607|FG009|Double Blind Treatment Period|Withdrawal by Subject|0
2327234|NCT03073200|4046608|FG010|Double Blind Treatment Period|Withdrawal by Subject|0
2327235|NCT03073200|4046609|FG011|Double Blind Treatment Period|Withdrawal by Subject|0
2327236|NCT03073200|4046610|FG012|Double Blind Treatment Period|Withdrawal by Subject|0
2327237|NCT03073200|4046611|FG013|Double Blind Treatment Period|Withdrawal by Subject|0
2327238|NCT03073200|4046612|FG014|Double Blind Treatment Period|Withdrawal by Subject|0
2327239|NCT03073200|4046598|FG000|Open-Label Maintenance Period|Lost to Follow-up|0
2327240|NCT03073200|4046599|FG001|Open-Label Maintenance Period|Lost to Follow-up|0
2327241|NCT03073200|4046600|FG002|Open-Label Maintenance Period|Lost to Follow-up|0
2327242|NCT03073200|4046601|FG003|Open-Label Maintenance Period|Lost to Follow-up|1
2327243|NCT03073200|4046602|FG004|Open-Label Maintenance Period|Lost to Follow-up|2
2327244|NCT03073200|4046603|FG005|Open-Label Maintenance Period|Lost to Follow-up|0
2327245|NCT03073200|4046604|FG006|Open-Label Maintenance Period|Lost to Follow-up|0
2327246|NCT03073200|4046605|FG007|Open-Label Maintenance Period|Lost to Follow-up|0
2327247|NCT03073200|4046606|FG008|Open-Label Maintenance Period|Lost to Follow-up|0
2327248|NCT03073200|4046607|FG009|Open-Label Maintenance Period|Lost to Follow-up|0
2327249|NCT03073200|4046608|FG010|Open-Label Maintenance Period|Lost to Follow-up|0
2327250|NCT03073200|4046609|FG011|Open-Label Maintenance Period|Lost to Follow-up|0
2327251|NCT03073200|4046610|FG012|Open-Label Maintenance Period|Lost to Follow-up|0
2327252|NCT03073200|4046611|FG013|Open-Label Maintenance Period|Lost to Follow-up|0
2327253|NCT03073200|4046612|FG014|Open-Label Maintenance Period|Lost to Follow-up|0
2327254|NCT03073200|4046598|FG000|Open-Label Maintenance Period|Participant moved to another city|0
2327255|NCT03073200|4046599|FG001|Open-Label Maintenance Period|Participant moved to another city|0
2327256|NCT03073200|4046600|FG002|Open-Label Maintenance Period|Participant moved to another city|0
2327257|NCT03073200|4046601|FG003|Open-Label Maintenance Period|Participant moved to another city|1
2327258|NCT03073200|4046602|FG004|Open-Label Maintenance Period|Participant moved to another city|0
2327259|NCT03073200|4046603|FG005|Open-Label Maintenance Period|Participant moved to another city|0
2327260|NCT03073200|4046604|FG006|Open-Label Maintenance Period|Participant moved to another city|0
2327261|NCT03073200|4046605|FG007|Open-Label Maintenance Period|Participant moved to another city|0
2327262|NCT03073200|4046606|FG008|Open-Label Maintenance Period|Participant moved to another city|0
2327263|NCT03073200|4046607|FG009|Open-Label Maintenance Period|Participant moved to another city|0
2327264|NCT03073200|4046608|FG010|Open-Label Maintenance Period|Participant moved to another city|0
2327265|NCT03073200|4046609|FG011|Open-Label Maintenance Period|Participant moved to another city|0
2327266|NCT03073200|4046610|FG012|Open-Label Maintenance Period|Participant moved to another city|0
2327267|NCT03073200|4046611|FG013|Open-Label Maintenance Period|Participant moved to another city|0
2327268|NCT03073200|4046612|FG014|Open-Label Maintenance Period|Participant moved to another city|0
2327269|NCT03073200|4046598|FG000|Open-Label Maintenance Period|Lack of Efficacy|0
2327270|NCT03073200|4046599|FG001|Open-Label Maintenance Period|Lack of Efficacy|0
2327271|NCT03073200|4046600|FG002|Open-Label Maintenance Period|Lack of Efficacy|0
2327272|NCT03073200|4046601|FG003|Open-Label Maintenance Period|Lack of Efficacy|0
2327273|NCT03073200|4046602|FG004|Open-Label Maintenance Period|Lack of Efficacy|1
2327274|NCT03073200|4046603|FG005|Open-Label Maintenance Period|Lack of Efficacy|0
2327275|NCT03073200|4046604|FG006|Open-Label Maintenance Period|Lack of Efficacy|0
2327276|NCT03073200|4046605|FG007|Open-Label Maintenance Period|Lack of Efficacy|0
2327277|NCT03073200|4046606|FG008|Open-Label Maintenance Period|Lack of Efficacy|0
2327278|NCT03073200|4046607|FG009|Open-Label Maintenance Period|Lack of Efficacy|0
2327279|NCT03073200|4046608|FG010|Open-Label Maintenance Period|Lack of Efficacy|0
2327280|NCT03073200|4046609|FG011|Open-Label Maintenance Period|Lack of Efficacy|0
2327281|NCT03073200|4046610|FG012|Open-Label Maintenance Period|Lack of Efficacy|0
2327282|NCT03073200|4046611|FG013|Open-Label Maintenance Period|Lack of Efficacy|0
2327283|NCT03073200|4046612|FG014|Open-Label Maintenance Period|Lack of Efficacy|0
2327284|NCT03073200|4046598|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0
2327285|NCT03073200|4046599|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0
2327286|NCT03073200|4046600|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0
2327287|NCT03073200|4046601|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2
2327288|NCT03073200|4046602|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1
2327289|NCT03073200|4046603|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0
2327290|NCT03073200|4046604|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0
2327291|NCT03073200|4046605|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0
2327292|NCT03073200|4046606|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0
2327293|NCT03073200|4046607|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0
2327294|NCT03073200|4046608|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0
2327295|NCT03073200|4046609|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0
2327296|NCT03073200|4046610|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0
2327297|NCT03073200|4046611|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0
2327298|NCT03073200|4046612|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0
2327299|NCT03073200|4046598|FG000|Extension Period|Lost to Follow-up|0
2327300|NCT03073200|4046599|FG001|Extension Period|Lost to Follow-up|0
2327301|NCT03073200|4046600|FG002|Extension Period|Lost to Follow-up|0
2327302|NCT03073200|4046601|FG003|Extension Period|Lost to Follow-up|0
2327303|NCT03073200|4046602|FG004|Extension Period|Lost to Follow-up|0
2327304|NCT03073200|4046603|FG005|Extension Period|Lost to Follow-up|0
2327305|NCT03073200|4046604|FG006|Extension Period|Lost to Follow-up|1
2327306|NCT03073200|4046605|FG007|Extension Period|Lost to Follow-up|1
2327307|NCT03073200|4046606|FG008|Extension Period|Lost to Follow-up|0
2327308|NCT03073200|4046607|FG009|Extension Period|Lost to Follow-up|0
2327309|NCT03073200|4046608|FG010|Extension Period|Lost to Follow-up|0
2327310|NCT03073200|4046609|FG011|Extension Period|Lost to Follow-up|0
2327311|NCT03073200|4046610|FG012|Extension Period|Lost to Follow-up|0
2327312|NCT03073200|4046611|FG013|Extension Period|Lost to Follow-up|0
2327313|NCT03073200|4046612|FG014|Extension Period|Lost to Follow-up|0
2327314|NCT03073200|4046598|FG000|Extension Period|Sponsor Decision|0
2327315|NCT03073200|4046599|FG001|Extension Period|Sponsor Decision|0
2327316|NCT03073200|4046600|FG002|Extension Period|Sponsor Decision|0
2327317|NCT03073200|4046601|FG003|Extension Period|Sponsor Decision|0
2327318|NCT03073200|4046602|FG004|Extension Period|Sponsor Decision|0
2327319|NCT03073200|4046603|FG005|Extension Period|Sponsor Decision|0
2327320|NCT03073200|4046604|FG006|Extension Period|Sponsor Decision|0
2327321|NCT03073200|4046605|FG007|Extension Period|Sponsor Decision|0
2327322|NCT03073200|4046606|FG008|Extension Period|Sponsor Decision|1
2327323|NCT03073200|4046607|FG009|Extension Period|Sponsor Decision|0
2327324|NCT03073200|4046608|FG010|Extension Period|Sponsor Decision|0
2327325|NCT03073200|4046609|FG011|Extension Period|Sponsor Decision|0
2327326|NCT03073200|4046610|FG012|Extension Period|Sponsor Decision|0
2327327|NCT03073200|4046611|FG013|Extension Period|Sponsor Decision|0
2327328|NCT03073200|4046612|FG014|Extension Period|Sponsor Decision|0
2327329|NCT03073200|4046598|FG000|Extension Period|Withdrawal by Parent/Guardian|0
2327330|NCT03073200|4046599|FG001|Extension Period|Withdrawal by Parent/Guardian|0
2327331|NCT03073200|4046600|FG002|Extension Period|Withdrawal by Parent/Guardian|0
2327332|NCT03073200|4046601|FG003|Extension Period|Withdrawal by Parent/Guardian|0
2327333|NCT03073200|4046602|FG004|Extension Period|Withdrawal by Parent/Guardian|0
2327334|NCT03073200|4046603|FG005|Extension Period|Withdrawal by Parent/Guardian|0
2327335|NCT03073200|4046604|FG006|Extension Period|Withdrawal by Parent/Guardian|1
2327336|NCT03073200|4046605|FG007|Extension Period|Withdrawal by Parent/Guardian|3
2327337|NCT03073200|4046606|FG008|Extension Period|Withdrawal by Parent/Guardian|1
2327338|NCT03073200|4046607|FG009|Extension Period|Withdrawal by Parent/Guardian|0
2327339|NCT03073200|4046608|FG010|Extension Period|Withdrawal by Parent/Guardian|0
2327340|NCT03073200|4046609|FG011|Extension Period|Withdrawal by Parent/Guardian|0
2327341|NCT03073200|4046610|FG012|Extension Period|Withdrawal by Parent/Guardian|0
2327342|NCT03073200|4046611|FG013|Extension Period|Withdrawal by Parent/Guardian|0
2327343|NCT03073200|4046612|FG014|Extension Period|Withdrawal by Parent/Guardian|0
2327344|NCT03073200|4046598|FG000|Extension Period|Withdrawal by Subject|0
2327345|NCT03073200|4046599|FG001|Extension Period|Withdrawal by Subject|0
2327346|NCT03073200|4046600|FG002|Extension Period|Withdrawal by Subject|0
2327347|NCT03073200|4046601|FG003|Extension Period|Withdrawal by Subject|0
2327348|NCT03073200|4046602|FG004|Extension Period|Withdrawal by Subject|0
2327349|NCT03073200|4046603|FG005|Extension Period|Withdrawal by Subject|0
2327350|NCT03073200|4046604|FG006|Extension Period|Withdrawal by Subject|1
2327351|NCT03073200|4046605|FG007|Extension Period|Withdrawal by Subject|2
2327352|NCT03073200|4046606|FG008|Extension Period|Withdrawal by Subject|0
2327353|NCT03073200|4046607|FG009|Extension Period|Withdrawal by Subject|0
2327354|NCT03073200|4046608|FG010|Extension Period|Withdrawal by Subject|0
2327355|NCT03073200|4046609|FG011|Extension Period|Withdrawal by Subject|0
2327356|NCT03073200|4046610|FG012|Extension Period|Withdrawal by Subject|0
2327357|NCT03073200|4046611|FG013|Extension Period|Withdrawal by Subject|0
2327358|NCT03073200|4046612|FG014|Extension Period|Withdrawal by Subject|0
2327359|NCT03073200|4046598|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
2327360|NCT03073200|4046599|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
2327361|NCT03073200|4046600|FG002|Randomized Withdrawal Period|Lost to Follow-up|0
2327362|NCT03073200|4046601|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
2327363|NCT03073200|4046602|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
2327364|NCT03073200|4046603|FG005|Randomized Withdrawal Period|Lost to Follow-up|0
2327365|NCT03073200|4046604|FG006|Randomized Withdrawal Period|Lost to Follow-up|0
2327366|NCT03073200|4046605|FG007|Randomized Withdrawal Period|Lost to Follow-up|0
2327367|NCT03073200|4046606|FG008|Randomized Withdrawal Period|Lost to Follow-up|0
2327368|NCT03073200|4046607|FG009|Randomized Withdrawal Period|Lost to Follow-up|0
2327369|NCT03073200|4046608|FG010|Randomized Withdrawal Period|Lost to Follow-up|0
2327370|NCT03073200|4046609|FG011|Randomized Withdrawal Period|Lost to Follow-up|1
2327371|NCT03073200|4046610|FG012|Randomized Withdrawal Period|Lost to Follow-up|0
2327372|NCT03073200|4046611|FG013|Randomized Withdrawal Period|Lost to Follow-up|0
2327373|NCT03073200|4046612|FG014|Randomized Withdrawal Period|Lost to Follow-up|0
2327374|NCT03073200|4046598|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327375|NCT03073200|4046599|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327376|NCT03073200|4046600|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327377|NCT03073200|4046601|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327378|NCT03073200|4046602|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327379|NCT03073200|4046603|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327380|NCT03073200|4046604|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327381|NCT03073200|4046605|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327382|NCT03073200|4046606|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327383|NCT03073200|4046607|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327384|NCT03073200|4046608|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327385|NCT03073200|4046609|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1
2327386|NCT03073200|4046610|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327387|NCT03073200|4046611|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327388|NCT03073200|4046612|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
2327389|NCT03073200|4046598|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
2327390|NCT03073200|4046599|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
2327391|NCT03073200|4046600|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
2327392|NCT03073200|4046601|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
2327393|NCT03073200|4046602|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0
2327394|NCT03073200|4046603|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0
2327395|NCT03073200|4046604|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0
2327396|NCT03073200|4046605|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0
2327397|NCT03073200|4046606|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0
2327398|NCT03073200|4046607|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0
2327399|NCT03073200|4046608|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1
2327400|NCT03073200|4046609|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1
2327401|NCT03073200|4046610|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0
2327402|NCT03073200|4046611|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0
2327403|NCT03073200|4046612|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0
2327404|NCT03073200|4046598|FG000|Randomized Withdrawal Period|Adverse Event|0
2218157|NCT01713348|3861634|FG002|Overall Study|Withdrawal by Subject|2
2218158|NCT01713348|3861635|FG003|Overall Study|Withdrawal by Subject|0
2218159|NCT01713348|3861632|FG000|Overall Study|Lost to Follow-up|1
2218160|NCT01713348|3861633|FG001|Overall Study|Lost to Follow-up|0
2218161|NCT01713348|3861634|FG002|Overall Study|Lost to Follow-up|0
2327405|NCT03073200|4046599|FG001|Randomized Withdrawal Period|Adverse Event|0
2327406|NCT03073200|4046600|FG002|Randomized Withdrawal Period|Adverse Event|0
2327407|NCT03073200|4046601|FG003|Randomized Withdrawal Period|Adverse Event|0
2327408|NCT03073200|4046602|FG004|Randomized Withdrawal Period|Adverse Event|0
2327409|NCT03073200|4046603|FG005|Randomized Withdrawal Period|Adverse Event|0
2327410|NCT03073200|4046604|FG006|Randomized Withdrawal Period|Adverse Event|0
2327411|NCT03073200|4046605|FG007|Randomized Withdrawal Period|Adverse Event|0
2327412|NCT03073200|4046606|FG008|Randomized Withdrawal Period|Adverse Event|0
2327413|NCT03073200|4046607|FG009|Randomized Withdrawal Period|Adverse Event|0
2327414|NCT03073200|4046608|FG010|Randomized Withdrawal Period|Adverse Event|1
2327415|NCT03073200|4046609|FG011|Randomized Withdrawal Period|Adverse Event|0
2327416|NCT03073200|4046610|FG012|Randomized Withdrawal Period|Adverse Event|0
2327417|NCT03073200|4046611|FG013|Randomized Withdrawal Period|Adverse Event|0
2327418|NCT03073200|4046612|FG014|Randomized Withdrawal Period|Adverse Event|0
2327419|NCT03073200|4046598|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
2327420|NCT03073200|4046599|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
2327421|NCT03073200|4046600|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
2327422|NCT03073200|4046601|FG003|Post-Treatment Follow-Up Period|Adverse Event|0
2327423|NCT03073200|4046602|FG004|Post-Treatment Follow-Up Period|Adverse Event|0
2327424|NCT03073200|4046603|FG005|Post-Treatment Follow-Up Period|Adverse Event|0
2327425|NCT03073200|4046604|FG006|Post-Treatment Follow-Up Period|Adverse Event|0
2327426|NCT03073200|4046605|FG007|Post-Treatment Follow-Up Period|Adverse Event|0
2327427|NCT03073200|4046606|FG008|Post-Treatment Follow-Up Period|Adverse Event|0
2327428|NCT03073200|4046607|FG009|Post-Treatment Follow-Up Period|Adverse Event|0
2327429|NCT03073200|4046608|FG010|Post-Treatment Follow-Up Period|Adverse Event|0
2327430|NCT03073200|4046609|FG011|Post-Treatment Follow-Up Period|Adverse Event|0
2327431|NCT03073200|4046610|FG012|Post-Treatment Follow-Up Period|Adverse Event|0
2327432|NCT03073200|4046611|FG013|Post-Treatment Follow-Up Period|Adverse Event|2
2327433|NCT03073200|4046612|FG014|Post-Treatment Follow-Up Period|Adverse Event|0
2327434|NCT03073200|4046598|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327435|NCT03073200|4046599|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327436|NCT03073200|4046600|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327437|NCT03073200|4046601|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327438|NCT03073200|4046602|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327439|NCT03073200|4046603|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327440|NCT03073200|4046604|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327441|NCT03073200|4046605|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327442|NCT03073200|4046606|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327443|NCT03073200|4046607|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327444|NCT03073200|4046608|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327445|NCT03073200|4046609|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327446|NCT03073200|4046610|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327447|NCT03073200|4046611|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
2327448|NCT03073200|4046612|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2327449|NCT03073200|4046598|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327450|NCT03073200|4046599|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327451|NCT03073200|4046600|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327452|NCT03073200|4046601|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327453|NCT03073200|4046602|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327454|NCT03073200|4046603|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327455|NCT03073200|4046604|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327456|NCT03073200|4046605|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327457|NCT03073200|4046606|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327458|NCT03073200|4046607|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327459|NCT03073200|4046608|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0
2218162|NCT01713348|3861635|FG003|Overall Study|Lost to Follow-up|0
2327460|NCT03073200|4046609|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327461|NCT03073200|4046610|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327462|NCT03073200|4046611|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1
2327463|NCT03073200|4046612|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0
2327464|NCT03073200|4046598|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
2327465|NCT03073200|4046599|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
2327466|NCT03073200|4046600|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
2327467|NCT03073200|4046601|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
2327468|NCT03073200|4046602|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
2327469|NCT03073200|4046603|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
2327470|NCT03073200|4046604|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
2327471|NCT03073200|4046605|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
2327472|NCT03073200|4046606|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
2327473|NCT03073200|4046607|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
2327474|NCT03073200|4046608|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
2327475|NCT03073200|4046609|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
2327476|NCT03073200|4046610|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
2327477|NCT03073200|4046611|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
2327478|NCT03073200|4046612|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0
2327479|NCT03073200|4046598|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327480|NCT03073200|4046599|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327481|NCT03073200|4046600|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327482|NCT03073200|4046601|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327483|NCT03073200|4046602|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327484|NCT03073200|4046603|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327485|NCT03073200|4046604|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327486|NCT03073200|4046605|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327487|NCT03073200|4046606|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327488|NCT03073200|4046607|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327489|NCT03073200|4046608|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327490|NCT03073200|4046609|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327491|NCT03073200|4046610|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327492|NCT03073200|4046611|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
2327493|NCT03073200|4046612|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1
2327494|NCT03073200|4046598|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327495|NCT03073200|4046599|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327496|NCT03073200|4046600|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327497|NCT03073200|4046601|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327498|NCT03073200|4046602|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327499|NCT03073200|4046603|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327500|NCT03073200|4046604|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327501|NCT03073200|4046605|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327502|NCT03073200|4046606|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327503|NCT03073200|4046607|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327504|NCT03073200|4046608|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327505|NCT03073200|4046609|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327506|NCT03073200|4046610|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327507|NCT03073200|4046611|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11
2327508|NCT03073200|4046612|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
2327509|NCT03073200|4046598|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327510|NCT03073200|4046599|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327511|NCT03073200|4046600|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327512|NCT03073200|4046601|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327513|NCT03073200|4046602|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327514|NCT03073200|4046603|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327515|NCT03073200|4046604|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327516|NCT03073200|4046605|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327517|NCT03073200|4046606|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327518|NCT03073200|4046607|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327519|NCT03073200|4046608|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327520|NCT03073200|4046609|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327521|NCT03073200|4046610|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327522|NCT03073200|4046611|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9
2327523|NCT03073200|4046612|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2327524|NCT03073200|4046598|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327525|NCT03073200|4046599|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327526|NCT03073200|4046600|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327527|NCT03073200|4046601|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2030885|NCT00380588|3600377|FG000|Overall Study|Unequivocal Disease Progression|25
2030886|NCT00380588|3600378|FG001|Overall Study|Unequivocal Disease Progression|34
2030887|NCT00380588|3600377|FG000|Overall Study|Next Cycle Not Started|4
2030888|NCT00380588|3600378|FG001|Overall Study|Next Cycle Not Started|0
2030889|NCT00380588|3600377|FG000|Overall Study|Adverse Event|7
2030890|NCT00380588|3600378|FG001|Overall Study|Adverse Event|3
2030891|NCT00380588|3600377|FG000|Overall Study|Withdrawal by Subject|1
2110456|NCT00895895|3705280|FG000|Period 2|Adverse Event|3
2110457|NCT00895895|3705281|FG001|Period 2|Adverse Event|3
2110458|NCT00895895|3705282|FG002|Period 2|Adverse Event|5
2030892|NCT00380588|3600378|FG001|Overall Study|Withdrawal by Subject|3
2030893|NCT00380588|3600377|FG000|Overall Study|Physician Decision|2
2030894|NCT00380588|3600378|FG001|Overall Study|Physician Decision|0
2030895|NCT00380692|3600386|FG000|Study Period II - Double Blind|Adverse Event|1
2030896|NCT00380692|3600387|FG001|Study Period II - Double Blind|Adverse Event|0
2030897|NCT00380692|3600386|FG000|Study Period II - Double Blind|Protocol Violation|2
2030898|NCT00380692|3600387|FG001|Study Period II - Double Blind|Protocol Violation|2
2030899|NCT00380692|3600386|FG000|Study Period II - Double Blind|Withdrawal by Subject|0
2030900|NCT00380692|3600387|FG001|Study Period II - Double Blind|Withdrawal by Subject|0
2030901|NCT00380692|3600386|FG000|Study Period II - Double Blind|Physician Decision|0
2030902|NCT00380692|3600387|FG001|Study Period II - Double Blind|Physician Decision|1
2030903|NCT00380692|3600386|FG000|Study Period II - Double Blind|Lack of Efficacy|1
2030904|NCT00380692|3600387|FG001|Study Period II - Double Blind|Lack of Efficacy|0
2030905|NCT00380692|3600386|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1
2327528|NCT03073200|4046602|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327529|NCT03073200|4046603|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327530|NCT03073200|4046604|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327531|NCT03073200|4046605|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327532|NCT03073200|4046606|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327533|NCT03073200|4046607|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327534|NCT03073200|4046608|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327535|NCT03073200|4046609|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327536|NCT03073200|4046610|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327537|NCT03073200|4046611|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2
2327538|NCT03073200|4046612|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
2327539|NCT03073213|4046637|FG000|Multiple Dose Period|Protocol Violation|0
2327540|NCT03073213|4046638|FG001|Multiple Dose Period|Protocol Violation|0
2327541|NCT03073213|4046639|FG002|Multiple Dose Period|Protocol Violation|1
2327542|NCT03073798|4046667|FG000|Overall Study|Adverse Event|1
2327543|NCT03073798|4046667|FG000|Overall Study|Withdrawal by Subject|1
2327544|NCT03074162|4046692|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0
2327545|NCT03074162|4046693|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0
2030906|NCT00380692|3600387|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0
2030907|NCT00380692|3600386|FG000|Study Period III - Open Label|Adverse Event|5
2030908|NCT00380692|3600387|FG001|Study Period III - Open Label|Adverse Event|3
2030909|NCT00380692|3600386|FG000|Study Period III - Open Label|Protocol Violation|0
2030910|NCT00380692|3600387|FG001|Study Period III - Open Label|Protocol Violation|0
2030911|NCT00380692|3600386|FG000|Study Period III - Open Label|Withdrawal by Subject|0
2030912|NCT00380692|3600387|FG001|Study Period III - Open Label|Withdrawal by Subject|1
2030913|NCT00380692|3600386|FG000|Study Period III - Open Label|Physician Decision|0
2327546|NCT03074162|4046694|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1
2327547|NCT03074162|4046695|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0
2327548|NCT03074162|4046696|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0
2327549|NCT03074162|4046697|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0
2327550|NCT03074162|4046692|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0
2327551|NCT03074162|4046693|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0
2327552|NCT03074162|4046694|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1
2327553|NCT03074162|4046695|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0
2327554|NCT03074162|4046696|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0
2327555|NCT03074162|4046697|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1
2327556|NCT03074162|4046692|FG000|Period 3|Withdrawal by Subject|1
2327557|NCT03074162|4046693|FG001|Period 3|Withdrawal by Subject|0
2327558|NCT03074162|4046694|FG002|Period 3|Withdrawal by Subject|0
2327559|NCT03074162|4046695|FG003|Period 3|Withdrawal by Subject|0
2327560|NCT03074162|4046696|FG004|Period 3|Withdrawal by Subject|1
2327561|NCT03074162|4046697|FG005|Period 3|Withdrawal by Subject|0
2327562|NCT03074331|4046705|FG000|Overall Study|Enrolled but Not Treated|1
2327563|NCT03074331|4046705|FG000|Overall Study|Lost to Follow-up|5
2327564|NCT03074331|4046705|FG000|Overall Study|Withdrew Consent|1
2327565|NCT03074500|4046721|FG000|Overall Study|Lost to Follow-up|1
2218163|NCT01713530|3861656|FG000|Overall Study|Adverse Event|0
2218164|NCT01713530|3861657|FG001|Overall Study|Adverse Event|5
2110459|NCT00895895|3705283|FG003|Period 2|Adverse Event|2
2327566|NCT03074500|4046722|FG001|Overall Study|Lost to Follow-up|0
2327567|NCT03074500|4046723|FG002|Overall Study|Lost to Follow-up|0
2327568|NCT03074500|4046721|FG000|Overall Study|Lack of Efficacy|0
2327569|NCT03074500|4046722|FG001|Overall Study|Lack of Efficacy|1
2327570|NCT03074500|4046723|FG002|Overall Study|Lack of Efficacy|0
2327571|NCT03074500|4046721|FG000|Overall Study|Adverse Event|0
2327572|NCT03074500|4046722|FG001|Overall Study|Adverse Event|0
2327573|NCT03074500|4046723|FG002|Overall Study|Adverse Event|1
2327574|NCT03075163|4046762|FG000|Overall Study|not eligible for treatment limb|138
2327575|NCT03075163|4046763|FG001|Overall Study|not eligible for treatment limb|138
2327576|NCT03075267|4046772|FG000|Overall Study|Protocol Violation|1
2327577|NCT03075267|4046773|FG001|Overall Study|Protocol Violation|0
2327578|NCT03075267|4046774|FG002|Overall Study|Protocol Violation|0
2327579|NCT03075410|4046791|FG000|Part A-Period 2 (14 Days)|Personal reasons|1
2327580|NCT03075410|4046792|FG001|Part A-Period 2 (14 Days)|Personal reasons|0
2327581|NCT03075410|4046793|FG002|Part A-Period 2 (14 Days)|Personal reasons|1
2327582|NCT03075410|4046794|FG003|Part A-Period 2 (14 Days)|Personal reasons|0
2327583|NCT03075410|4046795|FG004|Part A-Period 2 (14 Days)|Personal reasons|0
2327584|NCT03075410|4046796|FG005|Part A-Period 2 (14 Days)|Personal reasons|0
2327585|NCT03075410|4046797|FG006|Part A-Period 2 (14 Days)|Personal reasons|0
2327586|NCT03075410|4046798|FG007|Part A-Period 2 (14 Days)|Personal reasons|0
2327587|NCT03075410|4046799|FG008|Part A-Period 2 (14 Days)|Personal reasons|0
2327588|NCT03075410|4046791|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
2327589|NCT03075410|4046792|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2327590|NCT03075410|4046793|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2327591|NCT03075410|4046794|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2327592|NCT03075410|4046795|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2327593|NCT03075410|4046796|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2327594|NCT03075410|4046797|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2327595|NCT03075410|4046798|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2327596|NCT03075410|4046799|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2327597|NCT03075501|4046829|FG000|Overall Study|Scheduling difficulties|15
2327598|NCT03075501|4046830|FG001|Overall Study|Scheduling difficulties|9
2327599|NCT03075527|4046837|FG000|Overall Study|Ongoing treatment|2
2327600|NCT03075644|4046847|FG000|Overall Study|Withdrawal by Subject|1
2327601|NCT03075644|4046848|FG001|Overall Study|Withdrawal by Subject|1
2327602|NCT03075761|4046857|FG000|Overall Study|Lost to Follow-up|1
2327603|NCT03075761|4046858|FG001|Overall Study|Lost to Follow-up|6
2327604|NCT03075839|4046869|FG000|Overall Study|Lost to Follow-up|4
2327605|NCT03075878|4046873|FG000|Overall Study|Physician Decision|1
2327606|NCT03075891|4046879|FG000|Overall Study|Withdrawal by Subject|3
2327607|NCT03075891|4046880|FG001|Overall Study|Withdrawal by Subject|6
2327608|NCT03075891|4046879|FG000|Overall Study|Lost to Follow-up|1
2327609|NCT03075891|4046880|FG001|Overall Study|Lost to Follow-up|0
2327610|NCT03075891|4046879|FG000|Overall Study|Pregnancy|3
2327611|NCT03075891|4046880|FG001|Overall Study|Pregnancy|1
2327612|NCT03075891|4046879|FG000|Overall Study|visits not performed (no time)|1
2327613|NCT03075891|4046880|FG001|Overall Study|visits not performed (no time)|0
2327614|NCT03075891|4046879|FG000|Overall Study|Drug abuse relapse issue|0
2327615|NCT03075891|4046880|FG001|Overall Study|Drug abuse relapse issue|1
2327616|NCT03075891|4046879|FG000|Overall Study|Participant requiring study withdrawal|0
2327617|NCT03075891|4046880|FG001|Overall Study|Participant requiring study withdrawal|1
2327618|NCT03075891|4046879|FG000|Overall Study|Adverse event, non-fatal|1
2327619|NCT03075891|4046880|FG001|Overall Study|Adverse event, non-fatal|4
2327620|NCT03075904|4046888|FG000|Overall Study|Physician Decision|3
2327621|NCT03075904|4046888|FG000|Overall Study|Need for Medication not Permitted|1
2327622|NCT03076190|4046894|FG000|Overall Study|Lost to Follow-up|9
2327623|NCT03076190|4046895|FG001|Overall Study|Lost to Follow-up|34
2327624|NCT03076190|4046894|FG000|Overall Study|Excluded from Analysis (zero duration ev|9
2327625|NCT03076190|4046895|FG001|Overall Study|Excluded from Analysis (zero duration ev|7
2327626|NCT03076515|4046921|FG000|Overall Study|DMC decision based on interim analysis|25
2327627|NCT03076515|4046922|FG001|Overall Study|DMC decision based on interim analysis|29
2327628|NCT03076970|4046928|FG000|Washout Period 2|Adverse Event|0
2327629|NCT03076970|4046929|FG001|Washout Period 2|Adverse Event|0
2327630|NCT03076970|4046930|FG002|Washout Period 2|Adverse Event|0
2327631|NCT03076970|4046931|FG003|Washout Period 2|Adverse Event|0
2327632|NCT03076970|4046932|FG004|Washout Period 2|Adverse Event|1
2030914|NCT00380692|3600387|FG001|Study Period III - Open Label|Physician Decision|3
2030915|NCT00380692|3600386|FG000|Study Period III - Open Label|Lack of Efficacy|0
2327633|NCT03076970|4046933|FG005|Washout Period 2|Adverse Event|0
2327634|NCT03076970|4046928|FG000|Period 3|Withdrawal by Subject|0
2327635|NCT03076970|4046929|FG001|Period 3|Withdrawal by Subject|0
2327636|NCT03076970|4046930|FG002|Period 3|Withdrawal by Subject|0
2327637|NCT03076970|4046931|FG003|Period 3|Withdrawal by Subject|0
2327638|NCT03076970|4046932|FG004|Period 3|Withdrawal by Subject|0
2327639|NCT03076970|4046933|FG005|Period 3|Withdrawal by Subject|1
2327640|NCT03076970|4046928|FG000|Period 3|Failure to meet I/E criteria|0
2327641|NCT03076970|4046929|FG001|Period 3|Failure to meet I/E criteria|0
2327642|NCT03076970|4046930|FG002|Period 3|Failure to meet I/E criteria|0
2327643|NCT03076970|4046931|FG003|Period 3|Failure to meet I/E criteria|0
2327644|NCT03076970|4046932|FG004|Period 3|Failure to meet I/E criteria|1
2327645|NCT03076970|4046933|FG005|Period 3|Failure to meet I/E criteria|0
2327646|NCT03076996|4046953|FG000|Overall Study|Withdrawal by Subject|2
2327647|NCT03076996|4046953|FG000|Overall Study|Lost to Follow-up|3
2327648|NCT03076996|4046953|FG000|Overall Study|Literacy precluded participation|1
2327649|NCT03077438|4046984|FG000|Overall Study|Protocol Violation|3
2327650|NCT03077438|4046985|FG001|Overall Study|Protocol Violation|5
2327651|NCT03077438|4046984|FG000|Overall Study|Withdrawal by Subject|3
2327652|NCT03077438|4046985|FG001|Overall Study|Withdrawal by Subject|6
2327653|NCT03077438|4046984|FG000|Overall Study|Lost to Follow-up|6
2327654|NCT03077438|4046985|FG001|Overall Study|Lost to Follow-up|3
2327655|NCT03077607|4046997|FG000|Period 1 (15 Days)|Adverse Event|1
2327656|NCT03077607|4046998|FG001|Period 1 (15 Days)|Adverse Event|0
2327657|NCT03077607|4046997|FG000|Period 1 (15 Days)|Death|1
2327658|NCT03077607|4046998|FG001|Period 1 (15 Days)|Death|0
2327659|NCT03077607|4046997|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
2327660|NCT03077607|4046998|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
2327661|NCT03077607|4046997|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
2327662|NCT03077607|4046998|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
2327663|NCT03077646|4047018|FG000|Overall Study|Lost to Follow-up|29
2327664|NCT03077646|4047019|FG001|Overall Study|Lost to Follow-up|30
2327665|NCT03077646|4047020|FG002|Overall Study|Lost to Follow-up|31
2327666|NCT03077659|4047031|FG000|Overall Study|Withdrawal by Subject|0
2327667|NCT03077659|4047032|FG001|Overall Study|Withdrawal by Subject|0
2327668|NCT03077659|4047033|FG002|Overall Study|Withdrawal by Subject|1
2327669|NCT03077711|4047046|FG000|Overall Study|Lost to Follow-up|2
2327670|NCT03077711|4047047|FG001|Overall Study|Lost to Follow-up|2
2327671|NCT03077711|4047046|FG000|Overall Study|noncompliant taking medication|2
2327672|NCT03077711|4047047|FG001|Overall Study|noncompliant taking medication|0
2327673|NCT03077724|4047057|FG000|Overall Study|Lost to Follow-up|5
2327674|NCT03077724|4047058|FG001|Overall Study|Lost to Follow-up|1
2327675|NCT03077724|4047057|FG000|Overall Study|Withdrawal by Subject|3
2327676|NCT03077724|4047058|FG001|Overall Study|Withdrawal by Subject|1
2352460|NCT03777059|4101779|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
2352461|NCT03777059|4101780|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
2352462|NCT03777059|4101777|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
2352463|NCT03777059|4101778|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9
2352464|NCT03777059|4101779|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
2352465|NCT03777059|4101780|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10
2352466|NCT03777059|4101777|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
2352467|NCT03777059|4101778|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
2352468|NCT03777059|4101779|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4
2352469|NCT03777059|4101780|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5
2352470|NCT03777059|4101777|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0
2352471|NCT03777059|4101778|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1
2352472|NCT03777059|4101779|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0
2352473|NCT03777059|4101780|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0
2352474|NCT03777059|4101777|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4
2352475|NCT03777059|4101778|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5
2352476|NCT03777059|4101779|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7
2352477|NCT03777059|4101780|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8
2352478|NCT03777059|4101777|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
2352479|NCT03777059|4101778|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2
2352480|NCT03777059|4101779|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
2352481|NCT03777059|4101780|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1
2352482|NCT03777059|4101777|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
2352483|NCT03777059|4101778|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3
2352484|NCT03777059|4101779|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4
2352485|NCT03777059|4101780|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
2352486|NCT03777059|4101777|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
2352487|NCT03777059|4101778|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1
2352488|NCT03777059|4101779|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
2352489|NCT03777059|4101780|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3
2352490|NCT03777059|4101777|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
2352491|NCT03777059|4101778|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
2352492|NCT03777059|4101779|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
2327677|NCT03077919|4047076|FG000|Overall Study|Lost to Follow-up|4
2327678|NCT03077919|4047077|FG001|Overall Study|Lost to Follow-up|1
2327679|NCT03078556|4047134|FG000|Treatment Period 1 (4 Days)|Adverse Event|0
2327680|NCT03078556|4047135|FG001|Treatment Period 1 (4 Days)|Adverse Event|1
2327681|NCT03078556|4047136|FG002|Treatment Period 1 (4 Days)|Adverse Event|0
2327682|NCT03078556|4047137|FG003|Treatment Period 1 (4 Days)|Adverse Event|0
2327683|NCT03078556|4047134|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2
2327684|NCT03078556|4047135|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0
2327685|NCT03078556|4047136|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1
2327686|NCT03078556|4047137|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0
2327687|NCT03078556|4047134|FG000|Washout Period 1 (7 Days)|Adverse Event|0
2327688|NCT03078556|4047135|FG001|Washout Period 1 (7 Days)|Adverse Event|1
2327689|NCT03078556|4047136|FG002|Washout Period 1 (7 Days)|Adverse Event|0
2327690|NCT03078556|4047137|FG003|Washout Period 1 (7 Days)|Adverse Event|1
2327691|NCT03078556|4047134|FG000|Washout Period 1 (7 Days)|Physician Decision|0
2327692|NCT03078556|4047135|FG001|Washout Period 1 (7 Days)|Physician Decision|1
2327693|NCT03078556|4047136|FG002|Washout Period 1 (7 Days)|Physician Decision|0
2327694|NCT03078556|4047137|FG003|Washout Period 1 (7 Days)|Physician Decision|0
2327695|NCT03078582|4047164|FG000|Overall Study|Adverse Event|0
2327696|NCT03078582|4047165|FG001|Overall Study|Adverse Event|8
2030916|NCT00380692|3600387|FG001|Study Period III - Open Label|Lack of Efficacy|4
2030917|NCT00380692|3600386|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1
2030918|NCT00380692|3600387|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1
2030919|NCT00380718|3600393|FG000|Overall Study|Adverse Event|1
2030920|NCT00380718|3600393|FG000|Overall Study|Death after 30-day post-therapy followup|17
2030921|NCT00380744|3600404|FG000|Overall Study|Death|0
2030922|NCT00380744|3600405|FG001|Overall Study|Death|0
2030923|NCT00380744|3600406|FG002|Overall Study|Death|0
2030924|NCT00380744|3600407|FG003|Overall Study|Death|0
2030925|NCT00380744|3600408|FG004|Overall Study|Death|0
2030926|NCT00380744|3600409|FG005|Overall Study|Death|0
2030927|NCT00380744|3600410|FG006|Overall Study|Death|1
2110460|NCT00895895|3705284|FG004|Period 2|Adverse Event|5
2110461|NCT00895895|3705280|FG000|Period 2|Death|0
2110462|NCT00895895|3705281|FG001|Period 2|Death|0
2110463|NCT00895895|3705282|FG002|Period 2|Death|1
2110464|NCT00895895|3705283|FG003|Period 2|Death|0
2110465|NCT00895895|3705284|FG004|Period 2|Death|0
2110466|NCT00895895|3705280|FG000|Period 2|discontinued by sponsor|44
2110467|NCT00895895|3705281|FG001|Period 2|discontinued by sponsor|44
2110468|NCT00895895|3705282|FG002|Period 2|discontinued by sponsor|38
2110469|NCT00895895|3705283|FG003|Period 2|discontinued by sponsor|46
2110470|NCT00895895|3705284|FG004|Period 2|discontinued by sponsor|37
2110471|NCT00895895|3705280|FG000|Period 2|failed to return|2
2110472|NCT00895895|3705281|FG001|Period 2|failed to return|0
2110473|NCT00895895|3705282|FG002|Period 2|failed to return|0
2110474|NCT00895895|3705283|FG003|Period 2|failed to return|0
2110475|NCT00895895|3705284|FG004|Period 2|failed to return|0
2110476|NCT00895895|3705280|FG000|Period 2|investigator request|2
2110477|NCT00895895|3705281|FG001|Period 2|investigator request|0
2110478|NCT00895895|3705282|FG002|Period 2|investigator request|0
2110479|NCT00895895|3705283|FG003|Period 2|investigator request|0
2110480|NCT00895895|3705284|FG004|Period 2|investigator request|0
2110481|NCT00895895|3705280|FG000|Period 2|Lost to Follow-up|1
2110482|NCT00895895|3705281|FG001|Period 2|Lost to Follow-up|2
2110483|NCT00895895|3705282|FG002|Period 2|Lost to Follow-up|1
2110484|NCT00895895|3705283|FG003|Period 2|Lost to Follow-up|1
2110485|NCT00895895|3705284|FG004|Period 2|Lost to Follow-up|0
2327697|NCT03078751|4047195|FG000|Overall Study|Adverse Event|4
2327698|NCT03078751|4047196|FG001|Overall Study|Adverse Event|0
2327699|NCT03078751|4047195|FG000|Overall Study|Physician Decision|1
2327700|NCT03078751|4047196|FG001|Overall Study|Physician Decision|0
2327701|NCT03078751|4047195|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0
2327702|NCT03078751|4047196|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23
2327703|NCT03078751|4047195|FG000|Overall Study|Subject/guardian decision|8
2327704|NCT03078751|4047196|FG001|Overall Study|Subject/guardian decision|1
2327705|NCT03078751|4047195|FG000|Overall Study|Untreated|0
2327706|NCT03078751|4047196|FG001|Overall Study|Untreated|4
2327707|NCT03078816|4047202|FG000|Overall Study|Withdrawal by Subject|1
2327708|NCT03078907|4047208|FG000|Overall Study|Adverse Event|2
2327709|NCT03078907|4047209|FG001|Overall Study|Adverse Event|0
2327710|NCT03078907|4047208|FG000|Overall Study|Other|1
2327711|NCT03078907|4047209|FG001|Overall Study|Other|0
2327712|NCT03078907|4047208|FG000|Overall Study|Protocol Violation|0
2327713|NCT03078907|4047209|FG001|Overall Study|Protocol Violation|1
2327714|NCT03080454|4047254|FG000|Baseline|Adverse Event|2
2218165|NCT01713530|3861656|FG000|Overall Study|Withdrawal criteria|21
2218166|NCT01713530|3861657|FG001|Overall Study|Withdrawal criteria|12
2218167|NCT01713530|3861656|FG000|Overall Study|Unclassified|4
2218168|NCT01713530|3861657|FG001|Overall Study|Unclassified|2
2218169|NCT01713582|3861684|FG000|Overall Study|Disease progression|3
2218170|NCT01713582|3861685|FG001|Overall Study|Disease progression|3
2327715|NCT03080454|4047254|FG000|Anodal Doublestim (5 Days)|Adverse Event|1
2327716|NCT03080454|4047254|FG000|Anodal FU (7 Days)|Lost to Follow-up|4
2327717|NCT03080493|4047263|FG000|Overall Study|Did not provide NRS pain results|1
2327718|NCT03080493|4047264|FG001|Overall Study|Did not provide NRS pain results|0
2327719|NCT03080493|4047263|FG000|Overall Study|Adverse Event|0
2327720|NCT03080493|4047264|FG001|Overall Study|Adverse Event|1
2327721|NCT03080493|4047263|FG000|Overall Study|Randomization error (parity group)|0
2327722|NCT03080493|4047264|FG001|Overall Study|Randomization error (parity group)|1
2327723|NCT03080961|4047270|FG000|Overall Study|Withdrawal by Subject|3
2327724|NCT03081884|4047288|FG000|Overall Study|deferred prostate cancer treatment|1
2327725|NCT03081884|4047288|FG000|Overall Study|metastasis managed with systemic therapy|3
2327726|NCT03082261|4047302|FG000|Overall Study|Death|4
2327727|NCT03082261|4047302|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1
2327728|NCT03082261|4047302|FG000|Overall Study|Insurance denial|1
2327729|NCT03082261|4047302|FG000|Overall Study|Peripheral lead added|1
2327730|NCT03082261|4047302|FG000|Overall Study|Withdrawal by Subject|40
2327731|NCT03082261|4047302|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2
2327732|NCT03082261|4047302|FG000|Overall Study|Subject implanted with device other than study device|1
2327733|NCT03082261|4047302|FG000|Overall Study|Lost to Follow-up|14
2327734|NCT03082261|4047302|FG000|Overall Study|Subject moved to a different state|1
2327735|NCT03082261|4047302|FG000|Overall Study|Subject non-compliance|2
2327736|NCT03082261|4047302|FG000|Overall Study|Subject participation terminated by investigator|9
2327737|NCT03082261|4047302|FG000|Overall Study|Subject participation terminated by sponsor|4
2327738|NCT03082261|4047302|FG000|Overall Study|System explant|19
2327739|NCT03082261|4047302|FG000|Overall Study|Unable to place lead(s)|2
2327740|NCT03082261|4047302|FG000|Overall Study|Unsuccessful trial evaluation period|19
2327741|NCT03082599|4047339|FG000|Overall Study|Lost to Follow-up|1
2327742|NCT03082599|4047340|FG001|Overall Study|Lost to Follow-up|0
2327743|NCT03083132|4047357|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0
2218171|NCT01713582|3861686|FG002|Overall Study|Disease progression|3
2218172|NCT01713582|3861687|FG003|Overall Study|Disease progression|2
2218173|NCT01713582|3861688|FG004|Overall Study|Disease progression|3
2218174|NCT01713582|3861689|FG005|Overall Study|Disease progression|3
2218175|NCT01713582|3861690|FG006|Overall Study|Disease progression|3
2218176|NCT01713582|3861691|FG007|Overall Study|Disease progression|3
2218177|NCT01713582|3861692|FG008|Overall Study|Disease progression|3
2218178|NCT01713582|3861693|FG009|Overall Study|Disease progression|11
2218179|NCT01713582|3861694|FG010|Overall Study|Disease progression|10
2218180|NCT01713582|3861695|FG011|Overall Study|Disease progression|5
2218181|NCT01713582|3861696|FG012|Overall Study|Disease progression|3
2218182|NCT01713582|3861697|FG013|Overall Study|Disease progression|3
2218183|NCT01713582|3861698|FG014|Overall Study|Disease progression|6
2218184|NCT01713582|3861699|FG015|Overall Study|Disease progression|6
2218185|NCT01713582|3861700|FG016|Overall Study|Disease progression|5
2218186|NCT01713582|3861701|FG017|Overall Study|Disease progression|2
2218187|NCT01713582|3861702|FG018|Overall Study|Disease progression|3
2327744|NCT03083132|4047358|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2
2327745|NCT03083132|4047357|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1
2327746|NCT03083132|4047358|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0
2327747|NCT03083132|4047357|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0
2327748|NCT03083132|4047358|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1
2327749|NCT03083470|4047378|FG000|Overall Study|Lost to Follow-up|0
2327750|NCT03083470|4047379|FG001|Overall Study|Lost to Follow-up|0
2327751|NCT03083470|4047380|FG002|Overall Study|Lost to Follow-up|0
2327752|NCT03083470|4047381|FG003|Overall Study|Lost to Follow-up|0
2218188|NCT01713582|3861703|FG019|Overall Study|Disease progression|5
2327753|NCT03083470|4047382|FG004|Overall Study|Lost to Follow-up|1
2327754|NCT03083470|4047378|FG000|Overall Study|Withdrawal by Subject|0
2327755|NCT03083470|4047379|FG001|Overall Study|Withdrawal by Subject|0
2327756|NCT03083470|4047380|FG002|Overall Study|Withdrawal by Subject|0
2327757|NCT03083470|4047381|FG003|Overall Study|Withdrawal by Subject|0
2327758|NCT03083470|4047382|FG004|Overall Study|Withdrawal by Subject|1
2327759|NCT03083483|4047397|FG000|Overall Study|Adverse Event|1
2327760|NCT03083483|4047398|FG001|Overall Study|Adverse Event|1
2327761|NCT03083483|4047399|FG002|Overall Study|Adverse Event|1
2327762|NCT03083483|4047397|FG000|Overall Study|Lost to Follow-up|2
2327763|NCT03083483|4047398|FG001|Overall Study|Lost to Follow-up|1
2327764|NCT03083483|4047399|FG002|Overall Study|Lost to Follow-up|1
2327765|NCT03083483|4047397|FG000|Overall Study|technological issues|1
2327766|NCT03083483|4047398|FG001|Overall Study|technological issues|0
2327767|NCT03083483|4047399|FG002|Overall Study|technological issues|1
2327768|NCT03083639|4047409|FG000|Washout Period (at Least 6 Days)|Pregnancy|0
2327769|NCT03083639|4047410|FG001|Washout Period (at Least 6 Days)|Pregnancy|1
2327770|NCT03083639|4047409|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1
2327771|NCT03083639|4047410|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0
2327772|NCT03083847|4047435|FG000|Main|Physician Decision|0
2327773|NCT03083847|4047436|FG001|Main|Physician Decision|0
2327774|NCT03083847|4047437|FG002|Main|Physician Decision|0
2327775|NCT03083847|4047438|FG003|Main|Physician Decision|0
2327776|NCT03083847|4047439|FG004|Main|Physician Decision|0
2327777|NCT03083847|4047440|FG005|Main|Physician Decision|1
2327778|NCT03083847|4047441|FG006|Main|Physician Decision|0
2327779|NCT03083847|4047442|FG007|Main|Physician Decision|0
2327780|NCT03083847|4047443|FG008|Main|Physician Decision|0
2327781|NCT03083847|4047444|FG009|Main|Physician Decision|0
2327782|NCT03083847|4047435|FG000|Main|Pregnancy|0
2327783|NCT03083847|4047436|FG001|Main|Pregnancy|0
2327784|NCT03083847|4047437|FG002|Main|Pregnancy|0
2327785|NCT03083847|4047438|FG003|Main|Pregnancy|0
2327786|NCT03083847|4047439|FG004|Main|Pregnancy|0
2327787|NCT03083847|4047440|FG005|Main|Pregnancy|0
2327788|NCT03083847|4047441|FG006|Main|Pregnancy|0
2327789|NCT03083847|4047442|FG007|Main|Pregnancy|1
2327790|NCT03083847|4047443|FG008|Main|Pregnancy|0
2327791|NCT03083847|4047444|FG009|Main|Pregnancy|0
2327792|NCT03083847|4047435|FG000|Main|Adverse Event|0
2327793|NCT03083847|4047436|FG001|Main|Adverse Event|0
2327794|NCT03083847|4047437|FG002|Main|Adverse Event|0
2327795|NCT03083847|4047438|FG003|Main|Adverse Event|0
2327796|NCT03083847|4047439|FG004|Main|Adverse Event|0
2327797|NCT03083847|4047440|FG005|Main|Adverse Event|0
2327798|NCT03083847|4047441|FG006|Main|Adverse Event|0
2327799|NCT03083847|4047442|FG007|Main|Adverse Event|2
2327800|NCT03083847|4047443|FG008|Main|Adverse Event|0
2327801|NCT03083847|4047444|FG009|Main|Adverse Event|0
2327802|NCT03083847|4047435|FG000|Main|Withdrawal by Subject|0
2327803|NCT03083847|4047436|FG001|Main|Withdrawal by Subject|0
2327804|NCT03083847|4047437|FG002|Main|Withdrawal by Subject|0
2327805|NCT03083847|4047438|FG003|Main|Withdrawal by Subject|0
2327806|NCT03083847|4047439|FG004|Main|Withdrawal by Subject|0
2327807|NCT03083847|4047440|FG005|Main|Withdrawal by Subject|0
2327808|NCT03083847|4047441|FG006|Main|Withdrawal by Subject|1
2327809|NCT03083847|4047442|FG007|Main|Withdrawal by Subject|1
2327810|NCT03083847|4047443|FG008|Main|Withdrawal by Subject|0
2327811|NCT03083847|4047444|FG009|Main|Withdrawal by Subject|0
2327812|NCT03083990|4047474|FG000|Overall Study|Adverse Event|1
2327813|NCT03083990|4047475|FG001|Overall Study|Adverse Event|0
2327814|NCT03084302|4047481|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9
2327815|NCT03084302|4047481|FG000|Overall Study|No valid objective monitor data|6
2327816|NCT03084315|4047488|FG000|Overall Study|Lost to Follow-up|8
2327817|NCT03084315|4047489|FG001|Overall Study|Lost to Follow-up|7
2327818|NCT03084315|4047488|FG000|Overall Study|Withdrawal by Subject|2
2327819|NCT03084315|4047489|FG001|Overall Study|Withdrawal by Subject|2
2327820|NCT03084796|4047501|FG000|Overall Study|Adverse Event|4
2327821|NCT03084796|4047502|FG001|Overall Study|Adverse Event|5
2327822|NCT03084796|4047503|FG002|Overall Study|Adverse Event|6
2327823|NCT03084796|4047504|FG003|Overall Study|Adverse Event|2
2327824|NCT03084796|4047505|FG004|Overall Study|Adverse Event|3
2327825|NCT03084796|4047506|FG005|Overall Study|Adverse Event|5
2327826|NCT03084796|4047501|FG000|Overall Study|Withdrawal by Subject|3
2327827|NCT03084796|4047502|FG001|Overall Study|Withdrawal by Subject|5
2327828|NCT03084796|4047503|FG002|Overall Study|Withdrawal by Subject|2
2327829|NCT03084796|4047504|FG003|Overall Study|Withdrawal by Subject|1
2327830|NCT03084796|4047505|FG004|Overall Study|Withdrawal by Subject|3
2327831|NCT03084796|4047506|FG005|Overall Study|Withdrawal by Subject|0
2327832|NCT03084796|4047501|FG000|Overall Study|Protocol Violation|0
2327833|NCT03084796|4047502|FG001|Overall Study|Protocol Violation|0
2327834|NCT03084796|4047503|FG002|Overall Study|Protocol Violation|1
2327835|NCT03084796|4047504|FG003|Overall Study|Protocol Violation|0
2327836|NCT03084796|4047505|FG004|Overall Study|Protocol Violation|1
2327837|NCT03084796|4047506|FG005|Overall Study|Protocol Violation|1
2327838|NCT03084796|4047501|FG000|Overall Study|Lack of Efficacy|0
2327839|NCT03084796|4047502|FG001|Overall Study|Lack of Efficacy|0
2327840|NCT03084796|4047503|FG002|Overall Study|Lack of Efficacy|1
2327841|NCT03084796|4047504|FG003|Overall Study|Lack of Efficacy|0
2327842|NCT03084796|4047505|FG004|Overall Study|Lack of Efficacy|1
2327843|NCT03084796|4047506|FG005|Overall Study|Lack of Efficacy|0
2327844|NCT03084796|4047501|FG000|Overall Study|Lost to Follow-up|0
2327845|NCT03084796|4047502|FG001|Overall Study|Lost to Follow-up|0
2327846|NCT03084796|4047503|FG002|Overall Study|Lost to Follow-up|1
2327847|NCT03084796|4047504|FG003|Overall Study|Lost to Follow-up|1
2327848|NCT03084796|4047505|FG004|Overall Study|Lost to Follow-up|3
2327849|NCT03084796|4047506|FG005|Overall Study|Lost to Follow-up|1
2327850|NCT03084796|4047501|FG000|Overall Study|Randomization error|0
2327851|NCT03084796|4047502|FG001|Overall Study|Randomization error|0
2327852|NCT03084796|4047503|FG002|Overall Study|Randomization error|1
2327853|NCT03084796|4047504|FG003|Overall Study|Randomization error|0
2327854|NCT03084796|4047505|FG004|Overall Study|Randomization error|0
2327855|NCT03084796|4047506|FG005|Overall Study|Randomization error|0
2327856|NCT03085017|4047522|FG000|Overall Study|Death|0
2327857|NCT03085017|4047523|FG001|Overall Study|Death|3
2327858|NCT03085238|4047529|FG000|Overall Study|Adverse Event|2
2327859|NCT03085238|4047529|FG000|Overall Study|Death|2
2327860|NCT03085758|4047545|FG000|Overall Study|Death|26
2327861|NCT03085758|4047546|FG001|Overall Study|Death|24
2327862|NCT03085758|4047547|FG002|Overall Study|Death|53
2327863|NCT03085758|4047545|FG000|Overall Study|Lost to Follow-up|1
2327864|NCT03085758|4047546|FG001|Overall Study|Lost to Follow-up|1
2327865|NCT03085758|4047547|FG002|Overall Study|Lost to Follow-up|1
2327866|NCT03085758|4047545|FG000|Overall Study|Withdrawal by Subject|2
2327867|NCT03085758|4047546|FG001|Overall Study|Withdrawal by Subject|2
2327868|NCT03085758|4047547|FG002|Overall Study|Withdrawal by Subject|1
2327869|NCT03085758|4047545|FG000|Overall Study|Refusal to recall it up to day 90|0
2327870|NCT03085758|4047546|FG001|Overall Study|Refusal to recall it up to day 90|0
2327871|NCT03085758|4047547|FG002|Overall Study|Refusal to recall it up to day 90|1
2327872|NCT03085758|4047545|FG000|Overall Study|Pt seen by doctor in digestive surgery|0
2327873|NCT03085758|4047546|FG001|Overall Study|Pt seen by doctor in digestive surgery|1
2327874|NCT03085758|4047547|FG002|Overall Study|Pt seen by doctor in digestive surgery|0
2327875|NCT03085797|4047561|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1
2327876|NCT03085797|4047562|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0
2327877|NCT03085797|4047561|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16
2327878|NCT03085797|4047562|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17
2327879|NCT03085797|4047561|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0
2327880|NCT03085797|4047562|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1
2327881|NCT03085914|4047590|FG000|Overall Study|Death|6
2327882|NCT03085914|4047591|FG001|Overall Study|Death|6
2327883|NCT03085914|4047592|FG002|Overall Study|Death|4
2327884|NCT03085914|4047593|FG003|Overall Study|Death|1
2327885|NCT03085914|4047594|FG004|Overall Study|Death|5
2327886|NCT03085914|4047595|FG005|Overall Study|Death|2
2327887|NCT03085914|4047596|FG006|Overall Study|Death|2
2327888|NCT03085914|4047590|FG000|Overall Study|Withdrawal by Subject|1
2327889|NCT03085914|4047591|FG001|Overall Study|Withdrawal by Subject|1
2327890|NCT03085914|4047592|FG002|Overall Study|Withdrawal by Subject|2
2327891|NCT03085914|4047593|FG003|Overall Study|Withdrawal by Subject|2
2327892|NCT03085914|4047594|FG004|Overall Study|Withdrawal by Subject|2
2327893|NCT03085914|4047595|FG005|Overall Study|Withdrawal by Subject|0
2327894|NCT03085914|4047596|FG006|Overall Study|Withdrawal by Subject|1
2327895|NCT03085914|4047590|FG000|Overall Study|Lost to Follow-up|0
2327896|NCT03085914|4047591|FG001|Overall Study|Lost to Follow-up|0
2327897|NCT03085914|4047592|FG002|Overall Study|Lost to Follow-up|1
2327898|NCT03085914|4047593|FG003|Overall Study|Lost to Follow-up|0
2327899|NCT03085914|4047594|FG004|Overall Study|Lost to Follow-up|0
2327900|NCT03085914|4047595|FG005|Overall Study|Lost to Follow-up|1
2327901|NCT03085914|4047596|FG006|Overall Study|Lost to Follow-up|1
2327902|NCT03085914|4047590|FG000|Overall Study|Reason was not specified,|2
2327903|NCT03085914|4047591|FG001|Overall Study|Reason was not specified,|2
2327904|NCT03085914|4047592|FG002|Overall Study|Reason was not specified,|2
2327905|NCT03085914|4047593|FG003|Overall Study|Reason was not specified,|3
2327906|NCT03085914|4047594|FG004|Overall Study|Reason was not specified,|3
2327907|NCT03085914|4047595|FG005|Overall Study|Reason was not specified,|3
2327908|NCT03085914|4047596|FG006|Overall Study|Reason was not specified,|6
2327909|NCT03085914|4047590|FG000|Overall Study|Progressive Disease|0
2327910|NCT03085914|4047591|FG001|Overall Study|Progressive Disease|0
2327911|NCT03085914|4047592|FG002|Overall Study|Progressive Disease|2
2327912|NCT03085914|4047593|FG003|Overall Study|Progressive Disease|2
2327913|NCT03085914|4047594|FG004|Overall Study|Progressive Disease|1
2327914|NCT03085914|4047595|FG005|Overall Study|Progressive Disease|1
2327915|NCT03085914|4047596|FG006|Overall Study|Progressive Disease|1
2327916|NCT03085914|4047590|FG000|Overall Study|Study Terminated by the Sponsor|0
2327917|NCT03085914|4047591|FG001|Overall Study|Study Terminated by the Sponsor|0
2327918|NCT03085914|4047592|FG002|Overall Study|Study Terminated by the Sponsor|0
2327919|NCT03085914|4047593|FG003|Overall Study|Study Terminated by the Sponsor|1
2327920|NCT03085914|4047594|FG004|Overall Study|Study Terminated by the Sponsor|2
2327921|NCT03085914|4047595|FG005|Overall Study|Study Terminated by the Sponsor|1
2327922|NCT03085914|4047596|FG006|Overall Study|Study Terminated by the Sponsor|0
2327923|NCT03085927|4047617|FG000|Overall Study|Withdrawal by Subject|1
2327924|NCT03085927|4047618|FG001|Overall Study|Withdrawal by Subject|4
2327925|NCT03085927|4047617|FG000|Overall Study|Lost to Follow-up|3
2327926|NCT03085927|4047618|FG001|Overall Study|Lost to Follow-up|1
2327927|NCT03085927|4047617|FG000|Overall Study|Death|1
2327928|NCT03085927|4047618|FG001|Overall Study|Death|0
2327929|NCT03085927|4047617|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1
2327930|NCT03085927|4047618|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0
2327931|NCT03085927|4047617|FG000|Overall Study|Dyad Became Ineligible|0
2327932|NCT03085927|4047618|FG001|Overall Study|Dyad Became Ineligible|1
2327933|NCT03086018|4047626|FG000|Final Testing for End of Trial|Adverse Event|1
2327934|NCT03086018|4047626|FG000|Final Testing for End of Trial|Withdrawal by Subject|1
2327935|NCT03086057|4047636|FG000|Stage 1: PrEP Uptake|Incarcerated|3
2327936|NCT03086057|4047637|FG001|Stage 1: PrEP Uptake|Incarcerated|1
2327937|NCT03086057|4047638|FG002|Stage 1: PrEP Uptake|Incarcerated|0
2327938|NCT03086057|4047639|FG003|Stage 1: PrEP Uptake|Incarcerated|0
2327939|NCT03086057|4047636|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1
2327940|NCT03086057|4047637|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4
2327941|NCT03086057|4047638|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0
2327942|NCT03086057|4047639|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0
2327943|NCT03086057|4047636|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6
2327944|NCT03086057|4047637|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5
2327945|NCT03086057|4047638|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0
2327946|NCT03086057|4047639|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0
2327947|NCT03086057|4047636|FG000|Stage 1: PrEP Uptake|Death|1
2327948|NCT03086057|4047637|FG001|Stage 1: PrEP Uptake|Death|0
2327949|NCT03086057|4047638|FG002|Stage 1: PrEP Uptake|Death|0
2327950|NCT03086057|4047639|FG003|Stage 1: PrEP Uptake|Death|0
2327951|NCT03086057|4047636|FG000|Stage 2: PrEP Adherence|Incarcerated|0
2327952|NCT03086057|4047637|FG001|Stage 2: PrEP Adherence|Incarcerated|0
2327953|NCT03086057|4047638|FG002|Stage 2: PrEP Adherence|Incarcerated|2
2327954|NCT03086057|4047639|FG003|Stage 2: PrEP Adherence|Incarcerated|0
2327955|NCT03086057|4047636|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0
2327956|NCT03086057|4047637|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0
2327957|NCT03086057|4047638|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1
2327958|NCT03086057|4047639|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0
2327959|NCT03086057|4047636|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0
2030928|NCT00380744|3600404|FG000|Overall Study|Withdrawal by Subject|1
2030929|NCT00380744|3600405|FG001|Overall Study|Withdrawal by Subject|0
2030930|NCT00380744|3600406|FG002|Overall Study|Withdrawal by Subject|0
2030931|NCT00380744|3600407|FG003|Overall Study|Withdrawal by Subject|0
2030932|NCT00380744|3600408|FG004|Overall Study|Withdrawal by Subject|0
2030933|NCT00380744|3600409|FG005|Overall Study|Withdrawal by Subject|0
2030934|NCT00380744|3600410|FG006|Overall Study|Withdrawal by Subject|0
2030935|NCT00380874|3600438|FG000|Overall Study|Adverse Event|7
2030936|NCT00380874|3600439|FG001|Overall Study|Adverse Event|7
2030937|NCT00380874|3600438|FG000|Overall Study|Death|1
2030938|NCT00380874|3600439|FG001|Overall Study|Death|0
2030939|NCT00380874|3600438|FG000|Overall Study|Withdrawal by Subject|2
2030940|NCT00380874|3600439|FG001|Overall Study|Withdrawal by Subject|1
2030941|NCT00380874|3600438|FG000|Overall Study|Not related to study drug|3
2030942|NCT00380874|3600439|FG001|Overall Study|Not related to study drug|2
2030943|NCT00380978|3600447|FG000|Overall Study|Refused allocated intervention|0
2030944|NCT00380978|3600448|FG001|Overall Study|Refused allocated intervention|6
2030945|NCT00380978|3600447|FG000|Overall Study|Wrong study envelope|0
2030946|NCT00380978|3600448|FG001|Overall Study|Wrong study envelope|2
2030947|NCT00380978|3600447|FG000|Overall Study|Allocation prior to analgesia request|1
2030948|NCT00380978|3600448|FG001|Overall Study|Allocation prior to analgesia request|2
2030949|NCT00380978|3600447|FG000|Overall Study|Parous patient|1
2030950|NCT00380978|3600448|FG001|Overall Study|Parous patient|0
2030951|NCT00381043|3600460|FG000|Overall Study|Lost to Follow-up|8
2030952|NCT00381043|3600461|FG001|Overall Study|Lost to Follow-up|6
2030953|NCT00381043|3600460|FG000|Overall Study|Withdrawal by Subject|3
2030954|NCT00381043|3600461|FG001|Overall Study|Withdrawal by Subject|1
2030955|NCT00381043|3600460|FG000|Overall Study|wanted more care|0
2030956|NCT00381043|3600461|FG001|Overall Study|wanted more care|1
2030957|NCT00381043|3600460|FG000|Overall Study|incarcerated|1
2030958|NCT00381043|3600461|FG001|Overall Study|incarcerated|0
2030959|NCT00381095|3600469|FG000|Overall Study|Death|3
2030960|NCT00381095|3600470|FG001|Overall Study|Death|4
2110486|NCT00895895|3705280|FG000|Period 2|Other|1
2110487|NCT00895895|3705281|FG001|Period 2|Other|1
2110488|NCT00895895|3705282|FG002|Period 2|Other|3
2110489|NCT00895895|3705283|FG003|Period 2|Other|1
2110490|NCT00895895|3705284|FG004|Period 2|Other|1
2110491|NCT00895895|3705280|FG000|Period 2|Protocol Violation|1
2110492|NCT00895895|3705281|FG001|Period 2|Protocol Violation|0
2110493|NCT00895895|3705282|FG002|Period 2|Protocol Violation|1
2110494|NCT00895895|3705283|FG003|Period 2|Protocol Violation|1
2110495|NCT00895895|3705284|FG004|Period 2|Protocol Violation|1
2110496|NCT00895895|3705280|FG000|Period 2|Withdrawal by Subject|0
2110497|NCT00895895|3705281|FG001|Period 2|Withdrawal by Subject|2
2110498|NCT00895895|3705282|FG002|Period 2|Withdrawal by Subject|0
2110499|NCT00895895|3705283|FG003|Period 2|Withdrawal by Subject|3
2110500|NCT00895895|3705284|FG004|Period 2|Withdrawal by Subject|5
2110501|NCT00895895|3705280|FG000|Period 2|unsatisfactory response-efficacy|2
2110502|NCT00895895|3705281|FG001|Period 2|unsatisfactory response-efficacy|1
2110503|NCT00895895|3705282|FG002|Period 2|unsatisfactory response-efficacy|0
2110504|NCT00895895|3705283|FG003|Period 2|unsatisfactory response-efficacy|0
2110505|NCT00895895|3705284|FG004|Period 2|unsatisfactory response-efficacy|0
2110506|NCT00895947|3705329|FG000|Overall Study|Adverse Event|3
2110507|NCT00895947|3705330|FG001|Overall Study|Adverse Event|4
2110508|NCT00895947|3705329|FG000|Overall Study|Lost to Follow-up|3
2110509|NCT00895947|3705330|FG001|Overall Study|Lost to Follow-up|4
2110510|NCT00895947|3705329|FG000|Overall Study|Protocol Violation|4
2327960|NCT03086057|4047637|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0
2327961|NCT03086057|4047638|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3
2327962|NCT03086057|4047639|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2
2327963|NCT03086135|4047649|FG000|Overall Study|Adverse Event|1
2327964|NCT03086135|4047649|FG000|Overall Study|Lost to Follow-up|2
2327965|NCT03086330|4047671|FG000|Overall Study|Withdrawal by Subject|3
2327966|NCT03086330|4047672|FG001|Overall Study|Withdrawal by Subject|2
2327967|NCT03086330|4047671|FG000|Overall Study|Lost to Follow-up|1
2327968|NCT03086330|4047672|FG001|Overall Study|Lost to Follow-up|2
2327969|NCT03086343|4047680|FG000|Overall Study|Adverse Event|7
2327970|NCT03086343|4047681|FG001|Overall Study|Adverse Event|7
2327971|NCT03086343|4047680|FG000|Overall Study|Withdrawal by Subject|10
2327972|NCT03086343|4047681|FG001|Overall Study|Withdrawal by Subject|6
2327973|NCT03086343|4047680|FG000|Overall Study|Lost to Follow-up|3
2327974|NCT03086343|4047681|FG001|Overall Study|Lost to Follow-up|1
2327975|NCT03086343|4047680|FG000|Overall Study|Lack of Efficacy|4
2327976|NCT03086343|4047681|FG001|Overall Study|Lack of Efficacy|6
2327977|NCT03086343|4047680|FG000|Overall Study|Other, not specified|8
2327978|NCT03086343|4047681|FG001|Overall Study|Other, not specified|4
2327979|NCT03086343|4047680|FG000|Overall Study|Missing|0
2327980|NCT03086343|4047681|FG001|Overall Study|Missing|1
2327981|NCT03086447|4047702|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
2327982|NCT03086447|4047703|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
2327983|NCT03086447|4047702|FG000|Overall Study|Lost Lens|2
2327984|NCT03086447|4047703|FG001|Overall Study|Lost Lens|5
2327985|NCT03086447|4047702|FG000|Overall Study|Product quality complaint|0
2327986|NCT03086447|4047703|FG001|Overall Study|Product quality complaint|1
2327987|NCT03086447|4047702|FG000|Overall Study|Lens Damage|1
2327988|NCT03086447|4047703|FG001|Overall Study|Lens Damage|6
2327989|NCT03086447|4047702|FG000|Overall Study|Unsatisfactory Lens Fitting|0
2327990|NCT03086447|4047703|FG001|Overall Study|Unsatisfactory Lens Fitting|1
2327991|NCT03086447|4047702|FG000|Overall Study|Test Article No Longer Available|1
2327992|NCT03086447|4047703|FG001|Overall Study|Test Article No Longer Available|0
2327993|NCT03086447|4047702|FG000|Overall Study|Protocol Violation|2
2327994|NCT03086447|4047703|FG001|Overall Study|Protocol Violation|4
2327995|NCT03086447|4047702|FG000|Overall Study|Lost to Follow-up|0
2327996|NCT03086447|4047703|FG001|Overall Study|Lost to Follow-up|1
2327997|NCT03086447|4047702|FG000|Overall Study|Adverse Event|3
2327998|NCT03086447|4047703|FG001|Overall Study|Adverse Event|0
2327999|NCT03086447|4047702|FG000|Overall Study|Lens Discomfort|2
2328000|NCT03086447|4047703|FG001|Overall Study|Lens Discomfort|1
2328001|NCT03086460|4047709|FG000|Study Participants|Lost to Follow-up|2
2328002|NCT03086460|4047709|FG000|Study Participants|Protocol Violation|1
2328003|NCT03086460|4047709|FG000|Study Participants|Withdrawal by Subject|6
2328004|NCT03086460|4047709|FG000|Treatment A|Lost to Follow-up|1
2328005|NCT03086460|4047709|FG000|Treatment A|Protocol Violation|1
2328006|NCT03086460|4047709|FG000|Treatment A|Withdrawal by Subject|2
2328007|NCT03086460|4047709|FG000|Treatment C|Withdrawal by Subject|2
2328008|NCT03086460|4047709|FG000|Treatment E|Lost to Follow-up|1
2328009|NCT03086460|4047709|FG000|Treatment E|Withdrawal by Subject|3
2328010|NCT03086551|4047726|FG000|First Intervention|Failure to meet inclusion criterion|1
2328011|NCT03086551|4047727|FG001|First Intervention|Failure to meet inclusion criterion|0
2328012|NCT03086551|4047726|FG000|First Intervention|Lost to Follow-up|0
2328013|NCT03086551|4047727|FG001|First Intervention|Lost to Follow-up|1
2328014|NCT03086551|4047726|FG000|Washout|Lost to Follow-up|1
2328015|NCT03086551|4047727|FG001|Washout|Lost to Follow-up|2
2328016|NCT03086551|4047726|FG000|Washout|Withdrawal by Subject|2
2328017|NCT03086551|4047727|FG001|Washout|Withdrawal by Subject|1
2328018|NCT03087513|4047753|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2
2328019|NCT03087643|4047777|FG000|Overall Study|Withdrawal by Subject|2
2328020|NCT03087643|4047778|FG001|Overall Study|Withdrawal by Subject|4
2328021|NCT03087643|4047777|FG000|Overall Study|Death|2
2328022|NCT03087643|4047778|FG001|Overall Study|Death|2
2328023|NCT03087786|4047786|FG000|Overall Study|Withdrawal by Subject|2
2328024|NCT03087786|4047787|FG001|Overall Study|Withdrawal by Subject|0
2328025|NCT03087851|4047796|FG000|Overall Study|Withdraw on medical grounds|0
2328026|NCT03087851|4047797|FG001|Overall Study|Withdraw on medical grounds|1
2328027|NCT03087851|4047798|FG002|Overall Study|Withdraw on medical grounds|2
2328028|NCT03088917|4047854|FG000|Overall Study|In care/cured elsewhere|15
2328029|NCT03088917|4047854|FG000|Overall Study|Refuse re-evaluation|13
2328030|NCT03088917|4047854|FG000|Overall Study|Contact not established|13
2328031|NCT03088917|4047854|FG000|Overall Study|Severe comorbidity/short life expectancy|5
2328032|NCT03088917|4047854|FG000|Overall Study|Moved outside study region|50
2328033|NCT03089047|4047862|FG000|Overall Study|Lost to Follow-up|1
2328034|NCT03089047|4047863|FG001|Overall Study|Lost to Follow-up|0
2328035|NCT03089216|4047873|FG000|Overall Study|Adverse Event|0
2328036|NCT03089216|4047874|FG001|Overall Study|Adverse Event|0
2328037|NCT03089216|4047875|FG002|Overall Study|Adverse Event|0
2328038|NCT03089216|4047876|FG003|Overall Study|Adverse Event|1
2328039|NCT03089580|4047890|FG000|Overall Study|Lost to Follow-up|2
2328040|NCT03089697|4047898|FG000|Overall Study|Adverse Event|1
2328041|NCT03089697|4047899|FG001|Overall Study|Adverse Event|2
2328042|NCT03089697|4047898|FG000|Overall Study|Withdrawal by Subject|1
2328043|NCT03089697|4047899|FG001|Overall Study|Withdrawal by Subject|0
2328044|NCT03089853|4047907|FG000|Overall Study|Lost to Follow-up|2
2328045|NCT03089853|4047908|FG001|Overall Study|Lost to Follow-up|1
2328046|NCT03089944|4047928|FG000|Overall Study|Lost to Follow-up|8
2328047|NCT03089944|4047928|FG000|Overall Study|Withdrew Consent|2
2328048|NCT03089944|4047928|FG000|Overall Study|Adverse Event|1
2328049|NCT03089944|4047928|FG000|Overall Study|Other|1
2328050|NCT03090100|4047934|FG000|Overall Study|Adverse Event|9
2328051|NCT03090100|4047935|FG001|Overall Study|Adverse Event|11
2328052|NCT03090100|4047934|FG000|Overall Study|Pregnancy|1
2328053|NCT03090100|4047935|FG001|Overall Study|Pregnancy|1
2328054|NCT03090100|4047934|FG000|Overall Study|Lack of Efficacy|2
2328055|NCT03090100|4047935|FG001|Overall Study|Lack of Efficacy|7
2328056|NCT03090100|4047934|FG000|Overall Study|Lost to Follow-up|2
2328057|NCT03090100|4047935|FG001|Overall Study|Lost to Follow-up|2
2328058|NCT03090100|4047934|FG000|Overall Study|Withdrawal by Subject|7
2328059|NCT03090100|4047935|FG001|Overall Study|Withdrawal by Subject|19
2328060|NCT03090100|4047934|FG000|Overall Study|Protocol Violation|2
2328061|NCT03090100|4047935|FG001|Overall Study|Protocol Violation|6
2328062|NCT03090100|4047934|FG000|Overall Study|Non-compliance|2
2328063|NCT03090100|4047935|FG001|Overall Study|Non-compliance|0
2328064|NCT03090100|4047934|FG000|Overall Study|Other|2
2328065|NCT03090100|4047935|FG001|Overall Study|Other|2
2328066|NCT03091348|4047970|FG000|Overall Study|Lost to Follow-up|2
2328067|NCT03091348|4047971|FG001|Overall Study|Lost to Follow-up|1
2328068|NCT03091400|4047984|FG000|Washout - 2 Weeks|Withdrawal by Subject|1
2328069|NCT03091400|4047985|FG001|Washout - 2 Weeks|Withdrawal by Subject|0
2328070|NCT03091439|4047993|FG000|Overall Study|Study Terminated by the Sponsor|1
2328071|NCT03091439|4047994|FG001|Overall Study|Study Terminated by the Sponsor|0
2328072|NCT03091738|4048019|FG000|Overall Study|Adverse Event|1
2328073|NCT03091738|4048019|FG000|Overall Study|Lost to Follow-up|1
2328074|NCT03091777|4048030|FG000|Overall Study|Pregnancy|2
2328075|NCT03091777|4048031|FG001|Overall Study|Pregnancy|1
2328076|NCT03091777|4048032|FG002|Overall Study|Pregnancy|0
2328077|NCT03091777|4048030|FG000|Overall Study|Adverse Event|2
2328078|NCT03091777|4048031|FG001|Overall Study|Adverse Event|1
2328079|NCT03091777|4048032|FG002|Overall Study|Adverse Event|4
2328080|NCT03091777|4048030|FG000|Overall Study|Withdrawal by Subject|4
2328081|NCT03091777|4048031|FG001|Overall Study|Withdrawal by Subject|2
2328082|NCT03091777|4048032|FG002|Overall Study|Withdrawal by Subject|6
2328083|NCT03091777|4048030|FG000|Overall Study|Protocol Violation|2
2328084|NCT03091777|4048031|FG001|Overall Study|Protocol Violation|1
2328085|NCT03091777|4048032|FG002|Overall Study|Protocol Violation|1
2328086|NCT03091777|4048030|FG000|Overall Study|Lost to Follow-up|12
2328087|NCT03091777|4048031|FG001|Overall Study|Lost to Follow-up|14
2218189|NCT01713582|3861704|FG020|Overall Study|Disease progression|15
2218190|NCT01713582|3861684|FG000|Overall Study|Death|0
2328088|NCT03091777|4048032|FG002|Overall Study|Lost to Follow-up|7
2030961|NCT00381095|3600469|FG000|Overall Study|Lack of Efficacy|2
2030962|NCT00381095|3600470|FG001|Overall Study|Lack of Efficacy|4
2030963|NCT00381095|3600469|FG000|Overall Study|Other|2
2030964|NCT00381095|3600470|FG001|Overall Study|Other|2
2030965|NCT00381095|3600469|FG000|Overall Study|Protocol Violation|1
2030966|NCT00381095|3600470|FG001|Overall Study|Protocol Violation|1
2030967|NCT00381095|3600469|FG000|Overall Study|Withdrawal by Subject|3
2030968|NCT00381095|3600470|FG001|Overall Study|Withdrawal by Subject|3
2030969|NCT00381095|3600469|FG000|Overall Study|Adverse Event|2
2030970|NCT00381095|3600470|FG001|Overall Study|Adverse Event|7
2030971|NCT00381238|3600476|FG000|Overall Study|Adverse Event|3
2218191|NCT01713582|3861685|FG001|Overall Study|Death|0
2218192|NCT01713582|3861686|FG002|Overall Study|Death|0
2030972|NCT00381238|3600476|FG000|Overall Study|Protocol Violation|1
2030973|NCT00381238|3600476|FG000|Overall Study|Withdrawal by Subject|4
2030974|NCT00381238|3600476|FG000|Overall Study|Lack of Efficacy|2
2030975|NCT00381238|3600476|FG000|Overall Study|Withdrew by physician|1
2030976|NCT00381238|3600476|FG000|Overall Study|Disease progression|1
2030977|NCT00381303|3600482|FG000|Overall Study|Lost to Follow-up|25
2030978|NCT00381303|3600483|FG001|Overall Study|Lost to Follow-up|9
2328089|NCT03091777|4048030|FG000|Overall Study|Lack of Efficacy|0
2328090|NCT03091777|4048031|FG001|Overall Study|Lack of Efficacy|0
2328091|NCT03091777|4048032|FG002|Overall Study|Lack of Efficacy|5
2328092|NCT03091777|4048030|FG000|Overall Study|Noncompliance with study drug|2
2328093|NCT03091777|4048031|FG001|Overall Study|Noncompliance with study drug|3
2328094|NCT03091777|4048032|FG002|Overall Study|Noncompliance with study drug|1
2328095|NCT03091777|4048030|FG000|Overall Study|Physician Decision|1
2328096|NCT03091777|4048031|FG001|Overall Study|Physician Decision|0
2328097|NCT03091777|4048032|FG002|Overall Study|Physician Decision|1
2328098|NCT03091777|4048030|FG000|Overall Study|Abnormal Laboratory Value|7
2328099|NCT03091777|4048031|FG001|Overall Study|Abnormal Laboratory Value|11
2328100|NCT03091777|4048032|FG002|Overall Study|Abnormal Laboratory Value|12
2328101|NCT03091920|4048043|FG000|Overall Study|Adverse Event|0
2328102|NCT03091920|4048044|FG001|Overall Study|Adverse Event|1
2328103|NCT03091920|4048045|FG002|Overall Study|Adverse Event|0
2328104|NCT03092375|4048076|FG000|Overall Study|Lack of Efficacy|0
2328105|NCT03092375|4048077|FG001|Overall Study|Lack of Efficacy|1
2328106|NCT03092375|4048078|FG002|Overall Study|Lack of Efficacy|1
2328107|NCT03092375|4048079|FG003|Overall Study|Lack of Efficacy|0
2328108|NCT03092479|4048098|FG000|Overall Study|Lost to Follow-up|3
2328109|NCT03092479|4048099|FG001|Overall Study|Lost to Follow-up|2
2328110|NCT03092479|4048098|FG000|Overall Study|Withdrawal by Subject|4
2328111|NCT03092479|4048099|FG001|Overall Study|Withdrawal by Subject|0
2328112|NCT03092726|4048107|FG000|Overall Study|Adverse Event|3
2328113|NCT03092726|4048108|FG001|Overall Study|Adverse Event|10
2328114|NCT03092726|4048107|FG000|Overall Study|Lack of Efficacy|0
2328115|NCT03092726|4048108|FG001|Overall Study|Lack of Efficacy|1
2328116|NCT03092726|4048107|FG000|Overall Study|Lost to Follow-up|1
2328117|NCT03092726|4048108|FG001|Overall Study|Lost to Follow-up|0
2328118|NCT03092726|4048107|FG000|Overall Study|Withdrawal by Subject|5
2328119|NCT03092726|4048108|FG001|Overall Study|Withdrawal by Subject|3
2328120|NCT03092752|4048114|FG000|Overall Study|Aged <40 years|14209
2328121|NCT03092752|4048114|FG000|Overall Study|At least one claim with T2DM|61299
2328122|NCT03092752|4048114|FG000|Overall Study|Having no claim of study drugs|29282
2328123|NCT03092752|4048114|FG000|Overall Study|Average hospital visit interval >92 days|10779
2328124|NCT03092752|4048114|FG000|Overall Study|<6 month history|245900
2328125|NCT03092791|4048143|FG000|Overall Study|Lost to Follow-up|0
2328126|NCT03092791|4048144|FG001|Overall Study|Lost to Follow-up|0
2328127|NCT03092791|4048145|FG002|Overall Study|Lost to Follow-up|0
2328128|NCT03092791|4048146|FG003|Overall Study|Lost to Follow-up|0
2328129|NCT03092791|4048147|FG004|Overall Study|Lost to Follow-up|0
2328130|NCT03092791|4048148|FG005|Overall Study|Lost to Follow-up|0
2328131|NCT03092791|4048149|FG006|Overall Study|Lost to Follow-up|1
2328132|NCT03092791|4048150|FG007|Overall Study|Lost to Follow-up|0
2328133|NCT03092791|4048143|FG000|Overall Study|Withdrawal of Consent|0
2328134|NCT03092791|4048144|FG001|Overall Study|Withdrawal of Consent|0
2328135|NCT03092791|4048145|FG002|Overall Study|Withdrawal of Consent|0
2328136|NCT03092791|4048146|FG003|Overall Study|Withdrawal of Consent|0
2328137|NCT03092791|4048147|FG004|Overall Study|Withdrawal of Consent|4
2328138|NCT03092791|4048148|FG005|Overall Study|Withdrawal of Consent|12
2328139|NCT03092791|4048149|FG006|Overall Study|Withdrawal of Consent|6
2328140|NCT03092791|4048150|FG007|Overall Study|Withdrawal of Consent|4
2328141|NCT03092791|4048143|FG000|Overall Study|Study Termination|0
2328142|NCT03092791|4048144|FG001|Overall Study|Study Termination|0
2328143|NCT03092791|4048145|FG002|Overall Study|Study Termination|0
2328144|NCT03092791|4048146|FG003|Overall Study|Study Termination|0
2328145|NCT03092791|4048147|FG004|Overall Study|Study Termination|55
2328146|NCT03092791|4048148|FG005|Overall Study|Study Termination|46
2328147|NCT03092791|4048149|FG006|Overall Study|Study Termination|53
2328148|NCT03092791|4048150|FG007|Overall Study|Study Termination|55
2328149|NCT03092791|4048143|FG000|Overall Study|Death|0
2328150|NCT03092791|4048144|FG001|Overall Study|Death|0
2328151|NCT03092791|4048145|FG002|Overall Study|Death|0
2328152|NCT03092791|4048146|FG003|Overall Study|Death|0
2328153|NCT03092791|4048147|FG004|Overall Study|Death|0
2328154|NCT03092791|4048148|FG005|Overall Study|Death|1
2328155|NCT03092791|4048149|FG006|Overall Study|Death|0
2328156|NCT03092791|4048150|FG007|Overall Study|Death|1
2328157|NCT03092791|4048143|FG000|Overall Study|Reason Not Specified|0
2328158|NCT03092791|4048144|FG001|Overall Study|Reason Not Specified|0
2328159|NCT03092791|4048145|FG002|Overall Study|Reason Not Specified|0
2328160|NCT03092791|4048146|FG003|Overall Study|Reason Not Specified|0
2328161|NCT03092791|4048147|FG004|Overall Study|Reason Not Specified|1
2328162|NCT03092791|4048148|FG005|Overall Study|Reason Not Specified|1
2328163|NCT03092791|4048149|FG006|Overall Study|Reason Not Specified|0
2328164|NCT03092791|4048150|FG007|Overall Study|Reason Not Specified|0
2352493|NCT03777059|4101780|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
2352494|NCT03777059|4101777|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
2352495|NCT03777059|4101778|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
2352496|NCT03777059|4101779|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
2352497|NCT03777059|4101780|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
2352498|NCT03772522|4101792|FG000|Pre-intervention|Withdrawal by Subject|3
2352499|NCT03772522|4101793|FG001|Pre-intervention|Withdrawal by Subject|4
2352500|NCT03772522|4101792|FG000|Intervention|Withdrawal by Subject|1
2352501|NCT03772522|4101793|FG001|Intervention|Withdrawal by Subject|0
2352502|NCT03772522|4101792|FG000|Post-intervention Follow-up|Lost to Follow-up|1
2352503|NCT03772522|4101793|FG001|Post-intervention Follow-up|Lost to Follow-up|0
2352504|NCT03772327|4101805|FG000|Overall Study|Lost to Follow-up|3
2352505|NCT03772327|4101806|FG001|Overall Study|Lost to Follow-up|4
2352506|NCT03772327|4101805|FG000|Overall Study|Withdrawal by Subject|2
2352507|NCT03772327|4101806|FG001|Overall Study|Withdrawal by Subject|3
2352508|NCT03774576|4101816|FG000|Period 2|Adverse Event|1
2352509|NCT03772041|4101844|FG000|Overall Study|Adverse Event|8
2352510|NCT03772041|4101845|FG001|Overall Study|Adverse Event|3
2352511|NCT03772041|4101844|FG000|Overall Study|Withdrawal by Subject|0
2352512|NCT03772041|4101845|FG001|Overall Study|Withdrawal by Subject|2
2352513|NCT03772041|4101844|FG000|Overall Study|Protocol Violation|4
2352514|NCT03772041|4101845|FG001|Overall Study|Protocol Violation|2
2352515|NCT03772041|4101844|FG000|Overall Study|Physician Decision|2
2352516|NCT03772041|4101845|FG001|Overall Study|Physician Decision|3
2352517|NCT03775681|4101851|FG000|Overall Study|Physician Decision|3
2352518|NCT03774823|4101857|FG000|Overall Study|Withdrawal by Subject|1
2352519|NCT03774823|4101858|FG001|Overall Study|Withdrawal by Subject|1
2352520|NCT03774433|4101873|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14
2352521|NCT03769896|4101896|FG000|Open-label Phase|Lack of Efficacy|5
2352522|NCT03769896|4101897|FG001|Open-label Phase|Lack of Efficacy|0
2352523|NCT03769896|4101896|FG000|Open-label Phase|Adverse Event|3
2352524|NCT03769896|4101897|FG001|Open-label Phase|Adverse Event|0
2352525|NCT03769896|4101896|FG000|Open-label Phase|Withdrawal by Subject|1
2352526|NCT03769896|4101897|FG001|Open-label Phase|Withdrawal by Subject|0
2352527|NCT03769649|4101904|FG000|Overall Study|Lost to Follow-up|4
2352528|NCT03768726|4101918|FG000|Treatment Phase|Adverse Event|2
2328165|NCT03093181|4048210|FG000|Overall Study|Withdrawal by Subject|2
2328166|NCT03093181|4048211|FG001|Overall Study|Withdrawal by Subject|1
2328167|NCT03093181|4048212|FG002|Overall Study|Withdrawal by Subject|2
2328168|NCT03093181|4048210|FG000|Overall Study|Other (Not specified)|1
2328169|NCT03093181|4048211|FG001|Overall Study|Other (Not specified)|0
2328170|NCT03093181|4048212|FG002|Overall Study|Other (Not specified)|0
2328171|NCT03093181|4048210|FG000|Overall Study|Adverse Event|0
2328172|NCT03093181|4048211|FG001|Overall Study|Adverse Event|1
2328173|NCT03093181|4048212|FG002|Overall Study|Adverse Event|0
2328174|NCT03093181|4048210|FG000|Overall Study|Other (Protocol violation)|0
2328175|NCT03093181|4048211|FG001|Overall Study|Other (Protocol violation)|0
2328176|NCT03093181|4048212|FG002|Overall Study|Other (Protocol violation)|1
2328177|NCT03093324|4048235|FG000|Overall Study|Adverse Event|4
2328178|NCT03093324|4048236|FG001|Overall Study|Adverse Event|15
2328179|NCT03093324|4048235|FG000|Overall Study|Lost to Follow-up|1
2328180|NCT03093324|4048236|FG001|Overall Study|Lost to Follow-up|0
2328181|NCT03093324|4048235|FG000|Overall Study|Protocol Deviation|2
2328182|NCT03093324|4048236|FG001|Overall Study|Protocol Deviation|2
2328183|NCT03093324|4048235|FG000|Overall Study|Withdrawal by Subject|2
2328184|NCT03093324|4048236|FG001|Overall Study|Withdrawal by Subject|2
2328185|NCT03093350|4048242|FG000|Overall Study|Death|1
2328186|NCT03093350|4048242|FG000|Overall Study|Signed consent, never began treartment|1
2328187|NCT03093415|4048249|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17
2328188|NCT03093415|4048250|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36
2328189|NCT03093415|4048251|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0
2328190|NCT03093415|4048249|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40
2328191|NCT03093415|4048250|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
2328192|NCT03093415|4048251|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
2328193|NCT03093415|4048249|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28
2328194|NCT03093415|4048250|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6
2328195|NCT03093415|4048251|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0
2328196|NCT03093415|4048249|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
2328197|NCT03093415|4048250|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12
2328198|NCT03093415|4048251|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
2328199|NCT03093415|4048249|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18
2328200|NCT03093415|4048250|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12
2328201|NCT03093415|4048251|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0
2328202|NCT03093415|4048249|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
2328203|NCT03093415|4048250|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
2328204|NCT03093415|4048251|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0
2328205|NCT03093415|4048249|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15
2328206|NCT03093415|4048250|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32
2328207|NCT03093415|4048251|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0
2328208|NCT03093415|4048249|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5
2328209|NCT03093415|4048250|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3
2328210|NCT03093415|4048251|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0
2328211|NCT03093415|4048249|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4
2328212|NCT03093415|4048250|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2
2328213|NCT03093415|4048251|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0
2328214|NCT03093415|4048249|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9
2328215|NCT03093415|4048250|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3
2328216|NCT03093415|4048251|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0
2328217|NCT03093415|4048249|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1
2328218|NCT03093415|4048250|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8
2328219|NCT03093415|4048251|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3
2328220|NCT03093454|4048261|FG000|Overall Study|Withdrawal by Subject|1
2328221|NCT03093454|4048262|FG001|Overall Study|Withdrawal by Subject|1
2328222|NCT03093454|4048261|FG000|Overall Study|Scheduling conflict|3
2328223|NCT03093454|4048262|FG001|Overall Study|Scheduling conflict|1
2328224|NCT03093454|4048261|FG000|Overall Study|Physician Decision|2
2328225|NCT03093454|4048262|FG001|Overall Study|Physician Decision|1
2328226|NCT03093870|4048284|FG000|Overall Study|Withdrawal by Subject|2
2328227|NCT03093870|4048285|FG001|Overall Study|Withdrawal by Subject|6
2328228|NCT03093870|4048286|FG002|Overall Study|Withdrawal by Subject|5
2328229|NCT03093870|4048284|FG000|Overall Study|Death|1
2328230|NCT03093870|4048285|FG001|Overall Study|Death|35
2328231|NCT03093870|4048286|FG002|Overall Study|Death|35
2328232|NCT03093870|4048284|FG000|Overall Study|Radiographic disease progression|10
2328233|NCT03093870|4048285|FG001|Overall Study|Radiographic disease progression|0
2328234|NCT03093870|4048286|FG002|Overall Study|Radiographic disease progression|0
2328235|NCT03093870|4048284|FG000|Overall Study|Clinical disease progression|1
2328236|NCT03093870|4048285|FG001|Overall Study|Clinical disease progression|0
2328237|NCT03093870|4048286|FG002|Overall Study|Clinical disease progression|0
2328238|NCT03093870|4048284|FG000|Overall Study|Physician Decision|2
2328239|NCT03093870|4048285|FG001|Overall Study|Physician Decision|0
2328240|NCT03093870|4048286|FG002|Overall Study|Physician Decision|0
2328241|NCT03093870|4048284|FG000|Overall Study|Adverse Event|7
2328242|NCT03093870|4048285|FG001|Overall Study|Adverse Event|0
2328243|NCT03093870|4048286|FG002|Overall Study|Adverse Event|0
2328244|NCT03093870|4048284|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1
2328245|NCT03093870|4048285|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
2328246|NCT03093870|4048286|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
2328247|NCT03093870|4048284|FG000|Overall Study|Lost to Follow-up|0
2328248|NCT03093870|4048285|FG001|Overall Study|Lost to Follow-up|0
2328249|NCT03093870|4048286|FG002|Overall Study|Lost to Follow-up|1
2328250|NCT03094195|4048297|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
2328251|NCT03094195|4048298|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
2328252|NCT03094195|4048299|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
2328253|NCT03094195|4048300|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2328254|NCT03094195|4048301|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2328255|NCT03094195|4048302|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2328256|NCT03094195|4048303|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2328257|NCT03094195|4048304|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2328258|NCT03094195|4048297|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
2328259|NCT03094195|4048298|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2
2328260|NCT03094195|4048299|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1
2328261|NCT03094195|4048300|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
2328262|NCT03094195|4048301|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
2328263|NCT03094195|4048302|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0
2328264|NCT03094195|4048303|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0
2328265|NCT03094195|4048304|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0
2328266|NCT03094195|4048297|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0
2328267|NCT03094195|4048298|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0
2328268|NCT03094195|4048299|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1
2328269|NCT03094195|4048300|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
2328270|NCT03094195|4048301|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
2328271|NCT03094195|4048302|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0
2328272|NCT03094195|4048303|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0
2328273|NCT03094195|4048304|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0
2328274|NCT03094195|4048297|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2328275|NCT03094195|4048298|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
2328276|NCT03094195|4048299|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
2328277|NCT03094195|4048300|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2328278|NCT03094195|4048301|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2328279|NCT03094195|4048302|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2352529|NCT03768726|4101919|FG001|Treatment Phase|Adverse Event|2
2352530|NCT03768726|4101918|FG000|Treatment Phase|Lost to Follow-up|1
2352531|NCT03768726|4101919|FG001|Treatment Phase|Lost to Follow-up|0
2030979|NCT00381303|3600482|FG000|Overall Study|AE/HIV-related event|22
2030980|NCT00381303|3600483|FG001|Overall Study|AE/HIV-related event|6
2030981|NCT00381303|3600482|FG000|Overall Study|Non-Adherence|13
2030982|NCT00381303|3600483|FG001|Overall Study|Non-Adherence|6
2030983|NCT00381303|3600482|FG000|Overall Study|Withdrawal by Subject|13
2030984|NCT00381303|3600483|FG001|Overall Study|Withdrawal by Subject|6
2030985|NCT00381303|3600482|FG000|Overall Study|Virologic failure|6
2030986|NCT00381303|3600483|FG001|Overall Study|Virologic failure|4
2030987|NCT00381303|3600482|FG000|Overall Study|Ineligible to continue the trial|2
2030988|NCT00381303|3600483|FG001|Overall Study|Ineligible to continue the trial|1
2030989|NCT00381303|3600482|FG000|Overall Study|Pregnancy|2
2030990|NCT00381303|3600483|FG001|Overall Study|Pregnancy|0
2110511|NCT00895947|3705330|FG001|Overall Study|Protocol Violation|2
2110512|NCT00895947|3705329|FG000|Overall Study|Withdrawal by Subject|2
2110513|NCT00895947|3705330|FG001|Overall Study|Withdrawal by Subject|0
2110514|NCT00896051|3705356|FG000|Overall Study|Adverse Event|2
2110515|NCT00896051|3705357|FG001|Overall Study|Adverse Event|1
2110516|NCT00896051|3705356|FG000|Overall Study|Lost to Follow-up|3
2110517|NCT00896051|3705357|FG001|Overall Study|Lost to Follow-up|2
2110518|NCT00896051|3705356|FG000|Overall Study|Withdrawal by Subject|3
2110519|NCT00896051|3705357|FG001|Overall Study|Withdrawal by Subject|2
2110520|NCT00896051|3705356|FG000|Overall Study|Subject noncompliant|1
2110521|NCT00896051|3705357|FG001|Overall Study|Subject noncompliant|3
2110522|NCT00896051|3705356|FG000|Overall Study|Other|1
2110523|NCT00896051|3705357|FG001|Overall Study|Other|1
2110524|NCT00896168|3705383|FG000|Overall Study|Adverse Event|4
2110525|NCT00896168|3705384|FG001|Overall Study|Adverse Event|7
2110526|NCT00896168|3705383|FG000|Overall Study|Treatment failure|8
2110527|NCT00896168|3705384|FG001|Overall Study|Treatment failure|10
2110528|NCT00896168|3705383|FG000|Overall Study|Lost to Follow-up|1
2110529|NCT00896168|3705384|FG001|Overall Study|Lost to Follow-up|1
2110530|NCT00896168|3705383|FG000|Overall Study|Other|1
2110531|NCT00896168|3705384|FG001|Overall Study|Other|1
2110532|NCT00896233|3705394|FG000|Overall Study|Claustrophobia during MRI|1
2110533|NCT00896337|3705408|FG000|Overall Study|Death|7
2110534|NCT00896337|3705408|FG000|Overall Study|Withdrawal by Subject|7
2110535|NCT00896337|3705408|FG000|Overall Study|Lost to Follow-up|11
2110536|NCT00896363|3705420|FG000|Overall Study|Adverse Event|3
2110537|NCT00896363|3705421|FG001|Overall Study|Adverse Event|4
2110538|NCT00896363|3705422|FG002|Overall Study|Adverse Event|2
2110539|NCT00896363|3705420|FG000|Overall Study|Lack of Efficacy|0
2110540|NCT00896363|3705421|FG001|Overall Study|Lack of Efficacy|2
2110541|NCT00896363|3705422|FG002|Overall Study|Lack of Efficacy|1
2110542|NCT00896363|3705420|FG000|Overall Study|Withdrawal by Subject|3
2110543|NCT00896363|3705421|FG001|Overall Study|Withdrawal by Subject|5
2110544|NCT00896363|3705422|FG002|Overall Study|Withdrawal by Subject|5
2110545|NCT00896454|3705447|FG000|Overall Study|Death|10
2110546|NCT00896454|3705447|FG000|Overall Study|Adverse Event|8
2110547|NCT00896454|3705447|FG000|Overall Study|Disease Progression|5
2110548|NCT00896454|3705447|FG000|Overall Study|Other|4
2110549|NCT00896454|3705447|FG000|Overall Study|Requirement for alternative therapy|3
2110550|NCT00896454|3705447|FG000|Overall Study|Ongoing in study|2
2110551|NCT00896454|3705447|FG000|Overall Study|Withdrawal by Subject|1
2110552|NCT00896480|3705451|FG000|Overall Study|Disease progression/recurrence|21
2030991|NCT00381303|3600482|FG000|Overall Study|Physician Decision|1
2110553|NCT00896532|3705466|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2352532|NCT03768726|4101918|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2
2352533|NCT03768726|4101919|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0
2352534|NCT03768726|4101918|FG000|Treatment Phase|Withdrawal by Subject|3
2352535|NCT03768726|4101919|FG001|Treatment Phase|Withdrawal by Subject|1
2352536|NCT03768726|4101918|FG000|Follow-Up|Adverse Event|2
2328280|NCT03094195|4048303|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2328281|NCT03094195|4048304|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2328282|NCT03094611|4048328|FG000|Overall Study|Lack of Efficacy|1
2328283|NCT03094611|4048328|FG000|Overall Study|Stem Cell Transplant|1
2328284|NCT03095027|4048351|FG000|Period 2, Second Week of Wear|Adverse Event|1
2328285|NCT03095027|4048352|FG001|Period 2, Second Week of Wear|Adverse Event|0
2328286|NCT03095118|4048367|FG000|Overall Study|Adverse Event|1
2328287|NCT03095118|4048367|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1
2328288|NCT03095508|4048373|FG000|Overall Study|Adverse Event|0
2328289|NCT03095508|4048374|FG001|Overall Study|Adverse Event|1
2328290|NCT03095521|4048382|FG000|Overall Study|Withdrawal by Subject|0
2328291|NCT03095521|4048383|FG001|Overall Study|Withdrawal by Subject|1
2328292|NCT03095521|4048382|FG000|Overall Study|Lost to Follow-up|0
2328293|NCT03095521|4048383|FG001|Overall Study|Lost to Follow-up|1
2328294|NCT03095599|4048391|FG000|Overall Study|Withdrawal by Subject|1
2328295|NCT03095599|4048392|FG001|Overall Study|Withdrawal by Subject|0
2328296|NCT03095599|4048391|FG000|Overall Study|Lost to Follow-up|1
2328297|NCT03095599|4048392|FG001|Overall Study|Lost to Follow-up|0
2328298|NCT03095599|4048391|FG000|Overall Study|Withdrawal prior to vaccination|1
2328299|NCT03095599|4048392|FG001|Overall Study|Withdrawal prior to vaccination|0
2328300|NCT03095651|4048437|FG000|Overall Study|Lost to Follow-up|1
2328301|NCT03095651|4048438|FG001|Overall Study|Lost to Follow-up|1
2328302|NCT03095651|4048439|FG002|Overall Study|Lost to Follow-up|0
2328303|NCT03095651|4048440|FG003|Overall Study|Lost to Follow-up|1
2328304|NCT03095651|4048441|FG004|Overall Study|Lost to Follow-up|0
2328305|NCT03095651|4048442|FG005|Overall Study|Lost to Follow-up|0
2328306|NCT03095651|4048443|FG006|Overall Study|Lost to Follow-up|0
2328307|NCT03095651|4048444|FG007|Overall Study|Lost to Follow-up|0
2328308|NCT03095651|4048437|FG000|Overall Study|Withdrawal by Subject|0
2328309|NCT03095651|4048438|FG001|Overall Study|Withdrawal by Subject|0
2328310|NCT03095651|4048439|FG002|Overall Study|Withdrawal by Subject|0
2328311|NCT03095651|4048440|FG003|Overall Study|Withdrawal by Subject|0
2328312|NCT03095651|4048441|FG004|Overall Study|Withdrawal by Subject|0
2328313|NCT03095651|4048442|FG005|Overall Study|Withdrawal by Subject|1
2328314|NCT03095651|4048443|FG006|Overall Study|Withdrawal by Subject|0
2328315|NCT03095651|4048444|FG007|Overall Study|Withdrawal by Subject|0
2328316|NCT03096314|4048472|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9
2328317|NCT03096314|4048473|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12
2328318|NCT03096483|4048500|FG000|Overall Study|Withdrawal by site|1
2328319|NCT03096847|4048528|FG000|Overall Study|Other|2
2328320|NCT03096847|4048529|FG001|Overall Study|Other|1
2328321|NCT03096847|4048530|FG002|Overall Study|Other|2
2328322|NCT03096847|4048528|FG000|Overall Study|Lost to Follow-up|1
2328323|NCT03096847|4048529|FG001|Overall Study|Lost to Follow-up|0
2328324|NCT03096847|4048530|FG002|Overall Study|Lost to Follow-up|1
2328325|NCT03096847|4048528|FG000|Overall Study|Death|6
2328326|NCT03096847|4048529|FG001|Overall Study|Death|0
2328327|NCT03096847|4048530|FG002|Overall Study|Death|2
2328328|NCT03096847|4048528|FG000|Overall Study|Protocol Violation|3
2328329|NCT03096847|4048529|FG001|Overall Study|Protocol Violation|0
2328330|NCT03096847|4048530|FG002|Overall Study|Protocol Violation|6
2328331|NCT03096847|4048528|FG000|Overall Study|Physician Decision|12
2328332|NCT03096847|4048529|FG001|Overall Study|Physician Decision|2
2328333|NCT03096847|4048530|FG002|Overall Study|Physician Decision|8
2328334|NCT03096847|4048528|FG000|Overall Study|Withdrawal by Subject|24
2328335|NCT03096847|4048529|FG001|Overall Study|Withdrawal by Subject|1
2328336|NCT03096847|4048530|FG002|Overall Study|Withdrawal by Subject|12
2328337|NCT03096847|4048528|FG000|Overall Study|Adverse Event|72
2328338|NCT03096847|4048529|FG001|Overall Study|Adverse Event|6
2328339|NCT03096847|4048530|FG002|Overall Study|Adverse Event|28
2328340|NCT03096847|4048528|FG000|Overall Study|Progressive disease|97
2328341|NCT03096847|4048529|FG001|Overall Study|Progressive disease|10
2328342|NCT03096847|4048530|FG002|Overall Study|Progressive disease|78
2328343|NCT03096847|4048528|FG000|Overall Study|Non-compliance with study medication|1
2328344|NCT03096847|4048529|FG001|Overall Study|Non-compliance with study medication|0
2218193|NCT01713582|3861687|FG003|Overall Study|Death|1
2218194|NCT01713582|3861688|FG004|Overall Study|Death|1
2218195|NCT01713582|3861689|FG005|Overall Study|Death|3
2218196|NCT01713582|3861690|FG006|Overall Study|Death|3
2218197|NCT01713582|3861691|FG007|Overall Study|Death|2
2218198|NCT01713582|3861692|FG008|Overall Study|Death|3
2218199|NCT01713582|3861693|FG009|Overall Study|Death|4
2218200|NCT01713582|3861694|FG010|Overall Study|Death|3
2218201|NCT01713582|3861695|FG011|Overall Study|Death|0
2218202|NCT01713582|3861696|FG012|Overall Study|Death|0
2218203|NCT01713582|3861697|FG013|Overall Study|Death|0
2218204|NCT01713582|3861698|FG014|Overall Study|Death|0
2218205|NCT01713582|3861699|FG015|Overall Study|Death|0
2218206|NCT01713582|3861700|FG016|Overall Study|Death|0
2328345|NCT03096847|4048530|FG002|Overall Study|Non-compliance with study medication|0
2328346|NCT03096847|4048528|FG000|Overall Study|New therapy for study indication|1
2328347|NCT03096847|4048529|FG001|Overall Study|New therapy for study indication|0
2328348|NCT03096847|4048530|FG002|Overall Study|New therapy for study indication|1
2328349|NCT03097029|4048557|FG000|Overall Study|Withdrawal by Subject|1
2328350|NCT03097133|4048563|FG000|Overall Study|Lost to Follow-up|3
2328351|NCT03097133|4048564|FG001|Overall Study|Lost to Follow-up|2
2328352|NCT03097133|4048563|FG000|Overall Study|Withdrawal by Subject|2
2328353|NCT03097133|4048564|FG001|Overall Study|Withdrawal by Subject|5
2328354|NCT03097133|4048563|FG000|Overall Study|Discontinued DB, not entered FU Phase|21
2328355|NCT03097133|4048564|FG001|Overall Study|Discontinued DB, not entered FU Phase|25
2328356|NCT03097133|4048563|FG000|Overall Study|Other|3
2328357|NCT03097133|4048564|FG001|Overall Study|Other|2
2328358|NCT03097133|4048563|FG000|Overall Study|Adverse Event|1
2328359|NCT03097133|4048564|FG001|Overall Study|Adverse Event|0
2328360|NCT03097289|4048570|FG000|Overall Study|Adverse Event|1
2328361|NCT03097289|4048570|FG000|Overall Study|Equipment failure|2
2328362|NCT03097289|4048570|FG000|Overall Study|Collected platelet product unusable|3
2328363|NCT03097315|4048575|FG000|Overall Study|Withdrawal by Subject|1
2328364|NCT03097588|4048609|FG000|Overall Study|Adverse Event|1
2328365|NCT03097614|4048613|FG000|Overall Study|Adverse Event|3
2328366|NCT03097861|4048638|FG000|Overall Study|Adverse Event|3
2328367|NCT03097861|4048639|FG001|Overall Study|Adverse Event|8
2328368|NCT03097861|4048640|FG002|Overall Study|Adverse Event|4
2328369|NCT03097861|4048638|FG000|Overall Study|Investigator Decision|0
2328370|NCT03097861|4048639|FG001|Overall Study|Investigator Decision|1
2328371|NCT03097861|4048640|FG002|Overall Study|Investigator Decision|0
2328372|NCT03097861|4048638|FG000|Overall Study|Lost to Follow-up|0
2328373|NCT03097861|4048639|FG001|Overall Study|Lost to Follow-up|7
2328374|NCT03097861|4048640|FG002|Overall Study|Lost to Follow-up|1
2328375|NCT03097861|4048638|FG000|Overall Study|Withdrawal by Subject|1
2328376|NCT03097861|4048639|FG001|Overall Study|Withdrawal by Subject|5
2328377|NCT03097861|4048640|FG002|Overall Study|Withdrawal by Subject|3
2328378|NCT03097861|4048638|FG000|Overall Study|Reason not provided|3
2328379|NCT03097861|4048639|FG001|Overall Study|Reason not provided|1
2328380|NCT03097861|4048640|FG002|Overall Study|Reason not provided|1
2328381|NCT03098030|4048654|FG000|Overall Study|Death|10
2328382|NCT03098030|4048655|FG001|Overall Study|Death|156
2328383|NCT03098030|4048656|FG002|Overall Study|Death|156
2328384|NCT03098030|4048657|FG003|Overall Study|Death|82
2328385|NCT03098030|4048654|FG000|Overall Study|Withdrawal by Subject|0
2328386|NCT03098030|4048655|FG001|Overall Study|Withdrawal by Subject|7
2328387|NCT03098030|4048656|FG002|Overall Study|Withdrawal by Subject|8
2328388|NCT03098030|4048657|FG003|Overall Study|Withdrawal by Subject|2
2328389|NCT03098030|4048654|FG000|Overall Study|Lost to Follow-up|0
2328390|NCT03098030|4048655|FG001|Overall Study|Lost to Follow-up|0
2328391|NCT03098030|4048656|FG002|Overall Study|Lost to Follow-up|2
2328392|NCT03098030|4048657|FG003|Overall Study|Lost to Follow-up|1
2328393|NCT03098433|4048690|FG000|Overall Study|Withdrawal by Subject|10
2328394|NCT03098550|4048698|FG000|Overall Study|Disease Progression|30
2328395|NCT03098550|4048699|FG001|Overall Study|Disease Progression|19
2328396|NCT03098550|4048700|FG002|Overall Study|Disease Progression|41
2328397|NCT03098550|4048698|FG000|Overall Study|Study Drug Toxicity|2
2328398|NCT03098550|4048699|FG001|Overall Study|Study Drug Toxicity|1
2328399|NCT03098550|4048700|FG002|Overall Study|Study Drug Toxicity|0
2328400|NCT03098550|4048698|FG000|Overall Study|Death|1
2328401|NCT03098550|4048699|FG001|Overall Study|Death|0
2328402|NCT03098550|4048700|FG002|Overall Study|Death|0
2328403|NCT03098550|4048698|FG000|Overall Study|Adverse Event unrelated to Study Drug|6
2328404|NCT03098550|4048699|FG001|Overall Study|Adverse Event unrelated to Study Drug|0
2328405|NCT03098550|4048700|FG002|Overall Study|Adverse Event unrelated to Study Drug|1
2328406|NCT03098550|4048698|FG000|Overall Study|Administrative reason by sponsor|0
2328407|NCT03098550|4048699|FG001|Overall Study|Administrative reason by sponsor|0
2328408|NCT03098550|4048700|FG002|Overall Study|Administrative reason by sponsor|1
2328409|NCT03098550|4048698|FG000|Overall Study|Other reasons|2
2328410|NCT03098550|4048699|FG001|Overall Study|Other reasons|0
2328411|NCT03098550|4048700|FG002|Overall Study|Other reasons|0
2328412|NCT03098979|4048745|FG000|Overall Study|Adverse Event|1
2328413|NCT03098979|4048746|FG001|Overall Study|Adverse Event|0
2328414|NCT03098979|4048747|FG002|Overall Study|Adverse Event|1
2328415|NCT03098979|4048748|FG003|Overall Study|Adverse Event|4
2328416|NCT03098979|4048749|FG004|Overall Study|Adverse Event|6
2328417|NCT03098979|4048750|FG005|Overall Study|Adverse Event|1
2328418|NCT03098979|4048745|FG000|Overall Study|Withdrawal by Subject|2
2328419|NCT03098979|4048746|FG001|Overall Study|Withdrawal by Subject|1
2328420|NCT03098979|4048747|FG002|Overall Study|Withdrawal by Subject|1
2328421|NCT03098979|4048748|FG003|Overall Study|Withdrawal by Subject|1
2328422|NCT03098979|4048749|FG004|Overall Study|Withdrawal by Subject|2
2328423|NCT03098979|4048750|FG005|Overall Study|Withdrawal by Subject|1
2328424|NCT03098979|4048745|FG000|Overall Study|Death|1
2328425|NCT03098979|4048746|FG001|Overall Study|Death|0
2328426|NCT03098979|4048747|FG002|Overall Study|Death|2
2328427|NCT03098979|4048748|FG003|Overall Study|Death|0
2328428|NCT03098979|4048749|FG004|Overall Study|Death|1
2328429|NCT03098979|4048750|FG005|Overall Study|Death|0
2328430|NCT03098979|4048745|FG000|Overall Study|Physician Decision|2
2328431|NCT03098979|4048746|FG001|Overall Study|Physician Decision|1
2328432|NCT03098979|4048747|FG002|Overall Study|Physician Decision|0
2328433|NCT03098979|4048748|FG003|Overall Study|Physician Decision|0
2328434|NCT03098979|4048749|FG004|Overall Study|Physician Decision|0
2328435|NCT03098979|4048750|FG005|Overall Study|Physician Decision|0
2328436|NCT03098979|4048745|FG000|Overall Study|Non-compliance|0
2328437|NCT03098979|4048746|FG001|Overall Study|Non-compliance|0
2328438|NCT03098979|4048747|FG002|Overall Study|Non-compliance|0
2328439|NCT03098979|4048748|FG003|Overall Study|Non-compliance|0
2328440|NCT03098979|4048749|FG004|Overall Study|Non-compliance|0
2328441|NCT03098979|4048750|FG005|Overall Study|Non-compliance|1
2328442|NCT03098979|4048745|FG000|Overall Study|Protocol Violation|0
2328443|NCT03098979|4048746|FG001|Overall Study|Protocol Violation|0
2328444|NCT03098979|4048747|FG002|Overall Study|Protocol Violation|0
2328445|NCT03098979|4048748|FG003|Overall Study|Protocol Violation|0
2328446|NCT03098979|4048749|FG004|Overall Study|Protocol Violation|0
2328447|NCT03098979|4048750|FG005|Overall Study|Protocol Violation|1
2328448|NCT03099096|4048764|FG000|Overall Study|Adverse Event|1
2328449|NCT03099096|4048764|FG000|Overall Study|Physician Decision|1
2328450|NCT03099161|4048771|FG000|Overall Study|Adverse Event|0
2328451|NCT03099161|4048772|FG001|Overall Study|Adverse Event|0
2328452|NCT03099161|4048773|FG002|Overall Study|Adverse Event|2
2328453|NCT03099161|4048771|FG000|Overall Study|Physician Decision|2
2328454|NCT03099161|4048772|FG001|Overall Study|Physician Decision|0
2328455|NCT03099161|4048773|FG002|Overall Study|Physician Decision|0
2328456|NCT03099161|4048771|FG000|Overall Study|Progressive Disease|1
2328457|NCT03099161|4048772|FG001|Overall Study|Progressive Disease|4
2328458|NCT03099161|4048773|FG002|Overall Study|Progressive Disease|1
2328459|NCT03099187|4048783|FG000|Double-blind Treatment|Adverse Event|19
2328460|NCT03099187|4048784|FG001|Double-blind Treatment|Adverse Event|1
2328461|NCT03099187|4048785|FG002|Double-blind Treatment|Adverse Event|0
2328462|NCT03099187|4048786|FG003|Double-blind Treatment|Adverse Event|0
2328463|NCT03099187|4048783|FG000|Double-blind Treatment|Death|1
2328464|NCT03099187|4048784|FG001|Double-blind Treatment|Death|3
2328465|NCT03099187|4048785|FG002|Double-blind Treatment|Death|0
2328466|NCT03099187|4048786|FG003|Double-blind Treatment|Death|0
2328467|NCT03099187|4048783|FG000|Double-blind Treatment|Lack of Efficacy|1
2328468|NCT03099187|4048784|FG001|Double-blind Treatment|Lack of Efficacy|0
2328469|NCT03099187|4048785|FG002|Double-blind Treatment|Lack of Efficacy|0
2328470|NCT03099187|4048786|FG003|Double-blind Treatment|Lack of Efficacy|0
2328471|NCT03099187|4048783|FG000|Double-blind Treatment|Physician Decision|2
2328472|NCT03099187|4048784|FG001|Double-blind Treatment|Physician Decision|1
2328473|NCT03099187|4048785|FG002|Double-blind Treatment|Physician Decision|0
2328474|NCT03099187|4048786|FG003|Double-blind Treatment|Physician Decision|0
2328475|NCT03099187|4048783|FG000|Double-blind Treatment|Withdrawal by Subject|9
2328476|NCT03099187|4048784|FG001|Double-blind Treatment|Withdrawal by Subject|4
2328477|NCT03099187|4048785|FG002|Double-blind Treatment|Withdrawal by Subject|0
2328478|NCT03099187|4048786|FG003|Double-blind Treatment|Withdrawal by Subject|0
2328479|NCT03099187|4048783|FG000|Double-blind Treatment|Lung transplantation|0
2328480|NCT03099187|4048784|FG001|Double-blind Treatment|Lung transplantation|1
2328481|NCT03099187|4048785|FG002|Double-blind Treatment|Lung transplantation|0
2328482|NCT03099187|4048786|FG003|Double-blind Treatment|Lung transplantation|0
2328483|NCT03099187|4048783|FG000|Double-blind Treatment|Non-compliance with study drug|0
2328484|NCT03099187|4048784|FG001|Double-blind Treatment|Non-compliance with study drug|2
2328485|NCT03099187|4048785|FG002|Double-blind Treatment|Non-compliance with study drug|0
2328486|NCT03099187|4048786|FG003|Double-blind Treatment|Non-compliance with study drug|0
2328487|NCT03099187|4048783|FG000|Double-blind Treatment|Disease progression|0
2328488|NCT03099187|4048784|FG001|Double-blind Treatment|Disease progression|1
2328489|NCT03099187|4048785|FG002|Double-blind Treatment|Disease progression|0
2328490|NCT03099187|4048786|FG003|Double-blind Treatment|Disease progression|0
2328491|NCT03099187|4048783|FG000|Double-blind Treatment|Randomization error|0
2328492|NCT03099187|4048784|FG001|Double-blind Treatment|Randomization error|2
2328493|NCT03099187|4048785|FG002|Double-blind Treatment|Randomization error|0
2328494|NCT03099187|4048786|FG003|Double-blind Treatment|Randomization error|0
2328495|NCT03099187|4048783|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1
2328496|NCT03099187|4048784|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1
2328497|NCT03099187|4048785|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0
2328498|NCT03099187|4048786|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0
2328499|NCT03099187|4048783|FG000|12-month Safety Follow-up|Adverse Event|0
2328500|NCT03099187|4048784|FG001|12-month Safety Follow-up|Adverse Event|0
2328501|NCT03099187|4048785|FG002|12-month Safety Follow-up|Adverse Event|5
2328502|NCT03099187|4048786|FG003|12-month Safety Follow-up|Adverse Event|12
2328503|NCT03099187|4048783|FG000|12-month Safety Follow-up|Death|0
2328504|NCT03099187|4048784|FG001|12-month Safety Follow-up|Death|0
2328505|NCT03099187|4048785|FG002|12-month Safety Follow-up|Death|7
2328506|NCT03099187|4048786|FG003|12-month Safety Follow-up|Death|9
2328507|NCT03099187|4048783|FG000|12-month Safety Follow-up|Lung transplantation|0
2328508|NCT03099187|4048784|FG001|12-month Safety Follow-up|Lung transplantation|0
2328509|NCT03099187|4048785|FG002|12-month Safety Follow-up|Lung transplantation|2
2328510|NCT03099187|4048786|FG003|12-month Safety Follow-up|Lung transplantation|1
2328511|NCT03099187|4048783|FG000|12-month Safety Follow-up|Lost to Follow-up|0
2328512|NCT03099187|4048784|FG001|12-month Safety Follow-up|Lost to Follow-up|0
2328513|NCT03099187|4048785|FG002|12-month Safety Follow-up|Lost to Follow-up|1
2328514|NCT03099187|4048786|FG003|12-month Safety Follow-up|Lost to Follow-up|0
2328515|NCT03099187|4048783|FG000|12-month Safety Follow-up|Symptomatic deterioration|0
2328516|NCT03099187|4048784|FG001|12-month Safety Follow-up|Symptomatic deterioration|0
2328517|NCT03099187|4048785|FG002|12-month Safety Follow-up|Symptomatic deterioration|1
2328518|NCT03099187|4048786|FG003|12-month Safety Follow-up|Symptomatic deterioration|1
2328519|NCT03099187|4048783|FG000|12-month Safety Follow-up|Withdrawal by Subject|0
2328520|NCT03099187|4048784|FG001|12-month Safety Follow-up|Withdrawal by Subject|0
2328521|NCT03099187|4048785|FG002|12-month Safety Follow-up|Withdrawal by Subject|3
2328522|NCT03099187|4048786|FG003|12-month Safety Follow-up|Withdrawal by Subject|2
2328523|NCT03099187|4048783|FG000|12-month Safety Follow-up|Due to hospitalization|0
2328524|NCT03099187|4048784|FG001|12-month Safety Follow-up|Due to hospitalization|0
2328525|NCT03099187|4048785|FG002|12-month Safety Follow-up|Due to hospitalization|0
2328526|NCT03099187|4048786|FG003|12-month Safety Follow-up|Due to hospitalization|1
2328527|NCT03099538|4048806|FG000|Overall Study|Lack of Efficacy|3
2328528|NCT03099694|4048819|FG000|Overall Study|Withdrawal by Subject|11
2328529|NCT03099694|4048820|FG001|Overall Study|Withdrawal by Subject|13
2328530|NCT03099694|4048819|FG000|Overall Study|Lost to Follow-up|9
2328531|NCT03099694|4048820|FG001|Overall Study|Lost to Follow-up|5
2328532|NCT03100058|4048836|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2328533|NCT03100058|4048837|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2328534|NCT03100058|4048838|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
2328535|NCT03100058|4048839|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
2030992|NCT00381303|3600483|FG001|Overall Study|Physician Decision|0
2030993|NCT00381303|3600482|FG000|Overall Study|Physician's decision to close the site|3
2030994|NCT00381303|3600483|FG001|Overall Study|Physician's decision to close the site|1
2030995|NCT00381303|3600482|FG000|Overall Study|Subject moved out of state|2
2030996|NCT00381303|3600483|FG001|Overall Study|Subject moved out of state|0
2030997|NCT00381303|3600482|FG000|Overall Study|Subject taking too many different meds|1
2030998|NCT00381303|3600483|FG001|Overall Study|Subject taking too many different meds|0
2030999|NCT00381303|3600482|FG000|Overall Study|No virologic response by week 12|1
2031000|NCT00381303|3600483|FG001|Overall Study|No virologic response by week 12|0
2328536|NCT03100058|4048840|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
2328537|NCT03100058|4048841|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2328538|NCT03100058|4048842|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
2328539|NCT03100058|4048843|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
2328540|NCT03100058|4048844|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
2328541|NCT03100058|4048845|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2328542|NCT03100058|4048846|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2328543|NCT03100058|4048847|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2328544|NCT03100058|4048848|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2328545|NCT03100058|4048836|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
2328546|NCT03100058|4048837|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
2328547|NCT03100058|4048838|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
2328548|NCT03100058|4048839|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
2328549|NCT03100058|4048840|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
2328550|NCT03100058|4048841|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
2328551|NCT03100058|4048842|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
2328552|NCT03100058|4048843|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
2328553|NCT03100058|4048844|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
2328554|NCT03100058|4048845|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2328555|NCT03100058|4048846|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2328556|NCT03100058|4048847|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2328557|NCT03100058|4048848|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2328558|NCT03100058|4048836|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2328559|NCT03100058|4048837|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2328560|NCT03100058|4048838|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2328561|NCT03100058|4048839|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2328562|NCT03100058|4048840|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2328563|NCT03100058|4048841|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2328564|NCT03100058|4048842|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2328565|NCT03100058|4048843|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2328566|NCT03100058|4048844|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2328567|NCT03100058|4048845|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2328568|NCT03100058|4048846|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2328569|NCT03100058|4048847|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2328570|NCT03100058|4048848|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2328571|NCT03100058|4048836|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2328572|NCT03100058|4048837|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2328573|NCT03100058|4048838|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2328574|NCT03100058|4048839|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2328575|NCT03100058|4048840|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2328576|NCT03100058|4048841|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2328577|NCT03100058|4048842|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2328578|NCT03100058|4048843|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2328579|NCT03100058|4048844|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2328580|NCT03100058|4048845|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2328581|NCT03100058|4048846|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2328582|NCT03100058|4048847|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2328583|NCT03100058|4048848|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2328584|NCT03100058|4048836|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2328585|NCT03100058|4048837|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2328586|NCT03100058|4048838|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2328587|NCT03100058|4048839|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
2328588|NCT03100058|4048840|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2328589|NCT03100058|4048841|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2328590|NCT03100058|4048842|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2328591|NCT03100058|4048843|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
2328592|NCT03100058|4048844|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2328593|NCT03100058|4048845|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2328594|NCT03100058|4048846|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2328595|NCT03100058|4048847|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2328596|NCT03100058|4048848|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2328597|NCT03100058|4048836|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2328598|NCT03100058|4048837|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2328599|NCT03100058|4048838|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2328600|NCT03100058|4048839|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
2328601|NCT03100058|4048840|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2328602|NCT03100058|4048841|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2328603|NCT03100058|4048842|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
2328604|NCT03100058|4048843|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2328605|NCT03100058|4048844|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2328606|NCT03100058|4048845|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2328607|NCT03100058|4048846|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2328608|NCT03100058|4048847|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2328609|NCT03100058|4048848|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2328610|NCT03100058|4048836|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0
2328611|NCT03100058|4048837|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1
2328612|NCT03100058|4048838|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0
2328613|NCT03100058|4048839|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0
2328614|NCT03100058|4048840|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0
2328615|NCT03100058|4048841|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0
2328616|NCT03100058|4048842|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0
2328617|NCT03100058|4048843|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0
2328618|NCT03100058|4048844|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0
2328619|NCT03100058|4048845|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0
2328620|NCT03100058|4048846|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0
2328621|NCT03100058|4048847|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0
2328622|NCT03100058|4048848|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0
2328623|NCT03100058|4048836|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
2328624|NCT03100058|4048837|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2328625|NCT03100058|4048838|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2328626|NCT03100058|4048839|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2328627|NCT03100058|4048840|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2031001|NCT00381303|3600482|FG000|Overall Study|Subject was too busy for appointments|1
2031002|NCT00381303|3600483|FG001|Overall Study|Subject was too busy for appointments|0
2218207|NCT01713582|3861701|FG017|Overall Study|Death|0
2218208|NCT01713582|3861702|FG018|Overall Study|Death|0
2218209|NCT01713582|3861703|FG019|Overall Study|Death|0
2218210|NCT01713582|3861704|FG020|Overall Study|Death|0
2218211|NCT01713582|3861684|FG000|Overall Study|Adverse event-related|0
2031003|NCT00381303|3600482|FG000|Overall Study|Subject did not continue visits|1
2031004|NCT00381303|3600483|FG001|Overall Study|Subject did not continue visits|0
2328628|NCT03100058|4048841|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2328629|NCT03100058|4048842|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2328630|NCT03100058|4048843|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2328631|NCT03100058|4048844|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2328632|NCT03100058|4048845|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2328633|NCT03100058|4048846|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2328634|NCT03100058|4048847|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2328635|NCT03100058|4048848|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2328636|NCT03100058|4048836|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328637|NCT03100058|4048837|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328638|NCT03100058|4048838|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328639|NCT03100058|4048839|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328640|NCT03100058|4048840|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328641|NCT03100058|4048841|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328642|NCT03100058|4048842|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
2328643|NCT03100058|4048843|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328644|NCT03100058|4048844|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328645|NCT03100058|4048845|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328646|NCT03100058|4048846|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328647|NCT03100058|4048847|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328648|NCT03100058|4048848|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2328649|NCT03100058|4048836|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2328650|NCT03100058|4048837|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2328651|NCT03100058|4048838|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2328652|NCT03100058|4048839|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2328653|NCT03100058|4048840|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2328654|NCT03100058|4048841|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2328655|NCT03100058|4048842|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2328656|NCT03100058|4048843|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2328657|NCT03100058|4048844|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2328658|NCT03100058|4048845|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2328659|NCT03100058|4048846|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
2328660|NCT03100058|4048847|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
2328661|NCT03100058|4048848|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
2328662|NCT03100058|4048836|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2328663|NCT03100058|4048837|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2328664|NCT03100058|4048838|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2328665|NCT03100058|4048839|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2328666|NCT03100058|4048840|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2328667|NCT03100058|4048841|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2328668|NCT03100058|4048842|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2328669|NCT03100058|4048843|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2328670|NCT03100058|4048844|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2328671|NCT03100058|4048845|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2328672|NCT03100058|4048846|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
2328673|NCT03100058|4048847|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
2328674|NCT03100058|4048848|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2328675|NCT03100058|4048836|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2328676|NCT03100058|4048837|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2328677|NCT03100058|4048838|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2328678|NCT03100058|4048839|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2328679|NCT03100058|4048840|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2328680|NCT03100058|4048841|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2328681|NCT03100058|4048842|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2328682|NCT03100058|4048843|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2328683|NCT03100058|4048844|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2328684|NCT03100058|4048845|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
2328685|NCT03100058|4048846|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
2328686|NCT03100058|4048847|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2328687|NCT03100058|4048848|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
2328688|NCT03100058|4048836|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328689|NCT03100058|4048837|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328690|NCT03100058|4048838|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328691|NCT03100058|4048839|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328692|NCT03100058|4048840|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328693|NCT03100058|4048841|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328694|NCT03100058|4048842|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328695|NCT03100058|4048843|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328696|NCT03100058|4048844|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328697|NCT03100058|4048845|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328698|NCT03100058|4048846|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1
2328699|NCT03100058|4048847|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328700|NCT03100058|4048848|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2328701|NCT03100058|4048836|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2328702|NCT03100058|4048837|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2031005|NCT00381303|3600482|FG000|Overall Study|Subject primary physician's decision|1
2031006|NCT00381303|3600483|FG001|Overall Study|Subject primary physician's decision|0
2031007|NCT00381563|3600507|FG000|Overall Study|Withdrawal by Subject|5
2031008|NCT00381563|3600508|FG001|Overall Study|Withdrawal by Subject|5
2031009|NCT00381563|3600507|FG000|Overall Study|Lost to Follow-up|2
2031010|NCT00381563|3600508|FG001|Overall Study|Lost to Follow-up|0
2031011|NCT00381563|3600507|FG000|Overall Study|Protocol Violation|0
2031012|NCT00381563|3600508|FG001|Overall Study|Protocol Violation|1
2031013|NCT00381615|3600517|FG000|Overall Study|Withdrawal by Subject|1
2031014|NCT00381615|3600518|FG001|Overall Study|Withdrawal by Subject|3
2031015|NCT00381615|3600519|FG002|Overall Study|Withdrawal by Subject|0
2031016|NCT00381615|3600520|FG003|Overall Study|Withdrawal by Subject|1
2328703|NCT03100058|4048838|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2328704|NCT03100058|4048839|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2328705|NCT03100058|4048840|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2328706|NCT03100058|4048841|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2328707|NCT03100058|4048842|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2328708|NCT03100058|4048843|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2328709|NCT03100058|4048844|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2328710|NCT03100058|4048845|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2328711|NCT03100058|4048846|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2328712|NCT03100058|4048847|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2328713|NCT03100058|4048848|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
2328714|NCT03100058|4048836|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328715|NCT03100058|4048837|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328716|NCT03100058|4048838|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328717|NCT03100058|4048839|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328718|NCT03100058|4048840|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328719|NCT03100058|4048841|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328720|NCT03100058|4048842|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328721|NCT03100058|4048843|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328722|NCT03100058|4048844|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328723|NCT03100058|4048845|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
2328724|NCT03100058|4048846|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328725|NCT03100058|4048847|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328726|NCT03100058|4048848|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2328727|NCT03100344|4048895|FG000|Overall Study|Adverse Event|0
2328728|NCT03100344|4048896|FG001|Overall Study|Adverse Event|3
2328729|NCT03100344|4048897|FG002|Overall Study|Adverse Event|2
2328730|NCT03100344|4048898|FG003|Overall Study|Adverse Event|3
2328731|NCT03100344|4048895|FG000|Overall Study|Lack of Efficacy|2
2328732|NCT03100344|4048896|FG001|Overall Study|Lack of Efficacy|0
2328733|NCT03100344|4048897|FG002|Overall Study|Lack of Efficacy|0
2328734|NCT03100344|4048898|FG003|Overall Study|Lack of Efficacy|0
2328735|NCT03100344|4048895|FG000|Overall Study|Protocol Violation|1
2328736|NCT03100344|4048896|FG001|Overall Study|Protocol Violation|0
2328737|NCT03100344|4048897|FG002|Overall Study|Protocol Violation|0
2328738|NCT03100344|4048898|FG003|Overall Study|Protocol Violation|0
2328739|NCT03100344|4048895|FG000|Overall Study|Withdrawal by Subject|10
2328740|NCT03100344|4048896|FG001|Overall Study|Withdrawal by Subject|7
2031017|NCT00381615|3600517|FG000|Overall Study|Lost to Follow-up|3
2031018|NCT00381615|3600518|FG001|Overall Study|Lost to Follow-up|2
2031019|NCT00381615|3600519|FG002|Overall Study|Lost to Follow-up|0
2031020|NCT00381615|3600520|FG003|Overall Study|Lost to Follow-up|1
2031021|NCT00381615|3600517|FG000|Overall Study|Protocol Violation|0
2031022|NCT00381615|3600518|FG001|Overall Study|Protocol Violation|0
2031023|NCT00381615|3600519|FG002|Overall Study|Protocol Violation|1
2031024|NCT00381615|3600520|FG003|Overall Study|Protocol Violation|0
2031025|NCT00381641|3600551|FG000|Overall Study|Withdrawal by Subject|0
2328741|NCT03100344|4048897|FG002|Overall Study|Withdrawal by Subject|4
2328742|NCT03100344|4048898|FG003|Overall Study|Withdrawal by Subject|8
2328743|NCT03100344|4048895|FG000|Overall Study|Lost to Follow-up|1
2328744|NCT03100344|4048896|FG001|Overall Study|Lost to Follow-up|1
2328745|NCT03100344|4048897|FG002|Overall Study|Lost to Follow-up|1
2328746|NCT03100344|4048898|FG003|Overall Study|Lost to Follow-up|1
2328747|NCT03100825|4048913|FG000|Overall Study|Participant/Guardian Decision|7
2328748|NCT03100825|4048913|FG000|Overall Study|Physician Decision|1
2328749|NCT03100838|4048917|FG000|Overall Study|Adverse Event|1
2328750|NCT03100838|4048918|FG001|Overall Study|Adverse Event|0
2328751|NCT03100838|4048919|FG002|Overall Study|Adverse Event|0
2328752|NCT03100838|4048920|FG003|Overall Study|Adverse Event|0
2328753|NCT03100838|4048917|FG000|Overall Study|Physician Decision|1
2328754|NCT03100838|4048918|FG001|Overall Study|Physician Decision|1
2328755|NCT03100838|4048919|FG002|Overall Study|Physician Decision|1
2328756|NCT03100838|4048920|FG003|Overall Study|Physician Decision|1
2328757|NCT03100838|4048917|FG000|Overall Study|Pregnancy|0
2328758|NCT03100838|4048918|FG001|Overall Study|Pregnancy|1
2328759|NCT03100838|4048919|FG002|Overall Study|Pregnancy|0
2328760|NCT03100838|4048920|FG003|Overall Study|Pregnancy|0
2328761|NCT03100838|4048917|FG000|Overall Study|Lost to Follow-up|0
2328762|NCT03100838|4048918|FG001|Overall Study|Lost to Follow-up|0
2328763|NCT03100838|4048919|FG002|Overall Study|Lost to Follow-up|1
2328764|NCT03100838|4048920|FG003|Overall Study|Lost to Follow-up|0
2328765|NCT03100942|4048938|FG000|Randomized Treatment Period|Withdrew Consent|4
2328766|NCT03100942|4048939|FG001|Randomized Treatment Period|Withdrew Consent|5
2328767|NCT03100942|4048940|FG002|Randomized Treatment Period|Withdrew Consent|3
2328768|NCT03100942|4048941|FG003|Randomized Treatment Period|Withdrew Consent|3
2328769|NCT03100942|4048942|FG004|Randomized Treatment Period|Withdrew Consent|0
2328770|NCT03100942|4048943|FG005|Randomized Treatment Period|Withdrew Consent|0
2328771|NCT03100942|4048944|FG006|Randomized Treatment Period|Withdrew Consent|0
2328772|NCT03100942|4048938|FG000|Randomized Treatment Period|Adverse Event|5
2328773|NCT03100942|4048939|FG001|Randomized Treatment Period|Adverse Event|2
2328774|NCT03100942|4048940|FG002|Randomized Treatment Period|Adverse Event|1
2328775|NCT03100942|4048941|FG003|Randomized Treatment Period|Adverse Event|0
2328776|NCT03100942|4048942|FG004|Randomized Treatment Period|Adverse Event|0
2328777|NCT03100942|4048943|FG005|Randomized Treatment Period|Adverse Event|0
2328778|NCT03100942|4048944|FG006|Randomized Treatment Period|Adverse Event|0
2328779|NCT03100942|4048938|FG000|Randomized Treatment Period|Investigator's Discretion|2
2328780|NCT03100942|4048939|FG001|Randomized Treatment Period|Investigator's Discretion|1
2328781|NCT03100942|4048940|FG002|Randomized Treatment Period|Investigator's Discretion|0
2328782|NCT03100942|4048941|FG003|Randomized Treatment Period|Investigator's Discretion|0
2328783|NCT03100942|4048942|FG004|Randomized Treatment Period|Investigator's Discretion|0
2328784|NCT03100942|4048943|FG005|Randomized Treatment Period|Investigator's Discretion|0
2328785|NCT03100942|4048944|FG006|Randomized Treatment Period|Investigator's Discretion|0
2328786|NCT03100942|4048938|FG000|Randomized Treatment Period|Protocol Violation|0
2328787|NCT03100942|4048939|FG001|Randomized Treatment Period|Protocol Violation|1
2328788|NCT03100942|4048940|FG002|Randomized Treatment Period|Protocol Violation|1
2328789|NCT03100942|4048941|FG003|Randomized Treatment Period|Protocol Violation|1
2328790|NCT03100942|4048942|FG004|Randomized Treatment Period|Protocol Violation|0
2328791|NCT03100942|4048943|FG005|Randomized Treatment Period|Protocol Violation|0
2328792|NCT03100942|4048944|FG006|Randomized Treatment Period|Protocol Violation|0
2328793|NCT03100942|4048938|FG000|Randomized Treatment Period|Lost to Follow-up|0
2328794|NCT03100942|4048939|FG001|Randomized Treatment Period|Lost to Follow-up|0
2328795|NCT03100942|4048940|FG002|Randomized Treatment Period|Lost to Follow-up|1
2328796|NCT03100942|4048941|FG003|Randomized Treatment Period|Lost to Follow-up|0
2328797|NCT03100942|4048942|FG004|Randomized Treatment Period|Lost to Follow-up|0
2328798|NCT03100942|4048943|FG005|Randomized Treatment Period|Lost to Follow-up|0
2328799|NCT03100942|4048944|FG006|Randomized Treatment Period|Lost to Follow-up|0
2328800|NCT03100942|4048938|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
2328801|NCT03100942|4048939|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
2328802|NCT03100942|4048940|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
2328803|NCT03100942|4048941|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
2328804|NCT03100942|4048942|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
2328805|NCT03100942|4048943|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
2328806|NCT03100942|4048944|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
2328807|NCT03100942|4048938|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0
2328808|NCT03100942|4048939|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0
2328809|NCT03100942|4048940|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0
2328810|NCT03100942|4048941|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0
2328811|NCT03100942|4048942|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0
2328812|NCT03100942|4048943|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0
2328813|NCT03100942|4048944|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1
2328814|NCT03101020|4048968|FG000|Overall Study|Lack of time to participate|1
2328815|NCT03101020|4048969|FG001|Overall Study|Lack of time to participate|0
2328816|NCT03101020|4048968|FG000|Overall Study|Ran over by a car|0
2328817|NCT03101020|4048969|FG001|Overall Study|Ran over by a car|1
2328818|NCT03101020|4048968|FG000|Overall Study|Withdrawal by Subject|0
2328819|NCT03101020|4048969|FG001|Overall Study|Withdrawal by Subject|2
2328820|NCT03101150|4048999|FG000|Overall Study|Lost to Follow-up|2
2328821|NCT03101150|4049000|FG001|Overall Study|Lost to Follow-up|4
2328822|NCT03101150|4048999|FG000|Overall Study|Miscarriage|3
2328823|NCT03101150|4049000|FG001|Overall Study|Miscarriage|6
2328824|NCT03101241|4049008|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4
2328825|NCT03101241|4049009|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2
2328826|NCT03101241|4049008|FG000|Overall Study|Participant withdrew consent|3
2328827|NCT03101241|4049009|FG001|Overall Study|Participant withdrew consent|1
2328828|NCT03101241|4049008|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2
2328829|NCT03101241|4049009|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0
2328830|NCT03101241|4049008|FG000|Overall Study|Lost to Follow-up|2
2328831|NCT03101241|4049009|FG001|Overall Study|Lost to Follow-up|0
2328832|NCT03101241|4049008|FG000|Overall Study|Lack of Efficacy|0
2328833|NCT03101241|4049009|FG001|Overall Study|Lack of Efficacy|1
2328834|NCT03101241|4049008|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0
2328835|NCT03101241|4049009|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1
2328836|NCT03101267|4049018|FG000|Primary Study Period|Withdrawal by Subject|1
2328837|NCT03101267|4049019|FG001|Primary Study Period|Withdrawal by Subject|2
2328838|NCT03101267|4049020|FG002|Primary Study Period|Withdrawal by Subject|3
2328839|NCT03101267|4049018|FG000|Primary Study Period|Miscellaneous|2
2328840|NCT03101267|4049019|FG001|Primary Study Period|Miscellaneous|0
2328841|NCT03101267|4049020|FG002|Primary Study Period|Miscellaneous|0
2328842|NCT03101293|4049030|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1
2328843|NCT03101293|4049031|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0
2328844|NCT03101358|4049041|FG000|Overall Study|Non-compliance with study schedule|1
2328845|NCT03101358|4049042|FG001|Overall Study|Non-compliance with study schedule|0
2328846|NCT03101358|4049043|FG002|Overall Study|Non-compliance with study schedule|0
2328847|NCT03101358|4049044|FG003|Overall Study|Non-compliance with study schedule|1
2328848|NCT03101358|4049041|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0
2328849|NCT03101358|4049042|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0
2328850|NCT03101358|4049043|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1
2328851|NCT03101358|4049044|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0
2328852|NCT03101358|4049041|FG000|Overall Study|Physician Decision|1
2328853|NCT03101358|4049042|FG001|Overall Study|Physician Decision|0
2328854|NCT03101358|4049043|FG002|Overall Study|Physician Decision|0
2328855|NCT03101358|4049044|FG003|Overall Study|Physician Decision|3
2328856|NCT03101358|4049041|FG000|Overall Study|Adverse Event|0
2328857|NCT03101358|4049042|FG001|Overall Study|Adverse Event|0
2328858|NCT03101358|4049043|FG002|Overall Study|Adverse Event|1
2328859|NCT03101358|4049044|FG003|Overall Study|Adverse Event|0
2328860|NCT03101358|4049041|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
2328861|NCT03101358|4049042|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
2328862|NCT03101358|4049043|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
2328863|NCT03101358|4049044|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1
2328864|NCT03101358|4049041|FG000|Overall Study|Lost to Follow-up|1
2328865|NCT03101358|4049042|FG001|Overall Study|Lost to Follow-up|0
2328866|NCT03101358|4049043|FG002|Overall Study|Lost to Follow-up|0
2328867|NCT03101358|4049044|FG003|Overall Study|Lost to Follow-up|1
2328868|NCT03101371|4049057|FG000|Overall Study|Physician Decision|0
2328869|NCT03101371|4049058|FG001|Overall Study|Physician Decision|1
2328870|NCT03101371|4049057|FG000|Overall Study|Lost to Follow-up|1
2328871|NCT03101371|4049058|FG001|Overall Study|Lost to Follow-up|4
2328872|NCT03101371|4049057|FG000|Overall Study|Did not meet eligibility criteria|2
2328873|NCT03101371|4049058|FG001|Overall Study|Did not meet eligibility criteria|1
2328874|NCT03101462|4049066|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1
2328875|NCT03101462|4049067|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1
2328876|NCT03101514|4049073|FG000|Overall Study|Withdrawal by Subject|4
2328877|NCT03101514|4049073|FG000|Overall Study|Protocol Violation|2
2328878|NCT03101514|4049073|FG000|Overall Study|patient's information was incomplete|1
2328879|NCT03101592|4049080|FG000|Overall Study|participant files could not be located|111
2328880|NCT03101592|4049081|FG001|Overall Study|participant files could not be located|170
2328881|NCT03101592|4049082|FG002|Overall Study|participant files could not be located|118
2328882|NCT03102710|4049127|FG000|Overall Study|Dental metal affected MRI scan quality|1
2218212|NCT01713582|3861685|FG001|Overall Study|Adverse event-related|0
2218213|NCT01713582|3861686|FG002|Overall Study|Adverse event-related|0
2218214|NCT01713582|3861687|FG003|Overall Study|Adverse event-related|0
2218215|NCT01713582|3861688|FG004|Overall Study|Adverse event-related|0
2218216|NCT01713582|3861689|FG005|Overall Study|Adverse event-related|0
2218217|NCT01713582|3861690|FG006|Overall Study|Adverse event-related|0
2218218|NCT01713582|3861691|FG007|Overall Study|Adverse event-related|0
2218219|NCT01713582|3861692|FG008|Overall Study|Adverse event-related|0
2218220|NCT01713582|3861693|FG009|Overall Study|Adverse event-related|1
2218221|NCT01713582|3861694|FG010|Overall Study|Adverse event-related|1
2218222|NCT01713582|3861695|FG011|Overall Study|Adverse event-related|0
2218223|NCT01713582|3861696|FG012|Overall Study|Adverse event-related|0
2218224|NCT01713582|3861697|FG013|Overall Study|Adverse event-related|0
2218225|NCT01713582|3861698|FG014|Overall Study|Adverse event-related|0
2218226|NCT01713582|3861699|FG015|Overall Study|Adverse event-related|0
2218227|NCT01713582|3861700|FG016|Overall Study|Adverse event-related|0
2218228|NCT01713582|3861701|FG017|Overall Study|Adverse event-related|0
2218229|NCT01713582|3861702|FG018|Overall Study|Adverse event-related|1
2218230|NCT01713582|3861703|FG019|Overall Study|Adverse event-related|0
2218231|NCT01713582|3861704|FG020|Overall Study|Adverse event-related|0
2218232|NCT01713582|3861684|FG000|Overall Study|Adverse event-unrelated|0
2218233|NCT01713582|3861685|FG001|Overall Study|Adverse event-unrelated|0
2218234|NCT01713582|3861686|FG002|Overall Study|Adverse event-unrelated|0
2218235|NCT01713582|3861687|FG003|Overall Study|Adverse event-unrelated|0
2218236|NCT01713582|3861688|FG004|Overall Study|Adverse event-unrelated|0
2218237|NCT01713582|3861689|FG005|Overall Study|Adverse event-unrelated|1
2218238|NCT01713582|3861690|FG006|Overall Study|Adverse event-unrelated|1
2328883|NCT03102710|4049128|FG001|Overall Study|Dental metal affected MRI scan quality|0
2328884|NCT03102710|4049129|FG002|Overall Study|Dental metal affected MRI scan quality|0
2328885|NCT03102710|4049127|FG000|Overall Study|Technical issues during final MRI scan|0
2328886|NCT03102710|4049128|FG001|Overall Study|Technical issues during final MRI scan|1
2328887|NCT03102710|4049129|FG002|Overall Study|Technical issues during final MRI scan|0
2328888|NCT03102710|4049127|FG000|Overall Study|Nausea during MRI scan|0
2328889|NCT03102710|4049128|FG001|Overall Study|Nausea during MRI scan|1
2328890|NCT03102710|4049129|FG002|Overall Study|Nausea during MRI scan|0
2328891|NCT03102710|4049127|FG000|Overall Study|Subject unable to attend final session|0
2328892|NCT03102710|4049128|FG001|Overall Study|Subject unable to attend final session|1
2328893|NCT03102710|4049129|FG002|Overall Study|Subject unable to attend final session|0
2218239|NCT01713582|3861691|FG007|Overall Study|Adverse event-unrelated|1
2218240|NCT01713582|3861692|FG008|Overall Study|Adverse event-unrelated|0
2218241|NCT01713582|3861693|FG009|Overall Study|Adverse event-unrelated|0
2328894|NCT03102762|4049148|FG000|Overall Study|Lost to Follow-up|1
2328895|NCT03102762|4049149|FG001|Overall Study|Lost to Follow-up|0
2328896|NCT03102918|4049171|FG000|Overall Study|Protocol Violation|1
2328897|NCT03102918|4049172|FG001|Overall Study|Protocol Violation|0
2328898|NCT03103100|4049185|FG000|Overall Study|Adverse Event|1
2328899|NCT03103100|4049186|FG001|Overall Study|Adverse Event|0
2328900|NCT03103100|4049187|FG002|Overall Study|Adverse Event|0
2328901|NCT03103100|4049185|FG000|Overall Study|Physician Decision|1
2328902|NCT03103100|4049186|FG001|Overall Study|Physician Decision|0
2328903|NCT03103100|4049187|FG002|Overall Study|Physician Decision|2
2328904|NCT03103503|4049228|FG000|Overall Study|Death|64
2328905|NCT03103503|4049228|FG000|Overall Study|Physician Decision|57
2328906|NCT03103503|4049228|FG000|Overall Study|Withdrawal by Subject|10
2328907|NCT03103503|4049228|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10
2328908|NCT03103503|4049228|FG000|Overall Study|Lost to Follow-up|3
2218242|NCT01713582|3861694|FG010|Overall Study|Adverse event-unrelated|0
2218243|NCT01713582|3861695|FG011|Overall Study|Adverse event-unrelated|0
2218244|NCT01713582|3861696|FG012|Overall Study|Adverse event-unrelated|0
2218245|NCT01713582|3861697|FG013|Overall Study|Adverse event-unrelated|1
2218246|NCT01713582|3861698|FG014|Overall Study|Adverse event-unrelated|1
2218247|NCT01713582|3861699|FG015|Overall Study|Adverse event-unrelated|0
2218248|NCT01713582|3861700|FG016|Overall Study|Adverse event-unrelated|0
2218249|NCT01713582|3861701|FG017|Overall Study|Adverse event-unrelated|0
2218250|NCT01713582|3861702|FG018|Overall Study|Adverse event-unrelated|0
2218251|NCT01713582|3861703|FG019|Overall Study|Adverse event-unrelated|0
2218252|NCT01713582|3861704|FG020|Overall Study|Adverse event-unrelated|0
2218253|NCT01713582|3861684|FG000|Overall Study|Withdrawal of consent|0
2328909|NCT03103503|4049228|FG000|Overall Study|Study Closure|757
2218254|NCT01713582|3861685|FG001|Overall Study|Withdrawal of consent|0
2218255|NCT01713582|3861686|FG002|Overall Study|Withdrawal of consent|1
2328910|NCT03103542|4049232|FG000|Overall Study|Physician Decision|2
2328911|NCT03103542|4049232|FG000|Overall Study|Adverse Event|2
2328912|NCT03103542|4049232|FG000|Overall Study|Other|2
2328913|NCT03103542|4049232|FG000|Overall Study|Withdrawal by Subject|1
2328914|NCT03103763|4049240|FG000|Overall Study|Death|15
2328915|NCT03103763|4049241|FG001|Overall Study|Death|5
2328916|NCT03103763|4049242|FG002|Overall Study|Death|5
2328917|NCT03103763|4049240|FG000|Overall Study|Withdrawal by Subject|0
2328918|NCT03103763|4049241|FG001|Overall Study|Withdrawal by Subject|3
2328919|NCT03103763|4049242|FG002|Overall Study|Withdrawal by Subject|2
2328920|NCT03103906|4049252|FG000|Overall Study|Adverse Event|2
2328921|NCT03103906|4049253|FG001|Overall Study|Adverse Event|3
2328922|NCT03103906|4049252|FG000|Overall Study|Other|2
2328923|NCT03103906|4049253|FG001|Overall Study|Other|0
2328924|NCT03103919|4049261|FG000|Overall Study|Adverse Event|2
2328925|NCT03103919|4049262|FG001|Overall Study|Adverse Event|2
2352537|NCT03768726|4101919|FG001|Follow-Up|Adverse Event|2
2352538|NCT03768726|4101918|FG000|Follow-Up|Withdrawal By Parent/Guardian|1
2352539|NCT03768726|4101919|FG001|Follow-Up|Withdrawal By Parent/Guardian|1
2352540|NCT03768726|4101918|FG000|Follow-Up|Withdrawal by Subject|2
2352541|NCT03768726|4101919|FG001|Follow-Up|Withdrawal by Subject|0
2352542|NCT03768726|4101918|FG000|Follow-Up|Other|1
2352543|NCT03768726|4101919|FG001|Follow-Up|Other|0
2352544|NCT03768206|4101927|FG000|Overall Study|Lost to Follow-up|2
2352545|NCT03768206|4101928|FG001|Overall Study|Lost to Follow-up|1
2352546|NCT03768206|4101927|FG000|Overall Study|Withdrawal by Subject|0
2352547|NCT03768206|4101928|FG001|Overall Study|Withdrawal by Subject|1
2352548|NCT03767894|4101935|FG000|Overall Study|Withdrawal by Subject|1
2352549|NCT03766646|4101968|FG000|Overall Study|Withdrawal by Subject|1
2352550|NCT03766646|4101969|FG001|Overall Study|Withdrawal by Subject|0
2352551|NCT03766646|4101968|FG000|Overall Study|Protocol Violation|0
2352552|NCT03766646|4101969|FG001|Overall Study|Protocol Violation|3
2352553|NCT03765164|4102041|FG000|Pre-intervention|Withdrawal by Subject|5
2352554|NCT03765164|4102042|FG001|Pre-intervention|Withdrawal by Subject|6
2328926|NCT03104816|4049322|FG000|Overall Study|Lack of Efficacy|0
2328927|NCT03104816|4049323|FG001|Overall Study|Lack of Efficacy|2
2328928|NCT03104816|4049324|FG002|Overall Study|Lack of Efficacy|0
2328929|NCT03104816|4049322|FG000|Overall Study|Protocol Violation|2
2328930|NCT03104816|4049323|FG001|Overall Study|Protocol Violation|0
2328931|NCT03104816|4049324|FG002|Overall Study|Protocol Violation|2
2328932|NCT03105297|4049341|FG000|Baseline Phase (Day 1)|Other|21
2328933|NCT03105297|4049341|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
2328934|NCT03105297|4049341|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
2328935|NCT03105362|4049352|FG000|Overall Study|Withdrawal by Subject|1
2328936|NCT03105362|4049352|FG000|Overall Study|Lost to Follow-up|1
2328937|NCT03106077|4049376|FG000|Overall Study|Screen Failure|94
2328938|NCT03106077|4049377|FG001|Overall Study|Screen Failure|0
2328939|NCT03106753|4049398|FG000|Overall Study|Withdrawal by Subject|0
2328940|NCT03106753|4049399|FG001|Overall Study|Withdrawal by Subject|1
2328941|NCT03107026|4049423|FG000|Overall Study|Adverse Event|2
2328942|NCT03107026|4049424|FG001|Overall Study|Adverse Event|14
2328943|NCT03107026|4049425|FG002|Overall Study|Adverse Event|23
2328944|NCT03107026|4049423|FG000|Overall Study|Lost to Follow-up|12
2328945|NCT03107026|4049424|FG001|Overall Study|Lost to Follow-up|12
2328946|NCT03107026|4049425|FG002|Overall Study|Lost to Follow-up|13
2328947|NCT03107026|4049423|FG000|Overall Study|Protocol Violation|1
2328948|NCT03107026|4049424|FG001|Overall Study|Protocol Violation|2
2328949|NCT03107026|4049425|FG002|Overall Study|Protocol Violation|0
2328950|NCT03107026|4049423|FG000|Overall Study|Pregnancy|1
2328951|NCT03107026|4049424|FG001|Overall Study|Pregnancy|0
2328952|NCT03107026|4049425|FG002|Overall Study|Pregnancy|0
2328953|NCT03107026|4049423|FG000|Overall Study|Withdrawal by Subject|13
2328954|NCT03107026|4049424|FG001|Overall Study|Withdrawal by Subject|5
2328955|NCT03107026|4049425|FG002|Overall Study|Withdrawal by Subject|17
2328956|NCT03107026|4049423|FG000|Overall Study|non compliance with study visits|1
2328957|NCT03107026|4049424|FG001|Overall Study|non compliance with study visits|2
2328958|NCT03107026|4049425|FG002|Overall Study|non compliance with study visits|0
2328959|NCT03107026|4049423|FG000|Overall Study|non-compliance with study drug|2
2328960|NCT03107026|4049424|FG001|Overall Study|non-compliance with study drug|2
2328961|NCT03107026|4049425|FG002|Overall Study|non-compliance with study drug|3
2328962|NCT03107026|4049423|FG000|Overall Study|Physician Decision|0
2328963|NCT03107026|4049424|FG001|Overall Study|Physician Decision|1
2328964|NCT03107026|4049425|FG002|Overall Study|Physician Decision|0
2328965|NCT03107052|4049436|FG000|Overall Study|Adverse Event|6
2328966|NCT03107052|4049437|FG001|Overall Study|Adverse Event|1
2328967|NCT03107052|4049438|FG002|Overall Study|Adverse Event|2
2328968|NCT03107052|4049436|FG000|Overall Study|Withdrawal by Subject|9
2328969|NCT03107052|4049437|FG001|Overall Study|Withdrawal by Subject|5
2328970|NCT03107052|4049438|FG002|Overall Study|Withdrawal by Subject|8
2328971|NCT03107052|4049436|FG000|Overall Study|Protocol Violation|6
2328972|NCT03107052|4049437|FG001|Overall Study|Protocol Violation|0
2328973|NCT03107052|4049438|FG002|Overall Study|Protocol Violation|3
2328974|NCT03107052|4049436|FG000|Overall Study|Lost to Follow-up|4
2328975|NCT03107052|4049437|FG001|Overall Study|Lost to Follow-up|0
2328976|NCT03107052|4049438|FG002|Overall Study|Lost to Follow-up|1
2328977|NCT03107052|4049436|FG000|Overall Study|Lack of Efficacy|23
2328978|NCT03107052|4049437|FG001|Overall Study|Lack of Efficacy|7
2328979|NCT03107052|4049438|FG002|Overall Study|Lack of Efficacy|4
2328980|NCT03107052|4049436|FG000|Overall Study|Other than specified|4
2328981|NCT03107052|4049437|FG001|Overall Study|Other than specified|2
2328982|NCT03107052|4049438|FG002|Overall Study|Other than specified|0
2328983|NCT03107052|4049436|FG000|Overall Study|Study terminated due to futility|67
2328984|NCT03107052|4049437|FG001|Overall Study|Study terminated due to futility|31
2328985|NCT03107052|4049438|FG002|Overall Study|Study terminated due to futility|23
2328986|NCT03107091|4049446|FG000|Overall Study|Physician Decision|1
2328987|NCT03107377|4049453|FG000|Overall Study|Adverse Event|3
2328988|NCT03107377|4049454|FG001|Overall Study|Adverse Event|3
2328989|NCT03107377|4049453|FG000|Overall Study|Protocol Violation|9
2328990|NCT03107377|4049454|FG001|Overall Study|Protocol Violation|12
2328991|NCT03107377|4049453|FG000|Overall Study|Physician Decision|3
2328992|NCT03107377|4049454|FG001|Overall Study|Physician Decision|6
2328993|NCT03107377|4049453|FG000|Overall Study|Pregnancy|7
2328994|NCT03107377|4049454|FG001|Overall Study|Pregnancy|7
2328995|NCT03107377|4049453|FG000|Overall Study|Withdrawal by Subject|16
2328996|NCT03107377|4049454|FG001|Overall Study|Withdrawal by Subject|22
2328997|NCT03107377|4049453|FG000|Overall Study|Lost to Follow-up|37
2328998|NCT03107377|4049454|FG001|Overall Study|Lost to Follow-up|34
2328999|NCT03107377|4049453|FG000|Overall Study|Other reason not specified|16
2329000|NCT03107377|4049454|FG001|Overall Study|Other reason not specified|15
2329001|NCT03107611|4049463|FG000|Overall Study|Adverse Event|1
2329002|NCT03107611|4049464|FG001|Overall Study|Adverse Event|0
2329003|NCT03107611|4049465|FG002|Overall Study|Adverse Event|2
2329004|NCT03107611|4049463|FG000|Overall Study|Lost to Follow-up|3
2329005|NCT03107611|4049464|FG001|Overall Study|Lost to Follow-up|3
2329006|NCT03107611|4049465|FG002|Overall Study|Lost to Follow-up|3
2329007|NCT03107611|4049463|FG000|Overall Study|Protocol Violation|0
2329008|NCT03107611|4049464|FG001|Overall Study|Protocol Violation|0
2329009|NCT03107611|4049465|FG002|Overall Study|Protocol Violation|1
2329010|NCT03107611|4049463|FG000|Overall Study|Withdrawal by Subject|1
2329011|NCT03107611|4049464|FG001|Overall Study|Withdrawal by Subject|0
2329012|NCT03107611|4049465|FG002|Overall Study|Withdrawal by Subject|1
2329013|NCT03107611|4049463|FG000|Overall Study|Worsening signs/symptoms|2
2329014|NCT03107611|4049464|FG001|Overall Study|Worsening signs/symptoms|1
2329015|NCT03107611|4049465|FG002|Overall Study|Worsening signs/symptoms|2
2329016|NCT03107715|4049475|FG000|Overall Study|did not deliver at the home hospital|4
2329017|NCT03107715|4049476|FG001|Overall Study|did not deliver at the home hospital|6
2329018|NCT03107715|4049475|FG000|Overall Study|infant stillborn|0
2329019|NCT03107715|4049476|FG001|Overall Study|infant stillborn|1
2329020|NCT03107793|4049491|FG000|Induction Period (16 Weeks)|Adverse Event|5
2329021|NCT03107793|4049492|FG001|Induction Period (16 Weeks)|Adverse Event|0
2329022|NCT03107793|4049493|FG002|Induction Period (16 Weeks)|Adverse Event|0
2329023|NCT03107793|4049491|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3
2329024|NCT03107793|4049492|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0
2329025|NCT03107793|4049493|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
2329026|NCT03107793|4049491|FG000|Induction Period (16 Weeks)|Physician Decision|1
2031026|NCT00381641|3600552|FG001|Overall Study|Withdrawal by Subject|2
2031027|NCT00381680|3600560|FG000|Overall Study|Adverse Event|9
2031028|NCT00381680|3600561|FG001|Overall Study|Adverse Event|3
2031029|NCT00381680|3600560|FG000|Overall Study|Death|10
2031030|NCT00381680|3600561|FG001|Overall Study|Death|7
2031031|NCT00381680|3600560|FG000|Overall Study|Lost to Follow-up|3
2031032|NCT00381680|3600561|FG001|Overall Study|Lost to Follow-up|2
2031033|NCT00381680|3600560|FG000|Overall Study|Physician Decision|25
2031034|NCT00381680|3600561|FG001|Overall Study|Physician Decision|6
2031035|NCT00381680|3600560|FG000|Overall Study|Withdrawal by Subject|3
2031036|NCT00381680|3600561|FG001|Overall Study|Withdrawal by Subject|1
2031037|NCT00381680|3600560|FG000|Overall Study|Entry onto another COG Trial|1
2031038|NCT00381680|3600561|FG001|Overall Study|Entry onto another COG Trial|2
2031039|NCT00381680|3600560|FG000|Overall Study|Alternative Therapy|11
2031040|NCT00381680|3600561|FG001|Overall Study|Alternative Therapy|5
2031041|NCT00381680|3600560|FG000|Overall Study|Secondary Malignancy|3
2031042|NCT00381680|3600561|FG001|Overall Study|Secondary Malignancy|0
2031043|NCT00381680|3600560|FG000|Overall Study|Delay initiation|1
2031044|NCT00381680|3600561|FG001|Overall Study|Delay initiation|0
2031045|NCT00381680|3600560|FG000|Overall Study|Stem Cell Transplant|26
2031046|NCT00381680|3600561|FG001|Overall Study|Stem Cell Transplant|10
2031047|NCT00381680|3600560|FG000|Overall Study|Relapse|18
2031048|NCT00381680|3600561|FG001|Overall Study|Relapse|9
2031049|NCT00381680|3600560|FG000|Overall Study|Induction Failure|4
2031050|NCT00381680|3600561|FG001|Overall Study|Induction Failure|1
2031051|NCT00381680|3600560|FG000|Overall Study|Progression|1
2031052|NCT00381680|3600561|FG001|Overall Study|Progression|1
2031053|NCT00381680|3600560|FG000|Overall Study|Other not otherwise specified|7
2031054|NCT00381680|3600561|FG001|Overall Study|Other not otherwise specified|2
2031055|NCT00381680|3600560|FG000|Overall Study|Ineligible|3
2031056|NCT00381680|3600561|FG001|Overall Study|Ineligible|1
2031057|NCT00381693|3600571|FG000|Overall Study|Death|1
2031058|NCT00381693|3600571|FG000|Overall Study|Adverse Event|4
2031059|NCT00381693|3600571|FG000|Overall Study|Patient Choice|1
2031060|NCT00381693|3600571|FG000|Overall Study|Progression|2
2031061|NCT00381706|3600581|FG000|Overall Study|Never treated|7
2031062|NCT00381706|3600582|FG001|Overall Study|Never treated|2
2031063|NCT00381706|3600583|FG002|Overall Study|Never treated|1
2031064|NCT00381797|3600602|FG000|Overall Study|Withdrawal by Subject|1
2031065|NCT00381797|3600603|FG001|Overall Study|Withdrawal by Subject|1
2031066|NCT00381797|3600604|FG002|Overall Study|Withdrawal by Subject|0
2031067|NCT00381797|3600605|FG003|Overall Study|Withdrawal by Subject|0
2031068|NCT00381797|3600606|FG004|Overall Study|Withdrawal by Subject|2
2031069|NCT00381797|3600602|FG000|Overall Study|Ineligible|0
2031070|NCT00381797|3600603|FG001|Overall Study|Ineligible|0
2031071|NCT00381797|3600604|FG002|Overall Study|Ineligible|0
2329027|NCT03107793|4049492|FG001|Induction Period (16 Weeks)|Physician Decision|0
2329028|NCT03107793|4049493|FG002|Induction Period (16 Weeks)|Physician Decision|0
2329029|NCT03107793|4049491|FG000|Induction Period (16 Weeks)|Progressive Disease|1
2031072|NCT00381797|3600605|FG003|Overall Study|Ineligible|1
2031073|NCT00381797|3600606|FG004|Overall Study|Ineligible|0
2031074|NCT00381849|3600645|FG000|Wash Out|Withdrawal by Subject|0
2329030|NCT03107793|4049492|FG001|Induction Period (16 Weeks)|Progressive Disease|0
2329031|NCT03107793|4049493|FG002|Induction Period (16 Weeks)|Progressive Disease|0
2329032|NCT03107793|4049491|FG000|Maintenance Period (16-48 Week)|Adverse Event|0
2329033|NCT03107793|4049492|FG001|Maintenance Period (16-48 Week)|Adverse Event|6
2329034|NCT03107793|4049493|FG002|Maintenance Period (16-48 Week)|Adverse Event|10
2329035|NCT03107793|4049491|FG000|Maintenance Period (16-48 Week)|Death|0
2329036|NCT03107793|4049492|FG001|Maintenance Period (16-48 Week)|Death|2
2329037|NCT03107793|4049493|FG002|Maintenance Period (16-48 Week)|Death|0
2329038|NCT03107793|4049491|FG000|Maintenance Period (16-48 Week)|Lack of Efficacy|0
2329039|NCT03107793|4049492|FG001|Maintenance Period (16-48 Week)|Lack of Efficacy|21
2329040|NCT03107793|4049493|FG002|Maintenance Period (16-48 Week)|Lack of Efficacy|8
2329041|NCT03107793|4049491|FG000|Maintenance Period (16-48 Week)|Lost to Follow-up|0
2329042|NCT03107793|4049492|FG001|Maintenance Period (16-48 Week)|Lost to Follow-up|1
2329043|NCT03107793|4049493|FG002|Maintenance Period (16-48 Week)|Lost to Follow-up|0
2329044|NCT03107793|4049491|FG000|Maintenance Period (16-48 Week)|Withdrawal by Subject|0
2329045|NCT03107793|4049492|FG001|Maintenance Period (16-48 Week)|Withdrawal by Subject|12
2329046|NCT03107793|4049493|FG002|Maintenance Period (16-48 Week)|Withdrawal by Subject|4
2329047|NCT03107793|4049491|FG000|Maintenance Period (16-48 Week)|Physician Decision|0
2329048|NCT03107793|4049492|FG001|Maintenance Period (16-48 Week)|Physician Decision|1
2329049|NCT03107793|4049493|FG002|Maintenance Period (16-48 Week)|Physician Decision|2
2329050|NCT03107793|4049491|FG000|Maintenance Period (16-48 Week)|Pregnancy|0
2329051|NCT03107793|4049492|FG001|Maintenance Period (16-48 Week)|Pregnancy|1
2329052|NCT03107793|4049493|FG002|Maintenance Period (16-48 Week)|Pregnancy|1
2329053|NCT03107793|4049491|FG000|Maintenance Period (16-48 Week)|Disease Relapse|0
2329054|NCT03107793|4049492|FG001|Maintenance Period (16-48 Week)|Disease Relapse|2
2329055|NCT03107793|4049493|FG002|Maintenance Period (16-48 Week)|Disease Relapse|1
2329056|NCT03107793|4049491|FG000|Maintenance Period (16-48 Week)|Progressive Disease|0
2329057|NCT03107793|4049492|FG001|Maintenance Period (16-48 Week)|Progressive Disease|0
2329058|NCT03107793|4049493|FG002|Maintenance Period (16-48 Week)|Progressive Disease|1
2329059|NCT03107793|4049491|FG000|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
2329060|NCT03107793|4049492|FG001|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
2329061|NCT03107793|4049493|FG002|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|1
2329062|NCT03108027|4049500|FG000|Period 1|Subject/Guardian Decision|0
2329063|NCT03108027|4049501|FG001|Period 1|Subject/Guardian Decision|0
2329064|NCT03108027|4049502|FG002|Period 1|Subject/Guardian Decision|0
2329065|NCT03108027|4049503|FG003|Period 1|Subject/Guardian Decision|2
2329066|NCT03108027|4049504|FG004|Period 1|Subject/Guardian Decision|0
2329067|NCT03108027|4049505|FG005|Period 1|Subject/Guardian Decision|0
2329068|NCT03108027|4049500|FG000|Period 3|Adverse Event|0
2329069|NCT03108027|4049501|FG001|Period 3|Adverse Event|1
2329070|NCT03108027|4049502|FG002|Period 3|Adverse Event|0
2329071|NCT03108027|4049503|FG003|Period 3|Adverse Event|0
2329072|NCT03108027|4049504|FG004|Period 3|Adverse Event|0
2329073|NCT03108027|4049505|FG005|Period 3|Adverse Event|0
2329074|NCT03108157|4049515|FG000|Overall Study|Protocol Violation|15
2329075|NCT03108157|4049516|FG001|Overall Study|Protocol Violation|4
2329076|NCT03108521|4049551|FG000|Overall Study|Lost to Follow-up|3
2329077|NCT03108521|4049552|FG001|Overall Study|Lost to Follow-up|0
2329078|NCT03108521|4049551|FG000|Overall Study|Lack of Efficacy|2
2329079|NCT03108521|4049552|FG001|Overall Study|Lack of Efficacy|0
2329080|NCT03108521|4049551|FG000|Overall Study|Physician Decision|4
2329081|NCT03108521|4049552|FG001|Overall Study|Physician Decision|0
2329082|NCT03108521|4049551|FG000|Overall Study|Adverse Event|3
2329083|NCT03108521|4049552|FG001|Overall Study|Adverse Event|0
2329084|NCT03109184|4049599|FG000|Overall Study|Lost to Follow-up|6
2329085|NCT03109184|4049600|FG001|Overall Study|Lost to Follow-up|6
2329086|NCT03109184|4049599|FG000|Overall Study|Withdrawal by Subject|1
2329087|NCT03109184|4049600|FG001|Overall Study|Withdrawal by Subject|1
2329088|NCT03110029|4049630|FG000|Overall Study|Withdrawal by Subject|1
2329089|NCT03110029|4049631|FG001|Overall Study|Withdrawal by Subject|1
2329090|NCT03110185|4049639|FG000|Overall Study|Death|0
2329091|NCT03110185|4049640|FG001|Overall Study|Death|1
2329092|NCT03110185|4049639|FG000|Overall Study|Withdrawal by Subject|2
2329093|NCT03110185|4049640|FG001|Overall Study|Withdrawal by Subject|7
2329094|NCT03110185|4049639|FG000|Overall Study|Time Constraints|0
2329095|NCT03110185|4049640|FG001|Overall Study|Time Constraints|6
2329096|NCT03110185|4049639|FG000|Overall Study|Conflict with care|5
2329097|NCT03110185|4049640|FG001|Overall Study|Conflict with care|12
2329098|NCT03110185|4049639|FG000|Overall Study|Protocol Violation|1
2329099|NCT03110185|4049640|FG001|Overall Study|Protocol Violation|4
2329100|NCT03110185|4049639|FG000|Overall Study|MRI Incompatible|2
2329101|NCT03110185|4049640|FG001|Overall Study|MRI Incompatible|0
2329102|NCT03110185|4049639|FG000|Overall Study|Patient Refusal|0
2329103|NCT03110185|4049640|FG001|Overall Study|Patient Refusal|1
2329104|NCT03110562|4049671|FG000|Overall Study|Withdrawal by Subject|37
2329105|NCT03110562|4049672|FG001|Overall Study|Withdrawal by Subject|35
2329106|NCT03110562|4049671|FG000|Overall Study|Death|47
2329107|NCT03110562|4049672|FG001|Overall Study|Death|61
2329108|NCT03110562|4049671|FG000|Overall Study|Lost to Follow-up|7
2329109|NCT03110562|4049672|FG001|Overall Study|Lost to Follow-up|6
2329110|NCT03110562|4049671|FG000|Overall Study|Other|2
2329111|NCT03110562|4049672|FG001|Overall Study|Other|1
2329112|NCT03110562|4049671|FG000|Overall Study|Randomized but never treated|0
2329113|NCT03110562|4049672|FG001|Overall Study|Randomized but never treated|3
2329114|NCT03110562|4049671|FG000|Overall Study|Ongoing|102
2329115|NCT03110562|4049672|FG001|Overall Study|Ongoing|101
2329116|NCT03110770|4049699|FG000|Overall Study|Death|1
2329117|NCT03110770|4049700|FG001|Overall Study|Death|0
2329118|NCT03110770|4049701|FG002|Overall Study|Death|0
2329119|NCT03110770|4049702|FG003|Overall Study|Death|1
2329120|NCT03110770|4049703|FG004|Overall Study|Death|0
2329121|NCT03110770|4049699|FG000|Overall Study|Enrolled but did not receive product|0
2329122|NCT03110770|4049700|FG001|Overall Study|Enrolled but did not receive product|0
2329123|NCT03110770|4049701|FG002|Overall Study|Enrolled but did not receive product|0
2329124|NCT03110770|4049702|FG003|Overall Study|Enrolled but did not receive product|8
2329125|NCT03110770|4049703|FG004|Overall Study|Enrolled but did not receive product|7
2329126|NCT03110770|4049699|FG000|Overall Study|Lost to Follow-up|0
2329127|NCT03110770|4049700|FG001|Overall Study|Lost to Follow-up|0
2329128|NCT03110770|4049701|FG002|Overall Study|Lost to Follow-up|0
2329129|NCT03110770|4049702|FG003|Overall Study|Lost to Follow-up|53
2329130|NCT03110770|4049703|FG004|Overall Study|Lost to Follow-up|45
2329131|NCT03110770|4049699|FG000|Overall Study|Investigator Decision|0
2329132|NCT03110770|4049700|FG001|Overall Study|Investigator Decision|0
2329133|NCT03110770|4049701|FG002|Overall Study|Investigator Decision|0
2329134|NCT03110770|4049702|FG003|Overall Study|Investigator Decision|5
2329135|NCT03110770|4049703|FG004|Overall Study|Investigator Decision|3
2329136|NCT03110770|4049699|FG000|Overall Study|Withdrawal by Subject|0
2329137|NCT03110770|4049700|FG001|Overall Study|Withdrawal by Subject|0
2329138|NCT03110770|4049701|FG002|Overall Study|Withdrawal by Subject|0
2329139|NCT03110770|4049702|FG003|Overall Study|Withdrawal by Subject|24
2329140|NCT03110770|4049703|FG004|Overall Study|Withdrawal by Subject|24
2329141|NCT03110770|4049699|FG000|Overall Study|Moved from area|5
2329142|NCT03110770|4049700|FG001|Overall Study|Moved from area|0
2329143|NCT03110770|4049701|FG002|Overall Study|Moved from area|2
2329144|NCT03110770|4049702|FG003|Overall Study|Moved from area|42
2329145|NCT03110770|4049703|FG004|Overall Study|Moved from area|43
2329146|NCT03110770|4049699|FG000|Overall Study|Illness/Injury unrelated to product|0
2329147|NCT03110770|4049700|FG001|Overall Study|Illness/Injury unrelated to product|0
2329148|NCT03110770|4049701|FG002|Overall Study|Illness/Injury unrelated to product|0
2329149|NCT03110770|4049702|FG003|Overall Study|Illness/Injury unrelated to product|0
2329150|NCT03110770|4049703|FG004|Overall Study|Illness/Injury unrelated to product|1
2329151|NCT03111108|4049719|FG000|Overall Study|Death|0
2329152|NCT03111108|4049720|FG001|Overall Study|Death|1
2329153|NCT03111108|4049719|FG000|Overall Study|Withdrawal by Subject|1
2329154|NCT03111108|4049720|FG001|Overall Study|Withdrawal by Subject|0
2329155|NCT03113916|4049842|FG000|Overall Study|Withdrawal by Subject|9
2329156|NCT03113916|4049843|FG001|Overall Study|Withdrawal by Subject|7
2329157|NCT03113916|4049842|FG000|Overall Study|Pregnancy|1
2329158|NCT03113916|4049843|FG001|Overall Study|Pregnancy|3
2329159|NCT03113916|4049842|FG000|Overall Study|Lost to Follow-up|1
2329160|NCT03113916|4049843|FG001|Overall Study|Lost to Follow-up|2
2329161|NCT03114488|4049863|FG000|Time Period 2|Withdrawal by Subject|1
2329162|NCT03114488|4049864|FG001|Time Period 2|Withdrawal by Subject|3
2329163|NCT03114657|4049876|FG000|Overall Study|Adverse Event|9
2329164|NCT03114657|4049877|FG001|Overall Study|Adverse Event|6
2329165|NCT03114657|4049876|FG000|Overall Study|Death|4
2329166|NCT03114657|4049877|FG001|Overall Study|Death|0
2329167|NCT03114657|4049876|FG000|Overall Study|Multiple Reasons|1
2329168|NCT03114657|4049877|FG001|Overall Study|Multiple Reasons|2
2329169|NCT03114657|4049876|FG000|Overall Study|Physician Decision|2
2329170|NCT03114657|4049877|FG001|Overall Study|Physician Decision|2
2329171|NCT03114657|4049876|FG000|Overall Study|Study Terminated By Sponsor|355
2329172|NCT03114657|4049877|FG001|Overall Study|Study Terminated By Sponsor|374
2329173|NCT03114657|4049876|FG000|Overall Study|Symptomatic Deterioration|0
2329174|NCT03114657|4049877|FG001|Overall Study|Symptomatic Deterioration|1
2329175|NCT03114657|4049876|FG000|Overall Study|Withdrawal by Subject|28
2329176|NCT03114657|4049877|FG001|Overall Study|Withdrawal by Subject|22
2329177|NCT03114969|4049897|FG000|Overall Study|Lost to Follow-up|0
2329178|NCT03114969|4049898|FG001|Overall Study|Lost to Follow-up|0
2329179|NCT03114969|4049899|FG002|Overall Study|Lost to Follow-up|3
2329180|NCT03114969|4049900|FG003|Overall Study|Lost to Follow-up|2
2329181|NCT03114969|4049901|FG004|Overall Study|Lost to Follow-up|0
2329182|NCT03114969|4049902|FG005|Overall Study|Lost to Follow-up|0
2329183|NCT03114969|4049903|FG006|Overall Study|Lost to Follow-up|0
2329184|NCT03114969|4049904|FG007|Overall Study|Lost to Follow-up|0
2329185|NCT03114969|4049905|FG008|Overall Study|Lost to Follow-up|0
2329186|NCT03114969|4049897|FG000|Overall Study|Adverse Event|0
2329187|NCT03114969|4049898|FG001|Overall Study|Adverse Event|0
2329188|NCT03114969|4049899|FG002|Overall Study|Adverse Event|1
2329189|NCT03114969|4049900|FG003|Overall Study|Adverse Event|0
2329190|NCT03114969|4049901|FG004|Overall Study|Adverse Event|0
2329191|NCT03114969|4049902|FG005|Overall Study|Adverse Event|1
2329192|NCT03114969|4049903|FG006|Overall Study|Adverse Event|1
2329193|NCT03114969|4049904|FG007|Overall Study|Adverse Event|0
2218256|NCT01713582|3861687|FG003|Overall Study|Withdrawal of consent|0
2218257|NCT01713582|3861688|FG004|Overall Study|Withdrawal of consent|0
2329194|NCT03114969|4049905|FG008|Overall Study|Adverse Event|2
2329195|NCT03115112|4049947|FG000|Overall Study|Adverse Event|5
2329196|NCT03115112|4049948|FG001|Overall Study|Adverse Event|1
2329197|NCT03115112|4049947|FG000|Overall Study|Withdrawal by Subject|4
2329198|NCT03115112|4049948|FG001|Overall Study|Withdrawal by Subject|2
2329199|NCT03115112|4049947|FG000|Overall Study|Lost to Follow-up|0
2329200|NCT03115112|4049948|FG001|Overall Study|Lost to Follow-up|1
2329201|NCT03115112|4049947|FG000|Overall Study|Death|1
2329202|NCT03115112|4049948|FG001|Overall Study|Death|0
2329203|NCT03115112|4049947|FG000|Overall Study|Pregnancy|1
2329204|NCT03115112|4049948|FG001|Overall Study|Pregnancy|0
2329205|NCT03115112|4049947|FG000|Overall Study|Site closure|1
2329206|NCT03115112|4049948|FG001|Overall Study|Site closure|1
2329207|NCT03115476|4049972|FG000|LP0084-1369|Death|1
2329208|NCT03115476|4049973|FG001|LP0084-1369|Death|0
2329209|NCT03115476|4049974|FG002|LP0084-1369|Death|2
2329210|NCT03115476|4049972|FG000|LP0084-1369|Trial terminated by Sponsor|190
2329211|NCT03115476|4049973|FG001|LP0084-1369|Trial terminated by Sponsor|210
2329212|NCT03115476|4049974|FG002|LP0084-1369|Trial terminated by Sponsor|160
2329213|NCT03116152|4050006|FG000|Overall Study|Disease Progression|49
2329214|NCT03116152|4050007|FG001|Overall Study|Disease Progression|47
2329215|NCT03116152|4050006|FG000|Overall Study|Death|5
2329216|NCT03116152|4050007|FG001|Overall Study|Death|2
2329217|NCT03116152|4050006|FG000|Overall Study|Adverse Event|21
2329218|NCT03116152|4050007|FG001|Overall Study|Adverse Event|7
2329219|NCT03116152|4050006|FG000|Overall Study|Protocol Violation|2
2329220|NCT03116152|4050007|FG001|Overall Study|Protocol Violation|2
2329221|NCT03116152|4050006|FG000|Overall Study|Withdrawal by Subject|0
2329222|NCT03116152|4050007|FG001|Overall Study|Withdrawal by Subject|1
2329223|NCT03116152|4050006|FG000|Overall Study|Physician Decision|3
2329224|NCT03116152|4050007|FG001|Overall Study|Physician Decision|2
2329225|NCT03116152|4050006|FG000|Overall Study|other|11
2329226|NCT03116152|4050007|FG001|Overall Study|other|34
2329227|NCT03116698|4050026|FG000|Overall Study|Adverse Event|1
2329228|NCT03116698|4050027|FG001|Overall Study|Adverse Event|1
2329229|NCT03116698|4050028|FG002|Overall Study|Adverse Event|1
2329230|NCT03116698|4050029|FG003|Overall Study|Adverse Event|0
2329231|NCT03116698|4050026|FG000|Overall Study|Withdrawal by Subject|1
2329232|NCT03116698|4050027|FG001|Overall Study|Withdrawal by Subject|4
2329233|NCT03116698|4050028|FG002|Overall Study|Withdrawal by Subject|5
2329234|NCT03116698|4050029|FG003|Overall Study|Withdrawal by Subject|2
2329235|NCT03116698|4050026|FG000|Overall Study|Lost to Follow-up|2
2329236|NCT03116698|4050027|FG001|Overall Study|Lost to Follow-up|0
2329237|NCT03116698|4050028|FG002|Overall Study|Lost to Follow-up|0
2329238|NCT03116698|4050029|FG003|Overall Study|Lost to Follow-up|0
2329239|NCT03116698|4050026|FG000|Overall Study|Physician Decision|1
2329240|NCT03116698|4050027|FG001|Overall Study|Physician Decision|1
2329241|NCT03116698|4050028|FG002|Overall Study|Physician Decision|0
2329242|NCT03116698|4050029|FG003|Overall Study|Physician Decision|0
2329243|NCT03116698|4050026|FG000|Overall Study|Protocol Violation|1
2329244|NCT03116698|4050027|FG001|Overall Study|Protocol Violation|0
2329245|NCT03116698|4050028|FG002|Overall Study|Protocol Violation|0
2329246|NCT03116698|4050029|FG003|Overall Study|Protocol Violation|0
2329247|NCT03116698|4050026|FG000|Overall Study|Death|0
2329248|NCT03116698|4050027|FG001|Overall Study|Death|0
2329249|NCT03116698|4050028|FG002|Overall Study|Death|2
2329250|NCT03116698|4050029|FG003|Overall Study|Death|0
2329251|NCT03116828|4050041|FG000|Overall Study|Adverse Event|1
2329252|NCT03116828|4050042|FG001|Overall Study|Adverse Event|10
2329253|NCT03116828|4050041|FG000|Overall Study|Withdrawal by Subject|4
2329254|NCT03116828|4050042|FG001|Overall Study|Withdrawal by Subject|8
2329255|NCT03116828|4050041|FG000|Overall Study|OTHER|3
2329256|NCT03116828|4050042|FG001|Overall Study|OTHER|3
2329257|NCT03117361|4050072|FG000|Overall Study|Progressive disease|5
2329258|NCT03117361|4050072|FG000|Overall Study|Death|1
2329259|NCT03117361|4050072|FG000|Overall Study|Physician Decision|2
2329260|NCT03117361|4050072|FG000|Overall Study|On study treatment at the end of study|1
2329261|NCT03117361|4050072|FG000|Overall Study|Treatment-related adverse event|1
2329262|NCT03117738|4050113|FG000|Overall Study|Withdrawal by Subject|3
2329263|NCT03117738|4050114|FG001|Overall Study|Withdrawal by Subject|1
2329264|NCT03117738|4050113|FG000|Overall Study|Lost to Follow-up|1
2329265|NCT03117738|4050114|FG001|Overall Study|Lost to Follow-up|4
2329266|NCT03118297|4050122|FG000|Overall Study|Lost to Follow-up|0
2329267|NCT03118297|4050123|FG001|Overall Study|Lost to Follow-up|2
2329268|NCT03118518|4050135|FG000|Overall Study|Early Exit after treatment|2
2329269|NCT03118518|4050136|FG001|Overall Study|Early Exit after treatment|8
2329270|NCT03118518|4050135|FG000|Overall Study|Early Exit after randomization but prior to treatment|4
2329271|NCT03118518|4050136|FG001|Overall Study|Early Exit after randomization but prior to treatment|3
2329272|NCT03118739|4050153|FG000|Overall Study|Physician Decision|0
2329273|NCT03118739|4050154|FG001|Overall Study|Physician Decision|1
2329274|NCT03118739|4050153|FG000|Overall Study|Withdrawal by Subject|5
2329275|NCT03118739|4050154|FG001|Overall Study|Withdrawal by Subject|3
2329276|NCT03118739|4050153|FG000|Overall Study|Lost to Follow-up|2
2329277|NCT03118739|4050154|FG001|Overall Study|Lost to Follow-up|0
2329278|NCT03118765|4050165|FG000|Overall Study|Withdrawal by Subject|0
2329279|NCT03118765|4050166|FG001|Overall Study|Withdrawal by Subject|0
2329280|NCT03118765|4050167|FG002|Overall Study|Withdrawal by Subject|1
2329281|NCT03118765|4050168|FG003|Overall Study|Withdrawal by Subject|0
2329282|NCT03118765|4050169|FG004|Overall Study|Withdrawal by Subject|0
2329283|NCT03118765|4050165|FG000|Overall Study|Adverse Event|1
2329284|NCT03118765|4050166|FG001|Overall Study|Adverse Event|1
2329285|NCT03118765|4050167|FG002|Overall Study|Adverse Event|1
2329286|NCT03118765|4050168|FG003|Overall Study|Adverse Event|1
2329287|NCT03118765|4050169|FG004|Overall Study|Adverse Event|1
2329288|NCT03118765|4050165|FG000|Overall Study|Non compliance with Study Procedures|0
2329289|NCT03118765|4050166|FG001|Overall Study|Non compliance with Study Procedures|0
2329290|NCT03118765|4050167|FG002|Overall Study|Non compliance with Study Procedures|0
2329291|NCT03118765|4050168|FG003|Overall Study|Non compliance with Study Procedures|1
2329292|NCT03118765|4050169|FG004|Overall Study|Non compliance with Study Procedures|0
2329293|NCT03118765|4050165|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0
2329294|NCT03118765|4050166|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1
2329295|NCT03118765|4050167|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1
2329296|NCT03118765|4050168|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0
2329297|NCT03118765|4050169|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0
2329298|NCT03118765|4050165|FG000|Overall Study|COPD Exacerbation|1
2329299|NCT03118765|4050166|FG001|Overall Study|COPD Exacerbation|0
2329300|NCT03118765|4050167|FG002|Overall Study|COPD Exacerbation|0
2329301|NCT03118765|4050168|FG003|Overall Study|COPD Exacerbation|1
2329302|NCT03118765|4050169|FG004|Overall Study|COPD Exacerbation|0
2329303|NCT03118765|4050165|FG000|Overall Study|Lost to Follow-up|1
2329304|NCT03118765|4050166|FG001|Overall Study|Lost to Follow-up|0
2329305|NCT03118765|4050167|FG002|Overall Study|Lost to Follow-up|1
2329306|NCT03118765|4050168|FG003|Overall Study|Lost to Follow-up|0
2329307|NCT03118765|4050169|FG004|Overall Study|Lost to Follow-up|0
2329308|NCT03118765|4050165|FG000|Overall Study|Sponsor Decision|1
2329309|NCT03118765|4050166|FG001|Overall Study|Sponsor Decision|0
2329310|NCT03118765|4050167|FG002|Overall Study|Sponsor Decision|1
2329311|NCT03118765|4050168|FG003|Overall Study|Sponsor Decision|0
2329312|NCT03118765|4050169|FG004|Overall Study|Sponsor Decision|1
2329313|NCT03118934|4050189|FG000|Overall Study|Adverse Event|0
2329314|NCT03118934|4050190|FG001|Overall Study|Adverse Event|0
2329315|NCT03118934|4050191|FG002|Overall Study|Adverse Event|0
2329316|NCT03118934|4050192|FG003|Overall Study|Adverse Event|0
2329317|NCT03118934|4050193|FG004|Overall Study|Adverse Event|0
2329318|NCT03118934|4050194|FG005|Overall Study|Adverse Event|1
2329319|NCT03118934|4050189|FG000|Overall Study|Physician Decision|0
2329320|NCT03118934|4050190|FG001|Overall Study|Physician Decision|0
2329321|NCT03118934|4050191|FG002|Overall Study|Physician Decision|0
2329322|NCT03118934|4050192|FG003|Overall Study|Physician Decision|0
2329323|NCT03118934|4050193|FG004|Overall Study|Physician Decision|0
2329324|NCT03118934|4050194|FG005|Overall Study|Physician Decision|1
2329325|NCT03118934|4050189|FG000|Overall Study|Discontinued prior to exposure|0
2329326|NCT03118934|4050190|FG001|Overall Study|Discontinued prior to exposure|1
2329327|NCT03118934|4050191|FG002|Overall Study|Discontinued prior to exposure|1
2329328|NCT03118934|4050192|FG003|Overall Study|Discontinued prior to exposure|1
2329329|NCT03118934|4050193|FG004|Overall Study|Discontinued prior to exposure|2
2329330|NCT03118934|4050194|FG005|Overall Study|Discontinued prior to exposure|0
2329331|NCT03118947|4050204|FG000|Overall Study|Adverse Event|7
2329332|NCT03118947|4050204|FG000|Overall Study|Death|3
2329333|NCT03118947|4050204|FG000|Overall Study|Lack of Efficacy|4
2329334|NCT03118947|4050204|FG000|Overall Study|Non-compliance with study drug|1
2329335|NCT03118947|4050204|FG000|Overall Study|Protocol Violation|2
2329336|NCT03118947|4050204|FG000|Overall Study|Withdrawal by Subject|3
2329337|NCT03118947|4050204|FG000|Overall Study|Withdrawal by caregiver|3
2329338|NCT03118947|4050204|FG000|Overall Study|Change in patient's living situation|4
2329339|NCT03118947|4050204|FG000|Overall Study|Lost to Follow-up|2
2329340|NCT03119610|4050254|FG000|Overall Study|Adverse Event|1
2329341|NCT03119610|4050255|FG001|Overall Study|Adverse Event|0
2329342|NCT03119610|4050254|FG000|Overall Study|Lost to Follow-up|0
2329343|NCT03119610|4050255|FG001|Overall Study|Lost to Follow-up|1
2329344|NCT03119688|4050286|FG000|Overall Study|Adverse Event|4
2329345|NCT03119701|4050305|FG000|6-day Dosing|Death|4
2329346|NCT03119701|4050306|FG001|6-day Dosing|Death|1
2329347|NCT03119701|4050305|FG000|6-day Dosing|Adverse Event|3
2329348|NCT03119701|4050306|FG001|6-day Dosing|Adverse Event|0
2329349|NCT03119701|4050305|FG000|6-day Dosing|Physician Decision|0
2329350|NCT03119701|4050306|FG001|6-day Dosing|Physician Decision|1
2329351|NCT03119701|4050305|FG000|6-day Dosing|Withdrawal by Subject|0
2329352|NCT03119701|4050306|FG001|6-day Dosing|Withdrawal by Subject|1
2329353|NCT03119701|4050305|FG000|Mid-term (Final) Follow-up at D90|Death|3
2031075|NCT00381849|3600646|FG001|Wash Out|Withdrawal by Subject|1
2329354|NCT03119701|4050306|FG001|Mid-term (Final) Follow-up at D90|Death|1
2329355|NCT03120013|4050328|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
2329356|NCT03120013|4050329|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
2329357|NCT03120351|4050337|FG000|Overall Study|Physician Decision|1
2329358|NCT03120351|4050338|FG001|Overall Study|Physician Decision|1
2352555|NCT03765138|4102048|FG000|Overall Study|Lost to Follow-up|1
2352556|NCT03762681|4102116|FG000|Part 1|Withdrawal by Subject|0
2352557|NCT03762681|4102117|FG001|Part 1|Withdrawal by Subject|0
2352558|NCT03762681|4102118|FG002|Part 1|Withdrawal by Subject|0
2352559|NCT03762681|4102119|FG003|Part 1|Withdrawal by Subject|1
2352560|NCT03762681|4102120|FG004|Part 1|Withdrawal by Subject|0
2352561|NCT03762681|4102121|FG005|Part 1|Withdrawal by Subject|0
2352562|NCT03762681|4102122|FG006|Part 1|Withdrawal by Subject|0
2352563|NCT03762681|4102123|FG007|Part 1|Withdrawal by Subject|0
2352564|NCT03762681|4102116|FG000|Part 2a|Pandemic Travel Restrictions|0
2352565|NCT03762681|4102117|FG001|Part 2a|Pandemic Travel Restrictions|0
2352566|NCT03762681|4102118|FG002|Part 2a|Pandemic Travel Restrictions|0
2352567|NCT03762681|4102119|FG003|Part 2a|Pandemic Travel Restrictions|0
2352568|NCT03762681|4102120|FG004|Part 2a|Pandemic Travel Restrictions|0
2352569|NCT03762681|4102121|FG005|Part 2a|Pandemic Travel Restrictions|0
2352570|NCT03762681|4102122|FG006|Part 2a|Pandemic Travel Restrictions|0
2352571|NCT03762681|4102123|FG007|Part 2a|Pandemic Travel Restrictions|1
2352572|NCT03762668|4102152|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0
2352573|NCT03762668|4102153|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1
2352574|NCT03762616|4102159|FG000|Overall Study|Protocol Violation|2
2352575|NCT03762200|4102174|FG000|Overall Study|Death|2
2352576|NCT03761147|4102189|FG000|Overall Study|Withdrawal by Subject|6
2352577|NCT03761147|4102190|FG001|Overall Study|Withdrawal by Subject|1
2352578|NCT03761147|4102189|FG000|Overall Study|Adverse Event|1
2352579|NCT03761147|4102190|FG001|Overall Study|Adverse Event|3
2352580|NCT03760510|4102304|FG000|Overall Study|Not ventilated for 24 hours|105
2352581|NCT03760510|4102305|FG001|Overall Study|Not ventilated for 24 hours|97
2352582|NCT03760250|4102311|FG000|Overall Study|Withdrawal by Subject|1
2352583|NCT03760250|4102311|FG000|Overall Study|Physician Decision|1
2352584|NCT03759600|4102315|FG000|Overall Study|Ongoing at Data Cut-off|16
2352585|NCT03759600|4102315|FG000|Overall Study|Adverse Event|1
2352586|NCT03759600|4102315|FG000|Overall Study|Progressive Disease|3
2352587|NCT03759340|4102319|FG000|Overall Study|Adverse Event|2
2352588|NCT03759340|4102319|FG000|Overall Study|Lost to Follow-up|1
2352589|NCT03759340|4102319|FG000|Overall Study|Withdrawal by Subject|15
2352590|NCT03759340|4102319|FG000|Overall Study|Study Terminated by Sponsor|38
2352591|NCT03757988|4102342|FG000|Overall Study|Withdrawal by Subject|1
2352592|NCT03757234|4102363|FG000|Overall Study|Adverse Event|0
2352593|NCT03757234|4102364|FG001|Overall Study|Adverse Event|0
2352594|NCT03757234|4102365|FG002|Overall Study|Adverse Event|0
2352595|NCT03757234|4102366|FG003|Overall Study|Adverse Event|0
2352596|NCT03757234|4102367|FG004|Overall Study|Adverse Event|1
2352597|NCT03757234|4102363|FG000|Overall Study|Lost to Follow-up|1
2352598|NCT03757234|4102364|FG001|Overall Study|Lost to Follow-up|0
2352599|NCT03757234|4102365|FG002|Overall Study|Lost to Follow-up|0
2352600|NCT03757234|4102366|FG003|Overall Study|Lost to Follow-up|0
2352601|NCT03757234|4102367|FG004|Overall Study|Lost to Follow-up|1
2352602|NCT03757234|4102363|FG000|Overall Study|Withdrawal by Subject|1
2352603|NCT03757234|4102364|FG001|Overall Study|Withdrawal by Subject|1
2352604|NCT03757234|4102365|FG002|Overall Study|Withdrawal by Subject|0
2352605|NCT03757234|4102366|FG003|Overall Study|Withdrawal by Subject|1
2352606|NCT03757234|4102367|FG004|Overall Study|Withdrawal by Subject|2
2352607|NCT03757234|4102363|FG000|Overall Study|Other|1
2352608|NCT03757234|4102364|FG001|Overall Study|Other|1
2352609|NCT03757234|4102365|FG002|Overall Study|Other|0
2352610|NCT03757234|4102366|FG003|Overall Study|Other|0
2352611|NCT03757234|4102367|FG004|Overall Study|Other|0
2352612|NCT03756883|4102395|FG000|Overall Study|Adverse Event|2
2352613|NCT03756883|4102396|FG001|Overall Study|Adverse Event|2
2352614|NCT03756883|4102397|FG002|Overall Study|Adverse Event|2
2352615|NCT03756883|4102395|FG000|Overall Study|Lack of Efficacy|0
2352616|NCT03756883|4102396|FG001|Overall Study|Lack of Efficacy|1
2352617|NCT03756883|4102397|FG002|Overall Study|Lack of Efficacy|2
2352618|NCT03756883|4102395|FG000|Overall Study|Lost to Follow-up|3
2352619|NCT03756883|4102396|FG001|Overall Study|Lost to Follow-up|3
2352620|NCT03756883|4102397|FG002|Overall Study|Lost to Follow-up|0
2352621|NCT03756883|4102395|FG000|Overall Study|Protocol Violation|2
2352622|NCT03756883|4102396|FG001|Overall Study|Protocol Violation|0
2352623|NCT03756883|4102397|FG002|Overall Study|Protocol Violation|1
2352624|NCT03756883|4102395|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0
2352625|NCT03756883|4102396|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0
2352626|NCT03756883|4102397|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2
2352627|NCT03756883|4102395|FG000|Overall Study|Withdrawal by Subject|4
2352628|NCT03756883|4102396|FG001|Overall Study|Withdrawal by Subject|1
2352629|NCT03756883|4102397|FG002|Overall Study|Withdrawal by Subject|0
2352630|NCT03756883|4102395|FG000|Overall Study|Other Reasons|2
2352631|NCT03756883|4102396|FG001|Overall Study|Other Reasons|4
2352632|NCT03756883|4102397|FG002|Overall Study|Other Reasons|0
2352633|NCT03756285|4102416|FG000|Overall Study|Lost to Follow-up|0
2352634|NCT03756285|4102417|FG001|Overall Study|Lost to Follow-up|1
2352635|NCT03756285|4102416|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0
2329359|NCT03120520|4050348|FG000|Overall Study|Lost to Follow-up|1
2329360|NCT03120520|4050349|FG001|Overall Study|Lost to Follow-up|1
2329361|NCT03120520|4050350|FG002|Overall Study|Lost to Follow-up|1
2329362|NCT03120520|4050351|FG003|Overall Study|Lost to Follow-up|1
2329363|NCT03120520|4050348|FG000|Overall Study|Withdrawal by Subject|3
2329364|NCT03120520|4050349|FG001|Overall Study|Withdrawal by Subject|2
2329365|NCT03120520|4050350|FG002|Overall Study|Withdrawal by Subject|3
2329366|NCT03120520|4050351|FG003|Overall Study|Withdrawal by Subject|2
2329367|NCT03120520|4050348|FG000|Overall Study|Other|0
2329368|NCT03120520|4050349|FG001|Overall Study|Other|1
2329369|NCT03120520|4050350|FG002|Overall Study|Other|0
2329370|NCT03120520|4050351|FG003|Overall Study|Other|0
2329371|NCT03121950|4050411|FG000|Overall Study|Withdrawal by Subject|11
2329372|NCT03121950|4050412|FG001|Overall Study|Withdrawal by Subject|2
2329373|NCT03122145|4050422|FG000|Overall Study|Concurrent respiratory disease|3
2329374|NCT03122145|4050423|FG001|Overall Study|Concurrent respiratory disease|0
2329375|NCT03122171|4050429|FG000|Overall Study|Withdrawal by Subject|1
2329376|NCT03122184|4050435|FG000|Overall Study|Lost to Follow-up|4
2329377|NCT03122184|4050436|FG001|Overall Study|Lost to Follow-up|6
2329378|NCT03122184|4050435|FG000|Overall Study|Withdrawal by Subject|3
2329379|NCT03122184|4050436|FG001|Overall Study|Withdrawal by Subject|0
2329380|NCT03122184|4050435|FG000|Overall Study|Terminated due to cognitive problem|1
2329381|NCT03122184|4050436|FG001|Overall Study|Terminated due to cognitive problem|0
2329382|NCT03122223|4050446|FG000|Overall Study|Withdrawal by Subject|2
2329383|NCT03122223|4050447|FG001|Overall Study|Withdrawal by Subject|2
2329384|NCT03122223|4050448|FG002|Overall Study|Withdrawal by Subject|1
2329385|NCT03122223|4050449|FG003|Overall Study|Withdrawal by Subject|0
2329386|NCT03122223|4050446|FG000|Overall Study|Lost to Follow-up|0
2329387|NCT03122223|4050447|FG001|Overall Study|Lost to Follow-up|2
2329388|NCT03122223|4050448|FG002|Overall Study|Lost to Follow-up|2
2329389|NCT03122223|4050449|FG003|Overall Study|Lost to Follow-up|0
2218258|NCT01713582|3861689|FG005|Overall Study|Withdrawal of consent|1
2329390|NCT03122223|4050446|FG000|Overall Study|Participant unable to adhere|1
2329391|NCT03122223|4050447|FG001|Overall Study|Participant unable to adhere|1
2329392|NCT03122223|4050448|FG002|Overall Study|Participant unable to adhere|1
2329393|NCT03122223|4050449|FG003|Overall Study|Participant unable to adhere|0
2329394|NCT03122457|4050459|FG000|Overall Study|Withdrawal by Subject|6
2329395|NCT03122535|4050463|FG000|Overall Study|Lost to Follow-up|68
2329396|NCT03122535|4050464|FG001|Overall Study|Lost to Follow-up|68
2329397|NCT03122535|4050463|FG000|Overall Study|Physician Decision|3
2329398|NCT03122535|4050464|FG001|Overall Study|Physician Decision|3
2329399|NCT03122535|4050463|FG000|Overall Study|Withdrawal by Subject|2
2329400|NCT03122535|4050464|FG001|Overall Study|Withdrawal by Subject|2
2329401|NCT03122548|4050470|FG000|Overall Study|Death|2
2329402|NCT03122548|4050470|FG000|Overall Study|Progression - subject went into hospice|1
2329403|NCT03122548|4050470|FG000|Overall Study|Study Terminated by Sponsor|2
2329404|NCT03122860|4050493|FG000|Overall Study|Discontinued Before Treatment|1
2329405|NCT03122860|4050494|FG001|Overall Study|Discontinued Before Treatment|1
2329406|NCT03122860|4050495|FG002|Overall Study|Discontinued Before Treatment|2
2329407|NCT03122860|4050496|FG003|Overall Study|Discontinued Before Treatment|0
2329408|NCT03122860|4050497|FG004|Overall Study|Discontinued Before Treatment|1
2329409|NCT03122860|4050498|FG005|Overall Study|Discontinued Before Treatment|0
2329410|NCT03122860|4050493|FG000|Overall Study|Adverse Event|1
2329411|NCT03122860|4050494|FG001|Overall Study|Adverse Event|0
2329412|NCT03122860|4050495|FG002|Overall Study|Adverse Event|1
2329413|NCT03122860|4050496|FG003|Overall Study|Adverse Event|1
2329414|NCT03122860|4050497|FG004|Overall Study|Adverse Event|0
2329415|NCT03122860|4050498|FG005|Overall Study|Adverse Event|0
2218259|NCT01713582|3861690|FG006|Overall Study|Withdrawal of consent|0
2218260|NCT01713582|3861691|FG007|Overall Study|Withdrawal of consent|0
2218261|NCT01713582|3861692|FG008|Overall Study|Withdrawal of consent|0
2218262|NCT01713582|3861693|FG009|Overall Study|Withdrawal of consent|1
2218263|NCT01713582|3861694|FG010|Overall Study|Withdrawal of consent|0
2218264|NCT01713582|3861695|FG011|Overall Study|Withdrawal of consent|0
2218265|NCT01713582|3861696|FG012|Overall Study|Withdrawal of consent|0
2218266|NCT01713582|3861697|FG013|Overall Study|Withdrawal of consent|0
2218267|NCT01713582|3861698|FG014|Overall Study|Withdrawal of consent|0
2218268|NCT01713582|3861699|FG015|Overall Study|Withdrawal of consent|0
2218269|NCT01713582|3861700|FG016|Overall Study|Withdrawal of consent|0
2218270|NCT01713582|3861701|FG017|Overall Study|Withdrawal of consent|0
2218271|NCT01713582|3861702|FG018|Overall Study|Withdrawal of consent|1
2218272|NCT01713582|3861703|FG019|Overall Study|Withdrawal of consent|0
2218273|NCT01713582|3861704|FG020|Overall Study|Withdrawal of consent|0
2329416|NCT03122860|4050493|FG000|Overall Study|Lost to Follow-up|5
2329417|NCT03122860|4050494|FG001|Overall Study|Lost to Follow-up|2
2329418|NCT03122860|4050495|FG002|Overall Study|Lost to Follow-up|3
2329419|NCT03122860|4050496|FG003|Overall Study|Lost to Follow-up|3
2218274|NCT01713582|3861684|FG000|Overall Study|Lack of Efficacy|0
2329420|NCT03122860|4050497|FG004|Overall Study|Lost to Follow-up|5
2329421|NCT03122860|4050498|FG005|Overall Study|Lost to Follow-up|4
2329422|NCT03122860|4050493|FG000|Overall Study|Subject Non-Compliance|0
2329423|NCT03122860|4050494|FG001|Overall Study|Subject Non-Compliance|0
2329424|NCT03122860|4050495|FG002|Overall Study|Subject Non-Compliance|1
2218275|NCT01713582|3861685|FG001|Overall Study|Lack of Efficacy|0
2218276|NCT01713582|3861686|FG002|Overall Study|Lack of Efficacy|0
2218277|NCT01713582|3861687|FG003|Overall Study|Lack of Efficacy|0
2218278|NCT01713582|3861688|FG004|Overall Study|Lack of Efficacy|0
2218279|NCT01713582|3861689|FG005|Overall Study|Lack of Efficacy|0
2218280|NCT01713582|3861690|FG006|Overall Study|Lack of Efficacy|0
2218281|NCT01713582|3861691|FG007|Overall Study|Lack of Efficacy|0
2218282|NCT01713582|3861692|FG008|Overall Study|Lack of Efficacy|0
2218283|NCT01713582|3861693|FG009|Overall Study|Lack of Efficacy|1
2218284|NCT01713582|3861694|FG010|Overall Study|Lack of Efficacy|2
2218285|NCT01713582|3861695|FG011|Overall Study|Lack of Efficacy|0
2218286|NCT01713582|3861696|FG012|Overall Study|Lack of Efficacy|0
2218287|NCT01713582|3861697|FG013|Overall Study|Lack of Efficacy|0
2218288|NCT01713582|3861698|FG014|Overall Study|Lack of Efficacy|0
2218289|NCT01713582|3861699|FG015|Overall Study|Lack of Efficacy|0
2218290|NCT01713582|3861700|FG016|Overall Study|Lack of Efficacy|0
2218291|NCT01713582|3861701|FG017|Overall Study|Lack of Efficacy|0
2218292|NCT01713582|3861702|FG018|Overall Study|Lack of Efficacy|0
2218293|NCT01713582|3861703|FG019|Overall Study|Lack of Efficacy|0
2329425|NCT03122860|4050496|FG003|Overall Study|Subject Non-Compliance|0
2329426|NCT03122860|4050497|FG004|Overall Study|Subject Non-Compliance|0
2329427|NCT03122860|4050498|FG005|Overall Study|Subject Non-Compliance|0
2329428|NCT03122860|4050493|FG000|Overall Study|Withdrawal by Subject|3
2329429|NCT03122860|4050494|FG001|Overall Study|Withdrawal by Subject|2
2329430|NCT03122860|4050495|FG002|Overall Study|Withdrawal by Subject|5
2329431|NCT03122860|4050496|FG003|Overall Study|Withdrawal by Subject|7
2329432|NCT03122860|4050497|FG004|Overall Study|Withdrawal by Subject|9
2329433|NCT03122860|4050498|FG005|Overall Study|Withdrawal by Subject|8
2329434|NCT03122886|4050515|FG000|Overall Study|Withdrawal by Subject|1
2218294|NCT01713582|3861704|FG020|Overall Study|Lack of Efficacy|0
2218295|NCT01713582|3861684|FG000|Overall Study|Withdrawal by Subject|0
2218296|NCT01713582|3861685|FG001|Overall Study|Withdrawal by Subject|0
2218297|NCT01713582|3861686|FG002|Overall Study|Withdrawal by Subject|0
2218298|NCT01713582|3861687|FG003|Overall Study|Withdrawal by Subject|0
2218299|NCT01713582|3861688|FG004|Overall Study|Withdrawal by Subject|0
2218300|NCT01713582|3861689|FG005|Overall Study|Withdrawal by Subject|0
2218301|NCT01713582|3861690|FG006|Overall Study|Withdrawal by Subject|0
2218302|NCT01713582|3861691|FG007|Overall Study|Withdrawal by Subject|0
2218303|NCT01713582|3861692|FG008|Overall Study|Withdrawal by Subject|0
2218304|NCT01713582|3861693|FG009|Overall Study|Withdrawal by Subject|0
2218305|NCT01713582|3861694|FG010|Overall Study|Withdrawal by Subject|0
2218306|NCT01713582|3861695|FG011|Overall Study|Withdrawal by Subject|0
2218307|NCT01713582|3861696|FG012|Overall Study|Withdrawal by Subject|0
2218308|NCT01713582|3861697|FG013|Overall Study|Withdrawal by Subject|0
2218309|NCT01713582|3861698|FG014|Overall Study|Withdrawal by Subject|0
2218310|NCT01713582|3861699|FG015|Overall Study|Withdrawal by Subject|0
2218311|NCT01713582|3861700|FG016|Overall Study|Withdrawal by Subject|0
2218312|NCT01713582|3861701|FG017|Overall Study|Withdrawal by Subject|1
2218313|NCT01713582|3861702|FG018|Overall Study|Withdrawal by Subject|0
2218314|NCT01713582|3861703|FG019|Overall Study|Withdrawal by Subject|0
2218315|NCT01713582|3861704|FG020|Overall Study|Withdrawal by Subject|0
2218316|NCT01713582|3861684|FG000|Overall Study|Stopped to receive bone marrow graft|0
2218317|NCT01713582|3861685|FG001|Overall Study|Stopped to receive bone marrow graft|0
2218318|NCT01713582|3861686|FG002|Overall Study|Stopped to receive bone marrow graft|0
2218319|NCT01713582|3861687|FG003|Overall Study|Stopped to receive bone marrow graft|0
2218320|NCT01713582|3861688|FG004|Overall Study|Stopped to receive bone marrow graft|0
2218321|NCT01713582|3861689|FG005|Overall Study|Stopped to receive bone marrow graft|0
2218322|NCT01713582|3861690|FG006|Overall Study|Stopped to receive bone marrow graft|0
2218323|NCT01713582|3861691|FG007|Overall Study|Stopped to receive bone marrow graft|0
2218324|NCT01713582|3861692|FG008|Overall Study|Stopped to receive bone marrow graft|0
2218325|NCT01713582|3861693|FG009|Overall Study|Stopped to receive bone marrow graft|0
2218326|NCT01713582|3861694|FG010|Overall Study|Stopped to receive bone marrow graft|0
2218327|NCT01713582|3861695|FG011|Overall Study|Stopped to receive bone marrow graft|0
2218328|NCT01713582|3861696|FG012|Overall Study|Stopped to receive bone marrow graft|0
2218329|NCT01713582|3861697|FG013|Overall Study|Stopped to receive bone marrow graft|0
2218330|NCT01713582|3861698|FG014|Overall Study|Stopped to receive bone marrow graft|0
2218331|NCT01713582|3861699|FG015|Overall Study|Stopped to receive bone marrow graft|0
2218332|NCT01713582|3861700|FG016|Overall Study|Stopped to receive bone marrow graft|1
2218333|NCT01713582|3861701|FG017|Overall Study|Stopped to receive bone marrow graft|0
2218334|NCT01713582|3861702|FG018|Overall Study|Stopped to receive bone marrow graft|0
2218335|NCT01713582|3861703|FG019|Overall Study|Stopped to receive bone marrow graft|0
2218336|NCT01713582|3861704|FG020|Overall Study|Stopped to receive bone marrow graft|0
2218337|NCT01713582|3861684|FG000|Overall Study|Disease progression and adverse event|0
2218338|NCT01713582|3861685|FG001|Overall Study|Disease progression and adverse event|0
2218339|NCT01713582|3861686|FG002|Overall Study|Disease progression and adverse event|0
2218340|NCT01713582|3861687|FG003|Overall Study|Disease progression and adverse event|0
2218341|NCT01713582|3861688|FG004|Overall Study|Disease progression and adverse event|0
2329435|NCT03122886|4050516|FG001|Overall Study|Withdrawal by Subject|2
2218342|NCT01713582|3861689|FG005|Overall Study|Disease progression and adverse event|0
2218343|NCT01713582|3861690|FG006|Overall Study|Disease progression and adverse event|0
2218344|NCT01713582|3861691|FG007|Overall Study|Disease progression and adverse event|0
2218345|NCT01713582|3861692|FG008|Overall Study|Disease progression and adverse event|0
2218346|NCT01713582|3861693|FG009|Overall Study|Disease progression and adverse event|0
2218347|NCT01713582|3861694|FG010|Overall Study|Disease progression and adverse event|0
2218348|NCT01713582|3861695|FG011|Overall Study|Disease progression and adverse event|0
2218349|NCT01713582|3861696|FG012|Overall Study|Disease progression and adverse event|0
2218350|NCT01713582|3861697|FG013|Overall Study|Disease progression and adverse event|0
2218351|NCT01713582|3861698|FG014|Overall Study|Disease progression and adverse event|0
2218352|NCT01713582|3861699|FG015|Overall Study|Disease progression and adverse event|0
2218353|NCT01713582|3861700|FG016|Overall Study|Disease progression and adverse event|1
2218354|NCT01713582|3861701|FG017|Overall Study|Disease progression and adverse event|0
2218355|NCT01713582|3861702|FG018|Overall Study|Disease progression and adverse event|0
2218356|NCT01713582|3861703|FG019|Overall Study|Disease progression and adverse event|0
2218357|NCT01713582|3861704|FG020|Overall Study|Disease progression and adverse event|0
2218358|NCT01713686|3861791|FG000|Overall Study|Lost to Follow-up|9
2218359|NCT01713686|3861791|FG000|Overall Study|Withdrawal by Subject|6
2218360|NCT01713933|3861814|FG000|Overall Study|Lost to Follow-up|2
2218361|NCT01713933|3861814|FG000|Overall Study|Withdrawal by Subject|3
2218362|NCT01713933|3861814|FG000|Overall Study|Excluded from analysis as a BMI outlier|1
2218363|NCT01713946|3861821|FG000|Overall Study|Death|0
2218364|NCT01713946|3861822|FG001|Overall Study|Death|2
2218365|NCT01713946|3861823|FG002|Overall Study|Death|2
2218366|NCT01713946|3861821|FG000|Overall Study|Adverse Event|19
2218367|NCT01713946|3861822|FG001|Overall Study|Adverse Event|14
2218368|NCT01713946|3861823|FG002|Overall Study|Adverse Event|13
2218369|NCT01713946|3861821|FG000|Overall Study|Withdrawal by Subject|12
2218370|NCT01713946|3861822|FG001|Overall Study|Withdrawal by Subject|12
2218371|NCT01713946|3861823|FG002|Overall Study|Withdrawal by Subject|8
2218372|NCT01713946|3861821|FG000|Overall Study|Lack of Efficacy|8
2218373|NCT01713946|3861822|FG001|Overall Study|Lack of Efficacy|8
2218374|NCT01713946|3861823|FG002|Overall Study|Lack of Efficacy|14
2218375|NCT01713946|3861821|FG000|Overall Study|Protocol Violation|2
2218376|NCT01713946|3861822|FG001|Overall Study|Protocol Violation|4
2218377|NCT01713946|3861823|FG002|Overall Study|Protocol Violation|1
2218378|NCT01713946|3861821|FG000|Overall Study|Lost to Follow-up|0
2218379|NCT01713946|3861822|FG001|Overall Study|Lost to Follow-up|0
2218380|NCT01713946|3861823|FG002|Overall Study|Lost to Follow-up|1
2218381|NCT01713946|3861821|FG000|Overall Study|Administrative problems|1
2218382|NCT01713946|3861822|FG001|Overall Study|Administrative problems|0
2218383|NCT01713946|3861823|FG002|Overall Study|Administrative problems|0
2218384|NCT01713946|3861821|FG000|Overall Study|Did not continue in Ext|0
2329436|NCT03123120|4050538|FG000|Overall Study|Lost to Follow-up|0
2329437|NCT03123120|4050539|FG001|Overall Study|Lost to Follow-up|1
2329438|NCT03123120|4050538|FG000|Overall Study|Withdrawal by Subject|0
2329439|NCT03123120|4050539|FG001|Overall Study|Withdrawal by Subject|1
2329440|NCT03123354|4050554|FG000|Overall Study|Physician Decision|6
2329441|NCT03123471|4050560|FG000|Placebo-controlled Phase|Adverse Event|3
2329442|NCT03123471|4050561|FG001|Placebo-controlled Phase|Adverse Event|8
2329443|NCT03123471|4050560|FG000|Placebo-controlled Phase|Lack of Efficacy|3
2329444|NCT03123471|4050561|FG001|Placebo-controlled Phase|Lack of Efficacy|4
2218385|NCT01713946|3861822|FG001|Overall Study|Did not continue in Ext|3
2218386|NCT01713946|3861823|FG002|Overall Study|Did not continue in Ext|0
2218387|NCT01713946|3861821|FG000|Overall Study|Did not continue in Post-Ext. Phase|1
2218388|NCT01713946|3861822|FG001|Overall Study|Did not continue in Post-Ext. Phase|2
2218389|NCT01713946|3861823|FG002|Overall Study|Did not continue in Post-Ext. Phase|0
2218390|NCT01713946|3861821|FG000|Overall Study|Patients never switched to everolimus|0
2218391|NCT01713946|3861822|FG001|Overall Study|Patients never switched to everolimus|0
2218392|NCT01713946|3861823|FG002|Overall Study|Patients never switched to everolimus|5
2218393|NCT01713998|3861852|FG000|Overall Study|Lost to Follow-up|2
2218394|NCT01713998|3861853|FG001|Overall Study|Lost to Follow-up|0
2218395|NCT01713998|3861854|FG002|Overall Study|Lost to Follow-up|2
2218396|NCT01713998|3861852|FG000|Overall Study|Withdrawal by Subject|1
2218397|NCT01713998|3861853|FG001|Overall Study|Withdrawal by Subject|0
2218398|NCT01713998|3861854|FG002|Overall Study|Withdrawal by Subject|0
2218399|NCT01714063|3861884|FG000|Overall Study|Equipment malfunction|2
2218400|NCT01714310|3861899|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0
2218401|NCT01714310|3861900|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0
2218402|NCT01714310|3861901|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1
2218403|NCT01714310|3861899|FG000|Open Lisdexamfetamine Titration|Adverse Event|0
2218404|NCT01714310|3861900|FG001|Open Lisdexamfetamine Titration|Adverse Event|0
2218405|NCT01714310|3861901|FG002|Open Lisdexamfetamine Titration|Adverse Event|3
2218406|NCT01714310|3861899|FG000|Double Blind Adjunctive Treatment|Adverse Event|1
2218407|NCT01714310|3861900|FG001|Double Blind Adjunctive Treatment|Adverse Event|1
2218408|NCT01714310|3861901|FG002|Double Blind Adjunctive Treatment|Adverse Event|0
2329445|NCT03123471|4050560|FG000|Placebo-controlled Phase|Withdrawal by Subject|6
2329446|NCT03123471|4050561|FG001|Placebo-controlled Phase|Withdrawal by Subject|16
2218409|NCT01714310|3861899|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1
2218410|NCT01714310|3861900|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2
2218411|NCT01714310|3861901|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0
2218412|NCT01714544|3861949|FG000|Overall Study|Lost to Follow-up|1
2218413|NCT01714544|3861949|FG000|Overall Study|Physician Decision|1
2218414|NCT01714544|3861949|FG000|Overall Study|Withdrawal by Subject|1
2218415|NCT01714609|3861955|FG000|Overall Study|Protocol Violation|1
2218416|NCT01714609|3861956|FG001|Overall Study|Protocol Violation|0
2218417|NCT01714635|3861965|FG000|Overall Study|Discontinued|1
2218418|NCT01714635|3861966|FG001|Overall Study|Discontinued|0
2218419|NCT01714635|3861967|FG002|Overall Study|Discontinued|2
2218420|NCT01714635|3861965|FG000|Overall Study|Missed 6-month exam|1
2218421|NCT01714635|3861966|FG001|Overall Study|Missed 6-month exam|0
2218422|NCT01714635|3861967|FG002|Overall Study|Missed 6-month exam|0
2218423|NCT01714687|3861977|FG000|Overall Study|Withdrawal by Subject|1
2218424|NCT01714687|3861978|FG001|Overall Study|Withdrawal by Subject|0
2218425|NCT01714687|3861977|FG000|Overall Study|Lost to Follow-up|2
2218426|NCT01714687|3861978|FG001|Overall Study|Lost to Follow-up|4
2218427|NCT01714726|3861988|FG000|Double-Blinded Induction Period|Subject not in open label period|3
2218428|NCT01714726|3861989|FG001|Double-Blinded Induction Period|Subject not in open label period|1
2218429|NCT01714726|3861990|FG002|Double-Blinded Induction Period|Subject not in open label period|0
2218430|NCT01714726|3861991|FG003|Double-Blinded Induction Period|Subject not in open label period|0
2218431|NCT01714726|3861988|FG000|Double-Blinded Induction Period|Adverse Event|0
2218432|NCT01714726|3861989|FG001|Double-Blinded Induction Period|Adverse Event|1
2218433|NCT01714726|3861990|FG002|Double-Blinded Induction Period|Adverse Event|0
2218434|NCT01714726|3861991|FG003|Double-Blinded Induction Period|Adverse Event|0
2218435|NCT01714726|3861988|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5
2218436|NCT01714726|3861989|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3
2218437|NCT01714726|3861990|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0
2218438|NCT01714726|3861991|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0
2218439|NCT01714726|3861988|FG000|Double-Blinded Induction Period|Lost to Follow-up|0
2218440|NCT01714726|3861989|FG001|Double-Blinded Induction Period|Lost to Follow-up|2
2218441|NCT01714726|3861990|FG002|Double-Blinded Induction Period|Lost to Follow-up|0
2218442|NCT01714726|3861991|FG003|Double-Blinded Induction Period|Lost to Follow-up|0
2218443|NCT01714726|3861988|FG000|Open-Label Period|Other|0
2218444|NCT01714726|3861989|FG001|Open-Label Period|Other|0
2218445|NCT01714726|3861990|FG002|Open-Label Period|Other|1
2218446|NCT01714726|3861991|FG003|Open-Label Period|Other|3
2218447|NCT01714726|3861988|FG000|Open-Label Period|Adverse Event|0
2218448|NCT01714726|3861989|FG001|Open-Label Period|Adverse Event|0
2218449|NCT01714726|3861990|FG002|Open-Label Period|Adverse Event|1
2218450|NCT01714726|3861991|FG003|Open-Label Period|Adverse Event|0
2218451|NCT01714726|3861988|FG000|Open-Label Period|Withdrawal by Subject|0
2218452|NCT01714726|3861989|FG001|Open-Label Period|Withdrawal by Subject|0
2218453|NCT01714726|3861990|FG002|Open-Label Period|Withdrawal by Subject|9
2218454|NCT01714726|3861991|FG003|Open-Label Period|Withdrawal by Subject|19
2218455|NCT01714726|3861988|FG000|Open-Label Period|Developed specific withdrawal criteria|0
2218456|NCT01714726|3861989|FG001|Open-Label Period|Developed specific withdrawal criteria|0
2218457|NCT01714726|3861990|FG002|Open-Label Period|Developed specific withdrawal criteria|5
2218458|NCT01714726|3861991|FG003|Open-Label Period|Developed specific withdrawal criteria|2
2218459|NCT01714726|3861988|FG000|Open-Label Period|Lost to Follow-up|0
2218460|NCT01714726|3861989|FG001|Open-Label Period|Lost to Follow-up|0
2218461|NCT01714726|3861990|FG002|Open-Label Period|Lost to Follow-up|3
2218462|NCT01714726|3861991|FG003|Open-Label Period|Lost to Follow-up|4
2218463|NCT01714947|3862017|FG000|Part B|Progressive Disease|3
2218464|NCT01715129|3862030|FG000|Overall Study|Adverse Event, fatal|1
2218465|NCT01715129|3862030|FG000|Overall Study|Lack of Efficacy|3
2218466|NCT01715129|3862030|FG000|Overall Study|Protocol Violation|1
2218467|NCT01715129|3862030|FG000|Overall Study|Consent Withdrawn|2
2218468|NCT01715129|3862030|FG000|Overall Study|Lost to Follow-up|1
2218469|NCT01715129|3862030|FG000|Overall Study|Other|1
2218470|NCT01715298|3862052|FG000|Overall Study|Lost to Follow-up|0
2218471|NCT01715298|3862053|FG001|Overall Study|Lost to Follow-up|2
2218472|NCT01715298|3862052|FG000|Overall Study|Patient/guardian decision|7
2218473|NCT01715298|3862053|FG001|Overall Study|Patient/guardian decision|9
2218474|NCT01715415|3862061|FG000|Double-blind Treatment|Did Not Receive Study Drug|0
2218475|NCT01715415|3862062|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
2218476|NCT01715415|3862061|FG000|Double-blind Treatment|Adverse Event|3
2218477|NCT01715415|3862062|FG001|Double-blind Treatment|Adverse Event|0
2218478|NCT01715415|3862061|FG000|Double-blind Treatment|Withdrawal by Subject|1
2218479|NCT01715415|3862062|FG001|Double-blind Treatment|Withdrawal by Subject|1
2218480|NCT01715415|3862061|FG000|Double-blind Treatment|Other|1
2329447|NCT03123471|4050560|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3
2329448|NCT03123471|4050561|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0
2329449|NCT03123471|4050560|FG000|Placebo-controlled Phase|Lost to Follow-up|1
2329450|NCT03123471|4050561|FG001|Placebo-controlled Phase|Lost to Follow-up|3
2329451|NCT03123471|4050560|FG000|Placebo-controlled Phase|Protocol Deviation|2
2329452|NCT03123471|4050561|FG001|Placebo-controlled Phase|Protocol Deviation|1
2329453|NCT03123471|4050560|FG000|Placebo-controlled Phase|Miscellaneous|0
2329454|NCT03123471|4050561|FG001|Placebo-controlled Phase|Miscellaneous|1
2329455|NCT03123471|4050560|FG000|Apremilast Extension Phase|Lost to Follow-up|2
2031076|NCT00381888|3600656|FG000|Overall Study|Death|1
2031077|NCT00381888|3600656|FG000|Overall Study|Withdrawal by Subject|1
2031078|NCT00381888|3600656|FG000|Overall Study|Physician Decision|1
2031079|NCT00381888|3600656|FG000|Overall Study|Protocol Violation|9
2031080|NCT00381888|3600656|FG000|Overall Study|Had laparoscopic surgery|2
2031081|NCT00381888|3600656|FG000|Overall Study|Surgery was cancelled|2
2031082|NCT00381888|3600656|FG000|Overall Study|Adverse Event|1
2031083|NCT00381940|3600660|FG000|Overall Study|Lack of Efficacy|3
2031084|NCT00381940|3600660|FG000|Overall Study|Protocol Violation|1
2031085|NCT00381940|3600660|FG000|Overall Study|Ineligible|1
2031086|NCT00382018|3600672|FG000|Overall Study|Progression|0
2031087|NCT00382018|3600673|FG001|Overall Study|Progression|136
2031088|NCT00382018|3600674|FG002|Overall Study|Progression|51
2031089|NCT00382018|3600675|FG003|Overall Study|Progression|43
2031090|NCT00382018|3600672|FG000|Overall Study|Death|0
2031091|NCT00382018|3600673|FG001|Overall Study|Death|9
2031092|NCT00382018|3600674|FG002|Overall Study|Death|7
2031093|NCT00382018|3600675|FG003|Overall Study|Death|11
2031094|NCT00382018|3600672|FG000|Overall Study|Withdrawal by Subject|0
2031095|NCT00382018|3600673|FG001|Overall Study|Withdrawal by Subject|4
2031096|NCT00382018|3600674|FG002|Overall Study|Withdrawal by Subject|3
2031097|NCT00382018|3600675|FG003|Overall Study|Withdrawal by Subject|4
2031098|NCT00382018|3600672|FG000|Overall Study|Other, not protocol specified|0
2031099|NCT00382018|3600673|FG001|Overall Study|Other, not protocol specified|16
2031100|NCT00382018|3600674|FG002|Overall Study|Other, not protocol specified|3
2031101|NCT00382018|3600675|FG003|Overall Study|Other, not protocol specified|1
2031102|NCT00382070|3600699|FG000|Overall Study|No follow up data mapped to Other|17
2031103|NCT00382070|3600700|FG001|Overall Study|No follow up data mapped to Other|19
2031104|NCT00382070|3600699|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7
2031105|NCT00382070|3600700|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0
2031106|NCT00382070|3600699|FG000|Overall Study|No clinical assessment|9
2110554|NCT00896532|3705467|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110555|NCT00896532|3705468|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110556|NCT00896532|3705469|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
2110557|NCT00896532|3705470|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110558|NCT00896532|3705471|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
2110559|NCT00896532|3705472|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110560|NCT00896532|3705473|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110561|NCT00896532|3705474|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110562|NCT00896532|3705475|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110563|NCT00896532|3705476|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110564|NCT00896532|3705477|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110565|NCT00896532|3705478|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110566|NCT00896532|3705479|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110567|NCT00896532|3705480|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110568|NCT00896532|3705481|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110569|NCT00896532|3705482|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2329456|NCT03123471|4050561|FG001|Apremilast Extension Phase|Lost to Follow-up|5
2329457|NCT03123471|4050560|FG000|Apremilast Extension Phase|Adverse Event|1
2329458|NCT03123471|4050561|FG001|Apremilast Extension Phase|Adverse Event|5
2329459|NCT03123471|4050560|FG000|Apremilast Extension Phase|Lack of Efficacy|2
2329460|NCT03123471|4050561|FG001|Apremilast Extension Phase|Lack of Efficacy|8
2329461|NCT03123471|4050560|FG000|Apremilast Extension Phase|Withdrawal by Subject|3
2329462|NCT03123471|4050561|FG001|Apremilast Extension Phase|Withdrawal by Subject|7
2329463|NCT03123588|4050575|FG000|Overall Study|Study Terminated by Sponsor|2
2329464|NCT03123588|4050576|FG001|Overall Study|Study Terminated by Sponsor|5
2218481|NCT01715415|3862062|FG001|Double-blind Treatment|Other|0
2329465|NCT03123588|4050575|FG000|Overall Study|Withdrawal by Subject|1
2329466|NCT03123588|4050576|FG001|Overall Study|Withdrawal by Subject|0
2329467|NCT03123588|4050575|FG000|Overall Study|Adverse Event|1
2329468|NCT03123588|4050576|FG001|Overall Study|Adverse Event|0
2329469|NCT03123588|4050575|FG000|Overall Study|Physician Decision|2
2329470|NCT03123588|4050576|FG001|Overall Study|Physician Decision|1
2329471|NCT03123861|4050600|FG000|Overall Study|Protocol Violation|1
2329472|NCT03123861|4050601|FG001|Overall Study|Protocol Violation|1
2329473|NCT03123861|4050600|FG000|Overall Study|Withdrawal by Subject|2
2329474|NCT03123861|4050601|FG001|Overall Study|Withdrawal by Subject|2
2329475|NCT03123939|4050620|FG000|Overall Study|Lack of Efficacy|6
2329476|NCT03123939|4050620|FG000|Overall Study|Death|5
2329477|NCT03123939|4050620|FG000|Overall Study|Physician Decision|2
2329478|NCT03123939|4050620|FG000|Overall Study|Subject/guardian decision|2
2329479|NCT03123939|4050620|FG000|Overall Study|Lost to Follow-up|1
2329480|NCT03123939|4050620|FG000|Overall Study|New therapy for study indication|1
2329481|NCT03123939|4050620|FG000|Overall Study|Protocol deviation|1
2329482|NCT03123939|4050620|FG000|Overall Study|Progressive disease|18
2329483|NCT03123939|4050620|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4
2329484|NCT03123939|4050620|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1
2329485|NCT03124108|4050633|FG000|Overall Study|Adverse Event|0
2329486|NCT03124108|4050634|FG001|Overall Study|Adverse Event|1
2329487|NCT03124108|4050635|FG002|Overall Study|Adverse Event|0
2329488|NCT03124199|4050656|FG000|Overall Study|Lost to Follow-up|4
2329489|NCT03124381|4050686|FG000|Overall Study|Lost to Follow-up|1
2329490|NCT03124381|4050687|FG001|Overall Study|Lost to Follow-up|1
2329491|NCT03124381|4050686|FG000|Overall Study|Withdrawal by Subject|6
2329492|NCT03124381|4050687|FG001|Overall Study|Withdrawal by Subject|3
2329493|NCT03124381|4050686|FG000|Overall Study|Protocol Violation|0
2329494|NCT03124381|4050687|FG001|Overall Study|Protocol Violation|1
2329495|NCT03124381|4050686|FG000|Overall Study|Adverse Event|1
2329496|NCT03124381|4050687|FG001|Overall Study|Adverse Event|1
2329497|NCT03124381|4050686|FG000|Overall Study|Non-Compliance with Study Treatment|1
2329498|NCT03124381|4050687|FG001|Overall Study|Non-Compliance with Study Treatment|0
2329499|NCT03124407|4050697|FG000|Overall Study|Lost to Follow-up|1
2329500|NCT03124407|4050698|FG001|Overall Study|Lost to Follow-up|0
2329501|NCT03124407|4050699|FG002|Overall Study|Lost to Follow-up|0
2329502|NCT03124407|4050700|FG003|Overall Study|Lost to Follow-up|0
2329503|NCT03124407|4050697|FG000|Overall Study|Adverse Event|0
2329504|NCT03124407|4050698|FG001|Overall Study|Adverse Event|0
2329505|NCT03124407|4050699|FG002|Overall Study|Adverse Event|1
2329506|NCT03124407|4050700|FG003|Overall Study|Adverse Event|0
2329507|NCT03124459|4050720|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0
2329508|NCT03124459|4050721|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0
2329509|NCT03124459|4050722|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0
2329510|NCT03124459|4050723|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0
2329511|NCT03124459|4050724|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2
2329512|NCT03124459|4050725|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0
2329513|NCT03124459|4050720|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
2329514|NCT03124459|4050721|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
2329515|NCT03124459|4050722|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
2329516|NCT03124459|4050723|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
2329517|NCT03124459|4050724|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1
2329518|NCT03124459|4050725|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
2329519|NCT03124459|4050720|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
2329520|NCT03124459|4050721|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
2329521|NCT03124459|4050722|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
2329522|NCT03124459|4050723|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11
2329523|NCT03124459|4050724|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12
2329524|NCT03124459|4050725|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
2329525|NCT03124459|4050720|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
2329526|NCT03124459|4050721|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
2329527|NCT03124459|4050722|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
2329528|NCT03124459|4050723|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1
2329529|NCT03124459|4050724|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4
2329530|NCT03124459|4050725|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
2329531|NCT03124459|4050720|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
2329532|NCT03124459|4050721|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
2329533|NCT03124459|4050722|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
2329534|NCT03124459|4050723|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
2329535|NCT03124459|4050724|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
2329536|NCT03124459|4050725|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22
2329537|NCT03124459|4050720|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0
2329538|NCT03124459|4050721|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0
2329539|NCT03124459|4050722|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0
2329540|NCT03124459|4050723|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0
2329541|NCT03124459|4050724|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0
2329542|NCT03124459|4050725|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1
2329543|NCT03124537|4050740|FG000|Overall Study|Lost to Follow-up|3
2329544|NCT03124537|4050741|FG001|Overall Study|Lost to Follow-up|5
2329545|NCT03124537|4050740|FG000|Overall Study|App Crash, Incomplete Data|7
2329546|NCT03124537|4050741|FG001|Overall Study|App Crash, Incomplete Data|8
2329547|NCT03124563|4050753|FG000|Overall Study|Lost to Follow-up|1
2329548|NCT03124563|4050754|FG001|Overall Study|Lost to Follow-up|1
2329549|NCT03124563|4050753|FG000|Overall Study|Withdrawal by Subject|1
2329550|NCT03124563|4050754|FG001|Overall Study|Withdrawal by Subject|1
2329551|NCT03124784|4050776|FG000|Overall Study|Adverse Event|1
2329552|NCT03124784|4050776|FG000|Overall Study|Computer/Equip Malfunction|1
2329553|NCT03125200|4050829|FG000|Overall Study|Study Termination|0
2329554|NCT03125200|4050830|FG001|Overall Study|Study Termination|0
2329555|NCT03125200|4050831|FG002|Overall Study|Study Termination|0
2329556|NCT03125200|4050832|FG003|Overall Study|Study Termination|1
2329557|NCT03125200|4050833|FG004|Overall Study|Study Termination|1
2329558|NCT03125200|4050834|FG005|Overall Study|Study Termination|2
2329559|NCT03125200|4050835|FG006|Overall Study|Study Termination|1
2329560|NCT03125200|4050829|FG000|Overall Study|Clinical Progression|0
2329561|NCT03125200|4050830|FG001|Overall Study|Clinical Progression|0
2329562|NCT03125200|4050831|FG002|Overall Study|Clinical Progression|0
2329563|NCT03125200|4050832|FG003|Overall Study|Clinical Progression|1
2329564|NCT03125200|4050833|FG004|Overall Study|Clinical Progression|0
2329565|NCT03125200|4050834|FG005|Overall Study|Clinical Progression|1
2329566|NCT03125200|4050835|FG006|Overall Study|Clinical Progression|0
2329567|NCT03125200|4050829|FG000|Overall Study|Progressive Disease|2
2329568|NCT03125200|4050830|FG001|Overall Study|Progressive Disease|1
2329569|NCT03125200|4050831|FG002|Overall Study|Progressive Disease|2
2329570|NCT03125200|4050832|FG003|Overall Study|Progressive Disease|1
2329571|NCT03125200|4050833|FG004|Overall Study|Progressive Disease|2
2329572|NCT03125200|4050834|FG005|Overall Study|Progressive Disease|0
2329573|NCT03125200|4050835|FG006|Overall Study|Progressive Disease|1
2329574|NCT03125200|4050829|FG000|Overall Study|Lack of Efficacy|0
2218482|NCT01715415|3862061|FG000|Open-label Treatment|Adverse Event|0
2329575|NCT03125200|4050830|FG001|Overall Study|Lack of Efficacy|0
2329576|NCT03125200|4050831|FG002|Overall Study|Lack of Efficacy|0
2329577|NCT03125200|4050832|FG003|Overall Study|Lack of Efficacy|1
2329578|NCT03125200|4050833|FG004|Overall Study|Lack of Efficacy|0
2329579|NCT03125200|4050834|FG005|Overall Study|Lack of Efficacy|0
2329580|NCT03125200|4050835|FG006|Overall Study|Lack of Efficacy|0
2329581|NCT03125200|4050829|FG000|Overall Study|Toxicity|0
2329582|NCT03125200|4050830|FG001|Overall Study|Toxicity|0
2329583|NCT03125200|4050831|FG002|Overall Study|Toxicity|0
2329584|NCT03125200|4050832|FG003|Overall Study|Toxicity|1
2329585|NCT03125200|4050833|FG004|Overall Study|Toxicity|0
2329586|NCT03125200|4050834|FG005|Overall Study|Toxicity|0
2329587|NCT03125200|4050835|FG006|Overall Study|Toxicity|0
2329588|NCT03125200|4050829|FG000|Overall Study|Consent Withdrawn by Subject|0
2329589|NCT03125200|4050830|FG001|Overall Study|Consent Withdrawn by Subject|1
2329590|NCT03125200|4050831|FG002|Overall Study|Consent Withdrawn by Subject|0
2329591|NCT03125200|4050832|FG003|Overall Study|Consent Withdrawn by Subject|0
2329592|NCT03125200|4050833|FG004|Overall Study|Consent Withdrawn by Subject|1
2329593|NCT03125200|4050834|FG005|Overall Study|Consent Withdrawn by Subject|0
2329594|NCT03125200|4050835|FG006|Overall Study|Consent Withdrawn by Subject|1
2329595|NCT03125395|4050858|FG000|Overall Study|Adverse Event|2
2329596|NCT03125395|4050858|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
2329597|NCT03125395|4050858|FG000|Overall Study|Physician Decision|2
2329598|NCT03125395|4050858|FG000|Overall Study|Commercial drug is available|5
2329599|NCT03125629|4050862|FG000|Overall Study|Withdrawal by Subject|2
2031107|NCT00382070|3600700|FG001|Overall Study|No clinical assessment|11
2329600|NCT03125629|4050862|FG000|Overall Study|Equipment malfunction|1
2329613|NCT03125915|4050888|FG000|1 Month Follow up|Lost to Follow-up|3
2329614|NCT03125915|4050889|FG001|1 Month Follow up|Lost to Follow-up|3
2329615|NCT03125915|4050890|FG002|1 Month Follow up|Lost to Follow-up|2
2329616|NCT03125915|4050891|FG003|1 Month Follow up|Lost to Follow-up|3
2329617|NCT03125915|4050888|FG000|3 Month Follow-up|Lost to Follow-up|6
2329618|NCT03125915|4050889|FG001|3 Month Follow-up|Lost to Follow-up|4
2329619|NCT03125915|4050890|FG002|3 Month Follow-up|Lost to Follow-up|4
2329620|NCT03125915|4050891|FG003|3 Month Follow-up|Lost to Follow-up|2
2329621|NCT03125915|4050888|FG000|6 Month Follow-up|Lost to Follow-up|7
2329622|NCT03125915|4050889|FG001|6 Month Follow-up|Lost to Follow-up|3
2329623|NCT03125915|4050890|FG002|6 Month Follow-up|Lost to Follow-up|6
2329624|NCT03125915|4050891|FG003|6 Month Follow-up|Lost to Follow-up|3
2329625|NCT03125941|4050903|FG000|Overall Study|did not receive intervention|1
2329626|NCT03125941|4050904|FG001|Overall Study|did not receive intervention|2
2329627|NCT03126227|4050912|FG000|Overall Study|Adverse Event|43
2329628|NCT03126227|4050913|FG001|Overall Study|Adverse Event|4
2329629|NCT03126227|4050912|FG000|Overall Study|Death|0
2329630|NCT03126227|4050913|FG001|Overall Study|Death|1
2329631|NCT03126227|4050912|FG000|Overall Study|Lost to Follow-up|0
2329632|NCT03126227|4050913|FG001|Overall Study|Lost to Follow-up|1
2329633|NCT03126227|4050912|FG000|Overall Study|Physician Decision|2
2329634|NCT03126227|4050913|FG001|Overall Study|Physician Decision|0
2329635|NCT03126227|4050912|FG000|Overall Study|Protocol Violation|1
2329636|NCT03126227|4050913|FG001|Overall Study|Protocol Violation|0
2329637|NCT03126227|4050912|FG000|Overall Study|Withdrawal by Subject|19
2329638|NCT03126227|4050913|FG001|Overall Study|Withdrawal by Subject|3
2329639|NCT03126227|4050912|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8
2329640|NCT03126227|4050913|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1
2329641|NCT03126227|4050912|FG000|Overall Study|Lack of dosing compliance|2
2329642|NCT03126227|4050913|FG001|Overall Study|Lack of dosing compliance|0
2329643|NCT03126227|4050912|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2
2329644|NCT03126227|4050913|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0
2329645|NCT03126227|4050912|FG000|Overall Study|Scheduling conflict|1
2329646|NCT03126227|4050913|FG001|Overall Study|Scheduling conflict|0
2329647|NCT03126344|4050922|FG000|Overall Study|Lost to Follow-up|0
2329648|NCT03126344|4050923|FG001|Overall Study|Lost to Follow-up|0
2329649|NCT03126344|4050924|FG002|Overall Study|Lost to Follow-up|5
2329650|NCT03126539|4050955|FG000|Overall Study|Lost to Follow-up|1
2329651|NCT03126539|4050956|FG001|Overall Study|Lost to Follow-up|1
2329652|NCT03126539|4050957|FG002|Overall Study|Lost to Follow-up|1
2329653|NCT03126539|4050958|FG003|Overall Study|Lost to Follow-up|0
2329654|NCT03126539|4050959|FG004|Overall Study|Lost to Follow-up|0
2329655|NCT03126786|4050992|FG000|Overall Study|Adverse Event|3
2329656|NCT03126786|4050993|FG001|Overall Study|Adverse Event|0
2329657|NCT03126786|4050992|FG000|Overall Study|Lost to Follow-up|0
2329658|NCT03126786|4050993|FG001|Overall Study|Lost to Follow-up|1
2329659|NCT03126786|4050992|FG000|Overall Study|Withdrawal by Subject|3
2329660|NCT03126786|4050993|FG001|Overall Study|Withdrawal by Subject|1
2329661|NCT03127384|4051027|FG000|Overall Study|Lost to Follow-up|4
2329662|NCT03127384|4051027|FG000|Overall Study|Subject request|2
2329663|NCT03127644|4051045|FG000|Overall Study|Study-specific withdrawal criteria|0
2329664|NCT03127644|4051046|FG001|Overall Study|Study-specific withdrawal criteria|0
2329665|NCT03127644|4051047|FG002|Overall Study|Study-specific withdrawal criteria|2
2180377|NCT01401322|3806519|FG000|Overall Study|Withdrawal by Subject|1
2031108|NCT00382109|3600708|FG000|Overall Study|Adverse Event|3
2329666|NCT03128099|4051085|FG000|Overall Study|High dose task was too long|0
2329667|NCT03128099|4051086|FG001|Overall Study|High dose task was too long|4
2329668|NCT03128099|4051087|FG002|Overall Study|High dose task was too long|0
2329669|NCT03128099|4051085|FG000|Overall Study|Participant got a full time job.|1
2329670|NCT03128099|4051086|FG001|Overall Study|Participant got a full time job.|0
2329671|NCT03128099|4051087|FG002|Overall Study|Participant got a full time job.|0
2329672|NCT03128099|4051085|FG000|Overall Study|Became homeless and lost contact|1
2329673|NCT03128099|4051086|FG001|Overall Study|Became homeless and lost contact|0
2329674|NCT03128099|4051087|FG002|Overall Study|Became homeless and lost contact|0
2329675|NCT03128099|4051085|FG000|Overall Study|Did not complete all the assessments|0
2329676|NCT03128099|4051086|FG001|Overall Study|Did not complete all the assessments|0
2329677|NCT03128099|4051087|FG002|Overall Study|Did not complete all the assessments|1
2329678|NCT03128307|4051093|FG000|Overall Study|Lost to Follow-up|29
2329679|NCT03128307|4051093|FG000|Overall Study|Withdrawal by Subject|5
2329680|NCT03128411|4051101|FG000|Treatment Phase|Adverse Event|18
2329681|NCT03128411|4051101|FG000|Treatment Phase|Physician Decision|1
2329682|NCT03128411|4051101|FG000|Treatment Phase|Ongoing|41
2329683|NCT03128411|4051101|FG000|Long Term Follow-up Phase|Death|1
2329684|NCT03128411|4051101|FG000|Long Term Follow-up Phase|Ongoing|18
2329685|NCT03128723|4051105|FG000|Overall Study|Withdrawal by Subject|2
2329686|NCT03128892|4051109|FG000|Overall Study|Withdrawal by Subject|2
2329687|NCT03128892|4051109|FG000|Overall Study|Physician Decision|1
2329688|NCT03128931|4051113|FG000|Overall Study|Physician Decision|1
2329689|NCT03128931|4051113|FG000|Overall Study|Equipment Issues|3
2329690|NCT03129100|4051122|FG000|Lead-In Period (Period 1)|Adverse Event|2
2329691|NCT03129100|4051123|FG001|Lead-In Period (Period 1)|Adverse Event|6
2329692|NCT03129100|4051124|FG002|Lead-In Period (Period 1)|Adverse Event|0
2329693|NCT03129100|4051125|FG003|Lead-In Period (Period 1)|Adverse Event|0
2329694|NCT03129100|4051126|FG004|Lead-In Period (Period 1)|Adverse Event|0
2329695|NCT03129100|4051127|FG005|Lead-In Period (Period 1)|Adverse Event|0
2329696|NCT03129100|4051128|FG006|Lead-In Period (Period 1)|Adverse Event|0
2329697|NCT03129100|4051129|FG007|Lead-In Period (Period 1)|Adverse Event|0
2329698|NCT03129100|4051130|FG008|Lead-In Period (Period 1)|Adverse Event|0
2329699|NCT03129100|4051131|FG009|Lead-In Period (Period 1)|Adverse Event|0
2329700|NCT03129100|4051132|FG010|Lead-In Period (Period 1)|Adverse Event|0
2329701|NCT03129100|4051122|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2
2329702|NCT03129100|4051123|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0
2329703|NCT03129100|4051124|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0
2329704|NCT03129100|4051125|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0
2329705|NCT03129100|4051126|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0
2329706|NCT03129100|4051127|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0
2329707|NCT03129100|4051128|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0
2329708|NCT03129100|4051129|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0
2329709|NCT03129100|4051130|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0
2329710|NCT03129100|4051131|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0
2329711|NCT03129100|4051132|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0
2329712|NCT03129100|4051122|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8
2329713|NCT03129100|4051123|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8
2329714|NCT03129100|4051124|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0
2329715|NCT03129100|4051125|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0
2329716|NCT03129100|4051126|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0
2329717|NCT03129100|4051127|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0
2329718|NCT03129100|4051128|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0
2329719|NCT03129100|4051129|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0
2329720|NCT03129100|4051130|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0
2329721|NCT03129100|4051131|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0
2329722|NCT03129100|4051132|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0
2329723|NCT03129100|4051122|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3
2329724|NCT03129100|4051123|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2
2329725|NCT03129100|4051124|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0
2329726|NCT03129100|4051125|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0
2329727|NCT03129100|4051126|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0
2329728|NCT03129100|4051127|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0
2329729|NCT03129100|4051128|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0
2329730|NCT03129100|4051129|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0
2329731|NCT03129100|4051130|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0
2329732|NCT03129100|4051131|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0
2329733|NCT03129100|4051132|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0
2329734|NCT03129100|4051122|FG000|Lead-In Period (Period 1)|Surgery Programmed|0
2329735|NCT03129100|4051123|FG001|Lead-In Period (Period 1)|Surgery Programmed|1
2329736|NCT03129100|4051124|FG002|Lead-In Period (Period 1)|Surgery Programmed|0
2329737|NCT03129100|4051125|FG003|Lead-In Period (Period 1)|Surgery Programmed|0
2329738|NCT03129100|4051126|FG004|Lead-In Period (Period 1)|Surgery Programmed|0
2329739|NCT03129100|4051127|FG005|Lead-In Period (Period 1)|Surgery Programmed|0
2329740|NCT03129100|4051128|FG006|Lead-In Period (Period 1)|Surgery Programmed|0
2329741|NCT03129100|4051129|FG007|Lead-In Period (Period 1)|Surgery Programmed|0
2329742|NCT03129100|4051130|FG008|Lead-In Period (Period 1)|Surgery Programmed|0
2329743|NCT03129100|4051131|FG009|Lead-In Period (Period 1)|Surgery Programmed|0
2329744|NCT03129100|4051132|FG010|Lead-In Period (Period 1)|Surgery Programmed|0
2329745|NCT03129100|4051122|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0
2329746|NCT03129100|4051123|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0
2329747|NCT03129100|4051124|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2
2329748|NCT03129100|4051125|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1
2329749|NCT03129100|4051126|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0
2329750|NCT03129100|4051127|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2
2329751|NCT03129100|4051128|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0
2329752|NCT03129100|4051129|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0
2329753|NCT03129100|4051130|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0
2329754|NCT03129100|4051131|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0
2329755|NCT03129100|4051132|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0
2329756|NCT03129100|4051122|FG000|Period2 Extension Period (Group A and B)|Death|0
2329757|NCT03129100|4051123|FG001|Period2 Extension Period (Group A and B)|Death|0
2329758|NCT03129100|4051124|FG002|Period2 Extension Period (Group A and B)|Death|1
2329759|NCT03129100|4051125|FG003|Period2 Extension Period (Group A and B)|Death|0
2329760|NCT03129100|4051126|FG004|Period2 Extension Period (Group A and B)|Death|0
2329761|NCT03129100|4051127|FG005|Period2 Extension Period (Group A and B)|Death|0
2329762|NCT03129100|4051128|FG006|Period2 Extension Period (Group A and B)|Death|0
2329763|NCT03129100|4051129|FG007|Period2 Extension Period (Group A and B)|Death|0
2329764|NCT03129100|4051130|FG008|Period2 Extension Period (Group A and B)|Death|0
2329765|NCT03129100|4051131|FG009|Period2 Extension Period (Group A and B)|Death|0
2329766|NCT03129100|4051132|FG010|Period2 Extension Period (Group A and B)|Death|0
2329767|NCT03129100|4051122|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
2329768|NCT03129100|4051123|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
2329769|NCT03129100|4051124|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13
2329770|NCT03129100|4051125|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5
2329771|NCT03129100|4051126|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
2329772|NCT03129100|4051127|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
2329773|NCT03129100|4051128|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2
2329774|NCT03129100|4051129|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
2329775|NCT03129100|4051130|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
2329776|NCT03129100|4051131|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
2329777|NCT03129100|4051132|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
2329778|NCT03129100|4051122|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0
2329779|NCT03129100|4051123|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0
2329780|NCT03129100|4051124|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1
2329781|NCT03129100|4051125|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0
2329782|NCT03129100|4051126|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0
2329783|NCT03129100|4051127|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0
2031109|NCT00382109|3600709|FG001|Overall Study|Adverse Event|0
2329784|NCT03129100|4051128|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0
2329785|NCT03129100|4051129|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0
2329786|NCT03129100|4051130|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0
2329787|NCT03129100|4051131|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0
2329788|NCT03129100|4051132|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0
2329789|NCT03129100|4051122|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
2329790|NCT03129100|4051123|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
2329791|NCT03129100|4051124|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2
2329792|NCT03129100|4051125|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
2329793|NCT03129100|4051126|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
2329794|NCT03129100|4051127|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
2329795|NCT03129100|4051128|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
2329796|NCT03129100|4051129|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
2329797|NCT03129100|4051130|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
2329798|NCT03129100|4051131|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
2329799|NCT03129100|4051132|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
2329800|NCT03129100|4051122|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
2329801|NCT03129100|4051123|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
2329802|NCT03129100|4051124|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2
2329803|NCT03129100|4051125|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
2329804|NCT03129100|4051126|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
2329805|NCT03129100|4051127|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
2329806|NCT03129100|4051128|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
2329807|NCT03129100|4051129|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
2329808|NCT03129100|4051130|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
2329809|NCT03129100|4051131|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
2329810|NCT03129100|4051132|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
2329811|NCT03129100|4051122|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0
2329812|NCT03129100|4051123|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0
2329813|NCT03129100|4051124|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0
2329814|NCT03129100|4051125|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0
2329815|NCT03129100|4051126|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5
2329816|NCT03129100|4051127|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6
2329817|NCT03129100|4051128|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19
2329818|NCT03129100|4051129|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0
2218483|NCT01715415|3862062|FG001|Open-label Treatment|Adverse Event|1
2329819|NCT03129100|4051130|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0
2329820|NCT03129100|4051131|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0
2329821|NCT03129100|4051132|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0
2031110|NCT00382109|3600708|FG000|Overall Study|Physician Decision|6
2031111|NCT00382109|3600709|FG001|Overall Study|Physician Decision|1
2031112|NCT00382109|3600708|FG000|Overall Study|Withdrawal by Subject|1
2031113|NCT00382109|3600709|FG001|Overall Study|Withdrawal by Subject|0
2031114|NCT00382109|3600708|FG000|Overall Study|ineligible|2
2031115|NCT00382109|3600709|FG001|Overall Study|ineligible|0
2031116|NCT00382109|3600708|FG000|Overall Study|Other|0
2031117|NCT00382109|3600709|FG001|Overall Study|Other|2
2031118|NCT00382109|3600708|FG000|Overall Study|consent withdrawal|0
2031119|NCT00382109|3600709|FG001|Overall Study|consent withdrawal|1
2031120|NCT00382174|3600729|FG000|Overall Study|Lost to Follow-up|1
2031121|NCT00382174|3600730|FG001|Overall Study|Lost to Follow-up|4
2031122|NCT00382174|3600731|FG002|Overall Study|Lost to Follow-up|5
2031123|NCT00382174|3600729|FG000|Overall Study|Adverse Event|1
2031124|NCT00382174|3600730|FG001|Overall Study|Adverse Event|4
2031125|NCT00382174|3600731|FG002|Overall Study|Adverse Event|5
2031126|NCT00382174|3600729|FG000|Overall Study|Withdrawal by Subject|1
2031127|NCT00382174|3600730|FG001|Overall Study|Withdrawal by Subject|4
2031128|NCT00382174|3600731|FG002|Overall Study|Withdrawal by Subject|5
2031129|NCT00382174|3600729|FG000|Overall Study|Non compliance|1
2329822|NCT03129100|4051122|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
2329823|NCT03129100|4051123|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
2329824|NCT03129100|4051124|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
2329825|NCT03129100|4051125|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
2329826|NCT03129100|4051126|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
2329827|NCT03129100|4051127|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
2329828|NCT03129100|4051128|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
2329829|NCT03129100|4051129|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
2329830|NCT03129100|4051130|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
2329831|NCT03129100|4051131|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1
2329832|NCT03129100|4051132|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
2329833|NCT03130257|4051195|FG000|Overall Study|Withdrawal by Subject|1
2329834|NCT03130257|4051196|FG001|Overall Study|Withdrawal by Subject|0
2329835|NCT03130257|4051197|FG002|Overall Study|Withdrawal by Subject|2
2329836|NCT03130959|4051228|FG000|Treatment Period|Disease progression|18
2329837|NCT03130959|4051229|FG001|Treatment Period|Disease progression|15
2329838|NCT03130959|4051230|FG002|Treatment Period|Disease progression|12
2329839|NCT03130959|4051231|FG003|Treatment Period|Disease progression|8
2329840|NCT03130959|4051232|FG004|Treatment Period|Disease progression|12
2329841|NCT03130959|4051233|FG005|Treatment Period|Disease progression|11
2329842|NCT03130959|4051234|FG006|Treatment Period|Disease progression|6
2329843|NCT03130959|4051235|FG007|Treatment Period|Disease progression|9
2329844|NCT03130959|4051236|FG008|Treatment Period|Disease progression|15
2329845|NCT03130959|4051237|FG009|Treatment Period|Disease progression|9
2329846|NCT03130959|4051228|FG000|Treatment Period|Study drug toxicity|2
2329847|NCT03130959|4051229|FG001|Treatment Period|Study drug toxicity|3
2329848|NCT03130959|4051230|FG002|Treatment Period|Study drug toxicity|1
2329849|NCT03130959|4051231|FG003|Treatment Period|Study drug toxicity|2
2329850|NCT03130959|4051232|FG004|Treatment Period|Study drug toxicity|1
2329851|NCT03130959|4051233|FG005|Treatment Period|Study drug toxicity|2
2329852|NCT03130959|4051234|FG006|Treatment Period|Study drug toxicity|3
2329853|NCT03130959|4051235|FG007|Treatment Period|Study drug toxicity|0
2329854|NCT03130959|4051236|FG008|Treatment Period|Study drug toxicity|3
2329855|NCT03130959|4051237|FG009|Treatment Period|Study drug toxicity|4
2329856|NCT03130959|4051228|FG000|Treatment Period|Other reasons|1
2329857|NCT03130959|4051229|FG001|Treatment Period|Other reasons|0
2329858|NCT03130959|4051230|FG002|Treatment Period|Other reasons|0
2329859|NCT03130959|4051231|FG003|Treatment Period|Other reasons|0
2329860|NCT03130959|4051232|FG004|Treatment Period|Other reasons|0
2329861|NCT03130959|4051233|FG005|Treatment Period|Other reasons|0
2329862|NCT03130959|4051234|FG006|Treatment Period|Other reasons|1
2329863|NCT03130959|4051235|FG007|Treatment Period|Other reasons|0
2329864|NCT03130959|4051236|FG008|Treatment Period|Other reasons|0
2329865|NCT03130959|4051237|FG009|Treatment Period|Other reasons|0
2329866|NCT03130959|4051228|FG000|Treatment Period|Participant request to stop therapy|0
2329867|NCT03130959|4051229|FG001|Treatment Period|Participant request to stop therapy|1
2329868|NCT03130959|4051230|FG002|Treatment Period|Participant request to stop therapy|1
2329869|NCT03130959|4051231|FG003|Treatment Period|Participant request to stop therapy|1
2329870|NCT03130959|4051232|FG004|Treatment Period|Participant request to stop therapy|0
2329871|NCT03130959|4051233|FG005|Treatment Period|Participant request to stop therapy|0
2329872|NCT03130959|4051234|FG006|Treatment Period|Participant request to stop therapy|1
2329873|NCT03130959|4051235|FG007|Treatment Period|Participant request to stop therapy|1
2329874|NCT03130959|4051236|FG008|Treatment Period|Participant request to stop therapy|0
2329875|NCT03130959|4051237|FG009|Treatment Period|Participant request to stop therapy|0
2329876|NCT03130959|4051228|FG000|Treatment Period|Not reported|0
2329877|NCT03130959|4051229|FG001|Treatment Period|Not reported|2
2329878|NCT03130959|4051230|FG002|Treatment Period|Not reported|0
2329879|NCT03130959|4051231|FG003|Treatment Period|Not reported|1
2329880|NCT03130959|4051232|FG004|Treatment Period|Not reported|0
2329881|NCT03130959|4051233|FG005|Treatment Period|Not reported|2
2329882|NCT03130959|4051234|FG006|Treatment Period|Not reported|0
2329883|NCT03130959|4051235|FG007|Treatment Period|Not reported|0
2329884|NCT03130959|4051236|FG008|Treatment Period|Not reported|0
2329885|NCT03130959|4051237|FG009|Treatment Period|Not reported|2
2329886|NCT03130959|4051228|FG000|Treatment Period|Adverse Event unrelated to drug|0
2329887|NCT03130959|4051229|FG001|Treatment Period|Adverse Event unrelated to drug|0
2329888|NCT03130959|4051230|FG002|Treatment Period|Adverse Event unrelated to drug|1
2329889|NCT03130959|4051231|FG003|Treatment Period|Adverse Event unrelated to drug|1
2329890|NCT03130959|4051232|FG004|Treatment Period|Adverse Event unrelated to drug|1
2329891|NCT03130959|4051233|FG005|Treatment Period|Adverse Event unrelated to drug|0
2329892|NCT03130959|4051234|FG006|Treatment Period|Adverse Event unrelated to drug|1
2329893|NCT03130959|4051235|FG007|Treatment Period|Adverse Event unrelated to drug|0
2329894|NCT03130959|4051236|FG008|Treatment Period|Adverse Event unrelated to drug|1
2329895|NCT03130959|4051237|FG009|Treatment Period|Adverse Event unrelated to drug|1
2329896|NCT03130959|4051228|FG000|Treatment Period|Participant withdrew consent|0
2329897|NCT03130959|4051229|FG001|Treatment Period|Participant withdrew consent|0
2329898|NCT03130959|4051230|FG002|Treatment Period|Participant withdrew consent|0
2329899|NCT03130959|4051231|FG003|Treatment Period|Participant withdrew consent|2
2329900|NCT03130959|4051232|FG004|Treatment Period|Participant withdrew consent|1
2329901|NCT03130959|4051233|FG005|Treatment Period|Participant withdrew consent|0
2329902|NCT03130959|4051234|FG006|Treatment Period|Participant withdrew consent|0
2329903|NCT03130959|4051235|FG007|Treatment Period|Participant withdrew consent|0
2329904|NCT03130959|4051236|FG008|Treatment Period|Participant withdrew consent|0
2329905|NCT03130959|4051237|FG009|Treatment Period|Participant withdrew consent|2
2329906|NCT03130959|4051228|FG000|Follow-up Period|Death|16
2329907|NCT03130959|4051229|FG001|Follow-up Period|Death|17
2329908|NCT03130959|4051230|FG002|Follow-up Period|Death|12
2329909|NCT03130959|4051231|FG003|Follow-up Period|Death|10
2329910|NCT03130959|4051232|FG004|Follow-up Period|Death|11
2329911|NCT03130959|4051233|FG005|Follow-up Period|Death|8
2329912|NCT03130959|4051234|FG006|Follow-up Period|Death|9
2329913|NCT03130959|4051235|FG007|Follow-up Period|Death|7
2329914|NCT03130959|4051236|FG008|Follow-up Period|Death|17
2329915|NCT03130959|4051237|FG009|Follow-up Period|Death|10
2329916|NCT03130959|4051228|FG000|Follow-up Period|Participant withdrew consent|3
2329917|NCT03130959|4051229|FG001|Follow-up Period|Participant withdrew consent|1
2329918|NCT03130959|4051230|FG002|Follow-up Period|Participant withdrew consent|0
2329919|NCT03130959|4051231|FG003|Follow-up Period|Participant withdrew consent|3
2329920|NCT03130959|4051232|FG004|Follow-up Period|Participant withdrew consent|3
2329921|NCT03130959|4051233|FG005|Follow-up Period|Participant withdrew consent|0
2329922|NCT03130959|4051234|FG006|Follow-up Period|Participant withdrew consent|0
2329923|NCT03130959|4051235|FG007|Follow-up Period|Participant withdrew consent|1
2329924|NCT03130959|4051236|FG008|Follow-up Period|Participant withdrew consent|1
2329925|NCT03130959|4051237|FG009|Follow-up Period|Participant withdrew consent|3
2329926|NCT03130959|4051228|FG000|Follow-up Period|Lost to Follow-up|1
2329927|NCT03130959|4051229|FG001|Follow-up Period|Lost to Follow-up|1
2329928|NCT03130959|4051230|FG002|Follow-up Period|Lost to Follow-up|0
2329929|NCT03130959|4051231|FG003|Follow-up Period|Lost to Follow-up|0
2329930|NCT03130959|4051232|FG004|Follow-up Period|Lost to Follow-up|0
2329931|NCT03130959|4051233|FG005|Follow-up Period|Lost to Follow-up|2
2329932|NCT03130959|4051234|FG006|Follow-up Period|Lost to Follow-up|0
2329933|NCT03130959|4051235|FG007|Follow-up Period|Lost to Follow-up|0
2329934|NCT03130959|4051236|FG008|Follow-up Period|Lost to Follow-up|0
2329935|NCT03130959|4051237|FG009|Follow-up Period|Lost to Follow-up|1
2329936|NCT03130959|4051228|FG000|Follow-up Period|Other reasons|0
2329937|NCT03130959|4051229|FG001|Follow-up Period|Other reasons|1
2329938|NCT03130959|4051230|FG002|Follow-up Period|Other reasons|0
2329939|NCT03130959|4051231|FG003|Follow-up Period|Other reasons|1
2329940|NCT03130959|4051232|FG004|Follow-up Period|Other reasons|0
2329941|NCT03130959|4051233|FG005|Follow-up Period|Other reasons|0
2329942|NCT03130959|4051234|FG006|Follow-up Period|Other reasons|0
2329943|NCT03130959|4051235|FG007|Follow-up Period|Other reasons|0
2329944|NCT03130959|4051236|FG008|Follow-up Period|Other reasons|0
2329945|NCT03130959|4051237|FG009|Follow-up Period|Other reasons|2
2329946|NCT03131167|4051285|FG000|Overall Study|Other (Unspecified)|0
2329947|NCT03131167|4051286|FG001|Overall Study|Other (Unspecified)|0
2329948|NCT03131167|4051287|FG002|Overall Study|Other (Unspecified)|0
2329949|NCT03131167|4051288|FG003|Overall Study|Other (Unspecified)|0
2329950|NCT03131167|4051289|FG004|Overall Study|Other (Unspecified)|0
2329951|NCT03131167|4051290|FG005|Overall Study|Other (Unspecified)|1
2329952|NCT03131167|4051291|FG006|Overall Study|Other (Unspecified)|0
2329953|NCT03131167|4051292|FG007|Overall Study|Other (Unspecified)|0
2329954|NCT03131167|4051293|FG008|Overall Study|Other (Unspecified)|0
2329955|NCT03131167|4051294|FG009|Overall Study|Other (Unspecified)|0
2329956|NCT03131167|4051295|FG010|Overall Study|Other (Unspecified)|0
2329957|NCT03131167|4051296|FG011|Overall Study|Other (Unspecified)|0
2329958|NCT03131167|4051297|FG012|Overall Study|Other (Unspecified)|0
2329959|NCT03131219|4051349|FG000|Initial Evaluation Period|Adverse Event|1
2329960|NCT03131219|4051350|FG001|Initial Evaluation Period|Adverse Event|0
2329961|NCT03131219|4051349|FG000|Initial Evaluation Period|Protocol Violation|1
2329962|NCT03131219|4051350|FG001|Initial Evaluation Period|Protocol Violation|0
2329963|NCT03131219|4051349|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2
2329964|NCT03131219|4051350|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0
2329965|NCT03131453|4051359|FG000|Overall Study|Study terminated by Sponsor|424
2329966|NCT03131453|4051360|FG001|Overall Study|Study terminated by Sponsor|222
2329967|NCT03131453|4051361|FG002|Overall Study|Study terminated by Sponsor|438
2329968|NCT03131453|4051359|FG000|Overall Study|Withdrawal by Subject|18
2329969|NCT03131453|4051360|FG001|Overall Study|Withdrawal by Subject|7
2329970|NCT03131453|4051361|FG002|Overall Study|Withdrawal by Subject|13
2329971|NCT03131453|4051359|FG000|Overall Study|Adverse Event|10
2329972|NCT03131453|4051360|FG001|Overall Study|Adverse Event|3
2329973|NCT03131453|4051361|FG002|Overall Study|Adverse Event|3
2329974|NCT03131453|4051359|FG000|Overall Study|Lost to Follow-up|1
2329975|NCT03131453|4051360|FG001|Overall Study|Lost to Follow-up|0
2329976|NCT03131453|4051361|FG002|Overall Study|Lost to Follow-up|1
2329977|NCT03131453|4051359|FG000|Overall Study|Physician Decision|1
2329978|NCT03131453|4051360|FG001|Overall Study|Physician Decision|0
2329979|NCT03131453|4051361|FG002|Overall Study|Physician Decision|1
2329980|NCT03131453|4051359|FG000|Overall Study|Non-compliance with study treatment|1
2329981|NCT03131453|4051360|FG001|Overall Study|Non-compliance with study treatment|0
2329982|NCT03131453|4051361|FG002|Overall Study|Non-compliance with study treatment|0
2329983|NCT03131453|4051359|FG000|Overall Study|Technical problems|1
2329984|NCT03131453|4051360|FG001|Overall Study|Technical problems|0
2329985|NCT03131453|4051361|FG002|Overall Study|Technical problems|0
2329986|NCT03131453|4051359|FG000|Overall Study|Protocol deviation|0
2329987|NCT03131453|4051360|FG001|Overall Study|Protocol deviation|1
2329988|NCT03131453|4051361|FG002|Overall Study|Protocol deviation|0
2329989|NCT03131479|4051374|FG000|Overall Study|Adverse Event|0
2329990|NCT03131479|4051375|FG001|Overall Study|Adverse Event|0
2329991|NCT03131479|4051376|FG002|Overall Study|Adverse Event|1
2329992|NCT03131479|4051377|FG003|Overall Study|Adverse Event|1
2329993|NCT03131479|4051378|FG004|Overall Study|Adverse Event|0
2329994|NCT03131479|4051374|FG000|Overall Study|Subject/Guardian Decision|0
2329995|NCT03131479|4051375|FG001|Overall Study|Subject/Guardian Decision|0
2329996|NCT03131479|4051376|FG002|Overall Study|Subject/Guardian Decision|0
2329997|NCT03131479|4051377|FG003|Overall Study|Subject/Guardian Decision|1
2329998|NCT03131479|4051378|FG004|Overall Study|Subject/Guardian Decision|0
2352636|NCT03756285|4102417|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1
2352637|NCT03756285|4102416|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
2352638|NCT03756285|4102417|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
2352639|NCT03756129|4102430|FG000|Overall Study|Adverse Event|1
2352640|NCT03756129|4102431|FG001|Overall Study|Adverse Event|1
2352641|NCT03756129|4102432|FG002|Overall Study|Adverse Event|0
2352642|NCT03756129|4102433|FG003|Overall Study|Adverse Event|2
2352643|NCT03756129|4102434|FG004|Overall Study|Adverse Event|0
2352644|NCT03756129|4102435|FG005|Overall Study|Adverse Event|0
2352645|NCT03756129|4102430|FG000|Overall Study|Withdrawal by Subject|2
2352646|NCT03756129|4102431|FG001|Overall Study|Withdrawal by Subject|1
2352647|NCT03756129|4102432|FG002|Overall Study|Withdrawal by Subject|3
2352648|NCT03756129|4102433|FG003|Overall Study|Withdrawal by Subject|1
2352649|NCT03756129|4102434|FG004|Overall Study|Withdrawal by Subject|1
2352650|NCT03756129|4102435|FG005|Overall Study|Withdrawal by Subject|3
2352651|NCT03756129|4102430|FG000|Overall Study|Lost to Follow-up|0
2352652|NCT03756129|4102431|FG001|Overall Study|Lost to Follow-up|0
2352653|NCT03756129|4102432|FG002|Overall Study|Lost to Follow-up|0
2352654|NCT03756129|4102433|FG003|Overall Study|Lost to Follow-up|0
2352655|NCT03756129|4102434|FG004|Overall Study|Lost to Follow-up|0
2352656|NCT03756129|4102435|FG005|Overall Study|Lost to Follow-up|1
2352657|NCT03756129|4102430|FG000|Overall Study|Physician Decision|0
2352658|NCT03756129|4102431|FG001|Overall Study|Physician Decision|0
2352659|NCT03756129|4102432|FG002|Overall Study|Physician Decision|0
2352660|NCT03756129|4102433|FG003|Overall Study|Physician Decision|0
2352661|NCT03756129|4102434|FG004|Overall Study|Physician Decision|0
2352662|NCT03756129|4102435|FG005|Overall Study|Physician Decision|1
2352663|NCT03755882|4102471|FG000|Period 1|Protocol Violation|1
2352664|NCT03755882|4102472|FG001|Period 1|Protocol Violation|0
2352665|NCT03755882|4102471|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3
2352666|NCT03755882|4102472|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0
2352667|NCT03755661|4102480|FG000|Overall Study|Lost to Follow-up|1
2352668|NCT03755661|4102481|FG001|Overall Study|Lost to Follow-up|0
2352669|NCT03754582|4102487|FG000|Treatment Phase|Adverse Event|0
2352670|NCT03754582|4102488|FG001|Treatment Phase|Adverse Event|1
2352671|NCT03754582|4102489|FG002|Treatment Phase|Adverse Event|0
2352672|NCT03754582|4102487|FG000|Follow-up Phase|Other|0
2352673|NCT03754582|4102488|FG001|Follow-up Phase|Other|0
2352674|NCT03754582|4102489|FG002|Follow-up Phase|Other|1
2352675|NCT03752528|4102522|FG000|Part A|Lost to Follow-up|1
2352676|NCT03752528|4102522|FG000|Part A|Protocol Violation|1
2352677|NCT03752528|4102522|FG000|Part B|Protocol Violation|1
2352678|NCT03752528|4102522|FG000|Part B|Study terminated by sponsor|3
2352679|NCT03752151|4102529|FG000|Overall Study|Withdrawal by Subject|1
2352680|NCT03752151|4102529|FG000|Overall Study|Protocol Violation|1
2352681|NCT03751657|4102536|FG000|Overall Study|Physician Decision|0
2352682|NCT03751657|4102537|FG001|Overall Study|Physician Decision|1
2352683|NCT03751657|4102536|FG000|Overall Study|Withdrawal by Subject|1
2352684|NCT03751657|4102537|FG001|Overall Study|Withdrawal by Subject|1
2352685|NCT03751657|4102536|FG000|Overall Study|Lost to Follow-up|2
2352686|NCT03751657|4102537|FG001|Overall Study|Lost to Follow-up|1
2352687|NCT03751280|4102545|FG000|Overall Study|Adverse Event|0
2352688|NCT03751280|4102546|FG001|Overall Study|Adverse Event|1
2352689|NCT03751280|4102545|FG000|Overall Study|Lost to Follow-up|3
2352690|NCT03751280|4102546|FG001|Overall Study|Lost to Follow-up|5
2352691|NCT03751280|4102545|FG000|Overall Study|Physician Decision|0
2180378|NCT01401322|3806519|FG000|Overall Study|Physician Decision|1
2352692|NCT03751280|4102546|FG001|Overall Study|Physician Decision|2
2352693|NCT03751280|4102545|FG000|Overall Study|Protocol Violation|0
2352694|NCT03751280|4102546|FG001|Overall Study|Protocol Violation|2
2352695|NCT03751280|4102545|FG000|Overall Study|Withdrawal by Subject|5
2352696|NCT03751280|4102546|FG001|Overall Study|Withdrawal by Subject|2
2352697|NCT03751020|4102556|FG000|Overall Study|Withdrawal by Subject|2
2352698|NCT03751020|4102557|FG001|Overall Study|Withdrawal by Subject|0
2329999|NCT03131570|4051392|FG000|Overall Study|Adverse Event|1
2330000|NCT03131570|4051393|FG001|Overall Study|Adverse Event|0
2330001|NCT03131596|4051401|FG000|Overall Study|Protocol Violation|3
2330002|NCT03131596|4051402|FG001|Overall Study|Protocol Violation|3
2330003|NCT03131596|4051401|FG000|Overall Study|Lost to Follow-up|3
2330004|NCT03131596|4051402|FG001|Overall Study|Lost to Follow-up|0
2330005|NCT03131648|4051410|FG000|Initial Treatment Period|Not dosed|2
2031130|NCT00382174|3600730|FG001|Overall Study|Non compliance|0
2031131|NCT00382174|3600731|FG002|Overall Study|Non compliance|1
2031132|NCT00382174|3600729|FG000|Overall Study|Physician Decision|0
2031133|NCT00382174|3600730|FG001|Overall Study|Physician Decision|2
2031134|NCT00382174|3600731|FG002|Overall Study|Physician Decision|2
2031135|NCT00382174|3600729|FG000|Overall Study|Failed to meet criteria|0
2110570|NCT00896532|3705483|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110571|NCT00896532|3705484|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110572|NCT00896532|3705485|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110573|NCT00896532|3705486|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110574|NCT00896532|3705487|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110575|NCT00896532|3705488|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2110576|NCT00896532|3705466|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
2110577|NCT00896532|3705467|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
2110578|NCT00896532|3705468|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
2110579|NCT00896532|3705469|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
2110580|NCT00896532|3705470|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
2110581|NCT00896532|3705471|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
2110582|NCT00896532|3705472|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
2110583|NCT00896532|3705473|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110584|NCT00896532|3705474|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110585|NCT00896532|3705475|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110586|NCT00896532|3705476|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110587|NCT00896532|3705477|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110588|NCT00896532|3705478|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110589|NCT00896532|3705479|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110590|NCT00896532|3705480|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110591|NCT00896532|3705481|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110592|NCT00896532|3705482|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110593|NCT00896532|3705483|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110594|NCT00896532|3705484|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110595|NCT00896532|3705485|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110596|NCT00896532|3705486|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110597|NCT00896532|3705487|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110598|NCT00896532|3705488|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2110599|NCT00896532|3705466|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
2110600|NCT00896532|3705467|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
2110601|NCT00896532|3705468|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
2110602|NCT00896532|3705469|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
2110603|NCT00896532|3705470|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
2031136|NCT00382174|3600730|FG001|Overall Study|Failed to meet criteria|1
2031137|NCT00382174|3600731|FG002|Overall Study|Failed to meet criteria|1
2031138|NCT00382174|3600729|FG000|Overall Study|Wounds merged|0
2031139|NCT00382174|3600730|FG001|Overall Study|Wounds merged|2
2031140|NCT00382174|3600731|FG002|Overall Study|Wounds merged|2
2031141|NCT00382291|3600755|FG000|Overall Study|Adverse Event|1
2031142|NCT00382291|3600756|FG001|Overall Study|Adverse Event|2
2031143|NCT00382291|3600757|FG002|Overall Study|Adverse Event|2
2031144|NCT00382291|3600755|FG000|Overall Study|Protocol Violation|1
2031145|NCT00382291|3600756|FG001|Overall Study|Protocol Violation|0
2330006|NCT03131648|4051411|FG001|Initial Treatment Period|Not dosed|2
2330007|NCT03131648|4051412|FG002|Initial Treatment Period|Not dosed|0
2330008|NCT03131648|4051413|FG003|Initial Treatment Period|Not dosed|0
2330009|NCT03131648|4051414|FG004|Initial Treatment Period|Not dosed|0
2330010|NCT03131648|4051415|FG005|Initial Treatment Period|Not dosed|0
2330011|NCT03131648|4051416|FG006|Initial Treatment Period|Not dosed|0
2330012|NCT03131648|4051417|FG007|Initial Treatment Period|Not dosed|0
2330013|NCT03131648|4051410|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51
2330014|NCT03131648|4051411|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18
2330015|NCT03131648|4051412|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
2330016|NCT03131648|4051413|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
2330017|NCT03131648|4051414|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
2330018|NCT03131648|4051415|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
2330019|NCT03131648|4051416|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
2330020|NCT03131648|4051417|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0
2330021|NCT03131648|4051410|FG000|Open-label Treatment|Discontinued IMP|0
2330022|NCT03131648|4051411|FG001|Open-label Treatment|Discontinued IMP|0
2330023|NCT03131648|4051412|FG002|Open-label Treatment|Discontinued IMP|0
2330024|NCT03131648|4051413|FG003|Open-label Treatment|Discontinued IMP|0
2330025|NCT03131648|4051414|FG004|Open-label Treatment|Discontinued IMP|0
2330026|NCT03131648|4051415|FG005|Open-label Treatment|Discontinued IMP|0
2330027|NCT03131648|4051416|FG006|Open-label Treatment|Discontinued IMP|112
2330028|NCT03131648|4051417|FG007|Open-label Treatment|Discontinued IMP|0
2330029|NCT03131648|4051410|FG000|Open-label Treatment|Completed Week 50|0
2330030|NCT03131648|4051411|FG001|Open-label Treatment|Completed Week 50|0
2330031|NCT03131648|4051412|FG002|Open-label Treatment|Completed Week 50|0
2330032|NCT03131648|4051413|FG003|Open-label Treatment|Completed Week 50|0
2330033|NCT03131648|4051414|FG004|Open-label Treatment|Completed Week 50|0
2330034|NCT03131648|4051415|FG005|Open-label Treatment|Completed Week 50|0
2330035|NCT03131648|4051416|FG006|Open-label Treatment|Completed Week 50|6
2330036|NCT03131648|4051417|FG007|Open-label Treatment|Completed Week 50|0
2330037|NCT03131648|4051410|FG000|Maintenance Treatment Period|Not dosed|0
2330038|NCT03131648|4051411|FG001|Maintenance Treatment Period|Not dosed|0
2330039|NCT03131648|4051412|FG002|Maintenance Treatment Period|Not dosed|3
2330040|NCT03131648|4051413|FG003|Maintenance Treatment Period|Not dosed|2
2330041|NCT03131648|4051414|FG004|Maintenance Treatment Period|Not dosed|1
2330042|NCT03131648|4051415|FG005|Maintenance Treatment Period|Not dosed|0
2330043|NCT03131648|4051416|FG006|Maintenance Treatment Period|Not dosed|0
2330044|NCT03131648|4051417|FG007|Maintenance Treatment Period|Not dosed|0
2330045|NCT03131648|4051410|FG000|Maintenance Treatment Period|Discontinued IMP|0
2330046|NCT03131648|4051411|FG001|Maintenance Treatment Period|Discontinued IMP|0
2330047|NCT03131648|4051412|FG002|Maintenance Treatment Period|Discontinued IMP|3
2330048|NCT03131648|4051413|FG003|Maintenance Treatment Period|Discontinued IMP|5
2330049|NCT03131648|4051414|FG004|Maintenance Treatment Period|Discontinued IMP|4
2330050|NCT03131648|4051415|FG005|Maintenance Treatment Period|Discontinued IMP|4
2330051|NCT03131648|4051416|FG006|Maintenance Treatment Period|Discontinued IMP|0
2330052|NCT03131648|4051417|FG007|Maintenance Treatment Period|Discontinued IMP|0
2031146|NCT00382291|3600757|FG002|Overall Study|Protocol Violation|0
2031147|NCT00382291|3600755|FG000|Overall Study|Temporary study suspension|2
2031148|NCT00382291|3600756|FG001|Overall Study|Temporary study suspension|2
2031149|NCT00382291|3600757|FG002|Overall Study|Temporary study suspension|5
2031150|NCT00382291|3600755|FG000|Overall Study|Withdrawal by Subject|0
2031151|NCT00382291|3600756|FG001|Overall Study|Withdrawal by Subject|2
2031152|NCT00382291|3600757|FG002|Overall Study|Withdrawal by Subject|0
2031153|NCT00382291|3600755|FG000|Overall Study|Physician Decision|0
2031154|NCT00382291|3600756|FG001|Overall Study|Physician Decision|1
2031155|NCT00382291|3600757|FG002|Overall Study|Physician Decision|0
2330053|NCT03131648|4051410|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
2330054|NCT03131648|4051411|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
2330055|NCT03131648|4051412|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21
2330056|NCT03131648|4051413|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18
2330057|NCT03131648|4051414|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9
2330058|NCT03131648|4051415|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10
2330059|NCT03131648|4051416|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
2330060|NCT03131648|4051417|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0
2330061|NCT03131648|4051410|FG000|Maintenance Treatment Period|Completed Week 50|0
2330062|NCT03131648|4051411|FG001|Maintenance Treatment Period|Completed Week 50|0
2330063|NCT03131648|4051412|FG002|Maintenance Treatment Period|Completed Week 50|0
2330064|NCT03131648|4051413|FG003|Maintenance Treatment Period|Completed Week 50|0
2330065|NCT03131648|4051414|FG004|Maintenance Treatment Period|Completed Week 50|1
2330066|NCT03131648|4051415|FG005|Maintenance Treatment Period|Completed Week 50|0
2330067|NCT03131648|4051416|FG006|Maintenance Treatment Period|Completed Week 50|0
2330068|NCT03131648|4051417|FG007|Maintenance Treatment Period|Completed Week 50|0
2330069|NCT03131648|4051410|FG000|Open-label (Short Term Extension)|Discontinued IMP|0
2330070|NCT03131648|4051411|FG001|Open-label (Short Term Extension)|Discontinued IMP|0
2330071|NCT03131648|4051412|FG002|Open-label (Short Term Extension)|Discontinued IMP|0
2330072|NCT03131648|4051413|FG003|Open-label (Short Term Extension)|Discontinued IMP|0
2330073|NCT03131648|4051414|FG004|Open-label (Short Term Extension)|Discontinued IMP|0
2330074|NCT03131648|4051415|FG005|Open-label (Short Term Extension)|Discontinued IMP|0
2330075|NCT03131648|4051416|FG006|Open-label (Short Term Extension)|Discontinued IMP|0
2330076|NCT03131648|4051417|FG007|Open-label (Short Term Extension)|Discontinued IMP|3
2330077|NCT03131687|4051440|FG000|Overall Study|Adverse Event|0
2330078|NCT03131687|4051441|FG001|Overall Study|Adverse Event|1
2330079|NCT03131687|4051442|FG002|Overall Study|Adverse Event|0
2330080|NCT03131687|4051443|FG003|Overall Study|Adverse Event|1
2330081|NCT03131687|4051444|FG004|Overall Study|Adverse Event|2
2330082|NCT03131687|4051445|FG005|Overall Study|Adverse Event|2
2330083|NCT03131687|4051440|FG000|Overall Study|Death|1
2330084|NCT03131687|4051441|FG001|Overall Study|Death|0
2330085|NCT03131687|4051442|FG002|Overall Study|Death|0
2330086|NCT03131687|4051443|FG003|Overall Study|Death|0
2330087|NCT03131687|4051444|FG004|Overall Study|Death|0
2330088|NCT03131687|4051445|FG005|Overall Study|Death|0
2330089|NCT03131687|4051440|FG000|Overall Study|Withdrawal by Subject|3
2330090|NCT03131687|4051441|FG001|Overall Study|Withdrawal by Subject|3
2330091|NCT03131687|4051442|FG002|Overall Study|Withdrawal by Subject|3
2330092|NCT03131687|4051443|FG003|Overall Study|Withdrawal by Subject|1
2330093|NCT03131687|4051444|FG004|Overall Study|Withdrawal by Subject|2
2330094|NCT03131687|4051445|FG005|Overall Study|Withdrawal by Subject|1
2330095|NCT03131687|4051440|FG000|Overall Study|Lost to Follow-up|1
2330096|NCT03131687|4051441|FG001|Overall Study|Lost to Follow-up|4
2330097|NCT03131687|4051442|FG002|Overall Study|Lost to Follow-up|0
2330098|NCT03131687|4051443|FG003|Overall Study|Lost to Follow-up|1
2330099|NCT03131687|4051444|FG004|Overall Study|Lost to Follow-up|4
2330100|NCT03131687|4051445|FG005|Overall Study|Lost to Follow-up|2
2330101|NCT03131687|4051440|FG000|Overall Study|Participant Started New Diabetic Drug|1
2330102|NCT03131687|4051441|FG001|Overall Study|Participant Started New Diabetic Drug|0
2330103|NCT03131687|4051442|FG002|Overall Study|Participant Started New Diabetic Drug|0
2330104|NCT03131687|4051443|FG003|Overall Study|Participant Started New Diabetic Drug|0
2330105|NCT03131687|4051444|FG004|Overall Study|Participant Started New Diabetic Drug|0
2330106|NCT03131687|4051445|FG005|Overall Study|Participant Started New Diabetic Drug|0
2330107|NCT03131687|4051440|FG000|Overall Study|Principle Investigator Decision|0
2330108|NCT03131687|4051441|FG001|Overall Study|Principle Investigator Decision|1
2330109|NCT03131687|4051442|FG002|Overall Study|Principle Investigator Decision|0
2330110|NCT03131687|4051443|FG003|Overall Study|Principle Investigator Decision|0
2330111|NCT03131687|4051444|FG004|Overall Study|Principle Investigator Decision|0
2330112|NCT03131687|4051445|FG005|Overall Study|Principle Investigator Decision|0
2330113|NCT03131687|4051440|FG000|Overall Study|Inadvertent Enrollment|0
2330114|NCT03131687|4051441|FG001|Overall Study|Inadvertent Enrollment|0
2330115|NCT03131687|4051442|FG002|Overall Study|Inadvertent Enrollment|0
2330116|NCT03131687|4051443|FG003|Overall Study|Inadvertent Enrollment|1
2330117|NCT03131687|4051444|FG004|Overall Study|Inadvertent Enrollment|0
2330118|NCT03131687|4051445|FG005|Overall Study|Inadvertent Enrollment|0
2330119|NCT03131713|4051474|FG000|Overall Study|Lost to Follow-up|5
2330120|NCT03131713|4051475|FG001|Overall Study|Lost to Follow-up|0
2330121|NCT03131895|4051485|FG000|Washout Period (at Least 5 Days)|Adverse Event|1
2330122|NCT03131895|4051486|FG001|Washout Period (at Least 5 Days)|Adverse Event|0
2330123|NCT03131895|4051487|FG002|Washout Period (at Least 5 Days)|Adverse Event|0
2330124|NCT03131895|4051488|FG003|Washout Period (at Least 5 Days)|Adverse Event|1
2330125|NCT03131895|4051485|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2330126|NCT03131895|4051486|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3
2330127|NCT03131895|4051487|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2
2330128|NCT03131895|4051488|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3
2330129|NCT03131895|4051485|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2330130|NCT03131895|4051486|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
2330131|NCT03131895|4051487|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2330132|NCT03131895|4051488|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2330133|NCT03131895|4051485|FG000|Washout Period (at Least 5 Days)|Other|0
2330134|NCT03131895|4051486|FG001|Washout Period (at Least 5 Days)|Other|0
2330135|NCT03131895|4051487|FG002|Washout Period (at Least 5 Days)|Other|2
2330136|NCT03131895|4051488|FG003|Washout Period (at Least 5 Days)|Other|0
2330137|NCT03131895|4051485|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2330138|NCT03131895|4051486|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1
2330139|NCT03131895|4051487|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2330140|NCT03131895|4051488|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2330141|NCT03131895|4051485|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
2330142|NCT03131895|4051486|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2330143|NCT03131895|4051487|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2330144|NCT03131895|4051488|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2330145|NCT03131960|4051500|FG000|Overall Study|Adverse Event|0
2330146|NCT03131960|4051501|FG001|Overall Study|Adverse Event|1
2330147|NCT03131999|4051509|FG000|Overall Study|Withdrawal by Subject|0
2330148|NCT03131999|4051510|FG001|Overall Study|Withdrawal by Subject|1
2330149|NCT03132220|4051518|FG000|Overall Study|Lost to Follow-up|17
2330150|NCT03132220|4051519|FG001|Overall Study|Lost to Follow-up|8
2330151|NCT03132220|4051518|FG000|Overall Study|Withdrawal by Subject|1
2330152|NCT03132220|4051519|FG001|Overall Study|Withdrawal by Subject|4
2330153|NCT03133481|4051554|FG000|Overall Study|FC Catheter fell out post operative day1|0
2330154|NCT03133481|4051555|FG001|Overall Study|FC Catheter fell out post operative day1|4
2330155|NCT03133767|4051607|FG000|Overall Study|Lost to Follow-up|38
2330156|NCT03133767|4051608|FG001|Overall Study|Lost to Follow-up|24
2330157|NCT03133767|4051607|FG000|Overall Study|Protocol Violation|0
2330158|NCT03133767|4051608|FG001|Overall Study|Protocol Violation|1
2330159|NCT03134183|4051647|FG000|Overall Study|Withdrawal by Subject|1
2330160|NCT03134183|4051648|FG001|Overall Study|Withdrawal by Subject|1
2330161|NCT03134222|4051670|FG000|Treatment Period (Up to Week 12)|Adverse Event|4
2330162|NCT03134222|4051671|FG001|Treatment Period (Up to Week 12)|Adverse Event|1
2031156|NCT00382291|3600755|FG000|Overall Study|Lack of Efficacy|0
2031157|NCT00382291|3600756|FG001|Overall Study|Lack of Efficacy|0
2031158|NCT00382291|3600757|FG002|Overall Study|Lack of Efficacy|1
2031159|NCT00382408|3600769|FG000|Overall Study|Did not meet protocol requirement|3
2031160|NCT00382408|3600770|FG001|Overall Study|Did not meet protocol requirement|3
2031161|NCT00382408|3600769|FG000|Overall Study|Protocol Violation|2
2031162|NCT00382408|3600770|FG001|Overall Study|Protocol Violation|2
2031163|NCT00382408|3600769|FG000|Overall Study|Physician Decision|1
2031164|NCT00382408|3600770|FG001|Overall Study|Physician Decision|0
2031165|NCT00382408|3600769|FG000|Overall Study|Withdrawal by Subject|17
2031166|NCT00382408|3600770|FG001|Overall Study|Withdrawal by Subject|6
2031167|NCT00382408|3600769|FG000|Overall Study|Pregnancy|2
2031168|NCT00382408|3600770|FG001|Overall Study|Pregnancy|0
2031169|NCT00382408|3600769|FG000|Overall Study|Lost to Follow-up|19
2031170|NCT00382408|3600770|FG001|Overall Study|Lost to Follow-up|8
2031171|NCT00382408|3600769|FG000|Overall Study|Other|100
2031172|NCT00382408|3600770|FG001|Overall Study|Other|35
2110604|NCT00896532|3705471|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
2110605|NCT00896532|3705472|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
2110606|NCT00896532|3705473|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
2110607|NCT00896532|3705474|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110608|NCT00896532|3705475|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110609|NCT00896532|3705476|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110610|NCT00896532|3705477|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110611|NCT00896532|3705478|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110612|NCT00896532|3705479|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110613|NCT00896532|3705480|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110614|NCT00896532|3705481|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110615|NCT00896532|3705482|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110616|NCT00896532|3705483|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110617|NCT00896532|3705484|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110618|NCT00896532|3705485|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110619|NCT00896532|3705486|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110620|NCT00896532|3705487|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110621|NCT00896532|3705488|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2110622|NCT00896532|3705466|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110623|NCT00896532|3705467|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110624|NCT00896532|3705468|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
2330163|NCT03134222|4051672|FG002|Treatment Period (Up to Week 12)|Adverse Event|0
2330164|NCT03134222|4051673|FG003|Treatment Period (Up to Week 12)|Adverse Event|0
2330165|NCT03134222|4051674|FG004|Treatment Period (Up to Week 12)|Adverse Event|0
2330166|NCT03134222|4051670|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1
2031173|NCT00382720|3600788|FG000|Overall Study|Adverse Event|21
2031174|NCT00382720|3600789|FG001|Overall Study|Adverse Event|23
2031175|NCT00382720|3600790|FG002|Overall Study|Adverse Event|15
2031176|NCT00382720|3600788|FG000|Overall Study|Protocol Violation|2
2031177|NCT00382720|3600789|FG001|Overall Study|Protocol Violation|5
2031178|NCT00382720|3600790|FG002|Overall Study|Protocol Violation|1
2031179|NCT00382720|3600788|FG000|Overall Study|Death|0
2031180|NCT00382720|3600789|FG001|Overall Study|Death|1
2031181|NCT00382720|3600790|FG002|Overall Study|Death|2
2031182|NCT00382720|3600788|FG000|Overall Study|Progressive disease|37
2110625|NCT00896532|3705469|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110626|NCT00896532|3705470|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
2110627|NCT00896532|3705471|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110628|NCT00896532|3705472|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110629|NCT00896532|3705473|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110630|NCT00896532|3705474|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110631|NCT00896532|3705475|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110632|NCT00896532|3705476|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110633|NCT00896532|3705477|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110634|NCT00896532|3705478|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110635|NCT00896532|3705479|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2218484|NCT01715415|3862061|FG000|Open-label Treatment|Subject Noncompliant|0
2218485|NCT01715415|3862062|FG001|Open-label Treatment|Subject Noncompliant|1
2218486|NCT01715571|3862069|FG000|Overall Study|Lost to Follow-up|8
2110636|NCT00896532|3705480|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110637|NCT00896532|3705481|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110638|NCT00896532|3705482|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110639|NCT00896532|3705483|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110640|NCT00896532|3705484|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110641|NCT00896532|3705485|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110642|NCT00896532|3705486|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110643|NCT00896532|3705487|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110644|NCT00896532|3705488|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2110645|NCT00896532|3705466|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1
2110646|NCT00896532|3705467|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0
2110647|NCT00896532|3705468|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0
2110648|NCT00896532|3705469|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1
2110649|NCT00896532|3705470|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0
2110650|NCT00896532|3705471|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0
2110651|NCT00896532|3705472|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0
2110652|NCT00896532|3705473|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0
2110653|NCT00896532|3705474|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0
2110654|NCT00896532|3705475|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0
2110655|NCT00896532|3705476|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0
2110656|NCT00896532|3705477|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0
2218487|NCT01715805|3862073|FG000|Placebo + ADT Lead-in Period|Adverse Event|41
2218488|NCT01715805|3862074|FG001|Placebo + ADT Lead-in Period|Adverse Event|0
2218489|NCT01715805|3862075|FG002|Placebo + ADT Lead-in Period|Adverse Event|0
2031183|NCT00382720|3600789|FG001|Overall Study|Progressive disease|28
2218490|NCT01715805|3862076|FG003|Placebo + ADT Lead-in Period|Adverse Event|0
2218491|NCT01715805|3862073|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
2330167|NCT03134222|4051671|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1
2330168|NCT03134222|4051672|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1
2330169|NCT03134222|4051673|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0
2330170|NCT03134222|4051674|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0
2330171|NCT03134222|4051670|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0
2330172|NCT03134222|4051671|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1
2330173|NCT03134222|4051672|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0
2330174|NCT03134222|4051673|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0
2330175|NCT03134222|4051674|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0
2330176|NCT03134222|4051670|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0
2330177|NCT03134222|4051671|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1
2330178|NCT03134222|4051672|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1
2330179|NCT03134222|4051673|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0
2330180|NCT03134222|4051674|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0
2330181|NCT03134222|4051670|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0
2330182|NCT03134222|4051671|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2
2330183|NCT03134222|4051672|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0
2330184|NCT03134222|4051673|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0
2330185|NCT03134222|4051674|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1
2330186|NCT03134222|4051670|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2
2330187|NCT03134222|4051671|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
2330188|NCT03134222|4051672|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
2330189|NCT03134222|4051673|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
2330190|NCT03134222|4051674|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
2330191|NCT03134222|4051670|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
2330192|NCT03134222|4051671|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
2330193|NCT03134222|4051672|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
2330194|NCT03134222|4051673|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1
2330195|NCT03134222|4051674|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
2330196|NCT03134222|4051670|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
2330197|NCT03134222|4051671|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1
2330198|NCT03134222|4051672|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
2330199|NCT03134222|4051673|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
2330200|NCT03134222|4051674|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
2330201|NCT03134599|4051707|FG000|Week 1|Lost to Follow-up|0
2330202|NCT03134599|4051708|FG001|Week 1|Lost to Follow-up|0
2330203|NCT03134599|4051709|FG002|Week 1|Lost to Follow-up|0
2330204|NCT03134599|4051710|FG003|Week 1|Lost to Follow-up|0
2330205|NCT03134599|4051711|FG004|Week 1|Lost to Follow-up|1
2330206|NCT03134599|4051712|FG005|Week 1|Lost to Follow-up|0
2330207|NCT03134599|4051707|FG000|Week 2|Lost to Follow-up|1
2330208|NCT03134599|4051708|FG001|Week 2|Lost to Follow-up|0
2330209|NCT03134599|4051709|FG002|Week 2|Lost to Follow-up|0
2330210|NCT03134599|4051710|FG003|Week 2|Lost to Follow-up|1
2330211|NCT03134599|4051711|FG004|Week 2|Lost to Follow-up|1
2330212|NCT03134599|4051712|FG005|Week 2|Lost to Follow-up|0
2330213|NCT03134599|4051707|FG000|Week 3|Lost to Follow-up|0
2330214|NCT03134599|4051708|FG001|Week 3|Lost to Follow-up|0
2330215|NCT03134599|4051709|FG002|Week 3|Lost to Follow-up|0
2330216|NCT03134599|4051710|FG003|Week 3|Lost to Follow-up|1
2330217|NCT03134599|4051711|FG004|Week 3|Lost to Follow-up|0
2330218|NCT03134599|4051712|FG005|Week 3|Lost to Follow-up|1
2330219|NCT03134911|4051735|FG000|Overall Study|Screen failure|31
2330220|NCT03134911|4051735|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3
2330221|NCT03135028|4051818|FG000|Overall Study|Death|6
2330222|NCT03135028|4051818|FG000|Overall Study|Study Terminated by Sponsor|2
2330223|NCT03135028|4051818|FG000|Overall Study|Withdrew Consent|1
2330224|NCT03135210|4051824|FG000|Overall Study|Death|0
2330225|NCT03135210|4051825|FG001|Overall Study|Death|1
2330226|NCT03135431|4051842|FG000|Overall Study|Study Surgeon not available|2
2330227|NCT03135431|4051843|FG001|Overall Study|Study Surgeon not available|0
2330228|NCT03135522|4051851|FG000|Overall Study|Adverse Event|1
2330229|NCT03135522|4051852|FG001|Overall Study|Adverse Event|0
2330230|NCT03135548|4051865|FG000|Overall Study|Lost to Follow-up|3
2330231|NCT03135548|4051866|FG001|Overall Study|Lost to Follow-up|0
2330232|NCT03135548|4051867|FG002|Overall Study|Lost to Follow-up|0
2330233|NCT03135548|4051865|FG000|Overall Study|Withdrawal by Subject|2
2330234|NCT03135548|4051866|FG001|Overall Study|Withdrawal by Subject|2
2330235|NCT03135548|4051867|FG002|Overall Study|Withdrawal by Subject|1
2330236|NCT03135548|4051865|FG000|Overall Study|Other than listed|0
2330237|NCT03135548|4051866|FG001|Overall Study|Other than listed|2
2330238|NCT03135548|4051867|FG002|Overall Study|Other than listed|2
2330239|NCT03135899|4051883|FG000|Overall Study|Failed spirometry,unable to repeat visit|0
2330240|NCT03135899|4051884|FG001|Overall Study|Failed spirometry,unable to repeat visit|0
2330241|NCT03135899|4051885|FG002|Overall Study|Failed spirometry,unable to repeat visit|0
2330242|NCT03135899|4051886|FG003|Overall Study|Failed spirometry,unable to repeat visit|0
2330243|NCT03135899|4051887|FG004|Overall Study|Failed spirometry,unable to repeat visit|0
2330244|NCT03135899|4051888|FG005|Overall Study|Failed spirometry,unable to repeat visit|0
2330245|NCT03135899|4051889|FG006|Overall Study|Failed spirometry,unable to repeat visit|1
2218492|NCT01715805|3862074|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
2330246|NCT03135899|4051890|FG007|Overall Study|Failed spirometry,unable to repeat visit|0
2330247|NCT03135899|4051883|FG000|Overall Study|Withdrawal by Subject|0
2330248|NCT03135899|4051884|FG001|Overall Study|Withdrawal by Subject|0
2330249|NCT03135899|4051885|FG002|Overall Study|Withdrawal by Subject|0
2330250|NCT03135899|4051886|FG003|Overall Study|Withdrawal by Subject|0
2330251|NCT03135899|4051887|FG004|Overall Study|Withdrawal by Subject|0
2330252|NCT03135899|4051888|FG005|Overall Study|Withdrawal by Subject|2
2330253|NCT03135899|4051889|FG006|Overall Study|Withdrawal by Subject|0
2330254|NCT03135899|4051890|FG007|Overall Study|Withdrawal by Subject|0
2330255|NCT03136068|4051906|FG000|Overall Study|Lost to Follow-up|1
2330256|NCT03136068|4051907|FG001|Overall Study|Lost to Follow-up|1
2330257|NCT03136068|4051906|FG000|Overall Study|Protocol Violation|1
2330258|NCT03136068|4051907|FG001|Overall Study|Protocol Violation|0
2330259|NCT03136107|4051913|FG000|Overall Study|Other (Not specified)|1
2330260|NCT03136159|4051923|FG000|Overall Study|chorioamnionitis|2
2330261|NCT03136159|4051924|FG001|Overall Study|chorioamnionitis|0
2330262|NCT03136159|4051923|FG000|Overall Study|vertical skin incision|1
2330263|NCT03136159|4051924|FG001|Overall Study|vertical skin incision|0
2330264|NCT03136159|4051923|FG000|Overall Study|additional dressing|1
2330265|NCT03136159|4051924|FG001|Overall Study|additional dressing|0
2330266|NCT03136159|4051923|FG000|Overall Study|never got dressing placed|1
2330267|NCT03136159|4051924|FG001|Overall Study|never got dressing placed|0
2330268|NCT03136198|4051932|FG000|Overall Study|Withdrawal by Subject|0
2330269|NCT03136198|4051933|FG001|Overall Study|Withdrawal by Subject|1
2330270|NCT03136367|4051947|FG000|T1 Consultation|discontinued mistakenly included|2
2330271|NCT03136367|4051948|FG001|T1 Consultation|discontinued mistakenly included|6
2330272|NCT03136367|4051949|FG002|T1 Consultation|discontinued mistakenly included|1
2330273|NCT03136367|4051947|FG000|T1 Consultation|Discontinued other|0
2218493|NCT01715805|3862075|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
2031184|NCT00382720|3600790|FG002|Overall Study|Progressive disease|38
2031185|NCT00382720|3600788|FG000|Overall Study|Withdrew consent|1
2031186|NCT00382720|3600789|FG001|Overall Study|Withdrew consent|1
2031187|NCT00382720|3600790|FG002|Overall Study|Withdrew consent|2
2031188|NCT00382720|3600788|FG000|Overall Study|Withdrawal by Subject|11
2031189|NCT00382720|3600789|FG001|Overall Study|Withdrawal by Subject|20
2031190|NCT00382720|3600790|FG002|Overall Study|Withdrawal by Subject|12
2031191|NCT00382720|3600788|FG000|Overall Study|Surgery|1
2031192|NCT00382720|3600789|FG001|Overall Study|Surgery|1
2031193|NCT00382720|3600790|FG002|Overall Study|Surgery|4
2031194|NCT00382720|3600788|FG000|Overall Study|Patient did not receive study medication|1
2031195|NCT00382720|3600789|FG001|Overall Study|Patient did not receive study medication|1
2031196|NCT00382720|3600790|FG002|Overall Study|Patient did not receive study medication|4
2031197|NCT00382720|3600788|FG000|Overall Study|Clinically progressive disease|0
2330274|NCT03136367|4051948|FG001|T1 Consultation|Discontinued other|1
2330275|NCT03136367|4051949|FG002|T1 Consultation|Discontinued other|0
2330276|NCT03136367|4051947|FG000|T2 Post-consultation|Withdrawal by Subject|1
2330277|NCT03136367|4051948|FG001|T2 Post-consultation|Withdrawal by Subject|1
2330278|NCT03136367|4051949|FG002|T2 Post-consultation|Withdrawal by Subject|5
2330279|NCT03136367|4051947|FG000|T2 Post-consultation|discontinued mistakenly included|2
2330280|NCT03136367|4051948|FG001|T2 Post-consultation|discontinued mistakenly included|2
2330281|NCT03136367|4051949|FG002|T2 Post-consultation|discontinued mistakenly included|17
2330282|NCT03136367|4051947|FG000|T2 Post-consultation|Discontinued other|0
2330283|NCT03136367|4051948|FG001|T2 Post-consultation|Discontinued other|2
2330284|NCT03136367|4051949|FG002|T2 Post-consultation|Discontinued other|6
2330285|NCT03136367|4051947|FG000|T2 Post-consultation|Discontinued transferred care|0
2330286|NCT03136367|4051948|FG001|T2 Post-consultation|Discontinued transferred care|0
2330287|NCT03136367|4051949|FG002|T2 Post-consultation|Discontinued transferred care|3
2330288|NCT03136367|4051947|FG000|T2 Post-consultation|Discontinued lost contact|0
2330289|NCT03136367|4051948|FG001|T2 Post-consultation|Discontinued lost contact|1
2330290|NCT03136367|4051949|FG002|T2 Post-consultation|Discontinued lost contact|0
2330291|NCT03136367|4051947|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5
2330292|NCT03136367|4051948|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9
2330293|NCT03136367|4051949|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8
2330294|NCT03136367|4051947|FG000|T3 1 Week After Surgery|Discontinued transferred care|2
2031198|NCT00382720|3600789|FG001|Overall Study|Clinically progressive disease|1
2031199|NCT00382720|3600790|FG002|Overall Study|Clinically progressive disease|0
2031200|NCT00382720|3600788|FG000|Overall Study|Good prognosis|0
2031201|NCT00382720|3600789|FG001|Overall Study|Good prognosis|1
2031202|NCT00382720|3600790|FG002|Overall Study|Good prognosis|0
2031203|NCT00382720|3600788|FG000|Overall Study|Investigator/Clinical decision|5
2031204|NCT00382720|3600789|FG001|Overall Study|Investigator/Clinical decision|6
2031205|NCT00382720|3600790|FG002|Overall Study|Investigator/Clinical decision|6
2031206|NCT00382720|3600788|FG000|Overall Study|Discontinued at end of study|0
2031207|NCT00382720|3600789|FG001|Overall Study|Discontinued at end of study|1
2031208|NCT00382720|3600790|FG002|Overall Study|Discontinued at end of study|2
2031209|NCT00382733|3600798|FG000|Overall Study|Withdrawal by Subject|0
2031210|NCT00382733|3600799|FG001|Overall Study|Withdrawal by Subject|1
2031211|NCT00382733|3600800|FG002|Overall Study|Withdrawal by Subject|0
2031212|NCT00382733|3600801|FG003|Overall Study|Withdrawal by Subject|0
2031213|NCT00382733|3600802|FG004|Overall Study|Withdrawal by Subject|0
2031214|NCT00382863|3600835|FG000|Overall Study|Death|9
2110657|NCT00896532|3705478|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0
2110658|NCT00896532|3705479|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0
2110659|NCT00896532|3705480|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0
2110660|NCT00896532|3705481|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0
2110661|NCT00896532|3705482|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0
2110662|NCT00896532|3705483|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0
2110663|NCT00896532|3705484|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0
2110664|NCT00896532|3705485|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0
2330295|NCT03136367|4051948|FG001|T3 1 Week After Surgery|Discontinued transferred care|11
2330296|NCT03136367|4051949|FG002|T3 1 Week After Surgery|Discontinued transferred care|14
2330297|NCT03136367|4051947|FG000|T3 1 Week After Surgery|other discontinued|2
2330298|NCT03136367|4051948|FG001|T3 1 Week After Surgery|other discontinued|4
2330299|NCT03136367|4051949|FG002|T3 1 Week After Surgery|other discontinued|3
2330300|NCT03136367|4051947|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0
2330301|NCT03136367|4051948|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6
2330302|NCT03136367|4051949|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2
2330303|NCT03136367|4051947|FG000|T3 1 Week After Surgery|Discontinued lost contact|1
2330304|NCT03136367|4051948|FG001|T3 1 Week After Surgery|Discontinued lost contact|2
2330305|NCT03136367|4051949|FG002|T3 1 Week After Surgery|Discontinued lost contact|4
2330306|NCT03136367|4051947|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1
2330307|NCT03136367|4051948|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3
2330308|NCT03136367|4051949|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0
2330309|NCT03136367|4051947|FG000|T4 12 Weeks After Surgery|Death|0
2330310|NCT03136367|4051948|FG001|T4 12 Weeks After Surgery|Death|1
2330311|NCT03136367|4051949|FG002|T4 12 Weeks After Surgery|Death|3
2330312|NCT03136367|4051947|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1
2330313|NCT03136367|4051948|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0
2330314|NCT03136367|4051949|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0
2330315|NCT03136367|4051947|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0
2330316|NCT03136367|4051948|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1
2330317|NCT03136367|4051949|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5
2330318|NCT03136367|4051947|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0
2330319|NCT03136367|4051948|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0
2330320|NCT03136367|4051949|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1
2031215|NCT00382863|3600836|FG001|Overall Study|Death|9
2031216|NCT00382863|3600835|FG000|Overall Study|Lost to Follow-up|1
2031217|NCT00382863|3600836|FG001|Overall Study|Lost to Follow-up|2
2031218|NCT00382863|3600835|FG000|Overall Study|Withdrawal by Subject|5
2330321|NCT03136367|4051947|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1
2330322|NCT03136367|4051948|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1
2330323|NCT03136367|4051949|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1
2330324|NCT03136367|4051947|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1
2330325|NCT03136367|4051948|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0
2330326|NCT03136367|4051949|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0
2330327|NCT03136367|4051947|FG000|T5 1 Year After Surgery|Death|0
2330328|NCT03136367|4051948|FG001|T5 1 Year After Surgery|Death|0
2330329|NCT03136367|4051949|FG002|T5 1 Year After Surgery|Death|1
2330330|NCT03136367|4051947|FG000|T5 1 Year After Surgery|Discontinued lost contact|1
2330331|NCT03136367|4051948|FG001|T5 1 Year After Surgery|Discontinued lost contact|6
2330332|NCT03136367|4051949|FG002|T5 1 Year After Surgery|Discontinued lost contact|0
2330333|NCT03136367|4051947|FG000|T5 1 Year After Surgery|Lost to Follow-up|2
2330334|NCT03136367|4051948|FG001|T5 1 Year After Surgery|Lost to Follow-up|22
2330335|NCT03136367|4051949|FG002|T5 1 Year After Surgery|Lost to Follow-up|15
2330336|NCT03136367|4051947|FG000|T5 1 Year After Surgery|study ended before due|31
2330337|NCT03136367|4051948|FG001|T5 1 Year After Surgery|study ended before due|103
2330338|NCT03136367|4051949|FG002|T5 1 Year After Surgery|study ended before due|110
2330339|NCT03136367|4051947|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0
2330340|NCT03136367|4051948|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4
2330341|NCT03136367|4051949|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2
2330342|NCT03136380|4051962|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2330343|NCT03136380|4051963|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
2330344|NCT03136380|4051964|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2330345|NCT03136380|4051965|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2330346|NCT03136380|4051966|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2330347|NCT03136484|4051986|FG000|Overall Study|Withdrawal by Subject|19
2330348|NCT03136484|4051987|FG001|Overall Study|Withdrawal by Subject|14
2330349|NCT03136484|4051986|FG000|Overall Study|Lost to Follow-up|7
2330350|NCT03136484|4051987|FG001|Overall Study|Lost to Follow-up|8
2330351|NCT03136484|4051986|FG000|Overall Study|Death|1
2330352|NCT03136484|4051987|FG001|Overall Study|Death|0
2330353|NCT03136861|4052000|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
2330354|NCT03136861|4052001|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
2330355|NCT03136861|4052002|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2330356|NCT03136861|4052003|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2330357|NCT03136861|4052004|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2330358|NCT03136861|4052005|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2330359|NCT03136861|4052006|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2330360|NCT03136861|4052000|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
2330361|NCT03136861|4052001|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
2330362|NCT03136861|4052002|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2330363|NCT03136861|4052003|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2330364|NCT03136861|4052004|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2330365|NCT03136861|4052005|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2330366|NCT03136861|4052006|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2330367|NCT03136861|4052000|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
2330368|NCT03136861|4052001|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
2330369|NCT03136861|4052002|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2330370|NCT03136861|4052003|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2330371|NCT03136861|4052004|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2330372|NCT03136861|4052005|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2330373|NCT03136861|4052006|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2330374|NCT03136861|4052000|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2330375|NCT03136861|4052001|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
2330376|NCT03136861|4052002|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2330377|NCT03136861|4052003|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2330378|NCT03136861|4052004|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2330379|NCT03136861|4052005|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2330380|NCT03136861|4052006|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2330381|NCT03136861|4052000|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
2330382|NCT03136861|4052001|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
2330383|NCT03136861|4052002|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2330384|NCT03136861|4052003|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2330385|NCT03136861|4052004|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2330386|NCT03136861|4052005|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2330387|NCT03136861|4052006|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2330388|NCT03136861|4052000|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2330389|NCT03136861|4052001|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2330390|NCT03136861|4052002|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2330391|NCT03136861|4052003|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
2330392|NCT03136861|4052004|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
2330393|NCT03136861|4052005|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2330394|NCT03136861|4052006|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
2330395|NCT03136861|4052000|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2330396|NCT03136861|4052001|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2330397|NCT03136861|4052002|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
2330398|NCT03136861|4052003|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2218494|NCT01715805|3862076|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
2330399|NCT03136861|4052004|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2330400|NCT03136861|4052005|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2330401|NCT03136861|4052006|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2330402|NCT03136861|4052000|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2330403|NCT03136861|4052001|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2330404|NCT03136861|4052002|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
2330405|NCT03136861|4052003|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2330406|NCT03136861|4052004|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2330407|NCT03136861|4052005|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2330408|NCT03136861|4052006|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2330409|NCT03137069|4052030|FG000|Overall Study|Withdrawal by Subject|1
2330410|NCT03137069|4052031|FG001|Overall Study|Withdrawal by Subject|2
2330411|NCT03137069|4052032|FG002|Overall Study|Withdrawal by Subject|2
2330412|NCT03137069|4052033|FG003|Overall Study|Withdrawal by Subject|2
2330413|NCT03137069|4052034|FG004|Overall Study|Withdrawal by Subject|0
2218495|NCT01715805|3862073|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74
2218496|NCT01715805|3862074|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0
2218497|NCT01715805|3862075|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0
2218498|NCT01715805|3862076|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0
2218499|NCT01715805|3862073|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
2218500|NCT01715805|3862074|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
2218501|NCT01715805|3862075|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
2218502|NCT01715805|3862076|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
2218503|NCT01715805|3862073|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34
2218504|NCT01715805|3862074|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0
2218505|NCT01715805|3862075|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0
2218506|NCT01715805|3862076|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0
2218507|NCT01715805|3862073|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
2218508|NCT01715805|3862074|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
2218509|NCT01715805|3862075|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
2330414|NCT03137069|4052035|FG005|Overall Study|Withdrawal by Subject|0
2330415|NCT03137069|4052030|FG000|Overall Study|Adverse Event|0
2330416|NCT03137069|4052031|FG001|Overall Study|Adverse Event|3
2330417|NCT03137069|4052032|FG002|Overall Study|Adverse Event|1
2330418|NCT03137069|4052033|FG003|Overall Study|Adverse Event|1
2330419|NCT03137069|4052034|FG004|Overall Study|Adverse Event|0
2330420|NCT03137069|4052035|FG005|Overall Study|Adverse Event|1
2330421|NCT03137069|4052030|FG000|Overall Study|Protocol Violation|0
2330422|NCT03137069|4052031|FG001|Overall Study|Protocol Violation|1
2330423|NCT03137069|4052032|FG002|Overall Study|Protocol Violation|0
2330424|NCT03137069|4052033|FG003|Overall Study|Protocol Violation|1
2330425|NCT03137069|4052034|FG004|Overall Study|Protocol Violation|1
2330426|NCT03137069|4052035|FG005|Overall Study|Protocol Violation|1
2330427|NCT03137069|4052030|FG000|Overall Study|Physician Decision|0
2330428|NCT03137069|4052031|FG001|Overall Study|Physician Decision|0
2330429|NCT03137069|4052032|FG002|Overall Study|Physician Decision|0
2330430|NCT03137069|4052033|FG003|Overall Study|Physician Decision|1
2330431|NCT03137069|4052034|FG004|Overall Study|Physician Decision|0
2330432|NCT03137069|4052035|FG005|Overall Study|Physician Decision|0
2330433|NCT03137069|4052030|FG000|Overall Study|Study Terminated by Sponsor|0
2330434|NCT03137069|4052031|FG001|Overall Study|Study Terminated by Sponsor|0
2330435|NCT03137069|4052032|FG002|Overall Study|Study Terminated by Sponsor|0
2330436|NCT03137069|4052033|FG003|Overall Study|Study Terminated by Sponsor|0
2330437|NCT03137069|4052034|FG004|Overall Study|Study Terminated by Sponsor|1
2330438|NCT03137069|4052035|FG005|Overall Study|Study Terminated by Sponsor|0
2330439|NCT03137069|4052030|FG000|Overall Study|Data Entry Error|0
2330440|NCT03137069|4052031|FG001|Overall Study|Data Entry Error|0
2330441|NCT03137069|4052032|FG002|Overall Study|Data Entry Error|0
2330442|NCT03137069|4052033|FG003|Overall Study|Data Entry Error|1
2330443|NCT03137069|4052034|FG004|Overall Study|Data Entry Error|0
2330444|NCT03137069|4052035|FG005|Overall Study|Data Entry Error|0
2330445|NCT03137121|4052055|FG000|Overall Study|Withdrawal by Subject|0
2330446|NCT03137121|4052056|FG001|Overall Study|Withdrawal by Subject|1
2330447|NCT03137173|4052064|FG000|Overall Study|Withdrawal by Subject|8
2330448|NCT03137173|4052065|FG001|Overall Study|Withdrawal by Subject|13
2330449|NCT03137173|4052064|FG000|Overall Study|Death|1
2330450|NCT03137173|4052065|FG001|Overall Study|Death|3
2330451|NCT03137173|4052064|FG000|Overall Study|Physician Decision|1
2330452|NCT03137173|4052065|FG001|Overall Study|Physician Decision|0
2330453|NCT03137173|4052064|FG000|Overall Study|Lost to Follow-up|13
2330454|NCT03137173|4052065|FG001|Overall Study|Lost to Follow-up|18
2330455|NCT03137173|4052064|FG000|Overall Study|Other reasons|3
2330456|NCT03137173|4052065|FG001|Overall Study|Other reasons|2
2330457|NCT03137303|4052074|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1
2330458|NCT03137303|4052075|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4
2330459|NCT03137303|4052074|FG000|T1: 3-month Follow-up|Lost to Follow-up|5
2330460|NCT03137303|4052075|FG001|T1: 3-month Follow-up|Lost to Follow-up|6
2330461|NCT03137303|4052074|FG000|T2: 6-month Follow-up|Lost to Follow-up|5
2330462|NCT03137303|4052075|FG001|T2: 6-month Follow-up|Lost to Follow-up|5
2330463|NCT03137303|4052074|FG000|T3: 9-month Follow-up|Death|1
2330464|NCT03137303|4052075|FG001|T3: 9-month Follow-up|Death|0
2330465|NCT03137303|4052074|FG000|T3: 9-month Follow-up|Lost to Follow-up|4
2330466|NCT03137303|4052075|FG001|T3: 9-month Follow-up|Lost to Follow-up|4
2330467|NCT03137303|4052074|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0
2330468|NCT03137303|4052075|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1
2330469|NCT03137303|4052074|FG000|T4: 12-month Follow-up|Lost to Follow-up|7
2330470|NCT03137303|4052075|FG001|T4: 12-month Follow-up|Lost to Follow-up|4
2330471|NCT03137459|4052083|FG000|2-month Assessment|Withdrawal by Subject|13
2330472|NCT03137459|4052084|FG001|2-month Assessment|Withdrawal by Subject|3
2330473|NCT03137459|4052083|FG000|2-month Assessment|Unable to reach|42
2330474|NCT03137459|4052084|FG001|2-month Assessment|Unable to reach|32
2330475|NCT03137459|4052083|FG000|2-month Assessment|Refused assessment|7
2330476|NCT03137459|4052084|FG001|2-month Assessment|Refused assessment|5
2330477|NCT03137459|4052083|FG000|2-month Assessment|Acutely ill|6
2330478|NCT03137459|4052084|FG001|2-month Assessment|Acutely ill|2
2330479|NCT03137459|4052083|FG000|4-month Assessment|Death|4
2330480|NCT03137459|4052084|FG001|4-month Assessment|Death|2
2330481|NCT03137459|4052083|FG000|4-month Assessment|Withdrawal by Subject|4
2330482|NCT03137459|4052084|FG001|4-month Assessment|Withdrawal by Subject|2
2330483|NCT03137459|4052083|FG000|4-month Assessment|Unable to reach|44
2330484|NCT03137459|4052084|FG001|4-month Assessment|Unable to reach|29
2330485|NCT03137459|4052083|FG000|4-month Assessment|Refused assessment|24
2330486|NCT03137459|4052084|FG001|4-month Assessment|Refused assessment|10
2330487|NCT03137459|4052083|FG000|4-month Assessment|Acutely ill|2
2330488|NCT03137459|4052084|FG001|4-month Assessment|Acutely ill|3
2330489|NCT03137459|4052083|FG000|6-months|Lost to Follow-up|14
2330490|NCT03137459|4052084|FG001|6-months|Lost to Follow-up|11
2330491|NCT03137459|4052083|FG000|6-months|Death|0
2330492|NCT03137459|4052084|FG001|6-months|Death|2
2330493|NCT03137459|4052083|FG000|6-months|Refused assessment|6
2330494|NCT03137459|4052084|FG001|6-months|Refused assessment|3
2330495|NCT03137459|4052083|FG000|6-months|Acutely ill|1
2330496|NCT03137459|4052084|FG001|6-months|Acutely ill|1
2330497|NCT03137784|4052095|FG000|Overall Study|Adverse Event|1
2330498|NCT03137784|4052096|FG001|Overall Study|Adverse Event|1
2330499|NCT03137784|4052097|FG002|Overall Study|Adverse Event|0
2330500|NCT03137784|4052098|FG003|Overall Study|Adverse Event|0
2330501|NCT03137784|4052099|FG004|Overall Study|Adverse Event|0
2330502|NCT03137784|4052100|FG005|Overall Study|Adverse Event|0
2330503|NCT03137784|4052095|FG000|Overall Study|Subject/guardian decision|1
2330504|NCT03137784|4052096|FG001|Overall Study|Subject/guardian decision|0
2330505|NCT03137784|4052097|FG002|Overall Study|Subject/guardian decision|0
2330506|NCT03137784|4052098|FG003|Overall Study|Subject/guardian decision|0
2330507|NCT03137784|4052099|FG004|Overall Study|Subject/guardian decision|0
2330508|NCT03137784|4052100|FG005|Overall Study|Subject/guardian decision|0
2330509|NCT03137784|4052095|FG000|Overall Study|Non-compliance with study treatment|0
2330510|NCT03137784|4052096|FG001|Overall Study|Non-compliance with study treatment|0
2330511|NCT03137784|4052097|FG002|Overall Study|Non-compliance with study treatment|0
2330512|NCT03137784|4052098|FG003|Overall Study|Non-compliance with study treatment|0
2330513|NCT03137784|4052099|FG004|Overall Study|Non-compliance with study treatment|1
2330514|NCT03137784|4052100|FG005|Overall Study|Non-compliance with study treatment|0
2330515|NCT03137992|4052108|FG000|Washout Period 1|Adverse Event|1
2330516|NCT03137992|4052109|FG001|Washout Period 1|Adverse Event|1
2330517|NCT03137992|4052110|FG002|Washout Period 1|Adverse Event|0
2330518|NCT03137992|4052111|FG003|Washout Period 1|Adverse Event|0
2330519|NCT03137992|4052112|FG004|Washout Period 1|Adverse Event|0
2218510|NCT01715805|3862076|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
2218511|NCT01715805|3862073|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
2330520|NCT03137992|4052113|FG005|Washout Period 1|Adverse Event|1
2330521|NCT03137992|4052108|FG000|Washout Period 1|Withdrawal by Subject|0
2330522|NCT03137992|4052109|FG001|Washout Period 1|Withdrawal by Subject|1
2330523|NCT03137992|4052110|FG002|Washout Period 1|Withdrawal by Subject|1
2330524|NCT03137992|4052111|FG003|Washout Period 1|Withdrawal by Subject|0
2330525|NCT03137992|4052112|FG004|Washout Period 1|Withdrawal by Subject|0
2330526|NCT03137992|4052113|FG005|Washout Period 1|Withdrawal by Subject|0
2330527|NCT03137992|4052108|FG000|Washout Period 1|Principal Investigator Discretion|0
2330528|NCT03137992|4052109|FG001|Washout Period 1|Principal Investigator Discretion|1
2330529|NCT03137992|4052110|FG002|Washout Period 1|Principal Investigator Discretion|0
2330530|NCT03137992|4052111|FG003|Washout Period 1|Principal Investigator Discretion|0
2330531|NCT03137992|4052112|FG004|Washout Period 1|Principal Investigator Discretion|0
2330532|NCT03137992|4052113|FG005|Washout Period 1|Principal Investigator Discretion|0
2330533|NCT03137992|4052108|FG000|Washout Period 1|COPD Exacerbation|1
2330534|NCT03137992|4052109|FG001|Washout Period 1|COPD Exacerbation|1
2330535|NCT03137992|4052110|FG002|Washout Period 1|COPD Exacerbation|1
2330536|NCT03137992|4052111|FG003|Washout Period 1|COPD Exacerbation|0
2330537|NCT03137992|4052112|FG004|Washout Period 1|COPD Exacerbation|1
2330538|NCT03137992|4052113|FG005|Washout Period 1|COPD Exacerbation|1
2330539|NCT03137992|4052108|FG000|Washout Period 1|Subject Noncompliance|1
2330540|NCT03137992|4052109|FG001|Washout Period 1|Subject Noncompliance|0
2330541|NCT03137992|4052110|FG002|Washout Period 1|Subject Noncompliance|0
2330542|NCT03137992|4052111|FG003|Washout Period 1|Subject Noncompliance|0
2330543|NCT03137992|4052112|FG004|Washout Period 1|Subject Noncompliance|1
2330544|NCT03137992|4052113|FG005|Washout Period 1|Subject Noncompliance|0
2330545|NCT03137992|4052108|FG000|Period 2 (Visit 3)|COPD Exacerbation|1
2330546|NCT03137992|4052109|FG001|Period 2 (Visit 3)|COPD Exacerbation|1
2330547|NCT03137992|4052110|FG002|Period 2 (Visit 3)|COPD Exacerbation|0
2330548|NCT03137992|4052111|FG003|Period 2 (Visit 3)|COPD Exacerbation|0
2330549|NCT03137992|4052112|FG004|Period 2 (Visit 3)|COPD Exacerbation|0
2330550|NCT03137992|4052113|FG005|Period 2 (Visit 3)|COPD Exacerbation|1
2330551|NCT03137992|4052108|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2
2330552|NCT03137992|4052109|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3
2330553|NCT03137992|4052110|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3
2330554|NCT03137992|4052111|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4
2330555|NCT03137992|4052112|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3
2330556|NCT03137992|4052113|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7
2330557|NCT03137992|4052108|FG000|Period 2 (Visit 3)|Adverse Event|0
2330558|NCT03137992|4052109|FG001|Period 2 (Visit 3)|Adverse Event|1
2330559|NCT03137992|4052110|FG002|Period 2 (Visit 3)|Adverse Event|0
2330560|NCT03137992|4052111|FG003|Period 2 (Visit 3)|Adverse Event|0
2330561|NCT03137992|4052112|FG004|Period 2 (Visit 3)|Adverse Event|0
2330562|NCT03137992|4052113|FG005|Period 2 (Visit 3)|Adverse Event|0
2330563|NCT03137992|4052108|FG000|Period 2 (Visit 3)|Lost to Follow-up|0
2330564|NCT03137992|4052109|FG001|Period 2 (Visit 3)|Lost to Follow-up|0
2330565|NCT03137992|4052110|FG002|Period 2 (Visit 3)|Lost to Follow-up|0
2330566|NCT03137992|4052111|FG003|Period 2 (Visit 3)|Lost to Follow-up|1
2330567|NCT03137992|4052112|FG004|Period 2 (Visit 3)|Lost to Follow-up|0
2330568|NCT03137992|4052113|FG005|Period 2 (Visit 3)|Lost to Follow-up|0
2330569|NCT03137992|4052108|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0
2330570|NCT03137992|4052109|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2
2330571|NCT03137992|4052110|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0
2330572|NCT03137992|4052111|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0
2330573|NCT03137992|4052112|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1
2330574|NCT03137992|4052113|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0
2330575|NCT03137992|4052108|FG000|Washout Period 2|COPD Exacerbation|1
2330576|NCT03137992|4052109|FG001|Washout Period 2|COPD Exacerbation|1
2330577|NCT03137992|4052110|FG002|Washout Period 2|COPD Exacerbation|0
2330578|NCT03137992|4052111|FG003|Washout Period 2|COPD Exacerbation|0
2330579|NCT03137992|4052112|FG004|Washout Period 2|COPD Exacerbation|1
2330580|NCT03137992|4052113|FG005|Washout Period 2|COPD Exacerbation|0
2330581|NCT03137992|4052108|FG000|Washout Period 2|Subject Non-compliance|0
2330582|NCT03137992|4052109|FG001|Washout Period 2|Subject Non-compliance|1
2330583|NCT03137992|4052110|FG002|Washout Period 2|Subject Non-compliance|0
2330584|NCT03137992|4052111|FG003|Washout Period 2|Subject Non-compliance|0
2330585|NCT03137992|4052112|FG004|Washout Period 2|Subject Non-compliance|0
2330586|NCT03137992|4052113|FG005|Washout Period 2|Subject Non-compliance|0
2330587|NCT03137992|4052108|FG000|Washout Period 2|Adverse Event|0
2330588|NCT03137992|4052109|FG001|Washout Period 2|Adverse Event|0
2330589|NCT03137992|4052110|FG002|Washout Period 2|Adverse Event|0
2330590|NCT03137992|4052111|FG003|Washout Period 2|Adverse Event|1
2330591|NCT03137992|4052112|FG004|Washout Period 2|Adverse Event|1
2330592|NCT03137992|4052113|FG005|Washout Period 2|Adverse Event|0
2330593|NCT03137992|4052108|FG000|Washout Period 2|Withdrawal by Subject|1
2330594|NCT03137992|4052109|FG001|Washout Period 2|Withdrawal by Subject|0
2330595|NCT03137992|4052110|FG002|Washout Period 2|Withdrawal by Subject|0
2330596|NCT03137992|4052111|FG003|Washout Period 2|Withdrawal by Subject|0
2330597|NCT03137992|4052112|FG004|Washout Period 2|Withdrawal by Subject|1
2330598|NCT03137992|4052113|FG005|Washout Period 2|Withdrawal by Subject|0
2330599|NCT03137992|4052108|FG000|Washout Period 2|Sponsor Decision|0
2330600|NCT03137992|4052109|FG001|Washout Period 2|Sponsor Decision|0
2031219|NCT00382863|3600836|FG001|Overall Study|Withdrawal by Subject|25
2031220|NCT00382967|3600858|FG000|Overall Study|Protocol Violation|1
2031221|NCT00382967|3600859|FG001|Overall Study|Protocol Violation|1
2031222|NCT00382993|3600865|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
2031223|NCT00382993|3600866|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
2031224|NCT00382993|3600865|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
2031225|NCT00382993|3600866|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
2031226|NCT00382993|3600865|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
2110665|NCT00896532|3705486|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0
2110666|NCT00896532|3705487|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0
2110667|NCT00896532|3705488|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0
2110668|NCT00896532|3705466|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110669|NCT00896532|3705467|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110670|NCT00896532|3705468|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
2110671|NCT00896532|3705469|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110672|NCT00896532|3705470|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2330601|NCT03137992|4052110|FG002|Washout Period 2|Sponsor Decision|0
2330602|NCT03137992|4052111|FG003|Washout Period 2|Sponsor Decision|0
2330603|NCT03137992|4052112|FG004|Washout Period 2|Sponsor Decision|0
2330604|NCT03137992|4052113|FG005|Washout Period 2|Sponsor Decision|1
2330605|NCT03137992|4052108|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6
2330606|NCT03137992|4052109|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0
2330607|NCT03137992|4052110|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2
2330608|NCT03137992|4052111|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0
2330609|NCT03137992|4052112|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2
2330610|NCT03137992|4052113|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3
2330611|NCT03137992|4052108|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0
2330612|NCT03137992|4052109|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2
2330613|NCT03137992|4052110|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1
2330614|NCT03137992|4052111|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0
2330615|NCT03137992|4052112|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1
2330616|NCT03137992|4052113|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0
2330617|NCT03137992|4052108|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1
2330618|NCT03137992|4052109|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0
2330619|NCT03137992|4052110|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1
2330620|NCT03137992|4052111|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0
2330621|NCT03137992|4052112|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0
2330622|NCT03137992|4052113|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0
2330623|NCT03137992|4052108|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0
2330624|NCT03137992|4052109|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0
2330625|NCT03137992|4052110|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0
2330626|NCT03137992|4052111|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1
2330627|NCT03137992|4052112|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0
2330628|NCT03137992|4052113|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0
2330629|NCT03137992|4052108|FG000|Part 2 (Open-label Extension)|Per study team|1
2330630|NCT03137992|4052109|FG001|Part 2 (Open-label Extension)|Per study team|0
2330631|NCT03137992|4052110|FG002|Part 2 (Open-label Extension)|Per study team|0
2330632|NCT03137992|4052111|FG003|Part 2 (Open-label Extension)|Per study team|0
2330633|NCT03137992|4052112|FG004|Part 2 (Open-label Extension)|Per study team|0
2330634|NCT03137992|4052113|FG005|Part 2 (Open-label Extension)|Per study team|0
2330635|NCT03137992|4052108|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0
2330636|NCT03137992|4052109|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0
2330637|NCT03137992|4052110|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0
2330638|NCT03137992|4052111|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0
2330639|NCT03137992|4052112|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0
2330640|NCT03137992|4052113|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1
2330641|NCT03138655|4052173|FG000|Overall Study|Adverse Event|2
2330642|NCT03138655|4052174|FG001|Overall Study|Adverse Event|1
2031227|NCT00382993|3600866|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
2330643|NCT03138655|4052175|FG002|Overall Study|Adverse Event|2
2330644|NCT03138655|4052176|FG003|Overall Study|Adverse Event|1
2330645|NCT03138655|4052177|FG004|Overall Study|Adverse Event|1
2330646|NCT03138655|4052178|FG005|Overall Study|Adverse Event|4
2330647|NCT03138655|4052179|FG006|Overall Study|Adverse Event|2
2330648|NCT03138655|4052180|FG007|Overall Study|Adverse Event|2
2330649|NCT03138655|4052173|FG000|Overall Study|Withdrawal by Subject|0
2330650|NCT03138655|4052174|FG001|Overall Study|Withdrawal by Subject|1
2330651|NCT03138655|4052175|FG002|Overall Study|Withdrawal by Subject|0
2330652|NCT03138655|4052176|FG003|Overall Study|Withdrawal by Subject|0
2330653|NCT03138655|4052177|FG004|Overall Study|Withdrawal by Subject|0
2330654|NCT03138655|4052178|FG005|Overall Study|Withdrawal by Subject|0
2330655|NCT03138655|4052179|FG006|Overall Study|Withdrawal by Subject|1
2330656|NCT03138655|4052180|FG007|Overall Study|Withdrawal by Subject|0
2330657|NCT03138655|4052173|FG000|Overall Study|Reason not Specified|1
2330658|NCT03138655|4052174|FG001|Overall Study|Reason not Specified|0
2330659|NCT03138655|4052175|FG002|Overall Study|Reason not Specified|0
2330660|NCT03138655|4052176|FG003|Overall Study|Reason not Specified|2
2330661|NCT03138655|4052177|FG004|Overall Study|Reason not Specified|1
2330662|NCT03138655|4052178|FG005|Overall Study|Reason not Specified|1
2330663|NCT03138655|4052179|FG006|Overall Study|Reason not Specified|0
2330664|NCT03138655|4052180|FG007|Overall Study|Reason not Specified|0
2330665|NCT03138967|4052218|FG000|Overall Study|Death|0
2330666|NCT03138967|4052219|FG001|Overall Study|Death|1
2330667|NCT03138967|4052218|FG000|Overall Study|Physician Decision|1
2330668|NCT03138967|4052219|FG001|Overall Study|Physician Decision|3
2330669|NCT03139240|4052234|FG000|Overall Study|Lost to Follow-up|0
2330670|NCT03139240|4052235|FG001|Overall Study|Lost to Follow-up|1
2330671|NCT03139240|4052236|FG002|Overall Study|Lost to Follow-up|1
2330672|NCT03139240|4052237|FG003|Overall Study|Lost to Follow-up|0
2330673|NCT03139279|4052247|FG000|Overall Study|Physician Decision|2
2330674|NCT03139279|4052248|FG001|Overall Study|Physician Decision|0
2330675|NCT03139279|4052247|FG000|Overall Study|Protocol Violation|5
2330676|NCT03139279|4052248|FG001|Overall Study|Protocol Violation|4
2330677|NCT03139279|4052247|FG000|Overall Study|Withdrawal by Subject|0
2330678|NCT03139279|4052248|FG001|Overall Study|Withdrawal by Subject|2
2330679|NCT03139448|4052256|FG000|Overall Study|Lack of Efficacy|6
2330680|NCT03139448|4052257|FG001|Overall Study|Lack of Efficacy|7
2330681|NCT03139448|4052256|FG000|Overall Study|Location of procedure changed|2
2330682|NCT03139448|4052257|FG001|Overall Study|Location of procedure changed|8
2330683|NCT03139448|4052256|FG000|Overall Study|Withdrawal by Subject|3
2330684|NCT03139448|4052257|FG001|Overall Study|Withdrawal by Subject|6
2330685|NCT03139448|4052256|FG000|Overall Study|Screen fail|1
2330686|NCT03139448|4052257|FG001|Overall Study|Screen fail|3
2330687|NCT03139448|4052256|FG000|Overall Study|Physician Decision|0
2330688|NCT03139448|4052257|FG001|Overall Study|Physician Decision|2
2330689|NCT03139552|4052263|FG000|Overall Study|unable to attend tasting due to schedule|3
2330690|NCT03139604|4052289|FG000|Overall Study|Other|7
2330691|NCT03139604|4052290|FG001|Overall Study|Other|3
2330692|NCT03139604|4052289|FG000|Overall Study|Withdrawal by Subject|16
2330693|NCT03139604|4052290|FG001|Overall Study|Withdrawal by Subject|17
2330694|NCT03139604|4052289|FG000|Overall Study|Physician Decision|1
2330695|NCT03139604|4052290|FG001|Overall Study|Physician Decision|2
2330696|NCT03139604|4052289|FG000|Overall Study|Lost to Follow-up|3
2330697|NCT03139604|4052290|FG001|Overall Study|Lost to Follow-up|1
2330698|NCT03139604|4052289|FG000|Overall Study|Death|65
2330699|NCT03139604|4052290|FG001|Overall Study|Death|67
2330700|NCT03139604|4052289|FG000|Overall Study|Study Terminated by Sponsor|122
2330701|NCT03139604|4052290|FG001|Overall Study|Study Terminated by Sponsor|127
2330702|NCT03139604|4052289|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5
2330703|NCT03139604|4052290|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3
2330704|NCT03141086|4052324|FG000|Overall Study|Study Terminated By Sponsor|1
2330705|NCT03141086|4052325|FG001|Overall Study|Study Terminated By Sponsor|1
2330706|NCT03141086|4052324|FG000|Overall Study|Withdrawal by Subject|0
2330707|NCT03141086|4052325|FG001|Overall Study|Withdrawal by Subject|1
2330708|NCT03141086|4052324|FG000|Overall Study|Protocol Violation|0
2330709|NCT03141086|4052325|FG001|Overall Study|Protocol Violation|1
2330710|NCT03141086|4052324|FG000|Overall Study|Adverse Event|0
2330711|NCT03141086|4052325|FG001|Overall Study|Adverse Event|2
2031228|NCT00382993|3600865|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
2031229|NCT00382993|3600866|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
2031230|NCT00382993|3600865|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
2031231|NCT00382993|3600866|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
2330712|NCT03141151|4052333|FG000|Overall Study|Lost to Follow-up|3
2330713|NCT03141151|4052334|FG001|Overall Study|Lost to Follow-up|2
2330714|NCT03141151|4052333|FG000|Overall Study|Withdrawal by Subject|3
2330715|NCT03141151|4052334|FG001|Overall Study|Withdrawal by Subject|2
2330716|NCT03141307|4052369|FG000|In-Hospital|Withdrawal by Subject|0
2330717|NCT03141307|4052370|FG001|In-Hospital|Withdrawal by Subject|2
2330718|NCT03141307|4052369|FG000|In-Hospital|Protocol Violation|4
2330719|NCT03141307|4052370|FG001|In-Hospital|Protocol Violation|0
2330720|NCT03141307|4052369|FG000|Follow-Up|Lost to Follow-up|97
2330721|NCT03141307|4052370|FG001|Follow-Up|Lost to Follow-up|54
2330722|NCT03141788|4052396|FG000|Overall Study|Lost to Follow-up|1
2330723|NCT03141788|4052396|FG000|Overall Study|Protocol Violation|3
2330724|NCT03141788|4052396|FG000|Overall Study|Withdrawal by Subject|4
2330725|NCT03141905|4052405|FG000|Overall Study|Death|3
2330726|NCT03141905|4052406|FG001|Overall Study|Death|2
2330727|NCT03141905|4052405|FG000|Overall Study|Withdrawal by Subject|1
2330728|NCT03141905|4052406|FG001|Overall Study|Withdrawal by Subject|0
2330729|NCT03141905|4052405|FG000|Overall Study|Lost to Follow-up|3
2330730|NCT03141905|4052406|FG001|Overall Study|Lost to Follow-up|7
2330731|NCT03141905|4052405|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17
2330732|NCT03141905|4052406|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10
2330733|NCT03142451|4052428|FG000|Overall Study|Adverse Event|5
2330734|NCT03142451|4052429|FG001|Overall Study|Adverse Event|2
2330735|NCT03142451|4052428|FG000|Overall Study|Lost to Follow-up|25
2330736|NCT03142451|4052429|FG001|Overall Study|Lost to Follow-up|8
2330737|NCT03142451|4052428|FG000|Overall Study|Participant request|24
2330738|NCT03142451|4052429|FG001|Overall Study|Participant request|12
2330739|NCT03142451|4052428|FG000|Overall Study|Protocol Violation|3
2330740|NCT03142451|4052429|FG001|Overall Study|Protocol Violation|1
2330741|NCT03142451|4052428|FG000|Overall Study|Other|1
2330742|NCT03142451|4052429|FG001|Overall Study|Other|1
2330743|NCT03142750|4052437|FG000|Overall Study|Lost to Follow-up|4
2330744|NCT03142750|4052438|FG001|Overall Study|Lost to Follow-up|1
2330745|NCT03142932|4052450|FG000|Overall Study|Lost to Follow-up|2
2330746|NCT03142932|4052451|FG001|Overall Study|Lost to Follow-up|11
2330747|NCT03143101|4052460|FG000|Overall Study|Withdrawal by Subject|0
2330748|NCT03143101|4052461|FG001|Overall Study|Withdrawal by Subject|1
2330749|NCT03143101|4052462|FG002|Overall Study|Withdrawal by Subject|0
2330750|NCT03143101|4052460|FG000|Overall Study|Lost to Follow-up|2
2330751|NCT03143101|4052461|FG001|Overall Study|Lost to Follow-up|2
2330752|NCT03143101|4052462|FG002|Overall Study|Lost to Follow-up|0
2330753|NCT03143166|4052470|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
2330754|NCT03143855|4052489|FG000|Overall Study|Withdrawal by Subject|4
2330755|NCT03143855|4052490|FG001|Overall Study|Withdrawal by Subject|3
2330756|NCT03143855|4052489|FG000|Overall Study|Protocol Violation|1
2330757|NCT03143855|4052490|FG001|Overall Study|Protocol Violation|0
2330758|NCT03143855|4052489|FG000|Overall Study|Participant experienced withdrawal|0
2330759|NCT03143855|4052490|FG001|Overall Study|Participant experienced withdrawal|1
2330760|NCT03144180|4052520|FG000|Overall Study|STAT Delivery|1
2330761|NCT03144180|4052521|FG001|Overall Study|STAT Delivery|1
2330762|NCT03144180|4052520|FG000|Overall Study|Provider forgot to fill out forms|1
2330763|NCT03144180|4052521|FG001|Overall Study|Provider forgot to fill out forms|3
2330764|NCT03144180|4052520|FG000|Overall Study|Provider forgot to use the Q-cup|0
2330765|NCT03144180|4052521|FG001|Overall Study|Provider forgot to use the Q-cup|1
2330766|NCT03144180|4052520|FG000|Overall Study|Scrub tech removed tube cap|0
2330767|NCT03144180|4052521|FG001|Overall Study|Scrub tech removed tube cap|1
2330768|NCT03144687|4052547|FG000|Overall Study|Adverse Event|1
2330769|NCT03144687|4052548|FG001|Overall Study|Adverse Event|0
2330770|NCT03144687|4052547|FG000|Overall Study|Progressive disease|3
2330771|NCT03144687|4052548|FG001|Overall Study|Progressive disease|0
2330772|NCT03144687|4052547|FG000|Overall Study|Death|0
2330773|NCT03144687|4052548|FG001|Overall Study|Death|2
2330774|NCT03144687|4052547|FG000|Overall Study|Lost to Follow-up|0
2330775|NCT03144687|4052548|FG001|Overall Study|Lost to Follow-up|1
2330776|NCT03144687|4052547|FG000|Overall Study|Physician Decision|5
2330777|NCT03144687|4052548|FG001|Overall Study|Physician Decision|2
2330778|NCT03144687|4052547|FG000|Overall Study|Withdrawal by Subject|1
2330779|NCT03144687|4052548|FG001|Overall Study|Withdrawal by Subject|3
2330780|NCT03144687|4052547|FG000|Overall Study|Participants With Ongoing Treatment|3
2330781|NCT03144687|4052548|FG001|Overall Study|Participants With Ongoing Treatment|2
2330782|NCT03144804|4052558|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4
2330783|NCT03145064|4052562|FG000|Overall Study|Death|24
2330784|NCT03145064|4052562|FG000|Overall Study|Lost to Follow-up|3
2330785|NCT03145064|4052562|FG000|Overall Study|Withdrawal by Subject|6
2330786|NCT03145064|4052562|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4
2330787|NCT03145064|4052562|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4
2330788|NCT03145207|4052567|FG000|Overall Study|volunteer started taking allergy shots|1
2330789|NCT03145207|4052567|FG000|Overall Study|baseline blood pressure high|1
2352699|NCT03751020|4102558|FG002|Overall Study|Withdrawal by Subject|0
2352700|NCT03751020|4102556|FG000|Overall Study|Lost to Follow-up|7
2352701|NCT03751020|4102557|FG001|Overall Study|Lost to Follow-up|4
2352702|NCT03751020|4102558|FG002|Overall Study|Lost to Follow-up|10
2352703|NCT03750955|4102568|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
2330790|NCT03145766|4052594|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
2330791|NCT03145766|4052595|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
2218512|NCT01715805|3862074|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
2218513|NCT01715805|3862075|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
2330792|NCT03145766|4052596|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0
2330793|NCT03145766|4052597|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
2330794|NCT03145766|4052598|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2
2330795|NCT03145766|4052594|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
2330796|NCT03145766|4052595|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
2330797|NCT03145766|4052596|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
2330798|NCT03145766|4052597|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2
2330799|NCT03145766|4052598|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
2330800|NCT03145766|4052594|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
2330801|NCT03145766|4052595|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
2330802|NCT03145766|4052596|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
2330803|NCT03145766|4052597|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3
2330804|NCT03145766|4052598|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
2330805|NCT03145766|4052594|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4
2330806|NCT03145766|4052595|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
2330807|NCT03145766|4052596|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
2330808|NCT03145766|4052597|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
2330809|NCT03145766|4052598|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0
2330810|NCT03145766|4052594|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2
2330811|NCT03145766|4052595|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
2330812|NCT03145766|4052596|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
2330813|NCT03145766|4052597|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1
2330814|NCT03145766|4052598|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
2330815|NCT03145766|4052594|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
2330816|NCT03145766|4052595|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1
2330817|NCT03145766|4052596|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
2330818|NCT03145766|4052597|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2
2330819|NCT03145766|4052598|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3
2330820|NCT03145766|4052594|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
2330821|NCT03145766|4052595|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
2330822|NCT03145766|4052596|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
2330823|NCT03145766|4052597|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
2330824|NCT03145766|4052598|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
2330825|NCT03146403|4052628|FG000|Overall Study|Withdrawal by Subject|0
2330826|NCT03146403|4052629|FG001|Overall Study|Withdrawal by Subject|3
2330827|NCT03146403|4052628|FG000|Overall Study|Lost to Follow-up|2
2330828|NCT03146403|4052629|FG001|Overall Study|Lost to Follow-up|0
2330829|NCT03146663|4052650|FG000|Overall Study|Did not receive study treatment|1
2330830|NCT03146663|4052651|FG001|Overall Study|Did not receive study treatment|1
2330831|NCT03146741|4052658|FG000|Overall Study|Txp with non-HCV+ heart|4
2330832|NCT03146741|4052658|FG000|Overall Study|Listeted for MOT|2
2330833|NCT03146741|4052658|FG000|Overall Study|Physician Decision|2
2330834|NCT03146741|4052658|FG000|Overall Study|Awaiting txp|2
2330835|NCT03147248|4052684|FG000|Overall Study|Adverse Event|0
2330836|NCT03147248|4052685|FG001|Overall Study|Adverse Event|2
2330837|NCT03147248|4052686|FG002|Overall Study|Adverse Event|2
2330838|NCT03147248|4052687|FG003|Overall Study|Adverse Event|2
2330839|NCT03147248|4052688|FG004|Overall Study|Adverse Event|6
2330840|NCT03147248|4052689|FG005|Overall Study|Adverse Event|11
2330841|NCT03147248|4052684|FG000|Overall Study|Disease progression|1
2330842|NCT03147248|4052685|FG001|Overall Study|Disease progression|0
2330843|NCT03147248|4052686|FG002|Overall Study|Disease progression|0
2330844|NCT03147248|4052687|FG003|Overall Study|Disease progression|0
2330845|NCT03147248|4052688|FG004|Overall Study|Disease progression|0
2330846|NCT03147248|4052689|FG005|Overall Study|Disease progression|2
2330847|NCT03147248|4052684|FG000|Overall Study|Withdrawal by Subject|0
2330848|NCT03147248|4052685|FG001|Overall Study|Withdrawal by Subject|0
2330849|NCT03147248|4052686|FG002|Overall Study|Withdrawal by Subject|0
2330850|NCT03147248|4052687|FG003|Overall Study|Withdrawal by Subject|0
2330851|NCT03147248|4052688|FG004|Overall Study|Withdrawal by Subject|12
2330852|NCT03147248|4052689|FG005|Overall Study|Withdrawal by Subject|9
2330853|NCT03147248|4052684|FG000|Overall Study|Protocol Violation|0
2330854|NCT03147248|4052685|FG001|Overall Study|Protocol Violation|0
2330855|NCT03147248|4052686|FG002|Overall Study|Protocol Violation|0
2330856|NCT03147248|4052687|FG003|Overall Study|Protocol Violation|0
2330857|NCT03147248|4052688|FG004|Overall Study|Protocol Violation|2
2330858|NCT03147248|4052689|FG005|Overall Study|Protocol Violation|0
2330859|NCT03147248|4052684|FG000|Overall Study|Lost to Follow-up|0
2330860|NCT03147248|4052685|FG001|Overall Study|Lost to Follow-up|0
2330861|NCT03147248|4052686|FG002|Overall Study|Lost to Follow-up|0
2330862|NCT03147248|4052687|FG003|Overall Study|Lost to Follow-up|0
2330863|NCT03147248|4052688|FG004|Overall Study|Lost to Follow-up|2
2330864|NCT03147248|4052689|FG005|Overall Study|Lost to Follow-up|0
2330865|NCT03147248|4052684|FG000|Overall Study|Pregnancy|0
2330866|NCT03147248|4052685|FG001|Overall Study|Pregnancy|0
2330867|NCT03147248|4052686|FG002|Overall Study|Pregnancy|0
2330868|NCT03147248|4052687|FG003|Overall Study|Pregnancy|0
2330869|NCT03147248|4052688|FG004|Overall Study|Pregnancy|1
2330870|NCT03147248|4052689|FG005|Overall Study|Pregnancy|0
2330871|NCT03147248|4052684|FG000|Overall Study|Death|0
2330872|NCT03147248|4052685|FG001|Overall Study|Death|0
2330873|NCT03147248|4052686|FG002|Overall Study|Death|0
2330874|NCT03147248|4052687|FG003|Overall Study|Death|0
2330875|NCT03147248|4052688|FG004|Overall Study|Death|0
2330876|NCT03147248|4052689|FG005|Overall Study|Death|4
2330877|NCT03147248|4052684|FG000|Overall Study|Physician Decision|0
2330878|NCT03147248|4052685|FG001|Overall Study|Physician Decision|0
2330879|NCT03147248|4052686|FG002|Overall Study|Physician Decision|0
2330880|NCT03147248|4052687|FG003|Overall Study|Physician Decision|0
2330881|NCT03147248|4052688|FG004|Overall Study|Physician Decision|2
2330882|NCT03147248|4052689|FG005|Overall Study|Physician Decision|4
2330883|NCT03147248|4052684|FG000|Overall Study|Prolonged Dosing Interval|0
2330884|NCT03147248|4052685|FG001|Overall Study|Prolonged Dosing Interval|0
2330885|NCT03147248|4052686|FG002|Overall Study|Prolonged Dosing Interval|0
2330886|NCT03147248|4052687|FG003|Overall Study|Prolonged Dosing Interval|0
2330887|NCT03147248|4052688|FG004|Overall Study|Prolonged Dosing Interval|1
2330888|NCT03147248|4052689|FG005|Overall Study|Prolonged Dosing Interval|1
2330889|NCT03147495|4052705|FG000|Overall Study|Physician Decision|0
2330890|NCT03147495|4052706|FG001|Overall Study|Physician Decision|6
2330891|NCT03148067|4052729|FG000|Overall Study|Lost to Follow-up|3
2330892|NCT03148067|4052729|FG000|Overall Study|Death|1
2330893|NCT03148691|4052772|FG000|Overall Study|Protocol Violation|1
2330894|NCT03148691|4052773|FG001|Overall Study|Protocol Violation|2
2330895|NCT03148691|4052774|FG002|Overall Study|Protocol Violation|7
2330896|NCT03148691|4052772|FG000|Overall Study|Lost to Follow-up|0
2330897|NCT03148691|4052773|FG001|Overall Study|Lost to Follow-up|0
2330898|NCT03148691|4052774|FG002|Overall Study|Lost to Follow-up|1
2330899|NCT03148691|4052772|FG000|Overall Study|Other|1
2330900|NCT03148691|4052773|FG001|Overall Study|Other|0
2330901|NCT03148691|4052774|FG002|Overall Study|Other|0
2330902|NCT03148691|4052772|FG000|Overall Study|Withdrawal by Subject|1
2330903|NCT03148691|4052773|FG001|Overall Study|Withdrawal by Subject|0
2330904|NCT03148691|4052774|FG002|Overall Study|Withdrawal by Subject|0
2330905|NCT03148756|4052784|FG000|Overall Study|Study Terminated|0
2330906|NCT03148756|4052785|FG001|Overall Study|Study Terminated|1
2330907|NCT03149042|4052791|FG000|Overall Study|Invasive FFR not performed|21
2330908|NCT03149042|4052791|FG000|Overall Study|Poor CT Image Quality|1
2330909|NCT03149042|4052791|FG000|Overall Study|Invasive FFR Measurement cancelled|1
2330910|NCT03149055|4052796|FG000|Overall Study|Not treated|4
2330911|NCT03149328|4052815|FG000|Overall Study|Withdrawal by Subject|30
2330912|NCT03149328|4052816|FG001|Overall Study|Withdrawal by Subject|26
2330913|NCT03149328|4052815|FG000|Overall Study|Changed Dialysis Modality|18
2330914|NCT03149328|4052816|FG001|Overall Study|Changed Dialysis Modality|1
2330915|NCT03149328|4052815|FG000|Overall Study|Transplant|9
2330916|NCT03149328|4052816|FG001|Overall Study|Transplant|1
2330917|NCT03149328|4052815|FG000|Overall Study|Lost to Follow-up|25
2330918|NCT03149328|4052816|FG001|Overall Study|Lost to Follow-up|16
2330919|NCT03149328|4052815|FG000|Overall Study|Left Study Site|1
2330920|NCT03149328|4052816|FG001|Overall Study|Left Study Site|2
2330921|NCT03149328|4052815|FG000|Overall Study|Language Barrier|1
2330922|NCT03149328|4052816|FG001|Overall Study|Language Barrier|0
2330923|NCT03149848|4052822|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
2330924|NCT03149848|4052822|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2
2330925|NCT03150056|4052858|FG000|Overall Study|Withdrawal by Subject|0
2330926|NCT03150056|4052859|FG001|Overall Study|Withdrawal by Subject|0
2330927|NCT03150056|4052860|FG002|Overall Study|Withdrawal by Subject|0
2330928|NCT03150056|4052861|FG003|Overall Study|Withdrawal by Subject|0
2330929|NCT03150056|4052862|FG004|Overall Study|Withdrawal by Subject|0
2330930|NCT03150056|4052863|FG005|Overall Study|Withdrawal by Subject|2
2330931|NCT03150056|4052858|FG000|Overall Study|Study terminated by Sponsor|1
2330932|NCT03150056|4052859|FG001|Overall Study|Study terminated by Sponsor|3
2330933|NCT03150056|4052860|FG002|Overall Study|Study terminated by Sponsor|1
2330934|NCT03150056|4052861|FG003|Overall Study|Study terminated by Sponsor|1
2330935|NCT03150056|4052862|FG004|Overall Study|Study terminated by Sponsor|5
2330936|NCT03150056|4052863|FG005|Overall Study|Study terminated by Sponsor|6
2330937|NCT03150056|4052858|FG000|Overall Study|Death|9
2330938|NCT03150056|4052859|FG001|Overall Study|Death|2
2330939|NCT03150056|4052860|FG002|Overall Study|Death|2
2330940|NCT03150056|4052861|FG003|Overall Study|Death|7
2330941|NCT03150056|4052862|FG004|Overall Study|Death|8
2330942|NCT03150056|4052863|FG005|Overall Study|Death|10
2330943|NCT03150056|4052858|FG000|Overall Study|Ongoing in the study|0
2330944|NCT03150056|4052859|FG001|Overall Study|Ongoing in the study|0
2330945|NCT03150056|4052860|FG002|Overall Study|Ongoing in the study|1
2330946|NCT03150056|4052861|FG003|Overall Study|Ongoing in the study|1
2330947|NCT03150056|4052862|FG004|Overall Study|Ongoing in the study|3
2330948|NCT03150056|4052863|FG005|Overall Study|Ongoing in the study|0
2330949|NCT03150082|4052880|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
2330950|NCT03150082|4052881|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
2330951|NCT03150485|4052917|FG000|Overall Study|Unsatisfactory Lens Fitting|0
2330952|NCT03150485|4052918|FG001|Overall Study|Unsatisfactory Lens Fitting|1
2330953|NCT03150485|4052919|FG002|Overall Study|Unsatisfactory Lens Fitting|0
2330954|NCT03150485|4052920|FG003|Overall Study|Unsatisfactory Lens Fitting|0
2330955|NCT03150485|4052921|FG004|Overall Study|Unsatisfactory Lens Fitting|0
2330956|NCT03150485|4052922|FG005|Overall Study|Unsatisfactory Lens Fitting|0
2330957|NCT03150589|4052929|FG000|Overall Study|Withdrawal by Subject|16
2330958|NCT03150589|4052930|FG001|Overall Study|Withdrawal by Subject|9
2330959|NCT03150589|4052929|FG000|Overall Study|Adverse Event|7
2330960|NCT03150589|4052930|FG001|Overall Study|Adverse Event|6
2330961|NCT03150589|4052929|FG000|Overall Study|Protocol Violation|4
2330962|NCT03150589|4052930|FG001|Overall Study|Protocol Violation|3
2330963|NCT03150589|4052929|FG000|Overall Study|Lost to Follow-up|3
2330964|NCT03150589|4052930|FG001|Overall Study|Lost to Follow-up|3
2330965|NCT03150589|4052929|FG000|Overall Study|Death|2
2330966|NCT03150589|4052930|FG001|Overall Study|Death|3
2330967|NCT03150589|4052929|FG000|Overall Study|IP non-compliance and other reasons|12
2330968|NCT03150589|4052930|FG001|Overall Study|IP non-compliance and other reasons|3
2330969|NCT03150719|4052938|FG000|Overall Study|Adverse Event|0
2330970|NCT03150719|4052939|FG001|Overall Study|Adverse Event|1
2330971|NCT03150719|4052938|FG000|Overall Study|Death|0
2330972|NCT03150719|4052939|FG001|Overall Study|Death|1
2330973|NCT03150719|4052938|FG000|Overall Study|Other|1
2330974|NCT03150719|4052939|FG001|Overall Study|Other|0
2330975|NCT03151148|4052960|FG000|Overall Study|Lost to Follow-up|1
2330976|NCT03151148|4052961|FG001|Overall Study|Lost to Follow-up|0
2330977|NCT03151148|4052960|FG000|Overall Study|Withdrawal by Subject|1
2330978|NCT03151148|4052961|FG001|Overall Study|Withdrawal by Subject|0
2330979|NCT03151395|4052977|FG000|Overall Study|Adverse Event|2
2330980|NCT03151395|4052977|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
2330981|NCT03151395|4052977|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3
2330982|NCT03151395|4052977|FG000|Overall Study|Unspecified reason|4
2330983|NCT03151551|4052999|FG000|Open-Label Treatment Period|Adverse Event|0
2330984|NCT03151551|4053000|FG001|Open-Label Treatment Period|Adverse Event|2
2330985|NCT03151551|4052999|FG000|Open-Label Treatment Period|Lost to Follow-up|1
2330986|NCT03151551|4053000|FG001|Open-Label Treatment Period|Lost to Follow-up|1
2330987|NCT03151551|4052999|FG000|Open-Label Treatment Period|Withdrawal by Subject|12
2330988|NCT03151551|4053000|FG001|Open-Label Treatment Period|Withdrawal by Subject|18
2330989|NCT03151551|4052999|FG000|Open-Label Treatment Period|Lack of Efficacy|1
2330990|NCT03151551|4053000|FG001|Open-Label Treatment Period|Lack of Efficacy|1
2330991|NCT03151551|4052999|FG000|Open-Label Treatment Period|Physician Decision|3
2330992|NCT03151551|4053000|FG001|Open-Label Treatment Period|Physician Decision|0
2330993|NCT03151551|4052999|FG000|Open-Label Treatment Period|Protocol Deviation|1
2330994|NCT03151551|4053000|FG001|Open-Label Treatment Period|Protocol Deviation|2
2330995|NCT03151551|4052999|FG000|Post-Treatment Follow-Up Period|Adverse Event|1
2330996|NCT03151551|4053000|FG001|Post-Treatment Follow-Up Period|Adverse Event|3
2330997|NCT03151551|4052999|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4
2330998|NCT03151551|4053000|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
2330999|NCT03151551|4052999|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20
2331000|NCT03151551|4053000|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22
2331001|NCT03151551|4052999|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
2331002|NCT03151551|4053000|FG001|Post-Treatment Follow-Up Period|Physician Decision|1
2331003|NCT03152019|4053010|FG000|Overall Study|Adverse Event|0
2331004|NCT03152019|4053011|FG001|Overall Study|Adverse Event|1
2331005|NCT03152110|4053026|FG000|Overall Study|Withdrawal by Subject|3
2331006|NCT03152552|4053048|FG000|Treatment Period 1 (12 Weeks)|Death|0
2331007|NCT03152552|4053049|FG001|Treatment Period 1 (12 Weeks)|Death|1
2331008|NCT03152552|4053050|FG002|Treatment Period 1 (12 Weeks)|Death|0
2331009|NCT03152552|4053051|FG003|Treatment Period 1 (12 Weeks)|Death|0
2331010|NCT03152552|4053052|FG004|Treatment Period 1 (12 Weeks)|Death|1
2331011|NCT03152552|4053048|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2331012|NCT03152552|4053049|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1
2331013|NCT03152552|4053050|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2331014|NCT03152552|4053051|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2331015|NCT03152552|4053052|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2331016|NCT03152552|4053048|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
2331017|NCT03152552|4053049|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
2331018|NCT03152552|4053050|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
2331019|NCT03152552|4053051|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
2331020|NCT03152552|4053052|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
2331021|NCT03152552|4053048|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2331022|NCT03152552|4053049|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2331023|NCT03152552|4053050|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2331024|NCT03152552|4053051|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2331025|NCT03152552|4053052|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2331026|NCT03152552|4053048|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0
2331027|NCT03152552|4053049|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0
2331028|NCT03152552|4053050|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1
2331029|NCT03152552|4053051|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0
2331030|NCT03152552|4053052|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0
2331031|NCT03152552|4053048|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2331032|NCT03152552|4053049|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2031232|NCT00382993|3600865|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
2031233|NCT00382993|3600866|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
2031234|NCT00382993|3600865|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
2031235|NCT00382993|3600866|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
2031236|NCT00382993|3600865|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
2031237|NCT00382993|3600866|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
2031238|NCT00382993|3600865|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0
2031239|NCT00382993|3600866|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1
2031240|NCT00382993|3600865|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
2031241|NCT00382993|3600866|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
2031242|NCT00383019|3600874|FG000|Overall Study|Adverse Event|5
2031243|NCT00383019|3600875|FG001|Overall Study|Adverse Event|1
2031244|NCT00383019|3600874|FG000|Overall Study|Withdrawal by Subject|0
2031245|NCT00383019|3600875|FG001|Overall Study|Withdrawal by Subject|1
2110673|NCT00896532|3705471|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110674|NCT00896532|3705472|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110675|NCT00896532|3705473|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110676|NCT00896532|3705474|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110677|NCT00896532|3705475|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110678|NCT00896532|3705476|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110679|NCT00896532|3705477|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110680|NCT00896532|3705478|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110681|NCT00896532|3705479|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110682|NCT00896532|3705480|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110683|NCT00896532|3705481|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110684|NCT00896532|3705482|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110685|NCT00896532|3705483|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110686|NCT00896532|3705484|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110687|NCT00896532|3705485|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110688|NCT00896532|3705486|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110689|NCT00896532|3705487|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110690|NCT00896532|3705488|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2110691|NCT00896532|3705466|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110692|NCT00896532|3705467|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110693|NCT00896532|3705468|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
2110694|NCT00896532|3705469|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110695|NCT00896532|3705470|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110696|NCT00896532|3705471|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110697|NCT00896532|3705472|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110698|NCT00896532|3705473|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110699|NCT00896532|3705474|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110700|NCT00896532|3705475|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110701|NCT00896532|3705476|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110702|NCT00896532|3705477|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110703|NCT00896532|3705478|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110704|NCT00896532|3705479|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110705|NCT00896532|3705480|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110706|NCT00896532|3705481|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110707|NCT00896532|3705482|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2331033|NCT03152552|4053050|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2331034|NCT03152552|4053051|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
2331035|NCT03152552|4053052|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2331036|NCT03152552|4053048|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
2331037|NCT03152552|4053049|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
2331038|NCT03152552|4053050|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
2331039|NCT03152552|4053051|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
2331040|NCT03152552|4053052|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
2331041|NCT03154047|4053083|FG000|Overall Study|Death|1
2331042|NCT03154047|4053083|FG000|Overall Study|Study terminated by sponsor|76
2331043|NCT03154047|4053083|FG000|Overall Study|Withdrawal by Subject|3
2331044|NCT03154086|4053102|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331045|NCT03154086|4053103|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331046|NCT03154086|4053104|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331047|NCT03154086|4053105|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
2331048|NCT03154086|4053106|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331049|NCT03154086|4053107|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331050|NCT03154086|4053108|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331051|NCT03154086|4053109|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331052|NCT03154086|4053110|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331053|NCT03154086|4053111|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331054|NCT03154086|4053112|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331055|NCT03154086|4053113|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331056|NCT03154086|4053114|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331057|NCT03154086|4053115|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331058|NCT03154086|4053116|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2331059|NCT03154086|4053102|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331060|NCT03154086|4053103|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
2331061|NCT03154086|4053104|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331062|NCT03154086|4053105|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331063|NCT03154086|4053106|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331064|NCT03154086|4053107|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331065|NCT03154086|4053108|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331066|NCT03154086|4053109|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331067|NCT03154086|4053110|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331068|NCT03154086|4053111|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331069|NCT03154086|4053112|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331070|NCT03154086|4053113|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331071|NCT03154086|4053114|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331072|NCT03154086|4053115|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331073|NCT03154086|4053116|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2331074|NCT03154086|4053102|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331075|NCT03154086|4053103|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331076|NCT03154086|4053104|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
2331077|NCT03154086|4053105|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331078|NCT03154086|4053106|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331079|NCT03154086|4053107|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331080|NCT03154086|4053108|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331081|NCT03154086|4053109|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331082|NCT03154086|4053110|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331083|NCT03154086|4053111|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331084|NCT03154086|4053112|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331085|NCT03154086|4053113|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331086|NCT03154086|4053114|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331087|NCT03154086|4053115|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331088|NCT03154086|4053116|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2331089|NCT03154086|4053102|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
2331090|NCT03154086|4053103|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331091|NCT03154086|4053104|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331092|NCT03154086|4053105|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331093|NCT03154086|4053106|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331094|NCT03154086|4053107|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331095|NCT03154086|4053108|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331096|NCT03154086|4053109|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331097|NCT03154086|4053110|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331098|NCT03154086|4053111|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331099|NCT03154086|4053112|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331100|NCT03154086|4053113|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331101|NCT03154086|4053114|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331102|NCT03154086|4053115|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331103|NCT03154086|4053116|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2331104|NCT03154086|4053102|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331105|NCT03154086|4053103|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331106|NCT03154086|4053104|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331107|NCT03154086|4053105|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331108|NCT03154086|4053106|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331109|NCT03154086|4053107|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331110|NCT03154086|4053108|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331111|NCT03154086|4053109|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331112|NCT03154086|4053110|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
2331113|NCT03154086|4053111|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331114|NCT03154086|4053112|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331115|NCT03154086|4053113|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331116|NCT03154086|4053114|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331117|NCT03154086|4053115|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331118|NCT03154086|4053116|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2331119|NCT03154086|4053102|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331120|NCT03154086|4053103|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331121|NCT03154086|4053104|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331122|NCT03154086|4053105|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331123|NCT03154086|4053106|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331124|NCT03154086|4053107|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331125|NCT03154086|4053108|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331126|NCT03154086|4053109|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
2331127|NCT03154086|4053110|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331128|NCT03154086|4053111|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331129|NCT03154086|4053112|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331130|NCT03154086|4053113|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331131|NCT03154086|4053114|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331132|NCT03154086|4053115|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331133|NCT03154086|4053116|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2331134|NCT03154086|4053102|FG000|Part B (Up to 25 Days)|Adverse Event|0
2331135|NCT03154086|4053103|FG001|Part B (Up to 25 Days)|Adverse Event|0
2331136|NCT03154086|4053104|FG002|Part B (Up to 25 Days)|Adverse Event|0
2331137|NCT03154086|4053105|FG003|Part B (Up to 25 Days)|Adverse Event|0
2331138|NCT03154086|4053106|FG004|Part B (Up to 25 Days)|Adverse Event|0
2331139|NCT03154086|4053107|FG005|Part B (Up to 25 Days)|Adverse Event|0
2331140|NCT03154086|4053108|FG006|Part B (Up to 25 Days)|Adverse Event|0
2331141|NCT03154086|4053109|FG007|Part B (Up to 25 Days)|Adverse Event|0
2331142|NCT03154086|4053110|FG008|Part B (Up to 25 Days)|Adverse Event|0
2331143|NCT03154086|4053111|FG009|Part B (Up to 25 Days)|Adverse Event|0
2331144|NCT03154086|4053112|FG010|Part B (Up to 25 Days)|Adverse Event|1
2331145|NCT03154086|4053113|FG011|Part B (Up to 25 Days)|Adverse Event|0
2331146|NCT03154086|4053114|FG012|Part B (Up to 25 Days)|Adverse Event|0
2331147|NCT03154086|4053115|FG013|Part B (Up to 25 Days)|Adverse Event|0
2331148|NCT03154086|4053116|FG014|Part B (Up to 25 Days)|Adverse Event|0
2331149|NCT03154476|4053184|FG000|Overall Study|Lost to Follow-up|4
2331150|NCT03154476|4053185|FG001|Overall Study|Lost to Follow-up|4
2331151|NCT03155178|4053213|FG000|Overall Study|Did not meet treatment day baseline|7
2331152|NCT03155178|4053214|FG001|Overall Study|Did not meet treatment day baseline|7
2331153|NCT03155178|4053215|FG002|Overall Study|Did not meet treatment day baseline|7
2331154|NCT03155178|4053216|FG003|Overall Study|Did not meet treatment day baseline|7
2331155|NCT03155269|4053232|FG000|Overall Study|Withdrawal by Subject|4
2331156|NCT03155269|4053233|FG001|Overall Study|Withdrawal by Subject|5
2331157|NCT03155269|4053232|FG000|Overall Study|Lost to Follow-up|1
2331158|NCT03155269|4053233|FG001|Overall Study|Lost to Follow-up|2
2331159|NCT03155724|4053239|FG000|Overall Study|Death|3
2331160|NCT03155724|4053239|FG000|Overall Study|Physician Decision|1
2331161|NCT03155724|4053239|FG000|Overall Study|Study closure|7
2331162|NCT03155945|4053245|FG000|Overall Study|Lost to Follow-up|0
2331163|NCT03155945|4053246|FG001|Overall Study|Lost to Follow-up|1
2331164|NCT03155945|4053245|FG000|Overall Study|Withdrawal by Subject|0
2331165|NCT03155945|4053246|FG001|Overall Study|Withdrawal by Subject|1
2331166|NCT03155945|4053245|FG000|Overall Study|Other Reason|0
2331167|NCT03155945|4053246|FG001|Overall Study|Other Reason|1
2331168|NCT03156270|4053252|FG000|Overall Study|Failed pre-treatment screening|1
2331169|NCT03156270|4053252|FG000|Overall Study|Lost to Follow-up|1
2331170|NCT03156543|4053260|FG000|Overall Study|Withdrawal by Subject|1
2331171|NCT03156543|4053261|FG001|Overall Study|Withdrawal by Subject|0
2331172|NCT03156621|4053269|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0
2331173|NCT03156621|4053270|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2
2331174|NCT03156621|4053269|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0
2331175|NCT03156621|4053270|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1
2331176|NCT03157089|4053281|FG000|Overall Study|Treated only with pembrolizumab|1
2331177|NCT03157089|4053282|FG001|Overall Study|Treated only with pembrolizumab|0
2031246|NCT00383084|3600900|FG000|Overall Study|Withdrawal by Subject|12
2031247|NCT00383084|3600901|FG001|Overall Study|Withdrawal by Subject|10
2031248|NCT00383123|3600919|FG000|Overall Study|Adverse Event|1
2031249|NCT00383123|3600920|FG001|Overall Study|Adverse Event|0
2031250|NCT00383123|3600919|FG000|Overall Study|Lost to Follow-up|68
2031251|NCT00383123|3600920|FG001|Overall Study|Lost to Follow-up|61
2031252|NCT00383123|3600919|FG000|Overall Study|Protocol Violation|5
2031253|NCT00383123|3600920|FG001|Overall Study|Protocol Violation|1
2031254|NCT00383123|3600919|FG000|Overall Study|Withdrawal by Subject|27
2031255|NCT00383123|3600920|FG001|Overall Study|Withdrawal by Subject|18
2031256|NCT00383123|3600919|FG000|Overall Study|Other reason|10
2031257|NCT00383123|3600920|FG001|Overall Study|Other reason|6
2031258|NCT00383149|3600926|FG000|Overall Study|Adverse Event not Related to Study Drug|3
2031259|NCT00383149|3600926|FG000|Overall Study|Death|2
2031260|NCT00383149|3600926|FG000|Overall Study|Disease Progression|38
2031261|NCT00383149|3600926|FG000|Overall Study|Lost to Follow-up|1
2031262|NCT00383149|3600926|FG000|Overall Study|Other|1
2031263|NCT00383149|3600926|FG000|Overall Study|Study Drug Toxicity|4
2031264|NCT00383149|3600926|FG000|Overall Study|Request to Discontinue Treatment|4
2031265|NCT00383149|3600926|FG000|Overall Study|Participant Withdrew Consent|1
2031266|NCT00383162|3600932|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
2031267|NCT00383162|3600933|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
2031268|NCT00383162|3600932|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
2031269|NCT00383162|3600933|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
2031270|NCT00383162|3600932|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
2031271|NCT00383162|3600933|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
2031272|NCT00383162|3600932|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
2110708|NCT00896532|3705483|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110709|NCT00896532|3705484|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110710|NCT00896532|3705485|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110711|NCT00896532|3705486|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110712|NCT00896532|3705487|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110713|NCT00896532|3705488|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2110714|NCT00896532|3705466|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110715|NCT00896532|3705467|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110716|NCT00896532|3705468|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110717|NCT00896532|3705469|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
2110718|NCT00896532|3705470|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2331178|NCT03157089|4053281|FG000|Overall Study|Adverse Event|5
2331179|NCT03157089|4053282|FG001|Overall Study|Adverse Event|4
2331180|NCT03157089|4053281|FG000|Overall Study|Progressive disease|6
2331181|NCT03157089|4053282|FG001|Overall Study|Progressive disease|8
2331182|NCT03157531|4053293|FG000|Overall Study|Death|2
2331183|NCT03157531|4053293|FG000|Overall Study|Lost to Follow-up|4
2331184|NCT03157583|4053297|FG000|Overall Study|Other (did not meet study criteria)|1
2331185|NCT03158012|4053317|FG000|Overall Study|Withdrawal by Subject|0
2331186|NCT03158012|4053318|FG001|Overall Study|Withdrawal by Subject|1
2331187|NCT03158220|4053339|FG000|Overall Study|Screen Failure|0
2331188|NCT03158220|4053340|FG001|Overall Study|Screen Failure|1
2331189|NCT03158220|4053339|FG000|Overall Study|Withdrawal by Subject|8
2331190|NCT03158220|4053340|FG001|Overall Study|Withdrawal by Subject|9
2331191|NCT03158220|4053339|FG000|Overall Study|Status unknown|0
2331192|NCT03158220|4053340|FG001|Overall Study|Status unknown|1
2331193|NCT03158220|4053339|FG000|Overall Study|Lost to Follow-up|8
2331194|NCT03158220|4053340|FG001|Overall Study|Lost to Follow-up|5
2331195|NCT03158220|4053339|FG000|Overall Study|Physician Decision|1
2331196|NCT03158220|4053340|FG001|Overall Study|Physician Decision|0
2331197|NCT03158272|4053350|FG000|Overall Study|Disease progression|3
2331198|NCT03158272|4053351|FG001|Overall Study|Disease progression|3
2331199|NCT03158272|4053352|FG002|Overall Study|Disease progression|4
2331200|NCT03158272|4053353|FG003|Overall Study|Disease progression|6
2331201|NCT03158272|4053350|FG000|Overall Study|Death|0
2331202|NCT03158272|4053351|FG001|Overall Study|Death|0
2331203|NCT03158272|4053352|FG002|Overall Study|Death|1
2331204|NCT03158272|4053353|FG003|Overall Study|Death|0
2331205|NCT03158272|4053350|FG000|Overall Study|Other reasons|0
2331206|NCT03158272|4053351|FG001|Overall Study|Other reasons|0
2331207|NCT03158272|4053352|FG002|Overall Study|Other reasons|1
2331208|NCT03158272|4053353|FG003|Overall Study|Other reasons|0
2331209|NCT03158272|4053350|FG000|Overall Study|Adverse event unrelated to the drug|0
2331210|NCT03158272|4053351|FG001|Overall Study|Adverse event unrelated to the drug|1
2331211|NCT03158272|4053352|FG002|Overall Study|Adverse event unrelated to the drug|0
2331212|NCT03158272|4053353|FG003|Overall Study|Adverse event unrelated to the drug|0
2331213|NCT03158311|4053368|FG000|Overall Study|Subject/Guardian Decision|10
2331214|NCT03158311|4053369|FG001|Overall Study|Subject/Guardian Decision|6
2331215|NCT03158311|4053370|FG002|Overall Study|Subject/Guardian Decision|11
2331216|NCT03158311|4053368|FG000|Overall Study|Adverse Event|5
2331217|NCT03158311|4053369|FG001|Overall Study|Adverse Event|3
2331218|NCT03158311|4053370|FG002|Overall Study|Adverse Event|3
2331219|NCT03158311|4053368|FG000|Overall Study|Techinical Problems|3
2331220|NCT03158311|4053369|FG001|Overall Study|Techinical Problems|1
2331221|NCT03158311|4053370|FG002|Overall Study|Techinical Problems|5
2331222|NCT03158311|4053368|FG000|Overall Study|Physician Decision|2
2331223|NCT03158311|4053369|FG001|Overall Study|Physician Decision|3
2331224|NCT03158311|4053370|FG002|Overall Study|Physician Decision|7
2331225|NCT03158311|4053368|FG000|Overall Study|Lost to Follow-up|1
2331226|NCT03158311|4053369|FG001|Overall Study|Lost to Follow-up|1
2331227|NCT03158311|4053370|FG002|Overall Study|Lost to Follow-up|1
2331228|NCT03158311|4053368|FG000|Overall Study|Sponsor decision|1
2331229|NCT03158311|4053369|FG001|Overall Study|Sponsor decision|0
2331230|NCT03158311|4053370|FG002|Overall Study|Sponsor decision|0
2331231|NCT03158311|4053368|FG000|Overall Study|Pregnancy|0
2331232|NCT03158311|4053369|FG001|Overall Study|Pregnancy|2
2331233|NCT03158311|4053370|FG002|Overall Study|Pregnancy|0
2331234|NCT03158311|4053368|FG000|Overall Study|Randomized in error|0
2331235|NCT03158311|4053369|FG001|Overall Study|Randomized in error|0
2331236|NCT03158311|4053370|FG002|Overall Study|Randomized in error|1
2331237|NCT03159091|4053393|FG000|Overall Study|Incorrect inclusion ineligible patient|5
2331238|NCT03159091|4053394|FG001|Overall Study|Incorrect inclusion ineligible patient|3
2331239|NCT03159091|4053393|FG000|Overall Study|Patient has taken no dose of study drug|0
2331240|NCT03159091|4053394|FG001|Overall Study|Patient has taken no dose of study drug|1
2331241|NCT03159455|4053437|FG000|Overall Study|Adverse Event|0
2331242|NCT03159455|4053438|FG001|Overall Study|Adverse Event|0
2331243|NCT03159455|4053439|FG002|Overall Study|Adverse Event|0
2331244|NCT03159455|4053440|FG003|Overall Study|Adverse Event|0
2331245|NCT03159455|4053441|FG004|Overall Study|Adverse Event|0
2331246|NCT03159455|4053442|FG005|Overall Study|Adverse Event|1
2331247|NCT03159468|4053466|FG000|Overall Study|Withdrawal by Subject|0
2331248|NCT03159468|4053467|FG001|Overall Study|Withdrawal by Subject|0
2331249|NCT03159468|4053468|FG002|Overall Study|Withdrawal by Subject|3
2031273|NCT00383162|3600933|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
2031274|NCT00383162|3600932|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3
2031275|NCT00383162|3600933|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0
2031276|NCT00383162|3600932|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
2031277|NCT00383162|3600933|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
2031278|NCT00383162|3600932|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
2031279|NCT00383162|3600933|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
2031280|NCT00383162|3600932|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1
2031281|NCT00383162|3600933|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0
2031282|NCT00383162|3600932|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0
2031283|NCT00383162|3600933|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3
2031284|NCT00383188|3600944|FG000|Overall Study|Adverse Event|4
2031285|NCT00383188|3600945|FG001|Overall Study|Adverse Event|7
2031286|NCT00383188|3600946|FG002|Overall Study|Adverse Event|9
2031287|NCT00383188|3600947|FG003|Overall Study|Adverse Event|8
2031288|NCT00383188|3600948|FG004|Overall Study|Adverse Event|8
2031289|NCT00383188|3600944|FG000|Overall Study|Lack of Efficacy|9
2031290|NCT00383188|3600945|FG001|Overall Study|Lack of Efficacy|3
2031291|NCT00383188|3600946|FG002|Overall Study|Lack of Efficacy|3
2031292|NCT00383188|3600947|FG003|Overall Study|Lack of Efficacy|2
2031293|NCT00383188|3600948|FG004|Overall Study|Lack of Efficacy|6
2031294|NCT00383188|3600944|FG000|Overall Study|Other|3
2031295|NCT00383188|3600945|FG001|Overall Study|Other|1
2110719|NCT00896532|3705471|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110720|NCT00896532|3705472|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110721|NCT00896532|3705473|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110722|NCT00896532|3705474|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2331250|NCT03159468|4053469|FG003|Overall Study|Withdrawal by Subject|0
2331251|NCT03159468|4053470|FG004|Overall Study|Withdrawal by Subject|0
2331252|NCT03159468|4053471|FG005|Overall Study|Withdrawal by Subject|0
2331253|NCT03159611|4053487|FG000|Overall Study|Did Not Meet Inclusion Criteria|9
2331254|NCT03159611|4053488|FG001|Overall Study|Did Not Meet Inclusion Criteria|5
2331255|NCT03159611|4053487|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
2331256|NCT03159611|4053488|FG001|Overall Study|Did Not Meet Exclusion Criteria|3
2331257|NCT03159611|4053487|FG000|Overall Study|Protocol Violation|7
2331258|NCT03159611|4053488|FG001|Overall Study|Protocol Violation|4
2331259|NCT03159611|4053487|FG000|Overall Study|Adverse Event|1
2331260|NCT03159611|4053488|FG001|Overall Study|Adverse Event|0
2331261|NCT03159611|4053487|FG000|Overall Study|Withdrawal by Subject|1
2331262|NCT03159611|4053488|FG001|Overall Study|Withdrawal by Subject|1
2331263|NCT03159611|4053487|FG000|Overall Study|Non-compliance with protocol requirement|3
2331264|NCT03159611|4053488|FG001|Overall Study|Non-compliance with protocol requirement|2
2331265|NCT03159611|4053487|FG000|Overall Study|Inability to perform procedures|1
2331266|NCT03159611|4053488|FG001|Overall Study|Inability to perform procedures|0
2331267|NCT03160560|4053538|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2
2331268|NCT03160560|4053539|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
2331269|NCT03160560|4053540|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1
2331270|NCT03160560|4053541|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0
2331271|NCT03160560|4053538|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
2331272|NCT03160560|4053539|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
2331273|NCT03160560|4053540|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0
2331274|NCT03160560|4053541|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0
2331275|NCT03160573|4053555|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1
2331276|NCT03160573|4053556|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3
2331277|NCT03160573|4053557|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2
2331278|NCT03160573|4053558|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2
2331279|NCT03160703|4053572|FG000|Overall Study|Withdrawal by Subject|0
2331280|NCT03160703|4053573|FG001|Overall Study|Withdrawal by Subject|0
2331281|NCT03160703|4053574|FG002|Overall Study|Withdrawal by Subject|0
2331282|NCT03160703|4053575|FG003|Overall Study|Withdrawal by Subject|1
2331283|NCT03160716|4053585|FG000|Overall Study|Lost to Follow-up|1
2331284|NCT03160885|4053591|FG000|Initial Treatment Period|Not dosed|2
2331285|NCT03160885|4053592|FG001|Initial Treatment Period|Not dosed|0
2331286|NCT03160885|4053593|FG002|Initial Treatment Period|Not dosed|0
2331287|NCT03160885|4053594|FG003|Initial Treatment Period|Not dosed|0
2331288|NCT03160885|4053595|FG004|Initial Treatment Period|Not dosed|0
2331289|NCT03160885|4053596|FG005|Initial Treatment Period|Not dosed|0
2331290|NCT03160885|4053597|FG006|Initial Treatment Period|Not dosed|0
2331291|NCT03160885|4053591|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33
2331292|NCT03160885|4053592|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22
2331293|NCT03160885|4053593|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
2331294|NCT03160885|4053594|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
2331295|NCT03160885|4053595|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
2331296|NCT03160885|4053596|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
2331297|NCT03160885|4053597|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
2331298|NCT03160885|4053591|FG000|Open-label Treatment|Not dosed|0
2331299|NCT03160885|4053592|FG001|Open-label Treatment|Not dosed|0
2331300|NCT03160885|4053593|FG002|Open-label Treatment|Not dosed|0
2331301|NCT03160885|4053594|FG003|Open-label Treatment|Not dosed|0
2331302|NCT03160885|4053595|FG004|Open-label Treatment|Not dosed|0
2331303|NCT03160885|4053596|FG005|Open-label Treatment|Not dosed|0
2331304|NCT03160885|4053597|FG006|Open-label Treatment|Not dosed|2
2331305|NCT03160885|4053591|FG000|Open-label Treatment|Discontinued IMP|0
2331306|NCT03160885|4053592|FG001|Open-label Treatment|Discontinued IMP|0
2331307|NCT03160885|4053593|FG002|Open-label Treatment|Discontinued IMP|0
2331308|NCT03160885|4053594|FG003|Open-label Treatment|Discontinued IMP|0
2331309|NCT03160885|4053595|FG004|Open-label Treatment|Discontinued IMP|0
2331310|NCT03160885|4053596|FG005|Open-label Treatment|Discontinued IMP|0
2331311|NCT03160885|4053597|FG006|Open-label Treatment|Discontinued IMP|131
2331312|NCT03160885|4053591|FG000|Open-label Treatment|Completed Week 50|0
2331313|NCT03160885|4053592|FG001|Open-label Treatment|Completed Week 50|0
2331314|NCT03160885|4053593|FG002|Open-label Treatment|Completed Week 50|0
2331315|NCT03160885|4053594|FG003|Open-label Treatment|Completed Week 50|0
2331316|NCT03160885|4053595|FG004|Open-label Treatment|Completed Week 50|0
2331317|NCT03160885|4053596|FG005|Open-label Treatment|Completed Week 50|0
2331318|NCT03160885|4053597|FG006|Open-label Treatment|Completed Week 50|4
2331319|NCT03160885|4053591|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0
2331320|NCT03160885|4053592|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0
2331321|NCT03160885|4053593|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0
2331322|NCT03160885|4053594|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1
2331323|NCT03160885|4053595|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0
2331324|NCT03160885|4053596|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0
2331325|NCT03160885|4053597|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0
2331326|NCT03160885|4053591|FG000|Maintenance Treatment Period|Discontinued IMP|0
2331327|NCT03160885|4053592|FG001|Maintenance Treatment Period|Discontinued IMP|0
2331328|NCT03160885|4053593|FG002|Maintenance Treatment Period|Discontinued IMP|9
2331329|NCT03160885|4053594|FG003|Maintenance Treatment Period|Discontinued IMP|13
2331330|NCT03160885|4053595|FG004|Maintenance Treatment Period|Discontinued IMP|5
2331331|NCT03160885|4053596|FG005|Maintenance Treatment Period|Discontinued IMP|7
2331332|NCT03160885|4053597|FG006|Maintenance Treatment Period|Discontinued IMP|0
2331333|NCT03160885|4053591|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
2331334|NCT03160885|4053592|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
2331335|NCT03160885|4053593|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29
2331336|NCT03160885|4053594|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26
2331337|NCT03160885|4053595|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26
2331338|NCT03160885|4053596|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8
2331339|NCT03160885|4053597|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
2331340|NCT03160885|4053591|FG000|Maintenance Treatment Period|Completed Week 50|0
2331341|NCT03160885|4053592|FG001|Maintenance Treatment Period|Completed Week 50|0
2331342|NCT03160885|4053593|FG002|Maintenance Treatment Period|Completed Week 50|1
2331343|NCT03160885|4053594|FG003|Maintenance Treatment Period|Completed Week 50|0
2331344|NCT03160885|4053595|FG004|Maintenance Treatment Period|Completed Week 50|0
2331345|NCT03160885|4053596|FG005|Maintenance Treatment Period|Completed Week 50|0
2331346|NCT03160885|4053597|FG006|Maintenance Treatment Period|Completed Week 50|0
2331347|NCT03160898|4053618|FG000|Overall Study|Adverse Event|4
2331348|NCT03160898|4053619|FG001|Overall Study|Adverse Event|8
2331349|NCT03160898|4053620|FG002|Overall Study|Adverse Event|7
2331350|NCT03160898|4053621|FG003|Overall Study|Adverse Event|10
2331351|NCT03160898|4053618|FG000|Overall Study|Death|1
2331352|NCT03160898|4053619|FG001|Overall Study|Death|0
2331353|NCT03160898|4053620|FG002|Overall Study|Death|0
2331354|NCT03160898|4053621|FG003|Overall Study|Death|1
2331355|NCT03160898|4053618|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3
2331356|NCT03160898|4053619|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0
2331357|NCT03160898|4053620|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0
2331358|NCT03160898|4053621|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1
2331359|NCT03160898|4053618|FG000|Overall Study|Lost to Follow-up|1
2331360|NCT03160898|4053619|FG001|Overall Study|Lost to Follow-up|1
2331361|NCT03160898|4053620|FG002|Overall Study|Lost to Follow-up|1
2331362|NCT03160898|4053621|FG003|Overall Study|Lost to Follow-up|2
2331363|NCT03160898|4053618|FG000|Overall Study|Physician Decision|1
2331364|NCT03160898|4053619|FG001|Overall Study|Physician Decision|0
2331365|NCT03160898|4053620|FG002|Overall Study|Physician Decision|0
2331366|NCT03160898|4053621|FG003|Overall Study|Physician Decision|1
2331367|NCT03160898|4053618|FG000|Overall Study|Progressive Disease|4
2331368|NCT03160898|4053619|FG001|Overall Study|Progressive Disease|1
2331369|NCT03160898|4053620|FG002|Overall Study|Progressive Disease|2
2331370|NCT03160898|4053621|FG003|Overall Study|Progressive Disease|1
2331371|NCT03160898|4053618|FG000|Overall Study|Protocol Violation|1
2331372|NCT03160898|4053619|FG001|Overall Study|Protocol Violation|0
2331373|NCT03160898|4053620|FG002|Overall Study|Protocol Violation|2
2331374|NCT03160898|4053621|FG003|Overall Study|Protocol Violation|0
2331375|NCT03160898|4053618|FG000|Overall Study|Sponsor Discretion|2
2331376|NCT03160898|4053619|FG001|Overall Study|Sponsor Discretion|0
2331377|NCT03160898|4053620|FG002|Overall Study|Sponsor Discretion|0
2331378|NCT03160898|4053621|FG003|Overall Study|Sponsor Discretion|0
2331379|NCT03160898|4053618|FG000|Overall Study|Withdrawal by Subject|1
2331380|NCT03160898|4053619|FG001|Overall Study|Withdrawal by Subject|3
2331381|NCT03160898|4053620|FG002|Overall Study|Withdrawal by Subject|2
2331382|NCT03160898|4053621|FG003|Overall Study|Withdrawal by Subject|1
2331383|NCT03160898|4053618|FG000|Overall Study|Other|2
2331384|NCT03160898|4053619|FG001|Overall Study|Other|0
2331385|NCT03160898|4053620|FG002|Overall Study|Other|2
2331386|NCT03160898|4053621|FG003|Overall Study|Other|2
2331387|NCT03161405|4053646|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1
2331388|NCT03161483|4053657|FG000|Overall Study|Death|1
2331389|NCT03161483|4053658|FG001|Overall Study|Death|0
2331390|NCT03161483|4053659|FG002|Overall Study|Death|0
2331391|NCT03161483|4053660|FG003|Overall Study|Death|0
2331392|NCT03161483|4053657|FG000|Overall Study|Adverse Event|5
2331393|NCT03161483|4053658|FG001|Overall Study|Adverse Event|1
2331394|NCT03161483|4053659|FG002|Overall Study|Adverse Event|11
2331395|NCT03161483|4053660|FG003|Overall Study|Adverse Event|2
2331396|NCT03161483|4053657|FG000|Overall Study|Pregnancy|1
2331397|NCT03161483|4053658|FG001|Overall Study|Pregnancy|0
2331398|NCT03161483|4053659|FG002|Overall Study|Pregnancy|0
2331399|NCT03161483|4053660|FG003|Overall Study|Pregnancy|0
2331400|NCT03161483|4053657|FG000|Overall Study|Lack of Efficacy|0
2331401|NCT03161483|4053658|FG001|Overall Study|Lack of Efficacy|0
2331402|NCT03161483|4053659|FG002|Overall Study|Lack of Efficacy|1
2331403|NCT03161483|4053660|FG003|Overall Study|Lack of Efficacy|0
2331404|NCT03161483|4053657|FG000|Overall Study|Withdrawal by Subject|2
2331405|NCT03161483|4053658|FG001|Overall Study|Withdrawal by Subject|2
2331406|NCT03161483|4053659|FG002|Overall Study|Withdrawal by Subject|6
2331407|NCT03161483|4053660|FG003|Overall Study|Withdrawal by Subject|5
2331408|NCT03161483|4053657|FG000|Overall Study|Lost to Follow-up|0
2331409|NCT03161483|4053658|FG001|Overall Study|Lost to Follow-up|0
2331410|NCT03161483|4053659|FG002|Overall Study|Lost to Follow-up|1
2331411|NCT03161483|4053660|FG003|Overall Study|Lost to Follow-up|0
2331412|NCT03161483|4053657|FG000|Overall Study|Protocol Violation|0
2331413|NCT03161483|4053658|FG001|Overall Study|Protocol Violation|0
2331414|NCT03161483|4053659|FG002|Overall Study|Protocol Violation|1
2331415|NCT03161483|4053660|FG003|Overall Study|Protocol Violation|0
2331416|NCT03161483|4053657|FG000|Overall Study|Other reasons|1
2331417|NCT03161483|4053658|FG001|Overall Study|Other reasons|0
2331418|NCT03161483|4053659|FG002|Overall Study|Other reasons|0
2331419|NCT03161483|4053660|FG003|Overall Study|Other reasons|1
2331420|NCT03162055|4053681|FG000|Overall Study|Adverse Event|6
2331421|NCT03162055|4053682|FG001|Overall Study|Adverse Event|5
2331422|NCT03162055|4053681|FG000|Overall Study|Death|3
2331423|NCT03162055|4053682|FG001|Overall Study|Death|3
2331424|NCT03162055|4053681|FG000|Overall Study|Lost to Follow-up|0
2331425|NCT03162055|4053682|FG001|Overall Study|Lost to Follow-up|1
2331426|NCT03162055|4053681|FG000|Overall Study|Study-specific withdrawal criteria|22
2331427|NCT03162055|4053682|FG001|Overall Study|Study-specific withdrawal criteria|14
2331428|NCT03162055|4053681|FG000|Overall Study|Withdrawal by Subject|17
2331429|NCT03162055|4053682|FG001|Overall Study|Withdrawal by Subject|2
2331430|NCT03162055|4053681|FG000|Overall Study|Did not receive treatment|2
2331431|NCT03162055|4053682|FG001|Overall Study|Did not receive treatment|0
2331432|NCT03162055|4053681|FG000|Overall Study|Incorrect randomization|4
2331433|NCT03162055|4053682|FG001|Overall Study|Incorrect randomization|3
2331434|NCT03162055|4053681|FG000|Overall Study|Other|8
2331435|NCT03162055|4053682|FG001|Overall Study|Other|15
2331436|NCT03162328|4053688|FG000|Screening Period|Did not meet inclusion/exclusion|21
2331437|NCT03162328|4053689|FG001|Screening Period|Did not meet inclusion/exclusion|0
2331438|NCT03162328|4053690|FG002|Screening Period|Did not meet inclusion/exclusion|0
2331439|NCT03162328|4053688|FG000|Screening Period|Withdrawal by Subject|1
2331440|NCT03162328|4053689|FG001|Screening Period|Withdrawal by Subject|0
2331441|NCT03162328|4053690|FG002|Screening Period|Withdrawal by Subject|0
2331442|NCT03162328|4053688|FG000|Study Period|Withdrawal by Subject|0
2331443|NCT03162328|4053689|FG001|Study Period|Withdrawal by Subject|0
2331444|NCT03162328|4053690|FG002|Study Period|Withdrawal by Subject|1
2331445|NCT03162614|4053730|FG000|Overall Study|Lost to Follow-up|2
2331446|NCT03162614|4053731|FG001|Overall Study|Lost to Follow-up|1
2331447|NCT03162614|4053732|FG002|Overall Study|Lost to Follow-up|1
2331448|NCT03162614|4053733|FG003|Overall Study|Lost to Follow-up|1
2331449|NCT03162614|4053734|FG004|Overall Study|Lost to Follow-up|2
2331450|NCT03162614|4053735|FG005|Overall Study|Lost to Follow-up|0
2331451|NCT03162614|4053730|FG000|Overall Study|Protocol Violation|0
2331452|NCT03162614|4053731|FG001|Overall Study|Protocol Violation|1
2331453|NCT03162614|4053732|FG002|Overall Study|Protocol Violation|0
2331454|NCT03162614|4053733|FG003|Overall Study|Protocol Violation|1
2331455|NCT03162614|4053734|FG004|Overall Study|Protocol Violation|0
2331456|NCT03162614|4053735|FG005|Overall Study|Protocol Violation|0
2331457|NCT03162614|4053730|FG000|Overall Study|Withdrawal by Subject|2
2331458|NCT03162614|4053731|FG001|Overall Study|Withdrawal by Subject|1
2331459|NCT03162614|4053732|FG002|Overall Study|Withdrawal by Subject|1
2331460|NCT03162614|4053733|FG003|Overall Study|Withdrawal by Subject|1
2331461|NCT03162614|4053734|FG004|Overall Study|Withdrawal by Subject|0
2331462|NCT03162614|4053735|FG005|Overall Study|Withdrawal by Subject|0
2331463|NCT03162614|4053730|FG000|Overall Study|Missed vaccination, exclusion criteria|2
2331464|NCT03162614|4053731|FG001|Overall Study|Missed vaccination, exclusion criteria|2
2331465|NCT03162614|4053732|FG002|Overall Study|Missed vaccination, exclusion criteria|2
2331466|NCT03162614|4053733|FG003|Overall Study|Missed vaccination, exclusion criteria|4
2331467|NCT03162614|4053734|FG004|Overall Study|Missed vaccination, exclusion criteria|3
2331468|NCT03162614|4053735|FG005|Overall Study|Missed vaccination, exclusion criteria|0
2331469|NCT03162796|4053752|FG000|Placebo Controlled Period: Week 0 - 24|Other|0
2331470|NCT03162796|4053753|FG001|Placebo Controlled Period: Week 0 - 24|Other|1
2331471|NCT03162796|4053754|FG002|Placebo Controlled Period: Week 0 - 24|Other|1
2331472|NCT03162796|4053752|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1
2331473|NCT03162796|4053753|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
2331474|NCT03162796|4053754|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
2331475|NCT03162796|4053752|FG000|Placebo Controlled Period: Week 0 - 24|Death|1
2331476|NCT03162796|4053753|FG001|Placebo Controlled Period: Week 0 - 24|Death|0
2331477|NCT03162796|4053754|FG002|Placebo Controlled Period: Week 0 - 24|Death|0
2331478|NCT03162796|4053752|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1
2331479|NCT03162796|4053753|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
2331480|NCT03162796|4053754|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
2331481|NCT03162796|4053752|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3
2331482|NCT03162796|4053753|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0
2331483|NCT03162796|4053754|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1
2331484|NCT03162796|4053752|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4
2331485|NCT03162796|4053753|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
2331486|NCT03162796|4053754|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
2331487|NCT03162796|4053752|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2
2331488|NCT03162796|4053753|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3
2331489|NCT03162796|4053754|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1
2331490|NCT03162796|4053752|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
2331491|NCT03162796|4053753|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
2331492|NCT03162796|4053754|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
2331493|NCT03162796|4053752|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
2218514|NCT01715805|3862076|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
2218515|NCT01715805|3862073|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
2218516|NCT01715805|3862074|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
2218517|NCT01715805|3862075|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
2218518|NCT01715805|3862076|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
2218519|NCT01715805|3862073|FG000|Double-Blind or Continued Treatment|Adverse Event|0
2218520|NCT01715805|3862074|FG001|Double-Blind or Continued Treatment|Adverse Event|3
2218521|NCT01715805|3862075|FG002|Double-Blind or Continued Treatment|Adverse Event|23
2331494|NCT03162796|4053753|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
2331495|NCT03162796|4053754|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1
2331496|NCT03162796|4053752|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
2331497|NCT03162796|4053753|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2
2331498|NCT03162796|4053754|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0
2331499|NCT03162796|4053752|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
2331500|NCT03162796|4053753|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2
2331501|NCT03162796|4053754|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
2331502|NCT03163446|4053795|FG000|Overall Study|Unable to return for Day 180 visit|2
2331503|NCT03163446|4053796|FG001|Overall Study|Unable to return for Day 180 visit|0
2331504|NCT03163446|4053795|FG000|Overall Study|Withdrawal by Subject|2
2331505|NCT03163446|4053796|FG001|Overall Study|Withdrawal by Subject|6
2331506|NCT03163446|4053795|FG000|Overall Study|Death|16
2331507|NCT03163446|4053796|FG001|Overall Study|Death|5
2331508|NCT03163446|4053795|FG000|Overall Study|Lost to Follow-up|6
2331509|NCT03163446|4053796|FG001|Overall Study|Lost to Follow-up|5
2331510|NCT03163446|4053795|FG000|Overall Study|Physician Decision|1
2331511|NCT03163446|4053796|FG001|Overall Study|Physician Decision|1
2331512|NCT03163446|4053795|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1
2331513|NCT03163446|4053796|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0
2331514|NCT03164551|4053839|FG000|Overall Study|Imaging discontinued prior completion|8
2331515|NCT03164551|4053840|FG001|Overall Study|Imaging discontinued prior completion|0
2331516|NCT03164551|4053839|FG000|Overall Study|Participant was non-compliant|1
2031296|NCT00383188|3600946|FG002|Overall Study|Other|0
2031297|NCT00383188|3600947|FG003|Overall Study|Other|2
2031298|NCT00383188|3600948|FG004|Overall Study|Other|6
2031299|NCT00383188|3600944|FG000|Overall Study|No longer willing to participate|1
2031300|NCT00383188|3600945|FG001|Overall Study|No longer willing to participate|0
2031301|NCT00383188|3600946|FG002|Overall Study|No longer willing to participate|1
2031302|NCT00383188|3600947|FG003|Overall Study|No longer willing to participate|0
2031303|NCT00383188|3600948|FG004|Overall Study|No longer willing to participate|2
2110723|NCT00896532|3705475|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110724|NCT00896532|3705476|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110725|NCT00896532|3705477|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110726|NCT00896532|3705478|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110727|NCT00896532|3705479|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110728|NCT00896532|3705480|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110729|NCT00896532|3705481|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110730|NCT00896532|3705482|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110731|NCT00896532|3705483|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110732|NCT00896532|3705484|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110733|NCT00896532|3705485|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110734|NCT00896532|3705486|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110735|NCT00896532|3705487|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110736|NCT00896532|3705488|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2110737|NCT00896532|3705466|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0
2110738|NCT00896532|3705467|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1
2110739|NCT00896532|3705468|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0
2110740|NCT00896532|3705469|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1
2110741|NCT00896532|3705470|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1
2110742|NCT00896532|3705471|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0
2110743|NCT00896532|3705472|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0
2110744|NCT00896532|3705473|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0
2110745|NCT00896532|3705474|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0
2110746|NCT00896532|3705475|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0
2110747|NCT00896532|3705476|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0
2110748|NCT00896532|3705477|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0
2110749|NCT00896532|3705478|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0
2110750|NCT00896532|3705479|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0
2110751|NCT00896532|3705480|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0
2110752|NCT00896532|3705481|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0
2331517|NCT03164551|4053840|FG001|Overall Study|Participant was non-compliant|0
2331518|NCT03164551|4053839|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12
2331519|NCT03164551|4053840|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14
2331520|NCT03164551|4053839|FG000|Overall Study|Other|8
2331521|NCT03164551|4053840|FG001|Overall Study|Other|2
2331522|NCT03165045|4053855|FG000|Visit 1|No registration after visit 1|9
2331523|NCT03165045|4053855|FG000|Visit 1|No treatment documented|10
2331524|NCT03165045|4053855|FG000|Visit 1|No visit 1|10
2331525|NCT03165045|4053855|FG000|Visit 2|Available CCQ score at visit 1 only|109
2331526|NCT03165045|4053855|FG000|Visit 2|No available total CCQ score at all|29
2331527|NCT03165045|4053855|FG000|Visit 2|Available total CCQ score at vist 2 only|44
2331528|NCT03165110|4053870|FG000|Overall Study|Anroid phone software incompatibility|1
2331529|NCT03165955|4053910|FG000|Treatment|Withdrawal by Subject|3
2331530|NCT03165955|4053910|FG000|Treatment|Death|1
2331531|NCT03165955|4053910|FG000|Treatment|Adverse Event|1
2331532|NCT03165955|4053910|FG000|Treatment|Progressive disease|3
2331533|NCT03166124|4053925|FG000|Treatment Period 1|Adverse Event|0
2331534|NCT03166124|4053926|FG001|Treatment Period 1|Adverse Event|0
2331535|NCT03166124|4053927|FG002|Treatment Period 1|Adverse Event|1
2331536|NCT03166124|4053928|FG003|Treatment Period 1|Adverse Event|0
2331537|NCT03166124|4053925|FG000|Wash-out Period|Withdrawal by Subject|0
2331538|NCT03166124|4053926|FG001|Wash-out Period|Withdrawal by Subject|1
2331539|NCT03166124|4053927|FG002|Wash-out Period|Withdrawal by Subject|0
2331540|NCT03166124|4053928|FG003|Wash-out Period|Withdrawal by Subject|1
2331541|NCT03166124|4053925|FG000|Wash-out Period|Adverse Event|0
2331542|NCT03166124|4053926|FG001|Wash-out Period|Adverse Event|1
2331543|NCT03166124|4053927|FG002|Wash-out Period|Adverse Event|1
2331544|NCT03166124|4053928|FG003|Wash-out Period|Adverse Event|0
2331545|NCT03166215|4053941|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
2331546|NCT03166215|4053942|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
2331547|NCT03166215|4053943|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
2331548|NCT03166215|4053941|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
2331549|NCT03166215|4053942|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
2331550|NCT03166215|4053943|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
2331551|NCT03166735|4053959|FG000|Overall Study|Not Treated|1
2331552|NCT03166735|4053960|FG001|Overall Study|Not Treated|0
2331553|NCT03166735|4053961|FG002|Overall Study|Not Treated|0
2331554|NCT03166735|4053962|FG003|Overall Study|Not Treated|0
2331555|NCT03166735|4053963|FG004|Overall Study|Not Treated|0
2331556|NCT03166735|4053959|FG000|Overall Study|follow-up not completed as planned|0
2331557|NCT03166735|4053960|FG001|Overall Study|follow-up not completed as planned|1
2331558|NCT03166735|4053961|FG002|Overall Study|follow-up not completed as planned|1
2331559|NCT03166735|4053962|FG003|Overall Study|follow-up not completed as planned|0
2331560|NCT03166735|4053963|FG004|Overall Study|follow-up not completed as planned|1
2331561|NCT03166735|4053959|FG000|Overall Study|Withdrawal by Subject|0
2331562|NCT03166735|4053960|FG001|Overall Study|Withdrawal by Subject|0
2331563|NCT03166735|4053961|FG002|Overall Study|Withdrawal by Subject|1
2331564|NCT03166735|4053962|FG003|Overall Study|Withdrawal by Subject|1
2331565|NCT03166735|4053963|FG004|Overall Study|Withdrawal by Subject|2
2331566|NCT03166735|4053959|FG000|Overall Study|Lost to Follow-up|0
2331567|NCT03166735|4053960|FG001|Overall Study|Lost to Follow-up|2
2331568|NCT03166735|4053961|FG002|Overall Study|Lost to Follow-up|1
2331569|NCT03166735|4053962|FG003|Overall Study|Lost to Follow-up|0
2331570|NCT03166735|4053963|FG004|Overall Study|Lost to Follow-up|1
2331571|NCT03167073|4053978|FG000|Overall Study|Stillbirth|1
2331572|NCT03167073|4053979|FG001|Overall Study|Stillbirth|0
2331573|NCT03167151|4053988|FG000|Overall Study|Withdrawal by Subject|1
2331574|NCT03167151|4053989|FG001|Overall Study|Withdrawal by Subject|0
2331575|NCT03167151|4053990|FG002|Overall Study|Withdrawal by Subject|0
2331576|NCT03167151|4053988|FG000|Overall Study|No evidence of tumour at surgery|0
2331577|NCT03167151|4053989|FG001|Overall Study|No evidence of tumour at surgery|1
2331578|NCT03167151|4053990|FG002|Overall Study|No evidence of tumour at surgery|1
2331579|NCT03167359|4053998|FG000|Overall Study|Physician Decision|1
2331580|NCT03167359|4053998|FG000|Overall Study|Lost to Follow-up|1
2331581|NCT03167411|4054004|FG000|Overall Study|Adverse Event|0
2331582|NCT03167411|4054005|FG001|Overall Study|Adverse Event|1
2331583|NCT03168425|4054075|FG000|Overall Study|Lost to Follow-up|5
2331584|NCT03168425|4054076|FG001|Overall Study|Lost to Follow-up|8
2331585|NCT03168425|4054075|FG000|Overall Study|unable to confirm post op opioids|2
2331586|NCT03168425|4054076|FG001|Overall Study|unable to confirm post op opioids|3
2331587|NCT03168711|4054092|FG000|Overall Study|Adverse Event|2
2331588|NCT03168711|4054093|FG001|Overall Study|Adverse Event|0
2331589|NCT03168711|4054092|FG000|Overall Study|Withdrawal by Subject|0
2331590|NCT03168711|4054093|FG001|Overall Study|Withdrawal by Subject|1
2331591|NCT03168711|4054092|FG000|Overall Study|Death|0
2331592|NCT03168711|4054093|FG001|Overall Study|Death|1
2331593|NCT03168919|4054103|FG000|Overall Study|Withdrawal by Subject|2
2331594|NCT03169153|4054115|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2331595|NCT03169153|4054116|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2331596|NCT03169153|4054115|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
2331597|NCT03169153|4054116|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
2331598|NCT03169153|4054115|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
2331599|NCT03169153|4054116|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2
2331600|NCT03169153|4054115|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1
2031304|NCT00383188|3600944|FG000|Overall Study|Lost to Follow-up|0
2031305|NCT00383188|3600945|FG001|Overall Study|Lost to Follow-up|0
2031306|NCT00383188|3600946|FG002|Overall Study|Lost to Follow-up|0
2031307|NCT00383188|3600947|FG003|Overall Study|Lost to Follow-up|0
2031308|NCT00383188|3600948|FG004|Overall Study|Lost to Follow-up|1
2031309|NCT00383292|3600969|FG000|Overall Study|Adverse Event|4
2031310|NCT00383292|3600970|FG001|Overall Study|Adverse Event|1
2031311|NCT00383292|3600971|FG002|Overall Study|Adverse Event|2
2031312|NCT00383292|3600969|FG000|Overall Study|Death|3
2031313|NCT00383292|3600970|FG001|Overall Study|Death|3
2031314|NCT00383292|3600971|FG002|Overall Study|Death|3
2031315|NCT00383292|3600969|FG000|Overall Study|Physician Decision|4
2031316|NCT00383292|3600970|FG001|Overall Study|Physician Decision|0
2031317|NCT00383292|3600971|FG002|Overall Study|Physician Decision|1
2031318|NCT00383292|3600969|FG000|Overall Study|Withdrawal by Subject|3
2031319|NCT00383292|3600970|FG001|Overall Study|Withdrawal by Subject|2
2031320|NCT00383292|3600971|FG002|Overall Study|Withdrawal by Subject|2
2031321|NCT00383292|3600969|FG000|Overall Study|Other|1
2031322|NCT00383292|3600970|FG001|Overall Study|Other|0
2031323|NCT00383292|3600971|FG002|Overall Study|Other|0
2031324|NCT00383331|3600982|FG000|Overall Study|Protocol Violation|0
2031325|NCT00383331|3600983|FG001|Overall Study|Protocol Violation|1
2031326|NCT00383500|3600997|FG000|Overall Study|Withdrawal by Subject|8
2031327|NCT00383500|3600998|FG001|Overall Study|Withdrawal by Subject|3
2031328|NCT00383500|3600999|FG002|Overall Study|Withdrawal by Subject|0
2031329|NCT00383500|3600997|FG000|Overall Study|Lost to Follow-up|0
2031330|NCT00383500|3600998|FG001|Overall Study|Lost to Follow-up|0
2031331|NCT00383500|3600999|FG002|Overall Study|Lost to Follow-up|2
2110753|NCT00896532|3705482|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0
2110754|NCT00896532|3705483|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0
2110755|NCT00896532|3705484|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0
2110756|NCT00896532|3705485|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0
2110757|NCT00896532|3705486|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0
2110758|NCT00896532|3705487|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0
2110759|NCT00896532|3705488|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0
2110760|NCT00896532|3705466|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110761|NCT00896532|3705467|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110762|NCT00896532|3705468|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110763|NCT00896532|3705469|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110764|NCT00896532|3705470|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110765|NCT00896532|3705471|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110766|NCT00896532|3705472|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110767|NCT00896532|3705473|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110768|NCT00896532|3705474|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
2110769|NCT00896532|3705475|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110770|NCT00896532|3705476|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110771|NCT00896532|3705477|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110772|NCT00896532|3705478|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110773|NCT00896532|3705479|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110774|NCT00896532|3705480|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110775|NCT00896532|3705481|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110776|NCT00896532|3705482|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110777|NCT00896532|3705483|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110778|NCT00896532|3705484|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110779|NCT00896532|3705485|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2031332|NCT00383786|3601050|FG000|Overall Study|Protocol Violation|2
2331601|NCT03169153|4054116|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0
2331602|NCT03169244|4054124|FG000|Overall Study|Lost to Follow-up|1
2331603|NCT03169244|4054125|FG001|Overall Study|Lost to Follow-up|2
2331604|NCT03169244|4054124|FG000|Overall Study|Adverse Event|1
2331605|NCT03169244|4054125|FG001|Overall Study|Adverse Event|0
2331606|NCT03169244|4054124|FG000|Overall Study|Withdrawal by Subject|2
2331607|NCT03169244|4054125|FG001|Overall Study|Withdrawal by Subject|2
2331608|NCT03169244|4054124|FG000|Overall Study|Physician Decision|1
2331609|NCT03169244|4054125|FG001|Overall Study|Physician Decision|0
2331610|NCT03170154|4054140|FG000|Overall Study|Lost to Follow-up|4
2331611|NCT03170154|4054140|FG000|Overall Study|Death|2
2331612|NCT03170154|4054140|FG000|Overall Study|Withdrawal by Subject|2
2331613|NCT03170193|4054156|FG000|Overall Study|Withdrawal by Subject|0
2331614|NCT03170193|4054157|FG001|Overall Study|Withdrawal by Subject|0
2331615|NCT03170193|4054158|FG002|Overall Study|Withdrawal by Subject|0
2331616|NCT03170193|4054159|FG003|Overall Study|Withdrawal by Subject|1
2331617|NCT03170193|4054160|FG004|Overall Study|Withdrawal by Subject|0
2331618|NCT03170193|4054161|FG005|Overall Study|Withdrawal by Subject|0
2331619|NCT03170193|4054162|FG006|Overall Study|Withdrawal by Subject|0
2331620|NCT03170193|4054156|FG000|Overall Study|Lost to Follow-up|1
2331621|NCT03170193|4054157|FG001|Overall Study|Lost to Follow-up|1
2331622|NCT03170193|4054158|FG002|Overall Study|Lost to Follow-up|0
2331623|NCT03170193|4054159|FG003|Overall Study|Lost to Follow-up|0
2331624|NCT03170193|4054160|FG004|Overall Study|Lost to Follow-up|0
2331625|NCT03170193|4054161|FG005|Overall Study|Lost to Follow-up|0
2331626|NCT03170193|4054162|FG006|Overall Study|Lost to Follow-up|0
2331627|NCT03170232|4054195|FG000|Overall Study|Adverse Event|0
2331628|NCT03170232|4054196|FG001|Overall Study|Adverse Event|1
2331629|NCT03170232|4054195|FG000|Overall Study|Protocol Violation|0
2331630|NCT03170232|4054196|FG001|Overall Study|Protocol Violation|1
2331631|NCT03170232|4054195|FG000|Overall Study|Lack of Efficacy|0
2331632|NCT03170232|4054196|FG001|Overall Study|Lack of Efficacy|1
2331633|NCT03170232|4054195|FG000|Overall Study|Study closed/terminated|26
2331634|NCT03170232|4054196|FG001|Overall Study|Study closed/terminated|23
2331635|NCT03170232|4054195|FG000|Overall Study|Lost to Follow-up|1
2331636|NCT03170232|4054196|FG001|Overall Study|Lost to Follow-up|0
2331637|NCT03170232|4054195|FG000|Overall Study|Withdrawal by Subject|0
2331638|NCT03170232|4054196|FG001|Overall Study|Withdrawal by Subject|1
2331639|NCT03170271|4054204|FG000|Overall Study|Adverse Event|7
2331640|NCT03170271|4054205|FG001|Overall Study|Adverse Event|2
2331641|NCT03170271|4054204|FG000|Overall Study|Lost to Follow-up|0
2331642|NCT03170271|4054205|FG001|Overall Study|Lost to Follow-up|1
2331643|NCT03170271|4054204|FG000|Overall Study|Physician Decision|1
2331644|NCT03170271|4054205|FG001|Overall Study|Physician Decision|0
2331645|NCT03170271|4054204|FG000|Overall Study|Protocol-specified withdrawal criterion|2
2331646|NCT03170271|4054205|FG001|Overall Study|Protocol-specified withdrawal criterion|1
2331647|NCT03170271|4054204|FG000|Overall Study|Withdrawal by Subject|17
2331648|NCT03170271|4054205|FG001|Overall Study|Withdrawal by Subject|5
2331649|NCT03170271|4054204|FG000|Overall Study|Other|2
2331650|NCT03170271|4054205|FG001|Overall Study|Other|2
2331651|NCT03170271|4054204|FG000|Overall Study|Randomized in error|4
2331652|NCT03170271|4054205|FG001|Overall Study|Randomized in error|0
2331653|NCT03170544|4054244|FG000|Part 1|Lost to Follow-up|1
2331654|NCT03170544|4054245|FG001|Part 1|Lost to Follow-up|0
2331655|NCT03170544|4054246|FG002|Part 1|Lost to Follow-up|0
2331656|NCT03170544|4054247|FG003|Part 1|Lost to Follow-up|0
2331657|NCT03170544|4054248|FG004|Part 1|Lost to Follow-up|0
2331658|NCT03170544|4054249|FG005|Part 1|Lost to Follow-up|0
2331659|NCT03170544|4054250|FG006|Part 1|Lost to Follow-up|0
2331660|NCT03170544|4054251|FG007|Part 1|Lost to Follow-up|0
2331661|NCT03170544|4054252|FG008|Part 1|Lost to Follow-up|0
2331662|NCT03170544|4054253|FG009|Part 1|Lost to Follow-up|0
2331663|NCT03170544|4054254|FG010|Part 1|Lost to Follow-up|0
2331664|NCT03170544|4054255|FG011|Part 1|Lost to Follow-up|0
2331665|NCT03170544|4054244|FG000|Part 1|Not treated|0
2331666|NCT03170544|4054245|FG001|Part 1|Not treated|0
2331667|NCT03170544|4054246|FG002|Part 1|Not treated|0
2331668|NCT03170544|4054247|FG003|Part 1|Not treated|1
2331669|NCT03170544|4054248|FG004|Part 1|Not treated|0
2331670|NCT03170544|4054249|FG005|Part 1|Not treated|0
2331671|NCT03170544|4054250|FG006|Part 1|Not treated|0
2331672|NCT03170544|4054251|FG007|Part 1|Not treated|0
2331673|NCT03170544|4054252|FG008|Part 1|Not treated|0
2331674|NCT03170544|4054253|FG009|Part 1|Not treated|0
2331675|NCT03170544|4054254|FG010|Part 1|Not treated|0
2331676|NCT03170544|4054255|FG011|Part 1|Not treated|0
2331677|NCT03170609|4054345|FG000|Overall Study|Death|0
2331678|NCT03170609|4054346|FG001|Overall Study|Death|0
2331679|NCT03170609|4054347|FG002|Overall Study|Death|1
2331680|NCT03170609|4054348|FG003|Overall Study|Death|0
2331681|NCT03170609|4054349|FG004|Overall Study|Death|0
2331682|NCT03170609|4054350|FG005|Overall Study|Death|0
2331683|NCT03170609|4054351|FG006|Overall Study|Death|0
2331684|NCT03170609|4054345|FG000|Overall Study|Withdrawal by Subject|1
2331685|NCT03170609|4054346|FG001|Overall Study|Withdrawal by Subject|2
2331686|NCT03170609|4054347|FG002|Overall Study|Withdrawal by Subject|0
2331687|NCT03170609|4054348|FG003|Overall Study|Withdrawal by Subject|0
2331688|NCT03170609|4054349|FG004|Overall Study|Withdrawal by Subject|0
2331689|NCT03170609|4054350|FG005|Overall Study|Withdrawal by Subject|0
2331690|NCT03170609|4054351|FG006|Overall Study|Withdrawal by Subject|1
2331691|NCT03170609|4054345|FG000|Overall Study|Lost to Follow-up|1
2331692|NCT03170609|4054346|FG001|Overall Study|Lost to Follow-up|0
2331693|NCT03170609|4054347|FG002|Overall Study|Lost to Follow-up|5
2331694|NCT03170609|4054348|FG003|Overall Study|Lost to Follow-up|2
2331695|NCT03170609|4054349|FG004|Overall Study|Lost to Follow-up|1
2331696|NCT03170609|4054350|FG005|Overall Study|Lost to Follow-up|1
2331697|NCT03170609|4054351|FG006|Overall Study|Lost to Follow-up|0
2331698|NCT03170609|4054345|FG000|Overall Study|Other|1
2331699|NCT03170609|4054346|FG001|Overall Study|Other|0
2331700|NCT03170609|4054347|FG002|Overall Study|Other|0
2331701|NCT03170609|4054348|FG003|Overall Study|Other|0
2331702|NCT03170609|4054349|FG004|Overall Study|Other|0
2331703|NCT03170609|4054350|FG005|Overall Study|Other|1
2331704|NCT03170609|4054351|FG006|Overall Study|Other|0
2331705|NCT03171415|4054388|FG000|Overall Study|Lost to Follow-up|0
2331706|NCT03171415|4054389|FG001|Overall Study|Lost to Follow-up|0
2331707|NCT03171415|4054390|FG002|Overall Study|Lost to Follow-up|0
2331708|NCT03171415|4054391|FG003|Overall Study|Lost to Follow-up|0
2331709|NCT03171415|4054392|FG004|Overall Study|Lost to Follow-up|2
2331710|NCT03172130|4054417|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3
2331711|NCT03172130|4054418|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1
2331712|NCT03172325|4054426|FG000|Overall Study|Adverse Event|2
2331713|NCT03172325|4054427|FG001|Overall Study|Adverse Event|3
2331714|NCT03172325|4054426|FG000|Overall Study|Positive PPD|1
2331715|NCT03172325|4054427|FG001|Overall Study|Positive PPD|0
2331716|NCT03172325|4054426|FG000|Overall Study|Poor Compliance|1
2331717|NCT03172325|4054427|FG001|Overall Study|Poor Compliance|1
2331718|NCT03172364|4054435|FG000|Overall Study|Adverse Event|1
2331719|NCT03172364|4054436|FG001|Overall Study|Adverse Event|1
2331720|NCT03172364|4054435|FG000|Overall Study|Protocol Violation|1
2331721|NCT03172364|4054436|FG001|Overall Study|Protocol Violation|0
2331722|NCT03172481|4054444|FG000|Double-blind|Withdrawal by Subject|1
2331723|NCT03172481|4054445|FG001|Double-blind|Withdrawal by Subject|0
2331724|NCT03172494|4054454|FG000|Overall Study|Adverse Event|5
2331725|NCT03172494|4054455|FG001|Overall Study|Adverse Event|1
2331726|NCT03172494|4054456|FG002|Overall Study|Adverse Event|15
2331727|NCT03172494|4054454|FG000|Overall Study|Protocol Violation|3
2331728|NCT03172494|4054455|FG001|Overall Study|Protocol Violation|2
2331729|NCT03172494|4054456|FG002|Overall Study|Protocol Violation|1
2331730|NCT03172494|4054454|FG000|Overall Study|Lack of Efficacy|0
2331731|NCT03172494|4054455|FG001|Overall Study|Lack of Efficacy|0
2331732|NCT03172494|4054456|FG002|Overall Study|Lack of Efficacy|4
2331733|NCT03172494|4054454|FG000|Overall Study|Pregnancy|0
2331734|NCT03172494|4054455|FG001|Overall Study|Pregnancy|1
2331735|NCT03172494|4054456|FG002|Overall Study|Pregnancy|0
2331736|NCT03172494|4054454|FG000|Overall Study|Withdrawal by Subject|10
2331737|NCT03172494|4054455|FG001|Overall Study|Withdrawal by Subject|8
2331738|NCT03172494|4054456|FG002|Overall Study|Withdrawal by Subject|8
2331739|NCT03172494|4054454|FG000|Overall Study|Severe hypoglycaemic episode|0
2331740|NCT03172494|4054455|FG001|Overall Study|Severe hypoglycaemic episode|0
2331741|NCT03172494|4054456|FG002|Overall Study|Severe hypoglycaemic episode|1
2331742|NCT03172494|4054454|FG000|Overall Study|Non-compliance towards treatment|2
2331743|NCT03172494|4054455|FG001|Overall Study|Non-compliance towards treatment|0
2331744|NCT03172494|4054456|FG002|Overall Study|Non-compliance towards treatment|0
2331745|NCT03172702|4054465|FG000|Overall Study|Adverse Event|9
2331746|NCT03172702|4054465|FG000|Overall Study|Death|2
2331747|NCT03172702|4054465|FG000|Overall Study|Study-specific Withdrawal Criteria|10
2331748|NCT03172702|4054465|FG000|Overall Study|Withdrawal by Subject|5
2331749|NCT03172702|4054465|FG000|Overall Study|Other|2
2331750|NCT03173313|4054510|FG000|Overall Study|Lost to Follow-up|2
2331751|NCT03173313|4054511|FG001|Overall Study|Lost to Follow-up|3
2331752|NCT03173313|4054510|FG000|Overall Study|Withdrawal by Subject|0
2331753|NCT03173313|4054511|FG001|Overall Study|Withdrawal by Subject|1
2218522|NCT01715805|3862076|FG003|Double-Blind or Continued Treatment|Adverse Event|2
2331754|NCT03173313|4054510|FG000|Overall Study|Death|5
2331755|NCT03173313|4054511|FG001|Overall Study|Death|0
2331756|NCT03173313|4054510|FG000|Overall Study|Physician Decision|1
2031333|NCT00383786|3601051|FG001|Overall Study|Protocol Violation|6
2031334|NCT00383786|3601050|FG000|Overall Study|Withdrawal by Subject|2
2031335|NCT00383786|3601051|FG001|Overall Study|Withdrawal by Subject|5
2031336|NCT00383786|3601050|FG000|Overall Study|Physician Decision|0
2031337|NCT00383786|3601051|FG001|Overall Study|Physician Decision|1
2031338|NCT00384033|3601070|FG000|Overall Study|Adverse Event|10
2031339|NCT00384033|3601071|FG001|Overall Study|Adverse Event|8
2031340|NCT00384033|3601072|FG002|Overall Study|Adverse Event|11
2031341|NCT00384033|3601073|FG003|Overall Study|Adverse Event|20
2031342|NCT00384033|3601070|FG000|Overall Study|Failed to return|1
2031343|NCT00384033|3601071|FG001|Overall Study|Failed to return|3
2031344|NCT00384033|3601072|FG002|Overall Study|Failed to return|2
2031345|NCT00384033|3601073|FG003|Overall Study|Failed to return|2
2031346|NCT00384033|3601070|FG000|Overall Study|Physician Decision|1
2031347|NCT00384033|3601071|FG001|Overall Study|Physician Decision|0
2031348|NCT00384033|3601072|FG002|Overall Study|Physician Decision|0
2031349|NCT00384033|3601073|FG003|Overall Study|Physician Decision|0
2031350|NCT00384033|3601070|FG000|Overall Study|Lost to Follow-up|6
2031351|NCT00384033|3601071|FG001|Overall Study|Lost to Follow-up|12
2031352|NCT00384033|3601072|FG002|Overall Study|Lost to Follow-up|7
2031353|NCT00384033|3601073|FG003|Overall Study|Lost to Follow-up|7
2031354|NCT00384033|3601070|FG000|Overall Study|Other|2
2031355|NCT00384033|3601071|FG001|Overall Study|Other|0
2031356|NCT00384033|3601072|FG002|Overall Study|Other|0
2110780|NCT00896532|3705486|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110781|NCT00896532|3705487|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110782|NCT00896532|3705488|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2110783|NCT00896532|3705466|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110784|NCT00896532|3705467|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110785|NCT00896532|3705468|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110786|NCT00896532|3705469|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110787|NCT00896532|3705470|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110788|NCT00896532|3705471|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110789|NCT00896532|3705472|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110790|NCT00896532|3705473|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110791|NCT00896532|3705474|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110792|NCT00896532|3705475|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110793|NCT00896532|3705476|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110794|NCT00896532|3705477|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110795|NCT00896532|3705478|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1
2110796|NCT00896532|3705479|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110797|NCT00896532|3705480|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110798|NCT00896532|3705481|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110799|NCT00896532|3705482|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110800|NCT00896532|3705483|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110801|NCT00896532|3705484|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110802|NCT00896532|3705485|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110803|NCT00896532|3705486|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110804|NCT00896532|3705487|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110805|NCT00896532|3705488|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2110806|NCT00896532|3705466|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110807|NCT00896532|3705467|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110808|NCT00896532|3705468|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110809|NCT00896532|3705469|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110810|NCT00896532|3705470|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2031357|NCT00384033|3601073|FG003|Overall Study|Other|0
2031358|NCT00384033|3601070|FG000|Overall Study|Protocol Violation|5
2031359|NCT00384033|3601071|FG001|Overall Study|Protocol Violation|0
2031360|NCT00384033|3601072|FG002|Overall Study|Protocol Violation|5
2031361|NCT00384033|3601073|FG003|Overall Study|Protocol Violation|6
2031362|NCT00384033|3601070|FG000|Overall Study|Withdrawal by Subject|6
2031363|NCT00384033|3601071|FG001|Overall Study|Withdrawal by Subject|2
2031364|NCT00384033|3601072|FG002|Overall Study|Withdrawal by Subject|5
2031365|NCT00384033|3601073|FG003|Overall Study|Withdrawal by Subject|2
2031366|NCT00384033|3601070|FG000|Overall Study|Lack of Efficacy|7
2031367|NCT00384033|3601071|FG001|Overall Study|Lack of Efficacy|3
2031368|NCT00384033|3601072|FG002|Overall Study|Lack of Efficacy|3
2031369|NCT00384033|3601073|FG003|Overall Study|Lack of Efficacy|1
2031370|NCT00384033|3601070|FG000|Overall Study|Randomized but not treated|3
2031371|NCT00384033|3601071|FG001|Overall Study|Randomized but not treated|7
2031372|NCT00384033|3601072|FG002|Overall Study|Randomized but not treated|10
2031373|NCT00384033|3601073|FG003|Overall Study|Randomized but not treated|2
2031374|NCT00384059|3601085|FG000|Infant Series|Not consented|2
2031375|NCT00384059|3601086|FG001|Infant Series|Not consented|6
2031376|NCT00384059|3601085|FG000|Infant Series|Withdrawal by Subject|2
2031377|NCT00384059|3601086|FG001|Infant Series|Withdrawal by Subject|2
2031378|NCT00384059|3601085|FG000|Infant Series|Adverse Event|1
2031379|NCT00384059|3601086|FG001|Infant Series|Adverse Event|2
2031380|NCT00384059|3601085|FG000|Infant Series|Protocol Violation|1
2031381|NCT00384059|3601086|FG001|Infant Series|Protocol Violation|2
2031382|NCT00384059|3601085|FG000|Infant Series|Lost to Follow-up|0
2031383|NCT00384059|3601086|FG001|Infant Series|Lost to Follow-up|1
2031384|NCT00384059|3601085|FG000|After Infant Series|Protocol Violation|2
2031385|NCT00384059|3601086|FG001|After Infant Series|Protocol Violation|3
2031386|NCT00384059|3601085|FG000|After Infant Series|Withdrawal by Subject|2
2031387|NCT00384059|3601086|FG001|After Infant Series|Withdrawal by Subject|2
2031388|NCT00384059|3601085|FG000|After Infant Series|Failed to Return|0
2031389|NCT00384059|3601086|FG001|After Infant Series|Failed to Return|2
2031390|NCT00384059|3601085|FG000|After Infant Series|Adverse Event|0
2031391|NCT00384059|3601086|FG001|After Infant Series|Adverse Event|1
2031392|NCT00384059|3601085|FG000|After Infant Series|Physician Decision|0
2031393|NCT00384059|3601086|FG001|After Infant Series|Physician Decision|1
2031394|NCT00384059|3601085|FG000|After Infant Series|Lost to Follow-up|0
2031395|NCT00384059|3601086|FG001|After Infant Series|Lost to Follow-up|1
2031396|NCT00384059|3601085|FG000|Toddler Dose|Lost to Follow-up|1
2031397|NCT00384059|3601086|FG001|Toddler Dose|Lost to Follow-up|1
2031398|NCT00384059|3601085|FG000|Toddler Dose|Failed to return|0
2031399|NCT00384059|3601086|FG001|Toddler Dose|Failed to return|1
2031400|NCT00384085|3601116|FG000|Overall Study|Adverse Event|5
2031401|NCT00384085|3601117|FG001|Overall Study|Adverse Event|5
2031402|NCT00384085|3601118|FG002|Overall Study|Adverse Event|4
2031403|NCT00384085|3601116|FG000|Overall Study|Lack of Efficacy|0
2031404|NCT00384085|3601117|FG001|Overall Study|Lack of Efficacy|3
2031405|NCT00384085|3601118|FG002|Overall Study|Lack of Efficacy|2
2031406|NCT00384085|3601116|FG000|Overall Study|No longer Requires Study Treatment|1
2031407|NCT00384085|3601117|FG001|Overall Study|No longer Requires Study Treatment|0
2031408|NCT00384085|3601118|FG002|Overall Study|No longer Requires Study Treatment|1
2031409|NCT00384085|3601116|FG000|Overall Study|Protocol Violation|2
2031410|NCT00384085|3601117|FG001|Overall Study|Protocol Violation|2
2031411|NCT00384085|3601118|FG002|Overall Study|Protocol Violation|2
2031412|NCT00384085|3601116|FG000|Overall Study|Lost to Follow-up|9
2031413|NCT00384085|3601117|FG001|Overall Study|Lost to Follow-up|9
2031414|NCT00384085|3601118|FG002|Overall Study|Lost to Follow-up|10
2031415|NCT00384085|3601116|FG000|Overall Study|Progressive Disease|0
2031416|NCT00384085|3601117|FG001|Overall Study|Progressive Disease|1
2031417|NCT00384085|3601118|FG002|Overall Study|Progressive Disease|0
2031418|NCT00384085|3601116|FG000|Overall Study|Withdrawal by Subject|14
2031419|NCT00384085|3601117|FG001|Overall Study|Withdrawal by Subject|19
2031420|NCT00384085|3601118|FG002|Overall Study|Withdrawal by Subject|29
2031421|NCT00384085|3601116|FG000|Overall Study|Patient non-compliant|4
2031422|NCT00384085|3601117|FG001|Overall Study|Patient non-compliant|4
2031423|NCT00384085|3601118|FG002|Overall Study|Patient non-compliant|5
2031424|NCT00384085|3601116|FG000|Overall Study|Physician Decision|1
2031425|NCT00384085|3601117|FG001|Overall Study|Physician Decision|0
2031426|NCT00384085|3601118|FG002|Overall Study|Physician Decision|0
2031427|NCT00384085|3601116|FG000|Overall Study|Loss of site personnel|1
2031428|NCT00384085|3601117|FG001|Overall Study|Loss of site personnel|0
2031429|NCT00384085|3601118|FG002|Overall Study|Loss of site personnel|1
2031430|NCT00384085|3601116|FG000|Overall Study|Sponsor decision|1
2031431|NCT00384085|3601117|FG001|Overall Study|Sponsor decision|2
2031432|NCT00384085|3601118|FG002|Overall Study|Sponsor decision|1
2031433|NCT00384085|3601116|FG000|Overall Study|Patient moved|1
2031434|NCT00384085|3601117|FG001|Overall Study|Patient moved|0
2031435|NCT00384085|3601118|FG002|Overall Study|Patient moved|1
2031436|NCT00384085|3601116|FG000|Overall Study|Patient required surgery|0
2110811|NCT00896532|3705471|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110812|NCT00896532|3705472|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110813|NCT00896532|3705473|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110814|NCT00896532|3705474|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110815|NCT00896532|3705475|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110816|NCT00896532|3705476|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1
2110817|NCT00896532|3705477|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110818|NCT00896532|3705478|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1
2110819|NCT00896532|3705479|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110820|NCT00896532|3705480|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110821|NCT00896532|3705481|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110822|NCT00896532|3705482|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110823|NCT00896532|3705483|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110824|NCT00896532|3705484|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110825|NCT00896532|3705485|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110826|NCT00896532|3705486|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110827|NCT00896532|3705487|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110828|NCT00896532|3705488|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2110829|NCT00896532|3705466|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110830|NCT00896532|3705467|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110831|NCT00896532|3705468|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110832|NCT00896532|3705469|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110833|NCT00896532|3705470|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110834|NCT00896532|3705471|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110835|NCT00896532|3705472|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110836|NCT00896532|3705473|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110837|NCT00896532|3705474|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110838|NCT00896532|3705475|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110839|NCT00896532|3705476|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110840|NCT00896532|3705477|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2031437|NCT00384085|3601117|FG001|Overall Study|Patient required surgery|1
2031438|NCT00384085|3601118|FG002|Overall Study|Patient required surgery|0
2031439|NCT00384176|3601131|FG000|Overall Study|Death|239
2031440|NCT00384176|3601132|FG001|Overall Study|Death|247
2031441|NCT00384176|3601133|FG002|Overall Study|Death|105
2031442|NCT00384176|3601131|FG000|Overall Study|Withdrawal by Subject|52
2031443|NCT00384176|3601132|FG001|Overall Study|Withdrawal by Subject|48
2031444|NCT00384176|3601133|FG002|Overall Study|Withdrawal by Subject|22
2031445|NCT00384176|3601131|FG000|Overall Study|Lost to Follow-up|16
2031446|NCT00384176|3601132|FG001|Overall Study|Lost to Follow-up|18
2031447|NCT00384176|3601133|FG002|Overall Study|Lost to Follow-up|4
2031448|NCT00384176|3601131|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2
2031449|NCT00384176|3601132|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3
2031450|NCT00384176|3601133|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0
2031451|NCT00384176|3601131|FG000|Overall Study|Longer QTC as Visit 1|1
2031452|NCT00384176|3601132|FG001|Overall Study|Longer QTC as Visit 1|0
2031453|NCT00384176|3601133|FG002|Overall Study|Longer QTC as Visit 1|0
2031454|NCT00384176|3601131|FG000|Overall Study|Toxicity of treatment|1
2031455|NCT00384176|3601132|FG001|Overall Study|Toxicity of treatment|0
2031456|NCT00384176|3601133|FG002|Overall Study|Toxicity of treatment|0
2031457|NCT00384176|3601131|FG000|Overall Study|Did not receive study treatment|0
2031458|NCT00384176|3601132|FG001|Overall Study|Did not receive study treatment|1
2031459|NCT00384176|3601133|FG002|Overall Study|Did not receive study treatment|1
2031460|NCT00384176|3601131|FG000|Overall Study|Physician Decision|0
2031461|NCT00384176|3601132|FG001|Overall Study|Physician Decision|2
2031462|NCT00384176|3601133|FG002|Overall Study|Physician Decision|0
2031463|NCT00384176|3601131|FG000|Overall Study|Liver metastases, colon resec. planned|1
2031464|NCT00384176|3601132|FG001|Overall Study|Liver metastases, colon resec. planned|0
2031465|NCT00384176|3601133|FG002|Overall Study|Liver metastases, colon resec. planned|0
2031466|NCT00384189|3601145|FG000|Overall Study|Reason Not Specified|50
2031467|NCT00384189|3601146|FG001|Overall Study|Reason Not Specified|57
2031468|NCT00384189|3601147|FG002|Overall Study|Reason Not Specified|58
2031469|NCT00384189|3601148|FG003|Overall Study|Reason Not Specified|40
2031470|NCT00384332|3601168|FG000|Overall Study|Lost to Follow-up|4
2031471|NCT00384332|3601169|FG001|Overall Study|Lost to Follow-up|0
2031472|NCT00384397|3601180|FG000|Overall Study|Adverse Event|0
2031473|NCT00384397|3601181|FG001|Overall Study|Adverse Event|1
2031474|NCT00384397|3601182|FG002|Overall Study|Adverse Event|2
2031475|NCT00384397|3601180|FG000|Overall Study|Protocol Violation|7
2031476|NCT00384397|3601181|FG001|Overall Study|Protocol Violation|15
2031477|NCT00384397|3601182|FG002|Overall Study|Protocol Violation|13
2031478|NCT00384397|3601180|FG000|Overall Study|Lost to Follow-up|11
2031479|NCT00384397|3601181|FG001|Overall Study|Lost to Follow-up|13
2031480|NCT00384397|3601182|FG002|Overall Study|Lost to Follow-up|3
2031481|NCT00384397|3601180|FG000|Overall Study|Withdrawal by Subject|14
2031482|NCT00384397|3601181|FG001|Overall Study|Withdrawal by Subject|17
2031483|NCT00384397|3601182|FG002|Overall Study|Withdrawal by Subject|15
2031484|NCT00384839|3601245|FG000|Overall Study|Adverse Event|4
2031485|NCT00384839|3601245|FG000|Overall Study|Investigator Request|1
2031486|NCT00384839|3601245|FG000|Overall Study|Patient Request|1
2031487|NCT00384839|3601245|FG000|Overall Study|Ineligible|2
2031488|NCT00384930|3601271|FG000|Overall Study|Adverse Event|5
2031489|NCT00384930|3601272|FG001|Overall Study|Adverse Event|4
2031490|NCT00384930|3601273|FG002|Overall Study|Adverse Event|12
2031491|NCT00384930|3601274|FG003|Overall Study|Adverse Event|11
2031492|NCT00384930|3601275|FG004|Overall Study|Adverse Event|14
2031493|NCT00384930|3601271|FG000|Overall Study|Entry Criteria Not Met|2
2031494|NCT00384930|3601272|FG001|Overall Study|Entry Criteria Not Met|6
2031495|NCT00384930|3601273|FG002|Overall Study|Entry Criteria Not Met|7
2031496|NCT00384930|3601274|FG003|Overall Study|Entry Criteria Not Met|8
2031497|NCT00384930|3601275|FG004|Overall Study|Entry Criteria Not Met|4
2031498|NCT00384930|3601271|FG000|Overall Study|Lack of Efficacy|1
2031499|NCT00384930|3601272|FG001|Overall Study|Lack of Efficacy|1
2031500|NCT00384930|3601273|FG002|Overall Study|Lack of Efficacy|2
2031501|NCT00384930|3601274|FG003|Overall Study|Lack of Efficacy|1
2031502|NCT00384930|3601275|FG004|Overall Study|Lack of Efficacy|2
2031503|NCT00384930|3601271|FG000|Overall Study|Lost to Follow-up|5
2031504|NCT00384930|3601272|FG001|Overall Study|Lost to Follow-up|3
2031505|NCT00384930|3601273|FG002|Overall Study|Lost to Follow-up|0
2031506|NCT00384930|3601274|FG003|Overall Study|Lost to Follow-up|4
2031507|NCT00384930|3601275|FG004|Overall Study|Lost to Follow-up|6
2031508|NCT00384930|3601271|FG000|Overall Study|Physician Decision|0
2031509|NCT00384930|3601272|FG001|Overall Study|Physician Decision|1
2031510|NCT00384930|3601273|FG002|Overall Study|Physician Decision|1
2031511|NCT00384930|3601274|FG003|Overall Study|Physician Decision|0
2031512|NCT00384930|3601275|FG004|Overall Study|Physician Decision|1
2031513|NCT00384930|3601271|FG000|Overall Study|Protocol Violation|1
2031514|NCT00384930|3601272|FG001|Overall Study|Protocol Violation|0
2031515|NCT00384930|3601273|FG002|Overall Study|Protocol Violation|1
2031516|NCT00384930|3601274|FG003|Overall Study|Protocol Violation|6
2031517|NCT00384930|3601275|FG004|Overall Study|Protocol Violation|4
2031518|NCT00384930|3601271|FG000|Overall Study|Sponsor Decision|3
2031519|NCT00384930|3601272|FG001|Overall Study|Sponsor Decision|4
2110841|NCT00896532|3705478|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
2110842|NCT00896532|3705479|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
2110843|NCT00896532|3705480|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110844|NCT00896532|3705481|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110845|NCT00896532|3705482|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110846|NCT00896532|3705483|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110847|NCT00896532|3705484|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110848|NCT00896532|3705485|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110849|NCT00896532|3705486|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110850|NCT00896532|3705487|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110851|NCT00896532|3705488|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2110852|NCT00896532|3705466|FG000|Months 24-36: Denosumab Extension Phase|Other|0
2110853|NCT00896532|3705467|FG001|Months 24-36: Denosumab Extension Phase|Other|0
2110854|NCT00896532|3705468|FG002|Months 24-36: Denosumab Extension Phase|Other|0
2110855|NCT00896532|3705469|FG003|Months 24-36: Denosumab Extension Phase|Other|0
2110856|NCT00896532|3705470|FG004|Months 24-36: Denosumab Extension Phase|Other|0
2110857|NCT00896532|3705471|FG005|Months 24-36: Denosumab Extension Phase|Other|0
2110858|NCT00896532|3705472|FG006|Months 24-36: Denosumab Extension Phase|Other|0
2110859|NCT00896532|3705473|FG007|Months 24-36: Denosumab Extension Phase|Other|0
2110860|NCT00896532|3705474|FG008|Months 24-36: Denosumab Extension Phase|Other|0
2110861|NCT00896532|3705475|FG009|Months 24-36: Denosumab Extension Phase|Other|0
2110862|NCT00896532|3705476|FG010|Months 24-36: Denosumab Extension Phase|Other|1
2110863|NCT00896532|3705477|FG011|Months 24-36: Denosumab Extension Phase|Other|2
2110864|NCT00896532|3705478|FG012|Months 24-36: Denosumab Extension Phase|Other|2
2110865|NCT00896532|3705479|FG013|Months 24-36: Denosumab Extension Phase|Other|1
2110866|NCT00896532|3705480|FG014|Months 24-36: Denosumab Extension Phase|Other|0
2031520|NCT00384930|3601273|FG002|Overall Study|Sponsor Decision|0
2031521|NCT00384930|3601274|FG003|Overall Study|Sponsor Decision|5
2031522|NCT00384930|3601275|FG004|Overall Study|Sponsor Decision|0
2031523|NCT00384930|3601271|FG000|Overall Study|Withdrawal by Subject|9
2031524|NCT00384930|3601272|FG001|Overall Study|Withdrawal by Subject|7
2031525|NCT00384930|3601273|FG002|Overall Study|Withdrawal by Subject|7
2031526|NCT00384930|3601274|FG003|Overall Study|Withdrawal by Subject|6
2031527|NCT00384930|3601275|FG004|Overall Study|Withdrawal by Subject|16
2031528|NCT00384930|3601271|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1
2031529|NCT00384930|3601272|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1
2031530|NCT00384930|3601273|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0
2031531|NCT00384930|3601274|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0
2031532|NCT00384930|3601275|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0
2031533|NCT00384956|3601290|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3
2031534|NCT00385203|3601315|FG000|Overall Study|Adverse Event|5
2031535|NCT00385203|3601316|FG001|Overall Study|Adverse Event|4
2031536|NCT00385203|3601315|FG000|Overall Study|Death|1
2031537|NCT00385203|3601316|FG001|Overall Study|Death|0
2031538|NCT00385203|3601315|FG000|Overall Study|Condition under investigation worsened|18
2031539|NCT00385203|3601316|FG001|Overall Study|Condition under investigation worsened|3
2031540|NCT00385203|3601315|FG000|Overall Study|Incorrect enrollment|2
2031541|NCT00385203|3601316|FG001|Overall Study|Incorrect enrollment|0
2031542|NCT00385255|3601332|FG000|Overall Study|Serious Adverse Event|1
2031543|NCT00385255|3601333|FG001|Overall Study|Serious Adverse Event|2
2031544|NCT00385255|3601332|FG000|Overall Study|Protocol Violation|0
2031545|NCT00385255|3601333|FG001|Overall Study|Protocol Violation|4
2031546|NCT00385255|3601332|FG000|Overall Study|Withdrawal by Subject|0
2031547|NCT00385255|3601333|FG001|Overall Study|Withdrawal by Subject|8
2031548|NCT00385255|3601332|FG000|Overall Study|Migrated/moved from study area|0
2031549|NCT00385255|3601333|FG001|Overall Study|Migrated/moved from study area|1
2031550|NCT00385255|3601332|FG000|Overall Study|Lost to Follow-up|20
2031551|NCT00385255|3601333|FG001|Overall Study|Lost to Follow-up|58
2031552|NCT00385541|3601354|FG000|Overall Study|severe pain, clinician requested unblind|0
2031553|NCT00385541|3601355|FG001|Overall Study|severe pain, clinician requested unblind|1
2031554|NCT00385593|3601382|FG000|Overall Study|Adverse Event|3
2031555|NCT00385593|3601383|FG001|Overall Study|Adverse Event|2
2031556|NCT00385593|3601382|FG000|Overall Study|Withdrawal by Subject|17
2031557|NCT00385593|3601383|FG001|Overall Study|Withdrawal by Subject|7
2031558|NCT00385593|3601382|FG000|Overall Study|Lost to Follow-up|12
2031559|NCT00385593|3601383|FG001|Overall Study|Lost to Follow-up|8
2031560|NCT00385593|3601382|FG000|Overall Study|Protocol Violation|7
2031561|NCT00385593|3601383|FG001|Overall Study|Protocol Violation|4
2031562|NCT00385593|3601382|FG000|Overall Study|Several reasons|17
2031563|NCT00385593|3601383|FG001|Overall Study|Several reasons|15
2031564|NCT00385593|3601382|FG000|Overall Study|Incorrect inclusion|2
2031565|NCT00385593|3601383|FG001|Overall Study|Incorrect inclusion|0
2031566|NCT00385593|3601382|FG000|Overall Study|Incorrect randomization|0
2031567|NCT00385593|3601383|FG001|Overall Study|Incorrect randomization|1
2031568|NCT00385671|3601392|FG000|Overall Study|Adverse Event|14
2031569|NCT00385671|3601393|FG001|Overall Study|Adverse Event|27
2031570|NCT00385671|3601394|FG002|Overall Study|Adverse Event|18
2031571|NCT00385671|3601392|FG000|Overall Study|Lack of Efficacy|5
2031572|NCT00385671|3601393|FG001|Overall Study|Lack of Efficacy|9
2031573|NCT00385671|3601394|FG002|Overall Study|Lack of Efficacy|5
2031574|NCT00385671|3601392|FG000|Overall Study|Lost to Follow-up|6
2031575|NCT00385671|3601393|FG001|Overall Study|Lost to Follow-up|6
2031576|NCT00385671|3601394|FG002|Overall Study|Lost to Follow-up|5
2031577|NCT00385671|3601392|FG000|Overall Study|Physician Decision|2
2031578|NCT00385671|3601393|FG001|Overall Study|Physician Decision|1
2031579|NCT00385671|3601394|FG002|Overall Study|Physician Decision|2
2031580|NCT00385671|3601392|FG000|Overall Study|Protocol Violation|5
2031581|NCT00385671|3601393|FG001|Overall Study|Protocol Violation|2
2031582|NCT00385671|3601394|FG002|Overall Study|Protocol Violation|1
2031583|NCT00385671|3601392|FG000|Overall Study|Sponsor Decision|2
2031584|NCT00385671|3601393|FG001|Overall Study|Sponsor Decision|2
2031585|NCT00385671|3601394|FG002|Overall Study|Sponsor Decision|1
2031586|NCT00385671|3601392|FG000|Overall Study|Withdrawal by Subject|4
2110867|NCT00896532|3705481|FG015|Months 24-36: Denosumab Extension Phase|Other|0
2110868|NCT00896532|3705482|FG016|Months 24-36: Denosumab Extension Phase|Other|0
2110869|NCT00896532|3705483|FG017|Months 24-36: Denosumab Extension Phase|Other|0
2110870|NCT00896532|3705484|FG018|Months 24-36: Denosumab Extension Phase|Other|0
2110871|NCT00896532|3705485|FG019|Months 24-36: Denosumab Extension Phase|Other|0
2110872|NCT00896532|3705486|FG020|Months 24-36: Denosumab Extension Phase|Other|0
2110873|NCT00896532|3705487|FG021|Months 24-36: Denosumab Extension Phase|Other|0
2110874|NCT00896532|3705488|FG022|Months 24-36: Denosumab Extension Phase|Other|0
2110875|NCT00896532|3705466|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110876|NCT00896532|3705467|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110877|NCT00896532|3705468|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110878|NCT00896532|3705469|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110879|NCT00896532|3705470|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110880|NCT00896532|3705471|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110881|NCT00896532|3705472|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110882|NCT00896532|3705473|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110883|NCT00896532|3705474|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110884|NCT00896532|3705475|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110885|NCT00896532|3705476|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110886|NCT00896532|3705477|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110887|NCT00896532|3705478|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110888|NCT00896532|3705479|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110889|NCT00896532|3705480|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110890|NCT00896532|3705481|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1
2031587|NCT00385671|3601393|FG001|Overall Study|Withdrawal by Subject|4
2031588|NCT00385671|3601394|FG002|Overall Study|Withdrawal by Subject|4
2031589|NCT00385684|3601404|FG000|FIRST INTERVENTION OF PHASE A|Death|1
2031590|NCT00385684|3601405|FG001|FIRST INTERVENTION OF PHASE A|Death|0
2031591|NCT00385684|3601404|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0
2031592|NCT00385684|3601405|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1
2031593|NCT00385684|3601404|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0
2031594|NCT00385684|3601405|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1
2031595|NCT00385723|3601414|FG000|Overall Study|Lost to Follow-up|1
2031596|NCT00385723|3601415|FG001|Overall Study|Lost to Follow-up|1
2031597|NCT00385723|3601416|FG002|Overall Study|Lost to Follow-up|0
2031598|NCT00385723|3601414|FG000|Overall Study|Withdrawal by Subject|1
2031599|NCT00385723|3601415|FG001|Overall Study|Withdrawal by Subject|0
2031600|NCT00385723|3601416|FG002|Overall Study|Withdrawal by Subject|2
2031601|NCT00385736|3601427|FG000|Efficacy Analysis Set - Induction|Adverse Event|5
2031602|NCT00385736|3601428|FG001|Efficacy Analysis Set - Induction|Adverse Event|6
2031603|NCT00385736|3601429|FG002|Efficacy Analysis Set - Induction|Adverse Event|4
2031604|NCT00385736|3601427|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
2031605|NCT00385736|3601428|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
2031606|NCT00385736|3601429|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
2031607|NCT00385736|3601427|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0
2031608|NCT00385736|3601428|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2
2031609|NCT00385736|3601429|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0
2031610|NCT00385736|3601427|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4
2031611|NCT00385736|3601428|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2
2031612|NCT00385736|3601429|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1
2031613|NCT00385736|3601427|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0
2031614|NCT00385736|3601428|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0
2031615|NCT00385736|3601429|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2
2031616|NCT00385736|3601427|FG000|Efficacy Analysis Set - Induction|Other|0
2031617|NCT00385736|3601428|FG001|Efficacy Analysis Set - Induction|Other|0
2031618|NCT00385736|3601429|FG002|Efficacy Analysis Set - Induction|Other|1
2031619|NCT00385736|3601427|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23
2031620|NCT00385736|3601428|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15
2031621|NCT00385736|3601429|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23
2031622|NCT00385736|3601427|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
2031623|NCT00385736|3601428|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
2180379|NCT01401361|3806523|FG000|Overall Study|Withdrawal by Subject|16
2031624|NCT00385736|3601429|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
2031625|NCT00385736|3601427|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
2031626|NCT00385736|3601428|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
2031627|NCT00385736|3601429|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
2031628|NCT00385736|3601427|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
2031629|NCT00385736|3601428|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
2031630|NCT00385736|3601429|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
2031631|NCT00385736|3601427|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2
2031632|NCT00385736|3601428|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1
2031633|NCT00385736|3601429|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6
2031634|NCT00385736|3601427|FG000|Efficacy Analysis Set - Maintenance|Other|0
2031635|NCT00385736|3601428|FG001|Efficacy Analysis Set - Maintenance|Other|4
2031636|NCT00385736|3601429|FG002|Efficacy Analysis Set - Maintenance|Other|4
2031637|NCT00385736|3601427|FG000|Safety Analysis Set|Adverse Event|23
2031638|NCT00385736|3601428|FG001|Safety Analysis Set|Adverse Event|15
2031639|NCT00385736|3601429|FG002|Safety Analysis Set|Adverse Event|23
2031640|NCT00385736|3601427|FG000|Safety Analysis Set|Withdrawal by Subject|6
2031641|NCT00385736|3601428|FG001|Safety Analysis Set|Withdrawal by Subject|6
2031642|NCT00385736|3601429|FG002|Safety Analysis Set|Withdrawal by Subject|14
2031643|NCT00385736|3601427|FG000|Safety Analysis Set|Lost to Follow-up|0
2031644|NCT00385736|3601428|FG001|Safety Analysis Set|Lost to Follow-up|2
2031645|NCT00385736|3601429|FG002|Safety Analysis Set|Lost to Follow-up|2
2031646|NCT00385736|3601427|FG000|Safety Analysis Set|Lack of Efficacy|38
2031647|NCT00385736|3601428|FG001|Safety Analysis Set|Lack of Efficacy|16
2031648|NCT00385736|3601429|FG002|Safety Analysis Set|Lack of Efficacy|31
2031649|NCT00385736|3601427|FG000|Safety Analysis Set|Protocol Violation|2
2031650|NCT00385736|3601428|FG001|Safety Analysis Set|Protocol Violation|1
2031651|NCT00385736|3601429|FG002|Safety Analysis Set|Protocol Violation|6
2031652|NCT00385736|3601427|FG000|Safety Analysis Set|Other|1
2031653|NCT00385736|3601428|FG001|Safety Analysis Set|Other|4
2031654|NCT00385736|3601429|FG002|Safety Analysis Set|Other|4
2031655|NCT00385762|3601440|FG000|Overall Study|Adverse Event|1
2031656|NCT00385762|3601440|FG000|Overall Study|Lost to Follow-up|1
2031657|NCT00385827|3601466|FG000|Part 1|Adverse Event|1
2031658|NCT00385827|3601467|FG001|Part 1|Adverse Event|0
2031659|NCT00385827|3601468|FG002|Part 1|Adverse Event|0
2031660|NCT00385827|3601466|FG000|Part 1|Death|2
2031661|NCT00385827|3601467|FG001|Part 1|Death|0
2031662|NCT00385827|3601468|FG002|Part 1|Death|0
2031663|NCT00385827|3601466|FG000|Part 1|Lack of Efficacy|5
2031664|NCT00385827|3601467|FG001|Part 1|Lack of Efficacy|0
2031665|NCT00385827|3601468|FG002|Part 1|Lack of Efficacy|0
2031666|NCT00385827|3601466|FG000|Part 1|Other|1
2031667|NCT00385827|3601467|FG001|Part 1|Other|0
2031668|NCT00385827|3601468|FG002|Part 1|Other|0
2031669|NCT00385827|3601466|FG000|Part 2|Adverse Event|0
2031670|NCT00385827|3601467|FG001|Part 2|Adverse Event|6
2031671|NCT00385827|3601468|FG002|Part 2|Adverse Event|10
2031672|NCT00385827|3601466|FG000|Part 2|Death|0
2031673|NCT00385827|3601467|FG001|Part 2|Death|0
2031674|NCT00385827|3601468|FG002|Part 2|Death|2
2031675|NCT00385827|3601466|FG000|Part 2|Lack of Efficacy|0
2031676|NCT00385827|3601467|FG001|Part 2|Lack of Efficacy|14
2031677|NCT00385827|3601468|FG002|Part 2|Lack of Efficacy|13
2031678|NCT00385827|3601466|FG000|Part 2|Randomized but not treated|0
2031679|NCT00385827|3601467|FG001|Part 2|Randomized but not treated|2
2031680|NCT00385827|3601468|FG002|Part 2|Randomized but not treated|2
2031681|NCT00385827|3601466|FG000|Part 2|Other|0
2031682|NCT00385827|3601467|FG001|Part 2|Other|11
2031683|NCT00385827|3601468|FG002|Part 2|Other|21
2031684|NCT00385840|3601480|FG000|Overall Study|Adverse Event|1
2031685|NCT00385840|3601481|FG001|Overall Study|Adverse Event|1
2031686|NCT00385840|3601480|FG000|Overall Study|Lost to Follow-up|3
2031687|NCT00385840|3601481|FG001|Overall Study|Lost to Follow-up|13
2110891|NCT00896532|3705482|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3
2110892|NCT00896532|3705483|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110893|NCT00896532|3705484|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2031688|NCT00385918|3601489|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
2031689|NCT00385918|3601490|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
2031690|NCT00385918|3601491|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
2031691|NCT00385918|3601489|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
2031692|NCT00385918|3601490|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
2031693|NCT00385918|3601491|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
2031694|NCT00385918|3601489|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0
2031695|NCT00385918|3601490|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0
2031696|NCT00385918|3601491|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1
2031697|NCT00385918|3601489|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1
2031698|NCT00385918|3601490|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0
2031699|NCT00385918|3601491|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0
2031700|NCT00385918|3601489|FG000|Intervention Phase After Randomization|Physician Decision|1
2031701|NCT00385918|3601490|FG001|Intervention Phase After Randomization|Physician Decision|0
2031702|NCT00385918|3601491|FG002|Intervention Phase After Randomization|Physician Decision|0
2031703|NCT00385918|3601489|FG000|Intervention Phase After Randomization|Lost to Follow-up|1
2031704|NCT00385918|3601490|FG001|Intervention Phase After Randomization|Lost to Follow-up|0
2031705|NCT00385918|3601491|FG002|Intervention Phase After Randomization|Lost to Follow-up|0
2031706|NCT00385944|3601500|FG000|1st Maintenance Dose Period|Physician Decision|1
2031707|NCT00385944|3601501|FG001|1st Maintenance Dose Period|Physician Decision|0
2031708|NCT00385944|3601502|FG002|1st Maintenance Dose Period|Physician Decision|0
2031709|NCT00385944|3601500|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0
2031710|NCT00385944|3601501|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1
2031711|NCT00385944|3601502|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0
2031712|NCT00385944|3601500|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
2031713|NCT00385944|3601501|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
2031714|NCT00385944|3601502|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
2031715|NCT00385944|3601500|FG000|2nd Maintenance Dose Period|Invalid PD Data|2
2031716|NCT00385944|3601501|FG001|2nd Maintenance Dose Period|Invalid PD Data|3
2031717|NCT00385944|3601502|FG002|2nd Maintenance Dose Period|Invalid PD Data|0
2031718|NCT00386009|3601524|FG000|Overall Study|Adverse Event|0
2031719|NCT00386009|3601525|FG001|Overall Study|Adverse Event|2
2031720|NCT00386009|3601524|FG000|Overall Study|Death|1
2031721|NCT00386009|3601525|FG001|Overall Study|Death|0
2031722|NCT00386009|3601524|FG000|Overall Study|Entry Criteria Not Met|0
2031723|NCT00386009|3601525|FG001|Overall Study|Entry Criteria Not Met|2
2031724|NCT00386009|3601524|FG000|Overall Study|Lost to Follow-up|1
2031725|NCT00386009|3601525|FG001|Overall Study|Lost to Follow-up|1
2031726|NCT00386009|3601524|FG000|Overall Study|Protocol Violation|1
2031727|NCT00386009|3601525|FG001|Overall Study|Protocol Violation|0
2031728|NCT00386009|3601524|FG000|Overall Study|Sponsor Decision|1
2031729|NCT00386009|3601525|FG001|Overall Study|Sponsor Decision|1
2031730|NCT00386009|3601524|FG000|Overall Study|Withdrawal by Subject|5
2031731|NCT00386009|3601525|FG001|Overall Study|Withdrawal by Subject|4
2031732|NCT00386022|3601533|FG000|Plus Estrogen|Lost to Follow-up|2
2031733|NCT00386022|3601534|FG001|Plus Estrogen|Lost to Follow-up|0
2031734|NCT00386022|3601533|FG000|Plus Estrogen|Adverse Event|0
2031735|NCT00386022|3601534|FG001|Plus Estrogen|Adverse Event|1
2031736|NCT00386100|3601544|FG000|Overall Study|Did not receive study medication|6
2031737|NCT00386100|3601545|FG001|Overall Study|Did not receive study medication|4
2031738|NCT00386100|3601544|FG000|Overall Study|Adverse Event|15
2031739|NCT00386100|3601545|FG001|Overall Study|Adverse Event|25
2031740|NCT00386100|3601544|FG000|Overall Study|Death|0
2031741|NCT00386100|3601545|FG001|Overall Study|Death|1
2031742|NCT00386100|3601544|FG000|Overall Study|Insufficient therapeutic effect|30
2031743|NCT00386100|3601545|FG001|Overall Study|Insufficient therapeutic effect|6
2031744|NCT00386100|3601544|FG000|Overall Study|Lost to Follow-up|29
2031745|NCT00386100|3601545|FG001|Overall Study|Lost to Follow-up|29
2031746|NCT00386100|3601544|FG000|Overall Study|Non-compliance|18
2031747|NCT00386100|3601545|FG001|Overall Study|Non-compliance|19
2031748|NCT00386100|3601544|FG000|Overall Study|Protocol Violation|5
2031749|NCT00386100|3601545|FG001|Overall Study|Protocol Violation|3
2031750|NCT00386100|3601544|FG000|Overall Study|Withdrawal by Subject|32
2031751|NCT00386100|3601545|FG001|Overall Study|Withdrawal by Subject|31
2031752|NCT00386100|3601544|FG000|Overall Study|Bone mass density (BMD) loss >6%|4
2031753|NCT00386100|3601545|FG001|Overall Study|Bone mass density (BMD) loss >6%|4
2031754|NCT00386100|3601544|FG000|Overall Study|BMD <2.5|1
2031755|NCT00386100|3601545|FG001|Overall Study|BMD <2.5|0
2031756|NCT00386100|3601544|FG000|Overall Study|Consecutive elevated Hba1C|1
2031757|NCT00386100|3601545|FG001|Overall Study|Consecutive elevated Hba1C|0
2031758|NCT00386100|3601544|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0
2031759|NCT00386100|3601545|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1
2031760|NCT00386100|3601544|FG000|Overall Study|Laboratory findings|1
2031761|NCT00386100|3601545|FG001|Overall Study|Laboratory findings|0
2031762|NCT00386100|3601544|FG000|Overall Study|Participant's concern due to CPK levels|1
2031763|NCT00386100|3601545|FG001|Overall Study|Participant's concern due to CPK levels|0
2031764|NCT00386100|3601544|FG000|Overall Study|Participant moving out of state|2
2031765|NCT00386100|3601545|FG001|Overall Study|Participant moving out of state|0
2031766|NCT00386100|3601544|FG000|Overall Study|Excessive bone loss vs. baseline value|0
2031767|NCT00386100|3601545|FG001|Overall Study|Excessive bone loss vs. baseline value|1
2031768|NCT00386100|3601544|FG000|Overall Study|Didn't meet entry criteria|1
2031769|NCT00386100|3601545|FG001|Overall Study|Didn't meet entry criteria|1
2031770|NCT00386100|3601544|FG000|Overall Study|Participant's PCP wanted to stop drug|1
2031771|NCT00386100|3601545|FG001|Overall Study|Participant's PCP wanted to stop drug|0
2031772|NCT00386100|3601544|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0
2031773|NCT00386100|3601545|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1
2180380|NCT01401361|3806523|FG000|Overall Study|Lack of Efficacy|6
2031774|NCT00386100|3601544|FG000|Overall Study|Bad metabolic control & patient security|1
2031775|NCT00386100|3601545|FG001|Overall Study|Bad metabolic control & patient security|0
2031776|NCT00386100|3601544|FG000|Overall Study|Bone loss by DXA bone scan|1
2031777|NCT00386100|3601545|FG001|Overall Study|Bone loss by DXA bone scan|0
2031778|NCT00386100|3601544|FG000|Overall Study|DBP 93 mmHg at randomization|1
2031779|NCT00386100|3601545|FG001|Overall Study|DBP 93 mmHg at randomization|0
2031780|NCT00386100|3601544|FG000|Overall Study|7.6% bone loss|1
2031781|NCT00386100|3601545|FG001|Overall Study|7.6% bone loss|0
2031782|NCT00386100|3601544|FG000|Overall Study|Osteoporosis|0
2031783|NCT00386100|3601545|FG001|Overall Study|Osteoporosis|1
2031784|NCT00386100|3601544|FG000|Overall Study|Positive pregnancy test|1
2031785|NCT00386100|3601545|FG001|Overall Study|Positive pregnancy test|3
2031786|NCT00386100|3601544|FG000|Overall Study|Out of country for 5 months|1
2031787|NCT00386100|3601545|FG001|Overall Study|Out of country for 5 months|0
2031788|NCT00386100|3601544|FG000|Overall Study|Hb1Ac >8%|0
2031789|NCT00386100|3601545|FG001|Overall Study|Hb1Ac >8%|1
2031790|NCT00386100|3601544|FG000|Overall Study|Participant randomized in error|1
2031791|NCT00386100|3601545|FG001|Overall Study|Participant randomized in error|0
2031792|NCT00386152|3601554|FG000|Overall Study|Adverse Event|6
2031793|NCT00386152|3601555|FG001|Overall Study|Adverse Event|5
2031794|NCT00386152|3601556|FG002|Overall Study|Adverse Event|4
2031795|NCT00386152|3601554|FG000|Overall Study|Chang from original chemo stratification|4
2031796|NCT00386152|3601555|FG001|Overall Study|Chang from original chemo stratification|5
2031797|NCT00386152|3601556|FG002|Overall Study|Chang from original chemo stratification|6
2031798|NCT00386152|3601554|FG000|Overall Study|Death|3
2031799|NCT00386152|3601555|FG001|Overall Study|Death|0
2031800|NCT00386152|3601556|FG002|Overall Study|Death|1
2031801|NCT00386152|3601554|FG000|Overall Study|Disease progression|7
2031802|NCT00386152|3601555|FG001|Overall Study|Disease progression|4
2031803|NCT00386152|3601556|FG002|Overall Study|Disease progression|5
2031804|NCT00386152|3601554|FG000|Overall Study|Physician Decision|13
2031805|NCT00386152|3601555|FG001|Overall Study|Physician Decision|10
2031806|NCT00386152|3601556|FG002|Overall Study|Physician Decision|4
2031807|NCT00386152|3601554|FG000|Overall Study|Lost to Follow-up|1
2031808|NCT00386152|3601555|FG001|Overall Study|Lost to Follow-up|0
2031809|NCT00386152|3601556|FG002|Overall Study|Lost to Follow-up|0
2031810|NCT00386152|3601554|FG000|Overall Study|Completed chemotherapy|4
2031811|NCT00386152|3601555|FG001|Overall Study|Completed chemotherapy|5
2031812|NCT00386152|3601556|FG002|Overall Study|Completed chemotherapy|1
2031813|NCT00386152|3601554|FG000|Overall Study|Protocol Violation|3
2031814|NCT00386152|3601555|FG001|Overall Study|Protocol Violation|5
2031815|NCT00386152|3601556|FG002|Overall Study|Protocol Violation|2
2031816|NCT00386152|3601554|FG000|Overall Study|Withdrawal by Subject|3
2031817|NCT00386152|3601555|FG001|Overall Study|Withdrawal by Subject|6
2031818|NCT00386152|3601556|FG002|Overall Study|Withdrawal by Subject|10
2110894|NCT00896532|3705485|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110895|NCT00896532|3705486|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110896|NCT00896532|3705487|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110897|NCT00896532|3705488|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2110898|NCT00896532|3705466|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110899|NCT00896532|3705467|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110900|NCT00896532|3705468|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110901|NCT00896532|3705469|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110902|NCT00896532|3705470|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110903|NCT00896532|3705471|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110904|NCT00896532|3705472|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110905|NCT00896532|3705473|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2180381|NCT01401361|3806523|FG000|Overall Study|Physician Decision|1
2331757|NCT03173313|4054511|FG001|Overall Study|Physician Decision|0
2218523|NCT01715805|3862073|FG000|Double-Blind or Continued Treatment|Protocol Violation|0
2218524|NCT01715805|3862074|FG001|Double-Blind or Continued Treatment|Protocol Violation|14
2218525|NCT01715805|3862075|FG002|Double-Blind or Continued Treatment|Protocol Violation|12
2218526|NCT01715805|3862076|FG003|Double-Blind or Continued Treatment|Protocol Violation|19
2218527|NCT01715805|3862073|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0
2218528|NCT01715805|3862074|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11
2218529|NCT01715805|3862075|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11
2218530|NCT01715805|3862076|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13
2218531|NCT01715805|3862073|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0
2218532|NCT01715805|3862074|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7
2031819|NCT00386308|3601592|FG000|Overall Study|Adverse Event|3
2031820|NCT00386308|3601593|FG001|Overall Study|Adverse Event|3
2031821|NCT00386308|3601592|FG000|Overall Study|Protocol Violation|2
2031822|NCT00386308|3601593|FG001|Overall Study|Protocol Violation|5
2218533|NCT01715805|3862075|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10
2218534|NCT01715805|3862076|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10
2218535|NCT01715805|3862073|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0
2218536|NCT01715805|3862074|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1
2218537|NCT01715805|3862075|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0
2218538|NCT01715805|3862076|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3
2031823|NCT00386308|3601592|FG000|Overall Study|Lack of Efficacy|0
2031824|NCT00386308|3601593|FG001|Overall Study|Lack of Efficacy|2
2031825|NCT00386308|3601592|FG000|Overall Study|Lost to Follow-up|10
2031826|NCT00386308|3601593|FG001|Overall Study|Lost to Follow-up|6
2031827|NCT00386308|3601592|FG000|Overall Study|Withdrawal by Subject|6
2031828|NCT00386308|3601593|FG001|Overall Study|Withdrawal by Subject|2
2031829|NCT00386308|3601592|FG000|Overall Study|Other Event|8
2031830|NCT00386308|3601593|FG001|Overall Study|Other Event|1
2031831|NCT00386334|3601601|FG000|Double Blind Period|Adverse Event|9
2031832|NCT00386334|3601602|FG001|Double Blind Period|Adverse Event|14
2218539|NCT01715805|3862073|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
2218540|NCT01715805|3862074|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
2218541|NCT01715805|3862075|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
2218542|NCT01715805|3862076|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
2031833|NCT00386334|3601601|FG000|Double Blind Period|Protocol Violation|1
2031834|NCT00386334|3601602|FG001|Double Blind Period|Protocol Violation|1
2031835|NCT00386334|3601601|FG000|Double Blind Period|Withdrawal by Subject|9
2031836|NCT00386334|3601602|FG001|Double Blind Period|Withdrawal by Subject|13
2031837|NCT00386334|3601601|FG000|Double Blind Period|Lack of Efficacy|20
2031838|NCT00386334|3601602|FG001|Double Blind Period|Lack of Efficacy|11
2031839|NCT00386334|3601601|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
2031840|NCT00386334|3601602|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
2031841|NCT00386334|3601601|FG000|Double Blind Period|Other|3
2031842|NCT00386334|3601602|FG001|Double Blind Period|Other|3
2031843|NCT00386334|3601601|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
2031844|NCT00386334|3601602|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
2031845|NCT00386360|3601610|FG000|Overall Study|Adverse Event|4
2031846|NCT00386360|3601611|FG001|Overall Study|Adverse Event|2
2031847|NCT00386360|3601610|FG000|Overall Study|Physician Decision|2
2031848|NCT00386360|3601611|FG001|Overall Study|Physician Decision|2
2031849|NCT00386360|3601610|FG000|Overall Study|Lost to Follow-up|0
2031850|NCT00386360|3601611|FG001|Overall Study|Lost to Follow-up|2
2031851|NCT00386360|3601610|FG000|Overall Study|Protocol Violation|0
2031852|NCT00386360|3601611|FG001|Overall Study|Protocol Violation|3
2031853|NCT00386360|3601610|FG000|Overall Study|Withdrawal by Subject|3
2110906|NCT00896532|3705474|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110907|NCT00896532|3705475|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2218543|NCT01715831|3862084|FG000|Overall Study|Adverse Event|1
2273911|NCT02291289|3954583|FG000|Maintenance Treatment Phase|Multiple Reasons|0
2273912|NCT02291289|3954584|FG001|Maintenance Treatment Phase|Multiple Reasons|0
2273913|NCT02291289|3954585|FG002|Maintenance Treatment Phase|Multiple Reasons|0
2273914|NCT02291289|3954586|FG003|Maintenance Treatment Phase|Multiple Reasons|0
2273915|NCT02291289|3954587|FG004|Maintenance Treatment Phase|Multiple Reasons|4
2273916|NCT02291289|3954588|FG005|Maintenance Treatment Phase|Multiple Reasons|1
2273917|NCT02291289|3954589|FG006|Maintenance Treatment Phase|Multiple Reasons|0
2273918|NCT02291289|3954590|FG007|Maintenance Treatment Phase|Multiple Reasons|0
2273919|NCT02291289|3954591|FG008|Maintenance Treatment Phase|Multiple Reasons|0
2273920|NCT02291289|3954592|FG009|Maintenance Treatment Phase|Multiple Reasons|0
2273921|NCT02291289|3954593|FG010|Maintenance Treatment Phase|Multiple Reasons|0
2273922|NCT02291289|3954594|FG011|Maintenance Treatment Phase|Multiple Reasons|0
2273923|NCT02291289|3954583|FG000|Maintenance Treatment Phase|No Treatment Received|0
2273924|NCT02291289|3954584|FG001|Maintenance Treatment Phase|No Treatment Received|0
2273925|NCT02291289|3954585|FG002|Maintenance Treatment Phase|No Treatment Received|2
2273926|NCT02291289|3954586|FG003|Maintenance Treatment Phase|No Treatment Received|0
2273927|NCT02291289|3954587|FG004|Maintenance Treatment Phase|No Treatment Received|4
2273928|NCT02291289|3954588|FG005|Maintenance Treatment Phase|No Treatment Received|5
2273929|NCT02291289|3954589|FG006|Maintenance Treatment Phase|No Treatment Received|0
2273930|NCT02291289|3954590|FG007|Maintenance Treatment Phase|No Treatment Received|0
2273931|NCT02291289|3954591|FG008|Maintenance Treatment Phase|No Treatment Received|0
2273932|NCT02291289|3954592|FG009|Maintenance Treatment Phase|No Treatment Received|0
2273933|NCT02291289|3954593|FG010|Maintenance Treatment Phase|No Treatment Received|1
2273934|NCT02291289|3954594|FG011|Maintenance Treatment Phase|No Treatment Received|0
2218544|NCT01715857|3862088|FG000|Overall Study|Did Not Meet Eligibility Criteria|96
2218545|NCT01715896|3862099|FG000|Overall Study|Lost to Follow-up|0
2218546|NCT01715896|3862100|FG001|Overall Study|Lost to Follow-up|2
2218547|NCT01715896|3862099|FG000|Overall Study|Withdrawal by Subject|1
2218548|NCT01715896|3862100|FG001|Overall Study|Withdrawal by Subject|4
2218549|NCT01715896|3862099|FG000|Overall Study|Other|2
2218550|NCT01715896|3862100|FG001|Overall Study|Other|5
2218551|NCT01716104|3862152|FG000|Overall Study|Do not meet inclusion criteria|6
2218552|NCT01716104|3862153|FG001|Overall Study|Do not meet inclusion criteria|7
2218553|NCT01716117|3862161|FG000|Overall Study|Death|5
2218554|NCT01716117|3862162|FG001|Overall Study|Death|2
2218555|NCT01716117|3862161|FG000|Overall Study|Withdrawal by Subject|2
2218556|NCT01716117|3862162|FG001|Overall Study|Withdrawal by Subject|0
2218557|NCT01716156|3862179|FG000|Overall Study|Protocol Violation|1
2218558|NCT01716156|3862180|FG001|Overall Study|Protocol Violation|0
2218559|NCT01716156|3862181|FG002|Overall Study|Protocol Violation|0
2218560|NCT01716156|3862179|FG000|Overall Study|Withdrawal by Subject|0
2218561|NCT01716156|3862180|FG001|Overall Study|Withdrawal by Subject|1
2218562|NCT01716156|3862181|FG002|Overall Study|Withdrawal by Subject|2
2218563|NCT01716156|3862179|FG000|Overall Study|Lost to Follow-up|1
2218564|NCT01716156|3862180|FG001|Overall Study|Lost to Follow-up|0
2218565|NCT01716156|3862181|FG002|Overall Study|Lost to Follow-up|0
2218566|NCT01716169|3862193|FG000|Overall Study|Adverse Event|1
2218567|NCT01716169|3862193|FG000|Overall Study|Lost to Follow-up|1
2218568|NCT01716169|3862193|FG000|Overall Study|Withdrawal by Subject|1
2218569|NCT01716169|3862193|FG000|Overall Study|inconsistent dressing application|1
2218570|NCT01716234|3862230|FG000|Overall Study|Protocol Violation|0
2218571|NCT01716234|3862231|FG001|Overall Study|Protocol Violation|0
2218572|NCT01716234|3862232|FG002|Overall Study|Protocol Violation|0
2031854|NCT00386360|3601611|FG001|Overall Study|Withdrawal by Subject|6
2031855|NCT00386360|3601610|FG000|Overall Study|Did not take any study medication|0
2031856|NCT00386360|3601611|FG001|Overall Study|Did not take any study medication|2
2031857|NCT00386425|3601620|FG000|Overall Study|Physician Decision|3
2031858|NCT00386425|3601621|FG001|Overall Study|Physician Decision|0
2031859|NCT00386425|3601622|FG002|Overall Study|Physician Decision|0
2031860|NCT00386425|3601620|FG000|Overall Study|Withdrawal by Subject|0
2031861|NCT00386425|3601621|FG001|Overall Study|Withdrawal by Subject|1
2031862|NCT00386425|3601622|FG002|Overall Study|Withdrawal by Subject|0
2031863|NCT00386607|3601643|FG000|Core|Adverse Event|40
2031864|NCT00386607|3601644|FG001|Core|Adverse Event|0
2031865|NCT00386607|3601643|FG000|Core|Abnormal laboratory value(s)|3
2031866|NCT00386607|3601644|FG001|Core|Abnormal laboratory value(s)|0
2218573|NCT01716234|3862233|FG003|Overall Study|Protocol Violation|1
2218574|NCT01716234|3862234|FG004|Overall Study|Protocol Violation|1
2218575|NCT01716234|3862235|FG005|Overall Study|Protocol Violation|1
2218576|NCT01716234|3862236|FG006|Overall Study|Protocol Violation|0
2218577|NCT01716234|3862230|FG000|Overall Study|Lack of Efficacy|0
2218578|NCT01716234|3862231|FG001|Overall Study|Lack of Efficacy|0
2218579|NCT01716234|3862232|FG002|Overall Study|Lack of Efficacy|0
2218580|NCT01716234|3862233|FG003|Overall Study|Lack of Efficacy|1
2218581|NCT01716234|3862234|FG004|Overall Study|Lack of Efficacy|0
2218582|NCT01716234|3862235|FG005|Overall Study|Lack of Efficacy|0
2218583|NCT01716234|3862236|FG006|Overall Study|Lack of Efficacy|0
2218584|NCT01716234|3862230|FG000|Overall Study|Did not meet protocol eligibility|0
2218585|NCT01716234|3862231|FG001|Overall Study|Did not meet protocol eligibility|0
2031867|NCT00386607|3601643|FG000|Core|Unsatisfactory therapeutic effect|23
2031868|NCT00386607|3601644|FG001|Core|Unsatisfactory therapeutic effect|0
2031869|NCT00386607|3601643|FG000|Core|Condition no longer requires study drug|4
2031870|NCT00386607|3601644|FG001|Core|Condition no longer requires study drug|0
2031871|NCT00386607|3601643|FG000|Core|Patient withdrew consent|15
2031872|NCT00386607|3601644|FG001|Core|Patient withdrew consent|0
2031873|NCT00386607|3601643|FG000|Core|Lost to Follow-up|23
2031874|NCT00386607|3601644|FG001|Core|Lost to Follow-up|0
2031875|NCT00386607|3601643|FG000|Core|Administrative problems|1
2031876|NCT00386607|3601644|FG001|Core|Administrative problems|0
2031877|NCT00386607|3601643|FG000|Core|Protocol Deviation|6
2031878|NCT00386607|3601644|FG001|Core|Protocol Deviation|0
2031879|NCT00386607|3601643|FG000|Extension|Adverse Event|0
2031880|NCT00386607|3601644|FG001|Extension|Adverse Event|6
2031881|NCT00386607|3601643|FG000|Extension|Abnormal laboratory value(s)|0
2031882|NCT00386607|3601644|FG001|Extension|Abnormal laboratory value(s)|1
2031883|NCT00386607|3601643|FG000|Extension|Administrative problems|0
2031884|NCT00386607|3601644|FG001|Extension|Administrative problems|1
2110908|NCT00896532|3705476|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110909|NCT00896532|3705477|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110910|NCT00896532|3705478|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110911|NCT00896532|3705479|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110912|NCT00896532|3705480|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110913|NCT00896532|3705481|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
2110914|NCT00896532|3705482|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
2110915|NCT00896532|3705483|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
2110916|NCT00896532|3705484|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110917|NCT00896532|3705485|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110918|NCT00896532|3705486|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110919|NCT00896532|3705487|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110920|NCT00896532|3705488|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2110921|NCT00896532|3705466|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110922|NCT00896532|3705467|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110923|NCT00896532|3705468|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110924|NCT00896532|3705469|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110925|NCT00896532|3705470|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110926|NCT00896532|3705471|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110927|NCT00896532|3705472|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110928|NCT00896532|3705473|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110929|NCT00896532|3705474|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110930|NCT00896532|3705475|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110931|NCT00896532|3705476|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110932|NCT00896532|3705477|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110933|NCT00896532|3705478|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110934|NCT00896532|3705479|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110935|NCT00896532|3705480|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110936|NCT00896532|3705481|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110937|NCT00896532|3705482|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
2110938|NCT00896532|3705483|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110939|NCT00896532|3705484|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110940|NCT00896532|3705485|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110941|NCT00896532|3705486|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110942|NCT00896532|3705487|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110943|NCT00896532|3705488|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2110944|NCT00896532|3705466|FG000|Months 36-48: Romosozumab Retreatment|Other|0
2110945|NCT00896532|3705467|FG001|Months 36-48: Romosozumab Retreatment|Other|0
2110946|NCT00896532|3705468|FG002|Months 36-48: Romosozumab Retreatment|Other|0
2110947|NCT00896532|3705469|FG003|Months 36-48: Romosozumab Retreatment|Other|0
2110948|NCT00896532|3705470|FG004|Months 36-48: Romosozumab Retreatment|Other|0
2031885|NCT00386607|3601643|FG000|Extension|Lost to Follow-up|0
2031886|NCT00386607|3601644|FG001|Extension|Lost to Follow-up|3
2031887|NCT00386607|3601643|FG000|Extension|Patient withdrew consent|0
2031888|NCT00386607|3601644|FG001|Extension|Patient withdrew consent|5
2031889|NCT00386607|3601643|FG000|Extension|Unsatisfactory therapeutic effect|0
2031890|NCT00386607|3601644|FG001|Extension|Unsatisfactory therapeutic effect|1
2031891|NCT00386776|3601656|FG000|Overall Study|Withdrawal by Subject|8
2031892|NCT00387010|3601668|FG000|Dose Titration Period|Adverse Event|12
2031893|NCT00387010|3601668|FG000|Dose Titration Period|Lack of Efficacy|5
2031894|NCT00387010|3601668|FG000|Dose Titration Period|Withdrawal by Subject|3
2031895|NCT00387010|3601668|FG000|Dose Titration Period|Protocol Violation|1
2031896|NCT00387010|3601668|FG000|Dose Titration Period|Lost to Follow-up|2
2031897|NCT00387010|3601668|FG000|Dose Titration Period|Noncompliance with study medication|8
2031898|NCT00387010|3601668|FG000|Dose Titration Period|Noncompliance with study procedures|7
2031899|NCT00387010|3601668|FG000|Treatment Period|Adverse Event|4
2031900|NCT00387010|3601668|FG000|Treatment Period|Withdrawal by Subject|1
2031901|NCT00387010|3601668|FG000|Treatment Period|Noncompliance with study medication|2
2031902|NCT00387010|3601668|FG000|Treatment Period|Noncompliance with study procedures|3
2031903|NCT00387010|3601668|FG000|Treatment Period|Participant reported study drug stolen|1
2031904|NCT00387088|3601685|FG000|Overall Study|Adverse Event|143
2031905|NCT00387088|3601686|FG001|Overall Study|Adverse Event|156
2031906|NCT00387088|3601685|FG000|Overall Study|Protocol Violation|47
2031907|NCT00387088|3601686|FG001|Overall Study|Protocol Violation|35
2031908|NCT00387088|3601685|FG000|Overall Study|Withdrawal by Subject|20
2031909|NCT00387088|3601686|FG001|Overall Study|Withdrawal by Subject|35
2031910|NCT00387088|3601685|FG000|Overall Study|Lack of Efficacy|28
2031911|NCT00387088|3601686|FG001|Overall Study|Lack of Efficacy|67
2031912|NCT00387088|3601685|FG000|Overall Study|Lost to Follow-up|22
2031913|NCT00387088|3601686|FG001|Overall Study|Lost to Follow-up|28
2031914|NCT00387088|3601685|FG000|Overall Study|Other|58
2031915|NCT00387088|3601686|FG001|Overall Study|Other|52
2031916|NCT00387127|3601694|FG000|Overall Study|Lost to Follow-up|0
2031917|NCT00387127|3601695|FG001|Overall Study|Lost to Follow-up|4
2031918|NCT00387127|3601694|FG000|Overall Study|Death|16
2031919|NCT00387127|3601695|FG001|Overall Study|Death|16
2031920|NCT00387127|3601694|FG000|Overall Study|Physician Decision|0
2031921|NCT00387127|3601695|FG001|Overall Study|Physician Decision|1
2031922|NCT00387127|3601694|FG000|Overall Study|Withdrawal by Subject|3
2031923|NCT00387127|3601695|FG001|Overall Study|Withdrawal by Subject|2
2031924|NCT00387127|3601694|FG000|Overall Study|Required by Protocol Amendment #4|12
2031925|NCT00387127|3601695|FG001|Overall Study|Required by Protocol Amendment #4|10
2031926|NCT00387127|3601694|FG000|Overall Study|Serious Adverse Event|1
2031927|NCT00387127|3601695|FG001|Overall Study|Serious Adverse Event|1
2031928|NCT00387127|3601694|FG000|Overall Study|Sponsor Unblinded|1
2031929|NCT00387127|3601695|FG001|Overall Study|Sponsor Unblinded|0
2031930|NCT00387153|3601703|FG000|Overall Study|Adverse Event|1
2031931|NCT00387153|3601703|FG000|Overall Study|Disease Progression|3
2031932|NCT00387153|3601703|FG000|Overall Study|Lack of Response|4
2031933|NCT00387348|3601719|FG000|Overall Study|Death|1
2031934|NCT00387348|3601720|FG001|Overall Study|Death|1
2031935|NCT00387348|3601721|FG002|Overall Study|Death|0
2031936|NCT00387348|3601719|FG000|Overall Study|Physician Decision|1
2031937|NCT00387348|3601720|FG001|Overall Study|Physician Decision|0
2031938|NCT00387348|3601721|FG002|Overall Study|Physician Decision|1
2031939|NCT00387348|3601719|FG000|Overall Study|Withdrawal by Subject|0
2031940|NCT00387348|3601720|FG001|Overall Study|Withdrawal by Subject|2
2031941|NCT00387348|3601721|FG002|Overall Study|Withdrawal by Subject|2
2031942|NCT00387348|3601719|FG000|Overall Study|Adverse Event|1
2031943|NCT00387348|3601720|FG001|Overall Study|Adverse Event|0
2110949|NCT00896532|3705471|FG005|Months 36-48: Romosozumab Retreatment|Other|0
2110950|NCT00896532|3705472|FG006|Months 36-48: Romosozumab Retreatment|Other|0
2110951|NCT00896532|3705473|FG007|Months 36-48: Romosozumab Retreatment|Other|0
2110952|NCT00896532|3705474|FG008|Months 36-48: Romosozumab Retreatment|Other|0
2110953|NCT00896532|3705475|FG009|Months 36-48: Romosozumab Retreatment|Other|0
2110954|NCT00896532|3705476|FG010|Months 36-48: Romosozumab Retreatment|Other|0
2110955|NCT00896532|3705477|FG011|Months 36-48: Romosozumab Retreatment|Other|0
2110956|NCT00896532|3705478|FG012|Months 36-48: Romosozumab Retreatment|Other|0
2110957|NCT00896532|3705479|FG013|Months 36-48: Romosozumab Retreatment|Other|0
2110958|NCT00896532|3705480|FG014|Months 36-48: Romosozumab Retreatment|Other|0
2031944|NCT00387348|3601721|FG002|Overall Study|Adverse Event|1
2031945|NCT00387426|3601734|FG000|Overall Study|Lack of Response|7
2031946|NCT00387426|3601734|FG000|Overall Study|Toxicities|4
2031947|NCT00387426|3601734|FG000|Overall Study|Disease Progression|3
2031948|NCT00387465|3601741|FG000|Overall Study|Withdrawal by Subject|0
2031949|NCT00387465|3601742|FG001|Overall Study|Withdrawal by Subject|1
2031950|NCT00387465|3601743|FG002|Overall Study|Withdrawal by Subject|0
2031951|NCT00387647|3601767|FG000|Overall Study|Death|18
2031952|NCT00387712|3601782|FG000|Overall Study|Physician Decision|6
2031953|NCT00387712|3601783|FG001|Overall Study|Physician Decision|4
2031954|NCT00387712|3601782|FG000|Overall Study|Lost to Follow-up|17
2031955|NCT00387712|3601783|FG001|Overall Study|Lost to Follow-up|20
2031956|NCT00387712|3601782|FG000|Overall Study|Withdrawal by Subject|6
2031957|NCT00387712|3601783|FG001|Overall Study|Withdrawal by Subject|12
2031958|NCT00387725|3601793|FG000|Overall Study|Adverse Event|0
2031959|NCT00387725|3601794|FG001|Overall Study|Adverse Event|0
2031960|NCT00387725|3601795|FG002|Overall Study|Adverse Event|0
2031961|NCT00387725|3601796|FG003|Overall Study|Adverse Event|1
2031962|NCT00387725|3601793|FG000|Overall Study|Protocol Violation|0
2031963|NCT00387725|3601794|FG001|Overall Study|Protocol Violation|1
2031964|NCT00387725|3601795|FG002|Overall Study|Protocol Violation|0
2031965|NCT00387725|3601796|FG003|Overall Study|Protocol Violation|0
2031966|NCT00387725|3601793|FG000|Overall Study|Withdrawal by Subject|1
2031967|NCT00387725|3601794|FG001|Overall Study|Withdrawal by Subject|0
2031968|NCT00387725|3601795|FG002|Overall Study|Withdrawal by Subject|1
2031969|NCT00387725|3601796|FG003|Overall Study|Withdrawal by Subject|0
2031970|NCT00387725|3601793|FG000|Overall Study|Parent/legal guardian request|0
2031971|NCT00387725|3601794|FG001|Overall Study|Parent/legal guardian request|0
2031972|NCT00387725|3601795|FG002|Overall Study|Parent/legal guardian request|1
2031973|NCT00387725|3601796|FG003|Overall Study|Parent/legal guardian request|1
2031974|NCT00387764|3601812|FG000|Overall Study|Adverse Event|12
2031975|NCT00387764|3601812|FG000|Overall Study|Withdrawal by Subject|8
2031976|NCT00387764|3601812|FG000|Overall Study|Sponsor Terminated Study|1
2031977|NCT00387764|3601812|FG000|Overall Study|Physician Decision|1
2031978|NCT00387764|3601812|FG000|Overall Study|Other|2
2031979|NCT00387764|3601812|FG000|Overall Study|Death|7
2031980|NCT00387790|3601816|FG000|Overall Study|Adverse Event|5
2031981|NCT00387790|3601816|FG000|Overall Study|Lack of Efficacy|2
2031982|NCT00387790|3601816|FG000|Overall Study|Physician Decision|2
2031983|NCT00387790|3601816|FG000|Overall Study|Withdrawal by Subject|3
2031984|NCT00387790|3601816|FG000|Overall Study|Ineligible for study|2
2110959|NCT00896532|3705481|FG015|Months 36-48: Romosozumab Retreatment|Other|0
2110960|NCT00896532|3705482|FG016|Months 36-48: Romosozumab Retreatment|Other|0
2110961|NCT00896532|3705483|FG017|Months 36-48: Romosozumab Retreatment|Other|1
2110962|NCT00896532|3705484|FG018|Months 36-48: Romosozumab Retreatment|Other|0
2110963|NCT00896532|3705485|FG019|Months 36-48: Romosozumab Retreatment|Other|0
2110964|NCT00896532|3705486|FG020|Months 36-48: Romosozumab Retreatment|Other|0
2110965|NCT00896532|3705487|FG021|Months 36-48: Romosozumab Retreatment|Other|0
2110966|NCT00896532|3705488|FG022|Months 36-48: Romosozumab Retreatment|Other|0
2110967|NCT00896532|3705466|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110968|NCT00896532|3705467|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110969|NCT00896532|3705468|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110970|NCT00896532|3705469|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2031985|NCT00387881|3601831|FG000|Overall Study|Lost to Follow-up|23
2031986|NCT00387881|3601832|FG001|Overall Study|Lost to Follow-up|23
2031987|NCT00387881|3601831|FG000|Overall Study|Protocol Violation|2
2031988|NCT00387881|3601832|FG001|Overall Study|Protocol Violation|12
2031989|NCT00387881|3601831|FG000|Overall Study|Withdrawal by Subject|15
2031990|NCT00387881|3601832|FG001|Overall Study|Withdrawal by Subject|18
2031991|NCT00387881|3601831|FG000|Overall Study|Sponsor terminated Study|0
2031992|NCT00387881|3601832|FG001|Overall Study|Sponsor terminated Study|1
2031993|NCT00387881|3601831|FG000|Overall Study|Not eligible|6
2031994|NCT00387881|3601832|FG001|Overall Study|Not eligible|7
2031995|NCT00387881|3601831|FG000|Overall Study|No opportunity to treat headache|32
2031996|NCT00387881|3601832|FG001|Overall Study|No opportunity to treat headache|34
2031997|NCT00387881|3601831|FG000|Overall Study|Not otherwise specified|11
2031998|NCT00387881|3601832|FG001|Overall Study|Not otherwise specified|7
2031999|NCT00387894|3601838|FG000|Overall Study|Withdrawal by Subject|1
2032000|NCT00388037|3601846|FG000|Overall Study|Protocol Violation|1
2032001|NCT00388154|3601850|FG000|Overall Study|Withdrawal by Subject|1
2032002|NCT00388297|3601858|FG000|Overall Study|Lost to Follow-up|16
2032003|NCT00388297|3601859|FG001|Overall Study|Lost to Follow-up|12
2032004|NCT00388297|3601860|FG002|Overall Study|Lost to Follow-up|11
2032005|NCT00388297|3601861|FG003|Overall Study|Lost to Follow-up|8
2110971|NCT00896532|3705470|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110972|NCT00896532|3705471|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110973|NCT00896532|3705472|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110974|NCT00896532|3705473|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110975|NCT00896532|3705474|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110976|NCT00896532|3705475|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110977|NCT00896532|3705476|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110978|NCT00896532|3705477|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110979|NCT00896532|3705478|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2180382|NCT01401361|3806523|FG000|Overall Study|Lost to Follow-up|3
2032006|NCT00388349|3601871|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0
2032007|NCT00388349|3601872|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3
2032008|NCT00388362|3601880|FG000|Enrolled|Ineligible|1
2032009|NCT00388362|3601880|FG000|Enrolled|Adverse Event|9
2032010|NCT00388362|3601880|FG000|Enrolled|Death|1
2032011|NCT00388362|3601880|FG000|Enrolled|Loss insurance|1
2032012|NCT00388362|3601880|FG000|Enrolled|Withdrawal by Subject|1
2032013|NCT00388362|3601880|FG000|Remained on Study Median of 514 Days|Death|2
2032014|NCT00388505|3601910|FG000|Overall Study|Adverse Event or Death|43
2032015|NCT00388505|3601911|FG001|Overall Study|Adverse Event or Death|17
2032016|NCT00388505|3601910|FG000|Overall Study|Withdrawal by Subject|24
2032017|NCT00388505|3601911|FG001|Overall Study|Withdrawal by Subject|9
2032018|NCT00388505|3601910|FG000|Overall Study|Lost to Follow-up|5
2032019|NCT00388505|3601911|FG001|Overall Study|Lost to Follow-up|3
2032020|NCT00388505|3601910|FG000|Overall Study|Inappropriate Enrollment|0
2032021|NCT00388505|3601911|FG001|Overall Study|Inappropriate Enrollment|1
2032022|NCT00388505|3601910|FG000|Overall Study|Administrative Reason|1
2032023|NCT00388505|3601911|FG001|Overall Study|Administrative Reason|0
2032024|NCT00388505|3601910|FG000|Overall Study|Protocol Violation|6
2032025|NCT00388505|3601911|FG001|Overall Study|Protocol Violation|5
2032026|NCT00388505|3601910|FG000|Overall Study|Unable to classify|4
2032027|NCT00388505|3601911|FG001|Overall Study|Unable to classify|3
2032028|NCT00388583|3601919|FG000|Overall Study|Protocol Violation|1
2110980|NCT00896532|3705479|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110981|NCT00896532|3705480|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110982|NCT00896532|3705481|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110983|NCT00896532|3705482|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
2110984|NCT00896532|3705483|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110985|NCT00896532|3705484|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110986|NCT00896532|3705485|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110987|NCT00896532|3705486|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110988|NCT00896532|3705487|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110989|NCT00896532|3705488|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2110990|NCT00896532|3705466|FG000|Months 48-72: Follow-on Phase|Death|0
2110991|NCT00896532|3705467|FG001|Months 48-72: Follow-on Phase|Death|0
2110992|NCT00896532|3705468|FG002|Months 48-72: Follow-on Phase|Death|0
2110993|NCT00896532|3705469|FG003|Months 48-72: Follow-on Phase|Death|0
2110994|NCT00896532|3705470|FG004|Months 48-72: Follow-on Phase|Death|0
2110995|NCT00896532|3705471|FG005|Months 48-72: Follow-on Phase|Death|0
2110996|NCT00896532|3705472|FG006|Months 48-72: Follow-on Phase|Death|0
2110997|NCT00896532|3705473|FG007|Months 48-72: Follow-on Phase|Death|0
2110998|NCT00896532|3705474|FG008|Months 48-72: Follow-on Phase|Death|0
2110999|NCT00896532|3705475|FG009|Months 48-72: Follow-on Phase|Death|0
2111000|NCT00896532|3705476|FG010|Months 48-72: Follow-on Phase|Death|0
2111001|NCT00896532|3705477|FG011|Months 48-72: Follow-on Phase|Death|0
2111002|NCT00896532|3705478|FG012|Months 48-72: Follow-on Phase|Death|0
2111003|NCT00896532|3705479|FG013|Months 48-72: Follow-on Phase|Death|0
2111004|NCT00896532|3705480|FG014|Months 48-72: Follow-on Phase|Death|0
2111005|NCT00896532|3705481|FG015|Months 48-72: Follow-on Phase|Death|0
2111006|NCT00896532|3705482|FG016|Months 48-72: Follow-on Phase|Death|0
2111007|NCT00896532|3705483|FG017|Months 48-72: Follow-on Phase|Death|0
2111008|NCT00896532|3705484|FG018|Months 48-72: Follow-on Phase|Death|1
2111009|NCT00896532|3705485|FG019|Months 48-72: Follow-on Phase|Death|0
2111010|NCT00896532|3705486|FG020|Months 48-72: Follow-on Phase|Death|0
2111011|NCT00896532|3705487|FG021|Months 48-72: Follow-on Phase|Death|0
2111012|NCT00896532|3705488|FG022|Months 48-72: Follow-on Phase|Death|0
2111013|NCT00896532|3705466|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111014|NCT00896532|3705467|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2032029|NCT00388583|3601920|FG001|Overall Study|Protocol Violation|0
2032030|NCT00388583|3601919|FG000|Overall Study|Withdrawal by Subject|3
2032031|NCT00388583|3601920|FG001|Overall Study|Withdrawal by Subject|3
2032032|NCT00388583|3601919|FG000|Overall Study|Serious Adverse Event|2
2032033|NCT00388583|3601920|FG001|Overall Study|Serious Adverse Event|0
2032034|NCT00388583|3601919|FG000|Overall Study|Did not receive vaccine|0
2032035|NCT00388583|3601920|FG001|Overall Study|Did not receive vaccine|1
2032036|NCT00388674|3601928|FG000|Initial Treatment|Administrative Reason by Sponsor|241
2032037|NCT00388674|3601929|FG001|Initial Treatment|Administrative Reason by Sponsor|158
2032038|NCT00388674|3601928|FG000|Initial Treatment|Adverse Event|22
2032039|NCT00388674|3601929|FG001|Initial Treatment|Adverse Event|87
2032040|NCT00388674|3601928|FG000|Initial Treatment|Death|215
2032041|NCT00388674|3601929|FG001|Initial Treatment|Death|216
2032042|NCT00388674|3601928|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11
2032043|NCT00388674|3601929|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17
2032044|NCT00388674|3601928|FG000|Initial Treatment|HCC|12
2032045|NCT00388674|3601929|FG001|Initial Treatment|HCC|20
2032046|NCT00388674|3601928|FG000|Initial Treatment|Lost to Follow-up|526
2032047|NCT00388674|3601929|FG001|Initial Treatment|Lost to Follow-up|624
2032048|NCT00388674|3601928|FG000|Initial Treatment|Malignancy (Non-HCC)|7
2032049|NCT00388674|3601929|FG001|Initial Treatment|Malignancy (Non-HCC)|3
2032050|NCT00388674|3601928|FG000|Initial Treatment|Never Treated with Study Medication|1
2032051|NCT00388674|3601929|FG001|Initial Treatment|Never Treated with Study Medication|7
2032052|NCT00388674|3601928|FG000|Initial Treatment|Non-Study related Comorbidities|3
2032053|NCT00388674|3601929|FG001|Initial Treatment|Non-Study related Comorbidities|4
2032054|NCT00388674|3601928|FG000|Initial Treatment|Not Defined|125
2032055|NCT00388674|3601929|FG001|Initial Treatment|Not Defined|172
2032056|NCT00388674|3601928|FG000|Initial Treatment|Partial or inadequate Treatment|112
2032057|NCT00388674|3601929|FG001|Initial Treatment|Partial or inadequate Treatment|472
2032058|NCT00388674|3601928|FG000|Initial Treatment|Pregnancy|26
2032059|NCT00388674|3601929|FG001|Initial Treatment|Pregnancy|16
2032060|NCT00388674|3601928|FG000|Initial Treatment|Study Drug Toxicity|5
2032061|NCT00388674|3601929|FG001|Initial Treatment|Study Drug Toxicity|92
2032062|NCT00388674|3601928|FG000|Initial Treatment|Participant Request|501
2032063|NCT00388674|3601929|FG001|Initial Treatment|Participant Request|673
2032064|NCT00388674|3601928|FG000|Initial Treatment|No Off-Treatment Status Data|11
2032065|NCT00388674|3601929|FG001|Initial Treatment|No Off-Treatment Status Data|13
2032066|NCT00388674|3601928|FG000|Initial Treatment|Not Reported|10
2032067|NCT00388674|3601929|FG001|Initial Treatment|Not Reported|12
2032068|NCT00388674|3601928|FG000|End of Study|Administrative Reason By Sponsor|299
2032069|NCT00388674|3601929|FG001|End of Study|Administrative Reason By Sponsor|253
2032070|NCT00388674|3601928|FG000|End of Study|Death|239
2032071|NCT00388674|3601929|FG001|End of Study|Death|262
2032072|NCT00388674|3601928|FG000|End of Study|HBV Disease Progression (Non-HCC)|3
2032073|NCT00388674|3601929|FG001|End of Study|HBV Disease Progression (Non-HCC)|9
2032074|NCT00388674|3601928|FG000|End of Study|HCC|8
2032075|NCT00388674|3601929|FG001|End of Study|HCC|7
2032076|NCT00388674|3601928|FG000|End of Study|Lost to Follow-up|587
2032077|NCT00388674|3601929|FG001|End of Study|Lost to Follow-up|715
2032078|NCT00388674|3601928|FG000|End of Study|Malignancy (Non-HCC)|1
2032079|NCT00388674|3601929|FG001|End of Study|Malignancy (Non-HCC)|1
2032080|NCT00388674|3601928|FG000|End of Study|Non-Study Related Comorbidities|3
2032081|NCT00388674|3601929|FG001|End of Study|Non-Study Related Comorbidities|4
2032082|NCT00388674|3601928|FG000|End of Study|Not Defined|135
2032083|NCT00388674|3601929|FG001|End of Study|Not Defined|214
2032084|NCT00388674|3601928|FG000|End of Study|Participant Withdrew Consent|437
2032085|NCT00388674|3601929|FG001|End of Study|Participant Withdrew Consent|673
2032086|NCT00388674|3601928|FG000|End of Study|No Off-Treatment Status Data|22
2032087|NCT00388674|3601929|FG001|End of Study|No Off-Treatment Status Data|30
2032088|NCT00388674|3601928|FG000|End of Study|Not Reported|0
2032089|NCT00388674|3601929|FG001|End of Study|Not Reported|1
2032090|NCT00388726|3601937|FG000|Overall Study|Adverse Event|50
2032091|NCT00388726|3601938|FG001|Overall Study|Adverse Event|24
2032092|NCT00388726|3601937|FG000|Overall Study|Progressive Disease|336
2032093|NCT00388726|3601938|FG001|Overall Study|Progressive Disease|153
2032094|NCT00388726|3601937|FG000|Overall Study|Clinical Progression|61
2032095|NCT00388726|3601938|FG001|Overall Study|Clinical Progression|36
2032096|NCT00388726|3601937|FG000|Overall Study|Withdrawal by Subject|10
2032097|NCT00388726|3601938|FG001|Overall Study|Withdrawal by Subject|7
2032098|NCT00388726|3601937|FG000|Overall Study|Administrative|6
2180383|NCT01401361|3806523|FG000|Overall Study|Subject/family decision post procedure|2
2032099|NCT00388726|3601938|FG001|Overall Study|Administrative|9
2032100|NCT00388726|3601937|FG000|Overall Study|Physician Decision|18
2032101|NCT00388726|3601938|FG001|Overall Study|Physician Decision|13
2032102|NCT00388726|3601937|FG000|Overall Study|Death|3
2032103|NCT00388726|3601938|FG001|Overall Study|Death|2
2032104|NCT00388947|3601953|FG000|Overall Study|Protocol Violation|47
2032105|NCT00388973|3601959|FG000|Overall Study|Adverse Event|16
2032106|NCT00388973|3601960|FG001|Overall Study|Adverse Event|6
2032107|NCT00388973|3601959|FG000|Overall Study|Lack of Efficacy|1
2032108|NCT00388973|3601960|FG001|Overall Study|Lack of Efficacy|12
2032109|NCT00388973|3601959|FG000|Overall Study|Protocol Violation|3
2032110|NCT00388973|3601960|FG001|Overall Study|Protocol Violation|0
2032111|NCT00388973|3601959|FG000|Overall Study|Withdrawal by Subject|14
2032112|NCT00388973|3601960|FG001|Overall Study|Withdrawal by Subject|17
2032113|NCT00388973|3601959|FG000|Overall Study|Study specific Discontinuation Criteria|0
2032114|NCT00388973|3601960|FG001|Overall Study|Study specific Discontinuation Criteria|1
2032115|NCT00388973|3601959|FG000|Overall Study|Did not complete 61 days of treatment|5
2032116|NCT00388973|3601960|FG001|Overall Study|Did not complete 61 days of treatment|4
2032117|NCT00388973|3601959|FG000|Overall Study|Left region|0
2032118|NCT00388973|3601960|FG001|Overall Study|Left region|1
2032119|NCT00388973|3601959|FG000|Overall Study|Did not complete 2-week follow-up visit|17
2032120|NCT00388973|3601960|FG001|Overall Study|Did not complete 2-week follow-up visit|17
2032121|NCT00389064|3601968|FG000|Overall Study|Adverse Event|11
2032122|NCT00389064|3601969|FG001|Overall Study|Adverse Event|3
2032123|NCT00389064|3601968|FG000|Overall Study|Lack of Efficacy|3
2032124|NCT00389064|3601969|FG001|Overall Study|Lack of Efficacy|14
2032125|NCT00389064|3601968|FG000|Overall Study|Withdrawal by Subject|17
2032126|NCT00389064|3601969|FG001|Overall Study|Withdrawal by Subject|27
2032127|NCT00389064|3601968|FG000|Overall Study|Physician Decision|2
2032128|NCT00389064|3601969|FG001|Overall Study|Physician Decision|2
2032129|NCT00389064|3601968|FG000|Overall Study|Lost to Follow-up|1
2032130|NCT00389064|3601969|FG001|Overall Study|Lost to Follow-up|2
2032131|NCT00389064|3601968|FG000|Overall Study|Protocol Violation|2
2032132|NCT00389064|3601969|FG001|Overall Study|Protocol Violation|0
2032133|NCT00389064|3601968|FG000|Overall Study|Multiple Reasons|9
2032134|NCT00389064|3601969|FG001|Overall Study|Multiple Reasons|11
2032135|NCT00389207|3601987|FG000|Overall Study|Adverse Event|26
2032136|NCT00389207|3601988|FG001|Overall Study|Adverse Event|32
2032137|NCT00389207|3601989|FG002|Overall Study|Adverse Event|10
2032138|NCT00389207|3601987|FG000|Overall Study|Protocol Violation|3
2032139|NCT00389207|3601988|FG001|Overall Study|Protocol Violation|1
2032140|NCT00389207|3601989|FG002|Overall Study|Protocol Violation|4
2032141|NCT00389207|3601987|FG000|Overall Study|Lost to Follow-up|12
2032142|NCT00389207|3601988|FG001|Overall Study|Lost to Follow-up|9
2111015|NCT00896532|3705468|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111016|NCT00896532|3705469|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111017|NCT00896532|3705470|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111018|NCT00896532|3705471|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111019|NCT00896532|3705472|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111020|NCT00896532|3705473|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111021|NCT00896532|3705474|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111022|NCT00896532|3705475|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111023|NCT00896532|3705476|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111024|NCT00896532|3705477|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111025|NCT00896532|3705478|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111026|NCT00896532|3705479|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111027|NCT00896532|3705480|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111028|NCT00896532|3705481|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111029|NCT00896532|3705482|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111030|NCT00896532|3705483|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111031|NCT00896532|3705484|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111032|NCT00896532|3705485|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2032143|NCT00389207|3601989|FG002|Overall Study|Lost to Follow-up|7
2032144|NCT00389207|3601987|FG000|Overall Study|Withdrawal by Subject|5
2032145|NCT00389207|3601988|FG001|Overall Study|Withdrawal by Subject|7
2032146|NCT00389207|3601989|FG002|Overall Study|Withdrawal by Subject|11
2032147|NCT00389207|3601987|FG000|Overall Study|Other|17
2032148|NCT00389207|3601988|FG001|Overall Study|Other|23
2032149|NCT00389207|3601989|FG002|Overall Study|Other|9
2032150|NCT00389324|3602002|FG000|Run-In Phase|Adverse Event|1
2032151|NCT00389324|3602002|FG000|Run-In Phase|Lost to Follow-up|1
2032152|NCT00389324|3602002|FG000|Run-In Phase|Withdrawal by Subject|1
2032153|NCT00389324|3602002|FG000|Subcutaneous Phase|Adverse Event|2
2111033|NCT00896532|3705486|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111034|NCT00896532|3705487|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1
2111035|NCT00896532|3705488|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2111036|NCT00896532|3705466|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111037|NCT00896532|3705467|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111038|NCT00896532|3705468|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111039|NCT00896532|3705469|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111040|NCT00896532|3705470|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111041|NCT00896532|3705471|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111042|NCT00896532|3705472|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111043|NCT00896532|3705473|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111044|NCT00896532|3705474|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111045|NCT00896532|3705475|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111046|NCT00896532|3705476|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111047|NCT00896532|3705477|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111048|NCT00896532|3705478|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111049|NCT00896532|3705479|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111050|NCT00896532|3705480|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111051|NCT00896532|3705481|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111052|NCT00896532|3705482|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111053|NCT00896532|3705483|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111054|NCT00896532|3705484|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2032154|NCT00389324|3602002|FG000|Subcutaneous Phase|Non-compliance with study medication|2
2032155|NCT00389324|3602002|FG000|Subcutaneous Phase|Withdrawal by Subject|2
2032156|NCT00389324|3602002|FG000|Subcutaneous Phase|Lost to Follow-up|1
2032157|NCT00389441|3602009|FG000|Overall Study|Adverse Event|7
2032158|NCT00389441|3602009|FG000|Overall Study|Death|4
2032159|NCT00389441|3602009|FG000|Overall Study|Lost to Follow-up|2
2032160|NCT00389441|3602009|FG000|Overall Study|Withdrawal by Subject|4
2032161|NCT00389441|3602009|FG000|Overall Study|Physician Decision|1
2032162|NCT00389441|3602009|FG000|Overall Study|Protocol Violation|1
2032163|NCT00389441|3602009|FG000|Overall Study|Global deterioration of health status|4
2032164|NCT00389441|3602009|FG000|Overall Study|Objective progression or relapse|26
2032165|NCT00389441|3602009|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
2032166|NCT00389441|3602009|FG000|Overall Study|Clinical progression|1
2032167|NCT00389519|3602051|FG000|Placebo Run-In|Did not meet blood pressure criteria|119
2032168|NCT00389519|3602052|FG001|Placebo Run-In|Did not meet blood pressure criteria|0
2032169|NCT00389519|3602053|FG002|Placebo Run-In|Did not meet blood pressure criteria|0
2032170|NCT00389519|3602054|FG003|Placebo Run-In|Did not meet blood pressure criteria|0
2032171|NCT00389519|3602051|FG000|Placebo Run-In|Withdrawal by Subject|19
2032172|NCT00389519|3602052|FG001|Placebo Run-In|Withdrawal by Subject|0
2032173|NCT00389519|3602053|FG002|Placebo Run-In|Withdrawal by Subject|0
2032174|NCT00389519|3602054|FG003|Placebo Run-In|Withdrawal by Subject|0
2032175|NCT00389519|3602051|FG000|Placebo Run-In|Reason not specified|40
2032176|NCT00389519|3602052|FG001|Placebo Run-In|Reason not specified|0
2032177|NCT00389519|3602053|FG002|Placebo Run-In|Reason not specified|0
2032178|NCT00389519|3602054|FG003|Placebo Run-In|Reason not specified|0
2032179|NCT00389519|3602051|FG000|Randomized|Did not receive study drug|2
2032180|NCT00389519|3602052|FG001|Randomized|Did not receive study drug|0
2032181|NCT00389519|3602053|FG002|Randomized|Did not receive study drug|0
2032182|NCT00389519|3602054|FG003|Randomized|Did not receive study drug|0
2032183|NCT00389519|3602051|FG000|Treated|Adverse Event|1
2032184|NCT00389519|3602052|FG001|Treated|Adverse Event|0
2032185|NCT00389519|3602053|FG002|Treated|Adverse Event|0
2032186|NCT00389519|3602054|FG003|Treated|Adverse Event|2
2032187|NCT00389519|3602051|FG000|Treated|Reason not specified|1
2032188|NCT00389519|3602052|FG001|Treated|Reason not specified|1
2032189|NCT00389519|3602053|FG002|Treated|Reason not specified|0
2032190|NCT00389519|3602054|FG003|Treated|Reason not specified|2
2032191|NCT00389597|3602077|FG000|Overall Study|Lost to Follow-up|8
2032192|NCT00389597|3602078|FG001|Overall Study|Lost to Follow-up|6
2032193|NCT00389597|3602079|FG002|Overall Study|Lost to Follow-up|4
2032194|NCT00389597|3602080|FG003|Overall Study|Lost to Follow-up|6
2032195|NCT00389831|3602105|FG000|Overall Study|Lack of Efficacy|0
2032196|NCT00389831|3602106|FG001|Overall Study|Lack of Efficacy|2
2111055|NCT00896532|3705485|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111056|NCT00896532|3705486|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111057|NCT00896532|3705487|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
2111058|NCT00896532|3705488|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2111059|NCT00896649|3705535|FG000|Overall Study|Physician Decision|1
2111060|NCT00896649|3705535|FG000|Overall Study|Pregnancy|1
2111061|NCT00896649|3705535|FG000|Overall Study|missing documentation|1
2111062|NCT00896649|3705535|FG000|Overall Study|technical difficulties|2
2111063|NCT00897390|3705549|FG000|Overall Study|Adverse Event|2
2111064|NCT00897390|3705549|FG000|Overall Study|No Longer Met Study Criteria|1
2111065|NCT00897390|3705549|FG000|Overall Study|Personal Reasons|1
2111066|NCT00897390|3705549|FG000|Overall Study|Did not Return for the Clinic Visit|2
2111067|NCT00897715|3705576|FG000|Overall Study|Lost to Follow-up|0
2111068|NCT00897715|3705577|FG001|Overall Study|Lost to Follow-up|1
2111069|NCT00897715|3705576|FG000|Overall Study|Physician Decision|1
2111070|NCT00897715|3705577|FG001|Overall Study|Physician Decision|0
2111071|NCT00897715|3705576|FG000|Overall Study|increased risk of infection|1
2111072|NCT00897715|3705577|FG001|Overall Study|increased risk of infection|0
2032197|NCT00389831|3602105|FG000|Overall Study|Did not receive treatment.|0
2032198|NCT00389831|3602106|FG001|Overall Study|Did not receive treatment.|2
2032199|NCT00389831|3602105|FG000|Overall Study|Other reasons|0
2111073|NCT00898443|3705593|FG000|Overall Study|Withdrawal by Subject|1
2032200|NCT00389831|3602106|FG001|Overall Study|Other reasons|2
2032201|NCT00389831|3602105|FG000|Overall Study|Lost to Follow-up|0
2032202|NCT00389831|3602106|FG001|Overall Study|Lost to Follow-up|1
2032203|NCT00390013|3602140|FG000|Phase 1|tired|0
2032204|NCT00390013|3602141|FG001|Phase 1|tired|0
2032205|NCT00390013|3602142|FG002|Phase 1|tired|0
2032206|NCT00390013|3602143|FG003|Phase 1|tired|1
2032207|NCT00390013|3602140|FG000|Phase 2 First Treatment|tired|1
2032208|NCT00390013|3602141|FG001|Phase 2 First Treatment|tired|0
2032209|NCT00390013|3602142|FG002|Phase 2 First Treatment|tired|0
2032210|NCT00390013|3602143|FG003|Phase 2 First Treatment|tired|0
2032211|NCT00390013|3602140|FG000|Phase 2 First Treatment|Withdrawal by Subject|0
2032212|NCT00390013|3602141|FG001|Phase 2 First Treatment|Withdrawal by Subject|1
2032213|NCT00390013|3602142|FG002|Phase 2 First Treatment|Withdrawal by Subject|0
2032214|NCT00390013|3602143|FG003|Phase 2 First Treatment|Withdrawal by Subject|0
2032215|NCT00390221|3602156|FG000|Overall Study|Lost to Follow-up|0
2032216|NCT00390221|3602157|FG001|Overall Study|Lost to Follow-up|3
2032217|NCT00390221|3602158|FG002|Overall Study|Lost to Follow-up|0
2032218|NCT00390221|3602156|FG000|Overall Study|Adverse Event|1
2032219|NCT00390221|3602157|FG001|Overall Study|Adverse Event|4
2032220|NCT00390221|3602158|FG002|Overall Study|Adverse Event|3
2032221|NCT00390221|3602156|FG000|Overall Study|Investigator Decision|0
2032222|NCT00390221|3602157|FG001|Overall Study|Investigator Decision|0
2032223|NCT00390221|3602158|FG002|Overall Study|Investigator Decision|1
2032224|NCT00390221|3602156|FG000|Overall Study|Withdrawal by Subject|13
2032225|NCT00390221|3602157|FG001|Overall Study|Withdrawal by Subject|9
2032226|NCT00390221|3602158|FG002|Overall Study|Withdrawal by Subject|7
2032227|NCT00390221|3602156|FG000|Overall Study|Subject Non-compliance|1
2032228|NCT00390221|3602157|FG001|Overall Study|Subject Non-compliance|0
2032229|NCT00390221|3602158|FG002|Overall Study|Subject Non-compliance|2
2032230|NCT00390221|3602156|FG000|Overall Study|Other|3
2032231|NCT00390221|3602157|FG001|Overall Study|Other|4
2032232|NCT00390221|3602158|FG002|Overall Study|Other|2
2032233|NCT00390299|3602177|FG000|Overall Study|Cancellation|1
2032234|NCT00390299|3602178|FG001|Overall Study|Cancellation|0
2032235|NCT00390299|3602179|FG002|Overall Study|Cancellation|0
2032236|NCT00390299|3602180|FG003|Overall Study|Cancellation|0
2032237|NCT00390299|3602181|FG004|Overall Study|Cancellation|0
2032238|NCT00390416|3602212|FG000|Overall Study|Withdrawal by Subject|1
2032239|NCT00390416|3602212|FG000|Overall Study|Not treated|3
2032240|NCT00390455|3602235|FG000|Overall Study|Adverse Event|17
2032241|NCT00390455|3602236|FG001|Overall Study|Adverse Event|3
2032242|NCT00390455|3602235|FG000|Overall Study|Withdrawal by Subject|8
2032243|NCT00390455|3602236|FG001|Overall Study|Withdrawal by Subject|8
2032244|NCT00390455|3602235|FG000|Overall Study|Alternate Treatment|0
2032245|NCT00390455|3602236|FG001|Overall Study|Alternate Treatment|1
2032246|NCT00390455|3602235|FG000|Overall Study|Other Medical Reasons|7
2032247|NCT00390455|3602236|FG001|Overall Study|Other Medical Reasons|11
2032248|NCT00390468|3602242|FG000|Overall Study|Protocol Violation|2
2032249|NCT00390468|3602242|FG000|Overall Study|Lack of Efficacy|1
2032250|NCT00390546|3602248|FG000|Overall Study|Renal impairment|1
2032251|NCT00390546|3602249|FG001|Overall Study|Renal impairment|0
2032252|NCT00390546|3602248|FG000|Overall Study|Physician Decision|5
2032253|NCT00390546|3602249|FG001|Overall Study|Physician Decision|5
2032254|NCT00390572|3602268|FG000|Overall Study|Lost to Follow-up|8
2032255|NCT00390572|3602269|FG001|Overall Study|Lost to Follow-up|4
2032256|NCT00390572|3602268|FG000|Overall Study|health condition|0
2032257|NCT00390572|3602269|FG001|Overall Study|health condition|1
2032258|NCT00390689|3602289|FG000|Overall Study|Adverse Event|2
2032259|NCT00390689|3602290|FG001|Overall Study|Adverse Event|5
2111074|NCT00898443|3705594|FG001|Overall Study|Withdrawal by Subject|0
2111075|NCT00898807|3705608|FG000|Overall Study|Withdrawal by Subject|5
2111076|NCT00898807|3705609|FG001|Overall Study|Withdrawal by Subject|3
2111077|NCT00898807|3705608|FG000|Overall Study|Family pressure to discontinue|2
2111078|NCT00898807|3705609|FG001|Overall Study|Family pressure to discontinue|2
2111079|NCT00898807|3705608|FG000|Overall Study|Lost to Follow-up|1
2111080|NCT00898807|3705609|FG001|Overall Study|Lost to Follow-up|3
2111081|NCT00898807|3705608|FG000|Overall Study|Death|0
2111082|NCT00898807|3705609|FG001|Overall Study|Death|1
2180384|NCT01401452|3806527|FG000|Overall Study|Adverse reaction|9
2180385|NCT01401452|3806527|FG000|Overall Study|Lost to Follow-up|12
2180386|NCT01401452|3806527|FG000|Overall Study|Lack of Efficacy|30
2180387|NCT01401452|3806527|FG000|Overall Study|Participant developed breast cancer|1
2180388|NCT01401452|3806527|FG000|Overall Study|Tx stopped due to financial reasons|1
2180389|NCT01401452|3806527|FG000|Overall Study|Tx stopped by psychiatrist|1
2111083|NCT00899353|3705628|FG000|Overall Study|Adverse Event|2
2032260|NCT00390689|3602291|FG002|Overall Study|Adverse Event|2
2032261|NCT00390689|3602289|FG000|Overall Study|Lack of Efficacy|0
2032262|NCT00390689|3602290|FG001|Overall Study|Lack of Efficacy|0
2032263|NCT00390689|3602291|FG002|Overall Study|Lack of Efficacy|1
2032264|NCT00390689|3602289|FG000|Overall Study|Protocol Violation|1
2032265|NCT00390689|3602290|FG001|Overall Study|Protocol Violation|0
2032266|NCT00390689|3602291|FG002|Overall Study|Protocol Violation|0
2032267|NCT00390689|3602289|FG000|Overall Study|Investigator's judgement|2
2032268|NCT00390689|3602290|FG001|Overall Study|Investigator's judgement|0
2032269|NCT00390689|3602291|FG002|Overall Study|Investigator's judgement|0
2032270|NCT00390780|3602310|FG000|Overall Study|Not completed|10
2032271|NCT00390780|3602311|FG001|Overall Study|Not completed|4
2032272|NCT00390780|3602310|FG000|Overall Study|Protocol Violation|6
2032273|NCT00390780|3602311|FG001|Overall Study|Protocol Violation|4
2032274|NCT00390780|3602310|FG000|Overall Study|Lost to Follow-up|3
2032275|NCT00390780|3602311|FG001|Overall Study|Lost to Follow-up|6
2032276|NCT00390780|3602310|FG000|Overall Study|Adverse Event|2
2032277|NCT00390780|3602311|FG001|Overall Study|Adverse Event|3
2032278|NCT00390780|3602310|FG000|Overall Study|Death|1
2032279|NCT00390780|3602311|FG001|Overall Study|Death|3
2032280|NCT00390780|3602310|FG000|Overall Study|Withdrawal by Subject|1
2032281|NCT00390780|3602311|FG001|Overall Study|Withdrawal by Subject|2
2111084|NCT00899353|3705628|FG000|Overall Study|Lost to Follow-up|1
2111085|NCT00899353|3705628|FG000|Overall Study|Withdrawal by Subject|2
2111086|NCT00899392|3705651|FG000|Overall Study|Subject didn't finish/partial pilot data|21
2111087|NCT00899392|3705652|FG001|Overall Study|Subject didn't finish/partial pilot data|24
2111088|NCT00899431|3705661|FG000|Overall Study|Physician Decision|1
2111089|NCT00899431|3705662|FG001|Overall Study|Physician Decision|0
2218586|NCT01716234|3862232|FG002|Overall Study|Did not meet protocol eligibility|1
2218587|NCT01716234|3862233|FG003|Overall Study|Did not meet protocol eligibility|0
2218588|NCT01716234|3862234|FG004|Overall Study|Did not meet protocol eligibility|0
2111090|NCT00899431|3705663|FG002|Overall Study|Physician Decision|0
2111091|NCT00899548|3705692|FG000|Overall Study|Physician Decision|3
2111092|NCT00899678|3705716|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6
2111093|NCT00899678|3705717|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0
2111094|NCT00899678|3705718|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0
2111095|NCT00899678|3705716|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
2111096|NCT00899678|3705717|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
2111097|NCT00899678|3705718|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
2111098|NCT00899678|3705716|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1
2111099|NCT00899678|3705717|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0
2111100|NCT00899678|3705718|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0
2111101|NCT00899678|3705716|FG000|Induction Period (Weeks 0 to 6)|Other reason|1
2111102|NCT00899678|3705717|FG001|Induction Period (Weeks 0 to 6)|Other reason|0
2111103|NCT00899678|3705718|FG002|Induction Period (Weeks 0 to 6)|Other reason|0
2111104|NCT00899678|3705716|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
2111105|NCT00899678|3705717|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
2111106|NCT00899678|3705718|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
2111107|NCT00899678|3705716|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
2111108|NCT00899678|3705717|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
2111109|NCT00899678|3705718|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
2111110|NCT00899678|3705716|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
2111111|NCT00899678|3705717|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
2032282|NCT00390780|3602310|FG000|Overall Study|Inclusion criteria not satisfied|0
2032283|NCT00390780|3602311|FG001|Overall Study|Inclusion criteria not satisfied|2
2032284|NCT00390780|3602310|FG000|Overall Study|Lost to follow up and other reasons|0
2032285|NCT00390780|3602311|FG001|Overall Study|Lost to follow up and other reasons|1
2032286|NCT00390780|3602310|FG000|Overall Study|Investigator decision, SAE, other reason|0
2032287|NCT00390780|3602311|FG001|Overall Study|Investigator decision, SAE, other reason|1
2218589|NCT01716234|3862235|FG005|Overall Study|Did not meet protocol eligibility|4
2218590|NCT01716234|3862236|FG006|Overall Study|Did not meet protocol eligibility|0
2032288|NCT00390780|3602310|FG000|Overall Study|SAE, death|0
2032289|NCT00390780|3602311|FG001|Overall Study|SAE, death|1
2032290|NCT00390806|3602319|FG000|Overall Study|Lost to Follow-up|7
2032291|NCT00390806|3602320|FG001|Overall Study|Lost to Follow-up|6
2032292|NCT00390806|3602319|FG000|Overall Study|Protocol Violation|2
2032293|NCT00390806|3602320|FG001|Overall Study|Protocol Violation|2
2032294|NCT00390806|3602319|FG000|Overall Study|Withdrawal by Subject|12
2032295|NCT00390806|3602320|FG001|Overall Study|Withdrawal by Subject|15
2032296|NCT00390806|3602319|FG000|Overall Study|Investigator Decision|4
2032297|NCT00390806|3602320|FG001|Overall Study|Investigator Decision|6
2032298|NCT00390806|3602319|FG000|Overall Study|Death|1
2032299|NCT00390806|3602320|FG001|Overall Study|Death|0
2032300|NCT00390806|3602319|FG000|Overall Study|Physician Decision|0
2032301|NCT00390806|3602320|FG001|Overall Study|Physician Decision|1
2032302|NCT00390806|3602319|FG000|Overall Study|Ongoing|4
2032303|NCT00390806|3602320|FG001|Overall Study|Ongoing|2
2032304|NCT00390858|3602328|FG000|Overall Study|Adverse Event|6
2032305|NCT00390858|3602329|FG001|Overall Study|Adverse Event|2
2032306|NCT00390858|3602328|FG000|Overall Study|Lack of Efficacy|0
2032307|NCT00390858|3602329|FG001|Overall Study|Lack of Efficacy|1
2032308|NCT00390858|3602328|FG000|Overall Study|Withdrawal by Subject|3
2032309|NCT00390858|3602329|FG001|Overall Study|Withdrawal by Subject|4
2032310|NCT00390884|3602337|FG000|Overall Study|Withdrawal by Subject|2
2032311|NCT00390884|3602338|FG001|Overall Study|Withdrawal by Subject|2
2032312|NCT00390910|3602347|FG000|Overall Study|Adverse Event|1
2032313|NCT00390910|3602348|FG001|Overall Study|Adverse Event|0
2032314|NCT00390910|3602349|FG002|Overall Study|Adverse Event|0
2032315|NCT00390910|3602347|FG000|Overall Study|Lost to Follow-up|0
2032316|NCT00390910|3602348|FG001|Overall Study|Lost to Follow-up|1
2032317|NCT00390910|3602349|FG002|Overall Study|Lost to Follow-up|5
2032318|NCT00390910|3602347|FG000|Overall Study|Withdrawal by Subject|1
2032319|NCT00390910|3602348|FG001|Overall Study|Withdrawal by Subject|3
2032320|NCT00390910|3602349|FG002|Overall Study|Withdrawal by Subject|2
2032321|NCT00390910|3602347|FG000|Overall Study|Migrated/moved from study area|0
2032322|NCT00390910|3602348|FG001|Overall Study|Migrated/moved from study area|0
2032323|NCT00390910|3602349|FG002|Overall Study|Migrated/moved from study area|3
2032324|NCT00391027|3602370|FG000|Overall Study|Adverse Event|8
2032325|NCT00391027|3602371|FG001|Overall Study|Adverse Event|8
2032326|NCT00391027|3602370|FG000|Overall Study|Lack of Efficacy|3
2032327|NCT00391027|3602371|FG001|Overall Study|Lack of Efficacy|0
2032328|NCT00391027|3602370|FG000|Overall Study|Withdrawal by Subject|10
2032329|NCT00391027|3602371|FG001|Overall Study|Withdrawal by Subject|1
2032330|NCT00391027|3602370|FG000|Overall Study|Other|4
2032331|NCT00391027|3602371|FG001|Overall Study|Other|3
2032332|NCT00391053|3602381|FG000|Overall Study|Serious Adverse Events|1
2032333|NCT00391053|3602382|FG001|Overall Study|Serious Adverse Events|0
2032334|NCT00391053|3602383|FG002|Overall Study|Serious Adverse Events|1
2032335|NCT00391053|3602384|FG003|Overall Study|Serious Adverse Events|4
2032336|NCT00391053|3602381|FG000|Overall Study|Protocol Violation|2
2032337|NCT00391053|3602382|FG001|Overall Study|Protocol Violation|0
2032338|NCT00391053|3602383|FG002|Overall Study|Protocol Violation|0
2032339|NCT00391053|3602384|FG003|Overall Study|Protocol Violation|0
2032340|NCT00391053|3602381|FG000|Overall Study|Lost to Follow-up|1
2032341|NCT00391053|3602382|FG001|Overall Study|Lost to Follow-up|0
2032342|NCT00391053|3602383|FG002|Overall Study|Lost to Follow-up|0
2032343|NCT00391053|3602384|FG003|Overall Study|Lost to Follow-up|5
2032344|NCT00391053|3602381|FG000|Overall Study|Withdrawal by Subject|5
2032345|NCT00391053|3602382|FG001|Overall Study|Withdrawal by Subject|1
2032346|NCT00391053|3602383|FG002|Overall Study|Withdrawal by Subject|1
2032347|NCT00391053|3602384|FG003|Overall Study|Withdrawal by Subject|1
2032348|NCT00391092|3602405|FG000|Overall Study|Death|78
2032349|NCT00391092|3602406|FG001|Overall Study|Death|81
2032350|NCT00391092|3602405|FG000|Overall Study|Lost to Follow-up|13
2032351|NCT00391092|3602406|FG001|Overall Study|Lost to Follow-up|18
2032352|NCT00391092|3602405|FG000|Overall Study|Alive on treatment|29
2032353|NCT00391092|3602406|FG001|Overall Study|Alive on treatment|33
2032354|NCT00391092|3602405|FG000|Overall Study|Alive in follow-up|88
2032355|NCT00391092|3602406|FG001|Overall Study|Alive in follow-up|84
2032356|NCT00391118|3602415|FG000|Overall Study|Adverse Event|3
2032357|NCT00391118|3602416|FG001|Overall Study|Adverse Event|10
2032358|NCT00391118|3602417|FG002|Overall Study|Adverse Event|7
2032359|NCT00391118|3602415|FG000|Overall Study|Lost to Follow-up|0
2032360|NCT00391118|3602416|FG001|Overall Study|Lost to Follow-up|2
2032361|NCT00391118|3602417|FG002|Overall Study|Lost to Follow-up|3
2032362|NCT00391118|3602415|FG000|Overall Study|Withdrawal by Subject|0
2032363|NCT00391118|3602416|FG001|Overall Study|Withdrawal by Subject|9
2032364|NCT00391118|3602417|FG002|Overall Study|Withdrawal by Subject|1
2032365|NCT00391118|3602415|FG000|Overall Study|Death|0
2032366|NCT00391118|3602416|FG001|Overall Study|Death|1
2032367|NCT00391118|3602417|FG002|Overall Study|Death|0
2032368|NCT00391118|3602415|FG000|Overall Study|Physician Decision|0
2032369|NCT00391118|3602416|FG001|Overall Study|Physician Decision|3
2032370|NCT00391118|3602417|FG002|Overall Study|Physician Decision|0
2032371|NCT00391118|3602415|FG000|Overall Study|Protocol Entry Criteria Not Met|0
2032372|NCT00391118|3602416|FG001|Overall Study|Protocol Entry Criteria Not Met|3
2032373|NCT00391118|3602417|FG002|Overall Study|Protocol Entry Criteria Not Met|1
2032374|NCT00391118|3602415|FG000|Overall Study|Progressive Disease|7
2032375|NCT00391118|3602416|FG001|Overall Study|Progressive Disease|26
2032376|NCT00391118|3602417|FG002|Overall Study|Progressive Disease|43
2032377|NCT00391118|3602415|FG000|Overall Study|Sponsor Decision|0
2032378|NCT00391118|3602416|FG001|Overall Study|Sponsor Decision|1
2032379|NCT00391118|3602417|FG002|Overall Study|Sponsor Decision|3
2032380|NCT00391118|3602415|FG000|Overall Study|Protocol Violation|1
2032381|NCT00391118|3602416|FG001|Overall Study|Protocol Violation|0
2032382|NCT00391118|3602417|FG002|Overall Study|Protocol Violation|0
2032383|NCT00391222|3602431|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
2218591|NCT01716234|3862230|FG000|Overall Study|Adverse Event|7
2032384|NCT00391222|3602432|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
2032385|NCT00391222|3602433|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
2032386|NCT00391222|3602434|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
2032387|NCT00391222|3602431|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
2032388|NCT00391222|3602432|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
2032389|NCT00391222|3602433|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
2032390|NCT00391222|3602434|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
2032391|NCT00391222|3602431|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0
2032392|NCT00391222|3602432|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0
2032393|NCT00391222|3602433|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0
2032394|NCT00391222|3602434|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10
2032395|NCT00391222|3602431|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0
2032396|NCT00391222|3602432|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0
2032397|NCT00391222|3602433|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0
2032398|NCT00391222|3602434|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97
2111112|NCT00899678|3705718|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
2111113|NCT00899678|3705716|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
2111114|NCT00899678|3705717|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
2032399|NCT00391222|3602431|FG000|Period II (Open-label Risperidone LAI)|Other|0
2032400|NCT00391222|3602432|FG001|Period II (Open-label Risperidone LAI)|Other|0
2032401|NCT00391222|3602433|FG002|Period II (Open-label Risperidone LAI)|Other|0
2032402|NCT00391222|3602434|FG003|Period II (Open-label Risperidone LAI)|Other|24
2032403|NCT00391222|3602431|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
2032404|NCT00391222|3602432|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
2032405|NCT00391222|3602433|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
2032406|NCT00391222|3602434|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
2032407|NCT00391222|3602431|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2
2032408|NCT00391222|3602432|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4
2032409|NCT00391222|3602433|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4
2032410|NCT00391222|3602434|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0
2032411|NCT00391222|3602431|FG000|Period III (Double-Blind Treatment)|Adverse Event|5
2032412|NCT00391222|3602432|FG001|Period III (Double-Blind Treatment)|Adverse Event|2
2032413|NCT00391222|3602433|FG002|Period III (Double-Blind Treatment)|Adverse Event|4
2032414|NCT00391222|3602434|FG003|Period III (Double-Blind Treatment)|Adverse Event|0
2032415|NCT00391222|3602431|FG000|Period III (Double-Blind Treatment)|Pregnancy|0
2032416|NCT00391222|3602432|FG001|Period III (Double-Blind Treatment)|Pregnancy|2
2032417|NCT00391222|3602433|FG002|Period III (Double-Blind Treatment)|Pregnancy|0
2032418|NCT00391222|3602434|FG003|Period III (Double-Blind Treatment)|Pregnancy|0
2032419|NCT00391222|3602431|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
2032420|NCT00391222|3602432|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
2032421|NCT00391222|3602433|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
2032422|NCT00391222|3602434|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
2032423|NCT00391222|3602431|FG000|Period III (Double-Blind Treatment)|Other|6
2032424|NCT00391222|3602432|FG001|Period III (Double-Blind Treatment)|Other|1
2032425|NCT00391222|3602433|FG002|Period III (Double-Blind Treatment)|Other|6
2032426|NCT00391222|3602434|FG003|Period III (Double-Blind Treatment)|Other|0
2032427|NCT00391274|3602446|FG000|Overall Study|Death Due to Study Disease|55
2032428|NCT00391274|3602447|FG001|Overall Study|Death Due to Study Disease|45
2032429|NCT00391274|3602446|FG000|Overall Study|Lost to Follow-up|0
2032430|NCT00391274|3602447|FG001|Overall Study|Lost to Follow-up|3
2032431|NCT00391274|3602446|FG000|Overall Study|Physician Decision|4
2032432|NCT00391274|3602447|FG001|Overall Study|Physician Decision|2
2032433|NCT00391274|3602446|FG000|Overall Study|Withdrawal by Subject|0
2032434|NCT00391274|3602447|FG001|Overall Study|Withdrawal by Subject|3
2032435|NCT00391274|3602446|FG000|Overall Study|Death Due to Adverse Event|1
2032436|NCT00391274|3602447|FG001|Overall Study|Death Due to Adverse Event|3
2032437|NCT00391274|3602446|FG000|Overall Study|Death Due to Indeterminate Cause|1
2032438|NCT00391274|3602447|FG001|Overall Study|Death Due to Indeterminate Cause|0
2032439|NCT00391274|3602446|FG000|Overall Study|Death Not Study Related|0
2032440|NCT00391274|3602447|FG001|Overall Study|Death Not Study Related|1
2032441|NCT00391391|3602467|FG000|Overall Study|Adverse Event|0
2032442|NCT00391391|3602468|FG001|Overall Study|Adverse Event|0
2032443|NCT00391391|3602469|FG002|Overall Study|Adverse Event|0
2032444|NCT00391391|3602470|FG003|Overall Study|Adverse Event|1
2032445|NCT00391391|3602467|FG000|Overall Study|Lost to Follow-up|1
2032446|NCT00391391|3602468|FG001|Overall Study|Lost to Follow-up|3
2032447|NCT00391391|3602469|FG002|Overall Study|Lost to Follow-up|7
2032448|NCT00391391|3602470|FG003|Overall Study|Lost to Follow-up|4
2032449|NCT00391391|3602467|FG000|Overall Study|Protocol Violation|2
2032450|NCT00391391|3602468|FG001|Overall Study|Protocol Violation|3
2032451|NCT00391391|3602469|FG002|Overall Study|Protocol Violation|6
2032452|NCT00391391|3602470|FG003|Overall Study|Protocol Violation|7
2032453|NCT00391391|3602467|FG000|Overall Study|Withdrawal by Subject|6
2032454|NCT00391391|3602468|FG001|Overall Study|Withdrawal by Subject|4
2032455|NCT00391391|3602469|FG002|Overall Study|Withdrawal by Subject|10
2032456|NCT00391391|3602470|FG003|Overall Study|Withdrawal by Subject|7
2111115|NCT00899678|3705718|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
2111116|NCT00899678|3705716|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0
2111117|NCT00899678|3705717|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2
2111118|NCT00899678|3705718|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2
2111119|NCT00899847|3705741|FG000|Overall Study|Lack of suitable allogeneic donor|2
2111120|NCT00900029|3705752|FG000|Overall Study|Lost to Follow-up|0
2111121|NCT00900029|3705753|FG001|Overall Study|Lost to Follow-up|2
2111122|NCT00900029|3705754|FG002|Overall Study|Lost to Follow-up|1
2111123|NCT00900029|3705755|FG003|Overall Study|Lost to Follow-up|4
2111124|NCT00900029|3705756|FG004|Overall Study|Lost to Follow-up|4
2111125|NCT00900029|3705752|FG000|Overall Study|Withdrawal by Subject|2
2111126|NCT00900029|3705753|FG001|Overall Study|Withdrawal by Subject|2
2111127|NCT00900029|3705754|FG002|Overall Study|Withdrawal by Subject|1
2111128|NCT00900029|3705755|FG003|Overall Study|Withdrawal by Subject|1
2111129|NCT00900029|3705756|FG004|Overall Study|Withdrawal by Subject|1
2111130|NCT00900029|3705752|FG000|Overall Study|Adverse Event|0
2111131|NCT00900029|3705753|FG001|Overall Study|Adverse Event|0
2111132|NCT00900029|3705754|FG002|Overall Study|Adverse Event|1
2111133|NCT00900029|3705755|FG003|Overall Study|Adverse Event|1
2111134|NCT00900029|3705756|FG004|Overall Study|Adverse Event|1
2111135|NCT00900029|3705752|FG000|Overall Study|Death|1
2111136|NCT00900029|3705753|FG001|Overall Study|Death|0
2111137|NCT00900029|3705754|FG002|Overall Study|Death|0
2111138|NCT00900029|3705755|FG003|Overall Study|Death|1
2111139|NCT00900029|3705756|FG004|Overall Study|Death|0
2032457|NCT00391586|3602502|FG000|Overall Study|Progressive disease|13
2032458|NCT00391586|3602502|FG000|Overall Study|Adverse Event|5
2032459|NCT00391586|3602502|FG000|Overall Study|Physician Decision|2
2032460|NCT00391586|3602502|FG000|Overall Study|Death|4
2032461|NCT00391625|3602517|FG000|Month 14|Withdrawal by Subject|1
2032462|NCT00391625|3602517|FG000|Month 50|Physician Decision|1
2032463|NCT00391768|3602564|FG000|Overall Study|Withdrawal by Subject|0
2032464|NCT00391768|3602565|FG001|Overall Study|Withdrawal by Subject|0
2032465|NCT00391768|3602566|FG002|Overall Study|Withdrawal by Subject|1
2032466|NCT00391768|3602567|FG003|Overall Study|Withdrawal by Subject|0
2032467|NCT00391768|3602568|FG004|Overall Study|Withdrawal by Subject|0
2032468|NCT00391768|3602569|FG005|Overall Study|Withdrawal by Subject|1
2032469|NCT00391768|3602570|FG006|Overall Study|Withdrawal by Subject|1
2032470|NCT00391768|3602564|FG000|Overall Study|Lost to Follow-up|0
2032471|NCT00391768|3602565|FG001|Overall Study|Lost to Follow-up|0
2032472|NCT00391768|3602566|FG002|Overall Study|Lost to Follow-up|0
2032473|NCT00391768|3602567|FG003|Overall Study|Lost to Follow-up|1
2032474|NCT00391768|3602568|FG004|Overall Study|Lost to Follow-up|2
2032475|NCT00391768|3602569|FG005|Overall Study|Lost to Follow-up|2
2032476|NCT00391768|3602570|FG006|Overall Study|Lost to Follow-up|3
2032477|NCT00391807|3602604|FG000|Overall Study|Did not receive study medication|23
2032478|NCT00391807|3602604|FG000|Overall Study|Adverse Event|177
2032479|NCT00391807|3602604|FG000|Overall Study|Pregnancy|25
2032480|NCT00391807|3602604|FG000|Overall Study|Lost to Follow-up|227
2032481|NCT00391807|3602604|FG000|Overall Study|Withdrawal by Subject|147
2032482|NCT00391807|3602604|FG000|Overall Study|Protocol Violation|20
2032483|NCT00391807|3602604|FG000|Overall Study|Various|96
2032484|NCT00391846|3602610|FG000|Overall Study|Adverse Event|4
2032485|NCT00391846|3602611|FG001|Overall Study|Adverse Event|1
2032486|NCT00391846|3602610|FG000|Overall Study|Did not meet the required elig. crit|2
2032487|NCT00391846|3602611|FG001|Overall Study|Did not meet the required elig. crit|2
2032488|NCT00391846|3602610|FG000|Overall Study|Withdrawal by Subject|2
2032489|NCT00391846|3602611|FG001|Overall Study|Withdrawal by Subject|3
2032490|NCT00391846|3602610|FG000|Overall Study|Developed study specific DC criteria|0
2032491|NCT00391846|3602611|FG001|Overall Study|Developed study specific DC criteria|1
2032492|NCT00391872|3602619|FG000|Overall Study|Protocol Violation|7
2032493|NCT00391872|3602620|FG001|Overall Study|Protocol Violation|2
2032494|NCT00391872|3602619|FG000|Overall Study|Withdrawal by Subject|296
2032495|NCT00391872|3602620|FG001|Overall Study|Withdrawal by Subject|249
2032496|NCT00391872|3602619|FG000|Overall Study|Reason unknown|2
2032497|NCT00391872|3602620|FG001|Overall Study|Reason unknown|4
2032498|NCT00391872|3602619|FG000|Overall Study|Lost to Follow-up|2
2032499|NCT00391872|3602620|FG001|Overall Study|Lost to Follow-up|0
2032500|NCT00391898|3602628|FG000|Overall Study|Adverse Event|3
2032501|NCT00391898|3602629|FG001|Overall Study|Adverse Event|0
2032502|NCT00391898|3602628|FG000|Overall Study|Other|8
2032503|NCT00391898|3602629|FG001|Overall Study|Other|10
2032504|NCT00391976|3602638|FG000|Overall Study|Adverse Event|0
2032505|NCT00391976|3602639|FG001|Overall Study|Adverse Event|0
2032506|NCT00391976|3602640|FG002|Overall Study|Adverse Event|1
2032507|NCT00391976|3602638|FG000|Overall Study|Withdrawal of consent|0
2032508|NCT00391976|3602639|FG001|Overall Study|Withdrawal of consent|1
2032509|NCT00391976|3602640|FG002|Overall Study|Withdrawal of consent|1
2032510|NCT00391976|3602638|FG000|Overall Study|Lost to Follow-up|1
2032511|NCT00391976|3602639|FG001|Overall Study|Lost to Follow-up|2
2032512|NCT00391976|3602640|FG002|Overall Study|Lost to Follow-up|0
2032513|NCT00391976|3602638|FG000|Overall Study|Inappropriate enrollment|1
2032514|NCT00391976|3602639|FG001|Overall Study|Inappropriate enrollment|1
2032515|NCT00391976|3602640|FG002|Overall Study|Inappropriate enrollment|0
2032516|NCT00391976|3602638|FG000|Overall Study|Protocol deviation/violation|4
2032517|NCT00391976|3602639|FG001|Overall Study|Protocol deviation/violation|2
2032518|NCT00391976|3602640|FG002|Overall Study|Protocol deviation/violation|1
2032519|NCT00391976|3602638|FG000|Overall Study|Recurrence/no eradication of infection|21
2032520|NCT00391976|3602639|FG001|Overall Study|Recurrence/no eradication of infection|19
2180390|NCT01401452|3806527|FG000|Overall Study|No more visits within the 36 wk followup|4
2180391|NCT01401452|3806527|FG000|Overall Study|Subject did not come to follow up visits|2
2218592|NCT01716234|3862231|FG001|Overall Study|Adverse Event|10
2032521|NCT00391976|3602640|FG002|Overall Study|Recurrence/no eradication of infection|0
2032522|NCT00391976|3602638|FG000|Overall Study|Unable to classify|0
2032523|NCT00391976|3602639|FG001|Overall Study|Unable to classify|0
2032524|NCT00391976|3602640|FG002|Overall Study|Unable to classify|1
2032525|NCT00391976|3602638|FG000|Overall Study|Positive P. aeruginosa antibody test|0
2032526|NCT00391976|3602639|FG001|Overall Study|Positive P. aeruginosa antibody test|0
2032527|NCT00391976|3602640|FG002|Overall Study|Positive P. aeruginosa antibody test|31
2032528|NCT00392015|3602660|FG000|Overall Study|Lost to Follow-up|2
2032529|NCT00392015|3602661|FG001|Overall Study|Lost to Follow-up|0
2032530|NCT00392015|3602662|FG002|Overall Study|Lost to Follow-up|2
2032531|NCT00392015|3602663|FG003|Overall Study|Lost to Follow-up|1
2032532|NCT00392015|3602664|FG004|Overall Study|Lost to Follow-up|1
2032533|NCT00392015|3602665|FG005|Overall Study|Lost to Follow-up|0
2032534|NCT00392015|3602660|FG000|Overall Study|Withdrawal by Subject|0
2032535|NCT00392015|3602661|FG001|Overall Study|Withdrawal by Subject|0
2032536|NCT00392015|3602662|FG002|Overall Study|Withdrawal by Subject|2
2032537|NCT00392015|3602663|FG003|Overall Study|Withdrawal by Subject|0
2032538|NCT00392015|3602664|FG004|Overall Study|Withdrawal by Subject|0
2032539|NCT00392015|3602665|FG005|Overall Study|Withdrawal by Subject|0
2032540|NCT00392015|3602660|FG000|Overall Study|Adverse Event|0
2032541|NCT00392015|3602661|FG001|Overall Study|Adverse Event|0
2032542|NCT00392015|3602662|FG002|Overall Study|Adverse Event|0
2032543|NCT00392015|3602663|FG003|Overall Study|Adverse Event|0
2032544|NCT00392015|3602664|FG004|Overall Study|Adverse Event|1
2032545|NCT00392015|3602665|FG005|Overall Study|Adverse Event|0
2032546|NCT00392015|3602660|FG000|Overall Study|Previous trial recipient|0
2032547|NCT00392015|3602661|FG001|Overall Study|Previous trial recipient|0
2032548|NCT00392015|3602662|FG002|Overall Study|Previous trial recipient|0
2032549|NCT00392015|3602663|FG003|Overall Study|Previous trial recipient|0
2032550|NCT00392015|3602664|FG004|Overall Study|Previous trial recipient|1
2032551|NCT00392015|3602665|FG005|Overall Study|Previous trial recipient|0
2032552|NCT00392171|3602706|FG000|Overall Study|Did not meet inclusion criteria|4
2032553|NCT00392171|3602706|FG000|Overall Study|Disease progression|101
2032554|NCT00392197|3602712|FG000|Overall Study|Adverse Event|4
2032555|NCT00392197|3602713|FG001|Overall Study|Adverse Event|12
2032556|NCT00392197|3602712|FG000|Overall Study|Lack of Efficacy|3
2032557|NCT00392197|3602713|FG001|Overall Study|Lack of Efficacy|4
2111140|NCT00900146|3705773|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
2032558|NCT00392197|3602712|FG000|Overall Study|Lost to Follow-up|0
2032559|NCT00392197|3602713|FG001|Overall Study|Lost to Follow-up|1
2032560|NCT00392197|3602712|FG000|Overall Study|Physician Decision|3
2032561|NCT00392197|3602713|FG001|Overall Study|Physician Decision|2
2032562|NCT00392197|3602712|FG000|Overall Study|Protocol Violation|7
2032563|NCT00392197|3602713|FG001|Overall Study|Protocol Violation|5
2032564|NCT00392197|3602712|FG000|Overall Study|Withdrawal by Subject|4
2032565|NCT00392197|3602713|FG001|Overall Study|Withdrawal by Subject|6
2032566|NCT00392210|3602721|FG000|First Voiding Trial|Physician Decision|2
2032567|NCT00392210|3602722|FG001|First Voiding Trial|Physician Decision|2
2032568|NCT00392223|3602730|FG000|Overall Study|Adverse Event|5
2032569|NCT00392223|3602731|FG001|Overall Study|Adverse Event|4
2032570|NCT00392223|3602730|FG000|Overall Study|Lost to Follow-up|1
2032571|NCT00392223|3602731|FG001|Overall Study|Lost to Follow-up|4
2032572|NCT00392223|3602730|FG000|Overall Study|Protocol Violation|0
2032573|NCT00392223|3602731|FG001|Overall Study|Protocol Violation|3
2032574|NCT00392223|3602730|FG000|Overall Study|Withdrawal by Subject|3
2032575|NCT00392223|3602731|FG001|Overall Study|Withdrawal by Subject|2
2032576|NCT00392288|3602749|FG000|Overall Study|Adverse Event|17
2032577|NCT00392288|3602750|FG001|Overall Study|Adverse Event|7
2032578|NCT00392288|3602751|FG002|Overall Study|Adverse Event|8
2032579|NCT00392288|3602749|FG000|Overall Study|Lack of Efficacy|8
2032580|NCT00392288|3602750|FG001|Overall Study|Lack of Efficacy|5
2032581|NCT00392288|3602751|FG002|Overall Study|Lack of Efficacy|3
2032582|NCT00392288|3602749|FG000|Overall Study|Protocol Violation|1
2032583|NCT00392288|3602750|FG001|Overall Study|Protocol Violation|3
2032584|NCT00392288|3602751|FG002|Overall Study|Protocol Violation|1
2032585|NCT00392288|3602749|FG000|Overall Study|Lost to Follow-up|1
2032586|NCT00392288|3602750|FG001|Overall Study|Lost to Follow-up|1
2032587|NCT00392288|3602751|FG002|Overall Study|Lost to Follow-up|1
2032588|NCT00392288|3602749|FG000|Overall Study|Withdrawal by Subject|1
2032589|NCT00392288|3602750|FG001|Overall Study|Withdrawal by Subject|0
2032590|NCT00392288|3602751|FG002|Overall Study|Withdrawal by Subject|2
2032591|NCT00392288|3602749|FG000|Overall Study|Parent/legal guardian withdrawal|1
2032592|NCT00392288|3602750|FG001|Overall Study|Parent/legal guardian withdrawal|2
2032593|NCT00392288|3602751|FG002|Overall Study|Parent/legal guardian withdrawal|1
2032594|NCT00392288|3602749|FG000|Overall Study|Other|3
2032595|NCT00392288|3602750|FG001|Overall Study|Other|4
2032596|NCT00392288|3602751|FG002|Overall Study|Other|1
2032597|NCT00392379|3602761|FG000|Overall Study|Withdrawal by Subject|17
2032598|NCT00392379|3602762|FG001|Overall Study|Withdrawal by Subject|28
2032599|NCT00392379|3602761|FG000|Overall Study|Lost to Follow-up|4
2032600|NCT00392379|3602762|FG001|Overall Study|Lost to Follow-up|9
2032601|NCT00392379|3602761|FG000|Overall Study|Adverse Event|1
2032602|NCT00392379|3602762|FG001|Overall Study|Adverse Event|1
2032603|NCT00392665|3602782|FG000|Overall Study|Death|16
2032604|NCT00392665|3602783|FG001|Overall Study|Death|14
2032605|NCT00392665|3602782|FG000|Overall Study|Lost to Follow-up|1
2032606|NCT00392665|3602783|FG001|Overall Study|Lost to Follow-up|1
2032607|NCT00392769|3602819|FG000|Overall Study|Clinical Deterioration|9
2032608|NCT00392769|3602819|FG000|Overall Study|Adverse Event|1
2032609|NCT00392808|3602831|FG000|Overall Study|Lost to Follow-up|3
2032610|NCT00392808|3602832|FG001|Overall Study|Lost to Follow-up|2
2032611|NCT00392808|3602833|FG002|Overall Study|Lost to Follow-up|1
2032612|NCT00392808|3602834|FG003|Overall Study|Lost to Follow-up|2
2032613|NCT00392808|3602831|FG000|Overall Study|Unable to withdraw blood|3
2032614|NCT00392808|3602832|FG001|Overall Study|Unable to withdraw blood|1
2032615|NCT00392808|3602833|FG002|Overall Study|Unable to withdraw blood|1
2032616|NCT00392808|3602834|FG003|Overall Study|Unable to withdraw blood|2
2032617|NCT00392925|3602861|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
2032618|NCT00392925|3602862|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
2032619|NCT00392925|3602863|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
2032620|NCT00392925|3602864|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
2032621|NCT00392925|3602861|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
2032622|NCT00392925|3602862|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
2032623|NCT00392925|3602863|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
2032624|NCT00392925|3602864|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
2032625|NCT00392925|3602861|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
2032626|NCT00392925|3602862|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
2032627|NCT00392925|3602863|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
2032628|NCT00392925|3602864|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
2032629|NCT00392925|3602861|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
2032630|NCT00392925|3602862|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
2111141|NCT00900146|3705774|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
2111142|NCT00900146|3705775|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
2111143|NCT00900146|3705776|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
2111144|NCT00900146|3705777|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
2111145|NCT00900146|3705773|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
2111146|NCT00900146|3705774|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
2111147|NCT00900146|3705775|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
2111148|NCT00900146|3705776|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
2111149|NCT00900146|3705777|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
2111150|NCT00900146|3705773|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1
2111151|NCT00900146|3705774|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0
2111152|NCT00900146|3705775|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0
2111153|NCT00900146|3705776|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0
2111154|NCT00900146|3705777|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0
2111155|NCT00900146|3705773|FG000|Intermediate: Period III|Withdrawal by Subject|0
2180392|NCT01401452|3806527|FG000|Overall Study|Subject didn't return for routine visits|1
2032631|NCT00392925|3602863|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
2032632|NCT00392925|3602864|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
2032633|NCT00392925|3602861|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
2032634|NCT00392925|3602862|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
2032635|NCT00392925|3602863|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
2032636|NCT00392925|3602864|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
2032637|NCT00392925|3602861|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0
2032638|NCT00392925|3602862|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2
2032639|NCT00392925|3602863|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6
2032640|NCT00392925|3602864|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8
2032641|NCT00392925|3602861|FG000|Randomization to Treatment Group Period|Adverse Event|0
2032642|NCT00392925|3602862|FG001|Randomization to Treatment Group Period|Adverse Event|3
2032643|NCT00392925|3602863|FG002|Randomization to Treatment Group Period|Adverse Event|3
2218593|NCT01716234|3862232|FG002|Overall Study|Adverse Event|2
2218594|NCT01716234|3862233|FG003|Overall Study|Adverse Event|8
2218595|NCT01716234|3862234|FG004|Overall Study|Adverse Event|3
2218596|NCT01716234|3862235|FG005|Overall Study|Adverse Event|6
2331758|NCT03173313|4054510|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0
2331759|NCT03173313|4054511|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1
2331760|NCT03173313|4054510|FG000|Overall Study|Bone Fracture|1
2331761|NCT03173313|4054511|FG001|Overall Study|Bone Fracture|0
2331762|NCT03173547|4054519|FG000|Overall Study|Adverse Event|2
2331763|NCT03173547|4054520|FG001|Overall Study|Adverse Event|0
2331764|NCT03173547|4054519|FG000|Overall Study|Withdrawal by Subject|2
2331765|NCT03173547|4054520|FG001|Overall Study|Withdrawal by Subject|2
2331766|NCT03173560|4054528|FG000|Overall Study|Ongoing on Treatment|38
2331767|NCT03173560|4054529|FG001|Overall Study|Ongoing on Treatment|50
2331768|NCT03173560|4054528|FG000|Overall Study|Ongoing Survival Follow-up|56
2331769|NCT03173560|4054529|FG001|Overall Study|Ongoing Survival Follow-up|57
2331770|NCT03173560|4054528|FG000|Overall Study|Lost to Follow-up|1
2331771|NCT03173560|4054529|FG001|Overall Study|Lost to Follow-up|4
2331772|NCT03173560|4054528|FG000|Overall Study|Withdrawal by Subject|10
2331773|NCT03173560|4054529|FG001|Overall Study|Withdrawal by Subject|5
2331774|NCT03173560|4054528|FG000|Overall Study|Other|0
2331775|NCT03173560|4054529|FG001|Overall Study|Other|1
2331776|NCT03174925|4054568|FG000|Overall Study|Elastographic images not retrievable|2
2331777|NCT03174925|4054568|FG000|Overall Study|Elastography image not interpretable|1
2331778|NCT03175120|4054574|FG000|Overall Study|Adverse Event|2
2331779|NCT03175120|4054575|FG001|Overall Study|Adverse Event|2
2331780|NCT03175120|4054574|FG000|Overall Study|Protocol Violation|5
2331781|NCT03175120|4054575|FG001|Overall Study|Protocol Violation|2
2331782|NCT03175120|4054574|FG000|Overall Study|Lost to Follow-up|1
2331783|NCT03175120|4054575|FG001|Overall Study|Lost to Follow-up|0
2331784|NCT03175120|4054574|FG000|Overall Study|Withdrawal by Subject|2
2331785|NCT03175120|4054575|FG001|Overall Study|Withdrawal by Subject|5
2331786|NCT03175120|4054574|FG000|Overall Study|Other|2
2331787|NCT03175120|4054575|FG001|Overall Study|Other|3
2331788|NCT03175172|4054581|FG000|Overall Study|Death|3
2331789|NCT03175172|4054581|FG000|Overall Study|Withdrawal by Subject|3
2331790|NCT03175172|4054581|FG000|Overall Study|Lost to Follow-up|1
2331791|NCT03175172|4054581|FG000|Overall Study|Study Terminated by Sponsor|3
2331792|NCT03175562|4054585|FG000|Overall Study|Adverse Event|1
2032644|NCT00392925|3602864|FG003|Randomization to Treatment Group Period|Adverse Event|5
2032645|NCT00392925|3602861|FG000|Randomization to Treatment Group Period|Protocol Violation|0
2032646|NCT00392925|3602862|FG001|Randomization to Treatment Group Period|Protocol Violation|0
2032647|NCT00392925|3602863|FG002|Randomization to Treatment Group Period|Protocol Violation|2
2032648|NCT00392925|3602864|FG003|Randomization to Treatment Group Period|Protocol Violation|1
2032649|NCT00392925|3602861|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0
2331793|NCT03175562|4054585|FG000|Overall Study|Lost to Follow-up|3
2331794|NCT03175562|4054585|FG000|Overall Study|Withdrawal by Subject|7
2331795|NCT03175562|4054585|FG000|Overall Study|Other (Not Specified)|5
2331796|NCT03176238|4054603|FG000|Overall Study|Unacceptable AEs|15
2331797|NCT03176238|4054604|FG001|Overall Study|Unacceptable AEs|8
2331798|NCT03176238|4054603|FG000|Overall Study|Abnormal lab value(s)|2
2331799|NCT03176238|4054604|FG001|Overall Study|Abnormal lab value(s)|0
2032650|NCT00392925|3602862|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3
2032651|NCT00392925|3602863|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8
2032652|NCT00392925|3602864|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4
2032653|NCT00392990|3602886|FG000|Treatment on Study|Adverse Event|3
2032654|NCT00392990|3602887|FG001|Treatment on Study|Adverse Event|1
2032655|NCT00392990|3602886|FG000|Follow up for 2 Years|Death|4
2032656|NCT00392990|3602887|FG001|Follow up for 2 Years|Death|0
2032657|NCT00393029|3602895|FG000|Overall Study|Not treated|0
2032658|NCT00393029|3602896|FG001|Overall Study|Not treated|1
2032659|NCT00393042|3602903|FG000|First Intervention|Withdrawal by Subject|1
2032660|NCT00393042|3602904|FG001|First Intervention|Withdrawal by Subject|2
2032661|NCT00393042|3602903|FG000|First Intervention|Lost to Follow-up|3
2032662|NCT00393042|3602904|FG001|First Intervention|Lost to Follow-up|3
2032663|NCT00393042|3602903|FG000|First Intervention|Protocol Violation|1
2032664|NCT00393042|3602904|FG001|First Intervention|Protocol Violation|0
2032665|NCT00393042|3602903|FG000|First Intervention|Adverse Event|0
2032666|NCT00393042|3602904|FG001|First Intervention|Adverse Event|1
2032667|NCT00393042|3602903|FG000|Second Intervetion|Adverse Event|0
2032668|NCT00393042|3602904|FG001|Second Intervetion|Adverse Event|3
2032669|NCT00393042|3602903|FG000|Second Intervetion|Withdrawal by Subject|0
2032670|NCT00393042|3602904|FG001|Second Intervetion|Withdrawal by Subject|2
2032671|NCT00393042|3602903|FG000|Second Intervetion|Lack of Efficacy|1
2032672|NCT00393042|3602904|FG001|Second Intervetion|Lack of Efficacy|0
2032673|NCT00393042|3602903|FG000|Second Intervetion|Lost to Follow-up|0
2032674|NCT00393042|3602904|FG001|Second Intervetion|Lost to Follow-up|2
2032675|NCT00393042|3602903|FG000|Second Intervetion|Protocol Violation|1
2032676|NCT00393042|3602904|FG001|Second Intervetion|Protocol Violation|1
2032677|NCT00393094|3602962|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
2032678|NCT00393094|3602962|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
2032679|NCT00393367|3602970|FG000|Overall Study|Protocol Violation|2
2032680|NCT00393367|3602971|FG001|Overall Study|Protocol Violation|5
2032681|NCT00393367|3602970|FG000|Overall Study|Withdrawal by Subject|0
2111156|NCT00900146|3705774|FG001|Intermediate: Period III|Withdrawal by Subject|1
2111157|NCT00900146|3705775|FG002|Intermediate: Period III|Withdrawal by Subject|0
2111158|NCT00900146|3705776|FG003|Intermediate: Period III|Withdrawal by Subject|0
2111159|NCT00900146|3705777|FG004|Intermediate: Period III|Withdrawal by Subject|3
2111160|NCT00900146|3705773|FG000|Intermediate: Period III|Lost to Follow-up|2
2111161|NCT00900146|3705774|FG001|Intermediate: Period III|Lost to Follow-up|0
2111162|NCT00900146|3705775|FG002|Intermediate: Period III|Lost to Follow-up|0
2111163|NCT00900146|3705776|FG003|Intermediate: Period III|Lost to Follow-up|0
2111164|NCT00900146|3705777|FG004|Intermediate: Period III|Lost to Follow-up|1
2111165|NCT00900146|3705773|FG000|Intermediate: Period III|Administrative problems|85
2111166|NCT00900146|3705774|FG001|Intermediate: Period III|Administrative problems|92
2111167|NCT00900146|3705775|FG002|Intermediate: Period III|Administrative problems|84
2111168|NCT00900146|3705776|FG003|Intermediate: Period III|Administrative problems|90
2111169|NCT00900146|3705777|FG004|Intermediate: Period III|Administrative problems|163
2111170|NCT00900159|3705791|FG000|Second Intervention|disempanelled for inappropriate behavior|1
2218597|NCT01716234|3862236|FG006|Overall Study|Adverse Event|0
2180393|NCT01401452|3806527|FG000|Overall Study|Subject moved to another city|1
2032682|NCT00393367|3602971|FG001|Overall Study|Withdrawal by Subject|2
2032683|NCT00393458|3602987|FG000|Overall Study|Adverse Event|35
2032684|NCT00393458|3602988|FG001|Overall Study|Adverse Event|24
2032685|NCT00393458|3602989|FG002|Overall Study|Adverse Event|40
2032686|NCT00393458|3602990|FG003|Overall Study|Adverse Event|35
2032687|NCT00393458|3602987|FG000|Overall Study|Subject withdrew consent|27
2032688|NCT00393458|3602988|FG001|Overall Study|Subject withdrew consent|40
2032689|NCT00393458|3602989|FG002|Overall Study|Subject withdrew consent|33
2032690|NCT00393458|3602990|FG003|Overall Study|Subject withdrew consent|50
2032691|NCT00393458|3602987|FG000|Overall Study|Unsatisfactory therapeutic effect|12
2032692|NCT00393458|3602988|FG001|Overall Study|Unsatisfactory therapeutic effect|9
2032693|NCT00393458|3602989|FG002|Overall Study|Unsatisfactory therapeutic effect|12
2032694|NCT00393458|3602990|FG003|Overall Study|Unsatisfactory therapeutic effect|30
2032695|NCT00393458|3602987|FG000|Overall Study|Protocol deviation|11
2032696|NCT00393458|3602988|FG001|Overall Study|Protocol deviation|11
2032697|NCT00393458|3602989|FG002|Overall Study|Protocol deviation|11
2111171|NCT00900159|3705792|FG001|Second Intervention|disempanelled for inappropriate behavior|0
2111172|NCT00900562|3705809|FG000|Overall Study|Progressive disease|9
2111173|NCT00900562|3705810|FG001|Overall Study|Progressive disease|5
2111174|NCT00900562|3705809|FG000|Overall Study|Toxicity|1
2111175|NCT00900562|3705810|FG001|Overall Study|Toxicity|0
2111176|NCT00900562|3705809|FG000|Overall Study|Death|1
2111177|NCT00900562|3705810|FG001|Overall Study|Death|1
2111178|NCT00900562|3705809|FG000|Overall Study|Withdrawal by Subject|0
2111179|NCT00900562|3705810|FG001|Overall Study|Withdrawal by Subject|1
2111180|NCT00900562|3705809|FG000|Overall Study|Unrelated adverse event|1
2111181|NCT00900562|3705810|FG001|Overall Study|Unrelated adverse event|0
2111182|NCT00900601|3705817|FG000|Overall Study|Physician Decision|1
2111183|NCT00900627|3705827|FG000|Overall Study|Condition under investigation worsened|4
2111184|NCT00900627|3705828|FG001|Overall Study|Condition under investigation worsened|0
2111185|NCT00900627|3705829|FG002|Overall Study|Condition under investigation worsened|5
2111186|NCT00900627|3705830|FG003|Overall Study|Condition under investigation worsened|3
2111187|NCT00900627|3705831|FG004|Overall Study|Condition under investigation worsened|0
2111188|NCT00900627|3705832|FG005|Overall Study|Condition under investigation worsened|0
2111189|NCT00900627|3705827|FG000|Overall Study|Withdrawal by Subject|1
2111190|NCT00900627|3705828|FG001|Overall Study|Withdrawal by Subject|0
2111191|NCT00900627|3705829|FG002|Overall Study|Withdrawal by Subject|1
2111192|NCT00900627|3705830|FG003|Overall Study|Withdrawal by Subject|0
2111193|NCT00900627|3705831|FG004|Overall Study|Withdrawal by Subject|1
2111194|NCT00900627|3705832|FG005|Overall Study|Withdrawal by Subject|2
2111195|NCT00900627|3705827|FG000|Overall Study|Adverse Event|1
2111196|NCT00900627|3705828|FG001|Overall Study|Adverse Event|2
2111197|NCT00900627|3705829|FG002|Overall Study|Adverse Event|0
2111198|NCT00900627|3705830|FG003|Overall Study|Adverse Event|3
2111199|NCT00900627|3705831|FG004|Overall Study|Adverse Event|0
2111200|NCT00900627|3705832|FG005|Overall Study|Adverse Event|0
2111201|NCT00900627|3705827|FG000|Overall Study|Death|0
2111202|NCT00900627|3705828|FG001|Overall Study|Death|0
2111203|NCT00900627|3705829|FG002|Overall Study|Death|0
2111204|NCT00900627|3705830|FG003|Overall Study|Death|0
2111205|NCT00900627|3705831|FG004|Overall Study|Death|28
2111206|NCT00900627|3705832|FG005|Overall Study|Death|24
2111207|NCT00900731|3705857|FG000|Overall Study|Adverse Event|31
2111208|NCT00900731|3705858|FG001|Overall Study|Adverse Event|27
2111209|NCT00900731|3705857|FG000|Overall Study|Withdrawal by Subject|8
2111210|NCT00900731|3705858|FG001|Overall Study|Withdrawal by Subject|7
2111211|NCT00900731|3705857|FG000|Overall Study|Protocol Deviation|8
2111212|NCT00900731|3705858|FG001|Overall Study|Protocol Deviation|11
2111213|NCT00900731|3705857|FG000|Overall Study|Administrative Problems|5
2111214|NCT00900731|3705858|FG001|Overall Study|Administrative Problems|4
2111215|NCT00900731|3705857|FG000|Overall Study|Abnormal Test Procedure Result(s)|3
2111216|NCT00900731|3705858|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
2111217|NCT00900731|3705857|FG000|Overall Study|Abnormal Laboratory Value(s)|2
2111218|NCT00900731|3705858|FG001|Overall Study|Abnormal Laboratory Value(s)|4
2111219|NCT00900731|3705857|FG000|Overall Study|Lost to Follow-up|2
2111220|NCT00900731|3705858|FG001|Overall Study|Lost to Follow-up|3
2111221|NCT00900731|3705857|FG000|Overall Study|Lack of Efficacy|1
2111222|NCT00900731|3705858|FG001|Overall Study|Lack of Efficacy|3
2111223|NCT00900731|3705857|FG000|Overall Study|Death|0
2111224|NCT00900731|3705858|FG001|Overall Study|Death|2
2111225|NCT00900757|3705864|FG000|Overall Study|screen failure|19
2111226|NCT00900796|3705868|FG000|Phase 1|Lacked sufficient information|4
2111227|NCT00900796|3705868|FG000|Phase 1|Missing information at Week 16|7
2218598|NCT01716234|3862230|FG000|Overall Study|Withdrawal by Subject|3
2218599|NCT01716234|3862231|FG001|Overall Study|Withdrawal by Subject|0
2218600|NCT01716234|3862232|FG002|Overall Study|Withdrawal by Subject|2
2218601|NCT01716234|3862233|FG003|Overall Study|Withdrawal by Subject|2
2218602|NCT01716234|3862234|FG004|Overall Study|Withdrawal by Subject|1
2218603|NCT01716234|3862235|FG005|Overall Study|Withdrawal by Subject|3
2218604|NCT01716234|3862236|FG006|Overall Study|Withdrawal by Subject|0
2218605|NCT01716520|3862278|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
2218606|NCT01716520|3862279|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
2218607|NCT01716520|3862280|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
2218608|NCT01716520|3862281|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
2218609|NCT01716520|3862282|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
2218610|NCT01716520|3862283|FG005|Treatment Period 1 (14 Days)|Adverse Event|0
2218611|NCT01716520|3862278|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
2218612|NCT01716520|3862279|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
2032698|NCT00393458|3602990|FG003|Overall Study|Protocol deviation|10
2032699|NCT00393458|3602987|FG000|Overall Study|Administrative problems|7
2032700|NCT00393458|3602988|FG001|Overall Study|Administrative problems|8
2032701|NCT00393458|3602989|FG002|Overall Study|Administrative problems|5
2032702|NCT00393458|3602990|FG003|Overall Study|Administrative problems|2
2032703|NCT00393458|3602987|FG000|Overall Study|Lost to Follow-up|5
2032704|NCT00393458|3602988|FG001|Overall Study|Lost to Follow-up|6
2032705|NCT00393458|3602989|FG002|Overall Study|Lost to Follow-up|5
2032706|NCT00393458|3602990|FG003|Overall Study|Lost to Follow-up|3
2032707|NCT00393458|3602987|FG000|Overall Study|Abnormal laboratory value(s)|1
2032708|NCT00393458|3602988|FG001|Overall Study|Abnormal laboratory value(s)|1
2032709|NCT00393458|3602989|FG002|Overall Study|Abnormal laboratory value(s)|0
2032710|NCT00393458|3602990|FG003|Overall Study|Abnormal laboratory value(s)|0
2032711|NCT00393458|3602987|FG000|Overall Study|Death|1
2032712|NCT00393458|3602988|FG001|Overall Study|Death|1
2032713|NCT00393458|3602989|FG002|Overall Study|Death|5
2032714|NCT00393458|3602990|FG003|Overall Study|Death|5
2032715|NCT00393458|3602987|FG000|Overall Study|Abnormal test procedure result(s)|0
2032716|NCT00393458|3602988|FG001|Overall Study|Abnormal test procedure result(s)|1
2032717|NCT00393458|3602989|FG002|Overall Study|Abnormal test procedure result(s)|1
2032718|NCT00393458|3602990|FG003|Overall Study|Abnormal test procedure result(s)|2
2032719|NCT00393458|3602987|FG000|Overall Study|Subject no longer requires study drug|0
2032720|NCT00393458|3602988|FG001|Overall Study|Subject no longer requires study drug|1
2032721|NCT00393458|3602989|FG002|Overall Study|Subject no longer requires study drug|0
2032722|NCT00393458|3602990|FG003|Overall Study|Subject no longer requires study drug|0
2032723|NCT00393484|3603002|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
2032724|NCT00393484|3603003|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
2032725|NCT00393484|3603002|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
2032726|NCT00393484|3603003|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
2032727|NCT00393484|3603002|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
2032728|NCT00393484|3603003|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
2032729|NCT00393484|3603002|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
2032730|NCT00393484|3603003|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
2032731|NCT00393484|3603002|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
2032732|NCT00393484|3603003|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
2032733|NCT00393484|3603002|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
2032734|NCT00393484|3603003|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
2032735|NCT00393484|3603002|FG000|Open-label Period (Weeks 96 to 240)|Death|1
2032736|NCT00393484|3603003|FG001|Open-label Period (Weeks 96 to 240)|Death|0
2273935|NCT02291419|3954638|FG000|Overall Study|Early study termination|1
2032737|NCT00393484|3603002|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
2032738|NCT00393484|3603003|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
2032739|NCT00393484|3603002|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2
2032740|NCT00393484|3603003|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2
2032741|NCT00393484|3603002|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
2032742|NCT00393484|3603003|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
2032743|NCT00393510|3603013|FG000|Overall Study|Physician Decision|3
2032744|NCT00393510|3603014|FG001|Overall Study|Physician Decision|9
2032745|NCT00393523|3603025|FG000|Overall Study|Lost to Follow-up|0
2032746|NCT00393523|3603026|FG001|Overall Study|Lost to Follow-up|0
2032747|NCT00393523|3603027|FG002|Overall Study|Lost to Follow-up|0
2032748|NCT00393523|3603028|FG003|Overall Study|Lost to Follow-up|2
2032749|NCT00393523|3603029|FG004|Overall Study|Lost to Follow-up|1
2032750|NCT00393523|3603025|FG000|Overall Study|Protocol Violation|6
2032751|NCT00393523|3603026|FG001|Overall Study|Protocol Violation|2
2032752|NCT00393523|3603027|FG002|Overall Study|Protocol Violation|0
2032753|NCT00393523|3603028|FG003|Overall Study|Protocol Violation|1
2032754|NCT00393523|3603029|FG004|Overall Study|Protocol Violation|0
2032755|NCT00393523|3603025|FG000|Overall Study|Withdrawal by Subject|6
2032756|NCT00393523|3603026|FG001|Overall Study|Withdrawal by Subject|7
2032757|NCT00393523|3603027|FG002|Overall Study|Withdrawal by Subject|2
2032758|NCT00393523|3603028|FG003|Overall Study|Withdrawal by Subject|3
2032759|NCT00393523|3603029|FG004|Overall Study|Withdrawal by Subject|0
2032760|NCT00393523|3603025|FG000|Overall Study|Difficulties in specimen collection|0
2032761|NCT00393523|3603026|FG001|Overall Study|Difficulties in specimen collection|0
2032762|NCT00393523|3603027|FG002|Overall Study|Difficulties in specimen collection|1
2032763|NCT00393523|3603028|FG003|Overall Study|Difficulties in specimen collection|0
2032764|NCT00393523|3603029|FG004|Overall Study|Difficulties in specimen collection|0
2032765|NCT00393523|3603025|FG000|Overall Study|Vaccine supply issue|0
2032766|NCT00393523|3603026|FG001|Overall Study|Vaccine supply issue|0
2032767|NCT00393523|3603027|FG002|Overall Study|Vaccine supply issue|1
2032768|NCT00393523|3603028|FG003|Overall Study|Vaccine supply issue|0
2111228|NCT00900796|3705868|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
2111229|NCT00900796|3705868|FG000|Phase 2|Lost to Follow-up|5
2111230|NCT00901186|3705889|FG000|Overall Study|Lack of Efficacy|0
2111231|NCT00901186|3705890|FG001|Overall Study|Lack of Efficacy|1
2111232|NCT00901186|3705889|FG000|Overall Study|Abnormal laboratory values|0
2111233|NCT00901186|3705890|FG001|Overall Study|Abnormal laboratory values|1
2111234|NCT00901186|3705889|FG000|Overall Study|Lost to Follow-up|2
2111235|NCT00901186|3705890|FG001|Overall Study|Lost to Follow-up|0
2111236|NCT00901186|3705889|FG000|Overall Study|Adverse Event|2
2111237|NCT00901186|3705890|FG001|Overall Study|Adverse Event|4
2111238|NCT00901186|3705889|FG000|Overall Study|Administration problems|0
2111239|NCT00901186|3705890|FG001|Overall Study|Administration problems|1
2111240|NCT00901186|3705889|FG000|Overall Study|Protocol deviations|5
2111241|NCT00901186|3705890|FG001|Overall Study|Protocol deviations|4
2111242|NCT00901342|3705913|FG000|Overall Study|Adverse Event|1
2111243|NCT00901342|3705913|FG000|Overall Study|Death|4
2111244|NCT00901342|3705913|FG000|Overall Study|Disease progression|1
2111245|NCT00901342|3705913|FG000|Overall Study|Withdrawal by Subject|9
2111246|NCT00901394|3705920|FG000|Overall Study|Physician Decision|1
2111247|NCT00901394|3705921|FG001|Overall Study|Physician Decision|1
2111248|NCT00901394|3705922|FG002|Overall Study|Physician Decision|2
2111249|NCT00901459|3705930|FG000|Overall Study|Withdrawal by Subject|6
2111250|NCT00901485|3705941|FG000|Overall Study|Lack of Efficacy|0
2111251|NCT00901485|3705942|FG001|Overall Study|Lack of Efficacy|2
2111252|NCT00901485|3705941|FG000|Overall Study|Withdrawal by Subject|1
2111253|NCT00901485|3705942|FG001|Overall Study|Withdrawal by Subject|2
2111254|NCT00901576|3705954|FG000|Second Intervention|Withdrawal by Subject|0
2111255|NCT00901576|3705955|FG001|Second Intervention|Withdrawal by Subject|0
2111256|NCT00901576|3705956|FG002|Second Intervention|Withdrawal by Subject|0
2111257|NCT00901576|3705957|FG003|Second Intervention|Withdrawal by Subject|1
2111258|NCT00901576|3705958|FG004|Second Intervention|Withdrawal by Subject|0
2111259|NCT00901576|3705959|FG005|Second Intervention|Withdrawal by Subject|1
2111260|NCT00901576|3705954|FG000|Second Intervention|Physician Decision|1
2111261|NCT00901576|3705955|FG001|Second Intervention|Physician Decision|0
2111262|NCT00901576|3705956|FG002|Second Intervention|Physician Decision|0
2111263|NCT00901576|3705957|FG003|Second Intervention|Physician Decision|0
2111264|NCT00901576|3705958|FG004|Second Intervention|Physician Decision|0
2111265|NCT00901576|3705959|FG005|Second Intervention|Physician Decision|0
2111266|NCT00901628|3705969|FG000|Overall Study|disconnection of catheter|4
2032769|NCT00393523|3603029|FG004|Overall Study|Vaccine supply issue|0
2032770|NCT00393705|3603042|FG000|Overall Study|Adverse Event|0
2032771|NCT00393705|3603043|FG001|Overall Study|Adverse Event|2
2032772|NCT00393705|3603042|FG000|Overall Study|Death|0
2032773|NCT00393705|3603043|FG001|Overall Study|Death|1
2032774|NCT00393705|3603042|FG000|Overall Study|Lost to Follow-up|2
2032775|NCT00393705|3603043|FG001|Overall Study|Lost to Follow-up|2
2032776|NCT00393705|3603042|FG000|Overall Study|Entry Criteria Not Met|10
2032777|NCT00393705|3603043|FG001|Overall Study|Entry Criteria Not Met|10
2032778|NCT00393705|3603042|FG000|Overall Study|Protocol Violation|4
2032779|NCT00393705|3603043|FG001|Overall Study|Protocol Violation|3
2032780|NCT00393705|3603042|FG000|Overall Study|Withdrawal by Subject|5
2032781|NCT00393705|3603043|FG001|Overall Study|Withdrawal by Subject|3
2032782|NCT00393705|3603042|FG000|Overall Study|Physician Decision|2
2032783|NCT00393705|3603043|FG001|Overall Study|Physician Decision|2
2032784|NCT00393718|3603051|FG000|Overall Study|Adverse Event|20
2032785|NCT00393718|3603052|FG001|Overall Study|Adverse Event|8
2032786|NCT00393718|3603051|FG000|Overall Study|Protocol Violation|1
2032787|NCT00393718|3603052|FG001|Overall Study|Protocol Violation|2
2032788|NCT00393718|3603051|FG000|Overall Study|Lack of Efficacy|10
2032789|NCT00393718|3603052|FG001|Overall Study|Lack of Efficacy|9
2032790|NCT00393718|3603051|FG000|Overall Study|Hypoglycaemia|3
2032791|NCT00393718|3603052|FG001|Overall Study|Hypoglycaemia|2
2032792|NCT00393718|3603051|FG000|Overall Study|Subject decision|5
2032793|NCT00393718|3603052|FG001|Overall Study|Subject decision|0
2032794|NCT00393718|3603051|FG000|Overall Study|Withdrawal of consent|2
2032795|NCT00393718|3603052|FG001|Overall Study|Withdrawal of consent|1
2111267|NCT00901628|3705970|FG001|Overall Study|disconnection of catheter|8
2111268|NCT00901628|3705969|FG000|Overall Study|disconnection of drain|0
2111269|NCT00901628|3705970|FG001|Overall Study|disconnection of drain|1
2111270|NCT00901628|3705969|FG000|Overall Study|peroneal nerve palsy|0
2111271|NCT00901628|3705970|FG001|Overall Study|peroneal nerve palsy|1
2111272|NCT00901901|3705978|FG000|Treatment Period|Adverse Event|120
2111273|NCT00901901|3705979|FG001|Treatment Period|Adverse Event|128
2111274|NCT00901901|3705978|FG000|Treatment Period|Withdrawal by Subject|26
2111275|NCT00901901|3705979|FG001|Treatment Period|Withdrawal by Subject|24
2111276|NCT00901901|3705978|FG000|Treatment Period|Physician Decision|2
2111277|NCT00901901|3705979|FG001|Treatment Period|Physician Decision|2
2111278|NCT00901901|3705978|FG000|Treatment Period|Lost to Follow-up|3
2111279|NCT00901901|3705979|FG001|Treatment Period|Lost to Follow-up|5
2111280|NCT00901901|3705978|FG000|Treatment Period|Noncompliance with study medication|4
2111281|NCT00901901|3705979|FG001|Treatment Period|Noncompliance with study medication|1
2111282|NCT00901901|3705978|FG000|Treatment Period|Missing|1
2111283|NCT00901901|3705979|FG001|Treatment Period|Missing|0
2111284|NCT00901901|3705978|FG000|Treatment Period|Never treated|0
2111285|NCT00901901|3705979|FG001|Treatment Period|Never treated|3
2111286|NCT00901901|3705978|FG000|Treatment Period|Protocol driven decision point|0
2111287|NCT00901901|3705979|FG001|Treatment Period|Protocol driven decision point|2
2111288|NCT00901901|3705978|FG000|Treatment Period|Study terminated by sponsor|2
2111289|NCT00901901|3705979|FG001|Treatment Period|Study terminated by sponsor|0
2111290|NCT00901901|3705978|FG000|Treatment Period|Protocol Violation|5
2111291|NCT00901901|3705979|FG001|Treatment Period|Protocol Violation|9
2111292|NCT00901901|3705978|FG000|Treatment Period|Switch to commercial drug|1
2111293|NCT00901901|3705979|FG001|Treatment Period|Switch to commercial drug|1
2111294|NCT00901901|3705978|FG000|Treatment Period|Transfer to treatment continuation study|5
2218613|NCT01716520|3862280|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
2111295|NCT00901901|3705979|FG001|Treatment Period|Transfer to treatment continuation study|2
2111296|NCT00901901|3705978|FG000|Follow-up Period|Death|181
2111297|NCT00901901|3705979|FG001|Follow-up Period|Death|208
2111298|NCT00901901|3705978|FG000|Follow-up Period|Protocol driven decision point|47
2111299|NCT00901901|3705979|FG001|Follow-up Period|Protocol driven decision point|36
2111300|NCT00901901|3705978|FG000|Follow-up Period|Withdrawal by Subject|6
2111301|NCT00901901|3705979|FG001|Follow-up Period|Withdrawal by Subject|9
2111302|NCT00901901|3705978|FG000|Follow-up Period|Lost to Follow-up|12
2111303|NCT00901901|3705979|FG001|Follow-up Period|Lost to Follow-up|8
2111304|NCT00901901|3705978|FG000|Follow-up Period|Missing|94
2111305|NCT00901901|3705979|FG001|Follow-up Period|Missing|80
2111306|NCT00901927|3705987|FG000|Overall Study|Lack of Efficacy|1
2111307|NCT00901927|3705987|FG000|Overall Study|Protocol Violation|3
2111308|NCT00901927|3705987|FG000|Overall Study|Withdrawal by Subject|2
2111309|NCT00902174|3706026|FG000|Overall Study|Adverse Event|27
2111310|NCT00902174|3706027|FG001|Overall Study|Adverse Event|7
2111311|NCT00902174|3706026|FG000|Overall Study|Lack of Efficacy|1
2111312|NCT00902174|3706027|FG001|Overall Study|Lack of Efficacy|5
2111313|NCT00902174|3706026|FG000|Overall Study|Death|2
2111314|NCT00902174|3706027|FG001|Overall Study|Death|2
2111315|NCT00902174|3706026|FG000|Overall Study|Withdrawal by Subject|2
2111316|NCT00902174|3706027|FG001|Overall Study|Withdrawal by Subject|1
2111317|NCT00902174|3706026|FG000|Overall Study|Abnormal labs|1
2111318|NCT00902174|3706027|FG001|Overall Study|Abnormal labs|1
2111319|NCT00902174|3706026|FG000|Overall Study|Protocol Violation|1
2111320|NCT00902174|3706027|FG001|Overall Study|Protocol Violation|1
2111321|NCT00902174|3706026|FG000|Overall Study|Administration problem|0
2111322|NCT00902174|3706027|FG001|Overall Study|Administration problem|1
2111323|NCT00902265|3706040|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1
2111324|NCT00902265|3706040|FG000|Overall Study|Adverse Event|2
2032796|NCT00393718|3603051|FG000|Overall Study|Missed measurement|1
2032797|NCT00393718|3603052|FG001|Overall Study|Missed measurement|0
2032798|NCT00393718|3603051|FG000|Overall Study|Move|1
2032799|NCT00393718|3603052|FG001|Overall Study|Move|0
2032800|NCT00393848|3603071|FG000|Overall Study|Surgical schedule|0
2032801|NCT00393848|3603072|FG001|Overall Study|Surgical schedule|0
2032802|NCT00393848|3603073|FG002|Overall Study|Surgical schedule|0
2032803|NCT00393848|3603074|FG003|Overall Study|Surgical schedule|1
2032804|NCT00393848|3603071|FG000|Overall Study|Personal reasons|0
2032805|NCT00393848|3603072|FG001|Overall Study|Personal reasons|0
2032806|NCT00393848|3603073|FG002|Overall Study|Personal reasons|2
2032807|NCT00393848|3603074|FG003|Overall Study|Personal reasons|0
2032808|NCT00393861|3603085|FG000|Overall Study|Adverse Event|2
2032809|NCT00393861|3603085|FG000|Overall Study|Disease Progression|24
2032810|NCT00393887|3603107|FG000|Overall Study|Physician Decision|5
2032811|NCT00393887|3603108|FG001|Overall Study|Physician Decision|0
2032812|NCT00393887|3603107|FG000|Overall Study|Lost to Follow-up|11
2032813|NCT00393887|3603108|FG001|Overall Study|Lost to Follow-up|9
2032814|NCT00393913|3603114|FG000|Initial Assessment|diagnosed with other sleep disorder|21
2032815|NCT00393913|3603114|FG000|Initial Assessment|Withdrawal by Subject|16
2032816|NCT00393913|3603114|FG000|CPAP|Withdrawal by Subject|3
2111325|NCT00902265|3706040|FG000|Overall Study|Lack of Efficacy|2
2111326|NCT00902265|3706040|FG000|Overall Study|Protocol Violation|1
2111327|NCT00902278|3706049|FG000|Overall Study|Physician Decision|1
2111328|NCT00902278|3706050|FG001|Overall Study|Physician Decision|0
2111329|NCT00902278|3706051|FG002|Overall Study|Physician Decision|2
2111330|NCT00902278|3706052|FG003|Overall Study|Physician Decision|0
2111331|NCT00902278|3706053|FG004|Overall Study|Physician Decision|1
2111332|NCT00902278|3706049|FG000|Overall Study|Lost to Follow-up|3
2111333|NCT00902278|3706050|FG001|Overall Study|Lost to Follow-up|2
2032817|NCT00393913|3603114|FG000|CPAP|Physician Decision|1
2111334|NCT00902278|3706051|FG002|Overall Study|Lost to Follow-up|3
2218614|NCT01716520|3862281|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
2218615|NCT01716520|3862282|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
2218616|NCT01716520|3862283|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
2218617|NCT01716520|3862278|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2218618|NCT01716520|3862279|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2218619|NCT01716520|3862280|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2218620|NCT01716520|3862281|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2218621|NCT01716520|3862282|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2218622|NCT01716520|3862283|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2218623|NCT01716520|3862278|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2218624|NCT01716520|3862279|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1
2218625|NCT01716520|3862280|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2218626|NCT01716520|3862281|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2218627|NCT01716520|3862282|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2218628|NCT01716520|3862283|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2218629|NCT01716520|3862278|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2218630|NCT01716520|3862279|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2218631|NCT01716520|3862280|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2218632|NCT01716520|3862281|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2218633|NCT01716520|3862282|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2218634|NCT01716520|3862283|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
2218635|NCT01716520|3862278|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2218636|NCT01716520|3862279|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2218637|NCT01716520|3862280|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
2032818|NCT00393913|3603114|FG000|CPAP|TEchnical problem with CPAP|3
2032819|NCT00393939|3603121|FG000|Overall Study|Protocol Violation|1
2032820|NCT00393939|3603122|FG001|Overall Study|Protocol Violation|1
2032821|NCT00393939|3603121|FG000|Overall Study|Lost to Follow-up|2
2032822|NCT00393939|3603122|FG001|Overall Study|Lost to Follow-up|4
2032823|NCT00393939|3603121|FG000|Overall Study|Death|10
2218638|NCT01716520|3862281|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2218639|NCT01716520|3862282|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2032824|NCT00393939|3603122|FG001|Overall Study|Death|4
2032825|NCT00393939|3603121|FG000|Overall Study|Sponsor|5
2032826|NCT00393939|3603122|FG001|Overall Study|Sponsor|13
2032827|NCT00393939|3603121|FG000|Overall Study|Objective progression or relapse|239
2032828|NCT00393939|3603122|FG001|Overall Study|Objective progression or relapse|223
2032829|NCT00393939|3603121|FG000|Overall Study|Withdrawal by Subject|2
2032830|NCT00393939|3603122|FG001|Overall Study|Withdrawal by Subject|7
2032831|NCT00393939|3603121|FG000|Overall Study|Other|37
2032832|NCT00393939|3603122|FG001|Overall Study|Other|45
2032833|NCT00394082|3603137|FG000|Overall Study|Unacceptable toxicity|15
2032834|NCT00394082|3603137|FG000|Overall Study|Adverse Event|4
2032835|NCT00394082|3603137|FG000|Overall Study|Physician Decision|4
2032836|NCT00394082|3603137|FG000|Overall Study|Withdrawal by Subject|2
2032837|NCT00394082|3603137|FG000|Overall Study|Other|1
2032838|NCT00394095|3603143|FG000|Overall Study|Adverse Event|1
2218640|NCT01716520|3862283|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
2218641|NCT01716520|3862278|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
2218642|NCT01716520|3862279|FG001|Treatment Period 2 (14 Days)|Adverse Event|0
2218643|NCT01716520|3862280|FG002|Treatment Period 2 (14 Days)|Adverse Event|0
2218644|NCT01716520|3862281|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
2218645|NCT01716520|3862282|FG004|Treatment Period 2 (14 Days)|Adverse Event|1
2218646|NCT01716520|3862283|FG005|Treatment Period 2 (14 Days)|Adverse Event|0
2218647|NCT01716520|3862278|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
2218648|NCT01716520|3862279|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
2218649|NCT01716520|3862280|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
2032839|NCT00394095|3603144|FG001|Overall Study|Adverse Event|0
2032840|NCT00394212|3603153|FG000|Overall Study|Lost to Follow-up|3
2032841|NCT00394212|3603154|FG001|Overall Study|Lost to Follow-up|0
2032842|NCT00394212|3603153|FG000|Overall Study|Withdrawal by Subject|4
2032843|NCT00394212|3603154|FG001|Overall Study|Withdrawal by Subject|1
2032844|NCT00394251|3603162|FG000|Overall Study|Adverse Event|7
2032845|NCT00394251|3603163|FG001|Overall Study|Adverse Event|5
2032846|NCT00394251|3603162|FG000|Overall Study|Unacceptable Toxicity|20
2032847|NCT00394251|3603163|FG001|Overall Study|Unacceptable Toxicity|18
2032848|NCT00394251|3603162|FG000|Overall Study|Physician Decision|1
2032849|NCT00394251|3603163|FG001|Overall Study|Physician Decision|1
2032850|NCT00394251|3603162|FG000|Overall Study|Protocol Violation|0
2032851|NCT00394251|3603163|FG001|Overall Study|Protocol Violation|1
2032852|NCT00394251|3603162|FG000|Overall Study|Withdrawal by Subject|7
2032853|NCT00394251|3603163|FG001|Overall Study|Withdrawal by Subject|11
2032854|NCT00394251|3603162|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2
2032855|NCT00394251|3603163|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2
2032856|NCT00394433|3603213|FG000|Overall Study|Adverse Event|2
2032857|NCT00394433|3603213|FG000|Overall Study|Alternative Therapy|1
2032858|NCT00394472|3603219|FG000|Overall Study|Protocol Violation|1
2032859|NCT00394472|3603220|FG001|Overall Study|Protocol Violation|3
2032860|NCT00394472|3603219|FG000|Overall Study|incorrect enrolment|4
2032861|NCT00394472|3603220|FG001|Overall Study|incorrect enrolment|2
2032862|NCT00394472|3603219|FG000|Overall Study|Adverse Event|4
2032863|NCT00394472|3603220|FG001|Overall Study|Adverse Event|2
2032864|NCT00394472|3603219|FG000|Overall Study|Withdrawal by Subject|0
2032865|NCT00394472|3603220|FG001|Overall Study|Withdrawal by Subject|2
2032866|NCT00394472|3603219|FG000|Overall Study|Physician Decision|0
2032867|NCT00394472|3603220|FG001|Overall Study|Physician Decision|1
2032868|NCT00394472|3603219|FG000|Overall Study|Lost to Follow-up|0
2032869|NCT00394472|3603220|FG001|Overall Study|Lost to Follow-up|1
2032870|NCT00394524|3603228|FG000|Overall Study|Protocol Violation|2
2032871|NCT00394524|3603229|FG001|Overall Study|Protocol Violation|3
2032872|NCT00394524|3603228|FG000|Overall Study|Death|1
2032873|NCT00394524|3603229|FG001|Overall Study|Death|0
2032874|NCT00394524|3603228|FG000|Overall Study|Withdrawal by Subject|0
2032875|NCT00394524|3603229|FG001|Overall Study|Withdrawal by Subject|1
2032876|NCT00394589|3603240|FG000|Overall Study|Adverse Event|2
2032877|NCT00394589|3603241|FG001|Overall Study|Adverse Event|1
2032878|NCT00394589|3603242|FG002|Overall Study|Adverse Event|2
2032879|NCT00394589|3603240|FG000|Overall Study|Lack of Efficacy|2
2032880|NCT00394589|3603241|FG001|Overall Study|Lack of Efficacy|2
2032881|NCT00394589|3603242|FG002|Overall Study|Lack of Efficacy|3
2032882|NCT00394589|3603240|FG000|Overall Study|Protocol Violation|4
2032883|NCT00394589|3603241|FG001|Overall Study|Protocol Violation|0
2032884|NCT00394589|3603242|FG002|Overall Study|Protocol Violation|2
2032885|NCT00394654|3603252|FG000|Overall Study|Lost to Follow-up|1
2032886|NCT00394654|3603253|FG001|Overall Study|Lost to Follow-up|0
2032887|NCT00394654|3603252|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1
2032888|NCT00394654|3603253|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0
2218650|NCT01716520|3862281|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0
2218651|NCT01716520|3862282|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1
2032889|NCT00394706|3603267|FG000|Overall Study|Withdrawal by Subject|2
2032890|NCT00394706|3603268|FG001|Overall Study|Withdrawal by Subject|0
2032891|NCT00394706|3603269|FG002|Overall Study|Withdrawal by Subject|1
2032892|NCT00394706|3603270|FG003|Overall Study|Withdrawal by Subject|0
2032893|NCT00394706|3603271|FG004|Overall Study|Withdrawal by Subject|0
2032894|NCT00394706|3603272|FG005|Overall Study|Withdrawal by Subject|2
2032895|NCT00394706|3603273|FG006|Overall Study|Withdrawal by Subject|1
2032896|NCT00394706|3603274|FG007|Overall Study|Withdrawal by Subject|0
2032897|NCT00394706|3603267|FG000|Overall Study|Lost to Follow-up|2
2032898|NCT00394706|3603268|FG001|Overall Study|Lost to Follow-up|2
2032899|NCT00394706|3603269|FG002|Overall Study|Lost to Follow-up|8
2032900|NCT00394706|3603270|FG003|Overall Study|Lost to Follow-up|1
2032901|NCT00394706|3603271|FG004|Overall Study|Lost to Follow-up|2
2032902|NCT00394706|3603272|FG005|Overall Study|Lost to Follow-up|5
2032903|NCT00394706|3603273|FG006|Overall Study|Lost to Follow-up|2
2032904|NCT00394706|3603274|FG007|Overall Study|Lost to Follow-up|0
2032905|NCT00394771|3603292|FG000|Overall Study|Did not meet protocol requirements|1
2032906|NCT00394771|3603293|FG001|Overall Study|Did not meet protocol requirements|0
2032907|NCT00394771|3603294|FG002|Overall Study|Did not meet protocol requirements|2
2032908|NCT00394771|3603295|FG003|Overall Study|Did not meet protocol requirements|0
2032909|NCT00394771|3603292|FG000|Overall Study|Protocol Violation|2
2032910|NCT00394771|3603293|FG001|Overall Study|Protocol Violation|4
2032911|NCT00394771|3603294|FG002|Overall Study|Protocol Violation|9
2032912|NCT00394771|3603295|FG003|Overall Study|Protocol Violation|7
2032913|NCT00394771|3603292|FG000|Overall Study|Withdrawal by Subject|10
2032914|NCT00394771|3603293|FG001|Overall Study|Withdrawal by Subject|6
2032915|NCT00394771|3603294|FG002|Overall Study|Withdrawal by Subject|8
2032916|NCT00394771|3603295|FG003|Overall Study|Withdrawal by Subject|12
2032917|NCT00394771|3603292|FG000|Overall Study|Adverse Event|10
2032918|NCT00394771|3603293|FG001|Overall Study|Adverse Event|5
2032919|NCT00394771|3603294|FG002|Overall Study|Adverse Event|12
2032920|NCT00394771|3603295|FG003|Overall Study|Adverse Event|8
2032921|NCT00394771|3603292|FG000|Overall Study|Participant pregnant|0
2032922|NCT00394771|3603293|FG001|Overall Study|Participant pregnant|1
2032923|NCT00394771|3603294|FG002|Overall Study|Participant pregnant|2
2032924|NCT00394771|3603295|FG003|Overall Study|Participant pregnant|2
2032925|NCT00394771|3603292|FG000|Overall Study|Lost to Follow-up|15
2032926|NCT00394771|3603293|FG001|Overall Study|Lost to Follow-up|15
2032927|NCT00394771|3603294|FG002|Overall Study|Lost to Follow-up|13
2032928|NCT00394771|3603295|FG003|Overall Study|Lost to Follow-up|10
2032929|NCT00394771|3603292|FG000|Overall Study|Other|3
2032930|NCT00394771|3603293|FG001|Overall Study|Other|3
2032931|NCT00394771|3603294|FG002|Overall Study|Other|1
2032932|NCT00394771|3603295|FG003|Overall Study|Other|0
2032933|NCT00394836|3603307|FG000|Teatment or Follow-up Phase|Adverse Event|0
2111335|NCT00902278|3706052|FG003|Overall Study|Lost to Follow-up|0
2111336|NCT00902278|3706053|FG004|Overall Study|Lost to Follow-up|1
2111337|NCT00902304|3706068|FG000|Overall Study|Adverse Event|4
2111338|NCT00902304|3706069|FG001|Overall Study|Adverse Event|10
2111339|NCT00902304|3706070|FG002|Overall Study|Adverse Event|25
2111340|NCT00902304|3706068|FG000|Overall Study|Investigator discretion|3
2111341|NCT00902304|3706069|FG001|Overall Study|Investigator discretion|5
2111342|NCT00902304|3706070|FG002|Overall Study|Investigator discretion|13
2111343|NCT00902304|3706068|FG000|Overall Study|Lost to Follow-up|7
2111344|NCT00902304|3706069|FG001|Overall Study|Lost to Follow-up|7
2111345|NCT00902304|3706070|FG002|Overall Study|Lost to Follow-up|7
2111346|NCT00902304|3706068|FG000|Overall Study|Protocol Violation|9
2111347|NCT00902304|3706069|FG001|Overall Study|Protocol Violation|18
2111348|NCT00902304|3706070|FG002|Overall Study|Protocol Violation|20
2111349|NCT00902304|3706068|FG000|Overall Study|Withdrawal by Subject|32
2111350|NCT00902304|3706069|FG001|Overall Study|Withdrawal by Subject|22
2111351|NCT00902304|3706070|FG002|Overall Study|Withdrawal by Subject|43
2111352|NCT00902304|3706068|FG000|Overall Study|includes pregnancy|3
2111353|NCT00902304|3706069|FG001|Overall Study|includes pregnancy|9
2111354|NCT00902304|3706070|FG002|Overall Study|includes pregnancy|2
2111355|NCT00902330|3706081|FG000|Overall Study|Too overwhelmed by treatment|2
2111356|NCT00902330|3706082|FG001|Overall Study|Too overwhelmed by treatment|5
2111357|NCT00902330|3706081|FG000|Overall Study|Adverse Event|1
2111358|NCT00902330|3706082|FG001|Overall Study|Adverse Event|0
2111359|NCT00902330|3706081|FG000|Overall Study|No post baseline data|1
2111360|NCT00902330|3706082|FG001|Overall Study|No post baseline data|0
2032934|NCT00394836|3603308|FG001|Teatment or Follow-up Phase|Adverse Event|2
2032935|NCT00394836|3603307|FG000|Teatment or Follow-up Phase|Protocol Violation|0
2032936|NCT00394836|3603308|FG001|Teatment or Follow-up Phase|Protocol Violation|2
2032937|NCT00394836|3603307|FG000|Teatment or Follow-up Phase|Disease Progression|27
2032938|NCT00394836|3603308|FG001|Teatment or Follow-up Phase|Disease Progression|60
2032939|NCT00394836|3603307|FG000|Teatment or Follow-up Phase|Patient Refusal|1
2032940|NCT00394836|3603308|FG001|Teatment or Follow-up Phase|Patient Refusal|2
2032941|NCT00394836|3603307|FG000|Teatment or Follow-up Phase|Death|0
2032942|NCT00394836|3603308|FG001|Teatment or Follow-up Phase|Death|1
2032943|NCT00394836|3603307|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
2032944|NCT00394836|3603308|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
2032945|NCT00394836|3603307|FG000|Teatment or Follow-up Phase|Started alternative treatment|0
2032946|NCT00394836|3603308|FG001|Teatment or Follow-up Phase|Started alternative treatment|6
2032947|NCT00394836|3603307|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
2032948|NCT00394836|3603308|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
2032949|NCT00394836|3603307|FG000|Teatment or Follow-up Phase|Physician Decision|0
2032950|NCT00394836|3603308|FG001|Teatment or Follow-up Phase|Physician Decision|1
2032951|NCT00394836|3603307|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
2032952|NCT00394836|3603308|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
2032953|NCT00394836|3603307|FG000|Teatment or Follow-up Phase|Non compliance|0
2032954|NCT00394836|3603308|FG001|Teatment or Follow-up Phase|Non compliance|1
2032955|NCT00394836|3603307|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
2032956|NCT00394836|3603308|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
2032957|NCT00394836|3603307|FG000|Extended Follow-up Phase (2-5 Years)|Death|0
2032958|NCT00394836|3603308|FG001|Extended Follow-up Phase (2-5 Years)|Death|1
2032959|NCT00394836|3603307|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
2273936|NCT02291419|3954639|FG001|Overall Study|Early study termination|5
2218652|NCT01716520|3862283|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
2218653|NCT01716520|3862278|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2218654|NCT01716520|3862279|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2218655|NCT01716520|3862280|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2218656|NCT01716520|3862281|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
2218657|NCT01716520|3862282|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2218658|NCT01716520|3862283|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2218659|NCT01716520|3862278|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1
2218660|NCT01716520|3862279|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0
2218661|NCT01716520|3862280|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1
2218662|NCT01716520|3862281|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0
2218663|NCT01716520|3862282|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0
2218664|NCT01716520|3862283|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1
2218665|NCT01716520|3862278|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
2218666|NCT01716520|3862279|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2218667|NCT01716520|3862280|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2218668|NCT01716520|3862281|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2218669|NCT01716520|3862282|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2218670|NCT01716520|3862283|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2218671|NCT01716520|3862278|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2218672|NCT01716520|3862279|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2218673|NCT01716520|3862280|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2218674|NCT01716520|3862281|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2218675|NCT01716520|3862282|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2218676|NCT01716520|3862283|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
2218677|NCT01716520|3862278|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2218678|NCT01716520|3862279|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
2218679|NCT01716520|3862280|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2218680|NCT01716520|3862281|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2218681|NCT01716520|3862282|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2218682|NCT01716520|3862283|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2218683|NCT01716520|3862278|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2218684|NCT01716520|3862279|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2218685|NCT01716520|3862280|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2218686|NCT01716520|3862281|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2218687|NCT01716520|3862282|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2218688|NCT01716520|3862283|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2
2218689|NCT01716520|3862278|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2218690|NCT01716520|3862279|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2218691|NCT01716520|3862280|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
2218692|NCT01716520|3862281|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2331800|NCT03176238|4054603|FG000|Overall Study|Inter-current illness|0
2331801|NCT03176238|4054604|FG001|Overall Study|Inter-current illness|1
2331802|NCT03176238|4054603|FG000|Overall Study|Consent withdrawal|14
2331803|NCT03176238|4054604|FG001|Overall Study|Consent withdrawal|2
2331804|NCT03176238|4054603|FG000|Overall Study|Lost to Follow-up|3
2331805|NCT03176238|4054604|FG001|Overall Study|Lost to Follow-up|0
2331806|NCT03176238|4054603|FG000|Overall Study|Administrative problems|1
2331807|NCT03176238|4054604|FG001|Overall Study|Administrative problems|0
2331808|NCT03176238|4054603|FG000|Overall Study|Death|3
2331809|NCT03176238|4054604|FG001|Overall Study|Death|0
2331810|NCT03176238|4054603|FG000|Overall Study|Disease Progression|133
2331811|NCT03176238|4054604|FG001|Overall Study|Disease Progression|22
2331812|NCT03176238|4054603|FG000|Overall Study|Tx duration completed per EAP|0
2331813|NCT03176238|4054604|FG001|Overall Study|Tx duration completed per EAP|1
2331814|NCT03176238|4054603|FG000|Overall Study|Patient is switched to commercial drug|16
2331815|NCT03176238|4054604|FG001|Overall Study|Patient is switched to commercial drug|1
2331816|NCT03176238|4054603|FG000|Overall Study|Protocol Violation|1
2331817|NCT03176238|4054604|FG001|Overall Study|Protocol Violation|0
2032960|NCT00394836|3603308|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
2032961|NCT00394836|3603307|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
2032962|NCT00394836|3603308|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
2032963|NCT00394901|3603331|FG000|Baseline Phase|Protocol Violation|0
2032964|NCT00394901|3603332|FG001|Baseline Phase|Protocol Violation|0
2032965|NCT00394901|3603333|FG002|Baseline Phase|Protocol Violation|1
2032966|NCT00394901|3603334|FG003|Baseline Phase|Protocol Violation|0
2032967|NCT00394901|3603331|FG000|Double-blind Phase|Adverse Event|5
2032968|NCT00394901|3603332|FG001|Double-blind Phase|Adverse Event|7
2032969|NCT00394901|3603333|FG002|Double-blind Phase|Adverse Event|16
2032970|NCT00394901|3603334|FG003|Double-blind Phase|Adverse Event|20
2111361|NCT00902486|3706095|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
2111362|NCT00902486|3706096|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
2111363|NCT00902486|3706097|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
2111364|NCT00902486|3706098|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
2111365|NCT00902486|3706099|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
2111366|NCT00902486|3706100|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
2111367|NCT00902486|3706095|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
2111368|NCT00902486|3706096|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
2111369|NCT00902486|3706097|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
2111370|NCT00902486|3706098|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
2111371|NCT00902486|3706099|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
2111372|NCT00902486|3706100|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
2111373|NCT00902486|3706095|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
2111374|NCT00902486|3706096|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
2111375|NCT00902486|3706097|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
2111376|NCT00902486|3706098|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
2111377|NCT00902486|3706099|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
2111378|NCT00902486|3706100|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
2111379|NCT00902486|3706095|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
2111380|NCT00902486|3706096|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
2111381|NCT00902486|3706097|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
2111382|NCT00902486|3706098|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
2111383|NCT00902486|3706099|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
2111384|NCT00902486|3706100|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
2111385|NCT00902486|3706095|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
2111386|NCT00902486|3706096|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
2111387|NCT00902486|3706097|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
2032971|NCT00394901|3603331|FG000|Double-blind Phase|Lack of Efficacy|6
2032972|NCT00394901|3603332|FG001|Double-blind Phase|Lack of Efficacy|4
2032973|NCT00394901|3603333|FG002|Double-blind Phase|Lack of Efficacy|1
2032974|NCT00394901|3603334|FG003|Double-blind Phase|Lack of Efficacy|3
2032975|NCT00394901|3603331|FG000|Double-blind Phase|Withdrawal by Subject|2
2032976|NCT00394901|3603332|FG001|Double-blind Phase|Withdrawal by Subject|0
2032977|NCT00394901|3603333|FG002|Double-blind Phase|Withdrawal by Subject|0
2032978|NCT00394901|3603334|FG003|Double-blind Phase|Withdrawal by Subject|0
2032979|NCT00394901|3603331|FG000|Double-blind Phase|Lost to Follow-up|0
2032980|NCT00394901|3603332|FG001|Double-blind Phase|Lost to Follow-up|0
2032981|NCT00394901|3603333|FG002|Double-blind Phase|Lost to Follow-up|0
2032982|NCT00394901|3603334|FG003|Double-blind Phase|Lost to Follow-up|1
2032983|NCT00394901|3603331|FG000|Double-blind Phase|Protocol Violation|0
2032984|NCT00394901|3603332|FG001|Double-blind Phase|Protocol Violation|0
2032985|NCT00394901|3603333|FG002|Double-blind Phase|Protocol Violation|0
2032986|NCT00394901|3603334|FG003|Double-blind Phase|Protocol Violation|1
2111388|NCT00902486|3706098|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
2111389|NCT00902486|3706099|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
2111390|NCT00902486|3706100|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
2111391|NCT00902486|3706095|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0
2111392|NCT00902486|3706096|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0
2111393|NCT00902486|3706097|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0
2111394|NCT00902486|3706098|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0
2111395|NCT00902486|3706099|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1
2111396|NCT00902486|3706100|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2
2111397|NCT00902486|3706095|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
2111398|NCT00902486|3706096|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
2111399|NCT00902486|3706097|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
2111400|NCT00902486|3706098|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
2032987|NCT00394901|3603331|FG000|Double-blind Phase|Death|1
2032988|NCT00394901|3603332|FG001|Double-blind Phase|Death|0
2032989|NCT00394901|3603333|FG002|Double-blind Phase|Death|0
2032990|NCT00394901|3603334|FG003|Double-blind Phase|Death|0
2032991|NCT00394901|3603331|FG000|Double-blind Phase|Subject's Personal Reason|1
2032992|NCT00394901|3603332|FG001|Double-blind Phase|Subject's Personal Reason|0
2032993|NCT00394901|3603333|FG002|Double-blind Phase|Subject's Personal Reason|0
2032994|NCT00394901|3603334|FG003|Double-blind Phase|Subject's Personal Reason|1
2032995|NCT00394901|3603331|FG000|Double-blind Phase|Lack of Compliance|0
2032996|NCT00394901|3603332|FG001|Double-blind Phase|Lack of Compliance|3
2032997|NCT00394901|3603333|FG002|Double-blind Phase|Lack of Compliance|0
2032998|NCT00394901|3603334|FG003|Double-blind Phase|Lack of Compliance|0
2032999|NCT00394901|3603331|FG000|Double-blind Phase|Entry into another study was found|0
2033000|NCT00394901|3603332|FG001|Double-blind Phase|Entry into another study was found|0
2033001|NCT00394901|3603333|FG002|Double-blind Phase|Entry into another study was found|1
2033002|NCT00394901|3603334|FG003|Double-blind Phase|Entry into another study was found|0
2033003|NCT00394901|3603331|FG000|Double-blind Phase|Found not to meet entrance criteria|0
2033004|NCT00394901|3603332|FG001|Double-blind Phase|Found not to meet entrance criteria|0
2033005|NCT00394901|3603333|FG002|Double-blind Phase|Found not to meet entrance criteria|0
2033006|NCT00394901|3603334|FG003|Double-blind Phase|Found not to meet entrance criteria|1
2033007|NCT00394914|3603349|FG000|Treatment Period|Adverse Event|0
2033008|NCT00394914|3603350|FG001|Treatment Period|Adverse Event|3
2033009|NCT00394914|3603351|FG002|Treatment Period|Adverse Event|1
2033010|NCT00394914|3603349|FG000|Treatment Period|Lost to Follow-up|0
2033011|NCT00394914|3603350|FG001|Treatment Period|Lost to Follow-up|1
2033012|NCT00394914|3603351|FG002|Treatment Period|Lost to Follow-up|0
2033013|NCT00394914|3603349|FG000|Treatment Period|Withdrawal by Subject|0
2033014|NCT00394914|3603350|FG001|Treatment Period|Withdrawal by Subject|2
2033015|NCT00394914|3603351|FG002|Treatment Period|Withdrawal by Subject|2
2033016|NCT00394914|3603349|FG000|Treatment Period|Noncompliance with protocol|0
2033017|NCT00394914|3603350|FG001|Treatment Period|Noncompliance with protocol|3
2033018|NCT00394914|3603351|FG002|Treatment Period|Noncompliance with protocol|2
2033019|NCT00394914|3603349|FG000|Treatment Period|Did not meet protocol eligibility|0
2033020|NCT00394914|3603350|FG001|Treatment Period|Did not meet protocol eligibility|1
2033021|NCT00394914|3603351|FG002|Treatment Period|Did not meet protocol eligibility|1
2033022|NCT00394953|3603359|FG000|First Treatment Period|Adverse Event|1
2033023|NCT00394953|3603360|FG001|First Treatment Period|Adverse Event|2
2033024|NCT00394953|3603359|FG000|First Treatment Period|Death|6
2033025|NCT00394953|3603360|FG001|First Treatment Period|Death|7
2033026|NCT00394953|3603359|FG000|First Treatment Period|Lack of Efficacy|1
2033027|NCT00394953|3603360|FG001|First Treatment Period|Lack of Efficacy|1
2033028|NCT00394953|3603359|FG000|First Treatment Period|Withdrawal by Subject|6
2033029|NCT00394953|3603360|FG001|First Treatment Period|Withdrawal by Subject|3
2033030|NCT00394953|3603359|FG000|First Treatment Period|Lost to Follow-up|0
2033031|NCT00394953|3603360|FG001|First Treatment Period|Lost to Follow-up|1
2033032|NCT00394953|3603359|FG000|First Treatment Period|Renal transplant|11
2033033|NCT00394953|3603360|FG001|First Treatment Period|Renal transplant|7
2033034|NCT00394953|3603359|FG000|First Treatment Period|Not defined|4
2033035|NCT00394953|3603360|FG001|First Treatment Period|Not defined|1
2033036|NCT00394953|3603359|FG000|Second Treatment Period|Adverse Event|2
2033037|NCT00394953|3603360|FG001|Second Treatment Period|Adverse Event|5
2033038|NCT00394953|3603359|FG000|Second Treatment Period|Death|8
2033039|NCT00394953|3603360|FG001|Second Treatment Period|Death|4
2033040|NCT00394953|3603359|FG000|Second Treatment Period|Lack of Efficacy|9
2033041|NCT00394953|3603360|FG001|Second Treatment Period|Lack of Efficacy|47
2033042|NCT00394953|3603359|FG000|Second Treatment Period|Withdrawal by Subject|3
2033043|NCT00394953|3603360|FG001|Second Treatment Period|Withdrawal by Subject|3
2033044|NCT00394953|3603359|FG000|Second Treatment Period|Lost to Follow-up|0
2218693|NCT01716520|3862282|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2218694|NCT01716520|3862283|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2218695|NCT01716533|3862295|FG000|Overall Study|Failure of antibiotic treatment to treat|0
2218696|NCT01716533|3862296|FG001|Overall Study|Failure of antibiotic treatment to treat|0
2218697|NCT01716533|3862297|FG002|Overall Study|Failure of antibiotic treatment to treat|5
2218698|NCT01716533|3862298|FG003|Overall Study|Failure of antibiotic treatment to treat|0
2218699|NCT01716533|3862295|FG000|Overall Study|Withdrawal by Subject|0
2218700|NCT01716533|3862296|FG001|Overall Study|Withdrawal by Subject|0
2218701|NCT01716533|3862297|FG002|Overall Study|Withdrawal by Subject|0
2218702|NCT01716533|3862298|FG003|Overall Study|Withdrawal by Subject|5
2218703|NCT01716533|3862295|FG000|Overall Study|Death|0
2218704|NCT01716533|3862296|FG001|Overall Study|Death|0
2218705|NCT01716533|3862297|FG002|Overall Study|Death|0
2218706|NCT01716533|3862298|FG003|Overall Study|Death|2
2218707|NCT01716533|3862295|FG000|Overall Study|Immunosuppressants>14days past 6months|0
2218708|NCT01716533|3862296|FG001|Overall Study|Immunosuppressants>14days past 6months|0
2218709|NCT01716533|3862297|FG002|Overall Study|Immunosuppressants>14days past 6months|0
2218710|NCT01716533|3862298|FG003|Overall Study|Immunosuppressants>14days past 6months|1
2218711|NCT01716559|3862312|FG000|Overall Study|Adverse Event|11
2218712|NCT01716559|3862312|FG000|Overall Study|Death|21
2218713|NCT01716559|3862312|FG000|Overall Study|Withdrawal by Subject|4
2218714|NCT01716559|3862312|FG000|Overall Study|Other withdrawal reason|75
2218715|NCT01716585|3862318|FG000|Double-blind Treatment|Did Not Receive Study Drug|4
2218716|NCT01716585|3862319|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
2218717|NCT01716585|3862318|FG000|Double-blind Treatment|Adverse Event|2
2218718|NCT01716585|3862319|FG001|Double-blind Treatment|Adverse Event|1
2218719|NCT01716585|3862318|FG000|Double-blind Treatment|Withdrawal by Subject|3
2218720|NCT01716585|3862319|FG001|Double-blind Treatment|Withdrawal by Subject|0
2218721|NCT01716585|3862318|FG000|Double-blind Treatment|Lost to Follow-up|2
2218722|NCT01716585|3862319|FG001|Double-blind Treatment|Lost to Follow-up|0
2218723|NCT01716585|3862318|FG000|Double-blind Treatment|Subject Noncompliant|1
2218724|NCT01716585|3862319|FG001|Double-blind Treatment|Subject Noncompliant|0
2218725|NCT01716585|3862318|FG000|Double-blind Treatment|Other|1
2218726|NCT01716585|3862319|FG001|Double-blind Treatment|Other|0
2218727|NCT01716585|3862318|FG000|Open-label Treatment|Adverse Event|0
2218728|NCT01716585|3862319|FG001|Open-label Treatment|Adverse Event|2
2218729|NCT01716585|3862318|FG000|Open-label Treatment|Virologic Failure|0
2218730|NCT01716585|3862319|FG001|Open-label Treatment|Virologic Failure|2
2218731|NCT01716585|3862318|FG000|Open-label Treatment|Withdrawal by Subject|0
2218732|NCT01716585|3862319|FG001|Open-label Treatment|Withdrawal by Subject|3
2218733|NCT01716663|3862326|FG000|Overall Study|Withdrawn prior to procedure|4
2218734|NCT01716663|3862326|FG000|Overall Study|Treated with non-study catheter|2
2218735|NCT01716715|3862332|FG000|Overall Study|Never Treated|2
2218736|NCT01716715|3862333|FG001|Overall Study|Never Treated|4
2218737|NCT01716754|3862345|FG000|Overall Study|Death|0
2218738|NCT01716754|3862346|FG001|Overall Study|Death|0
2218739|NCT01716754|3862347|FG002|Overall Study|Death|0
2218740|NCT01716754|3862348|FG003|Overall Study|Death|1
2218741|NCT01716754|3862345|FG000|Overall Study|Protocol deviation|0
2218742|NCT01716754|3862346|FG001|Overall Study|Protocol deviation|2
2218743|NCT01716754|3862347|FG002|Overall Study|Protocol deviation|7
2218744|NCT01716754|3862348|FG003|Overall Study|Protocol deviation|2
2218745|NCT01716754|3862345|FG000|Overall Study|Non-compliance with study treatment|0
2218746|NCT01716754|3862346|FG001|Overall Study|Non-compliance with study treatment|0
2218747|NCT01716754|3862347|FG002|Overall Study|Non-compliance with study treatment|1
2033045|NCT00394953|3603360|FG001|Second Treatment Period|Lost to Follow-up|1
2033046|NCT00394953|3603359|FG000|Second Treatment Period|Renal transplant|4
2033047|NCT00394953|3603360|FG001|Second Treatment Period|Renal transplant|6
2033048|NCT00394953|3603359|FG000|Second Treatment Period|Not defined|3
2033049|NCT00394953|3603360|FG001|Second Treatment Period|Not defined|8
2033050|NCT00395018|3603366|FG000|On-Treatment|Death|4
2033051|NCT00395018|3603366|FG000|On-Treatment|Other Reason|2
2033052|NCT00395018|3603366|FG000|On-Treatment|Poor/non-compliance|2
2033053|NCT00395018|3603366|FG000|On-Treatment|Subject no longer meets study criteria|2
2033054|NCT00395018|3603366|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1
2033055|NCT00395018|3603366|FG000|Off-Treatment Follow-up|Lost to Follow-up|2
2033056|NCT00395018|3603366|FG000|Off-Treatment Follow-up|Poor/non-compliance|1
2033057|NCT00395083|3603398|FG000|Overall Study|Withdrawal by Subject|6
2033058|NCT00395083|3603399|FG001|Overall Study|Withdrawal by Subject|5
2033059|NCT00395083|3603398|FG000|Overall Study|Developed another disease|4
2033060|NCT00395083|3603399|FG001|Overall Study|Developed another disease|3
2033061|NCT00395226|3603438|FG000|Overall Study|Adverse Event|4
2033062|NCT00395226|3603439|FG001|Overall Study|Adverse Event|3
2033063|NCT00395226|3603438|FG000|Overall Study|Withdrawal by Subject|0
2033064|NCT00395226|3603439|FG001|Overall Study|Withdrawal by Subject|1
2033065|NCT00395226|3603438|FG000|Overall Study|Lost to Follow-up|0
2033066|NCT00395226|3603439|FG001|Overall Study|Lost to Follow-up|1
2033067|NCT00395304|3603452|FG000|Treatment Period 1|Withdrawal by Subject|0
2033068|NCT00395304|3603453|FG001|Treatment Period 1|Withdrawal by Subject|3
2033069|NCT00395304|3603454|FG002|Treatment Period 1|Withdrawal by Subject|0
2033070|NCT00395304|3603455|FG003|Treatment Period 1|Withdrawal by Subject|2
2033071|NCT00395304|3603456|FG004|Treatment Period 1|Withdrawal by Subject|1
2033072|NCT00395304|3603457|FG005|Treatment Period 1|Withdrawal by Subject|1
2033073|NCT00395304|3603452|FG000|Treatment Period 1|Lost to Follow-up|1
2033074|NCT00395304|3603453|FG001|Treatment Period 1|Lost to Follow-up|0
2033075|NCT00395304|3603454|FG002|Treatment Period 1|Lost to Follow-up|0
2033076|NCT00395304|3603455|FG003|Treatment Period 1|Lost to Follow-up|1
2033077|NCT00395304|3603456|FG004|Treatment Period 1|Lost to Follow-up|0
2033078|NCT00395304|3603457|FG005|Treatment Period 1|Lost to Follow-up|1
2033079|NCT00395304|3603452|FG000|Treatment Period 1|Physician Decision|0
2033080|NCT00395304|3603453|FG001|Treatment Period 1|Physician Decision|1
2111401|NCT00902486|3706099|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
2111402|NCT00902486|3706100|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
2111403|NCT00902486|3706095|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
2111404|NCT00902486|3706096|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
2111405|NCT00902486|3706097|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
2111406|NCT00902486|3706098|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
2111407|NCT00902486|3706099|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
2111408|NCT00902486|3706100|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
2111409|NCT00902486|3706095|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0
2111410|NCT00902486|3706096|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0
2111411|NCT00902486|3706097|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0
2111412|NCT00902486|3706098|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1
2111413|NCT00902486|3706099|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0
2111414|NCT00902486|3706100|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0
2111415|NCT00902486|3706095|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
2111416|NCT00902486|3706096|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
2111417|NCT00902486|3706097|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
2111418|NCT00902486|3706098|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
2111419|NCT00902486|3706099|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
2033081|NCT00395304|3603454|FG002|Treatment Period 1|Physician Decision|0
2033082|NCT00395304|3603455|FG003|Treatment Period 1|Physician Decision|0
2033083|NCT00395304|3603456|FG004|Treatment Period 1|Physician Decision|0
2033084|NCT00395304|3603457|FG005|Treatment Period 1|Physician Decision|0
2033085|NCT00395304|3603452|FG000|Treatment Period 2|Withdrawal by Subject|0
2033086|NCT00395304|3603453|FG001|Treatment Period 2|Withdrawal by Subject|0
2033087|NCT00395304|3603454|FG002|Treatment Period 2|Withdrawal by Subject|0
2033088|NCT00395304|3603455|FG003|Treatment Period 2|Withdrawal by Subject|1
2033089|NCT00395304|3603456|FG004|Treatment Period 2|Withdrawal by Subject|0
2033090|NCT00395304|3603457|FG005|Treatment Period 2|Withdrawal by Subject|2
2033091|NCT00395304|3603452|FG000|Treatment Period 2|Lost to Follow-up|0
2033092|NCT00395304|3603453|FG001|Treatment Period 2|Lost to Follow-up|3
2033093|NCT00395304|3603454|FG002|Treatment Period 2|Lost to Follow-up|0
2033094|NCT00395304|3603455|FG003|Treatment Period 2|Lost to Follow-up|0
2033095|NCT00395304|3603456|FG004|Treatment Period 2|Lost to Follow-up|0
2033096|NCT00395304|3603457|FG005|Treatment Period 2|Lost to Follow-up|0
2033097|NCT00395304|3603452|FG000|Treatment Period 2|Physician Decision|0
2111420|NCT00902486|3706100|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
2111421|NCT00902486|3706095|FG000|Follow-up (After Week 24)|Lost to Follow-up|0
2111422|NCT00902486|3706096|FG001|Follow-up (After Week 24)|Lost to Follow-up|0
2111423|NCT00902486|3706097|FG002|Follow-up (After Week 24)|Lost to Follow-up|0
2111424|NCT00902486|3706098|FG003|Follow-up (After Week 24)|Lost to Follow-up|1
2111425|NCT00902486|3706099|FG004|Follow-up (After Week 24)|Lost to Follow-up|0
2111426|NCT00902486|3706100|FG005|Follow-up (After Week 24)|Lost to Follow-up|0
2111427|NCT00902538|3706133|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
2111428|NCT00902538|3706134|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
2111429|NCT00902538|3706135|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
2111430|NCT00902538|3706136|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
2111431|NCT00902538|3706137|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
2111432|NCT00902538|3706138|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
2111433|NCT00902538|3706133|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
2111434|NCT00902538|3706134|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
2111435|NCT00902538|3706135|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
2111436|NCT00902538|3706136|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
2111437|NCT00902538|3706137|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
2111438|NCT00902538|3706138|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
2111439|NCT00902538|3706133|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
2111440|NCT00902538|3706134|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
2111441|NCT00902538|3706135|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
2111442|NCT00902538|3706136|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
2111443|NCT00902538|3706137|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
2111444|NCT00902538|3706138|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
2111445|NCT00902538|3706133|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
2111446|NCT00902538|3706134|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
2111447|NCT00902538|3706135|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
2111448|NCT00902538|3706136|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
2111449|NCT00902538|3706137|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
2033098|NCT00395304|3603453|FG001|Treatment Period 2|Physician Decision|0
2033099|NCT00395304|3603454|FG002|Treatment Period 2|Physician Decision|1
2033100|NCT00395304|3603455|FG003|Treatment Period 2|Physician Decision|0
2033101|NCT00395304|3603456|FG004|Treatment Period 2|Physician Decision|0
2033102|NCT00395304|3603457|FG005|Treatment Period 2|Physician Decision|0
2033103|NCT00395304|3603452|FG000|Treatment Period 2|Other|0
2033104|NCT00395304|3603453|FG001|Treatment Period 2|Other|1
2033105|NCT00395304|3603454|FG002|Treatment Period 2|Other|0
2033106|NCT00395304|3603455|FG003|Treatment Period 2|Other|0
2033107|NCT00395304|3603456|FG004|Treatment Period 2|Other|0
2033108|NCT00395304|3603457|FG005|Treatment Period 2|Other|0
2033109|NCT00395304|3603452|FG000|Treatment Period 3|Withdrawal by Subject|0
2033110|NCT00395304|3603453|FG001|Treatment Period 3|Withdrawal by Subject|0
2033111|NCT00395304|3603454|FG002|Treatment Period 3|Withdrawal by Subject|0
2033112|NCT00395304|3603455|FG003|Treatment Period 3|Withdrawal by Subject|1
2033113|NCT00395304|3603456|FG004|Treatment Period 3|Withdrawal by Subject|0
2033114|NCT00395304|3603457|FG005|Treatment Period 3|Withdrawal by Subject|1
2033115|NCT00395304|3603452|FG000|Treatment Period 3|Lost to Follow-up|1
2033116|NCT00395304|3603453|FG001|Treatment Period 3|Lost to Follow-up|1
2033117|NCT00395304|3603454|FG002|Treatment Period 3|Lost to Follow-up|0
2033118|NCT00395304|3603455|FG003|Treatment Period 3|Lost to Follow-up|0
2033119|NCT00395304|3603456|FG004|Treatment Period 3|Lost to Follow-up|0
2273937|NCT02291432|3954645|FG000|Overall Study|Withdrawal by Subject|2
2180394|NCT01401452|3806527|FG000|Overall Study|Subject's wife wants to get pregnant|1
2180395|NCT01401452|3806527|FG000|Overall Study|Psoriatic arthritis|1
2180396|NCT01401452|3806527|FG000|Overall Study|Participant stopped Tx|2
2180397|NCT01401452|3806527|FG000|Overall Study|Discontinuation for personal reasons|1
2180398|NCT01401452|3806527|FG000|Overall Study|Treatment failure|1
2180399|NCT01401452|3806527|FG000|Overall Study|Unsatisfactory output|1
2180400|NCT01401452|3806527|FG000|Overall Study|Subject withdrew because of Tx success|1
2180401|NCT01401452|3806527|FG000|Overall Study|Subject chose to discontinue treatment|1
2180402|NCT01401452|3806527|FG000|Overall Study|Participant withdrew consent|1
2180403|NCT01401465|3806533|FG000|Treatment Period 1|Adverse Event|4
2180404|NCT01401465|3806534|FG001|Treatment Period 1|Adverse Event|1
2180405|NCT01401465|3806533|FG000|Treatment Period 1|Pregnancy|0
2180406|NCT01401465|3806534|FG001|Treatment Period 1|Pregnancy|1
2180407|NCT01401465|3806533|FG000|Treatment Period 1|Protocol Violation|5
2180408|NCT01401465|3806534|FG001|Treatment Period 1|Protocol Violation|0
2180409|NCT01401465|3806533|FG000|Treatment Period 1|Withdrawal by Subject|1
2180410|NCT01401465|3806534|FG001|Treatment Period 1|Withdrawal by Subject|4
2180411|NCT01401465|3806533|FG000|Treatment Period 1|Non-Compliance to Study Drug|1
2180412|NCT01401465|3806534|FG001|Treatment Period 1|Non-Compliance to Study Drug|0
2180413|NCT01401465|3806533|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3
2180414|NCT01401465|3806534|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9
2180415|NCT01401465|3806533|FG000|Treatment Period 1|Scheduling Difficulties|1
2180416|NCT01401465|3806534|FG001|Treatment Period 1|Scheduling Difficulties|1
2180417|NCT01401465|3806533|FG000|Treatment Period 2|Lost to Follow-up|0
2180418|NCT01401465|3806534|FG001|Treatment Period 2|Lost to Follow-up|1
2180419|NCT01401465|3806533|FG000|Treatment Period 2|Withdrawal by Subject|0
2180420|NCT01401465|3806534|FG001|Treatment Period 2|Withdrawal by Subject|1
2180421|NCT01401478|3806543|FG000|Overall Study|Study drug not available|6
2180422|NCT01401478|3806543|FG000|Overall Study|Adverse Event|5
2180423|NCT01401478|3806543|FG000|Overall Study|Hyperphosphatemia|5
2180424|NCT01401478|3806543|FG000|Overall Study|Lost to Follow-up|5
2180425|NCT01401478|3806543|FG000|Overall Study|Kidney transplantation|3
2180426|NCT01401478|3806543|FG000|Overall Study|Withdrawal by Subject|3
2033120|NCT00395304|3603457|FG005|Treatment Period 3|Lost to Follow-up|0
2033121|NCT00395304|3603452|FG000|Treatment Period 3|Physician Decision|0
2033122|NCT00395304|3603453|FG001|Treatment Period 3|Physician Decision|1
2033123|NCT00395304|3603454|FG002|Treatment Period 3|Physician Decision|0
2033124|NCT00395304|3603455|FG003|Treatment Period 3|Physician Decision|0
2033125|NCT00395304|3603456|FG004|Treatment Period 3|Physician Decision|0
2033126|NCT00395304|3603457|FG005|Treatment Period 3|Physician Decision|0
2033127|NCT00395304|3603452|FG000|Treatment Period 3|Other|0
2033128|NCT00395304|3603453|FG001|Treatment Period 3|Other|0
2033129|NCT00395304|3603454|FG002|Treatment Period 3|Other|0
2111450|NCT00902538|3706138|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
2111451|NCT00902538|3706133|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
2111452|NCT00902538|3706134|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
2111453|NCT00902538|3706135|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
2111454|NCT00902538|3706136|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
2111455|NCT00902538|3706137|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
2111456|NCT00902538|3706138|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
2111457|NCT00902538|3706133|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4
2111458|NCT00902538|3706134|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2
2111459|NCT00902538|3706135|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3
2111460|NCT00902538|3706136|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0
2111461|NCT00902538|3706137|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0
2111462|NCT00902538|3706138|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0
2111463|NCT00902538|3706133|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
2111464|NCT00902538|3706134|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
2111465|NCT00902538|3706135|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
2111466|NCT00902538|3706136|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
2111467|NCT00902538|3706137|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
2111468|NCT00902538|3706138|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
2111469|NCT00902538|3706133|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
2111470|NCT00902538|3706134|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
2111471|NCT00902538|3706135|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
2111472|NCT00902538|3706136|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
2111473|NCT00902538|3706137|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
2111474|NCT00902538|3706138|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
2111475|NCT00902538|3706133|FG000|2-Randomized Double-blind 3 Treatments|Other|2
2111476|NCT00902538|3706134|FG001|2-Randomized Double-blind 3 Treatments|Other|1
2111477|NCT00902538|3706135|FG002|2-Randomized Double-blind 3 Treatments|Other|0
2111478|NCT00902538|3706136|FG003|2-Randomized Double-blind 3 Treatments|Other|0
2111479|NCT00902538|3706137|FG004|2-Randomized Double-blind 3 Treatments|Other|0
2111480|NCT00902538|3706138|FG005|2-Randomized Double-blind 3 Treatments|Other|0
2111481|NCT00902538|3706133|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
2111482|NCT00902538|3706134|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
2111483|NCT00902538|3706135|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
2111484|NCT00902538|3706136|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
2111485|NCT00902538|3706137|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
2111486|NCT00902538|3706138|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
2111487|NCT00902538|3706133|FG000|3-Single-blind, Single Treatment|Adverse Event|0
2111488|NCT00902538|3706134|FG001|3-Single-blind, Single Treatment|Adverse Event|5
2111489|NCT00902538|3706135|FG002|3-Single-blind, Single Treatment|Adverse Event|0
2111490|NCT00902538|3706136|FG003|3-Single-blind, Single Treatment|Adverse Event|0
2111491|NCT00902538|3706137|FG004|3-Single-blind, Single Treatment|Adverse Event|0
2111492|NCT00902538|3706138|FG005|3-Single-blind, Single Treatment|Adverse Event|0
2111493|NCT00902538|3706133|FG000|3-Single-blind, Single Treatment|Protocol Violation|0
2111494|NCT00902538|3706134|FG001|3-Single-blind, Single Treatment|Protocol Violation|5
2111495|NCT00902538|3706135|FG002|3-Single-blind, Single Treatment|Protocol Violation|0
2111496|NCT00902538|3706136|FG003|3-Single-blind, Single Treatment|Protocol Violation|0
2111497|NCT00902538|3706137|FG004|3-Single-blind, Single Treatment|Protocol Violation|0
2111498|NCT00902538|3706138|FG005|3-Single-blind, Single Treatment|Protocol Violation|0
2111499|NCT00902538|3706133|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0
2111500|NCT00902538|3706134|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4
2111501|NCT00902538|3706135|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0
2111502|NCT00902538|3706136|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0
2111503|NCT00902538|3706137|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0
2218748|NCT01716754|3862348|FG003|Overall Study|Non-compliance with study treatment|0
2218749|NCT01716754|3862345|FG000|Overall Study|Physician Decision|1
2218750|NCT01716754|3862346|FG001|Overall Study|Physician Decision|0
2218751|NCT01716754|3862347|FG002|Overall Study|Physician Decision|0
2218752|NCT01716754|3862348|FG003|Overall Study|Physician Decision|0
2218753|NCT01716754|3862345|FG000|Overall Study|Lost to Follow-up|1
2218754|NCT01716754|3862346|FG001|Overall Study|Lost to Follow-up|0
2218755|NCT01716754|3862347|FG002|Overall Study|Lost to Follow-up|0
2218756|NCT01716754|3862348|FG003|Overall Study|Lost to Follow-up|1
2218757|NCT01716754|3862345|FG000|Overall Study|Adverse Event|4
2218758|NCT01716754|3862346|FG001|Overall Study|Adverse Event|2
2218759|NCT01716754|3862347|FG002|Overall Study|Adverse Event|2
2218760|NCT01716754|3862348|FG003|Overall Study|Adverse Event|1
2218761|NCT01716754|3862345|FG000|Overall Study|Withdrawal by Subject|5
2218762|NCT01716754|3862346|FG001|Overall Study|Withdrawal by Subject|0
2218763|NCT01716754|3862347|FG002|Overall Study|Withdrawal by Subject|4
2218764|NCT01716754|3862348|FG003|Overall Study|Withdrawal by Subject|3
2218765|NCT01717040|3862372|FG000|Overall Study|Lost to Follow-up|2
2218766|NCT01717040|3862373|FG001|Overall Study|Lost to Follow-up|3
2218767|NCT01717040|3862372|FG000|Overall Study|Lack of Efficacy|1
2033130|NCT00395304|3603455|FG003|Treatment Period 3|Other|1
2033131|NCT00395304|3603456|FG004|Treatment Period 3|Other|0
2033132|NCT00395304|3603457|FG005|Treatment Period 3|Other|0
2033133|NCT00395343|3603466|FG000|Overall Study|Adverse Event|13
2033134|NCT00395343|3603467|FG001|Overall Study|Adverse Event|5
2033135|NCT00395343|3603466|FG000|Overall Study|Lack of Efficacy|0
2033136|NCT00395343|3603467|FG001|Overall Study|Lack of Efficacy|1
2033137|NCT00395343|3603466|FG000|Overall Study|Lost to Follow-up|4
2033138|NCT00395343|3603467|FG001|Overall Study|Lost to Follow-up|4
2033139|NCT00395343|3603466|FG000|Overall Study|Physician Decision|2
2033140|NCT00395343|3603467|FG001|Overall Study|Physician Decision|4
2033141|NCT00395343|3603466|FG000|Overall Study|Protocol Violation|6
2033142|NCT00395343|3603467|FG001|Overall Study|Protocol Violation|8
2033143|NCT00395343|3603466|FG000|Overall Study|Withdrawal by Subject|11
2033144|NCT00395343|3603467|FG001|Overall Study|Withdrawal by Subject|12
2033145|NCT00395343|3603466|FG000|Overall Study|Other|5
2033146|NCT00395343|3603467|FG001|Overall Study|Other|2
2033147|NCT00395447|3603475|FG000|Overall Study|Death|37
2033148|NCT00395447|3603476|FG001|Overall Study|Death|32
2033149|NCT00395447|3603475|FG000|Overall Study|Lost to Follow-up|52
2033150|NCT00395447|3603476|FG001|Overall Study|Lost to Follow-up|43
2033151|NCT00395447|3603475|FG000|Overall Study|Withdrawal by Subject|24
2033152|NCT00395447|3603476|FG001|Overall Study|Withdrawal by Subject|19
2033153|NCT00395447|3603475|FG000|Overall Study|Withdrawl - Other (not subject)|8
2111504|NCT00902538|3706138|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0
2111505|NCT00902538|3706133|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0
2033154|NCT00395447|3603476|FG001|Overall Study|Withdrawl - Other (not subject)|17
2033155|NCT00395460|3603484|FG000|Overall Study|Withdrawal by Subject|1
2033156|NCT00395460|3603485|FG001|Overall Study|Withdrawal by Subject|0
2033157|NCT00395486|3603493|FG000|Overall Study|Adverse Event|1
2033158|NCT00395486|3603494|FG001|Overall Study|Adverse Event|2
2033159|NCT00395486|3603493|FG000|Overall Study|Withdrawal by Subject|5
2033160|NCT00395486|3603494|FG001|Overall Study|Withdrawal by Subject|2
2033161|NCT00395486|3603493|FG000|Overall Study|Lost to Follow-up|0
2033162|NCT00395486|3603494|FG001|Overall Study|Lost to Follow-up|1
2033163|NCT00395512|3603504|FG000|Overall Study|Adverse Event|3
2033164|NCT00395512|3603505|FG001|Overall Study|Adverse Event|8
2033165|NCT00395512|3603506|FG002|Overall Study|Adverse Event|6
2033166|NCT00395512|3603507|FG003|Overall Study|Adverse Event|6
2033167|NCT00395512|3603504|FG000|Overall Study|Protocol Violation|2
2033168|NCT00395512|3603505|FG001|Overall Study|Protocol Violation|3
2033169|NCT00395512|3603506|FG002|Overall Study|Protocol Violation|6
2033170|NCT00395512|3603507|FG003|Overall Study|Protocol Violation|7
2033171|NCT00395512|3603504|FG000|Overall Study|Lost to Follow-up|2
2033172|NCT00395512|3603505|FG001|Overall Study|Lost to Follow-up|6
2033173|NCT00395512|3603506|FG002|Overall Study|Lost to Follow-up|5
2033174|NCT00395512|3603507|FG003|Overall Study|Lost to Follow-up|5
2033175|NCT00395512|3603504|FG000|Overall Study|Withdrawal by Subject|6
2033176|NCT00395512|3603505|FG001|Overall Study|Withdrawal by Subject|5
2033177|NCT00395512|3603506|FG002|Overall Study|Withdrawal by Subject|5
2033178|NCT00395512|3603507|FG003|Overall Study|Withdrawal by Subject|12
2218768|NCT01717040|3862373|FG001|Overall Study|Lack of Efficacy|1
2218769|NCT01717040|3862372|FG000|Overall Study|Adverse Event|1
2218770|NCT01717040|3862373|FG001|Overall Study|Adverse Event|0
2218771|NCT01717040|3862372|FG000|Overall Study|Required Medication Change|0
2218772|NCT01717040|3862373|FG001|Overall Study|Required Medication Change|1
2218773|NCT01717040|3862372|FG000|Overall Study|New Substance Use Disorder|1
2218774|NCT01717040|3862373|FG001|Overall Study|New Substance Use Disorder|0
2218775|NCT01717287|3862389|FG000|Overall Study|Lost to Follow-up|0
2218776|NCT01717287|3862390|FG001|Overall Study|Lost to Follow-up|2
2218777|NCT01717287|3862389|FG000|Overall Study|Protocol Violation|0
2218778|NCT01717287|3862390|FG001|Overall Study|Protocol Violation|1
2218779|NCT01717313|3862398|FG000|Phase A (Weeks 0 to 24)|Death|0
2218780|NCT01717313|3862399|FG001|Phase A (Weeks 0 to 24)|Death|1
2218781|NCT01717313|3862398|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
2218782|NCT01717313|3862399|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
2218783|NCT01717313|3862398|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
2218784|NCT01717313|3862399|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
2218785|NCT01717313|3862398|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4
2218786|NCT01717313|3862399|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2
2218787|NCT01717313|3862398|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
2033179|NCT00395512|3603504|FG000|Overall Study|Physician Decision|6
2033180|NCT00395512|3603505|FG001|Overall Study|Physician Decision|4
2033181|NCT00395512|3603506|FG002|Overall Study|Physician Decision|2
2033182|NCT00395512|3603507|FG003|Overall Study|Physician Decision|2
2033183|NCT00395512|3603504|FG000|Overall Study|Other|1
2033184|NCT00395512|3603505|FG001|Overall Study|Other|1
2033185|NCT00395512|3603506|FG002|Overall Study|Other|0
2033186|NCT00395512|3603507|FG003|Overall Study|Other|0
2033187|NCT00395512|3603504|FG000|Overall Study|Hyperglycemic Rescue|18
2033188|NCT00395512|3603505|FG001|Overall Study|Hyperglycemic Rescue|10
2033189|NCT00395512|3603506|FG002|Overall Study|Hyperglycemic Rescue|4
2033190|NCT00395512|3603507|FG003|Overall Study|Hyperglycemic Rescue|6
2111506|NCT00902538|3706134|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1
2111507|NCT00902538|3706135|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0
2111508|NCT00902538|3706136|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0
2111509|NCT00902538|3706137|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0
2111510|NCT00902538|3706138|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0
2111511|NCT00902538|3706133|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0
2111512|NCT00902538|3706134|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0
2111513|NCT00902538|3706135|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0
2111514|NCT00902538|3706136|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3
2111515|NCT00902538|3706137|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1
2111516|NCT00902538|3706138|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1
2111517|NCT00902538|3706133|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
2111518|NCT00902538|3706134|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
2111519|NCT00902538|3706135|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
2111520|NCT00902538|3706136|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
2111521|NCT00902538|3706137|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
2111522|NCT00902538|3706138|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
2111523|NCT00902538|3706133|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
2111524|NCT00902538|3706134|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
2111525|NCT00902538|3706135|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
2111526|NCT00902538|3706136|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
2111527|NCT00902538|3706137|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
2111528|NCT00902538|3706138|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
2111529|NCT00902564|3706150|FG000|Overall Study|Withdrawal by Subject|2
2111530|NCT00902577|3706154|FG000|Overall Study|Withdrawal by Subject|6
2111531|NCT00902577|3706154|FG000|Overall Study|FMISO production failure|2
2111532|NCT00902746|3706177|FG000|Overall Study|Protocol Violation|7
2111533|NCT00902746|3706177|FG000|Overall Study|Withdrawal by Subject|16
2111534|NCT00902746|3706177|FG000|Overall Study|Adverse Event|8
2111535|NCT00902746|3706177|FG000|Overall Study|Lost to Follow-up|3
2111536|NCT00902746|3706177|FG000|Overall Study|Physician Decision|2
2111537|NCT00902850|3706183|FG000|Overall Study|Physician Decision|2
2111538|NCT00902850|3706184|FG001|Overall Study|Physician Decision|2
2111539|NCT00903032|3706192|FG000|Overall Study|Withdrawal by Subject|5
2111540|NCT00903032|3706193|FG001|Overall Study|Withdrawal by Subject|3
2111541|NCT00903032|3706192|FG000|Overall Study|Lost to Follow-up|2
2111542|NCT00903032|3706193|FG001|Overall Study|Lost to Follow-up|2
2111543|NCT00903175|3706205|FG000|Period 1 - First Line|Adverse Event|36
2111544|NCT00903175|3706206|FG001|Period 1 - First Line|Adverse Event|50
2111545|NCT00903175|3706205|FG000|Period 1 - First Line|Abnormal lab value(s)|0
2111546|NCT00903175|3706206|FG001|Period 1 - First Line|Abnormal lab value(s)|1
2111547|NCT00903175|3706205|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1
2111548|NCT00903175|3706206|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0
2111549|NCT00903175|3706205|FG000|Period 1 - First Line|Protocol Violation|3
2111550|NCT00903175|3706206|FG001|Period 1 - First Line|Protocol Violation|3
2111551|NCT00903175|3706205|FG000|Period 1 - First Line|Withdrawal by Subject|8
2033191|NCT00395538|3603520|FG000|Overall Study|Did not re-consent to revised protocol|1
2033192|NCT00395538|3603521|FG001|Overall Study|Did not re-consent to revised protocol|10
2033193|NCT00395538|3603522|FG002|Overall Study|Did not re-consent to revised protocol|0
2033194|NCT00395538|3603520|FG000|Overall Study|FDA partial hold on PTH|0
2033195|NCT00395538|3603521|FG001|Overall Study|FDA partial hold on PTH|0
2033196|NCT00395538|3603522|FG002|Overall Study|FDA partial hold on PTH|11
2033197|NCT00395538|3603520|FG000|Overall Study|Failed screening|0
2033198|NCT00395538|3603521|FG001|Overall Study|Failed screening|0
2033199|NCT00395538|3603522|FG002|Overall Study|Failed screening|4
2033200|NCT00395538|3603520|FG000|Overall Study|Switch to Natpara|0
2033201|NCT00395538|3603521|FG001|Overall Study|Switch to Natpara|0
2033202|NCT00395538|3603522|FG002|Overall Study|Switch to Natpara|3
2033203|NCT00395538|3603520|FG000|Overall Study|Adverse Event|1
2033204|NCT00395538|3603521|FG001|Overall Study|Adverse Event|0
2033205|NCT00395538|3603522|FG002|Overall Study|Adverse Event|2
2033206|NCT00395538|3603520|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0
2033207|NCT00395538|3603521|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2
2033208|NCT00395538|3603522|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0
2033209|NCT00395538|3603520|FG000|Overall Study|Non-compliance with study protocol|0
2033210|NCT00395538|3603521|FG001|Overall Study|Non-compliance with study protocol|1
2033211|NCT00395538|3603522|FG002|Overall Study|Non-compliance with study protocol|0
2033212|NCT00395538|3603520|FG000|Overall Study|PTH resistance|0
2033213|NCT00395538|3603521|FG001|Overall Study|PTH resistance|0
2033214|NCT00395538|3603522|FG002|Overall Study|PTH resistance|1
2033215|NCT00395538|3603520|FG000|Overall Study|Pregnancy|1
2033216|NCT00395538|3603521|FG001|Overall Study|Pregnancy|0
2033217|NCT00395538|3603522|FG002|Overall Study|Pregnancy|0
2033218|NCT00395538|3603520|FG000|Overall Study|Partial recovery of parathyroid function|0
2033219|NCT00395538|3603521|FG001|Overall Study|Partial recovery of parathyroid function|0
2033220|NCT00395538|3603522|FG002|Overall Study|Partial recovery of parathyroid function|1
2033221|NCT00395538|3603520|FG000|Overall Study|Participant elected to discontinue|0
2033222|NCT00395538|3603521|FG001|Overall Study|Participant elected to discontinue|0
2033223|NCT00395538|3603522|FG002|Overall Study|Participant elected to discontinue|1
2033224|NCT00395629|3603533|FG000|Core Study|Adverse Event|0
2033225|NCT00395629|3603534|FG001|Core Study|Adverse Event|3
2033226|NCT00395629|3603535|FG002|Core Study|Adverse Event|4
2033227|NCT00395629|3603533|FG000|Core Study|Abnormal laboratory value(s)|0
2033228|NCT00395629|3603534|FG001|Core Study|Abnormal laboratory value(s)|0
2033229|NCT00395629|3603535|FG002|Core Study|Abnormal laboratory value(s)|1
2033230|NCT00395629|3603533|FG000|Core Study|Protocol Violation|1
2033231|NCT00395629|3603534|FG001|Core Study|Protocol Violation|0
2033232|NCT00395629|3603535|FG002|Core Study|Protocol Violation|0
2033233|NCT00395629|3603533|FG000|Core Study|Withdrawal by Subject|0
2033234|NCT00395629|3603534|FG001|Core Study|Withdrawal by Subject|1
2033235|NCT00395629|3603535|FG002|Core Study|Withdrawal by Subject|1
2033236|NCT00395629|3603533|FG000|Core Study|Lost to Follow-up|0
2033237|NCT00395629|3603534|FG001|Core Study|Lost to Follow-up|0
2033238|NCT00395629|3603535|FG002|Core Study|Lost to Follow-up|1
2033239|NCT00395629|3603533|FG000|Extension Study|Adverse Event|0
2033240|NCT00395629|3603534|FG001|Extension Study|Adverse Event|0
2033241|NCT00395629|3603535|FG002|Extension Study|Adverse Event|2
2033242|NCT00395629|3603533|FG000|Extension Study|Administrative problems|0
2033243|NCT00395629|3603534|FG001|Extension Study|Administrative problems|0
2033244|NCT00395629|3603535|FG002|Extension Study|Administrative problems|1
2033245|NCT00395642|3603546|FG000|Overall Study|Death|4
2033246|NCT00395642|3603546|FG000|Overall Study|Lost to Follow-up|1
2033247|NCT00395642|3603546|FG000|Overall Study|Physician Decision|7
2033248|NCT00395642|3603546|FG000|Overall Study|Withdrawal by Subject|1
2033249|NCT00395694|3603552|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1
2033250|NCT00395694|3603553|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2
2033251|NCT00395694|3603552|FG000|Continuation Phase|Adverse Event|1
2033252|NCT00395694|3603553|FG001|Continuation Phase|Adverse Event|0
2033253|NCT00395694|3603552|FG000|Continuation Phase|Lack of Efficacy|12
2033254|NCT00395694|3603553|FG001|Continuation Phase|Lack of Efficacy|11
2033255|NCT00395694|3603552|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1
2033256|NCT00395694|3603553|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0
2033257|NCT00395694|3603552|FG000|Continuation Phase|Poor Compliance|1
2033258|NCT00395694|3603553|FG001|Continuation Phase|Poor Compliance|0
2033259|NCT00395694|3603552|FG000|Continuation Phase|Withdrawal by Subject|0
2033260|NCT00395694|3603553|FG001|Continuation Phase|Withdrawal by Subject|2
2033261|NCT00395733|3603564|FG000|Period 2|Withdrawal by Subject|1
2033262|NCT00395733|3603565|FG001|Period 2|Withdrawal by Subject|2
2033263|NCT00395733|3603564|FG000|Period 2|Protocol Violation|0
2033264|NCT00395733|3603565|FG001|Period 2|Protocol Violation|1
2033265|NCT00395733|3603564|FG000|Period 2|Adverse Event|0
2033266|NCT00395733|3603565|FG001|Period 2|Adverse Event|2
2033267|NCT00395733|3603564|FG000|Period 2|Technical problems|1
2218788|NCT01717313|3862399|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
2033268|NCT00395733|3603565|FG001|Period 2|Technical problems|0
2033269|NCT00395746|3603574|FG000|Overall Study|Adverse Event|5
2033270|NCT00395746|3603575|FG001|Overall Study|Adverse Event|2
2033271|NCT00395746|3603576|FG002|Overall Study|Adverse Event|2
2033272|NCT00395746|3603574|FG000|Overall Study|Protocol Violation|0
2033273|NCT00395746|3603575|FG001|Overall Study|Protocol Violation|1
2033274|NCT00395746|3603576|FG002|Overall Study|Protocol Violation|0
2033275|NCT00395746|3603574|FG000|Overall Study|Lack of Efficacy|2
2033276|NCT00395746|3603575|FG001|Overall Study|Lack of Efficacy|0
2033277|NCT00395746|3603576|FG002|Overall Study|Lack of Efficacy|17
2033278|NCT00395746|3603574|FG000|Overall Study|Hypoglycaemia|2
2033279|NCT00395746|3603575|FG001|Overall Study|Hypoglycaemia|1
2033280|NCT00395746|3603576|FG002|Overall Study|Hypoglycaemia|0
2033281|NCT00395746|3603574|FG000|Overall Study|Subject decision|0
2033282|NCT00395746|3603575|FG001|Overall Study|Subject decision|0
2033283|NCT00395746|3603576|FG002|Overall Study|Subject decision|1
2033284|NCT00395746|3603574|FG000|Overall Study|Withdrawal of consent|0
2033285|NCT00395746|3603575|FG001|Overall Study|Withdrawal of consent|0
2033286|NCT00395746|3603576|FG002|Overall Study|Withdrawal of consent|1
2033287|NCT00395746|3603574|FG000|Overall Study|Difficultulty in use of device|0
2033288|NCT00395746|3603575|FG001|Overall Study|Difficultulty in use of device|0
2033289|NCT00395746|3603576|FG002|Overall Study|Difficultulty in use of device|1
2033290|NCT00395746|3603574|FG000|Overall Study|Unable to visit site on schedule|1
2033291|NCT00395746|3603575|FG001|Overall Study|Unable to visit site on schedule|0
2033292|NCT00395746|3603576|FG002|Overall Study|Unable to visit site on schedule|0
2033293|NCT00395850|3603588|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
2033294|NCT00395850|3603589|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
2033295|NCT00395850|3603590|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
2033296|NCT00395850|3603591|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
2033297|NCT00395850|3603588|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
2033298|NCT00395850|3603589|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
2033299|NCT00395850|3603590|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
2033300|NCT00395850|3603591|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
2033301|NCT00395850|3603588|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1
2033302|NCT00395850|3603589|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0
2033303|NCT00395850|3603590|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0
2111552|NCT00903175|3706206|FG001|Period 1 - First Line|Withdrawal by Subject|12
2111553|NCT00903175|3706205|FG000|Period 1 - First Line|Administrative problems|12
2111554|NCT00903175|3706206|FG001|Period 1 - First Line|Administrative problems|13
2111555|NCT00903175|3706205|FG000|Period 1 - First Line|Death|17
2111556|NCT00903175|3706206|FG001|Period 1 - First Line|Death|10
2218789|NCT01717313|3862398|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1
2033304|NCT00395850|3603591|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0
2033305|NCT00395850|3603588|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
2033306|NCT00395850|3603589|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
2033307|NCT00395850|3603590|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
2033308|NCT00395850|3603591|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
2033309|NCT00395850|3603588|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
2033310|NCT00395850|3603589|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
2033311|NCT00395850|3603590|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
2033312|NCT00395850|3603591|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
2033313|NCT00395850|3603588|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
2033314|NCT00395850|3603589|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
2033315|NCT00395850|3603590|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
2033316|NCT00395850|3603591|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
2033317|NCT00395850|3603588|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
2033318|NCT00395850|3603589|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
2033319|NCT00395850|3603590|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
2033320|NCT00395850|3603591|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
2033321|NCT00395863|3603603|FG000|Overall Study|Patients did not complete both exams|2
2033322|NCT00395863|3603604|FG001|Overall Study|Patients did not complete both exams|3
2033323|NCT00395967|3603622|FG000|Treatment Period|Failed Mobilization|1
2033324|NCT00395967|3603622|FG000|Follow-up Period|Death|1
2033325|NCT00395967|3603622|FG000|Follow-up Period|Lost to Follow-up|1
2111557|NCT00903175|3706205|FG000|Period 2 - Second Line|Missing|1
2111558|NCT00903175|3706206|FG001|Period 2 - Second Line|Missing|0
2111559|NCT00903175|3706205|FG000|Period 2 - Second Line|Adverse Event|16
2111560|NCT00903175|3706206|FG001|Period 2 - Second Line|Adverse Event|20
2111561|NCT00903175|3706205|FG000|Period 2 - Second Line|Withdrawal by Subject|7
2111562|NCT00903175|3706206|FG001|Period 2 - Second Line|Withdrawal by Subject|5
2111563|NCT00903175|3706205|FG000|Period 2 - Second Line|Lost to Follow-up|1
2111564|NCT00903175|3706206|FG001|Period 2 - Second Line|Lost to Follow-up|0
2111565|NCT00903175|3706205|FG000|Period 2 - Second Line|Administrative problems|19
2111566|NCT00903175|3706206|FG001|Period 2 - Second Line|Administrative problems|9
2111567|NCT00903175|3706205|FG000|Period 2 - Second Line|Death|5
2111568|NCT00903175|3706206|FG001|Period 2 - Second Line|Death|2
2111569|NCT00903201|3706215|FG000|Overall Study|Adverse Event|1
2111570|NCT00903201|3706216|FG001|Overall Study|Adverse Event|4
2111571|NCT00903201|3706217|FG002|Overall Study|Adverse Event|0
2111572|NCT00903201|3706215|FG000|Overall Study|Protocol Violation|2
2111573|NCT00903201|3706216|FG001|Overall Study|Protocol Violation|1
2111574|NCT00903201|3706217|FG002|Overall Study|Protocol Violation|0
2111575|NCT00903201|3706215|FG000|Overall Study|Lost to Follow-up|0
2111576|NCT00903201|3706216|FG001|Overall Study|Lost to Follow-up|1
2111577|NCT00903201|3706217|FG002|Overall Study|Lost to Follow-up|0
2111578|NCT00903201|3706215|FG000|Overall Study|Physician Decision|1
2111579|NCT00903201|3706216|FG001|Overall Study|Physician Decision|0
2111580|NCT00903201|3706217|FG002|Overall Study|Physician Decision|1
2111581|NCT00903201|3706215|FG000|Overall Study|Withdrawal by Subject|1
2111582|NCT00903201|3706216|FG001|Overall Study|Withdrawal by Subject|0
2111583|NCT00903201|3706217|FG002|Overall Study|Withdrawal by Subject|1
2180427|NCT01401478|3806543|FG000|Overall Study|Blood samples not available|1
2180428|NCT01401478|3806543|FG000|Overall Study|Hyperphosphatemia and adverse event|1
2180429|NCT01401478|3806543|FG000|Overall Study|Low intact parathyroid hormone|1
2180430|NCT01401478|3806543|FG000|Overall Study|Serious adverse event|1
2180431|NCT01401530|3806563|FG000|Overall Study|Disease Progression|1
2180432|NCT01401530|3806564|FG001|Overall Study|Disease Progression|2
2180433|NCT01401530|3806565|FG002|Overall Study|Disease Progression|1
2180434|NCT01401530|3806563|FG000|Overall Study|Adverse Event|1
2180435|NCT01401530|3806564|FG001|Overall Study|Adverse Event|1
2180436|NCT01401530|3806565|FG002|Overall Study|Adverse Event|1
2033326|NCT00396084|3603669|FG000|Overall Study|Adverse Event|0
2033327|NCT00396084|3603670|FG001|Overall Study|Adverse Event|0
2033328|NCT00396084|3603671|FG002|Overall Study|Adverse Event|0
2033329|NCT00396084|3603672|FG003|Overall Study|Adverse Event|0
2033330|NCT00396084|3603673|FG004|Overall Study|Adverse Event|1
2033331|NCT00396084|3603674|FG005|Overall Study|Adverse Event|2
2033332|NCT00396084|3603669|FG000|Overall Study|Withdrawal by Subject|0
2033333|NCT00396084|3603670|FG001|Overall Study|Withdrawal by Subject|0
2033334|NCT00396084|3603671|FG002|Overall Study|Withdrawal by Subject|0
2033335|NCT00396084|3603672|FG003|Overall Study|Withdrawal by Subject|1
2033336|NCT00396084|3603673|FG004|Overall Study|Withdrawal by Subject|0
2033337|NCT00396084|3603674|FG005|Overall Study|Withdrawal by Subject|0
2033338|NCT00396097|3603694|FG000|Overall Study|Withdrawal by Subject|17
2033339|NCT00396097|3603695|FG001|Overall Study|Withdrawal by Subject|17
2033340|NCT00396097|3603694|FG000|Overall Study|Lost to Follow-up|4
2033341|NCT00396097|3603695|FG001|Overall Study|Lost to Follow-up|9
2033342|NCT00396097|3603694|FG000|Overall Study|Other|3
2033343|NCT00396097|3603695|FG001|Overall Study|Other|5
2033344|NCT00396097|3603694|FG000|Overall Study|Protocol Violation|0
2033345|NCT00396097|3603695|FG001|Overall Study|Protocol Violation|6
2033346|NCT00396097|3603694|FG000|Overall Study|Adverse Event|1
2033347|NCT00396097|3603695|FG001|Overall Study|Adverse Event|5
2033348|NCT00396097|3603694|FG000|Overall Study|Insufficient Clinical Response|1
2033349|NCT00396097|3603695|FG001|Overall Study|Insufficient Clinical Response|4
2033350|NCT00396136|3603705|FG000|Overall Study|Death|43
2033351|NCT00396136|3603705|FG000|Overall Study|Withdrawal by Subject|59
2033352|NCT00396136|3603705|FG000|Overall Study|Lost to Follow-up|15
2033353|NCT00396136|3603705|FG000|Overall Study|Study device explanted|8
2033354|NCT00396162|3603711|FG000|Overall Study|Withdrawal by Subject|2
2033355|NCT00396162|3603712|FG001|Overall Study|Withdrawal by Subject|3
2218790|NCT01717313|3862399|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0
2218791|NCT01717313|3862398|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
2218792|NCT01717313|3862399|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
2218793|NCT01717313|3862398|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
2218794|NCT01717313|3862399|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
2218795|NCT01717313|3862398|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
2218796|NCT01717313|3862399|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
2033356|NCT00396253|3603727|FG000|Overall Study|Protocol Violation|1
2033357|NCT00396253|3603727|FG000|Overall Study|Withdrawal by Subject|7
2033358|NCT00396253|3603727|FG000|Overall Study|Death|3
2033359|NCT00396253|3603727|FG000|Overall Study|Physician Decision|1
2033360|NCT00396253|3603727|FG000|Overall Study|Change in eligibility status|1
2033361|NCT00396279|3603744|FG000|Overall Study|Ongoing in study|26
2033362|NCT00396279|3603744|FG000|Overall Study|Disease progression|2
2033363|NCT00396279|3603744|FG000|Overall Study|Withdrawal by Subject|1
2033364|NCT00396279|3603744|FG000|Overall Study|Physician Decision|1
2033365|NCT00396318|3603757|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
2033366|NCT00396331|3603765|FG000|Overall Study|Failed to mobilize - no transplant|8
2033367|NCT00396331|3603765|FG000|Overall Study|Did not go on to transplant|5
2033368|NCT00396331|3603765|FG000|Overall Study|Lost to Follow-up|3
2033369|NCT00396331|3603765|FG000|Overall Study|Death|16
2033370|NCT00396383|3603777|FG000|Overall Study|Death|2
2033371|NCT00396383|3603777|FG000|Overall Study|Lost to Follow-up|1
2033372|NCT00396409|3603783|FG000|Period 1 - 2007|Adverse Event|0
2033373|NCT00396409|3603784|FG001|Period 1 - 2007|Adverse Event|1
2033374|NCT00396409|3603783|FG000|Period 1 - 2007|Lack of Efficacy|0
2033375|NCT00396409|3603784|FG001|Period 1 - 2007|Lack of Efficacy|1
2033376|NCT00396409|3603783|FG000|Period 1 - 2007|Withdrawal by Subject|1
2033377|NCT00396409|3603784|FG001|Period 1 - 2007|Withdrawal by Subject|1
2033378|NCT00396409|3603783|FG000|Period 1 - 2007|Lost to Follow-up|2
2033379|NCT00396409|3603784|FG001|Period 1 - 2007|Lost to Follow-up|3
2033380|NCT00396409|3603783|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3
2033381|NCT00396409|3603784|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2
2033382|NCT00396409|3603783|FG000|Period 2 - 2008|Protocol Violation|1
2033383|NCT00396409|3603784|FG001|Period 2 - 2008|Protocol Violation|0
2033384|NCT00396409|3603783|FG000|Period 2 - 2008|Withdrawal by Subject|3
2033385|NCT00396409|3603784|FG001|Period 2 - 2008|Withdrawal by Subject|1
2033386|NCT00396409|3603783|FG000|Period 2 - 2008|Lost to Follow-up|3
2033387|NCT00396409|3603784|FG001|Period 2 - 2008|Lost to Follow-up|1
2033388|NCT00396565|3603795|FG000|Overall Study|Physician Decision|3
2033389|NCT00396565|3603796|FG001|Overall Study|Physician Decision|1
2033390|NCT00396565|3603797|FG002|Overall Study|Physician Decision|2
2033391|NCT00396565|3603795|FG000|Overall Study|Adverse Event|5
2033392|NCT00396565|3603796|FG001|Overall Study|Adverse Event|13
2033393|NCT00396565|3603797|FG002|Overall Study|Adverse Event|3
2033394|NCT00396565|3603795|FG000|Overall Study|Withdrawal by Subject|8
2033395|NCT00396565|3603796|FG001|Overall Study|Withdrawal by Subject|13
2033396|NCT00396565|3603797|FG002|Overall Study|Withdrawal by Subject|1
2033397|NCT00396565|3603795|FG000|Overall Study|Lack of Efficacy|32
2033398|NCT00396565|3603796|FG001|Overall Study|Lack of Efficacy|64
2033399|NCT00396565|3603797|FG002|Overall Study|Lack of Efficacy|11
2033400|NCT00396591|3603805|FG000|Overall Study|Disease Progression|13
2033401|NCT00396591|3603805|FG000|Overall Study|Adverse Event|2
2033402|NCT00396591|3603805|FG000|Overall Study|Participant request|1
2033403|NCT00396630|3603811|FG000|Overall Study|Lost to Follow-up|1
2033404|NCT00396630|3603812|FG001|Overall Study|Lost to Follow-up|1
2033405|NCT00396630|3603811|FG000|Overall Study|Withdrawal by Subject|1
2033406|NCT00396630|3603812|FG001|Overall Study|Withdrawal by Subject|1
2033407|NCT00396630|3603811|FG000|Overall Study|Not vaccinated at Visit 3|3
2033408|NCT00396630|3603812|FG001|Overall Study|Not vaccinated at Visit 3|3
2033409|NCT00396656|3603819|FG000|First Treatment Period|Withdrawal by Subject|0
2033410|NCT00396656|3603820|FG001|First Treatment Period|Withdrawal by Subject|2
2033411|NCT00396656|3603819|FG000|Second Treatment Period|Adverse Event|0
2033412|NCT00396656|3603820|FG001|Second Treatment Period|Adverse Event|1
2033413|NCT00396812|3603826|FG000|Overall Study|Physician Decision|1
2033414|NCT00396877|3603832|FG000|Overall Study|Lost to Follow-up|2
2033415|NCT00396877|3603833|FG001|Overall Study|Lost to Follow-up|1
2033416|NCT00396877|3603832|FG000|Overall Study|Parent(s)/guardian(s)'s request|4
2033417|NCT00396877|3603833|FG001|Overall Study|Parent(s)/guardian(s)'s request|7
2033418|NCT00397033|3603860|FG000|Overall Study|Adverse Event|7
2033419|NCT00397033|3603861|FG001|Overall Study|Adverse Event|10
2033420|NCT00397033|3603862|FG002|Overall Study|Adverse Event|4
2033421|NCT00397033|3603860|FG000|Overall Study|Lack of Efficacy|22
2033422|NCT00397033|3603861|FG001|Overall Study|Lack of Efficacy|12
2033423|NCT00397033|3603862|FG002|Overall Study|Lack of Efficacy|9
2033424|NCT00397033|3603860|FG000|Overall Study|Lost to Follow-up|3
2033425|NCT00397033|3603861|FG001|Overall Study|Lost to Follow-up|3
2033426|NCT00397033|3603862|FG002|Overall Study|Lost to Follow-up|3
2033427|NCT00397033|3603860|FG000|Overall Study|Withdrawal by Subject|12
2033428|NCT00397033|3603861|FG001|Overall Study|Withdrawal by Subject|7
2033429|NCT00397033|3603862|FG002|Overall Study|Withdrawal by Subject|5
2218797|NCT01717326|3862425|FG000|Overall Study|Death|0
2218798|NCT01717326|3862426|FG001|Overall Study|Death|0
2218799|NCT01717326|3862427|FG002|Overall Study|Death|0
2218800|NCT01717326|3862428|FG003|Overall Study|Death|0
2218801|NCT01717326|3862429|FG004|Overall Study|Death|0
2218802|NCT01717326|3862430|FG005|Overall Study|Death|0
2218803|NCT01717326|3862431|FG006|Overall Study|Death|0
2218804|NCT01717326|3862432|FG007|Overall Study|Death|0
2218805|NCT01717326|3862433|FG008|Overall Study|Death|0
2218806|NCT01717326|3862434|FG009|Overall Study|Death|0
2218807|NCT01717326|3862435|FG010|Overall Study|Death|1
2218808|NCT01717326|3862436|FG011|Overall Study|Death|0
2218809|NCT01717326|3862437|FG012|Overall Study|Death|0
2218810|NCT01717326|3862438|FG013|Overall Study|Death|0
2218811|NCT01717326|3862439|FG014|Overall Study|Death|0
2218812|NCT01717326|3862440|FG015|Overall Study|Death|0
2218813|NCT01717326|3862441|FG016|Overall Study|Death|0
2218814|NCT01717326|3862442|FG017|Overall Study|Death|0
2218815|NCT01717326|3862443|FG018|Overall Study|Death|0
2218816|NCT01717326|3862444|FG019|Overall Study|Death|0
2218817|NCT01717326|3862425|FG000|Overall Study|Lost to Follow-up|3
2218818|NCT01717326|3862426|FG001|Overall Study|Lost to Follow-up|0
2218819|NCT01717326|3862427|FG002|Overall Study|Lost to Follow-up|0
2218820|NCT01717326|3862428|FG003|Overall Study|Lost to Follow-up|2
2218821|NCT01717326|3862429|FG004|Overall Study|Lost to Follow-up|1
2218822|NCT01717326|3862430|FG005|Overall Study|Lost to Follow-up|0
2218823|NCT01717326|3862431|FG006|Overall Study|Lost to Follow-up|1
2218824|NCT01717326|3862432|FG007|Overall Study|Lost to Follow-up|0
2218825|NCT01717326|3862433|FG008|Overall Study|Lost to Follow-up|0
2218826|NCT01717326|3862434|FG009|Overall Study|Lost to Follow-up|0
2218827|NCT01717326|3862435|FG010|Overall Study|Lost to Follow-up|1
2218828|NCT01717326|3862436|FG011|Overall Study|Lost to Follow-up|0
2218829|NCT01717326|3862437|FG012|Overall Study|Lost to Follow-up|0
2218830|NCT01717326|3862438|FG013|Overall Study|Lost to Follow-up|0
2218831|NCT01717326|3862439|FG014|Overall Study|Lost to Follow-up|0
2218832|NCT01717326|3862440|FG015|Overall Study|Lost to Follow-up|2
2218833|NCT01717326|3862441|FG016|Overall Study|Lost to Follow-up|1
2218834|NCT01717326|3862442|FG017|Overall Study|Lost to Follow-up|0
2218835|NCT01717326|3862443|FG018|Overall Study|Lost to Follow-up|2
2218836|NCT01717326|3862444|FG019|Overall Study|Lost to Follow-up|3
2218837|NCT01717326|3862425|FG000|Overall Study|Physician Decision|0
2218838|NCT01717326|3862426|FG001|Overall Study|Physician Decision|0
2218839|NCT01717326|3862427|FG002|Overall Study|Physician Decision|0
2218840|NCT01717326|3862428|FG003|Overall Study|Physician Decision|0
2218841|NCT01717326|3862429|FG004|Overall Study|Physician Decision|0
2218842|NCT01717326|3862430|FG005|Overall Study|Physician Decision|0
2218843|NCT01717326|3862431|FG006|Overall Study|Physician Decision|0
2218844|NCT01717326|3862432|FG007|Overall Study|Physician Decision|0
2218845|NCT01717326|3862433|FG008|Overall Study|Physician Decision|0
2218846|NCT01717326|3862434|FG009|Overall Study|Physician Decision|1
2218847|NCT01717326|3862435|FG010|Overall Study|Physician Decision|0
2218848|NCT01717326|3862436|FG011|Overall Study|Physician Decision|0
2033430|NCT00397033|3603860|FG000|Overall Study|Other|0
2033431|NCT00397033|3603861|FG001|Overall Study|Other|5
2033432|NCT00397033|3603862|FG002|Overall Study|Other|2
2033433|NCT00397046|3603874|FG000|Overall Study|Disease Progression|3
2033434|NCT00397046|3603875|FG001|Overall Study|Disease Progression|3
2033435|NCT00397046|3603876|FG002|Overall Study|Disease Progression|10
2033436|NCT00397046|3603877|FG003|Overall Study|Disease Progression|5
2033437|NCT00397189|3603899|FG000|3 Weeks Period|Lost to Follow-up|5
2033438|NCT00397189|3603900|FG001|3 Weeks Period|Lost to Follow-up|4
2033439|NCT00397189|3603899|FG000|3 Weeks Period|Adverse Event|3
2033440|NCT00397189|3603900|FG001|3 Weeks Period|Adverse Event|2
2033441|NCT00397189|3603899|FG000|3 Weeks Period|Withdrawal by Subject|13
2033442|NCT00397189|3603900|FG001|3 Weeks Period|Withdrawal by Subject|9
2033443|NCT00397189|3603899|FG000|3 Weeks Period|Physician Decision|0
2033444|NCT00397189|3603900|FG001|3 Weeks Period|Physician Decision|2
2033445|NCT00397189|3603899|FG000|3 Weeks Period|Protocol Violation|0
2033446|NCT00397189|3603900|FG001|3 Weeks Period|Protocol Violation|3
2033447|NCT00397189|3603899|FG000|3 Weeks Period|Other|0
2033448|NCT00397189|3603900|FG001|3 Weeks Period|Other|2
2033449|NCT00397215|3603912|FG000|Month 0 (Day 0)|Adverse Event|0
2033450|NCT00397215|3603913|FG001|Month 0 (Day 0)|Adverse Event|1
2033451|NCT00397215|3603914|FG002|Month 0 (Day 0)|Adverse Event|0
2033452|NCT00397215|3603915|FG003|Month 0 (Day 0)|Adverse Event|0
2033453|NCT00397215|3603912|FG000|Month 0 (Day 0)|Withdrawal by Subject|3
2033454|NCT00397215|3603913|FG001|Month 0 (Day 0)|Withdrawal by Subject|3
2033455|NCT00397215|3603914|FG002|Month 0 (Day 0)|Withdrawal by Subject|3
2033456|NCT00397215|3603915|FG003|Month 0 (Day 0)|Withdrawal by Subject|1
2033457|NCT00397215|3603912|FG000|Month 0 (Day 0)|Other|4
2033458|NCT00397215|3603913|FG001|Month 0 (Day 0)|Other|1
2033459|NCT00397215|3603914|FG002|Month 0 (Day 0)|Other|3
2033460|NCT00397215|3603915|FG003|Month 0 (Day 0)|Other|3
2033461|NCT00397215|3603912|FG000|Month 6 (Day 180)|Adverse Event|0
2033462|NCT00397215|3603913|FG001|Month 6 (Day 180)|Adverse Event|3
2033463|NCT00397215|3603914|FG002|Month 6 (Day 180)|Adverse Event|2
2033464|NCT00397215|3603915|FG003|Month 6 (Day 180)|Adverse Event|0
2033465|NCT00397215|3603912|FG000|Month 6 (Day 180)|Other|2
2033466|NCT00397215|3603913|FG001|Month 6 (Day 180)|Other|0
2033467|NCT00397215|3603914|FG002|Month 6 (Day 180)|Other|3
2033468|NCT00397215|3603915|FG003|Month 6 (Day 180)|Other|0
2033469|NCT00397488|3603941|FG000|Overall Study|Withdrawal by Subject|3
2033470|NCT00397488|3603941|FG000|Overall Study|Adverse Event|3
2033471|NCT00397488|3603941|FG000|Overall Study|Death|1
2033472|NCT00397514|3603945|FG000|Overall Study|Withdrawal by Subject|1
2033473|NCT00397514|3603945|FG000|Overall Study|Pacing wire malfunction|1
2033474|NCT00397514|3603945|FG000|Overall Study|Not able to capture & pace LV intraoper.|4
2033475|NCT00397514|3603945|FG000|Overall Study|early extubation|2
2033476|NCT00397514|3603945|FG000|Overall Study|poor echocardiographic windows|1
2033477|NCT00397540|3603957|FG000|Overall Study|short follow-up duration < 12 months|1
2033478|NCT00397540|3603958|FG001|Overall Study|short follow-up duration < 12 months|0
2033479|NCT00397631|3603971|FG000|Overall Study|Adverse Event|5
2033480|NCT00397631|3603972|FG001|Overall Study|Adverse Event|6
2033481|NCT00397631|3603971|FG000|Overall Study|Lack of Efficacy|7
2033482|NCT00397631|3603972|FG001|Overall Study|Lack of Efficacy|10
2033483|NCT00397631|3603971|FG000|Overall Study|Lost to Follow-up|8
2033484|NCT00397631|3603972|FG001|Overall Study|Lost to Follow-up|9
2033485|NCT00397631|3603971|FG000|Overall Study|Physician Decision|2
2033486|NCT00397631|3603972|FG001|Overall Study|Physician Decision|0
2033487|NCT00397631|3603971|FG000|Overall Study|Protocol Violation|0
2033488|NCT00397631|3603972|FG001|Overall Study|Protocol Violation|1
2033489|NCT00397631|3603971|FG000|Overall Study|Withdrawal by Subject|7
2033490|NCT00397631|3603972|FG001|Overall Study|Withdrawal by Subject|14
2033491|NCT00397631|3603971|FG000|Overall Study|protocol discontinuation criteria|1
2033492|NCT00397631|3603972|FG001|Overall Study|protocol discontinuation criteria|4
2033493|NCT00397891|3604021|FG000|Overall Study|Withdrawal by Subject|1
2033494|NCT00397891|3604022|FG001|Overall Study|Withdrawal by Subject|0
2033495|NCT00397891|3604023|FG002|Overall Study|Withdrawal by Subject|0
2033496|NCT00397891|3604024|FG003|Overall Study|Withdrawal by Subject|0
2033497|NCT00397891|3604025|FG004|Overall Study|Withdrawal by Subject|1
2033498|NCT00397930|3604043|FG000|Overall Study|Personal reasons|14
2033499|NCT00397930|3604044|FG001|Overall Study|Personal reasons|8
2033500|NCT00397930|3604043|FG000|Overall Study|Other medical|9
2033501|NCT00397930|3604044|FG001|Overall Study|Other medical|4
2033502|NCT00397930|3604043|FG000|Overall Study|Unknown reasons|9
2033503|NCT00397930|3604044|FG001|Overall Study|Unknown reasons|14
2033504|NCT00397930|3604043|FG000|Overall Study|Noncompliant|3
2033505|NCT00397930|3604044|FG001|Overall Study|Noncompliant|2
2033506|NCT00397930|3604043|FG000|Overall Study|Too time-consuming|2
2033507|NCT00397930|3604044|FG001|Overall Study|Too time-consuming|9
2033508|NCT00397930|3604043|FG000|Overall Study|Started own yoga program|1
2033509|NCT00397930|3604044|FG001|Overall Study|Started own yoga program|1
2033510|NCT00397930|3604043|FG000|Overall Study|Did not want to be in control group|0
2033511|NCT00397930|3604044|FG001|Overall Study|Did not want to be in control group|1
2033512|NCT00397930|3604043|FG000|Overall Study|Withdrawal by Subject|0
2033513|NCT00397930|3604044|FG001|Overall Study|Withdrawal by Subject|8
2033514|NCT00397930|3604043|FG000|Overall Study|Missing data|0
2033515|NCT00397930|3604044|FG001|Overall Study|Missing data|4
2033516|NCT00397943|3604055|FG000|Overall Study|Unspecified reasons|12
2033517|NCT00397943|3604056|FG001|Overall Study|Unspecified reasons|9
2033518|NCT00397943|3604057|FG002|Overall Study|Unspecified reasons|0
2033519|NCT00397943|3604058|FG003|Overall Study|Unspecified reasons|0
2033520|NCT00397943|3604059|FG004|Overall Study|Unspecified reasons|0
2033521|NCT00397982|3604071|FG000|Overall Study|Withdrawal by Subject|1
2033522|NCT00397982|3604071|FG000|Overall Study|Adverse Event|1
2033523|NCT00397982|3604071|FG000|Overall Study|noncompliance|1
2033524|NCT00397982|3604071|FG000|Overall Study|Unrelated health issues|1
2033525|NCT00398047|3604076|FG000|Overall Study|all patient progressed before completion|3
2033526|NCT00398073|3604083|FG000|Overall Study|Withdrawal by Subject|1
2033527|NCT00398073|3604084|FG001|Overall Study|Withdrawal by Subject|0
2033528|NCT00398086|3604093|FG000|Overall Study|Unacceptable Toxicity|2
2033529|NCT00398086|3604094|FG001|Overall Study|Unacceptable Toxicity|8
2033530|NCT00398086|3604095|FG002|Overall Study|Unacceptable Toxicity|2
2033531|NCT00398086|3604093|FG000|Overall Study|Adverse Event|1
2033532|NCT00398086|3604094|FG001|Overall Study|Adverse Event|4
2033533|NCT00398086|3604095|FG002|Overall Study|Adverse Event|0
2033534|NCT00398086|3604093|FG000|Overall Study|Physician Decision|1
2033535|NCT00398086|3604094|FG001|Overall Study|Physician Decision|4
2033536|NCT00398086|3604095|FG002|Overall Study|Physician Decision|0
2033537|NCT00398086|3604093|FG000|Overall Study|Withdrawal by Subject|5
2033538|NCT00398086|3604094|FG001|Overall Study|Withdrawal by Subject|7
2033539|NCT00398086|3604095|FG002|Overall Study|Withdrawal by Subject|0
2033540|NCT00398112|3604103|FG000|Overall Study|Adverse Event|4
2033541|NCT00398112|3604103|FG000|Overall Study|Disease progression|9
2033542|NCT00398112|3604103|FG000|Overall Study|Alternative treatment|1
2033543|NCT00398112|3604103|FG000|Overall Study|Withdrawal by Subject|3
2033544|NCT00398112|3604103|FG000|Overall Study|Death|1
2331818|NCT03176238|4054603|FG000|Overall Study|Changes in the patient's condition|2
2331819|NCT03176238|4054604|FG001|Overall Study|Changes in the patient's condition|1
2331820|NCT03176238|4054603|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9
2331821|NCT03176238|4054604|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0
2331822|NCT03176407|4054614|FG000|Overall Study|Protocol Violation|1
2331823|NCT03176407|4054614|FG000|Overall Study|human failure|1
2331824|NCT03176407|4054614|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1
2331825|NCT03176459|4054622|FG000|Overall Study|Lost to Follow-up|5
2331826|NCT03176459|4054623|FG001|Overall Study|Lost to Follow-up|7
2331827|NCT03176784|4054642|FG000|Overall Study|Lost to Follow-up|77
2331828|NCT03176784|4054643|FG001|Overall Study|Lost to Follow-up|79
2331829|NCT03176784|4054644|FG002|Overall Study|Lost to Follow-up|79
2331830|NCT03176784|4054645|FG003|Overall Study|Lost to Follow-up|49
2331831|NCT03176784|4054642|FG000|Overall Study|Withdrawal by Subject|28
2331832|NCT03176784|4054643|FG001|Overall Study|Withdrawal by Subject|34
2331833|NCT03176784|4054644|FG002|Overall Study|Withdrawal by Subject|34
2331834|NCT03176784|4054645|FG003|Overall Study|Withdrawal by Subject|21
2033545|NCT00398138|3604107|FG000|Overall Study|Adverse Event|2
2033546|NCT00398216|3604116|FG000|Overall Study|Adverse Event|4
2033547|NCT00398216|3604117|FG001|Overall Study|Adverse Event|2
2033548|NCT00398216|3604118|FG002|Overall Study|Adverse Event|5
2033549|NCT00398216|3604119|FG003|Overall Study|Adverse Event|7
2033550|NCT00398216|3604120|FG004|Overall Study|Adverse Event|2
2180437|NCT01401530|3806563|FG000|Overall Study|Participant Choice|1
2033551|NCT00398216|3604116|FG000|Overall Study|Protocol Violation|2
2033552|NCT00398216|3604117|FG001|Overall Study|Protocol Violation|4
2033553|NCT00398216|3604118|FG002|Overall Study|Protocol Violation|5
2033554|NCT00398216|3604119|FG003|Overall Study|Protocol Violation|7
2033555|NCT00398216|3604120|FG004|Overall Study|Protocol Violation|5
2033556|NCT00398216|3604116|FG000|Overall Study|Lost to Follow-up|1
2033557|NCT00398216|3604117|FG001|Overall Study|Lost to Follow-up|6
2033558|NCT00398216|3604118|FG002|Overall Study|Lost to Follow-up|4
2033559|NCT00398216|3604119|FG003|Overall Study|Lost to Follow-up|4
2033560|NCT00398216|3604120|FG004|Overall Study|Lost to Follow-up|1
2033561|NCT00398216|3604116|FG000|Overall Study|Death|0
2033562|NCT00398216|3604117|FG001|Overall Study|Death|3
2033563|NCT00398216|3604118|FG002|Overall Study|Death|0
2033564|NCT00398216|3604119|FG003|Overall Study|Death|0
2111584|NCT00903331|3706229|FG000|Overall Study|Death|4
2111585|NCT00903331|3706230|FG001|Overall Study|Death|8
2111586|NCT00903331|3706229|FG000|Overall Study|Withdrawal of consent|1
2111587|NCT00903331|3706230|FG001|Overall Study|Withdrawal of consent|8
2111588|NCT00903331|3706229|FG000|Overall Study|Lung transplant|0
2111589|NCT00903331|3706230|FG001|Overall Study|Lung transplant|2
2111590|NCT00903344|3706238|FG000|Overall Study|Pregnancy|2
2111591|NCT00903344|3706239|FG001|Overall Study|Pregnancy|3
2111592|NCT00903344|3706238|FG000|Overall Study|Lost to Follow-up|3
2111593|NCT00903344|3706239|FG001|Overall Study|Lost to Follow-up|0
2111594|NCT00903357|3706245|FG000|First Intervention|Withdrawal by Subject|5
2111595|NCT00903357|3706246|FG001|First Intervention|Withdrawal by Subject|3
2111596|NCT00903357|3706245|FG000|First Intervention|Flu|0
2111597|NCT00903357|3706246|FG001|First Intervention|Flu|1
2111598|NCT00903357|3706245|FG000|Wash Out Period of 2 Weeks|Flu|0
2111599|NCT00903357|3706246|FG001|Wash Out Period of 2 Weeks|Flu|1
2111600|NCT00903357|3706245|FG000|Second Intervention|Lost to Follow-up|1
2111601|NCT00903357|3706246|FG001|Second Intervention|Lost to Follow-up|0
2111602|NCT00903370|3706258|FG000|Overall Study|Death|13
2111603|NCT00903370|3706259|FG001|Overall Study|Death|10
2111604|NCT00903370|3706258|FG000|Overall Study|Withdrawal by Subject|9
2111605|NCT00903370|3706259|FG001|Overall Study|Withdrawal by Subject|6
2111606|NCT00903370|3706258|FG000|Overall Study|Lost to Follow-up|6
2111607|NCT00903370|3706259|FG001|Overall Study|Lost to Follow-up|8
2111608|NCT00903383|3706269|FG000|Overall Study|Adverse Event|1
2111609|NCT00903383|3706270|FG001|Overall Study|Adverse Event|2
2111610|NCT00903383|3706271|FG002|Overall Study|Adverse Event|3
2111611|NCT00903383|3706272|FG003|Overall Study|Adverse Event|1
2111612|NCT00903383|3706269|FG000|Overall Study|Physician Decision|1
2111613|NCT00903383|3706270|FG001|Overall Study|Physician Decision|2
2111614|NCT00903383|3706271|FG002|Overall Study|Physician Decision|0
2111615|NCT00903383|3706272|FG003|Overall Study|Physician Decision|0
2111616|NCT00903383|3706269|FG000|Overall Study|Lost to Follow-up|0
2111617|NCT00903383|3706270|FG001|Overall Study|Lost to Follow-up|0
2111618|NCT00903383|3706271|FG002|Overall Study|Lost to Follow-up|0
2111619|NCT00903383|3706272|FG003|Overall Study|Lost to Follow-up|1
2218849|NCT01717326|3862437|FG012|Overall Study|Physician Decision|0
2218850|NCT01717326|3862438|FG013|Overall Study|Physician Decision|0
2218851|NCT01717326|3862439|FG014|Overall Study|Physician Decision|0
2218852|NCT01717326|3862440|FG015|Overall Study|Physician Decision|0
2218853|NCT01717326|3862441|FG016|Overall Study|Physician Decision|0
2218854|NCT01717326|3862442|FG017|Overall Study|Physician Decision|0
2218855|NCT01717326|3862443|FG018|Overall Study|Physician Decision|0
2218856|NCT01717326|3862444|FG019|Overall Study|Physician Decision|0
2218857|NCT01717326|3862425|FG000|Overall Study|Protocol Violation|0
2218858|NCT01717326|3862426|FG001|Overall Study|Protocol Violation|0
2218859|NCT01717326|3862427|FG002|Overall Study|Protocol Violation|0
2111620|NCT00903383|3706269|FG000|Overall Study|Decision of Sponsor|1
2111621|NCT00903383|3706270|FG001|Overall Study|Decision of Sponsor|0
2111622|NCT00903383|3706271|FG002|Overall Study|Decision of Sponsor|0
2218860|NCT01717326|3862428|FG003|Overall Study|Protocol Violation|0
2111623|NCT00903383|3706272|FG003|Overall Study|Decision of Sponsor|0
2033565|NCT00398216|3604120|FG004|Overall Study|Death|0
2033566|NCT00398216|3604116|FG000|Overall Study|Withdrawal by Subject|1
2033567|NCT00398216|3604117|FG001|Overall Study|Withdrawal by Subject|0
2033568|NCT00398216|3604118|FG002|Overall Study|Withdrawal by Subject|3
2033569|NCT00398216|3604119|FG003|Overall Study|Withdrawal by Subject|1
2033570|NCT00398216|3604120|FG004|Overall Study|Withdrawal by Subject|2
2033571|NCT00398216|3604116|FG000|Overall Study|administrative reasons|3
2033572|NCT00398216|3604117|FG001|Overall Study|administrative reasons|4
2033573|NCT00398216|3604118|FG002|Overall Study|administrative reasons|4
2033574|NCT00398216|3604119|FG003|Overall Study|administrative reasons|3
2033575|NCT00398216|3604120|FG004|Overall Study|administrative reasons|3
2033576|NCT00398216|3604116|FG000|Overall Study|entrance criteria|0
2033577|NCT00398216|3604117|FG001|Overall Study|entrance criteria|0
2033578|NCT00398216|3604118|FG002|Overall Study|entrance criteria|0
2033579|NCT00398216|3604119|FG003|Overall Study|entrance criteria|0
2033580|NCT00398216|3604120|FG004|Overall Study|entrance criteria|2
2033581|NCT00398320|3604132|FG000|Overall Study|Death|1
2033582|NCT00398320|3604132|FG000|Overall Study|Adverse Event|4
2033583|NCT00398320|3604132|FG000|Overall Study|Physician Decision|1
2033584|NCT00398411|3604142|FG000|Overall Study|Death|0
2033585|NCT00398411|3604143|FG001|Overall Study|Death|1
2033586|NCT00398567|3604161|FG000|Overall Study|Disease Progression|3
2033587|NCT00398567|3604162|FG001|Overall Study|Disease Progression|4
2033588|NCT00398567|3604163|FG002|Overall Study|Disease Progression|27
2033589|NCT00398567|3604161|FG000|Overall Study|Withdrawal by Subject|1
2033590|NCT00398567|3604162|FG001|Overall Study|Withdrawal by Subject|0
2033591|NCT00398567|3604163|FG002|Overall Study|Withdrawal by Subject|4
2033592|NCT00398567|3604161|FG000|Overall Study|Adverse Event|0
2033593|NCT00398567|3604162|FG001|Overall Study|Adverse Event|0
2033594|NCT00398567|3604163|FG002|Overall Study|Adverse Event|2
2033595|NCT00398567|3604161|FG000|Overall Study|Protocol Violation|0
2033596|NCT00398567|3604162|FG001|Overall Study|Protocol Violation|0
2033597|NCT00398567|3604163|FG002|Overall Study|Protocol Violation|1
2033598|NCT00398632|3604169|FG000|Overall Study|Withdrawal by Subject|1
2033599|NCT00398632|3604169|FG000|Overall Study|Lack of Efficacy|1
2033600|NCT00398866|3604177|FG000|Overall Study|Adverse Event|1
2033601|NCT00398866|3604178|FG001|Overall Study|Adverse Event|0
2033602|NCT00398866|3604179|FG002|Overall Study|Adverse Event|0
2033603|NCT00398866|3604177|FG000|Overall Study|Lack of Efficacy|0
2033604|NCT00398866|3604178|FG001|Overall Study|Lack of Efficacy|0
2033605|NCT00398866|3604179|FG002|Overall Study|Lack of Efficacy|1
2033606|NCT00398866|3604177|FG000|Overall Study|Lost to Follow-up|7
2033607|NCT00398866|3604178|FG001|Overall Study|Lost to Follow-up|6
2033608|NCT00398866|3604179|FG002|Overall Study|Lost to Follow-up|4
2033609|NCT00398866|3604177|FG000|Overall Study|Withdrawal by Subject|5
2033610|NCT00398866|3604178|FG001|Overall Study|Withdrawal by Subject|1
2033611|NCT00398866|3604179|FG002|Overall Study|Withdrawal by Subject|2
2033612|NCT00398866|3604177|FG000|Overall Study|Unable to complete requirements of study|1
2033613|NCT00398866|3604178|FG001|Overall Study|Unable to complete requirements of study|1
2033614|NCT00398866|3604179|FG002|Overall Study|Unable to complete requirements of study|1
2033615|NCT00399035|3604204|FG000|Overall Study|Death|289
2033616|NCT00399035|3604205|FG001|Overall Study|Death|141
2033617|NCT00399035|3604206|FG002|Overall Study|Death|234
2033618|NCT00399035|3604204|FG000|Overall Study|Lost to Follow-up|2
2033619|NCT00399035|3604205|FG001|Overall Study|Lost to Follow-up|1
2033620|NCT00399035|3604206|FG002|Overall Study|Lost to Follow-up|5
2033621|NCT00399035|3604204|FG000|Overall Study|Withdrawal by Subject|19
2033622|NCT00399035|3604205|FG001|Overall Study|Withdrawal by Subject|15
2033623|NCT00399035|3604206|FG002|Overall Study|Withdrawal by Subject|12
2033624|NCT00399035|3604204|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1
2033625|NCT00399035|3604205|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0
2033626|NCT00399035|3604206|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1
2033627|NCT00399035|3604204|FG000|Overall Study|Severe non-compliance with protocol|2
2033628|NCT00399035|3604205|FG001|Overall Study|Severe non-compliance with protocol|1
2033629|NCT00399035|3604206|FG002|Overall Study|Severe non-compliance with protocol|0
2033630|NCT00399360|3604230|FG000|Overall Study|Lost to Follow-up|2
2033631|NCT00399360|3604231|FG001|Overall Study|Lost to Follow-up|1
2033632|NCT00399360|3604232|FG002|Overall Study|Lost to Follow-up|2
2033633|NCT00399360|3604233|FG003|Overall Study|Lost to Follow-up|4
2033634|NCT00399360|3604230|FG000|Overall Study|Adverse Event|0
2033635|NCT00399360|3604231|FG001|Overall Study|Adverse Event|0
2033636|NCT00399360|3604232|FG002|Overall Study|Adverse Event|1
2033637|NCT00399360|3604233|FG003|Overall Study|Adverse Event|0
2033638|NCT00399360|3604230|FG000|Overall Study|Withdrawal by Subject|0
2033639|NCT00399360|3604231|FG001|Overall Study|Withdrawal by Subject|2
2033640|NCT00399360|3604232|FG002|Overall Study|Withdrawal by Subject|0
2033641|NCT00399360|3604233|FG003|Overall Study|Withdrawal by Subject|2
2033642|NCT00399490|3604248|FG000|Overall Study|Adverse Event|19
2033643|NCT00399490|3604248|FG000|Overall Study|Lack of Efficacy|31
2218861|NCT01717326|3862429|FG004|Overall Study|Protocol Violation|1
2033644|NCT00399490|3604248|FG000|Overall Study|Lost to Follow-up|5
2033645|NCT00399490|3604248|FG000|Overall Study|Withdrawal by Subject|18
2033646|NCT00399490|3604248|FG000|Overall Study|Other|25
2033647|NCT00399516|3604254|FG000|Overall Study|Lost to Follow-up|2
2033648|NCT00399529|3604258|FG000|Overall Study|Off Study Prior to Treatment|2
2033649|NCT00399542|3604265|FG000|Overall Study|Adverse Event|18
2033650|NCT00399542|3604266|FG001|Overall Study|Adverse Event|15
2033651|NCT00399542|3604265|FG000|Overall Study|Protocol Violation|13
2033652|NCT00399542|3604266|FG001|Overall Study|Protocol Violation|3
2033653|NCT00399542|3604265|FG000|Overall Study|Withdrawal by Subject|28
2033654|NCT00399542|3604266|FG001|Overall Study|Withdrawal by Subject|10
2033655|NCT00399542|3604265|FG000|Overall Study|Lack of Efficacy|18
2033656|NCT00399542|3604266|FG001|Overall Study|Lack of Efficacy|8
2033657|NCT00399542|3604265|FG000|Overall Study|Lost to Follow-up|6
2033658|NCT00399542|3604266|FG001|Overall Study|Lost to Follow-up|6
2033659|NCT00399542|3604265|FG000|Overall Study|Other|1
2033660|NCT00399542|3604266|FG001|Overall Study|Other|0
2033661|NCT00399542|3604265|FG000|Overall Study|Physician Decision|0
2033662|NCT00399542|3604266|FG001|Overall Study|Physician Decision|1
2033663|NCT00399568|3604274|FG000|Overall Study|Adverse Event|1
2033664|NCT00399568|3604275|FG001|Overall Study|Adverse Event|2
2033665|NCT00399568|3604274|FG000|Overall Study|Withdrawal by Subject|7
2033666|NCT00399568|3604275|FG001|Overall Study|Withdrawal by Subject|3
2033667|NCT00399568|3604274|FG000|Overall Study|Protocol non-compliance|2
2033668|NCT00399568|3604275|FG001|Overall Study|Protocol non-compliance|2
2033669|NCT00399568|3604274|FG000|Overall Study|Lost to Follow-up|2
2033670|NCT00399568|3604275|FG001|Overall Study|Lost to Follow-up|2
2033671|NCT00399763|3604285|FG000|Overall Study|Lost to Follow-up|2
2033672|NCT00399763|3604286|FG001|Overall Study|Lost to Follow-up|3
2033673|NCT00399802|3604294|FG000|Overall Study|Adverse Event|0
2033674|NCT00399802|3604295|FG001|Overall Study|Adverse Event|2
2033675|NCT00399802|3604294|FG000|Overall Study|Participant discontinued by mistake|0
2033676|NCT00399802|3604295|FG001|Overall Study|Participant discontinued by mistake|1
2033677|NCT00399893|3604312|FG000|Overall Study|Withdrawal by Subject|1
2033678|NCT00399893|3604313|FG001|Overall Study|Withdrawal by Subject|0
2033679|NCT00400153|3604322|FG000|Overall Study|AE due to study disease worsening|14
2033680|NCT00400153|3604323|FG001|Overall Study|AE due to study disease worsening|19
2033681|NCT00400153|3604324|FG002|Overall Study|AE due to study disease worsening|20
2033682|NCT00400153|3604322|FG000|Overall Study|AE due to other disease worsening|2
2033683|NCT00400153|3604323|FG001|Overall Study|AE due to other disease worsening|1
2033684|NCT00400153|3604324|FG002|Overall Study|AE due to other disease worsening|0
2033685|NCT00400153|3604322|FG000|Overall Study|AE due to other condition|3
2033686|NCT00400153|3604323|FG001|Overall Study|AE due to other condition|14
2033687|NCT00400153|3604324|FG002|Overall Study|AE due to other condition|15
2033688|NCT00400153|3604322|FG000|Overall Study|Protocol Violation|7
2033689|NCT00400153|3604323|FG001|Overall Study|Protocol Violation|4
2033690|NCT00400153|3604324|FG002|Overall Study|Protocol Violation|9
2218862|NCT01717326|3862430|FG005|Overall Study|Protocol Violation|0
2218863|NCT01717326|3862431|FG006|Overall Study|Protocol Violation|0
2218864|NCT01717326|3862432|FG007|Overall Study|Protocol Violation|0
2218865|NCT01717326|3862433|FG008|Overall Study|Protocol Violation|0
2218866|NCT01717326|3862434|FG009|Overall Study|Protocol Violation|0
2033691|NCT00400153|3604322|FG000|Overall Study|Lost to Follow-up|2
2033692|NCT00400153|3604323|FG001|Overall Study|Lost to Follow-up|1
2033693|NCT00400153|3604324|FG002|Overall Study|Lost to Follow-up|4
2033694|NCT00400153|3604322|FG000|Overall Study|Withdrawal by Subject|12
2033695|NCT00400153|3604323|FG001|Overall Study|Withdrawal by Subject|11
2033696|NCT00400153|3604324|FG002|Overall Study|Withdrawal by Subject|10
2033697|NCT00400153|3604322|FG000|Overall Study|Other reasons - not mentioned above|8
2033698|NCT00400153|3604323|FG001|Overall Study|Other reasons - not mentioned above|5
2033699|NCT00400153|3604324|FG002|Overall Study|Other reasons - not mentioned above|3
2033700|NCT00400179|3604339|FG000|Overall Study|Adverse Event|2
2033701|NCT00400179|3604340|FG001|Overall Study|Adverse Event|2
2218867|NCT01717326|3862435|FG010|Overall Study|Protocol Violation|0
2033702|NCT00400179|3604339|FG000|Overall Study|Death|1
2033703|NCT00400179|3604340|FG001|Overall Study|Death|2
2033704|NCT00400179|3604339|FG000|Overall Study|Withdrew Consent|1
2033705|NCT00400179|3604340|FG001|Overall Study|Withdrew Consent|5
2033706|NCT00400179|3604339|FG000|Overall Study|Disease progression|1
2033707|NCT00400179|3604340|FG001|Overall Study|Disease progression|1
2033708|NCT00400179|3604339|FG000|Overall Study|Intercurrent illness|0
2033709|NCT00400179|3604340|FG001|Overall Study|Intercurrent illness|1
2033710|NCT00400179|3604339|FG000|Overall Study|Investigator judgment|0
2033711|NCT00400179|3604340|FG001|Overall Study|Investigator judgment|1
2033712|NCT00400179|3604339|FG000|Overall Study|Randomization error/patient ineligible|1
2033713|NCT00400179|3604340|FG001|Overall Study|Randomization error/patient ineligible|6
2033714|NCT00400400|3604353|FG000|Overall Study|Adverse Event|9
2033715|NCT00400400|3604354|FG001|Overall Study|Adverse Event|8
2033716|NCT00400400|3604353|FG000|Overall Study|Protocol Violation|2
2033717|NCT00400400|3604354|FG001|Overall Study|Protocol Violation|0
2033718|NCT00400400|3604353|FG000|Overall Study|Withdrawal by Subject|1
2033719|NCT00400400|3604354|FG001|Overall Study|Withdrawal by Subject|3
2033720|NCT00400400|3604353|FG000|Overall Study|Administrative Problem|1
2033721|NCT00400400|3604354|FG001|Overall Study|Administrative Problem|0
2033722|NCT00400400|3604353|FG000|Overall Study|Lost to Follow-up|0
2033723|NCT00400400|3604354|FG001|Overall Study|Lost to Follow-up|1
2033724|NCT00400400|3604353|FG000|Overall Study|Did not receive study drug|1
2033725|NCT00400400|3604354|FG001|Overall Study|Did not receive study drug|3
2033726|NCT00400517|3604369|FG000|Overall Study|Withdrawal by Subject|1
2033727|NCT00400517|3604369|FG000|Overall Study|Physician Decision|1
2033728|NCT00400569|3604373|FG000|Overall Study|Death|1
2033729|NCT00400712|3604395|FG000|Overall Study|Death|1
2033730|NCT00400712|3604396|FG001|Overall Study|Death|0
2033731|NCT00400712|3604395|FG000|Overall Study|Withdrawal by Subject|11
2033732|NCT00400712|3604396|FG001|Overall Study|Withdrawal by Subject|12
2033733|NCT00400712|3604395|FG000|Overall Study|Physician Decision|5
2033734|NCT00400712|3604396|FG001|Overall Study|Physician Decision|4
2033735|NCT00400764|3604409|FG000|Phase Ib|Adverse Event|1
2033736|NCT00400764|3604410|FG001|Phase Ib|Adverse Event|0
2033737|NCT00400764|3604411|FG002|Phase Ib|Adverse Event|0
2033738|NCT00400764|3604412|FG003|Phase Ib|Adverse Event|0
2033739|NCT00400764|3604413|FG004|Phase Ib|Adverse Event|0
2033740|NCT00400764|3604409|FG000|Phase Ib|Death|1
2033741|NCT00400764|3604410|FG001|Phase Ib|Death|0
2033742|NCT00400764|3604411|FG002|Phase Ib|Death|0
2033743|NCT00400764|3604412|FG003|Phase Ib|Death|0
2033744|NCT00400764|3604413|FG004|Phase Ib|Death|0
2033745|NCT00400764|3604409|FG000|Phase Ib|Disease Progression|4
2033746|NCT00400764|3604410|FG001|Phase Ib|Disease Progression|4
2033747|NCT00400764|3604411|FG002|Phase Ib|Disease Progression|0
2033748|NCT00400764|3604412|FG003|Phase Ib|Disease Progression|0
2033749|NCT00400764|3604413|FG004|Phase Ib|Disease Progression|0
2033750|NCT00400764|3604409|FG000|Phase II|Death|0
2033751|NCT00400764|3604410|FG001|Phase II|Death|0
2033752|NCT00400764|3604411|FG002|Phase II|Death|1
2033753|NCT00400764|3604412|FG003|Phase II|Death|2
2033754|NCT00400764|3604413|FG004|Phase II|Death|0
2033755|NCT00400764|3604409|FG000|Phase II|Lost to Follow-up|0
2111624|NCT00903383|3706269|FG000|Overall Study|Withdrawal by Subject|4
2111625|NCT00903383|3706270|FG001|Overall Study|Withdrawal by Subject|1
2111626|NCT00903383|3706271|FG002|Overall Study|Withdrawal by Subject|0
2111627|NCT00903383|3706272|FG003|Overall Study|Withdrawal by Subject|2
2111628|NCT00903383|3706269|FG000|Overall Study|Patient Decision - Lack of Efficacy|0
2111629|NCT00903383|3706270|FG001|Overall Study|Patient Decision - Lack of Efficacy|1
2111630|NCT00903383|3706271|FG002|Overall Study|Patient Decision - Lack of Efficacy|0
2111631|NCT00903383|3706272|FG003|Overall Study|Patient Decision - Lack of Efficacy|0
2111632|NCT00903383|3706269|FG000|Overall Study|Patient Decision|0
2111633|NCT00903383|3706270|FG001|Overall Study|Patient Decision|0
2111634|NCT00903383|3706271|FG002|Overall Study|Patient Decision|0
2111635|NCT00903383|3706272|FG003|Overall Study|Patient Decision|1
2111636|NCT00903409|3706284|FG000|Overall Study|Adverse Event|11
2111637|NCT00903409|3706285|FG001|Overall Study|Adverse Event|9
2111638|NCT00903409|3706284|FG000|Overall Study|Non-compliance with Protocol|1
2111639|NCT00903409|3706285|FG001|Overall Study|Non-compliance with Protocol|1
2111640|NCT00903409|3706284|FG000|Overall Study|Laboratory Abnormality|2
2111641|NCT00903409|3706285|FG001|Overall Study|Laboratory Abnormality|0
2111642|NCT00903409|3706284|FG000|Overall Study|Withdrawal by Subject|8
2111643|NCT00903409|3706285|FG001|Overall Study|Withdrawal by Subject|8
2111644|NCT00903409|3706284|FG000|Overall Study|Other|2
2111645|NCT00903409|3706285|FG001|Overall Study|Other|3
2111646|NCT00903409|3706284|FG000|Overall Study|Lost to Follow-up|2
2111647|NCT00903409|3706285|FG001|Overall Study|Lost to Follow-up|6
2111648|NCT00903617|3706304|FG000|Overall Study|Adverse Event|0
2111649|NCT00903617|3706305|FG001|Overall Study|Adverse Event|1
2111650|NCT00903617|3706306|FG002|Overall Study|Adverse Event|1
2111651|NCT00903617|3706307|FG003|Overall Study|Adverse Event|0
2111652|NCT00903617|3706304|FG000|Overall Study|Protocol-defined stopping criteria|0
2111653|NCT00903617|3706305|FG001|Overall Study|Protocol-defined stopping criteria|2
2111654|NCT00903617|3706306|FG002|Overall Study|Protocol-defined stopping criteria|0
2111655|NCT00903617|3706307|FG003|Overall Study|Protocol-defined stopping criteria|0
2111656|NCT00903617|3706304|FG000|Overall Study|Lost to Follow-up|2
2111657|NCT00903617|3706305|FG001|Overall Study|Lost to Follow-up|0
2111658|NCT00903617|3706306|FG002|Overall Study|Lost to Follow-up|1
2111659|NCT00903617|3706307|FG003|Overall Study|Lost to Follow-up|1
2111660|NCT00903617|3706304|FG000|Overall Study|Withdrawal by Subject|1
2111661|NCT00903617|3706305|FG001|Overall Study|Withdrawal by Subject|2
2111662|NCT00903617|3706306|FG002|Overall Study|Withdrawal by Subject|3
2111663|NCT00903617|3706307|FG003|Overall Study|Withdrawal by Subject|0
2111664|NCT00903630|3706321|FG000|Phase 2|Adverse Event|0
2111665|NCT00903630|3706322|FG001|Phase 2|Adverse Event|0
2111666|NCT00903630|3706323|FG002|Phase 2|Adverse Event|1
2111667|NCT00903682|3706335|FG000|Overall Study|Adverse Event|6
2111668|NCT00903682|3706336|FG001|Overall Study|Adverse Event|13
2111669|NCT00903682|3706335|FG000|Overall Study|Lost to Follow-up|1
2111670|NCT00903682|3706336|FG001|Overall Study|Lost to Follow-up|0
2111671|NCT00903682|3706335|FG000|Overall Study|Withdrawal by Subject|5
2111672|NCT00903682|3706336|FG001|Overall Study|Withdrawal by Subject|0
2111673|NCT00903682|3706335|FG000|Overall Study|Pregnancy|0
2111674|NCT00903682|3706336|FG001|Overall Study|Pregnancy|1
2111675|NCT00903682|3706335|FG000|Overall Study|Subject Reached A Virologic Endpoint|1
2180438|NCT01401530|3806564|FG001|Overall Study|Participant Choice|2
2033756|NCT00400764|3604410|FG001|Phase II|Lost to Follow-up|0
2033757|NCT00400764|3604411|FG002|Phase II|Lost to Follow-up|1
2033758|NCT00400764|3604412|FG003|Phase II|Lost to Follow-up|0
2033759|NCT00400764|3604413|FG004|Phase II|Lost to Follow-up|0
2033760|NCT00400764|3604409|FG000|Phase II|Physician Decision|0
2033761|NCT00400764|3604410|FG001|Phase II|Physician Decision|0
2033762|NCT00400764|3604411|FG002|Phase II|Physician Decision|1
2033763|NCT00400764|3604412|FG003|Phase II|Physician Decision|1
2033764|NCT00400764|3604413|FG004|Phase II|Physician Decision|0
2033765|NCT00400764|3604409|FG000|Phase II|Sponsor's decision to terminate|0
2033766|NCT00400764|3604410|FG001|Phase II|Sponsor's decision to terminate|0
2033767|NCT00400764|3604411|FG002|Phase II|Sponsor's decision to terminate|18
2033768|NCT00400764|3604412|FG003|Phase II|Sponsor's decision to terminate|22
2033769|NCT00400764|3604413|FG004|Phase II|Sponsor's decision to terminate|11
2033770|NCT00400764|3604409|FG000|Phase II|Patient began new, non-protocol, therapy|0
2033771|NCT00400764|3604410|FG001|Phase II|Patient began new, non-protocol, therapy|0
2033772|NCT00400764|3604411|FG002|Phase II|Patient began new, non-protocol, therapy|1
2033773|NCT00400764|3604412|FG003|Phase II|Patient began new, non-protocol, therapy|0
2033774|NCT00400764|3604413|FG004|Phase II|Patient began new, non-protocol, therapy|0
2033775|NCT00400764|3604409|FG000|Phase II|Withdrawal by Subject|0
2033776|NCT00400764|3604410|FG001|Phase II|Withdrawal by Subject|0
2033777|NCT00400764|3604411|FG002|Phase II|Withdrawal by Subject|1
2033778|NCT00400764|3604412|FG003|Phase II|Withdrawal by Subject|1
2111676|NCT00903682|3706336|FG001|Overall Study|Subject Reached A Virologic Endpoint|1
2111677|NCT00903682|3706335|FG000|Overall Study|Subject Non-Compliant|1
2111678|NCT00903682|3706336|FG001|Overall Study|Subject Non-Compliant|0
2111679|NCT00903682|3706335|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1
2111680|NCT00903682|3706336|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0
2111681|NCT00903682|3706335|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
2111682|NCT00903682|3706336|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
2111683|NCT00903695|3706344|FG000|Overall Study|medical exclusion after 1st testing|1
2111684|NCT00903695|3706345|FG001|Overall Study|medical exclusion after 1st testing|0
2111685|NCT00903695|3706344|FG000|Overall Study|lung cancer|1
2111686|NCT00903695|3706345|FG001|Overall Study|lung cancer|0
2111687|NCT00903760|3706355|FG000|Overall Study|Disease Progression/Death|8
2111688|NCT00903760|3706356|FG001|Overall Study|Disease Progression/Death|6
2111689|NCT00903760|3706355|FG000|Overall Study|Stem Cell Transplant|8
2111690|NCT00903760|3706356|FG001|Overall Study|Stem Cell Transplant|4
2111691|NCT00903760|3706355|FG000|Overall Study|Physician Decision|1
2111692|NCT00903760|3706356|FG001|Overall Study|Physician Decision|2
2111693|NCT00903760|3706355|FG000|Overall Study|Death|0
2111694|NCT00903760|3706356|FG001|Overall Study|Death|1
2111695|NCT00903760|3706355|FG000|Overall Study|Lost to Follow-up|1
2111696|NCT00903760|3706356|FG001|Overall Study|Lost to Follow-up|0
2111697|NCT00903760|3706355|FG000|Overall Study|Withdrawal by Subject|1
2111698|NCT00903760|3706356|FG001|Overall Study|Withdrawal by Subject|2
2111699|NCT00903760|3706355|FG000|Overall Study|Off treatment for long period|0
2033779|NCT00400764|3604413|FG004|Phase II|Withdrawal by Subject|0
2033780|NCT00400946|3604457|FG000|Overall Study|Ineligible|0
2033781|NCT00400946|3604458|FG001|Overall Study|Ineligible|0
2033782|NCT00400946|3604459|FG002|Overall Study|Ineligible|0
2033783|NCT00400946|3604460|FG003|Overall Study|Ineligible|5
2033784|NCT00400946|3604461|FG004|Overall Study|Ineligible|1
2033785|NCT00400946|3604457|FG000|Overall Study|Induction Failure|0
2033786|NCT00400946|3604458|FG001|Overall Study|Induction Failure|0
2033787|NCT00400946|3604459|FG002|Overall Study|Induction Failure|0
2033788|NCT00400946|3604460|FG003|Overall Study|Induction Failure|11
2033789|NCT00400946|3604461|FG004|Overall Study|Induction Failure|8
2033790|NCT00400946|3604457|FG000|Overall Study|Induction Death|0
2033791|NCT00400946|3604458|FG001|Overall Study|Induction Death|0
2033792|NCT00400946|3604459|FG002|Overall Study|Induction Death|0
2033793|NCT00400946|3604460|FG003|Overall Study|Induction Death|13
2033794|NCT00400946|3604461|FG004|Overall Study|Induction Death|3
2033795|NCT00400946|3604457|FG000|Overall Study|Lost to Follow-up|1
2033796|NCT00400946|3604458|FG001|Overall Study|Lost to Follow-up|1
2033797|NCT00400946|3604459|FG002|Overall Study|Lost to Follow-up|0
2033798|NCT00400946|3604460|FG003|Overall Study|Lost to Follow-up|0
2033799|NCT00400946|3604461|FG004|Overall Study|Lost to Follow-up|1
2033800|NCT00400946|3604457|FG000|Overall Study|Remission Death|1
2033801|NCT00400946|3604458|FG001|Overall Study|Remission Death|1
2033802|NCT00400946|3604459|FG002|Overall Study|Remission Death|0
2033803|NCT00400946|3604460|FG003|Overall Study|Remission Death|0
2033804|NCT00400946|3604461|FG004|Overall Study|Remission Death|1
2033805|NCT00400946|3604457|FG000|Overall Study|Relapse|9
2033806|NCT00400946|3604458|FG001|Overall Study|Relapse|2
2033807|NCT00400946|3604459|FG002|Overall Study|Relapse|1
2033808|NCT00400946|3604460|FG003|Overall Study|Relapse|1
2033809|NCT00400946|3604461|FG004|Overall Study|Relapse|5
2033810|NCT00400946|3604457|FG000|Overall Study|Transplant in CR1|0
2033811|NCT00400946|3604458|FG001|Overall Study|Transplant in CR1|0
2033812|NCT00400946|3604459|FG002|Overall Study|Transplant in CR1|0
2033813|NCT00400946|3604460|FG003|Overall Study|Transplant in CR1|10
2033814|NCT00400946|3604461|FG004|Overall Study|Transplant in CR1|1
2033815|NCT00400946|3604457|FG000|Overall Study|Withdrawal by Subject|2
2033816|NCT00400946|3604458|FG001|Overall Study|Withdrawal by Subject|5
2033817|NCT00400946|3604459|FG002|Overall Study|Withdrawal by Subject|1
2033818|NCT00400946|3604460|FG003|Overall Study|Withdrawal by Subject|5
2033819|NCT00400946|3604461|FG004|Overall Study|Withdrawal by Subject|8
2033820|NCT00400946|3604457|FG000|Overall Study|Clinical|1
2033821|NCT00400946|3604458|FG001|Overall Study|Clinical|2
2033822|NCT00400946|3604459|FG002|Overall Study|Clinical|0
2033823|NCT00400946|3604460|FG003|Overall Study|Clinical|2
2033824|NCT00400946|3604461|FG004|Overall Study|Clinical|9
2033825|NCT00400946|3604457|FG000|Overall Study|Other|0
2033826|NCT00400946|3604458|FG001|Overall Study|Other|0
2033827|NCT00400946|3604459|FG002|Overall Study|Other|0
2033828|NCT00400946|3604460|FG003|Overall Study|Other|0
2033829|NCT00400946|3604461|FG004|Overall Study|Other|1
2033830|NCT00400985|3604479|FG000|Overall Study|Withdrawal by Subject|5
2033831|NCT00400985|3604479|FG000|Overall Study|system modification|8
2033832|NCT00400985|3604479|FG000|Overall Study|Death|30
2033833|NCT00400985|3604479|FG000|Overall Study|Lost to Follow-up|9
2033834|NCT00401193|3604490|FG000|Overall Study|Adverse Event|1
2033835|NCT00401193|3604491|FG001|Overall Study|Adverse Event|3
2033836|NCT00401193|3604492|FG002|Overall Study|Adverse Event|1
2033837|NCT00401193|3604490|FG000|Overall Study|Protocol Violation|3
2033838|NCT00401193|3604491|FG001|Overall Study|Protocol Violation|1
2033839|NCT00401193|3604492|FG002|Overall Study|Protocol Violation|1
2033840|NCT00401193|3604490|FG000|Overall Study|Lost to Follow-up|6
2033841|NCT00401193|3604491|FG001|Overall Study|Lost to Follow-up|5
2033842|NCT00401193|3604492|FG002|Overall Study|Lost to Follow-up|1
2033843|NCT00401193|3604490|FG000|Overall Study|Withdrawal by Subject|2
2033844|NCT00401193|3604491|FG001|Overall Study|Withdrawal by Subject|0
2033845|NCT00401193|3604492|FG002|Overall Study|Withdrawal by Subject|1
2033846|NCT00401193|3604490|FG000|Overall Study|Other Event|3
2033847|NCT00401193|3604491|FG001|Overall Study|Other Event|2
2033848|NCT00401193|3604492|FG002|Overall Study|Other Event|2
2033849|NCT00401245|3604505|FG000|Double Blind Titration Phase|Adverse Event|3
2033850|NCT00401245|3604506|FG001|Double Blind Titration Phase|Adverse Event|2
2033851|NCT00401245|3604507|FG002|Double Blind Titration Phase|Adverse Event|5
2033852|NCT00401245|3604508|FG003|Double Blind Titration Phase|Adverse Event|12
2033853|NCT00401245|3604509|FG004|Double Blind Titration Phase|Adverse Event|0
2033854|NCT00401245|3604510|FG005|Double Blind Titration Phase|Adverse Event|0
2033855|NCT00401245|3604511|FG006|Double Blind Titration Phase|Adverse Event|0
2033856|NCT00401245|3604512|FG007|Double Blind Titration Phase|Adverse Event|0
2033857|NCT00401245|3604505|FG000|Double Blind Titration Phase|Other|0
2033858|NCT00401245|3604506|FG001|Double Blind Titration Phase|Other|0
2033859|NCT00401245|3604507|FG002|Double Blind Titration Phase|Other|1
2033860|NCT00401245|3604508|FG003|Double Blind Titration Phase|Other|0
2033861|NCT00401245|3604509|FG004|Double Blind Titration Phase|Other|0
2033862|NCT00401245|3604510|FG005|Double Blind Titration Phase|Other|0
2033863|NCT00401245|3604511|FG006|Double Blind Titration Phase|Other|0
2033864|NCT00401245|3604512|FG007|Double Blind Titration Phase|Other|0
2033865|NCT00401245|3604505|FG000|Double Blind Titration Phase|Protocol Violation|0
2033866|NCT00401245|3604506|FG001|Double Blind Titration Phase|Protocol Violation|0
2033867|NCT00401245|3604507|FG002|Double Blind Titration Phase|Protocol Violation|0
2111700|NCT00903760|3706356|FG001|Overall Study|Off treatment for long period|1
2111701|NCT00903786|3706362|FG000|Overall Study|Physician Decision|6
2111702|NCT00903786|3706362|FG000|Overall Study|Lack of Efficacy|5
2111703|NCT00903786|3706362|FG000|Overall Study|Reason other than lack of efficacy|4
2111704|NCT00903877|3706367|FG000|Overall Study|Did not meet study criteria|33
2111705|NCT00903877|3706367|FG000|Overall Study|Withdrawal by Subject|3
2111706|NCT00903877|3706367|FG000|Overall Study|Adverse Event|2
2111707|NCT00903877|3706367|FG000|Overall Study|Lost to Follow-up|1
2111708|NCT00903877|3706367|FG000|Overall Study|Participation put on hold|4
2111709|NCT00903929|3706371|FG000|Overall Study|Withdrawal by Subject|0
2111710|NCT00903929|3706372|FG001|Overall Study|Withdrawal by Subject|0
2111711|NCT00903929|3706373|FG002|Overall Study|Withdrawal by Subject|1
2111712|NCT00903929|3706374|FG003|Overall Study|Withdrawal by Subject|2
2111713|NCT00903929|3706371|FG000|Overall Study|Adverse Event|0
2111714|NCT00903929|3706372|FG001|Overall Study|Adverse Event|0
2111715|NCT00903929|3706373|FG002|Overall Study|Adverse Event|0
2111716|NCT00903929|3706374|FG003|Overall Study|Adverse Event|1
2111717|NCT00903968|3706381|FG000|Overall Study|Adverse Event|0
2111718|NCT00903968|3706382|FG001|Overall Study|Adverse Event|0
2111719|NCT00903968|3706383|FG002|Overall Study|Adverse Event|0
2111720|NCT00903968|3706384|FG003|Overall Study|Adverse Event|0
2111721|NCT00903968|3706385|FG004|Overall Study|Adverse Event|0
2111722|NCT00903968|3706386|FG005|Overall Study|Adverse Event|0
2111723|NCT00903968|3706387|FG006|Overall Study|Adverse Event|1
2111724|NCT00903968|3706388|FG007|Overall Study|Adverse Event|8
2111725|NCT00903968|3706381|FG000|Overall Study|DLT|0
2111726|NCT00903968|3706382|FG001|Overall Study|DLT|0
2111727|NCT00903968|3706383|FG002|Overall Study|DLT|0
2111728|NCT00903968|3706384|FG003|Overall Study|DLT|0
2111729|NCT00903968|3706385|FG004|Overall Study|DLT|0
2111730|NCT00903968|3706386|FG005|Overall Study|DLT|0
2111731|NCT00903968|3706387|FG006|Overall Study|DLT|2
2111732|NCT00903968|3706388|FG007|Overall Study|DLT|0
2111733|NCT00903968|3706381|FG000|Overall Study|Withdrawal by Subject|1
2111734|NCT00903968|3706382|FG001|Overall Study|Withdrawal by Subject|0
2111735|NCT00903968|3706383|FG002|Overall Study|Withdrawal by Subject|1
2111736|NCT00903968|3706384|FG003|Overall Study|Withdrawal by Subject|0
2111737|NCT00903968|3706385|FG004|Overall Study|Withdrawal by Subject|1
2111738|NCT00903968|3706386|FG005|Overall Study|Withdrawal by Subject|1
2111739|NCT00903968|3706387|FG006|Overall Study|Withdrawal by Subject|0
2111740|NCT00903968|3706388|FG007|Overall Study|Withdrawal by Subject|4
2111741|NCT00903968|3706381|FG000|Overall Study|Non-Compliance|0
2111742|NCT00903968|3706382|FG001|Overall Study|Non-Compliance|0
2111743|NCT00903968|3706383|FG002|Overall Study|Non-Compliance|0
2111744|NCT00903968|3706384|FG003|Overall Study|Non-Compliance|0
2033868|NCT00401245|3604508|FG003|Double Blind Titration Phase|Protocol Violation|1
2033869|NCT00401245|3604509|FG004|Double Blind Titration Phase|Protocol Violation|0
2033870|NCT00401245|3604510|FG005|Double Blind Titration Phase|Protocol Violation|0
2033871|NCT00401245|3604511|FG006|Double Blind Titration Phase|Protocol Violation|0
2033872|NCT00401245|3604512|FG007|Double Blind Titration Phase|Protocol Violation|0
2033873|NCT00401245|3604505|FG000|Double Blind Titration Phase|Withdrawal by Subject|1
2033874|NCT00401245|3604506|FG001|Double Blind Titration Phase|Withdrawal by Subject|1
2033875|NCT00401245|3604507|FG002|Double Blind Titration Phase|Withdrawal by Subject|0
2033876|NCT00401245|3604508|FG003|Double Blind Titration Phase|Withdrawal by Subject|2
2033877|NCT00401245|3604509|FG004|Double Blind Titration Phase|Withdrawal by Subject|0
2033878|NCT00401245|3604510|FG005|Double Blind Titration Phase|Withdrawal by Subject|0
2033879|NCT00401245|3604511|FG006|Double Blind Titration Phase|Withdrawal by Subject|0
2033880|NCT00401245|3604512|FG007|Double Blind Titration Phase|Withdrawal by Subject|0
2033881|NCT00401245|3604505|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0
2033882|NCT00401245|3604506|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2
2033883|NCT00401245|3604507|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0
2033884|NCT00401245|3604508|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2
2033885|NCT00401245|3604509|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0
2033886|NCT00401245|3604510|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0
2033887|NCT00401245|3604511|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0
2033888|NCT00401245|3604512|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0
2033889|NCT00401245|3604505|FG000|Open Label Phase|Adverse Event|5
2033890|NCT00401245|3604506|FG001|Open Label Phase|Adverse Event|14
2033891|NCT00401245|3604507|FG002|Open Label Phase|Adverse Event|6
2033892|NCT00401245|3604508|FG003|Open Label Phase|Adverse Event|7
2033893|NCT00401245|3604509|FG004|Open Label Phase|Adverse Event|0
2033894|NCT00401245|3604510|FG005|Open Label Phase|Adverse Event|0
2033895|NCT00401245|3604511|FG006|Open Label Phase|Adverse Event|0
2033896|NCT00401245|3604512|FG007|Open Label Phase|Adverse Event|0
2033897|NCT00401245|3604505|FG000|Open Label Phase|Lost to Follow-up|5
2033898|NCT00401245|3604506|FG001|Open Label Phase|Lost to Follow-up|7
2033899|NCT00401245|3604507|FG002|Open Label Phase|Lost to Follow-up|5
2033900|NCT00401245|3604508|FG003|Open Label Phase|Lost to Follow-up|4
2033901|NCT00401245|3604509|FG004|Open Label Phase|Lost to Follow-up|0
2033902|NCT00401245|3604510|FG005|Open Label Phase|Lost to Follow-up|0
2033903|NCT00401245|3604511|FG006|Open Label Phase|Lost to Follow-up|0
2033904|NCT00401245|3604512|FG007|Open Label Phase|Lost to Follow-up|0
2033905|NCT00401245|3604505|FG000|Open Label Phase|Other|4
2033906|NCT00401245|3604506|FG001|Open Label Phase|Other|8
2033907|NCT00401245|3604507|FG002|Open Label Phase|Other|7
2033908|NCT00401245|3604508|FG003|Open Label Phase|Other|8
2033909|NCT00401245|3604509|FG004|Open Label Phase|Other|0
2033910|NCT00401245|3604510|FG005|Open Label Phase|Other|0
2033911|NCT00401245|3604511|FG006|Open Label Phase|Other|0
2111745|NCT00903968|3706385|FG004|Overall Study|Non-Compliance|0
2111746|NCT00903968|3706386|FG005|Overall Study|Non-Compliance|1
2111747|NCT00903968|3706387|FG006|Overall Study|Non-Compliance|0
2111748|NCT00903968|3706388|FG007|Overall Study|Non-Compliance|0
2111749|NCT00903968|3706381|FG000|Overall Study|Physician Decision|0
2111750|NCT00903968|3706382|FG001|Overall Study|Physician Decision|0
2111751|NCT00903968|3706383|FG002|Overall Study|Physician Decision|0
2111752|NCT00903968|3706384|FG003|Overall Study|Physician Decision|0
2111753|NCT00903968|3706385|FG004|Overall Study|Physician Decision|0
2111754|NCT00903968|3706386|FG005|Overall Study|Physician Decision|1
2111755|NCT00903968|3706387|FG006|Overall Study|Physician Decision|0
2111756|NCT00903968|3706388|FG007|Overall Study|Physician Decision|0
2111757|NCT00903968|3706381|FG000|Overall Study|Progressive Disease|2
2111758|NCT00903968|3706382|FG001|Overall Study|Progressive Disease|3
2111759|NCT00903968|3706383|FG002|Overall Study|Progressive Disease|2
2111760|NCT00903968|3706384|FG003|Overall Study|Progressive Disease|3
2111761|NCT00903968|3706385|FG004|Overall Study|Progressive Disease|3
2111762|NCT00903968|3706386|FG005|Overall Study|Progressive Disease|3
2111763|NCT00903968|3706387|FG006|Overall Study|Progressive Disease|0
2111764|NCT00903968|3706388|FG007|Overall Study|Progressive Disease|18
2111765|NCT00903968|3706381|FG000|Overall Study|Lack of Efficacy|0
2111766|NCT00903968|3706382|FG001|Overall Study|Lack of Efficacy|0
2111767|NCT00903968|3706383|FG002|Overall Study|Lack of Efficacy|0
2111768|NCT00903968|3706384|FG003|Overall Study|Lack of Efficacy|0
2111769|NCT00903968|3706385|FG004|Overall Study|Lack of Efficacy|0
2111770|NCT00903968|3706386|FG005|Overall Study|Lack of Efficacy|0
2111771|NCT00903968|3706387|FG006|Overall Study|Lack of Efficacy|0
2111772|NCT00903968|3706388|FG007|Overall Study|Lack of Efficacy|3
2111773|NCT00904033|3706424|FG000|Overall Study|Withdrawal by Subject|1
2111774|NCT00904033|3706425|FG001|Overall Study|Withdrawal by Subject|1
2111775|NCT00904033|3706426|FG002|Overall Study|Withdrawal by Subject|0
2111776|NCT00904033|3706427|FG003|Overall Study|Withdrawal by Subject|0
2111777|NCT00904033|3706424|FG000|Overall Study|Physician Decision|0
2111778|NCT00904033|3706425|FG001|Overall Study|Physician Decision|0
2111779|NCT00904033|3706426|FG002|Overall Study|Physician Decision|1
2111780|NCT00904033|3706427|FG003|Overall Study|Physician Decision|0
2111781|NCT00904033|3706424|FG000|Overall Study|Unable to obtain final blood draw|0
2111782|NCT00904033|3706425|FG001|Overall Study|Unable to obtain final blood draw|0
2111783|NCT00904033|3706426|FG002|Overall Study|Unable to obtain final blood draw|0
2111784|NCT00904033|3706427|FG003|Overall Study|Unable to obtain final blood draw|2
2111785|NCT00904150|3706440|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3
2111786|NCT00904150|3706441|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0
2111787|NCT00904150|3706440|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0
2111788|NCT00904150|3706441|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145
2111789|NCT00904215|3706447|FG000|Overall Study|Adverse Event|25
2111790|NCT00904215|3706447|FG000|Overall Study|Protocol Violation|10
2111791|NCT00904215|3706447|FG000|Overall Study|Lost to Follow-up|63
2111792|NCT00904215|3706447|FG000|Overall Study|Withdrawal by Subject|9
2111793|NCT00904215|3706447|FG000|Overall Study|Other|28
2218868|NCT01717326|3862436|FG011|Overall Study|Protocol Violation|0
2218869|NCT01717326|3862437|FG012|Overall Study|Protocol Violation|0
2218870|NCT01717326|3862438|FG013|Overall Study|Protocol Violation|0
2218871|NCT01717326|3862439|FG014|Overall Study|Protocol Violation|0
2218872|NCT01717326|3862440|FG015|Overall Study|Protocol Violation|0
2218873|NCT01717326|3862441|FG016|Overall Study|Protocol Violation|0
2218874|NCT01717326|3862442|FG017|Overall Study|Protocol Violation|0
2218875|NCT01717326|3862443|FG018|Overall Study|Protocol Violation|0
2218876|NCT01717326|3862444|FG019|Overall Study|Protocol Violation|0
2218877|NCT01717326|3862425|FG000|Overall Study|Withdrawal by Subject|0
2218878|NCT01717326|3862426|FG001|Overall Study|Withdrawal by Subject|1
2218879|NCT01717326|3862427|FG002|Overall Study|Withdrawal by Subject|0
2218880|NCT01717326|3862428|FG003|Overall Study|Withdrawal by Subject|0
2218881|NCT01717326|3862429|FG004|Overall Study|Withdrawal by Subject|0
2218882|NCT01717326|3862430|FG005|Overall Study|Withdrawal by Subject|0
2218883|NCT01717326|3862431|FG006|Overall Study|Withdrawal by Subject|0
2218884|NCT01717326|3862432|FG007|Overall Study|Withdrawal by Subject|0
2033912|NCT00401245|3604512|FG007|Open Label Phase|Other|0
2033913|NCT00401245|3604505|FG000|Open Label Phase|Protocol Violation|0
2218885|NCT01717326|3862433|FG008|Overall Study|Withdrawal by Subject|0
2218886|NCT01717326|3862434|FG009|Overall Study|Withdrawal by Subject|1
2218887|NCT01717326|3862435|FG010|Overall Study|Withdrawal by Subject|0
2218888|NCT01717326|3862436|FG011|Overall Study|Withdrawal by Subject|0
2033914|NCT00401245|3604506|FG001|Open Label Phase|Protocol Violation|1
2033915|NCT00401245|3604507|FG002|Open Label Phase|Protocol Violation|0
2033916|NCT00401245|3604508|FG003|Open Label Phase|Protocol Violation|1
2033917|NCT00401245|3604509|FG004|Open Label Phase|Protocol Violation|0
2033918|NCT00401245|3604510|FG005|Open Label Phase|Protocol Violation|0
2033919|NCT00401245|3604511|FG006|Open Label Phase|Protocol Violation|0
2033920|NCT00401245|3604512|FG007|Open Label Phase|Protocol Violation|0
2033921|NCT00401245|3604505|FG000|Open Label Phase|Withdrawal by Subject|3
2033922|NCT00401245|3604506|FG001|Open Label Phase|Withdrawal by Subject|3
2033923|NCT00401245|3604507|FG002|Open Label Phase|Withdrawal by Subject|2
2033924|NCT00401245|3604508|FG003|Open Label Phase|Withdrawal by Subject|1
2033925|NCT00401245|3604509|FG004|Open Label Phase|Withdrawal by Subject|0
2033926|NCT00401245|3604510|FG005|Open Label Phase|Withdrawal by Subject|0
2033927|NCT00401245|3604511|FG006|Open Label Phase|Withdrawal by Subject|0
2033928|NCT00401245|3604512|FG007|Open Label Phase|Withdrawal by Subject|0
2033929|NCT00401245|3604505|FG000|Open Label Phase|Lack of Efficacy|4
2033930|NCT00401245|3604506|FG001|Open Label Phase|Lack of Efficacy|2
2033931|NCT00401245|3604507|FG002|Open Label Phase|Lack of Efficacy|3
2033932|NCT00401245|3604508|FG003|Open Label Phase|Lack of Efficacy|0
2033933|NCT00401245|3604509|FG004|Open Label Phase|Lack of Efficacy|0
2033934|NCT00401245|3604510|FG005|Open Label Phase|Lack of Efficacy|0
2033935|NCT00401245|3604511|FG006|Open Label Phase|Lack of Efficacy|0
2033936|NCT00401245|3604512|FG007|Open Label Phase|Lack of Efficacy|0
2218889|NCT01717326|3862437|FG012|Overall Study|Withdrawal by Subject|1
2218890|NCT01717326|3862438|FG013|Overall Study|Withdrawal by Subject|0
2033937|NCT00401245|3604505|FG000|Double Blind Tapering Phase|Adverse Event|0
2033938|NCT00401245|3604506|FG001|Double Blind Tapering Phase|Adverse Event|0
2033939|NCT00401245|3604507|FG002|Double Blind Tapering Phase|Adverse Event|0
2033940|NCT00401245|3604508|FG003|Double Blind Tapering Phase|Adverse Event|0
2033941|NCT00401245|3604509|FG004|Double Blind Tapering Phase|Adverse Event|1
2033942|NCT00401245|3604510|FG005|Double Blind Tapering Phase|Adverse Event|1
2033943|NCT00401245|3604511|FG006|Double Blind Tapering Phase|Adverse Event|2
2033944|NCT00401245|3604512|FG007|Double Blind Tapering Phase|Adverse Event|4
2033945|NCT00401245|3604505|FG000|Double Blind Tapering Phase|Investigator request|0
2111794|NCT00904371|3706455|FG000|Overall Study|Adverse Event|2
2111795|NCT00904371|3706455|FG000|Overall Study|Lost to Follow-up|4
2111796|NCT00904371|3706455|FG000|Overall Study|Discontinued at target blood pressure|2
2111797|NCT00904371|3706455|FG000|Overall Study|Continued with Tritace|1
2111798|NCT00904670|3706475|FG000|Open Label Phase|Withdrawal by Subject|2
2111799|NCT00904670|3706476|FG001|Open Label Phase|Withdrawal by Subject|0
2111800|NCT00904670|3706475|FG000|Open Label Phase|Adverse Event|2
2111801|NCT00904670|3706476|FG001|Open Label Phase|Adverse Event|0
2111802|NCT00904670|3706475|FG000|Open Label Phase|Lack of Efficacy|1
2111803|NCT00904670|3706476|FG001|Open Label Phase|Lack of Efficacy|0
2111804|NCT00904670|3706475|FG000|Open Label Phase|Lost to Follow-up|1
2111805|NCT00904670|3706476|FG001|Open Label Phase|Lost to Follow-up|0
2111806|NCT00904722|3706484|FG000|Overall Study|Physician Decision|1
2111807|NCT00904748|3706488|FG000|Overall Study|Withdrawal by Subject|1
2111808|NCT00904748|3706489|FG001|Overall Study|Withdrawal by Subject|1
2111809|NCT00904748|3706490|FG002|Overall Study|Withdrawal by Subject|1
2218891|NCT01717326|3862439|FG014|Overall Study|Withdrawal by Subject|0
2218892|NCT01717326|3862440|FG015|Overall Study|Withdrawal by Subject|1
2218893|NCT01717326|3862441|FG016|Overall Study|Withdrawal by Subject|0
2218894|NCT01717326|3862442|FG017|Overall Study|Withdrawal by Subject|0
2218895|NCT01717326|3862443|FG018|Overall Study|Withdrawal by Subject|2
2218896|NCT01717326|3862444|FG019|Overall Study|Withdrawal by Subject|3
2218897|NCT01717391|3862486|FG000|Overall Study|Withdrawal by Subject|5
2218898|NCT01717391|3862486|FG000|Overall Study|Physician Decision|1
2218899|NCT01717391|3862486|FG000|Overall Study|FLT technical failure|3
2218900|NCT01717456|3862494|FG000|End of Treatment|Physician Decision|0
2218901|NCT01717456|3862495|FG001|End of Treatment|Physician Decision|1
2033946|NCT00401245|3604506|FG001|Double Blind Tapering Phase|Investigator request|0
2218902|NCT01717456|3862494|FG000|End of Treatment|Lost to Follow-up|0
2218903|NCT01717456|3862495|FG001|End of Treatment|Lost to Follow-up|1
2033947|NCT00401245|3604507|FG002|Double Blind Tapering Phase|Investigator request|0
2033948|NCT00401245|3604508|FG003|Double Blind Tapering Phase|Investigator request|0
2033949|NCT00401245|3604509|FG004|Double Blind Tapering Phase|Investigator request|0
2033950|NCT00401245|3604510|FG005|Double Blind Tapering Phase|Investigator request|0
2033951|NCT00401245|3604511|FG006|Double Blind Tapering Phase|Investigator request|0
2033952|NCT00401245|3604512|FG007|Double Blind Tapering Phase|Investigator request|1
2033953|NCT00401245|3604505|FG000|Double Blind Tapering Phase|Other|0
2033954|NCT00401245|3604506|FG001|Double Blind Tapering Phase|Other|0
2033955|NCT00401245|3604507|FG002|Double Blind Tapering Phase|Other|0
2033956|NCT00401245|3604508|FG003|Double Blind Tapering Phase|Other|0
2033957|NCT00401245|3604509|FG004|Double Blind Tapering Phase|Other|1
2033958|NCT00401245|3604510|FG005|Double Blind Tapering Phase|Other|0
2033959|NCT00401245|3604511|FG006|Double Blind Tapering Phase|Other|2
2033960|NCT00401245|3604512|FG007|Double Blind Tapering Phase|Other|2
2033961|NCT00401245|3604505|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0
2033962|NCT00401245|3604506|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0
2033963|NCT00401245|3604507|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0
2033964|NCT00401245|3604508|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0
2033965|NCT00401245|3604509|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2
2033966|NCT00401245|3604510|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2
2033967|NCT00401245|3604511|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3
2033968|NCT00401245|3604512|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0
2033969|NCT00401245|3604505|FG000|Double Blind Tapering Phase|Lack of Efficacy|0
2033970|NCT00401245|3604506|FG001|Double Blind Tapering Phase|Lack of Efficacy|0
2033971|NCT00401245|3604507|FG002|Double Blind Tapering Phase|Lack of Efficacy|0
2033972|NCT00401245|3604508|FG003|Double Blind Tapering Phase|Lack of Efficacy|0
2033973|NCT00401245|3604509|FG004|Double Blind Tapering Phase|Lack of Efficacy|0
2033974|NCT00401245|3604510|FG005|Double Blind Tapering Phase|Lack of Efficacy|1
2033975|NCT00401245|3604511|FG006|Double Blind Tapering Phase|Lack of Efficacy|0
2033976|NCT00401245|3604512|FG007|Double Blind Tapering Phase|Lack of Efficacy|0
2033977|NCT00401258|3604532|FG000|Overall Study|Adverse Event|7
2033978|NCT00401375|3604539|FG000|Overall Study|Protocol Violation|2
2033979|NCT00401375|3604540|FG001|Overall Study|Protocol Violation|2
2033980|NCT00401375|3604541|FG002|Overall Study|Protocol Violation|1
2033981|NCT00401375|3604539|FG000|Overall Study|Adverse Event|6
2033982|NCT00401375|3604540|FG001|Overall Study|Adverse Event|11
2033983|NCT00401375|3604541|FG002|Overall Study|Adverse Event|10
2033984|NCT00401375|3604539|FG000|Overall Study|Withdrawal by Subject|9
2033985|NCT00401375|3604540|FG001|Overall Study|Withdrawal by Subject|7
2033986|NCT00401375|3604541|FG002|Overall Study|Withdrawal by Subject|7
2033987|NCT00401375|3604539|FG000|Overall Study|Lost to Follow-up|0
2033988|NCT00401375|3604540|FG001|Overall Study|Lost to Follow-up|1
2033989|NCT00401375|3604541|FG002|Overall Study|Lost to Follow-up|1
2033990|NCT00401375|3604539|FG000|Overall Study|Other than specified|2
2033991|NCT00401375|3604540|FG001|Overall Study|Other than specified|1
2033992|NCT00401375|3604541|FG002|Overall Study|Other than specified|3
2033993|NCT00401375|3604539|FG000|Overall Study|Randomized but not treated|3
2033994|NCT00401375|3604540|FG001|Overall Study|Randomized but not treated|3
2033995|NCT00401375|3604541|FG002|Overall Study|Randomized but not treated|3
2033996|NCT00401531|3604600|FG000|Overall Study|Adverse Event|2
2033997|NCT00401531|3604601|FG001|Overall Study|Adverse Event|0
2033998|NCT00401531|3604600|FG000|Overall Study|Protocol Violation|3
2033999|NCT00401531|3604601|FG001|Overall Study|Protocol Violation|7
2034000|NCT00401531|3604600|FG000|Overall Study|Lost to Follow-up|1
2034001|NCT00401531|3604601|FG001|Overall Study|Lost to Follow-up|1
2034002|NCT00401531|3604600|FG000|Overall Study|Withdrawal by Subject|3
2034003|NCT00401531|3604601|FG001|Overall Study|Withdrawal by Subject|2
2034004|NCT00401544|3604611|FG000|Overall Study|Adverse Event|5
2034005|NCT00401544|3604612|FG001|Overall Study|Adverse Event|1
2034006|NCT00401544|3604613|FG002|Overall Study|Adverse Event|1
2034007|NCT00401544|3604614|FG003|Overall Study|Adverse Event|1
2034008|NCT00401544|3604611|FG000|Overall Study|Death|3
2034009|NCT00401544|3604612|FG001|Overall Study|Death|6
2034010|NCT00401544|3604613|FG002|Overall Study|Death|2
2034011|NCT00401544|3604614|FG003|Overall Study|Death|5
2034012|NCT00401544|3604611|FG000|Overall Study|Lost to Follow-up|2
2218904|NCT01717456|3862494|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
2218905|NCT01717456|3862495|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
2218906|NCT01717638|3862519|FG000|Overall Study|Lost to Follow-up|0
2218907|NCT01717638|3862520|FG001|Overall Study|Lost to Follow-up|0
2218908|NCT01717638|3862521|FG002|Overall Study|Lost to Follow-up|0
2218909|NCT01717638|3862522|FG003|Overall Study|Lost to Follow-up|0
2218910|NCT01717638|3862523|FG004|Overall Study|Lost to Follow-up|0
2218911|NCT01717638|3862524|FG005|Overall Study|Lost to Follow-up|1
2218912|NCT01717638|3862525|FG006|Overall Study|Lost to Follow-up|0
2218913|NCT01717638|3862526|FG007|Overall Study|Lost to Follow-up|0
2218914|NCT01717638|3862527|FG008|Overall Study|Lost to Follow-up|0
2218915|NCT01717638|3862528|FG009|Overall Study|Lost to Follow-up|0
2034013|NCT00401544|3604612|FG001|Overall Study|Lost to Follow-up|0
2034014|NCT00401544|3604613|FG002|Overall Study|Lost to Follow-up|1
2034015|NCT00401544|3604614|FG003|Overall Study|Lost to Follow-up|1
2034016|NCT00401544|3604611|FG000|Overall Study|Withdrawal by Subject|7
2034017|NCT00401544|3604612|FG001|Overall Study|Withdrawal by Subject|6
2034018|NCT00401544|3604613|FG002|Overall Study|Withdrawal by Subject|6
2034019|NCT00401544|3604614|FG003|Overall Study|Withdrawal by Subject|5
2034020|NCT00401544|3604611|FG000|Overall Study|Physician Decision|1
2034021|NCT00401544|3604612|FG001|Overall Study|Physician Decision|3
2034022|NCT00401544|3604613|FG002|Overall Study|Physician Decision|0
2034023|NCT00401544|3604614|FG003|Overall Study|Physician Decision|0
2034024|NCT00401544|3604611|FG000|Overall Study|Ineligibility determined|0
2034025|NCT00401544|3604612|FG001|Overall Study|Ineligibility determined|1
2034026|NCT00401544|3604613|FG002|Overall Study|Ineligibility determined|0
2034027|NCT00401544|3604614|FG003|Overall Study|Ineligibility determined|2
2034028|NCT00401544|3604611|FG000|Overall Study|Disease progression|0
2034029|NCT00401544|3604612|FG001|Overall Study|Disease progression|1
2034030|NCT00401544|3604613|FG002|Overall Study|Disease progression|0
2034031|NCT00401544|3604614|FG003|Overall Study|Disease progression|0
2034032|NCT00401544|3604611|FG000|Overall Study|Other|0
2034033|NCT00401544|3604612|FG001|Overall Study|Other|0
2034034|NCT00401544|3604613|FG002|Overall Study|Other|2
2034035|NCT00401544|3604614|FG003|Overall Study|Other|2
2034036|NCT00401726|3604640|FG000|Overall Study|Adverse Event|34
2034037|NCT00401726|3604641|FG001|Overall Study|Adverse Event|45
2034038|NCT00401726|3604640|FG000|Overall Study|Death|0
2034039|NCT00401726|3604641|FG001|Overall Study|Death|3
2034040|NCT00401726|3604640|FG000|Overall Study|Sponsor Request|0
2034041|NCT00401726|3604641|FG001|Overall Study|Sponsor Request|1
2034042|NCT00401726|3604640|FG000|Overall Study|Physician Decision|3
2034043|NCT00401726|3604641|FG001|Overall Study|Physician Decision|6
2034044|NCT00401726|3604640|FG000|Overall Study|Lost to Follow-up|23
2034045|NCT00401726|3604641|FG001|Overall Study|Lost to Follow-up|20
2034046|NCT00401726|3604640|FG000|Overall Study|Protocol Violation|6
2034047|NCT00401726|3604641|FG001|Overall Study|Protocol Violation|3
2111810|NCT00904748|3706491|FG003|Overall Study|Withdrawal by Subject|2
2111811|NCT00904748|3706492|FG004|Overall Study|Withdrawal by Subject|0
2111812|NCT00904748|3706493|FG005|Overall Study|Withdrawal by Subject|0
2111813|NCT00904748|3706488|FG000|Overall Study|Adverse Event|0
2111814|NCT00904748|3706489|FG001|Overall Study|Adverse Event|0
2111815|NCT00904748|3706490|FG002|Overall Study|Adverse Event|0
2111816|NCT00904748|3706491|FG003|Overall Study|Adverse Event|0
2111817|NCT00904748|3706492|FG004|Overall Study|Adverse Event|1
2111818|NCT00904748|3706493|FG005|Overall Study|Adverse Event|0
2111819|NCT00904839|3706540|FG000|Overall Study|Adverse Event|0
2111820|NCT00904839|3706541|FG001|Overall Study|Adverse Event|5
2111821|NCT00904839|3706542|FG002|Overall Study|Adverse Event|4
2111822|NCT00904839|3706540|FG000|Overall Study|Protocol Violation|0
2111823|NCT00904839|3706541|FG001|Overall Study|Protocol Violation|1
2111824|NCT00904839|3706542|FG002|Overall Study|Protocol Violation|1
2111825|NCT00904839|3706540|FG000|Overall Study|Lost to Follow-up|0
2111826|NCT00904839|3706541|FG001|Overall Study|Lost to Follow-up|1
2111827|NCT00904839|3706542|FG002|Overall Study|Lost to Follow-up|2
2111828|NCT00904839|3706540|FG000|Overall Study|Withdrawal by Subject|0
2111829|NCT00904839|3706541|FG001|Overall Study|Withdrawal by Subject|2
2111830|NCT00904839|3706542|FG002|Overall Study|Withdrawal by Subject|0
2111831|NCT00904839|3706540|FG000|Overall Study|Not treated|1
2111832|NCT00904839|3706541|FG001|Overall Study|Not treated|0
2111833|NCT00904839|3706542|FG002|Overall Study|Not treated|1
2218916|NCT01717638|3862529|FG010|Overall Study|Lost to Follow-up|0
2034048|NCT00401726|3604640|FG000|Overall Study|Withdrawal by Subject|18
2111834|NCT00904839|3706540|FG000|Overall Study|Other than above|0
2034049|NCT00401726|3604641|FG001|Overall Study|Withdrawal by Subject|24
2034050|NCT00401726|3604640|FG000|Overall Study|Lack of Efficacy|4
2034051|NCT00401726|3604641|FG001|Overall Study|Lack of Efficacy|6
2034052|NCT00401726|3604640|FG000|Overall Study|Protocol Deviation|9
2034053|NCT00401726|3604641|FG001|Overall Study|Protocol Deviation|4
2034054|NCT00401752|3604649|FG000|Overall Study|Adverse Event|2
2034055|NCT00401752|3604650|FG001|Overall Study|Adverse Event|5
2034056|NCT00401752|3604649|FG000|Overall Study|Withdrawal by Subject|2
2034057|NCT00401752|3604650|FG001|Overall Study|Withdrawal by Subject|6
2034058|NCT00401752|3604649|FG000|Overall Study|Lost to Follow-up|1
2034059|NCT00401752|3604650|FG001|Overall Study|Lost to Follow-up|4
2034060|NCT00401752|3604649|FG000|Overall Study|Development of any exclusion criteria|4
2034061|NCT00401752|3604650|FG001|Overall Study|Development of any exclusion criteria|2
2034062|NCT00401752|3604649|FG000|Overall Study|Physician Decision|1
2034063|NCT00401752|3604650|FG001|Overall Study|Physician Decision|1
2111835|NCT00904839|3706541|FG001|Overall Study|Other than above|9
2111836|NCT00904839|3706542|FG002|Overall Study|Other than above|7
2111837|NCT00904917|3706557|FG000|Overall Study|Lost to Follow-up|2
2111838|NCT00904917|3706558|FG001|Overall Study|Lost to Follow-up|2
2111839|NCT00904917|3706559|FG002|Overall Study|Lost to Follow-up|2
2111840|NCT00904917|3706560|FG003|Overall Study|Lost to Follow-up|2
2111841|NCT00904969|3706573|FG000|Overall Study|Lost to Follow-up|4
2111842|NCT00904969|3706573|FG000|Overall Study|Withdrawal by Subject|3
2111843|NCT00904969|3706573|FG000|Overall Study|Additional Treatments|11
2111844|NCT00904969|3706573|FG000|Overall Study|Case Aborted; Subject Exited|1
2111845|NCT00904982|3706596|FG000|Overall Study|Withdrawal by Subject|2
2111846|NCT00904982|3706597|FG001|Overall Study|Withdrawal by Subject|0
2111847|NCT00904982|3706598|FG002|Overall Study|Withdrawal by Subject|0
2111848|NCT00904982|3706599|FG003|Overall Study|Withdrawal by Subject|0
2111849|NCT00905021|3706618|FG000|Overall Study|Adverse Event|2
2111850|NCT00905034|3706623|FG000|Overall Study|Withdrawal by Subject|1
2111851|NCT00905255|3706646|FG000|Overall Study|Adverse Event|7
2111852|NCT00905255|3706647|FG001|Overall Study|Adverse Event|5
2111853|NCT00905255|3706646|FG000|Overall Study|Withdrawal by Subject|5
2111854|NCT00905255|3706647|FG001|Overall Study|Withdrawal by Subject|4
2111855|NCT00905255|3706646|FG000|Overall Study|Familial and Personal Reasons|1
2111856|NCT00905255|3706647|FG001|Overall Study|Familial and Personal Reasons|0
2111857|NCT00905307|3706677|FG000|Overall Study|Switched to Open Label Rescue|7
2111858|NCT00905307|3706678|FG001|Overall Study|Switched to Open Label Rescue|17
2111859|NCT00905307|3706679|FG002|Overall Study|Switched to Open Label Rescue|11
2111860|NCT00905307|3706680|FG003|Overall Study|Switched to Open Label Rescue|11
2218917|NCT01717638|3862530|FG011|Overall Study|Lost to Follow-up|0
2218918|NCT01717638|3862531|FG012|Overall Study|Lost to Follow-up|0
2034064|NCT00401830|3604676|FG000|Overall Study|Adverse Event|10
2034065|NCT00401830|3604677|FG001|Overall Study|Adverse Event|18
2034066|NCT00401830|3604676|FG000|Overall Study|Lack of Efficacy|11
2034067|NCT00401830|3604677|FG001|Overall Study|Lack of Efficacy|5
2034068|NCT00401830|3604676|FG000|Overall Study|Withdrawal by Subject|4
2034069|NCT00401830|3604677|FG001|Overall Study|Withdrawal by Subject|3
2034070|NCT00401830|3604676|FG000|Overall Study|Protocol Violation|3
2111861|NCT00905307|3706681|FG004|Overall Study|Switched to Open Label Rescue|4
2111862|NCT00905307|3706682|FG005|Overall Study|Switched to Open Label Rescue|15
2111863|NCT00905307|3706677|FG000|Overall Study|Lost to Follow-up|0
2111864|NCT00905307|3706678|FG001|Overall Study|Lost to Follow-up|0
2111865|NCT00905307|3706679|FG002|Overall Study|Lost to Follow-up|0
2111866|NCT00905307|3706680|FG003|Overall Study|Lost to Follow-up|0
2111867|NCT00905307|3706681|FG004|Overall Study|Lost to Follow-up|1
2111868|NCT00905307|3706682|FG005|Overall Study|Lost to Follow-up|1
2111869|NCT00905307|3706677|FG000|Overall Study|Adverse Event|3
2111870|NCT00905307|3706678|FG001|Overall Study|Adverse Event|4
2111871|NCT00905307|3706679|FG002|Overall Study|Adverse Event|5
2111872|NCT00905307|3706680|FG003|Overall Study|Adverse Event|11
2111873|NCT00905307|3706681|FG004|Overall Study|Adverse Event|3
2111874|NCT00905307|3706682|FG005|Overall Study|Adverse Event|5
2111875|NCT00905307|3706677|FG000|Overall Study|Withdrawal by Subject|5
2111876|NCT00905307|3706678|FG001|Overall Study|Withdrawal by Subject|13
2111877|NCT00905307|3706679|FG002|Overall Study|Withdrawal by Subject|15
2111878|NCT00905307|3706680|FG003|Overall Study|Withdrawal by Subject|11
2111879|NCT00905307|3706681|FG004|Overall Study|Withdrawal by Subject|4
2111880|NCT00905307|3706682|FG005|Overall Study|Withdrawal by Subject|13
2034071|NCT00401830|3604677|FG001|Overall Study|Protocol Violation|3
2034072|NCT00401830|3604676|FG000|Overall Study|Non-compliance with drug study|1
2034073|NCT00401830|3604677|FG001|Overall Study|Non-compliance with drug study|0
2034074|NCT00401830|3604676|FG000|Overall Study|Lost to Follow-up|1
2034075|NCT00401830|3604677|FG001|Overall Study|Lost to Follow-up|3
2034076|NCT00401830|3604676|FG000|Overall Study|Other: Personal / Family problems|1
2034077|NCT00401830|3604677|FG001|Overall Study|Other: Personal / Family problems|0
2034078|NCT00401843|3604686|FG000|Overall Study|Achieved Complete Response|1
2034079|NCT00401843|3604687|FG001|Overall Study|Achieved Complete Response|5
2034080|NCT00401843|3604688|FG002|Overall Study|Achieved Complete Response|11
2034081|NCT00401843|3604686|FG000|Overall Study|Adverse Event|7
2034082|NCT00401843|3604687|FG001|Overall Study|Adverse Event|26
2034083|NCT00401843|3604688|FG002|Overall Study|Adverse Event|27
2034084|NCT00401843|3604686|FG000|Overall Study|Death|0
2034085|NCT00401843|3604687|FG001|Overall Study|Death|8
2034086|NCT00401843|3604688|FG002|Overall Study|Death|10
2034087|NCT00401843|3604686|FG000|Overall Study|Disease progression|10
2034088|NCT00401843|3604687|FG001|Overall Study|Disease progression|60
2034089|NCT00401843|3604688|FG002|Overall Study|Disease progression|49
2034090|NCT00401843|3604686|FG000|Overall Study|End of Study|1
2034091|NCT00401843|3604687|FG001|Overall Study|End of Study|1
2034092|NCT00401843|3604688|FG002|Overall Study|End of Study|2
2034093|NCT00401843|3604686|FG000|Overall Study|Lost to Follow-up|0
2034094|NCT00401843|3604687|FG001|Overall Study|Lost to Follow-up|0
2034095|NCT00401843|3604688|FG002|Overall Study|Lost to Follow-up|2
2034096|NCT00401843|3604686|FG000|Overall Study|Other Unspecified|0
2034097|NCT00401843|3604687|FG001|Overall Study|Other Unspecified|3
2034098|NCT00401843|3604688|FG002|Overall Study|Other Unspecified|5
2034099|NCT00401843|3604686|FG000|Overall Study|Physician Decision|0
2034100|NCT00401843|3604687|FG001|Overall Study|Physician Decision|16
2034101|NCT00401843|3604688|FG002|Overall Study|Physician Decision|10
2034102|NCT00401843|3604686|FG000|Overall Study|Protocol Violation|0
2034103|NCT00401843|3604687|FG001|Overall Study|Protocol Violation|0
2034104|NCT00401843|3604688|FG002|Overall Study|Protocol Violation|1
2034105|NCT00401843|3604686|FG000|Overall Study|Withdrawal by Subject|1
2034106|NCT00401843|3604687|FG001|Overall Study|Withdrawal by Subject|5
2034107|NCT00401843|3604688|FG002|Overall Study|Withdrawal by Subject|5
2034108|NCT00401843|3604686|FG000|Overall Study|Withdrawal of consent to study agent|1
2034109|NCT00401843|3604687|FG001|Overall Study|Withdrawal of consent to study agent|15
2034110|NCT00401843|3604688|FG002|Overall Study|Withdrawal of consent to study agent|17
2034111|NCT00401843|3604686|FG000|Overall Study|Randomized but not Treated|0
2034112|NCT00401843|3604687|FG001|Overall Study|Randomized but not Treated|2
2034113|NCT00401843|3604688|FG002|Overall Study|Randomized but not Treated|3
2034114|NCT00401843|3604686|FG000|Overall Study|Received incorrect treatment|0
2034115|NCT00401843|3604687|FG001|Overall Study|Received incorrect treatment|3
2034116|NCT00401843|3604688|FG002|Overall Study|Received incorrect treatment|0
2034117|NCT00401960|3604715|FG000|Overall Study|Lost to Follow-up|3
2034118|NCT00401960|3604716|FG001|Overall Study|Lost to Follow-up|0
2034119|NCT00401960|3604715|FG000|Overall Study|Death|2
2034120|NCT00401960|3604716|FG001|Overall Study|Death|0
2034121|NCT00401973|3604727|FG000|Overall Study|Adverse Event|2
2034122|NCT00401973|3604728|FG001|Overall Study|Adverse Event|8
2034123|NCT00401973|3604729|FG002|Overall Study|Adverse Event|4
2034124|NCT00401973|3604727|FG000|Overall Study|Clinical Relapse|0
2111881|NCT00905307|3706677|FG000|Overall Study|Protocol Violation|1
2111882|NCT00905307|3706678|FG001|Overall Study|Protocol Violation|0
2111883|NCT00905307|3706679|FG002|Overall Study|Protocol Violation|1
2111884|NCT00905307|3706680|FG003|Overall Study|Protocol Violation|0
2111885|NCT00905307|3706681|FG004|Overall Study|Protocol Violation|0
2111886|NCT00905307|3706682|FG005|Overall Study|Protocol Violation|0
2111887|NCT00905307|3706677|FG000|Overall Study|Lack of Efficacy|6
2111888|NCT00905307|3706678|FG001|Overall Study|Lack of Efficacy|3
2111889|NCT00905307|3706679|FG002|Overall Study|Lack of Efficacy|5
2111890|NCT00905307|3706680|FG003|Overall Study|Lack of Efficacy|4
2111891|NCT00905307|3706681|FG004|Overall Study|Lack of Efficacy|4
2111892|NCT00905307|3706682|FG005|Overall Study|Lack of Efficacy|8
2111893|NCT00905359|3706711|FG000|Overall Study|Lost to Follow-up|17
2111894|NCT00905359|3706712|FG001|Overall Study|Lost to Follow-up|10
2111895|NCT00905359|3706711|FG000|Overall Study|Death|2
2111896|NCT00905359|3706712|FG001|Overall Study|Death|0
2111897|NCT00905359|3706711|FG000|Overall Study|Withdrawal consent|5
2111898|NCT00905359|3706712|FG001|Overall Study|Withdrawal consent|6
2111899|NCT00905424|3706720|FG000|Overall Study|Lost to Follow-up|3
2111900|NCT00905424|3706721|FG001|Overall Study|Lost to Follow-up|3
2111901|NCT00905424|3706720|FG000|Overall Study|Withdrawal by Subject|1
2034125|NCT00401973|3604728|FG001|Overall Study|Clinical Relapse|1
2034126|NCT00401973|3604729|FG002|Overall Study|Clinical Relapse|1
2034127|NCT00401973|3604727|FG000|Overall Study|Lack of Efficacy|0
2034128|NCT00401973|3604728|FG001|Overall Study|Lack of Efficacy|0
2034129|NCT00401973|3604729|FG002|Overall Study|Lack of Efficacy|3
2034130|NCT00401973|3604727|FG000|Overall Study|Lost to Follow-up|2
2034131|NCT00401973|3604728|FG001|Overall Study|Lost to Follow-up|2
2034132|NCT00401973|3604729|FG002|Overall Study|Lost to Follow-up|2
2034133|NCT00401973|3604727|FG000|Overall Study|Physician Decision|2
2034134|NCT00401973|3604728|FG001|Overall Study|Physician Decision|0
2034135|NCT00401973|3604729|FG002|Overall Study|Physician Decision|1
2034136|NCT00401973|3604727|FG000|Overall Study|Protocol Violation|1
2034137|NCT00401973|3604728|FG001|Overall Study|Protocol Violation|2
2034138|NCT00401973|3604729|FG002|Overall Study|Protocol Violation|3
2034139|NCT00401973|3604727|FG000|Overall Study|Sponsor Decision|0
2034140|NCT00401973|3604728|FG001|Overall Study|Sponsor Decision|1
2034141|NCT00401973|3604729|FG002|Overall Study|Sponsor Decision|0
2034142|NCT00401973|3604727|FG000|Overall Study|Withdrawal by Subject|4
2034143|NCT00401973|3604728|FG001|Overall Study|Withdrawal by Subject|12
2034144|NCT00401973|3604729|FG002|Overall Study|Withdrawal by Subject|9
2034145|NCT00402025|3604751|FG000|Overall Study|Adverse Event|0
2034146|NCT00402025|3604752|FG001|Overall Study|Adverse Event|0
2034147|NCT00402025|3604753|FG002|Overall Study|Adverse Event|2
2034148|NCT00402025|3604751|FG000|Overall Study|Death|0
2034149|NCT00402025|3604752|FG001|Overall Study|Death|1
2034150|NCT00402025|3604753|FG002|Overall Study|Death|5
2034151|NCT00402025|3604751|FG000|Overall Study|Disease Progression|1
2034152|NCT00402025|3604752|FG001|Overall Study|Disease Progression|1
2034153|NCT00402025|3604753|FG002|Overall Study|Disease Progression|2
2034154|NCT00402025|3604751|FG000|Overall Study|Physician Decision|1
2034155|NCT00402025|3604752|FG001|Overall Study|Physician Decision|1
2034156|NCT00402025|3604753|FG002|Overall Study|Physician Decision|0
2034157|NCT00402025|3604751|FG000|Overall Study|Participant Decision|0
2034158|NCT00402025|3604752|FG001|Overall Study|Participant Decision|0
2034159|NCT00402025|3604753|FG002|Overall Study|Participant Decision|1
2034160|NCT00402051|3604763|FG000|Overall Study|Progressive Disease|13
2034161|NCT00402051|3604764|FG001|Overall Study|Progressive Disease|20
2034162|NCT00402051|3604763|FG000|Overall Study|Adverse Event|11
2034163|NCT00402051|3604764|FG001|Overall Study|Adverse Event|4
2034164|NCT00402051|3604763|FG000|Overall Study|Physician Decision|7
2034165|NCT00402051|3604764|FG001|Overall Study|Physician Decision|3
2034166|NCT00402051|3604763|FG000|Overall Study|Withdrawal by Subject|3
2034167|NCT00402051|3604764|FG001|Overall Study|Withdrawal by Subject|3
2034168|NCT00402051|3604763|FG000|Overall Study|Death - Related to Study Drug|1
2034169|NCT00402051|3604764|FG001|Overall Study|Death - Related to Study Drug|2
2034170|NCT00402051|3604763|FG000|Overall Study|Death Due to Study Disease|2
2034171|NCT00402051|3604764|FG001|Overall Study|Death Due to Study Disease|1
2034172|NCT00402051|3604763|FG000|Overall Study|Death Due to Adverse Event|0
2111902|NCT00905424|3706721|FG001|Overall Study|Withdrawal by Subject|2
2111903|NCT00905424|3706720|FG000|Overall Study|Adverse Event|4
2111904|NCT00905424|3706721|FG001|Overall Study|Adverse Event|2
2111905|NCT00905424|3706720|FG000|Overall Study|Non-compliance with study medication|2
2034173|NCT00402051|3604764|FG001|Overall Study|Death Due to Adverse Event|2
2034174|NCT00402051|3604763|FG000|Overall Study|Lost to Follow-up|1
2034175|NCT00402051|3604764|FG001|Overall Study|Lost to Follow-up|0
2034176|NCT00402103|3604772|FG000|Overall Study|Adverse Event|60
2034177|NCT00402103|3604773|FG001|Overall Study|Adverse Event|7
2034178|NCT00402103|3604772|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2034179|NCT00402103|3604773|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2034180|NCT00402103|3604772|FG000|Overall Study|Condition no longer requires study drug|2
2034181|NCT00402103|3604773|FG001|Overall Study|Condition no longer requires study drug|0
2034182|NCT00402103|3604772|FG000|Overall Study|Protocol Deviation|8
2034183|NCT00402103|3604773|FG001|Overall Study|Protocol Deviation|0
2034184|NCT00402103|3604772|FG000|Overall Study|Patient withdrew consent|12
2034185|NCT00402103|3604773|FG001|Overall Study|Patient withdrew consent|1
2034186|NCT00402103|3604772|FG000|Overall Study|Lost to Follow-up|6
2034187|NCT00402103|3604773|FG001|Overall Study|Lost to Follow-up|3
2034188|NCT00402103|3604772|FG000|Overall Study|Administrative problems|2
2034189|NCT00402103|3604773|FG001|Overall Study|Administrative problems|0
2034190|NCT00402116|3604786|FG000|Overall Study|Jaw infection after surgery-other|1
2034191|NCT00402116|3604787|FG001|Overall Study|Jaw infection after surgery-other|0
2034192|NCT00402116|3604788|FG002|Overall Study|Jaw infection after surgery-other|0
2034193|NCT00402116|3604786|FG000|Overall Study|Withdrawal by Subject|1
2034194|NCT00402116|3604787|FG001|Overall Study|Withdrawal by Subject|0
2034195|NCT00402116|3604788|FG002|Overall Study|Withdrawal by Subject|5
2034196|NCT00402116|3604786|FG000|Overall Study|Treatment completed per protocol|1
2034197|NCT00402116|3604787|FG001|Overall Study|Treatment completed per protocol|1
2034198|NCT00402116|3604788|FG002|Overall Study|Treatment completed per protocol|2
2034199|NCT00402116|3604786|FG000|Overall Study|other complicating disease|0
2034200|NCT00402116|3604787|FG001|Overall Study|other complicating disease|0
2034201|NCT00402116|3604788|FG002|Overall Study|other complicating disease|2
2034202|NCT00402116|3604786|FG000|Overall Study|Disease Progression|0
2034203|NCT00402116|3604787|FG001|Overall Study|Disease Progression|4
2034204|NCT00402116|3604788|FG002|Overall Study|Disease Progression|38
2034205|NCT00402116|3604786|FG000|Overall Study|mistaken thrombocytopenia|0
2034206|NCT00402116|3604787|FG001|Overall Study|mistaken thrombocytopenia|0
2034207|NCT00402116|3604788|FG002|Overall Study|mistaken thrombocytopenia|1
2034208|NCT00402116|3604786|FG000|Overall Study|decline related hyponatremia/tumor|0
2111906|NCT00905424|3706721|FG001|Overall Study|Non-compliance with study medication|0
2111907|NCT00905424|3706720|FG000|Overall Study|Sponsor decision|1
2111908|NCT00905424|3706721|FG001|Overall Study|Sponsor decision|0
2111909|NCT00905424|3706720|FG000|Overall Study|Positive urine drug screen|0
2111910|NCT00905424|3706721|FG001|Overall Study|Positive urine drug screen|1
2111911|NCT00905424|3706720|FG000|Overall Study|Non-adherence to visit schedule|0
2111912|NCT00905424|3706721|FG001|Overall Study|Non-adherence to visit schedule|1
2111913|NCT00905437|3706731|FG000|Overall Study|Adverse Event|3
2111914|NCT00905437|3706732|FG001|Overall Study|Adverse Event|2
2111915|NCT00905437|3706731|FG000|Overall Study|Lost to Follow-up|0
2111916|NCT00905437|3706732|FG001|Overall Study|Lost to Follow-up|1
2111917|NCT00905437|3706731|FG000|Overall Study|Withdrawal by Subject|0
2111918|NCT00905437|3706732|FG001|Overall Study|Withdrawal by Subject|1
2111919|NCT00905437|3706731|FG000|Overall Study|Other|5
2111920|NCT00905437|3706732|FG001|Overall Study|Other|6
2111921|NCT00905489|3706771|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
2111922|NCT00905489|3706771|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
2111923|NCT00905489|3706771|FG000|Optional Extension Phase (OEP)|Adverse Event|1
2111924|NCT00905632|3706818|FG000|Overall Study|Adverse Event|0
2111925|NCT00905632|3706819|FG001|Overall Study|Adverse Event|0
2111926|NCT00905632|3706820|FG002|Overall Study|Adverse Event|0
2111927|NCT00905632|3706821|FG003|Overall Study|Adverse Event|0
2111928|NCT00905632|3706822|FG004|Overall Study|Adverse Event|0
2111929|NCT00905632|3706823|FG005|Overall Study|Adverse Event|1
2111930|NCT00905632|3706824|FG006|Overall Study|Adverse Event|4
2111931|NCT00905840|3706860|FG000|Overall Study|Lost to Follow-up|11
2111932|NCT00905840|3706860|FG000|Overall Study|Death|3
2111933|NCT00905840|3706860|FG000|Overall Study|Withdrawal by Subject|1
2111934|NCT00905840|3706860|FG000|Overall Study|Adverse Event|1
2111935|NCT00906087|3706876|FG000|Initial Washout|Withdrawal by Subject|1
2218919|NCT01717638|3862519|FG000|Overall Study|Father in hospital|0
2218920|NCT01717638|3862520|FG001|Overall Study|Father in hospital|0
2218921|NCT01717638|3862521|FG002|Overall Study|Father in hospital|0
2034209|NCT00402116|3604787|FG001|Overall Study|decline related hyponatremia/tumor|0
2034210|NCT00402116|3604788|FG002|Overall Study|decline related hyponatremia/tumor|1
2034211|NCT00402116|3604786|FG000|Overall Study|Adverse Event|0
2034212|NCT00402116|3604787|FG001|Overall Study|Adverse Event|1
2034213|NCT00402116|3604788|FG002|Overall Study|Adverse Event|6
2034214|NCT00402168|3604818|FG000|Randomized|Lost to Follow-up|1
2034215|NCT00402168|3604819|FG001|Randomized|Lost to Follow-up|0
2034216|NCT00402168|3604818|FG000|Randomized|Withdrawal by Subject|0
2034217|NCT00402168|3604819|FG001|Randomized|Withdrawal by Subject|1
2034218|NCT00402168|3604818|FG000|Treatment (up to 12 Months)|Death|0
2034219|NCT00402168|3604819|FG001|Treatment (up to 12 Months)|Death|1
2034220|NCT00402168|3604818|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2
2034221|NCT00402168|3604819|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0
2034222|NCT00402168|3604818|FG000|Treatment (up to 12 Months)|non-specified|0
2034223|NCT00402168|3604819|FG001|Treatment (up to 12 Months)|non-specified|1
2034224|NCT00402168|3604818|FG000|Long Term (LT)|Adverse Event|1
2034225|NCT00402168|3604819|FG001|Long Term (LT)|Adverse Event|5
2034226|NCT00402168|3604818|FG000|Long Term (LT)|Withdrawal by Subject|4
2034227|NCT00402168|3604819|FG001|Long Term (LT)|Withdrawal by Subject|7
2034228|NCT00402168|3604818|FG000|Long Term (LT)|Pregnancy|0
2034229|NCT00402168|3604819|FG001|Long Term (LT)|Pregnancy|1
2034230|NCT00402168|3604818|FG000|Long Term (LT)|Lost to Follow-up|1
2034231|NCT00402168|3604819|FG001|Long Term (LT)|Lost to Follow-up|0
2034232|NCT00402168|3604818|FG000|Long Term (LT)|Death|4
2034233|NCT00402168|3604819|FG001|Long Term (LT)|Death|0
2034234|NCT00402168|3604818|FG000|Long Term (LT)|Lack of Efficacy|0
2034235|NCT00402168|3604819|FG001|Long Term (LT)|Lack of Efficacy|2
2034236|NCT00402168|3604818|FG000|Long Term (LT)|non-specified|1
2034237|NCT00402168|3604819|FG001|Long Term (LT)|non-specified|2
2034238|NCT00402168|3604818|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
2034239|NCT00402168|3604819|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
2034240|NCT00402168|3604818|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4
2034241|NCT00402168|3604819|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0
2034242|NCT00402233|3604846|FG000|Overall Study|Adverse Event|1
2034243|NCT00402233|3604847|FG001|Overall Study|Adverse Event|7
2034244|NCT00402233|3604848|FG002|Overall Study|Adverse Event|9
2034245|NCT00402233|3604849|FG003|Overall Study|Adverse Event|9
2034246|NCT00402233|3604846|FG000|Overall Study|Protocol Violation|0
2034247|NCT00402233|3604847|FG001|Overall Study|Protocol Violation|1
2034248|NCT00402233|3604848|FG002|Overall Study|Protocol Violation|0
2034249|NCT00402233|3604849|FG003|Overall Study|Protocol Violation|0
2034250|NCT00402233|3604846|FG000|Overall Study|Withdrawal by Subject|2
2034251|NCT00402233|3604847|FG001|Overall Study|Withdrawal by Subject|1
2034252|NCT00402233|3604848|FG002|Overall Study|Withdrawal by Subject|2
2034253|NCT00402233|3604849|FG003|Overall Study|Withdrawal by Subject|2
2034254|NCT00402233|3604846|FG000|Overall Study|Worsening of disease under study|2
2034255|NCT00402233|3604847|FG001|Overall Study|Worsening of disease under study|0
2034256|NCT00402233|3604848|FG002|Overall Study|Worsening of disease under study|0
2034257|NCT00402233|3604849|FG003|Overall Study|Worsening of disease under study|0
2034258|NCT00402233|3604846|FG000|Overall Study|Worsening of other pre-existing disease|0
2034259|NCT00402233|3604847|FG001|Overall Study|Worsening of other pre-existing disease|1
2034260|NCT00402233|3604848|FG002|Overall Study|Worsening of other pre-existing disease|0
2034261|NCT00402233|3604849|FG003|Overall Study|Worsening of other pre-existing disease|0
2034262|NCT00402246|3604861|FG000|Overall Study|Death|62
2034263|NCT00402246|3604862|FG001|Overall Study|Death|58
2034264|NCT00402246|3604861|FG000|Overall Study|Lost to Follow-up|20
2034265|NCT00402246|3604862|FG001|Overall Study|Lost to Follow-up|28
2034266|NCT00402246|3604861|FG000|Overall Study|Withdrawal by Subject|72
2034267|NCT00402246|3604862|FG001|Overall Study|Withdrawal by Subject|87
2034268|NCT00402246|3604861|FG000|Overall Study|Physician Decision|24
2034269|NCT00402246|3604862|FG001|Overall Study|Physician Decision|26
2034270|NCT00402246|3604861|FG000|Overall Study|Protocol Violation|25
2034271|NCT00402246|3604862|FG001|Overall Study|Protocol Violation|24
2034272|NCT00402246|3604861|FG000|Overall Study|Missed Final Visit|1
2034273|NCT00402246|3604862|FG001|Overall Study|Missed Final Visit|2
2034274|NCT00402246|3604861|FG000|Overall Study|Insurance Issues|2
2034275|NCT00402246|3604862|FG001|Overall Study|Insurance Issues|1
2034276|NCT00402246|3604861|FG000|Overall Study|Heart Transplant|0
2034277|NCT00402246|3604862|FG001|Overall Study|Heart Transplant|1
2034278|NCT00402246|3604861|FG000|Overall Study|Patient's device explanted|6
2034279|NCT00402246|3604862|FG001|Overall Study|Patient's device explanted|2
2034280|NCT00402246|3604861|FG000|Overall Study|Center Closure|5
2034281|NCT00402246|3604862|FG001|Overall Study|Center Closure|3
2034282|NCT00402246|3604861|FG000|Overall Study|Deterioriating Condition|3
2034283|NCT00402246|3604862|FG001|Overall Study|Deterioriating Condition|2
2034284|NCT00402285|3604873|FG000|Overall Study|insufficient RNA quality|7
2034285|NCT00402285|3604874|FG001|Overall Study|insufficient RNA quality|6
2034286|NCT00402285|3604875|FG002|Overall Study|insufficient RNA quality|2
2034287|NCT00402298|3604883|FG000|Overall Study|Withdrawal by Subject|1
2034288|NCT00402298|3604884|FG001|Overall Study|Withdrawal by Subject|0
2034289|NCT00402324|3604892|FG000|Overall Study|Lost to Follow-up|11
2034290|NCT00402324|3604893|FG001|Overall Study|Lost to Follow-up|11
2034291|NCT00402324|3604892|FG000|Overall Study|Protocol Entry Criteria Not Met|5
2034292|NCT00402324|3604893|FG001|Overall Study|Protocol Entry Criteria Not Met|4
2034293|NCT00402324|3604892|FG000|Overall Study|Protocol Violation|8
2034294|NCT00402324|3604893|FG001|Overall Study|Protocol Violation|7
2034295|NCT00402324|3604892|FG000|Overall Study|Withdrawal by Subject|5
2034296|NCT00402324|3604893|FG001|Overall Study|Withdrawal by Subject|2
2034297|NCT00402324|3604892|FG000|Overall Study|Physician Decision|2
2034298|NCT00402324|3604893|FG001|Overall Study|Physician Decision|4
2034299|NCT00402324|3604892|FG000|Overall Study|Sponsor Decision|4
2034300|NCT00402324|3604893|FG001|Overall Study|Sponsor Decision|5
2034301|NCT00402324|3604892|FG000|Overall Study|Lack of Efficacy|1
2034302|NCT00402324|3604893|FG001|Overall Study|Lack of Efficacy|4
2034303|NCT00402324|3604892|FG000|Overall Study|Adverse Event|6
2034304|NCT00402324|3604893|FG001|Overall Study|Adverse Event|4
2034305|NCT00402324|3604892|FG000|Overall Study|Death|1
2034306|NCT00402324|3604893|FG001|Overall Study|Death|0
2034307|NCT00402337|3604904|FG000|Overall Study|Adverse Event|0
2034308|NCT00402337|3604905|FG001|Overall Study|Adverse Event|2
2034309|NCT00402337|3604906|FG002|Overall Study|Adverse Event|2
2034310|NCT00402337|3604907|FG003|Overall Study|Adverse Event|3
2034311|NCT00402337|3604908|FG004|Overall Study|Adverse Event|2
2034312|NCT00402337|3604904|FG000|Overall Study|Noncompliance|0
2034313|NCT00402337|3604905|FG001|Overall Study|Noncompliance|0
2034314|NCT00402337|3604906|FG002|Overall Study|Noncompliance|0
2034315|NCT00402337|3604907|FG003|Overall Study|Noncompliance|0
2034316|NCT00402337|3604908|FG004|Overall Study|Noncompliance|2
2034317|NCT00402337|3604904|FG000|Overall Study|Withdrawal by Subject|5
2034318|NCT00402337|3604905|FG001|Overall Study|Withdrawal by Subject|3
2034319|NCT00402337|3604906|FG002|Overall Study|Withdrawal by Subject|1
2034320|NCT00402337|3604907|FG003|Overall Study|Withdrawal by Subject|6
2111936|NCT00906087|3706876|FG000|Initial Washout|Physician Decision|1
2111937|NCT00906204|3706903|FG000|Primary Endpoint (Early Safety)|Physician Decision|1
2111938|NCT00906204|3706904|FG001|Primary Endpoint (Early Safety)|Physician Decision|0
2111939|NCT00906204|3706903|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
2111940|NCT00906204|3706904|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
2111941|NCT00906204|3706903|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
2111942|NCT00906204|3706904|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
2111943|NCT00906204|3706903|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2
2111944|NCT00906204|3706904|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2
2111945|NCT00906204|3706903|FG000|Secondary Endpoints (Long-term Safety)|Death|0
2111946|NCT00906204|3706904|FG001|Secondary Endpoints (Long-term Safety)|Death|1
2111947|NCT00906282|3706914|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
2111948|NCT00906282|3706914|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10
2111949|NCT00906282|3706914|FG000|Preoperative Chemotherapy|Progressive disease|6
2111950|NCT00906282|3706914|FG000|Preoperative Chemotherapy|Toxicity|1
2111951|NCT00906347|3706921|FG000|Received Study Drug|8 cm prior to initiation of study drug|18
2111952|NCT00906347|3706922|FG001|Received Study Drug|8 cm prior to initiation of study drug|30
2111953|NCT00906347|3706921|FG000|Received Study Drug|Nonreassuring fetal heart rate|13
2034321|NCT00402337|3604908|FG004|Overall Study|Withdrawal by Subject|4
2034322|NCT00402337|3604904|FG000|Overall Study|Lost to Follow-up|0
2034323|NCT00402337|3604905|FG001|Overall Study|Lost to Follow-up|0
2034324|NCT00402337|3604906|FG002|Overall Study|Lost to Follow-up|1
2034325|NCT00402337|3604907|FG003|Overall Study|Lost to Follow-up|2
2034326|NCT00402337|3604908|FG004|Overall Study|Lost to Follow-up|0
2034327|NCT00402337|3604904|FG000|Overall Study|Physician Decision|0
2034328|NCT00402337|3604905|FG001|Overall Study|Physician Decision|0
2034329|NCT00402337|3604906|FG002|Overall Study|Physician Decision|0
2034330|NCT00402337|3604907|FG003|Overall Study|Physician Decision|1
2034331|NCT00402337|3604908|FG004|Overall Study|Physician Decision|0
2034332|NCT00402337|3604904|FG000|Overall Study|Other Reason|0
2034333|NCT00402337|3604905|FG001|Overall Study|Other Reason|1
2034334|NCT00402337|3604906|FG002|Overall Study|Other Reason|0
2034335|NCT00402337|3604907|FG003|Overall Study|Other Reason|0
2034336|NCT00402337|3604908|FG004|Overall Study|Other Reason|0
2034337|NCT00402363|3604924|FG000|Overall Study|Adverse Event|9
2034338|NCT00402363|3604925|FG001|Overall Study|Adverse Event|14
2034339|NCT00402363|3604926|FG002|Overall Study|Adverse Event|2
2034340|NCT00402363|3604927|FG003|Overall Study|Adverse Event|2
2034341|NCT00402363|3604924|FG000|Overall Study|Withdrew Consent|10
2034342|NCT00402363|3604925|FG001|Overall Study|Withdrew Consent|5
2034343|NCT00402363|3604926|FG002|Overall Study|Withdrew Consent|2
2034344|NCT00402363|3604927|FG003|Overall Study|Withdrew Consent|1
2034345|NCT00402363|3604924|FG000|Overall Study|Protocol Violation|3
2034346|NCT00402363|3604925|FG001|Overall Study|Protocol Violation|5
2034347|NCT00402363|3604926|FG002|Overall Study|Protocol Violation|0
2034348|NCT00402363|3604927|FG003|Overall Study|Protocol Violation|3
2034349|NCT00402363|3604924|FG000|Overall Study|Lost to Follow-up|5
2034350|NCT00402363|3604925|FG001|Overall Study|Lost to Follow-up|4
2034351|NCT00402363|3604926|FG002|Overall Study|Lost to Follow-up|0
2034352|NCT00402363|3604927|FG003|Overall Study|Lost to Follow-up|2
2034353|NCT00402363|3604924|FG000|Overall Study|"Captured as Other"|6
2034354|NCT00402363|3604925|FG001|Overall Study|"Captured as Other"|2
2034355|NCT00402363|3604926|FG002|Overall Study|"Captured as Other"|2
2034356|NCT00402363|3604927|FG003|Overall Study|"Captured as Other"|2
2034357|NCT00402597|3604948|FG000|Overall Study|Death|15
2034358|NCT00402597|3604949|FG001|Overall Study|Death|7
2034359|NCT00402597|3604950|FG002|Overall Study|Death|6
2034360|NCT00402597|3604951|FG003|Overall Study|Death|4
2034361|NCT00402597|3604952|FG004|Overall Study|Death|6
2034362|NCT00402597|3604948|FG000|Overall Study|Adverse Event|81
2034363|NCT00402597|3604949|FG001|Overall Study|Adverse Event|18
2034364|NCT00402597|3604950|FG002|Overall Study|Adverse Event|106
2034365|NCT00402597|3604951|FG003|Overall Study|Adverse Event|39
2034366|NCT00402597|3604952|FG004|Overall Study|Adverse Event|71
2111954|NCT00906347|3706922|FG001|Received Study Drug|Nonreassuring fetal heart rate|1
2111955|NCT00906347|3706921|FG000|Received Study Drug|Refused study drug|1
2111956|NCT00906347|3706922|FG001|Received Study Drug|Refused study drug|0
2111957|NCT00906347|3706921|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8
2111958|NCT00906347|3706922|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0
2111959|NCT00906373|3706930|FG000|Overall Study|Withdrawal by Subject|0
2111960|NCT00906373|3706931|FG001|Overall Study|Withdrawal by Subject|5
2111961|NCT00906373|3706930|FG000|Overall Study|Other|0
2111962|NCT00906373|3706931|FG001|Overall Study|Other|1
2111963|NCT00906373|3706930|FG000|Overall Study|Still on treatment at cutoff date|0
2111964|NCT00906373|3706931|FG001|Overall Study|Still on treatment at cutoff date|2
2111965|NCT00906399|3706941|FG000|Year 1|Randomized But Not Treated|0
2111966|NCT00906399|3706942|FG001|Year 1|Randomized But Not Treated|1
2111967|NCT00906399|3706943|FG002|Year 1|Randomized But Not Treated|3
2111968|NCT00906399|3706944|FG003|Year 1|Randomized But Not Treated|0
2111969|NCT00906399|3706945|FG004|Year 1|Randomized But Not Treated|0
2111970|NCT00906399|3706946|FG005|Year 1|Randomized But Not Treated|0
2111971|NCT00906399|3706947|FG006|Year 1|Randomized But Not Treated|0
2111972|NCT00906399|3706941|FG000|Year 1|Adverse Event|4
2111973|NCT00906399|3706942|FG001|Year 1|Adverse Event|22
2111974|NCT00906399|3706943|FG002|Year 1|Adverse Event|24
2111975|NCT00906399|3706944|FG003|Year 1|Adverse Event|0
2111976|NCT00906399|3706945|FG004|Year 1|Adverse Event|0
2111977|NCT00906399|3706946|FG005|Year 1|Adverse Event|0
2111978|NCT00906399|3706947|FG006|Year 1|Adverse Event|0
2111979|NCT00906399|3706941|FG000|Year 1|Lost to Follow-up|4
2111980|NCT00906399|3706942|FG001|Year 1|Lost to Follow-up|4
2111981|NCT00906399|3706943|FG002|Year 1|Lost to Follow-up|2
2111982|NCT00906399|3706944|FG003|Year 1|Lost to Follow-up|0
2034367|NCT00402597|3604948|FG000|Overall Study|Lost to Follow-up|8
2111983|NCT00906399|3706945|FG004|Year 1|Lost to Follow-up|0
2111984|NCT00906399|3706946|FG005|Year 1|Lost to Follow-up|0
2111985|NCT00906399|3706947|FG006|Year 1|Lost to Follow-up|0
2111986|NCT00906399|3706941|FG000|Year 1|Withdrawal by Subject|30
2111987|NCT00906399|3706942|FG001|Year 1|Withdrawal by Subject|32
2034368|NCT00402597|3604949|FG001|Overall Study|Lost to Follow-up|1
2034369|NCT00402597|3604950|FG002|Overall Study|Lost to Follow-up|8
2034370|NCT00402597|3604951|FG003|Overall Study|Lost to Follow-up|2
2034371|NCT00402597|3604952|FG004|Overall Study|Lost to Follow-up|3
2034372|NCT00402597|3604948|FG000|Overall Study|Withdrawal by Subject|57
2034373|NCT00402597|3604949|FG001|Overall Study|Withdrawal by Subject|16
2034374|NCT00402597|3604950|FG002|Overall Study|Withdrawal by Subject|65
2034375|NCT00402597|3604951|FG003|Overall Study|Withdrawal by Subject|15
2034376|NCT00402597|3604952|FG004|Overall Study|Withdrawal by Subject|24
2034377|NCT00402597|3604948|FG000|Overall Study|reason not specified|30
2034378|NCT00402597|3604949|FG001|Overall Study|reason not specified|4
2034379|NCT00402597|3604950|FG002|Overall Study|reason not specified|27
2034380|NCT00402597|3604951|FG003|Overall Study|reason not specified|14
2034381|NCT00402597|3604952|FG004|Overall Study|reason not specified|20
2034382|NCT00402649|3604964|FG000|Overall Study|Lost to Follow-up|1
2034383|NCT00402649|3604964|FG000|Overall Study|Withdrawal by Subject|1
2034384|NCT00402688|3604971|FG000|Overall Study|Adverse Event|12
2034385|NCT00402688|3604972|FG001|Overall Study|Adverse Event|9
2034386|NCT00402688|3604973|FG002|Overall Study|Adverse Event|3
2034387|NCT00402688|3604971|FG000|Overall Study|Withdrawal by Subject|3
2034388|NCT00402688|3604972|FG001|Overall Study|Withdrawal by Subject|1
2034389|NCT00402688|3604973|FG002|Overall Study|Withdrawal by Subject|1
2034390|NCT00402688|3604971|FG000|Overall Study|Physician Decision|0
2034391|NCT00402688|3604972|FG001|Overall Study|Physician Decision|0
2034392|NCT00402688|3604973|FG002|Overall Study|Physician Decision|1
2111988|NCT00906399|3706943|FG002|Year 1|Withdrawal by Subject|36
2111989|NCT00906399|3706944|FG003|Year 1|Withdrawal by Subject|0
2111990|NCT00906399|3706945|FG004|Year 1|Withdrawal by Subject|0
2111991|NCT00906399|3706946|FG005|Year 1|Withdrawal by Subject|0
2111992|NCT00906399|3706947|FG006|Year 1|Withdrawal by Subject|0
2111993|NCT00906399|3706941|FG000|Year 1|Physician Decision|0
2111994|NCT00906399|3706942|FG001|Year 1|Physician Decision|1
2111995|NCT00906399|3706943|FG002|Year 1|Physician Decision|3
2111996|NCT00906399|3706944|FG003|Year 1|Physician Decision|0
2111997|NCT00906399|3706945|FG004|Year 1|Physician Decision|0
2111998|NCT00906399|3706946|FG005|Year 1|Physician Decision|0
2111999|NCT00906399|3706947|FG006|Year 1|Physician Decision|0
2112000|NCT00906399|3706941|FG000|Year 1|Death|2
2112001|NCT00906399|3706942|FG001|Year 1|Death|1
2112002|NCT00906399|3706943|FG002|Year 1|Death|1
2112003|NCT00906399|3706944|FG003|Year 1|Death|0
2112004|NCT00906399|3706945|FG004|Year 1|Death|0
2112005|NCT00906399|3706946|FG005|Year 1|Death|0
2112006|NCT00906399|3706947|FG006|Year 1|Death|0
2112007|NCT00906399|3706941|FG000|Year 1|Other|4
2112008|NCT00906399|3706942|FG001|Year 1|Other|2
2112009|NCT00906399|3706943|FG002|Year 1|Other|7
2112010|NCT00906399|3706944|FG003|Year 1|Other|0
2112011|NCT00906399|3706945|FG004|Year 1|Other|0
2112012|NCT00906399|3706946|FG005|Year 1|Other|0
2112013|NCT00906399|3706947|FG006|Year 1|Other|0
2112014|NCT00906399|3706941|FG000|Year 2|Adverse Event|0
2112015|NCT00906399|3706942|FG001|Year 2|Adverse Event|0
2112016|NCT00906399|3706943|FG002|Year 2|Adverse Event|0
2112017|NCT00906399|3706944|FG003|Year 2|Adverse Event|9
2112018|NCT00906399|3706945|FG004|Year 2|Adverse Event|8
2112019|NCT00906399|3706946|FG005|Year 2|Adverse Event|11
2112020|NCT00906399|3706947|FG006|Year 2|Adverse Event|6
2034393|NCT00402688|3604971|FG000|Overall Study|Lack of Efficacy|4
2112021|NCT00906399|3706941|FG000|Year 2|Lost to Follow-up|0
2112022|NCT00906399|3706942|FG001|Year 2|Lost to Follow-up|0
2112023|NCT00906399|3706943|FG002|Year 2|Lost to Follow-up|0
2112024|NCT00906399|3706944|FG003|Year 2|Lost to Follow-up|1
2112025|NCT00906399|3706945|FG004|Year 2|Lost to Follow-up|4
2112026|NCT00906399|3706946|FG005|Year 2|Lost to Follow-up|2
2034394|NCT00402688|3604972|FG001|Overall Study|Lack of Efficacy|4
2034395|NCT00402688|3604973|FG002|Overall Study|Lack of Efficacy|5
2034396|NCT00402688|3604971|FG000|Overall Study|Protocol Violation|1
2034397|NCT00402688|3604972|FG001|Overall Study|Protocol Violation|1
2034398|NCT00402688|3604973|FG002|Overall Study|Protocol Violation|1
2034399|NCT00402688|3604971|FG000|Overall Study|Lost to Follow-up|1
2034400|NCT00402688|3604972|FG001|Overall Study|Lost to Follow-up|0
2034401|NCT00402688|3604973|FG002|Overall Study|Lost to Follow-up|2
2034402|NCT00402688|3604971|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0
2034403|NCT00402688|3604972|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1
2034404|NCT00402688|3604973|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0
2034405|NCT00402688|3604971|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
2034406|NCT00402688|3604972|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
2034407|NCT00402688|3604973|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
2034408|NCT00402688|3604971|FG000|Overall Study|Patient Left Town and Forgot Medication|0
2112027|NCT00906399|3706947|FG006|Year 2|Lost to Follow-up|4
2112028|NCT00906399|3706941|FG000|Year 2|Withdrawal by Subject|0
2112029|NCT00906399|3706942|FG001|Year 2|Withdrawal by Subject|0
2112030|NCT00906399|3706943|FG002|Year 2|Withdrawal by Subject|0
2112031|NCT00906399|3706944|FG003|Year 2|Withdrawal by Subject|17
2112032|NCT00906399|3706945|FG004|Year 2|Withdrawal by Subject|18
2112033|NCT00906399|3706946|FG005|Year 2|Withdrawal by Subject|27
2112034|NCT00906399|3706947|FG006|Year 2|Withdrawal by Subject|13
2112035|NCT00906399|3706941|FG000|Year 2|Physician Decision|0
2112036|NCT00906399|3706942|FG001|Year 2|Physician Decision|0
2112037|NCT00906399|3706943|FG002|Year 2|Physician Decision|0
2112038|NCT00906399|3706944|FG003|Year 2|Physician Decision|0
2112039|NCT00906399|3706945|FG004|Year 2|Physician Decision|2
2112040|NCT00906399|3706946|FG005|Year 2|Physician Decision|6
2112041|NCT00906399|3706947|FG006|Year 2|Physician Decision|3
2112042|NCT00906399|3706941|FG000|Year 2|Death|0
2112043|NCT00906399|3706942|FG001|Year 2|Death|0
2112044|NCT00906399|3706943|FG002|Year 2|Death|0
2112045|NCT00906399|3706944|FG003|Year 2|Death|1
2112046|NCT00906399|3706945|FG004|Year 2|Death|0
2112047|NCT00906399|3706946|FG005|Year 2|Death|0
2112048|NCT00906399|3706947|FG006|Year 2|Death|3
2112049|NCT00906399|3706941|FG000|Year 2|Other|0
2112050|NCT00906399|3706942|FG001|Year 2|Other|0
2112051|NCT00906399|3706943|FG002|Year 2|Other|0
2112052|NCT00906399|3706944|FG003|Year 2|Other|2
2112053|NCT00906399|3706945|FG004|Year 2|Other|3
2112054|NCT00906399|3706946|FG005|Year 2|Other|1
2112055|NCT00906399|3706947|FG006|Year 2|Other|0
2112056|NCT00906698|3706978|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
2112057|NCT00906698|3706979|FG001|Overall Study|Dose-limiting toxicity (DLT)|6
2112058|NCT00906698|3706980|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
2112059|NCT00906698|3706981|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
2112060|NCT00906698|3706982|FG004|Overall Study|Dose-limiting toxicity (DLT)|1
2112061|NCT00906698|3706983|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
2112062|NCT00906698|3706978|FG000|Overall Study|Adverse Event|0
2112063|NCT00906698|3706979|FG001|Overall Study|Adverse Event|0
2112064|NCT00906698|3706980|FG002|Overall Study|Adverse Event|2
2112065|NCT00906698|3706981|FG003|Overall Study|Adverse Event|0
2112066|NCT00906698|3706982|FG004|Overall Study|Adverse Event|4
2112067|NCT00906698|3706983|FG005|Overall Study|Adverse Event|1
2112068|NCT00906698|3706978|FG000|Overall Study|Disease progression|3
2112069|NCT00906698|3706979|FG001|Overall Study|Disease progression|12
2112070|NCT00906698|3706980|FG002|Overall Study|Disease progression|4
2112071|NCT00906698|3706981|FG003|Overall Study|Disease progression|4
2112072|NCT00906698|3706982|FG004|Overall Study|Disease progression|12
2112073|NCT00906698|3706983|FG005|Overall Study|Disease progression|4
2112074|NCT00906698|3706978|FG000|Overall Study|Withdrawal by Subject|0
2112075|NCT00906698|3706979|FG001|Overall Study|Withdrawal by Subject|0
2112076|NCT00906698|3706980|FG002|Overall Study|Withdrawal by Subject|0
2112077|NCT00906698|3706981|FG003|Overall Study|Withdrawal by Subject|0
2112078|NCT00906698|3706982|FG004|Overall Study|Withdrawal by Subject|1
2112079|NCT00906698|3706983|FG005|Overall Study|Withdrawal by Subject|0
2034409|NCT00402688|3604972|FG001|Overall Study|Patient Left Town and Forgot Medication|0
2034410|NCT00402688|3604973|FG002|Overall Study|Patient Left Town and Forgot Medication|1
2034411|NCT00402727|3604994|FG000|Overall Study|Adverse Event|10
2034412|NCT00402727|3604995|FG001|Overall Study|Adverse Event|6
2034413|NCT00402727|3604994|FG000|Overall Study|Death|1
2034414|NCT00402727|3604995|FG001|Overall Study|Death|0
2034415|NCT00402727|3604994|FG000|Overall Study|Lack of Efficacy|1
2034416|NCT00402727|3604995|FG001|Overall Study|Lack of Efficacy|3
2034417|NCT00402727|3604994|FG000|Overall Study|Lost to Follow-up|24
2034418|NCT00402727|3604995|FG001|Overall Study|Lost to Follow-up|11
2034419|NCT00402727|3604994|FG000|Overall Study|Physician Decision|1
2034420|NCT00402727|3604995|FG001|Overall Study|Physician Decision|1
2034421|NCT00402727|3604994|FG000|Overall Study|Protocol Violation|0
2034422|NCT00402727|3604995|FG001|Overall Study|Protocol Violation|4
2034423|NCT00402727|3604994|FG000|Overall Study|Withdrawal by Subject|3
2034424|NCT00402727|3604995|FG001|Overall Study|Withdrawal by Subject|7
2034425|NCT00402727|3604994|FG000|Overall Study|supply problems|2
2034426|NCT00402727|3604995|FG001|Overall Study|supply problems|1
2034427|NCT00402727|3604994|FG000|Overall Study|non-compliance|0
2034428|NCT00402727|3604995|FG001|Overall Study|non-compliance|1
2034429|NCT00402740|3605001|FG000|Overall Study|Withdrawal by Subject|18
2034430|NCT00402740|3605001|FG000|Overall Study|Death|50
2034431|NCT00402740|3605001|FG000|Overall Study|Lost to Follow-up|6
2034432|NCT00402740|3605001|FG000|Overall Study|No stent. Completed FU at 30 days.|5
2034433|NCT00402740|3605001|FG000|Overall Study|Subject disposition unknown.|1
2034434|NCT00402779|3605011|FG000|Overall Study|Screen Failure|77
2034435|NCT00402779|3605012|FG001|Overall Study|Screen Failure|76
2034436|NCT00402831|3605020|FG000|Overall Study|Lost to Follow-up|1
2034437|NCT00402831|3605021|FG001|Overall Study|Lost to Follow-up|2
2034438|NCT00402831|3605020|FG000|Overall Study|Non-compliance with protocol|0
2034439|NCT00402831|3605021|FG001|Overall Study|Non-compliance with protocol|1
2034440|NCT00402987|3605037|FG000|Overall Study|Lack of Efficacy|0
2034441|NCT00402987|3605038|FG001|Overall Study|Lack of Efficacy|0
2034442|NCT00402987|3605039|FG002|Overall Study|Lack of Efficacy|1
2034443|NCT00402987|3605040|FG003|Overall Study|Lack of Efficacy|0
2034444|NCT00403130|3605095|FG000|2 Years From Start of Treatment|Not Eligible|3
2034445|NCT00403130|3605095|FG000|2 Years From Start of Treatment|Lost to Follow up|1
2112080|NCT00906698|3706978|FG000|Overall Study|incl. non compliance, lost to follow-up|0
2112081|NCT00906698|3706979|FG001|Overall Study|incl. non compliance, lost to follow-up|1
2112082|NCT00906698|3706980|FG002|Overall Study|incl. non compliance, lost to follow-up|0
2112083|NCT00906698|3706981|FG003|Overall Study|incl. non compliance, lost to follow-up|0
2112084|NCT00906698|3706982|FG004|Overall Study|incl. non compliance, lost to follow-up|0
2112085|NCT00906698|3706983|FG005|Overall Study|incl. non compliance, lost to follow-up|0
2112086|NCT00906945|3707035|FG000|Overall Study|Found to be not eligible|0
2112087|NCT00906945|3707036|FG001|Overall Study|Found to be not eligible|0
2112088|NCT00906945|3707037|FG002|Overall Study|Found to be not eligible|0
2112089|NCT00906945|3707038|FG003|Overall Study|Found to be not eligible|1
2112090|NCT00906945|3707039|FG004|Overall Study|Found to be not eligible|1
2112091|NCT00906945|3707040|FG005|Overall Study|Found to be not eligible|1
2112092|NCT00906945|3707035|FG000|Overall Study|Physician Decision|0
2112093|NCT00906945|3707036|FG001|Overall Study|Physician Decision|0
2112094|NCT00906945|3707037|FG002|Overall Study|Physician Decision|0
2112095|NCT00906945|3707038|FG003|Overall Study|Physician Decision|0
2112096|NCT00906945|3707039|FG004|Overall Study|Physician Decision|0
2112097|NCT00906945|3707040|FG005|Overall Study|Physician Decision|1
2112098|NCT00906971|3707067|FG000|Overall Study|Withdrawal by Subject|8
2112099|NCT00906971|3707068|FG001|Overall Study|Withdrawal by Subject|2
2112100|NCT00906971|3707067|FG000|Overall Study|Lost to Follow-up|0
2112101|NCT00906971|3707068|FG001|Overall Study|Lost to Follow-up|1
2112102|NCT00907153|3707089|FG000|Overall Study|Lost to Follow-up|1
2112103|NCT00907153|3707090|FG001|Overall Study|Lost to Follow-up|1
2112104|NCT00907153|3707089|FG000|Overall Study|Withdrawal by Subject|1
2112105|NCT00907153|3707090|FG001|Overall Study|Withdrawal by Subject|3
2112106|NCT00907257|3707098|FG000|Overall Study|Adverse Event|0
2112107|NCT00907257|3707099|FG001|Overall Study|Adverse Event|4
2112108|NCT00907257|3707098|FG000|Overall Study|Protocol Violation|1
2112109|NCT00907257|3707099|FG001|Overall Study|Protocol Violation|2
2112110|NCT00907257|3707098|FG000|Overall Study|Lost to Follow-up|3
2112111|NCT00907257|3707099|FG001|Overall Study|Lost to Follow-up|3
2218922|NCT01717638|3862522|FG003|Overall Study|Father in hospital|0
2218923|NCT01717638|3862523|FG004|Overall Study|Father in hospital|0
2218924|NCT01717638|3862524|FG005|Overall Study|Father in hospital|0
2218925|NCT01717638|3862525|FG006|Overall Study|Father in hospital|0
2218926|NCT01717638|3862526|FG007|Overall Study|Father in hospital|0
2218927|NCT01717638|3862527|FG008|Overall Study|Father in hospital|0
2218928|NCT01717638|3862528|FG009|Overall Study|Father in hospital|0
2218929|NCT01717638|3862529|FG010|Overall Study|Father in hospital|0
2218930|NCT01717638|3862530|FG011|Overall Study|Father in hospital|0
2218931|NCT01717638|3862531|FG012|Overall Study|Father in hospital|1
2218932|NCT01717638|3862519|FG000|Overall Study|Withdrawal by Subject|0
2218933|NCT01717638|3862520|FG001|Overall Study|Withdrawal by Subject|1
2218934|NCT01717638|3862521|FG002|Overall Study|Withdrawal by Subject|1
2218935|NCT01717638|3862522|FG003|Overall Study|Withdrawal by Subject|0
2218936|NCT01717638|3862523|FG004|Overall Study|Withdrawal by Subject|1
2218937|NCT01717638|3862524|FG005|Overall Study|Withdrawal by Subject|0
2218938|NCT01717638|3862525|FG006|Overall Study|Withdrawal by Subject|2
2218939|NCT01717638|3862526|FG007|Overall Study|Withdrawal by Subject|1
2218940|NCT01717638|3862527|FG008|Overall Study|Withdrawal by Subject|2
2218941|NCT01717638|3862528|FG009|Overall Study|Withdrawal by Subject|1
2218942|NCT01717638|3862529|FG010|Overall Study|Withdrawal by Subject|0
2218943|NCT01717638|3862530|FG011|Overall Study|Withdrawal by Subject|0
2218944|NCT01717638|3862531|FG012|Overall Study|Withdrawal by Subject|18
2218945|NCT01717768|3862584|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2218946|NCT01717768|3862585|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
2218947|NCT01717768|3862586|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2218948|NCT01717768|3862587|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2218949|NCT01717768|3862588|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2218950|NCT01717768|3862589|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2218951|NCT01717768|3862590|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2218952|NCT01717768|3862591|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2218953|NCT01717768|3862592|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2218954|NCT01717768|3862593|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2273938|NCT02291510|3954653|FG000|Overall Study|Adverse Event|0
2218955|NCT01717768|3862594|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2218956|NCT01717768|3862595|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2218957|NCT01717768|3862584|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2218958|NCT01717768|3862585|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2218959|NCT01717768|3862586|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2218960|NCT01717768|3862587|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2218961|NCT01717768|3862588|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2218962|NCT01717768|3862589|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2218963|NCT01717768|3862590|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2218964|NCT01717768|3862591|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2218965|NCT01717768|3862592|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2218966|NCT01717768|3862593|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2218967|NCT01717768|3862594|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2218968|NCT01717768|3862595|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
2218969|NCT01717768|3862584|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2218970|NCT01717768|3862585|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2218971|NCT01717768|3862586|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2034446|NCT00403130|3605095|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1
2034447|NCT00403130|3605095|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10
2034448|NCT00403234|3605103|FG000|Overall Study|Withdrawal by Subject|0
2034449|NCT00403234|3605104|FG001|Overall Study|Withdrawal by Subject|1
2034450|NCT00403234|3605105|FG002|Overall Study|Withdrawal by Subject|0
2034451|NCT00403234|3605106|FG003|Overall Study|Withdrawal by Subject|0
2034452|NCT00403234|3605103|FG000|Overall Study|Adverse Event|1
2034453|NCT00403234|3605104|FG001|Overall Study|Adverse Event|0
2034454|NCT00403234|3605105|FG002|Overall Study|Adverse Event|1
2034455|NCT00403234|3605106|FG003|Overall Study|Adverse Event|0
2034456|NCT00403260|3605118|FG000|Overall Study|Adverse Event|5
2034457|NCT00403260|3605119|FG001|Overall Study|Adverse Event|4
2034458|NCT00403260|3605118|FG000|Overall Study|Withdrawal by Subject|5
2112112|NCT00907257|3707098|FG000|Overall Study|Withdrawal by Subject|1
2218972|NCT01717768|3862587|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2218973|NCT01717768|3862588|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2218974|NCT01717768|3862589|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2218975|NCT01717768|3862590|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2218976|NCT01717768|3862591|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
2218977|NCT01717768|3862592|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2218978|NCT01717768|3862593|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2218979|NCT01717768|3862594|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2218980|NCT01717768|3862595|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2218981|NCT01717768|3862584|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2218982|NCT01717768|3862585|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2218983|NCT01717768|3862586|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2034459|NCT00403260|3605119|FG001|Overall Study|Withdrawal by Subject|6
2034460|NCT00403260|3605118|FG000|Overall Study|Lost to Follow-up|49
2034461|NCT00403260|3605119|FG001|Overall Study|Lost to Follow-up|25
2034462|NCT00403260|3605118|FG000|Overall Study|Re-appearance of P. falciparum|34
2034463|NCT00403260|3605119|FG001|Overall Study|Re-appearance of P. falciparum|25
2034464|NCT00403260|3605118|FG000|Overall Study|P. vivax infection|26
2034465|NCT00403260|3605119|FG001|Overall Study|P. vivax infection|4
2034466|NCT00403260|3605118|FG000|Overall Study|Mixed infection with P. vivax|2
2034467|NCT00403260|3605119|FG001|Overall Study|Mixed infection with P. vivax|0
2034468|NCT00403260|3605118|FG000|Overall Study|Mixed infection with P. falciparum|1
2034469|NCT00403260|3605119|FG001|Overall Study|Mixed infection with P. falciparum|0
2034470|NCT00403260|3605118|FG000|Overall Study|P. vivax infection at screening|1
2034471|NCT00403260|3605119|FG001|Overall Study|P. vivax infection at screening|0
2034472|NCT00403260|3605118|FG000|Overall Study|P. ovale infection|1
2034473|NCT00403260|3605119|FG001|Overall Study|P. ovale infection|0
2034474|NCT00403260|3605118|FG000|Overall Study|Gametocyte re-appearance|1
2034475|NCT00403260|3605119|FG001|Overall Study|Gametocyte re-appearance|1
2034476|NCT00403260|3605118|FG000|Overall Study|Withdrawn from study accidentally|0
2034477|NCT00403260|3605119|FG001|Overall Study|Withdrawn from study accidentally|1
2112113|NCT00907257|3707099|FG001|Overall Study|Withdrawal by Subject|2
2112114|NCT00907257|3707098|FG000|Overall Study|Per IRB-Subject became vulnerable|1
2112115|NCT00907257|3707099|FG001|Overall Study|Per IRB-Subject became vulnerable|0
2112116|NCT00907257|3707098|FG000|Overall Study|Moved|1
2112117|NCT00907257|3707099|FG001|Overall Study|Moved|0
2112118|NCT00907257|3707098|FG000|Overall Study|Personal Reasons|6
2112119|NCT00907257|3707099|FG001|Overall Study|Personal Reasons|1
2112120|NCT00907296|3707115|FG000|Overall Study|Ineligibility Determined|1
2112121|NCT00907296|3707116|FG001|Overall Study|Ineligibility Determined|0
2112122|NCT00907296|3707117|FG002|Overall Study|Ineligibility Determined|0
2112123|NCT00907296|3707118|FG003|Overall Study|Ineligibility Determined|1
2112124|NCT00907296|3707119|FG004|Overall Study|Ineligibility Determined|0
2112125|NCT00907296|3707120|FG005|Overall Study|Ineligibility Determined|0
2112126|NCT00907296|3707121|FG006|Overall Study|Ineligibility Determined|0
2112127|NCT00907296|3707122|FG007|Overall Study|Ineligibility Determined|1
2112128|NCT00907296|3707123|FG008|Overall Study|Ineligibility Determined|0
2112129|NCT00907296|3707124|FG009|Overall Study|Ineligibility Determined|0
2112130|NCT00907296|3707115|FG000|Overall Study|Protocol Deviation|0
2112131|NCT00907296|3707116|FG001|Overall Study|Protocol Deviation|1
2112132|NCT00907296|3707117|FG002|Overall Study|Protocol Deviation|0
2112133|NCT00907296|3707118|FG003|Overall Study|Protocol Deviation|0
2112134|NCT00907296|3707119|FG004|Overall Study|Protocol Deviation|0
2112135|NCT00907296|3707120|FG005|Overall Study|Protocol Deviation|0
2112136|NCT00907296|3707121|FG006|Overall Study|Protocol Deviation|0
2112137|NCT00907296|3707122|FG007|Overall Study|Protocol Deviation|0
2112138|NCT00907296|3707123|FG008|Overall Study|Protocol Deviation|0
2112139|NCT00907296|3707124|FG009|Overall Study|Protocol Deviation|0
2112140|NCT00907296|3707115|FG000|Overall Study|Noncompliance|1
2112141|NCT00907296|3707116|FG001|Overall Study|Noncompliance|1
2112142|NCT00907296|3707117|FG002|Overall Study|Noncompliance|1
2112143|NCT00907296|3707118|FG003|Overall Study|Noncompliance|0
2112144|NCT00907296|3707119|FG004|Overall Study|Noncompliance|0
2112145|NCT00907296|3707120|FG005|Overall Study|Noncompliance|1
2112146|NCT00907296|3707121|FG006|Overall Study|Noncompliance|0
2112147|NCT00907296|3707122|FG007|Overall Study|Noncompliance|2
2112148|NCT00907296|3707123|FG008|Overall Study|Noncompliance|0
2112149|NCT00907296|3707124|FG009|Overall Study|Noncompliance|0
2112150|NCT00907296|3707115|FG000|Overall Study|Adverse Event|2
2112151|NCT00907296|3707116|FG001|Overall Study|Adverse Event|0
2112152|NCT00907296|3707117|FG002|Overall Study|Adverse Event|0
2112153|NCT00907296|3707118|FG003|Overall Study|Adverse Event|0
2034478|NCT00403273|3605127|FG000|Overall Study|Lost to Follow-up|3
2034479|NCT00403273|3605128|FG001|Overall Study|Lost to Follow-up|2
2034480|NCT00403273|3605127|FG000|Overall Study|Physician Decision|0
2034481|NCT00403273|3605128|FG001|Overall Study|Physician Decision|1
2034482|NCT00403273|3605127|FG000|Overall Study|pt. wanted to have a surgical procedure|0
2034483|NCT00403273|3605128|FG001|Overall Study|pt. wanted to have a surgical procedure|1
2034484|NCT00403390|3605138|FG000|Overall Study|Withdrawal by Subject|1
2034485|NCT00403390|3605139|FG001|Overall Study|Withdrawal by Subject|0
2034486|NCT00403390|3605138|FG000|Overall Study|samples lost|1
2034487|NCT00403390|3605139|FG001|Overall Study|samples lost|0
2034488|NCT00403390|3605138|FG000|Overall Study|non-compliant|1
2034489|NCT00403390|3605139|FG001|Overall Study|non-compliant|0
2034490|NCT00403455|3605154|FG000|Overall Study|Withdrawal by Subject|1
2034491|NCT00403481|3605158|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
2034492|NCT00403481|3605158|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
2034493|NCT00403481|3605158|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
2034494|NCT00403481|3605158|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
2034495|NCT00403481|3605158|FG000|Olm 40 mg|Adverse Event|2
2034496|NCT00403481|3605158|FG000|Olm 40 mg|Protocol Violation|1
2034497|NCT00403481|3605158|FG000|Olm 40 mg|Withdrawal by Subject|1
2034498|NCT00403481|3605158|FG000|Olm 40 mg|Other|1
2034499|NCT00403481|3605158|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
2034500|NCT00403481|3605158|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
2034501|NCT00403481|3605158|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
2034502|NCT00403481|3605158|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
2034503|NCT00403481|3605158|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
2034504|NCT00403481|3605158|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
2034505|NCT00403494|3605167|FG000|Overall Study|Adverse Event|10
2034506|NCT00403494|3605168|FG001|Overall Study|Adverse Event|8
2034507|NCT00403494|3605167|FG000|Overall Study|Withdrew Consent|3
2034508|NCT00403494|3605168|FG001|Overall Study|Withdrew Consent|2
2034509|NCT00403494|3605167|FG000|Overall Study|Inappropriately enrolled|0
2034510|NCT00403494|3605168|FG001|Overall Study|Inappropriately enrolled|1
2034511|NCT00403494|3605167|FG000|Overall Study|Lost to Follow-up|0
2034512|NCT00403494|3605168|FG001|Overall Study|Lost to Follow-up|2
2034513|NCT00403494|3605167|FG000|Overall Study|Protocol noncompliance|0
2034514|NCT00403494|3605168|FG001|Overall Study|Protocol noncompliance|1
2034515|NCT00403494|3605167|FG000|Overall Study|Death|1
2034516|NCT00403494|3605168|FG001|Overall Study|Death|0
2034517|NCT00403494|3605167|FG000|Overall Study|Sponsor Request|1
2034518|NCT00403494|3605168|FG001|Overall Study|Sponsor Request|0
2034519|NCT00403546|3605178|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6
2034520|NCT00403546|3605179|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0
2034521|NCT00403546|3605180|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0
2034522|NCT00403546|3605178|FG000|Signed Informed Consent/Open-Label|Early Termination|8
2034523|NCT00403546|3605179|FG001|Signed Informed Consent/Open-Label|Early Termination|0
2034524|NCT00403546|3605180|FG002|Signed Informed Consent/Open-Label|Early Termination|0
2034525|NCT00403546|3605178|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9
2218984|NCT01717768|3862587|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2218985|NCT01717768|3862588|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2218986|NCT01717768|3862589|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2218987|NCT01717768|3862590|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2218988|NCT01717768|3862591|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2218989|NCT01717768|3862592|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2273939|NCT02291510|3954654|FG001|Overall Study|Adverse Event|0
2034526|NCT00403546|3605179|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0
2034527|NCT00403546|3605180|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0
2034528|NCT00403546|3605178|FG000|Signed Informed Consent/Open-Label|Adverse Event|5
2034529|NCT00403546|3605179|FG001|Signed Informed Consent/Open-Label|Adverse Event|0
2034530|NCT00403546|3605180|FG002|Signed Informed Consent/Open-Label|Adverse Event|0
2034531|NCT00403546|3605178|FG000|Screening Phase|Screening Failure|22
2034532|NCT00403546|3605179|FG001|Screening Phase|Screening Failure|0
2034533|NCT00403546|3605180|FG002|Screening Phase|Screening Failure|0
2034534|NCT00403546|3605178|FG000|Screening Phase|Adverse Event|1
2034535|NCT00403546|3605179|FG001|Screening Phase|Adverse Event|0
2034536|NCT00403546|3605180|FG002|Screening Phase|Adverse Event|0
2034537|NCT00403546|3605178|FG000|Screening Phase|Terminated Prior to Randomization|5
2034538|NCT00403546|3605179|FG001|Screening Phase|Terminated Prior to Randomization|0
2034539|NCT00403546|3605180|FG002|Screening Phase|Terminated Prior to Randomization|0
2034540|NCT00403546|3605178|FG000|Randomized Trial|Early Terminations|0
2034541|NCT00403546|3605179|FG001|Randomized Trial|Early Terminations|17
2034542|NCT00403546|3605180|FG002|Randomized Trial|Early Terminations|16
2034543|NCT00403585|3605189|FG000|Initial Treatment Phase|Lost to Follow-up|2
2034544|NCT00403585|3605189|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2
2034545|NCT00403585|3605189|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
2034546|NCT00403754|3605193|FG000|Core Treatment Period 1|Withdrawal by Subject|0
2034547|NCT00403754|3605194|FG001|Core Treatment Period 1|Withdrawal by Subject|1
2034548|NCT00403754|3605195|FG002|Core Treatment Period 1|Withdrawal by Subject|0
2034549|NCT00403754|3605196|FG003|Core Treatment Period 1|Withdrawal by Subject|0
2034550|NCT00403754|3605193|FG000|Core Treatment Period 2|Lack of Efficacy|0
2034551|NCT00403754|3605194|FG001|Core Treatment Period 2|Lack of Efficacy|0
2034552|NCT00403754|3605195|FG002|Core Treatment Period 2|Lack of Efficacy|1
2034553|NCT00403754|3605196|FG003|Core Treatment Period 2|Lack of Efficacy|0
2034554|NCT00403767|3605210|FG000|Overall Study|Adverse Event|993
2034555|NCT00403767|3605211|FG001|Overall Study|Adverse Event|919
2034556|NCT00403767|3605210|FG000|Overall Study|Non-compliant with study medication|134
2034557|NCT00403767|3605211|FG001|Overall Study|Non-compliant with study medication|164
2034558|NCT00403767|3605210|FG000|Overall Study|Consent withdrawn|671
2034559|NCT00403767|3605211|FG001|Overall Study|Consent withdrawn|673
2034560|NCT00403767|3605210|FG000|Overall Study|Investigator dec./not protocol-related|191
2034561|NCT00403767|3605211|FG001|Overall Study|Investigator dec./not protocol-related|178
2034562|NCT00403767|3605210|FG000|Overall Study|Lost to Follow-up|6
2034563|NCT00403767|3605211|FG001|Overall Study|Lost to Follow-up|8
2034564|NCT00403767|3605210|FG000|Overall Study|Protocol Violation|142
2034565|NCT00403767|3605211|FG001|Overall Study|Protocol Violation|124
2034566|NCT00403767|3605210|FG000|Overall Study|Clinical efficacy endpoint reached|300
2034567|NCT00403767|3605211|FG001|Overall Study|Clinical efficacy endpoint reached|332
2034568|NCT00403767|3605210|FG000|Overall Study|Study terminated by sponsor|82
2034569|NCT00403767|3605211|FG001|Overall Study|Study terminated by sponsor|69
2034570|NCT00403767|3605210|FG000|Overall Study|Missing/incomplete data|1
2034571|NCT00403767|3605211|FG001|Overall Study|Missing/incomplete data|1
2034572|NCT00403845|3605217|FG000|Treatment Period 1|Subject withdrew consent|1
2034573|NCT00403845|3605218|FG001|Treatment Period 1|Subject withdrew consent|0
2034574|NCT00403845|3605219|FG002|Treatment Period 1|Subject withdrew consent|0
2034575|NCT00403845|3605220|FG003|Treatment Period 1|Subject withdrew consent|0
2034576|NCT00403845|3605217|FG000|Treatment Period 1|Subject no longer needs study drug|0
2034577|NCT00403845|3605218|FG001|Treatment Period 1|Subject no longer needs study drug|0
2034578|NCT00403845|3605219|FG002|Treatment Period 1|Subject no longer needs study drug|0
2034579|NCT00403845|3605220|FG003|Treatment Period 1|Subject no longer needs study drug|1
2034580|NCT00403845|3605217|FG000|Treatment Period 2|Subject withdrew consent|1
2034581|NCT00403845|3605218|FG001|Treatment Period 2|Subject withdrew consent|0
2034582|NCT00403845|3605219|FG002|Treatment Period 2|Subject withdrew consent|0
2034583|NCT00403845|3605220|FG003|Treatment Period 2|Subject withdrew consent|0
2034584|NCT00403845|3605217|FG000|Treatment Period 3|Subject withdrew consent|0
2034585|NCT00403845|3605218|FG001|Treatment Period 3|Subject withdrew consent|0
2034586|NCT00403845|3605219|FG002|Treatment Period 3|Subject withdrew consent|0
2112154|NCT00907296|3707119|FG004|Overall Study|Adverse Event|0
2112155|NCT00907296|3707120|FG005|Overall Study|Adverse Event|0
2112156|NCT00907296|3707121|FG006|Overall Study|Adverse Event|1
2112157|NCT00907296|3707122|FG007|Overall Study|Adverse Event|0
2112158|NCT00907296|3707123|FG008|Overall Study|Adverse Event|0
2112159|NCT00907296|3707124|FG009|Overall Study|Adverse Event|1
2112160|NCT00907296|3707115|FG000|Overall Study|Withdrawal by Subject|7
2112161|NCT00907296|3707116|FG001|Overall Study|Withdrawal by Subject|2
2112162|NCT00907296|3707117|FG002|Overall Study|Withdrawal by Subject|1
2112163|NCT00907296|3707118|FG003|Overall Study|Withdrawal by Subject|1
2112164|NCT00907296|3707119|FG004|Overall Study|Withdrawal by Subject|1
2112165|NCT00907296|3707120|FG005|Overall Study|Withdrawal by Subject|5
2112166|NCT00907296|3707121|FG006|Overall Study|Withdrawal by Subject|3
2112167|NCT00907296|3707122|FG007|Overall Study|Withdrawal by Subject|2
2218990|NCT01717768|3862593|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
2218991|NCT01717768|3862594|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2218992|NCT01717768|3862595|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2218993|NCT01717859|3862621|FG000|Overall Study|Adverse Event|5
2112168|NCT00907296|3707123|FG008|Overall Study|Withdrawal by Subject|4
2112169|NCT00907296|3707124|FG009|Overall Study|Withdrawal by Subject|2
2034587|NCT00403845|3605220|FG003|Treatment Period 3|Subject withdrew consent|1
2034588|NCT00403845|3605217|FG000|Treatment Period 3|Adverse Event|0
2034589|NCT00403845|3605218|FG001|Treatment Period 3|Adverse Event|0
2034590|NCT00403845|3605219|FG002|Treatment Period 3|Adverse Event|0
2034591|NCT00403845|3605220|FG003|Treatment Period 3|Adverse Event|1
2034592|NCT00404066|3605230|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1
2034593|NCT00404066|3605230|FG000|Overall Study|Withdrawal by Subject - Adverse event|2
2034594|NCT00404079|3605236|FG000|Overall Study|Lost to follow up, adverse event etc|22
2034595|NCT00404079|3605237|FG001|Overall Study|Lost to follow up, adverse event etc|20
2034596|NCT00404092|3605247|FG000|Overall Study|Death|1
2034597|NCT00404092|3605248|FG001|Overall Study|Death|0
2034598|NCT00404092|3605249|FG002|Overall Study|Death|0
2034599|NCT00404092|3605250|FG003|Overall Study|Death|0
2034600|NCT00404092|3605247|FG000|Overall Study|Adverse Event|0
2034601|NCT00404092|3605248|FG001|Overall Study|Adverse Event|0
2034602|NCT00404092|3605249|FG002|Overall Study|Adverse Event|1
2034603|NCT00404092|3605250|FG003|Overall Study|Adverse Event|0
2034604|NCT00404235|3605262|FG000|Overall Study|Withdrawal by Subject|1
2034605|NCT00404235|3605263|FG001|Overall Study|Withdrawal by Subject|2
2034606|NCT00404248|3605272|FG000|Overall Study|pts declining status|0
2034607|NCT00404248|3605273|FG001|Overall Study|pts declining status|1
2034608|NCT00404248|3605274|FG002|Overall Study|pts declining status|0
2034609|NCT00404248|3605275|FG003|Overall Study|pts declining status|0
2034610|NCT00404248|3605276|FG004|Overall Study|pts declining status|0
2034611|NCT00404248|3605277|FG005|Overall Study|pts declining status|0
2034612|NCT00404248|3605278|FG006|Overall Study|pts declining status|0
2034613|NCT00404248|3605279|FG007|Overall Study|pts declining status|0
2034614|NCT00404248|3605280|FG008|Overall Study|pts declining status|0
2034615|NCT00404352|3605309|FG000|Double Blind (up to 24 Month)|Adverse Event|5
2034616|NCT00404352|3605310|FG001|Double Blind (up to 24 Month)|Adverse Event|4
2034617|NCT00404352|3605311|FG002|Double Blind (up to 24 Month)|Adverse Event|6
2034618|NCT00404352|3605312|FG003|Double Blind (up to 24 Month)|Adverse Event|0
2034619|NCT00404352|3605313|FG004|Double Blind (up to 24 Month)|Adverse Event|0
2034620|NCT00404352|3605314|FG005|Double Blind (up to 24 Month)|Adverse Event|0
2034621|NCT00404352|3605315|FG006|Double Blind (up to 24 Month)|Adverse Event|0
2034622|NCT00404352|3605316|FG007|Double Blind (up to 24 Month)|Adverse Event|0
2034623|NCT00404352|3605317|FG008|Double Blind (up to 24 Month)|Adverse Event|0
2034624|NCT00404352|3605309|FG000|Double Blind (up to 24 Month)|Pregnancy|0
2034625|NCT00404352|3605310|FG001|Double Blind (up to 24 Month)|Pregnancy|0
2034626|NCT00404352|3605311|FG002|Double Blind (up to 24 Month)|Pregnancy|2
2034627|NCT00404352|3605312|FG003|Double Blind (up to 24 Month)|Pregnancy|0
2034628|NCT00404352|3605313|FG004|Double Blind (up to 24 Month)|Pregnancy|0
2034629|NCT00404352|3605314|FG005|Double Blind (up to 24 Month)|Pregnancy|0
2034630|NCT00404352|3605315|FG006|Double Blind (up to 24 Month)|Pregnancy|0
2034631|NCT00404352|3605316|FG007|Double Blind (up to 24 Month)|Pregnancy|0
2034632|NCT00404352|3605317|FG008|Double Blind (up to 24 Month)|Pregnancy|0
2034633|NCT00404352|3605309|FG000|Double Blind (up to 24 Month)|Death|0
2034634|NCT00404352|3605310|FG001|Double Blind (up to 24 Month)|Death|0
2034635|NCT00404352|3605311|FG002|Double Blind (up to 24 Month)|Death|1
2034636|NCT00404352|3605312|FG003|Double Blind (up to 24 Month)|Death|0
2034637|NCT00404352|3605313|FG004|Double Blind (up to 24 Month)|Death|0
2034638|NCT00404352|3605314|FG005|Double Blind (up to 24 Month)|Death|0
2034639|NCT00404352|3605315|FG006|Double Blind (up to 24 Month)|Death|0
2034640|NCT00404352|3605316|FG007|Double Blind (up to 24 Month)|Death|0
2034641|NCT00404352|3605317|FG008|Double Blind (up to 24 Month)|Death|0
2034642|NCT00404352|3605309|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1
2034643|NCT00404352|3605310|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2
2034644|NCT00404352|3605311|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1
2034645|NCT00404352|3605312|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0
2034646|NCT00404352|3605313|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0
2034647|NCT00404352|3605314|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0
2034648|NCT00404352|3605315|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0
2034649|NCT00404352|3605316|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0
2034650|NCT00404352|3605317|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0
2034651|NCT00404352|3605309|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11
2034652|NCT00404352|3605310|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8
2034653|NCT00404352|3605311|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7
2034654|NCT00404352|3605312|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2034655|NCT00404352|3605313|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2034656|NCT00404352|3605314|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2034657|NCT00404352|3605315|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2034658|NCT00404352|3605316|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2034659|NCT00404352|3605317|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2034660|NCT00404352|3605309|FG000|Double Blind (up to 24 Month)|Disease progression|3
2034661|NCT00404352|3605310|FG001|Double Blind (up to 24 Month)|Disease progression|0
2034662|NCT00404352|3605311|FG002|Double Blind (up to 24 Month)|Disease progression|2
2034663|NCT00404352|3605312|FG003|Double Blind (up to 24 Month)|Disease progression|0
2331835|NCT03178045|4054713|FG000|Overall Study|Withdrawal by Subject|5
2034664|NCT00404352|3605313|FG004|Double Blind (up to 24 Month)|Disease progression|0
2034665|NCT00404352|3605314|FG005|Double Blind (up to 24 Month)|Disease progression|0
2034666|NCT00404352|3605315|FG006|Double Blind (up to 24 Month)|Disease progression|0
2034667|NCT00404352|3605316|FG007|Double Blind (up to 24 Month)|Disease progression|0
2034668|NCT00404352|3605317|FG008|Double Blind (up to 24 Month)|Disease progression|0
2034669|NCT00404352|3605309|FG000|Double Blind (up to 24 Month)|Poor compliance|1
2034670|NCT00404352|3605310|FG001|Double Blind (up to 24 Month)|Poor compliance|0
2034671|NCT00404352|3605311|FG002|Double Blind (up to 24 Month)|Poor compliance|0
2034672|NCT00404352|3605312|FG003|Double Blind (up to 24 Month)|Poor compliance|0
2034673|NCT00404352|3605313|FG004|Double Blind (up to 24 Month)|Poor compliance|0
2034674|NCT00404352|3605314|FG005|Double Blind (up to 24 Month)|Poor compliance|0
2034675|NCT00404352|3605315|FG006|Double Blind (up to 24 Month)|Poor compliance|0
2034676|NCT00404352|3605316|FG007|Double Blind (up to 24 Month)|Poor compliance|0
2034677|NCT00404352|3605317|FG008|Double Blind (up to 24 Month)|Poor compliance|0
2034678|NCT00404352|3605309|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31
2034679|NCT00404352|3605310|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30
2034680|NCT00404352|3605311|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59
2034681|NCT00404352|3605312|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0
2034682|NCT00404352|3605313|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0
2034683|NCT00404352|3605314|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0
2034684|NCT00404352|3605315|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0
2034685|NCT00404352|3605316|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0
2034686|NCT00404352|3605317|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0
2034687|NCT00404352|3605309|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0
2034688|NCT00404352|3605310|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2
2034689|NCT00404352|3605311|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0
2034690|NCT00404352|3605312|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0
2034691|NCT00404352|3605313|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0
2034692|NCT00404352|3605314|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0
2034693|NCT00404352|3605315|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0
2034694|NCT00404352|3605316|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0
2034695|NCT00404352|3605317|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0
2034696|NCT00404352|3605309|FG000|Double Blind (up to 24 Month)|Physician Decision|0
2034697|NCT00404352|3605310|FG001|Double Blind (up to 24 Month)|Physician Decision|0
2034698|NCT00404352|3605311|FG002|Double Blind (up to 24 Month)|Physician Decision|1
2034699|NCT00404352|3605312|FG003|Double Blind (up to 24 Month)|Physician Decision|0
2034700|NCT00404352|3605313|FG004|Double Blind (up to 24 Month)|Physician Decision|0
2034701|NCT00404352|3605314|FG005|Double Blind (up to 24 Month)|Physician Decision|0
2034702|NCT00404352|3605315|FG006|Double Blind (up to 24 Month)|Physician Decision|0
2034703|NCT00404352|3605316|FG007|Double Blind (up to 24 Month)|Physician Decision|0
2034704|NCT00404352|3605317|FG008|Double Blind (up to 24 Month)|Physician Decision|0
2034705|NCT00404352|3605309|FG000|Double Blind (up to 24 Month)|Other|0
2034706|NCT00404352|3605310|FG001|Double Blind (up to 24 Month)|Other|1
2034707|NCT00404352|3605311|FG002|Double Blind (up to 24 Month)|Other|0
2034708|NCT00404352|3605312|FG003|Double Blind (up to 24 Month)|Other|0
2112170|NCT00907296|3707115|FG000|Overall Study|Lost to Follow-up|9
2112171|NCT00907296|3707116|FG001|Overall Study|Lost to Follow-up|1
2112172|NCT00907296|3707117|FG002|Overall Study|Lost to Follow-up|0
2112173|NCT00907296|3707118|FG003|Overall Study|Lost to Follow-up|2
2112174|NCT00907296|3707119|FG004|Overall Study|Lost to Follow-up|0
2112175|NCT00907296|3707120|FG005|Overall Study|Lost to Follow-up|3
2112176|NCT00907296|3707121|FG006|Overall Study|Lost to Follow-up|2
2112177|NCT00907296|3707122|FG007|Overall Study|Lost to Follow-up|2
2112178|NCT00907296|3707123|FG008|Overall Study|Lost to Follow-up|0
2112179|NCT00907296|3707124|FG009|Overall Study|Lost to Follow-up|4
2112180|NCT00907335|3707148|FG000|Overall Study|Withdrawal by Subject|2
2112181|NCT00907335|3707149|FG001|Overall Study|Withdrawal by Subject|0
2112182|NCT00907335|3707148|FG000|Overall Study|Adverse Event|4
2112183|NCT00907335|3707149|FG001|Overall Study|Adverse Event|1
2112184|NCT00907335|3707148|FG000|Overall Study|Lost to Follow-up|2
2112185|NCT00907335|3707149|FG001|Overall Study|Lost to Follow-up|0
2112186|NCT00907374|3707157|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2
2112187|NCT00907374|3707158|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2
2112188|NCT00907478|3707179|FG000|Overall Study|Ineligibility determined|0
2112189|NCT00907478|3707180|FG001|Overall Study|Ineligibility determined|0
2112190|NCT00907478|3707181|FG002|Overall Study|Ineligibility determined|1
2112191|NCT00907478|3707179|FG000|Overall Study|Noncompliance|0
2112192|NCT00907478|3707180|FG001|Overall Study|Noncompliance|0
2112193|NCT00907478|3707181|FG002|Overall Study|Noncompliance|1
2112194|NCT00907478|3707179|FG000|Overall Study|Adverse Event|3
2112195|NCT00907478|3707180|FG001|Overall Study|Adverse Event|1
2112196|NCT00907478|3707181|FG002|Overall Study|Adverse Event|2
2112197|NCT00907478|3707179|FG000|Overall Study|Withdrawal by Subject|8
2112198|NCT00907478|3707180|FG001|Overall Study|Withdrawal by Subject|9
2112199|NCT00907478|3707181|FG002|Overall Study|Withdrawal by Subject|6
2112200|NCT00907478|3707179|FG000|Overall Study|Requirement for alternative therapy|1
2034709|NCT00404352|3605313|FG004|Double Blind (up to 24 Month)|Other|0
2034710|NCT00404352|3605314|FG005|Double Blind (up to 24 Month)|Other|0
2034711|NCT00404352|3605315|FG006|Double Blind (up to 24 Month)|Other|0
2034712|NCT00404352|3605316|FG007|Double Blind (up to 24 Month)|Other|0
2034713|NCT00404352|3605317|FG008|Double Blind (up to 24 Month)|Other|0
2034714|NCT00404352|3605309|FG000|Open Label (up to 24 Month)|Adverse Event|0
2034715|NCT00404352|3605310|FG001|Open Label (up to 24 Month)|Adverse Event|0
2034716|NCT00404352|3605311|FG002|Open Label (up to 24 Month)|Adverse Event|0
2034717|NCT00404352|3605312|FG003|Open Label (up to 24 Month)|Adverse Event|2
2034718|NCT00404352|3605313|FG004|Open Label (up to 24 Month)|Adverse Event|1
2034719|NCT00404352|3605314|FG005|Open Label (up to 24 Month)|Adverse Event|1
2034720|NCT00404352|3605315|FG006|Open Label (up to 24 Month)|Adverse Event|0
2034721|NCT00404352|3605316|FG007|Open Label (up to 24 Month)|Adverse Event|0
2034722|NCT00404352|3605317|FG008|Open Label (up to 24 Month)|Adverse Event|0
2034723|NCT00404352|3605309|FG000|Open Label (up to 24 Month)|Pregnancy|0
2034724|NCT00404352|3605310|FG001|Open Label (up to 24 Month)|Pregnancy|0
2034725|NCT00404352|3605311|FG002|Open Label (up to 24 Month)|Pregnancy|0
2034726|NCT00404352|3605312|FG003|Open Label (up to 24 Month)|Pregnancy|0
2034727|NCT00404352|3605313|FG004|Open Label (up to 24 Month)|Pregnancy|0
2034728|NCT00404352|3605314|FG005|Open Label (up to 24 Month)|Pregnancy|1
2034729|NCT00404352|3605315|FG006|Open Label (up to 24 Month)|Pregnancy|0
2034730|NCT00404352|3605316|FG007|Open Label (up to 24 Month)|Pregnancy|0
2034731|NCT00404352|3605317|FG008|Open Label (up to 24 Month)|Pregnancy|0
2034732|NCT00404352|3605309|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0
2034733|NCT00404352|3605310|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0
2034734|NCT00404352|3605311|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0
2034735|NCT00404352|3605312|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0
2034736|NCT00404352|3605313|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1
2112201|NCT00907478|3707180|FG001|Overall Study|Requirement for alternative therapy|2
2112202|NCT00907478|3707181|FG002|Overall Study|Requirement for alternative therapy|3
2112203|NCT00907478|3707179|FG000|Overall Study|Physician Decision|2
2112204|NCT00907478|3707180|FG001|Overall Study|Physician Decision|0
2112205|NCT00907478|3707181|FG002|Overall Study|Physician Decision|3
2112206|NCT00907478|3707179|FG000|Overall Study|Death|4
2112207|NCT00907478|3707180|FG001|Overall Study|Death|2
2112208|NCT00907478|3707181|FG002|Overall Study|Death|1
2112209|NCT00907478|3707179|FG000|Overall Study|Protocol-specified criteria|5
2112210|NCT00907478|3707180|FG001|Overall Study|Protocol-specified criteria|2
2112211|NCT00907478|3707181|FG002|Overall Study|Protocol-specified criteria|3
2112212|NCT00907478|3707179|FG000|Overall Study|Pregnancy|0
2112213|NCT00907478|3707180|FG001|Overall Study|Pregnancy|1
2112214|NCT00907478|3707181|FG002|Overall Study|Pregnancy|1
2112215|NCT00907478|3707179|FG000|Overall Study|Lost to Follow-up|1
2112216|NCT00907478|3707180|FG001|Overall Study|Lost to Follow-up|0
2112217|NCT00907478|3707181|FG002|Overall Study|Lost to Follow-up|0
2112218|NCT00907478|3707179|FG000|Overall Study|Other|3
2112219|NCT00907478|3707180|FG001|Overall Study|Other|0
2112220|NCT00907478|3707181|FG002|Overall Study|Other|1
2112221|NCT00907517|3707196|FG000|Overall Study|Progressive Disease|3
2112222|NCT00907517|3707197|FG001|Overall Study|Progressive Disease|3
2112223|NCT00907517|3707198|FG002|Overall Study|Progressive Disease|4
2112224|NCT00907517|3707199|FG003|Overall Study|Progressive Disease|4
2112225|NCT00907517|3707200|FG004|Overall Study|Progressive Disease|4
2112226|NCT00907517|3707196|FG000|Overall Study|Symptomatic Deterioration|0
2112227|NCT00907517|3707197|FG001|Overall Study|Symptomatic Deterioration|0
2112228|NCT00907517|3707198|FG002|Overall Study|Symptomatic Deterioration|0
2112229|NCT00907517|3707199|FG003|Overall Study|Symptomatic Deterioration|0
2112230|NCT00907517|3707200|FG004|Overall Study|Symptomatic Deterioration|1
2112231|NCT00907621|3707214|FG000|Overall Study|Lost to Follow-up|6
2112232|NCT00907621|3707215|FG001|Overall Study|Lost to Follow-up|3
2112233|NCT00907621|3707214|FG000|Overall Study|intercurrent febrile illness|1
2112234|NCT00907621|3707215|FG001|Overall Study|intercurrent febrile illness|1
2112235|NCT00907738|3707226|FG000|Overall Study|Adverse Event|2
2112236|NCT00907738|3707227|FG001|Overall Study|Adverse Event|0
2112237|NCT00907738|3707228|FG002|Overall Study|Adverse Event|1
2112238|NCT00907738|3707229|FG003|Overall Study|Adverse Event|0
2112239|NCT00907738|3707230|FG004|Overall Study|Adverse Event|0
2112240|NCT00907738|3707226|FG000|Overall Study|not specified or withdrew consent|3
2112241|NCT00907738|3707227|FG001|Overall Study|not specified or withdrew consent|0
2112242|NCT00907738|3707228|FG002|Overall Study|not specified or withdrew consent|0
2112243|NCT00907738|3707229|FG003|Overall Study|not specified or withdrew consent|0
2112244|NCT00907738|3707230|FG004|Overall Study|not specified or withdrew consent|0
2112245|NCT00907738|3707226|FG000|Overall Study|Disease progression|8
2112246|NCT00907738|3707227|FG001|Overall Study|Disease progression|1
2112247|NCT00907738|3707228|FG002|Overall Study|Disease progression|6
2112248|NCT00907738|3707229|FG003|Overall Study|Disease progression|4
2112249|NCT00907738|3707230|FG004|Overall Study|Disease progression|2
2112250|NCT00907777|3707248|FG000|Overall Study|Withdrawal by Subject|0
2112251|NCT00907777|3707249|FG001|Overall Study|Withdrawal by Subject|1
2112252|NCT00907803|3707258|FG000|Overall Study|Withdrawal of consent - long commute|1
2112253|NCT00907803|3707259|FG001|Overall Study|Withdrawal of consent - long commute|0
2112254|NCT00907803|3707260|FG002|Overall Study|Withdrawal of consent - long commute|0
2112255|NCT00907803|3707258|FG000|Overall Study|Adverse Event|2
2034737|NCT00404352|3605314|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0
2034738|NCT00404352|3605315|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0
2034739|NCT00404352|3605316|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0
2034740|NCT00404352|3605317|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0
2034741|NCT00404352|3605309|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0
2034742|NCT00404352|3605310|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0
2034743|NCT00404352|3605311|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0
2034744|NCT00404352|3605312|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0
2034745|NCT00404352|3605313|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0
2034746|NCT00404352|3605314|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5
2034747|NCT00404352|3605315|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0
2034748|NCT00404352|3605316|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0
2034749|NCT00404352|3605317|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0
2034750|NCT00404352|3605309|FG000|Open Label (up to 24 Month)|Disease progression|0
2034751|NCT00404352|3605310|FG001|Open Label (up to 24 Month)|Disease progression|0
2034752|NCT00404352|3605311|FG002|Open Label (up to 24 Month)|Disease progression|0
2034753|NCT00404352|3605312|FG003|Open Label (up to 24 Month)|Disease progression|1
2034754|NCT00404352|3605313|FG004|Open Label (up to 24 Month)|Disease progression|0
2034755|NCT00404352|3605314|FG005|Open Label (up to 24 Month)|Disease progression|0
2034756|NCT00404352|3605315|FG006|Open Label (up to 24 Month)|Disease progression|0
2034757|NCT00404352|3605316|FG007|Open Label (up to 24 Month)|Disease progression|0
2034758|NCT00404352|3605317|FG008|Open Label (up to 24 Month)|Disease progression|0
2034759|NCT00404352|3605309|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0
2034760|NCT00404352|3605310|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0
2034761|NCT00404352|3605311|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0
2112256|NCT00907803|3707259|FG001|Overall Study|Adverse Event|0
2112257|NCT00907803|3707260|FG002|Overall Study|Adverse Event|0
2112258|NCT00907803|3707258|FG000|Overall Study|Withdrawal by Subject|0
2112259|NCT00907803|3707259|FG001|Overall Study|Withdrawal by Subject|1
2112260|NCT00907803|3707260|FG002|Overall Study|Withdrawal by Subject|0
2112261|NCT00907803|3707258|FG000|Overall Study|Lost to Follow-up|0
2112262|NCT00907803|3707259|FG001|Overall Study|Lost to Follow-up|1
2112263|NCT00907803|3707260|FG002|Overall Study|Lost to Follow-up|0
2112264|NCT00907803|3707258|FG000|Overall Study|Protocol Violation|0
2112265|NCT00907803|3707259|FG001|Overall Study|Protocol Violation|1
2112266|NCT00907803|3707260|FG002|Overall Study|Protocol Violation|0
2112267|NCT00907881|3707268|FG000|Overall Study|Lost to Follow-up|59
2112268|NCT00907881|3707268|FG000|Overall Study|Noncompliance|5
2112269|NCT00907881|3707268|FG000|Overall Study|Withdrawal by Subject|5
2112270|NCT00907881|3707268|FG000|Overall Study|Protocol Violation|1
2112271|NCT00907881|3707268|FG000|Overall Study|Missing discontinuation information|15
2112272|NCT00908011|3707274|FG000|Overall Study|Withdrawal by Subject|2
2112273|NCT00908011|3707275|FG001|Overall Study|Withdrawal by Subject|2
2112274|NCT00908037|3707288|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2112275|NCT00908037|3707289|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2112276|NCT00908037|3707290|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2112277|NCT00908037|3707291|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2112278|NCT00908037|3707292|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1
2112279|NCT00908037|3707293|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2112280|NCT00908037|3707294|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3
2112281|NCT00908037|3707295|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2112282|NCT00908037|3707296|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1
2112283|NCT00908037|3707297|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2112284|NCT00908037|3707298|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2112285|NCT00908037|3707299|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2112286|NCT00908037|3707288|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2112287|NCT00908037|3707289|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2112288|NCT00908037|3707290|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2112289|NCT00908037|3707291|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2112290|NCT00908037|3707292|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
2112291|NCT00908037|3707293|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2112292|NCT00908037|3707294|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2112293|NCT00908037|3707295|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2112294|NCT00908037|3707296|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
2112295|NCT00908037|3707297|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2112296|NCT00908037|3707298|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2112297|NCT00908037|3707299|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2112298|NCT00908037|3707288|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2112299|NCT00908037|3707289|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2112300|NCT00908037|3707290|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2112301|NCT00908037|3707291|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
2112302|NCT00908037|3707292|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2112303|NCT00908037|3707293|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2112304|NCT00908037|3707294|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
2034762|NCT00404352|3605312|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0
2034763|NCT00404352|3605313|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0
2034764|NCT00404352|3605314|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0
2034765|NCT00404352|3605315|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1
2034766|NCT00404352|3605316|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1
2034767|NCT00404352|3605317|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0
2034768|NCT00404352|3605309|FG000|Open Label Extension (up to 36 Months)|Other|0
2034769|NCT00404352|3605310|FG001|Open Label Extension (up to 36 Months)|Other|0
2034770|NCT00404352|3605311|FG002|Open Label Extension (up to 36 Months)|Other|0
2034771|NCT00404352|3605312|FG003|Open Label Extension (up to 36 Months)|Other|0
2034772|NCT00404352|3605313|FG004|Open Label Extension (up to 36 Months)|Other|0
2034773|NCT00404352|3605314|FG005|Open Label Extension (up to 36 Months)|Other|0
2034774|NCT00404352|3605315|FG006|Open Label Extension (up to 36 Months)|Other|0
2034775|NCT00404352|3605316|FG007|Open Label Extension (up to 36 Months)|Other|0
2034776|NCT00404352|3605317|FG008|Open Label Extension (up to 36 Months)|Other|2
2034777|NCT00404495|3605336|FG000|Overall Study|Death|37
2034778|NCT00404495|3605337|FG001|Overall Study|Death|11
2034779|NCT00404495|3605336|FG000|Overall Study|Lost to Follow-up|5
2034780|NCT00404495|3605337|FG001|Overall Study|Lost to Follow-up|0
2034781|NCT00404495|3605336|FG000|Overall Study|Other|1
2034782|NCT00404495|3605337|FG001|Overall Study|Other|0
2034783|NCT00404495|3605336|FG000|Overall Study|Withdrawal by Subject|1
2034784|NCT00404495|3605337|FG001|Overall Study|Withdrawal by Subject|0
2034785|NCT00404547|3605345|FG000|Overall Study|Adverse Event|39
2034786|NCT00404547|3605346|FG001|Overall Study|Adverse Event|6
2034787|NCT00404547|3605345|FG000|Overall Study|Withdrawal by Subject|19
2034788|NCT00404547|3605346|FG001|Overall Study|Withdrawal by Subject|2
2034789|NCT00404547|3605345|FG000|Overall Study|Protocol Violation|0
2034790|NCT00404547|3605346|FG001|Overall Study|Protocol Violation|1
2034791|NCT00404547|3605345|FG000|Overall Study|Lost to Follow-up|20
2034792|NCT00404547|3605346|FG001|Overall Study|Lost to Follow-up|9
2034793|NCT00404547|3605345|FG000|Overall Study|Lack of compliance|5
2034794|NCT00404547|3605346|FG001|Overall Study|Lack of compliance|1
2034795|NCT00404547|3605345|FG000|Overall Study|Other|4
2034796|NCT00404547|3605346|FG001|Overall Study|Other|0
2034797|NCT00404547|3605345|FG000|Overall Study|Reason not stated|3
2112305|NCT00908037|3707295|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2112306|NCT00908037|3707296|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2112307|NCT00908037|3707297|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2112308|NCT00908037|3707298|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2112309|NCT00908037|3707299|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2112310|NCT00908037|3707288|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2112311|NCT00908037|3707289|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2112312|NCT00908037|3707290|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2112313|NCT00908037|3707291|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2112314|NCT00908037|3707292|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2112315|NCT00908037|3707293|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2112316|NCT00908037|3707294|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2112317|NCT00908037|3707295|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2112318|NCT00908037|3707296|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2112319|NCT00908037|3707297|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2112320|NCT00908037|3707298|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2112321|NCT00908037|3707299|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
2112322|NCT00908037|3707288|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2112323|NCT00908037|3707289|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2112324|NCT00908037|3707290|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2112325|NCT00908037|3707291|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2112326|NCT00908037|3707292|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2112327|NCT00908037|3707293|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2112328|NCT00908037|3707294|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2112329|NCT00908037|3707295|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2112330|NCT00908037|3707296|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2112331|NCT00908037|3707297|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
2112332|NCT00908037|3707298|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2112333|NCT00908037|3707299|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
2112334|NCT00908037|3707288|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2112335|NCT00908037|3707289|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2112336|NCT00908037|3707290|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2112337|NCT00908037|3707291|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2112338|NCT00908037|3707292|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2112339|NCT00908037|3707293|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2112340|NCT00908037|3707294|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2180439|NCT01401530|3806565|FG002|Overall Study|Participant Choice|1
2034798|NCT00404547|3605346|FG001|Overall Study|Reason not stated|6
2034799|NCT00404651|3605356|FG000|Overall Study|Serious Adverse Event|0
2034800|NCT00404651|3605357|FG001|Overall Study|Serious Adverse Event|0
2034801|NCT00404651|3605358|FG002|Overall Study|Serious Adverse Event|2
2034802|NCT00404651|3605359|FG003|Overall Study|Serious Adverse Event|0
2034803|NCT00404651|3605356|FG000|Overall Study|Protocol Violation|10
2034804|NCT00404651|3605357|FG001|Overall Study|Protocol Violation|5
2034805|NCT00404651|3605358|FG002|Overall Study|Protocol Violation|14
2034806|NCT00404651|3605359|FG003|Overall Study|Protocol Violation|5
2034807|NCT00404651|3605356|FG000|Overall Study|Lost to Follow-up|15
2034808|NCT00404651|3605357|FG001|Overall Study|Lost to Follow-up|11
2034809|NCT00404651|3605358|FG002|Overall Study|Lost to Follow-up|13
2034810|NCT00404651|3605359|FG003|Overall Study|Lost to Follow-up|10
2034811|NCT00404651|3605356|FG000|Overall Study|Withdrawal by Subject|14
2034812|NCT00404651|3605357|FG001|Overall Study|Withdrawal by Subject|12
2034813|NCT00404651|3605358|FG002|Overall Study|Withdrawal by Subject|16
2034814|NCT00404651|3605359|FG003|Overall Study|Withdrawal by Subject|6
2034815|NCT00404755|3605369|FG000|Phase I (Bupropion)|Adverse Event|3
2034816|NCT00404755|3605369|FG000|Phase I (Bupropion)|Other|1
2034817|NCT00404755|3605369|FG000|Phase II (Escitalopram)|Lost to Follow-up|2
2034818|NCT00404768|3605381|FG000|Part A and B|Withdrawn due to labor progression|1
2034819|NCT00404768|3605382|FG001|Part A and B|Withdrawn due to labor progression|0
2034820|NCT00404768|3605383|FG002|Part A and B|Withdrawn due to labor progression|0
2034821|NCT00404768|3605384|FG003|Part A and B|Withdrawn due to labor progression|0
2034822|NCT00404768|3605381|FG000|Part A and B|Withdrawn as delivery imminemnt|0
2034823|NCT00404768|3605382|FG001|Part A and B|Withdrawn as delivery imminemnt|1
2034824|NCT00404768|3605383|FG002|Part A and B|Withdrawn as delivery imminemnt|0
2034825|NCT00404768|3605384|FG003|Part A and B|Withdrawn as delivery imminemnt|0
2034826|NCT00404768|3605381|FG000|Part C|Adverse Event|0
2034827|NCT00404768|3605382|FG001|Part C|Adverse Event|0
2034828|NCT00404768|3605383|FG002|Part C|Adverse Event|0
2034829|NCT00404768|3605384|FG003|Part C|Adverse Event|3
2034830|NCT00404768|3605381|FG000|Part C|Lost to Follow-up|0
2034831|NCT00404768|3605382|FG001|Part C|Lost to Follow-up|0
2034832|NCT00404768|3605383|FG002|Part C|Lost to Follow-up|3
2034833|NCT00404768|3605384|FG003|Part C|Lost to Follow-up|1
2034834|NCT00404768|3605381|FG000|Part C|Withdrawal by Subject|0
2034835|NCT00404768|3605382|FG001|Part C|Withdrawal by Subject|0
2034836|NCT00404768|3605383|FG002|Part C|Withdrawal by Subject|2
2034837|NCT00404768|3605384|FG003|Part C|Withdrawal by Subject|1
2034838|NCT00404768|3605381|FG000|Part C|Early withdrawal from study medication|0
2034839|NCT00404768|3605382|FG001|Part C|Early withdrawal from study medication|0
2034840|NCT00404768|3605383|FG002|Part C|Early withdrawal from study medication|1
2034841|NCT00404768|3605384|FG003|Part C|Early withdrawal from study medication|0
2034842|NCT00404768|3605381|FG000|Part C|Participant did not respond to therapy|0
2034843|NCT00404768|3605382|FG001|Part C|Participant did not respond to therapy|0
2034844|NCT00404768|3605383|FG002|Part C|Participant did not respond to therapy|1
2034845|NCT00404768|3605384|FG003|Part C|Participant did not respond to therapy|1
2034846|NCT00404768|3605381|FG000|Part C|Physician withdrew the study medication|0
2034847|NCT00404768|3605382|FG001|Part C|Physician withdrew the study medication|0
2034848|NCT00404768|3605383|FG002|Part C|Physician withdrew the study medication|1
2034849|NCT00404768|3605384|FG003|Part C|Physician withdrew the study medication|0
2034850|NCT00404768|3605381|FG000|Part C|Participant delivered baby|0
2034851|NCT00404768|3605382|FG001|Part C|Participant delivered baby|0
2034852|NCT00404768|3605383|FG002|Part C|Participant delivered baby|0
2034853|NCT00404768|3605384|FG003|Part C|Participant delivered baby|1
2034854|NCT00404768|3605381|FG000|Part C|Unsatisfactory uterine response to IP|0
2034855|NCT00404768|3605382|FG001|Part C|Unsatisfactory uterine response to IP|0
2034856|NCT00404768|3605383|FG002|Part C|Unsatisfactory uterine response to IP|0
2034857|NCT00404768|3605384|FG003|Part C|Unsatisfactory uterine response to IP|1
2034858|NCT00404768|3605381|FG000|Part C|Active labor|0
2034859|NCT00404768|3605382|FG001|Part C|Active labor|0
2034860|NCT00404768|3605383|FG002|Part C|Active labor|0
2034861|NCT00404768|3605384|FG003|Part C|Active labor|1
2034862|NCT00404768|3605381|FG000|Part C|Lack of Efficacy|0
2034863|NCT00404768|3605382|FG001|Part C|Lack of Efficacy|0
2034864|NCT00404768|3605383|FG002|Part C|Lack of Efficacy|0
2034865|NCT00404768|3605384|FG003|Part C|Lack of Efficacy|2
2034866|NCT00404768|3605381|FG000|Part C|Treatment failure|0
2112341|NCT00908037|3707295|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2034867|NCT00404768|3605382|FG001|Part C|Treatment failure|0
2034868|NCT00404768|3605383|FG002|Part C|Treatment failure|0
2034869|NCT00404768|3605384|FG003|Part C|Treatment failure|1
2034870|NCT00404768|3605381|FG000|Part C|Investigator discretion|0
2034871|NCT00404768|3605382|FG001|Part C|Investigator discretion|0
2034872|NCT00404768|3605383|FG002|Part C|Investigator discretion|0
2034873|NCT00404768|3605384|FG003|Part C|Investigator discretion|1
2034874|NCT00404768|3605381|FG000|Part C|Researcher suspended study medication|0
2034875|NCT00404768|3605382|FG001|Part C|Researcher suspended study medication|0
2034876|NCT00404768|3605383|FG002|Part C|Researcher suspended study medication|0
2034877|NCT00404768|3605384|FG003|Part C|Researcher suspended study medication|1
2034878|NCT00404820|3605401|FG000|Overall Study|Adverse Event|4
2034879|NCT00404820|3605402|FG001|Overall Study|Adverse Event|16
2034880|NCT00404820|3605401|FG000|Overall Study|Withdrawal by Subject|5
2034881|NCT00404820|3605402|FG001|Overall Study|Withdrawal by Subject|3
2034882|NCT00404820|3605401|FG000|Overall Study|Lost to Follow-up|7
2034883|NCT00404820|3605402|FG001|Overall Study|Lost to Follow-up|3
2034884|NCT00404820|3605401|FG000|Overall Study|Administrative problems|2
2034885|NCT00404820|3605402|FG001|Overall Study|Administrative problems|0
2034886|NCT00404820|3605401|FG000|Overall Study|Death|1
2034887|NCT00404820|3605402|FG001|Overall Study|Death|0
2034888|NCT00404820|3605401|FG000|Overall Study|Other|0
2034889|NCT00404820|3605402|FG001|Overall Study|Other|2
2034890|NCT00404924|3605410|FG000|Overall Study|Adverse Event|75
2034891|NCT00404924|3605411|FG001|Overall Study|Adverse Event|16
2034892|NCT00404924|3605410|FG000|Overall Study|Condition under investigation worsened|475
2034893|NCT00404924|3605411|FG001|Overall Study|Condition under investigation worsened|264
2034894|NCT00404924|3605410|FG000|Overall Study|Lost to Follow-up|1
2034895|NCT00404924|3605411|FG001|Overall Study|Lost to Follow-up|1
2034896|NCT00404924|3605410|FG000|Overall Study|Withdrawal by Subject|26
2034897|NCT00404924|3605411|FG001|Overall Study|Withdrawal by Subject|13
2034898|NCT00404924|3605410|FG000|Overall Study|Other|25
2034899|NCT00404924|3605411|FG001|Overall Study|Other|11
2034900|NCT00404924|3605410|FG000|Overall Study|Randomised but not received treatment|1
2034901|NCT00404924|3605411|FG001|Overall Study|Randomised but not received treatment|1
2034902|NCT00405067|3605420|FG000|Overall Study|Adverse Event|4
2034903|NCT00405067|3605421|FG001|Overall Study|Adverse Event|9
2034904|NCT00405067|3605422|FG002|Overall Study|Adverse Event|4
2034905|NCT00405067|3605420|FG000|Overall Study|Lost to Follow-up|0
2034906|NCT00405067|3605421|FG001|Overall Study|Lost to Follow-up|0
2034907|NCT00405067|3605422|FG002|Overall Study|Lost to Follow-up|1
2034908|NCT00405275|3605432|FG000|Overall Study|Death|1
2034909|NCT00405275|3605433|FG001|Overall Study|Death|0
2034910|NCT00405275|3605432|FG000|Overall Study|Lost to Follow-up|5
2034911|NCT00405275|3605433|FG001|Overall Study|Lost to Follow-up|1
2034912|NCT00405275|3605432|FG000|Overall Study|Withdrawal by Subject|7
2034913|NCT00405275|3605433|FG001|Overall Study|Withdrawal by Subject|9
2034914|NCT00405275|3605432|FG000|Overall Study|Unwilling to continue|10
2034915|NCT00405275|3605433|FG001|Overall Study|Unwilling to continue|9
2034916|NCT00405392|3605454|FG000|Overall Study|Adverse Event|15
2034917|NCT00405392|3605455|FG001|Overall Study|Adverse Event|14
2034918|NCT00405392|3605454|FG000|Overall Study|Did not meet Eligibility criteria|7
2034919|NCT00405392|3605455|FG001|Overall Study|Did not meet Eligibility criteria|2
2034920|NCT00405392|3605454|FG000|Overall Study|Withdrawal by Subject|4
2034921|NCT00405392|3605455|FG001|Overall Study|Withdrawal by Subject|3
2034922|NCT00405392|3605454|FG000|Overall Study|Lost to Follow-up|1
2034923|NCT00405392|3605455|FG001|Overall Study|Lost to Follow-up|2
2034924|NCT00405392|3605454|FG000|Overall Study|Data missing|2
2034925|NCT00405392|3605455|FG001|Overall Study|Data missing|0
2034926|NCT00405392|3605454|FG000|Overall Study|Non-compliance|0
2034927|NCT00405392|3605455|FG001|Overall Study|Non-compliance|1
2034928|NCT00405392|3605454|FG000|Overall Study|Other|1
2034929|NCT00405392|3605455|FG001|Overall Study|Other|5
2034930|NCT00405548|3605481|FG000|Overall Study|Cognitive Memory problems on study day|1
2034931|NCT00405548|3605482|FG001|Overall Study|Cognitive Memory problems on study day|0
2034932|NCT00405548|3605481|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0
2034933|NCT00405548|3605482|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1
2034934|NCT00405548|3605481|FG000|Overall Study|Unable to self-administer shots|1
2034935|NCT00405548|3605482|FG001|Overall Study|Unable to self-administer shots|0
2034936|NCT00405548|3605481|FG000|Overall Study|Venous access failed during study day|1
2034937|NCT00405548|3605482|FG001|Overall Study|Venous access failed during study day|0
2034938|NCT00405548|3605481|FG000|Overall Study|Withdrawal by Subject|1
2034939|NCT00405548|3605482|FG001|Overall Study|Withdrawal by Subject|0
2034940|NCT00405587|3605492|FG000|Overall Study|Death|0
2034941|NCT00405587|3605493|FG001|Overall Study|Death|0
2034942|NCT00405587|3605494|FG002|Overall Study|Death|0
2034943|NCT00405587|3605495|FG003|Overall Study|Death|1
2034944|NCT00405587|3605492|FG000|Overall Study|Disease Progression|22
2034945|NCT00405587|3605493|FG001|Overall Study|Disease Progression|23
2034946|NCT00405587|3605494|FG002|Overall Study|Disease Progression|21
2034947|NCT00405587|3605495|FG003|Overall Study|Disease Progression|17
2034948|NCT00405587|3605492|FG000|Overall Study|Physician Decision|3
2034949|NCT00405587|3605493|FG001|Overall Study|Physician Decision|2
2034950|NCT00405587|3605494|FG002|Overall Study|Physician Decision|0
2034951|NCT00405587|3605495|FG003|Overall Study|Physician Decision|0
2034952|NCT00405587|3605492|FG000|Overall Study|Adverse Event|1
2034953|NCT00405587|3605493|FG001|Overall Study|Adverse Event|0
2034954|NCT00405587|3605494|FG002|Overall Study|Adverse Event|0
2034955|NCT00405587|3605495|FG003|Overall Study|Adverse Event|0
2034956|NCT00405587|3605492|FG000|Overall Study|Lost to Follow-up|0
2034957|NCT00405587|3605493|FG001|Overall Study|Lost to Follow-up|1
2034958|NCT00405587|3605494|FG002|Overall Study|Lost to Follow-up|1
2034959|NCT00405587|3605495|FG003|Overall Study|Lost to Follow-up|0
2034960|NCT00405587|3605492|FG000|Overall Study|Radiation induced necrosis|0
2034961|NCT00405587|3605493|FG001|Overall Study|Radiation induced necrosis|1
2034962|NCT00405587|3605494|FG002|Overall Study|Radiation induced necrosis|0
2034963|NCT00405587|3605495|FG003|Overall Study|Radiation induced necrosis|0
2034964|NCT00405587|3605492|FG000|Overall Study|Withdrawal by Subject|0
2034965|NCT00405587|3605493|FG001|Overall Study|Withdrawal by Subject|0
2034966|NCT00405587|3605494|FG002|Overall Study|Withdrawal by Subject|0
2034967|NCT00405587|3605495|FG003|Overall Study|Withdrawal by Subject|2
2034968|NCT00405587|3605492|FG000|Overall Study|Participant not dosed|0
2034969|NCT00405587|3605493|FG001|Overall Study|Participant not dosed|1
2034970|NCT00405587|3605494|FG002|Overall Study|Participant not dosed|0
2034971|NCT00405587|3605495|FG003|Overall Study|Participant not dosed|0
2034972|NCT00405639|3605533|FG000|Overall Study|Withdrawal by Subject|1
2034973|NCT00405639|3605534|FG001|Overall Study|Withdrawal by Subject|0
2034974|NCT00405639|3605533|FG000|Overall Study|Adverse Event|1
2034975|NCT00405639|3605534|FG001|Overall Study|Adverse Event|0
2034976|NCT00405639|3605533|FG000|Overall Study|Seizure prior to receiving BNP|1
2034977|NCT00405639|3605534|FG001|Overall Study|Seizure prior to receiving BNP|0
2112342|NCT00908037|3707296|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2112343|NCT00908037|3707297|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
2112344|NCT00908037|3707298|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2112345|NCT00908037|3707299|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2112346|NCT00908037|3707288|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2112347|NCT00908037|3707289|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2112348|NCT00908037|3707290|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2112349|NCT00908037|3707291|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2112350|NCT00908037|3707292|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2112351|NCT00908037|3707293|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2112352|NCT00908037|3707294|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2112353|NCT00908037|3707295|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2112354|NCT00908037|3707296|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2112355|NCT00908037|3707297|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2112356|NCT00908037|3707298|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
2112357|NCT00908037|3707299|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2112358|NCT00908037|3707288|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2112359|NCT00908037|3707289|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2112360|NCT00908037|3707290|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2112361|NCT00908037|3707291|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2112362|NCT00908037|3707292|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2112363|NCT00908037|3707293|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2112364|NCT00908037|3707294|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2112365|NCT00908037|3707295|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2112366|NCT00908037|3707296|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2112367|NCT00908037|3707297|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
2112368|NCT00908037|3707298|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2112369|NCT00908037|3707299|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2112370|NCT00908037|3707288|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2112371|NCT00908037|3707289|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2112372|NCT00908037|3707290|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2112373|NCT00908037|3707291|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2112374|NCT00908037|3707292|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2112375|NCT00908037|3707293|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2112376|NCT00908037|3707294|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2112377|NCT00908037|3707295|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2112378|NCT00908037|3707296|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2112379|NCT00908037|3707297|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2112380|NCT00908037|3707298|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
2112381|NCT00908037|3707299|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2112382|NCT00908076|3707353|FG000|Overall Study|Lack of Efficacy|1
2112383|NCT00908076|3707354|FG001|Overall Study|Lack of Efficacy|1
2112384|NCT00908115|3707360|FG000|Overall Study|Other|14
2112385|NCT00908141|3707366|FG000|Overall Study|Withdrawal by Subject|0
2112386|NCT00908141|3707367|FG001|Overall Study|Withdrawal by Subject|1
2112387|NCT00908232|3707373|FG000|Cycle 1 to 4|Death|5
2112388|NCT00908232|3707374|FG001|Cycle 1 to 4|Death|0
2112389|NCT00908232|3707375|FG002|Cycle 1 to 4|Death|0
2112390|NCT00908232|3707376|FG003|Cycle 1 to 4|Death|0
2112391|NCT00908232|3707373|FG000|Cycle 1 to 4|Withdrawal by Subject|4
2112392|NCT00908232|3707374|FG001|Cycle 1 to 4|Withdrawal by Subject|0
2112393|NCT00908232|3707375|FG002|Cycle 1 to 4|Withdrawal by Subject|0
2112394|NCT00908232|3707376|FG003|Cycle 1 to 4|Withdrawal by Subject|0
2112395|NCT00908232|3707373|FG000|Cycle 1 to 4|Progressive Disease|6
2112396|NCT00908232|3707374|FG001|Cycle 1 to 4|Progressive Disease|0
2112397|NCT00908232|3707375|FG002|Cycle 1 to 4|Progressive Disease|0
2112398|NCT00908232|3707376|FG003|Cycle 1 to 4|Progressive Disease|0
2112399|NCT00908232|3707373|FG000|Cycle 1 to 4|Adverse Event|12
2112400|NCT00908232|3707374|FG001|Cycle 1 to 4|Adverse Event|0
2034978|NCT00405652|3605540|FG000|Overall Study|Adverse Event|4
2034979|NCT00405756|3605557|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45
2034980|NCT00405756|3605558|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24
2034981|NCT00405756|3605559|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18
2034982|NCT00405756|3605557|FG000|Double-blind Treatment|Adverse Event|31
2034983|NCT00405756|3605558|FG001|Double-blind Treatment|Adverse Event|27
2034984|NCT00405756|3605559|FG002|Double-blind Treatment|Adverse Event|12
2034985|NCT00405756|3605557|FG000|Double-blind Treatment|Disease Progression|47
2034986|NCT00405756|3605558|FG001|Double-blind Treatment|Disease Progression|81
2034987|NCT00405756|3605559|FG002|Double-blind Treatment|Disease Progression|102
2034988|NCT00405756|3605557|FG000|Double-blind Treatment|Lack of Efficacy|1
2034989|NCT00405756|3605558|FG001|Double-blind Treatment|Lack of Efficacy|4
2034990|NCT00405756|3605559|FG002|Double-blind Treatment|Lack of Efficacy|2
2034991|NCT00405756|3605557|FG000|Double-blind Treatment|Withdrawal by Subject|15
2034992|NCT00405756|3605558|FG001|Double-blind Treatment|Withdrawal by Subject|9
2034993|NCT00405756|3605559|FG002|Double-blind Treatment|Withdrawal by Subject|10
2034994|NCT00405756|3605557|FG000|Double-blind Treatment|Lost to Follow-up|1
2034995|NCT00405756|3605558|FG001|Double-blind Treatment|Lost to Follow-up|0
2034996|NCT00405756|3605559|FG002|Double-blind Treatment|Lost to Follow-up|0
2034997|NCT00405756|3605557|FG000|Double-blind Treatment|Death|4
2034998|NCT00405756|3605558|FG001|Double-blind Treatment|Death|4
2034999|NCT00405756|3605559|FG002|Double-blind Treatment|Death|4
2035000|NCT00405756|3605557|FG000|Double-blind Treatment|Protocol Violation|1
2035001|NCT00405756|3605558|FG001|Double-blind Treatment|Protocol Violation|0
2035002|NCT00405756|3605559|FG002|Double-blind Treatment|Protocol Violation|2
2035003|NCT00405756|3605557|FG000|Double-blind Treatment|Other|7
2035004|NCT00405756|3605558|FG001|Double-blind Treatment|Other|4
2035005|NCT00405756|3605559|FG002|Double-blind Treatment|Other|4
2035006|NCT00405756|3605557|FG000|Open-label Extension|Ongoing in Open Label Period|7
2035007|NCT00405756|3605558|FG001|Open-label Extension|Ongoing in Open Label Period|15
2035008|NCT00405756|3605559|FG002|Open-label Extension|Ongoing in Open Label Period|25
2035009|NCT00405756|3605557|FG000|Open-label Extension|Adverse Event|1
2035010|NCT00405756|3605558|FG001|Open-label Extension|Adverse Event|3
2035011|NCT00405756|3605559|FG002|Open-label Extension|Adverse Event|7
2035012|NCT00405756|3605557|FG000|Open-label Extension|Disease Progression|8
2035013|NCT00405756|3605558|FG001|Open-label Extension|Disease Progression|23
2035014|NCT00405756|3605559|FG002|Open-label Extension|Disease Progression|26
2035015|NCT00405756|3605557|FG000|Open-label Extension|Withdrawal by Subject|2
2035016|NCT00405756|3605558|FG001|Open-label Extension|Withdrawal by Subject|3
2035017|NCT00405756|3605559|FG002|Open-label Extension|Withdrawal by Subject|3
2035018|NCT00405756|3605557|FG000|Open-label Extension|Death|1
2035019|NCT00405756|3605558|FG001|Open-label Extension|Death|2
2035020|NCT00405756|3605559|FG002|Open-label Extension|Death|4
2035021|NCT00405756|3605557|FG000|Open-label Extension|Other|0
2035022|NCT00405756|3605558|FG001|Open-label Extension|Other|1
2035023|NCT00405756|3605559|FG002|Open-label Extension|Other|7
2035024|NCT00405756|3605557|FG000|Follow-up|Ongoing in Follow-up Period|52
2035025|NCT00405756|3605558|FG001|Follow-up|Ongoing in Follow-up Period|51
2035026|NCT00405756|3605559|FG002|Follow-up|Ongoing in Follow-up Period|60
2035027|NCT00405756|3605557|FG000|Follow-up|Death|21
2035028|NCT00405756|3605558|FG001|Follow-up|Death|31
2035029|NCT00405756|3605559|FG002|Follow-up|Death|24
2035030|NCT00405756|3605557|FG000|Follow-up|Lost to Follow-up|2
2035031|NCT00405756|3605558|FG001|Follow-up|Lost to Follow-up|8
2035032|NCT00405756|3605559|FG002|Follow-up|Lost to Follow-up|4
2035033|NCT00405821|3605569|FG000|Overall Study|Death|5
2035034|NCT00405821|3605570|FG001|Overall Study|Death|7
2035035|NCT00405821|3605569|FG000|Overall Study|Lost to Follow-up|7
2035036|NCT00405821|3605570|FG001|Overall Study|Lost to Follow-up|7
2035037|NCT00405821|3605569|FG000|Overall Study|Protocol Violation|1
2035038|NCT00405821|3605570|FG001|Overall Study|Protocol Violation|0
2035039|NCT00405821|3605569|FG000|Overall Study|initiated ART|9
2035040|NCT00405821|3605570|FG001|Overall Study|initiated ART|8
2035041|NCT00405912|3605579|FG000|Overall Study|Withdrawal by Subject|12
2035042|NCT00405912|3605580|FG001|Overall Study|Withdrawal by Subject|11
2035043|NCT00405912|3605581|FG002|Overall Study|Withdrawal by Subject|12
2035044|NCT00405912|3605579|FG000|Overall Study|Lost to Follow-up|4
2035045|NCT00405912|3605580|FG001|Overall Study|Lost to Follow-up|8
2035046|NCT00405912|3605581|FG002|Overall Study|Lost to Follow-up|4
2035047|NCT00406029|3605603|FG000|Overall Study|Adverse Event|12
2035048|NCT00406029|3605604|FG001|Overall Study|Adverse Event|2
2035049|NCT00406029|3605605|FG002|Overall Study|Adverse Event|5
2035050|NCT00406029|3605606|FG003|Overall Study|Adverse Event|10
2035051|NCT00406029|3605607|FG004|Overall Study|Adverse Event|7
2035052|NCT00406029|3605603|FG000|Overall Study|Withdrawal by Subject|3
2035053|NCT00406029|3605604|FG001|Overall Study|Withdrawal by Subject|4
2035054|NCT00406029|3605605|FG002|Overall Study|Withdrawal by Subject|2
2035055|NCT00406029|3605606|FG003|Overall Study|Withdrawal by Subject|2
2035056|NCT00406029|3605607|FG004|Overall Study|Withdrawal by Subject|0
2035057|NCT00406029|3605603|FG000|Overall Study|Protocol Violation|1
2035058|NCT00406029|3605604|FG001|Overall Study|Protocol Violation|2
2035059|NCT00406029|3605605|FG002|Overall Study|Protocol Violation|0
2035060|NCT00406029|3605606|FG003|Overall Study|Protocol Violation|2
2035061|NCT00406029|3605607|FG004|Overall Study|Protocol Violation|0
2035062|NCT00406029|3605603|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
2112401|NCT00908232|3707375|FG002|Cycle 1 to 4|Adverse Event|0
2112402|NCT00908232|3707376|FG003|Cycle 1 to 4|Adverse Event|0
2112403|NCT00908232|3707373|FG000|Cycle 1 to 4|Other|1
2112404|NCT00908232|3707374|FG001|Cycle 1 to 4|Other|0
2112405|NCT00908232|3707375|FG002|Cycle 1 to 4|Other|0
2112406|NCT00908232|3707376|FG003|Cycle 1 to 4|Other|0
2112407|NCT00908232|3707373|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
2112408|NCT00908232|3707374|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
2112409|NCT00908232|3707375|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
2112410|NCT00908232|3707376|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
2112411|NCT00908232|3707373|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
2112412|NCT00908232|3707374|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
2112413|NCT00908232|3707375|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
2112414|NCT00908232|3707376|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
2112415|NCT00908232|3707373|FG000|Randomization (Cycle 5) to Cycle 8|Death|2
2112416|NCT00908232|3707374|FG001|Randomization (Cycle 5) to Cycle 8|Death|0
2112417|NCT00908232|3707375|FG002|Randomization (Cycle 5) to Cycle 8|Death|0
2112418|NCT00908232|3707376|FG003|Randomization (Cycle 5) to Cycle 8|Death|0
2112419|NCT00908232|3707373|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
2112420|NCT00908232|3707374|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
2112421|NCT00908232|3707375|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
2112422|NCT00908232|3707376|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
2112423|NCT00908232|3707373|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
2112424|NCT00908232|3707374|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
2112425|NCT00908232|3707375|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
2112426|NCT00908232|3707376|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
2112427|NCT00908232|3707373|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
2112428|NCT00908232|3707374|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
2112429|NCT00908232|3707375|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
2112430|NCT00908232|3707376|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
2112431|NCT00908232|3707373|FG000|Randomization (Cycle 5) to Cycle 8|Other|3
2112432|NCT00908232|3707374|FG001|Randomization (Cycle 5) to Cycle 8|Other|1
2112433|NCT00908232|3707375|FG002|Randomization (Cycle 5) to Cycle 8|Other|0
2112434|NCT00908232|3707376|FG003|Randomization (Cycle 5) to Cycle 8|Other|0
2112435|NCT00908232|3707373|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
2112436|NCT00908232|3707374|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
2112437|NCT00908232|3707375|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
2112438|NCT00908232|3707376|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
2112439|NCT00908310|3707382|FG000|Overall Study|Death|37
2112440|NCT00908310|3707382|FG000|Overall Study|Withdrawal by Subject|7
2112441|NCT00908310|3707382|FG000|Overall Study|Lost to Follow-up|7
2218994|NCT01717859|3862621|FG000|Overall Study|Moved out of state|1
2218995|NCT01717859|3862621|FG000|Overall Study|Patient concerned about mental health|1
2218996|NCT01717859|3862621|FG000|Overall Study|Lost to Follow-up|1
2035063|NCT00406029|3605604|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
2035064|NCT00406029|3605605|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
2035065|NCT00406029|3605606|FG003|Overall Study|Did Not Meet Eligibility Criteria|0
2035066|NCT00406029|3605607|FG004|Overall Study|Did Not Meet Eligibility Criteria|0
2035067|NCT00406029|3605603|FG000|Overall Study|Randomized in Error|0
2035068|NCT00406029|3605604|FG001|Overall Study|Randomized in Error|0
2035069|NCT00406029|3605605|FG002|Overall Study|Randomized in Error|2
2035070|NCT00406029|3605606|FG003|Overall Study|Randomized in Error|3
2035071|NCT00406029|3605607|FG004|Overall Study|Randomized in Error|1
2035072|NCT00406315|3605656|FG000|Overall Study|Death|1
2035073|NCT00406315|3605656|FG000|Overall Study|Adverse Event|39
2035074|NCT00406315|3605656|FG000|Overall Study|Laboratory Abnormality|4
2035075|NCT00406315|3605656|FG000|Overall Study|Lack of Efficacy|13
2035076|NCT00406315|3605656|FG000|Overall Study|Other|33
2035077|NCT00406315|3605656|FG000|Overall Study|Lost to Follow-up|21
2035078|NCT00406315|3605656|FG000|Overall Study|Withdrawal by Subject|30
2035079|NCT00406354|3605663|FG000|All Randomized Patients|Protocol Violation|0
2035080|NCT00406354|3605664|FG001|All Randomized Patients|Protocol Violation|0
2035081|NCT00406354|3605665|FG002|All Randomized Patients|Protocol Violation|1
2035082|NCT00406354|3605663|FG000|All Randomized and Treated Patients|Lack of Efficacy|7
2035083|NCT00406354|3605664|FG001|All Randomized and Treated Patients|Lack of Efficacy|4
2035084|NCT00406354|3605665|FG002|All Randomized and Treated Patients|Lack of Efficacy|17
2035085|NCT00406354|3605663|FG000|All Randomized and Treated Patients|Adverse Event|6
2035086|NCT00406354|3605664|FG001|All Randomized and Treated Patients|Adverse Event|2
2035087|NCT00406354|3605665|FG002|All Randomized and Treated Patients|Adverse Event|1
2035088|NCT00406354|3605663|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2
2035089|NCT00406354|3605664|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6
2035090|NCT00406354|3605665|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1
2035091|NCT00406354|3605663|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1
2035092|NCT00406354|3605664|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1
2035093|NCT00406354|3605665|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2
2035094|NCT00406354|3605663|FG000|All Randomized and Treated Patients|Physician Decision|0
2035095|NCT00406354|3605664|FG001|All Randomized and Treated Patients|Physician Decision|0
2035096|NCT00406354|3605665|FG002|All Randomized and Treated Patients|Physician Decision|1
2035097|NCT00406367|3605675|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
2035098|NCT00406367|3605676|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
2035099|NCT00406367|3605675|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
2035100|NCT00406367|3605676|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
2035101|NCT00406367|3605675|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
2035102|NCT00406367|3605676|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
2035103|NCT00406367|3605675|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
2035104|NCT00406367|3605676|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
2035105|NCT00406367|3605675|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
2035106|NCT00406367|3605676|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
2035107|NCT00406367|3605675|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
2035108|NCT00406367|3605676|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
2035109|NCT00406367|3605675|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
2035110|NCT00406367|3605676|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
2035111|NCT00406367|3605675|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
2035112|NCT00406367|3605676|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
2035113|NCT00406367|3605675|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
2035114|NCT00406367|3605676|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
2035115|NCT00406367|3605675|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
2035116|NCT00406367|3605676|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
2035117|NCT00406367|3605675|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
2035118|NCT00406367|3605676|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
2035119|NCT00406367|3605675|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
2035120|NCT00406367|3605676|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
2035121|NCT00406393|3605684|FG000|Overall Study|Did not undergo transplantation|2
2035122|NCT00406393|3605685|FG001|Overall Study|Did not undergo transplantation|1
2035123|NCT00406419|3605694|FG000|Overall Study|Death|3
2035124|NCT00406419|3605695|FG001|Overall Study|Death|1
2035125|NCT00406419|3605696|FG002|Overall Study|Death|4
2035126|NCT00406419|3605694|FG000|Overall Study|Protocol Violation|6
2035127|NCT00406419|3605695|FG001|Overall Study|Protocol Violation|2
2035128|NCT00406419|3605696|FG002|Overall Study|Protocol Violation|5
2035129|NCT00406419|3605694|FG000|Overall Study|Study Terminated by Sponsor|260
2035130|NCT00406419|3605695|FG001|Overall Study|Study Terminated by Sponsor|288
2035131|NCT00406419|3605696|FG002|Overall Study|Study Terminated by Sponsor|282
2035132|NCT00406419|3605694|FG000|Overall Study|Withdrawal by Subject|17
2035133|NCT00406419|3605695|FG001|Overall Study|Withdrawal by Subject|24
2035134|NCT00406419|3605696|FG002|Overall Study|Withdrawal by Subject|26
2035135|NCT00406419|3605694|FG000|Overall Study|Lack of Efficacy|12
2035136|NCT00406419|3605695|FG001|Overall Study|Lack of Efficacy|1
2035137|NCT00406419|3605696|FG002|Overall Study|Lack of Efficacy|6
2035138|NCT00406419|3605694|FG000|Overall Study|Non-Compliance with Study Drug|5
2035139|NCT00406419|3605695|FG001|Overall Study|Non-Compliance with Study Drug|6
2035140|NCT00406419|3605696|FG002|Overall Study|Non-Compliance with Study Drug|3
2035141|NCT00406419|3605694|FG000|Overall Study|Adverse Event|10
2035142|NCT00406419|3605695|FG001|Overall Study|Adverse Event|12
2035143|NCT00406419|3605696|FG002|Overall Study|Adverse Event|16
2035144|NCT00406419|3605694|FG000|Overall Study|Lost to Follow-up|11
2035145|NCT00406419|3605695|FG001|Overall Study|Lost to Follow-up|10
2035146|NCT00406419|3605696|FG002|Overall Study|Lost to Follow-up|5
2035147|NCT00406640|3605706|FG000|Acute Phase|Adverse Event|18
2035148|NCT00406640|3605707|FG001|Acute Phase|Adverse Event|13
2035149|NCT00406640|3605706|FG000|Acute Phase|Failed to Return|5
2035150|NCT00406640|3605707|FG001|Acute Phase|Failed to Return|1
2035151|NCT00406640|3605706|FG000|Acute Phase|Physician Decision|0
2035152|NCT00406640|3605707|FG001|Acute Phase|Physician Decision|1
2035153|NCT00406640|3605706|FG000|Acute Phase|Lost to Follow-up|7
2035154|NCT00406640|3605707|FG001|Acute Phase|Lost to Follow-up|4
2035155|NCT00406640|3605706|FG000|Acute Phase|Protocol deviation|4
2035156|NCT00406640|3605707|FG001|Acute Phase|Protocol deviation|10
2035157|NCT00406640|3605706|FG000|Acute Phase|Protocol Violation|3
2035158|NCT00406640|3605707|FG001|Acute Phase|Protocol Violation|2
2035159|NCT00406640|3605706|FG000|Acute Phase|Withdrawal by Subject|11
2035160|NCT00406640|3605707|FG001|Acute Phase|Withdrawal by Subject|9
2035161|NCT00406640|3605706|FG000|Acute Phase|Lack of Efficacy|3
2035162|NCT00406640|3605707|FG001|Acute Phase|Lack of Efficacy|3
2035163|NCT00406640|3605706|FG000|DB Continuation Phase for Responders|Adverse Event|11
2035164|NCT00406640|3605707|FG001|DB Continuation Phase for Responders|Adverse Event|11
2035165|NCT00406640|3605706|FG000|DB Continuation Phase for Responders|Death|1
2035166|NCT00406640|3605707|FG001|DB Continuation Phase for Responders|Death|0
2035167|NCT00406640|3605706|FG000|DB Continuation Phase for Responders|Failed to Return|0
2035168|NCT00406640|3605707|FG001|DB Continuation Phase for Responders|Failed to Return|2
2035169|NCT00406640|3605706|FG000|DB Continuation Phase for Responders|Physician Decision|2
2035170|NCT00406640|3605707|FG001|DB Continuation Phase for Responders|Physician Decision|3
2035171|NCT00406640|3605706|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1
2035172|NCT00406640|3605707|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7
2035173|NCT00406640|3605706|FG000|DB Continuation Phase for Responders|non-compliance|7
2035174|NCT00406640|3605707|FG001|DB Continuation Phase for Responders|non-compliance|5
2035175|NCT00406640|3605706|FG000|DB Continuation Phase for Responders|Protocol Violation|2
2035176|NCT00406640|3605707|FG001|DB Continuation Phase for Responders|Protocol Violation|2
2035177|NCT00406640|3605706|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8
2035178|NCT00406640|3605707|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6
2035179|NCT00406640|3605706|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1
2035180|NCT00406640|3605707|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1
2035181|NCT00406640|3605706|FG000|OL Extension Phase for Non-Responders|Adverse Event|6
2035182|NCT00406640|3605707|FG001|OL Extension Phase for Non-Responders|Adverse Event|6
2035183|NCT00406640|3605706|FG000|OL Extension Phase for Non-Responders|Failed to Return|1
2035184|NCT00406640|3605707|FG001|OL Extension Phase for Non-Responders|Failed to Return|0
2035185|NCT00406640|3605706|FG000|OL Extension Phase for Non-Responders|Physician Decision|1
2035186|NCT00406640|3605707|FG001|OL Extension Phase for Non-Responders|Physician Decision|0
2035187|NCT00406640|3605706|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2
2035188|NCT00406640|3605707|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3
2035189|NCT00406640|3605706|FG000|OL Extension Phase for Non-Responders|non-compliance|3
2035190|NCT00406640|3605707|FG001|OL Extension Phase for Non-Responders|non-compliance|2
2035191|NCT00406640|3605706|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
2035192|NCT00406640|3605707|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
2035193|NCT00406640|3605706|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6
2035194|NCT00406640|3605707|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7
2035195|NCT00406653|3605723|FG000|Induction Period|Adverse Event|1
2035196|NCT00406653|3605724|FG001|Induction Period|Adverse Event|10
2035197|NCT00406653|3605725|FG002|Induction Period|Adverse Event|4
2035198|NCT00406653|3605726|FG003|Induction Period|Adverse Event|11
2035199|NCT00406653|3605727|FG004|Induction Period|Adverse Event|0
2035200|NCT00406653|3605728|FG005|Induction Period|Adverse Event|0
2035201|NCT00406653|3605729|FG006|Induction Period|Adverse Event|0
2035202|NCT00406653|3605723|FG000|Induction Period|Lack of Efficacy|11
2035203|NCT00406653|3605724|FG001|Induction Period|Lack of Efficacy|14
2035204|NCT00406653|3605725|FG002|Induction Period|Lack of Efficacy|8
2035205|NCT00406653|3605726|FG003|Induction Period|Lack of Efficacy|10
2035206|NCT00406653|3605727|FG004|Induction Period|Lack of Efficacy|0
2035207|NCT00406653|3605728|FG005|Induction Period|Lack of Efficacy|0
2035208|NCT00406653|3605729|FG006|Induction Period|Lack of Efficacy|0
2035209|NCT00406653|3605723|FG000|Induction Period|Lost to Follow-up|0
2035210|NCT00406653|3605724|FG001|Induction Period|Lost to Follow-up|2
2035211|NCT00406653|3605725|FG002|Induction Period|Lost to Follow-up|0
2035212|NCT00406653|3605726|FG003|Induction Period|Lost to Follow-up|0
2035213|NCT00406653|3605727|FG004|Induction Period|Lost to Follow-up|0
2035214|NCT00406653|3605728|FG005|Induction Period|Lost to Follow-up|0
2035215|NCT00406653|3605729|FG006|Induction Period|Lost to Follow-up|0
2035216|NCT00406653|3605723|FG000|Induction Period|Withdrawal of Consent|2
2035217|NCT00406653|3605724|FG001|Induction Period|Withdrawal of Consent|5
2035218|NCT00406653|3605725|FG002|Induction Period|Withdrawal of Consent|1
2035219|NCT00406653|3605726|FG003|Induction Period|Withdrawal of Consent|2
2035220|NCT00406653|3605727|FG004|Induction Period|Withdrawal of Consent|0
2035221|NCT00406653|3605728|FG005|Induction Period|Withdrawal of Consent|0
2035222|NCT00406653|3605729|FG006|Induction Period|Withdrawal of Consent|0
2035223|NCT00406653|3605723|FG000|Induction Period|Subject No Longer Meets Study Criteria|0
2035224|NCT00406653|3605724|FG001|Induction Period|Subject No Longer Meets Study Criteria|0
2035225|NCT00406653|3605725|FG002|Induction Period|Subject No Longer Meets Study Criteria|0
2035226|NCT00406653|3605726|FG003|Induction Period|Subject No Longer Meets Study Criteria|2
2035227|NCT00406653|3605727|FG004|Induction Period|Subject No Longer Meets Study Criteria|0
2035228|NCT00406653|3605728|FG005|Induction Period|Subject No Longer Meets Study Criteria|0
2035229|NCT00406653|3605729|FG006|Induction Period|Subject No Longer Meets Study Criteria|0
2035230|NCT00406653|3605723|FG000|Induction Period|Pregnancy|1
2035231|NCT00406653|3605724|FG001|Induction Period|Pregnancy|0
2035232|NCT00406653|3605725|FG002|Induction Period|Pregnancy|0
2035233|NCT00406653|3605726|FG003|Induction Period|Pregnancy|0
2035234|NCT00406653|3605727|FG004|Induction Period|Pregnancy|0
2035235|NCT00406653|3605728|FG005|Induction Period|Pregnancy|0
2035236|NCT00406653|3605729|FG006|Induction Period|Pregnancy|0
2035237|NCT00406653|3605723|FG000|Induction Period|Declined participation but followup done|0
2035238|NCT00406653|3605724|FG001|Induction Period|Declined participation but followup done|2
2035239|NCT00406653|3605725|FG002|Induction Period|Declined participation but followup done|1
2035240|NCT00406653|3605726|FG003|Induction Period|Declined participation but followup done|1
2035241|NCT00406653|3605727|FG004|Induction Period|Declined participation but followup done|0
2035242|NCT00406653|3605728|FG005|Induction Period|Declined participation but followup done|0
2035243|NCT00406653|3605729|FG006|Induction Period|Declined participation but followup done|0
2035244|NCT00406653|3605723|FG000|Induction Period|Given prohibited drug|0
2035245|NCT00406653|3605724|FG001|Induction Period|Given prohibited drug|1
2035246|NCT00406653|3605725|FG002|Induction Period|Given prohibited drug|2
2035247|NCT00406653|3605726|FG003|Induction Period|Given prohibited drug|0
2035248|NCT00406653|3605727|FG004|Induction Period|Given prohibited drug|0
2035249|NCT00406653|3605728|FG005|Induction Period|Given prohibited drug|0
2035250|NCT00406653|3605729|FG006|Induction Period|Given prohibited drug|0
2035251|NCT00406653|3605723|FG000|Induction Period|Incarcerated|0
2035252|NCT00406653|3605724|FG001|Induction Period|Incarcerated|0
2035253|NCT00406653|3605725|FG002|Induction Period|Incarcerated|1
2035254|NCT00406653|3605726|FG003|Induction Period|Incarcerated|0
2035255|NCT00406653|3605727|FG004|Induction Period|Incarcerated|0
2035256|NCT00406653|3605728|FG005|Induction Period|Incarcerated|0
2035257|NCT00406653|3605729|FG006|Induction Period|Incarcerated|0
2035258|NCT00406653|3605723|FG000|Induction Period|Patient relocated|0
2035259|NCT00406653|3605724|FG001|Induction Period|Patient relocated|0
2035260|NCT00406653|3605725|FG002|Induction Period|Patient relocated|1
2035261|NCT00406653|3605726|FG003|Induction Period|Patient relocated|0
2035262|NCT00406653|3605727|FG004|Induction Period|Patient relocated|0
2035263|NCT00406653|3605728|FG005|Induction Period|Patient relocated|0
2035264|NCT00406653|3605729|FG006|Induction Period|Patient relocated|0
2035265|NCT00406653|3605723|FG000|Maintenance Period|Adverse Event|0
2035266|NCT00406653|3605724|FG001|Maintenance Period|Adverse Event|0
2035267|NCT00406653|3605725|FG002|Maintenance Period|Adverse Event|0
2035268|NCT00406653|3605726|FG003|Maintenance Period|Adverse Event|0
2035269|NCT00406653|3605727|FG004|Maintenance Period|Adverse Event|1
2035270|NCT00406653|3605728|FG005|Maintenance Period|Adverse Event|1
2035271|NCT00406653|3605729|FG006|Maintenance Period|Adverse Event|0
2035272|NCT00406653|3605723|FG000|Maintenance Period|Lack of Efficacy|0
2035273|NCT00406653|3605724|FG001|Maintenance Period|Lack of Efficacy|0
2035274|NCT00406653|3605725|FG002|Maintenance Period|Lack of Efficacy|0
2035275|NCT00406653|3605726|FG003|Maintenance Period|Lack of Efficacy|0
2035276|NCT00406653|3605727|FG004|Maintenance Period|Lack of Efficacy|20
2035277|NCT00406653|3605728|FG005|Maintenance Period|Lack of Efficacy|26
2035278|NCT00406653|3605729|FG006|Maintenance Period|Lack of Efficacy|0
2035279|NCT00406653|3605723|FG000|Maintenance Period|Lost to Follow-up|0
2035280|NCT00406653|3605724|FG001|Maintenance Period|Lost to Follow-up|0
2035281|NCT00406653|3605725|FG002|Maintenance Period|Lost to Follow-up|0
2035282|NCT00406653|3605726|FG003|Maintenance Period|Lost to Follow-up|0
2035283|NCT00406653|3605727|FG004|Maintenance Period|Lost to Follow-up|2
2035284|NCT00406653|3605728|FG005|Maintenance Period|Lost to Follow-up|1
2035285|NCT00406653|3605729|FG006|Maintenance Period|Lost to Follow-up|0
2035286|NCT00406653|3605723|FG000|Maintenance Period|Withdrawal of Consent|0
2035287|NCT00406653|3605724|FG001|Maintenance Period|Withdrawal of Consent|0
2035288|NCT00406653|3605725|FG002|Maintenance Period|Withdrawal of Consent|0
2035289|NCT00406653|3605726|FG003|Maintenance Period|Withdrawal of Consent|0
2035290|NCT00406653|3605727|FG004|Maintenance Period|Withdrawal of Consent|2
2035291|NCT00406653|3605728|FG005|Maintenance Period|Withdrawal of Consent|0
2035292|NCT00406653|3605729|FG006|Maintenance Period|Withdrawal of Consent|0
2035293|NCT00406653|3605723|FG000|Maintenance Period|Pregnancy|0
2035294|NCT00406653|3605724|FG001|Maintenance Period|Pregnancy|0
2035295|NCT00406653|3605725|FG002|Maintenance Period|Pregnancy|0
2035296|NCT00406653|3605726|FG003|Maintenance Period|Pregnancy|0
2035297|NCT00406653|3605727|FG004|Maintenance Period|Pregnancy|0
2035298|NCT00406653|3605728|FG005|Maintenance Period|Pregnancy|1
2035299|NCT00406653|3605729|FG006|Maintenance Period|Pregnancy|0
2035300|NCT00406653|3605723|FG000|Maintenance Period|Administrative Reason By Sponsor|0
2035301|NCT00406653|3605724|FG001|Maintenance Period|Administrative Reason By Sponsor|0
2035302|NCT00406653|3605725|FG002|Maintenance Period|Administrative Reason By Sponsor|0
2035303|NCT00406653|3605726|FG003|Maintenance Period|Administrative Reason By Sponsor|0
2035304|NCT00406653|3605727|FG004|Maintenance Period|Administrative Reason By Sponsor|4
2035305|NCT00406653|3605728|FG005|Maintenance Period|Administrative Reason By Sponsor|7
2035306|NCT00406653|3605729|FG006|Maintenance Period|Administrative Reason By Sponsor|0
2035307|NCT00406653|3605723|FG000|Maintenance Period|Error in disease score evaluation|0
2035308|NCT00406653|3605724|FG001|Maintenance Period|Error in disease score evaluation|0
2035309|NCT00406653|3605725|FG002|Maintenance Period|Error in disease score evaluation|0
2035310|NCT00406653|3605726|FG003|Maintenance Period|Error in disease score evaluation|0
2035311|NCT00406653|3605727|FG004|Maintenance Period|Error in disease score evaluation|1
2035312|NCT00406653|3605728|FG005|Maintenance Period|Error in disease score evaluation|0
2035313|NCT00406653|3605729|FG006|Maintenance Period|Error in disease score evaluation|0
2035314|NCT00406653|3605723|FG000|Open-Label Period|Death|0
2035315|NCT00406653|3605724|FG001|Open-Label Period|Death|0
2035316|NCT00406653|3605725|FG002|Open-Label Period|Death|0
2035317|NCT00406653|3605726|FG003|Open-Label Period|Death|0
2035318|NCT00406653|3605727|FG004|Open-Label Period|Death|0
2035319|NCT00406653|3605728|FG005|Open-Label Period|Death|0
2035320|NCT00406653|3605729|FG006|Open-Label Period|Death|1
2035321|NCT00406653|3605723|FG000|Open-Label Period|Adverse Event|0
2035322|NCT00406653|3605724|FG001|Open-Label Period|Adverse Event|0
2035323|NCT00406653|3605725|FG002|Open-Label Period|Adverse Event|0
2035324|NCT00406653|3605726|FG003|Open-Label Period|Adverse Event|0
2035325|NCT00406653|3605727|FG004|Open-Label Period|Adverse Event|0
2035326|NCT00406653|3605728|FG005|Open-Label Period|Adverse Event|0
2035327|NCT00406653|3605729|FG006|Open-Label Period|Adverse Event|18
2035328|NCT00406653|3605723|FG000|Open-Label Period|Lack of Efficacy|0
2035329|NCT00406653|3605724|FG001|Open-Label Period|Lack of Efficacy|0
2035330|NCT00406653|3605725|FG002|Open-Label Period|Lack of Efficacy|0
2035331|NCT00406653|3605726|FG003|Open-Label Period|Lack of Efficacy|0
2035332|NCT00406653|3605727|FG004|Open-Label Period|Lack of Efficacy|0
2035333|NCT00406653|3605728|FG005|Open-Label Period|Lack of Efficacy|0
2035334|NCT00406653|3605729|FG006|Open-Label Period|Lack of Efficacy|160
2035335|NCT00406653|3605723|FG000|Open-Label Period|Lost to Follow-up|0
2035336|NCT00406653|3605724|FG001|Open-Label Period|Lost to Follow-up|0
2035337|NCT00406653|3605725|FG002|Open-Label Period|Lost to Follow-up|0
2035338|NCT00406653|3605726|FG003|Open-Label Period|Lost to Follow-up|0
2035339|NCT00406653|3605727|FG004|Open-Label Period|Lost to Follow-up|0
2035340|NCT00406653|3605728|FG005|Open-Label Period|Lost to Follow-up|0
2035341|NCT00406653|3605729|FG006|Open-Label Period|Lost to Follow-up|6
2035342|NCT00406653|3605723|FG000|Open-Label Period|Withdrawal of Consent|0
2035343|NCT00406653|3605724|FG001|Open-Label Period|Withdrawal of Consent|0
2035344|NCT00406653|3605725|FG002|Open-Label Period|Withdrawal of Consent|0
2035345|NCT00406653|3605726|FG003|Open-Label Period|Withdrawal of Consent|0
2035346|NCT00406653|3605727|FG004|Open-Label Period|Withdrawal of Consent|0
2035347|NCT00406653|3605728|FG005|Open-Label Period|Withdrawal of Consent|0
2035348|NCT00406653|3605729|FG006|Open-Label Period|Withdrawal of Consent|11
2035349|NCT00406653|3605723|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0
2035350|NCT00406653|3605724|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0
2035351|NCT00406653|3605725|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0
2035352|NCT00406653|3605726|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0
2035353|NCT00406653|3605727|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0
2035354|NCT00406653|3605728|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0
2035355|NCT00406653|3605729|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1
2035356|NCT00406653|3605723|FG000|Open-Label Period|Pregnancy|0
2035357|NCT00406653|3605724|FG001|Open-Label Period|Pregnancy|0
2035358|NCT00406653|3605725|FG002|Open-Label Period|Pregnancy|0
2035359|NCT00406653|3605726|FG003|Open-Label Period|Pregnancy|0
2035360|NCT00406653|3605727|FG004|Open-Label Period|Pregnancy|0
2035361|NCT00406653|3605728|FG005|Open-Label Period|Pregnancy|0
2035362|NCT00406653|3605729|FG006|Open-Label Period|Pregnancy|2
2035363|NCT00406653|3605723|FG000|Open-Label Period|Administrative Reason By Sponsor|0
2035364|NCT00406653|3605724|FG001|Open-Label Period|Administrative Reason By Sponsor|0
2035365|NCT00406653|3605725|FG002|Open-Label Period|Administrative Reason By Sponsor|0
2035366|NCT00406653|3605726|FG003|Open-Label Period|Administrative Reason By Sponsor|0
2035367|NCT00406653|3605727|FG004|Open-Label Period|Administrative Reason By Sponsor|0
2035368|NCT00406653|3605728|FG005|Open-Label Period|Administrative Reason By Sponsor|0
2035369|NCT00406653|3605729|FG006|Open-Label Period|Administrative Reason By Sponsor|115
2035370|NCT00406653|3605723|FG000|Open-Label Period|Declined participation but followup done|0
2035371|NCT00406653|3605724|FG001|Open-Label Period|Declined participation but followup done|0
2035372|NCT00406653|3605725|FG002|Open-Label Period|Declined participation but followup done|0
2035373|NCT00406653|3605726|FG003|Open-Label Period|Declined participation but followup done|0
2035374|NCT00406653|3605727|FG004|Open-Label Period|Declined participation but followup done|0
2035375|NCT00406653|3605728|FG005|Open-Label Period|Declined participation but followup done|0
2035376|NCT00406653|3605729|FG006|Open-Label Period|Declined participation but followup done|8
2035377|NCT00406653|3605723|FG000|Open-Label Period|Discontinued by Sponsor|0
2035378|NCT00406653|3605724|FG001|Open-Label Period|Discontinued by Sponsor|0
2035379|NCT00406653|3605725|FG002|Open-Label Period|Discontinued by Sponsor|0
2035380|NCT00406653|3605726|FG003|Open-Label Period|Discontinued by Sponsor|0
2035381|NCT00406653|3605727|FG004|Open-Label Period|Discontinued by Sponsor|0
2035382|NCT00406653|3605728|FG005|Open-Label Period|Discontinued by Sponsor|0
2035383|NCT00406653|3605729|FG006|Open-Label Period|Discontinued by Sponsor|1
2035384|NCT00406653|3605723|FG000|Open-Label Period|Refused followup|0
2035385|NCT00406653|3605724|FG001|Open-Label Period|Refused followup|0
2035386|NCT00406653|3605725|FG002|Open-Label Period|Refused followup|0
2035387|NCT00406653|3605726|FG003|Open-Label Period|Refused followup|0
2035388|NCT00406653|3605727|FG004|Open-Label Period|Refused followup|0
2035389|NCT00406653|3605728|FG005|Open-Label Period|Refused followup|0
2035390|NCT00406653|3605729|FG006|Open-Label Period|Refused followup|1
2035391|NCT00406692|3605749|FG000|Overall Study|Withdrawal by Subject|4
2035392|NCT00406692|3605749|FG000|Overall Study|Physician Decision|1
2035393|NCT00406692|3605749|FG000|Overall Study|Adverse Event|1
2035394|NCT00406692|3605749|FG000|Overall Study|Lack of Efficacy|1
2035395|NCT00406718|3605756|FG000|Overall Study|Withdrawal by Subject|2
2035396|NCT00406718|3605757|FG001|Overall Study|Withdrawal by Subject|9
2035397|NCT00406718|3605758|FG002|Overall Study|Withdrawal by Subject|4
2035398|NCT00406718|3605756|FG000|Overall Study|Lost to Follow-up|2
2035399|NCT00406718|3605757|FG001|Overall Study|Lost to Follow-up|5
2035400|NCT00406718|3605758|FG002|Overall Study|Lost to Follow-up|4
2035401|NCT00406848|3605770|FG000|Overall Study|Withdrawal by Subject|27
2035402|NCT00406848|3605771|FG001|Overall Study|Withdrawal by Subject|22
2035403|NCT00406848|3605770|FG000|Overall Study|Adverse Event|38
2035404|NCT00406848|3605771|FG001|Overall Study|Adverse Event|7
2035405|NCT00406848|3605770|FG000|Overall Study|Lack of Efficacy|9
2035406|NCT00406848|3605771|FG001|Overall Study|Lack of Efficacy|14
2035407|NCT00406848|3605770|FG000|Overall Study|Protocol Violation|10
2035408|NCT00406848|3605771|FG001|Overall Study|Protocol Violation|6
2035409|NCT00406848|3605770|FG000|Overall Study|Lost to Follow-up|6
2035410|NCT00406848|3605771|FG001|Overall Study|Lost to Follow-up|2
2035411|NCT00406848|3605770|FG000|Overall Study|Physician Decision|2
2035412|NCT00406848|3605771|FG001|Overall Study|Physician Decision|2
2035413|NCT00406848|3605770|FG000|Overall Study|Sponsor Decision|1
2035414|NCT00406848|3605771|FG001|Overall Study|Sponsor Decision|1
2035415|NCT00407030|3605783|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2
2035416|NCT00407030|3605784|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1
2035417|NCT00407030|3605785|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0
2035418|NCT00407030|3605783|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
2035419|NCT00407030|3605784|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
2035420|NCT00407030|3605785|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
2035421|NCT00407030|3605783|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
2035422|NCT00407030|3605784|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
2035423|NCT00407030|3605785|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
2035424|NCT00407030|3605783|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
2112442|NCT00908310|3707382|FG000|Overall Study|Screening failure|5
2112443|NCT00908310|3707382|FG000|Overall Study|Other reasons|4
2112444|NCT00908349|3707386|FG000|Overall Study|Adverse Event|10
2112445|NCT00908349|3707386|FG000|Overall Study|Withdrawal by Subject|9
2112446|NCT00908349|3707386|FG000|Overall Study|Physician Decision|5
2112447|NCT00908349|3707386|FG000|Overall Study|Lost to Follow-up|5
2112448|NCT00908349|3707386|FG000|Overall Study|Various|6
2112449|NCT00908375|3707392|FG000|Overall Study|Withdrawal by Subject|2
2112450|NCT00908375|3707393|FG001|Overall Study|Withdrawal by Subject|4
2112451|NCT00908375|3707392|FG000|Overall Study|Lost to Follow-up|8
2112452|NCT00908375|3707393|FG001|Overall Study|Lost to Follow-up|6
2112453|NCT00908544|3707414|FG000|Overall Study|Withdrawal by Subject|2
2112454|NCT00908544|3707415|FG001|Overall Study|Withdrawal by Subject|4
2112455|NCT00908544|3707414|FG000|Overall Study|Lack of Efficacy|0
2112456|NCT00908544|3707415|FG001|Overall Study|Lack of Efficacy|1
2112457|NCT00908544|3707414|FG000|Overall Study|Pregnancy|1
2112458|NCT00908544|3707415|FG001|Overall Study|Pregnancy|0
2112459|NCT00908544|3707414|FG000|Overall Study|Relocation abroad|1
2112460|NCT00908544|3707415|FG001|Overall Study|Relocation abroad|1
2112461|NCT00908544|3707414|FG000|Overall Study|Unable to visit sutdy center|1
2112462|NCT00908544|3707415|FG001|Overall Study|Unable to visit sutdy center|0
2112463|NCT00908583|3707421|FG000|Phase 1|Withdrawal by Subject|1
2112464|NCT00908583|3707421|FG000|Phase 1|Adverse Event|4
2112465|NCT00908583|3707421|FG000|Phase 2|Physician Decision|1
2112466|NCT00908583|3707421|FG000|Phase 2|Adverse Event|1
2112467|NCT00908583|3707421|FG000|Phase 3|Adverse Event|2
2112468|NCT00908583|3707421|FG000|Phase 4|Adverse Event|1
2112469|NCT00908583|3707421|FG000|Phase 4|Physician Decision|1
2112470|NCT00908583|3707421|FG000|Phase 5|Adverse Event|3
2112471|NCT00908596|3707443|FG000|Overall Study|Other reasons|46
2112472|NCT00908596|3707444|FG001|Overall Study|Other reasons|6
2112473|NCT00908596|3707445|FG002|Overall Study|Other reasons|2
2112474|NCT00908596|3707446|FG003|Overall Study|Other reasons|0
2112475|NCT00908596|3707443|FG000|Overall Study|Lost to Follow-up|0
2112476|NCT00908596|3707444|FG001|Overall Study|Lost to Follow-up|1
2112477|NCT00908596|3707445|FG002|Overall Study|Lost to Follow-up|12
2112478|NCT00908596|3707446|FG003|Overall Study|Lost to Follow-up|4
2112479|NCT00908596|3707443|FG000|Overall Study|Death|0
2112480|NCT00908596|3707444|FG001|Overall Study|Death|5
2112481|NCT00908596|3707445|FG002|Overall Study|Death|57
2112482|NCT00908596|3707446|FG003|Overall Study|Death|32
2112483|NCT00908596|3707443|FG000|Overall Study|Protocol Violation|1
2112484|NCT00908596|3707444|FG001|Overall Study|Protocol Violation|0
2112485|NCT00908596|3707445|FG002|Overall Study|Protocol Violation|0
2112486|NCT00908596|3707446|FG003|Overall Study|Protocol Violation|0
2112487|NCT00908596|3707443|FG000|Overall Study|Withdrawal by Subject|0
2112488|NCT00908596|3707444|FG001|Overall Study|Withdrawal by Subject|1
2112489|NCT00908596|3707445|FG002|Overall Study|Withdrawal by Subject|3
2112490|NCT00908596|3707446|FG003|Overall Study|Withdrawal by Subject|1
2180440|NCT01401530|3806563|FG000|Overall Study|Physician Decision|0
2180441|NCT01401530|3806564|FG001|Overall Study|Physician Decision|1
2180442|NCT01401530|3806565|FG002|Overall Study|Physician Decision|0
2180443|NCT01401647|3806617|FG000|Overall Study|Withdrawal by Subject|1
2180444|NCT01401647|3806618|FG001|Overall Study|Withdrawal by Subject|5
2180445|NCT01401647|3806619|FG002|Overall Study|Withdrawal by Subject|2
2180446|NCT01401647|3806617|FG000|Overall Study|Lost to Follow-up|3
2180447|NCT01401647|3806618|FG001|Overall Study|Lost to Follow-up|3
2180448|NCT01401647|3806619|FG002|Overall Study|Lost to Follow-up|1
2218997|NCT01717859|3862621|FG000|Overall Study|Withdrawal by Subject|2
2180449|NCT01401842|3806633|FG000|Overall Study|Withdrawal by Subject|3
2180450|NCT01401842|3806634|FG001|Overall Study|Withdrawal by Subject|2
2180451|NCT01401842|3806633|FG000|Overall Study|academic reason|4
2180452|NCT01401842|3806634|FG001|Overall Study|academic reason|1
2180453|NCT01401842|3806633|FG000|Overall Study|changed companies|20
2180454|NCT01401842|3806634|FG001|Overall Study|changed companies|34
2180455|NCT01401842|3806633|FG000|Overall Study|discharged from US Army|3
2035425|NCT00407030|3605784|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
2035426|NCT00407030|3605785|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
2035427|NCT00407030|3605783|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
2035428|NCT00407030|3605784|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
2035429|NCT00407030|3605785|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
2035430|NCT00407030|3605783|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1
2035431|NCT00407030|3605784|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0
2035432|NCT00407030|3605785|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0
2035433|NCT00407030|3605783|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
2035434|NCT00407030|3605784|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
2035435|NCT00407030|3605785|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
2035436|NCT00407030|3605783|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11
2035437|NCT00407030|3605784|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11
2035438|NCT00407030|3605785|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0
2035439|NCT00407030|3605783|FG000|Extension Period - up to 68 Weeks|Adverse Event|1
2035440|NCT00407030|3605784|FG001|Extension Period - up to 68 Weeks|Adverse Event|0
2035441|NCT00407030|3605785|FG002|Extension Period - up to 68 Weeks|Adverse Event|0
2035442|NCT00407030|3605783|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4
2035443|NCT00407030|3605784|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4
2035444|NCT00407030|3605785|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0
2035445|NCT00407030|3605783|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5
2035446|NCT00407030|3605784|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5
2035447|NCT00407030|3605785|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0
2035448|NCT00407030|3605783|FG000|Extension Period - up to 68 Weeks|Patient Decision|1
2035449|NCT00407030|3605784|FG001|Extension Period - up to 68 Weeks|Patient Decision|2
2035450|NCT00407030|3605785|FG002|Extension Period - up to 68 Weeks|Patient Decision|0
2035451|NCT00407030|3605783|FG000|Extension Period - up to 68 Weeks|Physician Decision|1
2035452|NCT00407030|3605784|FG001|Extension Period - up to 68 Weeks|Physician Decision|2
2035453|NCT00407030|3605785|FG002|Extension Period - up to 68 Weeks|Physician Decision|0
2035454|NCT00407511|3605833|FG000|Overall Study|Adverse Event|9
2035455|NCT00407511|3605833|FG000|Overall Study|Lost to Follow-up|4
2035456|NCT00407511|3605833|FG000|Overall Study|Other|5
2035457|NCT00407511|3605833|FG000|Overall Study|Withdrawal by Subject|4
2035458|NCT00407537|3605839|FG000|Overall Study|Death|5
2035459|NCT00407537|3605840|FG001|Overall Study|Death|2
2035460|NCT00407537|3605839|FG000|Overall Study|Adverse Event|36
2035461|NCT00407537|3605840|FG001|Overall Study|Adverse Event|0
2035462|NCT00407537|3605839|FG000|Overall Study|Lost to Follow-up|12
2035463|NCT00407537|3605840|FG001|Overall Study|Lost to Follow-up|19
2035464|NCT00407537|3605839|FG000|Overall Study|Other|6
2035465|NCT00407537|3605840|FG001|Overall Study|Other|7
2035466|NCT00407537|3605839|FG000|Overall Study|Withdrawal by Subject|34
2035467|NCT00407537|3605840|FG001|Overall Study|Withdrawal by Subject|16
2035468|NCT00407550|3605848|FG000|Overall Study|Adverse Event|0
2035469|NCT00407550|3605849|FG001|Overall Study|Adverse Event|1
2035470|NCT00407550|3605848|FG000|Overall Study|Withdrawal by Subject|0
2035471|NCT00407550|3605849|FG001|Overall Study|Withdrawal by Subject|2
2035472|NCT00407550|3605848|FG000|Overall Study|Death|1
2035473|NCT00407550|3605849|FG001|Overall Study|Death|0
2035474|NCT00407550|3605848|FG000|Overall Study|Insurance or Other medical condition|2
2035475|NCT00407550|3605849|FG001|Overall Study|Insurance or Other medical condition|1
2035476|NCT00407563|3605855|FG000|Overall Study|Patient continues on treatment|1
2035477|NCT00407745|3605866|FG000|Overall Study|Lack of Efficacy|1
2035478|NCT00407745|3605867|FG001|Overall Study|Lack of Efficacy|2
2035479|NCT00407745|3605866|FG000|Overall Study|Withdrawal by Subject|3
2035480|NCT00407745|3605867|FG001|Overall Study|Withdrawal by Subject|3
2112491|NCT00908895|3707489|FG000|Overall Study|Lost to Follow-up|1
2112492|NCT00908895|3707490|FG001|Overall Study|Lost to Follow-up|3
2112493|NCT00908895|3707489|FG000|Overall Study|algodystrophy|2
2112494|NCT00908895|3707490|FG001|Overall Study|algodystrophy|2
2112495|NCT00908895|3707489|FG000|Overall Study|Adverse Event|1
2112496|NCT00908895|3707490|FG001|Overall Study|Adverse Event|1
2112497|NCT00908960|3707508|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1
2112498|NCT00908960|3707509|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1
2112499|NCT00908960|3707510|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2
2112500|NCT00909038|3707518|FG000|Overall Study|Protocol Violation|187
2112501|NCT00909038|3707518|FG000|Overall Study|Non-evaluable Subjects|230
2112502|NCT00909090|3707528|FG000|Overall Study|Lost to Follow-up|17
2112503|NCT00909090|3707529|FG001|Overall Study|Lost to Follow-up|17
2112504|NCT00909181|3707557|FG000|Overall Study|Lost to Follow-up|39
2112505|NCT00909181|3707558|FG001|Overall Study|Lost to Follow-up|18
2112506|NCT00909181|3707559|FG002|Overall Study|Lost to Follow-up|33
2112507|NCT00909363|3707590|FG000|Overall Study|Withdrawal by Subject|1
2112508|NCT00909363|3707591|FG001|Overall Study|Withdrawal by Subject|0
2112509|NCT00909363|3707592|FG002|Overall Study|Withdrawal by Subject|0
2112510|NCT00909363|3707590|FG000|Overall Study|Lack of Efficacy|1
2112511|NCT00909363|3707591|FG001|Overall Study|Lack of Efficacy|0
2112512|NCT00909363|3707592|FG002|Overall Study|Lack of Efficacy|0
2112513|NCT00909428|3707606|FG000|Overall Study|Lost to Follow-up|13
2035481|NCT00407745|3605866|FG000|Overall Study|Protocol Violation|5
2035482|NCT00407745|3605867|FG001|Overall Study|Protocol Violation|3
2035483|NCT00407745|3605866|FG000|Overall Study|Adverse Event|8
2035484|NCT00407745|3605867|FG001|Overall Study|Adverse Event|8
2035485|NCT00407745|3605866|FG000|Overall Study|Other|2
2035486|NCT00407745|3605867|FG001|Overall Study|Other|0
2035487|NCT00407745|3605866|FG000|Overall Study|Randomized, unknown if treated|0
2035488|NCT00407745|3605867|FG001|Overall Study|Randomized, unknown if treated|1
2035489|NCT00407758|3605873|FG000|Overall Study|ineligible -improper prior treatment|1
2035490|NCT00407797|3605877|FG000|Overall Study|Lost to Follow-up|2
2035491|NCT00407797|3605877|FG000|Overall Study|Adverse Event|6
2035492|NCT00407797|3605877|FG000|Overall Study|Other|7
2035493|NCT00407797|3605877|FG000|Overall Study|Withdrawal by Subject|3
2112514|NCT00909428|3707607|FG001|Overall Study|Lost to Follow-up|10
2112515|NCT00909428|3707608|FG002|Overall Study|Lost to Follow-up|9
2112516|NCT00909480|3707617|FG000|Overall Study|Adverse Event|5
2112517|NCT00909480|3707618|FG001|Overall Study|Adverse Event|3
2112518|NCT00909480|3707617|FG000|Overall Study|Protocol Violation|6
2112519|NCT00909480|3707618|FG001|Overall Study|Protocol Violation|8
2112520|NCT00909480|3707617|FG000|Overall Study|Withdrawal criteria|9
2112521|NCT00909480|3707618|FG001|Overall Study|Withdrawal criteria|11
2112522|NCT00909480|3707617|FG000|Overall Study|Unclassified|18
2112523|NCT00909480|3707618|FG001|Overall Study|Unclassified|19
2112524|NCT00909532|3707626|FG000|Overall Study|Adverse Event|4
2112525|NCT00909532|3707627|FG001|Overall Study|Adverse Event|1
2112526|NCT00909532|3707626|FG000|Overall Study|Pregnancy|0
2112527|NCT00909532|3707627|FG001|Overall Study|Pregnancy|1
2112528|NCT00909532|3707626|FG000|Overall Study|Prohibited Medication|2
2112529|NCT00909532|3707627|FG001|Overall Study|Prohibited Medication|1
2112530|NCT00909532|3707626|FG000|Overall Study|Withdrawal of Consent|1
2112531|NCT00909532|3707627|FG001|Overall Study|Withdrawal of Consent|1
2112532|NCT00909532|3707626|FG000|Overall Study|Noncompliance with Study Requirements|0
2112533|NCT00909532|3707627|FG001|Overall Study|Noncompliance with Study Requirements|2
2112534|NCT00909532|3707626|FG000|Overall Study|Physician Decision|1
2112535|NCT00909532|3707627|FG001|Overall Study|Physician Decision|0
2112536|NCT00909532|3707626|FG000|Overall Study|Wrong Genotype|1
2112537|NCT00909532|3707627|FG001|Overall Study|Wrong Genotype|0
2112538|NCT00909532|3707626|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
2112539|NCT00909532|3707627|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
2112540|NCT00909727|3707654|FG000|Overall Study|Adverse Event|1
2112541|NCT00909727|3707655|FG001|Overall Study|Adverse Event|0
2112542|NCT00909727|3707654|FG000|Overall Study|Wrong Genotype|1
2112543|NCT00909727|3707655|FG001|Overall Study|Wrong Genotype|0
2112544|NCT00909727|3707654|FG000|Overall Study|Withdrawal of Consent|1
2112545|NCT00909727|3707655|FG001|Overall Study|Withdrawal of Consent|0
2112546|NCT00909727|3707654|FG000|Overall Study|Prohibited Medication|1
2112547|NCT00909727|3707655|FG001|Overall Study|Prohibited Medication|0
2112548|NCT00909779|3707663|FG000|Overall Study|Adverse Event|53
2112549|NCT00909779|3707664|FG001|Overall Study|Adverse Event|55
2112550|NCT00909779|3707663|FG000|Overall Study|Lack of Efficacy|7
2112551|NCT00909779|3707664|FG001|Overall Study|Lack of Efficacy|4
2112552|NCT00909779|3707663|FG000|Overall Study|Lost to Follow-up|19
2112553|NCT00909779|3707664|FG001|Overall Study|Lost to Follow-up|15
2112554|NCT00909779|3707663|FG000|Overall Study|Physician Decision|8
2112555|NCT00909779|3707664|FG001|Overall Study|Physician Decision|2
2112556|NCT00909779|3707663|FG000|Overall Study|Protocol Violation|2
2112557|NCT00909779|3707664|FG001|Overall Study|Protocol Violation|5
2112558|NCT00909779|3707663|FG000|Overall Study|Withdrawal by Subject|116
2112559|NCT00909779|3707664|FG001|Overall Study|Withdrawal by Subject|80
2112560|NCT00909779|3707663|FG000|Overall Study|Site Ceasing Operation|2
2112561|NCT00909779|3707664|FG001|Overall Study|Site Ceasing Operation|2
2112562|NCT00909779|3707663|FG000|Overall Study|Medical Monitor Decision|1
2112563|NCT00909779|3707664|FG001|Overall Study|Medical Monitor Decision|0
2112564|NCT00909779|3707663|FG000|Overall Study|Noncompliance|1
2112565|NCT00909779|3707664|FG001|Overall Study|Noncompliance|1
2112566|NCT00909779|3707663|FG000|Overall Study|Randomized in error|1
2112567|NCT00909779|3707664|FG001|Overall Study|Randomized in error|1
2112568|NCT00909792|3707672|FG000|Period 1|Did not meet inclusion criteria|0
2112569|NCT00909792|3707673|FG001|Period 1|Did not meet inclusion criteria|1
2112570|NCT00909792|3707672|FG000|Period 2|Biomicroscopy|1
2112571|NCT00909792|3707673|FG001|Period 2|Biomicroscopy|0
2112572|NCT00909792|3707672|FG000|Period 2|Lost to Follow-up|0
2112573|NCT00909792|3707673|FG001|Period 2|Lost to Follow-up|1
2112574|NCT00909844|3707679|FG000|Overall Study|Adverse Event|1
2112575|NCT00909844|3707679|FG000|Overall Study|Withdrawal by Subject|1
2112576|NCT00909844|3707679|FG000|Overall Study|Lost to Follow-up|2
2112577|NCT00909857|3707686|FG000|Overall Study|Withdrawal by Subject|6
2112578|NCT00909857|3707687|FG001|Overall Study|Withdrawal by Subject|10
2112579|NCT00909857|3707686|FG000|Overall Study|Adverse Event|5
2112580|NCT00909857|3707687|FG001|Overall Study|Adverse Event|5
2112581|NCT00909857|3707686|FG000|Overall Study|Lost to Follow-up|2
2112582|NCT00909857|3707687|FG001|Overall Study|Lost to Follow-up|5
2112583|NCT00909857|3707686|FG000|Overall Study|Protocol Violation|2
2112584|NCT00909857|3707687|FG001|Overall Study|Protocol Violation|1
2112585|NCT00909857|3707686|FG000|Overall Study|Pregnancy|1
2035494|NCT00408005|3605891|FG000|Induction|Adverse Event|19
2035495|NCT00408005|3605892|FG001|Induction|Adverse Event|3
2035496|NCT00408005|3605893|FG002|Induction|Adverse Event|0
2035497|NCT00408005|3605894|FG003|Induction|Adverse Event|0
2035498|NCT00408005|3605895|FG004|Induction|Adverse Event|0
2035499|NCT00408005|3605896|FG005|Induction|Adverse Event|0
2035500|NCT00408005|3605897|FG006|Induction|Adverse Event|0
2035501|NCT00408005|3605898|FG007|Induction|Adverse Event|0
2035502|NCT00408005|3605891|FG000|Induction|Death|6
2035503|NCT00408005|3605892|FG001|Induction|Death|0
2035504|NCT00408005|3605893|FG002|Induction|Death|0
2035505|NCT00408005|3605894|FG003|Induction|Death|0
2035506|NCT00408005|3605895|FG004|Induction|Death|0
2035507|NCT00408005|3605896|FG005|Induction|Death|0
2035508|NCT00408005|3605897|FG006|Induction|Death|0
2035509|NCT00408005|3605898|FG007|Induction|Death|0
2035510|NCT00408005|3605891|FG000|Induction|Physician Decision|83
2035511|NCT00408005|3605892|FG001|Induction|Physician Decision|9
2035512|NCT00408005|3605893|FG002|Induction|Physician Decision|0
2035513|NCT00408005|3605894|FG003|Induction|Physician Decision|0
2035514|NCT00408005|3605895|FG004|Induction|Physician Decision|0
2035515|NCT00408005|3605896|FG005|Induction|Physician Decision|0
2035516|NCT00408005|3605897|FG006|Induction|Physician Decision|0
2035517|NCT00408005|3605898|FG007|Induction|Physician Decision|0
2035518|NCT00408005|3605891|FG000|Induction|Withdrawal by Subject|2
2035519|NCT00408005|3605892|FG001|Induction|Withdrawal by Subject|4
2035520|NCT00408005|3605893|FG002|Induction|Withdrawal by Subject|0
2035521|NCT00408005|3605894|FG003|Induction|Withdrawal by Subject|0
2035522|NCT00408005|3605895|FG004|Induction|Withdrawal by Subject|0
2035523|NCT00408005|3605896|FG005|Induction|Withdrawal by Subject|0
2035524|NCT00408005|3605897|FG006|Induction|Withdrawal by Subject|0
2035525|NCT00408005|3605898|FG007|Induction|Withdrawal by Subject|0
2035526|NCT00408005|3605891|FG000|Induction|Ineligible|33
2035527|NCT00408005|3605892|FG001|Induction|Ineligible|14
2035528|NCT00408005|3605893|FG002|Induction|Ineligible|0
2112586|NCT00909857|3707687|FG001|Overall Study|Pregnancy|0
2112587|NCT00909857|3707686|FG000|Overall Study|Other|1
2112588|NCT00909857|3707687|FG001|Overall Study|Other|0
2112589|NCT00909857|3707686|FG000|Overall Study|Did not receive study medication|19
2112590|NCT00909857|3707687|FG001|Overall Study|Did not receive study medication|24
2112591|NCT00909870|3707695|FG000|Overall Study|Adverse Event|13
2112592|NCT00909870|3707696|FG001|Overall Study|Adverse Event|7
2112593|NCT00909870|3707695|FG000|Overall Study|Protocol Violation|1
2112594|NCT00909870|3707696|FG001|Overall Study|Protocol Violation|2
2112595|NCT00909870|3707695|FG000|Overall Study|Withdrawal by Subject|5
2112596|NCT00909870|3707696|FG001|Overall Study|Withdrawal by Subject|8
2112597|NCT00909870|3707695|FG000|Overall Study|Lost to Follow-up|3
2112598|NCT00909870|3707696|FG001|Overall Study|Lost to Follow-up|3
2112599|NCT00909870|3707695|FG000|Overall Study|Physician Decision|0
2112600|NCT00909870|3707696|FG001|Overall Study|Physician Decision|2
2112601|NCT00909870|3707695|FG000|Overall Study|Other|1
2112602|NCT00909870|3707696|FG001|Overall Study|Other|5
2112603|NCT00910000|3707709|FG000|Overall Study|Adverse Event|0
2112604|NCT00910000|3707710|FG001|Overall Study|Adverse Event|3
2112605|NCT00910000|3707711|FG002|Overall Study|Adverse Event|2
2112606|NCT00910000|3707712|FG003|Overall Study|Adverse Event|2
2112607|NCT00910000|3707713|FG004|Overall Study|Adverse Event|0
2112608|NCT00910000|3707714|FG005|Overall Study|Adverse Event|1
2112609|NCT00910000|3707709|FG000|Overall Study|Withdrawal by Subject|0
2112610|NCT00910000|3707710|FG001|Overall Study|Withdrawal by Subject|0
2112611|NCT00910000|3707711|FG002|Overall Study|Withdrawal by Subject|1
2112612|NCT00910000|3707712|FG003|Overall Study|Withdrawal by Subject|0
2112613|NCT00910000|3707713|FG004|Overall Study|Withdrawal by Subject|1
2112614|NCT00910000|3707714|FG005|Overall Study|Withdrawal by Subject|0
2112615|NCT00910039|3707724|FG000|Overall Study|Physician Decision|1
2112616|NCT00910091|3707731|FG000|Pre-assignment|Withdrawal by Subject|0
2112617|NCT00910091|3707732|FG001|Pre-assignment|Withdrawal by Subject|2
2112618|NCT00910091|3707731|FG000|Treatment and Survival|Withdrawal by Subject|3
2112619|NCT00910091|3707732|FG001|Treatment and Survival|Withdrawal by Subject|4
2112620|NCT00910091|3707731|FG000|Treatment and Survival|Adverse Event|1
2112621|NCT00910091|3707732|FG001|Treatment and Survival|Adverse Event|0
2112622|NCT00910247|3707752|FG000|Overall Study|Adverse Event|15
2112623|NCT00910247|3707752|FG000|Overall Study|Death|2
2112624|NCT00910247|3707752|FG000|Overall Study|Lost to Follow-up|10
2112625|NCT00910247|3707752|FG000|Overall Study|Physician Decision|3
2112626|NCT00910247|3707752|FG000|Overall Study|Protocol Violation|10
2035529|NCT00408005|3605894|FG003|Induction|Ineligible|0
2035530|NCT00408005|3605895|FG004|Induction|Ineligible|0
2035531|NCT00408005|3605896|FG005|Induction|Ineligible|0
2035532|NCT00408005|3605897|FG006|Induction|Ineligible|0
2035533|NCT00408005|3605898|FG007|Induction|Ineligible|0
2035534|NCT00408005|3605891|FG000|Induction|Refusal of Further Protocol Therapy|225
2035535|NCT00408005|3605892|FG001|Induction|Refusal of Further Protocol Therapy|44
2035536|NCT00408005|3605893|FG002|Induction|Refusal of Further Protocol Therapy|0
2035537|NCT00408005|3605894|FG003|Induction|Refusal of Further Protocol Therapy|0
2112627|NCT00910247|3707752|FG000|Overall Study|Withdrawal by Subject|25
2112628|NCT00910247|3707752|FG000|Overall Study|Not collected|4
2112629|NCT00910273|3707758|FG000|Overall Study|Lack of Efficacy|6
2112630|NCT00910273|3707759|FG001|Overall Study|Lack of Efficacy|9
2035538|NCT00408005|3605895|FG004|Induction|Refusal of Further Protocol Therapy|0
2035539|NCT00408005|3605896|FG005|Induction|Refusal of Further Protocol Therapy|0
2035540|NCT00408005|3605897|FG006|Induction|Refusal of Further Protocol Therapy|0
2035541|NCT00408005|3605898|FG007|Induction|Refusal of Further Protocol Therapy|0
2035542|NCT00408005|3605891|FG000|Induction|Entered another COG therapeutic protocol|4
2035543|NCT00408005|3605892|FG001|Induction|Entered another COG therapeutic protocol|0
2035544|NCT00408005|3605893|FG002|Induction|Entered another COG therapeutic protocol|0
2035545|NCT00408005|3605894|FG003|Induction|Entered another COG therapeutic protocol|0
2035546|NCT00408005|3605895|FG004|Induction|Entered another COG therapeutic protocol|0
2035547|NCT00408005|3605896|FG005|Induction|Entered another COG therapeutic protocol|0
2035548|NCT00408005|3605897|FG006|Induction|Entered another COG therapeutic protocol|0
2035549|NCT00408005|3605898|FG007|Induction|Entered another COG therapeutic protocol|0
2035550|NCT00408005|3605891|FG000|Induction|Patient transferred Tx to Non-COG Site|3
2035551|NCT00408005|3605892|FG001|Induction|Patient transferred Tx to Non-COG Site|2
2035552|NCT00408005|3605893|FG002|Induction|Patient transferred Tx to Non-COG Site|0
2035553|NCT00408005|3605894|FG003|Induction|Patient transferred Tx to Non-COG Site|0
2035554|NCT00408005|3605895|FG004|Induction|Patient transferred Tx to Non-COG Site|0
2035555|NCT00408005|3605896|FG005|Induction|Patient transferred Tx to Non-COG Site|0
2035556|NCT00408005|3605897|FG006|Induction|Patient transferred Tx to Non-COG Site|0
2112631|NCT00910273|3707758|FG000|Overall Study|Adverse Event|1
2112632|NCT00910273|3707759|FG001|Overall Study|Adverse Event|1
2112633|NCT00910273|3707758|FG000|Overall Study|Withdrawal by Subject|1
2112634|NCT00910273|3707759|FG001|Overall Study|Withdrawal by Subject|0
2112635|NCT00910273|3707758|FG000|Overall Study|Discontinuation of study by sponsor|8
2112636|NCT00910273|3707759|FG001|Overall Study|Discontinuation of study by sponsor|2
2112637|NCT00910273|3707758|FG000|Overall Study|Protocol Violation|1
2112638|NCT00910273|3707759|FG001|Overall Study|Protocol Violation|0
2112639|NCT00910273|3707758|FG000|Overall Study|Lost to Follow-up|1
2112640|NCT00910273|3707759|FG001|Overall Study|Lost to Follow-up|1
2112641|NCT00910299|3707767|FG000|Overall Study|Withdrawal by Subject|16
2112642|NCT00910299|3707768|FG001|Overall Study|Withdrawal by Subject|13
2112643|NCT00910299|3707767|FG000|Overall Study|Sponsor Decision|58
2112644|NCT00910299|3707768|FG001|Overall Study|Sponsor Decision|60
2112645|NCT00910299|3707767|FG000|Overall Study|Didn't receive any study drug|2
2112646|NCT00910299|3707768|FG001|Overall Study|Didn't receive any study drug|1
2112647|NCT00910429|3707776|FG000|Overall Study|Death|18
2112648|NCT00910429|3707777|FG001|Overall Study|Death|12
2112649|NCT00910429|3707776|FG000|Overall Study|Withdrawal by Subject|3
2112650|NCT00910429|3707777|FG001|Overall Study|Withdrawal by Subject|2
2112651|NCT00910429|3707776|FG000|Overall Study|Protocol Violation|1
2112652|NCT00910429|3707777|FG001|Overall Study|Protocol Violation|0
2112653|NCT00910429|3707776|FG000|Overall Study|Lost to Follow-up|2
2112654|NCT00910429|3707777|FG001|Overall Study|Lost to Follow-up|1
2112655|NCT00910429|3707776|FG000|Overall Study|Adverse Event|10
2112656|NCT00910429|3707777|FG001|Overall Study|Adverse Event|5
2112657|NCT00910429|3707776|FG000|Overall Study|Drug non-compliance|1
2112658|NCT00910429|3707777|FG001|Overall Study|Drug non-compliance|0
2112659|NCT00910429|3707776|FG000|Overall Study|Lack of Efficacy|4
2112660|NCT00910429|3707777|FG001|Overall Study|Lack of Efficacy|1
2112661|NCT00910624|3707805|FG000|Treatment Phase|Adverse Event|2
2112662|NCT00910624|3707806|FG001|Treatment Phase|Adverse Event|6
2112663|NCT00910624|3707807|FG002|Treatment Phase|Adverse Event|6
2112664|NCT00910624|3707808|FG003|Treatment Phase|Adverse Event|0
2112665|NCT00910624|3707805|FG000|Treatment Phase|Treatment Failure|23
2112666|NCT00910624|3707806|FG001|Treatment Phase|Treatment Failure|10
2112667|NCT00910624|3707807|FG002|Treatment Phase|Treatment Failure|0
2112668|NCT00910624|3707808|FG003|Treatment Phase|Treatment Failure|0
2112669|NCT00910624|3707805|FG000|Treatment Phase|Lost to Follow-up|0
2112670|NCT00910624|3707806|FG001|Treatment Phase|Lost to Follow-up|0
2112671|NCT00910624|3707807|FG002|Treatment Phase|Lost to Follow-up|1
2112672|NCT00910624|3707808|FG003|Treatment Phase|Lost to Follow-up|0
2112673|NCT00910624|3707805|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
2112674|NCT00910624|3707806|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
2112675|NCT00910624|3707807|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
2112676|NCT00910624|3707808|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
2112677|NCT00910624|3707805|FG000|Treatment Phase|Withdrawal by Subject|2
2112678|NCT00910624|3707806|FG001|Treatment Phase|Withdrawal by Subject|1
2112679|NCT00910624|3707807|FG002|Treatment Phase|Withdrawal by Subject|0
2112680|NCT00910624|3707808|FG003|Treatment Phase|Withdrawal by Subject|0
2112681|NCT00910624|3707805|FG000|Treatment Phase|Non-Compliance With Protocol|0
2112682|NCT00910624|3707806|FG001|Treatment Phase|Non-Compliance With Protocol|1
2112683|NCT00910624|3707807|FG002|Treatment Phase|Non-Compliance With Protocol|1
2112684|NCT00910624|3707808|FG003|Treatment Phase|Non-Compliance With Protocol|0
2112685|NCT00910624|3707805|FG000|Follow-Up Phase|Adverse Event|0
2112686|NCT00910624|3707806|FG001|Follow-Up Phase|Adverse Event|0
2112687|NCT00910624|3707807|FG002|Follow-Up Phase|Adverse Event|1
2112688|NCT00910624|3707808|FG003|Follow-Up Phase|Adverse Event|0
2112689|NCT00910624|3707805|FG000|Follow-Up Phase|Lost to Follow-up|3
2112690|NCT00910624|3707806|FG001|Follow-Up Phase|Lost to Follow-up|1
2112691|NCT00910624|3707807|FG002|Follow-Up Phase|Lost to Follow-up|2
2112692|NCT00910624|3707808|FG003|Follow-Up Phase|Lost to Follow-up|0
2035557|NCT00408005|3605898|FG007|Induction|Patient transferred Tx to Non-COG Site|0
2035558|NCT00408005|3605891|FG000|Induction|Identified as Philadelphia Chr. Positive|6
2035559|NCT00408005|3605892|FG001|Induction|Identified as Philadelphia Chr. Positive|0
2035560|NCT00408005|3605893|FG002|Induction|Identified as Philadelphia Chr. Positive|0
2035561|NCT00408005|3605894|FG003|Induction|Identified as Philadelphia Chr. Positive|0
2035562|NCT00408005|3605895|FG004|Induction|Identified as Philadelphia Chr. Positive|0
2035563|NCT00408005|3605896|FG005|Induction|Identified as Philadelphia Chr. Positive|0
2035564|NCT00408005|3605897|FG006|Induction|Identified as Philadelphia Chr. Positive|0
2035565|NCT00408005|3605898|FG007|Induction|Identified as Philadelphia Chr. Positive|0
2035566|NCT00408005|3605891|FG000|Induction|Progressive Disease|0
2035567|NCT00408005|3605892|FG001|Induction|Progressive Disease|1
2035568|NCT00408005|3605893|FG002|Induction|Progressive Disease|0
2035569|NCT00408005|3605894|FG003|Induction|Progressive Disease|0
2035570|NCT00408005|3605895|FG004|Induction|Progressive Disease|0
2035571|NCT00408005|3605896|FG005|Induction|Progressive Disease|0
2035572|NCT00408005|3605897|FG006|Induction|Progressive Disease|0
2035573|NCT00408005|3605898|FG007|Induction|Progressive Disease|0
2035574|NCT00408005|3605891|FG000|Induction|Inevaluable|18
2035575|NCT00408005|3605892|FG001|Induction|Inevaluable|14
2035576|NCT00408005|3605893|FG002|Induction|Inevaluable|0
2035577|NCT00408005|3605894|FG003|Induction|Inevaluable|0
2035578|NCT00408005|3605895|FG004|Induction|Inevaluable|0
2035579|NCT00408005|3605896|FG005|Induction|Inevaluable|0
2035580|NCT00408005|3605897|FG006|Induction|Inevaluable|0
2035581|NCT00408005|3605898|FG007|Induction|Inevaluable|0
2035582|NCT00408005|3605891|FG000|Induction|Failed to Complete Randomization|3
2035583|NCT00408005|3605892|FG001|Induction|Failed to Complete Randomization|2
2035584|NCT00408005|3605893|FG002|Induction|Failed to Complete Randomization|0
2035585|NCT00408005|3605894|FG003|Induction|Failed to Complete Randomization|0
2035586|NCT00408005|3605895|FG004|Induction|Failed to Complete Randomization|0
2035587|NCT00408005|3605896|FG005|Induction|Failed to Complete Randomization|0
2035588|NCT00408005|3605897|FG006|Induction|Failed to Complete Randomization|0
2035589|NCT00408005|3605898|FG007|Induction|Failed to Complete Randomization|0
2035590|NCT00408005|3605891|FG000|Induction|Protocol Deviation|3
2035591|NCT00408005|3605892|FG001|Induction|Protocol Deviation|1
2035592|NCT00408005|3605893|FG002|Induction|Protocol Deviation|0
2035593|NCT00408005|3605894|FG003|Induction|Protocol Deviation|0
2035594|NCT00408005|3605895|FG004|Induction|Protocol Deviation|0
2035595|NCT00408005|3605896|FG005|Induction|Protocol Deviation|0
2035596|NCT00408005|3605897|FG006|Induction|Protocol Deviation|0
2035597|NCT00408005|3605898|FG007|Induction|Protocol Deviation|0
2035598|NCT00408005|3605891|FG000|Induction|Hematopoietic Stem Cell Transplantation|1
2035599|NCT00408005|3605892|FG001|Induction|Hematopoietic Stem Cell Transplantation|0
2035600|NCT00408005|3605893|FG002|Induction|Hematopoietic Stem Cell Transplantation|0
2035601|NCT00408005|3605894|FG003|Induction|Hematopoietic Stem Cell Transplantation|0
2035602|NCT00408005|3605895|FG004|Induction|Hematopoietic Stem Cell Transplantation|0
2035603|NCT00408005|3605896|FG005|Induction|Hematopoietic Stem Cell Transplantation|0
2035604|NCT00408005|3605897|FG006|Induction|Hematopoietic Stem Cell Transplantation|0
2035605|NCT00408005|3605898|FG007|Induction|Hematopoietic Stem Cell Transplantation|0
2035606|NCT00408005|3605891|FG000|Induction|Recurrent leukemia|1
2035607|NCT00408005|3605892|FG001|Induction|Recurrent leukemia|0
2035608|NCT00408005|3605893|FG002|Induction|Recurrent leukemia|0
2035609|NCT00408005|3605894|FG003|Induction|Recurrent leukemia|0
2035610|NCT00408005|3605895|FG004|Induction|Recurrent leukemia|0
2035611|NCT00408005|3605896|FG005|Induction|Recurrent leukemia|0
2035612|NCT00408005|3605897|FG006|Induction|Recurrent leukemia|0
2035613|NCT00408005|3605898|FG007|Induction|Recurrent leukemia|0
2035614|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
2035615|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0
2035616|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7
2035617|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4
2035618|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8
2035619|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12
2035620|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2
2035621|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0
2112693|NCT00910624|3707805|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
2112694|NCT00910624|3707806|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
2112695|NCT00910624|3707807|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
2112696|NCT00910624|3707808|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
2112697|NCT00910624|3707805|FG000|Follow-Up Phase|Withdrawal by Subject|1
2112698|NCT00910624|3707806|FG001|Follow-Up Phase|Withdrawal by Subject|0
2112699|NCT00910624|3707807|FG002|Follow-Up Phase|Withdrawal by Subject|0
2112700|NCT00910624|3707808|FG003|Follow-Up Phase|Withdrawal by Subject|0
2112701|NCT00910624|3707805|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
2112702|NCT00910624|3707806|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
2112703|NCT00910624|3707807|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
2112704|NCT00910624|3707808|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
2112705|NCT00910624|3707805|FG000|Follow-Up Phase|Administrative|0
2112706|NCT00910624|3707806|FG001|Follow-Up Phase|Administrative|1
2035622|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Death|0
2035623|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Death|0
2035624|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Death|3
2035625|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Death|0
2035626|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Death|5
2035627|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Death|5
2035628|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Death|3
2035629|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Death|1
2035630|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2035631|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2035632|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
2035633|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2035634|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
2035635|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2035636|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2112707|NCT00910624|3707807|FG002|Follow-Up Phase|Administrative|1
2112708|NCT00910624|3707808|FG003|Follow-Up Phase|Administrative|0
2112709|NCT00910663|3707818|FG000|Period 1|Withdrawal by Subject|0
2112710|NCT00910663|3707819|FG001|Period 1|Withdrawal by Subject|1
2112711|NCT00910689|3707829|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
2112712|NCT00910689|3707830|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
2112713|NCT00910689|3707831|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
2112714|NCT00910689|3707832|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
2112715|NCT00910689|3707829|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3
2112716|NCT00910689|3707830|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4
2112717|NCT00910689|3707831|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1
2112718|NCT00910689|3707832|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3
2112719|NCT00910689|3707829|FG000|Month 2- 4: Treatment Period|Adverse Event|2
2112720|NCT00910689|3707830|FG001|Month 2- 4: Treatment Period|Adverse Event|3
2112721|NCT00910689|3707831|FG002|Month 2- 4: Treatment Period|Adverse Event|2
2112722|NCT00910689|3707832|FG003|Month 2- 4: Treatment Period|Adverse Event|0
2112723|NCT00910689|3707829|FG000|Month 2- 4: Treatment Period|Time Demands|1
2112724|NCT00910689|3707830|FG001|Month 2- 4: Treatment Period|Time Demands|0
2112725|NCT00910689|3707831|FG002|Month 2- 4: Treatment Period|Time Demands|4
2218998|NCT01717976|3862660|FG000|Overall Study|Protocol Violation|0
2218999|NCT01717976|3862661|FG001|Overall Study|Protocol Violation|1
2219000|NCT01717989|3862667|FG000|Overall Study|Ineligibility determined|6
2219001|NCT01717989|3862667|FG000|Overall Study|Protocol deviation|6
2112726|NCT00910689|3707832|FG003|Month 2- 4: Treatment Period|Time Demands|8
2112727|NCT00910689|3707829|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2
2112728|NCT00910689|3707830|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1
2112729|NCT00910689|3707831|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0
2112730|NCT00910689|3707832|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0
2112731|NCT00910689|3707829|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0
2112732|NCT00910689|3707830|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0
2112733|NCT00910689|3707831|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1
2112734|NCT00910689|3707832|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0
2112735|NCT00910689|3707829|FG000|Month 2- 4: Treatment Period|Pregnancy|0
2112736|NCT00910689|3707830|FG001|Month 2- 4: Treatment Period|Pregnancy|2
2112737|NCT00910689|3707831|FG002|Month 2- 4: Treatment Period|Pregnancy|0
2112738|NCT00910689|3707832|FG003|Month 2- 4: Treatment Period|Pregnancy|0
2112739|NCT00910689|3707829|FG000|Month 2- 4: Treatment Period|Protocol Violation|1
2112740|NCT00910689|3707830|FG001|Month 2- 4: Treatment Period|Protocol Violation|0
2112741|NCT00910689|3707831|FG002|Month 2- 4: Treatment Period|Protocol Violation|0
2112742|NCT00910689|3707832|FG003|Month 2- 4: Treatment Period|Protocol Violation|0
2112743|NCT00910689|3707829|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
2112744|NCT00910689|3707830|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
2112745|NCT00910689|3707831|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
2112746|NCT00910689|3707832|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
2112747|NCT00910689|3707829|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1
2112748|NCT00910689|3707830|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0
2112749|NCT00910689|3707831|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2
2180456|NCT01401842|3806634|FG001|Overall Study|discharged from US Army|4
2180457|NCT01401842|3806633|FG000|Overall Study|invalid follow-up strength data|1
2180458|NCT01401842|3806634|FG001|Overall Study|invalid follow-up strength data|4
2180459|NCT01401842|3806633|FG000|Overall Study|on profile|9
2180460|NCT01401842|3806634|FG001|Overall Study|on profile|5
2180461|NCT01401842|3806633|FG000|Overall Study|other/unknown|28
2180462|NCT01401842|3806634|FG001|Overall Study|other/unknown|17
2180463|NCT01401959|3806654|FG000|Enrolled|Withdrawal by Subject|1
2180464|NCT01401959|3806655|FG001|Enrolled|Withdrawal by Subject|0
2180465|NCT01401959|3806656|FG002|Enrolled|Withdrawal by Subject|0
2180466|NCT01401959|3806654|FG000|Treated|Disease Progression|2
2180467|NCT01401959|3806655|FG001|Treated|Disease Progression|2
2180468|NCT01401959|3806656|FG002|Treated|Disease Progression|1
2219002|NCT01717989|3862667|FG000|Overall Study|Withdrawal by Subject|11
2219003|NCT01717989|3862667|FG000|Overall Study|Physician Decision|2
2035637|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2035638|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
2035639|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0
2035640|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24
2035641|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19
2035642|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27
2035643|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45
2035644|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10
2112750|NCT00910689|3707832|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4
2112751|NCT00910689|3707829|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
2112752|NCT00910689|3707830|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
2112753|NCT00910689|3707831|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
2112754|NCT00910689|3707832|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
2112755|NCT00910689|3707829|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1
2112756|NCT00910689|3707830|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1
2112757|NCT00910689|3707831|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0
2112758|NCT00910689|3707832|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0
2112759|NCT00910689|3707829|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0
2112760|NCT00910689|3707830|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0
2112761|NCT00910689|3707831|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2
2112762|NCT00910689|3707832|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0
2112763|NCT00910689|3707829|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0
2112764|NCT00910689|3707830|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0
2112765|NCT00910689|3707831|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1
2112766|NCT00910689|3707832|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1
2112767|NCT00910689|3707829|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
2112768|NCT00910689|3707830|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
2112769|NCT00910689|3707831|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
2112770|NCT00910689|3707832|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
2112771|NCT00910689|3707829|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2
2112772|NCT00910689|3707830|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4
2112773|NCT00910689|3707831|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2
2112774|NCT00910689|3707832|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2
2112775|NCT00910689|3707829|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1
2112776|NCT00910689|3707830|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0
2112777|NCT00910689|3707831|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0
2112778|NCT00910689|3707832|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0
2112779|NCT00910689|3707829|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
2112780|NCT00910689|3707830|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
2112781|NCT00910689|3707831|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
2112782|NCT00910689|3707832|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
2112783|NCT00910689|3707829|FG000|Months 11- 16: Evaluation Period II|Time Demands|2
2112784|NCT00910689|3707830|FG001|Months 11- 16: Evaluation Period II|Time Demands|1
2112785|NCT00910689|3707831|FG002|Months 11- 16: Evaluation Period II|Time Demands|0
2112786|NCT00910689|3707832|FG003|Months 11- 16: Evaluation Period II|Time Demands|0
2112787|NCT00910689|3707829|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0
2112788|NCT00910689|3707830|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0
2112789|NCT00910689|3707831|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0
2112790|NCT00910689|3707832|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1
2112791|NCT00910689|3707829|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0
2112792|NCT00910689|3707830|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2
2112793|NCT00910689|3707831|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1
2112794|NCT00910689|3707832|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0
2112795|NCT00910715|3707845|FG000|Overall Study|Lost to Follow-up|22
2112796|NCT00910715|3707846|FG001|Overall Study|Lost to Follow-up|26
2112797|NCT00910715|3707847|FG002|Overall Study|Lost to Follow-up|0
2112798|NCT00910728|3707866|FG000|Overall Study|Lack of Efficacy|2
2112799|NCT00910728|3707867|FG001|Overall Study|Lack of Efficacy|3
2112800|NCT00910728|3707868|FG002|Overall Study|Lack of Efficacy|1
2112801|NCT00910728|3707869|FG003|Overall Study|Lack of Efficacy|2
2180469|NCT01401959|3806654|FG000|Treated|Adverse Event|4
2180470|NCT01401959|3806655|FG001|Treated|Adverse Event|3
2180471|NCT01401959|3806656|FG002|Treated|Adverse Event|2
2180472|NCT01401959|3806654|FG000|Treated|Withdrawal by Subject|1
2180473|NCT01401959|3806655|FG001|Treated|Withdrawal by Subject|2
2180474|NCT01401959|3806656|FG002|Treated|Withdrawal by Subject|2
2180475|NCT01401959|3806654|FG000|Treated|Protocol Violation|0
2180476|NCT01401959|3806655|FG001|Treated|Protocol Violation|1
2180477|NCT01401959|3806656|FG002|Treated|Protocol Violation|0
2180478|NCT01402011|3806669|FG000|Delayed Treatment Period|Withdrawal by Subject|1
2180479|NCT01402011|3806670|FG001|Delayed Treatment Period|Withdrawal by Subject|0
2180480|NCT01402011|3806671|FG002|Delayed Treatment Period|Withdrawal by Subject|0
2180481|NCT01402011|3806669|FG000|Active Treatment Period|Withdrawal by Subject|1
2180482|NCT01402011|3806670|FG001|Active Treatment Period|Withdrawal by Subject|3
2035645|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4
2035646|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
2035647|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
2035648|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
2035649|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
2035650|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
2035651|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
2035652|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
2035653|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
2035654|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
2035655|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
2035656|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
2035657|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
2035658|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
2035659|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
2035660|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
2035661|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
2035662|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2035663|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2035664|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2035665|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2035666|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
2035667|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2035668|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2035669|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2035670|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
2035671|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
2035672|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
2035673|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
2035674|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
2035675|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
2035676|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
2035677|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
2035678|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0
2035679|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0
2112802|NCT00910728|3707870|FG004|Overall Study|Lack of Efficacy|1
2112803|NCT00910728|3707871|FG005|Overall Study|Lack of Efficacy|0
2112804|NCT00910728|3707872|FG006|Overall Study|Lack of Efficacy|2
2112805|NCT00910728|3707873|FG007|Overall Study|Lack of Efficacy|2
2112806|NCT00910728|3707874|FG008|Overall Study|Lack of Efficacy|2
2112807|NCT00910728|3707866|FG000|Overall Study|Withdrawal by Subject|0
2112808|NCT00910728|3707867|FG001|Overall Study|Withdrawal by Subject|0
2112809|NCT00910728|3707868|FG002|Overall Study|Withdrawal by Subject|0
2112810|NCT00910728|3707869|FG003|Overall Study|Withdrawal by Subject|0
2112811|NCT00910728|3707870|FG004|Overall Study|Withdrawal by Subject|3
2112812|NCT00910728|3707871|FG005|Overall Study|Withdrawal by Subject|1
2112813|NCT00910728|3707872|FG006|Overall Study|Withdrawal by Subject|2
2112814|NCT00910728|3707873|FG007|Overall Study|Withdrawal by Subject|0
2112815|NCT00910728|3707874|FG008|Overall Study|Withdrawal by Subject|0
2112816|NCT00910728|3707866|FG000|Overall Study|(not specified)|2
2112817|NCT00910728|3707867|FG001|Overall Study|(not specified)|0
2112818|NCT00910728|3707868|FG002|Overall Study|(not specified)|1
2112819|NCT00910728|3707869|FG003|Overall Study|(not specified)|0
2112820|NCT00910728|3707870|FG004|Overall Study|(not specified)|1
2112821|NCT00910728|3707871|FG005|Overall Study|(not specified)|0
2112822|NCT00910728|3707872|FG006|Overall Study|(not specified)|0
2112823|NCT00910728|3707873|FG007|Overall Study|(not specified)|0
2112824|NCT00910728|3707874|FG008|Overall Study|(not specified)|0
2112825|NCT00910728|3707866|FG000|Overall Study|Adverse Event|2
2112826|NCT00910728|3707867|FG001|Overall Study|Adverse Event|0
2112827|NCT00910728|3707868|FG002|Overall Study|Adverse Event|1
2112828|NCT00910728|3707869|FG003|Overall Study|Adverse Event|1
2112829|NCT00910728|3707870|FG004|Overall Study|Adverse Event|0
2112830|NCT00910728|3707871|FG005|Overall Study|Adverse Event|0
2112831|NCT00910728|3707872|FG006|Overall Study|Adverse Event|2
2112832|NCT00910728|3707873|FG007|Overall Study|Adverse Event|1
2112833|NCT00910728|3707874|FG008|Overall Study|Adverse Event|1
2112834|NCT00910858|3707906|FG000|Pharmacokinetic Phase|Adverse Event|1
2112835|NCT00910858|3707907|FG001|Pharmacokinetic Phase|Adverse Event|0
2112836|NCT00910858|3707908|FG002|Pharmacokinetic Phase|Adverse Event|0
2035680|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0
2035681|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0
2035682|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1
2035683|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0
2035684|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7
2035685|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7
2035686|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0
2035687|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0
2035688|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0
2035689|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0
2035690|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0
2035691|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1
2035692|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0
2035693|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0
2035694|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
2035695|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
2035696|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
2035697|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
2035698|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
2035699|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
2035700|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
2035701|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
2035702|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2035703|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2035704|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2035705|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2035706|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
2035707|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
2035708|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2035709|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2035710|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
2035711|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
2035712|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
2035713|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
2035714|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
2035715|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
2035716|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
2035717|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
2035718|NCT00408005|3605891|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0
2035719|NCT00408005|3605892|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0
2035720|NCT00408005|3605893|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3
2035721|NCT00408005|3605894|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1
2035722|NCT00408005|3605895|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1
2035723|NCT00408005|3605896|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1
2035724|NCT00408005|3605897|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0
2035725|NCT00408005|3605898|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0
2035726|NCT00408317|3605931|FG000|First Intervention Period|Adverse Event|0
2035727|NCT00408317|3605932|FG001|First Intervention Period|Adverse Event|1
2035728|NCT00408317|3605931|FG000|Second Intervention Period|Adverse Event|2
2035729|NCT00408317|3605932|FG001|Second Intervention Period|Adverse Event|0
2035730|NCT00408317|3605931|FG000|Second Intervention Period|Protocol Violation|0
2035731|NCT00408317|3605932|FG001|Second Intervention Period|Protocol Violation|1
2035732|NCT00408317|3605931|FG000|Second Intervention Period|Withdrawal of consent|0
2035733|NCT00408317|3605932|FG001|Second Intervention Period|Withdrawal of consent|1
2035734|NCT00408408|3605944|FG000|Overall Study|No follow up data|2
2035735|NCT00408408|3605945|FG001|Overall Study|No follow up data|3
2035736|NCT00408408|3605946|FG002|Overall Study|No follow up data|0
2035737|NCT00408408|3605947|FG003|Overall Study|No follow up data|7
2035738|NCT00408408|3605948|FG004|Overall Study|No follow up data|5
2035739|NCT00408408|3605949|FG005|Overall Study|No follow up data|3
2035740|NCT00408421|3605965|FG000|Treatment Initial Randomization|Adverse Event|5
2035741|NCT00408421|3605966|FG001|Treatment Initial Randomization|Adverse Event|9
2035742|NCT00408421|3605967|FG002|Treatment Initial Randomization|Adverse Event|0
2035743|NCT00408421|3605965|FG000|Treatment Initial Randomization|Lack of Efficacy|2
2035744|NCT00408421|3605966|FG001|Treatment Initial Randomization|Lack of Efficacy|2
2035745|NCT00408421|3605967|FG002|Treatment Initial Randomization|Lack of Efficacy|0
2112837|NCT00910858|3707906|FG000|Monotherapy Phase|Adverse Event|3
2035746|NCT00408421|3605965|FG000|Treatment Initial Randomization|Lost to Follow-up|0
2035747|NCT00408421|3605966|FG001|Treatment Initial Randomization|Lost to Follow-up|3
2035748|NCT00408421|3605967|FG002|Treatment Initial Randomization|Lost to Follow-up|0
2035749|NCT00408421|3605965|FG000|Treatment Initial Randomization|Physician Decision|1
2035750|NCT00408421|3605966|FG001|Treatment Initial Randomization|Physician Decision|0
2035751|NCT00408421|3605967|FG002|Treatment Initial Randomization|Physician Decision|0
2035752|NCT00408421|3605965|FG000|Treatment Initial Randomization|Protocol Violation|0
2035753|NCT00408421|3605966|FG001|Treatment Initial Randomization|Protocol Violation|1
2035754|NCT00408421|3605967|FG002|Treatment Initial Randomization|Protocol Violation|0
2035755|NCT00408421|3605965|FG000|Treatment Initial Randomization|Withdrawal by Subject|7
2035756|NCT00408421|3605966|FG001|Treatment Initial Randomization|Withdrawal by Subject|7
2035757|NCT00408421|3605967|FG002|Treatment Initial Randomization|Withdrawal by Subject|0
2035758|NCT00408421|3605965|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1
2035759|NCT00408421|3605966|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0
2035760|NCT00408421|3605967|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0
2035761|NCT00408421|3605965|FG000|Treatment Initial Randomization|Sponsor Decision|1
2035762|NCT00408421|3605966|FG001|Treatment Initial Randomization|Sponsor Decision|0
2035763|NCT00408421|3605967|FG002|Treatment Initial Randomization|Sponsor Decision|0
2035764|NCT00408421|3605965|FG000|Treatment Re-Randomization|Adverse Event|2
2035765|NCT00408421|3605966|FG001|Treatment Re-Randomization|Adverse Event|2
2035766|NCT00408421|3605967|FG002|Treatment Re-Randomization|Adverse Event|4
2035767|NCT00408421|3605965|FG000|Treatment Re-Randomization|Lack of Efficacy|1
2035768|NCT00408421|3605966|FG001|Treatment Re-Randomization|Lack of Efficacy|0
2035769|NCT00408421|3605967|FG002|Treatment Re-Randomization|Lack of Efficacy|0
2035770|NCT00408421|3605965|FG000|Treatment Re-Randomization|Lost to Follow-up|0
2035771|NCT00408421|3605966|FG001|Treatment Re-Randomization|Lost to Follow-up|0
2035772|NCT00408421|3605967|FG002|Treatment Re-Randomization|Lost to Follow-up|1
2035773|NCT00408421|3605965|FG000|Treatment Re-Randomization|Physician Decision|1
2035774|NCT00408421|3605966|FG001|Treatment Re-Randomization|Physician Decision|3
2035775|NCT00408421|3605967|FG002|Treatment Re-Randomization|Physician Decision|0
2035776|NCT00408421|3605965|FG000|Treatment Re-Randomization|Protocol Violation|1
2035777|NCT00408421|3605966|FG001|Treatment Re-Randomization|Protocol Violation|1
2035778|NCT00408421|3605967|FG002|Treatment Re-Randomization|Protocol Violation|0
2035779|NCT00408421|3605965|FG000|Treatment Re-Randomization|Withdrawal by Subject|2
2035780|NCT00408421|3605966|FG001|Treatment Re-Randomization|Withdrawal by Subject|1
2035781|NCT00408421|3605967|FG002|Treatment Re-Randomization|Withdrawal by Subject|0
2035782|NCT00408434|3605982|FG000|Overall Study|Adverse Event|0
2035783|NCT00408434|3605983|FG001|Overall Study|Adverse Event|0
2035784|NCT00408434|3605984|FG002|Overall Study|Adverse Event|1
2035785|NCT00408434|3605985|FG003|Overall Study|Adverse Event|0
2035786|NCT00408434|3605986|FG004|Overall Study|Adverse Event|0
2035787|NCT00408434|3605987|FG005|Overall Study|Adverse Event|0
2035788|NCT00408434|3605988|FG006|Overall Study|Adverse Event|0
2035789|NCT00408434|3605982|FG000|Overall Study|Progressive disease|6
2035790|NCT00408434|3605983|FG001|Overall Study|Progressive disease|3
2035791|NCT00408434|3605984|FG002|Overall Study|Progressive disease|4
2035792|NCT00408434|3605985|FG003|Overall Study|Progressive disease|3
2035793|NCT00408434|3605986|FG004|Overall Study|Progressive disease|3
2035794|NCT00408434|3605987|FG005|Overall Study|Progressive disease|1
2035795|NCT00408434|3605988|FG006|Overall Study|Progressive disease|4
2035796|NCT00408434|3605982|FG000|Overall Study|Other|0
2035797|NCT00408434|3605983|FG001|Overall Study|Other|0
2035798|NCT00408434|3605984|FG002|Overall Study|Other|1
2035799|NCT00408434|3605985|FG003|Overall Study|Other|0
2035800|NCT00408434|3605986|FG004|Overall Study|Other|2
2035801|NCT00408434|3605987|FG005|Overall Study|Other|1
2112838|NCT00910858|3707907|FG001|Monotherapy Phase|Adverse Event|2
2112839|NCT00910858|3707908|FG002|Monotherapy Phase|Adverse Event|0
2112840|NCT00910858|3707906|FG000|Monotherapy Phase|Lack of therapeutic effect|9
2112841|NCT00910858|3707907|FG001|Monotherapy Phase|Lack of therapeutic effect|6
2112842|NCT00910858|3707908|FG002|Monotherapy Phase|Lack of therapeutic effect|4
2112843|NCT00910858|3707906|FG000|Monotherapy Phase|Withdrawal by Subject|1
2112844|NCT00910858|3707907|FG001|Monotherapy Phase|Withdrawal by Subject|3
2112845|NCT00910858|3707908|FG002|Monotherapy Phase|Withdrawal by Subject|1
2112846|NCT00910858|3707906|FG000|Monotherapy Phase|Protocol Violation|1
2112847|NCT00910858|3707907|FG001|Monotherapy Phase|Protocol Violation|0
2112848|NCT00910858|3707908|FG002|Monotherapy Phase|Protocol Violation|0
2112849|NCT00910858|3707906|FG000|Monotherapy Phase|Other|3
2112850|NCT00910858|3707907|FG001|Monotherapy Phase|Other|4
2112851|NCT00910858|3707908|FG002|Monotherapy Phase|Other|2
2112852|NCT00910858|3707906|FG000|Combined Treatment Phase|Lack of therapeutic effect|8
2112853|NCT00910858|3707907|FG001|Combined Treatment Phase|Lack of therapeutic effect|6
2112854|NCT00910858|3707908|FG002|Combined Treatment Phase|Lack of therapeutic effect|3
2112855|NCT00910858|3707906|FG000|Combined Treatment Phase|Withdrawal by Subject|0
2112856|NCT00910858|3707907|FG001|Combined Treatment Phase|Withdrawal by Subject|2
2112857|NCT00910858|3707908|FG002|Combined Treatment Phase|Withdrawal by Subject|0
2112858|NCT00910858|3707906|FG000|Combined Treatment Phase|Protocol Violation|1
2112859|NCT00910858|3707907|FG001|Combined Treatment Phase|Protocol Violation|0
2112860|NCT00910858|3707908|FG002|Combined Treatment Phase|Protocol Violation|0
2035802|NCT00408434|3605988|FG006|Overall Study|Other|0
2035803|NCT00408434|3605982|FG000|Overall Study|Terminated by Investigator|0
2035804|NCT00408434|3605983|FG001|Overall Study|Terminated by Investigator|0
2035805|NCT00408434|3605984|FG002|Overall Study|Terminated by Investigator|0
2035806|NCT00408434|3605985|FG003|Overall Study|Terminated by Investigator|0
2035807|NCT00408434|3605986|FG004|Overall Study|Terminated by Investigator|1
2035808|NCT00408434|3605987|FG005|Overall Study|Terminated by Investigator|1
2035809|NCT00408434|3605988|FG006|Overall Study|Terminated by Investigator|0
2035810|NCT00408499|3606009|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0
2035811|NCT00408499|3606010|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0
2035812|NCT00408499|3606011|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1
2035813|NCT00408499|3606012|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0
2035814|NCT00408499|3606013|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0
2035815|NCT00408499|3606009|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
2035816|NCT00408499|3606010|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
2035817|NCT00408499|3606011|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
2035818|NCT00408499|3606012|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
2035819|NCT00408499|3606013|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
2035820|NCT00408499|3606009|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1
2035821|NCT00408499|3606010|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1
2035822|NCT00408499|3606011|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0
2035823|NCT00408499|3606012|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0
2035824|NCT00408499|3606013|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0
2035825|NCT00408499|3606009|FG000|Phase II- MTD Expansion|Adverse Event|0
2035826|NCT00408499|3606010|FG001|Phase II- MTD Expansion|Adverse Event|0
2035827|NCT00408499|3606011|FG002|Phase II- MTD Expansion|Adverse Event|0
2035828|NCT00408499|3606012|FG003|Phase II- MTD Expansion|Adverse Event|0
2035829|NCT00408499|3606013|FG004|Phase II- MTD Expansion|Adverse Event|9
2035830|NCT00408499|3606009|FG000|Phase II- MTD Expansion|Death|0
2035831|NCT00408499|3606010|FG001|Phase II- MTD Expansion|Death|0
2035832|NCT00408499|3606011|FG002|Phase II- MTD Expansion|Death|0
2035833|NCT00408499|3606012|FG003|Phase II- MTD Expansion|Death|0
2035834|NCT00408499|3606013|FG004|Phase II- MTD Expansion|Death|2
2035835|NCT00408499|3606009|FG000|Phase II- MTD Expansion|Physician Decision|0
2035836|NCT00408499|3606010|FG001|Phase II- MTD Expansion|Physician Decision|0
2035837|NCT00408499|3606011|FG002|Phase II- MTD Expansion|Physician Decision|0
2035838|NCT00408499|3606012|FG003|Phase II- MTD Expansion|Physician Decision|0
2035839|NCT00408499|3606013|FG004|Phase II- MTD Expansion|Physician Decision|1
2035840|NCT00408499|3606009|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0
2035841|NCT00408499|3606010|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0
2112861|NCT00910858|3707906|FG000|Combined Treatment Phase|Other|0
2112862|NCT00910858|3707907|FG001|Combined Treatment Phase|Other|2
2112863|NCT00910858|3707908|FG002|Combined Treatment Phase|Other|1
2112864|NCT00910871|3707924|FG000|Overall Study|Adverse Event|5
2112865|NCT00910871|3707924|FG000|Overall Study|Death|12
2112866|NCT00910871|3707924|FG000|Overall Study|Lost to Follow-up|8
2112867|NCT00910871|3707924|FG000|Overall Study|Protocol Violation|11
2112868|NCT00910871|3707924|FG000|Overall Study|Withdrawal by Subject|12
2112869|NCT00910871|3707924|FG000|Overall Study|Subject didn't meet eligibility criteria|5
2112870|NCT00910871|3707924|FG000|Overall Study|Undefined|1
2112871|NCT00910910|3707930|FG000|Overall Study|Adverse Event|63
2112872|NCT00910910|3707931|FG001|Overall Study|Adverse Event|35
2112873|NCT00910910|3707930|FG000|Overall Study|PD without histologic change|27
2112874|NCT00910910|3707931|FG001|Overall Study|PD without histologic change|23
2112875|NCT00910910|3707930|FG000|Overall Study|PD with histologic change|0
2112876|NCT00910910|3707931|FG001|Overall Study|PD with histologic change|2
2112877|NCT00910910|3707930|FG000|Overall Study|Withdrawal by Subject|7
2112878|NCT00910910|3707931|FG001|Overall Study|Withdrawal by Subject|5
2112879|NCT00910910|3707930|FG000|Overall Study|Lost to Follow-up|2
2112880|NCT00910910|3707931|FG001|Overall Study|Lost to Follow-up|2
2112881|NCT00910910|3707930|FG000|Overall Study|Death|9
2112882|NCT00910910|3707931|FG001|Overall Study|Death|3
2112883|NCT00910910|3707930|FG000|Overall Study|Protocol Violation|2
2112884|NCT00910910|3707931|FG001|Overall Study|Protocol Violation|2
2112885|NCT00910910|3707930|FG000|Overall Study|Completed 13 cycles of treatment|0
2112886|NCT00910910|3707931|FG001|Overall Study|Completed 13 cycles of treatment|118
2112887|NCT00910910|3707930|FG000|Overall Study|Other|114
2112888|NCT00910910|3707931|FG001|Overall Study|Other|32
2112889|NCT00910910|3707930|FG000|Overall Study|Untreated before cycle 1|1
2112890|NCT00910910|3707931|FG001|Overall Study|Untreated before cycle 1|2
2112891|NCT00910962|3707940|FG000|Overall Study|Adverse Event|5
2112892|NCT00910962|3707941|FG001|Overall Study|Adverse Event|20
2112893|NCT00910962|3707942|FG002|Overall Study|Adverse Event|17
2112894|NCT00910962|3707940|FG000|Overall Study|Protocol Violation|1
2112895|NCT00910962|3707941|FG001|Overall Study|Protocol Violation|3
2112896|NCT00910962|3707942|FG002|Overall Study|Protocol Violation|3
2112897|NCT00910962|3707940|FG000|Overall Study|Lost to Follow-up|0
2112898|NCT00910962|3707941|FG001|Overall Study|Lost to Follow-up|3
2112899|NCT00910962|3707942|FG002|Overall Study|Lost to Follow-up|1
2219004|NCT01717989|3862667|FG000|Overall Study|Lost to Follow-up|11
2112900|NCT00910962|3707940|FG000|Overall Study|Physician Decision|0
2112901|NCT00910962|3707941|FG001|Overall Study|Physician Decision|6
2112902|NCT00910962|3707942|FG002|Overall Study|Physician Decision|6
2035842|NCT00408499|3606011|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0
2035843|NCT00408499|3606012|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0
2035844|NCT00408499|3606013|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5
2035845|NCT00408499|3606009|FG000|Phase II- MTD Expansion|treatment delay|0
2035846|NCT00408499|3606010|FG001|Phase II- MTD Expansion|treatment delay|0
2035847|NCT00408499|3606011|FG002|Phase II- MTD Expansion|treatment delay|0
2035848|NCT00408499|3606012|FG003|Phase II- MTD Expansion|treatment delay|0
2035849|NCT00408499|3606013|FG004|Phase II- MTD Expansion|treatment delay|3
2035850|NCT00408629|3606069|FG000|Overall Study|Adverse Event|13
2035851|NCT00408629|3606070|FG001|Overall Study|Adverse Event|27
2035852|NCT00408629|3606069|FG000|Overall Study|Withdrawal by Subject|8
2035853|NCT00408629|3606070|FG001|Overall Study|Withdrawal by Subject|4
2035854|NCT00408629|3606069|FG000|Overall Study|Lost to Follow-up|1
2035855|NCT00408629|3606070|FG001|Overall Study|Lost to Follow-up|1
2035856|NCT00408629|3606069|FG000|Overall Study|Lack of Efficacy|63
2035857|NCT00408629|3606070|FG001|Overall Study|Lack of Efficacy|73
2035858|NCT00408629|3606069|FG000|Overall Study|Protocol Violation|1
2035859|NCT00408629|3606070|FG001|Overall Study|Protocol Violation|5
2035860|NCT00408629|3606069|FG000|Overall Study|Miscellaneous|11
2035861|NCT00408629|3606070|FG001|Overall Study|Miscellaneous|15
2035862|NCT00408681|3606077|FG000|Overall Study|Lack of Efficacy|2
2035863|NCT00408681|3606077|FG000|Overall Study|Adverse Event|7
2035864|NCT00408694|3606082|FG000|Overall Study|Ineligible|1
2035865|NCT00408694|3606082|FG000|Overall Study|No protocol treatment|1
2035866|NCT00408876|3606090|FG000|Overall Study|Adverse Event|9
2035867|NCT00408876|3606091|FG001|Overall Study|Adverse Event|17
2035868|NCT00408876|3606092|FG002|Overall Study|Adverse Event|27
2035869|NCT00408876|3606093|FG003|Overall Study|Adverse Event|10
2035870|NCT00408876|3606090|FG000|Overall Study|Withdrawal by Subject|3
2035871|NCT00408876|3606091|FG001|Overall Study|Withdrawal by Subject|6
2035872|NCT00408876|3606092|FG002|Overall Study|Withdrawal by Subject|6
2035873|NCT00408876|3606093|FG003|Overall Study|Withdrawal by Subject|14
2035874|NCT00408876|3606090|FG000|Overall Study|Lack of Efficacy|2
2035875|NCT00408876|3606091|FG001|Overall Study|Lack of Efficacy|4
2035876|NCT00408876|3606092|FG002|Overall Study|Lack of Efficacy|5
2035877|NCT00408876|3606093|FG003|Overall Study|Lack of Efficacy|6
2035878|NCT00408876|3606090|FG000|Overall Study|Lost to Follow-up|1
2035879|NCT00408876|3606091|FG001|Overall Study|Lost to Follow-up|6
2035880|NCT00408876|3606092|FG002|Overall Study|Lost to Follow-up|5
2035881|NCT00408876|3606093|FG003|Overall Study|Lost to Follow-up|2
2035882|NCT00408876|3606090|FG000|Overall Study|Protocol Violation|0
2035883|NCT00408876|3606091|FG001|Overall Study|Protocol Violation|3
2035884|NCT00408876|3606092|FG002|Overall Study|Protocol Violation|4
2035885|NCT00408876|3606093|FG003|Overall Study|Protocol Violation|3
2035886|NCT00408876|3606090|FG000|Overall Study|Physician Decision|1
2035887|NCT00408876|3606091|FG001|Overall Study|Physician Decision|0
2035888|NCT00408876|3606092|FG002|Overall Study|Physician Decision|3
2035889|NCT00408876|3606093|FG003|Overall Study|Physician Decision|0
2035890|NCT00408902|3606103|FG000|Overall Study|Lack of Efficacy|7
2035891|NCT00408902|3606103|FG000|Overall Study|Adverse Event|3
2035892|NCT00408928|3606108|FG000|Overall Study|Withdrawal by Subject|1
2035893|NCT00408928|3606108|FG000|Overall Study|Death|1
2035894|NCT00408928|3606108|FG000|Overall Study|Infection indistinguishable from GVHD|1
2035895|NCT00408993|3606114|FG000|Overall Study|Adverse Event|15
2035896|NCT00408993|3606115|FG001|Overall Study|Adverse Event|4
2112903|NCT00910962|3707940|FG000|Overall Study|Withdrawal by Subject|25
2112904|NCT00910962|3707941|FG001|Overall Study|Withdrawal by Subject|32
2112905|NCT00910962|3707942|FG002|Overall Study|Withdrawal by Subject|32
2112906|NCT00910962|3707940|FG000|Overall Study|Reached defined stopping criteria|12
2112907|NCT00910962|3707941|FG001|Overall Study|Reached defined stopping criteria|14
2112908|NCT00910962|3707942|FG002|Overall Study|Reached defined stopping criteria|17
2112909|NCT00910988|3707956|FG000|Overall Study|Lost to Follow-up|2
2112910|NCT00910988|3707957|FG001|Overall Study|Lost to Follow-up|4
2112911|NCT00910988|3707958|FG002|Overall Study|Lost to Follow-up|3
2112912|NCT00910988|3707959|FG003|Overall Study|Lost to Follow-up|0
2112913|NCT00911144|3707987|FG000|Overall Study|Withdrawal by Subject|16
2112914|NCT00911144|3707988|FG001|Overall Study|Withdrawal by Subject|5
2112915|NCT00911157|3707996|FG000|Overall Study|Adverse Event|4
2112916|NCT00911157|3707997|FG001|Overall Study|Adverse Event|1
2112917|NCT00911157|3707996|FG000|Overall Study|Withdrawal by Subject|1
2112918|NCT00911157|3707997|FG001|Overall Study|Withdrawal by Subject|1
2112919|NCT00911157|3707996|FG000|Overall Study|Need for prohibited drug (heparin)|1
2112920|NCT00911157|3707997|FG001|Overall Study|Need for prohibited drug (heparin)|0
2112921|NCT00911157|3707996|FG000|Overall Study|Need to treat for lung cancer|1
2112922|NCT00911157|3707997|FG001|Overall Study|Need to treat for lung cancer|0
2112923|NCT00911170|3708005|FG000|Treatment Period|Randomized in error|1
2112924|NCT00911170|3708006|FG001|Treatment Period|Randomized in error|1
2112925|NCT00911170|3708005|FG000|Treatment Period|Ineligibility determined|1
2035897|NCT00408993|3606114|FG000|Overall Study|Protocol Violation|1
2112926|NCT00911170|3708006|FG001|Treatment Period|Ineligibility determined|3
2112927|NCT00911170|3708005|FG000|Treatment Period|Protocol deviation|1
2112928|NCT00911170|3708006|FG001|Treatment Period|Protocol deviation|2
2112929|NCT00911170|3708005|FG000|Treatment Period|Adverse Event|9
2112930|NCT00911170|3708006|FG001|Treatment Period|Adverse Event|10
2035898|NCT00408993|3606115|FG001|Overall Study|Protocol Violation|6
2035899|NCT00408993|3606114|FG000|Overall Study|Lack of Efficacy|1
2035900|NCT00408993|3606115|FG001|Overall Study|Lack of Efficacy|4
2035901|NCT00408993|3606114|FG000|Overall Study|Withdrawal by Subject|2
2035902|NCT00408993|3606115|FG001|Overall Study|Withdrawal by Subject|3
2035903|NCT00409006|3606127|FG000|Overall Study|Death|15
2035904|NCT00409006|3606128|FG001|Overall Study|Death|6
2035905|NCT00409006|3606127|FG000|Overall Study|Lost to Follow-up|1
2035906|NCT00409006|3606128|FG001|Overall Study|Lost to Follow-up|2
2035907|NCT00409006|3606127|FG000|Overall Study|Withdrawal by Subject|3
2035908|NCT00409006|3606128|FG001|Overall Study|Withdrawal by Subject|2
2035909|NCT00409006|3606127|FG000|Overall Study|Physician Decision|1
2035910|NCT00409006|3606128|FG001|Overall Study|Physician Decision|2
2035911|NCT00409175|3606136|FG000|Overall Study|Adverse Event|4
2035912|NCT00409175|3606137|FG001|Overall Study|Adverse Event|3
2035913|NCT00409175|3606136|FG000|Overall Study|Withdrawal by Subject|1
2112931|NCT00911170|3708005|FG000|Treatment Period|Withdrawal by Subject|4
2112932|NCT00911170|3708006|FG001|Treatment Period|Withdrawal by Subject|4
2112933|NCT00911170|3708005|FG000|Treatment Period|Disease progression|0
2112934|NCT00911170|3708006|FG001|Treatment Period|Disease progression|2
2112935|NCT00911170|3708005|FG000|Treatment Period|Physician Decision|5
2112936|NCT00911170|3708006|FG001|Treatment Period|Physician Decision|5
2112937|NCT00911170|3708005|FG000|Treatment Period|Lost to Follow-up|0
2112938|NCT00911170|3708006|FG001|Treatment Period|Lost to Follow-up|1
2112939|NCT00911170|3708005|FG000|Treatment Period|Death|6
2112940|NCT00911170|3708006|FG001|Treatment Period|Death|9
2112941|NCT00911170|3708005|FG000|Long Term Follow-Up|Continuing in study|274
2112942|NCT00911170|3708006|FG001|Long Term Follow-Up|Continuing in study|269
2112943|NCT00911170|3708005|FG000|Long Term Follow-Up|Withdrawal by Subject|20
2112944|NCT00911170|3708006|FG001|Long Term Follow-Up|Withdrawal by Subject|21
2112945|NCT00911170|3708005|FG000|Long Term Follow-Up|Physician Decision|5
2112946|NCT00911170|3708006|FG001|Long Term Follow-Up|Physician Decision|4
2112947|NCT00911170|3708005|FG000|Long Term Follow-Up|Lost to Follow-up|8
2112948|NCT00911170|3708006|FG001|Long Term Follow-Up|Lost to Follow-up|7
2112949|NCT00911170|3708005|FG000|Long Term Follow-Up|Death|116
2112950|NCT00911170|3708006|FG001|Long Term Follow-Up|Death|121
2112951|NCT00911300|3708014|FG000|Overall Study|Primary Endpoint Component Occurred|1
2112952|NCT00911300|3708015|FG001|Overall Study|Primary Endpoint Component Occurred|2
2112953|NCT00911300|3708014|FG000|Overall Study|Death|1
2112954|NCT00911300|3708015|FG001|Overall Study|Death|0
2112955|NCT00911300|3708014|FG000|Overall Study|Thrombus Persistant in Second TEE|3
2112956|NCT00911300|3708015|FG001|Overall Study|Thrombus Persistant in Second TEE|7
2112957|NCT00911300|3708014|FG000|Overall Study|Adverse Event|14
2112958|NCT00911300|3708015|FG001|Overall Study|Adverse Event|6
2112959|NCT00911300|3708014|FG000|Overall Study|Protocol Violation|3
2112960|NCT00911300|3708015|FG001|Overall Study|Protocol Violation|2
2112961|NCT00911300|3708014|FG000|Overall Study|Consent Withdrawn|4
2112962|NCT00911300|3708015|FG001|Overall Study|Consent Withdrawn|12
2112963|NCT00911300|3708014|FG000|Overall Study|Coronary Angiography Performed|1
2112964|NCT00911300|3708015|FG001|Overall Study|Coronary Angiography Performed|0
2112965|NCT00911300|3708014|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3
2112966|NCT00911300|3708015|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3
2112967|NCT00911300|3708014|FG000|Overall Study|Received Commercial Treatment|1
2112968|NCT00911300|3708015|FG001|Overall Study|Received Commercial Treatment|0
2112969|NCT00911300|3708014|FG000|Overall Study|Recurrent Tachyarrhythmia|1
2112970|NCT00911300|3708015|FG001|Overall Study|Recurrent Tachyarrhythmia|1
2112971|NCT00911300|3708014|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
2112972|NCT00911300|3708015|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
2112973|NCT00911300|3708014|FG000|Overall Study|Nurse Unavailable in Participant's City|1
2112974|NCT00911300|3708015|FG001|Overall Study|Nurse Unavailable in Participant's City|0
2112975|NCT00911300|3708014|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
2112976|NCT00911300|3708015|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
2112977|NCT00911300|3708014|FG000|Overall Study|Participant Could Not Stay in Hospital|0
2112978|NCT00911300|3708015|FG001|Overall Study|Participant Could Not Stay in Hospital|1
2112979|NCT00911300|3708014|FG000|Overall Study|Investigator's Decision; New AF Episode|0
2112980|NCT00911300|3708015|FG001|Overall Study|Investigator's Decision; New AF Episode|1
2112981|NCT00911300|3708014|FG000|Overall Study|International Normalized Ratio Too High|0
2112982|NCT00911300|3708015|FG001|Overall Study|International Normalized Ratio Too High|1
2112983|NCT00911300|3708014|FG000|Overall Study|Participant Refused Hospital Consulation|0
2112984|NCT00911300|3708015|FG001|Overall Study|Participant Refused Hospital Consulation|1
2112985|NCT00911300|3708014|FG000|Overall Study|Underlying Disease (Myocarditis)|0
2112986|NCT00911300|3708015|FG001|Overall Study|Underlying Disease (Myocarditis)|1
2112987|NCT00911300|3708014|FG000|Overall Study|Physician Decision|0
2112988|NCT00911300|3708015|FG001|Overall Study|Physician Decision|1
2112989|NCT00911300|3708014|FG000|Overall Study|Treatment Stopped by Mistake|0
2112990|NCT00911300|3708015|FG001|Overall Study|Treatment Stopped by Mistake|1
2112991|NCT00911300|3708014|FG000|Overall Study|Randomized; No Study Medication Received|0
2112992|NCT00911300|3708015|FG001|Overall Study|Randomized; No Study Medication Received|2
2035914|NCT00409175|3606137|FG001|Overall Study|Withdrawal by Subject|2
2035915|NCT00409175|3606136|FG000|Overall Study|Negative genotype|0
2035916|NCT00409175|3606137|FG001|Overall Study|Negative genotype|1
2035917|NCT00409175|3606136|FG000|Overall Study|Liver transplantation|13
2035918|NCT00409175|3606137|FG001|Overall Study|Liver transplantation|13
2035919|NCT00409188|3606145|FG000|Overall Study|Ongoing at data cut-off|383
2035920|NCT00409188|3606146|FG001|Overall Study|Ongoing at data cut-off|175
2035921|NCT00409409|3606169|FG000|Overall Study|Adverse Event|7
2035922|NCT00409409|3606170|FG001|Overall Study|Adverse Event|2
2035923|NCT00409409|3606169|FG000|Overall Study|Withdrawal by Subject|1
2035924|NCT00409409|3606170|FG001|Overall Study|Withdrawal by Subject|1
2035925|NCT00409409|3606169|FG000|Overall Study|Any other reason not above-mentioned|0
2035926|NCT00409409|3606170|FG001|Overall Study|Any other reason not above-mentioned|1
2035927|NCT00409578|3606205|FG000|Overall Study|Adverse Event|27
2035928|NCT00409578|3606206|FG001|Overall Study|Adverse Event|37
2035929|NCT00409578|3606207|FG002|Overall Study|Adverse Event|25
2035930|NCT00409578|3606208|FG003|Overall Study|Adverse Event|33
2035931|NCT00409578|3606205|FG000|Overall Study|Abnormal laboratory value(s)|2
2035932|NCT00409578|3606206|FG001|Overall Study|Abnormal laboratory value(s)|2
2035933|NCT00409578|3606207|FG002|Overall Study|Abnormal laboratory value(s)|2
2035934|NCT00409578|3606208|FG003|Overall Study|Abnormal laboratory value(s)|4
2035935|NCT00409578|3606205|FG000|Overall Study|Lack of Efficacy|0
2035936|NCT00409578|3606206|FG001|Overall Study|Lack of Efficacy|0
2035937|NCT00409578|3606207|FG002|Overall Study|Lack of Efficacy|0
2035938|NCT00409578|3606208|FG003|Overall Study|Lack of Efficacy|2
2035939|NCT00409578|3606205|FG000|Overall Study|Subject no longer requires study drug|0
2035940|NCT00409578|3606206|FG001|Overall Study|Subject no longer requires study drug|0
2035941|NCT00409578|3606207|FG002|Overall Study|Subject no longer requires study drug|0
2035942|NCT00409578|3606208|FG003|Overall Study|Subject no longer requires study drug|1
2035943|NCT00409578|3606205|FG000|Overall Study|Withdrawal by Subject|8
2035944|NCT00409578|3606206|FG001|Overall Study|Withdrawal by Subject|15
2035945|NCT00409578|3606207|FG002|Overall Study|Withdrawal by Subject|16
2035946|NCT00409578|3606208|FG003|Overall Study|Withdrawal by Subject|17
2112993|NCT00911508|3708032|FG000|Overall Study|Lost to Follow-up|27
2112994|NCT00911508|3708033|FG001|Overall Study|Lost to Follow-up|18
2112995|NCT00911508|3708032|FG000|Overall Study|Withdrawal by Subject|79
2112996|NCT00911508|3708033|FG001|Overall Study|Withdrawal by Subject|112
2112997|NCT00911534|3708041|FG000|Overall Study|Adverse Event|4
2112998|NCT00911534|3708042|FG001|Overall Study|Adverse Event|4
2112999|NCT00911534|3708041|FG000|Overall Study|Lost to Follow-up|2
2113000|NCT00911534|3708042|FG001|Overall Study|Lost to Follow-up|4
2113001|NCT00911534|3708041|FG000|Overall Study|Withdrawal by Subject|2
2113002|NCT00911534|3708042|FG001|Overall Study|Withdrawal by Subject|1
2113003|NCT00911534|3708041|FG000|Overall Study|Lack of Efficacy|4
2113004|NCT00911534|3708042|FG001|Overall Study|Lack of Efficacy|1
2113005|NCT00911534|3708041|FG000|Overall Study|Withdrawal of consent|1
2113006|NCT00911534|3708042|FG001|Overall Study|Withdrawal of consent|4
2113007|NCT00911534|3708041|FG000|Overall Study|Other|2
2113008|NCT00911534|3708042|FG001|Overall Study|Other|2
2113009|NCT00911625|3708064|FG000|Overall Study|Lost to Follow-up|7
2113010|NCT00911625|3708065|FG001|Overall Study|Lost to Follow-up|0
2113011|NCT00911768|3708082|FG000|Overall Study|Protocol Violation|5
2113012|NCT00911768|3708083|FG001|Overall Study|Protocol Violation|4
2113013|NCT00911768|3708082|FG000|Overall Study|Withdrawal by Subject|1
2113014|NCT00911768|3708083|FG001|Overall Study|Withdrawal by Subject|0
2113015|NCT00911807|3708092|FG000|Overall Study|Adverse Event|2
2113016|NCT00911807|3708093|FG001|Overall Study|Adverse Event|1
2113017|NCT00911807|3708094|FG002|Overall Study|Adverse Event|5
2113018|NCT00911807|3708092|FG000|Overall Study|Death|0
2113019|NCT00911807|3708093|FG001|Overall Study|Death|0
2113020|NCT00911807|3708094|FG002|Overall Study|Death|1
2113021|NCT00911807|3708092|FG000|Overall Study|Protocol Violation|6
2113022|NCT00911807|3708093|FG001|Overall Study|Protocol Violation|4
2113023|NCT00911807|3708094|FG002|Overall Study|Protocol Violation|9
2113024|NCT00911807|3708092|FG000|Overall Study|Withdrawal by Subject|8
2331836|NCT03178045|4054714|FG001|Overall Study|Withdrawal by Subject|7
2113025|NCT00911807|3708093|FG001|Overall Study|Withdrawal by Subject|10
2113026|NCT00911807|3708094|FG002|Overall Study|Withdrawal by Subject|7
2113027|NCT00911807|3708092|FG000|Overall Study|Organizational reasons|1
2113028|NCT00911807|3708093|FG001|Overall Study|Organizational reasons|3
2113029|NCT00911807|3708094|FG002|Overall Study|Organizational reasons|1
2113030|NCT00911820|3708104|FG000|Overall Study|RECIST progression|12
2113031|NCT00911820|3708105|FG001|Overall Study|RECIST progression|8
2113032|NCT00911820|3708104|FG000|Overall Study|Adverse Event|8
2113033|NCT00911820|3708105|FG001|Overall Study|Adverse Event|8
2113034|NCT00911820|3708104|FG000|Overall Study|Clinical Progression|7
2113035|NCT00911820|3708105|FG001|Overall Study|Clinical Progression|5
2113036|NCT00911820|3708104|FG000|Overall Study|Physician Decision|5
2113037|NCT00911820|3708105|FG001|Overall Study|Physician Decision|9
2113038|NCT00911820|3708104|FG000|Overall Study|Decline in Performance Status|4
2113039|NCT00911820|3708105|FG001|Overall Study|Decline in Performance Status|2
2113040|NCT00911820|3708104|FG000|Overall Study|Withdrawal by Subject|3
2113041|NCT00911820|3708105|FG001|Overall Study|Withdrawal by Subject|4
2113042|NCT00911820|3708104|FG000|Overall Study|Death|1
2113043|NCT00911820|3708105|FG001|Overall Study|Death|2
2113044|NCT00911820|3708104|FG000|Overall Study|Pursue surgery|1
2035947|NCT00409578|3606205|FG000|Overall Study|Lost to Follow-up|2
2035948|NCT00409578|3606206|FG001|Overall Study|Lost to Follow-up|0
2035949|NCT00409578|3606207|FG002|Overall Study|Lost to Follow-up|2
2035950|NCT00409578|3606208|FG003|Overall Study|Lost to Follow-up|2
2035951|NCT00409578|3606205|FG000|Overall Study|Administrative problems|8
2035952|NCT00409578|3606206|FG001|Overall Study|Administrative problems|9
2035953|NCT00409578|3606207|FG002|Overall Study|Administrative problems|2
2035954|NCT00409578|3606208|FG003|Overall Study|Administrative problems|4
2035955|NCT00409578|3606205|FG000|Overall Study|Death|2
2035956|NCT00409578|3606206|FG001|Overall Study|Death|4
2035957|NCT00409578|3606207|FG002|Overall Study|Death|4
2035958|NCT00409578|3606208|FG003|Overall Study|Death|2
2035959|NCT00409578|3606205|FG000|Overall Study|Protocol Violation|3
2035960|NCT00409578|3606206|FG001|Overall Study|Protocol Violation|2
2035961|NCT00409578|3606207|FG002|Overall Study|Protocol Violation|3
2035962|NCT00409578|3606208|FG003|Overall Study|Protocol Violation|1
2035963|NCT00409578|3606205|FG000|Overall Study|Missing|0
2035964|NCT00409578|3606206|FG001|Overall Study|Missing|1
2035965|NCT00409578|3606207|FG002|Overall Study|Missing|0
2035966|NCT00409578|3606208|FG003|Overall Study|Missing|1
2035967|NCT00409617|3606218|FG000|Overall Study|Adverse Event|57
2035968|NCT00409617|3606218|FG000|Overall Study|Lack of Efficacy|54
2035969|NCT00409617|3606218|FG000|Overall Study|Lost to Follow-up|2
2035970|NCT00409617|3606218|FG000|Overall Study|Protocol Violation|24
2035971|NCT00409617|3606218|FG000|Overall Study|Withdrawal by Subject|8
2035972|NCT00409617|3606218|FG000|Overall Study|Administrative reasons|1
2035973|NCT00409617|3606218|FG000|Overall Study|Not described|14
2035974|NCT00409682|3606225|FG000|Open-label Induction Period|Adverse Event|1
2035975|NCT00409682|3606226|FG001|Open-label Induction Period|Adverse Event|0
2035976|NCT00409682|3606227|FG002|Open-label Induction Period|Adverse Event|0
2035977|NCT00409682|3606225|FG000|Open-label Induction Period|Lack of Efficacy|1
2035978|NCT00409682|3606226|FG001|Open-label Induction Period|Lack of Efficacy|0
2035979|NCT00409682|3606227|FG002|Open-label Induction Period|Lack of Efficacy|0
2035980|NCT00409682|3606225|FG000|Open-label Induction Period|Protocol Violation|1
2035981|NCT00409682|3606226|FG001|Open-label Induction Period|Protocol Violation|0
2035982|NCT00409682|3606227|FG002|Open-label Induction Period|Protocol Violation|0
2035983|NCT00409682|3606225|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1
2035984|NCT00409682|3606226|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0
2035985|NCT00409682|3606227|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0
2035986|NCT00409682|3606225|FG000|EOW Double-blind Maintenance Period|Adverse Event|0
2035987|NCT00409682|3606226|FG001|EOW Double-blind Maintenance Period|Adverse Event|10
2035988|NCT00409682|3606227|FG002|EOW Double-blind Maintenance Period|Adverse Event|12
2035989|NCT00409682|3606225|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0
2035990|NCT00409682|3606226|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18
2035991|NCT00409682|3606227|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11
2035992|NCT00409682|3606225|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0
2035993|NCT00409682|3606226|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1
2035994|NCT00409682|3606227|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0
2035995|NCT00409682|3606225|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
2035996|NCT00409682|3606226|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
2035997|NCT00409682|3606227|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
2035998|NCT00409682|3606225|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0
2035999|NCT00409682|3606226|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4
2036000|NCT00409682|3606227|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1
2036001|NCT00409682|3606225|FG000|EOW Double-blind Maintenance Period|Non-compliance|0
2036002|NCT00409682|3606226|FG001|EOW Double-blind Maintenance Period|Non-compliance|0
2113045|NCT00911820|3708105|FG001|Overall Study|Pursue surgery|1
2113046|NCT00911820|3708104|FG000|Overall Study|Pursue Radiation|1
2113047|NCT00911820|3708105|FG001|Overall Study|Pursue Radiation|0
2113048|NCT00911820|3708104|FG000|Overall Study|Still on Therapy|2
2113049|NCT00911820|3708105|FG001|Overall Study|Still on Therapy|2
2113050|NCT00911820|3708104|FG000|Overall Study|Pathology Not Confirmed|1
2113051|NCT00911820|3708105|FG001|Overall Study|Pathology Not Confirmed|0
2113052|NCT00911820|3708104|FG000|Overall Study|Withdraw before Receive Treatment|0
2113053|NCT00911820|3708105|FG001|Overall Study|Withdraw before Receive Treatment|2
2113054|NCT00911859|3708114|FG000|Treatment Period|Adverse Event|3
2113055|NCT00911859|3708115|FG001|Treatment Period|Adverse Event|3
2113056|NCT00911859|3708116|FG002|Treatment Period|Adverse Event|7
2113057|NCT00911859|3708114|FG000|Treatment Period|Death|1
2113058|NCT00911859|3708115|FG001|Treatment Period|Death|3
2113059|NCT00911859|3708116|FG002|Treatment Period|Death|5
2113060|NCT00911859|3708114|FG000|Treatment Period|Lack of Efficacy|1
2113061|NCT00911859|3708115|FG001|Treatment Period|Lack of Efficacy|7
2113062|NCT00911859|3708116|FG002|Treatment Period|Lack of Efficacy|5
2113063|NCT00911859|3708114|FG000|Treatment Period|Physician Decision|3
2113064|NCT00911859|3708115|FG001|Treatment Period|Physician Decision|3
2113065|NCT00911859|3708116|FG002|Treatment Period|Physician Decision|3
2113066|NCT00911859|3708114|FG000|Treatment Period|Withdrawal by Subject|0
2113067|NCT00911859|3708115|FG001|Treatment Period|Withdrawal by Subject|4
2113068|NCT00911859|3708116|FG002|Treatment Period|Withdrawal by Subject|5
2219005|NCT01717989|3862667|FG000|Overall Study|Death|439
2036003|NCT00409682|3606227|FG002|EOW Double-blind Maintenance Period|Non-compliance|1
2036004|NCT00409708|3606236|FG000|Treatment|Abnormal test procedure result(s)|1
2036005|NCT00409708|3606237|FG001|Treatment|Abnormal test procedure result(s)|0
2036006|NCT00409708|3606236|FG000|Treatment|Lack of Efficacy|0
2036007|NCT00409708|3606237|FG001|Treatment|Lack of Efficacy|1
2036008|NCT00409708|3606236|FG000|Treatment|Protocol Violation|6
2036009|NCT00409708|3606237|FG001|Treatment|Protocol Violation|2
2036010|NCT00409708|3606236|FG000|Treatment|Withdrawal by Subject|3
2036011|NCT00409708|3606237|FG001|Treatment|Withdrawal by Subject|8
2036012|NCT00409708|3606236|FG000|Treatment|Lost to Follow-up|0
2036013|NCT00409708|3606237|FG001|Treatment|Lost to Follow-up|6
2036014|NCT00409708|3606236|FG000|Treatment|Administrative problems|5
2036015|NCT00409708|3606237|FG001|Treatment|Administrative problems|0
2036016|NCT00409708|3606236|FG000|Washout|Lack of Efficacy|9
2036017|NCT00409708|3606237|FG001|Washout|Lack of Efficacy|1
2036018|NCT00409708|3606236|FG000|Washout|Protocol Violation|0
2036019|NCT00409708|3606237|FG001|Washout|Protocol Violation|1
2036020|NCT00409708|3606236|FG000|Washout|Withdrawal by Subject|11
2036021|NCT00409708|3606237|FG001|Washout|Withdrawal by Subject|5
2036022|NCT00409708|3606236|FG000|Washout|Lost to Follow-up|1
2036023|NCT00409708|3606237|FG001|Washout|Lost to Follow-up|3
2036024|NCT00409747|3606243|FG000|Overall Study|Withdrawal by Subject|1
2036025|NCT00409786|3606247|FG000|Overall Study|Withdrawal by Subject|3
2036026|NCT00409838|3606257|FG000|Short-term Period|Adverse Event|0
2036027|NCT00409838|3606258|FG001|Short-term Period|Adverse Event|1
2036028|NCT00409838|3606257|FG000|Short-term Period|Lost to Follow-up|0
2036029|NCT00409838|3606258|FG001|Short-term Period|Lost to Follow-up|1
2036030|NCT00409838|3606257|FG000|Short-term Period|Withdrawal by Subject|2
2036031|NCT00409838|3606258|FG001|Short-term Period|Withdrawal by Subject|3
2036032|NCT00409838|3606257|FG000|Short-term Period|Never Treated|1
2036033|NCT00409838|3606258|FG001|Short-term Period|Never Treated|0
2036034|NCT00409838|3606257|FG000|Long-term Extension Period|Adverse Event|10
2036035|NCT00409838|3606258|FG001|Long-term Extension Period|Adverse Event|0
2036036|NCT00409838|3606257|FG000|Long-term Extension Period|Death|1
2036037|NCT00409838|3606258|FG001|Long-term Extension Period|Death|0
2036038|NCT00409838|3606257|FG000|Long-term Extension Period|Lack of Efficacy|2
2036039|NCT00409838|3606258|FG001|Long-term Extension Period|Lack of Efficacy|0
2036040|NCT00409838|3606257|FG000|Long-term Extension Period|Withdrawal by Subject|3
2036041|NCT00409838|3606258|FG001|Long-term Extension Period|Withdrawal by Subject|0
2036042|NCT00409838|3606257|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
2036043|NCT00409838|3606258|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
2036044|NCT00409838|3606257|FG000|Long-term Extension Period|Pregnancy|1
2036045|NCT00409838|3606258|FG001|Long-term Extension Period|Pregnancy|0
2036046|NCT00410046|3606281|FG000|Overall Study|Adverse Event|3
2036047|NCT00410046|3606281|FG000|Overall Study|Withdrawal by Subject|1
2036048|NCT00410046|3606281|FG000|Overall Study|Lost to Follow-up|1
2036049|NCT00410072|3606292|FG000|Day 1 to Week 48|Adverse Event|1
2036050|NCT00410072|3606293|FG001|Day 1 to Week 48|Adverse Event|2
2036051|NCT00410072|3606292|FG000|Day 1 to Week 48|Lost to Follow-up|5
2036052|NCT00410072|3606293|FG001|Day 1 to Week 48|Lost to Follow-up|2
2036053|NCT00410072|3606292|FG000|Day 1 to Week 48|Other|0
2036054|NCT00410072|3606293|FG001|Day 1 to Week 48|Other|1
2036055|NCT00410072|3606292|FG000|Day 1 to Week 48|poor compliance/noncompliance|0
2036056|NCT00410072|3606293|FG001|Day 1 to Week 48|poor compliance/noncompliance|3
2036057|NCT00410072|3606292|FG000|Day 1 to Week 48|Pregnancy|0
2036058|NCT00410072|3606293|FG001|Day 1 to Week 48|Pregnancy|2
2036059|NCT00410072|3606292|FG000|Day 1 to Week 48|Withdrawal by Subject|0
2036060|NCT00410072|3606293|FG001|Day 1 to Week 48|Withdrawal by Subject|2
2036061|NCT00410072|3606292|FG000|After Week 48 to Week 96|Adverse Event|1
2036062|NCT00410072|3606293|FG001|After Week 48 to Week 96|Adverse Event|2
2036063|NCT00410072|3606292|FG000|After Week 48 to Week 96|Death|0
2036064|NCT00410072|3606293|FG001|After Week 48 to Week 96|Death|1
2036065|NCT00410072|3606292|FG000|After Week 48 to Week 96|Lack of Efficacy|1
2036066|NCT00410072|3606293|FG001|After Week 48 to Week 96|Lack of Efficacy|0
2036067|NCT00410072|3606292|FG000|After Week 48 to Week 96|Lost to Follow-up|2
2036068|NCT00410072|3606293|FG001|After Week 48 to Week 96|Lost to Follow-up|4
2036069|NCT00410072|3606292|FG000|After Week 48 to Week 96|Other|2
2036070|NCT00410072|3606293|FG001|After Week 48 to Week 96|Other|0
2036071|NCT00410072|3606292|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0
2036072|NCT00410072|3606293|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1
2036073|NCT00410072|3606292|FG000|After Week 48 to Week 96|Pregnancy|0
2036074|NCT00410072|3606293|FG001|After Week 48 to Week 96|Pregnancy|2
2036075|NCT00410072|3606292|FG000|After Week 48 to Week 96|Withdrawal by Subject|0
2036076|NCT00410072|3606293|FG001|After Week 48 to Week 96|Withdrawal by Subject|1
2036077|NCT00410124|3606301|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36
2036078|NCT00410124|3606302|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2
2036079|NCT00410124|3606301|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
2036080|NCT00410124|3606302|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
2036081|NCT00410124|3606301|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2
2036082|NCT00410124|3606302|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1
2036083|NCT00410124|3606301|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
2113069|NCT00911859|3708114|FG000|Treatment Period|Did not receive study treatment|0
2113070|NCT00911859|3708115|FG001|Treatment Period|Did not receive study treatment|1
2113071|NCT00911859|3708116|FG002|Treatment Period|Did not receive study treatment|0
2113072|NCT00911859|3708114|FG000|Maintainance Period|Lack of Efficacy|0
2113073|NCT00911859|3708115|FG001|Maintainance Period|Lack of Efficacy|0
2113074|NCT00911859|3708116|FG002|Maintainance Period|Lack of Efficacy|9
2113075|NCT00911859|3708114|FG000|Maintainance Period|Physician Decision|0
2113076|NCT00911859|3708115|FG001|Maintainance Period|Physician Decision|0
2113077|NCT00911859|3708116|FG002|Maintainance Period|Physician Decision|9
2113078|NCT00911859|3708114|FG000|Maintainance Period|Withdrawal by Subject|0
2113079|NCT00911859|3708115|FG001|Maintainance Period|Withdrawal by Subject|0
2113080|NCT00911859|3708116|FG002|Maintainance Period|Withdrawal by Subject|3
2113081|NCT00911859|3708114|FG000|Follow-up Period|Death|5
2113082|NCT00911859|3708115|FG001|Follow-up Period|Death|8
2113083|NCT00911859|3708116|FG002|Follow-up Period|Death|10
2113084|NCT00911859|3708114|FG000|Follow-up Period|Lost to Follow-up|1
2113085|NCT00911859|3708115|FG001|Follow-up Period|Lost to Follow-up|1
2113086|NCT00911859|3708116|FG002|Follow-up Period|Lost to Follow-up|0
2113087|NCT00911859|3708114|FG000|Follow-up Period|Withdrawal by Subject|0
2113088|NCT00911859|3708115|FG001|Follow-up Period|Withdrawal by Subject|4
2113089|NCT00911859|3708116|FG002|Follow-up Period|Withdrawal by Subject|4
2113090|NCT00911859|3708114|FG000|Follow-up Period|Study terminated by sponsor|5
2113091|NCT00911859|3708115|FG001|Follow-up Period|Study terminated by sponsor|33
2113092|NCT00911859|3708116|FG002|Follow-up Period|Study terminated by sponsor|27
2113093|NCT00911937|3708130|FG000|Overall Study|Death|1
2113094|NCT00911937|3708131|FG001|Overall Study|Death|0
2113095|NCT00911937|3708130|FG000|Overall Study|Lost to Follow-up|8
2113096|NCT00911937|3708131|FG001|Overall Study|Lost to Follow-up|5
2113097|NCT00911937|3708130|FG000|Overall Study|Withdrawal by Subject|10
2113098|NCT00911937|3708131|FG001|Overall Study|Withdrawal by Subject|7
2113099|NCT00911937|3708130|FG000|Overall Study|Withdrawn due to pregnancy|1
2113100|NCT00911937|3708131|FG001|Overall Study|Withdrawn due to pregnancy|0
2113101|NCT00911937|3708130|FG000|Overall Study|Adverse Event|11
2113102|NCT00911937|3708131|FG001|Overall Study|Adverse Event|25
2113103|NCT00911937|3708130|FG000|Overall Study|Lack of Efficacy|11
2113104|NCT00911937|3708131|FG001|Overall Study|Lack of Efficacy|6
2113105|NCT00911937|3708130|FG000|Overall Study|Did not meet inclusion criteria|9
2113106|NCT00911937|3708131|FG001|Overall Study|Did not meet inclusion criteria|11
2113107|NCT00911937|3708130|FG000|Overall Study|Protocol Violation|14
2113108|NCT00911937|3708131|FG001|Overall Study|Protocol Violation|23
2113109|NCT00911937|3708130|FG000|Overall Study|Randomized but not treated|13
2113110|NCT00911937|3708131|FG001|Overall Study|Randomized but not treated|13
2113111|NCT00911937|3708130|FG000|Overall Study|Other|9
2113112|NCT00911937|3708131|FG001|Overall Study|Other|5
2113113|NCT00911989|3708137|FG000|Overall Study|Adverse Event|1
2113114|NCT00912015|3708150|FG000|Overall Study|Lack of Efficacy|1
2113115|NCT00912015|3708151|FG001|Overall Study|Lack of Efficacy|0
2113116|NCT00912015|3708152|FG002|Overall Study|Lack of Efficacy|0
2113117|NCT00912015|3708153|FG003|Overall Study|Lack of Efficacy|0
2113118|NCT00912015|3708150|FG000|Overall Study|Withdrawal by Subject|8
2113119|NCT00912015|3708151|FG001|Overall Study|Withdrawal by Subject|8
2113120|NCT00912015|3708152|FG002|Overall Study|Withdrawal by Subject|3
2113121|NCT00912015|3708153|FG003|Overall Study|Withdrawal by Subject|0
2113122|NCT00912015|3708150|FG000|Overall Study|Protocol Violation|1
2113123|NCT00912015|3708151|FG001|Overall Study|Protocol Violation|0
2113124|NCT00912015|3708152|FG002|Overall Study|Protocol Violation|0
2113125|NCT00912015|3708153|FG003|Overall Study|Protocol Violation|1
2113126|NCT00912015|3708150|FG000|Overall Study|Adverse Event|6
2219006|NCT01717989|3862667|FG000|Overall Study|Protocol-specified criteria|551
2219007|NCT01717989|3862667|FG000|Overall Study|Other|40
2219008|NCT01718353|3862697|FG000|Overall Study|Lost to Follow-up|0
2219009|NCT01718353|3862698|FG001|Overall Study|Lost to Follow-up|1
2219010|NCT01718353|3862697|FG000|Overall Study|Principal Investigator's Decision|10
2219011|NCT01718353|3862698|FG001|Overall Study|Principal Investigator's Decision|4
2219012|NCT01718353|3862697|FG000|Overall Study|Randomized but not treated|2
2219013|NCT01718353|3862698|FG001|Overall Study|Randomized but not treated|0
2219014|NCT01718483|3862708|FG000|Overall Study|Withdrawal by Subject|14
2219015|NCT01718483|3862709|FG001|Overall Study|Withdrawal by Subject|12
2219016|NCT01718483|3862708|FG000|Overall Study|Adverse Event|5
2219017|NCT01718483|3862709|FG001|Overall Study|Adverse Event|12
2219018|NCT01718483|3862708|FG000|Overall Study|Lost to Follow-up|8
2219019|NCT01718483|3862709|FG001|Overall Study|Lost to Follow-up|3
2331837|NCT03178045|4054713|FG000|Overall Study|Surgery Cancelled/Relocated|34
2113127|NCT00912015|3708151|FG001|Overall Study|Adverse Event|0
2113128|NCT00912015|3708152|FG002|Overall Study|Adverse Event|0
2113129|NCT00912015|3708153|FG003|Overall Study|Adverse Event|1
2113130|NCT00912028|3708166|FG000|Overall Study|Lost to Follow-up|2
2113131|NCT00912028|3708167|FG001|Overall Study|Lost to Follow-up|3
2113132|NCT00912028|3708168|FG002|Overall Study|Lost to Follow-up|0
2113133|NCT00912028|3708169|FG003|Overall Study|Lost to Follow-up|1
2113134|NCT00912028|3708170|FG004|Overall Study|Lost to Follow-up|3
2219020|NCT01718483|3862708|FG000|Overall Study|Protocol Violation|4
2219021|NCT01718483|3862709|FG001|Overall Study|Protocol Violation|2
2219022|NCT01718483|3862708|FG000|Overall Study|Other|1
2219023|NCT01718483|3862709|FG001|Overall Study|Other|4
2036084|NCT00410124|3606302|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
2036085|NCT00410124|3606301|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
2036086|NCT00410124|3606302|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
2036087|NCT00410124|3606301|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2
2036088|NCT00410124|3606302|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0
2036089|NCT00410124|3606301|FG000|Core Phase Double Blind (15 Months)|Death|7
2036090|NCT00410124|3606302|FG001|Core Phase Double Blind (15 Months)|Death|4
2036091|NCT00410124|3606301|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137
2036092|NCT00410124|3606302|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124
2036093|NCT00410124|3606301|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7
2036094|NCT00410124|3606302|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19
2036095|NCT00410124|3606301|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
2036096|NCT00410124|3606302|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
2036097|NCT00410124|3606301|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
2036098|NCT00410124|3606302|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
2036099|NCT00410124|3606301|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
2036100|NCT00410124|3606302|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
2036101|NCT00410124|3606301|FG000|Extension Phase - Open Label (45 Months)|Death|2
2036102|NCT00410124|3606302|FG001|Extension Phase - Open Label (45 Months)|Death|10
2113135|NCT00912028|3708166|FG000|Overall Study|Withdrawal by Subject|3
2113136|NCT00912028|3708167|FG001|Overall Study|Withdrawal by Subject|0
2113137|NCT00912028|3708168|FG002|Overall Study|Withdrawal by Subject|0
2113138|NCT00912028|3708169|FG003|Overall Study|Withdrawal by Subject|0
2113139|NCT00912028|3708170|FG004|Overall Study|Withdrawal by Subject|0
2113140|NCT00912093|3708185|FG000|The Controlled Phase|Death|0
2113141|NCT00912093|3708186|FG001|The Controlled Phase|Death|1
2113142|NCT00912093|3708187|FG002|The Controlled Phase|Death|0
2113143|NCT00912093|3708188|FG003|The Controlled Phase|Death|0
2113144|NCT00912093|3708189|FG004|The Controlled Phase|Death|0
2113145|NCT00912093|3708185|FG000|The Controlled Phase|Medical Condition|0
2113146|NCT00912093|3708186|FG001|The Controlled Phase|Medical Condition|1
2113147|NCT00912093|3708187|FG002|The Controlled Phase|Medical Condition|0
2113148|NCT00912093|3708188|FG003|The Controlled Phase|Medical Condition|0
2113149|NCT00912093|3708189|FG004|The Controlled Phase|Medical Condition|0
2113150|NCT00912093|3708185|FG000|The Controlled Phase|Lost to Follow-up|0
2113151|NCT00912093|3708186|FG001|The Controlled Phase|Lost to Follow-up|0
2113152|NCT00912093|3708187|FG002|The Controlled Phase|Lost to Follow-up|0
2113153|NCT00912093|3708188|FG003|The Controlled Phase|Lost to Follow-up|0
2113154|NCT00912093|3708189|FG004|The Controlled Phase|Lost to Follow-up|1
2113155|NCT00912197|3708199|FG000|Overall Study|Withdrawal by Subject|3
2113156|NCT00912197|3708200|FG001|Overall Study|Withdrawal by Subject|3
2113157|NCT00912288|3708210|FG000|Overall Study|Death|0
2113158|NCT00912288|3708211|FG001|Overall Study|Death|1
2113159|NCT00912288|3708210|FG000|Overall Study|Adverse Event|1
2113160|NCT00912288|3708211|FG001|Overall Study|Adverse Event|1
2113161|NCT00912288|3708210|FG000|Overall Study|Lost to Follow-up|1
2113162|NCT00912288|3708211|FG001|Overall Study|Lost to Follow-up|0
2113163|NCT00912288|3708210|FG000|Overall Study|Protocol Violation|1
2113164|NCT00912288|3708211|FG001|Overall Study|Protocol Violation|0
2113165|NCT00912288|3708210|FG000|Overall Study|Withdrawal by Subject|3
2113166|NCT00912288|3708211|FG001|Overall Study|Withdrawal by Subject|3
2113167|NCT00912288|3708210|FG000|Overall Study|Study terminated by sponsor|34
2113168|NCT00912288|3708211|FG001|Overall Study|Study terminated by sponsor|35
2113169|NCT00912288|3708210|FG000|Overall Study|Other|1
2113170|NCT00912288|3708211|FG001|Overall Study|Other|0
2113171|NCT00912340|3708233|FG000|Overall Study|Adverse Event|2
2113172|NCT00912340|3708234|FG001|Overall Study|Adverse Event|4
2113173|NCT00912340|3708235|FG002|Overall Study|Adverse Event|0
2113174|NCT00912340|3708233|FG000|Overall Study|Protocol revised to remove arm|0
2113175|NCT00912340|3708234|FG001|Overall Study|Protocol revised to remove arm|0
2113176|NCT00912340|3708235|FG002|Overall Study|Protocol revised to remove arm|4
2113177|NCT00912405|3708243|FG000|Overall Study|Lost to Follow-up|5
2113178|NCT00912509|3708249|FG000|Overall Study|Lost to Follow-up|1
2113179|NCT00912509|3708250|FG001|Overall Study|Lost to Follow-up|0
2113180|NCT00912509|3708249|FG000|Overall Study|Lack of Efficacy|4
2113181|NCT00912509|3708250|FG001|Overall Study|Lack of Efficacy|3
2113182|NCT00912743|3708259|FG000|Overall Study|Adverse Event|3
2113183|NCT00912743|3708260|FG001|Overall Study|Adverse Event|1
2113184|NCT00912743|3708259|FG000|Overall Study|Lack of Efficacy|9
2113185|NCT00912743|3708260|FG001|Overall Study|Lack of Efficacy|18
2113186|NCT00912743|3708259|FG000|Overall Study|Toxicity|0
2113187|NCT00912743|3708260|FG001|Overall Study|Toxicity|1
2113188|NCT00912743|3708259|FG000|Overall Study|End of treatment form was not collected|1
2113189|NCT00912743|3708260|FG001|Overall Study|End of treatment form was not collected|0
2113190|NCT00912782|3708268|FG000|Overall Study|Death|2
2113191|NCT00912782|3708269|FG001|Overall Study|Death|1
2113192|NCT00912782|3708268|FG000|Overall Study|Lost to Follow-up|0
2113193|NCT00912782|3708269|FG001|Overall Study|Lost to Follow-up|1
2113194|NCT00912782|3708268|FG000|Overall Study|Did not receive vascular access type|1
2113195|NCT00912782|3708269|FG001|Overall Study|Did not receive vascular access type|2
2036103|NCT00410124|3606301|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56
2036104|NCT00410124|3606302|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78
2036105|NCT00410124|3606301|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
2036106|NCT00410124|3606302|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
2036107|NCT00410124|3606301|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
2036108|NCT00410124|3606302|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
2036109|NCT00410163|3606323|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
2036110|NCT00410163|3606324|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
2036111|NCT00410163|3606323|FG000|Treatment and Follow-up Phase (2 Years)|Death|1
2036112|NCT00410163|3606324|FG001|Treatment and Follow-up Phase (2 Years)|Death|1
2036113|NCT00410163|3606323|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
2036114|NCT00410163|3606324|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
2036115|NCT00410163|3606323|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
2036116|NCT00410163|3606324|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
2036117|NCT00410163|3606323|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
2036118|NCT00410163|3606324|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
2036119|NCT00410163|3606323|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
2036120|NCT00410163|3606324|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
2036121|NCT00410163|3606323|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
2036122|NCT00410163|3606324|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
2036123|NCT00410163|3606323|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
2036124|NCT00410163|3606324|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
2036125|NCT00410163|3606323|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
2036126|NCT00410163|3606324|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
2036127|NCT00410163|3606323|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
2036128|NCT00410163|3606324|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
2036129|NCT00410163|3606323|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1
2036130|NCT00410163|3606324|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1
2036131|NCT00410163|3606323|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
2036132|NCT00410163|3606324|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
2036133|NCT00410163|3606323|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
2036134|NCT00410163|3606324|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
2036135|NCT00410163|3606323|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
2036136|NCT00410163|3606324|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
2036137|NCT00410202|3606341|FG000|On-Treatment|Continuing treatment|69
2036138|NCT00410202|3606342|FG001|On-Treatment|Continuing treatment|71
2036139|NCT00410202|3606343|FG002|On-Treatment|Continuing treatment|66
2036140|NCT00410202|3606341|FG000|On-Treatment|Adverse Event|1
2036141|NCT00410202|3606342|FG001|On-Treatment|Adverse Event|3
2036142|NCT00410202|3606343|FG002|On-Treatment|Adverse Event|2
2036143|NCT00410202|3606341|FG000|On-Treatment|Death|1
2036144|NCT00410202|3606342|FG001|On-Treatment|Death|0
2036145|NCT00410202|3606343|FG002|On-Treatment|Death|0
2036146|NCT00410202|3606341|FG000|On-Treatment|Lost to Follow-up|1
2036147|NCT00410202|3606342|FG001|On-Treatment|Lost to Follow-up|0
2036148|NCT00410202|3606343|FG002|On-Treatment|Lost to Follow-up|1
2036149|NCT00410202|3606341|FG000|On-Treatment|Lack of Efficacy|1
2036150|NCT00410202|3606342|FG001|On-Treatment|Lack of Efficacy|4
2036151|NCT00410202|3606343|FG002|On-Treatment|Lack of Efficacy|0
2113196|NCT00912782|3708268|FG000|Overall Study|Relocated before study completion|0
2113197|NCT00912782|3708269|FG001|Overall Study|Relocated before study completion|1
2113198|NCT00912808|3708286|FG000|First Intervention (6 Weeks)|Adverse Event|2
2113199|NCT00912808|3708287|FG001|First Intervention (6 Weeks)|Adverse Event|1
2113200|NCT00912808|3708286|FG000|Washout|Withdrawal by Subject|0
2113201|NCT00912808|3708287|FG001|Washout|Withdrawal by Subject|1
2113202|NCT00912808|3708286|FG000|Second Intervention (6 Weeks)|Adverse Event|0
2113203|NCT00912808|3708287|FG001|Second Intervention (6 Weeks)|Adverse Event|1
2113204|NCT00912808|3708286|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1
2113205|NCT00912808|3708287|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0
2113206|NCT00912912|3708307|FG000|Overall Study|Withdrawal by Subject|1
2113207|NCT00912912|3708307|FG000|Overall Study|Disease Progression|3
2113208|NCT00912964|3708323|FG000|Overall Study|Eligibility criterion not met|1
2113209|NCT00912964|3708324|FG001|Overall Study|Eligibility criterion not met|1
2113210|NCT00912964|3708325|FG002|Overall Study|Eligibility criterion not met|0
2113211|NCT00912964|3708323|FG000|Overall Study|Adverse Event|15
2113212|NCT00912964|3708324|FG001|Overall Study|Adverse Event|18
2113213|NCT00912964|3708325|FG002|Overall Study|Adverse Event|12
2113214|NCT00912964|3708323|FG000|Overall Study|Lack of Efficacy|11
2113215|NCT00912964|3708324|FG001|Overall Study|Lack of Efficacy|4
2219024|NCT01718483|3862708|FG000|Overall Study|Pregnancy|1
2219025|NCT01718483|3862709|FG001|Overall Study|Pregnancy|1
2219026|NCT01718483|3862708|FG000|Overall Study|Lack of Efficacy|1
2219027|NCT01718483|3862709|FG001|Overall Study|Lack of Efficacy|0
2219028|NCT01718509|3862717|FG000|Overall Study|Lost to Follow-up|18
2036152|NCT00410202|3606341|FG000|On-Treatment|Withdrawal by Subject|2
2036153|NCT00410202|3606342|FG001|On-Treatment|Withdrawal by Subject|1
2036154|NCT00410202|3606343|FG002|On-Treatment|Withdrawal by Subject|1
2036155|NCT00410202|3606341|FG000|On-Treatment|Other Reason|0
2036156|NCT00410202|3606342|FG001|On-Treatment|Other Reason|0
2036157|NCT00410202|3606343|FG002|On-Treatment|Other Reason|1
2036158|NCT00410202|3606341|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10
2036159|NCT00410202|3606342|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8
2036160|NCT00410202|3606343|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11
2036161|NCT00410202|3606341|FG000|Off-treatment Follow up|Follow up not required per protocol|3
2036162|NCT00410202|3606342|FG001|Off-treatment Follow up|Follow up not required per protocol|0
2036163|NCT00410202|3606343|FG002|Off-treatment Follow up|Follow up not required per protocol|1
2036164|NCT00410202|3606341|FG000|Off-treatment Follow up|Lost to Follow-up|1
2036165|NCT00410202|3606342|FG001|Off-treatment Follow up|Lost to Follow-up|0
2036166|NCT00410202|3606343|FG002|Off-treatment Follow up|Lost to Follow-up|0
2036167|NCT00410384|3606364|FG000|Overall Study|Withdrawal by Subject|28
2036168|NCT00410384|3606365|FG001|Overall Study|Withdrawal by Subject|17
2036169|NCT00410384|3606366|FG002|Overall Study|Withdrawal by Subject|20
2036170|NCT00410384|3606364|FG000|Overall Study|Adverse Event|23
2036171|NCT00410384|3606365|FG001|Overall Study|Adverse Event|18
2036172|NCT00410384|3606366|FG002|Overall Study|Adverse Event|23
2036173|NCT00410384|3606364|FG000|Overall Study|Lack of Efficacy|20
2036174|NCT00410384|3606365|FG001|Overall Study|Lack of Efficacy|12
2036175|NCT00410384|3606366|FG002|Overall Study|Lack of Efficacy|17
2036176|NCT00410384|3606364|FG000|Overall Study|Lack of Compliance|2
2036177|NCT00410384|3606365|FG001|Overall Study|Lack of Compliance|2
2036178|NCT00410384|3606366|FG002|Overall Study|Lack of Compliance|2
2036179|NCT00410384|3606364|FG000|Overall Study|Lost to Follow-up|4
2036180|NCT00410384|3606365|FG001|Overall Study|Lost to Follow-up|6
2036181|NCT00410384|3606366|FG002|Overall Study|Lost to Follow-up|6
2036182|NCT00410384|3606364|FG000|Overall Study|Protocol Violation|6
2036183|NCT00410384|3606365|FG001|Overall Study|Protocol Violation|6
2036184|NCT00410384|3606366|FG002|Overall Study|Protocol Violation|6
2036185|NCT00410384|3606364|FG000|Overall Study|Physician Decision|3
2036186|NCT00410384|3606365|FG001|Overall Study|Physician Decision|3
2036187|NCT00410384|3606366|FG002|Overall Study|Physician Decision|4
2036188|NCT00410384|3606364|FG000|Overall Study|Other|3
2036189|NCT00410384|3606365|FG001|Overall Study|Other|8
2036190|NCT00410384|3606366|FG002|Overall Study|Other|4
2036191|NCT00410410|3606380|FG000|Induction Period (IP)|Death|1
2036192|NCT00410410|3606381|FG001|Induction Period (IP)|Death|0
2036193|NCT00410410|3606382|FG002|Induction Period (IP)|Death|0
2036194|NCT00410410|3606383|FG003|Induction Period (IP)|Death|0
2036195|NCT00410410|3606384|FG004|Induction Period (IP)|Death|0
2036196|NCT00410410|3606385|FG005|Induction Period (IP)|Death|0
2036197|NCT00410410|3606386|FG006|Induction Period (IP)|Death|0
2036198|NCT00410410|3606387|FG007|Induction Period (IP)|Death|0
2036199|NCT00410410|3606388|FG008|Induction Period (IP)|Death|0
2113216|NCT00912964|3708325|FG002|Overall Study|Lack of Efficacy|3
2113217|NCT00912964|3708323|FG000|Overall Study|Withdrawal by Subject|20
2113218|NCT00912964|3708324|FG001|Overall Study|Withdrawal by Subject|12
2113219|NCT00912964|3708325|FG002|Overall Study|Withdrawal by Subject|18
2113220|NCT00912964|3708323|FG000|Overall Study|Lost to Follow-up|4
2113221|NCT00912964|3708324|FG001|Overall Study|Lost to Follow-up|3
2113222|NCT00912964|3708325|FG002|Overall Study|Lost to Follow-up|3
2113223|NCT00912964|3708323|FG000|Overall Study|Protocol Violation|5
2113224|NCT00912964|3708324|FG001|Overall Study|Protocol Violation|3
2113225|NCT00912964|3708325|FG002|Overall Study|Protocol Violation|8
2113226|NCT00912964|3708323|FG000|Overall Study|Taking exclusionary medications|7
2113227|NCT00912964|3708324|FG001|Overall Study|Taking exclusionary medications|4
2113228|NCT00912964|3708325|FG002|Overall Study|Taking exclusionary medications|8
2113229|NCT00912964|3708323|FG000|Overall Study|Medical History|1
2113230|NCT00912964|3708324|FG001|Overall Study|Medical History|0
2113231|NCT00912964|3708325|FG002|Overall Study|Medical History|0
2113232|NCT00912964|3708323|FG000|Overall Study|Non-compliance with study procedures|2
2113233|NCT00912964|3708324|FG001|Overall Study|Non-compliance with study procedures|0
2113234|NCT00912964|3708325|FG002|Overall Study|Non-compliance with study procedures|0
2113235|NCT00912964|3708323|FG000|Overall Study|Violation of exclusion criterion|0
2113236|NCT00912964|3708324|FG001|Overall Study|Violation of exclusion criterion|0
2113237|NCT00912964|3708325|FG002|Overall Study|Violation of exclusion criterion|2
2113238|NCT00912964|3708323|FG000|Overall Study|Randomized but never received study drug|0
2113239|NCT00912964|3708324|FG001|Overall Study|Randomized but never received study drug|1
2113240|NCT00912964|3708325|FG002|Overall Study|Randomized but never received study drug|0
2113241|NCT00913380|3708384|FG000|Clinical Outcomes|Lost to Follow-up|6
2113242|NCT00913380|3708385|FG001|Clinical Outcomes|Lost to Follow-up|6
2113243|NCT00913458|3708391|FG000|Phase 1|Non-Responder|54
2113244|NCT00913458|3708392|FG001|Phase 1|Non-Responder|0
2113245|NCT00913458|3708393|FG002|Phase 1|Non-Responder|0
2113246|NCT00913458|3708394|FG003|Phase 1|Non-Responder|0
2113247|NCT00913458|3708395|FG004|Phase 1|Non-Responder|0
2113248|NCT00913458|3708396|FG005|Phase 1|Non-Responder|0
2113249|NCT00913458|3708397|FG006|Phase 1|Non-Responder|0
2113250|NCT00913458|3708391|FG000|Phase 1|Subject Request|17
2036200|NCT00410410|3606380|FG000|Induction Period (IP)|Adverse Event|3
2036201|NCT00410410|3606381|FG001|Induction Period (IP)|Adverse Event|4
2036202|NCT00410410|3606382|FG002|Induction Period (IP)|Adverse Event|2
2036203|NCT00410410|3606383|FG003|Induction Period (IP)|Adverse Event|4
2036204|NCT00410410|3606384|FG004|Induction Period (IP)|Adverse Event|1
2036205|NCT00410410|3606385|FG005|Induction Period (IP)|Adverse Event|0
2036206|NCT00410410|3606386|FG006|Induction Period (IP)|Adverse Event|0
2036207|NCT00410410|3606387|FG007|Induction Period (IP)|Adverse Event|0
2036208|NCT00410410|3606388|FG008|Induction Period (IP)|Adverse Event|0
2036209|NCT00410410|3606380|FG000|Induction Period (IP)|Lack of Efficacy|26
2036210|NCT00410410|3606381|FG001|Induction Period (IP)|Lack of Efficacy|24
2036211|NCT00410410|3606382|FG002|Induction Period (IP)|Lack of Efficacy|8
2036212|NCT00410410|3606383|FG003|Induction Period (IP)|Lack of Efficacy|8
2036213|NCT00410410|3606384|FG004|Induction Period (IP)|Lack of Efficacy|7
2036214|NCT00410410|3606385|FG005|Induction Period (IP)|Lack of Efficacy|7
2036215|NCT00410410|3606386|FG006|Induction Period (IP)|Lack of Efficacy|0
2036216|NCT00410410|3606387|FG007|Induction Period (IP)|Lack of Efficacy|0
2036217|NCT00410410|3606388|FG008|Induction Period (IP)|Lack of Efficacy|0
2036218|NCT00410410|3606380|FG000|Induction Period (IP)|Lost to Follow-up|2
2036219|NCT00410410|3606381|FG001|Induction Period (IP)|Lost to Follow-up|2
2036220|NCT00410410|3606382|FG002|Induction Period (IP)|Lost to Follow-up|2
2036221|NCT00410410|3606383|FG003|Induction Period (IP)|Lost to Follow-up|3
2036222|NCT00410410|3606384|FG004|Induction Period (IP)|Lost to Follow-up|0
2036223|NCT00410410|3606385|FG005|Induction Period (IP)|Lost to Follow-up|1
2036224|NCT00410410|3606386|FG006|Induction Period (IP)|Lost to Follow-up|0
2036225|NCT00410410|3606387|FG007|Induction Period (IP)|Lost to Follow-up|0
2036226|NCT00410410|3606388|FG008|Induction Period (IP)|Lost to Follow-up|0
2036227|NCT00410410|3606380|FG000|Induction Period (IP)|Withdrawal by Subject|3
2036228|NCT00410410|3606381|FG001|Induction Period (IP)|Withdrawal by Subject|5
2036229|NCT00410410|3606382|FG002|Induction Period (IP)|Withdrawal by Subject|3
2036230|NCT00410410|3606383|FG003|Induction Period (IP)|Withdrawal by Subject|5
2036231|NCT00410410|3606384|FG004|Induction Period (IP)|Withdrawal by Subject|2
2036232|NCT00410410|3606385|FG005|Induction Period (IP)|Withdrawal by Subject|0
2036233|NCT00410410|3606386|FG006|Induction Period (IP)|Withdrawal by Subject|0
2036234|NCT00410410|3606387|FG007|Induction Period (IP)|Withdrawal by Subject|0
2036235|NCT00410410|3606388|FG008|Induction Period (IP)|Withdrawal by Subject|0
2036236|NCT00410410|3606380|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2036237|NCT00410410|3606381|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2036238|NCT00410410|3606382|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
2036239|NCT00410410|3606383|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2036240|NCT00410410|3606384|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2036241|NCT00410410|3606385|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2036242|NCT00410410|3606386|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2036243|NCT00410410|3606387|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2036244|NCT00410410|3606388|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2036245|NCT00410410|3606380|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0
2036246|NCT00410410|3606381|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0
2036247|NCT00410410|3606382|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0
2036248|NCT00410410|3606383|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0
2036249|NCT00410410|3606384|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22
2036250|NCT00410410|3606385|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21
2036251|NCT00410410|3606386|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0
2036252|NCT00410410|3606387|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0
2036253|NCT00410410|3606388|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0
2036254|NCT00410410|3606380|FG000|Induction Period (IP)|Other|0
2036255|NCT00410410|3606381|FG001|Induction Period (IP)|Other|0
2036256|NCT00410410|3606382|FG002|Induction Period (IP)|Other|1
2036257|NCT00410410|3606383|FG003|Induction Period (IP)|Other|0
2036258|NCT00410410|3606384|FG004|Induction Period (IP)|Other|0
2036259|NCT00410410|3606385|FG005|Induction Period (IP)|Other|0
2036260|NCT00410410|3606386|FG006|Induction Period (IP)|Other|0
2036261|NCT00410410|3606387|FG007|Induction Period (IP)|Other|0
2036262|NCT00410410|3606388|FG008|Induction Period (IP)|Other|0
2036263|NCT00410410|3606380|FG000|Maintenance Period (MP)|Death|0
2036264|NCT00410410|3606381|FG001|Maintenance Period (MP)|Death|0
2036265|NCT00410410|3606382|FG002|Maintenance Period (MP)|Death|0
2036266|NCT00410410|3606383|FG003|Maintenance Period (MP)|Death|0
2036267|NCT00410410|3606384|FG004|Maintenance Period (MP)|Death|0
2036268|NCT00410410|3606385|FG005|Maintenance Period (MP)|Death|0
2036269|NCT00410410|3606386|FG006|Maintenance Period (MP)|Death|1
2036270|NCT00410410|3606387|FG007|Maintenance Period (MP)|Death|0
2036271|NCT00410410|3606388|FG008|Maintenance Period (MP)|Death|0
2036272|NCT00410410|3606380|FG000|Maintenance Period (MP)|Adverse Event|0
2036273|NCT00410410|3606381|FG001|Maintenance Period (MP)|Adverse Event|0
2036274|NCT00410410|3606382|FG002|Maintenance Period (MP)|Adverse Event|0
2036275|NCT00410410|3606383|FG003|Maintenance Period (MP)|Adverse Event|0
2036276|NCT00410410|3606384|FG004|Maintenance Period (MP)|Adverse Event|0
2036277|NCT00410410|3606385|FG005|Maintenance Period (MP)|Adverse Event|0
2036278|NCT00410410|3606386|FG006|Maintenance Period (MP)|Adverse Event|1
2036279|NCT00410410|3606387|FG007|Maintenance Period (MP)|Adverse Event|3
2036280|NCT00410410|3606388|FG008|Maintenance Period (MP)|Adverse Event|0
2036281|NCT00410410|3606380|FG000|Maintenance Period (MP)|Lack of Efficacy|0
2036282|NCT00410410|3606381|FG001|Maintenance Period (MP)|Lack of Efficacy|0
2036283|NCT00410410|3606382|FG002|Maintenance Period (MP)|Lack of Efficacy|0
2036284|NCT00410410|3606383|FG003|Maintenance Period (MP)|Lack of Efficacy|0
2036285|NCT00410410|3606384|FG004|Maintenance Period (MP)|Lack of Efficacy|0
2036286|NCT00410410|3606385|FG005|Maintenance Period (MP)|Lack of Efficacy|0
2036287|NCT00410410|3606386|FG006|Maintenance Period (MP)|Lack of Efficacy|25
2036288|NCT00410410|3606387|FG007|Maintenance Period (MP)|Lack of Efficacy|24
2036289|NCT00410410|3606388|FG008|Maintenance Period (MP)|Lack of Efficacy|0
2036290|NCT00410410|3606380|FG000|Maintenance Period (MP)|Lost to Follow-up|0
2036291|NCT00410410|3606381|FG001|Maintenance Period (MP)|Lost to Follow-up|0
2036292|NCT00410410|3606382|FG002|Maintenance Period (MP)|Lost to Follow-up|0
2036293|NCT00410410|3606383|FG003|Maintenance Period (MP)|Lost to Follow-up|0
2036294|NCT00410410|3606384|FG004|Maintenance Period (MP)|Lost to Follow-up|0
2036295|NCT00410410|3606385|FG005|Maintenance Period (MP)|Lost to Follow-up|0
2036296|NCT00410410|3606386|FG006|Maintenance Period (MP)|Lost to Follow-up|1
2036297|NCT00410410|3606387|FG007|Maintenance Period (MP)|Lost to Follow-up|2
2036298|NCT00410410|3606388|FG008|Maintenance Period (MP)|Lost to Follow-up|0
2036299|NCT00410410|3606380|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
2036300|NCT00410410|3606381|FG001|Maintenance Period (MP)|Withdrawal by Subject|0
2219029|NCT01718509|3862718|FG001|Overall Study|Lost to Follow-up|15
2219030|NCT01718509|3862717|FG000|Overall Study|Withdrawal by Subject|7
2219031|NCT01718509|3862718|FG001|Overall Study|Withdrawal by Subject|13
2219032|NCT01718509|3862717|FG000|Overall Study|Adverse Event|5
2219033|NCT01718509|3862718|FG001|Overall Study|Adverse Event|7
2219034|NCT01718509|3862717|FG000|Overall Study|Other|13
2219035|NCT01718509|3862718|FG001|Overall Study|Other|11
2219036|NCT01718509|3862717|FG000|Overall Study|Protocol Violation|4
2036301|NCT00410410|3606382|FG002|Maintenance Period (MP)|Withdrawal by Subject|0
2036302|NCT00410410|3606383|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
2036303|NCT00410410|3606384|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
2036304|NCT00410410|3606385|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
2036305|NCT00410410|3606386|FG006|Maintenance Period (MP)|Withdrawal by Subject|1
2036306|NCT00410410|3606387|FG007|Maintenance Period (MP)|Withdrawal by Subject|1
2036307|NCT00410410|3606388|FG008|Maintenance Period (MP)|Withdrawal by Subject|0
2036308|NCT00410410|3606380|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2036309|NCT00410410|3606381|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2036310|NCT00410410|3606382|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2036311|NCT00410410|3606383|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2036312|NCT00410410|3606384|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2036313|NCT00410410|3606385|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2036314|NCT00410410|3606386|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21
2036315|NCT00410410|3606387|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25
2036316|NCT00410410|3606388|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2036317|NCT00410410|3606380|FG000|Open-Label Period (OL)|Death|0
2113251|NCT00913458|3708392|FG001|Phase 1|Subject Request|0
2113252|NCT00913458|3708393|FG002|Phase 1|Subject Request|0
2113253|NCT00913458|3708394|FG003|Phase 1|Subject Request|0
2113254|NCT00913458|3708395|FG004|Phase 1|Subject Request|0
2113255|NCT00913458|3708396|FG005|Phase 1|Subject Request|0
2113256|NCT00913458|3708397|FG006|Phase 1|Subject Request|0
2113257|NCT00913458|3708391|FG000|Phase 1|Adverse Event|20
2113258|NCT00913458|3708392|FG001|Phase 1|Adverse Event|0
2113259|NCT00913458|3708393|FG002|Phase 1|Adverse Event|0
2113260|NCT00913458|3708394|FG003|Phase 1|Adverse Event|0
2113261|NCT00913458|3708395|FG004|Phase 1|Adverse Event|0
2113262|NCT00913458|3708396|FG005|Phase 1|Adverse Event|0
2113263|NCT00913458|3708397|FG006|Phase 1|Adverse Event|0
2113264|NCT00913458|3708391|FG000|Phase 1|Lost to Follow-up|2
2113265|NCT00913458|3708392|FG001|Phase 1|Lost to Follow-up|0
2113266|NCT00913458|3708393|FG002|Phase 1|Lost to Follow-up|0
2113267|NCT00913458|3708394|FG003|Phase 1|Lost to Follow-up|0
2113268|NCT00913458|3708395|FG004|Phase 1|Lost to Follow-up|0
2113269|NCT00913458|3708396|FG005|Phase 1|Lost to Follow-up|0
2113270|NCT00913458|3708397|FG006|Phase 1|Lost to Follow-up|0
2113271|NCT00913458|3708391|FG000|Phase 1|Protocol Violation|10
2113272|NCT00913458|3708392|FG001|Phase 1|Protocol Violation|0
2113273|NCT00913458|3708393|FG002|Phase 1|Protocol Violation|0
2113274|NCT00913458|3708394|FG003|Phase 1|Protocol Violation|0
2113275|NCT00913458|3708395|FG004|Phase 1|Protocol Violation|0
2113276|NCT00913458|3708396|FG005|Phase 1|Protocol Violation|0
2113277|NCT00913458|3708397|FG006|Phase 1|Protocol Violation|0
2113278|NCT00913458|3708391|FG000|Phase 1|Sponsor|2
2113279|NCT00913458|3708392|FG001|Phase 1|Sponsor|0
2113280|NCT00913458|3708393|FG002|Phase 1|Sponsor|0
2113281|NCT00913458|3708394|FG003|Phase 1|Sponsor|0
2113282|NCT00913458|3708395|FG004|Phase 1|Sponsor|0
2113283|NCT00913458|3708396|FG005|Phase 1|Sponsor|0
2113284|NCT00913458|3708397|FG006|Phase 1|Sponsor|0
2219037|NCT01718509|3862718|FG001|Overall Study|Protocol Violation|2
2219038|NCT01718509|3862717|FG000|Overall Study|Lack of Efficacy|1
2219039|NCT01718509|3862718|FG001|Overall Study|Lack of Efficacy|0
2036318|NCT00410410|3606381|FG001|Open-Label Period (OL)|Death|0
2036319|NCT00410410|3606382|FG002|Open-Label Period (OL)|Death|0
2036320|NCT00410410|3606383|FG003|Open-Label Period (OL)|Death|0
2036321|NCT00410410|3606384|FG004|Open-Label Period (OL)|Death|0
2036322|NCT00410410|3606385|FG005|Open-Label Period (OL)|Death|0
2036323|NCT00410410|3606386|FG006|Open-Label Period (OL)|Death|0
2036324|NCT00410410|3606387|FG007|Open-Label Period (OL)|Death|0
2036325|NCT00410410|3606388|FG008|Open-Label Period (OL)|Death|1
2036326|NCT00410410|3606380|FG000|Open-Label Period (OL)|Adverse Event|0
2036327|NCT00410410|3606381|FG001|Open-Label Period (OL)|Adverse Event|0
2036328|NCT00410410|3606382|FG002|Open-Label Period (OL)|Adverse Event|0
2036329|NCT00410410|3606383|FG003|Open-Label Period (OL)|Adverse Event|0
2036330|NCT00410410|3606384|FG004|Open-Label Period (OL)|Adverse Event|0
2036331|NCT00410410|3606385|FG005|Open-Label Period (OL)|Adverse Event|0
2113285|NCT00913458|3708391|FG000|Phase 1|Unsatisfactory Response per Investigator|7
2113286|NCT00913458|3708392|FG001|Phase 1|Unsatisfactory Response per Investigator|0
2113287|NCT00913458|3708393|FG002|Phase 1|Unsatisfactory Response per Investigator|0
2113288|NCT00913458|3708394|FG003|Phase 1|Unsatisfactory Response per Investigator|0
2113289|NCT00913458|3708395|FG004|Phase 1|Unsatisfactory Response per Investigator|0
2113290|NCT00913458|3708396|FG005|Phase 1|Unsatisfactory Response per Investigator|0
2113291|NCT00913458|3708397|FG006|Phase 1|Unsatisfactory Response per Investigator|0
2113292|NCT00913458|3708391|FG000|Phase 2|Non-Responder|0
2113293|NCT00913458|3708392|FG001|Phase 2|Non-Responder|5
2113294|NCT00913458|3708393|FG002|Phase 2|Non-Responder|7
2113295|NCT00913458|3708394|FG003|Phase 2|Non-Responder|12
2113296|NCT00913458|3708395|FG004|Phase 2|Non-Responder|0
2113297|NCT00913458|3708396|FG005|Phase 2|Non-Responder|0
2113298|NCT00913458|3708397|FG006|Phase 2|Non-Responder|0
2113299|NCT00913458|3708391|FG000|Phase 2|Subject Request|0
2113300|NCT00913458|3708392|FG001|Phase 2|Subject Request|0
2113301|NCT00913458|3708393|FG002|Phase 2|Subject Request|1
2113302|NCT00913458|3708394|FG003|Phase 2|Subject Request|2
2113303|NCT00913458|3708395|FG004|Phase 2|Subject Request|0
2113304|NCT00913458|3708396|FG005|Phase 2|Subject Request|0
2113305|NCT00913458|3708397|FG006|Phase 2|Subject Request|0
2113306|NCT00913458|3708391|FG000|Phase 2|Adverse Event|0
2113307|NCT00913458|3708392|FG001|Phase 2|Adverse Event|3
2113308|NCT00913458|3708393|FG002|Phase 2|Adverse Event|0
2113309|NCT00913458|3708394|FG003|Phase 2|Adverse Event|1
2113310|NCT00913458|3708395|FG004|Phase 2|Adverse Event|0
2113311|NCT00913458|3708396|FG005|Phase 2|Adverse Event|0
2113312|NCT00913458|3708397|FG006|Phase 2|Adverse Event|0
2113313|NCT00913458|3708391|FG000|Phase 2|Lost to Follow-up|0
2113314|NCT00913458|3708392|FG001|Phase 2|Lost to Follow-up|0
2113315|NCT00913458|3708393|FG002|Phase 2|Lost to Follow-up|0
2113316|NCT00913458|3708394|FG003|Phase 2|Lost to Follow-up|1
2113317|NCT00913458|3708395|FG004|Phase 2|Lost to Follow-up|0
2113318|NCT00913458|3708396|FG005|Phase 2|Lost to Follow-up|0
2113319|NCT00913458|3708397|FG006|Phase 2|Lost to Follow-up|0
2113320|NCT00913458|3708391|FG000|Phase 2|Protocol Violation|0
2113321|NCT00913458|3708392|FG001|Phase 2|Protocol Violation|2
2113322|NCT00913458|3708393|FG002|Phase 2|Protocol Violation|0
2113323|NCT00913458|3708394|FG003|Phase 2|Protocol Violation|0
2113324|NCT00913458|3708395|FG004|Phase 2|Protocol Violation|0
2113325|NCT00913458|3708396|FG005|Phase 2|Protocol Violation|0
2113326|NCT00913458|3708397|FG006|Phase 2|Protocol Violation|0
2113327|NCT00913458|3708391|FG000|Phase 2|Unsatisfactory Response per Investigator|0
2113328|NCT00913458|3708392|FG001|Phase 2|Unsatisfactory Response per Investigator|0
2113329|NCT00913458|3708393|FG002|Phase 2|Unsatisfactory Response per Investigator|11
2113330|NCT00913458|3708394|FG003|Phase 2|Unsatisfactory Response per Investigator|17
2113331|NCT00913458|3708395|FG004|Phase 2|Unsatisfactory Response per Investigator|0
2113332|NCT00913458|3708396|FG005|Phase 2|Unsatisfactory Response per Investigator|0
2113333|NCT00913458|3708397|FG006|Phase 2|Unsatisfactory Response per Investigator|0
2113334|NCT00913458|3708391|FG000|Phase 3|Adverse Event|0
2113335|NCT00913458|3708392|FG001|Phase 3|Adverse Event|0
2113336|NCT00913458|3708393|FG002|Phase 3|Adverse Event|0
2113337|NCT00913458|3708394|FG003|Phase 3|Adverse Event|0
2113338|NCT00913458|3708395|FG004|Phase 3|Adverse Event|5
2113339|NCT00913458|3708396|FG005|Phase 3|Adverse Event|4
2113340|NCT00913458|3708397|FG006|Phase 3|Adverse Event|1
2113341|NCT00913458|3708391|FG000|Phase 3|Lost to Follow-up|0
2113342|NCT00913458|3708392|FG001|Phase 3|Lost to Follow-up|0
2113343|NCT00913458|3708393|FG002|Phase 3|Lost to Follow-up|0
2113344|NCT00913458|3708394|FG003|Phase 3|Lost to Follow-up|0
2113345|NCT00913458|3708395|FG004|Phase 3|Lost to Follow-up|2
2113346|NCT00913458|3708396|FG005|Phase 3|Lost to Follow-up|0
2113347|NCT00913458|3708397|FG006|Phase 3|Lost to Follow-up|0
2113348|NCT00913458|3708391|FG000|Phase 3|Non-Responder|0
2113349|NCT00913458|3708392|FG001|Phase 3|Non-Responder|0
2113350|NCT00913458|3708393|FG002|Phase 3|Non-Responder|0
2113351|NCT00913458|3708394|FG003|Phase 3|Non-Responder|0
2113352|NCT00913458|3708395|FG004|Phase 3|Non-Responder|0
2113353|NCT00913458|3708396|FG005|Phase 3|Non-Responder|1
2113354|NCT00913458|3708397|FG006|Phase 3|Non-Responder|3
2113355|NCT00913458|3708391|FG000|Phase 3|Withdrawal by Subject|0
2113356|NCT00913458|3708392|FG001|Phase 3|Withdrawal by Subject|0
2113357|NCT00913458|3708393|FG002|Phase 3|Withdrawal by Subject|0
2113358|NCT00913458|3708394|FG003|Phase 3|Withdrawal by Subject|0
2113359|NCT00913458|3708395|FG004|Phase 3|Withdrawal by Subject|1
2113360|NCT00913458|3708396|FG005|Phase 3|Withdrawal by Subject|2
2036332|NCT00410410|3606386|FG006|Open-Label Period (OL)|Adverse Event|0
2036333|NCT00410410|3606387|FG007|Open-Label Period (OL)|Adverse Event|0
2036334|NCT00410410|3606388|FG008|Open-Label Period (OL)|Adverse Event|10
2036335|NCT00410410|3606380|FG000|Open-Label Period (OL)|Lack of Efficacy|0
2036336|NCT00410410|3606381|FG001|Open-Label Period (OL)|Lack of Efficacy|0
2036337|NCT00410410|3606382|FG002|Open-Label Period (OL)|Lack of Efficacy|0
2036338|NCT00410410|3606383|FG003|Open-Label Period (OL)|Lack of Efficacy|0
2036339|NCT00410410|3606384|FG004|Open-Label Period (OL)|Lack of Efficacy|0
2036340|NCT00410410|3606385|FG005|Open-Label Period (OL)|Lack of Efficacy|0
2036341|NCT00410410|3606386|FG006|Open-Label Period (OL)|Lack of Efficacy|0
2036342|NCT00410410|3606387|FG007|Open-Label Period (OL)|Lack of Efficacy|0
2036343|NCT00410410|3606388|FG008|Open-Label Period (OL)|Lack of Efficacy|161
2036344|NCT00410410|3606380|FG000|Open-Label Period (OL)|Lost to Follow-up|0
2036345|NCT00410410|3606381|FG001|Open-Label Period (OL)|Lost to Follow-up|0
2036346|NCT00410410|3606382|FG002|Open-Label Period (OL)|Lost to Follow-up|0
2036347|NCT00410410|3606383|FG003|Open-Label Period (OL)|Lost to Follow-up|0
2036348|NCT00410410|3606384|FG004|Open-Label Period (OL)|Lost to Follow-up|0
2036349|NCT00410410|3606385|FG005|Open-Label Period (OL)|Lost to Follow-up|0
2036350|NCT00410410|3606386|FG006|Open-Label Period (OL)|Lost to Follow-up|0
2036351|NCT00410410|3606387|FG007|Open-Label Period (OL)|Lost to Follow-up|0
2036352|NCT00410410|3606388|FG008|Open-Label Period (OL)|Lost to Follow-up|4
2036353|NCT00410410|3606380|FG000|Open-Label Period (OL)|Withdrawal by Subject|0
2036354|NCT00410410|3606381|FG001|Open-Label Period (OL)|Withdrawal by Subject|0
2036355|NCT00410410|3606382|FG002|Open-Label Period (OL)|Withdrawal by Subject|0
2036356|NCT00410410|3606383|FG003|Open-Label Period (OL)|Withdrawal by Subject|0
2036357|NCT00410410|3606384|FG004|Open-Label Period (OL)|Withdrawal by Subject|0
2036358|NCT00410410|3606385|FG005|Open-Label Period (OL)|Withdrawal by Subject|0
2036359|NCT00410410|3606386|FG006|Open-Label Period (OL)|Withdrawal by Subject|0
2036360|NCT00410410|3606387|FG007|Open-Label Period (OL)|Withdrawal by Subject|0
2036361|NCT00410410|3606388|FG008|Open-Label Period (OL)|Withdrawal by Subject|20
2036362|NCT00410410|3606380|FG000|Open-Label Period (OL)|Pregnancy|0
2036363|NCT00410410|3606381|FG001|Open-Label Period (OL)|Pregnancy|0
2036364|NCT00410410|3606382|FG002|Open-Label Period (OL)|Pregnancy|0
2036365|NCT00410410|3606383|FG003|Open-Label Period (OL)|Pregnancy|0
2036366|NCT00410410|3606384|FG004|Open-Label Period (OL)|Pregnancy|0
2036367|NCT00410410|3606385|FG005|Open-Label Period (OL)|Pregnancy|0
2036368|NCT00410410|3606386|FG006|Open-Label Period (OL)|Pregnancy|0
2036369|NCT00410410|3606387|FG007|Open-Label Period (OL)|Pregnancy|0
2036370|NCT00410410|3606388|FG008|Open-Label Period (OL)|Pregnancy|1
2036371|NCT00410410|3606380|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2036372|NCT00410410|3606381|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2036373|NCT00410410|3606382|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2036374|NCT00410410|3606383|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2036375|NCT00410410|3606384|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2036376|NCT00410410|3606385|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2036377|NCT00410410|3606386|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2036378|NCT00410410|3606387|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2036379|NCT00410410|3606388|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145
2036380|NCT00410410|3606380|FG000|Open-Label Period (OL)|Other|0
2036381|NCT00410410|3606381|FG001|Open-Label Period (OL)|Other|0
2036382|NCT00410410|3606382|FG002|Open-Label Period (OL)|Other|0
2036383|NCT00410410|3606383|FG003|Open-Label Period (OL)|Other|0
2036384|NCT00410410|3606384|FG004|Open-Label Period (OL)|Other|0
2036385|NCT00410410|3606385|FG005|Open-Label Period (OL)|Other|0
2036386|NCT00410410|3606386|FG006|Open-Label Period (OL)|Other|0
2036387|NCT00410410|3606387|FG007|Open-Label Period (OL)|Other|0
2036388|NCT00410410|3606388|FG008|Open-Label Period (OL)|Other|7
2036389|NCT00410514|3606444|FG000|Overall Study|Adverse Event|2
2036390|NCT00410514|3606445|FG001|Overall Study|Adverse Event|2
2036391|NCT00410514|3606446|FG002|Overall Study|Adverse Event|2
2036392|NCT00410514|3606444|FG000|Overall Study|Protocol Violation|0
2036393|NCT00410514|3606445|FG001|Overall Study|Protocol Violation|1
2036394|NCT00410514|3606446|FG002|Overall Study|Protocol Violation|1
2036395|NCT00410514|3606444|FG000|Overall Study|Lost to Follow-up|0
2036396|NCT00410514|3606445|FG001|Overall Study|Lost to Follow-up|0
2036397|NCT00410514|3606446|FG002|Overall Study|Lost to Follow-up|2
2036398|NCT00410514|3606444|FG000|Overall Study|Non-compliant with study procedures|0
2036399|NCT00410514|3606445|FG001|Overall Study|Non-compliant with study procedures|0
2036400|NCT00410514|3606446|FG002|Overall Study|Non-compliant with study procedures|2
2036401|NCT00410605|3606454|FG000|Overall Study|Adverse Event|12
2036402|NCT00410605|3606454|FG000|Overall Study|Physician Decision|3
2036403|NCT00410605|3606454|FG000|Overall Study|Withdrawal by Subject|5
2036404|NCT00410605|3606454|FG000|Overall Study|Started Non-Protocol Therapy|3
2036405|NCT00410605|3606454|FG000|Overall Study|Stopped treatmen to collect stem cells|1
2036406|NCT00410605|3606454|FG000|Overall Study|Transferred to another Institution|1
2036407|NCT00410761|3606460|FG000|Overall Study|Adverse Event|29
2036408|NCT00410761|3606461|FG001|Overall Study|Adverse Event|3
2036409|NCT00410761|3606460|FG000|Overall Study|objective disease progression|71
2036410|NCT00410761|3606461|FG001|Overall Study|objective disease progression|55
2036411|NCT00410761|3606460|FG000|Overall Study|Withdrawal by Subject|8
2036412|NCT00410761|3606461|FG001|Overall Study|Withdrawal by Subject|4
2036413|NCT00410761|3606460|FG000|Overall Study|Other|12
2036414|NCT00410761|3606461|FG001|Overall Study|Other|9
2036415|NCT00410761|3606460|FG000|Overall Study|Never received randomised treatment|0
2036416|NCT00410761|3606461|FG001|Overall Study|Never received randomised treatment|1
2036417|NCT00410813|3606469|FG000|Overall Study|Adverse Event|6
2036418|NCT00410813|3606470|FG001|Overall Study|Adverse Event|11
2036419|NCT00410813|3606469|FG000|Overall Study|Progression|32
2036420|NCT00410813|3606470|FG001|Overall Study|Progression|21
2036421|NCT00410813|3606469|FG000|Overall Study|Not protocol specified|3
2036422|NCT00410813|3606470|FG001|Overall Study|Not protocol specified|4
2036423|NCT00410813|3606469|FG000|Overall Study|Ineligible|2
2036424|NCT00410813|3606470|FG001|Overall Study|Ineligible|4
2036425|NCT00410813|3606469|FG000|Overall Study|Death|0
2036426|NCT00410813|3606470|FG001|Overall Study|Death|2
2036427|NCT00411151|3606526|FG000|Overall Study|Death|38
2036428|NCT00411151|3606526|FG000|Overall Study|Withdrawal by Subject|2
2036429|NCT00411151|3606526|FG000|Overall Study|Lost to Follow-up|2
2036430|NCT00411151|3606526|FG000|Overall Study|Protocol Violation|1
2036431|NCT00411151|3606526|FG000|Overall Study|Trial prematurely closed|4
2036432|NCT00411216|3606532|FG000|Overall Study|Ten participants were entered into the c|0
2036433|NCT00411216|3606533|FG001|Overall Study|Ten participants were entered into the c|2
2036434|NCT00411450|3606553|FG000|Overall Study|Ongoing at time of data cut-off.|3
2036435|NCT00411554|3606573|FG000|Overall Study|Adverse Event|2
2113361|NCT00913458|3708397|FG006|Phase 3|Withdrawal by Subject|0
2113362|NCT00913458|3708391|FG000|Phase 3|Unsatisfactory Response per Investigator|0
2113363|NCT00913458|3708392|FG001|Phase 3|Unsatisfactory Response per Investigator|0
2113364|NCT00913458|3708393|FG002|Phase 3|Unsatisfactory Response per Investigator|0
2113365|NCT00913458|3708394|FG003|Phase 3|Unsatisfactory Response per Investigator|0
2113366|NCT00913458|3708395|FG004|Phase 3|Unsatisfactory Response per Investigator|14
2113367|NCT00913458|3708396|FG005|Phase 3|Unsatisfactory Response per Investigator|11
2113368|NCT00913458|3708397|FG006|Phase 3|Unsatisfactory Response per Investigator|4
2113369|NCT00913523|3708426|FG000|Overall Study|Withdrawal by Subject|3
2113370|NCT00913523|3708427|FG001|Overall Study|Withdrawal by Subject|2
2113371|NCT00913523|3708428|FG002|Overall Study|Withdrawal by Subject|2
2113372|NCT00913523|3708426|FG000|Overall Study|Lost to Follow-up|1
2113373|NCT00913523|3708427|FG001|Overall Study|Lost to Follow-up|1
2113374|NCT00913523|3708428|FG002|Overall Study|Lost to Follow-up|1
2113375|NCT00913523|3708426|FG000|Overall Study|Adverse Event|1
2113376|NCT00913523|3708427|FG001|Overall Study|Adverse Event|0
2113377|NCT00913523|3708428|FG002|Overall Study|Adverse Event|0
2113378|NCT00913523|3708426|FG000|Overall Study|Protocol Violation|5
2113379|NCT00913523|3708427|FG001|Overall Study|Protocol Violation|8
2113380|NCT00913523|3708428|FG002|Overall Study|Protocol Violation|8
2113381|NCT00913523|3708426|FG000|Overall Study|Pregnancy|1
2113382|NCT00913523|3708427|FG001|Overall Study|Pregnancy|3
2113383|NCT00913523|3708428|FG002|Overall Study|Pregnancy|0
2180483|NCT01402011|3806671|FG002|Active Treatment Period|Withdrawal by Subject|0
2180484|NCT01402011|3806669|FG000|Nine Month Follow-up|Withdrawal by Subject|0
2180485|NCT01402011|3806670|FG001|Nine Month Follow-up|Withdrawal by Subject|1
2180486|NCT01402011|3806671|FG002|Nine Month Follow-up|Withdrawal by Subject|0
2180487|NCT01402063|3806693|FG000|Overall Study|Withdrawal by Subject|3
2180488|NCT01402063|3806694|FG001|Overall Study|Withdrawal by Subject|3
2180489|NCT01402102|3806702|FG000|Overall Study|Protocol Violation|1
2180490|NCT01402102|3806703|FG001|Overall Study|Protocol Violation|0
2180491|NCT01402102|3806702|FG000|Overall Study|Insufficiency of compliance|1
2180492|NCT01402102|3806703|FG001|Overall Study|Insufficiency of compliance|1
2180493|NCT01402102|3806702|FG000|Overall Study|Withdrawal by Subject|0
2180494|NCT01402102|3806703|FG001|Overall Study|Withdrawal by Subject|2
2180495|NCT01402284|3806739|FG000|Overall Study|Withdrawal consent|2
2180496|NCT01402284|3806739|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1
2180497|NCT01402284|3806739|FG000|Overall Study|Physician Decision|1
2180498|NCT01402284|3806739|FG000|Overall Study|Disease progression on study|10
2180499|NCT01402492|3806780|FG000|Overall Study|Withdrawal by Subject|17
2180500|NCT01402492|3806781|FG001|Overall Study|Withdrawal by Subject|11
2180501|NCT01402492|3806782|FG002|Overall Study|Withdrawal by Subject|11
2180502|NCT01402492|3806780|FG000|Overall Study|Adverse Event|2
2180503|NCT01402492|3806781|FG001|Overall Study|Adverse Event|3
2180504|NCT01402492|3806782|FG002|Overall Study|Adverse Event|4
2180505|NCT01402492|3806780|FG000|Overall Study|Physician Decision|0
2180506|NCT01402492|3806781|FG001|Overall Study|Physician Decision|3
2180507|NCT01402492|3806782|FG002|Overall Study|Physician Decision|0
2180508|NCT01402492|3806780|FG000|Overall Study|Incarcerated (N=3)|2
2180509|NCT01402492|3806781|FG001|Overall Study|Incarcerated (N=3)|0
2180510|NCT01402492|3806782|FG002|Overall Study|Incarcerated (N=3)|1
2180511|NCT01402544|3806790|FG000|Overall Study|Withdrawal by Subject|6
2180512|NCT01402570|3806794|FG000|Overall Study|Adverse Event|1
2180513|NCT01402700|3806799|FG000|Overall Study|Death|3
2180514|NCT01402700|3806799|FG000|Overall Study|Withdrawal by Subject|3
2180515|NCT01402700|3806799|FG000|Overall Study|Missed Visit|1
2180516|NCT01402817|3806803|FG000|Overall Study|Withdrawal by Subject|3
2180517|NCT01402817|3806803|FG000|Overall Study|Study Suspended by FDA|8
2180518|NCT01402869|3806811|FG000|Overall Study|Required Tooth Extraction|0
2036436|NCT00411554|3606574|FG001|Overall Study|Adverse Event|4
2036437|NCT00411554|3606573|FG000|Overall Study|Lack of Efficacy|2
2036438|NCT00411554|3606574|FG001|Overall Study|Lack of Efficacy|5
2036439|NCT00411554|3606573|FG000|Overall Study|Withdrawal by Subject|3
2036440|NCT00411554|3606574|FG001|Overall Study|Withdrawal by Subject|0
2036441|NCT00411554|3606573|FG000|Overall Study|Patient Moved|1
2036442|NCT00411554|3606574|FG001|Overall Study|Patient Moved|0
2036443|NCT00411632|3606585|FG000|Overall Study|Death|1
2036444|NCT00411645|3606591|FG000|Overall Study|Consent Withdrawn|13
2036445|NCT00411645|3606592|FG001|Overall Study|Consent Withdrawn|22
2036446|NCT00411645|3606591|FG000|Overall Study|Death|56
2036447|NCT00411645|3606592|FG001|Overall Study|Death|135
2036448|NCT00411645|3606591|FG000|Overall Study|Investigator/Sponsor Decision|10
2036449|NCT00411645|3606592|FG001|Overall Study|Investigator/Sponsor Decision|7
2036450|NCT00411645|3606591|FG000|Overall Study|Lost to Follow-up|2
2036451|NCT00411645|3606592|FG001|Overall Study|Lost to Follow-up|0
2036452|NCT00411671|3606599|FG000|Overall Study|Adverse Event|15
2036453|NCT00411671|3606599|FG000|Overall Study|Death|2
2036454|NCT00411671|3606599|FG000|Overall Study|Lost to Follow-up|3
2036455|NCT00411762|3606620|FG000|Overall Study|Withdrawal by Subject|5
2036456|NCT00411788|3606624|FG000|Overall Study|Protocol Violation|1
2036457|NCT00411788|3606624|FG000|Overall Study|Adverse Event|1
2036458|NCT00412061|3606630|FG000|Double Blind Phase|Disease Progression|101
2036459|NCT00412061|3606631|FG001|Double Blind Phase|Disease Progression|154
2036460|NCT00412061|3606630|FG000|Double Blind Phase|Adverse Event|61
2036461|NCT00412061|3606631|FG001|Double Blind Phase|Adverse Event|16
2036462|NCT00412061|3606630|FG000|Double Blind Phase|Final Primary Analysis|26
2036463|NCT00412061|3606631|FG001|Double Blind Phase|Final Primary Analysis|14
2036464|NCT00412061|3606630|FG000|Double Blind Phase|Withdrawal by Subject|18
2036465|NCT00412061|3606631|FG001|Double Blind Phase|Withdrawal by Subject|20
2036466|NCT00412061|3606630|FG000|Double Blind Phase|Death|6
2036467|NCT00412061|3606631|FG001|Double Blind Phase|Death|3
2036468|NCT00412061|3606630|FG000|Double Blind Phase|Protocol Violation|3
2036469|NCT00412061|3606631|FG001|Double Blind Phase|Protocol Violation|4
2036470|NCT00412061|3606630|FG000|Double Blind Phase|New Cander Therapy|1
2036471|NCT00412061|3606631|FG001|Double Blind Phase|New Cander Therapy|1
2036472|NCT00412061|3606630|FG000|Double Blind Phase|Lost to Follow-up|0
2036473|NCT00412061|3606631|FG001|Double Blind Phase|Lost to Follow-up|1
2036474|NCT00412061|3606630|FG000|Open Label Phase|Disease Progression|0
2036475|NCT00412061|3606631|FG001|Open Label Phase|Disease Progression|86
2036476|NCT00412061|3606630|FG000|Open Label Phase|Adverse Event|0
2036477|NCT00412061|3606631|FG001|Open Label Phase|Adverse Event|46
2036478|NCT00412061|3606630|FG000|Open Label Phase|Withdrawal by Subject|0
2036479|NCT00412061|3606631|FG001|Open Label Phase|Withdrawal by Subject|15
2036480|NCT00412061|3606630|FG000|Open Label Phase|Administrative Problems|0
2036481|NCT00412061|3606631|FG001|Open Label Phase|Administrative Problems|13
2036482|NCT00412061|3606630|FG000|Open Label Phase|Death|0
2036483|NCT00412061|3606631|FG001|Open Label Phase|Death|7
2036484|NCT00412061|3606630|FG000|Open Label Phase|Lost to Follow-up|0
2036485|NCT00412061|3606631|FG001|Open Label Phase|Lost to Follow-up|2
2036486|NCT00412061|3606630|FG000|Open Label Phase|New Cancer Therapy|0
2036487|NCT00412061|3606631|FG001|Open Label Phase|New Cancer Therapy|1
2036488|NCT00412113|3606667|FG000|Overall Study|Adverse Event|11
2036489|NCT00412113|3606668|FG001|Overall Study|Adverse Event|15
2036490|NCT00412113|3606667|FG000|Overall Study|did not receive treatment|1
2036491|NCT00412113|3606668|FG001|Overall Study|did not receive treatment|0
2036492|NCT00412217|3606676|FG000|Overall Study|Insufficient Data Available|8
2036493|NCT00412217|3606677|FG001|Overall Study|Insufficient Data Available|3
2036494|NCT00412217|3606676|FG000|Overall Study|Death|5
2036495|NCT00412217|3606677|FG001|Overall Study|Death|4
2036496|NCT00412217|3606676|FG000|Overall Study|Disease Progression|2
2036497|NCT00412217|3606677|FG001|Overall Study|Disease Progression|3
2036498|NCT00412217|3606676|FG000|Overall Study|Investigator Decision|1
2036499|NCT00412217|3606677|FG001|Overall Study|Investigator Decision|0
2036500|NCT00412217|3606676|FG000|Overall Study|Withdrawal by Subject|2
2036501|NCT00412217|3606677|FG001|Overall Study|Withdrawal by Subject|0
2036502|NCT00412217|3606676|FG000|Overall Study|Lost to Follow-up|1
2036503|NCT00412217|3606677|FG001|Overall Study|Lost to Follow-up|4
2036504|NCT00412217|3606676|FG000|Overall Study|Study Terminated by Sponsor|26
2036505|NCT00412217|3606677|FG001|Overall Study|Study Terminated by Sponsor|33
2036506|NCT00412217|3606676|FG000|Overall Study|Other|1
2036507|NCT00412217|3606677|FG001|Overall Study|Other|1
2036508|NCT00412360|3606689|FG000|Overall Study|Lost to Follow-up|0
2036509|NCT00412360|3606690|FG001|Overall Study|Lost to Follow-up|1
2036510|NCT00412360|3606689|FG000|Overall Study|Not Transplanted|1
2036511|NCT00412360|3606690|FG001|Overall Study|Not Transplanted|2
2036512|NCT00412373|3606698|FG000|Overall Study|Adverse Event|8
2036513|NCT00412373|3606699|FG001|Overall Study|Adverse Event|13
2036514|NCT00412373|3606698|FG000|Overall Study|Lack of Efficacy|16
2036515|NCT00412373|3606699|FG001|Overall Study|Lack of Efficacy|22
2036516|NCT00412373|3606698|FG000|Overall Study|Lost to Follow-up|7
2036517|NCT00412373|3606699|FG001|Overall Study|Lost to Follow-up|13
2036518|NCT00412373|3606698|FG000|Overall Study|Withdrawal by Subject|8
2036519|NCT00412373|3606699|FG001|Overall Study|Withdrawal by Subject|27
2036520|NCT00412373|3606698|FG000|Overall Study|Other|2
2036521|NCT00412373|3606699|FG001|Overall Study|Other|2
2036522|NCT00412542|3606759|FG000|Overall Study|Withdrawal by Subject|0
2036523|NCT00412542|3606760|FG001|Overall Study|Withdrawal by Subject|2
2036524|NCT00412542|3606759|FG000|Overall Study|Not Eligible|0
2036525|NCT00412542|3606760|FG001|Overall Study|Not Eligible|1
2036526|NCT00412607|3606764|FG000|Overall Study|Withdrawal by Subject|9
2036527|NCT00412607|3606764|FG000|Overall Study|Lost to Follow-up|19
2036528|NCT00412607|3606764|FG000|Overall Study|Death|61
2036529|NCT00412607|3606764|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15
2036530|NCT00412737|3606773|FG000|Overall Study|Death|1
2036531|NCT00412737|3606774|FG001|Overall Study|Death|0
2036532|NCT00412737|3606773|FG000|Overall Study|Adverse Event|3
2036533|NCT00412737|3606774|FG001|Overall Study|Adverse Event|2
2036534|NCT00412737|3606773|FG000|Overall Study|Refused Treatment|6
2036535|NCT00412737|3606774|FG001|Overall Study|Refused Treatment|2
2036536|NCT00412737|3606773|FG000|Overall Study|Failure to Return|6
2036537|NCT00412737|3606774|FG001|Overall Study|Failure to Return|2
2036538|NCT00412750|3606783|FG000|Overall Study|Abnormal laboratory value(s)|1
2036539|NCT00412750|3606784|FG001|Overall Study|Abnormal laboratory value(s)|0
2036540|NCT00412750|3606785|FG002|Overall Study|Abnormal laboratory value(s)|0
2036541|NCT00412750|3606783|FG000|Overall Study|Administrative problems|21
2036542|NCT00412750|3606784|FG001|Overall Study|Administrative problems|17
2036543|NCT00412750|3606785|FG002|Overall Study|Administrative problems|14
2036544|NCT00412750|3606783|FG000|Overall Study|Adverse Event|8
2036545|NCT00412750|3606784|FG001|Overall Study|Adverse Event|3
2036546|NCT00412750|3606785|FG002|Overall Study|Adverse Event|3
2036547|NCT00412750|3606783|FG000|Overall Study|Lost to Follow-up|1
2036548|NCT00412750|3606784|FG001|Overall Study|Lost to Follow-up|0
2036549|NCT00412750|3606785|FG002|Overall Study|Lost to Follow-up|1
2036550|NCT00412750|3606783|FG000|Overall Study|Withdrawal by Subject|0
2036551|NCT00412750|3606784|FG001|Overall Study|Withdrawal by Subject|1
2036552|NCT00412750|3606785|FG002|Overall Study|Withdrawal by Subject|2
2036553|NCT00412750|3606783|FG000|Overall Study|Lack of Efficacy|0
2036554|NCT00412750|3606784|FG001|Overall Study|Lack of Efficacy|0
2036555|NCT00412750|3606785|FG002|Overall Study|Lack of Efficacy|3
2036556|NCT00412854|3606807|FG000|Overall Study|Withdrawn due to adverse events|1
2036557|NCT00412854|3606808|FG001|Overall Study|Withdrawn due to adverse events|5
2036558|NCT00412854|3606807|FG000|Overall Study|Withdrawn for other reasons|13
2036559|NCT00412854|3606808|FG001|Overall Study|Withdrawn for other reasons|11
2036560|NCT00412893|3606821|FG000|Overall Study|Adverse Event|31
2036561|NCT00412893|3606822|FG001|Overall Study|Adverse Event|53
2036562|NCT00412893|3606821|FG000|Overall Study|Death|17
2113384|NCT00913523|3708426|FG000|Overall Study|Inadequate Number of Tampons Used|7
2113385|NCT00913523|3708427|FG001|Overall Study|Inadequate Number of Tampons Used|2
2113386|NCT00913523|3708428|FG002|Overall Study|Inadequate Number of Tampons Used|3
2113387|NCT00913744|3708455|FG000|Overall Study|Adverse Event|2
2113388|NCT00913744|3708456|FG001|Overall Study|Adverse Event|0
2113389|NCT00913744|3708455|FG000|Overall Study|Withdrawal by Subject|2
2113390|NCT00913744|3708456|FG001|Overall Study|Withdrawal by Subject|1
2113391|NCT00913744|3708455|FG000|Overall Study|Death|1
2113392|NCT00913744|3708456|FG001|Overall Study|Death|0
2113393|NCT00913770|3708465|FG000|Overall Study|Unable to contact|24
2113394|NCT00913770|3708466|FG001|Overall Study|Unable to contact|19
2113395|NCT00913770|3708467|FG002|Overall Study|Unable to contact|13
2113396|NCT00913770|3708465|FG000|Overall Study|Refused|11
2113397|NCT00913770|3708466|FG001|Overall Study|Refused|10
2113398|NCT00913770|3708467|FG002|Overall Study|Refused|8
2113399|NCT00913835|3708477|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
2113400|NCT00913835|3708478|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
2113401|NCT00913835|3708477|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
2113402|NCT00913835|3708478|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
2113403|NCT00913835|3708477|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
2113404|NCT00913835|3708478|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
2113405|NCT00913835|3708477|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
2113406|NCT00913835|3708478|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
2113407|NCT00913835|3708477|FG000|Lip Dox: Olaratumab Monotherapy|Other|0
2113408|NCT00913835|3708478|FG001|Lip Dox: Olaratumab Monotherapy|Other|3
2113409|NCT00913978|3708497|FG000|Overall Study|Surgeon choice|1
2113410|NCT00913978|3708498|FG001|Overall Study|Surgeon choice|3
2180519|NCT01402869|3806812|FG001|Overall Study|Required Tooth Extraction|0
2180520|NCT01402869|3806813|FG002|Overall Study|Required Tooth Extraction|1
2180521|NCT01402908|3806823|FG000|Overall Study|Withdrawal by Subject|30
2180522|NCT01402908|3806824|FG001|Overall Study|Withdrawal by Subject|17
2180523|NCT01402908|3806823|FG000|Overall Study|Lost to Follow-up|3
2180524|NCT01402908|3806824|FG001|Overall Study|Lost to Follow-up|1
2180525|NCT01402908|3806823|FG000|Overall Study|Physician Decision|1
2180526|NCT01402908|3806824|FG001|Overall Study|Physician Decision|0
2180527|NCT01402947|3806832|FG000|First Intervention|Adverse Event|0
2180528|NCT01402947|3806833|FG001|First Intervention|Adverse Event|1
2180529|NCT01402986|3806843|FG000|Overall Study|Withdrawal by Subject|7
2180530|NCT01402986|3806844|FG001|Overall Study|Withdrawal by Subject|10
2180531|NCT01402986|3806845|FG002|Overall Study|Withdrawal by Subject|7
2180532|NCT01402986|3806846|FG003|Overall Study|Withdrawal by Subject|13
2036563|NCT00412893|3606822|FG001|Overall Study|Death|21
2036564|NCT00412893|3606821|FG000|Overall Study|Insufficient Therapeutic Response|39
2036565|NCT00412893|3606822|FG001|Overall Study|Insufficient Therapeutic Response|23
2036566|NCT00412893|3606821|FG000|Overall Study|Lost to Follow-up|2
2036567|NCT00412893|3606822|FG001|Overall Study|Lost to Follow-up|1
2113411|NCT00914316|3708535|FG000|Phase 1|Physician Decision|4
2113412|NCT00914316|3708536|FG001|Phase 1|Physician Decision|0
2113413|NCT00914316|3708537|FG002|Phase 1|Physician Decision|1
2113414|NCT00914316|3708538|FG003|Phase 1|Physician Decision|2
2113415|NCT00914316|3708535|FG000|Phase 1|Withdrawal by Subject|0
2113416|NCT00914316|3708536|FG001|Phase 1|Withdrawal by Subject|2
2113417|NCT00914316|3708537|FG002|Phase 1|Withdrawal by Subject|4
2113418|NCT00914316|3708538|FG003|Phase 1|Withdrawal by Subject|0
2113419|NCT00914316|3708535|FG000|Phase 1|Adverse Event|1
2113420|NCT00914316|3708536|FG001|Phase 1|Adverse Event|0
2113421|NCT00914316|3708537|FG002|Phase 1|Adverse Event|0
2113422|NCT00914316|3708538|FG003|Phase 1|Adverse Event|0
2113423|NCT00914316|3708535|FG000|Phase 2|Withdrawal by Subject|1
2113424|NCT00914316|3708536|FG001|Phase 2|Withdrawal by Subject|0
2113425|NCT00914316|3708537|FG002|Phase 2|Withdrawal by Subject|1
2113426|NCT00914316|3708538|FG003|Phase 2|Withdrawal by Subject|0
2113427|NCT00914459|3708550|FG000|Overall Study|Protocol Violation|0
2219040|NCT01718535|3862741|FG000|Overall Study|Bidirectional Sequencing not possible|1
2219041|NCT01718535|3862742|FG001|Overall Study|Bidirectional Sequencing not possible|0
2219042|NCT01718535|3862743|FG002|Overall Study|Bidirectional Sequencing not possible|0
2219043|NCT01718535|3862744|FG003|Overall Study|Bidirectional Sequencing not possible|1
2219044|NCT01718535|3862745|FG004|Overall Study|Bidirectional Sequencing not possible|0
2113428|NCT00914459|3708551|FG001|Overall Study|Protocol Violation|1
2113429|NCT00914459|3708550|FG000|Overall Study|Parent/Legal guardian request|1
2113430|NCT00914459|3708551|FG001|Overall Study|Parent/Legal guardian request|0
2113431|NCT00914589|3708566|FG000|Overall Study|Adverse Event|1
2113432|NCT00914589|3708567|FG001|Overall Study|Adverse Event|0
2113433|NCT00914589|3708568|FG002|Overall Study|Adverse Event|1
2113434|NCT00914589|3708566|FG000|Overall Study|Protocol Violation|8
2113435|NCT00914589|3708567|FG001|Overall Study|Protocol Violation|6
2113436|NCT00914589|3708568|FG002|Overall Study|Protocol Violation|3
2113437|NCT00914589|3708566|FG000|Overall Study|unclassified|16
2113438|NCT00914589|3708567|FG001|Overall Study|unclassified|9
2113439|NCT00914589|3708568|FG002|Overall Study|unclassified|7
2113440|NCT00914589|3708566|FG000|Overall Study|Death|0
2113441|NCT00914589|3708567|FG001|Overall Study|Death|1
2113442|NCT00914589|3708568|FG002|Overall Study|Death|1
2113443|NCT00914628|3708578|FG000|Overall Study|Death|35
2113444|NCT00914628|3708579|FG001|Overall Study|Death|17
2113445|NCT00914628|3708578|FG000|Overall Study|Medical decision|4
2113446|NCT00914628|3708579|FG001|Overall Study|Medical decision|0
2113447|NCT00914628|3708578|FG000|Overall Study|Protocol Violation|1
2113448|NCT00914628|3708579|FG001|Overall Study|Protocol Violation|0
2113449|NCT00914628|3708578|FG000|Overall Study|Lack of Efficacy|1
2113450|NCT00914628|3708579|FG001|Overall Study|Lack of Efficacy|0
2113451|NCT00914628|3708578|FG000|Overall Study|non-randomized|1
2113452|NCT00914628|3708579|FG001|Overall Study|non-randomized|0
2113453|NCT00914628|3708578|FG000|Overall Study|Relapse|1
2113454|NCT00914628|3708579|FG001|Overall Study|Relapse|2
2113455|NCT00914628|3708578|FG000|Overall Study|Study terminated by Sponsor|14
2113456|NCT00914628|3708579|FG001|Overall Study|Study terminated by Sponsor|8
2113457|NCT00914628|3708578|FG000|Overall Study|Patients who did not receive a single dose|7
2036568|NCT00412893|3606821|FG000|Overall Study|Violation of Selection at Entry|17
2036569|NCT00412893|3606822|FG001|Overall Study|Violation of Selection at Entry|10
2036570|NCT00412893|3606821|FG000|Overall Study|Other Protocol Violation|10
2036571|NCT00412893|3606822|FG001|Overall Study|Other Protocol Violation|6
2036572|NCT00412893|3606821|FG000|Overall Study|Did Not Cooperate|12
2036573|NCT00412893|3606822|FG001|Overall Study|Did Not Cooperate|9
2036574|NCT00412893|3606821|FG000|Overall Study|Administrative Reason|12
2036575|NCT00412893|3606822|FG001|Overall Study|Administrative Reason|15
2036576|NCT00412893|3606821|FG000|Overall Study|Randomized but Never Received Study Drug|5
2036577|NCT00412893|3606822|FG001|Overall Study|Randomized but Never Received Study Drug|6
2036578|NCT00412958|3606832|FG000|Overall Study|Withdrawal by Subject|3
2036579|NCT00412958|3606833|FG001|Overall Study|Withdrawal by Subject|0
2036580|NCT00412958|3606834|FG002|Overall Study|Withdrawal by Subject|0
2036581|NCT00412958|3606835|FG003|Overall Study|Withdrawal by Subject|1
2036582|NCT00412958|3606832|FG000|Overall Study|Adverse Event|0
2036583|NCT00412958|3606833|FG001|Overall Study|Adverse Event|1
2036584|NCT00412958|3606834|FG002|Overall Study|Adverse Event|0
2036585|NCT00412958|3606835|FG003|Overall Study|Adverse Event|0
2036586|NCT00412958|3606832|FG000|Overall Study|Lost to Follow-up|0
2036587|NCT00412958|3606833|FG001|Overall Study|Lost to Follow-up|1
2036588|NCT00412958|3606834|FG002|Overall Study|Lost to Follow-up|0
2036589|NCT00412958|3606835|FG003|Overall Study|Lost to Follow-up|0
2036590|NCT00412958|3606832|FG000|Overall Study|Death|0
2036591|NCT00412958|3606833|FG001|Overall Study|Death|1
2036592|NCT00412958|3606834|FG002|Overall Study|Death|0
2036593|NCT00412958|3606835|FG003|Overall Study|Death|0
2036594|NCT00412958|3606832|FG000|Overall Study|Transport issue|0
2113458|NCT00914628|3708579|FG001|Overall Study|Patients who did not receive a single dose|1
2113459|NCT00914732|3708592|FG000|Overall Study|Lost to Follow-up|6
2113460|NCT00914732|3708593|FG001|Overall Study|Lost to Follow-up|7
2219045|NCT01718535|3862746|FG005|Overall Study|Bidirectional Sequencing not possible|0
2219046|NCT01718535|3862747|FG006|Overall Study|Bidirectional Sequencing not possible|0
2219047|NCT01718535|3862748|FG007|Overall Study|Bidirectional Sequencing not possible|0
2113461|NCT00914732|3708594|FG002|Overall Study|Lost to Follow-up|9
2113462|NCT00914732|3708592|FG000|Overall Study|Withdrawal by Subject|3
2113463|NCT00914732|3708593|FG001|Overall Study|Withdrawal by Subject|0
2113464|NCT00914732|3708594|FG002|Overall Study|Withdrawal by Subject|2
2113465|NCT00914732|3708592|FG000|Overall Study|Adverse Event|1
2113466|NCT00914732|3708593|FG001|Overall Study|Adverse Event|0
2113467|NCT00914732|3708594|FG002|Overall Study|Adverse Event|0
2113468|NCT00914810|3708605|FG000|Overall Study|Withdrawal by Subject|1
2113469|NCT00914810|3708606|FG001|Overall Study|Withdrawal by Subject|0
2113470|NCT00914810|3708605|FG000|Overall Study|Relocated out of state|1
2113471|NCT00914810|3708606|FG001|Overall Study|Relocated out of state|0
2113472|NCT00914810|3708605|FG000|Overall Study|Hospitalized and unable to follow up.|0
2113473|NCT00914810|3708606|FG001|Overall Study|Hospitalized and unable to follow up.|1
2113474|NCT00914849|3708614|FG000|Overall Study|Withdrawal by Subject|1
2113475|NCT00914849|3708615|FG001|Overall Study|Withdrawal by Subject|0
2113476|NCT00914849|3708614|FG000|Overall Study|Not eligible|0
2113477|NCT00914849|3708615|FG001|Overall Study|Not eligible|1
2113478|NCT00914927|3708649|FG000|Overall Study|Adverse Event|0
2113479|NCT00914927|3708650|FG001|Overall Study|Adverse Event|0
2113480|NCT00914927|3708651|FG002|Overall Study|Adverse Event|0
2113481|NCT00914927|3708652|FG003|Overall Study|Adverse Event|0
2113482|NCT00914927|3708653|FG004|Overall Study|Adverse Event|1
2113483|NCT00914927|3708654|FG005|Overall Study|Adverse Event|0
2113484|NCT00914927|3708655|FG006|Overall Study|Adverse Event|0
2113485|NCT00914927|3708649|FG000|Overall Study|Withdrawal by Subject|0
2113486|NCT00914927|3708650|FG001|Overall Study|Withdrawal by Subject|1
2113487|NCT00914927|3708651|FG002|Overall Study|Withdrawal by Subject|0
2113488|NCT00914927|3708652|FG003|Overall Study|Withdrawal by Subject|1
2113489|NCT00914927|3708653|FG004|Overall Study|Withdrawal by Subject|0
2113490|NCT00914927|3708654|FG005|Overall Study|Withdrawal by Subject|0
2113491|NCT00914927|3708655|FG006|Overall Study|Withdrawal by Subject|0
2113492|NCT00914927|3708649|FG000|Overall Study|Lost to Follow-up|0
2113493|NCT00914927|3708650|FG001|Overall Study|Lost to Follow-up|0
2113494|NCT00914927|3708651|FG002|Overall Study|Lost to Follow-up|0
2113495|NCT00914927|3708652|FG003|Overall Study|Lost to Follow-up|1
2113496|NCT00914927|3708653|FG004|Overall Study|Lost to Follow-up|0
2113497|NCT00914927|3708654|FG005|Overall Study|Lost to Follow-up|0
2113498|NCT00914927|3708655|FG006|Overall Study|Lost to Follow-up|0
2113499|NCT00914927|3708649|FG000|Overall Study|Administrative/Other|2
2113500|NCT00914927|3708650|FG001|Overall Study|Administrative/Other|1
2113501|NCT00914927|3708651|FG002|Overall Study|Administrative/Other|0
2113502|NCT00914927|3708652|FG003|Overall Study|Administrative/Other|0
2219048|NCT01718535|3862749|FG008|Overall Study|Bidirectional Sequencing not possible|0
2219049|NCT01718535|3862750|FG009|Overall Study|Bidirectional Sequencing not possible|0
2219050|NCT01719003|3862794|FG000|Overall Study|Non compliant with protocol|1
2219051|NCT01719003|3862795|FG001|Overall Study|Non compliant with protocol|1
2219052|NCT01719003|3862796|FG002|Overall Study|Non compliant with protocol|0
2219053|NCT01719003|3862797|FG003|Overall Study|Non compliant with protocol|1
2219054|NCT01719003|3862798|FG004|Overall Study|Non compliant with protocol|2
2219055|NCT01719003|3862799|FG005|Overall Study|Non compliant with protocol|1
2219056|NCT01719003|3862800|FG006|Overall Study|Non compliant with protocol|2
2219057|NCT01719003|3862801|FG007|Overall Study|Non compliant with protocol|3
2219058|NCT01719003|3862802|FG008|Overall Study|Non compliant with protocol|0
2219059|NCT01719003|3862794|FG000|Overall Study|Adverse Event|6
2219060|NCT01719003|3862795|FG001|Overall Study|Adverse Event|5
2219061|NCT01719003|3862796|FG002|Overall Study|Adverse Event|4
2219062|NCT01719003|3862797|FG003|Overall Study|Adverse Event|3
2219063|NCT01719003|3862798|FG004|Overall Study|Adverse Event|4
2219064|NCT01719003|3862799|FG005|Overall Study|Adverse Event|3
2219065|NCT01719003|3862800|FG006|Overall Study|Adverse Event|6
2219066|NCT01719003|3862801|FG007|Overall Study|Adverse Event|5
2219067|NCT01719003|3862802|FG008|Overall Study|Adverse Event|0
2219068|NCT01719003|3862794|FG000|Overall Study|Lost to Follow-up|0
2331838|NCT03178045|4054714|FG001|Overall Study|Surgery Cancelled/Relocated|30
2331839|NCT03178045|4054713|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47
2331840|NCT03178045|4054714|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46
2331841|NCT03178266|4054723|FG000|Overall Study|Death|0
2331842|NCT03178266|4054724|FG001|Overall Study|Death|1
2331843|NCT03178266|4054723|FG000|Overall Study|Disont. Early|0
2331844|NCT03178266|4054724|FG001|Overall Study|Disont. Early|1
2331845|NCT03178266|4054723|FG000|Overall Study|Withdrawal by Subject|0
2331846|NCT03178266|4054724|FG001|Overall Study|Withdrawal by Subject|2
2331847|NCT03178487|4054739|FG000|Overall Study|Adverse Event|1
2331848|NCT03178487|4054740|FG001|Overall Study|Adverse Event|1
2331849|NCT03178487|4054739|FG000|Overall Study|Withdrawal by Subject|2
2331850|NCT03178487|4054740|FG001|Overall Study|Withdrawal by Subject|1
2331851|NCT03178487|4054739|FG000|Overall Study|Lost to Follow-up|1
2113503|NCT00914927|3708653|FG004|Overall Study|Administrative/Other|1
2113504|NCT00914927|3708654|FG005|Overall Study|Administrative/Other|0
2113505|NCT00914927|3708655|FG006|Overall Study|Administrative/Other|0
2113506|NCT00914940|3708680|FG000|D0 to D100 Post-transplant|Death|2
2113507|NCT00914940|3708680|FG000|D101 to 2 Years Post-transplant|Death|8
2113508|NCT00914940|3708680|FG000|2 Years to 5 Years Post-transplant|Death|3
2113509|NCT00914966|3708684|FG000|Step 1: 1500 Units|Withdrawal by Subject|1
2113510|NCT00914966|3708684|FG000|Step 1: 1500 Units|Physician Decision|1
2113511|NCT00914966|3708684|FG000|Step 2: 2000 Units|Withdrawal by Subject|1
2113512|NCT00915005|3708695|FG000|Overall Study|Withdrawal by Subject|4
2113513|NCT00915005|3708696|FG001|Overall Study|Withdrawal by Subject|4
2113514|NCT00915005|3708695|FG000|Overall Study|Patient preferred protons therapy|6
2113515|NCT00915005|3708696|FG001|Overall Study|Patient preferred protons therapy|0
2113516|NCT00915005|3708695|FG000|Overall Study|Insurance denial|3
2113517|NCT00915005|3708696|FG001|Overall Study|Insurance denial|15
2113518|NCT00915018|3708704|FG000|Overall Study|Death|75
2113519|NCT00915018|3708705|FG001|Overall Study|Death|70
2113520|NCT00915018|3708704|FG000|Overall Study|Lost to Follow-up|10
2113521|NCT00915018|3708705|FG001|Overall Study|Lost to Follow-up|5
2113522|NCT00915018|3708704|FG000|Overall Study|Withdrawal by Subject|38
2113523|NCT00915018|3708705|FG001|Overall Study|Withdrawal by Subject|27
2113524|NCT00915018|3708704|FG000|Overall Study|By Sponsor due to Protocol Amendment|92
2113525|NCT00915018|3708705|FG001|Overall Study|By Sponsor due to Protocol Amendment|105
2113526|NCT00915278|3708730|FG000|Overall Study|Death|1
2113527|NCT00915278|3708731|FG001|Overall Study|Death|0
2113528|NCT00915278|3708732|FG002|Overall Study|Death|0
2113529|NCT00915278|3708733|FG003|Overall Study|Death|0
2113530|NCT00915278|3708734|FG004|Overall Study|Death|0
2113531|NCT00915278|3708735|FG005|Overall Study|Death|0
2113532|NCT00915278|3708730|FG000|Overall Study|Lost to Follow-up|0
2113533|NCT00915278|3708731|FG001|Overall Study|Lost to Follow-up|1
2113534|NCT00915278|3708732|FG002|Overall Study|Lost to Follow-up|0
2113535|NCT00915278|3708733|FG003|Overall Study|Lost to Follow-up|0
2113536|NCT00915278|3708734|FG004|Overall Study|Lost to Follow-up|0
2113537|NCT00915278|3708735|FG005|Overall Study|Lost to Follow-up|0
2113538|NCT00915278|3708730|FG000|Overall Study|Withdrawal by Subject|0
2113539|NCT00915278|3708731|FG001|Overall Study|Withdrawal by Subject|1
2113540|NCT00915278|3708732|FG002|Overall Study|Withdrawal by Subject|0
2113541|NCT00915278|3708733|FG003|Overall Study|Withdrawal by Subject|0
2113542|NCT00915278|3708734|FG004|Overall Study|Withdrawal by Subject|1
2113543|NCT00915278|3708735|FG005|Overall Study|Withdrawal by Subject|4
2113544|NCT00915278|3708730|FG000|Overall Study|Adverse Event|4
2113545|NCT00915278|3708731|FG001|Overall Study|Adverse Event|1
2113546|NCT00915278|3708732|FG002|Overall Study|Adverse Event|0
2113547|NCT00915278|3708733|FG003|Overall Study|Adverse Event|0
2113548|NCT00915278|3708734|FG004|Overall Study|Adverse Event|0
2113549|NCT00915278|3708735|FG005|Overall Study|Adverse Event|0
2113550|NCT00915278|3708730|FG000|Overall Study|Progressive disease/clinical progression|0
2113551|NCT00915278|3708731|FG001|Overall Study|Progressive disease/clinical progression|0
2113552|NCT00915278|3708732|FG002|Overall Study|Progressive disease/clinical progression|0
2113553|NCT00915278|3708733|FG003|Overall Study|Progressive disease/clinical progression|3
2113554|NCT00915278|3708734|FG004|Overall Study|Progressive disease/clinical progression|1
2113555|NCT00915278|3708735|FG005|Overall Study|Progressive disease/clinical progression|2
2113556|NCT00915278|3708730|FG000|Overall Study|Infusion related AEs|0
2113557|NCT00915278|3708731|FG001|Overall Study|Infusion related AEs|0
2113558|NCT00915278|3708732|FG002|Overall Study|Infusion related AEs|0
2113559|NCT00915278|3708733|FG003|Overall Study|Infusion related AEs|0
2113560|NCT00915278|3708734|FG004|Overall Study|Infusion related AEs|0
2113561|NCT00915278|3708735|FG005|Overall Study|Infusion related AEs|2
2113562|NCT00915278|3708730|FG000|Overall Study|Admission to hospice|0
2113563|NCT00915278|3708731|FG001|Overall Study|Admission to hospice|0
2113564|NCT00915278|3708732|FG002|Overall Study|Admission to hospice|1
2113565|NCT00915278|3708733|FG003|Overall Study|Admission to hospice|0
2113566|NCT00915278|3708734|FG004|Overall Study|Admission to hospice|0
2113567|NCT00915278|3708735|FG005|Overall Study|Admission to hospice|0
2113568|NCT00915343|3708749|FG000|Part B - Open Label Period|Treatment switch|0
2113569|NCT00915343|3708750|FG001|Part B - Open Label Period|Treatment switch|0
2113570|NCT00915343|3708751|FG002|Part B - Open Label Period|Treatment switch|1
2113571|NCT00915343|3708749|FG000|Part B - Open Label Period|Did not attend the last visit|0
2113572|NCT00915343|3708750|FG001|Part B - Open Label Period|Did not attend the last visit|0
2113573|NCT00915343|3708751|FG002|Part B - Open Label Period|Did not attend the last visit|1
2113574|NCT00915356|3708768|FG000|Overall Study|Withdrawal by Subject|1
2113575|NCT00915356|3708769|FG001|Overall Study|Withdrawal by Subject|0
2113576|NCT00915356|3708770|FG002|Overall Study|Withdrawal by Subject|0
2113577|NCT00915356|3708771|FG003|Overall Study|Withdrawal by Subject|0
2113578|NCT00915356|3708772|FG004|Overall Study|Withdrawal by Subject|0
2113579|NCT00915473|3708786|FG000|Screening|Withdrawal by Subject|1
2113580|NCT00915473|3708787|FG001|Screening|Withdrawal by Subject|0
2113581|NCT00915473|3708786|FG000|4-week Follow Up|Lost to Follow-up|1
2113582|NCT00915473|3708787|FG001|4-week Follow Up|Lost to Follow-up|5
2113583|NCT00915525|3708804|FG000|Overall Study|Protocol Violation|9
2113584|NCT00915525|3708805|FG001|Overall Study|Protocol Violation|4
2113585|NCT00915525|3708804|FG000|Overall Study|Withdrawal by Subject|59
2113586|NCT00915525|3708805|FG001|Overall Study|Withdrawal by Subject|21
2113587|NCT00915525|3708804|FG000|Overall Study|Lost to Follow-up|27
2113588|NCT00915525|3708805|FG001|Overall Study|Lost to Follow-up|16
2113589|NCT00915525|3708804|FG000|Overall Study|Pregnancy|2
2113590|NCT00915525|3708805|FG001|Overall Study|Pregnancy|0
2113591|NCT00915525|3708804|FG000|Overall Study|Lack of Efficacy|15
2113592|NCT00915525|3708805|FG001|Overall Study|Lack of Efficacy|32
2113593|NCT00915525|3708804|FG000|Overall Study|Adverse Event|29
2113594|NCT00915525|3708805|FG001|Overall Study|Adverse Event|13
2113595|NCT00915525|3708804|FG000|Overall Study|Missing|12
2113596|NCT00915525|3708805|FG001|Overall Study|Missing|1
2113597|NCT00915525|3708804|FG000|Overall Study|Other Reason|35
2113598|NCT00915525|3708805|FG001|Overall Study|Other Reason|12
2113599|NCT00915525|3708804|FG000|Overall Study|Site Closed|27
2113600|NCT00915525|3708805|FG001|Overall Study|Site Closed|9
2113601|NCT00915525|3708804|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
2113602|NCT00915525|3708805|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
2113603|NCT00915525|3708804|FG000|Overall Study|Study Burden|28
2113604|NCT00915525|3708805|FG001|Overall Study|Study Burden|12
2113605|NCT00915525|3708804|FG000|Overall Study|Non-Compliance|3
2113606|NCT00915525|3708805|FG001|Overall Study|Non-Compliance|1
2113607|NCT00915525|3708804|FG000|Overall Study|Patient Moved|15
2113608|NCT00915525|3708805|FG001|Overall Study|Patient Moved|9
2113609|NCT00915551|3708844|FG000|Overall Study|Withdrawal by Subject|0
2113610|NCT00915551|3708845|FG001|Overall Study|Withdrawal by Subject|1
2113611|NCT00915772|3708891|FG000|Overall Study|Adverse Event|12
2113612|NCT00915772|3708892|FG001|Overall Study|Adverse Event|13
2113613|NCT00915772|3708893|FG002|Overall Study|Adverse Event|11
2113614|NCT00915772|3708891|FG000|Overall Study|Protocol Violation|4
2113615|NCT00915772|3708892|FG001|Overall Study|Protocol Violation|1
2113616|NCT00915772|3708893|FG002|Overall Study|Protocol Violation|2
2113617|NCT00915772|3708891|FG000|Overall Study|Lost to Follow-up|1
2113618|NCT00915772|3708892|FG001|Overall Study|Lost to Follow-up|2
2113619|NCT00915772|3708893|FG002|Overall Study|Lost to Follow-up|2
2113620|NCT00915772|3708891|FG000|Overall Study|Lack of Efficacy|9
2113621|NCT00915772|3708892|FG001|Overall Study|Lack of Efficacy|15
2113622|NCT00915772|3708893|FG002|Overall Study|Lack of Efficacy|3
2113623|NCT00915772|3708891|FG000|Overall Study|Refused to continue trial medication|6
2113624|NCT00915772|3708892|FG001|Overall Study|Refused to continue trial medication|8
2113625|NCT00915772|3708893|FG002|Overall Study|Refused to continue trial medication|4
2113626|NCT00915772|3708891|FG000|Overall Study|Any other reason|4
2113627|NCT00915772|3708892|FG001|Overall Study|Any other reason|7
2113628|NCT00915772|3708893|FG002|Overall Study|Any other reason|7
2113629|NCT00915876|3708931|FG000|Overall Study|Adverse Event|0
2113630|NCT00915876|3708932|FG001|Overall Study|Adverse Event|1
2113631|NCT00916006|3708983|FG000|Overall Study|Adverse Event|1
2113632|NCT00916006|3708984|FG001|Overall Study|Adverse Event|1
2113633|NCT00916006|3708983|FG000|Overall Study|Withdrawal by Subject|2
2113634|NCT00916006|3708984|FG001|Overall Study|Withdrawal by Subject|5
2113635|NCT00916006|3708983|FG000|Overall Study|Protocol Violation|0
2113636|NCT00916006|3708984|FG001|Overall Study|Protocol Violation|1
2113637|NCT00916058|3709004|FG000|Phase 1|Screen Failure|0
2113638|NCT00916058|3709005|FG001|Phase 1|Screen Failure|0
2113639|NCT00916058|3709006|FG002|Phase 1|Screen Failure|0
2113640|NCT00916058|3709007|FG003|Phase 1|Screen Failure|0
2113641|NCT00916058|3709008|FG004|Phase 1|Screen Failure|0
2113642|NCT00916058|3709009|FG005|Phase 1|Screen Failure|1
2113643|NCT00916058|3709010|FG006|Phase 1|Screen Failure|0
2113644|NCT00916058|3709004|FG000|Phase 2|Screen Failure|0
2113645|NCT00916058|3709005|FG001|Phase 2|Screen Failure|0
2113646|NCT00916058|3709006|FG002|Phase 2|Screen Failure|0
2113647|NCT00916058|3709007|FG003|Phase 2|Screen Failure|0
2113648|NCT00916058|3709008|FG004|Phase 2|Screen Failure|0
2113649|NCT00916058|3709009|FG005|Phase 2|Screen Failure|0
2113650|NCT00916058|3709010|FG006|Phase 2|Screen Failure|3
2113651|NCT00916149|3709040|FG000|Overall Study|Lost to Follow-up|3
2113652|NCT00916149|3709041|FG001|Overall Study|Lost to Follow-up|2
2113653|NCT00916149|3709042|FG002|Overall Study|Lost to Follow-up|0
2113654|NCT00916149|3709040|FG000|Overall Study|Unable to place scalp EEG leads|1
2113655|NCT00916149|3709041|FG001|Overall Study|Unable to place scalp EEG leads|0
2113656|NCT00916149|3709042|FG002|Overall Study|Unable to place scalp EEG leads|0
2113657|NCT00916279|3709049|FG000|Overall Study|Death|2
2113658|NCT00916279|3709049|FG000|Overall Study|Lost to Follow-up|2
2113659|NCT00916305|3709058|FG000|Overall Study|Lost to Follow-up|21
2113660|NCT00916305|3709059|FG001|Overall Study|Lost to Follow-up|27
2113661|NCT00916305|3709058|FG000|Overall Study|Withdrawal by Subject|0
2113662|NCT00916305|3709059|FG001|Overall Study|Withdrawal by Subject|1
2113663|NCT00916344|3709065|FG000|Overall Study|Death|2
2113664|NCT00916344|3709065|FG000|Overall Study|ICD upgrade|1
2113665|NCT00916344|3709065|FG000|Overall Study|Drop-out|5
2113666|NCT00916357|3709069|FG000|Period 1|Withdrawal by Subject|1
2113667|NCT00916357|3709070|FG001|Period 1|Withdrawal by Subject|0
2113668|NCT00916357|3709071|FG002|Period 1|Withdrawal by Subject|0
2113669|NCT00916357|3709072|FG003|Period 1|Withdrawal by Subject|0
2113670|NCT00916357|3709073|FG004|Period 1|Withdrawal by Subject|0
2113671|NCT00916357|3709074|FG005|Period 1|Withdrawal by Subject|0
2113672|NCT00916357|3709069|FG000|Period 2|Weight loss > 3 kilograms (kg)|0
2113673|NCT00916357|3709070|FG001|Period 2|Weight loss > 3 kilograms (kg)|0
2113674|NCT00916357|3709071|FG002|Period 2|Weight loss > 3 kilograms (kg)|0
2113675|NCT00916357|3709072|FG003|Period 2|Weight loss > 3 kilograms (kg)|1
2113676|NCT00916357|3709073|FG004|Period 2|Weight loss > 3 kilograms (kg)|0
2113677|NCT00916357|3709074|FG005|Period 2|Weight loss > 3 kilograms (kg)|0
2113678|NCT00916370|3709085|FG000|Overall Study|Death|3
2113679|NCT00916370|3709086|FG001|Overall Study|Death|1
2113680|NCT00916370|3709085|FG000|Overall Study|Withdrawal by Subject|2
2113681|NCT00916370|3709086|FG001|Overall Study|Withdrawal by Subject|0
2113682|NCT00916370|3709085|FG000|Overall Study|Physician Decision|0
2113683|NCT00916370|3709086|FG001|Overall Study|Physician Decision|1
2113684|NCT00916383|3709093|FG000|Overall Study|Adverse Event|1
2113685|NCT00916383|3709093|FG000|Overall Study|Death|1
2113686|NCT00916383|3709093|FG000|Overall Study|Protocol Violation|1
2113687|NCT00916578|3709110|FG000|Overall Study|Physician Decision|2
2113688|NCT00916578|3709110|FG000|Overall Study|Withdrawal by Subject|3
2113689|NCT00916578|3709110|FG000|Overall Study|Insurance Denial|2
2113690|NCT00916617|3709118|FG000|Overall Study|Adverse Event|3
2113691|NCT00916617|3709119|FG001|Overall Study|Adverse Event|2
2113692|NCT00916617|3709120|FG002|Overall Study|Adverse Event|6
2113693|NCT00916617|3709121|FG003|Overall Study|Adverse Event|3
2113694|NCT00916617|3709118|FG000|Overall Study|Withdrawal by Subject|3
2113695|NCT00916617|3709119|FG001|Overall Study|Withdrawal by Subject|2
2113696|NCT00916617|3709120|FG002|Overall Study|Withdrawal by Subject|0
2113697|NCT00916617|3709121|FG003|Overall Study|Withdrawal by Subject|1
2113698|NCT00916617|3709118|FG000|Overall Study|Caregiver Request|3
2113699|NCT00916617|3709119|FG001|Overall Study|Caregiver Request|2
2113700|NCT00916617|3709120|FG002|Overall Study|Caregiver Request|1
2113701|NCT00916617|3709121|FG003|Overall Study|Caregiver Request|0
2113702|NCT00916617|3709118|FG000|Overall Study|Physician Decision|1
2113703|NCT00916617|3709119|FG001|Overall Study|Physician Decision|1
2113704|NCT00916617|3709120|FG002|Overall Study|Physician Decision|0
2113705|NCT00916617|3709121|FG003|Overall Study|Physician Decision|0
2113706|NCT00916617|3709118|FG000|Overall Study|Discontinuation of Study by Sponsor|8
2113707|NCT00916617|3709119|FG001|Overall Study|Discontinuation of Study by Sponsor|13
2113708|NCT00916617|3709120|FG002|Overall Study|Discontinuation of Study by Sponsor|3
2113709|NCT00916617|3709121|FG003|Overall Study|Discontinuation of Study by Sponsor|1
2113710|NCT00916617|3709118|FG000|Overall Study|Lost to Follow-up|2
2113711|NCT00916617|3709119|FG001|Overall Study|Lost to Follow-up|1
2113712|NCT00916617|3709120|FG002|Overall Study|Lost to Follow-up|0
2113713|NCT00916617|3709121|FG003|Overall Study|Lost to Follow-up|0
2113714|NCT00916617|3709118|FG000|Overall Study|Lack of Efficacy|1
2113715|NCT00916617|3709119|FG001|Overall Study|Lack of Efficacy|0
2113716|NCT00916617|3709120|FG002|Overall Study|Lack of Efficacy|0
2113717|NCT00916617|3709121|FG003|Overall Study|Lack of Efficacy|0
2113718|NCT00916617|3709118|FG000|Overall Study|Other|2
2113719|NCT00916617|3709119|FG001|Overall Study|Other|0
2113720|NCT00916617|3709120|FG002|Overall Study|Other|0
2113721|NCT00916617|3709121|FG003|Overall Study|Other|2
2113722|NCT00916721|3709137|FG000|Overall Study|Lost to Follow-up|0
2113723|NCT00916721|3709138|FG001|Overall Study|Lost to Follow-up|1
2113724|NCT00916721|3709137|FG000|Overall Study|Adverse Event|6
2113725|NCT00916721|3709138|FG001|Overall Study|Adverse Event|3
2113726|NCT00916721|3709137|FG000|Overall Study|Withdrawal by Subject|2
2113727|NCT00916721|3709138|FG001|Overall Study|Withdrawal by Subject|2
2113728|NCT00916721|3709137|FG000|Overall Study|Protocol Violation|2
2113729|NCT00916721|3709138|FG001|Overall Study|Protocol Violation|4
2113730|NCT00916929|3709146|FG000|Overall Study|Lost to Follow-up|1
2113731|NCT00916929|3709147|FG001|Overall Study|Lost to Follow-up|3
2113732|NCT00916929|3709146|FG000|Overall Study|Death|5
2113733|NCT00916929|3709147|FG001|Overall Study|Death|10
2113734|NCT00916929|3709146|FG000|Overall Study|Withdrawal by Subject|1
2113735|NCT00916929|3709147|FG001|Overall Study|Withdrawal by Subject|5
2113736|NCT00916929|3709146|FG000|Overall Study|Left ventricular epicardial lead|1
2219069|NCT01719003|3862795|FG001|Overall Study|Lost to Follow-up|6
2219070|NCT01719003|3862796|FG002|Overall Study|Lost to Follow-up|7
2219071|NCT01719003|3862797|FG003|Overall Study|Lost to Follow-up|2
2219072|NCT01719003|3862798|FG004|Overall Study|Lost to Follow-up|3
2219073|NCT01719003|3862799|FG005|Overall Study|Lost to Follow-up|4
2219074|NCT01719003|3862800|FG006|Overall Study|Lost to Follow-up|3
2219075|NCT01719003|3862801|FG007|Overall Study|Lost to Follow-up|2
2219076|NCT01719003|3862802|FG008|Overall Study|Lost to Follow-up|2
2219077|NCT01719003|3862794|FG000|Overall Study|Refusal to continue, not due to AE|2
2219078|NCT01719003|3862795|FG001|Overall Study|Refusal to continue, not due to AE|5
2219079|NCT01719003|3862796|FG002|Overall Study|Refusal to continue, not due to AE|4
2219080|NCT01719003|3862797|FG003|Overall Study|Refusal to continue, not due to AE|4
2219081|NCT01719003|3862798|FG004|Overall Study|Refusal to continue, not due to AE|4
2219082|NCT01719003|3862799|FG005|Overall Study|Refusal to continue, not due to AE|3
2219083|NCT01719003|3862800|FG006|Overall Study|Refusal to continue, not due to AE|8
2219084|NCT01719003|3862801|FG007|Overall Study|Refusal to continue, not due to AE|7
2219085|NCT01719003|3862802|FG008|Overall Study|Refusal to continue, not due to AE|1
2219086|NCT01719003|3862794|FG000|Overall Study|Reason other than those specified|0
2113737|NCT00916929|3709147|FG001|Overall Study|Left ventricular epicardial lead|2
2113738|NCT00916929|3709146|FG000|Overall Study|Transferred to hospice care|1
2113739|NCT00916929|3709147|FG001|Overall Study|Transferred to hospice care|1
2113740|NCT00916929|3709146|FG000|Overall Study|System explant|1
2219087|NCT01719003|3862795|FG001|Overall Study|Reason other than those specified|0
2219088|NCT01719003|3862796|FG002|Overall Study|Reason other than those specified|2
2113741|NCT00916929|3709147|FG001|Overall Study|System explant|0
2113742|NCT00916929|3709146|FG000|Overall Study|Moved to another state|0
2113743|NCT00916929|3709147|FG001|Overall Study|Moved to another state|1
2113744|NCT00916929|3709146|FG000|Overall Study|Device unable to process impedance data|0
2113745|NCT00916929|3709147|FG001|Overall Study|Device unable to process impedance data|7
2113746|NCT00917124|3709157|FG000|Overall Study|Protocol Violation|4
2113747|NCT00917124|3709158|FG001|Overall Study|Protocol Violation|6
2113748|NCT00917150|3709168|FG000|Overall Study|Adverse Event|12
2113749|NCT00917150|3709169|FG001|Overall Study|Adverse Event|7
2113750|NCT00917150|3709170|FG002|Overall Study|Adverse Event|12
2113751|NCT00917150|3709171|FG003|Overall Study|Adverse Event|11
2113752|NCT00917150|3709168|FG000|Overall Study|Death|1
2113753|NCT00917150|3709169|FG001|Overall Study|Death|4
2113754|NCT00917150|3709170|FG002|Overall Study|Death|3
2113755|NCT00917150|3709171|FG003|Overall Study|Death|2
2113756|NCT00917150|3709168|FG000|Overall Study|Lost to Follow-up|1
2113757|NCT00917150|3709169|FG001|Overall Study|Lost to Follow-up|0
2113758|NCT00917150|3709170|FG002|Overall Study|Lost to Follow-up|4
2113759|NCT00917150|3709171|FG003|Overall Study|Lost to Follow-up|2
2113760|NCT00917150|3709168|FG000|Overall Study|Physician Decision|0
2113761|NCT00917150|3709169|FG001|Overall Study|Physician Decision|2
2113762|NCT00917150|3709170|FG002|Overall Study|Physician Decision|0
2113763|NCT00917150|3709171|FG003|Overall Study|Physician Decision|1
2113764|NCT00917150|3709168|FG000|Overall Study|Protocol Violation|5
2113765|NCT00917150|3709169|FG001|Overall Study|Protocol Violation|5
2113766|NCT00917150|3709170|FG002|Overall Study|Protocol Violation|3
2113767|NCT00917150|3709171|FG003|Overall Study|Protocol Violation|5
2113768|NCT00917150|3709168|FG000|Overall Study|Withdrawal by Subject|15
2113769|NCT00917150|3709169|FG001|Overall Study|Withdrawal by Subject|16
2113770|NCT00917150|3709170|FG002|Overall Study|Withdrawal by Subject|18
2113771|NCT00917150|3709171|FG003|Overall Study|Withdrawal by Subject|11
2113772|NCT00917150|3709168|FG000|Overall Study|Other than specified|3
2113773|NCT00917150|3709169|FG001|Overall Study|Other than specified|3
2113774|NCT00917150|3709170|FG002|Overall Study|Other than specified|2
2113775|NCT00917150|3709171|FG003|Overall Study|Other than specified|2
2113776|NCT00917267|3709183|FG000|Overall Study|Adverse Event|15
2113777|NCT00917267|3709184|FG001|Overall Study|Adverse Event|36
2113778|NCT00917267|3709183|FG000|Overall Study|Physician Decision|2
2113779|NCT00917267|3709184|FG001|Overall Study|Physician Decision|4
2113780|NCT00917267|3709183|FG000|Overall Study|Protocol Violation|9
2113781|NCT00917267|3709184|FG001|Overall Study|Protocol Violation|18
2113782|NCT00917267|3709183|FG000|Overall Study|Withdrawal by Subject|5
2113783|NCT00917267|3709184|FG001|Overall Study|Withdrawal by Subject|12
2113784|NCT00917267|3709183|FG000|Overall Study|Lost to follow up|0
2113785|NCT00917267|3709184|FG001|Overall Study|Lost to follow up|2
2113786|NCT00917267|3709183|FG000|Overall Study|Entry Criteria Not Met|1
2113787|NCT00917267|3709184|FG001|Overall Study|Entry Criteria Not Met|0
2113788|NCT00917267|3709183|FG000|Overall Study|Sponsor Decision|5
2113789|NCT00917267|3709184|FG001|Overall Study|Sponsor Decision|5
2219089|NCT01719003|3862797|FG003|Overall Study|Reason other than those specified|3
2113790|NCT00917267|3709183|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
2113791|NCT00917267|3709184|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
2113792|NCT00917384|3709196|FG000|Overall Study|Lost to Follow-up|4
2113793|NCT00917384|3709197|FG001|Overall Study|Lost to Follow-up|2
2113794|NCT00917384|3709196|FG000|Overall Study|Withdrawal by Subject|10
2113795|NCT00917384|3709197|FG001|Overall Study|Withdrawal by Subject|2
2113796|NCT00917462|3709203|FG000|Overall Study|Clinical Deterioration|1
2219090|NCT01719003|3862798|FG004|Overall Study|Reason other than those specified|4
2219091|NCT01719003|3862799|FG005|Overall Study|Reason other than those specified|1
2219092|NCT01719003|3862800|FG006|Overall Study|Reason other than those specified|0
2219093|NCT01719003|3862801|FG007|Overall Study|Reason other than those specified|3
2219094|NCT01719003|3862802|FG008|Overall Study|Reason other than those specified|1
2219095|NCT01719003|3862794|FG000|Overall Study|Lack of Efficacy|0
2219096|NCT01719003|3862795|FG001|Overall Study|Lack of Efficacy|0
2219097|NCT01719003|3862796|FG002|Overall Study|Lack of Efficacy|0
2219098|NCT01719003|3862797|FG003|Overall Study|Lack of Efficacy|0
2219099|NCT01719003|3862798|FG004|Overall Study|Lack of Efficacy|0
2219100|NCT01719003|3862799|FG005|Overall Study|Lack of Efficacy|0
2219101|NCT01719003|3862800|FG006|Overall Study|Lack of Efficacy|1
2219102|NCT01719003|3862801|FG007|Overall Study|Lack of Efficacy|0
2113797|NCT00917501|3709209|FG000|Overall Study|Lost to Follow-up|4
2113798|NCT00917501|3709210|FG001|Overall Study|Lost to Follow-up|1
2113799|NCT00917501|3709209|FG000|Overall Study|Withdrawal by Subject|3
2113800|NCT00917501|3709210|FG001|Overall Study|Withdrawal by Subject|1
2113801|NCT00917501|3709209|FG000|Overall Study|Lack of Efficacy|1
2113802|NCT00917501|3709210|FG001|Overall Study|Lack of Efficacy|2
2113803|NCT00917501|3709209|FG000|Overall Study|trouble swollowing capsules|0
2113804|NCT00917501|3709210|FG001|Overall Study|trouble swollowing capsules|1
2113805|NCT00917553|3709218|FG000|Overall Study|Lost to Follow-up|2
2113806|NCT00917553|3709219|FG001|Overall Study|Lost to Follow-up|1
2113807|NCT00917579|3709225|FG000|Washout >= 2 Weeks|Adverse Event|1
2219103|NCT01719003|3862802|FG008|Overall Study|Lack of Efficacy|0
2219104|NCT01719172|3862821|FG000|Overall Study|Lost to Follow-up|1
2219105|NCT01719172|3862821|FG000|Overall Study|Death|1
2219106|NCT01719224|3862825|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
2113808|NCT00917579|3709226|FG001|Washout >= 2 Weeks|Adverse Event|0
2113809|NCT00917579|3709225|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1
2113810|NCT00917579|3709226|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0
2113811|NCT00917644|3709232|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
2113812|NCT00917644|3709233|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
2113813|NCT00917644|3709232|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
2113814|NCT00917644|3709233|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
2113815|NCT00917644|3709232|FG000|Period 2: Second Intervention|family emergency|1
2113816|NCT00917644|3709233|FG001|Period 2: Second Intervention|family emergency|0
2113817|NCT00917852|3709248|FG000|Overall Study|Death|6
2113818|NCT00918138|3709278|FG000|Overall Study|Subject withdrew consent|1
2113819|NCT00918138|3709279|FG001|Overall Study|Subject withdrew consent|1
2113820|NCT00918138|3709278|FG000|Overall Study|Death|1
2113821|NCT00918138|3709279|FG001|Overall Study|Death|0
2113822|NCT00918203|3709287|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1
2113823|NCT00918203|3709288|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1
2113824|NCT00918203|3709289|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0
2113825|NCT00918203|3709287|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2
2113826|NCT00918203|3709288|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8
2113827|NCT00918203|3709289|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0
2113828|NCT00918203|3709287|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2
2113829|NCT00918203|3709288|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1
2113830|NCT00918203|3709289|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0
2113831|NCT00918203|3709287|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1
2113832|NCT00918203|3709288|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0
2113833|NCT00918203|3709289|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0
2113834|NCT00918255|3709308|FG000|Overall Study|Adverse Event|1
2113835|NCT00918255|3709309|FG001|Overall Study|Adverse Event|0
2113836|NCT00918255|3709310|FG002|Overall Study|Adverse Event|0
2113837|NCT00918255|3709308|FG000|Overall Study|Withdrawal by Subject|1
2113838|NCT00918255|3709309|FG001|Overall Study|Withdrawal by Subject|0
2113839|NCT00918255|3709310|FG002|Overall Study|Withdrawal by Subject|2
2113840|NCT00918255|3709308|FG000|Overall Study|Lack of Efficacy|1
2113841|NCT00918255|3709309|FG001|Overall Study|Lack of Efficacy|0
2113842|NCT00918255|3709310|FG002|Overall Study|Lack of Efficacy|0
2113843|NCT00918255|3709308|FG000|Overall Study|Lost to Follow-up|1
2113844|NCT00918255|3709309|FG001|Overall Study|Lost to Follow-up|0
2113845|NCT00918255|3709310|FG002|Overall Study|Lost to Follow-up|2
2113846|NCT00918255|3709308|FG000|Overall Study|Exceeded allowed number of interventions|0
2113847|NCT00918255|3709309|FG001|Overall Study|Exceeded allowed number of interventions|0
2113848|NCT00918255|3709310|FG002|Overall Study|Exceeded allowed number of interventions|1
2113849|NCT00918255|3709308|FG000|Overall Study|Non-compliance|1
2113850|NCT00918255|3709309|FG001|Overall Study|Non-compliance|0
2113851|NCT00918255|3709310|FG002|Overall Study|Non-compliance|0
2113852|NCT00918255|3709308|FG000|Overall Study|Investigator discretion|1
2113853|NCT00918255|3709309|FG001|Overall Study|Investigator discretion|0
2113854|NCT00918255|3709310|FG002|Overall Study|Investigator discretion|0
2113855|NCT00918281|3709318|FG000|Overall Study|Physician Decision|29
2113856|NCT00918333|3709327|FG000|Overall Study|Drug not taken per protocol|1
2113857|NCT00918333|3709328|FG001|Overall Study|Drug not taken per protocol|0
2113858|NCT00918333|3709327|FG000|Overall Study|Inadequate amount of drugs provided|1
2113859|NCT00918333|3709328|FG001|Overall Study|Inadequate amount of drugs provided|4
2113860|NCT00918333|3709327|FG000|Overall Study|Ineligible|1
2113861|NCT00918333|3709328|FG001|Overall Study|Ineligible|0
2113862|NCT00918333|3709327|FG000|Overall Study|Withdrawal by Subject|0
2113863|NCT00918333|3709328|FG001|Overall Study|Withdrawal by Subject|1
2113864|NCT00918346|3709337|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0
2113865|NCT00918346|3709338|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1
2113866|NCT00918385|3709349|FG000|Monotherapy|Adverse Event|1
2113867|NCT00918385|3709350|FG001|Monotherapy|Adverse Event|6
2113868|NCT00918385|3709349|FG000|Monotherapy|Complicating illness|1
2113869|NCT00918385|3709350|FG001|Monotherapy|Complicating illness|0
2113870|NCT00918385|3709349|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1
2113871|NCT00918385|3709350|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1
2113872|NCT00918385|3709349|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
2113873|NCT00918385|3709350|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
2113874|NCT00918385|3709349|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1
2113875|NCT00918385|3709350|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0
2113876|NCT00918385|3709349|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
2113877|NCT00918385|3709350|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
2113878|NCT00918567|3709360|FG000|Overall Study|Lack of Efficacy|3
2113879|NCT00918567|3709361|FG001|Overall Study|Lack of Efficacy|1
2113880|NCT00918567|3709360|FG000|Overall Study|Withdrawal by Subject|1
2113881|NCT00918567|3709361|FG001|Overall Study|Withdrawal by Subject|1
2113882|NCT00918567|3709360|FG000|Overall Study|Adverse Event|1
2113883|NCT00918567|3709361|FG001|Overall Study|Adverse Event|0
2113884|NCT00918580|3709367|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1
2113885|NCT00918580|3709367|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
2113886|NCT00918580|3709367|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
2113887|NCT00918580|3709367|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
2113888|NCT00918580|3709367|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1
2113889|NCT00918580|3709367|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
2113890|NCT00918580|3709367|FG000|After 6-month FU to 1-year FU|Failed to Return|2
2113891|NCT00918684|3709378|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
2113892|NCT00918684|3709378|FG000|Treatment Phase|Lack of Efficacy|6
2113893|NCT00918684|3709378|FG000|Treatment Phase|Lost to Follow-up|2
2113894|NCT00918684|3709378|FG000|Treatment Phase|Physician Decision|8
2113895|NCT00918684|3709378|FG000|Treatment Phase|Protocol Violation|1
2113896|NCT00918684|3709378|FG000|Treatment Phase|Withdrawal by Subject|8
2113897|NCT00918736|3709388|FG000|Overall Study|Withdrawal by Subject|4
2113898|NCT00918749|3709395|FG000|Overall Study|Adverse Event|1
2113899|NCT00918749|3709396|FG001|Overall Study|Adverse Event|0
2113900|NCT00918749|3709397|FG002|Overall Study|Adverse Event|1
2113901|NCT00918749|3709395|FG000|Overall Study|Lost to Follow-up|0
2113902|NCT00918749|3709396|FG001|Overall Study|Lost to Follow-up|0
2113903|NCT00918749|3709397|FG002|Overall Study|Lost to Follow-up|1
2113904|NCT00918749|3709395|FG000|Overall Study|Withdrawal by Subject|5
2113905|NCT00918749|3709396|FG001|Overall Study|Withdrawal by Subject|3
2113906|NCT00918749|3709397|FG002|Overall Study|Withdrawal by Subject|5
2113907|NCT00918749|3709395|FG000|Overall Study|No Study Medication Taken|1
2113908|NCT00918749|3709396|FG001|Overall Study|No Study Medication Taken|0
2113909|NCT00918749|3709397|FG002|Overall Study|No Study Medication Taken|0
2113910|NCT00918879|3709416|FG000|Overall Study|Withdrawal by Subject|4
2113911|NCT00918879|3709417|FG001|Overall Study|Withdrawal by Subject|4
2113912|NCT00918879|3709416|FG000|Overall Study|Lost to Follow-up|1
2113913|NCT00918879|3709417|FG001|Overall Study|Lost to Follow-up|1
2113914|NCT00918879|3709416|FG000|Overall Study|Severe non-compliance to protocol|1
2113915|NCT00918879|3709417|FG001|Overall Study|Severe non-compliance to protocol|1
2113916|NCT00918957|3709429|FG000|Overall Study|Adverse Event|2
2113917|NCT00918957|3709430|FG001|Overall Study|Adverse Event|0
2113918|NCT00918957|3709429|FG000|Overall Study|Withdrawal by Subject|1
2113919|NCT00918957|3709430|FG001|Overall Study|Withdrawal by Subject|0
2113920|NCT00919061|3709440|FG000|Overall Study|Adverse Event|1
2113921|NCT00919061|3709440|FG000|Overall Study|Withdrawal by Subject|1
2113922|NCT00919633|3709495|FG000|Overall Study|Adverse Event|1
2113923|NCT00919633|3709496|FG001|Overall Study|Adverse Event|9
2113924|NCT00919633|3709497|FG002|Overall Study|Adverse Event|12
2113925|NCT00919633|3709498|FG003|Overall Study|Adverse Event|10
2113926|NCT00919633|3709495|FG000|Overall Study|Death|0
2113927|NCT00919633|3709496|FG001|Overall Study|Death|0
2113928|NCT00919633|3709497|FG002|Overall Study|Death|2
2113929|NCT00919633|3709498|FG003|Overall Study|Death|0
2113930|NCT00919633|3709495|FG000|Overall Study|Lack of Efficacy|17
2113931|NCT00919633|3709496|FG001|Overall Study|Lack of Efficacy|3
2113932|NCT00919633|3709497|FG002|Overall Study|Lack of Efficacy|2
2113933|NCT00919633|3709498|FG003|Overall Study|Lack of Efficacy|3
2113934|NCT00919633|3709495|FG000|Overall Study|Withdrawal by Subject|1
2113935|NCT00919633|3709496|FG001|Overall Study|Withdrawal by Subject|2
2113936|NCT00919633|3709497|FG002|Overall Study|Withdrawal by Subject|4
2113937|NCT00919633|3709498|FG003|Overall Study|Withdrawal by Subject|3
2113938|NCT00919633|3709495|FG000|Overall Study|Lost to Follow-up|3
2113939|NCT00919633|3709496|FG001|Overall Study|Lost to Follow-up|1
2113940|NCT00919633|3709497|FG002|Overall Study|Lost to Follow-up|0
2113941|NCT00919633|3709498|FG003|Overall Study|Lost to Follow-up|2
2113942|NCT00919633|3709495|FG000|Overall Study|Withdraw consent post transition to SOC|0
2113943|NCT00919633|3709496|FG001|Overall Study|Withdraw consent post transition to SOC|0
2113944|NCT00919633|3709497|FG002|Overall Study|Withdraw consent post transition to SOC|1
2113945|NCT00919633|3709498|FG003|Overall Study|Withdraw consent post transition to SOC|1
2113946|NCT00919633|3709495|FG000|Overall Study|Protocol Violation|0
2113947|NCT00919633|3709496|FG001|Overall Study|Protocol Violation|0
2113948|NCT00919633|3709497|FG002|Overall Study|Protocol Violation|0
2113949|NCT00919633|3709498|FG003|Overall Study|Protocol Violation|1
2113950|NCT00919633|3709495|FG000|Overall Study|Physician Decision|0
2113951|NCT00919633|3709496|FG001|Overall Study|Physician Decision|0
2113952|NCT00919633|3709497|FG002|Overall Study|Physician Decision|0
2113953|NCT00919633|3709498|FG003|Overall Study|Physician Decision|1
2113954|NCT00919633|3709495|FG000|Overall Study|Request of withdrawal w/o future contact|0
2113955|NCT00919633|3709496|FG001|Overall Study|Request of withdrawal w/o future contact|0
2113956|NCT00919633|3709497|FG002|Overall Study|Request of withdrawal w/o future contact|1
2113957|NCT00919633|3709498|FG003|Overall Study|Request of withdrawal w/o future contact|0
2113958|NCT00919633|3709495|FG000|Overall Study|Viral rebound outside protocol timepoint|0
2113959|NCT00919633|3709496|FG001|Overall Study|Viral rebound outside protocol timepoint|0
2113960|NCT00919633|3709497|FG002|Overall Study|Viral rebound outside protocol timepoint|1
2113961|NCT00919633|3709498|FG003|Overall Study|Viral rebound outside protocol timepoint|0
2113962|NCT00919711|3709510|FG000|Overall Study|Withdrawal by Subject|15
2113963|NCT00919711|3709511|FG001|Overall Study|Withdrawal by Subject|7
2113964|NCT00919711|3709510|FG000|Overall Study|Adverse Event|13
2113965|NCT00919711|3709511|FG001|Overall Study|Adverse Event|3
2113966|NCT00919711|3709510|FG000|Overall Study|Other|1
2113967|NCT00919711|3709511|FG001|Overall Study|Other|2
2113968|NCT00919711|3709510|FG000|Overall Study|Administrative Decision|0
2113969|NCT00919711|3709511|FG001|Overall Study|Administrative Decision|1
2113970|NCT00919711|3709510|FG000|Overall Study|Lost to Follow-up|2
2113971|NCT00919711|3709511|FG001|Overall Study|Lost to Follow-up|0
2113972|NCT00919711|3709510|FG000|Overall Study|Death|1
2113973|NCT00919711|3709511|FG001|Overall Study|Death|0
2113974|NCT00919711|3709510|FG000|Overall Study|Noncompliance|1
2113975|NCT00919711|3709511|FG001|Overall Study|Noncompliance|0
2113976|NCT00919854|3709542|FG000|Overall Study|Adverse Event|1
2113977|NCT00919867|3709552|FG000|First Intervention|Withdrawal by Subject|0
2113978|NCT00919867|3709553|FG001|First Intervention|Withdrawal by Subject|0
2113979|NCT00919867|3709554|FG002|First Intervention|Withdrawal by Subject|1
2113980|NCT00919867|3709555|FG003|First Intervention|Withdrawal by Subject|0
2113981|NCT00919867|3709556|FG004|First Intervention|Withdrawal by Subject|0
2113982|NCT00919867|3709557|FG005|First Intervention|Withdrawal by Subject|0
2113983|NCT00919867|3709552|FG000|First Intervention|Physician Decision|0
2113984|NCT00919867|3709553|FG001|First Intervention|Physician Decision|0
2113985|NCT00919867|3709554|FG002|First Intervention|Physician Decision|0
2113986|NCT00919867|3709555|FG003|First Intervention|Physician Decision|0
2113987|NCT00919867|3709556|FG004|First Intervention|Physician Decision|0
2113988|NCT00919867|3709557|FG005|First Intervention|Physician Decision|1
2180533|NCT01402986|3806843|FG000|Overall Study|Death|0
2180534|NCT01402986|3806844|FG001|Overall Study|Death|0
2180535|NCT01402986|3806845|FG002|Overall Study|Death|0
2180536|NCT01402986|3806846|FG003|Overall Study|Death|2
2180537|NCT01402986|3806843|FG000|Overall Study|Lost to Follow-up|0
2180538|NCT01402986|3806844|FG001|Overall Study|Lost to Follow-up|0
2180539|NCT01402986|3806845|FG002|Overall Study|Lost to Follow-up|0
2180540|NCT01402986|3806846|FG003|Overall Study|Lost to Follow-up|1
2180541|NCT01402986|3806843|FG000|Overall Study|Other|2
2180542|NCT01402986|3806844|FG001|Overall Study|Other|5
2180543|NCT01402986|3806845|FG002|Overall Study|Other|1
2180544|NCT01402986|3806846|FG003|Overall Study|Other|6
2180545|NCT01403051|3806858|FG000|Overall Study|Protocol Violation|2
2180546|NCT01403051|3806859|FG001|Overall Study|Protocol Violation|0
2180547|NCT01403051|3806858|FG000|Overall Study|Death|1
2180548|NCT01403051|3806859|FG001|Overall Study|Death|0
2180549|NCT01403051|3806858|FG000|Overall Study|Withdrawal by Subject|2
2180550|NCT01403051|3806859|FG001|Overall Study|Withdrawal by Subject|1
2180551|NCT01403051|3806858|FG000|Overall Study|Lost to Follow-up|5
2180552|NCT01403051|3806859|FG001|Overall Study|Lost to Follow-up|5
2180553|NCT01403064|3806870|FG000|Overall Study|Death|0
2180554|NCT01403064|3806871|FG001|Overall Study|Death|0
2180555|NCT01403064|3806872|FG002|Overall Study|Death|1
2180556|NCT01403064|3806873|FG003|Overall Study|Death|1
2180557|NCT01403064|3806870|FG000|Overall Study|Withdrawal by Subject|0
2180558|NCT01403064|3806871|FG001|Overall Study|Withdrawal by Subject|0
2180559|NCT01403064|3806872|FG002|Overall Study|Withdrawal by Subject|1
2180560|NCT01403064|3806873|FG003|Overall Study|Withdrawal by Subject|1
2180561|NCT01403064|3806870|FG000|Overall Study|Other|1
2180562|NCT01403064|3806871|FG001|Overall Study|Other|0
2180563|NCT01403064|3806872|FG002|Overall Study|Other|2
2180564|NCT01403064|3806873|FG003|Overall Study|Other|1
2180565|NCT01403116|3806894|FG000|Overall Study|Adverse Event|7
2180566|NCT01403116|3806895|FG001|Overall Study|Adverse Event|4
2180567|NCT01403116|3806894|FG000|Overall Study|Lost to Follow-up|7
2180568|NCT01403116|3806895|FG001|Overall Study|Lost to Follow-up|5
2180569|NCT01403116|3806894|FG000|Overall Study|Withdrawal by Subject|12
2180570|NCT01403116|3806895|FG001|Overall Study|Withdrawal by Subject|15
2180571|NCT01403116|3806894|FG000|Overall Study|Non-compliance of study drug|3
2180572|NCT01403116|3806895|FG001|Overall Study|Non-compliance of study drug|0
2180573|NCT01403116|3806894|FG000|Overall Study|Protocol Violation|0
2180574|NCT01403116|3806895|FG001|Overall Study|Protocol Violation|1
2180575|NCT01403116|3806894|FG000|Overall Study|undisclosed Hx of Prostate Ca|1
2180576|NCT01403116|3806895|FG001|Overall Study|undisclosed Hx of Prostate Ca|0
2180577|NCT01403116|3806894|FG000|Overall Study|Hct >54%|2
2180578|NCT01403116|3806895|FG001|Overall Study|Hct >54%|0
2180579|NCT01403116|3806894|FG000|Overall Study|unable to keep appointments|0
2180580|NCT01403116|3806895|FG001|Overall Study|unable to keep appointments|2
2180581|NCT01403610|3806935|FG000|Overall Study|Withdrawal by Subject|2
2180582|NCT01403610|3806936|FG001|Overall Study|Withdrawal by Subject|0
2180583|NCT01403610|3806937|FG002|Overall Study|Withdrawal by Subject|0
2180584|NCT01403610|3806938|FG003|Overall Study|Withdrawal by Subject|0
2180585|NCT01403610|3806935|FG000|Overall Study|Didn't recover from surgery sufficiently|0
2180586|NCT01403610|3806936|FG001|Overall Study|Didn't recover from surgery sufficiently|3
2180587|NCT01403610|3806937|FG002|Overall Study|Didn't recover from surgery sufficiently|0
2180588|NCT01403610|3806938|FG003|Overall Study|Didn't recover from surgery sufficiently|0
2180589|NCT01403805|3806950|FG000|Overall Study|Withdrawal by Subject|0
2180590|NCT01403805|3806951|FG001|Overall Study|Withdrawal by Subject|4
2180591|NCT01403805|3806950|FG000|Overall Study|Lost to Follow-up|0
2180592|NCT01403805|3806951|FG001|Overall Study|Lost to Follow-up|2
2180593|NCT01403805|3806950|FG000|Overall Study|Death|0
2180594|NCT01403805|3806951|FG001|Overall Study|Death|1
2180595|NCT01403987|3806964|FG000|Overall Study|Residents forgot their secret PIN|18
2180596|NCT01403987|3806965|FG001|Overall Study|Residents forgot their secret PIN|17
2180597|NCT01403987|3806966|FG002|Overall Study|Residents forgot their secret PIN|18
2113989|NCT00920140|3709587|FG000|Phase 1 (Dose Escalation)|Adverse Event|3
2113990|NCT00920140|3709588|FG001|Phase 1 (Dose Escalation)|Adverse Event|3
2113991|NCT00920140|3709589|FG002|Phase 1 (Dose Escalation)|Adverse Event|0
2113992|NCT00920140|3709590|FG003|Phase 1 (Dose Escalation)|Adverse Event|0
2113993|NCT00920140|3709591|FG004|Phase 1 (Dose Escalation)|Adverse Event|0
2113994|NCT00920140|3709587|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2
2113995|NCT00920140|3709588|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4
2113996|NCT00920140|3709589|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0
2113997|NCT00920140|3709590|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0
2113998|NCT00920140|3709591|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0
2113999|NCT00920140|3709587|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
2114000|NCT00920140|3709588|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
2114001|NCT00920140|3709589|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
2114002|NCT00920140|3709590|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
2114003|NCT00920140|3709591|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
2114004|NCT00920140|3709587|FG000|Phase 2|Adverse Event|0
2114005|NCT00920140|3709588|FG001|Phase 2|Adverse Event|0
2114006|NCT00920140|3709589|FG002|Phase 2|Adverse Event|14
2114007|NCT00920140|3709590|FG003|Phase 2|Adverse Event|2
2114008|NCT00920140|3709591|FG004|Phase 2|Adverse Event|3
2114009|NCT00920140|3709587|FG000|Phase 2|Lack of Efficacy|0
2114010|NCT00920140|3709588|FG001|Phase 2|Lack of Efficacy|0
2114011|NCT00920140|3709589|FG002|Phase 2|Lack of Efficacy|29
2114012|NCT00920140|3709590|FG003|Phase 2|Lack of Efficacy|14
2114013|NCT00920140|3709591|FG004|Phase 2|Lack of Efficacy|5
2114014|NCT00920140|3709587|FG000|Phase 2|Lost to Follow-up|0
2114015|NCT00920140|3709588|FG001|Phase 2|Lost to Follow-up|0
2114016|NCT00920140|3709589|FG002|Phase 2|Lost to Follow-up|0
2114017|NCT00920140|3709590|FG003|Phase 2|Lost to Follow-up|1
2114018|NCT00920140|3709591|FG004|Phase 2|Lost to Follow-up|0
2114019|NCT00920140|3709587|FG000|Phase 2|Physician Decision|0
2114020|NCT00920140|3709588|FG001|Phase 2|Physician Decision|0
2114021|NCT00920140|3709589|FG002|Phase 2|Physician Decision|3
2114022|NCT00920140|3709590|FG003|Phase 2|Physician Decision|3
2114023|NCT00920140|3709591|FG004|Phase 2|Physician Decision|2
2114024|NCT00920140|3709587|FG000|Phase 2|Withdrawal by Subject|0
2114025|NCT00920140|3709588|FG001|Phase 2|Withdrawal by Subject|0
2114026|NCT00920140|3709589|FG002|Phase 2|Withdrawal by Subject|4
2114027|NCT00920140|3709590|FG003|Phase 2|Withdrawal by Subject|2
2114028|NCT00920140|3709591|FG004|Phase 2|Withdrawal by Subject|1
2114029|NCT00920218|3709608|FG000|Overall Study|Serious Adverse Event|2
2114030|NCT00920218|3709609|FG001|Overall Study|Serious Adverse Event|0
2114031|NCT00920218|3709610|FG002|Overall Study|Serious Adverse Event|2
2114032|NCT00920218|3709611|FG003|Overall Study|Serious Adverse Event|1
2114033|NCT00920218|3709608|FG000|Overall Study|Withdrawal by Subject|0
2114034|NCT00920218|3709609|FG001|Overall Study|Withdrawal by Subject|3
2114035|NCT00920218|3709610|FG002|Overall Study|Withdrawal by Subject|2
2114036|NCT00920218|3709611|FG003|Overall Study|Withdrawal by Subject|0
2114037|NCT00920218|3709608|FG000|Overall Study|Migrated/moved from study area|0
2114038|NCT00920218|3709609|FG001|Overall Study|Migrated/moved from study area|0
2114039|NCT00920218|3709610|FG002|Overall Study|Migrated/moved from study area|1
2114040|NCT00920218|3709611|FG003|Overall Study|Migrated/moved from study area|0
2114041|NCT00920218|3709608|FG000|Overall Study|Lost to Follow-up|0
2114042|NCT00920218|3709609|FG001|Overall Study|Lost to Follow-up|1
2114043|NCT00920218|3709610|FG002|Overall Study|Lost to Follow-up|0
2114044|NCT00920218|3709611|FG003|Overall Study|Lost to Follow-up|3
2114045|NCT00920218|3709608|FG000|Overall Study|Transplant failed/malignancy recurrence|0
2114046|NCT00920218|3709609|FG001|Overall Study|Transplant failed/malignancy recurrence|1
2114047|NCT00920218|3709610|FG002|Overall Study|Transplant failed/malignancy recurrence|2
2114048|NCT00920218|3709611|FG003|Overall Study|Transplant failed/malignancy recurrence|3
2114049|NCT00920218|3709608|FG000|Overall Study|Other|0
2114050|NCT00920218|3709609|FG001|Overall Study|Other|0
2114051|NCT00920218|3709610|FG002|Overall Study|Other|1
2114052|NCT00920218|3709611|FG003|Overall Study|Other|0
2114053|NCT00920426|3709648|FG000|ITZ111451|Adverse Event|1
2114054|NCT00920426|3709649|FG001|ITZ111451|Adverse Event|0
2114055|NCT00920426|3709650|FG002|ITZ111451|Adverse Event|0
2114056|NCT00920426|3709651|FG003|ITZ111451|Adverse Event|0
2114057|NCT00920556|3709667|FG000|Overall Study|Adverse Event|16
2114058|NCT00920556|3709667|FG000|Overall Study|Physician Decision|7
2114059|NCT00920556|3709667|FG000|Overall Study|Withdrawal by Subject|1
2114060|NCT00920621|3709679|FG000|Overall Study|Lost to Follow-up|16
2114061|NCT00920621|3709680|FG001|Overall Study|Lost to Follow-up|17
2114062|NCT00920621|3709681|FG002|Overall Study|Lost to Follow-up|19
2114063|NCT00920621|3709682|FG003|Overall Study|Lost to Follow-up|21
2114064|NCT00920621|3709679|FG000|Overall Study|Fetal/neonatal deaths|16
2114065|NCT00920621|3709680|FG001|Overall Study|Fetal/neonatal deaths|14
2114066|NCT00920621|3709681|FG002|Overall Study|Fetal/neonatal deaths|16
2114067|NCT00920621|3709682|FG003|Overall Study|Fetal/neonatal deaths|14
2114068|NCT00920621|3709679|FG000|Overall Study|Blood sample not collected|22
2114069|NCT00920621|3709680|FG001|Overall Study|Blood sample not collected|14
2114070|NCT00920621|3709681|FG002|Overall Study|Blood sample not collected|0
2114071|NCT00920621|3709682|FG003|Overall Study|Blood sample not collected|0
2114072|NCT00920686|3709723|FG000|Overall Study|Lost to Follow-up|2
2114073|NCT00920686|3709724|FG001|Overall Study|Lost to Follow-up|3
2114074|NCT00920686|3709725|FG002|Overall Study|Lost to Follow-up|1
2114075|NCT00920686|3709723|FG000|Overall Study|Study drug dosing criteria not met|17
2114076|NCT00920686|3709724|FG001|Overall Study|Study drug dosing criteria not met|19
2114077|NCT00920686|3709725|FG002|Overall Study|Study drug dosing criteria not met|12
2114078|NCT00920699|3709740|FG000|Overall Study|Withdrawal by Subject|2
2114079|NCT00920699|3709741|FG001|Overall Study|Withdrawal by Subject|0
2114080|NCT00920699|3709742|FG002|Overall Study|Withdrawal by Subject|2
2114081|NCT00920699|3709740|FG000|Overall Study|no longer met eligibility|0
2114082|NCT00920699|3709741|FG001|Overall Study|no longer met eligibility|1
2114083|NCT00920699|3709742|FG002|Overall Study|no longer met eligibility|0
2114084|NCT00920699|3709740|FG000|Overall Study|Lost to Follow-up|0
2114085|NCT00920699|3709741|FG001|Overall Study|Lost to Follow-up|0
2114086|NCT00920699|3709742|FG002|Overall Study|Lost to Follow-up|2
2114087|NCT00920790|3709750|FG000|Overall Study|aggravation of general condition|14
2114088|NCT00920816|3709758|FG000|Overall Study|Death|77
2114089|NCT00920816|3709759|FG001|Overall Study|Death|36
2114090|NCT00920816|3709760|FG002|Overall Study|Death|58
2114091|NCT00920816|3709761|FG003|Overall Study|Death|28
2114092|NCT00920816|3709758|FG000|Overall Study|Adverse Event|1
2114093|NCT00920816|3709759|FG001|Overall Study|Adverse Event|0
2114094|NCT00920816|3709760|FG002|Overall Study|Adverse Event|1
2114095|NCT00920816|3709761|FG003|Overall Study|Adverse Event|0
2114096|NCT00920816|3709758|FG000|Overall Study|Lost to Follow-up|1
2114097|NCT00920816|3709759|FG001|Overall Study|Lost to Follow-up|2
2114098|NCT00920816|3709760|FG002|Overall Study|Lost to Follow-up|3
2114099|NCT00920816|3709761|FG003|Overall Study|Lost to Follow-up|4
2114100|NCT00920816|3709758|FG000|Overall Study|Objective progression or relapse|0
2114101|NCT00920816|3709759|FG001|Overall Study|Objective progression or relapse|0
2114102|NCT00920816|3709760|FG002|Overall Study|Objective progression or relapse|2
2114103|NCT00920816|3709761|FG003|Overall Study|Objective progression or relapse|0
2114104|NCT00920816|3709758|FG000|Overall Study|Withdrawal by Subject|7
2114105|NCT00920816|3709759|FG001|Overall Study|Withdrawal by Subject|2
2114106|NCT00920816|3709760|FG002|Overall Study|Withdrawal by Subject|1
2114107|NCT00920816|3709761|FG003|Overall Study|Withdrawal by Subject|1
2114108|NCT00920816|3709758|FG000|Overall Study|Ongoing|106
2114109|NCT00920816|3709759|FG001|Overall Study|Ongoing|56
2114110|NCT00920816|3709760|FG002|Overall Study|Ongoing|70
2114111|NCT00920816|3709761|FG003|Overall Study|Ongoing|36
2114112|NCT00920829|3709775|FG000|Allocation|No post randomization data|3
2331852|NCT03178487|4054740|FG001|Overall Study|Lost to Follow-up|0
2331853|NCT03178487|4054739|FG000|Overall Study|Other|0
2331854|NCT03178487|4054740|FG001|Overall Study|Other|2
2114113|NCT00920829|3709776|FG001|Allocation|No post randomization data|1
2114114|NCT00920829|3709777|FG002|Allocation|No post randomization data|0
2114115|NCT00920829|3709778|FG003|Allocation|No post randomization data|2
2114116|NCT00920829|3709775|FG000|Available for Analysis|Withdrawal by Subject|6
2114117|NCT00920829|3709776|FG001|Available for Analysis|Withdrawal by Subject|6
2114118|NCT00920829|3709777|FG002|Available for Analysis|Withdrawal by Subject|6
2114119|NCT00920829|3709778|FG003|Available for Analysis|Withdrawal by Subject|10
2114120|NCT00920829|3709775|FG000|Available for Analysis|Required Medical Treatment|0
2114121|NCT00920829|3709776|FG001|Available for Analysis|Required Medical Treatment|1
2114122|NCT00920829|3709777|FG002|Available for Analysis|Required Medical Treatment|2
2114123|NCT00920829|3709778|FG003|Available for Analysis|Required Medical Treatment|0
2114124|NCT00920829|3709775|FG000|Available for Analysis|Adverse Event|1
2114125|NCT00920829|3709776|FG001|Available for Analysis|Adverse Event|2
2114126|NCT00920829|3709777|FG002|Available for Analysis|Adverse Event|1
2114127|NCT00920829|3709778|FG003|Available for Analysis|Adverse Event|0
2114128|NCT00920829|3709775|FG000|Available for Analysis|Death|1
2114129|NCT00920829|3709776|FG001|Available for Analysis|Death|0
2114130|NCT00920829|3709777|FG002|Available for Analysis|Death|0
2114131|NCT00920829|3709778|FG003|Available for Analysis|Death|0
2114132|NCT00920829|3709775|FG000|Available for Analysis|Protocol Violation|0
2114133|NCT00920829|3709776|FG001|Available for Analysis|Protocol Violation|0
2114134|NCT00920829|3709777|FG002|Available for Analysis|Protocol Violation|1
2114135|NCT00920829|3709778|FG003|Available for Analysis|Protocol Violation|0
2114136|NCT00920829|3709775|FG000|Available for Analysis|Required more treatment|0
2114137|NCT00920829|3709776|FG001|Available for Analysis|Required more treatment|2
2114138|NCT00920829|3709777|FG002|Available for Analysis|Required more treatment|0
2114139|NCT00920829|3709778|FG003|Available for Analysis|Required more treatment|1
2114140|NCT00920855|3709791|FG000|Overall Study|Adverse Event|1
2114141|NCT00920855|3709792|FG001|Overall Study|Adverse Event|1
2114142|NCT00920855|3709793|FG002|Overall Study|Adverse Event|4
2114143|NCT00920855|3709791|FG000|Overall Study|Withdrawal by Subject|2
2114144|NCT00920855|3709792|FG001|Overall Study|Withdrawal by Subject|1
2114145|NCT00920855|3709793|FG002|Overall Study|Withdrawal by Subject|6
2114146|NCT00920855|3709791|FG000|Overall Study|Disease progression|2
2114147|NCT00920855|3709792|FG001|Overall Study|Disease progression|1
2114148|NCT00920855|3709793|FG002|Overall Study|Disease progression|10
2114149|NCT00920855|3709791|FG000|Overall Study|Noncompliance to study medication|0
2114150|NCT00920855|3709792|FG001|Overall Study|Noncompliance to study medication|0
2114151|NCT00920855|3709793|FG002|Overall Study|Noncompliance to study medication|1
2114152|NCT00920855|3709791|FG000|Overall Study|Response plateau; started maintenance|0
2114153|NCT00920855|3709792|FG001|Overall Study|Response plateau; started maintenance|0
2114154|NCT00920855|3709793|FG002|Overall Study|Response plateau; started maintenance|1
2114155|NCT00920907|3709804|FG000|Induction Period|Adverse Event|0
2114156|NCT00920907|3709805|FG001|Induction Period|Adverse Event|2
2114157|NCT00920907|3709804|FG000|Induction Period|Death|1
2114158|NCT00920907|3709805|FG001|Induction Period|Death|1
2114159|NCT00920907|3709804|FG000|Induction Period|Disease Progression|12
2114160|NCT00920907|3709805|FG001|Induction Period|Disease Progression|11
2114161|NCT00920907|3709804|FG000|Induction Period|Study Drug Toxicity|8
2114162|NCT00920907|3709805|FG001|Induction Period|Study Drug Toxicity|6
2114163|NCT00920907|3709804|FG000|Induction Period|No longer meets study criteria|0
2114164|NCT00920907|3709805|FG001|Induction Period|No longer meets study criteria|1
2114165|NCT00920907|3709804|FG000|Induction Period|Withdrawal by Subject|1
2114166|NCT00920907|3709805|FG001|Induction Period|Withdrawal by Subject|1
2114167|NCT00920907|3709804|FG000|Maintenance Period|Disease Progression|3
2114168|NCT00920907|3709805|FG001|Maintenance Period|Disease Progression|7
2114169|NCT00920907|3709804|FG000|Maintenance Period|Administrative (study closure)|7
2114170|NCT00920907|3709805|FG001|Maintenance Period|Administrative (study closure)|2
2114171|NCT00920907|3709804|FG000|Maintenance Period|Study Drug Toxicity|0
2114172|NCT00920907|3709805|FG001|Maintenance Period|Study Drug Toxicity|2
2114173|NCT00920907|3709804|FG000|Maintenance Period|Death|1
2114174|NCT00920907|3709805|FG001|Maintenance Period|Death|1
2114175|NCT00920907|3709804|FG000|Maintenance Period|Withdrawal by Subject|1
2114176|NCT00920907|3709805|FG001|Maintenance Period|Withdrawal by Subject|0
2114177|NCT00920907|3709804|FG000|Maintenance Period|Adverse Event|0
2114178|NCT00920907|3709805|FG001|Maintenance Period|Adverse Event|1
2114179|NCT00921024|3709815|FG000|Overall Study|Lost to Follow-up|2
2114180|NCT00921024|3709816|FG001|Overall Study|Lost to Follow-up|0
2114181|NCT00921024|3709815|FG000|Overall Study|Received concomittant therapy|2
2114182|NCT00921024|3709816|FG001|Overall Study|Received concomittant therapy|0
2114183|NCT00921024|3709815|FG000|Overall Study|Withdrawal by Subject|0
2114184|NCT00921024|3709816|FG001|Overall Study|Withdrawal by Subject|3
2114185|NCT00921557|3709854|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
2114186|NCT00921557|3709855|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
2114187|NCT00921557|3709856|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
2114188|NCT00921557|3709854|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0
2114189|NCT00921557|3709855|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1
2114190|NCT00921557|3709856|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0
2114191|NCT00921557|3709854|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
2114192|NCT00921557|3709855|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
2114193|NCT00921557|3709856|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
2114194|NCT00921557|3709854|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1
2114195|NCT00921557|3709855|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0
2114196|NCT00921557|3709856|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0
2114197|NCT00921557|3709854|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
2114198|NCT00921557|3709855|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
2114199|NCT00921557|3709856|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
2114200|NCT00922116|3709913|FG000|Overall Study|Adverse Event|4
2114201|NCT00922116|3709913|FG000|Overall Study|Death|1
2114202|NCT00922116|3709913|FG000|Overall Study|Lost to Follow-up|1
2114203|NCT00922116|3709913|FG000|Overall Study|Withdrawal by Subject|4
2114204|NCT00922116|3709913|FG000|Overall Study|Other|5
2114205|NCT00922207|3709924|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
2114206|NCT00922207|3709925|FG001|Overall Study|Adverse Event/Intercurrent Illness|0
2114207|NCT00922207|3709926|FG002|Overall Study|Adverse Event/Intercurrent Illness|0
2114208|NCT00922207|3709924|FG000|Overall Study|Insufficient Therapeutic Response|0
2114209|NCT00922207|3709925|FG001|Overall Study|Insufficient Therapeutic Response|0
2114210|NCT00922207|3709926|FG002|Overall Study|Insufficient Therapeutic Response|1
2114211|NCT00922207|3709924|FG000|Overall Study|Violation of Selection Criteria at Entry|0
2114212|NCT00922207|3709925|FG001|Overall Study|Violation of Selection Criteria at Entry|1
2114213|NCT00922207|3709926|FG002|Overall Study|Violation of Selection Criteria at Entry|0
2114214|NCT00922207|3709924|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
2114215|NCT00922207|3709925|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
2114216|NCT00922207|3709926|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0
2114217|NCT00922207|3709924|FG000|Overall Study|Withdrew Consent|2
2114218|NCT00922207|3709925|FG001|Overall Study|Withdrew Consent|5
2114219|NCT00922207|3709926|FG002|Overall Study|Withdrew Consent|2
2114220|NCT00922207|3709924|FG000|Overall Study|Abnormality of Laboratory Test|0
2114221|NCT00922207|3709925|FG001|Overall Study|Abnormality of Laboratory Test|1
2114222|NCT00922207|3709926|FG002|Overall Study|Abnormality of Laboratory Test|1
2114223|NCT00922272|3709939|FG000|Open-label Phase|Adverse Event|5
2114224|NCT00922272|3709940|FG001|Open-label Phase|Adverse Event|0
2114225|NCT00922272|3709939|FG000|Open-label Phase|Protocol Violation|1
2114226|NCT00922272|3709940|FG001|Open-label Phase|Protocol Violation|0
2114227|NCT00922272|3709939|FG000|Open-label Phase|Withdrawal by Subject|11
2114228|NCT00922272|3709940|FG001|Open-label Phase|Withdrawal by Subject|0
2114229|NCT00922272|3709939|FG000|Open-label Phase|Failure to meet randomization criteria|1
2114230|NCT00922272|3709940|FG001|Open-label Phase|Failure to meet randomization criteria|0
2114231|NCT00922272|3709939|FG000|Open-label Phase|Withdrawal criteria met|5
2114232|NCT00922272|3709940|FG001|Open-label Phase|Withdrawal criteria met|0
2114233|NCT00922272|3709939|FG000|Double-blind Phase|Adverse Event|1
2114234|NCT00922272|3709940|FG001|Double-blind Phase|Adverse Event|1
2114235|NCT00922272|3709939|FG000|Double-blind Phase|Withdrawal by Subject|1
2114236|NCT00922272|3709940|FG001|Double-blind Phase|Withdrawal by Subject|1
2114237|NCT00922272|3709939|FG000|Double-blind Phase|Lost to Follow-up|2
2114238|NCT00922272|3709940|FG001|Double-blind Phase|Lost to Follow-up|1
2114239|NCT00922272|3709939|FG000|Double-blind Phase|Withdrawal criteria met|1
2114240|NCT00922272|3709940|FG001|Double-blind Phase|Withdrawal criteria met|1
2114241|NCT00922272|3709939|FG000|Double-blind Phase|Noncompliance|1
2114242|NCT00922272|3709940|FG001|Double-blind Phase|Noncompliance|1
2114243|NCT00922272|3709939|FG000|Double-blind Phase|Positive urine drug screen|1
2114244|NCT00922272|3709940|FG001|Double-blind Phase|Positive urine drug screen|1
2114245|NCT00922428|3709948|FG000|Overall Study|retrospective/extremely implausible data|2
2114246|NCT00922428|3709948|FG000|Overall Study|no medication use or questionable use|13
2114247|NCT00922441|3709961|FG000|Overall Study|Protocol Violation|0
2114248|NCT00922441|3709962|FG001|Overall Study|Protocol Violation|0
2114249|NCT00922441|3709963|FG002|Overall Study|Protocol Violation|2
2114250|NCT00922441|3709961|FG000|Overall Study|Withdrawal by Subject|0
2114251|NCT00922441|3709962|FG001|Overall Study|Withdrawal by Subject|0
2114252|NCT00922441|3709963|FG002|Overall Study|Withdrawal by Subject|1
2114253|NCT00922480|3709973|FG000|Main Study|Protocol Violation|3
2114254|NCT00922480|3709974|FG001|Main Study|Protocol Violation|6
2114255|NCT00922480|3709973|FG000|Main Study|Adverse Event|6
2114256|NCT00922480|3709974|FG001|Main Study|Adverse Event|7
2114257|NCT00922480|3709973|FG000|Main Study|Lack of Efficacy|3
2114258|NCT00922480|3709974|FG001|Main Study|Lack of Efficacy|0
2114259|NCT00922480|3709973|FG000|Main Study|Withdrawal by Subject|20
2114260|NCT00922480|3709974|FG001|Main Study|Withdrawal by Subject|15
2114261|NCT00922480|3709973|FG000|Main Study|Lost to Follow-up|5
2114262|NCT00922480|3709974|FG001|Main Study|Lost to Follow-up|0
2114263|NCT00922480|3709973|FG000|Main Study|Physician Decision|0
2114264|NCT00922480|3709974|FG001|Main Study|Physician Decision|1
2114265|NCT00922480|3709973|FG000|Extension Study|Protocol Violation|3
2114266|NCT00922480|3709974|FG001|Extension Study|Protocol Violation|0
2114267|NCT00922480|3709973|FG000|Extension Study|Adverse Event|1
2114268|NCT00922480|3709974|FG001|Extension Study|Adverse Event|1
2114269|NCT00922480|3709973|FG000|Extension Study|Withdrawal by Subject|1
2114270|NCT00922480|3709974|FG001|Extension Study|Withdrawal by Subject|1
2114271|NCT00922480|3709973|FG000|Extension Study|Others|0
2114272|NCT00922480|3709974|FG001|Extension Study|Others|1
2114273|NCT00922623|3709982|FG000|Overall Study|Other|4
2114274|NCT00922623|3709982|FG000|Overall Study|Lost to Follow-up|1
2114275|NCT00922636|3709993|FG000|Overall Study|Adverse Event|3
2114276|NCT00922636|3709994|FG001|Overall Study|Adverse Event|3
2114277|NCT00922636|3709995|FG002|Overall Study|Adverse Event|2
2114278|NCT00922636|3709996|FG003|Overall Study|Adverse Event|3
2114279|NCT00922636|3709997|FG004|Overall Study|Adverse Event|2
2114280|NCT00922636|3709993|FG000|Overall Study|Lack of Efficacy|1
2114281|NCT00922636|3709994|FG001|Overall Study|Lack of Efficacy|7
2114282|NCT00922636|3709995|FG002|Overall Study|Lack of Efficacy|3
2114283|NCT00922636|3709996|FG003|Overall Study|Lack of Efficacy|2
2114284|NCT00922636|3709997|FG004|Overall Study|Lack of Efficacy|4
2114285|NCT00922636|3709993|FG000|Overall Study|Sponsor Decision|0
2114286|NCT00922636|3709994|FG001|Overall Study|Sponsor Decision|0
2114287|NCT00922636|3709995|FG002|Overall Study|Sponsor Decision|2
2114288|NCT00922636|3709996|FG003|Overall Study|Sponsor Decision|0
2114289|NCT00922636|3709997|FG004|Overall Study|Sponsor Decision|0
2114290|NCT00922636|3709993|FG000|Overall Study|Withdrawal by Subject|0
2114291|NCT00922636|3709994|FG001|Overall Study|Withdrawal by Subject|0
2114292|NCT00922636|3709995|FG002|Overall Study|Withdrawal by Subject|5
2114293|NCT00922636|3709996|FG003|Overall Study|Withdrawal by Subject|2
2114294|NCT00922636|3709997|FG004|Overall Study|Withdrawal by Subject|4
2219107|NCT01719224|3862826|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
2219108|NCT01719380|3862852|FG000|Overall Study|Adverse Event|0
2219109|NCT01719380|3862853|FG001|Overall Study|Adverse Event|0
2114295|NCT00922636|3709993|FG000|Overall Study|Protocol Violation|0
2114296|NCT00922636|3709994|FG001|Overall Study|Protocol Violation|0
2114297|NCT00922636|3709995|FG002|Overall Study|Protocol Violation|2
2114298|NCT00922636|3709996|FG003|Overall Study|Protocol Violation|2
2114299|NCT00922636|3709997|FG004|Overall Study|Protocol Violation|0
2114300|NCT00922636|3709993|FG000|Overall Study|Entry Criteria Not Met|0
2114301|NCT00922636|3709994|FG001|Overall Study|Entry Criteria Not Met|0
2114302|NCT00922636|3709995|FG002|Overall Study|Entry Criteria Not Met|1
2114303|NCT00922636|3709996|FG003|Overall Study|Entry Criteria Not Met|1
2114304|NCT00922636|3709997|FG004|Overall Study|Entry Criteria Not Met|0
2114305|NCT00922636|3709993|FG000|Overall Study|Parent/Caregiver Decision|2
2114306|NCT00922636|3709994|FG001|Overall Study|Parent/Caregiver Decision|4
2114307|NCT00922636|3709995|FG002|Overall Study|Parent/Caregiver Decision|3
2114308|NCT00922636|3709996|FG003|Overall Study|Parent/Caregiver Decision|5
2114309|NCT00922636|3709997|FG004|Overall Study|Parent/Caregiver Decision|2
2114310|NCT00922636|3709993|FG000|Overall Study|Lost to Follow-up|1
2114311|NCT00922636|3709994|FG001|Overall Study|Lost to Follow-up|2
2219110|NCT01719380|3862854|FG002|Overall Study|Adverse Event|1
2114312|NCT00922636|3709995|FG002|Overall Study|Lost to Follow-up|2
2114313|NCT00922636|3709996|FG003|Overall Study|Lost to Follow-up|2
2114314|NCT00922636|3709997|FG004|Overall Study|Lost to Follow-up|4
2114315|NCT00922766|3710018|FG000|Overall Study|Death|3
2114316|NCT00922766|3710018|FG000|Overall Study|Withdrawal by Subject|2
2114317|NCT00922766|3710018|FG000|Overall Study|Other|1
2114318|NCT00922766|3710018|FG000|Overall Study|Adverse Event|1
2114319|NCT00922779|3710022|FG000|Overall Study|Adverse Event|67
2114320|NCT00922779|3710022|FG000|Overall Study|Pregnancy|7
2114321|NCT00922779|3710022|FG000|Overall Study|Withdrawal by Subject|308
2114322|NCT00922779|3710022|FG000|Overall Study|Lost to Follow-up|44
2114323|NCT00922779|3710022|FG000|Overall Study|Other|27
2114324|NCT00922779|3710022|FG000|Overall Study|Missing|1874
2114325|NCT00922935|3710033|FG000|Overall Study|Protocol Violation|0
2114326|NCT00922935|3710034|FG001|Overall Study|Protocol Violation|3
2114327|NCT00922935|3710035|FG002|Overall Study|Protocol Violation|0
2114328|NCT00922935|3710033|FG000|Overall Study|Physician Decision|1
2114329|NCT00922935|3710034|FG001|Overall Study|Physician Decision|1
2114330|NCT00922935|3710035|FG002|Overall Study|Physician Decision|0
2114331|NCT00922935|3710033|FG000|Overall Study|Lost to Follow-up|0
2114332|NCT00922935|3710034|FG001|Overall Study|Lost to Follow-up|1
2114333|NCT00922935|3710035|FG002|Overall Study|Lost to Follow-up|0
2114334|NCT00922974|3710046|FG000|Phase II Component|Protocol Violation|2
2114335|NCT00922974|3710047|FG001|Phase II Component|Protocol Violation|0
2114336|NCT00922974|3710046|FG000|Phase II Component|Not evaluable for treatment review|5
2114337|NCT00922974|3710047|FG001|Phase II Component|Not evaluable for treatment review|0
2114338|NCT00922974|3710046|FG000|Phase III Component|Protocol Violation|8
2114339|NCT00922974|3710047|FG001|Phase III Component|Protocol Violation|6
2114340|NCT00922987|3710055|FG000|Overall Study|Insufficient clinical response|1
2114341|NCT00922987|3710055|FG000|Overall Study|Protocol Violation|2
2114342|NCT00922987|3710055|FG000|Overall Study|Adverse Event|1
2114343|NCT00923078|3710062|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
2114344|NCT00923078|3710063|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
2114345|NCT00923078|3710064|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
2114346|NCT00923078|3710062|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0
2114347|NCT00923078|3710063|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0
2114348|NCT00923078|3710064|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20
2114349|NCT00923091|3710079|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
2114350|NCT00923091|3710080|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
2114351|NCT00923091|3710081|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
2114352|NCT00923091|3710082|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
2114353|NCT00923091|3710083|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
2114354|NCT00923091|3710084|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
2114355|NCT00923091|3710085|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
2114356|NCT00923091|3710086|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
2114357|NCT00923091|3710087|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
2114358|NCT00923091|3710088|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
2114359|NCT00923091|3710089|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
2114360|NCT00923091|3710090|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
2114361|NCT00923091|3710091|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
2114362|NCT00923091|3710079|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
2114363|NCT00923091|3710080|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
2114364|NCT00923091|3710081|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
2114365|NCT00923091|3710082|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
2114366|NCT00923091|3710083|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
2114367|NCT00923091|3710084|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
2114368|NCT00923091|3710085|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
2114369|NCT00923091|3710086|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
2114370|NCT00923091|3710087|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
2114371|NCT00923091|3710088|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
2114372|NCT00923091|3710089|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
2114373|NCT00923091|3710090|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
2114374|NCT00923091|3710091|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
2114375|NCT00923091|3710079|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
2114376|NCT00923091|3710080|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
2114377|NCT00923091|3710081|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
2114378|NCT00923091|3710082|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
2114379|NCT00923091|3710083|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
2114380|NCT00923091|3710084|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
2114381|NCT00923091|3710085|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
2114382|NCT00923091|3710086|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
2114383|NCT00923091|3710087|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
2114384|NCT00923091|3710088|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
2114385|NCT00923091|3710089|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
2114386|NCT00923091|3710090|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
2114387|NCT00923091|3710091|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
2114388|NCT00923091|3710079|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114389|NCT00923091|3710080|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114390|NCT00923091|3710081|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114391|NCT00923091|3710082|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114392|NCT00923091|3710083|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114393|NCT00923091|3710084|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
2114394|NCT00923091|3710085|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114395|NCT00923091|3710086|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114396|NCT00923091|3710087|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114397|NCT00923091|3710088|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114398|NCT00923091|3710089|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114399|NCT00923091|3710090|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114400|NCT00923091|3710091|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2114401|NCT00923091|3710079|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2114402|NCT00923091|3710080|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
2114403|NCT00923091|3710081|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2114404|NCT00923091|3710082|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
2114405|NCT00923091|3710083|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2114406|NCT00923091|3710084|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
2114407|NCT00923091|3710085|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2114408|NCT00923091|3710086|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2114409|NCT00923091|3710087|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2114410|NCT00923091|3710088|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2114411|NCT00923091|3710089|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2114412|NCT00923091|3710090|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2114413|NCT00923091|3710091|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2114414|NCT00923091|3710079|FG000|Period III (Single-Blind)|Adverse Event|5
2114415|NCT00923091|3710080|FG001|Period III (Single-Blind)|Adverse Event|0
2114416|NCT00923091|3710081|FG002|Period III (Single-Blind)|Adverse Event|0
2114417|NCT00923091|3710082|FG003|Period III (Single-Blind)|Adverse Event|0
2114418|NCT00923091|3710083|FG004|Period III (Single-Blind)|Adverse Event|0
2114419|NCT00923091|3710084|FG005|Period III (Single-Blind)|Adverse Event|0
2114420|NCT00923091|3710085|FG006|Period III (Single-Blind)|Adverse Event|0
2114421|NCT00923091|3710086|FG007|Period III (Single-Blind)|Adverse Event|0
2114422|NCT00923091|3710087|FG008|Period III (Single-Blind)|Adverse Event|0
2114423|NCT00923091|3710088|FG009|Period III (Single-Blind)|Adverse Event|0
2114424|NCT00923091|3710089|FG010|Period III (Single-Blind)|Adverse Event|0
2114425|NCT00923091|3710090|FG011|Period III (Single-Blind)|Adverse Event|0
2114426|NCT00923091|3710091|FG012|Period III (Single-Blind)|Adverse Event|0
2114427|NCT00923091|3710079|FG000|Period III (Single-Blind)|Withdrawal by Subject|10
2114428|NCT00923091|3710080|FG001|Period III (Single-Blind)|Withdrawal by Subject|0
2114429|NCT00923091|3710081|FG002|Period III (Single-Blind)|Withdrawal by Subject|0
2114430|NCT00923091|3710082|FG003|Period III (Single-Blind)|Withdrawal by Subject|0
2114431|NCT00923091|3710083|FG004|Period III (Single-Blind)|Withdrawal by Subject|0
2114432|NCT00923091|3710084|FG005|Period III (Single-Blind)|Withdrawal by Subject|0
2114433|NCT00923091|3710085|FG006|Period III (Single-Blind)|Withdrawal by Subject|0
2114434|NCT00923091|3710086|FG007|Period III (Single-Blind)|Withdrawal by Subject|0
2114435|NCT00923091|3710087|FG008|Period III (Single-Blind)|Withdrawal by Subject|0
2114436|NCT00923091|3710088|FG009|Period III (Single-Blind)|Withdrawal by Subject|0
2114437|NCT00923091|3710089|FG010|Period III (Single-Blind)|Withdrawal by Subject|0
2114438|NCT00923091|3710090|FG011|Period III (Single-Blind)|Withdrawal by Subject|0
2114439|NCT00923091|3710091|FG012|Period III (Single-Blind)|Withdrawal by Subject|0
2114440|NCT00923091|3710079|FG000|Period III (Single-Blind)|Protocol Violation|3
2114441|NCT00923091|3710080|FG001|Period III (Single-Blind)|Protocol Violation|0
2114442|NCT00923091|3710081|FG002|Period III (Single-Blind)|Protocol Violation|0
2114443|NCT00923091|3710082|FG003|Period III (Single-Blind)|Protocol Violation|0
2114444|NCT00923091|3710083|FG004|Period III (Single-Blind)|Protocol Violation|0
2114445|NCT00923091|3710084|FG005|Period III (Single-Blind)|Protocol Violation|0
2114446|NCT00923091|3710085|FG006|Period III (Single-Blind)|Protocol Violation|0
2114447|NCT00923091|3710086|FG007|Period III (Single-Blind)|Protocol Violation|0
2114448|NCT00923091|3710087|FG008|Period III (Single-Blind)|Protocol Violation|0
2114449|NCT00923091|3710088|FG009|Period III (Single-Blind)|Protocol Violation|0
2114450|NCT00923091|3710089|FG010|Period III (Single-Blind)|Protocol Violation|0
2114451|NCT00923091|3710090|FG011|Period III (Single-Blind)|Protocol Violation|0
2114452|NCT00923091|3710091|FG012|Period III (Single-Blind)|Protocol Violation|0
2114453|NCT00923091|3710079|FG000|Period III (Single-Blind)|Lost to Follow-up|2
2114454|NCT00923091|3710080|FG001|Period III (Single-Blind)|Lost to Follow-up|0
2114455|NCT00923091|3710081|FG002|Period III (Single-Blind)|Lost to Follow-up|0
2114456|NCT00923091|3710082|FG003|Period III (Single-Blind)|Lost to Follow-up|0
2114457|NCT00923091|3710083|FG004|Period III (Single-Blind)|Lost to Follow-up|0
2114458|NCT00923091|3710084|FG005|Period III (Single-Blind)|Lost to Follow-up|0
2114459|NCT00923091|3710085|FG006|Period III (Single-Blind)|Lost to Follow-up|0
2114460|NCT00923091|3710086|FG007|Period III (Single-Blind)|Lost to Follow-up|0
2114461|NCT00923091|3710087|FG008|Period III (Single-Blind)|Lost to Follow-up|0
2114462|NCT00923091|3710088|FG009|Period III (Single-Blind)|Lost to Follow-up|0
2114463|NCT00923091|3710089|FG010|Period III (Single-Blind)|Lost to Follow-up|0
2114464|NCT00923091|3710090|FG011|Period III (Single-Blind)|Lost to Follow-up|0
2114465|NCT00923091|3710091|FG012|Period III (Single-Blind)|Lost to Follow-up|0
2114466|NCT00923091|3710079|FG000|Period IV (Double-Blind)|Adverse Event|2
2114467|NCT00923091|3710080|FG001|Period IV (Double-Blind)|Adverse Event|0
2114468|NCT00923091|3710081|FG002|Period IV (Double-Blind)|Adverse Event|0
2114469|NCT00923091|3710082|FG003|Period IV (Double-Blind)|Adverse Event|0
2114470|NCT00923091|3710083|FG004|Period IV (Double-Blind)|Adverse Event|0
2114471|NCT00923091|3710084|FG005|Period IV (Double-Blind)|Adverse Event|0
2114472|NCT00923091|3710085|FG006|Period IV (Double-Blind)|Adverse Event|0
2114473|NCT00923091|3710086|FG007|Period IV (Double-Blind)|Adverse Event|0
2114474|NCT00923091|3710087|FG008|Period IV (Double-Blind)|Adverse Event|0
2114475|NCT00923091|3710088|FG009|Period IV (Double-Blind)|Adverse Event|0
2114476|NCT00923091|3710089|FG010|Period IV (Double-Blind)|Adverse Event|0
2114477|NCT00923091|3710090|FG011|Period IV (Double-Blind)|Adverse Event|0
2114478|NCT00923091|3710091|FG012|Period IV (Double-Blind)|Adverse Event|0
2114479|NCT00923091|3710079|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0
2114480|NCT00923091|3710080|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1
2114481|NCT00923091|3710081|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0
2114482|NCT00923091|3710082|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0
2114483|NCT00923091|3710083|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0
2114484|NCT00923091|3710084|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0
2114485|NCT00923091|3710085|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0
2114486|NCT00923091|3710086|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0
2114487|NCT00923091|3710087|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0
2114488|NCT00923091|3710088|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0
2114489|NCT00923091|3710089|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0
2114490|NCT00923091|3710090|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0
2114491|NCT00923091|3710091|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0
2114492|NCT00923091|3710079|FG000|Period IV (Double-Blind)|Protocol Violation|0
2114493|NCT00923091|3710080|FG001|Period IV (Double-Blind)|Protocol Violation|1
2114494|NCT00923091|3710081|FG002|Period IV (Double-Blind)|Protocol Violation|0
2114495|NCT00923091|3710082|FG003|Period IV (Double-Blind)|Protocol Violation|0
2114496|NCT00923091|3710083|FG004|Period IV (Double-Blind)|Protocol Violation|0
2114497|NCT00923091|3710084|FG005|Period IV (Double-Blind)|Protocol Violation|0
2114498|NCT00923091|3710085|FG006|Period IV (Double-Blind)|Protocol Violation|0
2114499|NCT00923091|3710086|FG007|Period IV (Double-Blind)|Protocol Violation|0
2114500|NCT00923091|3710087|FG008|Period IV (Double-Blind)|Protocol Violation|0
2114501|NCT00923091|3710088|FG009|Period IV (Double-Blind)|Protocol Violation|0
2114502|NCT00923091|3710089|FG010|Period IV (Double-Blind)|Protocol Violation|0
2114503|NCT00923091|3710090|FG011|Period IV (Double-Blind)|Protocol Violation|0
2114504|NCT00923091|3710091|FG012|Period IV (Double-Blind)|Protocol Violation|0
2114505|NCT00923091|3710079|FG000|Period V (Double -Blind)|Withdrawal by Subject|0
2114506|NCT00923091|3710080|FG001|Period V (Double -Blind)|Withdrawal by Subject|0
2114507|NCT00923091|3710081|FG002|Period V (Double -Blind)|Withdrawal by Subject|0
2114508|NCT00923091|3710082|FG003|Period V (Double -Blind)|Withdrawal by Subject|0
2114509|NCT00923091|3710083|FG004|Period V (Double -Blind)|Withdrawal by Subject|0
2114510|NCT00923091|3710084|FG005|Period V (Double -Blind)|Withdrawal by Subject|0
2114511|NCT00923091|3710085|FG006|Period V (Double -Blind)|Withdrawal by Subject|0
2114512|NCT00923091|3710086|FG007|Period V (Double -Blind)|Withdrawal by Subject|0
2114513|NCT00923091|3710087|FG008|Period V (Double -Blind)|Withdrawal by Subject|1
2114514|NCT00923091|3710088|FG009|Period V (Double -Blind)|Withdrawal by Subject|0
2114515|NCT00923091|3710089|FG010|Period V (Double -Blind)|Withdrawal by Subject|0
2114516|NCT00923091|3710090|FG011|Period V (Double -Blind)|Withdrawal by Subject|0
2114517|NCT00923091|3710091|FG012|Period V (Double -Blind)|Withdrawal by Subject|1
2114518|NCT00923091|3710079|FG000|Period V (Double -Blind)|Protocol Violation|0
2114519|NCT00923091|3710080|FG001|Period V (Double -Blind)|Protocol Violation|0
2114520|NCT00923091|3710081|FG002|Period V (Double -Blind)|Protocol Violation|0
2114521|NCT00923091|3710082|FG003|Period V (Double -Blind)|Protocol Violation|0
2114522|NCT00923091|3710083|FG004|Period V (Double -Blind)|Protocol Violation|0
2114523|NCT00923091|3710084|FG005|Period V (Double -Blind)|Protocol Violation|0
2114524|NCT00923091|3710085|FG006|Period V (Double -Blind)|Protocol Violation|0
2114525|NCT00923091|3710086|FG007|Period V (Double -Blind)|Protocol Violation|0
2114526|NCT00923091|3710087|FG008|Period V (Double -Blind)|Protocol Violation|0
2114527|NCT00923091|3710088|FG009|Period V (Double -Blind)|Protocol Violation|0
2114528|NCT00923091|3710089|FG010|Period V (Double -Blind)|Protocol Violation|0
2114529|NCT00923091|3710090|FG011|Period V (Double -Blind)|Protocol Violation|0
2114530|NCT00923091|3710091|FG012|Period V (Double -Blind)|Protocol Violation|1
2114531|NCT00923091|3710079|FG000|Period V (Double -Blind)|Lost to Follow-up|0
2114532|NCT00923091|3710080|FG001|Period V (Double -Blind)|Lost to Follow-up|0
2114533|NCT00923091|3710081|FG002|Period V (Double -Blind)|Lost to Follow-up|0
2114534|NCT00923091|3710082|FG003|Period V (Double -Blind)|Lost to Follow-up|0
2114535|NCT00923091|3710083|FG004|Period V (Double -Blind)|Lost to Follow-up|0
2114536|NCT00923091|3710084|FG005|Period V (Double -Blind)|Lost to Follow-up|0
2114537|NCT00923091|3710085|FG006|Period V (Double -Blind)|Lost to Follow-up|0
2114538|NCT00923091|3710086|FG007|Period V (Double -Blind)|Lost to Follow-up|0
2114539|NCT00923091|3710087|FG008|Period V (Double -Blind)|Lost to Follow-up|0
2114540|NCT00923091|3710088|FG009|Period V (Double -Blind)|Lost to Follow-up|0
2114541|NCT00923091|3710089|FG010|Period V (Double -Blind)|Lost to Follow-up|1
2114542|NCT00923091|3710090|FG011|Period V (Double -Blind)|Lost to Follow-up|0
2114543|NCT00923091|3710091|FG012|Period V (Double -Blind)|Lost to Follow-up|0
2114544|NCT00923091|3710079|FG000|Period VI (Open-Label)|Adverse Event|17
2114545|NCT00923091|3710080|FG001|Period VI (Open-Label)|Adverse Event|0
2114546|NCT00923091|3710081|FG002|Period VI (Open-Label)|Adverse Event|4
2114547|NCT00923091|3710082|FG003|Period VI (Open-Label)|Adverse Event|1
2114548|NCT00923091|3710083|FG004|Period VI (Open-Label)|Adverse Event|1
2114549|NCT00923091|3710084|FG005|Period VI (Open-Label)|Adverse Event|0
2114550|NCT00923091|3710085|FG006|Period VI (Open-Label)|Adverse Event|0
2114551|NCT00923091|3710086|FG007|Period VI (Open-Label)|Adverse Event|0
2114552|NCT00923091|3710087|FG008|Period VI (Open-Label)|Adverse Event|0
2114553|NCT00923091|3710088|FG009|Period VI (Open-Label)|Adverse Event|0
2114554|NCT00923091|3710089|FG010|Period VI (Open-Label)|Adverse Event|0
2114555|NCT00923091|3710090|FG011|Period VI (Open-Label)|Adverse Event|0
2114556|NCT00923091|3710091|FG012|Period VI (Open-Label)|Adverse Event|0
2114557|NCT00923091|3710079|FG000|Period VI (Open-Label)|Withdrawal by Subject|15
2114558|NCT00923091|3710080|FG001|Period VI (Open-Label)|Withdrawal by Subject|7
2114559|NCT00923091|3710081|FG002|Period VI (Open-Label)|Withdrawal by Subject|5
2114560|NCT00923091|3710082|FG003|Period VI (Open-Label)|Withdrawal by Subject|0
2114561|NCT00923091|3710083|FG004|Period VI (Open-Label)|Withdrawal by Subject|1
2114562|NCT00923091|3710084|FG005|Period VI (Open-Label)|Withdrawal by Subject|0
2114563|NCT00923091|3710085|FG006|Period VI (Open-Label)|Withdrawal by Subject|0
2114564|NCT00923091|3710086|FG007|Period VI (Open-Label)|Withdrawal by Subject|0
2114565|NCT00923091|3710087|FG008|Period VI (Open-Label)|Withdrawal by Subject|0
2114566|NCT00923091|3710088|FG009|Period VI (Open-Label)|Withdrawal by Subject|0
2114567|NCT00923091|3710089|FG010|Period VI (Open-Label)|Withdrawal by Subject|0
2114568|NCT00923091|3710090|FG011|Period VI (Open-Label)|Withdrawal by Subject|0
2114569|NCT00923091|3710091|FG012|Period VI (Open-Label)|Withdrawal by Subject|0
2114570|NCT00923091|3710079|FG000|Period VI (Open-Label)|Protocol Violation|6
2114571|NCT00923091|3710080|FG001|Period VI (Open-Label)|Protocol Violation|1
2114572|NCT00923091|3710081|FG002|Period VI (Open-Label)|Protocol Violation|3
2114573|NCT00923091|3710082|FG003|Period VI (Open-Label)|Protocol Violation|1
2114574|NCT00923091|3710083|FG004|Period VI (Open-Label)|Protocol Violation|4
2114575|NCT00923091|3710084|FG005|Period VI (Open-Label)|Protocol Violation|0
2114576|NCT00923091|3710085|FG006|Period VI (Open-Label)|Protocol Violation|0
2114577|NCT00923091|3710086|FG007|Period VI (Open-Label)|Protocol Violation|0
2114578|NCT00923091|3710087|FG008|Period VI (Open-Label)|Protocol Violation|0
2114579|NCT00923091|3710088|FG009|Period VI (Open-Label)|Protocol Violation|0
2114580|NCT00923091|3710089|FG010|Period VI (Open-Label)|Protocol Violation|0
2114581|NCT00923091|3710090|FG011|Period VI (Open-Label)|Protocol Violation|0
2114582|NCT00923091|3710091|FG012|Period VI (Open-Label)|Protocol Violation|0
2114583|NCT00923091|3710079|FG000|Period VI (Open-Label)|Lost to Follow-up|1
2114584|NCT00923091|3710080|FG001|Period VI (Open-Label)|Lost to Follow-up|0
2114585|NCT00923091|3710081|FG002|Period VI (Open-Label)|Lost to Follow-up|1
2114586|NCT00923091|3710082|FG003|Period VI (Open-Label)|Lost to Follow-up|0
2114587|NCT00923091|3710083|FG004|Period VI (Open-Label)|Lost to Follow-up|0
2114588|NCT00923091|3710084|FG005|Period VI (Open-Label)|Lost to Follow-up|0
2114589|NCT00923091|3710085|FG006|Period VI (Open-Label)|Lost to Follow-up|0
2114590|NCT00923091|3710086|FG007|Period VI (Open-Label)|Lost to Follow-up|0
2114591|NCT00923091|3710087|FG008|Period VI (Open-Label)|Lost to Follow-up|0
2114592|NCT00923091|3710088|FG009|Period VI (Open-Label)|Lost to Follow-up|0
2114593|NCT00923091|3710089|FG010|Period VI (Open-Label)|Lost to Follow-up|0
2114594|NCT00923091|3710090|FG011|Period VI (Open-Label)|Lost to Follow-up|0
2114595|NCT00923091|3710091|FG012|Period VI (Open-Label)|Lost to Follow-up|0
2114596|NCT00923091|3710079|FG000|Period VI (Open-Label)|Other Reason|0
2114597|NCT00923091|3710080|FG001|Period VI (Open-Label)|Other Reason|0
2114598|NCT00923091|3710081|FG002|Period VI (Open-Label)|Other Reason|0
2114599|NCT00923091|3710082|FG003|Period VI (Open-Label)|Other Reason|1
2114600|NCT00923091|3710083|FG004|Period VI (Open-Label)|Other Reason|1
2114601|NCT00923091|3710084|FG005|Period VI (Open-Label)|Other Reason|0
2114602|NCT00923091|3710085|FG006|Period VI (Open-Label)|Other Reason|0
2114603|NCT00923091|3710086|FG007|Period VI (Open-Label)|Other Reason|0
2114604|NCT00923091|3710087|FG008|Period VI (Open-Label)|Other Reason|0
2114605|NCT00923091|3710088|FG009|Period VI (Open-Label)|Other Reason|0
2114606|NCT00923091|3710089|FG010|Period VI (Open-Label)|Other Reason|0
2114607|NCT00923091|3710090|FG011|Period VI (Open-Label)|Other Reason|0
2114608|NCT00923091|3710091|FG012|Period VI (Open-Label)|Other Reason|0
2114609|NCT00923130|3710125|FG000|Overall Study|Stopped treatment due to progression|17
2114610|NCT00923130|3710125|FG000|Overall Study|Death|1
2114611|NCT00923130|3710125|FG000|Overall Study|Discontinued treatment due to toxicities|3
2114612|NCT00923130|3710125|FG000|Overall Study|Switched to alternative treatment|2
2114613|NCT00923130|3710125|FG000|Overall Study|Refused further treatment|2
2114614|NCT00923156|3710132|FG000|Overall Study|Adverse Event|0
2114615|NCT00923156|3710133|FG001|Overall Study|Adverse Event|2
2114616|NCT00923156|3710134|FG002|Overall Study|Adverse Event|1
2114617|NCT00923156|3710132|FG000|Overall Study|Abnormal laboratory values|0
2114618|NCT00923156|3710133|FG001|Overall Study|Abnormal laboratory values|0
2114619|NCT00923156|3710134|FG002|Overall Study|Abnormal laboratory values|1
2114620|NCT00923156|3710132|FG000|Overall Study|Withdrawal by Subject|0
2114621|NCT00923156|3710133|FG001|Overall Study|Withdrawal by Subject|1
2114622|NCT00923156|3710134|FG002|Overall Study|Withdrawal by Subject|0
2114623|NCT00923156|3710132|FG000|Overall Study|Death|0
2114624|NCT00923156|3710133|FG001|Overall Study|Death|1
2114625|NCT00923156|3710134|FG002|Overall Study|Death|0
2114626|NCT00923156|3710132|FG000|Overall Study|Lack of Efficacy|0
2114627|NCT00923156|3710133|FG001|Overall Study|Lack of Efficacy|0
2114628|NCT00923156|3710134|FG002|Overall Study|Lack of Efficacy|1
2114629|NCT00923195|3710144|FG000|Overall Study|Death|0
2114630|NCT00923195|3710145|FG001|Overall Study|Death|1
2114631|NCT00923260|3710153|FG000|Overall Study|Lost to Follow-up|1
2114632|NCT00923260|3710154|FG001|Overall Study|Lost to Follow-up|1
2114633|NCT00923273|3710165|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
2114634|NCT00923273|3710166|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
2114635|NCT00923273|3710167|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
2114636|NCT00923273|3710168|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
2114637|NCT00923273|3710169|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
2114638|NCT00923273|3710165|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
2114639|NCT00923273|3710166|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
2114640|NCT00923273|3710167|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
2114641|NCT00923273|3710168|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
2114642|NCT00923273|3710169|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
2114643|NCT00923351|3710189|FG000|Overall Study|no apheresis/adequate tumor sample|0
2114644|NCT00923351|3710190|FG001|Overall Study|no apheresis/adequate tumor sample|0
2114645|NCT00923351|3710191|FG002|Overall Study|no apheresis/adequate tumor sample|12
2114646|NCT00923364|3710197|FG000|Overall Study|Death|3
2114647|NCT00923364|3710198|FG001|Overall Study|Death|0
2114648|NCT00923364|3710197|FG000|Overall Study|Did not go to transplant|1
2114649|NCT00923364|3710198|FG001|Overall Study|Did not go to transplant|0
2114650|NCT00923559|3710209|FG000|Overall Study|Lost to Follow-up|2
2114651|NCT00923559|3710210|FG001|Overall Study|Lost to Follow-up|3
2114652|NCT00923845|3710229|FG000|Induction Therapy|Poor performance status|0
2114653|NCT00923845|3710230|FG001|Induction Therapy|Poor performance status|2
2114654|NCT00923936|3710247|FG000|Overall Study|progressive disease on study|2
2114655|NCT00923936|3710248|FG001|Overall Study|progressive disease on study|1
2114656|NCT00923936|3710247|FG000|Overall Study|Adverse Event|2
2114657|NCT00923936|3710248|FG001|Overall Study|Adverse Event|1
2114658|NCT00923936|3710247|FG000|Overall Study|Lost to follow up|2
2114659|NCT00923936|3710248|FG001|Overall Study|Lost to follow up|0
2114660|NCT00923936|3710247|FG000|Overall Study|Continuing in follow up period|2
2114661|NCT00923936|3710248|FG001|Overall Study|Continuing in follow up period|1
2114662|NCT00923975|3710260|FG000|Overall Study|Did not meet inclusion criteria|1
2114663|NCT00924287|3710307|FG000|Overall Study|Death|1
2114664|NCT00924313|3710311|FG000|Overall Study|not imaged due to failed tracer imaging|1
2114665|NCT00924404|3710325|FG000|Overall Study|Lost to Follow-up|6
2114666|NCT00924404|3710326|FG001|Overall Study|Lost to Follow-up|4
2114667|NCT00924443|3710332|FG000|Overall Study|Physician Decision|2
2114668|NCT00924443|3710332|FG000|Overall Study|Protocol Violation|1
2114669|NCT00924469|3710338|FG000|Overall Study|Adverse Event|2
2114670|NCT00924469|3710339|FG001|Overall Study|Adverse Event|0
2114671|NCT00924469|3710338|FG000|Overall Study|Withdrawal by Subject|0
2114672|NCT00924469|3710339|FG001|Overall Study|Withdrawal by Subject|1
2114673|NCT00924469|3710338|FG000|Overall Study|Lost to Follow-up|0
2114674|NCT00924469|3710339|FG001|Overall Study|Lost to Follow-up|1
2114675|NCT00924508|3710350|FG000|Overall Study|Withdrawal by Subject|3
2114676|NCT00924560|3710360|FG000|Overall Study|Did Not Meet Protocol Requirements|4
2114677|NCT00924560|3710361|FG001|Overall Study|Did Not Meet Protocol Requirements|2
2114678|NCT00924560|3710362|FG002|Overall Study|Did Not Meet Protocol Requirements|1
2114679|NCT00924560|3710360|FG000|Overall Study|Non Compliance with the Protocol|20
2114680|NCT00924560|3710361|FG001|Overall Study|Non Compliance with the Protocol|15
2114681|NCT00924560|3710362|FG002|Overall Study|Non Compliance with the Protocol|4
2114682|NCT00924560|3710360|FG000|Overall Study|Physician Decision|2
2114683|NCT00924560|3710361|FG001|Overall Study|Physician Decision|3
2114684|NCT00924560|3710362|FG002|Overall Study|Physician Decision|4
2114685|NCT00924560|3710360|FG000|Overall Study|Withdrawal by Subject|50
2114686|NCT00924560|3710361|FG001|Overall Study|Withdrawal by Subject|44
2114687|NCT00924560|3710362|FG002|Overall Study|Withdrawal by Subject|18
2114688|NCT00924560|3710360|FG000|Overall Study|Adverse Event|39
2114689|NCT00924560|3710361|FG001|Overall Study|Adverse Event|33
2114690|NCT00924560|3710362|FG002|Overall Study|Adverse Event|0
2114691|NCT00924560|3710360|FG000|Overall Study|Pregnancy|5
2114692|NCT00924560|3710361|FG001|Overall Study|Pregnancy|7
2114693|NCT00924560|3710362|FG002|Overall Study|Pregnancy|1
2114694|NCT00924560|3710360|FG000|Overall Study|Lost to Follow-up|78
2114695|NCT00924560|3710361|FG001|Overall Study|Lost to Follow-up|94
2219111|NCT01719380|3862855|FG003|Overall Study|Adverse Event|2
2219112|NCT01719380|3862856|FG004|Overall Study|Adverse Event|0
2219113|NCT01719380|3862857|FG005|Overall Study|Adverse Event|1
2219114|NCT01719380|3862858|FG006|Overall Study|Adverse Event|0
2219115|NCT01719380|3862859|FG007|Overall Study|Adverse Event|1
2219116|NCT01719380|3862860|FG008|Overall Study|Adverse Event|4
2219117|NCT01719380|3862861|FG009|Overall Study|Adverse Event|3
2219118|NCT01719380|3862852|FG000|Overall Study|Death|0
2219119|NCT01719380|3862853|FG001|Overall Study|Death|1
2219120|NCT01719380|3862854|FG002|Overall Study|Death|0
2219121|NCT01719380|3862855|FG003|Overall Study|Death|0
2114696|NCT00924560|3710362|FG002|Overall Study|Lost to Follow-up|45
2114697|NCT00924560|3710360|FG000|Overall Study|Miscellaneous Reasons|13
2114698|NCT00924560|3710361|FG001|Overall Study|Miscellaneous Reasons|10
2114699|NCT00924560|3710362|FG002|Overall Study|Miscellaneous Reasons|10
2114700|NCT00924638|3710389|FG000|Overall Study|Death|3
2114701|NCT00924638|3710390|FG001|Overall Study|Death|2
2114702|NCT00924638|3710389|FG000|Overall Study|Lost to Follow-up|1
2114703|NCT00924638|3710390|FG001|Overall Study|Lost to Follow-up|1
2114704|NCT00924638|3710389|FG000|Overall Study|Withdrawal by Subject|5
2114705|NCT00924638|3710390|FG001|Overall Study|Withdrawal by Subject|7
2114706|NCT00924638|3710389|FG000|Overall Study|Physician Decision|3
2114707|NCT00924638|3710390|FG001|Overall Study|Physician Decision|3
2114708|NCT00924651|3710398|FG000|Overall Study|Chemo started too soon|2
2114709|NCT00924651|3710399|FG001|Overall Study|Chemo started too soon|3
2114710|NCT00924651|3710398|FG000|Overall Study|No Reason|3
2114711|NCT00924651|3710399|FG001|Overall Study|No Reason|7
2114712|NCT00924651|3710398|FG000|Overall Study|Overwhelmed|6
2114713|NCT00924651|3710399|FG001|Overall Study|Overwhelmed|6
2114714|NCT00924651|3710398|FG000|Overall Study|Noncompliant|1
2114715|NCT00924651|3710399|FG001|Overall Study|Noncompliant|4
2114716|NCT00924651|3710398|FG000|Overall Study|Medical|1
2114717|NCT00924651|3710399|FG001|Overall Study|Medical|3
2114718|NCT00924651|3710398|FG000|Overall Study|Changed Mind|10
2180598|NCT01404208|3807030|FG000|Overall Study|Discontinued|3
2180599|NCT01404208|3807031|FG001|Overall Study|Discontinued|0
2180600|NCT01404234|3807037|FG000|Overall Study|Withdrawal by Subject|2
2180601|NCT01404325|3807052|FG000|Overall Study|Lost to Follow-up|1
2180602|NCT01404325|3807053|FG001|Overall Study|Lost to Follow-up|0
2180603|NCT01404325|3807052|FG000|Overall Study|Death|2
2180604|NCT01404325|3807053|FG001|Overall Study|Death|0
2180605|NCT01404325|3807052|FG000|Overall Study|Graft loss/Retransplantation|1
2180606|NCT01404325|3807053|FG001|Overall Study|Graft loss/Retransplantation|0
2180607|NCT01404325|3807052|FG000|Overall Study|non-specified reason|0
2180608|NCT01404325|3807053|FG001|Overall Study|non-specified reason|2
2180609|NCT01404949|3807129|FG000|Overall Study|Not Treated|1
2180610|NCT01404988|3807136|FG000|Overall Study|Death|2
2180611|NCT01404988|3807137|FG001|Overall Study|Death|0
2180612|NCT01404988|3807138|FG002|Overall Study|Death|2
2180613|NCT01404988|3807136|FG000|Overall Study|Adverse Event|1
2180614|NCT01404988|3807137|FG001|Overall Study|Adverse Event|0
2180615|NCT01404988|3807138|FG002|Overall Study|Adverse Event|0
2180616|NCT01404988|3807136|FG000|Overall Study|Withdrawal by Subject|2
2180617|NCT01404988|3807137|FG001|Overall Study|Withdrawal by Subject|2
2180618|NCT01404988|3807138|FG002|Overall Study|Withdrawal by Subject|0
2180619|NCT01404988|3807136|FG000|Overall Study|Lost to Follow-up|1
2180620|NCT01404988|3807137|FG001|Overall Study|Lost to Follow-up|2
2180621|NCT01404988|3807138|FG002|Overall Study|Lost to Follow-up|1
2180622|NCT01405027|3807151|FG000|Overall Study|Withdrawn consent|3
2180623|NCT01405027|3807152|FG001|Overall Study|Withdrawn consent|0
2180624|NCT01405027|3807151|FG000|Overall Study|Lost to Follow-up|16
2180625|NCT01405027|3807152|FG001|Overall Study|Lost to Follow-up|24
2180626|NCT01405027|3807151|FG000|Overall Study|Investigator judgement|0
2180627|NCT01405027|3807152|FG001|Overall Study|Investigator judgement|2
2180628|NCT01405027|3807151|FG000|Overall Study|Death|1
2180629|NCT01405027|3807152|FG001|Overall Study|Death|0
2180630|NCT01405027|3807151|FG000|Overall Study|Other or Unknown|12
2180631|NCT01405027|3807152|FG001|Overall Study|Other or Unknown|25
2180632|NCT01405053|3807162|FG000|Overall Study|Adverse Event|3
2180633|NCT01405053|3807163|FG001|Overall Study|Adverse Event|0
2180634|NCT01405053|3807162|FG000|Overall Study|Lost to Follow-up|0
2180635|NCT01405053|3807163|FG001|Overall Study|Lost to Follow-up|1
2180636|NCT01405053|3807162|FG000|Overall Study|Participant choice|2
2180637|NCT01405053|3807163|FG001|Overall Study|Participant choice|1
2180638|NCT01405053|3807162|FG000|Overall Study|Inadequate therapeutic effect|2
2180639|NCT01405053|3807163|FG001|Overall Study|Inadequate therapeutic effect|1
2180640|NCT01405053|3807162|FG000|Overall Study|Withdrawal by Subject|3
2114719|NCT00924651|3710399|FG001|Overall Study|Changed Mind|1
2114720|NCT00924651|3710398|FG000|Overall Study|Incomplete Form|2
2114721|NCT00924651|3710399|FG001|Overall Study|Incomplete Form|1
2180641|NCT01405053|3807163|FG001|Overall Study|Withdrawal by Subject|4
2180642|NCT01405053|3807162|FG000|Overall Study|Other|0
2180643|NCT01405053|3807163|FG001|Overall Study|Other|1
2180644|NCT01405196|3807173|FG000|Overall Study|Study Terminated by Sponsor|0
2219122|NCT01719380|3862856|FG004|Overall Study|Death|0
2219123|NCT01719380|3862857|FG005|Overall Study|Death|0
2219124|NCT01719380|3862858|FG006|Overall Study|Death|0
2219125|NCT01719380|3862859|FG007|Overall Study|Death|0
2114722|NCT00924664|3710407|FG000|Overall Study|Adverse Event|23
2114723|NCT00924664|3710408|FG001|Overall Study|Adverse Event|39
2114724|NCT00924664|3710407|FG000|Overall Study|Lack of Efficacy|10
2114725|NCT00924664|3710408|FG001|Overall Study|Lack of Efficacy|15
2114726|NCT00924664|3710407|FG000|Overall Study|Lost to Follow-up|10
2114727|NCT00924664|3710408|FG001|Overall Study|Lost to Follow-up|12
2114728|NCT00924664|3710407|FG000|Overall Study|Withdrawal by Subject|47
2114729|NCT00924664|3710408|FG001|Overall Study|Withdrawal by Subject|71
2114730|NCT00924664|3710407|FG000|Overall Study|Protocol Violation|2
2114731|NCT00924664|3710408|FG001|Overall Study|Protocol Violation|5
2114732|NCT00924664|3710407|FG000|Overall Study|Pregnancy|1
2114733|NCT00924664|3710408|FG001|Overall Study|Pregnancy|1
2114734|NCT00924664|3710407|FG000|Overall Study|Death|0
2114735|NCT00924664|3710408|FG001|Overall Study|Death|2
2114736|NCT00924664|3710407|FG000|Overall Study|Study terminated by sponsor|199
2114737|NCT00924664|3710408|FG001|Overall Study|Study terminated by sponsor|330
2114738|NCT00924664|3710407|FG000|Overall Study|Other|29
2114739|NCT00924664|3710408|FG001|Overall Study|Other|52
2114740|NCT00924664|3710407|FG000|Overall Study|Randomized but not Treated|1
2114741|NCT00924664|3710408|FG001|Overall Study|Randomized but not Treated|0
2114742|NCT00924703|3710414|FG000|Overall Study|Withdrawal by Subject|11
2114743|NCT00924703|3710414|FG000|Overall Study|Physician Decision|5
2114744|NCT00924703|3710414|FG000|Overall Study|Lost to Follow-up|3
2114745|NCT00924703|3710414|FG000|Overall Study|Adverse Event|2
2114746|NCT00924703|3710414|FG000|Overall Study|Withdrawal by Sponsor|1
2114747|NCT00924729|3710420|FG000|Overall Study|insufficient volume for analysis|1
2114748|NCT00924729|3710421|FG001|Overall Study|insufficient volume for analysis|0
2114749|NCT00924729|3710420|FG000|Overall Study|Protocol Violation|1
2219126|NCT01719380|3862860|FG008|Overall Study|Death|3
2219127|NCT01719380|3862861|FG009|Overall Study|Death|3
2219128|NCT01719380|3862852|FG000|Overall Study|Participant/Guardian Decision|0
2219129|NCT01719380|3862853|FG001|Overall Study|Participant/Guardian Decision|0
2114750|NCT00924729|3710421|FG001|Overall Study|Protocol Violation|0
2114751|NCT00924781|3710433|FG000|Overall Study|Study terminated by sponsor|12
2114752|NCT00924781|3710434|FG001|Overall Study|Study terminated by sponsor|10
2114753|NCT00924820|3710450|FG000|Overall Study|Death|2
2114754|NCT00924820|3710450|FG000|Overall Study|Ineligible, Screen Failure|5
2114755|NCT00924898|3710465|FG000|Overall Study|Withdrawal by Subject|2
2114756|NCT00924950|3710474|FG000|Overall Study|Lost to Follow-up|2
2114757|NCT00925002|3710484|FG000|Overall Study|Other|1
2114758|NCT00925002|3710485|FG001|Overall Study|Other|4
2114759|NCT00925002|3710486|FG002|Overall Study|Other|0
2114760|NCT00925002|3710484|FG000|Overall Study|Death|1
2114761|NCT00925002|3710485|FG001|Overall Study|Death|1
2114762|NCT00925002|3710486|FG002|Overall Study|Death|5
2114763|NCT00925002|3710484|FG000|Overall Study|Adverse Event|3
2114764|NCT00925002|3710485|FG001|Overall Study|Adverse Event|1
2114765|NCT00925002|3710486|FG002|Overall Study|Adverse Event|2
2114766|NCT00925002|3710484|FG000|Overall Study|Participant withdrew consent|1
2114767|NCT00925002|3710485|FG001|Overall Study|Participant withdrew consent|3
2114768|NCT00925002|3710486|FG002|Overall Study|Participant withdrew consent|3
2114769|NCT00925015|3710498|FG000|Overall Study|Adverse Event|1
2114770|NCT00925015|3710499|FG001|Overall Study|Adverse Event|2
2114771|NCT00925015|3710500|FG002|Overall Study|Adverse Event|1
2114772|NCT00925015|3710498|FG000|Overall Study|Physician Decision|0
2114773|NCT00925015|3710499|FG001|Overall Study|Physician Decision|1
2114774|NCT00925015|3710500|FG002|Overall Study|Physician Decision|0
2114775|NCT00925015|3710498|FG000|Overall Study|Progressive Disease|7
2114776|NCT00925015|3710499|FG001|Overall Study|Progressive Disease|3
2114777|NCT00925015|3710500|FG002|Overall Study|Progressive Disease|4
2114778|NCT00925015|3710498|FG000|Overall Study|Withdrawal by Subject|0
2114779|NCT00925015|3710499|FG001|Overall Study|Withdrawal by Subject|0
2114780|NCT00925015|3710500|FG002|Overall Study|Withdrawal by Subject|1
2114781|NCT00925132|3710538|FG000|Overall Study|Withdrawal by Subject|2
2114782|NCT00925132|3710539|FG001|Overall Study|Withdrawal by Subject|0
2114783|NCT00925132|3710540|FG002|Overall Study|Withdrawal by Subject|0
2114784|NCT00925132|3710541|FG003|Overall Study|Withdrawal by Subject|0
2114785|NCT00925132|3710542|FG004|Overall Study|Withdrawal by Subject|1
2114786|NCT00925132|3710538|FG000|Overall Study|Removed due to disease progression|0
2114787|NCT00925132|3710539|FG001|Overall Study|Removed due to disease progression|0
2114788|NCT00925132|3710540|FG002|Overall Study|Removed due to disease progression|0
2114789|NCT00925132|3710541|FG003|Overall Study|Removed due to disease progression|0
2114790|NCT00925132|3710542|FG004|Overall Study|Removed due to disease progression|4
2114791|NCT00925288|3710550|FG000|Overall Study|Lost to Follow-up|9
2114792|NCT00925288|3710551|FG001|Overall Study|Lost to Follow-up|7
2114793|NCT00925301|3710561|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
2114794|NCT00925301|3710562|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
2114795|NCT00925301|3710563|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
2114796|NCT00925301|3710564|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
2114797|NCT00925301|3710561|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0
2114798|NCT00925301|3710562|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1
2114799|NCT00925301|3710563|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0
2114800|NCT00925301|3710564|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0
2114801|NCT00925301|3710561|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
2114802|NCT00925301|3710562|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
2114803|NCT00925301|3710563|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
2114804|NCT00925301|3710564|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
2114805|NCT00925301|3710561|FG000|6-Month Open-label (Stage 2)|Adverse Event|0
2114806|NCT00925301|3710562|FG001|6-Month Open-label (Stage 2)|Adverse Event|0
2114807|NCT00925301|3710563|FG002|6-Month Open-label (Stage 2)|Adverse Event|2
2114808|NCT00925301|3710564|FG003|6-Month Open-label (Stage 2)|Adverse Event|0
2114809|NCT00925301|3710561|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
2114810|NCT00925301|3710562|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
2114811|NCT00925301|3710563|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
2114812|NCT00925301|3710564|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
2114813|NCT00925301|3710561|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0
2114814|NCT00925301|3710562|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0
2114815|NCT00925301|3710563|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0
2114816|NCT00925301|3710564|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1
2114817|NCT00925301|3710561|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
2114818|NCT00925301|3710562|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
2114819|NCT00925301|3710563|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
2114820|NCT00925301|3710564|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
2114821|NCT00925353|3710575|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3
2114822|NCT00925522|3710579|FG000|Overall Study|study closed -- business decision|20
2114823|NCT00925587|3710585|FG000|Overall Study|Protocol Specified Criteria|6
2114824|NCT00925587|3710586|FG001|Overall Study|Protocol Specified Criteria|6
2114825|NCT00925587|3710585|FG000|Overall Study|Physician Decision|4
2114826|NCT00925587|3710586|FG001|Overall Study|Physician Decision|1
2114827|NCT00925587|3710585|FG000|Overall Study|Protocol Violation|6
2114828|NCT00925587|3710586|FG001|Overall Study|Protocol Violation|4
2114829|NCT00925587|3710585|FG000|Overall Study|Withdrawal by Subject|9
2114830|NCT00925587|3710586|FG001|Overall Study|Withdrawal by Subject|6
2114831|NCT00925587|3710585|FG000|Overall Study|Death|5
2114832|NCT00925587|3710586|FG001|Overall Study|Death|5
2114833|NCT00925587|3710585|FG000|Overall Study|Adverse Event|6
2114834|NCT00925587|3710586|FG001|Overall Study|Adverse Event|2
2114835|NCT00925587|3710585|FG000|Overall Study|Lost to Follow-up|0
2114836|NCT00925587|3710586|FG001|Overall Study|Lost to Follow-up|1
2114837|NCT00925600|3710594|FG000|Overall Study|Withdrawal by Subject|16
2114838|NCT00925600|3710595|FG001|Overall Study|Withdrawal by Subject|14
2114839|NCT00925600|3710594|FG000|Overall Study|Death|4
2114840|NCT00925600|3710595|FG001|Overall Study|Death|3
2114841|NCT00925600|3710594|FG000|Overall Study|Lost to Follow-up|2
2114842|NCT00925600|3710595|FG001|Overall Study|Lost to Follow-up|2
2114843|NCT00925600|3710594|FG000|Overall Study|Disease Progression|1
2114844|NCT00925600|3710595|FG001|Overall Study|Disease Progression|3
2114845|NCT00925600|3710594|FG000|Overall Study|Administrative Decision|1
2114846|NCT00925600|3710595|FG001|Overall Study|Administrative Decision|1
2114847|NCT00925600|3710594|FG000|Overall Study|Noncompliance|2
2114848|NCT00925600|3710595|FG001|Overall Study|Noncompliance|0
2114849|NCT00925600|3710594|FG000|Overall Study|Ineligibility Determined|2
2114850|NCT00925600|3710595|FG001|Overall Study|Ineligibility Determined|0
2114851|NCT00925600|3710594|FG000|Overall Study|Protocol Deviation|0
2114852|NCT00925600|3710595|FG001|Overall Study|Protocol Deviation|1
2114853|NCT00925600|3710594|FG000|Overall Study|Requirement for Alternative Therapy|0
2114854|NCT00925600|3710595|FG001|Overall Study|Requirement for Alternative Therapy|1
2114855|NCT00925600|3710594|FG000|Overall Study|Other|3
2114856|NCT00925600|3710595|FG001|Overall Study|Other|1
2114857|NCT00925600|3710594|FG000|Overall Study|Adverse Event|1
2114858|NCT00925600|3710595|FG001|Overall Study|Adverse Event|2
2180645|NCT01405196|3807174|FG001|Overall Study|Study Terminated by Sponsor|0
2180646|NCT01405196|3807175|FG002|Overall Study|Study Terminated by Sponsor|9
2180647|NCT01405196|3807176|FG003|Overall Study|Study Terminated by Sponsor|0
2180648|NCT01405196|3807173|FG000|Overall Study|Other|2
2180649|NCT01405196|3807174|FG001|Overall Study|Other|2
2180650|NCT01405196|3807175|FG002|Overall Study|Other|5
2180651|NCT01405196|3807176|FG003|Overall Study|Other|0
2180652|NCT01405196|3807173|FG000|Overall Study|Withdrawal by Subject|4
2180653|NCT01405196|3807174|FG001|Overall Study|Withdrawal by Subject|6
2180654|NCT01405196|3807175|FG002|Overall Study|Withdrawal by Subject|3
2180655|NCT01405196|3807176|FG003|Overall Study|Withdrawal by Subject|6
2180656|NCT01405196|3807173|FG000|Overall Study|Adverse Event|2
2180657|NCT01405196|3807174|FG001|Overall Study|Adverse Event|2
2180658|NCT01405196|3807175|FG002|Overall Study|Adverse Event|0
2180659|NCT01405196|3807176|FG003|Overall Study|Adverse Event|2
2180660|NCT01405196|3807173|FG000|Overall Study|Death|1
2180661|NCT01405196|3807174|FG001|Overall Study|Death|0
2180662|NCT01405196|3807175|FG002|Overall Study|Death|3
2180663|NCT01405196|3807176|FG003|Overall Study|Death|0
2180664|NCT01405196|3807173|FG000|Overall Study|Lost to Follow-up|2
2180665|NCT01405196|3807174|FG001|Overall Study|Lost to Follow-up|2
2180666|NCT01405196|3807175|FG002|Overall Study|Lost to Follow-up|3
2180667|NCT01405196|3807176|FG003|Overall Study|Lost to Follow-up|1
2180668|NCT01405456|3807197|FG000|Overall Study|Lost to Follow-up|2
2114859|NCT00925704|3710611|FG000|First Intervention|Withdrew consent|0
2114860|NCT00925704|3710612|FG001|First Intervention|Withdrew consent|0
2114861|NCT00925704|3710613|FG002|First Intervention|Withdrew consent|0
2114862|NCT00925704|3710614|FG003|First Intervention|Withdrew consent|1
2114863|NCT00925704|3710615|FG004|First Intervention|Withdrew consent|1
2114864|NCT00925704|3710616|FG005|First Intervention|Withdrew consent|0
2114865|NCT00925704|3710611|FG000|Second Intervention|Withdrawal by Subject|1
2114866|NCT00925704|3710612|FG001|Second Intervention|Withdrawal by Subject|0
2114867|NCT00925704|3710613|FG002|Second Intervention|Withdrawal by Subject|0
2114868|NCT00925704|3710614|FG003|Second Intervention|Withdrawal by Subject|0
2114869|NCT00925704|3710615|FG004|Second Intervention|Withdrawal by Subject|1
2114870|NCT00925704|3710616|FG005|Second Intervention|Withdrawal by Subject|0
2114871|NCT00925704|3710611|FG000|Third Intervention|Withdrew consent|0
2114872|NCT00925704|3710612|FG001|Third Intervention|Withdrew consent|0
2114873|NCT00925704|3710613|FG002|Third Intervention|Withdrew consent|0
2114874|NCT00925704|3710614|FG003|Third Intervention|Withdrew consent|0
2114875|NCT00925704|3710615|FG004|Third Intervention|Withdrew consent|0
2114876|NCT00925704|3710616|FG005|Third Intervention|Withdrew consent|1
2114877|NCT00925769|3710631|FG000|Overall Study|Major toxicity|1
2114878|NCT00925769|3710632|FG001|Overall Study|Major toxicity|0
2114879|NCT00925769|3710633|FG002|Overall Study|Major toxicity|1
2114880|NCT00925769|3710634|FG003|Overall Study|Major toxicity|1
2114881|NCT00925769|3710635|FG004|Overall Study|Major toxicity|0
2114882|NCT00925769|3710636|FG005|Overall Study|Major toxicity|0
2114883|NCT00925769|3710631|FG000|Overall Study|Disease progression|4
2114884|NCT00925769|3710632|FG001|Overall Study|Disease progression|5
2114885|NCT00925769|3710633|FG002|Overall Study|Disease progression|3
2114886|NCT00925769|3710634|FG003|Overall Study|Disease progression|4
2114887|NCT00925769|3710635|FG004|Overall Study|Disease progression|2
2114888|NCT00925769|3710636|FG005|Overall Study|Disease progression|3
2114889|NCT00925769|3710631|FG000|Overall Study|Death|0
2114890|NCT00925769|3710632|FG001|Overall Study|Death|0
2114891|NCT00925769|3710633|FG002|Overall Study|Death|1
2114892|NCT00925769|3710634|FG003|Overall Study|Death|0
2114893|NCT00925769|3710635|FG004|Overall Study|Death|0
2114894|NCT00925769|3710636|FG005|Overall Study|Death|0
2114895|NCT00925769|3710631|FG000|Overall Study|Physician Decision|1
2114896|NCT00925769|3710632|FG001|Overall Study|Physician Decision|0
2114897|NCT00925769|3710633|FG002|Overall Study|Physician Decision|0
2114898|NCT00925769|3710634|FG003|Overall Study|Physician Decision|0
2114899|NCT00925769|3710635|FG004|Overall Study|Physician Decision|0
2114900|NCT00925769|3710636|FG005|Overall Study|Physician Decision|0
2114901|NCT00925769|3710631|FG000|Overall Study|Missing documentation|0
2114902|NCT00925769|3710632|FG001|Overall Study|Missing documentation|1
2114903|NCT00925769|3710633|FG002|Overall Study|Missing documentation|0
2114904|NCT00925769|3710634|FG003|Overall Study|Missing documentation|0
2114905|NCT00925769|3710635|FG004|Overall Study|Missing documentation|0
2114906|NCT00925769|3710636|FG005|Overall Study|Missing documentation|0
2114907|NCT00925769|3710631|FG000|Overall Study|End of study visit not done|0
2114908|NCT00925769|3710632|FG001|Overall Study|End of study visit not done|0
2114909|NCT00925769|3710633|FG002|Overall Study|End of study visit not done|1
2114910|NCT00925769|3710634|FG003|Overall Study|End of study visit not done|0
2114911|NCT00925769|3710635|FG004|Overall Study|End of study visit not done|0
2114912|NCT00925769|3710636|FG005|Overall Study|End of study visit not done|0
2114913|NCT00925769|3710631|FG000|Overall Study|Participant is unable to swallow drug|0
2114914|NCT00925769|3710632|FG001|Overall Study|Participant is unable to swallow drug|0
2114915|NCT00925769|3710633|FG002|Overall Study|Participant is unable to swallow drug|0
2114916|NCT00925769|3710634|FG003|Overall Study|Participant is unable to swallow drug|1
2114917|NCT00925769|3710635|FG004|Overall Study|Participant is unable to swallow drug|0
2114918|NCT00925769|3710636|FG005|Overall Study|Participant is unable to swallow drug|0
2114919|NCT00925769|3710631|FG000|Overall Study|Adverse Event|0
2114920|NCT00925769|3710632|FG001|Overall Study|Adverse Event|0
2114921|NCT00925769|3710633|FG002|Overall Study|Adverse Event|0
2114922|NCT00925769|3710634|FG003|Overall Study|Adverse Event|0
2114923|NCT00925769|3710635|FG004|Overall Study|Adverse Event|1
2114924|NCT00925769|3710636|FG005|Overall Study|Adverse Event|0
2114925|NCT00925899|3710662|FG000|Part 1|Death|1
2114926|NCT00925899|3710663|FG001|Part 1|Death|2
2114927|NCT00925899|3710662|FG000|Part 1|Withdrawal by Subject|10
2114928|NCT00925899|3710663|FG001|Part 1|Withdrawal by Subject|9
2114929|NCT00925990|3710685|FG000|Overall Study|Adverse Event|1
2114930|NCT00925990|3710686|FG001|Overall Study|Adverse Event|3
2114931|NCT00925990|3710685|FG000|Overall Study|Withdrawal by Subject|2
2114932|NCT00925990|3710686|FG001|Overall Study|Withdrawal by Subject|2
2114933|NCT00925990|3710685|FG000|Overall Study|Lost to Follow-up|1
2114934|NCT00925990|3710686|FG001|Overall Study|Lost to Follow-up|3
2114935|NCT00925990|3710685|FG000|Overall Study|Physician Decision|1
2114936|NCT00925990|3710686|FG001|Overall Study|Physician Decision|1
2114937|NCT00925990|3710685|FG000|Overall Study|moved out of state, missed medication|0
2114938|NCT00925990|3710686|FG001|Overall Study|moved out of state, missed medication|2
2114939|NCT00926003|3710695|FG000|Post-Training Evaluation|Withdrawal by Subject|1
2114940|NCT00926003|3710696|FG001|Post-Training Evaluation|Withdrawal by Subject|0
2114941|NCT00926003|3710697|FG002|Post-Training Evaluation|Withdrawal by Subject|0
2114942|NCT00926003|3710695|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1
2114943|NCT00926003|3710696|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0
2114944|NCT00926003|3710697|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0
2114945|NCT00926029|3710708|FG000|Overall Study|Lost to Follow-up|2
2114946|NCT00926029|3710709|FG001|Overall Study|Lost to Follow-up|1
2114947|NCT00926029|3710710|FG002|Overall Study|Lost to Follow-up|1
2114948|NCT00926211|3710737|FG000|Overall Study|Lost to Follow-up|1
2114949|NCT00926237|3710742|FG000|Overall Study|Withdrawal by Subject|2
2114950|NCT00926237|3710743|FG001|Overall Study|Withdrawal by Subject|1
2114951|NCT00926289|3710765|FG000|Overall Study|Adverse Event|9
2114952|NCT00926289|3710766|FG001|Overall Study|Adverse Event|11
2114953|NCT00926289|3710765|FG000|Overall Study|Protocol Violation|8
2114954|NCT00926289|3710766|FG001|Overall Study|Protocol Violation|12
2114955|NCT00926289|3710765|FG000|Overall Study|Lost to Follow-up|3
2114956|NCT00926289|3710766|FG001|Overall Study|Lost to Follow-up|6
2114957|NCT00926289|3710765|FG000|Overall Study|Withdrawal by Subject|4
2114958|NCT00926289|3710766|FG001|Overall Study|Withdrawal by Subject|4
2114959|NCT00926289|3710765|FG000|Overall Study|Other|1
2114960|NCT00926289|3710766|FG001|Overall Study|Other|3
2114961|NCT00926328|3710774|FG000|Overall Study|Lost to Follow-up|12
2114962|NCT00926328|3710775|FG001|Overall Study|Lost to Follow-up|14
2114963|NCT00926367|3710783|FG000|Overall Study|Withdrawal by Subject|0
2114964|NCT00926367|3710784|FG001|Overall Study|Withdrawal by Subject|1
2114965|NCT00926367|3710783|FG000|Overall Study|Lost to Follow-up|1
2114966|NCT00926367|3710784|FG001|Overall Study|Lost to Follow-up|0
2114967|NCT00926367|3710783|FG000|Overall Study|Skin Irritation|1
2114968|NCT00926367|3710784|FG001|Overall Study|Skin Irritation|2
2114969|NCT00926393|3710807|FG000|Overall Study|Withdrawal by Subject|1
2114970|NCT00926393|3710808|FG001|Overall Study|Withdrawal by Subject|2
2114971|NCT00926393|3710807|FG000|Overall Study|Adverse Event|1
2114972|NCT00926393|3710808|FG001|Overall Study|Adverse Event|1
2114973|NCT00926536|3710825|FG000|Overall Study|Physician Decision|1
2114974|NCT00926536|3710826|FG001|Overall Study|Physician Decision|2
2114975|NCT00926783|3710843|FG000|Overall Study|Incomplete CFAE Procedures|3
2114976|NCT00926783|3710844|FG001|Overall Study|Incomplete CFAE Procedures|3
2114977|NCT00926796|3710852|FG000|Overall Study|Did not receive randomized treatment|4
2114978|NCT00926796|3710853|FG001|Overall Study|Did not receive randomized treatment|7
2114979|NCT00926796|3710852|FG000|Overall Study|Ineligible, negative for gonorrhea|57
2114980|NCT00926796|3710853|FG001|Overall Study|Ineligible, negative for gonorrhea|60
2114981|NCT00926796|3710852|FG000|Overall Study|Ineligible, but positive for gonorrhea|1
2114982|NCT00926796|3710853|FG001|Overall Study|Ineligible, but positive for gonorrhea|1
2114983|NCT00926796|3710852|FG000|Overall Study|Adverse Event|7
2114984|NCT00926796|3710853|FG001|Overall Study|Adverse Event|14
2114985|NCT00926796|3710852|FG000|Overall Study|Lost to Follow-up|22
2114986|NCT00926796|3710853|FG001|Overall Study|Lost to Follow-up|13
2114987|NCT00926796|3710852|FG000|Overall Study|Protocol Violation|15
2114988|NCT00926796|3710853|FG001|Overall Study|Protocol Violation|11
2114989|NCT00926796|3710852|FG000|Overall Study|Withdrawal by Subject|1
2114990|NCT00926796|3710853|FG001|Overall Study|Withdrawal by Subject|0
2114991|NCT00927069|3710895|FG000|Week 0 to Week 12|Worsening of psoriasis|1
2114992|NCT00927069|3710896|FG001|Week 0 to Week 12|Worsening of psoriasis|1
2114993|NCT00927069|3710897|FG002|Week 0 to Week 12|Worsening of psoriasis|0
2114994|NCT00927069|3710898|FG003|Week 0 to Week 12|Worsening of psoriasis|0
2114995|NCT00927069|3710895|FG000|Week 12 to Week 24|Lack of Efficacy|0
2114996|NCT00927069|3710896|FG001|Week 12 to Week 24|Lack of Efficacy|0
2114997|NCT00927069|3710897|FG002|Week 12 to Week 24|Lack of Efficacy|2
2114998|NCT00927069|3710898|FG003|Week 12 to Week 24|Lack of Efficacy|3
2114999|NCT00927069|3710895|FG000|Week 12 to Week 24|Lost to Follow-up|0
2115000|NCT00927069|3710896|FG001|Week 12 to Week 24|Lost to Follow-up|0
2115001|NCT00927069|3710897|FG002|Week 12 to Week 24|Lost to Follow-up|1
2115002|NCT00927069|3710898|FG003|Week 12 to Week 24|Lost to Follow-up|0
2115003|NCT00927069|3710895|FG000|Week 12 to Week 24|Withdrawal by Subject|1
2115004|NCT00927069|3710896|FG001|Week 12 to Week 24|Withdrawal by Subject|0
2115005|NCT00927069|3710897|FG002|Week 12 to Week 24|Withdrawal by Subject|0
2115006|NCT00927069|3710898|FG003|Week 12 to Week 24|Withdrawal by Subject|0
2115007|NCT00927069|3710895|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1
2115008|NCT00927069|3710896|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0
2115009|NCT00927069|3710897|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0
2115010|NCT00927069|3710898|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0
2115011|NCT00927082|3710912|FG000|Overall Study|Lost to Follow-up|9
2115012|NCT00927082|3710913|FG001|Overall Study|Lost to Follow-up|8
2115013|NCT00927082|3710914|FG002|Overall Study|Lost to Follow-up|12
2115014|NCT00927082|3710915|FG003|Overall Study|Lost to Follow-up|16
2115015|NCT00927082|3710912|FG000|Overall Study|Withdrawal by Subject|3
2115016|NCT00927082|3710913|FG001|Overall Study|Withdrawal by Subject|2
2115017|NCT00927082|3710914|FG002|Overall Study|Withdrawal by Subject|7
2115018|NCT00927082|3710915|FG003|Overall Study|Withdrawal by Subject|2
2115019|NCT00927082|3710912|FG000|Overall Study|Death|0
2115020|NCT00927082|3710913|FG001|Overall Study|Death|0
2115021|NCT00927082|3710914|FG002|Overall Study|Death|1
2115022|NCT00927082|3710915|FG003|Overall Study|Death|0
2115023|NCT00927082|3710912|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0
2115024|NCT00927082|3710913|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0
2115025|NCT00927082|3710914|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2
2115026|NCT00927082|3710915|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1
2115027|NCT00927095|3710932|FG000|Overall Study|Adverse Event|3
2115028|NCT00927095|3710933|FG001|Overall Study|Adverse Event|1
2115029|NCT00927095|3710934|FG002|Overall Study|Adverse Event|0
2115030|NCT00927095|3710932|FG000|Overall Study|Withdrawal by Subject|2
2115031|NCT00927095|3710933|FG001|Overall Study|Withdrawal by Subject|1
2115032|NCT00927095|3710934|FG002|Overall Study|Withdrawal by Subject|1
2115033|NCT00927095|3710932|FG000|Overall Study|Physician Decision|1
2115034|NCT00927095|3710933|FG001|Overall Study|Physician Decision|2
2115035|NCT00927095|3710934|FG002|Overall Study|Physician Decision|1
2115036|NCT00927186|3710953|FG000|12 Months Primary Study|Adverse Event|5
2115037|NCT00927186|3710954|FG001|12 Months Primary Study|Adverse Event|2
2115038|NCT00927186|3710953|FG000|12 Months Primary Study|Lost to Follow-up|1
2115039|NCT00927186|3710954|FG001|12 Months Primary Study|Lost to Follow-up|0
2115040|NCT00927186|3710953|FG000|12 Months Primary Study|Protocol Violation|0
2115041|NCT00927186|3710954|FG001|12 Months Primary Study|Protocol Violation|1
2115042|NCT00927186|3710953|FG000|12 Months Primary Study|Withdrawal by Subject|1
2115043|NCT00927186|3710954|FG001|12 Months Primary Study|Withdrawal by Subject|1
2115044|NCT00927251|3710963|FG000|Overall Study|Patients not implanted with 4296 lead|8
2115045|NCT00927355|3710980|FG000|Overall Study|Adverse Event|1
2115046|NCT00927355|3710981|FG001|Overall Study|Adverse Event|1
2115047|NCT00927368|3711002|FG000|Overall Study|enrollment in another study|1
2115048|NCT00927368|3711003|FG001|Overall Study|enrollment in another study|1
2115049|NCT00927368|3711004|FG002|Overall Study|enrollment in another study|2
2115050|NCT00927368|3711002|FG000|Overall Study|Lost to Follow-up|4
2115051|NCT00927368|3711003|FG001|Overall Study|Lost to Follow-up|0
2115052|NCT00927368|3711004|FG002|Overall Study|Lost to Follow-up|0
2115053|NCT00927368|3711002|FG000|Overall Study|equipment failure|1
2115054|NCT00927368|3711003|FG001|Overall Study|equipment failure|0
2115055|NCT00927368|3711004|FG002|Overall Study|equipment failure|0
2115056|NCT00927368|3711002|FG000|Overall Study|ineligible post randomization|0
2115057|NCT00927368|3711003|FG001|Overall Study|ineligible post randomization|3
2115058|NCT00927368|3711004|FG002|Overall Study|ineligible post randomization|1
2115059|NCT00927368|3711002|FG000|Overall Study|cancellation of surgery|0
2115060|NCT00927368|3711003|FG001|Overall Study|cancellation of surgery|1
2115061|NCT00927368|3711004|FG002|Overall Study|cancellation of surgery|2
2115062|NCT00927394|3711014|FG000|Overall Study|Adverse Event|14
2115063|NCT00927394|3711015|FG001|Overall Study|Adverse Event|9
2115064|NCT00927394|3711014|FG000|Overall Study|Unsatisfactory therapeutic effect|17
2115065|NCT00927394|3711015|FG001|Overall Study|Unsatisfactory therapeutic effect|23
2115066|NCT00927394|3711014|FG000|Overall Study|Withdrawal by Subject|20
2115067|NCT00927394|3711015|FG001|Overall Study|Withdrawal by Subject|24
2115068|NCT00927394|3711014|FG000|Overall Study|Lost to Follow-up|8
2115069|NCT00927394|3711015|FG001|Overall Study|Lost to Follow-up|14
2115070|NCT00927394|3711014|FG000|Overall Study|Administrative Problem|1
2115071|NCT00927394|3711015|FG001|Overall Study|Administrative Problem|0
2115072|NCT00927394|3711014|FG000|Overall Study|Death|1
2115073|NCT00927394|3711015|FG001|Overall Study|Death|1
2115074|NCT00927394|3711014|FG000|Overall Study|Protocol deviation|16
2115075|NCT00927394|3711015|FG001|Overall Study|Protocol deviation|13
2115076|NCT00927394|3711014|FG000|Overall Study|Randomized in error|0
2115077|NCT00927394|3711015|FG001|Overall Study|Randomized in error|1
2115078|NCT00927472|3711024|FG000|Overall Study|Withdrawal by Subject|10
2115079|NCT00927472|3711025|FG001|Overall Study|Withdrawal by Subject|11
2115080|NCT00927472|3711024|FG000|Overall Study|Lost to Follow-up|1
2115081|NCT00927472|3711025|FG001|Overall Study|Lost to Follow-up|6
2115082|NCT00927472|3711024|FG000|Overall Study|Protocol Violation|0
2115083|NCT00927472|3711025|FG001|Overall Study|Protocol Violation|1
2115084|NCT00927472|3711024|FG000|Overall Study|Post treatment Assessment out of window|0
2115085|NCT00927472|3711025|FG001|Overall Study|Post treatment Assessment out of window|4
2115086|NCT00927485|3711033|FG000|Overall Study|Adverse Event|4
2115087|NCT00927485|3711034|FG001|Overall Study|Adverse Event|2
2115088|NCT00927485|3711033|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2
2115089|NCT00927485|3711034|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2
2115090|NCT00927563|3711040|FG000|Overall Study|Lost to Follow-up|1
2115091|NCT00927563|3711040|FG000|Overall Study|Withdrawal by Subject|1
2115092|NCT00927589|3711052|FG000|Overall Study|Death|1
2115093|NCT00927589|3711052|FG000|Overall Study|Physician Decision|1
2115094|NCT00927589|3711052|FG000|Overall Study|Withdrawal by Subject|3
2115095|NCT00927589|3711052|FG000|Overall Study|Adverse Event|2
2115096|NCT00927589|3711052|FG000|Overall Study|Disease Progression|8
2115097|NCT00927589|3711052|FG000|Overall Study|Non-compliance|1
2115098|NCT00927758|3711056|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
2115099|NCT00927758|3711057|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
2115100|NCT00927758|3711058|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
2115101|NCT00927758|3711059|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
2115102|NCT00927758|3711060|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
2115103|NCT00927758|3711061|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
2115104|NCT00927758|3711056|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
2115105|NCT00927758|3711057|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
2115106|NCT00927758|3711058|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
2115107|NCT00927758|3711059|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
2115108|NCT00927758|3711060|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
2115109|NCT00927758|3711061|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
2115110|NCT00927784|3711071|FG000|Overall Study|Death|1
2115111|NCT00927784|3711072|FG001|Overall Study|Death|0
2115112|NCT00927784|3711071|FG000|Overall Study|Withdrawal by Subject|1
2115113|NCT00927784|3711072|FG001|Overall Study|Withdrawal by Subject|0
2115114|NCT00927810|3711082|FG000|Overall Study|Withdrawal by Subject|0
2115115|NCT00927810|3711083|FG001|Overall Study|Withdrawal by Subject|3
2115116|NCT00927810|3711084|FG002|Overall Study|Withdrawal by Subject|0
2115117|NCT00927810|3711085|FG003|Overall Study|Withdrawal by Subject|1
2115118|NCT00927810|3711082|FG000|Overall Study|Lost to Follow-up|0
2115119|NCT00927810|3711083|FG001|Overall Study|Lost to Follow-up|2
2115120|NCT00927810|3711084|FG002|Overall Study|Lost to Follow-up|1
2115121|NCT00927810|3711085|FG003|Overall Study|Lost to Follow-up|1
2115122|NCT00927810|3711082|FG000|Overall Study|Death|0
2115123|NCT00927810|3711083|FG001|Overall Study|Death|2
2115124|NCT00927810|3711084|FG002|Overall Study|Death|0
2115125|NCT00927810|3711085|FG003|Overall Study|Death|0
2115126|NCT00927810|3711082|FG000|Overall Study|Abnormal laboratory value(s)|0
2115127|NCT00927810|3711083|FG001|Overall Study|Abnormal laboratory value(s)|1
2115128|NCT00927810|3711084|FG002|Overall Study|Abnormal laboratory value(s)|0
2115129|NCT00927810|3711085|FG003|Overall Study|Abnormal laboratory value(s)|0
2115130|NCT00927823|3711103|FG000|Continuous Dosing Period|Death|0
2115131|NCT00927823|3711104|FG001|Continuous Dosing Period|Death|0
2115132|NCT00927823|3711105|FG002|Continuous Dosing Period|Death|6
2115133|NCT00927823|3711106|FG003|Continuous Dosing Period|Death|0
2115134|NCT00927823|3711103|FG000|Continuous Dosing Period|Lost to Follow-up|1
2115135|NCT00927823|3711104|FG001|Continuous Dosing Period|Lost to Follow-up|1
2115136|NCT00927823|3711105|FG002|Continuous Dosing Period|Lost to Follow-up|9
2115137|NCT00927823|3711106|FG003|Continuous Dosing Period|Lost to Follow-up|0
2115138|NCT00927823|3711103|FG000|Continuous Dosing Period|Withdrawal by Subject|1
2115139|NCT00927823|3711104|FG001|Continuous Dosing Period|Withdrawal by Subject|0
2115140|NCT00927823|3711105|FG002|Continuous Dosing Period|Withdrawal by Subject|2
2115141|NCT00927823|3711106|FG003|Continuous Dosing Period|Withdrawal by Subject|2
2115142|NCT00927823|3711103|FG000|Continuous Dosing Period|Other|1
2115143|NCT00927823|3711104|FG001|Continuous Dosing Period|Other|2
2115144|NCT00927823|3711105|FG002|Continuous Dosing Period|Other|9
2115145|NCT00927823|3711106|FG003|Continuous Dosing Period|Other|3
2115146|NCT00927862|3711138|FG000|Overall Study|Missing data needed for endpt analyses|27
2115147|NCT00927862|3711139|FG001|Overall Study|Missing data needed for endpt analyses|45
2115148|NCT00927901|3711158|FG000|Treatment Period 1|Subject withdrew consent|0
2115149|NCT00927901|3711159|FG001|Treatment Period 1|Subject withdrew consent|0
2115150|NCT00927901|3711160|FG002|Treatment Period 1|Subject withdrew consent|1
2115151|NCT00927901|3711161|FG003|Treatment Period 1|Subject withdrew consent|0
2115152|NCT00927901|3711158|FG000|Treatment Period 4|Adverse Event|0
2115153|NCT00927901|3711159|FG001|Treatment Period 4|Adverse Event|0
2115154|NCT00927901|3711160|FG002|Treatment Period 4|Adverse Event|0
2115155|NCT00927901|3711161|FG003|Treatment Period 4|Adverse Event|1
2115156|NCT00927901|3711158|FG000|Treatment Period 4|Subject withdrew consent|0
2115157|NCT00927901|3711159|FG001|Treatment Period 4|Subject withdrew consent|0
2115158|NCT00927901|3711160|FG002|Treatment Period 4|Subject withdrew consent|1
2115159|NCT00927901|3711161|FG003|Treatment Period 4|Subject withdrew consent|0
2115160|NCT00927927|3711189|FG000|Overall Study|Withdrawal by Subject|0
2115161|NCT00927927|3711190|FG001|Overall Study|Withdrawal by Subject|0
2115162|NCT00927927|3711191|FG002|Overall Study|Withdrawal by Subject|0
2115163|NCT00927927|3711192|FG003|Overall Study|Withdrawal by Subject|0
2115164|NCT00927927|3711193|FG004|Overall Study|Withdrawal by Subject|0
2115165|NCT00927927|3711194|FG005|Overall Study|Withdrawal by Subject|0
2115166|NCT00927927|3711195|FG006|Overall Study|Withdrawal by Subject|0
2115167|NCT00927927|3711196|FG007|Overall Study|Withdrawal by Subject|2
2115168|NCT00927927|3711197|FG008|Overall Study|Withdrawal by Subject|0
2115169|NCT00927927|3711198|FG009|Overall Study|Withdrawal by Subject|0
2115170|NCT00927927|3711199|FG010|Overall Study|Withdrawal by Subject|0
2115171|NCT00927927|3711200|FG011|Overall Study|Withdrawal by Subject|2
2115172|NCT00927927|3711201|FG012|Overall Study|Withdrawal by Subject|0
2115173|NCT00927927|3711202|FG013|Overall Study|Withdrawal by Subject|0
2115174|NCT00927927|3711203|FG014|Overall Study|Withdrawal by Subject|0
2115175|NCT00927940|3711235|FG000|Overall Study|Death|1
2115176|NCT00928018|3711246|FG000|Overall Study|Withdrawal by Subject|1
2115177|NCT00928018|3711247|FG001|Overall Study|Withdrawal by Subject|0
2115178|NCT00928057|3711259|FG000|Overall Study|Adverse Event|1
2219130|NCT01719380|3862854|FG002|Overall Study|Participant/Guardian Decision|1
2115179|NCT00928057|3711260|FG001|Overall Study|Adverse Event|2
2115180|NCT00928057|3711259|FG000|Overall Study|Withdrawal by Subject|1
2115181|NCT00928057|3711260|FG001|Overall Study|Withdrawal by Subject|0
2115182|NCT00928057|3711259|FG000|Overall Study|Lost to Follow-up|0
2115183|NCT00928057|3711260|FG001|Overall Study|Lost to Follow-up|1
2115184|NCT00928057|3711259|FG000|Overall Study|Protocol Violation|0
2115185|NCT00928057|3711260|FG001|Overall Study|Protocol Violation|1
2219131|NCT01719380|3862855|FG003|Overall Study|Participant/Guardian Decision|0
2219132|NCT01719380|3862856|FG004|Overall Study|Participant/Guardian Decision|0
2115186|NCT00928070|3711278|FG000|Overall Study|Lost to Follow-up|1
2115187|NCT00928070|3711279|FG001|Overall Study|Lost to Follow-up|2
2115188|NCT00928070|3711278|FG000|Overall Study|Withdrawal by Subject|10
2115189|NCT00928070|3711279|FG001|Overall Study|Withdrawal by Subject|3
2115190|NCT00928070|3711278|FG000|Overall Study|Adverse Event|14
2115191|NCT00928070|3711279|FG001|Overall Study|Adverse Event|26
2115192|NCT00928070|3711278|FG000|Overall Study|Lack of Efficacy|9
2115193|NCT00928070|3711279|FG001|Overall Study|Lack of Efficacy|5
2115194|NCT00928070|3711278|FG000|Overall Study|Did not meet entrance criteria|16
2115195|NCT00928070|3711279|FG001|Overall Study|Did not meet entrance criteria|9
2115196|NCT00928070|3711278|FG000|Overall Study|Protocol Violation|6
2115197|NCT00928070|3711279|FG001|Overall Study|Protocol Violation|5
2115198|NCT00928070|3711278|FG000|Overall Study|Randomized but not treated|2
2115199|NCT00928070|3711279|FG001|Overall Study|Randomized but not treated|2
2115200|NCT00928070|3711278|FG000|Overall Study|Other|5
2115201|NCT00928070|3711279|FG001|Overall Study|Other|5
2115202|NCT00928135|3711347|FG000|Overall Study|Withdrawal by Subject|1
2115203|NCT00928135|3711348|FG001|Overall Study|Withdrawal by Subject|0
2115204|NCT00928187|3711361|FG000|Overall Study|Death|1
2115205|NCT00928187|3711362|FG001|Overall Study|Death|2
2115206|NCT00928187|3711363|FG002|Overall Study|Death|3
2115207|NCT00928187|3711361|FG000|Overall Study|Lost to Follow-up|1
2115208|NCT00928187|3711362|FG001|Overall Study|Lost to Follow-up|2
2115209|NCT00928187|3711363|FG002|Overall Study|Lost to Follow-up|1
2115210|NCT00928187|3711361|FG000|Overall Study|Withdrawal by Subject|0
2115211|NCT00928187|3711362|FG001|Overall Study|Withdrawal by Subject|1
2115212|NCT00928187|3711363|FG002|Overall Study|Withdrawal by Subject|1
2115213|NCT00928187|3711361|FG000|Overall Study|Protocol Violation|0
2115214|NCT00928187|3711362|FG001|Overall Study|Protocol Violation|1
2115215|NCT00928187|3711363|FG002|Overall Study|Protocol Violation|0
2115216|NCT00928252|3711375|FG000|Overall Study|Physician Decision|3
2115217|NCT00928408|3711398|FG000|Overall Study|Other|2
2115218|NCT00928408|3711398|FG000|Overall Study|Withdrawal by Subject|4
2115219|NCT00928408|3711398|FG000|Overall Study|Death|5
2115220|NCT00928408|3711398|FG000|Overall Study|Lost to Follow-up|12
2115221|NCT00928434|3711409|FG000|Overall Study|Adverse Event|14
2115222|NCT00928434|3711410|FG001|Overall Study|Adverse Event|5
2115223|NCT00928434|3711411|FG002|Overall Study|Adverse Event|18
2115224|NCT00928434|3711409|FG000|Overall Study|Protocol Violation|5
2115225|NCT00928434|3711410|FG001|Overall Study|Protocol Violation|0
2115226|NCT00928434|3711411|FG002|Overall Study|Protocol Violation|8
2115227|NCT00928434|3711409|FG000|Overall Study|Physician Decision|2
2115228|NCT00928434|3711410|FG001|Overall Study|Physician Decision|0
2115229|NCT00928434|3711411|FG002|Overall Study|Physician Decision|3
2115230|NCT00928434|3711409|FG000|Overall Study|Lost to Follow-up|1
2115231|NCT00928434|3711410|FG001|Overall Study|Lost to Follow-up|0
2115232|NCT00928434|3711411|FG002|Overall Study|Lost to Follow-up|3
2115233|NCT00928434|3711409|FG000|Overall Study|Withdrawal by Subject|5
2115234|NCT00928434|3711410|FG001|Overall Study|Withdrawal by Subject|3
2115235|NCT00928434|3711411|FG002|Overall Study|Withdrawal by Subject|2
2115236|NCT00928434|3711409|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
2115237|NCT00928434|3711410|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
2115238|NCT00928434|3711411|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
2115239|NCT00928434|3711409|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2
2115240|NCT00928434|3711410|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1
2115241|NCT00928434|3711411|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1
2115242|NCT00928434|3711409|FG000|Overall Study|Other (not meeting above criteria)|5
2115243|NCT00928434|3711410|FG001|Overall Study|Other (not meeting above criteria)|1
2115244|NCT00928434|3711411|FG002|Overall Study|Other (not meeting above criteria)|2
2115245|NCT00928486|3711427|FG000|Overall Study|Adverse Event|2
2115246|NCT00928486|3711427|FG000|Overall Study|Disease Progression|7
2115247|NCT00928486|3711427|FG000|Overall Study|Withdrawal by Subject|1
2115248|NCT00928512|3711436|FG000|Overall Study|Adverse Event|4
2115249|NCT00928512|3711437|FG001|Overall Study|Adverse Event|3
2115250|NCT00928512|3711438|FG002|Overall Study|Adverse Event|2
2115251|NCT00928512|3711439|FG003|Overall Study|Adverse Event|8
2115252|NCT00928512|3711440|FG004|Overall Study|Adverse Event|6
2115253|NCT00928512|3711436|FG000|Overall Study|Lack of Efficacy|2
2115254|NCT00928512|3711437|FG001|Overall Study|Lack of Efficacy|0
2115255|NCT00928512|3711438|FG002|Overall Study|Lack of Efficacy|4
2115256|NCT00928512|3711439|FG003|Overall Study|Lack of Efficacy|7
2115257|NCT00928512|3711440|FG004|Overall Study|Lack of Efficacy|3
2115258|NCT00928512|3711436|FG000|Overall Study|Protocol Violation|0
2115259|NCT00928512|3711437|FG001|Overall Study|Protocol Violation|1
2115260|NCT00928512|3711438|FG002|Overall Study|Protocol Violation|0
2115261|NCT00928512|3711439|FG003|Overall Study|Protocol Violation|1
2115262|NCT00928512|3711440|FG004|Overall Study|Protocol Violation|3
2115263|NCT00928512|3711436|FG000|Overall Study|Withdrawal by Subject|3
2115264|NCT00928512|3711437|FG001|Overall Study|Withdrawal by Subject|0
2115265|NCT00928512|3711438|FG002|Overall Study|Withdrawal by Subject|3
2115266|NCT00928512|3711439|FG003|Overall Study|Withdrawal by Subject|4
2115267|NCT00928512|3711440|FG004|Overall Study|Withdrawal by Subject|0
2115268|NCT00928512|3711436|FG000|Overall Study|Lost to Follow-up|1
2115269|NCT00928512|3711437|FG001|Overall Study|Lost to Follow-up|1
2115270|NCT00928512|3711438|FG002|Overall Study|Lost to Follow-up|2
2115271|NCT00928512|3711439|FG003|Overall Study|Lost to Follow-up|1
2115272|NCT00928512|3711440|FG004|Overall Study|Lost to Follow-up|3
2219133|NCT01719380|3862857|FG005|Overall Study|Participant/Guardian Decision|0
2219134|NCT01719380|3862858|FG006|Overall Study|Participant/Guardian Decision|0
2115273|NCT00928512|3711436|FG000|Overall Study|Administrative Problems|0
2115274|NCT00928512|3711437|FG001|Overall Study|Administrative Problems|1
2115275|NCT00928512|3711438|FG002|Overall Study|Administrative Problems|0
2115276|NCT00928512|3711439|FG003|Overall Study|Administrative Problems|0
2115277|NCT00928512|3711440|FG004|Overall Study|Administrative Problems|0
2115278|NCT00928564|3711458|FG000|Overall Study|Lost to Follow-up|6
2115279|NCT00928564|3711459|FG001|Overall Study|Lost to Follow-up|0
2115280|NCT00928668|3711472|FG000|Overall Study|Adverse Event|1
2115281|NCT00928668|3711473|FG001|Overall Study|Adverse Event|0
2115282|NCT00928668|3711474|FG002|Overall Study|Adverse Event|0
2115283|NCT00928668|3711475|FG003|Overall Study|Adverse Event|0
2115284|NCT00928668|3711476|FG004|Overall Study|Adverse Event|0
2115285|NCT00928668|3711472|FG000|Overall Study|Protocol Violation|0
2115286|NCT00928668|3711473|FG001|Overall Study|Protocol Violation|0
2115287|NCT00928668|3711474|FG002|Overall Study|Protocol Violation|0
2219135|NCT01719380|3862859|FG007|Overall Study|Participant/Guardian Decision|0
2219136|NCT01719380|3862860|FG008|Overall Study|Participant/Guardian Decision|2
2219137|NCT01719380|3862861|FG009|Overall Study|Participant/Guardian Decision|2
2219138|NCT01719380|3862852|FG000|Overall Study|Physician Decision|0
2219139|NCT01719380|3862853|FG001|Overall Study|Physician Decision|0
2219140|NCT01719380|3862854|FG002|Overall Study|Physician Decision|2
2219141|NCT01719380|3862855|FG003|Overall Study|Physician Decision|0
2219142|NCT01719380|3862856|FG004|Overall Study|Physician Decision|0
2219143|NCT01719380|3862857|FG005|Overall Study|Physician Decision|0
2219144|NCT01719380|3862858|FG006|Overall Study|Physician Decision|0
2219145|NCT01719380|3862859|FG007|Overall Study|Physician Decision|0
2115288|NCT00928668|3711475|FG003|Overall Study|Protocol Violation|0
2115289|NCT00928668|3711476|FG004|Overall Study|Protocol Violation|1
2115290|NCT00928668|3711472|FG000|Overall Study|Withdrawal by Subject|0
2115291|NCT00928668|3711473|FG001|Overall Study|Withdrawal by Subject|1
2115292|NCT00928668|3711474|FG002|Overall Study|Withdrawal by Subject|1
2115293|NCT00928668|3711475|FG003|Overall Study|Withdrawal by Subject|0
2115294|NCT00928668|3711476|FG004|Overall Study|Withdrawal by Subject|0
2115295|NCT00928668|3711472|FG000|Overall Study|Other reasons not listed above|0
2115296|NCT00928668|3711473|FG001|Overall Study|Other reasons not listed above|0
2115297|NCT00928668|3711474|FG002|Overall Study|Other reasons not listed above|0
2115298|NCT00928668|3711475|FG003|Overall Study|Other reasons not listed above|1
2115299|NCT00928668|3711476|FG004|Overall Study|Other reasons not listed above|0
2115300|NCT00928707|3711502|FG000|Overall Study|Protocol Violation|1
2115301|NCT00928707|3711503|FG001|Overall Study|Protocol Violation|0
2115302|NCT00928746|3711525|FG000|Overall Study|Adverse Event|2
2115303|NCT00928746|3711525|FG000|Overall Study|Protocol Violation|1
2115304|NCT00928746|3711525|FG000|Overall Study|Withdrawal by Subject|1
2115305|NCT00928746|3711525|FG000|Overall Study|Other|2
2115306|NCT00928889|3711546|FG000|Overall Study|Lost to Follow-up|3
2115307|NCT00928889|3711547|FG001|Overall Study|Lost to Follow-up|1
2115308|NCT00928889|3711546|FG000|Overall Study|Protocol Violation|0
2115309|NCT00928889|3711547|FG001|Overall Study|Protocol Violation|1
2115310|NCT00928889|3711546|FG000|Overall Study|Adverse Event|1
2115311|NCT00928889|3711547|FG001|Overall Study|Adverse Event|0
2115312|NCT00928889|3711546|FG000|Overall Study|Other|1
2115313|NCT00928889|3711547|FG001|Overall Study|Other|0
2115314|NCT00929110|3711570|FG000|Overall Study|Adverse Event|40
2115315|NCT00929110|3711571|FG001|Overall Study|Adverse Event|29
2115316|NCT00929110|3711572|FG002|Overall Study|Adverse Event|18
2115317|NCT00929110|3711570|FG000|Overall Study|Subject withdrew consent|40
2115318|NCT00929110|3711571|FG001|Overall Study|Subject withdrew consent|23
2115319|NCT00929110|3711572|FG002|Overall Study|Subject withdrew consent|26
2115320|NCT00929110|3711570|FG000|Overall Study|Unsatisfactory therapeutic effect|20
2219146|NCT01719380|3862860|FG008|Overall Study|Physician Decision|1
2219147|NCT01719380|3862861|FG009|Overall Study|Physician Decision|1
2219148|NCT01719380|3862852|FG000|Overall Study|Lack of Efficacy|2
2219149|NCT01719380|3862853|FG001|Overall Study|Lack of Efficacy|6
2219150|NCT01719380|3862854|FG002|Overall Study|Lack of Efficacy|5
2331855|NCT03178669|4054751|FG000|Overall Study|Adverse Event|4
2115321|NCT00929110|3711571|FG001|Overall Study|Unsatisfactory therapeutic effect|9
2115322|NCT00929110|3711572|FG002|Overall Study|Unsatisfactory therapeutic effect|6
2115323|NCT00929110|3711570|FG000|Overall Study|Lost to Follow-up|7
2115324|NCT00929110|3711571|FG001|Overall Study|Lost to Follow-up|7
2115325|NCT00929110|3711572|FG002|Overall Study|Lost to Follow-up|3
2115326|NCT00929110|3711570|FG000|Overall Study|Protocol deviation|5
2115327|NCT00929110|3711571|FG001|Overall Study|Protocol deviation|2
2115328|NCT00929110|3711572|FG002|Overall Study|Protocol deviation|4
2115329|NCT00929110|3711570|FG000|Overall Study|Administrative problems|4
2115330|NCT00929110|3711571|FG001|Overall Study|Administrative problems|1
2219151|NCT01719380|3862855|FG003|Overall Study|Lack of Efficacy|6
2219152|NCT01719380|3862856|FG004|Overall Study|Lack of Efficacy|3
2219153|NCT01719380|3862857|FG005|Overall Study|Lack of Efficacy|7
2219154|NCT01719380|3862858|FG006|Overall Study|Lack of Efficacy|10
2219155|NCT01719380|3862859|FG007|Overall Study|Lack of Efficacy|6
2219156|NCT01719380|3862860|FG008|Overall Study|Lack of Efficacy|39
2219157|NCT01719380|3862861|FG009|Overall Study|Lack of Efficacy|42
2115331|NCT00929110|3711572|FG002|Overall Study|Administrative problems|2
2115332|NCT00929110|3711570|FG000|Overall Study|Death|2
2115333|NCT00929110|3711571|FG001|Overall Study|Death|2
2115334|NCT00929110|3711572|FG002|Overall Study|Death|2
2115335|NCT00929110|3711570|FG000|Overall Study|Abnormal laboratory value(s)|0
2115336|NCT00929110|3711571|FG001|Overall Study|Abnormal laboratory value(s)|1
2115337|NCT00929110|3711572|FG002|Overall Study|Abnormal laboratory value(s)|0
2115338|NCT00929110|3711570|FG000|Overall Study|Abnormal test procedure result(s)|0
2115339|NCT00929110|3711571|FG001|Overall Study|Abnormal test procedure result(s)|1
2115340|NCT00929110|3711572|FG002|Overall Study|Abnormal test procedure result(s)|1
2115341|NCT00929110|3711570|FG000|Overall Study|Patient inability to use the device|0
2115342|NCT00929110|3711571|FG001|Overall Study|Patient inability to use the device|1
2115343|NCT00929110|3711572|FG002|Overall Study|Patient inability to use the device|0
2115344|NCT00929162|3711582|FG000|Overall Study|Adverse Event|8
2115345|NCT00929162|3711583|FG001|Overall Study|Adverse Event|5
2115346|NCT00929162|3711582|FG000|Overall Study|Withdrawal by Subject|3
2115347|NCT00929162|3711583|FG001|Overall Study|Withdrawal by Subject|1
2115348|NCT00929162|3711582|FG000|Overall Study|Protocol Violation|32
2115349|NCT00929162|3711583|FG001|Overall Study|Protocol Violation|30
2115350|NCT00929162|3711582|FG000|Overall Study|Other termination reason|5
2115351|NCT00929162|3711583|FG001|Overall Study|Other termination reason|6
2115352|NCT00929201|3711589|FG000|Period 1|Withdrawal by Subject|0
2115353|NCT00929201|3711590|FG001|Period 1|Withdrawal by Subject|1
2115354|NCT00929240|3711597|FG000|Initial Treatment Phase|Adverse Event|31
2115355|NCT00929240|3711598|FG001|Initial Treatment Phase|Adverse Event|0
2115356|NCT00929240|3711599|FG002|Initial Treatment Phase|Adverse Event|0
2115357|NCT00929240|3711597|FG000|Initial Treatment Phase|Disease progression|41
2115358|NCT00929240|3711598|FG001|Initial Treatment Phase|Disease progression|0
2115359|NCT00929240|3711599|FG002|Initial Treatment Phase|Disease progression|0
2115360|NCT00929240|3711597|FG000|Initial Treatment Phase|Withdrawal by Subject|13
2115361|NCT00929240|3711598|FG001|Initial Treatment Phase|Withdrawal by Subject|0
2115362|NCT00929240|3711599|FG002|Initial Treatment Phase|Withdrawal by Subject|0
2115363|NCT00929240|3711597|FG000|Initial Treatment Phase|Protocol Violation|5
2115364|NCT00929240|3711598|FG001|Initial Treatment Phase|Protocol Violation|0
2115365|NCT00929240|3711599|FG002|Initial Treatment Phase|Protocol Violation|0
2115366|NCT00929240|3711597|FG000|Initial Treatment Phase|Death|2
2115367|NCT00929240|3711598|FG001|Initial Treatment Phase|Death|0
2115368|NCT00929240|3711599|FG002|Initial Treatment Phase|Death|0
2115369|NCT00929240|3711597|FG000|Initial Treatment Phase|Health authority/Study termination|3
2115370|NCT00929240|3711598|FG001|Initial Treatment Phase|Health authority/Study termination|0
2115371|NCT00929240|3711599|FG002|Initial Treatment Phase|Health authority/Study termination|0
2115372|NCT00929240|3711597|FG000|Initial Treatment Phase|Physician Decision|4
2115373|NCT00929240|3711598|FG001|Initial Treatment Phase|Physician Decision|0
2115374|NCT00929240|3711599|FG002|Initial Treatment Phase|Physician Decision|0
2115375|NCT00929240|3711597|FG000|Maintenance Phase|Disease progression|0
2115376|NCT00929240|3711598|FG001|Maintenance Phase|Disease progression|73
2115377|NCT00929240|3711599|FG002|Maintenance Phase|Disease progression|60
2115378|NCT00929240|3711597|FG000|Maintenance Phase|Adverse Event|0
2115379|NCT00929240|3711598|FG001|Maintenance Phase|Adverse Event|9
2115380|NCT00929240|3711599|FG002|Maintenance Phase|Adverse Event|12
2115381|NCT00929240|3711597|FG000|Maintenance Phase|Withdrawal by Subject|0
2115382|NCT00929240|3711598|FG001|Maintenance Phase|Withdrawal by Subject|2
2115383|NCT00929240|3711599|FG002|Maintenance Phase|Withdrawal by Subject|6
2115384|NCT00929240|3711597|FG000|Maintenance Phase|Protocol Violation|0
2115385|NCT00929240|3711598|FG001|Maintenance Phase|Protocol Violation|1
2115386|NCT00929240|3711599|FG002|Maintenance Phase|Protocol Violation|0
2115387|NCT00929240|3711597|FG000|Maintenance Phase|Health authority/Study termination|0
2115388|NCT00929240|3711598|FG001|Maintenance Phase|Health authority/Study termination|1
2115389|NCT00929240|3711599|FG002|Maintenance Phase|Health authority/Study termination|2
2115390|NCT00929240|3711597|FG000|Maintenance Phase|Physician Decision|0
2115391|NCT00929240|3711598|FG001|Maintenance Phase|Physician Decision|2
2115392|NCT00929240|3711599|FG002|Maintenance Phase|Physician Decision|1
2115393|NCT00929240|3711597|FG000|Maintenance Phase|Change of treatment|0
2115394|NCT00929240|3711598|FG001|Maintenance Phase|Change of treatment|4
2115395|NCT00929240|3711599|FG002|Maintenance Phase|Change of treatment|0
2115396|NCT00929240|3711597|FG000|Maintenance Phase|Treatment ongoing at study closure|0
2115397|NCT00929240|3711598|FG001|Maintenance Phase|Treatment ongoing at study closure|0
2115398|NCT00929240|3711599|FG002|Maintenance Phase|Treatment ongoing at study closure|10
2115399|NCT00929240|3711597|FG000|Maintenance Phase|Participant not treated|0
2115400|NCT00929240|3711598|FG001|Maintenance Phase|Participant not treated|2
2115401|NCT00929240|3711599|FG002|Maintenance Phase|Participant not treated|0
2115402|NCT00929526|3711664|FG000|Overall Study|Withdrawal by Subject|1
2115403|NCT00929526|3711665|FG001|Overall Study|Withdrawal by Subject|11
2115404|NCT00929526|3711664|FG000|Overall Study|Lost to Follow-up|8
2115405|NCT00929526|3711665|FG001|Overall Study|Lost to Follow-up|12
2115406|NCT00929526|3711664|FG000|Overall Study|Other|8
2219158|NCT01719380|3862852|FG000|Overall Study|Progressive Disease|0
2115407|NCT00929526|3711665|FG001|Overall Study|Other|6
2115408|NCT00929643|3711680|FG000|Overall Study|Protocol Violation|2
2115409|NCT00929656|3711686|FG000|Overall Study|Lost to Follow-up|0
2115410|NCT00929656|3711687|FG001|Overall Study|Lost to Follow-up|1
2115411|NCT00929669|3711693|FG000|Overall Study|elevated glucose levels|1
2115412|NCT00929695|3711699|FG000|Overall Study|Death|2
2115413|NCT00929695|3711700|FG001|Overall Study|Death|1
2115414|NCT00929695|3711699|FG000|Overall Study|Withdrawal by Subject|0
2115415|NCT00929695|3711700|FG001|Overall Study|Withdrawal by Subject|2
2115416|NCT00929695|3711699|FG000|Overall Study|discharge home|4
2115417|NCT00929695|3711700|FG001|Overall Study|discharge home|3
2115418|NCT00929695|3711699|FG000|Overall Study|incorrect stratification|2
2115419|NCT00929695|3711700|FG001|Overall Study|incorrect stratification|0
2115420|NCT00929708|3711716|FG000|Overall Study|Protocol Violation|2
2115421|NCT00929708|3711717|FG001|Overall Study|Protocol Violation|1
2115422|NCT00929708|3711718|FG002|Overall Study|Protocol Violation|1
2115423|NCT00929708|3711719|FG003|Overall Study|Protocol Violation|1
2115424|NCT00929708|3711720|FG004|Overall Study|Protocol Violation|1
2115425|NCT00929708|3711716|FG000|Overall Study|Withdrawal by Subject|2
2115426|NCT00929708|3711717|FG001|Overall Study|Withdrawal by Subject|0
2115427|NCT00929708|3711718|FG002|Overall Study|Withdrawal by Subject|0
2115428|NCT00929708|3711719|FG003|Overall Study|Withdrawal by Subject|2
2115429|NCT00929708|3711720|FG004|Overall Study|Withdrawal by Subject|1
2115430|NCT00929708|3711716|FG000|Overall Study|Adverse Event|0
2115431|NCT00929708|3711717|FG001|Overall Study|Adverse Event|0
2115432|NCT00929708|3711718|FG002|Overall Study|Adverse Event|0
2115433|NCT00929708|3711719|FG003|Overall Study|Adverse Event|0
2115434|NCT00929708|3711720|FG004|Overall Study|Adverse Event|3
2115435|NCT00929708|3711716|FG000|Overall Study|Physician Decision|0
2115436|NCT00929708|3711717|FG001|Overall Study|Physician Decision|2
2115437|NCT00929708|3711718|FG002|Overall Study|Physician Decision|2
2115438|NCT00929708|3711719|FG003|Overall Study|Physician Decision|2
2115439|NCT00929708|3711720|FG004|Overall Study|Physician Decision|1
2115440|NCT00929708|3711716|FG000|Overall Study|Lost to Follow-up|0
2115441|NCT00929708|3711717|FG001|Overall Study|Lost to Follow-up|0
2115442|NCT00929708|3711718|FG002|Overall Study|Lost to Follow-up|0
2115443|NCT00929708|3711719|FG003|Overall Study|Lost to Follow-up|1
2115444|NCT00929708|3711720|FG004|Overall Study|Lost to Follow-up|0
2115445|NCT00929734|3711734|FG000|Overall Study|Lost to Follow-up|2
2115446|NCT00929734|3711735|FG001|Overall Study|Lost to Follow-up|1
2115447|NCT00929734|3711734|FG000|Overall Study|Withdrawal by Subject|0
2115448|NCT00929734|3711735|FG001|Overall Study|Withdrawal by Subject|2
2115449|NCT00929864|3711770|FG000|Overall Study|Death|1
2115450|NCT00929864|3711771|FG001|Overall Study|Death|1
2115451|NCT00929864|3711770|FG000|Overall Study|Adverse Event|11
2115452|NCT00929864|3711771|FG001|Overall Study|Adverse Event|30
2115453|NCT00929864|3711770|FG000|Overall Study|Lack of Efficacy|19
2115454|NCT00929864|3711771|FG001|Overall Study|Lack of Efficacy|16
2115455|NCT00929864|3711770|FG000|Overall Study|Lost to Follow-up|7
2115456|NCT00929864|3711771|FG001|Overall Study|Lost to Follow-up|12
2115457|NCT00929864|3711770|FG000|Overall Study|Withdrawal by Subject|20
2115458|NCT00929864|3711771|FG001|Overall Study|Withdrawal by Subject|9
2115459|NCT00929864|3711770|FG000|Overall Study|No longer met criteria|2
2115460|NCT00929864|3711771|FG001|Overall Study|No longer met criteria|1
2115461|NCT00929864|3711770|FG000|Overall Study|Poor or non-compliance|3
2115462|NCT00929864|3711771|FG001|Overall Study|Poor or non-compliance|3
2115463|NCT00929864|3711770|FG000|Overall Study|Pregnancy|0
2115464|NCT00929864|3711771|FG001|Overall Study|Pregnancy|3
2115465|NCT00929864|3711770|FG000|Overall Study|Administrative reason by Sponsor|1
2115466|NCT00929864|3711771|FG001|Overall Study|Administrative reason by Sponsor|1
2115467|NCT00929864|3711770|FG000|Overall Study|Non-specified|2
2115468|NCT00929864|3711771|FG001|Overall Study|Non-specified|7
2180669|NCT01405456|3807198|FG001|Overall Study|Lost to Follow-up|1
2180670|NCT01405456|3807197|FG000|Overall Study|Physician Decision|1
2180671|NCT01405456|3807198|FG001|Overall Study|Physician Decision|0
2180672|NCT01405508|3807213|FG000|Overall Study|AE, non-serious non-fatal|1
2180673|NCT01405508|3807214|FG001|Overall Study|AE, non-serious non-fatal|1
2180674|NCT01405508|3807215|FG002|Overall Study|AE, non-serious non-fatal|0
2180675|NCT01405508|3807216|FG003|Overall Study|AE, non-serious non-fatal|0
2180676|NCT01405560|3807226|FG000|Overall Study|Physician Decision|1
2180677|NCT01405742|3807230|FG000|Overall Study|Lost to Follow-up|1
2180678|NCT01405742|3807231|FG001|Overall Study|Lost to Follow-up|0
2180679|NCT01405768|3807239|FG000|Overall Study|Didn't complete questionnaire correctly|4
2180680|NCT01405768|3807240|FG001|Overall Study|Didn't complete questionnaire correctly|0
2180681|NCT01405820|3807258|FG000|Randomized Treatment Period|Adverse Event|3
2180682|NCT01405820|3807259|FG001|Randomized Treatment Period|Adverse Event|3
2180683|NCT01405820|3807260|FG002|Randomized Treatment Period|Adverse Event|3
2180684|NCT01405820|3807261|FG003|Randomized Treatment Period|Adverse Event|0
2180685|NCT01405820|3807262|FG004|Randomized Treatment Period|Adverse Event|2
2180686|NCT01405820|3807263|FG005|Randomized Treatment Period|Adverse Event|1
2180687|NCT01405820|3807258|FG000|Randomized Treatment Period|Withdrawal by Subject|6
2180688|NCT01405820|3807259|FG001|Randomized Treatment Period|Withdrawal by Subject|2
2180689|NCT01405820|3807260|FG002|Randomized Treatment Period|Withdrawal by Subject|2
2180690|NCT01405820|3807261|FG003|Randomized Treatment Period|Withdrawal by Subject|2
2180691|NCT01405820|3807262|FG004|Randomized Treatment Period|Withdrawal by Subject|0
2115469|NCT00929994|3711781|FG000|Overall Study|Withdrawal by Subject|1
2115470|NCT00929994|3711781|FG000|Overall Study|medical issue unrelated to intervention|4
2115471|NCT00929994|3711781|FG000|Overall Study|employment|1
2115472|NCT00930046|3711790|FG000|Overall Study|Wound catheter malfunctioned|1
2115473|NCT00930046|3711791|FG001|Overall Study|Wound catheter malfunctioned|2
2115474|NCT00930059|3711799|FG000|Overall Study|Death|1
2115475|NCT00930059|3711800|FG001|Overall Study|Death|0
2115476|NCT00930059|3711799|FG000|Overall Study|Did not meet entrance criteria|1
2115477|NCT00930059|3711800|FG001|Overall Study|Did not meet entrance criteria|1
2115478|NCT00930059|3711799|FG000|Overall Study|Withdrawal by Subject|3
2115479|NCT00930059|3711800|FG001|Overall Study|Withdrawal by Subject|4
2115480|NCT00930059|3711799|FG000|Overall Study|Other|1
2115481|NCT00930059|3711800|FG001|Overall Study|Other|0
2115482|NCT00930059|3711799|FG000|Overall Study|1 site terminated by sponsor|1
2115483|NCT00930059|3711800|FG001|Overall Study|1 site terminated by sponsor|1
2115484|NCT00930059|3711799|FG000|Overall Study|Adverse Event|1
2115485|NCT00930059|3711800|FG001|Overall Study|Adverse Event|6
2115486|NCT00930176|3711806|FG000|Overall Study|Death|1
2115487|NCT00930553|3711819|FG000|Overall Study|Adverse Event|1
2115488|NCT00930553|3711819|FG000|Overall Study|Lack of Efficacy|7
2115489|NCT00930553|3711819|FG000|Overall Study|Physician Decision|39
2115490|NCT00930553|3711819|FG000|Overall Study|Protocol Violation|1
2115491|NCT00930553|3711819|FG000|Overall Study|Pregnancy|1
2115492|NCT00930553|3711819|FG000|Overall Study|Withdrawal by Subject|88
2115493|NCT00930553|3711819|FG000|Overall Study|Lost to Follow-up|25
2219159|NCT01719380|3862853|FG001|Overall Study|Progressive Disease|0
2219160|NCT01719380|3862854|FG002|Overall Study|Progressive Disease|0
2219161|NCT01719380|3862855|FG003|Overall Study|Progressive Disease|0
2219162|NCT01719380|3862856|FG004|Overall Study|Progressive Disease|0
2219163|NCT01719380|3862857|FG005|Overall Study|Progressive Disease|0
2219164|NCT01719380|3862858|FG006|Overall Study|Progressive Disease|0
2219165|NCT01719380|3862859|FG007|Overall Study|Progressive Disease|0
2219166|NCT01719380|3862860|FG008|Overall Study|Progressive Disease|1
2219167|NCT01719380|3862861|FG009|Overall Study|Progressive Disease|0
2219168|NCT01719757|3862915|FG000|Overall Study|Adverse Event|38
2219169|NCT01719757|3862915|FG000|Overall Study|Withdrawal by Subject|15
2115494|NCT00930553|3711819|FG000|Overall Study|Death|9
2115495|NCT00930553|3711819|FG000|Overall Study|Study terminated by sponsor|24
2115496|NCT00930553|3711819|FG000|Overall Study|Other than specified above|28
2115497|NCT00930644|3711841|FG000|Overall Study|Withdrawal by Subject|4
2115498|NCT00930644|3711841|FG000|Overall Study|Physician Decision|2
2115499|NCT00930644|3711841|FG000|Overall Study|Death|1
2115500|NCT00930644|3711841|FG000|Overall Study|Adverse Event|16
2115501|NCT00930761|3711850|FG000|Overall Study|3 newborns died; 1 mother quit the study|4
2115502|NCT00930761|3711851|FG001|Overall Study|3 newborns died; 1 mother quit the study|0
2115503|NCT00930761|3711850|FG000|Overall Study|less than 3 music therapy sessions|0
2115504|NCT00930761|3711851|FG001|Overall Study|less than 3 music therapy sessions|3
2115505|NCT00930774|3711861|FG000|Overall Study|Withdrawal by Subject|1
2115506|NCT00930774|3711862|FG001|Overall Study|Withdrawal by Subject|9
2115507|NCT00930774|3711863|FG002|Overall Study|Withdrawal by Subject|2
2115508|NCT00930774|3711864|FG003|Overall Study|Withdrawal by Subject|0
2115509|NCT00930813|3711877|FG000|Overall Study|Death|4
2115510|NCT00930813|3711878|FG001|Overall Study|Death|5
2115511|NCT00930813|3711877|FG000|Overall Study|Withdrawal by Subject|2
2115512|NCT00930813|3711878|FG001|Overall Study|Withdrawal by Subject|5
2115513|NCT00930813|3711877|FG000|Overall Study|Lost to Follow-up|2
2115514|NCT00930813|3711878|FG001|Overall Study|Lost to Follow-up|4
2115515|NCT00930930|3711888|FG000|Overall Study|Death|1
2115516|NCT00930930|3711889|FG001|Overall Study|Death|0
2115517|NCT00930930|3711888|FG000|Overall Study|Physician Decision|1
2115518|NCT00930930|3711889|FG001|Overall Study|Physician Decision|0
2115519|NCT00930930|3711888|FG000|Overall Study|Adverse Event|13
2115520|NCT00930930|3711889|FG001|Overall Study|Adverse Event|3
2115521|NCT00930930|3711888|FG000|Overall Study|Withdrawal by Subject|3
2115522|NCT00930930|3711889|FG001|Overall Study|Withdrawal by Subject|1
2115523|NCT00930930|3711888|FG000|Overall Study|Disease progression|2
2115524|NCT00930930|3711889|FG001|Overall Study|Disease progression|3
2115525|NCT00930930|3711888|FG000|Overall Study|excessive lapse btw txs, not eligible|0
2115526|NCT00930930|3711889|FG001|Overall Study|excessive lapse btw txs, not eligible|1
2115527|NCT00930930|3711888|FG000|Overall Study|patients not compliant|1
2115528|NCT00930930|3711889|FG001|Overall Study|patients not compliant|1
2115529|NCT00930969|3711895|FG000|Overall Study|Death|5
2115530|NCT00930969|3711895|FG000|Overall Study|Lost to Follow-up|1
2115531|NCT00930969|3711895|FG000|Overall Study|Physician Decision|13
2115532|NCT00930969|3711895|FG000|Overall Study|Withdrawal by Subject|19
2115533|NCT00930982|3711901|FG000|Overall Study|Adverse Event|19
2115534|NCT00930982|3711902|FG001|Overall Study|Adverse Event|23
2115535|NCT00930982|3711901|FG000|Overall Study|Protocol Violation|1
2115536|NCT00930982|3711902|FG001|Overall Study|Protocol Violation|5
2115537|NCT00930982|3711901|FG000|Overall Study|Withdrawal by Subject|1
2219170|NCT01719757|3862915|FG000|Overall Study|Lost to Follow-up|20
2219171|NCT01719757|3862915|FG000|Overall Study|Protocol Violation|1
2219172|NCT01719757|3862915|FG000|Overall Study|well controlled pain|27
2219173|NCT01719783|3862923|FG000|Dose 2|Physician Decision|1
2219174|NCT01719783|3862924|FG001|Dose 2|Physician Decision|0
2115538|NCT00930982|3711902|FG001|Overall Study|Withdrawal by Subject|1
2115539|NCT00931255|3711921|FG000|Overall Study|Follow up biopsy not done|2
2331856|NCT03178669|4054752|FG001|Overall Study|Adverse Event|1
2115540|NCT00931255|3711922|FG001|Overall Study|Follow up biopsy not done|3
2115541|NCT00931268|3711928|FG000|Overall Study|Lost to Follow-up|6
2115542|NCT00931307|3711932|FG000|Overall Study|Lack of Efficacy|12
2115543|NCT00931307|3711932|FG000|Overall Study|Biomicroscopy|1
2115544|NCT00931385|3711945|FG000|Overall Study|Adverse Event|2
2115545|NCT00931385|3711946|FG001|Overall Study|Adverse Event|1
2115546|NCT00931385|3711947|FG002|Overall Study|Adverse Event|0
2115547|NCT00931385|3711948|FG003|Overall Study|Adverse Event|3
2115548|NCT00931385|3711945|FG000|Overall Study|Protocol Violation|0
2115549|NCT00931385|3711946|FG001|Overall Study|Protocol Violation|0
2115550|NCT00931385|3711947|FG002|Overall Study|Protocol Violation|1
2115551|NCT00931385|3711948|FG003|Overall Study|Protocol Violation|0
2115552|NCT00931385|3711945|FG000|Overall Study|Withdrawal by Subject|0
2115553|NCT00931385|3711946|FG001|Overall Study|Withdrawal by Subject|1
2115554|NCT00931385|3711947|FG002|Overall Study|Withdrawal by Subject|0
2115555|NCT00931385|3711948|FG003|Overall Study|Withdrawal by Subject|1
2115556|NCT00931385|3711945|FG000|Overall Study|Lost to Follow-up|0
2115557|NCT00931385|3711946|FG001|Overall Study|Lost to Follow-up|0
2115558|NCT00931385|3711947|FG002|Overall Study|Lost to Follow-up|0
2115559|NCT00931385|3711948|FG003|Overall Study|Lost to Follow-up|1
2115560|NCT00931411|3711964|FG000|First Intervention - 42 Days|Adverse Event|2
2115561|NCT00931411|3711965|FG001|First Intervention - 42 Days|Adverse Event|3
2115562|NCT00931411|3711964|FG000|First Intervention - 42 Days|Lost to Follow-up|2
2115563|NCT00931411|3711965|FG001|First Intervention - 42 Days|Lost to Follow-up|0
2115564|NCT00931411|3711964|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
2115565|NCT00931411|3711965|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
2115566|NCT00931463|3711977|FG000|Overall Study|Death|8
2115567|NCT00931463|3711978|FG001|Overall Study|Death|4
2115568|NCT00931463|3711977|FG000|Overall Study|Withdrawal by Subject|5
2115569|NCT00931463|3711978|FG001|Overall Study|Withdrawal by Subject|0
2115570|NCT00931463|3711977|FG000|Overall Study|Lost to Follow-up|4
2115571|NCT00931463|3711978|FG001|Overall Study|Lost to Follow-up|1
2115572|NCT00931515|3712006|FG000|Overall Study|Lost to Follow-up|2
2115573|NCT00931515|3712007|FG001|Overall Study|Lost to Follow-up|5
2115574|NCT00931528|3712015|FG000|Overall Study|Protocol Violation|9
2115575|NCT00931528|3712016|FG001|Overall Study|Protocol Violation|12
2115576|NCT00931528|3712015|FG000|Overall Study|Withdrawal by Subject|4
2115577|NCT00931528|3712016|FG001|Overall Study|Withdrawal by Subject|12
2115578|NCT00931528|3712015|FG000|Overall Study|Lost to Follow-up|6
2115579|NCT00931528|3712016|FG001|Overall Study|Lost to Follow-up|13
2115580|NCT00931528|3712015|FG000|Overall Study|Assessment outside of Time Frame|22
2115581|NCT00931528|3712016|FG001|Overall Study|Assessment outside of Time Frame|23
2115582|NCT00931632|3712025|FG000|Overall Study|Withdrawal by Subject|2
2115583|NCT00931632|3712026|FG001|Overall Study|Withdrawal by Subject|3
2115584|NCT00931632|3712025|FG000|Overall Study|Adverse Event|19
2115585|NCT00931632|3712026|FG001|Overall Study|Adverse Event|15
2115586|NCT00931710|3712034|FG000|Overall Study|Adverse Event|16
2115587|NCT00931710|3712035|FG001|Overall Study|Adverse Event|10
2115588|NCT00931710|3712034|FG000|Overall Study|Abnormal test procedure results|2
2115589|NCT00931710|3712035|FG001|Overall Study|Abnormal test procedure results|0
2115590|NCT00931710|3712034|FG000|Overall Study|Unsatisfactory therapeutic effects|5
2115591|NCT00931710|3712035|FG001|Overall Study|Unsatisfactory therapeutic effects|12
2115592|NCT00931710|3712034|FG000|Overall Study|Patient withdrew consent|4
2115593|NCT00931710|3712035|FG001|Overall Study|Patient withdrew consent|9
2115594|NCT00931710|3712034|FG000|Overall Study|Lost to Follow-up|6
2115595|NCT00931710|3712035|FG001|Overall Study|Lost to Follow-up|5
2115596|NCT00931710|3712034|FG000|Overall Study|Protocol deviation|1
2115597|NCT00931710|3712035|FG001|Overall Study|Protocol deviation|2
2115598|NCT00931723|3712043|FG000|Overall Study|Withdrawal by Subject|11
2115599|NCT00931723|3712044|FG001|Overall Study|Withdrawal by Subject|13
2115600|NCT00931723|3712043|FG000|Overall Study|Adverse Event|6
2115601|NCT00931723|3712044|FG001|Overall Study|Adverse Event|13
2115602|NCT00931723|3712043|FG000|Overall Study|Lithium found in blood|0
2115603|NCT00931723|3712044|FG001|Overall Study|Lithium found in blood|1
2115604|NCT00931723|3712043|FG000|Overall Study|Condition under investigation worsened|1
2115605|NCT00931723|3712044|FG001|Overall Study|Condition under investigation worsened|2
2115606|NCT00931723|3712043|FG000|Overall Study|Lost to Follow-up|1
2115607|NCT00931723|3712044|FG001|Overall Study|Lost to Follow-up|2
2115608|NCT00931723|3712043|FG000|Overall Study|Study-specific discontinuation criteria|1
2115609|NCT00931723|3712044|FG001|Overall Study|Study-specific discontinuation criteria|1
2115610|NCT00931723|3712043|FG000|Overall Study|Severe non-compliance to protocol|2
2115611|NCT00931723|3712044|FG001|Overall Study|Severe non-compliance to protocol|0
2115612|NCT00931723|3712043|FG000|Overall Study|Safety reasons|0
2115613|NCT00931723|3712044|FG001|Overall Study|Safety reasons|1
2115614|NCT00931723|3712043|FG000|Overall Study|Took prohibited concomitant medication|0
2115615|NCT00931723|3712044|FG001|Overall Study|Took prohibited concomitant medication|1
2115616|NCT00931723|3712043|FG000|Overall Study|Lack or insufficient theraputic response|2
2115617|NCT00931723|3712044|FG001|Overall Study|Lack or insufficient theraputic response|5
2331857|NCT03178669|4054753|FG002|Overall Study|Adverse Event|4
2115618|NCT00931723|3712043|FG000|Overall Study|Sponsor decision|1
2115619|NCT00931723|3712044|FG001|Overall Study|Sponsor decision|0
2115620|NCT00931723|3712043|FG000|Overall Study|Late hospital discharge|1
2115621|NCT00931723|3712044|FG001|Overall Study|Late hospital discharge|0
2115622|NCT00931762|3712050|FG000|Overall Study|Abnormal Laboratory Value (s)|2
2115623|NCT00931762|3712050|FG000|Overall Study|Administrative Problems|5
2115624|NCT00931762|3712050|FG000|Overall Study|Death|1
2115625|NCT00931762|3712050|FG000|Overall Study|Disease Progression|3
2115626|NCT00931762|3712050|FG000|Overall Study|Adverse Event (s)|11
2115627|NCT00931762|3712050|FG000|Overall Study|Subject withdrew consent|13
2115628|NCT00931801|3712057|FG000|Overall Study|Adverse Event|0
2115629|NCT00931801|3712058|FG001|Overall Study|Adverse Event|0
2115630|NCT00931801|3712059|FG002|Overall Study|Adverse Event|1
2115631|NCT00931801|3712057|FG000|Overall Study|Lost to Follow-up|0
2115632|NCT00931801|3712058|FG001|Overall Study|Lost to Follow-up|1
2115633|NCT00931801|3712059|FG002|Overall Study|Lost to Follow-up|0
2115634|NCT00931801|3712057|FG000|Overall Study|Withdrawal by Subject|1
2115635|NCT00931801|3712058|FG001|Overall Study|Withdrawal by Subject|0
2115636|NCT00931801|3712059|FG002|Overall Study|Withdrawal by Subject|0
2115637|NCT00931801|3712057|FG000|Overall Study|Confirmed Virologic Failure|0
2115638|NCT00931801|3712058|FG001|Overall Study|Confirmed Virologic Failure|0
2115639|NCT00931801|3712059|FG002|Overall Study|Confirmed Virologic Failure|3
2115640|NCT00931892|3712083|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0
2115641|NCT00931892|3712084|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1
2115642|NCT00931918|3712132|FG000|Overall Study|Adverse Event|4
2115643|NCT00931918|3712133|FG001|Overall Study|Adverse Event|6
2115644|NCT00931918|3712132|FG000|Overall Study|Progressive Disease|2
2115645|NCT00931918|3712133|FG001|Overall Study|Progressive Disease|1
2115646|NCT00931918|3712132|FG000|Overall Study|Symptomatic Deterioration|1
2115647|NCT00931918|3712133|FG001|Overall Study|Symptomatic Deterioration|0
2115648|NCT00931918|3712132|FG000|Overall Study|Withdrawal by Patient|3
2115649|NCT00931918|3712133|FG001|Overall Study|Withdrawal by Patient|4
2115650|NCT00931918|3712132|FG000|Overall Study|Other Reason not Specified|4
2115651|NCT00931918|3712133|FG001|Overall Study|Other Reason not Specified|4
2115652|NCT00931918|3712132|FG000|Overall Study|Did not receive study drug|3
2115653|NCT00931918|3712133|FG001|Overall Study|Did not receive study drug|2
2115654|NCT00931944|3712139|FG000|Overall Study|Adverse Event|4
2115655|NCT00931944|3712139|FG000|Overall Study|W/D Consent (due to ALS progression))|19
2115656|NCT00931944|3712139|FG000|Overall Study|Withdrawal Consent (due to other)|2
2115657|NCT00931944|3712139|FG000|Overall Study|Death|28
2115658|NCT00931944|3712139|FG000|Overall Study|Other|2
2115659|NCT00932113|3712167|FG000|Overall Study|Lost to Follow-up|1
2115660|NCT00932113|3712168|FG001|Overall Study|Lost to Follow-up|0
2115661|NCT00932126|3712174|FG000|Overall Study|Adverse Event|0
2115662|NCT00932126|3712175|FG001|Overall Study|Adverse Event|0
2115663|NCT00932126|3712176|FG002|Overall Study|Adverse Event|0
2115664|NCT00932126|3712177|FG003|Overall Study|Adverse Event|0
2115665|NCT00932126|3712178|FG004|Overall Study|Adverse Event|0
2115666|NCT00932126|3712179|FG005|Overall Study|Adverse Event|0
2115667|NCT00932126|3712180|FG006|Overall Study|Adverse Event|1
2115668|NCT00932126|3712181|FG007|Overall Study|Adverse Event|2
2115669|NCT00932126|3712174|FG000|Overall Study|Protocol Violation|0
2115670|NCT00932126|3712175|FG001|Overall Study|Protocol Violation|0
2115671|NCT00932126|3712176|FG002|Overall Study|Protocol Violation|0
2115672|NCT00932126|3712177|FG003|Overall Study|Protocol Violation|0
2115673|NCT00932126|3712178|FG004|Overall Study|Protocol Violation|1
2115674|NCT00932126|3712179|FG005|Overall Study|Protocol Violation|0
2115675|NCT00932126|3712180|FG006|Overall Study|Protocol Violation|0
2115676|NCT00932126|3712181|FG007|Overall Study|Protocol Violation|0
2115677|NCT00932126|3712174|FG000|Overall Study|Withdrawal by Subject|0
2115678|NCT00932126|3712175|FG001|Overall Study|Withdrawal by Subject|0
2115679|NCT00932126|3712176|FG002|Overall Study|Withdrawal by Subject|1
2115680|NCT00932126|3712177|FG003|Overall Study|Withdrawal by Subject|0
2115681|NCT00932126|3712178|FG004|Overall Study|Withdrawal by Subject|0
2115682|NCT00932126|3712179|FG005|Overall Study|Withdrawal by Subject|0
2115683|NCT00932126|3712180|FG006|Overall Study|Withdrawal by Subject|0
2115684|NCT00932126|3712181|FG007|Overall Study|Withdrawal by Subject|1
2115685|NCT00932126|3712174|FG000|Overall Study|Objective progression or relapse|3
2115686|NCT00932126|3712175|FG001|Overall Study|Objective progression or relapse|3
2115687|NCT00932126|3712176|FG002|Overall Study|Objective progression or relapse|2
2115688|NCT00932126|3712177|FG003|Overall Study|Objective progression or relapse|3
2115689|NCT00932126|3712178|FG004|Overall Study|Objective progression or relapse|3
2115690|NCT00932126|3712179|FG005|Overall Study|Objective progression or relapse|3
2115691|NCT00932126|3712180|FG006|Overall Study|Objective progression or relapse|3
2115692|NCT00932126|3712181|FG007|Overall Study|Objective progression or relapse|5
2115693|NCT00932126|3712174|FG000|Overall Study|Other|0
2115694|NCT00932126|3712175|FG001|Overall Study|Other|0
2115695|NCT00932126|3712176|FG002|Overall Study|Other|0
2115696|NCT00932126|3712177|FG003|Overall Study|Other|0
2115697|NCT00932126|3712178|FG004|Overall Study|Other|1
2115698|NCT00932126|3712179|FG005|Overall Study|Other|0
2115699|NCT00932126|3712180|FG006|Overall Study|Other|1
2115700|NCT00932126|3712181|FG007|Overall Study|Other|2
2115701|NCT00932165|3712201|FG000|Overall Study|Lost to Follow-up|1
2115702|NCT00932360|3712224|FG000|Washout (One Week)|Withdrawal by Subject|0
2115703|NCT00932360|3712225|FG001|Washout (One Week)|Withdrawal by Subject|0
2115704|NCT00932360|3712226|FG002|Washout (One Week)|Withdrawal by Subject|0
2115705|NCT00932360|3712227|FG003|Washout (One Week)|Withdrawal by Subject|0
2115706|NCT00932360|3712228|FG004|Washout (One Week)|Withdrawal by Subject|2
2115707|NCT00932360|3712229|FG005|Washout (One Week)|Withdrawal by Subject|0
2115708|NCT00932373|3712254|FG000|Overall Study|Progressive disease|3
2115709|NCT00932373|3712255|FG001|Overall Study|Progressive disease|1
2115710|NCT00932373|3712256|FG002|Overall Study|Progressive disease|0
2115711|NCT00932373|3712257|FG003|Overall Study|Progressive disease|0
2219175|NCT01719861|3862950|FG000|Cycle 1|Death|4
2115712|NCT00932373|3712258|FG004|Overall Study|Progressive disease|10
2115713|NCT00932373|3712259|FG005|Overall Study|Progressive disease|1
2115714|NCT00932373|3712260|FG006|Overall Study|Progressive disease|0
2115715|NCT00932373|3712261|FG007|Overall Study|Progressive disease|2
2115716|NCT00932373|3712262|FG008|Overall Study|Progressive disease|1
2115717|NCT00932373|3712263|FG009|Overall Study|Progressive disease|9
2115718|NCT00932373|3712264|FG010|Overall Study|Progressive disease|2
2115719|NCT00932373|3712254|FG000|Overall Study|Adverse Event|0
2115720|NCT00932373|3712255|FG001|Overall Study|Adverse Event|0
2115721|NCT00932373|3712256|FG002|Overall Study|Adverse Event|0
2115722|NCT00932373|3712257|FG003|Overall Study|Adverse Event|0
2115723|NCT00932373|3712258|FG004|Overall Study|Adverse Event|2
2115724|NCT00932373|3712259|FG005|Overall Study|Adverse Event|1
2115725|NCT00932373|3712260|FG006|Overall Study|Adverse Event|0
2115726|NCT00932373|3712261|FG007|Overall Study|Adverse Event|1
2115727|NCT00932373|3712262|FG008|Overall Study|Adverse Event|0
2115728|NCT00932373|3712263|FG009|Overall Study|Adverse Event|2
2115729|NCT00932373|3712264|FG010|Overall Study|Adverse Event|1
2115730|NCT00932373|3712254|FG000|Overall Study|Physician Decision|0
2115731|NCT00932373|3712255|FG001|Overall Study|Physician Decision|0
2115732|NCT00932373|3712256|FG002|Overall Study|Physician Decision|1
2115733|NCT00932373|3712257|FG003|Overall Study|Physician Decision|0
2115734|NCT00932373|3712258|FG004|Overall Study|Physician Decision|2
2115735|NCT00932373|3712259|FG005|Overall Study|Physician Decision|0
2115736|NCT00932373|3712260|FG006|Overall Study|Physician Decision|0
2115737|NCT00932373|3712261|FG007|Overall Study|Physician Decision|0
2115738|NCT00932373|3712262|FG008|Overall Study|Physician Decision|0
2115739|NCT00932373|3712263|FG009|Overall Study|Physician Decision|1
2115740|NCT00932373|3712264|FG010|Overall Study|Physician Decision|0
2115741|NCT00932373|3712254|FG000|Overall Study|Dose limiting toxicity|0
2115742|NCT00932373|3712255|FG001|Overall Study|Dose limiting toxicity|0
2115743|NCT00932373|3712256|FG002|Overall Study|Dose limiting toxicity|0
2115744|NCT00932373|3712257|FG003|Overall Study|Dose limiting toxicity|0
2115745|NCT00932373|3712258|FG004|Overall Study|Dose limiting toxicity|0
2115746|NCT00932373|3712259|FG005|Overall Study|Dose limiting toxicity|1
2115747|NCT00932373|3712260|FG006|Overall Study|Dose limiting toxicity|0
2115748|NCT00932373|3712261|FG007|Overall Study|Dose limiting toxicity|0
2115749|NCT00932373|3712262|FG008|Overall Study|Dose limiting toxicity|0
2115750|NCT00932373|3712263|FG009|Overall Study|Dose limiting toxicity|0
2115751|NCT00932373|3712264|FG010|Overall Study|Dose limiting toxicity|0
2115752|NCT00932373|3712254|FG000|Overall Study|Withdrawal by Subject|0
2115753|NCT00932373|3712255|FG001|Overall Study|Withdrawal by Subject|0
2115754|NCT00932373|3712256|FG002|Overall Study|Withdrawal by Subject|0
2115755|NCT00932373|3712257|FG003|Overall Study|Withdrawal by Subject|0
2115756|NCT00932373|3712258|FG004|Overall Study|Withdrawal by Subject|0
2115757|NCT00932373|3712259|FG005|Overall Study|Withdrawal by Subject|0
2115758|NCT00932373|3712260|FG006|Overall Study|Withdrawal by Subject|0
2115759|NCT00932373|3712261|FG007|Overall Study|Withdrawal by Subject|0
2115760|NCT00932373|3712262|FG008|Overall Study|Withdrawal by Subject|1
2115761|NCT00932373|3712263|FG009|Overall Study|Withdrawal by Subject|0
2115762|NCT00932373|3712264|FG010|Overall Study|Withdrawal by Subject|0
2115763|NCT00932373|3712254|FG000|Overall Study|Clinical progression|0
2115764|NCT00932373|3712255|FG001|Overall Study|Clinical progression|0
2115765|NCT00932373|3712256|FG002|Overall Study|Clinical progression|0
2115766|NCT00932373|3712257|FG003|Overall Study|Clinical progression|0
2115767|NCT00932373|3712258|FG004|Overall Study|Clinical progression|0
2115768|NCT00932373|3712259|FG005|Overall Study|Clinical progression|0
2115769|NCT00932373|3712260|FG006|Overall Study|Clinical progression|1
2115770|NCT00932373|3712261|FG007|Overall Study|Clinical progression|0
2115771|NCT00932373|3712262|FG008|Overall Study|Clinical progression|0
2115772|NCT00932373|3712263|FG009|Overall Study|Clinical progression|0
2115773|NCT00932373|3712264|FG010|Overall Study|Clinical progression|0
2115774|NCT00932373|3712254|FG000|Overall Study|Lack of Efficacy|0
2115775|NCT00932373|3712255|FG001|Overall Study|Lack of Efficacy|0
2115776|NCT00932373|3712256|FG002|Overall Study|Lack of Efficacy|0
2115777|NCT00932373|3712257|FG003|Overall Study|Lack of Efficacy|0
2115778|NCT00932373|3712258|FG004|Overall Study|Lack of Efficacy|0
2115779|NCT00932373|3712259|FG005|Overall Study|Lack of Efficacy|0
2115780|NCT00932373|3712260|FG006|Overall Study|Lack of Efficacy|0
2115781|NCT00932373|3712261|FG007|Overall Study|Lack of Efficacy|0
2115782|NCT00932373|3712262|FG008|Overall Study|Lack of Efficacy|0
2115783|NCT00932373|3712263|FG009|Overall Study|Lack of Efficacy|1
2115784|NCT00932373|3712264|FG010|Overall Study|Lack of Efficacy|0
2219176|NCT01719861|3862950|FG000|Cycle 2|Death|1
2115785|NCT00932425|3712307|FG000|Overall Study|Lost to Follow-up|0
2115786|NCT00932425|3712308|FG001|Overall Study|Lost to Follow-up|1
2115787|NCT00932425|3712307|FG000|Overall Study|Withdrawal by Subject|0
2115788|NCT00932425|3712308|FG001|Overall Study|Withdrawal by Subject|1
2115789|NCT00932451|3712325|FG000|Overall Study|Withdrawal by Subject|69
2115790|NCT00932451|3712325|FG000|Overall Study|Lost to Follow-up|22
2115791|NCT00932451|3712325|FG000|Overall Study|Death|726
2115792|NCT00932451|3712325|FG000|Overall Study|Other reasons|5
2115793|NCT00932646|3712357|FG000|Overall Study|Adverse Event|2
2115794|NCT00932646|3712358|FG001|Overall Study|Adverse Event|1
2115795|NCT00932646|3712359|FG002|Overall Study|Adverse Event|1
2115796|NCT00932646|3712360|FG003|Overall Study|Adverse Event|1
2115797|NCT00932646|3712357|FG000|Overall Study|Lost to Follow-up|2
2115798|NCT00932646|3712358|FG001|Overall Study|Lost to Follow-up|1
2115799|NCT00932646|3712359|FG002|Overall Study|Lost to Follow-up|0
2115800|NCT00932646|3712360|FG003|Overall Study|Lost to Follow-up|0
2115801|NCT00932646|3712357|FG000|Overall Study|Withdrawal by Subject|1
2115802|NCT00932646|3712358|FG001|Overall Study|Withdrawal by Subject|1
2115803|NCT00932646|3712359|FG002|Overall Study|Withdrawal by Subject|3
2115804|NCT00932646|3712360|FG003|Overall Study|Withdrawal by Subject|0
2115805|NCT00932698|3712389|FG000|Part 1 (Dose Escalation)|Progressive Disease|3
2115806|NCT00932698|3712390|FG001|Part 1 (Dose Escalation)|Progressive Disease|2
2115807|NCT00932698|3712391|FG002|Part 1 (Dose Escalation)|Progressive Disease|2
2115808|NCT00932698|3712392|FG003|Part 1 (Dose Escalation)|Progressive Disease|2
2115809|NCT00932698|3712393|FG004|Part 1 (Dose Escalation)|Progressive Disease|3
2115810|NCT00932698|3712394|FG005|Part 1 (Dose Escalation)|Progressive Disease|5
2115811|NCT00932698|3712395|FG006|Part 1 (Dose Escalation)|Progressive Disease|2
2115812|NCT00932698|3712396|FG007|Part 1 (Dose Escalation)|Progressive Disease|0
2115813|NCT00932698|3712397|FG008|Part 1 (Dose Escalation)|Progressive Disease|0
2115814|NCT00932698|3712398|FG009|Part 1 (Dose Escalation)|Progressive Disease|0
2115815|NCT00932698|3712399|FG010|Part 1 (Dose Escalation)|Progressive Disease|0
2115816|NCT00932698|3712389|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2115817|NCT00932698|3712390|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1
2115818|NCT00932698|3712391|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2115819|NCT00932698|3712392|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1
2115820|NCT00932698|3712393|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2115821|NCT00932698|3712394|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1
2115822|NCT00932698|3712395|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1
2115823|NCT00932698|3712396|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2115824|NCT00932698|3712397|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2115825|NCT00932698|3712398|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2115826|NCT00932698|3712399|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2115827|NCT00932698|3712389|FG000|Part 1 (Dose Escalation)|Adverse Event|0
2115828|NCT00932698|3712390|FG001|Part 1 (Dose Escalation)|Adverse Event|0
2115829|NCT00932698|3712391|FG002|Part 1 (Dose Escalation)|Adverse Event|0
2115830|NCT00932698|3712392|FG003|Part 1 (Dose Escalation)|Adverse Event|0
2115831|NCT00932698|3712393|FG004|Part 1 (Dose Escalation)|Adverse Event|0
2115832|NCT00932698|3712394|FG005|Part 1 (Dose Escalation)|Adverse Event|1
2115833|NCT00932698|3712395|FG006|Part 1 (Dose Escalation)|Adverse Event|0
2115834|NCT00932698|3712396|FG007|Part 1 (Dose Escalation)|Adverse Event|0
2115835|NCT00932698|3712397|FG008|Part 1 (Dose Escalation)|Adverse Event|0
2115836|NCT00932698|3712398|FG009|Part 1 (Dose Escalation)|Adverse Event|0
2115837|NCT00932698|3712399|FG010|Part 1 (Dose Escalation)|Adverse Event|0
2115838|NCT00932698|3712389|FG000|Part 1 (Dose Escalation)|Other|0
2115839|NCT00932698|3712390|FG001|Part 1 (Dose Escalation)|Other|0
2115840|NCT00932698|3712391|FG002|Part 1 (Dose Escalation)|Other|1
2115841|NCT00932698|3712392|FG003|Part 1 (Dose Escalation)|Other|0
2115842|NCT00932698|3712393|FG004|Part 1 (Dose Escalation)|Other|0
2115843|NCT00932698|3712394|FG005|Part 1 (Dose Escalation)|Other|0
2115844|NCT00932698|3712395|FG006|Part 1 (Dose Escalation)|Other|1
2115845|NCT00932698|3712396|FG007|Part 1 (Dose Escalation)|Other|0
2115846|NCT00932698|3712397|FG008|Part 1 (Dose Escalation)|Other|0
2115847|NCT00932698|3712398|FG009|Part 1 (Dose Escalation)|Other|0
2115848|NCT00932698|3712399|FG010|Part 1 (Dose Escalation)|Other|0
2115849|NCT00932698|3712389|FG000|Part 2 (Dose Expansion)|Progressive Disease|0
2115850|NCT00932698|3712390|FG001|Part 2 (Dose Expansion)|Progressive Disease|0
2115851|NCT00932698|3712391|FG002|Part 2 (Dose Expansion)|Progressive Disease|0
2115852|NCT00932698|3712392|FG003|Part 2 (Dose Expansion)|Progressive Disease|0
2115853|NCT00932698|3712393|FG004|Part 2 (Dose Expansion)|Progressive Disease|0
2115854|NCT00932698|3712394|FG005|Part 2 (Dose Expansion)|Progressive Disease|0
2219177|NCT01720043|3862964|FG000|Overall Study|Withdrawal by Subject|1
2219178|NCT01720069|3862971|FG000|Overall Study|Could not use e-diary correctly|0
2219179|NCT01720069|3862972|FG001|Overall Study|Could not use e-diary correctly|1
2219180|NCT01720069|3862973|FG002|Overall Study|Could not use e-diary correctly|1
2219181|NCT01720069|3862971|FG000|Overall Study|Randomised without baseline values|0
2219182|NCT01720069|3862972|FG001|Overall Study|Randomised without baseline values|0
2115855|NCT00932698|3712395|FG006|Part 2 (Dose Expansion)|Progressive Disease|0
2115856|NCT00932698|3712396|FG007|Part 2 (Dose Expansion)|Progressive Disease|14
2115857|NCT00932698|3712397|FG008|Part 2 (Dose Expansion)|Progressive Disease|8
2219183|NCT01720069|3862973|FG002|Overall Study|Randomised without baseline values|1
2219184|NCT01720069|3862971|FG000|Overall Study|Adverse Event|0
2219185|NCT01720069|3862972|FG001|Overall Study|Adverse Event|0
2219186|NCT01720069|3862973|FG002|Overall Study|Adverse Event|1
2219187|NCT01720069|3862971|FG000|Overall Study|Lack of Efficacy|0
2219188|NCT01720069|3862972|FG001|Overall Study|Lack of Efficacy|4
2219189|NCT01720069|3862973|FG002|Overall Study|Lack of Efficacy|0
2219190|NCT01720069|3862971|FG000|Overall Study|Treatment period withdrawal criteria met|4
2219191|NCT01720069|3862972|FG001|Overall Study|Treatment period withdrawal criteria met|8
2219192|NCT01720069|3862973|FG002|Overall Study|Treatment period withdrawal criteria met|9
2219193|NCT01720069|3862971|FG000|Overall Study|Withdrawal by Subject|0
2219194|NCT01720069|3862972|FG001|Overall Study|Withdrawal by Subject|2
2219195|NCT01720069|3862973|FG002|Overall Study|Withdrawal by Subject|1
2331858|NCT03178669|4054754|FG003|Overall Study|Adverse Event|2
2331859|NCT03178669|4054755|FG004|Overall Study|Adverse Event|2
2331860|NCT03178669|4054751|FG000|Overall Study|Lack of Efficacy|0
2331861|NCT03178669|4054752|FG001|Overall Study|Lack of Efficacy|0
2331862|NCT03178669|4054753|FG002|Overall Study|Lack of Efficacy|2
2331863|NCT03178669|4054754|FG003|Overall Study|Lack of Efficacy|0
2331864|NCT03178669|4054755|FG004|Overall Study|Lack of Efficacy|1
2331865|NCT03178669|4054751|FG000|Overall Study|Physician Decision|0
2331866|NCT03178669|4054752|FG001|Overall Study|Physician Decision|0
2331867|NCT03178669|4054753|FG002|Overall Study|Physician Decision|0
2331868|NCT03178669|4054754|FG003|Overall Study|Physician Decision|0
2331869|NCT03178669|4054755|FG004|Overall Study|Physician Decision|1
2331870|NCT03178669|4054751|FG000|Overall Study|Withdrawal by Subject|1
2331871|NCT03178669|4054752|FG001|Overall Study|Withdrawal by Subject|0
2331872|NCT03178669|4054753|FG002|Overall Study|Withdrawal by Subject|1
2331873|NCT03178669|4054754|FG003|Overall Study|Withdrawal by Subject|1
2331874|NCT03178669|4054755|FG004|Overall Study|Withdrawal by Subject|0
2331875|NCT03178669|4054751|FG000|Overall Study|Lost to Follow-up|0
2331876|NCT03178669|4054752|FG001|Overall Study|Lost to Follow-up|0
2331877|NCT03178669|4054753|FG002|Overall Study|Lost to Follow-up|0
2331878|NCT03178669|4054754|FG003|Overall Study|Lost to Follow-up|1
2331879|NCT03178669|4054755|FG004|Overall Study|Lost to Follow-up|0
2115858|NCT00932698|3712398|FG009|Part 2 (Dose Expansion)|Progressive Disease|3
2115859|NCT00932698|3712399|FG010|Part 2 (Dose Expansion)|Progressive Disease|2
2115860|NCT00932698|3712389|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2115861|NCT00932698|3712390|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2115862|NCT00932698|3712391|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2115863|NCT00932698|3712392|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2115864|NCT00932698|3712393|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2115865|NCT00932698|3712394|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2115866|NCT00932698|3712395|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2115867|NCT00932698|3712396|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1
2115868|NCT00932698|3712397|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3
2115869|NCT00932698|3712398|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2
2115870|NCT00932698|3712399|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2115871|NCT00932698|3712389|FG000|Part 2 (Dose Expansion)|Adverse Event|0
2115872|NCT00932698|3712390|FG001|Part 2 (Dose Expansion)|Adverse Event|0
2115873|NCT00932698|3712391|FG002|Part 2 (Dose Expansion)|Adverse Event|0
2115874|NCT00932698|3712392|FG003|Part 2 (Dose Expansion)|Adverse Event|0
2115875|NCT00932698|3712393|FG004|Part 2 (Dose Expansion)|Adverse Event|0
2115876|NCT00932698|3712394|FG005|Part 2 (Dose Expansion)|Adverse Event|0
2115877|NCT00932698|3712395|FG006|Part 2 (Dose Expansion)|Adverse Event|0
2115878|NCT00932698|3712396|FG007|Part 2 (Dose Expansion)|Adverse Event|5
2115879|NCT00932698|3712397|FG008|Part 2 (Dose Expansion)|Adverse Event|1
2115880|NCT00932698|3712398|FG009|Part 2 (Dose Expansion)|Adverse Event|1
2115881|NCT00932698|3712399|FG010|Part 2 (Dose Expansion)|Adverse Event|0
2115882|NCT00932893|3712431|FG000|Overall Study|Death|115
2115883|NCT00932893|3712432|FG001|Overall Study|Death|24
2115884|NCT00932893|3712431|FG000|Overall Study|Lost to Follow-up|8
2115885|NCT00932893|3712432|FG001|Overall Study|Lost to Follow-up|0
2219196|NCT01720069|3862971|FG000|Overall Study|OCS bursts occured, discontinued in line|1
2219197|NCT01720069|3862972|FG001|Overall Study|OCS bursts occured, discontinued in line|0
2331880|NCT03178773|4054769|FG000|Overall Study|Death|0
2331881|NCT03178773|4054770|FG001|Overall Study|Death|1
2115886|NCT00932893|3712431|FG000|Overall Study|Withdrawal by Subject|5
2115887|NCT00932893|3712432|FG001|Overall Study|Withdrawal by Subject|2
2115888|NCT00932893|3712431|FG000|Overall Study|Other|5
2115889|NCT00932893|3712432|FG001|Overall Study|Other|144
2115890|NCT00933166|3712439|FG000|Overall Study|Lost to Follow-up|4
2115891|NCT00933166|3712439|FG000|Overall Study|Lack of Efficacy|9
2115892|NCT00933166|3712439|FG000|Overall Study|Unavailable|4
2115893|NCT00933166|3712439|FG000|Overall Study|Withdrawal by Subject|1
2115894|NCT00933244|3712446|FG000|Overall Study|Withdrawal by Subject|5
2115895|NCT00933244|3712447|FG001|Overall Study|Withdrawal by Subject|1
2115896|NCT00933244|3712448|FG002|Overall Study|Withdrawal by Subject|3
2115897|NCT00933270|3712456|FG000|Overall Study|Withdrawal by Subject|26
2115898|NCT00933270|3712456|FG000|Overall Study|Insufficient Follow-up|10
2115899|NCT00933270|3712456|FG000|Overall Study|Lost to Follow-up|14
2115900|NCT00933270|3712456|FG000|Overall Study|Adverse Event|1
2115901|NCT00933270|3712456|FG000|Overall Study|Missed Visit|2
2115902|NCT00933270|3712456|FG000|Overall Study|Death|24
2115903|NCT00933270|3712456|FG000|Overall Study|Moved or would not return|10
2115904|NCT00933335|3712463|FG000|Overall Study|Lost to Follow-up|1
2115905|NCT00933335|3712464|FG001|Overall Study|Lost to Follow-up|3
2115906|NCT00933335|3712463|FG000|Overall Study|Withdrawal by Subject|0
2115907|NCT00933335|3712464|FG001|Overall Study|Withdrawal by Subject|1
2115908|NCT00933335|3712463|FG000|Overall Study|Progressive Disease|0
2115909|NCT00933335|3712464|FG001|Overall Study|Progressive Disease|11
2115910|NCT00933335|3712463|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
2115911|NCT00933335|3712464|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
2115912|NCT00933335|3712463|FG000|Overall Study|Co-morbid Illness|1
2115913|NCT00933335|3712464|FG001|Overall Study|Co-morbid Illness|0
2115914|NCT00933543|3712487|FG000|Overall Study|Adverse Event|2
2115915|NCT00933543|3712488|FG001|Overall Study|Adverse Event|1
2115916|NCT00933543|3712487|FG000|Overall Study|Lost to Follow-up|0
2115917|NCT00933543|3712488|FG001|Overall Study|Lost to Follow-up|1
2115918|NCT00933543|3712487|FG000|Overall Study|Withdrawal by Subject|0
2115919|NCT00933543|3712488|FG001|Overall Study|Withdrawal by Subject|1
2115920|NCT00933543|3712487|FG000|Overall Study|Lack of Efficacy|0
2115921|NCT00933543|3712488|FG001|Overall Study|Lack of Efficacy|3
2115922|NCT00933543|3712487|FG000|Overall Study|Other|1
2115923|NCT00933543|3712488|FG001|Overall Study|Other|1
2115924|NCT00933608|3712496|FG000|Overall Study|Adverse Event|4
2115925|NCT00933608|3712497|FG001|Overall Study|Adverse Event|2
2115926|NCT00933608|3712496|FG000|Overall Study|Physician Decision|1
2115927|NCT00933608|3712497|FG001|Overall Study|Physician Decision|0
2115928|NCT00933686|3712505|FG000|Overall Study|Protocol Violation|0
2115929|NCT00933686|3712506|FG001|Overall Study|Protocol Violation|1
2115930|NCT00933686|3712505|FG000|Overall Study|Lost to Follow-up|2
2115931|NCT00933686|3712506|FG001|Overall Study|Lost to Follow-up|2
2115932|NCT00933686|3712505|FG000|Overall Study|Withdrawal by Subject|6
2115933|NCT00933686|3712506|FG001|Overall Study|Withdrawal by Subject|5
2115934|NCT00933686|3712505|FG000|Overall Study|Adverse Event|1
2115935|NCT00933686|3712506|FG001|Overall Study|Adverse Event|1
2115936|NCT00933686|3712505|FG000|Overall Study|Physician Decision|1
2115937|NCT00933686|3712506|FG001|Overall Study|Physician Decision|0
2115938|NCT00933686|3712505|FG000|Overall Study|Failure to show up at endpoint visits|0
2115939|NCT00933686|3712506|FG001|Overall Study|Failure to show up at endpoint visits|2
2115940|NCT00933933|3712517|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
2115941|NCT00933933|3712518|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
2115942|NCT00933933|3712519|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
2115943|NCT00933933|3712517|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
2115944|NCT00933933|3712518|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
2115945|NCT00933933|3712519|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
2115946|NCT00934050|3712549|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1
2115947|NCT00934050|3712550|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0
2115948|NCT00934050|3712551|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0
2115949|NCT00934050|3712552|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1
2115950|NCT00934050|3712553|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0
2115951|NCT00934050|3712554|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0
2115952|NCT00934050|3712549|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
2115953|NCT00934050|3712550|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
2115954|NCT00934050|3712551|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
2115955|NCT00934050|3712552|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
2115956|NCT00934050|3712553|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
2115957|NCT00934050|3712554|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
2115958|NCT00934050|3712549|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
2115959|NCT00934050|3712550|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
2115960|NCT00934050|3712551|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
2115961|NCT00934050|3712552|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
2115962|NCT00934050|3712553|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
2115963|NCT00934050|3712554|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
2115964|NCT00934050|3712549|FG000|Enrolled After 15 Dec 2009|Adverse Event|0
2115965|NCT00934050|3712550|FG001|Enrolled After 15 Dec 2009|Adverse Event|0
2115966|NCT00934050|3712551|FG002|Enrolled After 15 Dec 2009|Adverse Event|0
2115967|NCT00934050|3712552|FG003|Enrolled After 15 Dec 2009|Adverse Event|0
2115968|NCT00934050|3712553|FG004|Enrolled After 15 Dec 2009|Adverse Event|3
2115969|NCT00934050|3712554|FG005|Enrolled After 15 Dec 2009|Adverse Event|0
2115970|NCT00934050|3712549|FG000|Enrolled After 15 Dec 2009|Death|0
2115971|NCT00934050|3712550|FG001|Enrolled After 15 Dec 2009|Death|0
2115972|NCT00934050|3712551|FG002|Enrolled After 15 Dec 2009|Death|0
2115973|NCT00934050|3712552|FG003|Enrolled After 15 Dec 2009|Death|0
2115974|NCT00934050|3712553|FG004|Enrolled After 15 Dec 2009|Death|0
2115975|NCT00934050|3712554|FG005|Enrolled After 15 Dec 2009|Death|1
2115976|NCT00934050|3712549|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0
2115977|NCT00934050|3712550|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0
2115978|NCT00934050|3712551|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0
2115979|NCT00934050|3712552|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0
2115980|NCT00934050|3712553|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0
2115981|NCT00934050|3712554|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1
2115982|NCT00934050|3712549|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
2115983|NCT00934050|3712550|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
2115984|NCT00934050|3712551|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
2115985|NCT00934050|3712552|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
2115986|NCT00934050|3712553|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
2115987|NCT00934050|3712554|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
2115988|NCT00934089|3712566|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1
2115989|NCT00934089|3712567|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0
2115990|NCT00934089|3712566|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1
2115991|NCT00934089|3712567|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0
2115992|NCT00934102|3712573|FG000|Period 1, One Night of Wear|Personal Reasons|1
2115993|NCT00934102|3712574|FG001|Period 1, One Night of Wear|Personal Reasons|0
2115994|NCT00934102|3712575|FG002|Period 1, One Night of Wear|Personal Reasons|0
2115995|NCT00934128|3712585|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0
2115996|NCT00934128|3712586|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1
2115997|NCT00934128|3712585|FG000|First Intervention (2 Hours)|Adverse Event|4
2115998|NCT00934128|3712586|FG001|First Intervention (2 Hours)|Adverse Event|1
2115999|NCT00934128|3712585|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
2116000|NCT00934128|3712586|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
2116001|NCT00934128|3712585|FG000|Washout Period (1 Hour)|Patient preference|1
2116002|NCT00934128|3712586|FG001|Washout Period (1 Hour)|Patient preference|3
2116003|NCT00934128|3712585|FG000|Washout Period (1 Hour)|Pain|1
2116004|NCT00934128|3712586|FG001|Washout Period (1 Hour)|Pain|0
2116005|NCT00934128|3712585|FG000|Washout Period (1 Hour)|Too tired|1
2116006|NCT00934128|3712586|FG001|Washout Period (1 Hour)|Too tired|0
2116007|NCT00934128|3712585|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4
2116008|NCT00934128|3712586|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2
2116009|NCT00934128|3712585|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
2116010|NCT00934128|3712586|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
2116011|NCT00934362|3712613|FG000|Overall Study|Adverse Event|1
2116012|NCT00934362|3712614|FG001|Overall Study|Adverse Event|0
2116013|NCT00934440|3712629|FG000|Overall Study|Lost to Follow-up|1
2116014|NCT00934544|3712636|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12
2116015|NCT00934544|3712637|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4
2116016|NCT00934544|3712638|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0
2116017|NCT00934544|3712636|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
2116018|NCT00934544|3712637|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
2116019|NCT00934544|3712638|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
2116020|NCT00934544|3712636|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2
2116021|NCT00934544|3712637|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0
2116022|NCT00934544|3712638|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0
2116023|NCT00934544|3712636|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1
2116024|NCT00934544|3712637|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3
2116025|NCT00934544|3712638|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0
2116026|NCT00934544|3712636|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
2116027|NCT00934544|3712637|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
2116028|NCT00934544|3712638|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
2116029|NCT00934544|3712636|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
2116030|NCT00934544|3712637|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
2116031|NCT00934544|3712638|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
2116032|NCT00934544|3712636|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7
2116033|NCT00934544|3712637|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7
2116034|NCT00934544|3712638|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0
2116035|NCT00934544|3712636|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29
2116036|NCT00934544|3712637|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18
2116037|NCT00934544|3712638|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0
2116038|NCT00934544|3712636|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
2116039|NCT00934544|3712637|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
2116040|NCT00934544|3712638|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
2116041|NCT00934544|3712636|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35
2116042|NCT00934544|3712637|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5
2116043|NCT00934544|3712638|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10
2116044|NCT00934544|3712636|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
2116045|NCT00934544|3712637|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
2116046|NCT00934544|3712638|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
2219198|NCT01720069|3862973|FG002|Overall Study|OCS bursts occured, discontinued in line|0
2116047|NCT00934544|3712636|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
2116048|NCT00934544|3712637|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
2116049|NCT00934544|3712638|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
2116050|NCT00934544|3712636|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32
2116051|NCT00934544|3712637|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4
2116052|NCT00934544|3712638|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7
2116053|NCT00934544|3712636|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
2116054|NCT00934544|3712637|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
2116055|NCT00934544|3712638|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
2116056|NCT00934544|3712636|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
2116057|NCT00934544|3712637|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
2116058|NCT00934544|3712638|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
2116059|NCT00934544|3712636|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
2116060|NCT00934544|3712637|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
2116061|NCT00934544|3712638|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
2116062|NCT00934622|3712668|FG000|Overall Study|Lost to Follow-up|7
2116063|NCT00934622|3712668|FG000|Overall Study|2nd Intraoperative exclusion criteria|1
2116064|NCT00934648|3712709|FG000|Overall Study|Failure to return|8
2180692|NCT01405820|3807263|FG005|Randomized Treatment Period|Withdrawal by Subject|0
2180693|NCT01405820|3807258|FG000|Randomized Treatment Period|Other|2
2180694|NCT01405820|3807259|FG001|Randomized Treatment Period|Other|2
2219199|NCT01720069|3862971|FG000|Overall Study|Non-compliance on using e-diary|0
2219200|NCT01720069|3862972|FG001|Overall Study|Non-compliance on using e-diary|0
2219201|NCT01720069|3862973|FG002|Overall Study|Non-compliance on using e-diary|1
2219202|NCT01720069|3862971|FG000|Overall Study|Lost to Follow-up|0
2219203|NCT01720069|3862972|FG001|Overall Study|Lost to Follow-up|0
2219204|NCT01720069|3862973|FG002|Overall Study|Lost to Follow-up|1
2180695|NCT01405820|3807260|FG002|Randomized Treatment Period|Other|1
2180696|NCT01405820|3807261|FG003|Randomized Treatment Period|Other|1
2180697|NCT01405820|3807262|FG004|Randomized Treatment Period|Other|0
2180698|NCT01405820|3807263|FG005|Randomized Treatment Period|Other|0
2180699|NCT01405820|3807258|FG000|Randomized Treatment Period|Physician Decision|0
2180700|NCT01405820|3807259|FG001|Randomized Treatment Period|Physician Decision|2
2180701|NCT01405820|3807260|FG002|Randomized Treatment Period|Physician Decision|1
2219205|NCT01720225|3862987|FG000|Overall Study|Withdrawal by Subject|0
2219206|NCT01720225|3862988|FG001|Overall Study|Withdrawal by Subject|1
2219207|NCT01720225|3862987|FG000|Overall Study|Did not complete 2 cycles of therapy|3
2219208|NCT01720225|3862988|FG001|Overall Study|Did not complete 2 cycles of therapy|0
2219209|NCT01720264|3863007|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1
2219210|NCT01720264|3863007|FG000|Post-transplant (Day 16) to 1 Year|Death|8
2219211|NCT01720264|3863007|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4
2219212|NCT01720446|3863061|FG000|Overall Study|Lost to Follow-up|12
2219213|NCT01720446|3863062|FG001|Overall Study|Lost to Follow-up|6
2219214|NCT01720446|3863063|FG002|Overall Study|Lost to Follow-up|16
2219215|NCT01720446|3863064|FG003|Overall Study|Lost to Follow-up|16
2219216|NCT01720446|3863061|FG000|Overall Study|Withdrawal by Subject|2
2219217|NCT01720446|3863062|FG001|Overall Study|Withdrawal by Subject|5
2180702|NCT01405820|3807261|FG003|Randomized Treatment Period|Physician Decision|0
2180703|NCT01405820|3807262|FG004|Randomized Treatment Period|Physician Decision|0
2180704|NCT01405820|3807263|FG005|Randomized Treatment Period|Physician Decision|0
2180705|NCT01405820|3807258|FG000|Randomized Treatment Period|Rescue|0
2180706|NCT01405820|3807259|FG001|Randomized Treatment Period|Rescue|1
2180707|NCT01405820|3807260|FG002|Randomized Treatment Period|Rescue|13
2180708|NCT01405820|3807261|FG003|Randomized Treatment Period|Rescue|10
2180709|NCT01405820|3807262|FG004|Randomized Treatment Period|Rescue|8
2180710|NCT01405820|3807263|FG005|Randomized Treatment Period|Rescue|8
2180711|NCT01405820|3807258|FG000|Randomized Treatment Period|Incorrect Study Treatment|0
2180712|NCT01405820|3807259|FG001|Randomized Treatment Period|Incorrect Study Treatment|0
2180713|NCT01405820|3807260|FG002|Randomized Treatment Period|Incorrect Study Treatment|3
2180714|NCT01405820|3807261|FG003|Randomized Treatment Period|Incorrect Study Treatment|0
2219218|NCT01720446|3863063|FG002|Overall Study|Withdrawal by Subject|4
2219219|NCT01720446|3863064|FG003|Overall Study|Withdrawal by Subject|4
2219220|NCT01720524|3863079|FG000|Part A|Insufficient Clinical Response|2
2219221|NCT01720524|3863080|FG001|Part A|Insufficient Clinical Response|4
2116065|NCT00934648|3712709|FG000|Overall Study|Withdrawal by Subject|1
2116066|NCT00934661|3712715|FG000|Overall Study|Failure of Combined/Spinal Epidural|1
2116067|NCT00934661|3712716|FG001|Overall Study|Failure of Combined/Spinal Epidural|0
2116068|NCT00934843|3712724|FG000|Overall Study|Protocol Violation|0
2116069|NCT00934843|3712725|FG001|Overall Study|Protocol Violation|1
2116070|NCT00934856|3712737|FG000|Feasibility Part|Progressive disease|4
2116071|NCT00934856|3712738|FG001|Feasibility Part|Progressive disease|4
2116072|NCT00934856|3712739|FG002|Feasibility Part|Progressive disease|2
2116073|NCT00934856|3712740|FG003|Feasibility Part|Progressive disease|3
2116074|NCT00934856|3712741|FG004|Feasibility Part|Progressive disease|0
2116075|NCT00934856|3712742|FG005|Feasibility Part|Progressive disease|0
2116076|NCT00934856|3712737|FG000|Feasibility Part|Physician Decision|0
2116077|NCT00934856|3712738|FG001|Feasibility Part|Physician Decision|0
2116078|NCT00934856|3712739|FG002|Feasibility Part|Physician Decision|1
2116079|NCT00934856|3712740|FG003|Feasibility Part|Physician Decision|0
2116080|NCT00934856|3712741|FG004|Feasibility Part|Physician Decision|0
2116081|NCT00934856|3712742|FG005|Feasibility Part|Physician Decision|0
2116082|NCT00934856|3712737|FG000|Feasibility Part|Adverse Event|1
2116083|NCT00934856|3712738|FG001|Feasibility Part|Adverse Event|1
2116084|NCT00934856|3712739|FG002|Feasibility Part|Adverse Event|0
2116085|NCT00934856|3712740|FG003|Feasibility Part|Adverse Event|1
2116086|NCT00934856|3712741|FG004|Feasibility Part|Adverse Event|0
2116087|NCT00934856|3712742|FG005|Feasibility Part|Adverse Event|2
2116088|NCT00934856|3712737|FG000|Feasibility Part|Withdrawal by Subject|0
2116089|NCT00934856|3712738|FG001|Feasibility Part|Withdrawal by Subject|0
2116090|NCT00934856|3712739|FG002|Feasibility Part|Withdrawal by Subject|0
2116091|NCT00934856|3712740|FG003|Feasibility Part|Withdrawal by Subject|1
2116092|NCT00934856|3712741|FG004|Feasibility Part|Withdrawal by Subject|0
2116093|NCT00934856|3712742|FG005|Feasibility Part|Withdrawal by Subject|1
2116094|NCT00934856|3712737|FG000|Extension Part|Adverse Event|0
2116095|NCT00934856|3712738|FG001|Extension Part|Adverse Event|0
2116096|NCT00934856|3712739|FG002|Extension Part|Adverse Event|0
2116097|NCT00934856|3712740|FG003|Extension Part|Adverse Event|1
2116098|NCT00934856|3712741|FG004|Extension Part|Adverse Event|4
2116099|NCT00934856|3712742|FG005|Extension Part|Adverse Event|4
2116100|NCT00934856|3712737|FG000|Extension Part|Progressive disease|0
2116101|NCT00934856|3712738|FG001|Extension Part|Progressive disease|0
2116102|NCT00934856|3712739|FG002|Extension Part|Progressive disease|0
2116103|NCT00934856|3712740|FG003|Extension Part|Progressive disease|1
2116104|NCT00934856|3712741|FG004|Extension Part|Progressive disease|0
2116105|NCT00934856|3712742|FG005|Extension Part|Progressive disease|0
2116106|NCT00934856|3712737|FG000|Extension Part|Non-compliance with drug|0
2116107|NCT00934856|3712738|FG001|Extension Part|Non-compliance with drug|0
2116108|NCT00934856|3712739|FG002|Extension Part|Non-compliance with drug|0
2116109|NCT00934856|3712740|FG003|Extension Part|Non-compliance with drug|0
2116110|NCT00934856|3712741|FG004|Extension Part|Non-compliance with drug|0
2116111|NCT00934856|3712742|FG005|Extension Part|Non-compliance with drug|1
2116112|NCT00934947|3712788|FG000|Overall Study|Adverse Event|0
2116113|NCT00934947|3712789|FG001|Overall Study|Adverse Event|2
2116114|NCT00935012|3712797|FG000|Overall Study|Death|19
2116115|NCT00935012|3712797|FG000|Overall Study|Withdrawal by Subject|3
2116116|NCT00935012|3712797|FG000|Overall Study|Other|5
2116117|NCT00935012|3712797|FG000|Overall Study|Adverse Event|2
2116118|NCT00935220|3712810|FG000|Overall Study|Adverse Event|1
2116119|NCT00935220|3712810|FG000|Overall Study|Other reason (not specified)|1
2116120|NCT00935259|3712814|FG000|Period 1|Administrative (scheduling conflict)|1
2116121|NCT00935259|3712815|FG001|Period 1|Administrative (scheduling conflict)|1
2116122|NCT00935272|3712825|FG000|Overall Study|Lost to Follow-up|10
2116123|NCT00935272|3712826|FG001|Overall Study|Lost to Follow-up|3
2116124|NCT00935272|3712825|FG000|Overall Study|Withdrawal by Subject|8
2116125|NCT00935272|3712826|FG001|Overall Study|Withdrawal by Subject|2
2116126|NCT00935272|3712825|FG000|Overall Study|Physician Decision|1
2116127|NCT00935272|3712826|FG001|Overall Study|Physician Decision|0
2116128|NCT00935272|3712825|FG000|Overall Study|Protocol Violation|0
2116129|NCT00935272|3712826|FG001|Overall Study|Protocol Violation|1
2116130|NCT00935493|3712859|FG000|Overall Study|Lost to Follow-up|1
2116131|NCT00935493|3712860|FG001|Overall Study|Lost to Follow-up|1
2116132|NCT00935493|3712861|FG002|Overall Study|Lost to Follow-up|1
2116133|NCT00935493|3712859|FG000|Overall Study|Treatment Discontinued|0
2116134|NCT00935493|3712860|FG001|Overall Study|Treatment Discontinued|1
2116135|NCT00935493|3712861|FG002|Overall Study|Treatment Discontinued|0
2116136|NCT00935532|3712871|FG000|Overall Study|Adverse Event|11
2116137|NCT00935532|3712872|FG001|Overall Study|Adverse Event|6
2116138|NCT00935532|3712871|FG000|Overall Study|Death|1
2116139|NCT00935532|3712872|FG001|Overall Study|Death|0
2116140|NCT00935532|3712871|FG000|Overall Study|Lost to Follow-up|1
2116141|NCT00935532|3712872|FG001|Overall Study|Lost to Follow-up|0
2116142|NCT00935532|3712871|FG000|Overall Study|Physician Decision|1
2116143|NCT00935532|3712872|FG001|Overall Study|Physician Decision|2
2116144|NCT00935532|3712871|FG000|Overall Study|Protocol Violation|2
2116145|NCT00935532|3712872|FG001|Overall Study|Protocol Violation|1
2116146|NCT00935532|3712871|FG000|Overall Study|Subject Decision|2
2116147|NCT00935532|3712872|FG001|Overall Study|Subject Decision|1
2116148|NCT00935532|3712871|FG000|Overall Study|Sponsor Decision|0
2116149|NCT00935532|3712872|FG001|Overall Study|Sponsor Decision|1
2116150|NCT00935532|3712871|FG000|Overall Study|Loss Glucose Control|4
2116151|NCT00935532|3712872|FG001|Overall Study|Loss Glucose Control|0
2116152|NCT00935584|3712880|FG000|Overall Study|Withdrawal by Subject|9
2116153|NCT00935584|3712881|FG001|Overall Study|Withdrawal by Subject|0
2116154|NCT00935584|3712880|FG000|Overall Study|Death|3
2116155|NCT00935584|3712881|FG001|Overall Study|Death|0
2116156|NCT00935584|3712880|FG000|Overall Study|Lost to Follow-up|8
2116157|NCT00935584|3712881|FG001|Overall Study|Lost to Follow-up|0
2116158|NCT00935584|3712880|FG000|Overall Study|No show|9
2116159|NCT00935584|3712881|FG001|Overall Study|No show|0
2116160|NCT00935584|3712880|FG000|Overall Study|Relocated|3
2116161|NCT00935584|3712881|FG001|Overall Study|Relocated|0
2116162|NCT00935584|3712880|FG000|Overall Study|Patient changed provider|3
2116163|NCT00935584|3712881|FG001|Overall Study|Patient changed provider|0
2116164|NCT00935584|3712880|FG000|Overall Study|Provider dropped out of study|14
2116165|NCT00935584|3712881|FG001|Overall Study|Provider dropped out of study|4
2116166|NCT00935701|3712885|FG000|Overall Study|Failure to Transition to Acupuncture|1
2116167|NCT00935818|3712916|FG000|Overall Study|Withdrawal by Subject|45
2116168|NCT00935818|3712917|FG001|Overall Study|Withdrawal by Subject|50
2116169|NCT00935818|3712916|FG000|Overall Study|Lost to Follow-up|40
2116170|NCT00935818|3712917|FG001|Overall Study|Lost to Follow-up|42
2116171|NCT00935818|3712916|FG000|Overall Study|Adverse Event|6
2116172|NCT00935818|3712917|FG001|Overall Study|Adverse Event|7
2116173|NCT00935818|3712916|FG000|Overall Study|Physician Decision|0
2116174|NCT00935818|3712917|FG001|Overall Study|Physician Decision|1
2116175|NCT00935883|3712934|FG000|Treatment Period|Physician Decision|1
2116176|NCT00935883|3712935|FG001|Treatment Period|Physician Decision|0
2116177|NCT00935883|3712934|FG000|Treatment Period|Withdrawal by Subject|0
2116178|NCT00935883|3712935|FG001|Treatment Period|Withdrawal by Subject|2
2180715|NCT01405820|3807262|FG004|Randomized Treatment Period|Incorrect Study Treatment|2
2180716|NCT01405820|3807263|FG005|Randomized Treatment Period|Incorrect Study Treatment|0
2180717|NCT01405820|3807258|FG000|Randomized Treatment Period|Treatment Arm Closed|0
2180718|NCT01405820|3807259|FG001|Randomized Treatment Period|Treatment Arm Closed|0
2180719|NCT01405820|3807260|FG002|Randomized Treatment Period|Treatment Arm Closed|20
2180720|NCT01405820|3807261|FG003|Randomized Treatment Period|Treatment Arm Closed|36
2180721|NCT01405820|3807262|FG004|Randomized Treatment Period|Treatment Arm Closed|33
2180722|NCT01405820|3807263|FG005|Randomized Treatment Period|Treatment Arm Closed|28
2180723|NCT01405820|3807258|FG000|Randomized Treatment Period|Death|0
2180724|NCT01405820|3807259|FG001|Randomized Treatment Period|Death|0
2180725|NCT01405820|3807260|FG002|Randomized Treatment Period|Death|0
2180726|NCT01405820|3807261|FG003|Randomized Treatment Period|Death|1
2180727|NCT01405820|3807262|FG004|Randomized Treatment Period|Death|0
2180728|NCT01405820|3807263|FG005|Randomized Treatment Period|Death|0
2180729|NCT01405820|3807258|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0
2180730|NCT01405820|3807259|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0
2180731|NCT01405820|3807260|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0
2180732|NCT01405820|3807261|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1
2180733|NCT01405820|3807262|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0
2180734|NCT01405820|3807263|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0
2180735|NCT01405820|3807258|FG000|Open-Label Treatment Period|Withdrawal by Subject|3
2180736|NCT01405820|3807259|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
2180737|NCT01405820|3807260|FG002|Open-Label Treatment Period|Withdrawal by Subject|1
2180738|NCT01405820|3807261|FG003|Open-Label Treatment Period|Withdrawal by Subject|1
2180739|NCT01405820|3807262|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
2180740|NCT01405820|3807263|FG005|Open-Label Treatment Period|Withdrawal by Subject|1
2180741|NCT01405820|3807258|FG000|Open-Label Treatment Period|Other|1
2180742|NCT01405820|3807259|FG001|Open-Label Treatment Period|Other|1
2180743|NCT01405820|3807260|FG002|Open-Label Treatment Period|Other|1
2180744|NCT01405820|3807261|FG003|Open-Label Treatment Period|Other|1
2180745|NCT01405820|3807262|FG004|Open-Label Treatment Period|Other|1
2180746|NCT01405820|3807263|FG005|Open-Label Treatment Period|Other|1
2180747|NCT01405820|3807258|FG000|Open-Label Treatment Period|Physician Decision|0
2180748|NCT01405820|3807259|FG001|Open-Label Treatment Period|Physician Decision|0
2180749|NCT01405820|3807260|FG002|Open-Label Treatment Period|Physician Decision|1
2180750|NCT01405820|3807261|FG003|Open-Label Treatment Period|Physician Decision|2
2180751|NCT01405820|3807262|FG004|Open-Label Treatment Period|Physician Decision|1
2180752|NCT01405820|3807263|FG005|Open-Label Treatment Period|Physician Decision|0
2180753|NCT01405820|3807258|FG000|Open-Label Treatment Period|Adverse Event|0
2180754|NCT01405820|3807259|FG001|Open-Label Treatment Period|Adverse Event|0
2180755|NCT01405820|3807260|FG002|Open-Label Treatment Period|Adverse Event|0
2180756|NCT01405820|3807261|FG003|Open-Label Treatment Period|Adverse Event|1
2180757|NCT01405820|3807262|FG004|Open-Label Treatment Period|Adverse Event|0
2180758|NCT01405820|3807263|FG005|Open-Label Treatment Period|Adverse Event|0
2180759|NCT01405898|3807285|FG000|Overall Study|Withdrawal by Subject|2
2180760|NCT01405898|3807286|FG001|Overall Study|Withdrawal by Subject|2
2180761|NCT01405911|3807295|FG000|Overall Study|Pre-treatment lab AE|0
2180762|NCT01405911|3807296|FG001|Overall Study|Pre-treatment lab AE|1
2180763|NCT01405911|3807297|FG002|Overall Study|Pre-treatment lab AE|0
2180764|NCT01405911|3807295|FG000|Overall Study|Lost to Follow-up|0
2180765|NCT01405911|3807296|FG001|Overall Study|Lost to Follow-up|1
2180766|NCT01405911|3807297|FG002|Overall Study|Lost to Follow-up|0
2116179|NCT00936065|3712944|FG000|Overall Study|Adverse Event|1
2116180|NCT00936065|3712945|FG001|Overall Study|Adverse Event|0
2116181|NCT00936065|3712946|FG002|Overall Study|Adverse Event|1
2116182|NCT00936065|3712944|FG000|Overall Study|Lack of Efficacy|1
2116183|NCT00936065|3712945|FG001|Overall Study|Lack of Efficacy|0
2116184|NCT00936065|3712946|FG002|Overall Study|Lack of Efficacy|1
2116185|NCT00936065|3712944|FG000|Overall Study|Lost to Follow-up|1
2116186|NCT00936065|3712945|FG001|Overall Study|Lost to Follow-up|0
2116187|NCT00936065|3712946|FG002|Overall Study|Lost to Follow-up|0
2116188|NCT00936065|3712944|FG000|Overall Study|Protocol Violation|1
2116189|NCT00936065|3712945|FG001|Overall Study|Protocol Violation|2
2116190|NCT00936065|3712946|FG002|Overall Study|Protocol Violation|1
2116191|NCT00936065|3712944|FG000|Overall Study|Withdrawal by Subject|0
2116192|NCT00936065|3712945|FG001|Overall Study|Withdrawal by Subject|2
2116193|NCT00936065|3712946|FG002|Overall Study|Withdrawal by Subject|4
2116194|NCT00936117|3712954|FG000|Overall Study|Adverse Event|7
2116195|NCT00936117|3712954|FG000|Overall Study|Unable to continue oral medication|3
2116196|NCT00936208|3712961|FG000|Overall Study|Protocol Violation|37
2116197|NCT00936208|3712962|FG001|Overall Study|Protocol Violation|22
2116198|NCT00936221|3712970|FG000|Overall Study|Withdrawal by Subject|1
2116199|NCT00936221|3712971|FG001|Overall Study|Withdrawal by Subject|1
2116200|NCT00936611|3713034|FG000|Overall Study|Progressive Disease|3
2116201|NCT00936611|3713034|FG000|Overall Study|New Systemic Therapy|22
2116202|NCT00936611|3713034|FG000|Overall Study|Lost to Follow-up|1
2116203|NCT00936611|3713034|FG000|Overall Study|Withdrawal by Subject|2
2116204|NCT00936611|3713034|FG000|Overall Study|Still on Follow-up|1
2116205|NCT00936611|3713034|FG000|Overall Study|Still on Active Therapy|7
2116206|NCT00936611|3713034|FG000|Overall Study|Ineligible for Study Drug|3
2116207|NCT00936702|3713047|FG000|Overall Study|Disease progression|34
2116208|NCT00936702|3713047|FG000|Overall Study|Adverse Event|8
2116209|NCT00936702|3713047|FG000|Overall Study|Withdrawal by Subject|2
2116210|NCT00936702|3713047|FG000|Overall Study|Alternative Treatment|1
2116211|NCT00936702|3713047|FG000|Overall Study|Other|1
2116212|NCT00936715|3713051|FG000|Overall Study|Investigators Discretion|1
2116213|NCT00936715|3713051|FG000|Overall Study|Protocol Violation|1
2116214|NCT00936715|3713051|FG000|Overall Study|Safety or Tolerability Reasons|4
2116215|NCT00936858|3713059|FG000|Overall Study|Death|3
2116216|NCT00936858|3713059|FG000|Overall Study|Progression|29
2116217|NCT00936858|3713059|FG000|Overall Study|Withdrawal by Subject|5
2116218|NCT00936858|3713059|FG000|Overall Study|Adverse Event|1
2116219|NCT00936858|3713059|FG000|Overall Study|Physician Decision|7
2116220|NCT00936858|3713059|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4
2116221|NCT00936858|3713059|FG000|Overall Study|Lost to Follow-up|1
2116222|NCT00936884|3713066|FG000|Double-blind|Withdrawal by Subject|6
2116223|NCT00936884|3713067|FG001|Double-blind|Withdrawal by Subject|4
2116224|NCT00936884|3713068|FG002|Double-blind|Withdrawal by Subject|0
2116225|NCT00936884|3713066|FG000|Double-blind|Death|2
2116226|NCT00936884|3713067|FG001|Double-blind|Death|1
2116227|NCT00936884|3713068|FG002|Double-blind|Death|0
2116228|NCT00936884|3713066|FG000|Double-blind|Lack of Efficacy|1
2116229|NCT00936884|3713067|FG001|Double-blind|Lack of Efficacy|1
2116230|NCT00936884|3713068|FG002|Double-blind|Lack of Efficacy|0
2116231|NCT00936884|3713066|FG000|Double-blind|Adverse Event|1
2116232|NCT00936884|3713067|FG001|Double-blind|Adverse Event|0
2116233|NCT00936884|3713068|FG002|Double-blind|Adverse Event|0
2116234|NCT00936884|3713066|FG000|Double-blind|Physician Decision|1
2116235|NCT00936884|3713067|FG001|Double-blind|Physician Decision|0
2116236|NCT00936884|3713068|FG002|Double-blind|Physician Decision|0
2116237|NCT00936884|3713066|FG000|Double-blind|No post baseline diary entry|1
2116238|NCT00936884|3713067|FG001|Double-blind|No post baseline diary entry|0
2116239|NCT00936884|3713068|FG002|Double-blind|No post baseline diary entry|0
2116240|NCT00936884|3713066|FG000|Double-blind|Did not receive study drug|0
2116241|NCT00936884|3713067|FG001|Double-blind|Did not receive study drug|1
2116242|NCT00936884|3713068|FG002|Double-blind|Did not receive study drug|0
2116243|NCT00936897|3713077|FG000|Overall Study|Withdrawal by Subject|9
2116244|NCT00936897|3713078|FG001|Overall Study|Withdrawal by Subject|19
2116245|NCT00936897|3713077|FG000|Overall Study|Adverse Event|4
2116246|NCT00936897|3713078|FG001|Overall Study|Adverse Event|13
2116247|NCT00936897|3713077|FG000|Overall Study|Other|3
2116248|NCT00936897|3713078|FG001|Overall Study|Other|9
2116249|NCT00936897|3713077|FG000|Overall Study|Lost to Follow-up|1
2116250|NCT00936897|3713078|FG001|Overall Study|Lost to Follow-up|10
2116251|NCT00936897|3713077|FG000|Overall Study|Administrative Decision|1
2116252|NCT00936897|3713078|FG001|Overall Study|Administrative Decision|2
2116253|NCT00936897|3713077|FG000|Overall Study|Protocol Violation|1
2116254|NCT00936897|3713078|FG001|Overall Study|Protocol Violation|1
2116255|NCT00936897|3713077|FG000|Overall Study|Ineligibility Determined|0
2116256|NCT00936897|3713078|FG001|Overall Study|Ineligibility Determined|3
2116257|NCT00936897|3713077|FG000|Overall Study|Noncompliance|0
2116258|NCT00936897|3713078|FG001|Overall Study|Noncompliance|2
2116259|NCT00936897|3713077|FG000|Overall Study|Death|0
2116260|NCT00936897|3713078|FG001|Overall Study|Death|1
2116261|NCT00936910|3713084|FG000|Overall Study|Lack of Efficacy|3
2116262|NCT00936975|3713089|FG000|Overall Study|Withdrawal by Subject|1
2116263|NCT00936975|3713089|FG000|Overall Study|Disease progression|3
2116264|NCT00936975|3713089|FG000|Overall Study|Post-Tx scan uninterpretable|2
2116265|NCT00937040|3713096|FG000|Overall Study|Adverse Event|5
2116266|NCT00937040|3713097|FG001|Overall Study|Adverse Event|8
2116267|NCT00937040|3713096|FG000|Overall Study|Lost to Follow-up|12
2116268|NCT00937040|3713097|FG001|Overall Study|Lost to Follow-up|12
2116269|NCT00937040|3713096|FG000|Overall Study|Protocol Violation|3
2116270|NCT00937040|3713097|FG001|Overall Study|Protocol Violation|0
2116271|NCT00937040|3713096|FG000|Overall Study|Withdrawal by Subject|13
2116272|NCT00937040|3713097|FG001|Overall Study|Withdrawal by Subject|7
2116273|NCT00937040|3713096|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
2116274|NCT00937040|3713097|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
2116275|NCT00937040|3713096|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
2116276|NCT00937040|3713097|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
2116277|NCT00937157|3713128|FG000|Overall Study|Pregnancy|1
2116278|NCT00937157|3713128|FG000|Overall Study|Lost to Follow-up|3
2116279|NCT00937326|3713146|FG000|Overall Study|Adverse Event|0
2116280|NCT00937326|3713147|FG001|Overall Study|Adverse Event|3
2116281|NCT00937326|3713148|FG002|Overall Study|Adverse Event|1
2116282|NCT00937326|3713149|FG003|Overall Study|Adverse Event|1
2116283|NCT00937326|3713150|FG004|Overall Study|Adverse Event|2
2116284|NCT00937326|3713146|FG000|Overall Study|Death|0
2116285|NCT00937326|3713147|FG001|Overall Study|Death|0
2116286|NCT00937326|3713148|FG002|Overall Study|Death|1
2116287|NCT00937326|3713149|FG003|Overall Study|Death|0
2116288|NCT00937326|3713150|FG004|Overall Study|Death|0
2116289|NCT00937326|3713146|FG000|Overall Study|Withdrawal by Subject|3
2116290|NCT00937326|3713147|FG001|Overall Study|Withdrawal by Subject|4
2116291|NCT00937326|3713148|FG002|Overall Study|Withdrawal by Subject|1
2116292|NCT00937326|3713149|FG003|Overall Study|Withdrawal by Subject|4
2116293|NCT00937326|3713150|FG004|Overall Study|Withdrawal by Subject|3
2116294|NCT00937326|3713146|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0
2116295|NCT00937326|3713147|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0
2116296|NCT00937326|3713148|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1
2116297|NCT00937326|3713149|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0
2116298|NCT00937326|3713150|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0
2116299|NCT00937391|3713178|FG000|Stage 2|Withdrawal by Subject|1
2116300|NCT00937404|3713195|FG000|Overall Study|Protocol Violation|1
2116301|NCT00937404|3713195|FG000|Overall Study|Withdrawal by Subject|1
2116302|NCT00937495|3713199|FG000|Overall Study|Protocol Violation|2
2116303|NCT00937521|3713211|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0
2116304|NCT00937521|3713212|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0
2116305|NCT00937521|3713213|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2
2116306|NCT00937521|3713214|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0
2116307|NCT00937521|3713215|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0
2116308|NCT00937521|3713216|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0
2116309|NCT00937521|3713217|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1
2116310|NCT00937521|3713218|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0
2116311|NCT00937521|3713211|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
2116312|NCT00937521|3713212|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
2116313|NCT00937521|3713213|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
2116314|NCT00937521|3713214|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
2116315|NCT00937521|3713215|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
2116316|NCT00937521|3713216|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
2116317|NCT00937521|3713217|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
2116318|NCT00937521|3713218|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
2116319|NCT00937521|3713211|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2116320|NCT00937521|3713212|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2116321|NCT00937521|3713213|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
2116322|NCT00937521|3713214|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
2116323|NCT00937521|3713215|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2116324|NCT00937521|3713216|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2116325|NCT00937521|3713217|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2116326|NCT00937521|3713218|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2116327|NCT00937521|3713211|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
2116328|NCT00937521|3713212|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
2116329|NCT00937521|3713213|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
2116330|NCT00937521|3713214|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
2116331|NCT00937521|3713215|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
2116332|NCT00937521|3713216|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
2116333|NCT00937521|3713217|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
2116334|NCT00937521|3713218|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
2116335|NCT00937521|3713211|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1
2116336|NCT00937521|3713212|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2116337|NCT00937521|3713213|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2116338|NCT00937521|3713214|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2180767|NCT01405911|3807295|FG000|Overall Study|Protocol Violation|1
2116339|NCT00937521|3713215|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2116340|NCT00937521|3713216|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2116341|NCT00937521|3713217|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1
2116342|NCT00937521|3713218|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2116343|NCT00937521|3713211|FG000|Booster Phase|Adverse Event|0
2116344|NCT00937521|3713212|FG001|Booster Phase|Adverse Event|0
2116345|NCT00937521|3713213|FG002|Booster Phase|Adverse Event|0
2116346|NCT00937521|3713214|FG003|Booster Phase|Adverse Event|0
2116347|NCT00937521|3713215|FG004|Booster Phase|Adverse Event|0
2116348|NCT00937521|3713216|FG005|Booster Phase|Adverse Event|0
2116349|NCT00937521|3713217|FG006|Booster Phase|Adverse Event|1
2116350|NCT00937521|3713218|FG007|Booster Phase|Adverse Event|0
2116351|NCT00937521|3713211|FG000|Booster Phase|Withdrawal by Subject|1
2116352|NCT00937521|3713212|FG001|Booster Phase|Withdrawal by Subject|0
2116353|NCT00937521|3713213|FG002|Booster Phase|Withdrawal by Subject|0
2116354|NCT00937521|3713214|FG003|Booster Phase|Withdrawal by Subject|1
2116355|NCT00937521|3713215|FG004|Booster Phase|Withdrawal by Subject|0
2116356|NCT00937521|3713216|FG005|Booster Phase|Withdrawal by Subject|0
2116357|NCT00937521|3713217|FG006|Booster Phase|Withdrawal by Subject|0
2116358|NCT00937521|3713218|FG007|Booster Phase|Withdrawal by Subject|2
2116359|NCT00937521|3713211|FG000|Booster Phase|Lost to Follow-up|2
2116360|NCT00937521|3713212|FG001|Booster Phase|Lost to Follow-up|2
2116361|NCT00937521|3713213|FG002|Booster Phase|Lost to Follow-up|4
2116362|NCT00937521|3713214|FG003|Booster Phase|Lost to Follow-up|2
2116363|NCT00937521|3713215|FG004|Booster Phase|Lost to Follow-up|4
2116364|NCT00937521|3713216|FG005|Booster Phase|Lost to Follow-up|4
2116365|NCT00937521|3713217|FG006|Booster Phase|Lost to Follow-up|3
2116366|NCT00937521|3713218|FG007|Booster Phase|Lost to Follow-up|0
2116367|NCT00937521|3713211|FG000|Booster Phase|Administrative Reason|0
2116368|NCT00937521|3713212|FG001|Booster Phase|Administrative Reason|0
2116369|NCT00937521|3713213|FG002|Booster Phase|Administrative Reason|1
2116370|NCT00937521|3713214|FG003|Booster Phase|Administrative Reason|0
2116371|NCT00937521|3713215|FG004|Booster Phase|Administrative Reason|1
2116372|NCT00937521|3713216|FG005|Booster Phase|Administrative Reason|1
2116373|NCT00937521|3713217|FG006|Booster Phase|Administrative Reason|0
2116374|NCT00937521|3713218|FG007|Booster Phase|Administrative Reason|0
2116375|NCT00937521|3713211|FG000|Booster Phase|Protocol Deviation|0
2116376|NCT00937521|3713212|FG001|Booster Phase|Protocol Deviation|0
2116377|NCT00937521|3713213|FG002|Booster Phase|Protocol Deviation|0
2116378|NCT00937521|3713214|FG003|Booster Phase|Protocol Deviation|0
2116379|NCT00937521|3713215|FG004|Booster Phase|Protocol Deviation|0
2116380|NCT00937521|3713216|FG005|Booster Phase|Protocol Deviation|0
2116381|NCT00937521|3713217|FG006|Booster Phase|Protocol Deviation|1
2116382|NCT00937521|3713218|FG007|Booster Phase|Protocol Deviation|0
2116383|NCT00937547|3713254|FG000|Overall Study|misdiagnosis|1
2116384|NCT00937547|3713255|FG001|Overall Study|misdiagnosis|6
2116385|NCT00937547|3713256|FG002|Overall Study|misdiagnosis|7
2219222|NCT01720524|3863079|FG000|Part A|Adverse Event|2
2219223|NCT01720524|3863080|FG001|Part A|Adverse Event|2
2219224|NCT01720524|3863079|FG000|Part A|Death|2
2116386|NCT00937560|3713264|FG000|Initial Treatment|Death|6
2116387|NCT00937560|3713264|FG000|Initial Treatment|Withdraw consent|3
2116388|NCT00937560|3713264|FG000|Initial Treatment|Adverse Event|1
2116389|NCT00937560|3713264|FG000|Initial Treatment|Lost to Follow-up|1
2116390|NCT00937560|3713264|FG000|Initial Treatment|No end of study page|10
2116391|NCT00937560|3713264|FG000|Maintenance Treatment|Death|12
2116392|NCT00937560|3713264|FG000|Maintenance Treatment|Withdraw consent|5
2116393|NCT00937560|3713264|FG000|Maintenance Treatment|According to protocol|1
2116394|NCT00937768|3713270|FG000|Overall Study|Refused Further Treatment|3
2116395|NCT00937768|3713271|FG001|Overall Study|Refused Further Treatment|2
2116396|NCT00937768|3713270|FG000|Overall Study|Disease Progression|1
2116397|NCT00937768|3713271|FG001|Overall Study|Disease Progression|1
2116398|NCT00937768|3713270|FG000|Overall Study|Alternate Treatment|0
2116399|NCT00937768|3713271|FG001|Overall Study|Alternate Treatment|1
2116400|NCT00937768|3713270|FG000|Overall Study|No Further Funding|4
2116401|NCT00937768|3713271|FG001|Overall Study|No Further Funding|4
2116402|NCT00937833|3713283|FG000|Overall Study|Protocol Violation|1
2116403|NCT00937833|3713284|FG001|Overall Study|Protocol Violation|2
2116404|NCT00937833|3713283|FG000|Overall Study|Procedure delayed; enrollment closed|0
2116405|NCT00937833|3713284|FG001|Overall Study|Procedure delayed; enrollment closed|1
2116406|NCT00937833|3713283|FG000|Overall Study|Lost to Follow-up|10
2116407|NCT00937833|3713284|FG001|Overall Study|Lost to Follow-up|8
2116408|NCT00937833|3713283|FG000|Overall Study|Withdrawal by Subject|4
2116409|NCT00937833|3713284|FG001|Overall Study|Withdrawal by Subject|6
2116410|NCT00937950|3713299|FG000|Overall Study|Withdrawal by Subject|23
2116411|NCT00937950|3713299|FG000|Overall Study|Migrated/moved from study area|27
2116412|NCT00937950|3713299|FG000|Overall Study|Lost to Follow-up|144
2116413|NCT00937950|3713299|FG000|Overall Study|Missing confirmed|4
2116414|NCT00937950|3713299|FG000|Overall Study|Other|18
2116415|NCT00938015|3713303|FG000|Overall Study|Death|2
2116416|NCT00938015|3713303|FG000|Overall Study|Lost to Follow-up|32
2116417|NCT00938015|3713303|FG000|Overall Study|Adverse Event|32
2116418|NCT00938015|3713303|FG000|Overall Study|Non-responder|52
2219225|NCT01720524|3863080|FG001|Part A|Death|1
2219226|NCT01720524|3863079|FG000|Part A|Lost to Follow-up|0
2116419|NCT00938015|3713303|FG000|Overall Study|Reason not related to Etanercept|29
2116420|NCT00938041|3713307|FG000|Overall Study|Lost to Follow-up|6
2116421|NCT00938041|3713307|FG000|Overall Study|Received Alternative Therapy|1
2116422|NCT00938041|3713307|FG000|Overall Study|Progressive Disease|5
2116423|NCT00938041|3713307|FG000|Overall Study|Death|12
2116424|NCT00938041|3713307|FG000|Overall Study|Adrenal Insufficiency|3
2116425|NCT00938327|3713328|FG000|Overall Study|Adverse Event|2
2116426|NCT00938327|3713328|FG000|Overall Study|Protocol Violation|1
2116427|NCT00938327|3713328|FG000|Overall Study|Withdrawal by Subject|4
2116428|NCT00938327|3713328|FG000|Overall Study|Lost to Follow-up|37
2116429|NCT00938327|3713328|FG000|Overall Study|2nd dose received outside of the study|7
2116430|NCT00938327|3713328|FG000|Overall Study|Vaccine not received as out of stock|9
2116431|NCT00938340|3713332|FG000|Overall Study|Withdrawal by Subject|3
2116432|NCT00938340|3713332|FG000|Overall Study|Protocol Violation|1
2116433|NCT00938340|3713332|FG000|Overall Study|Adverse Event|1
2116434|NCT00938366|3713380|FG000|Overall Study|Withdrawal by Subject|1
2116435|NCT00938366|3713381|FG001|Overall Study|Withdrawal by Subject|0
2116436|NCT00938392|3713389|FG000|Overall Study|Adverse Event|0
2116437|NCT00938392|3713390|FG001|Overall Study|Adverse Event|1
2116438|NCT00938392|3713389|FG000|Overall Study|Withdrawal by Subject|0
2116439|NCT00938392|3713390|FG001|Overall Study|Withdrawal by Subject|1
2116440|NCT00938392|3713389|FG000|Overall Study|Lost to Follow-up|2
2116441|NCT00938392|3713390|FG001|Overall Study|Lost to Follow-up|2
2116442|NCT00938431|3713399|FG000|Overall Study|Adverse Event|5
2116443|NCT00938431|3713400|FG001|Overall Study|Adverse Event|8
2219227|NCT01720524|3863080|FG001|Part A|Lost to Follow-up|1
2219228|NCT01720524|3863079|FG000|Part A|Missed 28 day follow-up visit|1
2219229|NCT01720524|3863080|FG001|Part A|Missed 28 day follow-up visit|1
2219230|NCT01720524|3863079|FG000|Part A|Withdrawal by Subject|0
2219231|NCT01720524|3863080|FG001|Part A|Withdrawal by Subject|1
2219232|NCT01720524|3863079|FG000|Part A|Other|0
2219233|NCT01720524|3863080|FG001|Part A|Other|1
2219234|NCT01720524|3863079|FG000|Part A|Lost to Follow-up|0
2219235|NCT01720524|3863080|FG001|Part A|Lost to Follow-up|1
2219236|NCT01720524|3863079|FG000|Part B|No longer willing to participate in study|1
2219237|NCT01720524|3863080|FG001|Part B|No longer willing to participate in study|4
2219238|NCT01720524|3863079|FG000|Part B|Other|2
2219239|NCT01720524|3863080|FG001|Part B|Other|0
2219240|NCT01720524|3863079|FG000|Part B|Lost to Follow-up|2
2219241|NCT01720524|3863080|FG001|Part B|Lost to Follow-up|3
2219242|NCT01720524|3863079|FG000|Part B|Death|0
2219243|NCT01720524|3863080|FG001|Part B|Death|2
2219244|NCT01720602|3863088|FG000|Overall Study|Adverse Event|3
2219245|NCT01720602|3863088|FG000|Overall Study|Progressive disease on therapy|2
2219246|NCT01720667|3863094|FG000|Overall Study|Adverse Event|1
2219247|NCT01720667|3863095|FG001|Overall Study|Adverse Event|1
2219248|NCT01720667|3863094|FG000|Overall Study|Withdrawal by Subject|3
2219249|NCT01720667|3863095|FG001|Overall Study|Withdrawal by Subject|0
2219250|NCT01720797|3863105|FG000|Overall Study|Withdrawal by Subject|3
2219251|NCT01720797|3863106|FG001|Overall Study|Withdrawal by Subject|0
2116444|NCT00938431|3713401|FG002|Overall Study|Adverse Event|6
2116445|NCT00938431|3713399|FG000|Overall Study|Lack of Efficacy|0
2116446|NCT00938431|3713400|FG001|Overall Study|Lack of Efficacy|1
2116447|NCT00938431|3713401|FG002|Overall Study|Lack of Efficacy|0
2116448|NCT00938431|3713399|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1
2116449|NCT00938431|3713400|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0
2116450|NCT00938431|3713401|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0
2116451|NCT00938431|3713399|FG000|Overall Study|Dosing compliance issue|0
2116452|NCT00938431|3713400|FG001|Overall Study|Dosing compliance issue|0
2116453|NCT00938431|3713401|FG002|Overall Study|Dosing compliance issue|1
2116454|NCT00938431|3713399|FG000|Overall Study|Reached maximum dose early|0
2116455|NCT00938431|3713400|FG001|Overall Study|Reached maximum dose early|0
2116456|NCT00938431|3713401|FG002|Overall Study|Reached maximum dose early|1
2116457|NCT00938470|3713419|FG000|Overall Study|Disease Progression|3
2116458|NCT00938470|3713420|FG001|Overall Study|Disease Progression|0
2116459|NCT00938470|3713419|FG000|Overall Study|Alternate Treatment|1
2116460|NCT00938470|3713420|FG001|Overall Study|Alternate Treatment|0
2116461|NCT00938470|3713419|FG000|Overall Study|Death|3
2116462|NCT00938470|3713420|FG001|Overall Study|Death|2
2116463|NCT00938470|3713419|FG000|Overall Study|Other Reason|0
2116464|NCT00938470|3713420|FG001|Overall Study|Other Reason|1
2116465|NCT00938639|3713437|FG000|Overall Study|Moved away from study area|0
2116466|NCT00938639|3713438|FG001|Overall Study|Moved away from study area|1
2116467|NCT00938639|3713437|FG000|Overall Study|Lost to Follow-up|1
2116468|NCT00938639|3713438|FG001|Overall Study|Lost to Follow-up|2
2116469|NCT00938639|3713437|FG000|Overall Study|Family issues|1
2116470|NCT00938639|3713438|FG001|Overall Study|Family issues|1
2116471|NCT00938639|3713437|FG000|Overall Study|Participant noncompliance|1
2116472|NCT00938639|3713438|FG001|Overall Study|Participant noncompliance|0
2219252|NCT01721044|3863115|FG000|Treatment Period|Adverse Event|7
2219253|NCT01721044|3863116|FG001|Treatment Period|Adverse Event|7
2219254|NCT01721044|3863117|FG002|Treatment Period|Adverse Event|10
2219255|NCT01721044|3863115|FG000|Treatment Period|Death|0
2219256|NCT01721044|3863116|FG001|Treatment Period|Death|0
2219257|NCT01721044|3863117|FG002|Treatment Period|Death|1
2219258|NCT01721044|3863115|FG000|Treatment Period|Lack of Efficacy|16
2116473|NCT00938717|3713459|FG000|Overall Study|Adverse Event|10
2116474|NCT00938717|3713460|FG001|Overall Study|Adverse Event|41
2116475|NCT00938717|3713459|FG000|Overall Study|Protocol Violation|11
2116476|NCT00938717|3713460|FG001|Overall Study|Protocol Violation|8
2116477|NCT00938717|3713459|FG000|Overall Study|Withdrawal by Subject|26
2116478|NCT00938717|3713460|FG001|Overall Study|Withdrawal by Subject|24
2116479|NCT00938717|3713459|FG000|Overall Study|Lost to Follow-up|13
2116480|NCT00938717|3713460|FG001|Overall Study|Lost to Follow-up|18
2116481|NCT00938717|3713459|FG000|Overall Study|Lack of Efficacy|33
2116482|NCT00938717|3713460|FG001|Overall Study|Lack of Efficacy|15
2116483|NCT00938717|3713459|FG000|Overall Study|Other reason|5
2116484|NCT00938717|3713460|FG001|Overall Study|Other reason|2
2116485|NCT00938860|3713477|FG000|Overall Study|Adverse Event|2
2116486|NCT00938860|3713478|FG001|Overall Study|Adverse Event|1
2116487|NCT00938860|3713477|FG000|Overall Study|Abnormal laboratory values|2
2116488|NCT00938860|3713478|FG001|Overall Study|Abnormal laboratory values|2
2116489|NCT00938860|3713477|FG000|Overall Study|Withdrawal by Subject|11
2116490|NCT00938860|3713478|FG001|Overall Study|Withdrawal by Subject|8
2116491|NCT00938860|3713477|FG000|Overall Study|Lost to Follow-up|4
2116492|NCT00938860|3713478|FG001|Overall Study|Lost to Follow-up|4
2116493|NCT00938860|3713477|FG000|Overall Study|Administration problems|2
2116494|NCT00938860|3713478|FG001|Overall Study|Administration problems|0
2116495|NCT00938860|3713477|FG000|Overall Study|Death|1
2116496|NCT00938860|3713478|FG001|Overall Study|Death|1
2116497|NCT00938860|3713477|FG000|Overall Study|Protocol Violation|3
2116498|NCT00938860|3713478|FG001|Overall Study|Protocol Violation|1
2116499|NCT00938886|3713486|FG000|Overall Study|Death|0
2116500|NCT00938886|3713487|FG001|Overall Study|Death|1
2116501|NCT00938886|3713486|FG000|Overall Study|Withdrawal by Subject|4
2116502|NCT00938886|3713487|FG001|Overall Study|Withdrawal by Subject|7
2116503|NCT00938886|3713486|FG000|Overall Study|Lost to Follow-up|3
2116504|NCT00938886|3713487|FG001|Overall Study|Lost to Follow-up|2
2116505|NCT00938964|3713495|FG000|Overall Study|Death|3
2116506|NCT00938964|3713496|FG001|Overall Study|Death|3
2116507|NCT00938964|3713495|FG000|Overall Study|Lost to Follow-up|2
2116508|NCT00938964|3713496|FG001|Overall Study|Lost to Follow-up|3
2116509|NCT00938964|3713495|FG000|Overall Study|Withdrawal by Subject|22
2116510|NCT00938964|3713496|FG001|Overall Study|Withdrawal by Subject|18
2116511|NCT00938964|3713495|FG000|Overall Study|Found to Meet Exclusion Criteria|3
2116512|NCT00938964|3713496|FG001|Overall Study|Found to Meet Exclusion Criteria|4
2116513|NCT00939003|3713504|FG000|Double-blind Treatment Period|Adverse Event|1
2116514|NCT00939003|3713505|FG001|Double-blind Treatment Period|Adverse Event|1
2116515|NCT00939003|3713504|FG000|Double-blind Treatment Period|Lack of Efficacy|0
2116516|NCT00939003|3713505|FG001|Double-blind Treatment Period|Lack of Efficacy|1
2116517|NCT00939003|3713504|FG000|Double-blind Treatment Period|Pregnancy|0
2116518|NCT00939003|3713505|FG001|Double-blind Treatment Period|Pregnancy|1
2116519|NCT00939003|3713504|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1
2116520|NCT00939003|3713505|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1
2116521|NCT00939003|3713504|FG000|Open-label Treatment Period|Adverse Event|4
2116522|NCT00939003|3713505|FG001|Open-label Treatment Period|Adverse Event|8
2116523|NCT00939003|3713504|FG000|Open-label Treatment Period|Withdrawal by Subject|14
2116524|NCT00939003|3713505|FG001|Open-label Treatment Period|Withdrawal by Subject|7
2116525|NCT00939003|3713504|FG000|Open-label Treatment Period|Lack of Efficacy|6
2116526|NCT00939003|3713505|FG001|Open-label Treatment Period|Lack of Efficacy|9
2116527|NCT00939003|3713504|FG000|Open-label Treatment Period|Pregnancy|1
2116528|NCT00939003|3713505|FG001|Open-label Treatment Period|Pregnancy|1
2116529|NCT00939003|3713504|FG000|Open-label Treatment Period|Exclusion Criteria|1
2116530|NCT00939003|3713505|FG001|Open-label Treatment Period|Exclusion Criteria|0
2116531|NCT00939003|3713504|FG000|Open-label Treatment Period|Site Closure|3
2116532|NCT00939003|3713505|FG001|Open-label Treatment Period|Site Closure|4
2116533|NCT00939029|3713516|FG000|Overall Study|Withdrawal by Subject|3
2116534|NCT00939029|3713517|FG001|Overall Study|Withdrawal by Subject|7
2116535|NCT00939029|3713516|FG000|Overall Study|Lost to Follow-up|3
2116536|NCT00939029|3713517|FG001|Overall Study|Lost to Follow-up|4
2116537|NCT00939029|3713516|FG000|Overall Study|Adverse Event|0
2116538|NCT00939029|3713517|FG001|Overall Study|Adverse Event|1
2116539|NCT00939055|3713525|FG000|Overall Study|Discontinuation prior to procedure|4
2116540|NCT00939055|3713526|FG001|Overall Study|Discontinuation prior to procedure|0
2116541|NCT00939094|3713535|FG000|Overall Study|Adverse Event|9
2116542|NCT00939094|3713536|FG001|Overall Study|Adverse Event|0
2116543|NCT00939094|3713535|FG000|Overall Study|Withdrawal by Subject|1
2116544|NCT00939094|3713536|FG001|Overall Study|Withdrawal by Subject|6
2116545|NCT00939094|3713535|FG000|Overall Study|Lost to Follow-up|1
2116546|NCT00939094|3713536|FG001|Overall Study|Lost to Follow-up|1
2116547|NCT00939094|3713535|FG000|Overall Study|Eligibility criteria not fulfilled|2
2116548|NCT00939094|3713536|FG001|Overall Study|Eligibility criteria not fulfilled|0
2116549|NCT00939094|3713535|FG000|Overall Study|Severe non-compliance to protocol|0
2116550|NCT00939094|3713536|FG001|Overall Study|Severe non-compliance to protocol|1
2116551|NCT00939094|3713535|FG000|Overall Study|Study stopped by sponsor|0
2116552|NCT00939094|3713536|FG001|Overall Study|Study stopped by sponsor|2
2116553|NCT00939094|3713535|FG000|Overall Study|Abnormal ECG findings|1
2116554|NCT00939094|3713536|FG001|Overall Study|Abnormal ECG findings|0
2116555|NCT00939107|3713544|FG000|Overall Study|Lost to Follow-up|14
2116556|NCT00939107|3713545|FG001|Overall Study|Lost to Follow-up|12
2116557|NCT00939185|3713564|FG000|Overall Study|Adverse Event|3
2116558|NCT00939185|3713564|FG000|Overall Study|Lack of Efficacy|1
2116559|NCT00939185|3713564|FG000|Overall Study|Lost to Follow-up|6
2116560|NCT00939185|3713564|FG000|Overall Study|Other|3
2116561|NCT00939185|3713564|FG000|Overall Study|Withdrawal by Subject|2
2116562|NCT00939185|3713564|FG000|Overall Study|Randomized But Did Not Receive Treatment|10
2116563|NCT00939341|3713585|FG000|Overall Study|Adverse Event|15
2116564|NCT00939341|3713585|FG000|Overall Study|Pregnancy|1
2219259|NCT01721044|3863116|FG001|Treatment Period|Lack of Efficacy|4
2219260|NCT01721044|3863117|FG002|Treatment Period|Lack of Efficacy|4
2219261|NCT01721044|3863115|FG000|Treatment Period|Lost to Follow-up|0
2219262|NCT01721044|3863116|FG001|Treatment Period|Lost to Follow-up|0
2219263|NCT01721044|3863117|FG002|Treatment Period|Lost to Follow-up|1
2219264|NCT01721044|3863115|FG000|Treatment Period|Physician Decision|1
2219265|NCT01721044|3863116|FG001|Treatment Period|Physician Decision|0
2116565|NCT00939341|3713585|FG000|Overall Study|Lost to Follow-up|23
2116566|NCT00939341|3713585|FG000|Overall Study|Withdrawal by Subject|13
2116567|NCT00939341|3713585|FG000|Overall Study|Protocol Violation|6
2116568|NCT00939341|3713585|FG000|Overall Study|Incorrect enrolment|8
2116569|NCT00939393|3713598|FG000|Overall Study|Withdrawal by Subject|1
2116570|NCT00939393|3713599|FG001|Overall Study|Withdrawal by Subject|0
2116571|NCT00939393|3713598|FG000|Overall Study|Lost to Follow-up|3
2116572|NCT00939393|3713599|FG001|Overall Study|Lost to Follow-up|0
2116573|NCT00939484|3713614|FG000|Overall Study|Progression/Relapse|8
2116574|NCT00939484|3713615|FG001|Overall Study|Progression/Relapse|20
2116575|NCT00939484|3713616|FG002|Overall Study|Progression/Relapse|3
2116576|NCT00939510|3713626|FG000|Overall Study|Withdrawal by Subject|1
2116577|NCT00939523|3713630|FG000|Overall Study|Lack of Efficacy|1
2116578|NCT00939523|3713630|FG000|Overall Study|Physician Decision|2
2116579|NCT00939627|3713652|FG000|Overall Study|Disease Progression|16
2116580|NCT00939627|3713653|FG001|Overall Study|Disease Progression|12
2116581|NCT00939627|3713654|FG002|Overall Study|Disease Progression|0
2116582|NCT00939627|3713652|FG000|Overall Study|Adverse Event|6
2116583|NCT00939627|3713653|FG001|Overall Study|Adverse Event|7
2116584|NCT00939627|3713654|FG002|Overall Study|Adverse Event|0
2116585|NCT00939627|3713652|FG000|Overall Study|Death|0
2116586|NCT00939627|3713653|FG001|Overall Study|Death|2
2116587|NCT00939627|3713654|FG002|Overall Study|Death|0
2116588|NCT00939627|3713652|FG000|Overall Study|Withdrawal by Subject|2
2116589|NCT00939627|3713653|FG001|Overall Study|Withdrawal by Subject|4
2116590|NCT00939627|3713654|FG002|Overall Study|Withdrawal by Subject|0
2116591|NCT00939627|3713652|FG000|Overall Study|Other complicating disease|1
2116592|NCT00939627|3713653|FG001|Overall Study|Other complicating disease|1
2116593|NCT00939627|3713654|FG002|Overall Study|Other complicating disease|0
2116594|NCT00939627|3713652|FG000|Overall Study|Not compliant|2
2116595|NCT00939627|3713653|FG001|Overall Study|Not compliant|0
2116596|NCT00939627|3713654|FG002|Overall Study|Not compliant|0
2116597|NCT00939627|3713652|FG000|Overall Study|No off-tx reason given|0
2116598|NCT00939627|3713653|FG001|Overall Study|No off-tx reason given|2
2116599|NCT00939627|3713654|FG002|Overall Study|No off-tx reason given|0
2116600|NCT00939640|3713660|FG000|Overall Study|Physician Decision|1
2116601|NCT00939692|3713676|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
2116602|NCT00939692|3713677|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
2116603|NCT00939692|3713676|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
2116604|NCT00939692|3713677|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
2116605|NCT00939770|3713707|FG000|Overall Study|Adverse Event|1
2116606|NCT00939770|3713708|FG001|Overall Study|Adverse Event|1
2116607|NCT00939770|3713709|FG002|Overall Study|Adverse Event|0
2116608|NCT00939770|3713710|FG003|Overall Study|Adverse Event|0
2116609|NCT00939770|3713711|FG004|Overall Study|Adverse Event|6
2116610|NCT00939770|3713712|FG005|Overall Study|Adverse Event|2
2116611|NCT00939770|3713713|FG006|Overall Study|Adverse Event|1
2116612|NCT00939770|3713714|FG007|Overall Study|Adverse Event|1
2116613|NCT00939770|3713707|FG000|Overall Study|Lack of Efficacy|4
2116614|NCT00939770|3713708|FG001|Overall Study|Lack of Efficacy|6
2116615|NCT00939770|3713709|FG002|Overall Study|Lack of Efficacy|13
2116616|NCT00939770|3713710|FG003|Overall Study|Lack of Efficacy|9
2116617|NCT00939770|3713711|FG004|Overall Study|Lack of Efficacy|16
2116618|NCT00939770|3713712|FG005|Overall Study|Lack of Efficacy|8
2116619|NCT00939770|3713713|FG006|Overall Study|Lack of Efficacy|11
2116620|NCT00939770|3713714|FG007|Overall Study|Lack of Efficacy|1
2116621|NCT00939770|3713707|FG000|Overall Study|Lost to Follow-up|0
2116622|NCT00939770|3713708|FG001|Overall Study|Lost to Follow-up|0
2116623|NCT00939770|3713709|FG002|Overall Study|Lost to Follow-up|0
2116624|NCT00939770|3713710|FG003|Overall Study|Lost to Follow-up|0
2116625|NCT00939770|3713711|FG004|Overall Study|Lost to Follow-up|1
2116626|NCT00939770|3713712|FG005|Overall Study|Lost to Follow-up|0
2116627|NCT00939770|3713713|FG006|Overall Study|Lost to Follow-up|0
2116628|NCT00939770|3713714|FG007|Overall Study|Lost to Follow-up|0
2116629|NCT00939770|3713707|FG000|Overall Study|Physician Decision|0
2116630|NCT00939770|3713708|FG001|Overall Study|Physician Decision|0
2219266|NCT01721044|3863117|FG002|Treatment Period|Physician Decision|2
2116631|NCT00939770|3713709|FG002|Overall Study|Physician Decision|2
2116632|NCT00939770|3713710|FG003|Overall Study|Physician Decision|0
2116633|NCT00939770|3713711|FG004|Overall Study|Physician Decision|7
2116634|NCT00939770|3713712|FG005|Overall Study|Physician Decision|1
2116635|NCT00939770|3713713|FG006|Overall Study|Physician Decision|0
2116636|NCT00939770|3713714|FG007|Overall Study|Physician Decision|6
2116637|NCT00939770|3713707|FG000|Overall Study|Protocol Violation|0
2116638|NCT00939770|3713708|FG001|Overall Study|Protocol Violation|0
2116639|NCT00939770|3713709|FG002|Overall Study|Protocol Violation|0
2116640|NCT00939770|3713710|FG003|Overall Study|Protocol Violation|0
2116641|NCT00939770|3713711|FG004|Overall Study|Protocol Violation|1
2116642|NCT00939770|3713712|FG005|Overall Study|Protocol Violation|0
2116643|NCT00939770|3713713|FG006|Overall Study|Protocol Violation|0
2116644|NCT00939770|3713714|FG007|Overall Study|Protocol Violation|0
2116645|NCT00939770|3713707|FG000|Overall Study|Withdrawal by Subject|0
2116646|NCT00939770|3713708|FG001|Overall Study|Withdrawal by Subject|1
2116647|NCT00939770|3713709|FG002|Overall Study|Withdrawal by Subject|5
2116648|NCT00939770|3713710|FG003|Overall Study|Withdrawal by Subject|2
2116649|NCT00939770|3713711|FG004|Overall Study|Withdrawal by Subject|6
2116650|NCT00939770|3713712|FG005|Overall Study|Withdrawal by Subject|0
2116651|NCT00939770|3713713|FG006|Overall Study|Withdrawal by Subject|2
2116652|NCT00939770|3713714|FG007|Overall Study|Withdrawal by Subject|2
2116653|NCT00939783|3713745|FG000|Overall Study|Death|6
2116654|NCT00939783|3713745|FG000|Overall Study|Adverse Event|39
2116655|NCT00939783|3713745|FG000|Overall Study|Study Terminated by Sponsor|498
2116656|NCT00939783|3713745|FG000|Overall Study|Withdrawal by Subject|78
2116657|NCT00939783|3713745|FG000|Overall Study|Other|16
2116658|NCT00939783|3713745|FG000|Overall Study|Lost to Follow-up|8
2116659|NCT00939783|3713745|FG000|Overall Study|Protocol Violation|3
2116660|NCT00939783|3713745|FG000|Overall Study|Enrolled but not treated|1
2116661|NCT00939809|3713753|FG000|Overall Study|Adverse Event|2
2116662|NCT00939809|3713753|FG000|Overall Study|Death|1
2116663|NCT00939822|3713759|FG000|Overall Study|Lost to Follow-up|1
2116664|NCT00939822|3713760|FG001|Overall Study|Lost to Follow-up|0
2116665|NCT00939822|3713759|FG000|Overall Study|withdrew from study due to busy schedule|1
2116666|NCT00939822|3713760|FG001|Overall Study|withdrew from study due to busy schedule|1
2116667|NCT00939822|3713759|FG000|Overall Study|Mental health issues|0
2116668|NCT00939822|3713760|FG001|Overall Study|Mental health issues|2
2116669|NCT00940017|3713792|FG000|Overall Study|did not meet entrance criteria|3
2116670|NCT00940017|3713792|FG000|Overall Study|Adverse Event|1
2116671|NCT00940108|3713800|FG000|Overall Study|Adverse Event|2
2116672|NCT00940108|3713801|FG001|Overall Study|Adverse Event|4
2116673|NCT00940108|3713802|FG002|Overall Study|Adverse Event|0
2116674|NCT00940108|3713803|FG003|Overall Study|Adverse Event|2
2116675|NCT00940108|3713800|FG000|Overall Study|Withdrew Consent|2
2116676|NCT00940108|3713801|FG001|Overall Study|Withdrew Consent|1
2116677|NCT00940108|3713802|FG002|Overall Study|Withdrew Consent|0
2116678|NCT00940108|3713803|FG003|Overall Study|Withdrew Consent|1
2116679|NCT00940108|3713800|FG000|Overall Study|Dose 2 contraindicated|1
2116680|NCT00940108|3713801|FG001|Overall Study|Dose 2 contraindicated|1
2116681|NCT00940108|3713802|FG002|Overall Study|Dose 2 contraindicated|0
2116682|NCT00940108|3713803|FG003|Overall Study|Dose 2 contraindicated|1
2116683|NCT00940108|3713800|FG000|Overall Study|Declined further vaccination|0
2116684|NCT00940108|3713801|FG001|Overall Study|Declined further vaccination|1
2116685|NCT00940108|3713802|FG002|Overall Study|Declined further vaccination|3
2116686|NCT00940108|3713803|FG003|Overall Study|Declined further vaccination|0
2116687|NCT00940108|3713800|FG000|Overall Study|Refused - pyrexia after Dose 1|0
2116688|NCT00940108|3713801|FG001|Overall Study|Refused - pyrexia after Dose 1|1
2116689|NCT00940108|3713802|FG002|Overall Study|Refused - pyrexia after Dose 1|0
2116690|NCT00940108|3713803|FG003|Overall Study|Refused - pyrexia after Dose 1|0
2116691|NCT00940108|3713800|FG000|Overall Study|Viral illness after Dose 1|0
2116692|NCT00940108|3713801|FG001|Overall Study|Viral illness after Dose 1|1
2116693|NCT00940108|3713802|FG002|Overall Study|Viral illness after Dose 1|0
2116694|NCT00940108|3713803|FG003|Overall Study|Viral illness after Dose 1|0
2116695|NCT00940108|3713800|FG000|Overall Study|Diagnosed with H1N1|0
2116696|NCT00940108|3713801|FG001|Overall Study|Diagnosed with H1N1|0
2116697|NCT00940108|3713802|FG002|Overall Study|Diagnosed with H1N1|0
2116698|NCT00940108|3713803|FG003|Overall Study|Diagnosed with H1N1|1
2116699|NCT00940316|3713833|FG000|Reached First Response at 8 Weeks|Adverse Event|2
2116700|NCT00940316|3713834|FG001|Reached First Response at 8 Weeks|Adverse Event|1
2116701|NCT00940316|3713835|FG002|Reached First Response at 8 Weeks|Adverse Event|0
2116702|NCT00940316|3713833|FG000|Reached First Response at 8 Weeks|Progressive disease|1
2116703|NCT00940316|3713834|FG001|Reached First Response at 8 Weeks|Progressive disease|3
2116704|NCT00940316|3713835|FG002|Reached First Response at 8 Weeks|Progressive disease|0
2116705|NCT00940316|3713833|FG000|Moved on to be Treated Cycle 5|Adverse Event|2
2116706|NCT00940316|3713834|FG001|Moved on to be Treated Cycle 5|Adverse Event|0
2116707|NCT00940316|3713835|FG002|Moved on to be Treated Cycle 5|Adverse Event|0
2116708|NCT00940316|3713833|FG000|Treated After Cycle 5|Adverse Event|0
2116709|NCT00940316|3713834|FG001|Treated After Cycle 5|Adverse Event|0
2116710|NCT00940316|3713835|FG002|Treated After Cycle 5|Adverse Event|1
2116711|NCT00940316|3713833|FG000|Treated After Cycle 5|Progressive disease|0
2180768|NCT01405911|3807296|FG001|Overall Study|Protocol Violation|0
2180769|NCT01405911|3807297|FG002|Overall Study|Protocol Violation|0
2180770|NCT01405911|3807295|FG000|Overall Study|Withdrawal by Subject|3
2116712|NCT00940316|3713834|FG001|Treated After Cycle 5|Progressive disease|1
2116713|NCT00940316|3713835|FG002|Treated After Cycle 5|Progressive disease|0
2116714|NCT00940342|3713854|FG000|Overall Study|Adverse Event|0
2116715|NCT00940342|3713855|FG001|Overall Study|Adverse Event|2
2116716|NCT00940342|3713856|FG002|Overall Study|Adverse Event|1
2116717|NCT00940485|3713877|FG000|Overall Study|HBeAb positive at Baseline|3
2116718|NCT00940485|3713878|FG001|Overall Study|HBeAb positive at Baseline|2
2116719|NCT00940485|3713877|FG000|Overall Study|Lost to Follow-up|2
2116720|NCT00940485|3713878|FG001|Overall Study|Lost to Follow-up|3
2116721|NCT00940485|3713877|FG000|Overall Study|Adverse Event|8
2116722|NCT00940485|3713878|FG001|Overall Study|Adverse Event|0
2116723|NCT00940485|3713877|FG000|Overall Study|Withdrawal by Subject|1
2116724|NCT00940485|3713878|FG001|Overall Study|Withdrawal by Subject|1
2116725|NCT00940485|3713877|FG000|Overall Study|Others|1
2116726|NCT00940485|3713878|FG001|Overall Study|Others|1
2116727|NCT00940602|3713913|FG000|Overall Study|Administrative problems|1
2116728|NCT00940602|3713914|FG001|Overall Study|Administrative problems|1
2116729|NCT00940602|3713913|FG000|Overall Study|Patient/guardian decision|13
2116730|NCT00940602|3713914|FG001|Overall Study|Patient/guardian decision|28
2116731|NCT00940602|3713913|FG000|Overall Study|Physician Decision|8
2116732|NCT00940602|3713914|FG001|Overall Study|Physician Decision|5
2116733|NCT00940602|3713913|FG000|Overall Study|Pregnancy|1
2116734|NCT00940602|3713914|FG001|Overall Study|Pregnancy|0
2116735|NCT00940602|3713913|FG000|Overall Study|Protocol Deviation (untreated)|1
2116736|NCT00940602|3713914|FG001|Overall Study|Protocol Deviation (untreated)|0
2116737|NCT00940602|3713913|FG000|Overall Study|Disease progression|8
2116738|NCT00940602|3713914|FG001|Overall Study|Disease progression|2
2116739|NCT00940602|3713913|FG000|Overall Study|Death|38
2116740|NCT00940602|3713914|FG001|Overall Study|Death|19
2116741|NCT00940602|3713913|FG000|Overall Study|Lost to Follow-up|3
2116742|NCT00940602|3713914|FG001|Overall Study|Lost to Follow-up|1
2116743|NCT00940602|3713913|FG000|Overall Study|Patient withdrew consent|26
2116744|NCT00940602|3713914|FG001|Overall Study|Patient withdrew consent|13
2116745|NCT00940602|3713913|FG000|Overall Study|Adverse Event|7
2116746|NCT00940602|3713914|FG001|Overall Study|Adverse Event|2
2116747|NCT00940602|3713913|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43
2116748|NCT00940602|3713914|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5
2180771|NCT01405911|3807296|FG001|Overall Study|Withdrawal by Subject|1
2180772|NCT01405911|3807297|FG002|Overall Study|Withdrawal by Subject|1
2180773|NCT01405924|3807305|FG000|Overall Study|Protocol Violation|8
2180774|NCT01405924|3807305|FG000|Overall Study|Missing/Incomplete Data|2
2180775|NCT01405950|3807322|FG000|Overall Study|Withdrawal by Subject|1
2180776|NCT01405950|3807323|FG001|Overall Study|Withdrawal by Subject|0
2180777|NCT01405950|3807324|FG002|Overall Study|Withdrawal by Subject|0
2180778|NCT01405950|3807325|FG003|Overall Study|Withdrawal by Subject|0
2180779|NCT01406015|3807335|FG000|Overall Study|Withdrawal by Subject|3
2180780|NCT01406015|3807336|FG001|Overall Study|Withdrawal by Subject|3
2180781|NCT01406574|3807372|FG000|Overall Study|Adverse Event|0
2180782|NCT01406574|3807373|FG001|Overall Study|Adverse Event|0
2180783|NCT01406574|3807374|FG002|Overall Study|Adverse Event|1
2180784|NCT01406574|3807375|FG003|Overall Study|Adverse Event|3
2180785|NCT01406574|3807372|FG000|Overall Study|Physician Decision|0
2180786|NCT01406574|3807373|FG001|Overall Study|Physician Decision|0
2180787|NCT01406574|3807374|FG002|Overall Study|Physician Decision|0
2180788|NCT01406574|3807375|FG003|Overall Study|Physician Decision|1
2180789|NCT01406574|3807372|FG000|Overall Study|Withdrawal by Subject|0
2180790|NCT01406574|3807373|FG001|Overall Study|Withdrawal by Subject|1
2180791|NCT01406574|3807374|FG002|Overall Study|Withdrawal by Subject|0
2180792|NCT01406574|3807375|FG003|Overall Study|Withdrawal by Subject|0
2180793|NCT01406574|3807372|FG000|Overall Study|Definite progression of primary disease|1
2180794|NCT01406574|3807373|FG001|Overall Study|Definite progression of primary disease|0
2180795|NCT01406574|3807374|FG002|Overall Study|Definite progression of primary disease|0
2180796|NCT01406574|3807375|FG003|Overall Study|Definite progression of primary disease|0
2180797|NCT01406652|3807388|FG000|Overall Study|Lost-to-follow-up|3
2180798|NCT01406652|3807389|FG001|Overall Study|Lost-to-follow-up|4
2180799|NCT01406652|3807388|FG000|Overall Study|Withdrawal by Subject|2
2180800|NCT01406652|3807389|FG001|Overall Study|Withdrawal by Subject|2
2180801|NCT01406652|3807388|FG000|Overall Study|Insufficient follow-up|5
2180802|NCT01406652|3807389|FG001|Overall Study|Insufficient follow-up|4
2180803|NCT01406652|3807388|FG000|Overall Study|Infection not sure|10
2180804|NCT01406652|3807389|FG001|Overall Study|Infection not sure|10
2180805|NCT01406717|3807399|FG000|Overall Study|Subject non-compliance|4
2180806|NCT01406717|3807400|FG001|Overall Study|Subject non-compliance|3
2180807|NCT01406717|3807399|FG000|Overall Study|Protocol Violation|5
2180808|NCT01406717|3807400|FG001|Overall Study|Protocol Violation|1
2180809|NCT01406717|3807399|FG000|Overall Study|Lost to Follow-up|14
2180810|NCT01406717|3807400|FG001|Overall Study|Lost to Follow-up|8
2180811|NCT01406717|3807399|FG000|Overall Study|Withdrawal by Subject|19
2180812|NCT01406717|3807400|FG001|Overall Study|Withdrawal by Subject|15
2180813|NCT01406717|3807399|FG000|Overall Study|Adverse Event|1
2180814|NCT01406717|3807400|FG001|Overall Study|Adverse Event|2
2180815|NCT01406717|3807399|FG000|Overall Study|Lack of Efficacy|0
2116749|NCT00940823|3713927|FG000|Overall Study|Death|8
2116750|NCT00940823|3713928|FG001|Overall Study|Death|12
2116751|NCT00940823|3713927|FG000|Overall Study|Lost to Follow-up|27
2116752|NCT00940823|3713928|FG001|Overall Study|Lost to Follow-up|20
2116753|NCT00940875|3713938|FG000|Treatment Phase|Adverse Event|9
2116754|NCT00940875|3713939|FG001|Treatment Phase|Adverse Event|3
2116755|NCT00940875|3713938|FG000|Treatment Phase|Death|3
2116756|NCT00940875|3713939|FG001|Treatment Phase|Death|5
2116757|NCT00940875|3713938|FG000|Treatment Phase|Lack of Efficacy|1
2116758|NCT00940875|3713939|FG001|Treatment Phase|Lack of Efficacy|0
2116759|NCT00940875|3713938|FG000|Treatment Phase|Withdrawal by Subject|3
2116760|NCT00940875|3713939|FG001|Treatment Phase|Withdrawal by Subject|0
2116761|NCT00940875|3713938|FG000|Treatment Phase|Disease progression|9
2116762|NCT00940875|3713939|FG001|Treatment Phase|Disease progression|11
2116763|NCT00940875|3713938|FG000|Treatment Phase|Physician Decision|1
2116764|NCT00940875|3713939|FG001|Treatment Phase|Physician Decision|0
2116765|NCT00940875|3713938|FG000|Post-Study Treatment|Death|0
2116766|NCT00940875|3713939|FG001|Post-Study Treatment|Death|1
2116767|NCT00940875|3713938|FG000|Post-Study Treatment|Disease Progression|0
2116768|NCT00940875|3713939|FG001|Post-Study Treatment|Disease Progression|2
2116769|NCT00940888|3713946|FG000|Overall Study|Unsuccessful Implant|4
2116770|NCT00940888|3713946|FG000|Overall Study|Death|461
2116771|NCT00940888|3713946|FG000|Overall Study|Withdrawn - Non-Death|364
2116772|NCT00940888|3713946|FG000|Overall Study|Lost to Follow-up|6
2116773|NCT00940992|3713968|FG000|Overall Study|Adverse Event|2
2116774|NCT00940992|3713969|FG001|Overall Study|Adverse Event|0
2116775|NCT00940992|3713970|FG002|Overall Study|Adverse Event|1
2116776|NCT00940992|3713968|FG000|Overall Study|subject request|2
2116777|NCT00940992|3713969|FG001|Overall Study|subject request|1
2116778|NCT00940992|3713970|FG002|Overall Study|subject request|0
2116779|NCT00940992|3713968|FG000|Overall Study|Lost to Follow-up|0
2116780|NCT00940992|3713969|FG001|Overall Study|Lost to Follow-up|1
2116781|NCT00940992|3713970|FG002|Overall Study|Lost to Follow-up|1
2116782|NCT00941031|3713993|FG000|Induction Period|Lack of Efficacy|2
2116783|NCT00941031|3713994|FG001|Induction Period|Lack of Efficacy|1
2116784|NCT00941031|3713995|FG002|Induction Period|Lack of Efficacy|0
2116785|NCT00941031|3713996|FG003|Induction Period|Lack of Efficacy|5
2116786|NCT00941031|3713997|FG004|Induction Period|Lack of Efficacy|0
2116787|NCT00941031|3713998|FG005|Induction Period|Lack of Efficacy|0
2116788|NCT00941031|3713999|FG006|Induction Period|Lack of Efficacy|0
2116789|NCT00941031|3713993|FG000|Induction Period|Withdrawal by Subject|1
2116790|NCT00941031|3713994|FG001|Induction Period|Withdrawal by Subject|2
2116791|NCT00941031|3713995|FG002|Induction Period|Withdrawal by Subject|2
2116792|NCT00941031|3713996|FG003|Induction Period|Withdrawal by Subject|2
2116793|NCT00941031|3713997|FG004|Induction Period|Withdrawal by Subject|0
2180816|NCT01406717|3807400|FG001|Overall Study|Lack of Efficacy|1
2180817|NCT01406717|3807399|FG000|Overall Study|Non-completion of visit activity|0
2180818|NCT01406717|3807400|FG001|Overall Study|Non-completion of visit activity|1
2180819|NCT01406795|3807416|FG000|Overall Study|Withdrawal by Subject|1
2180820|NCT01406873|3807422|FG000|Overall Study|Withdrawal by Subject|1
2180821|NCT01406873|3807423|FG001|Overall Study|Withdrawal by Subject|1
2180822|NCT01406938|3807441|FG000|Induction Period|Subject/guardian decision|6
2180823|NCT01406938|3807442|FG001|Induction Period|Subject/guardian decision|8
2180824|NCT01406938|3807443|FG002|Induction Period|Subject/guardian decision|0
2180825|NCT01406938|3807444|FG003|Induction Period|Subject/guardian decision|0
2180826|NCT01406938|3807445|FG004|Induction Period|Subject/guardian decision|0
2180827|NCT01406938|3807446|FG005|Induction Period|Subject/guardian decision|0
2180828|NCT01406938|3807441|FG000|Induction Period|Protocol deviation|1
2180829|NCT01406938|3807442|FG001|Induction Period|Protocol deviation|0
2180830|NCT01406938|3807443|FG002|Induction Period|Protocol deviation|0
2180831|NCT01406938|3807444|FG003|Induction Period|Protocol deviation|0
2180832|NCT01406938|3807445|FG004|Induction Period|Protocol deviation|0
2180833|NCT01406938|3807446|FG005|Induction Period|Protocol deviation|0
2180834|NCT01406938|3807441|FG000|Induction Period|Adverse Event|8
2180835|NCT01406938|3807442|FG001|Induction Period|Adverse Event|9
2180836|NCT01406938|3807443|FG002|Induction Period|Adverse Event|0
2180837|NCT01406938|3807444|FG003|Induction Period|Adverse Event|0
2180838|NCT01406938|3807445|FG004|Induction Period|Adverse Event|0
2180839|NCT01406938|3807446|FG005|Induction Period|Adverse Event|0
2180840|NCT01406938|3807441|FG000|Induction Period|Lack of Efficacy|1
2180841|NCT01406938|3807442|FG001|Induction Period|Lack of Efficacy|0
2180842|NCT01406938|3807443|FG002|Induction Period|Lack of Efficacy|0
2180843|NCT01406938|3807444|FG003|Induction Period|Lack of Efficacy|0
2180844|NCT01406938|3807445|FG004|Induction Period|Lack of Efficacy|0
2180845|NCT01406938|3807446|FG005|Induction Period|Lack of Efficacy|0
2180846|NCT01406938|3807441|FG000|Induction Period|Lost to Follow-up|2
2180847|NCT01406938|3807442|FG001|Induction Period|Lost to Follow-up|3
2180848|NCT01406938|3807443|FG002|Induction Period|Lost to Follow-up|0
2180849|NCT01406938|3807444|FG003|Induction Period|Lost to Follow-up|0
2180850|NCT01406938|3807445|FG004|Induction Period|Lost to Follow-up|0
2180851|NCT01406938|3807446|FG005|Induction Period|Lost to Follow-up|0
2180852|NCT01406938|3807441|FG000|Maintenance Period|Adverse Event|0
2116794|NCT00941031|3713998|FG005|Induction Period|Withdrawal by Subject|0
2116795|NCT00941031|3713999|FG006|Induction Period|Withdrawal by Subject|0
2116796|NCT00941031|3713993|FG000|Induction Period|Adminstative Problems|1
2116797|NCT00941031|3713994|FG001|Induction Period|Adminstative Problems|1
2116798|NCT00941031|3713995|FG002|Induction Period|Adminstative Problems|1
2116799|NCT00941031|3713996|FG003|Induction Period|Adminstative Problems|0
2116800|NCT00941031|3713997|FG004|Induction Period|Adminstative Problems|0
2116801|NCT00941031|3713998|FG005|Induction Period|Adminstative Problems|0
2116802|NCT00941031|3713999|FG006|Induction Period|Adminstative Problems|0
2116803|NCT00941031|3713993|FG000|Induction Period|Adverse Event|1
2116804|NCT00941031|3713994|FG001|Induction Period|Adverse Event|0
2116805|NCT00941031|3713995|FG002|Induction Period|Adverse Event|3
2116806|NCT00941031|3713996|FG003|Induction Period|Adverse Event|2
2116807|NCT00941031|3713997|FG004|Induction Period|Adverse Event|0
2116808|NCT00941031|3713998|FG005|Induction Period|Adverse Event|0
2116809|NCT00941031|3713999|FG006|Induction Period|Adverse Event|0
2116810|NCT00941031|3713993|FG000|Maintenance Period|Withdrawal by Subject|0
2116811|NCT00941031|3713994|FG001|Maintenance Period|Withdrawal by Subject|0
2116812|NCT00941031|3713995|FG002|Maintenance Period|Withdrawal by Subject|0
2116813|NCT00941031|3713996|FG003|Maintenance Period|Withdrawal by Subject|0
2116814|NCT00941031|3713997|FG004|Maintenance Period|Withdrawal by Subject|6
2116815|NCT00941031|3713998|FG005|Maintenance Period|Withdrawal by Subject|2
2116816|NCT00941031|3713999|FG006|Maintenance Period|Withdrawal by Subject|13
2116817|NCT00941031|3713993|FG000|Maintenance Period|Administrative Problems|0
2116818|NCT00941031|3713994|FG001|Maintenance Period|Administrative Problems|0
2116819|NCT00941031|3713995|FG002|Maintenance Period|Administrative Problems|0
2116820|NCT00941031|3713996|FG003|Maintenance Period|Administrative Problems|0
2116821|NCT00941031|3713997|FG004|Maintenance Period|Administrative Problems|1
2116822|NCT00941031|3713998|FG005|Maintenance Period|Administrative Problems|0
2116823|NCT00941031|3713999|FG006|Maintenance Period|Administrative Problems|1
2116824|NCT00941031|3713993|FG000|Maintenance Period|Protocol Violation|0
2116825|NCT00941031|3713994|FG001|Maintenance Period|Protocol Violation|0
2116826|NCT00941031|3713995|FG002|Maintenance Period|Protocol Violation|0
2116827|NCT00941031|3713996|FG003|Maintenance Period|Protocol Violation|0
2116828|NCT00941031|3713997|FG004|Maintenance Period|Protocol Violation|0
2116829|NCT00941031|3713998|FG005|Maintenance Period|Protocol Violation|0
2116830|NCT00941031|3713999|FG006|Maintenance Period|Protocol Violation|1
2116831|NCT00941031|3713993|FG000|Maintenance Period|Adverse Event|0
2116832|NCT00941031|3713994|FG001|Maintenance Period|Adverse Event|0
2116833|NCT00941031|3713995|FG002|Maintenance Period|Adverse Event|0
2116834|NCT00941031|3713996|FG003|Maintenance Period|Adverse Event|0
2116835|NCT00941031|3713997|FG004|Maintenance Period|Adverse Event|0
2116836|NCT00941031|3713998|FG005|Maintenance Period|Adverse Event|2
2116837|NCT00941031|3713999|FG006|Maintenance Period|Adverse Event|8
2116838|NCT00941031|3713993|FG000|Maintenance Period|Lost to Follow-up|0
2116839|NCT00941031|3713994|FG001|Maintenance Period|Lost to Follow-up|0
2116840|NCT00941031|3713995|FG002|Maintenance Period|Lost to Follow-up|0
2116841|NCT00941031|3713996|FG003|Maintenance Period|Lost to Follow-up|0
2116842|NCT00941031|3713997|FG004|Maintenance Period|Lost to Follow-up|2
2116843|NCT00941031|3713998|FG005|Maintenance Period|Lost to Follow-up|2
2116844|NCT00941031|3713999|FG006|Maintenance Period|Lost to Follow-up|7
2116845|NCT00941031|3713993|FG000|Maintenance Period|Lack of Efficacy|0
2116846|NCT00941031|3713994|FG001|Maintenance Period|Lack of Efficacy|0
2116847|NCT00941031|3713995|FG002|Maintenance Period|Lack of Efficacy|0
2116848|NCT00941031|3713996|FG003|Maintenance Period|Lack of Efficacy|0
2116849|NCT00941031|3713997|FG004|Maintenance Period|Lack of Efficacy|0
2116850|NCT00941031|3713998|FG005|Maintenance Period|Lack of Efficacy|0
2116851|NCT00941031|3713999|FG006|Maintenance Period|Lack of Efficacy|13
2116852|NCT00941070|3714018|FG000|Overall Study|Patient non-compliant|1
2116853|NCT00941304|3714029|FG000|Overall Study|Lost to Follow-up|1
2116854|NCT00941304|3714030|FG001|Overall Study|Lost to Follow-up|0
2116855|NCT00941304|3714031|FG002|Overall Study|Lost to Follow-up|0
2116856|NCT00941304|3714032|FG003|Overall Study|Lost to Follow-up|0
2116857|NCT00941304|3714033|FG004|Overall Study|Lost to Follow-up|0
2116858|NCT00941330|3714047|FG000|Overall Study|Other|1
2116859|NCT00941330|3714048|FG001|Overall Study|Other|0
2116860|NCT00941330|3714047|FG000|Overall Study|Physician Decision|0
2116861|NCT00941330|3714048|FG001|Overall Study|Physician Decision|2
2116862|NCT00941603|3714060|FG000|Overall Study|Adverse Event|10
2116863|NCT00941603|3714061|FG001|Overall Study|Adverse Event|15
2116864|NCT00941603|3714062|FG002|Overall Study|Adverse Event|5
2116865|NCT00941603|3714063|FG003|Overall Study|Adverse Event|1
2116866|NCT00941603|3714064|FG004|Overall Study|Adverse Event|4
2116867|NCT00941603|3714065|FG005|Overall Study|Adverse Event|0
2116868|NCT00941603|3714060|FG000|Overall Study|Lost to Follow-up|0
2116869|NCT00941603|3714061|FG001|Overall Study|Lost to Follow-up|0
2116870|NCT00941603|3714062|FG002|Overall Study|Lost to Follow-up|0
2116871|NCT00941603|3714063|FG003|Overall Study|Lost to Follow-up|1
2116872|NCT00941603|3714064|FG004|Overall Study|Lost to Follow-up|0
2116873|NCT00941603|3714065|FG005|Overall Study|Lost to Follow-up|2
2116874|NCT00941603|3714060|FG000|Overall Study|Withdrawal by Subject|0
2116875|NCT00941603|3714061|FG001|Overall Study|Withdrawal by Subject|0
2116876|NCT00941603|3714062|FG002|Overall Study|Withdrawal by Subject|0
2116877|NCT00941603|3714063|FG003|Overall Study|Withdrawal by Subject|2
2180853|NCT01406938|3807442|FG001|Maintenance Period|Adverse Event|0
2116878|NCT00941603|3714064|FG004|Overall Study|Withdrawal by Subject|0
2116879|NCT00941603|3714065|FG005|Overall Study|Withdrawal by Subject|1
2116880|NCT00941603|3714060|FG000|Overall Study|Protocol Violation|0
2116881|NCT00941603|3714061|FG001|Overall Study|Protocol Violation|1
2116882|NCT00941603|3714062|FG002|Overall Study|Protocol Violation|0
2116883|NCT00941603|3714063|FG003|Overall Study|Protocol Violation|0
2116884|NCT00941603|3714064|FG004|Overall Study|Protocol Violation|0
2116885|NCT00941603|3714065|FG005|Overall Study|Protocol Violation|0
2116886|NCT00941603|3714060|FG000|Overall Study|Did not meet protocol eligibility|1
2116887|NCT00941603|3714061|FG001|Overall Study|Did not meet protocol eligibility|0
2116888|NCT00941603|3714062|FG002|Overall Study|Did not meet protocol eligibility|0
2116889|NCT00941603|3714063|FG003|Overall Study|Did not meet protocol eligibility|0
2116890|NCT00941603|3714064|FG004|Overall Study|Did not meet protocol eligibility|0
2116891|NCT00941603|3714065|FG005|Overall Study|Did not meet protocol eligibility|0
2116892|NCT00941655|3714081|FG000|Overall Study|received some chemo, 4 and 9 cycles|1
2116893|NCT00941655|3714082|FG001|Overall Study|received some chemo, 4 and 9 cycles|0
2116894|NCT00941655|3714081|FG000|Overall Study|not meet criteria for chemo foll surgery|4
2116895|NCT00941655|3714082|FG001|Overall Study|not meet criteria for chemo foll surgery|0
2116896|NCT00941655|3714081|FG000|Overall Study|progressed while on chemo|0
2116897|NCT00941655|3714082|FG001|Overall Study|progressed while on chemo|2
2116898|NCT00941655|3714081|FG000|Overall Study|refused further treatment|0
2116899|NCT00941655|3714082|FG001|Overall Study|refused further treatment|1
2116900|NCT00941655|3714081|FG000|Overall Study|withdrew consent|0
2116901|NCT00941655|3714082|FG001|Overall Study|withdrew consent|1
2116902|NCT00941655|3714081|FG000|Overall Study|non-compliant|0
2116903|NCT00941655|3714082|FG001|Overall Study|non-compliant|1
2116904|NCT00941720|3714111|FG000|Overall Study|Withdrawal by Subject|1
2116905|NCT00941720|3714111|FG000|Overall Study|Insurance denied participation|11
2116906|NCT00941720|3714111|FG000|Overall Study|ineligible|2
2116907|NCT00941733|3714117|FG000|Overall Study|Death|24
2116908|NCT00941733|3714118|FG001|Overall Study|Death|10
2116909|NCT00941733|3714117|FG000|Overall Study|Withdrawal by Subject|14
2116910|NCT00941733|3714118|FG001|Overall Study|Withdrawal by Subject|6
2116911|NCT00941733|3714117|FG000|Overall Study|Adverse Event|20
2116912|NCT00941733|3714118|FG001|Overall Study|Adverse Event|4
2116913|NCT00941733|3714117|FG000|Overall Study|Lost to Follow-up|1
2116914|NCT00941733|3714118|FG001|Overall Study|Lost to Follow-up|2
2116915|NCT00941733|3714117|FG000|Overall Study|Protocol Violation|15
2116916|NCT00941733|3714118|FG001|Overall Study|Protocol Violation|6
2116917|NCT00941798|3714126|FG000|Overall Study|Withdrawal by Subject|72
2116918|NCT00941798|3714127|FG001|Overall Study|Withdrawal by Subject|74
2116919|NCT00941798|3714126|FG000|Overall Study|Adverse Event|43
2116920|NCT00941798|3714127|FG001|Overall Study|Adverse Event|23
2116921|NCT00941798|3714126|FG000|Overall Study|Lost to Follow-up|29
2116922|NCT00941798|3714127|FG001|Overall Study|Lost to Follow-up|23
2116923|NCT00941798|3714126|FG000|Overall Study|Protocol Violation|17
2116924|NCT00941798|3714127|FG001|Overall Study|Protocol Violation|20
2116925|NCT00941798|3714126|FG000|Overall Study|Administrative problems|13
2116926|NCT00941798|3714127|FG001|Overall Study|Administrative problems|23
2116927|NCT00941798|3714126|FG000|Overall Study|Lack of Efficacy|10
2116928|NCT00941798|3714127|FG001|Overall Study|Lack of Efficacy|17
2116929|NCT00941798|3714126|FG000|Overall Study|Patient's inability to use device|6
2116930|NCT00941798|3714127|FG001|Overall Study|Patient's inability to use device|1
2116931|NCT00941798|3714126|FG000|Overall Study|Abnormal test procedure results|3
2116932|NCT00941798|3714127|FG001|Overall Study|Abnormal test procedure results|1
2116933|NCT00941798|3714126|FG000|Overall Study|Abnormal laboratory values|1
2116934|NCT00941798|3714127|FG001|Overall Study|Abnormal laboratory values|2
2116935|NCT00941798|3714126|FG000|Overall Study|Death|0
2116936|NCT00941798|3714127|FG001|Overall Study|Death|1
2116937|NCT00941863|3714138|FG000|Until Primary Completion Date (PCD)|Adverse Event|1
2116938|NCT00941863|3714139|FG001|Until Primary Completion Date (PCD)|Adverse Event|2
2116939|NCT00941863|3714140|FG002|Until Primary Completion Date (PCD)|Adverse Event|2
2116940|NCT00941863|3714141|FG003|Until Primary Completion Date (PCD)|Adverse Event|1
2116941|NCT00941863|3714142|FG004|Until Primary Completion Date (PCD)|Adverse Event|5
2116942|NCT00941863|3714138|FG000|Until Primary Completion Date (PCD)|Physician Decision|0
2116943|NCT00941863|3714139|FG001|Until Primary Completion Date (PCD)|Physician Decision|0
2116944|NCT00941863|3714140|FG002|Until Primary Completion Date (PCD)|Physician Decision|0
2116945|NCT00941863|3714141|FG003|Until Primary Completion Date (PCD)|Physician Decision|0
2116946|NCT00941863|3714142|FG004|Until Primary Completion Date (PCD)|Physician Decision|1
2116947|NCT00941863|3714138|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
2116948|NCT00941863|3714139|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
2116949|NCT00941863|3714140|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
2116950|NCT00941863|3714141|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
2116951|NCT00941863|3714142|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
2116952|NCT00941863|3714138|FG000|Until Primary Completion Date (PCD)|Death|0
2116953|NCT00941863|3714139|FG001|Until Primary Completion Date (PCD)|Death|0
2116954|NCT00941863|3714140|FG002|Until Primary Completion Date (PCD)|Death|1
2116955|NCT00941863|3714141|FG003|Until Primary Completion Date (PCD)|Death|2
2116956|NCT00941863|3714142|FG004|Until Primary Completion Date (PCD)|Death|7
2116957|NCT00941863|3714138|FG000|Until Primary Completion Date (PCD)|Disease progression|6
2116958|NCT00941863|3714139|FG001|Until Primary Completion Date (PCD)|Disease progression|1
2116959|NCT00941863|3714140|FG002|Until Primary Completion Date (PCD)|Disease progression|8
2116960|NCT00941863|3714141|FG003|Until Primary Completion Date (PCD)|Disease progression|14
2116961|NCT00941863|3714142|FG004|Until Primary Completion Date (PCD)|Disease progression|73
2116962|NCT00941863|3714138|FG000|Continued After PCD|Withdrawal by Subject|0
2116963|NCT00941863|3714139|FG001|Continued After PCD|Withdrawal by Subject|0
2116964|NCT00941863|3714140|FG002|Continued After PCD|Withdrawal by Subject|0
2116965|NCT00941863|3714141|FG003|Continued After PCD|Withdrawal by Subject|0
2116966|NCT00941863|3714142|FG004|Continued After PCD|Withdrawal by Subject|1
2116967|NCT00941863|3714138|FG000|Continued After PCD|Disease progression, recurrence, relapse|0
2116968|NCT00941863|3714139|FG001|Continued After PCD|Disease progression, recurrence, relapse|0
2116969|NCT00941863|3714140|FG002|Continued After PCD|Disease progression, recurrence, relapse|0
2116970|NCT00941863|3714141|FG003|Continued After PCD|Disease progression, recurrence, relapse|0
2116971|NCT00941863|3714142|FG004|Continued After PCD|Disease progression, recurrence, relapse|18
2116972|NCT00942084|3714172|FG000|Overall Study|Death|2
2116973|NCT00942162|3714183|FG000|Overall Study|Death|45
2116974|NCT00942162|3714184|FG001|Overall Study|Death|35
2116975|NCT00942162|3714185|FG002|Overall Study|Death|0
2116976|NCT00942162|3714183|FG000|Overall Study|Withdrawal by Subject|7
2219267|NCT01721044|3863115|FG000|Treatment Period|Protocol Violation|1
2219268|NCT01721044|3863116|FG001|Treatment Period|Protocol Violation|0
2219269|NCT01721044|3863117|FG002|Treatment Period|Protocol Violation|0
2116977|NCT00942162|3714184|FG001|Overall Study|Withdrawal by Subject|2
2116978|NCT00942162|3714185|FG002|Overall Study|Withdrawal by Subject|0
2116979|NCT00942162|3714183|FG000|Overall Study|Lost to Follow-up|4
2116980|NCT00942162|3714184|FG001|Overall Study|Lost to Follow-up|0
2116981|NCT00942162|3714185|FG002|Overall Study|Lost to Follow-up|0
2116982|NCT00942162|3714183|FG000|Overall Study|Other|14
2116983|NCT00942162|3714184|FG001|Overall Study|Other|13
2116984|NCT00942162|3714185|FG002|Overall Study|Other|2
2116985|NCT00942175|3714199|FG000|Overall Study|Adverse Event|2
2116986|NCT00942175|3714200|FG001|Overall Study|Adverse Event|1
2116987|NCT00942175|3714201|FG002|Overall Study|Adverse Event|0
2116988|NCT00942175|3714202|FG003|Overall Study|Adverse Event|0
2116989|NCT00942175|3714199|FG000|Overall Study|Protocol Violation|0
2116990|NCT00942175|3714200|FG001|Overall Study|Protocol Violation|1
2116991|NCT00942175|3714201|FG002|Overall Study|Protocol Violation|2
2116992|NCT00942175|3714202|FG003|Overall Study|Protocol Violation|0
2116993|NCT00942175|3714199|FG000|Overall Study|Pregnancy|0
2116994|NCT00942175|3714200|FG001|Overall Study|Pregnancy|0
2116995|NCT00942175|3714201|FG002|Overall Study|Pregnancy|0
2116996|NCT00942175|3714202|FG003|Overall Study|Pregnancy|1
2116997|NCT00942175|3714199|FG000|Overall Study|Elevated Alanine Amino Transferase|0
2116998|NCT00942175|3714200|FG001|Overall Study|Elevated Alanine Amino Transferase|0
2116999|NCT00942175|3714201|FG002|Overall Study|Elevated Alanine Amino Transferase|0
2117000|NCT00942175|3714202|FG003|Overall Study|Elevated Alanine Amino Transferase|1
2117001|NCT00942175|3714199|FG000|Overall Study|Low Platelet Count|0
2117002|NCT00942175|3714200|FG001|Overall Study|Low Platelet Count|2
2117003|NCT00942175|3714201|FG002|Overall Study|Low Platelet Count|0
2117004|NCT00942175|3714202|FG003|Overall Study|Low Platelet Count|0
2117005|NCT00942188|3714224|FG000|Overall Study|Adverse Event|0
2117006|NCT00942188|3714225|FG001|Overall Study|Adverse Event|3
2117007|NCT00942188|3714226|FG002|Overall Study|Adverse Event|2
2117008|NCT00942188|3714227|FG003|Overall Study|Adverse Event|0
2117009|NCT00942188|3714224|FG000|Overall Study|Lack of Efficacy|0
2117010|NCT00942188|3714225|FG001|Overall Study|Lack of Efficacy|0
2117011|NCT00942188|3714226|FG002|Overall Study|Lack of Efficacy|0
2117012|NCT00942188|3714227|FG003|Overall Study|Lack of Efficacy|1
2117013|NCT00942188|3714224|FG000|Overall Study|Protocol Violation|1
2117014|NCT00942188|3714225|FG001|Overall Study|Protocol Violation|1
2117015|NCT00942188|3714226|FG002|Overall Study|Protocol Violation|0
2117016|NCT00942188|3714227|FG003|Overall Study|Protocol Violation|0
2117017|NCT00942188|3714224|FG000|Overall Study|Lost to Follow-up|2
2117018|NCT00942188|3714225|FG001|Overall Study|Lost to Follow-up|1
2117019|NCT00942188|3714226|FG002|Overall Study|Lost to Follow-up|2
2117020|NCT00942188|3714227|FG003|Overall Study|Lost to Follow-up|0
2117021|NCT00942188|3714224|FG000|Overall Study|Withdrawal by Subject|1
2117022|NCT00942188|3714225|FG001|Overall Study|Withdrawal by Subject|3
2117023|NCT00942188|3714226|FG002|Overall Study|Withdrawal by Subject|4
2117024|NCT00942188|3714227|FG003|Overall Study|Withdrawal by Subject|2
2117025|NCT00942188|3714224|FG000|Overall Study|Physician Decision|0
2117026|NCT00942188|3714225|FG001|Overall Study|Physician Decision|0
2117027|NCT00942188|3714226|FG002|Overall Study|Physician Decision|1
2117028|NCT00942188|3714227|FG003|Overall Study|Physician Decision|0
2117029|NCT00942188|3714224|FG000|Overall Study|Sponsor Decision|0
2117030|NCT00942188|3714225|FG001|Overall Study|Sponsor Decision|2
2117031|NCT00942188|3714226|FG002|Overall Study|Sponsor Decision|0
2117032|NCT00942188|3714227|FG003|Overall Study|Sponsor Decision|1
2117033|NCT00942266|3714239|FG000|Overall Study|Withdrawal by Subject|1
2117034|NCT00942266|3714240|FG001|Overall Study|Withdrawal by Subject|0
2117035|NCT00942266|3714239|FG000|Overall Study|Adverse Event|2
2117036|NCT00942266|3714240|FG001|Overall Study|Adverse Event|1
2117037|NCT00942266|3714239|FG000|Overall Study|Disease Progression|38
2219270|NCT01721044|3863115|FG000|Treatment Period|Withdrawal by Subject|7
2117038|NCT00942266|3714240|FG001|Overall Study|Disease Progression|11
2117039|NCT00942266|3714239|FG000|Overall Study|Failure to thrive and pt withdrawal|0
2117040|NCT00942266|3714240|FG001|Overall Study|Failure to thrive and pt withdrawal|1
2117041|NCT00942266|3714239|FG000|Overall Study|Intercurrent illness|0
2117042|NCT00942266|3714240|FG001|Overall Study|Intercurrent illness|1
2117043|NCT00942266|3714239|FG000|Overall Study|Physician Decision|2
2117044|NCT00942266|3714240|FG001|Overall Study|Physician Decision|0
2117045|NCT00942266|3714239|FG000|Overall Study|medical deterioration (pneumonia)|0
2117046|NCT00942266|3714240|FG001|Overall Study|medical deterioration (pneumonia)|1
2117047|NCT00942357|3714289|FG000|Overall Study|Ineligible|37
2117048|NCT00942357|3714290|FG001|Overall Study|Ineligible|40
2117049|NCT00942422|3714296|FG000|Overall Study|Withdrawal by Subject|1
2117050|NCT00942422|3714296|FG000|Overall Study|Death|1
2117051|NCT00942422|3714296|FG000|Overall Study|Progressive diease|1
2117052|NCT00942604|3714341|FG000|Overall Study|Protocol Violation|1
2117053|NCT00942604|3714342|FG001|Overall Study|Protocol Violation|1
2117054|NCT00942604|3714341|FG000|Overall Study|Adverse Event|0
2117055|NCT00942604|3714342|FG001|Overall Study|Adverse Event|1
2117056|NCT00942604|3714341|FG000|Overall Study|Withdrawal by Subject|0
2117057|NCT00942604|3714342|FG001|Overall Study|Withdrawal by Subject|1
2117058|NCT00942604|3714341|FG000|Overall Study|Patient relocation|1
2117059|NCT00942604|3714342|FG001|Overall Study|Patient relocation|1
2117060|NCT00942708|3714348|FG000|Overall Study|Withdrawal by Subject|1
2117061|NCT00942734|3714353|FG000|Overall Study|Adverse Event|2
2117062|NCT00942734|3714353|FG000|Overall Study|Protocol Violation|3
2117063|NCT00942734|3714353|FG000|Overall Study|Disease Progression|2
2117064|NCT00942734|3714353|FG000|Overall Study|Physician Decision|1
2117065|NCT00942877|3714388|FG000|Overall Study|Refused further treatment|1
2117066|NCT00942877|3714389|FG001|Overall Study|Refused further treatment|1
2117067|NCT00942877|3714388|FG000|Overall Study|Patient was not treated|1
2117068|NCT00942877|3714389|FG001|Overall Study|Patient was not treated|0
2117069|NCT00942877|3714388|FG000|Overall Study|Adverse Event|1
2117070|NCT00942877|3714389|FG001|Overall Study|Adverse Event|0
2117071|NCT00942877|3714388|FG000|Overall Study|Progressive disease|42
2117072|NCT00942877|3714389|FG001|Overall Study|Progressive disease|3
2117073|NCT00942968|3714410|FG000|Overall Study|Adverse Event|60
2117074|NCT00942968|3714410|FG000|Overall Study|Death|76
2117075|NCT00942968|3714410|FG000|Overall Study|Protocol Violation|9
2117076|NCT00942968|3714410|FG000|Overall Study|Lost to Follow-up|4
2117077|NCT00942968|3714410|FG000|Overall Study|Withdrawal by Subject|44
2117078|NCT00942968|3714410|FG000|Overall Study|Sponsor request|5
2117079|NCT00942968|3714410|FG000|Overall Study|Physician Decision|11
2117080|NCT00942968|3714410|FG000|Overall Study|Progression of disease|12
2117081|NCT00942968|3714410|FG000|Overall Study|Inferior vena cava filter placement|4
2117082|NCT00942968|3714410|FG000|Overall Study|Pulmonary embolism (PE)|1
2117083|NCT00942968|3714410|FG000|Overall Study|Participant required pancreatic biopsy|1
2117084|NCT00942968|3714410|FG000|Overall Study|Deep vein thrombosis (DVT)|2
2117085|NCT00942994|3714416|FG000|Overall Study|Adverse Event|7
2117086|NCT00942994|3714417|FG001|Overall Study|Adverse Event|4
2117087|NCT00942994|3714416|FG000|Overall Study|Abnormal laboratory value(s)|1
2117088|NCT00942994|3714417|FG001|Overall Study|Abnormal laboratory value(s)|0
2117089|NCT00942994|3714416|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2117090|NCT00942994|3714417|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2117091|NCT00942994|3714416|FG000|Overall Study|Patient withdrew consent|5
2117092|NCT00942994|3714417|FG001|Overall Study|Patient withdrew consent|8
2117093|NCT00942994|3714416|FG000|Overall Study|Lost to Follow-up|1
2117094|NCT00942994|3714417|FG001|Overall Study|Lost to Follow-up|4
2117095|NCT00942994|3714416|FG000|Overall Study|Protocol deviation|1
2117096|NCT00942994|3714417|FG001|Overall Study|Protocol deviation|2
2117097|NCT00943072|3714425|FG000|Overall Study|Adverse Event|0
2117098|NCT00943072|3714426|FG001|Overall Study|Adverse Event|3
2117099|NCT00943072|3714425|FG000|Overall Study|Death|0
2117100|NCT00943072|3714426|FG001|Overall Study|Death|2
2117101|NCT00943072|3714425|FG000|Overall Study|Withdrawal by Subject|3
2117102|NCT00943072|3714426|FG001|Overall Study|Withdrawal by Subject|1
2117103|NCT00943072|3714425|FG000|Overall Study|Protocol Violation|0
2117104|NCT00943072|3714426|FG001|Overall Study|Protocol Violation|1
2117105|NCT00943072|3714425|FG000|Overall Study|Lost to Follow-up|1
2117106|NCT00943072|3714426|FG001|Overall Study|Lost to Follow-up|2
2117107|NCT00943072|3714425|FG000|Overall Study|Lack of Efficacy|0
2117108|NCT00943072|3714426|FG001|Overall Study|Lack of Efficacy|4
2117109|NCT00943072|3714425|FG000|Overall Study|Other|1
2117110|NCT00943072|3714426|FG001|Overall Study|Other|1
2117111|NCT00943111|3714445|FG000|52-Weeks Primary Analysis Period|Adverse Event|2
2117112|NCT00943111|3714446|FG001|52-Weeks Primary Analysis Period|Adverse Event|1
2117113|NCT00943111|3714447|FG002|52-Weeks Primary Analysis Period|Adverse Event|0
2117114|NCT00943111|3714445|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
2117115|NCT00943111|3714446|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
2117116|NCT00943111|3714447|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
2117117|NCT00943111|3714445|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
2117118|NCT00943111|3714446|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
2117119|NCT00943111|3714447|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
2117120|NCT00943111|3714445|FG000|5 Years Long-term Treatment Period|Adverse Event|0
2117121|NCT00943111|3714446|FG001|5 Years Long-term Treatment Period|Adverse Event|0
2117122|NCT00943111|3714447|FG002|5 Years Long-term Treatment Period|Adverse Event|9
2117123|NCT00943111|3714445|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0
2117124|NCT00943111|3714446|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0
2117125|NCT00943111|3714447|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8
2117126|NCT00943111|3714445|FG000|5 Years Long-term Treatment Period|Pregnancy|0
2117127|NCT00943111|3714446|FG001|5 Years Long-term Treatment Period|Pregnancy|0
2117128|NCT00943111|3714447|FG002|5 Years Long-term Treatment Period|Pregnancy|4
2117129|NCT00943111|3714445|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0
2117130|NCT00943111|3714446|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0
2117131|NCT00943111|3714447|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1
2117132|NCT00943111|3714445|FG000|5 Years Long-term Treatment Period|Other than specified above|0
2117133|NCT00943111|3714446|FG001|5 Years Long-term Treatment Period|Other than specified above|0
2117134|NCT00943111|3714447|FG002|5 Years Long-term Treatment Period|Other than specified above|2
2117135|NCT00943124|3714454|FG000|Period 1|Withdrawal by Subject|1
2117136|NCT00943124|3714455|FG001|Period 1|Withdrawal by Subject|1
2117137|NCT00943124|3714454|FG000|Period 1|Did Not Follow Study Procedures|1
2117138|NCT00943124|3714455|FG001|Period 1|Did Not Follow Study Procedures|0
2117139|NCT00943124|3714454|FG000|Period 1|Personal Reasons|0
2117140|NCT00943124|3714455|FG001|Period 1|Personal Reasons|1
2117141|NCT00943306|3714492|FG000|Overall Study|Physician Decision|1
2117142|NCT00943306|3714492|FG000|Overall Study|Death|1
2117143|NCT00943306|3714492|FG000|Overall Study|Sponsor decision due to non-compliance|1
2117144|NCT00943319|3714496|FG000|Overall Study|Death|1
2117145|NCT00943384|3714500|FG000|Overall Study|Dispositioned prior to treatment|23
2117146|NCT00943384|3714500|FG000|Overall Study|Treated off protocol-protocol violation|5
2117147|NCT00943384|3714500|FG000|Overall Study|Lost to Follow-up|16
2117148|NCT00943384|3714500|FG000|Overall Study|Withdrawal by Subject|5
2117149|NCT00943579|3714524|FG000|Overall Study|Adverse Event|4
2117150|NCT00943579|3714525|FG001|Overall Study|Adverse Event|3
2117151|NCT00943579|3714524|FG000|Overall Study|Lack of Efficacy|2
2117152|NCT00943579|3714525|FG001|Overall Study|Lack of Efficacy|2
2117153|NCT00943592|3714534|FG000|Overall Study|Death|3
2117154|NCT00943670|3714547|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2
2117155|NCT00943670|3714547|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
2117156|NCT00943670|3714547|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15
2117157|NCT00943670|3714547|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2
2117158|NCT00943670|3714547|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20
2117159|NCT00943670|3714547|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
2117160|NCT00943670|3714547|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
2117161|NCT00943670|3714547|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
2117162|NCT00943670|3714547|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
2117163|NCT00943670|3714547|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
2117164|NCT00943722|3714567|FG000|Overall Study|Adverse Event|0
2117165|NCT00943722|3714568|FG001|Overall Study|Adverse Event|0
2117166|NCT00943722|3714569|FG002|Overall Study|Adverse Event|0
2117167|NCT00943722|3714570|FG003|Overall Study|Adverse Event|1
2117168|NCT00943722|3714571|FG004|Overall Study|Adverse Event|0
2117169|NCT00943722|3714567|FG000|Overall Study|Lost to Follow-up|12
2117170|NCT00943722|3714568|FG001|Overall Study|Lost to Follow-up|8
2117171|NCT00943722|3714569|FG002|Overall Study|Lost to Follow-up|10
2117172|NCT00943722|3714570|FG003|Overall Study|Lost to Follow-up|8
2117173|NCT00943722|3714571|FG004|Overall Study|Lost to Follow-up|11
2117174|NCT00943722|3714567|FG000|Overall Study|Physician Decision|1
2117175|NCT00943722|3714568|FG001|Overall Study|Physician Decision|0
2117176|NCT00943722|3714569|FG002|Overall Study|Physician Decision|0
2117177|NCT00943722|3714570|FG003|Overall Study|Physician Decision|0
2117178|NCT00943722|3714571|FG004|Overall Study|Physician Decision|1
2117179|NCT00943722|3714567|FG000|Overall Study|Pregnancy|0
2117180|NCT00943722|3714568|FG001|Overall Study|Pregnancy|0
2117181|NCT00943722|3714569|FG002|Overall Study|Pregnancy|1
2117182|NCT00943722|3714570|FG003|Overall Study|Pregnancy|0
2117183|NCT00943722|3714571|FG004|Overall Study|Pregnancy|0
2117184|NCT00943722|3714567|FG000|Overall Study|Protocol Violation|0
2117185|NCT00943722|3714568|FG001|Overall Study|Protocol Violation|1
2117186|NCT00943722|3714569|FG002|Overall Study|Protocol Violation|0
2117187|NCT00943722|3714570|FG003|Overall Study|Protocol Violation|0
2117188|NCT00943722|3714571|FG004|Overall Study|Protocol Violation|2
2117189|NCT00943722|3714567|FG000|Overall Study|Withdrawal by Subject|12
2117190|NCT00943722|3714568|FG001|Overall Study|Withdrawal by Subject|13
2117191|NCT00943722|3714569|FG002|Overall Study|Withdrawal by Subject|2
2117192|NCT00943722|3714570|FG003|Overall Study|Withdrawal by Subject|13
2117193|NCT00943722|3714571|FG004|Overall Study|Withdrawal by Subject|8
2117194|NCT00943735|3714585|FG000|Overall Study|Adverse Event|12
2117195|NCT00943735|3714585|FG000|Overall Study|Withdrawal by Subject|8
2117196|NCT00943735|3714585|FG000|Overall Study|Death|1
2117197|NCT00943735|3714585|FG000|Overall Study|Other|8
2117198|NCT00943735|3714585|FG000|Overall Study|Other|3
2117199|NCT00943761|3714591|FG000|Overall Study|Lost to Follow-up|2
2117200|NCT00943761|3714592|FG001|Overall Study|Lost to Follow-up|0
2117201|NCT00943761|3714591|FG000|Overall Study|Withdrawal by Subject|2
2117202|NCT00943761|3714592|FG001|Overall Study|Withdrawal by Subject|1
2117203|NCT00943787|3714598|FG000|Overall Study|Physician Decision|4
2117204|NCT00943787|3714598|FG000|Overall Study|Withdrawal by Subject|3
2117205|NCT00943826|3714608|FG000|Concurrent Phase|Adverse Event|50
2117206|NCT00943826|3714609|FG001|Concurrent Phase|Adverse Event|27
2117207|NCT00943826|3714608|FG000|Concurrent Phase|Withdrew consent|3
2117208|NCT00943826|3714609|FG001|Concurrent Phase|Withdrew consent|7
2117209|NCT00943826|3714608|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5
2117210|NCT00943826|3714609|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7
2117211|NCT00943826|3714608|FG000|Concurrent Phase|Administrative reasons|2
2219271|NCT01721044|3863116|FG001|Treatment Period|Withdrawal by Subject|6
2219272|NCT01721044|3863117|FG002|Treatment Period|Withdrawal by Subject|1
2117212|NCT00943826|3714609|FG001|Concurrent Phase|Administrative reasons|1
2117213|NCT00943826|3714608|FG000|Concurrent Phase|Protocol Violation|1
2117214|NCT00943826|3714609|FG001|Concurrent Phase|Protocol Violation|0
2117215|NCT00943826|3714608|FG000|Maintenance Phase|Adverse Event|31
2117216|NCT00943826|3714609|FG001|Maintenance Phase|Adverse Event|30
2117217|NCT00943826|3714608|FG000|Maintenance Phase|Withdrew consent|2
2117218|NCT00943826|3714609|FG001|Maintenance Phase|Withdrew consent|4
2117219|NCT00943826|3714608|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6
2117220|NCT00943826|3714609|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3
2117221|NCT00943826|3714608|FG000|Maintenance Phase|Administrative reasons|4
2117222|NCT00943826|3714609|FG001|Maintenance Phase|Administrative reasons|1
2117223|NCT00943826|3714608|FG000|Maintenance Phase|Failure to return|0
2117224|NCT00943826|3714609|FG001|Maintenance Phase|Failure to return|1
2117225|NCT00943826|3714608|FG000|Monotherapy Phase|Adverse Event|42
2117226|NCT00943826|3714609|FG001|Monotherapy Phase|Adverse Event|5
2117227|NCT00943826|3714608|FG000|Monotherapy Phase|Administrative reasons|11
2117228|NCT00943826|3714609|FG001|Monotherapy Phase|Administrative reasons|5
2117229|NCT00943826|3714608|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8
2117230|NCT00943826|3714609|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2
2117231|NCT00943826|3714608|FG000|Monotherapy Phase|Withdrew Consent|2
2117232|NCT00943826|3714609|FG001|Monotherapy Phase|Withdrew Consent|3
2117233|NCT00943826|3714608|FG000|Monotherapy Phase|Failure to return|2
2117234|NCT00943826|3714609|FG001|Monotherapy Phase|Failure to return|1
2117235|NCT00943826|3714608|FG000|After Primary Overall Survival Analysis|Adverse Event|11
2117236|NCT00943826|3714609|FG001|After Primary Overall Survival Analysis|Adverse Event|0
2117237|NCT00943826|3714608|FG000|After Primary Overall Survival Analysis|Administrative reasons|10
2117238|NCT00943826|3714609|FG001|After Primary Overall Survival Analysis|Administrative reasons|16
2117239|NCT00943826|3714608|FG000|After Primary Overall Survival Analysis|Progression of Disease|2
2117240|NCT00943826|3714609|FG001|After Primary Overall Survival Analysis|Progression of Disease|4
2117241|NCT00943826|3714608|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4
2117242|NCT00943826|3714609|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0
2117243|NCT00943917|3714652|FG000|Stage I|Adverse Event|1
2117244|NCT00943917|3714653|FG001|Stage I|Adverse Event|2
2117245|NCT00943917|3714654|FG002|Stage I|Adverse Event|2
2117246|NCT00943917|3714655|FG003|Stage I|Adverse Event|0
2117247|NCT00943917|3714656|FG004|Stage I|Adverse Event|0
2117248|NCT00943917|3714657|FG005|Stage I|Adverse Event|0
2117249|NCT00943917|3714658|FG006|Stage I|Adverse Event|0
2117250|NCT00943917|3714659|FG007|Stage I|Adverse Event|0
2117251|NCT00943917|3714660|FG008|Stage I|Adverse Event|0
2117252|NCT00943917|3714661|FG009|Stage I|Adverse Event|0
2117253|NCT00943917|3714662|FG010|Stage I|Adverse Event|0
2117254|NCT00943917|3714663|FG011|Stage I|Adverse Event|0
2117255|NCT00943917|3714664|FG012|Stage I|Adverse Event|0
2117256|NCT00943917|3714665|FG013|Stage I|Adverse Event|0
2117257|NCT00943917|3714666|FG014|Stage I|Adverse Event|0
2117258|NCT00943917|3714652|FG000|Stage I|Lost to Follow-up|0
2117259|NCT00943917|3714653|FG001|Stage I|Lost to Follow-up|0
2117260|NCT00943917|3714654|FG002|Stage I|Lost to Follow-up|1
2117261|NCT00943917|3714655|FG003|Stage I|Lost to Follow-up|0
2117262|NCT00943917|3714656|FG004|Stage I|Lost to Follow-up|0
2117263|NCT00943917|3714657|FG005|Stage I|Lost to Follow-up|0
2117264|NCT00943917|3714658|FG006|Stage I|Lost to Follow-up|0
2117265|NCT00943917|3714659|FG007|Stage I|Lost to Follow-up|0
2117266|NCT00943917|3714660|FG008|Stage I|Lost to Follow-up|0
2117267|NCT00943917|3714661|FG009|Stage I|Lost to Follow-up|0
2117268|NCT00943917|3714662|FG010|Stage I|Lost to Follow-up|0
2117269|NCT00943917|3714663|FG011|Stage I|Lost to Follow-up|0
2117270|NCT00943917|3714664|FG012|Stage I|Lost to Follow-up|0
2117271|NCT00943917|3714665|FG013|Stage I|Lost to Follow-up|0
2117272|NCT00943917|3714666|FG014|Stage I|Lost to Follow-up|0
2117273|NCT00943917|3714652|FG000|Stage I|hyperglycemia|0
2117274|NCT00943917|3714653|FG001|Stage I|hyperglycemia|0
2117275|NCT00943917|3714654|FG002|Stage I|hyperglycemia|1
2117276|NCT00943917|3714655|FG003|Stage I|hyperglycemia|0
2117277|NCT00943917|3714656|FG004|Stage I|hyperglycemia|0
2117278|NCT00943917|3714657|FG005|Stage I|hyperglycemia|0
2117279|NCT00943917|3714658|FG006|Stage I|hyperglycemia|0
2117280|NCT00943917|3714659|FG007|Stage I|hyperglycemia|0
2117281|NCT00943917|3714660|FG008|Stage I|hyperglycemia|0
2117282|NCT00943917|3714661|FG009|Stage I|hyperglycemia|0
2117283|NCT00943917|3714662|FG010|Stage I|hyperglycemia|0
2117284|NCT00943917|3714663|FG011|Stage I|hyperglycemia|0
2117285|NCT00943917|3714664|FG012|Stage I|hyperglycemia|0
2117286|NCT00943917|3714665|FG013|Stage I|hyperglycemia|0
2117287|NCT00943917|3714666|FG014|Stage I|hyperglycemia|0
2117288|NCT00943917|3714652|FG000|Stage I|A1C elevation|1
2117289|NCT00943917|3714653|FG001|Stage I|A1C elevation|0
2117290|NCT00943917|3714654|FG002|Stage I|A1C elevation|0
2117291|NCT00943917|3714655|FG003|Stage I|A1C elevation|0
2117292|NCT00943917|3714656|FG004|Stage I|A1C elevation|0
2117293|NCT00943917|3714657|FG005|Stage I|A1C elevation|0
2117294|NCT00943917|3714658|FG006|Stage I|A1C elevation|0
2117295|NCT00943917|3714659|FG007|Stage I|A1C elevation|0
2117296|NCT00943917|3714660|FG008|Stage I|A1C elevation|0
2117297|NCT00943917|3714661|FG009|Stage I|A1C elevation|0
2117298|NCT00943917|3714662|FG010|Stage I|A1C elevation|0
2117299|NCT00943917|3714663|FG011|Stage I|A1C elevation|0
2117300|NCT00943917|3714664|FG012|Stage I|A1C elevation|0
2117301|NCT00943917|3714665|FG013|Stage I|A1C elevation|0
2117302|NCT00943917|3714666|FG014|Stage I|A1C elevation|0
2117303|NCT00943917|3714652|FG000|Stage I|Withdrawal by Subject|2
2117304|NCT00943917|3714653|FG001|Stage I|Withdrawal by Subject|1
2219273|NCT01721057|3863139|FG000|Treatment Period|Withdrawal by Subject|11
2219274|NCT01721057|3863140|FG001|Treatment Period|Withdrawal by Subject|5
2219275|NCT01721057|3863141|FG002|Treatment Period|Withdrawal by Subject|8
2219276|NCT01721057|3863142|FG003|Treatment Period|Withdrawal by Subject|0
2219277|NCT01721057|3863143|FG004|Treatment Period|Withdrawal by Subject|0
2219278|NCT01721057|3863144|FG005|Treatment Period|Withdrawal by Subject|0
2219279|NCT01721057|3863145|FG006|Treatment Period|Withdrawal by Subject|0
2219280|NCT01721057|3863139|FG000|Treatment Period|Adverse Event|7
2219281|NCT01721057|3863140|FG001|Treatment Period|Adverse Event|10
2219282|NCT01721057|3863141|FG002|Treatment Period|Adverse Event|12
2219283|NCT01721057|3863142|FG003|Treatment Period|Adverse Event|0
2219284|NCT01721057|3863143|FG004|Treatment Period|Adverse Event|0
2219285|NCT01721057|3863144|FG005|Treatment Period|Adverse Event|0
2219286|NCT01721057|3863145|FG006|Treatment Period|Adverse Event|0
2219287|NCT01721057|3863139|FG000|Treatment Period|Lack of Efficacy|7
2219288|NCT01721057|3863140|FG001|Treatment Period|Lack of Efficacy|3
2117305|NCT00943917|3714654|FG002|Stage I|Withdrawal by Subject|2
2117306|NCT00943917|3714655|FG003|Stage I|Withdrawal by Subject|0
2117307|NCT00943917|3714656|FG004|Stage I|Withdrawal by Subject|0
2117308|NCT00943917|3714657|FG005|Stage I|Withdrawal by Subject|0
2117309|NCT00943917|3714658|FG006|Stage I|Withdrawal by Subject|0
2117310|NCT00943917|3714659|FG007|Stage I|Withdrawal by Subject|0
2117311|NCT00943917|3714660|FG008|Stage I|Withdrawal by Subject|0
2117312|NCT00943917|3714661|FG009|Stage I|Withdrawal by Subject|0
2117313|NCT00943917|3714662|FG010|Stage I|Withdrawal by Subject|0
2117314|NCT00943917|3714663|FG011|Stage I|Withdrawal by Subject|0
2117315|NCT00943917|3714664|FG012|Stage I|Withdrawal by Subject|0
2117316|NCT00943917|3714665|FG013|Stage I|Withdrawal by Subject|0
2117317|NCT00943917|3714666|FG014|Stage I|Withdrawal by Subject|0
2117318|NCT00943917|3714652|FG000|Stage II|Adverse Event|0
2117319|NCT00943917|3714653|FG001|Stage II|Adverse Event|0
2117320|NCT00943917|3714654|FG002|Stage II|Adverse Event|0
2117321|NCT00943917|3714655|FG003|Stage II|Adverse Event|0
2117322|NCT00943917|3714656|FG004|Stage II|Adverse Event|0
2117323|NCT00943917|3714657|FG005|Stage II|Adverse Event|1
2117324|NCT00943917|3714658|FG006|Stage II|Adverse Event|3
2219289|NCT01721057|3863141|FG002|Treatment Period|Lack of Efficacy|0
2219290|NCT01721057|3863142|FG003|Treatment Period|Lack of Efficacy|0
2219291|NCT01721057|3863143|FG004|Treatment Period|Lack of Efficacy|0
2219292|NCT01721057|3863144|FG005|Treatment Period|Lack of Efficacy|0
2117325|NCT00943917|3714659|FG007|Stage II|Adverse Event|0
2117326|NCT00943917|3714660|FG008|Stage II|Adverse Event|1
2117327|NCT00943917|3714661|FG009|Stage II|Adverse Event|0
2117328|NCT00943917|3714662|FG010|Stage II|Adverse Event|0
2117329|NCT00943917|3714663|FG011|Stage II|Adverse Event|0
2117330|NCT00943917|3714664|FG012|Stage II|Adverse Event|0
2117331|NCT00943917|3714665|FG013|Stage II|Adverse Event|0
2117332|NCT00943917|3714666|FG014|Stage II|Adverse Event|0
2117333|NCT00943917|3714652|FG000|Stage II|Withdrawal by Subject|0
2117334|NCT00943917|3714653|FG001|Stage II|Withdrawal by Subject|0
2117335|NCT00943917|3714654|FG002|Stage II|Withdrawal by Subject|0
2117336|NCT00943917|3714655|FG003|Stage II|Withdrawal by Subject|0
2117337|NCT00943917|3714656|FG004|Stage II|Withdrawal by Subject|0
2117338|NCT00943917|3714657|FG005|Stage II|Withdrawal by Subject|1
2117339|NCT00943917|3714658|FG006|Stage II|Withdrawal by Subject|0
2117340|NCT00943917|3714659|FG007|Stage II|Withdrawal by Subject|0
2117341|NCT00943917|3714660|FG008|Stage II|Withdrawal by Subject|0
2117342|NCT00943917|3714661|FG009|Stage II|Withdrawal by Subject|0
2117343|NCT00943917|3714662|FG010|Stage II|Withdrawal by Subject|0
2117344|NCT00943917|3714663|FG011|Stage II|Withdrawal by Subject|0
2117345|NCT00943917|3714664|FG012|Stage II|Withdrawal by Subject|0
2117346|NCT00943917|3714665|FG013|Stage II|Withdrawal by Subject|0
2117347|NCT00943917|3714666|FG014|Stage II|Withdrawal by Subject|0
2219293|NCT01721057|3863145|FG006|Treatment Period|Lack of Efficacy|0
2219294|NCT01721057|3863139|FG000|Treatment Period|Lost to Follow-up|1
2117348|NCT00943917|3714652|FG000|Stage II|Pregnancy|0
2117349|NCT00943917|3714653|FG001|Stage II|Pregnancy|0
2117350|NCT00943917|3714654|FG002|Stage II|Pregnancy|0
2117351|NCT00943917|3714655|FG003|Stage II|Pregnancy|0
2117352|NCT00943917|3714656|FG004|Stage II|Pregnancy|0
2117353|NCT00943917|3714657|FG005|Stage II|Pregnancy|1
2117354|NCT00943917|3714658|FG006|Stage II|Pregnancy|0
2117355|NCT00943917|3714659|FG007|Stage II|Pregnancy|0
2117356|NCT00943917|3714660|FG008|Stage II|Pregnancy|0
2117357|NCT00943917|3714661|FG009|Stage II|Pregnancy|0
2117358|NCT00943917|3714662|FG010|Stage II|Pregnancy|0
2117359|NCT00943917|3714663|FG011|Stage II|Pregnancy|0
2117360|NCT00943917|3714664|FG012|Stage II|Pregnancy|0
2117361|NCT00943917|3714665|FG013|Stage II|Pregnancy|0
2117362|NCT00943917|3714666|FG014|Stage II|Pregnancy|0
2117363|NCT00943917|3714652|FG000|Stage II Continuation|Adverse Event|0
2117364|NCT00943917|3714653|FG001|Stage II Continuation|Adverse Event|0
2117365|NCT00943917|3714654|FG002|Stage II Continuation|Adverse Event|0
2117366|NCT00943917|3714655|FG003|Stage II Continuation|Adverse Event|0
2117367|NCT00943917|3714656|FG004|Stage II Continuation|Adverse Event|0
2117368|NCT00943917|3714657|FG005|Stage II Continuation|Adverse Event|0
2117369|NCT00943917|3714658|FG006|Stage II Continuation|Adverse Event|0
2117370|NCT00943917|3714659|FG007|Stage II Continuation|Adverse Event|0
2117371|NCT00943917|3714660|FG008|Stage II Continuation|Adverse Event|0
2117372|NCT00943917|3714661|FG009|Stage II Continuation|Adverse Event|0
2117373|NCT00943917|3714662|FG010|Stage II Continuation|Adverse Event|0
2117374|NCT00943917|3714663|FG011|Stage II Continuation|Adverse Event|1
2117375|NCT00943917|3714664|FG012|Stage II Continuation|Adverse Event|2
2117376|NCT00943917|3714665|FG013|Stage II Continuation|Adverse Event|1
2117377|NCT00943917|3714666|FG014|Stage II Continuation|Adverse Event|1
2117378|NCT00943917|3714652|FG000|Stage II Continuation|Withdrawal by Subject|0
2117379|NCT00943917|3714653|FG001|Stage II Continuation|Withdrawal by Subject|0
2117380|NCT00943917|3714654|FG002|Stage II Continuation|Withdrawal by Subject|0
2117381|NCT00943917|3714655|FG003|Stage II Continuation|Withdrawal by Subject|0
2117382|NCT00943917|3714656|FG004|Stage II Continuation|Withdrawal by Subject|0
2117383|NCT00943917|3714657|FG005|Stage II Continuation|Withdrawal by Subject|0
2117384|NCT00943917|3714658|FG006|Stage II Continuation|Withdrawal by Subject|0
2117385|NCT00943917|3714659|FG007|Stage II Continuation|Withdrawal by Subject|0
2219295|NCT01721057|3863140|FG001|Treatment Period|Lost to Follow-up|0
2219296|NCT01721057|3863141|FG002|Treatment Period|Lost to Follow-up|0
2219297|NCT01721057|3863142|FG003|Treatment Period|Lost to Follow-up|0
2219298|NCT01721057|3863143|FG004|Treatment Period|Lost to Follow-up|0
2219299|NCT01721057|3863144|FG005|Treatment Period|Lost to Follow-up|0
2219300|NCT01721057|3863145|FG006|Treatment Period|Lost to Follow-up|0
2117386|NCT00943917|3714660|FG008|Stage II Continuation|Withdrawal by Subject|0
2117387|NCT00943917|3714661|FG009|Stage II Continuation|Withdrawal by Subject|0
2117388|NCT00943917|3714662|FG010|Stage II Continuation|Withdrawal by Subject|0
2117389|NCT00943917|3714663|FG011|Stage II Continuation|Withdrawal by Subject|0
2117390|NCT00943917|3714664|FG012|Stage II Continuation|Withdrawal by Subject|0
2117391|NCT00943917|3714665|FG013|Stage II Continuation|Withdrawal by Subject|1
2117392|NCT00943917|3714666|FG014|Stage II Continuation|Withdrawal by Subject|3
2117393|NCT00943917|3714652|FG000|Stage II Continuation|Protocol Violation|0
2117394|NCT00943917|3714653|FG001|Stage II Continuation|Protocol Violation|0
2117395|NCT00943917|3714654|FG002|Stage II Continuation|Protocol Violation|0
2117396|NCT00943917|3714655|FG003|Stage II Continuation|Protocol Violation|0
2117397|NCT00943917|3714656|FG004|Stage II Continuation|Protocol Violation|0
2117398|NCT00943917|3714657|FG005|Stage II Continuation|Protocol Violation|0
2117399|NCT00943917|3714658|FG006|Stage II Continuation|Protocol Violation|0
2117400|NCT00943917|3714659|FG007|Stage II Continuation|Protocol Violation|0
2117401|NCT00943917|3714660|FG008|Stage II Continuation|Protocol Violation|0
2117402|NCT00943917|3714661|FG009|Stage II Continuation|Protocol Violation|1
2117403|NCT00943917|3714662|FG010|Stage II Continuation|Protocol Violation|0
2117404|NCT00943917|3714663|FG011|Stage II Continuation|Protocol Violation|1
2117405|NCT00943917|3714664|FG012|Stage II Continuation|Protocol Violation|0
2117406|NCT00943917|3714665|FG013|Stage II Continuation|Protocol Violation|0
2117407|NCT00943917|3714666|FG014|Stage II Continuation|Protocol Violation|0
2117408|NCT00943917|3714652|FG000|Stage II Continuation|hypoglycemia|0
2117409|NCT00943917|3714653|FG001|Stage II Continuation|hypoglycemia|0
2117410|NCT00943917|3714654|FG002|Stage II Continuation|hypoglycemia|0
2117411|NCT00943917|3714655|FG003|Stage II Continuation|hypoglycemia|0
2117412|NCT00943917|3714656|FG004|Stage II Continuation|hypoglycemia|0
2117413|NCT00943917|3714657|FG005|Stage II Continuation|hypoglycemia|0
2117414|NCT00943917|3714658|FG006|Stage II Continuation|hypoglycemia|0
2117415|NCT00943917|3714659|FG007|Stage II Continuation|hypoglycemia|0
2117416|NCT00943917|3714660|FG008|Stage II Continuation|hypoglycemia|0
2117417|NCT00943917|3714661|FG009|Stage II Continuation|hypoglycemia|0
2117418|NCT00943917|3714662|FG010|Stage II Continuation|hypoglycemia|0
2117419|NCT00943917|3714663|FG011|Stage II Continuation|hypoglycemia|0
2117420|NCT00943917|3714664|FG012|Stage II Continuation|hypoglycemia|1
2117421|NCT00943917|3714665|FG013|Stage II Continuation|hypoglycemia|0
2117422|NCT00943917|3714666|FG014|Stage II Continuation|hypoglycemia|0
2117423|NCT00943917|3714652|FG000|Stage II Continuation|A1C elevation|0
2117424|NCT00943917|3714653|FG001|Stage II Continuation|A1C elevation|0
2117425|NCT00943917|3714654|FG002|Stage II Continuation|A1C elevation|0
2117426|NCT00943917|3714655|FG003|Stage II Continuation|A1C elevation|0
2117427|NCT00943917|3714656|FG004|Stage II Continuation|A1C elevation|0
2117428|NCT00943917|3714657|FG005|Stage II Continuation|A1C elevation|0
2117429|NCT00943917|3714658|FG006|Stage II Continuation|A1C elevation|0
2117430|NCT00943917|3714659|FG007|Stage II Continuation|A1C elevation|0
2117431|NCT00943917|3714660|FG008|Stage II Continuation|A1C elevation|0
2117432|NCT00943917|3714661|FG009|Stage II Continuation|A1C elevation|0
2117433|NCT00943917|3714662|FG010|Stage II Continuation|A1C elevation|0
2117434|NCT00943917|3714663|FG011|Stage II Continuation|A1C elevation|0
2117435|NCT00943917|3714664|FG012|Stage II Continuation|A1C elevation|0
2117436|NCT00943917|3714665|FG013|Stage II Continuation|A1C elevation|1
2117437|NCT00943917|3714666|FG014|Stage II Continuation|A1C elevation|0
2117438|NCT00944034|3714732|FG000|Overall Study|Inappropriate enrollment|0
2117439|NCT00944034|3714733|FG001|Overall Study|Inappropriate enrollment|1
2117440|NCT00944034|3714734|FG002|Overall Study|Inappropriate enrollment|0
2117441|NCT00944034|3714735|FG003|Overall Study|Inappropriate enrollment|1
2117442|NCT00944034|3714736|FG004|Overall Study|Inappropriate enrollment|2
2117443|NCT00944034|3714737|FG005|Overall Study|Inappropriate enrollment|1
2117444|NCT00944034|3714738|FG006|Overall Study|Inappropriate enrollment|0
2117445|NCT00944034|3714739|FG007|Overall Study|Inappropriate enrollment|0
2117446|NCT00944034|3714740|FG008|Overall Study|Inappropriate enrollment|1
2117447|NCT00944034|3714741|FG009|Overall Study|Inappropriate enrollment|1
2117448|NCT00944034|3714742|FG010|Overall Study|Inappropriate enrollment|0
2117449|NCT00944034|3714743|FG011|Overall Study|Inappropriate enrollment|0
2117450|NCT00944034|3714732|FG000|Overall Study|Withdrawal by Subject|3
2117451|NCT00944034|3714733|FG001|Overall Study|Withdrawal by Subject|2
2117452|NCT00944034|3714734|FG002|Overall Study|Withdrawal by Subject|6
2117453|NCT00944034|3714735|FG003|Overall Study|Withdrawal by Subject|2
2117454|NCT00944034|3714736|FG004|Overall Study|Withdrawal by Subject|5
2117455|NCT00944034|3714737|FG005|Overall Study|Withdrawal by Subject|8
2117456|NCT00944034|3714738|FG006|Overall Study|Withdrawal by Subject|2
2117457|NCT00944034|3714739|FG007|Overall Study|Withdrawal by Subject|2
2117458|NCT00944034|3714740|FG008|Overall Study|Withdrawal by Subject|3
2117459|NCT00944034|3714741|FG009|Overall Study|Withdrawal by Subject|4
2117460|NCT00944034|3714742|FG010|Overall Study|Withdrawal by Subject|0
2117461|NCT00944034|3714743|FG011|Overall Study|Withdrawal by Subject|4
2117462|NCT00944034|3714732|FG000|Overall Study|Lost to Follow-up|0
2117463|NCT00944034|3714733|FG001|Overall Study|Lost to Follow-up|4
2117464|NCT00944034|3714734|FG002|Overall Study|Lost to Follow-up|2
2117465|NCT00944034|3714735|FG003|Overall Study|Lost to Follow-up|0
2117466|NCT00944034|3714736|FG004|Overall Study|Lost to Follow-up|5
2117467|NCT00944034|3714737|FG005|Overall Study|Lost to Follow-up|7
2117468|NCT00944034|3714738|FG006|Overall Study|Lost to Follow-up|0
2117469|NCT00944034|3714739|FG007|Overall Study|Lost to Follow-up|1
2117470|NCT00944034|3714740|FG008|Overall Study|Lost to Follow-up|5
2117471|NCT00944034|3714741|FG009|Overall Study|Lost to Follow-up|1
2117472|NCT00944034|3714742|FG010|Overall Study|Lost to Follow-up|1
2117473|NCT00944034|3714743|FG011|Overall Study|Lost to Follow-up|0
2117474|NCT00944034|3714732|FG000|Overall Study|Death|0
2117475|NCT00944034|3714733|FG001|Overall Study|Death|0
2117476|NCT00944034|3714734|FG002|Overall Study|Death|1
2117477|NCT00944034|3714735|FG003|Overall Study|Death|0
2117478|NCT00944034|3714736|FG004|Overall Study|Death|0
2117479|NCT00944034|3714737|FG005|Overall Study|Death|0
2117480|NCT00944034|3714738|FG006|Overall Study|Death|0
2117481|NCT00944034|3714739|FG007|Overall Study|Death|0
2117482|NCT00944034|3714740|FG008|Overall Study|Death|0
2117483|NCT00944034|3714741|FG009|Overall Study|Death|0
2117484|NCT00944034|3714742|FG010|Overall Study|Death|0
2117485|NCT00944034|3714743|FG011|Overall Study|Death|0
2117486|NCT00944034|3714732|FG000|Overall Study|Protocol Violation|2
2117487|NCT00944034|3714733|FG001|Overall Study|Protocol Violation|0
2117488|NCT00944034|3714734|FG002|Overall Study|Protocol Violation|0
2117489|NCT00944034|3714735|FG003|Overall Study|Protocol Violation|1
2117490|NCT00944034|3714736|FG004|Overall Study|Protocol Violation|2
2117491|NCT00944034|3714737|FG005|Overall Study|Protocol Violation|3
2117492|NCT00944034|3714738|FG006|Overall Study|Protocol Violation|0
2117493|NCT00944034|3714739|FG007|Overall Study|Protocol Violation|1
2117494|NCT00944034|3714740|FG008|Overall Study|Protocol Violation|1
2117495|NCT00944034|3714741|FG009|Overall Study|Protocol Violation|4
2117496|NCT00944034|3714742|FG010|Overall Study|Protocol Violation|0
2117497|NCT00944034|3714743|FG011|Overall Study|Protocol Violation|0
2117498|NCT00944034|3714732|FG000|Overall Study|Unable to classify|0
2117499|NCT00944034|3714733|FG001|Overall Study|Unable to classify|0
2117500|NCT00944034|3714734|FG002|Overall Study|Unable to classify|0
2117501|NCT00944034|3714735|FG003|Overall Study|Unable to classify|0
2117502|NCT00944034|3714736|FG004|Overall Study|Unable to classify|0
2117503|NCT00944034|3714737|FG005|Overall Study|Unable to classify|1
2117504|NCT00944034|3714738|FG006|Overall Study|Unable to classify|1
2117505|NCT00944034|3714739|FG007|Overall Study|Unable to classify|1
2117506|NCT00944034|3714740|FG008|Overall Study|Unable to classify|0
2117507|NCT00944034|3714741|FG009|Overall Study|Unable to classify|0
2117508|NCT00944034|3714742|FG010|Overall Study|Unable to classify|0
2117509|NCT00944034|3714743|FG011|Overall Study|Unable to classify|0
2117510|NCT00944034|3714732|FG000|Overall Study|Administrative reason|0
2117511|NCT00944034|3714733|FG001|Overall Study|Administrative reason|0
2117512|NCT00944034|3714734|FG002|Overall Study|Administrative reason|0
2117513|NCT00944034|3714735|FG003|Overall Study|Administrative reason|0
2117514|NCT00944034|3714736|FG004|Overall Study|Administrative reason|0
2117515|NCT00944034|3714737|FG005|Overall Study|Administrative reason|0
2117516|NCT00944034|3714738|FG006|Overall Study|Administrative reason|1
2117517|NCT00944034|3714739|FG007|Overall Study|Administrative reason|0
2117518|NCT00944034|3714740|FG008|Overall Study|Administrative reason|0
2117519|NCT00944034|3714741|FG009|Overall Study|Administrative reason|0
2117520|NCT00944034|3714742|FG010|Overall Study|Administrative reason|0
2117521|NCT00944034|3714743|FG011|Overall Study|Administrative reason|0
2117522|NCT00944125|3714799|FG000|3 to 6 Months|Withdrawal by Subject|0
2117523|NCT00944125|3714800|FG001|3 to 6 Months|Withdrawal by Subject|2
2117524|NCT00944125|3714799|FG000|6 Months to Study Completion|Withdrawal by Subject|0
2117525|NCT00944125|3714800|FG001|6 Months to Study Completion|Withdrawal by Subject|2
2117526|NCT00944645|3714822|FG000|Period 2|Adverse Event|1
2117527|NCT00944645|3714823|FG001|Period 2|Adverse Event|0
2117528|NCT00944645|3714822|FG000|Period 2|Lost to Follow-up|0
2117529|NCT00944645|3714823|FG001|Period 2|Lost to Follow-up|3
2117530|NCT00944645|3714822|FG000|Period 2|Withdrawal by Subject|7
2117531|NCT00944645|3714823|FG001|Period 2|Withdrawal by Subject|6
2117532|NCT00944658|3714831|FG000|Treatment 12 Weeks|Adverse Event|0
2117533|NCT00944658|3714832|FG001|Treatment 12 Weeks|Adverse Event|2
2117534|NCT00944697|3714859|FG000|Overall Study|Withdrawal by Subject|1
2117535|NCT00944697|3714860|FG001|Overall Study|Withdrawal by Subject|1
2117536|NCT00944697|3714859|FG000|Overall Study|Adverse Event|0
2117537|NCT00944697|3714860|FG001|Overall Study|Adverse Event|3
2117538|NCT00944697|3714859|FG000|Overall Study|Administrative|1
2117539|NCT00944697|3714860|FG001|Overall Study|Administrative|1
2117540|NCT00945009|3714882|FG000|Overall Study|Lack of Efficacy|10
2117541|NCT00945009|3714883|FG001|Overall Study|Lack of Efficacy|0
2117542|NCT00945009|3714884|FG002|Overall Study|Lack of Efficacy|0
2117543|NCT00945009|3714882|FG000|Overall Study|Physician Decision|21
2117544|NCT00945009|3714883|FG001|Overall Study|Physician Decision|4
2117545|NCT00945009|3714884|FG002|Overall Study|Physician Decision|3
2117546|NCT00945009|3714882|FG000|Overall Study|Protocol Violation|6
2117547|NCT00945009|3714883|FG001|Overall Study|Protocol Violation|1
2117548|NCT00945009|3714884|FG002|Overall Study|Protocol Violation|0
2117549|NCT00945009|3714882|FG000|Overall Study|Withdrawal by Subject|1
2117550|NCT00945009|3714883|FG001|Overall Study|Withdrawal by Subject|0
2117551|NCT00945009|3714884|FG002|Overall Study|Withdrawal by Subject|0
2117552|NCT00945009|3714882|FG000|Overall Study|Ineligible|6
2117553|NCT00945009|3714883|FG001|Overall Study|Ineligible|1
2117554|NCT00945009|3714884|FG002|Overall Study|Ineligible|0
2117555|NCT00945009|3714882|FG000|Overall Study|Inevaluable|0
2117556|NCT00945009|3714883|FG001|Overall Study|Inevaluable|1
2117557|NCT00945009|3714884|FG002|Overall Study|Inevaluable|0
2117558|NCT00945009|3714882|FG000|Overall Study|Refusal of further protocol|1
2117559|NCT00945009|3714883|FG001|Overall Study|Refusal of further protocol|0
2117560|NCT00945009|3714884|FG002|Overall Study|Refusal of further protocol|0
2117561|NCT00945191|3714924|FG000|Overall Study|Did not achieve a complete response|18
2117562|NCT00945191|3714924|FG000|Overall Study|Participant relocated to another state|1
2117563|NCT00945191|3714924|FG000|Overall Study|Disease progression|3
2117564|NCT00945191|3714924|FG000|Overall Study|Serious adverse event or adverse event|1
2117565|NCT00945191|3714924|FG000|Overall Study|Investigator's discretion|1
2117566|NCT00945243|3714928|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3
2117567|NCT00945321|3714979|FG000|Period 1|Adverse Event|0
2117568|NCT00945321|3714980|FG001|Period 1|Adverse Event|0
2117569|NCT00945321|3714981|FG002|Period 1|Adverse Event|0
2117570|NCT00945321|3714982|FG003|Period 1|Adverse Event|0
2117571|NCT00945321|3714983|FG004|Period 1|Adverse Event|1
2117572|NCT00945321|3714984|FG005|Period 1|Adverse Event|0
2117573|NCT00945321|3714979|FG000|Period 4|Lost to Follow-up|0
2117574|NCT00945321|3714980|FG001|Period 4|Lost to Follow-up|0
2117575|NCT00945321|3714981|FG002|Period 4|Lost to Follow-up|0
2117576|NCT00945321|3714982|FG003|Period 4|Lost to Follow-up|0
2117577|NCT00945321|3714983|FG004|Period 4|Lost to Follow-up|0
2117578|NCT00945321|3714984|FG005|Period 4|Lost to Follow-up|1
2117579|NCT00945477|3715011|FG000|Overall Study|Adverse Event|3
2117580|NCT00945477|3715011|FG000|Overall Study|Lack of Efficacy|2
2117581|NCT00945477|3715011|FG000|Overall Study|Withdrawal by Subject|1
2117582|NCT00945555|3715016|FG000|Overall Study|Referred to another hospital|5
2117583|NCT00945555|3715016|FG000|Overall Study|Worsening condition, intensive care unit|1
2117584|NCT00945555|3715016|FG000|Overall Study|Withdrawal by Subject|2
2117585|NCT00945555|3715016|FG000|Overall Study|Participant continued treatment at home|1
2117586|NCT00945555|3715016|FG000|Overall Study|Death|18
2117587|NCT00945555|3715016|FG000|Overall Study|Other|1
2117588|NCT00945659|3715034|FG000|Overall Study|Lost to Follow-up|7
2117589|NCT00945659|3715035|FG001|Overall Study|Lost to Follow-up|20
2117590|NCT00945659|3715036|FG002|Overall Study|Lost to Follow-up|17
2117591|NCT00945815|3715063|FG000|Overall Study|Death|3
2117592|NCT00945815|3715063|FG000|Overall Study|Not protocol specified|1
2117593|NCT00945815|3715063|FG000|Overall Study|Ineligible|3
2117594|NCT00945815|3715063|FG000|Overall Study|Did not begin protocol therapy|1
2117595|NCT00945893|3715078|FG000|Overall Study|Lost to Follow-up|2
2117596|NCT00945893|3715079|FG001|Overall Study|Lost to Follow-up|8
2117597|NCT00945893|3715078|FG000|Overall Study|Withdrawal of consent|1
2117598|NCT00945893|3715079|FG001|Overall Study|Withdrawal of consent|2
2180854|NCT01406938|3807443|FG002|Maintenance Period|Adverse Event|2
2180855|NCT01406938|3807444|FG003|Maintenance Period|Adverse Event|8
2117599|NCT00945906|3715089|FG000|Overall Study|Withdrawal by Subject|1
2117600|NCT00945906|3715089|FG000|Overall Study|Did not want to return for last visit|2
2117601|NCT00945906|3715089|FG000|Overall Study|Unable to return for last visit|2
2117602|NCT00945906|3715089|FG000|Overall Study|Moved to another country|2
2117603|NCT00945945|3715095|FG000|Overall Study|Adverse Event|15
2117604|NCT00945945|3715096|FG001|Overall Study|Adverse Event|35
2117605|NCT00945945|3715095|FG000|Overall Study|Withdrawal by Subject|7
2117606|NCT00945945|3715096|FG001|Overall Study|Withdrawal by Subject|10
2117607|NCT00945945|3715095|FG000|Overall Study|Lost to Follow-up|4
2117608|NCT00945945|3715096|FG001|Overall Study|Lost to Follow-up|5
2117609|NCT00945945|3715095|FG000|Overall Study|Lack of Efficacy|6
2117610|NCT00945945|3715096|FG001|Overall Study|Lack of Efficacy|2
2117611|NCT00945945|3715095|FG000|Overall Study|Protocol Violation|4
2117612|NCT00945945|3715096|FG001|Overall Study|Protocol Violation|2
2117613|NCT00945945|3715095|FG000|Overall Study|Entry Criteria Not Met|0
2117614|NCT00945945|3715096|FG001|Overall Study|Entry Criteria Not Met|1
2117615|NCT00946088|3715113|FG000|Overall Study|Withdrawal by Subject|0
2117616|NCT00946088|3715114|FG001|Overall Study|Withdrawal by Subject|1
2117617|NCT00946101|3715124|FG000|Overall Study|Lost to Follow-up|2
2117618|NCT00946101|3715125|FG001|Overall Study|Lost to Follow-up|1
2117619|NCT00946101|3715124|FG000|Overall Study|Withdrawal of consent|2
2117620|NCT00946101|3715125|FG001|Overall Study|Withdrawal of consent|0
2117621|NCT00946101|3715124|FG000|Overall Study|Physician Decision|0
2117622|NCT00946101|3715125|FG001|Overall Study|Physician Decision|1
2117623|NCT00946114|3715137|FG000|Overall Study|Death|5
2117624|NCT00946114|3715138|FG001|Overall Study|Death|2
2117625|NCT00946114|3715137|FG000|Overall Study|Other|1
2117626|NCT00946114|3715138|FG001|Overall Study|Other|0
2117627|NCT00946114|3715137|FG000|Overall Study|Withdrawal by Subject|2
2117628|NCT00946114|3715138|FG001|Overall Study|Withdrawal by Subject|0
2117629|NCT00946153|3715149|FG000|Phase 2|Adverse Event|0
2117630|NCT00946153|3715150|FG001|Phase 2|Adverse Event|0
2117631|NCT00946153|3715151|FG002|Phase 2|Adverse Event|0
2117632|NCT00946153|3715152|FG003|Phase 2|Adverse Event|0
2117633|NCT00946153|3715153|FG004|Phase 2|Adverse Event|6
2117634|NCT00946153|3715149|FG000|Phase 2|Need more reduction of dose|0
2117635|NCT00946153|3715150|FG001|Phase 2|Need more reduction of dose|0
2117636|NCT00946153|3715151|FG002|Phase 2|Need more reduction of dose|0
2117637|NCT00946153|3715152|FG003|Phase 2|Need more reduction of dose|0
2117638|NCT00946153|3715153|FG004|Phase 2|Need more reduction of dose|2
2117639|NCT00946153|3715149|FG000|Phase 2|Physician Decision|0
2117640|NCT00946153|3715150|FG001|Phase 2|Physician Decision|0
2117641|NCT00946153|3715151|FG002|Phase 2|Physician Decision|0
2117642|NCT00946153|3715152|FG003|Phase 2|Physician Decision|0
2117643|NCT00946153|3715153|FG004|Phase 2|Physician Decision|1
2117644|NCT00946153|3715149|FG000|Phase 2|14 days washout for recovery due to AE|0
2117645|NCT00946153|3715150|FG001|Phase 2|14 days washout for recovery due to AE|0
2117646|NCT00946153|3715151|FG002|Phase 2|14 days washout for recovery due to AE|0
2117647|NCT00946153|3715152|FG003|Phase 2|14 days washout for recovery due to AE|0
2117648|NCT00946153|3715153|FG004|Phase 2|14 days washout for recovery due to AE|4
2117649|NCT00946192|3715173|FG000|Overall Study|Lost to Follow-up|6
2117650|NCT00946192|3715174|FG001|Overall Study|Lost to Follow-up|11
2117651|NCT00946192|3715175|FG002|Overall Study|Lost to Follow-up|9
2117652|NCT00946192|3715173|FG000|Overall Study|Withdrawal by Subject|10
2117653|NCT00946192|3715174|FG001|Overall Study|Withdrawal by Subject|7
2117654|NCT00946192|3715175|FG002|Overall Study|Withdrawal by Subject|3
2117655|NCT00946192|3715173|FG000|Overall Study|Did not start medication|2
2117656|NCT00946192|3715174|FG001|Overall Study|Did not start medication|0
2117657|NCT00946192|3715175|FG002|Overall Study|Did not start medication|0
2117658|NCT00946296|3715198|FG000|Overall Study|Physician Decision|3
2117659|NCT00946296|3715199|FG001|Overall Study|Physician Decision|0
2117660|NCT00946309|3715207|FG000|Overall Study|Protocol Violation|1
2117661|NCT00946309|3715208|FG001|Overall Study|Protocol Violation|0
2117662|NCT00946309|3715207|FG000|Overall Study|Lost to Follow-up|0
2117663|NCT00946309|3715208|FG001|Overall Study|Lost to Follow-up|1
2117664|NCT00946309|3715207|FG000|Overall Study|Procedure cancelled/discontinued|0
2117665|NCT00946309|3715208|FG001|Overall Study|Procedure cancelled/discontinued|3
2117666|NCT00946322|3715215|FG000|Pre-treatment|participant failure to follow up|1
2117667|NCT00946322|3715215|FG000|Post-treatment|participant failure to follow up|2
2117668|NCT00946530|3715241|FG000|Overall Study|Withdrawal by Subject|0
2117669|NCT00946530|3715242|FG001|Overall Study|Withdrawal by Subject|3
2117670|NCT00946530|3715243|FG002|Overall Study|Withdrawal by Subject|0
2117671|NCT00946530|3715244|FG003|Overall Study|Withdrawal by Subject|3
2117672|NCT00946530|3715241|FG000|Overall Study|Physician Decision|1
2117673|NCT00946530|3715242|FG001|Overall Study|Physician Decision|1
2117674|NCT00946530|3715243|FG002|Overall Study|Physician Decision|1
2117675|NCT00946530|3715244|FG003|Overall Study|Physician Decision|1
2117676|NCT00946647|3715263|FG000|Phase 1 Part|Adverse Event|2
2117677|NCT00946647|3715264|FG001|Phase 1 Part|Adverse Event|5
2117678|NCT00946647|3715265|FG002|Phase 1 Part|Adverse Event|3
2117679|NCT00946647|3715266|FG003|Phase 1 Part|Adverse Event|0
2117680|NCT00946647|3715267|FG004|Phase 1 Part|Adverse Event|0
2117681|NCT00946647|3715263|FG000|Phase 1 Part|Disease progression|3
2117682|NCT00946647|3715264|FG001|Phase 1 Part|Disease progression|6
2117683|NCT00946647|3715265|FG002|Phase 1 Part|Disease progression|1
2117684|NCT00946647|3715266|FG003|Phase 1 Part|Disease progression|0
2117685|NCT00946647|3715267|FG004|Phase 1 Part|Disease progression|0
2117686|NCT00946647|3715263|FG000|Phase 1 Part|Withdrawal by Subject|1
2117687|NCT00946647|3715264|FG001|Phase 1 Part|Withdrawal by Subject|4
2117688|NCT00946647|3715265|FG002|Phase 1 Part|Withdrawal by Subject|3
2117689|NCT00946647|3715266|FG003|Phase 1 Part|Withdrawal by Subject|0
2117690|NCT00946647|3715267|FG004|Phase 1 Part|Withdrawal by Subject|0
2117691|NCT00946647|3715263|FG000|Phase 1 Part|Abnormal values|0
2117692|NCT00946647|3715264|FG001|Phase 1 Part|Abnormal values|2
2117693|NCT00946647|3715265|FG002|Phase 1 Part|Abnormal values|0
2117694|NCT00946647|3715266|FG003|Phase 1 Part|Abnormal values|0
2117695|NCT00946647|3715267|FG004|Phase 1 Part|Abnormal values|0
2117696|NCT00946647|3715263|FG000|Phase 1 Part|Reason missing|0
2117697|NCT00946647|3715264|FG001|Phase 1 Part|Reason missing|1
2117698|NCT00946647|3715265|FG002|Phase 1 Part|Reason missing|0
2117699|NCT00946647|3715266|FG003|Phase 1 Part|Reason missing|0
2117700|NCT00946647|3715267|FG004|Phase 1 Part|Reason missing|0
2117701|NCT00946647|3715263|FG000|Phase ll Part|Untreated|0
2117702|NCT00946647|3715264|FG001|Phase ll Part|Untreated|0
2117703|NCT00946647|3715265|FG002|Phase ll Part|Untreated|0
2117704|NCT00946647|3715266|FG003|Phase ll Part|Untreated|0
2117705|NCT00946647|3715267|FG004|Phase ll Part|Untreated|2
2117706|NCT00946647|3715263|FG000|Phase ll Part|Adverse Event|0
2117707|NCT00946647|3715264|FG001|Phase ll Part|Adverse Event|0
2117708|NCT00946647|3715265|FG002|Phase ll Part|Adverse Event|0
2117709|NCT00946647|3715266|FG003|Phase ll Part|Adverse Event|10
2117710|NCT00946647|3715267|FG004|Phase ll Part|Adverse Event|6
2117711|NCT00946647|3715263|FG000|Phase ll Part|Withdrawal by Subject|0
2117712|NCT00946647|3715264|FG001|Phase ll Part|Withdrawal by Subject|0
2117713|NCT00946647|3715265|FG002|Phase ll Part|Withdrawal by Subject|0
2117714|NCT00946647|3715266|FG003|Phase ll Part|Withdrawal by Subject|8
2117715|NCT00946647|3715267|FG004|Phase ll Part|Withdrawal by Subject|6
2117716|NCT00946647|3715263|FG000|Phase ll Part|Administrative problems|0
2117717|NCT00946647|3715264|FG001|Phase ll Part|Administrative problems|0
2117718|NCT00946647|3715265|FG002|Phase ll Part|Administrative problems|0
2117719|NCT00946647|3715266|FG003|Phase ll Part|Administrative problems|3
2117720|NCT00946647|3715267|FG004|Phase ll Part|Administrative problems|8
2117721|NCT00946647|3715263|FG000|Phase ll Part|Death|0
2117722|NCT00946647|3715264|FG001|Phase ll Part|Death|0
2117723|NCT00946647|3715265|FG002|Phase ll Part|Death|0
2117724|NCT00946647|3715266|FG003|Phase ll Part|Death|7
2117725|NCT00946647|3715267|FG004|Phase ll Part|Death|4
2117726|NCT00946647|3715263|FG000|Phase ll Part|Disease progression|0
2117727|NCT00946647|3715264|FG001|Phase ll Part|Disease progression|0
2117728|NCT00946647|3715265|FG002|Phase ll Part|Disease progression|0
2117729|NCT00946647|3715266|FG003|Phase ll Part|Disease progression|6
2117730|NCT00946647|3715267|FG004|Phase ll Part|Disease progression|14
2117731|NCT00946647|3715263|FG000|Phase ll Part|Protocol Violation|0
2117732|NCT00946647|3715264|FG001|Phase ll Part|Protocol Violation|0
2117733|NCT00946647|3715265|FG002|Phase ll Part|Protocol Violation|0
2117734|NCT00946647|3715266|FG003|Phase ll Part|Protocol Violation|4
2117735|NCT00946647|3715267|FG004|Phase ll Part|Protocol Violation|2
2117736|NCT00946647|3715263|FG000|Phase ll Part|Subj cond no longer required study drug|0
2117737|NCT00946647|3715264|FG001|Phase ll Part|Subj cond no longer required study drug|0
2117738|NCT00946647|3715265|FG002|Phase ll Part|Subj cond no longer required study drug|0
2117739|NCT00946647|3715266|FG003|Phase ll Part|Subj cond no longer required study drug|2
2117740|NCT00946647|3715267|FG004|Phase ll Part|Subj cond no longer required study drug|0
2117741|NCT00946712|3715282|FG000|Overall Study|Adverse Event|118
2117742|NCT00946712|3715283|FG001|Overall Study|Adverse Event|124
2117743|NCT00946712|3715282|FG000|Overall Study|Disease progression|308
2117744|NCT00946712|3715283|FG001|Overall Study|Disease progression|404
2117745|NCT00946712|3715282|FG000|Overall Study|Death|21
2117746|NCT00946712|3715283|FG001|Overall Study|Death|22
2117747|NCT00946712|3715282|FG000|Overall Study|No treatment given|25
2117748|NCT00946712|3715283|FG001|Overall Study|No treatment given|29
2117749|NCT00946712|3715282|FG000|Overall Study|Other reasons|61
2117750|NCT00946712|3715283|FG001|Overall Study|Other reasons|73
2117751|NCT00946712|3715282|FG000|Overall Study|On Treatment|0
2117752|NCT00946712|3715283|FG001|Overall Study|On Treatment|4
2117753|NCT00946712|3715282|FG000|Overall Study|Ineligible|14
2117754|NCT00946712|3715283|FG001|Overall Study|Ineligible|6
2117755|NCT00946881|3715290|FG000|First Treatment|Withdrawal by Subject|1
2117756|NCT00946881|3715290|FG000|First Treatment|Patient relocated to another state|1
2117757|NCT00946881|3715290|FG000|Retreatment|Withdrawal by Subject|1
2117758|NCT00946920|3715317|FG000|Overall Study|Withdrawal by Subject|28
2117759|NCT00946920|3715318|FG001|Overall Study|Withdrawal by Subject|15
2117760|NCT00946920|3715317|FG000|Overall Study|Lost to Follow-up|2
2117761|NCT00946920|3715318|FG001|Overall Study|Lost to Follow-up|2
2117762|NCT00946920|3715317|FG000|Overall Study|Physician Decision|5
2117763|NCT00946920|3715318|FG001|Overall Study|Physician Decision|2
2117764|NCT00946920|3715317|FG000|Overall Study|Adverse Event|41
2117765|NCT00946920|3715318|FG001|Overall Study|Adverse Event|14
2117766|NCT00946920|3715317|FG000|Overall Study|Protocol Violation|16
2117767|NCT00946920|3715318|FG001|Overall Study|Protocol Violation|8
2117768|NCT00946920|3715317|FG000|Overall Study|Miscellaneous reasons|18
2117769|NCT00946920|3715318|FG001|Overall Study|Miscellaneous reasons|3
2117770|NCT00946998|3715326|FG000|Overall Study|Exited prior to first outcome assessment|5
2117771|NCT00946998|3715327|FG001|Overall Study|Exited prior to first outcome assessment|3
2117772|NCT00947115|3715336|FG000|Overall Study|Missed reporting interval|3
2117773|NCT00947115|3715337|FG001|Overall Study|Missed reporting interval|4
2117774|NCT00947115|3715338|FG002|Overall Study|Missed reporting interval|2
2117775|NCT00947115|3715336|FG000|Overall Study|Physician Decision|0
2117776|NCT00947115|3715337|FG001|Overall Study|Physician Decision|2
2117777|NCT00947115|3715338|FG002|Overall Study|Physician Decision|0
2117778|NCT00947115|3715336|FG000|Overall Study|Death|0
2117779|NCT00947115|3715337|FG001|Overall Study|Death|1
2117780|NCT00947115|3715338|FG002|Overall Study|Death|1
2117781|NCT00947115|3715336|FG000|Overall Study|Migrated from study area|2
2117782|NCT00947115|3715337|FG001|Overall Study|Migrated from study area|0
2117783|NCT00947115|3715338|FG002|Overall Study|Migrated from study area|0
2117784|NCT00947115|3715336|FG000|Overall Study|Withdrawal by Subject|1
2117785|NCT00947115|3715337|FG001|Overall Study|Withdrawal by Subject|3
2117786|NCT00947115|3715338|FG002|Overall Study|Withdrawal by Subject|4
2117787|NCT00947115|3715336|FG000|Overall Study|Lost to Follow-up|11
2117788|NCT00947115|3715337|FG001|Overall Study|Lost to Follow-up|12
2117789|NCT00947115|3715338|FG002|Overall Study|Lost to Follow-up|8
2117790|NCT00947154|3715346|FG000|Overall Study|Lost to Follow-up|1
2117791|NCT00947193|3715355|FG000|Overall Study|Lost to Follow-up|1
2117792|NCT00947193|3715356|FG001|Overall Study|Lost to Follow-up|0
2117793|NCT00947193|3715355|FG000|Overall Study|Withdrawal by Subject|1
2117794|NCT00947193|3715356|FG001|Overall Study|Withdrawal by Subject|0
2117795|NCT00947193|3715355|FG000|Overall Study|Factor VIII >1%|1
2117796|NCT00947193|3715356|FG001|Overall Study|Factor VIII >1%|0
2117797|NCT00947349|3715413|FG000|Triple Treatment Combination Period|Adverse Event|0
2117798|NCT00947349|3715414|FG001|Triple Treatment Combination Period|Adverse Event|1
2117799|NCT00947349|3715415|FG002|Triple Treatment Combination Period|Adverse Event|0
2117800|NCT00947349|3715416|FG003|Triple Treatment Combination Period|Adverse Event|0
2117801|NCT00947349|3715413|FG000|Overall Study Standard of Care|Lack of Efficacy|0
2117802|NCT00947349|3715414|FG001|Overall Study Standard of Care|Lack of Efficacy|0
2117803|NCT00947349|3715415|FG002|Overall Study Standard of Care|Lack of Efficacy|1
2117804|NCT00947349|3715416|FG003|Overall Study Standard of Care|Lack of Efficacy|1
2117805|NCT00947349|3715413|FG000|Overall Study Standard of Care|Withdrawal by Subject|0
2117806|NCT00947349|3715414|FG001|Overall Study Standard of Care|Withdrawal by Subject|0
2117807|NCT00947349|3715415|FG002|Overall Study Standard of Care|Withdrawal by Subject|1
2117808|NCT00947349|3715416|FG003|Overall Study Standard of Care|Withdrawal by Subject|0
2117809|NCT00947349|3715413|FG000|Overall Study Standard of Care|Other|0
2117810|NCT00947349|3715414|FG001|Overall Study Standard of Care|Other|0
2117811|NCT00947349|3715415|FG002|Overall Study Standard of Care|Other|0
2117812|NCT00947349|3715416|FG003|Overall Study Standard of Care|Other|1
2117813|NCT00947427|3715446|FG000|Overall Study|Withdrawal by Subject|1
2117814|NCT00947427|3715447|FG001|Overall Study|Withdrawal by Subject|3
2117815|NCT00947427|3715446|FG000|Overall Study|Protocol Violation|0
2117816|NCT00947427|3715447|FG001|Overall Study|Protocol Violation|1
2117817|NCT00947531|3715464|FG000|Overall Study|Withdrawal by Subject|10
2117818|NCT00947531|3715465|FG001|Overall Study|Withdrawal by Subject|7
2117819|NCT00947531|3715464|FG000|Overall Study|Administrative Reason|0
2117820|NCT00947531|3715465|FG001|Overall Study|Administrative Reason|1
2117821|NCT00947531|3715464|FG000|Overall Study|Adverse Event|2
2117822|NCT00947531|3715465|FG001|Overall Study|Adverse Event|2
2117823|NCT00947531|3715464|FG000|Overall Study|Lack of Efficacy|1
2117824|NCT00947531|3715465|FG001|Overall Study|Lack of Efficacy|0
2117825|NCT00947531|3715464|FG000|Overall Study|Other|1
2117826|NCT00947531|3715465|FG001|Overall Study|Other|1
2117827|NCT00947544|3715471|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
2117828|NCT00947544|3715472|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
2117829|NCT00947856|3715511|FG000|Treatment Period|Progressive Disease|33
2117830|NCT00947856|3715512|FG001|Treatment Period|Progressive Disease|12
2117831|NCT00947856|3715511|FG000|Treatment Period|Adverse Event|15
2117832|NCT00947856|3715512|FG001|Treatment Period|Adverse Event|9
2117833|NCT00947856|3715511|FG000|Treatment Period|Physician Decision|14
2117834|NCT00947856|3715512|FG001|Treatment Period|Physician Decision|6
2117835|NCT00947856|3715511|FG000|Treatment Period|Study Stopped by Sponsor|4
2117836|NCT00947856|3715512|FG001|Treatment Period|Study Stopped by Sponsor|4
2117837|NCT00947856|3715511|FG000|Treatment Period|Withdrawal by Subject|12
2117838|NCT00947856|3715512|FG001|Treatment Period|Withdrawal by Subject|1
2117839|NCT00947856|3715511|FG000|Follow-up Period|Study Stopped by Sponsor|40
2117840|NCT00947856|3715512|FG001|Follow-up Period|Study Stopped by Sponsor|20
2117841|NCT00947856|3715511|FG000|Follow-up Period|Re-enrolled for Retreatment|2
2117842|NCT00947856|3715512|FG001|Follow-up Period|Re-enrolled for Retreatment|3
2117843|NCT00947856|3715511|FG000|Follow-up Period|Lost to Follow-up|7
2117844|NCT00947856|3715512|FG001|Follow-up Period|Lost to Follow-up|0
2117845|NCT00947856|3715511|FG000|Follow-up Period|Patient unavailable for site visits|1
2117846|NCT00947856|3715512|FG001|Follow-up Period|Patient unavailable for site visits|0
2117847|NCT00947856|3715511|FG000|Follow-up Period|Withdrawal by Subject|1
2117848|NCT00947856|3715512|FG001|Follow-up Period|Withdrawal by Subject|0
2117849|NCT00947882|3715531|FG000|Overall Study|Adverse Event|0
2117850|NCT00947882|3715532|FG001|Overall Study|Adverse Event|1
2117851|NCT00947882|3715533|FG002|Overall Study|Adverse Event|4
2117852|NCT00947882|3715534|FG003|Overall Study|Adverse Event|4
2117853|NCT00947882|3715531|FG000|Overall Study|Withdrawal by Subject|2
2117854|NCT00947882|3715532|FG001|Overall Study|Withdrawal by Subject|0
2117855|NCT00947882|3715533|FG002|Overall Study|Withdrawal by Subject|8
2117856|NCT00947882|3715534|FG003|Overall Study|Withdrawal by Subject|2
2117857|NCT00947882|3715531|FG000|Overall Study|Protocol Violation|0
2117858|NCT00947882|3715532|FG001|Overall Study|Protocol Violation|0
2117859|NCT00947882|3715533|FG002|Overall Study|Protocol Violation|1
2117860|NCT00947882|3715534|FG003|Overall Study|Protocol Violation|0
2117861|NCT00947882|3715531|FG000|Overall Study|Lost to Follow-up|0
2117862|NCT00947882|3715532|FG001|Overall Study|Lost to Follow-up|2
2117863|NCT00947882|3715533|FG002|Overall Study|Lost to Follow-up|1
2117864|NCT00947882|3715534|FG003|Overall Study|Lost to Follow-up|0
2117865|NCT00947882|3715531|FG000|Overall Study|Other/Unknown|10
2117866|NCT00947882|3715532|FG001|Overall Study|Other/Unknown|13
2117867|NCT00947882|3715533|FG002|Overall Study|Other/Unknown|3
2117868|NCT00947882|3715534|FG003|Overall Study|Other/Unknown|6
2117869|NCT00947882|3715531|FG000|Overall Study|Trial Terminated by Sponsor|62
2117870|NCT00947882|3715532|FG001|Overall Study|Trial Terminated by Sponsor|61
2117871|NCT00947882|3715533|FG002|Overall Study|Trial Terminated by Sponsor|62
2117872|NCT00947882|3715534|FG003|Overall Study|Trial Terminated by Sponsor|70
2117873|NCT00948025|3715547|FG000|Phase 1 (Pilot Phase)|Adverse Event|1
2117874|NCT00948025|3715548|FG001|Phase 1 (Pilot Phase)|Adverse Event|1
2117875|NCT00948025|3715547|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7
2117876|NCT00948025|3715548|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1
2117877|NCT00948025|3715547|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
2117878|NCT00948025|3715548|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
2117879|NCT00948064|3715558|FG000|Phase I|No treatment received|1
2117880|NCT00948064|3715559|FG001|Phase I|No treatment received|0
2117881|NCT00948064|3715560|FG002|Phase I|No treatment received|0
2117882|NCT00948064|3715558|FG000|Phase II|Physician Decision|0
2117883|NCT00948064|3715559|FG001|Phase II|Physician Decision|0
2117884|NCT00948064|3715560|FG002|Phase II|Physician Decision|1
2117885|NCT00948064|3715558|FG000|Phase II|Withdrawal by Subject|0
2117886|NCT00948064|3715559|FG001|Phase II|Withdrawal by Subject|1
2117887|NCT00948064|3715560|FG002|Phase II|Withdrawal by Subject|0
2117888|NCT00948155|3715584|FG000|First Intervention 21 Days|Lost to Follow-up|2
2117889|NCT00948155|3715585|FG001|First Intervention 21 Days|Lost to Follow-up|2
2117890|NCT00948155|3715584|FG000|Washout 14 Days|Lost to Follow-up|1
2117891|NCT00948155|3715585|FG001|Washout 14 Days|Lost to Follow-up|2
2117892|NCT00948246|3715593|FG000|Overall Study|Lost to Follow-up|11
2117893|NCT00948246|3715593|FG000|Overall Study|Adverse Event|11
2117894|NCT00948246|3715593|FG000|Overall Study|Death|1
2117895|NCT00948246|3715593|FG000|Overall Study|Withdrawal by Subject|1
2117896|NCT00948389|3715611|FG000|Overall Study|Disease Progression/Relapse/Death|3
2117897|NCT00948389|3715612|FG001|Overall Study|Disease Progression/Relapse/Death|3
2117898|NCT00948389|3715613|FG002|Overall Study|Disease Progression/Relapse/Death|7
2117899|NCT00948389|3715614|FG003|Overall Study|Disease Progression/Relapse/Death|8
2117900|NCT00948389|3715615|FG004|Overall Study|Disease Progression/Relapse/Death|1
2117901|NCT00948389|3715611|FG000|Overall Study|Thrombocytopenia, Grade 4|2
2117902|NCT00948389|3715612|FG001|Overall Study|Thrombocytopenia, Grade 4|0
2117903|NCT00948389|3715613|FG002|Overall Study|Thrombocytopenia, Grade 4|0
2117904|NCT00948389|3715614|FG003|Overall Study|Thrombocytopenia, Grade 4|1
2117905|NCT00948389|3715615|FG004|Overall Study|Thrombocytopenia, Grade 4|0
2117906|NCT00948389|3715611|FG000|Overall Study|Both Progression and Toxicity|1
2117907|NCT00948389|3715612|FG001|Overall Study|Both Progression and Toxicity|0
2117908|NCT00948389|3715613|FG002|Overall Study|Both Progression and Toxicity|0
2117909|NCT00948389|3715614|FG003|Overall Study|Both Progression and Toxicity|0
2219301|NCT01721057|3863139|FG000|Treatment Period|Physician Decision|0
2219302|NCT01721057|3863140|FG001|Treatment Period|Physician Decision|1
2219303|NCT01721057|3863141|FG002|Treatment Period|Physician Decision|3
2219304|NCT01721057|3863142|FG003|Treatment Period|Physician Decision|0
2219305|NCT01721057|3863143|FG004|Treatment Period|Physician Decision|0
2219306|NCT01721057|3863144|FG005|Treatment Period|Physician Decision|0
2219307|NCT01721057|3863145|FG006|Treatment Period|Physician Decision|0
2219308|NCT01721057|3863139|FG000|Treatment Period|Death|2
2219309|NCT01721057|3863140|FG001|Treatment Period|Death|0
2219310|NCT01721057|3863141|FG002|Treatment Period|Death|0
2219311|NCT01721057|3863142|FG003|Treatment Period|Death|0
2219312|NCT01721057|3863143|FG004|Treatment Period|Death|0
2219313|NCT01721057|3863144|FG005|Treatment Period|Death|0
2219314|NCT01721057|3863145|FG006|Treatment Period|Death|0
2219315|NCT01721057|3863139|FG000|Rescue Period|Adverse Event|0
2219316|NCT01721057|3863140|FG001|Rescue Period|Adverse Event|0
2219317|NCT01721057|3863141|FG002|Rescue Period|Adverse Event|0
2219318|NCT01721057|3863142|FG003|Rescue Period|Adverse Event|1
2219319|NCT01721057|3863143|FG004|Rescue Period|Adverse Event|0
2219320|NCT01721057|3863144|FG005|Rescue Period|Adverse Event|0
2219321|NCT01721057|3863145|FG006|Rescue Period|Adverse Event|0
2219322|NCT01721057|3863139|FG000|Rescue Period|Lack of Efficacy|0
2117910|NCT00948389|3715615|FG004|Overall Study|Both Progression and Toxicity|0
2117911|NCT00948428|3715632|FG000|Overall Study|Withdrawal by Subject|6
2117912|NCT00948428|3715633|FG001|Overall Study|Withdrawal by Subject|12
2219323|NCT01721057|3863140|FG001|Rescue Period|Lack of Efficacy|0
2219324|NCT01721057|3863141|FG002|Rescue Period|Lack of Efficacy|0
2219325|NCT01721057|3863142|FG003|Rescue Period|Lack of Efficacy|2
2219326|NCT01721057|3863143|FG004|Rescue Period|Lack of Efficacy|0
2219327|NCT01721057|3863144|FG005|Rescue Period|Lack of Efficacy|0
2219328|NCT01721057|3863145|FG006|Rescue Period|Lack of Efficacy|0
2219329|NCT01721070|3863172|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
2219330|NCT01721109|3863190|FG000|Overall Study|Lack of Efficacy|1
2219331|NCT01721109|3863190|FG000|Overall Study|Non- Compliance with Study Drug|3
2219332|NCT01721109|3863190|FG000|Overall Study|Withdrew Consent|1
2117913|NCT00948428|3715634|FG002|Overall Study|Withdrawal by Subject|7
2117914|NCT00948428|3715632|FG000|Overall Study|Adverse Event|6
2117915|NCT00948428|3715633|FG001|Overall Study|Adverse Event|3
2117916|NCT00948428|3715634|FG002|Overall Study|Adverse Event|0
2117917|NCT00948428|3715632|FG000|Overall Study|Lost to Follow-up|2
2117918|NCT00948428|3715633|FG001|Overall Study|Lost to Follow-up|1
2117919|NCT00948428|3715634|FG002|Overall Study|Lost to Follow-up|1
2117920|NCT00948428|3715632|FG000|Overall Study|Death|2
2117921|NCT00948428|3715633|FG001|Overall Study|Death|0
2117922|NCT00948428|3715634|FG002|Overall Study|Death|0
2117923|NCT00948428|3715632|FG000|Overall Study|Intercurrent Illness|1
2117924|NCT00948428|3715633|FG001|Overall Study|Intercurrent Illness|0
2117925|NCT00948428|3715634|FG002|Overall Study|Intercurrent Illness|0
2117926|NCT00948428|3715632|FG000|Overall Study|Non-compliance|1
2117927|NCT00948428|3715633|FG001|Overall Study|Non-compliance|2
2117928|NCT00948428|3715634|FG002|Overall Study|Non-compliance|0
2117929|NCT00948441|3715644|FG000|Overall Study|no longer meet inclusion criteria|1
2117930|NCT00948441|3715645|FG001|Overall Study|no longer meet inclusion criteria|4
2117931|NCT00948506|3715655|FG000|Overall Study|Withdrawal by Subject|3
2117932|NCT00948506|3715656|FG001|Overall Study|Withdrawal by Subject|1
2117933|NCT00948675|3715676|FG000|Overall Study|Lost to Follow-up|1
2117934|NCT00948675|3715677|FG001|Overall Study|Lost to Follow-up|0
2117935|NCT00948688|3715683|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1
2117936|NCT00948688|3715684|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0
2117937|NCT00948688|3715683|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1
2117938|NCT00948688|3715684|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0
2117939|NCT00948688|3715683|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0
2117940|NCT00948688|3715684|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1
2117941|NCT00948766|3715693|FG000|Core Study|Adverse Event|73
2117942|NCT00948766|3715694|FG001|Core Study|Adverse Event|51
2117943|NCT00948766|3715693|FG000|Core Study|Unsatisfactory Therapeutic Effect|13
2117944|NCT00948766|3715694|FG001|Core Study|Unsatisfactory Therapeutic Effect|14
2117945|NCT00948766|3715693|FG000|Core Study|Patient Withdrew Consent|27
2117946|NCT00948766|3715694|FG001|Core Study|Patient Withdrew Consent|46
2117947|NCT00948766|3715693|FG000|Core Study|Lost to Follow-up|3
2117948|NCT00948766|3715694|FG001|Core Study|Lost to Follow-up|2
2117949|NCT00948766|3715693|FG000|Core Study|Administrative Problems|2
2117950|NCT00948766|3715694|FG001|Core Study|Administrative Problems|2
2117951|NCT00948766|3715693|FG000|Core Study|Death|1
2117952|NCT00948766|3715694|FG001|Core Study|Death|1
2117953|NCT00948766|3715693|FG000|Core Study|Protocol Deviation|8
2117954|NCT00948766|3715694|FG001|Core Study|Protocol Deviation|10
2117955|NCT00948766|3715693|FG000|Extension Study|Adverse Event|43
2117956|NCT00948766|3715694|FG001|Extension Study|Adverse Event|0
2117957|NCT00948766|3715693|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2
2117958|NCT00948766|3715694|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0
2117959|NCT00948766|3715693|FG000|Extension Study|Study Drug No Longer Required|1
2117960|NCT00948766|3715694|FG001|Extension Study|Study Drug No Longer Required|0
2117961|NCT00948766|3715693|FG000|Extension Study|Patient Withdrew Consent|32
2117962|NCT00948766|3715694|FG001|Extension Study|Patient Withdrew Consent|0
2117963|NCT00948766|3715693|FG000|Extension Study|Lost to Follow-up|8
2117964|NCT00948766|3715694|FG001|Extension Study|Lost to Follow-up|0
2117965|NCT00948766|3715693|FG000|Extension Study|Administrative Problems|1
2117966|NCT00948766|3715694|FG001|Extension Study|Administrative Problems|0
2117967|NCT00948766|3715693|FG000|Extension Study|Death|4
2117968|NCT00948766|3715694|FG001|Extension Study|Death|0
2117969|NCT00948818|3715709|FG000|Overall Study|Adverse Event|10
2117970|NCT00948818|3715710|FG001|Overall Study|Adverse Event|32
2117971|NCT00948818|3715709|FG000|Overall Study|Protocol Violation|9
2117972|NCT00948818|3715710|FG001|Overall Study|Protocol Violation|10
2117973|NCT00948818|3715709|FG000|Overall Study|Withdrawal by Subject|25
2117974|NCT00948818|3715710|FG001|Overall Study|Withdrawal by Subject|25
2117975|NCT00948818|3715709|FG000|Overall Study|Lost to Follow-up|10
2117976|NCT00948818|3715710|FG001|Overall Study|Lost to Follow-up|17
2117977|NCT00948818|3715709|FG000|Overall Study|Lack of Efficacy|4
2117978|NCT00948818|3715710|FG001|Overall Study|Lack of Efficacy|5
2117979|NCT00948818|3715709|FG000|Overall Study|Other Reason|4
2117980|NCT00948818|3715710|FG001|Overall Study|Other Reason|5
2117981|NCT00948857|3715721|FG000|Overall Study|Lost to Follow-up|1
2117982|NCT00948857|3715722|FG001|Overall Study|Lost to Follow-up|0
2117983|NCT00948896|3715736|FG000|Randomization to 24 Months of Age|Death|1
2117984|NCT00948896|3715737|FG001|Randomization to 24 Months of Age|Death|0
2117985|NCT00948896|3715738|FG002|Randomization to 24 Months of Age|Death|0
2117986|NCT00948896|3715739|FG003|Randomization to 24 Months of Age|Death|0
2117987|NCT00948896|3715740|FG004|Randomization to 24 Months of Age|Death|2
2117988|NCT00948896|3715741|FG005|Randomization to 24 Months of Age|Death|1
2117989|NCT00948896|3715742|FG006|Randomization to 24 Months of Age|Death|2
2117990|NCT00948896|3715743|FG007|Randomization to 24 Months of Age|Death|1
2117991|NCT00948896|3715736|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3
2117992|NCT00948896|3715737|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5
2117993|NCT00948896|3715738|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4
2117994|NCT00948896|3715739|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4
2117995|NCT00948896|3715740|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0
2117996|NCT00948896|3715741|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1
2117997|NCT00948896|3715742|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0
2117998|NCT00948896|3715743|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0
2117999|NCT00948896|3715736|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4
2118000|NCT00948896|3715737|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4
2118001|NCT00948896|3715738|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2
2118002|NCT00948896|3715739|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5
2118003|NCT00948896|3715740|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0
2118004|NCT00948896|3715741|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0
2118005|NCT00948896|3715742|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1
2118006|NCT00948896|3715743|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0
2118007|NCT00948896|3715736|FG000|Randomization to 24 Months of Age|Protocol Violation|0
2118008|NCT00948896|3715737|FG001|Randomization to 24 Months of Age|Protocol Violation|1
2118009|NCT00948896|3715738|FG002|Randomization to 24 Months of Age|Protocol Violation|0
2118010|NCT00948896|3715739|FG003|Randomization to 24 Months of Age|Protocol Violation|1
2118011|NCT00948896|3715740|FG004|Randomization to 24 Months of Age|Protocol Violation|0
2118012|NCT00948896|3715741|FG005|Randomization to 24 Months of Age|Protocol Violation|0
2118013|NCT00948896|3715742|FG006|Randomization to 24 Months of Age|Protocol Violation|1
2118014|NCT00948896|3715743|FG007|Randomization to 24 Months of Age|Protocol Violation|1
2118015|NCT00948896|3715736|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0
2118016|NCT00948896|3715737|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3
2118017|NCT00948896|3715738|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3
2118018|NCT00948896|3715739|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1
2118019|NCT00948896|3715740|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0
2118020|NCT00948896|3715741|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2
2118021|NCT00948896|3715742|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0
2118022|NCT00948896|3715743|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0
2118023|NCT00948896|3715736|FG000|24 Months of Age to 36 Months of Age|Death|0
2118024|NCT00948896|3715737|FG001|24 Months of Age to 36 Months of Age|Death|2
2118025|NCT00948896|3715738|FG002|24 Months of Age to 36 Months of Age|Death|2
2118026|NCT00948896|3715739|FG003|24 Months of Age to 36 Months of Age|Death|0
2118027|NCT00948896|3715740|FG004|24 Months of Age to 36 Months of Age|Death|0
2118028|NCT00948896|3715741|FG005|24 Months of Age to 36 Months of Age|Death|1
2118029|NCT00948896|3715742|FG006|24 Months of Age to 36 Months of Age|Death|0
2118030|NCT00948896|3715743|FG007|24 Months of Age to 36 Months of Age|Death|0
2118031|NCT00948896|3715736|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
2118032|NCT00948896|3715737|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2118033|NCT00948896|3715738|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
2118034|NCT00948896|3715739|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
2118035|NCT00948896|3715740|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2118036|NCT00948896|3715741|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2118037|NCT00948896|3715742|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2118038|NCT00948896|3715743|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2118039|NCT00948896|3715736|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
2118040|NCT00948896|3715737|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2118041|NCT00948896|3715738|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
2118042|NCT00948896|3715739|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2118043|NCT00948896|3715740|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
2118044|NCT00948896|3715741|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2118045|NCT00948896|3715742|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2118046|NCT00948896|3715743|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2118047|NCT00948896|3715736|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0
2118048|NCT00948896|3715737|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0
2118049|NCT00948896|3715738|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1
2118050|NCT00948896|3715739|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0
2118051|NCT00948896|3715740|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0
2118052|NCT00948896|3715741|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1
2118053|NCT00948896|3715742|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0
2118054|NCT00948896|3715743|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0
2118055|NCT00948896|3715736|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2118056|NCT00948896|3715737|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2118057|NCT00948896|3715738|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2118058|NCT00948896|3715739|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
2118059|NCT00948896|3715740|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2118060|NCT00948896|3715741|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2118061|NCT00948896|3715742|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2118062|NCT00948896|3715743|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2118063|NCT00948922|3715768|FG000|Overall Study|Did not start study treatment|2
2118064|NCT00948922|3715769|FG001|Overall Study|Did not start study treatment|5
2118065|NCT00948922|3715770|FG002|Overall Study|Did not start study treatment|0
2118066|NCT00948922|3715768|FG000|Overall Study|Withdrawal by Subject|0
2118067|NCT00948922|3715769|FG001|Overall Study|Withdrawal by Subject|2
2118068|NCT00948922|3715770|FG002|Overall Study|Withdrawal by Subject|1
2118069|NCT00948922|3715768|FG000|Overall Study|Death|3
2118070|NCT00948922|3715769|FG001|Overall Study|Death|0
2118071|NCT00948922|3715770|FG002|Overall Study|Death|0
2118072|NCT00948922|3715768|FG000|Overall Study|Disease progression|0
2118073|NCT00948922|3715769|FG001|Overall Study|Disease progression|1
2118074|NCT00948922|3715770|FG002|Overall Study|Disease progression|0
2118075|NCT00948922|3715768|FG000|Overall Study|Insurance issues|1
2118076|NCT00948922|3715769|FG001|Overall Study|Insurance issues|0
2118077|NCT00948922|3715770|FG002|Overall Study|Insurance issues|0
2118078|NCT00948922|3715768|FG000|Overall Study|Transplant eligibility issues|2
2118079|NCT00948922|3715769|FG001|Overall Study|Transplant eligibility issues|3
2118080|NCT00948922|3715770|FG002|Overall Study|Transplant eligibility issues|0
2118081|NCT00948922|3715768|FG000|Overall Study|Not evaluable at time of analysis|0
2118082|NCT00948922|3715769|FG001|Overall Study|Not evaluable at time of analysis|3
2118083|NCT00948922|3715770|FG002|Overall Study|Not evaluable at time of analysis|0
2118084|NCT00948974|3715788|FG000|Overall Study|Lost to Follow-up|23
2118085|NCT00948974|3715789|FG001|Overall Study|Lost to Follow-up|20
2118086|NCT00949117|3715806|FG000|Overall Study|Lack of Efficacy|2
2118087|NCT00949117|3715807|FG001|Overall Study|Lack of Efficacy|3
2118088|NCT00949117|3715806|FG000|Overall Study|Protocol Violation|1
2118089|NCT00949117|3715807|FG001|Overall Study|Protocol Violation|1
2118090|NCT00949117|3715806|FG000|Overall Study|Adverse Event|0
2118091|NCT00949117|3715807|FG001|Overall Study|Adverse Event|1
2118092|NCT00949325|3715819|FG000|Overall Study|Adverse Event|0
2118093|NCT00949325|3715820|FG001|Overall Study|Adverse Event|2
2118094|NCT00949325|3715821|FG002|Overall Study|Adverse Event|0
2118095|NCT00949533|3715839|FG000|Overall Study|Lost to Follow-up|0
2118096|NCT00949533|3715840|FG001|Overall Study|Lost to Follow-up|1
2180856|NCT01406938|3807445|FG004|Maintenance Period|Adverse Event|4
2180857|NCT01406938|3807446|FG005|Maintenance Period|Adverse Event|2
2180858|NCT01406938|3807441|FG000|Maintenance Period|Death|0
2180859|NCT01406938|3807442|FG001|Maintenance Period|Death|0
2180860|NCT01406938|3807443|FG002|Maintenance Period|Death|0
2180861|NCT01406938|3807444|FG003|Maintenance Period|Death|0
2180862|NCT01406938|3807445|FG004|Maintenance Period|Death|1
2180863|NCT01406938|3807446|FG005|Maintenance Period|Death|0
2180864|NCT01406938|3807441|FG000|Maintenance Period|Subject/guardian decision|0
2180865|NCT01406938|3807442|FG001|Maintenance Period|Subject/guardian decision|0
2180866|NCT01406938|3807443|FG002|Maintenance Period|Subject/guardian decision|11
2180867|NCT01406938|3807444|FG003|Maintenance Period|Subject/guardian decision|7
2180868|NCT01406938|3807445|FG004|Maintenance Period|Subject/guardian decision|10
2180869|NCT01406938|3807446|FG005|Maintenance Period|Subject/guardian decision|7
2180870|NCT01406938|3807441|FG000|Maintenance Period|Protocol Violation|0
2180871|NCT01406938|3807442|FG001|Maintenance Period|Protocol Violation|0
2180872|NCT01406938|3807443|FG002|Maintenance Period|Protocol Violation|2
2180873|NCT01406938|3807444|FG003|Maintenance Period|Protocol Violation|2
2180874|NCT01406938|3807445|FG004|Maintenance Period|Protocol Violation|2
2180875|NCT01406938|3807446|FG005|Maintenance Period|Protocol Violation|2
2180876|NCT01406938|3807441|FG000|Maintenance Period|Pregnancy|0
2180877|NCT01406938|3807442|FG001|Maintenance Period|Pregnancy|0
2180878|NCT01406938|3807443|FG002|Maintenance Period|Pregnancy|0
2180879|NCT01406938|3807444|FG003|Maintenance Period|Pregnancy|0
2180880|NCT01406938|3807445|FG004|Maintenance Period|Pregnancy|1
2180881|NCT01406938|3807446|FG005|Maintenance Period|Pregnancy|0
2180882|NCT01406938|3807441|FG000|Maintenance Period|Lost to Follow-up|0
2180883|NCT01406938|3807442|FG001|Maintenance Period|Lost to Follow-up|0
2180884|NCT01406938|3807443|FG002|Maintenance Period|Lost to Follow-up|0
2180885|NCT01406938|3807444|FG003|Maintenance Period|Lost to Follow-up|0
2180886|NCT01406938|3807445|FG004|Maintenance Period|Lost to Follow-up|4
2180887|NCT01406938|3807446|FG005|Maintenance Period|Lost to Follow-up|0
2180888|NCT01406938|3807441|FG000|Maintenance Period|Lack of Efficacy|0
2180889|NCT01406938|3807442|FG001|Maintenance Period|Lack of Efficacy|0
2180890|NCT01406938|3807443|FG002|Maintenance Period|Lack of Efficacy|2
2180891|NCT01406938|3807444|FG003|Maintenance Period|Lack of Efficacy|1
2180892|NCT01406938|3807445|FG004|Maintenance Period|Lack of Efficacy|3
2180893|NCT01406938|3807446|FG005|Maintenance Period|Lack of Efficacy|5
2180894|NCT01406938|3807441|FG000|Follow up|Lack of Efficacy|3
2180895|NCT01406938|3807442|FG001|Follow up|Lack of Efficacy|2
2180896|NCT01406938|3807443|FG002|Follow up|Lack of Efficacy|1
2180897|NCT01406938|3807444|FG003|Follow up|Lack of Efficacy|0
2180898|NCT01406938|3807445|FG004|Follow up|Lack of Efficacy|0
2180899|NCT01406938|3807446|FG005|Follow up|Lack of Efficacy|0
2180900|NCT01406938|3807441|FG000|Follow up|Patient/guardian decision|4
2180901|NCT01406938|3807442|FG001|Follow up|Patient/guardian decision|2
2180902|NCT01406938|3807443|FG002|Follow up|Patient/guardian decision|4
2180903|NCT01406938|3807444|FG003|Follow up|Patient/guardian decision|2
2180904|NCT01406938|3807445|FG004|Follow up|Patient/guardian decision|4
2180905|NCT01406938|3807446|FG005|Follow up|Patient/guardian decision|1
2180906|NCT01406938|3807441|FG000|Follow up|Protocol Violation|0
2180907|NCT01406938|3807442|FG001|Follow up|Protocol Violation|0
2180908|NCT01406938|3807443|FG002|Follow up|Protocol Violation|1
2180909|NCT01406938|3807444|FG003|Follow up|Protocol Violation|0
2180910|NCT01406938|3807445|FG004|Follow up|Protocol Violation|0
2180911|NCT01406938|3807446|FG005|Follow up|Protocol Violation|0
2180912|NCT01406938|3807441|FG000|Follow up|Physician Decision|0
2180913|NCT01406938|3807442|FG001|Follow up|Physician Decision|0
2180914|NCT01406938|3807443|FG002|Follow up|Physician Decision|2
2180915|NCT01406938|3807444|FG003|Follow up|Physician Decision|0
2180916|NCT01406938|3807445|FG004|Follow up|Physician Decision|3
2180917|NCT01406938|3807446|FG005|Follow up|Physician Decision|1
2180918|NCT01406938|3807441|FG000|Follow up|Lost to Follow-up|1
2180919|NCT01406938|3807442|FG001|Follow up|Lost to Follow-up|1
2180920|NCT01406938|3807443|FG002|Follow up|Lost to Follow-up|0
2180921|NCT01406938|3807444|FG003|Follow up|Lost to Follow-up|1
2180922|NCT01406938|3807445|FG004|Follow up|Lost to Follow-up|2
2180923|NCT01406938|3807446|FG005|Follow up|Lost to Follow-up|1
2180924|NCT01407276|3807510|FG000|Overall Study|Withdrawal by Subject|0
2180925|NCT01407276|3807511|FG001|Overall Study|Withdrawal by Subject|0
2180926|NCT01407276|3807512|FG002|Overall Study|Withdrawal by Subject|0
2180927|NCT01407276|3807513|FG003|Overall Study|Withdrawal by Subject|0
2180928|NCT01407276|3807514|FG004|Overall Study|Withdrawal by Subject|0
2180929|NCT01407276|3807515|FG005|Overall Study|Withdrawal by Subject|0
2180930|NCT01407276|3807516|FG006|Overall Study|Withdrawal by Subject|0
2180931|NCT01407276|3807517|FG007|Overall Study|Withdrawal by Subject|1
2180932|NCT01407354|3807542|FG000|First Intervention|Withdrawal by Subject|0
2180933|NCT01407354|3807543|FG001|First Intervention|Withdrawal by Subject|2
2180934|NCT01407354|3807542|FG000|First Intervention|Adverse Event|1
2180935|NCT01407354|3807543|FG001|First Intervention|Adverse Event|0
2180936|NCT01407354|3807542|FG000|First Intervention|Physician Decision|1
2180937|NCT01407354|3807543|FG001|First Intervention|Physician Decision|0
2180938|NCT01407367|3807552|FG000|Overall Study|Death|24
2180939|NCT01407367|3807553|FG001|Overall Study|Death|32
2180940|NCT01407367|3807552|FG000|Overall Study|Renal Replacement Therapy (RRT)|12
2180941|NCT01407367|3807553|FG001|Overall Study|Renal Replacement Therapy (RRT)|29
2180942|NCT01407367|3807552|FG000|Overall Study|Withdrawal by Subject|4
2180943|NCT01407367|3807553|FG001|Overall Study|Withdrawal by Subject|15
2180944|NCT01407367|3807552|FG000|Overall Study|Lost to Follow-up|0
2180945|NCT01407367|3807553|FG001|Overall Study|Lost to Follow-up|2
2180946|NCT01407926|3807577|FG000|Overall Study|Lost to Follow-up|55
2180947|NCT01408030|3807595|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1
2180948|NCT01408030|3807596|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0
2180949|NCT01408030|3807597|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1
2180950|NCT01408030|3807598|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0
2180951|NCT01408030|3807595|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2
2180952|NCT01408030|3807596|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6
2180953|NCT01408030|3807597|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0
2180954|NCT01408030|3807598|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3
2180955|NCT01408030|3807595|FG000|Treatment Phase (on Drug)|Protocol Violation|0
2180956|NCT01408030|3807596|FG001|Treatment Phase (on Drug)|Protocol Violation|1
2180957|NCT01408030|3807597|FG002|Treatment Phase (on Drug)|Protocol Violation|0
2180958|NCT01408030|3807598|FG003|Treatment Phase (on Drug)|Protocol Violation|0
2180959|NCT01408030|3807595|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0
2180960|NCT01408030|3807596|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2
2180961|NCT01408030|3807597|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2
2180962|NCT01408030|3807598|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0
2180963|NCT01408030|3807595|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3
2180964|NCT01408030|3807596|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2
2180965|NCT01408030|3807597|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1
2180966|NCT01408030|3807598|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3
2180967|NCT01408030|3807595|FG000|Observation Phase (Off Drug)|Physician Decision|0
2180968|NCT01408030|3807596|FG001|Observation Phase (Off Drug)|Physician Decision|1
2180969|NCT01408030|3807597|FG002|Observation Phase (Off Drug)|Physician Decision|2
2180970|NCT01408030|3807598|FG003|Observation Phase (Off Drug)|Physician Decision|0
2180971|NCT01408030|3807595|FG000|Observation Phase (Off Drug)|Other|1
2180972|NCT01408030|3807596|FG001|Observation Phase (Off Drug)|Other|1
2180973|NCT01408030|3807597|FG002|Observation Phase (Off Drug)|Other|1
2180974|NCT01408030|3807598|FG003|Observation Phase (Off Drug)|Other|1
2180975|NCT01408043|3807608|FG000|Overall Study|unable to collect cells|1
2219333|NCT01721109|3863190|FG000|Overall Study|Lost to Follow-up|2
2219334|NCT01721161|3863196|FG000|Overall Study|Adverse Event|2
2219335|NCT01721161|3863197|FG001|Overall Study|Adverse Event|3
2219336|NCT01721161|3863196|FG000|Overall Study|Lost to Follow-up|1
2180976|NCT01408147|3807614|FG000|Overall Study|Withdrawal by Subject|0
2180977|NCT01408147|3807615|FG001|Overall Study|Withdrawal by Subject|1
2180978|NCT01408277|3807623|FG000|Overall Study|Adverse Event|3
2180979|NCT01408277|3807624|FG001|Overall Study|Adverse Event|4
2180980|NCT01408277|3807623|FG000|Overall Study|Lost to Follow-up|1
2180981|NCT01408277|3807624|FG001|Overall Study|Lost to Follow-up|0
2180982|NCT01408277|3807623|FG000|Overall Study|Withdrawal by Subject|2
2180983|NCT01408277|3807624|FG001|Overall Study|Withdrawal by Subject|0
2180984|NCT01408277|3807623|FG000|Overall Study|Protocol Violation|2
2180985|NCT01408277|3807624|FG001|Overall Study|Protocol Violation|0
2180986|NCT01408303|3807633|FG000|Overall Study|Adverse Event|3
2180987|NCT01408303|3807634|FG001|Overall Study|Adverse Event|7
2180988|NCT01408303|3807635|FG002|Overall Study|Adverse Event|2
2180989|NCT01408303|3807633|FG000|Overall Study|Lost to Follow-up|0
2180990|NCT01408303|3807634|FG001|Overall Study|Lost to Follow-up|1
2180991|NCT01408303|3807635|FG002|Overall Study|Lost to Follow-up|2
2180992|NCT01408303|3807633|FG000|Overall Study|Withdrawal by Subject|2
2180993|NCT01408303|3807634|FG001|Overall Study|Withdrawal by Subject|3
2180994|NCT01408303|3807635|FG002|Overall Study|Withdrawal by Subject|1
2180995|NCT01408303|3807633|FG000|Overall Study|Protocol Violation|0
2180996|NCT01408303|3807634|FG001|Overall Study|Protocol Violation|1
2180997|NCT01408303|3807635|FG002|Overall Study|Protocol Violation|0
2180998|NCT01408303|3807633|FG000|Overall Study|Noncompliance|1
2180999|NCT01408303|3807634|FG001|Overall Study|Noncompliance|0
2181000|NCT01408303|3807635|FG002|Overall Study|Noncompliance|1
2181001|NCT01408459|3807654|FG000|Overall Study|Withdrawal by Subject|1
2181002|NCT01408459|3807655|FG001|Overall Study|Withdrawal by Subject|1
2181003|NCT01408485|3807662|FG000|Overall Study|Withdrawal by Subject|21
2181004|NCT01408537|3807666|FG000|Overall Study|Withdrawal by Subject|2
2181005|NCT01408537|3807666|FG000|Overall Study|Protocol Violation|3
2181006|NCT01408537|3807666|FG000|Overall Study|Lost to Follow-up|3
2181007|NCT01408563|3807681|FG000|Overall Study|Ineligible after consent/ registration|2
2181008|NCT01408576|3807688|FG000|Overall Study|Lack of Efficacy|17
2181009|NCT01408576|3807689|FG001|Overall Study|Lack of Efficacy|30
2181010|NCT01408576|3807690|FG002|Overall Study|Lack of Efficacy|48
2181011|NCT01408576|3807688|FG000|Overall Study|Protocol Violation|1
2181012|NCT01408576|3807689|FG001|Overall Study|Protocol Violation|2
2181013|NCT01408576|3807690|FG002|Overall Study|Protocol Violation|2
2181014|NCT01408576|3807688|FG000|Overall Study|Lost to Follow-up|10
2181015|NCT01408576|3807689|FG001|Overall Study|Lost to Follow-up|9
2181016|NCT01408576|3807690|FG002|Overall Study|Lost to Follow-up|17
2181017|NCT01408576|3807688|FG000|Overall Study|Withdrawal by Subject|34
2181018|NCT01408576|3807689|FG001|Overall Study|Withdrawal by Subject|60
2181019|NCT01408576|3807690|FG002|Overall Study|Withdrawal by Subject|66
2181020|NCT01408576|3807688|FG000|Overall Study|Sponsor terminated study|89
2181021|NCT01408576|3807689|FG001|Overall Study|Sponsor terminated study|333
2181022|NCT01408576|3807690|FG002|Overall Study|Sponsor terminated study|330
2181023|NCT01408576|3807688|FG000|Overall Study|AE, serious fatal|4
2181024|NCT01408576|3807689|FG001|Overall Study|AE, serious fatal|4
2181025|NCT01408576|3807690|FG002|Overall Study|AE, serious fatal|1
2181026|NCT01408576|3807688|FG000|Overall Study|SAE, non-fatal|11
2181027|NCT01408576|3807689|FG001|Overall Study|SAE, non-fatal|23
2181028|NCT01408576|3807690|FG002|Overall Study|SAE, non-fatal|14
2181029|NCT01408576|3807688|FG000|Overall Study|AE, non-serious non-fatal|12
2181030|NCT01408576|3807689|FG001|Overall Study|AE, non-serious non-fatal|19
2219337|NCT01721161|3863197|FG001|Overall Study|Lost to Follow-up|2
2181031|NCT01408576|3807690|FG002|Overall Study|AE, non-serious non-fatal|11
2181032|NCT01408576|3807688|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2181033|NCT01408576|3807689|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2181034|NCT01408576|3807690|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2181035|NCT01408576|3807688|FG000|Overall Study|AE, unknown type|0
2181036|NCT01408576|3807689|FG001|Overall Study|AE, unknown type|1
2181037|NCT01408576|3807690|FG002|Overall Study|AE, unknown type|0
2181038|NCT01408576|3807688|FG000|Overall Study|Other|10
2181039|NCT01408576|3807689|FG001|Overall Study|Other|16
2181040|NCT01408576|3807690|FG002|Overall Study|Other|18
2181041|NCT01408628|3807710|FG000|Consented|Withdrawal by Subject|12
2181042|NCT01408628|3807710|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3
2181043|NCT01408628|3807710|FG000|Completed 6 Month Follow-Up|Protocol Violation|6
2181044|NCT01408628|3807710|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5
2181045|NCT01408706|3807717|FG000|Overall Study|Physician Decision|1
2181046|NCT01408706|3807718|FG001|Overall Study|Physician Decision|0
2181047|NCT01408732|3807775|FG000|Overall Study|Withdrawal by Subject|2
2181048|NCT01408732|3807776|FG001|Overall Study|Withdrawal by Subject|2
2181049|NCT01408888|3807787|FG000|First Intervention|Adverse Event|0
2181050|NCT01408888|3807788|FG001|First Intervention|Adverse Event|1
2181051|NCT01408888|3807787|FG000|First Intervention|Withdrawal by Subject|0
2181052|NCT01408888|3807788|FG001|First Intervention|Withdrawal by Subject|2
2181053|NCT01408888|3807787|FG000|Second Intervention|Withdrawal by Subject|1
2181054|NCT01408888|3807788|FG001|Second Intervention|Withdrawal by Subject|0
2181055|NCT01408888|3807787|FG000|Second Intervention|Adverse Event|1
2181056|NCT01408888|3807788|FG001|Second Intervention|Adverse Event|0
2181057|NCT01408901|3807808|FG000|6-Week Follow-Up|Lost to Follow-up|2
2181058|NCT01408901|3807809|FG001|6-Week Follow-Up|Lost to Follow-up|1
2181059|NCT01408901|3807810|FG002|6-Week Follow-Up|Lost to Follow-up|3
2181060|NCT01408901|3807811|FG003|6-Week Follow-Up|Lost to Follow-up|2
2181061|NCT01408901|3807808|FG000|6-Week Follow-Up|Death|1
2181062|NCT01408901|3807809|FG001|6-Week Follow-Up|Death|0
2181063|NCT01408901|3807810|FG002|6-Week Follow-Up|Death|0
2181064|NCT01408901|3807811|FG003|6-Week Follow-Up|Death|0
2181065|NCT01408901|3807808|FG000|6-Week Follow-Up|Cancelled visit|0
2181066|NCT01408901|3807809|FG001|6-Week Follow-Up|Cancelled visit|1
2181067|NCT01408901|3807810|FG002|6-Week Follow-Up|Cancelled visit|0
2181068|NCT01408901|3807811|FG003|6-Week Follow-Up|Cancelled visit|2
2181069|NCT01408901|3807808|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
2181070|NCT01408901|3807809|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
2181071|NCT01408901|3807810|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
2181072|NCT01408901|3807811|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
2181073|NCT01408901|3807808|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1
2181074|NCT01408901|3807809|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0
2181075|NCT01408901|3807810|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0
2181076|NCT01408901|3807811|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0
2181077|NCT01408901|3807808|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
2181078|NCT01408901|3807809|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
2181079|NCT01408901|3807810|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
2181080|NCT01408901|3807811|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
2181081|NCT01408901|3807808|FG000|26-Week Follow-Up|Lost to Follow-up|1
2181082|NCT01408901|3807809|FG001|26-Week Follow-Up|Lost to Follow-up|1
2181083|NCT01408901|3807810|FG002|26-Week Follow-Up|Lost to Follow-up|0
2181084|NCT01408901|3807811|FG003|26-Week Follow-Up|Lost to Follow-up|1
2181085|NCT01408901|3807808|FG000|26-Week Follow-Up|Death|0
2181086|NCT01408901|3807809|FG001|26-Week Follow-Up|Death|1
2181087|NCT01408901|3807810|FG002|26-Week Follow-Up|Death|0
2181088|NCT01408901|3807811|FG003|26-Week Follow-Up|Death|0
2181089|NCT01408914|3807826|FG000|Overall Study|Could not complete tx in protocol period|5
2181090|NCT01408914|3807827|FG001|Overall Study|Could not complete tx in protocol period|5
2181091|NCT01408914|3807828|FG002|Overall Study|Could not complete tx in protocol period|6
2181092|NCT01408914|3807826|FG000|Overall Study|Lost to Follow-up|4
2181093|NCT01408914|3807827|FG001|Overall Study|Lost to Follow-up|1
2181094|NCT01408914|3807828|FG002|Overall Study|Lost to Follow-up|2
2181095|NCT01408914|3807826|FG000|Overall Study|Physician Decision|1
2181096|NCT01408914|3807827|FG001|Overall Study|Physician Decision|1
2181097|NCT01408914|3807828|FG002|Overall Study|Physician Decision|0
2181098|NCT01408914|3807826|FG000|Overall Study|Withdrawal by Subject|1
2181099|NCT01408914|3807827|FG001|Overall Study|Withdrawal by Subject|0
2181100|NCT01408914|3807828|FG002|Overall Study|Withdrawal by Subject|1
2181101|NCT01408914|3807826|FG000|Overall Study|Moved out of study jurisdiction|1
2181102|NCT01408914|3807827|FG001|Overall Study|Moved out of study jurisdiction|1
2181103|NCT01408914|3807828|FG002|Overall Study|Moved out of study jurisdiction|0
2181104|NCT01408914|3807826|FG000|Overall Study|Late exclusion|0
2181105|NCT01408914|3807827|FG001|Overall Study|Late exclusion|3
2181106|NCT01408914|3807828|FG002|Overall Study|Late exclusion|3
2181107|NCT01408914|3807826|FG000|Overall Study|Change in local TB/HIV norms|0
2181108|NCT01408914|3807827|FG001|Overall Study|Change in local TB/HIV norms|1
2181109|NCT01408914|3807828|FG002|Overall Study|Change in local TB/HIV norms|1
2181110|NCT01409382|3807881|FG000|Overall Study|Lost to Follow-up|1
2181111|NCT01409382|3807882|FG001|Overall Study|Lost to Follow-up|1
2181112|NCT01409382|3807881|FG000|Overall Study|Protocol Violation|0
2181113|NCT01409382|3807882|FG001|Overall Study|Protocol Violation|3
2181114|NCT01409382|3807881|FG000|Overall Study|Multiple pregnancy|2
2181115|NCT01409382|3807882|FG001|Overall Study|Multiple pregnancy|4
2181116|NCT01409382|3807881|FG000|Overall Study|Still pregnant when study ended|13
2181117|NCT01409382|3807882|FG001|Overall Study|Still pregnant when study ended|2
2181118|NCT01409382|3807881|FG000|Overall Study|Did not manage to get pregnant|64
2181119|NCT01409382|3807882|FG001|Overall Study|Did not manage to get pregnant|70
2181120|NCT01409382|3807881|FG000|Overall Study|Had a 2nd trimester loss after accident|1
2181121|NCT01409382|3807882|FG001|Overall Study|Had a 2nd trimester loss after accident|0
2181122|NCT01409434|3807892|FG000|Overall Study|Protocol Violation|4
2181123|NCT01409564|3807898|FG000|Overall Study|low medication compliance|4
2181124|NCT01409564|3807899|FG001|Overall Study|low medication compliance|3
2181125|NCT01409564|3807898|FG000|Overall Study|brain abnormalities found in T1 MR|1
2181126|NCT01409564|3807899|FG001|Overall Study|brain abnormalities found in T1 MR|2
2181127|NCT01409707|3807912|FG000|Overall Study|Withdrawal by Subject|5
2181128|NCT01409707|3807913|FG001|Overall Study|Withdrawal by Subject|17
2181129|NCT01409707|3807914|FG002|Overall Study|Withdrawal by Subject|16
2181130|NCT01409811|3807921|FG000|Overall Study|Insurance denial|1
2181131|NCT01409837|3807927|FG000|Overall Study|Withdrawal by Subject|2
2219338|NCT01721161|3863196|FG000|Overall Study|Withdrawal by Subject|1
2219339|NCT01721161|3863197|FG001|Overall Study|Withdrawal by Subject|1
2219340|NCT01721161|3863196|FG000|Overall Study|Other|0
2219341|NCT01721161|3863197|FG001|Overall Study|Other|1
2181132|NCT01409837|3807928|FG001|Overall Study|Withdrawal by Subject|1
2181133|NCT01409837|3807927|FG000|Overall Study|Lost to Follow-up|1
2181134|NCT01409837|3807928|FG001|Overall Study|Lost to Follow-up|0
2219342|NCT01721200|3863206|FG000|Overall Study|Lost to Follow-up|3
2219343|NCT01721200|3863207|FG001|Overall Study|Lost to Follow-up|5
2219344|NCT01721317|3863229|FG000|Overall Study|Study Closed / Terminated|2
2219345|NCT01721317|3863230|FG001|Overall Study|Study Closed / Terminated|2
2219346|NCT01721317|3863229|FG000|Overall Study|Physician Decision|0
2219347|NCT01721317|3863230|FG001|Overall Study|Physician Decision|1
2219348|NCT01721317|3863229|FG000|Overall Study|Withdrawal by Subject|0
2219349|NCT01721317|3863230|FG001|Overall Study|Withdrawal by Subject|1
2219350|NCT01721330|3863238|FG000|Overall Study|Withdrawal by Subject|0
2219351|NCT01721330|3863239|FG001|Overall Study|Withdrawal by Subject|1
2219352|NCT01721369|3863245|FG000|Overall Study|Not initial etiological diagnosis|12
2219353|NCT01721408|3863251|FG000|Overall Study|Adverse Event|6
2219354|NCT01721408|3863252|FG001|Overall Study|Adverse Event|1
2219355|NCT01721408|3863251|FG000|Overall Study|Death|1
2219356|NCT01721408|3863252|FG001|Overall Study|Death|0
2219357|NCT01721408|3863251|FG000|Overall Study|Insufficient clinical response|15
2219358|NCT01721408|3863252|FG001|Overall Study|Insufficient clinical response|6
2181135|NCT01409837|3807927|FG000|Overall Study|Physician Decision|0
2181136|NCT01409837|3807928|FG001|Overall Study|Physician Decision|1
2181137|NCT01409915|3807938|FG000|Overall Study|Adverse Event|0
2181138|NCT01409915|3807939|FG001|Overall Study|Adverse Event|2
2181139|NCT01409915|3807938|FG000|Overall Study|Withdrawal by Subject|0
2181140|NCT01409915|3807939|FG001|Overall Study|Withdrawal by Subject|1
2181141|NCT01409915|3807938|FG000|Overall Study|Protocol Violation|1
2181142|NCT01409915|3807939|FG001|Overall Study|Protocol Violation|0
2181143|NCT01409928|3807945|FG000|Overall Study|Physician Decision|12
2181144|NCT01409993|3807951|FG000|Overall Study|Adverse Event|4
2181145|NCT01409993|3807952|FG001|Overall Study|Adverse Event|4
2181146|NCT01409993|3807953|FG002|Overall Study|Adverse Event|3
2181147|NCT01409993|3807954|FG003|Overall Study|Adverse Event|1
2181148|NCT01409993|3807951|FG000|Overall Study|Withdrawal by Subject|0
2181149|NCT01409993|3807952|FG001|Overall Study|Withdrawal by Subject|0
2181150|NCT01409993|3807953|FG002|Overall Study|Withdrawal by Subject|0
2181151|NCT01409993|3807954|FG003|Overall Study|Withdrawal by Subject|4
2181152|NCT01409993|3807951|FG000|Overall Study|Lost to Follow-up|0
2181153|NCT01409993|3807952|FG001|Overall Study|Lost to Follow-up|1
2181154|NCT01409993|3807953|FG002|Overall Study|Lost to Follow-up|0
2181155|NCT01409993|3807954|FG003|Overall Study|Lost to Follow-up|0
2181156|NCT01410110|3807999|FG000|Overall Study|Withdrawal by Subject|4
2181157|NCT01410110|3808000|FG001|Overall Study|Withdrawal by Subject|2
2181158|NCT01410227|3808006|FG000|Overall Study|Adverse Event|1
2181159|NCT01410227|3808007|FG001|Overall Study|Adverse Event|0
2181160|NCT01410227|3808008|FG002|Overall Study|Adverse Event|0
2181161|NCT01410227|3808009|FG003|Overall Study|Adverse Event|0
2181162|NCT01410227|3808006|FG000|Overall Study|Withdrawal by Subject|3
2181163|NCT01410227|3808007|FG001|Overall Study|Withdrawal by Subject|0
2181164|NCT01410227|3808008|FG002|Overall Study|Withdrawal by Subject|1
2181165|NCT01410227|3808009|FG003|Overall Study|Withdrawal by Subject|0
2181166|NCT01410227|3808006|FG000|Overall Study|Pregnancy|0
2181167|NCT01410227|3808007|FG001|Overall Study|Pregnancy|0
2181168|NCT01410227|3808008|FG002|Overall Study|Pregnancy|0
2181169|NCT01410227|3808009|FG003|Overall Study|Pregnancy|1
2181170|NCT01410227|3808006|FG000|Overall Study|Met Excl. Criteria After Starting Study|0
2181171|NCT01410227|3808007|FG001|Overall Study|Met Excl. Criteria After Starting Study|0
2181172|NCT01410227|3808008|FG002|Overall Study|Met Excl. Criteria After Starting Study|1
2181173|NCT01410227|3808009|FG003|Overall Study|Met Excl. Criteria After Starting Study|0
2181174|NCT01410240|3808022|FG000|Overall Study|Physician Decision|0
2181175|NCT01410240|3808023|FG001|Overall Study|Physician Decision|0
2181176|NCT01410240|3808024|FG002|Overall Study|Physician Decision|1
2181177|NCT01410240|3808022|FG000|Overall Study|Missed week 6 assessments|1
2181178|NCT01410240|3808023|FG001|Overall Study|Missed week 6 assessments|1
2181179|NCT01410240|3808024|FG002|Overall Study|Missed week 6 assessments|1
2181180|NCT01410357|3808041|FG000|Overall Study|Death|2
2181181|NCT01410357|3808042|FG001|Overall Study|Death|1
2181182|NCT01410357|3808041|FG000|Overall Study|Withdrawal by Subject|1
2181183|NCT01410357|3808042|FG001|Overall Study|Withdrawal by Subject|2
2181184|NCT01410357|3808041|FG000|Overall Study|Lost to Follow-up|23
2181185|NCT01410357|3808042|FG001|Overall Study|Lost to Follow-up|21
2181186|NCT01410448|3808061|FG000|Overall Study|No conversion to everolimus|0
2181187|NCT01410448|3808062|FG001|Overall Study|No conversion to everolimus|24
2181188|NCT01410448|3808061|FG000|Overall Study|Graft loss|4
2181189|NCT01410448|3808062|FG001|Overall Study|Graft loss|1
2181190|NCT01410448|3808061|FG000|Overall Study|Administrative issues|2
2181191|NCT01410448|3808062|FG001|Overall Study|Administrative issues|1
2181192|NCT01410448|3808061|FG000|Overall Study|Lost to Follow-up|1
2181193|NCT01410448|3808062|FG001|Overall Study|Lost to Follow-up|0
2181194|NCT01410448|3808061|FG000|Overall Study|Withdrawal by Subject|3
2181195|NCT01410448|3808062|FG001|Overall Study|Withdrawal by Subject|2
2181196|NCT01410448|3808061|FG000|Overall Study|Protocol Violation|0
2181197|NCT01410448|3808062|FG001|Overall Study|Protocol Violation|4
2181198|NCT01410448|3808061|FG000|Overall Study|Death|2
2181199|NCT01410448|3808062|FG001|Overall Study|Death|3
2181200|NCT01410474|3808070|FG000|Overall Study|Withdrawal by Subject|0
2181201|NCT01410474|3808071|FG001|Overall Study|Withdrawal by Subject|1
2181202|NCT01410604|3808100|FG000|Overall Study|Adverse Event|2
2181203|NCT01410604|3808101|FG001|Overall Study|Adverse Event|1
2181204|NCT01410604|3808100|FG000|Overall Study|Lost to Follow-up|1
2181205|NCT01410604|3808101|FG001|Overall Study|Lost to Follow-up|0
2181206|NCT01410604|3808100|FG000|Overall Study|Physician Decision|0
2181207|NCT01410604|3808101|FG001|Overall Study|Physician Decision|1
2181208|NCT01410890|3808126|FG000|Overall Study|Withdrawal by Subject|0
2181209|NCT01410890|3808127|FG001|Overall Study|Withdrawal by Subject|1
2181210|NCT01411085|3808135|FG000|Overall Study|Physician Decision|1
2181211|NCT01411085|3808135|FG000|Overall Study|Protocol Violation|1
2181212|NCT01411085|3808135|FG000|Overall Study|Adverse Event|1
2219359|NCT01721408|3863251|FG000|Overall Study|No longer willing to participate study|9
2219360|NCT01721408|3863252|FG001|Overall Study|No longer willing to participate study|10
2219361|NCT01721408|3863251|FG000|Overall Study|Protocol Violation|0
2219362|NCT01721408|3863252|FG001|Overall Study|Protocol Violation|2
2219363|NCT01721408|3863251|FG000|Overall Study|Other|3
2219364|NCT01721408|3863252|FG001|Overall Study|Other|3
2219365|NCT01721408|3863251|FG000|Overall Study|Lost to Follow-up|1
2219366|NCT01721408|3863252|FG001|Overall Study|Lost to Follow-up|2
2219367|NCT01721408|3863251|FG000|Overall Study|Does not meet entrance criteria|1
2219368|NCT01721408|3863252|FG001|Overall Study|Does not meet entrance criteria|0
2219369|NCT01721486|3863291|FG000|Overall Study|Protocol Violation|1
2219370|NCT01721486|3863292|FG001|Overall Study|Protocol Violation|0
2219371|NCT01721486|3863291|FG000|Overall Study|Physician Decision|0
2219372|NCT01721486|3863292|FG001|Overall Study|Physician Decision|1
2219373|NCT01721746|3863312|FG000|Treatment Period|Disease Progression|182
2219374|NCT01721746|3863313|FG001|Treatment Period|Disease Progression|40
2219375|NCT01721746|3863314|FG002|Treatment Period|Disease Progression|34
2219376|NCT01721746|3863312|FG000|Treatment Period|Study Drug Toxicity|15
2219377|NCT01721746|3863313|FG001|Treatment Period|Study Drug Toxicity|2
2219378|NCT01721746|3863314|FG002|Treatment Period|Study Drug Toxicity|9
2219379|NCT01721746|3863312|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|6
2219380|NCT01721746|3863313|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|1
2219381|NCT01721746|3863314|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|2
2219382|NCT01721746|3863312|FG000|Treatment Period|Subject Request to Discontinue Treatment|19
2219383|NCT01721746|3863313|FG001|Treatment Period|Subject Request to Discontinue Treatment|1
2219384|NCT01721746|3863314|FG002|Treatment Period|Subject Request to Discontinue Treatment|6
2219385|NCT01721746|3863312|FG000|Treatment Period|Subject Withdrew Consent|3
2219386|NCT01721746|3863313|FG001|Treatment Period|Subject Withdrew Consent|0
2219387|NCT01721746|3863314|FG002|Treatment Period|Subject Withdrew Consent|2
2219388|NCT01721746|3863312|FG000|Treatment Period|Maximum Clinical Benefit|1
2219389|NCT01721746|3863313|FG001|Treatment Period|Maximum Clinical Benefit|0
2219390|NCT01721746|3863314|FG002|Treatment Period|Maximum Clinical Benefit|3
2219391|NCT01721746|3863312|FG000|Treatment Period|Poor/Non-compliance|1
2219392|NCT01721746|3863313|FG001|Treatment Period|Poor/Non-compliance|0
2219393|NCT01721746|3863314|FG002|Treatment Period|Poor/Non-compliance|0
2219394|NCT01721746|3863312|FG000|Treatment Period|Subject No Longer Met Study Criteria|4
2219395|NCT01721746|3863313|FG001|Treatment Period|Subject No Longer Met Study Criteria|0
2219396|NCT01721746|3863314|FG002|Treatment Period|Subject No Longer Met Study Criteria|0
2219397|NCT01721746|3863312|FG000|Treatment Period|Other|2
2219398|NCT01721746|3863313|FG001|Treatment Period|Other|1
2219399|NCT01721746|3863314|FG002|Treatment Period|Other|1
2219400|NCT01721772|3863322|FG000|Overall Study|Disease progression|96
2219401|NCT01721772|3863323|FG001|Overall Study|Disease progression|175
2219402|NCT01721772|3863322|FG000|Overall Study|Study drug toxicity|5
2219403|NCT01721772|3863323|FG001|Overall Study|Study drug toxicity|7
2219404|NCT01721772|3863322|FG000|Overall Study|Unrelated adverse event|2
2219405|NCT01721772|3863323|FG001|Overall Study|Unrelated adverse event|3
2219406|NCT01721772|3863322|FG000|Overall Study|Withdrawal by Subject|7
2219407|NCT01721772|3863323|FG001|Overall Study|Withdrawal by Subject|5
2219408|NCT01721772|3863322|FG000|Overall Study|Maximum clinical benefit|1
2219409|NCT01721772|3863323|FG001|Overall Study|Maximum clinical benefit|1
2219410|NCT01721772|3863322|FG000|Overall Study|Other|0
2219411|NCT01721772|3863323|FG001|Overall Study|Other|1
2219412|NCT01721876|3863335|FG000|Overall Study|Not treated|1
2219413|NCT01721876|3863336|FG001|Overall Study|Not treated|4
2219414|NCT01721876|3863335|FG000|Overall Study|Disease progression / relapse|123
2219415|NCT01721876|3863336|FG001|Overall Study|Disease progression / relapse|156
2219416|NCT01721876|3863335|FG000|Overall Study|Death|6
2219417|NCT01721876|3863336|FG001|Overall Study|Death|13
2219418|NCT01721876|3863335|FG000|Overall Study|Adverse Event|41
2219419|NCT01721876|3863336|FG001|Overall Study|Adverse Event|165
2219420|NCT01721876|3863335|FG000|Overall Study|Protocol Violation|2
2219421|NCT01721876|3863336|FG001|Overall Study|Protocol Violation|1
2219422|NCT01721876|3863335|FG000|Overall Study|Withdrawal by Subject|15
2219423|NCT01721876|3863336|FG001|Overall Study|Withdrawal by Subject|38
2219424|NCT01721876|3863335|FG000|Overall Study|Reason not listed|34
2219425|NCT01721876|3863336|FG001|Overall Study|Reason not listed|63
2219426|NCT01721876|3863335|FG000|Overall Study|Sponsor terminated trial|0
2219427|NCT01721876|3863336|FG001|Overall Study|Sponsor terminated trial|4
2219428|NCT01721954|3863344|FG000|Overall Study|Death|58
2219429|NCT01721954|3863345|FG001|Overall Study|Death|64
2219430|NCT01721954|3863344|FG000|Overall Study|Withdrawal by Subject|8
2219431|NCT01721954|3863345|FG001|Overall Study|Withdrawal by Subject|4
2219432|NCT01721954|3863344|FG000|Overall Study|Adverse Event|2
2181213|NCT01411215|3808156|FG000|Overall Study|Adverse Event|1
2181214|NCT01411215|3808157|FG001|Overall Study|Adverse Event|2
2181215|NCT01411215|3808156|FG000|Overall Study|Lack of Efficacy|2
2181216|NCT01411215|3808157|FG001|Overall Study|Lack of Efficacy|4
2181217|NCT01411215|3808156|FG000|Overall Study|Lost to Follow-up|12
2181218|NCT01411215|3808157|FG001|Overall Study|Lost to Follow-up|18
2181219|NCT01411215|3808156|FG000|Overall Study|Did not meet entrance criteria|0
2181220|NCT01411215|3808157|FG001|Overall Study|Did not meet entrance criteria|1
2181221|NCT01411215|3808156|FG000|Overall Study|Study terminated by sponsor|2
2181222|NCT01411215|3808157|FG001|Overall Study|Study terminated by sponsor|15
2181223|NCT01411215|3808156|FG000|Overall Study|Protocol Violation|3
2181224|NCT01411215|3808157|FG001|Overall Study|Protocol Violation|5
2181225|NCT01411215|3808156|FG000|Overall Study|Withdrawal by Subject|34
2181226|NCT01411215|3808157|FG001|Overall Study|Withdrawal by Subject|21
2181227|NCT01411215|3808156|FG000|Overall Study|Other|12
2181228|NCT01411215|3808157|FG001|Overall Study|Other|17
2181229|NCT01411215|3808156|FG000|Overall Study|Screen failure|0
2181230|NCT01411215|3808157|FG001|Overall Study|Screen failure|1
2181231|NCT01411228|3808166|FG000|Overall Study|Lost to Follow-up|0
2181232|NCT01411228|3808167|FG001|Overall Study|Lost to Follow-up|0
2181233|NCT01411228|3808168|FG002|Overall Study|Lost to Follow-up|1
2181234|NCT01411228|3808166|FG000|Overall Study|Withdrawal by Subject|1
2181235|NCT01411228|3808167|FG001|Overall Study|Withdrawal by Subject|0
2181236|NCT01411228|3808168|FG002|Overall Study|Withdrawal by Subject|0
2181237|NCT01411241|3808178|FG000|Overall Study|Protocol Violation|0
2181238|NCT01411241|3808179|FG001|Overall Study|Protocol Violation|5
2181239|NCT01411241|3808178|FG000|Overall Study|Withdrawal by Subject|9
2181240|NCT01411241|3808179|FG001|Overall Study|Withdrawal by Subject|10
2181241|NCT01411241|3808178|FG000|Overall Study|Serious Adverse Event|0
2181242|NCT01411241|3808179|FG001|Overall Study|Serious Adverse Event|3
2181243|NCT01411241|3808178|FG000|Overall Study|Lost to Follow-up|2
2181244|NCT01411241|3808179|FG001|Overall Study|Lost to Follow-up|4
2181245|NCT01411319|3808218|FG000|Overall Study|Lost to Follow-up|1
2181246|NCT01411774|3808271|FG000|Overall Study|Withdrawal by Subject|0
2181247|NCT01411774|3808272|FG001|Overall Study|Withdrawal by Subject|3
2181248|NCT01411839|3808280|FG000|Overall Study|Lost to Follow-up|4
2181249|NCT01411839|3808281|FG001|Overall Study|Lost to Follow-up|3
2181250|NCT01411852|3808289|FG000|Prehospital Intervention Phase|No qualifying SBP|5
2181251|NCT01411852|3808290|FG001|Prehospital Intervention Phase|No qualifying SBP|4
2181252|NCT01411852|3808289|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
2181253|NCT01411852|3808290|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
2181254|NCT01411852|3808289|FG000|Prehospital Intervention Phase|Found to be under age|0
2181255|NCT01411852|3808290|FG001|Prehospital Intervention Phase|Found to be under age|1
2181256|NCT01411852|3808289|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
2181257|NCT01411852|3808290|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
2181258|NCT01411852|3808289|FG000|Hospital Intervention Phase|Severe head injury|5
2181259|NCT01411852|3808290|FG001|Hospital Intervention Phase|Severe head injury|4
2181260|NCT01411852|3808289|FG000|Hospital Intervention Phase|No qualifying SBP|5
2181261|NCT01411852|3808290|FG001|Hospital Intervention Phase|No qualifying SBP|1
2181262|NCT01411852|3808289|FG000|Hospital Intervention Phase|Miscommunication error|1
2181263|NCT01411852|3808290|FG001|Hospital Intervention Phase|Miscommunication error|2
2181264|NCT01411852|3808289|FG000|Hospital Intervention Phase|CPR administered|3
2181265|NCT01411852|3808290|FG001|Hospital Intervention Phase|CPR administered|1
2181266|NCT01411852|3808289|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4
2181267|NCT01411852|3808290|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1
2181268|NCT01411852|3808289|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0
2181269|NCT01411852|3808290|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2
2181270|NCT01411852|3808289|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0
2181271|NCT01411852|3808290|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1
2181272|NCT01411852|3808289|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
2181273|NCT01411852|3808290|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
2181274|NCT01411852|3808289|FG000|Hospital Intervention Phase|Other ineligible|2
2181275|NCT01411852|3808290|FG001|Hospital Intervention Phase|Other ineligible|2
2181276|NCT01411852|3808289|FG000|Hospital Intervention Phase|Spinal cord injury|2
2181277|NCT01411852|3808290|FG001|Hospital Intervention Phase|Spinal cord injury|0
2181278|NCT01411852|3808289|FG000|Hospital Intervention Phase|Withdrawal by Subject|1
2181279|NCT01411852|3808290|FG001|Hospital Intervention Phase|Withdrawal by Subject|0
2181280|NCT01411852|3808289|FG000|Hospital Intervention Phase|Vascular access failed|1
2181281|NCT01411852|3808290|FG001|Hospital Intervention Phase|Vascular access failed|0
2181282|NCT01411891|3808300|FG000|Overall Study|Catheter dislodgement or loss to follow-|3
2181283|NCT01411891|3808301|FG001|Overall Study|Catheter dislodgement or loss to follow-|2
2181284|NCT01411917|3808309|FG000|Overall Study|Patient did not undergo scheduled surger|0
2181285|NCT01411917|3808310|FG001|Overall Study|Patient did not undergo scheduled surger|1
2181286|NCT01411995|3808318|FG000|Overall Study|Failed IUD insertion|0
2181287|NCT01411995|3808319|FG001|Overall Study|Failed IUD insertion|1
2181288|NCT01412021|3808325|FG000|Overall Study|Case Report Forms Not Retrieved|7
2181289|NCT01412021|3808325|FG000|Overall Study|Treatment Prior to Approval|3
2181290|NCT01412021|3808325|FG000|Overall Study|Transferred to Other Hospital|9
2181291|NCT01412060|3808329|FG000|Open-label Run-in Period (RIP)|Adverse Event|86
2181292|NCT01412060|3808330|FG001|Open-label Run-in Period (RIP)|Adverse Event|0
2181293|NCT01412060|3808331|FG002|Open-label Run-in Period (RIP)|Adverse Event|0
2181294|NCT01412060|3808329|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
2181295|NCT01412060|3808330|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
2181296|NCT01412060|3808331|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
2181297|NCT01412060|3808329|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27
2181298|NCT01412060|3808330|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0
2181299|NCT01412060|3808331|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0
2181300|NCT01412060|3808329|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
2181301|NCT01412060|3808330|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
2181302|NCT01412060|3808331|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
2181303|NCT01412060|3808329|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32
2181304|NCT01412060|3808330|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0
2181305|NCT01412060|3808331|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0
2181306|NCT01412060|3808329|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
2181307|NCT01412060|3808330|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
2181308|NCT01412060|3808331|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
2181309|NCT01412060|3808329|FG000|Period Between RIP and SP|Adverse Event|4
2181310|NCT01412060|3808330|FG001|Period Between RIP and SP|Adverse Event|0
2181311|NCT01412060|3808331|FG002|Period Between RIP and SP|Adverse Event|0
2181312|NCT01412060|3808329|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19
2181313|NCT01412060|3808330|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0
2181314|NCT01412060|3808331|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0
2181315|NCT01412060|3808329|FG000|Period Between RIP and SP|Protocol Violation|2
2181316|NCT01412060|3808330|FG001|Period Between RIP and SP|Protocol Violation|0
2181317|NCT01412060|3808331|FG002|Period Between RIP and SP|Protocol Violation|0
2181318|NCT01412060|3808329|FG000|Period Between RIP and SP|Withdrawal of Consent|1
2181319|NCT01412060|3808330|FG001|Period Between RIP and SP|Withdrawal of Consent|0
2181320|NCT01412060|3808331|FG002|Period Between RIP and SP|Withdrawal of Consent|0
2181321|NCT01412060|3808329|FG000|Period Between RIP and SP|Lost to Follow-up|5
2181322|NCT01412060|3808330|FG001|Period Between RIP and SP|Lost to Follow-up|0
2181323|NCT01412060|3808331|FG002|Period Between RIP and SP|Lost to Follow-up|0
2181324|NCT01412060|3808329|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23
2181325|NCT01412060|3808330|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0
2181326|NCT01412060|3808331|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0
2181327|NCT01412060|3808329|FG000|Open-label Stabilization Period (SP)|Adverse Event|9
2181328|NCT01412060|3808330|FG001|Open-label Stabilization Period (SP)|Adverse Event|0
2181329|NCT01412060|3808331|FG002|Open-label Stabilization Period (SP)|Adverse Event|0
2181330|NCT01412060|3808329|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
2181331|NCT01412060|3808330|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
2181332|NCT01412060|3808331|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
2181333|NCT01412060|3808329|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14
2181334|NCT01412060|3808330|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0
2181335|NCT01412060|3808331|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0
2181336|NCT01412060|3808329|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
2181337|NCT01412060|3808330|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
2181338|NCT01412060|3808331|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
2181339|NCT01412060|3808329|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9
2181340|NCT01412060|3808330|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0
2181341|NCT01412060|3808331|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0
2181342|NCT01412060|3808329|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
2181343|NCT01412060|3808330|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
2181344|NCT01412060|3808331|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
2181345|NCT01412060|3808329|FG000|Period Between SP and DBP|Protocol Violation|2
2181346|NCT01412060|3808330|FG001|Period Between SP and DBP|Protocol Violation|0
2181347|NCT01412060|3808331|FG002|Period Between SP and DBP|Protocol Violation|0
2181348|NCT01412060|3808329|FG000|Period Between SP and DBP|Withdrawal of Consent|2
2181349|NCT01412060|3808330|FG001|Period Between SP and DBP|Withdrawal of Consent|0
2181350|NCT01412060|3808331|FG002|Period Between SP and DBP|Withdrawal of Consent|0
2181351|NCT01412060|3808329|FG000|Period Between SP and DBP|Lost to Follow-up|1
2181352|NCT01412060|3808330|FG001|Period Between SP and DBP|Lost to Follow-up|0
2181353|NCT01412060|3808331|FG002|Period Between SP and DBP|Lost to Follow-up|0
2181354|NCT01412060|3808329|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
2181355|NCT01412060|3808330|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
2181356|NCT01412060|3808331|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
2181357|NCT01412060|3808329|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55
2181358|NCT01412060|3808330|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0
2181359|NCT01412060|3808331|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0
2181360|NCT01412060|3808329|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0
2181361|NCT01412060|3808330|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5
2181362|NCT01412060|3808331|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6
2181363|NCT01412060|3808329|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0
2181364|NCT01412060|3808330|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4
2181365|NCT01412060|3808331|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5
2181366|NCT01412060|3808329|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
2181367|NCT01412060|3808330|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
2181368|NCT01412060|3808331|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
2181369|NCT01412060|3808329|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
2181370|NCT01412060|3808330|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
2181371|NCT01412060|3808331|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
2181372|NCT01412060|3808329|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
2181373|NCT01412060|3808330|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
2181374|NCT01412060|3808331|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
2181375|NCT01412060|3808329|FG000|Double-blind Treatment Phase (DBP)|Relapse|0
2181376|NCT01412060|3808330|FG001|Double-blind Treatment Phase (DBP)|Relapse|47
2181377|NCT01412060|3808331|FG002|Double-blind Treatment Phase (DBP)|Relapse|25
2181378|NCT01412151|3808345|FG000|Week 0 - 306 - Treatment Period|Death|1
2181379|NCT01412151|3808345|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
2181380|NCT01412151|3808345|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
2181381|NCT01412151|3808345|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
2181382|NCT01412229|3808355|FG000|Overall Study|Physician Decision|1
2181383|NCT01412424|3808386|FG000|Core Treatment Period|Treatment Failure|24
2181384|NCT01412424|3808386|FG000|Core Treatment Period|Adverse Event|21
2181385|NCT01412424|3808386|FG000|Core Treatment Period|Patient Request|5
2181386|NCT01412424|3808386|FG000|Core Treatment Period|Lost to Follow-up|2
2181387|NCT01412424|3808386|FG000|Core Treatment Period|Sponsor Request|1
2181388|NCT01412424|3808386|FG000|Extension Treatment Period|Adverse Event|2
2181389|NCT01412424|3808386|FG000|Extension Treatment Period|Treatment Failure|2
2181390|NCT01412424|3808386|FG000|Extension Treatment Period|Patient Request|2
2181391|NCT01412801|3808427|FG000|Overall Study|Death|0
2181392|NCT01412801|3808428|FG001|Overall Study|Death|1
2181393|NCT01412801|3808429|FG002|Overall Study|Death|0
2181394|NCT01412801|3808430|FG003|Overall Study|Death|4
2181395|NCT01412801|3808431|FG004|Overall Study|Death|2
2181396|NCT01412801|3808432|FG005|Overall Study|Death|2
2181397|NCT01412801|3808427|FG000|Overall Study|Lost to Follow-up|1
2181398|NCT01412801|3808428|FG001|Overall Study|Lost to Follow-up|2
2181399|NCT01412801|3808429|FG002|Overall Study|Lost to Follow-up|4
2181400|NCT01412801|3808430|FG003|Overall Study|Lost to Follow-up|0
2181401|NCT01412801|3808431|FG004|Overall Study|Lost to Follow-up|1
2181402|NCT01412801|3808432|FG005|Overall Study|Lost to Follow-up|1
2181403|NCT01412801|3808427|FG000|Overall Study|Withdrawal by Subject|3
2181404|NCT01412801|3808428|FG001|Overall Study|Withdrawal by Subject|2
2181405|NCT01412801|3808429|FG002|Overall Study|Withdrawal by Subject|1
2181406|NCT01412801|3808430|FG003|Overall Study|Withdrawal by Subject|0
2181407|NCT01412801|3808431|FG004|Overall Study|Withdrawal by Subject|0
2181408|NCT01412801|3808432|FG005|Overall Study|Withdrawal by Subject|0
2181409|NCT01412801|3808427|FG000|Overall Study|Relocated to another area|0
2181410|NCT01412801|3808428|FG001|Overall Study|Relocated to another area|0
2181411|NCT01412801|3808429|FG002|Overall Study|Relocated to another area|2
2181412|NCT01412801|3808430|FG003|Overall Study|Relocated to another area|0
2181413|NCT01412801|3808431|FG004|Overall Study|Relocated to another area|0
2181414|NCT01412801|3808432|FG005|Overall Study|Relocated to another area|0
2181415|NCT01412879|3808466|FG000|Initial Registration (Induction Therapy)|Adverse Event|5
2181416|NCT01412879|3808467|FG001|Initial Registration (Induction Therapy)|Adverse Event|3
2181417|NCT01412879|3808468|FG002|Initial Registration (Induction Therapy)|Adverse Event|0
2181418|NCT01412879|3808466|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
2181419|NCT01412879|3808467|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
2181420|NCT01412879|3808468|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
2181421|NCT01412879|3808466|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0
2181422|NCT01412879|3808467|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1
2181423|NCT01412879|3808468|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0
2181424|NCT01412879|3808466|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
2181425|NCT01412879|3808467|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
2181426|NCT01412879|3808468|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
2181427|NCT01412879|3808466|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1
2181428|NCT01412879|3808467|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0
2181429|NCT01412879|3808468|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0
2181430|NCT01412944|3808490|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2181431|NCT01412944|3808491|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2181432|NCT01412944|3808492|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
2181433|NCT01412944|3808493|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2181434|NCT01412944|3808494|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2181435|NCT01412944|3808495|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2181436|NCT01412944|3808490|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2181437|NCT01412944|3808491|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2181438|NCT01412944|3808492|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2181439|NCT01412944|3808493|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2181440|NCT01412944|3808494|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2181441|NCT01412944|3808495|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
2181442|NCT01412944|3808490|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2181443|NCT01412944|3808491|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2181444|NCT01412944|3808492|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2181445|NCT01412944|3808493|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2181446|NCT01412944|3808494|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2181447|NCT01412944|3808495|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
2181448|NCT01412944|3808490|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1
2181449|NCT01412944|3808491|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0
2181450|NCT01412944|3808492|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0
2181451|NCT01412944|3808493|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0
2181452|NCT01412944|3808494|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0
2181453|NCT01412944|3808495|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0
2181454|NCT01412944|3808490|FG000|IV: Per CAIN457A2307|Protocol deviation|0
2181455|NCT01412944|3808491|FG001|IV: Per CAIN457A2307|Protocol deviation|1
2181456|NCT01412944|3808492|FG002|IV: Per CAIN457A2307|Protocol deviation|0
2181457|NCT01412944|3808493|FG003|IV: Per CAIN457A2307|Protocol deviation|0
2181458|NCT01412944|3808494|FG004|IV: Per CAIN457A2307|Protocol deviation|0
2181459|NCT01412944|3808495|FG005|IV: Per CAIN457A2307|Protocol deviation|0
2181460|NCT01412944|3808490|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0
2181461|NCT01412944|3808491|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1
2181462|NCT01412944|3808492|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0
2181463|NCT01412944|3808493|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0
2181464|NCT01412944|3808494|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0
2181465|NCT01412944|3808495|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0
2181466|NCT01412944|3808490|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0
2181467|NCT01412944|3808491|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0
2181468|NCT01412944|3808492|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1
2181469|NCT01412944|3808493|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1
2181470|NCT01412944|3808494|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1
2181471|NCT01412944|3808495|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
2181472|NCT01412944|3808490|FG000|Entire: IV + Maintenance|Adverse Event|0
2181473|NCT01412944|3808491|FG001|Entire: IV + Maintenance|Adverse Event|0
2181474|NCT01412944|3808492|FG002|Entire: IV + Maintenance|Adverse Event|0
2181475|NCT01412944|3808493|FG003|Entire: IV + Maintenance|Adverse Event|0
2181476|NCT01412944|3808494|FG004|Entire: IV + Maintenance|Adverse Event|1
2181477|NCT01412944|3808495|FG005|Entire: IV + Maintenance|Adverse Event|0
2181478|NCT01412944|3808490|FG000|Entire: IV + Maintenance|Protocol deviation|0
2181479|NCT01412944|3808491|FG001|Entire: IV + Maintenance|Protocol deviation|0
2181480|NCT01412944|3808492|FG002|Entire: IV + Maintenance|Protocol deviation|0
2181481|NCT01412944|3808493|FG003|Entire: IV + Maintenance|Protocol deviation|0
2181482|NCT01412944|3808494|FG004|Entire: IV + Maintenance|Protocol deviation|0
2181483|NCT01412944|3808495|FG005|Entire: IV + Maintenance|Protocol deviation|1
2181484|NCT01412944|3808490|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
2181485|NCT01412944|3808491|FG001|Entire: IV + Maintenance|Lost to Follow-up|0
2181486|NCT01412944|3808492|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
2181487|NCT01412944|3808493|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
2181488|NCT01412944|3808494|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
2181489|NCT01412944|3808495|FG005|Entire: IV + Maintenance|Lost to Follow-up|1
2181490|NCT01412944|3808490|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
2181491|NCT01412944|3808491|FG001|Entire: IV + Maintenance|Lack of Efficacy|0
2181492|NCT01412944|3808492|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
2181493|NCT01412944|3808493|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
2181494|NCT01412944|3808494|FG004|Entire: IV + Maintenance|Lack of Efficacy|1
2181495|NCT01412944|3808495|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
2181496|NCT01412944|3808490|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2
2181497|NCT01412944|3808491|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1
2181498|NCT01412944|3808492|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0
2181499|NCT01412944|3808493|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0
2181500|NCT01412944|3808494|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0
2181501|NCT01412944|3808495|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
2181502|NCT01412944|3808490|FG000|Entire: IV + Maintenance|Protocol deviation|0
2181503|NCT01412944|3808491|FG001|Entire: IV + Maintenance|Protocol deviation|1
2181504|NCT01412944|3808492|FG002|Entire: IV + Maintenance|Protocol deviation|0
2181505|NCT01412944|3808493|FG003|Entire: IV + Maintenance|Protocol deviation|0
2181506|NCT01412944|3808494|FG004|Entire: IV + Maintenance|Protocol deviation|0
2181507|NCT01412944|3808495|FG005|Entire: IV + Maintenance|Protocol deviation|0
2181508|NCT01412944|3808490|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
2181509|NCT01412944|3808491|FG001|Entire: IV + Maintenance|Lost to Follow-up|1
2181510|NCT01412944|3808492|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
2181511|NCT01412944|3808493|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
2181512|NCT01412944|3808494|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
2181513|NCT01412944|3808495|FG005|Entire: IV + Maintenance|Lost to Follow-up|0
2181514|NCT01412944|3808490|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
2181515|NCT01412944|3808491|FG001|Entire: IV + Maintenance|Lack of Efficacy|1
2181516|NCT01412944|3808492|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
2181517|NCT01412944|3808493|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
2181518|NCT01412944|3808494|FG004|Entire: IV + Maintenance|Lack of Efficacy|0
2181519|NCT01412944|3808495|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
2181520|NCT01412944|3808490|FG000|Entire: IV + Maintenance|Adverse Event|0
2181521|NCT01412944|3808491|FG001|Entire: IV + Maintenance|Adverse Event|1
2181522|NCT01412944|3808492|FG002|Entire: IV + Maintenance|Adverse Event|0
2181523|NCT01412944|3808493|FG003|Entire: IV + Maintenance|Adverse Event|0
2181524|NCT01412944|3808494|FG004|Entire: IV + Maintenance|Adverse Event|0
2181525|NCT01412944|3808495|FG005|Entire: IV + Maintenance|Adverse Event|0
2181526|NCT01412957|3808513|FG000|Overall Study|Withdrawal by Subject|6
2181527|NCT01412957|3808514|FG001|Overall Study|Withdrawal by Subject|22
2181528|NCT01412957|3808513|FG000|Overall Study|Lost to Follow-up|7
2181529|NCT01412957|3808514|FG001|Overall Study|Lost to Follow-up|2
2181530|NCT01412957|3808513|FG000|Overall Study|Death|136
2181531|NCT01412957|3808514|FG001|Overall Study|Death|133
2181532|NCT01412983|3808520|FG000|1st Period|Ineligible|0
2181533|NCT01412983|3808521|FG001|1st Period|Ineligible|1
2181534|NCT01412983|3808520|FG000|1st Period|Positive slit lamp finding|0
2181535|NCT01412983|3808521|FG001|1st Period|Positive slit lamp finding|1
2181536|NCT01412983|3808520|FG000|1st Period|Unacceptable lens movement|0
2181537|NCT01412983|3808521|FG001|1st Period|Unacceptable lens movement|1
2181538|NCT01412983|3808520|FG000|1st Period|Inability to maintain wear|0
2181539|NCT01412983|3808521|FG001|1st Period|Inability to maintain wear|1
2181540|NCT01413178|3808539|FG000|Overall Study|Toxicity|1
2181541|NCT01413178|3808540|FG001|Overall Study|Toxicity|0
2181542|NCT01413178|3808539|FG000|Overall Study|Ineligible|0
2181543|NCT01413178|3808540|FG001|Overall Study|Ineligible|2
2181544|NCT01413191|3808546|FG000|Overall Study|Lost to Follow-up|5
2181545|NCT01413191|3808546|FG000|Overall Study|Disease Progression|5
2181546|NCT01413191|3808546|FG000|Overall Study|Death|1
2181547|NCT01413204|3808553|FG000|Overall Study|Adverse Event|1
2181548|NCT01413204|3808554|FG001|Overall Study|Adverse Event|2
2181549|NCT01413204|3808555|FG002|Overall Study|Adverse Event|2
2181550|NCT01413204|3808553|FG000|Overall Study|Physician Decision|3
2181551|NCT01413204|3808554|FG001|Overall Study|Physician Decision|0
2181552|NCT01413204|3808555|FG002|Overall Study|Physician Decision|2
2181553|NCT01413204|3808553|FG000|Overall Study|Withdrawal by Subject|1
2181554|NCT01413204|3808554|FG001|Overall Study|Withdrawal by Subject|4
2181555|NCT01413204|3808555|FG002|Overall Study|Withdrawal by Subject|4
2181556|NCT01413204|3808553|FG000|Overall Study|Clearly not eligible for the study|0
2181557|NCT01413204|3808554|FG001|Overall Study|Clearly not eligible for the study|0
2181558|NCT01413204|3808555|FG002|Overall Study|Clearly not eligible for the study|1
2181559|NCT01413204|3808553|FG000|Overall Study|Fasting plasma glucose level increased|1
2181560|NCT01413204|3808554|FG001|Overall Study|Fasting plasma glucose level increased|0
2181561|NCT01413204|3808555|FG002|Overall Study|Fasting plasma glucose level increased|10
2181562|NCT01413360|3808563|FG000|Overall Study|Lost to Follow-up|2
2181563|NCT01413360|3808563|FG000|Overall Study|Adverse Event|1
2181564|NCT01413503|3808567|FG000|Overall Study|Lost to Follow-up|1
2181565|NCT01413542|3808582|FG000|Overall Study|Physician Decision|1
2181566|NCT01413542|3808583|FG001|Overall Study|Physician Decision|0
2181567|NCT01413542|3808584|FG002|Overall Study|Physician Decision|3
2181568|NCT01413542|3808585|FG003|Overall Study|Physician Decision|0
2181569|NCT01413542|3808582|FG000|Overall Study|Adverse Event|0
2181570|NCT01413542|3808583|FG001|Overall Study|Adverse Event|0
2181571|NCT01413542|3808584|FG002|Overall Study|Adverse Event|0
2181572|NCT01413542|3808585|FG003|Overall Study|Adverse Event|1
2181573|NCT01413958|3808617|FG000|Overall Study|Lost to Follow-up|0
2181574|NCT01413958|3808618|FG001|Overall Study|Lost to Follow-up|1
2181575|NCT01414075|3808661|FG000|Overall Study|Adverse Event|1
2181576|NCT01414075|3808662|FG001|Overall Study|Adverse Event|0
2181577|NCT01414075|3808663|FG002|Overall Study|Adverse Event|1
2181578|NCT01414075|3808664|FG003|Overall Study|Adverse Event|0
2181579|NCT01414075|3808661|FG000|Overall Study|Death|1
2181580|NCT01414075|3808662|FG001|Overall Study|Death|0
2181581|NCT01414075|3808663|FG002|Overall Study|Death|0
2181582|NCT01414075|3808664|FG003|Overall Study|Death|1
2181583|NCT01414075|3808661|FG000|Overall Study|Withdrawal by Subject|0
2181584|NCT01414075|3808662|FG001|Overall Study|Withdrawal by Subject|0
2181585|NCT01414075|3808663|FG002|Overall Study|Withdrawal by Subject|0
2181586|NCT01414075|3808664|FG003|Overall Study|Withdrawal by Subject|1
2181587|NCT01414075|3808661|FG000|Overall Study|Other than specified|1
2181588|NCT01414075|3808662|FG001|Overall Study|Other than specified|0
2181589|NCT01414075|3808663|FG002|Overall Study|Other than specified|1
2181590|NCT01414075|3808664|FG003|Overall Study|Other than specified|0
2181591|NCT01414114|3808674|FG000|Overall Study|Adverse Event|2
2181592|NCT01414114|3808674|FG000|Overall Study|Withdrawal by Subject|1
2181593|NCT01414114|3808674|FG000|Overall Study|Other|2
2219433|NCT01721954|3863345|FG001|Overall Study|Adverse Event|0
2219434|NCT01721954|3863344|FG000|Overall Study|Lost to Follow-up|2
2219435|NCT01721954|3863345|FG001|Overall Study|Lost to Follow-up|1
2219436|NCT01722045|3863355|FG000|Overall Study|Adverse Event|8
2219437|NCT01722045|3863355|FG000|Overall Study|Death|3
2219438|NCT01722045|3863355|FG000|Overall Study|Withdrawal by Subject|8
2219439|NCT01722045|3863355|FG000|Overall Study|Lost to Follow-up|4
2219440|NCT01722045|3863355|FG000|Overall Study|Protocol Deviation|1
2219441|NCT01722045|3863355|FG000|Overall Study|Physician Decision|3
2219442|NCT01722045|3863355|FG000|Overall Study|Relocation (did not wish to transfer)|1
2219443|NCT01722071|3863359|FG000|Overall Study|Protocol Violation|1
2219444|NCT01722071|3863360|FG001|Overall Study|Protocol Violation|0
2273940|NCT02291510|3954655|FG002|Overall Study|Adverse Event|0
2273941|NCT02291510|3954656|FG003|Overall Study|Adverse Event|1
2273942|NCT02291549|3954668|FG000|Overall Study|Lost to Follow-up|1
2273943|NCT02291549|3954669|FG001|Overall Study|Lost to Follow-up|0
2273944|NCT02291549|3954668|FG000|Overall Study|Withdrawal by Subject|0
2273945|NCT02291549|3954669|FG001|Overall Study|Withdrawal by Subject|1
2273946|NCT02291601|3954677|FG000|Abdomen|Did not qualify|333
2273947|NCT02291601|3954678|FG001|Abdomen|Did not qualify|54
2273948|NCT02291601|3954679|FG002|Abdomen|Did not qualify|339
2273949|NCT02291601|3954677|FG000|Groin|Did not qualify|183
2273950|NCT02291601|3954678|FG001|Groin|Did not qualify|30
2273951|NCT02291601|3954679|FG002|Groin|Did not qualify|177
2273952|NCT02291614|3954701|FG000|Overall Study|Lost to Follow-up|0
2273953|NCT02291614|3954702|FG001|Overall Study|Lost to Follow-up|0
2273954|NCT02291614|3954703|FG002|Overall Study|Lost to Follow-up|0
2273955|NCT02291614|3954704|FG003|Overall Study|Lost to Follow-up|0
2273956|NCT02291614|3954705|FG004|Overall Study|Lost to Follow-up|0
2273957|NCT02291614|3954706|FG005|Overall Study|Lost to Follow-up|0
2273958|NCT02291614|3954707|FG006|Overall Study|Lost to Follow-up|0
2273959|NCT02291614|3954708|FG007|Overall Study|Lost to Follow-up|1
2273960|NCT02291614|3954709|FG008|Overall Study|Lost to Follow-up|0
2273961|NCT02291614|3954710|FG009|Overall Study|Lost to Follow-up|0
2273962|NCT02291614|3954711|FG010|Overall Study|Lost to Follow-up|0
2273963|NCT02291614|3954701|FG000|Overall Study|Withdrawal by Subject|0
2273964|NCT02291614|3954702|FG001|Overall Study|Withdrawal by Subject|1
2273965|NCT02291614|3954703|FG002|Overall Study|Withdrawal by Subject|0
2273966|NCT02291614|3954704|FG003|Overall Study|Withdrawal by Subject|0
2273967|NCT02291614|3954705|FG004|Overall Study|Withdrawal by Subject|0
2273968|NCT02291614|3954706|FG005|Overall Study|Withdrawal by Subject|0
2273969|NCT02291614|3954707|FG006|Overall Study|Withdrawal by Subject|0
2273970|NCT02291614|3954708|FG007|Overall Study|Withdrawal by Subject|0
2273971|NCT02291614|3954709|FG008|Overall Study|Withdrawal by Subject|0
2273972|NCT02291614|3954710|FG009|Overall Study|Withdrawal by Subject|2
2273973|NCT02291614|3954711|FG010|Overall Study|Withdrawal by Subject|2
2273974|NCT02291614|3954701|FG000|Overall Study|Decision by sponsor|0
2273975|NCT02291614|3954702|FG001|Overall Study|Decision by sponsor|0
2273976|NCT02291614|3954703|FG002|Overall Study|Decision by sponsor|0
2273977|NCT02291614|3954704|FG003|Overall Study|Decision by sponsor|1
2273978|NCT02291614|3954705|FG004|Overall Study|Decision by sponsor|0
2273979|NCT02291614|3954706|FG005|Overall Study|Decision by sponsor|0
2273980|NCT02291614|3954707|FG006|Overall Study|Decision by sponsor|0
2273981|NCT02291614|3954708|FG007|Overall Study|Decision by sponsor|0
2273982|NCT02291614|3954709|FG008|Overall Study|Decision by sponsor|0
2273983|NCT02291614|3954710|FG009|Overall Study|Decision by sponsor|0
2273984|NCT02291614|3954711|FG010|Overall Study|Decision by sponsor|0
2273985|NCT02291614|3954701|FG000|Overall Study|Death|0
2273986|NCT02291614|3954702|FG001|Overall Study|Death|0
2273987|NCT02291614|3954703|FG002|Overall Study|Death|1
2273988|NCT02291614|3954704|FG003|Overall Study|Death|0
2273989|NCT02291614|3954705|FG004|Overall Study|Death|1
2273990|NCT02291614|3954706|FG005|Overall Study|Death|1
2273991|NCT02291614|3954707|FG006|Overall Study|Death|1
2273992|NCT02291614|3954708|FG007|Overall Study|Death|0
2273993|NCT02291614|3954709|FG008|Overall Study|Death|0
2273994|NCT02291614|3954710|FG009|Overall Study|Death|0
2273995|NCT02291614|3954711|FG010|Overall Study|Death|0
2273996|NCT02291679|3954744|FG000|Overall Study|Adverse Event|2
2273997|NCT02291679|3954745|FG001|Overall Study|Adverse Event|12
2273998|NCT02291679|3954746|FG002|Overall Study|Adverse Event|19
2273999|NCT02291679|3954744|FG000|Overall Study|Protocol Violation|5
2274000|NCT02291679|3954745|FG001|Overall Study|Protocol Violation|1
2274001|NCT02291679|3954746|FG002|Overall Study|Protocol Violation|7
2274002|NCT02291679|3954744|FG000|Overall Study|Withdrew Consent|18
2274003|NCT02291679|3954745|FG001|Overall Study|Withdrew Consent|10
2274004|NCT02291679|3954746|FG002|Overall Study|Withdrew Consent|15
2274005|NCT02291679|3954744|FG000|Overall Study|Lost to Follow-up|12
2274006|NCT02291679|3954745|FG001|Overall Study|Lost to Follow-up|10
2274007|NCT02291679|3954746|FG002|Overall Study|Lost to Follow-up|9
2274008|NCT02291679|3954744|FG000|Overall Study|Insufficient Therapeutic Response|5
2274009|NCT02291679|3954745|FG001|Overall Study|Insufficient Therapeutic Response|5
2274010|NCT02291679|3954746|FG002|Overall Study|Insufficient Therapeutic Response|7
2274011|NCT02291679|3954744|FG000|Overall Study|Other|2
2274012|NCT02291679|3954745|FG001|Overall Study|Other|4
2274013|NCT02291679|3954746|FG002|Overall Study|Other|2
2274014|NCT02291861|3954770|FG000|Overall Study|Adverse Event|2
2181594|NCT01414205|3808699|FG000|Overall Study|Death|5
2181595|NCT01414205|3808700|FG001|Overall Study|Death|1
2181596|NCT01414205|3808699|FG000|Overall Study|Lost to Follow-up|1
2181597|NCT01414205|3808700|FG001|Overall Study|Lost to Follow-up|4
2181598|NCT01414205|3808699|FG000|Overall Study|Physician Decision|0
2181599|NCT01414205|3808700|FG001|Overall Study|Physician Decision|1
2181600|NCT01414205|3808699|FG000|Overall Study|Randomized but not Treated|1
2181601|NCT01414205|3808700|FG001|Overall Study|Randomized but not Treated|1
2181602|NCT01414257|3808715|FG000|Overall Study|No Visit After First Day of Treatment|12
2181603|NCT01414257|3808715|FG000|Overall Study|Protocol Violation|10
2181604|NCT01414738|3808755|FG000|Overall Study|Death|26
2181605|NCT01414738|3808755|FG000|Overall Study|Refused testing|5
2181606|NCT01414738|3808755|FG000|Overall Study|Lost to Follow-up|2
2181607|NCT01414738|3808755|FG000|Overall Study|Refused, disease progression|8
2181608|NCT01414738|3808755|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3
2181609|NCT01414855|3808759|FG000|Overall Study|Death|17
2181610|NCT01414855|3808759|FG000|Overall Study|Lost to Follow-up|5
2181611|NCT01414855|3808759|FG000|Overall Study|Withdrawal by Subject|7
2181612|NCT01415349|3808767|FG000|Treatment Period 1|Adverse Event|0
2181613|NCT01415349|3808768|FG001|Treatment Period 1|Adverse Event|1
2181614|NCT01415349|3808767|FG000|Treatment Period 1|Withdrawal by Subject|0
2181615|NCT01415349|3808768|FG001|Treatment Period 1|Withdrawal by Subject|1
2181616|NCT01415401|3808774|FG000|Overall Study|Adverse Event|5
2181617|NCT01415401|3808774|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1
2181618|NCT01415401|3808774|FG000|Overall Study|Terminated by Sponsor|1
2181619|NCT01415440|3808800|FG000|Overall Study|Lost to Follow-up|0
2181620|NCT01415440|3808801|FG001|Overall Study|Lost to Follow-up|1
2181621|NCT01415440|3808802|FG002|Overall Study|Lost to Follow-up|2
2181622|NCT01415440|3808800|FG000|Overall Study|Physician Decision|3
2181623|NCT01415440|3808801|FG001|Overall Study|Physician Decision|0
2181624|NCT01415440|3808802|FG002|Overall Study|Physician Decision|0
2181625|NCT01415440|3808800|FG000|Overall Study|Withdrawal by Subject|1
2181626|NCT01415440|3808801|FG001|Overall Study|Withdrawal by Subject|0
2181627|NCT01415440|3808802|FG002|Overall Study|Withdrawal by Subject|0
2181628|NCT01415518|3808815|FG000|Overall Study|Withdrawal by Subject|2
2181629|NCT01415518|3808816|FG001|Overall Study|Withdrawal by Subject|12
2181630|NCT01415518|3808815|FG000|Overall Study|Protocol Violation|6
2181631|NCT01415518|3808816|FG001|Overall Study|Protocol Violation|8
2181632|NCT01415518|3808815|FG000|Overall Study|Lost to Follow-up|3
2181633|NCT01415518|3808816|FG001|Overall Study|Lost to Follow-up|5
2181634|NCT01415518|3808815|FG000|Overall Study|Adverse Event|3
2181635|NCT01415518|3808816|FG001|Overall Study|Adverse Event|4
2181636|NCT01415518|3808815|FG000|Overall Study|Death|1
2181637|NCT01415518|3808816|FG001|Overall Study|Death|1
2181638|NCT01415518|3808815|FG000|Overall Study|Condition under Investigation Worsened|1
2181639|NCT01415518|3808816|FG001|Overall Study|Condition under Investigation Worsened|1
2181640|NCT01415531|3808824|FG000|Overall Study|Adverse Event|7
2181641|NCT01415531|3808825|FG001|Overall Study|Adverse Event|10
2181642|NCT01415531|3808824|FG000|Overall Study|Lack of Efficacy|3
2181643|NCT01415531|3808825|FG001|Overall Study|Lack of Efficacy|2
2181644|NCT01415531|3808824|FG000|Overall Study|Protocol Violation|0
2181645|NCT01415531|3808825|FG001|Overall Study|Protocol Violation|1
2181646|NCT01415531|3808824|FG000|Overall Study|Withdrawal by Subject|5
2181647|NCT01415531|3808825|FG001|Overall Study|Withdrawal by Subject|4
2181648|NCT01415531|3808824|FG000|Overall Study|Lost to Follow-up|6
2181649|NCT01415531|3808825|FG001|Overall Study|Lost to Follow-up|14
2181650|NCT01415531|3808824|FG000|Overall Study|Lack of Compliance|1
2181651|NCT01415531|3808825|FG001|Overall Study|Lack of Compliance|4
2181652|NCT01415531|3808824|FG000|Overall Study|Other Reasons|3
2181653|NCT01415531|3808825|FG001|Overall Study|Other Reasons|2
2181654|NCT01415908|3808842|FG000|Overall Study|Withdrawal by Subject|1
2181655|NCT01415908|3808843|FG001|Overall Study|Withdrawal by Subject|0
2181656|NCT01415921|3808851|FG000|Overall Study|Adverse Event|0
2181657|NCT01415921|3808852|FG001|Overall Study|Adverse Event|1
2181658|NCT01415921|3808851|FG000|Overall Study|Physician Decision|1
2181659|NCT01415921|3808852|FG001|Overall Study|Physician Decision|1
2181660|NCT01415921|3808851|FG000|Overall Study|Withdrawal by Subject|0
2181661|NCT01415921|3808852|FG001|Overall Study|Withdrawal by Subject|1
2181662|NCT01415921|3808851|FG000|Overall Study|Other|2
2181663|NCT01415921|3808852|FG001|Overall Study|Other|0
2181664|NCT01416142|3808889|FG000|PureVision2 HD|Inability to maintain lens wear|0
2181665|NCT01416142|3808890|FG001|PureVision2 HD|Inability to maintain lens wear|0
2181666|NCT01416142|3808891|FG002|PureVision2 HD|Inability to maintain lens wear|1
2181667|NCT01416155|3808899|FG000|Overall Study|Adverse Event|8
2181668|NCT01416155|3808899|FG000|Overall Study|Positive for anti-BG00002 antibodies|2
2181669|NCT01416155|3808899|FG000|Overall Study|Withdrawal by Subject|33
2181670|NCT01416155|3808899|FG000|Overall Study|Investigator decision|8
2181671|NCT01416155|3808899|FG000|Overall Study|Other|7
2181672|NCT01416181|3808905|FG000|Part 1|Other|10
2181673|NCT01416181|3808906|FG001|Part 1|Other|24
2181674|NCT01416181|3808905|FG000|Part 1|Death|0
2181675|NCT01416181|3808906|FG001|Part 1|Death|1
2181676|NCT01416181|3808905|FG000|Part 1|Investigator Decision|7
2181677|NCT01416181|3808906|FG001|Part 1|Investigator Decision|6
2181678|NCT01416181|3808905|FG000|Part 1|Withdrawal by Subject|74
2181679|NCT01416181|3808906|FG001|Part 1|Withdrawal by Subject|48
2181680|NCT01416181|3808905|FG000|Part 1|Lack of Efficacy|16
2181681|NCT01416181|3808906|FG001|Part 1|Lack of Efficacy|8
2181682|NCT01416181|3808905|FG000|Part 1|Lost to Follow-up|1
2181683|NCT01416181|3808906|FG001|Part 1|Lost to Follow-up|1
2181684|NCT01416181|3808905|FG000|Part 1|Adverse Event|15
2181685|NCT01416181|3808906|FG001|Part 1|Adverse Event|18
2181686|NCT01416181|3808905|FG000|Part 1|Ongoing in Follow-Up|14
2181687|NCT01416181|3808906|FG001|Part 1|Ongoing in Follow-Up|8
2181688|NCT01416181|3808905|FG000|Part 2|Adverse Event|11
2181689|NCT01416181|3808906|FG001|Part 2|Adverse Event|4
2181690|NCT01416181|3808905|FG000|Part 2|Other|234
2181691|NCT01416181|3808906|FG001|Part 2|Other|267
2181692|NCT01416181|3808905|FG000|Part 2|Investigator Decision|6
2181693|NCT01416181|3808906|FG001|Part 2|Investigator Decision|7
2181694|NCT01416181|3808905|FG000|Part 2|Withdrawal by Subject|14
2181695|NCT01416181|3808906|FG001|Part 2|Withdrawal by Subject|5
2181696|NCT01416181|3808905|FG000|Part 2|Lack of Efficacy|4
2181697|NCT01416181|3808906|FG001|Part 2|Lack of Efficacy|1
2181698|NCT01416181|3808905|FG000|Part 2|Lost to Follow-up|2
2181699|NCT01416181|3808906|FG001|Part 2|Lost to Follow-up|2
2181700|NCT01416389|3808929|FG000|Overall Study|Lost to Follow-up|1
2181701|NCT01416389|3808930|FG001|Overall Study|Lost to Follow-up|0
2181702|NCT01416389|3808929|FG000|Overall Study|Started New Therapy|2
2181703|NCT01416389|3808930|FG001|Overall Study|Started New Therapy|0
2181704|NCT01416441|3808938|FG000|Overall Study|Lost to Follow-up|5
2181705|NCT01416441|3808938|FG000|Overall Study|Adverse Event|6
2181706|NCT01416441|3808938|FG000|Overall Study|Sponsor Discontinued Trial Site|43
2181707|NCT01416441|3808938|FG000|Overall Study|Subject Met Withdrawal Criteria|10
2181708|NCT01416441|3808938|FG000|Overall Study|Investigator Withdrew Subject|2
2181709|NCT01416441|3808938|FG000|Overall Study|Subject Withdrew Consent|12
2181710|NCT01416441|3808938|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3
2181711|NCT01416571|3808942|FG000|Overall Study|Lost to Follow-up|2
2181712|NCT01416610|3808965|FG000|Overall Study|Adverse Event|4
2181713|NCT01416610|3808965|FG000|Overall Study|Adverse Event -Patient decision|3
2181714|NCT01416610|3808965|FG000|Overall Study|Lack of Efficacy|4
2181715|NCT01416610|3808965|FG000|Overall Study|No reason given|5
2181716|NCT01416610|3808965|FG000|Overall Study|Withdrawal by Subject|13
2181717|NCT01416610|3808965|FG000|Overall Study|Lost to Follow-up|7
2181718|NCT01416610|3808965|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7
2181719|NCT01416805|3808984|FG000|Overall Study|Lost to Follow-up|4
2181720|NCT01416805|3808985|FG001|Overall Study|Lost to Follow-up|4
2181721|NCT01417000|3808997|FG000|Overall Study|Death|59
2181722|NCT01417000|3808998|FG001|Overall Study|Death|28
2181723|NCT01417000|3808997|FG000|Overall Study|Lost to Follow-up|1
2181724|NCT01417000|3808998|FG001|Overall Study|Lost to Follow-up|0
2181725|NCT01417000|3808997|FG000|Overall Study|Study Terminated by Sponsor|1
2181726|NCT01417000|3808998|FG001|Overall Study|Study Terminated by Sponsor|1
2181727|NCT01417078|3809013|FG000|Overall Study|Withdrawal by Subject|1
2181728|NCT01417104|3809021|FG000|Overall Study|Withdrawal by Subject|5
2181729|NCT01417104|3809022|FG001|Overall Study|Withdrawal by Subject|1
2181730|NCT01417104|3809021|FG000|Overall Study|Failure to make contact|0
2181731|NCT01417104|3809022|FG001|Overall Study|Failure to make contact|1
2181732|NCT01417104|3809021|FG000|Overall Study|Adverse Event|1
2181733|NCT01417104|3809022|FG001|Overall Study|Adverse Event|0
2181734|NCT01417156|3809028|FG000|Overall Study|Adverse Event|12
2181735|NCT01417156|3809028|FG000|Overall Study|Protocol Violation|2
2181736|NCT01417195|3809034|FG000|Overall Study|Stimulation failure|1
2181737|NCT01417195|3809035|FG001|Overall Study|Stimulation failure|0
2181738|NCT01417195|3809034|FG000|Overall Study|No embryos for transfer|0
2181739|NCT01417195|3809035|FG001|Overall Study|No embryos for transfer|1
2181740|NCT01417195|3809034|FG000|Overall Study|No transfer due to risk of OHSS|1
2181741|NCT01417195|3809035|FG001|Overall Study|No transfer due to risk of OHSS|0
2181742|NCT01417195|3809034|FG000|Overall Study|No transfer due to elevated progesterone|1
2181743|NCT01417195|3809035|FG001|Overall Study|No transfer due to elevated progesterone|0
2181744|NCT01417234|3809042|FG000|Overall Study|Subject non-compliant|3
2181745|NCT01417481|3809081|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0
2181746|NCT01417481|3809082|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2
2181747|NCT01418209|3809122|FG000|Overall Study|Withdrawal by Subject|1
2181748|NCT01418209|3809123|FG001|Overall Study|Withdrawal by Subject|0
2181749|NCT01418209|3809124|FG002|Overall Study|Withdrawal by Subject|1
2181750|NCT01418209|3809122|FG000|Overall Study|Did not provide hot flash diary data|1
2181751|NCT01418209|3809123|FG001|Overall Study|Did not provide hot flash diary data|3
2181752|NCT01418209|3809124|FG002|Overall Study|Did not provide hot flash diary data|3
2181753|NCT01418339|3809134|FG000|Overall Study|Adverse Event|5
2181754|NCT01418339|3809135|FG001|Overall Study|Adverse Event|2
2181755|NCT01418339|3809134|FG000|Overall Study|Subject Withdrew Consent|1
2181756|NCT01418339|3809135|FG001|Overall Study|Subject Withdrew Consent|2
2181757|NCT01418339|3809134|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6
2181758|NCT01418339|3809135|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6
2181759|NCT01418352|3809145|FG000|Overall Study|Lost to Follow-up|2
2181760|NCT01418352|3809146|FG001|Overall Study|Lost to Follow-up|0
2181761|NCT01418352|3809147|FG002|Overall Study|Lost to Follow-up|0
2181762|NCT01418352|3809148|FG003|Overall Study|Lost to Follow-up|0
2181763|NCT01418352|3809145|FG000|Overall Study|Adverse Event|0
2181764|NCT01418352|3809146|FG001|Overall Study|Adverse Event|1
2181765|NCT01418352|3809147|FG002|Overall Study|Adverse Event|0
2181766|NCT01418352|3809148|FG003|Overall Study|Adverse Event|0
2181767|NCT01418352|3809145|FG000|Overall Study|Sponsor Discontinued Trial Site|0
2181768|NCT01418352|3809146|FG001|Overall Study|Sponsor Discontinued Trial Site|2
2181769|NCT01418352|3809147|FG002|Overall Study|Sponsor Discontinued Trial Site|2
2219445|NCT01722097|3863368|FG000|Overall Study|Patient sheets not returned|6
2219446|NCT01722097|3863369|FG001|Overall Study|Patient sheets not returned|5
2219447|NCT01722162|3863377|FG000|Overall Study|Withdrawal by Subject|1
2219448|NCT01722162|3863378|FG001|Overall Study|Withdrawal by Subject|1
2219449|NCT01722162|3863377|FG000|Overall Study|Found ineligible|1
2219450|NCT01722162|3863378|FG001|Overall Study|Found ineligible|0
2219451|NCT01722162|3863377|FG000|Overall Study|Unrelated to study adverse event|2
2219452|NCT01722162|3863378|FG001|Overall Study|Unrelated to study adverse event|2
2219453|NCT01722162|3863377|FG000|Overall Study|Adverse Event|1
2219454|NCT01722162|3863378|FG001|Overall Study|Adverse Event|1
2219455|NCT01722162|3863377|FG000|Overall Study|Insurance denial post enrollment|0
2219456|NCT01722162|3863378|FG001|Overall Study|Insurance denial post enrollment|1
2219457|NCT01722162|3863377|FG000|Overall Study|Noncompliance|0
2219458|NCT01722162|3863378|FG001|Overall Study|Noncompliance|1
2219459|NCT01722266|3863388|FG000|Overall Study|Withdrawal by Subject|1
2219460|NCT01722266|3863389|FG001|Overall Study|Withdrawal by Subject|2
2219461|NCT01722266|3863390|FG002|Overall Study|Withdrawal by Subject|0
2219462|NCT01722266|3863391|FG003|Overall Study|Withdrawal by Subject|0
2219463|NCT01722266|3863388|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0
2219464|NCT01722266|3863389|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1
2219465|NCT01722266|3863390|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3
2219466|NCT01722266|3863391|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0
2219467|NCT01722266|3863388|FG000|Overall Study|Dropped out due to Nausea|0
2219468|NCT01722266|3863389|FG001|Overall Study|Dropped out due to Nausea|0
2219469|NCT01722266|3863390|FG002|Overall Study|Dropped out due to Nausea|2
2219470|NCT01722266|3863391|FG003|Overall Study|Dropped out due to Nausea|0
2219471|NCT01722331|3863455|FG000|Part 1|Adverse Event|5
2219472|NCT01722331|3863456|FG001|Part 1|Adverse Event|0
2219473|NCT01722331|3863457|FG002|Part 1|Adverse Event|0
2219474|NCT01722331|3863458|FG003|Part 1|Adverse Event|0
2219475|NCT01722331|3863459|FG004|Part 1|Adverse Event|0
2219476|NCT01722331|3863460|FG005|Part 1|Adverse Event|0
2219477|NCT01722331|3863461|FG006|Part 1|Adverse Event|0
2219478|NCT01722331|3863455|FG000|Part 1|Lack of Efficacy|0
2219479|NCT01722331|3863456|FG001|Part 1|Lack of Efficacy|0
2219480|NCT01722331|3863457|FG002|Part 1|Lack of Efficacy|1
2219481|NCT01722331|3863458|FG003|Part 1|Lack of Efficacy|0
2219482|NCT01722331|3863459|FG004|Part 1|Lack of Efficacy|2
2219483|NCT01722331|3863460|FG005|Part 1|Lack of Efficacy|0
2219484|NCT01722331|3863461|FG006|Part 1|Lack of Efficacy|0
2219485|NCT01722331|3863455|FG000|Part 1|Lost to Follow-up|1
2219486|NCT01722331|3863456|FG001|Part 1|Lost to Follow-up|0
2219487|NCT01722331|3863457|FG002|Part 1|Lost to Follow-up|2
2219488|NCT01722331|3863458|FG003|Part 1|Lost to Follow-up|0
2219489|NCT01722331|3863459|FG004|Part 1|Lost to Follow-up|1
2219490|NCT01722331|3863460|FG005|Part 1|Lost to Follow-up|0
2219491|NCT01722331|3863461|FG006|Part 1|Lost to Follow-up|0
2219492|NCT01722331|3863455|FG000|Part 1|Physician Decision|0
2219493|NCT01722331|3863456|FG001|Part 1|Physician Decision|0
2219494|NCT01722331|3863457|FG002|Part 1|Physician Decision|3
2219495|NCT01722331|3863458|FG003|Part 1|Physician Decision|0
2219496|NCT01722331|3863459|FG004|Part 1|Physician Decision|1
2219497|NCT01722331|3863460|FG005|Part 1|Physician Decision|0
2219498|NCT01722331|3863461|FG006|Part 1|Physician Decision|0
2219499|NCT01722331|3863455|FG000|Part 1|Pregnancy|1
2219500|NCT01722331|3863456|FG001|Part 1|Pregnancy|0
2219501|NCT01722331|3863457|FG002|Part 1|Pregnancy|0
2219502|NCT01722331|3863458|FG003|Part 1|Pregnancy|0
2219503|NCT01722331|3863459|FG004|Part 1|Pregnancy|0
2219504|NCT01722331|3863460|FG005|Part 1|Pregnancy|0
2219505|NCT01722331|3863461|FG006|Part 1|Pregnancy|0
2219506|NCT01722331|3863455|FG000|Part 1|Progressive Disease|0
2219507|NCT01722331|3863456|FG001|Part 1|Progressive Disease|0
2219508|NCT01722331|3863457|FG002|Part 1|Progressive Disease|0
2219509|NCT01722331|3863458|FG003|Part 1|Progressive Disease|0
2219510|NCT01722331|3863459|FG004|Part 1|Progressive Disease|1
2219511|NCT01722331|3863460|FG005|Part 1|Progressive Disease|0
2219512|NCT01722331|3863461|FG006|Part 1|Progressive Disease|0
2181770|NCT01418352|3809148|FG003|Overall Study|Sponsor Discontinued Trial Site|2
2181771|NCT01418352|3809145|FG000|Overall Study|Subject Withdrew Consent|0
2181772|NCT01418352|3809146|FG001|Overall Study|Subject Withdrew Consent|1
2181773|NCT01418352|3809147|FG002|Overall Study|Subject Withdrew Consent|2
2181774|NCT01418352|3809148|FG003|Overall Study|Subject Withdrew Consent|1
2181775|NCT01418352|3809145|FG000|Overall Study|Protocol Deviation|0
2181776|NCT01418352|3809146|FG001|Overall Study|Protocol Deviation|0
2181777|NCT01418352|3809147|FG002|Overall Study|Protocol Deviation|1
2181778|NCT01418352|3809148|FG003|Overall Study|Protocol Deviation|0
2181779|NCT01418352|3809145|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1
2181780|NCT01418352|3809146|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0
2181781|NCT01418352|3809147|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0
2181782|NCT01418352|3809148|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0
2181783|NCT01418365|3809160|FG000|First Intervention|Withdrawal by Subject|0
2181784|NCT01418365|3809161|FG001|First Intervention|Withdrawal by Subject|1
2181785|NCT01418365|3809160|FG000|First Intervention|Non-compliance|1
2181786|NCT01418365|3809161|FG001|First Intervention|Non-compliance|0
2181787|NCT01418365|3809160|FG000|Second Intervention|Withdrawal by Subject|0
2181788|NCT01418365|3809161|FG001|Second Intervention|Withdrawal by Subject|1
2181789|NCT01418378|3809169|FG000|Overall Study|Death|1
2219513|NCT01722331|3863455|FG000|Part 1|Protocol Violation|1
2219514|NCT01722331|3863456|FG001|Part 1|Protocol Violation|0
2219515|NCT01722331|3863457|FG002|Part 1|Protocol Violation|0
2219516|NCT01722331|3863458|FG003|Part 1|Protocol Violation|0
2181790|NCT01418378|3809170|FG001|Overall Study|Death|2
2181791|NCT01418378|3809169|FG000|Overall Study|Physician Decision|0
2181792|NCT01418378|3809170|FG001|Overall Study|Physician Decision|1
2181793|NCT01418378|3809169|FG000|Overall Study|ligament imbalance|0
2181794|NCT01418378|3809170|FG001|Overall Study|ligament imbalance|1
2181795|NCT01418378|3809169|FG000|Overall Study|developed chronic myopathy|0
2181796|NCT01418378|3809170|FG001|Overall Study|developed chronic myopathy|1
2181797|NCT01418937|3809192|FG000|Overall Study|Lost to Follow-up|5
2181798|NCT01418937|3809192|FG000|Overall Study|Protocol Violation|1
2181799|NCT01418937|3809192|FG000|Overall Study|Pregnancy|1
2181800|NCT01418937|3809192|FG000|Overall Study|Withdrawal by Subject|1
2181801|NCT01419015|3809196|FG000|Overall Study|Death|2
2181802|NCT01419080|3809204|FG000|Overall Study|Withdrawal by Subject|75
2181803|NCT01419080|3809204|FG000|Overall Study|Death|30
2181804|NCT01419080|3809204|FG000|Overall Study|Lost to Follow-up|23
2181805|NCT01419080|3809204|FG000|Overall Study|Too Ill|3
2181806|NCT01419184|3809216|FG000|Overall Study|Site data not available|3
2181807|NCT01419184|3809217|FG001|Overall Study|Site data not available|2
2181808|NCT01419184|3809216|FG000|Overall Study|No IRLOS-No in-patient end date reported|3
2181809|NCT01419184|3809217|FG001|Overall Study|No IRLOS-No in-patient end date reported|6
2181810|NCT01419184|3809216|FG000|Overall Study|No IRLOS-randomized, not treated|2
2181811|NCT01419184|3809217|FG001|Overall Study|No IRLOS-randomized, not treated|4
2181812|NCT01419184|3809216|FG000|Overall Study|No IRLOS-non trial antibiotic used|1
2181813|NCT01419184|3809217|FG001|Overall Study|No IRLOS-non trial antibiotic used|2
2181814|NCT01419184|3809216|FG000|Overall Study|No IRLOS-No adverse event treatment date|0
2181815|NCT01419184|3809217|FG001|Overall Study|No IRLOS-No adverse event treatment date|1
2181816|NCT01419184|3809216|FG000|Overall Study|Participant randomized, not treated|1
2181817|NCT01419184|3809217|FG001|Overall Study|Participant randomized, not treated|0
2181818|NCT01419197|3809225|FG000|Overall Study|Death|247
2181819|NCT01419197|3809226|FG001|Overall Study|Death|122
2181820|NCT01419197|3809225|FG000|Overall Study|Physician Decision|4
2181821|NCT01419197|3809226|FG001|Overall Study|Physician Decision|4
2181822|NCT01419197|3809225|FG000|Overall Study|Non-compliance|3
2181823|NCT01419197|3809226|FG001|Overall Study|Non-compliance|1
2181824|NCT01419197|3809225|FG000|Overall Study|Withdrawal by Subject|33
2181825|NCT01419197|3809226|FG001|Overall Study|Withdrawal by Subject|32
2181826|NCT01419197|3809225|FG000|Overall Study|Study Completed by Sponsor|103
2181827|NCT01419197|3809226|FG001|Overall Study|Study Completed by Sponsor|34
2181828|NCT01419197|3809225|FG000|Overall Study|Reason Not Specified|0
2181829|NCT01419197|3809226|FG001|Overall Study|Reason Not Specified|1
2181830|NCT01419197|3809225|FG000|Overall Study|Lost to Follow-up|14
2181831|NCT01419197|3809226|FG001|Overall Study|Lost to Follow-up|4
2181832|NCT01419236|3809235|FG000|Overall Study|Adverse Event|1
2181833|NCT01419236|3809236|FG001|Overall Study|Adverse Event|0
2181834|NCT01419236|3809235|FG000|Overall Study|Lack of Efficacy|0
2181835|NCT01419236|3809236|FG001|Overall Study|Lack of Efficacy|1
2181836|NCT01419236|3809235|FG000|Overall Study|Lost to Follow-up|1
2181837|NCT01419236|3809236|FG001|Overall Study|Lost to Follow-up|0
2181838|NCT01419236|3809235|FG000|Overall Study|Physician Decision|1
2181839|NCT01419236|3809236|FG001|Overall Study|Physician Decision|0
2181840|NCT01419236|3809235|FG000|Overall Study|Withdrawal by Subject|1
2181841|NCT01419236|3809236|FG001|Overall Study|Withdrawal by Subject|4
2181842|NCT01419236|3809235|FG000|Overall Study|Entry Criteria Not Met|1
2181843|NCT01419236|3809236|FG001|Overall Study|Entry Criteria Not Met|0
2181844|NCT01419314|3809258|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
2181845|NCT01419314|3809259|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
2181846|NCT01419314|3809258|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
2181847|NCT01419314|3809259|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
2181848|NCT01419314|3809258|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
2181849|NCT01419314|3809259|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
2181850|NCT01419535|3809271|FG000|Overall Study|could not maintain iv line|1
2181851|NCT01419535|3809272|FG001|Overall Study|could not maintain iv line|1
2181852|NCT01419535|3809271|FG000|Overall Study|Withdrawal by Subject|0
2181853|NCT01419535|3809272|FG001|Overall Study|Withdrawal by Subject|1
2181854|NCT01419626|3809281|FG000|Overall Study|Protocol Violation|3
2181855|NCT01419626|3809282|FG001|Overall Study|Protocol Violation|2
2181856|NCT01419626|3809283|FG002|Overall Study|Protocol Violation|2
2181857|NCT01419626|3809281|FG000|Overall Study|Withdrawal by Subject|1
2181858|NCT01419626|3809282|FG001|Overall Study|Withdrawal by Subject|0
2219517|NCT01722331|3863459|FG004|Part 1|Protocol Violation|1
2181859|NCT01419626|3809283|FG002|Overall Study|Withdrawal by Subject|0
2181860|NCT01419626|3809281|FG000|Overall Study|Lost to Follow-up|0
2181861|NCT01419626|3809282|FG001|Overall Study|Lost to Follow-up|1
2181862|NCT01419626|3809283|FG002|Overall Study|Lost to Follow-up|1
2181863|NCT01419665|3809297|FG000|Combination Treatment|Adverse Event|7
2181864|NCT01419665|3809298|FG001|Combination Treatment|Adverse Event|10
2181865|NCT01419665|3809297|FG000|Combination Treatment|Physician Decision|5
2181866|NCT01419665|3809298|FG001|Combination Treatment|Physician Decision|8
2181867|NCT01419665|3809297|FG000|Combination Treatment|Protocol Violation|6
2181868|NCT01419665|3809298|FG001|Combination Treatment|Protocol Violation|2
2181869|NCT01419665|3809297|FG000|Combination Treatment|disease progression|10
2181870|NCT01419665|3809298|FG001|Combination Treatment|disease progression|9
2181871|NCT01419665|3809297|FG000|Combination Treatment|Death|5
2181872|NCT01419665|3809298|FG001|Combination Treatment|Death|7
2181873|NCT01419665|3809297|FG000|Combination Treatment|administrative problems|0
2181874|NCT01419665|3809298|FG001|Combination Treatment|administrative problems|1
2181875|NCT01419665|3809297|FG000|Combination Treatment|Withdrawal by Subject|5
2181876|NCT01419665|3809298|FG001|Combination Treatment|Withdrawal by Subject|4
2181877|NCT01419665|3809297|FG000|Maintenance Treatment and/or Follow up|switch to open label|44
2181878|NCT01419665|3809298|FG001|Maintenance Treatment and/or Follow up|switch to open label|39
2181879|NCT01419665|3809297|FG000|Maintenance Treatment and/or Follow up|administrative problems|0
2181880|NCT01419665|3809298|FG001|Maintenance Treatment and/or Follow up|administrative problems|6
2181881|NCT01419665|3809297|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
2181882|NCT01419665|3809298|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
2181883|NCT01419665|3809297|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1
2181884|NCT01419665|3809298|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1
2181885|NCT01419665|3809297|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5
2181886|NCT01419665|3809298|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2
2181887|NCT01419665|3809297|FG000|Maintenance Treatment and/or Follow up|disease progression|53
2181888|NCT01419665|3809298|FG001|Maintenance Treatment and/or Follow up|disease progression|37
2181889|NCT01419665|3809297|FG000|Maintenance Treatment and/or Follow up|Death|1
2181890|NCT01419665|3809298|FG001|Maintenance Treatment and/or Follow up|Death|2
2181891|NCT01419665|3809297|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11
2181892|NCT01419665|3809298|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7
2181893|NCT01419665|3809297|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1
2181894|NCT01419665|3809298|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2
2181895|NCT01419665|3809297|FG000|Open Label Phase|Death|1
2181896|NCT01419665|3809298|FG001|Open Label Phase|Death|0
2181897|NCT01419665|3809297|FG000|Open Label Phase|disease progression|0
2181898|NCT01419665|3809298|FG001|Open Label Phase|disease progression|1
2181899|NCT01419717|3809306|FG000|Overall Study|Protocol-specified Criteria|62
2181900|NCT01419717|3809306|FG000|Overall Study|Adverse Event|19
2181901|NCT01419717|3809306|FG000|Overall Study|Death|17
2181902|NCT01419717|3809306|FG000|Overall Study|Withdrawal by Subject|10
2181903|NCT01419717|3809306|FG000|Overall Study|Disease Progression|9
2181904|NCT01419717|3809306|FG000|Overall Study|Other|4
2181905|NCT01419717|3809306|FG000|Overall Study|Lost to Follow-up|2
2181906|NCT01419717|3809306|FG000|Overall Study|Administrative Decision|1
2181907|NCT01419717|3809306|FG000|Overall Study|Noncompliance|1
2181908|NCT01419769|3809310|FG000|Overall Study|Did not receive the AXIOS stent|3
2181909|NCT01419769|3809310|FG000|Overall Study|Not evaluable due to pigtail stents|1
2181910|NCT01420068|3809345|FG000|Overall Study|Administrative problems|1
2181911|NCT01420068|3809346|FG001|Overall Study|Administrative problems|3
2181912|NCT01420068|3809345|FG000|Overall Study|Withdrawal by Subject|1
2181913|NCT01420068|3809346|FG001|Overall Study|Withdrawal by Subject|2
2181914|NCT01420081|3809361|FG000|Overall Study|Death|1
2181915|NCT01420081|3809362|FG001|Overall Study|Death|0
2181916|NCT01420081|3809363|FG002|Overall Study|Death|8
2181917|NCT01420081|3809364|FG003|Overall Study|Death|0
2181918|NCT01420081|3809365|FG004|Overall Study|Death|7
2181919|NCT01420081|3809366|FG005|Overall Study|Death|12
2181920|NCT01420081|3809367|FG006|Overall Study|Death|0
2181921|NCT01420081|3809368|FG007|Overall Study|Death|1
2181922|NCT01420081|3809369|FG008|Overall Study|Death|1
2181923|NCT01420081|3809361|FG000|Overall Study|Lost to Follow-up|0
2181924|NCT01420081|3809362|FG001|Overall Study|Lost to Follow-up|0
2181925|NCT01420081|3809363|FG002|Overall Study|Lost to Follow-up|0
2181926|NCT01420081|3809364|FG003|Overall Study|Lost to Follow-up|0
2181927|NCT01420081|3809365|FG004|Overall Study|Lost to Follow-up|1
2181928|NCT01420081|3809366|FG005|Overall Study|Lost to Follow-up|1
2181929|NCT01420081|3809367|FG006|Overall Study|Lost to Follow-up|0
2181930|NCT01420081|3809368|FG007|Overall Study|Lost to Follow-up|0
2181931|NCT01420081|3809369|FG008|Overall Study|Lost to Follow-up|0
2181932|NCT01420081|3809361|FG000|Overall Study|Study Terminated by Sponsor|2
2181933|NCT01420081|3809362|FG001|Overall Study|Study Terminated by Sponsor|1
2181934|NCT01420081|3809363|FG002|Overall Study|Study Terminated by Sponsor|1
2181935|NCT01420081|3809364|FG003|Overall Study|Study Terminated by Sponsor|3
2181936|NCT01420081|3809365|FG004|Overall Study|Study Terminated by Sponsor|11
2181937|NCT01420081|3809366|FG005|Overall Study|Study Terminated by Sponsor|7
2181938|NCT01420081|3809367|FG006|Overall Study|Study Terminated by Sponsor|3
2181939|NCT01420081|3809368|FG007|Overall Study|Study Terminated by Sponsor|2
2181940|NCT01420081|3809369|FG008|Overall Study|Study Terminated by Sponsor|2
2181941|NCT01420081|3809361|FG000|Overall Study|Subject Refused Futher Follow-up|0
2181942|NCT01420081|3809362|FG001|Overall Study|Subject Refused Futher Follow-up|0
2181943|NCT01420081|3809363|FG002|Overall Study|Subject Refused Futher Follow-up|1
2181944|NCT01420081|3809364|FG003|Overall Study|Subject Refused Futher Follow-up|0
2181945|NCT01420081|3809365|FG004|Overall Study|Subject Refused Futher Follow-up|1
2181946|NCT01420081|3809366|FG005|Overall Study|Subject Refused Futher Follow-up|0
2181947|NCT01420081|3809367|FG006|Overall Study|Subject Refused Futher Follow-up|0
2181948|NCT01420081|3809368|FG007|Overall Study|Subject Refused Futher Follow-up|0
2181949|NCT01420081|3809369|FG008|Overall Study|Subject Refused Futher Follow-up|0
2181950|NCT01420081|3809361|FG000|Overall Study|Other Reasons|0
2181951|NCT01420081|3809362|FG001|Overall Study|Other Reasons|0
2181952|NCT01420081|3809363|FG002|Overall Study|Other Reasons|1
2181953|NCT01420081|3809364|FG003|Overall Study|Other Reasons|0
2181954|NCT01420081|3809365|FG004|Overall Study|Other Reasons|0
2181955|NCT01420081|3809366|FG005|Overall Study|Other Reasons|0
2181956|NCT01420081|3809367|FG006|Overall Study|Other Reasons|0
2181957|NCT01420081|3809368|FG007|Overall Study|Other Reasons|0
2181958|NCT01420081|3809369|FG008|Overall Study|Other Reasons|0
2181959|NCT01420536|3809400|FG000|Period 1 (30 Days)|Withdrawal by Subject|3
2181960|NCT01420536|3809401|FG001|Period 1 (30 Days)|Withdrawal by Subject|0
2181961|NCT01420549|3809411|FG000|Overall Study|Adverse Event|1
2181962|NCT01420549|3809412|FG001|Overall Study|Adverse Event|1
2181963|NCT01420549|3809411|FG000|Overall Study|Lost to Follow-up|2
2181964|NCT01420549|3809412|FG001|Overall Study|Lost to Follow-up|2
2181965|NCT01420549|3809411|FG000|Overall Study|Protocol Violation|0
2181966|NCT01420549|3809412|FG001|Overall Study|Protocol Violation|1
2181967|NCT01420549|3809411|FG000|Overall Study|Non-adherence to medication|4
2181968|NCT01420549|3809412|FG001|Overall Study|Non-adherence to medication|1
2181969|NCT01420627|3809418|FG000|EZN-2279 Treatment Period|Adverse Event|1
2181970|NCT01420679|3809445|FG000|Overall Study|Disease Progression|3
2181971|NCT01420679|3809446|FG001|Overall Study|Disease Progression|2
2181972|NCT01420679|3809445|FG000|Overall Study|Adverse Event|4
2181973|NCT01420679|3809446|FG001|Overall Study|Adverse Event|0
2181974|NCT01420679|3809445|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1
2181975|NCT01420679|3809446|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0
2181976|NCT01420679|3809445|FG000|Overall Study|Patient Decision|1
2181977|NCT01420679|3809446|FG001|Overall Study|Patient Decision|0
2181978|NCT01420679|3809445|FG000|Overall Study|Investigator Decision|1
2181979|NCT01420679|3809446|FG001|Overall Study|Investigator Decision|2
2181980|NCT01420679|3809445|FG000|Overall Study|Sponsor Decision|3
2181981|NCT01420679|3809446|FG001|Overall Study|Sponsor Decision|3
2181982|NCT01420679|3809445|FG000|Overall Study|Other|1
2181983|NCT01420679|3809446|FG001|Overall Study|Other|0
2181984|NCT01420926|3809467|FG000|Overall Study|Adverse Event|6
2181985|NCT01420926|3809468|FG001|Overall Study|Adverse Event|4
2181986|NCT01420926|3809467|FG000|Overall Study|Death|18
2181987|NCT01420926|3809468|FG001|Overall Study|Death|17
2181988|NCT01420926|3809467|FG000|Overall Study|Withdrawal by Subject|11
2181989|NCT01420926|3809468|FG001|Overall Study|Withdrawal by Subject|16
2181990|NCT01420926|3809467|FG000|Overall Study|Non-protocol treatment|17
2181991|NCT01420926|3809468|FG001|Overall Study|Non-protocol treatment|20
2181992|NCT01420926|3809467|FG000|Overall Study|Physician Decision|7
2181993|NCT01420926|3809468|FG001|Overall Study|Physician Decision|5
2181994|NCT01420926|3809467|FG000|Overall Study|Continues on active treatment|1
2181995|NCT01420926|3809468|FG001|Overall Study|Continues on active treatment|3
2181996|NCT01421017|3809477|FG000|Overall Study|Withdrawal by Subject|2
2181997|NCT01421017|3809478|FG001|Overall Study|Withdrawal by Subject|0
2181998|NCT01421017|3809479|FG002|Overall Study|Withdrawal by Subject|0
2181999|NCT01421017|3809477|FG000|Overall Study|POD|0
2182000|NCT01421017|3809478|FG001|Overall Study|POD|6
2182001|NCT01421017|3809479|FG002|Overall Study|POD|3
2182002|NCT01421134|3809489|FG000|Overall Study|Adverse Event|3
2182003|NCT01421134|3809490|FG001|Overall Study|Adverse Event|5
2182004|NCT01421134|3809489|FG000|Overall Study|Lack of Efficacy|2
2182005|NCT01421134|3809490|FG001|Overall Study|Lack of Efficacy|4
2182006|NCT01421134|3809489|FG000|Overall Study|Protocol Violation|0
2182007|NCT01421134|3809490|FG001|Overall Study|Protocol Violation|3
2182008|NCT01421134|3809489|FG000|Overall Study|Withdrawal by Subject|1
2182009|NCT01421134|3809490|FG001|Overall Study|Withdrawal by Subject|1
2182010|NCT01421134|3809489|FG000|Overall Study|Administrative|0
2182011|NCT01421134|3809490|FG001|Overall Study|Administrative|1
2182012|NCT01421134|3809489|FG000|Overall Study|Lost to Follow-up|1
2182013|NCT01421134|3809490|FG001|Overall Study|Lost to Follow-up|1
2182014|NCT01421147|3809498|FG000|Treatment Period|Adverse Event|2
2182015|NCT01421147|3809499|FG001|Treatment Period|Adverse Event|3
2182016|NCT01421147|3809498|FG000|Treatment Period|Lost to Follow-up|2
2182017|NCT01421147|3809499|FG001|Treatment Period|Lost to Follow-up|1
2219518|NCT01722331|3863460|FG005|Part 1|Protocol Violation|0
2182018|NCT01421147|3809498|FG000|Treatment Period|Physician Decision|2
2182019|NCT01421147|3809499|FG001|Treatment Period|Physician Decision|2
2182020|NCT01421147|3809498|FG000|Treatment Period|Withdrawal by Subject|10
2182021|NCT01421147|3809499|FG001|Treatment Period|Withdrawal by Subject|5
2182022|NCT01421147|3809498|FG000|Extension Period|Adverse Event|0
2182023|NCT01421147|3809499|FG001|Extension Period|Adverse Event|2
2182024|NCT01421147|3809498|FG000|Extension Period|Death|0
2182025|NCT01421147|3809499|FG001|Extension Period|Death|1
2182026|NCT01421147|3809498|FG000|Extension Period|Lost to Follow-up|2
2182027|NCT01421147|3809499|FG001|Extension Period|Lost to Follow-up|5
2182028|NCT01421147|3809498|FG000|Extension Period|Physician Decision|1
2182029|NCT01421147|3809499|FG001|Extension Period|Physician Decision|0
2182030|NCT01421147|3809498|FG000|Extension Period|Withdrawal by Subject|5
2182031|NCT01421147|3809499|FG001|Extension Period|Withdrawal by Subject|3
2182032|NCT01421225|3809534|FG000|Overall Study|Withdrawal by Subject|0
2182033|NCT01421225|3809535|FG001|Overall Study|Withdrawal by Subject|1
2182034|NCT01421277|3809544|FG000|Overall Study|Lack of qualifying event|0
2182035|NCT01421277|3809545|FG001|Overall Study|Lack of qualifying event|61
2182036|NCT01421277|3809544|FG000|Overall Study|Incomplete baseline data|0
2182037|NCT01421277|3809545|FG001|Overall Study|Incomplete baseline data|31
2182038|NCT01421303|3809551|FG000|Overall Study|Lost to Follow-up|13
2182039|NCT01421303|3809551|FG000|Overall Study|Non compliance with study procedure|1
2182040|NCT01421303|3809551|FG000|Overall Study|Other|7
2182041|NCT01421303|3809551|FG000|Overall Study|Withdrawal by Subject|1
2182042|NCT01421342|3809558|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
2182043|NCT01421342|3809559|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
2182044|NCT01421342|3809560|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
2182045|NCT01421342|3809558|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53
2182046|NCT01421342|3809559|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38
2182047|NCT01421342|3809560|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27
2182048|NCT01421342|3809558|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
2182049|NCT01421342|3809559|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
2182050|NCT01421342|3809560|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
2182051|NCT01421342|3809558|FG000|Acute Treatment Phase (12 Weeks)|Death|0
2182052|NCT01421342|3809559|FG001|Acute Treatment Phase (12 Weeks)|Death|0
2182053|NCT01421342|3809560|FG002|Acute Treatment Phase (12 Weeks)|Death|3
2182054|NCT01421342|3809558|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
2182055|NCT01421342|3809559|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
2182056|NCT01421342|3809560|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
2182057|NCT01421342|3809558|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15
2182058|NCT01421342|3809559|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7
2182059|NCT01421342|3809560|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13
2182060|NCT01421342|3809558|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
2182061|NCT01421342|3809559|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
2182062|NCT01421342|3809560|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
2182063|NCT01421342|3809558|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1
2182064|NCT01421342|3809559|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6
2182065|NCT01421342|3809560|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1
2182066|NCT01421342|3809558|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
2182067|NCT01421342|3809559|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
2182068|NCT01421342|3809560|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
2182069|NCT01421342|3809558|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
2182070|NCT01421342|3809559|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
2182071|NCT01421342|3809560|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
2182072|NCT01421342|3809558|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
2182073|NCT01421342|3809559|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
2182074|NCT01421342|3809560|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
2182075|NCT01421342|3809558|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4
2182076|NCT01421342|3809559|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3
2182077|NCT01421342|3809560|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6
2182078|NCT01421342|3809558|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
2182079|NCT01421342|3809559|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
2182080|NCT01421342|3809560|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
2182081|NCT01421342|3809558|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
2182082|NCT01421342|3809559|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
2182083|NCT01421342|3809560|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
2182084|NCT01421342|3809558|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5
2182085|NCT01421342|3809559|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4
2182086|NCT01421342|3809560|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5
2182087|NCT01421342|3809558|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
2182088|NCT01421342|3809559|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
2182089|NCT01421342|3809560|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
2182090|NCT01421342|3809558|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
2182091|NCT01421342|3809559|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
2182092|NCT01421342|3809560|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
2182093|NCT01421342|3809558|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
2182094|NCT01421342|3809559|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
2182095|NCT01421342|3809560|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
2182096|NCT01421342|3809558|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0
2182097|NCT01421342|3809559|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0
2182098|NCT01421342|3809560|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2
2182099|NCT01421342|3809558|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
2182100|NCT01421342|3809559|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
2182101|NCT01421342|3809560|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
2182102|NCT01421342|3809558|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
2182103|NCT01421342|3809559|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
2182104|NCT01421342|3809560|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
2182105|NCT01421342|3809558|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
2182106|NCT01421342|3809559|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
2182107|NCT01421342|3809560|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
2182108|NCT01421342|3809558|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
2182109|NCT01421342|3809559|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
2182110|NCT01421342|3809560|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
2182111|NCT01421342|3809558|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
2182112|NCT01421342|3809559|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
2182113|NCT01421342|3809560|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
2182114|NCT01421342|3809558|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
2182115|NCT01421342|3809559|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
2182116|NCT01421342|3809560|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
2182117|NCT01421342|3809558|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
2182118|NCT01421342|3809559|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
2182119|NCT01421342|3809560|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
2182120|NCT01421342|3809558|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
2182121|NCT01421342|3809559|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
2182122|NCT01421342|3809560|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
2182123|NCT01421342|3809558|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
2182124|NCT01421342|3809559|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
2182125|NCT01421342|3809560|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
2182126|NCT01421459|3809574|FG000|Overall Study|Adverse Event|6
2182127|NCT01421459|3809575|FG001|Overall Study|Adverse Event|10
2182128|NCT01421459|3809574|FG000|Overall Study|Death|1
2182129|NCT01421459|3809575|FG001|Overall Study|Death|1
2182130|NCT01421459|3809574|FG000|Overall Study|Lack of Efficacy|1
2182131|NCT01421459|3809575|FG001|Overall Study|Lack of Efficacy|2
2182132|NCT01421459|3809574|FG000|Overall Study|Lost to Follow-up|8
2182133|NCT01421459|3809575|FG001|Overall Study|Lost to Follow-up|9
2182134|NCT01421459|3809574|FG000|Overall Study|Physician Decision|9
2182135|NCT01421459|3809575|FG001|Overall Study|Physician Decision|9
2182136|NCT01421459|3809574|FG000|Overall Study|Protocol Violation|8
2182137|NCT01421459|3809575|FG001|Overall Study|Protocol Violation|5
2182138|NCT01421459|3809574|FG000|Overall Study|Withdrawal by Subject|12
2182139|NCT01421459|3809575|FG001|Overall Study|Withdrawal by Subject|16
2182140|NCT01421511|3809609|FG000|Overall Study|Lost to Follow-up|11
2182141|NCT01421511|3809610|FG001|Overall Study|Lost to Follow-up|14
2182142|NCT01421511|3809609|FG000|Overall Study|Randomized but didn't receive study drug|1
2182143|NCT01421511|3809610|FG001|Overall Study|Randomized but didn't receive study drug|7
2182144|NCT01421511|3809609|FG000|Overall Study|Physician Decision|0
2182145|NCT01421511|3809610|FG001|Overall Study|Physician Decision|1
2182146|NCT01421511|3809609|FG000|Overall Study|Withdrawal by Subject|6
2219519|NCT01722331|3863461|FG006|Part 1|Protocol Violation|0
2219520|NCT01722331|3863455|FG000|Part 1|Withdrawal by Subject|2
2219521|NCT01722331|3863456|FG001|Part 1|Withdrawal by Subject|0
2219522|NCT01722331|3863457|FG002|Part 1|Withdrawal by Subject|3
2219523|NCT01722331|3863458|FG003|Part 1|Withdrawal by Subject|0
2219524|NCT01722331|3863459|FG004|Part 1|Withdrawal by Subject|3
2219525|NCT01722331|3863460|FG005|Part 1|Withdrawal by Subject|0
2219526|NCT01722331|3863461|FG006|Part 1|Withdrawal by Subject|0
2219527|NCT01722331|3863455|FG000|Part 2|Adverse Event|3
2219528|NCT01722331|3863456|FG001|Part 2|Adverse Event|0
2219529|NCT01722331|3863457|FG002|Part 2|Adverse Event|0
2219530|NCT01722331|3863458|FG003|Part 2|Adverse Event|0
2219531|NCT01722331|3863459|FG004|Part 2|Adverse Event|0
2219532|NCT01722331|3863460|FG005|Part 2|Adverse Event|1
2219533|NCT01722331|3863461|FG006|Part 2|Adverse Event|0
2219534|NCT01722331|3863455|FG000|Part 2|Lack of Efficacy|3
2219535|NCT01722331|3863456|FG001|Part 2|Lack of Efficacy|0
2219536|NCT01722331|3863457|FG002|Part 2|Lack of Efficacy|11
2219537|NCT01722331|3863458|FG003|Part 2|Lack of Efficacy|0
2219538|NCT01722331|3863459|FG004|Part 2|Lack of Efficacy|0
2219539|NCT01722331|3863460|FG005|Part 2|Lack of Efficacy|3
2219540|NCT01722331|3863461|FG006|Part 2|Lack of Efficacy|3
2219541|NCT01722331|3863455|FG000|Part 2|Lost to Follow-up|0
2219542|NCT01722331|3863456|FG001|Part 2|Lost to Follow-up|0
2219543|NCT01722331|3863457|FG002|Part 2|Lost to Follow-up|3
2219544|NCT01722331|3863458|FG003|Part 2|Lost to Follow-up|0
2219545|NCT01722331|3863459|FG004|Part 2|Lost to Follow-up|0
2219546|NCT01722331|3863460|FG005|Part 2|Lost to Follow-up|1
2219547|NCT01722331|3863461|FG006|Part 2|Lost to Follow-up|1
2219548|NCT01722331|3863455|FG000|Part 2|Non-Compliance with Study Drug|1
2182147|NCT01421511|3809610|FG001|Overall Study|Withdrawal by Subject|5
2182148|NCT01421511|3809609|FG000|Overall Study|Death|1
2182149|NCT01421511|3809610|FG001|Overall Study|Death|1
2219549|NCT01722331|3863456|FG001|Part 2|Non-Compliance with Study Drug|0
2219550|NCT01722331|3863457|FG002|Part 2|Non-Compliance with Study Drug|1
2219551|NCT01722331|3863458|FG003|Part 2|Non-Compliance with Study Drug|0
2219552|NCT01722331|3863459|FG004|Part 2|Non-Compliance with Study Drug|0
2219553|NCT01722331|3863460|FG005|Part 2|Non-Compliance with Study Drug|0
2219554|NCT01722331|3863461|FG006|Part 2|Non-Compliance with Study Drug|0
2219555|NCT01722331|3863455|FG000|Part 2|Physician Decision|0
2219556|NCT01722331|3863456|FG001|Part 2|Physician Decision|0
2219557|NCT01722331|3863457|FG002|Part 2|Physician Decision|2
2219558|NCT01722331|3863458|FG003|Part 2|Physician Decision|0
2219559|NCT01722331|3863459|FG004|Part 2|Physician Decision|0
2219560|NCT01722331|3863460|FG005|Part 2|Physician Decision|0
2219561|NCT01722331|3863461|FG006|Part 2|Physician Decision|0
2219562|NCT01722331|3863455|FG000|Part 2|Pregnancy|0
2219563|NCT01722331|3863456|FG001|Part 2|Pregnancy|0
2219564|NCT01722331|3863457|FG002|Part 2|Pregnancy|0
2219565|NCT01722331|3863458|FG003|Part 2|Pregnancy|0
2219566|NCT01722331|3863459|FG004|Part 2|Pregnancy|0
2219567|NCT01722331|3863460|FG005|Part 2|Pregnancy|1
2219568|NCT01722331|3863461|FG006|Part 2|Pregnancy|0
2219569|NCT01722331|3863455|FG000|Part 2|Progressive Disease|0
2219570|NCT01722331|3863456|FG001|Part 2|Progressive Disease|0
2219571|NCT01722331|3863457|FG002|Part 2|Progressive Disease|1
2219572|NCT01722331|3863458|FG003|Part 2|Progressive Disease|0
2219573|NCT01722331|3863459|FG004|Part 2|Progressive Disease|0
2219574|NCT01722331|3863460|FG005|Part 2|Progressive Disease|0
2219575|NCT01722331|3863461|FG006|Part 2|Progressive Disease|0
2219576|NCT01722331|3863455|FG000|Part 2|Protocol Violation|1
2219577|NCT01722331|3863456|FG001|Part 2|Protocol Violation|0
2219578|NCT01722331|3863457|FG002|Part 2|Protocol Violation|0
2219579|NCT01722331|3863458|FG003|Part 2|Protocol Violation|0
2219580|NCT01722331|3863459|FG004|Part 2|Protocol Violation|0
2219581|NCT01722331|3863460|FG005|Part 2|Protocol Violation|0
2219582|NCT01722331|3863461|FG006|Part 2|Protocol Violation|0
2219583|NCT01722331|3863455|FG000|Part 2|Withdrawal by Subject|5
2219584|NCT01722331|3863456|FG001|Part 2|Withdrawal by Subject|0
2219585|NCT01722331|3863457|FG002|Part 2|Withdrawal by Subject|3
2219586|NCT01722331|3863458|FG003|Part 2|Withdrawal by Subject|0
2219587|NCT01722331|3863459|FG004|Part 2|Withdrawal by Subject|0
2219588|NCT01722331|3863460|FG005|Part 2|Withdrawal by Subject|2
2219589|NCT01722331|3863461|FG006|Part 2|Withdrawal by Subject|2
2219590|NCT01722331|3863455|FG000|Part 2|Other Protocol Specified Criteria|6
2219591|NCT01722331|3863456|FG001|Part 2|Other Protocol Specified Criteria|0
2219592|NCT01722331|3863457|FG002|Part 2|Other Protocol Specified Criteria|10
2219593|NCT01722331|3863458|FG003|Part 2|Other Protocol Specified Criteria|0
2219594|NCT01722331|3863459|FG004|Part 2|Other Protocol Specified Criteria|0
2219595|NCT01722331|3863460|FG005|Part 2|Other Protocol Specified Criteria|2
2219596|NCT01722331|3863461|FG006|Part 2|Other Protocol Specified Criteria|1
2219597|NCT01722331|3863455|FG000|Part 3|Adverse Event|2
2219598|NCT01722331|3863456|FG001|Part 3|Adverse Event|2
2219599|NCT01722331|3863457|FG002|Part 3|Adverse Event|0
2219600|NCT01722331|3863458|FG003|Part 3|Adverse Event|1
2219601|NCT01722331|3863459|FG004|Part 3|Adverse Event|0
2219602|NCT01722331|3863460|FG005|Part 3|Adverse Event|0
2219603|NCT01722331|3863461|FG006|Part 3|Adverse Event|0
2219604|NCT01722331|3863455|FG000|Part 3|Death|1
2219605|NCT01722331|3863456|FG001|Part 3|Death|0
2219606|NCT01722331|3863457|FG002|Part 3|Death|0
2219607|NCT01722331|3863458|FG003|Part 3|Death|0
2219608|NCT01722331|3863459|FG004|Part 3|Death|0
2219609|NCT01722331|3863460|FG005|Part 3|Death|0
2219610|NCT01722331|3863461|FG006|Part 3|Death|0
2219611|NCT01722331|3863455|FG000|Part 3|Lack of Efficacy|1
2219612|NCT01722331|3863456|FG001|Part 3|Lack of Efficacy|0
2219613|NCT01722331|3863457|FG002|Part 3|Lack of Efficacy|0
2219614|NCT01722331|3863458|FG003|Part 3|Lack of Efficacy|0
2219615|NCT01722331|3863459|FG004|Part 3|Lack of Efficacy|0
2219616|NCT01722331|3863460|FG005|Part 3|Lack of Efficacy|0
2219617|NCT01722331|3863461|FG006|Part 3|Lack of Efficacy|0
2219618|NCT01722331|3863455|FG000|Part 3|Lost to Follow-up|3
2219619|NCT01722331|3863456|FG001|Part 3|Lost to Follow-up|4
2219620|NCT01722331|3863457|FG002|Part 3|Lost to Follow-up|0
2219621|NCT01722331|3863458|FG003|Part 3|Lost to Follow-up|0
2219622|NCT01722331|3863459|FG004|Part 3|Lost to Follow-up|0
2219623|NCT01722331|3863460|FG005|Part 3|Lost to Follow-up|1
2219624|NCT01722331|3863461|FG006|Part 3|Lost to Follow-up|0
2219625|NCT01722331|3863455|FG000|Part 3|Non-Compliance with Study Drug|0
2219626|NCT01722331|3863456|FG001|Part 3|Non-Compliance with Study Drug|1
2219627|NCT01722331|3863457|FG002|Part 3|Non-Compliance with Study Drug|0
2219628|NCT01722331|3863458|FG003|Part 3|Non-Compliance with Study Drug|0
2219629|NCT01722331|3863459|FG004|Part 3|Non-Compliance with Study Drug|0
2219630|NCT01722331|3863460|FG005|Part 3|Non-Compliance with Study Drug|0
2219631|NCT01722331|3863461|FG006|Part 3|Non-Compliance with Study Drug|0
2219632|NCT01722331|3863455|FG000|Part 3|Physician Decision|1
2219633|NCT01722331|3863456|FG001|Part 3|Physician Decision|1
2219634|NCT01722331|3863457|FG002|Part 3|Physician Decision|0
2219635|NCT01722331|3863458|FG003|Part 3|Physician Decision|0
2219636|NCT01722331|3863459|FG004|Part 3|Physician Decision|0
2219637|NCT01722331|3863460|FG005|Part 3|Physician Decision|0
2219638|NCT01722331|3863461|FG006|Part 3|Physician Decision|1
2182150|NCT01421641|3809624|FG000|Overall Study|Protocol Violation|2
2182151|NCT01421641|3809625|FG001|Overall Study|Protocol Violation|2
2182152|NCT01421667|3809644|FG000|Overall Study|Withdrawal by Subject|0
2182153|NCT01421667|3809645|FG001|Overall Study|Withdrawal by Subject|1
2182154|NCT01421667|3809646|FG002|Overall Study|Withdrawal by Subject|2
2182155|NCT01421667|3809647|FG003|Overall Study|Withdrawal by Subject|1
2182156|NCT01421667|3809644|FG000|Overall Study|Lost to Follow-up|0
2182157|NCT01421667|3809645|FG001|Overall Study|Lost to Follow-up|1
2182158|NCT01421667|3809646|FG002|Overall Study|Lost to Follow-up|0
2182159|NCT01421667|3809647|FG003|Overall Study|Lost to Follow-up|0
2182160|NCT01421719|3809665|FG000|Overall Study|Withdrawal by Subject|4
2182161|NCT01422187|3809709|FG000|Overall Study|Personal reason|1
2182162|NCT01422187|3809710|FG001|Overall Study|Personal reason|0
2182163|NCT01422187|3809711|FG002|Overall Study|Personal reason|0
2182164|NCT01422187|3809709|FG000|Overall Study|Lost to Follow-up|0
2182165|NCT01422187|3809710|FG001|Overall Study|Lost to Follow-up|1
2182166|NCT01422187|3809711|FG002|Overall Study|Lost to Follow-up|0
2219639|NCT01722331|3863455|FG000|Part 3|Protocol Violation|2
2219640|NCT01722331|3863456|FG001|Part 3|Protocol Violation|1
2219641|NCT01722331|3863457|FG002|Part 3|Protocol Violation|0
2219642|NCT01722331|3863458|FG003|Part 3|Protocol Violation|0
2219643|NCT01722331|3863459|FG004|Part 3|Protocol Violation|0
2219644|NCT01722331|3863460|FG005|Part 3|Protocol Violation|0
2219645|NCT01722331|3863461|FG006|Part 3|Protocol Violation|0
2219646|NCT01722331|3863455|FG000|Part 3|Withdrawal by Subject|4
2219647|NCT01722331|3863456|FG001|Part 3|Withdrawal by Subject|7
2219648|NCT01722331|3863457|FG002|Part 3|Withdrawal by Subject|0
2219649|NCT01722331|3863458|FG003|Part 3|Withdrawal by Subject|0
2219650|NCT01722331|3863459|FG004|Part 3|Withdrawal by Subject|0
2219651|NCT01722331|3863460|FG005|Part 3|Withdrawal by Subject|2
2219652|NCT01722331|3863461|FG006|Part 3|Withdrawal by Subject|1
2219653|NCT01722331|3863455|FG000|Part 3|Other Protocol Specified Criteria|1
2219654|NCT01722331|3863456|FG001|Part 3|Other Protocol Specified Criteria|1
2219655|NCT01722331|3863457|FG002|Part 3|Other Protocol Specified Criteria|0
2219656|NCT01722331|3863458|FG003|Part 3|Other Protocol Specified Criteria|0
2219657|NCT01722331|3863459|FG004|Part 3|Other Protocol Specified Criteria|0
2219658|NCT01722331|3863460|FG005|Part 3|Other Protocol Specified Criteria|0
2219659|NCT01722331|3863461|FG006|Part 3|Other Protocol Specified Criteria|0
2219660|NCT01722669|3863521|FG000|Overall Study|Withdrawal by Subject|0
2219661|NCT01722669|3863522|FG001|Overall Study|Withdrawal by Subject|0
2219662|NCT01722669|3863523|FG002|Overall Study|Withdrawal by Subject|0
2219663|NCT01722669|3863524|FG003|Overall Study|Withdrawal by Subject|0
2219664|NCT01722669|3863525|FG004|Overall Study|Withdrawal by Subject|0
2219665|NCT01722669|3863526|FG005|Overall Study|Withdrawal by Subject|2
2219666|NCT01722877|3863559|FG000|Overall Study|Death|1
2219667|NCT01722877|3863559|FG000|Overall Study|Lost to Follow-up|1
2219668|NCT01722994|3863567|FG000|Overall Study|Missing data|25
2219669|NCT01722994|3863568|FG001|Overall Study|Missing data|17
2219670|NCT01723072|3863578|FG000|Overall Study|Withdrawal by Subject|7
2219671|NCT01723072|3863579|FG001|Overall Study|Withdrawal by Subject|13
2219672|NCT01723072|3863578|FG000|Overall Study|Discon for rescue medication after wk 24|0
2219673|NCT01723072|3863579|FG001|Overall Study|Discon for rescue medication after wk 24|5
2219674|NCT01723072|3863578|FG000|Overall Study|Other|4
2219675|NCT01723072|3863579|FG001|Overall Study|Other|3
2219676|NCT01723163|3863587|FG000|Treatment Phase|Withdrawal by Subject|14
2219677|NCT01723163|3863588|FG001|Treatment Phase|Withdrawal by Subject|6
2219678|NCT01723163|3863587|FG000|Treatment Phase|Withdrawal by PI|5
2219679|NCT01723163|3863588|FG001|Treatment Phase|Withdrawal by PI|1
2219680|NCT01723163|3863587|FG000|3-Month Follow-up|Withdrawal by Subject|1
2219681|NCT01723163|3863588|FG001|3-Month Follow-up|Withdrawal by Subject|0
2219682|NCT01723163|3863587|FG000|3-Month Follow-up|Unable to Contact|12
2219683|NCT01723163|3863588|FG001|3-Month Follow-up|Unable to Contact|19
2219684|NCT01723163|3863587|FG000|6-Month Follow-up|Death|1
2219685|NCT01723163|3863588|FG001|6-Month Follow-up|Death|0
2219686|NCT01723163|3863587|FG000|6-Month Follow-up|Unable to Contact|17
2219687|NCT01723163|3863588|FG001|6-Month Follow-up|Unable to Contact|15
2219688|NCT01723163|3863587|FG000|12-Month Follow-up|Death|1
2219689|NCT01723163|3863588|FG001|12-Month Follow-up|Death|0
2219690|NCT01723163|3863587|FG000|12-Month Follow-up|Unable to Contact|23
2219691|NCT01723163|3863588|FG001|12-Month Follow-up|Unable to Contact|28
2219692|NCT01723228|3863596|FG000|Overall Study|Adverse Event|2
2219693|NCT01723228|3863597|FG001|Overall Study|Adverse Event|6
2219694|NCT01723228|3863596|FG000|Overall Study|Withdrawal by Subject|2
2331882|NCT03178773|4054769|FG000|Overall Study|Lost to Follow-up|29
2331883|NCT03178773|4054770|FG001|Overall Study|Lost to Follow-up|25
2331884|NCT03178773|4054769|FG000|Overall Study|Withdrawal by Subject|10
2331885|NCT03178773|4054770|FG001|Overall Study|Withdrawal by Subject|14
2331886|NCT03178851|4054780|FG000|Overall Study|Death|48
2331887|NCT03178851|4054781|FG001|Overall Study|Death|2
2182167|NCT01422213|3809733|FG000|Overall Study|Adverse Event|8
2219695|NCT01723228|3863597|FG001|Overall Study|Withdrawal by Subject|1
2219696|NCT01723228|3863596|FG000|Overall Study|Protocol Violation|0
2219697|NCT01723228|3863597|FG001|Overall Study|Protocol Violation|2
2219698|NCT01723228|3863596|FG000|Overall Study|Lost to Follow-up|2
2219699|NCT01723228|3863597|FG001|Overall Study|Lost to Follow-up|1
2331888|NCT03178851|4054782|FG002|Overall Study|Death|25
2182168|NCT01422213|3809734|FG001|Overall Study|Adverse Event|7
2182169|NCT01422213|3809735|FG002|Overall Study|Adverse Event|11
2182170|NCT01422213|3809733|FG000|Overall Study|Lack of Efficacy|10
2182171|NCT01422213|3809734|FG001|Overall Study|Lack of Efficacy|2
2182172|NCT01422213|3809735|FG002|Overall Study|Lack of Efficacy|2
2182173|NCT01422213|3809733|FG000|Overall Study|Non-compliance with study drug|0
2182174|NCT01422213|3809734|FG001|Overall Study|Non-compliance with study drug|1
2182175|NCT01422213|3809735|FG002|Overall Study|Non-compliance with study drug|0
2182176|NCT01422213|3809733|FG000|Overall Study|Protocol Violation|0
2182177|NCT01422213|3809734|FG001|Overall Study|Protocol Violation|2
2182178|NCT01422213|3809735|FG002|Overall Study|Protocol Violation|4
2182179|NCT01422213|3809733|FG000|Overall Study|Withdrawal of Consent|7
2182180|NCT01422213|3809734|FG001|Overall Study|Withdrawal of Consent|3
2182181|NCT01422213|3809735|FG002|Overall Study|Withdrawal of Consent|5
2182182|NCT01422213|3809733|FG000|Overall Study|Lost to Follow-up|3
2182183|NCT01422213|3809734|FG001|Overall Study|Lost to Follow-up|3
2182184|NCT01422213|3809735|FG002|Overall Study|Lost to Follow-up|5
2182185|NCT01422213|3809733|FG000|Overall Study|Administrative or Other Reason(s)|5
2182186|NCT01422213|3809734|FG001|Overall Study|Administrative or Other Reason(s)|4
2182187|NCT01422213|3809735|FG002|Overall Study|Administrative or Other Reason(s)|2
2182188|NCT01422239|3809754|FG000|Overall Study|Lost to Follow-up|4
2182189|NCT01422239|3809755|FG001|Overall Study|Lost to Follow-up|3
2182190|NCT01422304|3809763|FG000|Overall Study|Adverse Event|0
2182191|NCT01422304|3809764|FG001|Overall Study|Adverse Event|1
2182192|NCT01422304|3809763|FG000|Overall Study|Lost to Follow-up|14
2182193|NCT01422304|3809764|FG001|Overall Study|Lost to Follow-up|20
2182194|NCT01422304|3809763|FG000|Overall Study|Never Entered Follow-up|2
2182195|NCT01422304|3809764|FG001|Overall Study|Never Entered Follow-up|1
2182196|NCT01422304|3809763|FG000|Overall Study|Protocol Violation|1
2182197|NCT01422304|3809764|FG001|Overall Study|Protocol Violation|0
2182198|NCT01422304|3809763|FG000|Overall Study|Withdrawal by Subject|4
2182199|NCT01422304|3809764|FG001|Overall Study|Withdrawal by Subject|2
2182200|NCT01422304|3809763|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
2182201|NCT01422304|3809764|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
2182202|NCT01422304|3809763|FG000|Overall Study|Not Treated|3
2182203|NCT01422304|3809764|FG001|Overall Study|Not Treated|11
2182204|NCT01422382|3809779|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
2182205|NCT01422408|3809783|FG000|Overall Study|Adverse Event|1
2182206|NCT01422408|3809783|FG000|Overall Study|Withdrawal by Subject|3
2182207|NCT01422538|3809803|FG000|Overall Study|Lost to Follow-up|0
2182208|NCT01422538|3809804|FG001|Overall Study|Lost to Follow-up|1
2182209|NCT01422538|3809805|FG002|Overall Study|Lost to Follow-up|1
2182210|NCT01422538|3809803|FG000|Overall Study|Missed visit|0
2182211|NCT01422538|3809804|FG001|Overall Study|Missed visit|1
2182212|NCT01422538|3809805|FG002|Overall Study|Missed visit|1
2182213|NCT01422720|3809814|FG000|Overall Study|Adverse Event|16
2182214|NCT01422720|3809814|FG000|Overall Study|Lack of Efficacy|1
2182215|NCT01422720|3809814|FG000|Overall Study|Withdrawal by Subject|4
2182216|NCT01422720|3809814|FG000|Overall Study|Ineligibility|1
2182217|NCT01422824|3809822|FG000|Overall Study|Case record form not evaluated|1
2182218|NCT01422824|3809822|FG000|Overall Study|Lost to Follow-up|37
2182219|NCT01422850|3809826|FG000|Overall Study|Physician Decision|3
2182220|NCT01422876|3809842|FG000|Week 24|Lost to Follow-up|1
2182221|NCT01422876|3809843|FG001|Week 24|Lost to Follow-up|1
2182222|NCT01422876|3809844|FG002|Week 24|Lost to Follow-up|2
2182223|NCT01422876|3809845|FG003|Week 24|Lost to Follow-up|4
2182224|NCT01422876|3809846|FG004|Week 24|Lost to Follow-up|2
2182225|NCT01422876|3809847|FG005|Week 24|Lost to Follow-up|0
2182226|NCT01422876|3809848|FG006|Week 24|Lost to Follow-up|1
2182227|NCT01422876|3809849|FG007|Week 24|Lost to Follow-up|3
2182228|NCT01422876|3809850|FG008|Week 24|Lost to Follow-up|3
2182229|NCT01422876|3809851|FG009|Week 24|Lost to Follow-up|4
2182230|NCT01422876|3809842|FG000|Week 24|Consent withdrawn|5
2182231|NCT01422876|3809843|FG001|Week 24|Consent withdrawn|1
2182232|NCT01422876|3809844|FG002|Week 24|Consent withdrawn|3
2182233|NCT01422876|3809845|FG003|Week 24|Consent withdrawn|4
2182234|NCT01422876|3809846|FG004|Week 24|Consent withdrawn|5
2182235|NCT01422876|3809847|FG005|Week 24|Consent withdrawn|6
2182236|NCT01422876|3809848|FG006|Week 24|Consent withdrawn|5
2182237|NCT01422876|3809849|FG007|Week 24|Consent withdrawn|4
2182238|NCT01422876|3809850|FG008|Week 24|Consent withdrawn|3
2219700|NCT01723228|3863596|FG000|Overall Study|Other|2
2219701|NCT01723228|3863597|FG001|Overall Study|Other|1
2219702|NCT01723254|3863611|FG000|Overall Study|Conflict with work schedule|0
2219703|NCT01723254|3863612|FG001|Overall Study|Conflict with work schedule|0
2219704|NCT01723254|3863613|FG002|Overall Study|Conflict with work schedule|0
2219705|NCT01723254|3863614|FG003|Overall Study|Conflict with work schedule|0
2219706|NCT01723254|3863615|FG004|Overall Study|Conflict with work schedule|0
2219707|NCT01723254|3863616|FG005|Overall Study|Conflict with work schedule|0
2219708|NCT01723254|3863617|FG006|Overall Study|Conflict with work schedule|0
2219709|NCT01723254|3863618|FG007|Overall Study|Conflict with work schedule|1
2219710|NCT01723254|3863611|FG000|Overall Study|Personal issues|0
2182239|NCT01422876|3809851|FG009|Week 24|Consent withdrawn|6
2182240|NCT01422876|3809842|FG000|Week 24|Death|0
2182241|NCT01422876|3809843|FG001|Week 24|Death|1
2182242|NCT01422876|3809844|FG002|Week 24|Death|0
2182243|NCT01422876|3809845|FG003|Week 24|Death|0
2182244|NCT01422876|3809846|FG004|Week 24|Death|0
2182245|NCT01422876|3809847|FG005|Week 24|Death|0
2182246|NCT01422876|3809848|FG006|Week 24|Death|0
2182247|NCT01422876|3809849|FG007|Week 24|Death|0
2182248|NCT01422876|3809850|FG008|Week 24|Death|0
2182249|NCT01422876|3809851|FG009|Week 24|Death|0
2182250|NCT01422876|3809842|FG000|Week 52|Lost to Follow-up|3
2182251|NCT01422876|3809843|FG001|Week 52|Lost to Follow-up|5
2182252|NCT01422876|3809844|FG002|Week 52|Lost to Follow-up|7
2182253|NCT01422876|3809845|FG003|Week 52|Lost to Follow-up|5
2182254|NCT01422876|3809846|FG004|Week 52|Lost to Follow-up|8
2182255|NCT01422876|3809847|FG005|Week 52|Lost to Follow-up|5
2182256|NCT01422876|3809848|FG006|Week 52|Lost to Follow-up|5
2182257|NCT01422876|3809849|FG007|Week 52|Lost to Follow-up|8
2182258|NCT01422876|3809850|FG008|Week 52|Lost to Follow-up|7
2182259|NCT01422876|3809851|FG009|Week 52|Lost to Follow-up|8
2182260|NCT01422876|3809842|FG000|Week 52|Consent withdrawn|9
2219711|NCT01723254|3863612|FG001|Overall Study|Personal issues|0
2219712|NCT01723254|3863613|FG002|Overall Study|Personal issues|0
2219713|NCT01723254|3863614|FG003|Overall Study|Personal issues|0
2219714|NCT01723254|3863615|FG004|Overall Study|Personal issues|0
2219715|NCT01723254|3863616|FG005|Overall Study|Personal issues|1
2219716|NCT01723254|3863617|FG006|Overall Study|Personal issues|0
2219717|NCT01723254|3863618|FG007|Overall Study|Personal issues|0
2219718|NCT01723254|3863611|FG000|Overall Study|No longer have time to participate|0
2219719|NCT01723254|3863612|FG001|Overall Study|No longer have time to participate|0
2219720|NCT01723254|3863613|FG002|Overall Study|No longer have time to participate|0
2219721|NCT01723254|3863614|FG003|Overall Study|No longer have time to participate|1
2219722|NCT01723254|3863615|FG004|Overall Study|No longer have time to participate|0
2219723|NCT01723254|3863616|FG005|Overall Study|No longer have time to participate|0
2219724|NCT01723254|3863617|FG006|Overall Study|No longer have time to participate|0
2219725|NCT01723254|3863618|FG007|Overall Study|No longer have time to participate|0
2219726|NCT01723254|3863611|FG000|Overall Study|Move/Left to another country/city|0
2219727|NCT01723254|3863612|FG001|Overall Study|Move/Left to another country/city|0
2219728|NCT01723254|3863613|FG002|Overall Study|Move/Left to another country/city|2
2219729|NCT01723254|3863614|FG003|Overall Study|Move/Left to another country/city|1
2219730|NCT01723254|3863615|FG004|Overall Study|Move/Left to another country/city|1
2219731|NCT01723254|3863616|FG005|Overall Study|Move/Left to another country/city|0
2219732|NCT01723254|3863617|FG006|Overall Study|Move/Left to another country/city|0
2219733|NCT01723254|3863618|FG007|Overall Study|Move/Left to another country/city|0
2219734|NCT01723254|3863611|FG000|Overall Study|Protocol Violation|0
2219735|NCT01723254|3863612|FG001|Overall Study|Protocol Violation|1
2219736|NCT01723254|3863613|FG002|Overall Study|Protocol Violation|0
2219737|NCT01723254|3863614|FG003|Overall Study|Protocol Violation|0
2219738|NCT01723254|3863615|FG004|Overall Study|Protocol Violation|0
2219739|NCT01723254|3863616|FG005|Overall Study|Protocol Violation|0
2219740|NCT01723254|3863617|FG006|Overall Study|Protocol Violation|0
2219741|NCT01723254|3863618|FG007|Overall Study|Protocol Violation|0
2219742|NCT01723254|3863611|FG000|Overall Study|Withdrawal by Subject|1
2219743|NCT01723254|3863612|FG001|Overall Study|Withdrawal by Subject|2
2219744|NCT01723254|3863613|FG002|Overall Study|Withdrawal by Subject|1
2219745|NCT01723254|3863614|FG003|Overall Study|Withdrawal by Subject|0
2219746|NCT01723254|3863615|FG004|Overall Study|Withdrawal by Subject|1
2219747|NCT01723254|3863616|FG005|Overall Study|Withdrawal by Subject|1
2219748|NCT01723254|3863617|FG006|Overall Study|Withdrawal by Subject|1
2219749|NCT01723254|3863618|FG007|Overall Study|Withdrawal by Subject|2
2219750|NCT01723397|3863647|FG000|Study Period 1|Protocol Violation|0
2219751|NCT01723397|3863648|FG001|Study Period 1|Protocol Violation|1
2219752|NCT01723397|3863647|FG000|Study Period 2|Protocol Violation|0
2219753|NCT01723397|3863648|FG001|Study Period 2|Protocol Violation|1
2219754|NCT01723826|3863711|FG000|Overall Study|Adverse Event|4
2219755|NCT01723826|3863712|FG001|Overall Study|Adverse Event|1
2219756|NCT01723826|3863713|FG002|Overall Study|Adverse Event|4
2219757|NCT01723826|3863714|FG003|Overall Study|Adverse Event|5
2219758|NCT01723826|3863711|FG000|Overall Study|Death according to AE eCRF|2
2219759|NCT01723826|3863712|FG001|Overall Study|Death according to AE eCRF|3
2219760|NCT01723826|3863713|FG002|Overall Study|Death according to AE eCRF|3
2219761|NCT01723826|3863714|FG003|Overall Study|Death according to AE eCRF|7
2219762|NCT01723826|3863711|FG000|Overall Study|Lost to Follow-up|1
2219763|NCT01723826|3863712|FG001|Overall Study|Lost to Follow-up|3
2219764|NCT01723826|3863713|FG002|Overall Study|Lost to Follow-up|1
2219765|NCT01723826|3863714|FG003|Overall Study|Lost to Follow-up|1
2219766|NCT01723826|3863711|FG000|Overall Study|Non-compliance|0
2219767|NCT01723826|3863712|FG001|Overall Study|Non-compliance|1
2219768|NCT01723826|3863713|FG002|Overall Study|Non-compliance|3
2219769|NCT01723826|3863714|FG003|Overall Study|Non-compliance|3
2219770|NCT01723826|3863711|FG000|Overall Study|Non-compliance With Study Drug|0
2219771|NCT01723826|3863712|FG001|Overall Study|Non-compliance With Study Drug|1
2219772|NCT01723826|3863713|FG002|Overall Study|Non-compliance With Study Drug|0
2219773|NCT01723826|3863714|FG003|Overall Study|Non-compliance With Study Drug|0
2219774|NCT01723826|3863711|FG000|Overall Study|Other Reason|8
2219775|NCT01723826|3863712|FG001|Overall Study|Other Reason|6
2219776|NCT01723826|3863713|FG002|Overall Study|Other Reason|12
2182261|NCT01422876|3809843|FG001|Week 52|Consent withdrawn|4
2182262|NCT01422876|3809844|FG002|Week 52|Consent withdrawn|6
2182263|NCT01422876|3809845|FG003|Week 52|Consent withdrawn|12
2182264|NCT01422876|3809846|FG004|Week 52|Consent withdrawn|7
2182265|NCT01422876|3809847|FG005|Week 52|Consent withdrawn|12
2182266|NCT01422876|3809848|FG006|Week 52|Consent withdrawn|10
2182267|NCT01422876|3809849|FG007|Week 52|Consent withdrawn|12
2182268|NCT01422876|3809850|FG008|Week 52|Consent withdrawn|13
2182269|NCT01422876|3809851|FG009|Week 52|Consent withdrawn|9
2182270|NCT01422876|3809842|FG000|Week 52|Death|0
2182271|NCT01422876|3809843|FG001|Week 52|Death|1
2182272|NCT01422876|3809844|FG002|Week 52|Death|0
2182273|NCT01422876|3809845|FG003|Week 52|Death|1
2182274|NCT01422876|3809846|FG004|Week 52|Death|0
2182275|NCT01422876|3809847|FG005|Week 52|Death|0
2182276|NCT01422876|3809848|FG006|Week 52|Death|1
2182277|NCT01422876|3809849|FG007|Week 52|Death|3
2182278|NCT01422876|3809850|FG008|Week 52|Death|1
2182279|NCT01422876|3809851|FG009|Week 52|Death|0
2182280|NCT01422889|3809869|FG000|Overall Study|No Data Entered for Study Stent|9
2182281|NCT01422915|3809873|FG000|Overall Study|Adverse Event|1
2182282|NCT01423084|3809880|FG000|Overall Study|Adverse Event|0
2182283|NCT01423084|3809881|FG001|Overall Study|Adverse Event|1
2182284|NCT01423084|3809880|FG000|Overall Study|Withdrawal by Subject|2
2182285|NCT01423084|3809881|FG001|Overall Study|Withdrawal by Subject|3
2219777|NCT01723826|3863714|FG003|Overall Study|Other Reason|14
2219778|NCT01723826|3863711|FG000|Overall Study|Physician Decision|1
2182286|NCT01423253|3809897|FG000|Overall Study|Adverse Event|2
2182287|NCT01423253|3809897|FG000|Overall Study|Lack of Efficacy|2
2182288|NCT01423253|3809897|FG000|Overall Study|Lost to Follow-up|1
2182289|NCT01423253|3809897|FG000|Overall Study|Protocol Violation|2
2182290|NCT01423253|3809897|FG000|Overall Study|Withdrawal by Subject|2
2182291|NCT01423604|3809904|FG000|Safety Run-In|Adverse Event|3
2182292|NCT01423604|3809905|FG001|Safety Run-In|Adverse Event|0
2182293|NCT01423604|3809904|FG000|Safety Run-In|Death|1
2182294|NCT01423604|3809905|FG001|Safety Run-In|Death|0
2182295|NCT01423604|3809904|FG000|Safety Run-In|Physician Decision|1
2182296|NCT01423604|3809905|FG001|Safety Run-In|Physician Decision|0
2182297|NCT01423604|3809904|FG000|Safety Run-In|Disease progression|3
2182298|NCT01423604|3809905|FG001|Safety Run-In|Disease progression|0
2182299|NCT01423604|3809904|FG000|Safety Run-In|Patient decision|1
2182300|NCT01423604|3809905|FG001|Safety Run-In|Patient decision|0
2182301|NCT01423604|3809904|FG000|Randomized|Adverse Event|4
2182302|NCT01423604|3809905|FG001|Randomized|Adverse Event|10
2182303|NCT01423604|3809904|FG000|Randomized|Death|1
2182304|NCT01423604|3809905|FG001|Randomized|Death|0
2182305|NCT01423604|3809904|FG000|Randomized|Physician Decision|16
2182306|NCT01423604|3809905|FG001|Randomized|Physician Decision|13
2182307|NCT01423604|3809904|FG000|Randomized|Other - unspecified|37
2182308|NCT01423604|3809905|FG001|Randomized|Other - unspecified|31
2182309|NCT01423604|3809904|FG000|Randomized|Patient decision|5
2182310|NCT01423604|3809905|FG001|Randomized|Patient decision|9
2182311|NCT01423617|3809914|FG000|Overall Study|Lost to Follow-up|0
2182312|NCT01423617|3809915|FG001|Overall Study|Lost to Follow-up|1
2182313|NCT01423812|3809939|FG000|Overall Study|Lost to Follow-up|2
2182314|NCT01423812|3809940|FG001|Overall Study|Lost to Follow-up|2
2219779|NCT01723826|3863712|FG001|Overall Study|Physician Decision|3
2219780|NCT01723826|3863713|FG002|Overall Study|Physician Decision|4
2219781|NCT01723826|3863714|FG003|Overall Study|Physician Decision|11
2219782|NCT01723826|3863711|FG000|Overall Study|Protocol Violation|1
2219783|NCT01723826|3863712|FG001|Overall Study|Protocol Violation|1
2219784|NCT01723826|3863713|FG002|Overall Study|Protocol Violation|3
2219785|NCT01723826|3863714|FG003|Overall Study|Protocol Violation|1
2219786|NCT01723826|3863711|FG000|Overall Study|Withdrawal by Subject|10
2219787|NCT01723826|3863712|FG001|Overall Study|Withdrawal by Subject|17
2219788|NCT01723826|3863713|FG002|Overall Study|Withdrawal by Subject|27
2219789|NCT01723826|3863714|FG003|Overall Study|Withdrawal by Subject|48
2219790|NCT01723904|3863724|FG000|Overall Study|Noncompliant|3
2219791|NCT01723904|3863724|FG000|Overall Study|Adverse Event|5
2219792|NCT01723904|3863724|FG000|Overall Study|Unable to follow protocol/ judged by inv|3
2219793|NCT01724021|3863730|FG000|Overall Study|Adverse Event|11
2219794|NCT01724021|3863731|FG001|Overall Study|Adverse Event|6
2219795|NCT01724021|3863730|FG000|Overall Study|Death|46
2219796|NCT01724021|3863731|FG001|Overall Study|Death|58
2219797|NCT01724021|3863730|FG000|Overall Study|Participant request/ Withdrew consent|18
2219798|NCT01724021|3863731|FG001|Overall Study|Participant request/ Withdrew consent|14
2219799|NCT01724021|3863730|FG000|Overall Study|Lost to Follow-up|15
2219800|NCT01724021|3863731|FG001|Overall Study|Lost to Follow-up|15
2219801|NCT01724021|3863730|FG000|Overall Study|Reason Not Specified|36
2219802|NCT01724021|3863731|FG001|Overall Study|Reason Not Specified|39
2219803|NCT01724021|3863730|FG000|Overall Study|Missing|1
2182315|NCT01423812|3809939|FG000|Overall Study|Withdrawal by Subject|1
2182316|NCT01423812|3809940|FG001|Overall Study|Withdrawal by Subject|2
2182317|NCT01423916|3809951|FG000|Overall Study|Adverse Event|5
2182318|NCT01423916|3809952|FG001|Overall Study|Adverse Event|9
2182319|NCT01423916|3809953|FG002|Overall Study|Adverse Event|2
2182320|NCT01423916|3809951|FG000|Overall Study|Met Withdrawal Criteria|1
2182321|NCT01423916|3809952|FG001|Overall Study|Met Withdrawal Criteria|1
2182322|NCT01423916|3809953|FG002|Overall Study|Met Withdrawal Criteria|1
2182323|NCT01423916|3809951|FG000|Overall Study|Physician Decision|1
2182324|NCT01423916|3809952|FG001|Overall Study|Physician Decision|0
2182325|NCT01423916|3809953|FG002|Overall Study|Physician Decision|1
2182326|NCT01423916|3809951|FG000|Overall Study|Withdrawal by Subject|3
2182327|NCT01423916|3809952|FG001|Overall Study|Withdrawal by Subject|10
2182328|NCT01423916|3809953|FG002|Overall Study|Withdrawal by Subject|3
2182329|NCT01423916|3809951|FG000|Overall Study|Protocol Deviation|1
2182330|NCT01423916|3809952|FG001|Overall Study|Protocol Deviation|0
2182331|NCT01423916|3809953|FG002|Overall Study|Protocol Deviation|0
2182332|NCT01424189|3809991|FG000|Overall Study|Adverse Event|1
2182333|NCT01424189|3809992|FG001|Overall Study|Adverse Event|0
2182334|NCT01424189|3809991|FG000|Overall Study|Lost to Follow-up|4
2182335|NCT01424189|3809992|FG001|Overall Study|Lost to Follow-up|1
2182336|NCT01424189|3809991|FG000|Overall Study|Withdrawal by Subject|4
2182337|NCT01424189|3809992|FG001|Overall Study|Withdrawal by Subject|4
2182338|NCT01424189|3809991|FG000|Overall Study|Subject moved|1
2182339|NCT01424189|3809992|FG001|Overall Study|Subject moved|0
2182340|NCT01424189|3809991|FG000|Overall Study|Death|3
2182341|NCT01424189|3809992|FG001|Overall Study|Death|1
2182342|NCT01424228|3810009|FG000|Overall Study|Withdrawal by Subject|27
2182343|NCT01424228|3810010|FG001|Overall Study|Withdrawal by Subject|11
2182344|NCT01424228|3810009|FG000|Overall Study|Adverse Event|10
2182345|NCT01424228|3810010|FG001|Overall Study|Adverse Event|14
2182346|NCT01424228|3810009|FG000|Overall Study|Sponsor's decision|9
2182347|NCT01424228|3810010|FG001|Overall Study|Sponsor's decision|12
2182348|NCT01424228|3810009|FG000|Overall Study|Lack of Efficacy|5
2182349|NCT01424228|3810010|FG001|Overall Study|Lack of Efficacy|7
2182350|NCT01424228|3810009|FG000|Overall Study|inclusion/exclusion criteria not met|2
2182351|NCT01424228|3810010|FG001|Overall Study|inclusion/exclusion criteria not met|2
2182352|NCT01424228|3810009|FG000|Overall Study|Non-compliance|2
2182353|NCT01424228|3810010|FG001|Overall Study|Non-compliance|0
2182354|NCT01424228|3810009|FG000|Overall Study|Worsening of symptoms|1
2182355|NCT01424228|3810010|FG001|Overall Study|Worsening of symptoms|0
2182356|NCT01424228|3810009|FG000|Overall Study|Unplanned journey|0
2182357|NCT01424228|3810010|FG001|Overall Study|Unplanned journey|1
2182358|NCT01424306|3810020|FG000|Overall Study|Protocol Violation|0
2182359|NCT01424306|3810021|FG001|Overall Study|Protocol Violation|0
2182360|NCT01424306|3810022|FG002|Overall Study|Protocol Violation|0
2182361|NCT01424306|3810023|FG003|Overall Study|Protocol Violation|0
2182362|NCT01424306|3810024|FG004|Overall Study|Protocol Violation|1
2182363|NCT01424306|3810025|FG005|Overall Study|Protocol Violation|0
2182364|NCT01424397|3810069|FG000|Period-2 (8 Days)|Withdrawal by Subject|0
2182365|NCT01424397|3810070|FG001|Period-2 (8 Days)|Withdrawal by Subject|0
2182366|NCT01424397|3810071|FG002|Period-2 (8 Days)|Withdrawal by Subject|1
2182367|NCT01424397|3810072|FG003|Period-2 (8 Days)|Withdrawal by Subject|0
2182368|NCT01424397|3810073|FG004|Period-2 (8 Days)|Withdrawal by Subject|0
2182369|NCT01424397|3810074|FG005|Period-2 (8 Days)|Withdrawal by Subject|0
2182370|NCT01424397|3810075|FG006|Period-2 (8 Days)|Withdrawal by Subject|0
2182371|NCT01424397|3810076|FG007|Period-2 (8 Days)|Withdrawal by Subject|0
2182372|NCT01424397|3810077|FG008|Period-2 (8 Days)|Withdrawal by Subject|0
2182373|NCT01424397|3810078|FG009|Period-2 (8 Days)|Withdrawal by Subject|0
2182374|NCT01424397|3810079|FG010|Period-2 (8 Days)|Withdrawal by Subject|0
2182375|NCT01424397|3810080|FG011|Period-2 (8 Days)|Withdrawal by Subject|0
2182376|NCT01424501|3810100|FG000|Overall Study|Withdrawal by Subject|1
2182377|NCT01424501|3810101|FG001|Overall Study|Withdrawal by Subject|0
2182378|NCT01424501|3810102|FG002|Overall Study|Withdrawal by Subject|1
2182379|NCT01424501|3810103|FG003|Overall Study|Withdrawal by Subject|0
2182380|NCT01424501|3810104|FG004|Overall Study|Withdrawal by Subject|0
2182381|NCT01424501|3810105|FG005|Overall Study|Withdrawal by Subject|0
2182382|NCT01424501|3810100|FG000|Overall Study|Lost to Follow-up|0
2182383|NCT01424501|3810101|FG001|Overall Study|Lost to Follow-up|1
2182384|NCT01424501|3810102|FG002|Overall Study|Lost to Follow-up|1
2182385|NCT01424501|3810103|FG003|Overall Study|Lost to Follow-up|0
2182386|NCT01424501|3810104|FG004|Overall Study|Lost to Follow-up|0
2182387|NCT01424501|3810105|FG005|Overall Study|Lost to Follow-up|0
2182388|NCT01424514|3810120|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
2182389|NCT01424514|3810121|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
2182390|NCT01424514|3810120|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
2182391|NCT01424514|3810121|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
2182392|NCT01424566|3810132|FG000|Single-blind Treatment|Adverse Event|71
2219804|NCT01724021|3863731|FG001|Overall Study|Missing|1
2219805|NCT01724177|3863772|FG000|Overall Study|Adverse Event|8
2219806|NCT01724177|3863772|FG000|Overall Study|Progressive disease or Relapsed Disease|16
2219807|NCT01724177|3863772|FG000|Overall Study|Nervous participant|1
2182393|NCT01424566|3810133|FG001|Single-blind Treatment|Adverse Event|0
2182394|NCT01424566|3810134|FG002|Single-blind Treatment|Adverse Event|0
2182395|NCT01424566|3810132|FG000|Single-blind Treatment|Withdrawal by Subject|16
2182396|NCT01424566|3810133|FG001|Single-blind Treatment|Withdrawal by Subject|0
2182397|NCT01424566|3810134|FG002|Single-blind Treatment|Withdrawal by Subject|0
2182398|NCT01424566|3810132|FG000|Single-blind Treatment|Withdrawal by Investigator|2
2182399|NCT01424566|3810133|FG001|Single-blind Treatment|Withdrawal by Investigator|0
2182400|NCT01424566|3810134|FG002|Single-blind Treatment|Withdrawal by Investigator|0
2182401|NCT01424566|3810132|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
2182402|NCT01424566|3810133|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
2182403|NCT01424566|3810134|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
2274015|NCT02291861|3954771|FG001|Overall Study|Adverse Event|4
2182404|NCT01424566|3810132|FG000|Single-blind Treatment|Met Exclusion Criteria|1
2182405|NCT01424566|3810133|FG001|Single-blind Treatment|Met Exclusion Criteria|0
2182406|NCT01424566|3810134|FG002|Single-blind Treatment|Met Exclusion Criteria|0
2182407|NCT01424566|3810132|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2
2182408|NCT01424566|3810133|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0
2182409|NCT01424566|3810134|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0
2182410|NCT01424566|3810132|FG000|Double-blind Treatment|Adverse Event|0
2182411|NCT01424566|3810133|FG001|Double-blind Treatment|Adverse Event|21
2182412|NCT01424566|3810134|FG002|Double-blind Treatment|Adverse Event|13
2182413|NCT01424566|3810132|FG000|Double-blind Treatment|Withdrawal by Subject|0
2182414|NCT01424566|3810133|FG001|Double-blind Treatment|Withdrawal by Subject|2
2182415|NCT01424566|3810134|FG002|Double-blind Treatment|Withdrawal by Subject|0
2182416|NCT01424566|3810132|FG000|Double-blind Treatment|Withdrawal by Investigator|0
2182417|NCT01424566|3810133|FG001|Double-blind Treatment|Withdrawal by Investigator|1
2182418|NCT01424566|3810134|FG002|Double-blind Treatment|Withdrawal by Investigator|1
2182419|NCT01424566|3810132|FG000|Double-blind Treatment|Lack of Efficacy|0
2182420|NCT01424566|3810133|FG001|Double-blind Treatment|Lack of Efficacy|1
2182421|NCT01424566|3810134|FG002|Double-blind Treatment|Lack of Efficacy|1
2182422|NCT01424644|3810143|FG000|Overall Study|Adverse Event|2
2182423|NCT01424644|3810144|FG001|Overall Study|Adverse Event|0
2182424|NCT01424644|3810143|FG000|Overall Study|Withdrawal by Subject|9
2182425|NCT01424644|3810144|FG001|Overall Study|Withdrawal by Subject|12
2182426|NCT01424644|3810143|FG000|Overall Study|Lost to Follow-up|16
2182427|NCT01424644|3810144|FG001|Overall Study|Lost to Follow-up|12
2182428|NCT01424644|3810143|FG000|Overall Study|Protocol Violation|4
2182429|NCT01424644|3810144|FG001|Overall Study|Protocol Violation|3
2182430|NCT01424644|3810143|FG000|Overall Study|Administrative Reason|1
2182431|NCT01424644|3810144|FG001|Overall Study|Administrative Reason|0
2182432|NCT01424644|3810143|FG000|Overall Study|Unable to Classify|1
2182433|NCT01424644|3810144|FG001|Overall Study|Unable to Classify|0
2182434|NCT01424670|3810152|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2
2182435|NCT01424670|3810153|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2
2182436|NCT01424670|3810152|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
2182437|NCT01424670|3810153|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
2182438|NCT01424670|3810152|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
2182439|NCT01424670|3810153|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
2182440|NCT01424670|3810152|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2
2182441|NCT01424670|3810153|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3
2182442|NCT01424670|3810152|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
2182443|NCT01424670|3810153|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
2182444|NCT01424670|3810152|FG000|Continuation Period|Adverse Event|13
2182445|NCT01424670|3810153|FG001|Continuation Period|Adverse Event|5
2182446|NCT01424670|3810152|FG000|Continuation Period|Lost to Follow-up|2
2182447|NCT01424670|3810153|FG001|Continuation Period|Lost to Follow-up|0
2182448|NCT01424670|3810152|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1
2182449|NCT01424670|3810153|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1
2182450|NCT01424670|3810152|FG000|Continuation Period|Physician Decision|5
2182451|NCT01424670|3810153|FG001|Continuation Period|Physician Decision|4
2182452|NCT01424670|3810152|FG000|Continuation Period|Withdrawal by Subject|13
2182453|NCT01424670|3810153|FG001|Continuation Period|Withdrawal by Subject|4
2182454|NCT01424722|3810161|FG000|Overall Study|Sponsor terminated investigation|2258
2182455|NCT01424813|3810167|FG000|Overall Study|Withdrawal by Subject|3
2182456|NCT01424813|3810168|FG001|Overall Study|Withdrawal by Subject|0
2182457|NCT01424813|3810167|FG000|Overall Study|Protocol Violation|1
2182458|NCT01424813|3810168|FG001|Overall Study|Protocol Violation|0
2182459|NCT01424813|3810167|FG000|Overall Study|Other|1
2182460|NCT01424813|3810168|FG001|Overall Study|Other|2
2182461|NCT01424930|3810176|FG000|Overall Study|Adverse Event|0
2182462|NCT01424930|3810177|FG001|Overall Study|Adverse Event|1
2182463|NCT01424930|3810176|FG000|Overall Study|Death|1
2182464|NCT01424930|3810177|FG001|Overall Study|Death|0
2182465|NCT01424930|3810176|FG000|Overall Study|Progressive Disease|3
2182466|NCT01424930|3810177|FG001|Overall Study|Progressive Disease|6
2182467|NCT01424930|3810176|FG000|Overall Study|Screen Failure|0
2182468|NCT01424930|3810177|FG001|Overall Study|Screen Failure|1
2182469|NCT01424930|3810176|FG000|Overall Study|Reason not specified|0
2182470|NCT01424930|3810177|FG001|Overall Study|Reason not specified|6
2182471|NCT01425190|3810195|FG000|Overall Study|Full dose not consumed.|1
2182472|NCT01425190|3810196|FG001|Overall Study|Full dose not consumed.|0
2182473|NCT01425190|3810197|FG002|Overall Study|Full dose not consumed.|0
2182474|NCT01425203|3810207|FG000|Treatment Phase|DC during PR Lead-in Phase|3
2182475|NCT01425203|3810208|FG001|Treatment Phase|DC during PR Lead-in Phase|1
2182476|NCT01425203|3810209|FG002|Treatment Phase|DC during PR Lead-in Phase|0
2182477|NCT01425203|3810207|FG000|Treatment Phase|Failure at futility timepoint|8
2182478|NCT01425203|3810208|FG001|Treatment Phase|Failure at futility timepoint|27
2182479|NCT01425203|3810209|FG002|Treatment Phase|Failure at futility timepoint|0
2182480|NCT01425203|3810207|FG000|Treatment Phase|Other virologic failure criteria|5
2182481|NCT01425203|3810208|FG001|Treatment Phase|Other virologic failure criteria|3
2182482|NCT01425203|3810209|FG002|Treatment Phase|Other virologic failure criteria|0
2182483|NCT01425203|3810207|FG000|Treatment Phase|Unidentified reasons|11
2219808|NCT01724177|3863772|FG000|Overall Study|Serious Adverse Event Related|1
2219809|NCT01724216|3863777|FG000|Overall Study|Scan was not completed|1
2219810|NCT01724359|3863781|FG000|Overall Study|Adverse Event|10
2219811|NCT01724359|3863781|FG000|Overall Study|Death|1
2219812|NCT01724359|3863781|FG000|Overall Study|Other|20
2219813|NCT01724489|3863789|FG000|Overall Study|Adverse Event|8
2219814|NCT01724489|3863790|FG001|Overall Study|Adverse Event|3
2219815|NCT01724489|3863789|FG000|Overall Study|Surgery, medication|1
2219816|NCT01724489|3863790|FG001|Overall Study|Surgery, medication|1
2219817|NCT01724489|3863789|FG000|Overall Study|Lost to Follow-up|1
2219818|NCT01724489|3863790|FG001|Overall Study|Lost to Follow-up|2
2219819|NCT01724489|3863789|FG000|Overall Study|Withdrawal by Subject|6
2219820|NCT01724489|3863790|FG001|Overall Study|Withdrawal by Subject|6
2219821|NCT01724528|3863798|FG000|Overall Study|Death|3
2219822|NCT01724528|3863799|FG001|Overall Study|Death|0
2219823|NCT01724528|3863798|FG000|Overall Study|Withdrawal by Subject|0
2219824|NCT01724528|3863799|FG001|Overall Study|Withdrawal by Subject|2
2219825|NCT01724528|3863798|FG000|Overall Study|Protocol Violation|0
2219826|NCT01724528|3863799|FG001|Overall Study|Protocol Violation|1
2219827|NCT01724528|3863798|FG000|Overall Study|Patient refused to attend last visit|1
2219828|NCT01724528|3863799|FG001|Overall Study|Patient refused to attend last visit|0
2219829|NCT01725126|3863811|FG000|Overall Study|Protocol Violation|0
2219830|NCT01725126|3863812|FG001|Overall Study|Protocol Violation|1
2219831|NCT01725126|3863813|FG002|Overall Study|Protocol Violation|0
2219832|NCT01725126|3863814|FG003|Overall Study|Protocol Violation|0
2219833|NCT01725126|3863815|FG004|Overall Study|Protocol Violation|0
2219834|NCT01725126|3863816|FG005|Overall Study|Protocol Violation|0
2219835|NCT01725126|3863811|FG000|Overall Study|Withdrawal by Subject|0
2219836|NCT01725126|3863812|FG001|Overall Study|Withdrawal by Subject|0
2219837|NCT01725126|3863813|FG002|Overall Study|Withdrawal by Subject|0
2219838|NCT01725126|3863814|FG003|Overall Study|Withdrawal by Subject|1
2219839|NCT01725126|3863815|FG004|Overall Study|Withdrawal by Subject|0
2219840|NCT01725126|3863816|FG005|Overall Study|Withdrawal by Subject|0
2219841|NCT01725217|3863842|FG000|Overall Study|Withdrawal by Subject|1
2219842|NCT01725217|3863843|FG001|Overall Study|Withdrawal by Subject|0
2219843|NCT01725217|3863844|FG002|Overall Study|Withdrawal by Subject|0
2219844|NCT01725282|3863865|FG000|Overall Study|Adverse Event|1
2219845|NCT01725282|3863866|FG001|Overall Study|Adverse Event|3
2219846|NCT01725282|3863867|FG002|Overall Study|Adverse Event|6
2219847|NCT01725282|3863868|FG003|Overall Study|Adverse Event|4
2219848|NCT01725282|3863865|FG000|Overall Study|Exacerbation of Target Disease|1
2219849|NCT01725282|3863866|FG001|Overall Study|Exacerbation of Target Disease|0
2219850|NCT01725282|3863867|FG002|Overall Study|Exacerbation of Target Disease|0
2219851|NCT01725282|3863868|FG003|Overall Study|Exacerbation of Target Disease|1
2219852|NCT01725282|3863865|FG000|Overall Study|Met Exclusion Criteria|0
2219853|NCT01725282|3863866|FG001|Overall Study|Met Exclusion Criteria|0
2219854|NCT01725282|3863867|FG002|Overall Study|Met Exclusion Criteria|1
2219855|NCT01725282|3863868|FG003|Overall Study|Met Exclusion Criteria|0
2219856|NCT01725282|3863865|FG000|Overall Study|Study Site Withdrawal|0
2219857|NCT01725282|3863866|FG001|Overall Study|Study Site Withdrawal|1
2219858|NCT01725282|3863867|FG002|Overall Study|Study Site Withdrawal|0
2219859|NCT01725282|3863868|FG003|Overall Study|Study Site Withdrawal|0
2219860|NCT01725282|3863865|FG000|Overall Study|Withdrawal by Subject|0
2219861|NCT01725282|3863866|FG001|Overall Study|Withdrawal by Subject|0
2219862|NCT01725282|3863867|FG002|Overall Study|Withdrawal by Subject|1
2219863|NCT01725282|3863868|FG003|Overall Study|Withdrawal by Subject|1
2219864|NCT01725282|3863865|FG000|Overall Study|Lack of Efficacy|0
2219865|NCT01725282|3863866|FG001|Overall Study|Lack of Efficacy|1
2219866|NCT01725282|3863867|FG002|Overall Study|Lack of Efficacy|0
2219867|NCT01725282|3863868|FG003|Overall Study|Lack of Efficacy|1
2219868|NCT01725308|3863881|FG000|Treatment Period I|Did Not Receive Drug|1
2219869|NCT01725308|3863882|FG001|Treatment Period I|Did Not Receive Drug|0
2182484|NCT01425203|3810208|FG001|Treatment Phase|Unidentified reasons|5
2182485|NCT01425203|3810209|FG002|Treatment Phase|Unidentified reasons|0
2182486|NCT01425203|3810207|FG000|Treatment Phase|Did not receive treatment|0
2182487|NCT01425203|3810208|FG001|Treatment Phase|Did not receive treatment|1
2182488|NCT01425203|3810209|FG002|Treatment Phase|Did not receive treatment|0
2182489|NCT01425203|3810207|FG000|Crossover Phase|Failure at futility timepoint|0
2182490|NCT01425203|3810208|FG001|Crossover Phase|Failure at futility timepoint|0
2182491|NCT01425203|3810209|FG002|Crossover Phase|Failure at futility timepoint|3
2182492|NCT01425203|3810207|FG000|Crossover Phase|Other virologic failure criteria|0
2182493|NCT01425203|3810208|FG001|Crossover Phase|Other virologic failure criteria|0
2182494|NCT01425203|3810209|FG002|Crossover Phase|Other virologic failure criteria|3
2182495|NCT01425268|3810227|FG000|Overall Study|Withdrawal by Subject|2
2182496|NCT01425268|3810228|FG001|Overall Study|Withdrawal by Subject|0
2182497|NCT01425268|3810227|FG000|Overall Study|Sponsor Decision|5
2182498|NCT01425268|3810228|FG001|Overall Study|Sponsor Decision|0
2182499|NCT01425268|3810227|FG000|Overall Study|Physician Decision|1
2182500|NCT01425268|3810228|FG001|Overall Study|Physician Decision|0
2182501|NCT01425281|3810236|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1
2182502|NCT01425281|3810237|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0
2182503|NCT01425281|3810236|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3
2182504|NCT01425281|3810237|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0
2182505|NCT01425281|3810236|FG000|At 180-day Clinical Follow-up|Death|0
2182506|NCT01425281|3810237|FG001|At 180-day Clinical Follow-up|Death|1
2182507|NCT01425281|3810236|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1
2182508|NCT01425281|3810237|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1
2182509|NCT01425281|3810236|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
2182510|NCT01425281|3810237|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
2219870|NCT01725308|3863883|FG002|Treatment Period I|Did Not Receive Drug|0
2219871|NCT01725308|3863881|FG000|Treatment Period I|Adverse Event|5
2219872|NCT01725308|3863882|FG001|Treatment Period I|Adverse Event|4
2219873|NCT01725308|3863883|FG002|Treatment Period I|Adverse Event|21
2219874|NCT01725308|3863881|FG000|Treatment Period I|Insufficient Response|7
2331889|NCT03178851|4054780|FG000|Overall Study|Withdrawal by Subject|8
2331890|NCT03178851|4054781|FG001|Overall Study|Withdrawal by Subject|0
2331891|NCT03178851|4054782|FG002|Overall Study|Withdrawal by Subject|0
2331892|NCT03178851|4054780|FG000|Overall Study|Lost to Follow-up|5
2331893|NCT03178851|4054781|FG001|Overall Study|Lost to Follow-up|2
2331894|NCT03178851|4054782|FG002|Overall Study|Lost to Follow-up|0
2331895|NCT03178851|4054780|FG000|Overall Study|Adverse Event|0
2331896|NCT03178851|4054781|FG001|Overall Study|Adverse Event|0
2331897|NCT03178851|4054782|FG002|Overall Study|Adverse Event|1
2331898|NCT03178851|4054780|FG000|Overall Study|Study Termination by Sponsor|31
2331899|NCT03178851|4054781|FG001|Overall Study|Study Termination by Sponsor|7
2331900|NCT03178851|4054782|FG002|Overall Study|Study Termination by Sponsor|26
2331901|NCT03178942|4054793|FG000|Overall Study|Withdrawal by Subject|2
2331902|NCT03178942|4054794|FG001|Overall Study|Withdrawal by Subject|0
2331903|NCT03178942|4054793|FG000|Overall Study|Lost to Follow-up|1
2331904|NCT03178942|4054794|FG001|Overall Study|Lost to Follow-up|2
2331905|NCT03179319|4054802|FG000|Overall Study|Lost to Follow-up|6
2331906|NCT03179319|4054803|FG001|Overall Study|Lost to Follow-up|0
2331907|NCT03179787|4054836|FG000|Overall Study|Lost to Follow-up|15
2331908|NCT03179787|4054836|FG000|Overall Study|Case report failures|2
2331909|NCT03179787|4054836|FG000|Overall Study|Treatment not administered|1
2331910|NCT03179891|4054840|FG000|First Intervention|Withdrawal by Subject|1
2331911|NCT03179891|4054841|FG001|First Intervention|Withdrawal by Subject|1
2331912|NCT03179891|4054840|FG000|First Intervention|Unspecified reason|1
2331913|NCT03179891|4054841|FG001|First Intervention|Unspecified reason|0
2331914|NCT03179891|4054840|FG000|First Intervention|Protocol Violation|0
2331915|NCT03179891|4054841|FG001|First Intervention|Protocol Violation|1
2331916|NCT03180138|4054853|FG000|Overall Study|Mobile-phone could not be verified|2
2331917|NCT03180138|4054854|FG001|Overall Study|Mobile-phone could not be verified|13
2331918|NCT03180138|4054855|FG002|Overall Study|Mobile-phone could not be verified|15
2331919|NCT03180138|4054853|FG000|Overall Study|No prior immunization records|17
2331920|NCT03180138|4054854|FG001|Overall Study|No prior immunization records|0
2331921|NCT03180138|4054855|FG002|Overall Study|No prior immunization records|6
2331922|NCT03180138|4054853|FG000|Overall Study|Found to be >24 mon after randomization|3
2331923|NCT03180138|4054854|FG001|Overall Study|Found to be >24 mon after randomization|0
2331924|NCT03180138|4054855|FG002|Overall Study|Found to be >24 mon after randomization|3
2331925|NCT03180528|4054897|FG000|Overall Study|Adverse Event|1
2331926|NCT03180528|4054897|FG000|Overall Study|Withdrawal by Subject|1
2331927|NCT03180528|4054897|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1
2331928|NCT03180619|4054904|FG000|Overall Study|Withdrew Consent|5
2331929|NCT03180619|4054905|FG001|Overall Study|Withdrew Consent|0
2331930|NCT03180619|4054906|FG002|Overall Study|Withdrew Consent|2
2331931|NCT03180619|4054904|FG000|Overall Study|Death|2
2331932|NCT03180619|4054905|FG001|Overall Study|Death|1
2331933|NCT03180619|4054906|FG002|Overall Study|Death|2
2331934|NCT03180619|4054904|FG000|Overall Study|Adverse Event|2
2331935|NCT03180619|4054905|FG001|Overall Study|Adverse Event|0
2331936|NCT03180619|4054906|FG002|Overall Study|Adverse Event|1
2331937|NCT03180619|4054904|FG000|Overall Study|Investigator's discretion|2
2331938|NCT03180619|4054905|FG001|Overall Study|Investigator's discretion|0
2331939|NCT03180619|4054906|FG002|Overall Study|Investigator's discretion|1
2331940|NCT03180645|4054924|FG000|Overall Study|Adverse Event|0
2331941|NCT03180645|4054925|FG001|Overall Study|Adverse Event|1
2331942|NCT03180645|4054926|FG002|Overall Study|Adverse Event|2
2331943|NCT03180801|4054941|FG000|Overall Study|Physician Decision|3
2331944|NCT03180801|4054942|FG001|Overall Study|Physician Decision|3
2331945|NCT03180801|4054943|FG002|Overall Study|Physician Decision|1
2331946|NCT03180801|4054941|FG000|Overall Study|Non-compliance|1
2331947|NCT03180801|4054942|FG001|Overall Study|Non-compliance|4
2331948|NCT03180801|4054943|FG002|Overall Study|Non-compliance|0
2331949|NCT03180801|4054941|FG000|Overall Study|Inoculation Target Reached|1
2331950|NCT03180801|4054942|FG001|Overall Study|Inoculation Target Reached|1
2331951|NCT03180801|4054943|FG002|Overall Study|Inoculation Target Reached|3
2331952|NCT03180801|4054941|FG000|Overall Study|Adverse Event|1
2331953|NCT03180801|4054942|FG001|Overall Study|Adverse Event|0
2331954|NCT03180801|4054943|FG002|Overall Study|Adverse Event|2
2331955|NCT03180801|4054941|FG000|Overall Study|Withdrawal by Subject|2
2182511|NCT01425281|3810236|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2
2182512|NCT01425281|3810237|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1
2182513|NCT01425281|3810236|FG000|At 2-year Clinical Follow-up|Death|2
2182514|NCT01425281|3810237|FG001|At 2-year Clinical Follow-up|Death|0
2182515|NCT01425281|3810236|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1
2182516|NCT01425281|3810237|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0
2182517|NCT01425281|3810236|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
2182518|NCT01425281|3810237|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
2182519|NCT01425281|3810236|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3
2182520|NCT01425281|3810237|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3
2182521|NCT01425281|3810236|FG000|At 3-year Clinical Follow-up|Death|2
2182522|NCT01425281|3810237|FG001|At 3-year Clinical Follow-up|Death|3
2182523|NCT01425281|3810236|FG000|At 4-year Clinical Follow-up|Death|7
2182524|NCT01425281|3810237|FG001|At 4-year Clinical Follow-up|Death|3
2182525|NCT01425281|3810236|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3
2182526|NCT01425281|3810237|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2
2182527|NCT01425281|3810236|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
2182528|NCT01425281|3810237|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
2182529|NCT01425281|3810236|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
2182530|NCT01425281|3810237|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
2182531|NCT01425281|3810236|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4
2182532|NCT01425281|3810237|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1
2182533|NCT01425281|3810236|FG000|At 5-year Clinical Follow-up|Death|2
2182534|NCT01425281|3810237|FG001|At 5-year Clinical Follow-up|Death|0
2182535|NCT01425281|3810236|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2
2182536|NCT01425281|3810237|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1
2182537|NCT01425281|3810236|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
2182538|NCT01425281|3810237|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
2182539|NCT01425281|3810236|FG000|At 5-year Clinical Follow-up|Refused/terminated|9
2182540|NCT01425281|3810237|FG001|At 5-year Clinical Follow-up|Refused/terminated|3
2182541|NCT01425359|3810257|FG000|Overall Study|Randomized but Not Treated|2
2182542|NCT01425359|3810258|FG001|Overall Study|Randomized but Not Treated|3
2182543|NCT01425359|3810257|FG000|Overall Study|Adverse Event|9
2182544|NCT01425359|3810258|FG001|Overall Study|Adverse Event|8
2182545|NCT01425359|3810257|FG000|Overall Study|Revascularization|0
2182546|NCT01425359|3810258|FG001|Overall Study|Revascularization|1
2182547|NCT01425359|3810257|FG000|Overall Study|Death|0
2182548|NCT01425359|3810258|FG001|Overall Study|Death|1
2182549|NCT01425359|3810257|FG000|Overall Study|Unsatisfactory Response|1
2182550|NCT01425359|3810258|FG001|Overall Study|Unsatisfactory Response|0
2182551|NCT01425359|3810257|FG000|Overall Study|Protocol Violation|1
2182552|NCT01425359|3810258|FG001|Overall Study|Protocol Violation|2
2182553|NCT01425359|3810257|FG000|Overall Study|Subject Withdrew Consent|1
2182554|NCT01425359|3810258|FG001|Overall Study|Subject Withdrew Consent|2
2182555|NCT01425359|3810257|FG000|Overall Study|Investigator's Discretion|2
2182556|NCT01425359|3810258|FG001|Overall Study|Investigator's Discretion|0
2182557|NCT01425359|3810257|FG000|Overall Study|Did Not Meet Qualifying Criteria|3
2182558|NCT01425359|3810258|FG001|Overall Study|Did Not Meet Qualifying Criteria|5
2182559|NCT01425463|3810267|FG000|Overall Study|Adverse Event|5
2182560|NCT01425463|3810268|FG001|Overall Study|Adverse Event|7
2182561|NCT01425463|3810267|FG000|Overall Study|Lack of Efficacy|1
2182562|NCT01425463|3810268|FG001|Overall Study|Lack of Efficacy|1
2182563|NCT01425463|3810267|FG000|Overall Study|Protocol Violation|2
2182564|NCT01425463|3810268|FG001|Overall Study|Protocol Violation|2
2182565|NCT01425463|3810267|FG000|Overall Study|Lost to Follow-up|5
2182566|NCT01425463|3810268|FG001|Overall Study|Lost to Follow-up|2
2182567|NCT01425463|3810267|FG000|Overall Study|Withdrawal by Subject|7
2182568|NCT01425463|3810268|FG001|Overall Study|Withdrawal by Subject|5
2182569|NCT01425463|3810267|FG000|Overall Study|Unknown Reason|4
2182570|NCT01425463|3810268|FG001|Overall Study|Unknown Reason|7
2182571|NCT01425528|3810276|FG000|Overall Study|Withdrawal by Subject|1
2182572|NCT01425528|3810277|FG001|Overall Study|Withdrawal by Subject|1
2182573|NCT01425632|3810286|FG000|Overall Study|Adverse Event|0
2182574|NCT01425632|3810287|FG001|Overall Study|Adverse Event|1
2219875|NCT01725308|3863882|FG001|Treatment Period I|Insufficient Response|0
2219876|NCT01725308|3863883|FG002|Treatment Period I|Insufficient Response|5
2219877|NCT01725308|3863881|FG000|Treatment Period I|Worsening of the Target Disease|8
2219878|NCT01725308|3863882|FG001|Treatment Period I|Worsening of the Target Disease|0
2219879|NCT01725308|3863883|FG002|Treatment Period I|Worsening of the Target Disease|2
2219880|NCT01725308|3863881|FG000|Treatment Period I|Changes in the Episodes|3
2219881|NCT01725308|3863882|FG001|Treatment Period I|Changes in the Episodes|0
2219882|NCT01725308|3863883|FG002|Treatment Period I|Changes in the Episodes|2
2219883|NCT01725308|3863881|FG000|Treatment Period I|Withdrawal of Consent|12
2219884|NCT01725308|3863882|FG001|Treatment Period I|Withdrawal of Consent|7
2219885|NCT01725308|3863883|FG002|Treatment Period I|Withdrawal of Consent|5
2219886|NCT01725308|3863881|FG000|Treatment Period I|Lost to Follow-up|3
2219887|NCT01725308|3863882|FG001|Treatment Period I|Lost to Follow-up|2
2219888|NCT01725308|3863883|FG002|Treatment Period I|Lost to Follow-up|2
2182575|NCT01425632|3810288|FG002|Overall Study|Adverse Event|1
2182576|NCT01425632|3810286|FG000|Overall Study|Physician Decision|1
2182577|NCT01425632|3810287|FG001|Overall Study|Physician Decision|0
2182578|NCT01425632|3810288|FG002|Overall Study|Physician Decision|0
2182579|NCT01425632|3810286|FG000|Overall Study|Protocol Violation|0
2182580|NCT01425632|3810287|FG001|Overall Study|Protocol Violation|0
2182581|NCT01425632|3810288|FG002|Overall Study|Protocol Violation|2
2182582|NCT01425632|3810286|FG000|Overall Study|Withdrawal by Subject|0
2182583|NCT01425632|3810287|FG001|Overall Study|Withdrawal by Subject|0
2182584|NCT01425632|3810288|FG002|Overall Study|Withdrawal by Subject|1
2182585|NCT01425723|3810298|FG000|Overall Study|Lack of Efficacy|0
2182586|NCT01425723|3810299|FG001|Overall Study|Lack of Efficacy|1
2182587|NCT01425723|3810298|FG000|Overall Study|Withdrawal by Subject|1
2182588|NCT01425723|3810299|FG001|Overall Study|Withdrawal by Subject|4
2182589|NCT01425723|3810298|FG000|Overall Study|Lost to Follow-up|0
2182590|NCT01425723|3810299|FG001|Overall Study|Lost to Follow-up|3
2182591|NCT01425723|3810298|FG000|Overall Study|Physician Decision|2
2182592|NCT01425723|3810299|FG001|Overall Study|Physician Decision|0
2182593|NCT01425723|3810298|FG000|Overall Study|Other|1
2182594|NCT01425723|3810299|FG001|Overall Study|Other|10
2182595|NCT01425749|3810316|FG000|Overall Study|progression of melanoma|0
2182596|NCT01425749|3810317|FG001|Overall Study|progression of melanoma|1
2182597|NCT01425801|3810326|FG000|Period 1|Withdrawal by Subject|0
2182598|NCT01425801|3810327|FG001|Period 1|Withdrawal by Subject|0
2182599|NCT01425801|3810328|FG002|Period 1|Withdrawal by Subject|0
2182600|NCT01425801|3810329|FG003|Period 1|Withdrawal by Subject|0
2182601|NCT01425801|3810330|FG004|Period 1|Withdrawal by Subject|1
2182602|NCT01425801|3810331|FG005|Period 1|Withdrawal by Subject|0
2182603|NCT01425801|3810326|FG000|Period 2|Withdrawal by Subject|0
2182604|NCT01425801|3810327|FG001|Period 2|Withdrawal by Subject|0
2182605|NCT01425801|3810328|FG002|Period 2|Withdrawal by Subject|0
2182606|NCT01425801|3810329|FG003|Period 2|Withdrawal by Subject|0
2182607|NCT01425801|3810330|FG004|Period 2|Withdrawal by Subject|1
2182608|NCT01425801|3810331|FG005|Period 2|Withdrawal by Subject|0
2182609|NCT01425801|3810326|FG000|Period 3|Stability criteria not fullfilled|0
2182610|NCT01425801|3810327|FG001|Period 3|Stability criteria not fullfilled|0
2182611|NCT01425801|3810328|FG002|Period 3|Stability criteria not fullfilled|1
2182612|NCT01425801|3810329|FG003|Period 3|Stability criteria not fullfilled|0
2182613|NCT01425801|3810330|FG004|Period 3|Stability criteria not fullfilled|0
2182614|NCT01425801|3810331|FG005|Period 3|Stability criteria not fullfilled|0
2182615|NCT01425801|3810326|FG000|Period 4|Not able to maintain visit schedule|0
2182616|NCT01425801|3810327|FG001|Period 4|Not able to maintain visit schedule|0
2182617|NCT01425801|3810328|FG002|Period 4|Not able to maintain visit schedule|1
2182618|NCT01425801|3810329|FG003|Period 4|Not able to maintain visit schedule|0
2182619|NCT01425801|3810330|FG004|Period 4|Not able to maintain visit schedule|0
2182620|NCT01425801|3810331|FG005|Period 4|Not able to maintain visit schedule|0
2182621|NCT01425814|3810345|FG000|Period 1|Stability criteria not fulfilled|0
2182622|NCT01425814|3810346|FG001|Period 1|Stability criteria not fulfilled|1
2182623|NCT01425814|3810347|FG002|Period 1|Stability criteria not fulfilled|0
2182624|NCT01425814|3810348|FG003|Period 1|Stability criteria not fulfilled|0
2182625|NCT01425814|3810349|FG004|Period 1|Stability criteria not fulfilled|0
2182626|NCT01425814|3810350|FG005|Period 1|Stability criteria not fulfilled|0
2182627|NCT01425814|3810345|FG000|Period 2|Stability criteria not fulfilled|0
2182628|NCT01425814|3810346|FG001|Period 2|Stability criteria not fulfilled|1
2182629|NCT01425814|3810347|FG002|Period 2|Stability criteria not fulfilled|0
2182630|NCT01425814|3810348|FG003|Period 2|Stability criteria not fulfilled|0
2182631|NCT01425814|3810349|FG004|Period 2|Stability criteria not fulfilled|0
2182632|NCT01425814|3810350|FG005|Period 2|Stability criteria not fulfilled|0
2219889|NCT01725308|3863881|FG000|Treatment Period I|Protocol Deviations|3
2219890|NCT01725308|3863882|FG001|Treatment Period I|Protocol Deviations|1
2219891|NCT01725308|3863883|FG002|Treatment Period I|Protocol Deviations|1
2219892|NCT01725308|3863881|FG000|Treatment Period I|Miscellaneous|2
2219893|NCT01725308|3863882|FG001|Treatment Period I|Miscellaneous|0
2219894|NCT01725308|3863883|FG002|Treatment Period I|Miscellaneous|3
2219895|NCT01725308|3863881|FG000|Treatment Period II|Did Not Meet Transition Criteria|0
2219896|NCT01725308|3863882|FG001|Treatment Period II|Did Not Meet Transition Criteria|3
2219897|NCT01725308|3863883|FG002|Treatment Period II|Did Not Meet Transition Criteria|4
2219898|NCT01725308|3863881|FG000|Treatment Period II|Did Not Receive Drug|4
2219899|NCT01725308|3863882|FG001|Treatment Period II|Did Not Receive Drug|0
2219900|NCT01725308|3863883|FG002|Treatment Period II|Did Not Receive Drug|0
2219901|NCT01725308|3863881|FG000|Treatment Period II|Adverse Event|13
2219902|NCT01725308|3863882|FG001|Treatment Period II|Adverse Event|8
2219903|NCT01725308|3863883|FG002|Treatment Period II|Adverse Event|20
2219904|NCT01725308|3863881|FG000|Treatment Period II|Insufficient Response|2
2219905|NCT01725308|3863882|FG001|Treatment Period II|Insufficient Response|4
2219906|NCT01725308|3863883|FG002|Treatment Period II|Insufficient Response|6
2219907|NCT01725308|3863881|FG000|Treatment Period II|Worsening of the Target Disease|1
2219908|NCT01725308|3863882|FG001|Treatment Period II|Worsening of the Target Disease|4
2219909|NCT01725308|3863883|FG002|Treatment Period II|Worsening of the Target Disease|2
2219910|NCT01725308|3863881|FG000|Treatment Period II|Changes in the Episodes|1
2219911|NCT01725308|3863882|FG001|Treatment Period II|Changes in the Episodes|0
2274016|NCT02291861|3954772|FG002|Overall Study|Adverse Event|1
2182633|NCT01425814|3810345|FG000|Period 3|Adverse Event|0
2182634|NCT01425814|3810346|FG001|Period 3|Adverse Event|0
2182635|NCT01425814|3810347|FG002|Period 3|Adverse Event|0
2182636|NCT01425814|3810348|FG003|Period 3|Adverse Event|0
2182637|NCT01425814|3810349|FG004|Period 3|Adverse Event|0
2182638|NCT01425814|3810350|FG005|Period 3|Adverse Event|1
2182639|NCT01425814|3810345|FG000|Period 4|Adverse Event|1
2182640|NCT01425814|3810346|FG001|Period 4|Adverse Event|0
2182641|NCT01425814|3810347|FG002|Period 4|Adverse Event|1
2182642|NCT01425814|3810348|FG003|Period 4|Adverse Event|0
2182643|NCT01425814|3810349|FG004|Period 4|Adverse Event|0
2182644|NCT01425814|3810350|FG005|Period 4|Adverse Event|0
2182645|NCT01425814|3810345|FG000|Period 5|Stability criteria not fulfilled|0
2182646|NCT01425814|3810346|FG001|Period 5|Stability criteria not fulfilled|0
2182647|NCT01425814|3810347|FG002|Period 5|Stability criteria not fulfilled|1
2182648|NCT01425814|3810348|FG003|Period 5|Stability criteria not fulfilled|0
2182649|NCT01425814|3810349|FG004|Period 5|Stability criteria not fulfilled|0
2182650|NCT01425814|3810350|FG005|Period 5|Stability criteria not fulfilled|1
2182651|NCT01426009|3810378|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1
2182652|NCT01426009|3810378|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1
2182653|NCT01426009|3810378|FG000|Washout 1|Withdrawal by Subject|1
2182654|NCT01426009|3810378|FG000|Washout 1|Personal Reasons|1
2182655|NCT01426009|3810378|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4
2182656|NCT01426009|3810378|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1
2182657|NCT01426009|3810378|FG000|Washout 2|electrive surgery|1
2182658|NCT01426009|3810378|FG000|Washout 3|personal reasons|1
2182659|NCT01426009|3810378|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1
2182660|NCT01426009|3810378|FG000|Washout 4|Lost to Follow-up|1
2182661|NCT01426217|3810400|FG000|Overall Study|lost sample|8
2182662|NCT01426217|3810401|FG001|Overall Study|lost sample|14
2182663|NCT01426269|3810415|FG000|Period 1: 12 Weeks|Adverse Event|5
2182664|NCT01426269|3810416|FG001|Period 1: 12 Weeks|Adverse Event|0
2182665|NCT01426269|3810417|FG002|Period 1: 12 Weeks|Adverse Event|0
2182666|NCT01426269|3810415|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22
2182667|NCT01426269|3810416|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0
2182668|NCT01426269|3810417|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0
2182669|NCT01426269|3810415|FG000|Period 1: 12 Weeks|Protocol Violation|5
2182670|NCT01426269|3810416|FG001|Period 1: 12 Weeks|Protocol Violation|0
2182671|NCT01426269|3810417|FG002|Period 1: 12 Weeks|Protocol Violation|0
2182672|NCT01426269|3810415|FG000|Period 1: 12 Weeks|Lost to Follow-up|22
2182673|NCT01426269|3810416|FG001|Period 1: 12 Weeks|Lost to Follow-up|0
2182674|NCT01426269|3810417|FG002|Period 1: 12 Weeks|Lost to Follow-up|0
2182675|NCT01426269|3810415|FG000|Period 1: 12 Weeks|Pregnancy|1
2182676|NCT01426269|3810416|FG001|Period 1: 12 Weeks|Pregnancy|0
2182677|NCT01426269|3810417|FG002|Period 1: 12 Weeks|Pregnancy|0
2182678|NCT01426269|3810415|FG000|Eligibility for Period 2, Randomization|Did not qualify|42
2182679|NCT01426269|3810416|FG001|Eligibility for Period 2, Randomization|Did not qualify|0
2182680|NCT01426269|3810417|FG002|Eligibility for Period 2, Randomization|Did not qualify|0
2182681|NCT01426269|3810415|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8
2182682|NCT01426269|3810416|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0
2182683|NCT01426269|3810417|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0
2182684|NCT01426269|3810415|FG000|Period 2: 40 Weeks|Adverse Event|0
2182685|NCT01426269|3810416|FG001|Period 2: 40 Weeks|Adverse Event|1
2182686|NCT01426269|3810417|FG002|Period 2: 40 Weeks|Adverse Event|2
2182687|NCT01426269|3810415|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0
2182688|NCT01426269|3810416|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9
2182689|NCT01426269|3810417|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11
2182690|NCT01426269|3810415|FG000|Period 2: 40 Weeks|Protocol Violation|0
2182691|NCT01426269|3810416|FG001|Period 2: 40 Weeks|Protocol Violation|5
2182692|NCT01426269|3810417|FG002|Period 2: 40 Weeks|Protocol Violation|5
2182693|NCT01426269|3810415|FG000|Period 2: 40 Weeks|Lost to Follow-up|0
2182694|NCT01426269|3810416|FG001|Period 2: 40 Weeks|Lost to Follow-up|8
2182695|NCT01426269|3810417|FG002|Period 2: 40 Weeks|Lost to Follow-up|6
2182696|NCT01426269|3810415|FG000|Period 2: 40 Weeks|Site closed|0
2182697|NCT01426269|3810416|FG001|Period 2: 40 Weeks|Site closed|6
2182698|NCT01426269|3810417|FG002|Period 2: 40 Weeks|Site closed|5
2182699|NCT01426269|3810415|FG000|Period 2: 40 Weeks|Relapsed|0
2182700|NCT01426269|3810416|FG001|Period 2: 40 Weeks|Relapsed|9
2182701|NCT01426269|3810417|FG002|Period 2: 40 Weeks|Relapsed|18
2182702|NCT01426347|3810430|FG000|Overall Study|Lost to Follow-up|0
2182703|NCT01426347|3810431|FG001|Overall Study|Lost to Follow-up|3
2182704|NCT01426347|3810430|FG000|Overall Study|Protocol Violation|2
2182705|NCT01426347|3810431|FG001|Overall Study|Protocol Violation|0
2182706|NCT01426347|3810430|FG000|Overall Study|Withdrawal by Subject|5
2182707|NCT01426347|3810431|FG001|Overall Study|Withdrawal by Subject|0
2182708|NCT01426373|3810446|FG000|Overall Study|Adverse Event|6
2182709|NCT01426373|3810446|FG000|Overall Study|Lost to Follow-up|14
2219912|NCT01725308|3863883|FG002|Treatment Period II|Changes in the Episodes|5
2219913|NCT01725308|3863881|FG000|Treatment Period II|Withdrawal of Consent|28
2219914|NCT01725308|3863882|FG001|Treatment Period II|Withdrawal of Consent|2
2219915|NCT01725308|3863883|FG002|Treatment Period II|Withdrawal of Consent|16
2219916|NCT01725308|3863881|FG000|Treatment Period II|Lost to Follow-up|1
2219917|NCT01725308|3863882|FG001|Treatment Period II|Lost to Follow-up|5
2182710|NCT01426373|3810446|FG000|Overall Study|Participant Convenience|10
2182711|NCT01426373|3810446|FG000|Overall Study|Miscellaneous Reasons|4
2182712|NCT01426386|3810458|FG000|Overall Study|Adverse Event|0
2182713|NCT01426386|3810459|FG001|Overall Study|Adverse Event|1
2182714|NCT01426386|3810460|FG002|Overall Study|Adverse Event|0
2182715|NCT01426386|3810461|FG003|Overall Study|Adverse Event|0
2182716|NCT01426386|3810462|FG004|Overall Study|Adverse Event|0
2182717|NCT01426386|3810463|FG005|Overall Study|Adverse Event|0
2182718|NCT01426386|3810458|FG000|Overall Study|Did not attend scheduled visit|1
2182719|NCT01426386|3810459|FG001|Overall Study|Did not attend scheduled visit|4
2182720|NCT01426386|3810460|FG002|Overall Study|Did not attend scheduled visit|0
2182721|NCT01426386|3810461|FG003|Overall Study|Did not attend scheduled visit|0
2182722|NCT01426386|3810462|FG004|Overall Study|Did not attend scheduled visit|2
2182723|NCT01426386|3810463|FG005|Overall Study|Did not attend scheduled visit|1
2182724|NCT01426386|3810458|FG000|Overall Study|Poor response|2
2182725|NCT01426386|3810459|FG001|Overall Study|Poor response|1
2182726|NCT01426386|3810460|FG002|Overall Study|Poor response|2
2182727|NCT01426386|3810461|FG003|Overall Study|Poor response|0
2182728|NCT01426386|3810462|FG004|Overall Study|Poor response|1
2182729|NCT01426386|3810463|FG005|Overall Study|Poor response|0
2182730|NCT01426386|3810458|FG000|Overall Study|Personal reasons|0
2182731|NCT01426386|3810459|FG001|Overall Study|Personal reasons|0
2182732|NCT01426386|3810460|FG002|Overall Study|Personal reasons|0
2182733|NCT01426386|3810461|FG003|Overall Study|Personal reasons|0
2182734|NCT01426386|3810462|FG004|Overall Study|Personal reasons|1
2182735|NCT01426386|3810463|FG005|Overall Study|Personal reasons|0
2182736|NCT01426412|3810486|FG000|Overall Study|Withdrawal by Subject|1
2182737|NCT01426412|3810487|FG001|Overall Study|Withdrawal by Subject|0
2182738|NCT01426412|3810488|FG002|Overall Study|Withdrawal by Subject|0
2182739|NCT01426412|3810489|FG003|Overall Study|Withdrawal by Subject|0
2182740|NCT01426412|3810490|FG004|Overall Study|Withdrawal by Subject|1
2182741|NCT01426412|3810491|FG005|Overall Study|Withdrawal by Subject|0
2182742|NCT01426412|3810492|FG006|Overall Study|Withdrawal by Subject|0
2182743|NCT01426412|3810493|FG007|Overall Study|Withdrawal by Subject|3
2182744|NCT01426412|3810494|FG008|Overall Study|Withdrawal by Subject|1
2182745|NCT01426425|3810525|FG000|Overall Study|Exited prior to EP study|22
2182746|NCT01426425|3810525|FG000|Overall Study|Inclusion/exclusion criteria not met|151
2182747|NCT01426425|3810525|FG000|Overall Study|Met inclusion/exclusion, not treated|2
2182748|NCT01426438|3810532|FG000|Overall Study|Lost to Follow-up|1
2182749|NCT01426438|3810533|FG001|Overall Study|Lost to Follow-up|3
2182750|NCT01426438|3810532|FG000|Overall Study|Off study Treatment|9
2182751|NCT01426438|3810533|FG001|Overall Study|Off study Treatment|3
2182752|NCT01426438|3810532|FG000|Overall Study|Poor scan quality|3
2182753|NCT01426438|3810533|FG001|Overall Study|Poor scan quality|2
2182754|NCT01426438|3810532|FG000|Overall Study|Missed Scan|2
2182755|NCT01426438|3810533|FG001|Overall Study|Missed Scan|2
2182756|NCT01426789|3810563|FG000|Part 1|Protocol deviation|0
2182757|NCT01426789|3810564|FG001|Part 1|Protocol deviation|1
2182758|NCT01426789|3810565|FG002|Part 1|Protocol deviation|0
2182759|NCT01426789|3810566|FG003|Part 1|Protocol deviation|0
2182760|NCT01426789|3810567|FG004|Part 1|Protocol deviation|0
2182761|NCT01426789|3810568|FG005|Part 1|Protocol deviation|0
2182762|NCT01426789|3810563|FG000|Part 1|Lost to Follow-up|1
2182763|NCT01426789|3810564|FG001|Part 1|Lost to Follow-up|2
2182764|NCT01426789|3810565|FG002|Part 1|Lost to Follow-up|0
2182765|NCT01426789|3810566|FG003|Part 1|Lost to Follow-up|0
2182766|NCT01426789|3810567|FG004|Part 1|Lost to Follow-up|0
2182767|NCT01426789|3810568|FG005|Part 1|Lost to Follow-up|0
2182768|NCT01426789|3810563|FG000|Part 1|Lack of Efficacy|2
2182769|NCT01426789|3810564|FG001|Part 1|Lack of Efficacy|1
2182770|NCT01426789|3810565|FG002|Part 1|Lack of Efficacy|0
2182771|NCT01426789|3810566|FG003|Part 1|Lack of Efficacy|0
2182772|NCT01426789|3810567|FG004|Part 1|Lack of Efficacy|0
2182773|NCT01426789|3810568|FG005|Part 1|Lack of Efficacy|0
2182774|NCT01426789|3810563|FG000|Part 1|Adverse Event|3
2182775|NCT01426789|3810564|FG001|Part 1|Adverse Event|0
2182776|NCT01426789|3810565|FG002|Part 1|Adverse Event|0
2182777|NCT01426789|3810566|FG003|Part 1|Adverse Event|0
2182778|NCT01426789|3810567|FG004|Part 1|Adverse Event|0
2182779|NCT01426789|3810568|FG005|Part 1|Adverse Event|0
2182780|NCT01426789|3810563|FG000|Part 2|Protocol deviation|0
2182781|NCT01426789|3810564|FG001|Part 2|Protocol deviation|0
2182782|NCT01426789|3810565|FG002|Part 2|Protocol deviation|1
2182783|NCT01426789|3810566|FG003|Part 2|Protocol deviation|0
2182784|NCT01426789|3810567|FG004|Part 2|Protocol deviation|0
2182785|NCT01426789|3810568|FG005|Part 2|Protocol deviation|0
2182786|NCT01426789|3810563|FG000|Part 2|Death|0
2182787|NCT01426789|3810564|FG001|Part 2|Death|0
2182788|NCT01426789|3810565|FG002|Part 2|Death|1
2182789|NCT01426789|3810566|FG003|Part 2|Death|0
2182790|NCT01426789|3810567|FG004|Part 2|Death|1
2182791|NCT01426789|3810568|FG005|Part 2|Death|0
2182792|NCT01426789|3810563|FG000|Part 2|Administrative problems|0
2182793|NCT01426789|3810564|FG001|Part 2|Administrative problems|0
2182794|NCT01426789|3810565|FG002|Part 2|Administrative problems|2
2182795|NCT01426789|3810566|FG003|Part 2|Administrative problems|0
2182796|NCT01426789|3810567|FG004|Part 2|Administrative problems|1
2182797|NCT01426789|3810568|FG005|Part 2|Administrative problems|0
2182798|NCT01426789|3810563|FG000|Part 2|Lost to Follow-up|0
2182799|NCT01426789|3810564|FG001|Part 2|Lost to Follow-up|0
2182800|NCT01426789|3810565|FG002|Part 2|Lost to Follow-up|4
2219918|NCT01725308|3863883|FG002|Treatment Period II|Lost to Follow-up|3
2219919|NCT01725308|3863881|FG000|Treatment Period II|Protocol Deviations|0
2219920|NCT01725308|3863882|FG001|Treatment Period II|Protocol Deviations|0
2219921|NCT01725308|3863883|FG002|Treatment Period II|Protocol Deviations|1
2219922|NCT01725308|3863881|FG000|Treatment Period II|Miscellaneous|5
2219923|NCT01725308|3863882|FG001|Treatment Period II|Miscellaneous|3
2219924|NCT01725308|3863883|FG002|Treatment Period II|Miscellaneous|7
2219925|NCT01725386|3863900|FG000|Overall Study|Death|84
2219926|NCT01725386|3863901|FG001|Overall Study|Death|40
2182801|NCT01426789|3810566|FG003|Part 2|Lost to Follow-up|0
2182802|NCT01426789|3810567|FG004|Part 2|Lost to Follow-up|1
2182803|NCT01426789|3810568|FG005|Part 2|Lost to Follow-up|0
2182804|NCT01426789|3810563|FG000|Part 2|Withdrawal by Subject|0
2182805|NCT01426789|3810564|FG001|Part 2|Withdrawal by Subject|0
2182806|NCT01426789|3810565|FG002|Part 2|Withdrawal by Subject|0
2182807|NCT01426789|3810566|FG003|Part 2|Withdrawal by Subject|1
2182808|NCT01426789|3810567|FG004|Part 2|Withdrawal by Subject|2
2182809|NCT01426789|3810568|FG005|Part 2|Withdrawal by Subject|0
2182810|NCT01426789|3810563|FG000|Part 2|Lack of Efficacy|0
2182811|NCT01426789|3810564|FG001|Part 2|Lack of Efficacy|0
2182812|NCT01426789|3810565|FG002|Part 2|Lack of Efficacy|5
2182813|NCT01426789|3810566|FG003|Part 2|Lack of Efficacy|0
2182814|NCT01426789|3810567|FG004|Part 2|Lack of Efficacy|2
2182815|NCT01426789|3810568|FG005|Part 2|Lack of Efficacy|0
2182816|NCT01426789|3810563|FG000|Part 2|Adverse Event|0
2182817|NCT01426789|3810564|FG001|Part 2|Adverse Event|0
2182818|NCT01426789|3810565|FG002|Part 2|Adverse Event|2
2182819|NCT01426789|3810566|FG003|Part 2|Adverse Event|0
2182820|NCT01426789|3810567|FG004|Part 2|Adverse Event|1
2182821|NCT01426789|3810568|FG005|Part 2|Adverse Event|0
2182822|NCT01426854|3810587|FG000|Overall Study|Adverse Event|1
2182823|NCT01426854|3810588|FG001|Overall Study|Adverse Event|5
2182824|NCT01426854|3810587|FG000|Overall Study|Subject Decision Unrelated to AE|5
2182825|NCT01426854|3810588|FG001|Overall Study|Subject Decision Unrelated to AE|6
2182826|NCT01426854|3810587|FG000|Overall Study|Lost to Follow-up|3
2182827|NCT01426854|3810588|FG001|Overall Study|Lost to Follow-up|0
2182828|NCT01426854|3810587|FG000|Overall Study|Noncompliance|0
2182829|NCT01426854|3810588|FG001|Overall Study|Noncompliance|1
2182830|NCT01426854|3810587|FG000|Overall Study|Treatment Failure|0
2182831|NCT01426854|3810588|FG001|Overall Study|Treatment Failure|16
2182832|NCT01426854|3810587|FG000|Overall Study|Protocol Deviation|0
2182833|NCT01426854|3810588|FG001|Overall Study|Protocol Deviation|1
2182834|NCT01426854|3810587|FG000|Overall Study|Other|3
2182835|NCT01426854|3810588|FG001|Overall Study|Other|2
2182836|NCT01426958|3810607|FG000|Overall Study|Adverse Event|2
2182837|NCT01427309|3810628|FG000|Overall Study|Lost to Follow-up|130
2182838|NCT01427309|3810629|FG001|Overall Study|Lost to Follow-up|145
2182839|NCT01427309|3810630|FG002|Overall Study|Lost to Follow-up|122
2182840|NCT01427309|3810631|FG003|Overall Study|Lost to Follow-up|135
2182841|NCT01427309|3810628|FG000|Overall Study|Protocol Violation|42
2182842|NCT01427309|3810629|FG001|Overall Study|Protocol Violation|69
2182843|NCT01427309|3810630|FG002|Overall Study|Protocol Violation|125
2182844|NCT01427309|3810631|FG003|Overall Study|Protocol Violation|124
2182845|NCT01427309|3810628|FG000|Overall Study|Adverse Event|0
2182846|NCT01427309|3810629|FG001|Overall Study|Adverse Event|0
2182847|NCT01427309|3810630|FG002|Overall Study|Adverse Event|3
2182848|NCT01427309|3810631|FG003|Overall Study|Adverse Event|1
2182849|NCT01427309|3810628|FG000|Overall Study|Serious adverse event|52
2182850|NCT01427309|3810629|FG001|Overall Study|Serious adverse event|45
2182851|NCT01427309|3810630|FG002|Overall Study|Serious adverse event|50
2182852|NCT01427309|3810631|FG003|Overall Study|Serious adverse event|61
2182853|NCT01427309|3810628|FG000|Overall Study|Withdrawal by Subject|148
2182854|NCT01427309|3810629|FG001|Overall Study|Withdrawal by Subject|148
2182855|NCT01427309|3810630|FG002|Overall Study|Withdrawal by Subject|61
2182856|NCT01427309|3810631|FG003|Overall Study|Withdrawal by Subject|55
2182857|NCT01427608|3810688|FG000|Overall Study|Death|1
2182858|NCT01427608|3810689|FG001|Overall Study|Death|0
2182859|NCT01427608|3810688|FG000|Overall Study|Withdrawal by Subject|7
2182860|NCT01427608|3810689|FG001|Overall Study|Withdrawal by Subject|3
2182861|NCT01427608|3810688|FG000|Overall Study|Relapsed-all cause|13
2182862|NCT01427608|3810689|FG001|Overall Study|Relapsed-all cause|34
2182863|NCT01427608|3810688|FG000|Overall Study|Events not attributed to study meds|0
2182864|NCT01427608|3810689|FG001|Overall Study|Events not attributed to study meds|1
2182865|NCT01427738|3810699|FG000|Overall Study|Death|12
2182866|NCT01427738|3810700|FG001|Overall Study|Death|9
2182867|NCT01427738|3810699|FG000|Overall Study|Severe debilitation, unable to continue|0
2182868|NCT01427738|3810700|FG001|Overall Study|Severe debilitation, unable to continue|1
2182869|NCT01427738|3810699|FG000|Overall Study|Subject unable to get to clinic|5
2182870|NCT01427738|3810700|FG001|Overall Study|Subject unable to get to clinic|2
2182871|NCT01427738|3810699|FG000|Overall Study|Withdrawal by Subject|0
2182872|NCT01427738|3810700|FG001|Overall Study|Withdrawal by Subject|2
2182873|NCT01427738|3810699|FG000|Overall Study|Subject not willing to adhere to reqs|1
2182874|NCT01427738|3810700|FG001|Overall Study|Subject not willing to adhere to reqs|2
2182875|NCT01427738|3810699|FG000|Overall Study|Lost to Follow-up|1
2182876|NCT01427738|3810700|FG001|Overall Study|Lost to Follow-up|5
2182877|NCT01427751|3810708|FG000|Overall Study|Adverse Event|18
2182878|NCT01427751|3810709|FG001|Overall Study|Adverse Event|2
2182879|NCT01427751|3810708|FG000|Overall Study|No further treatment benefit expected|5
2182880|NCT01427751|3810709|FG001|Overall Study|No further treatment benefit expected|1
2182881|NCT01427751|3810708|FG000|Overall Study|Lost to Follow-up|3
2182882|NCT01427751|3810709|FG001|Overall Study|Lost to Follow-up|1
2182883|NCT01427751|3810708|FG000|Overall Study|Withdrawal of consent|2
2182884|NCT01427751|3810709|FG001|Overall Study|Withdrawal of consent|2
2182885|NCT01427751|3810708|FG000|Overall Study|Protocol Violation|6
2182886|NCT01427751|3810709|FG001|Overall Study|Protocol Violation|4
2182887|NCT01427751|3810708|FG000|Overall Study|Death|2
2182888|NCT01427751|3810709|FG001|Overall Study|Death|0
2182889|NCT01427751|3810708|FG000|Overall Study|Other miscellaneous reasons|6
2182890|NCT01427751|3810709|FG001|Overall Study|Other miscellaneous reasons|4
2182891|NCT01427803|3810717|FG000|Overall Study|Lost to Follow-up|32
2182892|NCT01427803|3810718|FG001|Overall Study|Lost to Follow-up|26
2182893|NCT01427803|3810717|FG000|Overall Study|Withdrawal by Subject|20
2182894|NCT01427803|3810718|FG001|Overall Study|Withdrawal by Subject|0
2182895|NCT01427803|3810717|FG000|Overall Study|Unable to complete full treatment period|6
2182896|NCT01427803|3810718|FG001|Overall Study|Unable to complete full treatment period|0
2182897|NCT01427803|3810717|FG000|Overall Study|Protocol Violation|1
2182898|NCT01427803|3810718|FG001|Overall Study|Protocol Violation|0
2182899|NCT01427803|3810717|FG000|Overall Study|Physician Decision|3
2182900|NCT01427803|3810718|FG001|Overall Study|Physician Decision|0
2182901|NCT01427803|3810717|FG000|Overall Study|did not take product|1
2182902|NCT01427803|3810718|FG001|Overall Study|did not take product|0
2182903|NCT01427907|3810728|FG000|Overall Study|Withdrawal by Subject|3
2182904|NCT01427907|3810729|FG001|Overall Study|Withdrawal by Subject|4
2182905|NCT01427920|3810737|FG000|Overall Study|Adverse Event|1
2182906|NCT01427920|3810738|FG001|Overall Study|Adverse Event|2
2182907|NCT01427920|3810737|FG000|Overall Study|Lack of Efficacy|1
2182908|NCT01427920|3810738|FG001|Overall Study|Lack of Efficacy|0
2182909|NCT01427920|3810737|FG000|Overall Study|Protocol Violation|1
2182910|NCT01427920|3810738|FG001|Overall Study|Protocol Violation|3
2182911|NCT01427920|3810737|FG000|Overall Study|Withdrawal Criteria|4
2182912|NCT01427920|3810738|FG001|Overall Study|Withdrawal Criteria|4
2182913|NCT01427920|3810737|FG000|Overall Study|Unclassified|2
2182914|NCT01427920|3810738|FG001|Overall Study|Unclassified|8
2182915|NCT01427933|3810746|FG000|Overall Study|Withdrawal by Subject|5
2182916|NCT01427933|3810747|FG001|Overall Study|Withdrawal by Subject|8
2182917|NCT01427933|3810746|FG000|Overall Study|Lost to Follow-up|1
2182918|NCT01427933|3810747|FG001|Overall Study|Lost to Follow-up|5
2182919|NCT01427933|3810746|FG000|Overall Study|Other|1
2182920|NCT01427933|3810747|FG001|Overall Study|Other|0
2182921|NCT01427933|3810746|FG000|Overall Study|Investigator's Decision|1
2182922|NCT01427933|3810747|FG001|Overall Study|Investigator's Decision|0
2182923|NCT01427972|3810766|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0
2182924|NCT01427972|3810767|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0
2182925|NCT01427972|3810768|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0
2182926|NCT01427972|3810769|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0
2182927|NCT01427972|3810770|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0
2182928|NCT01427972|3810771|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0
2182929|NCT01427972|3810772|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0
2182930|NCT01427972|3810773|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1
2182931|NCT01427972|3810774|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0
2182932|NCT01427972|3810775|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0
2182933|NCT01427972|3810776|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0
2182934|NCT01427972|3810777|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0
2182935|NCT01427972|3810766|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0
2182936|NCT01427972|3810767|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0
2182937|NCT01427972|3810768|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0
2182938|NCT01427972|3810769|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0
2182939|NCT01427972|3810770|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0
2182940|NCT01427972|3810771|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2
2219927|NCT01725386|3863900|FG000|Overall Study|Lost to Follow-up|81
2219928|NCT01725386|3863901|FG001|Overall Study|Lost to Follow-up|6
2219929|NCT01725386|3863900|FG000|Overall Study|Withdrawal by Subject|10
2182941|NCT01427972|3810772|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0
2182942|NCT01427972|3810773|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0
2182943|NCT01427972|3810774|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0
2182944|NCT01427972|3810775|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0
2182945|NCT01427972|3810776|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0
2182946|NCT01427972|3810777|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0
2182947|NCT01427972|3810766|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2182948|NCT01427972|3810767|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
2219930|NCT01725386|3863901|FG001|Overall Study|Withdrawal by Subject|0
2219931|NCT01725451|3863907|FG000|Period 1|Withdrawal by Subject|1
2219932|NCT01725451|3863908|FG001|Period 1|Withdrawal by Subject|0
2182949|NCT01427972|3810768|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2182950|NCT01427972|3810769|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2182951|NCT01427972|3810770|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2182952|NCT01427972|3810771|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2182953|NCT01427972|3810772|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2182954|NCT01427972|3810773|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2182955|NCT01427972|3810774|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2182956|NCT01427972|3810775|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2182957|NCT01427972|3810776|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2182958|NCT01427972|3810777|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2219933|NCT01725451|3863909|FG002|Period 1|Withdrawal by Subject|0
2219934|NCT01725451|3863910|FG003|Period 1|Withdrawal by Subject|0
2219935|NCT01725451|3863907|FG000|Washout From Period 3|Protocol Violation|0
2219936|NCT01725451|3863908|FG001|Washout From Period 3|Protocol Violation|0
2219937|NCT01725451|3863909|FG002|Washout From Period 3|Protocol Violation|1
2219938|NCT01725451|3863910|FG003|Washout From Period 3|Protocol Violation|0
2219939|NCT01725451|3863907|FG000|Washout From Period 3|Adverse Event|0
2219940|NCT01725451|3863908|FG001|Washout From Period 3|Adverse Event|1
2219941|NCT01725451|3863909|FG002|Washout From Period 3|Adverse Event|0
2219942|NCT01725451|3863910|FG003|Washout From Period 3|Adverse Event|0
2219943|NCT01725451|3863907|FG000|Period 4|Adverse Event|0
2219944|NCT01725451|3863908|FG001|Period 4|Adverse Event|0
2219945|NCT01725451|3863909|FG002|Period 4|Adverse Event|1
2219946|NCT01725451|3863910|FG003|Period 4|Adverse Event|0
2219947|NCT01725529|3863928|FG000|Overall Study|Adverse Event|1
2219948|NCT01725529|3863929|FG001|Overall Study|Adverse Event|0
2219949|NCT01725529|3863930|FG002|Overall Study|Adverse Event|0
2219950|NCT01725529|3863928|FG000|Overall Study|Lost to Follow-up|2
2219951|NCT01725529|3863929|FG001|Overall Study|Lost to Follow-up|1
2219952|NCT01725529|3863930|FG002|Overall Study|Lost to Follow-up|1
2219953|NCT01725529|3863928|FG000|Overall Study|Protocol Violation|0
2219954|NCT01725529|3863929|FG001|Overall Study|Protocol Violation|1
2219955|NCT01725529|3863930|FG002|Overall Study|Protocol Violation|1
2219956|NCT01725529|3863928|FG000|Overall Study|Withdrawal by Subject|12
2219957|NCT01725529|3863929|FG001|Overall Study|Withdrawal by Subject|14
2219958|NCT01725529|3863930|FG002|Overall Study|Withdrawal by Subject|8
2219959|NCT01725750|3863940|FG000|Overall Study|Adverse Event|1
2219960|NCT01725750|3863941|FG001|Overall Study|Adverse Event|0
2219961|NCT01725750|3863940|FG000|Overall Study|Lost to Follow-up|1
2219962|NCT01725750|3863941|FG001|Overall Study|Lost to Follow-up|1
2219963|NCT01725750|3863940|FG000|Overall Study|Withdrawal by Subject|0
2219964|NCT01725750|3863941|FG001|Overall Study|Withdrawal by Subject|9
2219965|NCT01726023|3863969|FG000|Overall Study|Death|1
2219966|NCT01726023|3863970|FG001|Overall Study|Death|1
2219967|NCT01726023|3863969|FG000|Overall Study|Lost to Follow-up|5
2219968|NCT01726023|3863970|FG001|Overall Study|Lost to Follow-up|10
2219969|NCT01726023|3863969|FG000|Overall Study|Other Eligibility criteria|7
2219970|NCT01726023|3863970|FG001|Overall Study|Other Eligibility criteria|7
2219971|NCT01726023|3863969|FG000|Overall Study|Withdrawal by Subject|16
2219972|NCT01726023|3863970|FG001|Overall Study|Withdrawal by Subject|8
2219973|NCT01726049|3863994|FG000|Overall Study|Death|1
2219974|NCT01726049|3863995|FG001|Overall Study|Death|1
2219975|NCT01726049|3863994|FG000|Overall Study|Adverse Event|4
2219976|NCT01726049|3863995|FG001|Overall Study|Adverse Event|1
2219977|NCT01726049|3863994|FG000|Overall Study|refused second HC|0
2219978|NCT01726049|3863995|FG001|Overall Study|refused second HC|2
2219979|NCT01726270|3864001|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10
2219980|NCT01726270|3864001|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20
2219981|NCT01726270|3864001|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21
2219982|NCT01726270|3864001|FG000|Part 2, Actual-Use Phase|Adverse Event|6
2219983|NCT01726270|3864001|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5
2219984|NCT01726270|3864001|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7
2219985|NCT01726335|3864007|FG000|Overall Study|Lost to Follow-up|2
2219986|NCT01726335|3864007|FG000|Overall Study|Withdrawal by Subject|15
2219987|NCT01726335|3864007|FG000|Overall Study|Adverse Event|4
2219988|NCT01726335|3864007|FG000|Overall Study|Lost to Follow-up|2
2219989|NCT01726335|3864007|FG000|Overall Study|Exacerbation of psychotic symptoms|1
2219990|NCT01726517|3864025|FG000|Overall Study|Withdrawal by Subject|0
2219991|NCT01726517|3864026|FG001|Overall Study|Withdrawal by Subject|0
2219992|NCT01726517|3864027|FG002|Overall Study|Withdrawal by Subject|1
2219993|NCT01726517|3864028|FG003|Overall Study|Withdrawal by Subject|0
2219994|NCT01726517|3864029|FG004|Overall Study|Withdrawal by Subject|0
2219995|NCT01726803|3864060|FG000|Overall Study|Lost to Follow-up|6
2219996|NCT01726803|3864061|FG001|Overall Study|Lost to Follow-up|1
2219997|NCT01726803|3864060|FG000|Overall Study|Withdrawal by Subject|1
2219998|NCT01726803|3864061|FG001|Overall Study|Withdrawal by Subject|0
2219999|NCT01727024|3864067|FG000|Period 1|Lost to Follow-up|1
2220000|NCT01727024|3864068|FG001|Period 1|Lost to Follow-up|1
2220001|NCT01727024|3864067|FG000|Period 1|Withdrawal by Subject|2
2220002|NCT01727024|3864068|FG001|Period 1|Withdrawal by Subject|3
2220003|NCT01727141|3864087|FG000|Overall Study|Physician Decision|0
2220004|NCT01727141|3864088|FG001|Overall Study|Physician Decision|1
2220005|NCT01727141|3864089|FG002|Overall Study|Physician Decision|0
2182959|NCT01428063|3810810|FG000|Overall Study|Lack of Efficacy|8
2182960|NCT01428063|3810811|FG001|Overall Study|Lack of Efficacy|4
2182961|NCT01428063|3810812|FG002|Overall Study|Lack of Efficacy|1
2182962|NCT01428063|3810810|FG000|Overall Study|Adverse Event|2
2182963|NCT01428063|3810811|FG001|Overall Study|Adverse Event|3
2182964|NCT01428063|3810812|FG002|Overall Study|Adverse Event|0
2182965|NCT01428063|3810810|FG000|Overall Study|Lost to Follow-up|0
2182966|NCT01428063|3810811|FG001|Overall Study|Lost to Follow-up|2
2182967|NCT01428063|3810812|FG002|Overall Study|Lost to Follow-up|0
2182968|NCT01428063|3810810|FG000|Overall Study|No longer meets study criteria|0
2182969|NCT01428063|3810811|FG001|Overall Study|No longer meets study criteria|1
2182970|NCT01428063|3810812|FG002|Overall Study|No longer meets study criteria|0
2182971|NCT01428076|3810833|FG000|Overall Study|Adverse Event|0
2182972|NCT01428076|3810834|FG001|Overall Study|Adverse Event|1
2182973|NCT01428115|3810842|FG000|Overall Study|Lack of Efficacy|3
2182974|NCT01428115|3810842|FG000|Overall Study|Lost to Follow-up|10
2182975|NCT01428115|3810842|FG000|Overall Study|Pregnancy|1
2182976|NCT01428115|3810842|FG000|Overall Study|Protocol Violation|3
2182977|NCT01428115|3810842|FG000|Overall Study|Withdrawal by Subject|4
2182978|NCT01428128|3810847|FG000|Overall Study|Withdrawal by Subject|4
2182979|NCT01428128|3810847|FG000|Overall Study|Screen failure by p53|10
2182980|NCT01428128|3810847|FG000|Overall Study|Received Neulasta in one cycle|2
2182981|NCT01428128|3810847|FG000|Overall Study|Adverse Event|1
2182982|NCT01428193|3810852|FG000|Overall Study|Physician Decision|1
2182983|NCT01428193|3810852|FG000|Overall Study|Elevated screening liver enzymes|1
2182984|NCT01428219|3810856|FG000|Overall Study|25 patients enrolled, 3 were not treated|3
2182985|NCT01428258|3810866|FG000|Intervention 1|Withdrawal by Subject|2
2182986|NCT01428258|3810867|FG001|Intervention 1|Withdrawal by Subject|0
2182987|NCT01428453|3810895|FG000|Overall Study|Adverse Event|2
2182988|NCT01428453|3810896|FG001|Overall Study|Adverse Event|7
2182989|NCT01428453|3810895|FG000|Overall Study|Protocol Violation|1
2182990|NCT01428453|3810896|FG001|Overall Study|Protocol Violation|0
2182991|NCT01428453|3810895|FG000|Overall Study|Lost to Follow-up|0
2182992|NCT01428453|3810896|FG001|Overall Study|Lost to Follow-up|1
2182993|NCT01428453|3810895|FG000|Overall Study|Withdrawal by Subject|3
2182994|NCT01428453|3810896|FG001|Overall Study|Withdrawal by Subject|1
2182995|NCT01428583|3810904|FG000|Overall Study|Adverse Event|75
2182996|NCT01428583|3810904|FG000|Overall Study|Withdrawal by Subject|51
2182997|NCT01428583|3810904|FG000|Overall Study|Lack of Efficacy|37
2182998|NCT01428583|3810904|FG000|Overall Study|Lost to Follow-up|17
2182999|NCT01428583|3810904|FG000|Overall Study|Death|1
2220006|NCT01727141|3864090|FG003|Overall Study|Physician Decision|2
2220007|NCT01727141|3864087|FG000|Overall Study|Lost to Follow-up|0
2220008|NCT01727141|3864088|FG001|Overall Study|Lost to Follow-up|2
2220009|NCT01727141|3864089|FG002|Overall Study|Lost to Follow-up|0
2220010|NCT01727141|3864090|FG003|Overall Study|Lost to Follow-up|0
2220011|NCT01727141|3864087|FG000|Overall Study|Death|0
2220012|NCT01727141|3864088|FG001|Overall Study|Death|1
2220013|NCT01727141|3864089|FG002|Overall Study|Death|1
2220014|NCT01727141|3864090|FG003|Overall Study|Death|1
2220015|NCT01727141|3864087|FG000|Overall Study|Protocol deviation|1
2220016|NCT01727141|3864088|FG001|Overall Study|Protocol deviation|1
2220017|NCT01727141|3864089|FG002|Overall Study|Protocol deviation|0
2220018|NCT01727141|3864090|FG003|Overall Study|Protocol deviation|1
2220019|NCT01727141|3864087|FG000|Overall Study|Withdrawal by Subject|4
2220020|NCT01727141|3864088|FG001|Overall Study|Withdrawal by Subject|4
2220021|NCT01727141|3864089|FG002|Overall Study|Withdrawal by Subject|2
2220022|NCT01727141|3864090|FG003|Overall Study|Withdrawal by Subject|11
2220023|NCT01727154|3864100|FG000|Overall Study|Death|17
2220024|NCT01727154|3864100|FG000|Overall Study|Withdrawal by Subject|14
2220025|NCT01727154|3864100|FG000|Overall Study|Subject Withdrew Consent|18
2220026|NCT01727154|3864100|FG000|Overall Study|Study Terminated|6
2220027|NCT01727154|3864100|FG000|Overall Study|No Discontinuation Documentation|4
2220028|NCT01727258|3864111|FG000|Overall Study|Adverse Event|0
2220029|NCT01727258|3864112|FG001|Overall Study|Adverse Event|2
2220030|NCT01727258|3864113|FG002|Overall Study|Adverse Event|0
2220031|NCT01727258|3864111|FG000|Overall Study|Noncompliance with Study Drug|0
2220032|NCT01727258|3864112|FG001|Overall Study|Noncompliance with Study Drug|0
2220033|NCT01727258|3864113|FG002|Overall Study|Noncompliance with Study Drug|1
2220034|NCT01727258|3864111|FG000|Overall Study|Withdrawal by Subject|1
2220035|NCT01727258|3864112|FG001|Overall Study|Withdrawal by Subject|1
2220036|NCT01727258|3864113|FG002|Overall Study|Withdrawal by Subject|0
2220037|NCT01727258|3864111|FG000|Overall Study|Lost to Follow-up|1
2220038|NCT01727258|3864112|FG001|Overall Study|Lost to Follow-up|0
2220039|NCT01727258|3864113|FG002|Overall Study|Lost to Follow-up|0
2183000|NCT01428583|3810904|FG000|Overall Study|Pregnancy|1
2183001|NCT01428583|3810904|FG000|Overall Study|Protocol Violation|1
2183002|NCT01428583|3810904|FG000|Overall Study|Physician Decision|12
2183003|NCT01428583|3810904|FG000|Overall Study|Non-compliant|25
2183004|NCT01428583|3810904|FG000|Overall Study|Confirmed positive urine drug test|8
2183005|NCT01428583|3810904|FG000|Overall Study|Sponsor's request|3
2183006|NCT01428583|3810904|FG000|Overall Study|Other|6
2183007|NCT01428661|3810911|FG000|Double-Masked Phase|Protocol Violation|9
2183008|NCT01428661|3810912|FG001|Double-Masked Phase|Protocol Violation|4
2220040|NCT01727297|3864121|FG000|Overall Study|Death|13
2183009|NCT01428661|3810913|FG002|Double-Masked Phase|Protocol Violation|0
2183010|NCT01428661|3810911|FG000|Double-Masked Phase|Adverse Event|13
2183011|NCT01428661|3810912|FG001|Double-Masked Phase|Adverse Event|4
2183012|NCT01428661|3810913|FG002|Double-Masked Phase|Adverse Event|0
2183013|NCT01428661|3810911|FG000|Double-Masked Phase|Lost to Follow-up|14
2183014|NCT01428661|3810912|FG001|Double-Masked Phase|Lost to Follow-up|14
2183015|NCT01428661|3810913|FG002|Double-Masked Phase|Lost to Follow-up|0
2183016|NCT01428661|3810911|FG000|Double-Masked Phase|Withdrawal by Subject|18
2183017|NCT01428661|3810912|FG001|Double-Masked Phase|Withdrawal by Subject|20
2183018|NCT01428661|3810913|FG002|Double-Masked Phase|Withdrawal by Subject|0
2183019|NCT01428661|3810911|FG000|Double-Masked Phase|Lack of Efficacy|2
2183020|NCT01428661|3810912|FG001|Double-Masked Phase|Lack of Efficacy|1
2183021|NCT01428661|3810913|FG002|Double-Masked Phase|Lack of Efficacy|0
2183022|NCT01428661|3810911|FG000|Double-Masked Phase|*Various|1
2183023|NCT01428661|3810912|FG001|Double-Masked Phase|*Various|6
2183024|NCT01428661|3810913|FG002|Double-Masked Phase|*Various|0
2183025|NCT01428661|3810911|FG000|Open Label Extension|Protocol Violation|0
2183026|NCT01428661|3810912|FG001|Open Label Extension|Protocol Violation|0
2183027|NCT01428661|3810913|FG002|Open Label Extension|Protocol Violation|9
2183028|NCT01428661|3810911|FG000|Open Label Extension|Adverse Event|0
2183029|NCT01428661|3810912|FG001|Open Label Extension|Adverse Event|0
2183030|NCT01428661|3810913|FG002|Open Label Extension|Adverse Event|15
2183031|NCT01428661|3810911|FG000|Open Label Extension|Lost to Follow-up|0
2183032|NCT01428661|3810912|FG001|Open Label Extension|Lost to Follow-up|0
2183033|NCT01428661|3810913|FG002|Open Label Extension|Lost to Follow-up|38
2183034|NCT01428661|3810911|FG000|Open Label Extension|Withdrawal by Subject|0
2183035|NCT01428661|3810912|FG001|Open Label Extension|Withdrawal by Subject|0
2183036|NCT01428661|3810913|FG002|Open Label Extension|Withdrawal by Subject|49
2183037|NCT01428661|3810911|FG000|Open Label Extension|Lack of Efficacy|0
2183038|NCT01428661|3810912|FG001|Open Label Extension|Lack of Efficacy|0
2183039|NCT01428661|3810913|FG002|Open Label Extension|Lack of Efficacy|24
2183040|NCT01428661|3810911|FG000|Open Label Extension|**Various|0
2183041|NCT01428661|3810912|FG001|Open Label Extension|**Various|0
2183042|NCT01428661|3810913|FG002|Open Label Extension|**Various|185
2183043|NCT01428713|3810921|FG000|Overall Study|Non-compliance|2
2183044|NCT01428713|3810922|FG001|Overall Study|Non-compliance|2
2183045|NCT01428713|3810921|FG000|Overall Study|Withdrawal by Subject|1
2183046|NCT01428713|3810922|FG001|Overall Study|Withdrawal by Subject|1
2183047|NCT01428713|3810921|FG000|Overall Study|Adverse Event|0
2183048|NCT01428713|3810922|FG001|Overall Study|Adverse Event|2
2183049|NCT01428882|3810934|FG000|Overall Study|Lack of Efficacy|2
2183050|NCT01428882|3810935|FG001|Overall Study|Lack of Efficacy|7
2183051|NCT01428882|3810934|FG000|Overall Study|Protocol Violation|4
2183052|NCT01428882|3810935|FG001|Overall Study|Protocol Violation|3
2183053|NCT01429051|3810941|FG000|Titration Phase|Death|1
2183054|NCT01429051|3810941|FG000|Titration Phase|Withdrawal by Subject|7
2183055|NCT01429051|3810941|FG000|Titration Phase|Physician Decision|1
2183056|NCT01429051|3810941|FG000|Titration Phase|Unsuccessful titration at any dose|1
2183057|NCT01429051|3810941|FG000|Titration Phase|Less than 3 BTP episodes per week|2
2183058|NCT01429051|3810941|FG000|Efficacy Phase|Adverse Event|1
2183059|NCT01429051|3810941|FG000|Efficacy Phase|Death|1
2183060|NCT01429051|3810941|FG000|Tolerability Phase|Death|5
2183061|NCT01429051|3810941|FG000|Tolerability Phase|Adverse Event|2
2183062|NCT01429051|3810941|FG000|Tolerability Phase|Withdrawal by Subject|5
2183063|NCT01429051|3810941|FG000|Tolerability Phase|Physician Decision|1
2183064|NCT01429051|3810941|FG000|Tolerability Phase|Other|2
2183065|NCT01429077|3810971|FG000|Overall Study|Lost to Follow-up|0
2183066|NCT01429077|3810972|FG001|Overall Study|Lost to Follow-up|3
2183067|NCT01429285|3811001|FG000|Overall Study|Protocol Violation|9
2183068|NCT01429285|3811002|FG001|Overall Study|Protocol Violation|4
2183069|NCT01429285|3811001|FG000|Overall Study|Missing Data|5
2183070|NCT01429285|3811002|FG001|Overall Study|Missing Data|3
2183071|NCT01429285|3811001|FG000|Overall Study|Erroneously Enrolled Twice|8
2183072|NCT01429285|3811002|FG001|Overall Study|Erroneously Enrolled Twice|2
2183073|NCT01429298|3811010|FG000|Overall Study|Protocol Violation|4
2183074|NCT01429298|3811011|FG001|Overall Study|Protocol Violation|6
2183075|NCT01429441|3811028|FG000|Overall Study|Adverse Event|5
2183076|NCT01429441|3811029|FG001|Overall Study|Adverse Event|1
2183077|NCT01429441|3811028|FG000|Overall Study|Death|0
2183078|NCT01429441|3811029|FG001|Overall Study|Death|2
2183079|NCT01429441|3811028|FG000|Overall Study|Lost to Follow-up|5
2183080|NCT01429441|3811029|FG001|Overall Study|Lost to Follow-up|2
2220041|NCT01727297|3864122|FG001|Overall Study|Death|0
2220042|NCT01727297|3864121|FG000|Overall Study|Protocol Violation|1
2220043|NCT01727297|3864122|FG001|Overall Study|Protocol Violation|10
2220044|NCT01727297|3864121|FG000|Overall Study|Adverse Event|3
2183081|NCT01429441|3811028|FG000|Overall Study|Physician Decision|1
2183082|NCT01429441|3811029|FG001|Overall Study|Physician Decision|0
2183083|NCT01429441|3811028|FG000|Overall Study|Withdrawal by Subject|27
2183084|NCT01429441|3811029|FG001|Overall Study|Withdrawal by Subject|18
2183085|NCT01429584|3811060|FG000|Overall Study|Withdrawal by Subject|1
2183086|NCT01429584|3811061|FG001|Overall Study|Withdrawal by Subject|0
2183087|NCT01429584|3811060|FG000|Overall Study|Protocol Violation|0
2183088|NCT01429584|3811061|FG001|Overall Study|Protocol Violation|1
2220045|NCT01727297|3864122|FG001|Overall Study|Adverse Event|1
2183089|NCT01429623|3811069|FG000|Overall Study|Death|1
2183090|NCT01429623|3811070|FG001|Overall Study|Death|0
2183091|NCT01429623|3811069|FG000|Overall Study|Adverse Event|7
2183092|NCT01429623|3811070|FG001|Overall Study|Adverse Event|14
2183093|NCT01429623|3811069|FG000|Overall Study|Withdrawal by Subject|19
2183094|NCT01429623|3811070|FG001|Overall Study|Withdrawal by Subject|13
2183095|NCT01429623|3811069|FG000|Overall Study|Physician Decision|2
2183096|NCT01429623|3811070|FG001|Overall Study|Physician Decision|3
2183097|NCT01429623|3811069|FG000|Overall Study|Protocol Violation|3
2183098|NCT01429623|3811070|FG001|Overall Study|Protocol Violation|2
2183099|NCT01429623|3811069|FG000|Overall Study|Assorted|1
2183100|NCT01429623|3811070|FG001|Overall Study|Assorted|2
2183101|NCT01429623|3811069|FG000|Overall Study|Conversion to Alzheimer's disease|14
2183102|NCT01429623|3811070|FG001|Overall Study|Conversion to Alzheimer's disease|21
2183103|NCT01429623|3811069|FG000|Overall Study|No post baseline data|4
2183104|NCT01429623|3811070|FG001|Overall Study|No post baseline data|4
2183105|NCT01429792|3811076|FG000|Overall Study|Other Reasons|67
2183106|NCT01429792|3811076|FG000|Overall Study|Unknown Disposition|94
2183107|NCT01429792|3811076|FG000|Overall Study|Negative HCV-RNA at Week 4|1
2183108|NCT01429792|3811076|FG000|Overall Study|Negative HCV-RNA at Week 12|4
2183109|NCT01429792|3811076|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32
2183110|NCT01429792|3811076|FG000|Overall Study|Positive HCV-RNA at Week 24|50
2183111|NCT01429792|3811076|FG000|Overall Study|Withdrawal by Subject|70
2183112|NCT01429792|3811076|FG000|Overall Study|Lost to Follow-up|88
2183113|NCT01430104|3811111|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1
2183114|NCT01430130|3811118|FG000|Overall Study|Lost to Follow-up|1
2183115|NCT01430130|3811118|FG000|Overall Study|Infection on Control Side of Incision|1
2183116|NCT01430403|3811166|FG000|Overall Study|Lost to Follow-up|5
2183117|NCT01430403|3811167|FG001|Overall Study|Lost to Follow-up|5
2183118|NCT01430403|3811168|FG002|Overall Study|Lost to Follow-up|3
2183119|NCT01430403|3811166|FG000|Overall Study|Physician Decision|1
2183120|NCT01430403|3811167|FG001|Overall Study|Physician Decision|0
2183121|NCT01430403|3811168|FG002|Overall Study|Physician Decision|0
2183122|NCT01430403|3811166|FG000|Overall Study|Protocol Violation|2
2183123|NCT01430403|3811167|FG001|Overall Study|Protocol Violation|3
2183124|NCT01430403|3811168|FG002|Overall Study|Protocol Violation|2
2183125|NCT01430403|3811166|FG000|Overall Study|Withdrawal by Subject|9
2183126|NCT01430403|3811167|FG001|Overall Study|Withdrawal by Subject|1
2183127|NCT01430403|3811168|FG002|Overall Study|Withdrawal by Subject|3
2183128|NCT01430442|3811189|FG000|Overall Study|Subject Withdrew Consent|3
2183129|NCT01430442|3811190|FG001|Overall Study|Subject Withdrew Consent|0
2183130|NCT01430442|3811191|FG002|Overall Study|Subject Withdrew Consent|1
2183131|NCT01430442|3811192|FG003|Overall Study|Subject Withdrew Consent|0
2183132|NCT01430442|3811193|FG004|Overall Study|Subject Withdrew Consent|2
2183133|NCT01430442|3811194|FG005|Overall Study|Subject Withdrew Consent|1
2183134|NCT01430442|3811195|FG006|Overall Study|Subject Withdrew Consent|5
2183135|NCT01430442|3811196|FG007|Overall Study|Subject Withdrew Consent|2
2183136|NCT01430442|3811189|FG000|Overall Study|Lost to Follow-up|2
2183137|NCT01430442|3811190|FG001|Overall Study|Lost to Follow-up|0
2183138|NCT01430442|3811191|FG002|Overall Study|Lost to Follow-up|1
2220046|NCT01727297|3864121|FG000|Overall Study|Lost to Follow-up|11
2220047|NCT01727297|3864122|FG001|Overall Study|Lost to Follow-up|0
2220048|NCT01727297|3864121|FG000|Overall Study|Withdrawal by Subject|26
2220049|NCT01727297|3864122|FG001|Overall Study|Withdrawal by Subject|27
2220050|NCT01727297|3864121|FG000|Overall Study|Physician Decision|19
2220051|NCT01727297|3864122|FG001|Overall Study|Physician Decision|5
2220052|NCT01727297|3864121|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29
2220053|NCT01727297|3864122|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8
2220054|NCT01727336|3864141|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0
2220055|NCT01727336|3864142|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1
2220056|NCT01727336|3864143|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5
2220057|NCT01727336|3864144|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0
2220058|NCT01727336|3864145|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0
2220059|NCT01727336|3864146|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0
2220060|NCT01727336|3864141|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
2220061|NCT01727336|3864142|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1
2220062|NCT01727336|3864143|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
2220063|NCT01727336|3864144|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
2220064|NCT01727336|3864145|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
2220065|NCT01727336|3864146|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
2220066|NCT01727336|3864141|FG000|Part 2 Blinded|Death|0
2220067|NCT01727336|3864142|FG001|Part 2 Blinded|Death|0
2220068|NCT01727336|3864143|FG002|Part 2 Blinded|Death|0
2220069|NCT01727336|3864144|FG003|Part 2 Blinded|Death|0
2183139|NCT01430442|3811192|FG003|Overall Study|Lost to Follow-up|2
2183140|NCT01430442|3811193|FG004|Overall Study|Lost to Follow-up|2
2183141|NCT01430442|3811194|FG005|Overall Study|Lost to Follow-up|1
2183142|NCT01430442|3811195|FG006|Overall Study|Lost to Follow-up|5
2220070|NCT01727336|3864145|FG004|Part 2 Blinded|Death|20
2220071|NCT01727336|3864146|FG005|Part 2 Blinded|Death|16
2220072|NCT01727336|3864141|FG000|Part 2 Blinded|Lack of Efficacy|0
2220073|NCT01727336|3864142|FG001|Part 2 Blinded|Lack of Efficacy|0
2220074|NCT01727336|3864143|FG002|Part 2 Blinded|Lack of Efficacy|0
2183143|NCT01430442|3811196|FG007|Overall Study|Lost to Follow-up|1
2183144|NCT01430442|3811189|FG000|Overall Study|Pregnancy|1
2183145|NCT01430442|3811190|FG001|Overall Study|Pregnancy|0
2183146|NCT01430442|3811191|FG002|Overall Study|Pregnancy|0
2183147|NCT01430442|3811192|FG003|Overall Study|Pregnancy|0
2183148|NCT01430442|3811193|FG004|Overall Study|Pregnancy|0
2183149|NCT01430442|3811194|FG005|Overall Study|Pregnancy|1
2183150|NCT01430442|3811195|FG006|Overall Study|Pregnancy|0
2183151|NCT01430442|3811196|FG007|Overall Study|Pregnancy|0
2183152|NCT01430442|3811189|FG000|Overall Study|Patient No Longer Meets Study Criteria|7
2183153|NCT01430442|3811190|FG001|Overall Study|Patient No Longer Meets Study Criteria|6
2183154|NCT01430442|3811191|FG002|Overall Study|Patient No Longer Meets Study Criteria|3
2183155|NCT01430442|3811192|FG003|Overall Study|Patient No Longer Meets Study Criteria|2
2183156|NCT01430442|3811193|FG004|Overall Study|Patient No Longer Meets Study Criteria|5
2183157|NCT01430442|3811194|FG005|Overall Study|Patient No Longer Meets Study Criteria|5
2183158|NCT01430442|3811195|FG006|Overall Study|Patient No Longer Meets Study Criteria|9
2183159|NCT01430442|3811196|FG007|Overall Study|Patient No Longer Meets Study Criteria|6
2183160|NCT01430455|3811214|FG000|Overall Study|Withdrawal by Subject|1
2183161|NCT01430455|3811214|FG000|Overall Study|Switched to follow-up phase|1
2183162|NCT01430468|3811220|FG000|Overall Study|Physician Decision|2
2183163|NCT01430468|3811221|FG001|Overall Study|Physician Decision|1
2183164|NCT01430468|3811220|FG000|Overall Study|Withdrawal by Subject|5
2183165|NCT01430468|3811221|FG001|Overall Study|Withdrawal by Subject|5
2183166|NCT01430559|3811229|FG000|Overall Study|Adverse Event|7
2183167|NCT01430559|3811230|FG001|Overall Study|Adverse Event|3
2220075|NCT01727336|3864144|FG003|Part 2 Blinded|Lack of Efficacy|0
2220076|NCT01727336|3864145|FG004|Part 2 Blinded|Lack of Efficacy|42
2220077|NCT01727336|3864146|FG005|Part 2 Blinded|Lack of Efficacy|44
2220078|NCT01727336|3864141|FG000|Part 2 Blinded|Lost to Follow-up|0
2220079|NCT01727336|3864142|FG001|Part 2 Blinded|Lost to Follow-up|0
2220080|NCT01727336|3864143|FG002|Part 2 Blinded|Lost to Follow-up|0
2220081|NCT01727336|3864144|FG003|Part 2 Blinded|Lost to Follow-up|0
2220082|NCT01727336|3864145|FG004|Part 2 Blinded|Lost to Follow-up|0
2220083|NCT01727336|3864146|FG005|Part 2 Blinded|Lost to Follow-up|1
2220084|NCT01727336|3864141|FG000|Part 2 Blinded|Withdrawal by Subject|0
2220085|NCT01727336|3864142|FG001|Part 2 Blinded|Withdrawal by Subject|0
2220086|NCT01727336|3864143|FG002|Part 2 Blinded|Withdrawal by Subject|0
2220087|NCT01727336|3864144|FG003|Part 2 Blinded|Withdrawal by Subject|0
2220088|NCT01727336|3864145|FG004|Part 2 Blinded|Withdrawal by Subject|0
2220089|NCT01727336|3864146|FG005|Part 2 Blinded|Withdrawal by Subject|4
2220090|NCT01727336|3864141|FG000|Part 2 Blinded|use of prohibited medications|0
2220091|NCT01727336|3864142|FG001|Part 2 Blinded|use of prohibited medications|0
2220092|NCT01727336|3864143|FG002|Part 2 Blinded|use of prohibited medications|0
2220093|NCT01727336|3864144|FG003|Part 2 Blinded|use of prohibited medications|0
2220094|NCT01727336|3864145|FG004|Part 2 Blinded|use of prohibited medications|1
2220095|NCT01727336|3864146|FG005|Part 2 Blinded|use of prohibited medications|3
2220096|NCT01727505|3864175|FG000|First 24 Hours|Adverse Event|0
2220097|NCT01727505|3864176|FG001|First 24 Hours|Adverse Event|1
2220098|NCT01727505|3864175|FG000|Second 24 Hours|Missing data|0
2220099|NCT01727505|3864176|FG001|Second 24 Hours|Missing data|1
2220100|NCT01727700|3864185|FG000|Overall Study|Adverse Event|0
2220101|NCT01727700|3864186|FG001|Overall Study|Adverse Event|7
2220102|NCT01727700|3864187|FG002|Overall Study|Adverse Event|1
2220103|NCT01727700|3864185|FG000|Overall Study|Particpant withdrew consent|0
2220104|NCT01727700|3864186|FG001|Overall Study|Particpant withdrew consent|3
2220105|NCT01727700|3864187|FG002|Overall Study|Particpant withdrew consent|1
2220106|NCT01727700|3864185|FG000|Overall Study|Protocol Violation|2
2220107|NCT01727700|3864186|FG001|Overall Study|Protocol Violation|0
2220108|NCT01727700|3864187|FG002|Overall Study|Protocol Violation|0
2220109|NCT01727713|3864195|FG000|Overall Study|Lost to Follow-up|5
2220110|NCT01727713|3864195|FG000|Overall Study|Adverse Event|10
2220111|NCT01727713|3864195|FG000|Overall Study|Participant Met Withdrawal Criteria|5
2220112|NCT01727713|3864195|FG000|Overall Study|Withdrawal by Subject|13
2220113|NCT01727713|3864195|FG000|Overall Study|Protocol Deviation|2
2220114|NCT01728077|3864236|FG000|Overall Study|Lack of Efficacy|3
2220115|NCT01728077|3864237|FG001|Overall Study|Lack of Efficacy|1
2220116|NCT01728077|3864236|FG000|Overall Study|Lost to Follow-up|1
2220117|NCT01728077|3864237|FG001|Overall Study|Lost to Follow-up|0
2220118|NCT01728077|3864236|FG000|Overall Study|Subject choice|2
2220119|NCT01728077|3864237|FG001|Overall Study|Subject choice|3
2220120|NCT01728077|3864236|FG000|Overall Study|Death|0
2220121|NCT01728077|3864237|FG001|Overall Study|Death|1
2220122|NCT01728077|3864236|FG000|Overall Study|Patient moving|1
2220123|NCT01728077|3864237|FG001|Overall Study|Patient moving|0
2220124|NCT01728077|3864236|FG000|Overall Study|Non compliance|1
2220125|NCT01728077|3864237|FG001|Overall Study|Non compliance|0
2220126|NCT01728116|3864246|FG000|Overall Study|Sponsor Terminated Study|106
2220127|NCT01728116|3864247|FG001|Overall Study|Sponsor Terminated Study|35
2220128|NCT01728116|3864246|FG000|Overall Study|Withdrawal by Subject|16
2220129|NCT01728116|3864247|FG001|Overall Study|Withdrawal by Subject|9
2220130|NCT01728116|3864246|FG000|Overall Study|Adverse Event|13
2220131|NCT01728116|3864247|FG001|Overall Study|Adverse Event|0
2220132|NCT01728116|3864246|FG000|Overall Study|Procedure/device failure|7
2220133|NCT01728116|3864247|FG001|Overall Study|Procedure/device failure|0
2183168|NCT01430559|3811229|FG000|Overall Study|Entry criteria not met|1
2183169|NCT01430559|3811230|FG001|Overall Study|Entry criteria not met|1
2183170|NCT01430559|3811229|FG000|Overall Study|Lost to Follow-up|1
2183171|NCT01430559|3811230|FG001|Overall Study|Lost to Follow-up|0
2183172|NCT01430559|3811229|FG000|Overall Study|Medication error|1
2183173|NCT01430559|3811230|FG001|Overall Study|Medication error|0
2183174|NCT01430559|3811229|FG000|Overall Study|Withdrawal by Subject|3
2183175|NCT01430559|3811230|FG001|Overall Study|Withdrawal by Subject|2
2183176|NCT01430559|3811229|FG000|Overall Study|Protocol Violation|1
2183177|NCT01430559|3811230|FG001|Overall Study|Protocol Violation|0
2183178|NCT01430559|3811229|FG000|Overall Study|Other|3
2183179|NCT01430559|3811230|FG001|Overall Study|Other|3
2183180|NCT01430559|3811229|FG000|Overall Study|Randomized, Not Treated|3
2183181|NCT01430559|3811230|FG001|Overall Study|Randomized, Not Treated|3
2183182|NCT01430585|3811241|FG000|Overall Study|Death|1
2183183|NCT01430585|3811241|FG000|Overall Study|Objective Progression or Relapse|3
2183184|NCT01430585|3811241|FG000|Overall Study|Study Terminated by Sponsor|3
2183185|NCT01430585|3811241|FG000|Overall Study|Other|7
2183186|NCT01430611|3811253|FG000|Overall Study|Adverse Event|0
2183187|NCT01430611|3811254|FG001|Overall Study|Adverse Event|1
2183188|NCT01430611|3811253|FG000|Overall Study|Protocol Violation|1
2183189|NCT01430611|3811254|FG001|Overall Study|Protocol Violation|0
2183190|NCT01430611|3811253|FG000|Overall Study|Lost to Follow-up|1
2183191|NCT01430611|3811254|FG001|Overall Study|Lost to Follow-up|0
2183192|NCT01430611|3811253|FG000|Overall Study|Withdrawal by Subject|15
2183193|NCT01430611|3811254|FG001|Overall Study|Withdrawal by Subject|14
2183194|NCT01430624|3811263|FG000|Overall Study|Lost to Follow-up|23
2183195|NCT01430624|3811264|FG001|Overall Study|Lost to Follow-up|29
2183196|NCT01430624|3811265|FG002|Overall Study|Lost to Follow-up|27
2183197|NCT01430624|3811263|FG000|Overall Study|technical or eligibility|5
2183198|NCT01430624|3811264|FG001|Overall Study|technical or eligibility|5
2183199|NCT01430624|3811265|FG002|Overall Study|technical or eligibility|2
2183200|NCT01430754|3811297|FG000|Run-In Phase|Circadian Period Ineligible|24
2183201|NCT01430754|3811298|FG001|Run-In Phase|Circadian Period Ineligible|0
2183202|NCT01430754|3811297|FG000|Run-In Phase|Protocol Violation|6
2183203|NCT01430754|3811298|FG001|Run-In Phase|Protocol Violation|0
2183204|NCT01430754|3811297|FG000|Run-In Phase|Adverse Event|2
2183205|NCT01430754|3811298|FG001|Run-In Phase|Adverse Event|0
2183206|NCT01430754|3811297|FG000|Run-In Phase|Other|2
2183207|NCT01430754|3811298|FG001|Run-In Phase|Other|0
2183208|NCT01430754|3811297|FG000|Run-In Phase|Withdrawal by Subject|2
2183209|NCT01430754|3811298|FG001|Run-In Phase|Withdrawal by Subject|0
2183210|NCT01430754|3811297|FG000|Run-In Phase|Lost to Follow-up|1
2183211|NCT01430754|3811298|FG001|Run-In Phase|Lost to Follow-up|0
2183212|NCT01431079|3811326|FG000|Overall Study|Lost to Follow-up|35
2183213|NCT01431079|3811327|FG001|Overall Study|Lost to Follow-up|39
2183214|NCT01431144|3811372|FG000|Overall Study|Implant mobility and removal|2
2183215|NCT01431144|3811373|FG001|Overall Study|Implant mobility and removal|0
2183216|NCT01431274|3811412|FG000|Overall Study|Adverse Event|51
2183217|NCT01431274|3811413|FG001|Overall Study|Adverse Event|37
2183218|NCT01431274|3811414|FG002|Overall Study|Adverse Event|43
2183219|NCT01431274|3811415|FG003|Overall Study|Adverse Event|30
2183220|NCT01431274|3811416|FG004|Overall Study|Adverse Event|37
2183221|NCT01431274|3811412|FG000|Overall Study|Consent withdrawn not due to AE|29
2183222|NCT01431274|3811413|FG001|Overall Study|Consent withdrawn not due to AE|20
2183223|NCT01431274|3811414|FG002|Overall Study|Consent withdrawn not due to AE|17
2183224|NCT01431274|3811415|FG003|Overall Study|Consent withdrawn not due to AE|20
2183225|NCT01431274|3811416|FG004|Overall Study|Consent withdrawn not due to AE|11
2183226|NCT01431274|3811412|FG000|Overall Study|Non compliant with protocol|5
2183227|NCT01431274|3811413|FG001|Overall Study|Non compliant with protocol|8
2183228|NCT01431274|3811414|FG002|Overall Study|Non compliant with protocol|4
2183229|NCT01431274|3811415|FG003|Overall Study|Non compliant with protocol|4
2183230|NCT01431274|3811416|FG004|Overall Study|Non compliant with protocol|4
2183231|NCT01431274|3811412|FG000|Overall Study|Lost to Follow-up|6
2183232|NCT01431274|3811413|FG001|Overall Study|Lost to Follow-up|7
2183233|NCT01431274|3811414|FG002|Overall Study|Lost to Follow-up|1
2183234|NCT01431274|3811415|FG003|Overall Study|Lost to Follow-up|4
2183235|NCT01431274|3811416|FG004|Overall Study|Lost to Follow-up|0
2183236|NCT01431274|3811412|FG000|Overall Study|Other reason not stated above|6
2220134|NCT01728116|3864246|FG000|Overall Study|Lost to Follow-up|9
2220135|NCT01728116|3864247|FG001|Overall Study|Lost to Follow-up|2
2220136|NCT01728116|3864246|FG000|Overall Study|Physician Decision|2
2220137|NCT01728116|3864247|FG001|Overall Study|Physician Decision|0
2220138|NCT01728116|3864246|FG000|Overall Study|Subject Non-Compliance|2
2220139|NCT01728116|3864247|FG001|Overall Study|Subject Non-Compliance|0
2220140|NCT01728116|3864246|FG000|Overall Study|Inter-current finding at procedure|1
2220141|NCT01728116|3864247|FG001|Overall Study|Inter-current finding at procedure|0
2220142|NCT01728116|3864246|FG000|Overall Study|Incorrectly enrolled in Study|0
2220143|NCT01728116|3864247|FG001|Overall Study|Incorrectly enrolled in Study|1
2220144|NCT01728116|3864246|FG000|Overall Study|various not noted previously|5
2183237|NCT01431274|3811413|FG001|Overall Study|Other reason not stated above|5
2220145|NCT01728116|3864247|FG001|Overall Study|various not noted previously|0
2220146|NCT01728194|3864256|FG000|Overall Study|Lost to Follow-up|4
2220147|NCT01728194|3864257|FG001|Overall Study|Lost to Follow-up|3
2183238|NCT01431274|3811414|FG002|Overall Study|Other reason not stated above|7
2183239|NCT01431274|3811415|FG003|Overall Study|Other reason not stated above|2
2183240|NCT01431274|3811416|FG004|Overall Study|Other reason not stated above|4
2183241|NCT01431287|3811433|FG000|Overall Study|not treated|0
2183242|NCT01431287|3811434|FG001|Overall Study|not treated|0
2183243|NCT01431287|3811435|FG002|Overall Study|not treated|1
2183244|NCT01431287|3811436|FG003|Overall Study|not treated|0
2183245|NCT01431287|3811437|FG004|Overall Study|not treated|0
2183246|NCT01431287|3811433|FG000|Overall Study|Adverse Event|59
2183247|NCT01431287|3811434|FG001|Overall Study|Adverse Event|57
2220148|NCT01728194|3864256|FG000|Overall Study|Physician Decision|4
2220149|NCT01728194|3864257|FG001|Overall Study|Physician Decision|0
2220150|NCT01728194|3864256|FG000|Overall Study|Withdrawal by Subject|7
2183248|NCT01431287|3811435|FG002|Overall Study|Adverse Event|53
2183249|NCT01431287|3811436|FG003|Overall Study|Adverse Event|33
2183250|NCT01431287|3811437|FG004|Overall Study|Adverse Event|41
2183251|NCT01431287|3811433|FG000|Overall Study|Non compliant with protocol|6
2183252|NCT01431287|3811434|FG001|Overall Study|Non compliant with protocol|6
2183253|NCT01431287|3811435|FG002|Overall Study|Non compliant with protocol|5
2183254|NCT01431287|3811436|FG003|Overall Study|Non compliant with protocol|6
2183255|NCT01431287|3811437|FG004|Overall Study|Non compliant with protocol|5
2183256|NCT01431287|3811433|FG000|Overall Study|Lost to Follow-up|0
2183257|NCT01431287|3811434|FG001|Overall Study|Lost to Follow-up|3
2183258|NCT01431287|3811435|FG002|Overall Study|Lost to Follow-up|2
2183259|NCT01431287|3811436|FG003|Overall Study|Lost to Follow-up|3
2183260|NCT01431287|3811437|FG004|Overall Study|Lost to Follow-up|1
2183261|NCT01431287|3811433|FG000|Overall Study|Consent withdrawn not due to AE|29
2183262|NCT01431287|3811434|FG001|Overall Study|Consent withdrawn not due to AE|30
2183263|NCT01431287|3811435|FG002|Overall Study|Consent withdrawn not due to AE|34
2183264|NCT01431287|3811436|FG003|Overall Study|Consent withdrawn not due to AE|19
2183265|NCT01431287|3811437|FG004|Overall Study|Consent withdrawn not due to AE|29
2183266|NCT01431287|3811433|FG000|Overall Study|not stated above|4
2183267|NCT01431287|3811434|FG001|Overall Study|not stated above|2
2183268|NCT01431287|3811435|FG002|Overall Study|not stated above|2
2183269|NCT01431287|3811436|FG003|Overall Study|not stated above|2
2183270|NCT01431287|3811437|FG004|Overall Study|not stated above|1
2220151|NCT01728194|3864257|FG001|Overall Study|Withdrawal by Subject|3
2220152|NCT01728194|3864256|FG000|Overall Study|Perceived Medication Side Effects|4
2220153|NCT01728194|3864257|FG001|Overall Study|Perceived Medication Side Effects|0
2220154|NCT01728194|3864256|FG000|Overall Study|Family Member Request|1
2220155|NCT01728194|3864257|FG001|Overall Study|Family Member Request|0
2220156|NCT01728246|3864265|FG000|Overall Study|Participant needed rescue medication|1
2220157|NCT01728246|3864266|FG001|Overall Study|Participant needed rescue medication|5
2220158|NCT01728246|3864265|FG000|Overall Study|Protocol Violation|1
2220159|NCT01728246|3864266|FG001|Overall Study|Protocol Violation|0
2220160|NCT01728246|3864265|FG000|Overall Study|Withdrawal by Subject|2
2220161|NCT01728246|3864266|FG001|Overall Study|Withdrawal by Subject|3
2220162|NCT01728246|3864265|FG000|Overall Study|Lost to Follow-up|23
2220163|NCT01728246|3864266|FG001|Overall Study|Lost to Follow-up|22
2220164|NCT01728246|3864265|FG000|Overall Study|Lack of Efficacy|1
2220165|NCT01728246|3864266|FG001|Overall Study|Lack of Efficacy|1
2220166|NCT01728246|3864265|FG000|Overall Study|Adverse Event|8
2220167|NCT01728246|3864266|FG001|Overall Study|Adverse Event|5
2220168|NCT01728324|3864275|FG000|Termination of DBV|Adverse Event|14
2220169|NCT01728324|3864276|FG001|Termination of DBV|Adverse Event|13
2220170|NCT01728324|3864277|FG002|Termination of DBV|Adverse Event|4
2220171|NCT01728324|3864275|FG000|Termination of DBV|Lack of Efficacy|14
2220172|NCT01728324|3864276|FG001|Termination of DBV|Lack of Efficacy|12
2220173|NCT01728324|3864277|FG002|Termination of DBV|Lack of Efficacy|8
2220174|NCT01728324|3864275|FG000|Termination of DBV|Withdrawal by Subject|9
2220175|NCT01728324|3864276|FG001|Termination of DBV|Withdrawal by Subject|6
2220176|NCT01728324|3864277|FG002|Termination of DBV|Withdrawal by Subject|2
2220177|NCT01728324|3864275|FG000|Termination of DBV|Other than stated|1
2220178|NCT01728324|3864276|FG001|Termination of DBV|Other than stated|3
2220179|NCT01728324|3864277|FG002|Termination of DBV|Other than stated|0
2220180|NCT01728324|3864275|FG000|Termination of DBV|Adverse Event (Placebo Period)|0
2220181|NCT01728324|3864276|FG001|Termination of DBV|Adverse Event (Placebo Period)|1
2220182|NCT01728324|3864277|FG002|Termination of DBV|Adverse Event (Placebo Period)|0
2220183|NCT01728324|3864275|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0
2220184|NCT01728324|3864276|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1
2220185|NCT01728324|3864277|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0
2220186|NCT01728324|3864275|FG000|Termination of FDV|Adverse Event|14
2220187|NCT01728324|3864276|FG001|Termination of FDV|Adverse Event|13
2220188|NCT01728324|3864277|FG002|Termination of FDV|Adverse Event|4
2220189|NCT01728324|3864275|FG000|Termination of FDV|Lack of Efficacy|14
2220190|NCT01728324|3864276|FG001|Termination of FDV|Lack of Efficacy|12
2220191|NCT01728324|3864277|FG002|Termination of FDV|Lack of Efficacy|8
2220192|NCT01728324|3864275|FG000|Termination of FDV|Withdrawal by Subject|9
2220193|NCT01728324|3864276|FG001|Termination of FDV|Withdrawal by Subject|6
2220194|NCT01728324|3864277|FG002|Termination of FDV|Withdrawal by Subject|2
2220195|NCT01728324|3864275|FG000|Termination of FDV|Other than stated|1
2220196|NCT01728324|3864276|FG001|Termination of FDV|Other than stated|3
2220197|NCT01728324|3864277|FG002|Termination of FDV|Other than stated|0
2183271|NCT01431521|3811499|FG000|Overall Study|Withdrawal by Subject|0
2183272|NCT01431521|3811500|FG001|Overall Study|Withdrawal by Subject|0
2183273|NCT01431521|3811501|FG002|Overall Study|Withdrawal by Subject|1
2183274|NCT01431521|3811502|FG003|Overall Study|Withdrawal by Subject|0
2183275|NCT01431534|3811514|FG000|Treatment Phase|Adverse Event|0
2183276|NCT01431534|3811515|FG001|Treatment Phase|Adverse Event|0
2183277|NCT01431534|3811516|FG002|Treatment Phase|Adverse Event|1
2183278|NCT01431534|3811514|FG000|Treatment Phase|Progressive Disease|4
2183279|NCT01431534|3811515|FG001|Treatment Phase|Progressive Disease|3
2183280|NCT01431534|3811516|FG002|Treatment Phase|Progressive Disease|10
2183281|NCT01431638|3811531|FG000|Overall Study|Adverse Event|1
2183282|NCT01431638|3811532|FG001|Overall Study|Adverse Event|3
2183283|NCT01431638|3811533|FG002|Overall Study|Adverse Event|1
2183284|NCT01431638|3811531|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2183285|NCT01431638|3811532|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2183286|NCT01431638|3811533|FG002|Overall Study|Unsatisfactory therapeutic effect|4
2183287|NCT01431638|3811531|FG000|Overall Study|Participants condition no longer requires study drug|0
2183288|NCT01431638|3811532|FG001|Overall Study|Participants condition no longer requires study drug|1
2183289|NCT01431638|3811533|FG002|Overall Study|Participants condition no longer requires study drug|0
2183290|NCT01431638|3811531|FG000|Overall Study|Participant withdrew consent|14
2183291|NCT01431638|3811532|FG001|Overall Study|Participant withdrew consent|5
2183292|NCT01431638|3811533|FG002|Overall Study|Participant withdrew consent|8
2183293|NCT01431638|3811531|FG000|Overall Study|Lost to Follow-up|7
2183294|NCT01431638|3811532|FG001|Overall Study|Lost to Follow-up|9
2183295|NCT01431638|3811533|FG002|Overall Study|Lost to Follow-up|7
2183296|NCT01431638|3811531|FG000|Overall Study|Administrative problems|1
2183297|NCT01431638|3811532|FG001|Overall Study|Administrative problems|4
2183298|NCT01431638|3811533|FG002|Overall Study|Administrative problems|6
2183299|NCT01431638|3811531|FG000|Overall Study|Death|1
2183300|NCT01431638|3811532|FG001|Overall Study|Death|0
2183301|NCT01431638|3811533|FG002|Overall Study|Death|0
2183302|NCT01431638|3811531|FG000|Overall Study|Protocol deviation|1
2183303|NCT01431638|3811532|FG001|Overall Study|Protocol deviation|1
2183304|NCT01431638|3811533|FG002|Overall Study|Protocol deviation|4
2183305|NCT01431638|3811531|FG000|Overall Study|Participants Did not enter extension study from core study|39
2183306|NCT01431638|3811532|FG001|Overall Study|Participants Did not enter extension study from core study|46
2183307|NCT01431638|3811533|FG002|Overall Study|Participants Did not enter extension study from core study|32
2183308|NCT01431716|3811545|FG000|Overall Study|Withdrawal of consent|1
2183309|NCT01431950|3811591|FG000|Overall Study|Study Site Closed/Terminated|7
2183310|NCT01431950|3811592|FG001|Overall Study|Study Site Closed/Terminated|3
2183311|NCT01431950|3811591|FG000|Overall Study|Withdrawal by Subject|4
2183312|NCT01431950|3811592|FG001|Overall Study|Withdrawal by Subject|3
2183313|NCT01431950|3811591|FG000|Overall Study|Protocol Violation|2
2183314|NCT01431950|3811592|FG001|Overall Study|Protocol Violation|3
2183315|NCT01431950|3811591|FG000|Overall Study|Adverse Event|2
2183316|NCT01431950|3811592|FG001|Overall Study|Adverse Event|2
2183317|NCT01431950|3811591|FG000|Overall Study|Physician Decision|2
2183318|NCT01431950|3811592|FG001|Overall Study|Physician Decision|1
2183319|NCT01431950|3811591|FG000|Overall Study|Lack of Efficacy|2
2183320|NCT01431950|3811592|FG001|Overall Study|Lack of Efficacy|1
2183321|NCT01431950|3811591|FG000|Overall Study|Lost to Follow-up|0
2183322|NCT01431950|3811592|FG001|Overall Study|Lost to Follow-up|1
2183323|NCT01431950|3811591|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0
2183324|NCT01431950|3811592|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
2183325|NCT01431963|3811598|FG000|Overall Study|Adverse Event|18
2220198|NCT01728324|3864275|FG000|Termination of FDV|Adverse Event (Placebo Period)|0
2220199|NCT01728324|3864276|FG001|Termination of FDV|Adverse Event (Placebo Period)|1
2183326|NCT01431963|3811598|FG000|Overall Study|Lack of Efficacy|7
2183327|NCT01431963|3811598|FG000|Overall Study|Protocol Violation|1
2183328|NCT01431963|3811598|FG000|Overall Study|Protocol-defined Stopping Criteria|2
2183329|NCT01431963|3811598|FG000|Overall Study|Physician Decision|4
2183330|NCT01431963|3811598|FG000|Overall Study|Withdrawal by Subject|3
2183331|NCT01431976|3811602|FG000|Overall Study|Adverse Event|6
2183332|NCT01431976|3811602|FG000|Overall Study|Lack of Efficacy|2
2183333|NCT01431976|3811602|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4
2183334|NCT01431976|3811602|FG000|Overall Study|Physician Decision|1
2183335|NCT01431976|3811602|FG000|Overall Study|Withdrawal by Subject|1
2183336|NCT01432171|3811628|FG000|Overall Study|Death|1
2183337|NCT01432171|3811629|FG001|Overall Study|Death|2
2183338|NCT01432171|3811628|FG000|Overall Study|Lost to Follow-up|6
2183339|NCT01432171|3811629|FG001|Overall Study|Lost to Follow-up|5
2183340|NCT01432171|3811628|FG000|Overall Study|Withdrawal by Subject|3
2183341|NCT01432171|3811629|FG001|Overall Study|Withdrawal by Subject|1
2183342|NCT01432171|3811628|FG000|Overall Study|Noncompliance|2
2183343|NCT01432171|3811629|FG001|Overall Study|Noncompliance|3
2183344|NCT01432171|3811628|FG000|Overall Study|Insurance denial trial coverage|1
2183345|NCT01432171|3811629|FG001|Overall Study|Insurance denial trial coverage|0
2183346|NCT01432171|3811628|FG000|Overall Study|Patient moved to palliative care|1
2183347|NCT01432171|3811629|FG001|Overall Study|Patient moved to palliative care|0
2183348|NCT01432262|3811653|FG000|Overall Study|Withdrawal by Subject|2
2220200|NCT01728324|3864277|FG002|Termination of FDV|Adverse Event (Placebo Period)|0
2183349|NCT01432262|3811654|FG001|Overall Study|Withdrawal by Subject|1
2183350|NCT01432275|3811660|FG000|First BG Meter System (7 Days)|Adverse Event|0
2183351|NCT01432275|3811661|FG001|First BG Meter System (7 Days)|Adverse Event|2
2183352|NCT01432275|3811660|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0
2183353|NCT01432275|3811661|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1
2183354|NCT01432275|3811660|FG000|Second BG Meter System (7 Days)|Adverse Event|1
2183355|NCT01432275|3811661|FG001|Second BG Meter System (7 Days)|Adverse Event|1
2183356|NCT01432275|3811660|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1
2183357|NCT01432275|3811661|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0
2183358|NCT01432275|3811660|FG000|Second BG Meter System (7 Days)|Physician Decision|0
2183359|NCT01432275|3811661|FG001|Second BG Meter System (7 Days)|Physician Decision|1
2183360|NCT01432275|3811660|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0
2183361|NCT01432275|3811661|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1
2183362|NCT01432275|3811660|FG000|ADC With Calculator (10 Days)|Physician Decision|1
2183363|NCT01432275|3811661|FG001|ADC With Calculator (10 Days)|Physician Decision|1
2183364|NCT01432275|3811660|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2
2183365|NCT01432275|3811661|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0
2183366|NCT01432275|3811660|FG000|ADC With Calculator (10 Days)|Protocol Violation|0
2220201|NCT01728324|3864275|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0
2220202|NCT01728324|3864276|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1
2220203|NCT01728324|3864277|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0
2220204|NCT01728324|3864275|FG000|Termination of RBV|Adverse Event|15
2220205|NCT01728324|3864276|FG001|Termination of RBV|Adverse Event|16
2220206|NCT01728324|3864277|FG002|Termination of RBV|Adverse Event|5
2220207|NCT01728324|3864275|FG000|Termination of RBV|Lack of Efficacy|14
2220208|NCT01728324|3864276|FG001|Termination of RBV|Lack of Efficacy|11
2220209|NCT01728324|3864277|FG002|Termination of RBV|Lack of Efficacy|7
2220210|NCT01728324|3864275|FG000|Termination of RBV|Withdrawal by Subject|9
2220211|NCT01728324|3864276|FG001|Termination of RBV|Withdrawal by Subject|5
2220212|NCT01728324|3864277|FG002|Termination of RBV|Withdrawal by Subject|2
2220213|NCT01728324|3864275|FG000|Termination of RBV|Other than stated|1
2220214|NCT01728324|3864276|FG001|Termination of RBV|Other than stated|3
2220215|NCT01728324|3864277|FG002|Termination of RBV|Other than stated|1
2220216|NCT01728324|3864275|FG000|Termination of RBV|Adverse Event (Placebo Period)|0
2220217|NCT01728324|3864276|FG001|Termination of RBV|Adverse Event (Placebo Period)|1
2220218|NCT01728324|3864277|FG002|Termination of RBV|Adverse Event (Placebo Period)|0
2220219|NCT01728324|3864275|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0
2220220|NCT01728324|3864276|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1
2220221|NCT01728324|3864277|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0
2220222|NCT01728376|3864299|FG000|Overall Study|Adverse Event|1
2220223|NCT01728376|3864300|FG001|Overall Study|Adverse Event|1
2220224|NCT01728376|3864301|FG002|Overall Study|Adverse Event|1
2220225|NCT01728376|3864302|FG003|Overall Study|Adverse Event|1
2220226|NCT01728376|3864303|FG004|Overall Study|Adverse Event|1
2220227|NCT01728376|3864304|FG005|Overall Study|Adverse Event|0
2220228|NCT01728376|3864299|FG000|Overall Study|Persistent Positive Blood Cultures|1
2220229|NCT01728376|3864300|FG001|Overall Study|Persistent Positive Blood Cultures|0
2220230|NCT01728376|3864301|FG002|Overall Study|Persistent Positive Blood Cultures|1
2220231|NCT01728376|3864302|FG003|Overall Study|Persistent Positive Blood Cultures|0
2220232|NCT01728376|3864303|FG004|Overall Study|Persistent Positive Blood Cultures|0
2220233|NCT01728376|3864304|FG005|Overall Study|Persistent Positive Blood Cultures|0
2220234|NCT01728376|3864299|FG000|Overall Study|No relevant bacteria|2
2220235|NCT01728376|3864300|FG001|Overall Study|No relevant bacteria|0
2220236|NCT01728376|3864301|FG002|Overall Study|No relevant bacteria|0
2220237|NCT01728376|3864302|FG003|Overall Study|No relevant bacteria|0
2220238|NCT01728376|3864303|FG004|Overall Study|No relevant bacteria|1
2220239|NCT01728376|3864304|FG005|Overall Study|No relevant bacteria|1
2220240|NCT01728376|3864299|FG000|Overall Study|Did not receive treatment|0
2220241|NCT01728376|3864300|FG001|Overall Study|Did not receive treatment|1
2220242|NCT01728376|3864301|FG002|Overall Study|Did not receive treatment|0
2220243|NCT01728376|3864302|FG003|Overall Study|Did not receive treatment|0
2220244|NCT01728376|3864303|FG004|Overall Study|Did not receive treatment|0
2220245|NCT01728376|3864304|FG005|Overall Study|Did not receive treatment|0
2220246|NCT01728376|3864299|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0
2220247|NCT01728376|3864300|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0
2220248|NCT01728376|3864301|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0
2220249|NCT01728376|3864302|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1
2220250|NCT01728376|3864303|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0
2220251|NCT01728376|3864304|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1
2220252|NCT01728454|3864321|FG000|Stage 1 and 2|Pregnancy|1
2220253|NCT01728454|3864322|FG001|Stage 1 and 2|Pregnancy|0
2220254|NCT01728454|3864323|FG002|Stage 1 and 2|Pregnancy|0
2220255|NCT01728454|3864321|FG000|Stage 1 and 2|Non-compliance with Protocol|0
2220256|NCT01728454|3864322|FG001|Stage 1 and 2|Non-compliance with Protocol|0
2220257|NCT01728454|3864323|FG002|Stage 1 and 2|Non-compliance with Protocol|1
2220258|NCT01728454|3864321|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
2220259|NCT01728454|3864322|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
2183367|NCT01432275|3811661|FG001|ADC With Calculator (10 Days)|Protocol Violation|1
2183368|NCT01432327|3811671|FG000|Posttest 3 Months|depression|3
2183369|NCT01432327|3811672|FG001|Posttest 3 Months|depression|0
2183370|NCT01432327|3811673|FG002|Posttest 3 Months|depression|0
2183371|NCT01432327|3811674|FG003|Posttest 3 Months|depression|0
2183372|NCT01432327|3811671|FG000|Posttest 3 Months|Lost to Follow-up|1
2183373|NCT01432327|3811672|FG001|Posttest 3 Months|Lost to Follow-up|0
2183374|NCT01432327|3811673|FG002|Posttest 3 Months|Lost to Follow-up|2
2183375|NCT01432327|3811674|FG003|Posttest 3 Months|Lost to Follow-up|1
2183376|NCT01432327|3811671|FG000|Posttest 3 Months|Allergic reaction|0
2183377|NCT01432327|3811672|FG001|Posttest 3 Months|Allergic reaction|2
2183378|NCT01432327|3811673|FG002|Posttest 3 Months|Allergic reaction|0
2183379|NCT01432327|3811674|FG003|Posttest 3 Months|Allergic reaction|0
2183380|NCT01432327|3811671|FG000|Posttest 6 Months|Lost to Follow-up|0
2183381|NCT01432327|3811672|FG001|Posttest 6 Months|Lost to Follow-up|0
2183382|NCT01432327|3811673|FG002|Posttest 6 Months|Lost to Follow-up|3
2183383|NCT01432327|3811674|FG003|Posttest 6 Months|Lost to Follow-up|2
2183384|NCT01432327|3811671|FG000|Posttest 6 Months|Allergic reaction|0
2183385|NCT01432327|3811672|FG001|Posttest 6 Months|Allergic reaction|0
2183386|NCT01432327|3811673|FG002|Posttest 6 Months|Allergic reaction|1
2183387|NCT01432327|3811674|FG003|Posttest 6 Months|Allergic reaction|0
2183388|NCT01432327|3811671|FG000|Posttest 6 Months|Withdrawal by Subject|0
2183389|NCT01432327|3811672|FG001|Posttest 6 Months|Withdrawal by Subject|0
2183390|NCT01432327|3811673|FG002|Posttest 6 Months|Withdrawal by Subject|1
2183391|NCT01432327|3811674|FG003|Posttest 6 Months|Withdrawal by Subject|0
2183392|NCT01432327|3811671|FG000|Posttest 1 Year|Measurement have to take place in future|24
2183393|NCT01432327|3811672|FG001|Posttest 1 Year|Measurement have to take place in future|28
2183394|NCT01432327|3811673|FG002|Posttest 1 Year|Measurement have to take place in future|15
2183395|NCT01432327|3811674|FG003|Posttest 1 Year|Measurement have to take place in future|20
2183396|NCT01432327|3811671|FG000|Posttest 1 Year|Lost to Follow-up|0
2183397|NCT01432327|3811672|FG001|Posttest 1 Year|Lost to Follow-up|0
2183398|NCT01432327|3811673|FG002|Posttest 1 Year|Lost to Follow-up|4
2183399|NCT01432327|3811674|FG003|Posttest 1 Year|Lost to Follow-up|2
2183400|NCT01432327|3811671|FG000|Posttest 1 Year|Allergic reaction|0
2183401|NCT01432327|3811672|FG001|Posttest 1 Year|Allergic reaction|0
2183402|NCT01432327|3811673|FG002|Posttest 1 Year|Allergic reaction|1
2183403|NCT01432327|3811674|FG003|Posttest 1 Year|Allergic reaction|1
2183404|NCT01432366|3811684|FG000|Overall Study|Non-Responder|7
2183405|NCT01432366|3811684|FG000|Overall Study|Adverse Event|8
2183406|NCT01432366|3811684|FG000|Overall Study|Withdrawal Due to Non-Compliance|3
2183407|NCT01432366|3811684|FG000|Overall Study|Pregnancy|1
2183408|NCT01432366|3811684|FG000|Overall Study|Lost to Follow-up|13
2183409|NCT01432366|3811684|FG000|Overall Study|Lack of Efficacy|1
2183410|NCT01432366|3811684|FG000|Overall Study|Site Closed|20
2183411|NCT01432366|3811684|FG000|Overall Study|Investigator Forget to Complete Visits|1
2183412|NCT01432366|3811684|FG000|Overall Study|Other|14
2183413|NCT01432444|3811701|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10
2183414|NCT01432444|3811702|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0
2183415|NCT01432444|3811703|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0
2183416|NCT01432444|3811701|FG000|Tolerability/Cross-titration Phase|Adverse Event|16
2183417|NCT01432444|3811702|FG001|Tolerability/Cross-titration Phase|Adverse Event|0
2183418|NCT01432444|3811703|FG002|Tolerability/Cross-titration Phase|Adverse Event|0
2183419|NCT01432444|3811701|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
2183420|NCT01432444|3811702|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
2183421|NCT01432444|3811703|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
2183422|NCT01432444|3811701|FG000|Tolerability/Cross-titration Phase|Physician Decision|8
2183423|NCT01432444|3811702|FG001|Tolerability/Cross-titration Phase|Physician Decision|0
2183424|NCT01432444|3811703|FG002|Tolerability/Cross-titration Phase|Physician Decision|0
2183425|NCT01432444|3811701|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
2183426|NCT01432444|3811702|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
2183427|NCT01432444|3811703|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
2183428|NCT01432444|3811701|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1
2183429|NCT01432444|3811702|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0
2183430|NCT01432444|3811703|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0
2183431|NCT01432444|3811701|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5
2183432|NCT01432444|3811702|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0
2183433|NCT01432444|3811703|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0
2183434|NCT01432444|3811701|FG000|Treatment Phase|Lost to Follow-up|0
2183435|NCT01432444|3811702|FG001|Treatment Phase|Lost to Follow-up|33
2183436|NCT01432444|3811703|FG002|Treatment Phase|Lost to Follow-up|0
2183437|NCT01432444|3811701|FG000|Treatment Phase|Adverse Event|0
2183438|NCT01432444|3811702|FG001|Treatment Phase|Adverse Event|37
2183439|NCT01432444|3811703|FG002|Treatment Phase|Adverse Event|0
2183440|NCT01432444|3811701|FG000|Treatment Phase|Met Withdrawal Criteria|0
2183441|NCT01432444|3811702|FG001|Treatment Phase|Met Withdrawal Criteria|11
2183442|NCT01432444|3811703|FG002|Treatment Phase|Met Withdrawal Criteria|0
2183443|NCT01432444|3811701|FG000|Treatment Phase|Physician Decision|0
2183444|NCT01432444|3811702|FG001|Treatment Phase|Physician Decision|5
2183445|NCT01432444|3811703|FG002|Treatment Phase|Physician Decision|0
2183446|NCT01432444|3811701|FG000|Treatment Phase|Withdrawal by Subject|0
2183447|NCT01432444|3811702|FG001|Treatment Phase|Withdrawal by Subject|41
2183448|NCT01432444|3811703|FG002|Treatment Phase|Withdrawal by Subject|0
2183449|NCT01432444|3811701|FG000|Treatment Phase|Protocol Deviation|0
2183450|NCT01432444|3811702|FG001|Treatment Phase|Protocol Deviation|3
2183451|NCT01432444|3811703|FG002|Treatment Phase|Protocol Deviation|0
2183452|NCT01432444|3811701|FG000|Treatment Phase|Lack of Efficacy|0
2183453|NCT01432444|3811702|FG001|Treatment Phase|Lack of Efficacy|10
2183454|NCT01432444|3811703|FG002|Treatment Phase|Lack of Efficacy|0
2183455|NCT01432444|3811701|FG000|Extension Phase|Lost to Follow-up|0
2183456|NCT01432444|3811702|FG001|Extension Phase|Lost to Follow-up|0
2183457|NCT01432444|3811703|FG002|Extension Phase|Lost to Follow-up|17
2183458|NCT01432444|3811701|FG000|Extension Phase|Adverse Event|0
2183459|NCT01432444|3811702|FG001|Extension Phase|Adverse Event|0
2220260|NCT01728454|3864323|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
2220261|NCT01728454|3864321|FG000|Stage 1 and 2|Lost to Follow-up|1
2220262|NCT01728454|3864322|FG001|Stage 1 and 2|Lost to Follow-up|1
2220263|NCT01728454|3864323|FG002|Stage 1 and 2|Lost to Follow-up|0
2220264|NCT01728454|3864321|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
2220265|NCT01728454|3864322|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
2220266|NCT01728454|3864323|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
2220267|NCT01728454|3864321|FG000|Stage 3|Reason Missing|0
2220268|NCT01728454|3864322|FG001|Stage 3|Reason Missing|0
2220269|NCT01728454|3864323|FG002|Stage 3|Reason Missing|1
2220270|NCT01728454|3864321|FG000|Stage 3|Subject Required Other Treatment|0
2220271|NCT01728454|3864322|FG001|Stage 3|Subject Required Other Treatment|1
2220272|NCT01728454|3864323|FG002|Stage 3|Subject Required Other Treatment|0
2220273|NCT01728454|3864321|FG000|Stage 3|Pregnancy|1
2220274|NCT01728454|3864322|FG001|Stage 3|Pregnancy|0
2220275|NCT01728454|3864323|FG002|Stage 3|Pregnancy|0
2220276|NCT01728454|3864321|FG000|Stage 3|Withdrew Consent|1
2220277|NCT01728454|3864322|FG001|Stage 3|Withdrew Consent|0
2220278|NCT01728454|3864323|FG002|Stage 3|Withdrew Consent|1
2220279|NCT01728454|3864321|FG000|Stage 3|Non-compliance with Protocol|0
2220280|NCT01728454|3864322|FG001|Stage 3|Non-compliance with Protocol|0
2220281|NCT01728454|3864323|FG002|Stage 3|Non-compliance with Protocol|1
2220282|NCT01728454|3864321|FG000|Stage 3|Lost to Follow-up|0
2220283|NCT01728454|3864322|FG001|Stage 3|Lost to Follow-up|3
2220284|NCT01728454|3864323|FG002|Stage 3|Lost to Follow-up|1
2220285|NCT01728454|3864321|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1
2220286|NCT01728454|3864322|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0
2220287|NCT01728454|3864323|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0
2220288|NCT01728584|3864338|FG000|Overall Study|Adverse Event|1
2220289|NCT01728584|3864339|FG001|Overall Study|Adverse Event|0
2220290|NCT01728584|3864340|FG002|Overall Study|Adverse Event|0
2220291|NCT01728584|3864341|FG003|Overall Study|Adverse Event|0
2220292|NCT01728584|3864338|FG000|Overall Study|Physician Decision|4
2220293|NCT01728584|3864339|FG001|Overall Study|Physician Decision|0
2220294|NCT01728584|3864340|FG002|Overall Study|Physician Decision|1
2220295|NCT01728584|3864341|FG003|Overall Study|Physician Decision|0
2220296|NCT01728584|3864338|FG000|Overall Study|Withdrawal by Subject|1
2220297|NCT01728584|3864339|FG001|Overall Study|Withdrawal by Subject|0
2220298|NCT01728584|3864340|FG002|Overall Study|Withdrawal by Subject|0
2220299|NCT01728584|3864341|FG003|Overall Study|Withdrawal by Subject|0
2220300|NCT01728584|3864338|FG000|Overall Study|Screen failure|1
2220301|NCT01728584|3864339|FG001|Overall Study|Screen failure|0
2220302|NCT01728584|3864340|FG002|Overall Study|Screen failure|0
2220303|NCT01728584|3864341|FG003|Overall Study|Screen failure|0
2220304|NCT01728584|3864338|FG000|Overall Study|Other reason (not specified)|1
2220305|NCT01728584|3864339|FG001|Overall Study|Other reason (not specified)|0
2220306|NCT01728584|3864340|FG002|Overall Study|Other reason (not specified)|0
2220307|NCT01728584|3864341|FG003|Overall Study|Other reason (not specified)|1
2220308|NCT01728623|3864358|FG000|Overall Study|Disease progression|26
2220309|NCT01728623|3864358|FG000|Overall Study|Adverse Event|1
2220310|NCT01728623|3864358|FG000|Overall Study|Withdrawal by Subject|1
2220311|NCT01728779|3864374|FG000|Overall Study|Withdrawal by Subject|1
2220312|NCT01728792|3864383|FG000|Overall Study|Withdrawal of Consent|1
2220313|NCT01728792|3864384|FG001|Overall Study|Withdrawal of Consent|1
2220314|NCT01728792|3864385|FG002|Overall Study|Withdrawal of Consent|0
2220315|NCT01728792|3864386|FG003|Overall Study|Withdrawal of Consent|1
2220316|NCT01728792|3864387|FG004|Overall Study|Withdrawal of Consent|0
2220317|NCT01728792|3864383|FG000|Overall Study|Lost to Follow-up|2
2220318|NCT01728792|3864384|FG001|Overall Study|Lost to Follow-up|1
2220319|NCT01728792|3864385|FG002|Overall Study|Lost to Follow-up|4
2220320|NCT01728792|3864386|FG003|Overall Study|Lost to Follow-up|2
2220321|NCT01728792|3864387|FG004|Overall Study|Lost to Follow-up|0
2220322|NCT01729026|3864429|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2
2220323|NCT01729026|3864430|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2
2220324|NCT01729026|3864429|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
2220325|NCT01729026|3864430|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
2220326|NCT01729039|3864441|FG000|Overall Study|disqualified|2
2220327|NCT01729039|3864442|FG001|Overall Study|disqualified|5
2220328|NCT01729039|3864441|FG000|Overall Study|Withdrawal by Subject|8
2220329|NCT01729039|3864442|FG001|Overall Study|Withdrawal by Subject|7
2183460|NCT01432444|3811703|FG002|Extension Phase|Adverse Event|10
2183461|NCT01432444|3811701|FG000|Extension Phase|Sponsor Discontinued Trial|0
2183462|NCT01432444|3811702|FG001|Extension Phase|Sponsor Discontinued Trial|0
2183463|NCT01432444|3811703|FG002|Extension Phase|Sponsor Discontinued Trial|7
2183464|NCT01432444|3811701|FG000|Extension Phase|Met Withdrawal Criteria|0
2183465|NCT01432444|3811702|FG001|Extension Phase|Met Withdrawal Criteria|0
2183466|NCT01432444|3811703|FG002|Extension Phase|Met Withdrawal Criteria|144
2183467|NCT01432444|3811701|FG000|Extension Phase|Physician Decision|0
2183468|NCT01432444|3811702|FG001|Extension Phase|Physician Decision|0
2183469|NCT01432444|3811703|FG002|Extension Phase|Physician Decision|1
2183470|NCT01432444|3811701|FG000|Extension Phase|Withdrawal by Subject|0
2183471|NCT01432444|3811702|FG001|Extension Phase|Withdrawal by Subject|0
2183472|NCT01432444|3811703|FG002|Extension Phase|Withdrawal by Subject|13
2183473|NCT01432457|3811711|FG000|Overall Study|Adverse Event|7
2183474|NCT01432457|3811712|FG001|Overall Study|Adverse Event|10
2183475|NCT01432457|3811713|FG002|Overall Study|Adverse Event|16
2183476|NCT01432457|3811711|FG000|Overall Study|Lack of Efficacy|2
2183477|NCT01432457|3811712|FG001|Overall Study|Lack of Efficacy|1
2183478|NCT01432457|3811713|FG002|Overall Study|Lack of Efficacy|1
2183479|NCT01432457|3811711|FG000|Overall Study|Lost to Follow-up|11
2183480|NCT01432457|3811712|FG001|Overall Study|Lost to Follow-up|15
2183481|NCT01432457|3811713|FG002|Overall Study|Lost to Follow-up|20
2183482|NCT01432457|3811711|FG000|Overall Study|Protocol Violation|3
2183483|NCT01432457|3811712|FG001|Overall Study|Protocol Violation|2
2183484|NCT01432457|3811713|FG002|Overall Study|Protocol Violation|6
2183485|NCT01432457|3811711|FG000|Overall Study|Withdrawal by Subject|6
2183486|NCT01432457|3811712|FG001|Overall Study|Withdrawal by Subject|11
2183487|NCT01432457|3811713|FG002|Overall Study|Withdrawal by Subject|9
2183488|NCT01432457|3811711|FG000|Overall Study|Reasons not defined|2
2183489|NCT01432457|3811712|FG001|Overall Study|Reasons not defined|3
2183490|NCT01432457|3811713|FG002|Overall Study|Reasons not defined|4
2183491|NCT01432457|3811711|FG000|Overall Study|Did not take study drug|6
2183492|NCT01432457|3811712|FG001|Overall Study|Did not take study drug|6
2183493|NCT01432457|3811713|FG002|Overall Study|Did not take study drug|3
2183494|NCT01432574|3811738|FG000|Overall Study|Moved|2
2183495|NCT01432574|3811738|FG000|Overall Study|Not interested|1
2183496|NCT01432600|3811747|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0
2183497|NCT01432600|3811748|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1
2183498|NCT01432600|3811749|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1
2183499|NCT01432626|3811759|FG000|Overall Study|LV function recovered|2
2183500|NCT01432626|3811759|FG000|Overall Study|Withdrawal by Subject|2
2183501|NCT01432626|3811759|FG000|Overall Study|Only 1 image competed|2
2183502|NCT01432626|3811759|FG000|Overall Study|Imaging agent not available|1
2183503|NCT01432730|3811763|FG000|Period 1|Adverse Event|2
2183504|NCT01432730|3811764|FG001|Period 1|Adverse Event|0
2183505|NCT01432730|3811763|FG000|Period 2|Adverse Event|0
2183506|NCT01432730|3811764|FG001|Period 2|Adverse Event|4
2183507|NCT01432756|3811774|FG000|Overall Study|Lost to Follow-up|1
2183508|NCT01432756|3811775|FG001|Overall Study|Lost to Follow-up|0
2183509|NCT01432756|3811776|FG002|Overall Study|Lost to Follow-up|2
2183510|NCT01432756|3811777|FG003|Overall Study|Lost to Follow-up|1
2183511|NCT01432938|3811795|FG000|First Intervention|Protocol Violation|1
2183512|NCT01432938|3811796|FG001|First Intervention|Protocol Violation|0
2183513|NCT01432938|3811795|FG000|First Intervention|Physician Decision|1
2183514|NCT01432938|3811796|FG001|First Intervention|Physician Decision|0
2183515|NCT01432938|3811795|FG000|Second Intervention|Adverse Event|1
2183516|NCT01432938|3811796|FG001|Second Intervention|Adverse Event|0
2183517|NCT01432951|3811803|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1
2183518|NCT01433055|3811818|FG000|Overall Study|Diagnosed with cancer unrelated to study|1
2183519|NCT01433055|3811819|FG001|Overall Study|Diagnosed with cancer unrelated to study|0
2183520|NCT01433055|3811818|FG000|Overall Study|Severely elevated triglycerides at entry|1
2183521|NCT01433055|3811819|FG001|Overall Study|Severely elevated triglycerides at entry|0
2220330|NCT01729156|3864454|FG000|Overall Study|Withdrawal by Subject|1
2220331|NCT01729156|3864455|FG001|Overall Study|Withdrawal by Subject|0
2220332|NCT01729156|3864456|FG002|Overall Study|Withdrawal by Subject|0
2220333|NCT01729208|3864467|FG000|Baseline|Physician Decision|5
2220334|NCT01729208|3864468|FG001|Baseline|Physician Decision|4
2220335|NCT01729208|3864467|FG000|12 Months Follow-up|Withdrawal by Subject|4
2220336|NCT01729208|3864468|FG001|12 Months Follow-up|Withdrawal by Subject|7
2220337|NCT01729208|3864467|FG000|12 Months Follow-up|Lost to Follow-up|3
2220338|NCT01729208|3864468|FG001|12 Months Follow-up|Lost to Follow-up|3
2220339|NCT01729208|3864467|FG000|24 Months Follow-up|Lost to Follow-up|3
2220340|NCT01729208|3864468|FG001|24 Months Follow-up|Lost to Follow-up|0
2220341|NCT01729208|3864467|FG000|36 Months Follow-up|Physician Decision|1
2220342|NCT01729208|3864468|FG001|36 Months Follow-up|Physician Decision|0
2220343|NCT01729208|3864467|FG000|36 Months Follow-up|Withdrawal by Subject|2
2220344|NCT01729208|3864468|FG001|36 Months Follow-up|Withdrawal by Subject|4
2220345|NCT01729559|3864504|FG000|Overall Study|Protocol Violation|31
2220346|NCT01729559|3864505|FG001|Overall Study|Protocol Violation|28
2220347|NCT01729728|3864523|FG000|Overall Study|Adverse Event|0
2220348|NCT01729728|3864524|FG001|Overall Study|Adverse Event|6
2220349|NCT01729728|3864525|FG002|Overall Study|Adverse Event|0
2220350|NCT01729728|3864523|FG000|Overall Study|Protocol Violation|1
2183522|NCT01433159|3811846|FG000|Overall Study|Adverse Event|1
2183523|NCT01433159|3811847|FG001|Overall Study|Adverse Event|0
2183524|NCT01433159|3811846|FG000|Overall Study|Physician Decision|1
2183525|NCT01433159|3811847|FG001|Overall Study|Physician Decision|0
2183526|NCT01433159|3811846|FG000|Overall Study|Protocol Violation|0
2183527|NCT01433159|3811847|FG001|Overall Study|Protocol Violation|1
2183528|NCT01433172|3811856|FG000|Overall Study|Withdrawal by Subject|0
2183529|NCT01433172|3811857|FG001|Overall Study|Withdrawal by Subject|1
2183530|NCT01433172|3811858|FG002|Overall Study|Withdrawal by Subject|0
2183531|NCT01433172|3811856|FG000|Overall Study|Disease Progression|0
2183532|NCT01433172|3811857|FG001|Overall Study|Disease Progression|0
2183533|NCT01433172|3811858|FG002|Overall Study|Disease Progression|1
2183534|NCT01433172|3811856|FG000|Overall Study|Death|0
2183535|NCT01433172|3811857|FG001|Overall Study|Death|2
2183536|NCT01433172|3811858|FG002|Overall Study|Death|0
2183537|NCT01433250|3811868|FG000|Overall Study|Protocol Violation|0
2183538|NCT01433250|3811869|FG001|Overall Study|Protocol Violation|1
2183539|NCT01433250|3811868|FG000|Overall Study|Withdrawal by Subject|3
2183540|NCT01433250|3811869|FG001|Overall Study|Withdrawal by Subject|2
2183541|NCT01433263|3811877|FG000|Overall Study|Adverse Event|3
2183542|NCT01433263|3811878|FG001|Overall Study|Adverse Event|1
2183543|NCT01433263|3811877|FG000|Overall Study|Death|5
2183544|NCT01433263|3811878|FG001|Overall Study|Death|3
2183545|NCT01433263|3811877|FG000|Overall Study|Lost to Follow-up|0
2183546|NCT01433263|3811878|FG001|Overall Study|Lost to Follow-up|1
2183547|NCT01433263|3811877|FG000|Overall Study|Protocol Deviation|1
2183548|NCT01433263|3811878|FG001|Overall Study|Protocol Deviation|0
2183549|NCT01433263|3811877|FG000|Overall Study|Withdrawal by Subject|10
2183550|NCT01433263|3811878|FG001|Overall Study|Withdrawal by Subject|7
2183551|NCT01433354|3811887|FG000|Overall Study|Adverse Event|6
2183552|NCT01433354|3811887|FG000|Overall Study|Lost to Follow-up|1
2183553|NCT01433354|3811887|FG000|Overall Study|Administrative problems|90
2183554|NCT01433354|3811887|FG000|Overall Study|Protocol Violation|2
2183555|NCT01433354|3811887|FG000|Overall Study|Lack of Efficacy|17
2183556|NCT01433354|3811887|FG000|Overall Study|Subject Withdrew Consent|3
2183557|NCT01433549|3811901|FG000|Phase 2: Second Study Product|Adverse Event|0
2183558|NCT01433549|3811902|FG001|Phase 2: Second Study Product|Adverse Event|1
2183559|NCT01433978|3811935|FG000|Core Study|Adverse Event, Non-Fatal|0
2183560|NCT01433978|3811936|FG001|Core Study|Adverse Event, Non-Fatal|1
2183561|NCT01433978|3811937|FG002|Core Study|Adverse Event, Non-Fatal|0
2183562|NCT01433978|3811935|FG000|Core Study|Lack of Efficacy|5
2183563|NCT01433978|3811936|FG001|Core Study|Lack of Efficacy|1
2183564|NCT01433978|3811937|FG002|Core Study|Lack of Efficacy|0
2183565|NCT01433978|3811935|FG000|Core Study|Study Terminated by Sponsor|6
2183566|NCT01433978|3811936|FG001|Core Study|Study Terminated by Sponsor|9
2183567|NCT01433978|3811937|FG002|Core Study|Study Terminated by Sponsor|0
2183568|NCT01433978|3811935|FG000|Extension Phase|Adverse Event, Non-Fatal|0
2183569|NCT01433978|3811936|FG001|Extension Phase|Adverse Event, Non-Fatal|0
2183570|NCT01433978|3811937|FG002|Extension Phase|Adverse Event, Non-Fatal|1
2183571|NCT01433978|3811935|FG000|Extension Phase|Lack of Efficacy|0
2183572|NCT01433978|3811936|FG001|Extension Phase|Lack of Efficacy|0
2183573|NCT01433978|3811937|FG002|Extension Phase|Lack of Efficacy|1
2183574|NCT01433978|3811935|FG000|Extension Phase|Study Terminated by Sponsor|0
2183575|NCT01433978|3811936|FG001|Extension Phase|Study Terminated by Sponsor|0
2183576|NCT01433978|3811937|FG002|Extension Phase|Study Terminated by Sponsor|4
2183577|NCT01433991|3811948|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2
2183578|NCT01433991|3811949|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
2183579|NCT01433991|3811950|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
2183580|NCT01433991|3811951|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
2183581|NCT01433991|3811948|FG000|Treatment Phase (Combination Agent)|Adverse Event|1
2183582|NCT01433991|3811949|FG001|Treatment Phase (Combination Agent)|Adverse Event|0
2183583|NCT01433991|3811950|FG002|Treatment Phase (Combination Agent)|Adverse Event|3
2183584|NCT01433991|3811951|FG003|Treatment Phase (Combination Agent)|Adverse Event|1
2183585|NCT01433991|3811948|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0
2183586|NCT01433991|3811949|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0
2183587|NCT01433991|3811950|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0
2183588|NCT01433991|3811951|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1
2183589|NCT01433991|3811948|FG000|Treatment Phase (Combination Agent)|Participant Choice|0
2183590|NCT01433991|3811949|FG001|Treatment Phase (Combination Agent)|Participant Choice|0
2183591|NCT01433991|3811950|FG002|Treatment Phase (Combination Agent)|Participant Choice|0
2183592|NCT01433991|3811951|FG003|Treatment Phase (Combination Agent)|Participant Choice|1
2183593|NCT01433991|3811948|FG000|Treatment Phase (Combination Agent)|Clinical progression|0
2183594|NCT01433991|3811949|FG001|Treatment Phase (Combination Agent)|Clinical progression|1
2183595|NCT01433991|3811950|FG002|Treatment Phase (Combination Agent)|Clinical progression|2
2220351|NCT01729728|3864524|FG001|Overall Study|Protocol Violation|0
2220352|NCT01729728|3864525|FG002|Overall Study|Protocol Violation|1
2220353|NCT01729819|3864658|FG000|Overall Study|Adverse Event|2
2183596|NCT01433991|3811951|FG003|Treatment Phase (Combination Agent)|Clinical progression|3
2183597|NCT01433991|3811948|FG000|Treatment Phase (Combination Agent)|Progressive disease|1
2220354|NCT01729819|3864659|FG001|Overall Study|Adverse Event|4
2183598|NCT01433991|3811949|FG001|Treatment Phase (Combination Agent)|Progressive disease|0
2183599|NCT01433991|3811950|FG002|Treatment Phase (Combination Agent)|Progressive disease|0
2183600|NCT01433991|3811951|FG003|Treatment Phase (Combination Agent)|Progressive disease|0
2183601|NCT01433991|3811948|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0
2183602|NCT01433991|3811949|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0
2183603|NCT01433991|3811950|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1
2183604|NCT01433991|3811951|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0
2183605|NCT01434290|3811999|FG000|Overall Study|Protocol Violation|6
2183606|NCT01434290|3812000|FG001|Overall Study|Protocol Violation|3
2183607|NCT01434290|3811999|FG000|Overall Study|No protocol treatment|2
2183608|NCT01434290|3812000|FG001|Overall Study|No protocol treatment|4
2183609|NCT01434654|3812026|FG000|Overall Study|Withdrawal by Subject|1
2183610|NCT01434654|3812027|FG001|Overall Study|Withdrawal by Subject|0
2183611|NCT01434654|3812026|FG000|Overall Study|Lost to Follow-up|1
2183612|NCT01434654|3812027|FG001|Overall Study|Lost to Follow-up|0
2183613|NCT01434667|3812037|FG000|Overall Study|Lost to Follow-up|5
2183614|NCT01434667|3812038|FG001|Overall Study|Lost to Follow-up|10
2183615|NCT01434680|3812048|FG000|Overall Study|Withdrawal by Subject|1
2183616|NCT01434680|3812049|FG001|Overall Study|Withdrawal by Subject|0
2183617|NCT01434680|3812050|FG002|Overall Study|Withdrawal by Subject|2
2183618|NCT01434680|3812051|FG003|Overall Study|Withdrawal by Subject|0
2183619|NCT01434680|3812048|FG000|Overall Study|Lost to Follow-up|1
2183620|NCT01434680|3812049|FG001|Overall Study|Lost to Follow-up|1
2183621|NCT01434680|3812050|FG002|Overall Study|Lost to Follow-up|0
2183622|NCT01434680|3812051|FG003|Overall Study|Lost to Follow-up|0
2183623|NCT01434680|3812048|FG000|Overall Study|Protocol Violation|1
2183624|NCT01434680|3812049|FG001|Overall Study|Protocol Violation|1
2183625|NCT01434680|3812050|FG002|Overall Study|Protocol Violation|0
2183626|NCT01434680|3812051|FG003|Overall Study|Protocol Violation|0
2183627|NCT01434693|3812065|FG000|Overall Study|Adverse Event|1
2183628|NCT01434693|3812066|FG001|Overall Study|Adverse Event|0
2183629|NCT01434693|3812067|FG002|Overall Study|Adverse Event|0
2183630|NCT01434693|3812068|FG003|Overall Study|Adverse Event|0
2183631|NCT01434693|3812065|FG000|Overall Study|Withdrawal by Subject|1
2183632|NCT01434693|3812066|FG001|Overall Study|Withdrawal by Subject|0
2183633|NCT01434693|3812067|FG002|Overall Study|Withdrawal by Subject|1
2183634|NCT01434693|3812068|FG003|Overall Study|Withdrawal by Subject|1
2183635|NCT01434693|3812065|FG000|Overall Study|Lost to Follow-up|1
2183636|NCT01434693|3812066|FG001|Overall Study|Lost to Follow-up|0
2183637|NCT01434693|3812067|FG002|Overall Study|Lost to Follow-up|0
2183638|NCT01434693|3812068|FG003|Overall Study|Lost to Follow-up|0
2183639|NCT01434810|3812080|FG000|Overall Study|Did not receive treatment|11
2183640|NCT01434810|3812081|FG001|Overall Study|Did not receive treatment|3
2183641|NCT01434810|3812080|FG000|Overall Study|Missing data/received <5hr phototherapy|12
2183642|NCT01434810|3812081|FG001|Overall Study|Missing data/received <5hr phototherapy|7
2183643|NCT01434823|3812089|FG000|Overall Study|Incomplete data in medical record|4
2183644|NCT01434823|3812090|FG001|Overall Study|Incomplete data in medical record|7
2183645|NCT01435018|3812100|FG000|Overall Study|Death|37
2183646|NCT01435018|3812101|FG001|Overall Study|Death|18
2183647|NCT01435018|3812102|FG002|Overall Study|Death|25
2183648|NCT01435018|3812100|FG000|Overall Study|Site is closing|4
2183649|NCT01435018|3812101|FG001|Overall Study|Site is closing|9
2220355|NCT01729819|3864658|FG000|Overall Study|Lack of Efficacy|1
2220356|NCT01729819|3864659|FG001|Overall Study|Lack of Efficacy|0
2220357|NCT01729819|3864658|FG000|Overall Study|Lost to Follow-up|2
2220358|NCT01729819|3864659|FG001|Overall Study|Lost to Follow-up|0
2220359|NCT01729819|3864658|FG000|Overall Study|Other reason|1
2220360|NCT01729819|3864659|FG001|Overall Study|Other reason|0
2220361|NCT01729819|3864658|FG000|Overall Study|Protocol Violation|0
2220362|NCT01729819|3864659|FG001|Overall Study|Protocol Violation|1
2220363|NCT01729819|3864658|FG000|Overall Study|Withdrawal by Subject|0
2220364|NCT01729819|3864659|FG001|Overall Study|Withdrawal by Subject|2
2220365|NCT01729871|3864685|FG000|Overall Study|Adverse Event|7
2220366|NCT01729871|3864686|FG001|Overall Study|Adverse Event|7
2220367|NCT01729871|3864685|FG000|Overall Study|Death|0
2220368|NCT01729871|3864686|FG001|Overall Study|Death|1
2220369|NCT01729871|3864685|FG000|Overall Study|Lack of Efficacy|0
2220370|NCT01729871|3864686|FG001|Overall Study|Lack of Efficacy|1
2220371|NCT01729871|3864685|FG000|Overall Study|Physician Decision|0
2220372|NCT01729871|3864686|FG001|Overall Study|Physician Decision|2
2220373|NCT01729871|3864685|FG000|Overall Study|Protocol Violation|1
2220374|NCT01729871|3864686|FG001|Overall Study|Protocol Violation|0
2220375|NCT01729871|3864685|FG000|Overall Study|Withdrawal by Subject|0
2220376|NCT01729871|3864686|FG001|Overall Study|Withdrawal by Subject|3
2220377|NCT01729871|3864685|FG000|Overall Study|Other|4
2220378|NCT01729871|3864686|FG001|Overall Study|Other|9
2220379|NCT01730040|3864703|FG000|Overall Study|Randomized but not treated|0
2220380|NCT01730040|3864704|FG001|Overall Study|Randomized but not treated|0
2220381|NCT01730040|3864705|FG002|Overall Study|Randomized but not treated|0
2220382|NCT01730040|3864706|FG003|Overall Study|Randomized but not treated|0
2220383|NCT01730040|3864707|FG004|Overall Study|Randomized but not treated|0
2220384|NCT01730040|3864708|FG005|Overall Study|Randomized but not treated|1
2220385|NCT01730040|3864709|FG006|Overall Study|Randomized but not treated|0
2220386|NCT01730040|3864703|FG000|Overall Study|Subject moved|0
2183650|NCT01435018|3812102|FG002|Overall Study|Site is closing|7
2183651|NCT01435018|3812100|FG000|Overall Study|Withdrew consent|0
2183652|NCT01435018|3812101|FG001|Overall Study|Withdrew consent|3
2183653|NCT01435018|3812102|FG002|Overall Study|Withdrew consent|1
2183654|NCT01435018|3812100|FG000|Overall Study|Not willing to adhere to requirements|0
2183655|NCT01435018|3812101|FG001|Overall Study|Not willing to adhere to requirements|2
2183656|NCT01435018|3812102|FG002|Overall Study|Not willing to adhere to requirements|3
2183657|NCT01435018|3812100|FG000|Overall Study|Not able to get to clinic|2
2183658|NCT01435018|3812101|FG001|Overall Study|Not able to get to clinic|0
2183659|NCT01435018|3812102|FG002|Overall Study|Not able to get to clinic|2
2183660|NCT01435018|3812100|FG000|Overall Study|Severe debilitation, unable to continue|0
2183661|NCT01435018|3812101|FG001|Overall Study|Severe debilitation, unable to continue|0
2183662|NCT01435018|3812102|FG002|Overall Study|Severe debilitation, unable to continue|1
2183663|NCT01435018|3812100|FG000|Overall Study|Unable to contact participant/parent|1
2183664|NCT01435018|3812101|FG001|Overall Study|Unable to contact participant/parent|1
2183665|NCT01435018|3812102|FG002|Overall Study|Unable to contact participant/parent|1
2183666|NCT01435018|3812100|FG000|Overall Study|Enrollment Violation|0
2183667|NCT01435018|3812101|FG001|Overall Study|Enrollment Violation|1
2183668|NCT01435018|3812102|FG002|Overall Study|Enrollment Violation|0
2183669|NCT01435018|3812100|FG000|Overall Study|Never started chemotherapy|3
2183670|NCT01435018|3812101|FG001|Overall Study|Never started chemotherapy|0
2183671|NCT01435018|3812102|FG002|Overall Study|Never started chemotherapy|1
2183672|NCT01435031|3812112|FG000|ITT at 1 Month|Withdrawal by Subject|1
2183673|NCT01435031|3812112|FG000|ITT at 1 Month|Death|1
2183674|NCT01435031|3812112|FG000|ITT at 1 Month|Lost to Follow-up|4
2183675|NCT01435031|3812112|FG000|ITT at 6 Months|Death|2
2183676|NCT01435031|3812112|FG000|ITT at 6 Months|Lost to Follow-up|3
2183677|NCT01435031|3812112|FG000|ITT at 1 Year|Death|1
2183678|NCT01435031|3812112|FG000|ITT at 1 Year|Withdrawal by Subject|2
2183679|NCT01435031|3812112|FG000|ITT at 1 Year|Lost to Follow-up|6
2183680|NCT01435031|3812112|FG000|ITT at 2 Years|Death|7
2183681|NCT01435031|3812112|FG000|ITT at 2 Years|Withdrawal by Subject|2
2183682|NCT01435031|3812112|FG000|ITT at 2 Years|Lost to Follow-up|4
2183683|NCT01435031|3812112|FG000|ITT at 3 Years|Death|5
2183684|NCT01435031|3812112|FG000|ITT at 3 Years|Withdrawal by Subject|2
2183685|NCT01435031|3812112|FG000|ITT at 3 Years|Lost to Follow-up|4
2220387|NCT01730040|3864704|FG001|Overall Study|Subject moved|0
2220388|NCT01730040|3864705|FG002|Overall Study|Subject moved|1
2220389|NCT01730040|3864706|FG003|Overall Study|Subject moved|0
2220390|NCT01730040|3864707|FG004|Overall Study|Subject moved|0
2220391|NCT01730040|3864708|FG005|Overall Study|Subject moved|0
2220392|NCT01730040|3864709|FG006|Overall Study|Subject moved|1
2220393|NCT01730040|3864703|FG000|Overall Study|Physician Decision|0
2220394|NCT01730040|3864704|FG001|Overall Study|Physician Decision|0
2220395|NCT01730040|3864705|FG002|Overall Study|Physician Decision|0
2220396|NCT01730040|3864706|FG003|Overall Study|Physician Decision|0
2220397|NCT01730040|3864707|FG004|Overall Study|Physician Decision|0
2220398|NCT01730040|3864708|FG005|Overall Study|Physician Decision|1
2220399|NCT01730040|3864709|FG006|Overall Study|Physician Decision|1
2220400|NCT01730040|3864703|FG000|Overall Study|Other than specified|7
2220401|NCT01730040|3864704|FG001|Overall Study|Other than specified|8
2220402|NCT01730040|3864705|FG002|Overall Study|Other than specified|5
2220403|NCT01730040|3864706|FG003|Overall Study|Other than specified|5
2220404|NCT01730040|3864707|FG004|Overall Study|Other than specified|5
2220405|NCT01730040|3864708|FG005|Overall Study|Other than specified|4
2220406|NCT01730040|3864709|FG006|Overall Study|Other than specified|4
2220407|NCT01730040|3864703|FG000|Overall Study|Adverse Event|4
2220408|NCT01730040|3864704|FG001|Overall Study|Adverse Event|3
2220409|NCT01730040|3864705|FG002|Overall Study|Adverse Event|5
2220410|NCT01730040|3864706|FG003|Overall Study|Adverse Event|3
2220411|NCT01730040|3864707|FG004|Overall Study|Adverse Event|1
2220412|NCT01730040|3864708|FG005|Overall Study|Adverse Event|1
2220413|NCT01730040|3864709|FG006|Overall Study|Adverse Event|2
2220414|NCT01730040|3864703|FG000|Overall Study|Poor compliance to protocol|2
2220415|NCT01730040|3864704|FG001|Overall Study|Poor compliance to protocol|4
2220416|NCT01730040|3864705|FG002|Overall Study|Poor compliance to protocol|0
2220417|NCT01730040|3864706|FG003|Overall Study|Poor compliance to protocol|0
2220418|NCT01730040|3864707|FG004|Overall Study|Poor compliance to protocol|0
2220419|NCT01730040|3864708|FG005|Overall Study|Poor compliance to protocol|0
2220420|NCT01730040|3864709|FG006|Overall Study|Poor compliance to protocol|1
2274017|NCT02291861|3954773|FG003|Overall Study|Adverse Event|2
2274018|NCT02291861|3954770|FG000|Overall Study|Death|0
2274019|NCT02291861|3954771|FG001|Overall Study|Death|0
2274020|NCT02291861|3954772|FG002|Overall Study|Death|1
2274021|NCT02291861|3954773|FG003|Overall Study|Death|1
2274022|NCT02291861|3954770|FG000|Overall Study|Protocol Violation|1
2274023|NCT02291861|3954771|FG001|Overall Study|Protocol Violation|0
2274024|NCT02291861|3954772|FG002|Overall Study|Protocol Violation|0
2274025|NCT02291861|3954773|FG003|Overall Study|Protocol Violation|1
2274026|NCT02291861|3954770|FG000|Overall Study|Withdrawal by Subject|1
2274027|NCT02291861|3954771|FG001|Overall Study|Withdrawal by Subject|2
2274028|NCT02291861|3954772|FG002|Overall Study|Withdrawal by Subject|1
2274029|NCT02291861|3954773|FG003|Overall Study|Withdrawal by Subject|4
2274030|NCT02291861|3954770|FG000|Overall Study|Noncompliance|1
2183686|NCT01435031|3812112|FG000|ITT at 4 Years|Death|4
2183687|NCT01435031|3812112|FG000|ITT at 4 Years|Withdrawal by Subject|2
2183688|NCT01435031|3812112|FG000|ITT at 4 Years|Lost to Follow-up|1
2183689|NCT01435122|3812116|FG000|Overall Study|Early withdrawal due to toxicity|8
2183690|NCT01435265|3812126|FG000|Overall Study|Lost to Follow-up|0
2183691|NCT01435265|3812127|FG001|Overall Study|Lost to Follow-up|1
2183692|NCT01435356|3812144|FG000|Overall Study|Adverse Event|2
2183693|NCT01435356|3812145|FG001|Overall Study|Adverse Event|0
2183694|NCT01435356|3812144|FG000|Overall Study|Disease progression/recurrence|17
2183695|NCT01435356|3812145|FG001|Overall Study|Disease progression/recurrence|10
2183696|NCT01435356|3812144|FG000|Overall Study|Protocol Violation|0
2183697|NCT01435356|3812145|FG001|Overall Study|Protocol Violation|1
2183698|NCT01435356|3812144|FG000|Overall Study|Study Discontinuation, amendment 4|5
2183699|NCT01435356|3812145|FG001|Overall Study|Study Discontinuation, amendment 4|11
2183700|NCT01435356|3812144|FG000|Overall Study|Withdrawal by Subject|1
2183701|NCT01435356|3812145|FG001|Overall Study|Withdrawal by Subject|1
2183702|NCT01435356|3812144|FG000|Overall Study|Facial palsy|1
2183703|NCT01435356|3812145|FG001|Overall Study|Facial palsy|0
2183704|NCT01435356|3812144|FG000|Overall Study|IC withdrawal due to study cancellation|1
2183705|NCT01435356|3812145|FG001|Overall Study|IC withdrawal due to study cancellation|0
2183706|NCT01435356|3812144|FG000|Overall Study|Physician Decision|1
2183707|NCT01435356|3812145|FG001|Overall Study|Physician Decision|0
2183708|NCT01435356|3812144|FG000|Overall Study|Patient decision|3
2183709|NCT01435356|3812145|FG001|Overall Study|Patient decision|0
2183710|NCT01435356|3812144|FG000|Overall Study|Patient moved to another city|1
2183711|NCT01435356|3812145|FG001|Overall Study|Patient moved to another city|1
2183712|NCT01435382|3812155|FG000|Overall Study|Lost to Follow-up|1
2183713|NCT01435382|3812156|FG001|Overall Study|Lost to Follow-up|0
2183714|NCT01435382|3812157|FG002|Overall Study|Lost to Follow-up|1
2183715|NCT01435382|3812158|FG003|Overall Study|Lost to Follow-up|0
2183716|NCT01435382|3812155|FG000|Overall Study|Withdrawal by Subject|0
2183717|NCT01435382|3812156|FG001|Overall Study|Withdrawal by Subject|2
2183718|NCT01435382|3812157|FG002|Overall Study|Withdrawal by Subject|0
2183719|NCT01435382|3812158|FG003|Overall Study|Withdrawal by Subject|1
2183720|NCT01435460|3812176|FG000|Overall Study|Adverse Event|2
2183721|NCT01435460|3812177|FG001|Overall Study|Adverse Event|1
2183722|NCT01435460|3812176|FG000|Overall Study|Lost to Follow-up|6
2183723|NCT01435460|3812177|FG001|Overall Study|Lost to Follow-up|1
2183724|NCT01435460|3812176|FG000|Overall Study|Withdrawal by Subject|1
2183725|NCT01435460|3812177|FG001|Overall Study|Withdrawal by Subject|3
2183726|NCT01435460|3812176|FG000|Overall Study|Protocol Violation|0
2183727|NCT01435460|3812177|FG001|Overall Study|Protocol Violation|1
2183728|NCT01435460|3812176|FG000|Overall Study|Did not meet eligibility criteria|2
2183729|NCT01435460|3812177|FG001|Overall Study|Did not meet eligibility criteria|0
2183730|NCT01435577|3812194|FG000|Overall Study|Adverse Event|10
2183731|NCT01435577|3812195|FG001|Overall Study|Adverse Event|0
2183732|NCT01435577|3812194|FG000|Overall Study|Lack of Efficacy|7
2183733|NCT01435577|3812195|FG001|Overall Study|Lack of Efficacy|51
2183734|NCT01435577|3812194|FG000|Overall Study|Alternative treatment started|0
2183735|NCT01435577|3812195|FG001|Overall Study|Alternative treatment started|1
2183736|NCT01435616|3812216|FG000|Overall Study|Adverse Event|39
2183737|NCT01435616|3812217|FG001|Overall Study|Adverse Event|21
2183738|NCT01435616|3812216|FG000|Overall Study|Death|7
2183739|NCT01435616|3812217|FG001|Overall Study|Death|2
2183740|NCT01435616|3812216|FG000|Overall Study|Lost to Follow-up|22
2183741|NCT01435616|3812217|FG001|Overall Study|Lost to Follow-up|13
2183742|NCT01435616|3812216|FG000|Overall Study|Protocol Violation|16
2183743|NCT01435616|3812217|FG001|Overall Study|Protocol Violation|13
2183744|NCT01435616|3812216|FG000|Overall Study|Withdrawal by Subject|66
2220421|NCT01730053|3864731|FG000|Overall Study|Participant moved|0
2220422|NCT01730053|3864732|FG001|Overall Study|Participant moved|0
2220423|NCT01730053|3864733|FG002|Overall Study|Participant moved|1
2220424|NCT01730053|3864734|FG003|Overall Study|Participant moved|0
2220425|NCT01730053|3864735|FG004|Overall Study|Participant moved|0
2220426|NCT01730053|3864736|FG005|Overall Study|Participant moved|0
2220427|NCT01730053|3864731|FG000|Overall Study|Physician Decision|0
2220428|NCT01730053|3864732|FG001|Overall Study|Physician Decision|0
2220429|NCT01730053|3864733|FG002|Overall Study|Physician Decision|0
2220430|NCT01730053|3864734|FG003|Overall Study|Physician Decision|1
2220431|NCT01730053|3864735|FG004|Overall Study|Physician Decision|0
2220432|NCT01730053|3864736|FG005|Overall Study|Physician Decision|0
2220433|NCT01730053|3864731|FG000|Overall Study|Adverse Event|2
2220434|NCT01730053|3864732|FG001|Overall Study|Adverse Event|6
2220435|NCT01730053|3864733|FG002|Overall Study|Adverse Event|3
2220436|NCT01730053|3864734|FG003|Overall Study|Adverse Event|3
2220437|NCT01730053|3864735|FG004|Overall Study|Adverse Event|2
2220438|NCT01730053|3864736|FG005|Overall Study|Adverse Event|2
2220439|NCT01730053|3864731|FG000|Overall Study|Poor compliance to protocol|1
2220440|NCT01730053|3864732|FG001|Overall Study|Poor compliance to protocol|2
2220441|NCT01730053|3864733|FG002|Overall Study|Poor compliance to protocol|2
2220442|NCT01730053|3864734|FG003|Overall Study|Poor compliance to protocol|0
2220443|NCT01730053|3864735|FG004|Overall Study|Poor compliance to protocol|0
2183745|NCT01435616|3812217|FG001|Overall Study|Withdrawal by Subject|24
2220444|NCT01730053|3864736|FG005|Overall Study|Poor compliance to protocol|2
2183746|NCT01435616|3812216|FG000|Overall Study|Physician Decision|20
2183747|NCT01435616|3812217|FG001|Overall Study|Physician Decision|7
2183748|NCT01435616|3812216|FG000|Overall Study|Sponsor Decision|1
2183749|NCT01435616|3812217|FG001|Overall Study|Sponsor Decision|0
2183750|NCT01435655|3812225|FG000|Overall Study|Death|2
2183751|NCT01435655|3812225|FG000|Overall Study|Other|1
2183752|NCT01435759|3812234|FG000|Antidepressant Lead-in Phase|Adverse Event|40
2183753|NCT01435759|3812235|FG001|Antidepressant Lead-in Phase|Adverse Event|0
2183754|NCT01435759|3812236|FG002|Antidepressant Lead-in Phase|Adverse Event|0
2183755|NCT01435759|3812237|FG003|Antidepressant Lead-in Phase|Adverse Event|0
2183756|NCT01435759|3812238|FG004|Antidepressant Lead-in Phase|Adverse Event|0
2183757|NCT01435759|3812239|FG005|Antidepressant Lead-in Phase|Adverse Event|0
2183758|NCT01435759|3812234|FG000|Antidepressant Lead-in Phase|Protocol Violation|16
2183759|NCT01435759|3812235|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
2183760|NCT01435759|3812236|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
2183761|NCT01435759|3812237|FG003|Antidepressant Lead-in Phase|Protocol Violation|0
2183762|NCT01435759|3812238|FG004|Antidepressant Lead-in Phase|Protocol Violation|0
2183763|NCT01435759|3812239|FG005|Antidepressant Lead-in Phase|Protocol Violation|0
2183764|NCT01435759|3812234|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74
2183765|NCT01435759|3812235|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2183766|NCT01435759|3812236|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2183767|NCT01435759|3812237|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2183768|NCT01435759|3812238|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2183769|NCT01435759|3812239|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2183770|NCT01435759|3812234|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83
2183771|NCT01435759|3812235|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
2183772|NCT01435759|3812236|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
2183773|NCT01435759|3812237|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0
2183774|NCT01435759|3812238|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0
2183775|NCT01435759|3812239|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0
2183776|NCT01435759|3812234|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
2183777|NCT01435759|3812235|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2183778|NCT01435759|3812236|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2183779|NCT01435759|3812237|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2183780|NCT01435759|3812238|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2183781|NCT01435759|3812239|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2183782|NCT01435759|3812234|FG000|Antidepressant Lead-in Phase|Other|119
2183783|NCT01435759|3812235|FG001|Antidepressant Lead-in Phase|Other|0
2183784|NCT01435759|3812236|FG002|Antidepressant Lead-in Phase|Other|0
2183785|NCT01435759|3812237|FG003|Antidepressant Lead-in Phase|Other|0
2183786|NCT01435759|3812238|FG004|Antidepressant Lead-in Phase|Other|0
2183787|NCT01435759|3812239|FG005|Antidepressant Lead-in Phase|Other|0
2183788|NCT01435759|3812234|FG000|Double-blind Phase|Adverse Event|7
2183789|NCT01435759|3812235|FG001|Double-blind Phase|Adverse Event|0
2183790|NCT01435759|3812236|FG002|Double-blind Phase|Adverse Event|1
2183791|NCT01435759|3812237|FG003|Double-blind Phase|Adverse Event|1
2183792|NCT01435759|3812238|FG004|Double-blind Phase|Adverse Event|1
2183793|NCT01435759|3812239|FG005|Double-blind Phase|Adverse Event|3
2183794|NCT01435759|3812234|FG000|Double-blind Phase|Protocol Violation|2
2183795|NCT01435759|3812235|FG001|Double-blind Phase|Protocol Violation|0
2183796|NCT01435759|3812236|FG002|Double-blind Phase|Protocol Violation|1
2183797|NCT01435759|3812237|FG003|Double-blind Phase|Protocol Violation|2
2183798|NCT01435759|3812238|FG004|Double-blind Phase|Protocol Violation|0
2183799|NCT01435759|3812239|FG005|Double-blind Phase|Protocol Violation|1
2183800|NCT01435759|3812234|FG000|Double-blind Phase|Withdrawal by Subject|17
2183801|NCT01435759|3812235|FG001|Double-blind Phase|Withdrawal by Subject|4
2220445|NCT01730053|3864731|FG000|Overall Study|Other than specified|2
2220446|NCT01730053|3864732|FG001|Overall Study|Other than specified|6
2220447|NCT01730053|3864733|FG002|Overall Study|Other than specified|5
2220448|NCT01730053|3864734|FG003|Overall Study|Other than specified|4
2220449|NCT01730053|3864735|FG004|Overall Study|Other than specified|7
2220450|NCT01730053|3864736|FG005|Overall Study|Other than specified|9
2220451|NCT01730339|3864753|FG000|Overall Study|Withdrawal by Subject|3
2220452|NCT01730339|3864754|FG001|Overall Study|Withdrawal by Subject|2
2220453|NCT01730339|3864753|FG000|Overall Study|Lost to Follow-up|1
2220454|NCT01730339|3864754|FG001|Overall Study|Lost to Follow-up|1
2220455|NCT01730339|3864753|FG000|Overall Study|Un-specified|1
2220456|NCT01730339|3864754|FG001|Overall Study|Un-specified|0
2220457|NCT01730378|3864772|FG000|Overall Study|Lost to Follow-up|1
2220458|NCT01730378|3864773|FG001|Overall Study|Lost to Follow-up|0
2220459|NCT01730534|3864782|FG000|Overall Study|Withdrawal by Subject|97
2220460|NCT01730534|3864783|FG001|Overall Study|Withdrawal by Subject|127
2220461|NCT01730534|3864782|FG000|Overall Study|Lost to Follow-up|12
2220462|NCT01730534|3864783|FG001|Overall Study|Lost to Follow-up|18
2220463|NCT01730586|3864789|FG000|Overall Study|Progressive Disease|2
2036595|NCT00412958|3606833|FG001|Overall Study|Transport issue|1
2220464|NCT01730586|3864789|FG000|Overall Study|Inadequate Trial|8
2220465|NCT01730586|3864789|FG000|Overall Study|Adverse Event|2
2220466|NCT01730586|3864789|FG000|Overall Study|Hospice|1
2183802|NCT01435759|3812236|FG002|Double-blind Phase|Withdrawal by Subject|3
2183803|NCT01435759|3812237|FG003|Double-blind Phase|Withdrawal by Subject|4
2183804|NCT01435759|3812238|FG004|Double-blind Phase|Withdrawal by Subject|2
2183805|NCT01435759|3812239|FG005|Double-blind Phase|Withdrawal by Subject|2
2183806|NCT01435759|3812234|FG000|Double-blind Phase|Lost to Follow-up|31
2183807|NCT01435759|3812235|FG001|Double-blind Phase|Lost to Follow-up|1
2183808|NCT01435759|3812236|FG002|Double-blind Phase|Lost to Follow-up|2
2183809|NCT01435759|3812237|FG003|Double-blind Phase|Lost to Follow-up|0
2183810|NCT01435759|3812238|FG004|Double-blind Phase|Lost to Follow-up|3
2183811|NCT01435759|3812239|FG005|Double-blind Phase|Lost to Follow-up|3
2183812|NCT01435759|3812234|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
2183813|NCT01435759|3812235|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2183814|NCT01435759|3812236|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2183815|NCT01435759|3812237|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2183816|NCT01435759|3812238|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
2183817|NCT01435759|3812239|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2183818|NCT01435759|3812234|FG000|Double-blind Phase|Other|8
2183819|NCT01435759|3812235|FG001|Double-blind Phase|Other|2
2183820|NCT01435759|3812236|FG002|Double-blind Phase|Other|0
2183821|NCT01435759|3812237|FG003|Double-blind Phase|Other|2
2183822|NCT01435759|3812238|FG004|Double-blind Phase|Other|0
2183823|NCT01435759|3812239|FG005|Double-blind Phase|Other|0
2183824|NCT01435772|3812254|FG000|Overall Study|Adverse Event|1
2183825|NCT01435772|3812255|FG001|Overall Study|Adverse Event|0
2183826|NCT01435772|3812256|FG002|Overall Study|Adverse Event|2
2183827|NCT01435772|3812254|FG000|Overall Study|Withdrawal by Subject|0
2183828|NCT01435772|3812255|FG001|Overall Study|Withdrawal by Subject|1
2183829|NCT01435772|3812256|FG002|Overall Study|Withdrawal by Subject|3
2183830|NCT01435772|3812254|FG000|Overall Study|Other - study termination|2
2183831|NCT01435772|3812255|FG001|Overall Study|Other - study termination|2
2183832|NCT01435772|3812256|FG002|Overall Study|Other - study termination|10
2183833|NCT01435798|3812265|FG000|Overall Study|Withdrawal by Subject|1
2183834|NCT01435928|3812284|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83
2183835|NCT01435928|3812285|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0
2183836|NCT01435928|3812286|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0
2183837|NCT01435928|3812284|FG000|Open Label Phase - up to 24 Weeks|Death|1
2183838|NCT01435928|3812285|FG001|Open Label Phase - up to 24 Weeks|Death|0
2183839|NCT01435928|3812286|FG002|Open Label Phase - up to 24 Weeks|Death|0
2183840|NCT01435928|3812284|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
2183841|NCT01435928|3812285|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
2183842|NCT01435928|3812286|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
2183843|NCT01435928|3812284|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
2183844|NCT01435928|3812285|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
2183845|NCT01435928|3812286|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
2183846|NCT01435928|3812284|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39
2183847|NCT01435928|3812285|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0
2183848|NCT01435928|3812286|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0
2183849|NCT01435928|3812284|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
2183850|NCT01435928|3812285|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
2183851|NCT01435928|3812286|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
2183852|NCT01435928|3812284|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
2183853|NCT01435928|3812285|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
2183854|NCT01435928|3812286|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
2183855|NCT01435928|3812284|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
2183856|NCT01435928|3812285|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
2183857|NCT01435928|3812286|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
2183858|NCT01435928|3812284|FG000|Open Label Phase - up to 24 Weeks|Administrative|14
2183859|NCT01435928|3812285|FG001|Open Label Phase - up to 24 Weeks|Administrative|0
2183860|NCT01435928|3812286|FG002|Open Label Phase - up to 24 Weeks|Administrative|0
2183861|NCT01435928|3812284|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0
2183862|NCT01435928|3812285|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3
2183863|NCT01435928|3812286|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1
2183864|NCT01435928|3812284|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
2183865|NCT01435928|3812285|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
2183866|NCT01435928|3812286|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
2183867|NCT01435928|3812284|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0
2183868|NCT01435928|3812285|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11
2183869|NCT01435928|3812286|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4
2183870|NCT01435928|3812284|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
2183871|NCT01435928|3812285|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
2220467|NCT01730729|3864795|FG000|Overall Study|Adverse Event|1
2220468|NCT01730729|3864795|FG000|Overall Study|Death|1
2220469|NCT01730729|3864795|FG000|Overall Study|Progressive Disease|12
2220470|NCT01730950|3864826|FG000|Overall Study|Protocol Violation|6
2220471|NCT01730950|3864827|FG001|Overall Study|Protocol Violation|6
2220472|NCT01731002|3864837|FG000|Overall Study|Adverse Event|0
2220473|NCT01731002|3864838|FG001|Overall Study|Adverse Event|2
2183872|NCT01435928|3812286|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
2183873|NCT01435928|3812284|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0
2183874|NCT01435928|3812285|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47
2183875|NCT01435928|3812286|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39
2183876|NCT01435928|3812284|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0
2183877|NCT01435928|3812285|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43
2183878|NCT01435928|3812286|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58
2183879|NCT01435928|3812284|FG000|Double Blind Phase - 28 Weeks|Administrative|0
2183880|NCT01435928|3812285|FG001|Double Blind Phase - 28 Weeks|Administrative|5
2183881|NCT01435928|3812286|FG002|Double Blind Phase - 28 Weeks|Administrative|2
2183882|NCT01436071|3812314|FG000|Overall Study|Adverse Event|1
2183883|NCT01436071|3812315|FG001|Overall Study|Adverse Event|0
2183884|NCT01436071|3812314|FG000|Overall Study|Lack of Efficacy|16
2183885|NCT01436071|3812315|FG001|Overall Study|Lack of Efficacy|7
2183886|NCT01436071|3812314|FG000|Overall Study|Protocol Violation|0
2183887|NCT01436071|3812315|FG001|Overall Study|Protocol Violation|1
2183888|NCT01436071|3812314|FG000|Overall Study|Lost to Follow-up|3
2183889|NCT01436071|3812315|FG001|Overall Study|Lost to Follow-up|1
2183890|NCT01436071|3812314|FG000|Overall Study|Physician Decision|1
2183891|NCT01436071|3812315|FG001|Overall Study|Physician Decision|0
2183892|NCT01436071|3812314|FG000|Overall Study|Withdrawal by Subject|2
2183893|NCT01436071|3812315|FG001|Overall Study|Withdrawal by Subject|2
2183894|NCT01436071|3812314|FG000|Overall Study|Did Not Receive Trial Medication|3
2183895|NCT01436071|3812315|FG001|Overall Study|Did Not Receive Trial Medication|3
2183896|NCT01436110|3812324|FG000|Overall Study|Lack of Efficacy|23
2183897|NCT01436110|3812325|FG001|Overall Study|Lack of Efficacy|14
2183898|NCT01436110|3812326|FG002|Overall Study|Lack of Efficacy|9
2183899|NCT01436110|3812324|FG000|Overall Study|Withdrawal by Subject|6
2183900|NCT01436110|3812325|FG001|Overall Study|Withdrawal by Subject|8
2183901|NCT01436110|3812326|FG002|Overall Study|Withdrawal by Subject|4
2183902|NCT01436110|3812324|FG000|Overall Study|Adverse Event|2
2183903|NCT01436110|3812325|FG001|Overall Study|Adverse Event|1
2183904|NCT01436110|3812326|FG002|Overall Study|Adverse Event|2
2183905|NCT01436110|3812324|FG000|Overall Study|Physician Decision|3
2183906|NCT01436110|3812325|FG001|Overall Study|Physician Decision|1
2183907|NCT01436110|3812326|FG002|Overall Study|Physician Decision|1
2183908|NCT01436110|3812324|FG000|Overall Study|Lost to Follow-up|1
2183909|NCT01436110|3812325|FG001|Overall Study|Lost to Follow-up|1
2183910|NCT01436110|3812326|FG002|Overall Study|Lost to Follow-up|3
2183911|NCT01436110|3812324|FG000|Overall Study|Protocol Violation|3
2183912|NCT01436110|3812325|FG001|Overall Study|Protocol Violation|1
2183913|NCT01436110|3812326|FG002|Overall Study|Protocol Violation|1
2183914|NCT01436110|3812324|FG000|Overall Study|Did Not Receive Trial Medication|1
2183915|NCT01436110|3812325|FG001|Overall Study|Did Not Receive Trial Medication|0
2183916|NCT01436110|3812326|FG002|Overall Study|Did Not Receive Trial Medication|3
2183917|NCT01436149|3812336|FG000|Antidepressant Lead-in Phase|Adverse Event|39
2183918|NCT01436149|3812337|FG001|Antidepressant Lead-in Phase|Adverse Event|0
2183919|NCT01436149|3812338|FG002|Antidepressant Lead-in Phase|Adverse Event|0
2183920|NCT01436149|3812336|FG000|Antidepressant Lead-in Phase|Protocol Violation|29
2183921|NCT01436149|3812337|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
2183922|NCT01436149|3812338|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
2183923|NCT01436149|3812336|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61
2183924|NCT01436149|3812337|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2183925|NCT01436149|3812338|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2183926|NCT01436149|3812336|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96
2183927|NCT01436149|3812337|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
2183928|NCT01436149|3812338|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
2183929|NCT01436149|3812336|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
2183930|NCT01436149|3812337|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
2183931|NCT01436149|3812338|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
2183932|NCT01436149|3812336|FG000|Antidepressant Lead-in Phase|Other|119
2183933|NCT01436149|3812337|FG001|Antidepressant Lead-in Phase|Other|0
2183934|NCT01436149|3812338|FG002|Antidepressant Lead-in Phase|Other|0
2183935|NCT01436149|3812336|FG000|Randomized Phase|Adverse Event|9
2183936|NCT01436149|3812337|FG001|Randomized Phase|Adverse Event|10
2183937|NCT01436149|3812338|FG002|Randomized Phase|Adverse Event|11
2183938|NCT01436149|3812336|FG000|Randomized Phase|Protocol Violation|4
2183939|NCT01436149|3812337|FG001|Randomized Phase|Protocol Violation|5
2183940|NCT01436149|3812338|FG002|Randomized Phase|Protocol Violation|0
2183941|NCT01436149|3812336|FG000|Randomized Phase|Withdrawal by Subject|16
2183942|NCT01436149|3812337|FG001|Randomized Phase|Withdrawal by Subject|10
2183943|NCT01436149|3812338|FG002|Randomized Phase|Withdrawal by Subject|10
2183944|NCT01436149|3812336|FG000|Randomized Phase|Lost to Follow-up|34
2183945|NCT01436149|3812337|FG001|Randomized Phase|Lost to Follow-up|5
2183946|NCT01436149|3812338|FG002|Randomized Phase|Lost to Follow-up|6
2183947|NCT01436149|3812336|FG000|Randomized Phase|Lack of Efficacy|0
2183948|NCT01436149|3812337|FG001|Randomized Phase|Lack of Efficacy|0
2183949|NCT01436149|3812338|FG002|Randomized Phase|Lack of Efficacy|1
2183950|NCT01436149|3812336|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
2183951|NCT01436149|3812337|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
2183952|NCT01436149|3812338|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
2183953|NCT01436149|3812336|FG000|Randomized Phase|Other|12
2183954|NCT01436149|3812337|FG001|Randomized Phase|Other|5
2183955|NCT01436149|3812338|FG002|Randomized Phase|Other|11
2183956|NCT01436162|3812346|FG000|Single-blind Lead-in Phase|Adverse Event|26
2183957|NCT01436162|3812347|FG001|Single-blind Lead-in Phase|Adverse Event|0
2183958|NCT01436162|3812348|FG002|Single-blind Lead-in Phase|Adverse Event|0
2183959|NCT01436162|3812346|FG000|Single-blind Lead-in Phase|Protocol Violation|24
2183960|NCT01436162|3812347|FG001|Single-blind Lead-in Phase|Protocol Violation|0
2183961|NCT01436162|3812348|FG002|Single-blind Lead-in Phase|Protocol Violation|0
2183962|NCT01436162|3812346|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69
2220474|NCT01731002|3864839|FG002|Overall Study|Adverse Event|2
2220475|NCT01731002|3864837|FG000|Overall Study|Non-Compliant|0
2220476|NCT01731002|3864838|FG001|Overall Study|Non-Compliant|1
2220477|NCT01731002|3864839|FG002|Overall Study|Non-Compliant|0
2220478|NCT01731002|3864837|FG000|Overall Study|Lost to Follow-up|1
2220479|NCT01731002|3864838|FG001|Overall Study|Lost to Follow-up|0
2220480|NCT01731002|3864839|FG002|Overall Study|Lost to Follow-up|0
2220481|NCT01731002|3864837|FG000|Overall Study|Test Agent Discontinuation|0
2220482|NCT01731002|3864838|FG001|Overall Study|Test Agent Discontinuation|1
2220483|NCT01731002|3864839|FG002|Overall Study|Test Agent Discontinuation|0
2220484|NCT01731002|3864837|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
2220485|NCT01731002|3864838|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
2220486|NCT01731002|3864839|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
2220487|NCT01731002|3864837|FG000|Overall Study|Elevated IOP|1
2220488|NCT01731002|3864838|FG001|Overall Study|Elevated IOP|0
2220489|NCT01731002|3864839|FG002|Overall Study|Elevated IOP|0
2220490|NCT01731002|3864837|FG000|Overall Study|Inappropriate use of study medications|0
2220491|NCT01731002|3864838|FG001|Overall Study|Inappropriate use of study medications|0
2220492|NCT01731002|3864839|FG002|Overall Study|Inappropriate use of study medications|1
2220493|NCT01731171|3864862|FG000|Overall Study|Withdrawal by Subject|4
2220494|NCT01731171|3864863|FG001|Overall Study|Withdrawal by Subject|1
2220495|NCT01731171|3864862|FG000|Overall Study|Lost to Follow-up|3
2220496|NCT01731171|3864863|FG001|Overall Study|Lost to Follow-up|2
2220497|NCT01731171|3864862|FG000|Overall Study|Moved out of Area|0
2220498|NCT01731171|3864863|FG001|Overall Study|Moved out of Area|2
2220499|NCT01731171|3864862|FG000|Overall Study|Terminated for Lack of Adherence|0
2220500|NCT01731171|3864863|FG001|Overall Study|Terminated for Lack of Adherence|1
2220501|NCT01731171|3864862|FG000|Overall Study|Terminated for Safety Reasons|0
2220502|NCT01731171|3864863|FG001|Overall Study|Terminated for Safety Reasons|1
2220503|NCT01731470|3864869|FG000|Overall Study|Withdrawal by Subject|1
2220504|NCT01731470|3864869|FG000|Overall Study|Did not meet study criteria|1
2220505|NCT01731600|3864875|FG000|Overall Study|Adverse Event|2
2220506|NCT01731600|3864876|FG001|Overall Study|Adverse Event|0
2220507|NCT01731600|3864875|FG000|Overall Study|Withdrawal criteria|1
2220508|NCT01731600|3864876|FG001|Overall Study|Withdrawal criteria|0
2220509|NCT01731600|3864875|FG000|Overall Study|Other reasons|3
2220510|NCT01731600|3864876|FG001|Overall Study|Other reasons|0
2220511|NCT01731678|3864886|FG000|Overall Study|Withdrawal by Subject|3
2220512|NCT01731678|3864886|FG000|Overall Study|Did not meet inclusion criteria|1
2220513|NCT01731678|3864886|FG000|Overall Study|RMT too high, making TMS difficult|3
2220514|NCT01731886|3864908|FG000|Overall Study|Death|1
2220515|NCT01731886|3864909|FG001|Overall Study|Death|0
2220516|NCT01731886|3864908|FG000|Overall Study|Never started treatment|0
2220517|NCT01731886|3864909|FG001|Overall Study|Never started treatment|1
2220518|NCT01731886|3864908|FG000|Overall Study|Non-compliant|1
2220519|NCT01731886|3864909|FG001|Overall Study|Non-compliant|0
2220520|NCT01731912|3864916|FG000|Overall Study|noncompliance|2
2220521|NCT01731938|3864924|FG000|Preliminary Part I|Withdrawal by Subject|2
2220522|NCT01731938|3864925|FG001|Preliminary Part I|Withdrawal by Subject|2
2220523|NCT01731938|3864924|FG000|Preliminary Part I|Physician Decision|1
2220524|NCT01731938|3864925|FG001|Preliminary Part I|Physician Decision|0
2220525|NCT01731938|3864924|FG000|Preliminary Part I|Lost to Follow-up|0
2220526|NCT01731938|3864925|FG001|Preliminary Part I|Lost to Follow-up|3
2220527|NCT01731938|3864924|FG000|Preliminary Part I|Missed Week 6 visit|0
2220528|NCT01731938|3864925|FG001|Preliminary Part I|Missed Week 6 visit|3
2220529|NCT01731938|3864924|FG000|Primary Part II|Withdrawal by Subject|5
2220530|NCT01731938|3864925|FG001|Primary Part II|Withdrawal by Subject|4
2220531|NCT01731938|3864924|FG000|Primary Part II|Lost to Follow-up|4
2220532|NCT01731938|3864925|FG001|Primary Part II|Lost to Follow-up|5
2220533|NCT01731938|3864924|FG000|Primary Part II|Death|2
2220534|NCT01731938|3864925|FG001|Primary Part II|Death|1
2220535|NCT01731938|3864924|FG000|Primary Part II|Missed Week 6 visit|2
2220536|NCT01731938|3864925|FG001|Primary Part II|Missed Week 6 visit|3
2220537|NCT01731951|3864938|FG000|Overall Study|Documented Disease Progression|1
2220538|NCT01731951|3864939|FG001|Overall Study|Documented Disease Progression|0
2220539|NCT01731951|3864940|FG002|Overall Study|Documented Disease Progression|0
2220540|NCT01731951|3864941|FG003|Overall Study|Documented Disease Progression|0
2220541|NCT01731951|3864942|FG004|Overall Study|Documented Disease Progression|0
2220542|NCT01731951|3864943|FG005|Overall Study|Documented Disease Progression|0
2183963|NCT01436162|3812347|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0
2183964|NCT01436162|3812348|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0
2183965|NCT01436162|3812346|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43
2183966|NCT01436162|3812347|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0
2183967|NCT01436162|3812348|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0
2183968|NCT01436162|3812346|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
2183969|NCT01436162|3812347|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2183970|NCT01436162|3812348|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2183971|NCT01436162|3812346|FG000|Single-blind Lead-in Phase|Other|107
2183972|NCT01436162|3812347|FG001|Single-blind Lead-in Phase|Other|0
2183973|NCT01436162|3812348|FG002|Single-blind Lead-in Phase|Other|0
2183974|NCT01436162|3812346|FG000|Randomized Phase|Adverse Event|1
2183975|NCT01436162|3812347|FG001|Randomized Phase|Adverse Event|5
2183976|NCT01436162|3812348|FG002|Randomized Phase|Adverse Event|6
2183977|NCT01436162|3812346|FG000|Randomized Phase|Protocol Violation|4
2183978|NCT01436162|3812347|FG001|Randomized Phase|Protocol Violation|4
2183979|NCT01436162|3812348|FG002|Randomized Phase|Protocol Violation|2
2183980|NCT01436162|3812346|FG000|Randomized Phase|Withdrawal by Subject|16
2183981|NCT01436162|3812347|FG001|Randomized Phase|Withdrawal by Subject|9
2183982|NCT01436162|3812348|FG002|Randomized Phase|Withdrawal by Subject|8
2183983|NCT01436162|3812346|FG000|Randomized Phase|Lost to Follow-up|17
2183984|NCT01436162|3812347|FG001|Randomized Phase|Lost to Follow-up|5
2183985|NCT01436162|3812348|FG002|Randomized Phase|Lost to Follow-up|4
2183986|NCT01436162|3812346|FG000|Randomized Phase|Lack of Efficacy|0
2183987|NCT01436162|3812347|FG001|Randomized Phase|Lack of Efficacy|1
2183988|NCT01436162|3812348|FG002|Randomized Phase|Lack of Efficacy|1
2183989|NCT01436162|3812346|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
2183990|NCT01436162|3812347|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
2183991|NCT01436162|3812348|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
2183992|NCT01436162|3812346|FG000|Randomized Phase|Other|2
2183993|NCT01436162|3812347|FG001|Randomized Phase|Other|5
2183994|NCT01436162|3812348|FG002|Randomized Phase|Other|4
2183995|NCT01436175|3812356|FG000|Overall Study|Adverse Event|111
2183996|NCT01436175|3812356|FG000|Overall Study|Protocol Violation|49
2183997|NCT01436175|3812356|FG000|Overall Study|Withdrawal by Subject|108
2183998|NCT01436175|3812356|FG000|Overall Study|Lost to Follow-up|89
2183999|NCT01436175|3812356|FG000|Overall Study|Lack of Efficacy|24
2220543|NCT01731951|3864938|FG000|Overall Study|Lost to Follow-up|2
2220544|NCT01731951|3864939|FG001|Overall Study|Lost to Follow-up|0
2220545|NCT01731951|3864940|FG002|Overall Study|Lost to Follow-up|0
2220546|NCT01731951|3864941|FG003|Overall Study|Lost to Follow-up|1
2220547|NCT01731951|3864942|FG004|Overall Study|Lost to Follow-up|3
2220548|NCT01731951|3864943|FG005|Overall Study|Lost to Follow-up|1
2220549|NCT01731951|3864938|FG000|Overall Study|Withdrawal of Consent|1
2220550|NCT01731951|3864939|FG001|Overall Study|Withdrawal of Consent|0
2220551|NCT01731951|3864940|FG002|Overall Study|Withdrawal of Consent|0
2220552|NCT01731951|3864941|FG003|Overall Study|Withdrawal of Consent|0
2220553|NCT01731951|3864942|FG004|Overall Study|Withdrawal of Consent|0
2220554|NCT01731951|3864943|FG005|Overall Study|Withdrawal of Consent|2
2220555|NCT01731951|3864938|FG000|Overall Study|Death|13
2220556|NCT01731951|3864939|FG001|Overall Study|Death|15
2331956|NCT03180801|4054942|FG001|Overall Study|Withdrawal by Subject|2
2331957|NCT03180801|4054943|FG002|Overall Study|Withdrawal by Subject|1
2331958|NCT03180801|4054941|FG000|Overall Study|Lost to Follow-up|0
2331959|NCT03180801|4054942|FG001|Overall Study|Lost to Follow-up|2
2331960|NCT03180801|4054943|FG002|Overall Study|Lost to Follow-up|3
2352704|NCT03750955|4102569|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
2352705|NCT03750955|4102568|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
2352706|NCT03750955|4102569|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
2352707|NCT03750695|4102577|FG000|Overall Study|Lost to Follow-up|0
2352708|NCT03750695|4102578|FG001|Overall Study|Lost to Follow-up|1
2352709|NCT03748706|4102686|FG000|Overall Study|Lost to Follow-up|1
2352710|NCT03746405|4102714|FG000|Overall Study|Withdrawal by Subject|3
2352711|NCT03746405|4102715|FG001|Overall Study|Withdrawal by Subject|0
2352712|NCT03746405|4102714|FG000|Overall Study|technical difficulties|0
2352713|NCT03746405|4102715|FG001|Overall Study|technical difficulties|2
2352714|NCT03745937|4102725|FG000|Overall Study|Withdrawal by Subject|0
2352715|NCT03745937|4102726|FG001|Overall Study|Withdrawal by Subject|0
2352716|NCT03745937|4102727|FG002|Overall Study|Withdrawal by Subject|0
2184000|NCT01436175|3812356|FG000|Overall Study|Met blood pressure or pulse withdrawal|63
2184001|NCT01436175|3812356|FG000|Overall Study|Other|826
2184002|NCT01436201|3812361|FG000|Overall Study|Adverse Event|2
2184003|NCT01436201|3812361|FG000|Overall Study|Withdrawal by Subject|1
2184004|NCT01436201|3812361|FG000|Overall Study|Protocol Violation|1
2184005|NCT01436305|3812390|FG000|Overall Study|Death|1
2184006|NCT01436305|3812391|FG001|Overall Study|Death|0
2184007|NCT01436305|3812392|FG002|Overall Study|Death|0
2184008|NCT01436305|3812390|FG000|Overall Study|Lost to Follow-up|0
2184009|NCT01436305|3812391|FG001|Overall Study|Lost to Follow-up|1
2184010|NCT01436305|3812392|FG002|Overall Study|Lost to Follow-up|0
2184011|NCT01436305|3812390|FG000|Overall Study|Withdrawal by Subject|1
2184012|NCT01436305|3812391|FG001|Overall Study|Withdrawal by Subject|3
2184013|NCT01436305|3812392|FG002|Overall Study|Withdrawal by Subject|0
2184014|NCT01436357|3812402|FG000|Overall Study|Death|5
2184015|NCT01436357|3812403|FG001|Overall Study|Death|1
2184016|NCT01436357|3812402|FG000|Overall Study|Enrolled but not vaccinated|1
2184017|NCT01436357|3812403|FG001|Overall Study|Enrolled but not vaccinated|1
2184018|NCT01436357|3812402|FG000|Overall Study|Incarceration|18
2184019|NCT01436357|3812403|FG001|Overall Study|Incarceration|20
2184020|NCT01436357|3812402|FG000|Overall Study|Lost to Follow-up|67
2184021|NCT01436357|3812403|FG001|Overall Study|Lost to Follow-up|61
2184022|NCT01436357|3812402|FG000|Overall Study|Protocol Violation|1
2184023|NCT01436357|3812403|FG001|Overall Study|Protocol Violation|0
2184024|NCT01436357|3812402|FG000|Overall Study|Withdrawal by Subject|26
2184025|NCT01436357|3812403|FG001|Overall Study|Withdrawal by Subject|38
2184026|NCT01436357|3812402|FG000|Overall Study|Physician Decision|3
2184027|NCT01436357|3812403|FG001|Overall Study|Physician Decision|4
2184028|NCT01436357|3812402|FG000|Overall Study|Moved out of area|1
2184029|NCT01436357|3812403|FG001|Overall Study|Moved out of area|2
2184030|NCT01436357|3812402|FG000|Overall Study|Subject in rehab|0
2184031|NCT01436357|3812403|FG001|Overall Study|Subject in rehab|1
2184032|NCT01436370|3812417|FG000|Overall Study|Lost to Follow-up|0
2184033|NCT01436370|3812418|FG001|Overall Study|Lost to Follow-up|0
2184034|NCT01436370|3812419|FG002|Overall Study|Lost to Follow-up|0
2184035|NCT01436370|3812420|FG003|Overall Study|Lost to Follow-up|0
2184036|NCT01436370|3812421|FG004|Overall Study|Lost to Follow-up|1
2184037|NCT01436370|3812422|FG005|Overall Study|Lost to Follow-up|0
2184038|NCT01436370|3812423|FG006|Overall Study|Lost to Follow-up|0
2184039|NCT01436370|3812424|FG007|Overall Study|Lost to Follow-up|0
2184040|NCT01436396|3812452|FG000|Overall Study|Protocol Violation|7
2184041|NCT01436396|3812453|FG001|Overall Study|Protocol Violation|5
2184042|NCT01436396|3812452|FG000|Overall Study|Adverse Event|1
2184043|NCT01436396|3812453|FG001|Overall Study|Adverse Event|2
2184044|NCT01436396|3812452|FG000|Overall Study|Withdrawal by Subject|19
2184045|NCT01436396|3812453|FG001|Overall Study|Withdrawal by Subject|29
2184046|NCT01436396|3812452|FG000|Overall Study|Serious adverse event|2
2184047|NCT01436396|3812453|FG001|Overall Study|Serious adverse event|3
2184048|NCT01436396|3812452|FG000|Overall Study|Lost to Follow-up|3
2184049|NCT01436396|3812453|FG001|Overall Study|Lost to Follow-up|3
2184050|NCT01436500|3812465|FG000|Overall Study|Death|1
2184051|NCT01436500|3812466|FG001|Overall Study|Death|0
2184052|NCT01436500|3812467|FG002|Overall Study|Death|0
2184053|NCT01436500|3812468|FG003|Overall Study|Death|0
2184054|NCT01436500|3812469|FG004|Overall Study|Death|0
2184055|NCT01436500|3812465|FG000|Overall Study|Adverse Event|0
2184056|NCT01436500|3812466|FG001|Overall Study|Adverse Event|2
2184057|NCT01436500|3812467|FG002|Overall Study|Adverse Event|2
2184058|NCT01436500|3812468|FG003|Overall Study|Adverse Event|0
2184059|NCT01436500|3812469|FG004|Overall Study|Adverse Event|1
2184060|NCT01436500|3812465|FG000|Overall Study|Withdrawal by Subject|0
2184061|NCT01436500|3812466|FG001|Overall Study|Withdrawal by Subject|0
2184062|NCT01436500|3812467|FG002|Overall Study|Withdrawal by Subject|2
2184063|NCT01436500|3812468|FG003|Overall Study|Withdrawal by Subject|0
2184064|NCT01436500|3812469|FG004|Overall Study|Withdrawal by Subject|2
2184065|NCT01436500|3812465|FG000|Overall Study|Physician Decision|0
2184066|NCT01436500|3812466|FG001|Overall Study|Physician Decision|0
2184067|NCT01436500|3812467|FG002|Overall Study|Physician Decision|1
2184068|NCT01436500|3812468|FG003|Overall Study|Physician Decision|0
2184069|NCT01436500|3812469|FG004|Overall Study|Physician Decision|0
2184070|NCT01436500|3812465|FG000|Overall Study|liver transplant|1
2184071|NCT01436500|3812466|FG001|Overall Study|liver transplant|0
2184072|NCT01436500|3812467|FG002|Overall Study|liver transplant|0
2184073|NCT01436500|3812468|FG003|Overall Study|liver transplant|0
2184074|NCT01436500|3812469|FG004|Overall Study|liver transplant|0
2184075|NCT01436500|3812465|FG000|Overall Study|initiation of dialysis|0
2184076|NCT01436500|3812466|FG001|Overall Study|initiation of dialysis|0
2184077|NCT01436500|3812467|FG002|Overall Study|initiation of dialysis|0
2184078|NCT01436500|3812468|FG003|Overall Study|initiation of dialysis|0
2184079|NCT01436500|3812469|FG004|Overall Study|initiation of dialysis|1
2184080|NCT01436500|3812465|FG000|Overall Study|discontinued study drug|1
2184081|NCT01436500|3812466|FG001|Overall Study|discontinued study drug|0
2184082|NCT01436500|3812467|FG002|Overall Study|discontinued study drug|0
2184083|NCT01436500|3812468|FG003|Overall Study|discontinued study drug|0
2184084|NCT01436500|3812469|FG004|Overall Study|discontinued study drug|0
2184085|NCT01436500|3812465|FG000|Overall Study|Other|0
2184086|NCT01436500|3812466|FG001|Overall Study|Other|1
2184087|NCT01436500|3812467|FG002|Overall Study|Other|0
2184088|NCT01436500|3812468|FG003|Overall Study|Other|1
2184089|NCT01436500|3812469|FG004|Overall Study|Other|0
2184090|NCT01436643|3812494|FG000|2-week Pre-treatment|Abnormal test result|0
2184091|NCT01436643|3812495|FG001|2-week Pre-treatment|Abnormal test result|0
2184092|NCT01436643|3812496|FG002|2-week Pre-treatment|Abnormal test result|0
2220557|NCT01731951|3864940|FG002|Overall Study|Death|9
2220558|NCT01731951|3864941|FG003|Overall Study|Death|8
2220559|NCT01731951|3864942|FG004|Overall Study|Death|9
2220560|NCT01731951|3864943|FG005|Overall Study|Death|6
2220561|NCT01731990|3864963|FG000|Overall Study|Adverse Event|1
2220562|NCT01731990|3864964|FG001|Overall Study|Adverse Event|5
2220563|NCT01731990|3864963|FG000|Overall Study|Withdrawal by Subject|1
2220564|NCT01731990|3864964|FG001|Overall Study|Withdrawal by Subject|1
2220565|NCT01731990|3864963|FG000|Overall Study|Protocol deviation|1
2331961|NCT03181451|4054975|FG000|Overall Study|Adverse Event|0
2331962|NCT03181451|4054976|FG001|Overall Study|Adverse Event|1
2331963|NCT03181451|4054977|FG002|Overall Study|Adverse Event|0
2331964|NCT03181451|4054975|FG000|Overall Study|Withdrawal by Subject|0
2331965|NCT03181451|4054976|FG001|Overall Study|Withdrawal by Subject|1
2331966|NCT03181451|4054977|FG002|Overall Study|Withdrawal by Subject|0
2331967|NCT03181503|4054989|FG000|Overall Study|Adverse Event|2
2331968|NCT03181503|4054990|FG001|Overall Study|Adverse Event|2
2331969|NCT03181503|4054989|FG000|Overall Study|Protocol Violation|1
2331970|NCT03181503|4054990|FG001|Overall Study|Protocol Violation|0
2331971|NCT03181503|4054989|FG000|Overall Study|Withdrawal by Subject|3
2331972|NCT03181503|4054990|FG001|Overall Study|Withdrawal by Subject|0
2331973|NCT03181503|4054989|FG000|Overall Study|Lost to Follow-up|1
2331974|NCT03181503|4054990|FG001|Overall Study|Lost to Follow-up|1
2331975|NCT03181594|4054999|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4
2331976|NCT03181594|4054999|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3
2331977|NCT03181594|4054999|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1
2331978|NCT03181594|4054999|FG000|Initial Study Protocol (12-month FU)|Death|1
2331979|NCT03181594|4054999|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3
2331980|NCT03181594|4054999|FG000|Long-term Extension (15-24 Month FU)|Death|2
2331981|NCT03181932|4055014|FG000|Period 1 (Double-blind Period)|Adverse Event|5
2331982|NCT03181932|4055015|FG001|Period 1 (Double-blind Period)|Adverse Event|1
2331983|NCT03181932|4055014|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0
2331984|NCT03181932|4055015|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1
2331985|NCT03181932|4055014|FG000|Period 1 (Double-blind Period)|Protocol Violation|1
2331986|NCT03181932|4055015|FG001|Period 1 (Double-blind Period)|Protocol Violation|2
2331987|NCT03181932|4055014|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5
2331988|NCT03181932|4055015|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9
2331989|NCT03181932|4055014|FG000|Period 2 (Open-label Period)|Adverse Event|1
2331990|NCT03181932|4055015|FG001|Period 2 (Open-label Period)|Adverse Event|6
2331991|NCT03181932|4055014|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0
2331992|NCT03181932|4055015|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1
2331993|NCT03181932|4055014|FG000|Period 2 (Open-label Period)|Protocol Violation|3
2331994|NCT03181932|4055015|FG001|Period 2 (Open-label Period)|Protocol Violation|1
2331995|NCT03181932|4055014|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2
2331996|NCT03181932|4055015|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5
2331997|NCT03181932|4055014|FG000|Period 2 (Open-label Period)|Reason missing|2
2331998|NCT03181932|4055015|FG001|Period 2 (Open-label Period)|Reason missing|0
2331999|NCT03181958|4055025|FG000|Overall Study|Lost to Follow-up|17
2332000|NCT03181958|4055026|FG001|Overall Study|Lost to Follow-up|21
2332001|NCT03181958|4055027|FG002|Overall Study|Lost to Follow-up|15
2332002|NCT03182738|4055058|FG000|Overall Study|Lost to Follow-up|9
2332003|NCT03182738|4055059|FG001|Overall Study|Lost to Follow-up|3
2332004|NCT03182738|4055058|FG000|Overall Study|Pregnancy|0
2332005|NCT03182738|4055059|FG001|Overall Study|Pregnancy|1
2332006|NCT03182738|4055058|FG000|Overall Study|Withdrawal by Subject|0
2332007|NCT03182738|4055059|FG001|Overall Study|Withdrawal by Subject|1
2332008|NCT03182829|4055067|FG000|Overall Study|Protocol Violation|12
2332009|NCT03182829|4055068|FG001|Overall Study|Protocol Violation|12
2332010|NCT03182829|4055067|FG000|Overall Study|Other|4
2332011|NCT03182829|4055068|FG001|Overall Study|Other|3
2332012|NCT03182868|4055079|FG000|Overall Study|Protocol Violation|3
2332013|NCT03182868|4055080|FG001|Overall Study|Protocol Violation|0
2332014|NCT03182868|4055081|FG002|Overall Study|Protocol Violation|4
2332015|NCT03182868|4055082|FG003|Overall Study|Protocol Violation|1
2332016|NCT03182868|4055083|FG004|Overall Study|Protocol Violation|8
2332017|NCT03183063|4055117|FG000|Overall Study|Withdrawal by Subject|2
2332018|NCT03183063|4055118|FG001|Overall Study|Withdrawal by Subject|0
2332019|NCT03183063|4055119|FG002|Overall Study|Withdrawal by Subject|0
2332020|NCT03183063|4055117|FG000|Overall Study|Physician Decision|3
2332021|NCT03183063|4055118|FG001|Overall Study|Physician Decision|4
2332022|NCT03183063|4055119|FG002|Overall Study|Physician Decision|4
2184093|NCT01436643|3812497|FG003|2-week Pre-treatment|Abnormal test result|1
2184094|NCT01436643|3812494|FG000|2-week Pre-treatment|Adverse Event|0
2184095|NCT01436643|3812495|FG001|2-week Pre-treatment|Adverse Event|0
2220566|NCT01731990|3864964|FG001|Overall Study|Protocol deviation|2
2220567|NCT01731990|3864963|FG000|Overall Study|Death|1
2220568|NCT01731990|3864964|FG001|Overall Study|Death|0
2184096|NCT01436643|3812496|FG002|2-week Pre-treatment|Adverse Event|0
2184097|NCT01436643|3812497|FG003|2-week Pre-treatment|Adverse Event|5
2184098|NCT01436643|3812494|FG000|2-week Pre-treatment|Protocol Violation|0
2184099|NCT01436643|3812495|FG001|2-week Pre-treatment|Protocol Violation|0
2184100|NCT01436643|3812496|FG002|2-week Pre-treatment|Protocol Violation|0
2184101|NCT01436643|3812497|FG003|2-week Pre-treatment|Protocol Violation|4
2184102|NCT01436643|3812494|FG000|Core Phase (16 Weeks)|Adverse Event|0
2184103|NCT01436643|3812495|FG001|Core Phase (16 Weeks)|Adverse Event|3
2184104|NCT01436643|3812496|FG002|Core Phase (16 Weeks)|Adverse Event|1
2184105|NCT01436643|3812497|FG003|Core Phase (16 Weeks)|Adverse Event|0
2184106|NCT01436643|3812494|FG000|Core Phase (16 Weeks)|Abnormal Test result|0
2184107|NCT01436643|3812495|FG001|Core Phase (16 Weeks)|Abnormal Test result|0
2184108|NCT01436643|3812496|FG002|Core Phase (16 Weeks)|Abnormal Test result|1
2184109|NCT01436643|3812497|FG003|Core Phase (16 Weeks)|Abnormal Test result|0
2184110|NCT01436643|3812494|FG000|Core Phase (16 Weeks)|Protocol Violation|1
2184111|NCT01436643|3812495|FG001|Core Phase (16 Weeks)|Protocol Violation|1
2184112|NCT01436643|3812496|FG002|Core Phase (16 Weeks)|Protocol Violation|1
2184113|NCT01436643|3812497|FG003|Core Phase (16 Weeks)|Protocol Violation|0
2184114|NCT01437267|3812538|FG000|Overall Study|Withdrawal by Subject|0
2184115|NCT01437267|3812539|FG001|Overall Study|Withdrawal by Subject|0
2184116|NCT01437267|3812540|FG002|Overall Study|Withdrawal by Subject|0
2184117|NCT01437267|3812541|FG003|Overall Study|Withdrawal by Subject|1
2184118|NCT01437267|3812542|FG004|Overall Study|Withdrawal by Subject|0
2184119|NCT01437267|3812543|FG005|Overall Study|Withdrawal by Subject|0
2184120|NCT01437267|3812538|FG000|Overall Study|Protocol Violation|0
2184121|NCT01437267|3812539|FG001|Overall Study|Protocol Violation|1
2184122|NCT01437267|3812540|FG002|Overall Study|Protocol Violation|0
2184123|NCT01437267|3812541|FG003|Overall Study|Protocol Violation|0
2184124|NCT01437267|3812542|FG004|Overall Study|Protocol Violation|0
2184125|NCT01437267|3812543|FG005|Overall Study|Protocol Violation|0
2184126|NCT01437319|3812557|FG000|Phase I|Lost to Follow-up|2
2184127|NCT01437319|3812558|FG001|Phase I|Lost to Follow-up|0
2184128|NCT01437319|3812559|FG002|Phase I|Lost to Follow-up|0
2184129|NCT01437319|3812557|FG000|Phase I|Protocol Violation|1
2184130|NCT01437319|3812558|FG001|Phase I|Protocol Violation|0
2184131|NCT01437319|3812559|FG002|Phase I|Protocol Violation|0
2184132|NCT01437319|3812557|FG000|Phase I|Study related symptoms/complaints|27
2184133|NCT01437319|3812558|FG001|Phase I|Study related symptoms/complaints|0
2184134|NCT01437319|3812559|FG002|Phase I|Study related symptoms/complaints|0
2184135|NCT01437319|3812557|FG000|Phase I|Withdrawal by Subject|25
2184136|NCT01437319|3812558|FG001|Phase I|Withdrawal by Subject|0
2184137|NCT01437319|3812559|FG002|Phase I|Withdrawal by Subject|0
2184138|NCT01437319|3812557|FG000|Phase II|Withdrawal by Subject|0
2184139|NCT01437319|3812558|FG001|Phase II|Withdrawal by Subject|8
2184140|NCT01437319|3812559|FG002|Phase II|Withdrawal by Subject|16
2184141|NCT01437319|3812557|FG000|Phase II|Lost to Follow-up|0
2184142|NCT01437319|3812558|FG001|Phase II|Lost to Follow-up|7
2184143|NCT01437319|3812559|FG002|Phase II|Lost to Follow-up|2
2184144|NCT01437319|3812557|FG000|Phase II|Study related symptoms/complaints|0
2184145|NCT01437319|3812558|FG001|Phase II|Study related symptoms/complaints|28
2184146|NCT01437319|3812559|FG002|Phase II|Study related symptoms/complaints|19
2184147|NCT01437319|3812557|FG000|Phase II|Protocol Violation|0
2184148|NCT01437319|3812558|FG001|Phase II|Protocol Violation|1
2184149|NCT01437319|3812559|FG002|Phase II|Protocol Violation|0
2184150|NCT01437397|3812573|FG000|Overall Study|Lost to Follow-up|9
2184151|NCT01437397|3812574|FG001|Overall Study|Lost to Follow-up|4
2184152|NCT01437397|3812575|FG002|Overall Study|Lost to Follow-up|2
2184153|NCT01437397|3812576|FG003|Overall Study|Lost to Follow-up|4
2184154|NCT01437397|3812577|FG004|Overall Study|Lost to Follow-up|5
2184155|NCT01437397|3812573|FG000|Overall Study|Withdrawal by Subject|11
2184156|NCT01437397|3812574|FG001|Overall Study|Withdrawal by Subject|12
2184157|NCT01437397|3812575|FG002|Overall Study|Withdrawal by Subject|24
2184158|NCT01437397|3812576|FG003|Overall Study|Withdrawal by Subject|11
2184159|NCT01437397|3812577|FG004|Overall Study|Withdrawal by Subject|22
2184160|NCT01437397|3812573|FG000|Overall Study|Protocol Violation|10
2184161|NCT01437397|3812574|FG001|Overall Study|Protocol Violation|12
2184162|NCT01437397|3812575|FG002|Overall Study|Protocol Violation|13
2184163|NCT01437397|3812576|FG003|Overall Study|Protocol Violation|21
2184164|NCT01437397|3812577|FG004|Overall Study|Protocol Violation|19
2184165|NCT01437397|3812573|FG000|Overall Study|Lack of Efficacy|5
2184166|NCT01437397|3812574|FG001|Overall Study|Lack of Efficacy|4
2184167|NCT01437397|3812575|FG002|Overall Study|Lack of Efficacy|8
2184168|NCT01437397|3812576|FG003|Overall Study|Lack of Efficacy|10
2184169|NCT01437397|3812577|FG004|Overall Study|Lack of Efficacy|20
2184170|NCT01437397|3812573|FG000|Overall Study|Adverse Event|21
2184171|NCT01437397|3812574|FG001|Overall Study|Adverse Event|22
2184172|NCT01437397|3812575|FG002|Overall Study|Adverse Event|16
2184173|NCT01437397|3812576|FG003|Overall Study|Adverse Event|14
2184174|NCT01437397|3812577|FG004|Overall Study|Adverse Event|21
2184175|NCT01437397|3812573|FG000|Overall Study|Site termination/COPD exacerbation/other|10
2184176|NCT01437397|3812574|FG001|Overall Study|Site termination/COPD exacerbation/other|8
2184177|NCT01437397|3812575|FG002|Overall Study|Site termination/COPD exacerbation/other|9
2184178|NCT01437397|3812576|FG003|Overall Study|Site termination/COPD exacerbation/other|9
2220569|NCT01732107|3864970|FG000|Overall Study|Adverse Event|2
2184179|NCT01437397|3812577|FG004|Overall Study|Site termination/COPD exacerbation/other|14
2184180|NCT01437423|3812589|FG000|Overall Study|Lost to Follow-up|12
2184181|NCT01437423|3812589|FG000|Overall Study|Off label usage|3
2184182|NCT01437540|3812617|FG000|Overall Study|Not listed below|7
2184183|NCT01437540|3812618|FG001|Overall Study|Not listed below|6
2184184|NCT01437540|3812617|FG000|Overall Study|COPD exacerbation|13
2184185|NCT01437540|3812618|FG001|Overall Study|COPD exacerbation|3
2184186|NCT01437540|3812617|FG000|Overall Study|Lost to Follow-up|3
2184187|NCT01437540|3812618|FG001|Overall Study|Lost to Follow-up|5
2184188|NCT01437540|3812617|FG000|Overall Study|Lack of Efficacy|23
2184189|NCT01437540|3812618|FG001|Overall Study|Lack of Efficacy|11
2184190|NCT01437540|3812617|FG000|Overall Study|Protocol Violation|24
2184191|NCT01437540|3812618|FG001|Overall Study|Protocol Violation|12
2184192|NCT01437540|3812617|FG000|Overall Study|Adverse Event|26
2184193|NCT01437540|3812618|FG001|Overall Study|Adverse Event|13
2184194|NCT01437540|3812617|FG000|Overall Study|Withdrawal by Subject|31
2184195|NCT01437540|3812618|FG001|Overall Study|Withdrawal by Subject|15
2184196|NCT01437878|3812640|FG000|Overall Study|Withdrawal by Subject|1
2184197|NCT01437878|3812641|FG001|Overall Study|Withdrawal by Subject|0
2184198|NCT01437943|3812649|FG000|Overall Study|Aliskiren trials terminated by Novartis|4
2184199|NCT01437943|3812650|FG001|Overall Study|Aliskiren trials terminated by Novartis|2
2184200|NCT01437943|3812649|FG000|Overall Study|Subject expressed pregnancy plans|1
2184201|NCT01437943|3812650|FG001|Overall Study|Subject expressed pregnancy plans|0
2184202|NCT01437943|3812649|FG000|Overall Study|Adverse Event|2
2184203|NCT01437943|3812650|FG001|Overall Study|Adverse Event|0
2184204|NCT01437995|3812659|FG000|Overall Study|Lost to Follow-up|11
2184205|NCT01437995|3812660|FG001|Overall Study|Lost to Follow-up|18
2184206|NCT01437995|3812661|FG002|Overall Study|Lost to Follow-up|20
2184207|NCT01438060|3812680|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
2184208|NCT01438060|3812681|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
2184209|NCT01438060|3812680|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
2184210|NCT01438060|3812681|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
2184211|NCT01438060|3812680|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
2184212|NCT01438060|3812681|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
2184213|NCT01438060|3812680|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
2184214|NCT01438060|3812681|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
2184215|NCT01438060|3812680|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0
2184216|NCT01438060|3812681|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2
2184217|NCT01438060|3812680|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
2184218|NCT01438060|3812681|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
2184219|NCT01438060|3812680|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15
2184220|NCT01438060|3812681|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16
2184221|NCT01438060|3812680|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
2184222|NCT01438060|3812681|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
2184223|NCT01438060|3812680|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
2184224|NCT01438060|3812681|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
2184225|NCT01438060|3812680|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
2184226|NCT01438060|3812681|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
2184227|NCT01438060|3812680|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
2184228|NCT01438060|3812681|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
2184229|NCT01438060|3812680|FG000|Extension Phase: Week 10 to Week 130|Death|22
2184230|NCT01438060|3812681|FG001|Extension Phase: Week 10 to Week 130|Death|12
2184231|NCT01438060|3812680|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7
2184232|NCT01438060|3812681|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15
2184233|NCT01438060|3812680|FG000|On Study Beyond Week 140|Adverse Event|0
2184234|NCT01438060|3812681|FG001|On Study Beyond Week 140|Adverse Event|2
2184235|NCT01438060|3812680|FG000|On Study Beyond Week 140|Lack of Efficacy|0
2184236|NCT01438060|3812681|FG001|On Study Beyond Week 140|Lack of Efficacy|1
2184237|NCT01438060|3812680|FG000|On Study Beyond Week 140|Withdrawal by Subject|0
2184238|NCT01438060|3812681|FG001|On Study Beyond Week 140|Withdrawal by Subject|1
2184239|NCT01438060|3812680|FG000|On Study Beyond Week 140|Death|0
2184240|NCT01438060|3812681|FG001|On Study Beyond Week 140|Death|1
2184241|NCT01438060|3812680|FG000|On Study Beyond Week 140|Other Reason|0
2184242|NCT01438060|3812681|FG001|On Study Beyond Week 140|Other Reason|3
2184243|NCT01438151|3812692|FG000|Overall Study|study terminated|8
2184244|NCT01438177|3812696|FG000|Overall Study|Withdrawal by Subject|1
2184245|NCT01438177|3812696|FG000|Overall Study|Initiation of new therapy|1
2184246|NCT01438294|3812706|FG000|Overall Study|Lost to Follow-up|3
2184247|NCT01438294|3812707|FG001|Overall Study|Lost to Follow-up|7
2184248|NCT01438307|3812715|FG000|Overall Study|Death|1
2184249|NCT01438307|3812716|FG001|Overall Study|Death|1
2184250|NCT01438411|3812722|FG000|Overall Study|Adverse Event|8
2184251|NCT01438411|3812722|FG000|Overall Study|Lost to Follow-up|1
2184252|NCT01438411|3812722|FG000|Overall Study|Lack of Efficacy|1
2184253|NCT01438411|3812722|FG000|Overall Study|Withdrawal by Subject|3
2184254|NCT01438424|3812726|FG000|Overall Study|Continuing treatment|29
2184255|NCT01438424|3812726|FG000|Overall Study|Minimal virologic response|95
2184256|NCT01438424|3812726|FG000|Overall Study|Not identified|55
2184257|NCT01438424|3812726|FG000|Overall Study|Withdrawal by Subject|104
2184258|NCT01438424|3812726|FG000|Overall Study|Progression of chronic hepatitis B|22
2184259|NCT01438424|3812726|FG000|Overall Study|Death|22
2184260|NCT01438424|3812726|FG000|Overall Study|Adverse Event|17
2184261|NCT01438424|3812726|FG000|Overall Study|Lost to Follow-up|17
2184262|NCT01438424|3812726|FG000|Overall Study|Abnormal laboratory test result|14
2184263|NCT01438424|3812726|FG000|Overall Study|Need for drug prohibited by protocol|14
2184264|NCT01438424|3812726|FG000|Overall Study|Pregnancy|7
2184265|NCT01438424|3812726|FG000|Overall Study|No longer met inclusion criteria|1
2184266|NCT01438424|3812726|FG000|Overall Study|Participant noncompliance|20
2184267|NCT01438476|3812742|FG000|Overall Study|Protocol Violation|1
2184268|NCT01438476|3812743|FG001|Overall Study|Protocol Violation|0
2184269|NCT01438476|3812742|FG000|Overall Study|Withdrawal by Subject|1
2184270|NCT01438476|3812743|FG001|Overall Study|Withdrawal by Subject|0
2184271|NCT01438476|3812742|FG000|Overall Study|No Surgery- Disease|8
2184272|NCT01438476|3812743|FG001|Overall Study|No Surgery- Disease|10
2184273|NCT01438476|3812742|FG000|Overall Study|Communication barrier|0
2184274|NCT01438476|3812743|FG001|Overall Study|Communication barrier|1
2184275|NCT01438489|3812752|FG000|Overall Study|Lost to Follow-up|4
2184276|NCT01438489|3812753|FG001|Overall Study|Lost to Follow-up|2
2184277|NCT01438489|3812754|FG002|Overall Study|Lost to Follow-up|2
2184278|NCT01438489|3812752|FG000|Overall Study|Withdrawal by Subject|11
2184279|NCT01438489|3812753|FG001|Overall Study|Withdrawal by Subject|3
2184280|NCT01438489|3812754|FG002|Overall Study|Withdrawal by Subject|8
2184281|NCT01438489|3812752|FG000|Overall Study|Death|0
2184282|NCT01438489|3812753|FG001|Overall Study|Death|0
2184283|NCT01438489|3812754|FG002|Overall Study|Death|1
2184284|NCT01438489|3812752|FG000|Overall Study|Sponsor decision|4
2184285|NCT01438489|3812753|FG001|Overall Study|Sponsor decision|1
2184286|NCT01438489|3812754|FG002|Overall Study|Sponsor decision|4
2184287|NCT01438489|3812752|FG000|Overall Study|Subject choice/Subject moved|2
2184288|NCT01438489|3812753|FG001|Overall Study|Subject choice/Subject moved|1
2184289|NCT01438489|3812754|FG002|Overall Study|Subject choice/Subject moved|1
2184290|NCT01438489|3812752|FG000|Overall Study|Investigator decision|0
2184291|NCT01438489|3812753|FG001|Overall Study|Investigator decision|1
2184292|NCT01438489|3812754|FG002|Overall Study|Investigator decision|0
2184293|NCT01438489|3812752|FG000|Overall Study|AE/SAEs|2
2184294|NCT01438489|3812753|FG001|Overall Study|AE/SAEs|1
2184295|NCT01438489|3812754|FG002|Overall Study|AE/SAEs|1
2184296|NCT01438489|3812752|FG000|Overall Study|Received prohibited medication|1
2184297|NCT01438489|3812753|FG001|Overall Study|Received prohibited medication|0
2184298|NCT01438489|3812754|FG002|Overall Study|Received prohibited medication|0
2184299|NCT01438489|3812752|FG000|Overall Study|Did not complete all 3 follow-up visits|2
2184300|NCT01438489|3812753|FG001|Overall Study|Did not complete all 3 follow-up visits|5
2184301|NCT01438489|3812754|FG002|Overall Study|Did not complete all 3 follow-up visits|2
2184302|NCT01438489|3812752|FG000|Overall Study|Inadequate venous access|0
2184303|NCT01438489|3812753|FG001|Overall Study|Inadequate venous access|2
2184304|NCT01438489|3812754|FG002|Overall Study|Inadequate venous access|0
2184305|NCT01438541|3812764|FG000|Overall Study|Physician Decision|1
2184306|NCT01438541|3812764|FG000|Overall Study|Withdrawal by Subject|1
2184307|NCT01438541|3812764|FG000|Overall Study|discharge from the hospital|5
2184308|NCT01438814|3812776|FG000|Overall Study|Adverse Event|3
2184309|NCT01438814|3812777|FG001|Overall Study|Adverse Event|3
2184310|NCT01438814|3812776|FG000|Overall Study|Protocol Violation|1
2184311|NCT01438814|3812777|FG001|Overall Study|Protocol Violation|2
2184312|NCT01438814|3812776|FG000|Overall Study|Lost to Follow-up|4
2184313|NCT01438814|3812777|FG001|Overall Study|Lost to Follow-up|3
2184314|NCT01438814|3812776|FG000|Overall Study|Withdrawal by Subject|4
2184315|NCT01438814|3812777|FG001|Overall Study|Withdrawal by Subject|2
2184316|NCT01438814|3812776|FG000|Overall Study|Other|2
2184317|NCT01438814|3812777|FG001|Overall Study|Other|4
2184318|NCT01438840|3812785|FG000|Core Study|Adverse Event|0
2184319|NCT01438840|3812786|FG001|Core Study|Adverse Event|3
2184320|NCT01438840|3812787|FG002|Core Study|Adverse Event|0
2184321|NCT01438840|3812785|FG000|Core Study|Lack of Efficacy|15
2184322|NCT01438840|3812786|FG001|Core Study|Lack of Efficacy|7
2184323|NCT01438840|3812787|FG002|Core Study|Lack of Efficacy|0
2184324|NCT01438840|3812785|FG000|Core Study|Withdrawal of consent|1
2184325|NCT01438840|3812786|FG001|Core Study|Withdrawal of consent|0
2184326|NCT01438840|3812787|FG002|Core Study|Withdrawal of consent|0
2184327|NCT01438840|3812785|FG000|Extension Phase|Adverse Event|0
2184328|NCT01438840|3812786|FG001|Extension Phase|Adverse Event|0
2184329|NCT01438840|3812787|FG002|Extension Phase|Adverse Event|3
2184330|NCT01438840|3812785|FG000|Extension Phase|Lost to Follow-up|0
2184331|NCT01438840|3812786|FG001|Extension Phase|Lost to Follow-up|0
2184332|NCT01438840|3812787|FG002|Extension Phase|Lost to Follow-up|1
2184333|NCT01438840|3812785|FG000|Extension Phase|Withdrawal by Subject|0
2184334|NCT01438840|3812786|FG001|Extension Phase|Withdrawal by Subject|0
2184335|NCT01438840|3812787|FG002|Extension Phase|Withdrawal by Subject|3
2184336|NCT01438840|3812785|FG000|Extension Phase|Lack of Efficacy|0
2184337|NCT01438840|3812786|FG001|Extension Phase|Lack of Efficacy|0
2184338|NCT01438840|3812787|FG002|Extension Phase|Lack of Efficacy|2
2184339|NCT01438840|3812785|FG000|Extension Phase|Other|0
2184340|NCT01438840|3812786|FG001|Extension Phase|Other|0
2184341|NCT01438840|3812787|FG002|Extension Phase|Other|1
2184342|NCT01438957|3812799|FG000|Overall Study|Physician Decision|1
2184343|NCT01438957|3812800|FG001|Overall Study|Physician Decision|1
2184344|NCT01438957|3812801|FG002|Overall Study|Physician Decision|0
2184345|NCT01438957|3812802|FG003|Overall Study|Physician Decision|1
2184346|NCT01438957|3812803|FG004|Overall Study|Physician Decision|0
2184347|NCT01438996|3812818|FG000|Overall Study|Not meeting Inclusion Criteria|4
2184348|NCT01438996|3812819|FG001|Overall Study|Not meeting Inclusion Criteria|1
2184349|NCT01438996|3812820|FG002|Overall Study|Not meeting Inclusion Criteria|0
2184350|NCT01439009|3812830|FG000|Overall Study|Physician Decision|5
2184351|NCT01439009|3812831|FG001|Overall Study|Physician Decision|3
2184352|NCT01439009|3812830|FG000|Overall Study|Protocol Violation|2
2184353|NCT01439009|3812831|FG001|Overall Study|Protocol Violation|0
2184354|NCT01439009|3812830|FG000|Overall Study|Deviation of exclusion criteria|1
2220570|NCT01732107|3864970|FG000|Overall Study|Disease Progression|8
2220571|NCT01732107|3864970|FG000|Overall Study|Physician Decision|1
2220572|NCT01732107|3864970|FG000|Overall Study|Withdrawal by Subject|2
2220573|NCT01732458|3865021|FG000|Overall Study|Lost to Follow-up|0
2220574|NCT01732458|3865022|FG001|Overall Study|Lost to Follow-up|2
2220575|NCT01732458|3865023|FG002|Overall Study|Lost to Follow-up|0
2220576|NCT01732458|3865024|FG003|Overall Study|Lost to Follow-up|0
2220577|NCT01732458|3865021|FG000|Overall Study|Non-Compliance With Study Drug|0
2220578|NCT01732458|3865022|FG001|Overall Study|Non-Compliance With Study Drug|0
2220579|NCT01732458|3865023|FG002|Overall Study|Non-Compliance With Study Drug|1
2220580|NCT01732458|3865024|FG003|Overall Study|Non-Compliance With Study Drug|0
2220581|NCT01732458|3865021|FG000|Overall Study|Physician Decision|1
2220582|NCT01732458|3865022|FG001|Overall Study|Physician Decision|2
2220583|NCT01732458|3865023|FG002|Overall Study|Physician Decision|2
2220584|NCT01732458|3865024|FG003|Overall Study|Physician Decision|0
2220585|NCT01732458|3865021|FG000|Overall Study|Protocol Violation|2
2220586|NCT01732458|3865022|FG001|Overall Study|Protocol Violation|0
2220587|NCT01732458|3865023|FG002|Overall Study|Protocol Violation|0
2220588|NCT01732458|3865024|FG003|Overall Study|Protocol Violation|2
2220589|NCT01732458|3865021|FG000|Overall Study|Screen Failure|0
2220590|NCT01732458|3865022|FG001|Overall Study|Screen Failure|1
2220591|NCT01732458|3865023|FG002|Overall Study|Screen Failure|0
2220592|NCT01732458|3865024|FG003|Overall Study|Screen Failure|0
2220593|NCT01732471|3865046|FG000|Overall Study|Withdrawal by Subject|1
2220594|NCT01732484|3865050|FG000|Overall Study|Death|7
2220595|NCT01732484|3865050|FG000|Overall Study|Lost to Follow-up|14
2220596|NCT01732484|3865050|FG000|Overall Study|chronical illness|5
2220597|NCT01732510|3865063|FG000|Overall Study|Adverse Event|0
2220598|NCT01732510|3865064|FG001|Overall Study|Adverse Event|1
2220599|NCT01732510|3865065|FG002|Overall Study|Adverse Event|1
2220600|NCT01732510|3865066|FG003|Overall Study|Adverse Event|0
2220601|NCT01732510|3865067|FG004|Overall Study|Adverse Event|0
2220602|NCT01732510|3865068|FG005|Overall Study|Adverse Event|0
2220603|NCT01732510|3865069|FG006|Overall Study|Adverse Event|1
2220604|NCT01732510|3865063|FG000|Overall Study|Protocol Violation|0
2220605|NCT01732510|3865064|FG001|Overall Study|Protocol Violation|0
2220606|NCT01732510|3865065|FG002|Overall Study|Protocol Violation|0
2220607|NCT01732510|3865066|FG003|Overall Study|Protocol Violation|1
2220608|NCT01732510|3865067|FG004|Overall Study|Protocol Violation|0
2220609|NCT01732510|3865068|FG005|Overall Study|Protocol Violation|0
2220610|NCT01732510|3865069|FG006|Overall Study|Protocol Violation|0
2220611|NCT01732510|3865063|FG000|Overall Study|Withdrawal by Subject|1
2220612|NCT01732510|3865064|FG001|Overall Study|Withdrawal by Subject|3
2220613|NCT01732510|3865065|FG002|Overall Study|Withdrawal by Subject|2
2220614|NCT01732510|3865066|FG003|Overall Study|Withdrawal by Subject|1
2220615|NCT01732510|3865067|FG004|Overall Study|Withdrawal by Subject|5
2220616|NCT01732510|3865068|FG005|Overall Study|Withdrawal by Subject|0
2220617|NCT01732510|3865069|FG006|Overall Study|Withdrawal by Subject|1
2220618|NCT01732510|3865063|FG000|Overall Study|Lost to Follow-up|0
2220619|NCT01732510|3865064|FG001|Overall Study|Lost to Follow-up|0
2220620|NCT01732510|3865065|FG002|Overall Study|Lost to Follow-up|1
2220621|NCT01732510|3865066|FG003|Overall Study|Lost to Follow-up|1
2220622|NCT01732510|3865067|FG004|Overall Study|Lost to Follow-up|0
2220623|NCT01732510|3865068|FG005|Overall Study|Lost to Follow-up|1
2220624|NCT01732510|3865069|FG006|Overall Study|Lost to Follow-up|0
2220625|NCT01732510|3865063|FG000|Overall Study|Physician Decision|0
2220626|NCT01732510|3865064|FG001|Overall Study|Physician Decision|1
2220627|NCT01732510|3865065|FG002|Overall Study|Physician Decision|0
2220628|NCT01732510|3865066|FG003|Overall Study|Physician Decision|0
2220629|NCT01732510|3865067|FG004|Overall Study|Physician Decision|0
2220630|NCT01732510|3865068|FG005|Overall Study|Physician Decision|0
2220631|NCT01732510|3865069|FG006|Overall Study|Physician Decision|0
2220632|NCT01732510|3865063|FG000|Overall Study|Pregnancy|0
2220633|NCT01732510|3865064|FG001|Overall Study|Pregnancy|0
2220634|NCT01732510|3865065|FG002|Overall Study|Pregnancy|0
2220635|NCT01732510|3865066|FG003|Overall Study|Pregnancy|1
2220636|NCT01732510|3865067|FG004|Overall Study|Pregnancy|0
2220637|NCT01732510|3865068|FG005|Overall Study|Pregnancy|0
2184355|NCT01439009|3812831|FG001|Overall Study|Deviation of exclusion criteria|0
2184356|NCT01439074|3812843|FG000|Overall Study|Lost to Follow-up|3
2220638|NCT01732510|3865069|FG006|Overall Study|Pregnancy|0
2220639|NCT01732510|3865063|FG000|Overall Study|Study Terminated By Sponsor|0
2220640|NCT01732510|3865064|FG001|Overall Study|Study Terminated By Sponsor|0
2220641|NCT01732510|3865065|FG002|Overall Study|Study Terminated By Sponsor|0
2184357|NCT01439074|3812844|FG001|Overall Study|Lost to Follow-up|4
2184358|NCT01439074|3812843|FG000|Overall Study|Subject shedding|1
2184359|NCT01439074|3812844|FG001|Overall Study|Subject shedding|0
2184360|NCT01439074|3812843|FG000|Overall Study|Withdrawal by Subject|1
2184361|NCT01439074|3812844|FG001|Overall Study|Withdrawal by Subject|5
2184362|NCT01439074|3812843|FG000|Overall Study|Other|4
2184363|NCT01439074|3812844|FG001|Overall Study|Other|4
2184364|NCT01439126|3812856|FG000|Overall Study|Adverse Event|2
2184365|NCT01439126|3812857|FG001|Overall Study|Adverse Event|0
2184366|NCT01439126|3812856|FG000|Overall Study|Withdrawal by Subject|5
2184367|NCT01439126|3812857|FG001|Overall Study|Withdrawal by Subject|21
2184368|NCT01439126|3812856|FG000|Overall Study|Protocol Violation|6
2184369|NCT01439126|3812857|FG001|Overall Study|Protocol Violation|4
2184370|NCT01439126|3812856|FG000|Overall Study|Lost to Follow-up|6
2184371|NCT01439126|3812857|FG001|Overall Study|Lost to Follow-up|3
2184372|NCT01439126|3812856|FG000|Overall Study|Other-Use of prohibited treatment|0
2184373|NCT01439126|3812857|FG001|Overall Study|Other-Use of prohibited treatment|2
2184374|NCT01439126|3812856|FG000|Overall Study|Other-Miscellaneous|12
2184375|NCT01439126|3812857|FG001|Overall Study|Other-Miscellaneous|12
2220642|NCT01732510|3865066|FG003|Overall Study|Study Terminated By Sponsor|1
2220643|NCT01732510|3865067|FG004|Overall Study|Study Terminated By Sponsor|0
2220644|NCT01732510|3865068|FG005|Overall Study|Study Terminated By Sponsor|12
2220645|NCT01732510|3865069|FG006|Overall Study|Study Terminated By Sponsor|6
2220646|NCT01732536|3865090|FG000|Overall Study|Withdrawal by Subject|1
2220647|NCT01732536|3865091|FG001|Overall Study|Withdrawal by Subject|1
2220648|NCT01732549|3865102|FG000|Overall Study|Adverse Event|13
2220649|NCT01732549|3865103|FG001|Overall Study|Adverse Event|3
2220650|NCT01732549|3865102|FG000|Overall Study|Consent withdrawn|13
2220651|NCT01732549|3865103|FG001|Overall Study|Consent withdrawn|6
2220652|NCT01732549|3865102|FG000|Overall Study|Disease progression|37
2220653|NCT01732549|3865103|FG001|Overall Study|Disease progression|50
2220654|NCT01732549|3865102|FG000|Overall Study|Other|8
2220655|NCT01732549|3865103|FG001|Overall Study|Other|14
2220656|NCT01732588|3865113|FG000|First Intervention (7 Days)|Adverse Event|0
2220657|NCT01732588|3865114|FG001|First Intervention (7 Days)|Adverse Event|1
2220658|NCT01732588|3865115|FG002|First Intervention (7 Days)|Adverse Event|0
2220659|NCT01732627|3865125|FG000|Overall Study|Withdrawal by Subject|1
2220660|NCT01732627|3865126|FG001|Overall Study|Withdrawal by Subject|0
2220661|NCT01732640|3865132|FG000|Overall Study|Adverse Event|0
2220662|NCT01732640|3865133|FG001|Overall Study|Adverse Event|1
2220663|NCT01732640|3865132|FG000|Overall Study|Death|0
2220664|NCT01732640|3865133|FG001|Overall Study|Death|1
2220665|NCT01732692|3865145|FG000|Overall Study|Adverse Event|0
2220666|NCT01732692|3865146|FG001|Overall Study|Adverse Event|1
2220667|NCT01732757|3865168|FG000|Overall Study|Lost to Follow-up|1
2220668|NCT01732757|3865169|FG001|Overall Study|Lost to Follow-up|0
2220669|NCT01732757|3865170|FG002|Overall Study|Lost to Follow-up|0
2220670|NCT01732770|3865180|FG000|Overall Study|Lost to Follow-up|2
2220671|NCT01732770|3865181|FG001|Overall Study|Lost to Follow-up|3
2220672|NCT01732770|3865180|FG000|Overall Study|Withdrawal by Subject|5
2220673|NCT01732770|3865181|FG001|Overall Study|Withdrawal by Subject|3
2220674|NCT01732770|3865180|FG000|Overall Study|Decision by Sponsor|2
2220675|NCT01732770|3865181|FG001|Overall Study|Decision by Sponsor|2
2220676|NCT01732770|3865180|FG000|Overall Study|Death|1
2220677|NCT01732770|3865181|FG001|Overall Study|Death|0
2220678|NCT01732783|3865190|FG000|Overall Study|Discontinued Panitumumab Treatment|106
2220679|NCT01732783|3865191|FG001|Overall Study|Discontinued Panitumumab Treatment|25
2220680|NCT01732783|3865192|FG002|Overall Study|Discontinued Panitumumab Treatment|7
2220681|NCT01732783|3865190|FG000|Overall Study|Death|13
2220682|NCT01732783|3865191|FG001|Overall Study|Death|4
2220683|NCT01732783|3865192|FG002|Overall Study|Death|1
2220684|NCT01732783|3865190|FG000|Overall Study|Lost to Follow-up|7
2220685|NCT01732783|3865191|FG001|Overall Study|Lost to Follow-up|1
2220686|NCT01732783|3865192|FG002|Overall Study|Lost to Follow-up|1
2220687|NCT01732783|3865190|FG000|Overall Study|Administrative Decision|8
2220688|NCT01732783|3865191|FG001|Overall Study|Administrative Decision|2
2220689|NCT01732783|3865192|FG002|Overall Study|Administrative Decision|1
2220690|NCT01732783|3865190|FG000|Overall Study|Withdrawal by Subject|1
2220691|NCT01732783|3865191|FG001|Overall Study|Withdrawal by Subject|0
2220692|NCT01732783|3865192|FG002|Overall Study|Withdrawal by Subject|0
2220693|NCT01732796|3865203|FG000|Overall Study|Adverse Event|16
2220694|NCT01732796|3865204|FG001|Overall Study|Adverse Event|16
2220695|NCT01732796|3865205|FG002|Overall Study|Adverse Event|4
2220696|NCT01732796|3865203|FG000|Overall Study|Lack of Efficacy|21
2220697|NCT01732796|3865204|FG001|Overall Study|Lack of Efficacy|18
2220698|NCT01732796|3865205|FG002|Overall Study|Lack of Efficacy|5
2220699|NCT01732796|3865203|FG000|Overall Study|Lost to Follow-up|2
2220700|NCT01732796|3865204|FG001|Overall Study|Lost to Follow-up|0
2220701|NCT01732796|3865205|FG002|Overall Study|Lost to Follow-up|0
2220702|NCT01732796|3865203|FG000|Overall Study|Withdrawal by Subject|6
2220703|NCT01732796|3865204|FG001|Overall Study|Withdrawal by Subject|8
2220704|NCT01732796|3865205|FG002|Overall Study|Withdrawal by Subject|2
2220705|NCT01732796|3865203|FG000|Overall Study|Other reason not defined above|1
2220706|NCT01732796|3865204|FG001|Overall Study|Other reason not defined above|0
2220707|NCT01732796|3865205|FG002|Overall Study|Other reason not defined above|2
2220708|NCT01732822|3865226|FG000|Overall Study|Withdrawal by Subject|123
2220709|NCT01732822|3865227|FG001|Overall Study|Withdrawal by Subject|113
2220710|NCT01732835|3865255|FG000|6-month Primary Endpoint|Did not receive device|19
2220711|NCT01732835|3865255|FG000|6-month Primary Endpoint|Withdrawal by Subject|2
2184376|NCT01439165|3812865|FG000|Overall Study|Protocol Violation|3
2184377|NCT01439165|3812866|FG001|Overall Study|Protocol Violation|0
2184378|NCT01439165|3812865|FG000|Overall Study|Lost to Follow-up|11
2184379|NCT01439165|3812866|FG001|Overall Study|Lost to Follow-up|1
2184380|NCT01439165|3812865|FG000|Overall Study|Withdrawal by Subject|7
2184381|NCT01439165|3812866|FG001|Overall Study|Withdrawal by Subject|1
2184382|NCT01439204|3812874|FG000|Overall Study|Withdrawal by Subject|0
2184383|NCT01439204|3812875|FG001|Overall Study|Withdrawal by Subject|1
2184384|NCT01439204|3812874|FG000|Overall Study|Lost to Follow-up|0
2220712|NCT01732835|3865255|FG000|6-month Primary Endpoint|Adverse Event|3
2220713|NCT01732835|3865255|FG000|2-year Extended Follow-up|Withdrawal by Subject|1
2184385|NCT01439204|3812875|FG001|Overall Study|Lost to Follow-up|2
2184386|NCT01439204|3812874|FG000|Overall Study|No longer meets study criteria|1
2184387|NCT01439204|3812875|FG001|Overall Study|No longer meets study criteria|0
2184388|NCT01439204|3812874|FG000|Overall Study|poor/non-compliance|3
2184389|NCT01439204|3812875|FG001|Overall Study|poor/non-compliance|0
2184390|NCT01439282|3812883|FG000|Overall Study|Adverse Event|5
2184391|NCT01439282|3812884|FG001|Overall Study|Adverse Event|0
2184392|NCT01439282|3812883|FG000|Overall Study|Withdrawal by Subject|2
2184393|NCT01439282|3812884|FG001|Overall Study|Withdrawal by Subject|0
2184394|NCT01439282|3812883|FG000|Overall Study|Other|1
2184395|NCT01439282|3812884|FG001|Overall Study|Other|1
2184396|NCT01439360|3812893|FG000|Overall Study|Adverse Event|4
2184397|NCT01439360|3812894|FG001|Overall Study|Adverse Event|16
2184398|NCT01439360|3812893|FG000|Overall Study|Lost to Follow-up|43
2184399|NCT01439360|3812894|FG001|Overall Study|Lost to Follow-up|58
2184400|NCT01439360|3812893|FG000|Overall Study|Others|10
2184401|NCT01439360|3812894|FG001|Overall Study|Others|5
2184402|NCT01439360|3812893|FG000|Overall Study|Protocol Violation|1
2184403|NCT01439360|3812894|FG001|Overall Study|Protocol Violation|0
2184404|NCT01439360|3812893|FG000|Overall Study|Withdrawal by Subject|140
2184405|NCT01439360|3812894|FG001|Overall Study|Withdrawal by Subject|129
2184406|NCT01439373|3812902|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
2184407|NCT01439373|3812903|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
2184408|NCT01439373|3812902|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
2184409|NCT01439373|3812903|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
2184410|NCT01439555|3812913|FG000|Overall Study|Protocol Violation|1
2184411|NCT01439568|3812919|FG000|Overall Study|Lost to Follow-up|1
2184412|NCT01439568|3812920|FG001|Overall Study|Lost to Follow-up|0
2184413|NCT01439568|3812919|FG000|Overall Study|Withdrawal by Subject|2
2184414|NCT01439568|3812920|FG001|Overall Study|Withdrawal by Subject|2
2184415|NCT01439711|3812951|FG000|Overall Study|Ineligible|13
2184416|NCT01439711|3812951|FG000|Overall Study|Cancel|3
2184417|NCT01439711|3812951|FG000|Overall Study|Progression Prior to Beginning Tx|1
2184418|NCT01439711|3812951|FG000|Overall Study|Adverse Event|5
2184419|NCT01439711|3812951|FG000|Overall Study|Withdrawal by Subject|3
2184420|NCT01439711|3812951|FG000|Overall Study|Progression During Active Tx|3
2184421|NCT01439711|3812951|FG000|Overall Study|Noncompliance|3
2184422|NCT01439711|3812951|FG000|Overall Study|No MRI|9
2184423|NCT01439724|3812957|FG000|Overall Study|missing consultation|9
2184424|NCT01439724|3812958|FG001|Overall Study|missing consultation|8
2184425|NCT01439867|3812984|FG000|Overall Study|Non-compliance|0
2184426|NCT01439867|3812985|FG001|Overall Study|Non-compliance|1
2184427|NCT01439867|3812984|FG000|Overall Study|Withdrawal by Subject|1
2184428|NCT01439867|3812985|FG001|Overall Study|Withdrawal by Subject|2
2184429|NCT01439867|3812984|FG000|Overall Study|Administrative Decision|4
2184430|NCT01439867|3812985|FG001|Overall Study|Administrative Decision|5
2184431|NCT01439867|3812984|FG000|Overall Study|Protocol-specified Criteria|1
2184432|NCT01439867|3812985|FG001|Overall Study|Protocol-specified Criteria|0
2184433|NCT01439880|3812995|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
2184434|NCT01439880|3812996|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
2184435|NCT01439880|3812995|FG000|SOC-controlled Period (Year 1)|Death|2
2184436|NCT01439880|3812996|FG001|SOC-controlled Period (Year 1)|Death|1
2184437|NCT01439880|3812995|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0
2184438|NCT01439880|3812996|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1
2184439|NCT01439880|3812995|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10
2184440|NCT01439880|3812996|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5
2184441|NCT01439880|3812995|FG000|SOC-controlled Period (Year 1)|Other|8
2184442|NCT01439880|3812996|FG001|SOC-controlled Period (Year 1)|Other|13
2184443|NCT01439880|3812995|FG000|SOC-controlled Period (Year 1)|Reason Missing|0
2184444|NCT01439880|3812996|FG001|SOC-controlled Period (Year 1)|Reason Missing|2
2184445|NCT01439880|3812995|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
2184446|NCT01439880|3812996|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
2220714|NCT01732835|3865255|FG000|2-year Extended Follow-up|Adverse Event|3
2220715|NCT01732835|3865255|FG000|2-year Extended Follow-up|Death|1
2220716|NCT01732874|3865261|FG000|Overall Study|Withdrawal by Subject|5
2220717|NCT01732874|3865262|FG001|Overall Study|Withdrawal by Subject|1
2220718|NCT01732874|3865261|FG000|Overall Study|Death of Infant|3
2184447|NCT01439880|3812995|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
2184448|NCT01439880|3812996|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
2184449|NCT01439880|3812995|FG000|All-IP Period (Years 2 to 5)|Death|3
2184450|NCT01439880|3812996|FG001|All-IP Period (Years 2 to 5)|Death|13
2184451|NCT01439880|3812995|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1
2184452|NCT01439880|3812996|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0
2184453|NCT01439880|3812995|FG000|All-IP Period (Years 2 to 5)|Other|14
2184454|NCT01439880|3812996|FG001|All-IP Period (Years 2 to 5)|Other|31
2184455|NCT01439880|3812995|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1
2184456|NCT01439880|3812996|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0
2184457|NCT01439945|3813016|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3
2184458|NCT01439945|3813017|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3
2184459|NCT01439945|3813018|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3
2184460|NCT01439945|3813019|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1
2184461|NCT01439945|3813016|FG000|Double-Blind Treatment Phase|Ineligible|1
2184462|NCT01439945|3813017|FG001|Double-Blind Treatment Phase|Ineligible|2
2184463|NCT01439945|3813018|FG002|Double-Blind Treatment Phase|Ineligible|0
2220719|NCT01732874|3865262|FG001|Overall Study|Death of Infant|2
2220720|NCT01733121|3865295|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2
2220721|NCT01733121|3865296|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
2220722|NCT01733121|3865295|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3
2220723|NCT01733121|3865296|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
2220724|NCT01733121|3865295|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
2220725|NCT01733121|3865296|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
2220726|NCT01733121|3865295|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
2220727|NCT01733121|3865296|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
2220728|NCT01733316|3865335|FG000|RP103 Phase|Non-compliance|1
2220729|NCT01733316|3865335|FG000|Long Term Extension Phase|Adverse Event|1
2220730|NCT01733316|3865335|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2
2220731|NCT01733316|3865335|FG000|Long Term Extension Phase|Sponsor Decision|2
2220732|NCT01733329|3865348|FG000|Overall Study|Protocol Violation|1
2220733|NCT01733329|3865349|FG001|Overall Study|Protocol Violation|1
2220734|NCT01733329|3865348|FG000|Overall Study|Uterine artery injury|1
2220735|NCT01733329|3865349|FG001|Overall Study|Uterine artery injury|0
2220736|NCT01733680|3865386|FG000|Overall Study|Withdrawal by Subject|0
2220737|NCT01733680|3865387|FG001|Overall Study|Withdrawal by Subject|1
2220738|NCT01733732|3865399|FG000|Overall Study|Adverse Event|1
2220739|NCT01733732|3865400|FG001|Overall Study|Adverse Event|0
2220740|NCT01733732|3865399|FG000|Overall Study|Did not attend all study visits|1
2220741|NCT01733732|3865400|FG001|Overall Study|Did not attend all study visits|0
2220742|NCT01733758|3865429|FG000|Overall Study|Adverse Event|5
2220743|NCT01733758|3865430|FG001|Overall Study|Adverse Event|7
2220744|NCT01733758|3865431|FG002|Overall Study|Adverse Event|8
2220745|NCT01733758|3865432|FG003|Overall Study|Adverse Event|1
2220746|NCT01733758|3865429|FG000|Overall Study|Withdrawal by Subject|1
2220747|NCT01733758|3865430|FG001|Overall Study|Withdrawal by Subject|1
2220748|NCT01733758|3865431|FG002|Overall Study|Withdrawal by Subject|5
2220749|NCT01733758|3865432|FG003|Overall Study|Withdrawal by Subject|3
2220750|NCT01733758|3865429|FG000|Overall Study|Persistent Hyperglycemia|3
2220751|NCT01733758|3865430|FG001|Overall Study|Persistent Hyperglycemia|2
2220752|NCT01733758|3865431|FG002|Overall Study|Persistent Hyperglycemia|0
2220753|NCT01733758|3865432|FG003|Overall Study|Persistent Hyperglycemia|0
2220754|NCT01733758|3865429|FG000|Overall Study|Protocol Violation|0
2220755|NCT01733758|3865430|FG001|Overall Study|Protocol Violation|1
2220756|NCT01733758|3865431|FG002|Overall Study|Protocol Violation|2
2220757|NCT01733758|3865432|FG003|Overall Study|Protocol Violation|2
2220758|NCT01733758|3865429|FG000|Overall Study|Non-compliance|1
2220759|NCT01733758|3865430|FG001|Overall Study|Non-compliance|0
2220760|NCT01733758|3865431|FG002|Overall Study|Non-compliance|0
2220761|NCT01733758|3865432|FG003|Overall Study|Non-compliance|0
2220762|NCT01733758|3865429|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4
2220763|NCT01733758|3865430|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0
2220764|NCT01733758|3865431|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0
2220765|NCT01733758|3865432|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1
2220766|NCT01733758|3865429|FG000|Overall Study|Inv Decision, HbA1c not controlled|1
2220767|NCT01733758|3865430|FG001|Overall Study|Inv Decision, HbA1c not controlled|1
2220768|NCT01733758|3865431|FG002|Overall Study|Inv Decision, HbA1c not controlled|0
2220769|NCT01733758|3865432|FG003|Overall Study|Inv Decision, HbA1c not controlled|1
2220770|NCT01734382|3865478|FG000|Part 1|Adverse Event|2
2220771|NCT01734382|3865479|FG001|Part 1|Adverse Event|0
2220772|NCT01734382|3865480|FG002|Part 1|Adverse Event|0
2220773|NCT01734382|3865478|FG000|Part 2|Adverse Event|0
2220774|NCT01734382|3865479|FG001|Part 2|Adverse Event|0
2220775|NCT01734382|3865480|FG002|Part 2|Adverse Event|1
2220776|NCT01734382|3865478|FG000|Part 2|Lack of Efficacy|0
2220777|NCT01734382|3865479|FG001|Part 2|Lack of Efficacy|1
2220778|NCT01734382|3865480|FG002|Part 2|Lack of Efficacy|1
2220779|NCT01734382|3865478|FG000|Part 2|Other|0
2220780|NCT01734382|3865479|FG001|Part 2|Other|0
2220781|NCT01734382|3865480|FG002|Part 2|Other|1
2220782|NCT01734382|3865478|FG000|Part 2|Physician Decision|0
2184464|NCT01439945|3813019|FG003|Double-Blind Treatment Phase|Ineligible|1
2184465|NCT01439971|3813035|FG000|Overall Study|Required number in cohort dosed|0
2184466|NCT01439971|3813036|FG001|Overall Study|Required number in cohort dosed|1
2184467|NCT01439971|3813037|FG002|Overall Study|Required number in cohort dosed|2
2184468|NCT01439971|3813038|FG003|Overall Study|Required number in cohort dosed|0
2184469|NCT01439971|3813039|FG004|Overall Study|Required number in cohort dosed|1
2184470|NCT01440049|3813051|FG000|Overall Study|Adverse Event|5
2184471|NCT01440101|3813058|FG000|Overall Study|Adverse Event|2
2184472|NCT01440101|3813059|FG001|Overall Study|Adverse Event|0
2184473|NCT01440101|3813060|FG002|Overall Study|Adverse Event|0
2184474|NCT01440101|3813058|FG000|Overall Study|Withdrawal by Subject|0
2184475|NCT01440101|3813059|FG001|Overall Study|Withdrawal by Subject|3
2184476|NCT01440101|3813060|FG002|Overall Study|Withdrawal by Subject|1
2184477|NCT01440101|3813058|FG000|Overall Study|Other|0
2184478|NCT01440101|3813059|FG001|Overall Study|Other|1
2184479|NCT01440101|3813060|FG002|Overall Study|Other|0
2184480|NCT01440283|3813069|FG000|Overall Study|Death|3
2184481|NCT01440283|3813069|FG000|Overall Study|Withdrawal by Subject|4
2184482|NCT01440283|3813069|FG000|Overall Study|Physician Decision|3
2184483|NCT01440322|3813081|FG000|Overall Study|Discomfort|2
2184484|NCT01440322|3813082|FG001|Overall Study|Discomfort|0
2184485|NCT01440322|3813081|FG000|Overall Study|Biomicroscopy|1
2184486|NCT01440322|3813082|FG001|Overall Study|Biomicroscopy|0
2184487|NCT01440322|3813081|FG000|Overall Study|Symptoms and Problems|1
2184488|NCT01440322|3813082|FG001|Overall Study|Symptoms and Problems|0
2184489|NCT01440322|3813081|FG000|Overall Study|Unacceptable Subjective Vision|1
2184490|NCT01440322|3813082|FG001|Overall Study|Unacceptable Subjective Vision|0
2184491|NCT01440322|3813081|FG000|Overall Study|Other Product Related|1
2184492|NCT01440322|3813082|FG001|Overall Study|Other Product Related|0
2184493|NCT01440322|3813081|FG000|Overall Study|Unrelated Medical Problem|0
2184494|NCT01440322|3813082|FG001|Overall Study|Unrelated Medical Problem|1
2184495|NCT01440322|3813081|FG000|Overall Study|Other Non-Product Related|1
2184496|NCT01440322|3813082|FG001|Overall Study|Other Non-Product Related|0
2184497|NCT01440374|3813091|FG000|Part 1: Open-label Phase|Adverse Event|5
2184498|NCT01440374|3813092|FG001|Part 1: Open-label Phase|Adverse Event|0
2184499|NCT01440374|3813093|FG002|Part 1: Open-label Phase|Adverse Event|0
2184500|NCT01440374|3813094|FG003|Part 1: Open-label Phase|Adverse Event|0
2184501|NCT01440374|3813091|FG000|Part 1: Open-label Phase|Physician Decision|1
2184502|NCT01440374|3813092|FG001|Part 1: Open-label Phase|Physician Decision|0
2184503|NCT01440374|3813093|FG002|Part 1: Open-label Phase|Physician Decision|0
2184504|NCT01440374|3813094|FG003|Part 1: Open-label Phase|Physician Decision|0
2220783|NCT01734382|3865479|FG001|Part 2|Physician Decision|0
2220784|NCT01734382|3865480|FG002|Part 2|Physician Decision|3
2220785|NCT01734382|3865478|FG000|Part 2|Protocol Violation|0
2220786|NCT01734382|3865479|FG001|Part 2|Protocol Violation|1
2220787|NCT01734382|3865480|FG002|Part 2|Protocol Violation|0
2220788|NCT01734382|3865478|FG000|Part 2|Withdrawal by Subject|0
2220789|NCT01734382|3865479|FG001|Part 2|Withdrawal by Subject|0
2220790|NCT01734382|3865480|FG002|Part 2|Withdrawal by Subject|1
2220791|NCT01734395|3865492|FG000|Overall Study|Other|65
2220792|NCT01734395|3865492|FG000|Overall Study|Lost to Follow-up|287
2220793|NCT01734395|3865492|FG000|Overall Study|Lack of Efficacy|5
2220794|NCT01734395|3865492|FG000|Overall Study|Adverse Event|40
2220795|NCT01734395|3865492|FG000|Overall Study|Withdrawal by Subject|10
2220796|NCT01734395|3865492|FG000|Overall Study|Missing the reasons for not completed|3
2220797|NCT01734434|3865500|FG000|Overall Study|Death Infant|3
2220798|NCT01734434|3865501|FG001|Overall Study|Death Infant|1
2220799|NCT01734434|3865502|FG002|Overall Study|Death Infant|17
2220800|NCT01734434|3865503|FG003|Overall Study|Death Infant|5
2220801|NCT01734434|3865500|FG000|Overall Study|Lost to Follow-up|2
2220802|NCT01734434|3865501|FG001|Overall Study|Lost to Follow-up|9
2220803|NCT01734434|3865502|FG002|Overall Study|Lost to Follow-up|67
2220804|NCT01734434|3865503|FG003|Overall Study|Lost to Follow-up|11
2220805|NCT01734434|3865500|FG000|Overall Study|No Live Birth|1
2220806|NCT01734434|3865501|FG001|Overall Study|No Live Birth|2
2220807|NCT01734434|3865502|FG002|Overall Study|No Live Birth|32
2220808|NCT01734434|3865503|FG003|Overall Study|No Live Birth|6
2220809|NCT01734434|3865500|FG000|Overall Study|Withdrawal by Subject|4
2220810|NCT01734434|3865501|FG001|Overall Study|Withdrawal by Subject|0
2220811|NCT01734434|3865502|FG002|Overall Study|Withdrawal by Subject|8
2220812|NCT01734434|3865503|FG003|Overall Study|Withdrawal by Subject|1
2332023|NCT03183518|4055133|FG000|Overall Study|Other (Not specified)|2
2332024|NCT03183518|4055133|FG000|Overall Study|Other (Withdrawal of consent)|1
2332025|NCT03183908|4055149|FG000|Overall Study|Missing Symptom Diary Data|0
2332026|NCT03183908|4055150|FG001|Overall Study|Missing Symptom Diary Data|2
2332027|NCT03184077|4055162|FG000|Overall Study|Lost to Follow-up|21
2332028|NCT03184077|4055163|FG001|Overall Study|Lost to Follow-up|21
2332029|NCT03184441|4055185|FG000|Overall Study|Withdrawal by Subject|1
2332030|NCT03184519|4055192|FG000|Overall Study|Lost to Follow-up|6
2332031|NCT03184519|4055192|FG000|Overall Study|Physician Decision|21
2332032|NCT03184558|4055196|FG000|Overall Study|Withdrawal by Subject|2
2332033|NCT03184558|4055196|FG000|Overall Study|Death|16
2332034|NCT03184558|4055196|FG000|Overall Study|Lost to Follow-up|2
2332035|NCT03184558|4055196|FG000|Overall Study|Other|9
2332036|NCT03184701|4055200|FG000|Overall Study|Death|3
2184505|NCT01440374|3813091|FG000|Part 2; Double-blind Phase|Physician Decision|0
2184506|NCT01440374|3813092|FG001|Part 2; Double-blind Phase|Physician Decision|8
2184507|NCT01440374|3813093|FG002|Part 2; Double-blind Phase|Physician Decision|17
2184508|NCT01440374|3813094|FG003|Part 2; Double-blind Phase|Physician Decision|0
2184509|NCT01440374|3813091|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0
2184510|NCT01440374|3813092|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4
2184511|NCT01440374|3813093|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5
2184512|NCT01440374|3813094|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0
2184513|NCT01440374|3813091|FG000|Part 2; Double-blind Phase|Protocol Violation|0
2184514|NCT01440374|3813092|FG001|Part 2; Double-blind Phase|Protocol Violation|0
2184515|NCT01440374|3813093|FG002|Part 2; Double-blind Phase|Protocol Violation|1
2184516|NCT01440374|3813094|FG003|Part 2; Double-blind Phase|Protocol Violation|0
2184517|NCT01440374|3813091|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0
2184518|NCT01440374|3813092|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1
2184519|NCT01440374|3813093|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0
2184520|NCT01440374|3813094|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0
2184521|NCT01440374|3813091|FG000|Part 2; Double-blind Phase|Adverse Event|0
2184522|NCT01440374|3813092|FG001|Part 2; Double-blind Phase|Adverse Event|7
2184523|NCT01440374|3813093|FG002|Part 2; Double-blind Phase|Adverse Event|31
2184524|NCT01440374|3813094|FG003|Part 2; Double-blind Phase|Adverse Event|0
2184525|NCT01440374|3813091|FG000|Part 2; Double-blind Phase|Not treated|0
2184526|NCT01440374|3813092|FG001|Part 2; Double-blind Phase|Not treated|0
2184527|NCT01440374|3813093|FG002|Part 2; Double-blind Phase|Not treated|1
2184528|NCT01440374|3813094|FG003|Part 2; Double-blind Phase|Not treated|0
2184529|NCT01440374|3813091|FG000|Part 3: Extension|Withdrawal by Subject|0
2184530|NCT01440374|3813092|FG001|Part 3: Extension|Withdrawal by Subject|0
2184531|NCT01440374|3813093|FG002|Part 3: Extension|Withdrawal by Subject|0
2184532|NCT01440374|3813094|FG003|Part 3: Extension|Withdrawal by Subject|5
2184533|NCT01440374|3813091|FG000|Part 3: Extension|Adverse Event|0
2184534|NCT01440374|3813092|FG001|Part 3: Extension|Adverse Event|0
2184535|NCT01440374|3813093|FG002|Part 3: Extension|Adverse Event|0
2184536|NCT01440374|3813094|FG003|Part 3: Extension|Adverse Event|13
2184537|NCT01440374|3813091|FG000|Part 3: Extension|Physician Decision|0
2184538|NCT01440374|3813092|FG001|Part 3: Extension|Physician Decision|0
2184539|NCT01440374|3813093|FG002|Part 3: Extension|Physician Decision|0
2184540|NCT01440374|3813094|FG003|Part 3: Extension|Physician Decision|14
2184541|NCT01440569|3813134|FG000|Main Study|Enrolled but not treated|1
2184542|NCT01440569|3813135|FG001|Main Study|Enrolled but not treated|0
2184543|NCT01440569|3813134|FG000|Main Study|Adverse Event|9
2184544|NCT01440569|3813135|FG001|Main Study|Adverse Event|0
2184545|NCT01440569|3813134|FG000|Main Study|Pregnancy|1
2184546|NCT01440569|3813135|FG001|Main Study|Pregnancy|0
2184547|NCT01440569|3813134|FG000|Main Study|Investigator's Discretion|1
2184548|NCT01440569|3813135|FG001|Main Study|Investigator's Discretion|1
2184549|NCT01440569|3813134|FG000|Main Study|Withdrew Consent|7
2184550|NCT01440569|3813135|FG001|Main Study|Withdrew Consent|1
2184551|NCT01440569|3813134|FG000|Main Study|Lost to Follow-up|13
2184552|NCT01440569|3813135|FG001|Main Study|Lost to Follow-up|2
2184553|NCT01440569|3813134|FG000|Main Study|Subject Non-Compliance|3
2184554|NCT01440569|3813135|FG001|Main Study|Subject Non-Compliance|0
2184555|NCT01440569|3813134|FG000|Main Study|Protocol Violation|1
2184556|NCT01440569|3813135|FG001|Main Study|Protocol Violation|0
2184557|NCT01440569|3813134|FG000|Open-Label Rollover Phase|Adverse Event|3
2184558|NCT01440569|3813135|FG001|Open-Label Rollover Phase|Adverse Event|0
2184559|NCT01440569|3813134|FG000|Open-Label Rollover Phase|Pregnancy|1
2184560|NCT01440569|3813135|FG001|Open-Label Rollover Phase|Pregnancy|0
2184561|NCT01440569|3813134|FG000|Open-Label Rollover Phase|Lack of Efficacy|2
2184562|NCT01440569|3813135|FG001|Open-Label Rollover Phase|Lack of Efficacy|0
2184563|NCT01440569|3813134|FG000|Open-Label Rollover Phase|Investigator's Discretion|3
2184564|NCT01440569|3813135|FG001|Open-Label Rollover Phase|Investigator's Discretion|1
2184565|NCT01440569|3813134|FG000|Open-Label Rollover Phase|Withdrew Consent|11
2184566|NCT01440569|3813135|FG001|Open-Label Rollover Phase|Withdrew Consent|1
2184567|NCT01440569|3813134|FG000|Open-Label Rollover Phase|Lost to Follow-up|26
2184568|NCT01440569|3813135|FG001|Open-Label Rollover Phase|Lost to Follow-up|3
2184569|NCT01440569|3813134|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1
2220813|NCT01734434|3865500|FG000|Overall Study|Signed Adult Version of Consent Form|0
2220814|NCT01734434|3865501|FG001|Overall Study|Signed Adult Version of Consent Form|0
2220815|NCT01734434|3865502|FG002|Overall Study|Signed Adult Version of Consent Form|1
2220816|NCT01734434|3865503|FG003|Overall Study|Signed Adult Version of Consent Form|0
2220817|NCT01734434|3865500|FG000|Overall Study|Subject Not Reachable|0
2220818|NCT01734434|3865501|FG001|Overall Study|Subject Not Reachable|0
2220819|NCT01734434|3865502|FG002|Overall Study|Subject Not Reachable|1
2220820|NCT01734434|3865503|FG003|Overall Study|Subject Not Reachable|0
2184570|NCT01440569|3813135|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1
2184571|NCT01440647|3813152|FG000|Overall Study|Death|2
2184572|NCT01440647|3813153|FG001|Overall Study|Death|3
2184573|NCT01440803|3813187|FG000|Overall Study|Met study stopping rule|2
2184574|NCT01440803|3813188|FG001|Overall Study|Met study stopping rule|1
2184575|NCT01440803|3813187|FG000|Overall Study|Lost to Follow-up|0
2184576|NCT01440803|3813188|FG001|Overall Study|Lost to Follow-up|2
2184577|NCT01440803|3813187|FG000|Overall Study|Withdrawal by Subject|0
2184578|NCT01440803|3813188|FG001|Overall Study|Withdrawal by Subject|1
2184579|NCT01440816|3813197|FG000|Overall Study|Disease Progression|0
2184580|NCT01440816|3813198|FG001|Overall Study|Disease Progression|9
2184581|NCT01440816|3813197|FG000|Overall Study|To Be Seen By Local Oncologist|1
2184582|NCT01440816|3813198|FG001|Overall Study|To Be Seen By Local Oncologist|2
2184583|NCT01440881|3813208|FG000|Overall Study|Death|0
2184584|NCT01440881|3813209|FG001|Overall Study|Death|1
2184585|NCT01440946|3813231|FG000|Overall Study|Lost to Follow-up|1
2184586|NCT01440946|3813232|FG001|Overall Study|Lost to Follow-up|1
2184587|NCT01440946|3813231|FG000|Overall Study|Physician Decision|1
2184588|NCT01440946|3813232|FG001|Overall Study|Physician Decision|0
2184589|NCT01440972|3813245|FG000|Overall Study|Withdrawal by Subject|3
2184590|NCT01440972|3813246|FG001|Overall Study|Withdrawal by Subject|2
2184591|NCT01441063|3813256|FG000|Tocilizumab Alone|Required AZT/VGC addition|3
2184592|NCT01441063|3813256|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1
2184593|NCT01441102|3813267|FG000|Overall Study|Adverse Event|1
2184594|NCT01441102|3813267|FG000|Overall Study|Withdrawal by Subject|2
2184595|NCT01441180|3813274|FG000|Overall Study|Lost to Follow-up|1
2184596|NCT01441180|3813275|FG001|Overall Study|Lost to Follow-up|1
2184597|NCT01441180|3813276|FG002|Overall Study|Lost to Follow-up|1
2184598|NCT01441180|3813274|FG000|Overall Study|Discontinued|0
2184599|NCT01441180|3813275|FG001|Overall Study|Discontinued|0
2184600|NCT01441180|3813276|FG002|Overall Study|Discontinued|2
2184601|NCT01441414|3813330|FG000|Overall Study|Participant died|9
2184602|NCT01441414|3813330|FG000|Overall Study|Other reasons|3
2184603|NCT01441414|3813330|FG000|Overall Study|Study terminated by sponsor|2
2184604|NCT01441414|3813330|FG000|Overall Study|Subject refused further follow-up|1
2184605|NCT01441440|3813349|FG000|Overall Study|Death|1
2184606|NCT01441440|3813350|FG001|Overall Study|Death|0
2184607|NCT01441440|3813351|FG002|Overall Study|Death|1
2184608|NCT01441440|3813349|FG000|Overall Study|Adverse Event|2
2184609|NCT01441440|3813350|FG001|Overall Study|Adverse Event|9
2184610|NCT01441440|3813351|FG002|Overall Study|Adverse Event|9
2184611|NCT01441440|3813349|FG000|Overall Study|Lost to Follow-up|0
2184612|NCT01441440|3813350|FG001|Overall Study|Lost to Follow-up|2
2184613|NCT01441440|3813351|FG002|Overall Study|Lost to Follow-up|1
2184614|NCT01441440|3813349|FG000|Overall Study|Withdrawal by Subject|11
2184615|NCT01441440|3813350|FG001|Overall Study|Withdrawal by Subject|9
2184616|NCT01441440|3813351|FG002|Overall Study|Withdrawal by Subject|9
2184617|NCT01441440|3813349|FG000|Overall Study|Pregnancy|1
2184618|NCT01441440|3813350|FG001|Overall Study|Pregnancy|0
2184619|NCT01441440|3813351|FG002|Overall Study|Pregnancy|0
2184620|NCT01441440|3813349|FG000|Overall Study|Lack of Efficacy|1
2184621|NCT01441440|3813350|FG001|Overall Study|Lack of Efficacy|0
2184622|NCT01441440|3813351|FG002|Overall Study|Lack of Efficacy|1
2184623|NCT01441440|3813349|FG000|Overall Study|Moving|0
2184624|NCT01441440|3813350|FG001|Overall Study|Moving|1
2184625|NCT01441440|3813351|FG002|Overall Study|Moving|1
2184626|NCT01441440|3813349|FG000|Overall Study|Work-related matter|0
2184627|NCT01441440|3813350|FG001|Overall Study|Work-related matter|1
2184628|NCT01441440|3813351|FG002|Overall Study|Work-related matter|0
2184629|NCT01441440|3813349|FG000|Overall Study|Difficllty in keeping the schedule|1
2184630|NCT01441440|3813350|FG001|Overall Study|Difficllty in keeping the schedule|1
2184631|NCT01441440|3813351|FG002|Overall Study|Difficllty in keeping the schedule|0
2184632|NCT01441596|3813392|FG000|Overall Study|Other reason not defined below|0
2184633|NCT01441596|3813393|FG001|Overall Study|Other reason not defined below|2
2184634|NCT01441596|3813394|FG002|Overall Study|Other reason not defined below|1
2184635|NCT01441596|3813392|FG000|Overall Study|Withdrawal by Subject|4
2184636|NCT01441596|3813393|FG001|Overall Study|Withdrawal by Subject|0
2184637|NCT01441596|3813394|FG002|Overall Study|Withdrawal by Subject|2
2184638|NCT01441596|3813392|FG000|Overall Study|Not treated|0
2184639|NCT01441596|3813393|FG001|Overall Study|Not treated|1
2184640|NCT01441596|3813394|FG002|Overall Study|Not treated|1
2184641|NCT01441635|3813412|FG000|Overall Study|Adverse Event|4
2184642|NCT01441635|3813413|FG001|Overall Study|Adverse Event|3
2184643|NCT01441635|3813414|FG002|Overall Study|Adverse Event|1
2220821|NCT01734434|3865500|FG000|Overall Study|Treatment Defaulter|0
2220822|NCT01734434|3865501|FG001|Overall Study|Treatment Defaulter|0
2220823|NCT01734434|3865502|FG002|Overall Study|Treatment Defaulter|1
2220824|NCT01734434|3865503|FG003|Overall Study|Treatment Defaulter|0
2220825|NCT01734434|3865500|FG000|Overall Study|Wrong Version of Consent Form Signed|0
2220826|NCT01734434|3865501|FG001|Overall Study|Wrong Version of Consent Form Signed|0
2220827|NCT01734434|3865502|FG002|Overall Study|Wrong Version of Consent Form Signed|1
2220828|NCT01734434|3865503|FG003|Overall Study|Wrong Version of Consent Form Signed|0
2220829|NCT01734434|3865500|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0
2220830|NCT01734434|3865501|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0
2220831|NCT01734434|3865502|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1
2220832|NCT01734434|3865503|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0
2220833|NCT01734772|3865552|FG000|Overall Study|Adverse Event|1
2220834|NCT01734772|3865553|FG001|Overall Study|Adverse Event|2
2220835|NCT01734772|3865552|FG000|Overall Study|Withdrawal by Subject|0
2220836|NCT01734772|3865553|FG001|Overall Study|Withdrawal by Subject|1
2184644|NCT01441635|3813415|FG003|Overall Study|Adverse Event|5
2184645|NCT01441635|3813416|FG004|Overall Study|Adverse Event|1
2184646|NCT01441635|3813417|FG005|Overall Study|Adverse Event|2
2184647|NCT01441635|3813418|FG006|Overall Study|Adverse Event|2
2184648|NCT01441635|3813419|FG007|Overall Study|Adverse Event|2
2184649|NCT01441635|3813420|FG008|Overall Study|Adverse Event|1
2184650|NCT01441635|3813421|FG009|Overall Study|Adverse Event|0
2184651|NCT01441635|3813412|FG000|Overall Study|Withdrawal by Subject|1
2184652|NCT01441635|3813413|FG001|Overall Study|Withdrawal by Subject|1
2184653|NCT01441635|3813414|FG002|Overall Study|Withdrawal by Subject|0
2184654|NCT01441635|3813415|FG003|Overall Study|Withdrawal by Subject|1
2184655|NCT01441635|3813416|FG004|Overall Study|Withdrawal by Subject|0
2184656|NCT01441635|3813417|FG005|Overall Study|Withdrawal by Subject|0
2184657|NCT01441635|3813418|FG006|Overall Study|Withdrawal by Subject|2
2184658|NCT01441635|3813419|FG007|Overall Study|Withdrawal by Subject|0
2184659|NCT01441635|3813420|FG008|Overall Study|Withdrawal by Subject|1
2184660|NCT01441635|3813421|FG009|Overall Study|Withdrawal by Subject|1
2184661|NCT01441635|3813412|FG000|Overall Study|Lost to Follow-up|0
2184662|NCT01441635|3813413|FG001|Overall Study|Lost to Follow-up|1
2184663|NCT01441635|3813414|FG002|Overall Study|Lost to Follow-up|1
2184664|NCT01441635|3813415|FG003|Overall Study|Lost to Follow-up|1
2184665|NCT01441635|3813416|FG004|Overall Study|Lost to Follow-up|1
2184666|NCT01441635|3813417|FG005|Overall Study|Lost to Follow-up|3
2184667|NCT01441635|3813418|FG006|Overall Study|Lost to Follow-up|1
2184668|NCT01441635|3813419|FG007|Overall Study|Lost to Follow-up|1
2184669|NCT01441635|3813420|FG008|Overall Study|Lost to Follow-up|0
2184670|NCT01441635|3813421|FG009|Overall Study|Lost to Follow-up|1
2184671|NCT01441635|3813412|FG000|Overall Study|Noncompliance|0
2184672|NCT01441635|3813413|FG001|Overall Study|Noncompliance|1
2184673|NCT01441635|3813414|FG002|Overall Study|Noncompliance|0
2184674|NCT01441635|3813415|FG003|Overall Study|Noncompliance|0
2184675|NCT01441635|3813416|FG004|Overall Study|Noncompliance|0
2184676|NCT01441635|3813417|FG005|Overall Study|Noncompliance|0
2184677|NCT01441635|3813418|FG006|Overall Study|Noncompliance|1
2184678|NCT01441635|3813419|FG007|Overall Study|Noncompliance|0
2184679|NCT01441635|3813420|FG008|Overall Study|Noncompliance|0
2184680|NCT01441635|3813421|FG009|Overall Study|Noncompliance|0
2184681|NCT01441635|3813412|FG000|Overall Study|Surgery or Invasive Intervention|0
2184682|NCT01441635|3813413|FG001|Overall Study|Surgery or Invasive Intervention|0
2184683|NCT01441635|3813414|FG002|Overall Study|Surgery or Invasive Intervention|1
2184684|NCT01441635|3813415|FG003|Overall Study|Surgery or Invasive Intervention|0
2184685|NCT01441635|3813416|FG004|Overall Study|Surgery or Invasive Intervention|0
2184686|NCT01441635|3813417|FG005|Overall Study|Surgery or Invasive Intervention|0
2184687|NCT01441635|3813418|FG006|Overall Study|Surgery or Invasive Intervention|0
2184688|NCT01441635|3813419|FG007|Overall Study|Surgery or Invasive Intervention|0
2184689|NCT01441635|3813420|FG008|Overall Study|Surgery or Invasive Intervention|0
2184690|NCT01441635|3813421|FG009|Overall Study|Surgery or Invasive Intervention|0
2184691|NCT01441635|3813412|FG000|Overall Study|Received Exclusionary Medication|1
2184692|NCT01441635|3813413|FG001|Overall Study|Received Exclusionary Medication|0
2184693|NCT01441635|3813414|FG002|Overall Study|Received Exclusionary Medication|0
2184694|NCT01441635|3813415|FG003|Overall Study|Received Exclusionary Medication|0
2184695|NCT01441635|3813416|FG004|Overall Study|Received Exclusionary Medication|0
2184696|NCT01441635|3813417|FG005|Overall Study|Received Exclusionary Medication|0
2184697|NCT01441635|3813418|FG006|Overall Study|Received Exclusionary Medication|0
2184698|NCT01441635|3813419|FG007|Overall Study|Received Exclusionary Medication|0
2184699|NCT01441635|3813420|FG008|Overall Study|Received Exclusionary Medication|0
2184700|NCT01441635|3813421|FG009|Overall Study|Received Exclusionary Medication|0
2184701|NCT01441635|3813412|FG000|Overall Study|Other|0
2184702|NCT01441635|3813413|FG001|Overall Study|Other|0
2184703|NCT01441635|3813414|FG002|Overall Study|Other|0
2184704|NCT01441635|3813415|FG003|Overall Study|Other|0
2184705|NCT01441635|3813416|FG004|Overall Study|Other|0
2184706|NCT01441635|3813417|FG005|Overall Study|Other|0
2184707|NCT01441635|3813418|FG006|Overall Study|Other|0
2184708|NCT01441635|3813419|FG007|Overall Study|Other|1
2184709|NCT01441635|3813420|FG008|Overall Study|Other|0
2184710|NCT01441635|3813421|FG009|Overall Study|Other|0
2184711|NCT01441765|3813445|FG000|Overall Study|Death|1
2184712|NCT01441765|3813446|FG001|Overall Study|Death|0
2184713|NCT01441960|3813465|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
2184714|NCT01441960|3813466|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
2184715|NCT01441960|3813465|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1
2184716|NCT01441960|3813466|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1
2184717|NCT01441960|3813465|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
2184718|NCT01441960|3813466|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
2184719|NCT01441973|3813478|FG000|Overall Study|Disease progression|8
2184720|NCT01441973|3813479|FG001|Overall Study|Disease progression|6
2184721|NCT01441973|3813478|FG000|Overall Study|Adverse event unrelated to study drug|3
2184722|NCT01441973|3813479|FG001|Overall Study|Adverse event unrelated to study drug|2
2184723|NCT01441973|3813478|FG000|Overall Study|Participant request to discontinue|1
2184724|NCT01441973|3813479|FG001|Overall Study|Participant request to discontinue|1
2184725|NCT01441973|3813478|FG000|Overall Study|Poor compliance/noncompliance|0
2220837|NCT01734785|3865568|FG000|Open-Label Period|Adverse Event|0
2184726|NCT01441973|3813479|FG001|Overall Study|Poor compliance/noncompliance|1
2184727|NCT01441973|3813478|FG000|Overall Study|Administrative reason by sponsor|3
2184728|NCT01441973|3813479|FG001|Overall Study|Administrative reason by sponsor|5
2184729|NCT01441973|3813478|FG000|Overall Study|Participant withdrew consent|0
2184730|NCT01441973|3813479|FG001|Overall Study|Participant withdrew consent|1
2184731|NCT01442038|3813488|FG000|Overall Study|Death|35
2184732|NCT01442038|3813489|FG001|Overall Study|Death|29
2184733|NCT01442038|3813488|FG000|Overall Study|Investigator-Initiated Early Closure|44
2184734|NCT01442038|3813489|FG001|Overall Study|Investigator-Initiated Early Closure|43
2184735|NCT01442038|3813488|FG000|Overall Study|Participant Withdrew Consent|137
2184736|NCT01442038|3813489|FG001|Overall Study|Participant Withdrew Consent|102
2184737|NCT01442038|3813488|FG000|Overall Study|Lost to Follow-up|37
2184738|NCT01442038|3813489|FG001|Overall Study|Lost to Follow-up|51
2184739|NCT01442038|3813488|FG000|Overall Study|Adverse Event|26
2184740|NCT01442038|3813489|FG001|Overall Study|Adverse Event|15
2184741|NCT01442038|3813488|FG000|Overall Study|Protocol Deviation|9
2184742|NCT01442038|3813489|FG001|Overall Study|Protocol Deviation|20
2184743|NCT01442038|3813488|FG000|Overall Study|Investigator's Discretion|13
2184744|NCT01442038|3813489|FG001|Overall Study|Investigator's Discretion|16
2184745|NCT01442038|3813488|FG000|Overall Study|Study Terminated By Sponsor|2
2184746|NCT01442038|3813489|FG001|Overall Study|Study Terminated By Sponsor|3
2184747|NCT01442064|3813501|FG000|Overall Study|Adverse Event|2
2184748|NCT01442064|3813502|FG001|Overall Study|Adverse Event|2
2184749|NCT01442064|3813503|FG002|Overall Study|Adverse Event|2
2184750|NCT01442064|3813504|FG003|Overall Study|Adverse Event|1
2184751|NCT01442064|3813505|FG004|Overall Study|Adverse Event|2
2184752|NCT01442064|3813506|FG005|Overall Study|Adverse Event|0
2184753|NCT01442064|3813501|FG000|Overall Study|Death|0
2184754|NCT01442064|3813502|FG001|Overall Study|Death|1
2184755|NCT01442064|3813503|FG002|Overall Study|Death|3
2184756|NCT01442064|3813504|FG003|Overall Study|Death|3
2184757|NCT01442064|3813505|FG004|Overall Study|Death|1
2184758|NCT01442064|3813506|FG005|Overall Study|Death|3
2184759|NCT01442064|3813501|FG000|Overall Study|Lost to Follow-up|5
2184760|NCT01442064|3813502|FG001|Overall Study|Lost to Follow-up|5
2184761|NCT01442064|3813503|FG002|Overall Study|Lost to Follow-up|1
2184762|NCT01442064|3813504|FG003|Overall Study|Lost to Follow-up|1
2184763|NCT01442064|3813505|FG004|Overall Study|Lost to Follow-up|3
2184764|NCT01442064|3813506|FG005|Overall Study|Lost to Follow-up|3
2184765|NCT01442064|3813501|FG000|Overall Study|Physician Decision|1
2184766|NCT01442064|3813502|FG001|Overall Study|Physician Decision|1
2184767|NCT01442064|3813503|FG002|Overall Study|Physician Decision|2
2184768|NCT01442064|3813504|FG003|Overall Study|Physician Decision|3
2184769|NCT01442064|3813505|FG004|Overall Study|Physician Decision|3
2184770|NCT01442064|3813506|FG005|Overall Study|Physician Decision|1
2184771|NCT01442064|3813501|FG000|Overall Study|Withdrawal by Subject|6
2184772|NCT01442064|3813502|FG001|Overall Study|Withdrawal by Subject|3
2184773|NCT01442064|3813503|FG002|Overall Study|Withdrawal by Subject|2
2184774|NCT01442064|3813504|FG003|Overall Study|Withdrawal by Subject|2
2184775|NCT01442064|3813505|FG004|Overall Study|Withdrawal by Subject|2
2184776|NCT01442064|3813506|FG005|Overall Study|Withdrawal by Subject|1
2184777|NCT01442064|3813501|FG000|Overall Study|Sponsor decision|82
2184778|NCT01442064|3813502|FG001|Overall Study|Sponsor decision|88
2184779|NCT01442064|3813503|FG002|Overall Study|Sponsor decision|92
2184780|NCT01442064|3813504|FG003|Overall Study|Sponsor decision|88
2184781|NCT01442064|3813505|FG004|Overall Study|Sponsor decision|95
2184782|NCT01442064|3813506|FG005|Overall Study|Sponsor decision|87
2184783|NCT01442064|3813501|FG000|Overall Study|Subject non-compliance|0
2184784|NCT01442064|3813502|FG001|Overall Study|Subject non-compliance|0
2184785|NCT01442064|3813503|FG002|Overall Study|Subject non-compliance|0
2184786|NCT01442064|3813504|FG003|Overall Study|Subject non-compliance|0
2184787|NCT01442064|3813505|FG004|Overall Study|Subject non-compliance|0
2184788|NCT01442064|3813506|FG005|Overall Study|Subject non-compliance|2
2184789|NCT01442064|3813501|FG000|Overall Study|Condition mandated other intervention|1
2184790|NCT01442064|3813502|FG001|Overall Study|Condition mandated other intervention|1
2184791|NCT01442064|3813503|FG002|Overall Study|Condition mandated other intervention|2
2184792|NCT01442064|3813504|FG003|Overall Study|Condition mandated other intervention|0
2184793|NCT01442064|3813505|FG004|Overall Study|Condition mandated other intervention|0
2184794|NCT01442064|3813506|FG005|Overall Study|Condition mandated other intervention|2
2184795|NCT01442103|3813523|FG000|Overall Study|Lost to Follow-up|2
2184796|NCT01442155|3813536|FG000|Overall Study|Complete remission|35
2184797|NCT01442155|3813536|FG000|Overall Study|Recurrence|26
2184798|NCT01442155|3813536|FG000|Overall Study|Adverse Event|2
2184799|NCT01442155|3813536|FG000|Overall Study|Lost to Follow-up|2
2184800|NCT01442181|3813542|FG000|Overall Study|patient refused surgery|1
2184801|NCT01442181|3813543|FG001|Overall Study|patient refused surgery|0
2184802|NCT01442181|3813542|FG000|Overall Study|no insurance for surgery|1
2184803|NCT01442181|3813543|FG001|Overall Study|no insurance for surgery|0
2184804|NCT01442181|3813542|FG000|Overall Study|low ejection factor|0
2184805|NCT01442181|3813543|FG001|Overall Study|low ejection factor|1
2184806|NCT01442181|3813542|FG000|Overall Study|Lost to Follow-up|1
2184807|NCT01442181|3813543|FG001|Overall Study|Lost to Follow-up|1
2184808|NCT01442181|3813542|FG000|Overall Study|patient in an additional study|1
2184809|NCT01442181|3813543|FG001|Overall Study|patient in an additional study|0
2184810|NCT01442181|3813542|FG000|Overall Study|atrial fibrillation not noted|0
2184811|NCT01442181|3813543|FG001|Overall Study|atrial fibrillation not noted|1
2184812|NCT01442376|3813553|FG000|Overall Study|Adverse Event|0
2184813|NCT01442376|3813554|FG001|Overall Study|Adverse Event|3
2184814|NCT01442376|3813555|FG002|Overall Study|Adverse Event|2
2184815|NCT01442376|3813553|FG000|Overall Study|Death|0
2184816|NCT01442376|3813554|FG001|Overall Study|Death|1
2184817|NCT01442376|3813555|FG002|Overall Study|Death|1
2184818|NCT01442376|3813553|FG000|Overall Study|Withdrawal of consent|0
2184819|NCT01442376|3813554|FG001|Overall Study|Withdrawal of consent|0
2184820|NCT01442376|3813555|FG002|Overall Study|Withdrawal of consent|1
2184821|NCT01442376|3813553|FG000|Overall Study|Patients not treated|2
2184822|NCT01442376|3813554|FG001|Overall Study|Patients not treated|3
2184823|NCT01442376|3813555|FG002|Overall Study|Patients not treated|1
2184824|NCT01442376|3813553|FG000|Overall Study|Not eligible for subsequent cycles|1
2184825|NCT01442376|3813554|FG001|Overall Study|Not eligible for subsequent cycles|2
2184826|NCT01442376|3813555|FG002|Overall Study|Not eligible for subsequent cycles|0
2184827|NCT01442493|3813565|FG000|Overall Study|withdrawn from study|3
2184828|NCT01442493|3813566|FG001|Overall Study|withdrawn from study|2
2184829|NCT01442675|3813572|FG000|Overall Study|Protocol Violation|6
2184830|NCT01442675|3813572|FG000|Overall Study|Lost to Follow-up|2
2184831|NCT01442675|3813572|FG000|Overall Study|Withdrawal by Subject|4
2184832|NCT01442688|3813579|FG000|First Intervention|Withdrawal by Subject|1
2184833|NCT01442688|3813580|FG001|First Intervention|Withdrawal by Subject|0
2184834|NCT01442688|3813579|FG000|First Intervention|subject incarcerated|1
2184835|NCT01442688|3813580|FG001|First Intervention|subject incarcerated|0
2184836|NCT01442688|3813579|FG000|Second Intervention|Adverse Event|1
2184837|NCT01442688|3813580|FG001|Second Intervention|Adverse Event|0
2184838|NCT01442714|3813586|FG000|Overall Study|Death|11
2184839|NCT01442714|3813586|FG000|Overall Study|Withdrawal by Subject|1
2184840|NCT01442779|3813592|FG000|Overall Study|Withdrawal by Subject|3
2184841|NCT01442779|3813592|FG000|Overall Study|Death|3
2184842|NCT01442779|3813592|FG000|Overall Study|Non-compliance|1
2184843|NCT01443026|3813607|FG000|Overall Study|Physician Decision|1
2184844|NCT01443026|3813608|FG001|Overall Study|Physician Decision|0
2184845|NCT01443026|3813607|FG000|Overall Study|Death|0
2184846|NCT01443026|3813608|FG001|Overall Study|Death|1
2184847|NCT01443026|3813607|FG000|Overall Study|Withdrawal by Subject|0
2184848|NCT01443026|3813608|FG001|Overall Study|Withdrawal by Subject|3
2184849|NCT01443026|3813607|FG000|Overall Study|Lost to Follow-up|2
2184850|NCT01443026|3813608|FG001|Overall Study|Lost to Follow-up|1
2184851|NCT01443078|3813614|FG000|Overall Study|Responded to neoadjuvant platinum txt|27
2184852|NCT01443078|3813614|FG000|Overall Study|Withdrawal by Subject|1
2184853|NCT01443078|3813614|FG000|Overall Study|Patient had brain mets|1
2184854|NCT01443130|3813624|FG000|Overall Study|Lost to Follow-up|44
2184855|NCT01443130|3813625|FG001|Overall Study|Lost to Follow-up|42
2184856|NCT01443130|3813626|FG002|Overall Study|Lost to Follow-up|50
2184857|NCT01443130|3813627|FG003|Overall Study|Lost to Follow-up|23
2184858|NCT01443130|3813628|FG004|Overall Study|Lost to Follow-up|25
2184859|NCT01443130|3813629|FG005|Overall Study|Lost to Follow-up|21
2184860|NCT01443130|3813624|FG000|Overall Study|Death|0
2184861|NCT01443130|3813625|FG001|Overall Study|Death|1
2184862|NCT01443130|3813626|FG002|Overall Study|Death|0
2184863|NCT01443130|3813627|FG003|Overall Study|Death|7
2184864|NCT01443130|3813628|FG004|Overall Study|Death|10
2184865|NCT01443130|3813629|FG005|Overall Study|Death|8
2184866|NCT01443130|3813624|FG000|Overall Study|Adverse Event|2
2184867|NCT01443130|3813625|FG001|Overall Study|Adverse Event|1
2184868|NCT01443130|3813626|FG002|Overall Study|Adverse Event|1
2184869|NCT01443130|3813627|FG003|Overall Study|Adverse Event|0
2184870|NCT01443130|3813628|FG004|Overall Study|Adverse Event|0
2184871|NCT01443130|3813629|FG005|Overall Study|Adverse Event|0
2184872|NCT01443130|3813624|FG000|Overall Study|Protocol Violation|2
2184873|NCT01443130|3813625|FG001|Overall Study|Protocol Violation|1
2184874|NCT01443130|3813626|FG002|Overall Study|Protocol Violation|3
2184875|NCT01443130|3813627|FG003|Overall Study|Protocol Violation|2
2184876|NCT01443130|3813628|FG004|Overall Study|Protocol Violation|2
2184877|NCT01443130|3813629|FG005|Overall Study|Protocol Violation|3
2184878|NCT01443130|3813624|FG000|Overall Study|Withdrawal by Subject|15
2184879|NCT01443130|3813625|FG001|Overall Study|Withdrawal by Subject|14
2184880|NCT01443130|3813626|FG002|Overall Study|Withdrawal by Subject|12
2184881|NCT01443130|3813627|FG003|Overall Study|Withdrawal by Subject|7
2184882|NCT01443130|3813628|FG004|Overall Study|Withdrawal by Subject|7
2184883|NCT01443130|3813629|FG005|Overall Study|Withdrawal by Subject|2
2184884|NCT01443130|3813624|FG000|Overall Study|Death of Subject's Infant|5
2184885|NCT01443130|3813625|FG001|Overall Study|Death of Subject's Infant|10
2184886|NCT01443130|3813626|FG002|Overall Study|Death of Subject's Infant|11
2184887|NCT01443130|3813627|FG003|Overall Study|Death of Subject's Infant|0
2184888|NCT01443130|3813628|FG004|Overall Study|Death of Subject's Infant|0
2184889|NCT01443130|3813629|FG005|Overall Study|Death of Subject's Infant|0
2184890|NCT01443364|3813643|FG000|Overall Study|Lack of Efficacy|14
2184891|NCT01443364|3813643|FG000|Overall Study|Lost to Follow-up|3
2184892|NCT01443364|3813643|FG000|Overall Study|Withdrawal by Subject|5
2184893|NCT01443364|3813643|FG000|Overall Study|Other Reason|4
2184894|NCT01443364|3813643|FG000|Overall Study|SAE, non-fatal|6
2184895|NCT01443364|3813643|FG000|Overall Study|AE, non-serious non-fatal|8
2184896|NCT01443364|3813643|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2184897|NCT01443403|3813651|FG000|Overall Study|Adverse Event|1
2184898|NCT01443403|3813652|FG001|Overall Study|Adverse Event|1
2184899|NCT01443403|3813653|FG002|Overall Study|Adverse Event|4
2184900|NCT01443403|3813654|FG003|Overall Study|Adverse Event|5
2184901|NCT01443403|3813651|FG000|Overall Study|Withdrawal by Subject|0
2184902|NCT01443403|3813652|FG001|Overall Study|Withdrawal by Subject|1
2184903|NCT01443403|3813653|FG002|Overall Study|Withdrawal by Subject|2
2184904|NCT01443403|3813654|FG003|Overall Study|Withdrawal by Subject|1
2184905|NCT01443403|3813651|FG000|Overall Study|Lost to Follow-up|0
2184906|NCT01443403|3813652|FG001|Overall Study|Lost to Follow-up|0
2184907|NCT01443403|3813653|FG002|Overall Study|Lost to Follow-up|0
2184908|NCT01443403|3813654|FG003|Overall Study|Lost to Follow-up|1
2184909|NCT01443403|3813651|FG000|Overall Study|Protocol Violation|2
2184910|NCT01443403|3813652|FG001|Overall Study|Protocol Violation|1
2184911|NCT01443403|3813653|FG002|Overall Study|Protocol Violation|1
2184912|NCT01443403|3813654|FG003|Overall Study|Protocol Violation|1
2184913|NCT01443403|3813651|FG000|Overall Study|Use of Prohibited Treatment|2
2184914|NCT01443403|3813652|FG001|Overall Study|Use of Prohibited Treatment|3
2184915|NCT01443403|3813653|FG002|Overall Study|Use of Prohibited Treatment|0
2184916|NCT01443403|3813654|FG003|Overall Study|Use of Prohibited Treatment|0
2184917|NCT01443403|3813651|FG000|Overall Study|Other - Miscellaneous|1
2184918|NCT01443403|3813652|FG001|Overall Study|Other - Miscellaneous|0
2184919|NCT01443403|3813653|FG002|Overall Study|Other - Miscellaneous|0
2184920|NCT01443403|3813654|FG003|Overall Study|Other - Miscellaneous|1
2184921|NCT01443845|3813697|FG000|Overall Study|Protocol Violation|43
2184922|NCT01443845|3813698|FG001|Overall Study|Protocol Violation|45
2184923|NCT01443845|3813697|FG000|Overall Study|Other reasons, such as COPD exacerbation|44
2184924|NCT01443845|3813698|FG001|Overall Study|Other reasons, such as COPD exacerbation|44
2184925|NCT01443845|3813697|FG000|Overall Study|Deterioration in pulmonary function|1
2184926|NCT01443845|3813698|FG001|Overall Study|Deterioration in pulmonary function|4
2184927|NCT01443845|3813697|FG000|Overall Study|Lack of Efficacy|10
2184928|NCT01443845|3813698|FG001|Overall Study|Lack of Efficacy|5
2184929|NCT01443845|3813697|FG000|Overall Study|Adverse Event|64
2184930|NCT01443845|3813698|FG001|Overall Study|Adverse Event|138
2184931|NCT01443845|3813697|FG000|Overall Study|Withdrawal by Subject|63
2184932|NCT01443845|3813698|FG001|Overall Study|Withdrawal by Subject|67
2184933|NCT01443845|3813697|FG000|Overall Study|Military Conflict - Site Terminated|20
2184934|NCT01443845|3813698|FG001|Overall Study|Military Conflict - Site Terminated|21
2184935|NCT01443845|3813697|FG000|Overall Study|Lost to Follow-up|9
2184936|NCT01443845|3813698|FG001|Overall Study|Lost to Follow-up|13
2184937|NCT01443858|3813707|FG000|Overall Study|Withdrawal by Subject|9
2184938|NCT01443858|3813708|FG001|Overall Study|Withdrawal by Subject|8
2184939|NCT01443858|3813709|FG002|Overall Study|Withdrawal by Subject|5
2184940|NCT01443858|3813707|FG000|Overall Study|Lack of Efficacy|1
2184941|NCT01443858|3813708|FG001|Overall Study|Lack of Efficacy|0
2184942|NCT01443858|3813709|FG002|Overall Study|Lack of Efficacy|0
2184943|NCT01443858|3813707|FG000|Overall Study|Lost to Follow-up|5
2184944|NCT01443858|3813708|FG001|Overall Study|Lost to Follow-up|5
2184945|NCT01443858|3813709|FG002|Overall Study|Lost to Follow-up|2
2184946|NCT01444027|3813720|FG000|Overall Study|Withdrawal by Subject|4
2184947|NCT01444027|3813721|FG001|Overall Study|Withdrawal by Subject|10
2184948|NCT01444027|3813722|FG002|Overall Study|Withdrawal by Subject|24
2184949|NCT01444027|3813720|FG000|Overall Study|Lost to Follow-up|26
2184950|NCT01444027|3813721|FG001|Overall Study|Lost to Follow-up|20
2184951|NCT01444027|3813722|FG002|Overall Study|Lost to Follow-up|14
2184952|NCT01444300|3813746|FG000|Overall Study|Adverse Event|4
2184953|NCT01444300|3813747|FG001|Overall Study|Adverse Event|0
2184954|NCT01444378|3813754|FG000|Overall Study|Lost to Follow-up|1
2184955|NCT01444378|3813754|FG000|Overall Study|Withdrawal by Subject|1
2184956|NCT01444378|3813754|FG000|Overall Study|Death|3
2184957|NCT01444378|3813754|FG000|Overall Study|Administrative Closure Of The Study|2
2184958|NCT01444378|3813754|FG000|Overall Study|Missed Visits|10
2184959|NCT01444391|3813761|FG000|Overall Study|Death|1
2184960|NCT01444417|3813767|FG000|Overall Study|Ineligibility Determined|0
2184961|NCT01444417|3813768|FG001|Overall Study|Ineligibility Determined|1
2184962|NCT01444417|3813767|FG000|Overall Study|Withdrawal by Subject|2
2184963|NCT01444417|3813768|FG001|Overall Study|Withdrawal by Subject|0
2184964|NCT01444430|3813776|FG000|Overall Study|Withdrawal by Subject|53
2184965|NCT01444430|3813777|FG001|Overall Study|Withdrawal by Subject|72
2184966|NCT01444430|3813776|FG000|Overall Study|Death|6
2184967|NCT01444430|3813777|FG001|Overall Study|Death|8
2184968|NCT01444430|3813776|FG000|Overall Study|Lost to Follow-up|2
2184969|NCT01444430|3813777|FG001|Overall Study|Lost to Follow-up|0
2184970|NCT01444430|3813776|FG000|Overall Study|CRF termination module not completed.|0
2184971|NCT01444430|3813777|FG001|Overall Study|CRF termination module not completed.|1
2184972|NCT01444456|3813783|FG000|Overall Study|Withdrawal by Subject|21
2184973|NCT01444456|3813783|FG000|Overall Study|Physician Decision|9
2184974|NCT01444456|3813783|FG000|Overall Study|Lost to Follow-up|37
2184975|NCT01444456|3813783|FG000|Overall Study|Death|73
2184976|NCT01444456|3813783|FG000|Overall Study|Ineligibility determined|23
2184977|NCT01444456|3813783|FG000|Overall Study|Other|18
2184978|NCT01444456|3813783|FG000|Overall Study|Not treated|104
2184979|NCT01444651|3813789|FG000|Overall Study|Adverse Event|3
2184980|NCT01444651|3813790|FG001|Overall Study|Adverse Event|2
2184981|NCT01444651|3813789|FG000|Overall Study|Lost to Follow-up|5
2184982|NCT01444651|3813790|FG001|Overall Study|Lost to Follow-up|5
2184983|NCT01444651|3813789|FG000|Overall Study|Non-fasting|2
2184984|NCT01444651|3813790|FG001|Overall Study|Non-fasting|1
2184985|NCT01444651|3813789|FG000|Overall Study|Missing data|1
2184986|NCT01444651|3813790|FG001|Overall Study|Missing data|1
2184987|NCT01444742|3813800|FG000|Overall Study|Death|1
2184988|NCT01444781|3813807|FG000|Overall Study|Lost to Follow-up|0
2184989|NCT01444781|3813808|FG001|Overall Study|Lost to Follow-up|3
2184990|NCT01444781|3813809|FG002|Overall Study|Lost to Follow-up|1
2184991|NCT01444781|3813807|FG000|Overall Study|Withdrawal by Subject|3
2184992|NCT01444781|3813808|FG001|Overall Study|Withdrawal by Subject|1
2184993|NCT01444781|3813809|FG002|Overall Study|Withdrawal by Subject|2
2184994|NCT01444898|3813824|FG000|Overall Study|Withdrawal by Subject|1
2184995|NCT01445080|3813864|FG000|Overall Study|Adverse Event|5
2184996|NCT01445080|3813865|FG001|Overall Study|Adverse Event|3
2184997|NCT01445080|3813866|FG002|Overall Study|Adverse Event|11
2184998|NCT01445080|3813867|FG003|Overall Study|Adverse Event|6
2184999|NCT01445080|3813868|FG004|Overall Study|Adverse Event|2
2185000|NCT01445080|3813869|FG005|Overall Study|Adverse Event|3
2220838|NCT01734785|3865569|FG001|Open-Label Period|Adverse Event|0
2220839|NCT01734785|3865570|FG002|Open-Label Period|Adverse Event|0
2220840|NCT01734785|3865571|FG003|Open-Label Period|Adverse Event|9
2220841|NCT01734785|3865568|FG000|Open-Label Period|Lack of Efficacy|0
2220842|NCT01734785|3865569|FG001|Open-Label Period|Lack of Efficacy|0
2220843|NCT01734785|3865570|FG002|Open-Label Period|Lack of Efficacy|0
2220844|NCT01734785|3865571|FG003|Open-Label Period|Lack of Efficacy|1
2220845|NCT01734785|3865568|FG000|Open-Label Period|Protocol Violation|0
2220846|NCT01734785|3865569|FG001|Open-Label Period|Protocol Violation|0
2220847|NCT01734785|3865570|FG002|Open-Label Period|Protocol Violation|0
2220848|NCT01734785|3865571|FG003|Open-Label Period|Protocol Violation|13
2220849|NCT01734785|3865568|FG000|Open-Label Period|Lost to Follow-up|0
2220850|NCT01734785|3865569|FG001|Open-Label Period|Lost to Follow-up|0
2220851|NCT01734785|3865570|FG002|Open-Label Period|Lost to Follow-up|0
2220852|NCT01734785|3865571|FG003|Open-Label Period|Lost to Follow-up|14
2220853|NCT01734785|3865568|FG000|Open-Label Period|Withdrawal by Subject|0
2220854|NCT01734785|3865569|FG001|Open-Label Period|Withdrawal by Subject|0
2220855|NCT01734785|3865570|FG002|Open-Label Period|Withdrawal by Subject|0
2220856|NCT01734785|3865571|FG003|Open-Label Period|Withdrawal by Subject|12
2220857|NCT01734785|3865568|FG000|Open-Label Period|Other Reasons|0
2220858|NCT01734785|3865569|FG001|Open-Label Period|Other Reasons|0
2220859|NCT01734785|3865570|FG002|Open-Label Period|Other Reasons|0
2220860|NCT01734785|3865571|FG003|Open-Label Period|Other Reasons|224
2220861|NCT01734785|3865568|FG000|Double-Blind Period|Adverse Event|0
2220862|NCT01734785|3865569|FG001|Double-Blind Period|Adverse Event|3
2220863|NCT01734785|3865570|FG002|Double-Blind Period|Adverse Event|2
2220864|NCT01734785|3865571|FG003|Double-Blind Period|Adverse Event|0
2220865|NCT01734785|3865568|FG000|Double-Blind Period|Lack of Efficacy|0
2220866|NCT01734785|3865569|FG001|Double-Blind Period|Lack of Efficacy|1
2220867|NCT01734785|3865570|FG002|Double-Blind Period|Lack of Efficacy|0
2220868|NCT01734785|3865571|FG003|Double-Blind Period|Lack of Efficacy|0
2220869|NCT01734785|3865568|FG000|Double-Blind Period|Protocol Violation|0
2220870|NCT01734785|3865569|FG001|Double-Blind Period|Protocol Violation|1
2220871|NCT01734785|3865570|FG002|Double-Blind Period|Protocol Violation|1
2220872|NCT01734785|3865571|FG003|Double-Blind Period|Protocol Violation|0
2220873|NCT01734785|3865568|FG000|Double-Blind Period|Lost to Follow-up|2
2220874|NCT01734785|3865569|FG001|Double-Blind Period|Lost to Follow-up|4
2220875|NCT01734785|3865570|FG002|Double-Blind Period|Lost to Follow-up|2
2220876|NCT01734785|3865571|FG003|Double-Blind Period|Lost to Follow-up|0
2220877|NCT01734785|3865568|FG000|Double-Blind Period|Withdrawal by Subject|2
2220878|NCT01734785|3865569|FG001|Double-Blind Period|Withdrawal by Subject|0
2220879|NCT01734785|3865570|FG002|Double-Blind Period|Withdrawal by Subject|0
2220880|NCT01734785|3865571|FG003|Double-Blind Period|Withdrawal by Subject|0
2220881|NCT01734785|3865568|FG000|Double-Blind Period|Not treated|1
2220882|NCT01734785|3865569|FG001|Double-Blind Period|Not treated|0
2220883|NCT01734785|3865570|FG002|Double-Blind Period|Not treated|0
2220884|NCT01734785|3865571|FG003|Double-Blind Period|Not treated|0
2220885|NCT01734811|3865582|FG000|Overall Study|Lost to Follow-up|2
2220886|NCT01734811|3865583|FG001|Overall Study|Lost to Follow-up|3
2220887|NCT01734811|3865582|FG000|Overall Study|Withdrawal by Subject|2
2220888|NCT01734811|3865583|FG001|Overall Study|Withdrawal by Subject|0
2220889|NCT01734850|3865592|FG000|Overall Study|Continued to Week 48 but recommenced ART|3
2220890|NCT01734850|3865593|FG001|Overall Study|Continued to Week 48 but recommenced ART|2
2220891|NCT01734850|3865594|FG002|Overall Study|Continued to Week 48 but recommenced ART|3
2220892|NCT01734850|3865592|FG000|Overall Study|Not infused due to manufacturing failure|0
2220893|NCT01734850|3865593|FG001|Overall Study|Not infused due to manufacturing failure|0
2220894|NCT01734850|3865594|FG002|Overall Study|Not infused due to manufacturing failure|1
2185001|NCT01445080|3813870|FG006|Overall Study|Adverse Event|0
2220895|NCT01734902|3865612|FG000|Overall Study|Other than listed|0
2220896|NCT01734902|3865613|FG001|Overall Study|Other than listed|2
2220897|NCT01734993|3865619|FG000|Overall Study|Adverse Event|1
2220898|NCT01734993|3865619|FG000|Overall Study|Lack of Efficacy|1
2185002|NCT01445080|3813871|FG007|Overall Study|Adverse Event|3
2185003|NCT01445080|3813872|FG008|Overall Study|Adverse Event|10
2185004|NCT01445080|3813864|FG000|Overall Study|Physician Decision|0
2185005|NCT01445080|3813865|FG001|Overall Study|Physician Decision|0
2185006|NCT01445080|3813866|FG002|Overall Study|Physician Decision|1
2185007|NCT01445080|3813867|FG003|Overall Study|Physician Decision|0
2185008|NCT01445080|3813868|FG004|Overall Study|Physician Decision|0
2185009|NCT01445080|3813869|FG005|Overall Study|Physician Decision|3
2185010|NCT01445080|3813870|FG006|Overall Study|Physician Decision|2
2185011|NCT01445080|3813871|FG007|Overall Study|Physician Decision|2
2185012|NCT01445080|3813872|FG008|Overall Study|Physician Decision|0
2185013|NCT01445080|3813864|FG000|Overall Study|Withdrawal by Subject|1
2185014|NCT01445080|3813865|FG001|Overall Study|Withdrawal by Subject|0
2185015|NCT01445080|3813866|FG002|Overall Study|Withdrawal by Subject|0
2185016|NCT01445080|3813867|FG003|Overall Study|Withdrawal by Subject|1
2185017|NCT01445080|3813868|FG004|Overall Study|Withdrawal by Subject|0
2185018|NCT01445080|3813869|FG005|Overall Study|Withdrawal by Subject|0
2185019|NCT01445080|3813870|FG006|Overall Study|Withdrawal by Subject|0
2185020|NCT01445080|3813871|FG007|Overall Study|Withdrawal by Subject|0
2185021|NCT01445080|3813872|FG008|Overall Study|Withdrawal by Subject|2
2185022|NCT01445080|3813864|FG000|Overall Study|Ineligible/Inevaluable|1
2185023|NCT01445080|3813865|FG001|Overall Study|Ineligible/Inevaluable|2
2185024|NCT01445080|3813866|FG002|Overall Study|Ineligible/Inevaluable|0
2185025|NCT01445080|3813867|FG003|Overall Study|Ineligible/Inevaluable|1
2185026|NCT01445080|3813868|FG004|Overall Study|Ineligible/Inevaluable|2
2185027|NCT01445080|3813869|FG005|Overall Study|Ineligible/Inevaluable|3
2185028|NCT01445080|3813870|FG006|Overall Study|Ineligible/Inevaluable|0
2185029|NCT01445080|3813871|FG007|Overall Study|Ineligible/Inevaluable|0
2185030|NCT01445080|3813872|FG008|Overall Study|Ineligible/Inevaluable|6
2185031|NCT01445171|3813907|FG000|Overall Study|Lost to Follow-up|11
2185032|NCT01445171|3813907|FG000|Overall Study|Withdrawal by Subject|16
2185033|NCT01445171|3813907|FG000|Overall Study|Death|51
2185034|NCT01445171|3813907|FG000|Overall Study|Subjects declined to return for followup|9
2185035|NCT01445171|3813907|FG000|Overall Study|Consented but did not receive device|8
2185036|NCT01445301|3813916|FG000|Overall Study|Adverse Event|15
2185037|NCT01445301|3813917|FG001|Overall Study|Adverse Event|25
2185038|NCT01445301|3813918|FG002|Overall Study|Adverse Event|4
2185039|NCT01445301|3813916|FG000|Overall Study|Lack of Efficacy|0
2185040|NCT01445301|3813917|FG001|Overall Study|Lack of Efficacy|1
2185041|NCT01445301|3813918|FG002|Overall Study|Lack of Efficacy|0
2185042|NCT01445301|3813916|FG000|Overall Study|Protocol Violation|1
2185043|NCT01445301|3813917|FG001|Overall Study|Protocol Violation|0
2185044|NCT01445301|3813918|FG002|Overall Study|Protocol Violation|0
2185045|NCT01445301|3813916|FG000|Overall Study|Protocol-Defined Stopping Criteria|0
2185046|NCT01445301|3813917|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
2185047|NCT01445301|3813918|FG002|Overall Study|Protocol-Defined Stopping Criteria|1
2185048|NCT01445301|3813916|FG000|Overall Study|Physician Decision|0
2185049|NCT01445301|3813917|FG001|Overall Study|Physician Decision|2
2185050|NCT01445301|3813918|FG002|Overall Study|Physician Decision|0
2185051|NCT01445301|3813916|FG000|Overall Study|Withdrawal by Subject|5
2185052|NCT01445301|3813917|FG001|Overall Study|Withdrawal by Subject|6
2185053|NCT01445301|3813918|FG002|Overall Study|Withdrawal by Subject|4
2185054|NCT01445535|3813930|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0
2185055|NCT01445535|3813931|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0
2185056|NCT01445535|3813932|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0
2185057|NCT01445535|3813933|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1
2185058|NCT01445535|3813930|FG000|Overall Study|Disease progression|1
2185059|NCT01445535|3813931|FG001|Overall Study|Disease progression|0
2185060|NCT01445535|3813932|FG002|Overall Study|Disease progression|1
2185061|NCT01445535|3813933|FG003|Overall Study|Disease progression|0
2185062|NCT01445535|3813930|FG000|Overall Study|PI discretion|0
2185063|NCT01445535|3813931|FG001|Overall Study|PI discretion|0
2185064|NCT01445535|3813932|FG002|Overall Study|PI discretion|0
2185065|NCT01445535|3813933|FG003|Overall Study|PI discretion|1
2220899|NCT01735175|3865626|FG000|Overall Study|Withdrawal by Subject|9
2220900|NCT01735175|3865627|FG001|Overall Study|Withdrawal by Subject|2
2220901|NCT01735175|3865626|FG000|Overall Study|Lost to Follow-up|4
2220902|NCT01735175|3865627|FG001|Overall Study|Lost to Follow-up|2
2220903|NCT01735175|3865626|FG000|Overall Study|Death|3
2220904|NCT01735175|3865627|FG001|Overall Study|Death|2
2220905|NCT01735175|3865626|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13
2220906|NCT01735175|3865627|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7
2220907|NCT01735201|3865641|FG000|Overall Study|Adverse Event|1
2220908|NCT01735201|3865642|FG001|Overall Study|Adverse Event|1
2220909|NCT01735201|3865643|FG002|Overall Study|Adverse Event|0
2220910|NCT01735201|3865644|FG003|Overall Study|Adverse Event|1
2220911|NCT01735201|3865645|FG004|Overall Study|Adverse Event|1
2220912|NCT01735201|3865646|FG005|Overall Study|Adverse Event|3
2220913|NCT01735201|3865647|FG006|Overall Study|Adverse Event|2
2220914|NCT01735201|3865648|FG007|Overall Study|Adverse Event|1
2220915|NCT01735201|3865641|FG000|Overall Study|Personal Reasons|1
2220916|NCT01735201|3865642|FG001|Overall Study|Personal Reasons|0
2220917|NCT01735201|3865643|FG002|Overall Study|Personal Reasons|0
2185066|NCT01445548|3813944|FG000|Overall Study|Adverse Event|1
2185067|NCT01445613|3813948|FG000|30-day Follow-up|Withdrawal by Subject|6
2185068|NCT01445613|3813948|FG000|30-day Follow-up|Physician Decision|3
2185069|NCT01445613|3813948|FG000|30-day Follow-up|Missed visit|23
2185070|NCT01445613|3813948|FG000|30-day Follow-up|Death|3
2185071|NCT01445613|3813948|FG000|1-year Follow-up|Withdrawal by Subject|12
2185072|NCT01445613|3813948|FG000|1-year Follow-up|Missed visit|29
2185073|NCT01445613|3813948|FG000|1-year Follow-up|Lost to Follow-up|2
2185074|NCT01445613|3813948|FG000|1-year Follow-up|Death|30
2185075|NCT01445613|3813948|FG000|1-year Follow-up|Physician Decision|2
2185076|NCT01445613|3813948|FG000|1-year Follow-up|Received a non-study stent|2
2185077|NCT01445652|3813964|FG000|Overall Study|Not comfortable in lenses|5
2185078|NCT01445652|3813965|FG001|Overall Study|Not comfortable in lenses|0
2185079|NCT01445652|3813964|FG000|Overall Study|Failed to attend scheduled visit|2
2185080|NCT01445652|3813965|FG001|Overall Study|Failed to attend scheduled visit|3
2185081|NCT01445652|3813964|FG000|Overall Study|Failed teach session|2
2185082|NCT01445652|3813965|FG001|Overall Study|Failed teach session|0
2185083|NCT01445652|3813964|FG000|Overall Study|Adverse Event|1
2185084|NCT01445652|3813965|FG001|Overall Study|Adverse Event|0
2185085|NCT01445678|3813973|FG000|Overall Study|Adverse Event|12
2185086|NCT01445678|3813974|FG001|Overall Study|Adverse Event|8
2185087|NCT01445678|3813973|FG000|Overall Study|Lack of Efficacy|0
2185088|NCT01445678|3813974|FG001|Overall Study|Lack of Efficacy|2
2185089|NCT01445678|3813973|FG000|Overall Study|Lost to Follow-up|8
2185090|NCT01445678|3813974|FG001|Overall Study|Lost to Follow-up|5
2185091|NCT01445678|3813973|FG000|Overall Study|Protocol Violation|1
2185092|NCT01445678|3813974|FG001|Overall Study|Protocol Violation|1
2185093|NCT01445678|3813973|FG000|Overall Study|Withdrawal by Subject|9
2185094|NCT01445678|3813974|FG001|Overall Study|Withdrawal by Subject|5
2185095|NCT01445730|3813980|FG000|Overall Study|Adverse Event|1
2185096|NCT01445730|3813980|FG000|Overall Study|For the advice of a dentist|1
2185097|NCT01445730|3813980|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9
2185098|NCT01445769|3813984|FG000|Overall Study|Consent Withdrawn|2
2185099|NCT01445769|3813984|FG000|Overall Study|Disease Progression|1
2185100|NCT01445769|3813984|FG000|Overall Study|Lost to Follow-up|5
2185101|NCT01445847|3814001|FG000|Overall Study|Protocol Violation|13
2185102|NCT01445847|3814002|FG001|Overall Study|Protocol Violation|14
2185103|NCT01445847|3814001|FG000|Overall Study|Missed Data|1
2185104|NCT01445847|3814002|FG001|Overall Study|Missed Data|0
2185105|NCT01445886|3814012|FG000|Overall Study|Lost to Follow-up|2
2185106|NCT01445886|3814012|FG000|Overall Study|Protocol Violation|3
2185107|NCT01445951|3814021|FG000|Overall Study|Adverse Event|16
2185108|NCT01445951|3814022|FG001|Overall Study|Adverse Event|9
2185109|NCT01445951|3814023|FG002|Overall Study|Adverse Event|0
2185110|NCT01445951|3814021|FG000|Overall Study|Protocol Violation|2
2185111|NCT01445951|3814022|FG001|Overall Study|Protocol Violation|2
2185112|NCT01445951|3814023|FG002|Overall Study|Protocol Violation|2
2185113|NCT01445951|3814021|FG000|Overall Study|Withdrawal by Subject|21
2185114|NCT01445951|3814022|FG001|Overall Study|Withdrawal by Subject|16
2185115|NCT01445951|3814023|FG002|Overall Study|Withdrawal by Subject|8
2185116|NCT01445951|3814021|FG000|Overall Study|Physician Decision|3
2185117|NCT01445951|3814022|FG001|Overall Study|Physician Decision|1
2185118|NCT01445951|3814023|FG002|Overall Study|Physician Decision|0
2185119|NCT01445951|3814021|FG000|Overall Study|Lost to Follow-up|1
2185120|NCT01445951|3814022|FG001|Overall Study|Lost to Follow-up|2
2185121|NCT01445951|3814023|FG002|Overall Study|Lost to Follow-up|4
2185122|NCT01445951|3814021|FG000|Overall Study|Pregnancy|0
2185123|NCT01445951|3814022|FG001|Overall Study|Pregnancy|1
2185124|NCT01445951|3814023|FG002|Overall Study|Pregnancy|4
2185125|NCT01445951|3814021|FG000|Overall Study|Death|0
2185126|NCT01445951|3814022|FG001|Overall Study|Death|0
2185127|NCT01445951|3814023|FG002|Overall Study|Death|1
2185128|NCT01445951|3814021|FG000|Overall Study|Non-compliance with study drug|1
2185129|NCT01445951|3814022|FG001|Overall Study|Non-compliance with study drug|2
2185130|NCT01445951|3814023|FG002|Overall Study|Non-compliance with study drug|0
2185131|NCT01445951|3814021|FG000|Overall Study|Non-compliance with protocol|0
2185132|NCT01445951|3814022|FG001|Overall Study|Non-compliance with protocol|1
2185133|NCT01445951|3814023|FG002|Overall Study|Non-compliance with protocol|0
2185134|NCT01445951|3814021|FG000|Overall Study|Sponsor decision - subject travel|0
2185135|NCT01445951|3814022|FG001|Overall Study|Sponsor decision - subject travel|1
2185136|NCT01445951|3814023|FG002|Overall Study|Sponsor decision - subject travel|0
2185137|NCT01445951|3814021|FG000|Overall Study|Cough|0
2185138|NCT01445951|3814022|FG001|Overall Study|Cough|1
2185139|NCT01445951|3814023|FG002|Overall Study|Cough|0
2185140|NCT01446003|3814031|FG000|Period 1|Protocol Violation|2
2185141|NCT01446003|3814032|FG001|Period 1|Protocol Violation|0
2185142|NCT01446003|3814031|FG000|Period 2|Adverse Event|1
2185143|NCT01446003|3814032|FG001|Period 2|Adverse Event|0
2185144|NCT01446042|3814041|FG000|Overall Study|Withdrawal by Subject|12
2185145|NCT01446042|3814042|FG001|Overall Study|Withdrawal by Subject|2
2185146|NCT01446042|3814043|FG002|Overall Study|Withdrawal by Subject|4
2185147|NCT01446042|3814041|FG000|Overall Study|Adverse Event|1
2185148|NCT01446042|3814042|FG001|Overall Study|Adverse Event|0
2185149|NCT01446042|3814043|FG002|Overall Study|Adverse Event|4
2185150|NCT01446042|3814041|FG000|Overall Study|Lost to Follow-up|5
2185151|NCT01446042|3814042|FG001|Overall Study|Lost to Follow-up|0
2185152|NCT01446042|3814043|FG002|Overall Study|Lost to Follow-up|0
2185153|NCT01446042|3814041|FG000|Overall Study|Other reasons|2
2185154|NCT01446042|3814042|FG001|Overall Study|Other reasons|1
2185155|NCT01446042|3814043|FG002|Overall Study|Other reasons|1
2185156|NCT01446159|3814055|FG000|Overall Study|Withdrawal by Subject|1
2185157|NCT01446159|3814056|FG001|Overall Study|Withdrawal by Subject|0
2185158|NCT01446159|3814057|FG002|Overall Study|Withdrawal by Subject|14
2185159|NCT01446159|3814058|FG003|Overall Study|Withdrawal by Subject|11
2185160|NCT01446159|3814055|FG000|Overall Study|Lost to Follow-up|0
2185161|NCT01446159|3814056|FG001|Overall Study|Lost to Follow-up|0
2185162|NCT01446159|3814057|FG002|Overall Study|Lost to Follow-up|1
2185163|NCT01446159|3814058|FG003|Overall Study|Lost to Follow-up|2
2185164|NCT01446159|3814055|FG000|Overall Study|Death|2
2185165|NCT01446159|3814056|FG001|Overall Study|Death|3
2185166|NCT01446159|3814057|FG002|Overall Study|Death|43
2220918|NCT01735201|3865644|FG003|Overall Study|Personal Reasons|0
2220919|NCT01735201|3865645|FG004|Overall Study|Personal Reasons|0
2220920|NCT01735201|3865646|FG005|Overall Study|Personal Reasons|0
2220921|NCT01735201|3865647|FG006|Overall Study|Personal Reasons|0
2220922|NCT01735201|3865648|FG007|Overall Study|Personal Reasons|0
2220923|NCT01735201|3865641|FG000|Overall Study|Protocol Violation|1
2220924|NCT01735201|3865642|FG001|Overall Study|Protocol Violation|0
2220925|NCT01735201|3865643|FG002|Overall Study|Protocol Violation|0
2220926|NCT01735201|3865644|FG003|Overall Study|Protocol Violation|0
2220927|NCT01735201|3865645|FG004|Overall Study|Protocol Violation|0
2220928|NCT01735201|3865646|FG005|Overall Study|Protocol Violation|0
2220929|NCT01735201|3865647|FG006|Overall Study|Protocol Violation|0
2220930|NCT01735201|3865648|FG007|Overall Study|Protocol Violation|0
2220931|NCT01735201|3865641|FG000|Overall Study|Other Miscellaneous Reasons|0
2220932|NCT01735201|3865642|FG001|Overall Study|Other Miscellaneous Reasons|0
2220933|NCT01735201|3865643|FG002|Overall Study|Other Miscellaneous Reasons|0
2220934|NCT01735201|3865644|FG003|Overall Study|Other Miscellaneous Reasons|1
2220935|NCT01735201|3865645|FG004|Overall Study|Other Miscellaneous Reasons|0
2220936|NCT01735201|3865646|FG005|Overall Study|Other Miscellaneous Reasons|2
2220937|NCT01735201|3865647|FG006|Overall Study|Other Miscellaneous Reasons|1
2220938|NCT01735201|3865648|FG007|Overall Study|Other Miscellaneous Reasons|1
2220939|NCT01735279|3865672|FG000|Overall Study|Lost to Follow-up|11
2220940|NCT01735279|3865673|FG001|Overall Study|Lost to Follow-up|8
2220941|NCT01735396|3865679|FG000|Overall Study|not evaluable|1
2220942|NCT01735630|3865692|FG000|Overall Study|Adverse Event|8
2220943|NCT01735630|3865693|FG001|Overall Study|Adverse Event|7
2220944|NCT01735630|3865692|FG000|Overall Study|Lost to Follow-up|1
2220945|NCT01735630|3865693|FG001|Overall Study|Lost to Follow-up|0
2220946|NCT01735630|3865692|FG000|Overall Study|Physician Decision|0
2220947|NCT01735630|3865693|FG001|Overall Study|Physician Decision|1
2220948|NCT01735630|3865692|FG000|Overall Study|Sponsor Decision|2
2220949|NCT01735630|3865693|FG001|Overall Study|Sponsor Decision|1
2220950|NCT01735630|3865692|FG000|Overall Study|Withdrawal by Subject|7
2220951|NCT01735630|3865693|FG001|Overall Study|Withdrawal by Subject|9
2220952|NCT01735916|3865711|FG000|Overall Study|Subject not eligible to be randomized|11
2220953|NCT01735916|3865712|FG001|Overall Study|Subject not eligible to be randomized|0
2220954|NCT01735916|3865713|FG002|Overall Study|Subject not eligible to be randomized|0
2220955|NCT01735916|3865711|FG000|Overall Study|Early termination of study by sponsor|4
2220956|NCT01735916|3865712|FG001|Overall Study|Early termination of study by sponsor|19
2220957|NCT01735916|3865713|FG002|Overall Study|Early termination of study by sponsor|7
2220958|NCT01735916|3865711|FG000|Overall Study|Withdrawal by Subject|3
2220959|NCT01735916|3865712|FG001|Overall Study|Withdrawal by Subject|0
2220960|NCT01735916|3865713|FG002|Overall Study|Withdrawal by Subject|0
2220961|NCT01735994|3865733|FG000|Overall Study|Withdrawal by Subject|6
2220962|NCT01735994|3865734|FG001|Overall Study|Withdrawal by Subject|4
2220963|NCT01735994|3865733|FG000|Overall Study|Injury|2
2220964|NCT01735994|3865734|FG001|Overall Study|Injury|0
2220965|NCT01735994|3865733|FG000|Overall Study|Kicked off team|5
2220966|NCT01735994|3865734|FG001|Overall Study|Kicked off team|0
2220967|NCT01735994|3865733|FG000|Overall Study|Lost to Follow-up|50
2220968|NCT01735994|3865734|FG001|Overall Study|Lost to Follow-up|62
2220969|NCT01736124|3865764|FG000|Post-intervention Assessment|Death|2
2220970|NCT01736124|3865765|FG001|Post-intervention Assessment|Death|2
2220971|NCT01736124|3865764|FG000|Post-intervention Assessment|lost computer access|1
2220972|NCT01736124|3865765|FG001|Post-intervention Assessment|lost computer access|1
2220973|NCT01736124|3865764|FG000|Post-intervention Assessment|Moved away|3
2220974|NCT01736124|3865765|FG001|Post-intervention Assessment|Moved away|1
2220975|NCT01736124|3865764|FG000|Post-intervention Assessment|Withdrawal by Subject|11
2220976|NCT01736124|3865765|FG001|Post-intervention Assessment|Withdrawal by Subject|9
2220977|NCT01736124|3865764|FG000|Post-intervention Assessment|Illness|3
2220978|NCT01736124|3865765|FG001|Post-intervention Assessment|Illness|2
2220979|NCT01736124|3865764|FG000|Post-intervention Assessment|Lost to Follow-up|8
2220980|NCT01736124|3865765|FG001|Post-intervention Assessment|Lost to Follow-up|5
2220981|NCT01736124|3865764|FG000|Post-intervention Assessment|Temporarily away|3
2220982|NCT01736124|3865765|FG001|Post-intervention Assessment|Temporarily away|1
2220983|NCT01736124|3865764|FG000|6 Mo. Post-Intervention Assessment|Death|0
2185167|NCT01446159|3814058|FG003|Overall Study|Death|36
2185168|NCT01446159|3814055|FG000|Overall Study|Other|0
2185169|NCT01446159|3814056|FG001|Overall Study|Other|0
2185170|NCT01446159|3814057|FG002|Overall Study|Other|13
2185171|NCT01446159|3814058|FG003|Overall Study|Other|13
2185172|NCT01446237|3814070|FG000|Overall Study|Adverse Event|1
2185173|NCT01446237|3814070|FG000|Overall Study|Lost to Follow-up|2
2185174|NCT01446237|3814070|FG000|Overall Study|Withdrawal by Subject|7
2185175|NCT01446289|3814078|FG000|Overall Study|Withdrawal by Subject|1
2185176|NCT01446289|3814079|FG001|Overall Study|Withdrawal by Subject|0
2220984|NCT01736124|3865765|FG001|6 Mo. Post-Intervention Assessment|Death|1
2220985|NCT01736124|3865764|FG000|6 Mo. Post-Intervention Assessment|Moved away|0
2220986|NCT01736124|3865765|FG001|6 Mo. Post-Intervention Assessment|Moved away|2
2220987|NCT01736124|3865764|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
2220988|NCT01736124|3865765|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
2220989|NCT01736124|3865764|FG000|6 Mo. Post-Intervention Assessment|Illness|1
2220990|NCT01736124|3865765|FG001|6 Mo. Post-Intervention Assessment|Illness|2
2220991|NCT01736124|3865764|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1
2220992|NCT01736124|3865765|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4
2220993|NCT01736124|3865764|FG000|12 Mo. Post-Intervention Assessment|Death|1
2220994|NCT01736124|3865765|FG001|12 Mo. Post-Intervention Assessment|Death|0
2220995|NCT01736124|3865764|FG000|12 Mo. Post-Intervention Assessment|Moved away|1
2220996|NCT01736124|3865765|FG001|12 Mo. Post-Intervention Assessment|Moved away|0
2220997|NCT01736124|3865764|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0
2220998|NCT01736124|3865765|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2
2220999|NCT01736124|3865764|FG000|12 Mo. Post-Intervention Assessment|End of study|10
2221000|NCT01736124|3865765|FG001|12 Mo. Post-Intervention Assessment|End of study|10
2221001|NCT01736176|3865773|FG000|Overall Study|Adverse Event|3
2221002|NCT01736176|3865773|FG000|Overall Study|Withdrawal by Subject|4
2221003|NCT01736176|3865773|FG000|Overall Study|Lack of Efficacy|3
2221004|NCT01736176|3865773|FG000|Overall Study|Unable to Complete PEG Placement|1
2221005|NCT01736189|3865781|FG000|Overall Study|Violation of registration criteria|41
2221006|NCT01736189|3865781|FG000|Overall Study|Protocol Violation|4
2221007|NCT01736189|3865781|FG000|Overall Study|Criteria and protocol violations|1
2221008|NCT01736215|3865785|FG000|Overall Study|Early termination of erythropoietin use|1
2221009|NCT01736215|3865785|FG000|Overall Study|Adverse Event|4
2221010|NCT01736215|3865785|FG000|Overall Study|Progressive disease stop chemotherapy|1
2221011|NCT01736215|3865785|FG000|Overall Study|Insufficient data to perform analysis|8
2221012|NCT01736254|3865819|FG000|Period 2 (Days 2 to 12)|Adverse Event|3
2221013|NCT01736254|3865819|FG000|Period 3 (Days 13 to 23)|Adverse Event|1
2274031|NCT02291861|3954771|FG001|Overall Study|Noncompliance|1
2274032|NCT02291861|3954772|FG002|Overall Study|Noncompliance|2
2274033|NCT02291861|3954773|FG003|Overall Study|Noncompliance|1
2274034|NCT02291861|3954770|FG000|Overall Study|Lost to Follow-up|2
2274035|NCT02291861|3954771|FG001|Overall Study|Lost to Follow-up|1
2274036|NCT02291861|3954772|FG002|Overall Study|Lost to Follow-up|4
2274037|NCT02291861|3954773|FG003|Overall Study|Lost to Follow-up|0
2274038|NCT02291861|3954770|FG000|Overall Study|Other|0
2274039|NCT02291861|3954771|FG001|Overall Study|Other|0
2274040|NCT02291861|3954772|FG002|Overall Study|Other|0
2274041|NCT02291861|3954773|FG003|Overall Study|Other|1
2274042|NCT02291913|3954783|FG000|Overall Study|Progressive Disease|32
2274043|NCT02291913|3954783|FG000|Overall Study|Adverse Event|11
2274044|NCT02291913|3954783|FG000|Overall Study|Death|2
2274045|NCT02291913|3954783|FG000|Overall Study|Physician Decision|1
2274046|NCT02291913|3954783|FG000|Overall Study|Withdrawal by Subject|1
2274047|NCT02291913|3954783|FG000|Overall Study|Protocol Violation|1
2274048|NCT02292212|3954800|FG000|ViE Phase|Withdrawal by Subject|1
2274049|NCT02292212|3954800|FG000|ViE Phase|Protocol Violation|2
2274050|NCT02292446|3954824|FG000|Overall Study|Adverse Event|12
2274051|NCT02292446|3954824|FG000|Overall Study|Death|1
2274052|NCT02292446|3954824|FG000|Overall Study|Disease progression|2
2274053|NCT02292446|3954824|FG000|Overall Study|Subject/guardian decision|2
2274054|NCT02292446|3954824|FG000|Overall Study|Withdrawal by Subject|3
2274055|NCT02292719|3954865|FG000|Overall Study|Withdrawal by Subject|0
2274056|NCT02292719|3954866|FG001|Overall Study|Withdrawal by Subject|0
2274057|NCT02292719|3954867|FG002|Overall Study|Withdrawal by Subject|0
2274058|NCT02292719|3954868|FG003|Overall Study|Withdrawal by Subject|1
2274059|NCT02292719|3954869|FG004|Overall Study|Withdrawal by Subject|1
2274060|NCT02292719|3954870|FG005|Overall Study|Withdrawal by Subject|0
2274061|NCT02292719|3954865|FG000|Overall Study|Subject enrolled in new study.|0
2274062|NCT02292719|3954866|FG001|Overall Study|Subject enrolled in new study.|0
2274063|NCT02292719|3954867|FG002|Overall Study|Subject enrolled in new study.|1
2274064|NCT02292719|3954868|FG003|Overall Study|Subject enrolled in new study.|0
2274065|NCT02292719|3954869|FG004|Overall Study|Subject enrolled in new study.|0
2274066|NCT02292719|3954870|FG005|Overall Study|Subject enrolled in new study.|0
2274067|NCT02292771|3954886|FG000|Overall Study|Withdrawal by Subject|2
2185177|NCT01446289|3814080|FG002|Overall Study|Withdrawal by Subject|1
2185178|NCT01446289|3814081|FG003|Overall Study|Withdrawal by Subject|0
2185179|NCT01446419|3814095|FG000|Overall Study|Death|1
2185180|NCT01446419|3814096|FG001|Overall Study|Death|0
2185181|NCT01446419|3814095|FG000|Overall Study|Withdrawal by Subject|1
2185182|NCT01446419|3814096|FG001|Overall Study|Withdrawal by Subject|1
2185183|NCT01446419|3814095|FG000|Overall Study|Terminated per protocol|3
2185184|NCT01446419|3814096|FG001|Overall Study|Terminated per protocol|0
2185185|NCT01446809|3814128|FG000|Overall Study|Adverse Event|0
2185186|NCT01446809|3814129|FG001|Overall Study|Adverse Event|0
2185187|NCT01446809|3814130|FG002|Overall Study|Adverse Event|1
2185188|NCT01446809|3814128|FG000|Overall Study|Failure to complete study procedures|0
2185189|NCT01446809|3814129|FG001|Overall Study|Failure to complete study procedures|0
2185190|NCT01446809|3814130|FG002|Overall Study|Failure to complete study procedures|1
2185191|NCT01446874|3814142|FG000|Overall Study|Not eligible|1
2185192|NCT01446874|3814143|FG001|Overall Study|Not eligible|0
2185193|NCT01446874|3814144|FG002|Overall Study|Not eligible|0
2185194|NCT01446874|3814142|FG000|Overall Study|No surgery/No qualifying surgery|1
2185195|NCT01446874|3814143|FG001|Overall Study|No surgery/No qualifying surgery|0
2185196|NCT01446874|3814144|FG002|Overall Study|No surgery/No qualifying surgery|12
2185197|NCT01446874|3814142|FG000|Overall Study|Non-compliance|0
2185198|NCT01446874|3814143|FG001|Overall Study|Non-compliance|4
2185199|NCT01446874|3814144|FG002|Overall Study|Non-compliance|0
2185200|NCT01446874|3814142|FG000|Overall Study|Antibiotics for pre-op infection|0
2185201|NCT01446874|3814143|FG001|Overall Study|Antibiotics for pre-op infection|0
2185202|NCT01446874|3814144|FG002|Overall Study|Antibiotics for pre-op infection|2
2185203|NCT01446874|3814142|FG000|Overall Study|Withdrawal by Subject|0
2185204|NCT01446874|3814143|FG001|Overall Study|Withdrawal by Subject|0
2185205|NCT01446874|3814144|FG002|Overall Study|Withdrawal by Subject|4
2185206|NCT01446913|3814155|FG000|Overall Study|Significant illness|1
2185207|NCT01446913|3814156|FG001|Overall Study|Significant illness|1
2185208|NCT01446913|3814157|FG002|Overall Study|Significant illness|1
2185209|NCT01446913|3814155|FG000|Overall Study|Withdrawal by Subject|5
2185210|NCT01446913|3814156|FG001|Overall Study|Withdrawal by Subject|3
2185211|NCT01446913|3814157|FG002|Overall Study|Withdrawal by Subject|5
2185212|NCT01446913|3814155|FG000|Overall Study|Physician Decision|0
2185213|NCT01446913|3814156|FG001|Overall Study|Physician Decision|0
2185214|NCT01446913|3814157|FG002|Overall Study|Physician Decision|2
2185215|NCT01446913|3814155|FG000|Overall Study|Lost to Follow-up|3
2185216|NCT01446913|3814156|FG001|Overall Study|Lost to Follow-up|5
2185217|NCT01446913|3814157|FG002|Overall Study|Lost to Follow-up|3
2185218|NCT01446965|3814173|FG000|Randominization|One site was dismissed due to IRB irregularity|30
2185219|NCT01446965|3814174|FG001|Randominization|One site was dismissed due to IRB irregularity|16
2185220|NCT01446965|3814173|FG000|Participants Followed and Analyzed|Lost to Follow-up|10
2185221|NCT01446965|3814174|FG001|Participants Followed and Analyzed|Lost to Follow-up|12
2185222|NCT01447407|3814243|FG000|Overall Study|Withdrawal by Subject|2
2185223|NCT01447407|3814244|FG001|Overall Study|Withdrawal by Subject|0
2185224|NCT01447407|3814245|FG002|Overall Study|Withdrawal by Subject|0
2185225|NCT01447407|3814246|FG003|Overall Study|Withdrawal by Subject|1
2185226|NCT01447407|3814243|FG000|Overall Study|Physician Decision|0
2185227|NCT01447407|3814244|FG001|Overall Study|Physician Decision|0
2185228|NCT01447407|3814245|FG002|Overall Study|Physician Decision|1
2185229|NCT01447407|3814246|FG003|Overall Study|Physician Decision|1
2185230|NCT01447420|3814259|FG000|Overall Study|Adverse Event|2
2185231|NCT01447420|3814260|FG001|Overall Study|Adverse Event|4
2185232|NCT01447420|3814261|FG002|Overall Study|Adverse Event|2
2221014|NCT01736397|3865842|FG000|Overall Study|Lack of Efficacy|1
2221015|NCT01736397|3865843|FG001|Overall Study|Lack of Efficacy|11
2221016|NCT01736397|3865842|FG000|Overall Study|Withdrawal by Subject|6
2221017|NCT01736397|3865843|FG001|Overall Study|Withdrawal by Subject|5
2221018|NCT01736397|3865842|FG000|Overall Study|Lost to Follow-up|0
2221019|NCT01736397|3865843|FG001|Overall Study|Lost to Follow-up|1
2221020|NCT01736397|3865842|FG000|Overall Study|Adverse Event|6
2221021|NCT01736397|3865843|FG001|Overall Study|Adverse Event|3
2221022|NCT01736397|3865842|FG000|Overall Study|Not stated|1
2221023|NCT01736397|3865843|FG001|Overall Study|Not stated|4
2221024|NCT01736475|3865851|FG000|Overall Study|Adverse Event|4
2221025|NCT01736475|3865852|FG001|Overall Study|Adverse Event|0
2221026|NCT01736475|3865851|FG000|Overall Study|Withdrawal by Subject|2
2221027|NCT01736475|3865852|FG001|Overall Study|Withdrawal by Subject|0
2221028|NCT01736475|3865851|FG000|Overall Study|Protocol Violation|4
2221029|NCT01736475|3865852|FG001|Overall Study|Protocol Violation|0
2221030|NCT01736475|3865851|FG000|Overall Study|Other - Screen failure|1
2221031|NCT01736475|3865852|FG001|Overall Study|Other - Screen failure|0
2221032|NCT01736475|3865851|FG000|Overall Study|Other - Surgical procedure|1
2221033|NCT01736475|3865852|FG001|Overall Study|Other - Surgical procedure|0
2221034|NCT01736540|3865873|FG000|Overall Study|Did not complete scan within 45 days|2
2221035|NCT01736540|3865873|FG000|Overall Study|Death|1
2221036|NCT01736540|3865873|FG000|Overall Study|Abnormal test procedure|1
2221037|NCT01736540|3865873|FG000|Overall Study|Withdrawal by Subject|5
2221038|NCT01736540|3865873|FG000|Overall Study|Protocol Violation|1
2221039|NCT01736540|3865873|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1
2221040|NCT01736540|3865873|FG000|Overall Study|No show for MRI appointment|1
2221041|NCT01736540|3865873|FG000|Overall Study|Unable to make MRI appointment|3
2221042|NCT01736553|3865886|FG000|Overall Study|Death|12
2221043|NCT01736553|3865887|FG001|Overall Study|Death|0
2221044|NCT01736553|3865886|FG000|Overall Study|Withdrawal by Subject|5
2221045|NCT01736553|3865887|FG001|Overall Study|Withdrawal by Subject|2
2221046|NCT01736553|3865886|FG000|Overall Study|Lost to Follow-up|2
2185233|NCT01447420|3814259|FG000|Overall Study|Protocol Violation|3
2185234|NCT01447420|3814260|FG001|Overall Study|Protocol Violation|3
2185235|NCT01447420|3814261|FG002|Overall Study|Protocol Violation|0
2185236|NCT01447420|3814259|FG000|Overall Study|Withdrawal by Subject|4
2185237|NCT01447420|3814260|FG001|Overall Study|Withdrawal by Subject|1
2185238|NCT01447420|3814261|FG002|Overall Study|Withdrawal by Subject|0
2185239|NCT01447420|3814259|FG000|Overall Study|Lack of Efficacy|1
2185240|NCT01447420|3814260|FG001|Overall Study|Lack of Efficacy|19
2185241|NCT01447420|3814261|FG002|Overall Study|Lack of Efficacy|8
2185242|NCT01447433|3814270|FG000|Overall Study|Lost to Follow-up|0
2185243|NCT01447433|3814271|FG001|Overall Study|Lost to Follow-up|2
2185244|NCT01447433|3814270|FG000|Overall Study|Withdrawal by Subject|3
2185245|NCT01447433|3814271|FG001|Overall Study|Withdrawal by Subject|3
2185246|NCT01447433|3814270|FG000|Overall Study|Protocol Violation|1
2185247|NCT01447433|3814271|FG001|Overall Study|Protocol Violation|1
2185248|NCT01447446|3814283|FG000|Overall Study|Death|6
2185249|NCT01447446|3814284|FG001|Overall Study|Death|3
2185250|NCT01447446|3814285|FG002|Overall Study|Death|2
2185251|NCT01447446|3814286|FG003|Overall Study|Death|1
2185252|NCT01447446|3814287|FG004|Overall Study|Death|7
2185253|NCT01447446|3814288|FG005|Overall Study|Death|0
2185254|NCT01447446|3814283|FG000|Overall Study|Adverse Event|3
2185255|NCT01447446|3814284|FG001|Overall Study|Adverse Event|0
2185256|NCT01447446|3814285|FG002|Overall Study|Adverse Event|1
2185257|NCT01447446|3814286|FG003|Overall Study|Adverse Event|0
2185258|NCT01447446|3814287|FG004|Overall Study|Adverse Event|2
2185259|NCT01447446|3814288|FG005|Overall Study|Adverse Event|0
2185260|NCT01447446|3814283|FG000|Overall Study|Failure to Return/Consent Withdrawn|357
2185261|NCT01447446|3814284|FG001|Overall Study|Failure to Return/Consent Withdrawn|78
2185262|NCT01447446|3814285|FG002|Overall Study|Failure to Return/Consent Withdrawn|31
2185263|NCT01447446|3814286|FG003|Overall Study|Failure to Return/Consent Withdrawn|7
2185264|NCT01447446|3814287|FG004|Overall Study|Failure to Return/Consent Withdrawn|69
2185265|NCT01447446|3814288|FG005|Overall Study|Failure to Return/Consent Withdrawn|9
2185266|NCT01447446|3814283|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
2185267|NCT01447446|3814284|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
2185268|NCT01447446|3814285|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
2185269|NCT01447446|3814286|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
2185270|NCT01447446|3814287|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
2185271|NCT01447446|3814288|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
2185272|NCT01447446|3814283|FG000|Overall Study|Administrative/Other|34
2185273|NCT01447446|3814284|FG001|Overall Study|Administrative/Other|9
2185274|NCT01447446|3814285|FG002|Overall Study|Administrative/Other|10
2185275|NCT01447446|3814286|FG003|Overall Study|Administrative/Other|2
2185276|NCT01447446|3814287|FG004|Overall Study|Administrative/Other|33
2185277|NCT01447446|3814288|FG005|Overall Study|Administrative/Other|4
2185278|NCT01447446|3814283|FG000|Overall Study|SVR12 Assessment|13
2185279|NCT01447446|3814284|FG001|Overall Study|SVR12 Assessment|1
2185280|NCT01447446|3814285|FG002|Overall Study|SVR12 Assessment|2
2185281|NCT01447446|3814286|FG003|Overall Study|SVR12 Assessment|1
2185282|NCT01447446|3814287|FG004|Overall Study|SVR12 Assessment|5
2185283|NCT01447446|3814288|FG005|Overall Study|SVR12 Assessment|5
2221047|NCT01736553|3865887|FG001|Overall Study|Lost to Follow-up|2
2221048|NCT01736566|3865916|FG000|Long Term Follow-up|Still collecting data|42
2221049|NCT01736566|3865917|FG001|Long Term Follow-up|Still collecting data|0
2221050|NCT01736566|3865918|FG002|Long Term Follow-up|Still collecting data|49
2221051|NCT01736566|3865919|FG003|Long Term Follow-up|Still collecting data|0
2221052|NCT01736566|3865920|FG004|Long Term Follow-up|Still collecting data|1
2221053|NCT01736579|3865947|FG000|Overall Study|Termination of Study by Sponsor|2
2221054|NCT01736579|3865948|FG001|Overall Study|Termination of Study by Sponsor|2
2221055|NCT01736657|3865954|FG000|Overall Study|insufficient vascular access|1
2221056|NCT01736683|3865963|FG000|Overall Study|Disease Relapse|0
2221057|NCT01736683|3865964|FG001|Overall Study|Disease Relapse|0
2221058|NCT01736683|3865965|FG002|Overall Study|Disease Relapse|2
2221059|NCT01736683|3865966|FG003|Overall Study|Disease Relapse|1
2221060|NCT01736683|3865967|FG004|Overall Study|Disease Relapse|0
2221061|NCT01736683|3865963|FG000|Overall Study|Adverse Event|0
2221062|NCT01736683|3865964|FG001|Overall Study|Adverse Event|2
2221063|NCT01736683|3865965|FG002|Overall Study|Adverse Event|2
2221064|NCT01736683|3865966|FG003|Overall Study|Adverse Event|3
2221065|NCT01736683|3865967|FG004|Overall Study|Adverse Event|2
2221066|NCT01736683|3865963|FG000|Overall Study|Withdrawal by Subject|0
2221067|NCT01736683|3865964|FG001|Overall Study|Withdrawal by Subject|0
2221068|NCT01736683|3865965|FG002|Overall Study|Withdrawal by Subject|3
2221069|NCT01736683|3865966|FG003|Overall Study|Withdrawal by Subject|1
2221070|NCT01736683|3865967|FG004|Overall Study|Withdrawal by Subject|1
2221071|NCT01736683|3865963|FG000|Overall Study|Lack of Therapeutic Effect|7
2221072|NCT01736683|3865964|FG001|Overall Study|Lack of Therapeutic Effect|4
2221073|NCT01736683|3865965|FG002|Overall Study|Lack of Therapeutic Effect|13
2221074|NCT01736683|3865966|FG003|Overall Study|Lack of Therapeutic Effect|20
2221075|NCT01736683|3865967|FG004|Overall Study|Lack of Therapeutic Effect|1
2221076|NCT01736683|3865963|FG000|Overall Study|Progressive Disease|0
2221077|NCT01736683|3865964|FG001|Overall Study|Progressive Disease|0
2221078|NCT01736683|3865965|FG002|Overall Study|Progressive Disease|0
2185284|NCT01447446|3814283|FG000|Overall Study|New Treatment Started|8
2185285|NCT01447446|3814284|FG001|Overall Study|New Treatment Started|2
2185286|NCT01447446|3814285|FG002|Overall Study|New Treatment Started|1
2185287|NCT01447446|3814286|FG003|Overall Study|New Treatment Started|0
2185288|NCT01447446|3814287|FG004|Overall Study|New Treatment Started|2
2185289|NCT01447446|3814288|FG005|Overall Study|New Treatment Started|0
2185290|NCT01447446|3814283|FG000|Overall Study|Reason not Specified|1
2185291|NCT01447446|3814284|FG001|Overall Study|Reason not Specified|1
2185292|NCT01447446|3814285|FG002|Overall Study|Reason not Specified|1
2185293|NCT01447446|3814286|FG003|Overall Study|Reason not Specified|1
2185294|NCT01447446|3814287|FG004|Overall Study|Reason not Specified|1
2185295|NCT01447446|3814288|FG005|Overall Study|Reason not Specified|0
2185296|NCT01447576|3814329|FG000|Overall Study|Lost to Follow-up|52
2185297|NCT01447576|3814329|FG000|Overall Study|Adverse Event|127
2185298|NCT01447576|3814329|FG000|Overall Study|Participant met withdrawal criteria|40
2185299|NCT01447576|3814329|FG000|Overall Study|Withdrawal by Subject|100
2185300|NCT01447576|3814329|FG000|Overall Study|Protocol deviation|83
2185301|NCT01447576|3814329|FG000|Overall Study|Lack of Efficacy|68
2185302|NCT01447576|3814329|FG000|Overall Study|Physician Decision|6
2185303|NCT01447719|3814346|FG000|Overall Study|Image acquisition failure|2
2185304|NCT01447719|3814346|FG000|Overall Study|Invalid image or not imaged|3
2185305|NCT01447719|3814346|FG000|Overall Study|Subject still living at end of study|79
2185306|NCT01447719|3814346|FG000|Overall Study|Withdrawal by Subject|2
2185307|NCT01447719|3814346|FG000|Overall Study|Family withdrew autopsy consent|7
2185308|NCT01447927|3814387|FG000|Overall Study|Adverse Event|4
2185309|NCT01447927|3814388|FG001|Overall Study|Adverse Event|3
2185310|NCT01447927|3814387|FG000|Overall Study|Withdrawal by Subject|1
2185311|NCT01447927|3814388|FG001|Overall Study|Withdrawal by Subject|0
2185312|NCT01448044|3814396|FG000|Treatment Period|Adverse Event|4
2185313|NCT01448044|3814397|FG001|Treatment Period|Adverse Event|3
2185314|NCT01448044|3814396|FG000|Treatment Period|Lack of Efficacy|5
2185315|NCT01448044|3814397|FG001|Treatment Period|Lack of Efficacy|12
2185316|NCT01448044|3814396|FG000|Treatment Period|Subject requested discontinue study drug|1
2185317|NCT01448044|3814397|FG001|Treatment Period|Subject requested discontinue study drug|0
2185318|NCT01448044|3814396|FG000|Treatment Period|Completed 24 weeks treatment period only|8
2185319|NCT01448044|3814397|FG001|Treatment Period|Completed 24 weeks treatment period only|0
2185320|NCT01448044|3814396|FG000|Treatment Period|Participant does not meet study criteria|1
2185321|NCT01448044|3814397|FG001|Treatment Period|Participant does not meet study criteria|0
2185322|NCT01448044|3814396|FG000|Treatment Period|Lost to Follow-up|2
2185323|NCT01448044|3814397|FG001|Treatment Period|Lost to Follow-up|1
2185324|NCT01448044|3814396|FG000|Treatment Period|Other reason|2
2185325|NCT01448044|3814397|FG001|Treatment Period|Other reason|0
2185326|NCT01448044|3814396|FG000|Follow Up Period|Withdrawal by Subject|1
2185327|NCT01448044|3814397|FG001|Follow Up Period|Withdrawal by Subject|1
2185328|NCT01448044|3814396|FG000|Follow Up Period|Lost to Follow-up|6
2185329|NCT01448044|3814397|FG001|Follow Up Period|Lost to Follow-up|2
2185330|NCT01448044|3814396|FG000|Follow Up Period|Other|5
2185331|NCT01448044|3814397|FG001|Follow Up Period|Other|11
2185332|NCT01448057|3814405|FG000|Overall Study|Protocol Violation|3
2185333|NCT01448057|3814406|FG001|Overall Study|Protocol Violation|2
2185334|NCT01448057|3814405|FG000|Overall Study|Lost to Follow-up|3
2185335|NCT01448057|3814406|FG001|Overall Study|Lost to Follow-up|0
2185336|NCT01448057|3814405|FG000|Overall Study|Adverse Event|0
2185337|NCT01448057|3814406|FG001|Overall Study|Adverse Event|2
2185338|NCT01448057|3814405|FG000|Overall Study|Withdrawal by Subject|2
2185339|NCT01448057|3814406|FG001|Overall Study|Withdrawal by Subject|0
2185340|NCT01448213|3814414|FG000|Overall Study|Lost to Follow-up|12
2185341|NCT01448213|3814415|FG001|Overall Study|Lost to Follow-up|10
2185342|NCT01448213|3814414|FG000|Overall Study|Adverse Event|4
2185343|NCT01448213|3814415|FG001|Overall Study|Adverse Event|10
2185344|NCT01448213|3814414|FG000|Overall Study|Protocol Violation|1
2185345|NCT01448213|3814415|FG001|Overall Study|Protocol Violation|2
2185346|NCT01448616|3814460|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3
2185347|NCT01448616|3814461|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0
2185348|NCT01448616|3814462|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0
2185349|NCT01448616|3814463|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0
2185350|NCT01448616|3814460|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6
2185351|NCT01448616|3814461|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0
2185352|NCT01448616|3814462|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0
2185353|NCT01448616|3814463|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0
2185354|NCT01448616|3814460|FG000|Study Drug (Treatment Phase)|Adverse Event|0
2185355|NCT01448616|3814461|FG001|Study Drug (Treatment Phase)|Adverse Event|1
2185356|NCT01448616|3814462|FG002|Study Drug (Treatment Phase)|Adverse Event|1
2185357|NCT01448616|3814463|FG003|Study Drug (Treatment Phase)|Adverse Event|0
2185358|NCT01448616|3814460|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0
2185359|NCT01448616|3814461|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0
2221079|NCT01736683|3865966|FG003|Overall Study|Progressive Disease|1
2185360|NCT01448616|3814462|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1
2185361|NCT01448616|3814463|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2
2221080|NCT01736683|3865967|FG004|Overall Study|Progressive Disease|0
2185362|NCT01448616|3814460|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0
2185363|NCT01448616|3814461|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1
2185364|NCT01448616|3814462|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2
2221081|NCT01736683|3865963|FG000|Overall Study|Other|0
2221082|NCT01736683|3865964|FG001|Overall Study|Other|0
2221083|NCT01736683|3865965|FG002|Overall Study|Other|1
2221084|NCT01736683|3865966|FG003|Overall Study|Other|9
2221085|NCT01736683|3865967|FG004|Overall Study|Other|1
2221086|NCT01736696|3865988|FG000|Overall Study|Withdrawal by Subject|0
2221087|NCT01736696|3865989|FG001|Overall Study|Withdrawal by Subject|0
2221088|NCT01736696|3865990|FG002|Overall Study|Withdrawal by Subject|1
2221089|NCT01736696|3865991|FG003|Overall Study|Withdrawal by Subject|0
2221090|NCT01736696|3865992|FG004|Overall Study|Withdrawal by Subject|0
2221091|NCT01736696|3865993|FG005|Overall Study|Withdrawal by Subject|0
2221092|NCT01736696|3865994|FG006|Overall Study|Withdrawal by Subject|0
2221093|NCT01736917|3866036|FG000|Overall Study|Adverse Event|1
2221094|NCT01736917|3866036|FG000|Overall Study|Protocol Violation|10
2221095|NCT01737021|3866054|FG000|Overall Study|Lost to Follow-up|5
2221096|NCT01737021|3866055|FG001|Overall Study|Lost to Follow-up|3
2221097|NCT01737268|3866061|FG000|Overall Study|Adverse Event|6
2221098|NCT01737268|3866061|FG000|Overall Study|Worsening of Target Disease|2
2221099|NCT01737268|3866061|FG000|Overall Study|In consideration of the patient's safety|1
2221100|NCT01737398|3866077|FG000|Overall Study|Adverse event or SAE|16
2221101|NCT01737398|3866078|FG001|Overall Study|Adverse event or SAE|1
2221102|NCT01737398|3866077|FG000|Overall Study|Stopping rule met|2
2221103|NCT01737398|3866078|FG001|Overall Study|Stopping rule met|1
2221104|NCT01737398|3866077|FG000|Overall Study|Voluntary withdrawal|2
2221105|NCT01737398|3866078|FG001|Overall Study|Voluntary withdrawal|3
2221106|NCT01737398|3866077|FG000|Overall Study|Ineligibility|1
2221107|NCT01737398|3866078|FG001|Overall Study|Ineligibility|0
2221108|NCT01737398|3866077|FG000|Overall Study|Liver transplant|1
2221109|NCT01737398|3866078|FG001|Overall Study|Liver transplant|0
2221110|NCT01737398|3866077|FG000|Overall Study|Disease progression|2
2221111|NCT01737398|3866078|FG001|Overall Study|Disease progression|3
2221112|NCT01737398|3866077|FG000|Overall Study|Sponsor's decision|2
2332037|NCT03184701|4055200|FG000|Overall Study|Physician Decision|3
2332038|NCT03184701|4055200|FG000|Overall Study|Withdrawal by Subject|6
2332039|NCT03184701|4055200|FG000|Overall Study|Lost to Follow-up|5
2332040|NCT03184987|4055207|FG000|Overall Study|Withdrawal by Subject|0
2332041|NCT03184987|4055208|FG001|Overall Study|Withdrawal by Subject|1
2332042|NCT03184987|4055209|FG002|Overall Study|Withdrawal by Subject|2
2332043|NCT03184987|4055207|FG000|Overall Study|Physician Decision|0
2332044|NCT03184987|4055208|FG001|Overall Study|Physician Decision|0
2332045|NCT03184987|4055209|FG002|Overall Study|Physician Decision|1
2332046|NCT03184987|4055207|FG000|Overall Study|Adverse Event|1
2332047|NCT03184987|4055208|FG001|Overall Study|Adverse Event|0
2332048|NCT03184987|4055209|FG002|Overall Study|Adverse Event|1
2332049|NCT03185481|4055249|FG000|Overall Study|Adverse Event|1
2332050|NCT03185481|4055249|FG000|Overall Study|Study Terminated by Sponsor|4
2332051|NCT03186378|4055298|FG000|Overall Study|Lost to Follow-up|1
2332052|NCT03186378|4055299|FG001|Overall Study|Lost to Follow-up|0
2332053|NCT03186781|4055332|FG000|Overall Study|Lost to Follow-up|0
2332054|NCT03186781|4055333|FG001|Overall Study|Lost to Follow-up|0
2332055|NCT03186781|4055334|FG002|Overall Study|Lost to Follow-up|1
2332056|NCT03186781|4055335|FG003|Overall Study|Lost to Follow-up|0
2332057|NCT03186781|4055336|FG004|Overall Study|Lost to Follow-up|1
2332058|NCT03186781|4055337|FG005|Overall Study|Lost to Follow-up|0
2332059|NCT03186781|4055332|FG000|Overall Study|Moved from Area|0
2332060|NCT03186781|4055333|FG001|Overall Study|Moved from Area|0
2332061|NCT03186781|4055334|FG002|Overall Study|Moved from Area|0
2332062|NCT03186781|4055335|FG003|Overall Study|Moved from Area|0
2332063|NCT03186781|4055336|FG004|Overall Study|Moved from Area|1
2332064|NCT03186781|4055337|FG005|Overall Study|Moved from Area|0
2332065|NCT03186781|4055332|FG000|Overall Study|Withdrawal by Subject|0
2332066|NCT03186781|4055333|FG001|Overall Study|Withdrawal by Subject|0
2332067|NCT03186781|4055334|FG002|Overall Study|Withdrawal by Subject|0
2332068|NCT03186781|4055335|FG003|Overall Study|Withdrawal by Subject|0
2332069|NCT03186781|4055336|FG004|Overall Study|Withdrawal by Subject|1
2332070|NCT03186781|4055337|FG005|Overall Study|Withdrawal by Subject|0
2332071|NCT03187132|4055375|FG000|Inpatient Trauma Only|Lost to Follow-up|3
2332072|NCT03187132|4055376|FG001|Inpatient Trauma Only|Lost to Follow-up|12
2332073|NCT03187132|4055375|FG000|Inpatient Trauma Only|socioeconomic burden|1
2332074|NCT03187132|4055376|FG001|Inpatient Trauma Only|socioeconomic burden|0
2332075|NCT03187132|4055375|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0
2185365|NCT01448616|3814463|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2
2185366|NCT01448707|3814478|FG000|Overall Study|Adverse Event|3
2185367|NCT01448707|3814479|FG001|Overall Study|Adverse Event|1
2185368|NCT01448707|3814478|FG000|Overall Study|Lost to Follow-up|2
2185369|NCT01448707|3814479|FG001|Overall Study|Lost to Follow-up|6
2185370|NCT01448707|3814478|FG000|Overall Study|Withdrawal by Subject|6
2185371|NCT01448707|3814479|FG001|Overall Study|Withdrawal by Subject|7
2185372|NCT01448707|3814478|FG000|Overall Study|Other|7
2185373|NCT01448707|3814479|FG001|Overall Study|Other|4
2221113|NCT01737398|3866078|FG001|Overall Study|Sponsor's decision|0
2185374|NCT01448824|3814493|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2185375|NCT01448824|3814494|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2185376|NCT01448824|3814495|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2185377|NCT01448824|3814496|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2185378|NCT01448824|3814497|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2185379|NCT01448824|3814498|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2185380|NCT01448824|3814499|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
2185381|NCT01448824|3814500|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2185382|NCT01448824|3814493|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2185383|NCT01448824|3814494|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2185384|NCT01448824|3814495|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2185385|NCT01448824|3814496|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
2185386|NCT01448824|3814497|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
2185387|NCT01448824|3814498|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
2185388|NCT01448824|3814499|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2185389|NCT01448824|3814500|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2185390|NCT01448824|3814493|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2185391|NCT01448824|3814494|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2185392|NCT01448824|3814495|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2185393|NCT01448824|3814496|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2185394|NCT01448824|3814497|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2185395|NCT01448824|3814498|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
2185396|NCT01448824|3814499|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2185397|NCT01448824|3814500|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2185398|NCT01448824|3814493|FG000|Part 1: Washout Period|Lost to Follow-up|1
2185399|NCT01448824|3814494|FG001|Part 1: Washout Period|Lost to Follow-up|0
2185400|NCT01448824|3814495|FG002|Part 1: Washout Period|Lost to Follow-up|0
2185401|NCT01448824|3814496|FG003|Part 1: Washout Period|Lost to Follow-up|0
2185402|NCT01448824|3814497|FG004|Part 1: Washout Period|Lost to Follow-up|0
2185403|NCT01448824|3814498|FG005|Part 1: Washout Period|Lost to Follow-up|0
2185404|NCT01448824|3814499|FG006|Part 1: Washout Period|Lost to Follow-up|0
2185405|NCT01448824|3814500|FG007|Part 1: Washout Period|Lost to Follow-up|0
2185406|NCT01448824|3814493|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2185407|NCT01448824|3814494|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2221114|NCT01737697|3866118|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0
2221115|NCT01737697|3866119|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1
2221116|NCT01737697|3866120|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0
2221117|NCT01737697|3866121|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1
2221118|NCT01737697|3866122|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1
2221119|NCT01737697|3866123|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0
2221120|NCT01737697|3866124|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0
2221121|NCT01737697|3866125|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0
2221122|NCT01737697|3866126|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0
2221123|NCT01737697|3866127|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0
2221124|NCT01737697|3866128|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0
2221125|NCT01737697|3866129|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0
2221126|NCT01737697|3866130|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0
2221127|NCT01737697|3866131|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0
2221128|NCT01737697|3866132|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0
2221129|NCT01737697|3866118|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
2221130|NCT01737697|3866119|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
2221131|NCT01737697|3866120|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
2221132|NCT01737697|3866121|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221133|NCT01737697|3866122|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221134|NCT01737697|3866123|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221135|NCT01737697|3866124|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221136|NCT01737697|3866125|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221137|NCT01737697|3866126|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221138|NCT01737697|3866127|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221139|NCT01737697|3866128|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221140|NCT01737697|3866129|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221141|NCT01737697|3866130|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221142|NCT01737697|3866131|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221143|NCT01737697|3866132|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2221144|NCT01737697|3866118|FG000|Acute Phase-Initial 48 Hours|Family emergency|0
2221145|NCT01737697|3866119|FG001|Acute Phase-Initial 48 Hours|Family emergency|0
2221146|NCT01737697|3866120|FG002|Acute Phase-Initial 48 Hours|Family emergency|0
2221147|NCT01737697|3866121|FG003|Acute Phase-Initial 48 Hours|Family emergency|1
2221148|NCT01737697|3866122|FG004|Acute Phase-Initial 48 Hours|Family emergency|0
2221149|NCT01737697|3866123|FG005|Acute Phase-Initial 48 Hours|Family emergency|0
2221150|NCT01737697|3866124|FG006|Acute Phase-Initial 48 Hours|Family emergency|0
2221151|NCT01737697|3866125|FG007|Acute Phase-Initial 48 Hours|Family emergency|0
2185408|NCT01448824|3814495|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2185409|NCT01448824|3814496|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2185410|NCT01448824|3814497|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2185411|NCT01448824|3814498|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2185412|NCT01448824|3814499|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2185413|NCT01448824|3814500|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
2185414|NCT01448824|3814493|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2185415|NCT01448824|3814494|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2185416|NCT01448824|3814495|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2185417|NCT01448824|3814496|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2185418|NCT01448824|3814497|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2185419|NCT01448824|3814498|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2185420|NCT01448824|3814499|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2185421|NCT01448824|3814500|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
2185422|NCT01448824|3814493|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2185423|NCT01448824|3814494|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2185424|NCT01448824|3814495|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2185425|NCT01448824|3814496|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2185426|NCT01448824|3814497|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2185427|NCT01448824|3814498|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2185428|NCT01448824|3814499|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2185429|NCT01448824|3814500|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
2185430|NCT01448824|3814493|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2185431|NCT01448824|3814494|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2185432|NCT01448824|3814495|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2185433|NCT01448824|3814496|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2185434|NCT01448824|3814497|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2185435|NCT01448824|3814498|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2185436|NCT01448824|3814499|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2185437|NCT01448824|3814500|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
2185438|NCT01448850|3814530|FG000|Overall Study|Death|3
2185439|NCT01448850|3814531|FG001|Overall Study|Death|6
2185440|NCT01448850|3814530|FG000|Overall Study|Withdrawal by Subject|13
2185441|NCT01448850|3814531|FG001|Overall Study|Withdrawal by Subject|21
2185442|NCT01448850|3814530|FG000|Overall Study|Lost to Follow-up|3
2185443|NCT01448850|3814531|FG001|Overall Study|Lost to Follow-up|1
2185444|NCT01448850|3814530|FG000|Overall Study|Other|15
2185445|NCT01448850|3814531|FG001|Overall Study|Other|12
2185446|NCT01449006|3814540|FG000|Overall Study|Lost to Follow-up|1
2185447|NCT01449006|3814541|FG001|Overall Study|Lost to Follow-up|0
2185448|NCT01449006|3814540|FG000|Overall Study|Withdrawal by Subject|1
2185449|NCT01449006|3814541|FG001|Overall Study|Withdrawal by Subject|0
2185450|NCT01449006|3814540|FG000|Overall Study|Protocol Violation|1
2185451|NCT01449006|3814541|FG001|Overall Study|Protocol Violation|0
2185452|NCT01449279|3814555|FG000|Overall Study|Lack of Efficacy|5
2185453|NCT01449279|3814555|FG000|Overall Study|Toxicity|2
2185454|NCT01449370|3814588|FG000|Overall Study|Disease Progression|5
2185455|NCT01449370|3814589|FG001|Overall Study|Disease Progression|4
2185456|NCT01449370|3814590|FG002|Overall Study|Disease Progression|8
2185457|NCT01449370|3814591|FG003|Overall Study|Disease Progression|3
2185458|NCT01449370|3814592|FG004|Overall Study|Disease Progression|3
2185459|NCT01449370|3814593|FG005|Overall Study|Disease Progression|3
2185460|NCT01449370|3814594|FG006|Overall Study|Disease Progression|3
2185461|NCT01449370|3814595|FG007|Overall Study|Disease Progression|2
2185462|NCT01449370|3814596|FG008|Overall Study|Disease Progression|9
2185463|NCT01449370|3814597|FG009|Overall Study|Disease Progression|1
2185464|NCT01449370|3814598|FG010|Overall Study|Disease Progression|3
2185465|NCT01449370|3814599|FG011|Overall Study|Disease Progression|3
2185466|NCT01449370|3814600|FG012|Overall Study|Disease Progression|2
2185467|NCT01449370|3814601|FG013|Overall Study|Disease Progression|8
2185468|NCT01449370|3814602|FG014|Overall Study|Disease Progression|3
2185469|NCT01449370|3814603|FG015|Overall Study|Disease Progression|1
2185470|NCT01449370|3814604|FG016|Overall Study|Disease Progression|4
2185471|NCT01449370|3814605|FG017|Overall Study|Disease Progression|3
2185472|NCT01449370|3814606|FG018|Overall Study|Disease Progression|1
2185473|NCT01449370|3814607|FG019|Overall Study|Disease Progression|2
2185474|NCT01449370|3814608|FG020|Overall Study|Disease Progression|5
2185475|NCT01449370|3814609|FG021|Overall Study|Disease Progression|2
2185476|NCT01449370|3814610|FG022|Overall Study|Disease Progression|3
2185477|NCT01449370|3814611|FG023|Overall Study|Disease Progression|7
2185478|NCT01449370|3814612|FG024|Overall Study|Disease Progression|3
2185479|NCT01449370|3814588|FG000|Overall Study|Adverse Event|1
2185480|NCT01449370|3814589|FG001|Overall Study|Adverse Event|2
2185481|NCT01449370|3814590|FG002|Overall Study|Adverse Event|0
2185482|NCT01449370|3814591|FG003|Overall Study|Adverse Event|1
2221152|NCT01737697|3866126|FG008|Acute Phase-Initial 48 Hours|Family emergency|0
2221153|NCT01737697|3866127|FG009|Acute Phase-Initial 48 Hours|Family emergency|0
2221154|NCT01737697|3866128|FG010|Acute Phase-Initial 48 Hours|Family emergency|0
2185483|NCT01449370|3814592|FG004|Overall Study|Adverse Event|0
2185484|NCT01449370|3814593|FG005|Overall Study|Adverse Event|0
2185485|NCT01449370|3814594|FG006|Overall Study|Adverse Event|0
2185486|NCT01449370|3814595|FG007|Overall Study|Adverse Event|0
2185487|NCT01449370|3814596|FG008|Overall Study|Adverse Event|1
2185488|NCT01449370|3814597|FG009|Overall Study|Adverse Event|1
2185489|NCT01449370|3814598|FG010|Overall Study|Adverse Event|0
2185490|NCT01449370|3814599|FG011|Overall Study|Adverse Event|0
2185491|NCT01449370|3814600|FG012|Overall Study|Adverse Event|0
2185492|NCT01449370|3814601|FG013|Overall Study|Adverse Event|2
2185493|NCT01449370|3814602|FG014|Overall Study|Adverse Event|0
2185494|NCT01449370|3814603|FG015|Overall Study|Adverse Event|1
2185495|NCT01449370|3814604|FG016|Overall Study|Adverse Event|0
2185496|NCT01449370|3814605|FG017|Overall Study|Adverse Event|0
2185497|NCT01449370|3814606|FG018|Overall Study|Adverse Event|1
2185498|NCT01449370|3814607|FG019|Overall Study|Adverse Event|1
2185499|NCT01449370|3814608|FG020|Overall Study|Adverse Event|0
2185500|NCT01449370|3814609|FG021|Overall Study|Adverse Event|1
2185501|NCT01449370|3814610|FG022|Overall Study|Adverse Event|0
2185502|NCT01449370|3814611|FG023|Overall Study|Adverse Event|1
2185503|NCT01449370|3814612|FG024|Overall Study|Adverse Event|3
2185504|NCT01449370|3814588|FG000|Overall Study|Participant Decision|0
2185505|NCT01449370|3814589|FG001|Overall Study|Participant Decision|0
2185506|NCT01449370|3814590|FG002|Overall Study|Participant Decision|0
2185507|NCT01449370|3814591|FG003|Overall Study|Participant Decision|0
2185508|NCT01449370|3814592|FG004|Overall Study|Participant Decision|0
2185509|NCT01449370|3814593|FG005|Overall Study|Participant Decision|0
2185510|NCT01449370|3814594|FG006|Overall Study|Participant Decision|0
2185511|NCT01449370|3814595|FG007|Overall Study|Participant Decision|1
2185512|NCT01449370|3814596|FG008|Overall Study|Participant Decision|1
2185513|NCT01449370|3814597|FG009|Overall Study|Participant Decision|0
2185514|NCT01449370|3814598|FG010|Overall Study|Participant Decision|0
2185515|NCT01449370|3814599|FG011|Overall Study|Participant Decision|0
2185516|NCT01449370|3814600|FG012|Overall Study|Participant Decision|1
2185517|NCT01449370|3814601|FG013|Overall Study|Participant Decision|1
2185518|NCT01449370|3814602|FG014|Overall Study|Participant Decision|0
2185519|NCT01449370|3814603|FG015|Overall Study|Participant Decision|1
2185520|NCT01449370|3814604|FG016|Overall Study|Participant Decision|3
2185521|NCT01449370|3814605|FG017|Overall Study|Participant Decision|0
2185522|NCT01449370|3814606|FG018|Overall Study|Participant Decision|1
2185523|NCT01449370|3814607|FG019|Overall Study|Participant Decision|0
2185524|NCT01449370|3814608|FG020|Overall Study|Participant Decision|0
2185525|NCT01449370|3814609|FG021|Overall Study|Participant Decision|1
2185526|NCT01449370|3814610|FG022|Overall Study|Participant Decision|0
2221155|NCT01737697|3866129|FG011|Acute Phase-Initial 48 Hours|Family emergency|0
2221156|NCT01737697|3866130|FG012|Acute Phase-Initial 48 Hours|Family emergency|0
2221157|NCT01737697|3866131|FG013|Acute Phase-Initial 48 Hours|Family emergency|0
2221158|NCT01737697|3866132|FG014|Acute Phase-Initial 48 Hours|Family emergency|0
2221159|NCT01737697|3866118|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221160|NCT01737697|3866119|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1
2221161|NCT01737697|3866120|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221162|NCT01737697|3866121|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221163|NCT01737697|3866122|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221164|NCT01737697|3866123|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221165|NCT01737697|3866124|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221166|NCT01737697|3866125|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221167|NCT01737697|3866126|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221168|NCT01737697|3866127|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221169|NCT01737697|3866128|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221170|NCT01737697|3866129|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221171|NCT01737697|3866130|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221172|NCT01737697|3866131|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2332076|NCT03187132|4055376|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5
2332077|NCT03187132|4055375|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1
2332078|NCT03187132|4055376|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0
2332079|NCT03187132|4055375|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2
2332080|NCT03187132|4055376|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5
2332081|NCT03187132|4055375|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1
2332082|NCT03187132|4055376|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0
2332083|NCT03187132|4055375|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0
2332084|NCT03187132|4055376|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2
2332085|NCT03187132|4055375|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27
2332086|NCT03187132|4055376|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47
2332087|NCT03187132|4055375|FG000|Pain Clinic Only, Fully Remote|Disease burden|6
2332088|NCT03187132|4055376|FG001|Pain Clinic Only, Fully Remote|Disease burden|5
2332089|NCT03187132|4055375|FG000|Pain Clinic Only, Fully Remote|Language barrier|0
2332090|NCT03187132|4055376|FG001|Pain Clinic Only, Fully Remote|Language barrier|1
2332091|NCT03187132|4055375|FG000|Pain Clinic Only, Fully Remote|EMR|0
2332092|NCT03187132|4055376|FG001|Pain Clinic Only, Fully Remote|EMR|1
2036596|NCT00412958|3606834|FG002|Overall Study|Transport issue|0
2185527|NCT01449370|3814611|FG023|Overall Study|Participant Decision|0
2185528|NCT01449370|3814612|FG024|Overall Study|Participant Decision|1
2185529|NCT01449370|3814588|FG000|Overall Study|Lost to Follow-up|0
2185530|NCT01449370|3814589|FG001|Overall Study|Lost to Follow-up|0
2185531|NCT01449370|3814590|FG002|Overall Study|Lost to Follow-up|0
2185532|NCT01449370|3814591|FG003|Overall Study|Lost to Follow-up|0
2185533|NCT01449370|3814592|FG004|Overall Study|Lost to Follow-up|0
2185534|NCT01449370|3814593|FG005|Overall Study|Lost to Follow-up|0
2185535|NCT01449370|3814594|FG006|Overall Study|Lost to Follow-up|0
2185536|NCT01449370|3814595|FG007|Overall Study|Lost to Follow-up|0
2185537|NCT01449370|3814596|FG008|Overall Study|Lost to Follow-up|0
2185538|NCT01449370|3814597|FG009|Overall Study|Lost to Follow-up|0
2185539|NCT01449370|3814598|FG010|Overall Study|Lost to Follow-up|0
2185540|NCT01449370|3814599|FG011|Overall Study|Lost to Follow-up|0
2185541|NCT01449370|3814600|FG012|Overall Study|Lost to Follow-up|0
2185542|NCT01449370|3814601|FG013|Overall Study|Lost to Follow-up|0
2185543|NCT01449370|3814602|FG014|Overall Study|Lost to Follow-up|0
2185544|NCT01449370|3814603|FG015|Overall Study|Lost to Follow-up|0
2185545|NCT01449370|3814604|FG016|Overall Study|Lost to Follow-up|0
2185546|NCT01449370|3814605|FG017|Overall Study|Lost to Follow-up|0
2185547|NCT01449370|3814606|FG018|Overall Study|Lost to Follow-up|0
2221173|NCT01737697|3866132|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2221174|NCT01737697|3866118|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221175|NCT01737697|3866119|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221176|NCT01737697|3866120|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221177|NCT01737697|3866121|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221178|NCT01737697|3866122|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
2221179|NCT01737697|3866123|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221180|NCT01737697|3866124|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221181|NCT01737697|3866125|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221182|NCT01737697|3866126|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221183|NCT01737697|3866127|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221184|NCT01737697|3866128|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221185|NCT01737697|3866129|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221186|NCT01737697|3866130|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221187|NCT01737697|3866131|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221188|NCT01737697|3866132|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2221189|NCT01737697|3866118|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2221190|NCT01737697|3866119|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
2221191|NCT01737697|3866120|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
2221192|NCT01737697|3866121|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
2221193|NCT01737697|3866122|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
2221194|NCT01737697|3866123|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2221195|NCT01737697|3866124|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2221196|NCT01737697|3866125|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2221197|NCT01737697|3866126|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2221198|NCT01737697|3866127|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2221199|NCT01737697|3866128|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2221200|NCT01737697|3866129|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2221201|NCT01737697|3866130|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2221202|NCT01737697|3866131|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2221203|NCT01737697|3866132|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2221204|NCT01737697|3866118|FG000|Subacute Phase|Adverse Event|0
2221205|NCT01737697|3866119|FG001|Subacute Phase|Adverse Event|0
2221206|NCT01737697|3866120|FG002|Subacute Phase|Adverse Event|0
2221207|NCT01737697|3866121|FG003|Subacute Phase|Adverse Event|0
2221208|NCT01737697|3866122|FG004|Subacute Phase|Adverse Event|0
2221209|NCT01737697|3866123|FG005|Subacute Phase|Adverse Event|1
2221210|NCT01737697|3866124|FG006|Subacute Phase|Adverse Event|1
2221211|NCT01737697|3866125|FG007|Subacute Phase|Adverse Event|1
2221212|NCT01737697|3866126|FG008|Subacute Phase|Adverse Event|1
2221213|NCT01737697|3866127|FG009|Subacute Phase|Adverse Event|1
2221214|NCT01737697|3866128|FG010|Subacute Phase|Adverse Event|4
2221215|NCT01737697|3866129|FG011|Subacute Phase|Adverse Event|1
2221216|NCT01737697|3866130|FG012|Subacute Phase|Adverse Event|1
2221217|NCT01737697|3866131|FG013|Subacute Phase|Adverse Event|0
2221218|NCT01737697|3866132|FG014|Subacute Phase|Adverse Event|0
2221219|NCT01737697|3866118|FG000|Subacute Phase|Withdrawal by Subject|0
2221220|NCT01737697|3866119|FG001|Subacute Phase|Withdrawal by Subject|0
2221221|NCT01737697|3866120|FG002|Subacute Phase|Withdrawal by Subject|0
2221222|NCT01737697|3866121|FG003|Subacute Phase|Withdrawal by Subject|0
2221223|NCT01737697|3866122|FG004|Subacute Phase|Withdrawal by Subject|0
2221224|NCT01737697|3866123|FG005|Subacute Phase|Withdrawal by Subject|1
2221225|NCT01737697|3866124|FG006|Subacute Phase|Withdrawal by Subject|0
2221226|NCT01737697|3866125|FG007|Subacute Phase|Withdrawal by Subject|2
2221227|NCT01737697|3866126|FG008|Subacute Phase|Withdrawal by Subject|0
2221228|NCT01737697|3866127|FG009|Subacute Phase|Withdrawal by Subject|1
2221229|NCT01737697|3866128|FG010|Subacute Phase|Withdrawal by Subject|0
2221230|NCT01737697|3866129|FG011|Subacute Phase|Withdrawal by Subject|1
2185548|NCT01449370|3814607|FG019|Overall Study|Lost to Follow-up|0
2185549|NCT01449370|3814608|FG020|Overall Study|Lost to Follow-up|1
2185550|NCT01449370|3814609|FG021|Overall Study|Lost to Follow-up|0
2221231|NCT01737697|3866130|FG012|Subacute Phase|Withdrawal by Subject|1
2221232|NCT01737697|3866131|FG013|Subacute Phase|Withdrawal by Subject|1
2221233|NCT01737697|3866132|FG014|Subacute Phase|Withdrawal by Subject|0
2221234|NCT01737697|3866118|FG000|Subacute Phase|Lost to Follow-up|0
2221235|NCT01737697|3866119|FG001|Subacute Phase|Lost to Follow-up|0
2221236|NCT01737697|3866120|FG002|Subacute Phase|Lost to Follow-up|0
2221237|NCT01737697|3866121|FG003|Subacute Phase|Lost to Follow-up|0
2221238|NCT01737697|3866122|FG004|Subacute Phase|Lost to Follow-up|0
2221239|NCT01737697|3866123|FG005|Subacute Phase|Lost to Follow-up|0
2185551|NCT01449370|3814610|FG022|Overall Study|Lost to Follow-up|0
2185552|NCT01449370|3814611|FG023|Overall Study|Lost to Follow-up|0
2185553|NCT01449370|3814612|FG024|Overall Study|Lost to Follow-up|0
2185554|NCT01449370|3814588|FG000|Overall Study|Other|0
2185555|NCT01449370|3814589|FG001|Overall Study|Other|0
2185556|NCT01449370|3814590|FG002|Overall Study|Other|0
2185557|NCT01449370|3814591|FG003|Overall Study|Other|0
2185558|NCT01449370|3814592|FG004|Overall Study|Other|0
2185559|NCT01449370|3814593|FG005|Overall Study|Other|0
2185560|NCT01449370|3814594|FG006|Overall Study|Other|0
2185561|NCT01449370|3814595|FG007|Overall Study|Other|0
2185562|NCT01449370|3814596|FG008|Overall Study|Other|1
2185563|NCT01449370|3814597|FG009|Overall Study|Other|1
2185564|NCT01449370|3814598|FG010|Overall Study|Other|0
2185565|NCT01449370|3814599|FG011|Overall Study|Other|0
2185566|NCT01449370|3814600|FG012|Overall Study|Other|0
2185567|NCT01449370|3814601|FG013|Overall Study|Other|0
2185568|NCT01449370|3814602|FG014|Overall Study|Other|0
2185569|NCT01449370|3814603|FG015|Overall Study|Other|0
2185570|NCT01449370|3814604|FG016|Overall Study|Other|0
2185571|NCT01449370|3814605|FG017|Overall Study|Other|0
2185572|NCT01449370|3814606|FG018|Overall Study|Other|0
2185573|NCT01449370|3814607|FG019|Overall Study|Other|0
2185574|NCT01449370|3814608|FG020|Overall Study|Other|0
2185575|NCT01449370|3814609|FG021|Overall Study|Other|0
2185576|NCT01449370|3814610|FG022|Overall Study|Other|1
2185577|NCT01449370|3814611|FG023|Overall Study|Other|1
2185578|NCT01449370|3814612|FG024|Overall Study|Other|0
2185579|NCT01449370|3814588|FG000|Overall Study|Medication Prohibited by Protocol|0
2185580|NCT01449370|3814589|FG001|Overall Study|Medication Prohibited by Protocol|0
2185581|NCT01449370|3814590|FG002|Overall Study|Medication Prohibited by Protocol|0
2185582|NCT01449370|3814591|FG003|Overall Study|Medication Prohibited by Protocol|0
2185583|NCT01449370|3814592|FG004|Overall Study|Medication Prohibited by Protocol|0
2185584|NCT01449370|3814593|FG005|Overall Study|Medication Prohibited by Protocol|0
2221240|NCT01737697|3866124|FG006|Subacute Phase|Lost to Follow-up|0
2221241|NCT01737697|3866125|FG007|Subacute Phase|Lost to Follow-up|0
2221242|NCT01737697|3866126|FG008|Subacute Phase|Lost to Follow-up|0
2221243|NCT01737697|3866127|FG009|Subacute Phase|Lost to Follow-up|0
2221244|NCT01737697|3866128|FG010|Subacute Phase|Lost to Follow-up|0
2221245|NCT01737697|3866129|FG011|Subacute Phase|Lost to Follow-up|0
2221246|NCT01737697|3866130|FG012|Subacute Phase|Lost to Follow-up|0
2221247|NCT01737697|3866131|FG013|Subacute Phase|Lost to Follow-up|0
2221248|NCT01737697|3866132|FG014|Subacute Phase|Lost to Follow-up|1
2221249|NCT01737697|3866118|FG000|Subacute Phase|Hypo-or hyperkalemia|0
2221250|NCT01737697|3866119|FG001|Subacute Phase|Hypo-or hyperkalemia|0
2221251|NCT01737697|3866120|FG002|Subacute Phase|Hypo-or hyperkalemia|0
2221252|NCT01737697|3866121|FG003|Subacute Phase|Hypo-or hyperkalemia|0
2221253|NCT01737697|3866122|FG004|Subacute Phase|Hypo-or hyperkalemia|0
2221254|NCT01737697|3866123|FG005|Subacute Phase|Hypo-or hyperkalemia|0
2221255|NCT01737697|3866124|FG006|Subacute Phase|Hypo-or hyperkalemia|0
2221256|NCT01737697|3866125|FG007|Subacute Phase|Hypo-or hyperkalemia|0
2221257|NCT01737697|3866126|FG008|Subacute Phase|Hypo-or hyperkalemia|0
2221258|NCT01737697|3866127|FG009|Subacute Phase|Hypo-or hyperkalemia|0
2221259|NCT01737697|3866128|FG010|Subacute Phase|Hypo-or hyperkalemia|0
2221260|NCT01737697|3866129|FG011|Subacute Phase|Hypo-or hyperkalemia|1
2221261|NCT01737697|3866130|FG012|Subacute Phase|Hypo-or hyperkalemia|0
2221262|NCT01737697|3866131|FG013|Subacute Phase|Hypo-or hyperkalemia|1
2221263|NCT01737697|3866132|FG014|Subacute Phase|Hypo-or hyperkalemia|0
2221264|NCT01737697|3866118|FG000|Subacute Phase|Protocol Violation|0
2221265|NCT01737697|3866119|FG001|Subacute Phase|Protocol Violation|0
2221266|NCT01737697|3866120|FG002|Subacute Phase|Protocol Violation|0
2221267|NCT01737697|3866121|FG003|Subacute Phase|Protocol Violation|0
2221268|NCT01737697|3866122|FG004|Subacute Phase|Protocol Violation|0
2221269|NCT01737697|3866123|FG005|Subacute Phase|Protocol Violation|1
2221270|NCT01737697|3866124|FG006|Subacute Phase|Protocol Violation|0
2221271|NCT01737697|3866125|FG007|Subacute Phase|Protocol Violation|0
2221272|NCT01737697|3866126|FG008|Subacute Phase|Protocol Violation|0
2221273|NCT01737697|3866127|FG009|Subacute Phase|Protocol Violation|0
2221274|NCT01737697|3866128|FG010|Subacute Phase|Protocol Violation|1
2221275|NCT01737697|3866129|FG011|Subacute Phase|Protocol Violation|0
2221276|NCT01737697|3866130|FG012|Subacute Phase|Protocol Violation|0
2221277|NCT01737697|3866131|FG013|Subacute Phase|Protocol Violation|0
2221278|NCT01737697|3866132|FG014|Subacute Phase|Protocol Violation|0
2221279|NCT01737697|3866118|FG000|Subacute Phase|Physician Decision|0
2185585|NCT01449370|3814594|FG006|Overall Study|Medication Prohibited by Protocol|0
2185586|NCT01449370|3814595|FG007|Overall Study|Medication Prohibited by Protocol|0
2185587|NCT01449370|3814596|FG008|Overall Study|Medication Prohibited by Protocol|0
2185588|NCT01449370|3814597|FG009|Overall Study|Medication Prohibited by Protocol|0
2185589|NCT01449370|3814598|FG010|Overall Study|Medication Prohibited by Protocol|0
2185590|NCT01449370|3814599|FG011|Overall Study|Medication Prohibited by Protocol|0
2185591|NCT01449370|3814600|FG012|Overall Study|Medication Prohibited by Protocol|0
2185592|NCT01449370|3814601|FG013|Overall Study|Medication Prohibited by Protocol|0
2185593|NCT01449370|3814602|FG014|Overall Study|Medication Prohibited by Protocol|0
2185594|NCT01449370|3814603|FG015|Overall Study|Medication Prohibited by Protocol|0
2185595|NCT01449370|3814604|FG016|Overall Study|Medication Prohibited by Protocol|0
2185596|NCT01449370|3814605|FG017|Overall Study|Medication Prohibited by Protocol|0
2185597|NCT01449370|3814606|FG018|Overall Study|Medication Prohibited by Protocol|0
2185598|NCT01449370|3814607|FG019|Overall Study|Medication Prohibited by Protocol|0
2185599|NCT01449370|3814608|FG020|Overall Study|Medication Prohibited by Protocol|0
2185600|NCT01449370|3814609|FG021|Overall Study|Medication Prohibited by Protocol|0
2185601|NCT01449370|3814610|FG022|Overall Study|Medication Prohibited by Protocol|0
2185602|NCT01449370|3814611|FG023|Overall Study|Medication Prohibited by Protocol|1
2185603|NCT01449370|3814612|FG024|Overall Study|Medication Prohibited by Protocol|0
2185604|NCT01449370|3814588|FG000|Overall Study|Death|0
2185605|NCT01449370|3814589|FG001|Overall Study|Death|0
2185606|NCT01449370|3814590|FG002|Overall Study|Death|0
2185607|NCT01449370|3814591|FG003|Overall Study|Death|0
2185608|NCT01449370|3814592|FG004|Overall Study|Death|0
2185609|NCT01449370|3814593|FG005|Overall Study|Death|0
2185610|NCT01449370|3814594|FG006|Overall Study|Death|0
2185611|NCT01449370|3814595|FG007|Overall Study|Death|0
2221280|NCT01737697|3866119|FG001|Subacute Phase|Physician Decision|0
2221281|NCT01737697|3866120|FG002|Subacute Phase|Physician Decision|0
2221282|NCT01737697|3866121|FG003|Subacute Phase|Physician Decision|0
2221283|NCT01737697|3866122|FG004|Subacute Phase|Physician Decision|0
2221284|NCT01737697|3866123|FG005|Subacute Phase|Physician Decision|0
2221285|NCT01737697|3866124|FG006|Subacute Phase|Physician Decision|0
2221286|NCT01737697|3866125|FG007|Subacute Phase|Physician Decision|0
2221287|NCT01737697|3866126|FG008|Subacute Phase|Physician Decision|1
2221288|NCT01737697|3866127|FG009|Subacute Phase|Physician Decision|0
2221289|NCT01737697|3866128|FG010|Subacute Phase|Physician Decision|0
2221290|NCT01737697|3866129|FG011|Subacute Phase|Physician Decision|0
2221291|NCT01737697|3866130|FG012|Subacute Phase|Physician Decision|0
2221292|NCT01737697|3866131|FG013|Subacute Phase|Physician Decision|0
2221293|NCT01737697|3866132|FG014|Subacute Phase|Physician Decision|0
2221294|NCT01737697|3866118|FG000|Subacute Phase|Death|0
2221295|NCT01737697|3866119|FG001|Subacute Phase|Death|0
2221296|NCT01737697|3866120|FG002|Subacute Phase|Death|0
2221297|NCT01737697|3866121|FG003|Subacute Phase|Death|0
2221298|NCT01737697|3866122|FG004|Subacute Phase|Death|0
2221299|NCT01737697|3866123|FG005|Subacute Phase|Death|0
2221300|NCT01737697|3866124|FG006|Subacute Phase|Death|0
2221301|NCT01737697|3866125|FG007|Subacute Phase|Death|0
2221302|NCT01737697|3866126|FG008|Subacute Phase|Death|0
2221303|NCT01737697|3866127|FG009|Subacute Phase|Death|0
2221304|NCT01737697|3866128|FG010|Subacute Phase|Death|1
2221305|NCT01737697|3866129|FG011|Subacute Phase|Death|0
2221306|NCT01737697|3866130|FG012|Subacute Phase|Death|0
2221307|NCT01737697|3866131|FG013|Subacute Phase|Death|0
2221308|NCT01737697|3866132|FG014|Subacute Phase|Death|0
2221309|NCT01737710|3866170|FG000|Overall Study|Lost to Follow-up|0
2221310|NCT01737710|3866171|FG001|Overall Study|Lost to Follow-up|2
2221311|NCT01737710|3866172|FG002|Overall Study|Lost to Follow-up|2
2221312|NCT01737710|3866173|FG003|Overall Study|Lost to Follow-up|0
2221313|NCT01737710|3866174|FG004|Overall Study|Lost to Follow-up|0
2221314|NCT01737710|3866170|FG000|Overall Study|Withdrawal by Subject|1
2221315|NCT01737710|3866171|FG001|Overall Study|Withdrawal by Subject|1
2221316|NCT01737710|3866172|FG002|Overall Study|Withdrawal by Subject|1
2221317|NCT01737710|3866173|FG003|Overall Study|Withdrawal by Subject|0
2221318|NCT01737710|3866174|FG004|Overall Study|Withdrawal by Subject|0
2221319|NCT01737710|3866170|FG000|Overall Study|Vaccinated in Error/Ineligible|1
2221320|NCT01737710|3866171|FG001|Overall Study|Vaccinated in Error/Ineligible|1
2221321|NCT01737710|3866172|FG002|Overall Study|Vaccinated in Error/Ineligible|0
2221322|NCT01737710|3866173|FG003|Overall Study|Vaccinated in Error/Ineligible|0
2221323|NCT01737710|3866174|FG004|Overall Study|Vaccinated in Error/Ineligible|0
2221324|NCT01737762|3866187|FG000|Overall Study|Adverse Event|2
2221325|NCT01737762|3866188|FG001|Overall Study|Adverse Event|2
2221326|NCT01737762|3866187|FG000|Overall Study|Lost to Follow-up|1
2221327|NCT01737762|3866188|FG001|Overall Study|Lost to Follow-up|0
2221328|NCT01737762|3866187|FG000|Overall Study|Withdrawal by Subject|2
2221329|NCT01737762|3866188|FG001|Overall Study|Withdrawal by Subject|2
2221330|NCT01737762|3866187|FG000|Overall Study|Progressive disease|1
2221331|NCT01737762|3866188|FG001|Overall Study|Progressive disease|2
2332093|NCT03187197|4055385|FG000|Overall Study|Stopped Pradaxa®/VKA|11
2332094|NCT03187197|4055386|FG001|Overall Study|Stopped Pradaxa®/VKA|65
2332095|NCT03187197|4055387|FG002|Overall Study|Stopped Pradaxa®/VKA|4
2332096|NCT03187197|4055385|FG000|Overall Study|Withdrawal by Subject|8
2332097|NCT03187197|4055386|FG001|Overall Study|Withdrawal by Subject|63
2332098|NCT03187197|4055387|FG002|Overall Study|Withdrawal by Subject|4
2221332|NCT01737762|3866187|FG000|Overall Study|Physician Decision|1
2221333|NCT01737762|3866188|FG001|Overall Study|Physician Decision|1
2185612|NCT01449370|3814596|FG008|Overall Study|Death|0
2185613|NCT01449370|3814597|FG009|Overall Study|Death|0
2185614|NCT01449370|3814598|FG010|Overall Study|Death|0
2185615|NCT01449370|3814599|FG011|Overall Study|Death|0
2185616|NCT01449370|3814600|FG012|Overall Study|Death|0
2185617|NCT01449370|3814601|FG013|Overall Study|Death|0
2185618|NCT01449370|3814602|FG014|Overall Study|Death|0
2185619|NCT01449370|3814603|FG015|Overall Study|Death|0
2185620|NCT01449370|3814604|FG016|Overall Study|Death|0
2185621|NCT01449370|3814605|FG017|Overall Study|Death|0
2185622|NCT01449370|3814606|FG018|Overall Study|Death|0
2185623|NCT01449370|3814607|FG019|Overall Study|Death|0
2185624|NCT01449370|3814608|FG020|Overall Study|Death|0
2185625|NCT01449370|3814609|FG021|Overall Study|Death|0
2185626|NCT01449370|3814610|FG022|Overall Study|Death|0
2185627|NCT01449370|3814611|FG023|Overall Study|Death|0
2185628|NCT01449370|3814612|FG024|Overall Study|Death|1
2185629|NCT01449461|3814691|FG000|Overall Study|Adverse Event|0
2185630|NCT01449461|3814692|FG001|Overall Study|Adverse Event|3
2185631|NCT01449461|3814693|FG002|Overall Study|Adverse Event|2
2185632|NCT01449461|3814694|FG003|Overall Study|Adverse Event|3
2185633|NCT01449461|3814695|FG004|Overall Study|Adverse Event|4
2185634|NCT01449461|3814696|FG005|Overall Study|Adverse Event|4
2185635|NCT01449461|3814691|FG000|Overall Study|Death|0
2185636|NCT01449461|3814692|FG001|Overall Study|Death|2
2185637|NCT01449461|3814693|FG002|Overall Study|Death|0
2185638|NCT01449461|3814694|FG003|Overall Study|Death|0
2185639|NCT01449461|3814695|FG004|Overall Study|Death|7
2185640|NCT01449461|3814696|FG005|Overall Study|Death|1
2185641|NCT01449461|3814691|FG000|Overall Study|Physician Decision|0
2185642|NCT01449461|3814692|FG001|Overall Study|Physician Decision|1
2185643|NCT01449461|3814693|FG002|Overall Study|Physician Decision|0
2185644|NCT01449461|3814694|FG003|Overall Study|Physician Decision|4
2185645|NCT01449461|3814695|FG004|Overall Study|Physician Decision|1
2185646|NCT01449461|3814696|FG005|Overall Study|Physician Decision|0
2185647|NCT01449461|3814691|FG000|Overall Study|Documented Progressive Disease|4
2185648|NCT01449461|3814692|FG001|Overall Study|Documented Progressive Disease|7
2185649|NCT01449461|3814693|FG002|Overall Study|Documented Progressive Disease|14
2185650|NCT01449461|3814694|FG003|Overall Study|Documented Progressive Disease|15
2185651|NCT01449461|3814695|FG004|Overall Study|Documented Progressive Disease|24
2185652|NCT01449461|3814696|FG005|Overall Study|Documented Progressive Disease|5
2185653|NCT01449461|3814691|FG000|Overall Study|Clinical Progressive Disease|2
2185654|NCT01449461|3814692|FG001|Overall Study|Clinical Progressive Disease|2
2185655|NCT01449461|3814693|FG002|Overall Study|Clinical Progressive Disease|0
2185656|NCT01449461|3814694|FG003|Overall Study|Clinical Progressive Disease|3
2185657|NCT01449461|3814695|FG004|Overall Study|Clinical Progressive Disease|4
2185658|NCT01449461|3814696|FG005|Overall Study|Clinical Progressive Disease|2
2185659|NCT01449461|3814691|FG000|Overall Study|Protocol Violation|0
2185660|NCT01449461|3814692|FG001|Overall Study|Protocol Violation|0
2185661|NCT01449461|3814693|FG002|Overall Study|Protocol Violation|0
2185662|NCT01449461|3814694|FG003|Overall Study|Protocol Violation|1
2185663|NCT01449461|3814695|FG004|Overall Study|Protocol Violation|0
2185664|NCT01449461|3814696|FG005|Overall Study|Protocol Violation|0
2185665|NCT01449461|3814691|FG000|Overall Study|Site Terminated by Sponsor|0
2185666|NCT01449461|3814692|FG001|Overall Study|Site Terminated by Sponsor|1
2185667|NCT01449461|3814693|FG002|Overall Study|Site Terminated by Sponsor|2
2185668|NCT01449461|3814694|FG003|Overall Study|Site Terminated by Sponsor|3
2185669|NCT01449461|3814695|FG004|Overall Study|Site Terminated by Sponsor|4
2185670|NCT01449461|3814696|FG005|Overall Study|Site Terminated by Sponsor|1
2185671|NCT01449461|3814691|FG000|Overall Study|Withdrawal by Subject|0
2185672|NCT01449461|3814692|FG001|Overall Study|Withdrawal by Subject|1
2185673|NCT01449461|3814693|FG002|Overall Study|Withdrawal by Subject|0
2185674|NCT01449461|3814694|FG003|Overall Study|Withdrawal by Subject|0
2185675|NCT01449461|3814695|FG004|Overall Study|Withdrawal by Subject|2
2185676|NCT01449461|3814696|FG005|Overall Study|Withdrawal by Subject|1
2185677|NCT01449461|3814691|FG000|Overall Study|Reason not Specified|0
2185678|NCT01449461|3814692|FG001|Overall Study|Reason not Specified|1
2185679|NCT01449461|3814693|FG002|Overall Study|Reason not Specified|0
2185680|NCT01449461|3814694|FG003|Overall Study|Reason not Specified|3
2185681|NCT01449461|3814695|FG004|Overall Study|Reason not Specified|2
2185682|NCT01449461|3814696|FG005|Overall Study|Reason not Specified|1
2185683|NCT01449526|3814730|FG000|Overall Study|Lost to Follow-up|1
2185684|NCT01449526|3814731|FG001|Overall Study|Lost to Follow-up|2
2185685|NCT01449526|3814730|FG000|Overall Study|Withdrawal by Subject|1
2185686|NCT01449526|3814731|FG001|Overall Study|Withdrawal by Subject|1
2185687|NCT01449526|3814730|FG000|Overall Study|Symptoms/complaints|0
2185688|NCT01449526|3814731|FG001|Overall Study|Symptoms/complaints|1
2185689|NCT01449526|3814730|FG000|Overall Study|Lack of Motivation|0
2185690|NCT01449526|3814731|FG001|Overall Study|Lack of Motivation|1
2185691|NCT01449526|3814730|FG000|Overall Study|Cannot maintain visits|0
2185692|NCT01449526|3814731|FG001|Overall Study|Cannot maintain visits|1
2185693|NCT01449539|3814737|FG000|Overall Study|Withdrawal by Subject|3
2185694|NCT01449539|3814737|FG000|Overall Study|Toxicity not study related|1
2185695|NCT01449630|3814750|FG000|Period 1|Physician Decision|1
2185696|NCT01449630|3814751|FG001|Period 1|Physician Decision|0
2185697|NCT01449630|3814752|FG002|Period 1|Physician Decision|0
2185698|NCT01449630|3814753|FG003|Period 1|Physician Decision|1
2185699|NCT01449630|3814754|FG004|Period 1|Physician Decision|0
2185700|NCT01449630|3814755|FG005|Period 1|Physician Decision|0
2185701|NCT01449630|3814756|FG006|Period 1|Physician Decision|0
2185702|NCT01449630|3814757|FG007|Period 1|Physician Decision|0
2185703|NCT01449630|3814758|FG008|Period 1|Physician Decision|0
2185704|NCT01449630|3814750|FG000|Period 1|Sponsor Decision|0
2185705|NCT01449630|3814751|FG001|Period 1|Sponsor Decision|0
2185706|NCT01449630|3814752|FG002|Period 1|Sponsor Decision|0
2185707|NCT01449630|3814753|FG003|Period 1|Sponsor Decision|0
2185708|NCT01449630|3814754|FG004|Period 1|Sponsor Decision|0
2185709|NCT01449630|3814755|FG005|Period 1|Sponsor Decision|1
2185710|NCT01449630|3814756|FG006|Period 1|Sponsor Decision|0
2185711|NCT01449630|3814757|FG007|Period 1|Sponsor Decision|0
2185712|NCT01449630|3814758|FG008|Period 1|Sponsor Decision|0
2185713|NCT01449630|3814750|FG000|Period 2|Sponsor Decision|0
2185714|NCT01449630|3814751|FG001|Period 2|Sponsor Decision|0
2185715|NCT01449630|3814752|FG002|Period 2|Sponsor Decision|0
2185716|NCT01449630|3814753|FG003|Period 2|Sponsor Decision|0
2185717|NCT01449630|3814754|FG004|Period 2|Sponsor Decision|0
2185718|NCT01449630|3814755|FG005|Period 2|Sponsor Decision|0
2185719|NCT01449630|3814756|FG006|Period 2|Sponsor Decision|1
2185720|NCT01449630|3814757|FG007|Period 2|Sponsor Decision|0
2185721|NCT01449630|3814758|FG008|Period 2|Sponsor Decision|0
2185722|NCT01449682|3814782|FG000|Overall Study|Death|0
2185723|NCT01449682|3814783|FG001|Overall Study|Death|1
2185724|NCT01449682|3814782|FG000|Overall Study|Adverse Event|1
2185725|NCT01449682|3814783|FG001|Overall Study|Adverse Event|0
2185726|NCT01449708|3814791|FG000|Overall Study|Protocol Violation|0
2185727|NCT01449708|3814792|FG001|Overall Study|Protocol Violation|1
2185728|NCT01449708|3814791|FG000|Overall Study|surgical complication|1
2185729|NCT01449708|3814792|FG001|Overall Study|surgical complication|2
2185730|NCT01449708|3814791|FG000|Overall Study|respiratory failure|1
2185731|NCT01449708|3814792|FG001|Overall Study|respiratory failure|0
2185732|NCT01449721|3814803|FG000|Overall Study|Physician Decision|0
2185733|NCT01449721|3814804|FG001|Overall Study|Physician Decision|1
2185734|NCT01449721|3814803|FG000|Overall Study|Physician Decision|0
2185735|NCT01449721|3814804|FG001|Overall Study|Physician Decision|1
2185736|NCT01449812|3814826|FG000|Overall Study|Migrated/moved from study area|1
2185737|NCT01449812|3814827|FG001|Overall Study|Migrated/moved from study area|0
2185738|NCT01449812|3814828|FG002|Overall Study|Migrated/moved from study area|0
2185739|NCT01449812|3814826|FG000|Overall Study|Withdrawal by Subject|0
2185740|NCT01449812|3814827|FG001|Overall Study|Withdrawal by Subject|0
2185741|NCT01449812|3814828|FG002|Overall Study|Withdrawal by Subject|1
2185742|NCT01449812|3814826|FG000|Overall Study|Lost to Follow-up|1
2185743|NCT01449812|3814827|FG001|Overall Study|Lost to Follow-up|0
2185744|NCT01449812|3814828|FG002|Overall Study|Lost to Follow-up|0
2185745|NCT01449929|3814842|FG000|Randomization Phase 96 Week|Adverse Event|5
2185746|NCT01449929|3814843|FG001|Randomization Phase 96 Week|Adverse Event|13
2185747|NCT01449929|3814844|FG002|Randomization Phase 96 Week|Adverse Event|0
2185748|NCT01449929|3814842|FG000|Randomization Phase 96 Week|Lack of Efficacy|3
2185749|NCT01449929|3814843|FG001|Randomization Phase 96 Week|Lack of Efficacy|4
2185750|NCT01449929|3814844|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
2185751|NCT01449929|3814842|FG000|Randomization Phase 96 Week|Protocol Violation|5
2185752|NCT01449929|3814843|FG001|Randomization Phase 96 Week|Protocol Violation|6
2185753|NCT01449929|3814844|FG002|Randomization Phase 96 Week|Protocol Violation|0
2185754|NCT01449929|3814842|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
2185755|NCT01449929|3814843|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
2185756|NCT01449929|3814844|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
2185757|NCT01449929|3814842|FG000|Randomization Phase 96 Week|Lost to Follow-up|15
2185758|NCT01449929|3814843|FG001|Randomization Phase 96 Week|Lost to Follow-up|18
2185759|NCT01449929|3814844|FG002|Randomization Phase 96 Week|Lost to Follow-up|0
2185760|NCT01449929|3814842|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
2185761|NCT01449929|3814843|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8
2185762|NCT01449929|3814844|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0
2185763|NCT01449929|3814842|FG000|Randomization Phase 96 Week|Physician Decision|2
2185764|NCT01449929|3814843|FG001|Randomization Phase 96 Week|Physician Decision|3
2185765|NCT01449929|3814844|FG002|Randomization Phase 96 Week|Physician Decision|0
2185766|NCT01449929|3814842|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0
2185767|NCT01449929|3814843|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1
2221334|NCT01737762|3866187|FG000|Overall Study|Moved from area|2
2221335|NCT01737762|3866188|FG001|Overall Study|Moved from area|1
2221336|NCT01737762|3866187|FG000|Overall Study|Trial termination|11
2185768|NCT01449929|3814844|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0
2185769|NCT01449929|3814842|FG000|Extension Phase Approximately 3 Years|Adverse Event|0
2185770|NCT01449929|3814843|FG001|Extension Phase Approximately 3 Years|Adverse Event|0
2185771|NCT01449929|3814844|FG002|Extension Phase Approximately 3 Years|Adverse Event|2
2185772|NCT01449929|3814842|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0
2185773|NCT01449929|3814843|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0
2185774|NCT01449929|3814844|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2
2185775|NCT01449929|3814842|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0
2221337|NCT01737762|3866188|FG001|Overall Study|Trial termination|9
2185776|NCT01449929|3814843|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0
2185777|NCT01449929|3814844|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4
2185778|NCT01449955|3814856|FG000|Overall Study|Withdrawal by Subject|1
2185779|NCT01449955|3814857|FG001|Overall Study|Withdrawal by Subject|2
2185780|NCT01450007|3814873|FG000|Overall Study|Late exclusion before treatment|2
2185781|NCT01450007|3814874|FG001|Overall Study|Late exclusion before treatment|3
2185782|NCT01450007|3814875|FG002|Overall Study|Late exclusion before treatment|2
2185783|NCT01450007|3814873|FG000|Overall Study|Protocol Violation|0
2185784|NCT01450007|3814874|FG001|Overall Study|Protocol Violation|1
2185785|NCT01450007|3814875|FG002|Overall Study|Protocol Violation|1
2185786|NCT01450007|3814873|FG000|Overall Study|Adverse Event|0
2185787|NCT01450007|3814874|FG001|Overall Study|Adverse Event|1
2185788|NCT01450007|3814875|FG002|Overall Study|Adverse Event|0
2185789|NCT01450098|3814885|FG000|Period 3|Protocol Violation|0
2185790|NCT01450098|3814886|FG001|Period 3|Protocol Violation|1
2221338|NCT01737840|3866196|FG000|Overall Study|Diagnosed with an other pathology|2
2221339|NCT01737840|3866197|FG001|Overall Study|Diagnosed with an other pathology|2
2221340|NCT01737879|3866205|FG000|Overall Study|Death|1
2221341|NCT01737879|3866205|FG000|Overall Study|Sponsor decision|40
2221342|NCT01737931|3866212|FG000|Overall Study|Withdrawal by Subject|0
2221343|NCT01737931|3866213|FG001|Overall Study|Withdrawal by Subject|1
2221344|NCT01737931|3866214|FG002|Overall Study|Withdrawal by Subject|1
2221345|NCT01737931|3866212|FG000|Overall Study|Physician Decision|0
2221346|NCT01737931|3866213|FG001|Overall Study|Physician Decision|1
2221347|NCT01737931|3866214|FG002|Overall Study|Physician Decision|0
2221348|NCT01737996|3866239|FG000|Overall Study|Adverse Event|0
2221349|NCT01737996|3866240|FG001|Overall Study|Adverse Event|1
2221350|NCT01737996|3866241|FG002|Overall Study|Adverse Event|1
2221351|NCT01737996|3866239|FG000|Overall Study|Withdrawal by Subject|0
2221352|NCT01737996|3866240|FG001|Overall Study|Withdrawal by Subject|0
2221353|NCT01737996|3866241|FG002|Overall Study|Withdrawal by Subject|1
2221354|NCT01738191|3866251|FG000|Overall Study|Withdrawal by Subject|4
2221355|NCT01738191|3866252|FG001|Overall Study|Withdrawal by Subject|1
2221356|NCT01738438|3866267|FG000|Overall Study|Disease Progression|32
2221357|NCT01738438|3866267|FG000|Overall Study|Adverse Event|3
2221358|NCT01738477|3866273|FG000|Overall Study|Lost to Follow-up|1
2221359|NCT01738477|3866274|FG001|Overall Study|Lost to Follow-up|4
2221360|NCT01738503|3866288|FG000|Induction/Stabilization (Days -14 to -1)|Other|35
2221361|NCT01738503|3866289|FG001|Induction/Stabilization (Days -14 to -1)|Other|0
2221362|NCT01738503|3866290|FG002|Induction/Stabilization (Days -14 to -1)|Other|0
2221363|NCT01738503|3866291|FG003|Induction/Stabilization (Days -14 to -1)|Other|0
2221364|NCT01738503|3866292|FG004|Induction/Stabilization (Days -14 to -1)|Other|0
2221365|NCT01738503|3866293|FG005|Induction/Stabilization (Days -14 to -1)|Other|0
2221366|NCT01738503|3866294|FG006|Induction/Stabilization (Days -14 to -1)|Other|0
2221367|NCT01738503|3866288|FG000|Treatment Period|Adverse Event|0
2221368|NCT01738503|3866289|FG001|Treatment Period|Adverse Event|1
2221369|NCT01738503|3866290|FG002|Treatment Period|Adverse Event|0
2221370|NCT01738503|3866291|FG003|Treatment Period|Adverse Event|1
2221371|NCT01738503|3866292|FG004|Treatment Period|Adverse Event|2
2221372|NCT01738503|3866293|FG005|Treatment Period|Adverse Event|2
2221373|NCT01738503|3866294|FG006|Treatment Period|Adverse Event|2
2221374|NCT01738503|3866288|FG000|Treatment Period|Lost to Follow-up|0
2221375|NCT01738503|3866289|FG001|Treatment Period|Lost to Follow-up|0
2221376|NCT01738503|3866290|FG002|Treatment Period|Lost to Follow-up|3
2221377|NCT01738503|3866291|FG003|Treatment Period|Lost to Follow-up|4
2221378|NCT01738503|3866292|FG004|Treatment Period|Lost to Follow-up|1
2221379|NCT01738503|3866293|FG005|Treatment Period|Lost to Follow-up|1
2221380|NCT01738503|3866294|FG006|Treatment Period|Lost to Follow-up|5
2221381|NCT01738503|3866288|FG000|Treatment Period|Withdrawal by Subject|0
2221382|NCT01738503|3866289|FG001|Treatment Period|Withdrawal by Subject|1
2221383|NCT01738503|3866290|FG002|Treatment Period|Withdrawal by Subject|0
2221384|NCT01738503|3866291|FG003|Treatment Period|Withdrawal by Subject|1
2221385|NCT01738503|3866292|FG004|Treatment Period|Withdrawal by Subject|1
2221386|NCT01738503|3866293|FG005|Treatment Period|Withdrawal by Subject|1
2221387|NCT01738503|3866294|FG006|Treatment Period|Withdrawal by Subject|1
2221388|NCT01738503|3866288|FG000|Treatment Period|Protocol Violation|0
2221389|NCT01738503|3866289|FG001|Treatment Period|Protocol Violation|3
2221390|NCT01738503|3866290|FG002|Treatment Period|Protocol Violation|1
2221391|NCT01738503|3866291|FG003|Treatment Period|Protocol Violation|0
2221392|NCT01738503|3866292|FG004|Treatment Period|Protocol Violation|4
2221393|NCT01738503|3866293|FG005|Treatment Period|Protocol Violation|2
2221394|NCT01738503|3866294|FG006|Treatment Period|Protocol Violation|0
2221395|NCT01738503|3866288|FG000|Treatment Period|Other|0
2221396|NCT01738503|3866289|FG001|Treatment Period|Other|0
2221397|NCT01738503|3866290|FG002|Treatment Period|Other|1
2221398|NCT01738503|3866291|FG003|Treatment Period|Other|0
2221399|NCT01738503|3866292|FG004|Treatment Period|Other|0
2221400|NCT01738503|3866293|FG005|Treatment Period|Other|0
2221401|NCT01738503|3866294|FG006|Treatment Period|Other|0
2221402|NCT01738503|3866288|FG000|PET Imaging Sub-study|Adverse Event|0
2221403|NCT01738503|3866289|FG001|PET Imaging Sub-study|Adverse Event|0
2185791|NCT01450098|3814885|FG000|Period 3|Withdrawal by Subject|0
2221404|NCT01738503|3866290|FG002|PET Imaging Sub-study|Adverse Event|0
2185792|NCT01450098|3814886|FG001|Period 3|Withdrawal by Subject|2
2185793|NCT01450137|3814901|FG000|Up to Week 12|Adverse Event|2
2185794|NCT01450137|3814902|FG001|Up to Week 12|Adverse Event|1
2185795|NCT01450137|3814901|FG000|Up to Week 12|Withdrawal by Subject|0
2185796|NCT01450137|3814902|FG001|Up to Week 12|Withdrawal by Subject|2
2185797|NCT01450137|3814901|FG000|Week 12 to Study End|Death|0
2185798|NCT01450137|3814902|FG001|Week 12 to Study End|Death|1
2185799|NCT01450137|3814901|FG000|Week 12 to Study End|Withdrawal by Subject|0
2185800|NCT01450137|3814902|FG001|Week 12 to Study End|Withdrawal by Subject|1
2185801|NCT01450540|3814947|FG000|Overall Study|Withdrawal by Subject|19
2185802|NCT01450540|3814948|FG001|Overall Study|Withdrawal by Subject|13
2185803|NCT01450540|3814947|FG000|Overall Study|protocol deviation|3
2185804|NCT01450540|3814948|FG001|Overall Study|protocol deviation|23
2185805|NCT01450631|3814958|FG000|Overall Study|Lost to Follow-up|2
2185806|NCT01450631|3814959|FG001|Overall Study|Lost to Follow-up|4
2221405|NCT01738503|3866291|FG003|PET Imaging Sub-study|Adverse Event|0
2185807|NCT01450631|3814958|FG000|Overall Study|Withdrawal by Subject|1
2185808|NCT01450631|3814959|FG001|Overall Study|Withdrawal by Subject|0
2185809|NCT01450683|3814965|FG000|Overall Study|Adverse Event|2
2185810|NCT01450696|3814971|FG000|Overall Study|Never Treated|1
2185811|NCT01450696|3814972|FG001|Overall Study|Never Treated|1
2185812|NCT01450696|3814971|FG000|Overall Study|Death|77
2185813|NCT01450696|3814972|FG001|Overall Study|Death|84
2185814|NCT01450696|3814971|FG000|Overall Study|Lost to Follow-up|3
2185815|NCT01450696|3814972|FG001|Overall Study|Lost to Follow-up|3
2185816|NCT01450696|3814971|FG000|Overall Study|Non-Compliance|1
2185817|NCT01450696|3814972|FG001|Overall Study|Non-Compliance|0
2185818|NCT01450696|3814971|FG000|Overall Study|Withdrawal by Subject|13
2185819|NCT01450696|3814972|FG001|Overall Study|Withdrawal by Subject|2
2185820|NCT01450696|3814971|FG000|Overall Study|Study Terminated by Sponsor|53
2185821|NCT01450696|3814972|FG001|Overall Study|Study Terminated by Sponsor|58
2185822|NCT01450761|3814980|FG000|Randomization|Subject no longer meets study criteria|1
2185823|NCT01450761|3814981|FG001|Randomization|Subject no longer meets study criteria|2
2185824|NCT01450761|3814980|FG000|Randomization|Withdrawal by Subject|2
2185825|NCT01450761|3814981|FG001|Randomization|Withdrawal by Subject|0
2185826|NCT01450761|3814980|FG000|Randomization|Disease progression|0
2185827|NCT01450761|3814981|FG001|Randomization|Disease progression|2
2185828|NCT01450761|3814980|FG000|Randomization|Adverse Event unrelated to study drug|1
2185829|NCT01450761|3814981|FG001|Randomization|Adverse Event unrelated to study drug|0
2185830|NCT01450761|3814980|FG000|Randomization|Other|0
2185831|NCT01450761|3814981|FG001|Randomization|Other|1
2185832|NCT01450761|3814980|FG000|Lead-in Chemotherapy|Disease progression|33
2185833|NCT01450761|3814981|FG001|Lead-in Chemotherapy|Disease progression|32
2185834|NCT01450761|3814980|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
2185835|NCT01450761|3814981|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
2185836|NCT01450761|3814980|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14
2185837|NCT01450761|3814981|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12
2185838|NCT01450761|3814980|FG000|Lead-in Chemotherapy|Study drug toxicity|6
2185839|NCT01450761|3814981|FG001|Lead-in Chemotherapy|Study drug toxicity|10
2185840|NCT01450761|3814980|FG000|Lead-in Chemotherapy|No longer meets study criteria|3
2185841|NCT01450761|3814981|FG001|Lead-in Chemotherapy|No longer meets study criteria|7
2185842|NCT01450761|3814980|FG000|Lead-in Chemotherapy|Death|3
2185843|NCT01450761|3814981|FG001|Lead-in Chemotherapy|Death|3
2185844|NCT01450761|3814980|FG000|Lead-in Chemotherapy|Other|2
2185845|NCT01450761|3814981|FG001|Lead-in Chemotherapy|Other|2
2185846|NCT01450761|3814980|FG000|Lead-in Chemotherapy|Lost to Follow-up|2
2185847|NCT01450761|3814981|FG001|Lead-in Chemotherapy|Lost to Follow-up|0
2185848|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Disease progression|318
2185849|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Disease progression|415
2185850|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87
2185851|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9
2185852|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
2185853|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
2185854|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
2185855|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
2185856|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
2185857|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
2185858|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Death|5
2185859|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Death|6
2185860|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5
2185861|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4
2221406|NCT01738503|3866292|FG004|PET Imaging Sub-study|Adverse Event|0
2221407|NCT01738503|3866293|FG005|PET Imaging Sub-study|Adverse Event|1
2221408|NCT01738503|3866294|FG006|PET Imaging Sub-study|Adverse Event|0
2185862|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2
2185863|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1
2221409|NCT01738503|3866288|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2274068|NCT02292771|3954887|FG001|Overall Study|Withdrawal by Subject|1
2185864|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
2185865|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
2185866|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1
2185867|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2
2185868|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Not reported|2
2185869|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Not reported|2
2185870|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1
2221410|NCT01738503|3866289|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2221411|NCT01738503|3866290|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2221412|NCT01738503|3866291|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2221413|NCT01738503|3866292|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2221414|NCT01738503|3866293|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1
2221415|NCT01738503|3866294|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1
2221416|NCT01738581|3866318|FG000|Overall Study|Lost to Follow-up|1
2221417|NCT01738581|3866319|FG001|Overall Study|Lost to Follow-up|0
2221418|NCT01738594|3866328|FG000|Registration and Treatment Start|Adverse Event|0
2221419|NCT01738594|3866329|FG001|Registration and Treatment Start|Adverse Event|1
2221420|NCT01738594|3866330|FG002|Registration and Treatment Start|Adverse Event|0
2221421|NCT01738594|3866331|FG003|Registration and Treatment Start|Adverse Event|0
2221422|NCT01738594|3866332|FG004|Registration and Treatment Start|Adverse Event|0
2221423|NCT01738594|3866333|FG005|Registration and Treatment Start|Adverse Event|0
2221424|NCT01738594|3866334|FG006|Registration and Treatment Start|Adverse Event|0
2221425|NCT01738594|3866335|FG007|Registration and Treatment Start|Adverse Event|0
2221426|NCT01738594|3866328|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2221427|NCT01738594|3866329|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2221428|NCT01738594|3866330|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2221429|NCT01738594|3866331|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2221430|NCT01738594|3866332|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2221431|NCT01738594|3866333|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
2221432|NCT01738594|3866334|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2221433|NCT01738594|3866335|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2221434|NCT01738594|3866328|FG000|Completed 4 Cycles of Treatment|Progressive disease|0
2221435|NCT01738594|3866329|FG001|Completed 4 Cycles of Treatment|Progressive disease|2
2221436|NCT01738594|3866330|FG002|Completed 4 Cycles of Treatment|Progressive disease|0
2221437|NCT01738594|3866331|FG003|Completed 4 Cycles of Treatment|Progressive disease|0
2221438|NCT01738594|3866332|FG004|Completed 4 Cycles of Treatment|Progressive disease|0
2221439|NCT01738594|3866333|FG005|Completed 4 Cycles of Treatment|Progressive disease|0
2221440|NCT01738594|3866334|FG006|Completed 4 Cycles of Treatment|Progressive disease|0
2221441|NCT01738594|3866335|FG007|Completed 4 Cycles of Treatment|Progressive disease|0
2221442|NCT01738594|3866328|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0
2221443|NCT01738594|3866329|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0
2221444|NCT01738594|3866330|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0
2221445|NCT01738594|3866331|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0
2221446|NCT01738594|3866332|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0
2221447|NCT01738594|3866333|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1
2221448|NCT01738594|3866334|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0
2221449|NCT01738594|3866335|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0
2221450|NCT01738594|3866328|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2221451|NCT01738594|3866329|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2221452|NCT01738594|3866330|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2221453|NCT01738594|3866331|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2221454|NCT01738594|3866332|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2221455|NCT01738594|3866333|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1
2221456|NCT01738594|3866334|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2221457|NCT01738594|3866335|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2221458|NCT01738594|3866328|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2221459|NCT01738594|3866329|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2221460|NCT01738594|3866330|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2221461|NCT01738594|3866331|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2221462|NCT01738594|3866332|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
2221463|NCT01738594|3866333|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2221464|NCT01738594|3866334|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2221465|NCT01738594|3866335|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2221466|NCT01738594|3866328|FG000|Follow up for 1 Year|Death|0
2221467|NCT01738594|3866329|FG001|Follow up for 1 Year|Death|0
2221468|NCT01738594|3866330|FG002|Follow up for 1 Year|Death|0
2221469|NCT01738594|3866331|FG003|Follow up for 1 Year|Death|0
2221470|NCT01738594|3866332|FG004|Follow up for 1 Year|Death|0
2221471|NCT01738594|3866333|FG005|Follow up for 1 Year|Death|1
2185871|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0
2185872|NCT01450761|3814980|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
2185873|NCT01450761|3814981|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
2185874|NCT01450800|3814998|FG000|Overall Study|Protocol Violation|1
2185875|NCT01450800|3814999|FG001|Overall Study|Protocol Violation|3
2185876|NCT01450813|3815011|FG000|Overall Study|Physician Decision|1
2185877|NCT01450813|3815012|FG001|Overall Study|Physician Decision|1
2185878|NCT01450813|3815013|FG002|Overall Study|Physician Decision|0
2185879|NCT01450813|3815014|FG003|Overall Study|Physician Decision|3
2185880|NCT01450943|3815038|FG000|Overall Study|Screen failure, loss to follow-up|2
2185881|NCT01450943|3815039|FG001|Overall Study|Screen failure, loss to follow-up|7
2185882|NCT01450943|3815040|FG002|Overall Study|Screen failure, loss to follow-up|6
2185883|NCT01451164|3815056|FG000|Overall Study|Adverse Event|19
2185884|NCT01451164|3815057|FG001|Overall Study|Adverse Event|12
2185885|NCT01451164|3815058|FG002|Overall Study|Adverse Event|18
2185886|NCT01451164|3815059|FG003|Overall Study|Adverse Event|21
2185887|NCT01451164|3815056|FG000|Overall Study|Withdrawal Criteria|1
2185888|NCT01451164|3815057|FG001|Overall Study|Withdrawal Criteria|1
2185889|NCT01451164|3815058|FG002|Overall Study|Withdrawal Criteria|1
2185890|NCT01451164|3815059|FG003|Overall Study|Withdrawal Criteria|1
2185891|NCT01451164|3815056|FG000|Overall Study|Physician Decision|2
2185892|NCT01451164|3815057|FG001|Overall Study|Physician Decision|0
2185893|NCT01451164|3815058|FG002|Overall Study|Physician Decision|1
2185894|NCT01451164|3815059|FG003|Overall Study|Physician Decision|0
2185895|NCT01451164|3815056|FG000|Overall Study|Withdrawal by Subject|14
2185896|NCT01451164|3815057|FG001|Overall Study|Withdrawal by Subject|11
2185897|NCT01451164|3815058|FG002|Overall Study|Withdrawal by Subject|16
2185898|NCT01451164|3815059|FG003|Overall Study|Withdrawal by Subject|17
2185899|NCT01451164|3815056|FG000|Overall Study|Protocol Violation|0
2185900|NCT01451164|3815057|FG001|Overall Study|Protocol Violation|1
2185901|NCT01451164|3815058|FG002|Overall Study|Protocol Violation|0
2185902|NCT01451164|3815059|FG003|Overall Study|Protocol Violation|0
2185903|NCT01451164|3815056|FG000|Overall Study|Lack of Efficacy|7
2185904|NCT01451164|3815057|FG001|Overall Study|Lack of Efficacy|9
2185905|NCT01451164|3815058|FG002|Overall Study|Lack of Efficacy|9
2185906|NCT01451164|3815059|FG003|Overall Study|Lack of Efficacy|7
2185907|NCT01451203|3815071|FG000|Double-blind Treatment Period|Did not receive treatment|1
2185908|NCT01451203|3815072|FG001|Double-blind Treatment Period|Did not receive treatment|2
2185909|NCT01451203|3815071|FG000|Double-blind Treatment Period|Consent Withdrawn|3
2185910|NCT01451203|3815072|FG001|Double-blind Treatment Period|Consent Withdrawn|2
2185911|NCT01451203|3815071|FG000|Double-blind Treatment Period|Lack of Efficacy|71
2185912|NCT01451203|3815072|FG001|Double-blind Treatment Period|Lack of Efficacy|36
2185913|NCT01451203|3815071|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
2185914|NCT01451203|3815072|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
2185915|NCT01451203|3815071|FG000|Double-blind Treatment Period|Adverse Event|6
2185916|NCT01451203|3815072|FG001|Double-blind Treatment Period|Adverse Event|9
2185917|NCT01451203|3815071|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1
2185918|NCT01451203|3815072|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0
2185919|NCT01451203|3815071|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1
2185920|NCT01451203|3815072|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0
2185921|NCT01451203|3815071|FG000|Double-blind Treatment Period|Investigator decision|2
2185922|NCT01451203|3815072|FG001|Double-blind Treatment Period|Investigator decision|0
2185923|NCT01451203|3815071|FG000|Post-treatment Period|Consent withdrawn|2
2185924|NCT01451203|3815072|FG001|Post-treatment Period|Consent withdrawn|4
2185925|NCT01451203|3815071|FG000|Post-treatment Period|Lack of Efficacy|12
2185926|NCT01451203|3815072|FG001|Post-treatment Period|Lack of Efficacy|28
2185927|NCT01451203|3815071|FG000|Post-treatment Period|Adverse Event|0
2185928|NCT01451203|3815072|FG001|Post-treatment Period|Adverse Event|1
2185929|NCT01451203|3815071|FG000|Post-treatment Period|Investigator decision|0
2185930|NCT01451203|3815072|FG001|Post-treatment Period|Investigator decision|1
2185931|NCT01451398|3815088|FG000|Overall Study|Adverse Event|7
2185932|NCT01451398|3815089|FG001|Overall Study|Adverse Event|9
2185933|NCT01451398|3815088|FG000|Overall Study|Protocol Violation|1
2185934|NCT01451398|3815089|FG001|Overall Study|Protocol Violation|2
2185935|NCT01451398|3815088|FG000|Overall Study|Physician Decision|1
2185936|NCT01451398|3815089|FG001|Overall Study|Physician Decision|1
2185937|NCT01451398|3815088|FG000|Overall Study|Withdrawal by Subject|10
2185938|NCT01451398|3815089|FG001|Overall Study|Withdrawal by Subject|14
2185939|NCT01451398|3815088|FG000|Overall Study|Lost to Follow-up|6
2185940|NCT01451398|3815089|FG001|Overall Study|Lost to Follow-up|4
2185941|NCT01451398|3815088|FG000|Overall Study|Non-compliance with study drug|1
2185942|NCT01451398|3815089|FG001|Overall Study|Non-compliance with study drug|3
2185943|NCT01451398|3815088|FG000|Overall Study|Non-compliance with protocol|1
2185944|NCT01451398|3815089|FG001|Overall Study|Non-compliance with protocol|1
2185945|NCT01451398|3815088|FG000|Overall Study|Moved out of country|0
2185946|NCT01451398|3815089|FG001|Overall Study|Moved out of country|1
2185947|NCT01451398|3815088|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0
2185948|NCT01451398|3815089|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1
2185949|NCT01451398|3815088|FG000|Overall Study|Lack of Efficacy|0
2185950|NCT01451398|3815089|FG001|Overall Study|Lack of Efficacy|1
2185951|NCT01451424|3815108|FG000|Overall Study|Withdrawal by Subject|1
2185952|NCT01451424|3815109|FG001|Overall Study|Withdrawal by Subject|1
2185953|NCT01451424|3815110|FG002|Overall Study|Withdrawal by Subject|0
2185954|NCT01451424|3815111|FG003|Overall Study|Withdrawal by Subject|2
2185955|NCT01451424|3815108|FG000|Overall Study|Lost to Follow-up|0
2185956|NCT01451424|3815109|FG001|Overall Study|Lost to Follow-up|1
2185957|NCT01451424|3815110|FG002|Overall Study|Lost to Follow-up|0
2185958|NCT01451424|3815111|FG003|Overall Study|Lost to Follow-up|1
2185959|NCT01451424|3815108|FG000|Overall Study|Physician Decision|0
2185960|NCT01451424|3815109|FG001|Overall Study|Physician Decision|0
2185961|NCT01451424|3815110|FG002|Overall Study|Physician Decision|1
2185962|NCT01451424|3815111|FG003|Overall Study|Physician Decision|1
2221472|NCT01738594|3866334|FG006|Follow up for 1 Year|Death|0
2221473|NCT01738594|3866335|FG007|Follow up for 1 Year|Death|0
2221474|NCT01738594|3866328|FG000|Follow up for 1 Year|Other|0
2221475|NCT01738594|3866329|FG001|Follow up for 1 Year|Other|0
2221476|NCT01738594|3866330|FG002|Follow up for 1 Year|Other|0
2221477|NCT01738594|3866331|FG003|Follow up for 1 Year|Other|0
2221478|NCT01738594|3866332|FG004|Follow up for 1 Year|Other|0
2221479|NCT01738594|3866333|FG005|Follow up for 1 Year|Other|2
2221480|NCT01738594|3866334|FG006|Follow up for 1 Year|Other|0
2221481|NCT01738594|3866335|FG007|Follow up for 1 Year|Other|0
2221482|NCT01738646|3866345|FG000|Overall Study|Still Receiving Treatment|2
2221483|NCT01738919|3866388|FG000|Overall Study|Lost to Follow-up|1
2221484|NCT01738919|3866389|FG001|Overall Study|Lost to Follow-up|0
2221485|NCT01738919|3866388|FG000|Overall Study|Immigrated|0
2221486|NCT01738919|3866389|FG001|Overall Study|Immigrated|1
2221487|NCT01738919|3866388|FG000|Overall Study|Withdrawal by Subject|0
2221488|NCT01738919|3866389|FG001|Overall Study|Withdrawal by Subject|1
2221489|NCT01738919|3866388|FG000|Overall Study|Not treated in accordance to guidelines|0
2221490|NCT01738919|3866389|FG001|Overall Study|Not treated in accordance to guidelines|1
2221491|NCT01738971|3866400|FG000|Overall Study|Lost to Follow-up|19
2221492|NCT01738971|3866401|FG001|Overall Study|Lost to Follow-up|30
2221493|NCT01738971|3866402|FG002|Overall Study|Lost to Follow-up|17
2221494|NCT01738984|3866412|FG000|Overall Study|Pregnancy|4
2221495|NCT01738984|3866413|FG001|Overall Study|Pregnancy|0
2221496|NCT01738984|3866412|FG000|Overall Study|Withdrawal by Subject|1
2221497|NCT01738984|3866413|FG001|Overall Study|Withdrawal by Subject|0
2221498|NCT01738984|3866412|FG000|Overall Study|Lost to Follow-up|59
2221499|NCT01738984|3866413|FG001|Overall Study|Lost to Follow-up|39
2221500|NCT01739309|3866446|FG000|Overall Study|On study treatment|3
2221501|NCT01739335|3866454|FG000|Overall Study|Lost to Follow-up|7
2221502|NCT01739335|3866455|FG001|Overall Study|Lost to Follow-up|4
2221503|NCT01739335|3866454|FG000|Overall Study|Ineligible patient randomized|0
2221504|NCT01739335|3866455|FG001|Overall Study|Ineligible patient randomized|1
2221505|NCT01739348|3866469|FG000|Part I (Base Study)|Adverse Event|41
2221506|NCT01739348|3866470|FG001|Part I (Base Study)|Adverse Event|52
2221507|NCT01739348|3866471|FG002|Part I (Base Study)|Adverse Event|8
2221508|NCT01739348|3866472|FG003|Part I (Base Study)|Adverse Event|33
2221509|NCT01739348|3866469|FG000|Part I (Base Study)|Death|10
2221510|NCT01739348|3866470|FG001|Part I (Base Study)|Death|7
2221511|NCT01739348|3866471|FG002|Part I (Base Study)|Death|2
2221512|NCT01739348|3866472|FG003|Part I (Base Study)|Death|8
2221513|NCT01739348|3866469|FG000|Part I (Base Study)|Lack of Efficacy|3
2221514|NCT01739348|3866470|FG001|Part I (Base Study)|Lack of Efficacy|8
2221515|NCT01739348|3866471|FG002|Part I (Base Study)|Lack of Efficacy|0
2221516|NCT01739348|3866472|FG003|Part I (Base Study)|Lack of Efficacy|7
2221517|NCT01739348|3866469|FG000|Part I (Base Study)|Lost to Follow-up|4
2221518|NCT01739348|3866470|FG001|Part I (Base Study)|Lost to Follow-up|2
2221519|NCT01739348|3866471|FG002|Part I (Base Study)|Lost to Follow-up|4
2221520|NCT01739348|3866472|FG003|Part I (Base Study)|Lost to Follow-up|4
2221521|NCT01739348|3866469|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3
2221522|NCT01739348|3866470|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2
2221523|NCT01739348|3866471|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0
2221524|NCT01739348|3866472|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0
2221525|NCT01739348|3866469|FG000|Part I (Base Study)|Physician Decision|10
2221526|NCT01739348|3866470|FG001|Part I (Base Study)|Physician Decision|7
2221527|NCT01739348|3866471|FG002|Part I (Base Study)|Physician Decision|1
2221528|NCT01739348|3866472|FG003|Part I (Base Study)|Physician Decision|4
2221529|NCT01739348|3866469|FG000|Part I (Base Study)|Protocol Violation|2
2221530|NCT01739348|3866470|FG001|Part I (Base Study)|Protocol Violation|0
2221531|NCT01739348|3866471|FG002|Part I (Base Study)|Protocol Violation|1
2221532|NCT01739348|3866472|FG003|Part I (Base Study)|Protocol Violation|2
2221533|NCT01739348|3866469|FG000|Part I (Base Study)|Screen Failure|2
2221534|NCT01739348|3866470|FG001|Part I (Base Study)|Screen Failure|0
2221535|NCT01739348|3866471|FG002|Part I (Base Study)|Screen Failure|0
2221536|NCT01739348|3866472|FG003|Part I (Base Study)|Screen Failure|0
2221537|NCT01739348|3866469|FG000|Part I (Base Study)|Site Discontinued Study Participation|1
2221538|NCT01739348|3866470|FG001|Part I (Base Study)|Site Discontinued Study Participation|3
2221539|NCT01739348|3866471|FG002|Part I (Base Study)|Site Discontinued Study Participation|0
2221540|NCT01739348|3866472|FG003|Part I (Base Study)|Site Discontinued Study Participation|0
2185963|NCT01451424|3815108|FG000|Overall Study|Adverse Event|0
2185964|NCT01451424|3815109|FG001|Overall Study|Adverse Event|0
2185965|NCT01451424|3815110|FG002|Overall Study|Adverse Event|0
2185966|NCT01451424|3815111|FG003|Overall Study|Adverse Event|1
2185967|NCT01451437|3815135|FG000|Overall Study|Adverse Event|0
2185968|NCT01451437|3815136|FG001|Overall Study|Adverse Event|0
2185969|NCT01451437|3815137|FG002|Overall Study|Adverse Event|0
2185970|NCT01451437|3815138|FG003|Overall Study|Adverse Event|0
2185971|NCT01451437|3815139|FG004|Overall Study|Adverse Event|0
2185972|NCT01451437|3815140|FG005|Overall Study|Adverse Event|1
2185973|NCT01451437|3815141|FG006|Overall Study|Adverse Event|1
2185974|NCT01451437|3815142|FG007|Overall Study|Adverse Event|2
2185975|NCT01451437|3815143|FG008|Overall Study|Adverse Event|1
2185976|NCT01451437|3815135|FG000|Overall Study|Physician Decision|1
2185977|NCT01451437|3815136|FG001|Overall Study|Physician Decision|1
2185978|NCT01451437|3815137|FG002|Overall Study|Physician Decision|2
2185979|NCT01451437|3815138|FG003|Overall Study|Physician Decision|0
2185980|NCT01451437|3815139|FG004|Overall Study|Physician Decision|0
2185981|NCT01451437|3815140|FG005|Overall Study|Physician Decision|0
2185982|NCT01451437|3815141|FG006|Overall Study|Physician Decision|0
2185983|NCT01451437|3815142|FG007|Overall Study|Physician Decision|0
2185984|NCT01451437|3815143|FG008|Overall Study|Physician Decision|0
2185985|NCT01451437|3815135|FG000|Overall Study|Disease Progression|0
2185986|NCT01451437|3815136|FG001|Overall Study|Disease Progression|0
2185987|NCT01451437|3815137|FG002|Overall Study|Disease Progression|1
2185988|NCT01451437|3815138|FG003|Overall Study|Disease Progression|1
2185989|NCT01451437|3815139|FG004|Overall Study|Disease Progression|3
2185990|NCT01451437|3815140|FG005|Overall Study|Disease Progression|2
2185991|NCT01451437|3815141|FG006|Overall Study|Disease Progression|3
2185992|NCT01451437|3815142|FG007|Overall Study|Disease Progression|1
2185993|NCT01451437|3815143|FG008|Overall Study|Disease Progression|3
2185994|NCT01451437|3815135|FG000|Overall Study|Protocol Violation|0
2185995|NCT01451437|3815136|FG001|Overall Study|Protocol Violation|0
2185996|NCT01451437|3815137|FG002|Overall Study|Protocol Violation|0
2185997|NCT01451437|3815138|FG003|Overall Study|Protocol Violation|0
2185998|NCT01451437|3815139|FG004|Overall Study|Protocol Violation|0
2185999|NCT01451437|3815140|FG005|Overall Study|Protocol Violation|0
2221541|NCT01739348|3866469|FG000|Part I (Base Study)|Study Terminated by Sponsor|72
2221542|NCT01739348|3866470|FG001|Part I (Base Study)|Study Terminated by Sponsor|73
2221543|NCT01739348|3866471|FG002|Part I (Base Study)|Study Terminated by Sponsor|0
2221544|NCT01739348|3866472|FG003|Part I (Base Study)|Study Terminated by Sponsor|86
2221545|NCT01739348|3866469|FG000|Part I (Base Study)|Participant Moved|4
2221546|NCT01739348|3866470|FG001|Part I (Base Study)|Participant Moved|3
2221547|NCT01739348|3866471|FG002|Part I (Base Study)|Participant Moved|1
2221548|NCT01739348|3866472|FG003|Part I (Base Study)|Participant Moved|7
2221549|NCT01739348|3866469|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
2221550|NCT01739348|3866470|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
2221551|NCT01739348|3866471|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
2221552|NCT01739348|3866472|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
2221553|NCT01739348|3866469|FG000|Part I (Base Study)|Withdrawal by Subject|23
2221554|NCT01739348|3866470|FG001|Part I (Base Study)|Withdrawal by Subject|21
2221555|NCT01739348|3866471|FG002|Part I (Base Study)|Withdrawal by Subject|7
2221556|NCT01739348|3866472|FG003|Part I (Base Study)|Withdrawal by Subject|20
2221557|NCT01739348|3866469|FG000|Part II (Extension Study)|Adverse Event|10
2221558|NCT01739348|3866470|FG001|Part II (Extension Study)|Adverse Event|11
2221559|NCT01739348|3866471|FG002|Part II (Extension Study)|Adverse Event|7
2221560|NCT01739348|3866472|FG003|Part II (Extension Study)|Adverse Event|26
2221561|NCT01739348|3866469|FG000|Part II (Extension Study)|Death|3
2221562|NCT01739348|3866470|FG001|Part II (Extension Study)|Death|3
2221563|NCT01739348|3866471|FG002|Part II (Extension Study)|Death|2
2221564|NCT01739348|3866472|FG003|Part II (Extension Study)|Death|6
2221565|NCT01739348|3866469|FG000|Part II (Extension Study)|Lack of Efficacy|1
2221566|NCT01739348|3866470|FG001|Part II (Extension Study)|Lack of Efficacy|5
2221567|NCT01739348|3866471|FG002|Part II (Extension Study)|Lack of Efficacy|0
2221568|NCT01739348|3866472|FG003|Part II (Extension Study)|Lack of Efficacy|1
2221569|NCT01739348|3866469|FG000|Part II (Extension Study)|Lost to Follow-up|3
2221570|NCT01739348|3866470|FG001|Part II (Extension Study)|Lost to Follow-up|4
2221571|NCT01739348|3866471|FG002|Part II (Extension Study)|Lost to Follow-up|0
2221572|NCT01739348|3866472|FG003|Part II (Extension Study)|Lost to Follow-up|1
2221573|NCT01739348|3866469|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0
2221574|NCT01739348|3866470|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0
2221575|NCT01739348|3866471|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0
2221576|NCT01739348|3866472|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1
2221577|NCT01739348|3866469|FG000|Part II (Extension Study)|Physician Decision|7
2221578|NCT01739348|3866470|FG001|Part II (Extension Study)|Physician Decision|11
2221579|NCT01739348|3866471|FG002|Part II (Extension Study)|Physician Decision|6
2186000|NCT01451437|3815141|FG006|Overall Study|Protocol Violation|1
2186001|NCT01451437|3815142|FG007|Overall Study|Protocol Violation|0
2186002|NCT01451437|3815143|FG008|Overall Study|Protocol Violation|0
2186003|NCT01451437|3815135|FG000|Overall Study|Withdrawal by Subject|0
2186004|NCT01451437|3815136|FG001|Overall Study|Withdrawal by Subject|0
2186005|NCT01451437|3815137|FG002|Overall Study|Withdrawal by Subject|0
2186006|NCT01451437|3815138|FG003|Overall Study|Withdrawal by Subject|0
2186007|NCT01451437|3815139|FG004|Overall Study|Withdrawal by Subject|1
2186008|NCT01451437|3815140|FG005|Overall Study|Withdrawal by Subject|0
2186009|NCT01451437|3815141|FG006|Overall Study|Withdrawal by Subject|1
2186010|NCT01451437|3815142|FG007|Overall Study|Withdrawal by Subject|0
2186011|NCT01451437|3815143|FG008|Overall Study|Withdrawal by Subject|0
2186012|NCT01451541|3815184|FG000|Overall Study|Adverse Event|4
2186013|NCT01451541|3815185|FG001|Overall Study|Adverse Event|3
2186014|NCT01451541|3815186|FG002|Overall Study|Adverse Event|6
2186015|NCT01451541|3815184|FG000|Overall Study|Lack of Efficacy|2
2186016|NCT01451541|3815185|FG001|Overall Study|Lack of Efficacy|0
2186017|NCT01451541|3815186|FG002|Overall Study|Lack of Efficacy|0
2186018|NCT01451541|3815184|FG000|Overall Study|Lost to Follow-up|4
2186019|NCT01451541|3815185|FG001|Overall Study|Lost to Follow-up|4
2186020|NCT01451541|3815186|FG002|Overall Study|Lost to Follow-up|7
2186021|NCT01451541|3815184|FG000|Overall Study|Withdrawal by Subject|15
2186022|NCT01451541|3815185|FG001|Overall Study|Withdrawal by Subject|8
2186023|NCT01451541|3815186|FG002|Overall Study|Withdrawal by Subject|6
2186024|NCT01451541|3815184|FG000|Overall Study|randomization error, noncompliance|11
2186025|NCT01451541|3815185|FG001|Overall Study|randomization error, noncompliance|10
2186026|NCT01451541|3815186|FG002|Overall Study|randomization error, noncompliance|8
2186027|NCT01451554|3815198|FG000|Overall Study|Withdrawal by Subject|14
2186028|NCT01451554|3815199|FG001|Overall Study|Withdrawal by Subject|9
2186029|NCT01451606|3815207|FG000|Overall Study|Withdrawal by Subject|4
2186030|NCT01451606|3815208|FG001|Overall Study|Withdrawal by Subject|3
2221580|NCT01739348|3866472|FG003|Part II (Extension Study)|Physician Decision|12
2221581|NCT01739348|3866469|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329
2221582|NCT01739348|3866470|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315
2221583|NCT01739348|3866471|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34
2221584|NCT01739348|3866472|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323
2221585|NCT01739348|3866469|FG000|Part II (Extension Study)|Participant Moved|3
2221586|NCT01739348|3866470|FG001|Part II (Extension Study)|Participant Moved|3
2221587|NCT01739348|3866471|FG002|Part II (Extension Study)|Participant Moved|0
2221588|NCT01739348|3866472|FG003|Part II (Extension Study)|Participant Moved|3
2221589|NCT01739348|3866469|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
2221590|NCT01739348|3866470|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
2221591|NCT01739348|3866471|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
2221592|NCT01739348|3866472|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
2221593|NCT01739348|3866469|FG000|Part II (Extension Study)|Withdrawal by Subject|5
2221594|NCT01739348|3866470|FG001|Part II (Extension Study)|Withdrawal by Subject|2
2221595|NCT01739348|3866471|FG002|Part II (Extension Study)|Withdrawal by Subject|4
2221596|NCT01739348|3866472|FG003|Part II (Extension Study)|Withdrawal by Subject|7
2221597|NCT01739400|3866497|FG000|Overall Study|Physician Decision|3
2221598|NCT01739400|3866498|FG001|Overall Study|Physician Decision|0
2221599|NCT01739400|3866497|FG000|Overall Study|Lost to Follow-up|2
2221600|NCT01739400|3866498|FG001|Overall Study|Lost to Follow-up|0
2221601|NCT01739400|3866497|FG000|Overall Study|Death|5
2221602|NCT01739400|3866498|FG001|Overall Study|Death|2
2221603|NCT01739400|3866497|FG000|Overall Study|Withdrawal by Subject|7
2221604|NCT01739400|3866498|FG001|Overall Study|Withdrawal by Subject|7
2221605|NCT01739595|3866506|FG000|Overall Study|Adverse Event|3
2221606|NCT01739595|3866507|FG001|Overall Study|Adverse Event|0
2221607|NCT01739595|3866508|FG002|Overall Study|Adverse Event|0
2221608|NCT01739595|3866506|FG000|Overall Study|Lost to Follow-up|2
2221609|NCT01739595|3866507|FG001|Overall Study|Lost to Follow-up|0
2221610|NCT01739595|3866508|FG002|Overall Study|Lost to Follow-up|0
2221611|NCT01739595|3866506|FG000|Overall Study|Withdrawal by Subject|2
2221612|NCT01739595|3866507|FG001|Overall Study|Withdrawal by Subject|1
2221613|NCT01739595|3866508|FG002|Overall Study|Withdrawal by Subject|2
2221614|NCT01739595|3866506|FG000|Overall Study|Eligibility issue|3
2221615|NCT01739595|3866507|FG001|Overall Study|Eligibility issue|0
2221616|NCT01739595|3866508|FG002|Overall Study|Eligibility issue|0
2221617|NCT01739595|3866506|FG000|Overall Study|Protocol Violation|1
2221618|NCT01739595|3866507|FG001|Overall Study|Protocol Violation|0
2221619|NCT01739595|3866508|FG002|Overall Study|Protocol Violation|0
2221620|NCT01739595|3866506|FG000|Overall Study|Lab assessment|1
2221621|NCT01739595|3866507|FG001|Overall Study|Lab assessment|0
2221622|NCT01739595|3866508|FG002|Overall Study|Lab assessment|0
2221623|NCT01739595|3866506|FG000|Overall Study|Drug discrepancy|1
2221624|NCT01739595|3866507|FG001|Overall Study|Drug discrepancy|0
2221625|NCT01739595|3866508|FG002|Overall Study|Drug discrepancy|0
2221626|NCT01739764|3866527|FG000|Overall Study|Adverse Event|0
2221627|NCT01739764|3866528|FG001|Overall Study|Adverse Event|3
2221628|NCT01739764|3866529|FG002|Overall Study|Adverse Event|4
2221629|NCT01739764|3866527|FG000|Overall Study|Death|4
2221630|NCT01739764|3866528|FG001|Overall Study|Death|6
2221631|NCT01739764|3866529|FG002|Overall Study|Death|38
2221632|NCT01739764|3866527|FG000|Overall Study|Lost to Follow-up|0
2221633|NCT01739764|3866528|FG001|Overall Study|Lost to Follow-up|0
2221634|NCT01739764|3866529|FG002|Overall Study|Lost to Follow-up|5
2221635|NCT01739764|3866527|FG000|Overall Study|Non-Compliance|0
2332099|NCT03187197|4055385|FG000|Overall Study|Lost to Follow-up|1
2186031|NCT01451645|3815252|FG000|Overall Study|Protocol Violation|1
2186032|NCT01451645|3815253|FG001|Overall Study|Protocol Violation|0
2186033|NCT01451645|3815252|FG000|Overall Study|Adverse Event|0
2186034|NCT01451645|3815253|FG001|Overall Study|Adverse Event|3
2186035|NCT01451645|3815252|FG000|Overall Study|Withdrawal by Subject|4
2186036|NCT01451645|3815253|FG001|Overall Study|Withdrawal by Subject|2
2186037|NCT01451645|3815252|FG000|Overall Study|Lost to Follow-up|4
2186038|NCT01451645|3815253|FG001|Overall Study|Lost to Follow-up|3
2186039|NCT01451749|3815261|FG000|Overall Study|Protocol Violation|14
2186040|NCT01451749|3815262|FG001|Overall Study|Protocol Violation|7
2186041|NCT01451749|3815261|FG000|Overall Study|Lost to Follow-up|15
2186042|NCT01451749|3815262|FG001|Overall Study|Lost to Follow-up|5
2186043|NCT01451749|3815261|FG000|Overall Study|Meet the exclusion criteria,and|1
2186044|NCT01451749|3815262|FG001|Overall Study|Meet the exclusion criteria,and|1
2186045|NCT01451749|3815261|FG000|Overall Study|Adverse Event|2
2186046|NCT01451749|3815262|FG001|Overall Study|Adverse Event|0
2186047|NCT01451749|3815261|FG000|Overall Study|Withdrawal by Subject|0
2186048|NCT01451749|3815262|FG001|Overall Study|Withdrawal by Subject|1
2186049|NCT01451762|3815273|FG000|Overall Study|Lost to Follow-up|3
2186050|NCT01451762|3815274|FG001|Overall Study|Lost to Follow-up|6
2186051|NCT01451762|3815275|FG002|Overall Study|Lost to Follow-up|6
2186052|NCT01451814|3815298|FG000|Overall Study|Withdrawal by Subject|1
2186053|NCT01451814|3815299|FG001|Overall Study|Withdrawal by Subject|1
2186054|NCT01451814|3815298|FG000|Overall Study|Lost to Follow-up|5
2186055|NCT01451814|3815299|FG001|Overall Study|Lost to Follow-up|4
2186056|NCT01451827|3815309|FG000|Overall Study|Adverse Event|2
2186057|NCT01451827|3815310|FG001|Overall Study|Adverse Event|0
2186058|NCT01451827|3815311|FG002|Overall Study|Adverse Event|1
2186059|NCT01451827|3815312|FG003|Overall Study|Adverse Event|1
2186060|NCT01451827|3815309|FG000|Overall Study|Protocol deviation|1
2186061|NCT01451827|3815310|FG001|Overall Study|Protocol deviation|0
2186062|NCT01451827|3815311|FG002|Overall Study|Protocol deviation|0
2186063|NCT01451827|3815312|FG003|Overall Study|Protocol deviation|0
2186064|NCT01451827|3815309|FG000|Overall Study|Lost to Follow-up|0
2186065|NCT01451827|3815310|FG001|Overall Study|Lost to Follow-up|3
2186066|NCT01451827|3815311|FG002|Overall Study|Lost to Follow-up|0
2186067|NCT01451827|3815312|FG003|Overall Study|Lost to Follow-up|2
2186068|NCT01451827|3815309|FG000|Overall Study|Participant met withdrawal criteria|0
2186069|NCT01451827|3815310|FG001|Overall Study|Participant met withdrawal criteria|2
2186070|NCT01451827|3815311|FG002|Overall Study|Participant met withdrawal criteria|0
2186071|NCT01451827|3815312|FG003|Overall Study|Participant met withdrawal criteria|0
2186072|NCT01451827|3815309|FG000|Overall Study|Withdrawal by Subject|0
2186073|NCT01451827|3815310|FG001|Overall Study|Withdrawal by Subject|0
2186074|NCT01451827|3815311|FG002|Overall Study|Withdrawal by Subject|1
2186075|NCT01451827|3815312|FG003|Overall Study|Withdrawal by Subject|1
2186076|NCT01451931|3815325|FG000|Overall Study|Lost to Follow-up|17
2186077|NCT01451931|3815326|FG001|Overall Study|Lost to Follow-up|36
2186078|NCT01451931|3815327|FG002|Overall Study|Lost to Follow-up|21
2186079|NCT01451931|3815325|FG000|Overall Study|Withdrawal by Subject|16
2186080|NCT01451931|3815326|FG001|Overall Study|Withdrawal by Subject|22
2186081|NCT01451931|3815327|FG002|Overall Study|Withdrawal by Subject|22
2186082|NCT01452152|3815381|FG000|Overall Study|Study termination by sponsor|5
2186083|NCT01452152|3815382|FG001|Overall Study|Study termination by sponsor|0
2186084|NCT01452152|3815383|FG002|Overall Study|Study termination by sponsor|4
2186085|NCT01452347|3815415|FG000|Overall Study|Adverse Event|2
2186086|NCT01452347|3815416|FG001|Overall Study|Adverse Event|1
2186087|NCT01452347|3815415|FG000|Overall Study|Non compliance protocol|2
2186088|NCT01452347|3815416|FG001|Overall Study|Non compliance protocol|0
2186089|NCT01452347|3815415|FG000|Overall Study|Lost to Follow-up|2
2186090|NCT01452347|3815416|FG001|Overall Study|Lost to Follow-up|0
2186091|NCT01452347|3815415|FG000|Overall Study|Withdrawal by Subject|3
2221636|NCT01739764|3866528|FG001|Overall Study|Non-Compliance|0
2221637|NCT01739764|3866529|FG002|Overall Study|Non-Compliance|1
2221638|NCT01739764|3866527|FG000|Overall Study|Multiple Reasons|3
2221639|NCT01739764|3866528|FG001|Overall Study|Multiple Reasons|2
2221640|NCT01739764|3866529|FG002|Overall Study|Multiple Reasons|3
2221641|NCT01739764|3866527|FG000|Overall Study|Physician Decision|2
2221642|NCT01739764|3866528|FG001|Overall Study|Physician Decision|2
2221643|NCT01739764|3866529|FG002|Overall Study|Physician Decision|4
2221644|NCT01739764|3866527|FG000|Overall Study|Progressive Disease|3
2221645|NCT01739764|3866528|FG001|Overall Study|Progressive Disease|5
2221646|NCT01739764|3866529|FG002|Overall Study|Progressive Disease|16
2221647|NCT01739764|3866527|FG000|Overall Study|Protocol Violation|0
2221648|NCT01739764|3866528|FG001|Overall Study|Protocol Violation|0
2221649|NCT01739764|3866529|FG002|Overall Study|Protocol Violation|2
2221650|NCT01739764|3866527|FG000|Overall Study|Study Terminated by Sponsor|8
2221651|NCT01739764|3866528|FG001|Overall Study|Study Terminated by Sponsor|13
2221652|NCT01739764|3866529|FG002|Overall Study|Study Terminated by Sponsor|26
2221653|NCT01739764|3866527|FG000|Overall Study|Withdrawal by Subject|6
2221654|NCT01739764|3866528|FG001|Overall Study|Withdrawal by Subject|5
2221655|NCT01739764|3866529|FG002|Overall Study|Withdrawal by Subject|27
2221656|NCT01739790|3866539|FG000|Overall Study|Early Trial Termination|2
2221657|NCT01739790|3866540|FG001|Overall Study|Early Trial Termination|4
2221658|NCT01739803|3866548|FG000|Overall Study|Lost to Follow-up|9
2186092|NCT01452347|3815416|FG001|Overall Study|Withdrawal by Subject|3
2186093|NCT01452347|3815415|FG000|Overall Study|Not treated|6
2186094|NCT01452347|3815416|FG001|Overall Study|Not treated|3
2186095|NCT01452347|3815415|FG000|Overall Study|Other reason not defined above|2
2186096|NCT01452347|3815416|FG001|Overall Study|Other reason not defined above|0
2186097|NCT01452412|3815426|FG000|Overall Study|Withdrawal by Subject|15
2186098|NCT01452412|3815427|FG001|Overall Study|Withdrawal by Subject|11
2186099|NCT01452412|3815426|FG000|Overall Study|Adverse Event|4
2186100|NCT01452412|3815427|FG001|Overall Study|Adverse Event|3
2186101|NCT01452412|3815426|FG000|Overall Study|Lost to Follow-up|5
2186102|NCT01452412|3815427|FG001|Overall Study|Lost to Follow-up|3
2186103|NCT01452412|3815426|FG000|Overall Study|Death|1
2186104|NCT01452412|3815427|FG001|Overall Study|Death|0
2186105|NCT01452412|3815426|FG000|Overall Study|Initiated dialysis|1
2186106|NCT01452412|3815427|FG001|Overall Study|Initiated dialysis|0
2186107|NCT01452412|3815426|FG000|Overall Study|Other|2
2186108|NCT01452412|3815427|FG001|Overall Study|Other|0
2186109|NCT01452529|3815440|FG000|Run-in Period|Adverse Event|96
2186110|NCT01452529|3815441|FG001|Run-in Period|Adverse Event|0
2186111|NCT01452529|3815442|FG002|Run-in Period|Adverse Event|0
2186112|NCT01452529|3815440|FG000|Run-in Period|Withdrawal by Subject|49
2186113|NCT01452529|3815441|FG001|Run-in Period|Withdrawal by Subject|0
2186114|NCT01452529|3815442|FG002|Run-in Period|Withdrawal by Subject|0
2186115|NCT01452529|3815440|FG000|Run-in Period|Lost to Follow-up|19
2186116|NCT01452529|3815441|FG001|Run-in Period|Lost to Follow-up|0
2186117|NCT01452529|3815442|FG002|Run-in Period|Lost to Follow-up|0
2186118|NCT01452529|3815440|FG000|Run-in Period|Lack of Efficacy|46
2186119|NCT01452529|3815441|FG001|Run-in Period|Lack of Efficacy|0
2186120|NCT01452529|3815442|FG002|Run-in Period|Lack of Efficacy|0
2186121|NCT01452529|3815440|FG000|Run-in Period|Confirmed or suspected diversion|23
2186122|NCT01452529|3815441|FG001|Run-in Period|Confirmed or suspected diversion|0
2186123|NCT01452529|3815442|FG002|Run-in Period|Confirmed or suspected diversion|0
2186124|NCT01452529|3815440|FG000|Run-in Period|Administrative|21
2186125|NCT01452529|3815441|FG001|Run-in Period|Administrative|0
2186126|NCT01452529|3815442|FG002|Run-in Period|Administrative|0
2186127|NCT01452529|3815440|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59
2186128|NCT01452529|3815441|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0
2186129|NCT01452529|3815442|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0
2186130|NCT01452529|3815440|FG000|Double-blind (DB) Period|Adverse Event|0
2186131|NCT01452529|3815441|FG001|Double-blind (DB) Period|Adverse Event|18
2186132|NCT01452529|3815442|FG002|Double-blind (DB) Period|Adverse Event|11
2186133|NCT01452529|3815440|FG000|Double-blind (DB) Period|Withdrawal by Subject|0
2186134|NCT01452529|3815441|FG001|Double-blind (DB) Period|Withdrawal by Subject|15
2186135|NCT01452529|3815442|FG002|Double-blind (DB) Period|Withdrawal by Subject|14
2186136|NCT01452529|3815440|FG000|Double-blind (DB) Period|Lost to Follow-up|0
2186137|NCT01452529|3815441|FG001|Double-blind (DB) Period|Lost to Follow-up|5
2186138|NCT01452529|3815442|FG002|Double-blind (DB) Period|Lost to Follow-up|3
2186139|NCT01452529|3815440|FG000|Double-blind (DB) Period|Lack of Efficacy|0
2186140|NCT01452529|3815441|FG001|Double-blind (DB) Period|Lack of Efficacy|16
2186141|NCT01452529|3815442|FG002|Double-blind (DB) Period|Lack of Efficacy|44
2186142|NCT01452529|3815440|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0
2186143|NCT01452529|3815441|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2
2186144|NCT01452529|3815442|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3
2186145|NCT01452529|3815440|FG000|Double-blind (DB) Period|Administrative|0
2186146|NCT01452529|3815441|FG001|Double-blind (DB) Period|Administrative|11
2186147|NCT01452529|3815442|FG002|Double-blind (DB) Period|Administrative|7
2186148|NCT01452789|3815451|FG000|Overall Study|Withdrawal by Subject|3
2186149|NCT01452789|3815452|FG001|Overall Study|Withdrawal by Subject|2
2186150|NCT01452919|3815458|FG000|Open-Label Treatment|Adverse Event|5
2186151|NCT01452919|3815459|FG001|Open-Label Treatment|Adverse Event|0
2186152|NCT01452919|3815460|FG002|Open-Label Treatment|Adverse Event|0
2186153|NCT01452919|3815458|FG000|Open-Label Treatment|Lost to Follow-up|4
2186154|NCT01452919|3815459|FG001|Open-Label Treatment|Lost to Follow-up|0
2186155|NCT01452919|3815460|FG002|Open-Label Treatment|Lost to Follow-up|0
2186156|NCT01452919|3815458|FG000|Open-Label Treatment|Perceived lack of efficacy|3
2186157|NCT01452919|3815459|FG001|Open-Label Treatment|Perceived lack of efficacy|0
2186158|NCT01452919|3815460|FG002|Open-Label Treatment|Perceived lack of efficacy|0
2186159|NCT01452919|3815458|FG000|Open-Label Treatment|Protocol Violation|4
2186160|NCT01452919|3815459|FG001|Open-Label Treatment|Protocol Violation|0
2186161|NCT01452919|3815460|FG002|Open-Label Treatment|Protocol Violation|0
2186162|NCT01452919|3815458|FG000|Open-Label Treatment|Sponsor Decision|1
2186163|NCT01452919|3815459|FG001|Open-Label Treatment|Sponsor Decision|0
2186164|NCT01452919|3815460|FG002|Open-Label Treatment|Sponsor Decision|0
2186165|NCT01452919|3815458|FG000|Open-Label Treatment|Withdrawal by Subject|2
2186166|NCT01452919|3815459|FG001|Open-Label Treatment|Withdrawal by Subject|0
2186167|NCT01452919|3815460|FG002|Open-Label Treatment|Withdrawal by Subject|0
2186168|NCT01452919|3815458|FG000|Open-Label Treatment|Subject is moving or has moved|1
2186169|NCT01452919|3815459|FG001|Open-Label Treatment|Subject is moving or has moved|0
2186170|NCT01452919|3815460|FG002|Open-Label Treatment|Subject is moving or has moved|0
2186171|NCT01452919|3815458|FG000|Randomization Treatment|Adverse Event|0
2186172|NCT01452919|3815459|FG001|Randomization Treatment|Adverse Event|0
2186173|NCT01452919|3815460|FG002|Randomization Treatment|Adverse Event|2
2186174|NCT01452919|3815458|FG000|Randomization Treatment|Sponsor Decision|0
2186175|NCT01452919|3815459|FG001|Randomization Treatment|Sponsor Decision|1
2186176|NCT01452919|3815460|FG002|Randomization Treatment|Sponsor Decision|0
2186177|NCT01452919|3815458|FG000|Randomization Treatment|Withdrawal by Subject|0
2186178|NCT01452919|3815459|FG001|Randomization Treatment|Withdrawal by Subject|1
2186179|NCT01452919|3815460|FG002|Randomization Treatment|Withdrawal by Subject|0
2186180|NCT01452919|3815458|FG000|Randomization Treatment|Subject is moving or has moved|0
2186181|NCT01452919|3815459|FG001|Randomization Treatment|Subject is moving or has moved|1
2186182|NCT01452919|3815460|FG002|Randomization Treatment|Subject is moving or has moved|0
2186183|NCT01453023|3815470|FG000|Treatment Period (TP) 1|Protocol Violation|1
2186184|NCT01453023|3815471|FG001|Treatment Period (TP) 1|Protocol Violation|0
2186185|NCT01453023|3815470|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
2186186|NCT01453023|3815471|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
2186187|NCT01453023|3815470|FG000|Treatment Period 2|Protocol Violation|0
2186188|NCT01453023|3815471|FG001|Treatment Period 2|Protocol Violation|1
2186189|NCT01453036|3815480|FG000|Overall Study|Lost to Follow-up|26
2186190|NCT01453036|3815481|FG001|Overall Study|Lost to Follow-up|115
2186191|NCT01453036|3815482|FG002|Overall Study|Lost to Follow-up|31
2186192|NCT01453049|3815492|FG000|Overall Study|Protocol Violation|2
2186193|NCT01453049|3815493|FG001|Overall Study|Protocol Violation|5
2186194|NCT01453049|3815492|FG000|Overall Study|Lost to Follow-up|2
2186195|NCT01453049|3815493|FG001|Overall Study|Lost to Follow-up|1
2221659|NCT01739803|3866549|FG001|Overall Study|Lost to Follow-up|6
2221660|NCT01739933|3866557|FG000|Overall Study|Death|89
2221661|NCT01739933|3866558|FG001|Overall Study|Death|86
2221662|NCT01739933|3866557|FG000|Overall Study|Withdrawal by Subject|10
2221663|NCT01739933|3866558|FG001|Overall Study|Withdrawal by Subject|8
2221664|NCT01739933|3866557|FG000|Overall Study|Lost to Follow-up|3
2221665|NCT01739933|3866558|FG001|Overall Study|Lost to Follow-up|10
2221666|NCT01739933|3866557|FG000|Overall Study|Did not speak English required for neurospychological testing|4
2221667|NCT01739933|3866558|FG001|Overall Study|Did not speak English required for neurospychological testing|3
2221668|NCT01740089|3866567|FG000|First 12 Weeks of Treatment|Adverse Event|0
2221669|NCT01740089|3866568|FG001|First 12 Weeks of Treatment|Adverse Event|1
2221670|NCT01740089|3866569|FG002|First 12 Weeks of Treatment|Adverse Event|2
2221671|NCT01740089|3866567|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0
2221672|NCT01740089|3866568|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1
2221673|NCT01740089|3866569|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0
2221674|NCT01740089|3866567|FG000|After 12 Weeks|Lack of Efficacy|3
2221675|NCT01740089|3866568|FG001|After 12 Weeks|Lack of Efficacy|1
2332100|NCT03187197|4055386|FG001|Overall Study|Lost to Follow-up|60
2332101|NCT03187197|4055387|FG002|Overall Study|Lost to Follow-up|7
2332102|NCT03187197|4055385|FG000|Overall Study|Adverse Event|6
2332103|NCT03187197|4055386|FG001|Overall Study|Adverse Event|29
2332104|NCT03187197|4055387|FG002|Overall Study|Adverse Event|0
2332105|NCT03187197|4055385|FG000|Overall Study|Death|0
2332106|NCT03187197|4055386|FG001|Overall Study|Death|11
2332107|NCT03187197|4055387|FG002|Overall Study|Death|0
2332108|NCT03187197|4055385|FG000|Overall Study|Administrative problem|1
2332109|NCT03187197|4055386|FG001|Overall Study|Administrative problem|1
2332110|NCT03187197|4055387|FG002|Overall Study|Administrative problem|0
2332111|NCT03187197|4055385|FG000|Overall Study|Reason not listed|2
2332112|NCT03187197|4055386|FG001|Overall Study|Reason not listed|54
2332113|NCT03187197|4055387|FG002|Overall Study|Reason not listed|1
2332114|NCT03187197|4055385|FG000|Overall Study|Missing|1
2332115|NCT03187197|4055386|FG001|Overall Study|Missing|32
2332116|NCT03187197|4055387|FG002|Overall Study|Missing|3
2332117|NCT03187197|4055385|FG000|Overall Study|Status missing|2
2332118|NCT03187197|4055386|FG001|Overall Study|Status missing|33
2332119|NCT03187197|4055387|FG002|Overall Study|Status missing|3
2332120|NCT03187197|4055385|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14
2332121|NCT03187197|4055386|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45
2332122|NCT03187197|4055387|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1
2332123|NCT03187262|4055395|FG000|Induction|Lack of Efficacy|2
2332124|NCT03187262|4055395|FG000|Induction|Progressive Disease|4
2332125|NCT03187262|4055395|FG000|Consolidation|Progressive Disease|5
2332126|NCT03187301|4055399|FG000|Titration Period|Adverse Event|0
2332127|NCT03187301|4055400|FG001|Titration Period|Adverse Event|0
2332128|NCT03187301|4055401|FG002|Titration Period|Adverse Event|0
2332129|NCT03187301|4055402|FG003|Titration Period|Adverse Event|0
2332130|NCT03187301|4055403|FG004|Titration Period|Adverse Event|0
2332131|NCT03187301|4055404|FG005|Titration Period|Adverse Event|0
2332132|NCT03187301|4055405|FG006|Titration Period|Adverse Event|5
2332133|NCT03187301|4055399|FG000|Titration Period|Withdrawal by Subject|0
2332134|NCT03187301|4055400|FG001|Titration Period|Withdrawal by Subject|0
2332135|NCT03187301|4055401|FG002|Titration Period|Withdrawal by Subject|0
2332136|NCT03187301|4055402|FG003|Titration Period|Withdrawal by Subject|0
2332137|NCT03187301|4055403|FG004|Titration Period|Withdrawal by Subject|0
2332138|NCT03187301|4055404|FG005|Titration Period|Withdrawal by Subject|0
2332139|NCT03187301|4055405|FG006|Titration Period|Withdrawal by Subject|1
2332140|NCT03187301|4055399|FG000|Titration Period|Exclusion Criteria Met|0
2332141|NCT03187301|4055400|FG001|Titration Period|Exclusion Criteria Met|0
2186196|NCT01453049|3815492|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35
2186197|NCT01453049|3815493|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36
2186198|NCT01453049|3815492|FG000|Overall Study|Withdrawal by Subject|1
2186199|NCT01453049|3815493|FG001|Overall Study|Withdrawal by Subject|0
2186200|NCT01453049|3815492|FG000|Overall Study|Randomized in Error|1
2186201|NCT01453049|3815493|FG001|Overall Study|Randomized in Error|0
2186202|NCT01453153|3815511|FG000|Overall Study|Physician Decision|0
2186203|NCT01453153|3815512|FG001|Overall Study|Physician Decision|0
2186204|NCT01453153|3815513|FG002|Overall Study|Physician Decision|1
2186205|NCT01453153|3815511|FG000|Overall Study|Progressive Disease|3
2186206|NCT01453153|3815512|FG001|Overall Study|Progressive Disease|2
2186207|NCT01453153|3815513|FG002|Overall Study|Progressive Disease|16
2186208|NCT01453153|3815511|FG000|Overall Study|Withdrawal by Subject|0
2186209|NCT01453153|3815512|FG001|Overall Study|Withdrawal by Subject|1
2186210|NCT01453153|3815513|FG002|Overall Study|Withdrawal by Subject|2
2186211|NCT01453153|3815511|FG000|Overall Study|Adverse Event|1
2186212|NCT01453153|3815512|FG001|Overall Study|Adverse Event|1
2186213|NCT01453153|3815513|FG002|Overall Study|Adverse Event|1
2186214|NCT01453205|3815541|FG000|Overall Study|Lost to Follow-up|3
2186215|NCT01453205|3815542|FG001|Overall Study|Lost to Follow-up|0
2186216|NCT01453205|3815543|FG002|Overall Study|Lost to Follow-up|1
2186217|NCT01453205|3815541|FG000|Overall Study|Withdrawal by Subject|8
2186218|NCT01453205|3815542|FG001|Overall Study|Withdrawal by Subject|3
2186219|NCT01453205|3815543|FG002|Overall Study|Withdrawal by Subject|0
2186220|NCT01453205|3815541|FG000|Overall Study|Death|24
2186221|NCT01453205|3815542|FG001|Overall Study|Death|22
2186222|NCT01453205|3815543|FG002|Overall Study|Death|18
2186223|NCT01453205|3815541|FG000|Overall Study|Other|45
2186224|NCT01453205|3815542|FG001|Overall Study|Other|27
2186225|NCT01453205|3815543|FG002|Overall Study|Other|35
2186226|NCT01453296|3815554|FG000|Treatment Period 1|Adverse Event|0
2186227|NCT01453296|3815555|FG001|Treatment Period 1|Adverse Event|1
2186228|NCT01453296|3815554|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
2186229|NCT01453296|3815555|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
2186230|NCT01453296|3815554|FG000|Treatment Period 2|Adverse Event|1
2186231|NCT01453296|3815555|FG001|Treatment Period 2|Adverse Event|0
2186232|NCT01453296|3815554|FG000|Treatment Period 2|Withdrawal by Subject|1
2186233|NCT01453296|3815555|FG001|Treatment Period 2|Withdrawal by Subject|0
2186234|NCT01453348|3815564|FG000|Overall Study|Death|0
2186235|NCT01453348|3815565|FG001|Overall Study|Death|0
2186236|NCT01453348|3815566|FG002|Overall Study|Death|1
2186237|NCT01453348|3815564|FG000|Overall Study|Withdrawal by Subject|0
2186238|NCT01453348|3815565|FG001|Overall Study|Withdrawal by Subject|1
2186239|NCT01453348|3815566|FG002|Overall Study|Withdrawal by Subject|0
2186240|NCT01453348|3815564|FG000|Overall Study|Protocol Violation|1
2186241|NCT01453348|3815565|FG001|Overall Study|Protocol Violation|0
2186242|NCT01453348|3815566|FG002|Overall Study|Protocol Violation|0
2186243|NCT01453361|3815577|FG000|Overall Study|Disease Progression|6
2186244|NCT01453361|3815577|FG000|Overall Study|Screen-Failures|10
2186245|NCT01453374|3815581|FG000|Overall Study|Adverse Event|7
2186246|NCT01453374|3815581|FG000|Overall Study|Lack of Efficacy|1
2186247|NCT01453374|3815581|FG000|Overall Study|Lost to Follow-up|3
2186248|NCT01453374|3815581|FG000|Overall Study|Withdrawal by Subject|5
2186249|NCT01453374|3815581|FG000|Overall Study|Incarcerated|2
2186250|NCT01453439|3815619|FG000|Treatment Phase|Withdrawal by Subject|13
2186251|NCT01453439|3815620|FG001|Treatment Phase|Withdrawal by Subject|10
2186252|NCT01453439|3815619|FG000|Treatment Phase|Suicidal Ideation|2
2186253|NCT01453439|3815620|FG001|Treatment Phase|Suicidal Ideation|0
2186254|NCT01453439|3815619|FG000|Treatment Phase|Need for higher level of care|1
2186255|NCT01453439|3815620|FG001|Treatment Phase|Need for higher level of care|1
2186256|NCT01453439|3815619|FG000|Treatment Phase|Therapist conflict of interest|1
2186257|NCT01453439|3815620|FG001|Treatment Phase|Therapist conflict of interest|0
2186258|NCT01453439|3815619|FG000|Follow-up|Withdrawal by Subject|0
2186259|NCT01453439|3815620|FG001|Follow-up|Withdrawal by Subject|1
2186260|NCT01453439|3815619|FG000|Follow-up|Lost to Follow-up|5
2186261|NCT01453439|3815620|FG001|Follow-up|Lost to Follow-up|10
2186262|NCT01453595|3815642|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
2186263|NCT01453595|3815643|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1
2186264|NCT01453595|3815644|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
2186265|NCT01453725|3815652|FG000|Overall Study|Adverse Event|3
2186266|NCT01453725|3815653|FG001|Overall Study|Adverse Event|3
2186267|NCT01453725|3815652|FG000|Overall Study|Lost to Follow-up|4
2186268|NCT01453725|3815653|FG001|Overall Study|Lost to Follow-up|0
2186269|NCT01453725|3815652|FG000|Overall Study|Non-compliance With Protocol|1
2186270|NCT01453725|3815653|FG001|Overall Study|Non-compliance With Protocol|2
2186271|NCT01453725|3815652|FG000|Overall Study|Protocol Violation|1
2186272|NCT01453725|3815653|FG001|Overall Study|Protocol Violation|0
2186273|NCT01453725|3815652|FG000|Overall Study|Withdrawal by Subject|2
2186274|NCT01453725|3815653|FG001|Overall Study|Withdrawal by Subject|3
2186275|NCT01453725|3815652|FG000|Overall Study|Pregnancy Wish|0
2186276|NCT01453725|3815653|FG001|Overall Study|Pregnancy Wish|2
2186277|NCT01453725|3815652|FG000|Overall Study|Pregnancy|1
2186278|NCT01453725|3815653|FG001|Overall Study|Pregnancy|0
2186279|NCT01453725|3815652|FG000|Overall Study|Physician Decision|1
2186280|NCT01453725|3815653|FG001|Overall Study|Physician Decision|1
2186281|NCT01453855|3815663|FG000|Overall Study|Adverse Event|3
2186282|NCT01453855|3815664|FG001|Overall Study|Adverse Event|4
2186283|NCT01453855|3815663|FG000|Overall Study|Lost to Follow-up|2
2186284|NCT01453855|3815664|FG001|Overall Study|Lost to Follow-up|1
2186285|NCT01453855|3815663|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3
2186286|NCT01453855|3815664|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3
2186287|NCT01453855|3815663|FG000|Overall Study|Noncompliance|1
2186288|NCT01453855|3815664|FG001|Overall Study|Noncompliance|0
2186289|NCT01453855|3815663|FG000|Overall Study|Inadequate Control of IOP|1
2186290|NCT01453855|3815664|FG001|Overall Study|Inadequate Control of IOP|5
2186291|NCT01453855|3815663|FG000|Overall Study|Other|0
2186292|NCT01453855|3815664|FG001|Overall Study|Other|1
2186293|NCT01453998|3815682|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1
2186294|NCT01453998|3815683|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0
2186295|NCT01453998|3815684|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0
2186296|NCT01454063|3815697|FG000|Randomized|Adverse Event|1
2186297|NCT01454063|3815698|FG001|Randomized|Adverse Event|1
2186298|NCT01454063|3815697|FG000|Randomized|Protocol Violation|0
2186299|NCT01454063|3815698|FG001|Randomized|Protocol Violation|1
2186300|NCT01454076|3815709|FG000|Overall Study|Other|2
2186301|NCT01454076|3815710|FG001|Overall Study|Other|0
2186302|NCT01454076|3815711|FG002|Overall Study|Other|0
2186303|NCT01454076|3815712|FG003|Overall Study|Other|1
2186304|NCT01454076|3815713|FG004|Overall Study|Other|2
2186305|NCT01454076|3815709|FG000|Overall Study|Withdrawal by Subject|3
2186306|NCT01454076|3815710|FG001|Overall Study|Withdrawal by Subject|4
2186307|NCT01454076|3815711|FG002|Overall Study|Withdrawal by Subject|2
2186308|NCT01454076|3815712|FG003|Overall Study|Withdrawal by Subject|1
2186309|NCT01454076|3815713|FG004|Overall Study|Withdrawal by Subject|2
2186310|NCT01454076|3815709|FG000|Overall Study|Adverse Event|8
2186311|NCT01454076|3815710|FG001|Overall Study|Adverse Event|2
2186312|NCT01454076|3815711|FG002|Overall Study|Adverse Event|7
2186313|NCT01454076|3815712|FG003|Overall Study|Adverse Event|0
2186314|NCT01454076|3815713|FG004|Overall Study|Adverse Event|2
2186315|NCT01454102|3815750|FG000|Overall Study|Continuing in the treatment period|0
2186316|NCT01454102|3815751|FG001|Overall Study|Continuing in the treatment period|0
2186317|NCT01454102|3815752|FG002|Overall Study|Continuing in the treatment period|0
2186318|NCT01454102|3815753|FG003|Overall Study|Continuing in the treatment period|0
2186319|NCT01454102|3815754|FG004|Overall Study|Continuing in the treatment period|3
2186320|NCT01454102|3815755|FG005|Overall Study|Continuing in the treatment period|3
2186321|NCT01454102|3815756|FG006|Overall Study|Continuing in the treatment period|2
2186322|NCT01454102|3815757|FG007|Overall Study|Continuing in the treatment period|0
2186323|NCT01454102|3815758|FG008|Overall Study|Continuing in the treatment period|1
2186324|NCT01454102|3815759|FG009|Overall Study|Continuing in the treatment period|0
2186325|NCT01454102|3815760|FG010|Overall Study|Continuing in the treatment period|0
2186326|NCT01454102|3815761|FG011|Overall Study|Continuing in the treatment period|4
2186327|NCT01454102|3815762|FG012|Overall Study|Continuing in the treatment period|7
2186328|NCT01454102|3815763|FG013|Overall Study|Continuing in the treatment period|4
2186329|NCT01454102|3815764|FG014|Overall Study|Continuing in the treatment period|3
2186330|NCT01454102|3815765|FG015|Overall Study|Continuing in the treatment period|1
2186331|NCT01454284|3815808|FG000|Overall Study|Adverse Event|20
2186332|NCT01454284|3815809|FG001|Overall Study|Adverse Event|7
2186333|NCT01454284|3815808|FG000|Overall Study|Death|0
2186334|NCT01454284|3815809|FG001|Overall Study|Death|3
2186335|NCT01454284|3815808|FG000|Overall Study|Lost to Follow-up|13
2186336|NCT01454284|3815809|FG001|Overall Study|Lost to Follow-up|8
2186337|NCT01454284|3815808|FG000|Overall Study|Protocol Violation|9
2186338|NCT01454284|3815809|FG001|Overall Study|Protocol Violation|6
2186339|NCT01454284|3815808|FG000|Overall Study|Withdrawal by Subject|58
2186340|NCT01454284|3815809|FG001|Overall Study|Withdrawal by Subject|36
2186341|NCT01454284|3815808|FG000|Overall Study|Physician Decision|16
2186342|NCT01454284|3815809|FG001|Overall Study|Physician Decision|11
2186343|NCT01454284|3815808|FG000|Overall Study|Sponsor Decision|0
2186344|NCT01454284|3815809|FG001|Overall Study|Sponsor Decision|2
2186345|NCT01454401|3815826|FG000|Overall Study|Death|1
2186346|NCT01454401|3815826|FG000|Overall Study|hospitalised|1
2186347|NCT01454401|3815826|FG000|Overall Study|osteomyelitis|2
2186348|NCT01454401|3815826|FG000|Overall Study|non-adherence|1
2186349|NCT01454531|3815855|FG000|Overall Study|Adverse Event|14
2186350|NCT01454531|3815855|FG000|Overall Study|Withdrawal by Subject|5
2186351|NCT01454531|3815855|FG000|Overall Study|Lost to Follow-up|1
2186352|NCT01454531|3815855|FG000|Overall Study|Physician Decision|1
2186353|NCT01454531|3815855|FG000|Overall Study|Delay in IMP administration|1
2186354|NCT01454531|3815855|FG000|Overall Study|Other|1
2186355|NCT01454570|3815859|FG000|Overall Study|Withdrawal by Subject|2
2186356|NCT01454570|3815859|FG000|Overall Study|Screen Failure|7
2186357|NCT01454583|3815866|FG000|1st Year|Lost to Follow-up|1057
2221676|NCT01740089|3866569|FG002|After 12 Weeks|Lack of Efficacy|4
2221677|NCT01740089|3866567|FG000|After 12 Weeks|Adverse Event|2
2186358|NCT01454583|3815867|FG001|1st Year|Lost to Follow-up|318
2186359|NCT01454583|3815868|FG002|1st Year|Lost to Follow-up|180
2186360|NCT01454583|3815866|FG000|2nd Year|Lost to Follow-up|3965
2186361|NCT01454583|3815867|FG001|2nd Year|Lost to Follow-up|1049
2186362|NCT01454583|3815868|FG002|2nd Year|Lost to Follow-up|737
2186363|NCT01454583|3815866|FG000|3rd Year|Lost to Follow-up|1959
2186364|NCT01454583|3815867|FG001|3rd Year|Lost to Follow-up|512
2186365|NCT01454583|3815868|FG002|3rd Year|Lost to Follow-up|297
2186366|NCT01454596|3815888|FG000|Overall Study|Death|0
2186367|NCT01454596|3815889|FG001|Overall Study|Death|0
2186368|NCT01454596|3815890|FG002|Overall Study|Death|0
2186369|NCT01454596|3815891|FG003|Overall Study|Death|0
2186370|NCT01454596|3815892|FG004|Overall Study|Death|0
2186371|NCT01454596|3815893|FG005|Overall Study|Death|0
2186372|NCT01454596|3815894|FG006|Overall Study|Death|0
2186373|NCT01454596|3815895|FG007|Overall Study|Death|0
2186374|NCT01454596|3815896|FG008|Overall Study|Death|0
2186375|NCT01454596|3815897|FG009|Overall Study|Death|1
2186376|NCT01454596|3815898|FG010|Overall Study|Death|1
2186377|NCT01454596|3815899|FG011|Overall Study|Death|0
2186378|NCT01454726|3815927|FG000|Overall Study|Withdrawal by Subject|0
2186379|NCT01454726|3815928|FG001|Overall Study|Withdrawal by Subject|1
2186380|NCT01454739|3815936|FG000|Overall Study|Protocol Violation|2
2186381|NCT01454739|3815937|FG001|Overall Study|Protocol Violation|3
2186382|NCT01454739|3815936|FG000|Overall Study|Withdrawal by Subject|2
2186383|NCT01454739|3815937|FG001|Overall Study|Withdrawal by Subject|6
2186384|NCT01454739|3815936|FG000|Overall Study|Other|3
2186385|NCT01454739|3815937|FG001|Overall Study|Other|5
2186386|NCT01454739|3815936|FG000|Overall Study|Physician Decision|0
2186387|NCT01454739|3815937|FG001|Overall Study|Physician Decision|5
2186388|NCT01454739|3815936|FG000|Overall Study|Lost to Follow-up|0
2186389|NCT01454739|3815937|FG001|Overall Study|Lost to Follow-up|1
2186390|NCT01454739|3815936|FG000|Overall Study|Adverse Event|0
2186391|NCT01454739|3815937|FG001|Overall Study|Adverse Event|1
2186392|NCT01454778|3815950|FG000|Overall Study|Lost to Follow-up|2
2186393|NCT01454778|3815950|FG000|Overall Study|Death|1
2186394|NCT01454830|3815967|FG000|Overall Study|Withdrawal by Subject|4
2186395|NCT01454830|3815968|FG001|Overall Study|Withdrawal by Subject|4
2186396|NCT01454830|3815967|FG000|Overall Study|Post-allocation Exclude- AHI<10|18
2186397|NCT01454830|3815968|FG001|Overall Study|Post-allocation Exclude- AHI<10|12
2186398|NCT01454830|3815967|FG000|Overall Study|Post-allocation Exclude-refused PAP|0
2186399|NCT01454830|3815968|FG001|Overall Study|Post-allocation Exclude-refused PAP|2
2186400|NCT01454830|3815967|FG000|Overall Study|Post-allocation Exclude-other treatment|6
2186401|NCT01454830|3815968|FG001|Overall Study|Post-allocation Exclude-other treatment|7
2186402|NCT01454830|3815967|FG000|Overall Study|Withdrawal - no polysomnography|3
2186403|NCT01454830|3815968|FG001|Overall Study|Withdrawal - no polysomnography|2
2186404|NCT01454934|3815976|FG000|Overall Study|Clinical progression|28
2186405|NCT01454934|3815977|FG001|Overall Study|Clinical progression|25
2186406|NCT01454934|3815976|FG000|Overall Study|Other|6
2186407|NCT01454934|3815977|FG001|Overall Study|Other|17
2186408|NCT01454934|3815976|FG000|Overall Study|Adverse Event|28
2186409|NCT01454934|3815977|FG001|Overall Study|Adverse Event|24
2186410|NCT01454934|3815976|FG000|Overall Study|Withdrawn consent|2
2186411|NCT01454934|3815977|FG001|Overall Study|Withdrawn consent|5
2186412|NCT01454934|3815976|FG000|Overall Study|Withdrawal by Subject|11
2186413|NCT01454934|3815977|FG001|Overall Study|Withdrawal by Subject|15
2186414|NCT01454934|3815976|FG000|Overall Study|Disease progression|194
2186415|NCT01454934|3815977|FG001|Overall Study|Disease progression|181
2186416|NCT01454934|3815976|FG000|Overall Study|Lost to Follow-up|0
2186417|NCT01454934|3815977|FG001|Overall Study|Lost to Follow-up|1
2186418|NCT01454934|3815976|FG000|Overall Study|Not treated|1
2186419|NCT01454934|3815977|FG001|Overall Study|Not treated|2
2186420|NCT01455012|3816018|FG000|Overall Study|Adverse Event|0
2186421|NCT01455012|3816019|FG001|Overall Study|Adverse Event|2
2186422|NCT01455012|3816018|FG000|Overall Study|Lack of Efficacy|6
2186423|NCT01455012|3816019|FG001|Overall Study|Lack of Efficacy|1
2186424|NCT01455012|3816018|FG000|Overall Study|Withdrawal by Subject|3
2186425|NCT01455012|3816019|FG001|Overall Study|Withdrawal by Subject|1
2186426|NCT01455012|3816018|FG000|Overall Study|Unknown reason|2
2186427|NCT01455012|3816019|FG001|Overall Study|Unknown reason|0
2186428|NCT01455194|3816036|FG000|Overall Study|Screen Failure|20
2186429|NCT01455194|3816037|FG001|Overall Study|Screen Failure|0
2186430|NCT01455194|3816038|FG002|Overall Study|Screen Failure|0
2186431|NCT01455194|3816039|FG003|Overall Study|Screen Failure|0
2186432|NCT01455194|3816036|FG000|Overall Study|Randomisation Failure|90
2186433|NCT01455194|3816037|FG001|Overall Study|Randomisation Failure|0
2186434|NCT01455194|3816038|FG002|Overall Study|Randomisation Failure|0
2186435|NCT01455194|3816039|FG003|Overall Study|Randomisation Failure|0
2186436|NCT01455194|3816036|FG000|Overall Study|Deterioration in asthma|12
2186437|NCT01455194|3816037|FG001|Overall Study|Deterioration in asthma|6
2186438|NCT01455194|3816038|FG002|Overall Study|Deterioration in asthma|14
2186439|NCT01455194|3816039|FG003|Overall Study|Deterioration in asthma|9
2186440|NCT01455194|3816036|FG000|Overall Study|Adverse Event|1
2186441|NCT01455194|3816037|FG001|Overall Study|Adverse Event|1
2186442|NCT01455194|3816038|FG002|Overall Study|Adverse Event|1
2221678|NCT01740089|3866568|FG001|After 12 Weeks|Adverse Event|0
2221679|NCT01740089|3866569|FG002|After 12 Weeks|Adverse Event|5
2221680|NCT01740089|3866567|FG000|After 12 Weeks|Protocol Violation|1
2186443|NCT01455194|3816039|FG003|Overall Study|Adverse Event|3
2186444|NCT01455194|3816036|FG000|Overall Study|Withdrawal by Subject|21
2186445|NCT01455194|3816037|FG001|Overall Study|Withdrawal by Subject|16
2186446|NCT01455194|3816038|FG002|Overall Study|Withdrawal by Subject|12
2186447|NCT01455194|3816039|FG003|Overall Study|Withdrawal by Subject|9
2186448|NCT01455194|3816036|FG000|Overall Study|Lost to Follow-up|2
2186449|NCT01455194|3816037|FG001|Overall Study|Lost to Follow-up|0
2186450|NCT01455194|3816038|FG002|Overall Study|Lost to Follow-up|1
2186451|NCT01455194|3816039|FG003|Overall Study|Lost to Follow-up|1
2186452|NCT01455194|3816036|FG000|Overall Study|Pregnancy|0
2186453|NCT01455194|3816037|FG001|Overall Study|Pregnancy|1
2186454|NCT01455194|3816038|FG002|Overall Study|Pregnancy|1
2186455|NCT01455194|3816039|FG003|Overall Study|Pregnancy|0
2186456|NCT01455194|3816036|FG000|Overall Study|Discontinuation criterion fulfilled|3
2186457|NCT01455194|3816037|FG001|Overall Study|Discontinuation criterion fulfilled|2
2186458|NCT01455194|3816038|FG002|Overall Study|Discontinuation criterion fulfilled|0
2186459|NCT01455194|3816039|FG003|Overall Study|Discontinuation criterion fulfilled|2
2186460|NCT01455194|3816036|FG000|Overall Study|Miscellaneous|4
2186461|NCT01455194|3816037|FG001|Overall Study|Miscellaneous|5
2186462|NCT01455194|3816038|FG002|Overall Study|Miscellaneous|1
2186463|NCT01455194|3816039|FG003|Overall Study|Miscellaneous|4
2186464|NCT01455220|3816052|FG000|Overall Study|screen fail|30
2186465|NCT01455415|3816061|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9
2186466|NCT01455415|3816062|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6
2186467|NCT01455415|3816061|FG000|Period 1|Lost To Follow-up Related to Study Drug|3
2186468|NCT01455415|3816062|FG001|Period 1|Lost To Follow-up Related to Study Drug|3
2186469|NCT01455415|3816061|FG000|Period 1|Drug Error not Associated to AE|0
2186470|NCT01455415|3816062|FG001|Period 1|Drug Error not Associated to AE|1
2186471|NCT01455415|3816061|FG000|Period 1|AE Not Related to Study Drug|2
2186472|NCT01455415|3816062|FG001|Period 1|AE Not Related to Study Drug|6
2186473|NCT01455415|3816061|FG000|Period 1|Withdrawal by Subject|4
2186474|NCT01455415|3816062|FG001|Period 1|Withdrawal by Subject|5
2186475|NCT01455415|3816061|FG000|Period 1|Unspecified Reason|1
2186476|NCT01455415|3816062|FG001|Period 1|Unspecified Reason|1
2186477|NCT01455415|3816061|FG000|Period 1|Protocol Violation|0
2186478|NCT01455415|3816062|FG001|Period 1|Protocol Violation|2
2186479|NCT01455415|3816061|FG000|Washout|AE Related to Study Drug|2
2186480|NCT01455415|3816062|FG001|Washout|AE Related to Study Drug|0
2186481|NCT01455415|3816061|FG000|Washout|Lost to Follow-up|1
2186482|NCT01455415|3816062|FG001|Washout|Lost to Follow-up|0
2186483|NCT01455415|3816061|FG000|Washout|Drug Error not Associated to AE|2
2186484|NCT01455415|3816062|FG001|Washout|Drug Error not Associated to AE|1
2186485|NCT01455415|3816061|FG000|Washout|AE Not Related to Study Drug|2
2186486|NCT01455415|3816062|FG001|Washout|AE Not Related to Study Drug|3
2186487|NCT01455415|3816061|FG000|Washout|Unspecified Reason|1
2186488|NCT01455415|3816062|FG001|Washout|Unspecified Reason|2
2186489|NCT01455415|3816061|FG000|Washout|Protocol Violation|0
2186490|NCT01455415|3816062|FG001|Washout|Protocol Violation|1
2186491|NCT01455415|3816061|FG000|Period 2|AE Related to Study Drug|1
2186492|NCT01455415|3816062|FG001|Period 2|AE Related to Study Drug|2
2186493|NCT01455415|3816061|FG000|Period 2|Lost to Follow-up|2
2186494|NCT01455415|3816062|FG001|Period 2|Lost to Follow-up|1
2186495|NCT01455415|3816061|FG000|Period 2|AE Not Related to Study Drug|2
2186496|NCT01455415|3816062|FG001|Period 2|AE Not Related to Study Drug|1
2186497|NCT01455415|3816061|FG000|Period 2|Lack of Efficacy|2
2186498|NCT01455415|3816062|FG001|Period 2|Lack of Efficacy|0
2186499|NCT01455415|3816061|FG000|Period 2|Withdrawal by Subject|2
2186500|NCT01455415|3816062|FG001|Period 2|Withdrawal by Subject|3
2186501|NCT01455415|3816061|FG000|Period 2|Unspecified Reason|2
2186502|NCT01455415|3816062|FG001|Period 2|Unspecified Reason|3
2186503|NCT01455415|3816061|FG000|Period 2|Protocol Violation|2
2186504|NCT01455415|3816062|FG001|Period 2|Protocol Violation|0
2186505|NCT01455415|3816061|FG000|Follow-up|AE Related to Study Drug|0
2186506|NCT01455415|3816062|FG001|Follow-up|AE Related to Study Drug|1
2186507|NCT01455415|3816061|FG000|Follow-up|Lack of Efficacy|0
2221681|NCT01740089|3866568|FG001|After 12 Weeks|Protocol Violation|1
2221682|NCT01740089|3866569|FG002|After 12 Weeks|Protocol Violation|1
2221683|NCT01740089|3866567|FG000|After 12 Weeks|Withdrawal by Subject|1
2221684|NCT01740089|3866568|FG001|After 12 Weeks|Withdrawal by Subject|1
2221685|NCT01740089|3866569|FG002|After 12 Weeks|Withdrawal by Subject|1
2221686|NCT01740128|3866580|FG000|Overall Study|Pregnancy|0
2221687|NCT01740128|3866581|FG001|Overall Study|Pregnancy|1
2221688|NCT01740128|3866580|FG000|Overall Study|Protocol Violation|1
2221689|NCT01740128|3866581|FG001|Overall Study|Protocol Violation|2
2221690|NCT01740128|3866580|FG000|Overall Study|Lost to Follow-up|2
2221691|NCT01740128|3866581|FG001|Overall Study|Lost to Follow-up|2
2221692|NCT01740128|3866580|FG000|Overall Study|Withdrawal by Subject|1
2221693|NCT01740128|3866581|FG001|Overall Study|Withdrawal by Subject|0
2221694|NCT01740128|3866580|FG000|Overall Study|Insufficient protocol compliance|2
2221695|NCT01740128|3866581|FG001|Overall Study|Insufficient protocol compliance|2
2221696|NCT01740297|3866603|FG000|Overall Study|Continuing Study|10
2221697|NCT01740297|3866604|FG001|Overall Study|Continuing Study|67
2221698|NCT01740297|3866605|FG002|Overall Study|Continuing Study|68
2221699|NCT01740297|3866603|FG000|Overall Study|Withdrawal by Subject|1
2186508|NCT01455415|3816062|FG001|Follow-up|Lack of Efficacy|1
2186509|NCT01455415|3816061|FG000|Follow-up|Withdrawal by Subject|2
2186510|NCT01455415|3816062|FG001|Follow-up|Withdrawal by Subject|0
2186511|NCT01455415|3816061|FG000|Follow-up|Unspecified Reason|1
2186512|NCT01455415|3816062|FG001|Follow-up|Unspecified Reason|0
2186513|NCT01455428|3816070|FG000|Overall Study|Protocol Violation|2
2186514|NCT01455428|3816071|FG001|Overall Study|Protocol Violation|1
2186515|NCT01455428|3816070|FG000|Overall Study|Adverse Event|6
2186516|NCT01455428|3816071|FG001|Overall Study|Adverse Event|2
2186517|NCT01455428|3816070|FG000|Overall Study|Lost to Follow-up|1
2186518|NCT01455428|3816071|FG001|Overall Study|Lost to Follow-up|1
2186519|NCT01455428|3816070|FG000|Overall Study|Withdrawal by Subject|2
2186520|NCT01455428|3816071|FG001|Overall Study|Withdrawal by Subject|5
2186521|NCT01455428|3816070|FG000|Overall Study|Did not meet entrance criteria|0
2186522|NCT01455428|3816071|FG001|Overall Study|Did not meet entrance criteria|2
2186523|NCT01455428|3816070|FG000|Overall Study|Insufficient clinical response|0
2186524|NCT01455428|3816071|FG001|Overall Study|Insufficient clinical response|2
2186525|NCT01455428|3816070|FG000|Overall Study|Did not receive treatment|1
2186526|NCT01455428|3816071|FG001|Overall Study|Did not receive treatment|1
2186527|NCT01455428|3816070|FG000|Overall Study|Other|2
2186528|NCT01455428|3816071|FG001|Overall Study|Other|4
2186529|NCT01456039|3816114|FG000|Phase 1 (First Step)|Disease Progression|1
2186530|NCT01456039|3816115|FG001|Phase 1 (First Step)|Disease Progression|1
2186531|NCT01456039|3816116|FG002|Phase 1 (First Step)|Disease Progression|0
2186532|NCT01456039|3816114|FG000|Phase 1 (First Step)|Withdrawal by Subject|1
2186533|NCT01456039|3816115|FG001|Phase 1 (First Step)|Withdrawal by Subject|2
2186534|NCT01456039|3816116|FG002|Phase 1 (First Step)|Withdrawal by Subject|0
2186535|NCT01456039|3816114|FG000|Phase 1 (First Step)|Adverse Event|0
2186536|NCT01456039|3816115|FG001|Phase 1 (First Step)|Adverse Event|3
2221700|NCT01740297|3866604|FG001|Overall Study|Withdrawal by Subject|9
2186537|NCT01456039|3816116|FG002|Phase 1 (First Step)|Adverse Event|0
2186538|NCT01456039|3816114|FG000|Phase 1 (First Step)|Other|0
2186539|NCT01456039|3816115|FG001|Phase 1 (First Step)|Other|1
2186540|NCT01456039|3816116|FG002|Phase 1 (First Step)|Other|0
2186541|NCT01456039|3816114|FG000|Phase 2 (Second Step)|Disease Progression|0
2186542|NCT01456039|3816115|FG001|Phase 2 (Second Step)|Disease Progression|0
2186543|NCT01456039|3816116|FG002|Phase 2 (Second Step)|Disease Progression|17
2186544|NCT01456039|3816114|FG000|Phase 2 (Second Step)|Adverse Event|0
2186545|NCT01456039|3816115|FG001|Phase 2 (Second Step)|Adverse Event|0
2186546|NCT01456039|3816116|FG002|Phase 2 (Second Step)|Adverse Event|10
2186547|NCT01456039|3816114|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0
2186548|NCT01456039|3816115|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0
2186549|NCT01456039|3816116|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4
2186550|NCT01456039|3816114|FG000|Phase 2 (Second Step)|Protocol Violation|0
2186551|NCT01456039|3816115|FG001|Phase 2 (Second Step)|Protocol Violation|0
2186552|NCT01456039|3816116|FG002|Phase 2 (Second Step)|Protocol Violation|1
2186553|NCT01456039|3816114|FG000|Phase 2 (Second Step)|Other|0
2186554|NCT01456039|3816115|FG001|Phase 2 (Second Step)|Other|0
2186555|NCT01456039|3816116|FG002|Phase 2 (Second Step)|Other|1
2186556|NCT01456052|3816135|FG000|Overall Study|Adverse Event|1
2186557|NCT01456052|3816136|FG001|Overall Study|Adverse Event|1
2186558|NCT01456052|3816137|FG002|Overall Study|Adverse Event|2
2186559|NCT01456052|3816135|FG000|Overall Study|Consent withdrawn|0
2186560|NCT01456052|3816136|FG001|Overall Study|Consent withdrawn|2
2186561|NCT01456052|3816137|FG002|Overall Study|Consent withdrawn|1
2186562|NCT01456052|3816135|FG000|Overall Study|Protocol Violation|0
2186563|NCT01456052|3816136|FG001|Overall Study|Protocol Violation|1
2186564|NCT01456052|3816137|FG002|Overall Study|Protocol Violation|0
2186565|NCT01456052|3816135|FG000|Overall Study|Physician Decision|1
2186566|NCT01456052|3816136|FG001|Overall Study|Physician Decision|0
2186567|NCT01456052|3816137|FG002|Overall Study|Physician Decision|1
2186568|NCT01456052|3816135|FG000|Overall Study|Treatment Failure|0
2221701|NCT01740297|3866605|FG002|Overall Study|Withdrawal by Subject|11
2221702|NCT01740297|3866603|FG000|Overall Study|Death|8
2221703|NCT01740297|3866604|FG001|Overall Study|Death|23
2221704|NCT01740297|3866605|FG002|Overall Study|Death|19
2221705|NCT01740297|3866603|FG000|Overall Study|Sponsor Decision|0
2221706|NCT01740297|3866604|FG001|Overall Study|Sponsor Decision|1
2221707|NCT01740297|3866605|FG002|Overall Study|Sponsor Decision|0
2221708|NCT01740323|3866617|FG000|Overall Study|Adverse Event|1
2221709|NCT01740323|3866618|FG001|Overall Study|Adverse Event|0
2221710|NCT01740323|3866617|FG000|Overall Study|Randomized but did not take study drug|1
2221711|NCT01740323|3866618|FG001|Overall Study|Randomized but did not take study drug|0
2221712|NCT01740388|3866643|FG000|Overall Study|Withdrawal by Subject|1
2221713|NCT01740388|3866644|FG001|Overall Study|Withdrawal by Subject|2
2221714|NCT01740388|3866643|FG000|Overall Study|Lost to Follow-up|2
2221715|NCT01740388|3866644|FG001|Overall Study|Lost to Follow-up|0
2221716|NCT01740388|3866643|FG000|Overall Study|Physician Decision|2
2221717|NCT01740388|3866644|FG001|Overall Study|Physician Decision|6
2221718|NCT01740388|3866643|FG000|Overall Study|Subjects missing data, completed|41
2221719|NCT01740388|3866644|FG001|Overall Study|Subjects missing data, completed|36
2221720|NCT01740401|3866650|FG000|Overall Study|Progression of disease|6
2221721|NCT01740401|3866650|FG000|Overall Study|Adverse Event|2
2221722|NCT01740401|3866650|FG000|Overall Study|Did not reach primary endpoint|2
2221723|NCT01740427|3866670|FG000|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
2221724|NCT01740427|3866671|FG001|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
2221725|NCT01740427|3866670|FG000|Overall Study|Objective progression or relapse|172
2221726|NCT01740427|3866671|FG001|Overall Study|Objective progression or relapse|125
2186569|NCT01456052|3816136|FG001|Overall Study|Treatment Failure|1
2186570|NCT01456052|3816137|FG002|Overall Study|Treatment Failure|1
2186571|NCT01456130|3816146|FG000|Overall Study|Adverse Event|4
2186572|NCT01456130|3816146|FG000|Overall Study|Voluntary Withdrawal|1
2186573|NCT01456130|3816146|FG000|Overall Study|Lack of Efficacy|4
2186574|NCT01456130|3816146|FG000|Overall Study|Other|1
2186575|NCT01456169|3816157|FG000|Overall Study|Adverse Event|1
2186576|NCT01456169|3816158|FG001|Overall Study|Adverse Event|2
2186577|NCT01456169|3816159|FG002|Overall Study|Adverse Event|7
2186578|NCT01456169|3816157|FG000|Overall Study|Major Protocol Deviation|3
2186579|NCT01456169|3816158|FG001|Overall Study|Major Protocol Deviation|2
2186580|NCT01456169|3816159|FG002|Overall Study|Major Protocol Deviation|3
2186581|NCT01456169|3816157|FG000|Overall Study|Voluntary Withdrawal|3
2186582|NCT01456169|3816158|FG001|Overall Study|Voluntary Withdrawal|0
2186583|NCT01456169|3816159|FG002|Overall Study|Voluntary Withdrawal|2
2186584|NCT01456169|3816157|FG000|Overall Study|Lack of Efficacy|2
2186585|NCT01456169|3816158|FG001|Overall Study|Lack of Efficacy|0
2186586|NCT01456169|3816159|FG002|Overall Study|Lack of Efficacy|0
2186587|NCT01456169|3816157|FG000|Overall Study|Other|1
2186588|NCT01456169|3816158|FG001|Overall Study|Other|1
2186589|NCT01456169|3816159|FG002|Overall Study|Other|0
2186590|NCT01456195|3816171|FG000|Overall Study|Pretreatment Event/Adverse Event|1
2186591|NCT01456195|3816172|FG001|Overall Study|Pretreatment Event/Adverse Event|4
2186592|NCT01456195|3816173|FG002|Overall Study|Pretreatment Event/Adverse Event|1
2186593|NCT01456195|3816171|FG000|Overall Study|Lost to Follow-up|3
2186594|NCT01456195|3816172|FG001|Overall Study|Lost to Follow-up|1
2186595|NCT01456195|3816173|FG002|Overall Study|Lost to Follow-up|3
2186596|NCT01456195|3816171|FG000|Overall Study|Voluntary Withdrawal|5
2186597|NCT01456195|3816172|FG001|Overall Study|Voluntary Withdrawal|3
2186598|NCT01456195|3816173|FG002|Overall Study|Voluntary Withdrawal|7
2186599|NCT01456195|3816171|FG000|Overall Study|Lack of Efficacy|0
2186600|NCT01456195|3816172|FG001|Overall Study|Lack of Efficacy|1
2186601|NCT01456195|3816173|FG002|Overall Study|Lack of Efficacy|0
2186602|NCT01456195|3816171|FG000|Overall Study|Other Reasons|2
2186603|NCT01456195|3816172|FG001|Overall Study|Other Reasons|1
2186604|NCT01456195|3816173|FG002|Overall Study|Other Reasons|3
2186605|NCT01456221|3816183|FG000|Overall Study|Withdrawal by Subject|56
2186606|NCT01456221|3816184|FG001|Overall Study|Withdrawal by Subject|49
2186607|NCT01456221|3816183|FG000|Overall Study|Lost to Follow-up|1
2186608|NCT01456221|3816184|FG001|Overall Study|Lost to Follow-up|4
2186609|NCT01456221|3816183|FG000|Overall Study|Received medication|3
2186610|NCT01456221|3816184|FG001|Overall Study|Received medication|2
2186611|NCT01456221|3816183|FG000|Overall Study|Incomplete data|4
2186612|NCT01456221|3816184|FG001|Overall Study|Incomplete data|2
2186613|NCT01456780|3816215|FG000|Overall Study|Lost to Follow-up|3
2186614|NCT01456780|3816216|FG001|Overall Study|Lost to Follow-up|3
2186615|NCT01456780|3816217|FG002|Overall Study|Lost to Follow-up|0
2186616|NCT01456897|3816227|FG000|Overall Study|Adverse Event|19
2186617|NCT01456897|3816228|FG001|Overall Study|Adverse Event|22
2186618|NCT01456897|3816227|FG000|Overall Study|Protocol Violation|3
2186619|NCT01456897|3816228|FG001|Overall Study|Protocol Violation|4
2221727|NCT01740427|3866670|FG000|Overall Study|Adverse Event|20
2221728|NCT01740427|3866671|FG001|Overall Study|Adverse Event|9
2221729|NCT01740427|3866670|FG000|Overall Study|Global deterioration of health status|16
2221730|NCT01740427|3866671|FG001|Overall Study|Global deterioration of health status|9
2221731|NCT01740427|3866670|FG000|Overall Study|Subject refused continued treatment|12
2221732|NCT01740427|3866671|FG001|Overall Study|Subject refused continued treatment|9
2221733|NCT01740427|3866670|FG000|Overall Study|Unspecified reasons|6
2221734|NCT01740427|3866671|FG001|Overall Study|Unspecified reasons|4
2221735|NCT01740427|3866670|FG000|Overall Study|Death|6
2221736|NCT01740427|3866671|FG001|Overall Study|Death|2
2221737|NCT01740427|3866670|FG000|Overall Study|Protocol Violation|5
2221738|NCT01740427|3866671|FG001|Overall Study|Protocol Violation|3
2221739|NCT01740427|3866670|FG000|Overall Study|Lost to Follow-up|1
2221740|NCT01740427|3866671|FG001|Overall Study|Lost to Follow-up|0
2221741|NCT01740427|3866670|FG000|Overall Study|Study terminated by Sponsor|1
2186620|NCT01456897|3816227|FG000|Overall Study|Physician Decision|5
2186621|NCT01456897|3816228|FG001|Overall Study|Physician Decision|3
2186622|NCT01456897|3816227|FG000|Overall Study|Withdrawal by Subject|44
2186623|NCT01456897|3816228|FG001|Overall Study|Withdrawal by Subject|17
2186624|NCT01456897|3816227|FG000|Overall Study|Lack of Efficacy|4
2186625|NCT01456897|3816228|FG001|Overall Study|Lack of Efficacy|11
2186626|NCT01456936|3816238|FG000|Overall Study|Other reason|41
2186627|NCT01456936|3816239|FG001|Overall Study|Other reason|30
2186628|NCT01456936|3816240|FG002|Overall Study|Other reason|36
2186629|NCT01456936|3816241|FG003|Overall Study|Other reason|33
2186630|NCT01456936|3816238|FG000|Overall Study|No longer meets eligibility criteria|4
2186631|NCT01456936|3816239|FG001|Overall Study|No longer meets eligibility criteria|8
2186632|NCT01456936|3816240|FG002|Overall Study|No longer meets eligibility criteria|6
2221742|NCT01740427|3866671|FG001|Overall Study|Study terminated by Sponsor|0
2221743|NCT01740440|3866677|FG000|Overall Study|Lost to Follow-up|3
2221744|NCT01740791|3866712|FG000|Overall Study|Randomized but never treated|5
2186633|NCT01456936|3816241|FG003|Overall Study|No longer meets eligibility criteria|5
2186634|NCT01456936|3816238|FG000|Overall Study|Protocol Violation|4
2186635|NCT01456936|3816239|FG001|Overall Study|Protocol Violation|2
2186636|NCT01456936|3816240|FG002|Overall Study|Protocol Violation|5
2186637|NCT01456936|3816241|FG003|Overall Study|Protocol Violation|5
2186638|NCT01456936|3816238|FG000|Overall Study|Pregnancy|1
2186639|NCT01456936|3816239|FG001|Overall Study|Pregnancy|0
2186640|NCT01456936|3816240|FG002|Overall Study|Pregnancy|0
2186641|NCT01456936|3816241|FG003|Overall Study|Pregnancy|1
2186642|NCT01456936|3816238|FG000|Overall Study|Insufficient clinical response|4
2186643|NCT01456936|3816239|FG001|Overall Study|Insufficient clinical response|4
2186644|NCT01456936|3816240|FG002|Overall Study|Insufficient clinical response|14
2186645|NCT01456936|3816241|FG003|Overall Study|Insufficient clinical response|13
2186646|NCT01456936|3816238|FG000|Overall Study|No longer willing to participate|195
2186647|NCT01456936|3816239|FG001|Overall Study|No longer willing to participate|218
2186648|NCT01456936|3816240|FG002|Overall Study|No longer willing to participate|224
2186649|NCT01456936|3816241|FG003|Overall Study|No longer willing to participate|248
2186650|NCT01456936|3816238|FG000|Overall Study|Lost to Follow-up|135
2186651|NCT01456936|3816239|FG001|Overall Study|Lost to Follow-up|126
2186652|NCT01456936|3816240|FG002|Overall Study|Lost to Follow-up|144
2186653|NCT01456936|3816241|FG003|Overall Study|Lost to Follow-up|127
2186654|NCT01456936|3816238|FG000|Overall Study|Medication error|0
2186655|NCT01456936|3816239|FG001|Overall Study|Medication error|1
2186656|NCT01456936|3816240|FG002|Overall Study|Medication error|0
2186657|NCT01456936|3816241|FG003|Overall Study|Medication error|1
2186658|NCT01456936|3816238|FG000|Overall Study|Adverse event (study drug)|25
2186659|NCT01456936|3816239|FG001|Overall Study|Adverse event (study drug)|21
2186660|NCT01456936|3816240|FG002|Overall Study|Adverse event (study drug)|26
2186661|NCT01456936|3816241|FG003|Overall Study|Adverse event (study drug)|17
2186662|NCT01456936|3816238|FG000|Overall Study|Adverse event (study drug unrelated)|9
2186663|NCT01456936|3816239|FG001|Overall Study|Adverse event (study drug unrelated)|7
2186664|NCT01456936|3816240|FG002|Overall Study|Adverse event (study drug unrelated)|9
2186665|NCT01456936|3816241|FG003|Overall Study|Adverse event (study drug unrelated)|9
2186666|NCT01456936|3816238|FG000|Overall Study|Death|0
2186667|NCT01456936|3816239|FG001|Overall Study|Death|3
2186668|NCT01456936|3816240|FG002|Overall Study|Death|1
2186669|NCT01456936|3816241|FG003|Overall Study|Death|3
2186670|NCT01456936|3816238|FG000|Overall Study|Randomized but not treated|21
2186671|NCT01456936|3816239|FG001|Overall Study|Randomized but not treated|28
2186672|NCT01456936|3816240|FG002|Overall Study|Randomized but not treated|16
2186673|NCT01456936|3816241|FG003|Overall Study|Randomized but not treated|21
2186674|NCT01456949|3816251|FG000|Enrollment|PI death- incomplete data|6
2186675|NCT01456949|3816251|FG000|Enrollment|Death|1
2186676|NCT01456949|3816251|FG000|Enrollment|I/E criteria not met prior to procedure|13
2186677|NCT01456949|3816251|FG000|Enrollment|Physician Decision|10
2186678|NCT01456949|3816251|FG000|Enrollment|Withdrawal by Subject|7
2186679|NCT01456949|3816251|FG000|Study Cryoablation Procedure & Follow-up|Death|5
2186680|NCT01456949|3816251|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
2186681|NCT01456949|3816251|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
2186682|NCT01456949|3816251|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1
2186683|NCT01456949|3816251|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
2186684|NCT01456949|3816251|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
2186685|NCT01456949|3816251|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
2186686|NCT01456949|3816251|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
2186687|NCT01456962|3816257|FG000|Overall Study|Lost to Follow-up|2
2186688|NCT01456962|3816258|FG001|Overall Study|Lost to Follow-up|1
2186689|NCT01457014|3816264|FG000|First Night|Didn't meet inclusion/exclusion criteria|37
2186690|NCT01457014|3816265|FG001|First Night|Didn't meet inclusion/exclusion criteria|0
2186691|NCT01457014|3816266|FG002|First Night|Didn't meet inclusion/exclusion criteria|0
2186692|NCT01457014|3816267|FG003|First Night|Didn't meet inclusion/exclusion criteria|0
2186693|NCT01457014|3816264|FG000|First Night|Withdrawal by Subject|3
2186694|NCT01457014|3816265|FG001|First Night|Withdrawal by Subject|0
2186695|NCT01457014|3816266|FG002|First Night|Withdrawal by Subject|0
2186696|NCT01457014|3816267|FG003|First Night|Withdrawal by Subject|0
2186697|NCT01457118|3816279|FG000|Overall Study|Adverse Event|1
2186698|NCT01457118|3816280|FG001|Overall Study|Adverse Event|0
2186699|NCT01457118|3816281|FG002|Overall Study|Adverse Event|0
2186700|NCT01457118|3816282|FG003|Overall Study|Adverse Event|1
2186701|NCT01457118|3816279|FG000|Overall Study|Clinical Progression|0
2186702|NCT01457118|3816280|FG001|Overall Study|Clinical Progression|1
2186703|NCT01457118|3816281|FG002|Overall Study|Clinical Progression|0
2186704|NCT01457118|3816282|FG003|Overall Study|Clinical Progression|1
2186705|NCT01457118|3816279|FG000|Overall Study|Physician Decision|2
2186706|NCT01457118|3816280|FG001|Overall Study|Physician Decision|0
2186707|NCT01457118|3816281|FG002|Overall Study|Physician Decision|0
2186708|NCT01457118|3816282|FG003|Overall Study|Physician Decision|0
2186709|NCT01457118|3816279|FG000|Overall Study|Progressive Disease by RECIST|12
2186710|NCT01457118|3816280|FG001|Overall Study|Progressive Disease by RECIST|3
2186711|NCT01457118|3816281|FG002|Overall Study|Progressive Disease by RECIST|1
2186712|NCT01457118|3816282|FG003|Overall Study|Progressive Disease by RECIST|0
2186713|NCT01457118|3816279|FG000|Overall Study|Withdrawal by Subject|5
2186714|NCT01457118|3816280|FG001|Overall Study|Withdrawal by Subject|0
2186715|NCT01457118|3816281|FG002|Overall Study|Withdrawal by Subject|0
2186716|NCT01457118|3816282|FG003|Overall Study|Withdrawal by Subject|0
2186717|NCT01457339|3816300|FG000|Period 3 (100 mg)|Adverse Event|0
2186718|NCT01457339|3816301|FG001|Period 3 (100 mg)|Adverse Event|1
2186719|NCT01457339|3816300|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
2186720|NCT01457339|3816301|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
2186721|NCT01457339|3816300|FG000|Period 6 (250 mg)|Family Emergency|1
2186722|NCT01457339|3816301|FG001|Period 6 (250 mg)|Family Emergency|0
2186723|NCT01457339|3816300|FG000|Period 6 (250 mg)|Personal appointment|0
2186724|NCT01457339|3816301|FG001|Period 6 (250 mg)|Personal appointment|1
2186725|NCT01457352|3816326|FG000|Period 1|Adverse Event|2
2186726|NCT01457352|3816327|FG001|Period 1|Adverse Event|0
2186727|NCT01457352|3816326|FG000|Period 1|Withdrawal by Subject|2
2221745|NCT01740791|3866713|FG001|Overall Study|Randomized but never treated|3
2221746|NCT01740791|3866714|FG002|Overall Study|Randomized but never treated|2
2221747|NCT01740791|3866715|FG003|Overall Study|Randomized but never treated|2
2221748|NCT01740791|3866716|FG004|Overall Study|Randomized but never treated|1
2221749|NCT01740791|3866717|FG005|Overall Study|Randomized but never treated|3
2221750|NCT01740791|3866712|FG000|Overall Study|Lost to Follow-up|2
2221751|NCT01740791|3866713|FG001|Overall Study|Lost to Follow-up|0
2221752|NCT01740791|3866714|FG002|Overall Study|Lost to Follow-up|2
2221753|NCT01740791|3866715|FG003|Overall Study|Lost to Follow-up|3
2221754|NCT01740791|3866716|FG004|Overall Study|Lost to Follow-up|2
2221755|NCT01740791|3866717|FG005|Overall Study|Lost to Follow-up|3
2221756|NCT01740791|3866712|FG000|Overall Study|Withdrew Consent|4
2221757|NCT01740791|3866713|FG001|Overall Study|Withdrew Consent|0
2221758|NCT01740791|3866714|FG002|Overall Study|Withdrew Consent|1
2221759|NCT01740791|3866715|FG003|Overall Study|Withdrew Consent|2
2221760|NCT01740791|3866716|FG004|Overall Study|Withdrew Consent|0
2221761|NCT01740791|3866717|FG005|Overall Study|Withdrew Consent|3
2221762|NCT01740791|3866712|FG000|Overall Study|Investigator's discretion|1
2221763|NCT01740791|3866713|FG001|Overall Study|Investigator's discretion|0
2221764|NCT01740791|3866714|FG002|Overall Study|Investigator's discretion|1
2221765|NCT01740791|3866715|FG003|Overall Study|Investigator's discretion|0
2221766|NCT01740791|3866716|FG004|Overall Study|Investigator's discretion|0
2221767|NCT01740791|3866717|FG005|Overall Study|Investigator's discretion|1
2221768|NCT01740791|3866712|FG000|Overall Study|Adverse Event|0
2221769|NCT01740791|3866713|FG001|Overall Study|Adverse Event|0
2221770|NCT01740791|3866714|FG002|Overall Study|Adverse Event|0
2221771|NCT01740791|3866715|FG003|Overall Study|Adverse Event|0
2221772|NCT01740791|3866716|FG004|Overall Study|Adverse Event|0
2221773|NCT01740791|3866717|FG005|Overall Study|Adverse Event|1
2221774|NCT01741012|3866779|FG000|Overall Study|Lost to Follow-up|1
2221775|NCT01741012|3866779|FG000|Overall Study|Withdrawal by Subject|2
2221776|NCT01741259|3866786|FG000|Overall Study|Protocol Violation|6
2221777|NCT01741259|3866787|FG001|Overall Study|Protocol Violation|4
2221778|NCT01741259|3866786|FG000|Overall Study|Withdrawal by Subject|0
2221779|NCT01741259|3866787|FG001|Overall Study|Withdrawal by Subject|2
2221780|NCT01741532|3866843|FG000|Overall Study|Adverse Event|4
2221781|NCT01741532|3866844|FG001|Overall Study|Adverse Event|0
2221782|NCT01741532|3866843|FG000|Overall Study|Withdrawal by Subject|1
2221783|NCT01741532|3866844|FG001|Overall Study|Withdrawal by Subject|1
2221784|NCT01741532|3866843|FG000|Overall Study|Protocol Violation|0
2221785|NCT01741532|3866844|FG001|Overall Study|Protocol Violation|1
2221786|NCT01741532|3866843|FG000|Overall Study|Worsening of the disease|3
2221787|NCT01741532|3866844|FG001|Overall Study|Worsening of the disease|1
2221788|NCT01741532|3866843|FG000|Overall Study|Sponsor decision|1
2221789|NCT01741532|3866844|FG001|Overall Study|Sponsor decision|0
2221790|NCT01741532|3866843|FG000|Overall Study|Medical event|1
2221791|NCT01741532|3866844|FG001|Overall Study|Medical event|0
2221792|NCT01741545|3866856|FG000|Treatment Period|Lack of Efficacy|0
2221793|NCT01741545|3866857|FG001|Treatment Period|Lack of Efficacy|1
2221794|NCT01741545|3866856|FG000|Treatment Period|Adverse event, non-fatal|1
2221795|NCT01741545|3866857|FG001|Treatment Period|Adverse event, non-fatal|3
2221796|NCT01741545|3866856|FG000|Follow-up Period (24 Weeks)|Other than specified|0
2221797|NCT01741545|3866857|FG001|Follow-up Period (24 Weeks)|Other than specified|1
2221798|NCT01741545|3866856|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
2221799|NCT01741545|3866857|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
2221800|NCT01741688|3866863|FG000|Overall Study|Lack of insurance coverage|2
2221801|NCT01741688|3866863|FG000|Overall Study|Withdrawal by Subject|1
2221802|NCT01741701|3866870|FG000|Overall Study|Adverse Event|5
2221803|NCT01741701|3866871|FG001|Overall Study|Adverse Event|1
2221804|NCT01741701|3866870|FG000|Overall Study|Withdrawal by Subject|0
2221805|NCT01741701|3866871|FG001|Overall Study|Withdrawal by Subject|1
2221806|NCT01741792|3866880|FG000|Overall Study|Death|6
2221807|NCT01741792|3866881|FG001|Overall Study|Death|1
2221808|NCT01741792|3866882|FG002|Overall Study|Death|12
2221809|NCT01742078|3866914|FG000|Overall Study|Withdrawal by Subject|0
2221810|NCT01742078|3866915|FG001|Overall Study|Withdrawal by Subject|0
2221811|NCT01742078|3866916|FG002|Overall Study|Withdrawal by Subject|0
2221812|NCT01742078|3866917|FG003|Overall Study|Withdrawal by Subject|1
2221813|NCT01742078|3866918|FG004|Overall Study|Withdrawal by Subject|0
2221814|NCT01742078|3866919|FG005|Overall Study|Withdrawal by Subject|0
2221815|NCT01742078|3866920|FG006|Overall Study|Withdrawal by Subject|0
2221816|NCT01742078|3866921|FG007|Overall Study|Withdrawal by Subject|0
2186728|NCT01457352|3816327|FG001|Period 1|Withdrawal by Subject|0
2186729|NCT01457352|3816326|FG000|Period 1|Physician Decision|2
2186730|NCT01457352|3816327|FG001|Period 1|Physician Decision|0
2186731|NCT01457352|3816326|FG000|Period 1|MS related disease progression|1
2186732|NCT01457352|3816327|FG001|Period 1|MS related disease progression|0
2186733|NCT01457352|3816326|FG000|Period 1|Withdrawn|1
2186734|NCT01457352|3816327|FG001|Period 1|Withdrawn|0
2186735|NCT01457352|3816326|FG000|Period 1|withdrew per sponsor|1
2186736|NCT01457352|3816327|FG001|Period 1|withdrew per sponsor|0
2186737|NCT01457352|3816326|FG000|Period 1|Protocol Violation|4
2186738|NCT01457352|3816327|FG001|Period 1|Protocol Violation|0
2186739|NCT01457352|3816326|FG000|Period 1|Did not meet eligibility criteria|3
2186740|NCT01457352|3816327|FG001|Period 1|Did not meet eligibility criteria|0
2186741|NCT01457352|3816326|FG000|Period 2|Withdrawal by Subject|23
2186742|NCT01457352|3816327|FG001|Period 2|Withdrawal by Subject|0
2186743|NCT01457352|3816326|FG000|Period 2|Adverse Event|22
2186744|NCT01457352|3816327|FG001|Period 2|Adverse Event|0
2186745|NCT01457352|3816326|FG000|Period 2|no analysis|10
2186746|NCT01457352|3816327|FG001|Period 2|no analysis|0
2186747|NCT01457352|3816326|FG000|Period 2|Lack of Efficacy|8
2186748|NCT01457352|3816327|FG001|Period 2|Lack of Efficacy|0
2186749|NCT01457352|3816326|FG000|Period 2|Protocol Violation|4
2186750|NCT01457352|3816327|FG001|Period 2|Protocol Violation|0
2186751|NCT01457352|3816326|FG000|Period 2|Sponsor's withdrawal|7
2186752|NCT01457352|3816327|FG001|Period 2|Sponsor's withdrawal|0
2186753|NCT01457352|3816326|FG000|Period 2|Lost to Follow-up|1
2186754|NCT01457352|3816327|FG001|Period 2|Lost to Follow-up|0
2186755|NCT01457352|3816326|FG000|Period 2|dose change|1
2186756|NCT01457352|3816327|FG001|Period 2|dose change|0
2186757|NCT01457352|3816326|FG000|Period 2|Physician Decision|1
2186758|NCT01457352|3816327|FG001|Period 2|Physician Decision|0
2186759|NCT01457352|3816326|FG000|Period 2|Did not meet eligibility criteria|3
2186760|NCT01457352|3816327|FG001|Period 2|Did not meet eligibility criteria|0
2186761|NCT01457352|3816326|FG000|Period 3|Adverse Event|1
2186762|NCT01457352|3816327|FG001|Period 3|Adverse Event|1
2186763|NCT01457352|3816326|FG000|Period 3|Withdrawal by Subject|0
2186764|NCT01457352|3816327|FG001|Period 3|Withdrawal by Subject|2
2186765|NCT01457352|3816326|FG000|Period 3|incorrect treatment|0
2186766|NCT01457352|3816327|FG001|Period 3|incorrect treatment|1
2186767|NCT01457352|3816326|FG000|Period 3|Sponsor's withdrawal|0
2186768|NCT01457352|3816327|FG001|Period 3|Sponsor's withdrawal|1
2186769|NCT01457703|3816381|FG000|Overall Study|Screen Failure|5
2186770|NCT01457703|3816382|FG001|Overall Study|Screen Failure|7
2186771|NCT01457703|3816381|FG000|Overall Study|Withdrawal by Subject|1
2186772|NCT01457703|3816382|FG001|Overall Study|Withdrawal by Subject|4
2186773|NCT01457846|3816392|FG000|Overall Study|Death before treatment|1
2186774|NCT01457846|3816393|FG001|Overall Study|Death before treatment|2
2186775|NCT01457846|3816392|FG000|Overall Study|Did not receive treatment|0
2186776|NCT01457846|3816393|FG001|Overall Study|Did not receive treatment|1
2186777|NCT01457846|3816392|FG000|Overall Study|Death|27
2186778|NCT01457846|3816393|FG001|Overall Study|Death|16
2186779|NCT01457846|3816392|FG000|Overall Study|Unclassified reason for not completed|11
2186780|NCT01457846|3816393|FG001|Overall Study|Unclassified reason for not completed|10
2186781|NCT01457846|3816392|FG000|Overall Study|Withdrawal by Subject|1
2186782|NCT01457846|3816393|FG001|Overall Study|Withdrawal by Subject|1
2186783|NCT01457846|3816392|FG000|Overall Study|Lost to Follow-up|1
2186784|NCT01457846|3816393|FG001|Overall Study|Lost to Follow-up|0
2186785|NCT01457924|3816408|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0
2221817|NCT01742078|3866922|FG008|Overall Study|Withdrawal by Subject|0
2221818|NCT01742091|3866950|FG000|Overall Study|Adverse Event|0
2221819|NCT01742091|3866951|FG001|Overall Study|Adverse Event|0
2221820|NCT01742091|3866952|FG002|Overall Study|Adverse Event|0
2221821|NCT01742091|3866953|FG003|Overall Study|Adverse Event|0
2221822|NCT01742091|3866954|FG004|Overall Study|Adverse Event|1
2221823|NCT01742091|3866955|FG005|Overall Study|Adverse Event|0
2221824|NCT01742091|3866950|FG000|Overall Study|Physician Decision|0
2221825|NCT01742091|3866951|FG001|Overall Study|Physician Decision|0
2221826|NCT01742091|3866952|FG002|Overall Study|Physician Decision|0
2221827|NCT01742091|3866953|FG003|Overall Study|Physician Decision|0
2221828|NCT01742091|3866954|FG004|Overall Study|Physician Decision|0
2221829|NCT01742091|3866955|FG005|Overall Study|Physician Decision|1
2221830|NCT01742091|3866950|FG000|Overall Study|Withdrawal by Subject|0
2221831|NCT01742091|3866951|FG001|Overall Study|Withdrawal by Subject|0
2221832|NCT01742091|3866952|FG002|Overall Study|Withdrawal by Subject|0
2221833|NCT01742091|3866953|FG003|Overall Study|Withdrawal by Subject|1
2221834|NCT01742091|3866954|FG004|Overall Study|Withdrawal by Subject|0
2221835|NCT01742091|3866955|FG005|Overall Study|Withdrawal by Subject|0
2186786|NCT01457924|3816409|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4
2186787|NCT01457924|3816410|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1
2186788|NCT01457924|3816411|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0
2186789|NCT01457924|3816412|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2
2186790|NCT01457924|3816408|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0
2186791|NCT01457924|3816409|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0
2186792|NCT01457924|3816410|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0
2186793|NCT01457924|3816411|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0
2186794|NCT01457924|3816412|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1
2186795|NCT01457924|3816408|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
2186796|NCT01457924|3816409|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2186797|NCT01457924|3816410|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2186798|NCT01457924|3816411|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2186799|NCT01457924|3816412|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2186800|NCT01457924|3816408|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1
2186801|NCT01457924|3816409|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0
2186802|NCT01457924|3816410|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1
2186803|NCT01457924|3816411|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0
2186804|NCT01457924|3816412|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0
2186805|NCT01457924|3816408|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
2186806|NCT01457924|3816409|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
2186807|NCT01457924|3816410|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
2186808|NCT01457924|3816411|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
2186809|NCT01457924|3816412|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
2186810|NCT01457924|3816408|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
2186811|NCT01457924|3816409|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
2186812|NCT01457924|3816410|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
2186813|NCT01457924|3816411|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
2186814|NCT01457924|3816412|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
2186815|NCT01457924|3816408|FG000|FUP (Weeks 24-48)|Adverse Event|0
2186816|NCT01457924|3816409|FG001|FUP (Weeks 24-48)|Adverse Event|0
2186817|NCT01457924|3816410|FG002|FUP (Weeks 24-48)|Adverse Event|1
2186818|NCT01457924|3816411|FG003|FUP (Weeks 24-48)|Adverse Event|0
2186819|NCT01457924|3816412|FG004|FUP (Weeks 24-48)|Adverse Event|0
2186820|NCT01457924|3816408|FG000|FUP (Weeks 24-48)|Physician Decision|1
2186821|NCT01457924|3816409|FG001|FUP (Weeks 24-48)|Physician Decision|0
2186822|NCT01457924|3816410|FG002|FUP (Weeks 24-48)|Physician Decision|1
2186823|NCT01457924|3816411|FG003|FUP (Weeks 24-48)|Physician Decision|0
2186824|NCT01457924|3816412|FG004|FUP (Weeks 24-48)|Physician Decision|0
2186825|NCT01457924|3816408|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0
2186826|NCT01457924|3816409|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0
2186827|NCT01457924|3816410|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0
2186828|NCT01457924|3816411|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1
2186829|NCT01457924|3816412|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0
2186830|NCT01457924|3816408|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2
2186831|NCT01457924|3816409|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1
2186832|NCT01457924|3816410|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0
2186833|NCT01457924|3816411|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0
2186834|NCT01457924|3816412|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2
2186835|NCT01457924|3816408|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
2186836|NCT01457924|3816409|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
2186837|NCT01457924|3816410|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
2186838|NCT01457924|3816411|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
2186839|NCT01457924|3816412|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
2186840|NCT01457924|3816408|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
2221836|NCT01742091|3866950|FG000|Overall Study|Lost to Follow-up|0
2221837|NCT01742091|3866951|FG001|Overall Study|Lost to Follow-up|0
2221838|NCT01742091|3866952|FG002|Overall Study|Lost to Follow-up|0
2221839|NCT01742091|3866953|FG003|Overall Study|Lost to Follow-up|0
2221840|NCT01742091|3866954|FG004|Overall Study|Lost to Follow-up|0
2221841|NCT01742091|3866955|FG005|Overall Study|Lost to Follow-up|1
2221842|NCT01742286|3867000|FG000|Escalation Phase|Administrative problems|1
2221843|NCT01742286|3867001|FG001|Escalation Phase|Administrative problems|1
2221844|NCT01742286|3867002|FG002|Escalation Phase|Administrative problems|0
2221845|NCT01742286|3867003|FG003|Escalation Phase|Administrative problems|0
2221846|NCT01742286|3867004|FG004|Escalation Phase|Administrative problems|0
2221847|NCT01742286|3867005|FG005|Escalation Phase|Administrative problems|0
2221848|NCT01742286|3867006|FG006|Escalation Phase|Administrative problems|2
2332142|NCT03187301|4055401|FG002|Titration Period|Exclusion Criteria Met|0
2332143|NCT03187301|4055402|FG003|Titration Period|Exclusion Criteria Met|0
2332144|NCT03187301|4055403|FG004|Titration Period|Exclusion Criteria Met|0
2332145|NCT03187301|4055404|FG005|Titration Period|Exclusion Criteria Met|0
2332146|NCT03187301|4055405|FG006|Titration Period|Exclusion Criteria Met|1
2332147|NCT03187301|4055399|FG000|Pre-Intervention|Withdrawal by Subject|1
2332148|NCT03187301|4055400|FG001|Pre-Intervention|Withdrawal by Subject|0
2332149|NCT03187301|4055401|FG002|Pre-Intervention|Withdrawal by Subject|0
2332150|NCT03187301|4055402|FG003|Pre-Intervention|Withdrawal by Subject|0
2332151|NCT03187301|4055403|FG004|Pre-Intervention|Withdrawal by Subject|0
2332152|NCT03187301|4055404|FG005|Pre-Intervention|Withdrawal by Subject|0
2332153|NCT03187301|4055405|FG006|Pre-Intervention|Withdrawal by Subject|0
2332154|NCT03187756|4055443|FG000|Overall Study|Termination of study|4
2332155|NCT03188055|4055449|FG000|Overall Study|Unavailable for training|0
2332156|NCT03188055|4055450|FG001|Overall Study|Unavailable for training|0
2332157|NCT03188055|4055451|FG002|Overall Study|Unavailable for training|19
2332158|NCT03188055|4055452|FG003|Overall Study|Unavailable for training|0
2332159|NCT03188055|4055453|FG004|Overall Study|Unavailable for training|0
2186841|NCT01457924|3816409|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
2186842|NCT01457924|3816410|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
2186843|NCT01457924|3816411|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
2186844|NCT01457924|3816412|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
2186845|NCT01457924|3816408|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
2186846|NCT01457924|3816409|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
2186847|NCT01457924|3816410|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
2186848|NCT01457924|3816411|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
2186849|NCT01457924|3816412|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
2186850|NCT01457950|3816426|FG000|Double-Blind Phase|Continuation Criteria Not Met|1
2186851|NCT01457950|3816427|FG001|Double-Blind Phase|Continuation Criteria Not Met|0
2186852|NCT01457950|3816428|FG002|Double-Blind Phase|Continuation Criteria Not Met|0
2186853|NCT01457950|3816429|FG003|Double-Blind Phase|Continuation Criteria Not Met|0
2186854|NCT01457950|3816426|FG000|Double-Blind Phase|Protocol Violation|2
2186855|NCT01457950|3816427|FG001|Double-Blind Phase|Protocol Violation|1
2186856|NCT01457950|3816428|FG002|Double-Blind Phase|Protocol Violation|0
2186857|NCT01457950|3816429|FG003|Double-Blind Phase|Protocol Violation|0
2186858|NCT01457950|3816426|FG000|Double-Blind Phase|Withdrawal by Subject|6
2186859|NCT01457950|3816427|FG001|Double-Blind Phase|Withdrawal by Subject|2
2186860|NCT01457950|3816428|FG002|Double-Blind Phase|Withdrawal by Subject|0
2186861|NCT01457950|3816429|FG003|Double-Blind Phase|Withdrawal by Subject|0
2186862|NCT01457950|3816426|FG000|Open-Label Phase|Adverse Event|0
2186863|NCT01457950|3816427|FG001|Open-Label Phase|Adverse Event|0
2186864|NCT01457950|3816428|FG002|Open-Label Phase|Adverse Event|0
2186865|NCT01457950|3816429|FG003|Open-Label Phase|Adverse Event|1
2186866|NCT01457950|3816426|FG000|Open-Label Phase|Protocol Violation|0
2186867|NCT01457950|3816427|FG001|Open-Label Phase|Protocol Violation|0
2186868|NCT01457950|3816428|FG002|Open-Label Phase|Protocol Violation|0
2186869|NCT01457950|3816429|FG003|Open-Label Phase|Protocol Violation|1
2186870|NCT01457950|3816426|FG000|Open-Label Phase|Withdrawal by Subject|0
2186871|NCT01457950|3816427|FG001|Open-Label Phase|Withdrawal by Subject|0
2186872|NCT01457950|3816428|FG002|Open-Label Phase|Withdrawal by Subject|2
2186873|NCT01457950|3816429|FG003|Open-Label Phase|Withdrawal by Subject|0
2186874|NCT01458106|3816442|FG000|Overall Study|Withdrawal by Subject|2
2186875|NCT01458106|3816443|FG001|Overall Study|Withdrawal by Subject|0
2186876|NCT01458106|3816442|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1
2186877|NCT01458106|3816443|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0
2186878|NCT01458106|3816442|FG000|Overall Study|Withdrawn Per Protocol|0
2186879|NCT01458106|3816443|FG001|Overall Study|Withdrawn Per Protocol|1
2186880|NCT01458119|3816452|FG000|Overall Study|Physician Decision|4
2186881|NCT01458119|3816452|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1
2186882|NCT01458119|3816452|FG000|Overall Study|Pregnancy|1
2186883|NCT01458119|3816452|FG000|Overall Study|Death|2
2186884|NCT01458119|3816452|FG000|Overall Study|Adverse Event|1
2186885|NCT01458119|3816452|FG000|Overall Study|Consent Withdrawn by Participant|8
2186886|NCT01458119|3816452|FG000|Overall Study|Non-compliance With Study Drug|3
2221849|NCT01742286|3867000|FG000|Escalation Phase|Adverse Event|0
2221850|NCT01742286|3867001|FG001|Escalation Phase|Adverse Event|1
2221851|NCT01742286|3867002|FG002|Escalation Phase|Adverse Event|2
2221852|NCT01742286|3867003|FG003|Escalation Phase|Adverse Event|0
2221853|NCT01742286|3867004|FG004|Escalation Phase|Adverse Event|0
2221854|NCT01742286|3867005|FG005|Escalation Phase|Adverse Event|1
2221855|NCT01742286|3867006|FG006|Escalation Phase|Adverse Event|0
2221856|NCT01742286|3867000|FG000|Escalation Phase|Disease progression|3
2221857|NCT01742286|3867001|FG001|Escalation Phase|Disease progression|7
2221858|NCT01742286|3867002|FG002|Escalation Phase|Disease progression|4
2221859|NCT01742286|3867003|FG003|Escalation Phase|Disease progression|1
2221860|NCT01742286|3867004|FG004|Escalation Phase|Disease progression|4
2221861|NCT01742286|3867005|FG005|Escalation Phase|Disease progression|3
2221862|NCT01742286|3867006|FG006|Escalation Phase|Disease progression|2
2221863|NCT01742286|3867000|FG000|Escalation Phase|Death|0
2221864|NCT01742286|3867001|FG001|Escalation Phase|Death|0
2221865|NCT01742286|3867002|FG002|Escalation Phase|Death|0
2221866|NCT01742286|3867003|FG003|Escalation Phase|Death|0
2221867|NCT01742286|3867004|FG004|Escalation Phase|Death|0
2221868|NCT01742286|3867005|FG005|Escalation Phase|Death|1
2221869|NCT01742286|3867006|FG006|Escalation Phase|Death|0
2221870|NCT01742286|3867000|FG000|Escalation Phase|Physician Decision|0
2221871|NCT01742286|3867001|FG001|Escalation Phase|Physician Decision|3
2221872|NCT01742286|3867002|FG002|Escalation Phase|Physician Decision|0
2221873|NCT01742286|3867003|FG003|Escalation Phase|Physician Decision|1
2221874|NCT01742286|3867004|FG004|Escalation Phase|Physician Decision|0
2221875|NCT01742286|3867005|FG005|Escalation Phase|Physician Decision|0
2221876|NCT01742286|3867006|FG006|Escalation Phase|Physician Decision|2
2221877|NCT01742286|3867000|FG000|Escalation Phase|Subject/guardian decision|1
2221878|NCT01742286|3867001|FG001|Escalation Phase|Subject/guardian decision|0
2221879|NCT01742286|3867002|FG002|Escalation Phase|Subject/guardian decision|0
2221880|NCT01742286|3867003|FG003|Escalation Phase|Subject/guardian decision|0
2221881|NCT01742286|3867004|FG004|Escalation Phase|Subject/guardian decision|0
2221882|NCT01742286|3867005|FG005|Escalation Phase|Subject/guardian decision|0
2186887|NCT01458132|3816459|FG000|Overall Study|Other|15
2186888|NCT01458132|3816460|FG001|Overall Study|Other|3
2186889|NCT01458171|3816466|FG000|Overall Study|Adverse Event|1
2186890|NCT01458210|3816472|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
2186891|NCT01458210|3816472|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
2186892|NCT01458210|3816472|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
2186893|NCT01458210|3816472|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
2186894|NCT01458249|3816481|FG000|Overall Study|Not treated|1
2186895|NCT01458249|3816481|FG000|Overall Study|Adverse Event|4
2186896|NCT01458249|3816481|FG000|Overall Study|Other|2
2186897|NCT01458249|3816481|FG000|Overall Study|Ongoing|1
2221883|NCT01742286|3867006|FG006|Escalation Phase|Subject/guardian decision|0
2221884|NCT01742286|3867000|FG000|Expansion Phase|Administrative problems|0
2221885|NCT01742286|3867001|FG001|Expansion Phase|Administrative problems|0
2221886|NCT01742286|3867002|FG002|Expansion Phase|Administrative problems|0
2221887|NCT01742286|3867003|FG003|Expansion Phase|Administrative problems|0
2221888|NCT01742286|3867004|FG004|Expansion Phase|Administrative problems|0
2221889|NCT01742286|3867005|FG005|Expansion Phase|Administrative problems|0
2221890|NCT01742286|3867006|FG006|Expansion Phase|Administrative problems|5
2221891|NCT01742286|3867000|FG000|Expansion Phase|Physician Decision|0
2221892|NCT01742286|3867001|FG001|Expansion Phase|Physician Decision|0
2221893|NCT01742286|3867002|FG002|Expansion Phase|Physician Decision|4
2221894|NCT01742286|3867003|FG003|Expansion Phase|Physician Decision|0
2221895|NCT01742286|3867004|FG004|Expansion Phase|Physician Decision|0
2221896|NCT01742286|3867005|FG005|Expansion Phase|Physician Decision|0
2221897|NCT01742286|3867006|FG006|Expansion Phase|Physician Decision|9
2221898|NCT01742286|3867000|FG000|Expansion Phase|Adverse Event|0
2221899|NCT01742286|3867001|FG001|Expansion Phase|Adverse Event|0
2221900|NCT01742286|3867002|FG002|Expansion Phase|Adverse Event|0
2221901|NCT01742286|3867003|FG003|Expansion Phase|Adverse Event|0
2221902|NCT01742286|3867004|FG004|Expansion Phase|Adverse Event|0
2221903|NCT01742286|3867005|FG005|Expansion Phase|Adverse Event|0
2221904|NCT01742286|3867006|FG006|Expansion Phase|Adverse Event|6
2221905|NCT01742286|3867000|FG000|Expansion Phase|Disease progression|0
2221906|NCT01742286|3867001|FG001|Expansion Phase|Disease progression|0
2221907|NCT01742286|3867002|FG002|Expansion Phase|Disease progression|3
2221908|NCT01742286|3867003|FG003|Expansion Phase|Disease progression|0
2221909|NCT01742286|3867004|FG004|Expansion Phase|Disease progression|0
2221910|NCT01742286|3867005|FG005|Expansion Phase|Disease progression|0
2221911|NCT01742286|3867006|FG006|Expansion Phase|Disease progression|15
2221912|NCT01742286|3867000|FG000|Expansion Phase|Withdrawal by Subject|0
2221913|NCT01742286|3867001|FG001|Expansion Phase|Withdrawal by Subject|0
2221914|NCT01742286|3867002|FG002|Expansion Phase|Withdrawal by Subject|0
2221915|NCT01742286|3867003|FG003|Expansion Phase|Withdrawal by Subject|0
2221916|NCT01742286|3867004|FG004|Expansion Phase|Withdrawal by Subject|0
2221917|NCT01742286|3867005|FG005|Expansion Phase|Withdrawal by Subject|0
2221918|NCT01742286|3867006|FG006|Expansion Phase|Withdrawal by Subject|1
2221919|NCT01742897|3867056|FG000|Overall Study|Adverse Event|3
2221920|NCT01742897|3867056|FG000|Overall Study|Withdrawal by Subject|1
2221921|NCT01742897|3867056|FG000|Overall Study|Other|1
2221922|NCT01743001|3867081|FG000|Overall Study|Physician Decision|1
2221923|NCT01743001|3867082|FG001|Overall Study|Physician Decision|0
2221924|NCT01743001|3867081|FG000|Overall Study|Pregnancy|1
2221925|NCT01743001|3867082|FG001|Overall Study|Pregnancy|0
2221926|NCT01743001|3867081|FG000|Overall Study|Death|1
2221927|NCT01743001|3867082|FG001|Overall Study|Death|0
2221928|NCT01743027|3867092|FG000|Overall Study|Adverse Event|2
2221929|NCT01743027|3867093|FG001|Overall Study|Adverse Event|0
2221930|NCT01743027|3867094|FG002|Overall Study|Adverse Event|0
2221931|NCT01743027|3867095|FG003|Overall Study|Adverse Event|0
2221932|NCT01743027|3867092|FG000|Overall Study|Lost to Follow-up|0
2221933|NCT01743027|3867093|FG001|Overall Study|Lost to Follow-up|0
2221934|NCT01743027|3867094|FG002|Overall Study|Lost to Follow-up|2
2221935|NCT01743027|3867095|FG003|Overall Study|Lost to Follow-up|0
2221936|NCT01743027|3867092|FG000|Overall Study|Progressive Disease|1
2221937|NCT01743027|3867093|FG001|Overall Study|Progressive Disease|4
2221938|NCT01743027|3867094|FG002|Overall Study|Progressive Disease|3
2221939|NCT01743027|3867095|FG003|Overall Study|Progressive Disease|0
2221940|NCT01743027|3867092|FG000|Overall Study|Protocol Violation|1
2221941|NCT01743027|3867093|FG001|Overall Study|Protocol Violation|1
2221942|NCT01743027|3867094|FG002|Overall Study|Protocol Violation|1
2221943|NCT01743027|3867095|FG003|Overall Study|Protocol Violation|0
2221944|NCT01743027|3867092|FG000|Overall Study|Withdrawal by Subject|1
2221945|NCT01743027|3867093|FG001|Overall Study|Withdrawal by Subject|0
2221946|NCT01743027|3867094|FG002|Overall Study|Withdrawal by Subject|3
2221947|NCT01743027|3867095|FG003|Overall Study|Withdrawal by Subject|1
2221948|NCT01743040|3867105|FG000|Overall Study|Death|1
2221949|NCT01743040|3867105|FG000|Overall Study|Lost to Follow-up|66
2221950|NCT01743040|3867105|FG000|Overall Study|Physician Decision|40
2221951|NCT01743040|3867105|FG000|Overall Study|Protocol Violation|1
2221952|NCT01743040|3867105|FG000|Overall Study|Withdrawal by Subject|121
2221953|NCT01743092|3867111|FG000|Overall Study|Lost to Follow-up|14
2221954|NCT01743092|3867112|FG001|Overall Study|Lost to Follow-up|15
2274069|NCT02292771|3954886|FG000|Overall Study|Lost to Follow-up|2
2274070|NCT02292771|3954887|FG001|Overall Study|Lost to Follow-up|1
2186898|NCT01458275|3816489|FG000|Overall Study|Adverse Event|3
2186899|NCT01458275|3816490|FG001|Overall Study|Adverse Event|4
2186900|NCT01458275|3816491|FG002|Overall Study|Adverse Event|1
2186901|NCT01458275|3816489|FG000|Overall Study|Lost to Follow-up|3
2186902|NCT01458275|3816490|FG001|Overall Study|Lost to Follow-up|2
2186903|NCT01458275|3816491|FG002|Overall Study|Lost to Follow-up|5
2186904|NCT01458275|3816489|FG000|Overall Study|Protocol Violation|5
2186905|NCT01458275|3816490|FG001|Overall Study|Protocol Violation|5
2186906|NCT01458275|3816491|FG002|Overall Study|Protocol Violation|2
2186907|NCT01458275|3816489|FG000|Overall Study|Withdrawal by Subject|3
2186908|NCT01458275|3816490|FG001|Overall Study|Withdrawal by Subject|2
2186909|NCT01458275|3816491|FG002|Overall Study|Withdrawal by Subject|1
2186910|NCT01458366|3816516|FG000|Period 1: 70mg/m^2|Physician Decision|2
2186911|NCT01458366|3816517|FG001|Period 1: 70mg/m^2|Physician Decision|0
2186912|NCT01458366|3816518|FG002|Period 1: 70mg/m^2|Physician Decision|0
2186913|NCT01458366|3816519|FG003|Period 1: 70mg/m^2|Physician Decision|0
2186914|NCT01458366|3816520|FG004|Period 1: 70mg/m^2|Physician Decision|0
2186915|NCT01458366|3816516|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2186916|NCT01458366|3816517|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2186917|NCT01458366|3816518|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2186918|NCT01458366|3816519|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2186919|NCT01458366|3816520|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
2186920|NCT01458392|3816531|FG000|Overall Study|Death|2
2186921|NCT01458392|3816532|FG001|Overall Study|Death|11
2186922|NCT01458392|3816533|FG002|Overall Study|Death|22
2186923|NCT01458392|3816531|FG000|Overall Study|At the discretion of the sponsor|0
2186924|NCT01458392|3816532|FG001|Overall Study|At the discretion of the sponsor|2
2186925|NCT01458392|3816533|FG002|Overall Study|At the discretion of the sponsor|7
2186926|NCT01458392|3816531|FG000|Overall Study|Patient unwilling to comply with protoco|0
2186927|NCT01458392|3816532|FG001|Overall Study|Patient unwilling to comply with protoco|0
2186928|NCT01458392|3816533|FG002|Overall Study|Patient unwilling to comply with protoco|2
2186929|NCT01458522|3816564|FG000|Overall Study|Withdrawal by Subject|2
2186930|NCT01458522|3816565|FG001|Overall Study|Withdrawal by Subject|2
2186931|NCT01458522|3816564|FG000|Overall Study|Physician Decision|1
2186932|NCT01458522|3816565|FG001|Overall Study|Physician Decision|9
2186933|NCT01458535|3816583|FG000|Overall Study|Other|0
2186934|NCT01458535|3816584|FG001|Overall Study|Other|0
2186935|NCT01458535|3816585|FG002|Overall Study|Other|0
2186936|NCT01458535|3816586|FG003|Overall Study|Other|0
2186937|NCT01458535|3816587|FG004|Overall Study|Other|1
2186938|NCT01458535|3816588|FG005|Overall Study|Other|1
2186939|NCT01458535|3816583|FG000|Overall Study|Withdrawal by Subject|0
2186940|NCT01458535|3816584|FG001|Overall Study|Withdrawal by Subject|0
2186941|NCT01458535|3816585|FG002|Overall Study|Withdrawal by Subject|2
2186942|NCT01458535|3816586|FG003|Overall Study|Withdrawal by Subject|0
2186943|NCT01458535|3816587|FG004|Overall Study|Withdrawal by Subject|1
2186944|NCT01458535|3816588|FG005|Overall Study|Withdrawal by Subject|1
2186945|NCT01458535|3816583|FG000|Overall Study|Lost to Follow-up|0
2186946|NCT01458535|3816584|FG001|Overall Study|Lost to Follow-up|2
2186947|NCT01458535|3816585|FG002|Overall Study|Lost to Follow-up|0
2186948|NCT01458535|3816586|FG003|Overall Study|Lost to Follow-up|3
2186949|NCT01458535|3816587|FG004|Overall Study|Lost to Follow-up|2
2186950|NCT01458535|3816588|FG005|Overall Study|Lost to Follow-up|2
2186951|NCT01458535|3816583|FG000|Overall Study|Adverse Event|0
2186952|NCT01458535|3816584|FG001|Overall Study|Adverse Event|0
2186953|NCT01458535|3816585|FG002|Overall Study|Adverse Event|0
2186954|NCT01458535|3816586|FG003|Overall Study|Adverse Event|1
2186955|NCT01458535|3816587|FG004|Overall Study|Adverse Event|0
2186956|NCT01458535|3816588|FG005|Overall Study|Adverse Event|0
2186957|NCT01458574|3816644|FG000|Overall Study|Adverse Event|5
2186958|NCT01458574|3816645|FG001|Overall Study|Adverse Event|9
2186959|NCT01458574|3816646|FG002|Overall Study|Adverse Event|7
2186960|NCT01458574|3816644|FG000|Overall Study|Lack of Efficacy|70
2186961|NCT01458574|3816645|FG001|Overall Study|Lack of Efficacy|53
2186962|NCT01458574|3816646|FG002|Overall Study|Lack of Efficacy|132
2186963|NCT01458574|3816644|FG000|Overall Study|Lost to Follow-up|3
2186964|NCT01458574|3816645|FG001|Overall Study|Lost to Follow-up|2
2186965|NCT01458574|3816646|FG002|Overall Study|Lost to Follow-up|1
2186966|NCT01458574|3816644|FG000|Overall Study|Pregnancy|1
2221955|NCT01743469|3867139|FG000|Active Treatment Phase|Adverse Event|10
2186967|NCT01458574|3816645|FG001|Overall Study|Pregnancy|1
2186968|NCT01458574|3816646|FG002|Overall Study|Pregnancy|0
2186969|NCT01458574|3816644|FG000|Overall Study|Protocol Violation|0
2186970|NCT01458574|3816645|FG001|Overall Study|Protocol Violation|1
2186971|NCT01458574|3816646|FG002|Overall Study|Protocol Violation|0
2186972|NCT01458574|3816644|FG000|Overall Study|Withdrawal by Subject|6
2186973|NCT01458574|3816645|FG001|Overall Study|Withdrawal by Subject|3
2186974|NCT01458574|3816646|FG002|Overall Study|Withdrawal by Subject|5
2186975|NCT01458574|3816644|FG000|Overall Study|Other|2
2186976|NCT01458574|3816645|FG001|Overall Study|Other|1
2186977|NCT01458574|3816646|FG002|Overall Study|Other|0
2186978|NCT01458574|3816644|FG000|Overall Study|Randomized but not treated|0
2186979|NCT01458574|3816645|FG001|Overall Study|Randomized but not treated|1
2221956|NCT01743469|3867140|FG001|Active Treatment Phase|Adverse Event|5
2186980|NCT01458574|3816646|FG002|Overall Study|Randomized but not treated|0
2186981|NCT01458587|3816656|FG000|Overall Study|Withdrawal by Subject|1
2186982|NCT01458587|3816657|FG001|Overall Study|Withdrawal by Subject|0
2186983|NCT01458639|3816665|FG000|Overall Study|Physician Decision|4
2186984|NCT01458639|3816665|FG000|Overall Study|Equipment issue|1
2186985|NCT01458639|3816665|FG000|Overall Study|Inability to obtain subject blood sample|1
2221957|NCT01743469|3867141|FG002|Active Treatment Phase|Adverse Event|8
2221958|NCT01743469|3867142|FG003|Active Treatment Phase|Adverse Event|1
2221959|NCT01743469|3867139|FG000|Active Treatment Phase|Disease Progression|40
2221960|NCT01743469|3867140|FG001|Active Treatment Phase|Disease Progression|47
2221961|NCT01743469|3867141|FG002|Active Treatment Phase|Disease Progression|30
2221962|NCT01743469|3867142|FG003|Active Treatment Phase|Disease Progression|20
2221963|NCT01743469|3867139|FG000|Active Treatment Phase|Withdrawal by Subject|2
2221964|NCT01743469|3867140|FG001|Active Treatment Phase|Withdrawal by Subject|3
2221965|NCT01743469|3867141|FG002|Active Treatment Phase|Withdrawal by Subject|0
2221966|NCT01743469|3867142|FG003|Active Treatment Phase|Withdrawal by Subject|0
2221967|NCT01743469|3867139|FG000|Active Treatment Phase|Missing|1
2221968|NCT01743469|3867140|FG001|Active Treatment Phase|Missing|0
2221969|NCT01743469|3867141|FG002|Active Treatment Phase|Missing|0
2221970|NCT01743469|3867142|FG003|Active Treatment Phase|Missing|0
2221971|NCT01743469|3867139|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
2221972|NCT01743469|3867140|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
2221973|NCT01743469|3867141|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
2221974|NCT01743469|3867142|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
2221975|NCT01743469|3867139|FG000|Follow-up Period - Post-Treatment|Death|43
2221976|NCT01743469|3867140|FG001|Follow-up Period - Post-Treatment|Death|47
2221977|NCT01743469|3867141|FG002|Follow-up Period - Post-Treatment|Death|22
2221978|NCT01743469|3867142|FG003|Follow-up Period - Post-Treatment|Death|16
2221979|NCT01743469|3867139|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1
2221980|NCT01743469|3867140|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1
2221981|NCT01743469|3867141|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0
2221982|NCT01743469|3867142|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0
2221983|NCT01743560|3867167|FG000|Overall Study|Disease progression|26
2221984|NCT01743560|3867167|FG000|Overall Study|Adverse Event|8
2221985|NCT01743560|3867167|FG000|Overall Study|Death|3
2221986|NCT01743560|3867167|FG000|Overall Study|Withdrawal by Subject|2
2221987|NCT01743560|3867167|FG000|Overall Study|Protocol Violation|1
2221988|NCT01743560|3867167|FG000|Overall Study|>1 dose of study drug|3
2221989|NCT01743989|3867229|FG000|Treatment Phase|Unstable MR4.0|0
2221990|NCT01743989|3867230|FG001|Treatment Phase|Unstable MR4.0|6
2221991|NCT01743989|3867231|FG002|Treatment Phase|Unstable MR4.0|263
2221992|NCT01743989|3867229|FG000|Treatment Phase|Adverse Event|0
2221993|NCT01743989|3867230|FG001|Treatment Phase|Adverse Event|4
2221994|NCT01743989|3867231|FG002|Treatment Phase|Adverse Event|67
2221995|NCT01743989|3867229|FG000|Treatment Phase|Withdrawal by Subject|1
2221996|NCT01743989|3867230|FG001|Treatment Phase|Withdrawal by Subject|3
2221997|NCT01743989|3867231|FG002|Treatment Phase|Withdrawal by Subject|28
2221998|NCT01743989|3867229|FG000|Treatment Phase|Death|0
2221999|NCT01743989|3867230|FG001|Treatment Phase|Death|1
2222000|NCT01743989|3867231|FG002|Treatment Phase|Death|3
2222001|NCT01743989|3867229|FG000|Treatment Phase|Abnormal laboratory value(s)|0
2222002|NCT01743989|3867230|FG001|Treatment Phase|Abnormal laboratory value(s)|0
2222003|NCT01743989|3867231|FG002|Treatment Phase|Abnormal laboratory value(s)|3
2222004|NCT01743989|3867229|FG000|Treatment Phase|Protocol deviation|0
2222005|NCT01743989|3867230|FG001|Treatment Phase|Protocol deviation|0
2222006|NCT01743989|3867231|FG002|Treatment Phase|Protocol deviation|3
2222007|NCT01743989|3867229|FG000|Treatment Phase|Pregnancy|0
2222008|NCT01743989|3867230|FG001|Treatment Phase|Pregnancy|0
2222009|NCT01743989|3867231|FG002|Treatment Phase|Pregnancy|2
2332160|NCT03188055|4055454|FG005|Overall Study|Unavailable for training|
2332161|NCT03188055|4055449|FG000|Overall Study|Lost to Follow-up|0
2332162|NCT03188055|4055450|FG001|Overall Study|Lost to Follow-up|18
2332163|NCT03188055|4055451|FG002|Overall Study|Lost to Follow-up|0
2332164|NCT03188055|4055452|FG003|Overall Study|Lost to Follow-up|11
2332165|NCT03188055|4055453|FG004|Overall Study|Lost to Follow-up|0
2332166|NCT03188055|4055454|FG005|Overall Study|Lost to Follow-up|
2332167|NCT03188055|4055449|FG000|Overall Study|Withdrawal by Subject|0
2332168|NCT03188055|4055450|FG001|Overall Study|Withdrawal by Subject|1
2186986|NCT01458951|3816672|FG000|Overall Study|Other|1
2186987|NCT01458951|3816673|FG001|Overall Study|Other|0
2186988|NCT01458951|3816674|FG002|Overall Study|Other|0
2186989|NCT01458951|3816672|FG000|Overall Study|Protocol Violation|5
2186990|NCT01458951|3816673|FG001|Overall Study|Protocol Violation|1
2186991|NCT01458951|3816674|FG002|Overall Study|Protocol Violation|0
2186992|NCT01458951|3816672|FG000|Overall Study|Withdrawal by Subject|2
2186993|NCT01458951|3816673|FG001|Overall Study|Withdrawal by Subject|0
2186994|NCT01458951|3816674|FG002|Overall Study|Withdrawal by Subject|2
2186995|NCT01458951|3816672|FG000|Overall Study|Adverse Event|7
2186996|NCT01458951|3816673|FG001|Overall Study|Adverse Event|0
2186997|NCT01458951|3816674|FG002|Overall Study|Adverse Event|2
2186998|NCT01458951|3816672|FG000|Overall Study|Insufficient Clinical Response|17
2186999|NCT01458951|3816673|FG001|Overall Study|Insufficient Clinical Response|0
2187000|NCT01458951|3816674|FG002|Overall Study|Insufficient Clinical Response|11
2187001|NCT01459016|3816692|FG000|Overall Study|Withdrawal by Subject|11
2187002|NCT01459016|3816692|FG000|Overall Study|Amendment Discontinuation Criteria|4
2187003|NCT01459068|3816698|FG000|Overall Study|Withdrawal by Subject|8
2187004|NCT01459068|3816699|FG001|Overall Study|Withdrawal by Subject|18
2187005|NCT01459068|3816698|FG000|Overall Study|Lost to Follow-up|31
2187006|NCT01459068|3816699|FG001|Overall Study|Lost to Follow-up|15
2187007|NCT01459068|3816698|FG000|Overall Study|Death|0
2187008|NCT01459068|3816699|FG001|Overall Study|Death|1
2187009|NCT01459614|3816724|FG000|Overall Study|Adverse Event|1
2187010|NCT01459614|3816725|FG001|Overall Study|Adverse Event|0
2187011|NCT01459718|3816815|FG000|Overall Study|Physician Decision|1
2187012|NCT01459718|3816815|FG000|Overall Study|Lost to Follow-up|1
2187013|NCT01459718|3816815|FG000|Overall Study|Adverse Event|1
2187014|NCT01459783|3816821|FG000|Baseline to 6 Months|Death|1
2187015|NCT01459783|3816822|FG001|Baseline to 6 Months|Death|0
2187016|NCT01459783|3816821|FG000|Baseline to 6 Months|Withdrawal by Subject|12
2187017|NCT01459783|3816822|FG001|Baseline to 6 Months|Withdrawal by Subject|6
2187018|NCT01459783|3816821|FG000|Baseline to 6 Months|Lost to Follow-up|19
2187019|NCT01459783|3816822|FG001|Baseline to 6 Months|Lost to Follow-up|14
2187020|NCT01459783|3816821|FG000|6 Months to 12 Months|Death|0
2187021|NCT01459783|3816822|FG001|6 Months to 12 Months|Death|1
2187022|NCT01459783|3816821|FG000|6 Months to 12 Months|Withdrawal by Subject|6
2187023|NCT01459783|3816822|FG001|6 Months to 12 Months|Withdrawal by Subject|5
2187024|NCT01459783|3816821|FG000|6 Months to 12 Months|Lost to Follow-up|2
2187025|NCT01459783|3816822|FG001|6 Months to 12 Months|Lost to Follow-up|7
2187026|NCT01459783|3816821|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11
2187027|NCT01459783|3816822|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17
2187028|NCT01459796|3816830|FG000|Overall Study|Non compliance with protocol|2
2187029|NCT01459796|3816831|FG001|Overall Study|Non compliance with protocol|4
2187030|NCT01459796|3816830|FG000|Overall Study|Adverse Event|5
2187031|NCT01459796|3816831|FG001|Overall Study|Adverse Event|5
2187032|NCT01459796|3816830|FG000|Overall Study|Withdrawal by Subject|6
2187033|NCT01459796|3816831|FG001|Overall Study|Withdrawal by Subject|3
2187034|NCT01459796|3816830|FG000|Overall Study|Lost to Follow-up|5
2187035|NCT01459796|3816831|FG001|Overall Study|Lost to Follow-up|4
2187036|NCT01459796|3816830|FG000|Overall Study|Reason unspecified|1
2187037|NCT01459796|3816831|FG001|Overall Study|Reason unspecified|2
2187038|NCT01459796|3816830|FG000|Overall Study|Decision by the sponsor|75
2187039|NCT01459796|3816831|FG001|Overall Study|Decision by the sponsor|108
2187040|NCT01459913|3816841|FG000|Overall Study|Adverse Event|0
2187041|NCT01459913|3816842|FG001|Overall Study|Adverse Event|0
2187042|NCT01459913|3816843|FG002|Overall Study|Adverse Event|0
2187043|NCT01459913|3816844|FG003|Overall Study|Adverse Event|3
2187044|NCT01459913|3816841|FG000|Overall Study|Withdrawal by Subject|4
2187045|NCT01459913|3816842|FG001|Overall Study|Withdrawal by Subject|0
2187046|NCT01459913|3816843|FG002|Overall Study|Withdrawal by Subject|0
2187047|NCT01459913|3816844|FG003|Overall Study|Withdrawal by Subject|5
2187048|NCT01459913|3816841|FG000|Overall Study|Lost to Follow-up|7
2187049|NCT01459913|3816842|FG001|Overall Study|Lost to Follow-up|4
2187050|NCT01459913|3816843|FG002|Overall Study|Lost to Follow-up|1
2187051|NCT01459913|3816844|FG003|Overall Study|Lost to Follow-up|8
2187052|NCT01459913|3816841|FG000|Overall Study|Death|0
2187053|NCT01459913|3816842|FG001|Overall Study|Death|0
2187054|NCT01459913|3816843|FG002|Overall Study|Death|0
2187055|NCT01459913|3816844|FG003|Overall Study|Death|1
2187056|NCT01459913|3816841|FG000|Overall Study|Non- Compliance|0
2187057|NCT01459913|3816842|FG001|Overall Study|Non- Compliance|0
2187058|NCT01459913|3816843|FG002|Overall Study|Non- Compliance|0
2187059|NCT01459913|3816844|FG003|Overall Study|Non- Compliance|3
2187060|NCT01459913|3816841|FG000|Overall Study|Physician Decision|0
2187061|NCT01459913|3816842|FG001|Overall Study|Physician Decision|1
2187062|NCT01459913|3816843|FG002|Overall Study|Physician Decision|0
2187063|NCT01459913|3816844|FG003|Overall Study|Physician Decision|0
2187064|NCT01459913|3816841|FG000|Overall Study|Study Terminated by Sponsor|30
2187065|NCT01459913|3816842|FG001|Overall Study|Study Terminated by Sponsor|15
2187066|NCT01459913|3816843|FG002|Overall Study|Study Terminated by Sponsor|9
2187067|NCT01459913|3816844|FG003|Overall Study|Study Terminated by Sponsor|11
2187068|NCT01459913|3816841|FG000|Overall Study|Other|0
2187069|NCT01459913|3816842|FG001|Overall Study|Other|0
2187070|NCT01459913|3816843|FG002|Overall Study|Other|3
2187071|NCT01459913|3816844|FG003|Overall Study|Other|1
2187072|NCT01459913|3816841|FG000|Overall Study|Did Not Meet Inclusion Criteria|0
2187073|NCT01459913|3816842|FG001|Overall Study|Did Not Meet Inclusion Criteria|0
2187074|NCT01459913|3816843|FG002|Overall Study|Did Not Meet Inclusion Criteria|0
2187075|NCT01459913|3816844|FG003|Overall Study|Did Not Meet Inclusion Criteria|1
2187076|NCT01460290|3816861|FG000|Overall Study|Adverse Event|3
2187077|NCT01460290|3816861|FG000|Overall Study|Elevated liver function|1
2187078|NCT01460342|3816877|FG000|Overall Study|Adverse Event|5
2187079|NCT01460342|3816878|FG001|Overall Study|Adverse Event|4
2187080|NCT01460342|3816877|FG000|Overall Study|Lost to Follow-up|1
2187081|NCT01460342|3816878|FG001|Overall Study|Lost to Follow-up|2
2187082|NCT01460342|3816877|FG000|Overall Study|Protocol Violation|0
2187083|NCT01460342|3816878|FG001|Overall Study|Protocol Violation|1
2187084|NCT01460342|3816877|FG000|Overall Study|Withdrawal by Subject|3
2187085|NCT01460342|3816878|FG001|Overall Study|Withdrawal by Subject|4
2187086|NCT01460342|3816877|FG000|Overall Study|Physician Decision|1
2187087|NCT01460342|3816878|FG001|Overall Study|Physician Decision|3
2187088|NCT01460342|3816877|FG000|Overall Study|Lack of Efficacy|1
2187089|NCT01460342|3816878|FG001|Overall Study|Lack of Efficacy|0
2187090|NCT01460368|3816886|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2187091|NCT01460368|3816887|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2187092|NCT01460368|3816888|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2187093|NCT01460368|3816889|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2187094|NCT01460368|3816890|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1
2187095|NCT01460368|3816891|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2187096|NCT01460368|3816892|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2187097|NCT01460368|3816886|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2187098|NCT01460368|3816887|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
2187099|NCT01460368|3816888|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2187100|NCT01460368|3816889|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2187101|NCT01460368|3816890|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2187102|NCT01460368|3816891|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2187103|NCT01460368|3816892|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
2187104|NCT01460368|3816886|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2187105|NCT01460368|3816887|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
2187106|NCT01460368|3816888|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2187107|NCT01460368|3816889|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2187108|NCT01460368|3816890|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2187109|NCT01460368|3816891|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2187110|NCT01460368|3816892|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2187111|NCT01460368|3816886|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0
2187112|NCT01460368|3816887|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0
2187113|NCT01460368|3816888|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1
2187114|NCT01460368|3816889|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0
2187115|NCT01460368|3816890|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0
2187116|NCT01460368|3816891|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0
2187117|NCT01460368|3816892|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0
2187118|NCT01460368|3816886|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2187119|NCT01460368|3816887|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2187120|NCT01460368|3816888|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
2187121|NCT01460368|3816889|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
2187122|NCT01460368|3816890|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2187123|NCT01460368|3816891|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
2187124|NCT01460368|3816892|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2187125|NCT01460381|3816903|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1
2187126|NCT01460381|3816904|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0
2187127|NCT01460407|3816912|FG000|Period 2: Day 6 to Day 14|Adverse Event|0
2187128|NCT01460407|3816913|FG001|Period 2: Day 6 to Day 14|Adverse Event|1
2187129|NCT01460446|3816922|FG000|Overall Study|Non-compliance|2
2187130|NCT01460446|3816923|FG001|Overall Study|Non-compliance|9
2187131|NCT01460446|3816922|FG000|Overall Study|Consent Withdrawn|0
2187132|NCT01460446|3816923|FG001|Overall Study|Consent Withdrawn|4
2187133|NCT01460446|3816922|FG000|Overall Study|Non-compliance & Consent Withdrawn|1
2187134|NCT01460446|3816923|FG001|Overall Study|Non-compliance & Consent Withdrawn|3
2222010|NCT01743989|3867229|FG000|Treatment Phase|Lost to Follow-up|0
2222011|NCT01743989|3867230|FG001|Treatment Phase|Lost to Follow-up|0
2222012|NCT01743989|3867231|FG002|Treatment Phase|Lost to Follow-up|2
2222013|NCT01743989|3867229|FG000|Treatment Phase|Abnormal test procedure result(s)|0
2222014|NCT01743989|3867230|FG001|Treatment Phase|Abnormal test procedure result(s)|0
2222015|NCT01743989|3867231|FG002|Treatment Phase|Abnormal test procedure result(s)|1
2222016|NCT01743989|3867229|FG000|Treatment Phase|Administrative problems|0
2222017|NCT01743989|3867230|FG001|Treatment Phase|Administrative problems|0
2222018|NCT01743989|3867231|FG002|Treatment Phase|Administrative problems|1
2222019|NCT01743989|3867229|FG000|Treatment Phase|New cancer (CML) therapy|0
2222020|NCT01743989|3867230|FG001|Treatment Phase|New cancer (CML) therapy|1
2222021|NCT01743989|3867231|FG002|Treatment Phase|New cancer (CML) therapy|0
2222022|NCT01743989|3867229|FG000|Treatment Phase|Physician Decision|0
2222023|NCT01743989|3867230|FG001|Treatment Phase|Physician Decision|0
2222024|NCT01743989|3867231|FG002|Treatment Phase|Physician Decision|3
2222025|NCT01743989|3867229|FG000|Treatment Phase|Patient non-compliance to treatment|0
2222026|NCT01743989|3867230|FG001|Treatment Phase|Patient non-compliance to treatment|0
2222027|NCT01743989|3867231|FG002|Treatment Phase|Patient non-compliance to treatment|3
2222028|NCT01743989|3867229|FG000|Treatment Phase|Not randomized by mistake|0
2222029|NCT01743989|3867230|FG001|Treatment Phase|Not randomized by mistake|0
2222030|NCT01743989|3867231|FG002|Treatment Phase|Not randomized by mistake|1
2222031|NCT01743989|3867229|FG000|Treatment Phase|Included by mistake|0
2222032|NCT01743989|3867230|FG001|Treatment Phase|Included by mistake|0
2187135|NCT01460446|3816922|FG000|Overall Study|Surgery/Illness|1
2187136|NCT01460446|3816923|FG001|Overall Study|Surgery/Illness|1
2187137|NCT01460446|3816922|FG000|Overall Study|Pregnancy|1
2187138|NCT01460446|3816923|FG001|Overall Study|Pregnancy|0
2187139|NCT01460446|3816922|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
2187140|NCT01460446|3816923|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
2187141|NCT01460628|3816930|FG000|Overall Study|Adverse Event|3
2187142|NCT01460628|3816930|FG000|Overall Study|Withdrawal by Subject|2
2187143|NCT01460719|3816934|FG000|Overall Study|Adverse Event|1
2187144|NCT01460719|3816934|FG000|Overall Study|Withdrawal by Subject|1
2187145|NCT01460901|3816948|FG000|Overall Study|Withdrawal by Subject|2
2187146|NCT01461005|3816967|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1
2187147|NCT01461044|3816974|FG000|Overall Study|Death|58
2187148|NCT01461044|3816975|FG001|Overall Study|Death|35
2187149|NCT01461044|3816974|FG000|Overall Study|Lost to Follow-up|12
2187150|NCT01461044|3816975|FG001|Overall Study|Lost to Follow-up|5
2187151|NCT01461057|3816986|FG000|Overall Study|Death|10
2187152|NCT01461057|3816987|FG001|Overall Study|Death|9
2187153|NCT01461057|3816986|FG000|Overall Study|Withdrawal by Subject|2
2187154|NCT01461057|3816987|FG001|Overall Study|Withdrawal by Subject|3
2187155|NCT01461057|3816986|FG000|Overall Study|Physician Decision|0
2187156|NCT01461057|3816987|FG001|Overall Study|Physician Decision|2
2187157|NCT01461057|3816986|FG000|Overall Study|Adverse Event|0
2187158|NCT01461057|3816987|FG001|Overall Study|Adverse Event|1
2187159|NCT01461057|3816986|FG000|Overall Study|Progression of Disease|1
2187160|NCT01461057|3816987|FG001|Overall Study|Progression of Disease|0
2187161|NCT01461057|3816986|FG000|Overall Study|Study Terminated by Sponsor|2
2187162|NCT01461057|3816987|FG001|Overall Study|Study Terminated by Sponsor|0
2187163|NCT01461096|3816995|FG000|Overall Study|Death|3
2187164|NCT01461096|3816996|FG001|Overall Study|Death|6
2187165|NCT01461096|3816995|FG000|Overall Study|Severe debilitation, unable to continue|1
2187166|NCT01461096|3816996|FG001|Overall Study|Severe debilitation, unable to continue|1
2187167|NCT01461096|3816995|FG000|Overall Study|Subj not able to get to clinic|15
2187168|NCT01461096|3816996|FG001|Overall Study|Subj not able to get to clinic|13
2187169|NCT01461096|3816995|FG000|Overall Study|Site is closing|27
2187170|NCT01461096|3816996|FG001|Overall Study|Site is closing|30
2187171|NCT01461096|3816995|FG000|Overall Study|Withdrawal by Subject|5
2187172|NCT01461096|3816996|FG001|Overall Study|Withdrawal by Subject|3
2187173|NCT01461096|3816995|FG000|Overall Study|Subj not willing to adhere to reqs|3
2187174|NCT01461096|3816996|FG001|Overall Study|Subj not willing to adhere to reqs|4
2187175|NCT01461096|3816995|FG000|Overall Study|Lost to Follow-up|8
2187176|NCT01461096|3816996|FG001|Overall Study|Lost to Follow-up|4
2187177|NCT01461369|3817006|FG000|Overall Study|Lack of Efficacy|2
2187178|NCT01461369|3817007|FG001|Overall Study|Lack of Efficacy|0
2187179|NCT01461369|3817008|FG002|Overall Study|Lack of Efficacy|6
2187180|NCT01461369|3817006|FG000|Overall Study|Lost to Follow-up|0
2187181|NCT01461369|3817007|FG001|Overall Study|Lost to Follow-up|0
2187182|NCT01461369|3817008|FG002|Overall Study|Lost to Follow-up|3
2187183|NCT01461369|3817006|FG000|Overall Study|Adverse Event|9
2187184|NCT01461369|3817007|FG001|Overall Study|Adverse Event|12
2187185|NCT01461369|3817008|FG002|Overall Study|Adverse Event|4
2187186|NCT01461369|3817006|FG000|Overall Study|Protocol Violation|1
2187187|NCT01461369|3817007|FG001|Overall Study|Protocol Violation|2
2187188|NCT01461369|3817008|FG002|Overall Study|Protocol Violation|2
2187189|NCT01461369|3817006|FG000|Overall Study|Withdrawal by Subject|1
2187190|NCT01461369|3817007|FG001|Overall Study|Withdrawal by Subject|3
2187191|NCT01461369|3817008|FG002|Overall Study|Withdrawal by Subject|2
2187192|NCT01461538|3817039|FG000|Overall Study|Death|15
2187193|NCT01461538|3817040|FG001|Overall Study|Death|6
2187194|NCT01461538|3817041|FG002|Overall Study|Death|2
2187195|NCT01461538|3817039|FG000|Overall Study|Study Stopped by Sponsor|2
2187196|NCT01461538|3817040|FG001|Overall Study|Study Stopped by Sponsor|1
2187197|NCT01461538|3817041|FG002|Overall Study|Study Stopped by Sponsor|0
2187198|NCT01461538|3817039|FG000|Overall Study|Withdrawal by Subject|1
2187199|NCT01461538|3817040|FG001|Overall Study|Withdrawal by Subject|1
2187200|NCT01461538|3817041|FG002|Overall Study|Withdrawal by Subject|0
2187201|NCT01461551|3817054|FG000|Overall Study|Physician Decision|2
2187202|NCT01461551|3817055|FG001|Overall Study|Physician Decision|1
2187203|NCT01461551|3817056|FG002|Overall Study|Physician Decision|2
2187204|NCT01461707|3817080|FG000|Overall Study|Withdrawal by Subject|1
2187205|NCT01461707|3817081|FG001|Overall Study|Withdrawal by Subject|0
2187206|NCT01461811|3817098|FG000|Overall Study|Adverse Event|2
2187207|NCT01461811|3817099|FG001|Overall Study|Adverse Event|1
2187208|NCT01461811|3817098|FG000|Overall Study|Subject decision unrelated to an AE|1
2187209|NCT01461811|3817099|FG001|Overall Study|Subject decision unrelated to an AE|1
2187210|NCT01461811|3817098|FG000|Overall Study|Noncompliance|1
2187211|NCT01461811|3817099|FG001|Overall Study|Noncompliance|1
2187212|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Adverse Event|76
2187213|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Adverse Event|0
2187214|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Adverse Event|0
2187215|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Death|3
2187216|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Death|0
2187217|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Death|0
2187218|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Lost to Follow-up|5
2187219|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Lost to Follow-up|0
2187220|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Lost to Follow-up|0
2187221|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Physician Decision|9
2187222|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Physician Decision|0
2187223|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Physician Decision|0
2187224|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18
2187225|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0
2187226|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0
2187227|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Disease progression|45
2187228|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Disease progression|0
2187229|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Disease progression|0
2187230|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10
2187231|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0
2187232|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0
2187233|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
2187234|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
2187235|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
2187236|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Not responding to treatment|11
2187237|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Not responding to treatment|0
2187238|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Not responding to treatment|0
2187239|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1
2187240|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0
2187241|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0
2187242|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
2187243|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
2187244|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
2187245|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Sponsor decision|1
2187246|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Sponsor decision|0
2187247|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Sponsor decision|0
2187248|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Protocol deviation|2
2187249|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Protocol deviation|0
2187250|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Protocol deviation|0
2187251|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
2187252|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
2187253|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
2187254|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
2187255|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
2187256|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
2187257|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Promotor request|1
2187258|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Promotor request|0
2187259|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Promotor request|0
2187260|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
2187261|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
2187262|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
2187263|NCT01461928|3817129|FG000|Induction (up to 8 Months)|Medical advisor request|1
2187264|NCT01461928|3817130|FG001|Induction (up to 8 Months)|Medical advisor request|0
2187265|NCT01461928|3817131|FG002|Induction (up to 8 Months)|Medical advisor request|0
2187266|NCT01461928|3817129|FG000|Maintenance I (24 Months)|Death|3
2187267|NCT01461928|3817130|FG001|Maintenance I (24 Months)|Death|0
2187268|NCT01461928|3817131|FG002|Maintenance I (24 Months)|Death|0
2187269|NCT01461928|3817129|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32
2222033|NCT01743989|3867231|FG002|Treatment Phase|Included by mistake|1
2222034|NCT01743989|3867229|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82
2222035|NCT01743989|3867230|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59
2222036|NCT01743989|3867231|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0
2222037|NCT01743989|3867229|FG000|TFR Phase|Adverse Event|0
2222038|NCT01743989|3867230|FG001|TFR Phase|Adverse Event|1
2222039|NCT01743989|3867231|FG002|TFR Phase|Adverse Event|0
2222040|NCT01743989|3867229|FG000|TFR Phase|Lost to Follow-up|0
2222041|NCT01743989|3867230|FG001|TFR Phase|Lost to Follow-up|2
2222042|NCT01743989|3867231|FG002|TFR Phase|Lost to Follow-up|0
2222043|NCT01743989|3867229|FG000|TFR Phase|Physician Decision|0
2222044|NCT01743989|3867230|FG001|TFR Phase|Physician Decision|1
2222045|NCT01743989|3867231|FG002|TFR Phase|Physician Decision|0
2222046|NCT01743989|3867229|FG000|TFR Phase|Logistical problems|0
2222047|NCT01743989|3867230|FG001|TFR Phase|Logistical problems|2
2222048|NCT01743989|3867231|FG002|TFR Phase|Logistical problems|0
2222049|NCT01743989|3867229|FG000|TFR Phase|Protocol deviation|0
2222050|NCT01743989|3867230|FG001|TFR Phase|Protocol deviation|1
2222051|NCT01743989|3867231|FG002|TFR Phase|Protocol deviation|0
2222052|NCT01743989|3867229|FG000|TFR Phase|Withdrawal by Subject|0
2222053|NCT01743989|3867230|FG001|TFR Phase|Withdrawal by Subject|2
2222054|NCT01743989|3867231|FG002|TFR Phase|Withdrawal by Subject|0
2222055|NCT01743989|3867229|FG000|Re-treatment Phase|Adverse Event|8
2187270|NCT01461928|3817130|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0
2187271|NCT01461928|3817131|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0
2187272|NCT01461928|3817129|FG000|Maintenance I (24 Months)|Lost to Follow-up|2
2187273|NCT01461928|3817130|FG001|Maintenance I (24 Months)|Lost to Follow-up|0
2187274|NCT01461928|3817131|FG002|Maintenance I (24 Months)|Lost to Follow-up|0
2187275|NCT01461928|3817129|FG000|Maintenance I (24 Months)|Diseases progression|91
2187276|NCT01461928|3817130|FG001|Maintenance I (24 Months)|Diseases progression|0
2187277|NCT01461928|3817131|FG002|Maintenance I (24 Months)|Diseases progression|0
2187278|NCT01461928|3817129|FG000|Maintenance I (24 Months)|Adverse Event|70
2187279|NCT01461928|3817130|FG001|Maintenance I (24 Months)|Adverse Event|0
2187280|NCT01461928|3817131|FG002|Maintenance I (24 Months)|Adverse Event|0
2187281|NCT01461928|3817129|FG000|Maintenance I (24 Months)|Physician Decision|9
2187282|NCT01461928|3817130|FG001|Maintenance I (24 Months)|Physician Decision|0
2187283|NCT01461928|3817131|FG002|Maintenance I (24 Months)|Physician Decision|0
2187284|NCT01461928|3817129|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2
2187285|NCT01461928|3817130|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0
2187286|NCT01461928|3817131|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0
2187287|NCT01461928|3817129|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2
2187288|NCT01461928|3817130|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0
2187289|NCT01461928|3817131|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0
2187290|NCT01461928|3817129|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1
2187291|NCT01461928|3817130|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0
2187292|NCT01461928|3817131|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0
2187293|NCT01461928|3817129|FG000|Maintenance I (24 Months)|Not compliant|1
2187294|NCT01461928|3817130|FG001|Maintenance I (24 Months)|Not compliant|0
2187295|NCT01461928|3817131|FG002|Maintenance I (24 Months)|Not compliant|0
2187296|NCT01461928|3817129|FG000|Maintenance I (24 Months)|Did not meet criteria|5
2187297|NCT01461928|3817130|FG001|Maintenance I (24 Months)|Did not meet criteria|0
2187298|NCT01461928|3817131|FG002|Maintenance I (24 Months)|Did not meet criteria|0
2187299|NCT01461928|3817129|FG000|Maintenance II (15 Months)|Adverse Event|0
2187300|NCT01461928|3817130|FG001|Maintenance II (15 Months)|Adverse Event|2
2187301|NCT01461928|3817131|FG002|Maintenance II (15 Months)|Adverse Event|0
2187302|NCT01461928|3817129|FG000|Maintenance II (15 Months)|Death|0
2187303|NCT01461928|3817130|FG001|Maintenance II (15 Months)|Death|10
2187304|NCT01461928|3817131|FG002|Maintenance II (15 Months)|Death|8
2187305|NCT01461928|3817129|FG000|Maintenance II (15 Months)|Physician Decision|0
2187306|NCT01461928|3817130|FG001|Maintenance II (15 Months)|Physician Decision|0
2187307|NCT01461928|3817131|FG002|Maintenance II (15 Months)|Physician Decision|4
2187308|NCT01461928|3817129|FG000|Maintenance II (15 Months)|Lost to Follow-up|0
2187309|NCT01461928|3817130|FG001|Maintenance II (15 Months)|Lost to Follow-up|1
2187310|NCT01461928|3817131|FG002|Maintenance II (15 Months)|Lost to Follow-up|0
2187311|NCT01461928|3817129|FG000|Maintenance II (15 Months)|Moved to another town|0
2187312|NCT01461928|3817130|FG001|Maintenance II (15 Months)|Moved to another town|1
2187313|NCT01461928|3817131|FG002|Maintenance II (15 Months)|Moved to another town|0
2187314|NCT01461928|3817129|FG000|Maintenance II (15 Months)|Disease progression|0
2187315|NCT01461928|3817130|FG001|Maintenance II (15 Months)|Disease progression|0
2187316|NCT01461928|3817131|FG002|Maintenance II (15 Months)|Disease progression|3
2187317|NCT01461928|3817129|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0
2187318|NCT01461928|3817130|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9
2187319|NCT01461928|3817131|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8
2187320|NCT01461928|3817129|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0
2187321|NCT01461928|3817130|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0
2187322|NCT01461928|3817131|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1
2187323|NCT01461928|3817129|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0
2187324|NCT01461928|3817130|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0
2187325|NCT01461928|3817131|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1
2187326|NCT01461928|3817129|FG000|Maintenance II (15 Months)|Withdrew informed consent|0
2187327|NCT01461928|3817130|FG001|Maintenance II (15 Months)|Withdrew informed consent|0
2187328|NCT01461928|3817131|FG002|Maintenance II (15 Months)|Withdrew informed consent|1
2187329|NCT01461928|3817129|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0
2187330|NCT01461928|3817130|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0
2187331|NCT01461928|3817131|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1
2187332|NCT01461980|3817145|FG000|Overall Study|Other|9
2187333|NCT01461980|3817146|FG001|Overall Study|Other|8
2187334|NCT01461980|3817147|FG002|Overall Study|Other|6
2187335|NCT01461980|3817145|FG000|Overall Study|Medication error|7
2187336|NCT01461980|3817146|FG001|Overall Study|Medication error|5
2187337|NCT01461980|3817147|FG002|Overall Study|Medication error|6
2187338|NCT01461980|3817145|FG000|Overall Study|Adverse Event|12
2187339|NCT01461980|3817146|FG001|Overall Study|Adverse Event|5
2187340|NCT01461980|3817147|FG002|Overall Study|Adverse Event|6
2187341|NCT01461980|3817145|FG000|Overall Study|Protocol Violation|12
2187342|NCT01461980|3817146|FG001|Overall Study|Protocol Violation|19
2187343|NCT01461980|3817147|FG002|Overall Study|Protocol Violation|16
2187344|NCT01461980|3817145|FG000|Overall Study|No longer meets eligibility criteria|18
2187345|NCT01461980|3817146|FG001|Overall Study|No longer meets eligibility criteria|9
2187346|NCT01461980|3817147|FG002|Overall Study|No longer meets eligibility criteria|19
2187347|NCT01461980|3817145|FG000|Overall Study|Lost to Follow-up|52
2187348|NCT01461980|3817146|FG001|Overall Study|Lost to Follow-up|53
2187349|NCT01461980|3817147|FG002|Overall Study|Lost to Follow-up|51
2187350|NCT01461980|3817145|FG000|Overall Study|No longer willing to participate|52
2187351|NCT01461980|3817146|FG001|Overall Study|No longer willing to participate|38
2187352|NCT01461980|3817147|FG002|Overall Study|No longer willing to participate|54
2187353|NCT01461980|3817145|FG000|Overall Study|Randomized but not vaccinated|4
2187354|NCT01461980|3817146|FG001|Overall Study|Randomized but not vaccinated|8
2187355|NCT01461980|3817147|FG002|Overall Study|Randomized but not vaccinated|7
2187356|NCT01461993|3817159|FG000|Overall Study|Withdrawal by Subject|60
2187357|NCT01461993|3817160|FG001|Overall Study|Withdrawal by Subject|53
2187358|NCT01461993|3817161|FG002|Overall Study|Withdrawal by Subject|16
2187359|NCT01461993|3817159|FG000|Overall Study|Lost to Follow-up|44
2187360|NCT01461993|3817160|FG001|Overall Study|Lost to Follow-up|48
2187361|NCT01461993|3817161|FG002|Overall Study|Lost to Follow-up|22
2187362|NCT01461993|3817159|FG000|Overall Study|Protocol Violation|10
2187363|NCT01461993|3817160|FG001|Overall Study|Protocol Violation|9
2187364|NCT01461993|3817161|FG002|Overall Study|Protocol Violation|7
2187365|NCT01461993|3817159|FG000|Overall Study|Adverse Event|9
2187366|NCT01461993|3817160|FG001|Overall Study|Adverse Event|11
2187367|NCT01461993|3817161|FG002|Overall Study|Adverse Event|3
2187368|NCT01461993|3817159|FG000|Overall Study|No longer met eligibility criteria|13
2187369|NCT01461993|3817160|FG001|Overall Study|No longer met eligibility criteria|18
2187370|NCT01461993|3817161|FG002|Overall Study|No longer met eligibility criteria|10
2187371|NCT01461993|3817159|FG000|Overall Study|Did not meet entrance criteria|2
2187372|NCT01461993|3817160|FG001|Overall Study|Did not meet entrance criteria|3
2187373|NCT01461993|3817161|FG002|Overall Study|Did not meet entrance criteria|0
2187374|NCT01461993|3817159|FG000|Overall Study|Other|13
2187375|NCT01461993|3817160|FG001|Overall Study|Other|15
2187376|NCT01461993|3817161|FG002|Overall Study|Other|6
2187377|NCT01462045|3817173|FG000|Overall Study|Family matter|0
2187378|NCT01462045|3817174|FG001|Overall Study|Family matter|1
2187379|NCT01462045|3817175|FG002|Overall Study|Family matter|0
2187380|NCT01462084|3817183|FG000|Overall Study|Withdrawal by Subject|1
2187381|NCT01462084|3817184|FG001|Overall Study|Withdrawal by Subject|0
2187382|NCT01462084|3817183|FG000|Overall Study|Protocol Violation|1
2187383|NCT01462084|3817184|FG001|Overall Study|Protocol Violation|1
2187384|NCT01462110|3817193|FG000|Overall Study|Adverse Event|1
2187385|NCT01462110|3817194|FG001|Overall Study|Adverse Event|0
2187386|NCT01462162|3817200|FG000|Overall Study|Adverse Event|5
2187387|NCT01462162|3817200|FG000|Overall Study|Lack of Efficacy|4
2187388|NCT01462162|3817200|FG000|Overall Study|Abnormal laboratory parameters|1
2187389|NCT01462162|3817200|FG000|Overall Study|Other|2
2187390|NCT01462227|3817207|FG000|Second Assignment|Lost to Follow-up|1
2187391|NCT01462227|3817208|FG001|Second Assignment|Lost to Follow-up|0
2187392|NCT01462227|3817209|FG002|Second Assignment|Lost to Follow-up|0
2187393|NCT01462227|3817210|FG003|Second Assignment|Lost to Follow-up|0
2187394|NCT01462227|3817207|FG000|Second Assignment|Protocol Violation|0
2187395|NCT01462227|3817208|FG001|Second Assignment|Protocol Violation|1
2187396|NCT01462227|3817209|FG002|Second Assignment|Protocol Violation|1
2187397|NCT01462227|3817210|FG003|Second Assignment|Protocol Violation|0
2187398|NCT01462266|3817224|FG000|Overall Study|Adverse Event|7
2187399|NCT01462266|3817225|FG001|Overall Study|Adverse Event|6
2187400|NCT01462266|3817224|FG000|Overall Study|Death|2
2187401|NCT01462266|3817225|FG001|Overall Study|Death|1
2187402|NCT01462266|3817224|FG000|Overall Study|Lack of Efficacy|0
2187403|NCT01462266|3817225|FG001|Overall Study|Lack of Efficacy|2
2187404|NCT01462266|3817224|FG000|Overall Study|Lost to Follow-up|4
2187405|NCT01462266|3817225|FG001|Overall Study|Lost to Follow-up|3
2187406|NCT01462266|3817224|FG000|Overall Study|Non-compliance with study drug|3
2187407|NCT01462266|3817225|FG001|Overall Study|Non-compliance with study drug|0
2187408|NCT01462266|3817224|FG000|Overall Study|Creatinine and eGFR, excluded medication|8
2187409|NCT01462266|3817225|FG001|Overall Study|Creatinine and eGFR, excluded medication|4
2187410|NCT01462266|3817224|FG000|Overall Study|Physician Decision|2
2187411|NCT01462266|3817225|FG001|Overall Study|Physician Decision|5
2187412|NCT01462266|3817224|FG000|Overall Study|Protocol Violation|1
2187413|NCT01462266|3817225|FG001|Overall Study|Protocol Violation|3
2187414|NCT01462266|3817224|FG000|Overall Study|Withdrawal by Subject|7
2187415|NCT01462266|3817225|FG001|Overall Study|Withdrawal by Subject|2
2187416|NCT01462266|3817224|FG000|Overall Study|Screen failure|1
2187417|NCT01462266|3817225|FG001|Overall Study|Screen failure|1
2187418|NCT01462318|3817262|FG000|Main Study / TP-DI Study|Other|2
2187419|NCT01462318|3817263|FG001|Main Study / TP-DI Study|Other|0
2187420|NCT01462318|3817264|FG002|Main Study / TP-DI Study|Other|0
2187421|NCT01462318|3817262|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2
2187422|NCT01462318|3817263|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0
2187423|NCT01462318|3817264|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0
2187424|NCT01462318|3817262|FG000|Main Study / TP-DI Study|Adverse Event|4
2187425|NCT01462318|3817263|FG001|Main Study / TP-DI Study|Adverse Event|0
2187426|NCT01462318|3817264|FG002|Main Study / TP-DI Study|Adverse Event|0
2187427|NCT01462318|3817262|FG000|Extension Phase|Lost to Follow-up|0
2187428|NCT01462318|3817263|FG001|Extension Phase|Lost to Follow-up|0
2187429|NCT01462318|3817264|FG002|Extension Phase|Lost to Follow-up|1
2187430|NCT01462318|3817262|FG000|Extension Phase|Other|0
2187431|NCT01462318|3817263|FG001|Extension Phase|Other|0
2187432|NCT01462318|3817264|FG002|Extension Phase|Other|1
2187433|NCT01462318|3817262|FG000|Extension Phase|Disease Progression|0
2187434|NCT01462318|3817263|FG001|Extension Phase|Disease Progression|0
2187435|NCT01462318|3817264|FG002|Extension Phase|Disease Progression|1
2187436|NCT01462318|3817262|FG000|Extension Phase|Withdrawal by Subject|0
2187437|NCT01462318|3817263|FG001|Extension Phase|Withdrawal by Subject|0
2187438|NCT01462318|3817264|FG002|Extension Phase|Withdrawal by Subject|15
2187439|NCT01462318|3817262|FG000|Extension Phase|Investigator Decision|0
2187440|NCT01462318|3817263|FG001|Extension Phase|Investigator Decision|0
2187441|NCT01462318|3817264|FG002|Extension Phase|Investigator Decision|5
2187442|NCT01462318|3817262|FG000|Extension Phase|Adverse Event|0
2187443|NCT01462318|3817263|FG001|Extension Phase|Adverse Event|0
2187444|NCT01462318|3817264|FG002|Extension Phase|Adverse Event|22
2187445|NCT01462344|3817271|FG000|Overall Study|Withdrawal by Subject|245
2187446|NCT01462344|3817272|FG001|Overall Study|Withdrawal by Subject|226
2187447|NCT01462344|3817271|FG000|Overall Study|Adverse Event|24
2187448|NCT01462344|3817272|FG001|Overall Study|Adverse Event|23
2187449|NCT01462344|3817271|FG000|Overall Study|Asthma Exacerbation|34
2187450|NCT01462344|3817272|FG001|Overall Study|Asthma Exacerbation|35
2187451|NCT01462344|3817271|FG000|Overall Study|Lack of Efficacy|5
2187452|NCT01462344|3817272|FG001|Overall Study|Lack of Efficacy|6
2222056|NCT01743989|3867230|FG001|Re-treatment Phase|Adverse Event|4
2222057|NCT01743989|3867231|FG002|Re-treatment Phase|Adverse Event|0
2222058|NCT01743989|3867229|FG000|Re-treatment Phase|Death|1
2222059|NCT01743989|3867230|FG001|Re-treatment Phase|Death|1
2222060|NCT01743989|3867231|FG002|Re-treatment Phase|Death|0
2222061|NCT01743989|3867229|FG000|Re-treatment Phase|Administrative problems|1
2222062|NCT01743989|3867230|FG001|Re-treatment Phase|Administrative problems|1
2222063|NCT01743989|3867231|FG002|Re-treatment Phase|Administrative problems|0
2222064|NCT01743989|3867229|FG000|Re-treatment Phase|Withdrawal by Subject|5
2222065|NCT01743989|3867230|FG001|Re-treatment Phase|Withdrawal by Subject|1
2222066|NCT01743989|3867231|FG002|Re-treatment Phase|Withdrawal by Subject|0
2222067|NCT01743989|3867229|FG000|Re-treatment Phase|Unstable MR|1
2222068|NCT01743989|3867230|FG001|Re-treatment Phase|Unstable MR|0
2222069|NCT01743989|3867231|FG002|Re-treatment Phase|Unstable MR|0
2222070|NCT01743989|3867229|FG000|Re-treatment Phase|Physician Decision|0
2222071|NCT01743989|3867230|FG001|Re-treatment Phase|Physician Decision|1
2222072|NCT01743989|3867231|FG002|Re-treatment Phase|Physician Decision|0
2222073|NCT01743989|3867229|FG000|Re-treatment Phase|Lost to Follow-up|0
2222074|NCT01743989|3867230|FG001|Re-treatment Phase|Lost to Follow-up|1
2222075|NCT01743989|3867231|FG002|Re-treatment Phase|Lost to Follow-up|0
2222076|NCT01744197|3867255|FG000|Overall Study|Received 1 patch|2
2222077|NCT01744197|3867256|FG001|Overall Study|Received 1 patch|1
2222078|NCT01744197|3867255|FG000|Overall Study|No patch received|2
2222079|NCT01744197|3867256|FG001|Overall Study|No patch received|2
2222080|NCT01744392|3867282|FG000|Overall Study|Physician Decision|1
2222081|NCT01744483|3867290|FG000|Overall Study|Death|9
2222082|NCT01744483|3867291|FG001|Overall Study|Death|4
2222083|NCT01744483|3867292|FG002|Overall Study|Death|11
2222084|NCT01744483|3867290|FG000|Overall Study|Lost to Follow-up|8
2222085|NCT01744483|3867291|FG001|Overall Study|Lost to Follow-up|9
2222086|NCT01744483|3867292|FG002|Overall Study|Lost to Follow-up|11
2222087|NCT01744483|3867290|FG000|Overall Study|Protocol Violation|1
2222088|NCT01744483|3867291|FG001|Overall Study|Protocol Violation|2
2222089|NCT01744483|3867292|FG002|Overall Study|Protocol Violation|1
2222090|NCT01744483|3867290|FG000|Overall Study|Withdrawal by Subject|4
2222091|NCT01744483|3867291|FG001|Overall Study|Withdrawal by Subject|6
2222092|NCT01744483|3867292|FG002|Overall Study|Withdrawal by Subject|2
2222093|NCT01744483|3867290|FG000|Overall Study|No ICU Admit|5
2222094|NCT01744483|3867291|FG001|Overall Study|No ICU Admit|1
2222095|NCT01744483|3867292|FG002|Overall Study|No ICU Admit|2
2222096|NCT01744483|3867290|FG000|Overall Study|Routed to OSH|2
2222097|NCT01744483|3867291|FG001|Overall Study|Routed to OSH|0
2222098|NCT01744483|3867292|FG002|Overall Study|Routed to OSH|1
2222099|NCT01744496|3867302|FG000|Titration Period|Adverse Event|2
2222100|NCT01744496|3867303|FG001|Titration Period|Adverse Event|1
2222101|NCT01744496|3867302|FG000|Titration Period|Personal reasons|0
2222102|NCT01744496|3867303|FG001|Titration Period|Personal reasons|1
2222103|NCT01744496|3867302|FG000|Maintenance Period|Adverse Event|1
2222104|NCT01744496|3867303|FG001|Maintenance Period|Adverse Event|3
2222105|NCT01744496|3867302|FG000|Maintenance Period|Protocol Violation|1
2222106|NCT01744496|3867303|FG001|Maintenance Period|Protocol Violation|0
2222107|NCT01744496|3867302|FG000|Maintenance Period|Withdrawal by Subject|1
2222108|NCT01744496|3867303|FG001|Maintenance Period|Withdrawal by Subject|1
2222109|NCT01744496|3867302|FG000|Maintenance Period|Subject left town|1
2222110|NCT01744496|3867303|FG001|Maintenance Period|Subject left town|0
2222111|NCT01744665|3867326|FG000|Monitoring Phase|Adverse Event|4
2222112|NCT01744665|3867326|FG000|Monitoring Phase|Abnormal laboratory value(s)|1
2222113|NCT01744665|3867326|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7
2187453|NCT01462344|3817271|FG000|Overall Study|Protocol Violation|68
2187454|NCT01462344|3817272|FG001|Overall Study|Protocol Violation|53
2187455|NCT01462344|3817271|FG000|Overall Study|Lost to Follow-up|7
2187456|NCT01462344|3817272|FG001|Overall Study|Lost to Follow-up|7
2187457|NCT01462357|3817281|FG000|Overall Study|Death|0
2187458|NCT01462357|3817282|FG001|Overall Study|Death|0
2187459|NCT01462357|3817283|FG002|Overall Study|Death|1
2187460|NCT01462357|3817281|FG000|Overall Study|Withdrawal by Subject|3
2187461|NCT01462357|3817282|FG001|Overall Study|Withdrawal by Subject|11
2187462|NCT01462357|3817283|FG002|Overall Study|Withdrawal by Subject|3
2187463|NCT01462357|3817281|FG000|Overall Study|Migrated/moved from study area|2
2187464|NCT01462357|3817282|FG001|Overall Study|Migrated/moved from study area|3
2187465|NCT01462357|3817283|FG002|Overall Study|Migrated/moved from study area|1
2187466|NCT01462357|3817281|FG000|Overall Study|Lost to Follow-up|3
2187467|NCT01462357|3817282|FG001|Overall Study|Lost to Follow-up|5
2187468|NCT01462357|3817283|FG002|Overall Study|Lost to Follow-up|7
2187469|NCT01462435|3817295|FG000|Overall Study|Lack of Efficacy|1
2187470|NCT01462435|3817296|FG001|Overall Study|Lack of Efficacy|0
2187471|NCT01462435|3817297|FG002|Overall Study|Lack of Efficacy|0
2187472|NCT01462435|3817298|FG003|Overall Study|Lack of Efficacy|3
2187473|NCT01462435|3817295|FG000|Overall Study|Physician Decision|0
2187474|NCT01462435|3817296|FG001|Overall Study|Physician Decision|0
2187475|NCT01462435|3817297|FG002|Overall Study|Physician Decision|1
2187476|NCT01462435|3817298|FG003|Overall Study|Physician Decision|0
2187477|NCT01462435|3817295|FG000|Overall Study|Withdrawal by Subject|0
2187478|NCT01462435|3817296|FG001|Overall Study|Withdrawal by Subject|0
2187479|NCT01462435|3817297|FG002|Overall Study|Withdrawal by Subject|0
2187480|NCT01462435|3817298|FG003|Overall Study|Withdrawal by Subject|1
2187481|NCT01462435|3817295|FG000|Overall Study|Lost to Follow-up|0
2187482|NCT01462435|3817296|FG001|Overall Study|Lost to Follow-up|0
2187483|NCT01462435|3817297|FG002|Overall Study|Lost to Follow-up|0
2187484|NCT01462435|3817298|FG003|Overall Study|Lost to Follow-up|1
2187485|NCT01462695|3817314|FG000|Overall Study|Adverse Event|1
2187486|NCT01462695|3817315|FG001|Overall Study|Adverse Event|1
2187487|NCT01462695|3817314|FG000|Overall Study|Death|2
2187488|NCT01462695|3817315|FG001|Overall Study|Death|0
2187489|NCT01462695|3817314|FG000|Overall Study|Lack of Efficacy|6
2187490|NCT01462695|3817315|FG001|Overall Study|Lack of Efficacy|12
2187491|NCT01462695|3817314|FG000|Overall Study|Physician Decision|5
2187492|NCT01462695|3817315|FG001|Overall Study|Physician Decision|0
2187493|NCT01462695|3817314|FG000|Overall Study|Withdrawal by Subject|2
2187494|NCT01462695|3817315|FG001|Overall Study|Withdrawal by Subject|0
2222114|NCT01744665|3867326|FG000|Monitoring Phase|Withdrawal by Subject|5
2222115|NCT01744665|3867326|FG000|Monitoring Phase|Did not achieve MR4.5|1
2222116|NCT01744665|3867326|FG000|Consolidation Phase|Adverse Event|2
2222117|NCT01744665|3867326|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4
2222118|NCT01744665|3867326|FG000|Consolidation Phase|Withdrawal by Subject|4
2222119|NCT01744665|3867326|FG000|Consolidation Phase|Administrative problems|9
2222120|NCT01744665|3867326|FG000|Re-initiation Phase|Administrative problems|10
2222121|NCT01744665|3867326|FG000|Re-initiation Phase|Adverse Event|1
2222122|NCT01744665|3867326|FG000|Re-initiation Phase|No longer required treatment|1
2222123|NCT01744665|3867326|FG000|Re-initiation Phase|Withdrawal by Subject|1
2222124|NCT01744691|3867333|FG000|Overall Study|Progressive Disease|18
2222125|NCT01744691|3867333|FG000|Overall Study|Unacceptable toxicity, AE or death|18
2222126|NCT01744691|3867333|FG000|Overall Study|Withdrawal of consent for treatment|3
2222127|NCT01744691|3867333|FG000|Overall Study|Physician Decision|4
2222128|NCT01744782|3867409|FG000|Overall Study|Death|1
2222129|NCT01744977|3867444|FG000|Overall Study|Withdrawal by Subject|1
2222130|NCT01744977|3867445|FG001|Overall Study|Withdrawal by Subject|2
2222131|NCT01744977|3867444|FG000|Overall Study|Death|2
2222132|NCT01744977|3867445|FG001|Overall Study|Death|3
2222133|NCT01744977|3867444|FG000|Overall Study|Lost to Follow-up|2
2222134|NCT01744977|3867445|FG001|Overall Study|Lost to Follow-up|0
2222135|NCT01744977|3867444|FG000|Overall Study|No longer meets inclusion|6
2222136|NCT01744977|3867445|FG001|Overall Study|No longer meets inclusion|0
2222137|NCT01745094|3867464|FG000|Overall Study|Not Meeting the Eligibility Criteria|1
2222138|NCT01745094|3867465|FG001|Overall Study|Not Meeting the Eligibility Criteria|0
2222139|NCT01745094|3867466|FG002|Overall Study|Not Meeting the Eligibility Criteria|3
2222140|NCT01745094|3867467|FG003|Overall Study|Not Meeting the Eligibility Criteria|0
2222141|NCT01745094|3867464|FG000|Overall Study|Adverse Event|0
2222142|NCT01745094|3867465|FG001|Overall Study|Adverse Event|0
2222143|NCT01745094|3867466|FG002|Overall Study|Adverse Event|3
2222144|NCT01745094|3867467|FG003|Overall Study|Adverse Event|0
2222145|NCT01745094|3867464|FG000|Overall Study|Withdrawal by Subject|2
2222146|NCT01745094|3867465|FG001|Overall Study|Withdrawal by Subject|0
2222147|NCT01745094|3867466|FG002|Overall Study|Withdrawal by Subject|1
2222148|NCT01745094|3867467|FG003|Overall Study|Withdrawal by Subject|2
2222149|NCT01745094|3867464|FG000|Overall Study|Protocol Violation|1
2222150|NCT01745094|3867465|FG001|Overall Study|Protocol Violation|0
2222151|NCT01745094|3867466|FG002|Overall Study|Protocol Violation|3
2222152|NCT01745094|3867467|FG003|Overall Study|Protocol Violation|1
2222153|NCT01745094|3867464|FG000|Overall Study|Need Further Examinations Due to Biopsy|0
2222154|NCT01745094|3867465|FG001|Overall Study|Need Further Examinations Due to Biopsy|0
2222155|NCT01745094|3867466|FG002|Overall Study|Need Further Examinations Due to Biopsy|1
2187495|NCT01462695|3817314|FG000|Overall Study|Inevaluable (did not receive study drug)|1
2187496|NCT01462695|3817315|FG001|Overall Study|Inevaluable (did not receive study drug)|0
2187497|NCT01462929|3817342|FG000|Overall Study|Adverse Event|3
2187498|NCT01462929|3817343|FG001|Overall Study|Adverse Event|3
2187499|NCT01462929|3817344|FG002|Overall Study|Adverse Event|4
2187500|NCT01462929|3817342|FG000|Overall Study|Withdrawal by Subject|2
2187501|NCT01462929|3817343|FG001|Overall Study|Withdrawal by Subject|1
2187502|NCT01462929|3817344|FG002|Overall Study|Withdrawal by Subject|0
2187503|NCT01462929|3817342|FG000|Overall Study|Lack of Efficacy|0
2187504|NCT01462929|3817343|FG001|Overall Study|Lack of Efficacy|0
2187505|NCT01462929|3817344|FG002|Overall Study|Lack of Efficacy|1
2187506|NCT01462942|3817357|FG000|Overall Study|Adverse Event|7
2187507|NCT01462942|3817358|FG001|Overall Study|Adverse Event|12
2187508|NCT01462942|3817359|FG002|Overall Study|Adverse Event|10
2187509|NCT01462942|3817360|FG003|Overall Study|Adverse Event|11
2187510|NCT01462942|3817361|FG004|Overall Study|Adverse Event|11
2187511|NCT01462942|3817357|FG000|Overall Study|Other, including COPD exacerbation|3
2187512|NCT01462942|3817358|FG001|Overall Study|Other, including COPD exacerbation|5
2187513|NCT01462942|3817359|FG002|Overall Study|Other, including COPD exacerbation|2
2187514|NCT01462942|3817360|FG003|Overall Study|Other, including COPD exacerbation|8
2187515|NCT01462942|3817361|FG004|Overall Study|Other, including COPD exacerbation|5
2187516|NCT01462942|3817357|FG000|Overall Study|Withdrawal by Subject|14
2187517|NCT01462942|3817358|FG001|Overall Study|Withdrawal by Subject|10
2187518|NCT01462942|3817359|FG002|Overall Study|Withdrawal by Subject|14
2187519|NCT01462942|3817360|FG003|Overall Study|Withdrawal by Subject|16
2187520|NCT01462942|3817361|FG004|Overall Study|Withdrawal by Subject|19
2187521|NCT01462942|3817357|FG000|Overall Study|Lack of Efficacy|6
2187522|NCT01462942|3817358|FG001|Overall Study|Lack of Efficacy|0
2187523|NCT01462942|3817359|FG002|Overall Study|Lack of Efficacy|4
2187524|NCT01462942|3817360|FG003|Overall Study|Lack of Efficacy|5
2187525|NCT01462942|3817361|FG004|Overall Study|Lack of Efficacy|3
2187526|NCT01462942|3817357|FG000|Overall Study|Lost to Follow-up|0
2187527|NCT01462942|3817358|FG001|Overall Study|Lost to Follow-up|1
2187528|NCT01462942|3817359|FG002|Overall Study|Lost to Follow-up|1
2187529|NCT01462942|3817360|FG003|Overall Study|Lost to Follow-up|1
2187530|NCT01462942|3817361|FG004|Overall Study|Lost to Follow-up|1
2187531|NCT01462942|3817357|FG000|Overall Study|Protocol Violation|4
2187532|NCT01462942|3817358|FG001|Overall Study|Protocol Violation|6
2187533|NCT01462942|3817359|FG002|Overall Study|Protocol Violation|9
2187534|NCT01462942|3817360|FG003|Overall Study|Protocol Violation|9
2187535|NCT01462942|3817361|FG004|Overall Study|Protocol Violation|6
2187536|NCT01463007|3817373|FG000|Overall Study|Physician Decision|1
2187537|NCT01463033|3817380|FG000|Overall Study|Lost to Follow-up|4
2187538|NCT01463033|3817381|FG001|Overall Study|Lost to Follow-up|4
2187539|NCT01463033|3817380|FG000|Overall Study|Death|3
2187540|NCT01463033|3817381|FG001|Overall Study|Death|2
2187541|NCT01463098|3817402|FG000|Part A (11 Days)|Participant Choice|2
2187542|NCT01463098|3817403|FG001|Part A (11 Days)|Participant Choice|0
2187543|NCT01463098|3817404|FG002|Part A (11 Days)|Participant Choice|0
2187544|NCT01463098|3817405|FG003|Part A (11 Days)|Participant Choice|0
2187545|NCT01463098|3817406|FG004|Part A (11 Days)|Participant Choice|0
2187546|NCT01463098|3817407|FG005|Part A (11 Days)|Participant Choice|0
2187547|NCT01463098|3817408|FG006|Part A (11 Days)|Participant Choice|0
2187548|NCT01463098|3817409|FG007|Part A (11 Days)|Participant Choice|0
2187549|NCT01463098|3817410|FG008|Part A (11 Days)|Participant Choice|1
2187550|NCT01463098|3817411|FG009|Part A (11 Days)|Participant Choice|0
2187551|NCT01463098|3817412|FG010|Part A (11 Days)|Participant Choice|0
2187552|NCT01463098|3817413|FG011|Part A (11 Days)|Participant Choice|0
2187553|NCT01463098|3817414|FG012|Part A (11 Days)|Participant Choice|0
2187554|NCT01463098|3817415|FG013|Part A (11 Days)|Participant Choice|0
2187555|NCT01463098|3817402|FG000|Part A (11 Days)|Lost to Follow-up|0
2187556|NCT01463098|3817403|FG001|Part A (11 Days)|Lost to Follow-up|0
2187557|NCT01463098|3817404|FG002|Part A (11 Days)|Lost to Follow-up|0
2187558|NCT01463098|3817405|FG003|Part A (11 Days)|Lost to Follow-up|0
2187559|NCT01463098|3817406|FG004|Part A (11 Days)|Lost to Follow-up|1
2187560|NCT01463098|3817407|FG005|Part A (11 Days)|Lost to Follow-up|0
2187561|NCT01463098|3817408|FG006|Part A (11 Days)|Lost to Follow-up|0
2187562|NCT01463098|3817409|FG007|Part A (11 Days)|Lost to Follow-up|0
2187563|NCT01463098|3817410|FG008|Part A (11 Days)|Lost to Follow-up|0
2187564|NCT01463098|3817411|FG009|Part A (11 Days)|Lost to Follow-up|0
2187565|NCT01463098|3817412|FG010|Part A (11 Days)|Lost to Follow-up|0
2187566|NCT01463098|3817413|FG011|Part A (11 Days)|Lost to Follow-up|0
2187567|NCT01463098|3817414|FG012|Part A (11 Days)|Lost to Follow-up|0
2187568|NCT01463098|3817415|FG013|Part A (11 Days)|Lost to Follow-up|0
2187569|NCT01463098|3817402|FG000|Part B (11 Days)|Participant Choice|0
2187570|NCT01463098|3817403|FG001|Part B (11 Days)|Participant Choice|0
2187571|NCT01463098|3817404|FG002|Part B (11 Days)|Participant Choice|0
2187572|NCT01463098|3817405|FG003|Part B (11 Days)|Participant Choice|0
2187573|NCT01463098|3817406|FG004|Part B (11 Days)|Participant Choice|0
2187574|NCT01463098|3817407|FG005|Part B (11 Days)|Participant Choice|0
2187575|NCT01463098|3817408|FG006|Part B (11 Days)|Participant Choice|0
2187576|NCT01463098|3817409|FG007|Part B (11 Days)|Participant Choice|0
2187577|NCT01463098|3817410|FG008|Part B (11 Days)|Participant Choice|0
2187578|NCT01463098|3817411|FG009|Part B (11 Days)|Participant Choice|0
2187579|NCT01463098|3817412|FG010|Part B (11 Days)|Participant Choice|0
2187580|NCT01463098|3817413|FG011|Part B (11 Days)|Participant Choice|1
2187581|NCT01463098|3817414|FG012|Part B (11 Days)|Participant Choice|0
2187582|NCT01463098|3817415|FG013|Part B (11 Days)|Participant Choice|0
2187583|NCT01463111|3817464|FG000|Overall Study|Withdrawal by Subject|2
2187584|NCT01463111|3817464|FG000|Overall Study|Lost to Follow-up|5
2187585|NCT01463111|3817464|FG000|Overall Study|Physician Decision|2
2187586|NCT01463306|3817497|FG000|Overall Study|Adverse Event|6
2187587|NCT01463306|3817498|FG001|Overall Study|Adverse Event|9
2187588|NCT01463306|3817499|FG002|Overall Study|Adverse Event|3
2187589|NCT01463306|3817497|FG000|Overall Study|Death|3
2187590|NCT01463306|3817498|FG001|Overall Study|Death|3
2187591|NCT01463306|3817499|FG002|Overall Study|Death|0
2187592|NCT01463306|3817497|FG000|Overall Study|Lack of Efficacy|22
2187593|NCT01463306|3817498|FG001|Overall Study|Lack of Efficacy|16
2187594|NCT01463306|3817499|FG002|Overall Study|Lack of Efficacy|1
2187595|NCT01463306|3817497|FG000|Overall Study|Lost to Follow-up|5
2187596|NCT01463306|3817498|FG001|Overall Study|Lost to Follow-up|2
2187597|NCT01463306|3817499|FG002|Overall Study|Lost to Follow-up|0
2222156|NCT01745094|3867467|FG003|Overall Study|Need Further Examinations Due to Biopsy|0
2222157|NCT01745094|3867464|FG000|Overall Study|Show no Stable Solifenacin Intake|0
2222158|NCT01745094|3867465|FG001|Overall Study|Show no Stable Solifenacin Intake|0
2222159|NCT01745094|3867466|FG002|Overall Study|Show no Stable Solifenacin Intake|1
2222160|NCT01745094|3867467|FG003|Overall Study|Show no Stable Solifenacin Intake|0
2222161|NCT01745094|3867464|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1
2222162|NCT01745094|3867465|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0
2222163|NCT01745094|3867466|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0
2222164|NCT01745094|3867467|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0
2222165|NCT01745120|3867482|FG000|Overall Study|Investigator decision|1
2222166|NCT01745120|3867483|FG001|Overall Study|Investigator decision|0
2222167|NCT01745146|3867507|FG000|Overall Study|Withdrawal by Subject|1
2222168|NCT01745146|3867508|FG001|Overall Study|Withdrawal by Subject|3
2222169|NCT01745146|3867507|FG000|Overall Study|Lost to Follow-up|2
2222170|NCT01745146|3867508|FG001|Overall Study|Lost to Follow-up|0
2222171|NCT01745367|3867521|FG000|Overall Study|Death|1
2222172|NCT01745367|3867522|FG001|Overall Study|Death|0
2222173|NCT01745367|3867521|FG000|Overall Study|Withdrawal by Subject|1
2222174|NCT01745367|3867522|FG001|Overall Study|Withdrawal by Subject|2
2222175|NCT01745367|3867521|FG000|Overall Study|Termination of The Study by The Sponsor|6
2222176|NCT01745367|3867522|FG001|Overall Study|Termination of The Study by The Sponsor|18
2222177|NCT01745367|3867521|FG000|Overall Study|Other Reasons Unspecified|0
2222178|NCT01745367|3867522|FG001|Overall Study|Other Reasons Unspecified|2
2222179|NCT01745380|3867530|FG000|Overall Study|Lost to Follow-up|1
2222180|NCT01745380|3867531|FG001|Overall Study|Lost to Follow-up|0
2222181|NCT01745380|3867530|FG000|Overall Study|Lack of Efficacy|0
2222182|NCT01745380|3867531|FG001|Overall Study|Lack of Efficacy|1
2222183|NCT01745393|3867539|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
2222184|NCT01745393|3867540|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
2222185|NCT01745393|3867539|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
2222186|NCT01745393|3867540|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
2222187|NCT01745393|3867539|FG000|12-month Follow-up|Lost to Follow-up|6
2222188|NCT01745393|3867540|FG001|12-month Follow-up|Lost to Follow-up|5
2222189|NCT01745848|3867559|FG000|Overall Study|Adverse Event|6
2222190|NCT01746017|3867590|FG000|Period 1|Withdrawal by Subject|0
2222191|NCT01746017|3867591|FG001|Period 1|Withdrawal by Subject|0
2222192|NCT01746017|3867592|FG002|Period 1|Withdrawal by Subject|0
2222193|NCT01746017|3867593|FG003|Period 1|Withdrawal by Subject|0
2222194|NCT01746017|3867594|FG004|Period 1|Withdrawal by Subject|0
2222195|NCT01746017|3867595|FG005|Period 1|Withdrawal by Subject|0
2222196|NCT01746017|3867596|FG006|Period 1|Withdrawal by Subject|1
2222197|NCT01746017|3867597|FG007|Period 1|Withdrawal by Subject|0
2222198|NCT01746017|3867598|FG008|Period 1|Withdrawal by Subject|0
2222199|NCT01746017|3867599|FG009|Period 1|Withdrawal by Subject|0
2222200|NCT01746017|3867600|FG010|Period 1|Withdrawal by Subject|0
2222201|NCT01746017|3867590|FG000|Period 3|Withdrawal by Subject|0
2222202|NCT01746017|3867591|FG001|Period 3|Withdrawal by Subject|0
2222203|NCT01746017|3867592|FG002|Period 3|Withdrawal by Subject|0
2222204|NCT01746017|3867593|FG003|Period 3|Withdrawal by Subject|0
2222205|NCT01746017|3867594|FG004|Period 3|Withdrawal by Subject|0
2222206|NCT01746017|3867595|FG005|Period 3|Withdrawal by Subject|1
2222207|NCT01746017|3867596|FG006|Period 3|Withdrawal by Subject|0
2222208|NCT01746017|3867597|FG007|Period 3|Withdrawal by Subject|0
2222209|NCT01746017|3867598|FG008|Period 3|Withdrawal by Subject|0
2222210|NCT01746017|3867599|FG009|Period 3|Withdrawal by Subject|0
2222211|NCT01746017|3867600|FG010|Period 3|Withdrawal by Subject|0
2222212|NCT01746108|3867676|FG000|Overall Study|Migrated /moved from study area|0
2222213|NCT01746108|3867677|FG001|Overall Study|Migrated /moved from study area|1
2222214|NCT01746108|3867678|FG002|Overall Study|Migrated /moved from study area|0
2222215|NCT01746108|3867676|FG000|Overall Study|Adverse event, non-fatal|0
2222216|NCT01746108|3867677|FG001|Overall Study|Adverse event, non-fatal|1
2222217|NCT01746108|3867678|FG002|Overall Study|Adverse event, non-fatal|0
2222218|NCT01746108|3867676|FG000|Overall Study|Withdrawal by Subject|0
2187598|NCT01463306|3817497|FG000|Overall Study|Protocol Violation|4
2187599|NCT01463306|3817498|FG001|Overall Study|Protocol Violation|0
2187600|NCT01463306|3817499|FG002|Overall Study|Protocol Violation|0
2187601|NCT01463306|3817497|FG000|Overall Study|Withdrawal by Subject|19
2187602|NCT01463306|3817498|FG001|Overall Study|Withdrawal by Subject|9
2187603|NCT01463306|3817499|FG002|Overall Study|Withdrawal by Subject|1
2187604|NCT01463306|3817497|FG000|Overall Study|Other|26
2187605|NCT01463306|3817498|FG001|Overall Study|Other|13
2187606|NCT01463306|3817499|FG002|Overall Study|Other|0
2187607|NCT01463306|3817497|FG000|Overall Study|Approval expiry at site|1
2187608|NCT01463306|3817498|FG001|Overall Study|Approval expiry at site|0
2187609|NCT01463306|3817499|FG002|Overall Study|Approval expiry at site|0
2187610|NCT01463527|3817524|FG000|Overall Study|Protocol Violation|1
2187611|NCT01463527|3817525|FG001|Overall Study|Protocol Violation|1
2187612|NCT01463527|3817524|FG000|Overall Study|Crying >20% of sedation|5
2187613|NCT01463527|3817525|FG001|Overall Study|Crying >20% of sedation|6
2187614|NCT01463631|3817535|FG000|Overall Study|Withdrawal by Subject|0
2187615|NCT01463631|3817536|FG001|Overall Study|Withdrawal by Subject|0
2187616|NCT01463631|3817537|FG002|Overall Study|Withdrawal by Subject|0
2187617|NCT01463631|3817538|FG003|Overall Study|Withdrawal by Subject|1
2187618|NCT01463631|3817535|FG000|Overall Study|Death|0
2187619|NCT01463631|3817536|FG001|Overall Study|Death|0
2187620|NCT01463631|3817537|FG002|Overall Study|Death|1
2187621|NCT01463631|3817538|FG003|Overall Study|Death|0
2187622|NCT01463631|3817535|FG000|Overall Study|Progressive Disease|0
2187623|NCT01463631|3817536|FG001|Overall Study|Progressive Disease|0
2187624|NCT01463631|3817537|FG002|Overall Study|Progressive Disease|0
2187625|NCT01463631|3817538|FG003|Overall Study|Progressive Disease|5
2187626|NCT01463683|3817553|FG000|Overall Study|Adverse Event|2
2187627|NCT01463683|3817554|FG001|Overall Study|Adverse Event|0
2187628|NCT01463683|3817555|FG002|Overall Study|Adverse Event|0
2187629|NCT01463683|3817553|FG000|Overall Study|Lost to Follow-up|10
2187630|NCT01463683|3817554|FG001|Overall Study|Lost to Follow-up|9
2187631|NCT01463683|3817555|FG002|Overall Study|Lost to Follow-up|7
2187632|NCT01463683|3817553|FG000|Overall Study|Physician Decision|0
2187633|NCT01463683|3817554|FG001|Overall Study|Physician Decision|3
2187634|NCT01463683|3817555|FG002|Overall Study|Physician Decision|1
2187635|NCT01463683|3817553|FG000|Overall Study|Pregnancy|2
2187636|NCT01463683|3817554|FG001|Overall Study|Pregnancy|2
2187637|NCT01463683|3817555|FG002|Overall Study|Pregnancy|1
2187638|NCT01463683|3817553|FG000|Overall Study|Withdrawal by Subject|5
2187639|NCT01463683|3817554|FG001|Overall Study|Withdrawal by Subject|17
2187640|NCT01463683|3817555|FG002|Overall Study|Withdrawal by Subject|2
2187641|NCT01463696|3817571|FG000|Overall Study|Adverse Event|0
2187642|NCT01463696|3817572|FG001|Overall Study|Adverse Event|1
2187643|NCT01463696|3817573|FG002|Overall Study|Adverse Event|0
2187644|NCT01463696|3817574|FG003|Overall Study|Adverse Event|2
2187645|NCT01463696|3817575|FG004|Overall Study|Adverse Event|0
2187646|NCT01463696|3817576|FG005|Overall Study|Adverse Event|1
2187647|NCT01463696|3817577|FG006|Overall Study|Adverse Event|3
2187648|NCT01463696|3817578|FG007|Overall Study|Adverse Event|2
2187649|NCT01463696|3817571|FG000|Overall Study|Lost to Follow-up|0
2187650|NCT01463696|3817572|FG001|Overall Study|Lost to Follow-up|0
2187651|NCT01463696|3817573|FG002|Overall Study|Lost to Follow-up|1
2187652|NCT01463696|3817574|FG003|Overall Study|Lost to Follow-up|0
2187653|NCT01463696|3817575|FG004|Overall Study|Lost to Follow-up|0
2187654|NCT01463696|3817576|FG005|Overall Study|Lost to Follow-up|0
2187655|NCT01463696|3817577|FG006|Overall Study|Lost to Follow-up|0
2187656|NCT01463696|3817578|FG007|Overall Study|Lost to Follow-up|0
2187657|NCT01463696|3817571|FG000|Overall Study|Progressive Disease|0
2187658|NCT01463696|3817572|FG001|Overall Study|Progressive Disease|1
2222219|NCT01746108|3867677|FG001|Overall Study|Withdrawal by Subject|1
2222220|NCT01746108|3867678|FG002|Overall Study|Withdrawal by Subject|0
2222221|NCT01746108|3867676|FG000|Overall Study|Lost to Follow-up|0
2222222|NCT01746108|3867677|FG001|Overall Study|Lost to Follow-up|1
2222223|NCT01746108|3867678|FG002|Overall Study|Lost to Follow-up|0
2222224|NCT01746173|3867694|FG000|Overall Study|Disease Progression|2
2222225|NCT01746225|3867701|FG000|Overall Study|Death|1
2222226|NCT01746225|3867702|FG001|Overall Study|Death|0
2222227|NCT01746225|3867703|FG002|Overall Study|Death|1
2222228|NCT01746225|3867701|FG000|Overall Study|Withdrawal by Subject|5
2222229|NCT01746225|3867702|FG001|Overall Study|Withdrawal by Subject|15
2222230|NCT01746225|3867703|FG002|Overall Study|Withdrawal by Subject|19
2222231|NCT01746225|3867701|FG000|Overall Study|Physician Decision|14
2222232|NCT01746225|3867702|FG001|Overall Study|Physician Decision|11
2222233|NCT01746225|3867703|FG002|Overall Study|Physician Decision|3
2222234|NCT01746225|3867701|FG000|Overall Study|Adverse Event|15
2222235|NCT01746225|3867702|FG001|Overall Study|Adverse Event|12
2222236|NCT01746225|3867703|FG002|Overall Study|Adverse Event|17
2222237|NCT01746225|3867701|FG000|Overall Study|Continuing Treatment|5
2222238|NCT01746225|3867702|FG001|Overall Study|Continuing Treatment|8
2222239|NCT01746225|3867703|FG002|Overall Study|Continuing Treatment|3
2222240|NCT01746368|3867717|FG000|Overall Study|Lost to Follow-up|2
2222241|NCT01746368|3867718|FG001|Overall Study|Lost to Follow-up|0
2222242|NCT01746368|3867717|FG000|Overall Study|Withdrawal by Subject|0
2187659|NCT01463696|3817573|FG002|Overall Study|Progressive Disease|0
2187660|NCT01463696|3817574|FG003|Overall Study|Progressive Disease|1
2187661|NCT01463696|3817575|FG004|Overall Study|Progressive Disease|0
2187662|NCT01463696|3817576|FG005|Overall Study|Progressive Disease|1
2187663|NCT01463696|3817577|FG006|Overall Study|Progressive Disease|4
2187664|NCT01463696|3817578|FG007|Overall Study|Progressive Disease|2
2187665|NCT01463696|3817571|FG000|Overall Study|Withdrawal by Subject|0
2187666|NCT01463696|3817572|FG001|Overall Study|Withdrawal by Subject|0
2187667|NCT01463696|3817573|FG002|Overall Study|Withdrawal by Subject|0
2187668|NCT01463696|3817574|FG003|Overall Study|Withdrawal by Subject|1
2187669|NCT01463696|3817575|FG004|Overall Study|Withdrawal by Subject|1
2187670|NCT01463696|3817576|FG005|Overall Study|Withdrawal by Subject|1
2187671|NCT01463696|3817577|FG006|Overall Study|Withdrawal by Subject|2
2187672|NCT01463696|3817578|FG007|Overall Study|Withdrawal by Subject|0
2187673|NCT01463696|3817571|FG000|Overall Study|Not Treated|0
2187674|NCT01463696|3817572|FG001|Overall Study|Not Treated|0
2187675|NCT01463696|3817573|FG002|Overall Study|Not Treated|0
2187676|NCT01463696|3817574|FG003|Overall Study|Not Treated|0
2187677|NCT01463696|3817575|FG004|Overall Study|Not Treated|0
2187678|NCT01463696|3817576|FG005|Overall Study|Not Treated|0
2187679|NCT01463696|3817577|FG006|Overall Study|Not Treated|1
2187680|NCT01463696|3817578|FG007|Overall Study|Not Treated|0
2187681|NCT01463878|3817598|FG000|Overall Study|no longer met criteria for tube feed|2
2187682|NCT01463878|3817599|FG001|Overall Study|no longer met criteria for tube feed|2
2187683|NCT01463982|3817609|FG000|Overall Study|Withdrawal by Subject|0
2187684|NCT01463982|3817610|FG001|Overall Study|Withdrawal by Subject|1
2187685|NCT01463982|3817611|FG002|Overall Study|Withdrawal by Subject|1
2187686|NCT01463982|3817612|FG003|Overall Study|Withdrawal by Subject|0
2187687|NCT01463982|3817609|FG000|Overall Study|Treatment delay over 5 week|0
2187688|NCT01463982|3817610|FG001|Overall Study|Treatment delay over 5 week|0
2187689|NCT01463982|3817611|FG002|Overall Study|Treatment delay over 5 week|1
2187690|NCT01463982|3817612|FG003|Overall Study|Treatment delay over 5 week|0
2187691|NCT01464021|3817622|FG000|Overall Study|Withdrawal by Subject|13
2187692|NCT01464021|3817622|FG000|Overall Study|Lost to Follow-up|1
2187693|NCT01464021|3817622|FG000|Overall Study|Lack of Efficacy|1
2187694|NCT01464021|3817622|FG000|Overall Study|various|11
2222243|NCT01746368|3867718|FG001|Overall Study|Withdrawal by Subject|1
2222244|NCT01746732|3867755|FG000|Lead-In Period|Withdrawal by Subject|1
2222245|NCT01746732|3867756|FG001|Lead-In Period|Withdrawal by Subject|0
2222246|NCT01746732|3867757|FG002|Lead-In Period|Withdrawal by Subject|0
2222247|NCT01746732|3867755|FG000|Period 1|Physician Decision|0
2222248|NCT01746732|3867756|FG001|Period 1|Physician Decision|1
2222249|NCT01746732|3867757|FG002|Period 1|Physician Decision|0
2222250|NCT01746732|3867755|FG000|Period 2|Withdrawal by Subject|0
2222251|NCT01746732|3867756|FG001|Period 2|Withdrawal by Subject|0
2222252|NCT01746732|3867757|FG002|Period 2|Withdrawal by Subject|2
2222253|NCT01746732|3867755|FG000|Period 2|Adverse Event|0
2222254|NCT01746732|3867756|FG001|Period 2|Adverse Event|0
2222255|NCT01746732|3867757|FG002|Period 2|Adverse Event|1
2222256|NCT01746732|3867755|FG000|Period 2|Lost to Follow-up|0
2222257|NCT01746732|3867756|FG001|Period 2|Lost to Follow-up|0
2222258|NCT01746732|3867757|FG002|Period 2|Lost to Follow-up|1
2222259|NCT01746862|3867801|FG000|Overall Study|Withdrawal by Subject|1
2222260|NCT01746862|3867802|FG001|Overall Study|Withdrawal by Subject|1
2222261|NCT01746862|3867801|FG000|Overall Study|Protocol Violation|1
2222262|NCT01746862|3867802|FG001|Overall Study|Protocol Violation|0
2222263|NCT01746862|3867801|FG000|Overall Study|Consent withdrawal by parent's guardian|5
2222264|NCT01746862|3867802|FG001|Overall Study|Consent withdrawal by parent's guardian|2
2222265|NCT01746862|3867801|FG000|Overall Study|Entered puberty during the study|1
2222266|NCT01746862|3867802|FG001|Overall Study|Entered puberty during the study|0
2222267|NCT01746901|3867809|FG000|Naloxone Challenge Phase|Adverse Event|2
2222268|NCT01746901|3867810|FG001|Naloxone Challenge Phase|Adverse Event|0
2222269|NCT01746901|3867811|FG002|Naloxone Challenge Phase|Adverse Event|0
2222270|NCT01746901|3867812|FG003|Naloxone Challenge Phase|Adverse Event|0
2222271|NCT01746901|3867813|FG004|Naloxone Challenge Phase|Adverse Event|0
2222272|NCT01746901|3867814|FG005|Naloxone Challenge Phase|Adverse Event|0
2222273|NCT01746901|3867815|FG006|Naloxone Challenge Phase|Adverse Event|0
2222274|NCT01746901|3867816|FG007|Naloxone Challenge Phase|Adverse Event|0
2222275|NCT01746901|3867817|FG008|Naloxone Challenge Phase|Adverse Event|0
2222276|NCT01746901|3867809|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1
2222277|NCT01746901|3867810|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0
2222278|NCT01746901|3867811|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0
2222279|NCT01746901|3867812|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0
2222280|NCT01746901|3867813|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0
2222281|NCT01746901|3867814|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0
2222282|NCT01746901|3867815|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0
2222283|NCT01746901|3867816|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0
2222284|NCT01746901|3867817|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0
2222285|NCT01746901|3867809|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
2222286|NCT01746901|3867810|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
2222287|NCT01746901|3867811|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
2222288|NCT01746901|3867812|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
2222289|NCT01746901|3867813|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
2222290|NCT01746901|3867814|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
2187695|NCT01464255|3817646|FG000|Overall Study|unresolve corneal staining|0
2187696|NCT01464255|3817647|FG001|Overall Study|unresolve corneal staining|1
2187697|NCT01464307|3817656|FG000|Main Period|Death|0
2187698|NCT01464307|3817657|FG001|Main Period|Death|1
2187699|NCT01464307|3817656|FG000|Main Period|Adverse Event|6
2187700|NCT01464307|3817657|FG001|Main Period|Adverse Event|1
2187701|NCT01464307|3817656|FG000|Main Period|Lack of Efficacy|2
2187702|NCT01464307|3817657|FG001|Main Period|Lack of Efficacy|0
2187703|NCT01464307|3817656|FG000|Main Period|Withdrawal by Subject|5
2187704|NCT01464307|3817657|FG001|Main Period|Withdrawal by Subject|2
2187705|NCT01464307|3817656|FG000|Main Period|Predefined discontinuation criteria|2
2187706|NCT01464307|3817657|FG001|Main Period|Predefined discontinuation criteria|1
2187707|NCT01464307|3817656|FG000|Open-Label Extension Period|Adverse Event|15
2187708|NCT01464307|3817657|FG001|Open-Label Extension Period|Adverse Event|0
2187709|NCT01464307|3817656|FG000|Open-Label Extension Period|Withdrawal by Subject|14
2187710|NCT01464307|3817657|FG001|Open-Label Extension Period|Withdrawal by Subject|0
2187711|NCT01464307|3817656|FG000|Open-Label Extension Period|Lack of Efficacy|5
2187712|NCT01464307|3817657|FG001|Open-Label Extension Period|Lack of Efficacy|0
2187713|NCT01464307|3817656|FG000|Open-Label Extension Period|Death|1
2187714|NCT01464307|3817657|FG001|Open-Label Extension Period|Death|0
2187715|NCT01464307|3817656|FG000|Open-Label Extension Period|Lost to Follow-up|1
2187716|NCT01464307|3817657|FG001|Open-Label Extension Period|Lost to Follow-up|0
2187717|NCT01464307|3817656|FG000|Open-Label Extension Period|Non-compliance|9
2187718|NCT01464307|3817657|FG001|Open-Label Extension Period|Non-compliance|0
2187719|NCT01464307|3817656|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6
2187720|NCT01464307|3817657|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0
2187721|NCT01464333|3817664|FG000|Overall Study|Adverse Event|34
2187722|NCT01464333|3817664|FG000|Overall Study|Lack of Efficacy|72
2187723|NCT01464333|3817664|FG000|Overall Study|Withdrawal by Subject|11
2187724|NCT01464333|3817664|FG000|Overall Study|Other|4
2187725|NCT01464333|3817664|FG000|Overall Study|No Hospital Visit|42
2187726|NCT01464346|3817668|FG000|Overall Study|Withdrawal by Subject|0
2187727|NCT01464346|3817669|FG001|Overall Study|Withdrawal by Subject|0
2187728|NCT01464346|3817670|FG002|Overall Study|Withdrawal by Subject|1
2187729|NCT01464424|3817682|FG000|Period 1, First 6 Weeks|Adverse Event|0
2187730|NCT01464424|3817683|FG001|Period 1, First 6 Weeks|Adverse Event|1
2187731|NCT01464619|3817691|FG000|Overall Study|Lost to Follow-up|3
2187732|NCT01464619|3817692|FG001|Overall Study|Lost to Follow-up|4
2187733|NCT01464788|3817723|FG000|Overall Study|Lost to Follow-up|0
2187734|NCT01464788|3817724|FG001|Overall Study|Lost to Follow-up|1
2187735|NCT01464788|3817725|FG002|Overall Study|Lost to Follow-up|0
2187736|NCT01464788|3817723|FG000|Overall Study|Patient had hemorrhage after tPA started|0
2187737|NCT01464788|3817724|FG001|Overall Study|Patient had hemorrhage after tPA started|1
2187738|NCT01464788|3817725|FG002|Overall Study|Patient had hemorrhage after tPA started|0
2187739|NCT01464827|3817749|FG000|Overall Study|Adverse Event|0
2187740|NCT01464827|3817750|FG001|Overall Study|Adverse Event|0
2187741|NCT01464827|3817751|FG002|Overall Study|Adverse Event|0
2187742|NCT01464827|3817752|FG003|Overall Study|Adverse Event|0
2187743|NCT01464827|3817753|FG004|Overall Study|Adverse Event|0
2187744|NCT01464827|3817754|FG005|Overall Study|Adverse Event|0
2187745|NCT01464827|3817755|FG006|Overall Study|Adverse Event|0
2187746|NCT01464827|3817756|FG007|Overall Study|Adverse Event|0
2187747|NCT01464827|3817757|FG008|Overall Study|Adverse Event|0
2187748|NCT01464827|3817758|FG009|Overall Study|Adverse Event|0
2187749|NCT01464827|3817759|FG010|Overall Study|Adverse Event|0
2187750|NCT01464827|3817760|FG011|Overall Study|Adverse Event|0
2187751|NCT01464827|3817761|FG012|Overall Study|Adverse Event|1
2187752|NCT01464827|3817762|FG013|Overall Study|Adverse Event|0
2187753|NCT01464827|3817749|FG000|Overall Study|Withdrawal by Subject|1
2187754|NCT01464827|3817750|FG001|Overall Study|Withdrawal by Subject|0
2187755|NCT01464827|3817751|FG002|Overall Study|Withdrawal by Subject|0
2187756|NCT01464827|3817752|FG003|Overall Study|Withdrawal by Subject|0
2187757|NCT01464827|3817753|FG004|Overall Study|Withdrawal by Subject|1
2187758|NCT01464827|3817754|FG005|Overall Study|Withdrawal by Subject|0
2187759|NCT01464827|3817755|FG006|Overall Study|Withdrawal by Subject|0
2187760|NCT01464827|3817756|FG007|Overall Study|Withdrawal by Subject|1
2187761|NCT01464827|3817757|FG008|Overall Study|Withdrawal by Subject|0
2187762|NCT01464827|3817758|FG009|Overall Study|Withdrawal by Subject|0
2187763|NCT01464827|3817759|FG010|Overall Study|Withdrawal by Subject|0
2187764|NCT01464827|3817760|FG011|Overall Study|Withdrawal by Subject|0
2187765|NCT01464827|3817761|FG012|Overall Study|Withdrawal by Subject|0
2187766|NCT01464827|3817762|FG013|Overall Study|Withdrawal by Subject|0
2222291|NCT01746901|3867815|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
2222292|NCT01746901|3867816|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0
2222293|NCT01746901|3867817|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0
2222294|NCT01746901|3867809|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0
2222295|NCT01746901|3867810|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2
2222296|NCT01746901|3867811|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1
2222297|NCT01746901|3867812|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0
2222298|NCT01746901|3867813|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0
2222299|NCT01746901|3867814|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0
2222300|NCT01746901|3867815|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0
2187767|NCT01464827|3817749|FG000|Overall Study|Lost to Follow-up|0
2187768|NCT01464827|3817750|FG001|Overall Study|Lost to Follow-up|2
2187769|NCT01464827|3817751|FG002|Overall Study|Lost to Follow-up|0
2187770|NCT01464827|3817752|FG003|Overall Study|Lost to Follow-up|2
2187771|NCT01464827|3817753|FG004|Overall Study|Lost to Follow-up|3
2187772|NCT01464827|3817754|FG005|Overall Study|Lost to Follow-up|1
2187773|NCT01464827|3817755|FG006|Overall Study|Lost to Follow-up|2
2187774|NCT01464827|3817756|FG007|Overall Study|Lost to Follow-up|2
2187775|NCT01464827|3817757|FG008|Overall Study|Lost to Follow-up|0
2187776|NCT01464827|3817758|FG009|Overall Study|Lost to Follow-up|0
2187777|NCT01464827|3817759|FG010|Overall Study|Lost to Follow-up|0
2187778|NCT01464827|3817760|FG011|Overall Study|Lost to Follow-up|1
2187779|NCT01464827|3817761|FG012|Overall Study|Lost to Follow-up|0
2187780|NCT01464827|3817762|FG013|Overall Study|Lost to Follow-up|1
2187781|NCT01464827|3817749|FG000|Overall Study|Other|2
2187782|NCT01464827|3817750|FG001|Overall Study|Other|3
2187783|NCT01464827|3817751|FG002|Overall Study|Other|0
2187784|NCT01464827|3817752|FG003|Overall Study|Other|2
2187785|NCT01464827|3817753|FG004|Overall Study|Other|3
2187786|NCT01464827|3817754|FG005|Overall Study|Other|0
2187787|NCT01464827|3817755|FG006|Overall Study|Other|1
2187788|NCT01464827|3817756|FG007|Overall Study|Other|0
2187789|NCT01464827|3817757|FG008|Overall Study|Other|3
2187790|NCT01464827|3817758|FG009|Overall Study|Other|1
2187791|NCT01464827|3817759|FG010|Overall Study|Other|2
2187792|NCT01464827|3817760|FG011|Overall Study|Other|0
2187793|NCT01464827|3817761|FG012|Overall Study|Other|1
2187794|NCT01464827|3817762|FG013|Overall Study|Other|0
2187795|NCT01464827|3817749|FG000|Overall Study|Not Treated|0
2187796|NCT01464827|3817750|FG001|Overall Study|Not Treated|2
2187797|NCT01464827|3817751|FG002|Overall Study|Not Treated|0
2187798|NCT01464827|3817752|FG003|Overall Study|Not Treated|0
2187799|NCT01464827|3817753|FG004|Overall Study|Not Treated|1
2187800|NCT01464827|3817754|FG005|Overall Study|Not Treated|0
2187801|NCT01464827|3817755|FG006|Overall Study|Not Treated|1
2187802|NCT01464827|3817756|FG007|Overall Study|Not Treated|0
2187803|NCT01464827|3817757|FG008|Overall Study|Not Treated|0
2187804|NCT01464827|3817758|FG009|Overall Study|Not Treated|2
2187805|NCT01464827|3817759|FG010|Overall Study|Not Treated|0
2187806|NCT01464827|3817760|FG011|Overall Study|Not Treated|1
2187807|NCT01464827|3817761|FG012|Overall Study|Not Treated|0
2187808|NCT01464827|3817762|FG013|Overall Study|Not Treated|2
2187809|NCT01464879|3817816|FG000|Overall Study|Physician Decision|1
2187810|NCT01464879|3817816|FG000|Overall Study|Non-compliance|1
2187811|NCT01464931|3817828|FG000|Overall Study|Withdrawal by Subject|1
2187812|NCT01464931|3817829|FG001|Overall Study|Withdrawal by Subject|0
2187813|NCT01465022|3817851|FG000|Overall Study|Lost to Follow-up|15
2187814|NCT01465022|3817852|FG001|Overall Study|Lost to Follow-up|14
2187815|NCT01465022|3817853|FG002|Overall Study|Lost to Follow-up|0
2187816|NCT01465022|3817851|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8
2187817|NCT01465022|3817852|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9
2187818|NCT01465022|3817853|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0
2187819|NCT01465022|3817851|FG000|Overall Study|Not Randomized|0
2187820|NCT01465022|3817852|FG001|Overall Study|Not Randomized|0
2187821|NCT01465022|3817853|FG002|Overall Study|Not Randomized|70
2187822|NCT01465178|3817874|FG000|Overall Study|Withdrawal by Subject|1
2187823|NCT01465178|3817875|FG001|Overall Study|Withdrawal by Subject|0
2187824|NCT01465191|3817884|FG000|Overall Study|Protocol Violation|6
2187825|NCT01465191|3817885|FG001|Overall Study|Protocol Violation|3
2187826|NCT01465191|3817886|FG002|Overall Study|Protocol Violation|3
2187827|NCT01465191|3817884|FG000|Overall Study|Lost to Follow-up|3
2187828|NCT01465191|3817885|FG001|Overall Study|Lost to Follow-up|6
2187829|NCT01465191|3817886|FG002|Overall Study|Lost to Follow-up|4
2187830|NCT01465334|3817899|FG000|Overall Study|Disease Progression|1
2187831|NCT01465334|3817900|FG001|Overall Study|Disease Progression|0
2187832|NCT01465334|3817899|FG000|Overall Study|Adverse Event|1
2187833|NCT01465334|3817900|FG001|Overall Study|Adverse Event|0
2187834|NCT01465334|3817899|FG000|Overall Study|Richter's transformation|0
2187835|NCT01465334|3817900|FG001|Overall Study|Richter's transformation|3
2187836|NCT01465334|3817899|FG000|Overall Study|Refractory Disease|0
2187837|NCT01465334|3817900|FG001|Overall Study|Refractory Disease|3
2187838|NCT01465347|3817906|FG000|Overall Study|Withdrawal by Subject|1
2187839|NCT01465347|3817907|FG001|Overall Study|Withdrawal by Subject|1
2187840|NCT01465347|3817906|FG000|Overall Study|Physician Decision|0
2187841|NCT01465347|3817907|FG001|Overall Study|Physician Decision|1
2187842|NCT01465347|3817906|FG000|Overall Study|Admitted to hospice|0
2187843|NCT01465347|3817907|FG001|Overall Study|Admitted to hospice|1
2187844|NCT01465386|3817916|FG000|Overall Study|Lack of Efficacy|3
2187845|NCT01465386|3817916|FG000|Overall Study|Adverse Event|1
2187846|NCT01465464|3817939|FG000|Overall Study|Adverse Event|96
2222301|NCT01746901|3867816|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0
2187847|NCT01465464|3817940|FG001|Overall Study|Adverse Event|49
2187848|NCT01465464|3817939|FG000|Overall Study|Lack of Efficacy|139
2187849|NCT01465464|3817940|FG001|Overall Study|Lack of Efficacy|190
2187850|NCT01465464|3817939|FG000|Overall Study|Physician Decision|13
2187851|NCT01465464|3817940|FG001|Overall Study|Physician Decision|5
2187852|NCT01465464|3817939|FG000|Overall Study|Protocol Violation|1
2187853|NCT01465464|3817940|FG001|Overall Study|Protocol Violation|1
2187854|NCT01465464|3817939|FG000|Overall Study|Withdrawal by Subject|46
2187855|NCT01465464|3817940|FG001|Overall Study|Withdrawal by Subject|30
2187856|NCT01465464|3817939|FG000|Overall Study|Other|9
2187857|NCT01465464|3817940|FG001|Overall Study|Other|3
2187858|NCT01465464|3817939|FG000|Overall Study|Ongoing treatment at cutoff date|140
2187859|NCT01465464|3817940|FG001|Overall Study|Ongoing treatment at cutoff date|166
2187860|NCT01465659|3817950|FG000|Completed 1 Cycle of Treatment|Death|0
2187861|NCT01465659|3817951|FG001|Completed 1 Cycle of Treatment|Death|1
2187862|NCT01465659|3817952|FG002|Completed 1 Cycle of Treatment|Death|0
2187863|NCT01465659|3817953|FG003|Completed 1 Cycle of Treatment|Death|0
2187864|NCT01465659|3817950|FG000|Completed 1 Cycle of Treatment|Adverse Event|0
2187865|NCT01465659|3817951|FG001|Completed 1 Cycle of Treatment|Adverse Event|0
2187866|NCT01465659|3817952|FG002|Completed 1 Cycle of Treatment|Adverse Event|0
2187867|NCT01465659|3817953|FG003|Completed 1 Cycle of Treatment|Adverse Event|1
2187868|NCT01465659|3817950|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
2187869|NCT01465659|3817951|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0
2187870|NCT01465659|3817952|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
2187871|NCT01465659|3817953|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
2187872|NCT01465659|3817950|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
2187873|NCT01465659|3817951|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
2187874|NCT01465659|3817952|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
2187875|NCT01465659|3817953|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
2187876|NCT01465659|3817950|FG000|Completed Follow for 1 Year|Death|6
2187877|NCT01465659|3817951|FG001|Completed Follow for 1 Year|Death|3
2187878|NCT01465659|3817952|FG002|Completed Follow for 1 Year|Death|2
2187879|NCT01465659|3817953|FG003|Completed Follow for 1 Year|Death|4
2187880|NCT01465763|3817969|FG000|Overall Study|Withdrawal by Subject|4
2187881|NCT01465763|3817970|FG001|Overall Study|Withdrawal by Subject|0
2187882|NCT01465763|3817971|FG002|Overall Study|Withdrawal by Subject|1
2222302|NCT01746901|3867817|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0
2222303|NCT01746901|3867809|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2222304|NCT01746901|3867810|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
2222305|NCT01746901|3867811|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
2222306|NCT01746901|3867812|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2222307|NCT01746901|3867813|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2222308|NCT01746901|3867814|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2222309|NCT01746901|3867815|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2222310|NCT01746901|3867816|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2222311|NCT01746901|3867817|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2222312|NCT01746901|3867809|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
2222313|NCT01746901|3867810|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3
2222314|NCT01746901|3867811|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3
2222315|NCT01746901|3867812|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
2222316|NCT01746901|3867813|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
2222317|NCT01746901|3867814|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
2222318|NCT01746901|3867815|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
2222319|NCT01746901|3867816|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0
2222320|NCT01746901|3867817|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0
2222321|NCT01746901|3867809|FG000|Treatment Phase: First Intervention|Protocol Violation|0
2222322|NCT01746901|3867810|FG001|Treatment Phase: First Intervention|Protocol Violation|0
2222323|NCT01746901|3867811|FG002|Treatment Phase: First Intervention|Protocol Violation|0
2222324|NCT01746901|3867812|FG003|Treatment Phase: First Intervention|Protocol Violation|0
2222325|NCT01746901|3867813|FG004|Treatment Phase: First Intervention|Protocol Violation|0
2222326|NCT01746901|3867814|FG005|Treatment Phase: First Intervention|Protocol Violation|0
2222327|NCT01746901|3867815|FG006|Treatment Phase: First Intervention|Protocol Violation|1
2222328|NCT01746901|3867816|FG007|Treatment Phase: First Intervention|Protocol Violation|0
2222329|NCT01746901|3867817|FG008|Treatment Phase: First Intervention|Protocol Violation|0
2222330|NCT01746901|3867809|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2222331|NCT01746901|3867810|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2222332|NCT01746901|3867811|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2222333|NCT01746901|3867812|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2222334|NCT01746901|3867813|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2222335|NCT01746901|3867814|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2222336|NCT01746901|3867815|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2222337|NCT01746901|3867816|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1
2222338|NCT01746901|3867817|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2222339|NCT01746901|3867809|FG000|Treatment Phase: Third Intervention|Protocol Violation|0
2222340|NCT01746901|3867810|FG001|Treatment Phase: Third Intervention|Protocol Violation|0
2222341|NCT01746901|3867811|FG002|Treatment Phase: Third Intervention|Protocol Violation|0
2222342|NCT01746901|3867812|FG003|Treatment Phase: Third Intervention|Protocol Violation|0
2187883|NCT01465763|3817969|FG000|Overall Study|Insufficient Clinical Response|11
2187884|NCT01465763|3817970|FG001|Overall Study|Insufficient Clinical Response|0
2187885|NCT01465763|3817971|FG002|Overall Study|Insufficient Clinical Response|1
2187886|NCT01465763|3817969|FG000|Overall Study|Adverse Event|9
2187887|NCT01465763|3817970|FG001|Overall Study|Adverse Event|0
2187888|NCT01465763|3817971|FG002|Overall Study|Adverse Event|1
2187889|NCT01465763|3817969|FG000|Overall Study|Other|2
2187890|NCT01465763|3817970|FG001|Overall Study|Other|0
2187891|NCT01465763|3817971|FG002|Overall Study|Other|0
2187892|NCT01465763|3817969|FG000|Overall Study|Protocol Violation|4
2187893|NCT01465763|3817970|FG001|Overall Study|Protocol Violation|1
2187894|NCT01465763|3817971|FG002|Overall Study|Protocol Violation|1
2187895|NCT01465763|3817969|FG000|Overall Study|Death|1
2187896|NCT01465763|3817970|FG001|Overall Study|Death|0
2187897|NCT01465763|3817971|FG002|Overall Study|Death|0
2187898|NCT01465802|3817983|FG000|Overall Study|Study terminated by sponsor|1
2187899|NCT01465802|3817984|FG001|Overall Study|Study terminated by sponsor|0
2187900|NCT01465802|3817985|FG002|Overall Study|Study terminated by sponsor|0
2187901|NCT01465802|3817986|FG003|Overall Study|Study terminated by sponsor|1
2187902|NCT01465802|3817987|FG004|Overall Study|Study terminated by sponsor|7
2187903|NCT01465802|3817983|FG000|Overall Study|Withdrawal by Subject|7
2187904|NCT01465802|3817984|FG001|Overall Study|Withdrawal by Subject|7
2187905|NCT01465802|3817985|FG002|Overall Study|Withdrawal by Subject|0
2187906|NCT01465802|3817986|FG003|Overall Study|Withdrawal by Subject|8
2187907|NCT01465802|3817987|FG004|Overall Study|Withdrawal by Subject|1
2187908|NCT01465802|3817983|FG000|Overall Study|Lost to Follow-up|1
2187909|NCT01465802|3817984|FG001|Overall Study|Lost to Follow-up|1
2187910|NCT01465802|3817985|FG002|Overall Study|Lost to Follow-up|0
2187911|NCT01465802|3817986|FG003|Overall Study|Lost to Follow-up|0
2187912|NCT01465802|3817987|FG004|Overall Study|Lost to Follow-up|0
2187913|NCT01465802|3817983|FG000|Overall Study|Reason not specified|9
2187914|NCT01465802|3817984|FG001|Overall Study|Reason not specified|4
2187915|NCT01465802|3817985|FG002|Overall Study|Reason not specified|0
2187916|NCT01465802|3817986|FG003|Overall Study|Reason not specified|10
2187917|NCT01465802|3817987|FG004|Overall Study|Reason not specified|2
2187918|NCT01465802|3817983|FG000|Overall Study|Death|15
2187919|NCT01465802|3817984|FG001|Overall Study|Death|12
2187920|NCT01465802|3817985|FG002|Overall Study|Death|0
2187921|NCT01465802|3817986|FG003|Overall Study|Death|10
2187922|NCT01465802|3817987|FG004|Overall Study|Death|2
2187923|NCT01465958|3818005|FG000|Run-in Phase|Protocol Violation|1
2187924|NCT01465958|3818006|FG001|Run-in Phase|Protocol Violation|0
2187925|NCT01465958|3818005|FG000|Subcutaneous (SC) Phase|Adverse Event|0
2187926|NCT01465958|3818006|FG001|Subcutaneous (SC) Phase|Adverse Event|1
2187927|NCT01465997|3818015|FG000|Overall Study|Adverse Event|12
2187928|NCT01465997|3818016|FG001|Overall Study|Adverse Event|22
2187929|NCT01465997|3818015|FG000|Overall Study|Lack of Efficacy|13
2187930|NCT01465997|3818016|FG001|Overall Study|Lack of Efficacy|1
2187931|NCT01465997|3818015|FG000|Overall Study|Protocol Violation|1
2187932|NCT01465997|3818016|FG001|Overall Study|Protocol Violation|4
2187933|NCT01465997|3818015|FG000|Overall Study|Lost to Follow-up|6
2187934|NCT01465997|3818016|FG001|Overall Study|Lost to Follow-up|9
2187935|NCT01465997|3818015|FG000|Overall Study|Withdrawal by Subject|32
2187936|NCT01465997|3818016|FG001|Overall Study|Withdrawal by Subject|35
2187937|NCT01465997|3818015|FG000|Overall Study|investigator's decision|1
2187938|NCT01465997|3818016|FG001|Overall Study|investigator's decision|1
2187939|NCT01465997|3818015|FG000|Overall Study|Death|0
2187940|NCT01465997|3818016|FG001|Overall Study|Death|1
2187941|NCT01465997|3818015|FG000|Overall Study|sponsor's decision|1
2187942|NCT01465997|3818016|FG001|Overall Study|sponsor's decision|1
2187943|NCT01465997|3818015|FG000|Overall Study|subject withdrew consent|1
2187944|NCT01465997|3818016|FG001|Overall Study|subject withdrew consent|0
2187945|NCT01465997|3818015|FG000|Overall Study|local lab unblinded site|1
2187946|NCT01465997|3818016|FG001|Overall Study|local lab unblinded site|0
2187947|NCT01465997|3818015|FG000|Overall Study|withdrew before follow-up|0
2187948|NCT01465997|3818016|FG001|Overall Study|withdrew before follow-up|13
2187949|NCT01465997|3818015|FG000|Overall Study|decision by site staff|0
2187950|NCT01465997|3818016|FG001|Overall Study|decision by site staff|1
2187951|NCT01465997|3818015|FG000|Overall Study|subject left participation SP0993|0
2187952|NCT01465997|3818016|FG001|Overall Study|subject left participation SP0993|1
2187953|NCT01466062|3818024|FG000|Overall Study|Adverse Event|1
2187954|NCT01466062|3818024|FG000|Overall Study|Withdrawal by Subject|1
2187955|NCT01466153|3818044|FG000|Overall Study|Disease Progression|2
2187956|NCT01466153|3818045|FG001|Overall Study|Disease Progression|2
2187957|NCT01466153|3818046|FG002|Overall Study|Disease Progression|0
2187958|NCT01466153|3818044|FG000|Overall Study|Adverse Event|14
2187959|NCT01466153|3818045|FG001|Overall Study|Adverse Event|13
2187960|NCT01466153|3818046|FG002|Overall Study|Adverse Event|17
2187961|NCT01466153|3818044|FG000|Overall Study|Withdrawal of Consent|2
2187962|NCT01466153|3818045|FG001|Overall Study|Withdrawal of Consent|0
2187963|NCT01466153|3818046|FG002|Overall Study|Withdrawal of Consent|0
2187964|NCT01466153|3818044|FG000|Overall Study|Investigator Discretion|3
2187965|NCT01466153|3818045|FG001|Overall Study|Investigator Discretion|2
2187966|NCT01466153|3818046|FG002|Overall Study|Investigator Discretion|2
2187967|NCT01466153|3818044|FG000|Overall Study|Randomized-Not Treated|2
2187968|NCT01466153|3818045|FG001|Overall Study|Randomized-Not Treated|3
2187969|NCT01466153|3818046|FG002|Overall Study|Randomized-Not Treated|4
2187970|NCT01466153|3818044|FG000|Overall Study|Other-Unspecified|6
2187971|NCT01466153|3818045|FG001|Overall Study|Other-Unspecified|4
2222343|NCT01746901|3867813|FG004|Treatment Phase: Third Intervention|Protocol Violation|0
2222344|NCT01746901|3867814|FG005|Treatment Phase: Third Intervention|Protocol Violation|1
2222345|NCT01746901|3867815|FG006|Treatment Phase: Third Intervention|Protocol Violation|1
2222346|NCT01746901|3867816|FG007|Treatment Phase: Third Intervention|Protocol Violation|0
2222347|NCT01746901|3867817|FG008|Treatment Phase: Third Intervention|Protocol Violation|0
2222348|NCT01746901|3867809|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2222349|NCT01746901|3867810|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2222350|NCT01746901|3867811|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2222351|NCT01746901|3867812|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
2222352|NCT01746901|3867813|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2222353|NCT01746901|3867814|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2222354|NCT01746901|3867815|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2222355|NCT01746901|3867816|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2222356|NCT01746901|3867817|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2222357|NCT01746901|3867809|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0
2222358|NCT01746901|3867810|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0
2222359|NCT01746901|3867811|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0
2222360|NCT01746901|3867812|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0
2222361|NCT01746901|3867813|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0
2222362|NCT01746901|3867814|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1
2222363|NCT01746901|3867815|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0
2222364|NCT01746901|3867816|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0
2222365|NCT01746901|3867817|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1
2222366|NCT01746901|3867809|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0
2222367|NCT01746901|3867810|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0
2222368|NCT01746901|3867811|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0
2222369|NCT01746901|3867812|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0
2222370|NCT01746901|3867813|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0
2222371|NCT01746901|3867814|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0
2222372|NCT01746901|3867815|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1
2222373|NCT01746901|3867816|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0
2222374|NCT01746901|3867817|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1
2222375|NCT01747486|3867887|FG000|Stage 1|Physician Decision|3
2222376|NCT01747486|3867888|FG001|Stage 1|Physician Decision|0
2222377|NCT01747486|3867887|FG000|Stage 1|Withdrawal by Subject|4
2222378|NCT01747486|3867888|FG001|Stage 1|Withdrawal by Subject|3
2222379|NCT01747486|3867887|FG000|Stage 1|Disease progression|4
2222380|NCT01747486|3867888|FG001|Stage 1|Disease progression|9
2222381|NCT01747486|3867887|FG000|Stage 1|Death|1
2222382|NCT01747486|3867888|FG001|Stage 1|Death|1
2332169|NCT03188055|4055451|FG002|Overall Study|Withdrawal by Subject|0
2332170|NCT03188055|4055452|FG003|Overall Study|Withdrawal by Subject|1
2332171|NCT03188055|4055453|FG004|Overall Study|Withdrawal by Subject|0
2332172|NCT03188055|4055454|FG005|Overall Study|Withdrawal by Subject|
2332173|NCT03188120|4055465|FG000|Overall Study|Adverse Event|4
2332174|NCT03188120|4055465|FG000|Overall Study|Insufficient Effectiveness|8
2332175|NCT03188120|4055465|FG000|Overall Study|Improved|12
2332176|NCT03188120|4055465|FG000|Overall Study|Lost to Follow-up|7
2187972|NCT01466153|3818046|FG002|Overall Study|Other-Unspecified|2
2187973|NCT01466166|3818056|FG000|Overall Study|Death|1
2187974|NCT01466166|3818056|FG000|Overall Study|Lost to Follow-up|7
2187975|NCT01466166|3818056|FG000|Overall Study|Infusion Reaction (IR)|27
2187976|NCT01466166|3818056|FG000|Overall Study|Adverse Event (Other than IR)|11
2187977|NCT01466166|3818056|FG000|Overall Study|Elevated Serum Uric Acid|78
2187978|NCT01466166|3818056|FG000|Overall Study|Withdrawal by Subject|13
2187979|NCT01466166|3818056|FG000|Overall Study|Sponsor Decision|4
2187980|NCT01466166|3818056|FG000|Overall Study|Protocol Violation/Noncompliance|2
2187981|NCT01466166|3818056|FG000|Overall Study|Other|20
2187982|NCT01466179|3818060|FG000|Overall Study|Ongoing in core study|2
2187983|NCT01466179|3818060|FG000|Overall Study|Physician Decision|46
2187984|NCT01466179|3818060|FG000|Overall Study|Progressive disease|43
2187985|NCT01466179|3818060|FG000|Overall Study|Adverse Event|32
2187986|NCT01466179|3818060|FG000|Overall Study|Disease relapse|23
2187987|NCT01466179|3818060|FG000|Overall Study|Lack of Efficacy|14
2187988|NCT01466179|3818060|FG000|Overall Study|Death|7
2187989|NCT01466179|3818060|FG000|Overall Study|Withdrawal by Subject|7
2187990|NCT01466179|3818060|FG000|Overall Study|Protocol Violation|2
2187991|NCT01466179|3818060|FG000|Overall Study|Other|3
2187992|NCT01466192|3818067|FG000|Overall Study|Physician Decision|1
2187993|NCT01466192|3818067|FG000|Overall Study|Withdrawal by Subject|3
2187994|NCT01466270|3818073|FG000|Overall Study|Withdrawal by Subject|4
2187995|NCT01466270|3818074|FG001|Overall Study|Withdrawal by Subject|1
2187996|NCT01466270|3818073|FG000|Overall Study|Physician Decision|1
2187997|NCT01466270|3818074|FG001|Overall Study|Physician Decision|0
2187998|NCT01466270|3818073|FG000|Overall Study|Lost to Follow-up|1
2187999|NCT01466270|3818074|FG001|Overall Study|Lost to Follow-up|3
2188000|NCT01466270|3818073|FG000|Overall Study|Progression|1
2188001|NCT01466270|3818074|FG001|Overall Study|Progression|0
2188002|NCT01466270|3818073|FG000|Overall Study|Toxicity|4
2188003|NCT01466270|3818074|FG001|Overall Study|Toxicity|1
2188004|NCT01466270|3818073|FG000|Overall Study|Multiple|1
2188005|NCT01466270|3818074|FG001|Overall Study|Multiple|1
2188006|NCT01466348|3818082|FG000|Period I - First Intervention|Withdrawal by Subject|0
2188007|NCT01466348|3818083|FG001|Period I - First Intervention|Withdrawal by Subject|1
2188008|NCT01466387|3818119|FG000|Overall Study|Adverse Event|0
2188009|NCT01466387|3818120|FG001|Overall Study|Adverse Event|0
2188010|NCT01466387|3818121|FG002|Overall Study|Adverse Event|1
2188011|NCT01466387|3818122|FG003|Overall Study|Adverse Event|1
2188012|NCT01466387|3818123|FG004|Overall Study|Adverse Event|0
2188013|NCT01466387|3818124|FG005|Overall Study|Adverse Event|0
2188014|NCT01466387|3818119|FG000|Overall Study|Lost to Follow-up|0
2188015|NCT01466387|3818120|FG001|Overall Study|Lost to Follow-up|0
2188016|NCT01466387|3818121|FG002|Overall Study|Lost to Follow-up|0
2188017|NCT01466387|3818122|FG003|Overall Study|Lost to Follow-up|0
2188018|NCT01466387|3818123|FG004|Overall Study|Lost to Follow-up|0
2188019|NCT01466387|3818124|FG005|Overall Study|Lost to Follow-up|1
2188020|NCT01466387|3818119|FG000|Overall Study|Protocol Violation|1
2188021|NCT01466387|3818120|FG001|Overall Study|Protocol Violation|0
2188022|NCT01466387|3818121|FG002|Overall Study|Protocol Violation|0
2188023|NCT01466387|3818122|FG003|Overall Study|Protocol Violation|1
2188024|NCT01466387|3818123|FG004|Overall Study|Protocol Violation|0
2188025|NCT01466387|3818124|FG005|Overall Study|Protocol Violation|0
2188026|NCT01466491|3818151|FG000|Overall Study|Protocol Violation|0
2188027|NCT01466491|3818152|FG001|Overall Study|Protocol Violation|3
2188028|NCT01466491|3818153|FG002|Overall Study|Protocol Violation|2
2188029|NCT01466491|3818154|FG003|Overall Study|Protocol Violation|0
2188030|NCT01466491|3818151|FG000|Overall Study|Missing Data|0
2188031|NCT01466491|3818152|FG001|Overall Study|Missing Data|0
2188032|NCT01466491|3818153|FG002|Overall Study|Missing Data|1
2188033|NCT01466491|3818154|FG003|Overall Study|Missing Data|0
2188034|NCT01466595|3818166|FG000|Overall Study|Withdrawal by Subject|0
2188035|NCT01466595|3818167|FG001|Overall Study|Withdrawal by Subject|1
2188036|NCT01466660|3818175|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120
2188037|NCT01466660|3818176|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127
2188038|NCT01466660|3818175|FG000|Overall Study|Worsening of underlying cancer disease|5
2188039|NCT01466660|3818176|FG001|Overall Study|Worsening of underlying cancer disease|2
2188040|NCT01466660|3818175|FG000|Overall Study|Other adverse event|19
2188041|NCT01466660|3818176|FG001|Overall Study|Other adverse event|18
2188042|NCT01466660|3818175|FG000|Overall Study|Protocol Violation|2
2188043|NCT01466660|3818176|FG001|Overall Study|Protocol Violation|1
2188044|NCT01466660|3818175|FG000|Overall Study|Refused continuation of trial medication|4
2188045|NCT01466660|3818176|FG001|Overall Study|Refused continuation of trial medication|3
2188046|NCT01466660|3818175|FG000|Overall Study|Other reason not defined above|10
2188047|NCT01466660|3818176|FG001|Overall Study|Other reason not defined above|8
2188048|NCT01466673|3818184|FG000|Overall Study|Non-compliance with study treatment|2
2188049|NCT01466673|3818185|FG001|Overall Study|Non-compliance with study treatment|0
2188050|NCT01466673|3818184|FG000|Overall Study|Lost to Follow-up|3
2188051|NCT01466673|3818185|FG001|Overall Study|Lost to Follow-up|5
2188052|NCT01466673|3818184|FG000|Overall Study|Adverse Event|2
2188053|NCT01466673|3818185|FG001|Overall Study|Adverse Event|1
2188054|NCT01466790|3818219|FG000|Overall Study|Adverse Event|1
2188055|NCT01466790|3818220|FG001|Overall Study|Adverse Event|0
2188056|NCT01466790|3818221|FG002|Overall Study|Adverse Event|0
2188057|NCT01466790|3818222|FG003|Overall Study|Adverse Event|0
2188058|NCT01466790|3818223|FG004|Overall Study|Adverse Event|2
2188059|NCT01466790|3818224|FG005|Overall Study|Adverse Event|0
2188060|NCT01466790|3818225|FG006|Overall Study|Adverse Event|0
2188061|NCT01466790|3818226|FG007|Overall Study|Adverse Event|0
2188062|NCT01466790|3818219|FG000|Overall Study|Lost to Follow-up|2
2188063|NCT01466790|3818220|FG001|Overall Study|Lost to Follow-up|0
2188064|NCT01466790|3818221|FG002|Overall Study|Lost to Follow-up|0
2188065|NCT01466790|3818222|FG003|Overall Study|Lost to Follow-up|0
2188066|NCT01466790|3818223|FG004|Overall Study|Lost to Follow-up|0
2188067|NCT01466790|3818224|FG005|Overall Study|Lost to Follow-up|0
2188068|NCT01466790|3818225|FG006|Overall Study|Lost to Follow-up|0
2188069|NCT01466790|3818226|FG007|Overall Study|Lost to Follow-up|0
2188070|NCT01466790|3818219|FG000|Overall Study|Withdrawal by Subject|1
2188071|NCT01466790|3818220|FG001|Overall Study|Withdrawal by Subject|1
2188072|NCT01466790|3818221|FG002|Overall Study|Withdrawal by Subject|0
2188073|NCT01466790|3818222|FG003|Overall Study|Withdrawal by Subject|0
2188074|NCT01466790|3818223|FG004|Overall Study|Withdrawal by Subject|1
2188075|NCT01466790|3818224|FG005|Overall Study|Withdrawal by Subject|0
2188076|NCT01466790|3818225|FG006|Overall Study|Withdrawal by Subject|1
2188077|NCT01466790|3818226|FG007|Overall Study|Withdrawal by Subject|1
2188078|NCT01466881|3818240|FG000|Overall Study|Ineligible|5
2188079|NCT01466881|3818240|FG000|Overall Study|Adverse Event|6
2188080|NCT01466881|3818240|FG000|Overall Study|Progression/relapse|20
2188081|NCT01466881|3818240|FG000|Overall Study|Death|4
2188082|NCT01466881|3818240|FG000|Overall Study|Other reason not protocol specified|5
2188083|NCT01467076|3818283|FG000|Overall Study|Lost to Follow-up|1
2188084|NCT01467076|3818284|FG001|Overall Study|Lost to Follow-up|0
2188085|NCT01467076|3818285|FG002|Overall Study|Lost to Follow-up|0
2222383|NCT01747486|3867887|FG000|Stage 2|Physician Decision|2
2222384|NCT01747486|3867888|FG001|Stage 2|Physician Decision|0
2222385|NCT01747486|3867887|FG000|Stage 2|Withdrawal by Subject|1
2222386|NCT01747486|3867888|FG001|Stage 2|Withdrawal by Subject|0
2222387|NCT01747486|3867887|FG000|Stage 2|New Cancer Therapy|3
2222388|NCT01747486|3867888|FG001|Stage 2|New Cancer Therapy|0
2222389|NCT01747486|3867887|FG000|Stage 2|Disease Progression|3
2222390|NCT01747486|3867888|FG001|Stage 2|Disease Progression|0
2222391|NCT01747499|3867899|FG000|Overall Study|Steroid refractory aGvHD|1
2222392|NCT01747499|3867900|FG001|Overall Study|Steroid refractory aGvHD|0
2222393|NCT01747499|3867901|FG002|Overall Study|Steroid refractory aGvHD|0
2222394|NCT01747499|3867902|FG003|Overall Study|Steroid refractory aGvHD|1
2222395|NCT01747499|3867903|FG004|Overall Study|Steroid refractory aGvHD|4
2222396|NCT01747499|3867899|FG000|Overall Study|Physician Decision|0
2222397|NCT01747499|3867900|FG001|Overall Study|Physician Decision|1
2222398|NCT01747499|3867901|FG002|Overall Study|Physician Decision|0
2222399|NCT01747499|3867902|FG003|Overall Study|Physician Decision|0
2222400|NCT01747499|3867903|FG004|Overall Study|Physician Decision|2
2222401|NCT01747499|3867899|FG000|Overall Study|Death|0
2222402|NCT01747499|3867900|FG001|Overall Study|Death|0
2222403|NCT01747499|3867901|FG002|Overall Study|Death|0
2222404|NCT01747499|3867902|FG003|Overall Study|Death|1
2222405|NCT01747499|3867903|FG004|Overall Study|Death|1
2222406|NCT01747499|3867899|FG000|Overall Study|Withdrawal by Subject|0
2222407|NCT01747499|3867900|FG001|Overall Study|Withdrawal by Subject|0
2222408|NCT01747499|3867901|FG002|Overall Study|Withdrawal by Subject|0
2222409|NCT01747499|3867902|FG003|Overall Study|Withdrawal by Subject|0
2222410|NCT01747499|3867903|FG004|Overall Study|Withdrawal by Subject|6
2222411|NCT01747499|3867899|FG000|Overall Study|Developed AML and death|0
2222412|NCT01747499|3867900|FG001|Overall Study|Developed AML and death|0
2222413|NCT01747499|3867901|FG002|Overall Study|Developed AML and death|0
2222414|NCT01747499|3867902|FG003|Overall Study|Developed AML and death|0
2222415|NCT01747499|3867903|FG004|Overall Study|Developed AML and death|1
2222416|NCT01747499|3867899|FG000|Overall Study|Determined not to be eligible|0
2222417|NCT01747499|3867900|FG001|Overall Study|Determined not to be eligible|0
2222418|NCT01747499|3867901|FG002|Overall Study|Determined not to be eligible|0
2222419|NCT01747499|3867902|FG003|Overall Study|Determined not to be eligible|0
2222420|NCT01747499|3867903|FG004|Overall Study|Determined not to be eligible|1
2222421|NCT01747551|3867919|FG000|Overall Study|Progressive Disease|24
2222422|NCT01747551|3867920|FG001|Overall Study|Progressive Disease|17
2222423|NCT01747551|3867919|FG000|Overall Study|Death|3
2222424|NCT01747551|3867920|FG001|Overall Study|Death|1
2222425|NCT01747551|3867919|FG000|Overall Study|Adverse Event|7
2222426|NCT01747551|3867920|FG001|Overall Study|Adverse Event|1
2222427|NCT01747551|3867919|FG000|Overall Study|Prolonged Treatment Delay|2
2222428|NCT01747551|3867920|FG001|Overall Study|Prolonged Treatment Delay|0
2222429|NCT01747551|3867919|FG000|Overall Study|Withdrawal by Subject|3
2222430|NCT01747551|3867920|FG001|Overall Study|Withdrawal by Subject|1
2222431|NCT01747551|3867919|FG000|Overall Study|Physician Decision|2
2222432|NCT01747551|3867920|FG001|Overall Study|Physician Decision|1
2222433|NCT01747551|3867919|FG000|Overall Study|Other|2
2222434|NCT01747551|3867920|FG001|Overall Study|Other|0
2222435|NCT01747629|3867928|FG000|Overall Study|Adverse Event|1
2222436|NCT01747629|3867929|FG001|Overall Study|Adverse Event|2
2222437|NCT01747629|3867928|FG000|Overall Study|Withdrawal by Subject|2
2222438|NCT01747629|3867929|FG001|Overall Study|Withdrawal by Subject|2
2222439|NCT01747629|3867928|FG000|Overall Study|Noncompliance|1
2222440|NCT01747629|3867929|FG001|Overall Study|Noncompliance|1
2222441|NCT01747629|3867928|FG000|Overall Study|Inclusion criteria not met|1
2222442|NCT01747629|3867929|FG001|Overall Study|Inclusion criteria not met|0
2222443|NCT01747629|3867928|FG000|Overall Study|Not treated|1
2222444|NCT01747629|3867929|FG001|Overall Study|Not treated|0
2222445|NCT01747629|3867928|FG000|Overall Study|Other|2
2222446|NCT01747629|3867929|FG001|Overall Study|Other|1
2222447|NCT01747655|3867935|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
2222448|NCT01747655|3867936|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
2222449|NCT01747655|3867935|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8
2222450|NCT01747655|3867936|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0
2222451|NCT01747655|3867935|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
2188086|NCT01467271|3818293|FG000|Overall Study|Death|84
2188087|NCT01467271|3818293|FG000|Overall Study|Lost to Follow-up|83
2188088|NCT01467271|3818293|FG000|Overall Study|Retraction of patient's consent|21
2188089|NCT01467271|3818293|FG000|Overall Study|Other reason|14
2188090|NCT01467427|3818299|FG000|Overall Study|Withdrawal by Subject|1
2188091|NCT01467427|3818300|FG001|Overall Study|Withdrawal by Subject|0
2188092|NCT01467427|3818299|FG000|Overall Study|Entered extension phase|11
2188093|NCT01467427|3818300|FG001|Overall Study|Entered extension phase|11
2188094|NCT01467427|3818299|FG000|Overall Study|Not continuing in extension phase|0
2188095|NCT01467427|3818300|FG001|Overall Study|Not continuing in extension phase|2
2188096|NCT01467466|3818310|FG000|Overall Study|Withdrawal by Subject|15
2188097|NCT01467466|3818311|FG001|Overall Study|Withdrawal by Subject|18
2188098|NCT01467466|3818312|FG002|Overall Study|Withdrawal by Subject|13
2188099|NCT01467466|3818313|FG003|Overall Study|Withdrawal by Subject|11
2188100|NCT01467466|3818310|FG000|Overall Study|Revoked Consent Prior To Procedure|10
2188101|NCT01467466|3818311|FG001|Overall Study|Revoked Consent Prior To Procedure|9
2188102|NCT01467466|3818312|FG002|Overall Study|Revoked Consent Prior To Procedure|15
2188103|NCT01467466|3818313|FG003|Overall Study|Revoked Consent Prior To Procedure|5
2188104|NCT01467466|3818310|FG000|Overall Study|Procedure Cancelled|46
2188105|NCT01467466|3818311|FG001|Overall Study|Procedure Cancelled|45
2188106|NCT01467466|3818312|FG002|Overall Study|Procedure Cancelled|25
2188107|NCT01467466|3818313|FG003|Overall Study|Procedure Cancelled|29
2188108|NCT01467466|3818310|FG000|Overall Study|No Endpoint Blood Draw|38
2188109|NCT01467466|3818311|FG001|Overall Study|No Endpoint Blood Draw|32
2188110|NCT01467466|3818312|FG002|Overall Study|No Endpoint Blood Draw|51
2188111|NCT01467466|3818313|FG003|Overall Study|No Endpoint Blood Draw|43
2188112|NCT01467479|3818326|FG000|Overall Study|No Study Medication|1
2188113|NCT01467479|3818327|FG001|Overall Study|No Study Medication|0
2188114|NCT01467479|3818328|FG002|Overall Study|No Study Medication|2
2188115|NCT01467479|3818326|FG000|Overall Study|Adverse Event|1
2188116|NCT01467479|3818327|FG001|Overall Study|Adverse Event|2
2188117|NCT01467479|3818328|FG002|Overall Study|Adverse Event|0
2188118|NCT01467479|3818326|FG000|Overall Study|Death|0
2188119|NCT01467479|3818327|FG001|Overall Study|Death|0
2188120|NCT01467479|3818328|FG002|Overall Study|Death|1
2188121|NCT01467479|3818326|FG000|Overall Study|Lost to Follow-up|2
2188122|NCT01467479|3818327|FG001|Overall Study|Lost to Follow-up|5
2188123|NCT01467479|3818328|FG002|Overall Study|Lost to Follow-up|3
2188124|NCT01467479|3818326|FG000|Overall Study|Withdrawal of Consent|3
2188125|NCT01467479|3818327|FG001|Overall Study|Withdrawal of Consent|7
2188126|NCT01467479|3818328|FG002|Overall Study|Withdrawal of Consent|7
2188127|NCT01467479|3818326|FG000|Overall Study|Study Terminated by Sponsor|1
2188128|NCT01467479|3818327|FG001|Overall Study|Study Terminated by Sponsor|3
2188129|NCT01467479|3818328|FG002|Overall Study|Study Terminated by Sponsor|3
2188130|NCT01467479|3818326|FG000|Overall Study|Other|1
2188131|NCT01467479|3818327|FG001|Overall Study|Other|0
2188132|NCT01467479|3818328|FG002|Overall Study|Other|0
2188133|NCT01467492|3818339|FG000|Overall Study|Withdrawal by Subject|6
2188134|NCT01467492|3818340|FG001|Overall Study|Withdrawal by Subject|4
2188135|NCT01467492|3818339|FG000|Overall Study|Study Terminated by Sponsor|6
2188136|NCT01467492|3818340|FG001|Overall Study|Study Terminated by Sponsor|4
2188137|NCT01467492|3818339|FG000|Overall Study|Adverse Event|4
2188138|NCT01467492|3818340|FG001|Overall Study|Adverse Event|3
2188139|NCT01467492|3818339|FG000|Overall Study|Lost to Follow-up|3
2188140|NCT01467492|3818340|FG001|Overall Study|Lost to Follow-up|2
2188141|NCT01467492|3818339|FG000|Overall Study|Undefined|2
2188142|NCT01467492|3818340|FG001|Overall Study|Undefined|0
2188143|NCT01467492|3818339|FG000|Overall Study|Enrolled But Not Treated|1
2188144|NCT01467492|3818340|FG001|Overall Study|Enrolled But Not Treated|0
2188145|NCT01467505|3818349|FG000|Overall Study|Adverse Event|1
2188146|NCT01467505|3818350|FG001|Overall Study|Adverse Event|0
2188147|NCT01467505|3818349|FG000|Overall Study|Withdrawal by Subject|4
2188148|NCT01467505|3818350|FG001|Overall Study|Withdrawal by Subject|0
2188149|NCT01467505|3818349|FG000|Overall Study|Study Terminated by Sponsor|28
2188150|NCT01467505|3818350|FG001|Overall Study|Study Terminated by Sponsor|3
2188151|NCT01467570|3818367|FG000|Overall Study|Lost to Follow-up|8
2188152|NCT01467570|3818368|FG001|Overall Study|Lost to Follow-up|9
2188153|NCT01467583|3818379|FG000|Overall Study|Death|1
2188154|NCT01467583|3818380|FG001|Overall Study|Death|1
2188155|NCT01467583|3818381|FG002|Overall Study|Death|0
2188156|NCT01467583|3818379|FG000|Overall Study|Withdrawal by Subject|1
2188157|NCT01467583|3818380|FG001|Overall Study|Withdrawal by Subject|0
2188158|NCT01467583|3818381|FG002|Overall Study|Withdrawal by Subject|0
2188159|NCT01467583|3818379|FG000|Overall Study|Protocol Violation|0
2188160|NCT01467583|3818380|FG001|Overall Study|Protocol Violation|0
2188161|NCT01467583|3818381|FG002|Overall Study|Protocol Violation|2
2188162|NCT01467661|3818392|FG000|Overall Study|Adverse Event|16
2188163|NCT01467661|3818392|FG000|Overall Study|Withdrawal by Subject|1
2188164|NCT01467661|3818392|FG000|Overall Study|Lack of Efficacy|3
2188165|NCT01467661|3818392|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
2188166|NCT01467700|3818402|FG000|Overall Study|Pretreatment Event or Adverse Event|6
2188167|NCT01467700|3818403|FG001|Overall Study|Pretreatment Event or Adverse Event|4
2188168|NCT01467700|3818404|FG002|Overall Study|Pretreatment Event or Adverse Event|2
2188169|NCT01467700|3818405|FG003|Overall Study|Pretreatment Event or Adverse Event|3
2188170|NCT01467700|3818402|FG000|Overall Study|Major Protocol Deviation|3
2188171|NCT01467700|3818403|FG001|Overall Study|Major Protocol Deviation|3
2188172|NCT01467700|3818404|FG002|Overall Study|Major Protocol Deviation|2
2188173|NCT01467700|3818405|FG003|Overall Study|Major Protocol Deviation|3
2188174|NCT01467700|3818402|FG000|Overall Study|Lost to Follow-up|6
2188175|NCT01467700|3818403|FG001|Overall Study|Lost to Follow-up|5
2188176|NCT01467700|3818404|FG002|Overall Study|Lost to Follow-up|2
2188177|NCT01467700|3818405|FG003|Overall Study|Lost to Follow-up|3
2188178|NCT01467700|3818402|FG000|Overall Study|Voluntary Withdrawal|5
2188179|NCT01467700|3818403|FG001|Overall Study|Voluntary Withdrawal|7
2222452|NCT01747655|3867936|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
2222453|NCT01747772|3867942|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
2222454|NCT01747811|3867952|FG000|Overall Study|Lack of Efficacy|2
2222455|NCT01747811|3867953|FG001|Overall Study|Lack of Efficacy|4
2222456|NCT01747837|3867963|FG000|Overall Study|Lost to Follow-up|5
2222457|NCT01747837|3867964|FG001|Overall Study|Lost to Follow-up|2
2222458|NCT01747837|3867963|FG000|Overall Study|Death|4
2222459|NCT01747837|3867964|FG001|Overall Study|Death|4
2222460|NCT01747876|3867998|FG000|Overall Study|Adverse Event|1
2222461|NCT01747876|3867999|FG001|Overall Study|Adverse Event|0
2222462|NCT01747876|3868000|FG002|Overall Study|Adverse Event|2
2222463|NCT01747876|3867998|FG000|Overall Study|Withdrawal by Subject|0
2222464|NCT01747876|3867999|FG001|Overall Study|Withdrawal by Subject|1
2222465|NCT01747876|3868000|FG002|Overall Study|Withdrawal by Subject|1
2222466|NCT01747876|3867998|FG000|Overall Study|Disease progression|4
2222467|NCT01747876|3867999|FG001|Overall Study|Disease progression|13
2222468|NCT01747876|3868000|FG002|Overall Study|Disease progression|8
2222469|NCT01747876|3867998|FG000|Overall Study|Trtment duration compl. as per protocol|0
2222470|NCT01747876|3867999|FG001|Overall Study|Trtment duration compl. as per protocol|1
2222471|NCT01747876|3868000|FG002|Overall Study|Trtment duration compl. as per protocol|1
2222472|NCT01747915|3868014|FG000|Overall Study|Other|1
2222473|NCT01747915|3868015|FG001|Overall Study|Other|1
2222474|NCT01747915|3868016|FG002|Overall Study|Other|1
2222475|NCT01747915|3868014|FG000|Overall Study|Adverse Event|8
2222476|NCT01747915|3868015|FG001|Overall Study|Adverse Event|5
2222477|NCT01747915|3868016|FG002|Overall Study|Adverse Event|2
2222478|NCT01747915|3868014|FG000|Overall Study|Death|0
2222479|NCT01747915|3868015|FG001|Overall Study|Death|0
2222480|NCT01747915|3868016|FG002|Overall Study|Death|1
2222481|NCT01747915|3868014|FG000|Overall Study|Lack of Efficacy|0
2222482|NCT01747915|3868015|FG001|Overall Study|Lack of Efficacy|1
2222483|NCT01747915|3868016|FG002|Overall Study|Lack of Efficacy|0
2222484|NCT01747915|3868014|FG000|Overall Study|Lost to Follow-up|1
2222485|NCT01747915|3868015|FG001|Overall Study|Lost to Follow-up|0
2222486|NCT01747915|3868016|FG002|Overall Study|Lost to Follow-up|0
2222487|NCT01747915|3868014|FG000|Overall Study|Withdrawal by Subject|4
2222488|NCT01747915|3868015|FG001|Overall Study|Withdrawal by Subject|4
2222489|NCT01747915|3868016|FG002|Overall Study|Withdrawal by Subject|1
2222490|NCT01747915|3868014|FG000|Overall Study|Protocol Violation|1
2222491|NCT01747915|3868015|FG001|Overall Study|Protocol Violation|0
2222492|NCT01747915|3868016|FG002|Overall Study|Protocol Violation|0
2222493|NCT01747915|3868014|FG000|Overall Study|Pregnancy|0
2222494|NCT01747915|3868015|FG001|Overall Study|Pregnancy|0
2222495|NCT01747915|3868016|FG002|Overall Study|Pregnancy|1
2222496|NCT01748071|3868076|FG000|Overall Study|Adverse Event|2
2222497|NCT01748071|3868077|FG001|Overall Study|Adverse Event|2
2222498|NCT01748071|3868078|FG002|Overall Study|Adverse Event|0
2222499|NCT01748292|3868097|FG000|Overall Study|Adverse Event|2
2222500|NCT01748292|3868098|FG001|Overall Study|Adverse Event|4
2222501|NCT01748292|3868097|FG000|Overall Study|Lost to Follow-up|0
2222502|NCT01748292|3868098|FG001|Overall Study|Lost to Follow-up|3
2222503|NCT01748292|3868097|FG000|Overall Study|Death|0
2222504|NCT01748292|3868098|FG001|Overall Study|Death|3
2332177|NCT03188120|4055465|FG000|Overall Study|Other than specified|3
2332178|NCT03188120|4055465|FG000|Overall Study|No visit after the first visit|13
2332179|NCT03188185|4055471|FG000|Stage 1|Adverse Event|4
2332180|NCT03188185|4055472|FG001|Stage 1|Adverse Event|12
2332181|NCT03188185|4055473|FG002|Stage 1|Adverse Event|0
2332182|NCT03188185|4055474|FG003|Stage 1|Adverse Event|0
2332183|NCT03188185|4055471|FG000|Stage 1|Lack of Efficacy|0
2332184|NCT03188185|4055472|FG001|Stage 1|Lack of Efficacy|2
2332185|NCT03188185|4055473|FG002|Stage 1|Lack of Efficacy|0
2332186|NCT03188185|4055474|FG003|Stage 1|Lack of Efficacy|0
2332187|NCT03188185|4055471|FG000|Stage 1|Lost to Follow-up|6
2332188|NCT03188185|4055472|FG001|Stage 1|Lost to Follow-up|1
2332189|NCT03188185|4055473|FG002|Stage 1|Lost to Follow-up|0
2332190|NCT03188185|4055474|FG003|Stage 1|Lost to Follow-up|0
2332191|NCT03188185|4055471|FG000|Stage 1|Withdrawal by Subject|9
2332192|NCT03188185|4055472|FG001|Stage 1|Withdrawal by Subject|0
2332193|NCT03188185|4055473|FG002|Stage 1|Withdrawal by Subject|0
2332194|NCT03188185|4055474|FG003|Stage 1|Withdrawal by Subject|0
2332195|NCT03188185|4055471|FG000|Stage 1|Identified as a professional patient|0
2332196|NCT03188185|4055472|FG001|Stage 1|Identified as a professional patient|1
2222505|NCT01748292|3868097|FG000|Overall Study|Withdrawal by Subject|0
2222506|NCT01748292|3868098|FG001|Overall Study|Withdrawal by Subject|2
2222507|NCT01748552|3868116|FG000|Intervention Period 2 and Washout|Physician Decision|0
2222508|NCT01748552|3868117|FG001|Intervention Period 2 and Washout|Physician Decision|0
2332197|NCT03188185|4055473|FG002|Stage 1|Identified as a professional patient|0
2188180|NCT01467700|3818404|FG002|Overall Study|Voluntary Withdrawal|6
2188181|NCT01467700|3818405|FG003|Overall Study|Voluntary Withdrawal|2
2188182|NCT01467700|3818402|FG000|Overall Study|Study Termination|6
2188183|NCT01467700|3818403|FG001|Overall Study|Study Termination|5
2188184|NCT01467700|3818404|FG002|Overall Study|Study Termination|10
2188185|NCT01467700|3818405|FG003|Overall Study|Study Termination|7
2188186|NCT01467700|3818402|FG000|Overall Study|Pregnancy|0
2188187|NCT01467700|3818403|FG001|Overall Study|Pregnancy|1
2188188|NCT01467700|3818404|FG002|Overall Study|Pregnancy|1
2188189|NCT01467700|3818405|FG003|Overall Study|Pregnancy|0
2188190|NCT01467700|3818402|FG000|Overall Study|Lack of Efficacy|2
2188191|NCT01467700|3818403|FG001|Overall Study|Lack of Efficacy|0
2188192|NCT01467700|3818404|FG002|Overall Study|Lack of Efficacy|2
2188193|NCT01467700|3818405|FG003|Overall Study|Lack of Efficacy|1
2188194|NCT01467700|3818402|FG000|Overall Study|Reason not Specified|1
2188195|NCT01467700|3818403|FG001|Overall Study|Reason not Specified|3
2188196|NCT01467700|3818404|FG002|Overall Study|Reason not Specified|2
2188197|NCT01467700|3818405|FG003|Overall Study|Reason not Specified|8
2188198|NCT01467713|3818419|FG000|Overall Study|Pretreatment Event or Adverse Event|9
2188199|NCT01467713|3818420|FG001|Overall Study|Pretreatment Event or Adverse Event|4
2188200|NCT01467713|3818421|FG002|Overall Study|Pretreatment Event or Adverse Event|6
2188201|NCT01467713|3818422|FG003|Overall Study|Pretreatment Event or Adverse Event|5
2188202|NCT01467713|3818419|FG000|Overall Study|Major Protocol Deviation|2
2188203|NCT01467713|3818420|FG001|Overall Study|Major Protocol Deviation|4
2188204|NCT01467713|3818421|FG002|Overall Study|Major Protocol Deviation|4
2188205|NCT01467713|3818422|FG003|Overall Study|Major Protocol Deviation|1
2188206|NCT01467713|3818419|FG000|Overall Study|Lost to Follow-up|9
2188207|NCT01467713|3818420|FG001|Overall Study|Lost to Follow-up|12
2188208|NCT01467713|3818421|FG002|Overall Study|Lost to Follow-up|6
2188209|NCT01467713|3818422|FG003|Overall Study|Lost to Follow-up|9
2188210|NCT01467713|3818419|FG000|Overall Study|Voluntary Withdrawal|18
2188211|NCT01467713|3818420|FG001|Overall Study|Voluntary Withdrawal|14
2188212|NCT01467713|3818421|FG002|Overall Study|Voluntary Withdrawal|21
2188213|NCT01467713|3818422|FG003|Overall Study|Voluntary Withdrawal|20
2188214|NCT01467713|3818419|FG000|Overall Study|Study Termination|23
2188215|NCT01467713|3818420|FG001|Overall Study|Study Termination|33
2188216|NCT01467713|3818421|FG002|Overall Study|Study Termination|28
2188217|NCT01467713|3818422|FG003|Overall Study|Study Termination|29
2188218|NCT01467713|3818419|FG000|Overall Study|Pregnancy|0
2188219|NCT01467713|3818420|FG001|Overall Study|Pregnancy|1
2188220|NCT01467713|3818421|FG002|Overall Study|Pregnancy|1
2188221|NCT01467713|3818422|FG003|Overall Study|Pregnancy|3
2188222|NCT01467713|3818419|FG000|Overall Study|Relapse|35
2188223|NCT01467713|3818420|FG001|Overall Study|Relapse|25
2188224|NCT01467713|3818421|FG002|Overall Study|Relapse|28
2188225|NCT01467713|3818422|FG003|Overall Study|Relapse|35
2188226|NCT01467713|3818419|FG000|Overall Study|Reason not Specified|6
2188227|NCT01467713|3818420|FG001|Overall Study|Reason not Specified|11
2188228|NCT01467713|3818421|FG002|Overall Study|Reason not Specified|8
2188229|NCT01467713|3818422|FG003|Overall Study|Reason not Specified|7
2188230|NCT01467960|3818466|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0
2188231|NCT01467960|3818467|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0
2188232|NCT01467960|3818468|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0
2188233|NCT01467960|3818469|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30
2188234|NCT01467960|3818470|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30
2222509|NCT01748552|3868118|FG002|Intervention Period 2 and Washout|Physician Decision|1
2222510|NCT01748552|3868119|FG003|Intervention Period 2 and Washout|Physician Decision|0
2222511|NCT01748552|3868120|FG004|Intervention Period 2 and Washout|Physician Decision|0
2222512|NCT01748552|3868121|FG005|Intervention Period 2 and Washout|Physician Decision|0
2222513|NCT01748552|3868122|FG006|Intervention Period 2 and Washout|Physician Decision|0
2222514|NCT01748552|3868123|FG007|Intervention Period 2 and Washout|Physician Decision|0
2222515|NCT01748552|3868124|FG008|Intervention Period 2 and Washout|Physician Decision|0
2222516|NCT01748552|3868125|FG009|Intervention Period 2 and Washout|Physician Decision|0
2222517|NCT01748552|3868126|FG010|Intervention Period 2 and Washout|Physician Decision|0
2222518|NCT01748552|3868127|FG011|Intervention Period 2 and Washout|Physician Decision|0
2222519|NCT01748552|3868116|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0
2222520|NCT01748552|3868117|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0
2222521|NCT01748552|3868118|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0
2222522|NCT01748552|3868119|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0
2222523|NCT01748552|3868120|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0
2222524|NCT01748552|3868121|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0
2222525|NCT01748552|3868122|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3
2222526|NCT01748552|3868123|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3
2188235|NCT01467960|3818471|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30
2188236|NCT01468077|3818505|FG000|Overall Study|Adverse Event|2
2188237|NCT01468077|3818506|FG001|Overall Study|Adverse Event|2
2188238|NCT01468077|3818505|FG000|Overall Study|Lack of Efficacy|1
2188239|NCT01468077|3818506|FG001|Overall Study|Lack of Efficacy|1
2188240|NCT01468077|3818505|FG000|Overall Study|Physician Decision|1
2188241|NCT01468077|3818506|FG001|Overall Study|Physician Decision|0
2188242|NCT01468181|3818517|FG000|Overall Study|Adverse Event|8
2188243|NCT01468181|3818518|FG001|Overall Study|Adverse Event|1
2188244|NCT01468181|3818519|FG002|Overall Study|Adverse Event|6
2188245|NCT01468181|3818520|FG003|Overall Study|Adverse Event|2
2188246|NCT01468181|3818521|FG004|Overall Study|Adverse Event|2
2188247|NCT01468181|3818517|FG000|Overall Study|Protocol Violation|2
2188248|NCT01468181|3818518|FG001|Overall Study|Protocol Violation|0
2188249|NCT01468181|3818519|FG002|Overall Study|Protocol Violation|1
2188250|NCT01468181|3818520|FG003|Overall Study|Protocol Violation|0
2188251|NCT01468181|3818521|FG004|Overall Study|Protocol Violation|1
2188252|NCT01468181|3818517|FG000|Overall Study|Physician Decision|0
2188253|NCT01468181|3818518|FG001|Overall Study|Physician Decision|0
2188254|NCT01468181|3818519|FG002|Overall Study|Physician Decision|0
2188255|NCT01468181|3818520|FG003|Overall Study|Physician Decision|1
2188256|NCT01468181|3818521|FG004|Overall Study|Physician Decision|1
2188257|NCT01468181|3818517|FG000|Overall Study|Lost to Follow-up|0
2188258|NCT01468181|3818518|FG001|Overall Study|Lost to Follow-up|0
2188259|NCT01468181|3818519|FG002|Overall Study|Lost to Follow-up|1
2188260|NCT01468181|3818520|FG003|Overall Study|Lost to Follow-up|0
2188261|NCT01468181|3818521|FG004|Overall Study|Lost to Follow-up|1
2188262|NCT01468181|3818517|FG000|Overall Study|Withdrawal by Subject|0
2188263|NCT01468181|3818518|FG001|Overall Study|Withdrawal by Subject|1
2188264|NCT01468181|3818519|FG002|Overall Study|Withdrawal by Subject|0
2188265|NCT01468181|3818520|FG003|Overall Study|Withdrawal by Subject|0
2188266|NCT01468181|3818521|FG004|Overall Study|Withdrawal by Subject|0
2188267|NCT01468207|3818535|FG000|Treatment Period 1|Adverse Event|1
2188268|NCT01468207|3818536|FG001|Treatment Period 1|Adverse Event|0
2188269|NCT01468207|3818537|FG002|Treatment Period 1|Adverse Event|0
2188270|NCT01468207|3818538|FG003|Treatment Period 1|Adverse Event|0
2188271|NCT01468207|3818539|FG004|Treatment Period 1|Adverse Event|0
2188272|NCT01468207|3818540|FG005|Treatment Period 1|Adverse Event|0
2188273|NCT01468207|3818535|FG000|Treatment Period 1|Protocol Violation|1
2188274|NCT01468207|3818536|FG001|Treatment Period 1|Protocol Violation|1
2188275|NCT01468207|3818537|FG002|Treatment Period 1|Protocol Violation|0
2188276|NCT01468207|3818538|FG003|Treatment Period 1|Protocol Violation|0
2188277|NCT01468207|3818539|FG004|Treatment Period 1|Protocol Violation|0
2188278|NCT01468207|3818540|FG005|Treatment Period 1|Protocol Violation|0
2188279|NCT01468207|3818535|FG000|Treatment Period 1|Withdrawal by Subject|5
2188280|NCT01468207|3818536|FG001|Treatment Period 1|Withdrawal by Subject|4
2188281|NCT01468207|3818537|FG002|Treatment Period 1|Withdrawal by Subject|0
2188282|NCT01468207|3818538|FG003|Treatment Period 1|Withdrawal by Subject|0
2188283|NCT01468207|3818539|FG004|Treatment Period 1|Withdrawal by Subject|0
2188284|NCT01468207|3818540|FG005|Treatment Period 1|Withdrawal by Subject|0
2188285|NCT01468207|3818535|FG000|Treatment Period 1|Lost to Follow-up|2
2188286|NCT01468207|3818536|FG001|Treatment Period 1|Lost to Follow-up|1
2188287|NCT01468207|3818537|FG002|Treatment Period 1|Lost to Follow-up|0
2188288|NCT01468207|3818538|FG003|Treatment Period 1|Lost to Follow-up|0
2188289|NCT01468207|3818539|FG004|Treatment Period 1|Lost to Follow-up|0
2188290|NCT01468207|3818540|FG005|Treatment Period 1|Lost to Follow-up|0
2188291|NCT01468207|3818535|FG000|Treatment Period 1|Other|0
2188292|NCT01468207|3818536|FG001|Treatment Period 1|Other|2
2188293|NCT01468207|3818537|FG002|Treatment Period 1|Other|0
2188294|NCT01468207|3818538|FG003|Treatment Period 1|Other|0
2188295|NCT01468207|3818539|FG004|Treatment Period 1|Other|0
2188296|NCT01468207|3818540|FG005|Treatment Period 1|Other|0
2188297|NCT01468207|3818535|FG000|Treatment Period 2|Adverse Event|0
2188298|NCT01468207|3818536|FG001|Treatment Period 2|Adverse Event|0
2188299|NCT01468207|3818537|FG002|Treatment Period 2|Adverse Event|6
2188300|NCT01468207|3818538|FG003|Treatment Period 2|Adverse Event|1
2188301|NCT01468207|3818539|FG004|Treatment Period 2|Adverse Event|2
2188302|NCT01468207|3818540|FG005|Treatment Period 2|Adverse Event|1
2188303|NCT01468207|3818535|FG000|Treatment Period 2|Lack of Efficacy|0
2188304|NCT01468207|3818536|FG001|Treatment Period 2|Lack of Efficacy|0
2188305|NCT01468207|3818537|FG002|Treatment Period 2|Lack of Efficacy|1
2188306|NCT01468207|3818538|FG003|Treatment Period 2|Lack of Efficacy|1
2188307|NCT01468207|3818539|FG004|Treatment Period 2|Lack of Efficacy|0
2188308|NCT01468207|3818540|FG005|Treatment Period 2|Lack of Efficacy|2
2188309|NCT01468207|3818535|FG000|Treatment Period 2|Withdrawal by Subject|0
2188310|NCT01468207|3818536|FG001|Treatment Period 2|Withdrawal by Subject|0
2188311|NCT01468207|3818537|FG002|Treatment Period 2|Withdrawal by Subject|5
2188312|NCT01468207|3818538|FG003|Treatment Period 2|Withdrawal by Subject|0
2188313|NCT01468207|3818539|FG004|Treatment Period 2|Withdrawal by Subject|0
2188314|NCT01468207|3818540|FG005|Treatment Period 2|Withdrawal by Subject|2
2188315|NCT01468207|3818535|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0
2188316|NCT01468207|3818536|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0
2188317|NCT01468207|3818537|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30
2188318|NCT01468207|3818538|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23
2188319|NCT01468207|3818539|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18
2188320|NCT01468207|3818540|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13
2188321|NCT01468207|3818535|FG000|Treatment Period 2|Lost to Follow-up|0
2188322|NCT01468207|3818536|FG001|Treatment Period 2|Lost to Follow-up|0
2188323|NCT01468207|3818537|FG002|Treatment Period 2|Lost to Follow-up|5
2188324|NCT01468207|3818538|FG003|Treatment Period 2|Lost to Follow-up|1
2188325|NCT01468207|3818539|FG004|Treatment Period 2|Lost to Follow-up|0
2188326|NCT01468207|3818540|FG005|Treatment Period 2|Lost to Follow-up|0
2188327|NCT01468207|3818535|FG000|Treatment Period 2|Other|0
2188328|NCT01468207|3818536|FG001|Treatment Period 2|Other|0
2188329|NCT01468207|3818537|FG002|Treatment Period 2|Other|5
2188330|NCT01468207|3818538|FG003|Treatment Period 2|Other|1
2188331|NCT01468207|3818539|FG004|Treatment Period 2|Other|1
2188332|NCT01468207|3818540|FG005|Treatment Period 2|Other|2
2188333|NCT01468233|3818560|FG000|Treatment Period 1|Adverse Event|5
2188334|NCT01468233|3818561|FG001|Treatment Period 1|Adverse Event|3
2188335|NCT01468233|3818562|FG002|Treatment Period 1|Adverse Event|0
2188336|NCT01468233|3818563|FG003|Treatment Period 1|Adverse Event|0
2188337|NCT01468233|3818564|FG004|Treatment Period 1|Adverse Event|0
2188338|NCT01468233|3818565|FG005|Treatment Period 1|Adverse Event|0
2188339|NCT01468233|3818560|FG000|Treatment Period 1|Withdrawal by Subject|3
2188340|NCT01468233|3818561|FG001|Treatment Period 1|Withdrawal by Subject|4
2188341|NCT01468233|3818562|FG002|Treatment Period 1|Withdrawal by Subject|0
2188342|NCT01468233|3818563|FG003|Treatment Period 1|Withdrawal by Subject|0
2188343|NCT01468233|3818564|FG004|Treatment Period 1|Withdrawal by Subject|0
2188344|NCT01468233|3818565|FG005|Treatment Period 1|Withdrawal by Subject|0
2188345|NCT01468233|3818560|FG000|Treatment Period 1|Lost to Follow-up|3
2188346|NCT01468233|3818561|FG001|Treatment Period 1|Lost to Follow-up|0
2188347|NCT01468233|3818562|FG002|Treatment Period 1|Lost to Follow-up|0
2188348|NCT01468233|3818563|FG003|Treatment Period 1|Lost to Follow-up|0
2188349|NCT01468233|3818564|FG004|Treatment Period 1|Lost to Follow-up|0
2188350|NCT01468233|3818565|FG005|Treatment Period 1|Lost to Follow-up|0
2188351|NCT01468233|3818560|FG000|Treatment Period 1|Other|1
2188352|NCT01468233|3818561|FG001|Treatment Period 1|Other|1
2188353|NCT01468233|3818562|FG002|Treatment Period 1|Other|0
2188354|NCT01468233|3818563|FG003|Treatment Period 1|Other|0
2188355|NCT01468233|3818564|FG004|Treatment Period 1|Other|0
2188356|NCT01468233|3818565|FG005|Treatment Period 1|Other|0
2188357|NCT01468233|3818560|FG000|Treatment Period 2|Adverse Event|0
2188358|NCT01468233|3818561|FG001|Treatment Period 2|Adverse Event|0
2222527|NCT01748552|3868124|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3
2222528|NCT01748552|3868125|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0
2222529|NCT01748552|3868126|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0
2222530|NCT01748552|3868127|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0
2222531|NCT01748760|3868185|FG000|Overall Study|Withdrawal by Subject|1
2222532|NCT01748760|3868186|FG001|Overall Study|Withdrawal by Subject|1
2222533|NCT01748760|3868185|FG000|Overall Study|Lost to Follow-up|5
2222534|NCT01748760|3868186|FG001|Overall Study|Lost to Follow-up|1
2222535|NCT01748825|3868243|FG000|Dose Escalation|Refused further treatment|2
2222536|NCT01748825|3868244|FG001|Dose Escalation|Refused further treatment|2
2222537|NCT01748825|3868245|FG002|Dose Escalation|Refused further treatment|0
2222538|NCT01748825|3868246|FG003|Dose Escalation|Refused further treatment|0
2222539|NCT01748825|3868247|FG004|Dose Escalation|Refused further treatment|1
2222540|NCT01748825|3868248|FG005|Dose Escalation|Refused further treatment|2
2222541|NCT01748825|3868249|FG006|Dose Escalation|Refused further treatment|0
2222542|NCT01748825|3868250|FG007|Dose Escalation|Refused further treatment|0
2222543|NCT01748825|3868251|FG008|Dose Escalation|Refused further treatment|0
2222544|NCT01748825|3868252|FG009|Dose Escalation|Refused further treatment|0
2222545|NCT01748825|3868243|FG000|Dose Escalation|Switched to alternative treatment|0
2222546|NCT01748825|3868244|FG001|Dose Escalation|Switched to alternative treatment|0
2222547|NCT01748825|3868245|FG002|Dose Escalation|Switched to alternative treatment|0
2222548|NCT01748825|3868246|FG003|Dose Escalation|Switched to alternative treatment|1
2222549|NCT01748825|3868247|FG004|Dose Escalation|Switched to alternative treatment|0
2222550|NCT01748825|3868248|FG005|Dose Escalation|Switched to alternative treatment|0
2222551|NCT01748825|3868249|FG006|Dose Escalation|Switched to alternative treatment|0
2222552|NCT01748825|3868250|FG007|Dose Escalation|Switched to alternative treatment|0
2222553|NCT01748825|3868251|FG008|Dose Escalation|Switched to alternative treatment|0
2222554|NCT01748825|3868252|FG009|Dose Escalation|Switched to alternative treatment|0
2222555|NCT01748825|3868243|FG000|Dose Escalation|Adverse Event|0
2222556|NCT01748825|3868244|FG001|Dose Escalation|Adverse Event|0
2222557|NCT01748825|3868245|FG002|Dose Escalation|Adverse Event|0
2222558|NCT01748825|3868246|FG003|Dose Escalation|Adverse Event|0
2222559|NCT01748825|3868247|FG004|Dose Escalation|Adverse Event|0
2222560|NCT01748825|3868248|FG005|Dose Escalation|Adverse Event|0
2222561|NCT01748825|3868249|FG006|Dose Escalation|Adverse Event|1
2222562|NCT01748825|3868250|FG007|Dose Escalation|Adverse Event|0
2222563|NCT01748825|3868251|FG008|Dose Escalation|Adverse Event|0
2222564|NCT01748825|3868252|FG009|Dose Escalation|Adverse Event|0
2222565|NCT01748825|3868243|FG000|Dose Expansion|Refused further treatment|0
2222566|NCT01748825|3868244|FG001|Dose Expansion|Refused further treatment|0
2188359|NCT01468233|3818562|FG002|Treatment Period 2|Adverse Event|3
2188360|NCT01468233|3818563|FG003|Treatment Period 2|Adverse Event|0
2188361|NCT01468233|3818564|FG004|Treatment Period 2|Adverse Event|2
2188362|NCT01468233|3818565|FG005|Treatment Period 2|Adverse Event|1
2188363|NCT01468233|3818560|FG000|Treatment Period 2|Lack of Efficacy|0
2188364|NCT01468233|3818561|FG001|Treatment Period 2|Lack of Efficacy|0
2222567|NCT01748825|3868245|FG002|Dose Expansion|Refused further treatment|0
2222568|NCT01748825|3868246|FG003|Dose Expansion|Refused further treatment|0
2222569|NCT01748825|3868247|FG004|Dose Expansion|Refused further treatment|0
2188365|NCT01468233|3818562|FG002|Treatment Period 2|Lack of Efficacy|9
2188366|NCT01468233|3818563|FG003|Treatment Period 2|Lack of Efficacy|2
2188367|NCT01468233|3818564|FG004|Treatment Period 2|Lack of Efficacy|0
2188368|NCT01468233|3818565|FG005|Treatment Period 2|Lack of Efficacy|1
2188369|NCT01468233|3818560|FG000|Treatment Period 2|Withdrawal by Subject|0
2188370|NCT01468233|3818561|FG001|Treatment Period 2|Withdrawal by Subject|0
2188371|NCT01468233|3818562|FG002|Treatment Period 2|Withdrawal by Subject|9
2188372|NCT01468233|3818563|FG003|Treatment Period 2|Withdrawal by Subject|1
2188373|NCT01468233|3818564|FG004|Treatment Period 2|Withdrawal by Subject|1
2188374|NCT01468233|3818565|FG005|Treatment Period 2|Withdrawal by Subject|1
2188375|NCT01468233|3818560|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0
2188376|NCT01468233|3818561|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0
2188377|NCT01468233|3818562|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84
2188378|NCT01468233|3818563|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25
2188379|NCT01468233|3818564|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22
2188380|NCT01468233|3818565|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20
2188381|NCT01468233|3818560|FG000|Treatment Period 2|Lost to Follow-up|0
2188382|NCT01468233|3818561|FG001|Treatment Period 2|Lost to Follow-up|0
2188383|NCT01468233|3818562|FG002|Treatment Period 2|Lost to Follow-up|3
2188384|NCT01468233|3818563|FG003|Treatment Period 2|Lost to Follow-up|0
2188385|NCT01468233|3818564|FG004|Treatment Period 2|Lost to Follow-up|2
2188386|NCT01468233|3818565|FG005|Treatment Period 2|Lost to Follow-up|0
2188387|NCT01468233|3818560|FG000|Treatment Period 2|Other|0
2188388|NCT01468233|3818561|FG001|Treatment Period 2|Other|0
2188389|NCT01468233|3818562|FG002|Treatment Period 2|Other|3
2188390|NCT01468233|3818563|FG003|Treatment Period 2|Other|0
2188391|NCT01468233|3818564|FG004|Treatment Period 2|Other|1
2188392|NCT01468233|3818565|FG005|Treatment Period 2|Other|0
2188393|NCT01468311|3818583|FG000|Overall Study|mobilization failure|1
2188394|NCT01468311|3818583|FG000|Overall Study|Withdrawal by Subject|1
2188395|NCT01468454|3818608|FG000|Overall Study|Did not have surgery after PET|9
2188396|NCT01468597|3818629|FG000|Overall Study|Found ineligible|17
2188397|NCT01468597|3818629|FG000|Overall Study|concomitant valves|12
2188398|NCT01468597|3818629|FG000|Overall Study|off-pump CABG|1
2188399|NCT01468597|3818629|FG000|Overall Study|no platelet function data|5
2188400|NCT01468701|3818659|FG000|Overall Study|Not eligible|91
2188401|NCT01468701|3818660|FG001|Overall Study|Not eligible|140
2188402|NCT01468701|3818661|FG002|Overall Study|Not eligible|29
2188403|NCT01468701|3818662|FG003|Overall Study|Not eligible|12
2188404|NCT01468701|3818663|FG004|Overall Study|Not eligible|22
2188405|NCT01468701|3818664|FG005|Overall Study|Not eligible|2
2188406|NCT01468701|3818665|FG006|Overall Study|Not eligible|39
2188407|NCT01468701|3818666|FG007|Overall Study|Not eligible|1
2188408|NCT01468701|3818667|FG008|Overall Study|Not eligible|40
2188409|NCT01468701|3818668|FG009|Overall Study|Not eligible|126
2188410|NCT01468701|3818669|FG010|Overall Study|Not eligible|39
2188411|NCT01468701|3818670|FG011|Overall Study|Not eligible|33
2188412|NCT01468701|3818671|FG012|Overall Study|Not eligible|1
2188413|NCT01468701|3818672|FG013|Overall Study|Not eligible|19
2188414|NCT01468701|3818673|FG014|Overall Study|Not eligible|1
2188415|NCT01468701|3818674|FG015|Overall Study|Not eligible|32
2188416|NCT01468701|3818675|FG016|Overall Study|Not eligible|0
2188417|NCT01468701|3818659|FG000|Overall Study|Lost to Follow-up|306
2188418|NCT01468701|3818660|FG001|Overall Study|Lost to Follow-up|0
2188419|NCT01468701|3818661|FG002|Overall Study|Lost to Follow-up|0
2188420|NCT01468701|3818662|FG003|Overall Study|Lost to Follow-up|0
2188421|NCT01468701|3818663|FG004|Overall Study|Lost to Follow-up|0
2188422|NCT01468701|3818664|FG005|Overall Study|Lost to Follow-up|0
2188423|NCT01468701|3818665|FG006|Overall Study|Lost to Follow-up|0
2188424|NCT01468701|3818666|FG007|Overall Study|Lost to Follow-up|0
2188425|NCT01468701|3818667|FG008|Overall Study|Lost to Follow-up|215
2188426|NCT01468701|3818668|FG009|Overall Study|Lost to Follow-up|309
2188427|NCT01468701|3818669|FG010|Overall Study|Lost to Follow-up|224
2188428|NCT01468701|3818670|FG011|Overall Study|Lost to Follow-up|212
2188429|NCT01468701|3818671|FG012|Overall Study|Lost to Follow-up|11
2188430|NCT01468701|3818672|FG013|Overall Study|Lost to Follow-up|164
2188431|NCT01468701|3818673|FG014|Overall Study|Lost to Follow-up|17
2188432|NCT01468701|3818674|FG015|Overall Study|Lost to Follow-up|127
2188433|NCT01468701|3818675|FG016|Overall Study|Lost to Follow-up|1
2188434|NCT01468701|3818659|FG000|Overall Study|Withdrawal by Subject|165
2188435|NCT01468701|3818660|FG001|Overall Study|Withdrawal by Subject|0
2188436|NCT01468701|3818661|FG002|Overall Study|Withdrawal by Subject|0
2188437|NCT01468701|3818662|FG003|Overall Study|Withdrawal by Subject|0
2188438|NCT01468701|3818663|FG004|Overall Study|Withdrawal by Subject|0
2188439|NCT01468701|3818664|FG005|Overall Study|Withdrawal by Subject|0
2188440|NCT01468701|3818665|FG006|Overall Study|Withdrawal by Subject|0
2188441|NCT01468701|3818666|FG007|Overall Study|Withdrawal by Subject|0
2188442|NCT01468701|3818667|FG008|Overall Study|Withdrawal by Subject|83
2188443|NCT01468701|3818668|FG009|Overall Study|Withdrawal by Subject|88
2188444|NCT01468701|3818669|FG010|Overall Study|Withdrawal by Subject|100
2188445|NCT01468701|3818670|FG011|Overall Study|Withdrawal by Subject|114
2188446|NCT01468701|3818671|FG012|Overall Study|Withdrawal by Subject|9
2188447|NCT01468701|3818672|FG013|Overall Study|Withdrawal by Subject|47
2188448|NCT01468701|3818673|FG014|Overall Study|Withdrawal by Subject|6
2188449|NCT01468701|3818674|FG015|Overall Study|Withdrawal by Subject|31
2188450|NCT01468701|3818675|FG016|Overall Study|Withdrawal by Subject|0
2188451|NCT01468701|3818659|FG000|Overall Study|Other reasons than listed|437
2188452|NCT01468701|3818660|FG001|Overall Study|Other reasons than listed|0
2188453|NCT01468701|3818661|FG002|Overall Study|Other reasons than listed|0
2188454|NCT01468701|3818662|FG003|Overall Study|Other reasons than listed|0
2188455|NCT01468701|3818663|FG004|Overall Study|Other reasons than listed|0
2188456|NCT01468701|3818664|FG005|Overall Study|Other reasons than listed|0
2188457|NCT01468701|3818665|FG006|Overall Study|Other reasons than listed|0
2188458|NCT01468701|3818666|FG007|Overall Study|Other reasons than listed|0
2188459|NCT01468701|3818667|FG008|Overall Study|Other reasons than listed|318
2188460|NCT01468701|3818668|FG009|Overall Study|Other reasons than listed|658
2188461|NCT01468701|3818669|FG010|Overall Study|Other reasons than listed|433
2188462|NCT01468701|3818670|FG011|Overall Study|Other reasons than listed|504
2188463|NCT01468701|3818671|FG012|Overall Study|Other reasons than listed|28
2188464|NCT01468701|3818672|FG013|Overall Study|Other reasons than listed|239
2188465|NCT01468701|3818673|FG014|Overall Study|Other reasons than listed|39
2188466|NCT01468701|3818674|FG015|Overall Study|Other reasons than listed|172
2188467|NCT01468701|3818675|FG016|Overall Study|Other reasons than listed|0
2188468|NCT01468701|3818659|FG000|Overall Study|No end of study case report form|0
2188469|NCT01468701|3818660|FG001|Overall Study|No end of study case report form|0
2188470|NCT01468701|3818661|FG002|Overall Study|No end of study case report form|0
2188471|NCT01468701|3818662|FG003|Overall Study|No end of study case report form|0
2188472|NCT01468701|3818663|FG004|Overall Study|No end of study case report form|0
2188473|NCT01468701|3818664|FG005|Overall Study|No end of study case report form|0
2188474|NCT01468701|3818665|FG006|Overall Study|No end of study case report form|0
2188475|NCT01468701|3818666|FG007|Overall Study|No end of study case report form|0
2188476|NCT01468701|3818667|FG008|Overall Study|No end of study case report form|4
2188477|NCT01468701|3818668|FG009|Overall Study|No end of study case report form|1
2188478|NCT01468701|3818669|FG010|Overall Study|No end of study case report form|2
2188479|NCT01468701|3818670|FG011|Overall Study|No end of study case report form|3
2188480|NCT01468701|3818671|FG012|Overall Study|No end of study case report form|0
2188481|NCT01468701|3818672|FG013|Overall Study|No end of study case report form|1
2222570|NCT01748825|3868248|FG005|Dose Expansion|Refused further treatment|0
2222571|NCT01748825|3868249|FG006|Dose Expansion|Refused further treatment|0
2222572|NCT01748825|3868250|FG007|Dose Expansion|Refused further treatment|0
2222573|NCT01748825|3868251|FG008|Dose Expansion|Refused further treatment|1
2222574|NCT01748825|3868252|FG009|Dose Expansion|Refused further treatment|1
2222575|NCT01748825|3868243|FG000|Dose Expansion|Switched to alternative treatment|0
2222576|NCT01748825|3868244|FG001|Dose Expansion|Switched to alternative treatment|0
2222577|NCT01748825|3868245|FG002|Dose Expansion|Switched to alternative treatment|0
2222578|NCT01748825|3868246|FG003|Dose Expansion|Switched to alternative treatment|0
2222579|NCT01748825|3868247|FG004|Dose Expansion|Switched to alternative treatment|0
2222580|NCT01748825|3868248|FG005|Dose Expansion|Switched to alternative treatment|0
2222581|NCT01748825|3868249|FG006|Dose Expansion|Switched to alternative treatment|0
2222582|NCT01748825|3868250|FG007|Dose Expansion|Switched to alternative treatment|0
2222583|NCT01748825|3868251|FG008|Dose Expansion|Switched to alternative treatment|0
2222584|NCT01748825|3868252|FG009|Dose Expansion|Switched to alternative treatment|1
2222585|NCT01748825|3868243|FG000|Dose Expansion|Adverse Event|0
2222586|NCT01748825|3868244|FG001|Dose Expansion|Adverse Event|0
2222587|NCT01748825|3868245|FG002|Dose Expansion|Adverse Event|0
2222588|NCT01748825|3868246|FG003|Dose Expansion|Adverse Event|0
2222589|NCT01748825|3868247|FG004|Dose Expansion|Adverse Event|0
2222590|NCT01748825|3868248|FG005|Dose Expansion|Adverse Event|0
2222591|NCT01748825|3868249|FG006|Dose Expansion|Adverse Event|0
2222592|NCT01748825|3868250|FG007|Dose Expansion|Adverse Event|0
2222593|NCT01748825|3868251|FG008|Dose Expansion|Adverse Event|0
2222594|NCT01748825|3868252|FG009|Dose Expansion|Adverse Event|3
2222595|NCT01748825|3868243|FG000|Dose Expansion|Physician Decision|0
2222596|NCT01748825|3868244|FG001|Dose Expansion|Physician Decision|0
2222597|NCT01748825|3868245|FG002|Dose Expansion|Physician Decision|0
2222598|NCT01748825|3868246|FG003|Dose Expansion|Physician Decision|0
2222599|NCT01748825|3868247|FG004|Dose Expansion|Physician Decision|0
2222600|NCT01748825|3868248|FG005|Dose Expansion|Physician Decision|0
2222601|NCT01748825|3868249|FG006|Dose Expansion|Physician Decision|0
2222602|NCT01748825|3868250|FG007|Dose Expansion|Physician Decision|0
2222603|NCT01748825|3868251|FG008|Dose Expansion|Physician Decision|1
2222604|NCT01748825|3868252|FG009|Dose Expansion|Physician Decision|0
2222605|NCT01748994|3868314|FG000|Overall Study|Lost to Follow-up|8
2222606|NCT01748994|3868315|FG001|Overall Study|Lost to Follow-up|6
2222607|NCT01749033|3868324|FG000|Overall Study|Did not receive allocated intervention|3
2222608|NCT01749033|3868325|FG001|Overall Study|Did not receive allocated intervention|3
2222609|NCT01749033|3868326|FG002|Overall Study|Did not receive allocated intervention|0
2222610|NCT01749033|3868324|FG000|Overall Study|Lost to Follow-up|0
2222611|NCT01749033|3868325|FG001|Overall Study|Lost to Follow-up|2
2222612|NCT01749033|3868326|FG002|Overall Study|Lost to Follow-up|1
2222613|NCT01749735|3868377|FG000|Overall Study|Withdrawal by Subject|1
2222614|NCT01749735|3868378|FG001|Overall Study|Withdrawal by Subject|0
2222615|NCT01749800|3868387|FG000|Overall Study|not meeting inclusion criteria|3
2222616|NCT01749800|3868388|FG001|Overall Study|not meeting inclusion criteria|0
2188482|NCT01468701|3818673|FG014|Overall Study|No end of study case report form|0
2188483|NCT01468701|3818674|FG015|Overall Study|No end of study case report form|0
2188484|NCT01468701|3818675|FG016|Overall Study|No end of study case report form|0
2188485|NCT01468701|3818659|FG000|Overall Study|Not being followed up|0
2188486|NCT01468701|3818660|FG001|Overall Study|Not being followed up|4963
2188487|NCT01468701|3818661|FG002|Overall Study|Not being followed up|1755
2188488|NCT01468701|3818662|FG003|Overall Study|Not being followed up|703
2188489|NCT01468701|3818663|FG004|Overall Study|Not being followed up|1714
2188490|NCT01468701|3818664|FG005|Overall Study|Not being followed up|126
2188491|NCT01468701|3818665|FG006|Overall Study|Not being followed up|1170
2188492|NCT01468701|3818666|FG007|Overall Study|Not being followed up|4
2188493|NCT01468701|3818667|FG008|Overall Study|Not being followed up|0
2188494|NCT01468701|3818668|FG009|Overall Study|Not being followed up|0
2188495|NCT01468701|3818669|FG010|Overall Study|Not being followed up|0
2188496|NCT01468701|3818670|FG011|Overall Study|Not being followed up|0
2188497|NCT01468701|3818671|FG012|Overall Study|Not being followed up|0
2188498|NCT01468701|3818672|FG013|Overall Study|Not being followed up|0
2188499|NCT01468701|3818673|FG014|Overall Study|Not being followed up|0
2188500|NCT01468701|3818674|FG015|Overall Study|Not being followed up|0
2188501|NCT01468701|3818675|FG016|Overall Study|Not being followed up|0
2188502|NCT01468818|3818688|FG000|Overall Study|Death during treatment|2
2188503|NCT01468844|3818694|FG000|Overall Study|Adverse Event|1
2188504|NCT01468844|3818695|FG001|Overall Study|Adverse Event|0
2188505|NCT01468844|3818694|FG000|Overall Study|Withdrawal by Subject|1
2188506|NCT01468844|3818695|FG001|Overall Study|Withdrawal by Subject|0
2188507|NCT01468909|3818716|FG000|Overall Study|Never Treated|2
2188508|NCT01468909|3818717|FG001|Overall Study|Never Treated|2
2188509|NCT01468987|3818729|FG000|Overall Study|Adverse Event|12
2188510|NCT01468987|3818730|FG001|Overall Study|Adverse Event|9
2188511|NCT01468987|3818729|FG000|Overall Study|Death|4
2188512|NCT01468987|3818730|FG001|Overall Study|Death|1
2188513|NCT01468987|3818729|FG000|Overall Study|Lost to Follow-up|10
2188514|NCT01468987|3818730|FG001|Overall Study|Lost to Follow-up|5
2188515|NCT01468987|3818729|FG000|Overall Study|Protocol Violation|8
2188516|NCT01468987|3818730|FG001|Overall Study|Protocol Violation|2
2188517|NCT01468987|3818729|FG000|Overall Study|Withdrawal by Subject|28
2188518|NCT01468987|3818730|FG001|Overall Study|Withdrawal by Subject|28
2188519|NCT01468987|3818729|FG000|Overall Study|Physician Decision|8
2188520|NCT01468987|3818730|FG001|Overall Study|Physician Decision|15
2188521|NCT01468987|3818729|FG000|Overall Study|Sponsor Decision|1
2188522|NCT01468987|3818730|FG001|Overall Study|Sponsor Decision|0
2188523|NCT01469000|3818740|FG000|Overall Study|Withdrawal by Subject|16
2188524|NCT01469000|3818741|FG001|Overall Study|Withdrawal by Subject|3
2188525|NCT01469000|3818740|FG000|Overall Study|Sponsor Decision|4
2188526|NCT01469000|3818741|FG001|Overall Study|Sponsor Decision|1
2188527|NCT01469013|3818752|FG000|Part A (Treatment Period)|Adverse Event|1
2188528|NCT01469013|3818753|FG001|Part A (Treatment Period)|Adverse Event|0
2188529|NCT01469013|3818754|FG002|Part A (Treatment Period)|Adverse Event|0
2188530|NCT01469013|3818755|FG003|Part A (Treatment Period)|Adverse Event|0
2222617|NCT01749800|3868389|FG002|Overall Study|not meeting inclusion criteria|0
2222618|NCT01749800|3868387|FG000|Overall Study|Withdrawal by Subject|0
2222619|NCT01749800|3868388|FG001|Overall Study|Withdrawal by Subject|1
2222620|NCT01749800|3868389|FG002|Overall Study|Withdrawal by Subject|0
2222621|NCT01749982|3868432|FG000|Overall Study|Physician Decision|0
2222622|NCT01749982|3868433|FG001|Overall Study|Physician Decision|0
2222623|NCT01749982|3868434|FG002|Overall Study|Physician Decision|0
2222624|NCT01749982|3868435|FG003|Overall Study|Physician Decision|1
2222625|NCT01749982|3868432|FG000|Overall Study|Lost to Follow-up|0
2222626|NCT01749982|3868433|FG001|Overall Study|Lost to Follow-up|0
2188531|NCT01469013|3818756|FG004|Part A (Treatment Period)|Adverse Event|1
2188532|NCT01469013|3818757|FG005|Part A (Treatment Period)|Adverse Event|0
2188533|NCT01469013|3818758|FG006|Part A (Treatment Period)|Adverse Event|0
2188534|NCT01469013|3818759|FG007|Part A (Treatment Period)|Adverse Event|0
2188535|NCT01469013|3818760|FG008|Part A (Treatment Period)|Adverse Event|0
2188536|NCT01469013|3818761|FG009|Part A (Treatment Period)|Adverse Event|0
2188537|NCT01469013|3818762|FG010|Part A (Treatment Period)|Adverse Event|0
2188538|NCT01469013|3818763|FG011|Part A (Treatment Period)|Adverse Event|0
2188539|NCT01469013|3818764|FG012|Part A (Treatment Period)|Adverse Event|0
2188540|NCT01469013|3818752|FG000|Part A (Treatment Period)|Withdrawal by Subject|0
2188541|NCT01469013|3818753|FG001|Part A (Treatment Period)|Withdrawal by Subject|0
2188542|NCT01469013|3818754|FG002|Part A (Treatment Period)|Withdrawal by Subject|1
2188543|NCT01469013|3818755|FG003|Part A (Treatment Period)|Withdrawal by Subject|0
2188544|NCT01469013|3818756|FG004|Part A (Treatment Period)|Withdrawal by Subject|0
2188545|NCT01469013|3818757|FG005|Part A (Treatment Period)|Withdrawal by Subject|0
2188546|NCT01469013|3818758|FG006|Part A (Treatment Period)|Withdrawal by Subject|0
2188547|NCT01469013|3818759|FG007|Part A (Treatment Period)|Withdrawal by Subject|0
2188548|NCT01469013|3818760|FG008|Part A (Treatment Period)|Withdrawal by Subject|0
2188549|NCT01469013|3818761|FG009|Part A (Treatment Period)|Withdrawal by Subject|0
2188550|NCT01469013|3818762|FG010|Part A (Treatment Period)|Withdrawal by Subject|0
2188551|NCT01469013|3818763|FG011|Part A (Treatment Period)|Withdrawal by Subject|0
2188552|NCT01469013|3818764|FG012|Part A (Treatment Period)|Withdrawal by Subject|0
2188553|NCT01469013|3818752|FG000|Part B (Extension Period)|Adverse Event|0
2188554|NCT01469013|3818753|FG001|Part B (Extension Period)|Adverse Event|0
2188555|NCT01469013|3818754|FG002|Part B (Extension Period)|Adverse Event|0
2188556|NCT01469013|3818755|FG003|Part B (Extension Period)|Adverse Event|0
2188557|NCT01469013|3818756|FG004|Part B (Extension Period)|Adverse Event|0
2188558|NCT01469013|3818757|FG005|Part B (Extension Period)|Adverse Event|2
2188559|NCT01469013|3818758|FG006|Part B (Extension Period)|Adverse Event|5
2188560|NCT01469013|3818759|FG007|Part B (Extension Period)|Adverse Event|5
2188561|NCT01469013|3818760|FG008|Part B (Extension Period)|Adverse Event|3
2188562|NCT01469013|3818761|FG009|Part B (Extension Period)|Adverse Event|3
2188563|NCT01469013|3818762|FG010|Part B (Extension Period)|Adverse Event|1
2188564|NCT01469013|3818763|FG011|Part B (Extension Period)|Adverse Event|6
2188565|NCT01469013|3818764|FG012|Part B (Extension Period)|Adverse Event|3
2188566|NCT01469013|3818752|FG000|Part B (Extension Period)|Withdrawal by Subject|0
2188567|NCT01469013|3818753|FG001|Part B (Extension Period)|Withdrawal by Subject|0
2188568|NCT01469013|3818754|FG002|Part B (Extension Period)|Withdrawal by Subject|0
2188569|NCT01469013|3818755|FG003|Part B (Extension Period)|Withdrawal by Subject|0
2188570|NCT01469013|3818756|FG004|Part B (Extension Period)|Withdrawal by Subject|0
2188571|NCT01469013|3818757|FG005|Part B (Extension Period)|Withdrawal by Subject|0
2188572|NCT01469013|3818758|FG006|Part B (Extension Period)|Withdrawal by Subject|0
2188573|NCT01469013|3818759|FG007|Part B (Extension Period)|Withdrawal by Subject|0
2222627|NCT01749982|3868434|FG002|Overall Study|Lost to Follow-up|0
2222628|NCT01749982|3868435|FG003|Overall Study|Lost to Follow-up|1
2222629|NCT01749982|3868432|FG000|Overall Study|Withdrawal by Subject|0
2222630|NCT01749982|3868433|FG001|Overall Study|Withdrawal by Subject|0
2222631|NCT01749982|3868434|FG002|Overall Study|Withdrawal by Subject|0
2222632|NCT01749982|3868435|FG003|Overall Study|Withdrawal by Subject|1
2222633|NCT01750190|3868460|FG000|Overall Study|Adverse Event|47
2222634|NCT01750190|3868461|FG001|Overall Study|Adverse Event|19
2222635|NCT01750190|3868460|FG000|Overall Study|Death|38
2222636|NCT01750190|3868461|FG001|Overall Study|Death|11
2222637|NCT01750190|3868460|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2
2222638|NCT01750190|3868461|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43
2222639|NCT01750190|3868460|FG000|Overall Study|Lost to Follow-up|28
2222640|NCT01750190|3868461|FG001|Overall Study|Lost to Follow-up|7
2222641|NCT01750190|3868460|FG000|Overall Study|Physician Decision|16
2222642|NCT01750190|3868461|FG001|Overall Study|Physician Decision|17
2222643|NCT01750190|3868460|FG000|Overall Study|Protocol Violation|6
2222644|NCT01750190|3868461|FG001|Overall Study|Protocol Violation|5
2222645|NCT01750190|3868460|FG000|Overall Study|Study/Site Terminated by Sponsor|4
2222646|NCT01750190|3868461|FG001|Overall Study|Study/Site Terminated by Sponsor|1
2222647|NCT01750190|3868460|FG000|Overall Study|Withdrawal by Subject|83
2222648|NCT01750190|3868461|FG001|Overall Study|Withdrawal by Subject|89
2222649|NCT01750190|3868460|FG000|Overall Study|Kidney Transplant|8
2222650|NCT01750190|3868461|FG001|Overall Study|Kidney Transplant|4
2222651|NCT01750190|3868460|FG000|Overall Study|Dialysis|22
2222652|NCT01750190|3868461|FG001|Overall Study|Dialysis|8
2222653|NCT01750190|3868460|FG000|Overall Study|Other than Specified|13
2332198|NCT03188185|4055474|FG003|Stage 1|Identified as a professional patient|0
2332199|NCT03188185|4055471|FG000|Stage 2|Adverse Event|0
2332200|NCT03188185|4055472|FG001|Stage 2|Adverse Event|0
2332201|NCT03188185|4055473|FG002|Stage 2|Adverse Event|2
2332202|NCT03188185|4055474|FG003|Stage 2|Adverse Event|4
2332203|NCT03188185|4055471|FG000|Stage 2|Lack of Efficacy|0
2332204|NCT03188185|4055472|FG001|Stage 2|Lack of Efficacy|0
2332205|NCT03188185|4055473|FG002|Stage 2|Lack of Efficacy|3
2332206|NCT03188185|4055474|FG003|Stage 2|Lack of Efficacy|0
2332207|NCT03188185|4055471|FG000|Stage 2|Lost to Follow-up|0
2332208|NCT03188185|4055472|FG001|Stage 2|Lost to Follow-up|0
2332209|NCT03188185|4055473|FG002|Stage 2|Lost to Follow-up|1
2332210|NCT03188185|4055474|FG003|Stage 2|Lost to Follow-up|0
2332211|NCT03188185|4055471|FG000|Stage 2|Physician Decision|0
2332212|NCT03188185|4055472|FG001|Stage 2|Physician Decision|0
2332213|NCT03188185|4055473|FG002|Stage 2|Physician Decision|0
2332214|NCT03188185|4055474|FG003|Stage 2|Physician Decision|1
2332215|NCT03188185|4055471|FG000|Stage 2|Withdrawal by Subject|0
2332216|NCT03188185|4055472|FG001|Stage 2|Withdrawal by Subject|0
2332217|NCT03188185|4055473|FG002|Stage 2|Withdrawal by Subject|3
2332218|NCT03188185|4055474|FG003|Stage 2|Withdrawal by Subject|1
2332219|NCT03188263|4055486|FG000|Overall Study|Withdrawal by Subject|3
2332220|NCT03188263|4055487|FG001|Overall Study|Withdrawal by Subject|0
2332221|NCT03188263|4055486|FG000|Overall Study|Physician Decision|1
2332222|NCT03188263|4055487|FG001|Overall Study|Physician Decision|0
2332223|NCT03188536|4055504|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5
2332224|NCT03188536|4055504|FG000|Overall Study|Not participated/met inclusion criteria|1
2332225|NCT03188718|4055508|FG000|Overall Study|Participant noncompliance|4
2332226|NCT03188718|4055508|FG000|Overall Study|Withdrawal by Subject|1
2332227|NCT03188718|4055508|FG000|Overall Study|Device failure|3
2332228|NCT03188991|4055516|FG000|Overall Study|Withdrawal by Subject|0
2332229|NCT03188991|4055517|FG001|Overall Study|Withdrawal by Subject|0
2332230|NCT03188991|4055518|FG002|Overall Study|Withdrawal by Subject|0
2332231|NCT03188991|4055519|FG003|Overall Study|Withdrawal by Subject|1
2332232|NCT03189446|4055533|FG000|Overall Study|Adverse Event|2
2332233|NCT03189446|4055533|FG000|Overall Study|Withdrawal by Subject|2
2188574|NCT01469013|3818760|FG008|Part B (Extension Period)|Withdrawal by Subject|1
2188575|NCT01469013|3818761|FG009|Part B (Extension Period)|Withdrawal by Subject|0
2188576|NCT01469013|3818762|FG010|Part B (Extension Period)|Withdrawal by Subject|1
2188577|NCT01469013|3818763|FG011|Part B (Extension Period)|Withdrawal by Subject|0
2188578|NCT01469013|3818764|FG012|Part B (Extension Period)|Withdrawal by Subject|3
2188579|NCT01469052|3818810|FG000|Overall Study|Adverse Event|2
2188580|NCT01469052|3818811|FG001|Overall Study|Adverse Event|3
2188581|NCT01469052|3818812|FG002|Overall Study|Adverse Event|0
2188582|NCT01469052|3818813|FG003|Overall Study|Adverse Event|2
2188583|NCT01469052|3818814|FG004|Overall Study|Adverse Event|0
2188584|NCT01469052|3818815|FG005|Overall Study|Adverse Event|1
2188585|NCT01469052|3818810|FG000|Overall Study|Progressive disease|3
2188586|NCT01469052|3818811|FG001|Overall Study|Progressive disease|0
2188587|NCT01469052|3818812|FG002|Overall Study|Progressive disease|5
2188588|NCT01469052|3818813|FG003|Overall Study|Progressive disease|3
2188589|NCT01469052|3818814|FG004|Overall Study|Progressive disease|7
2188590|NCT01469052|3818815|FG005|Overall Study|Progressive disease|2
2188591|NCT01469052|3818810|FG000|Overall Study|Lack of Efficacy|0
2188592|NCT01469052|3818811|FG001|Overall Study|Lack of Efficacy|0
2188593|NCT01469052|3818812|FG002|Overall Study|Lack of Efficacy|0
2188594|NCT01469052|3818813|FG003|Overall Study|Lack of Efficacy|0
2188595|NCT01469052|3818814|FG004|Overall Study|Lack of Efficacy|0
2188596|NCT01469052|3818815|FG005|Overall Study|Lack of Efficacy|2
2188597|NCT01469052|3818810|FG000|Overall Study|Moved to rollover protocol|1
2188598|NCT01469052|3818811|FG001|Overall Study|Moved to rollover protocol|0
2188599|NCT01469052|3818812|FG002|Overall Study|Moved to rollover protocol|1
2188600|NCT01469052|3818813|FG003|Overall Study|Moved to rollover protocol|0
2188601|NCT01469052|3818814|FG004|Overall Study|Moved to rollover protocol|0
2188602|NCT01469052|3818815|FG005|Overall Study|Moved to rollover protocol|1
2188603|NCT01469052|3818810|FG000|Overall Study|Other|0
2188604|NCT01469052|3818811|FG001|Overall Study|Other|1
2188605|NCT01469052|3818812|FG002|Overall Study|Other|0
2188606|NCT01469052|3818813|FG003|Overall Study|Other|0
2188607|NCT01469052|3818814|FG004|Overall Study|Other|1
2188608|NCT01469052|3818815|FG005|Overall Study|Other|0
2188609|NCT01469065|3818832|FG000|Overall Study|Lack of Efficacy|0
2188610|NCT01469065|3818833|FG001|Overall Study|Lack of Efficacy|0
2188611|NCT01469065|3818834|FG002|Overall Study|Lack of Efficacy|0
2188612|NCT01469065|3818835|FG003|Overall Study|Lack of Efficacy|0
2188613|NCT01469065|3818836|FG004|Overall Study|Lack of Efficacy|1
2188614|NCT01469065|3818832|FG000|Overall Study|Other|0
2188615|NCT01469065|3818833|FG001|Overall Study|Other|1
2188616|NCT01469065|3818834|FG002|Overall Study|Other|0
2188617|NCT01469065|3818835|FG003|Overall Study|Other|0
2188618|NCT01469065|3818836|FG004|Overall Study|Other|0
2188619|NCT01469182|3818854|FG000|Overall Study|Adverse Event|21
2188620|NCT01469182|3818855|FG001|Overall Study|Adverse Event|3
2188621|NCT01469182|3818854|FG000|Overall Study|Lost to Follow-up|3
2188622|NCT01469182|3818855|FG001|Overall Study|Lost to Follow-up|0
2188623|NCT01469182|3818854|FG000|Overall Study|Withdrawal by Subject|4
2188624|NCT01469182|3818855|FG001|Overall Study|Withdrawal by Subject|1
2188625|NCT01469182|3818854|FG000|Overall Study|Protocol Violation|4
2188626|NCT01469182|3818855|FG001|Overall Study|Protocol Violation|2
2188627|NCT01469182|3818854|FG000|Overall Study|Did not meet Protocol Eligibility|3
2188628|NCT01469182|3818855|FG001|Overall Study|Did not meet Protocol Eligibility|0
2188629|NCT01469221|3818863|FG000|Double Blind Phase|Protocol Violation|1
2222654|NCT01750190|3868461|FG001|Overall Study|Other than Specified|4
2274071|NCT02292784|3954900|FG000|Overall Study|Lost to Follow-up|1
2274072|NCT02292784|3954901|FG001|Overall Study|Lost to Follow-up|17
2274073|NCT02292784|3954902|FG002|Overall Study|Lost to Follow-up|18
2274074|NCT02292784|3954900|FG000|Overall Study|Withdrawal by Subject|0
2274075|NCT02292784|3954901|FG001|Overall Study|Withdrawal by Subject|3
2274076|NCT02292784|3954902|FG002|Overall Study|Withdrawal by Subject|3
2274077|NCT02292849|3954913|FG000|Overall Study|Lost to Follow-up|0
2274078|NCT02292849|3954914|FG001|Overall Study|Lost to Follow-up|2
2274079|NCT02292849|3954915|FG002|Overall Study|Lost to Follow-up|2
2274080|NCT02292849|3954913|FG000|Overall Study|Physician Decision|4
2274081|NCT02292849|3954914|FG001|Overall Study|Physician Decision|0
2274082|NCT02292849|3954915|FG002|Overall Study|Physician Decision|0
2274083|NCT02292927|3954925|FG000|Overall Study|Protocol Violation|13
2274084|NCT02292927|3954926|FG001|Overall Study|Protocol Violation|7
2274085|NCT02293395|3954955|FG000|Overall Study|Lost to Follow-up|1
2274086|NCT02293395|3954956|FG001|Overall Study|Lost to Follow-up|0
2274087|NCT02293395|3954955|FG000|Overall Study|Withdrawal by Subject|8
2274088|NCT02293395|3954956|FG001|Overall Study|Withdrawal by Subject|7
2274089|NCT02293460|3954962|FG000|Overall Study|Protocol Violation|1
2274090|NCT02293460|3954962|FG000|Overall Study|Lack of Efficacy|2
2274091|NCT02293460|3954962|FG000|Overall Study|Adverse Event|2
2188630|NCT01469221|3818864|FG001|Double Blind Phase|Protocol Violation|0
2188631|NCT01469221|3818865|FG002|Double Blind Phase|Protocol Violation|0
2188632|NCT01469221|3818863|FG000|Double Blind Phase|Physician Decision|1
2188633|NCT01469221|3818864|FG001|Double Blind Phase|Physician Decision|1
2188634|NCT01469221|3818865|FG002|Double Blind Phase|Physician Decision|0
2188635|NCT01469221|3818863|FG000|Double Blind Phase|Sponsor Terminate Study|12
2188636|NCT01469221|3818864|FG001|Double Blind Phase|Sponsor Terminate Study|16
2188637|NCT01469221|3818865|FG002|Double Blind Phase|Sponsor Terminate Study|0
2188638|NCT01469364|3818885|FG000|Overall Study|Adverse Event|1
2188639|NCT01469364|3818885|FG000|Overall Study|Withdrawal by Subject|1
2188640|NCT01469377|3818892|FG000|Overall Study|Protocol Deviation|7
2188641|NCT01469377|3818893|FG001|Overall Study|Protocol Deviation|10
2188642|NCT01469377|3818894|FG002|Overall Study|Protocol Deviation|10
2188643|NCT01469377|3818892|FG000|Overall Study|Lost to Follow-up|3
2188644|NCT01469377|3818893|FG001|Overall Study|Lost to Follow-up|2
2188645|NCT01469377|3818894|FG002|Overall Study|Lost to Follow-up|5
2188646|NCT01469377|3818892|FG000|Overall Study|Withdrawal of Consent|12
2188647|NCT01469377|3818893|FG001|Overall Study|Withdrawal of Consent|14
2188648|NCT01469377|3818894|FG002|Overall Study|Withdrawal of Consent|15
2188649|NCT01469377|3818892|FG000|Overall Study|Adverse Event|8
2188650|NCT01469377|3818893|FG001|Overall Study|Adverse Event|18
2188651|NCT01469377|3818894|FG002|Overall Study|Adverse Event|36
2188652|NCT01469377|3818892|FG000|Overall Study|Insufficient Therapeutic Response|3
2188653|NCT01469377|3818893|FG001|Overall Study|Insufficient Therapeutic Response|4
2188654|NCT01469377|3818894|FG002|Overall Study|Insufficient Therapeutic Response|0
2188655|NCT01469377|3818892|FG000|Overall Study|Other Miscellaneous Reasons|2
2188656|NCT01469377|3818893|FG001|Overall Study|Other Miscellaneous Reasons|0
2188657|NCT01469377|3818894|FG002|Overall Study|Other Miscellaneous Reasons|0
2188658|NCT01469546|3818902|FG000|Received 5 mg Dose|Adverse Event|13
2188659|NCT01469546|3818902|FG000|Received 5 mg Dose|Death|2
2188660|NCT01469546|3818902|FG000|Received 5 mg Dose|Protocol Violation|2
2188661|NCT01469546|3818902|FG000|Received 5 mg Dose|Progressive Disease|3
2188662|NCT01469546|3818902|FG000|Received 5 mg Dose|Physician Decision|3
2188663|NCT01469637|3818919|FG000|First Intervention|Unacceptable behavior|0
2188664|NCT01469637|3818920|FG001|First Intervention|Unacceptable behavior|1
2188665|NCT01469637|3818919|FG000|Second Intervention|Incarcerated|1
2188666|NCT01469637|3818920|FG001|Second Intervention|Incarcerated|0
2188667|NCT01469819|3818934|FG000|Overall Study|Withdrawal by Subject|1
2188668|NCT01469819|3818934|FG000|Overall Study|Did not meet inclusionary criteria|2
2188669|NCT01469819|3818934|FG000|Overall Study|Could not swallow SmartPill|2
2188670|NCT01469819|3818934|FG000|Overall Study|Technical malfunction of SmartPill data|3
2188671|NCT01470001|3818946|FG000|Overall Study|Lost to Follow-up|1
2188672|NCT01470001|3818947|FG001|Overall Study|Lost to Follow-up|1
2188673|NCT01470001|3818946|FG000|Overall Study|Physician Decision|2
2188674|NCT01470001|3818947|FG001|Overall Study|Physician Decision|0
2188675|NCT01470001|3818946|FG000|Overall Study|Withdrawal by Subject|2
2188676|NCT01470001|3818947|FG001|Overall Study|Withdrawal by Subject|1
2188677|NCT01470144|3818988|FG000|Overall Study|Adverse Event|2
2188678|NCT01470144|3818988|FG000|Overall Study|Death|1
2188679|NCT01470144|3818988|FG000|Overall Study|Lung transplant|6
2188680|NCT01470144|3818988|FG000|Overall Study|Patient's and investigator's decision|1
2188681|NCT01470248|3819017|FG000|Overall Study|Withdrawal by Subject|1
2188682|NCT01470417|3819023|FG000|Overall Study|Disease progression|0
2188683|NCT01470417|3819024|FG001|Overall Study|Disease progression|2
2188684|NCT01470469|3819032|FG000|Overall Study|Withdrawal by Subject|4
2188685|NCT01470469|3819033|FG001|Overall Study|Withdrawal by Subject|6
2188686|NCT01470469|3819032|FG000|Overall Study|Lack of Efficacy|1
2188687|NCT01470469|3819033|FG001|Overall Study|Lack of Efficacy|7
2188688|NCT01470469|3819032|FG000|Overall Study|Adverse Event|0
2188689|NCT01470469|3819033|FG001|Overall Study|Adverse Event|7
2188690|NCT01470469|3819032|FG000|Overall Study|Lost to Follow-up|2
2188691|NCT01470469|3819033|FG001|Overall Study|Lost to Follow-up|2
2188692|NCT01470469|3819032|FG000|Overall Study|Protocol Violation|1
2188693|NCT01470469|3819033|FG001|Overall Study|Protocol Violation|1
2188694|NCT01470469|3819032|FG000|Overall Study|Other|2
2188695|NCT01470469|3819033|FG001|Overall Study|Other|1
2188696|NCT01470599|3819041|FG000|Overall Study|Did not meet entrance criteria|1
2188697|NCT01470599|3819042|FG001|Overall Study|Did not meet entrance criteria|0
2188698|NCT01470599|3819041|FG000|Overall Study|Lost to Follow-up|2
2188699|NCT01470599|3819042|FG001|Overall Study|Lost to Follow-up|1
2188700|NCT01470599|3819041|FG000|Overall Study|Withdrawal by Subject|3
2188701|NCT01470599|3819042|FG001|Overall Study|Withdrawal by Subject|4
2188702|NCT01470599|3819041|FG000|Overall Study|Other|1
2188703|NCT01470599|3819042|FG001|Overall Study|Other|0
2188704|NCT01470599|3819041|FG000|Overall Study|Protocol Violation|3
2188705|NCT01470599|3819042|FG001|Overall Study|Protocol Violation|1
2188706|NCT01470599|3819041|FG000|Overall Study|Adverse event related to study drug|2
2188707|NCT01470599|3819042|FG001|Overall Study|Adverse event related to study drug|5
2188708|NCT01470599|3819041|FG000|Overall Study|Insufficient clinical response|6
2188709|NCT01470599|3819042|FG001|Overall Study|Insufficient clinical response|27
2188710|NCT01470599|3819041|FG000|Overall Study|Adverse event not related to study drug|1
2188711|NCT01470599|3819042|FG001|Overall Study|Adverse event not related to study drug|5
2188712|NCT01470612|3819050|FG000|Overall Study|Adverse Event|20
2188713|NCT01470612|3819051|FG001|Overall Study|Adverse Event|80
2188714|NCT01470612|3819050|FG000|Overall Study|Death|0
2188715|NCT01470612|3819051|FG001|Overall Study|Death|1
2222655|NCT01750229|3868467|FG000|Randomized Crossover Phase|Adverse Event|1
2222656|NCT01750229|3868467|FG000|Randomized Crossover Phase|Withdrawal by Subject|1
2222657|NCT01750229|3868467|FG000|Long-term Follow-up Phase|Adverse Event|2
2188716|NCT01470612|3819050|FG000|Overall Study|Lack of Efficacy|20
2188717|NCT01470612|3819051|FG001|Overall Study|Lack of Efficacy|326
2188718|NCT01470612|3819050|FG000|Overall Study|Lost to Follow-up|2
2188719|NCT01470612|3819051|FG001|Overall Study|Lost to Follow-up|5
2188720|NCT01470612|3819050|FG000|Overall Study|Did not meet entrance criteria|0
2188721|NCT01470612|3819051|FG001|Overall Study|Did not meet entrance criteria|1
2188722|NCT01470612|3819050|FG000|Overall Study|Pregnancy|2
2188723|NCT01470612|3819051|FG001|Overall Study|Pregnancy|10
2188724|NCT01470612|3819050|FG000|Overall Study|Protocol Violation|2
2188725|NCT01470612|3819051|FG001|Overall Study|Protocol Violation|7
2188726|NCT01470612|3819050|FG000|Overall Study|Withdrawal by Subject|24
2188727|NCT01470612|3819051|FG001|Overall Study|Withdrawal by Subject|79
2188728|NCT01470612|3819050|FG000|Overall Study|Other|14
2188729|NCT01470612|3819051|FG001|Overall Study|Other|156
2188730|NCT01470989|3819087|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103
2188731|NCT01470989|3819088|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136
2188732|NCT01470989|3819087|FG000|Overall Study|Adverse Event|2
2188733|NCT01470989|3819088|FG001|Overall Study|Adverse Event|5
2188734|NCT01470989|3819087|FG000|Overall Study|Abnormal laboratory value|1
2188735|NCT01470989|3819088|FG001|Overall Study|Abnormal laboratory value|1
2188736|NCT01470989|3819087|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2188737|NCT01470989|3819088|FG001|Overall Study|Unsatisfactory therapeutic effect|6
2188738|NCT01470989|3819087|FG000|Overall Study|Withdrawal by Subject|19
2188739|NCT01470989|3819088|FG001|Overall Study|Withdrawal by Subject|17
2188740|NCT01470989|3819087|FG000|Overall Study|Lost to Follow-up|18
2188741|NCT01470989|3819088|FG001|Overall Study|Lost to Follow-up|13
2188742|NCT01470989|3819087|FG000|Overall Study|Administrative problems|2
2188743|NCT01470989|3819088|FG001|Overall Study|Administrative problems|4
2188744|NCT01470989|3819087|FG000|Overall Study|Death|2
2188745|NCT01470989|3819088|FG001|Overall Study|Death|2
2188746|NCT01470989|3819087|FG000|Overall Study|Protocol deviation|1
2188747|NCT01470989|3819088|FG001|Overall Study|Protocol deviation|2
2188748|NCT01471015|3819099|FG000|Overall Study|Death|0
2188749|NCT01471015|3819100|FG001|Overall Study|Death|1
2188750|NCT01471015|3819101|FG002|Overall Study|Death|1
2188751|NCT01471028|3819111|FG000|VTI-208|Adverse Event|39
2188752|NCT01471028|3819112|FG001|VTI-208|Adverse Event|41
2188753|NCT01471028|3819111|FG000|VTI-208|Withdrawal by Subject|0
2188754|NCT01471028|3819112|FG001|VTI-208|Withdrawal by Subject|2
2188755|NCT01471028|3819111|FG000|VTI-208|Lost to Follow-up|1
2188756|NCT01471028|3819112|FG001|VTI-208|Lost to Follow-up|1
2188757|NCT01471028|3819111|FG000|VTI-208E|Death|7
2188758|NCT01471028|3819112|FG001|VTI-208E|Death|10
2188759|NCT01471028|3819111|FG000|VTI-208E|Withdrawal by Subject|1
2188760|NCT01471028|3819112|FG001|VTI-208E|Withdrawal by Subject|0
2188761|NCT01471028|3819111|FG000|VTI-208E|Lost to Follow-up|0
2188762|NCT01471028|3819112|FG001|VTI-208E|Lost to Follow-up|2
2188763|NCT01471054|3819127|FG000|Overall Study|Study terminated prematurely|4
2188764|NCT01471054|3819128|FG001|Overall Study|Study terminated prematurely|0
2188765|NCT01471093|3819146|FG000|Overall Study|Adverse Event|1
2188766|NCT01471093|3819147|FG001|Overall Study|Adverse Event|0
2188767|NCT01471093|3819148|FG002|Overall Study|Adverse Event|0
2188768|NCT01471093|3819149|FG003|Overall Study|Adverse Event|0
2188769|NCT01471171|3819155|FG000|Treatment Period 1|Adverse Event|4
2188770|NCT01471171|3819156|FG001|Treatment Period 1|Adverse Event|1
2188771|NCT01471171|3819155|FG000|Treatment Period 2|Adverse Event|1
2188772|NCT01471171|3819156|FG001|Treatment Period 2|Adverse Event|0
2188773|NCT01471197|3819164|FG000|Overall Study|Disease Progression|4
2188774|NCT01471197|3819165|FG001|Overall Study|Disease Progression|2
2188775|NCT01471197|3819164|FG000|Overall Study|Death|1
2188776|NCT01471197|3819165|FG001|Overall Study|Death|0
2188777|NCT01471197|3819164|FG000|Overall Study|Study Drug Toxicity|1
2188778|NCT01471197|3819165|FG001|Overall Study|Study Drug Toxicity|0
2188779|NCT01471353|3819171|FG000|Overall Study|remain on study|3
2188780|NCT01471379|3819178|FG000|Overall Study|Adverse Event|1
2188781|NCT01471379|3819179|FG001|Overall Study|Adverse Event|0
2188782|NCT01471379|3819180|FG002|Overall Study|Adverse Event|0
2188783|NCT01471379|3819178|FG000|Overall Study|Study terminated|0
2188784|NCT01471379|3819179|FG001|Overall Study|Study terminated|1
2188785|NCT01471379|3819180|FG002|Overall Study|Study terminated|0
2188786|NCT01471522|3819200|FG000|Overall Study|Withdrawal by Subject|28
2188787|NCT01471522|3819201|FG001|Overall Study|Withdrawal by Subject|22
2188788|NCT01471522|3819200|FG000|Overall Study|Lost to Follow-up|36
2188789|NCT01471522|3819201|FG001|Overall Study|Lost to Follow-up|26
2188790|NCT01471574|3819212|FG000|Treatment Period|Lack of Efficacy|12
2188791|NCT01471574|3819213|FG001|Treatment Period|Lack of Efficacy|4
2188792|NCT01471574|3819214|FG002|Treatment Period|Lack of Efficacy|14
2188793|NCT01471574|3819215|FG003|Treatment Period|Lack of Efficacy|1
2188794|NCT01471574|3819212|FG000|Treatment Period|Adverse Event|7
2188795|NCT01471574|3819213|FG001|Treatment Period|Adverse Event|3
2188796|NCT01471574|3819214|FG002|Treatment Period|Adverse Event|6
2188797|NCT01471574|3819215|FG003|Treatment Period|Adverse Event|1
2188798|NCT01471574|3819212|FG000|Treatment Period|Withdrawal by Subject|5
2188799|NCT01471574|3819213|FG001|Treatment Period|Withdrawal by Subject|1
2188800|NCT01471574|3819214|FG002|Treatment Period|Withdrawal by Subject|1
2188801|NCT01471574|3819215|FG003|Treatment Period|Withdrawal by Subject|0
2188802|NCT01471574|3819212|FG000|Treatment Period|Patient Requested Discontinue Study drug|4
2188803|NCT01471574|3819213|FG001|Treatment Period|Patient Requested Discontinue Study drug|0
2188804|NCT01471574|3819214|FG002|Treatment Period|Patient Requested Discontinue Study drug|1
2188805|NCT01471574|3819215|FG003|Treatment Period|Patient Requested Discontinue Study drug|1
2188806|NCT01471574|3819212|FG000|Treatment Period|Lost to Follow-up|1
2188807|NCT01471574|3819213|FG001|Treatment Period|Lost to Follow-up|2
2188808|NCT01471574|3819214|FG002|Treatment Period|Lost to Follow-up|2
2188809|NCT01471574|3819215|FG003|Treatment Period|Lost to Follow-up|0
2188810|NCT01471574|3819212|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1
2188811|NCT01471574|3819213|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0
2188812|NCT01471574|3819214|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0
2188813|NCT01471574|3819215|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0
2188814|NCT01471574|3819212|FG000|Treatment Period|Other|1
2188815|NCT01471574|3819213|FG001|Treatment Period|Other|0
2188816|NCT01471574|3819214|FG002|Treatment Period|Other|0
2188817|NCT01471574|3819215|FG003|Treatment Period|Other|0
2188818|NCT01471574|3819212|FG000|Follow-up Period|Withdrawal by Subject|3
2222658|NCT01750229|3868467|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1
2222659|NCT01750242|3868477|FG000|Overall Study|Unreadable Images|3
2222660|NCT01750268|3868494|FG000|Overall Study|Lost to Follow-up|0
2222661|NCT01750268|3868495|FG001|Overall Study|Lost to Follow-up|2
2222662|NCT01750268|3868494|FG000|Overall Study|Physician Decision|0
2222663|NCT01750268|3868495|FG001|Overall Study|Physician Decision|3
2222664|NCT01750268|3868494|FG000|Overall Study|Withdrawal by Subject|2
2222665|NCT01750268|3868495|FG001|Overall Study|Withdrawal by Subject|0
2222666|NCT01750294|3868501|FG000|Overall Study|Withdrawal by Subject|1
2222667|NCT01750294|3868501|FG000|Overall Study|Safety Endpoint|1
2222668|NCT01750346|3868508|FG000|Overall Study|Adverse Event|1
2222669|NCT01750346|3868509|FG001|Overall Study|Adverse Event|0
2222670|NCT01750346|3868510|FG002|Overall Study|Adverse Event|0
2222671|NCT01750684|3868538|FG000|Overall Study|Death|1
2222672|NCT01750684|3868539|FG001|Overall Study|Death|0
2222673|NCT01750684|3868538|FG000|Overall Study|Non-compliance with Study Drug|0
2222674|NCT01750684|3868539|FG001|Overall Study|Non-compliance with Study Drug|1
2222675|NCT01750684|3868538|FG000|Overall Study|Withdrawn by Sponsor|0
2222676|NCT01750684|3868539|FG001|Overall Study|Withdrawn by Sponsor|1
2222677|NCT01750684|3868538|FG000|Overall Study|Protocol Violation|1
2222678|NCT01750684|3868539|FG001|Overall Study|Protocol Violation|0
2222679|NCT01750697|3868546|FG000|Overall Study|Transferred Back to Local Hospital|1
2222680|NCT01750697|3868546|FG000|Overall Study|Physician and Family Decision|1
2222681|NCT01750697|3868546|FG000|Overall Study|Transferred to Adult Services|5
2222682|NCT01750697|3868546|FG000|Overall Study|Physician Decision|1
2222683|NCT01750697|3868546|FG000|Overall Study|Withdrawal by Subject|1
2222684|NCT01750840|3868553|FG000|Overall Study|Lost to Follow-up|4
2222685|NCT01750879|3868560|FG000|Overall Study|Adverse Event|8
2222686|NCT01750879|3868561|FG001|Overall Study|Adverse Event|0
2222687|NCT01750879|3868560|FG000|Overall Study|Lack of Efficacy|1
2222688|NCT01750879|3868561|FG001|Overall Study|Lack of Efficacy|0
2222689|NCT01750879|3868560|FG000|Overall Study|Withdrawal by Subject|1
2222690|NCT01750879|3868561|FG001|Overall Study|Withdrawal by Subject|0
2222691|NCT01750879|3868560|FG000|Overall Study|Did not complete per protocol|0
2222692|NCT01750879|3868561|FG001|Overall Study|Did not complete per protocol|3
2222693|NCT01750918|3868588|FG000|Overall Study|Last patient transitioned to a rollover protocol|0
2222694|NCT01750918|3868589|FG001|Overall Study|Last patient transitioned to a rollover protocol|0
2222695|NCT01750918|3868590|FG002|Overall Study|Last patient transitioned to a rollover protocol|5
2222696|NCT01750918|3868591|FG003|Overall Study|Last patient transitioned to a rollover protocol|2
2222697|NCT01750918|3868592|FG004|Overall Study|Last patient transitioned to a rollover protocol|0
2222698|NCT01750918|3868593|FG005|Overall Study|Last patient transitioned to a rollover protocol|2
2222699|NCT01750918|3868594|FG006|Overall Study|Last patient transitioned to a rollover protocol|1
2222700|NCT01750918|3868595|FG007|Overall Study|Last patient transitioned to a rollover protocol|1
2222701|NCT01750918|3868588|FG000|Overall Study|Lost to Follow-up|0
2222702|NCT01750918|3868589|FG001|Overall Study|Lost to Follow-up|0
2222703|NCT01750918|3868590|FG002|Overall Study|Lost to Follow-up|2
2222704|NCT01750918|3868591|FG003|Overall Study|Lost to Follow-up|2
2222705|NCT01750918|3868592|FG004|Overall Study|Lost to Follow-up|0
2222706|NCT01750918|3868593|FG005|Overall Study|Lost to Follow-up|0
2222707|NCT01750918|3868594|FG006|Overall Study|Lost to Follow-up|0
2222708|NCT01750918|3868595|FG007|Overall Study|Lost to Follow-up|1
2222709|NCT01750918|3868588|FG000|Overall Study|Withdrawal by Subject|0
2222710|NCT01750918|3868589|FG001|Overall Study|Withdrawal by Subject|0
2222711|NCT01750918|3868590|FG002|Overall Study|Withdrawal by Subject|1
2222712|NCT01750918|3868591|FG003|Overall Study|Withdrawal by Subject|2
2222713|NCT01750918|3868592|FG004|Overall Study|Withdrawal by Subject|1
2222714|NCT01750918|3868593|FG005|Overall Study|Withdrawal by Subject|1
2222715|NCT01750918|3868594|FG006|Overall Study|Withdrawal by Subject|2
2222716|NCT01750918|3868595|FG007|Overall Study|Withdrawal by Subject|2
2222717|NCT01751061|3868666|FG000|Overall Study|Death|1
2222718|NCT01751061|3868667|FG001|Overall Study|Death|0
2222719|NCT01751061|3868666|FG000|Overall Study|patient death|5
2222720|NCT01751061|3868667|FG001|Overall Study|patient death|0
2222721|NCT01751061|3868666|FG000|Overall Study|Lost to Follow-up|40
2222722|NCT01751061|3868667|FG001|Overall Study|Lost to Follow-up|25
2222723|NCT01751061|3868666|FG000|Overall Study|patient regained decisional capacity|4
2222724|NCT01751061|3868667|FG001|Overall Study|patient regained decisional capacity|8
2188819|NCT01471574|3819213|FG001|Follow-up Period|Withdrawal by Subject|0
2188820|NCT01471574|3819214|FG002|Follow-up Period|Withdrawal by Subject|3
2188821|NCT01471574|3819215|FG003|Follow-up Period|Withdrawal by Subject|1
2188822|NCT01471574|3819212|FG000|Follow-up Period|Lost to Follow-up|4
2188823|NCT01471574|3819213|FG001|Follow-up Period|Lost to Follow-up|1
2188824|NCT01471574|3819214|FG002|Follow-up Period|Lost to Follow-up|3
2188825|NCT01471574|3819215|FG003|Follow-up Period|Lost to Follow-up|2
2188826|NCT01471574|3819212|FG000|Follow-up Period|Death|0
2188827|NCT01471574|3819213|FG001|Follow-up Period|Death|0
2188828|NCT01471574|3819214|FG002|Follow-up Period|Death|1
2188829|NCT01471574|3819215|FG003|Follow-up Period|Death|0
2188830|NCT01471574|3819212|FG000|Follow-up Period|Follow-up no longer required|0
2188831|NCT01471574|3819213|FG001|Follow-up Period|Follow-up no longer required|1
2188832|NCT01471574|3819214|FG002|Follow-up Period|Follow-up no longer required|0
2188833|NCT01471574|3819215|FG003|Follow-up Period|Follow-up no longer required|0
2188834|NCT01471691|3819241|FG000|Overall Study|Lack of Efficacy|0
2188835|NCT01471691|3819242|FG001|Overall Study|Lack of Efficacy|1
2188836|NCT01471782|3819254|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2
2188837|NCT01471782|3819255|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2
2188838|NCT01471782|3819256|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1
2188839|NCT01471782|3819257|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0
2188840|NCT01471782|3819258|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5
2188841|NCT01471782|3819259|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3
2188842|NCT01471782|3819254|FG000|Overall Study|Lack of Efficacy|1
2188843|NCT01471782|3819255|FG001|Overall Study|Lack of Efficacy|2
2188844|NCT01471782|3819256|FG002|Overall Study|Lack of Efficacy|1
2188845|NCT01471782|3819257|FG003|Overall Study|Lack of Efficacy|1
2188846|NCT01471782|3819258|FG004|Overall Study|Lack of Efficacy|5
2188847|NCT01471782|3819259|FG005|Overall Study|Lack of Efficacy|18
2188848|NCT01471782|3819254|FG000|Overall Study|Adverse Event|1
2188849|NCT01471782|3819255|FG001|Overall Study|Adverse Event|1
2188850|NCT01471782|3819256|FG002|Overall Study|Adverse Event|2
2188851|NCT01471782|3819257|FG003|Overall Study|Adverse Event|2
2188852|NCT01471782|3819258|FG004|Overall Study|Adverse Event|3
2188853|NCT01471782|3819259|FG005|Overall Study|Adverse Event|1
2188854|NCT01471782|3819254|FG000|Overall Study|Other|0
2188855|NCT01471782|3819255|FG001|Overall Study|Other|0
2188856|NCT01471782|3819256|FG002|Overall Study|Other|1
2188857|NCT01471782|3819257|FG003|Overall Study|Other|1
2188858|NCT01471782|3819258|FG004|Overall Study|Other|6
2188859|NCT01471782|3819259|FG005|Overall Study|Other|5
2188860|NCT01471782|3819254|FG000|Overall Study|Change of Chemotherapy|1
2188861|NCT01471782|3819255|FG001|Overall Study|Change of Chemotherapy|1
2188862|NCT01471782|3819256|FG002|Overall Study|Change of Chemotherapy|0
2188863|NCT01471782|3819257|FG003|Overall Study|Change of Chemotherapy|0
2188864|NCT01471782|3819258|FG004|Overall Study|Change of Chemotherapy|1
2188865|NCT01471782|3819259|FG005|Overall Study|Change of Chemotherapy|4
2188866|NCT01471782|3819254|FG000|Overall Study|Disease Relapse|0
2188867|NCT01471782|3819255|FG001|Overall Study|Disease Relapse|0
2188868|NCT01471782|3819256|FG002|Overall Study|Disease Relapse|0
2188869|NCT01471782|3819257|FG003|Overall Study|Disease Relapse|1
2222725|NCT01751061|3868666|FG000|Overall Study|Withdrawal by Subject|4
2222726|NCT01751061|3868667|FG001|Overall Study|Withdrawal by Subject|1
2222727|NCT01751061|3868666|FG000|Overall Study|Physician Decision|2
2222728|NCT01751061|3868667|FG001|Overall Study|Physician Decision|0
2222729|NCT01751087|3868676|FG000|Overall Study|Withdrawal by Subject|1
2222730|NCT01751087|3868677|FG001|Overall Study|Withdrawal by Subject|0
2222731|NCT01751087|3868678|FG002|Overall Study|Withdrawal by Subject|0
2222732|NCT01751087|3868676|FG000|Overall Study|Physician Decision|0
2222733|NCT01751087|3868677|FG001|Overall Study|Physician Decision|0
2222734|NCT01751087|3868678|FG002|Overall Study|Physician Decision|1
2222735|NCT01751113|3868686|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
2222736|NCT01751113|3868687|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
2222737|NCT01751113|3868688|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0
2222738|NCT01751113|3868689|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1
2222739|NCT01751113|3868690|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1
2222740|NCT01751113|3868691|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0
2222741|NCT01751113|3868686|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0
2222742|NCT01751113|3868687|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0
2222743|NCT01751113|3868688|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0
2222744|NCT01751113|3868689|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0
2222745|NCT01751113|3868690|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0
2222746|NCT01751113|3868691|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1
2222747|NCT01751139|3868700|FG000|Overall Study|Other|135
2222748|NCT01751139|3868700|FG000|Overall Study|Sponsor study termination|1609
2188870|NCT01471782|3819258|FG004|Overall Study|Disease Relapse|2
2188871|NCT01471782|3819259|FG005|Overall Study|Disease Relapse|1
2188872|NCT01471782|3819254|FG000|Overall Study|Physician Decision|0
2188873|NCT01471782|3819255|FG001|Overall Study|Physician Decision|0
2222749|NCT01751139|3868700|FG000|Overall Study|Lost to Follow-up|240
2222750|NCT01751139|3868700|FG000|Overall Study|Withdrawal by Subject|251
2222751|NCT01751139|3868700|FG000|Overall Study|Adverse Event|1
2222752|NCT01751139|3868700|FG000|Overall Study|Death|31
2188874|NCT01471782|3819256|FG002|Overall Study|Physician Decision|0
2188875|NCT01471782|3819257|FG003|Overall Study|Physician Decision|0
2188876|NCT01471782|3819258|FG004|Overall Study|Physician Decision|3
2188877|NCT01471782|3819259|FG005|Overall Study|Physician Decision|8
2188878|NCT01471782|3819254|FG000|Overall Study|Withdrawal by Parent/Guardian|0
2188879|NCT01471782|3819255|FG001|Overall Study|Withdrawal by Parent/Guardian|0
2188880|NCT01471782|3819256|FG002|Overall Study|Withdrawal by Parent/Guardian|0
2188881|NCT01471782|3819257|FG003|Overall Study|Withdrawal by Parent/Guardian|0
2188882|NCT01471782|3819258|FG004|Overall Study|Withdrawal by Parent/Guardian|1
2188883|NCT01471782|3819259|FG005|Overall Study|Withdrawal by Parent/Guardian|0
2188884|NCT01471782|3819254|FG000|Overall Study|Death|0
2188885|NCT01471782|3819255|FG001|Overall Study|Death|0
2188886|NCT01471782|3819256|FG002|Overall Study|Death|0
2188887|NCT01471782|3819257|FG003|Overall Study|Death|0
2188888|NCT01471782|3819258|FG004|Overall Study|Death|0
2188889|NCT01471782|3819259|FG005|Overall Study|Death|1
2188890|NCT01472185|3819286|FG000|Overall Study|Randomized but Not Treated|0
2188891|NCT01472185|3819287|FG001|Overall Study|Randomized but Not Treated|1
2188892|NCT01472185|3819286|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3
2188893|NCT01472185|3819287|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10
2222753|NCT01751165|3868707|FG000|Overall Study|Adverse event, serious fatal|1
2222754|NCT01751165|3868708|FG001|Overall Study|Adverse event, serious fatal|0
2222755|NCT01751165|3868709|FG002|Overall Study|Adverse event, serious fatal|1
2222756|NCT01751165|3868707|FG000|Overall Study|Withdrawal by Subject|0
2222757|NCT01751165|3868708|FG001|Overall Study|Withdrawal by Subject|0
2222758|NCT01751165|3868709|FG002|Overall Study|Withdrawal by Subject|1
2222759|NCT01751165|3868707|FG000|Overall Study|Serious adverse event|0
2222760|NCT01751165|3868708|FG001|Overall Study|Serious adverse event|2
2222761|NCT01751165|3868709|FG002|Overall Study|Serious adverse event|0
2222762|NCT01751165|3868707|FG000|Overall Study|Lost to Follow-up|1
2222763|NCT01751165|3868708|FG001|Overall Study|Lost to Follow-up|1
2222764|NCT01751165|3868709|FG002|Overall Study|Lost to Follow-up|1
2222765|NCT01751178|3868722|FG000|Overall Study|Adverse Event|2
2222766|NCT01751178|3868723|FG001|Overall Study|Adverse Event|0
2222767|NCT01751178|3868724|FG002|Overall Study|Adverse Event|0
2222768|NCT01751178|3868722|FG000|Overall Study|Other Reason (unknown)|1
2222769|NCT01751178|3868723|FG001|Overall Study|Other Reason (unknown)|0
2222770|NCT01751178|3868724|FG002|Overall Study|Other Reason (unknown)|2
2222771|NCT01751412|3868800|FG000|Overall Study|Disease Progression Before Treatment|1
2222772|NCT01751568|3868820|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1
2222773|NCT01751568|3868821|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
2222774|NCT01751568|3868822|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
2222775|NCT01751646|3868832|FG000|Overall Study|Lost to Follow-up|5
2222776|NCT01751646|3868833|FG001|Overall Study|Lost to Follow-up|1
2222777|NCT01751646|3868832|FG000|Overall Study|Withdrawal by Subject|0
2222778|NCT01751646|3868833|FG001|Overall Study|Withdrawal by Subject|4
2222779|NCT01751646|3868832|FG000|Overall Study|Starting hormone therapy|1
2222780|NCT01751646|3868833|FG001|Overall Study|Starting hormone therapy|0
2222781|NCT01751646|3868832|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2
2222782|NCT01751646|3868833|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3
2222783|NCT01751646|3868832|FG000|Overall Study|Inadvertent enrollment|1
2222784|NCT01751646|3868833|FG001|Overall Study|Inadvertent enrollment|1
2222785|NCT01751646|3868832|FG000|Overall Study|Moved out of the area|1
2222786|NCT01751646|3868833|FG001|Overall Study|Moved out of the area|5
2222787|NCT01751646|3868832|FG000|Overall Study|Inability to attend required visits|0
2222788|NCT01751646|3868833|FG001|Overall Study|Inability to attend required visits|1
2222789|NCT01751646|3868832|FG000|Overall Study|Off study due to multiple obligations|0
2222790|NCT01751646|3868833|FG001|Overall Study|Off study due to multiple obligations|1
2222791|NCT01751646|3868832|FG000|Overall Study|Fails to comply with study requirements|0
2222792|NCT01751646|3868833|FG001|Overall Study|Fails to comply with study requirements|1
2222793|NCT01751646|3868832|FG000|Overall Study|Childcare issues|1
2222794|NCT01751646|3868833|FG001|Overall Study|Childcare issues|1
2222795|NCT01751724|3868845|FG000|Overall Study|extubated bef.start assigned treatment|1
2222796|NCT01751724|3868846|FG001|Overall Study|extubated bef.start assigned treatment|0
2222797|NCT01751724|3868845|FG000|Overall Study|withdrawn by parent|0
2222798|NCT01751724|3868846|FG001|Overall Study|withdrawn by parent|2
2222799|NCT01751802|3868854|FG000|Overall Study|Adverse Event|4
2222800|NCT01751802|3868855|FG001|Overall Study|Adverse Event|2
2222801|NCT01751867|3868869|FG000|Overall Study|Completed treatment,dropped in follow-up|4
2222802|NCT01751867|3868870|FG001|Overall Study|Completed treatment,dropped in follow-up|8
2222803|NCT01751867|3868869|FG000|Overall Study|Diease Progression|4
2222804|NCT01751867|3868870|FG001|Overall Study|Diease Progression|18
2222805|NCT01751867|3868869|FG000|Overall Study|Adverse Event|8
2222806|NCT01751867|3868870|FG001|Overall Study|Adverse Event|15
2222807|NCT01751867|3868869|FG000|Overall Study|Poor Compliance|0
2222808|NCT01751867|3868870|FG001|Overall Study|Poor Compliance|5
2188894|NCT01472185|3819286|FG000|Overall Study|Hyperglycemia|5
2188895|NCT01472185|3819287|FG001|Overall Study|Hyperglycemia|2
2188896|NCT01472185|3819286|FG000|Overall Study|Investigator's Discretion|3
2188897|NCT01472185|3819287|FG001|Overall Study|Investigator's Discretion|1
2188898|NCT01472185|3819286|FG000|Overall Study|Lost to Follow-up|4
2188899|NCT01472185|3819287|FG001|Overall Study|Lost to Follow-up|1
2188900|NCT01472185|3819286|FG000|Overall Study|Protocol Violation|5
2188901|NCT01472185|3819287|FG001|Overall Study|Protocol Violation|1
2188902|NCT01472185|3819286|FG000|Overall Study|Subject Noncompliance|8
2188903|NCT01472185|3819287|FG001|Overall Study|Subject Noncompliance|15
2188904|NCT01472185|3819286|FG000|Overall Study|Subject Withdrew Consent|6
2188905|NCT01472185|3819287|FG001|Overall Study|Subject Withdrew Consent|3
2188906|NCT01472289|3819293|FG000|Overall Study|Death|2
2188907|NCT01472341|3819297|FG000|Overall Study|Started insulin therapy|55
2188908|NCT01472341|3819297|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92
2188909|NCT01472341|3819297|FG000|Overall Study|Withdrawal by Subject|39
2188910|NCT01472341|3819297|FG000|Overall Study|Lost to Follow-up|52
2188911|NCT01472341|3819297|FG000|Overall Study|Laboratory parameters unavailable|25
2188912|NCT01472341|3819297|FG000|Overall Study|Death|9
2188913|NCT01472380|3819301|FG000|Efavirenz Alone|Withdrawal by Subject|1
2188914|NCT01472380|3819301|FG000|1 Day Period Between Dosing|Protocol Violation|1
2188915|NCT01472757|3819356|FG000|Overall Study|Withdrawal by Subject|1
2188916|NCT01472757|3819357|FG001|Overall Study|Withdrawal by Subject|2
2188917|NCT01472757|3819358|FG002|Overall Study|Withdrawal by Subject|2
2188918|NCT01472757|3819359|FG003|Overall Study|Withdrawal by Subject|0
2222809|NCT01751867|3868869|FG000|Overall Study|Withdrawal by Subject|3
2222810|NCT01751867|3868870|FG001|Overall Study|Withdrawal by Subject|1
2222811|NCT01751867|3868869|FG000|Overall Study|Physician Decision|4
2222812|NCT01751867|3868870|FG001|Overall Study|Physician Decision|7
2222813|NCT01751867|3868869|FG000|Overall Study|Protocol Violation|0
2222814|NCT01751867|3868870|FG001|Overall Study|Protocol Violation|2
2222815|NCT01751867|3868869|FG000|Overall Study|Death|0
2222816|NCT01751867|3868870|FG001|Overall Study|Death|5
2222817|NCT01751867|3868869|FG000|Overall Study|Other|11
2222818|NCT01751867|3868870|FG001|Overall Study|Other|37
2222819|NCT01751867|3868869|FG000|Overall Study|Randomized but not treated.|2
2222820|NCT01751867|3868870|FG001|Overall Study|Randomized but not treated.|1
2222821|NCT01751906|3868878|FG000|Overall Study|Lost to Follow-up|151
2222822|NCT01751906|3868879|FG001|Overall Study|Lost to Follow-up|68
2222823|NCT01751906|3868878|FG000|Overall Study|Withdrawal by Subject|22
2222824|NCT01751906|3868879|FG001|Overall Study|Withdrawal by Subject|18
2222825|NCT01751906|3868878|FG000|Overall Study|Physician Decision|5
2222826|NCT01751906|3868879|FG001|Overall Study|Physician Decision|2
2222827|NCT01751906|3868878|FG000|Overall Study|Death|84
2222828|NCT01751906|3868879|FG001|Overall Study|Death|43
2222829|NCT01751906|3868878|FG000|Overall Study|Denied on premises for follow-up by law|1
2222830|NCT01751906|3868879|FG001|Overall Study|Denied on premises for follow-up by law|0
2222831|NCT01752036|3868900|FG000|Overall Study|Death|2
2222832|NCT01752634|3868928|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
2222833|NCT01752634|3868929|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
2222834|NCT01752634|3868930|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
2222835|NCT01752634|3868931|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
2222836|NCT01752634|3868932|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
2222837|NCT01752634|3868933|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
2222838|NCT01752634|3868928|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0
2222839|NCT01752634|3868929|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1
2222840|NCT01752634|3868930|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0
2222841|NCT01752634|3868931|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0
2222842|NCT01752634|3868932|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0
2222843|NCT01752634|3868933|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0
2222844|NCT01752634|3868928|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
2222845|NCT01752634|3868929|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
2222846|NCT01752634|3868930|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
2222847|NCT01752634|3868931|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
2222848|NCT01752634|3868932|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
2222849|NCT01752634|3868933|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
2222850|NCT01752634|3868928|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3
2222851|NCT01752634|3868929|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0
2222852|NCT01752634|3868930|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2
2222853|NCT01752634|3868931|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0
2222854|NCT01752634|3868932|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0
2222855|NCT01752634|3868933|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4
2222856|NCT01752634|3868928|FG000|Week 24 to Week 260|Lack of Efficacy|15
2222857|NCT01752634|3868929|FG001|Week 24 to Week 260|Lack of Efficacy|7
2222858|NCT01752634|3868930|FG002|Week 24 to Week 260|Lack of Efficacy|7
2222859|NCT01752634|3868931|FG003|Week 24 to Week 260|Lack of Efficacy|3
2222860|NCT01752634|3868932|FG004|Week 24 to Week 260|Lack of Efficacy|4
2222861|NCT01752634|3868933|FG005|Week 24 to Week 260|Lack of Efficacy|0
2222862|NCT01752634|3868928|FG000|Week 24 to Week 260|Subject/guardian decision|12
2222863|NCT01752634|3868929|FG001|Week 24 to Week 260|Subject/guardian decision|10
2222864|NCT01752634|3868930|FG002|Week 24 to Week 260|Subject/guardian decision|9
2188919|NCT01472757|3819356|FG000|Overall Study|Asthma exacerbation|4
2188920|NCT01472757|3819357|FG001|Overall Study|Asthma exacerbation|1
2188921|NCT01472757|3819358|FG002|Overall Study|Asthma exacerbation|2
2188922|NCT01472757|3819359|FG003|Overall Study|Asthma exacerbation|1
2188923|NCT01472757|3819356|FG000|Overall Study|Treatment period withdrawal criteria met|21
2188924|NCT01472757|3819357|FG001|Overall Study|Treatment period withdrawal criteria met|8
2188925|NCT01472757|3819358|FG002|Overall Study|Treatment period withdrawal criteria met|9
2188926|NCT01472757|3819359|FG003|Overall Study|Treatment period withdrawal criteria met|12
2188927|NCT01472757|3819356|FG000|Overall Study|Protocol Violation|3
2188928|NCT01472757|3819357|FG001|Overall Study|Protocol Violation|2
2188929|NCT01472757|3819358|FG002|Overall Study|Protocol Violation|4
2188930|NCT01472757|3819359|FG003|Overall Study|Protocol Violation|4
2188931|NCT01472757|3819356|FG000|Overall Study|Other reasons|1
2188932|NCT01472757|3819357|FG001|Overall Study|Other reasons|0
2188933|NCT01472757|3819358|FG002|Overall Study|Other reasons|2
2188934|NCT01472757|3819359|FG003|Overall Study|Other reasons|2
2188935|NCT01472835|3819380|FG000|Overall Study|Lost to Follow-up|2
2188936|NCT01472835|3819381|FG001|Overall Study|Lost to Follow-up|0
2188937|NCT01472939|3819398|FG000|Overall Study|Adverse Event|3
2188938|NCT01472939|3819399|FG001|Overall Study|Adverse Event|7
2188939|NCT01472939|3819400|FG002|Overall Study|Adverse Event|7
2188940|NCT01472939|3819401|FG003|Overall Study|Adverse Event|14
2188941|NCT01472939|3819398|FG000|Overall Study|Lack of Efficacy|1
2188942|NCT01472939|3819399|FG001|Overall Study|Lack of Efficacy|0
2188943|NCT01472939|3819400|FG002|Overall Study|Lack of Efficacy|0
2188944|NCT01472939|3819401|FG003|Overall Study|Lack of Efficacy|1
2188945|NCT01472939|3819398|FG000|Overall Study|Lost to Follow-up|3
2188946|NCT01472939|3819399|FG001|Overall Study|Lost to Follow-up|0
2188947|NCT01472939|3819400|FG002|Overall Study|Lost to Follow-up|2
2188948|NCT01472939|3819401|FG003|Overall Study|Lost to Follow-up|0
2188949|NCT01472939|3819398|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0
2188950|NCT01472939|3819399|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0
2188951|NCT01472939|3819400|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1
2188952|NCT01472939|3819401|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0
2188953|NCT01472939|3819398|FG000|Overall Study|Prohibited Medication|0
2188954|NCT01472939|3819399|FG001|Overall Study|Prohibited Medication|1
2188955|NCT01472939|3819400|FG002|Overall Study|Prohibited Medication|0
2188956|NCT01472939|3819401|FG003|Overall Study|Prohibited Medication|0
2188957|NCT01472939|3819398|FG000|Overall Study|Withdrawal By PI|1
2188958|NCT01472939|3819399|FG001|Overall Study|Withdrawal By PI|0
2188959|NCT01472939|3819400|FG002|Overall Study|Withdrawal By PI|0
2188960|NCT01472939|3819401|FG003|Overall Study|Withdrawal By PI|0
2188961|NCT01472939|3819398|FG000|Overall Study|Protocol Violation|3
2188962|NCT01472939|3819399|FG001|Overall Study|Protocol Violation|3
2188963|NCT01472939|3819400|FG002|Overall Study|Protocol Violation|0
2188964|NCT01472939|3819401|FG003|Overall Study|Protocol Violation|1
2188965|NCT01472939|3819398|FG000|Overall Study|Withdrawal by Subject|9
2188966|NCT01472939|3819399|FG001|Overall Study|Withdrawal by Subject|3
2188967|NCT01472939|3819400|FG002|Overall Study|Withdrawal by Subject|1
2188968|NCT01472939|3819401|FG003|Overall Study|Withdrawal by Subject|4
2188969|NCT01472965|3819416|FG000|Overall Study|Withdrawal by Subject|1
2188970|NCT01472965|3819417|FG001|Overall Study|Withdrawal by Subject|0
2188971|NCT01473355|3819429|FG000|Overall Study|Protocol Violation|2
2188972|NCT01473355|3819429|FG000|Overall Study|Adverse Event|2
2188973|NCT01473355|3819429|FG000|Overall Study|Lost to Follow-up|2
2188974|NCT01473381|3819470|FG000|Overall Study|Adverse Event|8
2188975|NCT01473381|3819471|FG001|Overall Study|Adverse Event|20
2188976|NCT01473381|3819472|FG002|Overall Study|Adverse Event|25
2188977|NCT01473381|3819473|FG003|Overall Study|Adverse Event|17
2188978|NCT01473381|3819470|FG000|Overall Study|Insufficient Therapeutic Response|10
2188979|NCT01473381|3819471|FG001|Overall Study|Insufficient Therapeutic Response|1
2188980|NCT01473381|3819472|FG002|Overall Study|Insufficient Therapeutic Response|2
2188981|NCT01473381|3819473|FG003|Overall Study|Insufficient Therapeutic Response|3
2188982|NCT01473381|3819470|FG000|Overall Study|Protocol Violation|17
2188983|NCT01473381|3819471|FG001|Overall Study|Protocol Violation|23
2188984|NCT01473381|3819472|FG002|Overall Study|Protocol Violation|19
2188985|NCT01473381|3819473|FG003|Overall Study|Protocol Violation|17
2188986|NCT01473381|3819470|FG000|Overall Study|Withdrawal of Consent|20
2188987|NCT01473381|3819471|FG001|Overall Study|Withdrawal of Consent|21
2188988|NCT01473381|3819472|FG002|Overall Study|Withdrawal of Consent|20
2188989|NCT01473381|3819473|FG003|Overall Study|Withdrawal of Consent|26
2188990|NCT01473381|3819470|FG000|Overall Study|Lost to Follow-up|25
2188991|NCT01473381|3819471|FG001|Overall Study|Lost to Follow-up|28
2188992|NCT01473381|3819472|FG002|Overall Study|Lost to Follow-up|35
2188993|NCT01473381|3819473|FG003|Overall Study|Lost to Follow-up|23
2188994|NCT01473381|3819470|FG000|Overall Study|Other Reasons|0
2188995|NCT01473381|3819471|FG001|Overall Study|Other Reasons|0
2188996|NCT01473381|3819472|FG002|Overall Study|Other Reasons|1
2188997|NCT01473381|3819473|FG003|Overall Study|Other Reasons|3
2188998|NCT01473394|3819486|FG000|Overall Study|Adverse Event|13
2188999|NCT01473394|3819487|FG001|Overall Study|Adverse Event|16
2222865|NCT01752634|3868931|FG003|Week 24 to Week 260|Subject/guardian decision|5
2189000|NCT01473394|3819486|FG000|Overall Study|Insufficient Therapeutic Response|4
2189001|NCT01473394|3819487|FG001|Overall Study|Insufficient Therapeutic Response|1
2189002|NCT01473394|3819486|FG000|Overall Study|Protocol Violation|7
2189003|NCT01473394|3819487|FG001|Overall Study|Protocol Violation|5
2189004|NCT01473394|3819486|FG000|Overall Study|Withdrew Consent|12
2189005|NCT01473394|3819487|FG001|Overall Study|Withdrew Consent|10
2189006|NCT01473394|3819486|FG000|Overall Study|Lost to Follow-up|9
2189007|NCT01473394|3819487|FG001|Overall Study|Lost to Follow-up|11
2189008|NCT01473407|3819495|FG000|Overall Study|Physician Decision|1
2189009|NCT01473407|3819496|FG001|Overall Study|Physician Decision|4
2189010|NCT01473407|3819495|FG000|Overall Study|Lost to Follow-up|10
2189011|NCT01473407|3819496|FG001|Overall Study|Lost to Follow-up|4
2189012|NCT01473407|3819495|FG000|Overall Study|Adverse Event|8
2189013|NCT01473407|3819496|FG001|Overall Study|Adverse Event|8
2189014|NCT01473407|3819495|FG000|Overall Study|Randomization Error|3
2189015|NCT01473407|3819496|FG001|Overall Study|Randomization Error|1
2189016|NCT01473407|3819495|FG000|Overall Study|Withdrawal by Subject|4
2189017|NCT01473407|3819496|FG001|Overall Study|Withdrawal by Subject|7
2189018|NCT01473407|3819495|FG000|Overall Study|Kidney Transplant|7
2189019|NCT01473407|3819496|FG001|Overall Study|Kidney Transplant|6
2189020|NCT01473407|3819495|FG000|Overall Study|Vacation/Travel|1
2189021|NCT01473407|3819496|FG001|Overall Study|Vacation/Travel|1
2189022|NCT01473407|3819495|FG000|Overall Study|Elevated Hemoglobin|1
2189023|NCT01473407|3819496|FG001|Overall Study|Elevated Hemoglobin|0
2189024|NCT01473407|3819495|FG000|Overall Study|Patient Received Aranesp|1
2189025|NCT01473407|3819496|FG001|Overall Study|Patient Received Aranesp|0
2189026|NCT01473407|3819495|FG000|Overall Study|Patient Lost Green Card Status|1
2189027|NCT01473407|3819496|FG001|Overall Study|Patient Lost Green Card Status|0
2189028|NCT01473407|3819495|FG000|Overall Study|Temperature Excursion|2
2189029|NCT01473407|3819496|FG001|Overall Study|Temperature Excursion|3
2189030|NCT01473407|3819495|FG000|Overall Study|Transfer to Another Facility/Unit|4
2189031|NCT01473407|3819496|FG001|Overall Study|Transfer to Another Facility/Unit|3
2189032|NCT01473407|3819495|FG000|Overall Study|Sponsor's Decision|10
2189033|NCT01473407|3819496|FG001|Overall Study|Sponsor's Decision|10
2189034|NCT01473407|3819495|FG000|Overall Study|Site Closure|1
2189035|NCT01473407|3819496|FG001|Overall Study|Site Closure|0
2189036|NCT01473420|3819504|FG000|Titration Period (18 Weeks)|Adverse Event|4
2189037|NCT01473420|3819505|FG001|Titration Period (18 Weeks)|Adverse Event|6
2189038|NCT01473420|3819504|FG000|Titration Period (18 Weeks)|Did not meet criteria|32
2189039|NCT01473420|3819505|FG001|Titration Period (18 Weeks)|Did not meet criteria|32
2189040|NCT01473420|3819504|FG000|Maintenance Period (16 Weeks)|Adverse Event|3
2189041|NCT01473420|3819505|FG001|Maintenance Period (16 Weeks)|Adverse Event|2
2189042|NCT01473420|3819504|FG000|Maintenance Period (16 Weeks)|Physician Decision|1
2222866|NCT01752634|3868932|FG004|Week 24 to Week 260|Subject/guardian decision|5
2222867|NCT01752634|3868933|FG005|Week 24 to Week 260|Subject/guardian decision|0
2222868|NCT01752634|3868928|FG000|Week 24 to Week 260|Physician Decision|1
2222869|NCT01752634|3868929|FG001|Week 24 to Week 260|Physician Decision|2
2222870|NCT01752634|3868930|FG002|Week 24 to Week 260|Physician Decision|4
2222871|NCT01752634|3868931|FG003|Week 24 to Week 260|Physician Decision|2
2222872|NCT01752634|3868932|FG004|Week 24 to Week 260|Physician Decision|1
2222873|NCT01752634|3868933|FG005|Week 24 to Week 260|Physician Decision|0
2222874|NCT01752634|3868928|FG000|Week 24 to Week 260|Death|0
2222875|NCT01752634|3868929|FG001|Week 24 to Week 260|Death|1
2222876|NCT01752634|3868930|FG002|Week 24 to Week 260|Death|0
2222877|NCT01752634|3868931|FG003|Week 24 to Week 260|Death|0
2222878|NCT01752634|3868932|FG004|Week 24 to Week 260|Death|0
2222879|NCT01752634|3868933|FG005|Week 24 to Week 260|Death|0
2222880|NCT01752634|3868928|FG000|Week 24 to Week 260|Pregnancy|0
2222881|NCT01752634|3868929|FG001|Week 24 to Week 260|Pregnancy|0
2222882|NCT01752634|3868930|FG002|Week 24 to Week 260|Pregnancy|1
2222883|NCT01752634|3868931|FG003|Week 24 to Week 260|Pregnancy|0
2222884|NCT01752634|3868932|FG004|Week 24 to Week 260|Pregnancy|0
2222885|NCT01752634|3868933|FG005|Week 24 to Week 260|Pregnancy|0
2222886|NCT01752634|3868928|FG000|Week 24 to Week 260|Noncompliance with study treatment|0
2222887|NCT01752634|3868929|FG001|Week 24 to Week 260|Noncompliance with study treatment|0
2222888|NCT01752634|3868930|FG002|Week 24 to Week 260|Noncompliance with study treatment|1
2222889|NCT01752634|3868931|FG003|Week 24 to Week 260|Noncompliance with study treatment|0
2222890|NCT01752634|3868932|FG004|Week 24 to Week 260|Noncompliance with study treatment|0
2222891|NCT01752634|3868933|FG005|Week 24 to Week 260|Noncompliance with study treatment|0
2222892|NCT01752634|3868928|FG000|Week 24 to Week 260|Lost to Follow-up|2
2222893|NCT01752634|3868929|FG001|Week 24 to Week 260|Lost to Follow-up|2
2222894|NCT01752634|3868930|FG002|Week 24 to Week 260|Lost to Follow-up|3
2222895|NCT01752634|3868931|FG003|Week 24 to Week 260|Lost to Follow-up|0
2222896|NCT01752634|3868932|FG004|Week 24 to Week 260|Lost to Follow-up|2
2222897|NCT01752634|3868933|FG005|Week 24 to Week 260|Lost to Follow-up|0
2222898|NCT01752634|3868928|FG000|Week 24 to Week 260|Adverse Event|4
2222899|NCT01752634|3868929|FG001|Week 24 to Week 260|Adverse Event|8
2222900|NCT01752634|3868930|FG002|Week 24 to Week 260|Adverse Event|8
2222901|NCT01752634|3868931|FG003|Week 24 to Week 260|Adverse Event|4
2222902|NCT01752634|3868932|FG004|Week 24 to Week 260|Adverse Event|2
2222903|NCT01752634|3868933|FG005|Week 24 to Week 260|Adverse Event|0
2222904|NCT01752842|3868954|FG000|Overall Study|Adverse Event|3
2222905|NCT01752842|3868955|FG001|Overall Study|Adverse Event|0
2222906|NCT01752842|3868954|FG000|Overall Study|Withdrawal by Subject|0
2222907|NCT01752842|3868955|FG001|Overall Study|Withdrawal by Subject|2
2222908|NCT01752855|3868963|FG000|Overall Study|Adverse Event|1
2189043|NCT01473420|3819505|FG001|Maintenance Period (16 Weeks)|Physician Decision|2
2189044|NCT01473420|3819504|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0
2189045|NCT01473420|3819505|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2
2189046|NCT01473420|3819504|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3
2189047|NCT01473420|3819505|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1
2189048|NCT01473420|3819504|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1
2189049|NCT01473420|3819505|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2
2189050|NCT01473420|3819504|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
2189051|NCT01473420|3819505|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
2189052|NCT01473420|3819504|FG000|Maintenance Period (16 Weeks)|Site closure|3
2189053|NCT01473420|3819505|FG001|Maintenance Period (16 Weeks)|Site closure|1
2189054|NCT01473420|3819504|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
2189055|NCT01473420|3819505|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
2189056|NCT01473420|3819504|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0
2189057|NCT01473420|3819505|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1
2189058|NCT01473420|3819504|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1
2189059|NCT01473420|3819505|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0
2189060|NCT01473420|3819504|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
2189061|NCT01473420|3819505|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
2189062|NCT01473524|3819520|FG000|DB Phase|Adverse Event|4
2189063|NCT01473524|3819521|FG001|DB Phase|Adverse Event|8
2189064|NCT01473524|3819522|FG002|DB Phase|Adverse Event|2
2189065|NCT01473524|3819523|FG003|DB Phase|Adverse Event|0
2189066|NCT01473524|3819524|FG004|DB Phase|Adverse Event|0
2189067|NCT01473524|3819525|FG005|DB Phase|Adverse Event|0
2189068|NCT01473524|3819520|FG000|DB Phase|Death|1
2189069|NCT01473524|3819521|FG001|DB Phase|Death|0
2189070|NCT01473524|3819522|FG002|DB Phase|Death|0
2189071|NCT01473524|3819523|FG003|DB Phase|Death|0
2189072|NCT01473524|3819524|FG004|DB Phase|Death|0
2189073|NCT01473524|3819525|FG005|DB Phase|Death|0
2189074|NCT01473524|3819520|FG000|DB Phase|Withdrawal by Subject|2
2189075|NCT01473524|3819521|FG001|DB Phase|Withdrawal by Subject|1
2189076|NCT01473524|3819522|FG002|DB Phase|Withdrawal by Subject|1
2189077|NCT01473524|3819523|FG003|DB Phase|Withdrawal by Subject|0
2189078|NCT01473524|3819524|FG004|DB Phase|Withdrawal by Subject|0
2189079|NCT01473524|3819525|FG005|DB Phase|Withdrawal by Subject|0
2189080|NCT01473524|3819520|FG000|LTSE Phase|Withdrawal by Subject|0
2189081|NCT01473524|3819521|FG001|LTSE Phase|Withdrawal by Subject|0
2189082|NCT01473524|3819522|FG002|LTSE Phase|Withdrawal by Subject|0
2189083|NCT01473524|3819523|FG003|LTSE Phase|Withdrawal by Subject|3
2189084|NCT01473524|3819524|FG004|LTSE Phase|Withdrawal by Subject|3
2189085|NCT01473524|3819525|FG005|LTSE Phase|Withdrawal by Subject|6
2189086|NCT01473524|3819520|FG000|LTSE Phase|Death|0
2189087|NCT01473524|3819521|FG001|LTSE Phase|Death|0
2189088|NCT01473524|3819522|FG002|LTSE Phase|Death|0
2189089|NCT01473524|3819523|FG003|LTSE Phase|Death|0
2189090|NCT01473524|3819524|FG004|LTSE Phase|Death|1
2189091|NCT01473524|3819525|FG005|LTSE Phase|Death|0
2189092|NCT01473524|3819520|FG000|LTSE Phase|Adverse Event of Pruritus|0
2189093|NCT01473524|3819521|FG001|LTSE Phase|Adverse Event of Pruritus|0
2189094|NCT01473524|3819522|FG002|LTSE Phase|Adverse Event of Pruritus|0
2189095|NCT01473524|3819523|FG003|LTSE Phase|Adverse Event of Pruritus|1
2189096|NCT01473524|3819524|FG004|LTSE Phase|Adverse Event of Pruritus|5
2189097|NCT01473524|3819525|FG005|LTSE Phase|Adverse Event of Pruritus|2
2189098|NCT01473524|3819520|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
2189099|NCT01473524|3819521|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
2189100|NCT01473524|3819522|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
2189101|NCT01473524|3819523|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2
2189102|NCT01473524|3819524|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4
2189103|NCT01473524|3819525|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6
2189104|NCT01473524|3819520|FG000|LTSE Phase|Lost to Follow-up|0
2189105|NCT01473524|3819521|FG001|LTSE Phase|Lost to Follow-up|0
2189106|NCT01473524|3819522|FG002|LTSE Phase|Lost to Follow-up|0
2189107|NCT01473524|3819523|FG003|LTSE Phase|Lost to Follow-up|1
2189108|NCT01473524|3819524|FG004|LTSE Phase|Lost to Follow-up|3
2189109|NCT01473524|3819525|FG005|LTSE Phase|Lost to Follow-up|2
2189110|NCT01473524|3819520|FG000|LTSE Phase|Principal Investigator Decision|0
2189111|NCT01473524|3819521|FG001|LTSE Phase|Principal Investigator Decision|0
2189112|NCT01473524|3819522|FG002|LTSE Phase|Principal Investigator Decision|0
2189113|NCT01473524|3819523|FG003|LTSE Phase|Principal Investigator Decision|1
2189114|NCT01473524|3819524|FG004|LTSE Phase|Principal Investigator Decision|1
2189115|NCT01473524|3819525|FG005|LTSE Phase|Principal Investigator Decision|3
2189116|NCT01473524|3819520|FG000|LTSE Phase|Liver Transplantation|0
2189117|NCT01473524|3819521|FG001|LTSE Phase|Liver Transplantation|0
2189118|NCT01473524|3819522|FG002|LTSE Phase|Liver Transplantation|0
2189119|NCT01473524|3819523|FG003|LTSE Phase|Liver Transplantation|0
2189120|NCT01473524|3819524|FG004|LTSE Phase|Liver Transplantation|0
2189121|NCT01473524|3819525|FG005|LTSE Phase|Liver Transplantation|1
2189122|NCT01473524|3819520|FG000|LTSE Phase|Pregnancy|0
2189123|NCT01473524|3819521|FG001|LTSE Phase|Pregnancy|0
2189124|NCT01473524|3819522|FG002|LTSE Phase|Pregnancy|0
2189125|NCT01473524|3819523|FG003|LTSE Phase|Pregnancy|1
2189126|NCT01473524|3819524|FG004|LTSE Phase|Pregnancy|0
2189127|NCT01473524|3819525|FG005|LTSE Phase|Pregnancy|0
2189128|NCT01473524|3819520|FG000|LTSE Phase|Protocol Violation|0
2189129|NCT01473524|3819521|FG001|LTSE Phase|Protocol Violation|0
2189130|NCT01473524|3819522|FG002|LTSE Phase|Protocol Violation|0
2189131|NCT01473524|3819523|FG003|LTSE Phase|Protocol Violation|0
2189132|NCT01473524|3819524|FG004|LTSE Phase|Protocol Violation|0
2189133|NCT01473524|3819525|FG005|LTSE Phase|Protocol Violation|1
2189134|NCT01473563|3819547|FG000|Overall Study|Lost to FU post tx discontinuation|1
2189135|NCT01473589|3819553|FG000|Overall Study|Adverse Event|1
2189136|NCT01473589|3819554|FG001|Overall Study|Adverse Event|1
2189137|NCT01473589|3819553|FG000|Overall Study|Death|2
2189138|NCT01473589|3819554|FG001|Overall Study|Death|0
2222909|NCT01752855|3868964|FG001|Overall Study|Adverse Event|0
2222910|NCT01752855|3868963|FG000|Overall Study|Withdrew Consent|0
2222911|NCT01752855|3868964|FG001|Overall Study|Withdrew Consent|2
2222912|NCT01752855|3868963|FG000|Overall Study|Lack of Efficacy|0
2222913|NCT01752855|3868964|FG001|Overall Study|Lack of Efficacy|2
2222914|NCT01752907|3868972|FG000|Overall Study|Withdrawal by Subject|4
2222915|NCT01752907|3868973|FG001|Overall Study|Withdrawal by Subject|10
2222916|NCT01752907|3868972|FG000|Overall Study|Lost to Follow-up|2
2222917|NCT01752907|3868973|FG001|Overall Study|Lost to Follow-up|1
2222918|NCT01752907|3868972|FG000|Overall Study|Decision by Sponsor|6
2222919|NCT01752907|3868973|FG001|Overall Study|Decision by Sponsor|9
2222920|NCT01752920|3868983|FG000|Overall Study|Adverse Event|1
2222921|NCT01752920|3868984|FG001|Overall Study|Adverse Event|0
2222922|NCT01752920|3868985|FG002|Overall Study|Adverse Event|5
2222923|NCT01752920|3868986|FG003|Overall Study|Adverse Event|10
2222924|NCT01752920|3868983|FG000|Overall Study|Clinical Disease Progression|6
2222925|NCT01752920|3868984|FG001|Overall Study|Clinical Disease Progression|4
2222926|NCT01752920|3868985|FG002|Overall Study|Clinical Disease Progression|1
2222927|NCT01752920|3868986|FG003|Overall Study|Clinical Disease Progression|13
2222928|NCT01752920|3868983|FG000|Overall Study|Physician Decision|1
2222929|NCT01752920|3868984|FG001|Overall Study|Physician Decision|0
2222930|NCT01752920|3868985|FG002|Overall Study|Physician Decision|0
2222931|NCT01752920|3868986|FG003|Overall Study|Physician Decision|3
2222932|NCT01752920|3868983|FG000|Overall Study|Radiographic Disease Progression|20
2222933|NCT01752920|3868984|FG001|Overall Study|Radiographic Disease Progression|7
2222934|NCT01752920|3868985|FG002|Overall Study|Radiographic Disease Progression|12
2222935|NCT01752920|3868986|FG003|Overall Study|Radiographic Disease Progression|29
2222936|NCT01752920|3868983|FG000|Overall Study|Study Terminated by Sponsor|0
2222937|NCT01752920|3868984|FG001|Overall Study|Study Terminated by Sponsor|0
2222938|NCT01752920|3868985|FG002|Overall Study|Study Terminated by Sponsor|0
2222939|NCT01752920|3868986|FG003|Overall Study|Study Terminated by Sponsor|1
2222940|NCT01752920|3868983|FG000|Overall Study|Withdrawal by Subject|0
2222941|NCT01752920|3868984|FG001|Overall Study|Withdrawal by Subject|1
2222942|NCT01752920|3868985|FG002|Overall Study|Withdrawal by Subject|0
2222943|NCT01752920|3868986|FG003|Overall Study|Withdrawal by Subject|1
2222944|NCT01752920|3868983|FG000|Overall Study|Lack of clinical benefit|1
2222945|NCT01752920|3868984|FG001|Overall Study|Lack of clinical benefit|1
2222946|NCT01752920|3868985|FG002|Overall Study|Lack of clinical benefit|1
2222947|NCT01752920|3868986|FG003|Overall Study|Lack of clinical benefit|1
2222948|NCT01752933|3869000|FG000|Treatment|Disease Progression|3
2222949|NCT01752933|3869001|FG001|Treatment|Disease Progression|29
2222950|NCT01752933|3869000|FG000|Treatment|Withdrawal by Subject|0
2222951|NCT01752933|3869001|FG001|Treatment|Withdrawal by Subject|5
2222952|NCT01752933|3869000|FG000|Treatment|Adverse Event|1
2222953|NCT01752933|3869001|FG001|Treatment|Adverse Event|4
2222954|NCT01752933|3869000|FG000|Treatment|Physician Decision|0
2222955|NCT01752933|3869001|FG001|Treatment|Physician Decision|3
2222956|NCT01752933|3869000|FG000|Treatment|Death|0
2222957|NCT01752933|3869001|FG001|Treatment|Death|2
2222958|NCT01752933|3869000|FG000|Treatment|Hepatocellular carcinoma not confirmed|0
2222959|NCT01752933|3869001|FG001|Treatment|Hepatocellular carcinoma not confirmed|1
2222960|NCT01752933|3869000|FG000|Treatment|Patient noncompliant|0
2222961|NCT01752933|3869001|FG001|Treatment|Patient noncompliant|1
2222962|NCT01752933|3869000|FG000|Treatment|Patient unable to travel to appointments|0
2222963|NCT01752933|3869001|FG001|Treatment|Patient unable to travel to appointments|1
2222964|NCT01752933|3869000|FG000|Overall Study and Follow-up|Death|4
2222965|NCT01752933|3869001|FG001|Overall Study and Follow-up|Death|34
2222966|NCT01752933|3869000|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
2222967|NCT01752933|3869001|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
2222968|NCT01752933|3869000|FG000|Overall Study and Follow-up|Withdrawal by Subject|0
2222969|NCT01752933|3869001|FG001|Overall Study and Follow-up|Withdrawal by Subject|3
2222970|NCT01752933|3869000|FG000|Overall Study and Follow-up|Lost to Follow-up|0
2222971|NCT01752933|3869001|FG001|Overall Study and Follow-up|Lost to Follow-up|2
2222972|NCT01752985|3869011|FG000|Treatment Period|Subject request to discontinue treatment|1
2222973|NCT01752985|3869012|FG001|Treatment Period|Subject request to discontinue treatment|0
2222974|NCT01752985|3869013|FG002|Treatment Period|Subject request to discontinue treatment|1
2222975|NCT01752985|3869011|FG000|Treatment Period|Subject no longer meets study criteria|0
2222976|NCT01752985|3869012|FG001|Treatment Period|Subject no longer meets study criteria|1
2222977|NCT01752985|3869013|FG002|Treatment Period|Subject no longer meets study criteria|1
2189139|NCT01473589|3819553|FG000|Overall Study|Lost to Follow-up|2
2189140|NCT01473589|3819554|FG001|Overall Study|Lost to Follow-up|2
2189141|NCT01473589|3819553|FG000|Overall Study|Protocol Violation|1
2189142|NCT01473589|3819554|FG001|Overall Study|Protocol Violation|0
2189143|NCT01473589|3819553|FG000|Overall Study|Withdrawal by Subject|5
2189144|NCT01473589|3819554|FG001|Overall Study|Withdrawal by Subject|11
2189145|NCT01473589|3819553|FG000|Overall Study|Physician Decision|0
2189146|NCT01473589|3819554|FG001|Overall Study|Physician Decision|1
2189147|NCT01473589|3819553|FG000|Overall Study|Entry criteria not met|0
2189148|NCT01473589|3819554|FG001|Overall Study|Entry criteria not met|1
2189149|NCT01473602|3819564|FG000|Overall Study|Adverse Event|1
2189150|NCT01473602|3819565|FG001|Overall Study|Adverse Event|2
2189151|NCT01473602|3819564|FG000|Overall Study|Death|0
2189152|NCT01473602|3819565|FG001|Overall Study|Death|1
2189153|NCT01473602|3819564|FG000|Overall Study|Lost to Follow-up|1
2189154|NCT01473602|3819565|FG001|Overall Study|Lost to Follow-up|1
2189155|NCT01473602|3819564|FG000|Overall Study|Withdrawal by Subject|5
2189156|NCT01473602|3819565|FG001|Overall Study|Withdrawal by Subject|4
2189157|NCT01473602|3819564|FG000|Overall Study|Physician Decision|1
2189158|NCT01473602|3819565|FG001|Overall Study|Physician Decision|0
2189159|NCT01473758|3819584|FG000|Cycle 1|Adverse Event|10
2189160|NCT01473758|3819585|FG001|Cycle 1|Adverse Event|2
2189161|NCT01473758|3819586|FG002|Cycle 1|Adverse Event|0
2189162|NCT01473758|3819587|FG003|Cycle 1|Adverse Event|0
2189163|NCT01473758|3819584|FG000|Cycle 1|Withdrawal by Subject|1
2189164|NCT01473758|3819585|FG001|Cycle 1|Withdrawal by Subject|1
2189165|NCT01473758|3819586|FG002|Cycle 1|Withdrawal by Subject|0
2189166|NCT01473758|3819587|FG003|Cycle 1|Withdrawal by Subject|0
2189167|NCT01473758|3819584|FG000|Cycle 2|Adverse Event|0
2189168|NCT01473758|3819585|FG001|Cycle 2|Adverse Event|0
2189169|NCT01473758|3819586|FG002|Cycle 2|Adverse Event|5
2189170|NCT01473758|3819587|FG003|Cycle 2|Adverse Event|0
2189171|NCT01473836|3819595|FG000|Overall Study|Adverse Event|4
2189172|NCT01473836|3819595|FG000|Overall Study|Lack of Efficacy|1
2189173|NCT01473836|3819595|FG000|Overall Study|Does not meet entrance criteria|1
2189174|NCT01473940|3819603|FG000|Induction Therapy|Death|0
2189175|NCT01473940|3819604|FG001|Induction Therapy|Death|0
2189176|NCT01473940|3819605|FG002|Induction Therapy|Death|1
2189177|NCT01473940|3819606|FG003|Induction Therapy|Death|1
2189178|NCT01473940|3819603|FG000|Induction Therapy|Progressive Disease|0
2189179|NCT01473940|3819604|FG001|Induction Therapy|Progressive Disease|1
2189180|NCT01473940|3819605|FG002|Induction Therapy|Progressive Disease|1
2189181|NCT01473940|3819606|FG003|Induction Therapy|Progressive Disease|0
2189182|NCT01473940|3819603|FG000|Maintenance Therapy|Progressive Disease|1
2189183|NCT01473940|3819604|FG001|Maintenance Therapy|Progressive Disease|2
2189184|NCT01473940|3819605|FG002|Maintenance Therapy|Progressive Disease|1
2189185|NCT01473940|3819606|FG003|Maintenance Therapy|Progressive Disease|4
2189186|NCT01473953|3819624|FG000|Overall Study|Other|1
2189187|NCT01473953|3819625|FG001|Overall Study|Other|0
2189188|NCT01473953|3819626|FG002|Overall Study|Other|0
2189189|NCT01473953|3819627|FG003|Overall Study|Other|0
2189190|NCT01473953|3819628|FG004|Overall Study|Other|0
2189191|NCT01474018|3819654|FG000|Overall Study|Lost to Follow-up|0
2189192|NCT01474018|3819655|FG001|Overall Study|Lost to Follow-up|1
2189193|NCT01474018|3819654|FG000|Overall Study|Withdrawal by Subject|0
2189194|NCT01474018|3819655|FG001|Overall Study|Withdrawal by Subject|2
2189195|NCT01474239|3819713|FG000|Overall Study|Disease Progression|37
2189196|NCT01474239|3819714|FG001|Overall Study|Disease Progression|25
2189197|NCT01474239|3819713|FG000|Overall Study|Adverse Event|12
2189198|NCT01474239|3819714|FG001|Overall Study|Adverse Event|3
2189199|NCT01474239|3819713|FG000|Overall Study|Withdrawal by Subject|1
2189200|NCT01474239|3819714|FG001|Overall Study|Withdrawal by Subject|2
2189201|NCT01474239|3819713|FG000|Overall Study|Death|1
2189202|NCT01474239|3819714|FG001|Overall Study|Death|1
2189203|NCT01474239|3819713|FG000|Overall Study|Clinical Disease Progression|7
2189204|NCT01474239|3819714|FG001|Overall Study|Clinical Disease Progression|1
2189205|NCT01474239|3819713|FG000|Overall Study|Withdrawal for Economic Reason|1
2189206|NCT01474239|3819714|FG001|Overall Study|Withdrawal for Economic Reason|0
2189207|NCT01474291|3819722|FG000|Overall Study|Not Evaluable for Efficacy|26
2189208|NCT01474291|3819722|FG000|Overall Study|Lack of Treatment Efficacy|88
2189209|NCT01474291|3819722|FG000|Overall Study|Adverse Event|53
2189210|NCT01474291|3819722|FG000|Overall Study|Lost to Follow-up|29
2189211|NCT01474291|3819722|FG000|Overall Study|Patient No Longer Wanted to Participate|12
2189212|NCT01474291|3819722|FG000|Overall Study|No Reason Reported|10
2189213|NCT01474291|3819722|FG000|Overall Study|Death|2
2189214|NCT01474317|3819729|FG000|Overall Study|Adverse Event|1
2189215|NCT01474317|3819729|FG000|Overall Study|Subject ineligible for study|1
2189216|NCT01474434|3819737|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
2189217|NCT01474434|3819738|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
2189218|NCT01474434|3819739|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
2189219|NCT01474434|3819740|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
2189220|NCT01474434|3819737|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
2189221|NCT01474434|3819738|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
2189222|NCT01474434|3819739|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
2189223|NCT01474434|3819740|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
2222978|NCT01752985|3869011|FG000|Treatment Period|Adverse Event|2
2189224|NCT01474434|3819737|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
2189225|NCT01474434|3819738|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
2189226|NCT01474434|3819739|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
2189227|NCT01474434|3819740|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
2189228|NCT01474486|3819754|FG000|Overall Study|Death|2
2189229|NCT01474486|3819754|FG000|Overall Study|Withdrawal by Subject|4
2189230|NCT01474486|3819754|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2
2189231|NCT01474512|3819765|FG000|Induction Period|Adverse Event|6
2189232|NCT01474512|3819766|FG001|Induction Period|Adverse Event|10
2189233|NCT01474512|3819767|FG002|Induction Period|Adverse Event|10
2222979|NCT01752985|3869012|FG001|Treatment Period|Adverse Event|1
2222980|NCT01752985|3869013|FG002|Treatment Period|Adverse Event|2
2222981|NCT01752985|3869011|FG000|Treatment Period|Withdrawal by Subject|1
2222982|NCT01752985|3869012|FG001|Treatment Period|Withdrawal by Subject|1
2222983|NCT01752985|3869013|FG002|Treatment Period|Withdrawal by Subject|0
2222984|NCT01752985|3869011|FG000|Treatment Period|Lost to Follow-up|0
2222985|NCT01752985|3869012|FG001|Treatment Period|Lost to Follow-up|0
2222986|NCT01752985|3869013|FG002|Treatment Period|Lost to Follow-up|1
2222987|NCT01753076|3869023|FG000|Overall Study|Adverse Event|17
2222988|NCT01753076|3869024|FG001|Overall Study|Adverse Event|18
2222989|NCT01753076|3869023|FG000|Overall Study|Lack of Efficacy|3
2222990|NCT01753076|3869024|FG001|Overall Study|Lack of Efficacy|1
2222991|NCT01753076|3869023|FG000|Overall Study|Lost to Follow-up|2
2222992|NCT01753076|3869024|FG001|Overall Study|Lost to Follow-up|1
2222993|NCT01753076|3869023|FG000|Overall Study|Physician Decision|4
2222994|NCT01753076|3869024|FG001|Overall Study|Physician Decision|2
2222995|NCT01753076|3869023|FG000|Overall Study|Withdrawal by Subject|14
2222996|NCT01753076|3869024|FG001|Overall Study|Withdrawal by Subject|24
2222997|NCT01753076|3869023|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1
2222998|NCT01753076|3869024|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0
2222999|NCT01753115|3869035|FG000|Overall Study|Lost to Follow-up|3
2223000|NCT01753115|3869036|FG001|Overall Study|Lost to Follow-up|6
2223001|NCT01753115|3869037|FG002|Overall Study|Lost to Follow-up|8
2223002|NCT01753115|3869035|FG000|Overall Study|Withdrawal by Subject|6
2223003|NCT01753115|3869036|FG001|Overall Study|Withdrawal by Subject|5
2223004|NCT01753115|3869037|FG002|Overall Study|Withdrawal by Subject|6
2223005|NCT01753115|3869035|FG000|Overall Study|Subject non-compliant|3
2223006|NCT01753115|3869036|FG001|Overall Study|Subject non-compliant|3
2223007|NCT01753115|3869037|FG002|Overall Study|Subject non-compliant|0
2223008|NCT01753115|3869035|FG000|Overall Study|Used excluded drug|0
2223009|NCT01753115|3869036|FG001|Overall Study|Used excluded drug|1
2223010|NCT01753115|3869037|FG002|Overall Study|Used excluded drug|0
2223011|NCT01753193|3869045|FG000|Overall Study|Withdrawal by Subject|23
2223012|NCT01753193|3869045|FG000|Overall Study|Lost to Follow-up|6
2223013|NCT01753193|3869045|FG000|Overall Study|Death|1
2223014|NCT01753193|3869045|FG000|Overall Study|Other|16
2223015|NCT01753297|3869051|FG000|Overall Study|Lost to Follow-up|7
2223016|NCT01753297|3869052|FG001|Overall Study|Lost to Follow-up|2
2223017|NCT01753297|3869051|FG000|Overall Study|Withdrawal by Subject|26
2223018|NCT01753297|3869052|FG001|Overall Study|Withdrawal by Subject|23
2223019|NCT01753297|3869051|FG000|Overall Study|Adverse Event (up to Month 36)|1
2223020|NCT01753297|3869052|FG001|Overall Study|Adverse Event (up to Month 36)|1
2223021|NCT01753297|3869051|FG000|Overall Study|Death|0
2223022|NCT01753297|3869052|FG001|Overall Study|Death|2
2223023|NCT01753297|3869051|FG000|Overall Study|Did not attend end of study visit|7
2223024|NCT01753297|3869052|FG001|Overall Study|Did not attend end of study visit|8
2223025|NCT01753310|3869062|FG000|Overall Study|Entered into open label extension study|25
2223026|NCT01753310|3869063|FG001|Overall Study|Entered into open label extension study|22
2223027|NCT01753310|3869062|FG000|Overall Study|Adverse Event|1
2223028|NCT01753310|3869063|FG001|Overall Study|Adverse Event|0
2223029|NCT01753310|3869062|FG000|Overall Study|Lost to Follow-up|2
2223030|NCT01753310|3869063|FG001|Overall Study|Lost to Follow-up|0
2223031|NCT01753310|3869062|FG000|Overall Study|Subject decision|2
2223032|NCT01753310|3869063|FG001|Overall Study|Subject decision|2
2223033|NCT01753310|3869062|FG000|Overall Study|Sponsor decision|1
2223034|NCT01753310|3869063|FG001|Overall Study|Sponsor decision|0
2223035|NCT01753310|3869062|FG000|Overall Study|Withdrawal by Subject|1
2223036|NCT01753310|3869063|FG001|Overall Study|Withdrawal by Subject|0
2223037|NCT01753323|3869072|FG000|Overall Study|Lack of Efficacy|0
2223038|NCT01753323|3869073|FG001|Overall Study|Lack of Efficacy|0
2223039|NCT01753323|3869074|FG002|Overall Study|Lack of Efficacy|8
2223040|NCT01753323|3869072|FG000|Overall Study|Protocol deviation|1
2223041|NCT01753323|3869073|FG001|Overall Study|Protocol deviation|0
2223042|NCT01753323|3869074|FG002|Overall Study|Protocol deviation|0
2223043|NCT01753323|3869072|FG000|Overall Study|Adverse Event|0
2223044|NCT01753323|3869073|FG001|Overall Study|Adverse Event|0
2223045|NCT01753323|3869074|FG002|Overall Study|Adverse Event|1
2223046|NCT01753336|3869083|FG000|Overall Study|Patient decision|12
2223047|NCT01753336|3869083|FG000|Overall Study|Lost to Follow-up|3
2223048|NCT01753336|3869083|FG000|Overall Study|Physician Decision|2
2223049|NCT01753336|3869083|FG000|Overall Study|Sponsor's decision|2
2223050|NCT01753336|3869083|FG000|Overall Study|Withdrawal by Subject|1
2223051|NCT01753401|3869098|FG000|Double-blind Period (8 Weeks)|Adverse Event|0
2189234|NCT01474512|3819768|FG003|Induction Period|Adverse Event|0
2189235|NCT01474512|3819769|FG004|Induction Period|Adverse Event|0
2189236|NCT01474512|3819770|FG005|Induction Period|Adverse Event|0
2189237|NCT01474512|3819771|FG006|Induction Period|Adverse Event|0
2189238|NCT01474512|3819772|FG007|Induction Period|Adverse Event|0
2189239|NCT01474512|3819773|FG008|Induction Period|Adverse Event|0
2189240|NCT01474512|3819774|FG009|Induction Period|Adverse Event|0
2189241|NCT01474512|3819775|FG010|Induction Period|Adverse Event|0
2189242|NCT01474512|3819776|FG011|Induction Period|Adverse Event|0
2189243|NCT01474512|3819777|FG012|Induction Period|Adverse Event|0
2189244|NCT01474512|3819778|FG013|Induction Period|Adverse Event|0
2189245|NCT01474512|3819779|FG014|Induction Period|Adverse Event|0
2189246|NCT01474512|3819780|FG015|Induction Period|Adverse Event|0
2189247|NCT01474512|3819781|FG016|Induction Period|Adverse Event|0
2189248|NCT01474512|3819782|FG017|Induction Period|Adverse Event|0
2189249|NCT01474512|3819765|FG000|Induction Period|Lack of Efficacy|7
2189250|NCT01474512|3819766|FG001|Induction Period|Lack of Efficacy|1
2189251|NCT01474512|3819767|FG002|Induction Period|Lack of Efficacy|0
2189252|NCT01474512|3819768|FG003|Induction Period|Lack of Efficacy|0
2189253|NCT01474512|3819769|FG004|Induction Period|Lack of Efficacy|0
2189254|NCT01474512|3819770|FG005|Induction Period|Lack of Efficacy|0
2189255|NCT01474512|3819771|FG006|Induction Period|Lack of Efficacy|0
2189256|NCT01474512|3819772|FG007|Induction Period|Lack of Efficacy|0
2189257|NCT01474512|3819773|FG008|Induction Period|Lack of Efficacy|0
2189258|NCT01474512|3819774|FG009|Induction Period|Lack of Efficacy|0
2189259|NCT01474512|3819775|FG010|Induction Period|Lack of Efficacy|0
2189260|NCT01474512|3819776|FG011|Induction Period|Lack of Efficacy|0
2189261|NCT01474512|3819777|FG012|Induction Period|Lack of Efficacy|0
2189262|NCT01474512|3819778|FG013|Induction Period|Lack of Efficacy|0
2189263|NCT01474512|3819779|FG014|Induction Period|Lack of Efficacy|0
2189264|NCT01474512|3819780|FG015|Induction Period|Lack of Efficacy|0
2189265|NCT01474512|3819781|FG016|Induction Period|Lack of Efficacy|0
2189266|NCT01474512|3819782|FG017|Induction Period|Lack of Efficacy|0
2189267|NCT01474512|3819765|FG000|Induction Period|Withdrawal by Subject|6
2189268|NCT01474512|3819766|FG001|Induction Period|Withdrawal by Subject|6
2189269|NCT01474512|3819767|FG002|Induction Period|Withdrawal by Subject|5
2189270|NCT01474512|3819768|FG003|Induction Period|Withdrawal by Subject|0
2189271|NCT01474512|3819769|FG004|Induction Period|Withdrawal by Subject|0
2189272|NCT01474512|3819770|FG005|Induction Period|Withdrawal by Subject|0
2189273|NCT01474512|3819771|FG006|Induction Period|Withdrawal by Subject|0
2189274|NCT01474512|3819772|FG007|Induction Period|Withdrawal by Subject|0
2189275|NCT01474512|3819773|FG008|Induction Period|Withdrawal by Subject|0
2189276|NCT01474512|3819774|FG009|Induction Period|Withdrawal by Subject|0
2189277|NCT01474512|3819775|FG010|Induction Period|Withdrawal by Subject|0
2189278|NCT01474512|3819776|FG011|Induction Period|Withdrawal by Subject|0
2189279|NCT01474512|3819777|FG012|Induction Period|Withdrawal by Subject|0
2189280|NCT01474512|3819778|FG013|Induction Period|Withdrawal by Subject|0
2189281|NCT01474512|3819779|FG014|Induction Period|Withdrawal by Subject|0
2189282|NCT01474512|3819780|FG015|Induction Period|Withdrawal by Subject|0
2189283|NCT01474512|3819781|FG016|Induction Period|Withdrawal by Subject|0
2189284|NCT01474512|3819782|FG017|Induction Period|Withdrawal by Subject|0
2189285|NCT01474512|3819765|FG000|Induction Period|Protocol Violation|3
2189286|NCT01474512|3819766|FG001|Induction Period|Protocol Violation|6
2189287|NCT01474512|3819767|FG002|Induction Period|Protocol Violation|0
2189288|NCT01474512|3819768|FG003|Induction Period|Protocol Violation|0
2189289|NCT01474512|3819769|FG004|Induction Period|Protocol Violation|0
2189290|NCT01474512|3819770|FG005|Induction Period|Protocol Violation|0
2189291|NCT01474512|3819771|FG006|Induction Period|Protocol Violation|0
2189292|NCT01474512|3819772|FG007|Induction Period|Protocol Violation|0
2189293|NCT01474512|3819773|FG008|Induction Period|Protocol Violation|0
2189294|NCT01474512|3819774|FG009|Induction Period|Protocol Violation|0
2189295|NCT01474512|3819775|FG010|Induction Period|Protocol Violation|0
2189296|NCT01474512|3819776|FG011|Induction Period|Protocol Violation|0
2189297|NCT01474512|3819777|FG012|Induction Period|Protocol Violation|0
2189298|NCT01474512|3819778|FG013|Induction Period|Protocol Violation|0
2189299|NCT01474512|3819779|FG014|Induction Period|Protocol Violation|0
2189300|NCT01474512|3819780|FG015|Induction Period|Protocol Violation|0
2189301|NCT01474512|3819781|FG016|Induction Period|Protocol Violation|0
2189302|NCT01474512|3819782|FG017|Induction Period|Protocol Violation|0
2189303|NCT01474512|3819765|FG000|Induction Period|Sponsor Decision|1
2189304|NCT01474512|3819766|FG001|Induction Period|Sponsor Decision|1
2189305|NCT01474512|3819767|FG002|Induction Period|Sponsor Decision|1
2189306|NCT01474512|3819768|FG003|Induction Period|Sponsor Decision|0
2189307|NCT01474512|3819769|FG004|Induction Period|Sponsor Decision|0
2189308|NCT01474512|3819770|FG005|Induction Period|Sponsor Decision|0
2189309|NCT01474512|3819771|FG006|Induction Period|Sponsor Decision|0
2189310|NCT01474512|3819772|FG007|Induction Period|Sponsor Decision|0
2189311|NCT01474512|3819773|FG008|Induction Period|Sponsor Decision|0
2189312|NCT01474512|3819774|FG009|Induction Period|Sponsor Decision|0
2189313|NCT01474512|3819775|FG010|Induction Period|Sponsor Decision|0
2189314|NCT01474512|3819776|FG011|Induction Period|Sponsor Decision|0
2189315|NCT01474512|3819777|FG012|Induction Period|Sponsor Decision|0
2189316|NCT01474512|3819778|FG013|Induction Period|Sponsor Decision|0
2189317|NCT01474512|3819779|FG014|Induction Period|Sponsor Decision|0
2189318|NCT01474512|3819780|FG015|Induction Period|Sponsor Decision|0
2189319|NCT01474512|3819781|FG016|Induction Period|Sponsor Decision|0
2189320|NCT01474512|3819782|FG017|Induction Period|Sponsor Decision|0
2189321|NCT01474512|3819765|FG000|Induction Period|Lost to Follow-up|1
2189322|NCT01474512|3819766|FG001|Induction Period|Lost to Follow-up|0
2189323|NCT01474512|3819767|FG002|Induction Period|Lost to Follow-up|2
2189324|NCT01474512|3819768|FG003|Induction Period|Lost to Follow-up|0
2189325|NCT01474512|3819769|FG004|Induction Period|Lost to Follow-up|0
2189326|NCT01474512|3819770|FG005|Induction Period|Lost to Follow-up|0
2189327|NCT01474512|3819771|FG006|Induction Period|Lost to Follow-up|0
2189328|NCT01474512|3819772|FG007|Induction Period|Lost to Follow-up|0
2189329|NCT01474512|3819773|FG008|Induction Period|Lost to Follow-up|0
2189330|NCT01474512|3819774|FG009|Induction Period|Lost to Follow-up|0
2189331|NCT01474512|3819775|FG010|Induction Period|Lost to Follow-up|0
2189332|NCT01474512|3819776|FG011|Induction Period|Lost to Follow-up|0
2189333|NCT01474512|3819777|FG012|Induction Period|Lost to Follow-up|0
2189334|NCT01474512|3819778|FG013|Induction Period|Lost to Follow-up|0
2189335|NCT01474512|3819779|FG014|Induction Period|Lost to Follow-up|0
2189336|NCT01474512|3819780|FG015|Induction Period|Lost to Follow-up|0
2189337|NCT01474512|3819781|FG016|Induction Period|Lost to Follow-up|0
2189338|NCT01474512|3819782|FG017|Induction Period|Lost to Follow-up|0
2189339|NCT01474512|3819765|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0
2189340|NCT01474512|3819766|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0
2189341|NCT01474512|3819767|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0
2189342|NCT01474512|3819768|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186
2189343|NCT01474512|3819769|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111
2189344|NCT01474512|3819770|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39
2189345|NCT01474512|3819771|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9
2189346|NCT01474512|3819772|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0
2189347|NCT01474512|3819773|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0
2189348|NCT01474512|3819774|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0
2189349|NCT01474512|3819775|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0
2189350|NCT01474512|3819776|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0
2189351|NCT01474512|3819777|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0
2189352|NCT01474512|3819778|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0
2189353|NCT01474512|3819779|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0
2189354|NCT01474512|3819780|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0
2189355|NCT01474512|3819781|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0
2189356|NCT01474512|3819782|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0
2189357|NCT01474512|3819765|FG000|Maintenance Period|Adverse Event|0
2189358|NCT01474512|3819766|FG001|Maintenance Period|Adverse Event|0
2189359|NCT01474512|3819767|FG002|Maintenance Period|Adverse Event|0
2189360|NCT01474512|3819768|FG003|Maintenance Period|Adverse Event|4
2189361|NCT01474512|3819769|FG004|Maintenance Period|Adverse Event|2
2189362|NCT01474512|3819770|FG005|Maintenance Period|Adverse Event|7
2189363|NCT01474512|3819771|FG006|Maintenance Period|Adverse Event|0
2189364|NCT01474512|3819772|FG007|Maintenance Period|Adverse Event|19
2189365|NCT01474512|3819773|FG008|Maintenance Period|Adverse Event|1
2189366|NCT01474512|3819774|FG009|Maintenance Period|Adverse Event|3
2189367|NCT01474512|3819775|FG010|Maintenance Period|Adverse Event|0
2189368|NCT01474512|3819776|FG011|Maintenance Period|Adverse Event|0
2189369|NCT01474512|3819777|FG012|Maintenance Period|Adverse Event|0
2189370|NCT01474512|3819778|FG013|Maintenance Period|Adverse Event|0
2189371|NCT01474512|3819779|FG014|Maintenance Period|Adverse Event|0
2189372|NCT01474512|3819780|FG015|Maintenance Period|Adverse Event|0
2189373|NCT01474512|3819781|FG016|Maintenance Period|Adverse Event|0
2189374|NCT01474512|3819782|FG017|Maintenance Period|Adverse Event|0
2189375|NCT01474512|3819765|FG000|Maintenance Period|Withdrawal by Subject|0
2189376|NCT01474512|3819766|FG001|Maintenance Period|Withdrawal by Subject|0
2189377|NCT01474512|3819767|FG002|Maintenance Period|Withdrawal by Subject|0
2189378|NCT01474512|3819768|FG003|Maintenance Period|Withdrawal by Subject|6
2189379|NCT01474512|3819769|FG004|Maintenance Period|Withdrawal by Subject|2
2189380|NCT01474512|3819770|FG005|Maintenance Period|Withdrawal by Subject|3
2189381|NCT01474512|3819771|FG006|Maintenance Period|Withdrawal by Subject|1
2189382|NCT01474512|3819772|FG007|Maintenance Period|Withdrawal by Subject|6
2189383|NCT01474512|3819773|FG008|Maintenance Period|Withdrawal by Subject|3
2189384|NCT01474512|3819774|FG009|Maintenance Period|Withdrawal by Subject|1
2189385|NCT01474512|3819775|FG010|Maintenance Period|Withdrawal by Subject|0
2189386|NCT01474512|3819776|FG011|Maintenance Period|Withdrawal by Subject|0
2189387|NCT01474512|3819777|FG012|Maintenance Period|Withdrawal by Subject|0
2189388|NCT01474512|3819778|FG013|Maintenance Period|Withdrawal by Subject|0
2189389|NCT01474512|3819779|FG014|Maintenance Period|Withdrawal by Subject|0
2189390|NCT01474512|3819780|FG015|Maintenance Period|Withdrawal by Subject|0
2189391|NCT01474512|3819781|FG016|Maintenance Period|Withdrawal by Subject|0
2189392|NCT01474512|3819782|FG017|Maintenance Period|Withdrawal by Subject|0
2189393|NCT01474512|3819765|FG000|Maintenance Period|Lost to Follow-up|0
2189394|NCT01474512|3819766|FG001|Maintenance Period|Lost to Follow-up|0
2189395|NCT01474512|3819767|FG002|Maintenance Period|Lost to Follow-up|0
2189396|NCT01474512|3819768|FG003|Maintenance Period|Lost to Follow-up|3
2189397|NCT01474512|3819769|FG004|Maintenance Period|Lost to Follow-up|3
2189398|NCT01474512|3819770|FG005|Maintenance Period|Lost to Follow-up|0
2189399|NCT01474512|3819771|FG006|Maintenance Period|Lost to Follow-up|0
2189400|NCT01474512|3819772|FG007|Maintenance Period|Lost to Follow-up|2
2189401|NCT01474512|3819773|FG008|Maintenance Period|Lost to Follow-up|1
2189402|NCT01474512|3819774|FG009|Maintenance Period|Lost to Follow-up|1
2189403|NCT01474512|3819775|FG010|Maintenance Period|Lost to Follow-up|0
2189404|NCT01474512|3819776|FG011|Maintenance Period|Lost to Follow-up|0
2189405|NCT01474512|3819777|FG012|Maintenance Period|Lost to Follow-up|0
2189406|NCT01474512|3819778|FG013|Maintenance Period|Lost to Follow-up|0
2189407|NCT01474512|3819779|FG014|Maintenance Period|Lost to Follow-up|0
2189408|NCT01474512|3819780|FG015|Maintenance Period|Lost to Follow-up|0
2189409|NCT01474512|3819781|FG016|Maintenance Period|Lost to Follow-up|0
2189410|NCT01474512|3819782|FG017|Maintenance Period|Lost to Follow-up|0
2189411|NCT01474512|3819765|FG000|Maintenance Period|Death|0
2189412|NCT01474512|3819766|FG001|Maintenance Period|Death|0
2189413|NCT01474512|3819767|FG002|Maintenance Period|Death|0
2189414|NCT01474512|3819768|FG003|Maintenance Period|Death|0
2189415|NCT01474512|3819769|FG004|Maintenance Period|Death|0
2189416|NCT01474512|3819770|FG005|Maintenance Period|Death|2
2189417|NCT01474512|3819771|FG006|Maintenance Period|Death|0
2189418|NCT01474512|3819772|FG007|Maintenance Period|Death|0
2189419|NCT01474512|3819773|FG008|Maintenance Period|Death|0
2189420|NCT01474512|3819774|FG009|Maintenance Period|Death|0
2189421|NCT01474512|3819775|FG010|Maintenance Period|Death|0
2189422|NCT01474512|3819776|FG011|Maintenance Period|Death|0
2189423|NCT01474512|3819777|FG012|Maintenance Period|Death|0
2189424|NCT01474512|3819778|FG013|Maintenance Period|Death|0
2189425|NCT01474512|3819779|FG014|Maintenance Period|Death|0
2189426|NCT01474512|3819780|FG015|Maintenance Period|Death|0
2189427|NCT01474512|3819781|FG016|Maintenance Period|Death|0
2189428|NCT01474512|3819782|FG017|Maintenance Period|Death|0
2189429|NCT01474512|3819765|FG000|Maintenance Period|Physician Decision|0
2189430|NCT01474512|3819766|FG001|Maintenance Period|Physician Decision|0
2189431|NCT01474512|3819767|FG002|Maintenance Period|Physician Decision|0
2189432|NCT01474512|3819768|FG003|Maintenance Period|Physician Decision|0
2189433|NCT01474512|3819769|FG004|Maintenance Period|Physician Decision|0
2189434|NCT01474512|3819770|FG005|Maintenance Period|Physician Decision|1
2189435|NCT01474512|3819771|FG006|Maintenance Period|Physician Decision|0
2189436|NCT01474512|3819772|FG007|Maintenance Period|Physician Decision|2
2189437|NCT01474512|3819773|FG008|Maintenance Period|Physician Decision|0
2189438|NCT01474512|3819774|FG009|Maintenance Period|Physician Decision|0
2189439|NCT01474512|3819775|FG010|Maintenance Period|Physician Decision|0
2189440|NCT01474512|3819776|FG011|Maintenance Period|Physician Decision|0
2189441|NCT01474512|3819777|FG012|Maintenance Period|Physician Decision|0
2189442|NCT01474512|3819778|FG013|Maintenance Period|Physician Decision|0
2189443|NCT01474512|3819779|FG014|Maintenance Period|Physician Decision|0
2189444|NCT01474512|3819780|FG015|Maintenance Period|Physician Decision|0
2189445|NCT01474512|3819781|FG016|Maintenance Period|Physician Decision|0
2189446|NCT01474512|3819782|FG017|Maintenance Period|Physician Decision|0
2189447|NCT01474512|3819765|FG000|Maintenance Period|Clinical Relapse|0
2189448|NCT01474512|3819766|FG001|Maintenance Period|Clinical Relapse|0
2189449|NCT01474512|3819767|FG002|Maintenance Period|Clinical Relapse|0
2189450|NCT01474512|3819768|FG003|Maintenance Period|Clinical Relapse|1
2189451|NCT01474512|3819769|FG004|Maintenance Period|Clinical Relapse|0
2189452|NCT01474512|3819770|FG005|Maintenance Period|Clinical Relapse|0
2189453|NCT01474512|3819771|FG006|Maintenance Period|Clinical Relapse|0
2189454|NCT01474512|3819772|FG007|Maintenance Period|Clinical Relapse|0
2189455|NCT01474512|3819773|FG008|Maintenance Period|Clinical Relapse|0
2189456|NCT01474512|3819774|FG009|Maintenance Period|Clinical Relapse|0
2189457|NCT01474512|3819775|FG010|Maintenance Period|Clinical Relapse|0
2189458|NCT01474512|3819776|FG011|Maintenance Period|Clinical Relapse|0
2189459|NCT01474512|3819777|FG012|Maintenance Period|Clinical Relapse|0
2189460|NCT01474512|3819778|FG013|Maintenance Period|Clinical Relapse|0
2189461|NCT01474512|3819779|FG014|Maintenance Period|Clinical Relapse|0
2189462|NCT01474512|3819780|FG015|Maintenance Period|Clinical Relapse|0
2189463|NCT01474512|3819781|FG016|Maintenance Period|Clinical Relapse|0
2189464|NCT01474512|3819782|FG017|Maintenance Period|Clinical Relapse|0
2189465|NCT01474512|3819765|FG000|Maintenance Period|Lack of Efficacy|0
2189466|NCT01474512|3819766|FG001|Maintenance Period|Lack of Efficacy|0
2189467|NCT01474512|3819767|FG002|Maintenance Period|Lack of Efficacy|0
2189468|NCT01474512|3819768|FG003|Maintenance Period|Lack of Efficacy|1
2189469|NCT01474512|3819769|FG004|Maintenance Period|Lack of Efficacy|0
2189470|NCT01474512|3819770|FG005|Maintenance Period|Lack of Efficacy|0
2189471|NCT01474512|3819771|FG006|Maintenance Period|Lack of Efficacy|0
2189472|NCT01474512|3819772|FG007|Maintenance Period|Lack of Efficacy|11
2189473|NCT01474512|3819773|FG008|Maintenance Period|Lack of Efficacy|11
2189474|NCT01474512|3819774|FG009|Maintenance Period|Lack of Efficacy|12
2189475|NCT01474512|3819775|FG010|Maintenance Period|Lack of Efficacy|0
2189476|NCT01474512|3819776|FG011|Maintenance Period|Lack of Efficacy|0
2189477|NCT01474512|3819777|FG012|Maintenance Period|Lack of Efficacy|0
2189478|NCT01474512|3819778|FG013|Maintenance Period|Lack of Efficacy|0
2189479|NCT01474512|3819779|FG014|Maintenance Period|Lack of Efficacy|0
2189480|NCT01474512|3819780|FG015|Maintenance Period|Lack of Efficacy|0
2189481|NCT01474512|3819781|FG016|Maintenance Period|Lack of Efficacy|0
2189482|NCT01474512|3819782|FG017|Maintenance Period|Lack of Efficacy|0
2189483|NCT01474512|3819765|FG000|Maintenance Period|Protocol Violation|0
2189484|NCT01474512|3819766|FG001|Maintenance Period|Protocol Violation|0
2189485|NCT01474512|3819767|FG002|Maintenance Period|Protocol Violation|0
2189486|NCT01474512|3819768|FG003|Maintenance Period|Protocol Violation|1
2189487|NCT01474512|3819769|FG004|Maintenance Period|Protocol Violation|0
2189488|NCT01474512|3819770|FG005|Maintenance Period|Protocol Violation|0
2189489|NCT01474512|3819771|FG006|Maintenance Period|Protocol Violation|0
2189490|NCT01474512|3819772|FG007|Maintenance Period|Protocol Violation|1
2189491|NCT01474512|3819773|FG008|Maintenance Period|Protocol Violation|0
2189492|NCT01474512|3819774|FG009|Maintenance Period|Protocol Violation|1
2189493|NCT01474512|3819775|FG010|Maintenance Period|Protocol Violation|0
2189494|NCT01474512|3819776|FG011|Maintenance Period|Protocol Violation|0
2189495|NCT01474512|3819777|FG012|Maintenance Period|Protocol Violation|0
2189496|NCT01474512|3819778|FG013|Maintenance Period|Protocol Violation|0
2189497|NCT01474512|3819779|FG014|Maintenance Period|Protocol Violation|0
2189498|NCT01474512|3819780|FG015|Maintenance Period|Protocol Violation|0
2189499|NCT01474512|3819781|FG016|Maintenance Period|Protocol Violation|0
2189500|NCT01474512|3819782|FG017|Maintenance Period|Protocol Violation|0
2189501|NCT01474512|3819765|FG000|Maintenance Period|Treated but Discontinued in Induction|0
2189502|NCT01474512|3819766|FG001|Maintenance Period|Treated but Discontinued in Induction|0
2189503|NCT01474512|3819767|FG002|Maintenance Period|Treated but Discontinued in Induction|0
2189504|NCT01474512|3819768|FG003|Maintenance Period|Treated but Discontinued in Induction|0
2189505|NCT01474512|3819769|FG004|Maintenance Period|Treated but Discontinued in Induction|1
2189506|NCT01474512|3819770|FG005|Maintenance Period|Treated but Discontinued in Induction|0
2189507|NCT01474512|3819771|FG006|Maintenance Period|Treated but Discontinued in Induction|0
2189508|NCT01474512|3819772|FG007|Maintenance Period|Treated but Discontinued in Induction|0
2189509|NCT01474512|3819773|FG008|Maintenance Period|Treated but Discontinued in Induction|0
2189510|NCT01474512|3819774|FG009|Maintenance Period|Treated but Discontinued in Induction|0
2189511|NCT01474512|3819775|FG010|Maintenance Period|Treated but Discontinued in Induction|0
2189512|NCT01474512|3819776|FG011|Maintenance Period|Treated but Discontinued in Induction|0
2189513|NCT01474512|3819777|FG012|Maintenance Period|Treated but Discontinued in Induction|0
2189514|NCT01474512|3819778|FG013|Maintenance Period|Treated but Discontinued in Induction|0
2189515|NCT01474512|3819779|FG014|Maintenance Period|Treated but Discontinued in Induction|0
2189516|NCT01474512|3819780|FG015|Maintenance Period|Treated but Discontinued in Induction|0
2189517|NCT01474512|3819781|FG016|Maintenance Period|Treated but Discontinued in Induction|0
2189518|NCT01474512|3819782|FG017|Maintenance Period|Treated but Discontinued in Induction|0
2189519|NCT01474512|3819765|FG000|Long-Term Extension Period|Withdrawal by Subject|0
2189520|NCT01474512|3819766|FG001|Long-Term Extension Period|Withdrawal by Subject|0
2189521|NCT01474512|3819767|FG002|Long-Term Extension Period|Withdrawal by Subject|0
2189522|NCT01474512|3819768|FG003|Long-Term Extension Period|Withdrawal by Subject|0
2189523|NCT01474512|3819769|FG004|Long-Term Extension Period|Withdrawal by Subject|0
2189524|NCT01474512|3819770|FG005|Long-Term Extension Period|Withdrawal by Subject|0
2189525|NCT01474512|3819771|FG006|Long-Term Extension Period|Withdrawal by Subject|0
2189526|NCT01474512|3819772|FG007|Long-Term Extension Period|Withdrawal by Subject|0
2189527|NCT01474512|3819773|FG008|Long-Term Extension Period|Withdrawal by Subject|0
2189528|NCT01474512|3819774|FG009|Long-Term Extension Period|Withdrawal by Subject|0
2189529|NCT01474512|3819775|FG010|Long-Term Extension Period|Withdrawal by Subject|0
2189530|NCT01474512|3819776|FG011|Long-Term Extension Period|Withdrawal by Subject|3
2189531|NCT01474512|3819777|FG012|Long-Term Extension Period|Withdrawal by Subject|61
2189532|NCT01474512|3819778|FG013|Long-Term Extension Period|Withdrawal by Subject|61
2189533|NCT01474512|3819779|FG014|Long-Term Extension Period|Withdrawal by Subject|0
2189534|NCT01474512|3819780|FG015|Long-Term Extension Period|Withdrawal by Subject|0
2189535|NCT01474512|3819781|FG016|Long-Term Extension Period|Withdrawal by Subject|0
2189536|NCT01474512|3819782|FG017|Long-Term Extension Period|Withdrawal by Subject|0
2189537|NCT01474512|3819765|FG000|Long-Term Extension Period|Adverse Event|0
2189538|NCT01474512|3819766|FG001|Long-Term Extension Period|Adverse Event|0
2189539|NCT01474512|3819767|FG002|Long-Term Extension Period|Adverse Event|0
2189540|NCT01474512|3819768|FG003|Long-Term Extension Period|Adverse Event|0
2189541|NCT01474512|3819769|FG004|Long-Term Extension Period|Adverse Event|0
2189542|NCT01474512|3819770|FG005|Long-Term Extension Period|Adverse Event|0
2189543|NCT01474512|3819771|FG006|Long-Term Extension Period|Adverse Event|0
2189544|NCT01474512|3819772|FG007|Long-Term Extension Period|Adverse Event|0
2223052|NCT01753401|3869099|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
2223053|NCT01753401|3869100|FG002|Double-blind Period (8 Weeks)|Adverse Event|0
2189545|NCT01474512|3819773|FG008|Long-Term Extension Period|Adverse Event|0
2189546|NCT01474512|3819774|FG009|Long-Term Extension Period|Adverse Event|0
2189547|NCT01474512|3819775|FG010|Long-Term Extension Period|Adverse Event|0
2189548|NCT01474512|3819776|FG011|Long-Term Extension Period|Adverse Event|1
2189549|NCT01474512|3819777|FG012|Long-Term Extension Period|Adverse Event|57
2189550|NCT01474512|3819778|FG013|Long-Term Extension Period|Adverse Event|58
2189551|NCT01474512|3819779|FG014|Long-Term Extension Period|Adverse Event|0
2189552|NCT01474512|3819780|FG015|Long-Term Extension Period|Adverse Event|0
2189553|NCT01474512|3819781|FG016|Long-Term Extension Period|Adverse Event|0
2189554|NCT01474512|3819782|FG017|Long-Term Extension Period|Adverse Event|0
2189555|NCT01474512|3819765|FG000|Long-Term Extension Period|Lost to Follow-up|0
2189556|NCT01474512|3819766|FG001|Long-Term Extension Period|Lost to Follow-up|0
2189557|NCT01474512|3819767|FG002|Long-Term Extension Period|Lost to Follow-up|0
2189558|NCT01474512|3819768|FG003|Long-Term Extension Period|Lost to Follow-up|0
2189559|NCT01474512|3819769|FG004|Long-Term Extension Period|Lost to Follow-up|0
2189560|NCT01474512|3819770|FG005|Long-Term Extension Period|Lost to Follow-up|0
2189561|NCT01474512|3819771|FG006|Long-Term Extension Period|Lost to Follow-up|0
2189562|NCT01474512|3819772|FG007|Long-Term Extension Period|Lost to Follow-up|0
2189563|NCT01474512|3819773|FG008|Long-Term Extension Period|Lost to Follow-up|0
2189564|NCT01474512|3819774|FG009|Long-Term Extension Period|Lost to Follow-up|0
2189565|NCT01474512|3819775|FG010|Long-Term Extension Period|Lost to Follow-up|0
2189566|NCT01474512|3819776|FG011|Long-Term Extension Period|Lost to Follow-up|0
2189567|NCT01474512|3819777|FG012|Long-Term Extension Period|Lost to Follow-up|25
2189568|NCT01474512|3819778|FG013|Long-Term Extension Period|Lost to Follow-up|25
2189569|NCT01474512|3819779|FG014|Long-Term Extension Period|Lost to Follow-up|0
2189570|NCT01474512|3819780|FG015|Long-Term Extension Period|Lost to Follow-up|0
2189571|NCT01474512|3819781|FG016|Long-Term Extension Period|Lost to Follow-up|0
2189572|NCT01474512|3819782|FG017|Long-Term Extension Period|Lost to Follow-up|0
2189573|NCT01474512|3819765|FG000|Long-Term Extension Period|Lack of Efficacy|0
2189574|NCT01474512|3819766|FG001|Long-Term Extension Period|Lack of Efficacy|0
2189575|NCT01474512|3819767|FG002|Long-Term Extension Period|Lack of Efficacy|0
2189576|NCT01474512|3819768|FG003|Long-Term Extension Period|Lack of Efficacy|0
2189577|NCT01474512|3819769|FG004|Long-Term Extension Period|Lack of Efficacy|0
2189578|NCT01474512|3819770|FG005|Long-Term Extension Period|Lack of Efficacy|0
2189579|NCT01474512|3819771|FG006|Long-Term Extension Period|Lack of Efficacy|0
2189580|NCT01474512|3819772|FG007|Long-Term Extension Period|Lack of Efficacy|0
2223054|NCT01753401|3869101|FG003|Double-blind Period (8 Weeks)|Adverse Event|0
2223055|NCT01753401|3869098|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
2223056|NCT01753401|3869099|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
2223057|NCT01753401|3869100|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
2223058|NCT01753401|3869101|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
2223059|NCT01753401|3869098|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0
2223060|NCT01753401|3869099|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1
2223061|NCT01753401|3869100|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0
2223062|NCT01753401|3869101|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0
2223063|NCT01753401|3869098|FG000|Open Label Period (44 Weeks)|Adverse Event|0
2223064|NCT01753401|3869099|FG001|Open Label Period (44 Weeks)|Adverse Event|0
2223065|NCT01753401|3869100|FG002|Open Label Period (44 Weeks)|Adverse Event|3
2223066|NCT01753401|3869101|FG003|Open Label Period (44 Weeks)|Adverse Event|4
2223067|NCT01753401|3869098|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0
2223068|NCT01753401|3869099|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0
2223069|NCT01753401|3869100|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0
2223070|NCT01753401|3869101|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2
2223071|NCT01753401|3869098|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0
2223072|NCT01753401|3869099|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0
2223073|NCT01753401|3869100|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1
2223074|NCT01753401|3869101|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1
2223075|NCT01753401|3869098|FG000|Open Label Period (44 Weeks)|Reason not provided|0
2223076|NCT01753401|3869099|FG001|Open Label Period (44 Weeks)|Reason not provided|0
2223077|NCT01753401|3869100|FG002|Open Label Period (44 Weeks)|Reason not provided|0
2223078|NCT01753401|3869101|FG003|Open Label Period (44 Weeks)|Reason not provided|2
2332234|NCT03189446|4055533|FG000|Overall Study|Physician Decision|1
2332235|NCT03189524|4055540|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7
2352717|NCT03745937|4102728|FG003|Overall Study|Withdrawal by Subject|1
2352718|NCT03745937|4102725|FG000|Overall Study|Not-specifed|0
2352719|NCT03745937|4102726|FG001|Overall Study|Not-specifed|1
2352720|NCT03745937|4102727|FG002|Overall Study|Not-specifed|0
2352721|NCT03745937|4102728|FG003|Overall Study|Not-specifed|1
2352722|NCT03745222|4102742|FG000|Overall Study|Withdrawal by Subject|0
2352723|NCT03745222|4102743|FG001|Overall Study|Withdrawal by Subject|1
2036597|NCT00412958|3606835|FG003|Overall Study|Transport issue|0
2036598|NCT00412971|3606847|FG000|Overall Study|Lost to Follow-up|17
2036599|NCT00412971|3606848|FG001|Overall Study|Lost to Follow-up|9
2036600|NCT00412971|3606847|FG000|Overall Study|Protocol Violation|13
2036601|NCT00412971|3606848|FG001|Overall Study|Protocol Violation|1
2189581|NCT01474512|3819773|FG008|Long-Term Extension Period|Lack of Efficacy|0
2189582|NCT01474512|3819774|FG009|Long-Term Extension Period|Lack of Efficacy|0
2352724|NCT03745222|4102744|FG002|Overall Study|Withdrawal by Subject|0
2352725|NCT03743038|4102779|FG000|Overall Study|Physician Decision|1
2352726|NCT03742271|4102802|FG000|Overall Study|Unsatisfactory Visual Response|1
2352727|NCT03742271|4102802|FG000|Overall Study|Withdrawal by Subject|3
2352728|NCT03742271|4102802|FG000|Overall Study|Lost to Follow-up|4
2352729|NCT03742271|4102802|FG000|Overall Study|Failed Insertion & removal|3
2352730|NCT03742271|4102802|FG000|Overall Study|Protocol Violation|1
2352731|NCT03741062|4102837|FG000|Overall Study|Protocol Violation|1
2352732|NCT03741062|4102838|FG001|Overall Study|Protocol Violation|0
2352733|NCT03739866|4102869|FG000|Overall Study|Lost to Follow-up|0
2352734|NCT03739866|4102870|FG001|Overall Study|Lost to Follow-up|0
2352735|NCT03739866|4102871|FG002|Overall Study|Lost to Follow-up|0
2352736|NCT03739866|4102872|FG003|Overall Study|Lost to Follow-up|1
2352737|NCT03739866|4102873|FG004|Overall Study|Lost to Follow-up|0
2189583|NCT01474512|3819775|FG010|Long-Term Extension Period|Lack of Efficacy|0
2189584|NCT01474512|3819776|FG011|Long-Term Extension Period|Lack of Efficacy|1
2189585|NCT01474512|3819777|FG012|Long-Term Extension Period|Lack of Efficacy|24
2189586|NCT01474512|3819778|FG013|Long-Term Extension Period|Lack of Efficacy|25
2189587|NCT01474512|3819779|FG014|Long-Term Extension Period|Lack of Efficacy|0
2189588|NCT01474512|3819780|FG015|Long-Term Extension Period|Lack of Efficacy|0
2189589|NCT01474512|3819781|FG016|Long-Term Extension Period|Lack of Efficacy|0
2189590|NCT01474512|3819782|FG017|Long-Term Extension Period|Lack of Efficacy|0
2189591|NCT01474512|3819765|FG000|Long-Term Extension Period|Physician Decision|0
2189592|NCT01474512|3819766|FG001|Long-Term Extension Period|Physician Decision|0
2189593|NCT01474512|3819767|FG002|Long-Term Extension Period|Physician Decision|0
2189594|NCT01474512|3819768|FG003|Long-Term Extension Period|Physician Decision|0
2189595|NCT01474512|3819769|FG004|Long-Term Extension Period|Physician Decision|0
2189596|NCT01474512|3819770|FG005|Long-Term Extension Period|Physician Decision|0
2189597|NCT01474512|3819771|FG006|Long-Term Extension Period|Physician Decision|0
2189598|NCT01474512|3819772|FG007|Long-Term Extension Period|Physician Decision|0
2189599|NCT01474512|3819773|FG008|Long-Term Extension Period|Physician Decision|0
2189600|NCT01474512|3819774|FG009|Long-Term Extension Period|Physician Decision|0
2189601|NCT01474512|3819775|FG010|Long-Term Extension Period|Physician Decision|0
2189602|NCT01474512|3819776|FG011|Long-Term Extension Period|Physician Decision|0
2189603|NCT01474512|3819777|FG012|Long-Term Extension Period|Physician Decision|21
2189604|NCT01474512|3819778|FG013|Long-Term Extension Period|Physician Decision|21
2189605|NCT01474512|3819779|FG014|Long-Term Extension Period|Physician Decision|0
2189606|NCT01474512|3819780|FG015|Long-Term Extension Period|Physician Decision|0
2189607|NCT01474512|3819781|FG016|Long-Term Extension Period|Physician Decision|0
2189608|NCT01474512|3819782|FG017|Long-Term Extension Period|Physician Decision|0
2189609|NCT01474512|3819765|FG000|Long-Term Extension Period|Clinical Relapse|0
2189610|NCT01474512|3819766|FG001|Long-Term Extension Period|Clinical Relapse|0
2189611|NCT01474512|3819767|FG002|Long-Term Extension Period|Clinical Relapse|0
2223079|NCT01753518|3869113|FG000|Intention-to-Treat Analysis|Missing consent form|5
2189612|NCT01474512|3819768|FG003|Long-Term Extension Period|Clinical Relapse|0
2189613|NCT01474512|3819769|FG004|Long-Term Extension Period|Clinical Relapse|0
2189614|NCT01474512|3819770|FG005|Long-Term Extension Period|Clinical Relapse|0
2189615|NCT01474512|3819771|FG006|Long-Term Extension Period|Clinical Relapse|0
2189616|NCT01474512|3819772|FG007|Long-Term Extension Period|Clinical Relapse|0
2189617|NCT01474512|3819773|FG008|Long-Term Extension Period|Clinical Relapse|0
2189618|NCT01474512|3819774|FG009|Long-Term Extension Period|Clinical Relapse|0
2189619|NCT01474512|3819775|FG010|Long-Term Extension Period|Clinical Relapse|0
2189620|NCT01474512|3819776|FG011|Long-Term Extension Period|Clinical Relapse|0
2189621|NCT01474512|3819777|FG012|Long-Term Extension Period|Clinical Relapse|9
2189622|NCT01474512|3819778|FG013|Long-Term Extension Period|Clinical Relapse|9
2189623|NCT01474512|3819779|FG014|Long-Term Extension Period|Clinical Relapse|0
2189624|NCT01474512|3819780|FG015|Long-Term Extension Period|Clinical Relapse|0
2189625|NCT01474512|3819781|FG016|Long-Term Extension Period|Clinical Relapse|0
2189626|NCT01474512|3819782|FG017|Long-Term Extension Period|Clinical Relapse|0
2189627|NCT01474512|3819765|FG000|Long-Term Extension Period|Death|0
2189628|NCT01474512|3819766|FG001|Long-Term Extension Period|Death|0
2189629|NCT01474512|3819767|FG002|Long-Term Extension Period|Death|0
2189630|NCT01474512|3819768|FG003|Long-Term Extension Period|Death|0
2189631|NCT01474512|3819769|FG004|Long-Term Extension Period|Death|0
2189632|NCT01474512|3819770|FG005|Long-Term Extension Period|Death|0
2189633|NCT01474512|3819771|FG006|Long-Term Extension Period|Death|0
2189634|NCT01474512|3819772|FG007|Long-Term Extension Period|Death|0
2189635|NCT01474512|3819773|FG008|Long-Term Extension Period|Death|0
2189636|NCT01474512|3819774|FG009|Long-Term Extension Period|Death|0
2189637|NCT01474512|3819775|FG010|Long-Term Extension Period|Death|0
2189638|NCT01474512|3819776|FG011|Long-Term Extension Period|Death|0
2189639|NCT01474512|3819777|FG012|Long-Term Extension Period|Death|9
2189640|NCT01474512|3819778|FG013|Long-Term Extension Period|Death|9
2189641|NCT01474512|3819779|FG014|Long-Term Extension Period|Death|0
2189642|NCT01474512|3819780|FG015|Long-Term Extension Period|Death|0
2189643|NCT01474512|3819781|FG016|Long-Term Extension Period|Death|0
2189644|NCT01474512|3819782|FG017|Long-Term Extension Period|Death|0
2189645|NCT01474512|3819765|FG000|Long-Term Extension Period|Sponsor Decision|0
2189646|NCT01474512|3819766|FG001|Long-Term Extension Period|Sponsor Decision|0
2189647|NCT01474512|3819767|FG002|Long-Term Extension Period|Sponsor Decision|0
2189648|NCT01474512|3819768|FG003|Long-Term Extension Period|Sponsor Decision|0
2189649|NCT01474512|3819769|FG004|Long-Term Extension Period|Sponsor Decision|0
2189650|NCT01474512|3819770|FG005|Long-Term Extension Period|Sponsor Decision|0
2189651|NCT01474512|3819771|FG006|Long-Term Extension Period|Sponsor Decision|0
2189652|NCT01474512|3819772|FG007|Long-Term Extension Period|Sponsor Decision|0
2189653|NCT01474512|3819773|FG008|Long-Term Extension Period|Sponsor Decision|0
2189654|NCT01474512|3819774|FG009|Long-Term Extension Period|Sponsor Decision|0
2189655|NCT01474512|3819775|FG010|Long-Term Extension Period|Sponsor Decision|0
2189656|NCT01474512|3819776|FG011|Long-Term Extension Period|Sponsor Decision|0
2189657|NCT01474512|3819777|FG012|Long-Term Extension Period|Sponsor Decision|6
2189658|NCT01474512|3819778|FG013|Long-Term Extension Period|Sponsor Decision|6
2189659|NCT01474512|3819779|FG014|Long-Term Extension Period|Sponsor Decision|0
2189660|NCT01474512|3819780|FG015|Long-Term Extension Period|Sponsor Decision|0
2223080|NCT01753518|3869114|FG001|Intention-to-Treat Analysis|Missing consent form|3
2274092|NCT02293460|3954962|FG000|Overall Study|Withdrawal by Subject|1
2189661|NCT01474512|3819781|FG016|Long-Term Extension Period|Sponsor Decision|0
2189662|NCT01474512|3819782|FG017|Long-Term Extension Period|Sponsor Decision|0
2189663|NCT01474512|3819765|FG000|Long-Term Extension Period|Protocol Violation|0
2189664|NCT01474512|3819766|FG001|Long-Term Extension Period|Protocol Violation|0
2189665|NCT01474512|3819767|FG002|Long-Term Extension Period|Protocol Violation|0
2189666|NCT01474512|3819768|FG003|Long-Term Extension Period|Protocol Violation|0
2189667|NCT01474512|3819769|FG004|Long-Term Extension Period|Protocol Violation|0
2189668|NCT01474512|3819770|FG005|Long-Term Extension Period|Protocol Violation|0
2189669|NCT01474512|3819771|FG006|Long-Term Extension Period|Protocol Violation|0
2189670|NCT01474512|3819772|FG007|Long-Term Extension Period|Protocol Violation|0
2189671|NCT01474512|3819773|FG008|Long-Term Extension Period|Protocol Violation|0
2189672|NCT01474512|3819774|FG009|Long-Term Extension Period|Protocol Violation|0
2189673|NCT01474512|3819775|FG010|Long-Term Extension Period|Protocol Violation|0
2189674|NCT01474512|3819776|FG011|Long-Term Extension Period|Protocol Violation|0
2189675|NCT01474512|3819777|FG012|Long-Term Extension Period|Protocol Violation|5
2189676|NCT01474512|3819778|FG013|Long-Term Extension Period|Protocol Violation|5
2189677|NCT01474512|3819779|FG014|Long-Term Extension Period|Protocol Violation|0
2189678|NCT01474512|3819780|FG015|Long-Term Extension Period|Protocol Violation|0
2189679|NCT01474512|3819781|FG016|Long-Term Extension Period|Protocol Violation|0
2189680|NCT01474512|3819782|FG017|Long-Term Extension Period|Protocol Violation|0
2189681|NCT01474512|3819765|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0
2189682|NCT01474512|3819766|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0
2189683|NCT01474512|3819767|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0
2189684|NCT01474512|3819768|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0
2189685|NCT01474512|3819769|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0
2189686|NCT01474512|3819770|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0
2189687|NCT01474512|3819771|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0
2189688|NCT01474512|3819772|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0
2189689|NCT01474512|3819773|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0
2189690|NCT01474512|3819774|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0
2189691|NCT01474512|3819775|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0
2189692|NCT01474512|3819776|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0
2189693|NCT01474512|3819777|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1
2189694|NCT01474512|3819778|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1
2189695|NCT01474512|3819779|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0
2189696|NCT01474512|3819780|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0
2189697|NCT01474512|3819781|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0
2189698|NCT01474512|3819782|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0
2189699|NCT01474512|3819765|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0
2189700|NCT01474512|3819766|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0
2189701|NCT01474512|3819767|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0
2189702|NCT01474512|3819768|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0
2189703|NCT01474512|3819769|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0
2189704|NCT01474512|3819770|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0
2189705|NCT01474512|3819771|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0
2189706|NCT01474512|3819772|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0
2189707|NCT01474512|3819773|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0
2189708|NCT01474512|3819774|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0
2189709|NCT01474512|3819775|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0
2189710|NCT01474512|3819776|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21
2189711|NCT01474512|3819777|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0
2189712|NCT01474512|3819778|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0
2189713|NCT01474512|3819779|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0
2189714|NCT01474512|3819780|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0
2189715|NCT01474512|3819781|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0
2189716|NCT01474512|3819782|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0
2189717|NCT01474512|3819765|FG000|Post-Treatment Follow-Up|Adverse Event|0
2189718|NCT01474512|3819766|FG001|Post-Treatment Follow-Up|Adverse Event|0
2189719|NCT01474512|3819767|FG002|Post-Treatment Follow-Up|Adverse Event|0
2189720|NCT01474512|3819768|FG003|Post-Treatment Follow-Up|Adverse Event|0
2189721|NCT01474512|3819769|FG004|Post-Treatment Follow-Up|Adverse Event|0
2189722|NCT01474512|3819770|FG005|Post-Treatment Follow-Up|Adverse Event|0
2189723|NCT01474512|3819771|FG006|Post-Treatment Follow-Up|Adverse Event|0
2189724|NCT01474512|3819772|FG007|Post-Treatment Follow-Up|Adverse Event|0
2189725|NCT01474512|3819773|FG008|Post-Treatment Follow-Up|Adverse Event|0
2189726|NCT01474512|3819774|FG009|Post-Treatment Follow-Up|Adverse Event|0
2189727|NCT01474512|3819775|FG010|Post-Treatment Follow-Up|Adverse Event|0
2189728|NCT01474512|3819776|FG011|Post-Treatment Follow-Up|Adverse Event|0
2189729|NCT01474512|3819777|FG012|Post-Treatment Follow-Up|Adverse Event|0
2189730|NCT01474512|3819778|FG013|Post-Treatment Follow-Up|Adverse Event|0
2189731|NCT01474512|3819779|FG014|Post-Treatment Follow-Up|Adverse Event|8
2189732|NCT01474512|3819780|FG015|Post-Treatment Follow-Up|Adverse Event|2
2189733|NCT01474512|3819781|FG016|Post-Treatment Follow-Up|Adverse Event|58
2189734|NCT01474512|3819782|FG017|Post-Treatment Follow-Up|Adverse Event|11
2189735|NCT01474512|3819765|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189736|NCT01474512|3819766|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189737|NCT01474512|3819767|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189738|NCT01474512|3819768|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189739|NCT01474512|3819769|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189740|NCT01474512|3819770|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189741|NCT01474512|3819771|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189742|NCT01474512|3819772|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189743|NCT01474512|3819773|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189744|NCT01474512|3819774|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189745|NCT01474512|3819775|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189746|NCT01474512|3819776|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189747|NCT01474512|3819777|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189748|NCT01474512|3819778|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0
2189749|NCT01474512|3819779|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3
2189750|NCT01474512|3819780|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2
2189751|NCT01474512|3819781|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36
2189752|NCT01474512|3819782|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17
2189753|NCT01474512|3819765|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0
2189754|NCT01474512|3819766|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0
2189755|NCT01474512|3819767|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0
2189756|NCT01474512|3819768|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0
2189757|NCT01474512|3819769|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0
2189758|NCT01474512|3819770|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0
2189759|NCT01474512|3819771|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0
2189760|NCT01474512|3819772|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0
2189761|NCT01474512|3819773|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0
2189762|NCT01474512|3819774|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0
2189763|NCT01474512|3819775|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0
2189764|NCT01474512|3819776|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0
2189765|NCT01474512|3819777|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0
2189766|NCT01474512|3819778|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0
2189767|NCT01474512|3819779|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3
2189768|NCT01474512|3819780|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2
2189769|NCT01474512|3819781|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31
2189770|NCT01474512|3819782|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3
2189771|NCT01474512|3819765|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0
2189772|NCT01474512|3819766|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0
2189773|NCT01474512|3819767|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0
2189774|NCT01474512|3819768|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0
2189775|NCT01474512|3819769|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0
2189776|NCT01474512|3819770|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0
2189777|NCT01474512|3819771|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0
2189778|NCT01474512|3819772|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0
2189779|NCT01474512|3819773|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0
2189780|NCT01474512|3819774|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0
2189781|NCT01474512|3819775|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0
2189782|NCT01474512|3819776|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0
2189783|NCT01474512|3819777|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0
2189784|NCT01474512|3819778|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0
2189785|NCT01474512|3819779|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0
2189786|NCT01474512|3819780|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0
2189787|NCT01474512|3819781|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12
2189788|NCT01474512|3819782|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7
2189789|NCT01474512|3819765|FG000|Post-Treatment Follow-Up|Physician Decision|0
2189790|NCT01474512|3819766|FG001|Post-Treatment Follow-Up|Physician Decision|0
2189791|NCT01474512|3819767|FG002|Post-Treatment Follow-Up|Physician Decision|0
2189792|NCT01474512|3819768|FG003|Post-Treatment Follow-Up|Physician Decision|0
2189793|NCT01474512|3819769|FG004|Post-Treatment Follow-Up|Physician Decision|0
2189794|NCT01474512|3819770|FG005|Post-Treatment Follow-Up|Physician Decision|0
2189795|NCT01474512|3819771|FG006|Post-Treatment Follow-Up|Physician Decision|0
2189796|NCT01474512|3819772|FG007|Post-Treatment Follow-Up|Physician Decision|0
2189797|NCT01474512|3819773|FG008|Post-Treatment Follow-Up|Physician Decision|0
2189798|NCT01474512|3819774|FG009|Post-Treatment Follow-Up|Physician Decision|0
2189799|NCT01474512|3819775|FG010|Post-Treatment Follow-Up|Physician Decision|0
2189800|NCT01474512|3819776|FG011|Post-Treatment Follow-Up|Physician Decision|0
2189801|NCT01474512|3819777|FG012|Post-Treatment Follow-Up|Physician Decision|0
2189802|NCT01474512|3819778|FG013|Post-Treatment Follow-Up|Physician Decision|0
2189803|NCT01474512|3819779|FG014|Post-Treatment Follow-Up|Physician Decision|0
2189804|NCT01474512|3819780|FG015|Post-Treatment Follow-Up|Physician Decision|0
2189805|NCT01474512|3819781|FG016|Post-Treatment Follow-Up|Physician Decision|4
2189806|NCT01474512|3819782|FG017|Post-Treatment Follow-Up|Physician Decision|5
2189807|NCT01474512|3819765|FG000|Post-Treatment Follow-Up|Clinical Relapse|0
2189808|NCT01474512|3819766|FG001|Post-Treatment Follow-Up|Clinical Relapse|0
2189809|NCT01474512|3819767|FG002|Post-Treatment Follow-Up|Clinical Relapse|0
2223081|NCT01753518|3869113|FG000|Intention-to-Treat Analysis|Multifetal gestation|2
2223082|NCT01753518|3869114|FG001|Intention-to-Treat Analysis|Multifetal gestation|3
2223083|NCT01753518|3869113|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0
2223084|NCT01753518|3869114|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1
2223085|NCT01753518|3869113|FG000|Postpartum Follow-up|Lost to Follow-up|22
2223086|NCT01753518|3869114|FG001|Postpartum Follow-up|Lost to Follow-up|15
2223087|NCT01753570|3869133|FG000|Overall Study|Adverse Event|1
2223088|NCT01753570|3869134|FG001|Overall Study|Adverse Event|0
2223089|NCT01753570|3869135|FG002|Overall Study|Adverse Event|1
2223090|NCT01753570|3869133|FG000|Overall Study|Physician Decision|0
2223091|NCT01753570|3869134|FG001|Overall Study|Physician Decision|1
2223092|NCT01753570|3869135|FG002|Overall Study|Physician Decision|0
2223093|NCT01753570|3869133|FG000|Overall Study|Withdrawal by Subject|1
2223094|NCT01753570|3869134|FG001|Overall Study|Withdrawal by Subject|4
2223095|NCT01753570|3869135|FG002|Overall Study|Withdrawal by Subject|0
2223096|NCT01753856|3869185|FG000|Overall Study|Adverse Event|1
2223097|NCT01753856|3869186|FG001|Overall Study|Adverse Event|0
2223098|NCT01753856|3869185|FG000|Overall Study|Withdrawal by Subject|0
2189810|NCT01474512|3819768|FG003|Post-Treatment Follow-Up|Clinical Relapse|0
2189811|NCT01474512|3819769|FG004|Post-Treatment Follow-Up|Clinical Relapse|0
2189812|NCT01474512|3819770|FG005|Post-Treatment Follow-Up|Clinical Relapse|0
2189813|NCT01474512|3819771|FG006|Post-Treatment Follow-Up|Clinical Relapse|0
2189814|NCT01474512|3819772|FG007|Post-Treatment Follow-Up|Clinical Relapse|0
2189815|NCT01474512|3819773|FG008|Post-Treatment Follow-Up|Clinical Relapse|0
2189816|NCT01474512|3819774|FG009|Post-Treatment Follow-Up|Clinical Relapse|0
2189817|NCT01474512|3819775|FG010|Post-Treatment Follow-Up|Clinical Relapse|0
2189818|NCT01474512|3819776|FG011|Post-Treatment Follow-Up|Clinical Relapse|0
2189819|NCT01474512|3819777|FG012|Post-Treatment Follow-Up|Clinical Relapse|0
2189820|NCT01474512|3819778|FG013|Post-Treatment Follow-Up|Clinical Relapse|0
2189821|NCT01474512|3819779|FG014|Post-Treatment Follow-Up|Clinical Relapse|0
2189822|NCT01474512|3819780|FG015|Post-Treatment Follow-Up|Clinical Relapse|0
2189823|NCT01474512|3819781|FG016|Post-Treatment Follow-Up|Clinical Relapse|6
2189824|NCT01474512|3819782|FG017|Post-Treatment Follow-Up|Clinical Relapse|2
2189825|NCT01474512|3819765|FG000|Post-Treatment Follow-Up|Protocol Violation|0
2189826|NCT01474512|3819766|FG001|Post-Treatment Follow-Up|Protocol Violation|0
2189827|NCT01474512|3819767|FG002|Post-Treatment Follow-Up|Protocol Violation|0
2189828|NCT01474512|3819768|FG003|Post-Treatment Follow-Up|Protocol Violation|0
2189829|NCT01474512|3819769|FG004|Post-Treatment Follow-Up|Protocol Violation|0
2189830|NCT01474512|3819770|FG005|Post-Treatment Follow-Up|Protocol Violation|0
2189831|NCT01474512|3819771|FG006|Post-Treatment Follow-Up|Protocol Violation|0
2189832|NCT01474512|3819772|FG007|Post-Treatment Follow-Up|Protocol Violation|0
2189833|NCT01474512|3819773|FG008|Post-Treatment Follow-Up|Protocol Violation|0
2189834|NCT01474512|3819774|FG009|Post-Treatment Follow-Up|Protocol Violation|0
2189835|NCT01474512|3819775|FG010|Post-Treatment Follow-Up|Protocol Violation|0
2189836|NCT01474512|3819776|FG011|Post-Treatment Follow-Up|Protocol Violation|0
2189837|NCT01474512|3819777|FG012|Post-Treatment Follow-Up|Protocol Violation|0
2189838|NCT01474512|3819778|FG013|Post-Treatment Follow-Up|Protocol Violation|0
2189839|NCT01474512|3819779|FG014|Post-Treatment Follow-Up|Protocol Violation|2
2189840|NCT01474512|3819780|FG015|Post-Treatment Follow-Up|Protocol Violation|2
2189841|NCT01474512|3819781|FG016|Post-Treatment Follow-Up|Protocol Violation|4
2189842|NCT01474512|3819782|FG017|Post-Treatment Follow-Up|Protocol Violation|0
2189843|NCT01474512|3819765|FG000|Post-Treatment Follow-Up|Sponsor Decision|0
2189844|NCT01474512|3819766|FG001|Post-Treatment Follow-Up|Sponsor Decision|0
2189845|NCT01474512|3819767|FG002|Post-Treatment Follow-Up|Sponsor Decision|0
2189846|NCT01474512|3819768|FG003|Post-Treatment Follow-Up|Sponsor Decision|0
2189847|NCT01474512|3819769|FG004|Post-Treatment Follow-Up|Sponsor Decision|0
2189848|NCT01474512|3819770|FG005|Post-Treatment Follow-Up|Sponsor Decision|0
2189849|NCT01474512|3819771|FG006|Post-Treatment Follow-Up|Sponsor Decision|0
2189850|NCT01474512|3819772|FG007|Post-Treatment Follow-Up|Sponsor Decision|0
2189851|NCT01474512|3819773|FG008|Post-Treatment Follow-Up|Sponsor Decision|0
2189852|NCT01474512|3819774|FG009|Post-Treatment Follow-Up|Sponsor Decision|0
2189853|NCT01474512|3819775|FG010|Post-Treatment Follow-Up|Sponsor Decision|0
2189854|NCT01474512|3819776|FG011|Post-Treatment Follow-Up|Sponsor Decision|0
2189855|NCT01474512|3819777|FG012|Post-Treatment Follow-Up|Sponsor Decision|0
2189856|NCT01474512|3819778|FG013|Post-Treatment Follow-Up|Sponsor Decision|0
2189857|NCT01474512|3819779|FG014|Post-Treatment Follow-Up|Sponsor Decision|1
2189858|NCT01474512|3819780|FG015|Post-Treatment Follow-Up|Sponsor Decision|0
2189859|NCT01474512|3819781|FG016|Post-Treatment Follow-Up|Sponsor Decision|4
2189860|NCT01474512|3819782|FG017|Post-Treatment Follow-Up|Sponsor Decision|0
2189861|NCT01474512|3819765|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189862|NCT01474512|3819766|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189863|NCT01474512|3819767|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189864|NCT01474512|3819768|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189865|NCT01474512|3819769|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189866|NCT01474512|3819770|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189867|NCT01474512|3819771|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189868|NCT01474512|3819772|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189869|NCT01474512|3819773|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189870|NCT01474512|3819774|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189871|NCT01474512|3819775|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189872|NCT01474512|3819776|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189873|NCT01474512|3819777|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189874|NCT01474512|3819778|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189875|NCT01474512|3819779|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
2189876|NCT01474512|3819780|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189877|NCT01474512|3819781|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2189878|NCT01474512|3819782|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
2189879|NCT01474512|3819765|FG000|Post-Treatment Follow-Up|Death|0
2189880|NCT01474512|3819766|FG001|Post-Treatment Follow-Up|Death|0
2189881|NCT01474512|3819767|FG002|Post-Treatment Follow-Up|Death|0
2189882|NCT01474512|3819768|FG003|Post-Treatment Follow-Up|Death|0
2189883|NCT01474512|3819769|FG004|Post-Treatment Follow-Up|Death|0
2189884|NCT01474512|3819770|FG005|Post-Treatment Follow-Up|Death|0
2189885|NCT01474512|3819771|FG006|Post-Treatment Follow-Up|Death|0
2189886|NCT01474512|3819772|FG007|Post-Treatment Follow-Up|Death|0
2189887|NCT01474512|3819773|FG008|Post-Treatment Follow-Up|Death|0
2189888|NCT01474512|3819774|FG009|Post-Treatment Follow-Up|Death|0
2189889|NCT01474512|3819775|FG010|Post-Treatment Follow-Up|Death|0
2189890|NCT01474512|3819776|FG011|Post-Treatment Follow-Up|Death|0
2189891|NCT01474512|3819777|FG012|Post-Treatment Follow-Up|Death|0
2189892|NCT01474512|3819778|FG013|Post-Treatment Follow-Up|Death|0
2189893|NCT01474512|3819779|FG014|Post-Treatment Follow-Up|Death|0
2189894|NCT01474512|3819780|FG015|Post-Treatment Follow-Up|Death|0
2189895|NCT01474512|3819781|FG016|Post-Treatment Follow-Up|Death|1
2189896|NCT01474512|3819782|FG017|Post-Treatment Follow-Up|Death|0
2189897|NCT01474538|3819814|FG000|Treatment Period 1|Death|1
2189898|NCT01474538|3819815|FG001|Treatment Period 1|Death|0
2189899|NCT01474538|3819814|FG000|Treatment Period 1|Physician Decision|1
2189900|NCT01474538|3819815|FG001|Treatment Period 1|Physician Decision|0
2189901|NCT01474538|3819814|FG000|Treatment Period 1|Withdrawal by Subject|1
2189902|NCT01474538|3819815|FG001|Treatment Period 1|Withdrawal by Subject|3
2189903|NCT01474538|3819814|FG000|Treatment Period 1|Protocol Violation|0
2189904|NCT01474538|3819815|FG001|Treatment Period 1|Protocol Violation|1
2189905|NCT01474538|3819814|FG000|Treatment Period 2|Death|1
2189906|NCT01474538|3819815|FG001|Treatment Period 2|Death|0
2189907|NCT01474538|3819814|FG000|Treatment Period 2|Adverse Event|1
2189908|NCT01474538|3819815|FG001|Treatment Period 2|Adverse Event|1
2189909|NCT01474538|3819814|FG000|Treatment Period 2|Withdrawal by Subject|2
2189910|NCT01474538|3819815|FG001|Treatment Period 2|Withdrawal by Subject|0
2189911|NCT01474538|3819814|FG000|Treatment Period 2|Sponsor decision|1
2189912|NCT01474538|3819815|FG001|Treatment Period 2|Sponsor decision|0
2189913|NCT01474538|3819814|FG000|Treatment Period 2|Physician Decision|0
2189914|NCT01474538|3819815|FG001|Treatment Period 2|Physician Decision|1
2189915|NCT01474538|3819814|FG000|Treatment Period 2|Protocol Violation|1
2189916|NCT01474538|3819815|FG001|Treatment Period 2|Protocol Violation|0
2189917|NCT01474551|3819821|FG000|Overall Study|Death|1
2189918|NCT01474681|3819836|FG000|Overall Study|Death|0
2189919|NCT01474681|3819837|FG001|Overall Study|Death|3
2189920|NCT01474681|3819838|FG002|Overall Study|Death|2
2189921|NCT01474681|3819839|FG003|Overall Study|Death|6
2189922|NCT01474746|3819855|FG000|Overall Study|Lost to Follow-up|1
2189923|NCT01474746|3819856|FG001|Overall Study|Lost to Follow-up|1
2189924|NCT01474746|3819855|FG000|Overall Study|Withdrawal by Subject|2
2189925|NCT01474746|3819856|FG001|Overall Study|Withdrawal by Subject|1
2189926|NCT01474772|3819864|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6
2189927|NCT01474772|3819865|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1
2189928|NCT01474772|3819864|FG000|Period 1|AE not Related to Study Drug|1
2189929|NCT01474772|3819865|FG001|Period 1|AE not Related to Study Drug|0
2189930|NCT01474772|3819864|FG000|Period 1|Withdrawal by Subject|3
2189931|NCT01474772|3819865|FG001|Period 1|Withdrawal by Subject|1
2189932|NCT01474772|3819864|FG000|Period 1|Lost to Follow-up|1
2189933|NCT01474772|3819865|FG001|Period 1|Lost to Follow-up|0
2189934|NCT01474772|3819864|FG000|Period 1|Reason not Specified|1
2189935|NCT01474772|3819865|FG001|Period 1|Reason not Specified|1
2189936|NCT01474772|3819864|FG000|Washout|AE not Related to Study Drug|2
2189937|NCT01474772|3819865|FG001|Washout|AE not Related to Study Drug|0
2189938|NCT01474772|3819864|FG000|Washout|Withdrawal by Subject|1
2189939|NCT01474772|3819865|FG001|Washout|Withdrawal by Subject|0
2189940|NCT01474772|3819864|FG000|Washout|Lost to Follow-up|0
2189941|NCT01474772|3819865|FG001|Washout|Lost to Follow-up|1
2189942|NCT01474772|3819864|FG000|Washout|Reason not Specified|0
2189943|NCT01474772|3819865|FG001|Washout|Reason not Specified|1
2189944|NCT01474772|3819864|FG000|Period 2|Death|0
2189945|NCT01474772|3819865|FG001|Period 2|Death|1
2189946|NCT01474772|3819864|FG000|Period 2|AE Related to Study Drug|0
2189947|NCT01474772|3819865|FG001|Period 2|AE Related to Study Drug|1
2189948|NCT01474772|3819864|FG000|Period 2|AE not Related to Study Drug|4
2189949|NCT01474772|3819865|FG001|Period 2|AE not Related to Study Drug|1
2189950|NCT01474772|3819864|FG000|Period 2|Lack of Efficacy|1
2189951|NCT01474772|3819865|FG001|Period 2|Lack of Efficacy|0
2189952|NCT01474772|3819864|FG000|Period 2|Withdrawal by Subject|3
2189953|NCT01474772|3819865|FG001|Period 2|Withdrawal by Subject|4
2189954|NCT01474772|3819864|FG000|Period 2|Lost to Follow-up|1
2189955|NCT01474772|3819865|FG001|Period 2|Lost to Follow-up|1
2189956|NCT01474772|3819864|FG000|Period 2|Reason not Specified|0
2189957|NCT01474772|3819865|FG001|Period 2|Reason not Specified|2
2189958|NCT01474772|3819864|FG000|Follow-up|AE not Related to Study Drug|0
2189959|NCT01474772|3819865|FG001|Follow-up|AE not Related to Study Drug|1
2189960|NCT01474876|3819887|FG000|Overall Study|Adverse Event|11
2189961|NCT01474876|3819888|FG001|Overall Study|Adverse Event|5
2189962|NCT01474876|3819889|FG002|Overall Study|Adverse Event|0
2189963|NCT01474876|3819887|FG000|Overall Study|Serious Adverse Event|2
2189964|NCT01474876|3819888|FG001|Overall Study|Serious Adverse Event|3
2189965|NCT01474876|3819889|FG002|Overall Study|Serious Adverse Event|0
2189966|NCT01474876|3819887|FG000|Overall Study|Lost to Follow-up|5
2189967|NCT01474876|3819888|FG001|Overall Study|Lost to Follow-up|4
2189968|NCT01474876|3819889|FG002|Overall Study|Lost to Follow-up|0
2189969|NCT01474876|3819887|FG000|Overall Study|Investigator's decision|28
2189970|NCT01474876|3819888|FG001|Overall Study|Investigator's decision|6
2189971|NCT01474876|3819889|FG002|Overall Study|Investigator's decision|0
2189972|NCT01474876|3819887|FG000|Overall Study|Patient's request|19
2189973|NCT01474876|3819888|FG001|Overall Study|Patient's request|5
2189974|NCT01474876|3819889|FG002|Overall Study|Patient's request|0
2189975|NCT01474876|3819887|FG000|Overall Study|Investigator's decision and pt request|1
2189976|NCT01474876|3819888|FG001|Overall Study|Investigator's decision and pt request|0
2189977|NCT01474876|3819889|FG002|Overall Study|Investigator's decision and pt request|0
2189978|NCT01474993|3819907|FG000|Overall Study|Lost to Follow-up|1
2189979|NCT01474993|3819908|FG001|Overall Study|Lost to Follow-up|2
2189980|NCT01474993|3819907|FG000|Overall Study|Adverse Event|0
2189981|NCT01474993|3819908|FG001|Overall Study|Adverse Event|1
2189982|NCT01475071|3819916|FG000|Overall Study|Physician Decision|1
2189983|NCT01475071|3819916|FG000|Overall Study|Withdrawal by Subject|6
2189984|NCT01475071|3819916|FG000|Overall Study|Lost to Follow-up|1
2189985|NCT01475097|3819924|FG000|Overall Study|Protocol Violation|1
2189986|NCT01475097|3819925|FG001|Overall Study|Protocol Violation|1
2189987|NCT01475136|3819935|FG000|Overall Study|Sponsor Decision|0
2189988|NCT01475136|3819936|FG001|Overall Study|Sponsor Decision|1
2189989|NCT01475136|3819937|FG002|Overall Study|Sponsor Decision|0
2189990|NCT01475136|3819938|FG003|Overall Study|Sponsor Decision|0
2189991|NCT01475136|3819935|FG000|Overall Study|Entry Criteria Not Met|0
2189992|NCT01475136|3819936|FG001|Overall Study|Entry Criteria Not Met|2
2189993|NCT01475136|3819937|FG002|Overall Study|Entry Criteria Not Met|3
2189994|NCT01475136|3819938|FG003|Overall Study|Entry Criteria Not Met|1
2189995|NCT01475136|3819935|FG000|Overall Study|Withdrawal by Subject|0
2189996|NCT01475136|3819936|FG001|Overall Study|Withdrawal by Subject|0
2189997|NCT01475136|3819937|FG002|Overall Study|Withdrawal by Subject|0
2189998|NCT01475136|3819938|FG003|Overall Study|Withdrawal by Subject|2
2189999|NCT01475136|3819935|FG000|Overall Study|Adverse Event|1
2190000|NCT01475136|3819936|FG001|Overall Study|Adverse Event|0
2190001|NCT01475136|3819937|FG002|Overall Study|Adverse Event|0
2190002|NCT01475136|3819938|FG003|Overall Study|Adverse Event|1
2190003|NCT01475136|3819935|FG000|Overall Study|Death|0
2190004|NCT01475136|3819936|FG001|Overall Study|Death|0
2190005|NCT01475136|3819937|FG002|Overall Study|Death|0
2190006|NCT01475136|3819938|FG003|Overall Study|Death|1
2190007|NCT01475162|3819948|FG000|Overall Study|Physician Decision|1
2190008|NCT01475162|3819948|FG000|Overall Study|Death|10
2190009|NCT01475162|3819948|FG000|Overall Study|Study closed for safety|3
2190010|NCT01475214|3819960|FG000|Overall Study|Lost to Follow-up|1
2190011|NCT01475214|3819961|FG001|Overall Study|Lost to Follow-up|0
2190012|NCT01475214|3819962|FG002|Overall Study|Lost to Follow-up|1
2190013|NCT01475214|3819960|FG000|Overall Study|Physician Decision|2
2190014|NCT01475214|3819961|FG001|Overall Study|Physician Decision|0
2190015|NCT01475214|3819962|FG002|Overall Study|Physician Decision|0
2190016|NCT01475214|3819960|FG000|Overall Study|Withdrawal by Subject|2
2190017|NCT01475214|3819961|FG001|Overall Study|Withdrawal by Subject|4
2223099|NCT01753856|3869186|FG001|Overall Study|Withdrawal by Subject|2
2223100|NCT01753856|3869185|FG000|Overall Study|Sponsor Decision|2
2223101|NCT01753856|3869186|FG001|Overall Study|Sponsor Decision|0
2223102|NCT01753999|3869195|FG000|Period 1 - Initial Assignment|Physician Decision|2
2223103|NCT01753999|3869196|FG001|Period 1 - Initial Assignment|Physician Decision|3
2223104|NCT01753999|3869195|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19
2223105|NCT01753999|3869196|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20
2223106|NCT01753999|3869195|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18
2190018|NCT01475214|3819962|FG002|Overall Study|Withdrawal by Subject|1
2190019|NCT01475253|3819974|FG000|Randomized, Blinded Study|Withdrawal by Subject|1
2190020|NCT01475253|3819975|FG001|Randomized, Blinded Study|Withdrawal by Subject|1
2190021|NCT01475253|3819976|FG002|Randomized, Blinded Study|Withdrawal by Subject|0
2190022|NCT01475253|3819977|FG003|Randomized, Blinded Study|Withdrawal by Subject|0
2190023|NCT01475253|3819974|FG000|Randomized, Blinded Study|Lost to Follow-up|1
2190024|NCT01475253|3819975|FG001|Randomized, Blinded Study|Lost to Follow-up|0
2190025|NCT01475253|3819976|FG002|Randomized, Blinded Study|Lost to Follow-up|0
2190026|NCT01475253|3819977|FG003|Randomized, Blinded Study|Lost to Follow-up|0
2223107|NCT01753999|3869196|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27
2223108|NCT01753999|3869195|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
2223109|NCT01753999|3869196|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
2223110|NCT01753999|3869195|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
2223111|NCT01753999|3869196|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
2223112|NCT01753999|3869195|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1
2223113|NCT01753999|3869196|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1
2223114|NCT01754129|3869207|FG000|Overall Study|Death|13
2223115|NCT01754129|3869207|FG000|Overall Study|Duodopa discontinuation|9
2223116|NCT01754129|3869207|FG000|Overall Study|Lost to Follow-up|7
2223117|NCT01754129|3869207|FG000|Overall Study|Withdrew consent|1
2223118|NCT01754129|3869207|FG000|Overall Study|Inclusion/exclusion criteria violation|3
2223119|NCT01754194|3869220|FG000|Overall Study|Lost to Follow-up|39
2223120|NCT01754194|3869221|FG001|Overall Study|Lost to Follow-up|14
2223121|NCT01754194|3869220|FG000|Overall Study|Withdrawal by Subject|4
2223122|NCT01754194|3869221|FG001|Overall Study|Withdrawal by Subject|5
2223123|NCT01754194|3869220|FG000|Overall Study|Other|9
2223124|NCT01754194|3869221|FG001|Overall Study|Other|8
2223125|NCT01754259|3869235|FG000|Overall Study|Withdrawal by Subject|2
2223126|NCT01754259|3869236|FG001|Overall Study|Withdrawal by Subject|4
2223127|NCT01754259|3869235|FG000|Overall Study|Adverse Event|3
2223128|NCT01754259|3869236|FG001|Overall Study|Adverse Event|1
2223129|NCT01754259|3869235|FG000|Overall Study|Lost to Follow-up|0
2223130|NCT01754259|3869236|FG001|Overall Study|Lost to Follow-up|1
2223131|NCT01754376|3869251|FG000|Overall Study|Adverse Event|1
2223132|NCT01754376|3869251|FG000|Overall Study|Lack of Efficacy|2
2223133|NCT01754402|3869272|FG000|Overall Study|Death|0
2223134|NCT01754402|3869273|FG001|Overall Study|Death|0
2223135|NCT01754402|3869274|FG002|Overall Study|Death|1
2223136|NCT01754402|3869272|FG000|Overall Study|Adverse Event|2
2223137|NCT01754402|3869273|FG001|Overall Study|Adverse Event|2
2223138|NCT01754402|3869274|FG002|Overall Study|Adverse Event|1
2223139|NCT01754402|3869272|FG000|Overall Study|Withdrawal by Subject|0
2223140|NCT01754402|3869273|FG001|Overall Study|Withdrawal by Subject|0
2223141|NCT01754402|3869274|FG002|Overall Study|Withdrawal by Subject|1
2223142|NCT01754402|3869272|FG000|Overall Study|Lack of Efficacy|0
2223143|NCT01754402|3869273|FG001|Overall Study|Lack of Efficacy|0
2223144|NCT01754402|3869274|FG002|Overall Study|Lack of Efficacy|1
2223145|NCT01754467|3869283|FG000|Overall Study|Lost to Follow-up|1
2223146|NCT01754493|3869297|FG000|Overall Study|Adverse Event|1
2223147|NCT01754493|3869297|FG000|Overall Study|Lost to Follow-up|3
2223148|NCT01754493|3869297|FG000|Overall Study|Withdrawal by Subject|1
2223149|NCT01754493|3869297|FG000|Overall Study|Moved out of town|1
2223150|NCT01754493|3869297|FG000|Overall Study|Scheduling conflict|1
2223151|NCT01754727|3869334|FG000|Overall Study|Adalimumab Treatment was not Documented|2
2223152|NCT01754753|3869340|FG000|Overall Study|Study close|43
2223153|NCT01754753|3869341|FG001|Overall Study|Study close|44
2223154|NCT01754753|3869340|FG000|Overall Study|Lost to Follow-up|9
2223155|NCT01754753|3869341|FG001|Overall Study|Lost to Follow-up|5
2223156|NCT01754766|3869350|FG000|Overall Study|Personal reasons|1
2223157|NCT01754766|3869351|FG001|Overall Study|Personal reasons|1
2223158|NCT01754766|3869352|FG002|Overall Study|Personal reasons|0
2223159|NCT01754922|3869371|FG000|Overall Study|Adverse Event|0
2223160|NCT01754922|3869372|FG001|Overall Study|Adverse Event|1
2223161|NCT01755026|3869381|FG000|Overall Study|Adverse Event|1
2223162|NCT01755026|3869382|FG001|Overall Study|Adverse Event|0
2223163|NCT01755026|3869381|FG000|Overall Study|Withdrawal by Subject|1
2223164|NCT01755026|3869382|FG001|Overall Study|Withdrawal by Subject|1
2223165|NCT01755091|3869391|FG000|Overall Study|Withdrawal by Subject|6
2223166|NCT01755091|3869392|FG001|Overall Study|Withdrawal by Subject|1
2223167|NCT01755091|3869393|FG002|Overall Study|Withdrawal by Subject|3
2223168|NCT01755091|3869391|FG000|Overall Study|Adverse Event|1
2223169|NCT01755091|3869392|FG001|Overall Study|Adverse Event|1
2223170|NCT01755091|3869393|FG002|Overall Study|Adverse Event|1
2223171|NCT01755091|3869391|FG000|Overall Study|Lost to Follow-up|1
2223172|NCT01755091|3869392|FG001|Overall Study|Lost to Follow-up|0
2223173|NCT01755091|3869393|FG002|Overall Study|Lost to Follow-up|1
2223174|NCT01755091|3869391|FG000|Overall Study|Physician Decision|1
2223175|NCT01755091|3869392|FG001|Overall Study|Physician Decision|1
2223176|NCT01755091|3869393|FG002|Overall Study|Physician Decision|2
2223177|NCT01755156|3869412|FG000|Phase A (Weeks 0-24)|Adverse Event|2
2223178|NCT01755156|3869413|FG001|Phase A (Weeks 0-24)|Adverse Event|3
2223179|NCT01755156|3869412|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1
2223180|NCT01755156|3869413|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0
2223181|NCT01755156|3869412|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5
2223182|NCT01755156|3869413|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3
2223183|NCT01755156|3869412|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1
2223184|NCT01755156|3869413|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0
2352738|NCT03739866|4102874|FG005|Overall Study|Lost to Follow-up|0
2190027|NCT01475331|3819997|FG000|Overall Study|Osteophyte obstruction of the proximal|1
2190028|NCT01475331|3819998|FG001|Overall Study|Osteophyte obstruction of the proximal|0
2190029|NCT01475331|3819997|FG000|Overall Study|excessive main duct communication|1
2190030|NCT01475331|3819998|FG001|Overall Study|excessive main duct communication|1
2190031|NCT01475331|3819997|FG000|Overall Study|Loss of needle positioning due pt. cough|1
2190032|NCT01475331|3819998|FG001|Overall Study|Loss of needle positioning due pt. cough|0
2190033|NCT01475331|3819997|FG000|Overall Study|Sign of malignancy during the procedure|2
2190034|NCT01475331|3819998|FG001|Overall Study|Sign of malignancy during the procedure|0
2190035|NCT01475331|3819997|FG000|Overall Study|cyst found to be prohibitively small|0
2190036|NCT01475331|3819998|FG001|Overall Study|cyst found to be prohibitively small|1
2190037|NCT01475370|3820007|FG000|Overall Study|Exacerbation of primary disease|2
2190038|NCT01475370|3820008|FG001|Overall Study|Exacerbation of primary disease|2
2190039|NCT01475370|3820009|FG002|Overall Study|Exacerbation of primary disease|2
2190040|NCT01475370|3820007|FG000|Overall Study|Study drug administration difficult|0
2190041|NCT01475370|3820008|FG001|Overall Study|Study drug administration difficult|1
2190042|NCT01475370|3820009|FG002|Overall Study|Study drug administration difficult|1
2190043|NCT01475370|3820007|FG000|Overall Study|Other than specified|1
2190044|NCT01475370|3820008|FG001|Overall Study|Other than specified|0
2190045|NCT01475370|3820009|FG002|Overall Study|Other than specified|0
2190046|NCT01475461|3820023|FG000|Run-in Period|Not meet eligibility criteria|16
2190047|NCT01475461|3820024|FG001|Run-in Period|Not meet eligibility criteria|0
2190048|NCT01475461|3820025|FG002|Run-in Period|Not meet eligibility criteria|0
2190049|NCT01475461|3820026|FG003|Run-in Period|Not meet eligibility criteria|0
2190050|NCT01475461|3820027|FG004|Run-in Period|Not meet eligibility criteria|0
2190051|NCT01475461|3820028|FG005|Run-in Period|Not meet eligibility criteria|0
2190052|NCT01475461|3820029|FG006|Run-in Period|Not meet eligibility criteria|0
2190053|NCT01475461|3820023|FG000|Run-in Period|Lost to Follow-up|7
2190054|NCT01475461|3820024|FG001|Run-in Period|Lost to Follow-up|0
2190055|NCT01475461|3820025|FG002|Run-in Period|Lost to Follow-up|0
2190056|NCT01475461|3820026|FG003|Run-in Period|Lost to Follow-up|0
2190057|NCT01475461|3820027|FG004|Run-in Period|Lost to Follow-up|0
2190058|NCT01475461|3820028|FG005|Run-in Period|Lost to Follow-up|0
2190059|NCT01475461|3820029|FG006|Run-in Period|Lost to Follow-up|0
2190060|NCT01475461|3820023|FG000|Run-in Period|Withdrawal by Subject|11
2190061|NCT01475461|3820024|FG001|Run-in Period|Withdrawal by Subject|0
2190062|NCT01475461|3820025|FG002|Run-in Period|Withdrawal by Subject|0
2190063|NCT01475461|3820026|FG003|Run-in Period|Withdrawal by Subject|0
2190064|NCT01475461|3820027|FG004|Run-in Period|Withdrawal by Subject|0
2190065|NCT01475461|3820028|FG005|Run-in Period|Withdrawal by Subject|0
2190066|NCT01475461|3820029|FG006|Run-in Period|Withdrawal by Subject|0
2190067|NCT01475461|3820023|FG000|Run-in Period|Other|3
2190068|NCT01475461|3820024|FG001|Run-in Period|Other|0
2190069|NCT01475461|3820025|FG002|Run-in Period|Other|0
2190070|NCT01475461|3820026|FG003|Run-in Period|Other|0
2190071|NCT01475461|3820027|FG004|Run-in Period|Other|0
2190072|NCT01475461|3820028|FG005|Run-in Period|Other|0
2190073|NCT01475461|3820029|FG006|Run-in Period|Other|0
2190074|NCT01475461|3820023|FG000|Run-in Period|Protocol Violation|4
2190075|NCT01475461|3820024|FG001|Run-in Period|Protocol Violation|0
2190076|NCT01475461|3820025|FG002|Run-in Period|Protocol Violation|0
2190077|NCT01475461|3820026|FG003|Run-in Period|Protocol Violation|0
2190078|NCT01475461|3820027|FG004|Run-in Period|Protocol Violation|0
2190079|NCT01475461|3820028|FG005|Run-in Period|Protocol Violation|0
2190080|NCT01475461|3820029|FG006|Run-in Period|Protocol Violation|0
2190081|NCT01475461|3820023|FG000|Treatment Period|Death|0
2190082|NCT01475461|3820024|FG001|Treatment Period|Death|0
2190083|NCT01475461|3820025|FG002|Treatment Period|Death|0
2190084|NCT01475461|3820026|FG003|Treatment Period|Death|1
2190085|NCT01475461|3820027|FG004|Treatment Period|Death|0
2190086|NCT01475461|3820028|FG005|Treatment Period|Death|0
2190087|NCT01475461|3820029|FG006|Treatment Period|Death|0
2190088|NCT01475461|3820023|FG000|Treatment Period|Lost to Follow-up|0
2190089|NCT01475461|3820024|FG001|Treatment Period|Lost to Follow-up|3
2190090|NCT01475461|3820025|FG002|Treatment Period|Lost to Follow-up|2
2190091|NCT01475461|3820026|FG003|Treatment Period|Lost to Follow-up|3
2190092|NCT01475461|3820027|FG004|Treatment Period|Lost to Follow-up|1
2190093|NCT01475461|3820028|FG005|Treatment Period|Lost to Follow-up|2
2190094|NCT01475461|3820029|FG006|Treatment Period|Lost to Follow-up|1
2190095|NCT01475461|3820023|FG000|Treatment Period|Withdrawal by Subject|0
2190096|NCT01475461|3820024|FG001|Treatment Period|Withdrawal by Subject|2
2190097|NCT01475461|3820025|FG002|Treatment Period|Withdrawal by Subject|2
2190098|NCT01475461|3820026|FG003|Treatment Period|Withdrawal by Subject|0
2190099|NCT01475461|3820027|FG004|Treatment Period|Withdrawal by Subject|2
2190100|NCT01475461|3820028|FG005|Treatment Period|Withdrawal by Subject|2
2190101|NCT01475461|3820029|FG006|Treatment Period|Withdrawal by Subject|0
2190102|NCT01475461|3820023|FG000|Treatment Period|Other|0
2190103|NCT01475461|3820024|FG001|Treatment Period|Other|1
2190104|NCT01475461|3820025|FG002|Treatment Period|Other|0
2190105|NCT01475461|3820026|FG003|Treatment Period|Other|0
2190106|NCT01475461|3820027|FG004|Treatment Period|Other|0
2190107|NCT01475461|3820028|FG005|Treatment Period|Other|0
2190108|NCT01475461|3820029|FG006|Treatment Period|Other|0
2190109|NCT01475461|3820023|FG000|Treatment Period|Protocol Violation|0
2190110|NCT01475461|3820024|FG001|Treatment Period|Protocol Violation|1
2190111|NCT01475461|3820025|FG002|Treatment Period|Protocol Violation|0
2190112|NCT01475461|3820026|FG003|Treatment Period|Protocol Violation|0
2190113|NCT01475461|3820027|FG004|Treatment Period|Protocol Violation|0
2190114|NCT01475461|3820028|FG005|Treatment Period|Protocol Violation|0
2190115|NCT01475461|3820029|FG006|Treatment Period|Protocol Violation|1
2190116|NCT01475461|3820023|FG000|Treatment Period|Lack of Efficacy|0
2190117|NCT01475461|3820024|FG001|Treatment Period|Lack of Efficacy|2
2190118|NCT01475461|3820025|FG002|Treatment Period|Lack of Efficacy|0
2190119|NCT01475461|3820026|FG003|Treatment Period|Lack of Efficacy|2
2190120|NCT01475461|3820027|FG004|Treatment Period|Lack of Efficacy|1
2190121|NCT01475461|3820028|FG005|Treatment Period|Lack of Efficacy|1
2190122|NCT01475461|3820029|FG006|Treatment Period|Lack of Efficacy|0
2190123|NCT01475461|3820023|FG000|Treatment Period|Medication Error|0
2190124|NCT01475461|3820024|FG001|Treatment Period|Medication Error|0
2190125|NCT01475461|3820025|FG002|Treatment Period|Medication Error|0
2190126|NCT01475461|3820026|FG003|Treatment Period|Medication Error|1
2190127|NCT01475461|3820027|FG004|Treatment Period|Medication Error|0
2190128|NCT01475461|3820028|FG005|Treatment Period|Medication Error|0
2190129|NCT01475461|3820029|FG006|Treatment Period|Medication Error|0
2190130|NCT01475461|3820023|FG000|Treatment Period|Adverse Event|0
2190131|NCT01475461|3820024|FG001|Treatment Period|Adverse Event|0
2190132|NCT01475461|3820025|FG002|Treatment Period|Adverse Event|0
2190133|NCT01475461|3820026|FG003|Treatment Period|Adverse Event|1
2190134|NCT01475461|3820027|FG004|Treatment Period|Adverse Event|0
2190135|NCT01475461|3820028|FG005|Treatment Period|Adverse Event|0
2223185|NCT01755156|3869412|FG000|Phase A (Weeks 0-24)|Physician Decision|0
2223186|NCT01755156|3869413|FG001|Phase A (Weeks 0-24)|Physician Decision|1
2223187|NCT01755156|3869412|FG000|Phase A (Weeks 0-24)|Protocol Violation|1
2223188|NCT01755156|3869413|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
2223189|NCT01755156|3869412|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6
2223190|NCT01755156|3869413|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13
2223191|NCT01755156|3869412|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
2223192|NCT01755156|3869413|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
2223193|NCT01755156|3869412|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
2223194|NCT01755156|3869413|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
2223195|NCT01755156|3869412|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12
2223196|NCT01755156|3869413|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5
2223197|NCT01755156|3869412|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27
2223198|NCT01755156|3869413|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31
2223199|NCT01755195|3869440|FG000|Overall Study|Participant noncompliance|2
2223200|NCT01755195|3869440|FG000|Overall Study|Switched to alternative treatment|4
2223201|NCT01755195|3869440|FG000|Overall Study|Withdrawal by Subject|1
2223202|NCT01755195|3869440|FG000|Overall Study|Participant refused to start treatment|1
2223203|NCT01755195|3869440|FG000|Overall Study|Participant has been consented for another trial|1
2223204|NCT01755195|3869440|FG000|Overall Study|Refused further treatment|3
2223205|NCT01755195|3869440|FG000|Overall Study|Complicating disease/intercurrent illness|1
2223206|NCT01755234|3869446|FG000|Overall Study|Lost to Follow-up|11
2223207|NCT01755234|3869447|FG001|Overall Study|Lost to Follow-up|6
2223208|NCT01755234|3869446|FG000|Overall Study|Change in surgical case|2
2223209|NCT01755234|3869447|FG001|Overall Study|Change in surgical case|1
2223210|NCT01755234|3869446|FG000|Overall Study|case cancelled|1
2223211|NCT01755234|3869447|FG001|Overall Study|case cancelled|0
2223212|NCT01755234|3869446|FG000|Overall Study|Withdrawal by Subject|0
2223213|NCT01755234|3869447|FG001|Overall Study|Withdrawal by Subject|1
2223214|NCT01755234|3869446|FG000|Overall Study|unblinded|1
2223215|NCT01755234|3869447|FG001|Overall Study|unblinded|0
2223216|NCT01755416|3869453|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
2223217|NCT01755416|3869454|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
2223218|NCT01755546|3869467|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
2223219|NCT01755546|3869467|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
2223220|NCT01755546|3869467|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
2223221|NCT01755546|3869467|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
2223222|NCT01755546|3869467|FG000|Titration Phase|Adverse Event|11
2223223|NCT01755546|3869467|FG000|Titration Phase|Lack of Efficacy|18
2332236|NCT03189524|4055541|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5
2332237|NCT03189524|4055542|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11
2332238|NCT03189524|4055540|FG000|Overall Study|Death|2
2332239|NCT03189524|4055541|FG001|Overall Study|Death|2
2332240|NCT03189524|4055542|FG002|Overall Study|Death|1
2332241|NCT03189524|4055540|FG000|Overall Study|Lost to Follow-up|1
2332242|NCT03189524|4055541|FG001|Overall Study|Lost to Follow-up|0
2332243|NCT03189524|4055542|FG002|Overall Study|Lost to Follow-up|8
2332244|NCT03189524|4055540|FG000|Overall Study|Withdrawal by Subject|1
2332245|NCT03189524|4055541|FG001|Overall Study|Withdrawal by Subject|1
2332246|NCT03189524|4055542|FG002|Overall Study|Withdrawal by Subject|3
2332247|NCT03189524|4055540|FG000|Overall Study|Progressive Disease|0
2190136|NCT01475461|3820029|FG006|Treatment Period|Adverse Event|0
2190137|NCT01475474|3820062|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
2190138|NCT01475474|3820062|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2
2190139|NCT01475487|3820069|FG000|Overall Study|had to leave early for personal reasons|2
2190140|NCT01475487|3820070|FG001|Overall Study|had to leave early for personal reasons|1
2190141|NCT01475721|3820098|FG000|Overall Study|Death|3
2190142|NCT01475721|3820099|FG001|Overall Study|Death|6
2190143|NCT01475721|3820098|FG000|Overall Study|Withdrawal by Subject|8
2190144|NCT01475721|3820099|FG001|Overall Study|Withdrawal by Subject|8
2190145|NCT01475734|3820107|FG000|Overall Study|Withdrawal by Subject|1
2190146|NCT01475734|3820108|FG001|Overall Study|Withdrawal by Subject|0
2190147|NCT01475734|3820107|FG000|Overall Study|Protocol Violation|1
2190148|NCT01475734|3820108|FG001|Overall Study|Protocol Violation|0
2190149|NCT01475734|3820107|FG000|Overall Study|Physician Decision|0
2190150|NCT01475734|3820108|FG001|Overall Study|Physician Decision|1
2190151|NCT01475825|3820118|FG000|Overall Study|Adverse Event|41
2190152|NCT01475825|3820119|FG001|Overall Study|Adverse Event|15
2190153|NCT01475825|3820120|FG002|Overall Study|Adverse Event|27
2190154|NCT01475825|3820121|FG003|Overall Study|Adverse Event|11
2190155|NCT01475825|3820118|FG000|Overall Study|Death|1
2190156|NCT01475825|3820119|FG001|Overall Study|Death|0
2190157|NCT01475825|3820120|FG002|Overall Study|Death|1
2190158|NCT01475825|3820121|FG003|Overall Study|Death|0
2190159|NCT01475825|3820118|FG000|Overall Study|Lack of Efficacy|0
2190160|NCT01475825|3820119|FG001|Overall Study|Lack of Efficacy|0
2190161|NCT01475825|3820120|FG002|Overall Study|Lack of Efficacy|1
2190162|NCT01475825|3820121|FG003|Overall Study|Lack of Efficacy|0
2190163|NCT01475825|3820118|FG000|Overall Study|Lost to Follow-up|0
2190164|NCT01475825|3820119|FG001|Overall Study|Lost to Follow-up|0
2190165|NCT01475825|3820120|FG002|Overall Study|Lost to Follow-up|3
2190166|NCT01475825|3820121|FG003|Overall Study|Lost to Follow-up|1
2190167|NCT01475825|3820118|FG000|Overall Study|Non-compliance with Study Drug|1
2190168|NCT01475825|3820119|FG001|Overall Study|Non-compliance with Study Drug|2
2190169|NCT01475825|3820120|FG002|Overall Study|Non-compliance with Study Drug|4
2190170|NCT01475825|3820121|FG003|Overall Study|Non-compliance with Study Drug|0
2223224|NCT01755546|3869467|FG000|Titration Phase|Protocol Violation|9
2223225|NCT01755546|3869467|FG000|Titration Phase|Lost to Follow-up|2
2223226|NCT01755546|3869467|FG000|Titration Phase|Other and Continuing|22
2223227|NCT01755546|3869467|FG000|Titration Phase|Withdrawal by Subject|8
2223228|NCT01755546|3869467|FG000|Long Term Treatment|Adverse Event|12
2223229|NCT01755546|3869467|FG000|Long Term Treatment|Lack of Efficacy|6
2223230|NCT01755546|3869467|FG000|Long Term Treatment|Protocol Violation|10
2223231|NCT01755546|3869467|FG000|Long Term Treatment|Withdrawal by Subject|35
2223232|NCT01755546|3869467|FG000|Long Term Treatment|Lost to Follow-up|17
2223233|NCT01755546|3869467|FG000|Long Term Treatment|other and ongoing|41
2223234|NCT01755598|3869473|FG000|Overall Study|Other|109
2223235|NCT01755598|3869474|FG001|Overall Study|Other|109
2223236|NCT01755598|3869473|FG000|Overall Study|Lost to Follow-up|32
2223237|NCT01755598|3869474|FG001|Overall Study|Lost to Follow-up|43
2223238|NCT01755598|3869473|FG000|Overall Study|Migrated/moved from study area|76
2223239|NCT01755598|3869474|FG001|Overall Study|Migrated/moved from study area|65
2223240|NCT01755598|3869473|FG000|Overall Study|Withdrawal by Subject|22
2223241|NCT01755598|3869474|FG001|Overall Study|Withdrawal by Subject|31
2223242|NCT01755598|3869473|FG000|Overall Study|Protocol Violation|7
2223243|NCT01755598|3869474|FG001|Overall Study|Protocol Violation|7
2223244|NCT01755598|3869473|FG000|Overall Study|Adverse Event|19
2223245|NCT01755598|3869474|FG001|Overall Study|Adverse Event|28
2223246|NCT01755637|3869480|FG000|Period 1|Adverse Event|0
2223247|NCT01755637|3869481|FG001|Period 1|Adverse Event|1
2223248|NCT01755702|3869493|FG000|Wash Out Period I|Other Reason|3
2223249|NCT01755702|3869493|FG000|Washout Period II|Other Reason|5
2223250|NCT01755767|3869507|FG000|Overall Study|Progressive Disease|8
2223251|NCT01755767|3869508|FG001|Overall Study|Progressive Disease|7
2223252|NCT01755767|3869509|FG002|Overall Study|Progressive Disease|91
2223253|NCT01755767|3869510|FG003|Overall Study|Progressive Disease|43
2223254|NCT01755767|3869507|FG000|Overall Study|Clinical Disease Progression|4
2223255|NCT01755767|3869508|FG001|Overall Study|Clinical Disease Progression|2
2223256|NCT01755767|3869509|FG002|Overall Study|Clinical Disease Progression|29
2223257|NCT01755767|3869510|FG003|Overall Study|Clinical Disease Progression|20
2223258|NCT01755767|3869507|FG000|Overall Study|Radiographic Disease Progression|9
2223259|NCT01755767|3869508|FG001|Overall Study|Radiographic Disease Progression|4
2223260|NCT01755767|3869509|FG002|Overall Study|Radiographic Disease Progression|44
2223261|NCT01755767|3869510|FG003|Overall Study|Radiographic Disease Progression|27
2223262|NCT01755767|3869507|FG000|Overall Study|Adverse Event|6
2223263|NCT01755767|3869508|FG001|Overall Study|Adverse Event|0
2223264|NCT01755767|3869509|FG002|Overall Study|Adverse Event|28
2223265|NCT01755767|3869510|FG003|Overall Study|Adverse Event|11
2223266|NCT01755767|3869507|FG000|Overall Study|Death|1
2223267|NCT01755767|3869508|FG001|Overall Study|Death|2
2223268|NCT01755767|3869509|FG002|Overall Study|Death|15
2332248|NCT03189524|4055541|FG001|Overall Study|Progressive Disease|2
2190171|NCT01475825|3820118|FG000|Overall Study|Other: Not available|0
2190172|NCT01475825|3820119|FG001|Overall Study|Other: Not available|0
2190173|NCT01475825|3820120|FG002|Overall Study|Other: Not available|2
2190174|NCT01475825|3820121|FG003|Overall Study|Other: Not available|0
2190175|NCT01475825|3820118|FG000|Overall Study|Protocol Violation|1
2190176|NCT01475825|3820119|FG001|Overall Study|Protocol Violation|0
2190177|NCT01475825|3820120|FG002|Overall Study|Protocol Violation|0
2190178|NCT01475825|3820121|FG003|Overall Study|Protocol Violation|0
2190179|NCT01475825|3820118|FG000|Overall Study|Physician Decision|0
2190180|NCT01475825|3820119|FG001|Overall Study|Physician Decision|1
2190181|NCT01475825|3820120|FG002|Overall Study|Physician Decision|0
2190182|NCT01475825|3820121|FG003|Overall Study|Physician Decision|0
2190183|NCT01475825|3820118|FG000|Overall Study|Withdrawal by Subject|8
2190184|NCT01475825|3820119|FG001|Overall Study|Withdrawal by Subject|3
2190185|NCT01475825|3820120|FG002|Overall Study|Withdrawal by Subject|11
2190186|NCT01475825|3820121|FG003|Overall Study|Withdrawal by Subject|7
2190187|NCT01475825|3820118|FG000|Overall Study|Did not enter OLC|15
2190188|NCT01475825|3820119|FG001|Overall Study|Did not enter OLC|11
2190189|NCT01475825|3820120|FG002|Overall Study|Did not enter OLC|15
2190190|NCT01475825|3820121|FG003|Overall Study|Did not enter OLC|11
2190191|NCT01475838|3820133|FG000|Randomized Phase|Randomized but Not Treated|0
2190192|NCT01475838|3820134|FG001|Randomized Phase|Randomized but Not Treated|5
2190193|NCT01475838|3820133|FG000|Randomized Phase|Adverse Event|6
2190194|NCT01475838|3820134|FG001|Randomized Phase|Adverse Event|1
2190195|NCT01475838|3820133|FG000|Randomized Phase|Pregnancy|0
2190196|NCT01475838|3820134|FG001|Randomized Phase|Pregnancy|1
2190197|NCT01475838|3820133|FG000|Randomized Phase|Investigators Discretion|1
2190198|NCT01475838|3820134|FG001|Randomized Phase|Investigators Discretion|2
2190199|NCT01475838|3820133|FG000|Randomized Phase|Withdrew Consent|10
2190200|NCT01475838|3820134|FG001|Randomized Phase|Withdrew Consent|14
2190201|NCT01475838|3820133|FG000|Randomized Phase|Lost to Follow-up|3
2190202|NCT01475838|3820134|FG001|Randomized Phase|Lost to Follow-up|4
2190203|NCT01475838|3820133|FG000|Randomized Phase|Participant Noncompliance|1
2190204|NCT01475838|3820134|FG001|Randomized Phase|Participant Noncompliance|5
2190205|NCT01475838|3820133|FG000|Randomized Phase|Protocol Violation|9
2190206|NCT01475838|3820134|FG001|Randomized Phase|Protocol Violation|4
2190207|NCT01475838|3820133|FG000|Extension Phase|Participant Noncompliance|1
2190208|NCT01475838|3820134|FG001|Extension Phase|Participant Noncompliance|0
2190209|NCT01475851|3820143|FG000|Overall Study|Protocol defined stopping criteria|1
2190210|NCT01475851|3820144|FG001|Overall Study|Protocol defined stopping criteria|0
2190211|NCT01476475|3820228|FG000|Overall Study|Adverse Event|6
2190212|NCT01476475|3820229|FG001|Overall Study|Adverse Event|0
2190213|NCT01476475|3820228|FG000|Overall Study|Poor compliance to protocol|1
2190214|NCT01476475|3820229|FG001|Overall Study|Poor compliance to protocol|1
2190215|NCT01476475|3820228|FG000|Overall Study|Other reasons|4
2190216|NCT01476475|3820229|FG001|Overall Study|Other reasons|2
2190217|NCT01476644|3820236|FG000|Overall Study|Death|5
2190218|NCT01476644|3820236|FG000|Overall Study|moved to another state|2
2190219|NCT01476644|3820236|FG000|Overall Study|Lost to Follow-up|19
2190220|NCT01476644|3820236|FG000|Overall Study|Withdrawal by Subject|13
2190221|NCT01476696|3820241|FG000|Overall Study|Sponsor decision|2
2190222|NCT01476696|3820242|FG001|Overall Study|Sponsor decision|1
2190223|NCT01476696|3820243|FG002|Overall Study|Sponsor decision|0
2190224|NCT01476696|3820241|FG000|Overall Study|Withdrawal by Subject|1
2190225|NCT01476696|3820242|FG001|Overall Study|Withdrawal by Subject|0
2190226|NCT01476696|3820243|FG002|Overall Study|Withdrawal by Subject|0
2190227|NCT01476722|3820256|FG000|Overall Study|Adverse Event|1
2190228|NCT01477333|3820282|FG000|Overall Study|Adverse Event|1
2190229|NCT01477333|3820282|FG000|Overall Study|Withdrawal by Subject|1
2190230|NCT01477333|3820282|FG000|Overall Study|Clinical Deterioration|1
2190231|NCT01477749|3820356|FG000|Overall Study|Physician Decision|4
2190232|NCT01477853|3820380|FG000|Phase A|Adverse Event|1
2190233|NCT01477853|3820381|FG001|Phase A|Adverse Event|2
2190234|NCT01477853|3820382|FG002|Phase A|Adverse Event|2
2190235|NCT01477853|3820380|FG000|Phase A|Lost to Follow-up|4
2190236|NCT01477853|3820381|FG001|Phase A|Lost to Follow-up|3
2190237|NCT01477853|3820382|FG002|Phase A|Lost to Follow-up|2
2190238|NCT01477853|3820380|FG000|Phase A|Physician Decision|1
2190239|NCT01477853|3820381|FG001|Phase A|Physician Decision|0
2190240|NCT01477853|3820382|FG002|Phase A|Physician Decision|1
2190241|NCT01477853|3820380|FG000|Phase A|Study terminated by sponsor|37
2190242|NCT01477853|3820381|FG001|Phase A|Study terminated by sponsor|40
2190243|NCT01477853|3820382|FG002|Phase A|Study terminated by sponsor|39
2190244|NCT01477853|3820380|FG000|Phase B|Lost to Follow-up|0
2190245|NCT01477853|3820381|FG001|Phase B|Lost to Follow-up|1
2190246|NCT01477853|3820382|FG002|Phase B|Lost to Follow-up|0
2190247|NCT01477853|3820380|FG000|Phase B|Study terminated by sponsor|12
2190248|NCT01477853|3820381|FG001|Phase B|Study terminated by sponsor|10
2190249|NCT01477853|3820382|FG002|Phase B|Study terminated by sponsor|11
2190250|NCT01477892|3820392|FG000|Overall Study|Withdrawal by Subject|0
2190251|NCT01477892|3820393|FG001|Overall Study|Withdrawal by Subject|2
2190252|NCT01478048|3820410|FG000|Overall Study|Disease Progression|52
2190253|NCT01478048|3820411|FG001|Overall Study|Disease Progression|35
2190254|NCT01478048|3820410|FG000|Overall Study|study drug toxicity|11
2190255|NCT01478048|3820411|FG001|Overall Study|study drug toxicity|14
2190256|NCT01478048|3820410|FG000|Overall Study|Adverse Event|2
2190257|NCT01478048|3820411|FG001|Overall Study|Adverse Event|11
2190258|NCT01478048|3820410|FG000|Overall Study|subject request to discontinue treatment|3
2190259|NCT01478048|3820411|FG001|Overall Study|subject request to discontinue treatment|5
2190260|NCT01478048|3820410|FG000|Overall Study|Withdrawal by Subject|2
2190261|NCT01478048|3820411|FG001|Overall Study|Withdrawal by Subject|5
2190262|NCT01478048|3820410|FG000|Overall Study|non-specified|6
2190263|NCT01478048|3820411|FG001|Overall Study|non-specified|4
2190264|NCT01478048|3820410|FG000|Overall Study|poor/non-compliance|0
2190265|NCT01478048|3820411|FG001|Overall Study|poor/non-compliance|1
2190266|NCT01478048|3820410|FG000|Overall Study|no longer meets study criteria|1
2190267|NCT01478048|3820411|FG001|Overall Study|no longer meets study criteria|0
2190268|NCT01478087|3820417|FG000|Overall Study|due to sponsor closing study|1
2190269|NCT01478321|3820432|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4
2190270|NCT01478321|3820432|FG000|Concurrent Therapy (5 Weeks)|Death|2
2190271|NCT01478321|3820432|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
2190272|NCT01478321|3820432|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5
2190273|NCT01478321|3820432|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1
2190274|NCT01478321|3820432|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1
2190275|NCT01478321|3820432|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
2190276|NCT01478321|3820432|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
2190277|NCT01478347|3820436|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
2190278|NCT01478347|3820436|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
2190279|NCT01478347|3820436|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
2190280|NCT01478360|3820442|FG000|Overall Study|Lost to Follow-up|1
2190281|NCT01478360|3820443|FG001|Overall Study|Lost to Follow-up|0
2190282|NCT01478360|3820442|FG000|Overall Study|Adverse Event|0
2190283|NCT01478360|3820443|FG001|Overall Study|Adverse Event|1
2190284|NCT01478360|3820442|FG000|Overall Study|Administrative problems|1
2190285|NCT01478360|3820443|FG001|Overall Study|Administrative problems|2
2190286|NCT01478373|3820449|FG000|Treatment Phase|Protocol Violation|1
2190287|NCT01478373|3820449|FG000|Survival Phase|Adverse Event|8
2190288|NCT01478373|3820449|FG000|Survival Phase|Protocol Violation|1
2190289|NCT01478373|3820449|FG000|Survival Phase|crossover to another study|2
2190290|NCT01478373|3820449|FG000|Survival Phase|Progressive Disease|27
2190291|NCT01478594|3820476|FG000|Overall Study|Randomized but Never Received Study Drug|0
2190292|NCT01478594|3820477|FG001|Overall Study|Randomized but Never Received Study Drug|1
2190293|NCT01478594|3820476|FG000|Overall Study|Death|45
2190294|NCT01478594|3820477|FG001|Overall Study|Death|18
2190295|NCT01478594|3820476|FG000|Overall Study|Lost to Follow-up|3
2190296|NCT01478594|3820477|FG001|Overall Study|Lost to Follow-up|1
2190297|NCT01478594|3820476|FG000|Overall Study|Withdrawal by Subject|9
2190298|NCT01478594|3820477|FG001|Overall Study|Withdrawal by Subject|3
2190299|NCT01478594|3820476|FG000|Overall Study|Study Closed by Sponsor|8
2190300|NCT01478594|3820477|FG001|Overall Study|Study Closed by Sponsor|5
2190301|NCT01478620|3820536|FG000|Overall Study|Lost to Follow-up|6
2190302|NCT01478828|3820540|FG000|Overall Study|Adverse Event|1
2190303|NCT01478958|3820552|FG000|Overall Study|Withdrawal by Subject|1
2190304|NCT01478958|3820553|FG001|Overall Study|Withdrawal by Subject|1
2190305|NCT01478958|3820554|FG002|Overall Study|Withdrawal by Subject|1
2190306|NCT01478958|3820552|FG000|Overall Study|Weight loss|1
2190307|NCT01478958|3820553|FG001|Overall Study|Weight loss|0
2190308|NCT01478958|3820554|FG002|Overall Study|Weight loss|0
2190309|NCT01478958|3820552|FG000|Overall Study|Re-located|0
2190310|NCT01478958|3820553|FG001|Overall Study|Re-located|1
2190311|NCT01478958|3820554|FG002|Overall Study|Re-located|0
2190312|NCT01478958|3820552|FG000|Overall Study|Unable to comply|0
2190313|NCT01478958|3820553|FG001|Overall Study|Unable to comply|0
2190314|NCT01478958|3820554|FG002|Overall Study|Unable to comply|2
2190315|NCT01478971|3820562|FG000|Standard of Care Period|Adverse Event|1
2190316|NCT01478971|3820562|FG000|Standard of Care Period|Withdrawal by Subject|3
2190317|NCT01478971|3820562|FG000|Standard of Care Period|Death|8
2190318|NCT01478971|3820562|FG000|Standard of Care Period|Lost to Follow-up|9
2190319|NCT01478971|3820562|FG000|Standard of Care Period|Other|4
2190320|NCT01478971|3820562|FG000|Peginesatide Treatment Period|Adverse Event|1
2190321|NCT01478971|3820562|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1
2190322|NCT01478971|3820562|FG000|Peginesatide Treatment Period|Death|4
2190323|NCT01478971|3820562|FG000|Peginesatide Treatment Period|Lost to Follow-up|4
2190324|NCT01478971|3820562|FG000|Peginesatide Treatment Period|Other|4
2190325|NCT01479374|3820598|FG000|Overall Study|Adverse Event|2
2190326|NCT01479374|3820599|FG001|Overall Study|Adverse Event|1
2190327|NCT01479374|3820600|FG002|Overall Study|Adverse Event|0
2190328|NCT01479374|3820598|FG000|Overall Study|Lost to Follow-up|1
2190329|NCT01479374|3820599|FG001|Overall Study|Lost to Follow-up|2
2190330|NCT01479374|3820600|FG002|Overall Study|Lost to Follow-up|0
2190331|NCT01479374|3820598|FG000|Overall Study|Decision Unrelated to Adverse Event|0
2190332|NCT01479374|3820599|FG001|Overall Study|Decision Unrelated to Adverse Event|1
2190333|NCT01479374|3820600|FG002|Overall Study|Decision Unrelated to Adverse Event|0
2190334|NCT01479374|3820598|FG000|Overall Study|Other|0
2190335|NCT01479374|3820599|FG001|Overall Study|Other|4
2190336|NCT01479374|3820600|FG002|Overall Study|Other|5
2190337|NCT01479439|3820620|FG000|Overall Study|Adverse Event|1
2190338|NCT01479439|3820621|FG001|Overall Study|Adverse Event|0
2190339|NCT01479439|3820622|FG002|Overall Study|Adverse Event|0
2190340|NCT01479439|3820620|FG000|Overall Study|Lost to Follow-up|0
2190341|NCT01479439|3820621|FG001|Overall Study|Lost to Follow-up|1
2190342|NCT01479439|3820622|FG002|Overall Study|Lost to Follow-up|0
2190343|NCT01479439|3820620|FG000|Overall Study|Protocol Violation|0
2190344|NCT01479439|3820621|FG001|Overall Study|Protocol Violation|0
2190345|NCT01479439|3820622|FG002|Overall Study|Protocol Violation|2
2190346|NCT01479465|3820637|FG000|Overall Study|Disease Progression|9
2190347|NCT01479465|3820638|FG001|Overall Study|Disease Progression|61
2190348|NCT01479465|3820639|FG002|Overall Study|Disease Progression|65
2190349|NCT01479465|3820640|FG003|Overall Study|Disease Progression|70
2190350|NCT01479465|3820637|FG000|Overall Study|Study Discontinued by Sponsor|0
2190351|NCT01479465|3820638|FG001|Overall Study|Study Discontinued by Sponsor|7
2190352|NCT01479465|3820639|FG002|Overall Study|Study Discontinued by Sponsor|5
2190353|NCT01479465|3820640|FG003|Overall Study|Study Discontinued by Sponsor|3
2190354|NCT01479465|3820637|FG000|Overall Study|Adverse Event|0
2190355|NCT01479465|3820638|FG001|Overall Study|Adverse Event|3
2190356|NCT01479465|3820639|FG002|Overall Study|Adverse Event|6
2190357|NCT01479465|3820640|FG003|Overall Study|Adverse Event|4
2190358|NCT01479465|3820637|FG000|Overall Study|Investigator Discretion|1
2190359|NCT01479465|3820638|FG001|Overall Study|Investigator Discretion|4
2190360|NCT01479465|3820639|FG002|Overall Study|Investigator Discretion|2
2190361|NCT01479465|3820640|FG003|Overall Study|Investigator Discretion|4
2190362|NCT01479465|3820637|FG000|Overall Study|Subject Request|1
2190363|NCT01479465|3820638|FG001|Overall Study|Subject Request|3
2190364|NCT01479465|3820639|FG002|Overall Study|Subject Request|4
2190365|NCT01479465|3820640|FG003|Overall Study|Subject Request|2
2190366|NCT01479465|3820637|FG000|Overall Study|Subject Withdrew Consent|0
2190367|NCT01479465|3820638|FG001|Overall Study|Subject Withdrew Consent|5
2190368|NCT01479465|3820639|FG002|Overall Study|Subject Withdrew Consent|2
2190369|NCT01479465|3820640|FG003|Overall Study|Subject Withdrew Consent|1
2190370|NCT01479465|3820637|FG000|Overall Study|Protocol Violation|0
2190371|NCT01479465|3820638|FG001|Overall Study|Protocol Violation|1
2190372|NCT01479465|3820639|FG002|Overall Study|Protocol Violation|1
2190373|NCT01479465|3820640|FG003|Overall Study|Protocol Violation|0
2190374|NCT01479465|3820637|FG000|Overall Study|Death|0
2190375|NCT01479465|3820638|FG001|Overall Study|Death|0
2190376|NCT01479465|3820639|FG002|Overall Study|Death|0
2190377|NCT01479465|3820640|FG003|Overall Study|Death|1
2190378|NCT01479465|3820637|FG000|Overall Study|Lost to Follow-up|0
2190379|NCT01479465|3820638|FG001|Overall Study|Lost to Follow-up|0
2190380|NCT01479465|3820639|FG002|Overall Study|Lost to Follow-up|1
2223269|NCT01755767|3869510|FG003|Overall Study|Death|4
2223270|NCT01755767|3869507|FG000|Overall Study|Subject Decision|0
2223271|NCT01755767|3869508|FG001|Overall Study|Subject Decision|0
2223272|NCT01755767|3869509|FG002|Overall Study|Subject Decision|10
2223273|NCT01755767|3869510|FG003|Overall Study|Subject Decision|3
2223274|NCT01755767|3869507|FG000|Overall Study|Withdrawal by Subject|0
2223275|NCT01755767|3869508|FG001|Overall Study|Withdrawal by Subject|0
2223276|NCT01755767|3869509|FG002|Overall Study|Withdrawal by Subject|2
2223277|NCT01755767|3869510|FG003|Overall Study|Withdrawal by Subject|1
2223278|NCT01755767|3869507|FG000|Overall Study|Other|0
2223279|NCT01755767|3869508|FG001|Overall Study|Other|0
2223280|NCT01755767|3869509|FG002|Overall Study|Other|2
2223281|NCT01755767|3869510|FG003|Overall Study|Other|3
2223282|NCT01755767|3869507|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
2223283|NCT01755767|3869508|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
2223284|NCT01755767|3869509|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5
2223285|NCT01755767|3869510|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2
2223286|NCT01755858|3869522|FG000|Overall Study|Adverse Event|1
2223287|NCT01755858|3869523|FG001|Overall Study|Adverse Event|1
2223288|NCT01756053|3869556|FG000|Period 1 (10 Days)|Protocol Violation|1
2223289|NCT01756053|3869557|FG001|Period 1 (10 Days)|Protocol Violation|1
2223290|NCT01756053|3869556|FG000|Period 2 (10 Days)|Protocol Violation|0
2223291|NCT01756053|3869557|FG001|Period 2 (10 Days)|Protocol Violation|2
2274093|NCT02293499|3954969|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
2274094|NCT02293499|3954970|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
2274095|NCT02293499|3954971|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10
2274096|NCT02293499|3954969|FG000|Intervention - Camp|Withdrawal by Subject|3
2274097|NCT02293499|3954970|FG001|Intervention - Camp|Withdrawal by Subject|6
2274098|NCT02293499|3954971|FG002|Intervention - Camp|Withdrawal by Subject|2
2274099|NCT02293499|3954969|FG000|Intervention - Camp|these are those not showing up at camp|24
2274100|NCT02293499|3954970|FG001|Intervention - Camp|these are those not showing up at camp|28
2274101|NCT02293499|3954971|FG002|Intervention - Camp|these are those not showing up at camp|4
2274102|NCT02293499|3954969|FG000|3 Month Follow Up|Withdrawal by Subject|1
2274103|NCT02293499|3954970|FG001|3 Month Follow Up|Withdrawal by Subject|0
2190381|NCT01479465|3820640|FG003|Overall Study|Lost to Follow-up|0
2190382|NCT01479530|3820674|FG000|Overall Study|Adverse Event|5
2190383|NCT01479530|3820675|FG001|Overall Study|Adverse Event|6
2190384|NCT01479530|3820674|FG000|Overall Study|Lack of Efficacy|0
2190385|NCT01479530|3820675|FG001|Overall Study|Lack of Efficacy|1
2190386|NCT01479530|3820674|FG000|Overall Study|Protocol Violation|2
2190387|NCT01479530|3820675|FG001|Overall Study|Protocol Violation|3
2190388|NCT01479530|3820674|FG000|Overall Study|Withdrawal of Consent|3
2190389|NCT01479530|3820675|FG001|Overall Study|Withdrawal of Consent|2
2190390|NCT01479595|3820704|FG000|Overall Study|Protocol deviation|0
2190391|NCT01479595|3820705|FG001|Overall Study|Protocol deviation|1
2190392|NCT01479595|3820704|FG000|Overall Study|Adverse Event|2
2190393|NCT01479595|3820705|FG001|Overall Study|Adverse Event|1
2190394|NCT01479621|3820717|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
2190395|NCT01479621|3820718|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2190396|NCT01479621|3820719|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2190397|NCT01479621|3820720|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2190398|NCT01479621|3820721|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2190399|NCT01479621|3820722|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2190400|NCT01479621|3820723|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2190401|NCT01479621|3820717|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
2190402|NCT01479621|3820718|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2190403|NCT01479621|3820719|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2190404|NCT01479621|3820720|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2190405|NCT01479621|3820721|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2190406|NCT01479621|3820722|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2190407|NCT01479621|3820723|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2190408|NCT01479621|3820717|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
2190409|NCT01479621|3820718|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2190410|NCT01479621|3820719|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2190411|NCT01479621|3820720|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2190412|NCT01479621|3820721|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2190413|NCT01479621|3820722|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2190414|NCT01479621|3820723|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2190415|NCT01479621|3820717|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
2190416|NCT01479621|3820718|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2190417|NCT01479621|3820719|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2190418|NCT01479621|3820720|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2190419|NCT01479621|3820721|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2190420|NCT01479621|3820722|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2190421|NCT01479621|3820723|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2190422|NCT01479621|3820717|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
2190423|NCT01479621|3820718|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
2190424|NCT01479621|3820719|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
2190425|NCT01479621|3820720|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
2190426|NCT01479621|3820721|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
2190427|NCT01479621|3820722|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
2190428|NCT01479621|3820723|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
2190429|NCT01479621|3820717|FG000|Treatment Period|Adverse Event|0
2190430|NCT01479621|3820718|FG001|Treatment Period|Adverse Event|0
2190431|NCT01479621|3820719|FG002|Treatment Period|Adverse Event|0
2190432|NCT01479621|3820720|FG003|Treatment Period|Adverse Event|0
2190433|NCT01479621|3820721|FG004|Treatment Period|Adverse Event|1
2190434|NCT01479621|3820722|FG005|Treatment Period|Adverse Event|2
2190435|NCT01479621|3820723|FG006|Treatment Period|Adverse Event|2
2190436|NCT01479621|3820717|FG000|Treatment Period|Withdrawal by Subject|0
2190437|NCT01479621|3820718|FG001|Treatment Period|Withdrawal by Subject|4
2190438|NCT01479621|3820719|FG002|Treatment Period|Withdrawal by Subject|2
2190439|NCT01479621|3820720|FG003|Treatment Period|Withdrawal by Subject|2
2190440|NCT01479621|3820721|FG004|Treatment Period|Withdrawal by Subject|5
2190441|NCT01479621|3820722|FG005|Treatment Period|Withdrawal by Subject|5
2190442|NCT01479621|3820723|FG006|Treatment Period|Withdrawal by Subject|1
2190443|NCT01479621|3820717|FG000|Treatment Period|Physician Decision|0
2190444|NCT01479621|3820718|FG001|Treatment Period|Physician Decision|0
2190445|NCT01479621|3820719|FG002|Treatment Period|Physician Decision|0
2190446|NCT01479621|3820720|FG003|Treatment Period|Physician Decision|0
2190447|NCT01479621|3820721|FG004|Treatment Period|Physician Decision|1
2190448|NCT01479621|3820722|FG005|Treatment Period|Physician Decision|1
2190449|NCT01479621|3820723|FG006|Treatment Period|Physician Decision|0
2190450|NCT01479621|3820717|FG000|Treatment Period|Non-compliance to study drug|0
2190451|NCT01479621|3820718|FG001|Treatment Period|Non-compliance to study drug|1
2190452|NCT01479621|3820719|FG002|Treatment Period|Non-compliance to study drug|0
2190453|NCT01479621|3820720|FG003|Treatment Period|Non-compliance to study drug|0
2190454|NCT01479621|3820721|FG004|Treatment Period|Non-compliance to study drug|0
2190455|NCT01479621|3820722|FG005|Treatment Period|Non-compliance to study drug|0
2190456|NCT01479621|3820723|FG006|Treatment Period|Non-compliance to study drug|1
2190457|NCT01479621|3820717|FG000|Treatment Period|Protocol Violation|0
2190458|NCT01479621|3820718|FG001|Treatment Period|Protocol Violation|9
2190459|NCT01479621|3820719|FG002|Treatment Period|Protocol Violation|6
2190460|NCT01479621|3820720|FG003|Treatment Period|Protocol Violation|5
2190461|NCT01479621|3820721|FG004|Treatment Period|Protocol Violation|2
2190462|NCT01479621|3820722|FG005|Treatment Period|Protocol Violation|10
2190463|NCT01479621|3820723|FG006|Treatment Period|Protocol Violation|6
2190464|NCT01479621|3820717|FG000|Treatment Period|Pregnancy|0
2190465|NCT01479621|3820718|FG001|Treatment Period|Pregnancy|0
2190466|NCT01479621|3820719|FG002|Treatment Period|Pregnancy|2
2190467|NCT01479621|3820720|FG003|Treatment Period|Pregnancy|0
2190468|NCT01479621|3820721|FG004|Treatment Period|Pregnancy|0
2190469|NCT01479621|3820722|FG005|Treatment Period|Pregnancy|0
2190470|NCT01479621|3820723|FG006|Treatment Period|Pregnancy|0
2190471|NCT01479621|3820717|FG000|Treatment Period|Sponsor request subject to be withdrawn|0
2190472|NCT01479621|3820718|FG001|Treatment Period|Sponsor request subject to be withdrawn|2
2190473|NCT01479621|3820719|FG002|Treatment Period|Sponsor request subject to be withdrawn|3
2190474|NCT01479621|3820720|FG003|Treatment Period|Sponsor request subject to be withdrawn|1
2190475|NCT01479621|3820721|FG004|Treatment Period|Sponsor request subject to be withdrawn|1
2190476|NCT01479621|3820722|FG005|Treatment Period|Sponsor request subject to be withdrawn|1
2190477|NCT01479621|3820723|FG006|Treatment Period|Sponsor request subject to be withdrawn|3
2190478|NCT01479621|3820717|FG000|Treatment Period|Lost to Follow-up|0
2190479|NCT01479621|3820718|FG001|Treatment Period|Lost to Follow-up|0
2190480|NCT01479621|3820719|FG002|Treatment Period|Lost to Follow-up|1
2190481|NCT01479621|3820720|FG003|Treatment Period|Lost to Follow-up|0
2190482|NCT01479621|3820721|FG004|Treatment Period|Lost to Follow-up|2
2190483|NCT01479621|3820722|FG005|Treatment Period|Lost to Follow-up|2
2190484|NCT01479621|3820723|FG006|Treatment Period|Lost to Follow-up|1
2190485|NCT01479621|3820717|FG000|Treatment Period|Met stopping criteria|0
2190486|NCT01479621|3820718|FG001|Treatment Period|Met stopping criteria|8
2190487|NCT01479621|3820719|FG002|Treatment Period|Met stopping criteria|7
2190488|NCT01479621|3820720|FG003|Treatment Period|Met stopping criteria|4
2190489|NCT01479621|3820721|FG004|Treatment Period|Met stopping criteria|9
2190490|NCT01479621|3820722|FG005|Treatment Period|Met stopping criteria|20
2190491|NCT01479621|3820723|FG006|Treatment Period|Met stopping criteria|6
2190492|NCT01479764|3820748|FG000|Randomized|Adverse Event|1
2190493|NCT01479764|3820749|FG001|Randomized|Adverse Event|1
2190494|NCT01479764|3820748|FG000|Randomized|Withdrawal by Subject|1
2190495|NCT01479764|3820749|FG001|Randomized|Withdrawal by Subject|0
2190496|NCT01479764|3820748|FG000|Treated|Lost to Follow-up|0
2190497|NCT01479764|3820749|FG001|Treated|Lost to Follow-up|2
2190498|NCT01479777|3820755|FG000|Overall Study|Physician Decision|2
2190499|NCT01479868|3820759|FG000|Overall Study|Adverse Event|1
2190500|NCT01479868|3820759|FG000|Overall Study|Lost to Follow-up|4
2190501|NCT01479868|3820759|FG000|Overall Study|Protocol Violation|1
2190502|NCT01479868|3820759|FG000|Overall Study|Withdrawal by Subject|1
2190503|NCT01479868|3820759|FG000|Overall Study|Sponsor's Decision|1
2190504|NCT01479868|3820759|FG000|Overall Study|Initiation of new HCV Therapy|1
2190505|NCT01479985|3820765|FG000|Overall Study|Tablet malfunction, no data saved|1
2190506|NCT01479985|3820766|FG001|Overall Study|Tablet malfunction, no data saved|1
2190507|NCT01479985|3820765|FG000|Overall Study|No decisional conflict scale responses|0
2190508|NCT01479985|3820766|FG001|Overall Study|No decisional conflict scale responses|2
2190509|NCT01479985|3820765|FG000|Overall Study|No post-visit survey|5
2190510|NCT01479985|3820766|FG001|Overall Study|No post-visit survey|3
2190511|NCT01480076|3820774|FG000|Overall Study|Run-in Failure|52
2190512|NCT01480076|3820774|FG000|Overall Study|Adverse Event|39
2190513|NCT01480076|3820774|FG000|Overall Study|Death|2
2190514|NCT01480076|3820774|FG000|Overall Study|Disease Progression|5
2190515|NCT01480076|3820774|FG000|Overall Study|Non-compliance With Study Protocol|15
2190516|NCT01480076|3820774|FG000|Overall Study|Withdrawal by Subject|105
2190517|NCT01480076|3820774|FG000|Overall Study|Lost to Follow-up|7
2190518|NCT01480076|3820774|FG000|Overall Study|Investigator Decision|13
2190519|NCT01480076|3820774|FG000|Overall Study|Other|52
2190520|NCT01480258|3820827|FG000|Infant Series|Protocol Violation|2
2190521|NCT01480258|3820828|FG001|Infant Series|Protocol Violation|0
2190522|NCT01480258|3820827|FG000|Infant Series|Physician Decision|0
2190523|NCT01480258|3820828|FG001|Infant Series|Physician Decision|1
2190524|NCT01480258|3820827|FG000|Infant Series|Not Vaccinated|3
2190525|NCT01480258|3820828|FG001|Infant Series|Not Vaccinated|0
2190526|NCT01480258|3820827|FG000|Infant Series|Adverse Event|1
2190527|NCT01480258|3820828|FG001|Infant Series|Adverse Event|1
2190528|NCT01480258|3820827|FG000|Infant Series|Withdrawal by Subject|1
2190529|NCT01480258|3820828|FG001|Infant Series|Withdrawal by Subject|6
2190530|NCT01480258|3820827|FG000|Interim Period|Lost to Follow-up|0
2190531|NCT01480258|3820828|FG001|Interim Period|Lost to Follow-up|2
2190532|NCT01480258|3820827|FG000|Interim Period|Physician Decision|1
2190533|NCT01480258|3820828|FG001|Interim Period|Physician Decision|0
2190534|NCT01480258|3820827|FG000|Interim Period|Protocol Violation|0
2190535|NCT01480258|3820828|FG001|Interim Period|Protocol Violation|1
2190536|NCT01480258|3820827|FG000|Interim Period|Withdrawal by Subject|9
2190537|NCT01480258|3820828|FG001|Interim Period|Withdrawal by Subject|6
2190538|NCT01480284|3820836|FG000|Overall Study|Withdrawal by Subject|2
2190539|NCT01480284|3820837|FG001|Overall Study|Withdrawal by Subject|0
2190540|NCT01480284|3820836|FG000|Overall Study|Adverse Event|1
2190541|NCT01480284|3820837|FG001|Overall Study|Adverse Event|0
2190542|NCT01480284|3820836|FG000|Overall Study|Study closed/terminated|3
2190543|NCT01480284|3820837|FG001|Overall Study|Study closed/terminated|0
2190544|NCT01480284|3820836|FG000|Overall Study|Lost to Follow-up|1
2190545|NCT01480284|3820837|FG001|Overall Study|Lost to Follow-up|0
2190546|NCT01480284|3820836|FG000|Overall Study|Physician Decision|1
2190547|NCT01480284|3820837|FG001|Overall Study|Physician Decision|0
2190548|NCT01480596|3820849|FG000|Overall Study|Adverse Event|3
2190549|NCT01480596|3820850|FG001|Overall Study|Adverse Event|0
2190550|NCT01480596|3820849|FG000|Overall Study|MG exacerbation or change in medication|2
2190551|NCT01480596|3820850|FG001|Overall Study|MG exacerbation or change in medication|2
2190552|NCT01480674|3820856|FG000|Overall Study|Death|23
2190553|NCT01480674|3820856|FG000|Overall Study|Lost to Follow-up|2
2190554|NCT01480674|3820856|FG000|Overall Study|visit not done|10
2190555|NCT01481116|3820867|FG000|Overall Study|Adverse Event|26
2190556|NCT01481116|3820868|FG001|Overall Study|Adverse Event|26
2190557|NCT01481116|3820869|FG002|Overall Study|Adverse Event|42
2190558|NCT01481116|3820867|FG000|Overall Study|Major Protocol Deviation|3
2190559|NCT01481116|3820868|FG001|Overall Study|Major Protocol Deviation|7
2190560|NCT01481116|3820869|FG002|Overall Study|Major Protocol Deviation|1
2190561|NCT01481116|3820867|FG000|Overall Study|Lost to Follow-up|8
2190562|NCT01481116|3820868|FG001|Overall Study|Lost to Follow-up|12
2190563|NCT01481116|3820869|FG002|Overall Study|Lost to Follow-up|11
2190564|NCT01481116|3820867|FG000|Overall Study|Withdrawal by Subject|37
2190565|NCT01481116|3820868|FG001|Overall Study|Withdrawal by Subject|33
2190566|NCT01481116|3820869|FG002|Overall Study|Withdrawal by Subject|37
2223292|NCT01756079|3869563|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
2223293|NCT01756079|3869563|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
2223294|NCT01756079|3869563|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2
2223295|NCT01756079|3869563|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
2223296|NCT01756079|3869563|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
2223297|NCT01756157|3869568|FG000|First Intervention Period|Withdrawal by Subject|1
2223298|NCT01756157|3869569|FG001|First Intervention Period|Withdrawal by Subject|0
2223299|NCT01756157|3869568|FG000|First Intervention Period|Lost to Follow-up|0
2223300|NCT01756157|3869569|FG001|First Intervention Period|Lost to Follow-up|2
2223301|NCT01756235|3869592|FG000|Overall Study|Adalimumab Treatment was not Documented|2
2223302|NCT01756274|3869596|FG000|Overall Study|Protocol Violation|2
2223303|NCT01756274|3869596|FG000|Overall Study|Laboratory error|1
2223304|NCT01756300|3869601|FG000|Overall Study|Death|1
2223305|NCT01756300|3869601|FG000|Overall Study|Withdrawal by Subject|1
2223306|NCT01756352|3869622|FG000|Overall Study|moved away and lost to followup|1
2223307|NCT01756456|3869636|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0
2223308|NCT01756456|3869637|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0
2223309|NCT01756456|3869638|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0
2223310|NCT01756456|3869639|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1
2223311|NCT01756456|3869640|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1
2223312|NCT01756456|3869641|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1
2223313|NCT01756456|3869636|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0
2223314|NCT01756456|3869637|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0
2223315|NCT01756456|3869638|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0
2223316|NCT01756456|3869639|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2
2223317|NCT01756456|3869640|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1
2223318|NCT01756456|3869641|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0
2223319|NCT01756456|3869636|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0
2223320|NCT01756456|3869637|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1
2223321|NCT01756456|3869638|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0
2223322|NCT01756456|3869639|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0
2223323|NCT01756456|3869640|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0
2223324|NCT01756456|3869641|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0
2223325|NCT01756456|3869636|FG000|Treatment Period: Phase I/II|Adverse Event|1
2223326|NCT01756456|3869637|FG001|Treatment Period: Phase I/II|Adverse Event|0
2223327|NCT01756456|3869638|FG002|Treatment Period: Phase I/II|Adverse Event|2
2223328|NCT01756456|3869639|FG003|Treatment Period: Phase I/II|Adverse Event|3
2223329|NCT01756456|3869640|FG004|Treatment Period: Phase I/II|Adverse Event|9
2223330|NCT01756456|3869641|FG005|Treatment Period: Phase I/II|Adverse Event|1
2223331|NCT01756456|3869636|FG000|Treatment Period: Phase I/II|Other causes|0
2223332|NCT01756456|3869637|FG001|Treatment Period: Phase I/II|Other causes|0
2223333|NCT01756456|3869638|FG002|Treatment Period: Phase I/II|Other causes|0
2223334|NCT01756456|3869639|FG003|Treatment Period: Phase I/II|Other causes|1
2223335|NCT01756456|3869640|FG004|Treatment Period: Phase I/II|Other causes|2
2223336|NCT01756456|3869641|FG005|Treatment Period: Phase I/II|Other causes|2
2223337|NCT01756456|3869636|FG000|Follow Up Period Phase I/II|still in study after week 20|0
2223338|NCT01756456|3869637|FG001|Follow Up Period Phase I/II|still in study after week 20|0
2223339|NCT01756456|3869638|FG002|Follow Up Period Phase I/II|still in study after week 20|0
2223340|NCT01756456|3869639|FG003|Follow Up Period Phase I/II|still in study after week 20|25
2223341|NCT01756456|3869640|FG004|Follow Up Period Phase I/II|still in study after week 20|23
2223342|NCT01756456|3869641|FG005|Follow Up Period Phase I/II|still in study after week 20|25
2223343|NCT01756456|3869636|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2223344|NCT01756456|3869637|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
2223345|NCT01756456|3869638|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2223346|NCT01756456|3869639|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2190567|NCT01481116|3820867|FG000|Overall Study|Study Termination|730
2190568|NCT01481116|3820868|FG001|Overall Study|Study Termination|729
2190569|NCT01481116|3820869|FG002|Overall Study|Study Termination|713
2190570|NCT01481116|3820867|FG000|Overall Study|Pregnancy|0
2190571|NCT01481116|3820868|FG001|Overall Study|Pregnancy|0
2190572|NCT01481116|3820869|FG002|Overall Study|Pregnancy|1
2190573|NCT01481116|3820867|FG000|Overall Study|Lack of Efficacy|3
2190574|NCT01481116|3820868|FG001|Overall Study|Lack of Efficacy|3
2190575|NCT01481116|3820869|FG002|Overall Study|Lack of Efficacy|1
2190576|NCT01481116|3820867|FG000|Overall Study|Contraindications|1
2190577|NCT01481116|3820868|FG001|Overall Study|Contraindications|1
2190578|NCT01481116|3820869|FG002|Overall Study|Contraindications|0
2190579|NCT01481116|3820867|FG000|Overall Study|Other|1
2190580|NCT01481116|3820868|FG001|Overall Study|Other|1
2190581|NCT01481116|3820869|FG002|Overall Study|Other|0
2190582|NCT01481116|3820867|FG000|Overall Study|Participant Started Taking Glipizide|1
2190583|NCT01481116|3820868|FG001|Overall Study|Participant Started Taking Glipizide|0
2190584|NCT01481116|3820869|FG002|Overall Study|Participant Started Taking Glipizide|0
2190585|NCT01481116|3820867|FG000|Overall Study|Participant Moved Out of Area|2
2190586|NCT01481116|3820868|FG001|Overall Study|Participant Moved Out of Area|0
2190587|NCT01481116|3820869|FG002|Overall Study|Participant Moved Out of Area|1
2190588|NCT01481116|3820867|FG000|Overall Study|Participant Moved Out of Country|1
2190589|NCT01481116|3820868|FG001|Overall Study|Participant Moved Out of Country|0
2190590|NCT01481116|3820869|FG002|Overall Study|Participant Moved Out of Country|1
2190591|NCT01481116|3820867|FG000|Overall Study|Investigator Decision|3
2190592|NCT01481116|3820868|FG001|Overall Study|Investigator Decision|2
2190593|NCT01481116|3820869|FG002|Overall Study|Investigator Decision|1
2190594|NCT01481116|3820867|FG000|Overall Study|Sponsor Decision|0
2190595|NCT01481116|3820868|FG001|Overall Study|Sponsor Decision|1
2190596|NCT01481116|3820869|FG002|Overall Study|Sponsor Decision|3
2190597|NCT01481116|3820867|FG000|Overall Study|Non-Compliant With Study Drug|0
2190598|NCT01481116|3820868|FG001|Overall Study|Non-Compliant With Study Drug|1
2190599|NCT01481116|3820869|FG002|Overall Study|Non-Compliant With Study Drug|1
2190600|NCT01481116|3820867|FG000|Overall Study|Investigator's Discretion|2
2190601|NCT01481116|3820868|FG001|Overall Study|Investigator's Discretion|0
2190602|NCT01481116|3820869|FG002|Overall Study|Investigator's Discretion|0
2190603|NCT01481116|3820867|FG000|Overall Study|Death|2
2190604|NCT01481116|3820868|FG001|Overall Study|Death|1
2190605|NCT01481116|3820869|FG002|Overall Study|Death|0
2190606|NCT01481116|3820867|FG000|Overall Study|Hypoglycemic Event|4
2190607|NCT01481116|3820868|FG001|Overall Study|Hypoglycemic Event|0
2190608|NCT01481116|3820869|FG002|Overall Study|Hypoglycemic Event|0
2190609|NCT01481324|3820884|FG000|Overall Study|Missing Data|0
2190610|NCT01481324|3820885|FG001|Overall Study|Missing Data|2
2190611|NCT01481324|3820886|FG002|Overall Study|Missing Data|2
2190612|NCT01481779|3820929|FG000|Overall Study|Adverse Event|23
2190613|NCT01481779|3820930|FG001|Overall Study|Adverse Event|5
2190614|NCT01481779|3820929|FG000|Overall Study|Lost to Follow-up|3
2190615|NCT01481779|3820930|FG001|Overall Study|Lost to Follow-up|2
2190616|NCT01481779|3820929|FG000|Overall Study|Protocol Violation|2
2190617|NCT01481779|3820930|FG001|Overall Study|Protocol Violation|3
2190618|NCT01481779|3820929|FG000|Overall Study|Withdrawal by Subject|26
2190619|NCT01481779|3820930|FG001|Overall Study|Withdrawal by Subject|13
2190620|NCT01481779|3820929|FG000|Overall Study|Physician Decision|13
2190621|NCT01481779|3820930|FG001|Overall Study|Physician Decision|4
2190622|NCT01481779|3820929|FG000|Overall Study|Sponsor Decision|3
2190623|NCT01481779|3820930|FG001|Overall Study|Sponsor Decision|1
2190624|NCT01481896|3820936|FG000|Overall Study|Lost to Follow-up|12
2190625|NCT01482065|3820952|FG000|Overall Study|Withdrawal by Subject|0
2190626|NCT01482065|3820953|FG001|Overall Study|Withdrawal by Subject|1
2190627|NCT01482169|3820968|FG000|Overall Study|Physician Decision|2
2190628|NCT01482221|3820978|FG000|Overall Study|Lack of Efficacy|1
2190629|NCT01482221|3820979|FG001|Overall Study|Lack of Efficacy|0
2190630|NCT01482221|3820980|FG002|Overall Study|Lack of Efficacy|1
2190631|NCT01482221|3820978|FG000|Overall Study|Lost to Follow-up|3
2190632|NCT01482221|3820979|FG001|Overall Study|Lost to Follow-up|2
2190633|NCT01482221|3820980|FG002|Overall Study|Lost to Follow-up|1
2190634|NCT01482221|3820978|FG000|Overall Study|Study-Specific Withdrawal Criteria|2
2190635|NCT01482221|3820979|FG001|Overall Study|Study-Specific Withdrawal Criteria|0
2190636|NCT01482221|3820980|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
2190637|NCT01482221|3820978|FG000|Overall Study|Condition under Investigation Worsened|3
2190638|NCT01482221|3820979|FG001|Overall Study|Condition under Investigation Worsened|2
2190639|NCT01482221|3820980|FG002|Overall Study|Condition under Investigation Worsened|4
2190640|NCT01482221|3820978|FG000|Overall Study|Severe Non-Compliance to Protocol|1
2190641|NCT01482221|3820979|FG001|Overall Study|Severe Non-Compliance to Protocol|0
2190642|NCT01482221|3820980|FG002|Overall Study|Severe Non-Compliance to Protocol|1
2190643|NCT01482221|3820978|FG000|Overall Study|Adverse Event|1
2190644|NCT01482221|3820979|FG001|Overall Study|Adverse Event|7
2190645|NCT01482221|3820980|FG002|Overall Study|Adverse Event|3
2190646|NCT01482221|3820978|FG000|Overall Study|Withdrawal by Subject|10
2190647|NCT01482221|3820979|FG001|Overall Study|Withdrawal by Subject|7
2190648|NCT01482221|3820980|FG002|Overall Study|Withdrawal by Subject|12
2190649|NCT01482221|3820978|FG000|Overall Study|Incorrect randomization|0
2190650|NCT01482221|3820979|FG001|Overall Study|Incorrect randomization|1
2190651|NCT01482221|3820980|FG002|Overall Study|Incorrect randomization|0
2190652|NCT01482221|3820978|FG000|Overall Study|Physician Decision|0
2190653|NCT01482221|3820979|FG001|Overall Study|Physician Decision|1
2190654|NCT01482221|3820980|FG002|Overall Study|Physician Decision|0
2190655|NCT01482312|3820988|FG000|Period 1, 90 Minutes of Wear|Other|1
2190656|NCT01482312|3820989|FG001|Period 1, 90 Minutes of Wear|Other|0
2190657|NCT01482312|3820990|FG002|Period 1, 90 Minutes of Wear|Other|0
2190658|NCT01482312|3820988|FG000|Period 2, 90 Minutes of Wear|Other|1
2190659|NCT01482312|3820989|FG001|Period 2, 90 Minutes of Wear|Other|0
2190660|NCT01482312|3820990|FG002|Period 2, 90 Minutes of Wear|Other|0
2190661|NCT01482429|3821010|FG000|Care Usual|Protocol Violation|0
2190662|NCT01482429|3821011|FG001|Care Usual|Protocol Violation|172
2190663|NCT01482429|3821010|FG000|Care Usual|Lost to Follow-up|0
2190664|NCT01482429|3821011|FG001|Care Usual|Lost to Follow-up|1
2190665|NCT01482429|3821010|FG000|Protocol|Protocol Violation|275
2190666|NCT01482429|3821011|FG001|Protocol|Protocol Violation|0
2190667|NCT01482767|3821085|FG000|Overall Study|Death|1
2190668|NCT01482767|3821086|FG001|Overall Study|Death|1
2190669|NCT01482767|3821085|FG000|Overall Study|Withdrawal by Subject|7
2190670|NCT01482767|3821086|FG001|Overall Study|Withdrawal by Subject|5
2190671|NCT01482767|3821085|FG000|Overall Study|Lost to Follow-up|12
2190672|NCT01482767|3821086|FG001|Overall Study|Lost to Follow-up|6
2190673|NCT01482767|3821085|FG000|Overall Study|Adverse Event|0
2190674|NCT01482767|3821086|FG001|Overall Study|Adverse Event|3
2223347|NCT01756456|3869640|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2223348|NCT01756456|3869641|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2223349|NCT01756456|3869636|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0
2223350|NCT01756456|3869637|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0
2223351|NCT01756456|3869638|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0
2223352|NCT01756456|3869639|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0
2223353|NCT01756456|3869640|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0
2223354|NCT01756456|3869641|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1
2223355|NCT01756456|3869636|FG000|Follow Up Period Phase I/II|Adverse Event|1
2223356|NCT01756456|3869637|FG001|Follow Up Period Phase I/II|Adverse Event|0
2223357|NCT01756456|3869638|FG002|Follow Up Period Phase I/II|Adverse Event|0
2223358|NCT01756456|3869639|FG003|Follow Up Period Phase I/II|Adverse Event|5
2223359|NCT01756456|3869640|FG004|Follow Up Period Phase I/II|Adverse Event|0
2223360|NCT01756456|3869641|FG005|Follow Up Period Phase I/II|Adverse Event|1
2223361|NCT01756456|3869636|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0
2223362|NCT01756456|3869637|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0
2223363|NCT01756456|3869638|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1
2223364|NCT01756456|3869639|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2
2223365|NCT01756456|3869640|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0
2223366|NCT01756456|3869641|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1
2223367|NCT01756456|3869636|FG000|Follow Up Period Phase I/II|Other causes|0
2223368|NCT01756456|3869637|FG001|Follow Up Period Phase I/II|Other causes|0
2223369|NCT01756456|3869638|FG002|Follow Up Period Phase I/II|Other causes|0
2223370|NCT01756456|3869639|FG003|Follow Up Period Phase I/II|Other causes|1
2223371|NCT01756456|3869640|FG004|Follow Up Period Phase I/II|Other causes|3
2223372|NCT01756456|3869641|FG005|Follow Up Period Phase I/II|Other causes|5
2223373|NCT01756833|3869666|FG000|Overall Study|Withdrawal by Subject|4
2223374|NCT01756833|3869667|FG001|Overall Study|Withdrawal by Subject|3
2223375|NCT01756846|3869675|FG000|Overall Study|Lost to Follow-up|5
2223376|NCT01756846|3869676|FG001|Overall Study|Lost to Follow-up|10
2223377|NCT01756846|3869675|FG000|Overall Study|Withdrawal by Subject|1
2223378|NCT01756846|3869676|FG001|Overall Study|Withdrawal by Subject|2
2223379|NCT01756898|3869695|FG000|Overall Study|Adverse Event|7
2223380|NCT01756898|3869696|FG001|Overall Study|Adverse Event|1
2223381|NCT01756898|3869697|FG002|Overall Study|Adverse Event|0
2223382|NCT01756898|3869698|FG003|Overall Study|Adverse Event|0
2223383|NCT01756898|3869695|FG000|Overall Study|Lack of Efficacy|4
2223384|NCT01756898|3869696|FG001|Overall Study|Lack of Efficacy|7
2223385|NCT01756898|3869697|FG002|Overall Study|Lack of Efficacy|6
2223386|NCT01756898|3869698|FG003|Overall Study|Lack of Efficacy|6
2223387|NCT01756898|3869695|FG000|Overall Study|Lost to Follow-up|2
2223388|NCT01756898|3869696|FG001|Overall Study|Lost to Follow-up|4
2223389|NCT01756898|3869697|FG002|Overall Study|Lost to Follow-up|2
2223390|NCT01756898|3869698|FG003|Overall Study|Lost to Follow-up|3
2223391|NCT01756898|3869695|FG000|Overall Study|Protocol Violation|1
2223392|NCT01756898|3869696|FG001|Overall Study|Protocol Violation|2
2223393|NCT01756898|3869697|FG002|Overall Study|Protocol Violation|2
2223394|NCT01756898|3869698|FG003|Overall Study|Protocol Violation|1
2223395|NCT01756898|3869695|FG000|Overall Study|Withdrew Consent|5
2223396|NCT01756898|3869696|FG001|Overall Study|Withdrew Consent|3
2223397|NCT01756898|3869697|FG002|Overall Study|Withdrew Consent|5
2223398|NCT01756898|3869698|FG003|Overall Study|Withdrew Consent|6
2223399|NCT01756898|3869695|FG000|Overall Study|Other|0
2223400|NCT01756898|3869696|FG001|Overall Study|Other|2
2223401|NCT01756898|3869697|FG002|Overall Study|Other|2
2223402|NCT01756898|3869698|FG003|Overall Study|Other|0
2190675|NCT01482767|3821085|FG000|Overall Study|Site closure|22
2190676|NCT01482767|3821086|FG001|Overall Study|Site closure|14
2190677|NCT01482767|3821085|FG000|Overall Study|Non-adherence to study requirements|4
2190678|NCT01482767|3821086|FG001|Overall Study|Non-adherence to study requirements|7
2190679|NCT01482767|3821085|FG000|Overall Study|Alternate HCV treatment|7
2190680|NCT01482767|3821086|FG001|Overall Study|Alternate HCV treatment|8
2190681|NCT01482767|3821085|FG000|Overall Study|Ineligible|0
2190682|NCT01482767|3821086|FG001|Overall Study|Ineligible|5
2190683|NCT01482767|3821085|FG000|Overall Study|Nurse error|1
2190684|NCT01482767|3821086|FG001|Overall Study|Nurse error|0
2190685|NCT01482819|3821092|FG000|Overall Study|Lost to Follow-up|2
2190686|NCT01482884|3821102|FG000|Overall Study|Medical decision due to lack of efficacy|0
2190687|NCT01482884|3821103|FG001|Overall Study|Medical decision due to lack of efficacy|1
2190688|NCT01482884|3821102|FG000|Overall Study|Protocol Violation|1
2190689|NCT01482884|3821103|FG001|Overall Study|Protocol Violation|0
2190690|NCT01482884|3821102|FG000|Overall Study|Lost to Follow-up|2
2190691|NCT01482884|3821103|FG001|Overall Study|Lost to Follow-up|2
2190692|NCT01482884|3821102|FG000|Overall Study|Lack of Efficacy|0
2190693|NCT01482884|3821103|FG001|Overall Study|Lack of Efficacy|1
2190694|NCT01482884|3821102|FG000|Overall Study|Adverse Event|2
2190695|NCT01482884|3821103|FG001|Overall Study|Adverse Event|1
2190696|NCT01482884|3821102|FG000|Overall Study|Withdrawal by Subject|8
2190697|NCT01482884|3821103|FG001|Overall Study|Withdrawal by Subject|13
2190698|NCT01482910|3821111|FG000|Overall Study|Adverse Event|6
2190699|NCT01482910|3821112|FG001|Overall Study|Adverse Event|5
2190700|NCT01482910|3821111|FG000|Overall Study|Lost to Follow-up|0
2190701|NCT01482910|3821112|FG001|Overall Study|Lost to Follow-up|1
2190702|NCT01482910|3821111|FG000|Overall Study|Protocol Violation|1
2190703|NCT01482910|3821112|FG001|Overall Study|Protocol Violation|1
2190704|NCT01482910|3821111|FG000|Overall Study|Withdrawal by Subject|7
2190705|NCT01482910|3821112|FG001|Overall Study|Withdrawal by Subject|2
2190706|NCT01482910|3821111|FG000|Overall Study|Death|1
2190707|NCT01482910|3821112|FG001|Overall Study|Death|0
2190708|NCT01482962|3821122|FG000|Overall Study|Progressive Disease|65
2190709|NCT01482962|3821123|FG001|Overall Study|Progressive Disease|53
2190710|NCT01482962|3821122|FG000|Overall Study|Unsatisfactory Therapeutic Response|37
2190711|NCT01482962|3821123|FG001|Overall Study|Unsatisfactory Therapeutic Response|23
2190712|NCT01482962|3821122|FG000|Overall Study|Adverse Event|18
2190713|NCT01482962|3821123|FG001|Overall Study|Adverse Event|22
2190714|NCT01482962|3821122|FG000|Overall Study|Withdrawal by Participant|8
2190715|NCT01482962|3821123|FG001|Overall Study|Withdrawal by Participant|13
2190716|NCT01482962|3821122|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3
2190717|NCT01482962|3821123|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9
2190718|NCT01482962|3821122|FG000|Overall Study|Other Reason|1
2190719|NCT01482962|3821123|FG001|Overall Study|Other Reason|5
2190720|NCT01482962|3821122|FG000|Overall Study|Study Terminated by Sponsor|5
2190721|NCT01482962|3821123|FG001|Overall Study|Study Terminated by Sponsor|2
2190722|NCT01482962|3821122|FG000|Overall Study|Did not Receive Study Drug|1
2190723|NCT01482962|3821123|FG001|Overall Study|Did not Receive Study Drug|6
2190724|NCT01483118|3821133|FG000|Overall Study|Lost to Follow-up|12
2190725|NCT01483118|3821134|FG001|Overall Study|Lost to Follow-up|16
2190726|NCT01483144|3821145|FG000|Overall Study|Adverse Event|9
2190727|NCT01483144|3821146|FG001|Overall Study|Adverse Event|4
2190728|NCT01483144|3821147|FG002|Overall Study|Adverse Event|6
2190729|NCT01483144|3821145|FG000|Overall Study|Withdrawal by Subject|0
2190730|NCT01483144|3821146|FG001|Overall Study|Withdrawal by Subject|2
2190731|NCT01483144|3821147|FG002|Overall Study|Withdrawal by Subject|5
2190732|NCT01483144|3821145|FG000|Overall Study|Physician Decision|1
2190733|NCT01483144|3821146|FG001|Overall Study|Physician Decision|0
2190734|NCT01483144|3821147|FG002|Overall Study|Physician Decision|0
2223403|NCT01757171|3869731|FG000|Overall Study|Adverse Event|5
2223404|NCT01757171|3869732|FG001|Overall Study|Adverse Event|1
2223405|NCT01757171|3869731|FG000|Overall Study|Disease Progression|1
2223406|NCT01757171|3869732|FG001|Overall Study|Disease Progression|0
2223407|NCT01757171|3869731|FG000|Overall Study|Hospitalization|1
2223408|NCT01757171|3869732|FG001|Overall Study|Hospitalization|0
2223409|NCT01757171|3869731|FG000|Overall Study|ECOG decline|1
2223410|NCT01757171|3869732|FG001|Overall Study|ECOG decline|0
2223411|NCT01757184|3869740|FG000|Double-blind Period|Adverse Event|1
2223412|NCT01757184|3869741|FG001|Double-blind Period|Adverse Event|0
2223413|NCT01757184|3869742|FG002|Double-blind Period|Adverse Event|0
2223414|NCT01757184|3869743|FG003|Double-blind Period|Adverse Event|0
2223415|NCT01757184|3869740|FG000|Open-label Period|Lost to Follow-up|0
2223416|NCT01757184|3869741|FG001|Open-label Period|Lost to Follow-up|0
2223417|NCT01757184|3869742|FG002|Open-label Period|Lost to Follow-up|2
2223418|NCT01757184|3869743|FG003|Open-label Period|Lost to Follow-up|0
2223419|NCT01757184|3869740|FG000|Open-label Period|Withdrawal by Subject|0
2223420|NCT01757184|3869741|FG001|Open-label Period|Withdrawal by Subject|0
2223421|NCT01757184|3869742|FG002|Open-label Period|Withdrawal by Subject|1
2223422|NCT01757184|3869743|FG003|Open-label Period|Withdrawal by Subject|1
2223423|NCT01757184|3869740|FG000|Open-label Period|Discontinued by Sponsor|0
2223424|NCT01757184|3869741|FG001|Open-label Period|Discontinued by Sponsor|0
2223425|NCT01757184|3869742|FG002|Open-label Period|Discontinued by Sponsor|1
2332249|NCT03189524|4055542|FG002|Overall Study|Progressive Disease|0
2332250|NCT03189745|4055565|FG000|Overall Study|Conflict in work schedule of participant|1
2190735|NCT01483144|3821145|FG000|Overall Study|Lost to Follow-up|2
2190736|NCT01483144|3821146|FG001|Overall Study|Lost to Follow-up|4
2190737|NCT01483144|3821147|FG002|Overall Study|Lost to Follow-up|1
2190738|NCT01483144|3821145|FG000|Overall Study|Protocol Violation|3
2190739|NCT01483144|3821146|FG001|Overall Study|Protocol Violation|3
2190740|NCT01483144|3821147|FG002|Overall Study|Protocol Violation|3
2223426|NCT01757184|3869743|FG003|Open-label Period|Discontinued by Sponsor|2
2223427|NCT01757197|3869757|FG000|Overall Study|Death|2
2223428|NCT01757275|3869763|FG000|Overall Study|Lost to Follow-up|1
2223429|NCT01757275|3869764|FG001|Overall Study|Lost to Follow-up|2
2223430|NCT01757275|3869763|FG000|Overall Study|Adverse Event|3
2223431|NCT01757275|3869764|FG001|Overall Study|Adverse Event|3
2223432|NCT01757275|3869763|FG000|Overall Study|Withdrawal by Subject|2
2223433|NCT01757275|3869764|FG001|Overall Study|Withdrawal by Subject|4
2223434|NCT01757275|3869763|FG000|Overall Study|Not treated|3
2223435|NCT01757275|3869764|FG001|Overall Study|Not treated|4
2223436|NCT01757288|3869773|FG000|Overall Study|Consent withdrawal|0
2223437|NCT01757288|3869774|FG001|Overall Study|Consent withdrawal|4
2223438|NCT01757288|3869775|FG002|Overall Study|Consent withdrawal|4
2223439|NCT01757288|3869773|FG000|Overall Study|Patient off study, IRB hold.|0
2223440|NCT01757288|3869774|FG001|Overall Study|Patient off study, IRB hold.|0
2223441|NCT01757288|3869775|FG002|Overall Study|Patient off study, IRB hold.|1
2223442|NCT01757288|3869773|FG000|Overall Study|Patient death prior to starting treatment|0
2223443|NCT01757288|3869774|FG001|Overall Study|Patient death prior to starting treatment|0
2223444|NCT01757288|3869775|FG002|Overall Study|Patient death prior to starting treatment|1
2223445|NCT01757288|3869773|FG000|Overall Study|Wrong medication administered|0
2223446|NCT01757288|3869774|FG001|Overall Study|Wrong medication administered|1
2223447|NCT01757288|3869775|FG002|Overall Study|Wrong medication administered|0
2223448|NCT01757288|3869773|FG000|Overall Study|Liver metastasis identified at CT simulation|0
2223449|NCT01757288|3869774|FG001|Overall Study|Liver metastasis identified at CT simulation|1
2223450|NCT01757288|3869775|FG002|Overall Study|Liver metastasis identified at CT simulation|0
2223451|NCT01757288|3869773|FG000|Overall Study|Not meeting protocol constraints|0
2223452|NCT01757288|3869774|FG001|Overall Study|Not meeting protocol constraints|1
2223453|NCT01757288|3869775|FG002|Overall Study|Not meeting protocol constraints|1
2223454|NCT01757288|3869773|FG000|Overall Study|Multiple missed appointments|0
2223455|NCT01757288|3869774|FG001|Overall Study|Multiple missed appointments|1
2223456|NCT01757288|3869775|FG002|Overall Study|Multiple missed appointments|0
2223457|NCT01757288|3869773|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
2223458|NCT01757288|3869774|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
2223459|NCT01757288|3869775|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1
2223460|NCT01757288|3869773|FG000|Overall Study|>2 weeks treatment break|0
2223461|NCT01757288|3869774|FG001|Overall Study|>2 weeks treatment break|0
2223462|NCT01757288|3869775|FG002|Overall Study|>2 weeks treatment break|1
2223463|NCT01757392|3869795|FG000|Overall Study|Withdrawal by Subject|1
2223464|NCT01757392|3869795|FG000|Overall Study|Screen Fail|3
2223465|NCT01757405|3869801|FG000|Overall Study|Lost to Follow-up|1
2223466|NCT01757405|3869802|FG001|Overall Study|Lost to Follow-up|1
2223467|NCT01757405|3869801|FG000|Overall Study|Withdrawal by Subject|0
2223468|NCT01757405|3869802|FG001|Overall Study|Withdrawal by Subject|1
2223469|NCT01757691|3869833|FG000|Overall Study|Administrative problems|2
2223470|NCT01757691|3869834|FG001|Overall Study|Administrative problems|0
2223471|NCT01757704|3869842|FG000|Overall Study|Protocol Violation|1
2223472|NCT01757704|3869843|FG001|Overall Study|Protocol Violation|3
2223473|NCT01757821|3869853|FG000|Overall Study|Adverse Event|1
2223474|NCT01757847|3869863|FG000|Overall Study|Withdrawal by Subject|3
2223475|NCT01757847|3869864|FG001|Overall Study|Withdrawal by Subject|4
2223476|NCT01758289|3869877|FG000|Overall Study|Premature Study Termination|44
2223477|NCT01758289|3869877|FG000|Overall Study|Adverse Event|9
2223478|NCT01758523|3869916|FG000|Overall Study|Adverse Event|2
2223479|NCT01758523|3869917|FG001|Overall Study|Adverse Event|1
2223480|NCT01758523|3869916|FG000|Overall Study|Lack of Efficacy|4
2223481|NCT01758523|3869917|FG001|Overall Study|Lack of Efficacy|2
2223482|NCT01758523|3869916|FG000|Overall Study|Lost to Follow-up|3
2223483|NCT01758523|3869917|FG001|Overall Study|Lost to Follow-up|4
2223484|NCT01758523|3869916|FG000|Overall Study|Withdrawal by Subject|12
2223485|NCT01758523|3869917|FG001|Overall Study|Withdrawal by Subject|7
2223486|NCT01758731|3869938|FG000|Overall Study|Physician Decision|1
2223487|NCT01758900|3869944|FG000|Overall Study|difficulty for further intubation|7
2223488|NCT01758900|3869945|FG001|Overall Study|difficulty for further intubation|8
2223489|NCT01759264|3869964|FG000|Overall Study|Serious Adverse Events (SAEs)|1
2223490|NCT01759264|3869964|FG000|Overall Study|Adverse Event|1
2223491|NCT01759264|3869964|FG000|Overall Study|Other|2
2223492|NCT01759264|3869964|FG000|Overall Study|Lost to Follow-up|2
2223493|NCT01759264|3869964|FG000|Overall Study|Withdrawal by Subject|3
2223494|NCT01759264|3869964|FG000|Overall Study|Discontinued Humira Due to Business Trip|1
2223495|NCT01759290|3869980|FG000|Overall Study|Subjects withdrawn consent|5
2223496|NCT01759290|3869980|FG000|Overall Study|Physician Decision|2
2223497|NCT01759290|3869980|FG000|Overall Study|Death|17
2223498|NCT01759290|3869980|FG000|Overall Study|Lost to Follow-up|53
2223499|NCT01759290|3869980|FG000|Overall Study|Unknown reason|4
2223500|NCT01759368|3869986|FG000|Overall Study|Lost to Follow-up|1
2223501|NCT01759368|3869987|FG001|Overall Study|Lost to Follow-up|0
2190741|NCT01483183|3821165|FG000|Overall Study|Physician Decision|0
2190742|NCT01483183|3821166|FG001|Overall Study|Physician Decision|0
2190743|NCT01483183|3821167|FG002|Overall Study|Physician Decision|0
2190744|NCT01483183|3821168|FG003|Overall Study|Physician Decision|0
2190745|NCT01483183|3821169|FG004|Overall Study|Physician Decision|0
2190746|NCT01483183|3821170|FG005|Overall Study|Physician Decision|0
2190747|NCT01483183|3821171|FG006|Overall Study|Physician Decision|2
2190748|NCT01483183|3821172|FG007|Overall Study|Physician Decision|0
2190749|NCT01483183|3821173|FG008|Overall Study|Physician Decision|0
2190750|NCT01483183|3821174|FG009|Overall Study|Physician Decision|0
2190751|NCT01483183|3821165|FG000|Overall Study|Withdrawal by Subject|0
2190752|NCT01483183|3821166|FG001|Overall Study|Withdrawal by Subject|0
2190753|NCT01483183|3821167|FG002|Overall Study|Withdrawal by Subject|0
2190754|NCT01483183|3821168|FG003|Overall Study|Withdrawal by Subject|0
2190755|NCT01483183|3821169|FG004|Overall Study|Withdrawal by Subject|0
2190756|NCT01483183|3821170|FG005|Overall Study|Withdrawal by Subject|0
2190757|NCT01483183|3821171|FG006|Overall Study|Withdrawal by Subject|0
2190758|NCT01483183|3821172|FG007|Overall Study|Withdrawal by Subject|0
2190759|NCT01483183|3821173|FG008|Overall Study|Withdrawal by Subject|0
2190760|NCT01483183|3821174|FG009|Overall Study|Withdrawal by Subject|1
2190761|NCT01483599|3821229|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2
2190762|NCT01483599|3821230|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2190763|NCT01483599|3821231|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2190764|NCT01483599|3821232|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1
2190765|NCT01483599|3821233|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1
2190766|NCT01483599|3821234|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4
2190767|NCT01483599|3821235|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3
2190768|NCT01483599|3821236|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2190769|NCT01483599|3821237|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2190770|NCT01483599|3821238|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2190771|NCT01483599|3821239|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2190772|NCT01483599|3821240|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2223502|NCT01759381|3869997|FG000|Overall Study|Death|1
2223503|NCT01759381|3869998|FG001|Overall Study|Death|0
2223504|NCT01759407|3870006|FG000|Overall Study|Protocol Violation|0
2223505|NCT01759407|3870007|FG001|Overall Study|Protocol Violation|2
2223506|NCT01759420|3870013|FG000|Overall Study|Screen failure|5
2223507|NCT01759420|3870013|FG000|Overall Study|Inaccurate EKG machine readings|1
2223508|NCT01759446|3870022|FG000|Overall Study|Protocol Violation|1
2223509|NCT01759446|3870023|FG001|Overall Study|Protocol Violation|0
2223510|NCT01759446|3870024|FG002|Overall Study|Protocol Violation|1
2223511|NCT01759446|3870025|FG003|Overall Study|Protocol Violation|0
2223512|NCT01759446|3870026|FG004|Overall Study|Protocol Violation|0
2223513|NCT01759446|3870022|FG000|Overall Study|Withdrawal by Subject|0
2223514|NCT01759446|3870023|FG001|Overall Study|Withdrawal by Subject|1
2223515|NCT01759446|3870024|FG002|Overall Study|Withdrawal by Subject|0
2223516|NCT01759446|3870025|FG003|Overall Study|Withdrawal by Subject|1
2223517|NCT01759446|3870026|FG004|Overall Study|Withdrawal by Subject|0
2223518|NCT01759511|3870038|FG000|Overall Study|Adverse Event|4
2223519|NCT01759511|3870038|FG000|Overall Study|Death|2
2223520|NCT01759511|3870038|FG000|Overall Study|Lack of Efficacy|2
2223521|NCT01759511|3870038|FG000|Overall Study|Physician Decision|1
2223522|NCT01759511|3870038|FG000|Overall Study|Progressive Disease|5
2223523|NCT01759511|3870038|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4
2223524|NCT01759511|3870038|FG000|Overall Study|Study Terminated by Sponsor|13
2223525|NCT01759511|3870038|FG000|Overall Study|Withdrawal by Subject|3
2223526|NCT01759862|3870048|FG000|Overall Study|Physician Decision|3
2223527|NCT01759862|3870049|FG001|Overall Study|Physician Decision|1
2223528|NCT01759862|3870048|FG000|Overall Study|Adverse Event|0
2223529|NCT01759862|3870049|FG001|Overall Study|Adverse Event|1
2223530|NCT01760447|3870120|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
2223531|NCT01760447|3870121|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
2223532|NCT01760447|3870122|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1
2223533|NCT01760447|3870123|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3
2223534|NCT01760447|3870120|FG000|Weeks 0-20|Withdrawal by Subject|2
2223535|NCT01760447|3870121|FG001|Weeks 0-20|Withdrawal by Subject|0
2223536|NCT01760447|3870122|FG002|Weeks 0-20|Withdrawal by Subject|1
2223537|NCT01760447|3870123|FG003|Weeks 0-20|Withdrawal by Subject|0
2223538|NCT01760447|3870120|FG000|Weeks 0-20|Lost to Follow-up|1
2223539|NCT01760447|3870121|FG001|Weeks 0-20|Lost to Follow-up|0
2223540|NCT01760447|3870122|FG002|Weeks 0-20|Lost to Follow-up|1
2223541|NCT01760447|3870123|FG003|Weeks 0-20|Lost to Follow-up|1
2223542|NCT01760447|3870120|FG000|Weeks 0-20|Randomized but not treated|0
2223543|NCT01760447|3870121|FG001|Weeks 0-20|Randomized but not treated|0
2223544|NCT01760447|3870122|FG002|Weeks 0-20|Randomized but not treated|2
2223545|NCT01760447|3870123|FG003|Weeks 0-20|Randomized but not treated|0
2223546|NCT01760447|3870120|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
2223547|NCT01760447|3870121|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
2223548|NCT01760447|3870122|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
2223549|NCT01760447|3870123|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0
2223550|NCT01760447|3870120|FG000|Weeks 20-54|Withdrawal by Subject|2
2190773|NCT01483599|3821241|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2190774|NCT01483599|3821242|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2190775|NCT01483599|3821229|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2190776|NCT01483599|3821230|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
2190777|NCT01483599|3821231|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2190778|NCT01483599|3821232|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
2190779|NCT01483599|3821233|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2190780|NCT01483599|3821234|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2190781|NCT01483599|3821235|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
2190782|NCT01483599|3821236|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2190783|NCT01483599|3821237|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2190784|NCT01483599|3821238|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2190785|NCT01483599|3821239|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2190786|NCT01483599|3821240|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2190787|NCT01483599|3821241|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2190788|NCT01483599|3821242|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2190789|NCT01483599|3821229|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
2190790|NCT01483599|3821230|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190791|NCT01483599|3821231|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190792|NCT01483599|3821232|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190793|NCT01483599|3821233|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190794|NCT01483599|3821234|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190795|NCT01483599|3821235|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190796|NCT01483599|3821236|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190797|NCT01483599|3821237|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190798|NCT01483599|3821238|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190799|NCT01483599|3821239|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190800|NCT01483599|3821240|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190801|NCT01483599|3821241|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2190802|NCT01483599|3821242|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2223551|NCT01760447|3870121|FG001|Weeks 20-54|Withdrawal by Subject|1
2223552|NCT01760447|3870122|FG002|Weeks 20-54|Withdrawal by Subject|1
2223553|NCT01760447|3870123|FG003|Weeks 20-54|Withdrawal by Subject|2
2223554|NCT01760447|3870120|FG000|Weeks 20-54|Lost to Follow-up|0
2223555|NCT01760447|3870121|FG001|Weeks 20-54|Lost to Follow-up|0
2223556|NCT01760447|3870122|FG002|Weeks 20-54|Lost to Follow-up|1
2223557|NCT01760447|3870123|FG003|Weeks 20-54|Lost to Follow-up|2
2223558|NCT01760733|3870151|FG000|Waiting List|Death|18
2223559|NCT01760733|3870151|FG000|Waiting List|Removed from waiting list|41
2223560|NCT01760733|3870151|FG000|Waiting List|Not received a transplant yet|13
2223561|NCT01760733|3870151|FG000|Transplanted|Not reached 10 years post transplant|184
2223562|NCT01760733|3870151|FG000|Transplanted|Death|26
2223563|NCT01760733|3870151|FG000|Transplanted|Graft loss|7
2223564|NCT01760876|3870165|FG000|Overall Study|Non-cardiac death (head injury)|1
2223565|NCT01760876|3870165|FG000|Overall Study|Carcinoma of prostate|1
2223566|NCT01760876|3870165|FG000|Overall Study|Impaired renal function|1
2223567|NCT01760876|3870165|FG000|Overall Study|Major depression|1
2223568|NCT01760876|3870165|FG000|Overall Study|Very poor baseline OCT quality|2
2223569|NCT01760954|3870173|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8
2223570|NCT01760954|3870174|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8
2223571|NCT01760954|3870175|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4
2223572|NCT01760954|3870176|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5
2223573|NCT01760954|3870173|FG000|Treatment Period (6 Months)|Adverse Event|5
2223574|NCT01760954|3870174|FG001|Treatment Period (6 Months)|Adverse Event|3
2223575|NCT01760954|3870175|FG002|Treatment Period (6 Months)|Adverse Event|4
2223576|NCT01760954|3870176|FG003|Treatment Period (6 Months)|Adverse Event|10
2223577|NCT01760954|3870173|FG000|Treatment Period (6 Months)|Lost to Follow-up|9
2223578|NCT01760954|3870174|FG001|Treatment Period (6 Months)|Lost to Follow-up|1
2223579|NCT01760954|3870175|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
2223580|NCT01760954|3870176|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
2223581|NCT01760954|3870173|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
2223582|NCT01760954|3870174|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
2223583|NCT01760954|3870175|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
2223584|NCT01760954|3870176|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
2223585|NCT01760954|3870173|FG000|Treatment Period (6 Months)|Pregnancy|5
2223586|NCT01760954|3870174|FG001|Treatment Period (6 Months)|Pregnancy|0
2223587|NCT01760954|3870175|FG002|Treatment Period (6 Months)|Pregnancy|3
2223588|NCT01760954|3870176|FG003|Treatment Period (6 Months)|Pregnancy|2
2223589|NCT01760954|3870173|FG000|Treatment Period (6 Months)|Non-compliance|1
2223590|NCT01760954|3870174|FG001|Treatment Period (6 Months)|Non-compliance|4
2223591|NCT01760954|3870175|FG002|Treatment Period (6 Months)|Non-compliance|0
2223592|NCT01760954|3870176|FG003|Treatment Period (6 Months)|Non-compliance|3
2223593|NCT01760954|3870173|FG000|Treatment Period (6 Months)|Other|0
2223594|NCT01760954|3870174|FG001|Treatment Period (6 Months)|Other|3
2223595|NCT01760954|3870175|FG002|Treatment Period (6 Months)|Other|3
2190803|NCT01483599|3821229|FG000|Controlled Period (CP) (up to Week 16)|Other|0
2190804|NCT01483599|3821230|FG001|Controlled Period (CP) (up to Week 16)|Other|2
2190805|NCT01483599|3821231|FG002|Controlled Period (CP) (up to Week 16)|Other|0
2190806|NCT01483599|3821232|FG003|Controlled Period (CP) (up to Week 16)|Other|1
2190807|NCT01483599|3821233|FG004|Controlled Period (CP) (up to Week 16)|Other|1
2190808|NCT01483599|3821234|FG005|Controlled Period (CP) (up to Week 16)|Other|0
2190809|NCT01483599|3821235|FG006|Controlled Period (CP) (up to Week 16)|Other|0
2190810|NCT01483599|3821236|FG007|Controlled Period (CP) (up to Week 16)|Other|0
2190811|NCT01483599|3821237|FG008|Controlled Period (CP) (up to Week 16)|Other|0
2190812|NCT01483599|3821238|FG009|Controlled Period (CP) (up to Week 16)|Other|0
2190813|NCT01483599|3821239|FG010|Controlled Period (CP) (up to Week 16)|Other|0
2190814|NCT01483599|3821240|FG011|Controlled Period (CP) (up to Week 16)|Other|0
2190815|NCT01483599|3821241|FG012|Controlled Period (CP) (up to Week 16)|Other|0
2190816|NCT01483599|3821242|FG013|Controlled Period (CP) (up to Week 16)|Other|0
2190817|NCT01483599|3821229|FG000|After Controlled Period(Week 16-Week 40)|Death|0
2190818|NCT01483599|3821230|FG001|After Controlled Period(Week 16-Week 40)|Death|0
2190819|NCT01483599|3821231|FG002|After Controlled Period(Week 16-Week 40)|Death|0
2190820|NCT01483599|3821232|FG003|After Controlled Period(Week 16-Week 40)|Death|0
2190821|NCT01483599|3821233|FG004|After Controlled Period(Week 16-Week 40)|Death|0
2190822|NCT01483599|3821234|FG005|After Controlled Period(Week 16-Week 40)|Death|0
2190823|NCT01483599|3821235|FG006|After Controlled Period(Week 16-Week 40)|Death|0
2190824|NCT01483599|3821236|FG007|After Controlled Period(Week 16-Week 40)|Death|0
2190825|NCT01483599|3821237|FG008|After Controlled Period(Week 16-Week 40)|Death|1
2190826|NCT01483599|3821238|FG009|After Controlled Period(Week 16-Week 40)|Death|0
2190827|NCT01483599|3821239|FG010|After Controlled Period(Week 16-Week 40)|Death|0
2190828|NCT01483599|3821240|FG011|After Controlled Period(Week 16-Week 40)|Death|0
2190829|NCT01483599|3821241|FG012|After Controlled Period(Week 16-Week 40)|Death|0
2190830|NCT01483599|3821242|FG013|After Controlled Period(Week 16-Week 40)|Death|0
2190831|NCT01483599|3821229|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2190832|NCT01483599|3821230|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2190833|NCT01483599|3821231|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2190834|NCT01483599|3821232|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2190835|NCT01483599|3821233|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2190836|NCT01483599|3821234|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2190837|NCT01483599|3821235|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2190838|NCT01483599|3821236|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2190839|NCT01483599|3821237|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2190840|NCT01483599|3821238|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2190841|NCT01483599|3821239|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2190842|NCT01483599|3821240|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2190843|NCT01483599|3821241|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2190844|NCT01483599|3821242|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2190845|NCT01483599|3821229|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2190846|NCT01483599|3821230|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2190847|NCT01483599|3821231|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2190848|NCT01483599|3821232|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2190849|NCT01483599|3821233|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2190850|NCT01483599|3821234|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2190851|NCT01483599|3821235|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2190852|NCT01483599|3821236|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2190853|NCT01483599|3821237|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
2190854|NCT01483599|3821238|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2190855|NCT01483599|3821239|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2190856|NCT01483599|3821240|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
2190857|NCT01483599|3821241|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2190858|NCT01483599|3821242|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
2190859|NCT01483599|3821229|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2190860|NCT01483599|3821230|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2190861|NCT01483599|3821231|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2190862|NCT01483599|3821232|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2190863|NCT01483599|3821233|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2190864|NCT01483599|3821234|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2190865|NCT01483599|3821235|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2190866|NCT01483599|3821236|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2190867|NCT01483599|3821237|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
2190868|NCT01483599|3821238|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2190869|NCT01483599|3821239|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
2190870|NCT01483599|3821240|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2190871|NCT01483599|3821241|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2223596|NCT01760954|3870176|FG003|Treatment Period (6 Months)|Other|1
2190872|NCT01483599|3821242|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
2190873|NCT01483599|3821229|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2190874|NCT01483599|3821230|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2190875|NCT01483599|3821231|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2190876|NCT01483599|3821232|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2190877|NCT01483599|3821233|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2190878|NCT01483599|3821234|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2190879|NCT01483599|3821235|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2190880|NCT01483599|3821236|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2190881|NCT01483599|3821237|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
2190882|NCT01483599|3821238|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2190883|NCT01483599|3821239|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2190884|NCT01483599|3821240|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2190885|NCT01483599|3821241|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
2190886|NCT01483599|3821242|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
2190887|NCT01483599|3821229|FG000|After Controlled Period(Week 16-Week 40)|Other|0
2190888|NCT01483599|3821230|FG001|After Controlled Period(Week 16-Week 40)|Other|0
2190889|NCT01483599|3821231|FG002|After Controlled Period(Week 16-Week 40)|Other|0
2190890|NCT01483599|3821232|FG003|After Controlled Period(Week 16-Week 40)|Other|0
2190891|NCT01483599|3821233|FG004|After Controlled Period(Week 16-Week 40)|Other|0
2190892|NCT01483599|3821234|FG005|After Controlled Period(Week 16-Week 40)|Other|0
2190893|NCT01483599|3821235|FG006|After Controlled Period(Week 16-Week 40)|Other|0
2190894|NCT01483599|3821236|FG007|After Controlled Period(Week 16-Week 40)|Other|1
2190895|NCT01483599|3821237|FG008|After Controlled Period(Week 16-Week 40)|Other|0
2190896|NCT01483599|3821238|FG009|After Controlled Period(Week 16-Week 40)|Other|4
2190897|NCT01483599|3821239|FG010|After Controlled Period(Week 16-Week 40)|Other|0
2190898|NCT01483599|3821240|FG011|After Controlled Period(Week 16-Week 40)|Other|0
2190899|NCT01483599|3821241|FG012|After Controlled Period(Week 16-Week 40)|Other|1
2190900|NCT01483599|3821242|FG013|After Controlled Period(Week 16-Week 40)|Other|0
2190901|NCT01483625|3821273|FG000|Overall Study|Adverse Event|1
2190902|NCT01483625|3821274|FG001|Overall Study|Adverse Event|1
2190903|NCT01483625|3821273|FG000|Overall Study|Refused to continue medication|2
2190904|NCT01483625|3821274|FG001|Overall Study|Refused to continue medication|1
2190905|NCT01483625|3821273|FG000|Overall Study|Due to other reason|1
2190906|NCT01483625|3821274|FG001|Overall Study|Due to other reason|0
2190907|NCT01483651|3821280|FG000|Overall Study|Withdrawal by Subject|0
2190908|NCT01483651|3821281|FG001|Overall Study|Withdrawal by Subject|1
2190909|NCT01483651|3821282|FG002|Overall Study|Withdrawal by Subject|1
2190910|NCT01483651|3821283|FG003|Overall Study|Withdrawal by Subject|0
2190911|NCT01483651|3821284|FG004|Overall Study|Withdrawal by Subject|0
2190912|NCT01483651|3821285|FG005|Overall Study|Withdrawal by Subject|1
2190913|NCT01483690|3821295|FG000|Overall Study|Adverse Event|1
2190914|NCT01483690|3821296|FG001|Overall Study|Adverse Event|2
2190915|NCT01483690|3821295|FG000|Overall Study|clinical deterioration|1
2190916|NCT01483690|3821296|FG001|Overall Study|clinical deterioration|0
2190917|NCT01483690|3821295|FG000|Overall Study|Physician Decision|0
2190918|NCT01483690|3821296|FG001|Overall Study|Physician Decision|2
2190919|NCT01483690|3821295|FG000|Overall Study|exclusionary procedure|0
2190920|NCT01483690|3821296|FG001|Overall Study|exclusionary procedure|1
2190921|NCT01483820|3821311|FG000|Overall Study|Lack of Efficacy|6
2190922|NCT01483820|3821311|FG000|Overall Study|Adverse Event|1
2190923|NCT01483820|3821311|FG000|Overall Study|Death|1
2190924|NCT01483924|3821320|FG000|Overall Study|Withdrawal by Subject|2
2190925|NCT01483924|3821321|FG001|Overall Study|Withdrawal by Subject|0
2190926|NCT01483924|3821322|FG002|Overall Study|Withdrawal by Subject|0
2190927|NCT01483924|3821323|FG003|Overall Study|Withdrawal by Subject|1
2190928|NCT01483924|3821324|FG004|Overall Study|Withdrawal by Subject|1
2190929|NCT01483924|3821320|FG000|Overall Study|Adverse Event|0
2190930|NCT01483924|3821321|FG001|Overall Study|Adverse Event|0
2190931|NCT01483924|3821322|FG002|Overall Study|Adverse Event|1
2190932|NCT01483924|3821323|FG003|Overall Study|Adverse Event|1
2190933|NCT01483924|3821324|FG004|Overall Study|Adverse Event|0
2190934|NCT01483924|3821320|FG000|Overall Study|Non-compliance|0
2190935|NCT01483924|3821321|FG001|Overall Study|Non-compliance|0
2190936|NCT01483924|3821322|FG002|Overall Study|Non-compliance|0
2190937|NCT01483924|3821323|FG003|Overall Study|Non-compliance|1
2190938|NCT01483924|3821324|FG004|Overall Study|Non-compliance|1
2190939|NCT01483924|3821320|FG000|Overall Study|Sponsor concern over ECG result|0
2223597|NCT01760954|3870173|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
2223598|NCT01760954|3870174|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
2223599|NCT01760954|3870175|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
2223600|NCT01760954|3870176|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
2223601|NCT01760954|3870173|FG000|Treatment Period (6 Months)|Exclusionary Medication|1
2223602|NCT01760954|3870174|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
2223603|NCT01760954|3870175|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
2223604|NCT01760954|3870176|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
2223605|NCT01760954|3870173|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
2190940|NCT01483924|3821321|FG001|Overall Study|Sponsor concern over ECG result|0
2190941|NCT01483924|3821322|FG002|Overall Study|Sponsor concern over ECG result|0
2190942|NCT01483924|3821323|FG003|Overall Study|Sponsor concern over ECG result|1
2190943|NCT01483924|3821324|FG004|Overall Study|Sponsor concern over ECG result|0
2190944|NCT01483937|3821347|FG000|Overall Study|Withdrawal by Subject|4
2190945|NCT01483937|3821348|FG001|Overall Study|Withdrawal by Subject|3
2190946|NCT01484028|3821379|FG000|Period 1|Lost to Follow-up|0
2190947|NCT01484028|3821380|FG001|Period 1|Lost to Follow-up|1
2190948|NCT01484028|3821381|FG002|Period 1|Lost to Follow-up|0
2190949|NCT01484028|3821382|FG003|Period 1|Lost to Follow-up|0
2190950|NCT01484028|3821379|FG000|Period 1|Non-Compliance to Protocol|0
2190951|NCT01484028|3821380|FG001|Period 1|Non-Compliance to Protocol|1
2190952|NCT01484028|3821381|FG002|Period 1|Non-Compliance to Protocol|0
2190953|NCT01484028|3821382|FG003|Period 1|Non-Compliance to Protocol|1
2190954|NCT01484028|3821379|FG000|Period 1|Lens Discomfort|0
2190955|NCT01484028|3821380|FG001|Period 1|Lens Discomfort|1
2190956|NCT01484028|3821381|FG002|Period 1|Lens Discomfort|0
2190957|NCT01484028|3821382|FG003|Period 1|Lens Discomfort|0
2190958|NCT01484054|3821394|FG000|Period 1|Withdrawal by Subject|0
2190959|NCT01484054|3821395|FG001|Period 1|Withdrawal by Subject|1
2190960|NCT01484132|3821402|FG000|Overall Study|Lost to Follow-up|8
2190961|NCT01484132|3821402|FG000|Overall Study|Difficulty with time commitment|2
2190962|NCT01484132|3821402|FG000|Overall Study|Ineligible|1
2190963|NCT01484132|3821402|FG000|Overall Study|No pre-treatment urine sample collected|1
2190964|NCT01484132|3821402|FG000|Overall Study|No post-treatment urine sample collected|10
2190965|NCT01484197|3821406|FG000|Treatment Period 1|Adverse Event|1
2190966|NCT01484197|3821407|FG001|Treatment Period 1|Adverse Event|0
2190967|NCT01484197|3821408|FG002|Treatment Period 1|Adverse Event|0
2190968|NCT01484197|3821409|FG003|Treatment Period 1|Adverse Event|0
2190969|NCT01484197|3821406|FG000|Treatment Period 2|Subject withdrew consent|0
2190970|NCT01484197|3821407|FG001|Treatment Period 2|Subject withdrew consent|0
2190971|NCT01484197|3821408|FG002|Treatment Period 2|Subject withdrew consent|0
2190972|NCT01484197|3821409|FG003|Treatment Period 2|Subject withdrew consent|1
2190973|NCT01484275|3821421|FG000|Overall Study|Study terminated by sponsor|28
2190974|NCT01484275|3821422|FG001|Overall Study|Study terminated by sponsor|32
2190975|NCT01484275|3821421|FG000|Overall Study|Other|10
2190976|NCT01484275|3821422|FG001|Overall Study|Other|0
2190977|NCT01484275|3821421|FG000|Overall Study|Death|3
2190978|NCT01484275|3821422|FG001|Overall Study|Death|4
2190979|NCT01484275|3821421|FG000|Overall Study|Withdrawal by Subject|1
2190980|NCT01484275|3821422|FG001|Overall Study|Withdrawal by Subject|5
2190981|NCT01484275|3821421|FG000|Overall Study|Lost to Follow-up|1
2190982|NCT01484275|3821422|FG001|Overall Study|Lost to Follow-up|1
2190983|NCT01484431|3821444|FG000|Period 1: High Dose|Physician Decision|0
2190984|NCT01484431|3821445|FG001|Period 1: High Dose|Physician Decision|1
2190985|NCT01484431|3821446|FG002|Period 1: High Dose|Physician Decision|0
2190986|NCT01484431|3821444|FG000|Period 2|Death|0
2190987|NCT01484431|3821445|FG001|Period 2|Death|1
2190988|NCT01484431|3821446|FG002|Period 2|Death|1
2223606|NCT01760954|3870174|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
2223607|NCT01760954|3870175|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
2223608|NCT01760954|3870176|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
2223609|NCT01760954|3870173|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
2223610|NCT01760954|3870174|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
2223611|NCT01760954|3870175|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
2332251|NCT03189745|4055566|FG001|Overall Study|Conflict in work schedule of participant|1
2332252|NCT03190369|4055611|FG000|Overall Study|Poor compliance to protocol|0
2332253|NCT03190369|4055612|FG001|Overall Study|Poor compliance to protocol|1
2332254|NCT03190369|4055611|FG000|Overall Study|Withdraw before treatment|1
2332255|NCT03190369|4055612|FG001|Overall Study|Withdraw before treatment|5
2332256|NCT03190369|4055611|FG000|Overall Study|Randomized but not treated|0
2332257|NCT03190369|4055612|FG001|Overall Study|Randomized but not treated|2
2332258|NCT03191396|4055638|FG000|Overall Study|Lost to Follow-up|0
2332259|NCT03191396|4055639|FG001|Overall Study|Lost to Follow-up|3
2332260|NCT03191396|4055638|FG000|Overall Study|Withdrawal by Subject|3
2332261|NCT03191396|4055639|FG001|Overall Study|Withdrawal by Subject|2
2332262|NCT03191552|4055648|FG000|Overall Study|Lost to Follow-up|1
2332263|NCT03191552|4055649|FG001|Overall Study|Lost to Follow-up|0
2332264|NCT03191552|4055650|FG002|Overall Study|Lost to Follow-up|0
2332265|NCT03191552|4055648|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0
2332266|NCT03191552|4055649|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1
2332267|NCT03191552|4055650|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0
2332268|NCT03191630|4055664|FG000|Overall Study|Lost to Follow-up|7
2332269|NCT03191630|4055665|FG001|Overall Study|Lost to Follow-up|7
2332270|NCT03191799|4055673|FG000|Overall Study|Withdrawal by Subject|4
2332271|NCT03191799|4055673|FG000|Overall Study|Physician Decision|2
2332272|NCT03191799|4055673|FG000|Overall Study|Lost to Follow-up|1
2190989|NCT01484431|3821444|FG000|Period 2|Physician Decision|0
2190990|NCT01484431|3821445|FG001|Period 2|Physician Decision|0
2190991|NCT01484431|3821446|FG002|Period 2|Physician Decision|1
2190992|NCT01484431|3821444|FG000|Period 2|Non-Compliance with Study Drug|1
2190993|NCT01484431|3821445|FG001|Period 2|Non-Compliance with Study Drug|0
2190994|NCT01484431|3821446|FG002|Period 2|Non-Compliance with Study Drug|0
2190995|NCT01484496|3821461|FG000|Period 1|Protocol Violation|3
2190996|NCT01484496|3821462|FG001|Period 1|Protocol Violation|4
2190997|NCT01484496|3821463|FG002|Period 1|Protocol Violation|0
2190998|NCT01484496|3821464|FG003|Period 1|Protocol Violation|0
2190999|NCT01484496|3821461|FG000|Period 1|Physician Decision|5
2191000|NCT01484496|3821462|FG001|Period 1|Physician Decision|1
2191001|NCT01484496|3821463|FG002|Period 1|Physician Decision|0
2191002|NCT01484496|3821464|FG003|Period 1|Physician Decision|0
2191003|NCT01484496|3821461|FG000|Period 1|Lack of Efficacy|10
2191004|NCT01484496|3821462|FG001|Period 1|Lack of Efficacy|15
2191005|NCT01484496|3821463|FG002|Period 1|Lack of Efficacy|0
2191006|NCT01484496|3821464|FG003|Period 1|Lack of Efficacy|0
2191007|NCT01484496|3821461|FG000|Period 1|Adverse Event|25
2191008|NCT01484496|3821462|FG001|Period 1|Adverse Event|40
2191009|NCT01484496|3821463|FG002|Period 1|Adverse Event|0
2191010|NCT01484496|3821464|FG003|Period 1|Adverse Event|0
2191011|NCT01484496|3821461|FG000|Period 1|Withdrawal by Subject|15
2191012|NCT01484496|3821462|FG001|Period 1|Withdrawal by Subject|12
2191013|NCT01484496|3821463|FG002|Period 1|Withdrawal by Subject|0
2191014|NCT01484496|3821464|FG003|Period 1|Withdrawal by Subject|0
2191015|NCT01484496|3821461|FG000|Period 1|Lost to Follow-up|2
2191016|NCT01484496|3821462|FG001|Period 1|Lost to Follow-up|6
2191017|NCT01484496|3821463|FG002|Period 1|Lost to Follow-up|0
2191018|NCT01484496|3821464|FG003|Period 1|Lost to Follow-up|0
2191019|NCT01484496|3821461|FG000|Period 1|Positive Pregnancy|1
2191020|NCT01484496|3821462|FG001|Period 1|Positive Pregnancy|6
2191021|NCT01484496|3821463|FG002|Period 1|Positive Pregnancy|0
2191022|NCT01484496|3821464|FG003|Period 1|Positive Pregnancy|0
2191023|NCT01484496|3821461|FG000|Period 1|Treatment Failure|3
2191024|NCT01484496|3821462|FG001|Period 1|Treatment Failure|6
2223612|NCT01760954|3870176|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
2223613|NCT01760954|3870173|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
2223614|NCT01760954|3870174|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
2223615|NCT01760954|3870175|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
2223616|NCT01760954|3870176|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
2223617|NCT01760954|3870173|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
2223618|NCT01760954|3870174|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
2223619|NCT01760954|3870175|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
2223620|NCT01760954|3870176|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
2223621|NCT01760954|3870173|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
2223622|NCT01760954|3870174|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
2223623|NCT01760954|3870175|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
2223624|NCT01760954|3870176|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
2223625|NCT01760954|3870173|FG000|Post-treatment Follow-up (12 Months)|Other|13
2223626|NCT01760954|3870174|FG001|Post-treatment Follow-up (12 Months)|Other|8
2223627|NCT01760954|3870175|FG002|Post-treatment Follow-up (12 Months)|Other|9
2223628|NCT01760954|3870176|FG003|Post-treatment Follow-up (12 Months)|Other|6
2223629|NCT01761162|3870200|FG000|Overall Study|Withdrawal by Subject|3
2223630|NCT01761266|3870216|FG000|Overall Study|Death|351
2223631|NCT01761266|3870217|FG001|Overall Study|Death|350
2223632|NCT01761266|3870216|FG000|Overall Study|Lost to Follow-up|5
2223633|NCT01761266|3870217|FG001|Overall Study|Lost to Follow-up|11
2223634|NCT01761266|3870216|FG000|Overall Study|Withdrawal by Subject|13
2223635|NCT01761266|3870217|FG001|Overall Study|Withdrawal by Subject|8
2223636|NCT01761266|3870216|FG000|Overall Study|Ongoing as of data-cut off|109
2223637|NCT01761266|3870217|FG001|Overall Study|Ongoing as of data-cut off|107
2223638|NCT01761292|3870235|FG000|Part 1|Adverse Event|1
2223639|NCT01761292|3870235|FG000|Part 1|not receiving treatment in Part 1|1
2223640|NCT01761292|3870235|FG000|Extension 1|Withdrawal by Subject|1
2223641|NCT01761565|3870246|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
2223642|NCT01762345|3870276|FG000|Overall Study|Adverse Event|5
2223643|NCT01762345|3870276|FG000|Overall Study|Protocol Violation|2
2223644|NCT01762800|3870310|FG000|Overall Study|Adverse Event|8
2223645|NCT01762800|3870311|FG001|Overall Study|Adverse Event|13
2223646|NCT01762800|3870310|FG000|Overall Study|Lack of Efficacy|3
2223647|NCT01762800|3870311|FG001|Overall Study|Lack of Efficacy|2
2223648|NCT01762800|3870310|FG000|Overall Study|Study Closed/Terminated|0
2223649|NCT01762800|3870311|FG001|Overall Study|Study Closed/Terminated|1
2223650|NCT01762800|3870310|FG000|Overall Study|Physician Decision|1
2223651|NCT01762800|3870311|FG001|Overall Study|Physician Decision|1
2223652|NCT01762800|3870310|FG000|Overall Study|Withdrawal by Subject|7
2191025|NCT01484496|3821463|FG002|Period 1|Treatment Failure|0
2191026|NCT01484496|3821464|FG003|Period 1|Treatment Failure|0
2191027|NCT01484496|3821461|FG000|Period 1|Lack of Compliance|2
2191028|NCT01484496|3821462|FG001|Period 1|Lack of Compliance|1
2191029|NCT01484496|3821463|FG002|Period 1|Lack of Compliance|0
2191030|NCT01484496|3821464|FG003|Period 1|Lack of Compliance|0
2191031|NCT01484496|3821461|FG000|Period 1|Unable to Visit Site|0
2191032|NCT01484496|3821462|FG001|Period 1|Unable to Visit Site|2
2191033|NCT01484496|3821463|FG002|Period 1|Unable to Visit Site|0
2191034|NCT01484496|3821464|FG003|Period 1|Unable to Visit Site|0
2191035|NCT01484496|3821461|FG000|Period 2|Lack of Efficacy|0
2191036|NCT01484496|3821462|FG001|Period 2|Lack of Efficacy|0
2191037|NCT01484496|3821463|FG002|Period 2|Lack of Efficacy|1
2191038|NCT01484496|3821464|FG003|Period 2|Lack of Efficacy|3
2191039|NCT01484496|3821461|FG000|Period 2|Adverse Event|0
2191040|NCT01484496|3821462|FG001|Period 2|Adverse Event|0
2191041|NCT01484496|3821463|FG002|Period 2|Adverse Event|5
2191042|NCT01484496|3821464|FG003|Period 2|Adverse Event|13
2191043|NCT01484496|3821461|FG000|Period 2|Other|0
2191044|NCT01484496|3821462|FG001|Period 2|Other|0
2191045|NCT01484496|3821463|FG002|Period 2|Other|9
2191046|NCT01484496|3821464|FG003|Period 2|Other|6
2191047|NCT01484561|3821474|FG000|Overall Study|Lack of Efficacy|3
2191048|NCT01484561|3821475|FG001|Overall Study|Lack of Efficacy|1
2191049|NCT01484561|3821474|FG000|Overall Study|Lost to Follow-up|1
2191050|NCT01484561|3821475|FG001|Overall Study|Lost to Follow-up|0
2191051|NCT01484561|3821474|FG000|Overall Study|Withdrawal by Subject|3
2191052|NCT01484561|3821475|FG001|Overall Study|Withdrawal by Subject|0
2191053|NCT01484561|3821474|FG000|Overall Study|Other|1
2191054|NCT01484561|3821475|FG001|Overall Study|Other|1
2191055|NCT01484561|3821474|FG000|Overall Study|Adverse Event|1
2191056|NCT01484561|3821475|FG001|Overall Study|Adverse Event|4
2223653|NCT01762800|3870311|FG001|Overall Study|Withdrawal by Subject|4
2223654|NCT01762943|3870332|FG000|Overall Study|Physician Decision|1
2223655|NCT01762943|3870333|FG001|Overall Study|Physician Decision|1
2223656|NCT01762943|3870332|FG000|Overall Study|Protocol Violation|1
2223657|NCT01762943|3870333|FG001|Overall Study|Protocol Violation|0
2223658|NCT01762943|3870332|FG000|Overall Study|Withdrawal by Subject|2
2223659|NCT01762943|3870333|FG001|Overall Study|Withdrawal by Subject|1
2223660|NCT01763047|3870349|FG000|Period 1|Test Article Not Available|4
2223661|NCT01763047|3870350|FG001|Period 1|Test Article Not Available|1
2223662|NCT01763047|3870349|FG000|Period 1|Protocol Violation|4
2223663|NCT01763047|3870350|FG001|Period 1|Protocol Violation|4
2223664|NCT01763047|3870349|FG000|Period 1|No Longer Meets Eligibility criteria|1
2223665|NCT01763047|3870350|FG001|Period 1|No Longer Meets Eligibility criteria|0
2223666|NCT01763047|3870349|FG000|Period 1|Adverse Event|0
2223667|NCT01763047|3870350|FG001|Period 1|Adverse Event|1
2223668|NCT01763047|3870349|FG000|Period 1|Unsatisfactory Visual Response|0
2223669|NCT01763047|3870350|FG001|Period 1|Unsatisfactory Visual Response|3
2223670|NCT01763047|3870349|FG000|Period 1|Lens Power Not Available|0
2223671|NCT01763047|3870350|FG001|Period 1|Lens Power Not Available|1
2223672|NCT01763047|3870349|FG000|Period 1|Study Site office Closed|0
2223673|NCT01763047|3870350|FG001|Period 1|Study Site office Closed|1
2223674|NCT01763047|3870349|FG000|Period 2|Lens Discomfort|1
2223675|NCT01763047|3870350|FG001|Period 2|Lens Discomfort|0
2223676|NCT01763047|3870349|FG000|Period 2|No longer meets Eligibility Criteria|1
2223677|NCT01763047|3870350|FG001|Period 2|No longer meets Eligibility Criteria|0
2223678|NCT01763047|3870349|FG000|Period 2|Study Site office Closed|1
2223679|NCT01763047|3870350|FG001|Period 2|Study Site office Closed|1
2223680|NCT01763047|3870349|FG000|Period 2|Unsatisfactory Visual Response|1
2223681|NCT01763047|3870350|FG001|Period 2|Unsatisfactory Visual Response|1
2223682|NCT01763047|3870349|FG000|Period 2|Protocol Violation|0
2223683|NCT01763047|3870350|FG001|Period 2|Protocol Violation|2
2223684|NCT01763047|3870349|FG000|Period 2|Unsatisfactory lens Fitting|0
2223685|NCT01763047|3870350|FG001|Period 2|Unsatisfactory lens Fitting|1
2223686|NCT01763164|3870361|FG000|Treatment Phase|Participant/Guardian decision|26
2223687|NCT01763164|3870362|FG001|Treatment Phase|Participant/Guardian decision|14
2223688|NCT01763164|3870361|FG000|Treatment Phase|Protocol Violation|1
2223689|NCT01763164|3870362|FG001|Treatment Phase|Protocol Violation|1
2223690|NCT01763164|3870361|FG000|Treatment Phase|Progressive Disease|142
2223691|NCT01763164|3870362|FG001|Treatment Phase|Progressive Disease|76
2223692|NCT01763164|3870361|FG000|Treatment Phase|Physician Decision|24
2223693|NCT01763164|3870362|FG001|Treatment Phase|Physician Decision|13
2223694|NCT01763164|3870361|FG000|Treatment Phase|Death|10
2223695|NCT01763164|3870362|FG001|Treatment Phase|Death|1
2223696|NCT01763164|3870361|FG000|Treatment Phase|Adverse Event|66
2223697|NCT01763164|3870362|FG001|Treatment Phase|Adverse Event|8
2223698|NCT01763164|3870361|FG000|Treatment Phase|Randomized but not Treated|0
2223699|NCT01763164|3870362|FG001|Treatment Phase|Randomized but not Treated|19
2223700|NCT01763164|3870361|FG000|Treatment Phase|Other|0
2223701|NCT01763164|3870362|FG001|Treatment Phase|Other|1
2223702|NCT01763164|3870361|FG000|Follow up Phase|New therapy for study indication|12
2223703|NCT01763164|3870362|FG001|Follow up Phase|New therapy for study indication|3
2223704|NCT01763164|3870361|FG000|Follow up Phase|Death|21
2223705|NCT01763164|3870362|FG001|Follow up Phase|Death|4
2223706|NCT01763164|3870361|FG000|Follow up Phase|Subject/guardian decision|9
2191057|NCT01484834|3821498|FG000|Overall Study|Lost to Follow-up|5
2191058|NCT01484834|3821499|FG001|Overall Study|Lost to Follow-up|8
2191059|NCT01484834|3821500|FG002|Overall Study|Lost to Follow-up|1
2191060|NCT01484834|3821501|FG003|Overall Study|Lost to Follow-up|4
2191061|NCT01484873|3821511|FG000|Overall Study|Withdrawal by Subject|2
2191062|NCT01484912|3821518|FG000|Overall Study|Withdrawal by Subject|1
2191063|NCT01484912|3821519|FG001|Overall Study|Withdrawal by Subject|0
2191064|NCT01484912|3821518|FG000|Overall Study|Physician Decision|0
2191065|NCT01484912|3821519|FG001|Overall Study|Physician Decision|1
2191066|NCT01484938|3821525|FG000|Overall Study|Adverse Event|2
2223707|NCT01763164|3870362|FG001|Follow up Phase|Subject/guardian decision|2
2191067|NCT01484938|3821525|FG000|Overall Study|Lost to Follow-up|1
2191068|NCT01484938|3821525|FG000|Overall Study|Noncompliance|1
2191069|NCT01484951|3821529|FG000|Overall Study|Adverse Event|3
2191070|NCT01484951|3821529|FG000|Overall Study|Personal Reasons|1
2191071|NCT01484951|3821529|FG000|Overall Study|Non-Compliance|1
2191072|NCT01484977|3821533|FG000|Overall Study|Adverse Event|8
2191073|NCT01484977|3821533|FG000|Overall Study|Lack of Efficacy|4
2191074|NCT01484977|3821533|FG000|Overall Study|Protocol Violation|6
2191075|NCT01484977|3821533|FG000|Overall Study|Lost to Follow-up|1
2191076|NCT01484977|3821533|FG000|Overall Study|Withdrawal by Subject|4
2191077|NCT01484977|3821533|FG000|Overall Study|Subject Protocol Non-compliant|1
2191078|NCT01484977|3821533|FG000|Overall Study|Moving Overseas|1
2191079|NCT01484977|3821533|FG000|Overall Study|Low White Blood Cell Count|1
2191080|NCT01484977|3821533|FG000|Overall Study|Lack of Compliance|1
2191081|NCT01485094|3821544|FG000|Overall Study|Adverse Event|1
2191082|NCT01485094|3821545|FG001|Overall Study|Adverse Event|1
2191083|NCT01485094|3821546|FG002|Overall Study|Adverse Event|1
2191084|NCT01485094|3821544|FG000|Overall Study|Lost to Follow-up|1
2191085|NCT01485094|3821545|FG001|Overall Study|Lost to Follow-up|0
2191086|NCT01485094|3821546|FG002|Overall Study|Lost to Follow-up|0
2191087|NCT01485094|3821544|FG000|Overall Study|Withdrawal by Subject|1
2191088|NCT01485094|3821545|FG001|Overall Study|Withdrawal by Subject|1
2191089|NCT01485094|3821546|FG002|Overall Study|Withdrawal by Subject|0
2191090|NCT01485120|3821554|FG000|Overall Study|Withdrawal by Subject|2
2191091|NCT01485172|3821565|FG000|Overall Study|Adverse Event|2
2191092|NCT01485172|3821566|FG001|Overall Study|Adverse Event|1
2191093|NCT01485172|3821567|FG002|Overall Study|Adverse Event|2
2191094|NCT01485172|3821568|FG003|Overall Study|Adverse Event|2
2191095|NCT01485172|3821569|FG004|Overall Study|Adverse Event|1
2191096|NCT01485172|3821570|FG005|Overall Study|Adverse Event|2
2191097|NCT01485172|3821565|FG000|Overall Study|Lack of Efficacy|2
2191098|NCT01485172|3821566|FG001|Overall Study|Lack of Efficacy|0
2191099|NCT01485172|3821567|FG002|Overall Study|Lack of Efficacy|0
2191100|NCT01485172|3821568|FG003|Overall Study|Lack of Efficacy|0
2191101|NCT01485172|3821569|FG004|Overall Study|Lack of Efficacy|0
2191102|NCT01485172|3821570|FG005|Overall Study|Lack of Efficacy|0
2191103|NCT01485172|3821565|FG000|Overall Study|Protocol Violation|0
2191104|NCT01485172|3821566|FG001|Overall Study|Protocol Violation|0
2191105|NCT01485172|3821567|FG002|Overall Study|Protocol Violation|4
2191106|NCT01485172|3821568|FG003|Overall Study|Protocol Violation|5
2191107|NCT01485172|3821569|FG004|Overall Study|Protocol Violation|1
2191108|NCT01485172|3821570|FG005|Overall Study|Protocol Violation|0
2191109|NCT01485172|3821565|FG000|Overall Study|Protocol defined stopping criteria|1
2191110|NCT01485172|3821566|FG001|Overall Study|Protocol defined stopping criteria|0
2191111|NCT01485172|3821567|FG002|Overall Study|Protocol defined stopping criteria|0
2191112|NCT01485172|3821568|FG003|Overall Study|Protocol defined stopping criteria|0
2191113|NCT01485172|3821569|FG004|Overall Study|Protocol defined stopping criteria|1
2191114|NCT01485172|3821570|FG005|Overall Study|Protocol defined stopping criteria|0
2191115|NCT01485172|3821565|FG000|Overall Study|Lost to Follow-up|0
2191116|NCT01485172|3821566|FG001|Overall Study|Lost to Follow-up|0
2191117|NCT01485172|3821567|FG002|Overall Study|Lost to Follow-up|1
2191118|NCT01485172|3821568|FG003|Overall Study|Lost to Follow-up|0
2191119|NCT01485172|3821569|FG004|Overall Study|Lost to Follow-up|0
2191120|NCT01485172|3821570|FG005|Overall Study|Lost to Follow-up|1
2191121|NCT01485172|3821565|FG000|Overall Study|Physician Decision|0
2191122|NCT01485172|3821566|FG001|Overall Study|Physician Decision|0
2191123|NCT01485172|3821567|FG002|Overall Study|Physician Decision|0
2191124|NCT01485172|3821568|FG003|Overall Study|Physician Decision|0
2191125|NCT01485172|3821569|FG004|Overall Study|Physician Decision|1
2191126|NCT01485172|3821570|FG005|Overall Study|Physician Decision|0
2191127|NCT01485172|3821565|FG000|Overall Study|Withdrawal by Subject|2
2191128|NCT01485172|3821566|FG001|Overall Study|Withdrawal by Subject|0
2191129|NCT01485172|3821567|FG002|Overall Study|Withdrawal by Subject|0
2191130|NCT01485172|3821568|FG003|Overall Study|Withdrawal by Subject|1
2191131|NCT01485172|3821569|FG004|Overall Study|Withdrawal by Subject|1
2191132|NCT01485172|3821570|FG005|Overall Study|Withdrawal by Subject|1
2191133|NCT01485354|3821584|FG000|Overall Study|Withdrawal by Subject|5
2191134|NCT01485536|3821600|FG000|Overall Study|Withdrawal by Subject|3
2191135|NCT01485536|3821600|FG000|Overall Study|Adverse Event|1
2191136|NCT01485614|3821623|FG000|Randomization|Not Treated|1
2191137|NCT01485614|3821624|FG001|Randomization|Not Treated|0
2191138|NCT01485614|3821625|FG002|Randomization|Not Treated|0
2191139|NCT01485614|3821626|FG003|Randomization|Not Treated|0
2191140|NCT01485614|3821623|FG000|Weeks 0-20|Lost to Follow-up|2
2191141|NCT01485614|3821624|FG001|Weeks 0-20|Lost to Follow-up|0
2191142|NCT01485614|3821625|FG002|Weeks 0-20|Lost to Follow-up|0
2191143|NCT01485614|3821626|FG003|Weeks 0-20|Lost to Follow-up|0
2191144|NCT01485614|3821623|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5
2191145|NCT01485614|3821624|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2
2191146|NCT01485614|3821625|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0
2191147|NCT01485614|3821626|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0
2191148|NCT01485614|3821623|FG000|Weeks 0-20|Withdrawal by Subject|3
2191149|NCT01485614|3821624|FG001|Weeks 0-20|Withdrawal by Subject|2
2191150|NCT01485614|3821625|FG002|Weeks 0-20|Withdrawal by Subject|1
2191151|NCT01485614|3821626|FG003|Weeks 0-20|Withdrawal by Subject|0
2191152|NCT01485614|3821623|FG000|Weeks 20-54|Lost to Follow-up|4
2191153|NCT01485614|3821624|FG001|Weeks 20-54|Lost to Follow-up|3
2191154|NCT01485614|3821625|FG002|Weeks 20-54|Lost to Follow-up|1
2191155|NCT01485614|3821626|FG003|Weeks 20-54|Lost to Follow-up|0
2191156|NCT01485614|3821623|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2
2191157|NCT01485614|3821624|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2
2191158|NCT01485614|3821625|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1
2191159|NCT01485614|3821626|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0
2191160|NCT01485614|3821623|FG000|Weeks 20-54|Withdrawal by Subject|5
2191161|NCT01485614|3821624|FG001|Weeks 20-54|Withdrawal by Subject|3
2191162|NCT01485614|3821625|FG002|Weeks 20-54|Withdrawal by Subject|0
2191163|NCT01485614|3821626|FG003|Weeks 20-54|Withdrawal by Subject|0
2191164|NCT01485627|3821644|FG000|Overall Study|Patient withdrew|6
2191165|NCT01485627|3821645|FG001|Overall Study|Patient withdrew|5
2191166|NCT01485627|3821644|FG000|Overall Study|Patient died|3
2191167|NCT01485627|3821645|FG001|Overall Study|Patient died|1
2191168|NCT01485627|3821644|FG000|Overall Study|Patient lost to followup|0
2191169|NCT01485627|3821645|FG001|Overall Study|Patient lost to followup|1
2191170|NCT01485627|3821644|FG000|Overall Study|Caregiver withdrew|3
2191171|NCT01485627|3821645|FG001|Overall Study|Caregiver withdrew|3
2191172|NCT01485627|3821644|FG000|Overall Study|Caregiver lost to follow up|11
2191173|NCT01485627|3821645|FG001|Overall Study|Caregiver lost to follow up|12
2191174|NCT01485627|3821644|FG000|Overall Study|Caregiver died|1
2191175|NCT01485627|3821645|FG001|Overall Study|Caregiver died|0
2191176|NCT01485627|3821644|FG000|Overall Study|caregiver was not bereaved|42
2191177|NCT01485627|3821645|FG001|Overall Study|caregiver was not bereaved|35
2191178|NCT01485640|3821655|FG000|Overall Study|Adverse Event|10
2191179|NCT01485640|3821655|FG000|Overall Study|Lack of Efficacy|2
2191180|NCT01485640|3821655|FG000|Overall Study|Protocol Violation|1
2191181|NCT01485640|3821655|FG000|Overall Study|Withdrawal by Subject|14
2191182|NCT01485640|3821655|FG000|Overall Study|Terminated by Sponsor|95
2191183|NCT01485796|3821670|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
2191184|NCT01485796|3821670|FG000|Period 2: Epoch 2|Withdrawal by Subject|6
2191185|NCT01485796|3821670|FG000|Period 2: Epoch 2|Adverse Event|3
2191186|NCT01485796|3821670|FG000|Period 2: Epoch 2|Switch to safety follow-up|26
2191187|NCT01485796|3821670|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
2223708|NCT01763164|3870361|FG000|Follow up Phase|Progressive disease|127
2223709|NCT01763164|3870362|FG001|Follow up Phase|Progressive disease|62
2223710|NCT01763164|3870361|FG000|Follow up Phase|Physician Decision|10
2223711|NCT01763164|3870362|FG001|Follow up Phase|Physician Decision|3
2223712|NCT01763164|3870361|FG000|Follow up Phase|Lost to Follow-up|1
2223713|NCT01763164|3870362|FG001|Follow up Phase|Lost to Follow-up|0
2223714|NCT01763164|3870361|FG000|Follow up Phase|Adverse Event|17
2223715|NCT01763164|3870362|FG001|Follow up Phase|Adverse Event|1
2223716|NCT01763203|3870370|FG000|Overall Study|Death|4
2223717|NCT01763203|3870371|FG001|Overall Study|Death|7
2223718|NCT01763203|3870370|FG000|Overall Study|Lost to Follow-up|12
2223719|NCT01763203|3870371|FG001|Overall Study|Lost to Follow-up|12
2223720|NCT01763203|3870370|FG000|Overall Study|Withdrawal by Subject|8
2223721|NCT01763203|3870371|FG001|Overall Study|Withdrawal by Subject|12
2223722|NCT01763203|3870370|FG000|Overall Study|Moved out of study region|7
2223723|NCT01763203|3870371|FG001|Overall Study|Moved out of study region|10
2223724|NCT01763203|3870370|FG000|Overall Study|Physician Decision|2
2223725|NCT01763203|3870371|FG001|Overall Study|Physician Decision|1
2223726|NCT01763684|3870473|FG000|Overall Study|Study terminated early due to low enrollment|126
2223727|NCT01763684|3870474|FG001|Overall Study|Study terminated early due to low enrollment|127
2223728|NCT01763684|3870473|FG000|Overall Study|Study surgery not performed|7
2223729|NCT01763684|3870474|FG001|Overall Study|Study surgery not performed|6
2223730|NCT01763827|3870486|FG000|Overall Study|Withdrawal by Subject|1
2223731|NCT01763827|3870487|FG001|Overall Study|Withdrawal by Subject|0
2223732|NCT01763827|3870488|FG002|Overall Study|Withdrawal by Subject|0
2223733|NCT01763827|3870489|FG003|Overall Study|Withdrawal by Subject|0
2223734|NCT01763827|3870490|FG004|Overall Study|Withdrawal by Subject|2
2223735|NCT01763827|3870491|FG005|Overall Study|Withdrawal by Subject|0
2223736|NCT01763827|3870486|FG000|Overall Study|Decision by sponsor|2
2223737|NCT01763827|3870487|FG001|Overall Study|Decision by sponsor|0
2223738|NCT01763827|3870488|FG002|Overall Study|Decision by sponsor|3
2223739|NCT01763827|3870489|FG003|Overall Study|Decision by sponsor|0
2223740|NCT01763827|3870490|FG004|Overall Study|Decision by sponsor|2
2223741|NCT01763827|3870491|FG005|Overall Study|Decision by sponsor|1
2223742|NCT01763827|3870486|FG000|Overall Study|Lost to Follow-up|0
2223743|NCT01763827|3870487|FG001|Overall Study|Lost to Follow-up|1
2223744|NCT01763827|3870488|FG002|Overall Study|Lost to Follow-up|1
2223745|NCT01763827|3870489|FG003|Overall Study|Lost to Follow-up|1
2223746|NCT01763827|3870490|FG004|Overall Study|Lost to Follow-up|2
2223747|NCT01763827|3870491|FG005|Overall Study|Lost to Follow-up|1
2223748|NCT01763866|3870529|FG000|Overall Study|Withdrawal by Subject|2
2223749|NCT01763866|3870530|FG001|Overall Study|Withdrawal by Subject|1
2223750|NCT01763866|3870531|FG002|Overall Study|Withdrawal by Subject|4
2223751|NCT01763866|3870532|FG003|Overall Study|Withdrawal by Subject|0
2223752|NCT01763866|3870533|FG004|Overall Study|Withdrawal by Subject|0
2191188|NCT01485796|3821670|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
2191189|NCT01485796|3821670|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
2223753|NCT01763866|3870534|FG005|Overall Study|Withdrawal by Subject|3
2191190|NCT01485796|3821670|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
2191191|NCT01485887|3821678|FG000|Overall Study|Withdrawal by Subject|2
2191192|NCT01485887|3821678|FG000|Overall Study|Adverse Event|8
2191193|NCT01485887|3821678|FG000|Overall Study|Deterioration of primary disease|1
2191194|NCT01485887|3821678|FG000|Overall Study|Primary disease markedly improved|1
2191195|NCT01485991|3821684|FG000|Overall Study|Adverse Event|0
2191196|NCT01485991|3821685|FG001|Overall Study|Adverse Event|4
2191197|NCT01485991|3821684|FG000|Overall Study|Lost to Follow-up|13
2191198|NCT01485991|3821685|FG001|Overall Study|Lost to Follow-up|10
2191199|NCT01485991|3821684|FG000|Overall Study|Withdrawal by Subject|13
2191200|NCT01485991|3821685|FG001|Overall Study|Withdrawal by Subject|20
2191201|NCT01485991|3821684|FG000|Overall Study|randomized but not treated|6
2191202|NCT01485991|3821685|FG001|Overall Study|randomized but not treated|2
2191203|NCT01486199|3821697|FG000|Two Year Period Between Study Days|Physician Decision|1
2191204|NCT01486199|3821698|FG001|Two Year Period Between Study Days|Physician Decision|0
2191205|NCT01486238|3821706|FG000|Overall Study|Death|0
2191206|NCT01486238|3821707|FG001|Overall Study|Death|2
2191207|NCT01486238|3821706|FG000|Overall Study|Withdrawal by Subject|2
2191208|NCT01486238|3821707|FG001|Overall Study|Withdrawal by Subject|1
2191209|NCT01486238|3821706|FG000|Overall Study|Lost to Follow-up|0
2191210|NCT01486238|3821707|FG001|Overall Study|Lost to Follow-up|3
2191211|NCT01486264|3821715|FG000|Overall Study|Death|1
2191212|NCT01486264|3821716|FG001|Overall Study|Death|1
2191213|NCT01486264|3821715|FG000|Overall Study|Adverse Event|3
2191214|NCT01486264|3821716|FG001|Overall Study|Adverse Event|3
2191215|NCT01486264|3821715|FG000|Overall Study|Lack of Efficacy|6
2191216|NCT01486264|3821716|FG001|Overall Study|Lack of Efficacy|10
2191217|NCT01486264|3821715|FG000|Overall Study|Withdrawal by Subject|7
2191218|NCT01486264|3821716|FG001|Overall Study|Withdrawal by Subject|18
2191219|NCT01486264|3821715|FG000|Overall Study|Physician Decision|1
2191220|NCT01486264|3821716|FG001|Overall Study|Physician Decision|1
2191221|NCT01486264|3821715|FG000|Overall Study|Protocol Violation|3
2191222|NCT01486264|3821716|FG001|Overall Study|Protocol Violation|0
2191223|NCT01486264|3821715|FG000|Overall Study|Lost to Follow-up|3
2191224|NCT01486264|3821716|FG001|Overall Study|Lost to Follow-up|2
2191225|NCT01486264|3821715|FG000|Overall Study|Other|5
2191226|NCT01486264|3821716|FG001|Overall Study|Other|11
2191227|NCT01486264|3821715|FG000|Overall Study|Not treated|0
2191228|NCT01486264|3821716|FG001|Overall Study|Not treated|1
2191229|NCT01486316|3821725|FG000|Overall Study|Device explanted with/without re-implant|3
2191230|NCT01486316|3821726|FG001|Overall Study|Device explanted with/without re-implant|2
2191231|NCT01486316|3821727|FG002|Overall Study|Device explanted with/without re-implant|0
2191232|NCT01486316|3821728|FG003|Overall Study|Device explanted with/without re-implant|2
2191233|NCT01486316|3821725|FG000|Overall Study|Not meeting eligibility criteria|0
2191234|NCT01486316|3821726|FG001|Overall Study|Not meeting eligibility criteria|0
2191235|NCT01486316|3821727|FG002|Overall Study|Not meeting eligibility criteria|1
2191236|NCT01486316|3821728|FG003|Overall Study|Not meeting eligibility criteria|0
2191237|NCT01486316|3821725|FG000|Overall Study|Withdrawal by Subject|1
2191238|NCT01486316|3821726|FG001|Overall Study|Withdrawal by Subject|0
2191239|NCT01486316|3821727|FG002|Overall Study|Withdrawal by Subject|3
2191240|NCT01486316|3821728|FG003|Overall Study|Withdrawal by Subject|0
2191241|NCT01486316|3821725|FG000|Overall Study|Physician Decision|0
2191242|NCT01486316|3821726|FG001|Overall Study|Physician Decision|0
2191243|NCT01486316|3821727|FG002|Overall Study|Physician Decision|1
2191244|NCT01486316|3821728|FG003|Overall Study|Physician Decision|0
2191245|NCT01486316|3821725|FG000|Overall Study|Death|0
2191246|NCT01486316|3821726|FG001|Overall Study|Death|1
2191247|NCT01486316|3821727|FG002|Overall Study|Death|0
2191248|NCT01486316|3821728|FG003|Overall Study|Death|0
2191249|NCT01486446|3821739|FG000|Overall Study|Adverse Event|1
2223754|NCT01763866|3870535|FG006|Overall Study|Withdrawal by Subject|4
2223755|NCT01763866|3870536|FG007|Overall Study|Withdrawal by Subject|0
2223756|NCT01763866|3870537|FG008|Overall Study|Withdrawal by Subject|1
2223757|NCT01763866|3870538|FG009|Overall Study|Withdrawal by Subject|1
2223758|NCT01763866|3870539|FG010|Overall Study|Withdrawal by Subject|2
2223759|NCT01763866|3870540|FG011|Overall Study|Withdrawal by Subject|2
2223760|NCT01763866|3870541|FG012|Overall Study|Withdrawal by Subject|2
2223761|NCT01763866|3870542|FG013|Overall Study|Withdrawal by Subject|0
2223762|NCT01763866|3870543|FG014|Overall Study|Withdrawal by Subject|6
2223763|NCT01763866|3870544|FG015|Overall Study|Withdrawal by Subject|3
2223764|NCT01763866|3870545|FG016|Overall Study|Withdrawal by Subject|0
2223765|NCT01763866|3870546|FG017|Overall Study|Withdrawal by Subject|1
2223766|NCT01763866|3870547|FG018|Overall Study|Withdrawal by Subject|1
2223767|NCT01763866|3870548|FG019|Overall Study|Withdrawal by Subject|1
2223768|NCT01763866|3870549|FG020|Overall Study|Withdrawal by Subject|2
2223769|NCT01763866|3870550|FG021|Overall Study|Withdrawal by Subject|1
2223770|NCT01763866|3870551|FG022|Overall Study|Withdrawal by Subject|2
2223771|NCT01763866|3870552|FG023|Overall Study|Withdrawal by Subject|1
2223772|NCT01763866|3870529|FG000|Overall Study|Decision by sponsor|0
2223773|NCT01763866|3870530|FG001|Overall Study|Decision by sponsor|0
2223774|NCT01763866|3870531|FG002|Overall Study|Decision by sponsor|1
2223775|NCT01763866|3870532|FG003|Overall Study|Decision by sponsor|0
2223776|NCT01763866|3870533|FG004|Overall Study|Decision by sponsor|2
2191250|NCT01486446|3821740|FG001|Overall Study|Adverse Event|0
2191251|NCT01486758|3821765|FG000|Overall Study|Lost to Follow-up|0
2191252|NCT01486758|3821766|FG001|Overall Study|Lost to Follow-up|1
2191253|NCT01486784|3821779|FG000|Overall Study|Withdrawal by Subject|0
2191254|NCT01486784|3821780|FG001|Overall Study|Withdrawal by Subject|0
2191255|NCT01486784|3821781|FG002|Overall Study|Withdrawal by Subject|1
2191256|NCT01486784|3821782|FG003|Overall Study|Withdrawal by Subject|0
2191257|NCT01486784|3821783|FG004|Overall Study|Withdrawal by Subject|1
2191258|NCT01486784|3821784|FG005|Overall Study|Withdrawal by Subject|2
2191259|NCT01486784|3821779|FG000|Overall Study|Subject did not meet entry criteria|0
2191260|NCT01486784|3821780|FG001|Overall Study|Subject did not meet entry criteria|0
2191261|NCT01486784|3821781|FG002|Overall Study|Subject did not meet entry criteria|0
2191262|NCT01486784|3821782|FG003|Overall Study|Subject did not meet entry criteria|0
2191263|NCT01486784|3821783|FG004|Overall Study|Subject did not meet entry criteria|1
2191264|NCT01486784|3821784|FG005|Overall Study|Subject did not meet entry criteria|0
2191265|NCT01486784|3821779|FG000|Overall Study|Death|0
2191266|NCT01486784|3821780|FG001|Overall Study|Death|0
2191267|NCT01486784|3821781|FG002|Overall Study|Death|0
2191268|NCT01486784|3821782|FG003|Overall Study|Death|0
2191269|NCT01486784|3821783|FG004|Overall Study|Death|0
2191270|NCT01486784|3821784|FG005|Overall Study|Death|1
2191271|NCT01486927|3821802|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1
2191272|NCT01486927|3821802|FG000|Overall Study|Physician Decision|1
2191273|NCT01486927|3821802|FG000|Overall Study|50 Exposure days not reached|2
2191274|NCT01486927|3821802|FG000|Overall Study|Withdrawal by Subject|8
2191275|NCT01486927|3821802|FG000|Overall Study|Subject did not reach 6 mo of treatment|1
2191276|NCT01486966|3821815|FG000|Overall Study|Adverse Event|0
2191277|NCT01486966|3821816|FG001|Overall Study|Adverse Event|1
2191278|NCT01486966|3821815|FG000|Overall Study|Withdrawal by Subject|0
2191279|NCT01486966|3821816|FG001|Overall Study|Withdrawal by Subject|1
2191280|NCT01487161|3821826|FG000|Overall Study|Adverse Event|1
2191281|NCT01487161|3821827|FG001|Overall Study|Adverse Event|0
2191282|NCT01487161|3821828|FG002|Overall Study|Adverse Event|0
2191283|NCT01487161|3821829|FG003|Overall Study|Adverse Event|0
2191284|NCT01487161|3821826|FG000|Overall Study|Withdrawal by Subject|1
2191285|NCT01487161|3821827|FG001|Overall Study|Withdrawal by Subject|1
2191286|NCT01487161|3821828|FG002|Overall Study|Withdrawal by Subject|1
2191287|NCT01487161|3821829|FG003|Overall Study|Withdrawal by Subject|2
2191288|NCT01487161|3821826|FG000|Overall Study|missing data|0
2191289|NCT01487161|3821827|FG001|Overall Study|missing data|1
2191290|NCT01487161|3821828|FG002|Overall Study|missing data|0
2223777|NCT01763866|3870534|FG005|Overall Study|Decision by sponsor|0
2223778|NCT01763866|3870535|FG006|Overall Study|Decision by sponsor|2
2223779|NCT01763866|3870536|FG007|Overall Study|Decision by sponsor|0
2223780|NCT01763866|3870537|FG008|Overall Study|Decision by sponsor|2
2223781|NCT01763866|3870538|FG009|Overall Study|Decision by sponsor|0
2223782|NCT01763866|3870539|FG010|Overall Study|Decision by sponsor|6
2223783|NCT01763866|3870540|FG011|Overall Study|Decision by sponsor|0
2223784|NCT01763866|3870541|FG012|Overall Study|Decision by sponsor|1
2223785|NCT01763866|3870542|FG013|Overall Study|Decision by sponsor|0
2223786|NCT01763866|3870543|FG014|Overall Study|Decision by sponsor|5
2223787|NCT01763866|3870544|FG015|Overall Study|Decision by sponsor|0
2223788|NCT01763866|3870545|FG016|Overall Study|Decision by sponsor|0
2223789|NCT01763866|3870546|FG017|Overall Study|Decision by sponsor|0
2223790|NCT01763866|3870547|FG018|Overall Study|Decision by sponsor|4
2223791|NCT01763866|3870548|FG019|Overall Study|Decision by sponsor|0
2223792|NCT01763866|3870549|FG020|Overall Study|Decision by sponsor|2
2223793|NCT01763866|3870550|FG021|Overall Study|Decision by sponsor|0
2223794|NCT01763866|3870551|FG022|Overall Study|Decision by sponsor|1
2223795|NCT01763866|3870552|FG023|Overall Study|Decision by sponsor|0
2223796|NCT01763866|3870529|FG000|Overall Study|Lost to Follow-up|0
2223797|NCT01763866|3870530|FG001|Overall Study|Lost to Follow-up|0
2223798|NCT01763866|3870531|FG002|Overall Study|Lost to Follow-up|0
2223799|NCT01763866|3870532|FG003|Overall Study|Lost to Follow-up|0
2223800|NCT01763866|3870533|FG004|Overall Study|Lost to Follow-up|0
2223801|NCT01763866|3870534|FG005|Overall Study|Lost to Follow-up|0
2223802|NCT01763866|3870535|FG006|Overall Study|Lost to Follow-up|1
2223803|NCT01763866|3870536|FG007|Overall Study|Lost to Follow-up|0
2223804|NCT01763866|3870537|FG008|Overall Study|Lost to Follow-up|0
2223805|NCT01763866|3870538|FG009|Overall Study|Lost to Follow-up|0
2223806|NCT01763866|3870539|FG010|Overall Study|Lost to Follow-up|0
2223807|NCT01763866|3870540|FG011|Overall Study|Lost to Follow-up|0
2223808|NCT01763866|3870541|FG012|Overall Study|Lost to Follow-up|1
2223809|NCT01763866|3870542|FG013|Overall Study|Lost to Follow-up|0
2223810|NCT01763866|3870543|FG014|Overall Study|Lost to Follow-up|1
2223811|NCT01763866|3870544|FG015|Overall Study|Lost to Follow-up|0
2223812|NCT01763866|3870545|FG016|Overall Study|Lost to Follow-up|0
2223813|NCT01763866|3870546|FG017|Overall Study|Lost to Follow-up|0
2223814|NCT01763866|3870547|FG018|Overall Study|Lost to Follow-up|1
2223815|NCT01763866|3870548|FG019|Overall Study|Lost to Follow-up|1
2223816|NCT01763866|3870549|FG020|Overall Study|Lost to Follow-up|0
2223817|NCT01763866|3870550|FG021|Overall Study|Lost to Follow-up|0
2223818|NCT01763866|3870551|FG022|Overall Study|Lost to Follow-up|0
2223819|NCT01763866|3870552|FG023|Overall Study|Lost to Follow-up|1
2223820|NCT01763866|3870529|FG000|Overall Study|Death|0
2223821|NCT01763866|3870530|FG001|Overall Study|Death|0
2191291|NCT01487161|3821829|FG003|Overall Study|missing data|0
2191292|NCT01487200|3821848|FG000|Overall Study|Withdrawal by Subject|0
2191293|NCT01487200|3821849|FG001|Overall Study|Withdrawal by Subject|1
2191294|NCT01487200|3821850|FG002|Overall Study|Withdrawal by Subject|0
2191295|NCT01487200|3821851|FG003|Overall Study|Withdrawal by Subject|0
2191296|NCT01487265|3821862|FG000|Overall Study|Adverse Event|8
2191297|NCT01487265|3821862|FG000|Overall Study|Withdrawal by Subject|5
2191298|NCT01487265|3821862|FG000|Overall Study|Disease Progression|21
2191299|NCT01487265|3821862|FG000|Overall Study|Death|2
2191300|NCT01487265|3821862|FG000|Overall Study|Still on Treatment|1
2191301|NCT01487525|3821868|FG000|Overall Study|Withdrawal by Subject|0
2191302|NCT01487525|3821869|FG001|Overall Study|Withdrawal by Subject|1
2191303|NCT01487577|3821875|FG000|Overall Study|Became ineligible after signing consent|1
2191304|NCT01487863|3821892|FG000|Overall Study|Death|19
2191305|NCT01487863|3821893|FG001|Overall Study|Death|19
2191306|NCT01488071|3821921|FG000|Overall Study|Adverse Event|15
2191307|NCT01488071|3821922|FG001|Overall Study|Adverse Event|23
2191308|NCT01488071|3821921|FG000|Overall Study|Lack of Efficacy|11
2191309|NCT01488071|3821922|FG001|Overall Study|Lack of Efficacy|17
2191310|NCT01488071|3821921|FG000|Overall Study|Non-compliance with study drug|2
2191311|NCT01488071|3821922|FG001|Overall Study|Non-compliance with study drug|0
2191312|NCT01488071|3821921|FG000|Overall Study|Protocol Violation|5
2191313|NCT01488071|3821922|FG001|Overall Study|Protocol Violation|7
2191314|NCT01488071|3821921|FG000|Overall Study|Withdrawal of Consent|14
2191315|NCT01488071|3821922|FG001|Overall Study|Withdrawal of Consent|12
2191316|NCT01488071|3821921|FG000|Overall Study|Lost to Follow-up|1
2191317|NCT01488071|3821922|FG001|Overall Study|Lost to Follow-up|0
2191318|NCT01488071|3821921|FG000|Overall Study|Administrative or Other Reason(s)|5
2191319|NCT01488071|3821922|FG001|Overall Study|Administrative or Other Reason(s)|4
2191320|NCT01488097|3821928|FG000|Overall Study|Lost to Follow-up|1
2191321|NCT01488370|3821960|FG000|Overall Study|Protocol Violation|0
2191322|NCT01488370|3821961|FG001|Overall Study|Protocol Violation|1
2191323|NCT01488370|3821962|FG002|Overall Study|Protocol Violation|1
2191324|NCT01488448|3821981|FG000|Overall Study|Withdrawal by Subject|3
2191325|NCT01488448|3821982|FG001|Overall Study|Withdrawal by Subject|1
2191326|NCT01488448|3821981|FG000|Overall Study|Adverse Event|9
2191327|NCT01488448|3821982|FG001|Overall Study|Adverse Event|4
2191328|NCT01488448|3821981|FG000|Overall Study|Physician Decision|4
2191329|NCT01488448|3821982|FG001|Overall Study|Physician Decision|9
2191330|NCT01488448|3821981|FG000|Overall Study|Protocol Violation|4
2191331|NCT01488448|3821982|FG001|Overall Study|Protocol Violation|3
2191332|NCT01488487|3821990|FG000|Overall Study|Adverse Event|6
2191333|NCT01488487|3821990|FG000|Overall Study|Death|1
2191334|NCT01488487|3821990|FG000|Overall Study|Withdrawal by Subject|2
2191335|NCT01488578|3821994|FG000|Overall Study|Protocol Violation|1836
2191336|NCT01488890|3822048|FG000|Overall Study|Serious adverse event|2
2191337|NCT01488890|3822049|FG001|Overall Study|Serious adverse event|0
2191338|NCT01488890|3822050|FG002|Overall Study|Serious adverse event|0
2191339|NCT01488890|3822051|FG003|Overall Study|Serious adverse event|0
2191340|NCT01488890|3822048|FG000|Overall Study|Protocol Violation|3
2191341|NCT01488890|3822049|FG001|Overall Study|Protocol Violation|0
2191342|NCT01488890|3822050|FG002|Overall Study|Protocol Violation|4
2223822|NCT01763866|3870531|FG002|Overall Study|Death|0
2223823|NCT01763866|3870532|FG003|Overall Study|Death|0
2223824|NCT01763866|3870533|FG004|Overall Study|Death|0
2223825|NCT01763866|3870534|FG005|Overall Study|Death|0
2223826|NCT01763866|3870535|FG006|Overall Study|Death|0
2223827|NCT01763866|3870536|FG007|Overall Study|Death|0
2223828|NCT01763866|3870537|FG008|Overall Study|Death|0
2223829|NCT01763866|3870538|FG009|Overall Study|Death|0
2223830|NCT01763866|3870539|FG010|Overall Study|Death|0
2223831|NCT01763866|3870540|FG011|Overall Study|Death|0
2223832|NCT01763866|3870541|FG012|Overall Study|Death|0
2223833|NCT01763866|3870542|FG013|Overall Study|Death|0
2223834|NCT01763866|3870543|FG014|Overall Study|Death|0
2223835|NCT01763866|3870544|FG015|Overall Study|Death|0
2223836|NCT01763866|3870545|FG016|Overall Study|Death|1
2223837|NCT01763866|3870546|FG017|Overall Study|Death|0
2223838|NCT01763866|3870547|FG018|Overall Study|Death|0
2223839|NCT01763866|3870548|FG019|Overall Study|Death|0
2223840|NCT01763866|3870549|FG020|Overall Study|Death|0
2223841|NCT01763866|3870550|FG021|Overall Study|Death|0
2223842|NCT01763866|3870551|FG022|Overall Study|Death|0
2223843|NCT01763866|3870552|FG023|Overall Study|Death|0
2223844|NCT01763905|3870606|FG000|Overall Study|Withdrawal by Subject|1
2223845|NCT01763905|3870607|FG001|Overall Study|Withdrawal by Subject|1
2223846|NCT01763905|3870608|FG002|Overall Study|Withdrawal by Subject|0
2223847|NCT01763905|3870609|FG003|Overall Study|Withdrawal by Subject|1
2223848|NCT01763905|3870606|FG000|Overall Study|Decision by sponsor|5
2223849|NCT01763905|3870607|FG001|Overall Study|Decision by sponsor|0
2223850|NCT01763905|3870608|FG002|Overall Study|Decision by sponsor|8
2223851|NCT01763905|3870609|FG003|Overall Study|Decision by sponsor|0
2223852|NCT01763905|3870606|FG000|Overall Study|Lost to Follow-up|0
2223853|NCT01763905|3870607|FG001|Overall Study|Lost to Follow-up|0
2223854|NCT01763905|3870608|FG002|Overall Study|Lost to Follow-up|1
2223855|NCT01763905|3870609|FG003|Overall Study|Lost to Follow-up|0
2223856|NCT01763918|3870623|FG000|Overall Study|Withdrawal by Subject|2
2223857|NCT01763918|3870624|FG001|Overall Study|Withdrawal by Subject|1
2191343|NCT01488890|3822051|FG003|Overall Study|Protocol Violation|0
2191344|NCT01488890|3822048|FG000|Overall Study|Lost to Follow-up|13
2191345|NCT01488890|3822049|FG001|Overall Study|Lost to Follow-up|10
2191346|NCT01488890|3822050|FG002|Overall Study|Lost to Follow-up|20
2191347|NCT01488890|3822051|FG003|Overall Study|Lost to Follow-up|3
2191348|NCT01488890|3822048|FG000|Overall Study|Withdrawal by Subject|14
2191349|NCT01488890|3822049|FG001|Overall Study|Withdrawal by Subject|10
2191350|NCT01488890|3822050|FG002|Overall Study|Withdrawal by Subject|11
2191351|NCT01488890|3822051|FG003|Overall Study|Withdrawal by Subject|2
2191352|NCT01488994|3822067|FG000|Overall Study|Withdrawal by Subject|0
2191353|NCT01488994|3822068|FG001|Overall Study|Withdrawal by Subject|1
2191354|NCT01489020|3822085|FG000|Overall Study|Withdrawal by Subject|1
2191355|NCT01489020|3822086|FG001|Overall Study|Withdrawal by Subject|0
2191356|NCT01489020|3822087|FG002|Overall Study|Withdrawal by Subject|0
2191357|NCT01489020|3822088|FG003|Overall Study|Withdrawal by Subject|0
2191358|NCT01489020|3822089|FG004|Overall Study|Withdrawal by Subject|0
2191359|NCT01489020|3822090|FG005|Overall Study|Withdrawal by Subject|0
2191360|NCT01489020|3822085|FG000|Overall Study|Adverse Event|0
2191361|NCT01489020|3822086|FG001|Overall Study|Adverse Event|0
2191362|NCT01489020|3822087|FG002|Overall Study|Adverse Event|3
2191363|NCT01489020|3822088|FG003|Overall Study|Adverse Event|0
2191364|NCT01489020|3822089|FG004|Overall Study|Adverse Event|3
2191365|NCT01489020|3822090|FG005|Overall Study|Adverse Event|0
2191366|NCT01489020|3822085|FG000|Overall Study|Concomitant disease|0
2191367|NCT01489020|3822086|FG001|Overall Study|Concomitant disease|0
2191368|NCT01489020|3822087|FG002|Overall Study|Concomitant disease|0
2191369|NCT01489020|3822088|FG003|Overall Study|Concomitant disease|0
2191370|NCT01489020|3822089|FG004|Overall Study|Concomitant disease|3
2191371|NCT01489020|3822090|FG005|Overall Study|Concomitant disease|0
2191372|NCT01489111|3822110|FG000|Overall Study|Withdrawal criterion|1
2191373|NCT01489189|3822116|FG000|Overall Study|Withdrawal by Subject|20
2191374|NCT01489189|3822117|FG001|Overall Study|Withdrawal by Subject|23
2191375|NCT01489189|3822116|FG000|Overall Study|Death|10
2191376|NCT01489189|3822117|FG001|Overall Study|Death|8
2191377|NCT01489189|3822116|FG000|Overall Study|Missed Visit|1
2191378|NCT01489189|3822117|FG001|Overall Study|Missed Visit|4
2191379|NCT01489254|3822127|FG000|Double-blind Part|Adverse Event|7
2191380|NCT01489254|3822128|FG001|Double-blind Part|Adverse Event|2
2191381|NCT01489254|3822129|FG002|Double-blind Part|Adverse Event|2
2191382|NCT01489254|3822130|FG003|Double-blind Part|Adverse Event|0
2191383|NCT01489254|3822127|FG000|Double-blind Part|Pregnancy|1
2191384|NCT01489254|3822128|FG001|Double-blind Part|Pregnancy|3
2191385|NCT01489254|3822129|FG002|Double-blind Part|Pregnancy|0
2191386|NCT01489254|3822130|FG003|Double-blind Part|Pregnancy|0
2191387|NCT01489254|3822127|FG000|Double-blind Part|Withdrawal by Subject|12
2191388|NCT01489254|3822128|FG001|Double-blind Part|Withdrawal by Subject|20
2191389|NCT01489254|3822129|FG002|Double-blind Part|Withdrawal by Subject|1
2191390|NCT01489254|3822130|FG003|Double-blind Part|Withdrawal by Subject|0
2191391|NCT01489254|3822127|FG000|Double-blind Part|Lost to Follow-up|1
2191392|NCT01489254|3822128|FG001|Double-blind Part|Lost to Follow-up|2
2191393|NCT01489254|3822129|FG002|Double-blind Part|Lost to Follow-up|0
2191394|NCT01489254|3822130|FG003|Double-blind Part|Lost to Follow-up|0
2191395|NCT01489254|3822127|FG000|Double-blind Part|Other reasons for not completing study|4
2191396|NCT01489254|3822128|FG001|Double-blind Part|Other reasons for not completing study|6
2191397|NCT01489254|3822129|FG002|Double-blind Part|Other reasons for not completing study|0
2191398|NCT01489254|3822130|FG003|Double-blind Part|Other reasons for not completing study|0
2191399|NCT01489254|3822127|FG000|Open-label Extension Part|Adverse Event|0
2191400|NCT01489254|3822128|FG001|Open-label Extension Part|Adverse Event|0
2191401|NCT01489254|3822129|FG002|Open-label Extension Part|Adverse Event|0
2191402|NCT01489254|3822130|FG003|Open-label Extension Part|Adverse Event|10
2191403|NCT01489254|3822127|FG000|Open-label Extension Part|Pregnancy|0
2191404|NCT01489254|3822128|FG001|Open-label Extension Part|Pregnancy|0
2191405|NCT01489254|3822129|FG002|Open-label Extension Part|Pregnancy|0
2191406|NCT01489254|3822130|FG003|Open-label Extension Part|Pregnancy|3
2191407|NCT01489254|3822127|FG000|Open-label Extension Part|Withdrawal by Subject|0
2191408|NCT01489254|3822128|FG001|Open-label Extension Part|Withdrawal by Subject|0
2191409|NCT01489254|3822129|FG002|Open-label Extension Part|Withdrawal by Subject|0
2191410|NCT01489254|3822130|FG003|Open-label Extension Part|Withdrawal by Subject|30
2191411|NCT01489254|3822127|FG000|Open-label Extension Part|Protocol Violation|0
2191412|NCT01489254|3822128|FG001|Open-label Extension Part|Protocol Violation|0
2191413|NCT01489254|3822129|FG002|Open-label Extension Part|Protocol Violation|0
2191414|NCT01489254|3822130|FG003|Open-label Extension Part|Protocol Violation|1
2191415|NCT01489254|3822127|FG000|Open-label Extension Part|Lost to Follow-up|0
2191416|NCT01489254|3822128|FG001|Open-label Extension Part|Lost to Follow-up|0
2191417|NCT01489254|3822129|FG002|Open-label Extension Part|Lost to Follow-up|0
2191418|NCT01489254|3822130|FG003|Open-label Extension Part|Lost to Follow-up|9
2191419|NCT01489254|3822127|FG000|Open-label Extension Part|Other reasons for not completing study|0
2191420|NCT01489254|3822128|FG001|Open-label Extension Part|Other reasons for not completing study|0
2191421|NCT01489254|3822129|FG002|Open-label Extension Part|Other reasons for not completing study|0
2191422|NCT01489254|3822130|FG003|Open-label Extension Part|Other reasons for not completing study|5
2332273|NCT03191799|4055673|FG000|Overall Study|Death|2
2191423|NCT01489358|3822142|FG000|Overall Study|Lost to Follow-up|0
2191424|NCT01489358|3822143|FG001|Overall Study|Lost to Follow-up|0
2191425|NCT01489358|3822144|FG002|Overall Study|Lost to Follow-up|2
2191426|NCT01489527|3822154|FG000|Overall Study|Pregnancy|9
2191427|NCT01489527|3822155|FG001|Overall Study|Pregnancy|14
2191428|NCT01489527|3822154|FG000|Overall Study|Participant moved|6
2191429|NCT01489527|3822155|FG001|Overall Study|Participant moved|7
2223858|NCT01763918|3870625|FG002|Overall Study|Withdrawal by Subject|1
2223859|NCT01763918|3870626|FG003|Overall Study|Withdrawal by Subject|2
2223860|NCT01763918|3870623|FG000|Overall Study|Sponsor Decision|4
2223861|NCT01763918|3870624|FG001|Overall Study|Sponsor Decision|0
2223862|NCT01763918|3870625|FG002|Overall Study|Sponsor Decision|9
2223863|NCT01763918|3870626|FG003|Overall Study|Sponsor Decision|0
2223864|NCT01763996|3870652|FG000|Treatment Period 2|Adverse Event|0
2223865|NCT01763996|3870653|FG001|Treatment Period 2|Adverse Event|1
2223866|NCT01764022|3870661|FG000|Overall Study|Death|3
2223867|NCT01764022|3870662|FG001|Overall Study|Death|5
2223868|NCT01764022|3870661|FG000|Overall Study|Withdrawal by Subject|2
2223869|NCT01764022|3870662|FG001|Overall Study|Withdrawal by Subject|6
2223870|NCT01764022|3870661|FG000|Overall Study|Lack of Efficacy|0
2223871|NCT01764022|3870662|FG001|Overall Study|Lack of Efficacy|1
2223872|NCT01764022|3870661|FG000|Overall Study|Physician Decision|0
2223873|NCT01764022|3870662|FG001|Overall Study|Physician Decision|2
2223874|NCT01764022|3870661|FG000|Overall Study|Lost to Follow-up|2
2223875|NCT01764022|3870662|FG001|Overall Study|Lost to Follow-up|0
2223876|NCT01764022|3870661|FG000|Overall Study|Protocol Violation|1
2223877|NCT01764022|3870662|FG001|Overall Study|Protocol Violation|0
2223878|NCT01764256|3870674|FG000|Received All Vaccinations|Adverse Event|1
2223879|NCT01764256|3870675|FG001|Received All Vaccinations|Adverse Event|1
2223880|NCT01764256|3870676|FG002|Received All Vaccinations|Adverse Event|0
2223881|NCT01764256|3870677|FG003|Received All Vaccinations|Adverse Event|0
2223882|NCT01764256|3870674|FG000|Received All Vaccinations|Did not meet inclusion criteria|0
2223883|NCT01764256|3870675|FG001|Received All Vaccinations|Did not meet inclusion criteria|0
2223884|NCT01764256|3870676|FG002|Received All Vaccinations|Did not meet inclusion criteria|1
2223885|NCT01764256|3870677|FG003|Received All Vaccinations|Did not meet inclusion criteria|0
2332274|NCT03192137|4055679|FG000|Overall Study|Adverse Event|10
2332275|NCT03192137|4055680|FG001|Overall Study|Adverse Event|11
2332276|NCT03192137|4055679|FG000|Overall Study|Physician Decision|1
2332277|NCT03192137|4055680|FG001|Overall Study|Physician Decision|0
2332278|NCT03192137|4055679|FG000|Overall Study|Lack of Efficacy|20
2332279|NCT03192137|4055680|FG001|Overall Study|Lack of Efficacy|37
2332280|NCT03192137|4055679|FG000|Overall Study|Withdrawal by Subject|3
2332281|NCT03192137|4055680|FG001|Overall Study|Withdrawal by Subject|3
2332282|NCT03192137|4055679|FG000|Overall Study|Protocol Violation|4
2332283|NCT03192137|4055680|FG001|Overall Study|Protocol Violation|3
2332284|NCT03192137|4055679|FG000|Overall Study|Surgery Cancelled|4
2332285|NCT03192137|4055680|FG001|Overall Study|Surgery Cancelled|1
2332286|NCT03192137|4055679|FG000|Overall Study|Other - Various Administrative Reasons|8
2332287|NCT03192137|4055680|FG001|Overall Study|Other - Various Administrative Reasons|3
2332288|NCT03192150|4055688|FG000|Overall Study|Adverse Event|14
2332289|NCT03192150|4055689|FG001|Overall Study|Adverse Event|12
2332290|NCT03192150|4055688|FG000|Overall Study|Lack of Efficacy|23
2332291|NCT03192150|4055689|FG001|Overall Study|Lack of Efficacy|30
2332292|NCT03192150|4055688|FG000|Overall Study|Lost to Follow-up|1
2332293|NCT03192150|4055689|FG001|Overall Study|Lost to Follow-up|1
2332294|NCT03192150|4055688|FG000|Overall Study|Withdrawal by Subject|4
2332295|NCT03192150|4055689|FG001|Overall Study|Withdrawal by Subject|2
2332296|NCT03192150|4055688|FG000|Overall Study|Protocol Violation|5
2332297|NCT03192150|4055689|FG001|Overall Study|Protocol Violation|2
2332298|NCT03192150|4055688|FG000|Overall Study|Surgery Canceled|6
2332299|NCT03192150|4055689|FG001|Overall Study|Surgery Canceled|2
2332300|NCT03192150|4055688|FG000|Overall Study|Other-Various Administrative Reasons|2
2332301|NCT03192150|4055689|FG001|Overall Study|Other-Various Administrative Reasons|5
2332302|NCT03192176|4055703|FG000|Overall Study|Adverse Event|1
2332303|NCT03192176|4055704|FG001|Overall Study|Adverse Event|0
2332304|NCT03192176|4055705|FG002|Overall Study|Adverse Event|4
2332305|NCT03192176|4055706|FG003|Overall Study|Adverse Event|5
2332306|NCT03192176|4055707|FG004|Overall Study|Adverse Event|3
2332307|NCT03192176|4055708|FG005|Overall Study|Adverse Event|2
2332308|NCT03192176|4055709|FG006|Overall Study|Adverse Event|3
2332309|NCT03192176|4055710|FG007|Overall Study|Adverse Event|3
2332310|NCT03192176|4055703|FG000|Overall Study|Lost to Follow-up|0
2332311|NCT03192176|4055704|FG001|Overall Study|Lost to Follow-up|0
2332312|NCT03192176|4055705|FG002|Overall Study|Lost to Follow-up|1
2332313|NCT03192176|4055706|FG003|Overall Study|Lost to Follow-up|2
2332314|NCT03192176|4055707|FG004|Overall Study|Lost to Follow-up|3
2332315|NCT03192176|4055708|FG005|Overall Study|Lost to Follow-up|1
2332316|NCT03192176|4055709|FG006|Overall Study|Lost to Follow-up|1
2332317|NCT03192176|4055710|FG007|Overall Study|Lost to Follow-up|1
2332318|NCT03192176|4055703|FG000|Overall Study|Physician Decision|1
2191430|NCT01489527|3822154|FG000|Overall Study|Withdrawal by Subject|0
2191431|NCT01489527|3822155|FG001|Overall Study|Withdrawal by Subject|4
2223886|NCT01764256|3870674|FG000|Received All Vaccinations|Lost to Follow-up|1
2223887|NCT01764256|3870675|FG001|Received All Vaccinations|Lost to Follow-up|0
2332319|NCT03192176|4055704|FG001|Overall Study|Physician Decision|0
2191432|NCT01489527|3822154|FG000|Overall Study|Lost to Follow-up|5
2191433|NCT01489527|3822155|FG001|Overall Study|Lost to Follow-up|1
2191434|NCT01489527|3822154|FG000|Overall Study|Procedures|1
2191435|NCT01489527|3822155|FG001|Overall Study|Procedures|0
2191436|NCT01489527|3822154|FG000|Overall Study|Not compliant|1
2191437|NCT01489527|3822155|FG001|Overall Study|Not compliant|0
2191438|NCT01489891|3822223|FG000|Overall Study|Endoscopy failure|1
2191439|NCT01489891|3822224|FG001|Overall Study|Endoscopy failure|0
2191440|NCT01489956|3822232|FG000|Overall Study|Lost to Follow-up|1
2191441|NCT01489956|3822233|FG001|Overall Study|Lost to Follow-up|0
2191442|NCT01489956|3822234|FG002|Overall Study|Lost to Follow-up|0
2191443|NCT01489956|3822232|FG000|Overall Study|Withdrawal by Subject|0
2191444|NCT01489956|3822233|FG001|Overall Study|Withdrawal by Subject|0
2191445|NCT01489956|3822234|FG002|Overall Study|Withdrawal by Subject|1
2191446|NCT01490060|3822257|FG000|Cycle 1|Change of Treatment|0
2191447|NCT01490060|3822258|FG001|Cycle 1|Change of Treatment|1
2191448|NCT01490060|3822259|FG002|Cycle 1|Change of Treatment|1
2191449|NCT01490060|3822260|FG003|Cycle 1|Change of Treatment|1
2191450|NCT01490060|3822257|FG000|Cycle 1|Insurance Denied|0
2191451|NCT01490060|3822258|FG001|Cycle 1|Insurance Denied|0
2191452|NCT01490060|3822259|FG002|Cycle 1|Insurance Denied|2
2191453|NCT01490060|3822260|FG003|Cycle 1|Insurance Denied|0
2191454|NCT01490060|3822257|FG000|Cycle 1|Withdrawal by Subject|0
2191455|NCT01490060|3822258|FG001|Cycle 1|Withdrawal by Subject|0
2191456|NCT01490060|3822259|FG002|Cycle 1|Withdrawal by Subject|0
2191457|NCT01490060|3822260|FG003|Cycle 1|Withdrawal by Subject|1
2191458|NCT01490060|3822257|FG000|Cycle 1|Treatment at Another Facility|0
2191459|NCT01490060|3822258|FG001|Cycle 1|Treatment at Another Facility|0
2191460|NCT01490060|3822259|FG002|Cycle 1|Treatment at Another Facility|0
2191461|NCT01490060|3822260|FG003|Cycle 1|Treatment at Another Facility|1
2191462|NCT01490060|3822257|FG000|Cycle 2|Change of Treatment|1
2191463|NCT01490060|3822258|FG001|Cycle 2|Change of Treatment|1
2191464|NCT01490060|3822259|FG002|Cycle 2|Change of Treatment|0
2191465|NCT01490060|3822260|FG003|Cycle 2|Change of Treatment|0
2191466|NCT01490060|3822257|FG000|Cycle 2|Non-Compliance|0
2191467|NCT01490060|3822258|FG001|Cycle 2|Non-Compliance|0
2191468|NCT01490060|3822259|FG002|Cycle 2|Non-Compliance|1
2191469|NCT01490060|3822260|FG003|Cycle 2|Non-Compliance|0
2191470|NCT01490060|3822257|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1
2191471|NCT01490060|3822258|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0
2191472|NCT01490060|3822259|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0
2191473|NCT01490060|3822260|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0
2191474|NCT01490086|3822282|FG000|Overall Study|Consent withdrawn|4
2191475|NCT01490086|3822283|FG001|Overall Study|Consent withdrawn|4
2191476|NCT01490086|3822284|FG002|Overall Study|Consent withdrawn|3
2191477|NCT01490086|3822285|FG003|Overall Study|Consent withdrawn|0
2191478|NCT01490086|3822286|FG004|Overall Study|Consent withdrawn|1
2191479|NCT01490086|3822282|FG000|Overall Study|Non-compliance|0
2191480|NCT01490086|3822283|FG001|Overall Study|Non-compliance|1
2191481|NCT01490086|3822284|FG002|Overall Study|Non-compliance|0
2191482|NCT01490086|3822285|FG003|Overall Study|Non-compliance|0
2191483|NCT01490086|3822286|FG004|Overall Study|Non-compliance|0
2191484|NCT01490086|3822282|FG000|Overall Study|Abnormal laboratory findings|1
2191485|NCT01490086|3822283|FG001|Overall Study|Abnormal laboratory findings|0
2191486|NCT01490086|3822284|FG002|Overall Study|Abnormal laboratory findings|0
2191487|NCT01490086|3822285|FG003|Overall Study|Abnormal laboratory findings|0
2191488|NCT01490086|3822286|FG004|Overall Study|Abnormal laboratory findings|0
2191489|NCT01490086|3822282|FG000|Overall Study|Lost to Follow-up|0
2191490|NCT01490086|3822283|FG001|Overall Study|Lost to Follow-up|0
2191491|NCT01490086|3822284|FG002|Overall Study|Lost to Follow-up|0
2191492|NCT01490086|3822285|FG003|Overall Study|Lost to Follow-up|0
2191493|NCT01490086|3822286|FG004|Overall Study|Lost to Follow-up|1
2191494|NCT01490086|3822282|FG000|Overall Study|Physician Decision|3
2191495|NCT01490086|3822283|FG001|Overall Study|Physician Decision|4
2191496|NCT01490086|3822284|FG002|Overall Study|Physician Decision|2
2191497|NCT01490086|3822285|FG003|Overall Study|Physician Decision|3
2191498|NCT01490086|3822286|FG004|Overall Study|Physician Decision|1
2191499|NCT01490086|3822282|FG000|Overall Study|Adverse Event|0
2191500|NCT01490086|3822283|FG001|Overall Study|Adverse Event|0
2191501|NCT01490086|3822284|FG002|Overall Study|Adverse Event|1
2191502|NCT01490086|3822285|FG003|Overall Study|Adverse Event|2
2191503|NCT01490086|3822286|FG004|Overall Study|Adverse Event|0
2191504|NCT01490086|3822282|FG000|Overall Study|Lack of Efficacy|0
2191505|NCT01490086|3822283|FG001|Overall Study|Lack of Efficacy|3
2191506|NCT01490086|3822284|FG002|Overall Study|Lack of Efficacy|1
2191507|NCT01490086|3822285|FG003|Overall Study|Lack of Efficacy|0
2191508|NCT01490086|3822286|FG004|Overall Study|Lack of Efficacy|8
2191509|NCT01490086|3822282|FG000|Overall Study|Worsening of symptoms|0
2191510|NCT01490086|3822283|FG001|Overall Study|Worsening of symptoms|1
2191511|NCT01490086|3822284|FG002|Overall Study|Worsening of symptoms|0
2191512|NCT01490086|3822285|FG003|Overall Study|Worsening of symptoms|1
2191513|NCT01490086|3822286|FG004|Overall Study|Worsening of symptoms|0
2191514|NCT01490086|3822282|FG000|Overall Study|Subject uncontrollable and abusive|0
2191515|NCT01490086|3822283|FG001|Overall Study|Subject uncontrollable and abusive|1
2191516|NCT01490086|3822284|FG002|Overall Study|Subject uncontrollable and abusive|0
2191517|NCT01490086|3822285|FG003|Overall Study|Subject uncontrollable and abusive|0
2191518|NCT01490086|3822286|FG004|Overall Study|Subject uncontrollable and abusive|0
2191519|NCT01490086|3822282|FG000|Overall Study|Subject left hospital|0
2191520|NCT01490086|3822283|FG001|Overall Study|Subject left hospital|1
2191521|NCT01490086|3822284|FG002|Overall Study|Subject left hospital|0
2223888|NCT01764256|3870676|FG002|Received All Vaccinations|Lost to Follow-up|0
2223889|NCT01764256|3870677|FG003|Received All Vaccinations|Lost to Follow-up|0
2223890|NCT01764256|3870674|FG000|Completed Study|Lost to Follow-up|0
2223891|NCT01764256|3870675|FG001|Completed Study|Lost to Follow-up|0
2223892|NCT01764256|3870676|FG002|Completed Study|Lost to Follow-up|0
2223893|NCT01764256|3870677|FG003|Completed Study|Lost to Follow-up|1
2223894|NCT01764386|3870693|FG000|Controlled Treatment Period (CTP)|Adverse Event|35
2223895|NCT01764386|3870694|FG001|Controlled Treatment Period (CTP)|Adverse Event|0
2223896|NCT01764386|3870693|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
2223897|NCT01764386|3870694|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
2223898|NCT01764386|3870693|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9
2223899|NCT01764386|3870694|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5
2223900|NCT01764386|3870693|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
2223901|NCT01764386|3870694|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
2223902|NCT01764386|3870693|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2
2223903|NCT01764386|3870694|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13
2223904|NCT01764386|3870693|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
2223905|NCT01764386|3870694|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
2223906|NCT01764386|3870693|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
2223907|NCT01764386|3870694|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
2223908|NCT01764386|3870693|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
2223909|NCT01764386|3870694|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
2223910|NCT01764464|3870703|FG000|First Intervention|Withdrawal by Subject|1
2223911|NCT01764464|3870704|FG001|First Intervention|Withdrawal by Subject|0
2332320|NCT03192176|4055705|FG002|Overall Study|Physician Decision|0
2332321|NCT03192176|4055706|FG003|Overall Study|Physician Decision|0
2332322|NCT03192176|4055707|FG004|Overall Study|Physician Decision|0
2332323|NCT03192176|4055708|FG005|Overall Study|Physician Decision|2
2332324|NCT03192176|4055709|FG006|Overall Study|Physician Decision|1
2332325|NCT03192176|4055710|FG007|Overall Study|Physician Decision|0
2332326|NCT03192176|4055703|FG000|Overall Study|Protocol Deviation|1
2332327|NCT03192176|4055704|FG001|Overall Study|Protocol Deviation|1
2332328|NCT03192176|4055705|FG002|Overall Study|Protocol Deviation|0
2332329|NCT03192176|4055706|FG003|Overall Study|Protocol Deviation|0
2332330|NCT03192176|4055707|FG004|Overall Study|Protocol Deviation|2
2332331|NCT03192176|4055708|FG005|Overall Study|Protocol Deviation|0
2332332|NCT03192176|4055709|FG006|Overall Study|Protocol Deviation|0
2332333|NCT03192176|4055710|FG007|Overall Study|Protocol Deviation|0
2332334|NCT03192176|4055703|FG000|Overall Study|Withdrawal by Subject|3
2332335|NCT03192176|4055704|FG001|Overall Study|Withdrawal by Subject|4
2332336|NCT03192176|4055705|FG002|Overall Study|Withdrawal by Subject|0
2332337|NCT03192176|4055706|FG003|Overall Study|Withdrawal by Subject|4
2332338|NCT03192176|4055707|FG004|Overall Study|Withdrawal by Subject|3
2332339|NCT03192176|4055708|FG005|Overall Study|Withdrawal by Subject|4
2332340|NCT03192176|4055709|FG006|Overall Study|Withdrawal by Subject|4
2332341|NCT03192176|4055710|FG007|Overall Study|Withdrawal by Subject|2
2332342|NCT03192176|4055703|FG000|Overall Study|Miscellaneous|1
2332343|NCT03192176|4055704|FG001|Overall Study|Miscellaneous|0
2332344|NCT03192176|4055705|FG002|Overall Study|Miscellaneous|1
2332345|NCT03192176|4055706|FG003|Overall Study|Miscellaneous|1
2332346|NCT03192176|4055707|FG004|Overall Study|Miscellaneous|1
2332347|NCT03192176|4055708|FG005|Overall Study|Miscellaneous|2
2332348|NCT03192176|4055709|FG006|Overall Study|Miscellaneous|0
2332349|NCT03192176|4055710|FG007|Overall Study|Miscellaneous|1
2332350|NCT03192306|4055731|FG000|Overall Study|Did not treat cold sore during study|149
2332351|NCT03192306|4055732|FG001|Overall Study|Did not treat cold sore during study|143
2332352|NCT03192306|4055731|FG000|Overall Study|Withdrawal by Subject|1
2332353|NCT03192306|4055732|FG001|Overall Study|Withdrawal by Subject|1
2332354|NCT03192306|4055731|FG000|Overall Study|Lost to Follow-up|1
2332355|NCT03192306|4055732|FG001|Overall Study|Lost to Follow-up|0
2332356|NCT03192306|4055731|FG000|Overall Study|Protocol Violation|1
2332357|NCT03192306|4055732|FG001|Overall Study|Protocol Violation|1
2332358|NCT03192475|4055740|FG000|Overall Study|Death|0
2332359|NCT03192475|4055741|FG001|Overall Study|Death|1
2332360|NCT03192475|4055740|FG000|Overall Study|Lost to Follow-up|13
2332361|NCT03192475|4055741|FG001|Overall Study|Lost to Follow-up|8
2332362|NCT03192488|4055748|FG000|First Washout (>6d)|Withdrawal by Subject|0
2191522|NCT01490086|3822285|FG003|Overall Study|Subject left hospital|1
2191523|NCT01490086|3822286|FG004|Overall Study|Subject left hospital|0
2191524|NCT01490125|3822298|FG000|Period I|Adverse Event|4
2191525|NCT01490125|3822299|FG001|Period I|Adverse Event|1
2191526|NCT01490125|3822300|FG002|Period I|Adverse Event|1
2191527|NCT01490125|3822301|FG003|Period I|Adverse Event|3
2191528|NCT01490125|3822302|FG004|Period I|Adverse Event|2
2191529|NCT01490125|3822303|FG005|Period I|Adverse Event|4
2223912|NCT01764464|3870703|FG000|First Intervention|Lost to Follow-up|1
2332363|NCT03192488|4055749|FG001|First Washout (>6d)|Withdrawal by Subject|0
2191530|NCT01490125|3822298|FG000|Period I|Protocol Violation|1
2191531|NCT01490125|3822299|FG001|Period I|Protocol Violation|1
2191532|NCT01490125|3822300|FG002|Period I|Protocol Violation|1
2191533|NCT01490125|3822301|FG003|Period I|Protocol Violation|1
2191534|NCT01490125|3822302|FG004|Period I|Protocol Violation|0
2191535|NCT01490125|3822303|FG005|Period I|Protocol Violation|0
2191536|NCT01490125|3822298|FG000|Period I|Withdrawal by Subject|1
2191537|NCT01490125|3822299|FG001|Period I|Withdrawal by Subject|3
2191538|NCT01490125|3822300|FG002|Period I|Withdrawal by Subject|2
2191539|NCT01490125|3822301|FG003|Period I|Withdrawal by Subject|1
2191540|NCT01490125|3822302|FG004|Period I|Withdrawal by Subject|2
2191541|NCT01490125|3822303|FG005|Period I|Withdrawal by Subject|1
2191542|NCT01490125|3822298|FG000|Period II|Adverse Event|2
2191543|NCT01490125|3822299|FG001|Period II|Adverse Event|3
2191544|NCT01490125|3822300|FG002|Period II|Adverse Event|2
2191545|NCT01490125|3822301|FG003|Period II|Adverse Event|2
2191546|NCT01490125|3822302|FG004|Period II|Adverse Event|4
2191547|NCT01490125|3822303|FG005|Period II|Adverse Event|2
2191548|NCT01490125|3822298|FG000|Period II|Protocol Violation|0
2191549|NCT01490125|3822299|FG001|Period II|Protocol Violation|0
2191550|NCT01490125|3822300|FG002|Period II|Protocol Violation|1
2191551|NCT01490125|3822301|FG003|Period II|Protocol Violation|1
2191552|NCT01490125|3822302|FG004|Period II|Protocol Violation|0
2191553|NCT01490125|3822303|FG005|Period II|Protocol Violation|0
2191554|NCT01490125|3822298|FG000|Period II|Lost to Follow-up|0
2191555|NCT01490125|3822299|FG001|Period II|Lost to Follow-up|1
2191556|NCT01490125|3822300|FG002|Period II|Lost to Follow-up|0
2191557|NCT01490125|3822301|FG003|Period II|Lost to Follow-up|0
2191558|NCT01490125|3822302|FG004|Period II|Lost to Follow-up|0
2191559|NCT01490125|3822303|FG005|Period II|Lost to Follow-up|0
2191560|NCT01490125|3822298|FG000|Period II|Withdrawal by Subject|1
2191561|NCT01490125|3822299|FG001|Period II|Withdrawal by Subject|0
2191562|NCT01490125|3822300|FG002|Period II|Withdrawal by Subject|0
2191563|NCT01490125|3822301|FG003|Period II|Withdrawal by Subject|0
2191564|NCT01490125|3822302|FG004|Period II|Withdrawal by Subject|0
2191565|NCT01490125|3822303|FG005|Period II|Withdrawal by Subject|0
2191566|NCT01490125|3822298|FG000|Period III|Adverse Event|3
2191567|NCT01490125|3822299|FG001|Period III|Adverse Event|1
2191568|NCT01490125|3822300|FG002|Period III|Adverse Event|0
2191569|NCT01490125|3822301|FG003|Period III|Adverse Event|1
2191570|NCT01490125|3822302|FG004|Period III|Adverse Event|0
2191571|NCT01490125|3822303|FG005|Period III|Adverse Event|0
2191572|NCT01490125|3822298|FG000|Period III|Death|0
2191573|NCT01490125|3822299|FG001|Period III|Death|0
2191574|NCT01490125|3822300|FG002|Period III|Death|0
2191575|NCT01490125|3822301|FG003|Period III|Death|1
2191576|NCT01490125|3822302|FG004|Period III|Death|0
2191577|NCT01490125|3822303|FG005|Period III|Death|0
2191578|NCT01490125|3822298|FG000|Period III|Lack of Efficacy|0
2191579|NCT01490125|3822299|FG001|Period III|Lack of Efficacy|0
2191580|NCT01490125|3822300|FG002|Period III|Lack of Efficacy|0
2191581|NCT01490125|3822301|FG003|Period III|Lack of Efficacy|0
2191582|NCT01490125|3822302|FG004|Period III|Lack of Efficacy|1
2191583|NCT01490125|3822303|FG005|Period III|Lack of Efficacy|0
2223913|NCT01764464|3870704|FG001|First Intervention|Lost to Follow-up|0
2223914|NCT01764464|3870703|FG000|First Intervention|Adverse Event|0
2223915|NCT01764464|3870704|FG001|First Intervention|Adverse Event|2
2223916|NCT01764464|3870703|FG000|First Intervention|did not receive study drug|0
2223917|NCT01764464|3870704|FG001|First Intervention|did not receive study drug|1
2223918|NCT01764464|3870703|FG000|Second Intervention (Cross-over)|Adverse Event|2
2223919|NCT01764464|3870704|FG001|Second Intervention (Cross-over)|Adverse Event|0
2274104|NCT02293499|3954971|FG002|3 Month Follow Up|Withdrawal by Subject|4
2274105|NCT02293499|3954969|FG000|3 Month Follow Up|Lost to Follow-up|14
2274106|NCT02293499|3954970|FG001|3 Month Follow Up|Lost to Follow-up|15
2274107|NCT02293499|3954971|FG002|3 Month Follow Up|Lost to Follow-up|6
2274108|NCT02293499|3954969|FG000|6 Month Follow Up|Lost to Follow-up|17
2274109|NCT02293499|3954970|FG001|6 Month Follow Up|Lost to Follow-up|27
2274110|NCT02293499|3954971|FG002|6 Month Follow Up|Lost to Follow-up|6
2274111|NCT02293499|3954969|FG000|6 Month Follow Up|Withdrawal by Subject|0
2274112|NCT02293499|3954970|FG001|6 Month Follow Up|Withdrawal by Subject|0
2274113|NCT02293499|3954971|FG002|6 Month Follow Up|Withdrawal by Subject|1
2274114|NCT02293499|3954969|FG000|9 Month Follow Up|Withdrawal by Subject|2
2274115|NCT02293499|3954970|FG001|9 Month Follow Up|Withdrawal by Subject|0
2274116|NCT02293499|3954971|FG002|9 Month Follow Up|Withdrawal by Subject|0
2274117|NCT02293499|3954969|FG000|9 Month Follow Up|Lost to Follow-up|24
2274118|NCT02293499|3954970|FG001|9 Month Follow Up|Lost to Follow-up|28
2274119|NCT02293499|3954971|FG002|9 Month Follow Up|Lost to Follow-up|4
2274120|NCT02293499|3954969|FG000|12 Month Follow Up|Lost to Follow-up|26
2274121|NCT02293499|3954970|FG001|12 Month Follow Up|Lost to Follow-up|25
2274122|NCT02293499|3954971|FG002|12 Month Follow Up|Lost to Follow-up|6
2274123|NCT02293499|3954969|FG000|12 Month Follow Up|Withdrawal by Subject|0
2274124|NCT02293499|3954970|FG001|12 Month Follow Up|Withdrawal by Subject|1
2274125|NCT02293499|3954971|FG002|12 Month Follow Up|Withdrawal by Subject|0
2274126|NCT02293499|3954969|FG000|15 Month Follow Up|Lost to Follow-up|22
2274127|NCT02293499|3954970|FG001|15 Month Follow Up|Lost to Follow-up|22
2274128|NCT02293499|3954971|FG002|15 Month Follow Up|Lost to Follow-up|7
2274129|NCT02293538|3954999|FG000|Overall Study|Adverse Event|0
2191584|NCT01490294|3822321|FG000|Overall Study|Prematurely discontinuation|4
2191585|NCT01490294|3822322|FG001|Overall Study|Prematurely discontinuation|0
2191586|NCT01490294|3822323|FG002|Overall Study|Prematurely discontinuation|1
2191587|NCT01490294|3822324|FG003|Overall Study|Prematurely discontinuation|1
2191588|NCT01490294|3822321|FG000|Overall Study|Adverse Event|1
2191589|NCT01490294|3822322|FG001|Overall Study|Adverse Event|0
2223920|NCT01764633|3870716|FG000|Overall Study|Withdrawal by Subject|105
2223921|NCT01764633|3870717|FG001|Overall Study|Withdrawal by Subject|88
2223922|NCT01764633|3870716|FG000|Overall Study|Lost to Follow-up|13
2223923|NCT01764633|3870717|FG001|Overall Study|Lost to Follow-up|5
2223924|NCT01764659|3870723|FG000|Overall Study|Death|1
2223925|NCT01764659|3870723|FG000|Overall Study|Physician Decision|1
2223926|NCT01764841|3870742|FG000|Overall Study|Logistical Difficulties|0
2223927|NCT01764841|3870743|FG001|Overall Study|Logistical Difficulties|1
2223928|NCT01764841|3870744|FG002|Overall Study|Logistical Difficulties|0
2223929|NCT01764841|3870745|FG003|Overall Study|Logistical Difficulties|0
2223930|NCT01764841|3870742|FG000|Overall Study|Death|3
2223931|NCT01764841|3870743|FG001|Overall Study|Death|0
2223932|NCT01764841|3870744|FG002|Overall Study|Death|1
2223933|NCT01764841|3870745|FG003|Overall Study|Death|4
2223934|NCT01764841|3870742|FG000|Overall Study|No Follow Up|1
2223935|NCT01764841|3870743|FG001|Overall Study|No Follow Up|0
2223936|NCT01764841|3870744|FG002|Overall Study|No Follow Up|1
2223937|NCT01764841|3870745|FG003|Overall Study|No Follow Up|0
2223938|NCT01764841|3870742|FG000|Overall Study|Protocol Violation|0
2223939|NCT01764841|3870743|FG001|Overall Study|Protocol Violation|1
2223940|NCT01764841|3870744|FG002|Overall Study|Protocol Violation|0
2223941|NCT01764841|3870745|FG003|Overall Study|Protocol Violation|0
2223942|NCT01764841|3870742|FG000|Overall Study|Withdrawal by Subject|16
2223943|NCT01764841|3870743|FG001|Overall Study|Withdrawal by Subject|24
2223944|NCT01764841|3870744|FG002|Overall Study|Withdrawal by Subject|11
2223945|NCT01764841|3870745|FG003|Overall Study|Withdrawal by Subject|15
2223946|NCT01764841|3870742|FG000|Overall Study|Lost to Follow-up|3
2223947|NCT01764841|3870743|FG001|Overall Study|Lost to Follow-up|0
2223948|NCT01764841|3870744|FG002|Overall Study|Lost to Follow-up|1
2223949|NCT01764841|3870745|FG003|Overall Study|Lost to Follow-up|0
2223950|NCT01764854|3870759|FG000|Overall Study|Adverse Event|0
2223951|NCT01764854|3870760|FG001|Overall Study|Adverse Event|0
2223952|NCT01764854|3870761|FG002|Overall Study|Adverse Event|2
2223953|NCT01764854|3870762|FG003|Overall Study|Adverse Event|0
2223954|NCT01764854|3870759|FG000|Overall Study|Withdrawal by Subject|0
2223955|NCT01764854|3870760|FG001|Overall Study|Withdrawal by Subject|0
2223956|NCT01764854|3870761|FG002|Overall Study|Withdrawal by Subject|1
2223957|NCT01764854|3870762|FG003|Overall Study|Withdrawal by Subject|0
2223958|NCT01764854|3870759|FG000|Overall Study|relocation|0
2223959|NCT01764854|3870760|FG001|Overall Study|relocation|0
2223960|NCT01764854|3870761|FG002|Overall Study|relocation|2
2223961|NCT01764854|3870762|FG003|Overall Study|relocation|0
2223962|NCT01764854|3870759|FG000|Overall Study|Protocol Violation|0
2223963|NCT01764854|3870760|FG001|Overall Study|Protocol Violation|0
2223964|NCT01764854|3870761|FG002|Overall Study|Protocol Violation|1
2223965|NCT01764854|3870762|FG003|Overall Study|Protocol Violation|2
2223966|NCT01764945|3870784|FG000|Overall Study|Adverse Event|0
2223967|NCT01764945|3870785|FG001|Overall Study|Adverse Event|1
2223968|NCT01764945|3870786|FG002|Overall Study|Adverse Event|0
2223969|NCT01764945|3870787|FG003|Overall Study|Adverse Event|0
2223970|NCT01764945|3870788|FG004|Overall Study|Adverse Event|0
2191590|NCT01490294|3822323|FG002|Overall Study|Adverse Event|0
2191591|NCT01490294|3822324|FG003|Overall Study|Adverse Event|0
2191592|NCT01490450|3822348|FG000|Period 1|Lack of Efficacy|2
2191593|NCT01490450|3822349|FG001|Period 1|Lack of Efficacy|0
2191594|NCT01490450|3822350|FG002|Period 1|Lack of Efficacy|3
2191595|NCT01490450|3822351|FG003|Period 1|Lack of Efficacy|0
2191596|NCT01490450|3822348|FG000|Period 1|Adverse Event|0
2191597|NCT01490450|3822349|FG001|Period 1|Adverse Event|0
2191598|NCT01490450|3822350|FG002|Period 1|Adverse Event|0
2191599|NCT01490450|3822351|FG003|Period 1|Adverse Event|5
2191600|NCT01490450|3822348|FG000|Period 1|Request to discontinue treatment|1
2191601|NCT01490450|3822349|FG001|Period 1|Request to discontinue treatment|0
2191602|NCT01490450|3822350|FG002|Period 1|Request to discontinue treatment|0
2191603|NCT01490450|3822351|FG003|Period 1|Request to discontinue treatment|0
2191604|NCT01490450|3822348|FG000|Period 1|Withdrawal by Subject|0
2191605|NCT01490450|3822349|FG001|Period 1|Withdrawal by Subject|0
2191606|NCT01490450|3822350|FG002|Period 1|Withdrawal by Subject|0
2191607|NCT01490450|3822351|FG003|Period 1|Withdrawal by Subject|3
2191608|NCT01490450|3822348|FG000|Period 1|No longer met study criteria|0
2191609|NCT01490450|3822349|FG001|Period 1|No longer met study criteria|1
2191610|NCT01490450|3822350|FG002|Period 1|No longer met study criteria|1
2191611|NCT01490450|3822351|FG003|Period 1|No longer met study criteria|0
2191612|NCT01490450|3822348|FG000|Period 2|Lack of Efficacy|0
2191613|NCT01490450|3822349|FG001|Period 2|Lack of Efficacy|0
2191614|NCT01490450|3822350|FG002|Period 2|Lack of Efficacy|0
2191615|NCT01490450|3822351|FG003|Period 2|Lack of Efficacy|1
2223971|NCT01764945|3870789|FG005|Overall Study|Adverse Event|0
2223972|NCT01764945|3870790|FG006|Overall Study|Adverse Event|1
2223973|NCT01764945|3870791|FG007|Overall Study|Adverse Event|0
2223974|NCT01765153|3870811|FG000|Training Phase 1|Format of intervention differed|1
2191616|NCT01490450|3822348|FG000|Period 2|Adverse Event|1
2191617|NCT01490450|3822349|FG001|Period 2|Adverse Event|1
2191618|NCT01490450|3822350|FG002|Period 2|Adverse Event|0
2191619|NCT01490450|3822351|FG003|Period 2|Adverse Event|1
2191620|NCT01490450|3822348|FG000|Period 2|Withdrawal by Subject|1
2191621|NCT01490450|3822349|FG001|Period 2|Withdrawal by Subject|0
2191622|NCT01490450|3822350|FG002|Period 2|Withdrawal by Subject|0
2191623|NCT01490450|3822351|FG003|Period 2|Withdrawal by Subject|0
2191624|NCT01490450|3822348|FG000|Period 2|Lost to Follow-up|0
2191625|NCT01490450|3822349|FG001|Period 2|Lost to Follow-up|0
2191626|NCT01490450|3822350|FG002|Period 2|Lost to Follow-up|0
2191627|NCT01490450|3822351|FG003|Period 2|Lost to Follow-up|2
2191628|NCT01490580|3822366|FG000|Overall Study|Parents withdrew consent|0
2191629|NCT01490580|3822367|FG001|Overall Study|Parents withdrew consent|2
2191630|NCT01490632|3822382|FG000|Part A: Initial Treatment Period|Adverse Event|0
2191631|NCT01490632|3822383|FG001|Part A: Initial Treatment Period|Adverse Event|0
2191632|NCT01490632|3822384|FG002|Part A: Initial Treatment Period|Adverse Event|2
2191633|NCT01490632|3822385|FG003|Part A: Initial Treatment Period|Adverse Event|4
2191634|NCT01490632|3822386|FG004|Part A: Initial Treatment Period|Adverse Event|4
2191635|NCT01490632|3822387|FG005|Part A: Initial Treatment Period|Adverse Event|0
2191636|NCT01490632|3822388|FG006|Part A: Initial Treatment Period|Adverse Event|0
2191637|NCT01490632|3822389|FG007|Part A: Initial Treatment Period|Adverse Event|0
2191638|NCT01490632|3822390|FG008|Part A: Initial Treatment Period|Adverse Event|0
2191639|NCT01490632|3822391|FG009|Part A: Initial Treatment Period|Adverse Event|0
2191640|NCT01490632|3822392|FG010|Part A: Initial Treatment Period|Adverse Event|0
2191641|NCT01490632|3822393|FG011|Part A: Initial Treatment Period|Adverse Event|0
2191642|NCT01490632|3822394|FG012|Part A: Initial Treatment Period|Adverse Event|0
2191643|NCT01490632|3822395|FG013|Part A: Initial Treatment Period|Adverse Event|0
2191644|NCT01490632|3822396|FG014|Part A: Initial Treatment Period|Adverse Event|0
2191645|NCT01490632|3822397|FG015|Part A: Initial Treatment Period|Adverse Event|0
2191646|NCT01490632|3822398|FG016|Part A: Initial Treatment Period|Adverse Event|0
2191647|NCT01490632|3822399|FG017|Part A: Initial Treatment Period|Adverse Event|0
2191648|NCT01490632|3822400|FG018|Part A: Initial Treatment Period|Adverse Event|0
2191649|NCT01490632|3822401|FG019|Part A: Initial Treatment Period|Adverse Event|0
2191650|NCT01490632|3822382|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3
2191651|NCT01490632|3822383|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1
2191652|NCT01490632|3822384|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2
2191653|NCT01490632|3822385|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2
2191654|NCT01490632|3822386|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0
2191655|NCT01490632|3822387|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0
2191656|NCT01490632|3822388|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0
2191657|NCT01490632|3822389|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0
2191658|NCT01490632|3822390|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0
2191659|NCT01490632|3822391|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0
2191660|NCT01490632|3822392|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0
2191661|NCT01490632|3822393|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0
2191662|NCT01490632|3822394|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0
2223975|NCT01765153|3870812|FG001|Training Phase 1|Format of intervention differed|0
2223976|NCT01765153|3870811|FG000|Training Phase 1|Poor participation in intervention|0
2223977|NCT01765153|3870812|FG001|Training Phase 1|Poor participation in intervention|1
2223978|NCT01765153|3870811|FG000|Rest Phase 1|Withdrawal by Subject|0
2223979|NCT01765153|3870812|FG001|Rest Phase 1|Withdrawal by Subject|1
2223980|NCT01765153|3870811|FG000|Training Phase 2|Withdrawal by Subject|0
2223981|NCT01765153|3870812|FG001|Training Phase 2|Withdrawal by Subject|1
2223982|NCT01765153|3870811|FG000|Rest Phase 2|Lost to Follow-up|2
2223983|NCT01765153|3870812|FG001|Rest Phase 2|Lost to Follow-up|1
2223984|NCT01765179|3870822|FG000|Overall Study|Adverse Event|3
2223985|NCT01765179|3870822|FG000|Overall Study|Lost to Follow-up|5
2223986|NCT01765179|3870822|FG000|Overall Study|Non-compliance with study drug|2
2223987|NCT01765179|3870822|FG000|Overall Study|Protocol Violation|1
2223988|NCT01765179|3870822|FG000|Overall Study|Withdrawal by Subject|8
2223989|NCT01765179|3870822|FG000|Overall Study|Hematocrit >54%|3
2223990|NCT01765179|3870822|FG000|Overall Study|prohibited med|1
2223991|NCT01765179|3870822|FG000|Overall Study|Out of country unable to finish study|1
2223992|NCT01765179|3870822|FG000|Overall Study|lack of venous access|1
2223993|NCT01765179|3870822|FG000|Overall Study|work conflict|1
2223994|NCT01765179|3870822|FG000|Overall Study|Ca elevated 10.6|1
2223995|NCT01765192|3870828|FG000|Treatment Period 1|Adverse Event|0
2223996|NCT01765192|3870829|FG001|Treatment Period 1|Adverse Event|1
2223997|NCT01765192|3870828|FG000|Washout Period|Voluntary Withdrawal|1
2223998|NCT01765192|3870829|FG001|Washout Period|Voluntary Withdrawal|1
2223999|NCT01765192|3870828|FG000|Washout Period|Reason not specified|1
2224000|NCT01765192|3870829|FG001|Washout Period|Reason not specified|0
2224001|NCT01765192|3870828|FG000|Treatment Period 2|Reason not specified|0
2224002|NCT01765192|3870829|FG001|Treatment Period 2|Reason not specified|2
2224003|NCT01765192|3870828|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0
2224004|NCT01765192|3870829|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1
2224005|NCT01765270|3870837|FG000|Overall Study|Physician Decision|1
2224006|NCT01765270|3870838|FG001|Overall Study|Physician Decision|0
2224007|NCT01765270|3870837|FG000|Overall Study|Withdrawal by Subject|0
2191663|NCT01490632|3822395|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0
2191664|NCT01490632|3822396|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0
2191665|NCT01490632|3822397|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0
2191666|NCT01490632|3822398|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0
2191667|NCT01490632|3822399|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0
2191668|NCT01490632|3822400|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0
2191669|NCT01490632|3822401|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0
2191670|NCT01490632|3822382|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0
2191671|NCT01490632|3822383|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0
2191672|NCT01490632|3822384|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1
2191673|NCT01490632|3822385|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1
2191674|NCT01490632|3822386|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2
2191675|NCT01490632|3822387|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0
2191676|NCT01490632|3822388|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0
2191677|NCT01490632|3822389|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0
2191678|NCT01490632|3822390|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0
2191679|NCT01490632|3822391|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0
2191680|NCT01490632|3822392|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0
2191681|NCT01490632|3822393|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0
2191682|NCT01490632|3822394|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0
2191683|NCT01490632|3822395|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0
2191684|NCT01490632|3822396|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0
2191685|NCT01490632|3822397|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0
2191686|NCT01490632|3822398|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0
2191687|NCT01490632|3822399|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0
2191688|NCT01490632|3822400|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0
2191689|NCT01490632|3822401|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0
2191690|NCT01490632|3822382|FG000|Part A: Initial Treatment Period|Physician Decision|0
2191691|NCT01490632|3822383|FG001|Part A: Initial Treatment Period|Physician Decision|1
2191692|NCT01490632|3822384|FG002|Part A: Initial Treatment Period|Physician Decision|0
2191693|NCT01490632|3822385|FG003|Part A: Initial Treatment Period|Physician Decision|1
2191694|NCT01490632|3822386|FG004|Part A: Initial Treatment Period|Physician Decision|0
2191695|NCT01490632|3822387|FG005|Part A: Initial Treatment Period|Physician Decision|0
2191696|NCT01490632|3822388|FG006|Part A: Initial Treatment Period|Physician Decision|0
2191697|NCT01490632|3822389|FG007|Part A: Initial Treatment Period|Physician Decision|0
2191698|NCT01490632|3822390|FG008|Part A: Initial Treatment Period|Physician Decision|0
2191699|NCT01490632|3822391|FG009|Part A: Initial Treatment Period|Physician Decision|0
2191700|NCT01490632|3822392|FG010|Part A: Initial Treatment Period|Physician Decision|0
2191701|NCT01490632|3822393|FG011|Part A: Initial Treatment Period|Physician Decision|0
2191702|NCT01490632|3822394|FG012|Part A: Initial Treatment Period|Physician Decision|0
2191703|NCT01490632|3822395|FG013|Part A: Initial Treatment Period|Physician Decision|0
2191704|NCT01490632|3822396|FG014|Part A: Initial Treatment Period|Physician Decision|0
2191705|NCT01490632|3822397|FG015|Part A: Initial Treatment Period|Physician Decision|0
2191706|NCT01490632|3822398|FG016|Part A: Initial Treatment Period|Physician Decision|0
2191707|NCT01490632|3822399|FG017|Part A: Initial Treatment Period|Physician Decision|0
2191708|NCT01490632|3822400|FG018|Part A: Initial Treatment Period|Physician Decision|0
2191709|NCT01490632|3822401|FG019|Part A: Initial Treatment Period|Physician Decision|0
2191710|NCT01490632|3822382|FG000|Part A: Initial Treatment Period|Sponsor Decision|2
2191711|NCT01490632|3822383|FG001|Part A: Initial Treatment Period|Sponsor Decision|0
2224008|NCT01765270|3870838|FG001|Overall Study|Withdrawal by Subject|1
2224009|NCT01765426|3870849|FG000|Overall Study|Lost to Follow-up|0
2224010|NCT01765426|3870850|FG001|Overall Study|Lost to Follow-up|1
2224011|NCT01765426|3870851|FG002|Overall Study|Lost to Follow-up|0
2224012|NCT01765426|3870852|FG003|Overall Study|Lost to Follow-up|0
2224013|NCT01765543|3870882|FG000|Overall Study|Death|1
2224014|NCT01765543|3870882|FG000|Overall Study|Withdrawal by Subject|2
2224015|NCT01765569|3870890|FG000|Period B|Withdrawal by Subject|1
2224016|NCT01765569|3870890|FG000|Period C|Death|1
2224017|NCT01765582|3870900|FG000|Overall Study|Other|3
2224018|NCT01765582|3870901|FG001|Overall Study|Other|6
2224019|NCT01765582|3870902|FG002|Overall Study|Other|9
2224020|NCT01765582|3870900|FG000|Overall Study|Lost to Follow-up|2
2224021|NCT01765582|3870901|FG001|Overall Study|Lost to Follow-up|2
2224022|NCT01765582|3870902|FG002|Overall Study|Lost to Follow-up|1
2224023|NCT01765582|3870900|FG000|Overall Study|Death|31
2224024|NCT01765582|3870901|FG001|Overall Study|Death|36
2224025|NCT01765582|3870902|FG002|Overall Study|Death|33
2224026|NCT01765582|3870900|FG000|Overall Study|Sponsor Decision|46
2224027|NCT01765582|3870901|FG001|Overall Study|Sponsor Decision|42
2224028|NCT01765582|3870902|FG002|Overall Study|Sponsor Decision|42
2224029|NCT01765582|3870900|FG000|Overall Study|Withdrawal of Consent|11
2224030|NCT01765582|3870901|FG001|Overall Study|Withdrawal of Consent|6
2224031|NCT01765582|3870902|FG002|Overall Study|Withdrawal of Consent|10
2224032|NCT01765673|3870915|FG000|Overall Study|No transportation for 2nd/3rd visits|1
2224033|NCT01765751|3870934|FG000|Overall Study|Lost to Follow-up|0
2224034|NCT01765751|3870935|FG001|Overall Study|Lost to Follow-up|2
2191712|NCT01490632|3822384|FG002|Part A: Initial Treatment Period|Sponsor Decision|0
2191713|NCT01490632|3822385|FG003|Part A: Initial Treatment Period|Sponsor Decision|0
2191714|NCT01490632|3822386|FG004|Part A: Initial Treatment Period|Sponsor Decision|0
2191715|NCT01490632|3822387|FG005|Part A: Initial Treatment Period|Sponsor Decision|0
2191716|NCT01490632|3822388|FG006|Part A: Initial Treatment Period|Sponsor Decision|0
2191717|NCT01490632|3822389|FG007|Part A: Initial Treatment Period|Sponsor Decision|0
2224035|NCT01765751|3870936|FG002|Overall Study|Lost to Follow-up|1
2224036|NCT01765764|3870950|FG000|Treatment Period|Adverse Event|1
2224037|NCT01765764|3870951|FG001|Treatment Period|Adverse Event|2
2224038|NCT01765764|3870952|FG002|Treatment Period|Adverse Event|1
2224039|NCT01765764|3870950|FG000|Treatment Period|Lost to Follow-up|0
2224040|NCT01765764|3870951|FG001|Treatment Period|Lost to Follow-up|3
2224041|NCT01765764|3870952|FG002|Treatment Period|Lost to Follow-up|2
2224042|NCT01765764|3870950|FG000|Treatment Period|Personal Reasons|1
2224043|NCT01765764|3870951|FG001|Treatment Period|Personal Reasons|2
2224044|NCT01765764|3870952|FG002|Treatment Period|Personal Reasons|1
2224045|NCT01765764|3870950|FG000|Treatment Period|Other Miscellaneous Reasons|1
2224046|NCT01765764|3870951|FG001|Treatment Period|Other Miscellaneous Reasons|2
2224047|NCT01765764|3870952|FG002|Treatment Period|Other Miscellaneous Reasons|2
2224048|NCT01765920|3870966|FG000|Overall Study|Incorrect inclusion ineligible patient|2
2224049|NCT01765920|3870967|FG001|Overall Study|Incorrect inclusion ineligible patient|5
2224050|NCT01765920|3870966|FG000|Overall Study|Patient code disclosure|0
2224051|NCT01765920|3870967|FG001|Overall Study|Patient code disclosure|1
2224052|NCT01766037|3870999|FG000|Overall Study|Adverse Event|1
2224053|NCT01766037|3871000|FG001|Overall Study|Adverse Event|0
2224054|NCT01766037|3870999|FG000|Overall Study|Lack of Efficacy|1
2224055|NCT01766037|3871000|FG001|Overall Study|Lack of Efficacy|0
2224056|NCT01766037|3870999|FG000|Overall Study|Lost to Follow-up|0
2224057|NCT01766037|3871000|FG001|Overall Study|Lost to Follow-up|10
2224058|NCT01766037|3870999|FG000|Overall Study|Physician Decision|0
2224059|NCT01766037|3871000|FG001|Overall Study|Physician Decision|1
2224060|NCT01766037|3870999|FG000|Overall Study|Withdrawal by Subject|18
2224061|NCT01766037|3871000|FG001|Overall Study|Withdrawal by Subject|16
2224062|NCT01766037|3870999|FG000|Overall Study|Moved from area|5
2224063|NCT01766037|3871000|FG001|Overall Study|Moved from area|0
2224064|NCT01766037|3870999|FG000|Overall Study|medical - unrelated|1
2224065|NCT01766037|3871000|FG001|Overall Study|medical - unrelated|2
2224066|NCT01766037|3870999|FG000|Overall Study|nausea / discomfort|3
2224067|NCT01766037|3871000|FG001|Overall Study|nausea / discomfort|0
2224068|NCT01766050|3871006|FG000|Overall Study|Adverse Event|1
2224069|NCT01766050|3871006|FG000|Overall Study|Lost to Follow-up|1
2224070|NCT01766050|3871006|FG000|Overall Study|Withdrawal by Subject|2
2224071|NCT01766206|3871042|FG000|Overall Study|Withdrawal by Subject|22
2224072|NCT01766206|3871042|FG000|Overall Study|Lost to Follow-up|10
2224073|NCT01766206|3871042|FG000|Overall Study|Inappropriate enrollment|18
2224074|NCT01766206|3871042|FG000|Overall Study|Withdrawal and inappropriate enrollment|1
2224075|NCT01766310|3871062|FG000|Overall Study|Lost to Follow-up|1
2224076|NCT01766310|3871063|FG001|Overall Study|Lost to Follow-up|3
2224077|NCT01766336|3871071|FG000|Overall Study|Adverse Event|11
2224078|NCT01766336|3871072|FG001|Overall Study|Adverse Event|8
2224079|NCT01766336|3871071|FG000|Overall Study|Death|4
2224080|NCT01766336|3871072|FG001|Overall Study|Death|3
2224081|NCT01766336|3871071|FG000|Overall Study|Lost to Follow-up|1
2224082|NCT01766336|3871072|FG001|Overall Study|Lost to Follow-up|3
2224083|NCT01766336|3871071|FG000|Overall Study|Physician Decision|4
2224084|NCT01766336|3871072|FG001|Overall Study|Physician Decision|2
2224085|NCT01766336|3871071|FG000|Overall Study|Protocol Violation|0
2224086|NCT01766336|3871072|FG001|Overall Study|Protocol Violation|1
2224087|NCT01766336|3871071|FG000|Overall Study|Sponsor Decision|52
2224088|NCT01766336|3871072|FG001|Overall Study|Sponsor Decision|43
2224089|NCT01766336|3871071|FG000|Overall Study|Withdrawal by Subject|18
2224090|NCT01766336|3871072|FG001|Overall Study|Withdrawal by Subject|15
2224091|NCT01766401|3871080|FG000|Overall Study|Adverse Event|7
2224092|NCT01766401|3871081|FG001|Overall Study|Adverse Event|22
2224093|NCT01766401|3871080|FG000|Overall Study|Lack of Efficacy|1
2224094|NCT01766401|3871081|FG001|Overall Study|Lack of Efficacy|2
2224095|NCT01766401|3871080|FG000|Overall Study|Protocol Violation|3
2224096|NCT01766401|3871081|FG001|Overall Study|Protocol Violation|8
2224097|NCT01766401|3871080|FG000|Overall Study|Withdrawal by Subject|15
2224098|NCT01766401|3871081|FG001|Overall Study|Withdrawal by Subject|12
2224099|NCT01766401|3871080|FG000|Overall Study|Lost to Follow-up|10
2224100|NCT01766401|3871081|FG001|Overall Study|Lost to Follow-up|11
2224101|NCT01766401|3871080|FG000|Overall Study|Pregnancy|1
2224102|NCT01766401|3871081|FG001|Overall Study|Pregnancy|1
2224103|NCT01766778|3871116|FG000|Overall Study|Adverse Event|4
2224104|NCT01766778|3871117|FG001|Overall Study|Adverse Event|4
2224105|NCT01766778|3871116|FG000|Overall Study|Withdrawal by Subject|1
2224106|NCT01766778|3871117|FG001|Overall Study|Withdrawal by Subject|0
2224107|NCT01766817|3871126|FG000|Overall Study|Drug-related adverse event|1
2224108|NCT01766817|3871127|FG001|Overall Study|Drug-related adverse event|2
2224109|NCT01766817|3871128|FG002|Overall Study|Drug-related adverse event|1
2224110|NCT01766817|3871126|FG000|Overall Study|Drug-unrelated adverse event|3
2224111|NCT01766817|3871127|FG001|Overall Study|Drug-unrelated adverse event|3
2224112|NCT01766817|3871128|FG002|Overall Study|Drug-unrelated adverse event|3
2191718|NCT01490632|3822390|FG008|Part A: Initial Treatment Period|Sponsor Decision|0
2191719|NCT01490632|3822391|FG009|Part A: Initial Treatment Period|Sponsor Decision|0
2191720|NCT01490632|3822392|FG010|Part A: Initial Treatment Period|Sponsor Decision|0
2191721|NCT01490632|3822393|FG011|Part A: Initial Treatment Period|Sponsor Decision|0
2191722|NCT01490632|3822394|FG012|Part A: Initial Treatment Period|Sponsor Decision|0
2191723|NCT01490632|3822395|FG013|Part A: Initial Treatment Period|Sponsor Decision|0
2191724|NCT01490632|3822396|FG014|Part A: Initial Treatment Period|Sponsor Decision|0
2191725|NCT01490632|3822397|FG015|Part A: Initial Treatment Period|Sponsor Decision|0
2191726|NCT01490632|3822398|FG016|Part A: Initial Treatment Period|Sponsor Decision|0
2191727|NCT01490632|3822399|FG017|Part A: Initial Treatment Period|Sponsor Decision|0
2191728|NCT01490632|3822400|FG018|Part A: Initial Treatment Period|Sponsor Decision|0
2191729|NCT01490632|3822401|FG019|Part A: Initial Treatment Period|Sponsor Decision|0
2191730|NCT01490632|3822382|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2
2224113|NCT01766817|3871126|FG000|Overall Study|Death|1
2224114|NCT01766817|3871127|FG001|Overall Study|Death|1
2224115|NCT01766817|3871128|FG002|Overall Study|Death|0
2224116|NCT01766817|3871126|FG000|Overall Study|Unable to take study drug|0
2224117|NCT01766817|3871127|FG001|Overall Study|Unable to take study drug|1
2224118|NCT01766817|3871128|FG002|Overall Study|Unable to take study drug|0
2224119|NCT01766817|3871126|FG000|Overall Study|Withdrawal by Subject|2
2224120|NCT01766817|3871127|FG001|Overall Study|Withdrawal by Subject|0
2224121|NCT01766817|3871128|FG002|Overall Study|Withdrawal by Subject|3
2224122|NCT01766817|3871126|FG000|Overall Study|Subject non-compliance|0
2224123|NCT01766817|3871127|FG001|Overall Study|Subject non-compliance|1
2224124|NCT01766817|3871128|FG002|Overall Study|Subject non-compliance|2
2224125|NCT01766817|3871126|FG000|Overall Study|Physician Decision|3
2224126|NCT01766817|3871127|FG001|Overall Study|Physician Decision|3
2224127|NCT01766817|3871128|FG002|Overall Study|Physician Decision|4
2224128|NCT01766817|3871126|FG000|Overall Study|Other|1
2224129|NCT01766817|3871127|FG001|Overall Study|Other|0
2224130|NCT01766817|3871128|FG002|Overall Study|Other|0
2224131|NCT01766921|3871138|FG000|Overall Study|Administrative Reason|5
2224132|NCT01766921|3871139|FG001|Overall Study|Administrative Reason|5
2224133|NCT01766921|3871138|FG000|Overall Study|Death|1
2224134|NCT01766921|3871139|FG001|Overall Study|Death|1
2224135|NCT01766921|3871138|FG000|Overall Study|Lost to Follow-up|1
2224136|NCT01766921|3871139|FG001|Overall Study|Lost to Follow-up|3
2224137|NCT01766921|3871138|FG000|Overall Study|Unclassified|2
2224138|NCT01766921|3871139|FG001|Overall Study|Unclassified|2
2224139|NCT01766921|3871138|FG000|Overall Study|Protocol Violation|1
2224140|NCT01766921|3871139|FG001|Overall Study|Protocol Violation|1
2224141|NCT01766921|3871138|FG000|Overall Study|Withdrawal by Subject|14
2224142|NCT01766921|3871139|FG001|Overall Study|Withdrawal by Subject|5
2224143|NCT01767116|3871184|FG000|Overall Study|Lost to Follow-up|2
2224144|NCT01767116|3871185|FG001|Overall Study|Lost to Follow-up|2
2224145|NCT01767142|3871191|FG000|Overall Study|Lost to Follow-up|3
2224146|NCT01767194|3871206|FG000|Overall Study|Adverse Event|1
2224147|NCT01767194|3871207|FG001|Overall Study|Adverse Event|1
2224148|NCT01767194|3871206|FG000|Overall Study|Death|0
2224149|NCT01767194|3871207|FG001|Overall Study|Death|1
2224150|NCT01767194|3871206|FG000|Overall Study|Lack of Efficacy|12
2224151|NCT01767194|3871207|FG001|Overall Study|Lack of Efficacy|11
2224152|NCT01767194|3871206|FG000|Overall Study|Physician Decision|2
2224153|NCT01767194|3871207|FG001|Overall Study|Physician Decision|23
2224154|NCT01767194|3871206|FG000|Overall Study|Withdrawal by Subject|0
2224155|NCT01767194|3871207|FG001|Overall Study|Withdrawal by Subject|1
2224156|NCT01767194|3871206|FG000|Overall Study|Ineligible|1
2224157|NCT01767194|3871207|FG001|Overall Study|Ineligible|1
2224158|NCT01767194|3871206|FG000|Overall Study|Refusal by patient/parent|2
2224159|NCT01767194|3871207|FG001|Overall Study|Refusal by patient/parent|4
2224160|NCT01767194|3871206|FG000|Overall Study|Criteria not met on time for next cycle|0
2224161|NCT01767194|3871207|FG001|Overall Study|Criteria not met on time for next cycle|1
2224162|NCT01767376|3871226|FG000|Overall Study|Lost to Follow-up|3
2224163|NCT01767376|3871227|FG001|Overall Study|Lost to Follow-up|2
2224164|NCT01767376|3871228|FG002|Overall Study|Lost to Follow-up|0
2224165|NCT01767376|3871226|FG000|Overall Study|Withdrawal by Subject|1
2224166|NCT01767376|3871227|FG001|Overall Study|Withdrawal by Subject|1
2224167|NCT01767376|3871228|FG002|Overall Study|Withdrawal by Subject|0
2224168|NCT01767467|3871244|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8
2224169|NCT01767467|3871245|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8
2224170|NCT01767467|3871244|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1
2224171|NCT01767467|3871245|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0
2224172|NCT01767467|3871244|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
2224173|NCT01767467|3871245|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
2224174|NCT01767467|3871244|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
2224175|NCT01767467|3871245|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
2224176|NCT01767467|3871244|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1
2224177|NCT01767467|3871245|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0
2224178|NCT01767467|3871244|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0
2224179|NCT01767467|3871245|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1
2224180|NCT01767467|3871244|FG000|End of Study Phase (up to Month 13)|Adverse Event|29
2191731|NCT01490632|3822383|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2
2191732|NCT01490632|3822384|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191733|NCT01490632|3822385|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1
2191734|NCT01490632|3822386|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2
2224181|NCT01767467|3871245|FG001|End of Study Phase (up to Month 13)|Adverse Event|39
2224182|NCT01767467|3871244|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2
2224183|NCT01767467|3871245|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0
2191735|NCT01490632|3822387|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191736|NCT01490632|3822388|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191737|NCT01490632|3822389|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191738|NCT01490632|3822390|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191739|NCT01490632|3822391|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191740|NCT01490632|3822392|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191741|NCT01490632|3822393|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191742|NCT01490632|3822394|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191743|NCT01490632|3822395|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191744|NCT01490632|3822396|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191745|NCT01490632|3822397|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191746|NCT01490632|3822398|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191747|NCT01490632|3822399|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191748|NCT01490632|3822400|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191749|NCT01490632|3822401|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0
2191750|NCT01490632|3822382|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191751|NCT01490632|3822383|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191752|NCT01490632|3822384|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191753|NCT01490632|3822385|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191754|NCT01490632|3822386|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
2191755|NCT01490632|3822387|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191756|NCT01490632|3822388|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191757|NCT01490632|3822389|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191758|NCT01490632|3822390|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191759|NCT01490632|3822391|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191760|NCT01490632|3822392|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191761|NCT01490632|3822393|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191762|NCT01490632|3822394|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191763|NCT01490632|3822395|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191764|NCT01490632|3822396|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191765|NCT01490632|3822397|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191766|NCT01490632|3822398|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191767|NCT01490632|3822399|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191768|NCT01490632|3822400|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191769|NCT01490632|3822401|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2191770|NCT01490632|3822382|FG000|Part B: Extension or Step-Up Period|Adverse Event|0
2191771|NCT01490632|3822383|FG001|Part B: Extension or Step-Up Period|Adverse Event|0
2191772|NCT01490632|3822384|FG002|Part B: Extension or Step-Up Period|Adverse Event|0
2191773|NCT01490632|3822385|FG003|Part B: Extension or Step-Up Period|Adverse Event|0
2191774|NCT01490632|3822386|FG004|Part B: Extension or Step-Up Period|Adverse Event|0
2191775|NCT01490632|3822387|FG005|Part B: Extension or Step-Up Period|Adverse Event|2
2191776|NCT01490632|3822388|FG006|Part B: Extension or Step-Up Period|Adverse Event|2
2191777|NCT01490632|3822389|FG007|Part B: Extension or Step-Up Period|Adverse Event|0
2191778|NCT01490632|3822390|FG008|Part B: Extension or Step-Up Period|Adverse Event|0
2191779|NCT01490632|3822391|FG009|Part B: Extension or Step-Up Period|Adverse Event|2
2191780|NCT01490632|3822392|FG010|Part B: Extension or Step-Up Period|Adverse Event|3
2191781|NCT01490632|3822393|FG011|Part B: Extension or Step-Up Period|Adverse Event|1
2191782|NCT01490632|3822394|FG012|Part B: Extension or Step-Up Period|Adverse Event|0
2191783|NCT01490632|3822395|FG013|Part B: Extension or Step-Up Period|Adverse Event|0
2191784|NCT01490632|3822396|FG014|Part B: Extension or Step-Up Period|Adverse Event|0
2191785|NCT01490632|3822397|FG015|Part B: Extension or Step-Up Period|Adverse Event|0
2191786|NCT01490632|3822398|FG016|Part B: Extension or Step-Up Period|Adverse Event|0
2191787|NCT01490632|3822399|FG017|Part B: Extension or Step-Up Period|Adverse Event|0
2191788|NCT01490632|3822400|FG018|Part B: Extension or Step-Up Period|Adverse Event|0
2191789|NCT01490632|3822401|FG019|Part B: Extension or Step-Up Period|Adverse Event|0
2191790|NCT01490632|3822382|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191791|NCT01490632|3822383|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191792|NCT01490632|3822384|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191793|NCT01490632|3822385|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191794|NCT01490632|3822386|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191795|NCT01490632|3822387|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191796|NCT01490632|3822388|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1
2191797|NCT01490632|3822389|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191798|NCT01490632|3822390|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1
2191799|NCT01490632|3822391|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3
2191800|NCT01490632|3822392|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1
2191801|NCT01490632|3822393|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191802|NCT01490632|3822394|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191803|NCT01490632|3822395|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191804|NCT01490632|3822396|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191805|NCT01490632|3822397|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191806|NCT01490632|3822398|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191807|NCT01490632|3822399|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191808|NCT01490632|3822400|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191809|NCT01490632|3822401|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2191810|NCT01490632|3822382|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191811|NCT01490632|3822383|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191812|NCT01490632|3822384|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191813|NCT01490632|3822385|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191814|NCT01490632|3822386|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191815|NCT01490632|3822387|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191816|NCT01490632|3822388|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2
2191817|NCT01490632|3822389|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191818|NCT01490632|3822390|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191819|NCT01490632|3822391|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1
2191820|NCT01490632|3822392|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191821|NCT01490632|3822393|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191822|NCT01490632|3822394|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191823|NCT01490632|3822395|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191824|NCT01490632|3822396|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191825|NCT01490632|3822397|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191826|NCT01490632|3822398|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191827|NCT01490632|3822399|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191828|NCT01490632|3822400|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191829|NCT01490632|3822401|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2191830|NCT01490632|3822382|FG000|Part B: Extension or Step-Up Period|Physician Decision|0
2191831|NCT01490632|3822383|FG001|Part B: Extension or Step-Up Period|Physician Decision|0
2191832|NCT01490632|3822384|FG002|Part B: Extension or Step-Up Period|Physician Decision|0
2191833|NCT01490632|3822385|FG003|Part B: Extension or Step-Up Period|Physician Decision|0
2191834|NCT01490632|3822386|FG004|Part B: Extension or Step-Up Period|Physician Decision|0
2191835|NCT01490632|3822387|FG005|Part B: Extension or Step-Up Period|Physician Decision|0
2191836|NCT01490632|3822388|FG006|Part B: Extension or Step-Up Period|Physician Decision|1
2191837|NCT01490632|3822389|FG007|Part B: Extension or Step-Up Period|Physician Decision|0
2191838|NCT01490632|3822390|FG008|Part B: Extension or Step-Up Period|Physician Decision|0
2191839|NCT01490632|3822391|FG009|Part B: Extension or Step-Up Period|Physician Decision|0
2191840|NCT01490632|3822392|FG010|Part B: Extension or Step-Up Period|Physician Decision|0
2191841|NCT01490632|3822393|FG011|Part B: Extension or Step-Up Period|Physician Decision|0
2191842|NCT01490632|3822394|FG012|Part B: Extension or Step-Up Period|Physician Decision|0
2191843|NCT01490632|3822395|FG013|Part B: Extension or Step-Up Period|Physician Decision|0
2191844|NCT01490632|3822396|FG014|Part B: Extension or Step-Up Period|Physician Decision|0
2191845|NCT01490632|3822397|FG015|Part B: Extension or Step-Up Period|Physician Decision|0
2191846|NCT01490632|3822398|FG016|Part B: Extension or Step-Up Period|Physician Decision|0
2191847|NCT01490632|3822399|FG017|Part B: Extension or Step-Up Period|Physician Decision|0
2191848|NCT01490632|3822400|FG018|Part B: Extension or Step-Up Period|Physician Decision|0
2191849|NCT01490632|3822401|FG019|Part B: Extension or Step-Up Period|Physician Decision|0
2191850|NCT01490632|3822382|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191851|NCT01490632|3822383|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191852|NCT01490632|3822384|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191853|NCT01490632|3822385|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191854|NCT01490632|3822386|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191855|NCT01490632|3822387|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1
2191856|NCT01490632|3822388|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191857|NCT01490632|3822389|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191858|NCT01490632|3822390|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191859|NCT01490632|3822391|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191860|NCT01490632|3822392|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191861|NCT01490632|3822393|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0
2274130|NCT02293538|3955000|FG001|Overall Study|Adverse Event|1
2191862|NCT01490632|3822394|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191863|NCT01490632|3822395|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191864|NCT01490632|3822396|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191865|NCT01490632|3822397|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191866|NCT01490632|3822398|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191867|NCT01490632|3822399|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191868|NCT01490632|3822400|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191869|NCT01490632|3822401|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0
2191870|NCT01490632|3822382|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191871|NCT01490632|3822383|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191872|NCT01490632|3822384|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191873|NCT01490632|3822385|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191874|NCT01490632|3822386|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191875|NCT01490632|3822387|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191876|NCT01490632|3822388|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
2191877|NCT01490632|3822389|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191878|NCT01490632|3822390|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
2191879|NCT01490632|3822391|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191880|NCT01490632|3822392|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
2191881|NCT01490632|3822393|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
2191882|NCT01490632|3822394|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191883|NCT01490632|3822395|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191884|NCT01490632|3822396|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191885|NCT01490632|3822397|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191886|NCT01490632|3822398|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191887|NCT01490632|3822399|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191888|NCT01490632|3822400|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191889|NCT01490632|3822401|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2191890|NCT01490632|3822382|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191891|NCT01490632|3822383|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191892|NCT01490632|3822384|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191893|NCT01490632|3822385|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191894|NCT01490632|3822386|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191895|NCT01490632|3822387|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
2191896|NCT01490632|3822388|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
2191897|NCT01490632|3822389|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
2191898|NCT01490632|3822390|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
2191899|NCT01490632|3822391|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
2191900|NCT01490632|3822392|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
2191901|NCT01490632|3822393|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
2191902|NCT01490632|3822394|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191903|NCT01490632|3822395|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191904|NCT01490632|3822396|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191905|NCT01490632|3822397|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191906|NCT01490632|3822398|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191907|NCT01490632|3822399|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191908|NCT01490632|3822400|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191909|NCT01490632|3822401|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2191910|NCT01490632|3822382|FG000|Part C: Washout or Step-Down Period|Adverse Event|0
2191911|NCT01490632|3822383|FG001|Part C: Washout or Step-Down Period|Adverse Event|0
2191912|NCT01490632|3822384|FG002|Part C: Washout or Step-Down Period|Adverse Event|0
2191913|NCT01490632|3822385|FG003|Part C: Washout or Step-Down Period|Adverse Event|0
2191914|NCT01490632|3822386|FG004|Part C: Washout or Step-Down Period|Adverse Event|0
2191915|NCT01490632|3822387|FG005|Part C: Washout or Step-Down Period|Adverse Event|0
2224184|NCT01767467|3871244|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
2224185|NCT01767467|3871245|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
2224186|NCT01767467|3871244|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
2224187|NCT01767467|3871245|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
2224188|NCT01767467|3871244|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6
2224189|NCT01767467|3871245|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4
2224190|NCT01767467|3871244|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
2224191|NCT01767467|3871245|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
2224192|NCT01767467|3871244|FG000|End of Study Phase (up to Month 13)|Physician Decision|1
2224193|NCT01767467|3871245|FG001|End of Study Phase (up to Month 13)|Physician Decision|0
2224194|NCT01767467|3871244|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0
2224195|NCT01767467|3871245|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2
2224196|NCT01767493|3871258|FG000|Overall Study|screen failures|3
2224197|NCT01767519|3871274|FG000|Overall Study|Other Reasons|4
2191916|NCT01490632|3822388|FG006|Part C: Washout or Step-Down Period|Adverse Event|0
2191917|NCT01490632|3822389|FG007|Part C: Washout or Step-Down Period|Adverse Event|0
2191918|NCT01490632|3822390|FG008|Part C: Washout or Step-Down Period|Adverse Event|0
2191919|NCT01490632|3822391|FG009|Part C: Washout or Step-Down Period|Adverse Event|0
2191920|NCT01490632|3822392|FG010|Part C: Washout or Step-Down Period|Adverse Event|0
2191921|NCT01490632|3822393|FG011|Part C: Washout or Step-Down Period|Adverse Event|0
2191922|NCT01490632|3822394|FG012|Part C: Washout or Step-Down Period|Adverse Event|0
2191923|NCT01490632|3822395|FG013|Part C: Washout or Step-Down Period|Adverse Event|0
2191924|NCT01490632|3822396|FG014|Part C: Washout or Step-Down Period|Adverse Event|2
2191925|NCT01490632|3822397|FG015|Part C: Washout or Step-Down Period|Adverse Event|2
2191926|NCT01490632|3822398|FG016|Part C: Washout or Step-Down Period|Adverse Event|0
2191927|NCT01490632|3822399|FG017|Part C: Washout or Step-Down Period|Adverse Event|0
2191928|NCT01490632|3822400|FG018|Part C: Washout or Step-Down Period|Adverse Event|0
2191929|NCT01490632|3822401|FG019|Part C: Washout or Step-Down Period|Adverse Event|0
2191930|NCT01490632|3822382|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191931|NCT01490632|3822383|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191932|NCT01490632|3822384|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191933|NCT01490632|3822385|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191934|NCT01490632|3822386|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191935|NCT01490632|3822387|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191936|NCT01490632|3822388|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191937|NCT01490632|3822389|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191938|NCT01490632|3822390|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191939|NCT01490632|3822391|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191940|NCT01490632|3822392|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191941|NCT01490632|3822393|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191942|NCT01490632|3822394|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191943|NCT01490632|3822395|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1
2191944|NCT01490632|3822396|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191945|NCT01490632|3822397|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191946|NCT01490632|3822398|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191947|NCT01490632|3822399|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191948|NCT01490632|3822400|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191949|NCT01490632|3822401|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2191950|NCT01490632|3822382|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191951|NCT01490632|3822383|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191952|NCT01490632|3822384|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191953|NCT01490632|3822385|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191954|NCT01490632|3822386|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191955|NCT01490632|3822387|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191956|NCT01490632|3822388|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191957|NCT01490632|3822389|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191958|NCT01490632|3822390|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191959|NCT01490632|3822391|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191960|NCT01490632|3822392|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191961|NCT01490632|3822393|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191962|NCT01490632|3822394|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191963|NCT01490632|3822395|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191964|NCT01490632|3822396|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
2191965|NCT01490632|3822397|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
2191966|NCT01490632|3822398|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191967|NCT01490632|3822399|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191968|NCT01490632|3822400|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191969|NCT01490632|3822401|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2191970|NCT01490632|3822382|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191971|NCT01490632|3822383|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191972|NCT01490632|3822384|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191973|NCT01490632|3822385|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191974|NCT01490632|3822386|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191975|NCT01490632|3822387|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191976|NCT01490632|3822388|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191977|NCT01490632|3822389|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191978|NCT01490632|3822390|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191979|NCT01490632|3822391|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191980|NCT01490632|3822392|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191981|NCT01490632|3822393|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191982|NCT01490632|3822394|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
2191983|NCT01490632|3822395|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
2191984|NCT01490632|3822396|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
2191985|NCT01490632|3822397|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
2191986|NCT01490632|3822398|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191987|NCT01490632|3822399|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191988|NCT01490632|3822400|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191989|NCT01490632|3822401|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2191990|NCT01490632|3822382|FG000|Part D: Re-Treatment Period|Adverse Event|0
2191991|NCT01490632|3822383|FG001|Part D: Re-Treatment Period|Adverse Event|0
2191992|NCT01490632|3822384|FG002|Part D: Re-Treatment Period|Adverse Event|0
2191993|NCT01490632|3822385|FG003|Part D: Re-Treatment Period|Adverse Event|0
2191994|NCT01490632|3822386|FG004|Part D: Re-Treatment Period|Adverse Event|0
2191995|NCT01490632|3822387|FG005|Part D: Re-Treatment Period|Adverse Event|0
2191996|NCT01490632|3822388|FG006|Part D: Re-Treatment Period|Adverse Event|0
2191997|NCT01490632|3822389|FG007|Part D: Re-Treatment Period|Adverse Event|0
2191998|NCT01490632|3822390|FG008|Part D: Re-Treatment Period|Adverse Event|0
2191999|NCT01490632|3822391|FG009|Part D: Re-Treatment Period|Adverse Event|0
2192000|NCT01490632|3822392|FG010|Part D: Re-Treatment Period|Adverse Event|0
2192001|NCT01490632|3822393|FG011|Part D: Re-Treatment Period|Adverse Event|0
2192002|NCT01490632|3822394|FG012|Part D: Re-Treatment Period|Adverse Event|0
2192003|NCT01490632|3822395|FG013|Part D: Re-Treatment Period|Adverse Event|0
2192004|NCT01490632|3822396|FG014|Part D: Re-Treatment Period|Adverse Event|0
2192005|NCT01490632|3822397|FG015|Part D: Re-Treatment Period|Adverse Event|0
2192006|NCT01490632|3822398|FG016|Part D: Re-Treatment Period|Adverse Event|0
2192007|NCT01490632|3822399|FG017|Part D: Re-Treatment Period|Adverse Event|1
2192008|NCT01490632|3822400|FG018|Part D: Re-Treatment Period|Adverse Event|1
2192009|NCT01490632|3822401|FG019|Part D: Re-Treatment Period|Adverse Event|3
2192010|NCT01490632|3822382|FG000|Part D: Re-Treatment Period|Death|0
2192011|NCT01490632|3822383|FG001|Part D: Re-Treatment Period|Death|0
2192012|NCT01490632|3822384|FG002|Part D: Re-Treatment Period|Death|0
2192013|NCT01490632|3822385|FG003|Part D: Re-Treatment Period|Death|0
2192014|NCT01490632|3822386|FG004|Part D: Re-Treatment Period|Death|0
2192015|NCT01490632|3822387|FG005|Part D: Re-Treatment Period|Death|0
2192016|NCT01490632|3822388|FG006|Part D: Re-Treatment Period|Death|0
2192017|NCT01490632|3822389|FG007|Part D: Re-Treatment Period|Death|0
2192018|NCT01490632|3822390|FG008|Part D: Re-Treatment Period|Death|0
2192019|NCT01490632|3822391|FG009|Part D: Re-Treatment Period|Death|0
2192020|NCT01490632|3822392|FG010|Part D: Re-Treatment Period|Death|0
2192021|NCT01490632|3822393|FG011|Part D: Re-Treatment Period|Death|0
2192022|NCT01490632|3822394|FG012|Part D: Re-Treatment Period|Death|0
2192023|NCT01490632|3822395|FG013|Part D: Re-Treatment Period|Death|0
2192024|NCT01490632|3822396|FG014|Part D: Re-Treatment Period|Death|0
2192025|NCT01490632|3822397|FG015|Part D: Re-Treatment Period|Death|0
2192026|NCT01490632|3822398|FG016|Part D: Re-Treatment Period|Death|0
2192027|NCT01490632|3822399|FG017|Part D: Re-Treatment Period|Death|0
2192028|NCT01490632|3822400|FG018|Part D: Re-Treatment Period|Death|1
2192029|NCT01490632|3822401|FG019|Part D: Re-Treatment Period|Death|0
2192030|NCT01490632|3822382|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0
2192031|NCT01490632|3822383|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0
2192032|NCT01490632|3822384|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0
2192033|NCT01490632|3822385|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0
2192034|NCT01490632|3822386|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0
2192035|NCT01490632|3822387|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0
2192036|NCT01490632|3822388|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0
2192037|NCT01490632|3822389|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0
2192038|NCT01490632|3822390|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0
2192039|NCT01490632|3822391|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0
2192040|NCT01490632|3822392|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0
2192041|NCT01490632|3822393|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0
2192042|NCT01490632|3822394|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0
2192043|NCT01490632|3822395|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0
2192044|NCT01490632|3822396|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0
2192045|NCT01490632|3822397|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0
2192046|NCT01490632|3822398|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0
2192047|NCT01490632|3822399|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3
2192048|NCT01490632|3822400|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1
2192049|NCT01490632|3822401|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2
2192050|NCT01490632|3822382|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0
2192051|NCT01490632|3822383|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0
2192052|NCT01490632|3822384|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0
2192053|NCT01490632|3822385|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0
2192054|NCT01490632|3822386|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0
2192055|NCT01490632|3822387|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0
2192056|NCT01490632|3822388|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0
2192057|NCT01490632|3822389|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0
2192058|NCT01490632|3822390|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0
2192059|NCT01490632|3822391|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0
2192060|NCT01490632|3822392|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0
2192061|NCT01490632|3822393|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0
2192062|NCT01490632|3822394|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0
2192063|NCT01490632|3822395|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0
2192064|NCT01490632|3822396|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0
2192065|NCT01490632|3822397|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0
2192066|NCT01490632|3822398|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0
2192067|NCT01490632|3822399|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0
2192068|NCT01490632|3822400|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1
2192069|NCT01490632|3822401|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0
2192070|NCT01490632|3822382|FG000|Part D: Re-Treatment Period|Physician Decision|0
2192071|NCT01490632|3822383|FG001|Part D: Re-Treatment Period|Physician Decision|0
2192072|NCT01490632|3822384|FG002|Part D: Re-Treatment Period|Physician Decision|0
2192073|NCT01490632|3822385|FG003|Part D: Re-Treatment Period|Physician Decision|0
2192074|NCT01490632|3822386|FG004|Part D: Re-Treatment Period|Physician Decision|0
2192075|NCT01490632|3822387|FG005|Part D: Re-Treatment Period|Physician Decision|0
2192076|NCT01490632|3822388|FG006|Part D: Re-Treatment Period|Physician Decision|0
2192077|NCT01490632|3822389|FG007|Part D: Re-Treatment Period|Physician Decision|0
2192078|NCT01490632|3822390|FG008|Part D: Re-Treatment Period|Physician Decision|0
2224198|NCT01767519|3871275|FG001|Overall Study|Other Reasons|4
2224199|NCT01767519|3871276|FG002|Overall Study|Other Reasons|2
2224200|NCT01767519|3871274|FG000|Overall Study|Protocol Violation|0
2224201|NCT01767519|3871275|FG001|Overall Study|Protocol Violation|3
2224202|NCT01767519|3871276|FG002|Overall Study|Protocol Violation|0
2224203|NCT01767519|3871274|FG000|Overall Study|Personal Reasons|1
2224204|NCT01767519|3871275|FG001|Overall Study|Personal Reasons|0
2224205|NCT01767519|3871276|FG002|Overall Study|Personal Reasons|0
2224206|NCT01767519|3871274|FG000|Overall Study|Lost to Follow-up|3
2224207|NCT01767519|3871275|FG001|Overall Study|Lost to Follow-up|1
2224208|NCT01767519|3871276|FG002|Overall Study|Lost to Follow-up|2
2224209|NCT01767519|3871274|FG000|Overall Study|Lack of Efficacy|1
2224210|NCT01767519|3871275|FG001|Overall Study|Lack of Efficacy|0
2224211|NCT01767519|3871276|FG002|Overall Study|Lack of Efficacy|0
2224212|NCT01767519|3871274|FG000|Overall Study|Adverse Event|5
2224213|NCT01767519|3871275|FG001|Overall Study|Adverse Event|5
2224214|NCT01767519|3871276|FG002|Overall Study|Adverse Event|1
2224215|NCT01767597|3871286|FG000|Overall Study|Incomplete intervention|3
2224216|NCT01767597|3871287|FG001|Overall Study|Incomplete intervention|1
2224217|NCT01767597|3871286|FG000|Overall Study|Withdrawal by Subject|1
2224218|NCT01767597|3871287|FG001|Overall Study|Withdrawal by Subject|0
2224219|NCT01767857|3871318|FG000|Overall Study|Adverse Event|27
2224220|NCT01767857|3871319|FG001|Overall Study|Adverse Event|7
2224221|NCT01767857|3871318|FG000|Overall Study|Death|28
2224222|NCT01767857|3871319|FG001|Overall Study|Death|13
2224223|NCT01767857|3871318|FG000|Overall Study|Lack of Efficacy|299
2224224|NCT01767857|3871319|FG001|Overall Study|Lack of Efficacy|151
2224225|NCT01767857|3871318|FG000|Overall Study|Lost to Follow-up|1
2224226|NCT01767857|3871319|FG001|Overall Study|Lost to Follow-up|1
2224227|NCT01767857|3871318|FG000|Overall Study|Withdrawal by Subject|38
2224228|NCT01767857|3871319|FG001|Overall Study|Withdrawal by Subject|18
2224229|NCT01767857|3871318|FG000|Overall Study|Physician Decision|17
2224230|NCT01767857|3871319|FG001|Overall Study|Physician Decision|10
2224231|NCT01767857|3871318|FG000|Overall Study|Protocol Terminated|1
2224232|NCT01767857|3871319|FG001|Overall Study|Protocol Terminated|0
2224233|NCT01767857|3871318|FG000|Overall Study|Randomized But Never Treated|19
2224234|NCT01767857|3871319|FG001|Overall Study|Randomized But Never Treated|13
2224235|NCT01767909|3871328|FG000|Overall Study|Withdrawal by Subject|4
2224236|NCT01767909|3871329|FG001|Overall Study|Withdrawal by Subject|7
2224237|NCT01767909|3871328|FG000|Overall Study|Adverse Event|3
2224238|NCT01767909|3871329|FG001|Overall Study|Adverse Event|1
2224239|NCT01767909|3871328|FG000|Overall Study|Withdrawal by Study Partner|3
2224240|NCT01767909|3871329|FG001|Overall Study|Withdrawal by Study Partner|1
2224241|NCT01767909|3871328|FG000|Overall Study|Non-Compliance|2
2224242|NCT01767909|3871329|FG001|Overall Study|Non-Compliance|0
2224243|NCT01767909|3871328|FG000|Overall Study|Perceived Lack of Efficacy|1
2224244|NCT01767909|3871329|FG001|Overall Study|Perceived Lack of Efficacy|0
2224245|NCT01767909|3871328|FG000|Overall Study|Investigator Recommendation|0
2224246|NCT01767909|3871329|FG001|Overall Study|Investigator Recommendation|1
2224247|NCT01767909|3871328|FG000|Overall Study|Lost to Follow-up|0
2224248|NCT01767909|3871329|FG001|Overall Study|Lost to Follow-up|1
2224249|NCT01767909|3871328|FG000|Overall Study|LP uncessessful|0
2224250|NCT01767909|3871329|FG001|Overall Study|LP uncessessful|1
2224251|NCT01767987|3871343|FG000|Overall Study|Physician Decision|4
2224252|NCT01767987|3871344|FG001|Overall Study|Physician Decision|1
2224253|NCT01768117|3871373|FG000|Overall Study|Lost to Follow-up|1
2224254|NCT01768117|3871373|FG000|Overall Study|Withdrawal by Subject|2
2224255|NCT01768117|3871373|FG000|Overall Study|Protocol Violation|3
2224256|NCT01768286|3871381|FG000|Overall Study|Randomized But Not Treated|0
2224257|NCT01768286|3871382|FG001|Overall Study|Randomized But Not Treated|0
2224258|NCT01768286|3871383|FG002|Overall Study|Randomized But Not Treated|1
2224259|NCT01768286|3871384|FG003|Overall Study|Randomized But Not Treated|0
2192079|NCT01490632|3822391|FG009|Part D: Re-Treatment Period|Physician Decision|0
2192080|NCT01490632|3822392|FG010|Part D: Re-Treatment Period|Physician Decision|0
2192081|NCT01490632|3822393|FG011|Part D: Re-Treatment Period|Physician Decision|0
2192082|NCT01490632|3822394|FG012|Part D: Re-Treatment Period|Physician Decision|0
2192083|NCT01490632|3822395|FG013|Part D: Re-Treatment Period|Physician Decision|0
2192084|NCT01490632|3822396|FG014|Part D: Re-Treatment Period|Physician Decision|0
2192085|NCT01490632|3822397|FG015|Part D: Re-Treatment Period|Physician Decision|0
2192086|NCT01490632|3822398|FG016|Part D: Re-Treatment Period|Physician Decision|0
2192087|NCT01490632|3822399|FG017|Part D: Re-Treatment Period|Physician Decision|0
2192088|NCT01490632|3822400|FG018|Part D: Re-Treatment Period|Physician Decision|1
2192089|NCT01490632|3822401|FG019|Part D: Re-Treatment Period|Physician Decision|1
2192090|NCT01490632|3822382|FG000|Part D: Re-Treatment Period|Protocol Violation|0
2192091|NCT01490632|3822383|FG001|Part D: Re-Treatment Period|Protocol Violation|0
2192092|NCT01490632|3822384|FG002|Part D: Re-Treatment Period|Protocol Violation|0
2192093|NCT01490632|3822385|FG003|Part D: Re-Treatment Period|Protocol Violation|0
2192094|NCT01490632|3822386|FG004|Part D: Re-Treatment Period|Protocol Violation|0
2192095|NCT01490632|3822387|FG005|Part D: Re-Treatment Period|Protocol Violation|0
2192096|NCT01490632|3822388|FG006|Part D: Re-Treatment Period|Protocol Violation|0
2192097|NCT01490632|3822389|FG007|Part D: Re-Treatment Period|Protocol Violation|0
2192098|NCT01490632|3822390|FG008|Part D: Re-Treatment Period|Protocol Violation|0
2192099|NCT01490632|3822391|FG009|Part D: Re-Treatment Period|Protocol Violation|0
2192100|NCT01490632|3822392|FG010|Part D: Re-Treatment Period|Protocol Violation|0
2192101|NCT01490632|3822393|FG011|Part D: Re-Treatment Period|Protocol Violation|0
2192102|NCT01490632|3822394|FG012|Part D: Re-Treatment Period|Protocol Violation|0
2192103|NCT01490632|3822395|FG013|Part D: Re-Treatment Period|Protocol Violation|0
2192104|NCT01490632|3822396|FG014|Part D: Re-Treatment Period|Protocol Violation|0
2192105|NCT01490632|3822397|FG015|Part D: Re-Treatment Period|Protocol Violation|0
2192106|NCT01490632|3822398|FG016|Part D: Re-Treatment Period|Protocol Violation|0
2192107|NCT01490632|3822399|FG017|Part D: Re-Treatment Period|Protocol Violation|0
2192108|NCT01490632|3822400|FG018|Part D: Re-Treatment Period|Protocol Violation|1
2192109|NCT01490632|3822401|FG019|Part D: Re-Treatment Period|Protocol Violation|0
2192110|NCT01490632|3822382|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192111|NCT01490632|3822383|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192112|NCT01490632|3822384|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192113|NCT01490632|3822385|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192114|NCT01490632|3822386|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192115|NCT01490632|3822387|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192116|NCT01490632|3822388|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192117|NCT01490632|3822389|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192118|NCT01490632|3822390|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192119|NCT01490632|3822391|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192120|NCT01490632|3822392|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192121|NCT01490632|3822393|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192122|NCT01490632|3822394|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192123|NCT01490632|3822395|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192124|NCT01490632|3822396|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192125|NCT01490632|3822397|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192126|NCT01490632|3822398|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0
2192127|NCT01490632|3822399|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1
2192128|NCT01490632|3822400|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1
2192129|NCT01490632|3822401|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1
2192130|NCT01490697|3822450|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
2192131|NCT01490697|3822451|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
2192132|NCT01490814|3822476|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3
2192133|NCT01490814|3822477|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3
2192134|NCT01490814|3822476|FG000|Overall Study|Physician Decision|1
2192135|NCT01490814|3822477|FG001|Overall Study|Physician Decision|0
2192136|NCT01490814|3822476|FG000|Overall Study|Withdrawal by Subject|0
2192137|NCT01490814|3822477|FG001|Overall Study|Withdrawal by Subject|5
2192138|NCT01490840|3822485|FG000|Phase 1|Lost to Follow-up|1
2192139|NCT01490840|3822486|FG001|Phase 1|Lost to Follow-up|0
2192140|NCT01490840|3822485|FG000|Phase 1|Adverse Event|2
2192141|NCT01490840|3822486|FG001|Phase 1|Adverse Event|1
2192142|NCT01490840|3822485|FG000|Phase 1|Withdrawal by Subject|6
2192143|NCT01490840|3822486|FG001|Phase 1|Withdrawal by Subject|5
2192144|NCT01490840|3822485|FG000|Phase 1|Visit 6a omitted|1
2192145|NCT01490840|3822486|FG001|Phase 1|Visit 6a omitted|0
2192146|NCT01490840|3822485|FG000|Phase 2|Withdrawal by Subject|4
2192147|NCT01490840|3822486|FG001|Phase 2|Withdrawal by Subject|3
2192148|NCT01490840|3822485|FG000|Phase 2|Permanent interruption of fingolimod|0
2192149|NCT01490840|3822486|FG001|Phase 2|Permanent interruption of fingolimod|1
2192150|NCT01490840|3822485|FG000|Phase 2|Lost to Follow-up|1
2192151|NCT01490840|3822486|FG001|Phase 2|Lost to Follow-up|1
2192152|NCT01490840|3822485|FG000|Phase 2|Adverse Event|1
2192153|NCT01490840|3822486|FG001|Phase 2|Adverse Event|1
2192154|NCT01490866|3822492|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6
2192155|NCT01490866|3822492|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6
2192156|NCT01490866|3822492|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
2192157|NCT01490866|3822492|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
2192158|NCT01490866|3822492|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
2192159|NCT01490866|3822492|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2
2192160|NCT01490866|3822492|FG000|Axitinib Maintenance Therapy|Disease Progression|30
2192161|NCT01490866|3822492|FG000|Axitinib Maintenance Therapy|Adverse Event|12
2192162|NCT01490866|3822492|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3
2192163|NCT01490866|3822492|FG000|Axitinib Maintenance Therapy|Protocol Violation|2
2192164|NCT01490866|3822492|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2
2192165|NCT01490918|3822506|FG000|Overall Study|Lost to Follow-up|2
2192166|NCT01490918|3822507|FG001|Overall Study|Lost to Follow-up|1
2192167|NCT01490918|3822508|FG002|Overall Study|Lost to Follow-up|0
2192168|NCT01490918|3822506|FG000|Overall Study|Withdrawal by Subject|7
2224260|NCT01768286|3871381|FG000|Overall Study|Lack of Efficacy|7
2224261|NCT01768286|3871382|FG001|Overall Study|Lack of Efficacy|4
2224262|NCT01768286|3871383|FG002|Overall Study|Lack of Efficacy|0
2224263|NCT01768286|3871384|FG003|Overall Study|Lack of Efficacy|1
2224264|NCT01768286|3871381|FG000|Overall Study|Withdrew Consent|0
2224265|NCT01768286|3871382|FG001|Overall Study|Withdrew Consent|0
2224266|NCT01768286|3871383|FG002|Overall Study|Withdrew Consent|1
2224267|NCT01768286|3871384|FG003|Overall Study|Withdrew Consent|0
2224268|NCT01768559|3871421|FG000|Overall Study|Randomized but not treated|0
2224269|NCT01768559|3871422|FG001|Overall Study|Randomized but not treated|0
2224270|NCT01768559|3871423|FG002|Overall Study|Randomized but not treated|1
2224271|NCT01768559|3871421|FG000|Overall Study|Adverse Event|15
2224272|NCT01768559|3871422|FG001|Overall Study|Adverse Event|2
2224273|NCT01768559|3871423|FG002|Overall Study|Adverse Event|5
2224274|NCT01768559|3871421|FG000|Overall Study|Lack of Efficacy|6
2224275|NCT01768559|3871422|FG001|Overall Study|Lack of Efficacy|4
2224276|NCT01768559|3871423|FG002|Overall Study|Lack of Efficacy|0
2224277|NCT01768559|3871421|FG000|Overall Study|Poor compliance to protocol|0
2224278|NCT01768559|3871422|FG001|Overall Study|Poor compliance to protocol|3
2224279|NCT01768559|3871423|FG002|Overall Study|Poor compliance to protocol|2
2332364|NCT03192488|4055750|FG002|First Washout (>6d)|Withdrawal by Subject|1
2332365|NCT03192488|4055751|FG003|First Washout (>6d)|Withdrawal by Subject|0
2332366|NCT03192488|4055752|FG004|First Washout (>6d)|Withdrawal by Subject|0
2332367|NCT03192488|4055753|FG005|First Washout (>6d)|Withdrawal by Subject|1
2332368|NCT03192488|4055748|FG000|Third Intervention (d1)|Adverse Event|0
2332369|NCT03192488|4055749|FG001|Third Intervention (d1)|Adverse Event|0
2332370|NCT03192488|4055750|FG002|Third Intervention (d1)|Adverse Event|0
2332371|NCT03192488|4055751|FG003|Third Intervention (d1)|Adverse Event|0
2332372|NCT03192488|4055752|FG004|Third Intervention (d1)|Adverse Event|1
2332373|NCT03192488|4055753|FG005|Third Intervention (d1)|Adverse Event|0
2332374|NCT03192904|4055782|FG000|Overall Study|Physician Decision|3
2332375|NCT03192904|4055783|FG001|Overall Study|Physician Decision|1
2332376|NCT03192904|4055782|FG000|Overall Study|Lost to Follow-up|0
2332377|NCT03192904|4055783|FG001|Overall Study|Lost to Follow-up|1
2332378|NCT03193021|4055791|FG000|Overall Study|Lost to Follow-up|1
2332379|NCT03193021|4055792|FG001|Overall Study|Lost to Follow-up|1
2332380|NCT03193047|4055800|FG000|Overall Study|Physician Decision|1
2332381|NCT03193047|4055801|FG001|Overall Study|Physician Decision|0
2332382|NCT03193047|4055800|FG000|Overall Study|Participant Left State|1
2332383|NCT03193047|4055801|FG001|Overall Study|Participant Left State|0
2332384|NCT03193736|4055847|FG000|Overall Study|Death|2
2332385|NCT03193736|4055847|FG000|Overall Study|Withdrawal by Subject|1
2332386|NCT03193736|4055847|FG000|Overall Study|Lost to Follow-up|1
2332387|NCT03193736|4055847|FG000|Overall Study|implant not received|1
2332388|NCT03194217|4055855|FG000|Overall Study|Adverse Event|0
2332389|NCT03194217|4055856|FG001|Overall Study|Adverse Event|2
2332390|NCT03194217|4055857|FG002|Overall Study|Adverse Event|3
2332391|NCT03194217|4055858|FG003|Overall Study|Adverse Event|3
2332392|NCT03194217|4055855|FG000|Overall Study|Failure to meet randomisation criteria|0
2332393|NCT03194217|4055856|FG001|Overall Study|Failure to meet randomisation criteria|0
2332394|NCT03194217|4055857|FG002|Overall Study|Failure to meet randomisation criteria|0
2332395|NCT03194217|4055858|FG003|Overall Study|Failure to meet randomisation criteria|1
2332396|NCT03194217|4055855|FG000|Overall Study|Other|0
2332397|NCT03194217|4055856|FG001|Overall Study|Other|1
2332398|NCT03194217|4055857|FG002|Overall Study|Other|1
2332399|NCT03194217|4055858|FG003|Overall Study|Other|0
2332400|NCT03194464|4055886|FG000|Overall Study|data not usable|2
2332401|NCT03194490|4055894|FG000|Overall Study|Lost to Follow-up|1
2332402|NCT03194490|4055895|FG001|Overall Study|Lost to Follow-up|3
2332403|NCT03194490|4055894|FG000|Overall Study|participant developed specific neck pain|1
2332404|NCT03194490|4055895|FG001|Overall Study|participant developed specific neck pain|0
2332405|NCT03196193|4055975|FG000|Overall Study|Adverse Event|1
2332406|NCT03196193|4055976|FG001|Overall Study|Adverse Event|0
2332407|NCT03196193|4055975|FG000|Overall Study|Computed Tomography (CT) data missing|2
2332408|NCT03196193|4055976|FG001|Overall Study|Computed Tomography (CT) data missing|0
2332409|NCT03196284|4055988|FG000|Main Part|Withdrawal by Subject|0
2332410|NCT03196284|4055989|FG001|Main Part|Withdrawal by Subject|1
2332411|NCT03196284|4055990|FG002|Main Part|Withdrawal by Subject|0
2332412|NCT03196284|4055988|FG000|Extension Part|Lack of Efficacy|0
2332413|NCT03196284|4055989|FG001|Extension Part|Lack of Efficacy|0
2332414|NCT03196284|4055990|FG002|Extension Part|Lack of Efficacy|1
2192169|NCT01490918|3822507|FG001|Overall Study|Withdrawal by Subject|8
2192170|NCT01490918|3822508|FG002|Overall Study|Withdrawal by Subject|3
2192171|NCT01490918|3822506|FG000|Overall Study|Adverse Event|0
2192172|NCT01490918|3822507|FG001|Overall Study|Adverse Event|0
2192173|NCT01490918|3822508|FG002|Overall Study|Adverse Event|1
2192174|NCT01490918|3822506|FG000|Overall Study|other cause|4
2192175|NCT01490918|3822507|FG001|Overall Study|other cause|5
2192176|NCT01490918|3822508|FG002|Overall Study|other cause|8
2192177|NCT01491035|3822545|FG000|Overall Study|Lost to Follow-up|0
2192178|NCT01491035|3822546|FG001|Overall Study|Lost to Follow-up|0
2192179|NCT01491035|3822547|FG002|Overall Study|Lost to Follow-up|0
2192180|NCT01491035|3822548|FG003|Overall Study|Lost to Follow-up|0
2192181|NCT01491035|3822549|FG004|Overall Study|Lost to Follow-up|1
2192182|NCT01491035|3822550|FG005|Overall Study|Lost to Follow-up|0
2192183|NCT01491035|3822551|FG006|Overall Study|Lost to Follow-up|0
2192184|NCT01491035|3822552|FG007|Overall Study|Lost to Follow-up|0
2192185|NCT01491178|3822593|FG000|Overall Study|Adverse Event|1016
2192186|NCT01491178|3822593|FG000|Overall Study|Improvement of NVAF|210
2192187|NCT01491178|3822593|FG000|Overall Study|To conduct invasive treatment|59
2192188|NCT01491178|3822593|FG000|Overall Study|Lost to follow-up (unknown reason)|287
2192189|NCT01491178|3822593|FG000|Overall Study|Lost to follow-up (changing hospital)|545
2192190|NCT01491178|3822593|FG000|Overall Study|To take a contraindication|20
2192191|NCT01491178|3822593|FG000|Overall Study|Other than specified above|657
2192192|NCT01491607|3822610|FG000|Overall Study|Lost to Follow-up|7
2192193|NCT01491607|3822610|FG000|Overall Study|Withdrawal by Subject|3
2192194|NCT01491672|3822683|FG000|Overall Study|Lost to Follow-up|0
2192195|NCT01491672|3822684|FG001|Overall Study|Lost to Follow-up|4
2192196|NCT01491672|3822685|FG002|Overall Study|Lost to Follow-up|1
2192197|NCT01491672|3822683|FG000|Overall Study|Withdrawal by Subject|6
2192198|NCT01491672|3822684|FG001|Overall Study|Withdrawal by Subject|7
2192199|NCT01491672|3822685|FG002|Overall Study|Withdrawal by Subject|0
2192200|NCT01491672|3822683|FG000|Overall Study|Adverse Event|8
2192201|NCT01491672|3822684|FG001|Overall Study|Adverse Event|10
2192202|NCT01491672|3822685|FG002|Overall Study|Adverse Event|4
2192203|NCT01491672|3822683|FG000|Overall Study|Disease progression|42
2192204|NCT01491672|3822684|FG001|Overall Study|Disease progression|34
2192205|NCT01491672|3822685|FG002|Overall Study|Disease progression|6
2192206|NCT01491672|3822683|FG000|Overall Study|Protocol deviation|0
2192207|NCT01491672|3822684|FG001|Overall Study|Protocol deviation|1
2192208|NCT01491672|3822685|FG002|Overall Study|Protocol deviation|0
2192209|NCT01491672|3822683|FG000|Overall Study|Death|0
2192210|NCT01491672|3822684|FG001|Overall Study|Death|4
2192211|NCT01491672|3822685|FG002|Overall Study|Death|0
2192212|NCT01491737|3822697|FG000|Overall Study|Withdrawal by Subject|20
2192213|NCT01491737|3822698|FG001|Overall Study|Withdrawal by Subject|17
2192214|NCT01491737|3822697|FG000|Overall Study|Lost to Follow-up|2
2192215|NCT01491737|3822698|FG001|Overall Study|Lost to Follow-up|10
2192216|NCT01491737|3822697|FG000|Overall Study|Death|63
2192217|NCT01491737|3822698|FG001|Overall Study|Death|57
2192218|NCT01491737|3822697|FG000|Overall Study|Study Termination by Sponsor|36
2192219|NCT01491737|3822698|FG001|Overall Study|Study Termination by Sponsor|36
2192220|NCT01491737|3822697|FG000|Overall Study|Reason Not Specified|8
2192221|NCT01491737|3822698|FG001|Overall Study|Reason Not Specified|9
2192222|NCT01491802|3822704|FG000|Overall Study|Adverse Event|1
2192223|NCT01491802|3822705|FG001|Overall Study|Adverse Event|1
2192224|NCT01491802|3822704|FG000|Overall Study|Withdrawal by Subject|0
2192225|NCT01491802|3822705|FG001|Overall Study|Withdrawal by Subject|1
2192226|NCT01491841|3822712|FG000|Overall Study|Screen Failure|10
2192227|NCT01491841|3822712|FG000|Overall Study|Withdrawal by Subject|1
2192228|NCT01491854|3822724|FG000|Overall Study|mainly due to premature termination|93
2192229|NCT01491854|3822724|FG000|Overall Study|Death|1
2192230|NCT01491854|3822724|FG000|Overall Study|Withdrawal by Subject|3
2192231|NCT01491854|3822724|FG000|Overall Study|Lost to Follow-up|33
2192232|NCT01491919|3822731|FG000|Overall Study|Insufficient PK sampling|1
2192233|NCT01491919|3822732|FG001|Overall Study|Insufficient PK sampling|2
2192234|NCT01491919|3822733|FG002|Overall Study|Insufficient PK sampling|1
2192235|NCT01491945|3822743|FG000|Overall Study|Death|30
2192236|NCT01491945|3822743|FG000|Overall Study|Withdrwan/LTF|16
2192237|NCT01491945|3822743|FG000|Overall Study|Conversion|4
2192238|NCT01491945|3822743|FG000|Overall Study|Missed Visit|1
2192239|NCT01492088|3822768|FG000|Overall Study|Withdrawal by Patient|0
2192240|NCT01492088|3822769|FG001|Overall Study|Withdrawal by Patient|2
2192241|NCT01492088|3822770|FG002|Overall Study|Withdrawal by Patient|0
2192242|NCT01492088|3822768|FG000|Overall Study|Death|1
2192243|NCT01492088|3822769|FG001|Overall Study|Death|6
2192244|NCT01492088|3822770|FG002|Overall Study|Death|2
2192245|NCT01492088|3822768|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2
2192246|NCT01492088|3822769|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0
2192247|NCT01492088|3822770|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1
2192248|NCT01492088|3822768|FG000|Overall Study|Alive at Last Follow-up|0
2192249|NCT01492088|3822769|FG001|Overall Study|Alive at Last Follow-up|6
2192250|NCT01492088|3822770|FG002|Overall Study|Alive at Last Follow-up|11
2192251|NCT01492101|3822783|FG000|Overall Study|Death|323
2192252|NCT01492101|3822784|FG001|Overall Study|Death|322
2192253|NCT01492101|3822783|FG000|Overall Study|Withdrawal by Subject|14
2192254|NCT01492101|3822784|FG001|Overall Study|Withdrawal by Subject|18
2192255|NCT01492101|3822783|FG000|Overall Study|Lost to Follow-up|0
2192256|NCT01492101|3822784|FG001|Overall Study|Lost to Follow-up|2
2192257|NCT01492400|3822801|FG000|Overall Study|Miscellaneous Reasons|2
2192258|NCT01492400|3822802|FG001|Overall Study|Miscellaneous Reasons|3
2192259|NCT01492400|3822801|FG000|Overall Study|Personal Reasons|0
2224280|NCT01768559|3871421|FG000|Overall Study|Other than specified|9
2192260|NCT01492400|3822802|FG001|Overall Study|Personal Reasons|5
2192261|NCT01492400|3822801|FG000|Overall Study|Lost to Follow-up|3
2192262|NCT01492400|3822802|FG001|Overall Study|Lost to Follow-up|1
2192263|NCT01492400|3822801|FG000|Overall Study|Pregnancy|0
2192264|NCT01492400|3822802|FG001|Overall Study|Pregnancy|1
2192265|NCT01492400|3822801|FG000|Overall Study|Lack of Efficacy|1
2192266|NCT01492400|3822802|FG001|Overall Study|Lack of Efficacy|1
2192267|NCT01492400|3822801|FG000|Overall Study|Adverse Event|10
2192268|NCT01492400|3822802|FG001|Overall Study|Adverse Event|5
2192269|NCT01492426|3822810|FG000|Treatment|Death|0
2192270|NCT01492426|3822811|FG001|Treatment|Death|1
2192271|NCT01492426|3822810|FG000|Treatment|Other|1
2192272|NCT01492426|3822811|FG001|Treatment|Other|0
2192273|NCT01492426|3822810|FG000|Treatment|Adverse Event|25
2192274|NCT01492426|3822811|FG001|Treatment|Adverse Event|25
2192275|NCT01492426|3822810|FG000|Treatment|Lack of Efficacy|38
2192276|NCT01492426|3822811|FG001|Treatment|Lack of Efficacy|5
2192277|NCT01492426|3822810|FG000|Treatment|Participant withdrew consent|1
2192278|NCT01492426|3822811|FG001|Treatment|Participant withdrew consent|2
2192279|NCT01492426|3822810|FG000|Treatment|Poor compliance/noncompliance|1
2192280|NCT01492426|3822811|FG001|Treatment|Poor compliance/noncompliance|0
2192281|NCT01492426|3822810|FG000|Treatment|Subject requested discontinue study drug|7
2192282|NCT01492426|3822811|FG001|Treatment|Subject requested discontinue study drug|3
2192283|NCT01492426|3822810|FG000|Treatment|Lost to Follow-up|9
2192284|NCT01492426|3822811|FG001|Treatment|Lost to Follow-up|4
2192285|NCT01492426|3822810|FG000|Treatment|Participant does not meet study criteria|1
2192286|NCT01492426|3822811|FG001|Treatment|Participant does not meet study criteria|0
2192287|NCT01492426|3822810|FG000|Follow-Up|Protocol Requires no Follow-Up|2
2192288|NCT01492426|3822811|FG001|Follow-Up|Protocol Requires no Follow-Up|1
2192289|NCT01492426|3822810|FG000|Follow-Up|Death|1
2192290|NCT01492426|3822811|FG001|Follow-Up|Death|0
2192291|NCT01492426|3822810|FG000|Follow-Up|Other|4
2192292|NCT01492426|3822811|FG001|Follow-Up|Other|2
2192293|NCT01492426|3822810|FG000|Follow-Up|Participant Withdrew Consent|6
2192294|NCT01492426|3822811|FG001|Follow-Up|Participant Withdrew Consent|1
2192295|NCT01492426|3822810|FG000|Follow-Up|Lost to Follow-up|12
2192296|NCT01492426|3822811|FG001|Follow-Up|Lost to Follow-up|6
2192297|NCT01492439|3822823|FG000|Overall Study|Withdrew from RTE|4
2192298|NCT01492439|3822824|FG001|Overall Study|Withdrew from RTE|9
2192299|NCT01492686|3822862|FG000|Double-blind Phase|Adverse Event|0
2192300|NCT01492686|3822863|FG001|Double-blind Phase|Adverse Event|2
2192301|NCT01492686|3822862|FG000|Double-blind Phase|Physician Decision|0
2192302|NCT01492686|3822863|FG001|Double-blind Phase|Physician Decision|1
2192303|NCT01492686|3822862|FG000|Double-blind Phase|Withdrawal by Subject|0
2192304|NCT01492686|3822863|FG001|Double-blind Phase|Withdrawal by Subject|2
2192305|NCT01492686|3822862|FG000|Double-blind Phase|Due to a discontinuation criterion|2
2192306|NCT01492686|3822863|FG001|Double-blind Phase|Due to a discontinuation criterion|3
2192307|NCT01492686|3822862|FG000|Open-label Phase|Adverse Event|1
2192308|NCT01492686|3822863|FG001|Open-label Phase|Adverse Event|2
2192309|NCT01492686|3822862|FG000|Open-label Phase|Physician Decision|1
2192310|NCT01492686|3822863|FG001|Open-label Phase|Physician Decision|0
2192311|NCT01492686|3822862|FG000|Open-label Phase|Withdrawal by Subject|6
2192312|NCT01492686|3822863|FG001|Open-label Phase|Withdrawal by Subject|7
2192313|NCT01492686|3822862|FG000|Open-label Phase|Due to a discontinuation criterion|4
2192314|NCT01492686|3822863|FG001|Open-label Phase|Due to a discontinuation criterion|9
2192315|NCT01493089|3822891|FG000|Overall Study|Protocol Violation|2
2224281|NCT01768559|3871422|FG001|Overall Study|Other than specified|8
2224282|NCT01768559|3871423|FG002|Overall Study|Other than specified|5
2224283|NCT01768572|3871438|FG000|Overall Study|Adverse Event|7
2224284|NCT01768572|3871439|FG001|Overall Study|Adverse Event|8
2224285|NCT01768572|3871440|FG002|Overall Study|Adverse Event|4
2224286|NCT01768572|3871438|FG000|Overall Study|Lack of Efficacy|1
2224287|NCT01768572|3871439|FG001|Overall Study|Lack of Efficacy|3
2224288|NCT01768572|3871440|FG002|Overall Study|Lack of Efficacy|1
2224289|NCT01768572|3871438|FG000|Overall Study|Other, Not due to an adverse event|1
2224290|NCT01768572|3871439|FG001|Overall Study|Other, Not due to an adverse event|1
2224291|NCT01768572|3871440|FG002|Overall Study|Other, Not due to an adverse event|1
2224292|NCT01768637|3871450|FG000|Overall Study|Lost to Follow-up|2
2224293|NCT01768637|3871451|FG001|Overall Study|Lost to Follow-up|7
2224294|NCT01768637|3871450|FG000|Overall Study|Difficult blood draw|1
2224295|NCT01768637|3871451|FG001|Overall Study|Difficult blood draw|0
2224296|NCT01768676|3871459|FG000|Overall Study|Adverse Event|3
2224297|NCT01768676|3871460|FG001|Overall Study|Adverse Event|3
2224298|NCT01768676|3871459|FG000|Overall Study|Lost to Follow-up|13
2224299|NCT01768676|3871460|FG001|Overall Study|Lost to Follow-up|16
2224300|NCT01768676|3871459|FG000|Overall Study|Protocol Violation|1
2192316|NCT01493089|3822892|FG001|Overall Study|Protocol Violation|2
2224301|NCT01768676|3871460|FG001|Overall Study|Protocol Violation|1
2192317|NCT01493089|3822891|FG000|Overall Study|Withdrawal by Subject|1
2192318|NCT01493089|3822892|FG001|Overall Study|Withdrawal by Subject|0
2192319|NCT01493089|3822891|FG000|Overall Study|Physician Decision|0
2192320|NCT01493089|3822892|FG001|Overall Study|Physician Decision|1
2192321|NCT01493284|3822913|FG000|Overall Study|Death|29
2192322|NCT01493284|3822913|FG000|Overall Study|Withdrawal by Subject|32
2192323|NCT01493414|3822917|FG000|Overall Study|Adverse Event|405
2192324|NCT01493414|3822917|FG000|Overall Study|Disease progression|204
2192325|NCT01493414|3822917|FG000|Overall Study|Death|101
2192326|NCT01493414|3822917|FG000|Overall Study|Physician Decision|93
2192327|NCT01493414|3822917|FG000|Overall Study|Withdrawal by Subject|79
2192328|NCT01493414|3822917|FG000|Overall Study|Protocol deviation|27
2192329|NCT01493414|3822917|FG000|Overall Study|Administrative problems|25
2192330|NCT01493414|3822917|FG000|Overall Study|Lost to Follow-up|16
2192331|NCT01493427|3822925|FG000|Overall Study|Adverse Event|10
2192332|NCT01493427|3822925|FG000|Overall Study|Personal Reasons|4
2192333|NCT01493427|3822925|FG000|Overall Study|Lost to Follow-up|2
2192334|NCT01493427|3822925|FG000|Overall Study|Inability to Follow Instructions|2
2192335|NCT01493427|3822925|FG000|Overall Study|Other|2
2192336|NCT01493531|3822932|FG000|Overall Study|Adverse Event|4
2192337|NCT01493531|3822933|FG001|Overall Study|Adverse Event|12
2192338|NCT01493531|3822934|FG002|Overall Study|Adverse Event|9
2192339|NCT01493531|3822932|FG000|Overall Study|Gout flare|3
2192340|NCT01493531|3822933|FG001|Overall Study|Gout flare|0
2192341|NCT01493531|3822934|FG002|Overall Study|Gout flare|2
2192342|NCT01493531|3822932|FG000|Overall Study|Protocol Violation|8
2192343|NCT01493531|3822933|FG001|Overall Study|Protocol Violation|15
2192344|NCT01493531|3822934|FG002|Overall Study|Protocol Violation|12
2192345|NCT01493531|3822932|FG000|Overall Study|Sponsor terminated study|5
2192346|NCT01493531|3822933|FG001|Overall Study|Sponsor terminated study|2
2192347|NCT01493531|3822934|FG002|Overall Study|Sponsor terminated study|3
2192348|NCT01493531|3822932|FG000|Overall Study|Lost to Follow-up|5
2192349|NCT01493531|3822933|FG001|Overall Study|Lost to Follow-up|7
2192350|NCT01493531|3822934|FG002|Overall Study|Lost to Follow-up|11
2192351|NCT01493531|3822932|FG000|Overall Study|Withdrawal by Subject|16
2192352|NCT01493531|3822933|FG001|Overall Study|Withdrawal by Subject|13
2192353|NCT01493531|3822934|FG002|Overall Study|Withdrawal by Subject|11
2192354|NCT01493531|3822932|FG000|Overall Study|Death|0
2192355|NCT01493531|3822933|FG001|Overall Study|Death|1
2192356|NCT01493531|3822934|FG002|Overall Study|Death|0
2192357|NCT01493557|3822945|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
2192358|NCT01493557|3822946|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
2192359|NCT01493557|3822947|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
2192360|NCT01493557|3822945|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
2192361|NCT01493557|3822946|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
2192362|NCT01493557|3822947|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9
2192363|NCT01493557|3822945|FG000|Not Randomized to Management Strategies|Other adverse event|0
2192364|NCT01493557|3822946|FG001|Not Randomized to Management Strategies|Other adverse event|0
2192365|NCT01493557|3822947|FG002|Not Randomized to Management Strategies|Other adverse event|54
2192366|NCT01493557|3822945|FG000|Not Randomized to Management Strategies|Protocol Violation|0
2192367|NCT01493557|3822946|FG001|Not Randomized to Management Strategies|Protocol Violation|0
2192368|NCT01493557|3822947|FG002|Not Randomized to Management Strategies|Protocol Violation|1
2192369|NCT01493557|3822945|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0
2192370|NCT01493557|3822946|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0
2192371|NCT01493557|3822947|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4
2192372|NCT01493557|3822945|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0
2192373|NCT01493557|3822946|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0
2224302|NCT01768676|3871459|FG000|Overall Study|Physician Decision|4
2224303|NCT01768676|3871460|FG001|Overall Study|Physician Decision|1
2224304|NCT01768676|3871459|FG000|Overall Study|Withdrawal by Subject|3
2224305|NCT01768676|3871460|FG001|Overall Study|Withdrawal by Subject|10
2224306|NCT01768858|3871483|FG000|Overall Study|Lost to Follow-up|9
2224307|NCT01768858|3871483|FG000|Overall Study|Lack of Efficacy|8
2224308|NCT01768858|3871483|FG000|Overall Study|Serious Adverse Event|1
2224309|NCT01768858|3871483|FG000|Overall Study|Participant moved to Germany|1
2224310|NCT01768858|3871483|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1
2224311|NCT01768858|3871483|FG000|Overall Study|Exanthema|1
2224312|NCT01768858|3871483|FG000|Overall Study|Withdrawal by Subject|1
2224313|NCT01769105|3871489|FG000|First Intervention|Protocol Violation|2
2224314|NCT01769105|3871490|FG001|First Intervention|Protocol Violation|2
2224315|NCT01769105|3871489|FG000|Cross-over|Lost to Follow-up|5
2224316|NCT01769105|3871490|FG001|Cross-over|Lost to Follow-up|0
2224317|NCT01769196|3871509|FG000|Overall Study|Adverse Event|24
2224318|NCT01769196|3871510|FG001|Overall Study|Adverse Event|20
2224319|NCT01769196|3871509|FG000|Overall Study|Death|21
2192374|NCT01493557|3822947|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10
2192375|NCT01493557|3822945|FG000|Not Randomized to Management Strategies|Early termination|0
2192376|NCT01493557|3822946|FG001|Not Randomized to Management Strategies|Early termination|0
2192377|NCT01493557|3822947|FG002|Not Randomized to Management Strategies|Early termination|34
2192378|NCT01493557|3822945|FG000|Not Randomized to Management Strategies|Other than stated above|0
2192379|NCT01493557|3822946|FG001|Not Randomized to Management Strategies|Other than stated above|0
2192380|NCT01493557|3822947|FG002|Not Randomized to Management Strategies|Other than stated above|21
2192381|NCT01493557|3822945|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3
2192382|NCT01493557|3822946|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2
2192383|NCT01493557|3822947|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0
2192384|NCT01493557|3822945|FG000|Randomized to Management Strategies|Other adverse event|8
2192385|NCT01493557|3822946|FG001|Randomized to Management Strategies|Other adverse event|5
2192386|NCT01493557|3822947|FG002|Randomized to Management Strategies|Other adverse event|0
2192387|NCT01493557|3822945|FG000|Randomized to Management Strategies|Protocol Violation|3
2192388|NCT01493557|3822946|FG001|Randomized to Management Strategies|Protocol Violation|0
2192389|NCT01493557|3822947|FG002|Randomized to Management Strategies|Protocol Violation|0
2192390|NCT01493557|3822945|FG000|Randomized to Management Strategies|Withdrawal by Subject|0
2192391|NCT01493557|3822946|FG001|Randomized to Management Strategies|Withdrawal by Subject|1
2192392|NCT01493557|3822947|FG002|Randomized to Management Strategies|Withdrawal by Subject|0
2192393|NCT01493557|3822945|FG000|Randomized to Management Strategies|Other than stated above|1
2192394|NCT01493557|3822946|FG001|Randomized to Management Strategies|Other than stated above|3
2224320|NCT01769196|3871510|FG001|Overall Study|Death|26
2224321|NCT01769196|3871509|FG000|Overall Study|Investigator Discretion|7
2224322|NCT01769196|3871510|FG001|Overall Study|Investigator Discretion|3
2224323|NCT01769196|3871509|FG000|Overall Study|Lack of Efficacy|3
2224324|NCT01769196|3871510|FG001|Overall Study|Lack of Efficacy|2
2224325|NCT01769196|3871509|FG000|Overall Study|Progressive disease|11
2224326|NCT01769196|3871510|FG001|Overall Study|Progressive disease|6
2224327|NCT01769196|3871509|FG000|Overall Study|Protocol defined criteria for withdrawal|9
2224328|NCT01769196|3871510|FG001|Overall Study|Protocol defined criteria for withdrawal|11
2224329|NCT01769196|3871509|FG000|Overall Study|Protocol Violation|0
2224330|NCT01769196|3871510|FG001|Overall Study|Protocol Violation|3
2224331|NCT01769196|3871509|FG000|Overall Study|Study terminated by sponsor|160
2224332|NCT01769196|3871510|FG001|Overall Study|Study terminated by sponsor|161
2224333|NCT01769196|3871509|FG000|Overall Study|Participant never dosed with study drug|1
2224334|NCT01769196|3871510|FG001|Overall Study|Participant never dosed with study drug|0
2224335|NCT01769196|3871509|FG000|Overall Study|Withdrew consent|36
2224336|NCT01769196|3871510|FG001|Overall Study|Withdrew consent|40
2224337|NCT01769326|3871557|FG000|Overall Study|Lost to Follow-up|1
2224338|NCT01769326|3871558|FG001|Overall Study|Lost to Follow-up|2
2224339|NCT01769326|3871559|FG002|Overall Study|Lost to Follow-up|0
2224340|NCT01769326|3871560|FG003|Overall Study|Lost to Follow-up|0
2224341|NCT01769326|3871557|FG000|Overall Study|unrelated injry|1
2224342|NCT01769326|3871558|FG001|Overall Study|unrelated injry|1
2224343|NCT01769326|3871559|FG002|Overall Study|unrelated injry|0
2224344|NCT01769326|3871560|FG003|Overall Study|unrelated injry|0
2224345|NCT01769326|3871557|FG000|Overall Study|got a job|0
2224346|NCT01769326|3871558|FG001|Overall Study|got a job|1
2224347|NCT01769326|3871559|FG002|Overall Study|got a job|0
2224348|NCT01769326|3871560|FG003|Overall Study|got a job|0
2224349|NCT01769326|3871557|FG000|Overall Study|Got sick and could not complete study|0
2224350|NCT01769326|3871558|FG001|Overall Study|Got sick and could not complete study|0
2224351|NCT01769326|3871559|FG002|Overall Study|Got sick and could not complete study|1
2224352|NCT01769326|3871560|FG003|Overall Study|Got sick and could not complete study|0
2224353|NCT01769339|3871570|FG000|Overall Study|Lost to Follow-up|42
2224354|NCT01769339|3871570|FG000|Overall Study|Adverse Event|1
2224355|NCT01769378|3871607|FG000|Overall Study|Adverse Event|10
2224356|NCT01769378|3871608|FG001|Overall Study|Adverse Event|0
2224357|NCT01769378|3871607|FG000|Overall Study|Entry criteria not met|1
2224358|NCT01769378|3871608|FG001|Overall Study|Entry criteria not met|0
2224359|NCT01769378|3871607|FG000|Overall Study|Protocol Violation|1
2224360|NCT01769378|3871608|FG001|Overall Study|Protocol Violation|1
2224361|NCT01769378|3871607|FG000|Overall Study|Withdrawal by Subject|10
2224362|NCT01769378|3871608|FG001|Overall Study|Withdrawal by Subject|3
2224363|NCT01769378|3871607|FG000|Overall Study|Sponsor Decision|1
2224364|NCT01769378|3871608|FG001|Overall Study|Sponsor Decision|0
2224365|NCT01769378|3871607|FG000|Overall Study|Lost to Follow-up|2
2224366|NCT01769378|3871608|FG001|Overall Study|Lost to Follow-up|0
2224367|NCT01769391|3871616|FG000|Overall Study|Death|10
2224368|NCT01769391|3871617|FG001|Overall Study|Death|1
2332415|NCT03196284|4055988|FG000|Extension Part|Withdrawal by Subject|0
2332416|NCT03196284|4055989|FG001|Extension Part|Withdrawal by Subject|0
2332417|NCT03196284|4055990|FG002|Extension Part|Withdrawal by Subject|1
2332418|NCT03196284|4055988|FG000|Extension Part|Physician Decision|0
2332419|NCT03196284|4055989|FG001|Extension Part|Physician Decision|0
2332420|NCT03196284|4055990|FG002|Extension Part|Physician Decision|1
2332421|NCT03196297|4056010|FG000|Main Period|Withdrawal by Subject|4
2332422|NCT03196297|4056010|FG000|Extension Period|Withdrawal by Subject|1
2332423|NCT03196297|4056010|FG000|Extension Period|Lack of Efficacy|2
2332424|NCT03196349|4056029|FG000|Overall Study|Did not receive study drug|0
2332425|NCT03196349|4056030|FG001|Overall Study|Did not receive study drug|1
2332426|NCT03196349|4056031|FG002|Overall Study|Did not receive study drug|2
2332427|NCT03196349|4056029|FG000|Overall Study|No data entered|2
2192395|NCT01493557|3822947|FG002|Randomized to Management Strategies|Other than stated above|0
2192396|NCT01493557|3822945|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1
2192397|NCT01493557|3822946|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1
2192398|NCT01493557|3822947|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0
2192399|NCT01493557|3822945|FG000|Adding the Second Strategy|Other adverse event|1
2192400|NCT01493557|3822946|FG001|Adding the Second Strategy|Other adverse event|2
2224369|NCT01769391|3871616|FG000|Overall Study|Adverse Event|0
2224370|NCT01769391|3871617|FG001|Overall Study|Adverse Event|3
2224371|NCT01769391|3871616|FG000|Overall Study|Progressive Disease|1
2224372|NCT01769391|3871617|FG001|Overall Study|Progressive Disease|2
2224373|NCT01769391|3871616|FG000|Overall Study|Withdrawal by Subject|4
2224374|NCT01769391|3871617|FG001|Overall Study|Withdrawal by Subject|3
2224375|NCT01769391|3871616|FG000|Overall Study|Investigator Decision|2
2224376|NCT01769391|3871617|FG001|Overall Study|Investigator Decision|0
2224377|NCT01769404|3871629|FG000|Treatment Period 1|Did not meet eligibility criteria|1
2224378|NCT01769404|3871630|FG001|Treatment Period 1|Did not meet eligibility criteria|0
2224379|NCT01769404|3871629|FG000|Treatment Period 1|Withdrawal by Subject|3
2224380|NCT01769404|3871630|FG001|Treatment Period 1|Withdrawal by Subject|0
2224381|NCT01769404|3871629|FG000|Treatment Period 1|Sponsor decision|1
2224382|NCT01769404|3871630|FG001|Treatment Period 1|Sponsor decision|0
2224383|NCT01769404|3871629|FG000|Treatment Period 2|Sponsor decision|7
2224384|NCT01769404|3871630|FG001|Treatment Period 2|Sponsor decision|0
2224385|NCT01769456|3871638|FG000|Overall Study|Lost to Follow-up|19
2224386|NCT01769456|3871638|FG000|Overall Study|Withdrawal by Subject|3
2224387|NCT01769456|3871638|FG000|Overall Study|Did not receive PCC intervention|6
2224388|NCT01769456|3871638|FG000|Overall Study|Moved out of the area|3
2224389|NCT01769456|3871638|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5
2224390|NCT01769456|3871638|FG000|Overall Study|Parental request to youth to withdraw|1
2224391|NCT01769469|3871643|FG000|Overall Study|Consent Withdrawn|5
2224392|NCT01769469|3871643|FG000|Overall Study|Moved Out Of Area|3
2224393|NCT01769469|3871643|FG000|Overall Study|Lost to Follow-up|17
2224394|NCT01769469|3871643|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
2224395|NCT01769469|3871643|FG000|Overall Study|Subject Confirmed HIV Positive|3
2224396|NCT01769508|3871649|FG000|Overall Study|Death|3
2192401|NCT01493557|3822947|FG002|Adding the Second Strategy|Other adverse event|0
2192402|NCT01493557|3822945|FG000|Adding the Second Strategy|Withdrawal by Subject|0
2192403|NCT01493557|3822946|FG001|Adding the Second Strategy|Withdrawal by Subject|1
2192404|NCT01493557|3822947|FG002|Adding the Second Strategy|Withdrawal by Subject|0
2192405|NCT01493687|3822983|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2
2192406|NCT01493687|3822984|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
2192407|NCT01493687|3822983|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
2192408|NCT01493687|3822984|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
2192409|NCT01493687|3822983|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7
2192410|NCT01493687|3822984|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
2192411|NCT01493687|3822983|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
2192412|NCT01493687|3822984|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
2192413|NCT01493687|3822983|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
2192414|NCT01493687|3822984|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
2192415|NCT01493687|3822983|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
2192416|NCT01493687|3822984|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
2192417|NCT01493687|3822983|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
2192418|NCT01493687|3822984|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
2192419|NCT01493687|3822983|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5
2192420|NCT01493687|3822984|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1
2192421|NCT01493687|3822983|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
2192422|NCT01493687|3822984|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
2192423|NCT01493687|3822983|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5
2192424|NCT01493687|3822984|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4
2192425|NCT01493687|3822983|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
2192426|NCT01493687|3822984|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
2192427|NCT01493687|3822983|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
2192428|NCT01493687|3822984|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
2192429|NCT01493687|3822983|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
2192430|NCT01493687|3822984|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
2192431|NCT01493687|3822983|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
2192432|NCT01493687|3822984|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
2192433|NCT01493687|3822983|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0
2192434|NCT01493687|3822984|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1
2192435|NCT01493778|3822996|FG000|Overall Study|Withdrawal by Subject|8
2192436|NCT01493960|3823023|FG000|Overall Study|Adverse Event|0
2192437|NCT01493960|3823024|FG001|Overall Study|Adverse Event|1
2192438|NCT01493960|3823023|FG000|Overall Study|Lack of Efficacy|15
2192439|NCT01493960|3823024|FG001|Overall Study|Lack of Efficacy|9
2192440|NCT01493960|3823023|FG000|Overall Study|Protocol Violation|3
2192441|NCT01493960|3823024|FG001|Overall Study|Protocol Violation|0
2192442|NCT01493960|3823023|FG000|Overall Study|Withdrawal by Subject|10
2192443|NCT01493960|3823024|FG001|Overall Study|Withdrawal by Subject|4
2192444|NCT01493960|3823023|FG000|Overall Study|Non-specified|4
2192445|NCT01493960|3823024|FG001|Overall Study|Non-specified|4
2192446|NCT01494038|3823032|FG000|Overall Study|Protocol Violation|1
2192447|NCT01494038|3823033|FG001|Overall Study|Protocol Violation|1
2192448|NCT01494038|3823032|FG000|Overall Study|Lost to Follow-up|18
2192449|NCT01494038|3823033|FG001|Overall Study|Lost to Follow-up|20
2192450|NCT01494038|3823032|FG000|Overall Study|Withdrawal by Subject|44
2192451|NCT01494038|3823033|FG001|Overall Study|Withdrawal by Subject|34
2192452|NCT01494038|3823032|FG000|Overall Study|Not able to get to clinic|21
2192453|NCT01494038|3823033|FG001|Overall Study|Not able to get to clinic|15
2192454|NCT01494038|3823032|FG000|Overall Study|Not willing to adhere to reqs|2
2192455|NCT01494038|3823033|FG001|Overall Study|Not willing to adhere to reqs|9
2192456|NCT01494038|3823032|FG000|Overall Study|Death|2
2192457|NCT01494038|3823033|FG001|Overall Study|Death|4
2192458|NCT01494298|3823065|FG000|Overall Study|Protocol Violation|2
2192459|NCT01494298|3823066|FG001|Overall Study|Protocol Violation|8
2192460|NCT01494350|3823074|FG000|Overall Study|Worsening of lesion|1
2192461|NCT01494467|3823080|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1
2192462|NCT01494467|3823081|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
2192463|NCT01494467|3823080|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6
2192464|NCT01494467|3823081|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
2192465|NCT01494467|3823080|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
2192466|NCT01494467|3823081|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
2192467|NCT01494467|3823080|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
2192468|NCT01494467|3823081|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
2192469|NCT01494467|3823080|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
2192470|NCT01494467|3823081|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
2192471|NCT01494467|3823080|FG000|Part A Vehicle Control (12 Weeks)|Other|1
2192472|NCT01494467|3823081|FG001|Part A Vehicle Control (12 Weeks)|Other|1
2192473|NCT01494467|3823080|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
2192474|NCT01494467|3823081|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
2192475|NCT01494467|3823080|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2
2192476|NCT01494467|3823081|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0
2192477|NCT01494467|3823080|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
2192478|NCT01494467|3823081|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
2192479|NCT01494467|3823080|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3
2192480|NCT01494467|3823081|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5
2192481|NCT01494467|3823080|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
2192482|NCT01494467|3823081|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
2224397|NCT01769508|3871649|FG000|Overall Study|Withdrawal by Subject|1
2224398|NCT01769508|3871649|FG000|Overall Study|Adverse Event|1
2224399|NCT01769508|3871649|FG000|Overall Study|Lost to Follow-up|1
2224400|NCT01770145|3871689|FG000|Baseline|Adverse Event|20
2224401|NCT01770145|3871689|FG000|Baseline|Withdrawal by Subject|1
2224402|NCT01770145|3871689|FG000|Baseline|Lost to Follow-up|1
2224403|NCT01770145|3871689|FG000|Baseline|Unable to define optimal dose|4
2224404|NCT01770145|3871689|FG000|Treatment|Adverse Event|3
2224405|NCT01770145|3871689|FG000|Treatment|Withdrawal by Subject|1
2224406|NCT01770353|3871704|FG000|Overall Study|Progressive disease|2
2224407|NCT01770353|3871705|FG001|Overall Study|Progressive disease|1
2224408|NCT01770353|3871704|FG000|Overall Study|Adverse Event|0
2224409|NCT01770353|3871705|FG001|Overall Study|Adverse Event|1
2224410|NCT01770353|3871704|FG000|Overall Study|Protocol Violation|1
2224411|NCT01770353|3871705|FG001|Overall Study|Protocol Violation|0
2224412|NCT01770353|3871704|FG000|Overall Study|Physician Decision|0
2224413|NCT01770353|3871705|FG001|Overall Study|Physician Decision|3
2224414|NCT01770353|3871704|FG000|Overall Study|Clinical deterioration|3
2224415|NCT01770353|3871705|FG001|Overall Study|Clinical deterioration|6
2224416|NCT01770353|3871704|FG000|Overall Study|Toxicity related diarrhoea + progression|0
2224417|NCT01770353|3871705|FG001|Overall Study|Toxicity related diarrhoea + progression|1
2274131|NCT02293538|3954999|FG000|Overall Study|Lost to Follow-up|1
2274132|NCT02293538|3955000|FG001|Overall Study|Lost to Follow-up|0
2274133|NCT02293538|3954999|FG000|Overall Study|Withdrawal by Subject|0
2274134|NCT02293538|3955000|FG001|Overall Study|Withdrawal by Subject|1
2274135|NCT02293837|3955015|FG000|Overall Study|Lost to Follow-up|0
2274136|NCT02293837|3955016|FG001|Overall Study|Lost to Follow-up|2
2274137|NCT02293837|3955017|FG002|Overall Study|Lost to Follow-up|1
2274138|NCT02293837|3955018|FG003|Overall Study|Lost to Follow-up|0
2274139|NCT02293837|3955015|FG000|Overall Study|Withdrawal by Subject|2
2274140|NCT02293837|3955016|FG001|Overall Study|Withdrawal by Subject|1
2274141|NCT02293837|3955017|FG002|Overall Study|Withdrawal by Subject|2
2274142|NCT02293837|3955018|FG003|Overall Study|Withdrawal by Subject|1
2274143|NCT02293837|3955015|FG000|Overall Study|COVID-19 Related|1
2274144|NCT02293837|3955016|FG001|Overall Study|COVID-19 Related|1
2274145|NCT02293837|3955017|FG002|Overall Study|COVID-19 Related|0
2274146|NCT02293837|3955018|FG003|Overall Study|COVID-19 Related|0
2274147|NCT02293837|3955015|FG000|Overall Study|Participant ill and could not be infused|0
2192483|NCT01494467|3823080|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
2192484|NCT01494467|3823081|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
2192485|NCT01494467|3823080|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
2192486|NCT01494467|3823081|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
2192487|NCT01494467|3823080|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
2192488|NCT01494467|3823081|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
2192489|NCT01494506|3823096|FG000|Overall Study|Lack of Efficacy|77
2192490|NCT01494506|3823097|FG001|Overall Study|Lack of Efficacy|83
2192491|NCT01494506|3823098|FG002|Overall Study|Lack of Efficacy|57
2192492|NCT01494506|3823096|FG000|Overall Study|Adverse Event|17
2192493|NCT01494506|3823097|FG001|Overall Study|Adverse Event|10
2192494|NCT01494506|3823098|FG002|Overall Study|Adverse Event|11
2192495|NCT01494506|3823096|FG000|Overall Study|Death|9
2192496|NCT01494506|3823097|FG001|Overall Study|Death|5
2192497|NCT01494506|3823098|FG002|Overall Study|Death|2
2192498|NCT01494506|3823096|FG000|Overall Study|Physician Decision|7
2192499|NCT01494506|3823097|FG001|Overall Study|Physician Decision|5
2192500|NCT01494506|3823098|FG002|Overall Study|Physician Decision|4
2192501|NCT01494506|3823096|FG000|Overall Study|Withdrawal by Subject|17
2192502|NCT01494506|3823097|FG001|Overall Study|Withdrawal by Subject|20
2192503|NCT01494506|3823098|FG002|Overall Study|Withdrawal by Subject|14
2192504|NCT01494506|3823096|FG000|Overall Study|Clinical Deterioration|21
2192505|NCT01494506|3823097|FG001|Overall Study|Clinical Deterioration|17
2192506|NCT01494506|3823098|FG002|Overall Study|Clinical Deterioration|13
2192507|NCT01494506|3823096|FG000|Overall Study|Sponsor Decision|0
2192508|NCT01494506|3823097|FG001|Overall Study|Sponsor Decision|0
2192509|NCT01494506|3823098|FG002|Overall Study|Sponsor Decision|1
2192510|NCT01494506|3823096|FG000|Overall Study|Other|0
2192511|NCT01494506|3823097|FG001|Overall Study|Other|3
2192512|NCT01494506|3823098|FG002|Overall Study|Other|1
2192513|NCT01494532|3823114|FG000|Overall Study|Adverse Event|4
2192514|NCT01494532|3823115|FG001|Overall Study|Adverse Event|1
2192515|NCT01494532|3823116|FG002|Overall Study|Adverse Event|8
2192516|NCT01494532|3823117|FG003|Overall Study|Adverse Event|6
2192517|NCT01494532|3823118|FG004|Overall Study|Adverse Event|5
2192518|NCT01494532|3823119|FG005|Overall Study|Adverse Event|0
2192519|NCT01494532|3823114|FG000|Overall Study|Lack of Efficacy|0
2192520|NCT01494532|3823115|FG001|Overall Study|Lack of Efficacy|0
2192521|NCT01494532|3823116|FG002|Overall Study|Lack of Efficacy|0
2192522|NCT01494532|3823117|FG003|Overall Study|Lack of Efficacy|0
2192523|NCT01494532|3823118|FG004|Overall Study|Lack of Efficacy|2
2192524|NCT01494532|3823119|FG005|Overall Study|Lack of Efficacy|0
2192525|NCT01494532|3823114|FG000|Overall Study|Protocol deviation|2
2192526|NCT01494532|3823115|FG001|Overall Study|Protocol deviation|1
2224418|NCT01770379|3871731|FG000|Overall Study|Technical issues|1
2224419|NCT01770379|3871732|FG001|Overall Study|Technical issues|0
2224420|NCT01770379|3871733|FG002|Overall Study|Technical issues|0
2224421|NCT01770379|3871731|FG000|Overall Study|Withdrawal by Subject|7
2224422|NCT01770379|3871732|FG001|Overall Study|Withdrawal by Subject|10
2224423|NCT01770379|3871733|FG002|Overall Study|Withdrawal by Subject|7
2224424|NCT01770379|3871731|FG000|Overall Study|study terminated by sponsor|22
2224425|NCT01770379|3871732|FG001|Overall Study|study terminated by sponsor|23
2224426|NCT01770379|3871733|FG002|Overall Study|study terminated by sponsor|22
2224427|NCT01770379|3871731|FG000|Overall Study|Protocol Violation|0
2224428|NCT01770379|3871732|FG001|Overall Study|Protocol Violation|1
2224429|NCT01770379|3871733|FG002|Overall Study|Protocol Violation|1
2224430|NCT01770379|3871731|FG000|Overall Study|Physician Decision|0
2224431|NCT01770379|3871732|FG001|Overall Study|Physician Decision|1
2224432|NCT01770379|3871733|FG002|Overall Study|Physician Decision|2
2224433|NCT01770379|3871731|FG000|Overall Study|Lost to Follow-up|0
2224434|NCT01770379|3871732|FG001|Overall Study|Lost to Follow-up|0
2224435|NCT01770379|3871733|FG002|Overall Study|Lost to Follow-up|2
2224436|NCT01770379|3871731|FG000|Overall Study|Lack of Efficacy|8
2224437|NCT01770379|3871732|FG001|Overall Study|Lack of Efficacy|6
2224438|NCT01770379|3871733|FG002|Overall Study|Lack of Efficacy|6
2224439|NCT01770379|3871731|FG000|Overall Study|Adverse Event|1
2224440|NCT01770379|3871732|FG001|Overall Study|Adverse Event|3
2224441|NCT01770379|3871733|FG002|Overall Study|Adverse Event|2
2224442|NCT01770392|3871743|FG000|Washout Period of at Least 14 Days|Adverse Event|1
2224443|NCT01770509|3871774|FG000|Overall Study|Injury|0
2224444|NCT01770509|3871775|FG001|Overall Study|Injury|1
2224445|NCT01770509|3871774|FG000|Overall Study|Lost to Follow-up|1
2224446|NCT01770509|3871775|FG001|Overall Study|Lost to Follow-up|2
2224447|NCT01770743|3871814|FG000|Overall Study|Adverse Event|1
2224448|NCT01770743|3871815|FG001|Overall Study|Adverse Event|0
2224449|NCT01770743|3871816|FG002|Overall Study|Adverse Event|0
2224450|NCT01770743|3871817|FG003|Overall Study|Adverse Event|0
2224451|NCT01770743|3871818|FG004|Overall Study|Adverse Event|0
2224452|NCT01770743|3871814|FG000|Overall Study|Withdrawal by Subject|0
2224453|NCT01770743|3871815|FG001|Overall Study|Withdrawal by Subject|0
2224454|NCT01770743|3871816|FG002|Overall Study|Withdrawal by Subject|1
2192527|NCT01494532|3823116|FG002|Overall Study|Protocol deviation|3
2192528|NCT01494532|3823117|FG003|Overall Study|Protocol deviation|2
2224455|NCT01770743|3871817|FG003|Overall Study|Withdrawal by Subject|1
2224456|NCT01770743|3871818|FG004|Overall Study|Withdrawal by Subject|1
2192529|NCT01494532|3823118|FG004|Overall Study|Protocol deviation|3
2192530|NCT01494532|3823119|FG005|Overall Study|Protocol deviation|0
2192531|NCT01494532|3823114|FG000|Overall Study|Protocol-defined stopping criteria|0
2192532|NCT01494532|3823115|FG001|Overall Study|Protocol-defined stopping criteria|0
2192533|NCT01494532|3823116|FG002|Overall Study|Protocol-defined stopping criteria|1
2192534|NCT01494532|3823117|FG003|Overall Study|Protocol-defined stopping criteria|0
2192535|NCT01494532|3823118|FG004|Overall Study|Protocol-defined stopping criteria|0
2192536|NCT01494532|3823119|FG005|Overall Study|Protocol-defined stopping criteria|0
2192537|NCT01494532|3823114|FG000|Overall Study|Lost to Follow-up|1
2192538|NCT01494532|3823115|FG001|Overall Study|Lost to Follow-up|0
2192539|NCT01494532|3823116|FG002|Overall Study|Lost to Follow-up|0
2192540|NCT01494532|3823117|FG003|Overall Study|Lost to Follow-up|2
2192541|NCT01494532|3823118|FG004|Overall Study|Lost to Follow-up|0
2192542|NCT01494532|3823119|FG005|Overall Study|Lost to Follow-up|0
2192543|NCT01494532|3823114|FG000|Overall Study|Physician Decision|0
2192544|NCT01494532|3823115|FG001|Overall Study|Physician Decision|1
2192545|NCT01494532|3823116|FG002|Overall Study|Physician Decision|1
2192546|NCT01494532|3823117|FG003|Overall Study|Physician Decision|2
2192547|NCT01494532|3823118|FG004|Overall Study|Physician Decision|0
2192548|NCT01494532|3823119|FG005|Overall Study|Physician Decision|0
2192549|NCT01494532|3823114|FG000|Overall Study|Withdrawal by Subject|3
2192550|NCT01494532|3823115|FG001|Overall Study|Withdrawal by Subject|1
2192551|NCT01494532|3823116|FG002|Overall Study|Withdrawal by Subject|4
2192552|NCT01494532|3823117|FG003|Overall Study|Withdrawal by Subject|3
2192553|NCT01494532|3823118|FG004|Overall Study|Withdrawal by Subject|2
2192554|NCT01494532|3823119|FG005|Overall Study|Withdrawal by Subject|0
2192555|NCT01494584|3823141|FG000|Overall Study|Study Closed/Terminated|1
2192556|NCT01494610|3823164|FG000|Period 1|Withdrawal by Subject|1
2192557|NCT01494610|3823165|FG001|Period 1|Withdrawal by Subject|1
2192558|NCT01494610|3823164|FG000|Period 3|Adverse Event|1
2192559|NCT01494610|3823165|FG001|Period 3|Adverse Event|0
2192560|NCT01494610|3823164|FG000|Period 3|Withdrawal by Subject|1
2192561|NCT01494610|3823165|FG001|Period 3|Withdrawal by Subject|0
2192562|NCT01494610|3823164|FG000|Period 4|Protocol Violation|1
2192563|NCT01494610|3823165|FG001|Period 4|Protocol Violation|0
2192564|NCT01494649|3823179|FG000|Overall Study|Lost to Follow-up|0
2192565|NCT01494649|3823180|FG001|Overall Study|Lost to Follow-up|1
2192566|NCT01494818|3823199|FG000|Overall Study|Relocation|1
2192567|NCT01494818|3823200|FG001|Overall Study|Relocation|2
2192568|NCT01494818|3823199|FG000|Overall Study|Lost to Follow-up|1
2192569|NCT01494818|3823200|FG001|Overall Study|Lost to Follow-up|0
2192570|NCT01494922|3823206|FG000|Overall Study|Adverse Event|1
2192571|NCT01494987|3823212|FG000|Overall Study|Adverse Event|6
2192572|NCT01494987|3823213|FG001|Overall Study|Adverse Event|5
2192573|NCT01494987|3823212|FG000|Overall Study|Hyperglycemia|6
2192574|NCT01494987|3823213|FG001|Overall Study|Hyperglycemia|4
2192575|NCT01494987|3823212|FG000|Overall Study|Investigator's Discretion|1
2192576|NCT01494987|3823213|FG001|Overall Study|Investigator's Discretion|2
2192577|NCT01494987|3823212|FG000|Overall Study|Lost to Follow-up|1
2192578|NCT01494987|3823213|FG001|Overall Study|Lost to Follow-up|1
2192579|NCT01494987|3823212|FG000|Overall Study|Protocol Violation|3
2192580|NCT01494987|3823213|FG001|Overall Study|Protocol Violation|3
2192581|NCT01494987|3823212|FG000|Overall Study|Subject Non-Compliance|9
2192582|NCT01494987|3823213|FG001|Overall Study|Subject Non-Compliance|10
2192583|NCT01494987|3823212|FG000|Overall Study|Subject Withdrew Consent|2
2192584|NCT01494987|3823213|FG001|Overall Study|Subject Withdrew Consent|3
2192585|NCT01495000|3823221|FG000|Overall Study|Lost to Follow-up|2
2192586|NCT01495000|3823222|FG001|Overall Study|Lost to Follow-up|2
2192587|NCT01495000|3823221|FG000|Overall Study|Protocol Violation|1
2192588|NCT01495000|3823222|FG001|Overall Study|Protocol Violation|0
2192589|NCT01495000|3823221|FG000|Overall Study|Withdrawal by Subject|10
2192590|NCT01495000|3823222|FG001|Overall Study|Withdrawal by Subject|10
2192591|NCT01495702|3823278|FG000|Randomized Phase|Randomized But Not Treated|1
2192592|NCT01495702|3823279|FG001|Randomized Phase|Randomized But Not Treated|4
2192593|NCT01495702|3823278|FG000|Randomized Phase|Adverse Event|2
2192594|NCT01495702|3823279|FG001|Randomized Phase|Adverse Event|2
2192595|NCT01495702|3823278|FG000|Randomized Phase|Death|1
2192596|NCT01495702|3823279|FG001|Randomized Phase|Death|0
2192597|NCT01495702|3823278|FG000|Randomized Phase|Lack of Efficacy|2
2224457|NCT01770743|3871814|FG000|Overall Study|Lost to Follow-up|0
2224458|NCT01770743|3871815|FG001|Overall Study|Lost to Follow-up|2
2224459|NCT01770743|3871816|FG002|Overall Study|Lost to Follow-up|0
2224460|NCT01770743|3871817|FG003|Overall Study|Lost to Follow-up|0
2224461|NCT01770743|3871818|FG004|Overall Study|Lost to Follow-up|1
2224462|NCT01770743|3871814|FG000|Overall Study|Sponsor Terminated Subject|1
2224463|NCT01770743|3871815|FG001|Overall Study|Sponsor Terminated Subject|0
2224464|NCT01770743|3871816|FG002|Overall Study|Sponsor Terminated Subject|0
2224465|NCT01770743|3871817|FG003|Overall Study|Sponsor Terminated Subject|1
2224466|NCT01770743|3871818|FG004|Overall Study|Sponsor Terminated Subject|0
2224467|NCT01770743|3871814|FG000|Overall Study|Moving Out of State|0
2224468|NCT01770743|3871815|FG001|Overall Study|Moving Out of State|1
2224469|NCT01770743|3871816|FG002|Overall Study|Moving Out of State|0
2224470|NCT01770743|3871817|FG003|Overall Study|Moving Out of State|0
2224471|NCT01770743|3871818|FG004|Overall Study|Moving Out of State|0
2192598|NCT01495702|3823279|FG001|Randomized Phase|Lack of Efficacy|0
2192599|NCT01495702|3823278|FG000|Randomized Phase|Investigators Discretion|2
2192600|NCT01495702|3823279|FG001|Randomized Phase|Investigators Discretion|0
2192601|NCT01495702|3823278|FG000|Randomized Phase|Withdrew Consent|10
2192602|NCT01495702|3823279|FG001|Randomized Phase|Withdrew Consent|18
2192603|NCT01495702|3823278|FG000|Randomized Phase|Lost to Follow-up|4
2192604|NCT01495702|3823279|FG001|Randomized Phase|Lost to Follow-up|3
2192605|NCT01495702|3823278|FG000|Randomized Phase|Participant Noncompliance|1
2192606|NCT01495702|3823279|FG001|Randomized Phase|Participant Noncompliance|0
2192607|NCT01495702|3823278|FG000|Randomized Phase|Protocol Violation|3
2192608|NCT01495702|3823279|FG001|Randomized Phase|Protocol Violation|1
2192609|NCT01495793|3823286|FG000|Overall Study|Lost to Follow-up|1
2192610|NCT01495793|3823286|FG000|Overall Study|Violation of inclusion criteria|1
2192611|NCT01495975|3823325|FG000|Overall Study|Lost to Follow-up|1
2192612|NCT01495975|3823326|FG001|Overall Study|Lost to Follow-up|0
2192613|NCT01496066|3823334|FG000|Overall Study|Lost to Follow-up|8
2192614|NCT01496066|3823335|FG001|Overall Study|Lost to Follow-up|5
2192615|NCT01496066|3823334|FG000|Overall Study|Explant|3
2192616|NCT01496066|3823335|FG001|Overall Study|Explant|0
2192617|NCT01496066|3823334|FG000|Overall Study|Death|1
2192618|NCT01496066|3823335|FG001|Overall Study|Death|4
2192619|NCT01496183|3823363|FG000|Overall Study|Physician Decision|3
2192620|NCT01496183|3823364|FG001|Overall Study|Physician Decision|1
2192621|NCT01496183|3823363|FG000|Overall Study|Withdrawal by Subject|0
2192622|NCT01496183|3823364|FG001|Overall Study|Withdrawal by Subject|1
2192623|NCT01496274|3823377|FG000|Overall Study|Protocol Violation|0
2192624|NCT01496274|3823378|FG001|Overall Study|Protocol Violation|1
2192625|NCT01496274|3823377|FG000|Overall Study|Adverse Event|1
2192626|NCT01496274|3823378|FG001|Overall Study|Adverse Event|1
2192627|NCT01496274|3823377|FG000|Overall Study|Withdrawal by Subject|2
2192628|NCT01496274|3823378|FG001|Overall Study|Withdrawal by Subject|0
2192629|NCT01496274|3823377|FG000|Overall Study|Lost to Follow-up|0
2192630|NCT01496274|3823378|FG001|Overall Study|Lost to Follow-up|3
2192631|NCT01496287|3823399|FG000|Overall Study|Lost to Follow-up|1
2192632|NCT01496287|3823399|FG000|Overall Study|Incomplete anesthesia|5
2192633|NCT01496365|3823438|FG000|Overall Study|Adverse Event|2
2192634|NCT01496365|3823439|FG001|Overall Study|Adverse Event|3
2192635|NCT01496365|3823440|FG002|Overall Study|Adverse Event|3
2192636|NCT01496365|3823441|FG003|Overall Study|Adverse Event|2
2192637|NCT01496365|3823442|FG004|Overall Study|Adverse Event|5
2192638|NCT01496365|3823443|FG005|Overall Study|Adverse Event|6
2192639|NCT01496365|3823444|FG006|Overall Study|Adverse Event|4
2192640|NCT01496365|3823438|FG000|Overall Study|Withdrawal by Subject|6
2192641|NCT01496365|3823439|FG001|Overall Study|Withdrawal by Subject|6
2192642|NCT01496365|3823440|FG002|Overall Study|Withdrawal by Subject|0
2192643|NCT01496365|3823441|FG003|Overall Study|Withdrawal by Subject|1
2192644|NCT01496365|3823442|FG004|Overall Study|Withdrawal by Subject|3
2192645|NCT01496365|3823443|FG005|Overall Study|Withdrawal by Subject|2
2192646|NCT01496365|3823444|FG006|Overall Study|Withdrawal by Subject|1
2192647|NCT01496365|3823438|FG000|Overall Study|Protocol Violation|2
2192648|NCT01496365|3823439|FG001|Overall Study|Protocol Violation|1
2224472|NCT01770860|3871830|FG000|Overall Study|Withdrawal by Subject|4
2224473|NCT01770860|3871830|FG000|Overall Study|Lost to Follow-up|1
2224474|NCT01770860|3871830|FG000|Overall Study|Administrative decision made by the PI|1
2224475|NCT01770912|3871840|FG000|Overall Study|Lost to Follow-up|2
2224476|NCT01770912|3871841|FG001|Overall Study|Lost to Follow-up|0
2224477|NCT01771250|3871860|FG000|Period 1|Met exclusion criteria|1
2224478|NCT01771250|3871861|FG001|Period 1|Met exclusion criteria|0
2224479|NCT01771731|3871882|FG000|Overall Study|Physician Decision|1
2224480|NCT01771731|3871883|FG001|Overall Study|Physician Decision|0
2224481|NCT01771731|3871882|FG000|Overall Study|Protocol Violation|0
2224482|NCT01771731|3871883|FG001|Overall Study|Protocol Violation|1
2224483|NCT01771731|3871882|FG000|Overall Study|Adverse event: Pain Crisis|1
2224484|NCT01771731|3871883|FG001|Overall Study|Adverse event: Pain Crisis|1
2224485|NCT01771809|3871891|FG000|Overall Study|Adverse Event|4
2224486|NCT01771809|3871892|FG001|Overall Study|Adverse Event|12
2224487|NCT01771809|3871891|FG000|Overall Study|Protocol Violation|0
2224488|NCT01771809|3871892|FG001|Overall Study|Protocol Violation|1
2224489|NCT01771809|3871891|FG000|Overall Study|Withdrawal by Subject|34
2224490|NCT01771809|3871892|FG001|Overall Study|Withdrawal by Subject|42
2224491|NCT01771809|3871891|FG000|Overall Study|Lost to Follow-up|1
2224492|NCT01771809|3871892|FG001|Overall Study|Lost to Follow-up|3
2224493|NCT01771809|3871891|FG000|Overall Study|Other (Insufficient clinical response)|22
2224494|NCT01771809|3871892|FG001|Overall Study|Other (Insufficient clinical response)|20
2224495|NCT01771809|3871891|FG000|Overall Study|Death|1
2224496|NCT01771809|3871892|FG001|Overall Study|Death|0
2224497|NCT01771809|3871891|FG000|Overall Study|Other (other)|9
2224498|NCT01771809|3871892|FG001|Overall Study|Other (other)|5
2224499|NCT01771913|3871900|FG000|Overall Study|Withdrawal by Subject|1
2224500|NCT01771913|3871901|FG001|Overall Study|Withdrawal by Subject|0
2224501|NCT01772134|3871938|FG000|Overall Study|Adverse Event|6
2224502|NCT01772134|3871939|FG001|Overall Study|Adverse Event|5
2224503|NCT01772134|3871940|FG002|Overall Study|Adverse Event|10
2192649|NCT01496365|3823440|FG002|Overall Study|Protocol Violation|1
2192650|NCT01496365|3823441|FG003|Overall Study|Protocol Violation|0
2192651|NCT01496365|3823442|FG004|Overall Study|Protocol Violation|0
2224504|NCT01772134|3871938|FG000|Overall Study|Withdrew Consent|3
2192652|NCT01496365|3823443|FG005|Overall Study|Protocol Violation|1
2192653|NCT01496365|3823444|FG006|Overall Study|Protocol Violation|0
2192654|NCT01496365|3823438|FG000|Overall Study|Lack of Efficacy|1
2192655|NCT01496365|3823439|FG001|Overall Study|Lack of Efficacy|0
2192656|NCT01496365|3823440|FG002|Overall Study|Lack of Efficacy|0
2192657|NCT01496365|3823441|FG003|Overall Study|Lack of Efficacy|0
2192658|NCT01496365|3823442|FG004|Overall Study|Lack of Efficacy|0
2192659|NCT01496365|3823443|FG005|Overall Study|Lack of Efficacy|1
2192660|NCT01496365|3823444|FG006|Overall Study|Lack of Efficacy|0
2192661|NCT01496365|3823438|FG000|Overall Study|Lost to Follow-up|0
2192662|NCT01496365|3823439|FG001|Overall Study|Lost to Follow-up|1
2192663|NCT01496365|3823440|FG002|Overall Study|Lost to Follow-up|0
2192664|NCT01496365|3823441|FG003|Overall Study|Lost to Follow-up|0
2192665|NCT01496365|3823442|FG004|Overall Study|Lost to Follow-up|2
2192666|NCT01496365|3823443|FG005|Overall Study|Lost to Follow-up|0
2192667|NCT01496365|3823444|FG006|Overall Study|Lost to Follow-up|0
2192668|NCT01496365|3823438|FG000|Overall Study|Other|4
2192669|NCT01496365|3823439|FG001|Overall Study|Other|4
2192670|NCT01496365|3823440|FG002|Overall Study|Other|2
2192671|NCT01496365|3823441|FG003|Overall Study|Other|1
2192672|NCT01496365|3823442|FG004|Overall Study|Other|3
2192673|NCT01496365|3823443|FG005|Overall Study|Other|0
2192674|NCT01496365|3823444|FG006|Overall Study|Other|1
2192675|NCT01496430|3823463|FG000|Overall Study|Adverse Event|0
2192676|NCT01496430|3823464|FG001|Overall Study|Adverse Event|0
2192677|NCT01496430|3823465|FG002|Overall Study|Adverse Event|1
2192678|NCT01496430|3823463|FG000|Overall Study|Major Protocol Deviation|0
2192679|NCT01496430|3823464|FG001|Overall Study|Major Protocol Deviation|0
2192680|NCT01496430|3823465|FG002|Overall Study|Major Protocol Deviation|1
2192681|NCT01496430|3823463|FG000|Overall Study|Lost to Follow-up|2
2192682|NCT01496430|3823464|FG001|Overall Study|Lost to Follow-up|3
2192683|NCT01496430|3823465|FG002|Overall Study|Lost to Follow-up|1
2192684|NCT01496430|3823463|FG000|Overall Study|Voluntary Withdrawal|2
2192685|NCT01496430|3823464|FG001|Overall Study|Voluntary Withdrawal|1
2192686|NCT01496430|3823465|FG002|Overall Study|Voluntary Withdrawal|6
2192687|NCT01496430|3823463|FG000|Overall Study|Principal Investigator Discretion|0
2192688|NCT01496430|3823464|FG001|Overall Study|Principal Investigator Discretion|1
2192689|NCT01496430|3823465|FG002|Overall Study|Principal Investigator Discretion|1
2192690|NCT01496430|3823463|FG000|Overall Study|Other|2
2192691|NCT01496430|3823464|FG001|Overall Study|Other|0
2192692|NCT01496430|3823465|FG002|Overall Study|Other|0
2192693|NCT01496456|3823473|FG000|Overall Study|Protocol Violation|1
2192694|NCT01496456|3823473|FG000|Overall Study|Lost to Follow-up|7
2192695|NCT01496469|3823482|FG000|Overall Study|Adverse Event|1
2192696|NCT01496469|3823483|FG001|Overall Study|Adverse Event|0
2192697|NCT01496469|3823482|FG000|Overall Study|Protocol Violation|2
2192698|NCT01496469|3823483|FG001|Overall Study|Protocol Violation|0
2192699|NCT01496469|3823482|FG000|Overall Study|Lost to Follow-up|1
2192700|NCT01496469|3823483|FG001|Overall Study|Lost to Follow-up|1
2192701|NCT01496469|3823482|FG000|Overall Study|Withdrawal by Subject|4
2192702|NCT01496469|3823483|FG001|Overall Study|Withdrawal by Subject|4
2192703|NCT01496469|3823482|FG000|Overall Study|BP exceeds protocol limits|1
2192704|NCT01496469|3823483|FG001|Overall Study|BP exceeds protocol limits|2
2192705|NCT01496469|3823482|FG000|Overall Study|Other|1
2192706|NCT01496469|3823483|FG001|Overall Study|Other|1
2192707|NCT01496612|3823489|FG000|1st Intervention|Adverse Event|1
2192708|NCT01496612|3823490|FG001|1st Intervention|Adverse Event|0
2192709|NCT01496612|3823489|FG000|1st Intervention|Withdrawal by Subject|1
2192710|NCT01496612|3823490|FG001|1st Intervention|Withdrawal by Subject|0
2192711|NCT01496807|3823498|FG000|Overall Study|Progressive Disease|21
2192712|NCT01496807|3823498|FG000|Overall Study|Participant preference/toxicity|8
2192713|NCT01496807|3823498|FG000|Overall Study|Change in diagnosis|1
2192714|NCT01496846|3823508|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
2192715|NCT01496846|3823509|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
2192716|NCT01496846|3823510|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2192717|NCT01496846|3823511|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2192718|NCT01496846|3823512|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2192719|NCT01496846|3823513|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2192720|NCT01496885|3823524|FG000|Overall Study|Lost to Follow-up|13
2192721|NCT01496885|3823524|FG000|Overall Study|Withdrawal by Subject|7
2192722|NCT01496885|3823524|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2
2192723|NCT01496885|3823524|FG000|Overall Study|Death|1
2192724|NCT01497067|3823528|FG000|Overall Study|Lost to Follow-up|56
2192725|NCT01497067|3823528|FG000|Overall Study|Adverse Event|3
2192726|NCT01497067|3823528|FG000|Overall Study|Patient decision unrel to Adverse Event|10
2192727|NCT01497067|3823528|FG000|Overall Study|Other|13
2224505|NCT01772134|3871939|FG001|Overall Study|Withdrew Consent|1
2224506|NCT01772134|3871940|FG002|Overall Study|Withdrew Consent|5
2224507|NCT01772134|3871938|FG000|Overall Study|Lost to Follow-up|2
2224508|NCT01772134|3871939|FG001|Overall Study|Lost to Follow-up|0
2224509|NCT01772134|3871940|FG002|Overall Study|Lost to Follow-up|0
2224510|NCT01772134|3871938|FG000|Overall Study|Protocol Deviation|4
2224511|NCT01772134|3871939|FG001|Overall Study|Protocol Deviation|3
2192728|NCT01497197|3823535|FG000|Overall Study|Lost to Follow-up|1
2192729|NCT01497197|3823536|FG001|Overall Study|Lost to Follow-up|0
2192730|NCT01497197|3823535|FG000|Overall Study|Protocol Violation|0
2192731|NCT01497197|3823536|FG001|Overall Study|Protocol Violation|2
2192732|NCT01497197|3823535|FG000|Overall Study|Withdrawal by Subject|2
2192733|NCT01497197|3823536|FG001|Overall Study|Withdrawal by Subject|1
2192734|NCT01497197|3823535|FG000|Overall Study|Excessive/lack of response to treatment|1
2192735|NCT01497197|3823536|FG001|Overall Study|Excessive/lack of response to treatment|0
2192736|NCT01497197|3823535|FG000|Overall Study|Risk of OHSS|1
2192737|NCT01497197|3823536|FG001|Overall Study|Risk of OHSS|0
2192738|NCT01497197|3823535|FG000|Overall Study|No oocytes retrieved|3
2192739|NCT01497197|3823536|FG001|Overall Study|No oocytes retrieved|2
2192740|NCT01497197|3823535|FG000|Overall Study|No fertilisation|6
2192741|NCT01497197|3823536|FG001|Overall Study|No fertilisation|5
2192742|NCT01497197|3823535|FG000|Overall Study|Intention to freeze all embryos|0
2192743|NCT01497197|3823536|FG001|Overall Study|Intention to freeze all embryos|1
2192744|NCT01497197|3823535|FG000|Overall Study|All embryos discarded|0
2192745|NCT01497197|3823536|FG001|Overall Study|All embryos discarded|3
2192746|NCT01497197|3823535|FG000|Overall Study|Other|3
2192747|NCT01497197|3823536|FG001|Overall Study|Other|1
2192748|NCT01497262|3823542|FG000|Overall Study|Abnormal Lab Values|4
2192749|NCT01497262|3823542|FG000|Overall Study|Abnormal Test Procedure Result|1
2192750|NCT01497262|3823542|FG000|Overall Study|Physician Decision|1
2192751|NCT01497262|3823542|FG000|Overall Study|Withdrawal by Subject|2
2192752|NCT01497262|3823542|FG000|Overall Study|Adverse Event|2
2192753|NCT01497262|3823542|FG000|Overall Study|Protocol Violation|1
2192754|NCT01497275|3823546|FG000|Overall Study|Death|1
2192755|NCT01497275|3823546|FG000|Overall Study|Adverse Event|1
2192756|NCT01497366|3823552|FG000|Overall Study|Virologic failure|2
2192757|NCT01497366|3823553|FG001|Overall Study|Virologic failure|50
2192758|NCT01497366|3823552|FG000|Overall Study|Lost to Follow-up|11
2192759|NCT01497366|3823553|FG001|Overall Study|Lost to Follow-up|10
2192760|NCT01497366|3823552|FG000|Overall Study|Withdrawal by Subject|6
2192761|NCT01497366|3823553|FG001|Overall Study|Withdrawal by Subject|6
2192762|NCT01497366|3823552|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7
2192763|NCT01497366|3823553|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0
2192764|NCT01497366|3823552|FG000|Overall Study|Other|5
2192765|NCT01497366|3823553|FG001|Overall Study|Other|0
2192766|NCT01497366|3823552|FG000|Overall Study|Death|1
2192767|NCT01497366|3823553|FG001|Overall Study|Death|1
2192768|NCT01497366|3823552|FG000|Overall Study|Randomized but not treated|7
2192769|NCT01497366|3823553|FG001|Overall Study|Randomized but not treated|21
2192770|NCT01497899|3823606|FG000|Double-Blind Phase|Randomized but not Treated|1
2192771|NCT01497899|3823607|FG001|Double-Blind Phase|Randomized but not Treated|0
2192772|NCT01497899|3823608|FG002|Double-Blind Phase|Randomized but not Treated|0
2192773|NCT01497899|3823609|FG003|Double-Blind Phase|Randomized but not Treated|0
2192774|NCT01497899|3823606|FG000|Double-Blind Phase|Adverse Event|1
2192775|NCT01497899|3823607|FG001|Double-Blind Phase|Adverse Event|0
2192776|NCT01497899|3823608|FG002|Double-Blind Phase|Adverse Event|0
2192777|NCT01497899|3823609|FG003|Double-Blind Phase|Adverse Event|0
2224512|NCT01772134|3871940|FG002|Overall Study|Protocol Deviation|3
2224513|NCT01772134|3871938|FG000|Overall Study|Lack of Efficacy|11
2224514|NCT01772134|3871939|FG001|Overall Study|Lack of Efficacy|5
2224515|NCT01772134|3871940|FG002|Overall Study|Lack of Efficacy|3
2224516|NCT01772134|3871938|FG000|Overall Study|Protocol-defined Stopping Criteria|1
2224517|NCT01772134|3871939|FG001|Overall Study|Protocol-defined Stopping Criteria|0
2224518|NCT01772134|3871940|FG002|Overall Study|Protocol-defined Stopping Criteria|0
2224519|NCT01772134|3871938|FG000|Overall Study|Randomized Study Medication Not Received|2
2224520|NCT01772134|3871939|FG001|Overall Study|Randomized Study Medication Not Received|0
2224521|NCT01772134|3871940|FG002|Overall Study|Randomized Study Medication Not Received|1
2224522|NCT01772147|3871951|FG000|Overall Study|Adverse Event|13
2224523|NCT01772147|3871952|FG001|Overall Study|Adverse Event|10
2224524|NCT01772147|3871953|FG002|Overall Study|Adverse Event|6
2224525|NCT01772147|3871951|FG000|Overall Study|Withdrew Consent|7
2224526|NCT01772147|3871952|FG001|Overall Study|Withdrew Consent|8
2224527|NCT01772147|3871953|FG002|Overall Study|Withdrew Consent|4
2224528|NCT01772147|3871951|FG000|Overall Study|Lost to Follow-up|1
2224529|NCT01772147|3871952|FG001|Overall Study|Lost to Follow-up|0
2224530|NCT01772147|3871953|FG002|Overall Study|Lost to Follow-up|1
2224531|NCT01772147|3871951|FG000|Overall Study|Protocol Deviation|2
2224532|NCT01772147|3871952|FG001|Overall Study|Protocol Deviation|1
2224533|NCT01772147|3871953|FG002|Overall Study|Protocol Deviation|1
2224534|NCT01772147|3871951|FG000|Overall Study|Lack of Efficacy|8
2224535|NCT01772147|3871952|FG001|Overall Study|Lack of Efficacy|6
2224536|NCT01772147|3871953|FG002|Overall Study|Lack of Efficacy|6
2224537|NCT01772160|3871961|FG000|Overall Study|Death|3
2224538|NCT01772160|3871961|FG000|Overall Study|Eligibility criteria not fulfilled|3
2224539|NCT01772160|3871961|FG000|Overall Study|Consent withdrawal|3
2224540|NCT01772160|3871961|FG000|Overall Study|Migrated / moved from the study area|4
2224541|NCT01772160|3871961|FG000|Overall Study|Lost to Follow-up|30
2224542|NCT01772160|3871961|FG000|Overall Study|Other|5
2224543|NCT01772316|3871965|FG000|Overall Study|Serious adverse event|1
2224544|NCT01772316|3871965|FG000|Overall Study|Inform consent withdrawn|1
2224545|NCT01772316|3871965|FG000|Overall Study|Withdrawn by sponsor decision|5
2192778|NCT01497899|3823606|FG000|Double-Blind Phase|Lack of Efficacy|0
2192779|NCT01497899|3823607|FG001|Double-Blind Phase|Lack of Efficacy|1
2192780|NCT01497899|3823608|FG002|Double-Blind Phase|Lack of Efficacy|0
2192781|NCT01497899|3823609|FG003|Double-Blind Phase|Lack of Efficacy|0
2192782|NCT01497899|3823606|FG000|Double-Blind Phase|Investigator's Discretion|1
2192783|NCT01497899|3823607|FG001|Double-Blind Phase|Investigator's Discretion|0
2192784|NCT01497899|3823608|FG002|Double-Blind Phase|Investigator's Discretion|0
2192785|NCT01497899|3823609|FG003|Double-Blind Phase|Investigator's Discretion|0
2192786|NCT01497899|3823606|FG000|Double-Blind Phase|Withdrew Consent|0
2192787|NCT01497899|3823607|FG001|Double-Blind Phase|Withdrew Consent|1
2192788|NCT01497899|3823608|FG002|Double-Blind Phase|Withdrew Consent|0
2192789|NCT01497899|3823609|FG003|Double-Blind Phase|Withdrew Consent|0
2192790|NCT01497899|3823606|FG000|Double-Blind Phase|Lost to Follow-up|3
2192791|NCT01497899|3823607|FG001|Double-Blind Phase|Lost to Follow-up|2
2192792|NCT01497899|3823608|FG002|Double-Blind Phase|Lost to Follow-up|0
2192793|NCT01497899|3823609|FG003|Double-Blind Phase|Lost to Follow-up|0
2192794|NCT01497899|3823606|FG000|Double-Blind Phase|Subject Non-Compliance|0
2192795|NCT01497899|3823607|FG001|Double-Blind Phase|Subject Non-Compliance|1
2192796|NCT01497899|3823608|FG002|Double-Blind Phase|Subject Non-Compliance|0
2192797|NCT01497899|3823609|FG003|Double-Blind Phase|Subject Non-Compliance|0
2192798|NCT01497899|3823606|FG000|Open-Label Extension Phase|Adverse Event|1
2192799|NCT01497899|3823607|FG001|Open-Label Extension Phase|Adverse Event|0
2192800|NCT01497899|3823608|FG002|Open-Label Extension Phase|Adverse Event|0
2192801|NCT01497899|3823609|FG003|Open-Label Extension Phase|Adverse Event|0
2192802|NCT01497899|3823606|FG000|Open-Label Extension Phase|Death|1
2192803|NCT01497899|3823607|FG001|Open-Label Extension Phase|Death|0
2192804|NCT01497899|3823608|FG002|Open-Label Extension Phase|Death|0
2192805|NCT01497899|3823609|FG003|Open-Label Extension Phase|Death|0
2192806|NCT01497899|3823606|FG000|Open-Label Extension Phase|Withdrew Consent|8
2192807|NCT01497899|3823607|FG001|Open-Label Extension Phase|Withdrew Consent|3
2192808|NCT01497899|3823608|FG002|Open-Label Extension Phase|Withdrew Consent|2
2192809|NCT01497899|3823609|FG003|Open-Label Extension Phase|Withdrew Consent|0
2192810|NCT01497899|3823606|FG000|Open-Label Extension Phase|Pregnancy|0
2192811|NCT01497899|3823607|FG001|Open-Label Extension Phase|Pregnancy|1
2192812|NCT01497899|3823608|FG002|Open-Label Extension Phase|Pregnancy|1
2192813|NCT01497899|3823609|FG003|Open-Label Extension Phase|Pregnancy|0
2192814|NCT01497899|3823606|FG000|Open-Label Extension Phase|Protocol Violation|0
2192815|NCT01497899|3823607|FG001|Open-Label Extension Phase|Protocol Violation|0
2192816|NCT01497899|3823608|FG002|Open-Label Extension Phase|Protocol Violation|1
2192817|NCT01497899|3823609|FG003|Open-Label Extension Phase|Protocol Violation|0
2192818|NCT01497899|3823606|FG000|Open-Label Extension Phase|Lost to Follow-up|9
2192819|NCT01497899|3823607|FG001|Open-Label Extension Phase|Lost to Follow-up|3
2192820|NCT01497899|3823608|FG002|Open-Label Extension Phase|Lost to Follow-up|5
2192821|NCT01497899|3823609|FG003|Open-Label Extension Phase|Lost to Follow-up|5
2192822|NCT01497938|3823618|FG000|Overall Study|Adverse Event|0
2192823|NCT01497938|3823619|FG001|Overall Study|Adverse Event|1
2192824|NCT01497938|3823618|FG000|Overall Study|Physician Decision|0
2192825|NCT01497938|3823619|FG001|Overall Study|Physician Decision|1
2192826|NCT01497938|3823618|FG000|Overall Study|Withdrawal by Subject|4
2192827|NCT01497938|3823619|FG001|Overall Study|Withdrawal by Subject|0
2192828|NCT01497938|3823618|FG000|Overall Study|Device Violation|1
2192829|NCT01497938|3823619|FG001|Overall Study|Device Violation|0
2192830|NCT01498068|3823627|FG000|Overall Study|Withdrawal by Subject|1
2192831|NCT01498068|3823628|FG001|Overall Study|Withdrawal by Subject|1
2192832|NCT01498120|3823634|FG000|Overall Study|Lost to Follow-up|1
2192833|NCT01498120|3823634|FG000|Overall Study|Withdrawal by Subject|5
2192834|NCT01498120|3823634|FG000|Overall Study|AE, non-serious non-fatal|3
2192835|NCT01498120|3823634|FG000|Overall Study|Other|4
2192836|NCT01498185|3823643|FG000|Overall Study|Adverse Event|0
2192837|NCT01498185|3823644|FG001|Overall Study|Adverse Event|0
2192838|NCT01498185|3823645|FG002|Overall Study|Adverse Event|0
2192839|NCT01498185|3823646|FG003|Overall Study|Adverse Event|1
2192840|NCT01498185|3823647|FG004|Overall Study|Adverse Event|0
2192841|NCT01498185|3823643|FG000|Overall Study|Withdrawal by Subject|1
2192842|NCT01498185|3823644|FG001|Overall Study|Withdrawal by Subject|1
2192843|NCT01498185|3823645|FG002|Overall Study|Withdrawal by Subject|0
2192844|NCT01498185|3823646|FG003|Overall Study|Withdrawal by Subject|2
2192845|NCT01498185|3823647|FG004|Overall Study|Withdrawal by Subject|1
2192846|NCT01498185|3823643|FG000|Overall Study|No longer met criteria, etc|0
2192847|NCT01498185|3823644|FG001|Overall Study|No longer met criteria, etc|0
2192848|NCT01498185|3823645|FG002|Overall Study|No longer met criteria, etc|0
2192849|NCT01498185|3823646|FG003|Overall Study|No longer met criteria, etc|0
2192850|NCT01498185|3823647|FG004|Overall Study|No longer met criteria, etc|2
2192851|NCT01498289|3823665|FG000|Overall Study|Adverse Event|16
2192852|NCT01498289|3823666|FG001|Overall Study|Adverse Event|18
2192853|NCT01498289|3823665|FG000|Overall Study|Death|6
2192854|NCT01498289|3823666|FG001|Overall Study|Death|8
2192855|NCT01498289|3823665|FG000|Overall Study|Withdrawal unrelated to AE|16
2192856|NCT01498289|3823666|FG001|Overall Study|Withdrawal unrelated to AE|16
2192857|NCT01498289|3823665|FG000|Overall Study|Progression/relapse|53
2192858|NCT01498289|3823666|FG001|Overall Study|Progression/relapse|59
2192859|NCT01498289|3823665|FG000|Overall Study|Not protocol specified|7
2192860|NCT01498289|3823666|FG001|Overall Study|Not protocol specified|2
2192861|NCT01498289|3823665|FG000|Overall Study|Reason under review|0
2192862|NCT01498289|3823666|FG001|Overall Study|Reason under review|1
2192863|NCT01498445|3823699|FG000|Overall Study|Lack of Efficacy|0
2192864|NCT01498445|3823700|FG001|Overall Study|Lack of Efficacy|0
2192865|NCT01498445|3823701|FG002|Overall Study|Lack of Efficacy|1
2192866|NCT01498445|3823702|FG003|Overall Study|Lack of Efficacy|2
2192867|NCT01498445|3823703|FG004|Overall Study|Lack of Efficacy|0
2192868|NCT01498445|3823704|FG005|Overall Study|Lack of Efficacy|0
2192869|NCT01498445|3823699|FG000|Overall Study|Screen Failure|0
2192870|NCT01498445|3823700|FG001|Overall Study|Screen Failure|0
2192871|NCT01498445|3823701|FG002|Overall Study|Screen Failure|0
2192872|NCT01498445|3823702|FG003|Overall Study|Screen Failure|0
2192873|NCT01498445|3823703|FG004|Overall Study|Screen Failure|1
2192874|NCT01498445|3823704|FG005|Overall Study|Screen Failure|1
2192875|NCT01498458|3823718|FG000|Overall Study|Adverse Event|4
2192876|NCT01498458|3823718|FG000|Overall Study|Physician Decision|3
2192877|NCT01498575|3823738|FG000|Overall Sample|Withdrawal by Subject|60
2192878|NCT01498575|3823739|FG001|Overall Sample|Withdrawal by Subject|14
2192879|NCT01498575|3823738|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
2192880|NCT01498575|3823739|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
2192881|NCT01498575|3823738|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23
2192882|NCT01498575|3823739|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18
2192883|NCT01498640|3823758|FG000|Overall Study|Lost to Follow-up|1
2192884|NCT01498640|3823758|FG000|Overall Study|Death|1
2192885|NCT01498640|3823758|FG000|Overall Study|Other|3
2192886|NCT01498653|3823768|FG000|Overall Study|Adverse Event|2
2192887|NCT01498653|3823769|FG001|Overall Study|Adverse Event|2
2192888|NCT01498653|3823768|FG000|Overall Study|Lack of Efficacy|12
2192889|NCT01498653|3823769|FG001|Overall Study|Lack of Efficacy|26
2192890|NCT01498653|3823768|FG000|Overall Study|Protocol Violation|0
2192891|NCT01498653|3823769|FG001|Overall Study|Protocol Violation|4
2192892|NCT01498653|3823768|FG000|Overall Study|Lost to Follow-up|1
2192893|NCT01498653|3823769|FG001|Overall Study|Lost to Follow-up|0
2192894|NCT01498653|3823768|FG000|Overall Study|Physician Decision|2
2192895|NCT01498653|3823769|FG001|Overall Study|Physician Decision|0
2192896|NCT01498653|3823768|FG000|Overall Study|Withdrawal by Subject|2
2192897|NCT01498653|3823769|FG001|Overall Study|Withdrawal by Subject|3
2192898|NCT01498679|3823777|FG000|Overall Study|Adverse Event|1
2192899|NCT01498679|3823778|FG001|Overall Study|Adverse Event|4
2192900|NCT01498679|3823777|FG000|Overall Study|Lack of Efficacy|72
2192901|NCT01498679|3823778|FG001|Overall Study|Lack of Efficacy|12
2192902|NCT01498679|3823777|FG000|Overall Study|Protocol Violation|4
2192903|NCT01498679|3823778|FG001|Overall Study|Protocol Violation|0
2192904|NCT01498679|3823777|FG000|Overall Study|Physician Decision|0
2192905|NCT01498679|3823778|FG001|Overall Study|Physician Decision|2
2192906|NCT01498679|3823777|FG000|Overall Study|Withdrawal by Subject|12
2192907|NCT01498679|3823778|FG001|Overall Study|Withdrawal by Subject|4
2192908|NCT01498692|3823784|FG000|Overall Study|Death|4
2192909|NCT01498692|3823784|FG000|Overall Study|Withdrawal by Subject|1
2192910|NCT01498692|3823784|FG000|Overall Study|Missed 12-month visit|3
2192911|NCT01498822|3823799|FG000|Overall Study|Protocol Violation|8
2192912|NCT01498822|3823800|FG001|Overall Study|Protocol Violation|4
2192913|NCT01498822|3823799|FG000|Overall Study|Other Reason|5
2192914|NCT01498822|3823800|FG001|Overall Study|Other Reason|2
2192915|NCT01498822|3823799|FG000|Overall Study|Lack of Efficacy|7
2192916|NCT01498822|3823800|FG001|Overall Study|Lack of Efficacy|2
2192917|NCT01498822|3823799|FG000|Overall Study|AE, non-serious non-fatal|8
2192918|NCT01498822|3823800|FG001|Overall Study|AE, non-serious non-fatal|17
2192919|NCT01498822|3823799|FG000|Overall Study|SAE, non-fatal|2
2192920|NCT01498822|3823800|FG001|Overall Study|SAE, non-fatal|2
2192921|NCT01498822|3823799|FG000|Overall Study|Adverse Event, serious fatal|1
2192922|NCT01498822|3823800|FG001|Overall Study|Adverse Event, serious fatal|1
2192923|NCT01498822|3823799|FG000|Overall Study|Withdrawal by Subject|15
2192924|NCT01498822|3823800|FG001|Overall Study|Withdrawal by Subject|25
2192925|NCT01498822|3823799|FG000|Overall Study|Lost to Follow-up|8
2192926|NCT01498822|3823800|FG001|Overall Study|Lost to Follow-up|3
2192927|NCT01498887|3823810|FG000|Overall Study|Administrative problems|1
2192928|NCT01498887|3823811|FG001|Overall Study|Administrative problems|0
2192929|NCT01498887|3823810|FG000|Overall Study|Lost to Follow-up|1
2192930|NCT01498887|3823811|FG001|Overall Study|Lost to Follow-up|1
2192931|NCT01498887|3823810|FG000|Overall Study|Withdrawal by Subject|1
2192932|NCT01498887|3823811|FG001|Overall Study|Withdrawal by Subject|0
2192933|NCT01498887|3823810|FG000|Overall Study|Protocol Violation|1
2192934|NCT01498887|3823811|FG001|Overall Study|Protocol Violation|3
2192935|NCT01498887|3823810|FG000|Overall Study|Lack of Efficacy|5
2192936|NCT01498887|3823811|FG001|Overall Study|Lack of Efficacy|3
2192937|NCT01498887|3823810|FG000|Overall Study|Abnormal result from test procedure|1
2192938|NCT01498887|3823811|FG001|Overall Study|Abnormal result from test procedure|1
2192939|NCT01498887|3823810|FG000|Overall Study|Abnormal laboratory value|2
2192940|NCT01498887|3823811|FG001|Overall Study|Abnormal laboratory value|2
2192941|NCT01498887|3823810|FG000|Overall Study|Adverse Event|4
2192942|NCT01498887|3823811|FG001|Overall Study|Adverse Event|1
2192943|NCT01498952|3823820|FG000|Overall Study|Death|2
2192944|NCT01498952|3823821|FG001|Overall Study|Death|2
2192945|NCT01498952|3823822|FG002|Overall Study|Death|0
2192946|NCT01498952|3823823|FG003|Overall Study|Death|0
2192947|NCT01498952|3823824|FG004|Overall Study|Death|0
2192948|NCT01499043|3823843|FG000|Overall Study|Progressive disease (radiographic)|2
2192949|NCT01499043|3823843|FG000|Overall Study|Progressive disease (clinical)|1
2192950|NCT01499043|3823843|FG000|Overall Study|Withdrawal by Subject|2
2192951|NCT01499043|3823843|FG000|Overall Study|Adverse Event|1
2192952|NCT01499082|3823854|FG000|Overall Study|Randomized but not Treated|0
2192953|NCT01499082|3823855|FG001|Overall Study|Randomized but not Treated|1
2192954|NCT01499082|3823854|FG000|Overall Study|Adverse Event|12
2192955|NCT01499082|3823855|FG001|Overall Study|Adverse Event|16
2192956|NCT01499082|3823854|FG000|Overall Study|Lack of Efficacy|1
2192957|NCT01499082|3823855|FG001|Overall Study|Lack of Efficacy|1
2192958|NCT01499082|3823854|FG000|Overall Study|Protocol Violation|6
2192959|NCT01499082|3823855|FG001|Overall Study|Protocol Violation|8
2192960|NCT01499082|3823854|FG000|Overall Study|Diverse Reasons|18
2192961|NCT01499082|3823855|FG001|Overall Study|Diverse Reasons|14
2192962|NCT01499082|3823854|FG000|Overall Study|Site Closure for Noncompliance|5
2192963|NCT01499082|3823855|FG001|Overall Study|Site Closure for Noncompliance|2
2192964|NCT01499082|3823854|FG000|Overall Study|Hypoglycemia|2
2192965|NCT01499082|3823855|FG001|Overall Study|Hypoglycemia|3
2192966|NCT01499082|3823854|FG000|Overall Study|Lost to Follow-up|1
2192967|NCT01499082|3823855|FG001|Overall Study|Lost to Follow-up|3
2192968|NCT01499095|3823865|FG000|Overall Study|Randomized But Not Treated|1
2192969|NCT01499095|3823866|FG001|Overall Study|Randomized But Not Treated|1
2192970|NCT01499095|3823865|FG000|Overall Study|Adverse Event|12
2192971|NCT01499095|3823866|FG001|Overall Study|Adverse Event|7
2192972|NCT01499095|3823865|FG000|Overall Study|Lack of Efficacy|2
2192973|NCT01499095|3823866|FG001|Overall Study|Lack of Efficacy|1
2192974|NCT01499095|3823865|FG000|Overall Study|Protocol Violation|6
2192975|NCT01499095|3823866|FG001|Overall Study|Protocol Violation|7
2192976|NCT01499095|3823865|FG000|Overall Study|Received Rescue Therapy|32
2192977|NCT01499095|3823866|FG001|Overall Study|Received Rescue Therapy|40
2192978|NCT01499095|3823865|FG000|Overall Study|Diverse Reasons|22
2192979|NCT01499095|3823866|FG001|Overall Study|Diverse Reasons|25
2192980|NCT01499095|3823865|FG000|Overall Study|Lost to Follow-up|6
2192981|NCT01499095|3823866|FG001|Overall Study|Lost to Follow-up|4
2192982|NCT01499095|3823865|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0
2192983|NCT01499095|3823866|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5
2192984|NCT01499095|3823865|FG000|Overall Study|Hypoglycemia|3
2192985|NCT01499095|3823866|FG001|Overall Study|Hypoglycemia|1
2192986|NCT01499095|3823865|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
2192987|NCT01499095|3823866|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
2192988|NCT01499095|3823865|FG000|Overall Study|Change in Injection Schedule|2
2192989|NCT01499095|3823866|FG001|Overall Study|Change in Injection Schedule|0
2192990|NCT01499095|3823865|FG000|Overall Study|Perceived Lack of Efficacy|1
2192991|NCT01499095|3823866|FG001|Overall Study|Perceived Lack of Efficacy|1
2192992|NCT01499134|3823877|FG000|Overall Study|Withdrawal by Subject|0
2192993|NCT01499134|3823878|FG001|Overall Study|Withdrawal by Subject|1
2224546|NCT01772368|3871969|FG000|Overall Study|Adverse Event|1
2224547|NCT01772368|3871969|FG000|Overall Study|Withdrawal by Subject|3
2224548|NCT01772368|3871969|FG000|Overall Study|Protocol Violation|2
2224549|NCT01772368|3871969|FG000|Overall Study|Other|1
2224550|NCT01772537|3871988|FG000|Overall Study|unsuccessful lumbar drain placement|1
2224551|NCT01772537|3871989|FG001|Overall Study|unsuccessful lumbar drain placement|0
2224552|NCT01772537|3871990|FG002|Overall Study|unsuccessful lumbar drain placement|0
2224553|NCT01772550|3872003|FG000|Overall Study|Unable to insert IV in antecubital vein|1
2224554|NCT01772550|3872004|FG001|Overall Study|Unable to insert IV in antecubital vein|1
2224555|NCT01772550|3872005|FG002|Overall Study|Unable to insert IV in antecubital vein|5
2224556|NCT01772550|3872003|FG000|Overall Study|Adverse Event|0
2224557|NCT01772550|3872004|FG001|Overall Study|Adverse Event|0
2224558|NCT01772550|3872005|FG002|Overall Study|Adverse Event|1
2224559|NCT01772576|3872013|FG000|Overall Study|Death|15
2224560|NCT01772576|3872013|FG000|Overall Study|Protocol Violation|1
2224561|NCT01772576|3872013|FG000|Overall Study|Lost to Follow-up|3
2224562|NCT01772576|3872013|FG000|Overall Study|Study device not used|3
2224563|NCT01772576|3872013|FG000|Overall Study|Adverse Event|6
2224564|NCT01772576|3872013|FG000|Overall Study|Withdrawal by Subject|6
2224565|NCT01772693|3872028|FG000|Overall Study|Health Concerns Unrelated to Study|2
2224566|NCT01772693|3872029|FG001|Overall Study|Health Concerns Unrelated to Study|1
2224567|NCT01772693|3872028|FG000|Overall Study|Withdrawal by Subject|2
2224568|NCT01772693|3872029|FG001|Overall Study|Withdrawal by Subject|0
2224569|NCT01772693|3872028|FG000|Overall Study|Alternative Treatment|2
2224570|NCT01772693|3872029|FG001|Overall Study|Alternative Treatment|0
2224571|NCT01772823|3872054|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
2224572|NCT01772823|3872055|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
2224573|NCT01772823|3872054|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
2224574|NCT01772823|3872055|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
2192994|NCT01499199|3823902|FG000|Overall Study|Adverse Event|1
2192995|NCT01499199|3823902|FG000|Overall Study|Lack of Efficacy|1
2192996|NCT01499277|3823908|FG000|Overall Study|Adverse Event|3
2192997|NCT01499277|3823909|FG001|Overall Study|Adverse Event|6
2192998|NCT01499277|3823908|FG000|Overall Study|Death|3
2192999|NCT01499277|3823909|FG001|Overall Study|Death|2
2193000|NCT01499277|3823908|FG000|Overall Study|Lost to Follow-up|15
2193001|NCT01499277|3823909|FG001|Overall Study|Lost to Follow-up|8
2193002|NCT01499277|3823908|FG000|Overall Study|Protocol Violation|2
2193003|NCT01499277|3823909|FG001|Overall Study|Protocol Violation|3
2193004|NCT01499277|3823908|FG000|Overall Study|Withdrawal by Subject|16
2193005|NCT01499277|3823909|FG001|Overall Study|Withdrawal by Subject|6
2193006|NCT01499277|3823908|FG000|Overall Study|Lack of therapeutic response and other|8
2193007|NCT01499277|3823909|FG001|Overall Study|Lack of therapeutic response and other|7
2193008|NCT01499290|3823917|FG000|Overall Study|Withdrawal by Subject|22
2193009|NCT01499290|3823918|FG001|Overall Study|Withdrawal by Subject|15
2193010|NCT01499290|3823917|FG000|Overall Study|Not specified in study report|11
2193011|NCT01499290|3823918|FG001|Overall Study|Not specified in study report|5
2193012|NCT01499290|3823917|FG000|Overall Study|Condition improved/subject recovered|1
2193013|NCT01499290|3823918|FG001|Overall Study|Condition improved/subject recovered|0
2193014|NCT01499290|3823917|FG000|Overall Study|Lack of Efficacy|7
2193015|NCT01499290|3823918|FG001|Overall Study|Lack of Efficacy|8
2193016|NCT01499290|3823917|FG000|Overall Study|Adverse Event|14
2193017|NCT01499290|3823918|FG001|Overall Study|Adverse Event|7
2193018|NCT01499303|3823945|FG000|Overall Study|Ongoing|2
2193019|NCT01499303|3823946|FG001|Overall Study|Ongoing|1
2193020|NCT01499303|3823945|FG000|Overall Study|Withdrawal by Subject|0
2193021|NCT01499303|3823946|FG001|Overall Study|Withdrawal by Subject|1
2193022|NCT01499303|3823945|FG000|Overall Study|Adverse Event|1
2193023|NCT01499303|3823946|FG001|Overall Study|Adverse Event|4
2193024|NCT01499303|3823945|FG000|Overall Study|Other|0
2193025|NCT01499303|3823946|FG001|Overall Study|Other|1
2193026|NCT01499355|3823952|FG000|Run-In Period|Study Termination|15
2193027|NCT01499355|3823953|FG001|Run-In Period|Study Termination|0
2193028|NCT01499355|3823954|FG002|Run-In Period|Study Termination|0
2193029|NCT01499355|3823955|FG003|Run-In Period|Study Termination|0
2193030|NCT01499355|3823952|FG000|Run-In Period|Other|3
2193031|NCT01499355|3823953|FG001|Run-In Period|Other|0
2193032|NCT01499355|3823954|FG002|Run-In Period|Other|0
2193033|NCT01499355|3823955|FG003|Run-In Period|Other|0
2193034|NCT01499355|3823952|FG000|Run-In Period|Death|2
2193035|NCT01499355|3823953|FG001|Run-In Period|Death|0
2193036|NCT01499355|3823954|FG002|Run-In Period|Death|0
2193037|NCT01499355|3823955|FG003|Run-In Period|Death|0
2193038|NCT01499355|3823952|FG000|Run-In Period|Investigator Decision|2
2193039|NCT01499355|3823953|FG001|Run-In Period|Investigator Decision|0
2193040|NCT01499355|3823954|FG002|Run-In Period|Investigator Decision|0
2193041|NCT01499355|3823955|FG003|Run-In Period|Investigator Decision|0
2193042|NCT01499355|3823952|FG000|Run-In Period|Consent Withdrawn|1
2193043|NCT01499355|3823953|FG001|Run-In Period|Consent Withdrawn|0
2193044|NCT01499355|3823954|FG002|Run-In Period|Consent Withdrawn|0
2193045|NCT01499355|3823955|FG003|Run-In Period|Consent Withdrawn|0
2193046|NCT01499355|3823952|FG000|Run-In Period|Adverse Event|8
2193047|NCT01499355|3823953|FG001|Run-In Period|Adverse Event|0
2193048|NCT01499355|3823954|FG002|Run-In Period|Adverse Event|0
2193049|NCT01499355|3823955|FG003|Run-In Period|Adverse Event|0
2193050|NCT01499355|3823952|FG000|Double-Blind Period|Adverse Event|0
2193051|NCT01499355|3823953|FG001|Double-Blind Period|Adverse Event|2
2193052|NCT01499355|3823954|FG002|Double-Blind Period|Adverse Event|3
2193053|NCT01499355|3823955|FG003|Double-Blind Period|Adverse Event|2
2193054|NCT01499355|3823952|FG000|Double-Blind Period|Study Termination|0
2193055|NCT01499355|3823953|FG001|Double-Blind Period|Study Termination|18
2193056|NCT01499355|3823954|FG002|Double-Blind Period|Study Termination|16
2193057|NCT01499355|3823955|FG003|Double-Blind Period|Study Termination|14
2193058|NCT01499355|3823952|FG000|Double-Blind Period|Other|0
2193059|NCT01499355|3823953|FG001|Double-Blind Period|Other|1
2193060|NCT01499355|3823954|FG002|Double-Blind Period|Other|2
2193061|NCT01499355|3823955|FG003|Double-Blind Period|Other|2
2193062|NCT01499355|3823952|FG000|Double-Blind Period|Death|0
2193063|NCT01499355|3823953|FG001|Double-Blind Period|Death|1
2193064|NCT01499355|3823954|FG002|Double-Blind Period|Death|0
2193065|NCT01499355|3823955|FG003|Double-Blind Period|Death|0
2193066|NCT01499355|3823952|FG000|Double-Blind Period|Investigator Decision|0
2193067|NCT01499355|3823953|FG001|Double-Blind Period|Investigator Decision|0
2193068|NCT01499355|3823954|FG002|Double-Blind Period|Investigator Decision|3
2193069|NCT01499355|3823955|FG003|Double-Blind Period|Investigator Decision|3
2193070|NCT01499355|3823952|FG000|Double-Blind Period|Consent Withdrawn|0
2193071|NCT01499355|3823953|FG001|Double-Blind Period|Consent Withdrawn|0
2193072|NCT01499355|3823954|FG002|Double-Blind Period|Consent Withdrawn|1
2193073|NCT01499355|3823955|FG003|Double-Blind Period|Consent Withdrawn|2
2193074|NCT01499355|3823952|FG000|Double-Blind Period|Lost to Follow-up|0
2193075|NCT01499355|3823953|FG001|Double-Blind Period|Lost to Follow-up|1
2193076|NCT01499355|3823954|FG002|Double-Blind Period|Lost to Follow-up|0
2193077|NCT01499355|3823955|FG003|Double-Blind Period|Lost to Follow-up|0
2193078|NCT01499368|3823968|FG000|Overall Study|Did not meet I/E criteria|8
2193079|NCT01499368|3823969|FG001|Overall Study|Did not meet I/E criteria|4
2193080|NCT01499368|3823970|FG002|Overall Study|Did not meet I/E criteria|4
2193081|NCT01499368|3823968|FG000|Overall Study|Prohibited Concomitant medication|1
2193082|NCT01499368|3823969|FG001|Overall Study|Prohibited Concomitant medication|1
2193083|NCT01499368|3823970|FG002|Overall Study|Prohibited Concomitant medication|0
2193084|NCT01499368|3823968|FG000|Overall Study|Withdrawal by Subject|11
2193085|NCT01499368|3823969|FG001|Overall Study|Withdrawal by Subject|10
2193086|NCT01499368|3823970|FG002|Overall Study|Withdrawal by Subject|8
2193087|NCT01499368|3823968|FG000|Overall Study|Lost to Follow-up|3
2193088|NCT01499368|3823969|FG001|Overall Study|Lost to Follow-up|2
2193089|NCT01499368|3823970|FG002|Overall Study|Lost to Follow-up|5
2193090|NCT01499368|3823968|FG000|Overall Study|Adverse Event|4
2193091|NCT01499368|3823969|FG001|Overall Study|Adverse Event|0
2193092|NCT01499368|3823970|FG002|Overall Study|Adverse Event|2
2193093|NCT01499368|3823968|FG000|Overall Study|Physician Decision|0
2193094|NCT01499368|3823969|FG001|Overall Study|Physician Decision|1
2193095|NCT01499368|3823970|FG002|Overall Study|Physician Decision|0
2193096|NCT01499368|3823968|FG000|Overall Study|Deviation from visit window|0
2193097|NCT01499368|3823969|FG001|Overall Study|Deviation from visit window|0
2193098|NCT01499368|3823970|FG002|Overall Study|Deviation from visit window|1
2193099|NCT01499368|3823968|FG000|Overall Study|Error of Prescriptions|0
2193100|NCT01499368|3823969|FG001|Overall Study|Error of Prescriptions|0
2193101|NCT01499368|3823970|FG002|Overall Study|Error of Prescriptions|1
2193102|NCT01499511|3823987|FG000|Overall Study|Death|1
2193103|NCT01499511|3823988|FG001|Overall Study|Death|0
2193104|NCT01499576|3823995|FG000|Overall Study|Physician Decision|12
2193105|NCT01499576|3823995|FG000|Overall Study|Withdrawal by Subject|9
2193106|NCT01499667|3824013|FG000|Overall Study|administrative problems|4
2193107|NCT01499667|3824014|FG001|Overall Study|administrative problems|5
2193108|NCT01499667|3824015|FG002|Overall Study|administrative problems|5
2193109|NCT01499667|3824013|FG000|Overall Study|Protocol Violation|1
2193110|NCT01499667|3824014|FG001|Overall Study|Protocol Violation|3
2193111|NCT01499667|3824015|FG002|Overall Study|Protocol Violation|2
2193112|NCT01499667|3824013|FG000|Overall Study|Adverse Event|0
2193113|NCT01499667|3824014|FG001|Overall Study|Adverse Event|2
2224575|NCT01772823|3872054|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
2224576|NCT01772823|3872055|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
2224577|NCT01772823|3872054|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
2224578|NCT01772823|3872055|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
2224579|NCT01772823|3872054|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
2224580|NCT01772823|3872055|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
2224581|NCT01772823|3872054|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
2224582|NCT01772823|3872055|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
2224583|NCT01772823|3872054|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
2224584|NCT01772823|3872055|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
2224585|NCT01772823|3872054|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
2224586|NCT01772823|3872055|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
2224587|NCT01772823|3872054|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4
2224588|NCT01772823|3872055|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3
2224589|NCT01772823|3872054|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1
2224590|NCT01772823|3872055|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0
2224591|NCT01772823|3872054|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
2224592|NCT01772823|3872055|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
2224593|NCT01772823|3872054|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
2224594|NCT01772823|3872055|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
2224595|NCT01772823|3872054|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
2224596|NCT01772823|3872055|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
2224597|NCT01772823|3872054|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
2224598|NCT01772823|3872055|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
2224599|NCT01772823|3872054|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
2224600|NCT01772823|3872055|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
2224601|NCT01772823|3872054|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
2224602|NCT01772823|3872055|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
2224603|NCT01773070|3872066|FG000|Overall Study|Withdrawal by Subject|24
2224604|NCT01773070|3872066|FG000|Overall Study|Lost to Follow-up|39
2224605|NCT01773070|3872066|FG000|Overall Study|Other|15
2224606|NCT01773070|3872066|FG000|Overall Study|Death (unrelated to study procedures)|3
2224607|NCT01773109|3872070|FG000|Overall Study|Symptomatic Progression|2
2224608|NCT01773109|3872070|FG000|Overall Study|Death|1
2224609|NCT01773122|3872078|FG000|Overall Study|Due to amended age eligibility criteria|3
2224610|NCT01773122|3872079|FG001|Overall Study|Due to amended age eligibility criteria|1
2224611|NCT01773122|3872080|FG002|Overall Study|Due to amended age eligibility criteria|0
2224612|NCT01773122|3872081|FG003|Overall Study|Due to amended age eligibility criteria|1
2224613|NCT01773226|3872107|FG000|Overall Study|Withdrawal by Subject|1
2193114|NCT01499667|3824015|FG002|Overall Study|Adverse Event|2
2193115|NCT01499667|3824013|FG000|Overall Study|Withdrawal by Subject|2
2193116|NCT01499667|3824014|FG001|Overall Study|Withdrawal by Subject|1
2193117|NCT01499667|3824015|FG002|Overall Study|Withdrawal by Subject|1
2193118|NCT01499667|3824013|FG000|Overall Study|Lack of Efficacy|2
2193119|NCT01499667|3824014|FG001|Overall Study|Lack of Efficacy|0
2193120|NCT01499667|3824015|FG002|Overall Study|Lack of Efficacy|0
2193121|NCT01499810|3824023|FG000|Overall Study|Lost to Follow-up|10
2193122|NCT01499810|3824023|FG000|Overall Study|Protocol Violation|1
2193123|NCT01499810|3824023|FG000|Overall Study|Withdrawal by Subject|1
2193124|NCT01499849|3824030|FG000|Overall Study|Adverse Event|28
2193125|NCT01499849|3824031|FG001|Overall Study|Adverse Event|32
2193126|NCT01499849|3824030|FG000|Overall Study|Chemo completed or Change in Therapy|70
2193127|NCT01499849|3824031|FG001|Overall Study|Chemo completed or Change in Therapy|67
2193128|NCT01499849|3824030|FG000|Overall Study|Withdrawal by Subject|43
2193129|NCT01499849|3824031|FG001|Overall Study|Withdrawal by Subject|43
2193130|NCT01499849|3824030|FG000|Overall Study|Death|5
2193131|NCT01499849|3824031|FG001|Overall Study|Death|7
2193132|NCT01499849|3824030|FG000|Overall Study|Disease Progression|11
2193133|NCT01499849|3824031|FG001|Overall Study|Disease Progression|10
2193134|NCT01499849|3824030|FG000|Overall Study|Protocol Violation|11
2193135|NCT01499849|3824031|FG001|Overall Study|Protocol Violation|11
2193136|NCT01499849|3824030|FG000|Overall Study|Physician Decision|20
2193137|NCT01499849|3824031|FG001|Overall Study|Physician Decision|19
2193138|NCT01499849|3824030|FG000|Overall Study|Lack of Efficacy|3
2193139|NCT01499849|3824031|FG001|Overall Study|Lack of Efficacy|4
2193140|NCT01499849|3824030|FG000|Overall Study|Lost to Follow-up|6
2193141|NCT01499849|3824031|FG001|Overall Study|Lost to Follow-up|3
2193142|NCT01499849|3824030|FG000|Overall Study|Other Reasons|27
2193143|NCT01499849|3824031|FG001|Overall Study|Other Reasons|30
2193144|NCT01499940|3824055|FG000|Overall Study|Study was withdrawn before completion.|9
2193145|NCT01500031|3824059|FG000|Overall Study|Death|1
2193146|NCT01500031|3824059|FG000|Overall Study|Withdrawal by Subject|4
2193147|NCT01500057|3824065|FG000|Overall Study|Lost to Follow-up|6
2193148|NCT01500057|3824066|FG001|Overall Study|Lost to Follow-up|4
2193149|NCT01500083|3824074|FG000|Overall Study|Adverse Event|4
2193150|NCT01500083|3824075|FG001|Overall Study|Adverse Event|17
2193151|NCT01500083|3824074|FG000|Overall Study|Death|0
2193152|NCT01500083|3824075|FG001|Overall Study|Death|2
2193153|NCT01500083|3824074|FG000|Overall Study|Lost to Follow-up|1
2193154|NCT01500083|3824075|FG001|Overall Study|Lost to Follow-up|0
2193155|NCT01500083|3824074|FG000|Overall Study|Withdrawal of Consent|0
2193156|NCT01500083|3824075|FG001|Overall Study|Withdrawal of Consent|1
2193157|NCT01500083|3824074|FG000|Overall Study|Disease Progression|2
2193158|NCT01500083|3824075|FG001|Overall Study|Disease Progression|10
2193159|NCT01500083|3824074|FG000|Overall Study|Investigator Discretion|3
2193160|NCT01500083|3824075|FG001|Overall Study|Investigator Discretion|8
2193161|NCT01500083|3824074|FG000|Overall Study|Other Reasons|2
2193162|NCT01500083|3824075|FG001|Overall Study|Other Reasons|5
2193163|NCT01500096|3824085|FG000|Overall Study|Lost to Follow-up|1
2193164|NCT01500096|3824086|FG001|Overall Study|Lost to Follow-up|0
2193165|NCT01500096|3824087|FG002|Overall Study|Lost to Follow-up|0
2193166|NCT01500096|3824088|FG003|Overall Study|Lost to Follow-up|2
2193167|NCT01500135|3824100|FG000|Overall Study|Withdrawal of Consent|4
2193168|NCT01500135|3824101|FG001|Overall Study|Withdrawal of Consent|0
2193169|NCT01500135|3824100|FG000|Overall Study|Lost to Follow-up|6
2193170|NCT01500135|3824101|FG001|Overall Study|Lost to Follow-up|4
2193171|NCT01500135|3824100|FG000|Overall Study|Fatal Adverse Event (AE)|5
2193172|NCT01500135|3824101|FG001|Overall Study|Fatal Adverse Event (AE)|5
2193173|NCT01500135|3824100|FG000|Overall Study|Principal Investigator (PI) Discretion|1
2193174|NCT01500135|3824101|FG001|Overall Study|Principal Investigator (PI) Discretion|0
2193175|NCT01500135|3824100|FG000|Overall Study|Patient Missed Scheduled Appointments|0
2193176|NCT01500135|3824101|FG001|Overall Study|Patient Missed Scheduled Appointments|1
2193177|NCT01500135|3824100|FG000|Overall Study|Participant was a Safety Concern|1
2193178|NCT01500135|3824101|FG001|Overall Study|Participant was a Safety Concern|0
2193179|NCT01500135|3824100|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0
2193180|NCT01500135|3824101|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1
2193181|NCT01500187|3824109|FG000|Overall Study|Lost to Follow-up|6
2193182|NCT01500187|3824110|FG001|Overall Study|Lost to Follow-up|0
2193183|NCT01500200|3824119|FG000|Stage 1|Adverse Event|1
2193184|NCT01500200|3824120|FG001|Stage 1|Adverse Event|4
2193185|NCT01500200|3824121|FG002|Stage 1|Adverse Event|5
2193186|NCT01500200|3824122|FG003|Stage 1|Adverse Event|0
2193187|NCT01500200|3824123|FG004|Stage 1|Adverse Event|0
2193188|NCT01500200|3824124|FG005|Stage 1|Adverse Event|0
2193189|NCT01500200|3824119|FG000|Stage 1|Lost to Follow-up|2
2193190|NCT01500200|3824120|FG001|Stage 1|Lost to Follow-up|2
2193191|NCT01500200|3824121|FG002|Stage 1|Lost to Follow-up|1
2193192|NCT01500200|3824122|FG003|Stage 1|Lost to Follow-up|0
2193193|NCT01500200|3824123|FG004|Stage 1|Lost to Follow-up|0
2193194|NCT01500200|3824124|FG005|Stage 1|Lost to Follow-up|0
2193195|NCT01500200|3824119|FG000|Stage 1|Withdrawal by Subject|3
2193196|NCT01500200|3824120|FG001|Stage 1|Withdrawal by Subject|0
2193197|NCT01500200|3824121|FG002|Stage 1|Withdrawal by Subject|0
2193198|NCT01500200|3824122|FG003|Stage 1|Withdrawal by Subject|0
2193199|NCT01500200|3824123|FG004|Stage 1|Withdrawal by Subject|0
2193200|NCT01500200|3824124|FG005|Stage 1|Withdrawal by Subject|0
2193201|NCT01500200|3824119|FG000|Stage 1|Noncompliance with Study Drug|1
2193202|NCT01500200|3824120|FG001|Stage 1|Noncompliance with Study Drug|0
2193203|NCT01500200|3824121|FG002|Stage 1|Noncompliance with Study Drug|0
2193204|NCT01500200|3824122|FG003|Stage 1|Noncompliance with Study Drug|0
2193205|NCT01500200|3824123|FG004|Stage 1|Noncompliance with Study Drug|0
2193206|NCT01500200|3824124|FG005|Stage 1|Noncompliance with Study Drug|0
2193207|NCT01500200|3824119|FG000|Stage 1|Physician Decision|1
2193208|NCT01500200|3824120|FG001|Stage 1|Physician Decision|0
2193209|NCT01500200|3824121|FG002|Stage 1|Physician Decision|0
2193210|NCT01500200|3824122|FG003|Stage 1|Physician Decision|0
2193211|NCT01500200|3824123|FG004|Stage 1|Physician Decision|0
2193212|NCT01500200|3824124|FG005|Stage 1|Physician Decision|0
2193213|NCT01500200|3824119|FG000|Stage 2|Adverse Event|0
2193214|NCT01500200|3824120|FG001|Stage 2|Adverse Event|0
2193215|NCT01500200|3824121|FG002|Stage 2|Adverse Event|0
2193216|NCT01500200|3824122|FG003|Stage 2|Adverse Event|0
2193217|NCT01500200|3824123|FG004|Stage 2|Adverse Event|5
2193218|NCT01500200|3824124|FG005|Stage 2|Adverse Event|4
2193219|NCT01500213|3824140|FG000|Overall Study|Adverse Event|35
2193220|NCT01500213|3824141|FG001|Overall Study|Adverse Event|35
2193221|NCT01500213|3824140|FG000|Overall Study|Chemo Completed or Change in Therapy|84
2193222|NCT01500213|3824141|FG001|Overall Study|Chemo Completed or Change in Therapy|81
2193223|NCT01500213|3824140|FG000|Overall Study|Withdrawal by Subject|28
2193224|NCT01500213|3824141|FG001|Overall Study|Withdrawal by Subject|37
2193225|NCT01500213|3824140|FG000|Overall Study|Death|7
2193226|NCT01500213|3824141|FG001|Overall Study|Death|3
2193227|NCT01500213|3824140|FG000|Overall Study|Disease Progression|13
2193228|NCT01500213|3824141|FG001|Overall Study|Disease Progression|21
2193229|NCT01500213|3824140|FG000|Overall Study|Protocol Violation|19
2193230|NCT01500213|3824141|FG001|Overall Study|Protocol Violation|19
2193231|NCT01500213|3824140|FG000|Overall Study|Physician Decision|12
2193232|NCT01500213|3824141|FG001|Overall Study|Physician Decision|10
2193233|NCT01500213|3824140|FG000|Overall Study|Lack of Efficacy|9
2193234|NCT01500213|3824141|FG001|Overall Study|Lack of Efficacy|7
2193235|NCT01500213|3824140|FG000|Overall Study|Lost to Follow-up|3
2193236|NCT01500213|3824141|FG001|Overall Study|Lost to Follow-up|6
2193237|NCT01500213|3824140|FG000|Overall Study|Other Reasons|7
2193238|NCT01500213|3824141|FG001|Overall Study|Other Reasons|5
2193239|NCT01500226|3824149|FG000|Overall Study|Adverse Event|31
2193240|NCT01500226|3824150|FG001|Overall Study|Adverse Event|38
2193241|NCT01500226|3824149|FG000|Overall Study|Chemo Completed or Change in Therapy|235
2193242|NCT01500226|3824150|FG001|Overall Study|Chemo Completed or Change in Therapy|237
2193243|NCT01500226|3824149|FG000|Overall Study|Withdrawal by Subject|93
2193244|NCT01500226|3824150|FG001|Overall Study|Withdrawal by Subject|96
2193245|NCT01500226|3824149|FG000|Overall Study|Death|12
2193246|NCT01500226|3824150|FG001|Overall Study|Death|4
2193247|NCT01500226|3824149|FG000|Overall Study|Disease Progression|16
2193248|NCT01500226|3824150|FG001|Overall Study|Disease Progression|14
2193249|NCT01500226|3824149|FG000|Overall Study|Protocol Violation|53
2193250|NCT01500226|3824150|FG001|Overall Study|Protocol Violation|39
2193251|NCT01500226|3824149|FG000|Overall Study|Physician Decision|17
2193252|NCT01500226|3824150|FG001|Overall Study|Physician Decision|15
2193253|NCT01500226|3824149|FG000|Overall Study|Lack of Efficacy|14
2193254|NCT01500226|3824150|FG001|Overall Study|Lack of Efficacy|30
2193255|NCT01500226|3824149|FG000|Overall Study|Lost to Follow-up|9
2193256|NCT01500226|3824150|FG001|Overall Study|Lost to Follow-up|5
2193257|NCT01500226|3824149|FG000|Overall Study|Other Reasons|19
2193258|NCT01500226|3824150|FG001|Overall Study|Other Reasons|16
2193259|NCT01500252|3824158|FG000|Overall Study|Death|4
2193260|NCT01500252|3824159|FG001|Overall Study|Death|2
2224614|NCT01773291|3872114|FG000|Overall Study|Protocol Violation|1
2224615|NCT01773291|3872115|FG001|Overall Study|Protocol Violation|0
2224616|NCT01773291|3872116|FG002|Overall Study|Protocol Violation|0
2224617|NCT01773291|3872114|FG000|Overall Study|Withdrawal by Subject|0
2224618|NCT01773291|3872115|FG001|Overall Study|Withdrawal by Subject|0
2224619|NCT01773291|3872116|FG002|Overall Study|Withdrawal by Subject|1
2224620|NCT01773421|3872129|FG000|Treatment Phase|Other|0
2224621|NCT01773421|3872130|FG001|Treatment Phase|Other|0
2224622|NCT01773421|3872131|FG002|Treatment Phase|Other|2
2224623|NCT01773421|3872132|FG003|Treatment Phase|Other|0
2224624|NCT01773421|3872133|FG004|Treatment Phase|Other|0
2224625|NCT01773421|3872134|FG005|Treatment Phase|Other|0
2224626|NCT01773421|3872135|FG006|Treatment Phase|Other|0
2224627|NCT01773421|3872129|FG000|Treatment Phase|Adverse Event|0
2224628|NCT01773421|3872130|FG001|Treatment Phase|Adverse Event|0
2224629|NCT01773421|3872131|FG002|Treatment Phase|Adverse Event|3
2224630|NCT01773421|3872132|FG003|Treatment Phase|Adverse Event|1
2224631|NCT01773421|3872133|FG004|Treatment Phase|Adverse Event|0
2036602|NCT00412984|3606856|FG000|Overall Study|Death|331
2193261|NCT01500252|3824158|FG000|Overall Study|Lost to Follow-up|5
2193262|NCT01500252|3824159|FG001|Overall Study|Lost to Follow-up|4
2193263|NCT01500278|3824168|FG000|Week 0 - Week 12|Lack of Efficacy|0
2193264|NCT01500278|3824169|FG001|Week 0 - Week 12|Lack of Efficacy|1
2193265|NCT01500278|3824168|FG000|Week 0 - Week 12|Protocol Violation|10
2193266|NCT01500278|3824169|FG001|Week 0 - Week 12|Protocol Violation|16
2193267|NCT01500278|3824168|FG000|Week 0 - Week 12|Lost to Follow-up|1
2224632|NCT01773421|3872134|FG005|Treatment Phase|Adverse Event|0
2224633|NCT01773421|3872135|FG006|Treatment Phase|Adverse Event|0
2224634|NCT01773421|3872129|FG000|Treatment Phase|Withdrawal by Subject|0
2224635|NCT01773421|3872130|FG001|Treatment Phase|Withdrawal by Subject|0
2224636|NCT01773421|3872131|FG002|Treatment Phase|Withdrawal by Subject|1
2193268|NCT01500278|3824169|FG001|Week 0 - Week 12|Lost to Follow-up|1
2193269|NCT01500278|3824168|FG000|Week 0 - Week 12|Withdrawal by Subject|7
2193270|NCT01500278|3824169|FG001|Week 0 - Week 12|Withdrawal by Subject|2
2193271|NCT01500278|3824168|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1
2193272|NCT01500278|3824169|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0
2193273|NCT01500278|3824168|FG000|Week 0 - Week 12|Patient decision|1
2193274|NCT01500278|3824169|FG001|Week 0 - Week 12|Patient decision|0
2193275|NCT01500278|3824168|FG000|Week 0 - Week 12|Exclusion criteria not met|1
2193276|NCT01500278|3824169|FG001|Week 0 - Week 12|Exclusion criteria not met|0
2193277|NCT01500278|3824168|FG000|Week 0 - Week 12|Investigator decision|1
2193278|NCT01500278|3824169|FG001|Week 0 - Week 12|Investigator decision|0
2193279|NCT01500278|3824168|FG000|Week 0 - Week 12|Prior history of serious disease|1
2193280|NCT01500278|3824169|FG001|Week 0 - Week 12|Prior history of serious disease|0
2193281|NCT01500278|3824168|FG000|Week 0 - Week 12|Sponsor decision|1
2193282|NCT01500278|3824169|FG001|Week 0 - Week 12|Sponsor decision|0
2193283|NCT01500278|3824168|FG000|Week 0 - Week 12|Personal reason|0
2193284|NCT01500278|3824169|FG001|Week 0 - Week 12|Personal reason|1
2193285|NCT01500278|3824168|FG000|Week 0 - Week 12|Other serious disease|0
2193286|NCT01500278|3824169|FG001|Week 0 - Week 12|Other serious disease|1
2193287|NCT01500278|3824168|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7
2193288|NCT01500278|3824169|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8
2193289|NCT01500278|3824168|FG000|Week 13 - Week 104|Lack of Efficacy|11
2193290|NCT01500278|3824169|FG001|Week 13 - Week 104|Lack of Efficacy|12
2193291|NCT01500278|3824168|FG000|Week 13 - Week 104|Protocol Violation|6
2193292|NCT01500278|3824169|FG001|Week 13 - Week 104|Protocol Violation|6
2193293|NCT01500278|3824168|FG000|Week 13 - Week 104|Lost to Follow-up|6
2193294|NCT01500278|3824169|FG001|Week 13 - Week 104|Lost to Follow-up|5
2193295|NCT01500278|3824168|FG000|Week 13 - Week 104|Withdrawal by Subject|22
2193296|NCT01500278|3824169|FG001|Week 13 - Week 104|Withdrawal by Subject|13
2193297|NCT01500278|3824168|FG000|Week 13 - Week 104|Week 24 Non-Responder|20
2193298|NCT01500278|3824169|FG001|Week 13 - Week 104|Week 24 Non-Responder|16
2193299|NCT01500278|3824168|FG000|Week 13 - Week 104|Non/bad compliance|7
2193300|NCT01500278|3824169|FG001|Week 13 - Week 104|Non/bad compliance|5
2193301|NCT01500278|3824168|FG000|Week 13 - Week 104|Recurrent infections|1
2193302|NCT01500278|3824169|FG001|Week 13 - Week 104|Recurrent infections|0
2193303|NCT01500278|3824168|FG000|Week 13 - Week 104|False positive test|1
2193304|NCT01500278|3824169|FG001|Week 13 - Week 104|False positive test|2
2193305|NCT01500278|3824168|FG000|Week 13 - Week 104|Sponsor request|4
2193306|NCT01500278|3824169|FG001|Week 13 - Week 104|Sponsor request|0
2193307|NCT01500278|3824168|FG000|Week 13 - Week 104|Withdrawn in error|1
2193308|NCT01500278|3824169|FG001|Week 13 - Week 104|Withdrawn in error|0
2193309|NCT01500278|3824168|FG000|Week 13 - Week 104|Exclusion criteria not met|1
2193310|NCT01500278|3824169|FG001|Week 13 - Week 104|Exclusion criteria not met|0
2193311|NCT01500278|3824168|FG000|Week 13 - Week 104|Protocol deviation|1
2193312|NCT01500278|3824169|FG001|Week 13 - Week 104|Protocol deviation|0
2193313|NCT01500278|3824168|FG000|Week 13 - Week 104|Principal investigator retiring|1
2193314|NCT01500278|3824169|FG001|Week 13 - Week 104|Principal investigator retiring|0
2193315|NCT01500278|3824168|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
2193316|NCT01500278|3824169|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
2193317|NCT01500278|3824168|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0
2193318|NCT01500278|3824169|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2
2193319|NCT01500278|3824168|FG000|Week 13 - Week 104|Relocation|0
2193320|NCT01500278|3824169|FG001|Week 13 - Week 104|Relocation|1
2193321|NCT01500278|3824168|FG000|Week 13 - Week 104|Sponsor decision|0
2193322|NCT01500278|3824169|FG001|Week 13 - Week 104|Sponsor decision|2
2193323|NCT01500278|3824168|FG000|Week 13 - Week 104|Medical monitor decision|0
2193324|NCT01500278|3824169|FG001|Week 13 - Week 104|Medical monitor decision|2
2193325|NCT01500278|3824168|FG000|Week 13 - Week 104|Personal reason|0
2193326|NCT01500278|3824169|FG001|Week 13 - Week 104|Personal reason|1
2193327|NCT01500278|3824168|FG000|Week 13 - Week 104|Not completed|0
2193328|NCT01500278|3824169|FG001|Week 13 - Week 104|Not completed|1
2193329|NCT01500278|3824168|FG000|Week 13 - Week 104|Death|2
2193330|NCT01500278|3824169|FG001|Week 13 - Week 104|Death|4
2193331|NCT01500278|3824168|FG000|Week 13 - Week 104|Adverse Event|54
2193332|NCT01500278|3824169|FG001|Week 13 - Week 104|Adverse Event|54
2193333|NCT01500317|3824180|FG000|Overall Study|Withdrawal by Subject|3
2193334|NCT01500317|3824181|FG001|Overall Study|Withdrawal by Subject|2
2193335|NCT01500317|3824182|FG002|Overall Study|Withdrawal by Subject|0
2193336|NCT01500382|3824194|FG000|Washout Period|Study site went out of business|0
2193337|NCT01500382|3824195|FG001|Washout Period|Study site went out of business|0
2193338|NCT01500382|3824196|FG002|Washout Period|Study site went out of business|1
2193339|NCT01500382|3824197|FG003|Washout Period|Study site went out of business|0
2193340|NCT01500434|3824207|FG000|Overall Study|Death|1
2224637|NCT01773421|3872132|FG003|Treatment Phase|Withdrawal by Subject|1
2224638|NCT01773421|3872133|FG004|Treatment Phase|Withdrawal by Subject|0
2224639|NCT01773421|3872134|FG005|Treatment Phase|Withdrawal by Subject|0
2224640|NCT01773421|3872135|FG006|Treatment Phase|Withdrawal by Subject|0
2224641|NCT01773421|3872129|FG000|Extension Phase|Other|0
2193341|NCT01500434|3824207|FG000|Overall Study|Withdrawal by Subject|1
2224642|NCT01773421|3872130|FG001|Extension Phase|Other|0
2193342|NCT01500434|3824207|FG000|Overall Study|Missed 12-month follow-up|5
2193343|NCT01500629|3824222|FG000|Washout Period of 14 to 30 Days|Pregnancy|1
2193344|NCT01500629|3824223|FG001|Washout Period of 14 to 30 Days|Pregnancy|0
2193345|NCT01500694|3824238|FG000|Overall Study|Adverse Event|4
2193346|NCT01500694|3824239|FG001|Overall Study|Adverse Event|3
2193347|NCT01500694|3824238|FG000|Overall Study|Protocol Violation|0
2193348|NCT01500694|3824239|FG001|Overall Study|Protocol Violation|1
2193349|NCT01500694|3824238|FG000|Overall Study|Withdrawal by Subject|23
2193350|NCT01500694|3824239|FG001|Overall Study|Withdrawal by Subject|14
2193351|NCT01500694|3824238|FG000|Overall Study|Lost to Follow-up|2
2193352|NCT01500694|3824239|FG001|Overall Study|Lost to Follow-up|3
2193353|NCT01500694|3824238|FG000|Overall Study|Lack of Efficacy|14
2193354|NCT01500694|3824239|FG001|Overall Study|Lack of Efficacy|5
2193355|NCT01500694|3824238|FG000|Overall Study|Other|9
2193356|NCT01500694|3824239|FG001|Overall Study|Other|3
2193357|NCT01500720|3824247|FG000|Overall Study|Randomized But Not Treated|1
2193358|NCT01500720|3824248|FG001|Overall Study|Randomized But Not Treated|1
2193359|NCT01500720|3824247|FG000|Overall Study|Other|4
2193360|NCT01500720|3824248|FG001|Overall Study|Other|8
2193361|NCT01501110|3824283|FG000|Overall Study|Death|0
2193362|NCT01501110|3824284|FG001|Overall Study|Death|1
2193363|NCT01502033|3824306|FG000|Overall Study|1 participant had scalp discomfort|1
2193364|NCT01502033|3824306|FG000|Overall Study|1 participant had worsening depression|1
2193365|NCT01502033|3824306|FG000|Overall Study|1 participant went back to school|1
2193366|NCT01502072|3824315|FG000|Overall Study|Withdrawal by Subject|1
2193367|NCT01502072|3824316|FG001|Overall Study|Withdrawal by Subject|0
2193368|NCT01502072|3824317|FG002|Overall Study|Withdrawal by Subject|0
2193369|NCT01502072|3824315|FG000|Overall Study|Death|0
2193370|NCT01502072|3824316|FG001|Overall Study|Death|1
2193371|NCT01502072|3824317|FG002|Overall Study|Death|0
2193372|NCT01502228|3824325|FG000|Overall Study|Death|1
2193373|NCT01502293|3824332|FG000|Overall Study|Progressive Disease|20
2193374|NCT01502293|3824333|FG001|Overall Study|Progressive Disease|12
2193375|NCT01502293|3824334|FG002|Overall Study|Progressive Disease|2
2193376|NCT01502293|3824332|FG000|Overall Study|Withdrawal by Subject|3
2193377|NCT01502293|3824333|FG001|Overall Study|Withdrawal by Subject|3
2193378|NCT01502293|3824334|FG002|Overall Study|Withdrawal by Subject|1
2193379|NCT01502293|3824332|FG000|Overall Study|Adverse Event|0
2193380|NCT01502293|3824333|FG001|Overall Study|Adverse Event|2
2193381|NCT01502293|3824334|FG002|Overall Study|Adverse Event|0
2193382|NCT01502293|3824332|FG000|Overall Study|Reason Not Specified|2
2193383|NCT01502293|3824333|FG001|Overall Study|Reason Not Specified|0
2193384|NCT01502293|3824334|FG002|Overall Study|Reason Not Specified|0
2193385|NCT01502293|3824332|FG000|Overall Study|Physician Decision|0
2193386|NCT01502293|3824333|FG001|Overall Study|Physician Decision|0
2193387|NCT01502293|3824334|FG002|Overall Study|Physician Decision|1
2193388|NCT01502410|3824371|FG000|Overall Study|Adverse Event|1
2193389|NCT01502410|3824372|FG001|Overall Study|Adverse Event|2
2193390|NCT01502410|3824373|FG002|Overall Study|Adverse Event|0
2193391|NCT01502410|3824374|FG003|Overall Study|Adverse Event|0
2193392|NCT01502410|3824371|FG000|Overall Study|Lack of Efficacy|7
2193393|NCT01502410|3824372|FG001|Overall Study|Lack of Efficacy|7
2193394|NCT01502410|3824373|FG002|Overall Study|Lack of Efficacy|0
2193395|NCT01502410|3824374|FG003|Overall Study|Lack of Efficacy|0
2193396|NCT01502410|3824371|FG000|Overall Study|Physician Decision|0
2193397|NCT01502410|3824372|FG001|Overall Study|Physician Decision|1
2193398|NCT01502410|3824373|FG002|Overall Study|Physician Decision|0
2193399|NCT01502410|3824374|FG003|Overall Study|Physician Decision|0
2193400|NCT01502410|3824371|FG000|Overall Study|Withdrawal by Subject|2
2193401|NCT01502410|3824372|FG001|Overall Study|Withdrawal by Subject|0
2193402|NCT01502410|3824373|FG002|Overall Study|Withdrawal by Subject|0
2193403|NCT01502410|3824374|FG003|Overall Study|Withdrawal by Subject|0
2224643|NCT01773421|3872131|FG002|Extension Phase|Other|0
2224644|NCT01773421|3872132|FG003|Extension Phase|Other|0
2224645|NCT01773421|3872133|FG004|Extension Phase|Other|1
2224646|NCT01773421|3872134|FG005|Extension Phase|Other|2
2224647|NCT01773421|3872135|FG006|Extension Phase|Other|0
2224648|NCT01773421|3872129|FG000|Extension Phase|Adverse Event|0
2224649|NCT01773421|3872130|FG001|Extension Phase|Adverse Event|0
2224650|NCT01773421|3872131|FG002|Extension Phase|Adverse Event|0
2224651|NCT01773421|3872132|FG003|Extension Phase|Adverse Event|0
2224652|NCT01773421|3872133|FG004|Extension Phase|Adverse Event|2
2224653|NCT01773421|3872134|FG005|Extension Phase|Adverse Event|0
2224654|NCT01773421|3872135|FG006|Extension Phase|Adverse Event|0
2224655|NCT01773473|3872153|FG000|Overall Study|Adverse Event|3
2224656|NCT01773473|3872154|FG001|Overall Study|Adverse Event|2
2224657|NCT01773473|3872153|FG000|Overall Study|Protocol Violation|0
2224658|NCT01773473|3872154|FG001|Overall Study|Protocol Violation|4
2224659|NCT01773473|3872153|FG000|Overall Study|Physician Decision|3
2224660|NCT01773473|3872154|FG001|Overall Study|Physician Decision|5
2332428|NCT03196349|4056030|FG001|Overall Study|No data entered|4
2193404|NCT01502423|3824385|FG000|Overall Study|Withdrawal by Subject|0
2224661|NCT01773473|3872153|FG000|Overall Study|Sponsor Decision|2
2224662|NCT01773473|3872154|FG001|Overall Study|Sponsor Decision|0
2224663|NCT01773473|3872153|FG000|Overall Study|Lack of Efficacy|0
2224664|NCT01773473|3872154|FG001|Overall Study|Lack of Efficacy|1
2224665|NCT01773473|3872153|FG000|Overall Study|Non-Compliance with study drug|1
2193405|NCT01502423|3824386|FG001|Overall Study|Withdrawal by Subject|1
2193406|NCT01502631|3824394|FG000|Overall Study|Adverse Event|5
2193407|NCT01502631|3824395|FG001|Overall Study|Adverse Event|8
2193408|NCT01502631|3824394|FG000|Overall Study|Lost to Follow-up|2
2193409|NCT01502631|3824395|FG001|Overall Study|Lost to Follow-up|2
2193410|NCT01502631|3824394|FG000|Overall Study|Participant withdrew consent|2
2193411|NCT01502631|3824395|FG001|Overall Study|Participant withdrew consent|4
2193412|NCT01502631|3824394|FG000|Overall Study|Participant non-compliant|1
2193413|NCT01502631|3824395|FG001|Overall Study|Participant non-compliant|0
2193414|NCT01502631|3824394|FG000|Overall Study|Investigator's decision|0
2193415|NCT01502631|3824395|FG001|Overall Study|Investigator's decision|1
2193416|NCT01502631|3824394|FG000|Overall Study|Other|10
2193417|NCT01502631|3824395|FG001|Overall Study|Other|5
2193418|NCT01502644|3824404|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
2193419|NCT01502644|3824405|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
2193420|NCT01502644|3824406|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
2193421|NCT01502644|3824407|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
2193422|NCT01502644|3824404|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
2193423|NCT01502644|3824405|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
2193424|NCT01502644|3824406|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
2193425|NCT01502644|3824407|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
2193426|NCT01502644|3824404|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
2193427|NCT01502644|3824405|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
2193428|NCT01502644|3824406|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
2193429|NCT01502644|3824407|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
2193430|NCT01502644|3824404|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0
2193431|NCT01502644|3824405|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6
2193432|NCT01502644|3824406|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2
2193433|NCT01502644|3824407|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7
2193434|NCT01502644|3824404|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
2193435|NCT01502644|3824405|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
2193436|NCT01502644|3824406|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
2193437|NCT01502644|3824407|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
2193438|NCT01502709|3824417|FG000|Overall Study|Lost to Follow-up|4
2193439|NCT01502709|3824418|FG001|Overall Study|Lost to Follow-up|0
2193440|NCT01502956|3824459|FG000|Overall Study|Death|0
2193441|NCT01502956|3824460|FG001|Overall Study|Death|2
2193442|NCT01502956|3824459|FG000|Overall Study|Lost to Follow-up|14
2193443|NCT01502956|3824460|FG001|Overall Study|Lost to Follow-up|11
2193444|NCT01502956|3824459|FG000|Overall Study|Physician Decision|2
2193445|NCT01502956|3824460|FG001|Overall Study|Physician Decision|3
2193446|NCT01502956|3824459|FG000|Overall Study|Withdrawal by Subject|8
2193447|NCT01502956|3824460|FG001|Overall Study|Withdrawal by Subject|10
2193448|NCT01503021|3824468|FG000|Overall Study|Adverse Event|7
2193449|NCT01503021|3824469|FG001|Overall Study|Adverse Event|6
2193450|NCT01503021|3824468|FG000|Overall Study|Death|0
2193451|NCT01503021|3824469|FG001|Overall Study|Death|2
2193452|NCT01503021|3824468|FG000|Overall Study|Lost to Follow-up|2
2193453|NCT01503021|3824469|FG001|Overall Study|Lost to Follow-up|0
2193454|NCT01503021|3824468|FG000|Overall Study|Physician Decision|3
2193455|NCT01503021|3824469|FG001|Overall Study|Physician Decision|0
2193456|NCT01503021|3824468|FG000|Overall Study|Protocol Violation|1
2193457|NCT01503021|3824469|FG001|Overall Study|Protocol Violation|3
2193458|NCT01503021|3824468|FG000|Overall Study|Withdrawal by Subject|9
2193459|NCT01503021|3824469|FG001|Overall Study|Withdrawal by Subject|8
2193460|NCT01503021|3824468|FG000|Overall Study|Moved, received transplant, etc.|5
2193461|NCT01503021|3824469|FG001|Overall Study|Moved, received transplant, etc.|7
2193462|NCT01503164|3824482|FG000|Overall Study|Withdrawal by Subject|2
2193463|NCT01503164|3824483|FG001|Overall Study|Withdrawal by Subject|1
2193464|NCT01503229|3824489|FG000|Overall Study|Withdrew consent|1
2193465|NCT01504204|3824525|FG000|Overall Study|Lost to Follow-up|1
2193466|NCT01504204|3824526|FG001|Overall Study|Lost to Follow-up|1
2193467|NCT01504412|3824537|FG000|Overall Study|Adverse Event|1
2224666|NCT01773473|3872154|FG001|Overall Study|Non-Compliance with study drug|4
2224667|NCT01773473|3872153|FG000|Overall Study|Withdrawal by Subject|5
2224668|NCT01773473|3872154|FG001|Overall Study|Withdrawal by Subject|3
2224669|NCT01773473|3872153|FG000|Overall Study|Lost to Follow-up|2
2224670|NCT01773473|3872154|FG001|Overall Study|Lost to Follow-up|0
2224671|NCT01773889|3872160|FG000|Overall Study|lack of funding|2
2224672|NCT01773967|3872170|FG000|Overall Study|Lost to Follow-up|15
2224673|NCT01773967|3872171|FG001|Overall Study|Lost to Follow-up|13
2224674|NCT01773993|3872177|FG000|Overall Study|No Visit After Treatment|35
2224675|NCT01774084|3872193|FG000|Overall Study|Personal reasons|1
2224676|NCT01774084|3872194|FG001|Overall Study|Personal reasons|0
2224677|NCT01774097|3872202|FG000|Overall Study|Withdrawal by Subject|1
2224678|NCT01774097|3872203|FG001|Overall Study|Withdrawal by Subject|1
2224679|NCT01774097|3872202|FG000|Overall Study|Adverse Event|1
2224680|NCT01774097|3872203|FG001|Overall Study|Adverse Event|1
2193468|NCT01504412|3824538|FG001|Overall Study|Adverse Event|8
2193469|NCT01504412|3824539|FG002|Overall Study|Adverse Event|1
2193470|NCT01504412|3824540|FG003|Overall Study|Adverse Event|7
2193471|NCT01504412|3824541|FG004|Overall Study|Adverse Event|10
2193472|NCT01504412|3824537|FG000|Overall Study|Withdrawal by Subject|2
2193473|NCT01504412|3824538|FG001|Overall Study|Withdrawal by Subject|1
2193474|NCT01504412|3824539|FG002|Overall Study|Withdrawal by Subject|1
2193475|NCT01504412|3824540|FG003|Overall Study|Withdrawal by Subject|5
2193476|NCT01504412|3824541|FG004|Overall Study|Withdrawal by Subject|1
2193477|NCT01504412|3824537|FG000|Overall Study|Other|2
2193478|NCT01504412|3824538|FG001|Overall Study|Other|1
2193479|NCT01504412|3824539|FG002|Overall Study|Other|1
2193480|NCT01504412|3824540|FG003|Overall Study|Other|6
2193481|NCT01504412|3824541|FG004|Overall Study|Other|1
2193482|NCT01504412|3824537|FG000|Overall Study|Lost to Follow-up|0
2193483|NCT01504412|3824538|FG001|Overall Study|Lost to Follow-up|2
2193484|NCT01504412|3824539|FG002|Overall Study|Lost to Follow-up|0
2193485|NCT01504412|3824540|FG003|Overall Study|Lost to Follow-up|0
2193486|NCT01504412|3824541|FG004|Overall Study|Lost to Follow-up|0
2193487|NCT01504412|3824537|FG000|Overall Study|Lack of Efficacy|0
2193488|NCT01504412|3824538|FG001|Overall Study|Lack of Efficacy|0
2193489|NCT01504412|3824539|FG002|Overall Study|Lack of Efficacy|1
2193490|NCT01504412|3824540|FG003|Overall Study|Lack of Efficacy|0
2193491|NCT01504412|3824541|FG004|Overall Study|Lack of Efficacy|1
2193492|NCT01504412|3824537|FG000|Overall Study|Death|0
2193493|NCT01504412|3824538|FG001|Overall Study|Death|0
2193494|NCT01504412|3824539|FG002|Overall Study|Death|0
2193495|NCT01504412|3824540|FG003|Overall Study|Death|1
2193496|NCT01504412|3824541|FG004|Overall Study|Death|0
2224681|NCT01774110|3872211|FG000|Overall Study|Lost to Follow-up|7
2224682|NCT01774253|3872225|FG000|Overall Study|Lack of Efficacy|4
2224683|NCT01774253|3872225|FG000|Overall Study|Physician Decision|2
2224684|NCT01774253|3872225|FG000|Overall Study|Withdrawal by Subject|2
2224685|NCT01774253|3872225|FG000|Overall Study|Death|1
2224686|NCT01774305|3872231|FG000|Overall Study|Physician Decision|1
2224687|NCT01774305|3872232|FG001|Overall Study|Physician Decision|0
2224688|NCT01774344|3872240|FG000|Overall Study|Withdrawal by Subject|3
2224689|NCT01774344|3872241|FG001|Overall Study|Withdrawal by Subject|10
2224690|NCT01774344|3872240|FG000|Overall Study|Protocol Violation|0
2224691|NCT01774344|3872241|FG001|Overall Study|Protocol Violation|1
2224692|NCT01774344|3872240|FG000|Overall Study|Lost to Follow-up|4
2224693|NCT01774344|3872241|FG001|Overall Study|Lost to Follow-up|10
2224694|NCT01774344|3872240|FG000|Overall Study|End of survival follow-up not available|2
2224695|NCT01774344|3872241|FG001|Overall Study|End of survival follow-up not available|2
2224696|NCT01774344|3872240|FG000|Overall Study|Data collection finished|4
2224697|NCT01774344|3872241|FG001|Overall Study|Data collection finished|14
2224698|NCT01774344|3872240|FG000|Overall Study|Other|0
2224699|NCT01774344|3872241|FG001|Overall Study|Other|1
2224700|NCT01774344|3872240|FG000|Overall Study|Did not enter Survival Follow up|49
2224701|NCT01774344|3872241|FG001|Overall Study|Did not enter Survival Follow up|83
2224702|NCT01774591|3872249|FG000|Overall Study|Physician Decision|1
2224703|NCT01774591|3872250|FG001|Overall Study|Physician Decision|1
2224704|NCT01774591|3872249|FG000|Overall Study|Withdrawal by Subject|0
2224705|NCT01774591|3872250|FG001|Overall Study|Withdrawal by Subject|1
2224706|NCT01774591|3872249|FG000|Overall Study|Adverse Event|0
2224707|NCT01774591|3872250|FG001|Overall Study|Adverse Event|2
2224708|NCT01774786|3872271|FG000|Overall Study|Death|300
2224709|NCT01774786|3872272|FG001|Overall Study|Death|319
2224710|NCT01774786|3872271|FG000|Overall Study|Lost to Follow-up|6
2224711|NCT01774786|3872272|FG001|Overall Study|Lost to Follow-up|7
2224712|NCT01774786|3872271|FG000|Overall Study|Withdrawal by Subject|18
2224713|NCT01774786|3872272|FG001|Overall Study|Withdrawal by Subject|14
2224714|NCT01774786|3872271|FG000|Overall Study|Physician Decision|2
2224715|NCT01774786|3872272|FG001|Overall Study|Physician Decision|0
2224716|NCT01774786|3872271|FG000|Overall Study|Non-compliance|0
2224717|NCT01774786|3872272|FG001|Overall Study|Non-compliance|1
2224718|NCT01774786|3872271|FG000|Overall Study|Reason Not Specified|2
2224719|NCT01774786|3872272|FG001|Overall Study|Reason Not Specified|5
2224720|NCT01774799|3872282|FG000|Overall Study|Lost to Follow-up|1
2224721|NCT01774799|3872283|FG001|Overall Study|Lost to Follow-up|1
2224722|NCT01774799|3872284|FG002|Overall Study|Lost to Follow-up|0
2224723|NCT01774799|3872285|FG003|Overall Study|Lost to Follow-up|0
2224724|NCT01774903|3872300|FG000|Overall Study|Adverse Event|7
2224725|NCT01774903|3872300|FG000|Overall Study|Withdrawal by Subject|2
2224726|NCT01774903|3872300|FG000|Overall Study|Lack of Efficacy|1
2224727|NCT01774903|3872300|FG000|Overall Study|Ineligible to continue the trial|1
2224728|NCT01774929|3872305|FG000|Overall Study|Adverse Event|3
2224729|NCT01774968|3872311|FG000|Overall Study|Adverse Event|4
2224730|NCT01774968|3872312|FG001|Overall Study|Adverse Event|4
2224731|NCT01774968|3872311|FG000|Overall Study|Death|0
2224732|NCT01774968|3872312|FG001|Overall Study|Death|1
2224733|NCT01774968|3872311|FG000|Overall Study|Lost to Follow-up|1
2224734|NCT01774968|3872312|FG001|Overall Study|Lost to Follow-up|3
2224735|NCT01774968|3872311|FG000|Overall Study|Physician Decision|5
2224736|NCT01774968|3872312|FG001|Overall Study|Physician Decision|1
2224737|NCT01774968|3872311|FG000|Overall Study|Protocol Violation|14
2224738|NCT01774968|3872312|FG001|Overall Study|Protocol Violation|13
2193497|NCT01504841|3824575|FG000|Overall Study|Withdrawal by Subject|1
2193498|NCT01504841|3824576|FG001|Overall Study|Withdrawal by Subject|1
2193499|NCT01504841|3824577|FG002|Overall Study|Withdrawal by Subject|0
2193500|NCT01504867|3824595|FG000|Overall Study|Inclusion criteria not met|2
2193501|NCT01504867|3824596|FG001|Overall Study|Inclusion criteria not met|2
2193502|NCT01504867|3824595|FG000|Overall Study|Consent revoked|5
2193503|NCT01504867|3824596|FG001|Overall Study|Consent revoked|1
2193504|NCT01504971|3824615|FG000|Overall Study|Physician Decision|13
2193505|NCT01505010|3824629|FG000|Overall Study|Protocol Violation|0
2193506|NCT01505010|3824630|FG001|Overall Study|Protocol Violation|1
2193507|NCT01505010|3824629|FG000|Overall Study|Lost to Follow-up|0
2193508|NCT01505010|3824630|FG001|Overall Study|Lost to Follow-up|1
2193509|NCT01505114|3824653|FG000|Overall Study|Withdrawal by Subject|5
2193510|NCT01505114|3824654|FG001|Overall Study|Withdrawal by Subject|4
2193511|NCT01505114|3824655|FG002|Overall Study|Withdrawal by Subject|4
2224739|NCT01774968|3872311|FG000|Overall Study|Sponsor Decision|0
2224740|NCT01774968|3872312|FG001|Overall Study|Sponsor Decision|2
2224741|NCT01774968|3872311|FG000|Overall Study|Withdrawal by Subject|6
2224742|NCT01774968|3872312|FG001|Overall Study|Withdrawal by Subject|11
2224743|NCT01774981|3872326|FG000|Overall Study|Adverse Event|0
2224744|NCT01774981|3872327|FG001|Overall Study|Adverse Event|0
2224745|NCT01774981|3872328|FG002|Overall Study|Adverse Event|0
2224746|NCT01774981|3872329|FG003|Overall Study|Adverse Event|0
2224747|NCT01774981|3872330|FG004|Overall Study|Adverse Event|0
2224748|NCT01774981|3872331|FG005|Overall Study|Adverse Event|1
2224749|NCT01774981|3872332|FG006|Overall Study|Adverse Event|0
2224750|NCT01774981|3872333|FG007|Overall Study|Adverse Event|0
2224751|NCT01774981|3872326|FG000|Overall Study|Withdrawal by Subject|0
2224752|NCT01774981|3872327|FG001|Overall Study|Withdrawal by Subject|0
2224753|NCT01774981|3872328|FG002|Overall Study|Withdrawal by Subject|0
2224754|NCT01774981|3872329|FG003|Overall Study|Withdrawal by Subject|0
2224755|NCT01774981|3872330|FG004|Overall Study|Withdrawal by Subject|0
2224756|NCT01774981|3872331|FG005|Overall Study|Withdrawal by Subject|0
2224757|NCT01774981|3872332|FG006|Overall Study|Withdrawal by Subject|0
2224758|NCT01774981|3872333|FG007|Overall Study|Withdrawal by Subject|1
2224759|NCT01774981|3872326|FG000|Overall Study|Death|0
2224760|NCT01774981|3872327|FG001|Overall Study|Death|0
2224761|NCT01774981|3872328|FG002|Overall Study|Death|0
2224762|NCT01774981|3872329|FG003|Overall Study|Death|0
2224763|NCT01774981|3872330|FG004|Overall Study|Death|1
2224764|NCT01774981|3872331|FG005|Overall Study|Death|0
2224765|NCT01774981|3872332|FG006|Overall Study|Death|0
2224766|NCT01774981|3872333|FG007|Overall Study|Death|0
2224767|NCT01775124|3872358|FG000|Core Period|Disease Progression|0
2224768|NCT01775124|3872359|FG001|Core Period|Disease Progression|1
2224769|NCT01775124|3872358|FG000|Core Period|Physician Decision|1
2224770|NCT01775124|3872359|FG001|Core Period|Physician Decision|1
2224771|NCT01775124|3872358|FG000|Core Period|Death|0
2224772|NCT01775124|3872359|FG001|Core Period|Death|1
2224773|NCT01775124|3872358|FG000|Core Period|Administrative problems|1
2224774|NCT01775124|3872359|FG001|Core Period|Administrative problems|0
2224775|NCT01775124|3872358|FG000|Core Period|Withdrawal by Subject|4
2224776|NCT01775124|3872359|FG001|Core Period|Withdrawal by Subject|2
2224777|NCT01775124|3872358|FG000|Core Period|Adverse Event|5
2224778|NCT01775124|3872359|FG001|Core Period|Adverse Event|5
2224779|NCT01775124|3872358|FG000|Extension Period|Adverse Event|3
2224780|NCT01775124|3872359|FG001|Extension Period|Adverse Event|2
2224781|NCT01775124|3872358|FG000|Extension Period|Physician Decision|0
2224782|NCT01775124|3872359|FG001|Extension Period|Physician Decision|2
2224783|NCT01775124|3872358|FG000|Extension Period|Administrative problems|0
2224784|NCT01775124|3872359|FG001|Extension Period|Administrative problems|1
2224785|NCT01775124|3872358|FG000|Extension Period|Lost to Follow-up|0
2224786|NCT01775124|3872359|FG001|Extension Period|Lost to Follow-up|1
2224787|NCT01775124|3872358|FG000|Extension Period|Withdrawal by Subject|9
2224788|NCT01775124|3872359|FG001|Extension Period|Withdrawal by Subject|12
2224789|NCT01775137|3872366|FG000|Overall Study|Death|1
2224790|NCT01775137|3872366|FG000|Overall Study|Protocol deviation|2
2224791|NCT01775137|3872366|FG000|Overall Study|Unsatisfactory therapeutic effect|2
2224792|NCT01775137|3872366|FG000|Overall Study|Adverse Event|1
2224793|NCT01775137|3872366|FG000|Overall Study|Withdrawal by participants|5
2224794|NCT01775189|3872373|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
2224795|NCT01775189|3872374|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
2224796|NCT01775189|3872375|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
2224797|NCT01775189|3872376|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
2224798|NCT01775189|3872377|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
2224799|NCT01775189|3872378|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
2224800|NCT01775189|3872379|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
2224801|NCT01775189|3872373|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
2224802|NCT01775189|3872374|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1
2224803|NCT01775189|3872375|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0
2224804|NCT01775189|3872376|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
2224805|NCT01775189|3872377|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
2224806|NCT01775189|3872378|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
2224807|NCT01775189|3872379|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
2193512|NCT01505114|3824656|FG003|Overall Study|Withdrawal by Subject|7
2193513|NCT01505114|3824653|FG000|Overall Study|Death|1
2193514|NCT01505114|3824654|FG001|Overall Study|Death|0
2193515|NCT01505114|3824655|FG002|Overall Study|Death|0
2193516|NCT01505114|3824656|FG003|Overall Study|Death|1
2193517|NCT01505114|3824653|FG000|Overall Study|unable to adhere to visit schedule|3
2193518|NCT01505114|3824654|FG001|Overall Study|unable to adhere to visit schedule|2
2193519|NCT01505114|3824655|FG002|Overall Study|unable to adhere to visit schedule|3
2193520|NCT01505114|3824656|FG003|Overall Study|unable to adhere to visit schedule|3
2193521|NCT01505114|3824653|FG000|Overall Study|Lost to Follow-up|11
2193522|NCT01505114|3824654|FG001|Overall Study|Lost to Follow-up|5
2193523|NCT01505114|3824655|FG002|Overall Study|Lost to Follow-up|8
2193524|NCT01505114|3824656|FG003|Overall Study|Lost to Follow-up|7
2193525|NCT01505114|3824653|FG000|Overall Study|relocated|4
2193526|NCT01505114|3824654|FG001|Overall Study|relocated|2
2193527|NCT01505114|3824655|FG002|Overall Study|relocated|2
2193528|NCT01505114|3824656|FG003|Overall Study|relocated|3
2193529|NCT01505114|3824653|FG000|Overall Study|inadvertent enrollment due to peanut all|0
2193530|NCT01505114|3824654|FG001|Overall Study|inadvertent enrollment due to peanut all|0
2193531|NCT01505114|3824655|FG002|Overall Study|inadvertent enrollment due to peanut all|0
2193532|NCT01505114|3824656|FG003|Overall Study|inadvertent enrollment due to peanut all|1
2193533|NCT01505114|3824653|FG000|Overall Study|staff safety concerns|0
2193534|NCT01505114|3824654|FG001|Overall Study|staff safety concerns|0
2193535|NCT01505114|3824655|FG002|Overall Study|staff safety concerns|0
2193536|NCT01505114|3824656|FG003|Overall Study|staff safety concerns|1
2193537|NCT01505114|3824653|FG000|Overall Study|investigator decision|1
2193538|NCT01505114|3824654|FG001|Overall Study|investigator decision|0
2193539|NCT01505114|3824655|FG002|Overall Study|investigator decision|1
2193540|NCT01505114|3824656|FG003|Overall Study|investigator decision|0
2193541|NCT01505374|3824690|FG000|Overall Study|Lost to Follow-up|1
2193542|NCT01505374|3824691|FG001|Overall Study|Lost to Follow-up|0
2193543|NCT01505387|3824700|FG000|Overall Study|Protocol Violation|1
2193544|NCT01505387|3824701|FG001|Overall Study|Protocol Violation|0
2193545|NCT01505387|3824700|FG000|Overall Study|Withdrawal by Subject|1
2193546|NCT01505387|3824701|FG001|Overall Study|Withdrawal by Subject|1
2193547|NCT01505491|3824719|FG000|Overall Study|Other reason not listed|1
2193548|NCT01505491|3824720|FG001|Overall Study|Other reason not listed|0
2193549|NCT01505491|3824721|FG002|Overall Study|Other reason not listed|0
2193550|NCT01505491|3824719|FG000|Overall Study|Withdrawal by Subject|1
2193551|NCT01505491|3824720|FG001|Overall Study|Withdrawal by Subject|1
2193552|NCT01505491|3824721|FG002|Overall Study|Withdrawal by Subject|4
2193553|NCT01505491|3824719|FG000|Overall Study|Lost to Follow-up|0
2193554|NCT01505491|3824720|FG001|Overall Study|Lost to Follow-up|0
2193555|NCT01505491|3824721|FG002|Overall Study|Lost to Follow-up|1
2193556|NCT01505530|3824732|FG000|Overall Study|Progressive Disease|19
2193557|NCT01505530|3824733|FG001|Overall Study|Progressive Disease|17
2193558|NCT01505530|3824734|FG002|Overall Study|Progressive Disease|18
2193559|NCT01505530|3824732|FG000|Overall Study|Adverse Event|1
2193560|NCT01505530|3824733|FG001|Overall Study|Adverse Event|1
2193561|NCT01505530|3824734|FG002|Overall Study|Adverse Event|0
2193562|NCT01505530|3824732|FG000|Overall Study|Withdrawal by Subject|7
2193563|NCT01505530|3824733|FG001|Overall Study|Withdrawal by Subject|8
2193564|NCT01505530|3824734|FG002|Overall Study|Withdrawal by Subject|6
2193565|NCT01505530|3824732|FG000|Overall Study|Physician Decision|6
2193566|NCT01505530|3824733|FG001|Overall Study|Physician Decision|2
2193567|NCT01505530|3824734|FG002|Overall Study|Physician Decision|5
2193568|NCT01505530|3824732|FG000|Overall Study|Sponsor Decision|1
2193569|NCT01505530|3824733|FG001|Overall Study|Sponsor Decision|8
2193570|NCT01505530|3824734|FG002|Overall Study|Sponsor Decision|7
2193571|NCT01505530|3824732|FG000|Overall Study|Death|7
2193572|NCT01505530|3824733|FG001|Overall Study|Death|6
2193573|NCT01505530|3824734|FG002|Overall Study|Death|5
2193574|NCT01505530|3824732|FG000|Overall Study|entry criteria not met|0
2193575|NCT01505530|3824733|FG001|Overall Study|entry criteria not met|1
2193576|NCT01505530|3824734|FG002|Overall Study|entry criteria not met|0
2193577|NCT01505608|3824744|FG000|Phase I|Lack of Efficacy|0
2193578|NCT01505608|3824745|FG001|Phase I|Lack of Efficacy|4
2193579|NCT01505608|3824744|FG000|Phase I|Adverse Event|0
2193580|NCT01505608|3824745|FG001|Phase I|Adverse Event|1
2193581|NCT01505608|3824744|FG000|Phase I|Withdrawal by Subject|0
2193582|NCT01505608|3824745|FG001|Phase I|Withdrawal by Subject|1
2193583|NCT01505608|3824744|FG000|Phase II|Lack of Efficacy|2
2193584|NCT01505608|3824745|FG001|Phase II|Lack of Efficacy|1
2193585|NCT01505608|3824744|FG000|Phase II|Protocol Violation|0
2193586|NCT01505608|3824745|FG001|Phase II|Protocol Violation|1
2193587|NCT01505634|3824757|FG000|Overall Study|Withdrawal by Subject|2
2193588|NCT01505634|3824758|FG001|Overall Study|Withdrawal by Subject|5
2193589|NCT01505634|3824759|FG002|Overall Study|Withdrawal by Subject|1
2193590|NCT01505634|3824757|FG000|Overall Study|Physician Decision|1
2193591|NCT01505634|3824758|FG001|Overall Study|Physician Decision|1
2193592|NCT01505634|3824759|FG002|Overall Study|Physician Decision|0
2193593|NCT01505634|3824757|FG000|Overall Study|Adverse Event|1
2193594|NCT01505634|3824758|FG001|Overall Study|Adverse Event|0
2193595|NCT01505634|3824759|FG002|Overall Study|Adverse Event|0
2193596|NCT01505634|3824757|FG000|Overall Study|Insufficient supply of drug at site|1
2193597|NCT01505634|3824758|FG001|Overall Study|Insufficient supply of drug at site|0
2193598|NCT01505634|3824759|FG002|Overall Study|Insufficient supply of drug at site|0
2193599|NCT01505634|3824757|FG000|Overall Study|Protocol Violation|2
2193600|NCT01505634|3824758|FG001|Overall Study|Protocol Violation|0
2193601|NCT01505634|3824759|FG002|Overall Study|Protocol Violation|0
2193602|NCT01505634|3824757|FG000|Overall Study|Lost to Follow-up|1
2193603|NCT01505634|3824758|FG001|Overall Study|Lost to Follow-up|4
2193604|NCT01505634|3824759|FG002|Overall Study|Lost to Follow-up|4
2193605|NCT01505634|3824757|FG000|Overall Study|Death|1
2193606|NCT01505634|3824758|FG001|Overall Study|Death|0
2193607|NCT01505634|3824759|FG002|Overall Study|Death|0
2193608|NCT01505634|3824757|FG000|Overall Study|In a conflict zone|0
2193609|NCT01505634|3824758|FG001|Overall Study|In a conflict zone|0
2193610|NCT01505634|3824759|FG002|Overall Study|In a conflict zone|1
2193611|NCT01505647|3824769|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
2193612|NCT01505647|3824770|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
2193613|NCT01505647|3824769|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1
2193614|NCT01505647|3824770|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0
2193615|NCT01505647|3824769|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
2193616|NCT01505647|3824770|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
2193617|NCT01505647|3824769|FG000|Day 43 Through Day 182 Follow-up|Death|0
2193618|NCT01505647|3824770|FG001|Day 43 Through Day 182 Follow-up|Death|1
2193619|NCT01505647|3824769|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
2193620|NCT01505647|3824770|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
2193621|NCT01505868|3824800|FG000|Overall Study|Withdrawal by Subject|1
2193622|NCT01505868|3824801|FG001|Overall Study|Withdrawal by Subject|0
2193623|NCT01505868|3824802|FG002|Overall Study|Withdrawal by Subject|0
2193624|NCT01505868|3824803|FG003|Overall Study|Withdrawal by Subject|0
2193625|NCT01505868|3824804|FG004|Overall Study|Withdrawal by Subject|0
2193626|NCT01505881|3824818|FG000|Overall Study|Adverse Event|0
2193627|NCT01505881|3824819|FG001|Overall Study|Adverse Event|1
2193628|NCT01505881|3824818|FG000|Overall Study|Lost to Follow-up|2
2193629|NCT01505881|3824819|FG001|Overall Study|Lost to Follow-up|0
2193630|NCT01505881|3824818|FG000|Overall Study|Withdrawal by Subject|2
2193631|NCT01505881|3824819|FG001|Overall Study|Withdrawal by Subject|0
2193632|NCT01506193|3824838|FG000|Overall Study|Protocol Violation|1
2193633|NCT01506193|3824839|FG001|Overall Study|Protocol Violation|0
2193634|NCT01506193|3824840|FG002|Overall Study|Protocol Violation|1
2193635|NCT01506193|3824838|FG000|Overall Study|Migrated/moved from study area|0
2193636|NCT01506193|3824839|FG001|Overall Study|Migrated/moved from study area|0
2193637|NCT01506193|3824840|FG002|Overall Study|Migrated/moved from study area|1
2193638|NCT01506193|3824838|FG000|Overall Study|Adverse event, non-fatal|0
2193639|NCT01506193|3824839|FG001|Overall Study|Adverse event, non-fatal|0
2193640|NCT01506193|3824840|FG002|Overall Study|Adverse event, non-fatal|1
2193641|NCT01506193|3824838|FG000|Overall Study|Withdrawal by Subject|5
2193642|NCT01506193|3824839|FG001|Overall Study|Withdrawal by Subject|1
2193643|NCT01506193|3824840|FG002|Overall Study|Withdrawal by Subject|8
2193644|NCT01506193|3824838|FG000|Overall Study|Lost to Follow-up|8
2193645|NCT01506193|3824839|FG001|Overall Study|Lost to Follow-up|3
2193646|NCT01506193|3824840|FG002|Overall Study|Lost to Follow-up|3
2193647|NCT01506271|3824852|FG000|Overall Study|Progressive disease|0
2193648|NCT01506271|3824853|FG001|Overall Study|Progressive disease|1
2193649|NCT01506271|3824854|FG002|Overall Study|Progressive disease|0
2193650|NCT01506271|3824852|FG000|Overall Study|Protocol Violation|3
2193651|NCT01506271|3824853|FG001|Overall Study|Protocol Violation|1
2193652|NCT01506271|3824854|FG002|Overall Study|Protocol Violation|0
2193653|NCT01506271|3824852|FG000|Overall Study|Death|0
2193654|NCT01506271|3824853|FG001|Overall Study|Death|1
2193655|NCT01506271|3824854|FG002|Overall Study|Death|0
2193656|NCT01506271|3824852|FG000|Overall Study|Adverse Event|0
2193657|NCT01506271|3824853|FG001|Overall Study|Adverse Event|2
2193658|NCT01506271|3824854|FG002|Overall Study|Adverse Event|0
2193659|NCT01506271|3824852|FG000|Overall Study|Insufficient supply of study drug|1
2193660|NCT01506271|3824853|FG001|Overall Study|Insufficient supply of study drug|0
2193661|NCT01506271|3824854|FG002|Overall Study|Insufficient supply of study drug|0
2193662|NCT01506271|3824852|FG000|Overall Study|Withdrawal by Subject|0
2193663|NCT01506271|3824853|FG001|Overall Study|Withdrawal by Subject|1
2193664|NCT01506271|3824854|FG002|Overall Study|Withdrawal by Subject|1
2193665|NCT01506271|3824852|FG000|Overall Study|Lost to Follow-up|0
2193666|NCT01506271|3824853|FG001|Overall Study|Lost to Follow-up|1
2193667|NCT01506271|3824854|FG002|Overall Study|Lost to Follow-up|2
2193668|NCT01506323|3824864|FG000|Overall Study|Lost to Follow-up|5
2193669|NCT01506323|3824865|FG001|Overall Study|Lost to Follow-up|4
2193670|NCT01506323|3824864|FG000|Overall Study|Withdrawal by Subject|4
2193671|NCT01506323|3824865|FG001|Overall Study|Withdrawal by Subject|4
2193672|NCT01506323|3824864|FG000|Overall Study|Lack of Efficacy|1
2193673|NCT01506323|3824865|FG001|Overall Study|Lack of Efficacy|3
2193674|NCT01506323|3824864|FG000|Overall Study|Moved out of area|5
2193675|NCT01506323|3824865|FG001|Overall Study|Moved out of area|2
2193676|NCT01506323|3824864|FG000|Overall Study|Schedule or Transportation conflict|8
2193677|NCT01506323|3824865|FG001|Overall Study|Schedule or Transportation conflict|0
2193678|NCT01506323|3824864|FG000|Overall Study|Started another treatment|1
2193679|NCT01506323|3824865|FG001|Overall Study|Started another treatment|0
2193680|NCT01506453|3824882|FG000|Overall Study|Withdrawal prior to treatment|0
2193681|NCT01506453|3824883|FG001|Overall Study|Withdrawal prior to treatment|2
2193682|NCT01506479|3824892|FG000|Overall Study|Lost to Follow-up|1
2193683|NCT01506479|3824893|FG001|Overall Study|Lost to Follow-up|2
2193684|NCT01506479|3824894|FG002|Overall Study|Lost to Follow-up|2
2193685|NCT01506479|3824892|FG000|Overall Study|Withdrawal by Subject|1
2193686|NCT01506479|3824893|FG001|Overall Study|Withdrawal by Subject|2
2193687|NCT01506479|3824894|FG002|Overall Study|Withdrawal by Subject|1
2193688|NCT01506479|3824892|FG000|Overall Study|Missing assessment|1
2193689|NCT01506479|3824893|FG001|Overall Study|Missing assessment|0
2193690|NCT01506479|3824894|FG002|Overall Study|Missing assessment|0
2193691|NCT01506479|3824892|FG000|Overall Study|Adverse Event|0
2193692|NCT01506479|3824893|FG001|Overall Study|Adverse Event|1
2193693|NCT01506479|3824894|FG002|Overall Study|Adverse Event|0
2193694|NCT01506596|3824904|FG000|Overall Study|ineligible pathology|1
2193695|NCT01506609|3824914|FG000|Overall Study|Adverse Event Related to Progression|0
2193696|NCT01506609|3824915|FG001|Overall Study|Adverse Event Related to Progression|0
2193697|NCT01506609|3824916|FG002|Overall Study|Adverse Event Related to Progression|0
2193698|NCT01506609|3824917|FG003|Overall Study|Adverse Event Related to Progression|3
2193699|NCT01506609|3824918|FG004|Overall Study|Adverse Event Related to Progression|7
2193700|NCT01506609|3824919|FG005|Overall Study|Adverse Event Related to Progression|3
2193701|NCT01506609|3824914|FG000|Overall Study|Adverse Event Not Related to Progression|0
2193702|NCT01506609|3824915|FG001|Overall Study|Adverse Event Not Related to Progression|1
2193703|NCT01506609|3824916|FG002|Overall Study|Adverse Event Not Related to Progression|0
2193704|NCT01506609|3824917|FG003|Overall Study|Adverse Event Not Related to Progression|6
2193705|NCT01506609|3824918|FG004|Overall Study|Adverse Event Not Related to Progression|10
2193706|NCT01506609|3824919|FG005|Overall Study|Adverse Event Not Related to Progression|5
2193707|NCT01506609|3824914|FG000|Overall Study|Withdrawal by Subject|0
2193708|NCT01506609|3824915|FG001|Overall Study|Withdrawal by Subject|0
2193709|NCT01506609|3824916|FG002|Overall Study|Withdrawal by Subject|0
2193710|NCT01506609|3824917|FG003|Overall Study|Withdrawal by Subject|9
2193711|NCT01506609|3824918|FG004|Overall Study|Withdrawal by Subject|7
2193712|NCT01506609|3824919|FG005|Overall Study|Withdrawal by Subject|7
2193713|NCT01506609|3824914|FG000|Overall Study|Lost to Follow-up|0
2193714|NCT01506609|3824915|FG001|Overall Study|Lost to Follow-up|0
2193715|NCT01506609|3824916|FG002|Overall Study|Lost to Follow-up|0
2193716|NCT01506609|3824917|FG003|Overall Study|Lost to Follow-up|1
2193717|NCT01506609|3824918|FG004|Overall Study|Lost to Follow-up|2
2193718|NCT01506609|3824919|FG005|Overall Study|Lost to Follow-up|0
2193719|NCT01506609|3824914|FG000|Overall Study|Sponsor Discontinued Study|0
2193720|NCT01506609|3824915|FG001|Overall Study|Sponsor Discontinued Study|0
2193721|NCT01506609|3824916|FG002|Overall Study|Sponsor Discontinued Study|0
2193722|NCT01506609|3824917|FG003|Overall Study|Sponsor Discontinued Study|2
2193723|NCT01506609|3824918|FG004|Overall Study|Sponsor Discontinued Study|2
2193724|NCT01506609|3824919|FG005|Overall Study|Sponsor Discontinued Study|0
2193725|NCT01506609|3824914|FG000|Overall Study|Progressive Disease per Protocol|1
2193726|NCT01506609|3824915|FG001|Overall Study|Progressive Disease per Protocol|0
2193727|NCT01506609|3824916|FG002|Overall Study|Progressive Disease per Protocol|0
2193728|NCT01506609|3824917|FG003|Overall Study|Progressive Disease per Protocol|64
2193729|NCT01506609|3824918|FG004|Overall Study|Progressive Disease per Protocol|57
2193730|NCT01506609|3824919|FG005|Overall Study|Progressive Disease per Protocol|74
2193731|NCT01506609|3824914|FG000|Overall Study|Other, Not Specified|0
2193732|NCT01506609|3824915|FG001|Overall Study|Other, Not Specified|0
2193733|NCT01506609|3824916|FG002|Overall Study|Other, Not Specified|0
2193734|NCT01506609|3824917|FG003|Overall Study|Other, Not Specified|10
2193735|NCT01506609|3824918|FG004|Overall Study|Other, Not Specified|7
2193736|NCT01506609|3824919|FG005|Overall Study|Other, Not Specified|3
2193737|NCT01506609|3824914|FG000|Overall Study|Missing / Unknown Reason|1
2193738|NCT01506609|3824915|FG001|Overall Study|Missing / Unknown Reason|0
2193739|NCT01506609|3824916|FG002|Overall Study|Missing / Unknown Reason|1
2224808|NCT01775189|3872373|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2332429|NCT03196349|4056031|FG002|Overall Study|No data entered|0
2193740|NCT01506609|3824917|FG003|Overall Study|Missing / Unknown Reason|4
2193741|NCT01506609|3824918|FG004|Overall Study|Missing / Unknown Reason|4
2193742|NCT01506609|3824919|FG005|Overall Study|Missing / Unknown Reason|2
2193743|NCT01506726|3824932|FG000|Overall Study|Adverse Event|1
2193744|NCT01506726|3824933|FG001|Overall Study|Adverse Event|2
2193745|NCT01506882|3824941|FG000|Overall Study|Lack of Efficacy|4
2193746|NCT01506882|3824942|FG001|Overall Study|Lack of Efficacy|3
2193747|NCT01506882|3824941|FG000|Overall Study|Lost to Follow-up|1
2193748|NCT01506882|3824942|FG001|Overall Study|Lost to Follow-up|0
2193749|NCT01506882|3824941|FG000|Overall Study|Withdrawal by Subject|9
2193750|NCT01506882|3824942|FG001|Overall Study|Withdrawal by Subject|3
2193751|NCT01506882|3824941|FG000|Overall Study|SAE, non-fatal|2
2193752|NCT01506882|3824942|FG001|Overall Study|SAE, non-fatal|0
2193753|NCT01506882|3824941|FG000|Overall Study|AE, non-serious non-fatal|3
2193754|NCT01506882|3824942|FG001|Overall Study|AE, non-serious non-fatal|1
2193755|NCT01506882|3824941|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
2193756|NCT01506882|3824942|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2193757|NCT01506882|3824941|FG000|Overall Study|Other Reason|2
2193758|NCT01506882|3824942|FG001|Overall Study|Other Reason|0
2193759|NCT01506908|3824952|FG000|Overall Study|Adverse Event|1
2193760|NCT01506908|3824953|FG001|Overall Study|Adverse Event|0
2193761|NCT01506947|3824961|FG000|Overall Study|Lost to Follow-up|7
2193762|NCT01506947|3824961|FG000|Overall Study|Adverse Event|5
2193763|NCT01506947|3824961|FG000|Overall Study|Death|1
2193764|NCT01506947|3824961|FG000|Overall Study|Did Not Meet Eligibility Criteria|3
2193765|NCT01506960|3824967|FG000|Overall Study|Did not meet angiographic criteria|47
2193766|NCT01507051|3824977|FG000|Overall Study|Withdrawal by Subject|1
2193767|NCT01507051|3824978|FG001|Overall Study|Withdrawal by Subject|3
2193768|NCT01507051|3824979|FG002|Overall Study|Withdrawal by Subject|1
2193769|NCT01507051|3824980|FG003|Overall Study|Withdrawal by Subject|6
2193770|NCT01507051|3824977|FG000|Overall Study|Physician Decision|0
2193771|NCT01507051|3824978|FG001|Overall Study|Physician Decision|0
2193772|NCT01507051|3824979|FG002|Overall Study|Physician Decision|0
2193773|NCT01507051|3824980|FG003|Overall Study|Physician Decision|1
2224809|NCT01775189|3872374|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
2224810|NCT01775189|3872375|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
2224811|NCT01775189|3872376|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2224812|NCT01775189|3872377|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2224813|NCT01775189|3872378|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2224814|NCT01775189|3872379|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2224815|NCT01775189|3872373|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0
2224816|NCT01775189|3872374|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0
2224817|NCT01775189|3872375|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0
2224818|NCT01775189|3872376|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0
2224819|NCT01775189|3872377|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0
2224820|NCT01775189|3872378|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1
2224821|NCT01775189|3872379|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0
2224822|NCT01775189|3872373|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0
2224823|NCT01775189|3872374|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0
2224824|NCT01775189|3872375|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0
2224825|NCT01775189|3872376|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1
2224826|NCT01775189|3872377|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0
2224827|NCT01775189|3872378|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0
2224828|NCT01775189|3872379|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0
2224829|NCT01775189|3872373|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0
2224830|NCT01775189|3872374|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0
2224831|NCT01775189|3872375|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0
2224832|NCT01775189|3872376|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1
2224833|NCT01775189|3872377|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0
2224834|NCT01775189|3872378|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0
2224835|NCT01775189|3872379|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1
2224836|NCT01775501|3872422|FG000|Overall Study|Discontinued prior to treatment|1
2224837|NCT01775553|3872426|FG000|Overall Study|Adverse Event|1
2224838|NCT01775553|3872426|FG000|Overall Study|Disease Progression|12
2224839|NCT01775670|3872432|FG000|Overall Study|Lost to Follow-up|1
2224840|NCT01775670|3872433|FG001|Overall Study|Lost to Follow-up|1
2224841|NCT01775787|3872467|FG000|First 7-10 Days|Adverse Event|0
2224842|NCT01775787|3872468|FG001|First 7-10 Days|Adverse Event|1
2224843|NCT01775787|3872467|FG000|First 7-10 Days|family emergency|0
2224844|NCT01775787|3872468|FG001|First 7-10 Days|family emergency|1
2224845|NCT01775787|3872467|FG000|First 7-10 Days|time commitment|0
2224846|NCT01775787|3872468|FG001|First 7-10 Days|time commitment|2
2224847|NCT01775787|3872467|FG000|First 7-10 Days|concerns with using IV|1
2224848|NCT01775787|3872468|FG001|First 7-10 Days|concerns with using IV|2
2224849|NCT01775787|3872467|FG000|Second 7-10 Days|time commitment|0
2224850|NCT01775787|3872468|FG001|Second 7-10 Days|time commitment|1
2224851|NCT01775787|3872467|FG000|Second 7-10 Days|concerns with using IV|0
2224852|NCT01775787|3872468|FG001|Second 7-10 Days|concerns with using IV|1
2224853|NCT01775904|3872513|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
2224854|NCT01775904|3872513|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1
2224855|NCT01775930|3872523|FG000|Overall Study|Futility stopping boundary met|1
2224856|NCT01775995|3872529|FG000|Overall Study|Lost to Follow-up|1
2224857|NCT01775995|3872530|FG001|Overall Study|Lost to Follow-up|1
2224858|NCT01776008|3872536|FG000|Overall Study|ineligible|2
2224859|NCT01776307|3872553|FG000|Overall Study|Not dosed|0
2224860|NCT01776307|3872554|FG001|Overall Study|Not dosed|0
2224861|NCT01776307|3872555|FG002|Overall Study|Not dosed|1
2224862|NCT01776424|3872587|FG000|Overall Study|Lost to Follow-up|10
2224863|NCT01776424|3872588|FG001|Overall Study|Lost to Follow-up|8
2224864|NCT01776424|3872589|FG002|Overall Study|Lost to Follow-up|9
2224865|NCT01776424|3872587|FG000|Overall Study|Withdrawal by Subject|10
2224866|NCT01776424|3872588|FG001|Overall Study|Withdrawal by Subject|11
2224867|NCT01776424|3872589|FG002|Overall Study|Withdrawal by Subject|15
2224868|NCT01776541|3872599|FG000|Overall Study|Administrative Reason|6
2224869|NCT01776541|3872600|FG001|Overall Study|Administrative Reason|2
2224870|NCT01776541|3872599|FG000|Overall Study|Death|4
2224871|NCT01776541|3872600|FG001|Overall Study|Death|0
2193774|NCT01507051|3824977|FG000|Overall Study|Adverse Event|1
2193775|NCT01507051|3824978|FG001|Overall Study|Adverse Event|0
2193776|NCT01507051|3824979|FG002|Overall Study|Adverse Event|0
2193777|NCT01507051|3824980|FG003|Overall Study|Adverse Event|0
2193778|NCT01507090|3824990|FG000|Overall Study|incomplete dataset|18
2193779|NCT01507246|3825038|FG000|Overall Study|Required different surgical procedures|2
2193780|NCT01507246|3825039|FG001|Overall Study|Required different surgical procedures|1
2193781|NCT01507298|3825050|FG000|Overall Study|Protocol Violation|0
2193782|NCT01507298|3825051|FG001|Overall Study|Protocol Violation|6
2193783|NCT01507662|3825073|FG000|Overall Study|Death|26
2193784|NCT01507662|3825074|FG001|Overall Study|Death|18
2193785|NCT01507662|3825073|FG000|Overall Study|Withdrawal by Subject|290
2193786|NCT01507662|3825074|FG001|Overall Study|Withdrawal by Subject|287
2193787|NCT01507662|3825073|FG000|Overall Study|Lost to Follow-up|498
2193788|NCT01507662|3825074|FG001|Overall Study|Lost to Follow-up|523
2193789|NCT01507662|3825073|FG000|Overall Study|Proxy interview done|2
2193790|NCT01507662|3825074|FG001|Overall Study|Proxy interview done|3
2193791|NCT01507831|3825102|FG000|Overall Study|Randomized but not treated|0
2193792|NCT01507831|3825103|FG001|Overall Study|Randomized but not treated|3
2193793|NCT01507831|3825102|FG000|Overall Study|Adverse Event|48
2193794|NCT01507831|3825103|FG001|Overall Study|Adverse Event|113
2193795|NCT01507831|3825102|FG000|Overall Study|Death|6
2193796|NCT01507831|3825103|FG001|Overall Study|Death|2
2193797|NCT01507831|3825102|FG000|Overall Study|Poor compliance to protocol|38
2193798|NCT01507831|3825103|FG001|Overall Study|Poor compliance to protocol|60
2193799|NCT01507831|3825102|FG000|Overall Study|Physician Decision|0
2193800|NCT01507831|3825103|FG001|Overall Study|Physician Decision|4
2193801|NCT01507831|3825102|FG000|Overall Study|Participant moved|5
2193802|NCT01507831|3825103|FG001|Overall Study|Participant moved|19
2193803|NCT01507831|3825102|FG000|Overall Study|Consent withdrawn by participant|34
2193804|NCT01507831|3825103|FG001|Overall Study|Consent withdrawn by participant|72
2193805|NCT01507831|3825102|FG000|Overall Study|Related to study drug administration|5
2193806|NCT01507831|3825103|FG001|Overall Study|Related to study drug administration|14
2193807|NCT01507831|3825102|FG000|Overall Study|Last visit outside protocol visit window|51
2193808|NCT01507831|3825103|FG001|Overall Study|Last visit outside protocol visit window|143
2193809|NCT01507831|3825102|FG000|Overall Study|Selection criteria finally not met|0
2193810|NCT01507831|3825103|FG001|Overall Study|Selection criteria finally not met|1
2193811|NCT01507831|3825102|FG000|Overall Study|Site closure|0
2193812|NCT01507831|3825103|FG001|Overall Study|Site closure|3
2193813|NCT01507831|3825102|FG000|Overall Study|Potential lost to follow-up|3
2193814|NCT01507831|3825103|FG001|Overall Study|Potential lost to follow-up|0
2193815|NCT01507831|3825102|FG000|Overall Study|Other|3
2193816|NCT01507831|3825103|FG001|Overall Study|Other|6
2193817|NCT01507896|3825109|FG000|Overall Study|Withdrawal by Subject|1
2193818|NCT01507896|3825109|FG000|Overall Study|The surgery was denied by the sponsor.|1
2193819|NCT01508130|3825176|FG000|Overall Study|Adverse Event|81
2193820|NCT01508130|3825177|FG001|Overall Study|Adverse Event|28
2193821|NCT01508130|3825176|FG000|Overall Study|Death|3
2193822|NCT01508130|3825177|FG001|Overall Study|Death|1
2193823|NCT01508130|3825176|FG000|Overall Study|Protocol Violation|2
2193824|NCT01508130|3825177|FG001|Overall Study|Protocol Violation|0
2193825|NCT01508130|3825176|FG000|Overall Study|Lost to Follow-up|25
2193826|NCT01508130|3825177|FG001|Overall Study|Lost to Follow-up|2
2193827|NCT01508130|3825176|FG000|Overall Study|Withdrawal by Subject|3
2193828|NCT01508130|3825177|FG001|Overall Study|Withdrawal by Subject|3
2193829|NCT01508130|3825176|FG000|Overall Study|Subject's substantial non-compliance|25
2193830|NCT01508130|3825177|FG001|Overall Study|Subject's substantial non-compliance|9
2193831|NCT01508130|3825176|FG000|Overall Study|Insufficient therapeutic response|74
2193832|NCT01508130|3825177|FG001|Overall Study|Insufficient therapeutic response|23
2193833|NCT01508130|3825176|FG000|Overall Study|Administrative|14
2193834|NCT01508130|3825177|FG001|Overall Study|Administrative|3
2193835|NCT01508169|3825187|FG000|Overall Study|Adverse Event|1
2193836|NCT01508169|3825188|FG001|Overall Study|Adverse Event|0
2193837|NCT01508169|3825187|FG000|Overall Study|Withdrawal by Subject|1
2193838|NCT01508169|3825188|FG001|Overall Study|Withdrawal by Subject|0
2193839|NCT01508169|3825187|FG000|Overall Study|Lost to Follow-up|1
2224872|NCT01776541|3872599|FG000|Overall Study|Lost to Follow-up|27
2224873|NCT01776541|3872600|FG001|Overall Study|Lost to Follow-up|48
2224874|NCT01776541|3872599|FG000|Overall Study|Unclassified|5
2224875|NCT01776541|3872600|FG001|Overall Study|Unclassified|4
2224876|NCT01776541|3872599|FG000|Overall Study|Protocol Violation|2
2224877|NCT01776541|3872600|FG001|Overall Study|Protocol Violation|1
2224878|NCT01776541|3872599|FG000|Overall Study|Withdrawal by Subject|12
2224879|NCT01776541|3872600|FG001|Overall Study|Withdrawal by Subject|20
2224880|NCT01776554|3872609|FG000|Overall Study|Adverse Event|1
2224881|NCT01776554|3872610|FG001|Overall Study|Adverse Event|0
2224882|NCT01776554|3872609|FG000|Overall Study|Withdrawal by Subject|3
2224883|NCT01776554|3872610|FG001|Overall Study|Withdrawal by Subject|8
2224884|NCT01776554|3872609|FG000|Overall Study|Lost to Follow-up|6
2224885|NCT01776554|3872610|FG001|Overall Study|Lost to Follow-up|9
2224886|NCT01776554|3872609|FG000|Overall Study|Administrative Reason|2
2224887|NCT01776554|3872610|FG001|Overall Study|Administrative Reason|5
2193840|NCT01508169|3825188|FG001|Overall Study|Lost to Follow-up|2
2224888|NCT01776554|3872609|FG000|Overall Study|Protocol Violation|1
2193841|NCT01508325|3825202|FG000|Overall Study|Withdrawal by Subject|8
2193842|NCT01508325|3825203|FG001|Overall Study|Withdrawal by Subject|9
2193843|NCT01508325|3825202|FG000|Overall Study|Protocol Violation|0
2193844|NCT01508325|3825203|FG001|Overall Study|Protocol Violation|3
2193845|NCT01508325|3825202|FG000|Overall Study|Physician Decision|2
2193846|NCT01508325|3825203|FG001|Overall Study|Physician Decision|1
2193847|NCT01508325|3825202|FG000|Overall Study|Adverse Event|1
2193848|NCT01508325|3825203|FG001|Overall Study|Adverse Event|0
2193849|NCT01508325|3825202|FG000|Overall Study|Lost to Follow-up|5
2193850|NCT01508325|3825203|FG001|Overall Study|Lost to Follow-up|6
2193851|NCT01508325|3825202|FG000|Overall Study|Other|2
2193852|NCT01508325|3825203|FG001|Overall Study|Other|2
2193853|NCT01508650|3825215|FG000|Overall Study|Lost to Follow-up|0
2193854|NCT01508650|3825216|FG001|Overall Study|Lost to Follow-up|3
2193855|NCT01508676|3825224|FG000|Phase I (2 Weeks)|Medication Exclusion|1
2193856|NCT01508676|3825225|FG001|Phase I (2 Weeks)|Medication Exclusion|1
2193857|NCT01508676|3825224|FG000|Phase I (2 Weeks)|Wrong Pain Type|1
2193858|NCT01508676|3825225|FG001|Phase I (2 Weeks)|Wrong Pain Type|0
2193859|NCT01508676|3825224|FG000|Phase I (2 Weeks)|Positive Drug Screen|0
2193860|NCT01508676|3825225|FG001|Phase I (2 Weeks)|Positive Drug Screen|2
2193861|NCT01508676|3825224|FG000|Phase II (2 Weeks)|Skin Sensitivity|0
2193862|NCT01508676|3825225|FG001|Phase II (2 Weeks)|Skin Sensitivity|1
2193863|NCT01508676|3825224|FG000|Phase II (2 Weeks)|Medication Exclusion|1
2193864|NCT01508676|3825225|FG001|Phase II (2 Weeks)|Medication Exclusion|0
2193865|NCT01508702|3825234|FG000|Overall Study|Adverse Event|7
2193866|NCT01508702|3825235|FG001|Overall Study|Adverse Event|3
2193867|NCT01508702|3825234|FG000|Overall Study|Gout flare|2
2193868|NCT01508702|3825235|FG001|Overall Study|Gout flare|0
2193869|NCT01508702|3825234|FG000|Overall Study|Protocol Violation|2
2193870|NCT01508702|3825235|FG001|Overall Study|Protocol Violation|1
2193871|NCT01508702|3825234|FG000|Overall Study|Lost to Follow-up|1
2193872|NCT01508702|3825235|FG001|Overall Study|Lost to Follow-up|2
2193873|NCT01508702|3825234|FG000|Overall Study|Withdrawal by Subject|11
2193874|NCT01508702|3825235|FG001|Overall Study|Withdrawal by Subject|7
2193875|NCT01508910|3825253|FG000|Treatment|Death|2
2193876|NCT01508910|3825254|FG001|Treatment|Death|3
2193877|NCT01508910|3825255|FG002|Treatment|Death|2
2193878|NCT01508910|3825256|FG003|Treatment|Death|0
2193879|NCT01508910|3825253|FG000|Treatment|Lost to Follow-up|0
2193880|NCT01508910|3825254|FG001|Treatment|Lost to Follow-up|0
2193881|NCT01508910|3825255|FG002|Treatment|Lost to Follow-up|2
2193882|NCT01508910|3825256|FG003|Treatment|Lost to Follow-up|1
2193883|NCT01508910|3825253|FG000|Treatment|Withdrawal by Subject|0
2224889|NCT01776554|3872610|FG001|Overall Study|Protocol Violation|0
2224890|NCT01776554|3872609|FG000|Overall Study|Unclassified|4
2224891|NCT01776554|3872610|FG001|Overall Study|Unclassified|1
2224892|NCT01777139|3872645|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
2224893|NCT01777139|3872646|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
2224894|NCT01777139|3872645|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
2224895|NCT01777139|3872646|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
2224896|NCT01777139|3872645|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
2224897|NCT01777139|3872646|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
2224898|NCT01777139|3872645|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
2224899|NCT01777139|3872646|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
2224900|NCT01777139|3872645|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
2224901|NCT01777139|3872646|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
2224902|NCT01777139|3872645|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
2224903|NCT01777139|3872646|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
2224904|NCT01777139|3872645|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
2224905|NCT01777139|3872646|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
2224906|NCT01777139|3872645|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
2224907|NCT01777139|3872646|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
2224908|NCT01777152|3872655|FG000|Overall Study|Withdrawal by Subject|22
2224909|NCT01777152|3872656|FG001|Overall Study|Withdrawal by Subject|16
2224910|NCT01777152|3872655|FG000|Overall Study|Lost to Follow-up|3
2224911|NCT01777152|3872656|FG001|Overall Study|Lost to Follow-up|5
2224912|NCT01777152|3872655|FG000|Overall Study|Death|68
2224913|NCT01777152|3872656|FG001|Overall Study|Death|89
2224914|NCT01777152|3872655|FG000|Overall Study|Not eligible, no study drug received|1
2224915|NCT01777152|3872656|FG001|Overall Study|Not eligible, no study drug received|0
2224916|NCT01777152|3872655|FG000|Overall Study|Change of diagnosis|1
2224917|NCT01777152|3872656|FG001|Overall Study|Change of diagnosis|0
2224918|NCT01777191|3872665|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
2224919|NCT01777191|3872666|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
2224920|NCT01777191|3872665|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
2224921|NCT01777191|3872666|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
2224922|NCT01777191|3872665|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
2224923|NCT01777191|3872666|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
2193884|NCT01508910|3825254|FG001|Treatment|Withdrawal by Subject|1
2193885|NCT01508910|3825255|FG002|Treatment|Withdrawal by Subject|6
2193886|NCT01508910|3825256|FG003|Treatment|Withdrawal by Subject|1
2193887|NCT01508910|3825253|FG000|Treatment|Sponsor Decision|0
2193888|NCT01508910|3825254|FG001|Treatment|Sponsor Decision|0
2193889|NCT01508910|3825255|FG002|Treatment|Sponsor Decision|0
2193890|NCT01508910|3825256|FG003|Treatment|Sponsor Decision|1
2193891|NCT01508936|3825270|FG000|Overall Study|Adverse Event|11
2193892|NCT01508936|3825271|FG001|Overall Study|Adverse Event|32
2193893|NCT01508936|3825270|FG000|Overall Study|Lack of Efficacy|0
2193894|NCT01508936|3825271|FG001|Overall Study|Lack of Efficacy|1
2193895|NCT01508936|3825270|FG000|Overall Study|Withdrawal by Subject|4
2193896|NCT01508936|3825271|FG001|Overall Study|Withdrawal by Subject|18
2193897|NCT01508936|3825270|FG000|Overall Study|Protocol Violation|2
2193898|NCT01508936|3825271|FG001|Overall Study|Protocol Violation|3
2193899|NCT01508936|3825270|FG000|Overall Study|Lost to Follow-up|2
2193900|NCT01508936|3825271|FG001|Overall Study|Lost to Follow-up|9
2193901|NCT01508936|3825270|FG000|Overall Study|Other|0
2193902|NCT01508936|3825271|FG001|Overall Study|Other|5
2193903|NCT01508936|3825270|FG000|Overall Study|Data from 2 sites deemed invalid|4
2193904|NCT01508936|3825271|FG001|Overall Study|Data from 2 sites deemed invalid|11
2193905|NCT01509079|3825299|FG000|Overall Study|Lack of Efficacy|0
2193906|NCT01509079|3825300|FG001|Overall Study|Lack of Efficacy|2
2193907|NCT01509079|3825299|FG000|Overall Study|started an excluded medication|0
2193908|NCT01509079|3825300|FG001|Overall Study|started an excluded medication|1
2193909|NCT01509547|3825332|FG000|Overall Study|Lost to Follow-up|24
2193910|NCT01509547|3825333|FG001|Overall Study|Lost to Follow-up|14
2193911|NCT01509547|3825332|FG000|Overall Study|Withdrawal by Subject|11
2193912|NCT01509547|3825333|FG001|Overall Study|Withdrawal by Subject|24
2193913|NCT01509547|3825332|FG000|Overall Study|Physician Decision|0
2193914|NCT01509547|3825333|FG001|Overall Study|Physician Decision|1
2193915|NCT01509664|3825388|FG000|Overall Study|Lost to Follow-up|15
2193916|NCT01509664|3825389|FG001|Overall Study|Lost to Follow-up|21
2193917|NCT01509846|3825418|FG000|Received Vaccination 2|Withdrawal by Subject|0
2193918|NCT01509846|3825419|FG001|Received Vaccination 2|Withdrawal by Subject|0
2193919|NCT01509846|3825420|FG002|Received Vaccination 2|Withdrawal by Subject|1
2193920|NCT01509846|3825421|FG003|Received Vaccination 2|Withdrawal by Subject|0
2193921|NCT01509846|3825422|FG004|Received Vaccination 2|Withdrawal by Subject|0
2193922|NCT01509846|3825418|FG000|Received Vaccination 2|Illness|0
2193923|NCT01509846|3825419|FG001|Received Vaccination 2|Illness|0
2193924|NCT01509846|3825420|FG002|Received Vaccination 2|Illness|0
2193925|NCT01509846|3825421|FG003|Received Vaccination 2|Illness|0
2193926|NCT01509846|3825422|FG004|Received Vaccination 2|Illness|1
2193927|NCT01509846|3825418|FG000|Received Vaccination 2|Not vaccinated per protocol|5
2193928|NCT01509846|3825419|FG001|Received Vaccination 2|Not vaccinated per protocol|0
2193929|NCT01509846|3825420|FG002|Received Vaccination 2|Not vaccinated per protocol|0
2193930|NCT01509846|3825421|FG003|Received Vaccination 2|Not vaccinated per protocol|0
2193931|NCT01509846|3825422|FG004|Received Vaccination 2|Not vaccinated per protocol|2
2193932|NCT01509846|3825418|FG000|Received Vaccination 3|Withdrawal by Subject|0
2193933|NCT01509846|3825419|FG001|Received Vaccination 3|Withdrawal by Subject|1
2193934|NCT01509846|3825420|FG002|Received Vaccination 3|Withdrawal by Subject|0
2193935|NCT01509846|3825421|FG003|Received Vaccination 3|Withdrawal by Subject|0
2193936|NCT01509846|3825422|FG004|Received Vaccination 3|Withdrawal by Subject|0
2193937|NCT01509846|3825418|FG000|Received Vaccination 3|Pregnancy|0
2193938|NCT01509846|3825419|FG001|Received Vaccination 3|Pregnancy|0
2193939|NCT01509846|3825420|FG002|Received Vaccination 3|Pregnancy|0
2193940|NCT01509846|3825421|FG003|Received Vaccination 3|Pregnancy|1
2193941|NCT01509846|3825422|FG004|Received Vaccination 3|Pregnancy|0
2193942|NCT01509846|3825418|FG000|Received Vaccination 3|Lost to Follow-up|0
2193943|NCT01509846|3825419|FG001|Received Vaccination 3|Lost to Follow-up|0
2193944|NCT01509846|3825420|FG002|Received Vaccination 3|Lost to Follow-up|1
2193945|NCT01509846|3825421|FG003|Received Vaccination 3|Lost to Follow-up|0
2193946|NCT01509846|3825422|FG004|Received Vaccination 3|Lost to Follow-up|0
2193947|NCT01510028|3825466|FG000|Overall Study|Lack of Efficacy|1
2193948|NCT01510028|3825467|FG001|Overall Study|Lack of Efficacy|0
2193949|NCT01510028|3825468|FG002|Overall Study|Lack of Efficacy|0
2193950|NCT01510028|3825469|FG003|Overall Study|Lack of Efficacy|0
2193951|NCT01510145|3825481|FG000|Overall Study|Adverse Event|6
2193952|NCT01510145|3825481|FG000|Overall Study|Lost to Follow-up|5
2193953|NCT01510145|3825481|FG000|Overall Study|Withdrawal by Subject|6
2193954|NCT01510145|3825481|FG000|Overall Study|Relative reported subject withdrew|1
2193955|NCT01510158|3825488|FG000|Overall Study|Adverse Event|7
2193956|NCT01510158|3825489|FG001|Overall Study|Adverse Event|8
2193957|NCT01510158|3825490|FG002|Overall Study|Adverse Event|5
2193958|NCT01510158|3825488|FG000|Overall Study|Gout flare|1
2193959|NCT01510158|3825489|FG001|Overall Study|Gout flare|0
2193960|NCT01510158|3825490|FG002|Overall Study|Gout flare|0
2193961|NCT01510158|3825488|FG000|Overall Study|Protocol Violation|17
2193962|NCT01510158|3825489|FG001|Overall Study|Protocol Violation|16
2193963|NCT01510158|3825490|FG002|Overall Study|Protocol Violation|24
2193964|NCT01510158|3825488|FG000|Overall Study|Sponsor terminated study.|2
2193965|NCT01510158|3825489|FG001|Overall Study|Sponsor terminated study.|0
2193966|NCT01510158|3825490|FG002|Overall Study|Sponsor terminated study.|2
2193967|NCT01510158|3825488|FG000|Overall Study|Lost to Follow-up|13
2193968|NCT01510158|3825489|FG001|Overall Study|Lost to Follow-up|16
2193969|NCT01510158|3825490|FG002|Overall Study|Lost to Follow-up|9
2193970|NCT01510158|3825488|FG000|Overall Study|Withdrawal by Subject|10
2193971|NCT01510158|3825489|FG001|Overall Study|Withdrawal by Subject|13
2193972|NCT01510158|3825490|FG002|Overall Study|Withdrawal by Subject|10
2193973|NCT01510158|3825488|FG000|Overall Study|Death|1
2193974|NCT01510158|3825489|FG001|Overall Study|Death|0
2193975|NCT01510158|3825490|FG002|Overall Study|Death|0
2193976|NCT01510717|3825556|FG000|Overall Study|Adverse Event|1
2193977|NCT01510717|3825557|FG001|Overall Study|Adverse Event|2
2193978|NCT01510717|3825556|FG000|Overall Study|Death|1
2193979|NCT01510717|3825557|FG001|Overall Study|Death|0
2193980|NCT01510717|3825556|FG000|Overall Study|Lost to Follow-up|0
2193981|NCT01510717|3825557|FG001|Overall Study|Lost to Follow-up|1
2193982|NCT01510717|3825556|FG000|Overall Study|Withdrawal by Subject|0
2193983|NCT01510717|3825557|FG001|Overall Study|Withdrawal by Subject|2
2193984|NCT01510769|3825567|FG000|Overall Study|Adverse Event|7
2193985|NCT01510769|3825568|FG001|Overall Study|Adverse Event|6
2193986|NCT01510769|3825569|FG002|Overall Study|Adverse Event|4
2193987|NCT01510769|3825567|FG000|Overall Study|Gout Flare|0
2193988|NCT01510769|3825568|FG001|Overall Study|Gout Flare|3
2193989|NCT01510769|3825569|FG002|Overall Study|Gout Flare|1
2193990|NCT01510769|3825567|FG000|Overall Study|Protocol Violation|11
2193991|NCT01510769|3825568|FG001|Overall Study|Protocol Violation|10
2193992|NCT01510769|3825569|FG002|Overall Study|Protocol Violation|9
2193993|NCT01510769|3825567|FG000|Overall Study|Lost to Follow-up|5
2193994|NCT01510769|3825568|FG001|Overall Study|Lost to Follow-up|1
2193995|NCT01510769|3825569|FG002|Overall Study|Lost to Follow-up|5
2193996|NCT01510769|3825567|FG000|Overall Study|Withdrawal by Subject|3
2193997|NCT01510769|3825568|FG001|Overall Study|Withdrawal by Subject|4
2193998|NCT01510769|3825569|FG002|Overall Study|Withdrawal by Subject|3
2193999|NCT01510769|3825567|FG000|Overall Study|Death|1
2194000|NCT01510769|3825568|FG001|Overall Study|Death|1
2194001|NCT01510769|3825569|FG002|Overall Study|Death|0
2194002|NCT01510912|3825584|FG000|Overall Study|Adverse Event|99
2224924|NCT01777191|3872665|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
2224925|NCT01777191|3872666|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
2224926|NCT01777191|3872665|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
2224927|NCT01777191|3872666|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
2224928|NCT01777191|3872665|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
2224929|NCT01777191|3872666|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
2224930|NCT01777191|3872665|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
2224931|NCT01777191|3872666|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
2224932|NCT01777191|3872665|FG000|Safety Extension Per (Week 12-Week 48)|Death|0
2224933|NCT01777191|3872666|FG001|Safety Extension Per (Week 12-Week 48)|Death|1
2224934|NCT01777191|3872665|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
2224935|NCT01777191|3872666|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
2224936|NCT01777191|3872665|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
2224937|NCT01777191|3872666|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
2224938|NCT01777191|3872665|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
2224939|NCT01777191|3872666|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
2224940|NCT01777269|3872686|FG000|Overall Study|Adverse Event|24
2224941|NCT01777269|3872687|FG001|Overall Study|Adverse Event|33
2224942|NCT01777269|3872686|FG000|Overall Study|Lack of Efficacy|8
2224943|NCT01777269|3872687|FG001|Overall Study|Lack of Efficacy|10
2224944|NCT01777269|3872686|FG000|Overall Study|Protocol Violation|4
2224945|NCT01777269|3872687|FG001|Overall Study|Protocol Violation|4
2224946|NCT01777269|3872686|FG000|Overall Study|Participants reached stopping criteria|1
2224947|NCT01777269|3872687|FG001|Overall Study|Participants reached stopping criteria|1
2224948|NCT01777269|3872686|FG000|Overall Study|Lost to Follow-up|4
2224949|NCT01777269|3872687|FG001|Overall Study|Lost to Follow-up|0
2224950|NCT01777269|3872686|FG000|Overall Study|Physician Decision|5
2224951|NCT01777269|3872687|FG001|Overall Study|Physician Decision|2
2224952|NCT01777269|3872686|FG000|Overall Study|Withdrawal by Subject|9
2224953|NCT01777269|3872687|FG001|Overall Study|Withdrawal by Subject|9
2224954|NCT01777282|3872698|FG000|Overall Study|Persistent Hyperglycemia|0
2224955|NCT01777282|3872699|FG001|Overall Study|Persistent Hyperglycemia|0
2224956|NCT01777282|3872700|FG002|Overall Study|Persistent Hyperglycemia|1
2224957|NCT01777282|3872701|FG003|Overall Study|Persistent Hyperglycemia|0
2224958|NCT01777282|3872702|FG004|Overall Study|Persistent Hyperglycemia|0
2224959|NCT01777282|3872698|FG000|Overall Study|New Antidiabetic Medication|0
2224960|NCT01777282|3872699|FG001|Overall Study|New Antidiabetic Medication|0
2224961|NCT01777282|3872700|FG002|Overall Study|New Antidiabetic Medication|1
2224962|NCT01777282|3872701|FG003|Overall Study|New Antidiabetic Medication|0
2224963|NCT01777282|3872702|FG004|Overall Study|New Antidiabetic Medication|0
2224964|NCT01777282|3872698|FG000|Overall Study|Adverse Event|4
2224965|NCT01777282|3872699|FG001|Overall Study|Adverse Event|4
2224966|NCT01777282|3872700|FG002|Overall Study|Adverse Event|2
2224967|NCT01777282|3872701|FG003|Overall Study|Adverse Event|1
2194003|NCT01510912|3825584|FG000|Overall Study|Lack of Efficacy|12
2194004|NCT01510912|3825584|FG000|Overall Study|Non-compliance with trial drug|23
2194005|NCT01510912|3825584|FG000|Overall Study|Withdrawal by Subject|49
2194006|NCT01510912|3825584|FG000|Overall Study|Physician Decision|1
2194007|NCT01510912|3825584|FG000|Overall Study|Protocol Violation|27
2194008|NCT01510912|3825584|FG000|Overall Study|Lost to Follow-up|26
2194009|NCT01510912|3825584|FG000|Overall Study|Other, including joint replacement|5
2194010|NCT01511055|3825598|FG000|Overall Study|Withdrawal by Subject|6
2194011|NCT01511107|3825608|FG000|Overall Study|Ineligible|3
2194012|NCT01511107|3825609|FG001|Overall Study|Ineligible|2
2194013|NCT01511107|3825608|FG000|Overall Study|Lost to Follow-up|10
2194014|NCT01511107|3825609|FG001|Overall Study|Lost to Follow-up|19
2194015|NCT01511107|3825608|FG000|Overall Study|Withdrawal by Subject|9
2194016|NCT01511107|3825609|FG001|Overall Study|Withdrawal by Subject|20
2194017|NCT01511250|3825625|FG000|Overall Study|Withdrawal of Consent|1
2194018|NCT01511250|3825626|FG001|Overall Study|Withdrawal of Consent|0
2194019|NCT01511250|3825627|FG002|Overall Study|Withdrawal of Consent|0
2194020|NCT01511250|3825628|FG003|Overall Study|Withdrawal of Consent|0
2194021|NCT01511250|3825629|FG004|Overall Study|Withdrawal of Consent|0
2194022|NCT01511250|3825630|FG005|Overall Study|Withdrawal of Consent|0
2194023|NCT01511250|3825631|FG006|Overall Study|Withdrawal of Consent|0
2194024|NCT01511250|3825632|FG007|Overall Study|Withdrawal of Consent|1
2194025|NCT01511250|3825633|FG008|Overall Study|Withdrawal of Consent|1
2194026|NCT01511250|3825634|FG009|Overall Study|Withdrawal of Consent|0
2194027|NCT01511250|3825625|FG000|Overall Study|Sponsor/Investigator Decision|1
2194028|NCT01511250|3825626|FG001|Overall Study|Sponsor/Investigator Decision|0
2194029|NCT01511250|3825627|FG002|Overall Study|Sponsor/Investigator Decision|0
2194030|NCT01511250|3825628|FG003|Overall Study|Sponsor/Investigator Decision|0
2194031|NCT01511250|3825629|FG004|Overall Study|Sponsor/Investigator Decision|0
2194032|NCT01511250|3825630|FG005|Overall Study|Sponsor/Investigator Decision|0
2194033|NCT01511250|3825631|FG006|Overall Study|Sponsor/Investigator Decision|0
2194034|NCT01511250|3825632|FG007|Overall Study|Sponsor/Investigator Decision|0
2194035|NCT01511250|3825633|FG008|Overall Study|Sponsor/Investigator Decision|0
2194036|NCT01511250|3825634|FG009|Overall Study|Sponsor/Investigator Decision|0
2194037|NCT01511250|3825625|FG000|Overall Study|Lost to Follow-up|7
2194038|NCT01511250|3825626|FG001|Overall Study|Lost to Follow-up|3
2194039|NCT01511250|3825627|FG002|Overall Study|Lost to Follow-up|3
2194040|NCT01511250|3825628|FG003|Overall Study|Lost to Follow-up|3
2194041|NCT01511250|3825629|FG004|Overall Study|Lost to Follow-up|0
2194042|NCT01511250|3825630|FG005|Overall Study|Lost to Follow-up|0
2194043|NCT01511250|3825631|FG006|Overall Study|Lost to Follow-up|2
2194044|NCT01511250|3825632|FG007|Overall Study|Lost to Follow-up|3
2194045|NCT01511250|3825633|FG008|Overall Study|Lost to Follow-up|13
2194046|NCT01511250|3825634|FG009|Overall Study|Lost to Follow-up|5
2194047|NCT01511250|3825625|FG000|Overall Study|Protocol Violation|0
2194048|NCT01511250|3825626|FG001|Overall Study|Protocol Violation|2
2194049|NCT01511250|3825627|FG002|Overall Study|Protocol Violation|1
2194050|NCT01511250|3825628|FG003|Overall Study|Protocol Violation|0
2194051|NCT01511250|3825629|FG004|Overall Study|Protocol Violation|0
2194052|NCT01511250|3825630|FG005|Overall Study|Protocol Violation|0
2194053|NCT01511250|3825631|FG006|Overall Study|Protocol Violation|0
2194054|NCT01511250|3825632|FG007|Overall Study|Protocol Violation|0
2194055|NCT01511250|3825633|FG008|Overall Study|Protocol Violation|0
2194056|NCT01511250|3825634|FG009|Overall Study|Protocol Violation|0
2224968|NCT01777282|3872702|FG004|Overall Study|Adverse Event|3
2224969|NCT01777282|3872698|FG000|Overall Study|Withdrawal by Subject|4
2224970|NCT01777282|3872699|FG001|Overall Study|Withdrawal by Subject|0
2224971|NCT01777282|3872700|FG002|Overall Study|Withdrawal by Subject|0
2224972|NCT01777282|3872701|FG003|Overall Study|Withdrawal by Subject|1
2224973|NCT01777282|3872702|FG004|Overall Study|Withdrawal by Subject|2
2224974|NCT01777282|3872698|FG000|Overall Study|Protocol Violation|2
2224975|NCT01777282|3872699|FG001|Overall Study|Protocol Violation|0
2224976|NCT01777282|3872700|FG002|Overall Study|Protocol Violation|1
2224977|NCT01777282|3872701|FG003|Overall Study|Protocol Violation|0
2224978|NCT01777282|3872702|FG004|Overall Study|Protocol Violation|2
2224979|NCT01777282|3872698|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1
2224980|NCT01777282|3872699|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0
2224981|NCT01777282|3872700|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1
2224982|NCT01777282|3872701|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0
2224983|NCT01777282|3872702|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0
2224984|NCT01777308|3872716|FG000|Overall Study|Withdrawal by Subject|5
2224985|NCT01777308|3872717|FG001|Overall Study|Withdrawal by Subject|1
2224986|NCT01777308|3872716|FG000|Overall Study|Migrated/moved from study area|1
2224987|NCT01777308|3872717|FG001|Overall Study|Migrated/moved from study area|0
2224988|NCT01777308|3872716|FG000|Overall Study|Lost to Follow-up|7
2224989|NCT01777308|3872717|FG001|Overall Study|Lost to Follow-up|2
2224990|NCT01777308|3872716|FG000|Overall Study|Blood draw refusal at Visit 3|1
2224991|NCT01777308|3872717|FG001|Overall Study|Blood draw refusal at Visit 3|0
2224992|NCT01777321|3872726|FG000|Overall Study|Withdrawal by Subject|0
2224993|NCT01777321|3872727|FG001|Overall Study|Withdrawal by Subject|1
2274148|NCT02293837|3955016|FG001|Overall Study|Participant ill and could not be infused|0
2274149|NCT02293837|3955017|FG002|Overall Study|Participant ill and could not be infused|1
2274150|NCT02293837|3955018|FG003|Overall Study|Participant ill and could not be infused|0
2274151|NCT02293863|3955035|FG000|Overall Study|Death|4
2274152|NCT02293863|3955036|FG001|Overall Study|Death|6
2274153|NCT02293863|3955037|FG002|Overall Study|Death|4
2194057|NCT01511419|3825662|FG000|Dose 2|Physician Decision|1
2194058|NCT01511419|3825663|FG001|Dose 2|Physician Decision|0
2194059|NCT01511445|3825695|FG000|Overall Study|Lost to Follow-up|3
2194060|NCT01511445|3825696|FG001|Overall Study|Lost to Follow-up|1
2194061|NCT01511445|3825695|FG000|Overall Study|Protocol Violation|1
2194062|NCT01511445|3825696|FG001|Overall Study|Protocol Violation|3
2194063|NCT01511445|3825695|FG000|Overall Study|Protocol Violation|1
2194064|NCT01511445|3825696|FG001|Overall Study|Protocol Violation|0
2194065|NCT01511536|3825705|FG000|Phase 1|Other|0
2194066|NCT01511536|3825706|FG001|Phase 1|Other|1
2194067|NCT01511536|3825707|FG002|Phase 1|Other|0
2194068|NCT01511536|3825705|FG000|Phase 2|Other|0
2194069|NCT01511536|3825706|FG001|Phase 2|Other|0
2194070|NCT01511536|3825707|FG002|Phase 2|Other|9
2194071|NCT01511939|3825744|FG000|Overall Study|Withdrawal by Subject|2
2194072|NCT01511939|3825745|FG001|Overall Study|Withdrawal by Subject|1
2194073|NCT01511939|3825746|FG002|Overall Study|Withdrawal by Subject|0
2194074|NCT01512108|3825767|FG000|Overall Study|Adverse Event|9
2194075|NCT01512108|3825768|FG001|Overall Study|Adverse Event|4
2194076|NCT01512108|3825767|FG000|Overall Study|Protocol Violation|1
2194077|NCT01512108|3825768|FG001|Overall Study|Protocol Violation|2
2194078|NCT01512108|3825767|FG000|Overall Study|Withdrawal Criteria|1
2194079|NCT01512108|3825768|FG001|Overall Study|Withdrawal Criteria|0
2194080|NCT01512108|3825767|FG000|Overall Study|Unclassified|11
2194081|NCT01512108|3825768|FG001|Overall Study|Unclassified|3
2194082|NCT01512160|3825778|FG000|Overall Study|Lost to Follow-up|1
2194083|NCT01512160|3825779|FG001|Overall Study|Lost to Follow-up|0
2194084|NCT01512160|3825780|FG002|Overall Study|Lost to Follow-up|0
2194085|NCT01512160|3825781|FG003|Overall Study|Lost to Follow-up|0
2194086|NCT01512160|3825778|FG000|Overall Study|Withdrawal by Subject|1
2194087|NCT01512160|3825779|FG001|Overall Study|Withdrawal by Subject|0
2194088|NCT01512160|3825780|FG002|Overall Study|Withdrawal by Subject|0
2194089|NCT01512160|3825781|FG003|Overall Study|Withdrawal by Subject|1
2224994|NCT01777334|3872735|FG000|Overall Study|Adverse Event|18
2224995|NCT01777334|3872736|FG001|Overall Study|Adverse Event|14
2224996|NCT01777334|3872735|FG000|Overall Study|Lack of Efficacy|15
2224997|NCT01777334|3872736|FG001|Overall Study|Lack of Efficacy|29
2224998|NCT01777334|3872735|FG000|Overall Study|Protocol Violation|3
2224999|NCT01777334|3872736|FG001|Overall Study|Protocol Violation|7
2225000|NCT01777334|3872735|FG000|Overall Study|Lost to Follow-up|3
2225001|NCT01777334|3872736|FG001|Overall Study|Lost to Follow-up|2
2225002|NCT01777334|3872735|FG000|Overall Study|Withdrawal by Subject|14
2225003|NCT01777334|3872736|FG001|Overall Study|Withdrawal by Subject|11
2225004|NCT01777490|3872764|FG000|Overall Study|Dyad withdrew with data use prohibition|0
2225005|NCT01777490|3872765|FG001|Overall Study|Dyad withdrew with data use prohibition|0
2225006|NCT01777490|3872766|FG002|Overall Study|Dyad withdrew with data use prohibition|1
2225007|NCT01777490|3872767|FG003|Overall Study|Dyad withdrew with data use prohibition|1
2225008|NCT01777542|3872779|FG000|Second Intervention (20 Weeks)|Adverse Event|0
2225009|NCT01777542|3872780|FG001|Second Intervention (20 Weeks)|Adverse Event|1
2225010|NCT01777581|3872798|FG000|Overall Study|Lost to Follow-up|1
2225011|NCT01777581|3872799|FG001|Overall Study|Lost to Follow-up|1
2225012|NCT01777581|3872798|FG000|Overall Study|Adverse Event|2
2225013|NCT01777581|3872799|FG001|Overall Study|Adverse Event|0
2225014|NCT01777581|3872798|FG000|Overall Study|Lack of Efficacy|0
2225015|NCT01777581|3872799|FG001|Overall Study|Lack of Efficacy|1
2225016|NCT01777620|3872807|FG000|Overall Study|Subject Withdrawal|1
2225017|NCT01777620|3872808|FG001|Overall Study|Subject Withdrawal|0
2225018|NCT01777763|3872816|FG000|Overall Study|Adverse Event|2
2225019|NCT01777763|3872817|FG001|Overall Study|Adverse Event|32
2225020|NCT01777763|3872816|FG000|Overall Study|Protocol Violation|1
2225021|NCT01777763|3872817|FG001|Overall Study|Protocol Violation|7
2225022|NCT01777763|3872816|FG000|Overall Study|Withdrawal by Subject|0
2225023|NCT01777763|3872817|FG001|Overall Study|Withdrawal by Subject|2
2225024|NCT01777763|3872816|FG000|Overall Study|Treatment Failure|1
2225025|NCT01777763|3872817|FG001|Overall Study|Treatment Failure|6
2225026|NCT01777776|3872827|FG000|Overall Study|Adverse Event|2
2225027|NCT01777776|3872828|FG001|Overall Study|Adverse Event|4
2225028|NCT01777776|3872829|FG002|Overall Study|Adverse Event|0
2225029|NCT01777776|3872830|FG003|Overall Study|Adverse Event|0
2225030|NCT01777776|3872827|FG000|Overall Study|Disease Progression|4
2225031|NCT01777776|3872828|FG001|Overall Study|Disease Progression|8
2225032|NCT01777776|3872829|FG002|Overall Study|Disease Progression|6
2225033|NCT01777776|3872830|FG003|Overall Study|Disease Progression|3
2225034|NCT01777776|3872827|FG000|Overall Study|Withdrawal by Subject|0
2225035|NCT01777776|3872828|FG001|Overall Study|Withdrawal by Subject|0
2225036|NCT01777776|3872829|FG002|Overall Study|Withdrawal by Subject|0
2225037|NCT01777776|3872830|FG003|Overall Study|Withdrawal by Subject|1
2225038|NCT01777932|3872849|FG000|Overall Study|Disease progression|136
2225039|NCT01777932|3872849|FG000|Overall Study|Death|3
2225040|NCT01777932|3872849|FG000|Overall Study|Adverse Event|34
2225041|NCT01777932|3872849|FG000|Overall Study|Lost to Follow-up|3
2225042|NCT01777932|3872849|FG000|Overall Study|Investigator decision|10
2225043|NCT01777932|3872849|FG000|Overall Study|Reimbursement limit|9
2194090|NCT01512264|3825817|FG000|Overall Study|Lost to Follow-up|0
2194091|NCT01512264|3825818|FG001|Overall Study|Lost to Follow-up|0
2194092|NCT01512264|3825819|FG002|Overall Study|Lost to Follow-up|0
2194093|NCT01512264|3825820|FG003|Overall Study|Lost to Follow-up|1
2194094|NCT01512368|3825830|FG000|Overall Study|Protocol Violation|3
2194095|NCT01512693|3825854|FG000|Overall Study|Withdrawal by Subject|0
2194096|NCT01512693|3825855|FG001|Overall Study|Withdrawal by Subject|1
2194097|NCT01512745|3825863|FG000|Overall Study|Adverse Event|22
2194098|NCT01512745|3825864|FG001|Overall Study|Adverse Event|3
2194099|NCT01512745|3825863|FG000|Overall Study|Death|9
2194100|NCT01512745|3825864|FG001|Overall Study|Death|13
2194101|NCT01512745|3825863|FG000|Overall Study|Withdrawal by Subject|2
2194102|NCT01512745|3825864|FG001|Overall Study|Withdrawal by Subject|2
2194103|NCT01512745|3825863|FG000|Overall Study|Lost to Follow-up|4
2194104|NCT01512745|3825864|FG001|Overall Study|Lost to Follow-up|0
2194105|NCT01512745|3825863|FG000|Overall Study|Lack of Efficacy|2
2194106|NCT01512745|3825864|FG001|Overall Study|Lack of Efficacy|2
2194107|NCT01512745|3825863|FG000|Overall Study|Protocol Violation|1
2194108|NCT01512745|3825864|FG001|Overall Study|Protocol Violation|0
2194109|NCT01512979|3825906|FG000|Overall Study|Adverse Event|2
2194110|NCT01512979|3825907|FG001|Overall Study|Adverse Event|2
2194111|NCT01512979|3825906|FG000|Overall Study|Protocol Violation|1
2194112|NCT01512979|3825907|FG001|Overall Study|Protocol Violation|4
2194113|NCT01512979|3825906|FG000|Overall Study|Lost to Follow-up|2
2194114|NCT01512979|3825907|FG001|Overall Study|Lost to Follow-up|5
2194115|NCT01512979|3825906|FG000|Overall Study|Withdrawal by Subject|1
2194116|NCT01512979|3825907|FG001|Overall Study|Withdrawal by Subject|2
2194117|NCT01512979|3825906|FG000|Overall Study|Reason other than stated above|13
2194118|NCT01512979|3825907|FG001|Overall Study|Reason other than stated above|9
2194119|NCT01513148|3825924|FG000|Overall Study|Protocol Violation|2
2194120|NCT01513148|3825925|FG001|Overall Study|Protocol Violation|2
2194121|NCT01513239|3825974|FG000|Period 1: Main Phase|Adverse Event|1
2194122|NCT01513239|3825975|FG001|Period 1: Main Phase|Adverse Event|1
2194123|NCT01513239|3825976|FG002|Period 1: Main Phase|Adverse Event|2
2194124|NCT01513239|3825977|FG003|Period 1: Main Phase|Adverse Event|0
2194125|NCT01513239|3825978|FG004|Period 1: Main Phase|Adverse Event|0
2194126|NCT01513239|3825979|FG005|Period 1: Main Phase|Adverse Event|0
2194127|NCT01513239|3825974|FG000|Period 1: Main Phase|Death|29
2194128|NCT01513239|3825975|FG001|Period 1: Main Phase|Death|22
2194129|NCT01513239|3825976|FG002|Period 1: Main Phase|Death|32
2194130|NCT01513239|3825977|FG003|Period 1: Main Phase|Death|0
2194131|NCT01513239|3825978|FG004|Period 1: Main Phase|Death|0
2194132|NCT01513239|3825979|FG005|Period 1: Main Phase|Death|0
2194133|NCT01513239|3825974|FG000|Period 1: Main Phase|Lost to Follow-up|11
2194134|NCT01513239|3825975|FG001|Period 1: Main Phase|Lost to Follow-up|10
2194135|NCT01513239|3825976|FG002|Period 1: Main Phase|Lost to Follow-up|6
2194136|NCT01513239|3825977|FG003|Period 1: Main Phase|Lost to Follow-up|0
2194137|NCT01513239|3825978|FG004|Period 1: Main Phase|Lost to Follow-up|0
2194138|NCT01513239|3825979|FG005|Period 1: Main Phase|Lost to Follow-up|0
2194139|NCT01513239|3825974|FG000|Period 1: Main Phase|Physician Decision|4
2194140|NCT01513239|3825975|FG001|Period 1: Main Phase|Physician Decision|4
2194141|NCT01513239|3825976|FG002|Period 1: Main Phase|Physician Decision|4
2194142|NCT01513239|3825977|FG003|Period 1: Main Phase|Physician Decision|0
2194143|NCT01513239|3825978|FG004|Period 1: Main Phase|Physician Decision|0
2194144|NCT01513239|3825979|FG005|Period 1: Main Phase|Physician Decision|0
2194145|NCT01513239|3825974|FG000|Period 1: Main Phase|Protocol Violation|2
2194146|NCT01513239|3825975|FG001|Period 1: Main Phase|Protocol Violation|2
2194147|NCT01513239|3825976|FG002|Period 1: Main Phase|Protocol Violation|2
2194148|NCT01513239|3825977|FG003|Period 1: Main Phase|Protocol Violation|0
2194149|NCT01513239|3825978|FG004|Period 1: Main Phase|Protocol Violation|0
2194150|NCT01513239|3825979|FG005|Period 1: Main Phase|Protocol Violation|0
2194151|NCT01513239|3825974|FG000|Period 1: Main Phase|Technical Problems|1
2194152|NCT01513239|3825975|FG001|Period 1: Main Phase|Technical Problems|2
2194153|NCT01513239|3825976|FG002|Period 1: Main Phase|Technical Problems|0
2194154|NCT01513239|3825977|FG003|Period 1: Main Phase|Technical Problems|0
2194155|NCT01513239|3825978|FG004|Period 1: Main Phase|Technical Problems|0
2194156|NCT01513239|3825979|FG005|Period 1: Main Phase|Technical Problems|0
2194157|NCT01513239|3825974|FG000|Period 1: Main Phase|Withdrawal by Subject|27
2194158|NCT01513239|3825975|FG001|Period 1: Main Phase|Withdrawal by Subject|29
2194159|NCT01513239|3825976|FG002|Period 1: Main Phase|Withdrawal by Subject|42
2194160|NCT01513239|3825977|FG003|Period 1: Main Phase|Withdrawal by Subject|0
2194161|NCT01513239|3825978|FG004|Period 1: Main Phase|Withdrawal by Subject|0
2194162|NCT01513239|3825979|FG005|Period 1: Main Phase|Withdrawal by Subject|0
2194163|NCT01513239|3825974|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
2194164|NCT01513239|3825975|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
2194165|NCT01513239|3825976|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
2194166|NCT01513239|3825977|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
2194167|NCT01513239|3825978|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
2194168|NCT01513239|3825979|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
2194169|NCT01513239|3825974|FG000|Period 2: 9 Month Extension Phase|Death|0
2194170|NCT01513239|3825975|FG001|Period 2: 9 Month Extension Phase|Death|0
2194171|NCT01513239|3825976|FG002|Period 2: 9 Month Extension Phase|Death|0
2194172|NCT01513239|3825977|FG003|Period 2: 9 Month Extension Phase|Death|2
2194173|NCT01513239|3825978|FG004|Period 2: 9 Month Extension Phase|Death|5
2194174|NCT01513239|3825979|FG005|Period 2: 9 Month Extension Phase|Death|2
2274154|NCT02293863|3955035|FG000|Overall Study|Lost to Follow-up|2
2194175|NCT01513239|3825974|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2194176|NCT01513239|3825975|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2194177|NCT01513239|3825976|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2194178|NCT01513239|3825977|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
2194179|NCT01513239|3825978|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
2194180|NCT01513239|3825979|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2194181|NCT01513239|3825974|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0
2194182|NCT01513239|3825975|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0
2194183|NCT01513239|3825976|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0
2194184|NCT01513239|3825977|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1
2194185|NCT01513239|3825978|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0
2194186|NCT01513239|3825979|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0
2194187|NCT01513239|3825974|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0
2194188|NCT01513239|3825975|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0
2194189|NCT01513239|3825976|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0
2194190|NCT01513239|3825977|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0
2194191|NCT01513239|3825978|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1
2194192|NCT01513239|3825979|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1
2194193|NCT01513291|3825993|FG000|Treatment Period|Adverse Event|8
2194194|NCT01513291|3825994|FG001|Treatment Period|Adverse Event|4
2194195|NCT01513291|3825995|FG002|Treatment Period|Adverse Event|0
2194196|NCT01513291|3825996|FG003|Treatment Period|Adverse Event|0
2194197|NCT01513291|3825997|FG004|Treatment Period|Adverse Event|0
2194198|NCT01513291|3825993|FG000|Treatment Period|Lack of Efficacy|3
2194199|NCT01513291|3825994|FG001|Treatment Period|Lack of Efficacy|0
2194200|NCT01513291|3825995|FG002|Treatment Period|Lack of Efficacy|0
2194201|NCT01513291|3825996|FG003|Treatment Period|Lack of Efficacy|0
2194202|NCT01513291|3825997|FG004|Treatment Period|Lack of Efficacy|0
2194203|NCT01513291|3825993|FG000|Treatment Period|Lost to Follow-up|2
2194204|NCT01513291|3825994|FG001|Treatment Period|Lost to Follow-up|3
2194205|NCT01513291|3825995|FG002|Treatment Period|Lost to Follow-up|0
2194206|NCT01513291|3825996|FG003|Treatment Period|Lost to Follow-up|0
2194207|NCT01513291|3825997|FG004|Treatment Period|Lost to Follow-up|0
2194208|NCT01513291|3825993|FG000|Treatment Period|Physician Decision|1
2194209|NCT01513291|3825994|FG001|Treatment Period|Physician Decision|0
2194210|NCT01513291|3825995|FG002|Treatment Period|Physician Decision|0
2194211|NCT01513291|3825996|FG003|Treatment Period|Physician Decision|0
2194212|NCT01513291|3825997|FG004|Treatment Period|Physician Decision|0
2194213|NCT01513291|3825993|FG000|Treatment Period|Protocol Violation|1
2194214|NCT01513291|3825994|FG001|Treatment Period|Protocol Violation|2
2194215|NCT01513291|3825995|FG002|Treatment Period|Protocol Violation|0
2194216|NCT01513291|3825996|FG003|Treatment Period|Protocol Violation|0
2194217|NCT01513291|3825997|FG004|Treatment Period|Protocol Violation|0
2194218|NCT01513291|3825993|FG000|Treatment Period|Withdrawal by Subject|8
2194219|NCT01513291|3825994|FG001|Treatment Period|Withdrawal by Subject|5
2194220|NCT01513291|3825995|FG002|Treatment Period|Withdrawal by Subject|0
2194221|NCT01513291|3825996|FG003|Treatment Period|Withdrawal by Subject|0
2194222|NCT01513291|3825997|FG004|Treatment Period|Withdrawal by Subject|0
2194223|NCT01513291|3825993|FG000|Treatment Period|Randomized not treated|0
2194224|NCT01513291|3825994|FG001|Treatment Period|Randomized not treated|2
2194225|NCT01513291|3825995|FG002|Treatment Period|Randomized not treated|0
2194226|NCT01513291|3825996|FG003|Treatment Period|Randomized not treated|0
2194227|NCT01513291|3825997|FG004|Treatment Period|Randomized not treated|0
2194228|NCT01513291|3825993|FG000|Run-out Period|Lost to Follow-up|0
2194229|NCT01513291|3825994|FG001|Run-out Period|Lost to Follow-up|0
2194230|NCT01513291|3825995|FG002|Run-out Period|Lost to Follow-up|0
2194231|NCT01513291|3825996|FG003|Run-out Period|Lost to Follow-up|1
2274155|NCT02293863|3955036|FG001|Overall Study|Lost to Follow-up|2
2194232|NCT01513291|3825997|FG004|Run-out Period|Lost to Follow-up|0
2194233|NCT01513291|3825993|FG000|Run-out Period|Withdrawal by Subject|0
2194234|NCT01513291|3825994|FG001|Run-out Period|Withdrawal by Subject|0
2194235|NCT01513291|3825995|FG002|Run-out Period|Withdrawal by Subject|0
2194236|NCT01513291|3825996|FG003|Run-out Period|Withdrawal by Subject|1
2194237|NCT01513291|3825997|FG004|Run-out Period|Withdrawal by Subject|0
2194238|NCT01513317|3826011|FG000|Overall Study|Withdrawal by Subject|15
2194239|NCT01513317|3826012|FG001|Overall Study|Withdrawal by Subject|4
2194240|NCT01513317|3826011|FG000|Overall Study|Death|1
2194241|NCT01513317|3826012|FG001|Overall Study|Death|1
2194242|NCT01513317|3826011|FG000|Overall Study|Study terminated by sponsor|18
2194243|NCT01513317|3826012|FG001|Overall Study|Study terminated by sponsor|18
2194244|NCT01513317|3826011|FG000|Overall Study|Other|0
2194245|NCT01513317|3826012|FG001|Overall Study|Other|1
2194246|NCT01513330|3826018|FG000|SenSura Mio First,|Adverse Event|2
2194247|NCT01513330|3826019|FG001|SenSura Mio First,|Adverse Event|0
2194248|NCT01513330|3826018|FG000|SenSura Mio First,|Lack of Efficacy|0
2194249|NCT01513330|3826019|FG001|SenSura Mio First,|Lack of Efficacy|1
2194250|NCT01513330|3826018|FG000|SenSura Mio First,|Withdrawal by Subject|1
2194251|NCT01513330|3826019|FG001|SenSura Mio First,|Withdrawal by Subject|1
2194252|NCT01513330|3826018|FG000|SenSura Mio First,|Other|1
2194253|NCT01513330|3826019|FG001|SenSura Mio First,|Other|0
2194254|NCT01513330|3826018|FG000|Standard Care First,|Lack of Efficacy|2
2194255|NCT01513330|3826019|FG001|Standard Care First,|Lack of Efficacy|2
2194256|NCT01513330|3826018|FG000|Standard Care First,|Withdrawal by Subject|1
2194257|NCT01513330|3826019|FG001|Standard Care First,|Withdrawal by Subject|2
2194258|NCT01513330|3826018|FG000|Standard Care First,|Other|1
2194259|NCT01513330|3826019|FG001|Standard Care First,|Other|0
2194260|NCT01513460|3826037|FG000|Overall Study|Death|0
2194261|NCT01513460|3826038|FG001|Overall Study|Death|0
2194262|NCT01513460|3826039|FG002|Overall Study|Death|1
2194263|NCT01513460|3826037|FG000|Overall Study|Lost to Follow-up|0
2194264|NCT01513460|3826038|FG001|Overall Study|Lost to Follow-up|0
2194265|NCT01513460|3826039|FG002|Overall Study|Lost to Follow-up|2
2194266|NCT01513460|3826037|FG000|Overall Study|Abnormal laboratory value|1
2194267|NCT01513460|3826038|FG001|Overall Study|Abnormal laboratory value|0
2194268|NCT01513460|3826039|FG002|Overall Study|Abnormal laboratory value|1
2194269|NCT01513460|3826037|FG000|Overall Study|Lack of Efficacy|1
2194270|NCT01513460|3826038|FG001|Overall Study|Lack of Efficacy|2
2194271|NCT01513460|3826039|FG002|Overall Study|Lack of Efficacy|5
2194272|NCT01513460|3826037|FG000|Overall Study|Protocol deviations|3
2194273|NCT01513460|3826038|FG001|Overall Study|Protocol deviations|4
2194274|NCT01513460|3826039|FG002|Overall Study|Protocol deviations|3
2194275|NCT01513460|3826037|FG000|Overall Study|Withdrawal by Subject|7
2194276|NCT01513460|3826038|FG001|Overall Study|Withdrawal by Subject|8
2194277|NCT01513460|3826039|FG002|Overall Study|Withdrawal by Subject|21
2194278|NCT01513460|3826037|FG000|Overall Study|Adverse Event|16
2194279|NCT01513460|3826038|FG001|Overall Study|Adverse Event|18
2194280|NCT01513460|3826039|FG002|Overall Study|Adverse Event|23
2194281|NCT01513460|3826037|FG000|Overall Study|Abnormal test procedure|1
2194282|NCT01513460|3826038|FG001|Overall Study|Abnormal test procedure|0
2194283|NCT01513460|3826039|FG002|Overall Study|Abnormal test procedure|0
2194284|NCT01513473|3826051|FG000|Main Trial (26 Weeks)|Adverse Event|0
2194285|NCT01513473|3826052|FG001|Main Trial (26 Weeks)|Adverse Event|2
2194286|NCT01513473|3826051|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4
2194287|NCT01513473|3826052|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7
2194288|NCT01513473|3826051|FG000|Main Trial (26 Weeks)|Unclassified|0
2194289|NCT01513473|3826052|FG001|Main Trial (26 Weeks)|Unclassified|2
2194290|NCT01513473|3826051|FG000|Extension Trial (26 Weeks)|Adverse Event|0
2194291|NCT01513473|3826052|FG001|Extension Trial (26 Weeks)|Adverse Event|1
2194292|NCT01513473|3826051|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1
2194293|NCT01513473|3826052|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5
2194294|NCT01513551|3826065|FG000|Overall Study|Death|0
2194295|NCT01513551|3826066|FG001|Overall Study|Death|1
2194296|NCT01513551|3826067|FG002|Overall Study|Death|0
2194297|NCT01513551|3826065|FG000|Overall Study|Lost to Follow-up|3
2194298|NCT01513551|3826066|FG001|Overall Study|Lost to Follow-up|5
2194299|NCT01513551|3826067|FG002|Overall Study|Lost to Follow-up|2
2194300|NCT01513551|3826065|FG000|Overall Study|Withdrawal by Subject|1
2194301|NCT01513551|3826066|FG001|Overall Study|Withdrawal by Subject|0
2194302|NCT01513551|3826067|FG002|Overall Study|Withdrawal by Subject|2
2194303|NCT01513551|3826065|FG000|Overall Study|Randomized but not vaccinated|0
2194304|NCT01513551|3826066|FG001|Overall Study|Randomized but not vaccinated|0
2194305|NCT01513551|3826067|FG002|Overall Study|Randomized but not vaccinated|1
2194306|NCT01513590|3826077|FG000|Overall Study|Adverse Event|2
2194307|NCT01513590|3826078|FG001|Overall Study|Adverse Event|3
2194308|NCT01513590|3826077|FG000|Overall Study|Withdrawal Criteria|3
2194309|NCT01513590|3826078|FG001|Overall Study|Withdrawal Criteria|0
2194310|NCT01513590|3826077|FG000|Overall Study|Unclassified|5
2194311|NCT01513590|3826078|FG001|Overall Study|Unclassified|10
2194312|NCT01513759|3826084|FG000|Overall Study|Protocol Violation|4
2194313|NCT01513759|3826084|FG000|Overall Study|Death during catheter placement|1
2194314|NCT01513967|3826109|FG000|Overall Study|Pregnancy|0
2194315|NCT01513967|3826110|FG001|Overall Study|Pregnancy|0
2194316|NCT01513967|3826111|FG002|Overall Study|Pregnancy|0
2194317|NCT01513967|3826112|FG003|Overall Study|Pregnancy|0
2194318|NCT01513967|3826113|FG004|Overall Study|Pregnancy|0
2194319|NCT01513967|3826114|FG005|Overall Study|Pregnancy|0
2194320|NCT01513967|3826115|FG006|Overall Study|Pregnancy|1
2194321|NCT01513967|3826116|FG007|Overall Study|Pregnancy|0
2194322|NCT01513967|3826109|FG000|Overall Study|missed a study visit|0
2194323|NCT01513967|3826110|FG001|Overall Study|missed a study visit|0
2194324|NCT01513967|3826111|FG002|Overall Study|missed a study visit|0
2194325|NCT01513967|3826112|FG003|Overall Study|missed a study visit|0
2194326|NCT01513967|3826113|FG004|Overall Study|missed a study visit|0
2194327|NCT01513967|3826114|FG005|Overall Study|missed a study visit|0
2194328|NCT01513967|3826115|FG006|Overall Study|missed a study visit|1
2194329|NCT01513967|3826116|FG007|Overall Study|missed a study visit|0
2194330|NCT01513967|3826109|FG000|Overall Study|excluded due to positive drug screen|0
2194331|NCT01513967|3826110|FG001|Overall Study|excluded due to positive drug screen|0
2194332|NCT01513967|3826111|FG002|Overall Study|excluded due to positive drug screen|0
2194333|NCT01513967|3826112|FG003|Overall Study|excluded due to positive drug screen|0
2194334|NCT01513967|3826113|FG004|Overall Study|excluded due to positive drug screen|0
2194335|NCT01513967|3826114|FG005|Overall Study|excluded due to positive drug screen|0
2194336|NCT01513967|3826115|FG006|Overall Study|excluded due to positive drug screen|0
2194337|NCT01513967|3826116|FG007|Overall Study|excluded due to positive drug screen|2
2194338|NCT01513967|3826109|FG000|Overall Study|Physician Decision|0
2194339|NCT01513967|3826110|FG001|Overall Study|Physician Decision|0
2194340|NCT01513967|3826111|FG002|Overall Study|Physician Decision|0
2194341|NCT01513967|3826112|FG003|Overall Study|Physician Decision|0
2194342|NCT01513967|3826113|FG004|Overall Study|Physician Decision|0
2194343|NCT01513967|3826114|FG005|Overall Study|Physician Decision|1
2194344|NCT01513967|3826115|FG006|Overall Study|Physician Decision|0
2194345|NCT01513967|3826116|FG007|Overall Study|Physician Decision|0
2194346|NCT01514136|3826136|FG000|Test Period 1; Test A|Protocol Violation|1
2194347|NCT01514136|3826137|FG001|Test Period 1; Test A|Protocol Violation|0
2194348|NCT01514136|3826138|FG002|Test Period 1; Test A|Protocol Violation|0
2194349|NCT01514136|3826139|FG003|Test Period 1; Test A|Protocol Violation|0
2194350|NCT01514136|3826140|FG004|Test Period 1; Test A|Protocol Violation|0
2194351|NCT01514136|3826141|FG005|Test Period 1; Test A|Protocol Violation|0
2194352|NCT01514136|3826142|FG006|Test Period 1; Test A|Protocol Violation|0
2194353|NCT01514136|3826143|FG007|Test Period 1; Test A|Protocol Violation|0
2194354|NCT01514136|3826136|FG000|Test Period 1; Test A|Break from study holiday|2
2194355|NCT01514136|3826137|FG001|Test Period 1; Test A|Break from study holiday|0
2194356|NCT01514136|3826138|FG002|Test Period 1; Test A|Break from study holiday|0
2194357|NCT01514136|3826139|FG003|Test Period 1; Test A|Break from study holiday|0
2194358|NCT01514136|3826140|FG004|Test Period 1; Test A|Break from study holiday|0
2194359|NCT01514136|3826141|FG005|Test Period 1; Test A|Break from study holiday|0
2194360|NCT01514136|3826142|FG006|Test Period 1; Test A|Break from study holiday|0
2194361|NCT01514136|3826143|FG007|Test Period 1; Test A|Break from study holiday|0
2194362|NCT01514136|3826136|FG000|Test Period 1; Test B|Withdrawal by Subject|0
2194363|NCT01514136|3826137|FG001|Test Period 1; Test B|Withdrawal by Subject|1
2194364|NCT01514136|3826138|FG002|Test Period 1; Test B|Withdrawal by Subject|0
2194365|NCT01514136|3826139|FG003|Test Period 1; Test B|Withdrawal by Subject|0
2194366|NCT01514136|3826140|FG004|Test Period 1; Test B|Withdrawal by Subject|0
2194367|NCT01514136|3826141|FG005|Test Period 1; Test B|Withdrawal by Subject|0
2194368|NCT01514136|3826142|FG006|Test Period 1; Test B|Withdrawal by Subject|0
2194369|NCT01514136|3826143|FG007|Test Period 1; Test B|Withdrawal by Subject|0
2194370|NCT01514136|3826136|FG000|Test Period 1; Test D|Subject took a break due to holiday|0
2194371|NCT01514136|3826137|FG001|Test Period 1; Test D|Subject took a break due to holiday|0
2194372|NCT01514136|3826138|FG002|Test Period 1; Test D|Subject took a break due to holiday|0
2194373|NCT01514136|3826139|FG003|Test Period 1; Test D|Subject took a break due to holiday|2
2194374|NCT01514136|3826140|FG004|Test Period 1; Test D|Subject took a break due to holiday|0
2194375|NCT01514136|3826141|FG005|Test Period 1; Test D|Subject took a break due to holiday|0
2194376|NCT01514136|3826142|FG006|Test Period 1; Test D|Subject took a break due to holiday|0
2194377|NCT01514136|3826143|FG007|Test Period 1; Test D|Subject took a break due to holiday|0
2194378|NCT01514136|3826136|FG000|Test Period 2; Test A*|Adverse Event|0
2194379|NCT01514136|3826137|FG001|Test Period 2; Test A*|Adverse Event|0
2194380|NCT01514136|3826138|FG002|Test Period 2; Test A*|Adverse Event|0
2194381|NCT01514136|3826139|FG003|Test Period 2; Test A*|Adverse Event|0
2194382|NCT01514136|3826140|FG004|Test Period 2; Test A*|Adverse Event|1
2194383|NCT01514136|3826141|FG005|Test Period 2; Test A*|Adverse Event|0
2194384|NCT01514136|3826142|FG006|Test Period 2; Test A*|Adverse Event|0
2194385|NCT01514136|3826143|FG007|Test Period 2; Test A*|Adverse Event|0
2194386|NCT01514136|3826136|FG000|Test Period 2; Test A*|Holiday|0
2194387|NCT01514136|3826137|FG001|Test Period 2; Test A*|Holiday|0
2194388|NCT01514136|3826138|FG002|Test Period 2; Test A*|Holiday|0
2194389|NCT01514136|3826139|FG003|Test Period 2; Test A*|Holiday|0
2194390|NCT01514136|3826140|FG004|Test Period 2; Test A*|Holiday|1
2194391|NCT01514136|3826141|FG005|Test Period 2; Test A*|Holiday|0
2194392|NCT01514136|3826142|FG006|Test Period 2; Test A*|Holiday|0
2194393|NCT01514136|3826143|FG007|Test Period 2; Test A*|Holiday|0
2194394|NCT01514136|3826136|FG000|Test Period 2; Test B*|Withdrawal by Subject|0
2194395|NCT01514136|3826137|FG001|Test Period 2; Test B*|Withdrawal by Subject|0
2194396|NCT01514136|3826138|FG002|Test Period 2; Test B*|Withdrawal by Subject|0
2194397|NCT01514136|3826139|FG003|Test Period 2; Test B*|Withdrawal by Subject|0
2194398|NCT01514136|3826140|FG004|Test Period 2; Test B*|Withdrawal by Subject|0
2194399|NCT01514136|3826141|FG005|Test Period 2; Test B*|Withdrawal by Subject|2
2194400|NCT01514136|3826142|FG006|Test Period 2; Test B*|Withdrawal by Subject|0
2194401|NCT01514136|3826143|FG007|Test Period 2; Test B*|Withdrawal by Subject|0
2194402|NCT01514136|3826136|FG000|Test Period 2; Test C*|Withdrawal by Subject|0
2194403|NCT01514136|3826137|FG001|Test Period 2; Test C*|Withdrawal by Subject|0
2194404|NCT01514136|3826138|FG002|Test Period 2; Test C*|Withdrawal by Subject|0
2194405|NCT01514136|3826139|FG003|Test Period 2; Test C*|Withdrawal by Subject|0
2194406|NCT01514136|3826140|FG004|Test Period 2; Test C*|Withdrawal by Subject|0
2194407|NCT01514136|3826141|FG005|Test Period 2; Test C*|Withdrawal by Subject|0
2194408|NCT01514136|3826142|FG006|Test Period 2; Test C*|Withdrawal by Subject|1
2194409|NCT01514136|3826143|FG007|Test Period 2; Test C*|Withdrawal by Subject|0
2194410|NCT01514136|3826136|FG000|Test Period 2; Test C*|holiday|0
2194411|NCT01514136|3826137|FG001|Test Period 2; Test C*|holiday|0
2194412|NCT01514136|3826138|FG002|Test Period 2; Test C*|holiday|0
2194413|NCT01514136|3826139|FG003|Test Period 2; Test C*|holiday|0
2194414|NCT01514136|3826140|FG004|Test Period 2; Test C*|holiday|0
2194415|NCT01514136|3826141|FG005|Test Period 2; Test C*|holiday|0
2194416|NCT01514136|3826142|FG006|Test Period 2; Test C*|holiday|1
2194417|NCT01514136|3826143|FG007|Test Period 2; Test C*|holiday|0
2194418|NCT01514136|3826136|FG000|Test Period 2; Test C*|Protocol Violation|0
2225044|NCT01777932|3872849|FG000|Overall Study|Patient refused further treatment|10
2332430|NCT03196349|4056029|FG000|Overall Study|Study Terminated early|15
2332431|NCT03196349|4056030|FG001|Overall Study|Study Terminated early|9
2332432|NCT03196349|4056031|FG002|Overall Study|Study Terminated early|11
2332433|NCT03196505|4056041|FG000|Overall Study|Physician Decision|26
2332434|NCT03196505|4056042|FG001|Overall Study|Physician Decision|26
2332435|NCT03196635|4056048|FG000|Overall Study|Withdrawal by Subject|1
2332436|NCT03196791|4056068|FG000|Overall Study|Protocol Violation|7
2332437|NCT03196791|4056069|FG001|Overall Study|Protocol Violation|3
2332438|NCT03196791|4056068|FG000|Overall Study|Withdrawal by Subject|3
2332439|NCT03196791|4056069|FG001|Overall Study|Withdrawal by Subject|2
2352739|NCT03739866|4102875|FG006|Overall Study|Lost to Follow-up|0
2352740|NCT03739866|4102876|FG007|Overall Study|Lost to Follow-up|0
2352741|NCT03739866|4102869|FG000|Overall Study|Enrolled but not treated|0
2352742|NCT03739866|4102870|FG001|Overall Study|Enrolled but not treated|0
2352743|NCT03739866|4102871|FG002|Overall Study|Enrolled but not treated|1
2352744|NCT03739866|4102872|FG003|Overall Study|Enrolled but not treated|0
2352745|NCT03739866|4102873|FG004|Overall Study|Enrolled but not treated|1
2352746|NCT03739866|4102874|FG005|Overall Study|Enrolled but not treated|0
2352747|NCT03739866|4102875|FG006|Overall Study|Enrolled but not treated|0
2352748|NCT03739866|4102876|FG007|Overall Study|Enrolled but not treated|0
2352749|NCT03739528|4102904|FG000|Overall Study|Not treated|8
2352750|NCT03739528|4102905|FG001|Overall Study|Not treated|12
2352751|NCT03739528|4102904|FG000|Overall Study|Treatment and study discontinued|6
2352752|NCT03739528|4102905|FG001|Overall Study|Treatment and study discontinued|2
2352753|NCT03739528|4102904|FG000|Overall Study|Treatment discontinued + study completed|1
2352754|NCT03739528|4102905|FG001|Overall Study|Treatment discontinued + study completed|3
2352755|NCT03739242|4102916|FG000|Overall Study|Withdrawal by Subject|1
2352756|NCT03739242|4102917|FG001|Overall Study|Withdrawal by Subject|1
2352757|NCT03739242|4102916|FG000|Overall Study|Protocol Violation|0
2352758|NCT03739242|4102917|FG001|Overall Study|Protocol Violation|1
2352759|NCT03738865|4102925|FG000|Overall Study|Withdrawal by Subject|3
2352760|NCT03738865|4102926|FG001|Overall Study|Withdrawal by Subject|3
2352761|NCT03738865|4102925|FG000|Overall Study|Adverse Event|2
2352762|NCT03738865|4102926|FG001|Overall Study|Adverse Event|0
2352763|NCT03738865|4102925|FG000|Overall Study|Physician Decision|0
2352764|NCT03738865|4102926|FG001|Overall Study|Physician Decision|1
2352765|NCT03738475|4102943|FG000|Overall Study|Participant Non-Compliance|1
2352766|NCT03738475|4102944|FG001|Overall Study|Participant Non-Compliance|0
2352767|NCT03738241|4102960|FG000|Overall Study|Withdrawal by Subject|0
2352768|NCT03738241|4102961|FG001|Overall Study|Withdrawal by Subject|0
2352769|NCT03738241|4102962|FG002|Overall Study|Withdrawal by Subject|0
2352770|NCT03738241|4102963|FG003|Overall Study|Withdrawal by Subject|0
2352771|NCT03738241|4102964|FG004|Overall Study|Withdrawal by Subject|0
2352772|NCT03738241|4102965|FG005|Overall Study|Withdrawal by Subject|0
2352773|NCT03738241|4102966|FG006|Overall Study|Withdrawal by Subject|0
2352774|NCT03738241|4102967|FG007|Overall Study|Withdrawal by Subject|0
2352775|NCT03738241|4102968|FG008|Overall Study|Withdrawal by Subject|0
2352776|NCT03738241|4102969|FG009|Overall Study|Withdrawal by Subject|1
2352777|NCT03738241|4102960|FG000|Overall Study|Physician Decision|0
2352778|NCT03738241|4102961|FG001|Overall Study|Physician Decision|0
2352779|NCT03738241|4102962|FG002|Overall Study|Physician Decision|0
2352780|NCT03738241|4102963|FG003|Overall Study|Physician Decision|0
2352781|NCT03738241|4102964|FG004|Overall Study|Physician Decision|0
2352782|NCT03738241|4102965|FG005|Overall Study|Physician Decision|0
2352783|NCT03738241|4102966|FG006|Overall Study|Physician Decision|0
2352784|NCT03738241|4102967|FG007|Overall Study|Physician Decision|0
2352785|NCT03738241|4102968|FG008|Overall Study|Physician Decision|1
2352786|NCT03738241|4102969|FG009|Overall Study|Physician Decision|0
2352787|NCT03738241|4102960|FG000|Overall Study|Adverse Event|1
2352788|NCT03738241|4102961|FG001|Overall Study|Adverse Event|0
2352789|NCT03738241|4102962|FG002|Overall Study|Adverse Event|0
2352790|NCT03738241|4102963|FG003|Overall Study|Adverse Event|0
2352791|NCT03738241|4102964|FG004|Overall Study|Adverse Event|0
2352792|NCT03738241|4102965|FG005|Overall Study|Adverse Event|0
2352793|NCT03738241|4102966|FG006|Overall Study|Adverse Event|0
2352794|NCT03738241|4102967|FG007|Overall Study|Adverse Event|0
2352795|NCT03738241|4102968|FG008|Overall Study|Adverse Event|0
2194419|NCT01514136|3826137|FG001|Test Period 2; Test C*|Protocol Violation|0
2194420|NCT01514136|3826138|FG002|Test Period 2; Test C*|Protocol Violation|0
2194421|NCT01514136|3826139|FG003|Test Period 2; Test C*|Protocol Violation|0
2194422|NCT01514136|3826140|FG004|Test Period 2; Test C*|Protocol Violation|0
2194423|NCT01514136|3826141|FG005|Test Period 2; Test C*|Protocol Violation|0
2194424|NCT01514136|3826142|FG006|Test Period 2; Test C*|Protocol Violation|1
2194425|NCT01514136|3826143|FG007|Test Period 2; Test C*|Protocol Violation|0
2194426|NCT01514201|3826198|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
2194427|NCT01514201|3826199|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
2194428|NCT01514201|3826200|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
2194429|NCT01514201|3826201|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
2352796|NCT03738241|4102969|FG009|Overall Study|Adverse Event|0
2352797|NCT03736785|4103026|FG000|Overall Study|Adverse Event|1
2194430|NCT01514201|3826198|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
2194431|NCT01514201|3826199|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
2194432|NCT01514201|3826200|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
2194433|NCT01514201|3826201|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
2194434|NCT01514201|3826198|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
2194435|NCT01514201|3826199|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
2194436|NCT01514201|3826200|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
2194437|NCT01514201|3826201|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2194438|NCT01514201|3826198|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
2194439|NCT01514201|3826199|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
2194440|NCT01514201|3826200|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2194441|NCT01514201|3826201|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2194442|NCT01514201|3826198|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
2194443|NCT01514201|3826199|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
2194444|NCT01514201|3826200|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
2194445|NCT01514201|3826201|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
2194446|NCT01514201|3826198|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
2194447|NCT01514201|3826199|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
2194448|NCT01514201|3826200|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
2194449|NCT01514201|3826201|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
2194450|NCT01514201|3826198|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0
2194451|NCT01514201|3826199|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0
2194452|NCT01514201|3826200|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0
2194453|NCT01514201|3826201|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1
2194454|NCT01514201|3826198|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
2194455|NCT01514201|3826199|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
2194456|NCT01514201|3826200|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
2194457|NCT01514201|3826201|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
2194458|NCT01514201|3826198|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
2194459|NCT01514201|3826199|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
2194460|NCT01514201|3826200|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
2194461|NCT01514201|3826201|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
2194462|NCT01514201|3826198|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
2225045|NCT01777997|3872857|FG000|12 Week lead-in of no ART|Severe debilitation|2
2225046|NCT01777997|3872857|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
2225047|NCT01777997|3872857|FG000|Weeks 48 to 72/96 on ART|Death|1
2225048|NCT01777997|3872857|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
2225049|NCT01778010|3872861|FG000|Overall Study|Withdrawal by Subject|2
2225050|NCT01778010|3872861|FG000|Overall Study|abnormal ECG before meds|1
2225051|NCT01778010|3872861|FG000|Overall Study|Arrested|1
2225052|NCT01778010|3872861|FG000|Overall Study|rash while on placebo|1
2225053|NCT01778023|3872880|FG000|Overall Study|Withdrawal by Subject|0
2225054|NCT01778023|3872881|FG001|Overall Study|Withdrawal by Subject|3
2225055|NCT01778049|3872889|FG000|Open Label Treatment Period|Adverse Event|5
2225056|NCT01778049|3872890|FG001|Open Label Treatment Period|Adverse Event|15
2225057|NCT01778049|3872891|FG002|Open Label Treatment Period|Adverse Event|0
2225058|NCT01778049|3872892|FG003|Open Label Treatment Period|Adverse Event|0
2225059|NCT01778049|3872893|FG004|Open Label Treatment Period|Adverse Event|0
2225060|NCT01778049|3872894|FG005|Open Label Treatment Period|Adverse Event|0
2225061|NCT01778049|3872889|FG000|Open Label Treatment Period|Lack of Efficacy|1
2225062|NCT01778049|3872890|FG001|Open Label Treatment Period|Lack of Efficacy|1
2225063|NCT01778049|3872891|FG002|Open Label Treatment Period|Lack of Efficacy|0
2225064|NCT01778049|3872892|FG003|Open Label Treatment Period|Lack of Efficacy|0
2225065|NCT01778049|3872893|FG004|Open Label Treatment Period|Lack of Efficacy|0
2225066|NCT01778049|3872894|FG005|Open Label Treatment Period|Lack of Efficacy|0
2225067|NCT01778049|3872889|FG000|Open Label Treatment Period|Protocol Violation|5
2225068|NCT01778049|3872890|FG001|Open Label Treatment Period|Protocol Violation|5
2225069|NCT01778049|3872891|FG002|Open Label Treatment Period|Protocol Violation|0
2225070|NCT01778049|3872892|FG003|Open Label Treatment Period|Protocol Violation|0
2225071|NCT01778049|3872893|FG004|Open Label Treatment Period|Protocol Violation|0
2225072|NCT01778049|3872894|FG005|Open Label Treatment Period|Protocol Violation|0
2225073|NCT01778049|3872889|FG000|Open Label Treatment Period|Lost to Follow-up|4
2225074|NCT01778049|3872890|FG001|Open Label Treatment Period|Lost to Follow-up|3
2225075|NCT01778049|3872891|FG002|Open Label Treatment Period|Lost to Follow-up|0
2225076|NCT01778049|3872892|FG003|Open Label Treatment Period|Lost to Follow-up|0
2225077|NCT01778049|3872893|FG004|Open Label Treatment Period|Lost to Follow-up|0
2225078|NCT01778049|3872894|FG005|Open Label Treatment Period|Lost to Follow-up|0
2225079|NCT01778049|3872889|FG000|Open Label Treatment Period|Withdrawal by Subject|4
2225080|NCT01778049|3872890|FG001|Open Label Treatment Period|Withdrawal by Subject|10
2225081|NCT01778049|3872891|FG002|Open Label Treatment Period|Withdrawal by Subject|0
2225082|NCT01778049|3872892|FG003|Open Label Treatment Period|Withdrawal by Subject|0
2225083|NCT01778049|3872893|FG004|Open Label Treatment Period|Withdrawal by Subject|0
2225084|NCT01778049|3872894|FG005|Open Label Treatment Period|Withdrawal by Subject|0
2194463|NCT01514201|3826199|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
2194464|NCT01514201|3826200|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
2194465|NCT01514201|3826201|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
2194466|NCT01514201|3826198|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2194467|NCT01514201|3826199|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2194468|NCT01514201|3826200|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2194469|NCT01514201|3826201|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
2194470|NCT01514201|3826198|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2194471|NCT01514201|3826199|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2194472|NCT01514201|3826200|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2194473|NCT01514201|3826201|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
2194474|NCT01514240|3826223|FG000|Overall Study|Adverse Event|4
2194475|NCT01514240|3826224|FG001|Overall Study|Adverse Event|4
2194476|NCT01514240|3826223|FG000|Overall Study|Subject Decision|2
2194477|NCT01514240|3826224|FG001|Overall Study|Subject Decision|7
2194478|NCT01514357|3826253|FG000|Overall Study|Screen failure|2
2194479|NCT01514357|3826254|FG001|Overall Study|Screen failure|0
2225085|NCT01778049|3872889|FG000|Open Label Treatment Period|Not treated|2
2225086|NCT01778049|3872890|FG001|Open Label Treatment Period|Not treated|1
2225087|NCT01778049|3872891|FG002|Open Label Treatment Period|Not treated|0
2225088|NCT01778049|3872892|FG003|Open Label Treatment Period|Not treated|0
2225089|NCT01778049|3872893|FG004|Open Label Treatment Period|Not treated|0
2225090|NCT01778049|3872894|FG005|Open Label Treatment Period|Not treated|0
2225091|NCT01778049|3872889|FG000|Open Label Treatment Period|Other reason not defined above|77
2225092|NCT01778049|3872890|FG001|Open Label Treatment Period|Other reason not defined above|94
2225093|NCT01778049|3872891|FG002|Open Label Treatment Period|Other reason not defined above|0
2225094|NCT01778049|3872892|FG003|Open Label Treatment Period|Other reason not defined above|0
2225095|NCT01778049|3872893|FG004|Open Label Treatment Period|Other reason not defined above|0
2225096|NCT01778049|3872894|FG005|Open Label Treatment Period|Other reason not defined above|0
2225097|NCT01778049|3872889|FG000|Double Blind Treatment Period|Adverse Event|0
2225098|NCT01778049|3872890|FG001|Double Blind Treatment Period|Adverse Event|0
2225099|NCT01778049|3872891|FG002|Double Blind Treatment Period|Adverse Event|4
2225100|NCT01778049|3872892|FG003|Double Blind Treatment Period|Adverse Event|5
2225101|NCT01778049|3872893|FG004|Double Blind Treatment Period|Adverse Event|3
2225102|NCT01778049|3872894|FG005|Double Blind Treatment Period|Adverse Event|2
2225103|NCT01778049|3872889|FG000|Double Blind Treatment Period|Lack of Efficacy|0
2225104|NCT01778049|3872890|FG001|Double Blind Treatment Period|Lack of Efficacy|0
2225105|NCT01778049|3872891|FG002|Double Blind Treatment Period|Lack of Efficacy|0
2225106|NCT01778049|3872892|FG003|Double Blind Treatment Period|Lack of Efficacy|0
2225107|NCT01778049|3872893|FG004|Double Blind Treatment Period|Lack of Efficacy|0
2225108|NCT01778049|3872894|FG005|Double Blind Treatment Period|Lack of Efficacy|1
2225109|NCT01778049|3872889|FG000|Double Blind Treatment Period|Protocol Violation|0
2225110|NCT01778049|3872890|FG001|Double Blind Treatment Period|Protocol Violation|0
2225111|NCT01778049|3872891|FG002|Double Blind Treatment Period|Protocol Violation|2
2225112|NCT01778049|3872892|FG003|Double Blind Treatment Period|Protocol Violation|0
2225113|NCT01778049|3872893|FG004|Double Blind Treatment Period|Protocol Violation|0
2225114|NCT01778049|3872894|FG005|Double Blind Treatment Period|Protocol Violation|0
2225115|NCT01778049|3872889|FG000|Double Blind Treatment Period|Lost to Follow-up|0
2225116|NCT01778049|3872890|FG001|Double Blind Treatment Period|Lost to Follow-up|0
2225117|NCT01778049|3872891|FG002|Double Blind Treatment Period|Lost to Follow-up|4
2225118|NCT01778049|3872892|FG003|Double Blind Treatment Period|Lost to Follow-up|1
2225119|NCT01778049|3872893|FG004|Double Blind Treatment Period|Lost to Follow-up|5
2225120|NCT01778049|3872894|FG005|Double Blind Treatment Period|Lost to Follow-up|2
2225121|NCT01778049|3872889|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
2225122|NCT01778049|3872890|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
2225123|NCT01778049|3872891|FG002|Double Blind Treatment Period|Withdrawal by Subject|1
2225124|NCT01778049|3872892|FG003|Double Blind Treatment Period|Withdrawal by Subject|2
2225125|NCT01778049|3872893|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
2225126|NCT01778049|3872894|FG005|Double Blind Treatment Period|Withdrawal by Subject|1
2225127|NCT01778049|3872889|FG000|Double Blind Treatment Period|Not treated|0
2225128|NCT01778049|3872890|FG001|Double Blind Treatment Period|Not treated|0
2225129|NCT01778049|3872891|FG002|Double Blind Treatment Period|Not treated|0
2225130|NCT01778049|3872892|FG003|Double Blind Treatment Period|Not treated|2
2225131|NCT01778049|3872893|FG004|Double Blind Treatment Period|Not treated|2
2225132|NCT01778049|3872894|FG005|Double Blind Treatment Period|Not treated|0
2225133|NCT01778049|3872889|FG000|Double Blind Treatment Period|Other reason not defined above|0
2225134|NCT01778049|3872890|FG001|Double Blind Treatment Period|Other reason not defined above|0
2225135|NCT01778049|3872891|FG002|Double Blind Treatment Period|Other reason not defined above|4
2225136|NCT01778049|3872892|FG003|Double Blind Treatment Period|Other reason not defined above|2
2225137|NCT01778049|3872893|FG004|Double Blind Treatment Period|Other reason not defined above|2
2225138|NCT01778049|3872894|FG005|Double Blind Treatment Period|Other reason not defined above|1
2225139|NCT01778062|3872908|FG000|Overall Study|Adverse Event|1
2225140|NCT01778062|3872909|FG001|Overall Study|Adverse Event|3
2225141|NCT01778062|3872908|FG000|Overall Study|Consent Withdrawal|1
2194480|NCT01514357|3826253|FG000|Overall Study|Withdrawal by Subject|2
2194481|NCT01514357|3826254|FG001|Overall Study|Withdrawal by Subject|0
2194482|NCT01514370|3826262|FG000|Overall Study|Protocol Violation|2
2194483|NCT01514370|3826263|FG001|Overall Study|Protocol Violation|3
2194484|NCT01514370|3826262|FG000|Overall Study|Lost to Follow-up|0
2194485|NCT01514370|3826263|FG001|Overall Study|Lost to Follow-up|2
2194486|NCT01514370|3826262|FG000|Overall Study|Withdrawal by Subject|2
2194487|NCT01514370|3826263|FG001|Overall Study|Withdrawal by Subject|1
2194488|NCT01514370|3826262|FG000|Overall Study|Adverse Event|1
2194489|NCT01514370|3826263|FG001|Overall Study|Adverse Event|3
2194490|NCT01514370|3826262|FG000|Overall Study|Other|6
2194491|NCT01514370|3826263|FG001|Overall Study|Other|7
2194492|NCT01514422|3826280|FG000|Overall Study|Lost to Follow-up|1
2194493|NCT01514448|3826286|FG000|Overall Study|Death|7
2194494|NCT01514448|3826287|FG001|Overall Study|Death|8
2194495|NCT01514448|3826286|FG000|Overall Study|Withdrawal by Subject|2
2194496|NCT01514448|3826287|FG001|Overall Study|Withdrawal by Subject|0
2194497|NCT01514448|3826286|FG000|Overall Study|Lost to Follow-up|2
2194498|NCT01514448|3826287|FG001|Overall Study|Lost to Follow-up|0
2194499|NCT01514448|3826286|FG000|Overall Study|New Cancer Therapy|1
2194500|NCT01514448|3826287|FG001|Overall Study|New Cancer Therapy|0
2194501|NCT01514461|3826297|FG000|Overall Study|Adverse Event|2
2194502|NCT01514461|3826298|FG001|Overall Study|Adverse Event|1
2194503|NCT01514461|3826299|FG002|Overall Study|Adverse Event|3
2194504|NCT01514461|3826297|FG000|Overall Study|Physician Decision|1
2194505|NCT01514461|3826298|FG001|Overall Study|Physician Decision|1
2194506|NCT01514461|3826299|FG002|Overall Study|Physician Decision|0
2194507|NCT01514461|3826297|FG000|Overall Study|Patient/guardian decision|1
2194508|NCT01514461|3826298|FG001|Overall Study|Patient/guardian decision|1
2194509|NCT01514461|3826299|FG002|Overall Study|Patient/guardian decision|1
2194510|NCT01514461|3826297|FG000|Overall Study|Death|1
2194511|NCT01514461|3826298|FG001|Overall Study|Death|0
2194512|NCT01514461|3826299|FG002|Overall Study|Death|0
2194513|NCT01514682|3826325|FG000|Overall Study|Withdrawal by Subject|2
2194514|NCT01514682|3826326|FG001|Overall Study|Withdrawal by Subject|3
2194515|NCT01514682|3826325|FG000|Overall Study|Physician Decision|4
2194516|NCT01514682|3826326|FG001|Overall Study|Physician Decision|3
2194517|NCT01514760|3826336|FG000|Overall Study|Lost to Follow-up|2
2194518|NCT01514864|3826351|FG000|Overall Study|Disease progression|7
2194519|NCT01514864|3826352|FG001|Overall Study|Disease progression|5
2194520|NCT01514864|3826351|FG000|Overall Study|Study drug toxicity|2
2194521|NCT01514864|3826352|FG001|Overall Study|Study drug toxicity|0
2194522|NCT01515189|3826399|FG000|Induction|Disease Progression|109
2194523|NCT01515189|3826400|FG001|Induction|Disease Progression|155
2194524|NCT01515189|3826399|FG000|Induction|Study drug toxicity|86
2194525|NCT01515189|3826400|FG001|Induction|Study drug toxicity|36
2194526|NCT01515189|3826399|FG000|Induction|Death|24
2194527|NCT01515189|3826400|FG001|Induction|Death|17
2194528|NCT01515189|3826399|FG000|Induction|Adverse Event|14
2194529|NCT01515189|3826400|FG001|Induction|Adverse Event|9
2194530|NCT01515189|3826399|FG000|Induction|Withdrawal by Subject|3
2194531|NCT01515189|3826400|FG001|Induction|Withdrawal by Subject|9
2194532|NCT01515189|3826399|FG000|Induction|No longer meets study criteria|0
2194533|NCT01515189|3826400|FG001|Induction|No longer meets study criteria|2
2194534|NCT01515189|3826399|FG000|Induction|Lost to Follow-up|1
2194535|NCT01515189|3826400|FG001|Induction|Lost to Follow-up|0
2194536|NCT01515189|3826399|FG000|Induction|Other|0
2194537|NCT01515189|3826400|FG001|Induction|Other|4
2194538|NCT01515189|3826399|FG000|First Re-Induction Phase|Disease progression|6
2194539|NCT01515189|3826400|FG001|First Re-Induction Phase|Disease progression|14
2194540|NCT01515189|3826399|FG000|First Re-Induction Phase|Study drug toxicity|5
2194541|NCT01515189|3826400|FG001|First Re-Induction Phase|Study drug toxicity|0
2194542|NCT01515189|3826399|FG000|First Re-Induction Phase|Withdrawal by Subject|1
2194543|NCT01515189|3826400|FG001|First Re-Induction Phase|Withdrawal by Subject|1
2194544|NCT01515189|3826399|FG000|First Re-Induction Phase|No longer meets study criteria|1
2194545|NCT01515189|3826400|FG001|First Re-Induction Phase|No longer meets study criteria|0
2194546|NCT01515189|3826399|FG000|First Re-Induction Phase|Other|1
2194547|NCT01515189|3826400|FG001|First Re-Induction Phase|Other|0
2194548|NCT01515306|3826408|FG000|Overall Study|Adverse Event|2
2194549|NCT01515306|3826409|FG001|Overall Study|Adverse Event|0
2194550|NCT01515306|3826408|FG000|Overall Study|Progressive Disease|1
2194551|NCT01515306|3826409|FG001|Overall Study|Progressive Disease|0
2194552|NCT01515306|3826408|FG000|Overall Study|Ongoing receiving treatment|9
2194553|NCT01515306|3826409|FG001|Overall Study|Ongoing receiving treatment|14
2194554|NCT01515319|3826427|FG000|Overall Study|Withdrawal by Subject|0
2194555|NCT01515319|3826428|FG001|Overall Study|Withdrawal by Subject|0
2194556|NCT01515319|3826429|FG002|Overall Study|Withdrawal by Subject|0
2194557|NCT01515319|3826430|FG003|Overall Study|Withdrawal by Subject|0
2194558|NCT01515319|3826431|FG004|Overall Study|Withdrawal by Subject|0
2194559|NCT01515319|3826432|FG005|Overall Study|Withdrawal by Subject|0
2194560|NCT01515319|3826433|FG006|Overall Study|Withdrawal by Subject|1
2194561|NCT01515319|3826434|FG007|Overall Study|Withdrawal by Subject|0
2194562|NCT01515319|3826435|FG008|Overall Study|Withdrawal by Subject|0
2194563|NCT01515319|3826436|FG009|Overall Study|Withdrawal by Subject|0
2194564|NCT01515319|3826427|FG000|Overall Study|Adverse Event|0
2194565|NCT01515319|3826428|FG001|Overall Study|Adverse Event|0
2194566|NCT01515319|3826429|FG002|Overall Study|Adverse Event|0
2194567|NCT01515319|3826430|FG003|Overall Study|Adverse Event|0
2194568|NCT01515319|3826431|FG004|Overall Study|Adverse Event|0
2194569|NCT01515319|3826432|FG005|Overall Study|Adverse Event|0
2194570|NCT01515319|3826433|FG006|Overall Study|Adverse Event|0
2194571|NCT01515319|3826434|FG007|Overall Study|Adverse Event|0
2194572|NCT01515319|3826435|FG008|Overall Study|Adverse Event|3
2194573|NCT01515319|3826436|FG009|Overall Study|Adverse Event|0
2194574|NCT01515319|3826427|FG000|Overall Study|Protocol Violation|0
2194575|NCT01515319|3826428|FG001|Overall Study|Protocol Violation|0
2194576|NCT01515319|3826429|FG002|Overall Study|Protocol Violation|0
2194577|NCT01515319|3826430|FG003|Overall Study|Protocol Violation|0
2194578|NCT01515319|3826431|FG004|Overall Study|Protocol Violation|0
2194579|NCT01515319|3826432|FG005|Overall Study|Protocol Violation|0
2194580|NCT01515319|3826433|FG006|Overall Study|Protocol Violation|0
2194581|NCT01515319|3826434|FG007|Overall Study|Protocol Violation|0
2194582|NCT01515319|3826435|FG008|Overall Study|Protocol Violation|2
2194583|NCT01515319|3826436|FG009|Overall Study|Protocol Violation|0
2194584|NCT01515423|3826476|FG000|Open Label Phase|Adverse Event|57
2194585|NCT01515423|3826477|FG001|Open Label Phase|Adverse Event|0
2194586|NCT01515423|3826478|FG002|Open Label Phase|Adverse Event|0
2194587|NCT01515423|3826476|FG000|Open Label Phase|Death|2
2194588|NCT01515423|3826477|FG001|Open Label Phase|Death|0
2194589|NCT01515423|3826478|FG002|Open Label Phase|Death|0
2194590|NCT01515423|3826476|FG000|Open Label Phase|Lack of Efficacy|117
2194591|NCT01515423|3826477|FG001|Open Label Phase|Lack of Efficacy|0
2194592|NCT01515423|3826478|FG002|Open Label Phase|Lack of Efficacy|0
2194593|NCT01515423|3826476|FG000|Open Label Phase|Lost to Follow-up|21
2194594|NCT01515423|3826477|FG001|Open Label Phase|Lost to Follow-up|0
2194595|NCT01515423|3826478|FG002|Open Label Phase|Lost to Follow-up|0
2194596|NCT01515423|3826476|FG000|Open Label Phase|Withdrawal by Subject|118
2194597|NCT01515423|3826477|FG001|Open Label Phase|Withdrawal by Subject|0
2194598|NCT01515423|3826478|FG002|Open Label Phase|Withdrawal by Subject|0
2194599|NCT01515423|3826476|FG000|Open Label Phase|excluded from DB Phase|70
2194600|NCT01515423|3826477|FG001|Open Label Phase|excluded from DB Phase|0
2194601|NCT01515423|3826478|FG002|Open Label Phase|excluded from DB Phase|0
2194602|NCT01515423|3826476|FG000|Open Label Phase|Other|28
2194603|NCT01515423|3826477|FG001|Open Label Phase|Other|0
2194604|NCT01515423|3826478|FG002|Open Label Phase|Other|0
2194605|NCT01515423|3826476|FG000|DOUBLE BLIND|Adverse Event|0
2194606|NCT01515423|3826477|FG001|DOUBLE BLIND|Adverse Event|15
2194607|NCT01515423|3826478|FG002|DOUBLE BLIND|Adverse Event|13
2194608|NCT01515423|3826476|FG000|DOUBLE BLIND|Death|0
2194609|NCT01515423|3826477|FG001|DOUBLE BLIND|Death|1
2194610|NCT01515423|3826478|FG002|DOUBLE BLIND|Death|2
2194611|NCT01515423|3826476|FG000|DOUBLE BLIND|Lost to Follow-up|0
2194612|NCT01515423|3826477|FG001|DOUBLE BLIND|Lost to Follow-up|7
2194613|NCT01515423|3826478|FG002|DOUBLE BLIND|Lost to Follow-up|12
2194614|NCT01515423|3826476|FG000|DOUBLE BLIND|Pregnancy|0
2194615|NCT01515423|3826477|FG001|DOUBLE BLIND|Pregnancy|2
2194616|NCT01515423|3826478|FG002|DOUBLE BLIND|Pregnancy|0
2194617|NCT01515423|3826476|FG000|DOUBLE BLIND|Withdrawal by Subject|0
2194618|NCT01515423|3826477|FG001|DOUBLE BLIND|Withdrawal by Subject|50
2194619|NCT01515423|3826478|FG002|DOUBLE BLIND|Withdrawal by Subject|53
2194620|NCT01515423|3826476|FG000|DOUBLE BLIND|Other|0
2194621|NCT01515423|3826477|FG001|DOUBLE BLIND|Other|6
2194622|NCT01515423|3826478|FG002|DOUBLE BLIND|Other|12
2194623|NCT01515423|3826476|FG000|DOUBLE BLIND|Blind broken by investigator|0
2194624|NCT01515423|3826477|FG001|DOUBLE BLIND|Blind broken by investigator|1
2194625|NCT01515423|3826478|FG002|DOUBLE BLIND|Blind broken by investigator|0
2225142|NCT01778062|3872909|FG001|Overall Study|Consent Withdrawal|5
2194626|NCT01515475|3826489|FG000|Overall Study|Lost to Follow-up|20
2194627|NCT01515475|3826490|FG001|Overall Study|Lost to Follow-up|15
2194628|NCT01515475|3826491|FG002|Overall Study|Lost to Follow-up|12
2194629|NCT01515475|3826492|FG003|Overall Study|Lost to Follow-up|12
2194630|NCT01515748|3826550|FG000|Overall Study|Withdrawal by Subject|32
2194631|NCT01515748|3826551|FG001|Overall Study|Withdrawal by Subject|41
2194632|NCT01515748|3826550|FG000|Overall Study|Lost to Follow-up|2
2194633|NCT01515748|3826551|FG001|Overall Study|Lost to Follow-up|4
2194634|NCT01515748|3826550|FG000|Overall Study|Ongoing|86
2194635|NCT01515748|3826551|FG001|Overall Study|Ongoing|90
2194636|NCT01515865|3826558|FG000|Part A (Open-label)|Other|3
2194637|NCT01515865|3826559|FG001|Part A (Open-label)|Other|0
2194638|NCT01515865|3826560|FG002|Part A (Open-label)|Other|0
2194639|NCT01515865|3826558|FG000|Part B (Open-label)|Withdrawal by Subject|1
2194640|NCT01515865|3826559|FG001|Part B (Open-label)|Withdrawal by Subject|0
2194641|NCT01515865|3826560|FG002|Part B (Open-label)|Withdrawal by Subject|0
2194642|NCT01515865|3826558|FG000|Part B (Open-label)|Other|1
2194643|NCT01515865|3826559|FG001|Part B (Open-label)|Other|0
2194644|NCT01515865|3826560|FG002|Part B (Open-label)|Other|0
2194645|NCT01516008|3826604|FG000|Overall Study|Adverse Event|0
2194646|NCT01516008|3826605|FG001|Overall Study|Adverse Event|2
2194647|NCT01516008|3826606|FG002|Overall Study|Adverse Event|7
2194648|NCT01516008|3826604|FG000|Overall Study|Lack of Efficacy|44
2194649|NCT01516008|3826605|FG001|Overall Study|Lack of Efficacy|14
2194650|NCT01516008|3826606|FG002|Overall Study|Lack of Efficacy|10
2194651|NCT01516008|3826604|FG000|Overall Study|Protocol Violation|1
2194652|NCT01516008|3826605|FG001|Overall Study|Protocol Violation|0
2194653|NCT01516008|3826606|FG002|Overall Study|Protocol Violation|0
2194654|NCT01516008|3826604|FG000|Overall Study|Reason not specified|0
2194655|NCT01516008|3826605|FG001|Overall Study|Reason not specified|0
2194656|NCT01516008|3826606|FG002|Overall Study|Reason not specified|1
2194657|NCT01516437|3826636|FG000|Overall Study|Reason not specified|0
2194658|NCT01516437|3826637|FG001|Overall Study|Reason not specified|0
2194659|NCT01516437|3826638|FG002|Overall Study|Reason not specified|1
2194660|NCT01516437|3826639|FG003|Overall Study|Reason not specified|1
2194661|NCT01516736|3826675|FG000|Overall Study|Withdrawal by Subject|10
2194662|NCT01516736|3826676|FG001|Overall Study|Withdrawal by Subject|4
2194663|NCT01516736|3826675|FG000|Overall Study|Adverse Event|4
2194664|NCT01516736|3826676|FG001|Overall Study|Adverse Event|5
2194665|NCT01516736|3826675|FG000|Overall Study|Death|3
2194666|NCT01516736|3826676|FG001|Overall Study|Death|1
2194667|NCT01516736|3826675|FG000|Overall Study|Physician Decision|2
2194668|NCT01516736|3826676|FG001|Overall Study|Physician Decision|1
2194669|NCT01516736|3826675|FG000|Overall Study|Lack of Efficacy|1
2194670|NCT01516736|3826676|FG001|Overall Study|Lack of Efficacy|0
2194671|NCT01516736|3826675|FG000|Overall Study|Protocol Violation|0
2194672|NCT01516736|3826676|FG001|Overall Study|Protocol Violation|1
2194673|NCT01516736|3826675|FG000|Overall Study|Other (not specified)|0
2194674|NCT01516736|3826676|FG001|Overall Study|Other (not specified)|1
2194675|NCT01516749|3826682|FG000|Active Therapy|Lost to Follow-up|1
2194676|NCT01516749|3826682|FG000|Follow-up Off Therapy|Lost to Follow-up|1
2194677|NCT01516879|3826688|FG000|Overall Study|Withdrawal by Subject|9
2194678|NCT01516879|3826689|FG001|Overall Study|Withdrawal by Subject|11
2194679|NCT01516879|3826688|FG000|Overall Study|Death|0
2194680|NCT01516879|3826689|FG001|Overall Study|Death|2
2194681|NCT01516879|3826688|FG000|Overall Study|Lost to Follow-up|2
2194682|NCT01516879|3826689|FG001|Overall Study|Lost to Follow-up|11
2194683|NCT01516879|3826688|FG000|Overall Study|Other|5
2194684|NCT01516879|3826689|FG001|Overall Study|Other|10
2194685|NCT01516892|3826695|FG000|Overall Study|Adverse Event|25
2194686|NCT01516892|3826695|FG000|Overall Study|Lack of Efficacy|35
2194687|NCT01516892|3826695|FG000|Overall Study|Pregnancy|5
2194688|NCT01516892|3826695|FG000|Overall Study|Lost to Follow-up|82
2194689|NCT01516892|3826695|FG000|Overall Study|Subject Withdrew Consent|92
2194690|NCT01516892|3826695|FG000|Overall Study|Protocol Violation|60
2194691|NCT01516892|3826695|FG000|Overall Study|Other Miscellaneous Reasons|43
2194692|NCT01516892|3826695|FG000|Overall Study|Missing|1
2194693|NCT01516970|3826716|FG000|Overall Study|Lost to Follow-up|7
2194694|NCT01516970|3826717|FG001|Overall Study|Lost to Follow-up|8
2194695|NCT01516970|3826716|FG000|Overall Study|Adverse Event|1
2194696|NCT01516970|3826717|FG001|Overall Study|Adverse Event|5
2194697|NCT01516970|3826716|FG000|Overall Study|Withdrawal by Subject|1
2194698|NCT01516970|3826717|FG001|Overall Study|Withdrawal by Subject|1
2194699|NCT01516970|3826716|FG000|Overall Study|Other|9
2194700|NCT01516970|3826717|FG001|Overall Study|Other|7
2194701|NCT01517178|3826732|FG000|Period 1|Adverse Event|1
2194702|NCT01517178|3826733|FG001|Period 1|Adverse Event|2
2194703|NCT01517178|3826732|FG000|Period 1|Lack of Efficacy|0
2194704|NCT01517178|3826733|FG001|Period 1|Lack of Efficacy|1
2194705|NCT01517178|3826732|FG000|Period 1|E.g. study termination|3
2194706|NCT01517178|3826733|FG001|Period 1|E.g. study termination|1
2194707|NCT01517178|3826732|FG000|Period 1|Withdrawal by Subject|0
2194708|NCT01517178|3826733|FG001|Period 1|Withdrawal by Subject|1
2194709|NCT01517178|3826732|FG000|Period 2|Adverse Event|1
2194710|NCT01517178|3826733|FG001|Period 2|Adverse Event|0
2194711|NCT01517178|3826732|FG000|Period 2|Withdrawal by Subject|3
2194712|NCT01517178|3826733|FG001|Period 2|Withdrawal by Subject|0
2194713|NCT01517178|3826732|FG000|Period 2|E.g. study termination|2
2194714|NCT01517178|3826733|FG001|Period 2|E.g. study termination|2
2194715|NCT01517282|3826743|FG000|Overall Study|Consent withdrawn|0
2194716|NCT01517282|3826744|FG001|Overall Study|Consent withdrawn|1
2194717|NCT01517282|3826745|FG002|Overall Study|Consent withdrawn|1
2194718|NCT01517282|3826746|FG003|Overall Study|Consent withdrawn|1
2194719|NCT01517282|3826743|FG000|Overall Study|Physician Decision|1
2194720|NCT01517282|3826744|FG001|Overall Study|Physician Decision|0
2194721|NCT01517282|3826745|FG002|Overall Study|Physician Decision|0
2194722|NCT01517282|3826746|FG003|Overall Study|Physician Decision|0
2194723|NCT01517295|3826758|FG000|Overall Study|Physician Decision|1
2194724|NCT01517295|3826759|FG001|Overall Study|Physician Decision|0
2194725|NCT01517373|3826770|FG000|Run-in Period|Death|1
2194726|NCT01517373|3826771|FG001|Run-in Period|Death|0
2194727|NCT01517373|3826772|FG002|Run-in Period|Death|0
2194728|NCT01517373|3826773|FG003|Run-in Period|Death|0
2194729|NCT01517373|3826774|FG004|Run-in Period|Death|0
2194730|NCT01517373|3826775|FG005|Run-in Period|Death|0
2194731|NCT01517373|3826770|FG000|Run-in Period|Adverse Event|5
2194732|NCT01517373|3826771|FG001|Run-in Period|Adverse Event|0
2194733|NCT01517373|3826772|FG002|Run-in Period|Adverse Event|0
2194734|NCT01517373|3826773|FG003|Run-in Period|Adverse Event|0
2194735|NCT01517373|3826774|FG004|Run-in Period|Adverse Event|0
2194736|NCT01517373|3826775|FG005|Run-in Period|Adverse Event|0
2194737|NCT01517373|3826770|FG000|Run-in Period|Did not meet eligibility criteria|34
2194738|NCT01517373|3826771|FG001|Run-in Period|Did not meet eligibility criteria|0
2194739|NCT01517373|3826772|FG002|Run-in Period|Did not meet eligibility criteria|0
2194740|NCT01517373|3826773|FG003|Run-in Period|Did not meet eligibility criteria|0
2194741|NCT01517373|3826774|FG004|Run-in Period|Did not meet eligibility criteria|0
2194742|NCT01517373|3826775|FG005|Run-in Period|Did not meet eligibility criteria|0
2194743|NCT01517373|3826770|FG000|Run-in Period|Lost to Follow-up|1
2194744|NCT01517373|3826771|FG001|Run-in Period|Lost to Follow-up|0
2194745|NCT01517373|3826772|FG002|Run-in Period|Lost to Follow-up|0
2194746|NCT01517373|3826773|FG003|Run-in Period|Lost to Follow-up|0
2194747|NCT01517373|3826774|FG004|Run-in Period|Lost to Follow-up|0
2194748|NCT01517373|3826775|FG005|Run-in Period|Lost to Follow-up|0
2194749|NCT01517373|3826770|FG000|Run-in Period|Withdrawal by Subject|12
2194750|NCT01517373|3826771|FG001|Run-in Period|Withdrawal by Subject|0
2194751|NCT01517373|3826772|FG002|Run-in Period|Withdrawal by Subject|0
2194752|NCT01517373|3826773|FG003|Run-in Period|Withdrawal by Subject|0
2194753|NCT01517373|3826774|FG004|Run-in Period|Withdrawal by Subject|0
2194754|NCT01517373|3826775|FG005|Run-in Period|Withdrawal by Subject|0
2194755|NCT01517373|3826770|FG000|Run-in Period|Sponsor Decision|3
2194756|NCT01517373|3826771|FG001|Run-in Period|Sponsor Decision|0
2194757|NCT01517373|3826772|FG002|Run-in Period|Sponsor Decision|0
2194758|NCT01517373|3826773|FG003|Run-in Period|Sponsor Decision|0
2194759|NCT01517373|3826774|FG004|Run-in Period|Sponsor Decision|0
2194760|NCT01517373|3826775|FG005|Run-in Period|Sponsor Decision|0
2194761|NCT01517373|3826770|FG000|Run-in Period|Other|1
2194762|NCT01517373|3826771|FG001|Run-in Period|Other|0
2194763|NCT01517373|3826772|FG002|Run-in Period|Other|0
2194764|NCT01517373|3826773|FG003|Run-in Period|Other|0
2194765|NCT01517373|3826774|FG004|Run-in Period|Other|0
2194766|NCT01517373|3826775|FG005|Run-in Period|Other|0
2194767|NCT01517373|3826770|FG000|Treatment Period|Adverse Event|0
2194768|NCT01517373|3826771|FG001|Treatment Period|Adverse Event|0
2194769|NCT01517373|3826772|FG002|Treatment Period|Adverse Event|0
2194770|NCT01517373|3826773|FG003|Treatment Period|Adverse Event|0
2194771|NCT01517373|3826774|FG004|Treatment Period|Adverse Event|0
2194772|NCT01517373|3826775|FG005|Treatment Period|Adverse Event|2
2194773|NCT01517373|3826770|FG000|Treatment Period|Lost to Follow-up|0
2194774|NCT01517373|3826771|FG001|Treatment Period|Lost to Follow-up|0
2194775|NCT01517373|3826772|FG002|Treatment Period|Lost to Follow-up|1
2194776|NCT01517373|3826773|FG003|Treatment Period|Lost to Follow-up|1
2194777|NCT01517373|3826774|FG004|Treatment Period|Lost to Follow-up|0
2194778|NCT01517373|3826775|FG005|Treatment Period|Lost to Follow-up|0
2194779|NCT01517373|3826770|FG000|Treatment Period|Withdrawal by Subject|0
2194780|NCT01517373|3826771|FG001|Treatment Period|Withdrawal by Subject|3
2194781|NCT01517373|3826772|FG002|Treatment Period|Withdrawal by Subject|2
2194782|NCT01517373|3826773|FG003|Treatment Period|Withdrawal by Subject|2
2194783|NCT01517373|3826774|FG004|Treatment Period|Withdrawal by Subject|2
2194784|NCT01517373|3826775|FG005|Treatment Period|Withdrawal by Subject|3
2194785|NCT01517373|3826770|FG000|Treatment Period|Other|0
2194786|NCT01517373|3826771|FG001|Treatment Period|Other|0
2194787|NCT01517373|3826772|FG002|Treatment Period|Other|0
2194788|NCT01517373|3826773|FG003|Treatment Period|Other|0
2194789|NCT01517373|3826774|FG004|Treatment Period|Other|1
2194790|NCT01517373|3826775|FG005|Treatment Period|Other|0
2194791|NCT01517373|3826770|FG000|Treatment Period|Protocol Violation|0
2194792|NCT01517373|3826771|FG001|Treatment Period|Protocol Violation|0
2194793|NCT01517373|3826772|FG002|Treatment Period|Protocol Violation|0
2194794|NCT01517373|3826773|FG003|Treatment Period|Protocol Violation|0
2194795|NCT01517373|3826774|FG004|Treatment Period|Protocol Violation|1
2194796|NCT01517373|3826775|FG005|Treatment Period|Protocol Violation|0
2194797|NCT01517373|3826770|FG000|Treatment Period|Lack of Efficacy|0
2194798|NCT01517373|3826771|FG001|Treatment Period|Lack of Efficacy|1
2194799|NCT01517373|3826772|FG002|Treatment Period|Lack of Efficacy|1
2194800|NCT01517373|3826773|FG003|Treatment Period|Lack of Efficacy|3
2194801|NCT01517373|3826774|FG004|Treatment Period|Lack of Efficacy|2
2194802|NCT01517373|3826775|FG005|Treatment Period|Lack of Efficacy|0
2225143|NCT01778062|3872908|FG000|Overall Study|major protocol deviation|4
2225144|NCT01778062|3872909|FG001|Overall Study|major protocol deviation|3
2225145|NCT01778127|3872918|FG000|Overall Study|Lost to Follow-up|5
2225146|NCT01778127|3872919|FG001|Overall Study|Lost to Follow-up|1
2225147|NCT01778127|3872920|FG002|Overall Study|Lost to Follow-up|2
2225148|NCT01778127|3872918|FG000|Overall Study|Withdrawal by Subject|3
2225149|NCT01778127|3872919|FG001|Overall Study|Withdrawal by Subject|1
2225150|NCT01778127|3872920|FG002|Overall Study|Withdrawal by Subject|4
2225151|NCT01778530|3872963|FG000|Overall Study|Progression on study|1
2225152|NCT01778530|3872963|FG000|Overall Study|Adverse event/side effect|1
2225153|NCT01778556|3872969|FG000|Intervention 1 (5 Days)|Protocol Violation|0
2225154|NCT01778556|3872970|FG001|Intervention 1 (5 Days)|Protocol Violation|1
2225155|NCT01778556|3872969|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
2225156|NCT01778556|3872970|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1
2225157|NCT01778556|3872969|FG000|Intervention 2 (14 Days)|Protocol Violation|1
2225158|NCT01778556|3872970|FG001|Intervention 2 (14 Days)|Protocol Violation|0
2225159|NCT01778556|3872969|FG000|Long-term Follow-up|noncompliance with metreleptin|1
2194803|NCT01517373|3826770|FG000|Treatment Period|Medication error without AEs|0
2194804|NCT01517373|3826771|FG001|Treatment Period|Medication error without AEs|0
2194805|NCT01517373|3826772|FG002|Treatment Period|Medication error without AEs|2
2225160|NCT01778556|3872970|FG001|Long-term Follow-up|noncompliance with metreleptin|0
2225161|NCT01778751|3872991|FG000|Overall Study|Lost to Follow-up|1
2194806|NCT01517373|3826773|FG003|Treatment Period|Medication error without AEs|1
2194807|NCT01517373|3826774|FG004|Treatment Period|Medication error without AEs|0
2194808|NCT01517373|3826775|FG005|Treatment Period|Medication error without AEs|2
2194809|NCT01517412|3826790|FG000|Overall Study|Adverse Event|10
2194810|NCT01517412|3826791|FG001|Overall Study|Adverse Event|11
2194811|NCT01517412|3826790|FG000|Overall Study|Lack of Efficacy|10
2194812|NCT01517412|3826791|FG001|Overall Study|Lack of Efficacy|5
2194813|NCT01517412|3826790|FG000|Overall Study|Poor compliance to protocol|8
2194814|NCT01517412|3826791|FG001|Overall Study|Poor compliance to protocol|3
2194815|NCT01517412|3826790|FG000|Overall Study|Other than specified above|8
2194816|NCT01517412|3826791|FG001|Overall Study|Other than specified above|5
2194817|NCT01517750|3826805|FG000|Overall Study|Lost to Follow-up|1
2194818|NCT01517750|3826806|FG001|Overall Study|Lost to Follow-up|2
2194819|NCT01517750|3826807|FG002|Overall Study|Lost to Follow-up|4
2194820|NCT01517750|3826808|FG003|Overall Study|Lost to Follow-up|1
2225162|NCT01778751|3872992|FG001|Overall Study|Lost to Follow-up|0
2225163|NCT01778751|3872991|FG000|Overall Study|Withdrawal by Subject|0
2225164|NCT01778751|3872992|FG001|Overall Study|Withdrawal by Subject|2
2225165|NCT01778751|3872991|FG000|Overall Study|Transfered care|1
2225166|NCT01778751|3872992|FG001|Overall Study|Transfered care|0
2225167|NCT01778855|3873000|FG000|Overall Study|Death|0
2225168|NCT01778855|3873001|FG001|Overall Study|Death|1
2225169|NCT01778985|3873009|FG000|Overall Study|Lost to Follow-up|1
2225170|NCT01778985|3873010|FG001|Overall Study|Lost to Follow-up|0
2225171|NCT01778985|3873009|FG000|Overall Study|Physician Decision|2
2225172|NCT01778985|3873010|FG001|Overall Study|Physician Decision|2
2225173|NCT01778985|3873009|FG000|Overall Study|Protocol Violation|4
2225174|NCT01778985|3873010|FG001|Overall Study|Protocol Violation|1
2225175|NCT01779440|3873053|FG000|Overall Study|Withdrawal by Subject|3
2225176|NCT01779440|3873054|FG001|Overall Study|Withdrawal by Subject|5
2225177|NCT01779648|3873062|FG000|Overall Study|Protocol Violation|1
2225178|NCT01779648|3873063|FG001|Overall Study|Protocol Violation|0
2225179|NCT01779700|3873071|FG000|Overall Study|Adverse Event|4
2225180|NCT01779700|3873072|FG001|Overall Study|Adverse Event|3
2225181|NCT01779700|3873071|FG000|Overall Study|Withdrawal by Subject|0
2225182|NCT01779700|3873072|FG001|Overall Study|Withdrawal by Subject|2
2225183|NCT01779856|3873078|FG000|Overall Study|Withdrawal by Subject|15
2225184|NCT01779856|3873078|FG000|Overall Study|Death|3
2225185|NCT01779856|3873078|FG000|Overall Study|Physician Decision|1
2225186|NCT01779856|3873078|FG000|Overall Study|Inclusion/Exclusion Not Met|2
2225187|NCT01779856|3873078|FG000|Overall Study|Delays in scheduling implant|1
2225188|NCT01779856|3873078|FG000|Overall Study|Subject ineligible for Implant|2
2225189|NCT01779869|3873089|FG000|Overall Study|Physician Decision|2
2225190|NCT01780389|3873115|FG000|Overall Study|Adverse Event|1
2225191|NCT01780506|3873126|FG000|Double-Blind Phase|Randomized but not Treated|3
2225192|NCT01780506|3873127|FG001|Double-Blind Phase|Randomized but not Treated|2
2225193|NCT01780506|3873126|FG000|Double-Blind Phase|Adverse Event|4
2225194|NCT01780506|3873127|FG001|Double-Blind Phase|Adverse Event|14
2225195|NCT01780506|3873126|FG000|Double-Blind Phase|Death|1
2225196|NCT01780506|3873127|FG001|Double-Blind Phase|Death|2
2225197|NCT01780506|3873126|FG000|Double-Blind Phase|Pregnancy|2
2225198|NCT01780506|3873127|FG001|Double-Blind Phase|Pregnancy|1
2225199|NCT01780506|3873126|FG000|Double-Blind Phase|Lack of Efficacy|1
2225200|NCT01780506|3873127|FG001|Double-Blind Phase|Lack of Efficacy|1
2225201|NCT01780506|3873126|FG000|Double-Blind Phase|Investigator's Discretion|5
2225202|NCT01780506|3873127|FG001|Double-Blind Phase|Investigator's Discretion|2
2225203|NCT01780506|3873126|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
2225204|NCT01780506|3873127|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3
2225205|NCT01780506|3873126|FG000|Double-Blind Phase|Protocol Violation|4
2225206|NCT01780506|3873127|FG001|Double-Blind Phase|Protocol Violation|3
2225207|NCT01780506|3873126|FG000|Double-Blind Phase|Withdrew Consent|23
2225208|NCT01780506|3873127|FG001|Double-Blind Phase|Withdrew Consent|24
2225209|NCT01780506|3873126|FG000|Double-Blind Phase|Lost to Follow-up|23
2225210|NCT01780506|3873127|FG001|Double-Blind Phase|Lost to Follow-up|26
2225211|NCT01780506|3873126|FG000|Open-Label Extension Phase|Enrolled but not Treated|0
2225212|NCT01780506|3873127|FG001|Open-Label Extension Phase|Enrolled but not Treated|1
2225213|NCT01780545|3873137|FG000|Overall Study|Withdrawal by Subject|3
2225214|NCT01780545|3873138|FG001|Overall Study|Withdrawal by Subject|1
2225215|NCT01780545|3873137|FG000|Overall Study|Lost to Follow-up|1
2225216|NCT01780545|3873138|FG001|Overall Study|Lost to Follow-up|1
2225217|NCT01780584|3873150|FG000|Overall Study|Death|1
2225218|NCT01780584|3873151|FG001|Overall Study|Death|0
2225219|NCT01780584|3873152|FG002|Overall Study|Death|1
2225220|NCT01780584|3873150|FG000|Overall Study|Adverse Event|0
2225221|NCT01780584|3873151|FG001|Overall Study|Adverse Event|1
2225222|NCT01780584|3873152|FG002|Overall Study|Adverse Event|0
2225223|NCT01780584|3873150|FG000|Overall Study|Protocol Violation|0
2225224|NCT01780584|3873151|FG001|Overall Study|Protocol Violation|0
2332440|NCT03196973|4056078|FG000|Overall Study|Adverse Event|1
2225225|NCT01780584|3873152|FG002|Overall Study|Protocol Violation|1
2225226|NCT01780662|3873163|FG000|Overall Study|Adverse Event|1
2225227|NCT01780662|3873164|FG001|Overall Study|Adverse Event|0
2225228|NCT01780662|3873165|FG002|Overall Study|Adverse Event|2
2225229|NCT01780662|3873163|FG000|Overall Study|Physician Decision|0
2194821|NCT01517867|3826824|FG000|Overall Study|never started treatment|29
2194822|NCT01517867|3826825|FG001|Overall Study|never started treatment|32
2194823|NCT01517867|3826824|FG000|Overall Study|Withdrawal by Subject|34
2194824|NCT01517867|3826825|FG001|Overall Study|Withdrawal by Subject|30
2194825|NCT01517867|3826824|FG000|Overall Study|Still in treatment at study end|0
2194826|NCT01517867|3826825|FG001|Overall Study|Still in treatment at study end|3
2194827|NCT01517893|3826833|FG000|Overall Study|Withdrawal by Subject|3
2194828|NCT01517893|3826834|FG001|Overall Study|Withdrawal by Subject|0
2194829|NCT01517984|3826843|FG000|Overall Study|Lost to Follow-up|0
2194830|NCT01517984|3826844|FG001|Overall Study|Lost to Follow-up|1
2194831|NCT01517984|3826845|FG002|Overall Study|Lost to Follow-up|0
2194832|NCT01517984|3826846|FG003|Overall Study|Lost to Follow-up|0
2194833|NCT01517984|3826843|FG000|Overall Study|Withdrawal by Subject|1
2194834|NCT01517984|3826844|FG001|Overall Study|Withdrawal by Subject|8
2194835|NCT01517984|3826845|FG002|Overall Study|Withdrawal by Subject|4
2194836|NCT01517984|3826846|FG003|Overall Study|Withdrawal by Subject|1
2194837|NCT01517984|3826843|FG000|Overall Study|Screen Failure|4
2194838|NCT01517984|3826844|FG001|Overall Study|Screen Failure|0
2194839|NCT01517984|3826845|FG002|Overall Study|Screen Failure|0
2194840|NCT01517984|3826846|FG003|Overall Study|Screen Failure|0
2194841|NCT01517984|3826843|FG000|Overall Study|Ineligible for randomization|0
2194842|NCT01517984|3826844|FG001|Overall Study|Ineligible for randomization|14
2194843|NCT01517984|3826845|FG002|Overall Study|Ineligible for randomization|0
2194844|NCT01517984|3826846|FG003|Overall Study|Ineligible for randomization|0
2194845|NCT01518153|3826853|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
2194846|NCT01518153|3826854|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
2194847|NCT01518153|3826855|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
2194848|NCT01518153|3826853|FG000|Stem Cell Transplant|Death|2
2194849|NCT01518153|3826854|FG001|Stem Cell Transplant|Death|0
2194850|NCT01518153|3826855|FG002|Stem Cell Transplant|Death|0
2194851|NCT01518153|3826853|FG000|Stem Cell Transplant|Secondary graft failure|1
2194852|NCT01518153|3826854|FG001|Stem Cell Transplant|Secondary graft failure|0
2194853|NCT01518153|3826855|FG002|Stem Cell Transplant|Secondary graft failure|0
2194854|NCT01518153|3826853|FG000|Stem Cell Transplant|Adverse Event|1
2194855|NCT01518153|3826854|FG001|Stem Cell Transplant|Adverse Event|0
2194856|NCT01518153|3826855|FG002|Stem Cell Transplant|Adverse Event|0
2194857|NCT01518153|3826853|FG000|Donor Lymphocyte Infusion|Death|0
2194858|NCT01518153|3826854|FG001|Donor Lymphocyte Infusion|Death|2
2194859|NCT01518153|3826855|FG002|Donor Lymphocyte Infusion|Death|1
2194860|NCT01518192|3826866|FG000|Overall Study|Lost to Follow-up|29
2194861|NCT01518192|3826867|FG001|Overall Study|Lost to Follow-up|26
2194862|NCT01518192|3826868|FG002|Overall Study|Lost to Follow-up|35
2194863|NCT01518244|3826882|FG000|Overall Study|Adverse Event|3
2194864|NCT01518257|3826888|FG000|Overall Study|Lost to Follow-up|1
2194865|NCT01518257|3826889|FG001|Overall Study|Lost to Follow-up|0
2194866|NCT01518257|3826888|FG000|Overall Study|Other Miscellaneous Reason|1
2194867|NCT01518257|3826889|FG001|Overall Study|Other Miscellaneous Reason|0
2194868|NCT01518309|3826899|FG000|Overall Study|Adverse Event|6
2194869|NCT01518309|3826899|FG000|Overall Study|Death|6
2194870|NCT01518309|3826899|FG000|Overall Study|Lack of Efficacy|7
2194871|NCT01518309|3826899|FG000|Overall Study|Withdrawal by Subject|6
2194872|NCT01518309|3826899|FG000|Overall Study|Physician Decision|3
2194873|NCT01518309|3826899|FG000|Overall Study|Sponsor Decision|2
2194874|NCT01518309|3826899|FG000|Overall Study|Not in Predefined Categories|9
2194875|NCT01518322|3826903|FG000|Overall Study|FeNO measurement was missing|13
2194876|NCT01518374|3826912|FG000|Overall Study|Withdrawal by Subject|2
2194877|NCT01518374|3826912|FG000|Overall Study|Protocol Violation|3
2194878|NCT01518374|3826912|FG000|Overall Study|Lost to Follow-up|2
2194879|NCT01518699|3826926|FG000|Period 2|Protocol Violation|1
2194880|NCT01518699|3826927|FG001|Period 2|Protocol Violation|1
2194881|NCT01518699|3826928|FG002|Period 2|Protocol Violation|0
2194882|NCT01518699|3826929|FG003|Period 2|Protocol Violation|0
2194883|NCT01518699|3826930|FG004|Period 2|Protocol Violation|0
2194884|NCT01518699|3826931|FG005|Period 2|Protocol Violation|0
2194885|NCT01518699|3826926|FG000|Period 2|Lost to Follow-up|0
2194886|NCT01518699|3826927|FG001|Period 2|Lost to Follow-up|1
2194887|NCT01518699|3826928|FG002|Period 2|Lost to Follow-up|0
2194888|NCT01518699|3826929|FG003|Period 2|Lost to Follow-up|0
2194889|NCT01518699|3826930|FG004|Period 2|Lost to Follow-up|0
2194890|NCT01518699|3826931|FG005|Period 2|Lost to Follow-up|0
2225230|NCT01780662|3873164|FG001|Overall Study|Physician Decision|5
2225231|NCT01780662|3873165|FG002|Overall Study|Physician Decision|7
2225232|NCT01780662|3873163|FG000|Overall Study|Protocol Violation|0
2225233|NCT01780662|3873164|FG001|Overall Study|Protocol Violation|1
2225234|NCT01780662|3873165|FG002|Overall Study|Protocol Violation|0
2225235|NCT01780662|3873163|FG000|Overall Study|Ineligible|0
2225236|NCT01780662|3873164|FG001|Overall Study|Ineligible|0
2225237|NCT01780662|3873165|FG002|Overall Study|Ineligible|1
2225238|NCT01780831|3873178|FG000|Overall Study|Withdrawal by Subject|0
2225239|NCT01780831|3873179|FG001|Overall Study|Withdrawal by Subject|0
2225240|NCT01780831|3873180|FG002|Overall Study|Withdrawal by Subject|4
2225241|NCT01780831|3873181|FG003|Overall Study|Withdrawal by Subject|0
2225242|NCT01780831|3873178|FG000|Overall Study|Lost to Follow-up|0
2225243|NCT01780831|3873179|FG001|Overall Study|Lost to Follow-up|0
2194891|NCT01518699|3826926|FG000|Period 2|Adverse Event|1
2194892|NCT01518699|3826927|FG001|Period 2|Adverse Event|0
2194893|NCT01518699|3826928|FG002|Period 2|Adverse Event|0
2194894|NCT01518699|3826929|FG003|Period 2|Adverse Event|0
2194895|NCT01518699|3826930|FG004|Period 2|Adverse Event|0
2194896|NCT01518699|3826931|FG005|Period 2|Adverse Event|0
2194897|NCT01518946|3826948|FG000|Open-label Phase|Other|4
2194898|NCT01518946|3826949|FG001|Open-label Phase|Other|0
2194899|NCT01518946|3826950|FG002|Open-label Phase|Other|0
2194900|NCT01518946|3826948|FG000|Randomized Phase (First Intervention)|Other|0
2194901|NCT01518946|3826949|FG001|Randomized Phase (First Intervention)|Other|1
2194902|NCT01518946|3826950|FG002|Randomized Phase (First Intervention)|Other|0
2194903|NCT01518972|3826959|FG000|Overall Study|Lost to Follow-up|2
2194904|NCT01518972|3826960|FG001|Overall Study|Lost to Follow-up|1
2194905|NCT01518972|3826959|FG000|Overall Study|Withdrawal by Subject|1
2194906|NCT01518972|3826960|FG001|Overall Study|Withdrawal by Subject|0
2194907|NCT01518972|3826959|FG000|Overall Study|Moved from area|1
2194908|NCT01518972|3826960|FG001|Overall Study|Moved from area|0
2194909|NCT01518972|3826959|FG000|Overall Study|Transportation problems|1
2194910|NCT01518972|3826960|FG001|Overall Study|Transportation problems|0
2194911|NCT01518972|3826959|FG000|Overall Study|Exclusionary medical condition|1
2194912|NCT01518972|3826960|FG001|Overall Study|Exclusionary medical condition|0
2194913|NCT01518972|3826959|FG000|Overall Study|Missed safety visits|0
2194914|NCT01518972|3826960|FG001|Overall Study|Missed safety visits|1
2194915|NCT01518972|3826959|FG000|Overall Study|Exclusionary medication|0
2194916|NCT01518972|3826960|FG001|Overall Study|Exclusionary medication|1
2194917|NCT01518972|3826959|FG000|Overall Study|Declined medication starting on day 12|0
2194918|NCT01518972|3826960|FG001|Overall Study|Declined medication starting on day 12|1
2194919|NCT01519089|3826977|FG000|Overall Study|Adverse Event|4
2194920|NCT01519089|3826978|FG001|Overall Study|Adverse Event|4
2194921|NCT01519089|3826977|FG000|Overall Study|Lack of Efficacy|0
2194922|NCT01519089|3826978|FG001|Overall Study|Lack of Efficacy|2
2194923|NCT01519089|3826977|FG000|Overall Study|Lost to Follow-up|1
2194924|NCT01519089|3826978|FG001|Overall Study|Lost to Follow-up|0
2194925|NCT01519089|3826977|FG000|Overall Study|Withdrawal by Subject|0
2194926|NCT01519089|3826978|FG001|Overall Study|Withdrawal by Subject|2
2194927|NCT01519089|3826977|FG000|Overall Study|Other|2
2194928|NCT01519089|3826978|FG001|Overall Study|Other|6
2194929|NCT01519089|3826977|FG000|Overall Study|Not received study drug|0
2194930|NCT01519089|3826978|FG001|Overall Study|Not received study drug|1
2194931|NCT01519167|3826988|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
2194932|NCT01519167|3826989|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
2194933|NCT01519167|3826988|FG000|Overall Study|Adverse Event|0
2194934|NCT01519167|3826989|FG001|Overall Study|Adverse Event|1
2194935|NCT01519167|3826988|FG000|Overall Study|Lack of Efficacy|0
2194936|NCT01519167|3826989|FG001|Overall Study|Lack of Efficacy|1
2194937|NCT01519167|3826988|FG000|Overall Study|Medical condition changes&deep sedation|0
2194938|NCT01519167|3826989|FG001|Overall Study|Medical condition changes&deep sedation|2
2194939|NCT01519167|3826988|FG000|Overall Study|Physician Decision|0
2194940|NCT01519167|3826989|FG001|Overall Study|Physician Decision|1
2194941|NCT01519206|3826995|FG000|Overall Study|Lost to Follow-up|3
2194942|NCT01519206|3826995|FG000|Overall Study|Missed Visit|2
2194943|NCT01519245|3827008|FG000|Overall Study|Met exclusion criteria, not analysed|1
2194944|NCT01519245|3827009|FG001|Overall Study|Met exclusion criteria, not analysed|2
2194945|NCT01519323|3827049|FG000|Overall Study|Death|3
2194946|NCT01519323|3827050|FG001|Overall Study|Death|2
2194947|NCT01519323|3827049|FG000|Overall Study|Study terminated by sponsor|0
2194948|NCT01519323|3827050|FG001|Overall Study|Study terminated by sponsor|1
2194949|NCT01519427|3827071|FG000|Overall Study|disease progression|2
2194950|NCT01519518|3827095|FG000|Overall Study|Consent not available|7
2194951|NCT01519518|3827096|FG001|Overall Study|Consent not available|10
2194952|NCT01519635|3827113|FG000|Overall Study|Withdrawal by Subject|0
2194953|NCT01519635|3827114|FG001|Overall Study|Withdrawal by Subject|1
2194954|NCT01519635|3827113|FG000|Overall Study|No possibility to put a catheter|1
2194955|NCT01519635|3827114|FG001|Overall Study|No possibility to put a catheter|2
2194956|NCT01519661|3827129|FG000|Overall Study|Protocol deviation|6
2194957|NCT01519661|3827129|FG000|Overall Study|Lost to Follow-up|3
2194958|NCT01519661|3827129|FG000|Overall Study|Withdrawal by Subject|17
2194959|NCT01519661|3827129|FG000|Overall Study|Lack of Efficacy|6
2194960|NCT01519661|3827129|FG000|Overall Study|Adverse Event|29
2194961|NCT01519674|3827137|FG000|Overall Study|Adverse Event|3
2194962|NCT01519674|3827138|FG001|Overall Study|Adverse Event|3
2194963|NCT01519674|3827139|FG002|Overall Study|Adverse Event|0
2194964|NCT01519674|3827137|FG000|Overall Study|Lack of Efficacy|1
2194965|NCT01519674|3827138|FG001|Overall Study|Lack of Efficacy|1
2194966|NCT01519674|3827139|FG002|Overall Study|Lack of Efficacy|1
2194967|NCT01519674|3827137|FG000|Overall Study|Protocol Violation|0
2194968|NCT01519674|3827138|FG001|Overall Study|Protocol Violation|3
2194969|NCT01519674|3827139|FG002|Overall Study|Protocol Violation|1
2194970|NCT01519674|3827137|FG000|Overall Study|Withdrawal Criteria|7
2194971|NCT01519674|3827138|FG001|Overall Study|Withdrawal Criteria|2
2194972|NCT01519674|3827139|FG002|Overall Study|Withdrawal Criteria|7
2194973|NCT01519674|3827137|FG000|Overall Study|Unsclassified|10
2194974|NCT01519674|3827138|FG001|Overall Study|Unsclassified|4
2194975|NCT01519674|3827139|FG002|Overall Study|Unsclassified|3
2194976|NCT01519700|3827151|FG000|Overall Study|Death|1
2194977|NCT01519700|3827152|FG001|Overall Study|Death|0
2194978|NCT01519700|3827153|FG002|Overall Study|Death|0
2194979|NCT01519700|3827154|FG003|Overall Study|Death|0
2194980|NCT01519700|3827151|FG000|Overall Study|Lost to Follow-up|0
2194981|NCT01519700|3827152|FG001|Overall Study|Lost to Follow-up|0
2194982|NCT01519700|3827153|FG002|Overall Study|Lost to Follow-up|1
2194983|NCT01519700|3827154|FG003|Overall Study|Lost to Follow-up|1
2194984|NCT01519700|3827151|FG000|Overall Study|Physician Decision|1
2194985|NCT01519700|3827152|FG001|Overall Study|Physician Decision|1
2194986|NCT01519700|3827153|FG002|Overall Study|Physician Decision|3
2194987|NCT01519700|3827154|FG003|Overall Study|Physician Decision|0
2194988|NCT01519700|3827151|FG000|Overall Study|Withdrawal by Subject|5
2194989|NCT01519700|3827152|FG001|Overall Study|Withdrawal by Subject|3
2194990|NCT01519700|3827153|FG002|Overall Study|Withdrawal by Subject|3
2194991|NCT01519700|3827154|FG003|Overall Study|Withdrawal by Subject|2
2194992|NCT01519700|3827151|FG000|Overall Study|Other Reason|2
2194993|NCT01519700|3827152|FG001|Overall Study|Other Reason|2
2194994|NCT01519700|3827153|FG002|Overall Study|Other Reason|0
2194995|NCT01519700|3827154|FG003|Overall Study|Other Reason|4
2194996|NCT01519765|3827185|FG000|Overall Study|Adverse Event|0
2194997|NCT01519765|3827186|FG001|Overall Study|Adverse Event|1
2194998|NCT01519765|3827185|FG000|Overall Study|Lack of Efficacy|2
2194999|NCT01519765|3827186|FG001|Overall Study|Lack of Efficacy|0
2195000|NCT01519765|3827185|FG000|Overall Study|Protocol Violation|1
2195001|NCT01519765|3827186|FG001|Overall Study|Protocol Violation|0
2195002|NCT01519765|3827185|FG000|Overall Study|Withdrawal by Subject|0
2195003|NCT01519765|3827186|FG001|Overall Study|Withdrawal by Subject|1
2195004|NCT01519778|3827193|FG000|Overall Study|Withdrawal by Subject|3
2195005|NCT01519778|3827193|FG000|Overall Study|Lost to Follow-up|10
2195006|NCT01519778|3827193|FG000|Overall Study|Physician Decision|1
2195007|NCT01519791|3827199|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
2195008|NCT01519791|3827200|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
2195009|NCT01519791|3827199|FG000|Overall Study|Protocol Violation|6
2195010|NCT01519791|3827200|FG001|Overall Study|Protocol Violation|19
2195011|NCT01519791|3827199|FG000|Overall Study|Other Reason|87
2195012|NCT01519791|3827200|FG001|Overall Study|Other Reason|222
2195013|NCT01519791|3827199|FG000|Overall Study|subjects randomized in error|2
2195014|NCT01519791|3827200|FG001|Overall Study|subjects randomized in error|0
2195015|NCT01519791|3827199|FG000|Overall Study|Lack of Efficacy|16
2195016|NCT01519791|3827200|FG001|Overall Study|Lack of Efficacy|20
2195017|NCT01519791|3827199|FG000|Overall Study|SAE, non-fatal|6
2195018|NCT01519791|3827200|FG001|Overall Study|SAE, non-fatal|22
2195019|NCT01519791|3827199|FG000|Overall Study|AE, serious fatal|0
2195020|NCT01519791|3827200|FG001|Overall Study|AE, serious fatal|1
2195021|NCT01519791|3827199|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0
2195022|NCT01519791|3827200|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1
2195023|NCT01519791|3827199|FG000|Overall Study|AE, non-serious non-fatal|12
2195024|NCT01519791|3827200|FG001|Overall Study|AE, non-serious non-fatal|31
2195025|NCT01519791|3827199|FG000|Overall Study|Withdrawal by Subject|15
2195026|NCT01519791|3827200|FG001|Overall Study|Withdrawal by Subject|37
2225244|NCT01780831|3873180|FG002|Overall Study|Lost to Follow-up|0
2225245|NCT01780831|3873181|FG003|Overall Study|Lost to Follow-up|1
2225246|NCT01780935|3873262|FG000|Overall Study|Admin problems due to early termination|321
2225247|NCT01780935|3873263|FG001|Overall Study|Admin problems due to early termination|309
2225248|NCT01780935|3873262|FG000|Overall Study|Adverse Event|2
2225249|NCT01780935|3873263|FG001|Overall Study|Adverse Event|4
2225250|NCT01780935|3873262|FG000|Overall Study|Death|1
2225251|NCT01780935|3873263|FG001|Overall Study|Death|6
2225252|NCT01780935|3873262|FG000|Overall Study|Lost to Follow-up|2
2225253|NCT01780935|3873263|FG001|Overall Study|Lost to Follow-up|6
2225254|NCT01780935|3873262|FG000|Overall Study|Physician Decision|1
2225255|NCT01780935|3873263|FG001|Overall Study|Physician Decision|1
2225256|NCT01780935|3873262|FG000|Overall Study|Protocol deviation|0
2225257|NCT01780935|3873263|FG001|Overall Study|Protocol deviation|1
2225258|NCT01780935|3873262|FG000|Overall Study|Patient withdrew consent|8
2225259|NCT01780935|3873263|FG001|Overall Study|Patient withdrew consent|9
2225260|NCT01780974|3873271|FG000|Overall Study|Death|1
2225261|NCT01780974|3873272|FG001|Overall Study|Death|0
2225262|NCT01780974|3873271|FG000|Overall Study|Adverse Event|1
2225263|NCT01780974|3873272|FG001|Overall Study|Adverse Event|3
2225264|NCT01780987|3873280|FG000|Overall Study|Adverse Event|0
2225265|NCT01780987|3873281|FG001|Overall Study|Adverse Event|4
2225266|NCT01780987|3873280|FG000|Overall Study|Withdrawal by Subject|2
2225267|NCT01780987|3873281|FG001|Overall Study|Withdrawal by Subject|0
2225268|NCT01780987|3873280|FG000|Overall Study|Request of Changing Hospital|0
2225269|NCT01780987|3873281|FG001|Overall Study|Request of Changing Hospital|1
2195027|NCT01519791|3827199|FG000|Overall Study|Lost to Follow-up|6
2195028|NCT01519791|3827200|FG001|Overall Study|Lost to Follow-up|14
2225270|NCT01780987|3873280|FG000|Overall Study|Changing Residence|1
2225271|NCT01780987|3873281|FG001|Overall Study|Changing Residence|0
2225272|NCT01780987|3873280|FG000|Overall Study|Not Receiving any Study Medication|0
2225273|NCT01780987|3873281|FG001|Overall Study|Not Receiving any Study Medication|1
2225274|NCT01781234|3873316|FG000|Overall Study|Adverse Event|2
2195029|NCT01519817|3827208|FG000|Overall Study|Withdrawal by Subject|1
2195030|NCT01519817|3827209|FG001|Overall Study|Withdrawal by Subject|0
2195031|NCT01519817|3827210|FG002|Overall Study|Withdrawal by Subject|0
2195032|NCT01519817|3827211|FG003|Overall Study|Withdrawal by Subject|0
2195033|NCT01519817|3827208|FG000|Overall Study|Off study due to infection|0
2195034|NCT01519817|3827209|FG001|Overall Study|Off study due to infection|0
2195035|NCT01519817|3827210|FG002|Overall Study|Off study due to infection|0
2195036|NCT01519817|3827211|FG003|Overall Study|Off study due to infection|1
2195037|NCT01519869|3827221|FG000|Overall Study|Lost to Follow-up|1
2195038|NCT01519921|3827236|FG000|Overall Study|Adverse Event|10
2195039|NCT01519921|3827237|FG001|Overall Study|Adverse Event|9
2195040|NCT01519921|3827236|FG000|Overall Study|Lack of Efficacy|4
2195041|NCT01519921|3827237|FG001|Overall Study|Lack of Efficacy|3
2195042|NCT01519921|3827236|FG000|Overall Study|Withdrawal by Subject|3
2195043|NCT01519921|3827237|FG001|Overall Study|Withdrawal by Subject|0
2195044|NCT01519921|3827236|FG000|Overall Study|Lost to Follow-up|2
2195045|NCT01519921|3827237|FG001|Overall Study|Lost to Follow-up|1
2195046|NCT01519921|3827236|FG000|Overall Study|Treatment refusal|2
2195047|NCT01519921|3827237|FG001|Overall Study|Treatment refusal|1
2195048|NCT01519921|3827236|FG000|Overall Study|High alanine aminotransferase (ALT)|0
2195049|NCT01519921|3827237|FG001|Overall Study|High alanine aminotransferase (ALT)|1
2195050|NCT01519934|3827243|FG000|Overall Study|Lost to Follow-up|3
2195051|NCT01519947|3827251|FG000|Overall Study|Death|0
2195052|NCT01519947|3827252|FG001|Overall Study|Death|0
2195053|NCT01519947|3827253|FG002|Overall Study|Death|0
2195054|NCT01519947|3827254|FG003|Overall Study|Death|1
2195055|NCT01519947|3827251|FG000|Overall Study|Protocol Violation|0
2195056|NCT01519947|3827252|FG001|Overall Study|Protocol Violation|0
2195057|NCT01519947|3827253|FG002|Overall Study|Protocol Violation|2
2195058|NCT01519947|3827254|FG003|Overall Study|Protocol Violation|1
2195059|NCT01519947|3827251|FG000|Overall Study|Peritoneal Dialysis Needed|0
2195060|NCT01519947|3827252|FG001|Overall Study|Peritoneal Dialysis Needed|1
2195061|NCT01519947|3827253|FG002|Overall Study|Peritoneal Dialysis Needed|0
2195062|NCT01519947|3827254|FG003|Overall Study|Peritoneal Dialysis Needed|0
2195063|NCT01519947|3827251|FG000|Overall Study|Development of Anemia|0
2195064|NCT01519947|3827252|FG001|Overall Study|Development of Anemia|1
2195065|NCT01519947|3827253|FG002|Overall Study|Development of Anemia|0
2195066|NCT01519947|3827254|FG003|Overall Study|Development of Anemia|1
2195067|NCT01519947|3827251|FG000|Overall Study|Blood Transfusion|0
2195068|NCT01519947|3827252|FG001|Overall Study|Blood Transfusion|1
2195069|NCT01519947|3827253|FG002|Overall Study|Blood Transfusion|1
2195070|NCT01519947|3827254|FG003|Overall Study|Blood Transfusion|0
2195071|NCT01519947|3827251|FG000|Overall Study|Withdrawal by Subject|0
2195072|NCT01519947|3827252|FG001|Overall Study|Withdrawal by Subject|1
2195073|NCT01519947|3827253|FG002|Overall Study|Withdrawal by Subject|0
2195074|NCT01519947|3827254|FG003|Overall Study|Withdrawal by Subject|1
2195075|NCT01519947|3827251|FG000|Overall Study|Lost to Follow-up|0
2195076|NCT01519947|3827252|FG001|Overall Study|Lost to Follow-up|0
2195077|NCT01519947|3827253|FG002|Overall Study|Lost to Follow-up|3
2195078|NCT01519947|3827254|FG003|Overall Study|Lost to Follow-up|2
2195079|NCT01519947|3827251|FG000|Overall Study|Poor Response|1
2195080|NCT01519947|3827252|FG001|Overall Study|Poor Response|0
2195081|NCT01519947|3827253|FG002|Overall Study|Poor Response|0
2195082|NCT01519947|3827254|FG003|Overall Study|Poor Response|1
2195083|NCT01519947|3827251|FG000|Overall Study|Adverse Event|1
2195084|NCT01519947|3827252|FG001|Overall Study|Adverse Event|0
2195085|NCT01519947|3827253|FG002|Overall Study|Adverse Event|1
2195086|NCT01519947|3827254|FG003|Overall Study|Adverse Event|1
2195087|NCT01520324|3827277|FG000|Overall Study|Subject discontinued (moderate illness)|1
2195088|NCT01520363|3827283|FG000|Overall Study|Withdrawal by Subject|2
2195089|NCT01520363|3827284|FG001|Overall Study|Withdrawal by Subject|0
2195090|NCT01520402|3827314|FG000|Overall Study|Withdrawal by Subject|2
2195091|NCT01520402|3827314|FG000|Overall Study|Physician Decision|3
2195092|NCT01520506|3827345|FG000|Overall Study|Missed Visit|4
2195093|NCT01520506|3827345|FG000|Overall Study|Lost to Follow-up|1
2195094|NCT01520506|3827345|FG000|Overall Study|Withdrawal by Subject|1
2195095|NCT01520870|3827421|FG000|Overall Study|Withdrawal by Subject|2
2195096|NCT01520909|3827427|FG000|Part 1 (Randomized Period)|Adverse Event|1
2195097|NCT01520909|3827428|FG001|Part 1 (Randomized Period)|Adverse Event|2
2195098|NCT01520909|3827429|FG002|Part 1 (Randomized Period)|Adverse Event|0
2195099|NCT01520909|3827427|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
2195100|NCT01520909|3827428|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
2225275|NCT01781234|3873317|FG001|Overall Study|Adverse Event|0
2225276|NCT01781234|3873316|FG000|Overall Study|Protocol Violation|3
2225277|NCT01781234|3873317|FG001|Overall Study|Protocol Violation|0
2225278|NCT01781234|3873316|FG000|Overall Study|Withdrawal by Subject|4
2225279|NCT01781234|3873317|FG001|Overall Study|Withdrawal by Subject|3
2225280|NCT01781286|3873325|FG000|Overall Study|Lost to Follow-up|0
2225281|NCT01781286|3873326|FG001|Overall Study|Lost to Follow-up|0
2225282|NCT01781286|3873327|FG002|Overall Study|Lost to Follow-up|0
2225283|NCT01781286|3873328|FG003|Overall Study|Lost to Follow-up|0
2225284|NCT01781286|3873329|FG004|Overall Study|Lost to Follow-up|0
2225285|NCT01781286|3873330|FG005|Overall Study|Lost to Follow-up|1
2225286|NCT01781286|3873325|FG000|Overall Study|Time Constraints|2
2195101|NCT01520909|3827429|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
2195102|NCT01520909|3827427|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
2195103|NCT01520909|3827428|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
2195104|NCT01520909|3827429|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
2195105|NCT01520909|3827427|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
2195106|NCT01520909|3827428|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
2195107|NCT01520909|3827429|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
2195108|NCT01520922|3827451|FG000|Treatment Phase|Physician Decision|2
2195109|NCT01520922|3827452|FG001|Treatment Phase|Physician Decision|1
2195110|NCT01520922|3827451|FG000|Treatment Phase|Progression|0
2195111|NCT01520922|3827452|FG001|Treatment Phase|Progression|2
2195112|NCT01520922|3827451|FG000|Treatment Phase|Adverse Event|3
2195113|NCT01520922|3827452|FG001|Treatment Phase|Adverse Event|5
2195114|NCT01520922|3827451|FG000|Follow up|Lost to Follow-up|0
2195115|NCT01520922|3827452|FG001|Follow up|Lost to Follow-up|1
2195116|NCT01520922|3827451|FG000|Survival Follow-up|Withdrawal by Subject|1
2195117|NCT01520922|3827452|FG001|Survival Follow-up|Withdrawal by Subject|0
2195118|NCT01520987|3827466|FG000|Overall Study|Withdrawal by Subject|1
2195119|NCT01520987|3827467|FG001|Overall Study|Withdrawal by Subject|0
2195120|NCT01520987|3827468|FG002|Overall Study|Withdrawal by Subject|0
2195121|NCT01520987|3827469|FG003|Overall Study|Withdrawal by Subject|0
2195122|NCT01520987|3827470|FG004|Overall Study|Withdrawal by Subject|0
2195123|NCT01520987|3827471|FG005|Overall Study|Withdrawal by Subject|1
2195124|NCT01520987|3827472|FG006|Overall Study|Withdrawal by Subject|0
2195125|NCT01520987|3827473|FG007|Overall Study|Withdrawal by Subject|0
2195126|NCT01521117|3827498|FG000|First Intervention (6 Weeks)|Adverse Event|5
2195127|NCT01521117|3827499|FG001|First Intervention (6 Weeks)|Adverse Event|1
2195128|NCT01521117|3827498|FG000|First Intervention (6 Weeks)|Scheduling Issues|0
2195129|NCT01521117|3827499|FG001|First Intervention (6 Weeks)|Scheduling Issues|2
2195130|NCT01521117|3827498|FG000|Second Intervention (6 Weeks)|Adverse Event|0
2195131|NCT01521117|3827499|FG001|Second Intervention (6 Weeks)|Adverse Event|3
2195132|NCT01521364|3827514|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
2195133|NCT01521364|3827514|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
2195134|NCT01521494|3827530|FG000|Overall Study|Adverse Event|1
2195135|NCT01521494|3827531|FG001|Overall Study|Adverse Event|2
2195136|NCT01521494|3827532|FG002|Overall Study|Adverse Event|9
2195137|NCT01521494|3827533|FG003|Overall Study|Adverse Event|6
2195138|NCT01521494|3827534|FG004|Overall Study|Adverse Event|2
2195139|NCT01521494|3827530|FG000|Overall Study|Lack of Efficacy|0
2195140|NCT01521494|3827531|FG001|Overall Study|Lack of Efficacy|0
2195141|NCT01521494|3827532|FG002|Overall Study|Lack of Efficacy|0
2195142|NCT01521494|3827533|FG003|Overall Study|Lack of Efficacy|0
2195143|NCT01521494|3827534|FG004|Overall Study|Lack of Efficacy|2
2195144|NCT01521494|3827530|FG000|Overall Study|Withdrawal by Subject|1
2195145|NCT01521494|3827531|FG001|Overall Study|Withdrawal by Subject|1
2195146|NCT01521494|3827532|FG002|Overall Study|Withdrawal by Subject|0
2195147|NCT01521494|3827533|FG003|Overall Study|Withdrawal by Subject|2
2195148|NCT01521494|3827534|FG004|Overall Study|Withdrawal by Subject|0
2195149|NCT01521494|3827530|FG000|Overall Study|Decrease in serum phosphate|0
2195150|NCT01521494|3827531|FG001|Overall Study|Decrease in serum phosphate|2
2195151|NCT01521494|3827532|FG002|Overall Study|Decrease in serum phosphate|3
2195152|NCT01521494|3827533|FG003|Overall Study|Decrease in serum phosphate|12
2195153|NCT01521494|3827534|FG004|Overall Study|Decrease in serum phosphate|0
2195154|NCT01521494|3827530|FG000|Overall Study|Decrease in serum calcium|0
2195155|NCT01521494|3827531|FG001|Overall Study|Decrease in serum calcium|0
2195156|NCT01521494|3827532|FG002|Overall Study|Decrease in serum calcium|0
2195157|NCT01521494|3827533|FG003|Overall Study|Decrease in serum calcium|1
2195158|NCT01521494|3827534|FG004|Overall Study|Decrease in serum calcium|1
2195159|NCT01521494|3827530|FG000|Overall Study|Physician Decision|0
2195160|NCT01521494|3827531|FG001|Overall Study|Physician Decision|0
2195161|NCT01521494|3827532|FG002|Overall Study|Physician Decision|0
2195162|NCT01521494|3827533|FG003|Overall Study|Physician Decision|0
2195163|NCT01521494|3827534|FG004|Overall Study|Physician Decision|2
2195164|NCT01521507|3827548|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2
2195165|NCT01521507|3827549|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0
2195166|NCT01521507|3827548|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1
2195167|NCT01521507|3827549|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3
2195168|NCT01521507|3827548|FG000|Stage 1: Randomized Design|Lost to Follow-up|0
2195169|NCT01521507|3827549|FG001|Stage 1: Randomized Design|Lost to Follow-up|2
2195170|NCT01521507|3827548|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0
2195171|NCT01521507|3827549|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1
2195172|NCT01521507|3827548|FG000|Stage 2: Observational Design|Withdrawal by Subject|3
2195173|NCT01521507|3827549|FG001|Stage 2: Observational Design|Withdrawal by Subject|1
2195174|NCT01521507|3827548|FG000|Stage 2: Observational Design|Physician Decision|1
2195175|NCT01521507|3827549|FG001|Stage 2: Observational Design|Physician Decision|0
2195176|NCT01521559|3827573|FG000|Overall Study|Adverse Event|0
2195177|NCT01521559|3827574|FG001|Overall Study|Adverse Event|4
2195178|NCT01521559|3827573|FG000|Overall Study|Death|1
2195179|NCT01521559|3827574|FG001|Overall Study|Death|0
2195180|NCT01521559|3827573|FG000|Overall Study|Withdrawal by Subject|9
2195181|NCT01521559|3827574|FG001|Overall Study|Withdrawal by Subject|11
2195182|NCT01521559|3827573|FG000|Overall Study|Lost to Follow-up|3
2195183|NCT01521559|3827574|FG001|Overall Study|Lost to Follow-up|1
2195184|NCT01521559|3827573|FG000|Overall Study|Protocol Violation|1
2195185|NCT01521559|3827574|FG001|Overall Study|Protocol Violation|0
2195186|NCT01521559|3827573|FG000|Overall Study|Other|1
2195187|NCT01521559|3827574|FG001|Overall Study|Other|2
2195188|NCT01521884|3827610|FG000|Overall Study|Non Responders|10
2195189|NCT01521884|3827610|FG000|Overall Study|Adverse Event|5
2195190|NCT01521884|3827610|FG000|Overall Study|Pregnancy|1
2195191|NCT01521884|3827610|FG000|Overall Study|Withdrawal by Subject|1
2195192|NCT01521884|3827610|FG000|Overall Study|Physician Decision|2
2195193|NCT01521884|3827610|FG000|Overall Study|Protocol Violation|3
2195194|NCT01521884|3827610|FG000|Overall Study|Participant non-eligible|1
2195195|NCT01521884|3827610|FG000|Overall Study|Lost to Follow-up|4
2195196|NCT01521897|3827614|FG000|Overall Study|Protocol Violation|18
2195197|NCT01521897|3827614|FG000|Overall Study|Lost to Follow-up|5
2195198|NCT01521923|3827622|FG000|Overall Study|AE, serious fatal|1
2195199|NCT01521923|3827623|FG001|Overall Study|AE, serious fatal|0
2195200|NCT01521923|3827624|FG002|Overall Study|AE, serious fatal|0
2195201|NCT01521923|3827625|FG003|Overall Study|AE, serious fatal|0
2195202|NCT01521923|3827622|FG000|Overall Study|SAE, non-fatal|0
2195203|NCT01521923|3827623|FG001|Overall Study|SAE, non-fatal|2
2195204|NCT01521923|3827624|FG002|Overall Study|SAE, non-fatal|2
2195205|NCT01521923|3827625|FG003|Overall Study|SAE, non-fatal|0
2195206|NCT01521923|3827622|FG000|Overall Study|AE, non-serious, non-fatal|1
2195207|NCT01521923|3827623|FG001|Overall Study|AE, non-serious, non-fatal|3
2195208|NCT01521923|3827624|FG002|Overall Study|AE, non-serious, non-fatal|6
2195209|NCT01521923|3827625|FG003|Overall Study|AE, non-serious, non-fatal|2
2195210|NCT01521923|3827622|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
2195211|NCT01521923|3827623|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
2195212|NCT01521923|3827624|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
2195213|NCT01521923|3827625|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
2195214|NCT01521923|3827622|FG000|Overall Study|Lack of Efficacy|1
2195215|NCT01521923|3827623|FG001|Overall Study|Lack of Efficacy|1
2195216|NCT01521923|3827624|FG002|Overall Study|Lack of Efficacy|0
2195217|NCT01521923|3827625|FG003|Overall Study|Lack of Efficacy|0
2195218|NCT01521923|3827622|FG000|Overall Study|Protocol Violation|0
2195219|NCT01521923|3827623|FG001|Overall Study|Protocol Violation|0
2195220|NCT01521923|3827624|FG002|Overall Study|Protocol Violation|1
2195221|NCT01521923|3827625|FG003|Overall Study|Protocol Violation|0
2195222|NCT01521923|3827622|FG000|Overall Study|Lost to Follow-up|1
2195223|NCT01521923|3827623|FG001|Overall Study|Lost to Follow-up|0
2195224|NCT01521923|3827624|FG002|Overall Study|Lost to Follow-up|2
2195225|NCT01521923|3827625|FG003|Overall Study|Lost to Follow-up|1
2195226|NCT01521923|3827622|FG000|Overall Study|Withdrawal by Subject|1
2195227|NCT01521923|3827623|FG001|Overall Study|Withdrawal by Subject|1
2195228|NCT01521923|3827624|FG002|Overall Study|Withdrawal by Subject|1
2195229|NCT01521923|3827625|FG003|Overall Study|Withdrawal by Subject|2
2195230|NCT01521923|3827622|FG000|Overall Study|Other|2
2195231|NCT01521923|3827623|FG001|Overall Study|Other|1
2195232|NCT01521923|3827624|FG002|Overall Study|Other|3
2195233|NCT01521923|3827625|FG003|Overall Study|Other|6
2195234|NCT01521923|3827622|FG000|Overall Study|AE, captured in Period 1|0
2195235|NCT01521923|3827623|FG001|Overall Study|AE, captured in Period 1|1
2195236|NCT01521923|3827624|FG002|Overall Study|AE, captured in Period 1|0
2195237|NCT01521923|3827625|FG003|Overall Study|AE, captured in Period 1|1
2195238|NCT01522235|3827653|FG000|Overall Study|Physician Decision|1
2195239|NCT01522235|3827654|FG001|Overall Study|Physician Decision|1
2195240|NCT01522248|3827666|FG000|Overall Study|Lost to Follow-up|1
2195241|NCT01522248|3827667|FG001|Overall Study|Lost to Follow-up|0
2195242|NCT01522404|3827694|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1
2195243|NCT01522404|3827695|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0
2195244|NCT01522404|3827694|FG000|First Intervention (up to Week 29)|Adverse Event|1
2195245|NCT01522404|3827695|FG001|First Intervention (up to Week 29)|Adverse Event|0
2195246|NCT01522404|3827694|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1
2195247|NCT01522404|3827695|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0
2195248|NCT01522443|3827724|FG000|Overall Study|No longer receiving clinical benefit|36
2195249|NCT01522443|3827725|FG001|Overall Study|No longer receiving clinical benefit|28
2195250|NCT01522443|3827724|FG000|Overall Study|Adverse Event|10
2195251|NCT01522443|3827725|FG001|Overall Study|Adverse Event|15
2195252|NCT01522443|3827724|FG000|Overall Study|Withdrawal by Subject|5
2195253|NCT01522443|3827725|FG001|Overall Study|Withdrawal by Subject|8
2195254|NCT01522443|3827724|FG000|Overall Study|No study treatment given|1
2195255|NCT01522443|3827725|FG001|Overall Study|No study treatment given|1
2195256|NCT01522443|3827724|FG000|Overall Study|Other|1
2195257|NCT01522443|3827725|FG001|Overall Study|Other|3
2195258|NCT01522456|3827731|FG000|Overall Study|Adverse Event|2
2195259|NCT01522456|3827731|FG000|Overall Study|Lost to Follow-up|2
2195260|NCT01522456|3827731|FG000|Overall Study|Withdrawal by Subject|2
2195261|NCT01522456|3827731|FG000|Overall Study|Pregnancy|1
2195262|NCT01522456|3827731|FG000|Overall Study|Tolerability Assessment|1
2195263|NCT01522651|3827747|FG000|Overall Study|Adverse Event|3
2195264|NCT01522651|3827748|FG001|Overall Study|Adverse Event|4
2195265|NCT01522651|3827749|FG002|Overall Study|Adverse Event|4
2195266|NCT01522651|3827750|FG003|Overall Study|Adverse Event|5
2195267|NCT01522651|3827751|FG004|Overall Study|Adverse Event|4
2195268|NCT01522651|3827747|FG000|Overall Study|Cardioversion|1
2195269|NCT01522651|3827748|FG001|Overall Study|Cardioversion|0
2195270|NCT01522651|3827749|FG002|Overall Study|Cardioversion|0
2195271|NCT01522651|3827750|FG003|Overall Study|Cardioversion|0
2195272|NCT01522651|3827751|FG004|Overall Study|Cardioversion|0
2195273|NCT01522651|3827747|FG000|Overall Study|Device Malfunction|0
2195274|NCT01522651|3827748|FG001|Overall Study|Device Malfunction|1
2195275|NCT01522651|3827749|FG002|Overall Study|Device Malfunction|0
2195276|NCT01522651|3827750|FG003|Overall Study|Device Malfunction|0
2195277|NCT01522651|3827751|FG004|Overall Study|Device Malfunction|0
2195278|NCT01522651|3827747|FG000|Overall Study|Investigator's Discretion|0
2195279|NCT01522651|3827748|FG001|Overall Study|Investigator's Discretion|1
2195280|NCT01522651|3827749|FG002|Overall Study|Investigator's Discretion|0
2195281|NCT01522651|3827750|FG003|Overall Study|Investigator's Discretion|0
2195282|NCT01522651|3827751|FG004|Overall Study|Investigator's Discretion|0
2195283|NCT01522651|3827747|FG000|Overall Study|Protocol Violation|3
2195284|NCT01522651|3827748|FG001|Overall Study|Protocol Violation|0
2195285|NCT01522651|3827749|FG002|Overall Study|Protocol Violation|0
2195286|NCT01522651|3827750|FG003|Overall Study|Protocol Violation|0
2195287|NCT01522651|3827751|FG004|Overall Study|Protocol Violation|0
2195288|NCT01522651|3827747|FG000|Overall Study|Reason Not Specified|0
2195289|NCT01522651|3827748|FG001|Overall Study|Reason Not Specified|0
2195290|NCT01522651|3827749|FG002|Overall Study|Reason Not Specified|0
2195291|NCT01522651|3827750|FG003|Overall Study|Reason Not Specified|1
2195292|NCT01522651|3827751|FG004|Overall Study|Reason Not Specified|0
2195293|NCT01522651|3827747|FG000|Overall Study|Participant Non-Compliance|1
2195294|NCT01522651|3827748|FG001|Overall Study|Participant Non-Compliance|0
2195295|NCT01522651|3827749|FG002|Overall Study|Participant Non-Compliance|0
2195296|NCT01522651|3827750|FG003|Overall Study|Participant Non-Compliance|0
2195297|NCT01522651|3827751|FG004|Overall Study|Participant Non-Compliance|0
2195298|NCT01522651|3827747|FG000|Overall Study|Withdrew Consent|1
2195299|NCT01522651|3827748|FG001|Overall Study|Withdrew Consent|1
2195300|NCT01522651|3827749|FG002|Overall Study|Withdrew Consent|0
2195301|NCT01522651|3827750|FG003|Overall Study|Withdrew Consent|1
2195302|NCT01522651|3827751|FG004|Overall Study|Withdrew Consent|1
2195303|NCT01522651|3827747|FG000|Overall Study|Randomized but Never Treated|0
2195304|NCT01522651|3827748|FG001|Overall Study|Randomized but Never Treated|1
2195305|NCT01522651|3827749|FG002|Overall Study|Randomized but Never Treated|0
2195306|NCT01522651|3827750|FG003|Overall Study|Randomized but Never Treated|1
2195307|NCT01522651|3827751|FG004|Overall Study|Randomized but Never Treated|1
2195308|NCT01522950|3827793|FG000|Overall Study|Withdrawal by Subject|3
2195309|NCT01522950|3827794|FG001|Overall Study|Withdrawal by Subject|2
2195310|NCT01522950|3827795|FG002|Overall Study|Withdrawal by Subject|1
2195311|NCT01522950|3827793|FG000|Overall Study|Adverse Event|3
2195312|NCT01522950|3827794|FG001|Overall Study|Adverse Event|1
2195313|NCT01522950|3827795|FG002|Overall Study|Adverse Event|1
2195314|NCT01522950|3827793|FG000|Overall Study|Protocol Violation|0
2195315|NCT01522950|3827794|FG001|Overall Study|Protocol Violation|0
2195316|NCT01522950|3827795|FG002|Overall Study|Protocol Violation|2
2195317|NCT01522950|3827793|FG000|Overall Study|Death|0
2195318|NCT01522950|3827794|FG001|Overall Study|Death|1
2195319|NCT01522950|3827795|FG002|Overall Study|Death|1
2195320|NCT01522950|3827793|FG000|Overall Study|Study Medication Sensitivity|0
2195321|NCT01522950|3827794|FG001|Overall Study|Study Medication Sensitivity|1
2195322|NCT01522950|3827795|FG002|Overall Study|Study Medication Sensitivity|0
2195323|NCT01523275|3827820|FG000|Overall Study|Lost to Follow-up|1
2195324|NCT01523275|3827821|FG001|Overall Study|Lost to Follow-up|2
2195325|NCT01523275|3827820|FG000|Overall Study|Withdrawal by Subject|1
2195326|NCT01523275|3827821|FG001|Overall Study|Withdrawal by Subject|0
2195327|NCT01523301|3827829|FG000|Overall Study|Adverse Event|25
2195328|NCT01523301|3827830|FG001|Overall Study|Adverse Event|16
2195329|NCT01523301|3827829|FG000|Overall Study|Lack of Efficacy|0
2195330|NCT01523301|3827830|FG001|Overall Study|Lack of Efficacy|2
2195331|NCT01523301|3827829|FG000|Overall Study|Protocol Violation|3
2195332|NCT01523301|3827830|FG001|Overall Study|Protocol Violation|4
2195333|NCT01523301|3827829|FG000|Overall Study|Lost to Follow-up|1
2195334|NCT01523301|3827830|FG001|Overall Study|Lost to Follow-up|0
2195335|NCT01523301|3827829|FG000|Overall Study|Withdrawal by Subject|6
2195336|NCT01523301|3827830|FG001|Overall Study|Withdrawal by Subject|8
2195337|NCT01523301|3827829|FG000|Overall Study|Other Reason|0
2195338|NCT01523301|3827830|FG001|Overall Study|Other Reason|2
2195339|NCT01523366|3827838|FG000|Treatment Period 1|Withdrawal by Subject|1
2195340|NCT01523366|3827839|FG001|Treatment Period 1|Withdrawal by Subject|0
2195341|NCT01523366|3827838|FG000|Treatment Period 2|Not completed at least 7 days treatment|1
2195342|NCT01523366|3827839|FG001|Treatment Period 2|Not completed at least 7 days treatment|0
2195343|NCT01523392|3827849|FG000|Treatment Period 1|Withdrawal by Subject|2
2195344|NCT01523392|3827850|FG001|Treatment Period 1|Withdrawal by Subject|0
2195345|NCT01523392|3827849|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1
2195346|NCT01523392|3827850|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0
2195347|NCT01523392|3827849|FG000|Washout Period - 10 to 14 Days|Adverse Event|1
2195348|NCT01523392|3827850|FG001|Washout Period - 10 to 14 Days|Adverse Event|0
2195349|NCT01523457|3827860|FG000|Overall Study|Withdrawal by Subject|7
2195350|NCT01523457|3827861|FG001|Overall Study|Withdrawal by Subject|2
2225287|NCT01781286|3873326|FG001|Overall Study|Time Constraints|0
2225288|NCT01781286|3873327|FG002|Overall Study|Time Constraints|2
2225289|NCT01781286|3873328|FG003|Overall Study|Time Constraints|0
2225290|NCT01781286|3873329|FG004|Overall Study|Time Constraints|0
2225291|NCT01781286|3873330|FG005|Overall Study|Time Constraints|0
2225292|NCT01781286|3873325|FG000|Overall Study|Noncompliance|0
2225293|NCT01781286|3873326|FG001|Overall Study|Noncompliance|0
2225294|NCT01781286|3873327|FG002|Overall Study|Noncompliance|0
2225295|NCT01781286|3873328|FG003|Overall Study|Noncompliance|1
2225296|NCT01781286|3873329|FG004|Overall Study|Noncompliance|0
2225297|NCT01781286|3873330|FG005|Overall Study|Noncompliance|0
2225298|NCT01781299|3873342|FG000|Overall Study|Withdrawal by Subject|0
2225299|NCT01781299|3873343|FG001|Overall Study|Withdrawal by Subject|1
2225300|NCT01781429|3873376|FG000|Overall Study|Death|0
2225301|NCT01781429|3873377|FG001|Overall Study|Death|0
2225302|NCT01781429|3873378|FG002|Overall Study|Death|0
2225303|NCT01781429|3873379|FG003|Overall Study|Death|0
2225304|NCT01781429|3873380|FG004|Overall Study|Death|0
2225305|NCT01781429|3873381|FG005|Overall Study|Death|0
2225306|NCT01781429|3873382|FG006|Overall Study|Death|0
2225307|NCT01781429|3873383|FG007|Overall Study|Death|0
2225308|NCT01781429|3873384|FG008|Overall Study|Death|0
2225309|NCT01781429|3873385|FG009|Overall Study|Death|1
2225310|NCT01781429|3873386|FG010|Overall Study|Death|0
2225311|NCT01781429|3873387|FG011|Overall Study|Death|0
2225312|NCT01781429|3873388|FG012|Overall Study|Death|1
2225313|NCT01781429|3873389|FG013|Overall Study|Death|0
2225314|NCT01781429|3873390|FG014|Overall Study|Death|1
2225315|NCT01781429|3873391|FG015|Overall Study|Death|0
2225316|NCT01781429|3873376|FG000|Overall Study|Withdrawal by Subject|0
2225317|NCT01781429|3873377|FG001|Overall Study|Withdrawal by Subject|0
2225318|NCT01781429|3873378|FG002|Overall Study|Withdrawal by Subject|0
2225319|NCT01781429|3873379|FG003|Overall Study|Withdrawal by Subject|0
2225320|NCT01781429|3873380|FG004|Overall Study|Withdrawal by Subject|0
2225321|NCT01781429|3873381|FG005|Overall Study|Withdrawal by Subject|0
2225322|NCT01781429|3873382|FG006|Overall Study|Withdrawal by Subject|0
2225323|NCT01781429|3873383|FG007|Overall Study|Withdrawal by Subject|0
2225324|NCT01781429|3873384|FG008|Overall Study|Withdrawal by Subject|1
2225325|NCT01781429|3873385|FG009|Overall Study|Withdrawal by Subject|3
2225326|NCT01781429|3873386|FG010|Overall Study|Withdrawal by Subject|1
2225327|NCT01781429|3873387|FG011|Overall Study|Withdrawal by Subject|1
2225328|NCT01781429|3873388|FG012|Overall Study|Withdrawal by Subject|5
2225329|NCT01781429|3873389|FG013|Overall Study|Withdrawal by Subject|2
2225330|NCT01781429|3873390|FG014|Overall Study|Withdrawal by Subject|3
2225331|NCT01781429|3873391|FG015|Overall Study|Withdrawal by Subject|0
2225332|NCT01781429|3873376|FG000|Overall Study|Disease Progression|1
2225333|NCT01781429|3873377|FG001|Overall Study|Disease Progression|0
2225334|NCT01781429|3873378|FG002|Overall Study|Disease Progression|1
2225335|NCT01781429|3873379|FG003|Overall Study|Disease Progression|1
2225336|NCT01781429|3873380|FG004|Overall Study|Disease Progression|1
2225337|NCT01781429|3873381|FG005|Overall Study|Disease Progression|4
2225338|NCT01781429|3873382|FG006|Overall Study|Disease Progression|7
2225339|NCT01781429|3873383|FG007|Overall Study|Disease Progression|4
2225340|NCT01781429|3873384|FG008|Overall Study|Disease Progression|6
2225341|NCT01781429|3873385|FG009|Overall Study|Disease Progression|15
2225342|NCT01781429|3873386|FG010|Overall Study|Disease Progression|15
2225343|NCT01781429|3873387|FG011|Overall Study|Disease Progression|15
2225344|NCT01781429|3873388|FG012|Overall Study|Disease Progression|15
2195351|NCT01523587|3827890|FG000|Overall Study|Other than listed|5
2195352|NCT01523587|3827891|FG001|Overall Study|Other than listed|5
2195353|NCT01523587|3827890|FG000|Overall Study|Worsening of underlying cancer disease|19
2195354|NCT01523587|3827891|FG001|Overall Study|Worsening of underlying cancer disease|34
2195355|NCT01523587|3827890|FG000|Overall Study|Adverse Event|68
2195356|NCT01523587|3827891|FG001|Overall Study|Adverse Event|52
2195357|NCT01523587|3827890|FG000|Overall Study|Protocol Violation|5
2195358|NCT01523587|3827891|FG001|Overall Study|Protocol Violation|3
2195359|NCT01523587|3827890|FG000|Overall Study|Lost to Follow-up|2
2195360|NCT01523587|3827891|FG001|Overall Study|Lost to Follow-up|2
2195361|NCT01523587|3827890|FG000|Overall Study|Withdrawal by Subject|28
2195362|NCT01523587|3827891|FG001|Overall Study|Withdrawal by Subject|20
2195363|NCT01523587|3827890|FG000|Overall Study|Withdrew due to Progressive disease|265
2195364|NCT01523587|3827891|FG001|Overall Study|Withdrew due to Progressive disease|279
2195365|NCT01523587|3827890|FG000|Overall Study|Randomised but bot treated|6
2195366|NCT01523587|3827891|FG001|Overall Study|Randomised but bot treated|2
2225345|NCT01781429|3873389|FG013|Overall Study|Disease Progression|4
2225346|NCT01781429|3873390|FG014|Overall Study|Disease Progression|11
2225347|NCT01781429|3873391|FG015|Overall Study|Disease Progression|0
2225348|NCT01781429|3873376|FG000|Overall Study|Unacceptable Toxicity|0
2225349|NCT01781429|3873377|FG001|Overall Study|Unacceptable Toxicity|0
2225350|NCT01781429|3873378|FG002|Overall Study|Unacceptable Toxicity|0
2225351|NCT01781429|3873379|FG003|Overall Study|Unacceptable Toxicity|0
2195367|NCT01523743|3827920|FG000|Period 1|Adverse Event|1
2195368|NCT01523743|3827921|FG001|Period 1|Adverse Event|0
2195369|NCT01523743|3827920|FG000|Period 1|Withdrawal by Subject|6
2195370|NCT01523743|3827921|FG001|Period 1|Withdrawal by Subject|2
2195371|NCT01523743|3827920|FG000|Period 1|Lost to Follow-up|1
2195372|NCT01523743|3827921|FG001|Period 1|Lost to Follow-up|0
2195373|NCT01523743|3827920|FG000|Period 1|Lack of Efficacy|1
2195374|NCT01523743|3827921|FG001|Period 1|Lack of Efficacy|0
2195375|NCT01523743|3827920|FG000|Period 1|Felt unable to empty bladder|1
2195376|NCT01523743|3827921|FG001|Period 1|Felt unable to empty bladder|0
2195377|NCT01523743|3827920|FG000|Period 2|Withdrawal by Subject|0
2195378|NCT01523743|3827921|FG001|Period 2|Withdrawal by Subject|2
2195379|NCT01523743|3827920|FG000|Period 2|Adverse Event|1
2195380|NCT01523743|3827921|FG001|Period 2|Adverse Event|0
2195381|NCT01523756|3827927|FG000|Baseline Period|Adverse Event|0
2195382|NCT01523756|3827928|FG001|Baseline Period|Adverse Event|1
2195383|NCT01523756|3827927|FG000|Test Period 1|Adverse Event|1
2195384|NCT01523756|3827928|FG001|Test Period 1|Adverse Event|0
2195385|NCT01523756|3827927|FG000|Test Period 2|Withdrawal by Subject|0
2195386|NCT01523756|3827928|FG001|Test Period 2|Withdrawal by Subject|1
2195387|NCT01523873|3827993|FG000|Overall Study|Protocol Violation|422
2195388|NCT01523886|3828001|FG000|Overall Study|surgery cancelled|0
2195389|NCT01523886|3828002|FG001|Overall Study|surgery cancelled|1
2195390|NCT01524133|3828038|FG000|Treatment Phase|Withdrawal by Subject|13
2195391|NCT01524133|3828039|FG001|Treatment Phase|Withdrawal by Subject|28
2195392|NCT01524133|3828040|FG002|Treatment Phase|Withdrawal by Subject|31
2195393|NCT01524133|3828038|FG000|Treatment Phase|Physician Decision|6
2195394|NCT01524133|3828039|FG001|Treatment Phase|Physician Decision|3
2195395|NCT01524133|3828040|FG002|Treatment Phase|Physician Decision|3
2195396|NCT01524133|3828038|FG000|Treatment Phase|Lost to Follow-up|0
2195397|NCT01524133|3828039|FG001|Treatment Phase|Lost to Follow-up|1
2195398|NCT01524133|3828040|FG002|Treatment Phase|Lost to Follow-up|2
2195399|NCT01524133|3828038|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4
2195400|NCT01524133|3828039|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5
2195401|NCT01524133|3828040|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10
2195402|NCT01524133|3828038|FG000|Overall Study 52 Weeks|Physician Decision|1
2195403|NCT01524133|3828039|FG001|Overall Study 52 Weeks|Physician Decision|0
2195404|NCT01524133|3828040|FG002|Overall Study 52 Weeks|Physician Decision|2
2195405|NCT01524133|3828038|FG000|Overall Study 52 Weeks|Lost to Follow-up|16
2195406|NCT01524133|3828039|FG001|Overall Study 52 Weeks|Lost to Follow-up|15
2195407|NCT01524133|3828040|FG002|Overall Study 52 Weeks|Lost to Follow-up|15
2195408|NCT01524198|3828050|FG000|Overall Study|Protocol Violation|8
2195409|NCT01524198|3828051|FG001|Overall Study|Protocol Violation|6
2195410|NCT01524198|3828050|FG000|Overall Study|Withdrawal by Subject|15
2195411|NCT01524198|3828051|FG001|Overall Study|Withdrawal by Subject|10
2225352|NCT01781429|3873380|FG004|Overall Study|Unacceptable Toxicity|0
2225353|NCT01781429|3873381|FG005|Overall Study|Unacceptable Toxicity|0
2225354|NCT01781429|3873382|FG006|Overall Study|Unacceptable Toxicity|0
2225355|NCT01781429|3873383|FG007|Overall Study|Unacceptable Toxicity|0
2225356|NCT01781429|3873384|FG008|Overall Study|Unacceptable Toxicity|0
2225357|NCT01781429|3873385|FG009|Overall Study|Unacceptable Toxicity|0
2225358|NCT01781429|3873386|FG010|Overall Study|Unacceptable Toxicity|0
2225359|NCT01781429|3873387|FG011|Overall Study|Unacceptable Toxicity|2
2225360|NCT01781429|3873388|FG012|Overall Study|Unacceptable Toxicity|0
2225361|NCT01781429|3873389|FG013|Overall Study|Unacceptable Toxicity|0
2225362|NCT01781429|3873390|FG014|Overall Study|Unacceptable Toxicity|0
2225363|NCT01781429|3873391|FG015|Overall Study|Unacceptable Toxicity|0
2225364|NCT01781429|3873376|FG000|Overall Study|Patient Condition Changed|0
2225365|NCT01781429|3873377|FG001|Overall Study|Patient Condition Changed|0
2225366|NCT01781429|3873378|FG002|Overall Study|Patient Condition Changed|0
2225367|NCT01781429|3873379|FG003|Overall Study|Patient Condition Changed|0
2225368|NCT01781429|3873380|FG004|Overall Study|Patient Condition Changed|0
2225369|NCT01781429|3873381|FG005|Overall Study|Patient Condition Changed|0
2225370|NCT01781429|3873382|FG006|Overall Study|Patient Condition Changed|0
2225371|NCT01781429|3873383|FG007|Overall Study|Patient Condition Changed|0
2225372|NCT01781429|3873384|FG008|Overall Study|Patient Condition Changed|0
2225373|NCT01781429|3873385|FG009|Overall Study|Patient Condition Changed|4
2225374|NCT01781429|3873386|FG010|Overall Study|Patient Condition Changed|0
2225375|NCT01781429|3873387|FG011|Overall Study|Patient Condition Changed|1
2225376|NCT01781429|3873388|FG012|Overall Study|Patient Condition Changed|0
2225377|NCT01781429|3873389|FG013|Overall Study|Patient Condition Changed|1
2225378|NCT01781429|3873390|FG014|Overall Study|Patient Condition Changed|0
2225379|NCT01781429|3873391|FG015|Overall Study|Patient Condition Changed|0
2225380|NCT01781429|3873376|FG000|Overall Study|Other - as entered by PI in eCRF|0
2225381|NCT01781429|3873377|FG001|Overall Study|Other - as entered by PI in eCRF|1
2225382|NCT01781429|3873378|FG002|Overall Study|Other - as entered by PI in eCRF|0
2225383|NCT01781429|3873379|FG003|Overall Study|Other - as entered by PI in eCRF|0
2225384|NCT01781429|3873380|FG004|Overall Study|Other - as entered by PI in eCRF|0
2225385|NCT01781429|3873381|FG005|Overall Study|Other - as entered by PI in eCRF|0
2225386|NCT01781429|3873382|FG006|Overall Study|Other - as entered by PI in eCRF|0
2225387|NCT01781429|3873383|FG007|Overall Study|Other - as entered by PI in eCRF|0
2225388|NCT01781429|3873384|FG008|Overall Study|Other - as entered by PI in eCRF|0
2195412|NCT01524224|3828065|FG000|Overall Study|Progressive Disease|1
2195413|NCT01524224|3828066|FG001|Overall Study|Progressive Disease|0
2195414|NCT01524224|3828067|FG002|Overall Study|Progressive Disease|2
2195415|NCT01524224|3828068|FG003|Overall Study|Progressive Disease|1
2195416|NCT01524224|3828069|FG004|Overall Study|Progressive Disease|2
2195417|NCT01524224|3828070|FG005|Overall Study|Progressive Disease|1
2195418|NCT01524224|3828071|FG006|Overall Study|Progressive Disease|1
2195419|NCT01524224|3828072|FG007|Overall Study|Progressive Disease|5
2195420|NCT01524224|3828065|FG000|Overall Study|Withdrawal by Subject|2
2195421|NCT01524224|3828066|FG001|Overall Study|Withdrawal by Subject|0
2195422|NCT01524224|3828067|FG002|Overall Study|Withdrawal by Subject|0
2195423|NCT01524224|3828068|FG003|Overall Study|Withdrawal by Subject|0
2195424|NCT01524224|3828069|FG004|Overall Study|Withdrawal by Subject|0
2195425|NCT01524224|3828070|FG005|Overall Study|Withdrawal by Subject|0
2195426|NCT01524224|3828071|FG006|Overall Study|Withdrawal by Subject|2
2195427|NCT01524224|3828072|FG007|Overall Study|Withdrawal by Subject|0
2195428|NCT01524224|3828065|FG000|Overall Study|Adverse Event|0
2195429|NCT01524224|3828066|FG001|Overall Study|Adverse Event|1
2195430|NCT01524224|3828067|FG002|Overall Study|Adverse Event|0
2225389|NCT01781429|3873385|FG009|Overall Study|Other - as entered by PI in eCRF|1
2225390|NCT01781429|3873386|FG010|Overall Study|Other - as entered by PI in eCRF|1
2225391|NCT01781429|3873387|FG011|Overall Study|Other - as entered by PI in eCRF|2
2225392|NCT01781429|3873388|FG012|Overall Study|Other - as entered by PI in eCRF|1
2225393|NCT01781429|3873389|FG013|Overall Study|Other - as entered by PI in eCRF|1
2225394|NCT01781429|3873390|FG014|Overall Study|Other - as entered by PI in eCRF|1
2225395|NCT01781429|3873391|FG015|Overall Study|Other - as entered by PI in eCRF|0
2225396|NCT01781429|3873376|FG000|Overall Study|Enrolled, but not treated|0
2225397|NCT01781429|3873377|FG001|Overall Study|Enrolled, but not treated|0
2225398|NCT01781429|3873378|FG002|Overall Study|Enrolled, but not treated|0
2225399|NCT01781429|3873379|FG003|Overall Study|Enrolled, but not treated|0
2225400|NCT01781429|3873380|FG004|Overall Study|Enrolled, but not treated|0
2225401|NCT01781429|3873381|FG005|Overall Study|Enrolled, but not treated|0
2225402|NCT01781429|3873382|FG006|Overall Study|Enrolled, but not treated|0
2225403|NCT01781429|3873383|FG007|Overall Study|Enrolled, but not treated|0
2225404|NCT01781429|3873384|FG008|Overall Study|Enrolled, but not treated|0
2225405|NCT01781429|3873385|FG009|Overall Study|Enrolled, but not treated|0
2225406|NCT01781429|3873386|FG010|Overall Study|Enrolled, but not treated|1
2225407|NCT01781429|3873387|FG011|Overall Study|Enrolled, but not treated|0
2225408|NCT01781429|3873388|FG012|Overall Study|Enrolled, but not treated|0
2225409|NCT01781429|3873389|FG013|Overall Study|Enrolled, but not treated|0
2225410|NCT01781429|3873390|FG014|Overall Study|Enrolled, but not treated|0
2225411|NCT01781429|3873391|FG015|Overall Study|Enrolled, but not treated|0
2225412|NCT01781572|3873494|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7
2225413|NCT01781572|3873495|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0
2225414|NCT01781572|3873496|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11
2225415|NCT01781572|3873494|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8
2225416|NCT01781572|3873495|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6
2225417|NCT01781572|3873496|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23
2225418|NCT01781572|3873494|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1
2225419|NCT01781572|3873495|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0
2225420|NCT01781572|3873496|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2
2225421|NCT01781572|3873494|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
2225422|NCT01781572|3873495|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
2225423|NCT01781572|3873496|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4
2225424|NCT01781572|3873494|FG000|MEK162 45mg BID+LEE011 200mg|Death|0
2225425|NCT01781572|3873495|FG001|MEK162 45mg BID+LEE011 200mg|Death|0
2225426|NCT01781572|3873496|FG002|MEK162 45mg BID+LEE011 200mg|Death|1
2225427|NCT01781572|3873494|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2
2225428|NCT01781572|3873495|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
2225429|NCT01781572|3873496|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
2225430|NCT01781572|3873494|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1
2225431|NCT01781572|3873495|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
2225432|NCT01781572|3873496|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
2225433|NCT01781572|3873494|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1
2225434|NCT01781572|3873495|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
2225435|NCT01781572|3873496|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
2225436|NCT01781572|3873494|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3
2225437|NCT01781572|3873495|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2
2225438|NCT01781572|3873496|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0
2225439|NCT01781572|3873494|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
2225440|NCT01781572|3873495|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
2225441|NCT01781572|3873496|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0
2225442|NCT01781572|3873494|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4
2225443|NCT01781572|3873495|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3
2225444|NCT01781572|3873496|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0
2225445|NCT01781572|3873494|FG000|MEK162 45mg BID+LEE011 300mg|Death|1
2225446|NCT01781572|3873495|FG001|MEK162 45mg BID+LEE011 300mg|Death|0
2195431|NCT01524224|3828068|FG003|Overall Study|Adverse Event|0
2195432|NCT01524224|3828069|FG004|Overall Study|Adverse Event|0
2195433|NCT01524224|3828070|FG005|Overall Study|Adverse Event|1
2195434|NCT01524224|3828071|FG006|Overall Study|Adverse Event|0
2195435|NCT01524224|3828072|FG007|Overall Study|Adverse Event|0
2195436|NCT01524224|3828065|FG000|Overall Study|Physician Decision|0
2195437|NCT01524224|3828066|FG001|Overall Study|Physician Decision|0
2195438|NCT01524224|3828067|FG002|Overall Study|Physician Decision|0
2195439|NCT01524224|3828068|FG003|Overall Study|Physician Decision|1
2195440|NCT01524224|3828069|FG004|Overall Study|Physician Decision|1
2195441|NCT01524224|3828070|FG005|Overall Study|Physician Decision|0
2195442|NCT01524224|3828071|FG006|Overall Study|Physician Decision|0
2195443|NCT01524224|3828072|FG007|Overall Study|Physician Decision|1
2195444|NCT01524224|3828065|FG000|Overall Study|Sponsor Decision|0
2195445|NCT01524224|3828066|FG001|Overall Study|Sponsor Decision|0
2195446|NCT01524224|3828067|FG002|Overall Study|Sponsor Decision|0
2195447|NCT01524224|3828068|FG003|Overall Study|Sponsor Decision|0
2195448|NCT01524224|3828069|FG004|Overall Study|Sponsor Decision|1
2195449|NCT01524224|3828070|FG005|Overall Study|Sponsor Decision|0
2195450|NCT01524224|3828071|FG006|Overall Study|Sponsor Decision|0
2195451|NCT01524224|3828072|FG007|Overall Study|Sponsor Decision|0
2195452|NCT01524289|3828092|FG000|Overall Study|Lost to Follow-up|0
2195453|NCT01524289|3828093|FG001|Overall Study|Lost to Follow-up|1
2195454|NCT01524289|3828092|FG000|Overall Study|Physician Decision|1
2195455|NCT01524289|3828093|FG001|Overall Study|Physician Decision|0
2195456|NCT01524289|3828092|FG000|Overall Study|Protocol Violation|5
2195457|NCT01524289|3828093|FG001|Overall Study|Protocol Violation|1
2195458|NCT01524289|3828092|FG000|Overall Study|Withdrawal by Subject|11
2195459|NCT01524289|3828093|FG001|Overall Study|Withdrawal by Subject|7
2195460|NCT01524289|3828092|FG000|Overall Study|Adverse Event|12
2195461|NCT01524289|3828093|FG001|Overall Study|Adverse Event|5
2195462|NCT01524289|3828092|FG000|Overall Study|Did not take study medication|1
2195463|NCT01524289|3828093|FG001|Overall Study|Did not take study medication|0
2195464|NCT01524627|3828116|FG000|Overall Study|Physician Decision|0
2195465|NCT01524627|3828117|FG001|Overall Study|Physician Decision|1
2195466|NCT01524627|3828116|FG000|Overall Study|Lost to Follow-up|1
2195467|NCT01524627|3828117|FG001|Overall Study|Lost to Follow-up|1
2195468|NCT01524679|3828125|FG000|Overall Study|Lost to Follow-up|1
2195469|NCT01524679|3828126|FG001|Overall Study|Lost to Follow-up|4
2195470|NCT01524679|3828125|FG000|Overall Study|Withdrawal by Subject|4
2195471|NCT01524679|3828126|FG001|Overall Study|Withdrawal by Subject|4
2195472|NCT01524679|3828125|FG000|Overall Study|Adverse Event|9
2195473|NCT01524679|3828126|FG001|Overall Study|Adverse Event|0
2195474|NCT01524679|3828125|FG000|Overall Study|Protocol Violation|1
2195475|NCT01524679|3828126|FG001|Overall Study|Protocol Violation|0
2195476|NCT01524679|3828125|FG000|Overall Study|Lack of Efficacy|2
2195477|NCT01524679|3828126|FG001|Overall Study|Lack of Efficacy|0
2195478|NCT01524679|3828125|FG000|Overall Study|e.g.wish for children, relocation|6
2195479|NCT01524679|3828126|FG001|Overall Study|e.g.wish for children, relocation|1
2195480|NCT01524692|3828132|FG000|Overall Study|Withdrawal by Subject|3
2195481|NCT01524770|3828137|FG000|First Intervention|Withdrawal by Subject|1
2195482|NCT01524770|3828138|FG001|First Intervention|Withdrawal by Subject|0
2195483|NCT01524770|3828137|FG000|First Intervention|Adverse Event|1
2195484|NCT01524770|3828138|FG001|First Intervention|Adverse Event|1
2195485|NCT01524770|3828137|FG000|First Intervention|Protocol Violation|1
2195486|NCT01524770|3828138|FG001|First Intervention|Protocol Violation|0
2195487|NCT01524783|3828146|FG000|Blinded Period|Adverse Event|64
2195488|NCT01524783|3828147|FG001|Blinded Period|Adverse Event|7
2225447|NCT01781572|3873496|FG002|MEK162 45mg BID+LEE011 300mg|Death|0
2225448|NCT01781572|3873494|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0
2225449|NCT01781572|3873495|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5
2225450|NCT01781572|3873496|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0
2225451|NCT01781572|3873494|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0
2225452|NCT01781572|3873495|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1
2225453|NCT01781572|3873496|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0
2225454|NCT01781572|3873494|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0
2225455|NCT01781572|3873495|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2
2225456|NCT01781572|3873496|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0
2225457|NCT01781572|3873494|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0
2225458|NCT01781572|3873495|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6
2225459|NCT01781572|3873496|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0
2225460|NCT01781572|3873494|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0
2225461|NCT01781572|3873495|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1
2225462|NCT01781572|3873496|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0
2225463|NCT01781572|3873494|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0
2225464|NCT01781572|3873495|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5
2225465|NCT01781572|3873496|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0
2225466|NCT01781611|3873527|FG000|Overall Study|Adverse Event|4
2225467|NCT01781611|3873528|FG001|Overall Study|Adverse Event|0
2225468|NCT01781832|3873544|FG000|Overall Study|Withdrawal by Subject|1
2225469|NCT01781962|3873548|FG000|Overall Study|Other Miscellaneous Reasons|5
2225470|NCT01781975|3873554|FG000|Overall Study|Death|1
2225471|NCT01781975|3873555|FG001|Overall Study|Death|0
2225472|NCT01781975|3873554|FG000|Overall Study|Withdrawal by Subject|1
2195489|NCT01524783|3828148|FG002|Blinded Period|Adverse Event|0
2195490|NCT01524783|3828146|FG000|Blinded Period|Disease Progression|89
2195491|NCT01524783|3828147|FG001|Blinded Period|Disease Progression|75
2195492|NCT01524783|3828148|FG002|Blinded Period|Disease Progression|0
2195493|NCT01524783|3828146|FG000|Blinded Period|Withdrawal by Subject|19
2195494|NCT01524783|3828147|FG001|Blinded Period|Withdrawal by Subject|6
2195495|NCT01524783|3828148|FG002|Blinded Period|Withdrawal by Subject|0
2195496|NCT01524783|3828146|FG000|Blinded Period|Protocol deviation|2
2195497|NCT01524783|3828147|FG001|Blinded Period|Protocol deviation|1
2195498|NCT01524783|3828148|FG002|Blinded Period|Protocol deviation|0
2195499|NCT01524783|3828146|FG000|Blinded Period|Death|5
2195500|NCT01524783|3828147|FG001|Blinded Period|Death|2
2195501|NCT01524783|3828148|FG002|Blinded Period|Death|0
2195502|NCT01524783|3828146|FG000|Open-label Period|Disease progression|13
2195503|NCT01524783|3828147|FG001|Open-label Period|Disease progression|0
2195504|NCT01524783|3828148|FG002|Open-label Period|Disease progression|2
2195505|NCT01524783|3828146|FG000|Open-label Period|Administrative problems|5
2195506|NCT01524783|3828147|FG001|Open-label Period|Administrative problems|0
2195507|NCT01524783|3828148|FG002|Open-label Period|Administrative problems|2
2195508|NCT01524783|3828146|FG000|Open-label Period|Adverse Event|5
2195509|NCT01524783|3828147|FG001|Open-label Period|Adverse Event|0
2195510|NCT01524783|3828148|FG002|Open-label Period|Adverse Event|1
2195511|NCT01524783|3828146|FG000|Open-label Period|Withdrawal by Subject|2
2195512|NCT01524783|3828147|FG001|Open-label Period|Withdrawal by Subject|0
2195513|NCT01524783|3828148|FG002|Open-label Period|Withdrawal by Subject|1
2195514|NCT01524783|3828146|FG000|Open-label Period|Protocol deviation|1
2195515|NCT01524783|3828147|FG001|Open-label Period|Protocol deviation|0
2195516|NCT01524783|3828148|FG002|Open-label Period|Protocol deviation|0
2195517|NCT01524796|3828160|FG000|Overall Study|Adverse Event|13
2195518|NCT01524796|3828160|FG000|Overall Study|Lack of Efficacy|3
2195519|NCT01524796|3828160|FG000|Overall Study|Lost to Follow-up|1
2195520|NCT01524796|3828160|FG000|Overall Study|The price|1
2195521|NCT01524796|3828160|FG000|Overall Study|Withdrawal by Subject|4
2195522|NCT01524796|3828160|FG000|Overall Study|Move|1
2195523|NCT01524796|3828160|FG000|Overall Study|Deterioration of pains|1
2195524|NCT01524796|3828160|FG000|Overall Study|Gall stone surgery|1
2195525|NCT01524796|3828160|FG000|Overall Study|Nervous about confidentiality|1
2195526|NCT01524796|3828160|FG000|Overall Study|Switch to carbamazapine|1
2195527|NCT01524796|3828160|FG000|Overall Study|Adverse Event and Lack of Efficacy|1
2195528|NCT01524887|3828167|FG000|Overall Study|Withdrawal by Subject|6
2195529|NCT01524887|3828168|FG001|Overall Study|Withdrawal by Subject|2
2195530|NCT01524887|3828169|FG002|Overall Study|Withdrawal by Subject|3
2195531|NCT01524887|3828167|FG000|Overall Study|Adverse Event|5
2225473|NCT01781975|3873555|FG001|Overall Study|Withdrawal by Subject|1
2225474|NCT01782131|3873563|FG000|Overall Study|Death|93
2225475|NCT01782131|3873564|FG001|Overall Study|Death|96
2225476|NCT01782131|3873563|FG000|Overall Study|Lost to Follow-up|1
2225477|NCT01782131|3873564|FG001|Overall Study|Lost to Follow-up|3
2225478|NCT01782131|3873563|FG000|Overall Study|Withdrawal by Subject|10
2225479|NCT01782131|3873564|FG001|Overall Study|Withdrawal by Subject|10
2225480|NCT01782131|3873563|FG000|Overall Study|Randomized but not treated|5
2225481|NCT01782131|3873564|FG001|Overall Study|Randomized but not treated|5
2225482|NCT01782131|3873563|FG000|Overall Study|Reason not provided|0
2225483|NCT01782131|3873564|FG001|Overall Study|Reason not provided|1
2225484|NCT01782222|3873577|FG000|Overall Study|Adverse Event|4
2225485|NCT01782222|3873578|FG001|Overall Study|Adverse Event|5
2225486|NCT01782222|3873579|FG002|Overall Study|Adverse Event|3
2225487|NCT01782222|3873577|FG000|Overall Study|Lack of Efficacy|2
2225488|NCT01782222|3873578|FG001|Overall Study|Lack of Efficacy|1
2225489|NCT01782222|3873579|FG002|Overall Study|Lack of Efficacy|0
2225490|NCT01782222|3873577|FG000|Overall Study|Protocol Violation|1
2225491|NCT01782222|3873578|FG001|Overall Study|Protocol Violation|0
2225492|NCT01782222|3873579|FG002|Overall Study|Protocol Violation|0
2225493|NCT01782222|3873577|FG000|Overall Study|Withdrawal by Subject|1
2225494|NCT01782222|3873578|FG001|Overall Study|Withdrawal by Subject|4
2225495|NCT01782222|3873579|FG002|Overall Study|Withdrawal by Subject|1
2225496|NCT01782222|3873577|FG000|Overall Study|Moved to other state|0
2225497|NCT01782222|3873578|FG001|Overall Study|Moved to other state|1
2225498|NCT01782222|3873579|FG002|Overall Study|Moved to other state|0
2225499|NCT01782313|3873587|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3
2225500|NCT01782313|3873587|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3
2225501|NCT01782313|3873587|FG000|Treated Cycle 3|Progressive Disease|21
2225502|NCT01782313|3873587|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
2225503|NCT01782313|3873587|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
2225504|NCT01782313|3873587|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6
2225505|NCT01782313|3873587|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
2225506|NCT01782313|3873587|FG000|Survival Follow up|Lost to Follow-up|1
2225507|NCT01782326|3873593|FG000|Planned Treatment Epoch|Subject/guardian decision|149
2225508|NCT01782326|3873594|FG001|Planned Treatment Epoch|Subject/guardian decision|151
2225509|NCT01782326|3873593|FG000|Planned Treatment Epoch|Death|29
2225510|NCT01782326|3873594|FG001|Planned Treatment Epoch|Death|30
2225511|NCT01782326|3873593|FG000|Planned Treatment Epoch|Physician Decision|18
2225512|NCT01782326|3873594|FG001|Planned Treatment Epoch|Physician Decision|16
2225513|NCT01782326|3873593|FG000|Planned Treatment Epoch|Protocol deviation|2
2195532|NCT01524887|3828168|FG001|Overall Study|Adverse Event|1
2195533|NCT01524887|3828169|FG002|Overall Study|Adverse Event|1
2195534|NCT01524887|3828167|FG000|Overall Study|Protocol Violation|0
2195535|NCT01524887|3828168|FG001|Overall Study|Protocol Violation|0
2195536|NCT01524887|3828169|FG002|Overall Study|Protocol Violation|1
2195537|NCT01524887|3828167|FG000|Overall Study|Study termination|73
2195538|NCT01524887|3828168|FG001|Overall Study|Study termination|87
2195539|NCT01524887|3828169|FG002|Overall Study|Study termination|79
2195540|NCT01524887|3828167|FG000|Overall Study|Withdrawal by Caregiver|0
2195541|NCT01524887|3828168|FG001|Overall Study|Withdrawal by Caregiver|0
2195542|NCT01524887|3828169|FG002|Overall Study|Withdrawal by Caregiver|2
2195543|NCT01524887|3828167|FG000|Overall Study|Use of prohibited medication|1
2195544|NCT01524887|3828168|FG001|Overall Study|Use of prohibited medication|0
2195545|NCT01524887|3828169|FG002|Overall Study|Use of prohibited medication|0
2195546|NCT01524900|3828182|FG000|Overall Study|Lost to Follow-up|3
2195547|NCT01524900|3828183|FG001|Overall Study|Lost to Follow-up|12
2195548|NCT01524900|3828184|FG002|Overall Study|Lost to Follow-up|1
2195549|NCT01524900|3828185|FG003|Overall Study|Lost to Follow-up|0
2195550|NCT01524900|3828186|FG004|Overall Study|Lost to Follow-up|0
2195551|NCT01524900|3828182|FG000|Overall Study|Other reason than stated above|1
2195552|NCT01524900|3828183|FG001|Overall Study|Other reason than stated above|1
2195553|NCT01524900|3828184|FG002|Overall Study|Other reason than stated above|0
2195554|NCT01524900|3828185|FG003|Overall Study|Other reason than stated above|0
2195555|NCT01524900|3828186|FG004|Overall Study|Other reason than stated above|0
2195556|NCT01524900|3828182|FG000|Overall Study|No reason documented|2
2195557|NCT01524900|3828183|FG001|Overall Study|No reason documented|1
2195558|NCT01524900|3828184|FG002|Overall Study|No reason documented|0
2195559|NCT01524900|3828185|FG003|Overall Study|No reason documented|1
2195560|NCT01524900|3828186|FG004|Overall Study|No reason documented|0
2195561|NCT01524913|3828202|FG000|Overall Study|Lost to Follow-up|4
2195562|NCT01524913|3828203|FG001|Overall Study|Lost to Follow-up|0
2195563|NCT01524913|3828204|FG002|Overall Study|Lost to Follow-up|0
2195564|NCT01524978|3828223|FG000|Overall Study|Other|16
2195565|NCT01524978|3828224|FG001|Overall Study|Other|2
2195566|NCT01524978|3828225|FG002|Overall Study|Other|1
2195567|NCT01524978|3828226|FG003|Overall Study|Other|2
2195568|NCT01524978|3828227|FG004|Overall Study|Other|1
2195569|NCT01524978|3828228|FG005|Overall Study|Other|3
2195570|NCT01524978|3828229|FG006|Overall Study|Other|17
2195571|NCT01524978|3828230|FG007|Overall Study|Other|1
2195572|NCT01524978|3828231|FG008|Overall Study|Other|2
2195573|NCT01524978|3828232|FG009|Overall Study|Other|2
2195574|NCT01524978|3828233|FG010|Overall Study|Other|5
2195575|NCT01524978|3828223|FG000|Overall Study|Withdrawal by Subject|12
2195576|NCT01524978|3828224|FG001|Overall Study|Withdrawal by Subject|0
2195577|NCT01524978|3828225|FG002|Overall Study|Withdrawal by Subject|1
2195578|NCT01524978|3828226|FG003|Overall Study|Withdrawal by Subject|1
2195579|NCT01524978|3828227|FG004|Overall Study|Withdrawal by Subject|3
2195580|NCT01524978|3828228|FG005|Overall Study|Withdrawal by Subject|1
2195581|NCT01524978|3828229|FG006|Overall Study|Withdrawal by Subject|6
2195582|NCT01524978|3828230|FG007|Overall Study|Withdrawal by Subject|2
2195583|NCT01524978|3828231|FG008|Overall Study|Withdrawal by Subject|4
2195584|NCT01524978|3828232|FG009|Overall Study|Withdrawal by Subject|0
2195585|NCT01524978|3828233|FG010|Overall Study|Withdrawal by Subject|5
2195586|NCT01524978|3828223|FG000|Overall Study|Lost to Follow-up|0
2195587|NCT01524978|3828224|FG001|Overall Study|Lost to Follow-up|0
2195588|NCT01524978|3828225|FG002|Overall Study|Lost to Follow-up|3
2195589|NCT01524978|3828226|FG003|Overall Study|Lost to Follow-up|0
2195590|NCT01524978|3828227|FG004|Overall Study|Lost to Follow-up|1
2195591|NCT01524978|3828228|FG005|Overall Study|Lost to Follow-up|1
2195592|NCT01524978|3828229|FG006|Overall Study|Lost to Follow-up|2
2195593|NCT01524978|3828230|FG007|Overall Study|Lost to Follow-up|0
2195594|NCT01524978|3828231|FG008|Overall Study|Lost to Follow-up|1
2195595|NCT01524978|3828232|FG009|Overall Study|Lost to Follow-up|1
2195596|NCT01524978|3828233|FG010|Overall Study|Lost to Follow-up|1
2195597|NCT01524978|3828223|FG000|Overall Study|Death|34
2195598|NCT01524978|3828224|FG001|Overall Study|Death|2
2195599|NCT01524978|3828225|FG002|Overall Study|Death|5
2195600|NCT01524978|3828226|FG003|Overall Study|Death|24
2195601|NCT01524978|3828227|FG004|Overall Study|Death|4
2195602|NCT01524978|3828228|FG005|Overall Study|Death|4
2195603|NCT01524978|3828229|FG006|Overall Study|Death|1
2195604|NCT01524978|3828230|FG007|Overall Study|Death|9
2195605|NCT01524978|3828231|FG008|Overall Study|Death|5
2195606|NCT01524978|3828232|FG009|Overall Study|Death|6
2195607|NCT01524978|3828233|FG010|Overall Study|Death|17
2195608|NCT01524991|3828248|FG000|Overall Study|Adverse Event|12
2195609|NCT01524991|3828248|FG000|Overall Study|Death|1
2195610|NCT01524991|3828248|FG000|Overall Study|Disease ProgressionDu|17
2195611|NCT01524991|3828248|FG000|Overall Study|Other complicating disease|1
2195612|NCT01524991|3828248|FG000|Overall Study|Withdrawal by Subject|2
2195613|NCT01524991|3828248|FG000|Overall Study|Symptomatic Deterioration|1
2195614|NCT01525082|3828252|FG000|Overall Study|Death|1
2195615|NCT01525225|3828268|FG000|Enrollment|No longer met study criteria|1
2195616|NCT01525225|3828268|FG000|Enrollment|Other|1
2195617|NCT01525238|3828275|FG000|Overall Study|Withdrawal by Subject|1
2195618|NCT01525238|3828276|FG001|Overall Study|Withdrawal by Subject|0
2195619|NCT01525238|3828277|FG002|Overall Study|Withdrawal by Subject|0
2195620|NCT01525407|3828300|FG000|Overall Study|Change in recipient treatment plan|2
2195621|NCT01525407|3828301|FG001|Overall Study|Change in recipient treatment plan|2
2195622|NCT01525407|3828300|FG000|Overall Study|Withdrawal by Subject|0
2195623|NCT01525407|3828301|FG001|Overall Study|Withdrawal by Subject|1
2195624|NCT01525407|3828300|FG000|Overall Study|Transplant was delayed|0
2195625|NCT01525407|3828301|FG001|Overall Study|Transplant was delayed|1
2195626|NCT01525407|3828300|FG000|Overall Study|Delay in Transplant|1
2195627|NCT01525407|3828301|FG001|Overall Study|Delay in Transplant|0
2195628|NCT01525550|3828318|FG000|Overall Study|Lost to Follow-up|8
2195629|NCT01525550|3828319|FG001|Overall Study|Lost to Follow-up|2
2195630|NCT01525550|3828318|FG000|Overall Study|Death|19
2195631|NCT01525550|3828319|FG001|Overall Study|Death|28
2195632|NCT01525550|3828318|FG000|Overall Study|Other|0
2225514|NCT01782326|3873594|FG001|Planned Treatment Epoch|Protocol deviation|3
2225515|NCT01782326|3873593|FG000|Planned Treatment Epoch|Lost to Follow-up|4
2225516|NCT01782326|3873594|FG001|Planned Treatment Epoch|Lost to Follow-up|4
2225517|NCT01782326|3873593|FG000|Planned Treatment Epoch|Technical problems|0
2225518|NCT01782326|3873594|FG001|Planned Treatment Epoch|Technical problems|4
2225519|NCT01782326|3873593|FG000|Double-blind Treatment|Adverse Event|129
2225520|NCT01782326|3873594|FG001|Double-blind Treatment|Adverse Event|145
2225521|NCT01782326|3873593|FG000|Double-blind Treatment|Subject/guardian decision|111
2225522|NCT01782326|3873594|FG001|Double-blind Treatment|Subject/guardian decision|125
2225523|NCT01782326|3873593|FG000|Double-blind Treatment|Lack of Efficacy|17
2225524|NCT01782326|3873594|FG001|Double-blind Treatment|Lack of Efficacy|22
2225525|NCT01782326|3873593|FG000|Double-blind Treatment|Physician Decision|13
2225526|NCT01782326|3873594|FG001|Double-blind Treatment|Physician Decision|16
2225527|NCT01782326|3873593|FG000|Double-blind Treatment|Protocol deviation|8
2225528|NCT01782326|3873594|FG001|Double-blind Treatment|Protocol deviation|7
2225529|NCT01782326|3873593|FG000|Double-blind Treatment|Technical problems|0
2225530|NCT01782326|3873594|FG001|Double-blind Treatment|Technical problems|5
2225531|NCT01782378|3873602|FG000|First Series|Lost to Follow-up|7
2225532|NCT01782378|3873603|FG001|First Series|Lost to Follow-up|8
2225533|NCT01782378|3873602|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0
2225534|NCT01782378|3873603|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25
2225535|NCT01782378|3873602|FG000|Second Series|Lost to Follow-up|8
2225536|NCT01782378|3873603|FG001|Second Series|Lost to Follow-up|7
2225537|NCT01782378|3873602|FG000|Second Series|Did not choose to complete S2 Optional|18
2225538|NCT01782378|3873603|FG001|Second Series|Did not choose to complete S2 Optional|0
2225539|NCT01782469|3873609|FG000|Overall Study|Lost to Follow-up|1
2225540|NCT01782482|3873615|FG000|Overall Study|Adverse Event|2
2225541|NCT01782482|3873616|FG001|Overall Study|Adverse Event|1
2225542|NCT01782482|3873615|FG000|Overall Study|Lost to Follow-up|2
2225543|NCT01782482|3873616|FG001|Overall Study|Lost to Follow-up|3
2225544|NCT01782482|3873615|FG000|Overall Study|Physician Decision|1
2225545|NCT01782482|3873616|FG001|Overall Study|Physician Decision|0
2225546|NCT01782482|3873615|FG000|Overall Study|Protocol Violation|1
2225547|NCT01782482|3873616|FG001|Overall Study|Protocol Violation|0
2225548|NCT01782482|3873615|FG000|Overall Study|Withdrawal by Subject|2
2225549|NCT01782482|3873616|FG001|Overall Study|Withdrawal by Subject|3
2225550|NCT01782482|3873615|FG000|Overall Study|Randomized in Error|2
2225551|NCT01782482|3873616|FG001|Overall Study|Randomized in Error|2
2225552|NCT01782482|3873615|FG000|Overall Study|Habitually wearing toric lens OS|0
2225553|NCT01782482|3873616|FG001|Overall Study|Habitually wearing toric lens OS|1
2225554|NCT01782495|3873633|FG000|Overall Study|Adverse Event|0
2225555|NCT01782495|3873634|FG001|Overall Study|Adverse Event|0
2225556|NCT01782495|3873635|FG002|Overall Study|Adverse Event|0
2225557|NCT01782495|3873636|FG003|Overall Study|Adverse Event|0
2225558|NCT01782495|3873637|FG004|Overall Study|Adverse Event|0
2225559|NCT01782495|3873638|FG005|Overall Study|Adverse Event|0
2225560|NCT01782495|3873639|FG006|Overall Study|Adverse Event|0
2225561|NCT01782495|3873640|FG007|Overall Study|Adverse Event|2
2225562|NCT01782495|3873641|FG008|Overall Study|Adverse Event|0
2225563|NCT01782495|3873642|FG009|Overall Study|Adverse Event|0
2225564|NCT01782495|3873643|FG010|Overall Study|Adverse Event|0
2225565|NCT01782495|3873633|FG000|Overall Study|Withdrew Consent|0
2225566|NCT01782495|3873634|FG001|Overall Study|Withdrew Consent|1
2225567|NCT01782495|3873635|FG002|Overall Study|Withdrew Consent|0
2225568|NCT01782495|3873636|FG003|Overall Study|Withdrew Consent|0
2225569|NCT01782495|3873637|FG004|Overall Study|Withdrew Consent|0
2225570|NCT01782495|3873638|FG005|Overall Study|Withdrew Consent|0
2225571|NCT01782495|3873639|FG006|Overall Study|Withdrew Consent|0
2225572|NCT01782495|3873640|FG007|Overall Study|Withdrew Consent|1
2225573|NCT01782495|3873641|FG008|Overall Study|Withdrew Consent|0
2225574|NCT01782495|3873642|FG009|Overall Study|Withdrew Consent|0
2225575|NCT01782495|3873643|FG010|Overall Study|Withdrew Consent|0
2225576|NCT01782664|3873673|FG000|Overall Study|Adverse Event|2
2225577|NCT01782664|3873674|FG001|Overall Study|Adverse Event|2
2225578|NCT01782664|3873675|FG002|Overall Study|Adverse Event|2
2225579|NCT01782664|3873676|FG003|Overall Study|Adverse Event|2
2225580|NCT01782664|3873677|FG004|Overall Study|Adverse Event|0
2225581|NCT01782664|3873678|FG005|Overall Study|Adverse Event|0
2225582|NCT01782664|3873673|FG000|Overall Study|Lack of Efficacy|2
2225583|NCT01782664|3873674|FG001|Overall Study|Lack of Efficacy|0
2195633|NCT01525550|3828319|FG001|Overall Study|Other|4
2195634|NCT01525550|3828318|FG000|Overall Study|Sponsor's Decision|30
2195635|NCT01525550|3828319|FG001|Overall Study|Sponsor's Decision|11
2195636|NCT01525550|3828318|FG000|Overall Study|Withdrawal by Subject|4
2195637|NCT01525550|3828319|FG001|Overall Study|Withdrawal by Subject|0
2195638|NCT01525589|3828332|FG000|Overall Study|Non-treatment-related AE|1
2195639|NCT01525589|3828333|FG001|Overall Study|Non-treatment-related AE|0
2195640|NCT01525589|3828334|FG002|Overall Study|Non-treatment-related AE|0
2195641|NCT01525589|3828332|FG000|Overall Study|Progressive disease|48
2195642|NCT01525589|3828333|FG001|Overall Study|Progressive disease|15
2195643|NCT01525589|3828334|FG002|Overall Study|Progressive disease|29
2195644|NCT01525589|3828332|FG000|Overall Study|Never treated|2
2195645|NCT01525589|3828333|FG001|Overall Study|Never treated|0
2195646|NCT01525589|3828334|FG002|Overall Study|Never treated|0
2195647|NCT01525589|3828332|FG000|Overall Study|Physician Decision|4
2195648|NCT01525589|3828333|FG001|Overall Study|Physician Decision|2
2195649|NCT01525589|3828334|FG002|Overall Study|Physician Decision|2
2195650|NCT01525589|3828332|FG000|Overall Study|Death|0
2195651|NCT01525589|3828333|FG001|Overall Study|Death|0
2195652|NCT01525589|3828334|FG002|Overall Study|Death|2
2195653|NCT01525589|3828332|FG000|Overall Study|Treatment-related AE|1
2195654|NCT01525589|3828333|FG001|Overall Study|Treatment-related AE|1
2195655|NCT01525589|3828334|FG002|Overall Study|Treatment-related AE|2
2195656|NCT01525589|3828332|FG000|Overall Study|Other reasons|0
2195657|NCT01525589|3828333|FG001|Overall Study|Other reasons|1
2195658|NCT01525589|3828334|FG002|Overall Study|Other reasons|0
2195659|NCT01525589|3828332|FG000|Overall Study|Withdrawal by Subject|0
2195660|NCT01525589|3828333|FG001|Overall Study|Withdrawal by Subject|1
2195661|NCT01525589|3828334|FG002|Overall Study|Withdrawal by Subject|0
2195662|NCT01525602|3828350|FG000|Overall Study|Adverse Event|1
2195663|NCT01525602|3828351|FG001|Overall Study|Adverse Event|0
2195664|NCT01525602|3828352|FG002|Overall Study|Adverse Event|1
2195665|NCT01525602|3828353|FG003|Overall Study|Adverse Event|1
2195666|NCT01525602|3828354|FG004|Overall Study|Adverse Event|3
2195667|NCT01525602|3828355|FG005|Overall Study|Adverse Event|3
2195668|NCT01525602|3828356|FG006|Overall Study|Adverse Event|0
2195669|NCT01525602|3828357|FG007|Overall Study|Adverse Event|1
2195670|NCT01525602|3828350|FG000|Overall Study|Disease progression|6
2195671|NCT01525602|3828351|FG001|Overall Study|Disease progression|3
2195672|NCT01525602|3828352|FG002|Overall Study|Disease progression|2
2195673|NCT01525602|3828353|FG003|Overall Study|Disease progression|5
2195674|NCT01525602|3828354|FG004|Overall Study|Disease progression|22
2195675|NCT01525602|3828355|FG005|Overall Study|Disease progression|2
2195676|NCT01525602|3828356|FG006|Overall Study|Disease progression|3
2195677|NCT01525602|3828357|FG007|Overall Study|Disease progression|3
2195678|NCT01525602|3828350|FG000|Overall Study|Clinical progression|2
2195679|NCT01525602|3828351|FG001|Overall Study|Clinical progression|0
2195680|NCT01525602|3828352|FG002|Overall Study|Clinical progression|0
2195681|NCT01525602|3828353|FG003|Overall Study|Clinical progression|0
2195682|NCT01525602|3828354|FG004|Overall Study|Clinical progression|0
2195683|NCT01525602|3828355|FG005|Overall Study|Clinical progression|0
2195684|NCT01525602|3828356|FG006|Overall Study|Clinical progression|1
2195685|NCT01525602|3828357|FG007|Overall Study|Clinical progression|1
2195686|NCT01525602|3828350|FG000|Overall Study|Non-compliance|0
2195687|NCT01525602|3828351|FG001|Overall Study|Non-compliance|0
2195688|NCT01525602|3828352|FG002|Overall Study|Non-compliance|0
2195689|NCT01525602|3828353|FG003|Overall Study|Non-compliance|0
2195690|NCT01525602|3828354|FG004|Overall Study|Non-compliance|1
2195691|NCT01525602|3828355|FG005|Overall Study|Non-compliance|0
2195692|NCT01525602|3828356|FG006|Overall Study|Non-compliance|0
2195693|NCT01525602|3828357|FG007|Overall Study|Non-compliance|0
2195694|NCT01525602|3828350|FG000|Overall Study|Withdrawal by Subject|0
2195695|NCT01525602|3828351|FG001|Overall Study|Withdrawal by Subject|0
2195696|NCT01525602|3828352|FG002|Overall Study|Withdrawal by Subject|0
2195697|NCT01525602|3828353|FG003|Overall Study|Withdrawal by Subject|0
2195698|NCT01525602|3828354|FG004|Overall Study|Withdrawal by Subject|3
2195699|NCT01525602|3828355|FG005|Overall Study|Withdrawal by Subject|1
2195700|NCT01525602|3828356|FG006|Overall Study|Withdrawal by Subject|0
2195701|NCT01525602|3828357|FG007|Overall Study|Withdrawal by Subject|1
2195702|NCT01525602|3828350|FG000|Overall Study|Physician Decision|0
2195703|NCT01525602|3828351|FG001|Overall Study|Physician Decision|0
2195704|NCT01525602|3828352|FG002|Overall Study|Physician Decision|0
2195705|NCT01525602|3828353|FG003|Overall Study|Physician Decision|0
2195706|NCT01525602|3828354|FG004|Overall Study|Physician Decision|3
2195707|NCT01525602|3828355|FG005|Overall Study|Physician Decision|0
2195708|NCT01525602|3828356|FG006|Overall Study|Physician Decision|1
2195709|NCT01525602|3828357|FG007|Overall Study|Physician Decision|0
2195710|NCT01525602|3828350|FG000|Overall Study|Death|0
2195711|NCT01525602|3828351|FG001|Overall Study|Death|0
2195712|NCT01525602|3828352|FG002|Overall Study|Death|0
2195713|NCT01525602|3828353|FG003|Overall Study|Death|0
2195714|NCT01525602|3828354|FG004|Overall Study|Death|1
2195715|NCT01525602|3828355|FG005|Overall Study|Death|1
2195716|NCT01525602|3828356|FG006|Overall Study|Death|0
2195717|NCT01525602|3828357|FG007|Overall Study|Death|0
2195718|NCT01525602|3828350|FG000|Overall Study|Unqualified based on biopsy; not dosed|0
2195719|NCT01525602|3828351|FG001|Overall Study|Unqualified based on biopsy; not dosed|0
2195720|NCT01525602|3828352|FG002|Overall Study|Unqualified based on biopsy; not dosed|0
2195721|NCT01525602|3828353|FG003|Overall Study|Unqualified based on biopsy; not dosed|0
2195722|NCT01525602|3828354|FG004|Overall Study|Unqualified based on biopsy; not dosed|0
2195723|NCT01525602|3828355|FG005|Overall Study|Unqualified based on biopsy; not dosed|0
2195724|NCT01525602|3828356|FG006|Overall Study|Unqualified based on biopsy; not dosed|1
2195725|NCT01525602|3828357|FG007|Overall Study|Unqualified based on biopsy; not dosed|1
2195726|NCT01525615|3828385|FG000|Overall Study|Adverse Event|11
2195727|NCT01525615|3828386|FG001|Overall Study|Adverse Event|7
2195728|NCT01525615|3828387|FG002|Overall Study|Adverse Event|5
2195729|NCT01525615|3828385|FG000|Overall Study|Lost to Follow-up|1
2195730|NCT01525615|3828386|FG001|Overall Study|Lost to Follow-up|0
2195731|NCT01525615|3828387|FG002|Overall Study|Lost to Follow-up|0
2195732|NCT01525615|3828385|FG000|Overall Study|Withdrawal by Subject|1
2195733|NCT01525615|3828386|FG001|Overall Study|Withdrawal by Subject|0
2225584|NCT01782664|3873675|FG002|Overall Study|Lack of Efficacy|2
2225585|NCT01782664|3873676|FG003|Overall Study|Lack of Efficacy|2
2225586|NCT01782664|3873677|FG004|Overall Study|Lack of Efficacy|0
2225587|NCT01782664|3873678|FG005|Overall Study|Lack of Efficacy|0
2225588|NCT01782664|3873673|FG000|Overall Study|Protocol Violation|0
2225589|NCT01782664|3873674|FG001|Overall Study|Protocol Violation|1
2225590|NCT01782664|3873675|FG002|Overall Study|Protocol Violation|0
2225591|NCT01782664|3873676|FG003|Overall Study|Protocol Violation|1
2225592|NCT01782664|3873677|FG004|Overall Study|Protocol Violation|0
2225593|NCT01782664|3873678|FG005|Overall Study|Protocol Violation|0
2225594|NCT01782664|3873673|FG000|Overall Study|Withdrawal by Subject|2
2225595|NCT01782664|3873674|FG001|Overall Study|Withdrawal by Subject|2
2225596|NCT01782664|3873675|FG002|Overall Study|Withdrawal by Subject|0
2225597|NCT01782664|3873676|FG003|Overall Study|Withdrawal by Subject|0
2225598|NCT01782664|3873677|FG004|Overall Study|Withdrawal by Subject|0
2225599|NCT01782664|3873678|FG005|Overall Study|Withdrawal by Subject|0
2225600|NCT01782690|3873692|FG000|Overall Study|Not reported|7
2225601|NCT01782690|3873692|FG000|Overall Study|Toxicity of gemcitabine|1
2225602|NCT01782690|3873692|FG000|Overall Study|Toxicity of erlotinib|1
2225603|NCT01782690|3873692|FG000|Overall Study|Lost to Follow-up|31
2225604|NCT01782690|3873692|FG000|Overall Study|Withdrawal of informed consent|2
2225605|NCT01782690|3873692|FG000|Overall Study|Absent rash|9
2225606|NCT01782690|3873692|FG000|Overall Study|Physician Decision|13
2225607|NCT01782690|3873692|FG000|Overall Study|Patient's wish|21
2225608|NCT01782690|3873692|FG000|Overall Study|Tumor progression|74
2225609|NCT01782690|3873692|FG000|Overall Study|Death|133
2225610|NCT01782690|3873692|FG000|Overall Study|Study completion unknown|7
2225611|NCT01782742|3873698|FG000|Double-blind Treatment Phase|Adverse Event|1
2225612|NCT01782742|3873699|FG001|Double-blind Treatment Phase|Adverse Event|0
2225613|NCT01782859|3873713|FG000|Overall Study|Protocol Violation|6
2225614|NCT01782859|3873714|FG001|Overall Study|Protocol Violation|6
2225615|NCT01782859|3873713|FG000|Overall Study|Withdrawal by Subject|0
2225616|NCT01782859|3873714|FG001|Overall Study|Withdrawal by Subject|1
2225617|NCT01782872|3873725|FG000|Overall Study|Protocol Violation|0
2225618|NCT01782872|3873726|FG001|Overall Study|Protocol Violation|0
2225619|NCT01782872|3873727|FG002|Overall Study|Protocol Violation|0
2225620|NCT01782872|3873728|FG003|Overall Study|Protocol Violation|1
2225621|NCT01782872|3873725|FG000|Overall Study|Withdrawal by Subject|0
2225622|NCT01782872|3873726|FG001|Overall Study|Withdrawal by Subject|1
2225623|NCT01782872|3873727|FG002|Overall Study|Withdrawal by Subject|0
2225624|NCT01782872|3873728|FG003|Overall Study|Withdrawal by Subject|0
2225625|NCT01782885|3873740|FG000|Overall Study|Lost to Follow-up|4
2225626|NCT01782885|3873741|FG001|Overall Study|Lost to Follow-up|6
2225627|NCT01783418|3873783|FG000|Overall Study|Withdrawal by Subject|1
2225628|NCT01783418|3873784|FG001|Overall Study|Withdrawal by Subject|0
2225629|NCT01783444|3873793|FG000|Treatment Phase|Adverse Event|9
2225630|NCT01783444|3873794|FG001|Treatment Phase|Adverse Event|20
2225631|NCT01783444|3873795|FG002|Treatment Phase|Adverse Event|19
2225632|NCT01783444|3873793|FG000|Treatment Phase|Disease Progression|76
2225633|NCT01783444|3873794|FG001|Treatment Phase|Disease Progression|66
2225634|NCT01783444|3873795|FG002|Treatment Phase|Disease Progression|64
2225635|NCT01783444|3873793|FG000|Treatment Phase|Death|2
2225636|NCT01783444|3873794|FG001|Treatment Phase|Death|2
2225637|NCT01783444|3873795|FG002|Treatment Phase|Death|2
2225638|NCT01783444|3873793|FG000|Treatment Phase|Protocol Violation|1
2225639|NCT01783444|3873794|FG001|Treatment Phase|Protocol Violation|1
2225640|NCT01783444|3873795|FG002|Treatment Phase|Protocol Violation|2
2225641|NCT01783444|3873793|FG000|Treatment Phase|Withdrawal by Subject|6
2225642|NCT01783444|3873794|FG001|Treatment Phase|Withdrawal by Subject|8
2225643|NCT01783444|3873795|FG002|Treatment Phase|Withdrawal by Subject|9
2225644|NCT01783444|3873793|FG000|Treatment Phase|Administrative problems|2
2225645|NCT01783444|3873794|FG001|Treatment Phase|Administrative problems|0
2225646|NCT01783444|3873795|FG002|Treatment Phase|Administrative problems|1
2225647|NCT01783444|3873793|FG000|Treatment Phase|Physician Decision|8
2225648|NCT01783444|3873794|FG001|Treatment Phase|Physician Decision|6
2332441|NCT03196973|4056079|FG001|Overall Study|Adverse Event|1
2195734|NCT01525615|3828387|FG002|Overall Study|Withdrawal by Subject|0
2195735|NCT01525615|3828385|FG000|Overall Study|Other reason not described above|1
2195736|NCT01525615|3828386|FG001|Overall Study|Other reason not described above|0
2195737|NCT01525615|3828387|FG002|Overall Study|Other reason not described above|1
2195738|NCT01525628|3828400|FG000|Overall Study|Adverse Event|1
2195739|NCT01525628|3828401|FG001|Overall Study|Adverse Event|1
2195740|NCT01525628|3828402|FG002|Overall Study|Adverse Event|2
2195741|NCT01525628|3828403|FG003|Overall Study|Adverse Event|0
2195742|NCT01525628|3828404|FG004|Overall Study|Adverse Event|1
2195743|NCT01525628|3828400|FG000|Overall Study|Lack of Efficacy|0
2195744|NCT01525628|3828401|FG001|Overall Study|Lack of Efficacy|2
2195745|NCT01525628|3828402|FG002|Overall Study|Lack of Efficacy|2
2195746|NCT01525628|3828403|FG003|Overall Study|Lack of Efficacy|1
2195747|NCT01525628|3828404|FG004|Overall Study|Lack of Efficacy|2
2195748|NCT01525628|3828400|FG000|Overall Study|Protocol Violation|0
2195749|NCT01525628|3828401|FG001|Overall Study|Protocol Violation|0
2195750|NCT01525628|3828402|FG002|Overall Study|Protocol Violation|1
2195751|NCT01525628|3828403|FG003|Overall Study|Protocol Violation|0
2195752|NCT01525628|3828404|FG004|Overall Study|Protocol Violation|0
2195753|NCT01525628|3828400|FG000|Overall Study|Lost to Follow-up|1
2195754|NCT01525628|3828401|FG001|Overall Study|Lost to Follow-up|1
2195755|NCT01525628|3828402|FG002|Overall Study|Lost to Follow-up|0
2195756|NCT01525628|3828403|FG003|Overall Study|Lost to Follow-up|0
2225649|NCT01783444|3873795|FG002|Treatment Phase|Physician Decision|5
2225650|NCT01783444|3873793|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7
2225651|NCT01783444|3873794|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8
2225652|NCT01783444|3873795|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11
2225653|NCT01783444|3873793|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9
2225654|NCT01783444|3873794|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7
2225655|NCT01783444|3873795|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5
2225656|NCT01783444|3873793|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4
2225657|NCT01783444|3873794|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
2225658|NCT01783444|3873795|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
2225659|NCT01783444|3873793|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
2225660|NCT01783444|3873794|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1
2225661|NCT01783444|3873795|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
2225662|NCT01783444|3873793|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7
2225663|NCT01783444|3873794|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16
2225664|NCT01783444|3873795|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15
2225665|NCT01783444|3873793|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69
2225666|NCT01783444|3873794|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53
2225667|NCT01783444|3873795|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52
2225668|NCT01783483|3873814|FG000|Overall Study|Death|3
2225669|NCT01783483|3873815|FG001|Overall Study|Death|3
2225670|NCT01783483|3873814|FG000|Overall Study|Lost to Follow-up|14
2225671|NCT01783483|3873815|FG001|Overall Study|Lost to Follow-up|10
2225672|NCT01783483|3873814|FG000|Overall Study|Withdrawal by Subject|2
2225673|NCT01783483|3873815|FG001|Overall Study|Withdrawal by Subject|1
2225674|NCT01783483|3873814|FG000|Overall Study|Physician Decision|1
2225675|NCT01783483|3873815|FG001|Overall Study|Physician Decision|1
2225676|NCT01783496|3873827|FG000|Overall Study|Lost to Follow-up|0
2225677|NCT01783496|3873828|FG001|Overall Study|Lost to Follow-up|0
2225678|NCT01783496|3873829|FG002|Overall Study|Lost to Follow-up|0
2225679|NCT01783496|3873830|FG003|Overall Study|Lost to Follow-up|2
2225680|NCT01783496|3873831|FG004|Overall Study|Lost to Follow-up|0
2225681|NCT01783496|3873832|FG005|Overall Study|Lost to Follow-up|1
2225682|NCT01783496|3873827|FG000|Overall Study|Withdrawal by Subject|1
2225683|NCT01783496|3873828|FG001|Overall Study|Withdrawal by Subject|0
2225684|NCT01783496|3873829|FG002|Overall Study|Withdrawal by Subject|0
2225685|NCT01783496|3873830|FG003|Overall Study|Withdrawal by Subject|0
2225686|NCT01783496|3873831|FG004|Overall Study|Withdrawal by Subject|0
2225687|NCT01783496|3873832|FG005|Overall Study|Withdrawal by Subject|0
2225688|NCT01783548|3873857|FG000|Overall Study|Adverse Event|8
2225689|NCT01783548|3873858|FG001|Overall Study|Adverse Event|4
2225690|NCT01783548|3873857|FG000|Overall Study|Withdrawal by Subject|11
2225691|NCT01783548|3873858|FG001|Overall Study|Withdrawal by Subject|8
2225692|NCT01783548|3873857|FG000|Overall Study|Non-compliance|4
2225693|NCT01783548|3873858|FG001|Overall Study|Non-compliance|0
2225694|NCT01783548|3873857|FG000|Overall Study|Protocol Violation|2
2225695|NCT01783548|3873858|FG001|Overall Study|Protocol Violation|2
2225696|NCT01783548|3873857|FG000|Overall Study|Lost to Follow-up|8
2225697|NCT01783548|3873858|FG001|Overall Study|Lost to Follow-up|3
2225698|NCT01783548|3873857|FG000|Overall Study|Lack of Efficacy|1
2225699|NCT01783548|3873858|FG001|Overall Study|Lack of Efficacy|1
2274156|NCT02293863|3955037|FG002|Overall Study|Lost to Follow-up|2
2274157|NCT02293863|3955035|FG000|Overall Study|Withdrawal by Subject|3
2274158|NCT02293863|3955036|FG001|Overall Study|Withdrawal by Subject|3
2274159|NCT02293863|3955037|FG002|Overall Study|Withdrawal by Subject|1
2274160|NCT02293863|3955035|FG000|Overall Study|Reason Not Specified|0
2274161|NCT02293863|3955036|FG001|Overall Study|Reason Not Specified|2
2195757|NCT01525628|3828404|FG004|Overall Study|Lost to Follow-up|0
2195758|NCT01525628|3828400|FG000|Overall Study|Withdrawal by Subject|0
2195759|NCT01525628|3828401|FG001|Overall Study|Withdrawal by Subject|1
2195760|NCT01525628|3828402|FG002|Overall Study|Withdrawal by Subject|0
2195761|NCT01525628|3828403|FG003|Overall Study|Withdrawal by Subject|0
2195762|NCT01525628|3828404|FG004|Overall Study|Withdrawal by Subject|0
2195763|NCT01525628|3828400|FG000|Overall Study|Other reason not defined above|0
2195764|NCT01525628|3828401|FG001|Overall Study|Other reason not defined above|0
2195765|NCT01525628|3828402|FG002|Overall Study|Other reason not defined above|0
2195766|NCT01525628|3828403|FG003|Overall Study|Other reason not defined above|3
2195767|NCT01525628|3828404|FG004|Overall Study|Other reason not defined above|0
2195768|NCT01525641|3828418|FG000|Overall Study|Case report form not collected|25
2195769|NCT01525641|3828418|FG000|Overall Study|No visit since the first visit|16
2195770|NCT01525641|3828418|FG000|Overall Study|Adverse Event|73
2195771|NCT01525641|3828418|FG000|Overall Study|Lack of Efficacy|24
2195772|NCT01525641|3828418|FG000|Overall Study|Improvement|5
2195773|NCT01525641|3828418|FG000|Overall Study|Lost to follow-up (relocation)|1
2195774|NCT01525641|3828418|FG000|Overall Study|Lost to follow-up (Unknown reason)|10
2195775|NCT01525641|3828418|FG000|Overall Study|Lost to follow-up (Changing hospital)|19
2195776|NCT01525641|3828418|FG000|Overall Study|Other than stated above|7
2195777|NCT01525849|3828439|FG000|Overall Study|Lost to Follow-up|3
2195778|NCT01525849|3828440|FG001|Overall Study|Lost to Follow-up|2
2195779|NCT01525849|3828439|FG000|Overall Study|Withdrawal by Subject|1
2195780|NCT01525849|3828440|FG001|Overall Study|Withdrawal by Subject|9
2195781|NCT01525849|3828439|FG000|Overall Study|Unrelated medical issue (not treated)|1
2195782|NCT01525849|3828440|FG001|Overall Study|Unrelated medical issue (not treated)|2
2195783|NCT01525849|3828439|FG000|Overall Study|Anatomic exclusion criteria identified|0
2195784|NCT01525849|3828440|FG001|Overall Study|Anatomic exclusion criteria identified|3
2195785|NCT01525875|3828452|FG000|Placebo-controlled Period|Withdrawal by Subject|1
2195786|NCT01525875|3828453|FG001|Placebo-controlled Period|Withdrawal by Subject|2
2195787|NCT01525875|3828452|FG000|Open-label Period|Lost to Follow-up|0
2195788|NCT01525875|3828453|FG001|Open-label Period|Lost to Follow-up|2
2195789|NCT01526057|3828462|FG000|Overall Study|Withdrawal by Subject|3
2195790|NCT01526057|3828463|FG001|Overall Study|Withdrawal by Subject|2
2195791|NCT01526057|3828464|FG002|Overall Study|Withdrawal by Subject|2
2195792|NCT01526057|3828462|FG000|Overall Study|Adverse Event|3
2195793|NCT01526057|3828463|FG001|Overall Study|Adverse Event|1
2195794|NCT01526057|3828464|FG002|Overall Study|Adverse Event|1
2195795|NCT01526057|3828462|FG000|Overall Study|Death|1
2195796|NCT01526057|3828463|FG001|Overall Study|Death|0
2195797|NCT01526057|3828464|FG002|Overall Study|Death|0
2195798|NCT01526057|3828462|FG000|Overall Study|Lost to Follow-up|1
2195799|NCT01526057|3828463|FG001|Overall Study|Lost to Follow-up|0
2195800|NCT01526057|3828464|FG002|Overall Study|Lost to Follow-up|1
2195801|NCT01526057|3828462|FG000|Overall Study|Other|1
2225700|NCT01783678|3873892|FG000|Overall Study|Randomized but Not Treated|0
2225701|NCT01783678|3873893|FG001|Overall Study|Randomized but Not Treated|0
2225702|NCT01783678|3873894|FG002|Overall Study|Randomized but Not Treated|0
2225703|NCT01783678|3873895|FG003|Overall Study|Randomized but Not Treated|1
2225704|NCT01783678|3873896|FG004|Overall Study|Randomized but Not Treated|0
2225705|NCT01783678|3873897|FG005|Overall Study|Randomized but Not Treated|0
2225706|NCT01783678|3873892|FG000|Overall Study|Lack of Efficacy|1
2225707|NCT01783678|3873893|FG001|Overall Study|Lack of Efficacy|13
2225708|NCT01783678|3873894|FG002|Overall Study|Lack of Efficacy|1
2225709|NCT01783678|3873895|FG003|Overall Study|Lack of Efficacy|3
2225710|NCT01783678|3873896|FG004|Overall Study|Lack of Efficacy|6
2225711|NCT01783678|3873897|FG005|Overall Study|Lack of Efficacy|5
2225712|NCT01783678|3873892|FG000|Overall Study|Lost to Follow-up|0
2225713|NCT01783678|3873893|FG001|Overall Study|Lost to Follow-up|4
2225714|NCT01783678|3873894|FG002|Overall Study|Lost to Follow-up|0
2225715|NCT01783678|3873895|FG003|Overall Study|Lost to Follow-up|2
2225716|NCT01783678|3873896|FG004|Overall Study|Lost to Follow-up|1
2225717|NCT01783678|3873897|FG005|Overall Study|Lost to Follow-up|0
2225718|NCT01783678|3873892|FG000|Overall Study|Withdrew Consent|1
2225719|NCT01783678|3873893|FG001|Overall Study|Withdrew Consent|1
2225720|NCT01783678|3873894|FG002|Overall Study|Withdrew Consent|0
2225721|NCT01783678|3873895|FG003|Overall Study|Withdrew Consent|2
2225722|NCT01783678|3873896|FG004|Overall Study|Withdrew Consent|0
2225723|NCT01783678|3873897|FG005|Overall Study|Withdrew Consent|0
2225724|NCT01783730|3873912|FG000|Overall Study|Failed to meet inclusion criteria|6
2225725|NCT01783743|3873918|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427
2225726|NCT01783743|3873919|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439
2225727|NCT01783743|3873918|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
2225728|NCT01783743|3873919|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
2225729|NCT01783743|3873918|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
2225730|NCT01783743|3873919|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
2225731|NCT01783821|3873927|FG000|Overall Study|Screen Failure|1
2225732|NCT01783821|3873928|FG001|Overall Study|Screen Failure|1
2225733|NCT01783886|3873962|FG000|Overall Study|Lost to Follow-up|0
2225734|NCT01783886|3873963|FG001|Overall Study|Lost to Follow-up|3
2225735|NCT01783886|3873964|FG002|Overall Study|Lost to Follow-up|0
2225736|NCT01783886|3873962|FG000|Overall Study|Protocol deviation|0
2225737|NCT01783886|3873963|FG001|Overall Study|Protocol deviation|0
2225738|NCT01783886|3873964|FG002|Overall Study|Protocol deviation|2
2225739|NCT01783886|3873962|FG000|Overall Study|Withdrawal of consent by participant|1
2225740|NCT01783886|3873963|FG001|Overall Study|Withdrawal of consent by participant|3
2225741|NCT01783886|3873964|FG002|Overall Study|Withdrawal of consent by participant|4
2332442|NCT03196973|4056080|FG002|Overall Study|Adverse Event|2
2332443|NCT03196973|4056078|FG000|Overall Study|Lack of Efficacy|2
2332444|NCT03196973|4056079|FG001|Overall Study|Lack of Efficacy|6
2332445|NCT03196973|4056080|FG002|Overall Study|Lack of Efficacy|1
2332446|NCT03196973|4056078|FG000|Overall Study|Lost to Follow-up|4
2332447|NCT03196973|4056079|FG001|Overall Study|Lost to Follow-up|3
2332448|NCT03196973|4056080|FG002|Overall Study|Lost to Follow-up|2
2332449|NCT03196973|4056078|FG000|Overall Study|Consent withdrawn|2
2332450|NCT03196973|4056079|FG001|Overall Study|Consent withdrawn|1
2332451|NCT03196973|4056080|FG002|Overall Study|Consent withdrawn|0
2332452|NCT03196973|4056078|FG000|Overall Study|Administration of a wrong kit of study medication|0
2225742|NCT01783886|3873962|FG000|Overall Study|Adverse Event|4
2225743|NCT01783886|3873963|FG001|Overall Study|Adverse Event|5
2225744|NCT01783886|3873964|FG002|Overall Study|Adverse Event|4
2225745|NCT01783938|3873987|FG000|Overall Study|Disease Progression|18
2225746|NCT01783938|3873988|FG001|Overall Study|Disease Progression|41
2225747|NCT01783938|3873987|FG000|Overall Study|Study Drug Toxicity|27
2225748|NCT01783938|3873988|FG001|Overall Study|Study Drug Toxicity|14
2225749|NCT01783938|3873987|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4
2225750|NCT01783938|3873988|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
2225751|NCT01783938|3873987|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2
2225752|NCT01783938|3873988|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3
2225753|NCT01783938|3873987|FG000|Overall Study|Participant Withdrew Consent|2
2225754|NCT01783938|3873988|FG001|Overall Study|Participant Withdrew Consent|0
2225755|NCT01783938|3873987|FG000|Overall Study|Maximum Clinical Benefit|1
2225756|NCT01783938|3873988|FG001|Overall Study|Maximum Clinical Benefit|0
2225757|NCT01783938|3873987|FG000|Overall Study|Other Reasons|3
2225758|NCT01783938|3873988|FG001|Overall Study|Other Reasons|1
2225759|NCT01784029|3874008|FG000|Overall Study|Lost to Follow-up|19
2225760|NCT01784029|3874009|FG001|Overall Study|Lost to Follow-up|20
2225761|NCT01784029|3874010|FG002|Overall Study|Lost to Follow-up|22
2225762|NCT01784068|3874022|FG000|NTCS Phase|Adverse Event|5
2225763|NCT01784068|3874023|FG001|NTCS Phase|Adverse Event|0
2225764|NCT01784068|3874022|FG000|NTCS Phase|Physician Decision|2
2225765|NCT01784068|3874023|FG001|NTCS Phase|Physician Decision|0
2225766|NCT01784068|3874022|FG000|NTCS Phase|Patient/guardian decision|3
2225767|NCT01784068|3874023|FG001|NTCS Phase|Patient/guardian decision|0
2225768|NCT01784068|3874022|FG000|NTCS Phase|Death|2
2225769|NCT01784068|3874023|FG001|NTCS Phase|Death|0
2225770|NCT01784068|3874022|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203
2225771|NCT01784068|3874023|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0
2225772|NCT01784068|3874022|FG000|TFR Phase|Physician Decision|0
2225773|NCT01784068|3874023|FG001|TFR Phase|Physician Decision|1
2225774|NCT01784068|3874022|FG000|TFR Phase|Patient/guardian decision|0
2225775|NCT01784068|3874023|FG001|TFR Phase|Patient/guardian decision|3
2225776|NCT01784068|3874022|FG000|TFR Phase|Death|0
2225777|NCT01784068|3874023|FG001|TFR Phase|Death|1
2225778|NCT01784068|3874022|FG000|TFR Phase|Lack of Efficacy|0
2225779|NCT01784068|3874023|FG001|TFR Phase|Lack of Efficacy|88
2225780|NCT01784211|3874036|FG000|Part A (Days 1-15)|Adverse Event|1
2332453|NCT03196973|4056079|FG001|Overall Study|Administration of a wrong kit of study medication|1
2225781|NCT01784211|3874037|FG001|Part A (Days 1-15)|Adverse Event|1
2225782|NCT01784211|3874038|FG002|Part A (Days 1-15)|Adverse Event|0
2225783|NCT01784211|3874039|FG003|Part A (Days 1-15)|Adverse Event|0
2225784|NCT01784211|3874040|FG004|Part A (Days 1-15)|Adverse Event|0
2225785|NCT01784211|3874041|FG005|Part A (Days 1-15)|Adverse Event|0
2225786|NCT01784211|3874036|FG000|Part A (Days 1-15)|Withdrawal by Subject|2
2225787|NCT01784211|3874037|FG001|Part A (Days 1-15)|Withdrawal by Subject|1
2225788|NCT01784211|3874038|FG002|Part A (Days 1-15)|Withdrawal by Subject|0
2225789|NCT01784211|3874039|FG003|Part A (Days 1-15)|Withdrawal by Subject|0
2225790|NCT01784211|3874040|FG004|Part A (Days 1-15)|Withdrawal by Subject|0
2225791|NCT01784211|3874041|FG005|Part A (Days 1-15)|Withdrawal by Subject|0
2225792|NCT01784419|3874053|FG000|Overall Study|Adverse Event|3
2225793|NCT01784523|3874059|FG000|Overall Study|Study closed early|7
2225794|NCT01784523|3874060|FG001|Overall Study|Study closed early|4
2225795|NCT01784861|3874144|FG000|Overall Study|Adverse Event|0
2225796|NCT01784861|3874145|FG001|Overall Study|Adverse Event|0
2225797|NCT01784861|3874146|FG002|Overall Study|Adverse Event|1
2225798|NCT01784861|3874147|FG003|Overall Study|Adverse Event|2
2225799|NCT01784861|3874148|FG004|Overall Study|Adverse Event|1
2225800|NCT01784861|3874149|FG005|Overall Study|Adverse Event|0
2225801|NCT01784861|3874144|FG000|Overall Study|Withdrawal by Subject|0
2225802|NCT01784861|3874145|FG001|Overall Study|Withdrawal by Subject|0
2225803|NCT01784861|3874146|FG002|Overall Study|Withdrawal by Subject|0
2225804|NCT01784861|3874147|FG003|Overall Study|Withdrawal by Subject|1
2225805|NCT01784861|3874148|FG004|Overall Study|Withdrawal by Subject|0
2225806|NCT01784861|3874149|FG005|Overall Study|Withdrawal by Subject|0
2225807|NCT01784861|3874144|FG000|Overall Study|Physician Decision|0
2225808|NCT01784861|3874145|FG001|Overall Study|Physician Decision|0
2225809|NCT01784861|3874146|FG002|Overall Study|Physician Decision|0
2225810|NCT01784861|3874147|FG003|Overall Study|Physician Decision|2
2225811|NCT01784861|3874148|FG004|Overall Study|Physician Decision|0
2225812|NCT01784861|3874149|FG005|Overall Study|Physician Decision|1
2225813|NCT01784965|3874176|FG000|Overall Study|Withdrawal by Subject|6
2225814|NCT01784965|3874177|FG001|Overall Study|Withdrawal by Subject|3
2225815|NCT01784965|3874176|FG000|Overall Study|Adverse Event|0
2225816|NCT01784965|3874177|FG001|Overall Study|Adverse Event|8
2225817|NCT01785069|3874189|FG000|Overall Study|Implanted with nonstudy device|1
2225818|NCT01785069|3874190|FG001|Overall Study|Implanted with nonstudy device|2
2225819|NCT01785069|3874191|FG002|Overall Study|Implanted with nonstudy device|1
2225820|NCT01785069|3874192|FG003|Overall Study|Implanted with nonstudy device|0
2225821|NCT01785069|3874189|FG000|Overall Study|Death|0
2225822|NCT01785069|3874190|FG001|Overall Study|Death|0
2225823|NCT01785069|3874191|FG002|Overall Study|Death|2
2225824|NCT01785069|3874192|FG003|Overall Study|Death|0
2225825|NCT01785069|3874189|FG000|Overall Study|Subject choice|2
2225826|NCT01785069|3874190|FG001|Overall Study|Subject choice|2
2225827|NCT01785069|3874191|FG002|Overall Study|Subject choice|0
2225828|NCT01785069|3874192|FG003|Overall Study|Subject choice|1
2225829|NCT01785069|3874189|FG000|Overall Study|Lost to Follow-up|1
2225830|NCT01785069|3874190|FG001|Overall Study|Lost to Follow-up|2
2225831|NCT01785069|3874191|FG002|Overall Study|Lost to Follow-up|4
2225832|NCT01785069|3874192|FG003|Overall Study|Lost to Follow-up|1
2225833|NCT01785069|3874189|FG000|Overall Study|Reason not Specified|1
2225834|NCT01785069|3874190|FG001|Overall Study|Reason not Specified|2
2225835|NCT01785069|3874191|FG002|Overall Study|Reason not Specified|1
2225836|NCT01785069|3874192|FG003|Overall Study|Reason not Specified|4
2225837|NCT01785069|3874189|FG000|Overall Study|Not evaluable|7
2225838|NCT01785069|3874190|FG001|Overall Study|Not evaluable|4
2225839|NCT01785069|3874191|FG002|Overall Study|Not evaluable|5
2225840|NCT01785069|3874192|FG003|Overall Study|Not evaluable|8
2225841|NCT01785160|3874218|FG000|Treatment Period 1: Raltegravir|Not treated|1
2225842|NCT01785160|3874218|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1
2225843|NCT01785472|3874259|FG000|Overall Study|Adverse Event|5
2225844|NCT01785472|3874260|FG001|Overall Study|Adverse Event|4
2225845|NCT01785472|3874261|FG002|Overall Study|Adverse Event|6
2225846|NCT01785472|3874259|FG000|Overall Study|Lack of Efficacy|2
2225847|NCT01785472|3874260|FG001|Overall Study|Lack of Efficacy|0
2225848|NCT01785472|3874261|FG002|Overall Study|Lack of Efficacy|1
2225849|NCT01785472|3874259|FG000|Overall Study|Lost to Follow-up|1
2225850|NCT01785472|3874260|FG001|Overall Study|Lost to Follow-up|2
2225851|NCT01785472|3874261|FG002|Overall Study|Lost to Follow-up|0
2225852|NCT01785472|3874259|FG000|Overall Study|Physician Decision|1
2225853|NCT01785472|3874260|FG001|Overall Study|Physician Decision|1
2225854|NCT01785472|3874261|FG002|Overall Study|Physician Decision|1
2225855|NCT01785472|3874259|FG000|Overall Study|Protocol deviation|0
2225856|NCT01785472|3874260|FG001|Overall Study|Protocol deviation|2
2225857|NCT01785472|3874261|FG002|Overall Study|Protocol deviation|2
2225858|NCT01785472|3874259|FG000|Overall Study|Subject/guardian decision|15
2225859|NCT01785472|3874260|FG001|Overall Study|Subject/guardian decision|10
2225860|NCT01785472|3874261|FG002|Overall Study|Subject/guardian decision|11
2225861|NCT01785472|3874259|FG000|Overall Study|Technical problems|0
2225862|NCT01785472|3874260|FG001|Overall Study|Technical problems|0
2225863|NCT01785472|3874261|FG002|Overall Study|Technical problems|1
2225864|NCT01785524|3874273|FG000|Overall Study|Withdrawal by Subject|2
2225865|NCT01785524|3874274|FG001|Overall Study|Withdrawal by Subject|2
2225866|NCT01785602|3874282|FG000|Overall Study|Withdrawal by Subject|2
2225867|NCT01785602|3874283|FG001|Overall Study|Withdrawal by Subject|0
2225868|NCT01785602|3874282|FG000|Overall Study|Lost to Follow-up|1
2225869|NCT01785602|3874283|FG001|Overall Study|Lost to Follow-up|1
2225870|NCT01785602|3874282|FG000|Overall Study|Adverse Event|3
2225871|NCT01785602|3874283|FG001|Overall Study|Adverse Event|5
2225872|NCT01785602|3874282|FG000|Overall Study|Administrative problems|7
2225873|NCT01785602|3874283|FG001|Overall Study|Administrative problems|3
2225874|NCT01785615|3874292|FG000|Dietary Phase|Lost to Follow-up|0
2225875|NCT01785615|3874293|FG001|Dietary Phase|Lost to Follow-up|0
2225876|NCT01785615|3874294|FG002|Dietary Phase|Lost to Follow-up|0
2225877|NCT01785615|3874295|FG003|Dietary Phase|Lost to Follow-up|24
2225878|NCT01785628|3874309|FG000|Overall Study|Lost to Follow-up|2
2225879|NCT01785628|3874310|FG001|Overall Study|Lost to Follow-up|3
2225880|NCT01785849|3874331|FG000|Overall Study|Death|7
2225881|NCT01785849|3874332|FG001|Overall Study|Death|9
2225882|NCT01785849|3874331|FG000|Overall Study|Protocol Specified Criteria|29
2225883|NCT01785849|3874332|FG001|Overall Study|Protocol Specified Criteria|1
2225884|NCT01785849|3874331|FG000|Overall Study|Withdrawal by Subject|15
2225885|NCT01785849|3874332|FG001|Overall Study|Withdrawal by Subject|12
2225886|NCT01785849|3874331|FG000|Overall Study|Sponsor Decision|0
2225887|NCT01785849|3874332|FG001|Overall Study|Sponsor Decision|1
2225888|NCT01785849|3874331|FG000|Overall Study|Lost to Follow-up|10
2225889|NCT01785849|3874332|FG001|Overall Study|Lost to Follow-up|11
2225890|NCT01785875|3874338|FG000|Overall Study|Withdrawal by Subject|41
2225891|NCT01785875|3874339|FG001|Overall Study|Withdrawal by Subject|34
2225892|NCT01785875|3874340|FG002|Overall Study|Withdrawal by Subject|36
2225893|NCT01785875|3874338|FG000|Overall Study|Lost to Follow-up|19
2225894|NCT01785875|3874339|FG001|Overall Study|Lost to Follow-up|22
2225895|NCT01785875|3874340|FG002|Overall Study|Lost to Follow-up|6
2225896|NCT01785875|3874338|FG000|Overall Study|Death|27
2225897|NCT01785875|3874339|FG001|Overall Study|Death|16
2225898|NCT01785875|3874340|FG002|Overall Study|Death|7
2225899|NCT01785875|3874338|FG000|Overall Study|Sponsor Decision|0
2225900|NCT01785875|3874339|FG001|Overall Study|Sponsor Decision|2
2225901|NCT01785875|3874340|FG002|Overall Study|Sponsor Decision|0
2225902|NCT01785875|3874338|FG000|Overall Study|Protocol Specified Criteria|207
2225903|NCT01785875|3874339|FG001|Overall Study|Protocol Specified Criteria|214
2225904|NCT01785875|3874340|FG002|Overall Study|Protocol Specified Criteria|55
2225905|NCT01785875|3874338|FG000|Overall Study|Missing|0
2225906|NCT01785875|3874339|FG001|Overall Study|Missing|1
2225907|NCT01785875|3874340|FG002|Overall Study|Missing|3
2225908|NCT01786109|3874354|FG000|Overall Study|fail manometry barostat tube placement|1
2225909|NCT01786109|3874355|FG001|Overall Study|fail manometry barostat tube placement|0
2225910|NCT01786109|3874356|FG002|Overall Study|fail manometry barostat tube placement|0
2225911|NCT01786109|3874354|FG000|Overall Study|unrelated illness|0
2225912|NCT01786109|3874355|FG001|Overall Study|unrelated illness|0
2225913|NCT01786109|3874356|FG002|Overall Study|unrelated illness|1
2225914|NCT01786109|3874354|FG000|Overall Study|adverse effects colon preparation|0
2225915|NCT01786109|3874355|FG001|Overall Study|adverse effects colon preparation|0
2225916|NCT01786109|3874356|FG002|Overall Study|adverse effects colon preparation|1
2225917|NCT01786148|3874366|FG000|Overall Study|Lost to Follow-up|21
2225918|NCT01786148|3874367|FG001|Overall Study|Lost to Follow-up|13
2225919|NCT01786148|3874366|FG000|Overall Study|Death|0
2225920|NCT01786148|3874367|FG001|Overall Study|Death|1
2225921|NCT01786148|3874366|FG000|Overall Study|Withdrawal by Subject|0
2225922|NCT01786148|3874367|FG001|Overall Study|Withdrawal by Subject|7
2225923|NCT01786148|3874366|FG000|Overall Study|Incarceration|1
2225924|NCT01786148|3874367|FG001|Overall Study|Incarceration|1
2225925|NCT01786174|3874386|FG000|Overall Study|Discontinued Study Drug|2
2225926|NCT01786174|3874387|FG001|Overall Study|Discontinued Study Drug|0
2225927|NCT01786330|3874425|FG000|Overall Study|Withdrawal by Subject|0
2225928|NCT01786330|3874426|FG001|Overall Study|Withdrawal by Subject|1
2225929|NCT01786330|3874425|FG000|Overall Study|Lost to Follow-up|0
2225930|NCT01786330|3874426|FG001|Overall Study|Lost to Follow-up|1
2225931|NCT01786330|3874425|FG000|Overall Study|Excluded intraoperatively|0
2225932|NCT01786330|3874426|FG001|Overall Study|Excluded intraoperatively|1
2225933|NCT01786330|3874425|FG000|Overall Study|Protocol Violation|1
2225934|NCT01786330|3874426|FG001|Overall Study|Protocol Violation|0
2225935|NCT01786512|3874452|FG000|Overall Study|Lost to Follow-up|0
2225936|NCT01786512|3874453|FG001|Overall Study|Lost to Follow-up|0
2225937|NCT01786512|3874454|FG002|Overall Study|Lost to Follow-up|0
2225938|NCT01786512|3874455|FG003|Overall Study|Lost to Follow-up|0
2225939|NCT01786512|3874456|FG004|Overall Study|Lost to Follow-up|0
2225940|NCT01786512|3874457|FG005|Overall Study|Lost to Follow-up|0
2225941|NCT01786512|3874458|FG006|Overall Study|Lost to Follow-up|0
2225942|NCT01786512|3874459|FG007|Overall Study|Lost to Follow-up|0
2225943|NCT01786512|3874460|FG008|Overall Study|Lost to Follow-up|0
2225944|NCT01786512|3874461|FG009|Overall Study|Lost to Follow-up|1
2225945|NCT01786512|3874462|FG010|Overall Study|Lost to Follow-up|0
2225946|NCT01786512|3874452|FG000|Overall Study|Decision by sponsor|0
2225947|NCT01786512|3874453|FG001|Overall Study|Decision by sponsor|0
2225948|NCT01786512|3874454|FG002|Overall Study|Decision by sponsor|0
2225949|NCT01786512|3874455|FG003|Overall Study|Decision by sponsor|0
2225950|NCT01786512|3874456|FG004|Overall Study|Decision by sponsor|0
2225951|NCT01786512|3874457|FG005|Overall Study|Decision by sponsor|0
2225952|NCT01786512|3874458|FG006|Overall Study|Decision by sponsor|0
2225953|NCT01786512|3874459|FG007|Overall Study|Decision by sponsor|0
2225954|NCT01786512|3874460|FG008|Overall Study|Decision by sponsor|0
2225955|NCT01786512|3874461|FG009|Overall Study|Decision by sponsor|0
2225956|NCT01786512|3874462|FG010|Overall Study|Decision by sponsor|2
2225957|NCT01786512|3874452|FG000|Overall Study|Withdrawal by Subject|0
2225958|NCT01786512|3874453|FG001|Overall Study|Withdrawal by Subject|1
2225959|NCT01786512|3874454|FG002|Overall Study|Withdrawal by Subject|0
2225960|NCT01786512|3874455|FG003|Overall Study|Withdrawal by Subject|0
2225961|NCT01786512|3874456|FG004|Overall Study|Withdrawal by Subject|0
2225962|NCT01786512|3874457|FG005|Overall Study|Withdrawal by Subject|0
2225963|NCT01786512|3874458|FG006|Overall Study|Withdrawal by Subject|1
2225964|NCT01786512|3874459|FG007|Overall Study|Withdrawal by Subject|0
2225965|NCT01786512|3874460|FG008|Overall Study|Withdrawal by Subject|0
2225966|NCT01786512|3874461|FG009|Overall Study|Withdrawal by Subject|3
2225967|NCT01786512|3874462|FG010|Overall Study|Withdrawal by Subject|7
2225968|NCT01786512|3874452|FG000|Overall Study|Death|0
2225969|NCT01786512|3874453|FG001|Overall Study|Death|0
2225970|NCT01786512|3874454|FG002|Overall Study|Death|0
2225971|NCT01786512|3874455|FG003|Overall Study|Death|0
2225972|NCT01786512|3874456|FG004|Overall Study|Death|0
2225973|NCT01786512|3874457|FG005|Overall Study|Death|0
2225974|NCT01786512|3874458|FG006|Overall Study|Death|0
2225975|NCT01786512|3874459|FG007|Overall Study|Death|0
2225976|NCT01786512|3874460|FG008|Overall Study|Death|4
2225977|NCT01786512|3874461|FG009|Overall Study|Death|1
2225978|NCT01786512|3874462|FG010|Overall Study|Death|3
2225979|NCT01786551|3874494|FG000|Overall Study|Participant withdrew consent|2
2225980|NCT01786564|3874498|FG000|Overall Study|Lost to Follow-up|47
2225981|NCT01786564|3874498|FG000|Overall Study|Ineligible|17
2225982|NCT01786603|3874504|FG000|Overall Study|Death|5
2225983|NCT01786603|3874505|FG001|Overall Study|Death|1
2225984|NCT01786603|3874504|FG000|Overall Study|Adverse Event|6
2225985|NCT01786603|3874505|FG001|Overall Study|Adverse Event|2
2225986|NCT01786603|3874504|FG000|Overall Study|Physician decision to withdraw|6
2225987|NCT01786603|3874505|FG001|Overall Study|Physician decision to withdraw|7
2225988|NCT01786603|3874504|FG000|Overall Study|Lost to Follow-up|1
2225989|NCT01786603|3874505|FG001|Overall Study|Lost to Follow-up|2
2225990|NCT01786629|3874513|FG000|Overall Study|Lack of Efficacy|0
2225991|NCT01786629|3874514|FG001|Overall Study|Lack of Efficacy|4
2225992|NCT01786629|3874513|FG000|Overall Study|Adverse Event|0
2225993|NCT01786629|3874514|FG001|Overall Study|Adverse Event|1
2225994|NCT01786668|3874524|FG000|Overall Study|Adverse Event|0
2225995|NCT01786668|3874525|FG001|Overall Study|Adverse Event|1
2225996|NCT01786668|3874526|FG002|Overall Study|Adverse Event|1
2225997|NCT01786668|3874527|FG003|Overall Study|Adverse Event|2
2225998|NCT01786668|3874524|FG000|Overall Study|Withdrawal by Subject|0
2225999|NCT01786668|3874525|FG001|Overall Study|Withdrawal by Subject|0
2226000|NCT01786668|3874526|FG002|Overall Study|Withdrawal by Subject|3
2226001|NCT01786668|3874527|FG003|Overall Study|Withdrawal by Subject|1
2226002|NCT01786668|3874524|FG000|Overall Study|Pregnancy|0
2226003|NCT01786668|3874525|FG001|Overall Study|Pregnancy|0
2226004|NCT01786668|3874526|FG002|Overall Study|Pregnancy|0
2226005|NCT01786668|3874527|FG003|Overall Study|Pregnancy|1
2226006|NCT01786668|3874524|FG000|Overall Study|Lost to Follow-up|1
2226007|NCT01786668|3874525|FG001|Overall Study|Lost to Follow-up|0
2226008|NCT01786668|3874526|FG002|Overall Study|Lost to Follow-up|1
2226009|NCT01786668|3874527|FG003|Overall Study|Lost to Follow-up|0
2226010|NCT01786707|3874539|FG000|Overall Study|Lost to Follow-up|1
2226011|NCT01786707|3874540|FG001|Overall Study|Lost to Follow-up|1
2226012|NCT01786993|3874581|FG000|Overall Study|Death|6
2226013|NCT01786993|3874582|FG001|Overall Study|Death|7
2226014|NCT01786993|3874581|FG000|Overall Study|Withdrawal by Subject|3
2226015|NCT01786993|3874582|FG001|Overall Study|Withdrawal by Subject|2
2226016|NCT01786993|3874581|FG000|Overall Study|Lost to Follow-up|0
2226017|NCT01786993|3874582|FG001|Overall Study|Lost to Follow-up|1
2226018|NCT01786993|3874581|FG000|Overall Study|Subject Non-Compliance|1
2226019|NCT01786993|3874582|FG001|Overall Study|Subject Non-Compliance|0
2226020|NCT01786993|3874581|FG000|Overall Study|System Explant|1
2226021|NCT01786993|3874582|FG001|Overall Study|System Explant|0
2226022|NCT01786993|3874581|FG000|Overall Study|Hospice Admission|1
2226023|NCT01786993|3874582|FG001|Overall Study|Hospice Admission|0
2226024|NCT01787032|3874604|FG000|Overall Study|Protocol Violation|0
2226025|NCT01787032|3874605|FG001|Overall Study|Protocol Violation|0
2226026|NCT01787032|3874606|FG002|Overall Study|Protocol Violation|0
2226027|NCT01787032|3874607|FG003|Overall Study|Protocol Violation|0
2226028|NCT01787032|3874608|FG004|Overall Study|Protocol Violation|1
2226029|NCT01787032|3874609|FG005|Overall Study|Protocol Violation|1
2226030|NCT01787097|3874619|FG000|Overall Study|Withdrawal by Subject|1
2226031|NCT01787097|3874620|FG001|Overall Study|Withdrawal by Subject|0
2226032|NCT01787097|3874621|FG002|Overall Study|Withdrawal by Subject|0
2226033|NCT01787097|3874622|FG003|Overall Study|Withdrawal by Subject|0
2226034|NCT01787188|3874654|FG000|Overall Study|Adverse Event|2
2226035|NCT01787188|3874655|FG001|Overall Study|Adverse Event|4
2226036|NCT01787188|3874656|FG002|Overall Study|Adverse Event|6
2226037|NCT01787188|3874654|FG000|Overall Study|Lack of Efficacy|7
2226038|NCT01787188|3874655|FG001|Overall Study|Lack of Efficacy|3
2226039|NCT01787188|3874656|FG002|Overall Study|Lack of Efficacy|5
2226040|NCT01787188|3874654|FG000|Overall Study|Non-compliance with Study Drug|0
2226041|NCT01787188|3874655|FG001|Overall Study|Non-compliance with Study Drug|1
2226042|NCT01787188|3874656|FG002|Overall Study|Non-compliance with Study Drug|0
2226043|NCT01787188|3874654|FG000|Overall Study|Withdrawal by Subject|4
2226044|NCT01787188|3874655|FG001|Overall Study|Withdrawal by Subject|3
2226045|NCT01787188|3874656|FG002|Overall Study|Withdrawal by Subject|2
2226046|NCT01787188|3874654|FG000|Overall Study|Protocol Violation|3
2226047|NCT01787188|3874655|FG001|Overall Study|Protocol Violation|2
2226048|NCT01787188|3874656|FG002|Overall Study|Protocol Violation|3
2226049|NCT01787188|3874654|FG000|Overall Study|Lost to Follow-up|1
2226050|NCT01787188|3874655|FG001|Overall Study|Lost to Follow-up|2
2226051|NCT01787188|3874656|FG002|Overall Study|Lost to Follow-up|2
2226052|NCT01787188|3874654|FG000|Overall Study|Other, including patient moved|0
2226053|NCT01787188|3874655|FG001|Overall Study|Other, including patient moved|3
2226054|NCT01787188|3874656|FG002|Overall Study|Other, including patient moved|0
2226055|NCT01787279|3874676|FG000|Overall Study|Lost to Follow-up|2
2226056|NCT01787279|3874676|FG000|Overall Study|Lack of Efficacy|1
2226057|NCT01787292|3874680|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2
2226058|NCT01787292|3874681|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2
2226059|NCT01787292|3874680|FG000|Home Based Exercise Program|Withdrawal by Subject|3
2226060|NCT01787292|3874681|FG001|Home Based Exercise Program|Withdrawal by Subject|1
2226061|NCT01787331|3874692|FG000|Overall Study|Physician Decision|1
2226062|NCT01787331|3874692|FG000|Overall Study|Withdrawal by Subject|1
2226063|NCT01787461|3874715|FG000|Overall Study|Adverse Event|4
2226064|NCT01787461|3874716|FG001|Overall Study|Adverse Event|3
2226065|NCT01787461|3874715|FG000|Overall Study|Lost to Follow-up|3
2226066|NCT01787461|3874716|FG001|Overall Study|Lost to Follow-up|2
2226067|NCT01787461|3874715|FG000|Overall Study|No longer met eligibility criteria|1
2226068|NCT01787461|3874716|FG001|Overall Study|No longer met eligibility criteria|0
2226069|NCT01787461|3874715|FG000|Overall Study|Withdrawal by Subject|3
2226070|NCT01787461|3874716|FG001|Overall Study|Withdrawal by Subject|4
2226071|NCT01787461|3874715|FG000|Overall Study|Protocol Violation|3
2226072|NCT01787461|3874716|FG001|Overall Study|Protocol Violation|0
2226073|NCT01787591|3874724|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
2226074|NCT01787591|3874725|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
2226075|NCT01787591|3874726|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
2226076|NCT01787591|3874727|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
2226077|NCT01787760|3874750|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1
2226078|NCT01787760|3874751|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0
2226079|NCT01787760|3874752|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0
2226080|NCT01787760|3874750|FG000|Overall Study|Decompensated on left exotropia|0
2226081|NCT01787760|3874751|FG001|Overall Study|Decompensated on left exotropia|0
2226082|NCT01787760|3874752|FG002|Overall Study|Decompensated on left exotropia|1
2226083|NCT01787760|3874750|FG000|Overall Study|Dryness|0
2226084|NCT01787760|3874751|FG001|Overall Study|Dryness|1
2226085|NCT01787760|3874752|FG002|Overall Study|Dryness|0
2226086|NCT01787760|3874750|FG000|Overall Study|Relocation|1
2226087|NCT01787760|3874751|FG001|Overall Study|Relocation|1
2226088|NCT01787760|3874752|FG002|Overall Study|Relocation|0
2226089|NCT01787760|3874750|FG000|Overall Study|Lens discomfort|3
2226090|NCT01787760|3874751|FG001|Overall Study|Lens discomfort|0
2226091|NCT01787760|3874752|FG002|Overall Study|Lens discomfort|0
2226092|NCT01787760|3874750|FG000|Overall Study|Lens handling difficulty|1
2226093|NCT01787760|3874751|FG001|Overall Study|Lens handling difficulty|2
2226094|NCT01787760|3874752|FG002|Overall Study|Lens handling difficulty|0
2226095|NCT01787760|3874750|FG000|Overall Study|Protocol Violation|6
2226096|NCT01787760|3874751|FG001|Overall Study|Protocol Violation|0
2226097|NCT01787760|3874752|FG002|Overall Study|Protocol Violation|1
2226098|NCT01787760|3874750|FG000|Overall Study|Withdrawal by Subject|5
2226099|NCT01787760|3874751|FG001|Overall Study|Withdrawal by Subject|1
2226100|NCT01787760|3874752|FG002|Overall Study|Withdrawal by Subject|2
2226101|NCT01787760|3874750|FG000|Overall Study|Lost to Follow-up|1
2226102|NCT01787760|3874751|FG001|Overall Study|Lost to Follow-up|0
2226103|NCT01787760|3874752|FG002|Overall Study|Lost to Follow-up|1
2226104|NCT01787760|3874750|FG000|Overall Study|Stroke|1
2226105|NCT01787760|3874751|FG001|Overall Study|Stroke|0
2226106|NCT01787760|3874752|FG002|Overall Study|Stroke|0
2226107|NCT01787760|3874750|FG000|Overall Study|Unsatisfactory lens fitting performance|3
2226108|NCT01787760|3874751|FG001|Overall Study|Unsatisfactory lens fitting performance|6
2226109|NCT01787760|3874752|FG002|Overall Study|Unsatisfactory lens fitting performance|0
2226110|NCT01787760|3874750|FG000|Overall Study|Unsatisfactory physiological response|2
2226111|NCT01787760|3874751|FG001|Overall Study|Unsatisfactory physiological response|4
2226112|NCT01787760|3874752|FG002|Overall Study|Unsatisfactory physiological response|0
2226113|NCT01787760|3874750|FG000|Overall Study|Unsatisfactory visual response|1
2226114|NCT01787760|3874751|FG001|Overall Study|Unsatisfactory visual response|1
2226115|NCT01787760|3874752|FG002|Overall Study|Unsatisfactory visual response|0
2226116|NCT01787760|3874750|FG000|Overall Study|Near vision blur|1
2226117|NCT01787760|3874751|FG001|Overall Study|Near vision blur|0
2226118|NCT01787760|3874752|FG002|Overall Study|Near vision blur|0
2226119|NCT01787825|3874765|FG000|Overall Study|Subject Did Not Ingest Capsules|1
2226120|NCT01787825|3874766|FG001|Overall Study|Subject Did Not Ingest Capsules|0
2226121|NCT01787825|3874765|FG000|Overall Study|Data Not Analyzable|5
2226122|NCT01787825|3874766|FG001|Overall Study|Data Not Analyzable|1
2226123|NCT01787838|3874773|FG000|Overall Study|refused|1413
2226124|NCT01788046|3874786|FG000|Overall Study|Withdrawal by Subject|12
2226125|NCT01788046|3874787|FG001|Overall Study|Withdrawal by Subject|12
2226126|NCT01788046|3874786|FG000|Overall Study|Lost to Follow-up|12
2226127|NCT01788046|3874787|FG001|Overall Study|Lost to Follow-up|19
2226128|NCT01788046|3874786|FG000|Overall Study|Death|7
2226129|NCT01788046|3874787|FG001|Overall Study|Death|5
2226130|NCT01788046|3874786|FG000|Overall Study|Protocol Specified Criteria|25
2226131|NCT01788046|3874787|FG001|Overall Study|Protocol Specified Criteria|1
2226132|NCT01788163|3874811|FG000|Overall Study|Other|53
2226133|NCT01788163|3874812|FG001|Overall Study|Other|0
2226134|NCT01788163|3874813|FG002|Overall Study|Other|0
2226135|NCT01788163|3874814|FG003|Overall Study|Other|0
2226136|NCT01788163|3874815|FG004|Overall Study|Other|0
2226137|NCT01788163|3874816|FG005|Overall Study|Other|7
2226138|NCT01788163|3874817|FG006|Overall Study|Other|1
2226139|NCT01788163|3874818|FG007|Overall Study|Other|48
2226140|NCT01788163|3874819|FG008|Overall Study|Other|15
2226141|NCT01788163|3874811|FG000|Overall Study|Withdrawal by Subject|2
2226142|NCT01788163|3874812|FG001|Overall Study|Withdrawal by Subject|0
2226143|NCT01788163|3874813|FG002|Overall Study|Withdrawal by Subject|0
2226144|NCT01788163|3874814|FG003|Overall Study|Withdrawal by Subject|0
2226145|NCT01788163|3874815|FG004|Overall Study|Withdrawal by Subject|0
2226146|NCT01788163|3874816|FG005|Overall Study|Withdrawal by Subject|0
2226147|NCT01788163|3874817|FG006|Overall Study|Withdrawal by Subject|0
2226148|NCT01788163|3874818|FG007|Overall Study|Withdrawal by Subject|0
2226149|NCT01788163|3874819|FG008|Overall Study|Withdrawal by Subject|1
2226150|NCT01788215|3874900|FG000|Overall Study|Withdrawal by Subject|0
2226151|NCT01788215|3874901|FG001|Overall Study|Withdrawal by Subject|1
2226152|NCT01788215|3874900|FG000|Overall Study|Lost to Follow-up|2
2226153|NCT01788215|3874901|FG001|Overall Study|Lost to Follow-up|0
2226154|NCT01788228|3874909|FG000|Overall Study|Migrated/moved from study area|1
2226155|NCT01788228|3874910|FG001|Overall Study|Migrated/moved from study area|0
2226156|NCT01788358|3874919|FG000|Overall Study|Other|11
2226157|NCT01788358|3874919|FG000|Overall Study|Logistical difficulties|1
2226158|NCT01788358|3874919|FG000|Overall Study|Lost to Follow-up|5
2226159|NCT01788358|3874919|FG000|Overall Study|Protocol Violation|3
2226160|NCT01788358|3874919|FG000|Overall Study|Withdrawal by Subject|26
2226161|NCT01788358|3874919|FG000|Overall Study|Lack of Efficacy|1
2226162|NCT01788358|3874919|FG000|Overall Study|Adverse Event|51
2226163|NCT01788423|3874926|FG000|Overall Study|See Comments in Completed (above)|0
2226164|NCT01788423|3874927|FG001|Overall Study|See Comments in Completed (above)|4
2226165|NCT01788423|3874928|FG002|Overall Study|See Comments in Completed (above)|5
2226166|NCT01788566|3874936|FG000|Overall Study|Death|4
2226167|NCT01788566|3874936|FG000|Overall Study|Adverse Event|1
2226168|NCT01788566|3874936|FG000|Overall Study|Clinical Progressive Disease|3
2226169|NCT01788943|3874951|FG000|Overall Study|Withdrawal by Subject|1
2226170|NCT01788943|3874952|FG001|Overall Study|Withdrawal by Subject|0
2226171|NCT01789047|3874960|FG000|Overall Study|Adverse Event|3
2226172|NCT01789047|3874961|FG001|Overall Study|Adverse Event|2
2226173|NCT01789047|3874960|FG000|Overall Study|Withdrawal by Subject|1
2226174|NCT01789047|3874961|FG001|Overall Study|Withdrawal by Subject|2
2226175|NCT01789203|3874978|FG000|Overall Study|Adverse Event|2
2226176|NCT01789203|3874979|FG001|Overall Study|Adverse Event|2
2226177|NCT01789203|3874978|FG000|Overall Study|Withdrawal by Subject|1
2226178|NCT01789203|3874979|FG001|Overall Study|Withdrawal by Subject|0
2226179|NCT01789203|3874978|FG000|Overall Study|Death|1
2226180|NCT01789203|3874979|FG001|Overall Study|Death|0
2226181|NCT01789203|3874978|FG000|Overall Study|Protocol Violation|2
2226182|NCT01789203|3874979|FG001|Overall Study|Protocol Violation|1
2226183|NCT01789203|3874978|FG000|Overall Study|Other|1
2226184|NCT01789203|3874979|FG001|Overall Study|Other|1
2226185|NCT01789203|3874978|FG000|Overall Study|patient non-adherent|2
2226186|NCT01789203|3874979|FG001|Overall Study|patient non-adherent|0
2226187|NCT01789281|3874993|FG000|Overall Study|Disease progression|15
2226188|NCT01789281|3874994|FG001|Overall Study|Disease progression|4
2226189|NCT01789281|3874993|FG000|Overall Study|Adverse Event|5
2226190|NCT01789281|3874994|FG001|Overall Study|Adverse Event|5
2226191|NCT01789281|3874993|FG000|Overall Study|Withdrawal by Subject|1
2226192|NCT01789281|3874994|FG001|Overall Study|Withdrawal by Subject|0
2226193|NCT01789281|3874993|FG000|Overall Study|Lost to Follow-up|1
2226194|NCT01789281|3874994|FG001|Overall Study|Lost to Follow-up|0
2332454|NCT03196973|4056080|FG002|Overall Study|Administration of a wrong kit of study medication|0
2332455|NCT03197129|4056103|FG000|Overall Study|did not answer the VPT: shyness|4
2332456|NCT03197129|4056104|FG001|Overall Study|did not answer the VPT: shyness|5
2332457|NCT03197324|4056112|FG000|Overall Study|Adverse Event|0
2226195|NCT01789281|3874993|FG000|Overall Study|Administrative problems|0
2226196|NCT01789281|3874994|FG001|Overall Study|Administrative problems|1
2226197|NCT01789320|3875001|FG000|Overall Study|Re-enrolled into study|1
2226198|NCT01789320|3875001|FG000|Overall Study|Lost to Follow-up|1
2226199|NCT01789476|3875007|FG000|Overall Study|Lack of Efficacy|6
2226200|NCT01789476|3875008|FG001|Overall Study|Lack of Efficacy|2
2226201|NCT01789476|3875007|FG000|Overall Study|Adverse Event|1
2226202|NCT01789476|3875008|FG001|Overall Study|Adverse Event|0
2226203|NCT01789476|3875007|FG000|Overall Study|Unable to get IV access|1
2226204|NCT01789476|3875008|FG001|Overall Study|Unable to get IV access|0
2226205|NCT01789567|3875014|FG000|Overall Study|Death|6
2226206|NCT01789606|3875020|FG000|Overall Study|Participant not Purchased the Product|0
2226207|NCT01789606|3875021|FG001|Overall Study|Participant not Purchased the Product|20
2226208|NCT01789606|3875020|FG000|Overall Study|Withdrawal by Subject|0
2226209|NCT01789606|3875021|FG001|Overall Study|Withdrawal by Subject|1
2226210|NCT01789606|3875020|FG000|Overall Study|Ineligible|6
2226211|NCT01789606|3875021|FG001|Overall Study|Ineligible|2
2226212|NCT01789606|3875020|FG000|Overall Study|Administrative Reasons|17
2226213|NCT01789606|3875021|FG001|Overall Study|Administrative Reasons|6
2226214|NCT01789606|3875020|FG000|Overall Study|No Study Medication Taken|0
2226215|NCT01789606|3875021|FG001|Overall Study|No Study Medication Taken|1
2226216|NCT01789606|3875020|FG000|Overall Study|Protocol Violation|0
2226217|NCT01789606|3875021|FG001|Overall Study|Protocol Violation|55
2226218|NCT01789606|3875020|FG000|Overall Study|Adverse Event|0
2226219|NCT01789606|3875021|FG001|Overall Study|Adverse Event|3
2226220|NCT01789606|3875020|FG000|Overall Study|Lost to Follow-up|0
2226221|NCT01789606|3875021|FG001|Overall Study|Lost to Follow-up|14
2226222|NCT01789606|3875020|FG000|Overall Study|Ineligible or not Willing to Continue|0
2226223|NCT01789606|3875021|FG001|Overall Study|Ineligible or not Willing to Continue|348
2274162|NCT02293863|3955037|FG002|Overall Study|Reason Not Specified|2
2274163|NCT02293902|3955050|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5
2274164|NCT02293902|3955051|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6
2274165|NCT02293902|3955052|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8
2274166|NCT02293902|3955053|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0
2274167|NCT02293902|3955054|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0
2274168|NCT02293902|3955050|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
2274169|NCT02293902|3955051|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
2274170|NCT02293902|3955052|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
2274171|NCT02293902|3955053|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
2274172|NCT02293902|3955054|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
2274173|NCT02293902|3955050|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
2274174|NCT02293902|3955051|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2274175|NCT02293902|3955052|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2274176|NCT02293902|3955053|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2274177|NCT02293902|3955054|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2274178|NCT02293902|3955050|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
2274179|NCT02293902|3955051|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
2274180|NCT02293902|3955052|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
2274181|NCT02293902|3955053|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
2274182|NCT02293902|3955054|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
2274183|NCT02293902|3955050|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
2274184|NCT02293902|3955051|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
2274185|NCT02293902|3955052|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
2274186|NCT02293902|3955053|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
2274187|NCT02293902|3955054|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
2274188|NCT02293993|3955076|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
2274189|NCT02293993|3955077|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
2274190|NCT02293993|3955078|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
2274191|NCT02293993|3955079|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
2274192|NCT02293993|3955076|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0
2274193|NCT02293993|3955077|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2
2274194|NCT02293993|3955078|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1
2274195|NCT02293993|3955079|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0
2274196|NCT02293993|3955076|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
2274197|NCT02293993|3955077|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
2274198|NCT02293993|3955078|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1
2274199|NCT02293993|3955079|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
2274200|NCT02293993|3955076|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
2274201|NCT02293993|3955077|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
2274202|NCT02293993|3955078|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3
2274203|NCT02293993|3955079|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1
2274204|NCT02293993|3955076|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
2274205|NCT02293993|3955077|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1
2226224|NCT01789970|3875061|FG000|Open-label Titration Period|Adverse Event|68
2226225|NCT01789970|3875062|FG001|Open-label Titration Period|Adverse Event|0
2226226|NCT01789970|3875063|FG002|Open-label Titration Period|Adverse Event|0
2226227|NCT01789970|3875061|FG000|Open-label Titration Period|Lack of Efficacy|31
2226228|NCT01789970|3875062|FG001|Open-label Titration Period|Lack of Efficacy|0
2226229|NCT01789970|3875063|FG002|Open-label Titration Period|Lack of Efficacy|0
2226230|NCT01789970|3875061|FG000|Open-label Titration Period|Withdrawal by Subject|31
2226231|NCT01789970|3875062|FG001|Open-label Titration Period|Withdrawal by Subject|0
2226232|NCT01789970|3875063|FG002|Open-label Titration Period|Withdrawal by Subject|0
2226233|NCT01789970|3875061|FG000|Open-label Titration Period|Protocol Violation|18
2226234|NCT01789970|3875062|FG001|Open-label Titration Period|Protocol Violation|0
2226235|NCT01789970|3875063|FG002|Open-label Titration Period|Protocol Violation|0
2226236|NCT01789970|3875061|FG000|Open-label Titration Period|Lost to Follow-up|5
2226237|NCT01789970|3875062|FG001|Open-label Titration Period|Lost to Follow-up|0
2226238|NCT01789970|3875063|FG002|Open-label Titration Period|Lost to Follow-up|0
2226239|NCT01789970|3875061|FG000|Open-label Titration Period|Noncompliance to study drug admin|11
2226240|NCT01789970|3875062|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
2226241|NCT01789970|3875063|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
2226242|NCT01789970|3875061|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2
2226243|NCT01789970|3875062|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0
2226244|NCT01789970|3875063|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0
2226245|NCT01789970|3875061|FG000|Open-label Titration Period|Noncompliance with study procedures|8
2226246|NCT01789970|3875062|FG001|Open-label Titration Period|Noncompliance with study procedures|0
2226247|NCT01789970|3875063|FG002|Open-label Titration Period|Noncompliance with study procedures|0
2226248|NCT01789970|3875061|FG000|Open-label Titration Period|Pregnancy|2
2226249|NCT01789970|3875062|FG001|Open-label Titration Period|Pregnancy|0
2226250|NCT01789970|3875063|FG002|Open-label Titration Period|Pregnancy|0
2226251|NCT01789970|3875061|FG000|Open-label Titration Period|Other|76
2226252|NCT01789970|3875062|FG001|Open-label Titration Period|Other|0
2226253|NCT01789970|3875063|FG002|Open-label Titration Period|Other|0
2226254|NCT01789970|3875061|FG000|Open-label Titration Period|Dropped out prior to dosing|2
2226255|NCT01789970|3875062|FG001|Open-label Titration Period|Dropped out prior to dosing|0
2226256|NCT01789970|3875063|FG002|Open-label Titration Period|Dropped out prior to dosing|0
2226257|NCT01789970|3875061|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
2226258|NCT01789970|3875062|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
2226259|NCT01789970|3875063|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
2226260|NCT01789970|3875061|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2226261|NCT01789970|3875062|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
2226262|NCT01789970|3875063|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
2226263|NCT01789970|3875061|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2226264|NCT01789970|3875062|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
2332458|NCT03197324|4056113|FG001|Overall Study|Adverse Event|1
2332459|NCT03197376|4056123|FG000|Primary and Booster Phase|Adverse Event|0
2332460|NCT03197376|4056124|FG001|Primary and Booster Phase|Adverse Event|0
2332461|NCT03197376|4056125|FG002|Primary and Booster Phase|Adverse Event|0
2332462|NCT03197376|4056126|FG003|Primary and Booster Phase|Adverse Event|1
2332463|NCT03197376|4056123|FG000|Primary and Booster Phase|Death|1
2332464|NCT03197376|4056124|FG001|Primary and Booster Phase|Death|0
2332465|NCT03197376|4056125|FG002|Primary and Booster Phase|Death|0
2332466|NCT03197376|4056126|FG003|Primary and Booster Phase|Death|2
2332467|NCT03197376|4056123|FG000|Primary and Booster Phase|Lost to Follow-up|0
2332468|NCT03197376|4056124|FG001|Primary and Booster Phase|Lost to Follow-up|0
2332469|NCT03197376|4056125|FG002|Primary and Booster Phase|Lost to Follow-up|1
2332470|NCT03197376|4056126|FG003|Primary and Booster Phase|Lost to Follow-up|0
2332471|NCT03197376|4056123|FG000|Primary and Booster Phase|Physician Decision|1
2332472|NCT03197376|4056124|FG001|Primary and Booster Phase|Physician Decision|0
2332473|NCT03197376|4056125|FG002|Primary and Booster Phase|Physician Decision|1
2332474|NCT03197376|4056126|FG003|Primary and Booster Phase|Physician Decision|3
2332475|NCT03197376|4056123|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11
2332476|NCT03197376|4056124|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10
2332477|NCT03197376|4056125|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14
2332478|NCT03197376|4056126|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11
2332479|NCT03197376|4056123|FG000|Primary and Booster Phase|Ineligibility criteria|1
2332480|NCT03197376|4056124|FG001|Primary and Booster Phase|Ineligibility criteria|1
2332481|NCT03197376|4056125|FG002|Primary and Booster Phase|Ineligibility criteria|4
2332482|NCT03197376|4056126|FG003|Primary and Booster Phase|Ineligibility criteria|2
2332483|NCT03197376|4056123|FG000|Primary and Booster Phase|Not vaccine related|1
2332484|NCT03197376|4056124|FG001|Primary and Booster Phase|Not vaccine related|2
2332485|NCT03197376|4056125|FG002|Primary and Booster Phase|Not vaccine related|0
2332486|NCT03197376|4056126|FG003|Primary and Booster Phase|Not vaccine related|6
2332487|NCT03197376|4056123|FG000|Immune Persistence Phase|Lost to Follow-up|0
2332488|NCT03197376|4056124|FG001|Immune Persistence Phase|Lost to Follow-up|0
2332489|NCT03197376|4056125|FG002|Immune Persistence Phase|Lost to Follow-up|2
2226265|NCT01789970|3875063|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
2226266|NCT01789970|3875061|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
2226267|NCT01789970|3875062|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
2226268|NCT01789970|3875063|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
2226269|NCT01789970|3875061|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
2226270|NCT01789970|3875062|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
2226271|NCT01789970|3875063|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
2226272|NCT01789970|3875061|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
2226273|NCT01789970|3875062|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
2226274|NCT01789970|3875063|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
2226275|NCT01789970|3875061|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
2226276|NCT01789970|3875062|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
2226277|NCT01789970|3875063|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
2226278|NCT01789970|3875061|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
2226279|NCT01789970|3875062|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
2226280|NCT01789970|3875063|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
2226281|NCT01789970|3875061|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
2226282|NCT01789970|3875062|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
2226283|NCT01789970|3875063|FG002|Double-blind Treatment Period (12 Weeks)|Other|3
2226284|NCT01789970|3875061|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
2226285|NCT01789970|3875062|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
2226286|NCT01789970|3875063|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
2226287|NCT01790048|3875079|FG000|Overall Study|Incorrect Age|9
2226288|NCT01790048|3875080|FG001|Overall Study|Incorrect Age|14
2226289|NCT01790048|3875079|FG000|Overall Study|data entry error|0
2226290|NCT01790048|3875080|FG001|Overall Study|data entry error|1
2226291|NCT01790048|3875079|FG000|Overall Study|Other|0
2226292|NCT01790048|3875080|FG001|Overall Study|Other|2
2226293|NCT01790048|3875079|FG000|Overall Study|SAM at Enrollment|2
2226294|NCT01790048|3875080|FG001|Overall Study|SAM at Enrollment|0
2226295|NCT01790048|3875079|FG000|Overall Study|Measurement error|1
2226296|NCT01790048|3875080|FG001|Overall Study|Measurement error|0
2226297|NCT01790113|3875090|FG000|Overall Study|Adverse Event|2
2226298|NCT01790113|3875091|FG001|Overall Study|Adverse Event|7
2226299|NCT01790113|3875090|FG000|Overall Study|Study ended due to FDA clearance|1
2226300|NCT01790113|3875091|FG001|Overall Study|Study ended due to FDA clearance|68
2226301|NCT01790126|3875100|FG000|Overall Study|PSA Progression|12
2226302|NCT01790126|3875101|FG001|Overall Study|PSA Progression|16
2226303|NCT01790126|3875102|FG002|Overall Study|PSA Progression|16
2226304|NCT01790126|3875100|FG000|Overall Study|Other|5
2226305|NCT01790126|3875101|FG001|Overall Study|Other|4
2226306|NCT01790126|3875102|FG002|Overall Study|Other|8
2226307|NCT01790126|3875100|FG000|Overall Study|Initiation of Non-Protocol Therapy|3
2226308|NCT01790126|3875101|FG001|Overall Study|Initiation of Non-Protocol Therapy|4
2226309|NCT01790126|3875102|FG002|Overall Study|Initiation of Non-Protocol Therapy|2
2226310|NCT01790126|3875100|FG000|Overall Study|Withdrawal by Physician|1
2226311|NCT01790126|3875101|FG001|Overall Study|Withdrawal by Physician|1
2226312|NCT01790126|3875102|FG002|Overall Study|Withdrawal by Physician|2
2226313|NCT01790126|3875100|FG000|Overall Study|Withdrawal by Subject|3
2226314|NCT01790126|3875101|FG001|Overall Study|Withdrawal by Subject|1
2226315|NCT01790126|3875102|FG002|Overall Study|Withdrawal by Subject|2
2226316|NCT01790126|3875100|FG000|Overall Study|Lost to Follow-up|1
2226317|NCT01790126|3875101|FG001|Overall Study|Lost to Follow-up|0
2226318|NCT01790126|3875102|FG002|Overall Study|Lost to Follow-up|1
2226319|NCT01790126|3875100|FG000|Overall Study|Adverse Event|0
2226320|NCT01790126|3875101|FG001|Overall Study|Adverse Event|2
2226321|NCT01790126|3875102|FG002|Overall Study|Adverse Event|0
2226322|NCT01790126|3875100|FG000|Overall Study|Death|2
2226323|NCT01790126|3875101|FG001|Overall Study|Death|0
2226324|NCT01790126|3875102|FG002|Overall Study|Death|0
2226325|NCT01790126|3875100|FG000|Overall Study|Radiographic Progression|3
2226326|NCT01790126|3875101|FG001|Overall Study|Radiographic Progression|1
2226327|NCT01790126|3875102|FG002|Overall Study|Radiographic Progression|0
2226328|NCT01790295|3875129|FG000|Overall Study|Adverse Event|1
2226329|NCT01790295|3875129|FG000|Overall Study|Death|4
2226330|NCT01790295|3875129|FG000|Overall Study|Lack of Efficacy|2
2226331|NCT01790295|3875129|FG000|Overall Study|Study closure|4
2226332|NCT01790438|3875136|FG000|Overall Study|Adverse Event|3
2226333|NCT01790438|3875137|FG001|Overall Study|Adverse Event|2
2226334|NCT01790438|3875136|FG000|Overall Study|Death|4
2226335|NCT01790438|3875137|FG001|Overall Study|Death|0
2226336|NCT01790438|3875136|FG000|Overall Study|Lost to Follow-up|5
2226337|NCT01790438|3875137|FG001|Overall Study|Lost to Follow-up|2
2226338|NCT01790438|3875136|FG000|Overall Study|Withdrawal by Subject|13
2226339|NCT01790438|3875137|FG001|Overall Study|Withdrawal by Subject|2
2226340|NCT01790438|3875136|FG000|Overall Study|Physician Decision|3
2226341|NCT01790438|3875137|FG001|Overall Study|Physician Decision|1
2226342|NCT01790438|3875136|FG000|Overall Study|Sponsor Decision|0
2226343|NCT01790438|3875137|FG001|Overall Study|Sponsor Decision|3
2226344|NCT01790438|3875136|FG000|Overall Study|Protocol Required Discontinuation|7
2226345|NCT01790438|3875137|FG001|Overall Study|Protocol Required Discontinuation|1
2226346|NCT01790503|3875172|FG000|Overall Study|Adverse Event|1
2226347|NCT01790503|3875173|FG001|Overall Study|Adverse Event|0
2226348|NCT01790503|3875174|FG002|Overall Study|Adverse Event|0
2226349|NCT01790503|3875175|FG003|Overall Study|Adverse Event|0
2226350|NCT01790503|3875176|FG004|Overall Study|Adverse Event|0
2226351|NCT01790503|3875177|FG005|Overall Study|Adverse Event|2
2226352|NCT01790503|3875178|FG006|Overall Study|Adverse Event|0
2226353|NCT01790503|3875179|FG007|Overall Study|Adverse Event|0
2226354|NCT01790503|3875180|FG008|Overall Study|Adverse Event|2
2226355|NCT01790503|3875181|FG009|Overall Study|Adverse Event|4
2226356|NCT01790503|3875182|FG010|Overall Study|Adverse Event|7
2226357|NCT01790503|3875172|FG000|Overall Study|Withdrawal by Subject|0
2226358|NCT01790503|3875173|FG001|Overall Study|Withdrawal by Subject|0
2226359|NCT01790503|3875174|FG002|Overall Study|Withdrawal by Subject|1
2226360|NCT01790503|3875175|FG003|Overall Study|Withdrawal by Subject|1
2226361|NCT01790503|3875176|FG004|Overall Study|Withdrawal by Subject|1
2226362|NCT01790503|3875177|FG005|Overall Study|Withdrawal by Subject|2
2226363|NCT01790503|3875178|FG006|Overall Study|Withdrawal by Subject|1
2226364|NCT01790503|3875179|FG007|Overall Study|Withdrawal by Subject|0
2226365|NCT01790503|3875180|FG008|Overall Study|Withdrawal by Subject|0
2226366|NCT01790503|3875181|FG009|Overall Study|Withdrawal by Subject|0
2226367|NCT01790503|3875182|FG010|Overall Study|Withdrawal by Subject|1
2226368|NCT01790503|3875172|FG000|Overall Study|Disease progression|2
2226369|NCT01790503|3875173|FG001|Overall Study|Disease progression|1
2226370|NCT01790503|3875174|FG002|Overall Study|Disease progression|0
2226371|NCT01790503|3875175|FG003|Overall Study|Disease progression|1
2226372|NCT01790503|3875176|FG004|Overall Study|Disease progression|2
2226373|NCT01790503|3875177|FG005|Overall Study|Disease progression|1
2226374|NCT01790503|3875178|FG006|Overall Study|Disease progression|0
2226375|NCT01790503|3875179|FG007|Overall Study|Disease progression|1
2226376|NCT01790503|3875180|FG008|Overall Study|Disease progression|0
2226377|NCT01790503|3875181|FG009|Overall Study|Disease progression|17
2226378|NCT01790503|3875182|FG010|Overall Study|Disease progression|7
2226379|NCT01790503|3875172|FG000|Overall Study|Protocol Violation|0
2226380|NCT01790503|3875173|FG001|Overall Study|Protocol Violation|0
2226381|NCT01790503|3875174|FG002|Overall Study|Protocol Violation|0
2226382|NCT01790503|3875175|FG003|Overall Study|Protocol Violation|0
2226383|NCT01790503|3875176|FG004|Overall Study|Protocol Violation|0
2226384|NCT01790503|3875177|FG005|Overall Study|Protocol Violation|0
2226385|NCT01790503|3875178|FG006|Overall Study|Protocol Violation|0
2226386|NCT01790503|3875179|FG007|Overall Study|Protocol Violation|0
2226387|NCT01790503|3875180|FG008|Overall Study|Protocol Violation|0
2226388|NCT01790503|3875181|FG009|Overall Study|Protocol Violation|1
2226389|NCT01790503|3875182|FG010|Overall Study|Protocol Violation|0
2226390|NCT01790503|3875172|FG000|Overall Study|Physician Decision|0
2226391|NCT01790503|3875173|FG001|Overall Study|Physician Decision|0
2226392|NCT01790503|3875174|FG002|Overall Study|Physician Decision|0
2226393|NCT01790503|3875175|FG003|Overall Study|Physician Decision|0
2226394|NCT01790503|3875176|FG004|Overall Study|Physician Decision|0
2226395|NCT01790503|3875177|FG005|Overall Study|Physician Decision|0
2226396|NCT01790503|3875178|FG006|Overall Study|Physician Decision|0
2226397|NCT01790503|3875179|FG007|Overall Study|Physician Decision|0
2226398|NCT01790503|3875180|FG008|Overall Study|Physician Decision|0
2226399|NCT01790503|3875181|FG009|Overall Study|Physician Decision|1
2226400|NCT01790503|3875182|FG010|Overall Study|Physician Decision|1
2226401|NCT01790503|3875172|FG000|Overall Study|Death|0
2226402|NCT01790503|3875173|FG001|Overall Study|Death|0
2226403|NCT01790503|3875174|FG002|Overall Study|Death|0
2226404|NCT01790503|3875175|FG003|Overall Study|Death|0
2226405|NCT01790503|3875176|FG004|Overall Study|Death|0
2226406|NCT01790503|3875177|FG005|Overall Study|Death|0
2226407|NCT01790503|3875178|FG006|Overall Study|Death|0
2226408|NCT01790503|3875179|FG007|Overall Study|Death|0
2226409|NCT01790503|3875180|FG008|Overall Study|Death|0
2332490|NCT03197376|4056126|FG003|Immune Persistence Phase|Lost to Follow-up|1
2332491|NCT03197376|4056123|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4
2332492|NCT03197376|4056124|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4
2036603|NCT00412984|3606857|FG001|Overall Study|Death|349
2036604|NCT00412984|3606856|FG000|Overall Study|Adverse Event|679
2036605|NCT00412984|3606857|FG001|Overall Study|Adverse Event|738
2226410|NCT01790503|3875181|FG009|Overall Study|Death|1
2226411|NCT01790503|3875182|FG010|Overall Study|Death|0
2226412|NCT01790503|3875172|FG000|Overall Study|Non Compliance|0
2226413|NCT01790503|3875173|FG001|Overall Study|Non Compliance|0
2226414|NCT01790503|3875174|FG002|Overall Study|Non Compliance|0
2226415|NCT01790503|3875175|FG003|Overall Study|Non Compliance|0
2226416|NCT01790503|3875176|FG004|Overall Study|Non Compliance|1
2226417|NCT01790503|3875177|FG005|Overall Study|Non Compliance|0
2226418|NCT01790503|3875178|FG006|Overall Study|Non Compliance|0
2226419|NCT01790503|3875179|FG007|Overall Study|Non Compliance|0
2226420|NCT01790503|3875180|FG008|Overall Study|Non Compliance|0
2226421|NCT01790503|3875181|FG009|Overall Study|Non Compliance|0
2226422|NCT01790503|3875182|FG010|Overall Study|Non Compliance|0
2226423|NCT01790503|3875172|FG000|Overall Study|Other|0
2226424|NCT01790503|3875173|FG001|Overall Study|Other|0
2226425|NCT01790503|3875174|FG002|Overall Study|Other|0
2226426|NCT01790503|3875175|FG003|Overall Study|Other|0
2226427|NCT01790503|3875176|FG004|Overall Study|Other|1
2226428|NCT01790503|3875177|FG005|Overall Study|Other|0
2226429|NCT01790503|3875178|FG006|Overall Study|Other|0
2226430|NCT01790503|3875179|FG007|Overall Study|Other|0
2226431|NCT01790503|3875180|FG008|Overall Study|Other|1
2226432|NCT01790503|3875181|FG009|Overall Study|Other|2
2226433|NCT01790503|3875182|FG010|Overall Study|Other|0
2226434|NCT01790516|3875221|FG000|Overall Study|Physician Decision|1
2226435|NCT01790516|3875222|FG001|Overall Study|Physician Decision|0
2226436|NCT01790568|3875228|FG000|Overall Study|Progression prior to transplant|0
2226437|NCT01790568|3875229|FG001|Overall Study|Progression prior to transplant|1
2226438|NCT01790594|3875244|FG000|Overall Study|Death|1
2226439|NCT01790594|3875245|FG001|Overall Study|Death|0
2226440|NCT01790594|3875246|FG002|Overall Study|Death|0
2226441|NCT01790594|3875244|FG000|Overall Study|Physician Decision|2
2226442|NCT01790594|3875245|FG001|Overall Study|Physician Decision|1
2226443|NCT01790594|3875246|FG002|Overall Study|Physician Decision|0
2226444|NCT01790594|3875244|FG000|Overall Study|Withdrawal by Subject|2
2226445|NCT01790594|3875245|FG001|Overall Study|Withdrawal by Subject|0
2226446|NCT01790594|3875246|FG002|Overall Study|Withdrawal by Subject|0
2226447|NCT01790594|3875244|FG000|Overall Study|Transplant was not done|0
2226448|NCT01790594|3875245|FG001|Overall Study|Transplant was not done|0
2226449|NCT01790594|3875246|FG002|Overall Study|Transplant was not done|3
2226450|NCT01790594|3875244|FG000|Overall Study|Terminated prior to week 76|0
2226451|NCT01790594|3875245|FG001|Overall Study|Terminated prior to week 76|2
2226452|NCT01790594|3875246|FG002|Overall Study|Terminated prior to week 76|0
2226453|NCT01790633|3875255|FG000|Overall Study|Protocol Violation|1
2226454|NCT01790633|3875256|FG001|Overall Study|Protocol Violation|2
2226455|NCT01790633|3875255|FG000|Overall Study|Did not have serology performed|47
2226456|NCT01790633|3875256|FG001|Overall Study|Did not have serology performed|0
2226457|NCT01790633|3875255|FG000|Overall Study|RT failure and no follow-up ELISA|0
2226458|NCT01790633|3875256|FG001|Overall Study|RT failure and no follow-up ELISA|3
2226459|NCT01790828|3875286|FG000|Overall Study|Other|34
2226460|NCT01790932|3875290|FG000|Overall Study|Disease Progression|41
2226461|NCT01790932|3875290|FG000|Overall Study|Adverse Event|7
2226462|NCT01790932|3875290|FG000|Overall Study|Physician Decision|1
2226463|NCT01790932|3875290|FG000|Overall Study|Withdrawal by Subject|1
2226464|NCT01790984|3875296|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
2226465|NCT01790984|3875297|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
2226466|NCT01790984|3875298|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
2226467|NCT01790984|3875299|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
2226468|NCT01791127|3875322|FG000|Overall Study|Death|356
2226469|NCT01791127|3875322|FG000|Overall Study|Patient has withdrawn from study|293
2226470|NCT01791127|3875322|FG000|Overall Study|Lost to Follow-up|42
2226471|NCT01791127|3875322|FG000|Overall Study|All Siello leads are explanted|31
2226472|NCT01791127|3875322|FG000|Overall Study|Completion of 30 day safety registry|1
2226473|NCT01791127|3875322|FG000|Overall Study|Study terminated for EP Passion|749
2226474|NCT01791153|3875343|FG000|Part 1: Blinded Period|Adverse Event|7
2226475|NCT01791153|3875344|FG001|Part 1: Blinded Period|Adverse Event|3
2226476|NCT01791153|3875345|FG002|Part 1: Blinded Period|Adverse Event|2
2226477|NCT01791153|3875346|FG003|Part 1: Blinded Period|Adverse Event|0
2226478|NCT01791153|3875347|FG004|Part 1: Blinded Period|Adverse Event|0
2226479|NCT01791153|3875348|FG005|Part 1: Blinded Period|Adverse Event|0
2226480|NCT01791153|3875349|FG006|Part 1: Blinded Period|Adverse Event|0
2226481|NCT01791153|3875350|FG007|Part 1: Blinded Period|Adverse Event|0
2226482|NCT01791153|3875343|FG000|Part 1: Blinded Period|Lack of Efficacy|1
2226483|NCT01791153|3875344|FG001|Part 1: Blinded Period|Lack of Efficacy|3
2226484|NCT01791153|3875345|FG002|Part 1: Blinded Period|Lack of Efficacy|2
2226485|NCT01791153|3875346|FG003|Part 1: Blinded Period|Lack of Efficacy|2
2226486|NCT01791153|3875347|FG004|Part 1: Blinded Period|Lack of Efficacy|0
2226487|NCT01791153|3875348|FG005|Part 1: Blinded Period|Lack of Efficacy|0
2226488|NCT01791153|3875349|FG006|Part 1: Blinded Period|Lack of Efficacy|0
2226489|NCT01791153|3875350|FG007|Part 1: Blinded Period|Lack of Efficacy|0
2226490|NCT01791153|3875343|FG000|Part 1: Blinded Period|Non-Compliance|1
2226491|NCT01791153|3875344|FG001|Part 1: Blinded Period|Non-Compliance|0
2226492|NCT01791153|3875345|FG002|Part 1: Blinded Period|Non-Compliance|0
2226493|NCT01791153|3875346|FG003|Part 1: Blinded Period|Non-Compliance|0
2226494|NCT01791153|3875347|FG004|Part 1: Blinded Period|Non-Compliance|0
2226495|NCT01791153|3875348|FG005|Part 1: Blinded Period|Non-Compliance|0
2226496|NCT01791153|3875349|FG006|Part 1: Blinded Period|Non-Compliance|0
2226497|NCT01791153|3875350|FG007|Part 1: Blinded Period|Non-Compliance|0
2226498|NCT01791153|3875343|FG000|Part 1: Blinded Period|Physician Decision|0
2226499|NCT01791153|3875344|FG001|Part 1: Blinded Period|Physician Decision|0
2226500|NCT01791153|3875345|FG002|Part 1: Blinded Period|Physician Decision|0
2226501|NCT01791153|3875346|FG003|Part 1: Blinded Period|Physician Decision|1
2226502|NCT01791153|3875347|FG004|Part 1: Blinded Period|Physician Decision|0
2226503|NCT01791153|3875348|FG005|Part 1: Blinded Period|Physician Decision|0
2226504|NCT01791153|3875349|FG006|Part 1: Blinded Period|Physician Decision|0
2226505|NCT01791153|3875350|FG007|Part 1: Blinded Period|Physician Decision|0
2226506|NCT01791153|3875343|FG000|Part 1: Blinded Period|Protocol Violation|0
2226507|NCT01791153|3875344|FG001|Part 1: Blinded Period|Protocol Violation|0
2226508|NCT01791153|3875345|FG002|Part 1: Blinded Period|Protocol Violation|0
2226509|NCT01791153|3875346|FG003|Part 1: Blinded Period|Protocol Violation|1
2226510|NCT01791153|3875347|FG004|Part 1: Blinded Period|Protocol Violation|0
2226511|NCT01791153|3875348|FG005|Part 1: Blinded Period|Protocol Violation|0
2226512|NCT01791153|3875349|FG006|Part 1: Blinded Period|Protocol Violation|0
2226513|NCT01791153|3875350|FG007|Part 1: Blinded Period|Protocol Violation|0
2226514|NCT01791153|3875343|FG000|Part 1: Blinded Period|Withdrawal by Subject|6
2226515|NCT01791153|3875344|FG001|Part 1: Blinded Period|Withdrawal by Subject|2
2226516|NCT01791153|3875345|FG002|Part 1: Blinded Period|Withdrawal by Subject|2
2226517|NCT01791153|3875346|FG003|Part 1: Blinded Period|Withdrawal by Subject|1
2226518|NCT01791153|3875347|FG004|Part 1: Blinded Period|Withdrawal by Subject|0
2226519|NCT01791153|3875348|FG005|Part 1: Blinded Period|Withdrawal by Subject|0
2226520|NCT01791153|3875349|FG006|Part 1: Blinded Period|Withdrawal by Subject|0
2226521|NCT01791153|3875350|FG007|Part 1: Blinded Period|Withdrawal by Subject|0
2226522|NCT01791153|3875343|FG000|Part 2: Open-label Period|Adverse Event|0
2226523|NCT01791153|3875344|FG001|Part 2: Open-label Period|Adverse Event|0
2226524|NCT01791153|3875345|FG002|Part 2: Open-label Period|Adverse Event|0
2226525|NCT01791153|3875346|FG003|Part 2: Open-label Period|Adverse Event|0
2226526|NCT01791153|3875347|FG004|Part 2: Open-label Period|Adverse Event|0
2226527|NCT01791153|3875348|FG005|Part 2: Open-label Period|Adverse Event|1
2226528|NCT01791153|3875349|FG006|Part 2: Open-label Period|Adverse Event|1
2226529|NCT01791153|3875350|FG007|Part 2: Open-label Period|Adverse Event|2
2226530|NCT01791153|3875343|FG000|Part 2: Open-label Period|Death|0
2226531|NCT01791153|3875344|FG001|Part 2: Open-label Period|Death|0
2226532|NCT01791153|3875345|FG002|Part 2: Open-label Period|Death|0
2226533|NCT01791153|3875346|FG003|Part 2: Open-label Period|Death|0
2226534|NCT01791153|3875347|FG004|Part 2: Open-label Period|Death|0
2226535|NCT01791153|3875348|FG005|Part 2: Open-label Period|Death|1
2226536|NCT01791153|3875349|FG006|Part 2: Open-label Period|Death|1
2226537|NCT01791153|3875350|FG007|Part 2: Open-label Period|Death|1
2226538|NCT01791153|3875343|FG000|Part 2: Open-label Period|Lost to Follow-up|0
2226539|NCT01791153|3875344|FG001|Part 2: Open-label Period|Lost to Follow-up|0
2226540|NCT01791153|3875345|FG002|Part 2: Open-label Period|Lost to Follow-up|0
2226541|NCT01791153|3875346|FG003|Part 2: Open-label Period|Lost to Follow-up|0
2226542|NCT01791153|3875347|FG004|Part 2: Open-label Period|Lost to Follow-up|0
2226543|NCT01791153|3875348|FG005|Part 2: Open-label Period|Lost to Follow-up|0
2226544|NCT01791153|3875349|FG006|Part 2: Open-label Period|Lost to Follow-up|1
2226545|NCT01791153|3875350|FG007|Part 2: Open-label Period|Lost to Follow-up|0
2226546|NCT01791153|3875343|FG000|Part 2: Open-label Period|Lack of Efficacy|0
2226547|NCT01791153|3875344|FG001|Part 2: Open-label Period|Lack of Efficacy|0
2226548|NCT01791153|3875345|FG002|Part 2: Open-label Period|Lack of Efficacy|0
2226549|NCT01791153|3875346|FG003|Part 2: Open-label Period|Lack of Efficacy|0
2226550|NCT01791153|3875347|FG004|Part 2: Open-label Period|Lack of Efficacy|0
2226551|NCT01791153|3875348|FG005|Part 2: Open-label Period|Lack of Efficacy|0
2226552|NCT01791153|3875349|FG006|Part 2: Open-label Period|Lack of Efficacy|0
2226553|NCT01791153|3875350|FG007|Part 2: Open-label Period|Lack of Efficacy|1
2226554|NCT01791153|3875343|FG000|Part 2: Open-label Period|Withdrawal by Subject|0
2226555|NCT01791153|3875344|FG001|Part 2: Open-label Period|Withdrawal by Subject|0
2226556|NCT01791153|3875345|FG002|Part 2: Open-label Period|Withdrawal by Subject|0
2226557|NCT01791153|3875346|FG003|Part 2: Open-label Period|Withdrawal by Subject|0
2226558|NCT01791153|3875347|FG004|Part 2: Open-label Period|Withdrawal by Subject|1
2226559|NCT01791153|3875348|FG005|Part 2: Open-label Period|Withdrawal by Subject|1
2226560|NCT01791153|3875349|FG006|Part 2: Open-label Period|Withdrawal by Subject|3
2226561|NCT01791153|3875350|FG007|Part 2: Open-label Period|Withdrawal by Subject|2
2226562|NCT01791153|3875343|FG000|Part 2: Open-label Period|Physician Decision|0
2226563|NCT01791153|3875344|FG001|Part 2: Open-label Period|Physician Decision|0
2226564|NCT01791153|3875345|FG002|Part 2: Open-label Period|Physician Decision|0
2226565|NCT01791153|3875346|FG003|Part 2: Open-label Period|Physician Decision|0
2226566|NCT01791153|3875347|FG004|Part 2: Open-label Period|Physician Decision|1
2226567|NCT01791153|3875348|FG005|Part 2: Open-label Period|Physician Decision|1
2226568|NCT01791153|3875349|FG006|Part 2: Open-label Period|Physician Decision|0
2226569|NCT01791153|3875350|FG007|Part 2: Open-label Period|Physician Decision|0
2226570|NCT01791205|3875367|FG000|Phase II|Lack of Efficacy|6
2226571|NCT01791205|3875368|FG001|Phase II|Lack of Efficacy|0
2226572|NCT01791205|3875367|FG000|Phase II|Adverse Event|2
2226573|NCT01791205|3875368|FG001|Phase II|Adverse Event|0
2226574|NCT01791205|3875367|FG000|Phase II|Safety|1
2226575|NCT01791205|3875368|FG001|Phase II|Safety|0
2226576|NCT01791205|3875367|FG000|Phase II|Lost to Follow-up|1
2226577|NCT01791205|3875368|FG001|Phase II|Lost to Follow-up|0
2226578|NCT01791205|3875367|FG000|Phase II|Remission of disease|1
2226579|NCT01791205|3875368|FG001|Phase II|Remission of disease|0
2226580|NCT01791205|3875367|FG000|Phase II|Physician's decision|1
2226581|NCT01791205|3875368|FG001|Phase II|Physician's decision|0
2226582|NCT01791244|3875376|FG000|Overall Study|Adverse Event|5
2226583|NCT01791244|3875377|FG001|Overall Study|Adverse Event|7
2226584|NCT01791244|3875376|FG000|Overall Study|Insufficient clinical response|10
2226585|NCT01791244|3875377|FG001|Overall Study|Insufficient clinical response|10
2226586|NCT01791244|3875376|FG000|Overall Study|Laboratory Abnormality|0
2226587|NCT01791244|3875377|FG001|Overall Study|Laboratory Abnormality|1
2226588|NCT01791413|3875387|FG000|Overall Study|Lost to Follow-up|5
2226589|NCT01791413|3875388|FG001|Overall Study|Lost to Follow-up|1
2226590|NCT01791517|3875407|FG000|Phase I: Period 1|Withdrawal by Subject|0
2226591|NCT01791517|3875408|FG001|Phase I: Period 1|Withdrawal by Subject|1
2226592|NCT01791517|3875409|FG002|Phase I: Period 1|Withdrawal by Subject|1
2226593|NCT01791517|3875410|FG003|Phase I: Period 1|Withdrawal by Subject|0
2226594|NCT01791517|3875411|FG004|Phase I: Period 1|Withdrawal by Subject|1
2226595|NCT01791517|3875412|FG005|Phase I: Period 1|Withdrawal by Subject|1
2226596|NCT01791517|3875413|FG006|Phase I: Period 1|Withdrawal by Subject|0
2226597|NCT01791517|3875414|FG007|Phase I: Period 1|Withdrawal by Subject|0
2226598|NCT01791517|3875415|FG008|Phase I: Period 1|Withdrawal by Subject|0
2226599|NCT01791517|3875416|FG009|Phase I: Period 1|Withdrawal by Subject|0
2226600|NCT01791517|3875417|FG010|Phase I: Period 1|Withdrawal by Subject|0
2226601|NCT01791517|3875418|FG011|Phase I: Period 1|Withdrawal by Subject|0
2226602|NCT01791517|3875407|FG000|Phase I: Period 1|Adverse Event|0
2226603|NCT01791517|3875408|FG001|Phase I: Period 1|Adverse Event|0
2226604|NCT01791517|3875409|FG002|Phase I: Period 1|Adverse Event|1
2226605|NCT01791517|3875410|FG003|Phase I: Period 1|Adverse Event|1
2226606|NCT01791517|3875411|FG004|Phase I: Period 1|Adverse Event|0
2226607|NCT01791517|3875412|FG005|Phase I: Period 1|Adverse Event|0
2226608|NCT01791517|3875413|FG006|Phase I: Period 1|Adverse Event|0
2226609|NCT01791517|3875414|FG007|Phase I: Period 1|Adverse Event|0
2226610|NCT01791517|3875415|FG008|Phase I: Period 1|Adverse Event|0
2226611|NCT01791517|3875416|FG009|Phase I: Period 1|Adverse Event|0
2226612|NCT01791517|3875417|FG010|Phase I: Period 1|Adverse Event|0
2226613|NCT01791517|3875418|FG011|Phase I: Period 1|Adverse Event|0
2226614|NCT01791517|3875407|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1
2332493|NCT03197376|4056125|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2
2332494|NCT03197376|4056126|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3
2332495|NCT03197376|4056123|FG000|Immune Persistence Phase|Not vaccine related|1
2332496|NCT03197376|4056124|FG001|Immune Persistence Phase|Not vaccine related|0
2332497|NCT03197376|4056125|FG002|Immune Persistence Phase|Not vaccine related|1
2332498|NCT03197376|4056126|FG003|Immune Persistence Phase|Not vaccine related|1
2332499|NCT03197558|4056184|FG000|Overall Study|Tubes not placed|1
2332500|NCT03197883|4056190|FG000|Overall Study|Adverse Event|1
2332501|NCT03197883|4056191|FG001|Overall Study|Adverse Event|1
2332502|NCT03197883|4056190|FG000|Overall Study|Lost to Follow-up|1
2332503|NCT03197883|4056191|FG001|Overall Study|Lost to Follow-up|0
2332504|NCT03197883|4056190|FG000|Overall Study|Protocol Violation|1
2332505|NCT03197883|4056191|FG001|Overall Study|Protocol Violation|0
2332506|NCT03197883|4056190|FG000|Overall Study|Other (Not Specified)|0
2332507|NCT03197883|4056191|FG001|Overall Study|Other (Not Specified)|5
2332508|NCT03198507|4056229|FG000|Overall Study|Withdrawal by Subject|1
2332509|NCT03198507|4056230|FG001|Overall Study|Withdrawal by Subject|0
2332510|NCT03198520|4056236|FG000|Overall Study|Physician Decision|2
2332511|NCT03198520|4056236|FG000|Overall Study|Protocol Violation|2
2332512|NCT03198520|4056236|FG000|Overall Study|Withdrawal by Subject|1
2332513|NCT03198520|4056236|FG000|Overall Study|Study Ended|1
2332514|NCT03198715|4056253|FG000|Overall Study|Death|0
2332515|NCT03198715|4056254|FG001|Overall Study|Death|0
2332516|NCT03198715|4056255|FG002|Overall Study|Death|1
2332517|NCT03198715|4056256|FG003|Overall Study|Death|0
2332518|NCT03198715|4056257|FG004|Overall Study|Death|2
2332519|NCT03198715|4056253|FG000|Overall Study|Other|0
2332520|NCT03198715|4056254|FG001|Overall Study|Other|1
2332521|NCT03198715|4056255|FG002|Overall Study|Other|1
2332522|NCT03198715|4056256|FG003|Overall Study|Other|0
2332523|NCT03198715|4056257|FG004|Overall Study|Other|0
2332524|NCT03198754|4056271|FG000|Overall Study|Withdrawal by Subject|5
2332525|NCT03198754|4056272|FG001|Overall Study|Withdrawal by Subject|4
2332526|NCT03198754|4056271|FG000|Overall Study|Lost to Follow-up|4
2332527|NCT03198754|4056272|FG001|Overall Study|Lost to Follow-up|3
2332528|NCT03198754|4056271|FG000|Overall Study|Ineligible|2
2332529|NCT03198754|4056272|FG001|Overall Study|Ineligible|1
2332530|NCT03198767|4056285|FG000|Overall Study|Protocol Violation|0
2332531|NCT03198767|4056286|FG001|Overall Study|Protocol Violation|0
2332532|NCT03198767|4056287|FG002|Overall Study|Protocol Violation|0
2332533|NCT03198767|4056288|FG003|Overall Study|Protocol Violation|6
2332534|NCT03198767|4056289|FG004|Overall Study|Protocol Violation|0
2332535|NCT03198767|4056290|FG005|Overall Study|Protocol Violation|0
2332536|NCT03198767|4056291|FG006|Overall Study|Protocol Violation|0
2332537|NCT03199911|4056358|FG000|Overall Study|Lost to Follow-up|5
2332538|NCT03199911|4056359|FG001|Overall Study|Lost to Follow-up|5
2332539|NCT03199911|4056358|FG000|Overall Study|Did not proceed with surgery|2
2332540|NCT03199911|4056359|FG001|Overall Study|Did not proceed with surgery|1
2332541|NCT03199963|4056367|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5
2332542|NCT03199963|4056368|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5
2332543|NCT03199963|4056367|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9
2332544|NCT03199963|4056368|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2
2226615|NCT01791517|3875408|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2226616|NCT01791517|3875409|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2226617|NCT01791517|3875410|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2226618|NCT01791517|3875411|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2226619|NCT01791517|3875412|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2226620|NCT01791517|3875413|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2226621|NCT01791517|3875414|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2226622|NCT01791517|3875415|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2226623|NCT01791517|3875416|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2226624|NCT01791517|3875417|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2226625|NCT01791517|3875418|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2226626|NCT01791517|3875407|FG000|Phase I: Period 1|Protocol Violation|0
2226627|NCT01791517|3875408|FG001|Phase I: Period 1|Protocol Violation|1
2226628|NCT01791517|3875409|FG002|Phase I: Period 1|Protocol Violation|0
2226629|NCT01791517|3875410|FG003|Phase I: Period 1|Protocol Violation|0
2226630|NCT01791517|3875411|FG004|Phase I: Period 1|Protocol Violation|0
2226631|NCT01791517|3875412|FG005|Phase I: Period 1|Protocol Violation|0
2226632|NCT01791517|3875413|FG006|Phase I: Period 1|Protocol Violation|0
2226633|NCT01791517|3875414|FG007|Phase I: Period 1|Protocol Violation|0
2226634|NCT01791517|3875415|FG008|Phase I: Period 1|Protocol Violation|0
2226635|NCT01791517|3875416|FG009|Phase I: Period 1|Protocol Violation|0
2226636|NCT01791517|3875417|FG010|Phase I: Period 1|Protocol Violation|0
2226637|NCT01791517|3875418|FG011|Phase I: Period 1|Protocol Violation|0
2226638|NCT01791517|3875407|FG000|Phase I: Period 1|Lost to Follow-up|0
2226639|NCT01791517|3875408|FG001|Phase I: Period 1|Lost to Follow-up|0
2226640|NCT01791517|3875409|FG002|Phase I: Period 1|Lost to Follow-up|0
2226641|NCT01791517|3875410|FG003|Phase I: Period 1|Lost to Follow-up|1
2226642|NCT01791517|3875411|FG004|Phase I: Period 1|Lost to Follow-up|0
2226643|NCT01791517|3875412|FG005|Phase I: Period 1|Lost to Follow-up|0
2226644|NCT01791517|3875413|FG006|Phase I: Period 1|Lost to Follow-up|1
2226645|NCT01791517|3875414|FG007|Phase I: Period 1|Lost to Follow-up|0
2226646|NCT01791517|3875415|FG008|Phase I: Period 1|Lost to Follow-up|1
2226647|NCT01791517|3875416|FG009|Phase I: Period 1|Lost to Follow-up|1
2226648|NCT01791517|3875417|FG010|Phase I: Period 1|Lost to Follow-up|0
2226649|NCT01791517|3875418|FG011|Phase I: Period 1|Lost to Follow-up|0
2226650|NCT01791517|3875407|FG000|Phase I: Period 1|Lens Handling DIfficulties|0
2226651|NCT01791517|3875408|FG001|Phase I: Period 1|Lens Handling DIfficulties|0
2226652|NCT01791517|3875409|FG002|Phase I: Period 1|Lens Handling DIfficulties|0
2226653|NCT01791517|3875410|FG003|Phase I: Period 1|Lens Handling DIfficulties|0
2226654|NCT01791517|3875411|FG004|Phase I: Period 1|Lens Handling DIfficulties|0
2226655|NCT01791517|3875412|FG005|Phase I: Period 1|Lens Handling DIfficulties|0
2226656|NCT01791517|3875413|FG006|Phase I: Period 1|Lens Handling DIfficulties|0
2226657|NCT01791517|3875414|FG007|Phase I: Period 1|Lens Handling DIfficulties|0
2226658|NCT01791517|3875415|FG008|Phase I: Period 1|Lens Handling DIfficulties|0
2226659|NCT01791517|3875416|FG009|Phase I: Period 1|Lens Handling DIfficulties|0
2226660|NCT01791517|3875417|FG010|Phase I: Period 1|Lens Handling DIfficulties|0
2226661|NCT01791517|3875418|FG011|Phase I: Period 1|Lens Handling DIfficulties|1
2226662|NCT01791517|3875407|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1
2226663|NCT01791517|3875408|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0
2226664|NCT01791517|3875409|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0
2226665|NCT01791517|3875410|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0
2226666|NCT01791517|3875411|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0
2226667|NCT01791517|3875412|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0
2226668|NCT01791517|3875413|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0
2226669|NCT01791517|3875414|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0
2226670|NCT01791517|3875415|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0
2226671|NCT01791517|3875416|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0
2226672|NCT01791517|3875417|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0
2226673|NCT01791517|3875418|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0
2226674|NCT01791517|3875407|FG000|Phase I: Period 2|Protocol Violation|0
2226675|NCT01791517|3875408|FG001|Phase I: Period 2|Protocol Violation|0
2226676|NCT01791517|3875409|FG002|Phase I: Period 2|Protocol Violation|0
2226677|NCT01791517|3875410|FG003|Phase I: Period 2|Protocol Violation|1
2226678|NCT01791517|3875411|FG004|Phase I: Period 2|Protocol Violation|0
2226679|NCT01791517|3875412|FG005|Phase I: Period 2|Protocol Violation|0
2226680|NCT01791517|3875413|FG006|Phase I: Period 2|Protocol Violation|0
2226681|NCT01791517|3875414|FG007|Phase I: Period 2|Protocol Violation|0
2226682|NCT01791517|3875415|FG008|Phase I: Period 2|Protocol Violation|0
2226683|NCT01791517|3875416|FG009|Phase I: Period 2|Protocol Violation|0
2226684|NCT01791517|3875417|FG010|Phase I: Period 2|Protocol Violation|0
2226685|NCT01791517|3875418|FG011|Phase I: Period 2|Protocol Violation|0
2226686|NCT01791517|3875407|FG000|Phase I: Period 2|Withdrawal by Subject|0
2226687|NCT01791517|3875408|FG001|Phase I: Period 2|Withdrawal by Subject|0
2226688|NCT01791517|3875409|FG002|Phase I: Period 2|Withdrawal by Subject|0
2226689|NCT01791517|3875410|FG003|Phase I: Period 2|Withdrawal by Subject|0
2226690|NCT01791517|3875411|FG004|Phase I: Period 2|Withdrawal by Subject|0
2226691|NCT01791517|3875412|FG005|Phase I: Period 2|Withdrawal by Subject|0
2226692|NCT01791517|3875413|FG006|Phase I: Period 2|Withdrawal by Subject|0
2226693|NCT01791517|3875414|FG007|Phase I: Period 2|Withdrawal by Subject|0
2226694|NCT01791517|3875415|FG008|Phase I: Period 2|Withdrawal by Subject|0
2226695|NCT01791517|3875416|FG009|Phase I: Period 2|Withdrawal by Subject|1
2226696|NCT01791517|3875417|FG010|Phase I: Period 2|Withdrawal by Subject|1
2226697|NCT01791517|3875418|FG011|Phase I: Period 2|Withdrawal by Subject|0
2226698|NCT01791517|3875407|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0
2226699|NCT01791517|3875408|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0
2226700|NCT01791517|3875409|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0
2226701|NCT01791517|3875410|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0
2226702|NCT01791517|3875411|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0
2226703|NCT01791517|3875412|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0
2226704|NCT01791517|3875413|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0
2226705|NCT01791517|3875414|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0
2226706|NCT01791517|3875415|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0
2226707|NCT01791517|3875416|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0
2226708|NCT01791517|3875417|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1
2226709|NCT01791517|3875418|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0
2226710|NCT01791517|3875407|FG000|Phase I: Period 2|Lens Discomfort|0
2226711|NCT01791517|3875408|FG001|Phase I: Period 2|Lens Discomfort|0
2226712|NCT01791517|3875409|FG002|Phase I: Period 2|Lens Discomfort|0
2226713|NCT01791517|3875410|FG003|Phase I: Period 2|Lens Discomfort|0
2226714|NCT01791517|3875411|FG004|Phase I: Period 2|Lens Discomfort|0
2226715|NCT01791517|3875412|FG005|Phase I: Period 2|Lens Discomfort|1
2226716|NCT01791517|3875413|FG006|Phase I: Period 2|Lens Discomfort|0
2226717|NCT01791517|3875414|FG007|Phase I: Period 2|Lens Discomfort|0
2226718|NCT01791517|3875415|FG008|Phase I: Period 2|Lens Discomfort|0
2226719|NCT01791517|3875416|FG009|Phase I: Period 2|Lens Discomfort|0
2226720|NCT01791517|3875417|FG010|Phase I: Period 2|Lens Discomfort|0
2226721|NCT01791517|3875418|FG011|Phase I: Period 2|Lens Discomfort|0
2226722|NCT01791517|3875407|FG000|Phase I: Period 2|Lost to Follow-up|0
2226723|NCT01791517|3875408|FG001|Phase I: Period 2|Lost to Follow-up|3
2226724|NCT01791517|3875409|FG002|Phase I: Period 2|Lost to Follow-up|2
2226725|NCT01791517|3875410|FG003|Phase I: Period 2|Lost to Follow-up|0
2226726|NCT01791517|3875411|FG004|Phase I: Period 2|Lost to Follow-up|0
2226727|NCT01791517|3875412|FG005|Phase I: Period 2|Lost to Follow-up|0
2226728|NCT01791517|3875413|FG006|Phase I: Period 2|Lost to Follow-up|0
2226729|NCT01791517|3875414|FG007|Phase I: Period 2|Lost to Follow-up|0
2226730|NCT01791517|3875415|FG008|Phase I: Period 2|Lost to Follow-up|0
2226731|NCT01791517|3875416|FG009|Phase I: Period 2|Lost to Follow-up|0
2226732|NCT01791517|3875417|FG010|Phase I: Period 2|Lost to Follow-up|0
2226733|NCT01791517|3875418|FG011|Phase I: Period 2|Lost to Follow-up|0
2226734|NCT01791517|3875407|FG000|Phase I: Period 3|Lens Discomfort|0
2226735|NCT01791517|3875408|FG001|Phase I: Period 3|Lens Discomfort|0
2226736|NCT01791517|3875409|FG002|Phase I: Period 3|Lens Discomfort|0
2226737|NCT01791517|3875410|FG003|Phase I: Period 3|Lens Discomfort|0
2226738|NCT01791517|3875411|FG004|Phase I: Period 3|Lens Discomfort|0
2226739|NCT01791517|3875412|FG005|Phase I: Period 3|Lens Discomfort|0
2226740|NCT01791517|3875413|FG006|Phase I: Period 3|Lens Discomfort|0
2226741|NCT01791517|3875414|FG007|Phase I: Period 3|Lens Discomfort|0
2226742|NCT01791517|3875415|FG008|Phase I: Period 3|Lens Discomfort|0
2226743|NCT01791517|3875416|FG009|Phase I: Period 3|Lens Discomfort|0
2226744|NCT01791517|3875417|FG010|Phase I: Period 3|Lens Discomfort|0
2226745|NCT01791517|3875418|FG011|Phase I: Period 3|Lens Discomfort|1
2226746|NCT01791517|3875407|FG000|Phase I: Period 3|Lost to Follow-up|0
2226747|NCT01791517|3875408|FG001|Phase I: Period 3|Lost to Follow-up|1
2226748|NCT01791517|3875409|FG002|Phase I: Period 3|Lost to Follow-up|0
2226749|NCT01791517|3875410|FG003|Phase I: Period 3|Lost to Follow-up|0
2226750|NCT01791517|3875411|FG004|Phase I: Period 3|Lost to Follow-up|1
2226751|NCT01791517|3875412|FG005|Phase I: Period 3|Lost to Follow-up|0
2226752|NCT01791517|3875413|FG006|Phase I: Period 3|Lost to Follow-up|0
2226753|NCT01791517|3875414|FG007|Phase I: Period 3|Lost to Follow-up|0
2226754|NCT01791517|3875415|FG008|Phase I: Period 3|Lost to Follow-up|0
2226755|NCT01791517|3875416|FG009|Phase I: Period 3|Lost to Follow-up|0
2226756|NCT01791517|3875417|FG010|Phase I: Period 3|Lost to Follow-up|0
2226757|NCT01791517|3875418|FG011|Phase I: Period 3|Lost to Follow-up|0
2226758|NCT01791517|3875407|FG000|Phase I: Period 3|Adverse Event|0
2226759|NCT01791517|3875408|FG001|Phase I: Period 3|Adverse Event|0
2226760|NCT01791517|3875409|FG002|Phase I: Period 3|Adverse Event|0
2226761|NCT01791517|3875410|FG003|Phase I: Period 3|Adverse Event|1
2226762|NCT01791517|3875411|FG004|Phase I: Period 3|Adverse Event|0
2226763|NCT01791517|3875412|FG005|Phase I: Period 3|Adverse Event|0
2226764|NCT01791517|3875413|FG006|Phase I: Period 3|Adverse Event|0
2226765|NCT01791517|3875414|FG007|Phase I: Period 3|Adverse Event|0
2226766|NCT01791517|3875415|FG008|Phase I: Period 3|Adverse Event|0
2226767|NCT01791517|3875416|FG009|Phase I: Period 3|Adverse Event|0
2226768|NCT01791517|3875417|FG010|Phase I: Period 3|Adverse Event|0
2226769|NCT01791517|3875418|FG011|Phase I: Period 3|Adverse Event|0
2226770|NCT01791517|3875407|FG000|Phase II|Lost to Follow-up|1
2226771|NCT01791517|3875408|FG001|Phase II|Lost to Follow-up|0
2226772|NCT01791517|3875409|FG002|Phase II|Lost to Follow-up|1
2226773|NCT01791517|3875410|FG003|Phase II|Lost to Follow-up|0
2226774|NCT01791517|3875411|FG004|Phase II|Lost to Follow-up|1
2226775|NCT01791517|3875412|FG005|Phase II|Lost to Follow-up|2
2226776|NCT01791517|3875413|FG006|Phase II|Lost to Follow-up|0
2226777|NCT01791517|3875414|FG007|Phase II|Lost to Follow-up|1
2226778|NCT01791517|3875415|FG008|Phase II|Lost to Follow-up|1
2226779|NCT01791517|3875416|FG009|Phase II|Lost to Follow-up|1
2226780|NCT01791517|3875417|FG010|Phase II|Lost to Follow-up|0
2226781|NCT01791517|3875418|FG011|Phase II|Lost to Follow-up|0
2226782|NCT01791517|3875407|FG000|Phase II|Withdrawal by Subject|1
2226783|NCT01791517|3875408|FG001|Phase II|Withdrawal by Subject|0
2226784|NCT01791517|3875409|FG002|Phase II|Withdrawal by Subject|0
2226785|NCT01791517|3875410|FG003|Phase II|Withdrawal by Subject|0
2226786|NCT01791517|3875411|FG004|Phase II|Withdrawal by Subject|0
2226787|NCT01791517|3875412|FG005|Phase II|Withdrawal by Subject|2
2226788|NCT01791517|3875413|FG006|Phase II|Withdrawal by Subject|0
2226789|NCT01791517|3875414|FG007|Phase II|Withdrawal by Subject|1
2226790|NCT01791517|3875415|FG008|Phase II|Withdrawal by Subject|0
2226791|NCT01791517|3875416|FG009|Phase II|Withdrawal by Subject|0
2226792|NCT01791517|3875417|FG010|Phase II|Withdrawal by Subject|1
2226793|NCT01791517|3875418|FG011|Phase II|Withdrawal by Subject|0
2226794|NCT01791517|3875407|FG000|Phase II|Lack of Efficacy|0
2226795|NCT01791517|3875408|FG001|Phase II|Lack of Efficacy|0
2226796|NCT01791517|3875409|FG002|Phase II|Lack of Efficacy|0
2226797|NCT01791517|3875410|FG003|Phase II|Lack of Efficacy|0
2226798|NCT01791517|3875411|FG004|Phase II|Lack of Efficacy|1
2226799|NCT01791517|3875412|FG005|Phase II|Lack of Efficacy|0
2226800|NCT01791517|3875413|FG006|Phase II|Lack of Efficacy|0
2226801|NCT01791517|3875414|FG007|Phase II|Lack of Efficacy|0
2226802|NCT01791517|3875415|FG008|Phase II|Lack of Efficacy|0
2226803|NCT01791517|3875416|FG009|Phase II|Lack of Efficacy|0
2226804|NCT01791517|3875417|FG010|Phase II|Lack of Efficacy|0
2226805|NCT01791517|3875418|FG011|Phase II|Lack of Efficacy|0
2226806|NCT01791517|3875407|FG000|Phase II|Adverse Event|0
2226807|NCT01791517|3875408|FG001|Phase II|Adverse Event|0
2226808|NCT01791517|3875409|FG002|Phase II|Adverse Event|0
2226809|NCT01791517|3875410|FG003|Phase II|Adverse Event|0
2226810|NCT01791517|3875411|FG004|Phase II|Adverse Event|0
2226811|NCT01791517|3875412|FG005|Phase II|Adverse Event|0
2226812|NCT01791517|3875413|FG006|Phase II|Adverse Event|2
2226813|NCT01791517|3875414|FG007|Phase II|Adverse Event|1
2226814|NCT01791517|3875415|FG008|Phase II|Adverse Event|0
2226815|NCT01791517|3875416|FG009|Phase II|Adverse Event|1
2226816|NCT01791517|3875417|FG010|Phase II|Adverse Event|0
2226817|NCT01791517|3875418|FG011|Phase II|Adverse Event|0
2226818|NCT01791517|3875407|FG000|Phase II|Lens Handling Difficulties|0
2226819|NCT01791517|3875408|FG001|Phase II|Lens Handling Difficulties|0
2226820|NCT01791517|3875409|FG002|Phase II|Lens Handling Difficulties|0
2226821|NCT01791517|3875410|FG003|Phase II|Lens Handling Difficulties|0
2226822|NCT01791517|3875411|FG004|Phase II|Lens Handling Difficulties|0
2226823|NCT01791517|3875412|FG005|Phase II|Lens Handling Difficulties|0
2226824|NCT01791517|3875413|FG006|Phase II|Lens Handling Difficulties|0
2226825|NCT01791517|3875414|FG007|Phase II|Lens Handling Difficulties|0
2226826|NCT01791517|3875415|FG008|Phase II|Lens Handling Difficulties|1
2226827|NCT01791517|3875416|FG009|Phase II|Lens Handling Difficulties|0
2226828|NCT01791517|3875417|FG010|Phase II|Lens Handling Difficulties|0
2226829|NCT01791517|3875418|FG011|Phase II|Lens Handling Difficulties|0
2226830|NCT01791517|3875407|FG000|Phase II|Unsatisfactory Lens Fitting|0
2226831|NCT01791517|3875408|FG001|Phase II|Unsatisfactory Lens Fitting|0
2226832|NCT01791517|3875409|FG002|Phase II|Unsatisfactory Lens Fitting|0
2226833|NCT01791517|3875410|FG003|Phase II|Unsatisfactory Lens Fitting|0
2226834|NCT01791517|3875411|FG004|Phase II|Unsatisfactory Lens Fitting|0
2226835|NCT01791517|3875412|FG005|Phase II|Unsatisfactory Lens Fitting|0
2226836|NCT01791517|3875413|FG006|Phase II|Unsatisfactory Lens Fitting|0
2226837|NCT01791517|3875414|FG007|Phase II|Unsatisfactory Lens Fitting|0
2226838|NCT01791517|3875415|FG008|Phase II|Unsatisfactory Lens Fitting|0
2226839|NCT01791517|3875416|FG009|Phase II|Unsatisfactory Lens Fitting|1
2226840|NCT01791517|3875417|FG010|Phase II|Unsatisfactory Lens Fitting|0
2226841|NCT01791517|3875418|FG011|Phase II|Unsatisfactory Lens Fitting|0
2226842|NCT01791517|3875407|FG000|Phase II|Pre-Existing Ocular Issue|0
2226843|NCT01791517|3875408|FG001|Phase II|Pre-Existing Ocular Issue|0
2226844|NCT01791517|3875409|FG002|Phase II|Pre-Existing Ocular Issue|0
2226845|NCT01791517|3875410|FG003|Phase II|Pre-Existing Ocular Issue|0
2226846|NCT01791517|3875411|FG004|Phase II|Pre-Existing Ocular Issue|0
2226847|NCT01791517|3875412|FG005|Phase II|Pre-Existing Ocular Issue|0
2226848|NCT01791517|3875413|FG006|Phase II|Pre-Existing Ocular Issue|0
2226849|NCT01791517|3875414|FG007|Phase II|Pre-Existing Ocular Issue|0
2226850|NCT01791517|3875415|FG008|Phase II|Pre-Existing Ocular Issue|0
2226851|NCT01791517|3875416|FG009|Phase II|Pre-Existing Ocular Issue|0
2226852|NCT01791517|3875417|FG010|Phase II|Pre-Existing Ocular Issue|0
2226853|NCT01791517|3875418|FG011|Phase II|Pre-Existing Ocular Issue|1
2226854|NCT01791725|3875439|FG000|Overall Study|Withdrawal by Subject|0
2226855|NCT01791725|3875440|FG001|Overall Study|Withdrawal by Subject|1
2226856|NCT01791725|3875441|FG002|Overall Study|Withdrawal by Subject|0
2226857|NCT01791803|3875453|FG000|Overall Study|Withdrawal by Subject|0
2226858|NCT01791803|3875454|FG001|Overall Study|Withdrawal by Subject|0
2226859|NCT01791803|3875455|FG002|Overall Study|Withdrawal by Subject|0
2226860|NCT01791803|3875456|FG003|Overall Study|Withdrawal by Subject|2
2226861|NCT01791803|3875453|FG000|Overall Study|Physician Decision|0
2226862|NCT01791803|3875454|FG001|Overall Study|Physician Decision|2
2226863|NCT01791803|3875455|FG002|Overall Study|Physician Decision|0
2226864|NCT01791803|3875456|FG003|Overall Study|Physician Decision|1
2226865|NCT01791803|3875453|FG000|Overall Study|Death|0
2226866|NCT01791803|3875454|FG001|Overall Study|Death|0
2226867|NCT01791803|3875455|FG002|Overall Study|Death|2
2226868|NCT01791803|3875456|FG003|Overall Study|Death|2
2226869|NCT01791894|3875469|FG000|Overall Study|Adverse Event|1
2226870|NCT01792115|3875490|FG000|Overall Study|Lost to Follow-up|0
2226871|NCT01792115|3875491|FG001|Overall Study|Lost to Follow-up|1
2226872|NCT01792115|3875492|FG002|Overall Study|Lost to Follow-up|0
2226873|NCT01792284|3875500|FG000|Lead-in Period|Adverse Event|15
2226874|NCT01792284|3875501|FG001|Lead-in Period|Adverse Event|0
2226875|NCT01792284|3875502|FG002|Lead-in Period|Adverse Event|0
2226876|NCT01792284|3875500|FG000|Lead-in Period|Lost to Follow-up|2
2226877|NCT01792284|3875501|FG001|Lead-in Period|Lost to Follow-up|0
2226878|NCT01792284|3875502|FG002|Lead-in Period|Lost to Follow-up|0
2226879|NCT01792284|3875500|FG000|Lead-in Period|Protocol Violation|1
2226880|NCT01792284|3875501|FG001|Lead-in Period|Protocol Violation|0
2226881|NCT01792284|3875502|FG002|Lead-in Period|Protocol Violation|0
2226882|NCT01792284|3875500|FG000|Lead-in Period|Withdrawal by Subject|10
2226883|NCT01792284|3875501|FG001|Lead-in Period|Withdrawal by Subject|0
2226884|NCT01792284|3875502|FG002|Lead-in Period|Withdrawal by Subject|0
2226885|NCT01792284|3875500|FG000|Lead-in Period|Physician Decision|1
2226886|NCT01792284|3875501|FG001|Lead-in Period|Physician Decision|0
2226887|NCT01792284|3875502|FG002|Lead-in Period|Physician Decision|0
2226888|NCT01792284|3875500|FG000|Lead-in Period|Protocol Required Discontinuation|1
2226889|NCT01792284|3875501|FG001|Lead-in Period|Protocol Required Discontinuation|0
2226890|NCT01792284|3875502|FG002|Lead-in Period|Protocol Required Discontinuation|0
2226891|NCT01792284|3875500|FG000|Randomization Period 1|Withdrawal by Subject|0
2226892|NCT01792284|3875501|FG001|Randomization Period 1|Withdrawal by Subject|1
2226893|NCT01792284|3875502|FG002|Randomization Period 1|Withdrawal by Subject|1
2226894|NCT01792284|3875500|FG000|Randomization Period 1|Physician Decision|0
2226895|NCT01792284|3875501|FG001|Randomization Period 1|Physician Decision|1
2226896|NCT01792284|3875502|FG002|Randomization Period 1|Physician Decision|1
2226897|NCT01792284|3875500|FG000|Randomization Period 1|Adverse Event|0
2226898|NCT01792284|3875501|FG001|Randomization Period 1|Adverse Event|0
2226899|NCT01792284|3875502|FG002|Randomization Period 1|Adverse Event|2
2226900|NCT01792284|3875500|FG000|Randomization Period 1|Lost to Follow-up|0
2226901|NCT01792284|3875501|FG001|Randomization Period 1|Lost to Follow-up|0
2226902|NCT01792284|3875502|FG002|Randomization Period 1|Lost to Follow-up|1
2226903|NCT01792284|3875500|FG000|Randomization Period 2|Protocol Violation|0
2226904|NCT01792284|3875501|FG001|Randomization Period 2|Protocol Violation|1
2226905|NCT01792284|3875502|FG002|Randomization Period 2|Protocol Violation|0
2226906|NCT01792284|3875500|FG000|Randomization Period 2|Withdrawal by Subject|0
2226907|NCT01792284|3875501|FG001|Randomization Period 2|Withdrawal by Subject|2
2226908|NCT01792284|3875502|FG002|Randomization Period 2|Withdrawal by Subject|0
2226909|NCT01792518|3875512|FG000|Overall Study|Adverse Event|3
2226910|NCT01792518|3875513|FG001|Overall Study|Adverse Event|4
2226911|NCT01792518|3875512|FG000|Overall Study|Protocol Violation|0
2226912|NCT01792518|3875513|FG001|Overall Study|Protocol Violation|1
2226913|NCT01792518|3875512|FG000|Overall Study|Lost to Follow-up|3
2226914|NCT01792518|3875513|FG001|Overall Study|Lost to Follow-up|1
2226915|NCT01792518|3875512|FG000|Overall Study|Withdrawal by Subject|2
2226916|NCT01792518|3875513|FG001|Overall Study|Withdrawal by Subject|0
2226917|NCT01792518|3875512|FG000|Overall Study|Other Reason|0
2226918|NCT01792518|3875513|FG001|Overall Study|Other Reason|1
2226919|NCT01792635|3875522|FG000|Part B|Adverse Event|0
2226920|NCT01792635|3875523|FG001|Part B|Adverse Event|0
2226921|NCT01792635|3875524|FG002|Part B|Adverse Event|1
2226922|NCT01792635|3875522|FG000|Part B|Study terminated|0
2226923|NCT01792635|3875523|FG001|Part B|Study terminated|4
2226924|NCT01792635|3875524|FG002|Part B|Study terminated|3
2226925|NCT01792830|3875555|FG000|Overall Study|Withdrawal by Subject|22
2226926|NCT01792830|3875556|FG001|Overall Study|Withdrawal by Subject|0
2226927|NCT01792830|3875557|FG002|Overall Study|Withdrawal by Subject|0
2226928|NCT01792830|3875558|FG003|Overall Study|Withdrawal by Subject|2
2226929|NCT01792830|3875559|FG004|Overall Study|Withdrawal by Subject|1
2226930|NCT01792830|3875560|FG005|Overall Study|Withdrawal by Subject|1
2226931|NCT01792830|3875561|FG006|Overall Study|Withdrawal by Subject|1
2226932|NCT01792830|3875562|FG007|Overall Study|Withdrawal by Subject|1
2226933|NCT01792830|3875563|FG008|Overall Study|Withdrawal by Subject|7
2226934|NCT01792830|3875564|FG009|Overall Study|Withdrawal by Subject|0
2226935|NCT01792830|3875565|FG010|Overall Study|Withdrawal by Subject|2
2226936|NCT01792830|3875555|FG000|Overall Study|Death|3
2226937|NCT01792830|3875556|FG001|Overall Study|Death|0
2226938|NCT01792830|3875557|FG002|Overall Study|Death|0
2226939|NCT01792830|3875558|FG003|Overall Study|Death|1
2226940|NCT01792830|3875559|FG004|Overall Study|Death|0
2226941|NCT01792830|3875560|FG005|Overall Study|Death|0
2226942|NCT01792830|3875561|FG006|Overall Study|Death|1
2226943|NCT01792830|3875562|FG007|Overall Study|Death|0
2226944|NCT01792830|3875563|FG008|Overall Study|Death|1
2226945|NCT01792830|3875564|FG009|Overall Study|Death|0
2226946|NCT01792830|3875565|FG010|Overall Study|Death|1
2226947|NCT01792830|3875555|FG000|Overall Study|Adverse Event|0
2226948|NCT01792830|3875556|FG001|Overall Study|Adverse Event|0
2226949|NCT01792830|3875557|FG002|Overall Study|Adverse Event|0
2226950|NCT01792830|3875558|FG003|Overall Study|Adverse Event|0
2226951|NCT01792830|3875559|FG004|Overall Study|Adverse Event|0
2226952|NCT01792830|3875560|FG005|Overall Study|Adverse Event|0
2226953|NCT01792830|3875561|FG006|Overall Study|Adverse Event|0
2226954|NCT01792830|3875562|FG007|Overall Study|Adverse Event|0
2226955|NCT01792830|3875563|FG008|Overall Study|Adverse Event|1
2226956|NCT01792830|3875564|FG009|Overall Study|Adverse Event|0
2226957|NCT01792830|3875565|FG010|Overall Study|Adverse Event|0
2226958|NCT01793051|3875601|FG000|Overall Study|Withdrawal by Subject|6
2226959|NCT01793051|3875602|FG001|Overall Study|Withdrawal by Subject|4
2226960|NCT01793051|3875601|FG000|Overall Study|Adverse Event|0
2226961|NCT01793051|3875602|FG001|Overall Study|Adverse Event|2
2226962|NCT01793051|3875601|FG000|Overall Study|Too ill to continue|1
2226963|NCT01793051|3875602|FG001|Overall Study|Too ill to continue|0
2226964|NCT01793051|3875601|FG000|Overall Study|Switched chemo|1
2226965|NCT01793051|3875602|FG001|Overall Study|Switched chemo|1
2226966|NCT01793051|3875601|FG000|Overall Study|Lack of compliance|1
2226967|NCT01793051|3875602|FG001|Overall Study|Lack of compliance|0
2226968|NCT01793051|3875601|FG000|Overall Study|Requested to be removed from the study|1
2226969|NCT01793051|3875602|FG001|Overall Study|Requested to be removed from the study|1
2226970|NCT01793142|3875608|FG000|Overall Study|Randomized not treated|7
2226971|NCT01793688|3875616|FG000|Overall Study|Protocol Violation|2
2226972|NCT01793792|3875620|FG000|Overall Study|Death|5
2226973|NCT01793792|3875620|FG000|Overall Study|Lost to Follow-up|5
2226974|NCT01793792|3875620|FG000|Overall Study|Withdrawal by Subject|1
2226975|NCT01793792|3875620|FG000|Overall Study|Device Not Implanted|1
2226976|NCT01793883|3875627|FG000|Overall Study|Withdrawal by Subject|3
2226977|NCT01793883|3875628|FG001|Overall Study|Withdrawal by Subject|7
2226978|NCT01793883|3875629|FG002|Overall Study|Withdrawal by Subject|3
2226979|NCT01793883|3875627|FG000|Overall Study|Subject noncompliance|0
2226980|NCT01793883|3875628|FG001|Overall Study|Subject noncompliance|1
2226981|NCT01793883|3875629|FG002|Overall Study|Subject noncompliance|1
2226982|NCT01793883|3875627|FG000|Overall Study|Lost to Follow-up|5
2226983|NCT01793883|3875628|FG001|Overall Study|Lost to Follow-up|1
2226984|NCT01793883|3875629|FG002|Overall Study|Lost to Follow-up|3
2226985|NCT01793883|3875627|FG000|Overall Study|Randomized in error|1
2226986|NCT01793883|3875628|FG001|Overall Study|Randomized in error|0
2226987|NCT01793883|3875629|FG002|Overall Study|Randomized in error|0
2226988|NCT01793883|3875627|FG000|Overall Study|Unable to complete spriometry|1
2226989|NCT01793883|3875628|FG001|Overall Study|Unable to complete spriometry|0
2226990|NCT01793883|3875629|FG002|Overall Study|Unable to complete spriometry|0
2226991|NCT01793883|3875627|FG000|Overall Study|Unable to complete measurements|1
2226992|NCT01793883|3875628|FG001|Overall Study|Unable to complete measurements|0
2226993|NCT01793883|3875629|FG002|Overall Study|Unable to complete measurements|0
2226994|NCT01793883|3875627|FG000|Overall Study|Met exclusion criteria|1
2226995|NCT01793883|3875628|FG001|Overall Study|Met exclusion criteria|0
2226996|NCT01793883|3875629|FG002|Overall Study|Met exclusion criteria|0
2226997|NCT01793883|3875627|FG000|Overall Study|Dosing error|0
2226998|NCT01793883|3875628|FG001|Overall Study|Dosing error|1
2226999|NCT01793883|3875629|FG002|Overall Study|Dosing error|0
2227000|NCT01793883|3875627|FG000|Overall Study|Respiratory distress during spirometry|0
2227001|NCT01793883|3875628|FG001|Overall Study|Respiratory distress during spirometry|0
2227002|NCT01793883|3875629|FG002|Overall Study|Respiratory distress during spirometry|1
2227003|NCT01793935|3875648|FG000|Overall Study|Pregnancy|1
2227004|NCT01793935|3875649|FG001|Overall Study|Pregnancy|0
2227005|NCT01793935|3875648|FG000|Overall Study|Protocol Violation|2
2227006|NCT01793935|3875649|FG001|Overall Study|Protocol Violation|1
2227007|NCT01793935|3875648|FG000|Overall Study|Adverse Event|2
2227008|NCT01793935|3875649|FG001|Overall Study|Adverse Event|0
2227009|NCT01793935|3875648|FG000|Overall Study|Patient did not take study medication|1
2227010|NCT01793935|3875649|FG001|Overall Study|Patient did not take study medication|1
2227011|NCT01793935|3875648|FG000|Overall Study|Lost to Follow-up|0
2227012|NCT01793935|3875649|FG001|Overall Study|Lost to Follow-up|1
2227013|NCT01794000|3875657|FG000|Double-Blind Phase (DBP)|Adverse Event|5
2227014|NCT01794000|3875658|FG001|Double-Blind Phase (DBP)|Adverse Event|2
2227015|NCT01794000|3875657|FG000|Double-Blind Phase (DBP)|Death|1
2227016|NCT01794000|3875658|FG001|Double-Blind Phase (DBP)|Death|2
2227017|NCT01794000|3875657|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
2227018|NCT01794000|3875658|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
2227019|NCT01794000|3875657|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
2227020|NCT01794000|3875658|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
2227021|NCT01794000|3875657|FG000|Double-Blind Phase (DBP)|Physician Decision|2
2227022|NCT01794000|3875658|FG001|Double-Blind Phase (DBP)|Physician Decision|0
2227023|NCT01794000|3875657|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148
2227024|NCT01794000|3875658|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149
2227025|NCT01794000|3875657|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6
2227026|NCT01794000|3875658|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11
2227027|NCT01794000|3875657|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3
2227028|NCT01794000|3875658|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2227029|NCT01794117|3875680|FG000|Overall Study|Adverse Event|1
2227030|NCT01794117|3875681|FG001|Overall Study|Adverse Event|0
2227031|NCT01794117|3875682|FG002|Overall Study|Adverse Event|0
2227032|NCT01794117|3875683|FG003|Overall Study|Adverse Event|0
2227033|NCT01794117|3875680|FG000|Overall Study|Participant noncompliance|0
2227034|NCT01794117|3875681|FG001|Overall Study|Participant noncompliance|1
2227035|NCT01794117|3875682|FG002|Overall Study|Participant noncompliance|0
2227036|NCT01794117|3875683|FG003|Overall Study|Participant noncompliance|0
2227037|NCT01794117|3875680|FG000|Overall Study|Refused further treatment|0
2227038|NCT01794117|3875681|FG001|Overall Study|Refused further treatment|2
2227039|NCT01794117|3875682|FG002|Overall Study|Refused further treatment|0
2227040|NCT01794117|3875683|FG003|Overall Study|Refused further treatment|0
2227041|NCT01794299|3875694|FG000|Overall Study|ATIR manufacturing not possible|1
2227042|NCT01794299|3875694|FG000|Overall Study|Death|14
2227043|NCT01794299|3875694|FG000|Overall Study|Graft failure|1
2227044|NCT01794299|3875694|FG000|Overall Study|ATIR batch rejected|2
2227045|NCT01794299|3875694|FG000|Overall Study|Relapse|2
2227046|NCT01794299|3875694|FG000|Overall Study|Discontinued from active follow-up|1
2227047|NCT01794299|3875694|FG000|Overall Study|Relapse and rejection of ATIR batch|1
2227048|NCT01794689|3875720|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3
2227049|NCT01794689|3875721|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0
2227050|NCT01794689|3875722|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2
2227051|NCT01794689|3875723|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4
2227052|NCT01794689|3875720|FG000|Intervention 1 (2 Nights)|Protocol Violation|1
2227053|NCT01794689|3875721|FG001|Intervention 1 (2 Nights)|Protocol Violation|0
2227054|NCT01794689|3875722|FG002|Intervention 1 (2 Nights)|Protocol Violation|1
2227055|NCT01794689|3875723|FG003|Intervention 1 (2 Nights)|Protocol Violation|0
2227056|NCT01794689|3875720|FG000|Intervention 1 (2 Nights)|Physician Decision|1
2227057|NCT01794689|3875721|FG001|Intervention 1 (2 Nights)|Physician Decision|1
2227058|NCT01794689|3875722|FG002|Intervention 1 (2 Nights)|Physician Decision|0
2227059|NCT01794689|3875723|FG003|Intervention 1 (2 Nights)|Physician Decision|0
2227060|NCT01794689|3875720|FG000|Intervention 1 (2 Nights)|Adverse Event|0
2227061|NCT01794689|3875721|FG001|Intervention 1 (2 Nights)|Adverse Event|1
2227062|NCT01794689|3875722|FG002|Intervention 1 (2 Nights)|Adverse Event|0
2227063|NCT01794689|3875723|FG003|Intervention 1 (2 Nights)|Adverse Event|0
2227064|NCT01794780|3875769|FG000|Overall Study|Adverse Event|0
2227065|NCT01794780|3875770|FG001|Overall Study|Adverse Event|1
2227066|NCT01794780|3875771|FG002|Overall Study|Adverse Event|2
2227067|NCT01794780|3875772|FG003|Overall Study|Adverse Event|0
2227068|NCT01794780|3875773|FG004|Overall Study|Adverse Event|0
2227069|NCT01794780|3875774|FG005|Overall Study|Adverse Event|0
2227070|NCT01794780|3875775|FG006|Overall Study|Adverse Event|0
2227071|NCT01794780|3875776|FG007|Overall Study|Adverse Event|0
2227072|NCT01794780|3875769|FG000|Overall Study|Death|0
2227073|NCT01794780|3875770|FG001|Overall Study|Death|2
2227074|NCT01794780|3875771|FG002|Overall Study|Death|14
2227075|NCT01794780|3875772|FG003|Overall Study|Death|1
2227076|NCT01794780|3875773|FG004|Overall Study|Death|0
2227077|NCT01794780|3875774|FG005|Overall Study|Death|9
2227078|NCT01794780|3875775|FG006|Overall Study|Death|4
2227079|NCT01794780|3875776|FG007|Overall Study|Death|0
2227080|NCT01794780|3875769|FG000|Overall Study|Lost to Follow-up|10
2227081|NCT01794780|3875770|FG001|Overall Study|Lost to Follow-up|64
2227082|NCT01794780|3875771|FG002|Overall Study|Lost to Follow-up|165
2227083|NCT01794780|3875772|FG003|Overall Study|Lost to Follow-up|53
2227084|NCT01794780|3875773|FG004|Overall Study|Lost to Follow-up|2
2227085|NCT01794780|3875774|FG005|Overall Study|Lost to Follow-up|99
2227086|NCT01794780|3875775|FG006|Overall Study|Lost to Follow-up|30
2227087|NCT01794780|3875776|FG007|Overall Study|Lost to Follow-up|5
2227088|NCT01794780|3875769|FG000|Overall Study|Withdrew informed consent|7
2227089|NCT01794780|3875770|FG001|Overall Study|Withdrew informed consent|17
2227090|NCT01794780|3875771|FG002|Overall Study|Withdrew informed consent|36
2227091|NCT01794780|3875772|FG003|Overall Study|Withdrew informed consent|9
2227092|NCT01794780|3875773|FG004|Overall Study|Withdrew informed consent|0
2227093|NCT01794780|3875774|FG005|Overall Study|Withdrew informed consent|48
2227094|NCT01794780|3875775|FG006|Overall Study|Withdrew informed consent|4
2227095|NCT01794780|3875776|FG007|Overall Study|Withdrew informed consent|3
2227096|NCT01794780|3875769|FG000|Overall Study|Other|0
2227097|NCT01794780|3875770|FG001|Overall Study|Other|12
2227098|NCT01794780|3875771|FG002|Overall Study|Other|25
2227099|NCT01794780|3875772|FG003|Overall Study|Other|20
2227100|NCT01794780|3875773|FG004|Overall Study|Other|1
2227101|NCT01794780|3875774|FG005|Overall Study|Other|24
2227102|NCT01794780|3875775|FG006|Overall Study|Other|4
2227103|NCT01794780|3875776|FG007|Overall Study|Other|1
2227104|NCT01794845|3875810|FG000|Overall Study|Withdrawal by Subject|1
2227105|NCT01794923|3875817|FG000|Overall Study|Adverse Event|0
2227106|NCT01794923|3875818|FG001|Overall Study|Adverse Event|0
2227107|NCT01794923|3875819|FG002|Overall Study|Adverse Event|1
2227108|NCT01794949|3875829|FG000|Overall Study|Lost to Follow-up|1
2227109|NCT01794949|3875830|FG001|Overall Study|Lost to Follow-up|0
2227110|NCT01795495|3875853|FG000|Overall Study|Protocol Violation|1
2227111|NCT01795495|3875854|FG001|Overall Study|Protocol Violation|0
2227112|NCT01795495|3875855|FG002|Overall Study|Protocol Violation|1
2227113|NCT01795495|3875853|FG000|Overall Study|Physician Decision|0
2227114|NCT01795495|3875854|FG001|Overall Study|Physician Decision|0
2227115|NCT01795495|3875855|FG002|Overall Study|Physician Decision|1
2227116|NCT01795547|3875872|FG000|Overall Study|Adverse Event|16
2227117|NCT01795547|3875873|FG001|Overall Study|Adverse Event|27
2227118|NCT01795547|3875872|FG000|Overall Study|Lack of Efficacy|8
2227119|NCT01795547|3875873|FG001|Overall Study|Lack of Efficacy|3
2227120|NCT01795547|3875872|FG000|Overall Study|Protocol Violation|6
2227121|NCT01795547|3875873|FG001|Overall Study|Protocol Violation|4
2227122|NCT01795547|3875872|FG000|Overall Study|Lost to Follow-up|2
2227123|NCT01795547|3875873|FG001|Overall Study|Lost to Follow-up|5
2227124|NCT01795547|3875872|FG000|Overall Study|Withdrawal of consent|7
2227125|NCT01795547|3875873|FG001|Overall Study|Withdrawal of consent|12
2227126|NCT01795547|3875872|FG000|Overall Study|Not Treated|4
2227127|NCT01795547|3875873|FG001|Overall Study|Not Treated|10
2227128|NCT01795547|3875872|FG000|Overall Study|Non-compliance with IMP|1
2227129|NCT01795547|3875873|FG001|Overall Study|Non-compliance with IMP|1
2227130|NCT01795547|3875872|FG000|Overall Study|Others|4
2227131|NCT01795547|3875873|FG001|Overall Study|Others|1
2227132|NCT01795547|3875872|FG000|Overall Study|Not stated|0
2227133|NCT01795547|3875873|FG001|Overall Study|Not stated|1
2227134|NCT01795638|3875883|FG000|Overall Study|Death|0
2227135|NCT01795638|3875884|FG001|Overall Study|Death|3
2227136|NCT01795638|3875883|FG000|Overall Study|transferred to quaternary hospital|2
2227137|NCT01795638|3875884|FG001|Overall Study|transferred to quaternary hospital|3
2227138|NCT01795638|3875883|FG000|Overall Study|Protocol Violation|3
2227139|NCT01795638|3875884|FG001|Overall Study|Protocol Violation|0
2227140|NCT01795638|3875883|FG000|Overall Study|discharged from hospital|7
2227141|NCT01795638|3875884|FG001|Overall Study|discharged from hospital|5
2227142|NCT01795638|3875883|FG000|Overall Study|Withdrawal by Subject|1
2227143|NCT01795638|3875884|FG001|Overall Study|Withdrawal by Subject|0
2227144|NCT01795898|3875919|FG000|Overall Study|Adverse Event|27
2227145|NCT01795898|3875919|FG000|Overall Study|Lost to Follow-up|20
2227146|NCT01795898|3875919|FG000|Overall Study|Withdrawal of consent|6
2227147|NCT01795898|3875919|FG000|Overall Study|Diagnosed with metastasis|1
2227148|NCT01795898|3875919|FG000|Overall Study|No pain|1
2227149|NCT01795898|3875919|FG000|Overall Study|Death|1
2227150|NCT01795898|3875919|FG000|Overall Study|Withdrew consent & had adverse events|3
2227151|NCT01795898|3875919|FG000|Overall Study|Physician Decision|1
2227152|NCT01795937|3875926|FG000|Overall Study|Withdrawal by Subject|1
2227153|NCT01795937|3875927|FG001|Overall Study|Withdrawal by Subject|0
2227154|NCT01795937|3875928|FG002|Overall Study|Withdrawal by Subject|0
2227155|NCT01795937|3875926|FG000|Overall Study|Physician Decision|0
2227156|NCT01795937|3875927|FG001|Overall Study|Physician Decision|1
2227157|NCT01795937|3875928|FG002|Overall Study|Physician Decision|0
2227158|NCT01796301|3875956|FG000|Overall Study|Withdrawal by Subject|15
2227159|NCT01796301|3875957|FG001|Overall Study|Withdrawal by Subject|15
2227160|NCT01796301|3875956|FG000|Overall Study|Lost to Follow-up|3
2227161|NCT01796301|3875957|FG001|Overall Study|Lost to Follow-up|3
2227162|NCT01796301|3875956|FG000|Overall Study|Death|0
2227163|NCT01796301|3875957|FG001|Overall Study|Death|1
2227164|NCT01796301|3875956|FG000|Overall Study|Decision by Sponsor|0
2227165|NCT01796301|3875957|FG001|Overall Study|Decision by Sponsor|1
2227166|NCT01796392|3875965|FG000|Overall Study|Withdrawal by Subject|2
2227167|NCT01796392|3875966|FG001|Overall Study|Withdrawal by Subject|0
2227168|NCT01796392|3875965|FG000|Overall Study|Death|5
2227169|NCT01796392|3875966|FG001|Overall Study|Death|1
2227170|NCT01796392|3875965|FG000|Overall Study|Excluded for medical reasons|1
2227171|NCT01796392|3875966|FG001|Overall Study|Excluded for medical reasons|2
2227172|NCT01796392|3875965|FG000|Overall Study|Lost to Follow-up|1
2227173|NCT01796392|3875966|FG001|Overall Study|Lost to Follow-up|0
2227174|NCT01796470|3875977|FG000|Overall Study|Adverse Event|4
2227175|NCT01796470|3875978|FG001|Overall Study|Adverse Event|2
2227176|NCT01796470|3875979|FG002|Overall Study|Adverse Event|2
2227177|NCT01796470|3875980|FG003|Overall Study|Adverse Event|1
2227178|NCT01796470|3875981|FG004|Overall Study|Adverse Event|3
2227179|NCT01796470|3875977|FG000|Overall Study|Death|2
2227180|NCT01796470|3875978|FG001|Overall Study|Death|0
2227181|NCT01796470|3875979|FG002|Overall Study|Death|0
2227182|NCT01796470|3875980|FG003|Overall Study|Death|0
2227183|NCT01796470|3875981|FG004|Overall Study|Death|1
2227184|NCT01796470|3875977|FG000|Overall Study|Initiated New Therapy|9
2227185|NCT01796470|3875978|FG001|Overall Study|Initiated New Therapy|0
2227186|NCT01796470|3875979|FG002|Overall Study|Initiated New Therapy|0
2227187|NCT01796470|3875980|FG003|Overall Study|Initiated New Therapy|0
2227188|NCT01796470|3875981|FG004|Overall Study|Initiated New Therapy|2
2227189|NCT01796470|3875977|FG000|Overall Study|Lost to Follow-up|0
2227190|NCT01796470|3875978|FG001|Overall Study|Lost to Follow-up|1
2227191|NCT01796470|3875979|FG002|Overall Study|Lost to Follow-up|0
2227192|NCT01796470|3875980|FG003|Overall Study|Lost to Follow-up|0
2227193|NCT01796470|3875981|FG004|Overall Study|Lost to Follow-up|0
2227194|NCT01796470|3875977|FG000|Overall Study|Physician Decision|5
2227195|NCT01796470|3875978|FG001|Overall Study|Physician Decision|4
2227196|NCT01796470|3875979|FG002|Overall Study|Physician Decision|1
2227197|NCT01796470|3875980|FG003|Overall Study|Physician Decision|0
2227198|NCT01796470|3875981|FG004|Overall Study|Physician Decision|1
2227199|NCT01796470|3875977|FG000|Overall Study|Progressive Disease|7
2227200|NCT01796470|3875978|FG001|Overall Study|Progressive Disease|7
2227201|NCT01796470|3875979|FG002|Overall Study|Progressive Disease|3
2227202|NCT01796470|3875980|FG003|Overall Study|Progressive Disease|2
2227203|NCT01796470|3875981|FG004|Overall Study|Progressive Disease|0
2227204|NCT01796470|3875977|FG000|Overall Study|Protocol Criteria for Withdrawal|1
2227205|NCT01796470|3875978|FG001|Overall Study|Protocol Criteria for Withdrawal|0
2227206|NCT01796470|3875979|FG002|Overall Study|Protocol Criteria for Withdrawal|0
2227207|NCT01796470|3875980|FG003|Overall Study|Protocol Criteria for Withdrawal|0
2227208|NCT01796470|3875981|FG004|Overall Study|Protocol Criteria for Withdrawal|0
2227209|NCT01796470|3875977|FG000|Overall Study|Withdrawal by Subject|7
2227210|NCT01796470|3875978|FG001|Overall Study|Withdrawal by Subject|0
2227211|NCT01796470|3875979|FG002|Overall Study|Withdrawal by Subject|0
2227212|NCT01796470|3875980|FG003|Overall Study|Withdrawal by Subject|0
2227213|NCT01796470|3875981|FG004|Overall Study|Withdrawal by Subject|1
2227214|NCT01796548|3875997|FG000|Overall Study|Lost to Follow-up|1
2227215|NCT01796548|3875997|FG000|Overall Study|Other|2
2227216|NCT01796860|3876014|FG000|Overall Study|Withdrawal by Subject|3
2227217|NCT01796964|3876029|FG000|Overall Study|Adverse Event|1
2227218|NCT01796964|3876030|FG001|Overall Study|Adverse Event|1
2227219|NCT01796964|3876029|FG000|Overall Study|Death|1
2227220|NCT01796964|3876030|FG001|Overall Study|Death|0
2227221|NCT01796964|3876029|FG000|Overall Study|Protocol Violation|0
2227222|NCT01796964|3876030|FG001|Overall Study|Protocol Violation|1
2227223|NCT01796964|3876029|FG000|Overall Study|Withdrawal by Subject|1
2227224|NCT01796964|3876030|FG001|Overall Study|Withdrawal by Subject|1
2227225|NCT01797081|3876059|FG000|Overall Study|Adverse Event|1
2227226|NCT01797081|3876060|FG001|Overall Study|Adverse Event|0
2227227|NCT01797081|3876061|FG002|Overall Study|Adverse Event|1
2227228|NCT01797081|3876062|FG003|Overall Study|Adverse Event|0
2227229|NCT01797081|3876059|FG000|Overall Study|Pregnancy|1
2227230|NCT01797081|3876060|FG001|Overall Study|Pregnancy|0
2227231|NCT01797081|3876061|FG002|Overall Study|Pregnancy|0
2227232|NCT01797081|3876062|FG003|Overall Study|Pregnancy|0
2227233|NCT01797081|3876059|FG000|Overall Study|Personal Reasons|12
2227234|NCT01797081|3876060|FG001|Overall Study|Personal Reasons|4
2227235|NCT01797081|3876061|FG002|Overall Study|Personal Reasons|4
2227236|NCT01797081|3876062|FG003|Overall Study|Personal Reasons|8
2227237|NCT01797081|3876059|FG000|Overall Study|Protocol Violation|0
2227238|NCT01797081|3876060|FG001|Overall Study|Protocol Violation|0
2227239|NCT01797081|3876061|FG002|Overall Study|Protocol Violation|0
2227240|NCT01797081|3876062|FG003|Overall Study|Protocol Violation|1
2227241|NCT01797094|3876072|FG000|Overall Study|Adverse Event|1
2227242|NCT01797094|3876073|FG001|Overall Study|Adverse Event|1
2227243|NCT01797094|3876072|FG000|Overall Study|Personal Reasons|4
2227244|NCT01797094|3876073|FG001|Overall Study|Personal Reasons|0
2227245|NCT01797094|3876072|FG000|Overall Study|Protocol Violation|0
2227246|NCT01797094|3876073|FG001|Overall Study|Protocol Violation|1
2227247|NCT01797094|3876072|FG000|Overall Study|Other Miscellaneous Reasons|1
2227248|NCT01797094|3876073|FG001|Overall Study|Other Miscellaneous Reasons|0
2227249|NCT01797120|3876081|FG000|Overall Study|Disesae progression|37
2227250|NCT01797120|3876082|FG001|Overall Study|Disesae progression|49
2227251|NCT01797120|3876081|FG000|Overall Study|Adverse Event|13
2227252|NCT01797120|3876082|FG001|Overall Study|Adverse Event|5
2227253|NCT01797120|3876081|FG000|Overall Study|Withdrawal by Subject|6
2227254|NCT01797120|3876082|FG001|Overall Study|Withdrawal by Subject|6
2227255|NCT01797120|3876081|FG000|Overall Study|Symptomatic progression|2
2227256|NCT01797120|3876082|FG001|Overall Study|Symptomatic progression|1
2227257|NCT01797120|3876081|FG000|Overall Study|Non-compliance|1
2227258|NCT01797120|3876082|FG001|Overall Study|Non-compliance|0
2227259|NCT01797120|3876081|FG000|Overall Study|Physician Decision|3
2227260|NCT01797120|3876082|FG001|Overall Study|Physician Decision|0
2227261|NCT01797120|3876081|FG000|Overall Study|still on treatment|2
2227262|NCT01797120|3876082|FG001|Overall Study|still on treatment|4
2227263|NCT01797120|3876081|FG000|Overall Study|never start protocol therapy|2
2227264|NCT01797120|3876082|FG001|Overall Study|never start protocol therapy|0
2227265|NCT01797185|3876096|FG000|Overall Study|Adverse Event|5
2227266|NCT01797185|3876097|FG001|Overall Study|Adverse Event|15
2227267|NCT01797185|3876098|FG002|Overall Study|Adverse Event|6
2227268|NCT01797185|3876096|FG000|Overall Study|Withdrawal by Subject|6
2227269|NCT01797185|3876097|FG001|Overall Study|Withdrawal by Subject|9
2227270|NCT01797185|3876098|FG002|Overall Study|Withdrawal by Subject|5
2227271|NCT01797185|3876096|FG000|Overall Study|Site terminated|8
2227272|NCT01797185|3876097|FG001|Overall Study|Site terminated|4
2227273|NCT01797185|3876098|FG002|Overall Study|Site terminated|0
2227274|NCT01797185|3876096|FG000|Overall Study|Lost to Follow-up|2
2227275|NCT01797185|3876097|FG001|Overall Study|Lost to Follow-up|6
2227276|NCT01797185|3876098|FG002|Overall Study|Lost to Follow-up|1
2227277|NCT01797185|3876096|FG000|Overall Study|Withdrawn per sponsor|5
2227278|NCT01797185|3876097|FG001|Overall Study|Withdrawn per sponsor|0
2227279|NCT01797185|3876098|FG002|Overall Study|Withdrawn per sponsor|0
2227280|NCT01797185|3876096|FG000|Overall Study|Physician Decision|1
2227281|NCT01797185|3876097|FG001|Overall Study|Physician Decision|3
2227282|NCT01797185|3876098|FG002|Overall Study|Physician Decision|0
2227283|NCT01797185|3876096|FG000|Overall Study|Protocol Violation|1
2227284|NCT01797185|3876097|FG001|Overall Study|Protocol Violation|1
2227285|NCT01797185|3876098|FG002|Overall Study|Protocol Violation|0
2227286|NCT01797263|3876108|FG000|Overall Study|Withdrawal by Subject|21
2227287|NCT01797263|3876109|FG001|Overall Study|Withdrawal by Subject|25
2227288|NCT01797263|3876108|FG000|Overall Study|Death|1
2227289|NCT01797263|3876109|FG001|Overall Study|Death|0
2227290|NCT01797263|3876108|FG000|Overall Study|Lost to Follow-up|15
2227291|NCT01797263|3876109|FG001|Overall Study|Lost to Follow-up|15
2227292|NCT01797302|3876118|FG000|Overall Study|Lost to Follow-up|16
2227293|NCT01797302|3876119|FG001|Overall Study|Lost to Follow-up|23
2227294|NCT01797302|3876120|FG002|Overall Study|Lost to Follow-up|22
2227295|NCT01797302|3876118|FG000|Overall Study|Withdrawal by Subject|1
2227296|NCT01797302|3876119|FG001|Overall Study|Withdrawal by Subject|3
2227297|NCT01797302|3876120|FG002|Overall Study|Withdrawal by Subject|4
2227298|NCT01797432|3876137|FG000|Overall Study|Lost to Follow-up|1
2227299|NCT01797432|3876137|FG000|Overall Study|Adverse Event|1
2227300|NCT01797432|3876137|FG000|Overall Study|Withdrawal by Subject|1
2227301|NCT01797432|3876137|FG000|Overall Study|lived too far from study site|1
2227302|NCT01797445|3876143|FG000|Double-Blind Phase|Randomized but Not Treated|4
2227303|NCT01797445|3876144|FG001|Double-Blind Phase|Randomized but Not Treated|2
2227304|NCT01797445|3876143|FG000|Double-Blind Phase|Adverse Event|3
2227305|NCT01797445|3876144|FG001|Double-Blind Phase|Adverse Event|0
2227306|NCT01797445|3876143|FG000|Double-Blind Phase|Death|5
2227307|NCT01797445|3876144|FG001|Double-Blind Phase|Death|4
2227308|NCT01797445|3876143|FG000|Double-Blind Phase|Pregnancy|0
2227309|NCT01797445|3876144|FG001|Double-Blind Phase|Pregnancy|1
2227310|NCT01797445|3876143|FG000|Double-Blind Phase|Lack of Efficacy|1
2227311|NCT01797445|3876144|FG001|Double-Blind Phase|Lack of Efficacy|2
2227312|NCT01797445|3876143|FG000|Double-Blind Phase|Investigator's Discretion|15
2227313|NCT01797445|3876144|FG001|Double-Blind Phase|Investigator's Discretion|17
2227314|NCT01797445|3876143|FG000|Double-Blind Phase|Noncompliance with Study Drug|5
2227315|NCT01797445|3876144|FG001|Double-Blind Phase|Noncompliance with Study Drug|1
2227316|NCT01797445|3876143|FG000|Double-Blind Phase|Protocol Violation|0
2227317|NCT01797445|3876144|FG001|Double-Blind Phase|Protocol Violation|1
2227318|NCT01797445|3876143|FG000|Double-Blind Phase|Withdrew Consent|20
2227319|NCT01797445|3876144|FG001|Double-Blind Phase|Withdrew Consent|35
2227320|NCT01797445|3876143|FG000|Double-Blind Phase|Lost to Follow-up|34
2227321|NCT01797445|3876144|FG001|Double-Blind Phase|Lost to Follow-up|26
2227322|NCT01797445|3876143|FG000|Open-Label Extension Phase|Investigator's Discretion|1
2227323|NCT01797445|3876144|FG001|Open-Label Extension Phase|Investigator's Discretion|0
2274206|NCT02293993|3955078|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
2274207|NCT02293993|3955079|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
2274208|NCT02294019|3955097|FG000|Overall Study|Adverse Event|2
2274209|NCT02294019|3955097|FG000|Overall Study|Protocol Violation|68
2274210|NCT02294019|3955097|FG000|Overall Study|Lost to Follow-up|31
2274211|NCT02294019|3955097|FG000|Overall Study|Other|1
2274212|NCT02294019|3955097|FG000|Overall Study|Withdrawal by Subject|1
2274213|NCT02294058|3955104|FG000|Overall Study|Adverse Event|16
2274214|NCT02294058|3955105|FG001|Overall Study|Adverse Event|7
2274215|NCT02294058|3955106|FG002|Overall Study|Adverse Event|13
2274216|NCT02294058|3955104|FG000|Overall Study|Lack of Efficacy|3
2274217|NCT02294058|3955105|FG001|Overall Study|Lack of Efficacy|3
2274218|NCT02294058|3955106|FG002|Overall Study|Lack of Efficacy|0
2274219|NCT02294058|3955104|FG000|Overall Study|Lost to Follow-up|1
2274220|NCT02294058|3955105|FG001|Overall Study|Lost to Follow-up|0
2274221|NCT02294058|3955106|FG002|Overall Study|Lost to Follow-up|2
2274222|NCT02294058|3955104|FG000|Overall Study|Withdrawal by Subject|10
2274223|NCT02294058|3955105|FG001|Overall Study|Withdrawal by Subject|14
2274224|NCT02294058|3955106|FG002|Overall Study|Withdrawal by Subject|13
2274225|NCT02294058|3955104|FG000|Overall Study|Physician Decision|2
2274226|NCT02294058|3955105|FG001|Overall Study|Physician Decision|1
2274227|NCT02294058|3955106|FG002|Overall Study|Physician Decision|0
2274228|NCT02294058|3955104|FG000|Overall Study|Miscellaneous|4
2274229|NCT02294058|3955105|FG001|Overall Study|Miscellaneous|1
2274230|NCT02294058|3955106|FG002|Overall Study|Miscellaneous|1
2274231|NCT02294175|3955117|FG000|Overall Study|Withdrawal by Subject|1
2274232|NCT02294175|3955118|FG001|Overall Study|Withdrawal by Subject|2
2274233|NCT02294175|3955117|FG000|Overall Study|pt taking excluded medication|3
2274234|NCT02294175|3955118|FG001|Overall Study|pt taking excluded medication|1
2274235|NCT02294175|3955117|FG000|Overall Study|Protocol Violation|1
2274236|NCT02294175|3955118|FG001|Overall Study|Protocol Violation|0
2274237|NCT02294175|3955117|FG000|Overall Study|Lost to Follow-up|0
2274238|NCT02294175|3955118|FG001|Overall Study|Lost to Follow-up|1
2274239|NCT02294175|3955117|FG000|Overall Study|wound healed|0
2274240|NCT02294175|3955118|FG001|Overall Study|wound healed|2
2274241|NCT02294227|3955127|FG000|Overall Study|Death|0
2274242|NCT02294227|3955128|FG001|Overall Study|Death|0
2274243|NCT02294227|3955129|FG002|Overall Study|Death|1
2274244|NCT02294227|3955127|FG000|Overall Study|Subject/Guardian Decision|6
2274245|NCT02294227|3955128|FG001|Overall Study|Subject/Guardian Decision|3
2274246|NCT02294227|3955129|FG002|Overall Study|Subject/Guardian Decision|7
2274247|NCT02294227|3955127|FG000|Overall Study|Physician Decision|1
2274248|NCT02294227|3955128|FG001|Overall Study|Physician Decision|2
2274249|NCT02294227|3955129|FG002|Overall Study|Physician Decision|1
2274250|NCT02294227|3955127|FG000|Overall Study|Lost to Follow-up|1
2274251|NCT02294227|3955128|FG001|Overall Study|Lost to Follow-up|0
2274252|NCT02294227|3955129|FG002|Overall Study|Lost to Follow-up|0
2274253|NCT02294227|3955127|FG000|Overall Study|Lack of Efficacy|11
2274254|NCT02294227|3955128|FG001|Overall Study|Lack of Efficacy|12
2332545|NCT03199963|4056367|FG000|Blinded Phase - Overall Study|Adverse Event|10
2227324|NCT01797536|3876191|FG000|Overall Study|Adverse Event|0
2227325|NCT01797536|3876192|FG001|Overall Study|Adverse Event|1
2227326|NCT01797536|3876193|FG002|Overall Study|Adverse Event|0
2227327|NCT01797536|3876194|FG003|Overall Study|Adverse Event|0
2227328|NCT01797562|3876204|FG000|Overall Study|Protocol Violation|5
2227329|NCT01797705|3876230|FG000|Overall Study|Equipment anomalies during sleep studies|4
2227330|NCT01797705|3876230|FG000|Overall Study|Withdrawal by Subject|1
2227331|NCT01797731|3876236|FG000|Overall Study|Didn't have proper radiographs required|3
2227332|NCT01797731|3876237|FG001|Overall Study|Didn't have proper radiographs required|3
2227333|NCT01797783|3876245|FG000|Overall Study|Adverse Event|1
2227334|NCT01797783|3876246|FG001|Overall Study|Adverse Event|1
2227335|NCT01797783|3876245|FG000|Overall Study|Withdrawal by Subject|1
2227336|NCT01797783|3876246|FG001|Overall Study|Withdrawal by Subject|0
2227337|NCT01797835|3876268|FG000|Overall Study|Lost to Follow-up|31
2227338|NCT01797835|3876269|FG001|Overall Study|Lost to Follow-up|27
2227339|NCT01797965|3876279|FG000|Overall Study|Adverse Event|104
2227340|NCT01797965|3876280|FG001|Overall Study|Adverse Event|129
2227341|NCT01797965|3876281|FG002|Overall Study|Adverse Event|4
2227342|NCT01797965|3876282|FG003|Overall Study|Adverse Event|21
2227343|NCT01797965|3876279|FG000|Overall Study|Lost to Follow-up|9
2227344|NCT01797965|3876280|FG001|Overall Study|Lost to Follow-up|8
2227345|NCT01797965|3876281|FG002|Overall Study|Lost to Follow-up|1
2227346|NCT01797965|3876282|FG003|Overall Study|Lost to Follow-up|2
2227347|NCT01797965|3876279|FG000|Overall Study|Consent withdrawn|130
2227348|NCT01797965|3876280|FG001|Overall Study|Consent withdrawn|117
2227349|NCT01797965|3876281|FG002|Overall Study|Consent withdrawn|3
2227350|NCT01797965|3876282|FG003|Overall Study|Consent withdrawn|35
2227351|NCT01797965|3876279|FG000|Overall Study|Investigator decision|21
2227352|NCT01797965|3876280|FG001|Overall Study|Investigator decision|15
2227353|NCT01797965|3876281|FG002|Overall Study|Investigator decision|0
2227354|NCT01797965|3876282|FG003|Overall Study|Investigator decision|0
2227355|NCT01797965|3876279|FG000|Overall Study|Death|2
2227356|NCT01797965|3876280|FG001|Overall Study|Death|4
2227357|NCT01797965|3876281|FG002|Overall Study|Death|0
2227358|NCT01797965|3876282|FG003|Overall Study|Death|0
2227359|NCT01797965|3876279|FG000|Overall Study|Disease progression, defined by protocol|3
2227360|NCT01797965|3876280|FG001|Overall Study|Disease progression, defined by protocol|1
2227361|NCT01797965|3876281|FG002|Overall Study|Disease progression, defined by protocol|0
2227362|NCT01797965|3876282|FG003|Overall Study|Disease progression, defined by protocol|0
2227363|NCT01797965|3876279|FG000|Overall Study|Reason Not Specified|280
2227364|NCT01797965|3876280|FG001|Overall Study|Reason Not Specified|295
2227365|NCT01797965|3876281|FG002|Overall Study|Reason Not Specified|0
2227366|NCT01797965|3876282|FG003|Overall Study|Reason Not Specified|15
2227367|NCT01798004|3876293|FG000|Overall Study|Death|2
2227368|NCT01798004|3876293|FG000|Overall Study|Lack of Efficacy|8
2227369|NCT01798004|3876293|FG000|Overall Study|Physician Decision|25
2227370|NCT01798004|3876293|FG000|Overall Study|Withdrawal by Subject|4
2227371|NCT01798004|3876293|FG000|Overall Study|Ineligible|4
2227372|NCT01798004|3876293|FG000|Overall Study|Patient/parent refusal|7
2227373|NCT01798004|3876293|FG000|Overall Study|Initiation of other non-protocol therapy|5
2227374|NCT01798004|3876293|FG000|Overall Study|Enrollment another COG therapeutic trial|32
2227375|NCT01798056|3876299|FG000|Overall Study|Serious Adverse Event|13
2227376|NCT01798056|3876300|FG001|Overall Study|Serious Adverse Event|12
2227377|NCT01798056|3876299|FG000|Overall Study|Withdrawal by Subject|12
2227378|NCT01798056|3876300|FG001|Overall Study|Withdrawal by Subject|9
2227379|NCT01798056|3876299|FG000|Overall Study|Migrated/moved from study area|1
2227380|NCT01798056|3876300|FG001|Overall Study|Migrated/moved from study area|1
2227381|NCT01798056|3876299|FG000|Overall Study|Lost to Follow-up|1
2227382|NCT01798056|3876300|FG001|Overall Study|Lost to Follow-up|1
2227383|NCT01798056|3876299|FG000|Overall Study|Other|0
2227384|NCT01798056|3876300|FG001|Overall Study|Other|2
2227385|NCT01798134|3876308|FG000|Overall Study|Lost to Follow-up|1
2227386|NCT01798134|3876308|FG000|Overall Study|Withdrawal by Subject|3
2227387|NCT01798134|3876308|FG000|Overall Study|Death|2
2227388|NCT01798134|3876308|FG000|Overall Study|Adverse Event|3
2227389|NCT01798134|3876308|FG000|Overall Study|Physician Decision|3
2227390|NCT01798134|3876308|FG000|Overall Study|Liver transplant/surgery|4
2227391|NCT01798485|3876380|FG000|Overall Study|Adverse Event|32
2227392|NCT01798485|3876381|FG001|Overall Study|Adverse Event|40
2227393|NCT01798485|3876380|FG000|Overall Study|Withdrawal by Subject|27
2227394|NCT01798485|3876381|FG001|Overall Study|Withdrawal by Subject|31
2227395|NCT01798485|3876380|FG000|Overall Study|Lost to Follow-up|0
2227396|NCT01798485|3876381|FG001|Overall Study|Lost to Follow-up|3
2227397|NCT01798485|3876380|FG000|Overall Study|Physician Decision|14
2227398|NCT01798485|3876381|FG001|Overall Study|Physician Decision|10
2227399|NCT01798485|3876380|FG000|Overall Study|Objective Disease Progression|152
2227400|NCT01798485|3876381|FG001|Overall Study|Objective Disease Progression|106
2227401|NCT01798485|3876380|FG000|Overall Study|Death|25
2227402|NCT01798485|3876381|FG001|Overall Study|Death|22
2227403|NCT01798485|3876380|FG000|Overall Study|Sponsor Decision|61
2227404|NCT01798485|3876381|FG001|Overall Study|Sponsor Decision|54
2227405|NCT01798485|3876380|FG000|Overall Study|Clinical Progression|35
2227406|NCT01798485|3876381|FG001|Overall Study|Clinical Progression|24
2227407|NCT01798706|3876416|FG000|Overall Study|Adverse Event|15
2227408|NCT01798706|3876417|FG001|Overall Study|Adverse Event|10
2227409|NCT01798706|3876416|FG000|Overall Study|Lack of Efficacy|0
2332546|NCT03199963|4056368|FG001|Blinded Phase - Overall Study|Adverse Event|5
2332547|NCT03199963|4056367|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109
2332548|NCT03199963|4056368|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54
2332549|NCT03199963|4056367|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7
2332550|NCT03199963|4056368|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5
2332551|NCT03199963|4056367|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0
2332552|NCT03199963|4056368|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1
2332553|NCT03200366|4056379|FG000|Patient Navigation Intervention Given|Death|0
2332554|NCT03200366|4056380|FG001|Patient Navigation Intervention Given|Death|2
2227410|NCT01798706|3876417|FG001|Overall Study|Lack of Efficacy|2
2227411|NCT01798706|3876416|FG000|Overall Study|Poor compliance to protocol|1
2227412|NCT01798706|3876417|FG001|Overall Study|Poor compliance to protocol|0
2227413|NCT01798706|3876416|FG000|Overall Study|Other than specified above|5
2227414|NCT01798706|3876417|FG001|Overall Study|Other than specified above|9
2227415|NCT01798849|3876426|FG000|Overall Study|Physician Decision|0
2227416|NCT01798849|3876427|FG001|Overall Study|Physician Decision|0
2227417|NCT01798849|3876428|FG002|Overall Study|Physician Decision|1
2227418|NCT01798927|3876465|FG000|Overall Study|Withdrawal by Subject|1
2227419|NCT01798992|3876478|FG000|Overall Study|Administrative withdrawal|0
2227420|NCT01798992|3876479|FG001|Overall Study|Administrative withdrawal|1
2227421|NCT01798992|3876480|FG002|Overall Study|Administrative withdrawal|0
2227422|NCT01798992|3876481|FG003|Overall Study|Administrative withdrawal|1
2227423|NCT01798992|3876478|FG000|Overall Study|Lost to Follow-up|0
2227424|NCT01798992|3876479|FG001|Overall Study|Lost to Follow-up|1
2227425|NCT01798992|3876480|FG002|Overall Study|Lost to Follow-up|1
2227426|NCT01798992|3876481|FG003|Overall Study|Lost to Follow-up|0
2227427|NCT01798992|3876478|FG000|Overall Study|Insufficient biopsy tissue|0
2227428|NCT01798992|3876479|FG001|Overall Study|Insufficient biopsy tissue|0
2227429|NCT01798992|3876480|FG002|Overall Study|Insufficient biopsy tissue|1
2227430|NCT01798992|3876481|FG003|Overall Study|Insufficient biopsy tissue|0
2227431|NCT01799226|3876511|FG000|Overall Study|Withdrawal by Subject|1
2227432|NCT01799226|3876512|FG001|Overall Study|Withdrawal by Subject|0
2227433|NCT01799226|3876511|FG000|Overall Study|Disqualified at Day 14|1
2227434|NCT01799226|3876512|FG001|Overall Study|Disqualified at Day 14|0
2227435|NCT01799239|3876518|FG000|Period 1 (7 Days)|Lack of Efficacy|1
2227436|NCT01799239|3876519|FG001|Period 1 (7 Days)|Lack of Efficacy|0
2227437|NCT01799239|3876518|FG000|Period 1 (7 Days)|Withdrawal by Subject|2
2227438|NCT01799239|3876519|FG001|Period 1 (7 Days)|Withdrawal by Subject|0
2227439|NCT01799239|3876518|FG000|Period 1 (7 Days)|Protocol Violation|0
2227440|NCT01799239|3876519|FG001|Period 1 (7 Days)|Protocol Violation|1
2227441|NCT01799239|3876518|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
2227442|NCT01799239|3876519|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
2227443|NCT01799239|3876518|FG000|Period 2 (7 Days)|Protocol Violation|1
2227444|NCT01799239|3876519|FG001|Period 2 (7 Days)|Protocol Violation|0
2227445|NCT01799590|3876536|FG000|Overall Study|Adverse Event|13
2227446|NCT01799590|3876537|FG001|Overall Study|Adverse Event|7
2227447|NCT01799590|3876538|FG002|Overall Study|Adverse Event|5
2227448|NCT01799590|3876536|FG000|Overall Study|Pregnancy|2
2227449|NCT01799590|3876537|FG001|Overall Study|Pregnancy|0
2227450|NCT01799590|3876538|FG002|Overall Study|Pregnancy|0
2227451|NCT01799590|3876536|FG000|Overall Study|Lack of Efficacy|3
2227452|NCT01799590|3876537|FG001|Overall Study|Lack of Efficacy|1
2227453|NCT01799590|3876538|FG002|Overall Study|Lack of Efficacy|3
2227454|NCT01799590|3876536|FG000|Overall Study|Participants convenience|4
2227455|NCT01799590|3876537|FG001|Overall Study|Participants convenience|4
2227456|NCT01799590|3876538|FG002|Overall Study|Participants convenience|2
2227457|NCT01799590|3876536|FG000|Overall Study|Aggravation of complications|0
2227458|NCT01799590|3876537|FG001|Overall Study|Aggravation of complications|1
2227459|NCT01799590|3876538|FG002|Overall Study|Aggravation of complications|1
2227460|NCT01799590|3876536|FG000|Overall Study|Using drugs with restricted days of use|0
2227461|NCT01799590|3876537|FG001|Overall Study|Using drugs with restricted days of use|3
2227462|NCT01799590|3876538|FG002|Overall Study|Using drugs with restricted days of use|2
2227463|NCT01799590|3876536|FG000|Overall Study|Use of prohibited concomitant drugs|1
2227464|NCT01799590|3876537|FG001|Overall Study|Use of prohibited concomitant drugs|0
2227465|NCT01799590|3876538|FG002|Overall Study|Use of prohibited concomitant drugs|0
2227466|NCT01799590|3876536|FG000|Overall Study|Other|3
2227467|NCT01799590|3876537|FG001|Overall Study|Other|0
2227468|NCT01799590|3876538|FG002|Overall Study|Other|1
2227469|NCT01799720|3876549|FG000|Overall Study|Withdrawal by Subject|3
2227470|NCT01799720|3876550|FG001|Overall Study|Withdrawal by Subject|0
2227471|NCT01799720|3876551|FG002|Overall Study|Withdrawal by Subject|0
2227472|NCT01799720|3876549|FG000|Overall Study|Protocol Violation|0
2227473|NCT01799720|3876550|FG001|Overall Study|Protocol Violation|1
2227474|NCT01799720|3876551|FG002|Overall Study|Protocol Violation|0
2227475|NCT01799720|3876549|FG000|Overall Study|Pregnancy|0
2227476|NCT01799720|3876550|FG001|Overall Study|Pregnancy|0
2227477|NCT01799720|3876551|FG002|Overall Study|Pregnancy|1
2227478|NCT01799889|3876571|FG000|Overall Study|Adverse Event|4
2227479|NCT01799889|3876572|FG001|Overall Study|Adverse Event|4
2227480|NCT01799889|3876573|FG002|Overall Study|Adverse Event|5
2227481|NCT01799889|3876574|FG003|Overall Study|Adverse Event|1
2227482|NCT01799889|3876575|FG004|Overall Study|Adverse Event|11
2227483|NCT01799889|3876576|FG005|Overall Study|Adverse Event|1
2227484|NCT01799889|3876577|FG006|Overall Study|Adverse Event|5
2227485|NCT01799889|3876578|FG007|Overall Study|Adverse Event|2
2227486|NCT01799889|3876579|FG008|Overall Study|Adverse Event|3
2227487|NCT01799889|3876580|FG009|Overall Study|Adverse Event|1
2227488|NCT01799889|3876581|FG010|Overall Study|Adverse Event|1
2227489|NCT01799889|3876582|FG011|Overall Study|Adverse Event|0
2227490|NCT01799889|3876571|FG000|Overall Study|Death|1
2227491|NCT01799889|3876572|FG001|Overall Study|Death|0
2227492|NCT01799889|3876573|FG002|Overall Study|Death|5
2227493|NCT01799889|3876574|FG003|Overall Study|Death|3
2227494|NCT01799889|3876575|FG004|Overall Study|Death|1
2227495|NCT01799889|3876576|FG005|Overall Study|Death|0
2227496|NCT01799889|3876577|FG006|Overall Study|Death|0
2227497|NCT01799889|3876578|FG007|Overall Study|Death|0
2227498|NCT01799889|3876579|FG008|Overall Study|Death|1
2227499|NCT01799889|3876580|FG009|Overall Study|Death|0
2227500|NCT01799889|3876581|FG010|Overall Study|Death|1
2227501|NCT01799889|3876582|FG011|Overall Study|Death|0
2227502|NCT01799889|3876571|FG000|Overall Study|Lack of Efficacy|1
2227503|NCT01799889|3876572|FG001|Overall Study|Lack of Efficacy|1
2227504|NCT01799889|3876573|FG002|Overall Study|Lack of Efficacy|0
2227505|NCT01799889|3876574|FG003|Overall Study|Lack of Efficacy|1
2227506|NCT01799889|3876575|FG004|Overall Study|Lack of Efficacy|2
2227507|NCT01799889|3876576|FG005|Overall Study|Lack of Efficacy|2
2227508|NCT01799889|3876577|FG006|Overall Study|Lack of Efficacy|0
2227509|NCT01799889|3876578|FG007|Overall Study|Lack of Efficacy|0
2227510|NCT01799889|3876579|FG008|Overall Study|Lack of Efficacy|2
2227511|NCT01799889|3876580|FG009|Overall Study|Lack of Efficacy|0
2227512|NCT01799889|3876581|FG010|Overall Study|Lack of Efficacy|1
2227513|NCT01799889|3876582|FG011|Overall Study|Lack of Efficacy|0
2227514|NCT01799889|3876571|FG000|Overall Study|Lost to Follow-up|0
2227515|NCT01799889|3876572|FG001|Overall Study|Lost to Follow-up|1
2227516|NCT01799889|3876573|FG002|Overall Study|Lost to Follow-up|0
2227517|NCT01799889|3876574|FG003|Overall Study|Lost to Follow-up|0
2227518|NCT01799889|3876575|FG004|Overall Study|Lost to Follow-up|0
2227519|NCT01799889|3876576|FG005|Overall Study|Lost to Follow-up|0
2227520|NCT01799889|3876577|FG006|Overall Study|Lost to Follow-up|0
2227521|NCT01799889|3876578|FG007|Overall Study|Lost to Follow-up|0
2227522|NCT01799889|3876579|FG008|Overall Study|Lost to Follow-up|0
2227523|NCT01799889|3876580|FG009|Overall Study|Lost to Follow-up|0
2227524|NCT01799889|3876581|FG010|Overall Study|Lost to Follow-up|0
2227525|NCT01799889|3876582|FG011|Overall Study|Lost to Follow-up|0
2227526|NCT01799889|3876571|FG000|Overall Study|Physician Decision|3
2227527|NCT01799889|3876572|FG001|Overall Study|Physician Decision|2
2227528|NCT01799889|3876573|FG002|Overall Study|Physician Decision|4
2227529|NCT01799889|3876574|FG003|Overall Study|Physician Decision|4
2227530|NCT01799889|3876575|FG004|Overall Study|Physician Decision|5
2227531|NCT01799889|3876576|FG005|Overall Study|Physician Decision|5
2227532|NCT01799889|3876577|FG006|Overall Study|Physician Decision|5
2227533|NCT01799889|3876578|FG007|Overall Study|Physician Decision|2
2332555|NCT03200366|4056381|FG002|Patient Navigation Intervention Given|Death|0
2332556|NCT03200366|4056379|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0
2332557|NCT03200366|4056380|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25
2332558|NCT03200366|4056381|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0
2332559|NCT03200366|4056379|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
2332560|NCT03200366|4056380|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1
2332561|NCT03200366|4056381|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
2332562|NCT03200366|4056379|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
2332563|NCT03200366|4056380|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2
2332564|NCT03200366|4056381|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
2332565|NCT03200366|4056379|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0
2332566|NCT03200366|4056380|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1
2332567|NCT03200366|4056381|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0
2332568|NCT03200366|4056379|FG000|6 Month Post-Baseline Interview|Death|1
2332569|NCT03200366|4056380|FG001|6 Month Post-Baseline Interview|Death|1
2332570|NCT03200366|4056381|FG002|6 Month Post-Baseline Interview|Death|1
2332571|NCT03200366|4056379|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27
2332572|NCT03200366|4056380|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21
2332573|NCT03200366|4056381|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17
2332574|NCT03200366|4056379|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1
2332575|NCT03200366|4056380|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1
2227534|NCT01799889|3876579|FG008|Overall Study|Physician Decision|6
2227535|NCT01799889|3876580|FG009|Overall Study|Physician Decision|0
2227536|NCT01799889|3876581|FG010|Overall Study|Physician Decision|0
2227537|NCT01799889|3876582|FG011|Overall Study|Physician Decision|1
2227538|NCT01799889|3876571|FG000|Overall Study|Progressive Disease|30
2227539|NCT01799889|3876572|FG001|Overall Study|Progressive Disease|26
2227540|NCT01799889|3876573|FG002|Overall Study|Progressive Disease|25
2227541|NCT01799889|3876574|FG003|Overall Study|Progressive Disease|30
2227542|NCT01799889|3876575|FG004|Overall Study|Progressive Disease|23
2227543|NCT01799889|3876576|FG005|Overall Study|Progressive Disease|9
2227544|NCT01799889|3876577|FG006|Overall Study|Progressive Disease|8
2227545|NCT01799889|3876578|FG007|Overall Study|Progressive Disease|13
2227546|NCT01799889|3876579|FG008|Overall Study|Progressive Disease|18
2227547|NCT01799889|3876580|FG009|Overall Study|Progressive Disease|5
2227548|NCT01799889|3876581|FG010|Overall Study|Progressive Disease|3
2227549|NCT01799889|3876582|FG011|Overall Study|Progressive Disease|1
2227550|NCT01799889|3876571|FG000|Overall Study|Specified Criteria for Withdrawal|0
2227551|NCT01799889|3876572|FG001|Overall Study|Specified Criteria for Withdrawal|1
2227552|NCT01799889|3876573|FG002|Overall Study|Specified Criteria for Withdrawal|1
2227553|NCT01799889|3876574|FG003|Overall Study|Specified Criteria for Withdrawal|0
2227554|NCT01799889|3876575|FG004|Overall Study|Specified Criteria for Withdrawal|0
2227555|NCT01799889|3876576|FG005|Overall Study|Specified Criteria for Withdrawal|0
2227556|NCT01799889|3876577|FG006|Overall Study|Specified Criteria for Withdrawal|0
2227557|NCT01799889|3876578|FG007|Overall Study|Specified Criteria for Withdrawal|0
2227558|NCT01799889|3876579|FG008|Overall Study|Specified Criteria for Withdrawal|0
2227559|NCT01799889|3876580|FG009|Overall Study|Specified Criteria for Withdrawal|0
2227560|NCT01799889|3876581|FG010|Overall Study|Specified Criteria for Withdrawal|0
2227561|NCT01799889|3876582|FG011|Overall Study|Specified Criteria for Withdrawal|0
2227562|NCT01799889|3876571|FG000|Overall Study|Study Terminated By Sponsor|1
2227563|NCT01799889|3876572|FG001|Overall Study|Study Terminated By Sponsor|0
2227564|NCT01799889|3876573|FG002|Overall Study|Study Terminated By Sponsor|0
2227565|NCT01799889|3876574|FG003|Overall Study|Study Terminated By Sponsor|0
2227566|NCT01799889|3876575|FG004|Overall Study|Study Terminated By Sponsor|2
2227567|NCT01799889|3876576|FG005|Overall Study|Study Terminated By Sponsor|1
2227568|NCT01799889|3876577|FG006|Overall Study|Study Terminated By Sponsor|0
2227569|NCT01799889|3876578|FG007|Overall Study|Study Terminated By Sponsor|2
2227570|NCT01799889|3876579|FG008|Overall Study|Study Terminated By Sponsor|1
2227571|NCT01799889|3876580|FG009|Overall Study|Study Terminated By Sponsor|1
2227572|NCT01799889|3876581|FG010|Overall Study|Study Terminated By Sponsor|0
2227573|NCT01799889|3876582|FG011|Overall Study|Study Terminated By Sponsor|0
2227574|NCT01799889|3876571|FG000|Overall Study|Withdrawal by Subject|1
2227575|NCT01799889|3876572|FG001|Overall Study|Withdrawal by Subject|6
2227576|NCT01799889|3876573|FG002|Overall Study|Withdrawal by Subject|4
2227577|NCT01799889|3876574|FG003|Overall Study|Withdrawal by Subject|0
2227578|NCT01799889|3876575|FG004|Overall Study|Withdrawal by Subject|5
2227579|NCT01799889|3876576|FG005|Overall Study|Withdrawal by Subject|1
2227580|NCT01799889|3876577|FG006|Overall Study|Withdrawal by Subject|3
2227581|NCT01799889|3876578|FG007|Overall Study|Withdrawal by Subject|1
2227582|NCT01799889|3876579|FG008|Overall Study|Withdrawal by Subject|2
2227583|NCT01799889|3876580|FG009|Overall Study|Withdrawal by Subject|1
2227584|NCT01799889|3876581|FG010|Overall Study|Withdrawal by Subject|1
2227585|NCT01799889|3876582|FG011|Overall Study|Withdrawal by Subject|1
2227586|NCT01799889|3876571|FG000|Overall Study|Non-Compliance With Study Drug|0
2227587|NCT01799889|3876572|FG001|Overall Study|Non-Compliance With Study Drug|0
2227588|NCT01799889|3876573|FG002|Overall Study|Non-Compliance With Study Drug|0
2227589|NCT01799889|3876574|FG003|Overall Study|Non-Compliance With Study Drug|0
2227590|NCT01799889|3876575|FG004|Overall Study|Non-Compliance With Study Drug|0
2227591|NCT01799889|3876576|FG005|Overall Study|Non-Compliance With Study Drug|1
2227592|NCT01799889|3876577|FG006|Overall Study|Non-Compliance With Study Drug|0
2227593|NCT01799889|3876578|FG007|Overall Study|Non-Compliance With Study Drug|0
2227594|NCT01799889|3876579|FG008|Overall Study|Non-Compliance With Study Drug|0
2227595|NCT01799889|3876580|FG009|Overall Study|Non-Compliance With Study Drug|0
2227596|NCT01799889|3876581|FG010|Overall Study|Non-Compliance With Study Drug|0
2227597|NCT01799889|3876582|FG011|Overall Study|Non-Compliance With Study Drug|0
2227598|NCT01799941|3876619|FG000|Overall Study|Adverse Event|34
2227599|NCT01799941|3876619|FG000|Overall Study|Withdrawal by Subject|21
2227600|NCT01799941|3876619|FG000|Overall Study|Death|2
2227601|NCT01799941|3876619|FG000|Overall Study|Investigator Decision|4
2227602|NCT01799941|3876619|FG000|Overall Study|Lack of Efficacy|3
2227603|NCT01799941|3876619|FG000|Overall Study|Lost to Follow-up|17
2227604|NCT01799941|3876619|FG000|Overall Study|Other|15
2227605|NCT01799993|3876631|FG000|Overall Study|"Didn't complete CRF page End of FU"|30
2227606|NCT01799993|3876632|FG001|Overall Study|"Didn't complete CRF page End of FU"|40
2227607|NCT01799993|3876631|FG000|Overall Study|Death|61
2227608|NCT01799993|3876632|FG001|Overall Study|Death|45
2227609|NCT01799993|3876631|FG000|Overall Study|Withdrawal by Subject|23
2227610|NCT01799993|3876632|FG001|Overall Study|Withdrawal by Subject|24
2227611|NCT01799993|3876631|FG000|Overall Study|Lost to Follow-up|5
2227612|NCT01799993|3876632|FG001|Overall Study|Lost to Follow-up|8
2227613|NCT01799993|3876631|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5
2227614|NCT01799993|3876632|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3
2227615|NCT01799993|3876631|FG000|Overall Study|Protocol driven decision point|0
2227616|NCT01799993|3876632|FG001|Overall Study|Protocol driven decision point|3
2227617|NCT01799993|3876631|FG000|Overall Study|Protocol Violation|1
2227618|NCT01799993|3876632|FG001|Overall Study|Protocol Violation|1
2227619|NCT01799993|3876631|FG000|Overall Study|Deterioration of general conditions|2
2227620|NCT01799993|3876632|FG001|Overall Study|Deterioration of general conditions|0
2227621|NCT01799993|3876631|FG000|Overall Study|Screen failure|0
2227622|NCT01799993|3876632|FG001|Overall Study|Screen failure|1
2227623|NCT01799993|3876631|FG000|Overall Study|Adverse Event|1
2227624|NCT01799993|3876632|FG001|Overall Study|Adverse Event|0
2227625|NCT01799993|3876631|FG000|Overall Study|Lack of Efficacy|1
2227626|NCT01799993|3876632|FG001|Overall Study|Lack of Efficacy|0
2227627|NCT01799993|3876631|FG000|Overall Study|Recovery|0
2227628|NCT01799993|3876632|FG001|Overall Study|Recovery|1
2227629|NCT01799993|3876631|FG000|Overall Study|Logistical difficulties|1
2227630|NCT01799993|3876632|FG001|Overall Study|Logistical difficulties|0
2227631|NCT01799993|3876631|FG000|Overall Study|Protocol deviation|1
2227632|NCT01799993|3876632|FG001|Overall Study|Protocol deviation|0
2227633|NCT01799993|3876631|FG000|Overall Study|Non-compliance with medical device|1
2227634|NCT01799993|3876632|FG001|Overall Study|Non-compliance with medical device|0
2227635|NCT01799993|3876631|FG000|Overall Study|Withdrawal by parent/guardian|0
2227636|NCT01799993|3876632|FG001|Overall Study|Withdrawal by parent/guardian|1
2227637|NCT01799993|3876631|FG000|Overall Study|Other|1
2227638|NCT01799993|3876632|FG001|Overall Study|Other|0
2227639|NCT01799993|3876631|FG000|Overall Study|Subject didn't return for follow-up|0
2227640|NCT01799993|3876632|FG001|Overall Study|Subject didn't return for follow-up|1
2227641|NCT01800058|3876638|FG000|Overall Study|Lost to Follow-up|1
2227642|NCT01800201|3876645|FG000|Overall Study|Withdrawal by Subject|2
2227643|NCT01800201|3876646|FG001|Overall Study|Withdrawal by Subject|0
2227644|NCT01800201|3876645|FG000|Overall Study|patient privacy concerns|1
2227645|NCT01800201|3876646|FG001|Overall Study|patient privacy concerns|1
2227646|NCT01800201|3876645|FG000|Overall Study|did not want to use device|0
2227647|NCT01800201|3876646|FG001|Overall Study|did not want to use device|1
2227648|NCT01800201|3876645|FG000|Overall Study|PI withdrawal, cognitive concerns|0
2227649|NCT01800201|3876646|FG001|Overall Study|PI withdrawal, cognitive concerns|1
2227650|NCT01800903|3876721|FG000|Second Test Period|unable to catheterise|1
2227651|NCT01800903|3876722|FG001|Second Test Period|unable to catheterise|0
2227652|NCT01800903|3876723|FG002|Second Test Period|unable to catheterise|0
2227653|NCT01800903|3876724|FG003|Second Test Period|unable to catheterise|0
2227654|NCT01800903|3876725|FG004|Second Test Period|unable to catheterise|0
2227655|NCT01800903|3876726|FG005|Second Test Period|unable to catheterise|0
2227656|NCT01800916|3876732|FG000|Test Period 1 (1 Week)|Convex product user|0
2227657|NCT01800916|3876733|FG001|Test Period 1 (1 Week)|Convex product user|0
2227658|NCT01800916|3876734|FG002|Test Period 1 (1 Week)|Convex product user|0
2227659|NCT01800916|3876735|FG003|Test Period 1 (1 Week)|Convex product user|1
2227660|NCT01800916|3876736|FG004|Test Period 1 (1 Week)|Convex product user|0
2227661|NCT01800916|3876737|FG005|Test Period 1 (1 Week)|Convex product user|0
2227662|NCT01800916|3876738|FG006|Test Period 1 (1 Week)|Convex product user|0
2227663|NCT01800916|3876739|FG007|Test Period 1 (1 Week)|Convex product user|0
2227664|NCT01800916|3876740|FG008|Test Period 1 (1 Week)|Convex product user|0
2227665|NCT01800916|3876732|FG000|Test Period 1 (1 Week)|Adverse Event|0
2227666|NCT01800916|3876733|FG001|Test Period 1 (1 Week)|Adverse Event|0
2227667|NCT01800916|3876734|FG002|Test Period 1 (1 Week)|Adverse Event|0
2227668|NCT01800916|3876735|FG003|Test Period 1 (1 Week)|Adverse Event|0
2227669|NCT01800916|3876736|FG004|Test Period 1 (1 Week)|Adverse Event|1
2227670|NCT01800916|3876737|FG005|Test Period 1 (1 Week)|Adverse Event|0
2227671|NCT01800916|3876738|FG006|Test Period 1 (1 Week)|Adverse Event|0
2227672|NCT01800916|3876739|FG007|Test Period 1 (1 Week)|Adverse Event|0
2227673|NCT01800916|3876740|FG008|Test Period 1 (1 Week)|Adverse Event|0
2227674|NCT01800968|3876752|FG000|Overall Study|Death|23
2227675|NCT01800968|3876753|FG001|Overall Study|Death|16
2227676|NCT01800968|3876752|FG000|Overall Study|Lost to Follow-up|5
2227677|NCT01800968|3876753|FG001|Overall Study|Lost to Follow-up|7
2227678|NCT01800968|3876752|FG000|Overall Study|Withdrawal by Subject|7
2227679|NCT01800968|3876753|FG001|Overall Study|Withdrawal by Subject|9
2227680|NCT01800968|3876752|FG000|Overall Study|Physician Decision|1
2227681|NCT01800968|3876753|FG001|Overall Study|Physician Decision|0
2227682|NCT01801007|3876759|FG000|Overall Study|Adverse Event|2
2227683|NCT01801007|3876759|FG000|Overall Study|Lost to Follow-up|4
2227684|NCT01801007|3876759|FG000|Overall Study|Withdrawal by Subject|5
2227685|NCT01801111|3876763|FG000|Overall Study|Adverse Event|12
2227686|NCT01801111|3876763|FG000|Overall Study|Death|8
2227687|NCT01801111|3876763|FG000|Overall Study|Physician Decision|5
2227688|NCT01801111|3876763|FG000|Overall Study|Other|1
2227689|NCT01801111|3876763|FG000|Overall Study|Withdrawal by Subject|4
2227690|NCT01801111|3876763|FG000|Overall Study|Study Terminated by Sponsor|27
2227691|NCT01801111|3876763|FG000|Overall Study|Progressive Disease|81
2227692|NCT01801280|3876784|FG000|Period 1|Withdrawal by Subject|0
2227693|NCT01801280|3876785|FG001|Period 1|Withdrawal by Subject|1
2227694|NCT01801280|3876786|FG002|Period 1|Withdrawal by Subject|0
2227695|NCT01801280|3876787|FG003|Period 1|Withdrawal by Subject|0
2227696|NCT01801280|3876784|FG000|Period 2|Withdrawal by Subject|1
2227697|NCT01801280|3876785|FG001|Period 2|Withdrawal by Subject|0
2227698|NCT01801280|3876786|FG002|Period 2|Withdrawal by Subject|0
2227699|NCT01801280|3876787|FG003|Period 2|Withdrawal by Subject|0
2227700|NCT01801280|3876784|FG000|Period 4|Protocol Violation|0
2227701|NCT01801280|3876785|FG001|Period 4|Protocol Violation|0
2227702|NCT01801280|3876786|FG002|Period 4|Protocol Violation|1
2227703|NCT01801280|3876787|FG003|Period 4|Protocol Violation|0
2227704|NCT01801358|3876803|FG000|Overall Study|Adverse Event|0
2227705|NCT01801358|3876804|FG001|Overall Study|Adverse Event|2
2227706|NCT01801358|3876805|FG002|Overall Study|Adverse Event|1
2227707|NCT01801358|3876806|FG003|Overall Study|Adverse Event|0
2227708|NCT01801358|3876807|FG004|Overall Study|Adverse Event|0
2227709|NCT01801358|3876808|FG005|Overall Study|Adverse Event|1
2227710|NCT01801358|3876803|FG000|Overall Study|Physician Decision|0
2227711|NCT01801358|3876804|FG001|Overall Study|Physician Decision|0
2227712|NCT01801358|3876805|FG002|Overall Study|Physician Decision|1
2227713|NCT01801358|3876806|FG003|Overall Study|Physician Decision|0
2227714|NCT01801358|3876807|FG004|Overall Study|Physician Decision|0
2227715|NCT01801358|3876808|FG005|Overall Study|Physician Decision|0
2227716|NCT01801358|3876803|FG000|Overall Study|Progressive Disease|6
2227717|NCT01801358|3876804|FG001|Overall Study|Progressive Disease|4
2227718|NCT01801358|3876805|FG002|Overall Study|Progressive Disease|4
2227719|NCT01801358|3876806|FG003|Overall Study|Progressive Disease|5
2227720|NCT01801358|3876807|FG004|Overall Study|Progressive Disease|6
2227721|NCT01801358|3876808|FG005|Overall Study|Progressive Disease|5
2227722|NCT01801358|3876803|FG000|Overall Study|Withdrawal by Subject|0
2227723|NCT01801358|3876804|FG001|Overall Study|Withdrawal by Subject|0
2227724|NCT01801358|3876805|FG002|Overall Study|Withdrawal by Subject|0
2227725|NCT01801358|3876806|FG003|Overall Study|Withdrawal by Subject|1
2227726|NCT01801358|3876807|FG004|Overall Study|Withdrawal by Subject|0
2227727|NCT01801358|3876808|FG005|Overall Study|Withdrawal by Subject|2
2227728|NCT01801436|3876843|FG000|Overall Study|Withdrawal by Subject|3
2227729|NCT01801436|3876843|FG000|Overall Study|Adverse Event|2
2227730|NCT01801436|3876843|FG000|Overall Study|Progressive disease|4
2227731|NCT01801475|3876855|FG000|Overall Study|Withdrawal by Subject|0
2227732|NCT01801475|3876856|FG001|Overall Study|Withdrawal by Subject|0
2227733|NCT01801475|3876857|FG002|Overall Study|Withdrawal by Subject|0
2227734|NCT01801475|3876858|FG003|Overall Study|Withdrawal by Subject|0
2227735|NCT01801475|3876859|FG004|Overall Study|Withdrawal by Subject|1
2227736|NCT01801735|3876868|FG000|Overall Study|Adverse Event|79
2227737|NCT01801735|3876868|FG000|Overall Study|Lack of Efficacy|28
2227738|NCT01801735|3876868|FG000|Overall Study|Withdrawal by Subject|27
2227739|NCT01801735|3876868|FG000|Overall Study|Protocol Violation|25
2227740|NCT01801735|3876868|FG000|Overall Study|Lost to Follow-up|15
2227741|NCT01801735|3876868|FG000|Overall Study|Non-compliance with Trial Drug|13
2227742|NCT01801735|3876868|FG000|Overall Study|Physician Decision|3
2227743|NCT01801735|3876868|FG000|Overall Study|Death|1
2227744|NCT01801735|3876868|FG000|Overall Study|Other, including site closure|19
2227745|NCT01801865|3876872|FG000|Overall Study|Patients scanned on another MRI scanner|35
2227746|NCT01801865|3876872|FG000|Overall Study|Physician Decision|7
2227747|NCT01801917|3876880|FG000|Period 1 - Randomized|Adverse Event|1
2227748|NCT01801917|3876881|FG001|Period 1 - Randomized|Adverse Event|0
2227749|NCT01801917|3876882|FG002|Period 1 - Randomized|Adverse Event|1
2227750|NCT01801917|3876883|FG003|Period 1 - Randomized|Adverse Event|0
2227751|NCT01801930|3876898|FG000|Overall Study|Clear progression of the primary disease is observed|6
2227752|NCT01801930|3876899|FG001|Overall Study|Clear progression of the primary disease is observed|5
2227753|NCT01801930|3876900|FG002|Overall Study|Clear progression of the primary disease is observed|6
2227754|NCT01801930|3876901|FG003|Overall Study|Clear progression of the primary disease is observed|6
2227755|NCT01801930|3876898|FG000|Overall Study|DLT occurs|0
2227756|NCT01801930|3876899|FG001|Overall Study|DLT occurs|1
2227757|NCT01801930|3876900|FG002|Overall Study|DLT occurs|0
2227758|NCT01801930|3876901|FG003|Overall Study|DLT occurs|0
2227759|NCT01801982|3876911|FG000|Overall Study|Lost to Follow-up|1
2227760|NCT01802073|3876917|FG000|Overall Study|Lost to Follow-up|0
2227761|NCT01802073|3876918|FG001|Overall Study|Lost to Follow-up|1
2227762|NCT01802073|3876917|FG000|Overall Study|Non-compliant|4
2227763|NCT01802073|3876918|FG001|Overall Study|Non-compliant|2
2227764|NCT01802073|3876917|FG000|Overall Study|Withdrawal by Subject|1
2227765|NCT01802073|3876918|FG001|Overall Study|Withdrawal by Subject|1
2227766|NCT01802073|3876917|FG000|Overall Study|Physician Decision|0
2227767|NCT01802073|3876918|FG001|Overall Study|Physician Decision|7
2227768|NCT01802216|3876943|FG000|4 Month Visit|Participant did not show to visit|3
2227769|NCT01802216|3876944|FG001|4 Month Visit|Participant did not show to visit|4
2227770|NCT01802216|3876943|FG000|8 Month Visit|Participant did not show to visit|3
2227771|NCT01802216|3876944|FG001|8 Month Visit|Participant did not show to visit|5
2227772|NCT01802216|3876943|FG000|12 Month Visit|Participant did not show to visit|3
2227773|NCT01802216|3876944|FG001|12 Month Visit|Participant did not show to visit|4
2227774|NCT01802281|3876952|FG000|Overall Study|Death|1
2227775|NCT01802281|3876953|FG001|Overall Study|Death|2
2227776|NCT01802281|3876952|FG000|Overall Study|Withdrawal by Subject|2
2227777|NCT01802281|3876953|FG001|Overall Study|Withdrawal by Subject|1
2227778|NCT01802281|3876952|FG000|Overall Study|Ineligible|5
2227779|NCT01802281|3876953|FG001|Overall Study|Ineligible|3
2227780|NCT01802320|3876959|FG000|Overall Study|Death|1
2227781|NCT01802320|3876959|FG000|Overall Study|Withdrawal by Subject|1
2227782|NCT01802333|3876966|FG000|Overall Study|Ineligible|2
2227783|NCT01802333|3876967|FG001|Overall Study|Ineligible|6
2227784|NCT01802333|3876968|FG002|Overall Study|Ineligible|8
2227785|NCT01802333|3876966|FG000|Overall Study|Adverse Event|1
2227786|NCT01802333|3876967|FG001|Overall Study|Adverse Event|8
2227787|NCT01802333|3876968|FG002|Overall Study|Adverse Event|8
2227788|NCT01802333|3876966|FG000|Overall Study|Withdrawal by Subject|6
2227789|NCT01802333|3876967|FG001|Overall Study|Withdrawal by Subject|6
2227790|NCT01802333|3876968|FG002|Overall Study|Withdrawal by Subject|5
2227791|NCT01802333|3876966|FG000|Overall Study|Progression/relapse|1
2227792|NCT01802333|3876967|FG001|Overall Study|Progression/relapse|3
2227793|NCT01802333|3876968|FG002|Overall Study|Progression/relapse|0
2227794|NCT01802333|3876966|FG000|Overall Study|Death|7
2227795|NCT01802333|3876967|FG001|Overall Study|Death|14
2227796|NCT01802333|3876968|FG002|Overall Study|Death|13
2227797|NCT01802333|3876966|FG000|Overall Study|Other - not protocol specified|32
2227798|NCT01802333|3876967|FG001|Overall Study|Other - not protocol specified|22
2227799|NCT01802333|3876968|FG002|Overall Study|Other - not protocol specified|24
2227800|NCT01802333|3876966|FG000|Overall Study|Did not start treatment|0
2227801|NCT01802333|3876967|FG001|Overall Study|Did not start treatment|2
2227802|NCT01802333|3876968|FG002|Overall Study|Did not start treatment|5
2227803|NCT01802385|3876984|FG000|Overall Study|Death|106
2227804|NCT01802385|3876985|FG001|Overall Study|Death|120
2227805|NCT01802411|3876993|FG000|Overall Study|Death|2
2227806|NCT01802411|3876994|FG001|Overall Study|Death|1
2227807|NCT01802411|3876993|FG000|Overall Study|Adverse Event|2
2227808|NCT01802411|3876994|FG001|Overall Study|Adverse Event|7
2227809|NCT01802411|3876993|FG000|Overall Study|Lack of Efficacy|8
2227810|NCT01802411|3876994|FG001|Overall Study|Lack of Efficacy|10
2227811|NCT01802411|3876993|FG000|Overall Study|Withdrawal by Subject|0
2227812|NCT01802411|3876994|FG001|Overall Study|Withdrawal by Subject|2
2227813|NCT01802411|3876993|FG000|Overall Study|Planned pleurodesis as part of the proc|1
2227814|NCT01802411|3876994|FG001|Overall Study|Planned pleurodesis as part of the proc|0
2227815|NCT01802411|3876993|FG000|Overall Study|Surgery aborted after bronchoscopy|1
2227816|NCT01802411|3876994|FG001|Overall Study|Surgery aborted after bronchoscopy|0
2227817|NCT01802411|3876993|FG000|Overall Study|Proc changed to video-asst thorascopic|0
2227818|NCT01802411|3876994|FG001|Overall Study|Proc changed to video-asst thorascopic|1
2227819|NCT01802437|3877002|FG000|Overall Study|Lost to Follow-up|1
2227820|NCT01802437|3877003|FG001|Overall Study|Lost to Follow-up|0
2227821|NCT01802437|3877002|FG000|Overall Study|Withdrawal by Subject|3
2227822|NCT01802437|3877003|FG001|Overall Study|Withdrawal by Subject|4
2227823|NCT01802515|3877012|FG000|Overall Study|Withdrawal by Subject|3
2227824|NCT01802515|3877013|FG001|Overall Study|Withdrawal by Subject|0
2227825|NCT01802515|3877014|FG002|Overall Study|Withdrawal by Subject|0
2227826|NCT01802580|3877033|FG000|Overall Study|Physician Decision|1
2227827|NCT01802580|3877034|FG001|Overall Study|Physician Decision|0
2227828|NCT01802580|3877033|FG000|Overall Study|Protocol Violation|2
2227829|NCT01802580|3877034|FG001|Overall Study|Protocol Violation|0
2227830|NCT01802580|3877033|FG000|Overall Study|Withdrawal by Subject|5
2227831|NCT01802580|3877034|FG001|Overall Study|Withdrawal by Subject|6
2227832|NCT01802580|3877033|FG000|Overall Study|Other|1
2227833|NCT01802580|3877034|FG001|Overall Study|Other|3
2227834|NCT01802580|3877033|FG000|Overall Study|Lack of Efficacy|0
2227835|NCT01802580|3877034|FG001|Overall Study|Lack of Efficacy|2
2227836|NCT01802775|3877053|FG000|Overall Study|Death|0
2227837|NCT01802775|3877054|FG001|Overall Study|Death|3
2227838|NCT01802775|3877053|FG000|Overall Study|Reason not provided|0
2227839|NCT01802775|3877054|FG001|Overall Study|Reason not provided|1
2227840|NCT01802775|3877053|FG000|Overall Study|Physician Decision|1
2227841|NCT01802775|3877054|FG001|Overall Study|Physician Decision|0
2227842|NCT01802775|3877053|FG000|Overall Study|Adverse Event|1
2227843|NCT01802775|3877054|FG001|Overall Study|Adverse Event|1
2227844|NCT01802775|3877053|FG000|Overall Study|Withdrawal by Subject|3
2227845|NCT01802775|3877054|FG001|Overall Study|Withdrawal by Subject|5
2227846|NCT01802775|3877053|FG000|Overall Study|Lost to Follow-up|1
2227847|NCT01802775|3877054|FG001|Overall Study|Lost to Follow-up|2
2227848|NCT01802879|3877060|FG000|Overall Study|Administrative problems|2
2227849|NCT01802879|3877060|FG000|Overall Study|Disease progression|6
2227850|NCT01803269|3877142|FG000|Overall Study|Withdrawal by Subject|3
2227851|NCT01803269|3877143|FG001|Overall Study|Withdrawal by Subject|0
2227852|NCT01803269|3877144|FG002|Overall Study|Withdrawal by Subject|0
2227853|NCT01803282|3877164|FG000|Overall Study|Progressive Disease|4
2227854|NCT01803282|3877165|FG001|Overall Study|Progressive Disease|3
2227855|NCT01803282|3877166|FG002|Overall Study|Progressive Disease|6
2227856|NCT01803282|3877167|FG003|Overall Study|Progressive Disease|22
2227857|NCT01803282|3877168|FG004|Overall Study|Progressive Disease|5
2227858|NCT01803282|3877169|FG005|Overall Study|Progressive Disease|8
2227859|NCT01803282|3877170|FG006|Overall Study|Progressive Disease|23
2227860|NCT01803282|3877171|FG007|Overall Study|Progressive Disease|24
2227861|NCT01803282|3877172|FG008|Overall Study|Progressive Disease|3
2227862|NCT01803282|3877173|FG009|Overall Study|Progressive Disease|29
2227863|NCT01803282|3877174|FG010|Overall Study|Progressive Disease|6
2227864|NCT01803282|3877175|FG011|Overall Study|Progressive Disease|11
2227865|NCT01803282|3877164|FG000|Overall Study|Death|0
2227866|NCT01803282|3877165|FG001|Overall Study|Death|0
2227867|NCT01803282|3877166|FG002|Overall Study|Death|0
2227868|NCT01803282|3877167|FG003|Overall Study|Death|0
2227869|NCT01803282|3877168|FG004|Overall Study|Death|2
2227870|NCT01803282|3877169|FG005|Overall Study|Death|1
2227871|NCT01803282|3877170|FG006|Overall Study|Death|1
2227872|NCT01803282|3877171|FG007|Overall Study|Death|5
2227873|NCT01803282|3877172|FG008|Overall Study|Death|1
2227874|NCT01803282|3877173|FG009|Overall Study|Death|1
2227875|NCT01803282|3877174|FG010|Overall Study|Death|0
2227876|NCT01803282|3877175|FG011|Overall Study|Death|0
2227877|NCT01803282|3877164|FG000|Overall Study|Withdrew Consent|0
2227878|NCT01803282|3877165|FG001|Overall Study|Withdrew Consent|0
2227879|NCT01803282|3877166|FG002|Overall Study|Withdrew Consent|0
2227880|NCT01803282|3877167|FG003|Overall Study|Withdrew Consent|6
2227881|NCT01803282|3877168|FG004|Overall Study|Withdrew Consent|1
2227882|NCT01803282|3877169|FG005|Overall Study|Withdrew Consent|0
2227883|NCT01803282|3877170|FG006|Overall Study|Withdrew Consent|8
2227884|NCT01803282|3877171|FG007|Overall Study|Withdrew Consent|3
2227885|NCT01803282|3877172|FG008|Overall Study|Withdrew Consent|1
2227886|NCT01803282|3877173|FG009|Overall Study|Withdrew Consent|5
2227887|NCT01803282|3877174|FG010|Overall Study|Withdrew Consent|0
2227888|NCT01803282|3877175|FG011|Overall Study|Withdrew Consent|1
2227889|NCT01803282|3877164|FG000|Overall Study|Investigator's Discretion|0
2227890|NCT01803282|3877165|FG001|Overall Study|Investigator's Discretion|0
2227891|NCT01803282|3877166|FG002|Overall Study|Investigator's Discretion|0
2227892|NCT01803282|3877167|FG003|Overall Study|Investigator's Discretion|7
2227893|NCT01803282|3877168|FG004|Overall Study|Investigator's Discretion|2
2227894|NCT01803282|3877169|FG005|Overall Study|Investigator's Discretion|1
2227895|NCT01803282|3877170|FG006|Overall Study|Investigator's Discretion|7
2227896|NCT01803282|3877171|FG007|Overall Study|Investigator's Discretion|10
2227897|NCT01803282|3877172|FG008|Overall Study|Investigator's Discretion|6
2227898|NCT01803282|3877173|FG009|Overall Study|Investigator's Discretion|7
2227899|NCT01803282|3877174|FG010|Overall Study|Investigator's Discretion|1
2227900|NCT01803282|3877175|FG011|Overall Study|Investigator's Discretion|0
2227901|NCT01803282|3877164|FG000|Overall Study|Adverse Event|0
2227902|NCT01803282|3877165|FG001|Overall Study|Adverse Event|0
2227903|NCT01803282|3877166|FG002|Overall Study|Adverse Event|0
2332576|NCT03200366|4056381|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0
2332577|NCT03200366|4056379|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1
2332578|NCT03200366|4056380|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
2332579|NCT03200366|4056381|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
2332580|NCT03200366|4056379|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
2332581|NCT03200366|4056380|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
2332582|NCT03200366|4056381|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1
2332583|NCT03200366|4056379|FG000|9 Month Post-Baseline Interview|Death|1
2332584|NCT03200366|4056380|FG001|9 Month Post-Baseline Interview|Death|1
2332585|NCT03200366|4056381|FG002|9 Month Post-Baseline Interview|Death|1
2332586|NCT03200366|4056379|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23
2332587|NCT03200366|4056380|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18
2332588|NCT03200366|4056381|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9
2332589|NCT03200366|4056379|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0
2332590|NCT03200366|4056380|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0
2332591|NCT03200366|4056381|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1
2332592|NCT03200366|4056379|FG000|9 Month Post-Baseline Interview|Refused interview|0
2332593|NCT03200366|4056380|FG001|9 Month Post-Baseline Interview|Refused interview|2
2332594|NCT03200366|4056381|FG002|9 Month Post-Baseline Interview|Refused interview|0
2332595|NCT03200860|4056410|FG000|Overall Study|Withdrawal by Subject|1
2332596|NCT03200860|4056411|FG001|Overall Study|Withdrawal by Subject|0
2332597|NCT03200912|4056420|FG000|Overall Study|Adverse Event|3
2332598|NCT03200912|4056421|FG001|Overall Study|Adverse Event|0
2332599|NCT03200912|4056422|FG002|Overall Study|Adverse Event|0
2332600|NCT03200912|4056420|FG000|Overall Study|Withdrawal by Subject|1
2332601|NCT03200912|4056421|FG001|Overall Study|Withdrawal by Subject|2
2332602|NCT03200912|4056422|FG002|Overall Study|Withdrawal by Subject|4
2332603|NCT03200912|4056420|FG000|Overall Study|Non-compliance with study drug|0
2332604|NCT03200912|4056421|FG001|Overall Study|Non-compliance with study drug|1
2332605|NCT03200912|4056422|FG002|Overall Study|Non-compliance with study drug|0
2332606|NCT03201003|4056441|FG000|Overall Study|Adverse Event|14
2332607|NCT03201003|4056442|FG001|Overall Study|Adverse Event|1
2332608|NCT03201003|4056441|FG000|Overall Study|Other reasons|5
2332609|NCT03201003|4056442|FG001|Overall Study|Other reasons|1
2332610|NCT03201003|4056441|FG000|Overall Study|Withdrawal by Subject|4
2332611|NCT03201003|4056442|FG001|Overall Study|Withdrawal by Subject|1
2332612|NCT03201003|4056441|FG000|Overall Study|Lost to Follow-up|2
2332613|NCT03201003|4056442|FG001|Overall Study|Lost to Follow-up|0
2332614|NCT03201003|4056441|FG000|Overall Study|Protocol Violation|1
2332615|NCT03201003|4056442|FG001|Overall Study|Protocol Violation|0
2332616|NCT03201211|4056451|FG000|Overall Study|Adverse Event|1
2332617|NCT03201211|4056452|FG001|Overall Study|Adverse Event|0
2332618|NCT03201211|4056453|FG002|Overall Study|Adverse Event|0
2332619|NCT03201211|4056451|FG000|Overall Study|Protocol Violation|1
2332620|NCT03201211|4056452|FG001|Overall Study|Protocol Violation|0
2332621|NCT03201211|4056453|FG002|Overall Study|Protocol Violation|0
2227904|NCT01803282|3877167|FG003|Overall Study|Adverse Event|0
2227905|NCT01803282|3877168|FG004|Overall Study|Adverse Event|0
2227906|NCT01803282|3877169|FG005|Overall Study|Adverse Event|0
2227907|NCT01803282|3877170|FG006|Overall Study|Adverse Event|1
2227908|NCT01803282|3877171|FG007|Overall Study|Adverse Event|2
2227909|NCT01803282|3877172|FG008|Overall Study|Adverse Event|0
2227910|NCT01803282|3877173|FG009|Overall Study|Adverse Event|1
2227911|NCT01803282|3877174|FG010|Overall Study|Adverse Event|0
2227912|NCT01803282|3877175|FG011|Overall Study|Adverse Event|3
2227913|NCT01803282|3877164|FG000|Overall Study|Non-Compliance with Study Drug|0
2227914|NCT01803282|3877165|FG001|Overall Study|Non-Compliance with Study Drug|0
2227915|NCT01803282|3877166|FG002|Overall Study|Non-Compliance with Study Drug|0
2227916|NCT01803282|3877167|FG003|Overall Study|Non-Compliance with Study Drug|1
2227917|NCT01803282|3877168|FG004|Overall Study|Non-Compliance with Study Drug|0
2227918|NCT01803282|3877169|FG005|Overall Study|Non-Compliance with Study Drug|0
2227919|NCT01803282|3877170|FG006|Overall Study|Non-Compliance with Study Drug|0
2227920|NCT01803282|3877171|FG007|Overall Study|Non-Compliance with Study Drug|0
2227921|NCT01803282|3877172|FG008|Overall Study|Non-Compliance with Study Drug|0
2227922|NCT01803282|3877173|FG009|Overall Study|Non-Compliance with Study Drug|0
2227923|NCT01803282|3877174|FG010|Overall Study|Non-Compliance with Study Drug|0
2227924|NCT01803282|3877175|FG011|Overall Study|Non-Compliance with Study Drug|0
2227925|NCT01803282|3877164|FG000|Overall Study|Unknown Reason|0
2227926|NCT01803282|3877165|FG001|Overall Study|Unknown Reason|0
2227927|NCT01803282|3877166|FG002|Overall Study|Unknown Reason|0
2227928|NCT01803282|3877167|FG003|Overall Study|Unknown Reason|0
2227929|NCT01803282|3877168|FG004|Overall Study|Unknown Reason|0
2227930|NCT01803282|3877169|FG005|Overall Study|Unknown Reason|0
2227931|NCT01803282|3877170|FG006|Overall Study|Unknown Reason|0
2227932|NCT01803282|3877171|FG007|Overall Study|Unknown Reason|1
2227933|NCT01803282|3877172|FG008|Overall Study|Unknown Reason|0
2227934|NCT01803282|3877173|FG009|Overall Study|Unknown Reason|0
2227935|NCT01803282|3877174|FG010|Overall Study|Unknown Reason|0
2227936|NCT01803282|3877175|FG011|Overall Study|Unknown Reason|0
2227937|NCT01803282|3877164|FG000|Overall Study|Specified Criteria for Withdrawal|0
2227938|NCT01803282|3877165|FG001|Overall Study|Specified Criteria for Withdrawal|0
2227939|NCT01803282|3877166|FG002|Overall Study|Specified Criteria for Withdrawal|0
2227940|NCT01803282|3877167|FG003|Overall Study|Specified Criteria for Withdrawal|0
2227941|NCT01803282|3877168|FG004|Overall Study|Specified Criteria for Withdrawal|0
2227942|NCT01803282|3877169|FG005|Overall Study|Specified Criteria for Withdrawal|0
2227943|NCT01803282|3877170|FG006|Overall Study|Specified Criteria for Withdrawal|0
2227944|NCT01803282|3877171|FG007|Overall Study|Specified Criteria for Withdrawal|0
2227945|NCT01803282|3877172|FG008|Overall Study|Specified Criteria for Withdrawal|0
2227946|NCT01803282|3877173|FG009|Overall Study|Specified Criteria for Withdrawal|1
2227947|NCT01803282|3877174|FG010|Overall Study|Specified Criteria for Withdrawal|1
2227948|NCT01803282|3877175|FG011|Overall Study|Specified Criteria for Withdrawal|0
2227949|NCT01803282|3877164|FG000|Overall Study|Enrolled but Never Treated|0
2227950|NCT01803282|3877165|FG001|Overall Study|Enrolled but Never Treated|0
2227951|NCT01803282|3877166|FG002|Overall Study|Enrolled but Never Treated|0
2227952|NCT01803282|3877167|FG003|Overall Study|Enrolled but Never Treated|0
2227953|NCT01803282|3877168|FG004|Overall Study|Enrolled but Never Treated|1
2227954|NCT01803282|3877169|FG005|Overall Study|Enrolled but Never Treated|0
2227955|NCT01803282|3877170|FG006|Overall Study|Enrolled but Never Treated|1
2227956|NCT01803282|3877171|FG007|Overall Study|Enrolled but Never Treated|1
2227957|NCT01803282|3877172|FG008|Overall Study|Enrolled but Never Treated|0
2227958|NCT01803282|3877173|FG009|Overall Study|Enrolled but Never Treated|1
2227959|NCT01803282|3877174|FG010|Overall Study|Enrolled but Never Treated|0
2227960|NCT01803282|3877175|FG011|Overall Study|Enrolled but Never Treated|0
2227961|NCT01803464|3877205|FG000|Overall Study|Incomplete data|0
2227962|NCT01803464|3877206|FG001|Overall Study|Incomplete data|0
2227963|NCT01803464|3877207|FG002|Overall Study|Incomplete data|4
2227964|NCT01803464|3877208|FG003|Overall Study|Incomplete data|0
2227965|NCT01803464|3877205|FG000|Overall Study|Withdrawal by Subject|1
2227966|NCT01803464|3877206|FG001|Overall Study|Withdrawal by Subject|0
2227967|NCT01803464|3877207|FG002|Overall Study|Withdrawal by Subject|0
2227968|NCT01803464|3877208|FG003|Overall Study|Withdrawal by Subject|0
2227969|NCT01803607|3877224|FG000|Overall Study|Adverse Event|5
2227970|NCT01803607|3877225|FG001|Overall Study|Adverse Event|3
2227971|NCT01803607|3877224|FG000|Overall Study|Lack of Efficacy|0
2227972|NCT01803607|3877225|FG001|Overall Study|Lack of Efficacy|1
2227973|NCT01803607|3877224|FG000|Overall Study|Protocol Violation|3
2227974|NCT01803607|3877225|FG001|Overall Study|Protocol Violation|2
2227975|NCT01803607|3877224|FG000|Overall Study|Study terminated by sponsor|54
2227976|NCT01803607|3877225|FG001|Overall Study|Study terminated by sponsor|56
2227977|NCT01803607|3877224|FG000|Overall Study|Withdrawal by Subject|6
2227978|NCT01803607|3877225|FG001|Overall Study|Withdrawal by Subject|5
2227979|NCT01803646|3877233|FG000|Overall Study|Protocol Violation|1
2227980|NCT01803646|3877234|FG001|Overall Study|Protocol Violation|0
2227981|NCT01803646|3877233|FG000|Overall Study|Adverse Event|1
2227982|NCT01803646|3877234|FG001|Overall Study|Adverse Event|1
2227983|NCT01803646|3877233|FG000|Overall Study|Withdrawal by Subject|9
2227984|NCT01803646|3877234|FG001|Overall Study|Withdrawal by Subject|6
2227985|NCT01803646|3877233|FG000|Overall Study|Randomization error|1
2227986|NCT01803646|3877234|FG001|Overall Study|Randomization error|2
2227987|NCT01803646|3877233|FG000|Overall Study|Lost to Follow-up|5
2227988|NCT01803646|3877234|FG001|Overall Study|Lost to Follow-up|1
2227989|NCT01803737|3877242|FG000|Overall Study|Lack of Time|1
2227990|NCT01803737|3877243|FG001|Overall Study|Lack of Time|0
2227991|NCT01803737|3877242|FG000|Overall Study|Medical Reason|0
2227992|NCT01803737|3877243|FG001|Overall Study|Medical Reason|1
2227993|NCT01803737|3877242|FG000|Overall Study|Lost to Follow-up|0
2227994|NCT01803737|3877243|FG001|Overall Study|Lost to Follow-up|2
2227995|NCT01803880|3877252|FG000|Overall Study|Adverse Event|1
2227996|NCT01803880|3877253|FG001|Overall Study|Adverse Event|0
2227997|NCT01803880|3877254|FG002|Overall Study|Adverse Event|0
2227998|NCT01803880|3877252|FG000|Overall Study|Withdrawal by Subject|1
2227999|NCT01803880|3877253|FG001|Overall Study|Withdrawal by Subject|1
2228000|NCT01803880|3877254|FG002|Overall Study|Withdrawal by Subject|4
2228001|NCT01803880|3877252|FG000|Overall Study|Physician Decision|0
2228002|NCT01803880|3877253|FG001|Overall Study|Physician Decision|0
2228003|NCT01803880|3877254|FG002|Overall Study|Physician Decision|1
2228004|NCT01803880|3877252|FG000|Overall Study|Unable to return for follow-up visits|0
2228005|NCT01803880|3877253|FG001|Overall Study|Unable to return for follow-up visits|1
2228006|NCT01803880|3877254|FG002|Overall Study|Unable to return for follow-up visits|2
2228007|NCT01803880|3877252|FG000|Overall Study|Lost to Follow-up|1
2228008|NCT01803880|3877253|FG001|Overall Study|Lost to Follow-up|2
2228009|NCT01803880|3877254|FG002|Overall Study|Lost to Follow-up|3
2228010|NCT01803880|3877252|FG000|Overall Study|Protocol Violation|1
2228011|NCT01803880|3877253|FG001|Overall Study|Protocol Violation|0
2228012|NCT01803880|3877254|FG002|Overall Study|Protocol Violation|0
2228013|NCT01803880|3877252|FG000|Overall Study|Early study termination|0
2228014|NCT01803880|3877253|FG001|Overall Study|Early study termination|6
2228015|NCT01803880|3877254|FG002|Overall Study|Early study termination|5
2228016|NCT01803880|3877252|FG000|Overall Study|Incomplete data entry by sites|2
2228017|NCT01803880|3877253|FG001|Overall Study|Incomplete data entry by sites|0
2228018|NCT01803880|3877254|FG002|Overall Study|Incomplete data entry by sites|0
2228019|NCT01804049|3877276|FG000|Overall Study|Adverse Event|2
2228020|NCT01804049|3877277|FG001|Overall Study|Adverse Event|10
2228021|NCT01804049|3877276|FG000|Overall Study|Lost to Follow-up|2
2228022|NCT01804049|3877277|FG001|Overall Study|Lost to Follow-up|1
2228023|NCT01804049|3877276|FG000|Overall Study|Decreased interest/personal|4
2228024|NCT01804049|3877277|FG001|Overall Study|Decreased interest/personal|5
2228025|NCT01804049|3877276|FG000|Overall Study|Other health concerns|2
2228026|NCT01804049|3877277|FG001|Overall Study|Other health concerns|7
2228027|NCT01804049|3877276|FG000|Overall Study|Moved out of area|0
2228028|NCT01804049|3877277|FG001|Overall Study|Moved out of area|7
2228029|NCT01804049|3877276|FG000|Overall Study|other MD recommended|1
2228030|NCT01804049|3877277|FG001|Overall Study|other MD recommended|1
2228031|NCT01804049|3877276|FG000|Overall Study|Enrollment in dual studies|0
2228032|NCT01804049|3877277|FG001|Overall Study|Enrollment in dual studies|1
2228033|NCT01804140|3877320|FG000|Overall Study|No sampling or biopsy procedures done|114
2228034|NCT01804582|3877339|FG000|Overall Study|Lost to Follow-up|47
2228035|NCT01804582|3877340|FG001|Overall Study|Lost to Follow-up|56
2228036|NCT01804582|3877339|FG000|Overall Study|Physician Decision|2
2228037|NCT01804582|3877340|FG001|Overall Study|Physician Decision|0
2228038|NCT01804673|3877347|FG000|Overall Study|Adverse Event|4
2228039|NCT01804673|3877347|FG000|Overall Study|Withdrawal by Subject|1
2228040|NCT01804673|3877347|FG000|Overall Study|Lack of Efficacy|9
2228041|NCT01804673|3877347|FG000|Overall Study|Change to Oral Therapy|37
2228042|NCT01804673|3877347|FG000|Overall Study|No Further Therapy Required|84
2228043|NCT01804673|3877347|FG000|Overall Study|Use of Prohibited Medication|1
2228044|NCT01804673|3877347|FG000|Overall Study|Other|4
2228045|NCT01804842|3877354|FG000|Overall Study|Adverse Event|1
2228046|NCT01804842|3877355|FG001|Overall Study|Adverse Event|1
2228047|NCT01804842|3877356|FG002|Overall Study|Adverse Event|0
2228048|NCT01804842|3877354|FG000|Overall Study|Lost to Follow-up|1
2228049|NCT01804842|3877355|FG001|Overall Study|Lost to Follow-up|0
2228050|NCT01804842|3877356|FG002|Overall Study|Lost to Follow-up|0
2228051|NCT01804842|3877354|FG000|Overall Study|Non-Compliance|1
2228052|NCT01804842|3877355|FG001|Overall Study|Non-Compliance|1
2228053|NCT01804842|3877356|FG002|Overall Study|Non-Compliance|0
2228054|NCT01804842|3877354|FG000|Overall Study|Personal Reason|0
2228055|NCT01804842|3877355|FG001|Overall Study|Personal Reason|0
2228056|NCT01804842|3877356|FG002|Overall Study|Personal Reason|1
2228057|NCT01804946|3877377|FG000|Overall Study|Protocol Violation|1
2228058|NCT01804946|3877378|FG001|Overall Study|Protocol Violation|0
2228059|NCT01804946|3877377|FG000|Overall Study|Adverse Event|0
2228060|NCT01804946|3877378|FG001|Overall Study|Adverse Event|1
2228061|NCT01804946|3877377|FG000|Overall Study|Insufficient data available|0
2228062|NCT01804946|3877378|FG001|Overall Study|Insufficient data available|1
2228063|NCT01804946|3877377|FG000|Overall Study|Do not meet inclusion criteria|1
2228064|NCT01804946|3877378|FG001|Overall Study|Do not meet inclusion criteria|2
2274255|NCT02294227|3955129|FG002|Overall Study|Lack of Efficacy|8
2274256|NCT02294227|3955127|FG000|Overall Study|Adverse Event|6
2274257|NCT02294227|3955128|FG001|Overall Study|Adverse Event|8
2274258|NCT02294227|3955129|FG002|Overall Study|Adverse Event|2
2274259|NCT02294318|3955145|FG000|Overall Study|Worsening of drinking|3
2274260|NCT02294318|3955146|FG001|Overall Study|Worsening of drinking|0
2274261|NCT02294318|3955145|FG000|Overall Study|Not exposed to intervention|0
2274262|NCT02294318|3955146|FG001|Overall Study|Not exposed to intervention|2
2228065|NCT01805037|3877403|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0
2228066|NCT01805037|3877404|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2
2228067|NCT01805037|3877403|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0
2228068|NCT01805037|3877404|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2
2228069|NCT01805037|3877403|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0
2228070|NCT01805037|3877404|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1
2228071|NCT01805037|3877403|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0
2228072|NCT01805037|3877404|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1
2228073|NCT01805037|3877403|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0
2228074|NCT01805037|3877404|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10
2228075|NCT01805037|3877403|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0
2228076|NCT01805037|3877404|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1
2228077|NCT01805037|3877403|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0
2228078|NCT01805037|3877404|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1
2228079|NCT01805037|3877403|FG000|Follow Up (up to 3 Years)|Death|0
2228080|NCT01805037|3877404|FG001|Follow Up (up to 3 Years)|Death|2
2228081|NCT01805037|3877403|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0
2228082|NCT01805037|3877404|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3
2228083|NCT01805037|3877403|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0
2228084|NCT01805037|3877404|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1
2228085|NCT01805180|3877426|FG000|Lead-in Donor Phase|screen failure|1
2228086|NCT01805180|3877427|FG001|Lead-in Donor Phase|screen failure|0
2228087|NCT01805180|3877428|FG002|Lead-in Donor Phase|screen failure|0
2228088|NCT01806064|3877530|FG000|Overall Study|Randomized Not Enrolled|0
2228089|NCT01806064|3877531|FG001|Overall Study|Randomized Not Enrolled|0
2228090|NCT01806064|3877532|FG002|Overall Study|Randomized Not Enrolled|0
2228091|NCT01806064|3877533|FG003|Overall Study|Randomized Not Enrolled|1
2228092|NCT01806064|3877534|FG004|Overall Study|Randomized Not Enrolled|2
2228093|NCT01806168|3877553|FG000|Overall Study|Adverse Event|1
2228094|NCT01806168|3877554|FG001|Overall Study|Adverse Event|0
2228095|NCT01806168|3877555|FG002|Overall Study|Adverse Event|0
2228096|NCT01806168|3877553|FG000|Overall Study|Withdrawal by Subject|0
2228097|NCT01806168|3877554|FG001|Overall Study|Withdrawal by Subject|1
2228098|NCT01806168|3877555|FG002|Overall Study|Withdrawal by Subject|2
2228099|NCT01806168|3877553|FG000|Overall Study|Protocol Violation|0
2228100|NCT01806168|3877554|FG001|Overall Study|Protocol Violation|0
2228101|NCT01806168|3877555|FG002|Overall Study|Protocol Violation|1
2228102|NCT01806298|3877576|FG000|Overall Study|Adverse Event|3
2228103|NCT01806298|3877576|FG000|Overall Study|Protocol Non-compliance|1
2228104|NCT01806298|3877576|FG000|Overall Study|Withdrawal by Subject|1
2228105|NCT01806298|3877576|FG000|Overall Study|Other|5
2228106|NCT01806389|3877580|FG000|Overall Study|Withdrawal by Subject|4
2228107|NCT01806506|3877596|FG000|Overall Study|Lost to Follow-up|2
2228108|NCT01806506|3877597|FG001|Overall Study|Lost to Follow-up|1
2228109|NCT01806545|3877605|FG000|Overall Study|Adverse Event|2
2228110|NCT01806545|3877606|FG001|Overall Study|Adverse Event|3
2228111|NCT01806545|3877605|FG000|Overall Study|Lost to Follow-up|1
2228112|NCT01806545|3877606|FG001|Overall Study|Lost to Follow-up|0
2228113|NCT01806545|3877605|FG000|Overall Study|Withdrawal by Subject|3
2228114|NCT01806545|3877606|FG001|Overall Study|Withdrawal by Subject|2
2228115|NCT01806584|3877618|FG000|Overall Study|Adverse Event|2
2228116|NCT01806584|3877619|FG001|Overall Study|Adverse Event|1
2228117|NCT01806584|3877618|FG000|Overall Study|Death|1
2228118|NCT01806584|3877619|FG001|Overall Study|Death|0
2228119|NCT01806584|3877618|FG000|Overall Study|Lost to Follow-up|0
2228120|NCT01806584|3877619|FG001|Overall Study|Lost to Follow-up|2
2228121|NCT01806584|3877618|FG000|Overall Study|Study terminated by sponsor|9
2228122|NCT01806584|3877619|FG001|Overall Study|Study terminated by sponsor|14
2228123|NCT01806584|3877618|FG000|Overall Study|Withdrawal by Subject|1
2228124|NCT01806584|3877619|FG001|Overall Study|Withdrawal by Subject|1
2228125|NCT01806584|3877618|FG000|Overall Study|Other unspecified|1
2228126|NCT01806584|3877619|FG001|Overall Study|Other unspecified|0
2228127|NCT01806597|3877628|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1
2228128|NCT01806597|3877629|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1
2228129|NCT01806597|3877630|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0
2228130|NCT01806597|3877631|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0
2228131|NCT01806597|3877632|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2
2228132|NCT01806597|3877633|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0
2228133|NCT01806597|3877628|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
2228134|NCT01806597|3877629|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2228135|NCT01806597|3877630|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2228136|NCT01806597|3877631|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2228137|NCT01806597|3877632|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
2228138|NCT01806597|3877633|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2228139|NCT01806597|3877628|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0
2228140|NCT01806597|3877629|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1
2228141|NCT01806597|3877630|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0
2228142|NCT01806597|3877631|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0
2228143|NCT01806597|3877632|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0
2228144|NCT01806597|3877633|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0
2228145|NCT01806597|3877628|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
2228146|NCT01806597|3877629|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
2228147|NCT01806597|3877630|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
2228148|NCT01806597|3877631|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
2228149|NCT01806597|3877632|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
2228150|NCT01806597|3877633|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
2228151|NCT01806597|3877628|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0
2228152|NCT01806597|3877629|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1
2228153|NCT01806597|3877630|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0
2228154|NCT01806597|3877631|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0
2228155|NCT01806597|3877632|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0
2228156|NCT01806597|3877633|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0
2228157|NCT01806597|3877628|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
2228158|NCT01806597|3877629|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
2228159|NCT01806597|3877630|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
2228160|NCT01806597|3877631|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
2228161|NCT01806597|3877632|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
2228162|NCT01806597|3877633|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
2228163|NCT01806597|3877628|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
2228164|NCT01806597|3877629|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
2228165|NCT01806597|3877630|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
2228166|NCT01806597|3877631|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
2228167|NCT01806597|3877632|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
2228168|NCT01806597|3877633|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
2228169|NCT01806597|3877628|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
2228170|NCT01806597|3877629|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2228171|NCT01806597|3877630|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2228172|NCT01806597|3877631|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2228173|NCT01806597|3877632|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2228174|NCT01806597|3877633|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2228175|NCT01806597|3877628|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
2228176|NCT01806597|3877629|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
2228177|NCT01806597|3877630|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2228178|NCT01806597|3877631|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2228179|NCT01806597|3877632|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2228180|NCT01806597|3877633|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2228181|NCT01806597|3877628|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
2228182|NCT01806597|3877629|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2228183|NCT01806597|3877630|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2228184|NCT01806597|3877631|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2228185|NCT01806597|3877632|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2228186|NCT01806597|3877633|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2228187|NCT01806597|3877628|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2228188|NCT01806597|3877629|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
2228189|NCT01806597|3877630|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2228190|NCT01806597|3877631|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
2228191|NCT01806597|3877632|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2228192|NCT01806597|3877633|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2228193|NCT01806597|3877628|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
2228194|NCT01806597|3877629|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
2228195|NCT01806597|3877630|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
2228196|NCT01806597|3877631|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
2228197|NCT01806597|3877632|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
2228198|NCT01806597|3877633|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
2228199|NCT01806597|3877628|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
2228200|NCT01806597|3877629|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
2228201|NCT01806597|3877630|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
2228202|NCT01806597|3877631|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
2228203|NCT01806597|3877632|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
2228204|NCT01806597|3877633|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
2228205|NCT01806597|3877628|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1
2228206|NCT01806597|3877629|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0
2228207|NCT01806597|3877630|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0
2228208|NCT01806597|3877631|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0
2228209|NCT01806597|3877632|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0
2228210|NCT01806597|3877633|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0
2228211|NCT01806597|3877628|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2228212|NCT01806597|3877629|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2228213|NCT01806597|3877630|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2228214|NCT01806597|3877631|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2228215|NCT01806597|3877632|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2228216|NCT01806597|3877633|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
2228217|NCT01806597|3877628|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2228218|NCT01806597|3877629|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2228219|NCT01806597|3877630|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2228220|NCT01806597|3877631|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2228221|NCT01806597|3877632|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2228222|NCT01806597|3877633|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
2228223|NCT01806597|3877628|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2228224|NCT01806597|3877629|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2228225|NCT01806597|3877630|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2228226|NCT01806597|3877631|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2228227|NCT01806597|3877632|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2228228|NCT01806597|3877633|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
2228229|NCT01806597|3877628|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2228230|NCT01806597|3877629|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2228231|NCT01806597|3877630|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2228232|NCT01806597|3877631|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2228233|NCT01806597|3877632|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2228234|NCT01806597|3877633|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
2228235|NCT01806597|3877628|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2228236|NCT01806597|3877629|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2228237|NCT01806597|3877630|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2228238|NCT01806597|3877631|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2228239|NCT01806597|3877632|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2228240|NCT01806597|3877633|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
2228241|NCT01806623|3877647|FG000|Overall Study|Withdrawal by Subject|1
2228242|NCT01806623|3877647|FG000|Overall Study|Adverse Event|1
2228243|NCT01806623|3877647|FG000|Overall Study|Did not meet the inclusion criteria|56
2228244|NCT01806662|3877651|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
2228245|NCT01806662|3877652|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
2228246|NCT01806662|3877651|FG000|First Intervention (Weeks 0-16)|Adverse Event|0
2228247|NCT01806662|3877652|FG001|First Intervention (Weeks 0-16)|Adverse Event|1
2228248|NCT01806662|3877651|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
2228249|NCT01806662|3877652|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
2228250|NCT01806662|3877651|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
2228251|NCT01806662|3877652|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
2228252|NCT01806714|3877685|FG000|Overall Study|No functioning phone number|200
2228253|NCT01806714|3877686|FG001|Overall Study|No functioning phone number|170
2228254|NCT01806740|3877692|FG000|Overall Study|Withdrawal by Subject|4
2228255|NCT01806740|3877692|FG000|Overall Study|Physician Decision|1
2228256|NCT01806740|3877692|FG000|Overall Study|Patient's refusal of treatment|1
2228257|NCT01806779|3877701|FG000|Overall Study|Physician Decision|2
2228258|NCT01806779|3877702|FG001|Overall Study|Physician Decision|0
2228259|NCT01806779|3877703|FG002|Overall Study|Physician Decision|1
2228260|NCT01806779|3877701|FG000|Overall Study|Lack of Efficacy|1
2228261|NCT01806779|3877702|FG001|Overall Study|Lack of Efficacy|1
2228262|NCT01806779|3877703|FG002|Overall Study|Lack of Efficacy|0
2228263|NCT01806779|3877701|FG000|Overall Study|Lost to Follow-up|19
2228264|NCT01806779|3877702|FG001|Overall Study|Lost to Follow-up|20
2228265|NCT01806779|3877703|FG002|Overall Study|Lost to Follow-up|0
2228266|NCT01806779|3877701|FG000|Overall Study|Withdrawal by Subject|20
2228267|NCT01806779|3877702|FG001|Overall Study|Withdrawal by Subject|23
2228268|NCT01806779|3877703|FG002|Overall Study|Withdrawal by Subject|22
2228269|NCT01806896|3877720|FG000|Overall Study|Adverse Event|2
2228270|NCT01806896|3877721|FG001|Overall Study|Adverse Event|0
2228271|NCT01806896|3877720|FG000|Overall Study|Other|1
2228272|NCT01806896|3877721|FG001|Overall Study|Other|0
2228273|NCT01807065|3877763|FG000|Overall Study|Receive no sip-T due to IV access|1
2228274|NCT01807065|3877764|FG001|Overall Study|Receive no sip-T due to IV access|1
2228275|NCT01807156|3877783|FG000|Overall Study|Physician Decision|1
2228276|NCT01807221|3877793|FG000|Overall Study|Progressive disease|1
2228277|NCT01807221|3877794|FG001|Overall Study|Progressive disease|0
2228278|NCT01807221|3877795|FG002|Overall Study|Progressive disease|1
2228279|NCT01807221|3877796|FG003|Overall Study|Progressive disease|0
2228280|NCT01807221|3877797|FG004|Overall Study|Progressive disease|0
2228281|NCT01807221|3877798|FG005|Overall Study|Progressive disease|0
2228282|NCT01807221|3877793|FG000|Overall Study|Death|7
2228283|NCT01807221|3877794|FG001|Overall Study|Death|9
2228284|NCT01807221|3877795|FG002|Overall Study|Death|4
2228285|NCT01807221|3877796|FG003|Overall Study|Death|2
2228286|NCT01807221|3877797|FG004|Overall Study|Death|1
2228287|NCT01807221|3877798|FG005|Overall Study|Death|6
2228288|NCT01807221|3877793|FG000|Overall Study|Physician Decision|2
2228289|NCT01807221|3877794|FG001|Overall Study|Physician Decision|1
2228290|NCT01807221|3877795|FG002|Overall Study|Physician Decision|0
2228291|NCT01807221|3877796|FG003|Overall Study|Physician Decision|0
2228292|NCT01807221|3877797|FG004|Overall Study|Physician Decision|0
2228293|NCT01807221|3877798|FG005|Overall Study|Physician Decision|0
2228294|NCT01807221|3877793|FG000|Overall Study|Adverse Event|33
2228295|NCT01807221|3877794|FG001|Overall Study|Adverse Event|22
2228296|NCT01807221|3877795|FG002|Overall Study|Adverse Event|26
2228297|NCT01807221|3877796|FG003|Overall Study|Adverse Event|25
2228298|NCT01807221|3877797|FG004|Overall Study|Adverse Event|18
2228299|NCT01807221|3877798|FG005|Overall Study|Adverse Event|21
2228300|NCT01807221|3877793|FG000|Overall Study|Protocol Violation|0
2228301|NCT01807221|3877794|FG001|Overall Study|Protocol Violation|2
2228302|NCT01807221|3877795|FG002|Overall Study|Protocol Violation|1
2228303|NCT01807221|3877796|FG003|Overall Study|Protocol Violation|2
2228304|NCT01807221|3877797|FG004|Overall Study|Protocol Violation|0
2228305|NCT01807221|3877798|FG005|Overall Study|Protocol Violation|1
2228306|NCT01807221|3877793|FG000|Overall Study|Non-compliance|1
2228307|NCT01807221|3877794|FG001|Overall Study|Non-compliance|2
2228308|NCT01807221|3877795|FG002|Overall Study|Non-compliance|0
2228309|NCT01807221|3877796|FG003|Overall Study|Non-compliance|1
2228310|NCT01807221|3877797|FG004|Overall Study|Non-compliance|0
2228311|NCT01807221|3877798|FG005|Overall Study|Non-compliance|0
2228312|NCT01807221|3877793|FG000|Overall Study|Logistical difficulties|0
2228313|NCT01807221|3877794|FG001|Overall Study|Logistical difficulties|1
2228314|NCT01807221|3877795|FG002|Overall Study|Logistical difficulties|0
2228315|NCT01807221|3877796|FG003|Overall Study|Logistical difficulties|0
2228316|NCT01807221|3877797|FG004|Overall Study|Logistical difficulties|1
2228317|NCT01807221|3877798|FG005|Overall Study|Logistical difficulties|0
2228318|NCT01807221|3877793|FG000|Overall Study|Withdrawal by Subject|33
2228319|NCT01807221|3877794|FG001|Overall Study|Withdrawal by Subject|15
2228320|NCT01807221|3877795|FG002|Overall Study|Withdrawal by Subject|8
2228321|NCT01807221|3877796|FG003|Overall Study|Withdrawal by Subject|14
2228322|NCT01807221|3877797|FG004|Overall Study|Withdrawal by Subject|16
2228323|NCT01807221|3877798|FG005|Overall Study|Withdrawal by Subject|13
2228324|NCT01807221|3877793|FG000|Overall Study|Sponsor decision|2
2228325|NCT01807221|3877794|FG001|Overall Study|Sponsor decision|0
2228326|NCT01807221|3877795|FG002|Overall Study|Sponsor decision|1
2228327|NCT01807221|3877796|FG003|Overall Study|Sponsor decision|1
2228328|NCT01807221|3877797|FG004|Overall Study|Sponsor decision|0
2228329|NCT01807221|3877798|FG005|Overall Study|Sponsor decision|0
2228330|NCT01807221|3877793|FG000|Overall Study|Lost to Follow-up|1
2228331|NCT01807221|3877794|FG001|Overall Study|Lost to Follow-up|0
2228332|NCT01807221|3877795|FG002|Overall Study|Lost to Follow-up|2
2228333|NCT01807221|3877796|FG003|Overall Study|Lost to Follow-up|1
2228334|NCT01807221|3877797|FG004|Overall Study|Lost to Follow-up|0
2228335|NCT01807221|3877798|FG005|Overall Study|Lost to Follow-up|0
2228336|NCT01807234|3877818|FG000|Overall Study|Lost to Follow-up|2
2228337|NCT01807234|3877819|FG001|Overall Study|Lost to Follow-up|5
2228338|NCT01807234|3877820|FG002|Overall Study|Lost to Follow-up|1
2228339|NCT01807234|3877821|FG003|Overall Study|Lost to Follow-up|1
2228340|NCT01807234|3877822|FG004|Overall Study|Lost to Follow-up|1
2228341|NCT01807234|3877823|FG005|Overall Study|Lost to Follow-up|2
2228342|NCT01807234|3877818|FG000|Overall Study|Withdrawal by Subject|3
2228343|NCT01807234|3877819|FG001|Overall Study|Withdrawal by Subject|1
2228344|NCT01807234|3877820|FG002|Overall Study|Withdrawal by Subject|1
2228345|NCT01807234|3877821|FG003|Overall Study|Withdrawal by Subject|1
2228346|NCT01807234|3877822|FG004|Overall Study|Withdrawal by Subject|2
2228347|NCT01807234|3877823|FG005|Overall Study|Withdrawal by Subject|1
2228348|NCT01807234|3877818|FG000|Overall Study|Lack of Efficacy|0
2228349|NCT01807234|3877819|FG001|Overall Study|Lack of Efficacy|0
2228350|NCT01807234|3877820|FG002|Overall Study|Lack of Efficacy|0
2228351|NCT01807234|3877821|FG003|Overall Study|Lack of Efficacy|0
2228352|NCT01807234|3877822|FG004|Overall Study|Lack of Efficacy|1
2228353|NCT01807234|3877823|FG005|Overall Study|Lack of Efficacy|1
2228354|NCT01807299|3877837|FG000|Overall Study|Protocol Violation|3
2228355|NCT01807299|3877838|FG001|Overall Study|Protocol Violation|1
2228356|NCT01807299|3877839|FG002|Overall Study|Protocol Violation|0
2228357|NCT01807299|3877840|FG003|Overall Study|Protocol Violation|2
2228358|NCT01807520|3877857|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2228359|NCT01807520|3877858|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
2228360|NCT01807520|3877859|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
2228361|NCT01807520|3877860|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2228362|NCT01807520|3877861|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2228363|NCT01807520|3877862|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2228364|NCT01807520|3877863|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2228365|NCT01807520|3877857|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
2228366|NCT01807520|3877858|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2228367|NCT01807520|3877859|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
2228368|NCT01807520|3877860|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2228369|NCT01807520|3877861|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2228370|NCT01807520|3877862|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2228371|NCT01807520|3877863|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2228372|NCT01807520|3877857|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2228373|NCT01807520|3877858|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2228374|NCT01807520|3877859|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
2228375|NCT01807520|3877860|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2228376|NCT01807520|3877861|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2228377|NCT01807520|3877862|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2228378|NCT01807520|3877863|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2228379|NCT01807520|3877857|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
2228380|NCT01807520|3877858|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2228381|NCT01807520|3877859|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2228382|NCT01807520|3877860|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2228383|NCT01807520|3877861|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2228384|NCT01807520|3877862|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2228385|NCT01807520|3877863|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2228386|NCT01807520|3877857|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2228387|NCT01807520|3877858|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2228388|NCT01807520|3877859|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
2228389|NCT01807520|3877860|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2228390|NCT01807520|3877861|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2228391|NCT01807520|3877862|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2228392|NCT01807520|3877863|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2228393|NCT01807520|3877857|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
2228394|NCT01807520|3877858|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2228395|NCT01807520|3877859|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2228396|NCT01807520|3877860|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2228397|NCT01807520|3877861|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2228398|NCT01807520|3877862|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2228399|NCT01807520|3877863|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2228400|NCT01807520|3877857|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7
2228401|NCT01807520|3877858|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4
2228402|NCT01807520|3877859|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2228403|NCT01807520|3877860|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2228404|NCT01807520|3877861|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2
2228405|NCT01807520|3877862|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2228406|NCT01807520|3877863|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2228407|NCT01807520|3877857|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2228408|NCT01807520|3877858|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2228409|NCT01807520|3877859|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2228410|NCT01807520|3877860|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
2228411|NCT01807520|3877861|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2228412|NCT01807520|3877862|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2228413|NCT01807520|3877863|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2228414|NCT01807520|3877857|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
2228415|NCT01807520|3877858|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2228416|NCT01807520|3877859|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2228417|NCT01807520|3877860|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2228418|NCT01807520|3877861|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2228419|NCT01807520|3877862|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2228420|NCT01807520|3877863|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2228421|NCT01807520|3877857|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2228422|NCT01807520|3877858|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
2228423|NCT01807520|3877859|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2228424|NCT01807520|3877860|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2228425|NCT01807520|3877861|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2228426|NCT01807520|3877862|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2228427|NCT01807520|3877863|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2228428|NCT01807520|3877857|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
2228429|NCT01807520|3877858|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2228430|NCT01807520|3877859|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2228431|NCT01807520|3877860|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
2228432|NCT01807520|3877861|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2228433|NCT01807520|3877862|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2228434|NCT01807520|3877863|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2228435|NCT01807520|3877857|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
2228436|NCT01807520|3877858|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
2228437|NCT01807520|3877859|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2228438|NCT01807520|3877860|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2228439|NCT01807520|3877861|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
2228440|NCT01807520|3877862|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2228441|NCT01807520|3877863|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2228442|NCT01807520|3877857|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
2228443|NCT01807520|3877858|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
2228444|NCT01807520|3877859|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2228445|NCT01807520|3877860|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
2228446|NCT01807520|3877861|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2228447|NCT01807520|3877862|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2228448|NCT01807520|3877863|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2228449|NCT01807520|3877857|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
2228450|NCT01807520|3877858|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
2228451|NCT01807520|3877859|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
2228452|NCT01807520|3877860|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
2228453|NCT01807520|3877861|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
2228454|NCT01807520|3877862|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
2228455|NCT01807520|3877863|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
2228456|NCT01807520|3877857|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2228457|NCT01807520|3877858|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2228458|NCT01807520|3877859|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2228459|NCT01807520|3877860|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2228460|NCT01807520|3877861|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2228461|NCT01807520|3877862|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
2228462|NCT01807520|3877863|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2228463|NCT01807520|3877857|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0
2228464|NCT01807520|3877858|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0
2228465|NCT01807520|3877859|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0
2228466|NCT01807520|3877860|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0
2228467|NCT01807520|3877861|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0
2228468|NCT01807520|3877862|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1
2228469|NCT01807520|3877863|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0
2228470|NCT01807520|3877857|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2228471|NCT01807520|3877858|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2228472|NCT01807520|3877859|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2228473|NCT01807520|3877860|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2228474|NCT01807520|3877861|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2228475|NCT01807520|3877862|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
2228476|NCT01807520|3877863|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
2228477|NCT01807598|3877890|FG000|Overall Study|Withdrawal by Subject|4
2228478|NCT01807598|3877890|FG000|Overall Study|Adverse Event|1
2228479|NCT01807598|3877890|FG000|Overall Study|Other Physician Decision|1
2228480|NCT01807650|3877909|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13
2228481|NCT01807650|3877909|FG000|Overall Study|Adverse Event|5
2228482|NCT01807650|3877909|FG000|Overall Study|Other|2
2228483|NCT01807923|3877962|FG000|Overall Study|Adverse Event|2
2228484|NCT01807923|3877963|FG001|Overall Study|Adverse Event|1
2228485|NCT01807923|3877964|FG002|Overall Study|Adverse Event|2
2228486|NCT01807923|3877962|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
2228487|NCT01807923|3877963|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3
2228488|NCT01807923|3877964|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2
2228489|NCT01807923|3877962|FG000|Overall Study|Physician Decision|0
2228490|NCT01807923|3877963|FG001|Overall Study|Physician Decision|0
2228491|NCT01807923|3877964|FG002|Overall Study|Physician Decision|1
2228492|NCT01807923|3877962|FG000|Overall Study|Not Eligible (Genotype)|0
2228493|NCT01807923|3877963|FG001|Overall Study|Not Eligible (Genotype)|0
2228494|NCT01807923|3877964|FG002|Overall Study|Not Eligible (Genotype)|1
2228495|NCT01807923|3877962|FG000|Overall Study|Randomized But Not Treated|3
2228496|NCT01807923|3877963|FG001|Overall Study|Randomized But Not Treated|2
2228497|NCT01807923|3877964|FG002|Overall Study|Randomized But Not Treated|5
2228498|NCT01807949|3877977|FG000|Overall Study|Adverse Event|1
2228499|NCT01807949|3877978|FG001|Overall Study|Adverse Event|2
2228500|NCT01807949|3877979|FG002|Overall Study|Adverse Event|2
2228501|NCT01807949|3877977|FG000|Overall Study|Withdrawal by Subject|1
2228502|NCT01807949|3877978|FG001|Overall Study|Withdrawal by Subject|2
2228503|NCT01807949|3877979|FG002|Overall Study|Withdrawal by Subject|2
2228504|NCT01807949|3877977|FG000|Overall Study|Non-Compliance|0
2228505|NCT01807949|3877978|FG001|Overall Study|Non-Compliance|0
2228506|NCT01807949|3877979|FG002|Overall Study|Non-Compliance|1
2228507|NCT01807949|3877977|FG000|Overall Study|Undefined|0
2228508|NCT01807949|3877978|FG001|Overall Study|Undefined|1
2228509|NCT01807949|3877979|FG002|Overall Study|Undefined|2
2228510|NCT01807949|3877977|FG000|Overall Study|Randomized But Not Treated|0
2228511|NCT01807949|3877978|FG001|Overall Study|Randomized But Not Treated|2
2228512|NCT01807949|3877979|FG002|Overall Study|Randomized But Not Treated|2
2228513|NCT01808066|3877989|FG000|Overall Study|Withdrawal by Subject|15
2228514|NCT01808092|3877996|FG000|Overall Study|Death|39
2228515|NCT01808092|3877997|FG001|Overall Study|Death|29
2228516|NCT01808092|3877996|FG000|Overall Study|Lost to Follow-up|3
2228517|NCT01808092|3877997|FG001|Overall Study|Lost to Follow-up|7
2228518|NCT01808092|3877996|FG000|Overall Study|Withdrawal by Subject|9
2228519|NCT01808092|3877997|FG001|Overall Study|Withdrawal by Subject|4
2228520|NCT01808092|3877996|FG000|Overall Study|Other Eligibility criteria|3
2228521|NCT01808092|3877997|FG001|Overall Study|Other Eligibility criteria|5
2228522|NCT01808118|3878003|FG000|Period 1|Adverse Event|15
2228523|NCT01808118|3878004|FG001|Period 1|Adverse Event|0
2228524|NCT01808118|3878005|FG002|Period 1|Adverse Event|0
2228525|NCT01808118|3878003|FG000|Period 1|Withdrew consent|24
2228526|NCT01808118|3878004|FG001|Period 1|Withdrew consent|0
2228527|NCT01808118|3878005|FG002|Period 1|Withdrew consent|0
2228528|NCT01808118|3878003|FG000|Period 1|Lost to Follow-up|9
2228529|NCT01808118|3878004|FG001|Period 1|Lost to Follow-up|0
2228530|NCT01808118|3878005|FG002|Period 1|Lost to Follow-up|0
2228531|NCT01808118|3878003|FG000|Period 1|Did not meet criteria for remission|303
2228532|NCT01808118|3878004|FG001|Period 1|Did not meet criteria for remission|0
2228533|NCT01808118|3878005|FG002|Period 1|Did not meet criteria for remission|0
2228534|NCT01808118|3878003|FG000|Period 1|Enrolled in error|7
2228535|NCT01808118|3878004|FG001|Period 1|Enrolled in error|0
2228536|NCT01808118|3878005|FG002|Period 1|Enrolled in error|0
2228537|NCT01808118|3878003|FG000|Period 1|Did not meet inclusion criteria|3
2228538|NCT01808118|3878004|FG001|Period 1|Did not meet inclusion criteria|0
2228539|NCT01808118|3878005|FG002|Period 1|Did not meet inclusion criteria|0
2228540|NCT01808118|3878003|FG000|Period 1|Non-conformance with inclusion criteria|3
2228541|NCT01808118|3878004|FG001|Period 1|Non-conformance with inclusion criteria|0
2228542|NCT01808118|3878005|FG002|Period 1|Non-conformance with inclusion criteria|0
2228543|NCT01808118|3878003|FG000|Period 1|Investigator decision: site closure|2
2228544|NCT01808118|3878004|FG001|Period 1|Investigator decision: site closure|0
2228545|NCT01808118|3878005|FG002|Period 1|Investigator decision: site closure|0
2228546|NCT01808118|3878003|FG000|Period 1|Non-compliance per sponsor|1
2228547|NCT01808118|3878004|FG001|Period 1|Non-compliance per sponsor|0
2228548|NCT01808118|3878005|FG002|Period 1|Non-compliance per sponsor|0
2228549|NCT01808118|3878003|FG000|Period 1|Lack of Efficacy|1
2228550|NCT01808118|3878004|FG001|Period 1|Lack of Efficacy|0
2228551|NCT01808118|3878005|FG002|Period 1|Lack of Efficacy|0
2228552|NCT01808118|3878003|FG000|Period 2|Adverse Event|0
2228553|NCT01808118|3878004|FG001|Period 2|Adverse Event|4
2228554|NCT01808118|3878005|FG002|Period 2|Adverse Event|0
2228555|NCT01808118|3878003|FG000|Period 2|Withdrew consent|0
2228556|NCT01808118|3878004|FG001|Period 2|Withdrew consent|7
2228557|NCT01808118|3878005|FG002|Period 2|Withdrew consent|6
2228558|NCT01808118|3878003|FG000|Period 2|Lost to Follow-up|0
2228559|NCT01808118|3878004|FG001|Period 2|Lost to Follow-up|0
2228560|NCT01808118|3878005|FG002|Period 2|Lost to Follow-up|2
2228561|NCT01808118|3878003|FG000|Period 2|Investigator no longer conducting trials|0
2228562|NCT01808118|3878004|FG001|Period 2|Investigator no longer conducting trials|1
2228563|NCT01808118|3878005|FG002|Period 2|Investigator no longer conducting trials|0
2228564|NCT01808118|3878003|FG000|Period 2|Switched to other therapy|0
2228565|NCT01808118|3878004|FG001|Period 2|Switched to other therapy|1
2228566|NCT01808118|3878005|FG002|Period 2|Switched to other therapy|0
2228567|NCT01808144|3878021|FG000|Overall Study|Death|1
2228568|NCT01808144|3878022|FG001|Overall Study|Death|0
2228569|NCT01808144|3878021|FG000|Overall Study|Withdrawal by Subject|16
2228570|NCT01808144|3878022|FG001|Overall Study|Withdrawal by Subject|23
2228571|NCT01808144|3878021|FG000|Overall Study|Lost to Follow-up|6
2228572|NCT01808144|3878022|FG001|Overall Study|Lost to Follow-up|3
2228573|NCT01808144|3878021|FG000|Overall Study|Protocol Violation|6
2228574|NCT01808144|3878022|FG001|Overall Study|Protocol Violation|6
2228575|NCT01808144|3878021|FG000|Overall Study|Gout flare|0
2228576|NCT01808144|3878022|FG001|Overall Study|Gout flare|1
2228577|NCT01808144|3878021|FG000|Overall Study|Adverse Event|11
2228578|NCT01808144|3878022|FG001|Overall Study|Adverse Event|15
2228579|NCT01808196|3878028|FG000|Overall Study|Lost to Follow-up|1
2228580|NCT01808209|3878034|FG000|Overall Study|Lost to Follow-up|0
2228581|NCT01808209|3878035|FG001|Overall Study|Lost to Follow-up|1
2228582|NCT01808222|3878045|FG000|Overall Study|mpMR scan was not performed|1
2228583|NCT01808248|3878051|FG000|Overall Study|Lack of Efficacy|3
2228584|NCT01808248|3878051|FG000|Overall Study|Withdrawal by Subject|1
2228585|NCT01808248|3878051|FG000|Overall Study|Lost to Follow-up|1
2228586|NCT01808313|3878057|FG000|Overall Study|Adverse Event|5
2228587|NCT01808313|3878057|FG000|Overall Study|Protocol Violation|2
2228588|NCT01808313|3878057|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
2228589|NCT01808313|3878057|FG000|Overall Study|Lost to Follow-up|1
2228590|NCT01808313|3878057|FG000|Overall Study|Physician Decision|1
2228591|NCT01808339|3878065|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
2228592|NCT01808339|3878066|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
2228593|NCT01808339|3878067|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
2228594|NCT01808339|3878068|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
2228595|NCT01808339|3878069|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
2228596|NCT01808339|3878070|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
2228597|NCT01808339|3878065|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2228598|NCT01808339|3878066|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2228599|NCT01808339|3878067|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2228600|NCT01808339|3878068|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2228601|NCT01808339|3878069|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2228602|NCT01808339|3878070|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2228603|NCT01808339|3878065|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2228604|NCT01808339|3878066|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2228605|NCT01808339|3878067|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
2228606|NCT01808339|3878068|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2228607|NCT01808339|3878069|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2228608|NCT01808339|3878070|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2228609|NCT01808508|3878081|FG000|Overall Study|Lost to Follow-up|1
2228610|NCT01808508|3878082|FG001|Overall Study|Lost to Follow-up|0
2228611|NCT01808508|3878083|FG002|Overall Study|Lost to Follow-up|0
2228612|NCT01808534|3878091|FG000|Overall Study|Disease progression|3
2228613|NCT01808534|3878091|FG000|Overall Study|Physician Decision|1
2228614|NCT01808573|3878119|FG000|Overall Study|Death|212
2228615|NCT01808573|3878120|FG001|Overall Study|Death|240
2228616|NCT01808573|3878119|FG000|Overall Study|Withdrawal by Subject|12
2228617|NCT01808573|3878120|FG001|Overall Study|Withdrawal by Subject|10
2228618|NCT01808573|3878119|FG000|Overall Study|Lost to Follow-up|3
2228619|NCT01808573|3878120|FG001|Overall Study|Lost to Follow-up|0
2228620|NCT01808573|3878119|FG000|Overall Study|Discontinuation of study by sponsor|79
2228621|NCT01808573|3878120|FG001|Overall Study|Discontinuation of study by sponsor|64
2228622|NCT01808573|3878119|FG000|Overall Study|Randomized in Error|1
2228623|NCT01808573|3878120|FG001|Overall Study|Randomized in Error|0
2228624|NCT01808612|3878129|FG000|Treatment Period|Adverse Event|8
2228625|NCT01808612|3878130|FG001|Treatment Period|Adverse Event|4
2228626|NCT01808612|3878131|FG002|Treatment Period|Adverse Event|3
2228627|NCT01808612|3878129|FG000|Treatment Period|Lost to Follow-up|2
2228628|NCT01808612|3878130|FG001|Treatment Period|Lost to Follow-up|2
2228629|NCT01808612|3878131|FG002|Treatment Period|Lost to Follow-up|1
2228630|NCT01808612|3878129|FG000|Treatment Period|Protocol Violation|1
2228631|NCT01808612|3878130|FG001|Treatment Period|Protocol Violation|0
2228632|NCT01808612|3878131|FG002|Treatment Period|Protocol Violation|0
2228633|NCT01808612|3878129|FG000|Treatment Period|Withdrawal by Subject|1
2228634|NCT01808612|3878130|FG001|Treatment Period|Withdrawal by Subject|0
2228635|NCT01808612|3878131|FG002|Treatment Period|Withdrawal by Subject|4
2228636|NCT01808612|3878129|FG000|Treatment Period|Physician Decision|1
2228637|NCT01808612|3878130|FG001|Treatment Period|Physician Decision|0
2228638|NCT01808612|3878131|FG002|Treatment Period|Physician Decision|4
2228639|NCT01808612|3878129|FG000|Treatment Period|Sponsor Decision|1
2228640|NCT01808612|3878130|FG001|Treatment Period|Sponsor Decision|0
2228641|NCT01808612|3878131|FG002|Treatment Period|Sponsor Decision|0
2228642|NCT01808612|3878129|FG000|Treatment Period|Lack of Efficacy|1
2228643|NCT01808612|3878130|FG001|Treatment Period|Lack of Efficacy|1
2228644|NCT01808612|3878131|FG002|Treatment Period|Lack of Efficacy|2
2228645|NCT01808612|3878129|FG000|Discontinuation Period|Adverse Event|1
2228646|NCT01808612|3878130|FG001|Discontinuation Period|Adverse Event|0
2228647|NCT01808612|3878131|FG002|Discontinuation Period|Adverse Event|0
2228648|NCT01808612|3878129|FG000|Discontinuation Period|Physician Decision|1
2228649|NCT01808612|3878130|FG001|Discontinuation Period|Physician Decision|0
2228650|NCT01808612|3878131|FG002|Discontinuation Period|Physician Decision|0
2228651|NCT01808612|3878129|FG000|Discontinuation Period|Lost to Follow-up|0
2228652|NCT01808612|3878130|FG001|Discontinuation Period|Lost to Follow-up|1
2228653|NCT01808612|3878131|FG002|Discontinuation Period|Lost to Follow-up|0
2228654|NCT01808651|3878145|FG000|Study Period 1|Lost to Follow-up|1
2228655|NCT01808651|3878146|FG001|Study Period 1|Lost to Follow-up|3
2228656|NCT01808651|3878147|FG002|Study Period 1|Lost to Follow-up|0
2228657|NCT01808651|3878145|FG000|Study Period 1|Protocol Violation|1
2228658|NCT01808651|3878146|FG001|Study Period 1|Protocol Violation|0
2228659|NCT01808651|3878147|FG002|Study Period 1|Protocol Violation|1
2228660|NCT01808651|3878145|FG000|Study Period 1|Physician Decision|3
2228661|NCT01808651|3878146|FG001|Study Period 1|Physician Decision|2
2228662|NCT01808651|3878147|FG002|Study Period 1|Physician Decision|0
2228663|NCT01808651|3878145|FG000|Study Period 1|Lack of Efficacy|2
2228664|NCT01808651|3878146|FG001|Study Period 1|Lack of Efficacy|1
2228665|NCT01808651|3878147|FG002|Study Period 1|Lack of Efficacy|0
2228666|NCT01808651|3878145|FG000|Study Period 1|Adverse Event|10
2228667|NCT01808651|3878146|FG001|Study Period 1|Adverse Event|4
2228668|NCT01808651|3878147|FG002|Study Period 1|Adverse Event|1
2228669|NCT01808651|3878145|FG000|Study Period 1|Participant Decision|9
2228670|NCT01808651|3878146|FG001|Study Period 1|Participant Decision|7
2228671|NCT01808651|3878147|FG002|Study Period 1|Participant Decision|3
2228672|NCT01808690|3878160|FG000|Overall Study|Withdrawal by Subject|1
2228673|NCT01808690|3878161|FG001|Overall Study|Withdrawal by Subject|2
2228674|NCT01809132|3878206|FG000|Overall Study|Withdrawal by Subject|0
2228675|NCT01809132|3878207|FG001|Overall Study|Withdrawal by Subject|0
2228676|NCT01809132|3878208|FG002|Overall Study|Withdrawal by Subject|1
2228677|NCT01809197|3878218|FG000|Overall Study|Lost to Follow-up|4
2228678|NCT01809197|3878219|FG001|Overall Study|Lost to Follow-up|2
2228679|NCT01809197|3878218|FG000|Overall Study|Adverse Event|2
2228680|NCT01809197|3878219|FG001|Overall Study|Adverse Event|3
2228681|NCT01809197|3878218|FG000|Overall Study|Failed slit lamp exam|1
2228682|NCT01809197|3878219|FG001|Overall Study|Failed slit lamp exam|0
2228683|NCT01809197|3878218|FG000|Overall Study|Non-Compliance|1
2228684|NCT01809197|3878219|FG001|Overall Study|Non-Compliance|1
2228685|NCT01809197|3878218|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
2228686|NCT01809197|3878219|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
2228687|NCT01809197|3878218|FG000|Overall Study|Withdrawal by Subject|1
2228688|NCT01809197|3878219|FG001|Overall Study|Withdrawal by Subject|1
2228689|NCT01809197|3878218|FG000|Overall Study|Product not available|0
2228690|NCT01809197|3878219|FG001|Overall Study|Product not available|1
2228691|NCT01809210|3878232|FG000|Overall Study|Withdrawal by Subject|0
2228692|NCT01809210|3878233|FG001|Overall Study|Withdrawal by Subject|0
2228693|NCT01809210|3878234|FG002|Overall Study|Withdrawal by Subject|1
2228694|NCT01809210|3878235|FG003|Overall Study|Withdrawal by Subject|1
2228695|NCT01809210|3878236|FG004|Overall Study|Withdrawal by Subject|1
2228696|NCT01809210|3878237|FG005|Overall Study|Withdrawal by Subject|0
2228697|NCT01809210|3878238|FG006|Overall Study|Withdrawal by Subject|4
2228698|NCT01809210|3878232|FG000|Overall Study|Death|1
2228699|NCT01809210|3878233|FG001|Overall Study|Death|1
2228700|NCT01809210|3878234|FG002|Overall Study|Death|2
2228701|NCT01809210|3878235|FG003|Overall Study|Death|0
2228702|NCT01809210|3878236|FG004|Overall Study|Death|1
2228703|NCT01809210|3878237|FG005|Overall Study|Death|3
2228704|NCT01809210|3878238|FG006|Overall Study|Death|1
2228705|NCT01809262|3878254|FG000|Period 1 (First Dose + Washout)|Adverse Event|0
2228706|NCT01809262|3878255|FG001|Period 1 (First Dose + Washout)|Adverse Event|0
2228707|NCT01809262|3878256|FG002|Period 1 (First Dose + Washout)|Adverse Event|0
2228708|NCT01809262|3878257|FG003|Period 1 (First Dose + Washout)|Adverse Event|0
2228709|NCT01809262|3878258|FG004|Period 1 (First Dose + Washout)|Adverse Event|1
2228710|NCT01809262|3878259|FG005|Period 1 (First Dose + Washout)|Adverse Event|0
2228711|NCT01809262|3878260|FG006|Period 1 (First Dose + Washout)|Adverse Event|0
2228712|NCT01809262|3878261|FG007|Period 1 (First Dose + Washout)|Adverse Event|0
2228713|NCT01809262|3878262|FG008|Period 1 (First Dose + Washout)|Adverse Event|0
2228714|NCT01809262|3878263|FG009|Period 1 (First Dose + Washout)|Adverse Event|0
2228715|NCT01809262|3878254|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0
2228716|NCT01809262|3878255|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1
2228717|NCT01809262|3878256|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0
2228718|NCT01809262|3878257|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0
2228719|NCT01809262|3878258|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0
2228720|NCT01809262|3878259|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0
2228721|NCT01809262|3878260|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0
2228722|NCT01809262|3878261|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0
2228723|NCT01809262|3878262|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0
2228724|NCT01809262|3878263|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0
2228725|NCT01809314|3878275|FG000|Overall Study|Withdrawal Prior to Treatment|1
2228726|NCT01809314|3878275|FG000|Overall Study|Adverse Event|6
2228727|NCT01809314|3878275|FG000|Overall Study|Insufficient Therapeutic Response|14
2228728|NCT01809314|3878275|FG000|Overall Study|Lost to Follow-up|724
2228729|NCT01809327|3878284|FG000|Overall Study|Lost to Follow-up|5
2228730|NCT01809327|3878285|FG001|Overall Study|Lost to Follow-up|2
2228731|NCT01809327|3878286|FG002|Overall Study|Lost to Follow-up|4
2228732|NCT01809327|3878287|FG003|Overall Study|Lost to Follow-up|2
2228733|NCT01809327|3878288|FG004|Overall Study|Lost to Follow-up|3
2228734|NCT01809327|3878284|FG000|Overall Study|Withdrawal by Subject|6
2228735|NCT01809327|3878285|FG001|Overall Study|Withdrawal by Subject|4
2228736|NCT01809327|3878286|FG002|Overall Study|Withdrawal by Subject|4
2228737|NCT01809327|3878287|FG003|Overall Study|Withdrawal by Subject|2
2228738|NCT01809327|3878288|FG004|Overall Study|Withdrawal by Subject|5
2228739|NCT01809327|3878284|FG000|Overall Study|Adverse Event|4
2228740|NCT01809327|3878285|FG001|Overall Study|Adverse Event|3
2228741|NCT01809327|3878286|FG002|Overall Study|Adverse Event|7
2228742|NCT01809327|3878287|FG003|Overall Study|Adverse Event|4
2228743|NCT01809327|3878288|FG004|Overall Study|Adverse Event|8
2228744|NCT01809327|3878284|FG000|Overall Study|Death|1
2228745|NCT01809327|3878285|FG001|Overall Study|Death|0
2228746|NCT01809327|3878286|FG002|Overall Study|Death|0
2228747|NCT01809327|3878287|FG003|Overall Study|Death|0
2228748|NCT01809327|3878288|FG004|Overall Study|Death|0
2228749|NCT01809327|3878284|FG000|Overall Study|Protocol Violation|0
2228750|NCT01809327|3878285|FG001|Overall Study|Protocol Violation|1
2228751|NCT01809327|3878286|FG002|Overall Study|Protocol Violation|0
2228752|NCT01809327|3878287|FG003|Overall Study|Protocol Violation|0
2228753|NCT01809327|3878288|FG004|Overall Study|Protocol Violation|0
2228754|NCT01809327|3878284|FG000|Overall Study|Physician Decision|1
2228755|NCT01809327|3878285|FG001|Overall Study|Physician Decision|1
2228756|NCT01809327|3878286|FG002|Overall Study|Physician Decision|0
2228757|NCT01809327|3878287|FG003|Overall Study|Physician Decision|0
2228758|NCT01809327|3878288|FG004|Overall Study|Physician Decision|0
2228759|NCT01809327|3878284|FG000|Overall Study|Pregnancy|1
2228760|NCT01809327|3878285|FG001|Overall Study|Pregnancy|0
2228761|NCT01809327|3878286|FG002|Overall Study|Pregnancy|0
2228762|NCT01809327|3878287|FG003|Overall Study|Pregnancy|0
2228763|NCT01809327|3878288|FG004|Overall Study|Pregnancy|0
2228764|NCT01809327|3878284|FG000|Overall Study|Other|14
2228765|NCT01809327|3878285|FG001|Overall Study|Other|15
2228766|NCT01809327|3878286|FG002|Overall Study|Other|7
2228767|NCT01809327|3878287|FG003|Overall Study|Other|4
2228768|NCT01809327|3878288|FG004|Overall Study|Other|9
2228769|NCT01810016|3878324|FG000|Overall Study|Progressive disease|1
2228770|NCT01810016|3878325|FG001|Overall Study|Progressive disease|1
2228771|NCT01810016|3878326|FG002|Overall Study|Progressive disease|0
2228772|NCT01810016|3878324|FG000|Overall Study|Death|0
2228773|NCT01810016|3878325|FG001|Overall Study|Death|0
2228774|NCT01810016|3878326|FG002|Overall Study|Death|1
2228775|NCT01810042|3878334|FG000|Overall Study|Lost to Follow-up|10
2228776|NCT01810263|3878340|FG000|Overall Study|Lost to Follow-up|8
2228777|NCT01810263|3878341|FG001|Overall Study|Lost to Follow-up|7
2228778|NCT01810380|3878359|FG000|Overall Study|Randomised not treated|2
2228779|NCT01810380|3878360|FG001|Overall Study|Randomised not treated|1
2228780|NCT01810380|3878361|FG002|Overall Study|Randomised not treated|1
2228781|NCT01810380|3878359|FG000|Overall Study|Adverse Event|11
2228782|NCT01810380|3878360|FG001|Overall Study|Adverse Event|14
2228783|NCT01810380|3878361|FG002|Overall Study|Adverse Event|4
2228784|NCT01810380|3878359|FG000|Overall Study|Lack of Efficacy|24
2228785|NCT01810380|3878360|FG001|Overall Study|Lack of Efficacy|10
2228786|NCT01810380|3878361|FG002|Overall Study|Lack of Efficacy|11
2228787|NCT01810380|3878359|FG000|Overall Study|Protocol Violation|1
2228788|NCT01810380|3878360|FG001|Overall Study|Protocol Violation|0
2228789|NCT01810380|3878361|FG002|Overall Study|Protocol Violation|1
2228790|NCT01810380|3878359|FG000|Overall Study|Withdrawal by Subject|6
2228791|NCT01810380|3878360|FG001|Overall Study|Withdrawal by Subject|0
2228792|NCT01810380|3878361|FG002|Overall Study|Withdrawal by Subject|6
2228793|NCT01810380|3878359|FG000|Overall Study|Administrative or other reasons|11
2228794|NCT01810380|3878360|FG001|Overall Study|Administrative or other reasons|13
2228795|NCT01810380|3878361|FG002|Overall Study|Administrative or other reasons|9
2228796|NCT01810432|3878369|FG000|Washout|Protocol Violation|0
2228797|NCT01810432|3878370|FG001|Washout|Protocol Violation|1
2228798|NCT01810432|3878369|FG000|Washout|Adverse Event|1
2228799|NCT01810432|3878370|FG001|Washout|Adverse Event|0
2228800|NCT01810432|3878369|FG000|Period 2|Withdrawal by Subject|2
2228801|NCT01810432|3878370|FG001|Period 2|Withdrawal by Subject|1
2228802|NCT01810432|3878369|FG000|Period 2|Physician Decision|1
2228803|NCT01810432|3878370|FG001|Period 2|Physician Decision|0
2228804|NCT01810432|3878369|FG000|Period 2|Lost to Follow-up|1
2228805|NCT01810432|3878370|FG001|Period 2|Lost to Follow-up|1
2228806|NCT01810783|3878389|FG000|Overall Study|Adverse Event|32
2228807|NCT01810783|3878389|FG000|Overall Study|Withdrawal by Subject|22
2228808|NCT01810783|3878389|FG000|Overall Study|Lack of Efficacy|12
2228809|NCT01810783|3878389|FG000|Overall Study|Lost to Follow-up|10
2228810|NCT01810783|3878389|FG000|Overall Study|Protocol Violation|5
2228811|NCT01810783|3878389|FG000|Overall Study|Non-compliance with IMP|4
2228812|NCT01810783|3878389|FG000|Overall Study|Adminstrative or other reason(s)|23
2228813|NCT01810783|3878389|FG000|Overall Study|Enrolled, not treated|1
2228814|NCT01810939|3878393|FG000|Part A Treatment Period|Non-compliance with Study Drug|1
2228815|NCT01810939|3878394|FG001|Part A Treatment Period|Non-compliance with Study Drug|0
2228816|NCT01810939|3878395|FG002|Part A Treatment Period|Non-compliance with Study Drug|0
2228817|NCT01810939|3878393|FG000|Part A Treatment Period|Protocol Violation|2
2228818|NCT01810939|3878394|FG001|Part A Treatment Period|Protocol Violation|0
2228819|NCT01810939|3878395|FG002|Part A Treatment Period|Protocol Violation|0
2228820|NCT01810939|3878393|FG000|Part A Treatment Period|Adverse Event|10
2228821|NCT01810939|3878394|FG001|Part A Treatment Period|Adverse Event|0
2228822|NCT01810939|3878395|FG002|Part A Treatment Period|Adverse Event|0
2228823|NCT01810939|3878393|FG000|Part A Treatment Period|Withdrawal by Subject|5
2228824|NCT01810939|3878394|FG001|Part A Treatment Period|Withdrawal by Subject|0
2228825|NCT01810939|3878395|FG002|Part A Treatment Period|Withdrawal by Subject|0
2228826|NCT01810939|3878393|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2
2228827|NCT01810939|3878394|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0
2228828|NCT01810939|3878395|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0
2228829|NCT01810939|3878393|FG000|Part A Treatment Period|Protocol-specified (High K+)|3
2228830|NCT01810939|3878394|FG001|Part A Treatment Period|Protocol-specified (High K+)|0
2228831|NCT01810939|3878395|FG002|Part A Treatment Period|Protocol-specified (High K+)|0
2228832|NCT01810939|3878393|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1
2274263|NCT02294396|3955156|FG000|Overall Study|Adverse Event|26
2274264|NCT02294396|3955157|FG001|Overall Study|Adverse Event|25
2274265|NCT02294396|3955158|FG002|Overall Study|Adverse Event|21
2332622|NCT03201211|4056451|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
2332623|NCT03201211|4056452|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
2332624|NCT03201211|4056453|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
2332625|NCT03201211|4056451|FG000|Overall Study|OTHER unknown reasons|0
2332626|NCT03201211|4056452|FG001|Overall Study|OTHER unknown reasons|1
2332627|NCT03201211|4056453|FG002|Overall Study|OTHER unknown reasons|0
2274266|NCT02294396|3955159|FG003|Overall Study|Adverse Event|24
2274267|NCT02294396|3955156|FG000|Overall Study|Electrocardiogram adviser's judgment|1
2274268|NCT02294396|3955157|FG001|Overall Study|Electrocardiogram adviser's judgment|0
2274269|NCT02294396|3955158|FG002|Overall Study|Electrocardiogram adviser's judgment|0
2274270|NCT02294396|3955159|FG003|Overall Study|Electrocardiogram adviser's judgment|1
2274271|NCT02294396|3955156|FG000|Overall Study|Withdrawal by Subject|8
2228833|NCT01810939|3878394|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0
2228834|NCT01810939|3878395|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0
2228835|NCT01810939|3878393|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0
2228836|NCT01810939|3878394|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1
2228837|NCT01810939|3878395|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1
2228838|NCT01810939|3878393|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
2228839|NCT01810939|3878394|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
2228840|NCT01810939|3878395|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
2228841|NCT01810939|3878393|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0
2228842|NCT01810939|3878394|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1
2228843|NCT01810939|3878395|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1
2228844|NCT01810939|3878393|FG000|Part B Placebo-Controlled Withdrawal|Death|0
2228845|NCT01810939|3878394|FG001|Part B Placebo-Controlled Withdrawal|Death|0
2228846|NCT01810939|3878395|FG002|Part B Placebo-Controlled Withdrawal|Death|1
2228847|NCT01810939|3878393|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
2228848|NCT01810939|3878394|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
2228849|NCT01810939|3878395|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
2228850|NCT01810939|3878393|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
2228851|NCT01810939|3878394|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
2228852|NCT01810939|3878395|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
2228853|NCT01810939|3878393|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
2228854|NCT01810939|3878394|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
2228855|NCT01810939|3878395|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
2228856|NCT01810939|3878393|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
2228857|NCT01810939|3878394|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
2228858|NCT01810939|3878395|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
2228859|NCT01810939|3878393|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
2228860|NCT01810939|3878394|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
2228861|NCT01810939|3878395|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
2228862|NCT01810939|3878393|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
2228863|NCT01810939|3878394|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
2228864|NCT01810939|3878395|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
2228865|NCT01811186|3878457|FG000|Overall Study|Adverse Event|54
2228866|NCT01811186|3878458|FG001|Overall Study|Adverse Event|38
2228867|NCT01811186|3878457|FG000|Overall Study|Protocol Violation|5
2228868|NCT01811186|3878458|FG001|Overall Study|Protocol Violation|6
2228869|NCT01811186|3878457|FG000|Overall Study|Withdrawal by Subject|5
2228870|NCT01811186|3878458|FG001|Overall Study|Withdrawal by Subject|10
2228871|NCT01811186|3878457|FG000|Overall Study|Lack of Efficacy|3
2228872|NCT01811186|3878458|FG001|Overall Study|Lack of Efficacy|6
2228873|NCT01811186|3878457|FG000|Overall Study|Lost to Follow-up|4
2228874|NCT01811186|3878458|FG001|Overall Study|Lost to Follow-up|2
2228875|NCT01811225|3878472|FG000|Treatment Period 1|Adverse Event|2
2228876|NCT01811225|3878473|FG001|Treatment Period 1|Adverse Event|3
2228877|NCT01811225|3878472|FG000|Treatment Period 1|Lost to Follow-up|12
2228878|NCT01811225|3878473|FG001|Treatment Period 1|Lost to Follow-up|8
2228879|NCT01811225|3878472|FG000|Treatment Period 1|transporation|1
2228880|NCT01811225|3878473|FG001|Treatment Period 1|transporation|0
2228881|NCT01811225|3878472|FG000|Treatment Period 1|unable to remain smoke free overnight|10
2228882|NCT01811225|3878473|FG001|Treatment Period 1|unable to remain smoke free overnight|6
2228883|NCT01811225|3878472|FG000|Treatment Period 2|Lost to Follow-up|1
2228884|NCT01811225|3878473|FG001|Treatment Period 2|Lost to Follow-up|2
2228885|NCT01811225|3878472|FG000|Treatment Period 2|unable to remain smoke free overnight|3
2228886|NCT01811225|3878473|FG001|Treatment Period 2|unable to remain smoke free overnight|4
2228887|NCT01811238|3878479|FG000|Overall Study|Withdrawal by Subject|42
2228888|NCT01811238|3878479|FG000|Overall Study|Adverse Event|25
2228889|NCT01811238|3878479|FG000|Overall Study|Protocol Violation|4
2228890|NCT01811238|3878479|FG000|Overall Study|Lack of Efficacy|4
2228891|NCT01811238|3878479|FG000|Overall Study|subject refused study medication|6
2274272|NCT02294396|3955157|FG001|Overall Study|Withdrawal by Subject|6
2274273|NCT02294396|3955158|FG002|Overall Study|Withdrawal by Subject|6
2274274|NCT02294396|3955159|FG003|Overall Study|Withdrawal by Subject|8
2274275|NCT02294396|3955156|FG000|Overall Study|Lost to Follow-up|0
2274276|NCT02294396|3955157|FG001|Overall Study|Lost to Follow-up|0
2274277|NCT02294396|3955158|FG002|Overall Study|Lost to Follow-up|1
2274278|NCT02294396|3955159|FG003|Overall Study|Lost to Follow-up|1
2274279|NCT02294396|3955156|FG000|Overall Study|Protocol Deviation|3
2274280|NCT02294396|3955157|FG001|Overall Study|Protocol Deviation|2
2274281|NCT02294396|3955158|FG002|Overall Study|Protocol Deviation|2
2274282|NCT02294396|3955159|FG003|Overall Study|Protocol Deviation|1
2274283|NCT02294396|3955156|FG000|Overall Study|Miscellaneous|2
2274284|NCT02294396|3955157|FG001|Overall Study|Miscellaneous|0
2274285|NCT02294396|3955158|FG002|Overall Study|Miscellaneous|5
2274286|NCT02294396|3955159|FG003|Overall Study|Miscellaneous|2
2274287|NCT02294474|3955171|FG000|Overall Study|Adverse Event|7
2274288|NCT02294474|3955172|FG001|Overall Study|Adverse Event|7
2228892|NCT01811472|3878520|FG000|Overall Study|Adverse Event|1
2228893|NCT01811472|3878521|FG001|Overall Study|Adverse Event|0
2228894|NCT01811472|3878522|FG002|Overall Study|Adverse Event|4
2228895|NCT01811472|3878520|FG000|Overall Study|Lost to Follow-up|0
2228896|NCT01811472|3878521|FG001|Overall Study|Lost to Follow-up|0
2228897|NCT01811472|3878522|FG002|Overall Study|Lost to Follow-up|1
2228898|NCT01811472|3878520|FG000|Overall Study|Subject/guardian decision|1
2228899|NCT01811472|3878521|FG001|Overall Study|Subject/guardian decision|0
2228900|NCT01811472|3878522|FG002|Overall Study|Subject/guardian decision|0
2228901|NCT01811485|3878534|FG000|Overall Study|Adverse Event|1
2228902|NCT01811485|3878535|FG001|Overall Study|Adverse Event|3
2228903|NCT01811485|3878536|FG002|Overall Study|Adverse Event|2
2228904|NCT01811485|3878534|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2228905|NCT01811485|3878535|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2228906|NCT01811485|3878536|FG002|Overall Study|Unsatisfactory therapeutic effect|3
2228907|NCT01811485|3878534|FG000|Overall Study|Administrative problems|1
2228908|NCT01811485|3878535|FG001|Overall Study|Administrative problems|0
2228909|NCT01811485|3878536|FG002|Overall Study|Administrative problems|0
2228910|NCT01811485|3878534|FG000|Overall Study|Protocol Deviation|0
2228911|NCT01811485|3878535|FG001|Overall Study|Protocol Deviation|1
2228912|NCT01811485|3878536|FG002|Overall Study|Protocol Deviation|0
2228913|NCT01811563|3878549|FG000|Overall Study|Lost to Follow-up|5
2228914|NCT01811563|3878550|FG001|Overall Study|Lost to Follow-up|2
2228915|NCT01811563|3878549|FG000|Overall Study|Incorrect Randomization procedure|0
2228916|NCT01811563|3878550|FG001|Overall Study|Incorrect Randomization procedure|1
2228917|NCT01811706|3878579|FG000|First Intervention ( 4 Weeks)|Adverse Event|1
2228918|NCT01811706|3878580|FG001|First Intervention ( 4 Weeks)|Adverse Event|0
2228919|NCT01811732|3878590|FG000|Overall Study|Lost to Follow-up|24
2228920|NCT01811732|3878591|FG001|Overall Study|Lost to Follow-up|30
2228921|NCT01811732|3878590|FG000|Overall Study|Withdrawal by Subject|16
2228922|NCT01811732|3878591|FG001|Overall Study|Withdrawal by Subject|10
2228923|NCT01811732|3878590|FG000|Overall Study|Adverse Event|3
2228924|NCT01811732|3878591|FG001|Overall Study|Adverse Event|9
2228925|NCT01811732|3878590|FG000|Overall Study|Lack of Efficacy|3
2228926|NCT01811732|3878591|FG001|Overall Study|Lack of Efficacy|1
2228927|NCT01811732|3878590|FG000|Overall Study|Non-compliance with study drug/procedure|3
2228928|NCT01811732|3878591|FG001|Overall Study|Non-compliance with study drug/procedure|3
2228929|NCT01811732|3878590|FG000|Overall Study|Physician Decision|2
2228930|NCT01811732|3878591|FG001|Overall Study|Physician Decision|0
2228931|NCT01811732|3878590|FG000|Overall Study|Death|1
2228932|NCT01811732|3878591|FG001|Overall Study|Death|1
2228933|NCT01811732|3878590|FG000|Overall Study|Insufficient venous access|0
2228934|NCT01811732|3878591|FG001|Overall Study|Insufficient venous access|1
2228935|NCT01811732|3878590|FG000|Overall Study|Protocol Violation|0
2228936|NCT01811732|3878591|FG001|Overall Study|Protocol Violation|1
2228937|NCT01811732|3878590|FG000|Overall Study|Subject incarcerated|1
2228938|NCT01811732|3878591|FG001|Overall Study|Subject incarcerated|2
2228939|NCT01811732|3878590|FG000|Overall Study|Admitted to another facility|1
2228940|NCT01811732|3878591|FG001|Overall Study|Admitted to another facility|0
2228941|NCT01811732|3878590|FG000|Overall Study|Correct study drug not available on site|1
2228942|NCT01811732|3878591|FG001|Overall Study|Correct study drug not available on site|0
2228943|NCT01811953|3878617|FG000|Overall Study|Adverse Event|0
2228944|NCT01811953|3878618|FG001|Overall Study|Adverse Event|0
2228945|NCT01811953|3878619|FG002|Overall Study|Adverse Event|0
2228946|NCT01811953|3878620|FG003|Overall Study|Adverse Event|1
2228947|NCT01811953|3878621|FG004|Overall Study|Adverse Event|0
2228948|NCT01811953|3878622|FG005|Overall Study|Adverse Event|1
2228949|NCT01811953|3878617|FG000|Overall Study|Protocol Violation|0
2228950|NCT01811953|3878618|FG001|Overall Study|Protocol Violation|0
2228951|NCT01811953|3878619|FG002|Overall Study|Protocol Violation|0
2228952|NCT01811953|3878620|FG003|Overall Study|Protocol Violation|0
2228953|NCT01811953|3878621|FG004|Overall Study|Protocol Violation|1
2228954|NCT01811953|3878622|FG005|Overall Study|Protocol Violation|0
2228955|NCT01812057|3878660|FG000|Overall Study|Protocol Violation|1
2228956|NCT01812057|3878661|FG001|Overall Study|Protocol Violation|0
2228957|NCT01812057|3878660|FG000|Overall Study|Physician Decision|1
2228958|NCT01812057|3878661|FG001|Overall Study|Physician Decision|0
2228959|NCT01812109|3878671|FG000|Overall Study|research personnel delay|16
2228960|NCT01812109|3878671|FG000|Overall Study|NIRS Unattainable|17
2228961|NCT01812655|3878687|FG000|Overall Study|Protocol Violation|1
2228962|NCT01812655|3878688|FG001|Overall Study|Protocol Violation|1
2228963|NCT01812655|3878689|FG002|Overall Study|Protocol Violation|0
2228964|NCT01812707|3878717|FG000|Overall Study|Adverse Event|0
2228965|NCT01812707|3878718|FG001|Overall Study|Adverse Event|0
2228966|NCT01812707|3878719|FG002|Overall Study|Adverse Event|0
2228967|NCT01812707|3878720|FG003|Overall Study|Adverse Event|2
2228968|NCT01812707|3878717|FG000|Overall Study|Poor compliance to protocol|1
2228969|NCT01812707|3878718|FG001|Overall Study|Poor compliance to protocol|0
2228970|NCT01812707|3878719|FG002|Overall Study|Poor compliance to protocol|0
2228971|NCT01812707|3878720|FG003|Overall Study|Poor compliance to protocol|0
2228972|NCT01812707|3878717|FG000|Overall Study|Consent withdrawn by participant|1
2228973|NCT01812707|3878718|FG001|Overall Study|Consent withdrawn by participant|0
2228974|NCT01812707|3878719|FG002|Overall Study|Consent withdrawn by participant|0
2228975|NCT01812707|3878720|FG003|Overall Study|Consent withdrawn by participant|0
2228976|NCT01812759|3878734|FG000|Overall Study|Physician Decision|0
2228977|NCT01812759|3878735|FG001|Overall Study|Physician Decision|0
2228978|NCT01812759|3878736|FG002|Overall Study|Physician Decision|1
2228979|NCT01812837|3878747|FG000|Overall Study|Lost to Follow-up|1
2228980|NCT01812837|3878748|FG001|Overall Study|Lost to Follow-up|1
2228981|NCT01812837|3878749|FG002|Overall Study|Lost to Follow-up|0
2228982|NCT01812837|3878747|FG000|Overall Study|Protocol Violation|1
2228983|NCT01812837|3878748|FG001|Overall Study|Protocol Violation|0
2228984|NCT01812837|3878749|FG002|Overall Study|Protocol Violation|0
2228985|NCT01813019|3878759|FG000|Overall Study|Adverse Event|0
2228986|NCT01813019|3878760|FG001|Overall Study|Adverse Event|3
2228987|NCT01813019|3878759|FG000|Overall Study|Withdrawal by Subject|3
2228988|NCT01813019|3878760|FG001|Overall Study|Withdrawal by Subject|2
2228989|NCT01813019|3878759|FG000|Overall Study|administrative problems|2
2228990|NCT01813019|3878760|FG001|Overall Study|administrative problems|0
2228991|NCT01813019|3878759|FG000|Overall Study|Protocol Deviation|2
2228992|NCT01813019|3878760|FG001|Overall Study|Protocol Deviation|1
2228993|NCT01813058|3878768|FG000|Overall Study|Withdrawal by Subject|5
2228994|NCT01813058|3878769|FG001|Overall Study|Withdrawal by Subject|4
2228995|NCT01813071|3878784|FG000|Overall Study|Protocol Violation|0
2228996|NCT01813071|3878785|FG001|Overall Study|Protocol Violation|0
2228997|NCT01813071|3878786|FG002|Overall Study|Protocol Violation|0
2228998|NCT01813071|3878787|FG003|Overall Study|Protocol Violation|0
2228999|NCT01813071|3878788|FG004|Overall Study|Protocol Violation|1
2229000|NCT01813071|3878789|FG005|Overall Study|Protocol Violation|4
2229001|NCT01813071|3878790|FG006|Overall Study|Protocol Violation|2
2229002|NCT01813071|3878791|FG007|Overall Study|Protocol Violation|4
2229003|NCT01813071|3878792|FG008|Overall Study|Protocol Violation|2
2229004|NCT01813071|3878784|FG000|Overall Study|Withdrawal by Subject|0
2229005|NCT01813071|3878785|FG001|Overall Study|Withdrawal by Subject|0
2229006|NCT01813071|3878786|FG002|Overall Study|Withdrawal by Subject|0
2229007|NCT01813071|3878787|FG003|Overall Study|Withdrawal by Subject|0
2229008|NCT01813071|3878788|FG004|Overall Study|Withdrawal by Subject|0
2229009|NCT01813071|3878789|FG005|Overall Study|Withdrawal by Subject|1
2229010|NCT01813071|3878790|FG006|Overall Study|Withdrawal by Subject|0
2229011|NCT01813071|3878791|FG007|Overall Study|Withdrawal by Subject|0
2229012|NCT01813071|3878792|FG008|Overall Study|Withdrawal by Subject|0
2229013|NCT01813071|3878784|FG000|Overall Study|Adverse Event|0
2229014|NCT01813071|3878785|FG001|Overall Study|Adverse Event|0
2229015|NCT01813071|3878786|FG002|Overall Study|Adverse Event|0
2229016|NCT01813071|3878787|FG003|Overall Study|Adverse Event|0
2229017|NCT01813071|3878788|FG004|Overall Study|Adverse Event|0
2229018|NCT01813071|3878789|FG005|Overall Study|Adverse Event|1
2229019|NCT01813071|3878790|FG006|Overall Study|Adverse Event|0
2229020|NCT01813071|3878791|FG007|Overall Study|Adverse Event|0
2229021|NCT01813071|3878792|FG008|Overall Study|Adverse Event|0
2229022|NCT01813071|3878784|FG000|Overall Study|Physician Decision|0
2229023|NCT01813071|3878785|FG001|Overall Study|Physician Decision|0
2229024|NCT01813071|3878786|FG002|Overall Study|Physician Decision|0
2229025|NCT01813071|3878787|FG003|Overall Study|Physician Decision|0
2229026|NCT01813071|3878788|FG004|Overall Study|Physician Decision|0
2229027|NCT01813071|3878789|FG005|Overall Study|Physician Decision|0
2229028|NCT01813071|3878790|FG006|Overall Study|Physician Decision|1
2229029|NCT01813071|3878791|FG007|Overall Study|Physician Decision|0
2229030|NCT01813071|3878792|FG008|Overall Study|Physician Decision|0
2229031|NCT01813071|3878784|FG000|Overall Study|Met inc/exc criteria|0
2229032|NCT01813071|3878785|FG001|Overall Study|Met inc/exc criteria|0
2229033|NCT01813071|3878786|FG002|Overall Study|Met inc/exc criteria|0
2229034|NCT01813071|3878787|FG003|Overall Study|Met inc/exc criteria|0
2229035|NCT01813071|3878788|FG004|Overall Study|Met inc/exc criteria|0
2229036|NCT01813071|3878789|FG005|Overall Study|Met inc/exc criteria|1
2229037|NCT01813071|3878790|FG006|Overall Study|Met inc/exc criteria|0
2229038|NCT01813071|3878791|FG007|Overall Study|Met inc/exc criteria|1
2229039|NCT01813071|3878792|FG008|Overall Study|Met inc/exc criteria|1
2229040|NCT01813357|3878859|FG000|Overall Study|Lost to Follow-up|5
2229041|NCT01813357|3878860|FG001|Overall Study|Lost to Follow-up|6
2229042|NCT01813422|3878868|FG000|Overall Study|Withdrawal by Subject|14
2229043|NCT01813422|3878869|FG001|Overall Study|Withdrawal by Subject|8
2229044|NCT01813422|3878868|FG000|Overall Study|Death|2
2229045|NCT01813422|3878869|FG001|Overall Study|Death|3
2229046|NCT01813422|3878868|FG000|Overall Study|Sponsor Decision|2
2229047|NCT01813422|3878869|FG001|Overall Study|Sponsor Decision|1
2229048|NCT01813422|3878868|FG000|Overall Study|Lost to Follow-up|2
2229049|NCT01813422|3878869|FG001|Overall Study|Lost to Follow-up|4
2229050|NCT01813435|3878877|FG000|Overall Study|did not finish experimental regimen|1902
2229051|NCT01813435|3878878|FG001|Overall Study|did not finish experimental regimen|770
2229052|NCT01813435|3878877|FG000|Overall Study|Lost to Follow-up|268
2229053|NCT01813435|3878878|FG001|Overall Study|Lost to Follow-up|237
2229054|NCT01813474|3878887|FG000|Overall Study|Withdrawal by Subject|0
2229055|NCT01813474|3878888|FG001|Overall Study|Withdrawal by Subject|0
2229056|NCT01813474|3878889|FG002|Overall Study|Withdrawal by Subject|1
2229057|NCT01813474|3878887|FG000|Overall Study|Adverse Event|1
2229058|NCT01813474|3878888|FG001|Overall Study|Adverse Event|1
2229059|NCT01813474|3878889|FG002|Overall Study|Adverse Event|0
2229060|NCT01813474|3878887|FG000|Overall Study|Lack of Efficacy|2
2229061|NCT01813474|3878888|FG001|Overall Study|Lack of Efficacy|6
2229062|NCT01813474|3878889|FG002|Overall Study|Lack of Efficacy|9
2229063|NCT01813474|3878887|FG000|Overall Study|Death|0
2229064|NCT01813474|3878888|FG001|Overall Study|Death|0
2229065|NCT01813474|3878889|FG002|Overall Study|Death|1
2229066|NCT01813721|3878898|FG000|Overall Study|Ineligibility determined|63
2229067|NCT01813721|3878898|FG000|Overall Study|Withdrawal by Subject|1
2229068|NCT01813890|3878927|FG000|Overall Study|Adverse Event|0
2229069|NCT01813890|3878928|FG001|Overall Study|Adverse Event|3
2229070|NCT01813890|3878929|FG002|Overall Study|Adverse Event|4
2229071|NCT01813890|3878927|FG000|Overall Study|Lack of Efficacy|9
2229072|NCT01813890|3878928|FG001|Overall Study|Lack of Efficacy|1
2229073|NCT01813890|3878929|FG002|Overall Study|Lack of Efficacy|2
2229074|NCT01814007|3878937|FG000|Overall Study|Withdrawal by Subject|1
2229075|NCT01814046|3878944|FG000|Drug Administration|Death due to complications of RSV|1
2229076|NCT01814046|3878945|FG001|Drug Administration|Death due to complications of RSV|0
2229077|NCT01814046|3878946|FG002|Drug Administration|Death due to complications of RSV|0
2229078|NCT01814072|3878985|FG000|Overall Study|Lost to Follow-up|2
2229079|NCT01814072|3878986|FG001|Overall Study|Lost to Follow-up|2
2229080|NCT01814072|3878987|FG002|Overall Study|Lost to Follow-up|2
2229081|NCT01814072|3878988|FG003|Overall Study|Lost to Follow-up|0
2229082|NCT01814072|3878989|FG004|Overall Study|Lost to Follow-up|2
2229083|NCT01814072|3878990|FG005|Overall Study|Lost to Follow-up|3
2229084|NCT01814072|3878991|FG006|Overall Study|Lost to Follow-up|3
2229085|NCT01814072|3878992|FG007|Overall Study|Lost to Follow-up|1
2229086|NCT01814072|3878993|FG008|Overall Study|Lost to Follow-up|2
2229087|NCT01814072|3878994|FG009|Overall Study|Lost to Follow-up|3
2229088|NCT01814072|3878995|FG010|Overall Study|Lost to Follow-up|1
2229089|NCT01814072|3878996|FG011|Overall Study|Lost to Follow-up|2
2229090|NCT01814072|3878997|FG012|Overall Study|Lost to Follow-up|2
2229091|NCT01814072|3878998|FG013|Overall Study|Lost to Follow-up|1
2229092|NCT01814072|3878999|FG014|Overall Study|Lost to Follow-up|2
2229093|NCT01814072|3879000|FG015|Overall Study|Lost to Follow-up|1
2229094|NCT01814072|3879001|FG016|Overall Study|Lost to Follow-up|3
2229095|NCT01814072|3879002|FG017|Overall Study|Lost to Follow-up|1
2229096|NCT01814072|3879003|FG018|Overall Study|Lost to Follow-up|3
2229097|NCT01814072|3879004|FG019|Overall Study|Lost to Follow-up|3
2229098|NCT01814072|3879005|FG020|Overall Study|Lost to Follow-up|2
2229099|NCT01814072|3879006|FG021|Overall Study|Lost to Follow-up|1
2229100|NCT01814072|3879007|FG022|Overall Study|Lost to Follow-up|3
2229101|NCT01814072|3879008|FG023|Overall Study|Lost to Follow-up|1
2229102|NCT01814072|3879009|FG024|Overall Study|Lost to Follow-up|4
2229103|NCT01814072|3879010|FG025|Overall Study|Lost to Follow-up|1
2229104|NCT01814072|3879011|FG026|Overall Study|Lost to Follow-up|1
2229105|NCT01814072|3879012|FG027|Overall Study|Lost to Follow-up|2
2229106|NCT01814072|3879013|FG028|Overall Study|Lost to Follow-up|3
2229107|NCT01814072|3879014|FG029|Overall Study|Lost to Follow-up|3
2229108|NCT01814072|3879015|FG030|Overall Study|Lost to Follow-up|2
2229109|NCT01814072|3879016|FG031|Overall Study|Lost to Follow-up|0
2229110|NCT01814072|3878985|FG000|Overall Study|Withdrawal by Subject|2
2229111|NCT01814072|3878986|FG001|Overall Study|Withdrawal by Subject|0
2229112|NCT01814072|3878987|FG002|Overall Study|Withdrawal by Subject|1
2229113|NCT01814072|3878988|FG003|Overall Study|Withdrawal by Subject|0
2229114|NCT01814072|3878989|FG004|Overall Study|Withdrawal by Subject|2
2229115|NCT01814072|3878990|FG005|Overall Study|Withdrawal by Subject|3
2229116|NCT01814072|3878991|FG006|Overall Study|Withdrawal by Subject|1
2229117|NCT01814072|3878992|FG007|Overall Study|Withdrawal by Subject|0
2229118|NCT01814072|3878993|FG008|Overall Study|Withdrawal by Subject|1
2229119|NCT01814072|3878994|FG009|Overall Study|Withdrawal by Subject|2
2229120|NCT01814072|3878995|FG010|Overall Study|Withdrawal by Subject|0
2229121|NCT01814072|3878996|FG011|Overall Study|Withdrawal by Subject|0
2229122|NCT01814072|3878997|FG012|Overall Study|Withdrawal by Subject|1
2229123|NCT01814072|3878998|FG013|Overall Study|Withdrawal by Subject|1
2229124|NCT01814072|3878999|FG014|Overall Study|Withdrawal by Subject|1
2229125|NCT01814072|3879000|FG015|Overall Study|Withdrawal by Subject|1
2229126|NCT01814072|3879001|FG016|Overall Study|Withdrawal by Subject|0
2229127|NCT01814072|3879002|FG017|Overall Study|Withdrawal by Subject|0
2229128|NCT01814072|3879003|FG018|Overall Study|Withdrawal by Subject|0
2229129|NCT01814072|3879004|FG019|Overall Study|Withdrawal by Subject|2
2229130|NCT01814072|3879005|FG020|Overall Study|Withdrawal by Subject|0
2229131|NCT01814072|3879006|FG021|Overall Study|Withdrawal by Subject|0
2229132|NCT01814072|3879007|FG022|Overall Study|Withdrawal by Subject|1
2229133|NCT01814072|3879008|FG023|Overall Study|Withdrawal by Subject|0
2229134|NCT01814072|3879009|FG024|Overall Study|Withdrawal by Subject|2
2229135|NCT01814072|3879010|FG025|Overall Study|Withdrawal by Subject|1
2229136|NCT01814072|3879011|FG026|Overall Study|Withdrawal by Subject|1
2229137|NCT01814072|3879012|FG027|Overall Study|Withdrawal by Subject|2
2229138|NCT01814072|3879013|FG028|Overall Study|Withdrawal by Subject|1
2229139|NCT01814072|3879014|FG029|Overall Study|Withdrawal by Subject|0
2229140|NCT01814072|3879015|FG030|Overall Study|Withdrawal by Subject|0
2229141|NCT01814072|3879016|FG031|Overall Study|Withdrawal by Subject|0
2229142|NCT01814137|3879058|FG000|Overall Study|Adverse Event|0
2229143|NCT01814137|3879059|FG001|Overall Study|Adverse Event|1
2229144|NCT01814137|3879058|FG000|Overall Study|Withdrawal by Subject|2
2229145|NCT01814137|3879059|FG001|Overall Study|Withdrawal by Subject|2
2229146|NCT01814137|3879058|FG000|Overall Study|Physician Decision|1
2229147|NCT01814137|3879059|FG001|Overall Study|Physician Decision|1
2229148|NCT01814137|3879058|FG000|Overall Study|Unclassified|2
2229149|NCT01814137|3879059|FG001|Overall Study|Unclassified|1
2229150|NCT01814332|3879072|FG000|Overall Study|Adverse Event|8
2229151|NCT01814332|3879073|FG001|Overall Study|Adverse Event|3
2229152|NCT01814332|3879072|FG000|Overall Study|Withdrawal by Subject|3
2229153|NCT01814332|3879073|FG001|Overall Study|Withdrawal by Subject|8
2229154|NCT01814332|3879072|FG000|Overall Study|Protocol Violation|0
2229155|NCT01814332|3879073|FG001|Overall Study|Protocol Violation|4
2229156|NCT01814332|3879072|FG000|Overall Study|Lost to Follow-up|5
2229157|NCT01814332|3879073|FG001|Overall Study|Lost to Follow-up|1
2229158|NCT01814371|3879081|FG000|Overall Study|Lost to Follow-up|30
2229159|NCT01814371|3879082|FG001|Overall Study|Lost to Follow-up|27
2229160|NCT01814397|3879091|FG000|Overall Study|Adverse Event|7
2229161|NCT01814397|3879091|FG000|Overall Study|Withdrawal by Subject|7
2229162|NCT01814553|3879097|FG000|Overall Study|PD per clinical progression|6
2229163|NCT01814553|3879098|FG001|Overall Study|PD per clinical progression|8
2229164|NCT01814553|3879097|FG000|Overall Study|Other Adverse Event|4
2229165|NCT01814553|3879098|FG001|Overall Study|Other Adverse Event|5
2229166|NCT01814553|3879097|FG000|Overall Study|Withdrawal by Subject|1
2229167|NCT01814553|3879098|FG001|Overall Study|Withdrawal by Subject|1
2229168|NCT01814553|3879097|FG000|Overall Study|Other than stated|7
2229169|NCT01814553|3879098|FG001|Overall Study|Other than stated|8
2229170|NCT01814670|3879104|FG000|Overall Study|Protocol Violation|12
2229171|NCT01814696|3879110|FG000|Overall Study|Withdrawal by Subject|1
2229172|NCT01814696|3879111|FG001|Overall Study|Withdrawal by Subject|0
2229173|NCT01814696|3879110|FG000|Overall Study|Randomized to wrong group|1
2229174|NCT01814696|3879111|FG001|Overall Study|Randomized to wrong group|0
2229175|NCT01814748|3879119|FG000|Overall Study|Lost to Follow-up|1
2229176|NCT01814748|3879120|FG001|Overall Study|Lost to Follow-up|2
2229177|NCT01814748|3879119|FG000|Overall Study|Study site terminated by sponsor|1
2229178|NCT01814748|3879120|FG001|Overall Study|Study site terminated by sponsor|1
2229179|NCT01814748|3879119|FG000|Overall Study|Withdrawal by Subject|6
2229180|NCT01814748|3879120|FG001|Overall Study|Withdrawal by Subject|4
2229181|NCT01814761|3879128|FG000|Overall Study|Other Reasons|1
2229182|NCT01814761|3879129|FG001|Overall Study|Other Reasons|10
2229183|NCT01814761|3879128|FG000|Overall Study|Ocular Adverse Event|6
2229184|NCT01814761|3879129|FG001|Overall Study|Ocular Adverse Event|15
2229185|NCT01814761|3879128|FG000|Overall Study|Lost to Follow-up|1
2229186|NCT01814761|3879129|FG001|Overall Study|Lost to Follow-up|5
2229187|NCT01814800|3879150|FG000|Overall Study|Adverse Event|2
2229188|NCT01814800|3879150|FG000|Overall Study|Pregnancy|1
2229189|NCT01814800|3879150|FG000|Overall Study|Sponsor decision|1
2229190|NCT01814800|3879150|FG000|Overall Study|Subject relocation|1
2229191|NCT01814878|3879169|FG000|Overall Study|Adverse Event|16
2229192|NCT01814878|3879170|FG001|Overall Study|Adverse Event|5
2229193|NCT01814878|3879169|FG000|Overall Study|Withdrawal by Subject|20
2229194|NCT01814878|3879170|FG001|Overall Study|Withdrawal by Subject|16
2229195|NCT01814878|3879169|FG000|Overall Study|Protocol Violation|5
2229196|NCT01814878|3879170|FG001|Overall Study|Protocol Violation|5
2229197|NCT01814878|3879169|FG000|Overall Study|Physician Decision|3
2229198|NCT01814878|3879170|FG001|Overall Study|Physician Decision|1
2229199|NCT01814878|3879169|FG000|Overall Study|Screening failure (drop-out)|0
2229200|NCT01814878|3879170|FG001|Overall Study|Screening failure (drop-out)|3
2229201|NCT01814878|3879169|FG000|Overall Study|Other|2
2229202|NCT01814878|3879170|FG001|Overall Study|Other|0
2229203|NCT01815099|3879182|FG000|Overall Study|Lack of Efficacy|1
2229204|NCT01815099|3879182|FG000|Overall Study|unable to attend study visits|1
2229205|NCT01815138|3879189|FG000|Overall Study|Withdrawal by Subject|0
2229206|NCT01815138|3879190|FG001|Overall Study|Withdrawal by Subject|1
2229207|NCT01815138|3879189|FG000|Overall Study|Physician Decision|8
2229208|NCT01815138|3879190|FG001|Overall Study|Physician Decision|5
2229209|NCT01815424|3879215|FG000|Week 0 to 16|Adverse Event|1
2229210|NCT01815424|3879216|FG001|Week 0 to 16|Adverse Event|3
2229211|NCT01815424|3879217|FG002|Week 0 to 16|Adverse Event|3
2229212|NCT01815424|3879218|FG003|Week 0 to 16|Adverse Event|0
2229213|NCT01815424|3879219|FG004|Week 0 to 16|Adverse Event|0
2229214|NCT01815424|3879215|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2
2229215|NCT01815424|3879216|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0
2229216|NCT01815424|3879217|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0
2229217|NCT01815424|3879218|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0
2229218|NCT01815424|3879219|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0
2229219|NCT01815424|3879215|FG000|Week 0 to 16|Lost to Follow-up|0
2229220|NCT01815424|3879216|FG001|Week 0 to 16|Lost to Follow-up|1
2229221|NCT01815424|3879217|FG002|Week 0 to 16|Lost to Follow-up|0
2229222|NCT01815424|3879218|FG003|Week 0 to 16|Lost to Follow-up|0
2229223|NCT01815424|3879219|FG004|Week 0 to 16|Lost to Follow-up|0
2229224|NCT01815424|3879215|FG000|Week 0 to 16|Withdrawal by Subject|0
2229225|NCT01815424|3879216|FG001|Week 0 to 16|Withdrawal by Subject|0
2229226|NCT01815424|3879217|FG002|Week 0 to 16|Withdrawal by Subject|1
2229227|NCT01815424|3879218|FG003|Week 0 to 16|Withdrawal by Subject|0
2229228|NCT01815424|3879219|FG004|Week 0 to 16|Withdrawal by Subject|0
2229229|NCT01815424|3879215|FG000|Week 0 to 16|Other|1
2229230|NCT01815424|3879216|FG001|Week 0 to 16|Other|0
2229231|NCT01815424|3879217|FG002|Week 0 to 16|Other|3
2229232|NCT01815424|3879218|FG003|Week 0 to 16|Other|0
2229233|NCT01815424|3879219|FG004|Week 0 to 16|Other|0
2229234|NCT01815424|3879215|FG000|Week 0 to 16|Protocol Violation|1
2229235|NCT01815424|3879216|FG001|Week 0 to 16|Protocol Violation|0
2229236|NCT01815424|3879217|FG002|Week 0 to 16|Protocol Violation|0
2229237|NCT01815424|3879218|FG003|Week 0 to 16|Protocol Violation|0
2229238|NCT01815424|3879219|FG004|Week 0 to 16|Protocol Violation|0
2229239|NCT01815424|3879215|FG000|Week 0 to 16|Insufficient Clinical Response|2
2229240|NCT01815424|3879216|FG001|Week 0 to 16|Insufficient Clinical Response|0
2229241|NCT01815424|3879217|FG002|Week 0 to 16|Insufficient Clinical Response|4
2229242|NCT01815424|3879218|FG003|Week 0 to 16|Insufficient Clinical Response|0
2229243|NCT01815424|3879219|FG004|Week 0 to 16|Insufficient Clinical Response|0
2229244|NCT01815424|3879215|FG000|Week 16 to 52|Other|0
2229245|NCT01815424|3879216|FG001|Week 16 to 52|Other|1
2229246|NCT01815424|3879217|FG002|Week 16 to 52|Other|0
2229247|NCT01815424|3879218|FG003|Week 16 to 52|Other|0
2229248|NCT01815424|3879219|FG004|Week 16 to 52|Other|0
2229249|NCT01815424|3879215|FG000|Week 16 to 52|Adverse Event|0
2229250|NCT01815424|3879216|FG001|Week 16 to 52|Adverse Event|0
2229251|NCT01815424|3879217|FG002|Week 16 to 52|Adverse Event|0
2229252|NCT01815424|3879218|FG003|Week 16 to 52|Adverse Event|0
2229253|NCT01815424|3879219|FG004|Week 16 to 52|Adverse Event|1
2229254|NCT01815424|3879215|FG000|Week 16 to 52|Insufficient Clinical Response|1
2229255|NCT01815424|3879216|FG001|Week 16 to 52|Insufficient Clinical Response|0
2229256|NCT01815424|3879217|FG002|Week 16 to 52|Insufficient Clinical Response|0
2229257|NCT01815424|3879218|FG003|Week 16 to 52|Insufficient Clinical Response|1
2229258|NCT01815424|3879219|FG004|Week 16 to 52|Insufficient Clinical Response|1
2229259|NCT01815424|3879215|FG000|Week 16 to 52|Lost to Follow-up|0
2229260|NCT01815424|3879216|FG001|Week 16 to 52|Lost to Follow-up|2
2229261|NCT01815424|3879217|FG002|Week 16 to 52|Lost to Follow-up|0
2229262|NCT01815424|3879218|FG003|Week 16 to 52|Lost to Follow-up|2
2229263|NCT01815424|3879219|FG004|Week 16 to 52|Lost to Follow-up|1
2229264|NCT01815424|3879215|FG000|Week 16 to 52|Withdrawal by Subject|1
2229265|NCT01815424|3879216|FG001|Week 16 to 52|Withdrawal by Subject|2
2229266|NCT01815424|3879217|FG002|Week 16 to 52|Withdrawal by Subject|0
2229267|NCT01815424|3879218|FG003|Week 16 to 52|Withdrawal by Subject|0
2229268|NCT01815424|3879219|FG004|Week 16 to 52|Withdrawal by Subject|0
2229269|NCT01815736|3879270|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11
2229270|NCT01815736|3879271|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17
2229271|NCT01815736|3879270|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10
2229272|NCT01815736|3879271|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9
2229273|NCT01815736|3879270|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11
2229274|NCT01815736|3879271|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2
2229275|NCT01815736|3879270|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7
2229276|NCT01815736|3879271|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4
2229277|NCT01815736|3879270|FG000|Randomized Treatment Phase-Up to Week 96|Death|4
2229278|NCT01815736|3879271|FG001|Randomized Treatment Phase-Up to Week 96|Death|0
2229279|NCT01815736|3879270|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1
2229280|NCT01815736|3879271|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0
2229281|NCT01815736|3879270|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1
2229282|NCT01815736|3879271|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0
2229283|NCT01815736|3879270|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4
2229284|NCT01815736|3879271|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3
2229285|NCT01815736|3879270|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31
2229286|NCT01815736|3879271|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15
2229287|NCT01815736|3879270|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13
2229288|NCT01815736|3879271|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9
2229289|NCT01815736|3879270|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5
2229290|NCT01815736|3879271|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1
2229291|NCT01815736|3879270|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1
2229292|NCT01815736|3879271|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1
2229293|NCT01815736|3879270|FG000|Extension Treatment Phase- After Week 96|Death|1
2229294|NCT01815736|3879271|FG001|Extension Treatment Phase- After Week 96|Death|0
2229295|NCT01815840|3879281|FG000|Overall Study|Missing|1
2229296|NCT01815840|3879282|FG001|Overall Study|Missing|0
2229297|NCT01815840|3879281|FG000|Overall Study|Withdrew Consent|31
2229298|NCT01815840|3879282|FG001|Overall Study|Withdrew Consent|30
2229299|NCT01815840|3879281|FG000|Overall Study|Administrative/Other|1
2229300|NCT01815840|3879282|FG001|Overall Study|Administrative/Other|3
2229301|NCT01815840|3879281|FG000|Overall Study|Adverse Event|10
2229302|NCT01815840|3879282|FG001|Overall Study|Adverse Event|16
2229303|NCT01815840|3879281|FG000|Overall Study|Death|2
2229304|NCT01815840|3879282|FG001|Overall Study|Death|2
2229305|NCT01815840|3879281|FG000|Overall Study|Disease progression|3
2229306|NCT01815840|3879282|FG001|Overall Study|Disease progression|2
2229307|NCT01815840|3879281|FG000|Overall Study|Investigators Decision|2
2229308|NCT01815840|3879282|FG001|Overall Study|Investigators Decision|3
2229309|NCT01815840|3879281|FG000|Overall Study|Lost to Follow-up|3
2229310|NCT01815840|3879282|FG001|Overall Study|Lost to Follow-up|6
2229311|NCT01815840|3879281|FG000|Overall Study|Refused Treatment|5
2229312|NCT01815840|3879282|FG001|Overall Study|Refused Treatment|1
2229313|NCT01815840|3879281|FG000|Overall Study|Sponsor Termination Treatment|1
2229314|NCT01815840|3879282|FG001|Overall Study|Sponsor Termination Treatment|0
2229315|NCT01815918|3879290|FG000|Overall Study|Patient samples not analyzable|3
2229316|NCT01815918|3879291|FG001|Overall Study|Patient samples not analyzable|4
2229317|NCT01815918|3879290|FG000|Overall Study|Lack of Efficacy|15
2229318|NCT01815918|3879291|FG001|Overall Study|Lack of Efficacy|15
2229319|NCT01816048|3879301|FG000|Overall Study|Adverse Event|1
2229320|NCT01816048|3879301|FG000|Overall Study|Death|1
2229321|NCT01816048|3879301|FG000|Overall Study|Withdrawal by Subject|1
2229322|NCT01816048|3879301|FG000|Overall Study|Disease Progression|3
2229323|NCT01816061|3879308|FG000|Overall Study|Lost to Follow-up|13
2229324|NCT01816061|3879309|FG001|Overall Study|Lost to Follow-up|24
2229325|NCT01816074|3879319|FG000|Phase 1|Time commitment issues|0
2229326|NCT01816074|3879320|FG001|Phase 1|Time commitment issues|0
2229327|NCT01816074|3879321|FG002|Phase 1|Time commitment issues|1
2229328|NCT01816074|3879322|FG003|Phase 1|Time commitment issues|0
2229329|NCT01816074|3879319|FG000|Phase 2|Time commitment Issues|0
2229330|NCT01816074|3879320|FG001|Phase 2|Time commitment Issues|2
2229331|NCT01816074|3879321|FG002|Phase 2|Time commitment Issues|0
2229332|NCT01816074|3879322|FG003|Phase 2|Time commitment Issues|0
2229333|NCT01816074|3879319|FG000|Phase 2|Unsatisfied with Randomization assignmen|1
2229334|NCT01816074|3879320|FG001|Phase 2|Unsatisfied with Randomization assignmen|0
2229335|NCT01816074|3879321|FG002|Phase 2|Unsatisfied with Randomization assignmen|0
2229336|NCT01816074|3879322|FG003|Phase 2|Unsatisfied with Randomization assignmen|0
2229337|NCT01816074|3879319|FG000|Phase 2|Physician Decision|0
2229338|NCT01816074|3879320|FG001|Phase 2|Physician Decision|0
2229339|NCT01816074|3879321|FG002|Phase 2|Physician Decision|0
2229340|NCT01816074|3879322|FG003|Phase 2|Physician Decision|1
2229341|NCT01816074|3879319|FG000|Phase 2|Withdrawal by Subject|1
2229342|NCT01816074|3879320|FG001|Phase 2|Withdrawal by Subject|0
2229343|NCT01816074|3879321|FG002|Phase 2|Withdrawal by Subject|0
2229344|NCT01816074|3879322|FG003|Phase 2|Withdrawal by Subject|0
2229345|NCT01816243|3879350|FG000|Overall Study|Adverse Event|6
2229346|NCT01816243|3879350|FG000|Overall Study|Lost to Follow-up|1
2229347|NCT01816243|3879350|FG000|Overall Study|Lack of Efficacy|1
2229348|NCT01816243|3879350|FG000|Overall Study|Not eligible for the study|1
2229349|NCT01816243|3879350|FG000|Overall Study|Amputation|3
2229350|NCT01816295|3879356|FG000|Double Blind Phase|Adverse Event|11
2229351|NCT01816295|3879357|FG001|Double Blind Phase|Adverse Event|8
2229352|NCT01816295|3879356|FG000|Double Blind Phase|Entry Criteria Not Met|0
2229353|NCT01816295|3879357|FG001|Double Blind Phase|Entry Criteria Not Met|2
2229354|NCT01816295|3879356|FG000|Double Blind Phase|Lost to Follow-up|3
2229355|NCT01816295|3879357|FG001|Double Blind Phase|Lost to Follow-up|5
2229356|NCT01816295|3879356|FG000|Double Blind Phase|Physician Decision|2
2229357|NCT01816295|3879357|FG001|Double Blind Phase|Physician Decision|2
2229358|NCT01816295|3879356|FG000|Double Blind Phase|Protocol Violation|17
2229359|NCT01816295|3879357|FG001|Double Blind Phase|Protocol Violation|11
2229360|NCT01816295|3879356|FG000|Double Blind Phase|Sponsor Decision|8
2229361|NCT01816295|3879357|FG001|Double Blind Phase|Sponsor Decision|8
2229362|NCT01816295|3879356|FG000|Double Blind Phase|Withdrawal by Subject|22
2229363|NCT01816295|3879357|FG001|Double Blind Phase|Withdrawal by Subject|20
2229364|NCT01816295|3879356|FG000|OLE Phase|Adverse Event|17
2229365|NCT01816295|3879357|FG001|OLE Phase|Adverse Event|15
2229366|NCT01816295|3879356|FG000|OLE Phase|Death|1
2229367|NCT01816295|3879357|FG001|OLE Phase|Death|0
2229368|NCT01816295|3879356|FG000|OLE Phase|Entry Criteria Not Met|3
2229369|NCT01816295|3879357|FG001|OLE Phase|Entry Criteria Not Met|5
2229370|NCT01816295|3879356|FG000|OLE Phase|Lost to Follow-up|5
2229371|NCT01816295|3879357|FG001|OLE Phase|Lost to Follow-up|5
2229372|NCT01816295|3879356|FG000|OLE Phase|Physician Decision|3
2229373|NCT01816295|3879357|FG001|OLE Phase|Physician Decision|1
2229374|NCT01816295|3879356|FG000|OLE Phase|Protocol Violation|4
2229375|NCT01816295|3879357|FG001|OLE Phase|Protocol Violation|4
2229376|NCT01816295|3879356|FG000|OLE Phase|Sponsor Decision|7
2229377|NCT01816295|3879357|FG001|OLE Phase|Sponsor Decision|9
2229378|NCT01816295|3879356|FG000|OLE Phase|Withdrawal by Subject|10
2229379|NCT01816295|3879357|FG001|OLE Phase|Withdrawal by Subject|10
2229380|NCT01816295|3879356|FG000|OLE Phase|Lack of Efficacy|3
2229381|NCT01816295|3879357|FG001|OLE Phase|Lack of Efficacy|7
2229382|NCT01816477|3879381|FG000|Overall Study|Withdrawal by Subject|13
2229383|NCT01816477|3879382|FG001|Overall Study|Withdrawal by Subject|1
2229384|NCT01816477|3879381|FG000|Overall Study|Unable to tolerate catheter placement|3
2229385|NCT01816477|3879382|FG001|Overall Study|Unable to tolerate catheter placement|0
2229386|NCT01816594|3879390|FG000|Overall Study|Local Progress|0
2229387|NCT01816594|3879391|FG001|Overall Study|Local Progress|2
2229388|NCT01816594|3879390|FG000|Overall Study|Adverse Event|9
2229389|NCT01816594|3879391|FG001|Overall Study|Adverse Event|0
2229390|NCT01816594|3879390|FG000|Overall Study|Withdrawal by Subject|1
2229391|NCT01816594|3879391|FG001|Overall Study|Withdrawal by Subject|0
2332628|NCT03201419|4056470|FG000|Overall Study|Adverse Event|3
2332629|NCT03201419|4056471|FG001|Overall Study|Adverse Event|1
2332630|NCT03201419|4056472|FG002|Overall Study|Adverse Event|0
2332631|NCT03201419|4056473|FG003|Overall Study|Adverse Event|0
2332632|NCT03201419|4056474|FG004|Overall Study|Adverse Event|1
2332633|NCT03201419|4056475|FG005|Overall Study|Adverse Event|1
2332634|NCT03201419|4056476|FG006|Overall Study|Adverse Event|5
2332635|NCT03201419|4056477|FG007|Overall Study|Adverse Event|0
2332636|NCT03201419|4056478|FG008|Overall Study|Adverse Event|0
2332637|NCT03201419|4056470|FG000|Overall Study|Lost to Follow-up|1
2332638|NCT03201419|4056471|FG001|Overall Study|Lost to Follow-up|0
2332639|NCT03201419|4056472|FG002|Overall Study|Lost to Follow-up|0
2332640|NCT03201419|4056473|FG003|Overall Study|Lost to Follow-up|0
2332641|NCT03201419|4056474|FG004|Overall Study|Lost to Follow-up|0
2332642|NCT03201419|4056475|FG005|Overall Study|Lost to Follow-up|0
2332643|NCT03201419|4056476|FG006|Overall Study|Lost to Follow-up|0
2332644|NCT03201419|4056477|FG007|Overall Study|Lost to Follow-up|0
2332645|NCT03201419|4056478|FG008|Overall Study|Lost to Follow-up|0
2332646|NCT03201419|4056470|FG000|Overall Study|Protocol Deviation|0
2332647|NCT03201419|4056471|FG001|Overall Study|Protocol Deviation|0
2332648|NCT03201419|4056472|FG002|Overall Study|Protocol Deviation|0
2332649|NCT03201419|4056473|FG003|Overall Study|Protocol Deviation|0
2332650|NCT03201419|4056474|FG004|Overall Study|Protocol Deviation|0
2332651|NCT03201419|4056475|FG005|Overall Study|Protocol Deviation|0
2332652|NCT03201419|4056476|FG006|Overall Study|Protocol Deviation|1
2332653|NCT03201419|4056477|FG007|Overall Study|Protocol Deviation|0
2332654|NCT03201419|4056478|FG008|Overall Study|Protocol Deviation|0
2332655|NCT03201419|4056470|FG000|Overall Study|Withdrawal by Subject|4
2332656|NCT03201419|4056471|FG001|Overall Study|Withdrawal by Subject|2
2332657|NCT03201419|4056472|FG002|Overall Study|Withdrawal by Subject|1
2332658|NCT03201419|4056473|FG003|Overall Study|Withdrawal by Subject|0
2332659|NCT03201419|4056474|FG004|Overall Study|Withdrawal by Subject|0
2332660|NCT03201419|4056475|FG005|Overall Study|Withdrawal by Subject|0
2332661|NCT03201419|4056476|FG006|Overall Study|Withdrawal by Subject|0
2332662|NCT03201419|4056477|FG007|Overall Study|Withdrawal by Subject|1
2332663|NCT03201419|4056478|FG008|Overall Study|Withdrawal by Subject|2
2332664|NCT03201419|4056470|FG000|Overall Study|Other|0
2332665|NCT03201419|4056471|FG001|Overall Study|Other|0
2332666|NCT03201419|4056472|FG002|Overall Study|Other|1
2332667|NCT03201419|4056473|FG003|Overall Study|Other|0
2332668|NCT03201419|4056474|FG004|Overall Study|Other|0
2332669|NCT03201419|4056475|FG005|Overall Study|Other|0
2332670|NCT03201419|4056476|FG006|Overall Study|Other|0
2332671|NCT03201419|4056477|FG007|Overall Study|Other|0
2332672|NCT03201419|4056478|FG008|Overall Study|Other|0
2332673|NCT03201562|4056515|FG000|Overall Study|Physician Decision|0
2332674|NCT03201562|4056516|FG001|Overall Study|Physician Decision|0
2332675|NCT03201562|4056517|FG002|Overall Study|Physician Decision|1
2332676|NCT03201562|4056515|FG000|Overall Study|Adverse Event|0
2332677|NCT03201562|4056516|FG001|Overall Study|Adverse Event|0
2332678|NCT03201562|4056517|FG002|Overall Study|Adverse Event|1
2332679|NCT03201562|4056515|FG000|Overall Study|Lost to Follow-up|0
2332680|NCT03201562|4056516|FG001|Overall Study|Lost to Follow-up|1
2332681|NCT03201562|4056517|FG002|Overall Study|Lost to Follow-up|2
2332682|NCT03201809|4056527|FG000|Overall Study|Lost to Follow-up|2
2332683|NCT03201809|4056528|FG001|Overall Study|Lost to Follow-up|0
2332684|NCT03201900|4056534|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
2332685|NCT03201900|4056534|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
2332686|NCT03201900|4056534|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
2332687|NCT03201900|4056534|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
2332688|NCT03201900|4056534|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
2332689|NCT03201900|4056534|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11
2332690|NCT03201900|4056534|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2
2332691|NCT03201900|4056534|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1
2332692|NCT03201900|4056534|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1
2332693|NCT03201900|4056534|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1
2332694|NCT03201900|4056534|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1
2332695|NCT03201900|4056534|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3
2332696|NCT03201900|4056534|FG000|Extension Phase (From Week 63 to 156)|Other|1
2332697|NCT03202511|4056557|FG000|Overall Study|Withdrawal by Subject|1
2332698|NCT03202511|4056558|FG001|Overall Study|Withdrawal by Subject|0
2332699|NCT03203291|4056573|FG000|Overall Study|Withdrawal by Subject|1
2332700|NCT03203447|4056579|FG000|Overall Study|Withdrawal by Subject|2
2332701|NCT03203447|4056580|FG001|Overall Study|Withdrawal by Subject|1
2332702|NCT03203447|4056579|FG000|Overall Study|Lost to Follow-up|1
2332703|NCT03203447|4056580|FG001|Overall Study|Lost to Follow-up|10
2332704|NCT03203447|4056579|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159
2332705|NCT03203447|4056580|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152
2332706|NCT03204279|4056609|FG000|Overall Study|Withdrawal by Subject|0
2332707|NCT03204279|4056610|FG001|Overall Study|Withdrawal by Subject|1
2332708|NCT03204981|4056648|FG000|Overall Study|Physician Decision|2
2332709|NCT03204981|4056648|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4
2229392|NCT01816594|3879390|FG000|Overall Study|Physician Decision|1
2229393|NCT01816594|3879391|FG001|Overall Study|Physician Decision|0
2229394|NCT01816685|3879405|FG000|Overall Study|Lost to Follow-up|7
2229395|NCT01816685|3879406|FG001|Overall Study|Lost to Follow-up|9
2229396|NCT01816685|3879405|FG000|Overall Study|Surgery Cancelled|3
2229397|NCT01816685|3879406|FG001|Overall Study|Surgery Cancelled|2
2229398|NCT01816763|3879424|FG000|Overall Study|The main reason for an incomplete survey|4
2229399|NCT01816763|3879425|FG001|Overall Study|The main reason for an incomplete survey|15
2229400|NCT01816763|3879426|FG002|Overall Study|The main reason for an incomplete survey|11
2229401|NCT01816893|3879448|FG000|Washout Period|Withdrawal by Subject|2
2229402|NCT01816893|3879449|FG001|Washout Period|Withdrawal by Subject|0
2229403|NCT01816906|3879457|FG000|Six Months|Did Not Show Up for Baseline Measurement|7
2229404|NCT01816906|3879458|FG001|Six Months|Did Not Show Up for Baseline Measurement|6
2229405|NCT01816906|3879457|FG000|Six Months|Lost to Follow-up|14
2229406|NCT01816906|3879458|FG001|Six Months|Lost to Follow-up|16
2229407|NCT01816906|3879457|FG000|12 Months|Adverse Event|2
2229408|NCT01816906|3879458|FG001|12 Months|Adverse Event|2
2229409|NCT01816906|3879457|FG000|12 Months|Death|0
2229410|NCT01816906|3879458|FG001|12 Months|Death|2
2229411|NCT01816906|3879457|FG000|12 Months|Lost to Follow-up|2
2229412|NCT01816906|3879458|FG001|12 Months|Lost to Follow-up|1
2229413|NCT01816984|3879474|FG000|Overall Study|declining health status|1
2229414|NCT01817075|3879480|FG000|Overall Study|Adverse Event|7
2229415|NCT01817075|3879481|FG001|Overall Study|Adverse Event|5
2229416|NCT01817075|3879480|FG000|Overall Study|Physician Decision|9
2229417|NCT01817075|3879481|FG001|Overall Study|Physician Decision|12
2229418|NCT01817075|3879480|FG000|Overall Study|Withdrawal by Subject|31
2229419|NCT01817075|3879481|FG001|Overall Study|Withdrawal by Subject|15
2229420|NCT01817075|3879480|FG000|Overall Study|Received Sorafenib after enrollment|0
2229421|NCT01817075|3879481|FG001|Overall Study|Received Sorafenib after enrollment|1
2229422|NCT01817075|3879480|FG000|Overall Study|Ineligible|0
2229423|NCT01817075|3879481|FG001|Overall Study|Ineligible|2
2229424|NCT01817530|3879511|FG000|Overall Study|Exclusionary Medication Received|0
2229425|NCT01817530|3879512|FG001|Overall Study|Exclusionary Medication Received|0
2229426|NCT01817530|3879513|FG002|Overall Study|Exclusionary Medication Received|0
2229427|NCT01817530|3879514|FG003|Overall Study|Exclusionary Medication Received|0
2229428|NCT01817530|3879515|FG004|Overall Study|Exclusionary Medication Received|1
2229429|NCT01817530|3879516|FG005|Overall Study|Exclusionary Medication Received|0
2229430|NCT01817530|3879517|FG006|Overall Study|Exclusionary Medication Received|0
2229431|NCT01817530|3879518|FG007|Overall Study|Exclusionary Medication Received|0
2229432|NCT01817530|3879511|FG000|Overall Study|Adverse Event|6
2229433|NCT01817530|3879512|FG001|Overall Study|Adverse Event|3
2229434|NCT01817530|3879513|FG002|Overall Study|Adverse Event|2
2229435|NCT01817530|3879514|FG003|Overall Study|Adverse Event|5
2229436|NCT01817530|3879515|FG004|Overall Study|Adverse Event|0
2229437|NCT01817530|3879516|FG005|Overall Study|Adverse Event|10
2229438|NCT01817530|3879517|FG006|Overall Study|Adverse Event|5
2229439|NCT01817530|3879518|FG007|Overall Study|Adverse Event|8
2229440|NCT01817530|3879511|FG000|Overall Study|Subject Noncompliant|3
2229441|NCT01817530|3879512|FG001|Overall Study|Subject Noncompliant|1
2229442|NCT01817530|3879513|FG002|Overall Study|Subject Noncompliant|0
2229443|NCT01817530|3879514|FG003|Overall Study|Subject Noncompliant|4
2229444|NCT01817530|3879515|FG004|Overall Study|Subject Noncompliant|0
2229445|NCT01817530|3879516|FG005|Overall Study|Subject Noncompliant|1
2229446|NCT01817530|3879517|FG006|Overall Study|Subject Noncompliant|1
2229447|NCT01817530|3879518|FG007|Overall Study|Subject Noncompliant|1
2229448|NCT01817530|3879511|FG000|Overall Study|Lack of Efficacy|1
2229449|NCT01817530|3879512|FG001|Overall Study|Lack of Efficacy|0
2229450|NCT01817530|3879513|FG002|Overall Study|Lack of Efficacy|0
2229451|NCT01817530|3879514|FG003|Overall Study|Lack of Efficacy|0
2229452|NCT01817530|3879515|FG004|Overall Study|Lack of Efficacy|0
2229453|NCT01817530|3879516|FG005|Overall Study|Lack of Efficacy|1
2229454|NCT01817530|3879517|FG006|Overall Study|Lack of Efficacy|0
2229455|NCT01817530|3879518|FG007|Overall Study|Lack of Efficacy|1
2229456|NCT01817530|3879511|FG000|Overall Study|Pregnancy|0
2229457|NCT01817530|3879512|FG001|Overall Study|Pregnancy|0
2229458|NCT01817530|3879513|FG002|Overall Study|Pregnancy|0
2229459|NCT01817530|3879514|FG003|Overall Study|Pregnancy|0
2229460|NCT01817530|3879515|FG004|Overall Study|Pregnancy|0
2229461|NCT01817530|3879516|FG005|Overall Study|Pregnancy|1
2229462|NCT01817530|3879517|FG006|Overall Study|Pregnancy|0
2229463|NCT01817530|3879518|FG007|Overall Study|Pregnancy|0
2229464|NCT01817530|3879511|FG000|Overall Study|Other|0
2229465|NCT01817530|3879512|FG001|Overall Study|Other|1
2229466|NCT01817530|3879513|FG002|Overall Study|Other|0
2332710|NCT03205046|4056656|FG000|Overall Study|Death|10
2332711|NCT03205046|4056657|FG001|Overall Study|Death|6
2332712|NCT03205046|4056656|FG000|Overall Study|Withdrawal by Subject|1
2332713|NCT03205046|4056657|FG001|Overall Study|Withdrawal by Subject|2
2332714|NCT03205046|4056656|FG000|Overall Study|Lost to Follow-up|0
2229467|NCT01817530|3879514|FG003|Overall Study|Other|0
2229468|NCT01817530|3879515|FG004|Overall Study|Other|1
2229469|NCT01817530|3879516|FG005|Overall Study|Other|0
2229470|NCT01817530|3879517|FG006|Overall Study|Other|5
2229471|NCT01817530|3879518|FG007|Overall Study|Other|0
2229472|NCT01817530|3879511|FG000|Overall Study|Surgery or Invasive Intervention|1
2229473|NCT01817530|3879512|FG001|Overall Study|Surgery or Invasive Intervention|0
2229474|NCT01817530|3879513|FG002|Overall Study|Surgery or Invasive Intervention|0
2229475|NCT01817530|3879514|FG003|Overall Study|Surgery or Invasive Intervention|0
2229476|NCT01817530|3879515|FG004|Overall Study|Surgery or Invasive Intervention|1
2229477|NCT01817530|3879516|FG005|Overall Study|Surgery or Invasive Intervention|1
2229478|NCT01817530|3879517|FG006|Overall Study|Surgery or Invasive Intervention|1
2229479|NCT01817530|3879518|FG007|Overall Study|Surgery or Invasive Intervention|0
2229480|NCT01817530|3879511|FG000|Overall Study|Consent Withdrawn by Subject|3
2229481|NCT01817530|3879512|FG001|Overall Study|Consent Withdrawn by Subject|4
2229482|NCT01817530|3879513|FG002|Overall Study|Consent Withdrawn by Subject|7
2229483|NCT01817530|3879514|FG003|Overall Study|Consent Withdrawn by Subject|3
2229484|NCT01817530|3879515|FG004|Overall Study|Consent Withdrawn by Subject|5
2229485|NCT01817530|3879516|FG005|Overall Study|Consent Withdrawn by Subject|3
2229486|NCT01817530|3879517|FG006|Overall Study|Consent Withdrawn by Subject|3
2229487|NCT01817530|3879518|FG007|Overall Study|Consent Withdrawn by Subject|10
2229488|NCT01817530|3879511|FG000|Overall Study|Lost to Follow-up|1
2229489|NCT01817530|3879512|FG001|Overall Study|Lost to Follow-up|4
2229490|NCT01817530|3879513|FG002|Overall Study|Lost to Follow-up|2
2229491|NCT01817530|3879514|FG003|Overall Study|Lost to Follow-up|1
2229492|NCT01817530|3879515|FG004|Overall Study|Lost to Follow-up|3
2229493|NCT01817530|3879516|FG005|Overall Study|Lost to Follow-up|2
2229494|NCT01817530|3879517|FG006|Overall Study|Lost to Follow-up|8
2229495|NCT01817530|3879518|FG007|Overall Study|Lost to Follow-up|4
2229496|NCT01817582|3879539|FG000|Overall Study|Withdrawal by Subject|0
2229497|NCT01817582|3879540|FG001|Overall Study|Withdrawal by Subject|1
2229498|NCT01817582|3879541|FG002|Overall Study|Withdrawal by Subject|0
2229499|NCT01817582|3879539|FG000|Overall Study|Participant revealed masked treatment|1
2229500|NCT01817582|3879540|FG001|Overall Study|Participant revealed masked treatment|0
2229501|NCT01817582|3879541|FG002|Overall Study|Participant revealed masked treatment|0
2229502|NCT01817582|3879539|FG000|Overall Study|Randomized but exclusion criteria met|1
2229503|NCT01817582|3879540|FG001|Overall Study|Randomized but exclusion criteria met|0
2229504|NCT01817582|3879541|FG002|Overall Study|Randomized but exclusion criteria met|0
2229505|NCT01817725|3879558|FG000|Overall Study|Withdrawal by Subject|1
2229506|NCT01817751|3879562|FG000|Overall Study|Physician Decision|1
2229507|NCT01817764|3879568|FG000|Overall Study|Adverse Event|7
2229508|NCT01817764|3879569|FG001|Overall Study|Adverse Event|10
2229509|NCT01817764|3879568|FG000|Overall Study|Lack of Efficacy|9
2229510|NCT01817764|3879569|FG001|Overall Study|Lack of Efficacy|7
2229511|NCT01817764|3879568|FG000|Overall Study|Protocol Violation|7
2229512|NCT01817764|3879569|FG001|Overall Study|Protocol Violation|5
2229513|NCT01817764|3879568|FG000|Overall Study|Lost to Follow-up|1
2229514|NCT01817764|3879569|FG001|Overall Study|Lost to Follow-up|4
2229515|NCT01817764|3879568|FG000|Overall Study|Withdrawal by Subject|10
2229516|NCT01817764|3879569|FG001|Overall Study|Withdrawal by Subject|12
2229517|NCT01817777|3879577|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3
2229518|NCT01817777|3879578|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0
2229519|NCT01817777|3879579|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0
2229520|NCT01817777|3879577|FG000|Observational Phase (8 Weeks)|Early Study Termination|2
2229521|NCT01817777|3879578|FG001|Observational Phase (8 Weeks)|Early Study Termination|0
2229522|NCT01817777|3879579|FG002|Observational Phase (8 Weeks)|Early Study Termination|0
2229523|NCT01817777|3879577|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
2229524|NCT01817777|3879578|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
2229525|NCT01817777|3879579|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
2229526|NCT01817777|3879577|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0
2229527|NCT01817777|3879578|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1
2229528|NCT01817777|3879579|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2
2229529|NCT01817777|3879577|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0
2229530|NCT01817777|3879578|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1
2229531|NCT01817777|3879579|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3
2229532|NCT01817790|3879587|FG000|Overall Study|Adverse Event|0
2229533|NCT01817790|3879588|FG001|Overall Study|Adverse Event|2
2229534|NCT01817790|3879587|FG000|Overall Study|Lost to Follow-up|0
2229535|NCT01817790|3879588|FG001|Overall Study|Lost to Follow-up|1
2229536|NCT01817790|3879587|FG000|Overall Study|Protocol Violation|2
2229537|NCT01817790|3879588|FG001|Overall Study|Protocol Violation|1
2229538|NCT01817790|3879587|FG000|Overall Study|Withdrawal by Subject|1
2229539|NCT01817790|3879588|FG001|Overall Study|Withdrawal by Subject|3
2229540|NCT01817790|3879587|FG000|Overall Study|Other: Could not attend appointment|1
2229541|NCT01817790|3879588|FG001|Overall Study|Other: Could not attend appointment|1
2229542|NCT01817959|3879630|FG000|Overall Study|Graft loss|1
2229543|NCT01817959|3879631|FG001|Overall Study|Graft loss|1
2229544|NCT01817959|3879630|FG000|Overall Study|forbidden medication|1
2229545|NCT01817959|3879631|FG001|Overall Study|forbidden medication|1
2229546|NCT01817959|3879630|FG000|Overall Study|Adverse Event|1
2229547|NCT01817959|3879631|FG001|Overall Study|Adverse Event|0
2229548|NCT01817959|3879630|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1
2229549|NCT01817959|3879631|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1
2274289|NCT02294474|3955171|FG000|Overall Study|Lack of Efficacy|2
2229550|NCT01818141|3879648|FG000|Overall Study|Withdrawal by Subject|2
2229551|NCT01818141|3879649|FG001|Overall Study|Withdrawal by Subject|0
2229552|NCT01818141|3879648|FG000|Overall Study|No baseline C.diff colonies|1
2229553|NCT01818141|3879649|FG001|Overall Study|No baseline C.diff colonies|1
2229554|NCT01818141|3879648|FG000|Overall Study|Lost to Follow-up|0
2229555|NCT01818141|3879649|FG001|Overall Study|Lost to Follow-up|2
2229556|NCT01818258|3879671|FG000|Overall Study|Death|3
2229557|NCT01818258|3879672|FG001|Overall Study|Death|0
2229558|NCT01818258|3879671|FG000|Overall Study|Withdrawal by Subject|0
2229559|NCT01818258|3879672|FG001|Overall Study|Withdrawal by Subject|1
2229560|NCT01818258|3879671|FG000|Overall Study|Lost to Follow-up|0
2229561|NCT01818258|3879672|FG001|Overall Study|Lost to Follow-up|1
2229562|NCT01818258|3879671|FG000|Overall Study|Unable to Travel to Clinic|0
2229563|NCT01818258|3879672|FG001|Overall Study|Unable to Travel to Clinic|1
2229564|NCT01818284|3879681|FG000|Overall Study|Not eligible due to White Blood Counts|4
2229565|NCT01818284|3879682|FG001|Overall Study|Not eligible due to White Blood Counts|4
2229566|NCT01818284|3879681|FG000|Overall Study|Death|0
2229567|NCT01818284|3879682|FG001|Overall Study|Death|2
2229568|NCT01818297|3879689|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
2229569|NCT01818297|3879690|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
2229570|NCT01818297|3879689|FG000|Open Label Phase (3-12 Months)|Physician Decision|1
2229571|NCT01818297|3879690|FG001|Open Label Phase (3-12 Months)|Physician Decision|0
2229572|NCT01818297|3879689|FG000|Open Label Phase (3-12 Months)|Early study closure|17
2229573|NCT01818297|3879690|FG001|Open Label Phase (3-12 Months)|Early study closure|10
2229574|NCT01818336|3879696|FG000|Overall Study|Declined retest visit|0
2229575|NCT01818336|3879697|FG001|Overall Study|Declined retest visit|11
2229576|NCT01818336|3879696|FG000|Overall Study|Lost to Follow-up|0
2229577|NCT01818336|3879697|FG001|Overall Study|Lost to Follow-up|1
2229578|NCT01818492|3879723|FG000|Overall Study|Adverse Event|2
2229579|NCT01818492|3879723|FG000|Overall Study|Death|3
2229580|NCT01818492|3879723|FG000|Overall Study|Withdrawal by Subject|1
2229581|NCT01818492|3879723|FG000|Overall Study|Additional therapy when not allowed PP|4
2229582|NCT01818531|3879755|FG000|Overall Study|Withdrawn for case delay after block|1
2229583|NCT01818531|3879756|FG001|Overall Study|Withdrawn for case delay after block|0
2229584|NCT01818531|3879755|FG000|Overall Study|Withdrawn for long-acting opioid patch|0
2229585|NCT01818531|3879756|FG001|Overall Study|Withdrawn for long-acting opioid patch|1
2229586|NCT01818531|3879755|FG000|Overall Study|Withdrawn for failure to place block|0
2229587|NCT01818531|3879756|FG001|Overall Study|Withdrawn for failure to place block|1
2229588|NCT01818596|3879764|FG000|Overall Study|Enrolled but Not Treated|4
2229589|NCT01818596|3879765|FG001|Overall Study|Enrolled but Not Treated|0
2229590|NCT01818596|3879764|FG000|Overall Study|Adverse Event|7
2229591|NCT01818596|3879765|FG001|Overall Study|Adverse Event|0
2229592|NCT01818596|3879764|FG000|Overall Study|Death|3
2229593|NCT01818596|3879765|FG001|Overall Study|Death|0
2229594|NCT01818596|3879764|FG000|Overall Study|Investigator's Discretion|4
2229595|NCT01818596|3879765|FG001|Overall Study|Investigator's Discretion|0
2229596|NCT01818596|3879764|FG000|Overall Study|Protocol Violation|1
2229597|NCT01818596|3879765|FG001|Overall Study|Protocol Violation|0
2229598|NCT01818596|3879764|FG000|Overall Study|Withdrew Consent|5
2229599|NCT01818596|3879765|FG001|Overall Study|Withdrew Consent|0
2229600|NCT01818596|3879764|FG000|Overall Study|Lost to Follow-up|7
2229601|NCT01818596|3879765|FG001|Overall Study|Lost to Follow-up|0
2229602|NCT01818700|3879772|FG000|Overall Study|Adverse Event|67
2229603|NCT01818700|3879772|FG000|Overall Study|Lack of Efficacy|2
2229604|NCT01818700|3879772|FG000|Overall Study|Lost to Follow-up|5
2229605|NCT01818700|3879772|FG000|Overall Study|Withdrawal by Subject|27
2229606|NCT01818700|3879772|FG000|Overall Study|Protocol Violation|2
2229607|NCT01818700|3879772|FG000|Overall Study|Other|1
2229608|NCT01818726|3879780|FG000|Overall Study|Administrative reasons|5
2229609|NCT01818726|3879781|FG001|Overall Study|Administrative reasons|1
2229610|NCT01818726|3879780|FG000|Overall Study|Withdrawal by Subject|0
2229611|NCT01818726|3879781|FG001|Overall Study|Withdrawal by Subject|1
2229612|NCT01818726|3879780|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1
2229613|NCT01818726|3879781|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0
2229614|NCT01818752|3879794|FG000|Overall Study|Adverse Event|64
2229615|NCT01818752|3879795|FG001|Overall Study|Adverse Event|74
2229616|NCT01818752|3879794|FG000|Overall Study|Death|14
2229617|NCT01818752|3879795|FG001|Overall Study|Death|18
2229618|NCT01818752|3879794|FG000|Overall Study|Non-compliance|16
2229619|NCT01818752|3879795|FG001|Overall Study|Non-compliance|20
2229620|NCT01818752|3879794|FG000|Overall Study|Withdrawal by Subject|15
2229621|NCT01818752|3879795|FG001|Overall Study|Withdrawal by Subject|14
2229622|NCT01818752|3879794|FG000|Overall Study|Physician Decision|9
2229623|NCT01818752|3879795|FG001|Overall Study|Physician Decision|8
2229624|NCT01818752|3879794|FG000|Overall Study|Disease Progression|54
2229625|NCT01818752|3879795|FG001|Overall Study|Disease Progression|48
2229626|NCT01818752|3879794|FG000|Overall Study|Other|7
2229627|NCT01818752|3879795|FG001|Overall Study|Other|8
2229628|NCT01818752|3879794|FG000|Overall Study|Continuing Treatment|1
2229629|NCT01818752|3879795|FG001|Overall Study|Continuing Treatment|4
2229630|NCT01818752|3879794|FG000|Overall Study|Randomized but not Dosed|7
2229631|NCT01818752|3879795|FG001|Overall Study|Randomized but not Dosed|4
2229632|NCT01818765|3879801|FG000|Overall Study|Death|2
2229633|NCT01819129|3879817|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
2229634|NCT01819129|3879818|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
2229635|NCT01819129|3879817|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1
2229636|NCT01819129|3879818|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0
2229637|NCT01819129|3879817|FG000|Overall Study|Other, Subject moved out of the country|0
2229638|NCT01819129|3879818|FG001|Overall Study|Other, Subject moved out of the country|1
2229639|NCT01819129|3879817|FG000|Overall Study|Withdrawal by Subject|15
2229640|NCT01819129|3879818|FG001|Overall Study|Withdrawal by Subject|15
2229641|NCT01819129|3879817|FG000|Overall Study|Lost to Follow-up|5
2229642|NCT01819129|3879818|FG001|Overall Study|Lost to Follow-up|2
2229643|NCT01819129|3879817|FG000|Overall Study|Lack of Efficacy|0
2229644|NCT01819129|3879818|FG001|Overall Study|Lack of Efficacy|1
2229645|NCT01819129|3879817|FG000|Overall Study|Adverse Event|1
2229646|NCT01819129|3879818|FG001|Overall Study|Adverse Event|4
2229647|NCT01819129|3879817|FG000|Overall Study|Death|1
2229648|NCT01819129|3879818|FG001|Overall Study|Death|1
2229649|NCT01819129|3879817|FG000|Overall Study|Withdrawal Criteria|20
2229650|NCT01819129|3879818|FG001|Overall Study|Withdrawal Criteria|15
2229651|NCT01819194|3879824|FG000|Overall Study|Loss of study articles|2
2229652|NCT01819272|3879838|FG000|Overall Study|Adverse Event|1
2229653|NCT01819272|3879839|FG001|Overall Study|Adverse Event|0
2229654|NCT01819272|3879840|FG002|Overall Study|Adverse Event|0
2229655|NCT01819272|3879841|FG003|Overall Study|Adverse Event|2
2229656|NCT01819272|3879842|FG004|Overall Study|Adverse Event|0
2229657|NCT01819272|3879843|FG005|Overall Study|Adverse Event|0
2229658|NCT01819272|3879838|FG000|Overall Study|Lost to Follow-up|3
2229659|NCT01819272|3879839|FG001|Overall Study|Lost to Follow-up|0
2229660|NCT01819272|3879840|FG002|Overall Study|Lost to Follow-up|1
2229661|NCT01819272|3879841|FG003|Overall Study|Lost to Follow-up|0
2229662|NCT01819272|3879842|FG004|Overall Study|Lost to Follow-up|0
2229663|NCT01819272|3879843|FG005|Overall Study|Lost to Follow-up|3
2229664|NCT01819272|3879838|FG000|Overall Study|Protocol Violation|0
2229665|NCT01819272|3879839|FG001|Overall Study|Protocol Violation|0
2229666|NCT01819272|3879840|FG002|Overall Study|Protocol Violation|0
2229667|NCT01819272|3879841|FG003|Overall Study|Protocol Violation|1
2229668|NCT01819272|3879842|FG004|Overall Study|Protocol Violation|2
2229669|NCT01819272|3879843|FG005|Overall Study|Protocol Violation|3
2229670|NCT01819272|3879838|FG000|Overall Study|Physician Decision|0
2229671|NCT01819272|3879839|FG001|Overall Study|Physician Decision|1
2229672|NCT01819272|3879840|FG002|Overall Study|Physician Decision|0
2229673|NCT01819272|3879841|FG003|Overall Study|Physician Decision|0
2229674|NCT01819272|3879842|FG004|Overall Study|Physician Decision|0
2229675|NCT01819272|3879843|FG005|Overall Study|Physician Decision|0
2229676|NCT01819272|3879838|FG000|Overall Study|Withdrawal of Consent|0
2229677|NCT01819272|3879839|FG001|Overall Study|Withdrawal of Consent|1
2229678|NCT01819272|3879840|FG002|Overall Study|Withdrawal of Consent|2
2229679|NCT01819272|3879841|FG003|Overall Study|Withdrawal of Consent|1
2229680|NCT01819272|3879842|FG004|Overall Study|Withdrawal of Consent|0
2229681|NCT01819272|3879843|FG005|Overall Study|Withdrawal of Consent|1
2229682|NCT01819272|3879838|FG000|Overall Study|Loss of Glucose Control|2
2229683|NCT01819272|3879839|FG001|Overall Study|Loss of Glucose Control|1
2229684|NCT01819272|3879840|FG002|Overall Study|Loss of Glucose Control|0
2229685|NCT01819272|3879841|FG003|Overall Study|Loss of Glucose Control|1
2229686|NCT01819272|3879842|FG004|Overall Study|Loss of Glucose Control|2
2229687|NCT01819272|3879843|FG005|Overall Study|Loss of Glucose Control|0
2229688|NCT01819506|3879885|FG000|Overall Study|Physician Decision|5
2229689|NCT01819506|3879886|FG001|Overall Study|Physician Decision|2
2229690|NCT01819506|3879885|FG000|Overall Study|Withdrawal by Subject|3
2229691|NCT01819506|3879886|FG001|Overall Study|Withdrawal by Subject|3
2229692|NCT01819727|3879898|FG000|Overall Study|Adverse Event|8
2229693|NCT01819727|3879899|FG001|Overall Study|Adverse Event|9
2229694|NCT01819727|3879898|FG000|Overall Study|Death|1
2229695|NCT01819727|3879899|FG001|Overall Study|Death|0
2229696|NCT01819727|3879898|FG000|Overall Study|Lost to Follow-up|1
2229697|NCT01819727|3879899|FG001|Overall Study|Lost to Follow-up|1
2229698|NCT01819727|3879898|FG000|Overall Study|Physician Decision|3
2229699|NCT01819727|3879899|FG001|Overall Study|Physician Decision|2
2229700|NCT01819727|3879898|FG000|Overall Study|Pregnancy|1
2229701|NCT01819727|3879899|FG001|Overall Study|Pregnancy|0
2229702|NCT01819727|3879898|FG000|Overall Study|Protocol Violation|0
2229703|NCT01819727|3879899|FG001|Overall Study|Protocol Violation|2
2229704|NCT01819727|3879898|FG000|Overall Study|Study Terminated by Sponsor|0
2229705|NCT01819727|3879899|FG001|Overall Study|Study Terminated by Sponsor|1
2229706|NCT01819727|3879898|FG000|Overall Study|Withdrawal by Subject|6
2229707|NCT01819727|3879899|FG001|Overall Study|Withdrawal by Subject|11
2229708|NCT01819727|3879898|FG000|Overall Study|Unable to demostrate ability self-inject|0
2229709|NCT01819727|3879899|FG001|Overall Study|Unable to demostrate ability self-inject|1
2229710|NCT01819727|3879898|FG000|Overall Study|Quit due to lack of health benifits|0
2229711|NCT01819727|3879899|FG001|Overall Study|Quit due to lack of health benifits|1
2229712|NCT01820260|3879948|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229713|NCT01820260|3879949|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229714|NCT01820260|3879950|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2274290|NCT02294474|3955172|FG001|Overall Study|Lack of Efficacy|1
2229715|NCT01820260|3879951|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229716|NCT01820260|3879952|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229717|NCT01820260|3879953|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229718|NCT01820260|3879954|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1
2229719|NCT01820260|3879955|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229720|NCT01820260|3879956|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229721|NCT01820260|3879957|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229722|NCT01820260|3879958|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229723|NCT01820260|3879959|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229724|NCT01820260|3879960|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229725|NCT01820260|3879961|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
2229726|NCT01820260|3879948|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0
2229727|NCT01820260|3879949|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0
2229728|NCT01820260|3879950|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0
2229729|NCT01820260|3879951|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0
2229730|NCT01820260|3879952|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0
2229731|NCT01820260|3879953|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0
2229732|NCT01820260|3879954|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0
2229733|NCT01820260|3879955|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0
2229734|NCT01820260|3879956|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0
2229735|NCT01820260|3879957|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1
2229736|NCT01820260|3879958|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0
2229737|NCT01820260|3879959|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0
2229738|NCT01820260|3879960|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0
2229739|NCT01820260|3879961|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0
2229740|NCT01820364|3879997|FG000|Part I: LGX818|Death|1
2229741|NCT01820364|3879998|FG001|Part I: LGX818|Death|0
2229742|NCT01820364|3879997|FG000|Part I: LGX818|Administrative Problems|3
2229743|NCT01820364|3879998|FG001|Part I: LGX818|Administrative Problems|0
2229744|NCT01820364|3879997|FG000|Part I: LGX818|Adverse Event|6
2229745|NCT01820364|3879998|FG001|Part I: LGX818|Adverse Event|0
2229746|NCT01820364|3879997|FG000|Part I: LGX818|Disease Progression|4
2229747|NCT01820364|3879998|FG001|Part I: LGX818|Disease Progression|0
2229748|NCT01820364|3879997|FG000|Part II: LGX818 + MEK162|Study Termination|0
2229749|NCT01820364|3879998|FG001|Part II: LGX818 + MEK162|Study Termination|1
2229750|NCT01820559|3880020|FG000|Overall Study|Adverse Event|4
2229751|NCT01820559|3880021|FG001|Overall Study|Adverse Event|6
2229752|NCT01820559|3880022|FG002|Overall Study|Adverse Event|13
2229753|NCT01820559|3880020|FG000|Overall Study|Withdrawal by Subject|1
2229754|NCT01820559|3880021|FG001|Overall Study|Withdrawal by Subject|2
2229755|NCT01820559|3880022|FG002|Overall Study|Withdrawal by Subject|5
2229756|NCT01820559|3880020|FG000|Overall Study|Protocol Violation|2
2229757|NCT01820559|3880021|FG001|Overall Study|Protocol Violation|1
2229758|NCT01820559|3880022|FG002|Overall Study|Protocol Violation|3
2229759|NCT01820559|3880020|FG000|Overall Study|Subject's non-compliance|1
2229760|NCT01820559|3880021|FG001|Overall Study|Subject's non-compliance|0
2229761|NCT01820559|3880022|FG002|Overall Study|Subject's non-compliance|2
2229762|NCT01820559|3880020|FG000|Overall Study|Lost to Follow-up|3
2229763|NCT01820559|3880021|FG001|Overall Study|Lost to Follow-up|2
2229764|NCT01820559|3880022|FG002|Overall Study|Lost to Follow-up|2
2229765|NCT01820559|3880020|FG000|Overall Study|At sponsor request|0
2229766|NCT01820559|3880021|FG001|Overall Study|At sponsor request|0
2229767|NCT01820559|3880022|FG002|Overall Study|At sponsor request|1
2229768|NCT01820559|3880020|FG000|Overall Study|Lack of Efficacy|3
2229769|NCT01820559|3880021|FG001|Overall Study|Lack of Efficacy|2
2229770|NCT01820559|3880022|FG002|Overall Study|Lack of Efficacy|3
2229771|NCT01820572|3880032|FG000|Randomization|Not Treated|2
2229772|NCT01820572|3880033|FG001|Randomization|Not Treated|1
2229773|NCT01820572|3880032|FG000|Treatment Period|Adverse Event|12
2229774|NCT01820572|3880033|FG001|Treatment Period|Adverse Event|7
2229775|NCT01820572|3880032|FG000|Treatment Period|Death|3
2229776|NCT01820572|3880033|FG001|Treatment Period|Death|3
2229777|NCT01820572|3880032|FG000|Treatment Period|Lack of Efficacy|1
2229778|NCT01820572|3880033|FG001|Treatment Period|Lack of Efficacy|0
2229779|NCT01820572|3880032|FG000|Treatment Period|poor/non compliance|0
2229780|NCT01820572|3880033|FG001|Treatment Period|poor/non compliance|3
2229781|NCT01820572|3880032|FG000|Treatment Period|request to discontinue|6
2229782|NCT01820572|3880033|FG001|Treatment Period|request to discontinue|11
2229783|NCT01820572|3880032|FG000|Treatment Period|No longer meets study criteria|3
2229784|NCT01820572|3880033|FG001|Treatment Period|No longer meets study criteria|10
2229785|NCT01820572|3880032|FG000|Treatment Period|withdrew consent|1
2229786|NCT01820572|3880033|FG001|Treatment Period|withdrew consent|2
2229787|NCT01820585|3880043|FG000|Overall Study|Adverse Event|9
2332715|NCT03205046|4056657|FG001|Overall Study|Lost to Follow-up|1
2229788|NCT01820585|3880044|FG001|Overall Study|Adverse Event|13
2229789|NCT01820585|3880045|FG002|Overall Study|Adverse Event|23
2229790|NCT01820585|3880046|FG003|Overall Study|Adverse Event|34
2229791|NCT01820585|3880043|FG000|Overall Study|Lack of Efficacy|9
2229792|NCT01820585|3880044|FG001|Overall Study|Lack of Efficacy|7
2229793|NCT01820585|3880045|FG002|Overall Study|Lack of Efficacy|5
2229794|NCT01820585|3880046|FG003|Overall Study|Lack of Efficacy|1
2229795|NCT01820585|3880043|FG000|Overall Study|Withdrawal by Subject|3
2229796|NCT01820585|3880044|FG001|Overall Study|Withdrawal by Subject|7
2229797|NCT01820585|3880045|FG002|Overall Study|Withdrawal by Subject|3
2229798|NCT01820585|3880046|FG003|Overall Study|Withdrawal by Subject|8
2229799|NCT01820585|3880043|FG000|Overall Study|Lost to Follow-up|3
2229800|NCT01820585|3880044|FG001|Overall Study|Lost to Follow-up|3
2229801|NCT01820585|3880045|FG002|Overall Study|Lost to Follow-up|0
2229802|NCT01820585|3880046|FG003|Overall Study|Lost to Follow-up|3
2229803|NCT01820585|3880043|FG000|Overall Study|Protocol Violation|3
2229804|NCT01820585|3880044|FG001|Overall Study|Protocol Violation|1
2229805|NCT01820585|3880045|FG002|Overall Study|Protocol Violation|1
2229806|NCT01820585|3880046|FG003|Overall Study|Protocol Violation|1
2229807|NCT01820585|3880043|FG000|Overall Study|Subject non-compliance|0
2229808|NCT01820585|3880044|FG001|Overall Study|Subject non-compliance|0
2229809|NCT01820585|3880045|FG002|Overall Study|Subject non-compliance|1
2229810|NCT01820585|3880046|FG003|Overall Study|Subject non-compliance|2
2229811|NCT01820585|3880043|FG000|Overall Study|at sponsor request|0
2229812|NCT01820585|3880044|FG001|Overall Study|at sponsor request|0
2229813|NCT01820585|3880045|FG002|Overall Study|at sponsor request|1
2229814|NCT01820585|3880046|FG003|Overall Study|at sponsor request|0
2229815|NCT01820585|3880043|FG000|Overall Study|Pregnancy|0
2229816|NCT01820585|3880044|FG001|Overall Study|Pregnancy|1
2229817|NCT01820585|3880045|FG002|Overall Study|Pregnancy|0
2229818|NCT01820585|3880046|FG003|Overall Study|Pregnancy|0
2229819|NCT01820637|3880056|FG000|Overall Study|Death|2
2229820|NCT01820637|3880056|FG000|Overall Study|Withdrawal by Subject|1
2229821|NCT01821118|3880070|FG000|Overall Study|Death|0
2229822|NCT01821118|3880071|FG001|Overall Study|Death|1
2229823|NCT01821391|3880125|FG000|Overall Study|Adverse Event|1
2229824|NCT01821391|3880126|FG001|Overall Study|Adverse Event|0
2229825|NCT01821560|3880149|FG000|Overall Study|Lost to Follow-up|5
2229826|NCT01821560|3880150|FG001|Overall Study|Lost to Follow-up|5
2229827|NCT01821560|3880149|FG000|Overall Study|Withdrawal by Subject|1
2229828|NCT01821560|3880150|FG001|Overall Study|Withdrawal by Subject|1
2229829|NCT01821560|3880149|FG000|Overall Study|Protocol Violation|0
2229830|NCT01821560|3880150|FG001|Overall Study|Protocol Violation|1
2229831|NCT01821625|3880156|FG000|Overall Study|Withdrawal by Subject|2
2229832|NCT01821625|3880156|FG000|Overall Study|Lack of Efficacy|2
2229833|NCT01821625|3880156|FG000|Overall Study|Adverse Event|1
2229834|NCT01821625|3880156|FG000|Overall Study|Medical contraindication|1
2229835|NCT01821729|3880160|FG000|Overall Study|Withdrawal by Subject|1
2229836|NCT01821807|3880166|FG000|Overall Study|Lost to Follow-up|3
2229837|NCT01821807|3880167|FG001|Overall Study|Lost to Follow-up|1
2229838|NCT01821937|3880175|FG000|Overall Study|Adverse Event|0
2229839|NCT01821937|3880176|FG001|Overall Study|Adverse Event|3
2229840|NCT01822132|3880190|FG000|Overall Study|Lost to Follow-up|4
2229841|NCT01822132|3880191|FG001|Overall Study|Lost to Follow-up|2
2229842|NCT01822223|3880209|FG000|Overall Study|Death|0
2229843|NCT01822223|3880210|FG001|Overall Study|Death|1
2229844|NCT01822353|3880231|FG000|Overall Study|Adverse Event|1
2229845|NCT01822353|3880232|FG001|Overall Study|Adverse Event|3
2229846|NCT01822353|3880233|FG002|Overall Study|Adverse Event|1
2229847|NCT01822353|3880231|FG000|Overall Study|Pregnancy|0
2229848|NCT01822353|3880232|FG001|Overall Study|Pregnancy|1
2229849|NCT01822353|3880233|FG002|Overall Study|Pregnancy|0
2229850|NCT01822353|3880231|FG000|Overall Study|Withdrawal by Subject|3
2229851|NCT01822353|3880232|FG001|Overall Study|Withdrawal by Subject|1
2229852|NCT01822353|3880233|FG002|Overall Study|Withdrawal by Subject|0
2229853|NCT01822366|3880248|FG000|Overall Study|Lost to Follow-up|5
2229854|NCT01822366|3880249|FG001|Overall Study|Lost to Follow-up|1
2229855|NCT01822366|3880250|FG002|Overall Study|Lost to Follow-up|5
2229856|NCT01822366|3880251|FG003|Overall Study|Lost to Follow-up|1
2229857|NCT01822366|3880248|FG000|Overall Study|Withdrawal by Subject|0
2229858|NCT01822366|3880249|FG001|Overall Study|Withdrawal by Subject|6
2229859|NCT01822366|3880250|FG002|Overall Study|Withdrawal by Subject|0
2229860|NCT01822366|3880251|FG003|Overall Study|Withdrawal by Subject|6
2229861|NCT01822366|3880248|FG000|Overall Study|Partial Intervention Completion|0
2229862|NCT01822366|3880249|FG001|Overall Study|Partial Intervention Completion|15
2229863|NCT01822366|3880250|FG002|Overall Study|Partial Intervention Completion|0
2229864|NCT01822366|3880251|FG003|Overall Study|Partial Intervention Completion|15
2229865|NCT01822496|3880292|FG000|Overall Study|Protocol Violation|2
2229866|NCT01822496|3880293|FG001|Overall Study|Protocol Violation|2
2332716|NCT03205046|4056656|FG000|Overall Study|Study terminated by sponsor|2
2229867|NCT01822496|3880294|FG002|Overall Study|Protocol Violation|0
2229868|NCT01822496|3880295|FG003|Overall Study|Protocol Violation|1
2229869|NCT01822496|3880292|FG000|Overall Study|Withdrawal by Subject|0
2229870|NCT01822496|3880293|FG001|Overall Study|Withdrawal by Subject|0
2229871|NCT01822496|3880294|FG002|Overall Study|Withdrawal by Subject|0
2229872|NCT01822496|3880295|FG003|Overall Study|Withdrawal by Subject|3
2229873|NCT01822535|3880307|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
2229874|NCT01822535|3880308|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
2229875|NCT01822535|3880307|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
2229876|NCT01822535|3880308|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
2229877|NCT01822535|3880307|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
2229878|NCT01822535|3880308|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
2229879|NCT01822561|3880326|FG000|Overall Study|Withdrawal by Subject|2
2229880|NCT01822587|3880350|FG000|Overall Study|Lost to Follow-up|7
2229881|NCT01822587|3880351|FG001|Overall Study|Lost to Follow-up|9
2229882|NCT01822587|3880352|FG002|Overall Study|Lost to Follow-up|12
2229883|NCT01822587|3880350|FG000|Overall Study|Physician Decision|9
2229884|NCT01822587|3880351|FG001|Overall Study|Physician Decision|6
2229885|NCT01822587|3880352|FG002|Overall Study|Physician Decision|6
2229886|NCT01822665|3880360|FG000|Overall Study|Adverse Event|3
2229887|NCT01822665|3880360|FG000|Overall Study|Other Reason|5
2229888|NCT01822678|3880381|FG000|Overall Study|Withdrawal by Subject|5
2229889|NCT01822678|3880382|FG001|Overall Study|Withdrawal by Subject|4
2229890|NCT01822678|3880383|FG002|Overall Study|Withdrawal by Subject|4
2229891|NCT01822678|3880381|FG000|Overall Study|Adverse Event|4
2229892|NCT01822678|3880382|FG001|Overall Study|Adverse Event|3
2229893|NCT01822678|3880383|FG002|Overall Study|Adverse Event|1
2229894|NCT01822678|3880381|FG000|Overall Study|Lack of Efficacy|3
2229895|NCT01822678|3880382|FG001|Overall Study|Lack of Efficacy|6
2229896|NCT01822678|3880383|FG002|Overall Study|Lack of Efficacy|5
2229897|NCT01822678|3880381|FG000|Overall Study|Lost to Follow-up|0
2229898|NCT01822678|3880382|FG001|Overall Study|Lost to Follow-up|2
2229899|NCT01822678|3880383|FG002|Overall Study|Lost to Follow-up|1
2229900|NCT01822691|3880391|FG000|Overall Study|Withdrawal by Subject|2
2229901|NCT01822756|3880400|FG000|Overall Study|Adverse Event|0
2229902|NCT01822756|3880401|FG001|Overall Study|Adverse Event|0
2229903|NCT01822756|3880402|FG002|Overall Study|Adverse Event|0
2229904|NCT01822756|3880403|FG003|Overall Study|Adverse Event|2
2229905|NCT01822756|3880404|FG004|Overall Study|Adverse Event|0
2229906|NCT01822756|3880400|FG000|Overall Study|Disease progression|11
2229907|NCT01822756|3880401|FG001|Overall Study|Disease progression|1
2229908|NCT01822756|3880402|FG002|Overall Study|Disease progression|7
2229909|NCT01822756|3880403|FG003|Overall Study|Disease progression|2
2229910|NCT01822756|3880404|FG004|Overall Study|Disease progression|6
2229911|NCT01822756|3880400|FG000|Overall Study|Death|2
2229912|NCT01822756|3880401|FG001|Overall Study|Death|2
2229913|NCT01822756|3880402|FG002|Overall Study|Death|1
2229914|NCT01822756|3880403|FG003|Overall Study|Death|0
2229915|NCT01822756|3880404|FG004|Overall Study|Death|0
2229916|NCT01822756|3880400|FG000|Overall Study|Lost to Follow-up|1
2229917|NCT01822756|3880401|FG001|Overall Study|Lost to Follow-up|0
2229918|NCT01822756|3880402|FG002|Overall Study|Lost to Follow-up|1
2229919|NCT01822756|3880403|FG003|Overall Study|Lost to Follow-up|0
2229920|NCT01822756|3880404|FG004|Overall Study|Lost to Follow-up|1
2229921|NCT01822756|3880400|FG000|Overall Study|Physician Decision|0
2229922|NCT01822756|3880401|FG001|Overall Study|Physician Decision|1
2229923|NCT01822756|3880402|FG002|Overall Study|Physician Decision|0
2229924|NCT01822756|3880403|FG003|Overall Study|Physician Decision|0
2229925|NCT01822756|3880404|FG004|Overall Study|Physician Decision|0
2229926|NCT01822756|3880400|FG000|Overall Study|disease progression & patient preference|2
2229927|NCT01822756|3880401|FG001|Overall Study|disease progression & patient preference|0
2229928|NCT01822756|3880402|FG002|Overall Study|disease progression & patient preference|1
2229929|NCT01822756|3880403|FG003|Overall Study|disease progression & patient preference|0
2229930|NCT01822756|3880404|FG004|Overall Study|disease progression & patient preference|0
2229931|NCT01822821|3880418|FG000|Overall Study|Eligible surgery cancelled|1
2229932|NCT01822821|3880419|FG001|Overall Study|Eligible surgery cancelled|1
2229933|NCT01822821|3880418|FG000|Overall Study|Other reasons|1
2229934|NCT01822821|3880419|FG001|Overall Study|Other reasons|0
2229935|NCT01822899|3880431|FG000|Overall Study|Adverse Event|6
2229936|NCT01822899|3880432|FG001|Overall Study|Adverse Event|5
2229937|NCT01822899|3880431|FG000|Overall Study|Lack of Efficacy|6
2229938|NCT01822899|3880432|FG001|Overall Study|Lack of Efficacy|3
2229939|NCT01822899|3880431|FG000|Overall Study|Protocol Violation|6
2229940|NCT01822899|3880432|FG001|Overall Study|Protocol Violation|3
2229941|NCT01822899|3880431|FG000|Overall Study|Lost to Follow-up|1
2229942|NCT01822899|3880432|FG001|Overall Study|Lost to Follow-up|0
2229943|NCT01822899|3880431|FG000|Overall Study|Withdrawal by Subject|5
2229944|NCT01822899|3880432|FG001|Overall Study|Withdrawal by Subject|7
2229945|NCT01822925|3880442|FG000|Overall Study|Adverse Event|1
2229946|NCT01822925|3880443|FG001|Overall Study|Adverse Event|1
2229947|NCT01822925|3880444|FG002|Overall Study|Adverse Event|1
2229948|NCT01822925|3880445|FG003|Overall Study|Adverse Event|1
2229949|NCT01822925|3880442|FG000|Overall Study|Lost to Follow-up|0
2229950|NCT01822925|3880443|FG001|Overall Study|Lost to Follow-up|1
2229951|NCT01822925|3880444|FG002|Overall Study|Lost to Follow-up|0
2229952|NCT01822925|3880445|FG003|Overall Study|Lost to Follow-up|0
2229953|NCT01822925|3880442|FG000|Overall Study|Protocol Violation|1
2229954|NCT01822925|3880443|FG001|Overall Study|Protocol Violation|0
2229955|NCT01822925|3880444|FG002|Overall Study|Protocol Violation|0
2229956|NCT01822925|3880445|FG003|Overall Study|Protocol Violation|1
2229957|NCT01822925|3880442|FG000|Overall Study|Withdrawal by Subject|2
2229958|NCT01822925|3880443|FG001|Overall Study|Withdrawal by Subject|0
2229959|NCT01822925|3880444|FG002|Overall Study|Withdrawal by Subject|2
2229960|NCT01822925|3880445|FG003|Overall Study|Withdrawal by Subject|2
2229961|NCT01822925|3880442|FG000|Overall Study|Taking prohibited medication|2
2229962|NCT01822925|3880443|FG001|Overall Study|Taking prohibited medication|0
2229963|NCT01822925|3880444|FG002|Overall Study|Taking prohibited medication|0
2229964|NCT01822925|3880445|FG003|Overall Study|Taking prohibited medication|1
2229965|NCT01823107|3880455|FG000|Overall Study|Withdrawal by Subject|1
2229966|NCT01823146|3880461|FG000|Overall Study|Withdrawal by Subject|0
2229967|NCT01823146|3880462|FG001|Overall Study|Withdrawal by Subject|1
2229968|NCT01823146|3880461|FG000|Overall Study|Lost to Follow-up|2
2229969|NCT01823146|3880462|FG001|Overall Study|Lost to Follow-up|1
2229970|NCT01823224|3880470|FG000|Overall Study|Lost to Follow-up|5
2229971|NCT01823224|3880471|FG001|Overall Study|Lost to Follow-up|6
2229972|NCT01823224|3880470|FG000|Overall Study|didn't qualify|1
2229973|NCT01823224|3880471|FG001|Overall Study|didn't qualify|2
2229974|NCT01823224|3880470|FG000|Overall Study|pharmacy error|0
2229975|NCT01823224|3880471|FG001|Overall Study|pharmacy error|1
2229976|NCT01823224|3880470|FG000|Overall Study|missed med dose|0
2229977|NCT01823224|3880471|FG001|Overall Study|missed med dose|1
2229978|NCT01823224|3880470|FG000|Overall Study|Withdrawal by Subject|0
2229979|NCT01823224|3880471|FG001|Overall Study|Withdrawal by Subject|1
2229980|NCT01823289|3880479|FG000|Overall Study|Lost to Follow-up|5
2229981|NCT01823289|3880479|FG000|Overall Study|Adverse Event|5
2229982|NCT01823289|3880479|FG000|Overall Study|Lack of Efficacy|1
2229983|NCT01823289|3880479|FG000|Overall Study|Physician Decision|9
2229984|NCT01823289|3880479|FG000|Overall Study|Administered contraindicated medicine|1
2229985|NCT01823289|3880479|FG000|Overall Study|Transaminase increased more than 3 times|1
2229986|NCT01823289|3880479|FG000|Overall Study|Drug affected efficacy and safety|1
2229987|NCT01823289|3880479|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1
2229988|NCT01823328|3880485|FG000|Overall Study|Withdrawal by Subject|8
2229989|NCT01823328|3880486|FG001|Overall Study|Withdrawal by Subject|6
2229990|NCT01823341|3880492|FG000|Overall Study|Failed run-in|7
2229991|NCT01823341|3880492|FG000|Overall Study|Withdrawal by Subject|7
2229992|NCT01823341|3880492|FG000|Overall Study|Adverse Event|1
2229993|NCT01823536|3880521|FG000|Overall Study|Lost to Follow-up|1
2229994|NCT01823536|3880522|FG001|Overall Study|Lost to Follow-up|0
2229995|NCT01823536|3880523|FG002|Overall Study|Lost to Follow-up|0
2229996|NCT01823536|3880524|FG003|Overall Study|Lost to Follow-up|1
2229997|NCT01823536|3880525|FG004|Overall Study|Lost to Follow-up|1
2229998|NCT01823536|3880526|FG005|Overall Study|Lost to Follow-up|0
2229999|NCT01823536|3880521|FG000|Overall Study|Protocol Violation|0
2230000|NCT01823536|3880522|FG001|Overall Study|Protocol Violation|1
2230001|NCT01823536|3880523|FG002|Overall Study|Protocol Violation|0
2230002|NCT01823536|3880524|FG003|Overall Study|Protocol Violation|0
2230003|NCT01823536|3880525|FG004|Overall Study|Protocol Violation|0
2230004|NCT01823536|3880526|FG005|Overall Study|Protocol Violation|0
2230005|NCT01823536|3880521|FG000|Overall Study|Withdrawal by Subject|1
2230006|NCT01823536|3880522|FG001|Overall Study|Withdrawal by Subject|1
2230007|NCT01823536|3880523|FG002|Overall Study|Withdrawal by Subject|0
2230008|NCT01823536|3880524|FG003|Overall Study|Withdrawal by Subject|0
2230009|NCT01823536|3880525|FG004|Overall Study|Withdrawal by Subject|0
2230010|NCT01823536|3880526|FG005|Overall Study|Withdrawal by Subject|0
2230011|NCT01823536|3880521|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0
2230012|NCT01823536|3880522|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0
2230013|NCT01823536|3880523|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1
2230014|NCT01823536|3880524|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0
2230015|NCT01823536|3880525|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0
2230016|NCT01823536|3880526|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0
2230017|NCT01823536|3880521|FG000|Overall Study|Met exclusion criterion No 6|0
2230018|NCT01823536|3880522|FG001|Overall Study|Met exclusion criterion No 6|0
2230019|NCT01823536|3880523|FG002|Overall Study|Met exclusion criterion No 6|0
2230020|NCT01823536|3880524|FG003|Overall Study|Met exclusion criterion No 6|1
2230021|NCT01823536|3880525|FG004|Overall Study|Met exclusion criterion No 6|0
2230022|NCT01823536|3880526|FG005|Overall Study|Met exclusion criterion No 6|0
2230023|NCT01823536|3880521|FG000|Overall Study|Subject moved out of the state|0
2230024|NCT01823536|3880522|FG001|Overall Study|Subject moved out of the state|0
2230025|NCT01823536|3880523|FG002|Overall Study|Subject moved out of the state|0
2230026|NCT01823536|3880524|FG003|Overall Study|Subject moved out of the state|0
2230027|NCT01823536|3880525|FG004|Overall Study|Subject moved out of the state|1
2230028|NCT01823536|3880526|FG005|Overall Study|Subject moved out of the state|0
2230029|NCT01823679|3880577|FG000|Overall Study|Death|1
2230030|NCT01823835|3880597|FG000|Overall Study|Adverse Event|0
2230031|NCT01823835|3880598|FG001|Overall Study|Adverse Event|0
2230032|NCT01823835|3880599|FG002|Overall Study|Adverse Event|0
2230033|NCT01823835|3880600|FG003|Overall Study|Adverse Event|0
2230034|NCT01823835|3880601|FG004|Overall Study|Adverse Event|1
2230035|NCT01823835|3880602|FG005|Overall Study|Adverse Event|0
2230036|NCT01823835|3880603|FG006|Overall Study|Adverse Event|1
2230037|NCT01823835|3880604|FG007|Overall Study|Adverse Event|0
2230038|NCT01823835|3880605|FG008|Overall Study|Adverse Event|0
2230039|NCT01823835|3880606|FG009|Overall Study|Adverse Event|0
2230040|NCT01823835|3880607|FG010|Overall Study|Adverse Event|1
2230041|NCT01823835|3880608|FG011|Overall Study|Adverse Event|2
2230042|NCT01823835|3880609|FG012|Overall Study|Adverse Event|0
2230043|NCT01823835|3880610|FG013|Overall Study|Adverse Event|0
2230044|NCT01823835|3880611|FG014|Overall Study|Adverse Event|0
2230045|NCT01823835|3880597|FG000|Overall Study|Physician Decision|0
2230046|NCT01823835|3880598|FG001|Overall Study|Physician Decision|0
2230047|NCT01823835|3880599|FG002|Overall Study|Physician Decision|0
2230048|NCT01823835|3880600|FG003|Overall Study|Physician Decision|0
2230049|NCT01823835|3880601|FG004|Overall Study|Physician Decision|0
2230050|NCT01823835|3880602|FG005|Overall Study|Physician Decision|0
2230051|NCT01823835|3880603|FG006|Overall Study|Physician Decision|0
2230052|NCT01823835|3880604|FG007|Overall Study|Physician Decision|0
2230053|NCT01823835|3880605|FG008|Overall Study|Physician Decision|0
2230054|NCT01823835|3880606|FG009|Overall Study|Physician Decision|0
2230055|NCT01823835|3880607|FG010|Overall Study|Physician Decision|0
2230056|NCT01823835|3880608|FG011|Overall Study|Physician Decision|2
2230057|NCT01823835|3880609|FG012|Overall Study|Physician Decision|0
2230058|NCT01823835|3880610|FG013|Overall Study|Physician Decision|0
2230059|NCT01823835|3880611|FG014|Overall Study|Physician Decision|0
2230060|NCT01823835|3880597|FG000|Overall Study|Progressive Disease|3
2230061|NCT01823835|3880598|FG001|Overall Study|Progressive Disease|4
2230062|NCT01823835|3880599|FG002|Overall Study|Progressive Disease|3
2230063|NCT01823835|3880600|FG003|Overall Study|Progressive Disease|6
2230064|NCT01823835|3880601|FG004|Overall Study|Progressive Disease|4
2230065|NCT01823835|3880602|FG005|Overall Study|Progressive Disease|6
2230066|NCT01823835|3880603|FG006|Overall Study|Progressive Disease|5
2230067|NCT01823835|3880604|FG007|Overall Study|Progressive Disease|3
2230068|NCT01823835|3880605|FG008|Overall Study|Progressive Disease|3
2230069|NCT01823835|3880606|FG009|Overall Study|Progressive Disease|18
2230070|NCT01823835|3880607|FG010|Overall Study|Progressive Disease|8
2230071|NCT01823835|3880608|FG011|Overall Study|Progressive Disease|46
2230072|NCT01823835|3880609|FG012|Overall Study|Progressive Disease|18
2230073|NCT01823835|3880610|FG013|Overall Study|Progressive Disease|4
2230074|NCT01823835|3880611|FG014|Overall Study|Progressive Disease|6
2230075|NCT01823835|3880597|FG000|Overall Study|Study Termination|0
2230076|NCT01823835|3880598|FG001|Overall Study|Study Termination|0
2230077|NCT01823835|3880599|FG002|Overall Study|Study Termination|0
2230078|NCT01823835|3880600|FG003|Overall Study|Study Termination|0
2230079|NCT01823835|3880601|FG004|Overall Study|Study Termination|1
2230080|NCT01823835|3880602|FG005|Overall Study|Study Termination|0
2230081|NCT01823835|3880603|FG006|Overall Study|Study Termination|0
2230082|NCT01823835|3880604|FG007|Overall Study|Study Termination|0
2230083|NCT01823835|3880605|FG008|Overall Study|Study Termination|0
2230084|NCT01823835|3880606|FG009|Overall Study|Study Termination|0
2230085|NCT01823835|3880607|FG010|Overall Study|Study Termination|0
2230086|NCT01823835|3880608|FG011|Overall Study|Study Termination|1
2230087|NCT01823835|3880609|FG012|Overall Study|Study Termination|0
2230088|NCT01823835|3880610|FG013|Overall Study|Study Termination|0
2230089|NCT01823835|3880611|FG014|Overall Study|Study Termination|0
2230090|NCT01823835|3880597|FG000|Overall Study|Withdrawal by Subject|0
2230091|NCT01823835|3880598|FG001|Overall Study|Withdrawal by Subject|0
2230092|NCT01823835|3880599|FG002|Overall Study|Withdrawal by Subject|1
2230093|NCT01823835|3880600|FG003|Overall Study|Withdrawal by Subject|0
2230094|NCT01823835|3880601|FG004|Overall Study|Withdrawal by Subject|0
2230095|NCT01823835|3880602|FG005|Overall Study|Withdrawal by Subject|0
2230096|NCT01823835|3880603|FG006|Overall Study|Withdrawal by Subject|0
2230097|NCT01823835|3880604|FG007|Overall Study|Withdrawal by Subject|0
2230098|NCT01823835|3880605|FG008|Overall Study|Withdrawal by Subject|0
2230099|NCT01823835|3880606|FG009|Overall Study|Withdrawal by Subject|1
2230100|NCT01823835|3880607|FG010|Overall Study|Withdrawal by Subject|1
2230101|NCT01823835|3880608|FG011|Overall Study|Withdrawal by Subject|2
2230102|NCT01823835|3880609|FG012|Overall Study|Withdrawal by Subject|1
2230103|NCT01823835|3880610|FG013|Overall Study|Withdrawal by Subject|0
2230104|NCT01823835|3880611|FG014|Overall Study|Withdrawal by Subject|0
2230105|NCT01823991|3880662|FG000|Overall Study|Withdrawal by Subject|8
2230106|NCT01823991|3880663|FG001|Overall Study|Withdrawal by Subject|5
2230107|NCT01824290|3880692|FG000|Period 1: Double Blind|Entry Criteria Not Met|1
2230108|NCT01824290|3880693|FG001|Period 1: Double Blind|Entry Criteria Not Met|0
2230109|NCT01824290|3880694|FG002|Period 1: Double Blind|Entry Criteria Not Met|0
2230110|NCT01824290|3880695|FG003|Period 1: Double Blind|Entry Criteria Not Met|0
2230111|NCT01824290|3880692|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1
2230112|NCT01824290|3880693|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1
2230113|NCT01824290|3880694|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0
2230114|NCT01824290|3880695|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0
2230115|NCT01824290|3880692|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
2230116|NCT01824290|3880693|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
2230117|NCT01824290|3880694|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
2230118|NCT01824290|3880695|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
2230119|NCT01824290|3880692|FG000|Period 2: Open-Label Treatment|Adverse Event|0
2230120|NCT01824290|3880693|FG001|Period 2: Open-Label Treatment|Adverse Event|0
2230121|NCT01824290|3880694|FG002|Period 2: Open-Label Treatment|Adverse Event|0
2230122|NCT01824290|3880695|FG003|Period 2: Open-Label Treatment|Adverse Event|1
2230123|NCT01824290|3880692|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
2230124|NCT01824290|3880693|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
2230125|NCT01824290|3880694|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
2230126|NCT01824290|3880695|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
2230127|NCT01824290|3880692|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0
2230128|NCT01824290|3880693|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0
2230129|NCT01824290|3880694|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2
2230130|NCT01824290|3880695|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1
2230131|NCT01824303|3880709|FG000|Randomized Study|Withdrawal by Subject|1
2230132|NCT01824303|3880710|FG001|Randomized Study|Withdrawal by Subject|1
2230133|NCT01824303|3880709|FG000|Randomized Study|Other Miscellaneous Reasons|1
2230134|NCT01824303|3880710|FG001|Randomized Study|Other Miscellaneous Reasons|0
2230135|NCT01824342|3880720|FG000|Overall Study|Withdrawal by Subject|0
2230136|NCT01824342|3880721|FG001|Overall Study|Withdrawal by Subject|3
2230137|NCT01824342|3880720|FG000|Overall Study|Adverse Event|1
2230138|NCT01824342|3880721|FG001|Overall Study|Adverse Event|1
2230139|NCT01824342|3880720|FG000|Overall Study|Disease Progression|1
2230140|NCT01824342|3880721|FG001|Overall Study|Disease Progression|1
2230141|NCT01824342|3880720|FG000|Overall Study|Physician Decision|5
2230142|NCT01824342|3880721|FG001|Overall Study|Physician Decision|0
2230143|NCT01824342|3880720|FG000|Overall Study|Death|2
2230144|NCT01824342|3880721|FG001|Overall Study|Death|0
2230145|NCT01824355|3880727|FG000|Overall Study|Adverse Event|2
2230146|NCT01824355|3880727|FG000|Overall Study|unevaluable reference method results per|1
2230147|NCT01824394|3880734|FG000|Overall Study|Early Termination|1
2230148|NCT01824394|3880735|FG001|Overall Study|Early Termination|1
2230149|NCT01824394|3880736|FG002|Overall Study|Early Termination|3
2230150|NCT01824394|3880734|FG000|Overall Study|Withdrawn due to Study Termination|91
2230151|NCT01824394|3880735|FG001|Overall Study|Withdrawn due to Study Termination|83
2230152|NCT01824394|3880736|FG002|Overall Study|Withdrawn due to Study Termination|41
2230153|NCT01824394|3880734|FG000|Overall Study|Lost to Follow-up|0
2230154|NCT01824394|3880735|FG001|Overall Study|Lost to Follow-up|9
2230155|NCT01824394|3880736|FG002|Overall Study|Lost to Follow-up|3
2230156|NCT01824394|3880734|FG000|Overall Study|Death|3
2230157|NCT01824394|3880735|FG001|Overall Study|Death|2
2230158|NCT01824394|3880736|FG002|Overall Study|Death|4
2230159|NCT01824394|3880734|FG000|Overall Study|Discontinued Subjects|1
2230160|NCT01824394|3880735|FG001|Overall Study|Discontinued Subjects|1
2230161|NCT01824394|3880736|FG002|Overall Study|Discontinued Subjects|2
2230162|NCT01824394|3880734|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23
2230163|NCT01824394|3880735|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20
2230164|NCT01824394|3880736|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21
2332717|NCT03205046|4056657|FG001|Overall Study|Study terminated by sponsor|1
2332718|NCT03205150|4056666|FG000|Overall Study|Protocol deviation|1
2332719|NCT03205150|4056667|FG001|Overall Study|Protocol deviation|3
2332720|NCT03205150|4056668|FG002|Overall Study|Protocol deviation|0
2332721|NCT03205150|4056666|FG000|Overall Study|Patient/guardian decision|0
2332722|NCT03205150|4056667|FG001|Overall Study|Patient/guardian decision|3
2332723|NCT03205150|4056668|FG002|Overall Study|Patient/guardian decision|0
2332724|NCT03205150|4056666|FG000|Overall Study|Adverse Event|1
2332725|NCT03205150|4056667|FG001|Overall Study|Adverse Event|1
2332726|NCT03205150|4056668|FG002|Overall Study|Adverse Event|1
2332727|NCT03205150|4056666|FG000|Overall Study|Lost to Follow-up|0
2332728|NCT03205150|4056667|FG001|Overall Study|Lost to Follow-up|0
2332729|NCT03205150|4056668|FG002|Overall Study|Lost to Follow-up|1
2332730|NCT03205163|4056679|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
2332731|NCT03205163|4056680|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
2332732|NCT03205371|4056716|FG000|Overall Study|Withdrawal by Subject|4
2332733|NCT03205371|4056717|FG001|Overall Study|Withdrawal by Subject|1
2332734|NCT03205371|4056718|FG002|Overall Study|Withdrawal by Subject|0
2332735|NCT03205371|4056719|FG003|Overall Study|Withdrawal by Subject|0
2332736|NCT03205371|4056720|FG004|Overall Study|Withdrawal by Subject|0
2332737|NCT03205371|4056721|FG005|Overall Study|Withdrawal by Subject|0
2332738|NCT03205371|4056722|FG006|Overall Study|Withdrawal by Subject|4
2332739|NCT03205371|4056723|FG007|Overall Study|Withdrawal by Subject|0
2332740|NCT03205371|4056724|FG008|Overall Study|Withdrawal by Subject|2
2332741|NCT03205371|4056725|FG009|Overall Study|Withdrawal by Subject|0
2332742|NCT03205371|4056726|FG010|Overall Study|Withdrawal by Subject|0
2332743|NCT03205371|4056727|FG011|Overall Study|Withdrawal by Subject|1
2332744|NCT03205371|4056716|FG000|Overall Study|Lost to Follow-up|0
2332745|NCT03205371|4056717|FG001|Overall Study|Lost to Follow-up|0
2332746|NCT03205371|4056718|FG002|Overall Study|Lost to Follow-up|0
2332747|NCT03205371|4056719|FG003|Overall Study|Lost to Follow-up|0
2332748|NCT03205371|4056720|FG004|Overall Study|Lost to Follow-up|0
2332749|NCT03205371|4056721|FG005|Overall Study|Lost to Follow-up|0
2332750|NCT03205371|4056722|FG006|Overall Study|Lost to Follow-up|5
2332751|NCT03205371|4056723|FG007|Overall Study|Lost to Follow-up|2
2332752|NCT03205371|4056724|FG008|Overall Study|Lost to Follow-up|3
2332753|NCT03205371|4056725|FG009|Overall Study|Lost to Follow-up|0
2332754|NCT03205371|4056726|FG010|Overall Study|Lost to Follow-up|0
2332755|NCT03205371|4056727|FG011|Overall Study|Lost to Follow-up|0
2332756|NCT03205371|4056716|FG000|Overall Study|Protocol Violation|0
2332757|NCT03205371|4056717|FG001|Overall Study|Protocol Violation|0
2332758|NCT03205371|4056718|FG002|Overall Study|Protocol Violation|0
2332759|NCT03205371|4056719|FG003|Overall Study|Protocol Violation|0
2332760|NCT03205371|4056720|FG004|Overall Study|Protocol Violation|0
2332761|NCT03205371|4056721|FG005|Overall Study|Protocol Violation|0
2332762|NCT03205371|4056722|FG006|Overall Study|Protocol Violation|1
2332763|NCT03205371|4056723|FG007|Overall Study|Protocol Violation|0
2230165|NCT01824472|3880751|FG000|Overall Study|Lost to Follow-up|0
2230166|NCT01824472|3880752|FG001|Overall Study|Lost to Follow-up|0
2230167|NCT01824472|3880753|FG002|Overall Study|Lost to Follow-up|1
2230168|NCT01824472|3880751|FG000|Overall Study|Withdrawal by Subject|1
2230169|NCT01824472|3880752|FG001|Overall Study|Withdrawal by Subject|5
2230170|NCT01824472|3880753|FG002|Overall Study|Withdrawal by Subject|3
2230171|NCT01824472|3880751|FG000|Overall Study|Ineligible post randomization&screening|0
2230172|NCT01824472|3880752|FG001|Overall Study|Ineligible post randomization&screening|2
2230173|NCT01824472|3880753|FG002|Overall Study|Ineligible post randomization&screening|0
2274291|NCT02294474|3955171|FG000|Overall Study|Protocol Violation|4
2274292|NCT02294474|3955172|FG001|Overall Study|Protocol Violation|2
2274293|NCT02294474|3955171|FG000|Overall Study|Other than specified above|12
2274294|NCT02294474|3955172|FG001|Overall Study|Other than specified above|12
2274295|NCT02294604|3955182|FG000|Overall Study|Did not provide samples for culture|0
2274296|NCT02294604|3955183|FG001|Overall Study|Did not provide samples for culture|1
2274297|NCT02294604|3955184|FG002|Overall Study|Did not provide samples for culture|0
2274298|NCT02294604|3955182|FG000|Overall Study|Culture contamination|1
2274299|NCT02294604|3955183|FG001|Overall Study|Culture contamination|2
2274300|NCT02294604|3955184|FG002|Overall Study|Culture contamination|0
2274301|NCT02294682|3955211|FG000|Overall Study|Could not swallow pills|1
2274302|NCT02294682|3955212|FG001|Overall Study|Could not swallow pills|0
2274303|NCT02294734|3955220|FG000|Overall Study|Adverse Event|5
2274304|NCT02294734|3955221|FG001|Overall Study|Adverse Event|5
2274305|NCT02294734|3955220|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1
2274306|NCT02294734|3955221|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0
2274307|NCT02294734|3955220|FG000|Overall Study|Lost to Follow-up|2
2274308|NCT02294734|3955221|FG001|Overall Study|Lost to Follow-up|0
2274309|NCT02294734|3955220|FG000|Overall Study|Physician Decision|2
2274310|NCT02294734|3955221|FG001|Overall Study|Physician Decision|1
2274311|NCT02294734|3955220|FG000|Overall Study|Withdrawal by Subject|4
2274312|NCT02294734|3955221|FG001|Overall Study|Withdrawal by Subject|2
2274313|NCT02294773|3955231|FG000|Overall Study|Withdrawal by Subject|0
2274314|NCT02294773|3955232|FG001|Overall Study|Withdrawal by Subject|2
2274315|NCT02294786|3955240|FG000|Overall Study|Withdrawal by Subject|0
2274316|NCT02294786|3955241|FG001|Overall Study|Withdrawal by Subject|1
2274317|NCT02294786|3955240|FG000|Overall Study|Physician Decision|6
2274318|NCT02294786|3955241|FG001|Overall Study|Physician Decision|7
2274319|NCT02294786|3955240|FG000|Overall Study|Lost to Follow-up|1
2274320|NCT02294786|3955241|FG001|Overall Study|Lost to Follow-up|2
2274321|NCT02294786|3955240|FG000|Overall Study|Protocol Violation|1
2274322|NCT02294786|3955241|FG001|Overall Study|Protocol Violation|0
2274323|NCT02294786|3955240|FG000|Overall Study|Adverse Event|1
2274324|NCT02294786|3955241|FG001|Overall Study|Adverse Event|1
2274325|NCT02294786|3955240|FG000|Overall Study|Death|2
2274326|NCT02294786|3955241|FG001|Overall Study|Death|3
2274327|NCT02295020|3955250|FG000|Overall Study|Adverse Event|0
2274328|NCT02295020|3955251|FG001|Overall Study|Adverse Event|1
2274329|NCT02295020|3955250|FG000|Overall Study|Withdrawal by Subject|3
2274330|NCT02295020|3955251|FG001|Overall Study|Withdrawal by Subject|2
2274331|NCT02295280|3955265|FG000|Overall Study|Adverse Event|0
2274332|NCT02295280|3955266|FG001|Overall Study|Adverse Event|1
2274333|NCT02295644|3955293|FG000|Overall Study|Did not meet inclusion criterion|0
2274334|NCT02295644|3955294|FG001|Overall Study|Did not meet inclusion criterion|0
2274335|NCT02295644|3955295|FG002|Overall Study|Did not meet inclusion criterion|1
2274336|NCT02295644|3955296|FG003|Overall Study|Did not meet inclusion criterion|2
2274337|NCT02295774|3955315|FG000|Overall Study|Physician Decision|1
2274338|NCT02295774|3955315|FG000|Overall Study|Withdrawal by Subject|2
2274339|NCT02295995|3955322|FG000|Overall Study|Lost to Follow-up|5
2274340|NCT02295995|3955323|FG001|Overall Study|Lost to Follow-up|1
2332764|NCT03205371|4056724|FG008|Overall Study|Protocol Violation|0
2332765|NCT03205371|4056725|FG009|Overall Study|Protocol Violation|0
2332766|NCT03205371|4056726|FG010|Overall Study|Protocol Violation|0
2332767|NCT03205371|4056727|FG011|Overall Study|Protocol Violation|0
2332768|NCT03205371|4056716|FG000|Overall Study|Adverse Event|0
2332769|NCT03205371|4056717|FG001|Overall Study|Adverse Event|0
2332770|NCT03205371|4056718|FG002|Overall Study|Adverse Event|0
2332771|NCT03205371|4056719|FG003|Overall Study|Adverse Event|0
2332772|NCT03205371|4056720|FG004|Overall Study|Adverse Event|0
2332773|NCT03205371|4056721|FG005|Overall Study|Adverse Event|0
2332774|NCT03205371|4056722|FG006|Overall Study|Adverse Event|0
2332775|NCT03205371|4056723|FG007|Overall Study|Adverse Event|1
2332776|NCT03205371|4056724|FG008|Overall Study|Adverse Event|0
2332777|NCT03205371|4056725|FG009|Overall Study|Adverse Event|0
2332778|NCT03205371|4056726|FG010|Overall Study|Adverse Event|0
2332779|NCT03205371|4056727|FG011|Overall Study|Adverse Event|0
2332780|NCT03205488|4056776|FG000|Overall Study|Adverse Event|1
2332781|NCT03205488|4056777|FG001|Overall Study|Adverse Event|2
2332782|NCT03205488|4056778|FG002|Overall Study|Adverse Event|4
2274341|NCT02296112|3955339|FG000|Overall Study|Disease progression|7
2274342|NCT02296112|3955339|FG000|Overall Study|Toxicity|1
2332783|NCT03205488|4056776|FG000|Overall Study|Protocol Violation|0
2332784|NCT03205488|4056777|FG001|Overall Study|Protocol Violation|0
2332785|NCT03205488|4056778|FG002|Overall Study|Protocol Violation|1
2230174|NCT01824498|3880767|FG000|Washout (8 Weeks)|Withdrawal by Subject|2
2230175|NCT01824498|3880768|FG001|Washout (8 Weeks)|Withdrawal by Subject|0
2230176|NCT01824498|3880769|FG002|Washout (8 Weeks)|Withdrawal by Subject|2
2230177|NCT01824498|3880770|FG003|Washout (8 Weeks)|Withdrawal by Subject|1
2230178|NCT01824498|3880771|FG004|Washout (8 Weeks)|Withdrawal by Subject|1
2230179|NCT01824498|3880772|FG005|Washout (8 Weeks)|Withdrawal by Subject|0
2230180|NCT01824576|3880780|FG000|Overall Study|Device deficiency|2
2230181|NCT01824602|3880805|FG000|Overall Study|Withdrawal by Subject|0
2230182|NCT01824602|3880806|FG001|Overall Study|Withdrawal by Subject|0
2230183|NCT01824602|3880807|FG002|Overall Study|Withdrawal by Subject|1
2230184|NCT01824602|3880808|FG003|Overall Study|Withdrawal by Subject|2
2230185|NCT01824602|3880805|FG000|Overall Study|Patient non-compliance|0
2230186|NCT01824602|3880806|FG001|Overall Study|Patient non-compliance|0
2230187|NCT01824602|3880807|FG002|Overall Study|Patient non-compliance|1
2230188|NCT01824602|3880808|FG003|Overall Study|Patient non-compliance|0
2230189|NCT01824602|3880805|FG000|Overall Study|Adverse Event|1
2230190|NCT01824602|3880806|FG001|Overall Study|Adverse Event|0
2230191|NCT01824602|3880807|FG002|Overall Study|Adverse Event|2
2230192|NCT01824602|3880808|FG003|Overall Study|Adverse Event|2
2230193|NCT01824602|3880805|FG000|Overall Study|Treatment failure|0
2230194|NCT01824602|3880806|FG001|Overall Study|Treatment failure|0
2230195|NCT01824602|3880807|FG002|Overall Study|Treatment failure|0
2230196|NCT01824602|3880808|FG003|Overall Study|Treatment failure|1
2230197|NCT01824693|3880821|FG000|Overall Study|Death|0
2230198|NCT01824693|3880822|FG001|Overall Study|Death|1
2230199|NCT01824693|3880823|FG002|Overall Study|Death|0
2230200|NCT01824693|3880821|FG000|Overall Study|Physician Decision|1
2230201|NCT01824693|3880822|FG001|Overall Study|Physician Decision|1
2230202|NCT01824693|3880823|FG002|Overall Study|Physician Decision|1
2230203|NCT01824693|3880821|FG000|Overall Study|Withdrawal by Subject|0
2230204|NCT01824693|3880822|FG001|Overall Study|Withdrawal by Subject|0
2230205|NCT01824693|3880823|FG002|Overall Study|Withdrawal by Subject|1
2230206|NCT01824693|3880821|FG000|Overall Study|Progressive Disease|0
2230207|NCT01824693|3880822|FG001|Overall Study|Progressive Disease|5
2230208|NCT01824693|3880823|FG002|Overall Study|Progressive Disease|0
2230209|NCT01824693|3880821|FG000|Overall Study|Ineligible|0
2230210|NCT01824693|3880822|FG001|Overall Study|Ineligible|0
2230211|NCT01824693|3880823|FG002|Overall Study|Ineligible|3
2230212|NCT01824693|3880821|FG000|Overall Study|No Transplant Planned|0
2230213|NCT01824693|3880822|FG001|Overall Study|No Transplant Planned|0
2230214|NCT01824693|3880823|FG002|Overall Study|No Transplant Planned|10
2230215|NCT01824823|3880832|FG000|Overall Study|Lack of Efficacy|1
2230216|NCT01824823|3880833|FG001|Overall Study|Lack of Efficacy|1
2230217|NCT01824823|3880832|FG000|Overall Study|Off-treatment reason not submitted|1
2230218|NCT01824823|3880833|FG001|Overall Study|Off-treatment reason not submitted|0
2230219|NCT01824979|3880848|FG000|Overall Study|Withdrawal by Subject|5
2230220|NCT01824979|3880849|FG001|Overall Study|Withdrawal by Subject|0
2230221|NCT01824979|3880848|FG000|Overall Study|Physician Decision|2
2230222|NCT01824979|3880849|FG001|Overall Study|Physician Decision|0
2230223|NCT01824979|3880848|FG000|Overall Study|Protocol Violation|6
2230224|NCT01824979|3880849|FG001|Overall Study|Protocol Violation|13
2230225|NCT01825200|3880882|FG000|Overall Study|Lost to Follow-up|5
2230226|NCT01825200|3880883|FG001|Overall Study|Lost to Follow-up|6
2230227|NCT01825200|3880882|FG000|Overall Study|Withdrawal by Subject|0
2230228|NCT01825200|3880883|FG001|Overall Study|Withdrawal by Subject|1
2230229|NCT01825577|3880915|FG000|Overall Study|Physician Decision|2
2230230|NCT01825577|3880915|FG000|Overall Study|Withdrawal by Subject|1
2230231|NCT01825577|3880915|FG000|Overall Study|Withdrawn by family members|2
2230232|NCT01825577|3880915|FG000|Overall Study|Lack of Efficacy|3
2230233|NCT01825785|3880935|FG000|Overall Study|Adverse Event|0
2230234|NCT01825785|3880936|FG001|Overall Study|Adverse Event|0
2230235|NCT01825785|3880937|FG002|Overall Study|Adverse Event|0
2230236|NCT01825785|3880938|FG003|Overall Study|Adverse Event|0
2230237|NCT01825785|3880939|FG004|Overall Study|Adverse Event|1
2230238|NCT01825785|3880940|FG005|Overall Study|Adverse Event|0
2230239|NCT01825785|3880941|FG006|Overall Study|Adverse Event|0
2230240|NCT01825785|3880935|FG000|Overall Study|Withdrawal by Subject|0
2230241|NCT01825785|3880936|FG001|Overall Study|Withdrawal by Subject|0
2230242|NCT01825785|3880937|FG002|Overall Study|Withdrawal by Subject|0
2230243|NCT01825785|3880938|FG003|Overall Study|Withdrawal by Subject|0
2230244|NCT01825785|3880939|FG004|Overall Study|Withdrawal by Subject|1
2230245|NCT01825785|3880940|FG005|Overall Study|Withdrawal by Subject|1
2230246|NCT01825785|3880941|FG006|Overall Study|Withdrawal by Subject|0
2230247|NCT01825798|3880965|FG000|Overall Study|Adverse Event|1
2230248|NCT01825798|3880966|FG001|Overall Study|Adverse Event|5
2230249|NCT01825798|3880965|FG000|Overall Study|Lost to Follow-up|1
2230250|NCT01825798|3880966|FG001|Overall Study|Lost to Follow-up|0
2230251|NCT01825837|3880976|FG000|PART I|Withdrawal by Subject|0
2230252|NCT01825837|3880977|FG001|PART I|Withdrawal by Subject|0
2230253|NCT01825837|3880978|FG002|PART I|Withdrawal by Subject|0
2230254|NCT01825837|3880979|FG003|PART I|Withdrawal by Subject|6
2230255|NCT01825837|3880976|FG000|PART I|Patient non-compliance|0
2230256|NCT01825837|3880977|FG001|PART I|Patient non-compliance|0
2230257|NCT01825837|3880978|FG002|PART I|Patient non-compliance|0
2230258|NCT01825837|3880979|FG003|PART I|Patient non-compliance|1
2230259|NCT01825837|3880976|FG000|PART I|Treatment failure|0
2230260|NCT01825837|3880977|FG001|PART I|Treatment failure|0
2230261|NCT01825837|3880978|FG002|PART I|Treatment failure|0
2230262|NCT01825837|3880979|FG003|PART I|Treatment failure|7
2230263|NCT01825837|3880976|FG000|PART I|reason unspecified|0
2230264|NCT01825837|3880977|FG001|PART I|reason unspecified|0
2230265|NCT01825837|3880978|FG002|PART I|reason unspecified|0
2230266|NCT01825837|3880979|FG003|PART I|reason unspecified|3
2230267|NCT01825837|3880976|FG000|PART II|Withdrawal by Subject|3
2230268|NCT01825837|3880977|FG001|PART II|Withdrawal by Subject|3
2230269|NCT01825837|3880978|FG002|PART II|Withdrawal by Subject|7
2230270|NCT01825837|3880979|FG003|PART II|Withdrawal by Subject|0
2230271|NCT01825837|3880976|FG000|PART II|Patient non-compliance|5
2230272|NCT01825837|3880977|FG001|PART II|Patient non-compliance|2
2230273|NCT01825837|3880978|FG002|PART II|Patient non-compliance|4
2230274|NCT01825837|3880979|FG003|PART II|Patient non-compliance|0
2230275|NCT01825837|3880976|FG000|PART II|Adverse Event|3
2230276|NCT01825837|3880977|FG001|PART II|Adverse Event|3
2230277|NCT01825837|3880978|FG002|PART II|Adverse Event|1
2230278|NCT01825837|3880979|FG003|PART II|Adverse Event|0
2230279|NCT01825837|3880976|FG000|PART II|Treatment failure|6
2230280|NCT01825837|3880977|FG001|PART II|Treatment failure|4
2230281|NCT01825837|3880978|FG002|PART II|Treatment failure|5
2230282|NCT01825837|3880979|FG003|PART II|Treatment failure|0
2230283|NCT01825837|3880976|FG000|PART II|reason unspecified|2
2230284|NCT01825837|3880977|FG001|PART II|reason unspecified|2
2230285|NCT01825837|3880978|FG002|PART II|reason unspecified|2
2230286|NCT01825837|3880979|FG003|PART II|reason unspecified|0
2230287|NCT01825876|3880987|FG000|Period 2|Withdrawal by Subject|0
2230288|NCT01825876|3880988|FG001|Period 2|Withdrawal by Subject|1
2230289|NCT01825941|3881008|FG000|Overall Study|Lost to Follow-up|4
2230290|NCT01825941|3881009|FG001|Overall Study|Lost to Follow-up|1
2230291|NCT01826201|3881015|FG000|Overall Study|Non compliance with protocol|4
2230292|NCT01826214|3881023|FG000|Overall Study|Adverse Event|7
2230293|NCT01826214|3881024|FG001|Overall Study|Adverse Event|6
2230294|NCT01826214|3881023|FG000|Overall Study|Death|3
2332786|NCT03205566|4056792|FG000|Phase 1|Protocol Violation|1
2332787|NCT03205566|4056793|FG001|Phase 1|Protocol Violation|1
2332788|NCT03206749|4056806|FG000|Overall Study|Withdrawal of consent|5
2332789|NCT03206749|4056807|FG001|Overall Study|Withdrawal of consent|3
2332790|NCT03206749|4056808|FG002|Overall Study|Withdrawal of consent|6
2332791|NCT03206749|4056806|FG000|Overall Study|Lost to Follow-up|0
2332792|NCT03206749|4056807|FG001|Overall Study|Lost to Follow-up|0
2332793|NCT03206749|4056808|FG002|Overall Study|Lost to Follow-up|1
2332794|NCT03206788|4056819|FG000|Overall Study|Withdrawal by Subject|0
2332795|NCT03206788|4056820|FG001|Overall Study|Withdrawal by Subject|1
2332796|NCT03206788|4056819|FG000|Overall Study|Adverse Event|0
2332797|NCT03206788|4056820|FG001|Overall Study|Adverse Event|1
2332798|NCT03206788|4056819|FG000|Overall Study|Physician Decision|0
2332799|NCT03206788|4056820|FG001|Overall Study|Physician Decision|1
2332800|NCT03206918|4056826|FG000|Overall Study|Death|11
2332801|NCT03206918|4056826|FG000|Overall Study|Withdrawal by Subject|5
2332802|NCT03206918|4056826|FG000|Overall Study|Study terminated by sponsor|12
2332803|NCT03206918|4056826|FG000|Overall Study|Lost to Follow-up|3
2332804|NCT03206918|4056826|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60
2332805|NCT03206970|4056831|FG000|Overall Study|Death|21
2332806|NCT03206970|4056831|FG000|Overall Study|Withdrawal by Subject|13
2332807|NCT03206970|4056831|FG000|Overall Study|Lost to Follow-up|3
2332808|NCT03206970|4056831|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49
2332809|NCT03207243|4056859|FG000|Overall Study|Adverse Event|2
2332810|NCT03207243|4056860|FG001|Overall Study|Adverse Event|2
2332811|NCT03207243|4056859|FG000|Overall Study|Loss of Asthma Control|47
2332812|NCT03207243|4056860|FG001|Overall Study|Loss of Asthma Control|31
2332813|NCT03207243|4056859|FG000|Overall Study|Withdrawal by Subject|2
2332814|NCT03207243|4056860|FG001|Overall Study|Withdrawal by Subject|4
2332815|NCT03207243|4056859|FG000|Overall Study|Physician Decision|1
2332816|NCT03207243|4056860|FG001|Overall Study|Physician Decision|1
2332817|NCT03207243|4056859|FG000|Overall Study|Lost to Follow-up|0
2332818|NCT03207243|4056860|FG001|Overall Study|Lost to Follow-up|1
2332819|NCT03207243|4056859|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7
2332820|NCT03207243|4056860|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2
2332821|NCT03207243|4056859|FG000|Overall Study|Protocol Violation|0
2332822|NCT03207243|4056860|FG001|Overall Study|Protocol Violation|3
2332823|NCT03207750|4056900|FG000|Overall Study|Adverse Event|3
2332824|NCT03207750|4056901|FG001|Overall Study|Adverse Event|2
2332825|NCT03207750|4056900|FG000|Overall Study|Lost to Follow-up|21
2332826|NCT03207750|4056901|FG001|Overall Study|Lost to Follow-up|29
2332827|NCT03207750|4056900|FG000|Overall Study|Protocol Violation|0
2230295|NCT01826214|3881024|FG001|Overall Study|Death|1
2230296|NCT01826214|3881023|FG000|Overall Study|Lost to Follow-up|1
2332828|NCT03207750|4056901|FG001|Overall Study|Protocol Violation|1
2230297|NCT01826214|3881024|FG001|Overall Study|Lost to Follow-up|0
2230298|NCT01826214|3881023|FG000|Overall Study|Physician Decision|0
2230299|NCT01826214|3881024|FG001|Overall Study|Physician Decision|2
2230300|NCT01826214|3881023|FG000|Overall Study|Progressive disease|22
2230301|NCT01826214|3881024|FG001|Overall Study|Progressive disease|21
2230302|NCT01826214|3881023|FG000|Overall Study|Study terminated by Sponsor|0
2230303|NCT01826214|3881024|FG001|Overall Study|Study terminated by Sponsor|1
2230304|NCT01826214|3881023|FG000|Overall Study|Subject/guardian decision|2
2230305|NCT01826214|3881024|FG001|Overall Study|Subject/guardian decision|3
2230306|NCT01826370|3881034|FG000|Overall Study|Protocol Violation|6
2230307|NCT01826370|3881034|FG000|Overall Study|Lost to Follow-up|12
2230308|NCT01826370|3881034|FG000|Overall Study|Other reason not defined above|2
2230309|NCT01826422|3881040|FG000|Overall Study|Withdrawal by Subject|1
2230310|NCT01826422|3881041|FG001|Overall Study|Withdrawal by Subject|3
2230311|NCT01826448|3881049|FG000|Overall Study|Adverse Event|1
2230312|NCT01826448|3881050|FG001|Overall Study|Adverse Event|3
2230313|NCT01826448|3881049|FG000|Overall Study|Disease progression|2
2230314|NCT01826448|3881050|FG001|Overall Study|Disease progression|4
2230315|NCT01826448|3881049|FG000|Overall Study|Withdrawal by Subject|1
2230316|NCT01826448|3881050|FG001|Overall Study|Withdrawal by Subject|0
2230317|NCT01826448|3881049|FG000|Overall Study|Physician Decision|0
2230318|NCT01826448|3881050|FG001|Overall Study|Physician Decision|1
2230319|NCT01826448|3881049|FG000|Overall Study|2 active cancers|0
2230320|NCT01826448|3881050|FG001|Overall Study|2 active cancers|1
2230321|NCT01826487|3881058|FG000|Overall Study|Adverse Event|1
2230322|NCT01826487|3881059|FG001|Overall Study|Adverse Event|1
2230323|NCT01826487|3881058|FG000|Overall Study|Lost to Follow-up|1
2230324|NCT01826487|3881059|FG001|Overall Study|Lost to Follow-up|0
2230325|NCT01826487|3881058|FG000|Overall Study|Withdrawal by Subject|1
2230326|NCT01826487|3881059|FG001|Overall Study|Withdrawal by Subject|3
2230327|NCT01826487|3881058|FG000|Overall Study|Protocol Violation|1
2230328|NCT01826487|3881059|FG001|Overall Study|Protocol Violation|1
2230329|NCT01826604|3881080|FG000|Overall Study|Lost to Follow-up|8
2230330|NCT01826604|3881081|FG001|Overall Study|Lost to Follow-up|9
2230331|NCT01826825|3881100|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0
2230332|NCT01826825|3881101|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2
2230333|NCT01826981|3881133|FG000|Overall Study|Lack of Efficacy|0
2230334|NCT01826981|3881134|FG001|Overall Study|Lack of Efficacy|1
2230335|NCT01826981|3881135|FG002|Overall Study|Lack of Efficacy|0
2230336|NCT01826981|3881136|FG003|Overall Study|Lack of Efficacy|0
2230337|NCT01826981|3881137|FG004|Overall Study|Lack of Efficacy|5
2230338|NCT01826981|3881138|FG005|Overall Study|Lack of Efficacy|0
2230339|NCT01826981|3881139|FG006|Overall Study|Lack of Efficacy|0
2230340|NCT01826981|3881140|FG007|Overall Study|Lack of Efficacy|8
2230341|NCT01826981|3881141|FG008|Overall Study|Lack of Efficacy|7
2230342|NCT01826981|3881142|FG009|Overall Study|Lack of Efficacy|0
2230343|NCT01826981|3881143|FG010|Overall Study|Lack of Efficacy|1
2230344|NCT01826981|3881144|FG011|Overall Study|Lack of Efficacy|0
2230345|NCT01826981|3881145|FG012|Overall Study|Lack of Efficacy|0
2230346|NCT01826981|3881146|FG013|Overall Study|Lack of Efficacy|3
2230347|NCT01826981|3881147|FG014|Overall Study|Lack of Efficacy|0
2230348|NCT01826981|3881133|FG000|Overall Study|Lost to Follow-up|0
2230349|NCT01826981|3881134|FG001|Overall Study|Lost to Follow-up|0
2230350|NCT01826981|3881135|FG002|Overall Study|Lost to Follow-up|0
2230351|NCT01826981|3881136|FG003|Overall Study|Lost to Follow-up|0
2230352|NCT01826981|3881137|FG004|Overall Study|Lost to Follow-up|1
2230353|NCT01826981|3881138|FG005|Overall Study|Lost to Follow-up|1
2230354|NCT01826981|3881139|FG006|Overall Study|Lost to Follow-up|0
2230355|NCT01826981|3881140|FG007|Overall Study|Lost to Follow-up|1
2230356|NCT01826981|3881141|FG008|Overall Study|Lost to Follow-up|0
2230357|NCT01826981|3881142|FG009|Overall Study|Lost to Follow-up|1
2230358|NCT01826981|3881143|FG010|Overall Study|Lost to Follow-up|1
2230359|NCT01826981|3881144|FG011|Overall Study|Lost to Follow-up|1
2230360|NCT01826981|3881145|FG012|Overall Study|Lost to Follow-up|1
2230361|NCT01826981|3881146|FG013|Overall Study|Lost to Follow-up|0
2230362|NCT01826981|3881147|FG014|Overall Study|Lost to Follow-up|0
2230363|NCT01826981|3881133|FG000|Overall Study|Withdrew Consent|0
2230364|NCT01826981|3881134|FG001|Overall Study|Withdrew Consent|0
2230365|NCT01826981|3881135|FG002|Overall Study|Withdrew Consent|0
2230366|NCT01826981|3881136|FG003|Overall Study|Withdrew Consent|0
2230367|NCT01826981|3881137|FG004|Overall Study|Withdrew Consent|0
2230368|NCT01826981|3881138|FG005|Overall Study|Withdrew Consent|0
2230369|NCT01826981|3881139|FG006|Overall Study|Withdrew Consent|1
2230370|NCT01826981|3881140|FG007|Overall Study|Withdrew Consent|1
2230371|NCT01826981|3881141|FG008|Overall Study|Withdrew Consent|0
2230372|NCT01826981|3881142|FG009|Overall Study|Withdrew Consent|0
2230373|NCT01826981|3881143|FG010|Overall Study|Withdrew Consent|0
2230374|NCT01826981|3881144|FG011|Overall Study|Withdrew Consent|1
2230375|NCT01826981|3881145|FG012|Overall Study|Withdrew Consent|0
2230376|NCT01826981|3881146|FG013|Overall Study|Withdrew Consent|1
2230377|NCT01826981|3881147|FG014|Overall Study|Withdrew Consent|0
2230378|NCT01826981|3881133|FG000|Overall Study|Adverse Event|0
2230379|NCT01826981|3881134|FG001|Overall Study|Adverse Event|0
2230380|NCT01826981|3881135|FG002|Overall Study|Adverse Event|0
2230381|NCT01826981|3881136|FG003|Overall Study|Adverse Event|0
2230382|NCT01826981|3881137|FG004|Overall Study|Adverse Event|1
2230383|NCT01826981|3881138|FG005|Overall Study|Adverse Event|0
2230384|NCT01826981|3881139|FG006|Overall Study|Adverse Event|0
2230385|NCT01826981|3881140|FG007|Overall Study|Adverse Event|0
2230386|NCT01826981|3881141|FG008|Overall Study|Adverse Event|0
2230387|NCT01826981|3881142|FG009|Overall Study|Adverse Event|0
2230388|NCT01826981|3881143|FG010|Overall Study|Adverse Event|0
2230389|NCT01826981|3881144|FG011|Overall Study|Adverse Event|0
2230390|NCT01826981|3881145|FG012|Overall Study|Adverse Event|0
2230391|NCT01826981|3881146|FG013|Overall Study|Adverse Event|0
2230392|NCT01826981|3881147|FG014|Overall Study|Adverse Event|0
2230393|NCT01826981|3881133|FG000|Overall Study|Upper G-I Haemorrhage|0
2230394|NCT01826981|3881134|FG001|Overall Study|Upper G-I Haemorrhage|0
2230395|NCT01826981|3881135|FG002|Overall Study|Upper G-I Haemorrhage|0
2230396|NCT01826981|3881136|FG003|Overall Study|Upper G-I Haemorrhage|0
2230397|NCT01826981|3881137|FG004|Overall Study|Upper G-I Haemorrhage|0
2230398|NCT01826981|3881138|FG005|Overall Study|Upper G-I Haemorrhage|0
2230399|NCT01826981|3881139|FG006|Overall Study|Upper G-I Haemorrhage|0
2230400|NCT01826981|3881140|FG007|Overall Study|Upper G-I Haemorrhage|0
2230401|NCT01826981|3881141|FG008|Overall Study|Upper G-I Haemorrhage|0
2230402|NCT01826981|3881142|FG009|Overall Study|Upper G-I Haemorrhage|0
2230403|NCT01826981|3881143|FG010|Overall Study|Upper G-I Haemorrhage|0
2230404|NCT01826981|3881144|FG011|Overall Study|Upper G-I Haemorrhage|0
2230405|NCT01826981|3881145|FG012|Overall Study|Upper G-I Haemorrhage|0
2230406|NCT01826981|3881146|FG013|Overall Study|Upper G-I Haemorrhage|1
2230407|NCT01826981|3881147|FG014|Overall Study|Upper G-I Haemorrhage|0
2230408|NCT01826981|3881133|FG000|Overall Study|Enrolled/Randomized but Not Treated|0
2230409|NCT01826981|3881134|FG001|Overall Study|Enrolled/Randomized but Not Treated|0
2230410|NCT01826981|3881135|FG002|Overall Study|Enrolled/Randomized but Not Treated|0
2230411|NCT01826981|3881136|FG003|Overall Study|Enrolled/Randomized but Not Treated|0
2230412|NCT01826981|3881137|FG004|Overall Study|Enrolled/Randomized but Not Treated|0
2230413|NCT01826981|3881138|FG005|Overall Study|Enrolled/Randomized but Not Treated|0
2230414|NCT01826981|3881139|FG006|Overall Study|Enrolled/Randomized but Not Treated|0
2230415|NCT01826981|3881140|FG007|Overall Study|Enrolled/Randomized but Not Treated|1
2230416|NCT01826981|3881141|FG008|Overall Study|Enrolled/Randomized but Not Treated|0
2230417|NCT01826981|3881142|FG009|Overall Study|Enrolled/Randomized but Not Treated|0
2230418|NCT01826981|3881143|FG010|Overall Study|Enrolled/Randomized but Not Treated|0
2230419|NCT01826981|3881144|FG011|Overall Study|Enrolled/Randomized but Not Treated|0
2230420|NCT01826981|3881145|FG012|Overall Study|Enrolled/Randomized but Not Treated|0
2230421|NCT01826981|3881146|FG013|Overall Study|Enrolled/Randomized but Not Treated|0
2230422|NCT01826981|3881147|FG014|Overall Study|Enrolled/Randomized but Not Treated|0
2230423|NCT01827046|3881185|FG000|Overall Study|Lost to Follow-up|1
2230424|NCT01827046|3881186|FG001|Overall Study|Lost to Follow-up|5
2230425|NCT01827046|3881185|FG000|Overall Study|Withdrawal by Subject|0
2230426|NCT01827046|3881186|FG001|Overall Study|Withdrawal by Subject|4
2230427|NCT01827163|3881192|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2
2230428|NCT01827163|3881192|FG000|Overall Study|Adverse Event|9
2230429|NCT01827254|3881196|FG000|Overall Study|Death|10
2230430|NCT01827254|3881196|FG000|Overall Study|Case report form not completed|4
2230431|NCT01827254|3881196|FG000|Overall Study|Invalidated centre|3
2230432|NCT01827254|3881196|FG000|Overall Study|Discontinued prior initiation: sunitinib|1
2230433|NCT01827254|3881196|FG000|Overall Study|Did not complete re-challenge|1
2230434|NCT01827254|3881196|FG000|Overall Study|Disease progression|36
2230435|NCT01827254|3881196|FG000|Overall Study|Intolerance to treatment|4
2230436|NCT01827267|3881206|FG000|Overall Study|Did not receive study drug|1
2230437|NCT01827267|3881207|FG001|Overall Study|Did not receive study drug|1
2230438|NCT01827267|3881206|FG000|Overall Study|Physician Decision|1
2230439|NCT01827267|3881207|FG001|Overall Study|Physician Decision|0
2230440|NCT01827267|3881206|FG000|Overall Study|Disease Progression|1
2230441|NCT01827267|3881207|FG001|Overall Study|Disease Progression|1
2230442|NCT01827267|3881206|FG000|Overall Study|Sponsor Discontinued Study|2
2230443|NCT01827267|3881207|FG001|Overall Study|Sponsor Discontinued Study|8
2230444|NCT01827267|3881206|FG000|Overall Study|Still on study|0
2230445|NCT01827267|3881207|FG001|Overall Study|Still on study|2
2230446|NCT01827319|3881223|FG000|Overall Study|Lost to Follow-up|3
2230447|NCT01827332|3881229|FG000|Overall Study|Lost to Follow-up|2
2230448|NCT01827332|3881230|FG001|Overall Study|Lost to Follow-up|1
2230449|NCT01827371|3881249|FG000|Overall Study|Adverse Event|0
2230450|NCT01827371|3881250|FG001|Overall Study|Adverse Event|0
2230451|NCT01827371|3881251|FG002|Overall Study|Adverse Event|4
2230452|NCT01827371|3881252|FG003|Overall Study|Adverse Event|2
2230453|NCT01827371|3881249|FG000|Overall Study|Lost to Follow-up|0
2230454|NCT01827371|3881250|FG001|Overall Study|Lost to Follow-up|2
2230455|NCT01827371|3881251|FG002|Overall Study|Lost to Follow-up|0
2230456|NCT01827371|3881252|FG003|Overall Study|Lost to Follow-up|4
2230457|NCT01827371|3881249|FG000|Overall Study|Protocol Violation|1
2230458|NCT01827371|3881250|FG001|Overall Study|Protocol Violation|0
2230459|NCT01827371|3881251|FG002|Overall Study|Protocol Violation|0
2230460|NCT01827371|3881252|FG003|Overall Study|Protocol Violation|0
2230461|NCT01827371|3881249|FG000|Overall Study|Withdrawal by Subject|1
2230462|NCT01827371|3881250|FG001|Overall Study|Withdrawal by Subject|2
2230463|NCT01827371|3881251|FG002|Overall Study|Withdrawal by Subject|2
2230464|NCT01827371|3881252|FG003|Overall Study|Withdrawal by Subject|3
2230465|NCT01827371|3881249|FG000|Overall Study|Physician Decision|0
2230466|NCT01827371|3881250|FG001|Overall Study|Physician Decision|1
2230467|NCT01827371|3881251|FG002|Overall Study|Physician Decision|0
2230468|NCT01827371|3881252|FG003|Overall Study|Physician Decision|1
2230469|NCT01827371|3881249|FG000|Overall Study|Temporary study halt to vaccinations|11
2230470|NCT01827371|3881250|FG001|Overall Study|Temporary study halt to vaccinations|2
2230471|NCT01827371|3881251|FG002|Overall Study|Temporary study halt to vaccinations|5
2230472|NCT01827371|3881252|FG003|Overall Study|Temporary study halt to vaccinations|13
2230473|NCT01827592|3881294|FG000|Overall Study|Adverse Event|11
2230474|NCT01827592|3881295|FG001|Overall Study|Adverse Event|9
2230475|NCT01827592|3881296|FG002|Overall Study|Adverse Event|2
2230476|NCT01827592|3881294|FG000|Overall Study|Physician Decision|0
2230477|NCT01827592|3881295|FG001|Overall Study|Physician Decision|2
2230478|NCT01827592|3881296|FG002|Overall Study|Physician Decision|1
2230479|NCT01827592|3881294|FG000|Overall Study|Protocol Violation|2
2230480|NCT01827592|3881295|FG001|Overall Study|Protocol Violation|1
2230481|NCT01827592|3881296|FG002|Overall Study|Protocol Violation|0
2230482|NCT01827592|3881294|FG000|Overall Study|Lost to Follow-up|1
2230483|NCT01827592|3881295|FG001|Overall Study|Lost to Follow-up|2
2230484|NCT01827592|3881296|FG002|Overall Study|Lost to Follow-up|2
2230485|NCT01827592|3881294|FG000|Overall Study|Withdrawal by Subject|12
2230486|NCT01827592|3881295|FG001|Overall Study|Withdrawal by Subject|11
2230487|NCT01827592|3881296|FG002|Overall Study|Withdrawal by Subject|11
2230488|NCT01827592|3881294|FG000|Overall Study|Patient's substantial non-compliance|1
2230489|NCT01827592|3881295|FG001|Overall Study|Patient's substantial non-compliance|1
2230490|NCT01827592|3881296|FG002|Overall Study|Patient's substantial non-compliance|6
2230491|NCT01827592|3881294|FG000|Overall Study|Trial terminated by Sponsor|47
2230492|NCT01827592|3881295|FG001|Overall Study|Trial terminated by Sponsor|53
2230493|NCT01827592|3881296|FG002|Overall Study|Trial terminated by Sponsor|51
2230494|NCT01827592|3881294|FG000|Overall Study|Others|0
2230495|NCT01827592|3881295|FG001|Overall Study|Others|1
2230496|NCT01827592|3881296|FG002|Overall Study|Others|3
2230497|NCT01827670|3881306|FG000|Overall Study|Withdrawal of Consent|3
2230498|NCT01827670|3881307|FG001|Overall Study|Withdrawal of Consent|2
2230499|NCT01827670|3881306|FG000|Overall Study|Lost to Follow-up|0
2230500|NCT01827670|3881307|FG001|Overall Study|Lost to Follow-up|1
2230501|NCT01827839|3881330|FG000|Overall Study|Adverse Event|1
2230502|NCT01827839|3881330|FG000|Overall Study|Consent Withdrawal|2
2230503|NCT01827943|3881354|FG000|Overall Study|Protocol Violation|8
2230504|NCT01827943|3881354|FG000|Overall Study|Never treated because of an rapid progression|1
2230505|NCT01828034|3881362|FG000|Overall Study|Withdrawal by Subject|0
2230506|NCT01828034|3881363|FG001|Overall Study|Withdrawal by Subject|0
2230507|NCT01828034|3881364|FG002|Overall Study|Withdrawal by Subject|0
2230508|NCT01828034|3881365|FG003|Overall Study|Withdrawal by Subject|1
2230509|NCT01828073|3881374|FG000|Overall Study|Lost to Follow-up|1
2230510|NCT01828073|3881375|FG001|Overall Study|Lost to Follow-up|2
2230511|NCT01828112|3881389|FG000|Overall Study|Adverse Event|6
2230512|NCT01828112|3881390|FG001|Overall Study|Adverse Event|8
2230513|NCT01828112|3881389|FG000|Overall Study|Death|9
2230514|NCT01828112|3881390|FG001|Overall Study|Death|5
2230515|NCT01828112|3881389|FG000|Overall Study|Physician Decision|5
2230516|NCT01828112|3881390|FG001|Overall Study|Physician Decision|5
2230517|NCT01828112|3881389|FG000|Overall Study|Progressive disease|56
2230518|NCT01828112|3881390|FG001|Overall Study|Progressive disease|82
2230519|NCT01828112|3881389|FG000|Overall Study|Subject/guardian decision|6
2230520|NCT01828112|3881390|FG001|Overall Study|Subject/guardian decision|8
2230521|NCT01828281|3881428|FG000|Overall Study|Withdrawal by Subject|1
2230522|NCT01828281|3881429|FG001|Overall Study|Withdrawal by Subject|0
2230523|NCT01828567|3881460|FG000|Overall Study|Lost to Follow-up|27
2230524|NCT01828567|3881461|FG001|Overall Study|Lost to Follow-up|9
2230525|NCT01828567|3881460|FG000|Overall Study|Excluded - did not meet criteria|4
2230526|NCT01828567|3881461|FG001|Overall Study|Excluded - did not meet criteria|1
2230527|NCT01829048|3881497|FG000|Overall Study|Withdrawal by Subject|0
2230528|NCT01829048|3881498|FG001|Overall Study|Withdrawal by Subject|0
2230529|NCT01829048|3881499|FG002|Overall Study|Withdrawal by Subject|0
2230530|NCT01829048|3881500|FG003|Overall Study|Withdrawal by Subject|2
2230531|NCT01829048|3881501|FG004|Overall Study|Withdrawal by Subject|0
2230532|NCT01829113|3881516|FG000|Overall Study|Disease Progression|37
2230533|NCT01829113|3881517|FG001|Overall Study|Disease Progression|48
2230534|NCT01829113|3881516|FG000|Overall Study|Adverse Event|14
2230535|NCT01829113|3881517|FG001|Overall Study|Adverse Event|10
2230536|NCT01829113|3881516|FG000|Overall Study|Withdrawal by Subject|17
2230537|NCT01829113|3881517|FG001|Overall Study|Withdrawal by Subject|10
2230538|NCT01829113|3881516|FG000|Overall Study|Death|4
2230539|NCT01829113|3881517|FG001|Overall Study|Death|6
2230540|NCT01829113|3881516|FG000|Overall Study|Sponsor Decision|1
2230541|NCT01829113|3881517|FG001|Overall Study|Sponsor Decision|1
2230542|NCT01829113|3881516|FG000|Overall Study|No Study Treatment Received|3
2230543|NCT01829113|3881517|FG001|Overall Study|No Study Treatment Received|2
2230544|NCT01829113|3881516|FG000|Overall Study|Physician Decision|1
2230545|NCT01829113|3881517|FG001|Overall Study|Physician Decision|1
2230546|NCT01829165|3881527|FG000|Overall Study|Did not complete intervention|2
2230547|NCT01829165|3881528|FG001|Overall Study|Did not complete intervention|0
2230548|NCT01829191|3881536|FG000|Overall Study|Relocation|0
2230549|NCT01829191|3881537|FG001|Overall Study|Relocation|1
2230550|NCT01829191|3881536|FG000|Overall Study|Lens discomfort|0
2230551|NCT01829191|3881537|FG001|Overall Study|Lens discomfort|3
2230552|NCT01829191|3881536|FG000|Overall Study|Lens handling difficulty|1
2230553|NCT01829191|3881537|FG001|Overall Study|Lens handling difficulty|4
2230554|NCT01829191|3881536|FG000|Overall Study|Protocol Violation|4
2230555|NCT01829191|3881537|FG001|Overall Study|Protocol Violation|1
2230556|NCT01829191|3881536|FG000|Overall Study|Withdrawal by Subject|2
2230557|NCT01829191|3881537|FG001|Overall Study|Withdrawal by Subject|3
2230558|NCT01829191|3881536|FG000|Overall Study|Lost to Follow-up|0
2230559|NCT01829191|3881537|FG001|Overall Study|Lost to Follow-up|1
2230560|NCT01829191|3881536|FG000|Overall Study|Subject was fit for ortho - k|0
2230561|NCT01829191|3881537|FG001|Overall Study|Subject was fit for ortho - k|1
2230562|NCT01829230|3881548|FG000|Overall Study|Protocol Violation|0
2230563|NCT01829230|3881549|FG001|Overall Study|Protocol Violation|2
2230564|NCT01829230|3881548|FG000|Overall Study|Withdrawal by Subject|0
2230565|NCT01829230|3881549|FG001|Overall Study|Withdrawal by Subject|1
2230566|NCT01829230|3881548|FG000|Overall Study|Lost to Follow-up|1
2230567|NCT01829230|3881549|FG001|Overall Study|Lost to Follow-up|1
2230568|NCT01829243|3881555|FG000|First Intervention|Screen Failure|4
2230569|NCT01829243|3881556|FG001|First Intervention|Screen Failure|2
2230570|NCT01829295|3881566|FG000|6-12 Months|Did not want to switch antimetabolites|0
2230571|NCT01829295|3881567|FG001|6-12 Months|Did not want to switch antimetabolites|0
2230572|NCT01829295|3881568|FG002|6-12 Months|Did not want to switch antimetabolites|9
2230573|NCT01829295|3881569|FG003|6-12 Months|Did not want to switch antimetabolites|11
2230574|NCT01829295|3881566|FG000|6-12 Months|Adverse Event|0
2230575|NCT01829295|3881567|FG001|6-12 Months|Adverse Event|0
2230576|NCT01829295|3881568|FG002|6-12 Months|Adverse Event|3
2230577|NCT01829295|3881569|FG003|6-12 Months|Adverse Event|2
2230578|NCT01829295|3881566|FG000|6-12 Months|Lost to Follow-up|2
2230579|NCT01829295|3881567|FG001|6-12 Months|Lost to Follow-up|0
2230580|NCT01829295|3881568|FG002|6-12 Months|Lost to Follow-up|0
2230581|NCT01829295|3881569|FG003|6-12 Months|Lost to Follow-up|0
2230582|NCT01829295|3881566|FG000|6-12 Months|Withdrawal by Subject|2
2230583|NCT01829295|3881567|FG001|6-12 Months|Withdrawal by Subject|2
2230584|NCT01829295|3881568|FG002|6-12 Months|Withdrawal by Subject|0
2230585|NCT01829295|3881569|FG003|6-12 Months|Withdrawal by Subject|0
2230586|NCT01829347|3881581|FG000|VTI-210|Death|5
2230587|NCT01829347|3881582|FG001|VTI-210|Death|3
2230588|NCT01829347|3881581|FG000|VTI-210|Withdrawal by Subject|1
2230589|NCT01829347|3881582|FG001|VTI-210|Withdrawal by Subject|0
2230590|NCT01829347|3881581|FG000|VTI-210E|Death|2
2230591|NCT01829347|3881582|FG001|VTI-210E|Death|1
2230592|NCT01829347|3881581|FG000|VTI-210E|Study terminated prematurely|1
2230593|NCT01829347|3881582|FG001|VTI-210E|Study terminated prematurely|5
2230594|NCT01829360|3881592|FG000|Overall Study|Protocol Violation|0
2230595|NCT01829360|3881593|FG001|Overall Study|Protocol Violation|0
2230596|NCT01829360|3881594|FG002|Overall Study|Protocol Violation|1
2230597|NCT01829360|3881595|FG003|Overall Study|Protocol Violation|0
2230598|NCT01829425|3881622|FG000|Overall Study|Withdrawal by Subject|4
2230599|NCT01829425|3881623|FG001|Overall Study|Withdrawal by Subject|3
2230600|NCT01829425|3881622|FG000|Overall Study|Lost to Follow-up|2
2230601|NCT01829425|3881623|FG001|Overall Study|Lost to Follow-up|1
2230602|NCT01829464|3881632|FG000|Overall Study|Adverse Event|1
2230603|NCT01829464|3881633|FG001|Overall Study|Adverse Event|0
2230604|NCT01829464|3881634|FG002|Overall Study|Adverse Event|0
2230605|NCT01829464|3881632|FG000|Overall Study|Lost to Follow-up|0
2230606|NCT01829464|3881633|FG001|Overall Study|Lost to Follow-up|0
2230607|NCT01829464|3881634|FG002|Overall Study|Lost to Follow-up|1
2230608|NCT01829464|3881632|FG000|Overall Study|Withdrawal by Subject|2
2230609|NCT01829464|3881633|FG001|Overall Study|Withdrawal by Subject|0
2230610|NCT01829464|3881634|FG002|Overall Study|Withdrawal by Subject|0
2230611|NCT01829464|3881632|FG000|Overall Study|Study terminated by sponsor|25
2230612|NCT01829464|3881633|FG001|Overall Study|Study terminated by sponsor|28
2230613|NCT01829464|3881634|FG002|Overall Study|Study terminated by sponsor|25
2230614|NCT01829464|3881632|FG000|Overall Study|Lack of Efficacy|0
2230615|NCT01829464|3881633|FG001|Overall Study|Lack of Efficacy|1
2230616|NCT01829464|3881634|FG002|Overall Study|Lack of Efficacy|0
2230617|NCT01830127|3881667|FG000|Overall Study|Adverse Event|1
2230618|NCT01830127|3881668|FG001|Overall Study|Adverse Event|6
2230619|NCT01830127|3881667|FG000|Overall Study|Lack of Efficacy|3
2230620|NCT01830127|3881668|FG001|Overall Study|Lack of Efficacy|0
2230621|NCT01830127|3881667|FG000|Overall Study|Withdrawal by Subject|1
2230622|NCT01830127|3881668|FG001|Overall Study|Withdrawal by Subject|1
2230623|NCT01830127|3881667|FG000|Overall Study|Other reason not defined above|0
2230624|NCT01830127|3881668|FG001|Overall Study|Other reason not defined above|2
2230625|NCT01830543|3881714|FG000|Overall Study|Subject Decision|19
2230626|NCT01830543|3881715|FG001|Overall Study|Subject Decision|21
2230627|NCT01830543|3881716|FG002|Overall Study|Subject Decision|57
2230628|NCT01830543|3881714|FG000|Overall Study|Adverse Event|91
2230629|NCT01830543|3881715|FG001|Overall Study|Adverse Event|77
2230630|NCT01830543|3881716|FG002|Overall Study|Adverse Event|76
2230631|NCT01830543|3881714|FG000|Overall Study|Death|20
2230632|NCT01830543|3881715|FG001|Overall Study|Death|22
2230633|NCT01830543|3881716|FG002|Overall Study|Death|22
2230634|NCT01830543|3881714|FG000|Overall Study|Protocol Violation|3
2230635|NCT01830543|3881715|FG001|Overall Study|Protocol Violation|7
2230636|NCT01830543|3881716|FG002|Overall Study|Protocol Violation|7
2230637|NCT01830543|3881714|FG000|Overall Study|Physician Decision|11
2230638|NCT01830543|3881715|FG001|Overall Study|Physician Decision|5
2230639|NCT01830543|3881716|FG002|Overall Study|Physician Decision|12
2230640|NCT01830543|3881714|FG000|Overall Study|Withdrawal by consent|3
2230641|NCT01830543|3881715|FG001|Overall Study|Withdrawal by consent|3
2230642|NCT01830543|3881716|FG002|Overall Study|Withdrawal by consent|3
2230643|NCT01830543|3881714|FG000|Overall Study|Other|12
2230644|NCT01830543|3881715|FG001|Overall Study|Other|17
2230645|NCT01830543|3881716|FG002|Overall Study|Other|37
2230646|NCT01830595|3881724|FG000|First Period|Withdrawal by Subject|1
2230647|NCT01830595|3881725|FG001|First Period|Withdrawal by Subject|3
2230648|NCT01830595|3881724|FG000|Washout|Withdrawal by Subject|2
2230649|NCT01830595|3881725|FG001|Washout|Withdrawal by Subject|2
2230650|NCT01830816|3881752|FG000|Overall Study|Progressive Disease|12
2230651|NCT01830816|3881753|FG001|Overall Study|Progressive Disease|7
2230652|NCT01830816|3881754|FG002|Overall Study|Progressive Disease|7
2230653|NCT01830816|3881752|FG000|Overall Study|Adverse Event|3
2230654|NCT01830816|3881753|FG001|Overall Study|Adverse Event|4
2230655|NCT01830816|3881754|FG002|Overall Study|Adverse Event|0
2230656|NCT01830816|3881752|FG000|Overall Study|Study Terminated by Sponsor|1
2230657|NCT01830816|3881753|FG001|Overall Study|Study Terminated by Sponsor|1
2230658|NCT01830816|3881754|FG002|Overall Study|Study Terminated by Sponsor|0
2230659|NCT01830816|3881752|FG000|Overall Study|Withdrawal by Subject|1
2230660|NCT01830816|3881753|FG001|Overall Study|Withdrawal by Subject|1
2230661|NCT01830816|3881754|FG002|Overall Study|Withdrawal by Subject|0
2230662|NCT01830816|3881752|FG000|Overall Study|Lost to Follow-up|0
2230663|NCT01830816|3881753|FG001|Overall Study|Lost to Follow-up|1
2230664|NCT01830816|3881754|FG002|Overall Study|Lost to Follow-up|0
2230665|NCT01830816|3881752|FG000|Overall Study|Symptomatic Deterioration|1
2230666|NCT01830816|3881753|FG001|Overall Study|Symptomatic Deterioration|0
2230667|NCT01830816|3881754|FG002|Overall Study|Symptomatic Deterioration|0
2230668|NCT01830816|3881752|FG000|Overall Study|Reason not Specified|2
2230669|NCT01830816|3881753|FG001|Overall Study|Reason not Specified|0
2230670|NCT01830816|3881754|FG002|Overall Study|Reason not Specified|0
2230671|NCT01830855|3881778|FG000|Overall Study|Other|7
2230672|NCT01830855|3881779|FG001|Overall Study|Other|1
2230673|NCT01830855|3881780|FG002|Overall Study|Other|4
2230674|NCT01830855|3881781|FG003|Overall Study|Other|4
2230675|NCT01830855|3881778|FG000|Overall Study|Medication error without associated AE|1
2230676|NCT01830855|3881779|FG001|Overall Study|Medication error without associated AE|0
2230677|NCT01830855|3881780|FG002|Overall Study|Medication error without associated AE|0
2230678|NCT01830855|3881781|FG003|Overall Study|Medication error without associated AE|1
2230679|NCT01830855|3881778|FG000|Overall Study|Pregnancy|3
2230680|NCT01830855|3881779|FG001|Overall Study|Pregnancy|1
2230681|NCT01830855|3881780|FG002|Overall Study|Pregnancy|2
2230682|NCT01830855|3881781|FG003|Overall Study|Pregnancy|1
2230683|NCT01830855|3881778|FG000|Overall Study|No longer meets eligibility criteria|11
2230684|NCT01830855|3881779|FG001|Overall Study|No longer meets eligibility criteria|2
2230685|NCT01830855|3881780|FG002|Overall Study|No longer meets eligibility criteria|3
2230686|NCT01830855|3881781|FG003|Overall Study|No longer meets eligibility criteria|5
2230687|NCT01830855|3881778|FG000|Overall Study|Adverse Event|11
2230688|NCT01830855|3881779|FG001|Overall Study|Adverse Event|5
2230689|NCT01830855|3881780|FG002|Overall Study|Adverse Event|6
2230690|NCT01830855|3881781|FG003|Overall Study|Adverse Event|3
2230691|NCT01830855|3881778|FG000|Overall Study|Protocol deviation|10
2230692|NCT01830855|3881779|FG001|Overall Study|Protocol deviation|5
2230693|NCT01830855|3881780|FG002|Overall Study|Protocol deviation|6
2230694|NCT01830855|3881781|FG003|Overall Study|Protocol deviation|6
2230695|NCT01830855|3881778|FG000|Overall Study|Withdrawal by Subject|33
2230696|NCT01830855|3881779|FG001|Overall Study|Withdrawal by Subject|14
2230697|NCT01830855|3881780|FG002|Overall Study|Withdrawal by Subject|10
2230698|NCT01830855|3881781|FG003|Overall Study|Withdrawal by Subject|12
2230699|NCT01830855|3881778|FG000|Overall Study|No longer willing to participate|32
2230700|NCT01830855|3881779|FG001|Overall Study|No longer willing to participate|13
2230701|NCT01830855|3881780|FG002|Overall Study|No longer willing to participate|12
2230702|NCT01830855|3881781|FG003|Overall Study|No longer willing to participate|17
2230703|NCT01830855|3881778|FG000|Overall Study|Lost to Follow-up|47
2230704|NCT01830855|3881779|FG001|Overall Study|Lost to Follow-up|20
2230705|NCT01830855|3881780|FG002|Overall Study|Lost to Follow-up|23
2230706|NCT01830855|3881781|FG003|Overall Study|Lost to Follow-up|33
2230707|NCT01830881|3881798|FG000|Overall Study|Changed decision to have an abortion|0
2230708|NCT01830881|3881799|FG001|Overall Study|Changed decision to have an abortion|1
2230709|NCT01830920|3881812|FG000|Overall Study|Adverse Event|1
2230710|NCT01830920|3881813|FG001|Overall Study|Adverse Event|0
2230711|NCT01830920|3881814|FG002|Overall Study|Adverse Event|1
2230712|NCT01830920|3881815|FG003|Overall Study|Adverse Event|0
2230713|NCT01830920|3881816|FG004|Overall Study|Adverse Event|0
2230714|NCT01830920|3881812|FG000|Overall Study|Withdrawal by Subject|2
2230715|NCT01830920|3881813|FG001|Overall Study|Withdrawal by Subject|2
2230716|NCT01830920|3881814|FG002|Overall Study|Withdrawal by Subject|1
2230717|NCT01830920|3881815|FG003|Overall Study|Withdrawal by Subject|7
2230718|NCT01830920|3881816|FG004|Overall Study|Withdrawal by Subject|1
2230719|NCT01830920|3881812|FG000|Overall Study|Death|3
2230720|NCT01830920|3881813|FG001|Overall Study|Death|3
2230721|NCT01830920|3881814|FG002|Overall Study|Death|5
2230722|NCT01830920|3881815|FG003|Overall Study|Death|4
2230723|NCT01830920|3881816|FG004|Overall Study|Death|4
2230724|NCT01830920|3881812|FG000|Overall Study|Other|15
2230725|NCT01830920|3881813|FG001|Overall Study|Other|1
2332829|NCT03207750|4056900|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
2332830|NCT03207750|4056901|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
2332831|NCT03207750|4056900|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
2332832|NCT03207750|4056901|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
2332833|NCT03207750|4056900|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
2332834|NCT03207750|4056901|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
2332835|NCT03207750|4056900|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
2332836|NCT03207750|4056901|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
2332837|NCT03207750|4056900|FG000|Overall Study|OTHER, NOT SPECIFIED|5
2332838|NCT03207750|4056901|FG001|Overall Study|OTHER, NOT SPECIFIED|4
2332839|NCT03207763|4056909|FG000|Overall Study|Lost to Follow-up|1
2332840|NCT03207763|4056910|FG001|Overall Study|Lost to Follow-up|0
2332841|NCT03208088|4056934|FG000|Period 2|Withdrawal by Subject|0
2332842|NCT03208088|4056935|FG001|Period 2|Withdrawal by Subject|0
2332843|NCT03208088|4056936|FG002|Period 2|Withdrawal by Subject|0
2332844|NCT03208088|4056937|FG003|Period 2|Withdrawal by Subject|0
2332845|NCT03208088|4056938|FG004|Period 2|Withdrawal by Subject|0
2332846|NCT03208088|4056939|FG005|Period 2|Withdrawal by Subject|0
2332847|NCT03208088|4056940|FG006|Period 2|Withdrawal by Subject|0
2332848|NCT03208088|4056941|FG007|Period 2|Withdrawal by Subject|0
2332849|NCT03208088|4056942|FG008|Period 2|Withdrawal by Subject|1
2332850|NCT03208088|4056943|FG009|Period 2|Withdrawal by Subject|0
2332851|NCT03208088|4056934|FG000|Period 3|Unsatisfactory Test Article|0
2332852|NCT03208088|4056935|FG001|Period 3|Unsatisfactory Test Article|0
2332853|NCT03208088|4056936|FG002|Period 3|Unsatisfactory Test Article|0
2332854|NCT03208088|4056937|FG003|Period 3|Unsatisfactory Test Article|1
2332855|NCT03208088|4056938|FG004|Period 3|Unsatisfactory Test Article|0
2332856|NCT03208088|4056939|FG005|Period 3|Unsatisfactory Test Article|0
2332857|NCT03208088|4056940|FG006|Period 3|Unsatisfactory Test Article|0
2332858|NCT03208088|4056941|FG007|Period 3|Unsatisfactory Test Article|0
2332859|NCT03208088|4056942|FG008|Period 3|Unsatisfactory Test Article|0
2332860|NCT03208088|4056943|FG009|Period 3|Unsatisfactory Test Article|0
2332861|NCT03208088|4056934|FG000|Period 4|Unsatisfactory Test Article|0
2332862|NCT03208088|4056935|FG001|Period 4|Unsatisfactory Test Article|0
2332863|NCT03208088|4056936|FG002|Period 4|Unsatisfactory Test Article|0
2332864|NCT03208088|4056937|FG003|Period 4|Unsatisfactory Test Article|1
2230726|NCT01830920|3881814|FG002|Overall Study|Other|1
2230727|NCT01830920|3881815|FG003|Overall Study|Other|5
2230728|NCT01830920|3881816|FG004|Overall Study|Other|3
2230729|NCT01830972|3881839|FG000|Part II|Withdrawal by Subject|2
2230730|NCT01830972|3881840|FG001|Part II|Withdrawal by Subject|2
2230731|NCT01830972|3881839|FG000|Part III|Withdrawal by Subject|1
2230732|NCT01830972|3881840|FG001|Part III|Withdrawal by Subject|0
2230733|NCT01830972|3881839|FG000|Part III|Noncompliance|1
2230734|NCT01830972|3881840|FG001|Part III|Noncompliance|0
2230735|NCT01830972|3881839|FG000|Part IV|Withdrawal by Subject|2
2230736|NCT01830972|3881840|FG001|Part IV|Withdrawal by Subject|1
2230737|NCT01830972|3881839|FG000|Part IV|Non-Compliance|1
2230738|NCT01830972|3881840|FG001|Part IV|Non-Compliance|0
2230739|NCT01831089|3881871|FG000|Cohort I: Dose Level 1|Progressive disease|3
2230740|NCT01831089|3881872|FG001|Cohort I: Dose Level 1|Progressive disease|0
2230741|NCT01831089|3881873|FG002|Cohort I: Dose Level 1|Progressive disease|0
2230742|NCT01831089|3881874|FG003|Cohort I: Dose Level 1|Progressive disease|0
2230743|NCT01831089|3881875|FG004|Cohort I: Dose Level 1|Progressive disease|0
2230744|NCT01831089|3881876|FG005|Cohort I: Dose Level 1|Progressive disease|0
2230745|NCT01831089|3881871|FG000|Cohort II: Dose Level 2|Progressive disease|0
2230746|NCT01831089|3881872|FG001|Cohort II: Dose Level 2|Progressive disease|2
2230747|NCT01831089|3881873|FG002|Cohort II: Dose Level 2|Progressive disease|0
2230748|NCT01831089|3881874|FG003|Cohort II: Dose Level 2|Progressive disease|0
2230749|NCT01831089|3881875|FG004|Cohort II: Dose Level 2|Progressive disease|0
2230750|NCT01831089|3881876|FG005|Cohort II: Dose Level 2|Progressive disease|0
2230751|NCT01831089|3881871|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0
2230752|NCT01831089|3881872|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1
2230753|NCT01831089|3881873|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0
2230754|NCT01831089|3881874|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0
2230755|NCT01831089|3881875|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0
2230756|NCT01831089|3881876|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0
2230757|NCT01831089|3881871|FG000|Cohort III: Dose Level 3|Progressive disease|0
2230758|NCT01831089|3881872|FG001|Cohort III: Dose Level 3|Progressive disease|0
2230759|NCT01831089|3881873|FG002|Cohort III: Dose Level 3|Progressive disease|3
2230760|NCT01831089|3881874|FG003|Cohort III: Dose Level 3|Progressive disease|0
2230761|NCT01831089|3881875|FG004|Cohort III: Dose Level 3|Progressive disease|0
2230762|NCT01831089|3881876|FG005|Cohort III: Dose Level 3|Progressive disease|0
2230763|NCT01831089|3881871|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0
2230764|NCT01831089|3881872|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0
2230765|NCT01831089|3881873|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1
2230766|NCT01831089|3881874|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0
2230767|NCT01831089|3881875|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0
2230768|NCT01831089|3881876|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0
2230769|NCT01831089|3881871|FG000|Cohort III: Dose Level 3|Adverse Event|0
2230770|NCT01831089|3881872|FG001|Cohort III: Dose Level 3|Adverse Event|0
2230771|NCT01831089|3881873|FG002|Cohort III: Dose Level 3|Adverse Event|1
2230772|NCT01831089|3881874|FG003|Cohort III: Dose Level 3|Adverse Event|0
2230773|NCT01831089|3881875|FG004|Cohort III: Dose Level 3|Adverse Event|0
2230774|NCT01831089|3881876|FG005|Cohort III: Dose Level 3|Adverse Event|0
2230775|NCT01831089|3881871|FG000|Cohort III: Dose Level 3|Global end of study|0
2230776|NCT01831089|3881872|FG001|Cohort III: Dose Level 3|Global end of study|0
2230777|NCT01831089|3881873|FG002|Cohort III: Dose Level 3|Global end of study|1
2230778|NCT01831089|3881874|FG003|Cohort III: Dose Level 3|Global end of study|0
2230779|NCT01831089|3881875|FG004|Cohort III: Dose Level 3|Global end of study|0
2230780|NCT01831089|3881876|FG005|Cohort III: Dose Level 3|Global end of study|0
2230781|NCT01831089|3881871|FG000|Cohort IV: Dose Level 4|Progressive disease|0
2230782|NCT01831089|3881872|FG001|Cohort IV: Dose Level 4|Progressive disease|0
2230783|NCT01831089|3881873|FG002|Cohort IV: Dose Level 4|Progressive disease|0
2230784|NCT01831089|3881874|FG003|Cohort IV: Dose Level 4|Progressive disease|6
2230785|NCT01831089|3881875|FG004|Cohort IV: Dose Level 4|Progressive disease|0
2230786|NCT01831089|3881876|FG005|Cohort IV: Dose Level 4|Progressive disease|0
2230787|NCT01831089|3881871|FG000|Cohort V: Dose Level 5|Progressive disease|0
2230788|NCT01831089|3881872|FG001|Cohort V: Dose Level 5|Progressive disease|0
2230789|NCT01831089|3881873|FG002|Cohort V: Dose Level 5|Progressive disease|0
2230790|NCT01831089|3881874|FG003|Cohort V: Dose Level 5|Progressive disease|0
2230791|NCT01831089|3881875|FG004|Cohort V: Dose Level 5|Progressive disease|30
2230792|NCT01831089|3881876|FG005|Cohort V: Dose Level 5|Progressive disease|0
2230793|NCT01831089|3881871|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0
2230794|NCT01831089|3881872|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0
2230795|NCT01831089|3881873|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0
2230796|NCT01831089|3881874|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0
2230797|NCT01831089|3881875|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3
2230798|NCT01831089|3881876|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0
2230799|NCT01831089|3881871|FG000|Cohort V: Dose Level 5|Death|0
2230800|NCT01831089|3881872|FG001|Cohort V: Dose Level 5|Death|0
2230801|NCT01831089|3881873|FG002|Cohort V: Dose Level 5|Death|0
2230802|NCT01831089|3881874|FG003|Cohort V: Dose Level 5|Death|0
2230803|NCT01831089|3881875|FG004|Cohort V: Dose Level 5|Death|1
2230804|NCT01831089|3881876|FG005|Cohort V: Dose Level 5|Death|0
2230805|NCT01831089|3881871|FG000|Cohort V: Dose Level 5|Global end of study|0
2230806|NCT01831089|3881872|FG001|Cohort V: Dose Level 5|Global end of study|0
2230807|NCT01831089|3881873|FG002|Cohort V: Dose Level 5|Global end of study|0
2230808|NCT01831089|3881874|FG003|Cohort V: Dose Level 5|Global end of study|0
2230809|NCT01831089|3881875|FG004|Cohort V: Dose Level 5|Global end of study|2
2230810|NCT01831089|3881876|FG005|Cohort V: Dose Level 5|Global end of study|0
2230811|NCT01831089|3881871|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0
2230812|NCT01831089|3881872|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0
2230813|NCT01831089|3881873|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0
2230814|NCT01831089|3881874|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0
2230815|NCT01831089|3881875|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1
2230816|NCT01831089|3881876|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0
2230817|NCT01831089|3881871|FG000|Cohort B: Arm B|Progressive disease|0
2230818|NCT01831089|3881872|FG001|Cohort B: Arm B|Progressive disease|0
2230819|NCT01831089|3881873|FG002|Cohort B: Arm B|Progressive disease|0
2230820|NCT01831089|3881874|FG003|Cohort B: Arm B|Progressive disease|0
2230821|NCT01831089|3881875|FG004|Cohort B: Arm B|Progressive disease|0
2230822|NCT01831089|3881876|FG005|Cohort B: Arm B|Progressive disease|8
2230823|NCT01831089|3881871|FG000|Cohort B: Arm B|Physician Decision|0
2230824|NCT01831089|3881872|FG001|Cohort B: Arm B|Physician Decision|0
2230825|NCT01831089|3881873|FG002|Cohort B: Arm B|Physician Decision|0
2230826|NCT01831089|3881874|FG003|Cohort B: Arm B|Physician Decision|0
2230827|NCT01831089|3881875|FG004|Cohort B: Arm B|Physician Decision|0
2230828|NCT01831089|3881876|FG005|Cohort B: Arm B|Physician Decision|2
2230829|NCT01831089|3881871|FG000|Cohort B: Arm B|Never treated|0
2230830|NCT01831089|3881872|FG001|Cohort B: Arm B|Never treated|0
2230831|NCT01831089|3881873|FG002|Cohort B: Arm B|Never treated|0
2230832|NCT01831089|3881874|FG003|Cohort B: Arm B|Never treated|0
2230833|NCT01831089|3881875|FG004|Cohort B: Arm B|Never treated|0
2230834|NCT01831089|3881876|FG005|Cohort B: Arm B|Never treated|2
2230835|NCT01831089|3881871|FG000|Cohort B: Arm B|Adverse Event|0
2230836|NCT01831089|3881872|FG001|Cohort B: Arm B|Adverse Event|0
2230837|NCT01831089|3881873|FG002|Cohort B: Arm B|Adverse Event|0
2230838|NCT01831089|3881874|FG003|Cohort B: Arm B|Adverse Event|0
2230839|NCT01831089|3881875|FG004|Cohort B: Arm B|Adverse Event|0
2230840|NCT01831089|3881876|FG005|Cohort B: Arm B|Adverse Event|1
2230841|NCT01831089|3881871|FG000|Cohort B: Arm B|Global end of study|0
2230842|NCT01831089|3881872|FG001|Cohort B: Arm B|Global end of study|0
2230843|NCT01831089|3881873|FG002|Cohort B: Arm B|Global end of study|0
2230844|NCT01831089|3881874|FG003|Cohort B: Arm B|Global end of study|0
2230845|NCT01831089|3881875|FG004|Cohort B: Arm B|Global end of study|0
2230846|NCT01831089|3881876|FG005|Cohort B: Arm B|Global end of study|1
2274343|NCT02296112|3955339|FG000|Overall Study|Began an alternate therapy|1
2274344|NCT02296125|3955350|FG000|Overall Study|Withdrawal by Subject|18
2274345|NCT02296125|3955351|FG001|Overall Study|Withdrawal by Subject|8
2274346|NCT02296125|3955352|FG002|Overall Study|Withdrawal by Subject|6
2274347|NCT02296125|3955353|FG003|Overall Study|Withdrawal by Subject|2
2274348|NCT02296125|3955350|FG000|Overall Study|Adverse Event|41
2274349|NCT02296125|3955351|FG001|Overall Study|Adverse Event|52
2274350|NCT02296125|3955352|FG002|Overall Study|Adverse Event|9
2274351|NCT02296125|3955353|FG003|Overall Study|Adverse Event|4
2274352|NCT02296125|3955350|FG000|Overall Study|Severe non-compliance to protocol|0
2274353|NCT02296125|3955351|FG001|Overall Study|Severe non-compliance to protocol|1
2274354|NCT02296125|3955352|FG002|Overall Study|Severe non-compliance to protocol|0
2274355|NCT02296125|3955353|FG003|Overall Study|Severe non-compliance to protocol|0
2274356|NCT02296125|3955350|FG000|Overall Study|Condition under investigation worsened|153
2274357|NCT02296125|3955351|FG001|Overall Study|Condition under investigation worsened|199
2274358|NCT02296125|3955352|FG002|Overall Study|Condition under investigation worsened|39
2274359|NCT02296125|3955353|FG003|Overall Study|Condition under investigation worsened|56
2274360|NCT02296125|3955350|FG000|Overall Study|Any reason not specifically recorded|6
2274361|NCT02296125|3955351|FG001|Overall Study|Any reason not specifically recorded|4
2274362|NCT02296125|3955352|FG002|Overall Study|Any reason not specifically recorded|2
2274363|NCT02296125|3955353|FG003|Overall Study|Any reason not specifically recorded|0
2274364|NCT02296138|3955366|FG000|Overall Study|Adverse Event|348
2274365|NCT02296138|3955367|FG001|Overall Study|Adverse Event|259
2274366|NCT02296138|3955366|FG000|Overall Study|Lack of Efficacy|59
2274367|NCT02296138|3955367|FG001|Overall Study|Lack of Efficacy|37
2274368|NCT02296138|3955366|FG000|Overall Study|Protocol Violation|35
2274369|NCT02296138|3955367|FG001|Overall Study|Protocol Violation|36
2274370|NCT02296138|3955366|FG000|Overall Study|Lost to Follow-up|9
2274371|NCT02296138|3955367|FG001|Overall Study|Lost to Follow-up|12
2274372|NCT02296138|3955366|FG000|Overall Study|Withdrawal by Subject|184
2274373|NCT02296138|3955367|FG001|Overall Study|Withdrawal by Subject|131
2274374|NCT02296138|3955366|FG000|Overall Study|Not Treated|1
2274375|NCT02296138|3955367|FG001|Overall Study|Not Treated|1
2274376|NCT02296138|3955366|FG000|Overall Study|Patients with data irregularities|10
2274377|NCT02296138|3955367|FG001|Overall Study|Patients with data irregularities|11
2274378|NCT02296138|3955366|FG000|Overall Study|Other than specified|15
2274379|NCT02296138|3955367|FG001|Overall Study|Other than specified|13
2274380|NCT02296190|3955383|FG000|Overall Study|Lost to Follow-up|0
2230847|NCT01831258|3881917|FG000|Overall Study|Withdrawal by Subject|2
2230848|NCT01831258|3881918|FG001|Overall Study|Withdrawal by Subject|1
2230849|NCT01831258|3881917|FG000|Overall Study|Lost to Follow-up|3
2230850|NCT01831258|3881918|FG001|Overall Study|Lost to Follow-up|2
2230851|NCT01831427|3881937|FG000|Overall Study|Adverse Event|0
2230852|NCT01831427|3881938|FG001|Overall Study|Adverse Event|1
2230853|NCT01831427|3881939|FG002|Overall Study|Adverse Event|0
2230854|NCT01831427|3881940|FG003|Overall Study|Adverse Event|0
2230855|NCT01831427|3881941|FG004|Overall Study|Adverse Event|0
2230856|NCT01831427|3881942|FG005|Overall Study|Adverse Event|1
2230857|NCT01831427|3881943|FG006|Overall Study|Adverse Event|0
2230858|NCT01831427|3881944|FG007|Overall Study|Adverse Event|1
2230859|NCT01831427|3881945|FG008|Overall Study|Adverse Event|0
2230860|NCT01831427|3881946|FG009|Overall Study|Adverse Event|0
2230861|NCT01831427|3881947|FG010|Overall Study|Adverse Event|2
2230862|NCT01831427|3881937|FG000|Overall Study|Investigator's Discretion|0
2230863|NCT01831427|3881938|FG001|Overall Study|Investigator's Discretion|0
2230864|NCT01831427|3881939|FG002|Overall Study|Investigator's Discretion|0
2230865|NCT01831427|3881940|FG003|Overall Study|Investigator's Discretion|1
2230866|NCT01831427|3881941|FG004|Overall Study|Investigator's Discretion|0
2230867|NCT01831427|3881942|FG005|Overall Study|Investigator's Discretion|0
2230868|NCT01831427|3881943|FG006|Overall Study|Investigator's Discretion|0
2230869|NCT01831427|3881944|FG007|Overall Study|Investigator's Discretion|0
2230870|NCT01831427|3881945|FG008|Overall Study|Investigator's Discretion|0
2230871|NCT01831427|3881946|FG009|Overall Study|Investigator's Discretion|0
2230872|NCT01831427|3881947|FG010|Overall Study|Investigator's Discretion|0
2230873|NCT01831427|3881937|FG000|Overall Study|Withdrew Consent|0
2230874|NCT01831427|3881938|FG001|Overall Study|Withdrew Consent|0
2230875|NCT01831427|3881939|FG002|Overall Study|Withdrew Consent|0
2230876|NCT01831427|3881940|FG003|Overall Study|Withdrew Consent|0
2230877|NCT01831427|3881941|FG004|Overall Study|Withdrew Consent|0
2230878|NCT01831427|3881942|FG005|Overall Study|Withdrew Consent|0
2230879|NCT01831427|3881943|FG006|Overall Study|Withdrew Consent|2
2230880|NCT01831427|3881944|FG007|Overall Study|Withdrew Consent|0
2230881|NCT01831427|3881945|FG008|Overall Study|Withdrew Consent|0
2230882|NCT01831427|3881946|FG009|Overall Study|Withdrew Consent|1
2230883|NCT01831427|3881947|FG010|Overall Study|Withdrew Consent|1
2230884|NCT01831466|3881994|FG000|Overall Study|Protocol Violation|1
2230885|NCT01831466|3881995|FG001|Overall Study|Protocol Violation|1
2230886|NCT01831466|3881996|FG002|Overall Study|Protocol Violation|2
2230887|NCT01831466|3881997|FG003|Overall Study|Protocol Violation|0
2230888|NCT01831466|3881998|FG004|Overall Study|Protocol Violation|0
2230889|NCT01831466|3881999|FG005|Overall Study|Protocol Violation|1
2230890|NCT01831466|3882000|FG006|Overall Study|Protocol Violation|0
2230891|NCT01831466|3882001|FG007|Overall Study|Protocol Violation|0
2230892|NCT01831466|3882002|FG008|Overall Study|Protocol Violation|0
2230893|NCT01831466|3882003|FG009|Overall Study|Protocol Violation|0
2230894|NCT01831466|3882004|FG010|Overall Study|Protocol Violation|0
2230895|NCT01831466|3882005|FG011|Overall Study|Protocol Violation|0
2230896|NCT01831466|3881994|FG000|Overall Study|Other|2
2230897|NCT01831466|3881995|FG001|Overall Study|Other|3
2230898|NCT01831466|3881996|FG002|Overall Study|Other|2
2230899|NCT01831466|3881997|FG003|Overall Study|Other|2
2230900|NCT01831466|3881998|FG004|Overall Study|Other|2
2230901|NCT01831466|3881999|FG005|Overall Study|Other|1
2230902|NCT01831466|3882000|FG006|Overall Study|Other|0
2230903|NCT01831466|3882001|FG007|Overall Study|Other|0
2230904|NCT01831466|3882002|FG008|Overall Study|Other|0
2230905|NCT01831466|3882003|FG009|Overall Study|Other|0
2230906|NCT01831466|3882004|FG010|Overall Study|Other|0
2230907|NCT01831466|3882005|FG011|Overall Study|Other|0
2230908|NCT01831466|3881994|FG000|Overall Study|Non-compliance with study treatment|2
2230909|NCT01831466|3881995|FG001|Overall Study|Non-compliance with study treatment|1
2230910|NCT01831466|3881996|FG002|Overall Study|Non-compliance with study treatment|1
2230911|NCT01831466|3881997|FG003|Overall Study|Non-compliance with study treatment|0
2230912|NCT01831466|3881998|FG004|Overall Study|Non-compliance with study treatment|0
2230913|NCT01831466|3881999|FG005|Overall Study|Non-compliance with study treatment|1
2230914|NCT01831466|3882000|FG006|Overall Study|Non-compliance with study treatment|0
2230915|NCT01831466|3882001|FG007|Overall Study|Non-compliance with study treatment|0
2230916|NCT01831466|3882002|FG008|Overall Study|Non-compliance with study treatment|0
2230917|NCT01831466|3882003|FG009|Overall Study|Non-compliance with study treatment|0
2230918|NCT01831466|3882004|FG010|Overall Study|Non-compliance with study treatment|0
2230919|NCT01831466|3882005|FG011|Overall Study|Non-compliance with study treatment|0
2230920|NCT01831466|3881994|FG000|Overall Study|Death|0
2230921|NCT01831466|3881995|FG001|Overall Study|Death|1
2230922|NCT01831466|3881996|FG002|Overall Study|Death|0
2230923|NCT01831466|3881997|FG003|Overall Study|Death|0
2230924|NCT01831466|3881998|FG004|Overall Study|Death|0
2230925|NCT01831466|3881999|FG005|Overall Study|Death|0
2230926|NCT01831466|3882000|FG006|Overall Study|Death|0
2230927|NCT01831466|3882001|FG007|Overall Study|Death|0
2230928|NCT01831466|3882002|FG008|Overall Study|Death|0
2230929|NCT01831466|3882003|FG009|Overall Study|Death|0
2230930|NCT01831466|3882004|FG010|Overall Study|Death|0
2230931|NCT01831466|3882005|FG011|Overall Study|Death|0
2230932|NCT01831466|3881994|FG000|Overall Study|Withdrawal by Subject|6
2230933|NCT01831466|3881995|FG001|Overall Study|Withdrawal by Subject|3
2230934|NCT01831466|3881996|FG002|Overall Study|Withdrawal by Subject|3
2230935|NCT01831466|3881997|FG003|Overall Study|Withdrawal by Subject|3
2230936|NCT01831466|3881998|FG004|Overall Study|Withdrawal by Subject|3
2230937|NCT01831466|3881999|FG005|Overall Study|Withdrawal by Subject|5
2230938|NCT01831466|3882000|FG006|Overall Study|Withdrawal by Subject|0
2230939|NCT01831466|3882001|FG007|Overall Study|Withdrawal by Subject|0
2230940|NCT01831466|3882002|FG008|Overall Study|Withdrawal by Subject|0
2230941|NCT01831466|3882003|FG009|Overall Study|Withdrawal by Subject|1
2230942|NCT01831466|3882004|FG010|Overall Study|Withdrawal by Subject|0
2230943|NCT01831466|3882005|FG011|Overall Study|Withdrawal by Subject|1
2230944|NCT01831466|3881994|FG000|Overall Study|Lost to Follow-up|0
2230945|NCT01831466|3881995|FG001|Overall Study|Lost to Follow-up|1
2230946|NCT01831466|3881996|FG002|Overall Study|Lost to Follow-up|4
2230947|NCT01831466|3881997|FG003|Overall Study|Lost to Follow-up|2
2230948|NCT01831466|3881998|FG004|Overall Study|Lost to Follow-up|0
2230949|NCT01831466|3881999|FG005|Overall Study|Lost to Follow-up|3
2230950|NCT01831466|3882000|FG006|Overall Study|Lost to Follow-up|0
2230951|NCT01831466|3882001|FG007|Overall Study|Lost to Follow-up|0
2230952|NCT01831466|3882002|FG008|Overall Study|Lost to Follow-up|0
2230953|NCT01831466|3882003|FG009|Overall Study|Lost to Follow-up|1
2230954|NCT01831466|3882004|FG010|Overall Study|Lost to Follow-up|0
2230955|NCT01831466|3882005|FG011|Overall Study|Lost to Follow-up|1
2230956|NCT01831466|3881994|FG000|Overall Study|Lack of Efficacy|5
2230957|NCT01831466|3881995|FG001|Overall Study|Lack of Efficacy|8
2230958|NCT01831466|3881996|FG002|Overall Study|Lack of Efficacy|7
2230959|NCT01831466|3881997|FG003|Overall Study|Lack of Efficacy|6
2230960|NCT01831466|3881998|FG004|Overall Study|Lack of Efficacy|9
2230961|NCT01831466|3881999|FG005|Overall Study|Lack of Efficacy|8
2230962|NCT01831466|3882000|FG006|Overall Study|Lack of Efficacy|1
2230963|NCT01831466|3882001|FG007|Overall Study|Lack of Efficacy|1
2230964|NCT01831466|3882002|FG008|Overall Study|Lack of Efficacy|2
2230965|NCT01831466|3882003|FG009|Overall Study|Lack of Efficacy|2
2230966|NCT01831466|3882004|FG010|Overall Study|Lack of Efficacy|2
2230967|NCT01831466|3882005|FG011|Overall Study|Lack of Efficacy|0
2230968|NCT01831466|3881994|FG000|Overall Study|Adverse Event|0
2230969|NCT01831466|3881995|FG001|Overall Study|Adverse Event|0
2230970|NCT01831466|3881996|FG002|Overall Study|Adverse Event|4
2230971|NCT01831466|3881997|FG003|Overall Study|Adverse Event|6
2230972|NCT01831466|3881998|FG004|Overall Study|Adverse Event|3
2230973|NCT01831466|3881999|FG005|Overall Study|Adverse Event|7
2230974|NCT01831466|3882000|FG006|Overall Study|Adverse Event|0
2230975|NCT01831466|3882001|FG007|Overall Study|Adverse Event|1
2230976|NCT01831466|3882002|FG008|Overall Study|Adverse Event|1
2230977|NCT01831466|3882003|FG009|Overall Study|Adverse Event|1
2230978|NCT01831466|3882004|FG010|Overall Study|Adverse Event|0
2230979|NCT01831466|3882005|FG011|Overall Study|Adverse Event|2
2230980|NCT01831544|3882025|FG000|Overall Study|Death|1
2230981|NCT01831544|3882025|FG000|Overall Study|Still on original MVAD device|2
2230982|NCT01831726|3882029|FG000|Overall Study|Adverse Event|16
2230983|NCT01831726|3882029|FG000|Overall Study|Death|7
2230984|NCT01831726|3882029|FG000|Overall Study|Disease Progression|49
2230985|NCT01831726|3882029|FG000|Overall Study|Physician Decision|1
2230986|NCT01831726|3882029|FG000|Overall Study|Subject/guardian decision|7
2230987|NCT01831765|3882036|FG000|Overall Study|Lack of Efficacy|1
2230988|NCT01831765|3882037|FG001|Overall Study|Lack of Efficacy|0
2230989|NCT01831765|3882038|FG002|Overall Study|Lack of Efficacy|0
2230990|NCT01831765|3882036|FG000|Overall Study|Other, sponsor withdrew subject|0
2230991|NCT01831765|3882037|FG001|Overall Study|Other, sponsor withdrew subject|1
2230992|NCT01831765|3882038|FG002|Overall Study|Other, sponsor withdrew subject|0
2230993|NCT01831765|3882036|FG000|Overall Study|Pregnancy|1
2332865|NCT03208088|4056938|FG004|Period 4|Unsatisfactory Test Article|0
2332866|NCT03208088|4056939|FG005|Period 4|Unsatisfactory Test Article|0
2332867|NCT03208088|4056940|FG006|Period 4|Unsatisfactory Test Article|0
2332868|NCT03208088|4056941|FG007|Period 4|Unsatisfactory Test Article|0
2332869|NCT03208088|4056942|FG008|Period 4|Unsatisfactory Test Article|0
2332870|NCT03208088|4056943|FG009|Period 4|Unsatisfactory Test Article|0
2332871|NCT03208933|4056979|FG000|Overall Study|Death|3
2332872|NCT03208933|4056979|FG000|Overall Study|Withdrawal by Subject|3
2332873|NCT03208933|4056979|FG000|Overall Study|Adverse Event|1
2332874|NCT03208933|4056979|FG000|Overall Study|Lost to Follow-up|2
2332875|NCT03208933|4056979|FG000|Overall Study|Physician Decision|3
2332876|NCT03208933|4056979|FG000|Overall Study|Protocol Violation|1
2332877|NCT03209362|4056990|FG000|Overall Study|Adverse Event|0
2332878|NCT03209362|4056991|FG001|Overall Study|Adverse Event|1
2332879|NCT03209362|4056990|FG000|Overall Study|Lost to Follow-up|0
2332880|NCT03209362|4056991|FG001|Overall Study|Lost to Follow-up|1
2332881|NCT03209362|4056990|FG000|Overall Study|Withdrawal by Subject|2
2332882|NCT03209362|4056991|FG001|Overall Study|Withdrawal by Subject|0
2332883|NCT03209362|4056990|FG000|Overall Study|Other|0
2332884|NCT03209362|4056991|FG001|Overall Study|Other|1
2332885|NCT03209492|4056997|FG000|Overall Study|Case Report Forms Uncollected|5
2332886|NCT03209518|4057008|FG000|Overall Study|Case Report Forms Uncollected|1
2332887|NCT03209518|4057008|FG000|Overall Study|Protocol Deviation|1
2230994|NCT01831765|3882037|FG001|Overall Study|Pregnancy|1
2230995|NCT01831765|3882038|FG002|Overall Study|Pregnancy|2
2230996|NCT01831765|3882036|FG000|Overall Study|Death|0
2230997|NCT01831765|3882037|FG001|Overall Study|Death|1
2230998|NCT01831765|3882038|FG002|Overall Study|Death|1
2230999|NCT01831765|3882036|FG000|Overall Study|Other, site closed|1
2231000|NCT01831765|3882037|FG001|Overall Study|Other, site closed|1
2231001|NCT01831765|3882038|FG002|Overall Study|Other, site closed|0
2231002|NCT01831765|3882036|FG000|Overall Study|Adverse Event|5
2231003|NCT01831765|3882037|FG001|Overall Study|Adverse Event|3
2231004|NCT01831765|3882038|FG002|Overall Study|Adverse Event|3
2231005|NCT01831765|3882036|FG000|Overall Study|Withdrawal by Subject|22
2231006|NCT01831765|3882037|FG001|Overall Study|Withdrawal by Subject|7
2231007|NCT01831765|3882038|FG002|Overall Study|Withdrawal by Subject|17
2231008|NCT01831765|3882036|FG000|Overall Study|Withdrawal criteria|12
2231009|NCT01831765|3882037|FG001|Overall Study|Withdrawal criteria|10
2231010|NCT01831765|3882038|FG002|Overall Study|Withdrawal criteria|16
2231011|NCT01831765|3882036|FG000|Overall Study|Lost to Follow-up|2
2231012|NCT01831765|3882037|FG001|Overall Study|Lost to Follow-up|3
2231013|NCT01831765|3882038|FG002|Overall Study|Lost to Follow-up|3
2231014|NCT01831791|3882048|FG000|Overall Study|Withdrawal by Subject|10
2231015|NCT01831804|3882061|FG000|Overall Study|Adverse Event|0
2231016|NCT01831804|3882062|FG001|Overall Study|Adverse Event|0
2231017|NCT01831804|3882063|FG002|Overall Study|Adverse Event|0
2231018|NCT01831804|3882064|FG003|Overall Study|Adverse Event|0
2231019|NCT01831804|3882065|FG004|Overall Study|Adverse Event|0
2231020|NCT01831804|3882066|FG005|Overall Study|Adverse Event|0
2231021|NCT01831804|3882067|FG006|Overall Study|Adverse Event|1
2231022|NCT01831804|3882068|FG007|Overall Study|Adverse Event|0
2231023|NCT01831804|3882069|FG008|Overall Study|Adverse Event|1
2231024|NCT01831804|3882061|FG000|Overall Study|Protocol Violation|0
2231025|NCT01831804|3882062|FG001|Overall Study|Protocol Violation|0
2231026|NCT01831804|3882063|FG002|Overall Study|Protocol Violation|2
2231027|NCT01831804|3882064|FG003|Overall Study|Protocol Violation|0
2231028|NCT01831804|3882065|FG004|Overall Study|Protocol Violation|0
2231029|NCT01831804|3882066|FG005|Overall Study|Protocol Violation|0
2231030|NCT01831804|3882067|FG006|Overall Study|Protocol Violation|0
2231031|NCT01831804|3882068|FG007|Overall Study|Protocol Violation|0
2231032|NCT01831804|3882069|FG008|Overall Study|Protocol Violation|0
2231033|NCT01831804|3882061|FG000|Overall Study|Protocol defined stopping criteria|1
2231034|NCT01831804|3882062|FG001|Overall Study|Protocol defined stopping criteria|1
2231035|NCT01831804|3882063|FG002|Overall Study|Protocol defined stopping criteria|3
2231036|NCT01831804|3882064|FG003|Overall Study|Protocol defined stopping criteria|0
2231037|NCT01831804|3882065|FG004|Overall Study|Protocol defined stopping criteria|1
2231038|NCT01831804|3882066|FG005|Overall Study|Protocol defined stopping criteria|0
2231039|NCT01831804|3882067|FG006|Overall Study|Protocol defined stopping criteria|0
2231040|NCT01831804|3882068|FG007|Overall Study|Protocol defined stopping criteria|0
2231041|NCT01831804|3882069|FG008|Overall Study|Protocol defined stopping criteria|0
2231042|NCT01831804|3882061|FG000|Overall Study|Lost to Follow-up|0
2231043|NCT01831804|3882062|FG001|Overall Study|Lost to Follow-up|0
2231044|NCT01831804|3882063|FG002|Overall Study|Lost to Follow-up|1
2231045|NCT01831804|3882064|FG003|Overall Study|Lost to Follow-up|0
2231046|NCT01831804|3882065|FG004|Overall Study|Lost to Follow-up|0
2231047|NCT01831804|3882066|FG005|Overall Study|Lost to Follow-up|0
2231048|NCT01831804|3882067|FG006|Overall Study|Lost to Follow-up|0
2231049|NCT01831804|3882068|FG007|Overall Study|Lost to Follow-up|0
2231050|NCT01831804|3882069|FG008|Overall Study|Lost to Follow-up|1
2231051|NCT01831804|3882061|FG000|Overall Study|Investigator discretion|0
2231052|NCT01831804|3882062|FG001|Overall Study|Investigator discretion|0
2231053|NCT01831804|3882063|FG002|Overall Study|Investigator discretion|0
2231054|NCT01831804|3882064|FG003|Overall Study|Investigator discretion|0
2231055|NCT01831804|3882065|FG004|Overall Study|Investigator discretion|1
2231056|NCT01831804|3882066|FG005|Overall Study|Investigator discretion|0
2231057|NCT01831804|3882067|FG006|Overall Study|Investigator discretion|0
2231058|NCT01831804|3882068|FG007|Overall Study|Investigator discretion|1
2231059|NCT01831804|3882069|FG008|Overall Study|Investigator discretion|0
2231060|NCT01831804|3882061|FG000|Overall Study|Withdrew Consent|0
2231061|NCT01831804|3882062|FG001|Overall Study|Withdrew Consent|1
2231062|NCT01831804|3882063|FG002|Overall Study|Withdrew Consent|0
2231063|NCT01831804|3882064|FG003|Overall Study|Withdrew Consent|0
2231064|NCT01831804|3882065|FG004|Overall Study|Withdrew Consent|0
2231065|NCT01831804|3882066|FG005|Overall Study|Withdrew Consent|0
2231066|NCT01831804|3882067|FG006|Overall Study|Withdrew Consent|0
2231067|NCT01831804|3882068|FG007|Overall Study|Withdrew Consent|2
2332888|NCT03209570|4057014|FG000|Overall Study|Death|1
2332889|NCT03209570|4057015|FG001|Overall Study|Death|0
2332890|NCT03209570|4057014|FG000|Overall Study|Incomplete Data|8
2332891|NCT03209570|4057015|FG001|Overall Study|Incomplete Data|10
2332892|NCT03209570|4057014|FG000|Overall Study|Protocol Violation|1
2332893|NCT03209570|4057015|FG001|Overall Study|Protocol Violation|0
2332894|NCT03209570|4057014|FG000|Overall Study|Withdrawal by Subject|0
2332895|NCT03209570|4057015|FG001|Overall Study|Withdrawal by Subject|3
2332896|NCT03209973|4057032|FG000|Overall Study|Withdrawal by Subject|7
2332897|NCT03209973|4057032|FG000|Overall Study|Lost to Follow-up|2
2332898|NCT03209973|4057032|FG000|Overall Study|Death|8
2332899|NCT03209973|4057032|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32
2231068|NCT01831804|3882069|FG008|Overall Study|Withdrew Consent|0
2231069|NCT01831817|3882102|FG000|Overall Study|Lost to Follow-up|1
2231070|NCT01831817|3882103|FG001|Overall Study|Lost to Follow-up|0
2231071|NCT01831817|3882104|FG002|Overall Study|Lost to Follow-up|0
2231072|NCT01831817|3882105|FG003|Overall Study|Lost to Follow-up|0
2231073|NCT01831817|3882102|FG000|Overall Study|Withdrawl of Consent|3
2231074|NCT01831817|3882103|FG001|Overall Study|Withdrawl of Consent|0
2231075|NCT01831817|3882104|FG002|Overall Study|Withdrawl of Consent|0
2231076|NCT01831817|3882105|FG003|Overall Study|Withdrawl of Consent|0
2231077|NCT01831856|3882117|FG000|Overall Study|Adverse Event|5
2231078|NCT01831856|3882118|FG001|Overall Study|Adverse Event|8
2231079|NCT01831856|3882117|FG000|Overall Study|Lack of Efficacy|13
2231080|NCT01831856|3882118|FG001|Overall Study|Lack of Efficacy|11
2231081|NCT01831856|3882117|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16
2231082|NCT01831856|3882118|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18
2231083|NCT01832038|3882155|FG000|Overall Study|Death|5
2231084|NCT01832038|3882155|FG000|Overall Study|Adverse Event|50
2231085|NCT01832038|3882155|FG000|Overall Study|Lack of Efficacy|81
2231086|NCT01832038|3882155|FG000|Overall Study|Protocol Violation|7
2231087|NCT01832038|3882155|FG000|Overall Study|Lost to Follow-up|10
2231088|NCT01832038|3882155|FG000|Overall Study|Withdrawal by Subject|49
2231089|NCT01832038|3882155|FG000|Overall Study|Visit non-compliance|2
2231090|NCT01832038|3882155|FG000|Overall Study|Subject refused to return visit|2
2231091|NCT01832038|3882155|FG000|Overall Study|Not convenient to come back to site|2
2231092|NCT01832038|3882155|FG000|Overall Study|Participant was asked to quit|5
2231093|NCT01832038|3882155|FG000|Overall Study|Back home|1
2231094|NCT01832038|3882155|FG000|Overall Study|Pregnancy|1
2231095|NCT01832038|3882155|FG000|Overall Study|Low compliance|3
2231096|NCT01832038|3882155|FG000|Overall Study|Prohibit procedure|2
2231097|NCT01832038|3882155|FG000|Overall Study|Not possible to visit the hospital|1
2231098|NCT01832038|3882155|FG000|Overall Study|Changes of implementation system|3
2231099|NCT01832038|3882155|FG000|Overall Study|Plan to pregnancy|7
2231100|NCT01832038|3882155|FG000|Overall Study|Bad mood and has suicidal thought|1
2231101|NCT01832038|3882155|FG000|Overall Study|Prohibited concomitant medication|1
2231102|NCT01832038|3882155|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1
2231103|NCT01832038|3882155|FG000|Overall Study|Subject considered the efficacy was poor|1
2231104|NCT01832155|3882191|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
2231105|NCT01832155|3882192|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
2231106|NCT01832155|3882191|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
2231107|NCT01832155|3882192|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
2231108|NCT01832402|3882215|FG000|Overall Study|Lost to Follow-up|2
2231109|NCT01832402|3882216|FG001|Overall Study|Lost to Follow-up|0
2231110|NCT01832402|3882215|FG000|Overall Study|Withdrawal by Subject|3
2231111|NCT01832402|3882216|FG001|Overall Study|Withdrawal by Subject|3
2231112|NCT01832402|3882215|FG000|Overall Study|Declining Performance status|2
2231113|NCT01832402|3882216|FG001|Overall Study|Declining Performance status|1
2231114|NCT01832480|3882228|FG000|Overall Study|Lost to Follow-up|33
2231115|NCT01832480|3882229|FG001|Overall Study|Lost to Follow-up|30
2231116|NCT01832480|3882228|FG000|Overall Study|Withdrawal by Subject|0
2231117|NCT01832480|3882229|FG001|Overall Study|Withdrawal by Subject|2
2231118|NCT01832480|3882228|FG000|Overall Study|post randomization ineligible|8
2231119|NCT01832480|3882229|FG001|Overall Study|post randomization ineligible|10
2231120|NCT01832493|3882235|FG000|Overall Study|Physician Decision|2
2231121|NCT01832493|3882235|FG000|Overall Study|Protocol Violation|4
2231122|NCT01832493|3882235|FG000|Overall Study|Unable to place LV lead|2
2231123|NCT01832532|3882259|FG000|Overall Study|Withdrawal by Subject|5
2231124|NCT01832532|3882260|FG001|Overall Study|Withdrawal by Subject|2
2231125|NCT01832727|3882279|FG000|Overall Study|Adverse Event|4
2231126|NCT01832727|3882280|FG001|Overall Study|Adverse Event|6
2231127|NCT01832727|3882281|FG002|Overall Study|Adverse Event|1
2231128|NCT01832727|3882282|FG003|Overall Study|Adverse Event|0
2231129|NCT01832727|3882283|FG004|Overall Study|Adverse Event|1
2231130|NCT01832727|3882284|FG005|Overall Study|Adverse Event|1
2231131|NCT01832727|3882285|FG006|Overall Study|Adverse Event|2
2231132|NCT01832727|3882286|FG007|Overall Study|Adverse Event|1
2231133|NCT01832727|3882287|FG008|Overall Study|Adverse Event|9
2231134|NCT01832727|3882279|FG000|Overall Study|Disease progression|3
2231135|NCT01832727|3882280|FG001|Overall Study|Disease progression|0
2231136|NCT01832727|3882281|FG002|Overall Study|Disease progression|2
2231137|NCT01832727|3882282|FG003|Overall Study|Disease progression|1
2231138|NCT01832727|3882283|FG004|Overall Study|Disease progression|3
2231139|NCT01832727|3882284|FG005|Overall Study|Disease progression|3
2231140|NCT01832727|3882285|FG006|Overall Study|Disease progression|6
2231141|NCT01832727|3882286|FG007|Overall Study|Disease progression|2
2231142|NCT01832727|3882287|FG008|Overall Study|Disease progression|7
2231143|NCT01832727|3882279|FG000|Overall Study|Lost to Follow-up|0
2231144|NCT01832727|3882280|FG001|Overall Study|Lost to Follow-up|0
2231145|NCT01832727|3882281|FG002|Overall Study|Lost to Follow-up|0
2231146|NCT01832727|3882282|FG003|Overall Study|Lost to Follow-up|1
2231147|NCT01832727|3882283|FG004|Overall Study|Lost to Follow-up|0
2231148|NCT01832727|3882284|FG005|Overall Study|Lost to Follow-up|0
2231149|NCT01832727|3882285|FG006|Overall Study|Lost to Follow-up|0
2231150|NCT01832727|3882286|FG007|Overall Study|Lost to Follow-up|0
2231151|NCT01832727|3882287|FG008|Overall Study|Lost to Follow-up|0
2231152|NCT01832727|3882279|FG000|Overall Study|Physician Decision|1
2231153|NCT01832727|3882280|FG001|Overall Study|Physician Decision|0
2231154|NCT01832727|3882281|FG002|Overall Study|Physician Decision|0
2231155|NCT01832727|3882282|FG003|Overall Study|Physician Decision|1
2231156|NCT01832727|3882283|FG004|Overall Study|Physician Decision|0
2231157|NCT01832727|3882284|FG005|Overall Study|Physician Decision|1
2231158|NCT01832727|3882285|FG006|Overall Study|Physician Decision|0
2231159|NCT01832727|3882286|FG007|Overall Study|Physician Decision|0
2231160|NCT01832727|3882287|FG008|Overall Study|Physician Decision|0
2231161|NCT01832727|3882279|FG000|Overall Study|Withdrawal by Subject|1
2231162|NCT01832727|3882280|FG001|Overall Study|Withdrawal by Subject|1
2231163|NCT01832727|3882281|FG002|Overall Study|Withdrawal by Subject|0
2231164|NCT01832727|3882282|FG003|Overall Study|Withdrawal by Subject|1
2231165|NCT01832727|3882283|FG004|Overall Study|Withdrawal by Subject|0
2231166|NCT01832727|3882284|FG005|Overall Study|Withdrawal by Subject|1
2231167|NCT01832727|3882285|FG006|Overall Study|Withdrawal by Subject|0
2231168|NCT01832727|3882286|FG007|Overall Study|Withdrawal by Subject|2
2231169|NCT01832727|3882287|FG008|Overall Study|Withdrawal by Subject|1
2231170|NCT01832727|3882279|FG000|Overall Study|Study terminated by sponsor|0
2231171|NCT01832727|3882280|FG001|Overall Study|Study terminated by sponsor|0
2231172|NCT01832727|3882281|FG002|Overall Study|Study terminated by sponsor|0
2231173|NCT01832727|3882282|FG003|Overall Study|Study terminated by sponsor|0
2231174|NCT01832727|3882283|FG004|Overall Study|Study terminated by sponsor|0
2231175|NCT01832727|3882284|FG005|Overall Study|Study terminated by sponsor|0
2231176|NCT01832727|3882285|FG006|Overall Study|Study terminated by sponsor|0
2231177|NCT01832727|3882286|FG007|Overall Study|Study terminated by sponsor|1
2231178|NCT01832727|3882287|FG008|Overall Study|Study terminated by sponsor|1
2231179|NCT01832766|3882330|FG000|Washout|Lost to Follow-up|0
2231180|NCT01832766|3882331|FG001|Washout|Lost to Follow-up|1
2231181|NCT01832818|3882337|FG000|Overall Study|Lost to Follow-up|6
2231182|NCT01833065|3882369|FG000|Overall Study|Adverse Event|6
2231183|NCT01833065|3882370|FG001|Overall Study|Adverse Event|1
2231184|NCT01833065|3882371|FG002|Overall Study|Adverse Event|0
2231185|NCT01833065|3882372|FG003|Overall Study|Adverse Event|2
2231186|NCT01833065|3882373|FG004|Overall Study|Adverse Event|3
2231187|NCT01833065|3882369|FG000|Overall Study|Protocol Violation|1
2231188|NCT01833065|3882370|FG001|Overall Study|Protocol Violation|0
2231189|NCT01833065|3882371|FG002|Overall Study|Protocol Violation|0
2231190|NCT01833065|3882372|FG003|Overall Study|Protocol Violation|0
2231191|NCT01833065|3882373|FG004|Overall Study|Protocol Violation|2
2231192|NCT01833065|3882369|FG000|Overall Study|Lost to Follow-up|1
2231193|NCT01833065|3882370|FG001|Overall Study|Lost to Follow-up|0
2231194|NCT01833065|3882371|FG002|Overall Study|Lost to Follow-up|0
2231195|NCT01833065|3882372|FG003|Overall Study|Lost to Follow-up|0
2231196|NCT01833065|3882373|FG004|Overall Study|Lost to Follow-up|3
2231197|NCT01833065|3882369|FG000|Overall Study|Withdrawal by Subject|6
2231198|NCT01833065|3882370|FG001|Overall Study|Withdrawal by Subject|2
2231199|NCT01833065|3882371|FG002|Overall Study|Withdrawal by Subject|4
2231200|NCT01833065|3882372|FG003|Overall Study|Withdrawal by Subject|3
2231201|NCT01833065|3882373|FG004|Overall Study|Withdrawal by Subject|11
2231202|NCT01833065|3882369|FG000|Overall Study|Subject's substantial non-compliance|0
2231203|NCT01833065|3882370|FG001|Overall Study|Subject's substantial non-compliance|1
2231204|NCT01833065|3882371|FG002|Overall Study|Subject's substantial non-compliance|0
2231205|NCT01833065|3882372|FG003|Overall Study|Subject's substantial non-compliance|0
2231206|NCT01833065|3882373|FG004|Overall Study|Subject's substantial non-compliance|0
2231207|NCT01833065|3882369|FG000|Overall Study|Trial terminated by sponsor|8
2231208|NCT01833065|3882370|FG001|Overall Study|Trial terminated by sponsor|8
2231209|NCT01833065|3882371|FG002|Overall Study|Trial terminated by sponsor|7
2231210|NCT01833065|3882372|FG003|Overall Study|Trial terminated by sponsor|3
2231211|NCT01833065|3882373|FG004|Overall Study|Trial terminated by sponsor|13
2231212|NCT01833065|3882369|FG000|Overall Study|Others|2
2231213|NCT01833065|3882370|FG001|Overall Study|Others|1
2231214|NCT01833065|3882371|FG002|Overall Study|Others|1
2231215|NCT01833065|3882372|FG003|Overall Study|Others|1
2231216|NCT01833065|3882373|FG004|Overall Study|Others|4
2231217|NCT01833143|3882405|FG000|Overall Study|Not Treated|1
2231218|NCT01833169|3882409|FG000|Overall Study|Disease Progression|99
2231219|NCT01833169|3882409|FG000|Overall Study|Adverse Event|33
2231220|NCT01833169|3882409|FG000|Overall Study|Withdrawal by Subject|9
2231221|NCT01833169|3882409|FG000|Overall Study|Death|3
2231222|NCT01833169|3882409|FG000|Overall Study|Physician Decision|2
2231223|NCT01833455|3882424|FG000|Overall Study|Withdrawal by Subject|1
2231224|NCT01833455|3882425|FG001|Overall Study|Withdrawal by Subject|0
2231225|NCT01833494|3882456|FG000|Overall Study|Adverse Event|24
2231226|NCT01833494|3882456|FG000|Overall Study|Physician Decision|6
2231227|NCT01833494|3882456|FG000|Overall Study|Withdrawal by Subject|6
2231228|NCT01833494|3882456|FG000|Overall Study|Decrease in serum phosphorus|4
2332900|NCT03209973|4057032|FG000|Overall Study|Sponsor Decision|18
2332901|NCT03209973|4057032|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1
2332902|NCT03209973|4057032|FG000|Overall Study|Participant Refused to Return to Treatment|2
2332903|NCT03210220|4057049|FG000|Overall Study|Physician Decision|1
2332904|NCT03210220|4057050|FG001|Overall Study|Physician Decision|0
2332905|NCT03210259|4057058|FG000|12-Week Run-in Period|Adverse Event|1
2332906|NCT03210259|4057059|FG001|12-Week Run-in Period|Adverse Event|0
2332907|NCT03210259|4057060|FG002|12-Week Run-in Period|Adverse Event|0
2231229|NCT01833494|3882456|FG000|Overall Study|Decrease in serum calcium|4
2231230|NCT01833494|3882456|FG000|Overall Study|Increase in serum ferritin|1
2231231|NCT01833520|3882462|FG000|Overall Study|Lack of Efficacy|3
2231232|NCT01833520|3882463|FG001|Overall Study|Lack of Efficacy|3
2231233|NCT01833520|3882464|FG002|Overall Study|Lack of Efficacy|8
2231234|NCT01833520|3882465|FG003|Overall Study|Lack of Efficacy|3
2231235|NCT01833533|3882479|FG000|Overall Study|Adverse Event|0
2231236|NCT01833533|3882480|FG001|Overall Study|Adverse Event|1
2231237|NCT01833533|3882479|FG000|Overall Study|Lost to Follow-up|4
2231238|NCT01833533|3882480|FG001|Overall Study|Lost to Follow-up|9
2231239|NCT01833533|3882479|FG000|Overall Study|To Enter an Extension Study|0
2231240|NCT01833533|3882480|FG001|Overall Study|To Enter an Extension Study|4
2231241|NCT01833533|3882479|FG000|Overall Study|Other|2
2231242|NCT01833533|3882480|FG001|Overall Study|Other|7
2231243|NCT01833832|3882521|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1
2231244|NCT01833897|3882529|FG000|Overall Study|Lack of Efficacy|1
2231245|NCT01834222|3882563|FG000|Overall Study|Not meet inclusion/exclusion criteria|1
2231246|NCT01834274|3882578|FG000|Overall Study|Study Termination|41
2231247|NCT01834274|3882579|FG001|Overall Study|Study Termination|38
2231248|NCT01834274|3882578|FG000|Overall Study|Withdrawal by Subject|1
2231249|NCT01834274|3882579|FG001|Overall Study|Withdrawal by Subject|1
2231250|NCT01834274|3882578|FG000|Overall Study|Lost to Follow-up|3
2231251|NCT01834274|3882579|FG001|Overall Study|Lost to Follow-up|1
2231252|NCT01834274|3882578|FG000|Overall Study|Other|2
2231253|NCT01834274|3882579|FG001|Overall Study|Other|1
2231254|NCT01834586|3882603|FG000|Overall Study|Adverse Event|1
2231255|NCT01834729|3882626|FG000|Overall Study|Did not return bowel diaries|0
2231256|NCT01834729|3882627|FG001|Overall Study|Did not return bowel diaries|0
2231257|NCT01834729|3882628|FG002|Overall Study|Did not return bowel diaries|3
2231258|NCT01834729|3882629|FG003|Overall Study|Did not return bowel diaries|0
2231259|NCT01834729|3882626|FG000|Overall Study|Withdrawal by Subject|1
2231260|NCT01834729|3882627|FG001|Overall Study|Withdrawal by Subject|1
2231261|NCT01834729|3882628|FG002|Overall Study|Withdrawal by Subject|0
2231262|NCT01834729|3882629|FG003|Overall Study|Withdrawal by Subject|0
2231263|NCT01834729|3882626|FG000|Overall Study|Adverse Event|0
2231264|NCT01834729|3882627|FG001|Overall Study|Adverse Event|0
2231265|NCT01834729|3882628|FG002|Overall Study|Adverse Event|0
2231266|NCT01834729|3882629|FG003|Overall Study|Adverse Event|2
2231267|NCT01835015|3882645|FG000|Overall Study|Adverse Event|0
2231268|NCT01835015|3882646|FG001|Overall Study|Adverse Event|0
2231269|NCT01835015|3882647|FG002|Overall Study|Adverse Event|1
2231270|NCT01835015|3882648|FG003|Overall Study|Adverse Event|0
2231271|NCT01835015|3882649|FG004|Overall Study|Adverse Event|0
2231272|NCT01835132|3882662|FG000|Initial Phase|Insufficient Therapeutic Response|2
2231273|NCT01835158|3882668|FG000|Overall Study|Withdrawal by Subject|1
2231274|NCT01835158|3882669|FG001|Overall Study|Withdrawal by Subject|6
2231275|NCT01835223|3882677|FG000|Overall Study|Adverse Event|1
2231276|NCT01835223|3882678|FG001|Overall Study|Adverse Event|0
2231277|NCT01835223|3882677|FG000|Overall Study|Withdrawal by Subject|2
2231278|NCT01835223|3882678|FG001|Overall Study|Withdrawal by Subject|0
2231279|NCT01835223|3882677|FG000|Overall Study|Disease progression|2
2231280|NCT01835223|3882678|FG001|Overall Study|Disease progression|1
2231281|NCT01835223|3882677|FG000|Overall Study|Became Inelligible|4
2231282|NCT01835223|3882678|FG001|Overall Study|Became Inelligible|0
2231283|NCT01835431|3882706|FG000|Overall Study|Adverse Event|1
2231284|NCT01835431|3882707|FG001|Overall Study|Adverse Event|0
2231285|NCT01835431|3882706|FG000|Overall Study|other|0
2231286|NCT01835431|3882707|FG001|Overall Study|other|2
2231287|NCT01835431|3882706|FG000|Overall Study|Withdrawal by Subject|6
2231288|NCT01835431|3882707|FG001|Overall Study|Withdrawal by Subject|10
2231289|NCT01835431|3882706|FG000|Overall Study|Protocol Violation|1
2231290|NCT01835431|3882707|FG001|Overall Study|Protocol Violation|0
2231291|NCT01835470|3882713|FG000|Long Term Treatment Period|Subject Request to Discontinue|1
2231292|NCT01835470|3882713|FG000|Long Term Treatment Period|Lack of Efficacy|3
2231293|NCT01835548|3882724|FG000|Dose Optimization Period|Adverse Event|0
2231294|NCT01835548|3882725|FG001|Dose Optimization Period|Adverse Event|0
2231295|NCT01835548|3882726|FG002|Dose Optimization Period|Adverse Event|1
2231296|NCT01835548|3882724|FG000|Dose Optimization Period|Withdrawal by Subject|0
2231297|NCT01835548|3882725|FG001|Dose Optimization Period|Withdrawal by Subject|0
2332908|NCT03210259|4057058|FG000|12-Week Run-in Period|Death|1
2231298|NCT01835548|3882726|FG002|Dose Optimization Period|Withdrawal by Subject|1
2231299|NCT01835548|3882724|FG000|Double-Blind Treatment Period|Adverse Event|0
2231300|NCT01835548|3882725|FG001|Double-Blind Treatment Period|Adverse Event|1
2231301|NCT01835548|3882726|FG002|Double-Blind Treatment Period|Adverse Event|0
2231302|NCT01835548|3882724|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
2231303|NCT01835548|3882725|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
2231304|NCT01835548|3882726|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0
2231305|NCT01835587|3882742|FG000|Overall Study|Disease Recurrence or Relapse|0
2231306|NCT01835587|3882743|FG001|Overall Study|Disease Recurrence or Relapse|3
2231307|NCT01835587|3882744|FG002|Overall Study|Disease Recurrence or Relapse|0
2231308|NCT01835587|3882745|FG003|Overall Study|Disease Recurrence or Relapse|3
2231309|NCT01835587|3882742|FG000|Overall Study|Withdrawal by Subject|2
2231310|NCT01835587|3882743|FG001|Overall Study|Withdrawal by Subject|0
2231311|NCT01835587|3882744|FG002|Overall Study|Withdrawal by Subject|0
2231312|NCT01835587|3882745|FG003|Overall Study|Withdrawal by Subject|3
2231313|NCT01835587|3882742|FG000|Overall Study|Adverse Event|0
2231314|NCT01835587|3882743|FG001|Overall Study|Adverse Event|0
2231315|NCT01835587|3882744|FG002|Overall Study|Adverse Event|2
2231316|NCT01835587|3882745|FG003|Overall Study|Adverse Event|2
2231317|NCT01835587|3882742|FG000|Overall Study|Death|0
2231318|NCT01835587|3882743|FG001|Overall Study|Death|0
2231319|NCT01835587|3882744|FG002|Overall Study|Death|0
2231320|NCT01835587|3882745|FG003|Overall Study|Death|1
2231321|NCT01835587|3882742|FG000|Overall Study|Miscellaneous|0
2231322|NCT01835587|3882743|FG001|Overall Study|Miscellaneous|1
2231323|NCT01835587|3882744|FG002|Overall Study|Miscellaneous|0
2231324|NCT01835587|3882745|FG003|Overall Study|Miscellaneous|0
2231325|NCT01835899|3882789|FG000|Overall Study|Adverse Event|0
2231326|NCT01835899|3882790|FG001|Overall Study|Adverse Event|0
2231327|NCT01835899|3882791|FG002|Overall Study|Adverse Event|1
2231328|NCT01835899|3882789|FG000|Overall Study|Other than stated above|0
2231329|NCT01835899|3882790|FG001|Overall Study|Other than stated above|1
2231330|NCT01835899|3882791|FG002|Overall Study|Other than stated above|0
2231331|NCT01836198|3882856|FG000|Part A, Period 2|Protocol Violation|0
2231332|NCT01836198|3882857|FG001|Part A, Period 2|Protocol Violation|1
2231333|NCT01836198|3882858|FG002|Part A, Period 2|Protocol Violation|0
2231334|NCT01836276|3882876|FG000|Overall Study|Lost to Follow-up|28
2231335|NCT01836276|3882877|FG001|Overall Study|Lost to Follow-up|51
2231336|NCT01836458|3882896|FG000|Overall Study|Unsatisfactory therapeutic effect|3
2231337|NCT01836458|3882897|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2231338|NCT01836458|3882898|FG002|Overall Study|Unsatisfactory therapeutic effect|5
2231339|NCT01836458|3882899|FG003|Overall Study|Unsatisfactory therapeutic effect|6
2231340|NCT01836471|3882914|FG000|Overall Study|Pregnancy|1
2231341|NCT01836471|3882915|FG001|Overall Study|Pregnancy|0
2231342|NCT01836471|3882916|FG002|Overall Study|Pregnancy|0
2231343|NCT01836471|3882917|FG003|Overall Study|Pregnancy|0
2231344|NCT01836471|3882918|FG004|Overall Study|Pregnancy|0
2231345|NCT01836471|3882914|FG000|Overall Study|Withdrawal by Subject|3
2231346|NCT01836471|3882915|FG001|Overall Study|Withdrawal by Subject|4
2231347|NCT01836471|3882916|FG002|Overall Study|Withdrawal by Subject|1
2231348|NCT01836471|3882917|FG003|Overall Study|Withdrawal by Subject|0
2231349|NCT01836471|3882918|FG004|Overall Study|Withdrawal by Subject|2
2231350|NCT01836471|3882914|FG000|Overall Study|Physician Decision|0
2231351|NCT01836471|3882915|FG001|Overall Study|Physician Decision|1
2231352|NCT01836471|3882916|FG002|Overall Study|Physician Decision|0
2231353|NCT01836471|3882917|FG003|Overall Study|Physician Decision|0
2231354|NCT01836471|3882918|FG004|Overall Study|Physician Decision|0
2231355|NCT01836471|3882914|FG000|Overall Study|Lost to Follow-up|0
2231356|NCT01836471|3882915|FG001|Overall Study|Lost to Follow-up|0
2231357|NCT01836471|3882916|FG002|Overall Study|Lost to Follow-up|0
2231358|NCT01836471|3882917|FG003|Overall Study|Lost to Follow-up|1
2231359|NCT01836471|3882918|FG004|Overall Study|Lost to Follow-up|1
2231360|NCT01836471|3882914|FG000|Overall Study|Adverse Event|6
2231361|NCT01836471|3882915|FG001|Overall Study|Adverse Event|3
2231362|NCT01836471|3882916|FG002|Overall Study|Adverse Event|1
2231363|NCT01836471|3882917|FG003|Overall Study|Adverse Event|1
2231364|NCT01836471|3882918|FG004|Overall Study|Adverse Event|2
2231365|NCT01836471|3882914|FG000|Overall Study|Non compliance with tx|1
2231366|NCT01836471|3882915|FG001|Overall Study|Non compliance with tx|1
2231367|NCT01836471|3882916|FG002|Overall Study|Non compliance with tx|0
2231368|NCT01836471|3882917|FG003|Overall Study|Non compliance with tx|0
2231369|NCT01836471|3882918|FG004|Overall Study|Non compliance with tx|0
2231370|NCT01836523|3882935|FG000|Overall Study|Adverse Event|15
2231371|NCT01836523|3882936|FG001|Overall Study|Adverse Event|41
2231372|NCT01836523|3882937|FG002|Overall Study|Adverse Event|49
2231373|NCT01836523|3882938|FG003|Overall Study|Adverse Event|14
2231374|NCT01836523|3882935|FG000|Overall Study|Protocol Violation|6
2231375|NCT01836523|3882936|FG001|Overall Study|Protocol Violation|3
2231376|NCT01836523|3882937|FG002|Overall Study|Protocol Violation|2
2231377|NCT01836523|3882938|FG003|Overall Study|Protocol Violation|4
2231378|NCT01836523|3882935|FG000|Overall Study|Met Withdrawal Criteria|13
2231379|NCT01836523|3882936|FG001|Overall Study|Met Withdrawal Criteria|13
2231380|NCT01836523|3882937|FG002|Overall Study|Met Withdrawal Criteria|21
2231381|NCT01836523|3882938|FG003|Overall Study|Met Withdrawal Criteria|27
2231382|NCT01836523|3882935|FG000|Overall Study|Unclassified|17
2231383|NCT01836523|3882936|FG001|Overall Study|Unclassified|28
2231384|NCT01836523|3882937|FG002|Overall Study|Unclassified|19
2231385|NCT01836523|3882938|FG003|Overall Study|Unclassified|29
2231386|NCT01836549|3882954|FG000|Overall Study|Did not receive study drug|0
2231387|NCT01836549|3882955|FG001|Overall Study|Did not receive study drug|0
2231388|NCT01836549|3882956|FG002|Overall Study|Did not receive study drug|1
2231389|NCT01836549|3882957|FG003|Overall Study|Did not receive study drug|0
2231390|NCT01836549|3882958|FG004|Overall Study|Did not receive study drug|0
2231391|NCT01836549|3882959|FG005|Overall Study|Did not receive study drug|0
2231392|NCT01836549|3882960|FG006|Overall Study|Did not receive study drug|0
2231393|NCT01836549|3882954|FG000|Overall Study|Patient declared ineligible|0
2231394|NCT01836549|3882955|FG001|Overall Study|Patient declared ineligible|0
2231395|NCT01836549|3882956|FG002|Overall Study|Patient declared ineligible|0
2231396|NCT01836549|3882957|FG003|Overall Study|Patient declared ineligible|1
2231397|NCT01836549|3882958|FG004|Overall Study|Patient declared ineligible|0
2231398|NCT01836549|3882959|FG005|Overall Study|Patient declared ineligible|0
2231399|NCT01836549|3882960|FG006|Overall Study|Patient declared ineligible|0
2231400|NCT01836549|3882954|FG000|Overall Study|Patient inevaluable to start therapy|0
2231401|NCT01836549|3882955|FG001|Overall Study|Patient inevaluable to start therapy|0
2231402|NCT01836549|3882956|FG002|Overall Study|Patient inevaluable to start therapy|0
2231403|NCT01836549|3882957|FG003|Overall Study|Patient inevaluable to start therapy|0
2231404|NCT01836549|3882958|FG004|Overall Study|Patient inevaluable to start therapy|0
2231405|NCT01836549|3882959|FG005|Overall Study|Patient inevaluable to start therapy|0
2231406|NCT01836549|3882960|FG006|Overall Study|Patient inevaluable to start therapy|1
2231407|NCT01837680|3883018|FG000|Overall Study|Lost to Follow-up|2
2231408|NCT01837680|3883019|FG001|Overall Study|Lost to Follow-up|2
2231409|NCT01837680|3883018|FG000|Overall Study|lack of insurance|0
2231410|NCT01837680|3883019|FG001|Overall Study|lack of insurance|2
2231411|NCT01837680|3883018|FG000|Overall Study|allergic reaction|6
2231412|NCT01837680|3883019|FG001|Overall Study|allergic reaction|0
2231413|NCT01837680|3883018|FG000|Overall Study|switched to oral hypoglycemic or diet|2
2231414|NCT01837680|3883019|FG001|Overall Study|switched to oral hypoglycemic or diet|4
2231415|NCT01837719|3883025|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
2231416|NCT01837719|3883025|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
2231417|NCT01837797|3883043|FG000|Period 1|Adverse Event|9
2231418|NCT01837797|3883044|FG001|Period 1|Adverse Event|0
2231419|NCT01837797|3883045|FG002|Period 1|Adverse Event|0
2231420|NCT01837797|3883046|FG003|Period 1|Adverse Event|0
2231421|NCT01837797|3883047|FG004|Period 1|Adverse Event|0
2231422|NCT01837797|3883043|FG000|Period 1|Withdrawal by Subject|6
2231423|NCT01837797|3883044|FG001|Period 1|Withdrawal by Subject|0
2231424|NCT01837797|3883045|FG002|Period 1|Withdrawal by Subject|0
2231425|NCT01837797|3883046|FG003|Period 1|Withdrawal by Subject|0
2231426|NCT01837797|3883047|FG004|Period 1|Withdrawal by Subject|0
2231427|NCT01837797|3883043|FG000|Period 1|Administrative reasons|76
2231428|NCT01837797|3883044|FG001|Period 1|Administrative reasons|0
2231429|NCT01837797|3883045|FG002|Period 1|Administrative reasons|0
2231430|NCT01837797|3883046|FG003|Period 1|Administrative reasons|0
2231431|NCT01837797|3883047|FG004|Period 1|Administrative reasons|0
2231432|NCT01837797|3883043|FG000|Period 1|Withdrawal of consent before treatment|1
2332909|NCT03210259|4057059|FG001|12-Week Run-in Period|Death|0
2332910|NCT03210259|4057060|FG002|12-Week Run-in Period|Death|0
2332911|NCT03210259|4057058|FG000|12-Week Run-in Period|Withdrawal by Subject|9
2332912|NCT03210259|4057059|FG001|12-Week Run-in Period|Withdrawal by Subject|0
2332913|NCT03210259|4057060|FG002|12-Week Run-in Period|Withdrawal by Subject|0
2332914|NCT03210259|4057058|FG000|12-Week Run-in Period|Lost to Follow-up|4
2332915|NCT03210259|4057059|FG001|12-Week Run-in Period|Lost to Follow-up|0
2332916|NCT03210259|4057060|FG002|12-Week Run-in Period|Lost to Follow-up|0
2332917|NCT03210259|4057058|FG000|12-Week Run-in Period|Lack of Efficacy|6
2332918|NCT03210259|4057059|FG001|12-Week Run-in Period|Lack of Efficacy|0
2332919|NCT03210259|4057060|FG002|12-Week Run-in Period|Lack of Efficacy|0
2332920|NCT03210259|4057058|FG000|48-Week Randomized Responder Period|Missed study visit|0
2332921|NCT03210259|4057059|FG001|48-Week Randomized Responder Period|Missed study visit|1
2332922|NCT03210259|4057060|FG002|48-Week Randomized Responder Period|Missed study visit|2
2332923|NCT03210259|4057058|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0
2332924|NCT03210259|4057059|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3
2332925|NCT03210259|4057060|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8
2332926|NCT03210259|4057058|FG000|48-Week Randomized Responder Period|Pregnancy|0
2332927|NCT03210259|4057059|FG001|48-Week Randomized Responder Period|Pregnancy|1
2332928|NCT03210259|4057060|FG002|48-Week Randomized Responder Period|Pregnancy|0
2332929|NCT03210259|4057058|FG000|48-Week Randomized Responder Period|Physician Decision|0
2332930|NCT03210259|4057059|FG001|48-Week Randomized Responder Period|Physician Decision|0
2332931|NCT03210259|4057060|FG002|48-Week Randomized Responder Period|Physician Decision|1
2332932|NCT03210259|4057058|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0
2332933|NCT03210259|4057059|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5
2332934|NCT03210259|4057060|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17
2332935|NCT03210259|4057058|FG000|48-Week Randomized Responder Period|Adverse Event|0
2332936|NCT03210259|4057059|FG001|48-Week Randomized Responder Period|Adverse Event|1
2332937|NCT03210259|4057060|FG002|48-Week Randomized Responder Period|Adverse Event|1
2332938|NCT03210519|4057087|FG000|Overall Study|Adverse Event|2
2332939|NCT03210519|4057088|FG001|Overall Study|Adverse Event|0
2036606|NCT00412984|3606856|FG000|Overall Study|Withdrawal by Subject|921
2231433|NCT01837797|3883044|FG001|Period 1|Withdrawal of consent before treatment|0
2231434|NCT01837797|3883045|FG002|Period 1|Withdrawal of consent before treatment|0
2231435|NCT01837797|3883046|FG003|Period 1|Withdrawal of consent before treatment|0
2231436|NCT01837797|3883047|FG004|Period 1|Withdrawal of consent before treatment|0
2231437|NCT01837797|3883043|FG000|Period 1|Other|10
2231438|NCT01837797|3883044|FG001|Period 1|Other|0
2231439|NCT01837797|3883045|FG002|Period 1|Other|0
2231440|NCT01837797|3883046|FG003|Period 1|Other|0
2231441|NCT01837797|3883047|FG004|Period 1|Other|0
2231442|NCT01837797|3883043|FG000|Period 2|Administrative or other reasons|0
2231443|NCT01837797|3883044|FG001|Period 2|Administrative or other reasons|5
2231444|NCT01837797|3883045|FG002|Period 2|Administrative or other reasons|2
2231445|NCT01837797|3883046|FG003|Period 2|Administrative or other reasons|4
2231446|NCT01837797|3883047|FG004|Period 2|Administrative or other reasons|0
2231447|NCT01837797|3883043|FG000|Period 2|Adverse Event|0
2231448|NCT01837797|3883044|FG001|Period 2|Adverse Event|0
2231449|NCT01837797|3883045|FG002|Period 2|Adverse Event|0
2231450|NCT01837797|3883046|FG003|Period 2|Adverse Event|1
2231451|NCT01837797|3883047|FG004|Period 2|Adverse Event|0
2231452|NCT01837797|3883043|FG000|Period 3|Adverse Event|0
2231453|NCT01837797|3883044|FG001|Period 3|Adverse Event|0
2231454|NCT01837797|3883045|FG002|Period 3|Adverse Event|0
2231455|NCT01837797|3883046|FG003|Period 3|Adverse Event|0
2231456|NCT01837797|3883047|FG004|Period 3|Adverse Event|1
2231457|NCT01837797|3883043|FG000|Period 3|Administrative reasons|0
2231458|NCT01837797|3883044|FG001|Period 3|Administrative reasons|0
2231459|NCT01837797|3883045|FG002|Period 3|Administrative reasons|0
2231460|NCT01837797|3883046|FG003|Period 3|Administrative reasons|0
2231461|NCT01837797|3883047|FG004|Period 3|Administrative reasons|20
2231462|NCT01837797|3883043|FG000|Period 3|Other|0
2231463|NCT01837797|3883044|FG001|Period 3|Other|0
2231464|NCT01837797|3883045|FG002|Period 3|Other|0
2231465|NCT01837797|3883046|FG003|Period 3|Other|0
2231466|NCT01837797|3883047|FG004|Period 3|Other|2
2231467|NCT01837823|3883055|FG000|Overall Study|Lost to Follow-up|6
2231468|NCT01837966|3883078|FG000|Overall Study|Withdrawal by Subject|2
2231469|NCT01837966|3883079|FG001|Overall Study|Withdrawal by Subject|1
2231470|NCT01838044|3883087|FG000|Overall Study|Adverse Event|4
2231471|NCT01838044|3883088|FG001|Overall Study|Adverse Event|6
2231472|NCT01838044|3883087|FG000|Overall Study|Protocol Violation|3
2231473|NCT01838044|3883088|FG001|Overall Study|Protocol Violation|3
2231474|NCT01838044|3883087|FG000|Overall Study|Withdrawal by Subject|0
2231475|NCT01838044|3883088|FG001|Overall Study|Withdrawal by Subject|2
2231476|NCT01838044|3883087|FG000|Overall Study|Insufficient clinical response|1
2231477|NCT01838044|3883088|FG001|Overall Study|Insufficient clinical response|2
2231478|NCT01838044|3883087|FG000|Overall Study|Medication error without associated AE|0
2231479|NCT01838044|3883088|FG001|Overall Study|Medication error without associated AE|1
2231480|NCT01838044|3883087|FG000|Overall Study|Lost to Follow-up|0
2231481|NCT01838044|3883088|FG001|Overall Study|Lost to Follow-up|2
2231482|NCT01838200|3883097|FG000|Overall Study|Adverse Event|0
2231483|NCT01838200|3883098|FG001|Overall Study|Adverse Event|2
2231484|NCT01838200|3883097|FG000|Overall Study|Progressive disease|3
2231485|NCT01838200|3883098|FG001|Overall Study|Progressive disease|0
2274381|NCT02296190|3955384|FG001|Overall Study|Lost to Follow-up|0
2274382|NCT02296190|3955385|FG002|Overall Study|Lost to Follow-up|0
2274383|NCT02296190|3955386|FG003|Overall Study|Lost to Follow-up|0
2274384|NCT02296190|3955387|FG004|Overall Study|Lost to Follow-up|1
2274385|NCT02296190|3955388|FG005|Overall Study|Lost to Follow-up|0
2274386|NCT02296190|3955383|FG000|Overall Study|Failure to induce PSVT|6
2274387|NCT02296190|3955384|FG001|Overall Study|Failure to induce PSVT|10
2274388|NCT02296190|3955385|FG002|Overall Study|Failure to induce PSVT|5
2274389|NCT02296190|3955386|FG003|Overall Study|Failure to induce PSVT|13
2274390|NCT02296190|3955387|FG004|Overall Study|Failure to induce PSVT|8
2274391|NCT02296190|3955388|FG005|Overall Study|Failure to induce PSVT|0
2274392|NCT02296190|3955383|FG000|Overall Study|Physician Decision|1
2274393|NCT02296190|3955384|FG001|Overall Study|Physician Decision|1
2274394|NCT02296190|3955385|FG002|Overall Study|Physician Decision|0
2274395|NCT02296190|3955386|FG003|Overall Study|Physician Decision|1
2274396|NCT02296190|3955387|FG004|Overall Study|Physician Decision|2
2274397|NCT02296190|3955388|FG005|Overall Study|Physician Decision|0
2274398|NCT02296190|3955383|FG000|Overall Study|Withdrawal by Subject|0
2274399|NCT02296190|3955384|FG001|Overall Study|Withdrawal by Subject|1
2274400|NCT02296190|3955385|FG002|Overall Study|Withdrawal by Subject|0
2274401|NCT02296190|3955386|FG003|Overall Study|Withdrawal by Subject|0
2274402|NCT02296190|3955387|FG004|Overall Study|Withdrawal by Subject|0
2274403|NCT02296190|3955388|FG005|Overall Study|Withdrawal by Subject|0
2274404|NCT02296190|3955383|FG000|Overall Study|PSVT < 5 minutes|5
2274405|NCT02296190|3955384|FG001|Overall Study|PSVT < 5 minutes|6
2274406|NCT02296190|3955385|FG002|Overall Study|PSVT < 5 minutes|6
2274407|NCT02296190|3955386|FG003|Overall Study|PSVT < 5 minutes|6
2274408|NCT02296190|3955387|FG004|Overall Study|PSVT < 5 minutes|5
2274409|NCT02296190|3955388|FG005|Overall Study|PSVT < 5 minutes|0
2274410|NCT02296190|3955383|FG000|Overall Study|Patient was given Propofol|0
2274411|NCT02296190|3955384|FG001|Overall Study|Patient was given Propofol|1
2274412|NCT02296190|3955385|FG002|Overall Study|Patient was given Propofol|0
2274413|NCT02296190|3955386|FG003|Overall Study|Patient was given Propofol|1
2274414|NCT02296190|3955387|FG004|Overall Study|Patient was given Propofol|0
2274415|NCT02296190|3955388|FG005|Overall Study|Patient was given Propofol|0
2274416|NCT02296190|3955383|FG000|Overall Study|Patient with Atrial Tachycardia|0
2274417|NCT02296190|3955384|FG001|Overall Study|Patient with Atrial Tachycardia|0
2274418|NCT02296190|3955385|FG002|Overall Study|Patient with Atrial Tachycardia|0
2274419|NCT02296190|3955386|FG003|Overall Study|Patient with Atrial Tachycardia|1
2231486|NCT01838213|3883106|FG000|Overall Study|Ineligible|166
2231487|NCT01838213|3883107|FG001|Overall Study|Ineligible|191
2231488|NCT01838447|3883142|FG000|Overall Study|Change in surgical plan|1
2231489|NCT01838447|3883143|FG001|Overall Study|Change in surgical plan|2
2231490|NCT01838447|3883142|FG000|Overall Study|Withdrawal by Subject|1
2231491|NCT01838447|3883143|FG001|Overall Study|Withdrawal by Subject|1
2231492|NCT01838499|3883151|FG000|Overall Study|Protocol Violation|0
2231493|NCT01838499|3883152|FG001|Overall Study|Protocol Violation|1
2231494|NCT01838499|3883151|FG000|Overall Study|Lost to Follow-up|2
2231495|NCT01838499|3883152|FG001|Overall Study|Lost to Follow-up|4
2231496|NCT01838499|3883151|FG000|Overall Study|Lack of Efficacy|1
2231497|NCT01838499|3883152|FG001|Overall Study|Lack of Efficacy|2
2231498|NCT01838499|3883151|FG000|Overall Study|Adverse Event|2
2231499|NCT01838499|3883152|FG001|Overall Study|Adverse Event|1
2231500|NCT01838499|3883151|FG000|Overall Study|Withdrawal by Subject|19
2231501|NCT01838499|3883152|FG001|Overall Study|Withdrawal by Subject|9
2231502|NCT01838551|3883158|FG000|Overall Study|Adverse Event|16
2231503|NCT01838551|3883158|FG000|Overall Study|Death|1
2231504|NCT01838551|3883158|FG000|Overall Study|Lack of Efficacy|10
2231505|NCT01838551|3883158|FG000|Overall Study|Physician Decision|4
2231506|NCT01838551|3883158|FG000|Overall Study|Withdrawal by Subject|10
2231507|NCT01838551|3883158|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7
2231508|NCT01838590|3883166|FG000|Overall Study|Lack of Efficacy|12
2231509|NCT01838590|3883167|FG001|Overall Study|Lack of Efficacy|4
2231510|NCT01838590|3883166|FG000|Overall Study|Lost to Follow-up|0
2231511|NCT01838590|3883167|FG001|Overall Study|Lost to Follow-up|1
2231512|NCT01838616|3883179|FG000|Titration Period|Adverse Event|18
2231513|NCT01838616|3883180|FG001|Titration Period|Adverse Event|48
2231514|NCT01838616|3883179|FG000|Titration Period|Lack of Efficacy|5
2231515|NCT01838616|3883180|FG001|Titration Period|Lack of Efficacy|12
2231516|NCT01838616|3883179|FG000|Titration Period|Withdrawal by Subject|5
2231517|NCT01838616|3883180|FG001|Titration Period|Withdrawal by Subject|5
2231518|NCT01838616|3883179|FG000|Titration Period|Technical problems|1
2231519|NCT01838616|3883180|FG001|Titration Period|Technical problems|0
2231520|NCT01838616|3883179|FG000|Titration Period|Other|1
2231521|NCT01838616|3883180|FG001|Titration Period|Other|0
2231522|NCT01838616|3883179|FG000|Titration Period|Protocol Violation|0
2231523|NCT01838616|3883180|FG001|Titration Period|Protocol Violation|1
2231524|NCT01838616|3883179|FG000|Continuation Period|Lack of Efficacy|3
2231525|NCT01838616|3883180|FG001|Continuation Period|Lack of Efficacy|5
2231526|NCT01838616|3883179|FG000|Continuation Period|Adverse Event|8
2231527|NCT01838616|3883180|FG001|Continuation Period|Adverse Event|4
2231528|NCT01838616|3883179|FG000|Continuation Period|Protocol Violation|2
2231529|NCT01838616|3883180|FG001|Continuation Period|Protocol Violation|0
2231530|NCT01838616|3883179|FG000|Continuation Period|Lost to Follow-up|1
2231531|NCT01838616|3883180|FG001|Continuation Period|Lost to Follow-up|0
2231532|NCT01838616|3883179|FG000|Continuation Period|Withdrawal by Subject|0
2231533|NCT01838616|3883180|FG001|Continuation Period|Withdrawal by Subject|4
2231534|NCT01838616|3883179|FG000|Continuation Period|Technical problems|0
2231535|NCT01838616|3883180|FG001|Continuation Period|Technical problems|1
2231536|NCT01838616|3883179|FG000|Pick-up Arm|Lack of Efficacy|4
2231537|NCT01838616|3883180|FG001|Pick-up Arm|Lack of Efficacy|0
2231538|NCT01838616|3883179|FG000|Pick-up Arm|Adverse Event|9
2231539|NCT01838616|3883180|FG001|Pick-up Arm|Adverse Event|0
2231540|NCT01838616|3883179|FG000|Pick-up Arm|Withdrawal by Subject|1
2231541|NCT01838616|3883180|FG001|Pick-up Arm|Withdrawal by Subject|0
2231542|NCT01838616|3883179|FG000|Pick-up Arm|Technical problems|1
2231543|NCT01838616|3883180|FG001|Pick-up Arm|Technical problems|0
2231544|NCT01838642|3883191|FG000|Overall Study|Died on study|1
2231545|NCT01838681|3883200|FG000|Period A|Adverse Event|39
2231546|NCT01838681|3883201|FG001|Period A|Adverse Event|0
2231547|NCT01838681|3883202|FG002|Period A|Adverse Event|0
2231548|NCT01838681|3883203|FG003|Period A|Adverse Event|0
2231549|NCT01838681|3883200|FG000|Period A|Lack of Efficacy|21
2231550|NCT01838681|3883201|FG001|Period A|Lack of Efficacy|0
2231551|NCT01838681|3883202|FG002|Period A|Lack of Efficacy|0
2231552|NCT01838681|3883203|FG003|Period A|Lack of Efficacy|0
2231553|NCT01838681|3883200|FG000|Period A|Early response|148
2231554|NCT01838681|3883201|FG001|Period A|Early response|0
2231555|NCT01838681|3883202|FG002|Period A|Early response|0
2231556|NCT01838681|3883203|FG003|Period A|Early response|0
2231557|NCT01838681|3883200|FG000|Period A|Withdrawal by Subject|70
2231558|NCT01838681|3883201|FG001|Period A|Withdrawal by Subject|0
2231559|NCT01838681|3883202|FG002|Period A|Withdrawal by Subject|0
2231560|NCT01838681|3883203|FG003|Period A|Withdrawal by Subject|0
2231561|NCT01838681|3883200|FG000|Period A|Protocol Violation|16
2231562|NCT01838681|3883201|FG001|Period A|Protocol Violation|0
2231563|NCT01838681|3883202|FG002|Period A|Protocol Violation|0
2231564|NCT01838681|3883203|FG003|Period A|Protocol Violation|0
2231565|NCT01838681|3883200|FG000|Period A|Non-compliance with IMP|6
2231566|NCT01838681|3883201|FG001|Period A|Non-compliance with IMP|0
2231567|NCT01838681|3883202|FG002|Period A|Non-compliance with IMP|0
2231568|NCT01838681|3883203|FG003|Period A|Non-compliance with IMP|0
2231569|NCT01838681|3883200|FG000|Period A|Lost to Follow-up|4
2231570|NCT01838681|3883201|FG001|Period A|Lost to Follow-up|0
2231571|NCT01838681|3883202|FG002|Period A|Lost to Follow-up|0
2231572|NCT01838681|3883203|FG003|Period A|Lost to Follow-up|0
2231573|NCT01838681|3883200|FG000|Period A|Withdrawal before treatment|4
2231574|NCT01838681|3883201|FG001|Period A|Withdrawal before treatment|0
2231575|NCT01838681|3883202|FG002|Period A|Withdrawal before treatment|0
2231576|NCT01838681|3883203|FG003|Period A|Withdrawal before treatment|0
2231577|NCT01838681|3883200|FG000|Period A|Administrative or other reasons|17
2231578|NCT01838681|3883201|FG001|Period A|Administrative or other reasons|0
2231579|NCT01838681|3883202|FG002|Period A|Administrative or other reasons|0
2231580|NCT01838681|3883203|FG003|Period A|Administrative or other reasons|0
2231581|NCT01838681|3883200|FG000|Period B/A+|Adverse Event|0
2231582|NCT01838681|3883201|FG001|Period B/A+|Adverse Event|13
2231583|NCT01838681|3883202|FG002|Period B/A+|Adverse Event|27
2231584|NCT01838681|3883203|FG003|Period B/A+|Adverse Event|16
2231585|NCT01838681|3883200|FG000|Period B/A+|Lack of Efficacy|0
2231586|NCT01838681|3883201|FG001|Period B/A+|Lack of Efficacy|9
2231587|NCT01838681|3883202|FG002|Period B/A+|Lack of Efficacy|11
2231588|NCT01838681|3883203|FG003|Period B/A+|Lack of Efficacy|6
2231589|NCT01838681|3883200|FG000|Period B/A+|Withdrawal by Subject|0
2231590|NCT01838681|3883201|FG001|Period B/A+|Withdrawal by Subject|28
2231591|NCT01838681|3883202|FG002|Period B/A+|Withdrawal by Subject|35
2231592|NCT01838681|3883203|FG003|Period B/A+|Withdrawal by Subject|47
2231593|NCT01838681|3883200|FG000|Period B/A+|Protocol Violation|0
2231594|NCT01838681|3883201|FG001|Period B/A+|Protocol Violation|1
2231595|NCT01838681|3883202|FG002|Period B/A+|Protocol Violation|4
2231596|NCT01838681|3883203|FG003|Period B/A+|Protocol Violation|6
2231597|NCT01838681|3883200|FG000|Period B/A+|Non-compliance with IMP|0
2231598|NCT01838681|3883201|FG001|Period B/A+|Non-compliance with IMP|2
2231599|NCT01838681|3883202|FG002|Period B/A+|Non-compliance with IMP|3
2231600|NCT01838681|3883203|FG003|Period B/A+|Non-compliance with IMP|3
2231601|NCT01838681|3883200|FG000|Period B/A+|Lost to Follow-up|0
2231602|NCT01838681|3883201|FG001|Period B/A+|Lost to Follow-up|2
2231603|NCT01838681|3883202|FG002|Period B/A+|Lost to Follow-up|5
2332940|NCT03210961|4057113|FG000|Overall Study|Adverse Event|0
2332941|NCT03210961|4057114|FG001|Overall Study|Adverse Event|0
2332942|NCT03210961|4057115|FG002|Overall Study|Adverse Event|0
2332943|NCT03210961|4057116|FG003|Overall Study|Adverse Event|0
2332944|NCT03210961|4057117|FG004|Overall Study|Adverse Event|0
2332945|NCT03210961|4057118|FG005|Overall Study|Adverse Event|0
2332946|NCT03210961|4057119|FG006|Overall Study|Adverse Event|0
2332947|NCT03210961|4057120|FG007|Overall Study|Adverse Event|0
2332948|NCT03210961|4057121|FG008|Overall Study|Adverse Event|0
2332949|NCT03210961|4057122|FG009|Overall Study|Adverse Event|0
2332950|NCT03210961|4057123|FG010|Overall Study|Adverse Event|0
2332951|NCT03210961|4057124|FG011|Overall Study|Adverse Event|0
2332952|NCT03210961|4057125|FG012|Overall Study|Adverse Event|0
2332953|NCT03210961|4057126|FG013|Overall Study|Adverse Event|1
2332954|NCT03210961|4057127|FG014|Overall Study|Adverse Event|0
2332955|NCT03210961|4057113|FG000|Overall Study|Lost to Follow-up|0
2332956|NCT03210961|4057114|FG001|Overall Study|Lost to Follow-up|0
2332957|NCT03210961|4057115|FG002|Overall Study|Lost to Follow-up|0
2332958|NCT03210961|4057116|FG003|Overall Study|Lost to Follow-up|0
2332959|NCT03210961|4057117|FG004|Overall Study|Lost to Follow-up|0
2332960|NCT03210961|4057118|FG005|Overall Study|Lost to Follow-up|0
2332961|NCT03210961|4057119|FG006|Overall Study|Lost to Follow-up|0
2332962|NCT03210961|4057120|FG007|Overall Study|Lost to Follow-up|0
2332963|NCT03210961|4057121|FG008|Overall Study|Lost to Follow-up|0
2332964|NCT03210961|4057122|FG009|Overall Study|Lost to Follow-up|0
2332965|NCT03210961|4057123|FG010|Overall Study|Lost to Follow-up|0
2332966|NCT03210961|4057124|FG011|Overall Study|Lost to Follow-up|0
2332967|NCT03210961|4057125|FG012|Overall Study|Lost to Follow-up|0
2332968|NCT03210961|4057126|FG013|Overall Study|Lost to Follow-up|0
2332969|NCT03210961|4057127|FG014|Overall Study|Lost to Follow-up|1
2332970|NCT03210961|4057113|FG000|Overall Study|Withdrawal by Subject|0
2332971|NCT03210961|4057114|FG001|Overall Study|Withdrawal by Subject|0
2332972|NCT03210961|4057115|FG002|Overall Study|Withdrawal by Subject|0
2332973|NCT03210961|4057116|FG003|Overall Study|Withdrawal by Subject|0
2332974|NCT03210961|4057117|FG004|Overall Study|Withdrawal by Subject|0
2332975|NCT03210961|4057118|FG005|Overall Study|Withdrawal by Subject|0
2332976|NCT03210961|4057119|FG006|Overall Study|Withdrawal by Subject|0
2332977|NCT03210961|4057120|FG007|Overall Study|Withdrawal by Subject|0
2332978|NCT03210961|4057121|FG008|Overall Study|Withdrawal by Subject|0
2332979|NCT03210961|4057122|FG009|Overall Study|Withdrawal by Subject|0
2332980|NCT03210961|4057123|FG010|Overall Study|Withdrawal by Subject|0
2332981|NCT03210961|4057124|FG011|Overall Study|Withdrawal by Subject|0
2332982|NCT03210961|4057125|FG012|Overall Study|Withdrawal by Subject|0
2332983|NCT03210961|4057126|FG013|Overall Study|Withdrawal by Subject|0
2332984|NCT03210961|4057127|FG014|Overall Study|Withdrawal by Subject|1
2332985|NCT03210961|4057113|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
2332986|NCT03210961|4057114|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
2332987|NCT03210961|4057115|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
2231604|NCT01838681|3883203|FG003|Period B/A+|Lost to Follow-up|11
2231605|NCT01838681|3883200|FG000|Period B/A+|Withdrawal before treatment|0
2231606|NCT01838681|3883201|FG001|Period B/A+|Withdrawal before treatment|1
2231607|NCT01838681|3883202|FG002|Period B/A+|Withdrawal before treatment|0
2231608|NCT01838681|3883203|FG003|Period B/A+|Withdrawal before treatment|0
2231609|NCT01838681|3883200|FG000|Period B/A+|Administrative or other reasons|0
2231610|NCT01838681|3883201|FG001|Period B/A+|Administrative or other reasons|6
2231611|NCT01838681|3883202|FG002|Period B/A+|Administrative or other reasons|10
2231612|NCT01838681|3883203|FG003|Period B/A+|Administrative or other reasons|28
2231613|NCT01838694|3883211|FG000|Overall Study|Adverse Event|0
2231614|NCT01838694|3883212|FG001|Overall Study|Adverse Event|1
2231615|NCT01838876|3883234|FG000|Overall Study|Adverse Event|49
2231616|NCT01838876|3883234|FG000|Overall Study|Insufficient Therapeutic Response|10
2231617|NCT01838876|3883234|FG000|Overall Study|Protocol Violation|34
2231618|NCT01838876|3883234|FG000|Overall Study|Withdrawal of Consent|33
2231619|NCT01838876|3883234|FG000|Overall Study|Lost to Follow-up|21
2231620|NCT01838876|3883234|FG000|Overall Study|Study or Site Terminated by Sponsor|1
2231621|NCT01838876|3883234|FG000|Overall Study|Reason not Specified|7
2231622|NCT01838876|3883234|FG000|Overall Study|Did not meet eligibility criteria|78
2231623|NCT01838941|3883240|FG000|Overall Study|Adverse Event|1
2231624|NCT01838941|3883240|FG000|Overall Study|Withdrawal by Subject|1
2231625|NCT01839188|3883271|FG000|Overall Study|Withdrawal by Subject|1
2231626|NCT01839279|3883283|FG000|Overall Study|Adverse Event|4
2231627|NCT01839279|3883284|FG001|Overall Study|Adverse Event|1
2231628|NCT01839279|3883285|FG002|Overall Study|Adverse Event|1
2231629|NCT01839279|3883283|FG000|Overall Study|Withdrawal by Subject|4
2231630|NCT01839279|3883284|FG001|Overall Study|Withdrawal by Subject|1
2231631|NCT01839279|3883285|FG002|Overall Study|Withdrawal by Subject|1
2231632|NCT01839279|3883283|FG000|Overall Study|Classified as 'Other'|5
2231633|NCT01839279|3883284|FG001|Overall Study|Classified as 'Other'|0
2231634|NCT01839279|3883285|FG002|Overall Study|Classified as 'Other'|0
2231635|NCT01839487|3883315|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1
2231636|NCT01839487|3883316|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
2231637|NCT01839487|3883317|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
2231638|NCT01839487|3883318|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
2231639|NCT01839487|3883319|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
2231640|NCT01839487|3883320|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
2231641|NCT01839487|3883315|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14
2231642|NCT01839487|3883316|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6
2231643|NCT01839487|3883317|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0
2231644|NCT01839487|3883318|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0
2231645|NCT01839487|3883319|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0
2231646|NCT01839487|3883320|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0
2231647|NCT01839487|3883315|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
2231648|NCT01839487|3883316|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1
2231649|NCT01839487|3883317|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
2231650|NCT01839487|3883318|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
2231651|NCT01839487|3883319|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
2231652|NCT01839487|3883320|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
2231653|NCT01839487|3883315|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1
2231654|NCT01839487|3883316|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
2231655|NCT01839487|3883317|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
2231656|NCT01839487|3883318|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
2231657|NCT01839487|3883319|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
2231658|NCT01839487|3883320|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
2231659|NCT01839487|3883315|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
2231660|NCT01839487|3883316|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
2231661|NCT01839487|3883317|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12
2231662|NCT01839487|3883318|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9
2231663|NCT01839487|3883319|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4
2231664|NCT01839487|3883320|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8
2231665|NCT01839487|3883315|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0
2231666|NCT01839487|3883316|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0
2231667|NCT01839487|3883317|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46
2231668|NCT01839487|3883318|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49
2231669|NCT01839487|3883319|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71
2231670|NCT01839487|3883320|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32
2231671|NCT01839487|3883315|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
2231672|NCT01839487|3883316|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
2231673|NCT01839487|3883317|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2
2231674|NCT01839487|3883318|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
2231675|NCT01839487|3883319|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1
2231676|NCT01839487|3883320|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
2231677|NCT01839487|3883315|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
2231678|NCT01839487|3883316|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
2231679|NCT01839487|3883317|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
2231680|NCT01839487|3883318|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1
2231681|NCT01839487|3883319|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10
2231682|NCT01839487|3883320|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3
2231683|NCT01839487|3883315|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
2231684|NCT01839487|3883316|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
2231685|NCT01839487|3883317|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
2231686|NCT01839487|3883318|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3
2231687|NCT01839487|3883319|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2
2231688|NCT01839487|3883320|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
2231689|NCT01839656|3883351|FG000|Overall Study|Withdrawal by Subject|1
2231690|NCT01839656|3883352|FG001|Overall Study|Withdrawal by Subject|1
2231691|NCT01839656|3883351|FG000|Overall Study|Adverse event, serious fatal|1
2231692|NCT01839656|3883352|FG001|Overall Study|Adverse event, serious fatal|4
2231693|NCT01839656|3883351|FG000|Overall Study|Early study closure|0
2231694|NCT01839656|3883352|FG001|Overall Study|Early study closure|11
2231695|NCT01839656|3883351|FG000|Overall Study|Adverse Event|1
2231696|NCT01839656|3883352|FG001|Overall Study|Adverse Event|0
2231697|NCT01839916|3883380|FG000|Overall Study|Death|9
2231698|NCT01839916|3883380|FG000|Overall Study|Physician Decision|17
2231699|NCT01839916|3883380|FG000|Overall Study|Relapse|12
2231700|NCT01839916|3883380|FG000|Overall Study|GVHD|2
2231701|NCT01839916|3883380|FG000|Overall Study|Graft Failure|1
2231702|NCT01840163|3883397|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19
2231703|NCT01840163|3883398|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16
2231704|NCT01840163|3883397|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
2231705|NCT01840163|3883398|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
2231706|NCT01840163|3883397|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
2231707|NCT01840163|3883398|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
2231708|NCT01840228|3883406|FG000|Overall Study|Lost to Follow-up|1
2231709|NCT01840228|3883407|FG001|Overall Study|Lost to Follow-up|1
2231710|NCT01840410|3883427|FG000|Overall Study|Physician Decision|1
2231711|NCT01840410|3883428|FG001|Overall Study|Physician Decision|2
2231712|NCT01840410|3883427|FG000|Overall Study|Pregnancy|1
2231713|NCT01840410|3883428|FG001|Overall Study|Pregnancy|0
2231714|NCT01840410|3883427|FG000|Overall Study|Protocol deviation|1
2231715|NCT01840410|3883428|FG001|Overall Study|Protocol deviation|0
2231716|NCT01840410|3883427|FG000|Overall Study|Lost to Follow-up|1
2231717|NCT01840410|3883428|FG001|Overall Study|Lost to Follow-up|0
2231718|NCT01840410|3883427|FG000|Overall Study|Withdrawal by Subject|2
2231719|NCT01840410|3883428|FG001|Overall Study|Withdrawal by Subject|1
2231720|NCT01840410|3883427|FG000|Overall Study|Adverse Event|1
2231721|NCT01840410|3883428|FG001|Overall Study|Adverse Event|1
2231722|NCT01840579|3883446|FG000|Overall Study|Status not recorded|0
2231723|NCT01840579|3883447|FG001|Overall Study|Status not recorded|0
2231724|NCT01840579|3883448|FG002|Overall Study|Status not recorded|2
2231725|NCT01840579|3883449|FG003|Overall Study|Status not recorded|3
2231726|NCT01840579|3883450|FG004|Overall Study|Status not recorded|4
2231727|NCT01840579|3883451|FG005|Overall Study|Status not recorded|3
2231728|NCT01840579|3883452|FG006|Overall Study|Status not recorded|0
2231729|NCT01840579|3883453|FG007|Overall Study|Status not recorded|3
2231730|NCT01840579|3883454|FG008|Overall Study|Status not recorded|3
2231731|NCT01840579|3883455|FG009|Overall Study|Status not recorded|3
2231732|NCT01840579|3883446|FG000|Overall Study|Progressive disease|3
2231733|NCT01840579|3883447|FG001|Overall Study|Progressive disease|5
2231734|NCT01840579|3883448|FG002|Overall Study|Progressive disease|0
2231735|NCT01840579|3883449|FG003|Overall Study|Progressive disease|0
2231736|NCT01840579|3883450|FG004|Overall Study|Progressive disease|0
2231737|NCT01840579|3883451|FG005|Overall Study|Progressive disease|0
2231738|NCT01840579|3883452|FG006|Overall Study|Progressive disease|0
2231739|NCT01840579|3883453|FG007|Overall Study|Progressive disease|0
2231740|NCT01840579|3883454|FG008|Overall Study|Progressive disease|0
2231741|NCT01840579|3883455|FG009|Overall Study|Progressive disease|0
2231742|NCT01840579|3883446|FG000|Overall Study|Ongoing in study|0
2231743|NCT01840579|3883447|FG001|Overall Study|Ongoing in study|1
2231744|NCT01840579|3883448|FG002|Overall Study|Ongoing in study|0
2231745|NCT01840579|3883449|FG003|Overall Study|Ongoing in study|0
2231746|NCT01840579|3883450|FG004|Overall Study|Ongoing in study|0
2231747|NCT01840579|3883451|FG005|Overall Study|Ongoing in study|0
2231748|NCT01840579|3883452|FG006|Overall Study|Ongoing in study|0
2231749|NCT01840579|3883453|FG007|Overall Study|Ongoing in study|0
2231750|NCT01840579|3883454|FG008|Overall Study|Ongoing in study|0
2231751|NCT01840579|3883455|FG009|Overall Study|Ongoing in study|0
2231752|NCT01840579|3883446|FG000|Overall Study|Death|0
2231753|NCT01840579|3883447|FG001|Overall Study|Death|0
2231754|NCT01840579|3883448|FG002|Overall Study|Death|0
2231755|NCT01840579|3883449|FG003|Overall Study|Death|0
2231756|NCT01840579|3883450|FG004|Overall Study|Death|0
2231757|NCT01840579|3883451|FG005|Overall Study|Death|1
2231758|NCT01840579|3883452|FG006|Overall Study|Death|0
2231759|NCT01840579|3883453|FG007|Overall Study|Death|0
2231760|NCT01840579|3883454|FG008|Overall Study|Death|0
2231761|NCT01840579|3883455|FG009|Overall Study|Death|0
2231762|NCT01840579|3883446|FG000|Overall Study|Adverse Event|0
2231763|NCT01840579|3883447|FG001|Overall Study|Adverse Event|1
2231764|NCT01840579|3883448|FG002|Overall Study|Adverse Event|0
2231765|NCT01840579|3883449|FG003|Overall Study|Adverse Event|0
2231766|NCT01840579|3883450|FG004|Overall Study|Adverse Event|0
2231767|NCT01840579|3883451|FG005|Overall Study|Adverse Event|0
2231768|NCT01840579|3883452|FG006|Overall Study|Adverse Event|0
2231769|NCT01840579|3883453|FG007|Overall Study|Adverse Event|0
2231770|NCT01840579|3883454|FG008|Overall Study|Adverse Event|0
2231771|NCT01840579|3883455|FG009|Overall Study|Adverse Event|0
2231772|NCT01840579|3883446|FG000|Overall Study|Follow-up ended by Sponsor|0
2231773|NCT01840579|3883447|FG001|Overall Study|Follow-up ended by Sponsor|0
2231774|NCT01840579|3883448|FG002|Overall Study|Follow-up ended by Sponsor|0
2231775|NCT01840579|3883449|FG003|Overall Study|Follow-up ended by Sponsor|0
2231776|NCT01840579|3883450|FG004|Overall Study|Follow-up ended by Sponsor|0
2231777|NCT01840579|3883451|FG005|Overall Study|Follow-up ended by Sponsor|0
2231778|NCT01840579|3883452|FG006|Overall Study|Follow-up ended by Sponsor|2
2231779|NCT01840579|3883453|FG007|Overall Study|Follow-up ended by Sponsor|0
2231780|NCT01840579|3883454|FG008|Overall Study|Follow-up ended by Sponsor|0
2231781|NCT01840579|3883455|FG009|Overall Study|Follow-up ended by Sponsor|0
2231782|NCT01840605|3883491|FG000|Overall Study|Adverse Event|0
2231783|NCT01840605|3883492|FG001|Overall Study|Adverse Event|1
2231784|NCT01840605|3883491|FG000|Overall Study|Physician Decision|2
2231785|NCT01840605|3883492|FG001|Overall Study|Physician Decision|1
2231786|NCT01840943|3883509|FG000|Overall Study|Withdrawal by Subject|5
2231787|NCT01840943|3883510|FG001|Overall Study|Withdrawal by Subject|6
2231788|NCT01840943|3883509|FG000|Overall Study|Physician Decision|4
2231789|NCT01840943|3883510|FG001|Overall Study|Physician Decision|2
2231790|NCT01840943|3883509|FG000|Overall Study|Lost to Follow-up|4
2231791|NCT01840943|3883510|FG001|Overall Study|Lost to Follow-up|4
2231792|NCT01841060|3883524|FG000|Overall Study|Protocol Violation|10
2231793|NCT01841073|3883530|FG000|Overall Study|Adverse Event|1
2231794|NCT01841073|3883531|FG001|Overall Study|Adverse Event|1
2231795|NCT01841073|3883530|FG000|Overall Study|Physician Decision|1
2231796|NCT01841073|3883531|FG001|Overall Study|Physician Decision|0
2231797|NCT01841073|3883530|FG000|Overall Study|Lost to Follow-up|0
2231798|NCT01841073|3883531|FG001|Overall Study|Lost to Follow-up|2
2231799|NCT01841554|3883569|FG000|Overall Study|Death|7
2231800|NCT01841554|3883569|FG000|Overall Study|No Implantation|1
2231801|NCT01841554|3883569|FG000|Overall Study|Discontinued Follow Up|5
2231802|NCT01841554|3883569|FG000|Overall Study|Study exit due to secondary intervention|6
2231803|NCT01841567|3883573|FG000|Overall Study|Adverse Event|3
2231804|NCT01841593|3883579|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0
2231805|NCT01841593|3883580|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1
2231806|NCT01841593|3883579|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1
2231807|NCT01841593|3883580|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0
2231808|NCT01841697|3883609|FG000|Overall Study|Death|0
2231809|NCT01841697|3883610|FG001|Overall Study|Death|1
2231810|NCT01841697|3883609|FG000|Overall Study|Lost to Follow-up|4
2231811|NCT01841697|3883610|FG001|Overall Study|Lost to Follow-up|1
2231812|NCT01841697|3883609|FG000|Overall Study|Withdrawal by Subject|16
2231813|NCT01841697|3883610|FG001|Overall Study|Withdrawal by Subject|16
2231814|NCT01841762|3883616|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
2231815|NCT01841762|3883616|FG000|Treatment Period|Adverse Event|16
2231816|NCT01841762|3883616|FG000|Treatment Period|Death|1
2231817|NCT01841762|3883616|FG000|Treatment Period|Withdrawal by Subject|7
2231818|NCT01841762|3883616|FG000|Treatment Period|Lost to Follow-up|1
2231819|NCT01841762|3883616|FG000|Treatment Period|Physician Decision|2
2231820|NCT01841762|3883616|FG000|Treatment Period|Other, including non-compliance|5
2231821|NCT01841762|3883616|FG000|Post-Treatment Safety Follow-Up Period|Death|1
2231822|NCT01841762|3883616|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
2231823|NCT01841762|3883616|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
2231824|NCT01841762|3883616|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
2231825|NCT01841970|3883620|FG000|Overall Study|Withdrawal by Subject|1
2231826|NCT01841970|3883620|FG000|Overall Study|Physician Decision|2
2231827|NCT01841970|3883620|FG000|Overall Study|Lost to Follow-up|8
2231828|NCT01842308|3883641|FG000|Overall Study|Withdrawal by Subject|0
2231829|NCT01842308|3883642|FG001|Overall Study|Withdrawal by Subject|0
2231830|NCT01842308|3883643|FG002|Overall Study|Withdrawal by Subject|0
2231831|NCT01842308|3883644|FG003|Overall Study|Withdrawal by Subject|0
2231832|NCT01842308|3883645|FG004|Overall Study|Withdrawal by Subject|1
2231833|NCT01842334|3883660|FG000|Overall Study|Withdrawal by Subject|3
2231834|NCT01842334|3883661|FG001|Overall Study|Withdrawal by Subject|3
2231835|NCT01842334|3883660|FG000|Overall Study|Moved away mid-study|0
2231836|NCT01842334|3883661|FG001|Overall Study|Moved away mid-study|1
2231837|NCT01842438|3883669|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6
2231838|NCT01842438|3883670|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8
2231839|NCT01842438|3883669|FG000|T2: 6month Follow-up|Withdrawal by Subject|4
2231840|NCT01842438|3883670|FG001|T2: 6month Follow-up|Withdrawal by Subject|3
2231841|NCT01842438|3883669|FG000|T2: 6month Follow-up|Death|0
2231842|NCT01842438|3883670|FG001|T2: 6month Follow-up|Death|1
2231843|NCT01842581|3883687|FG000|Overall Study|Adverse Event|6
2231844|NCT01842581|3883688|FG001|Overall Study|Adverse Event|4
2231845|NCT01842581|3883687|FG000|Overall Study|HE breakthrough|26
2231846|NCT01842581|3883688|FG001|Overall Study|HE breakthrough|13
2231847|NCT01842581|3883687|FG000|Overall Study|Liver transplant|2
2231848|NCT01842581|3883688|FG001|Overall Study|Liver transplant|0
2231849|NCT01842581|3883687|FG000|Overall Study|Lost to Follow-up|2
2231850|NCT01842581|3883688|FG001|Overall Study|Lost to Follow-up|5
2231851|NCT01842581|3883687|FG000|Overall Study|Withdrawal by Subject|5
2231852|NCT01842581|3883688|FG001|Overall Study|Withdrawal by Subject|7
2231853|NCT01842581|3883687|FG000|Overall Study|Other than specified|3
2231854|NCT01842581|3883688|FG001|Overall Study|Other than specified|1
2231855|NCT01842607|3883698|FG000|Overall Study|Adverse Event|11
2231856|NCT01842607|3883698|FG000|Overall Study|Lack of Efficacy|19
2231857|NCT01842607|3883698|FG000|Overall Study|Protocol Violation|8
2231858|NCT01842607|3883698|FG000|Overall Study|Protocol defined stopping criteria|2
2231859|NCT01842607|3883698|FG000|Overall Study|Lost to Follow-up|3
2231860|NCT01842607|3883698|FG000|Overall Study|Physician Decision|9
2231861|NCT01842607|3883698|FG000|Overall Study|Withdrawal by Subject|14
2231862|NCT01842620|3883702|FG000|Period 1|Withdrawal by Subject|1
2231863|NCT01842620|3883703|FG001|Period 1|Withdrawal by Subject|0
2231864|NCT01842633|3883712|FG000|Overall Study|Screen Failure|1
2231865|NCT01842633|3883713|FG001|Overall Study|Screen Failure|0
2231866|NCT01842633|3883714|FG002|Overall Study|Screen Failure|0
2231867|NCT01842633|3883712|FG000|Overall Study|Adverse Event|1
2231868|NCT01842633|3883713|FG001|Overall Study|Adverse Event|1
2231869|NCT01842633|3883714|FG002|Overall Study|Adverse Event|0
2231870|NCT01842633|3883712|FG000|Overall Study|Withdrawal by Subject|0
2231871|NCT01842633|3883713|FG001|Overall Study|Withdrawal by Subject|1
2231872|NCT01842633|3883714|FG002|Overall Study|Withdrawal by Subject|0
2231873|NCT01842633|3883712|FG000|Overall Study|Technical issues|1
2231874|NCT01842633|3883713|FG001|Overall Study|Technical issues|0
2231875|NCT01842633|3883714|FG002|Overall Study|Technical issues|0
2231876|NCT01842958|3883758|FG000|Overall Study|Lost to Follow-up|1
2231877|NCT01842958|3883759|FG001|Overall Study|Lost to Follow-up|1
2231878|NCT01843023|3883767|FG000|Overall Study|Death|1
2231879|NCT01843023|3883768|FG001|Overall Study|Death|0
2231880|NCT01843023|3883767|FG000|Overall Study|Lost to Follow-up|24
2231881|NCT01843023|3883768|FG001|Overall Study|Lost to Follow-up|29
2231882|NCT01843023|3883767|FG000|Overall Study|Withdrawal by Subject|8
2231883|NCT01843023|3883768|FG001|Overall Study|Withdrawal by Subject|6
2231884|NCT01843062|3883776|FG000|Overall Study|Protocol Violation|1
2231885|NCT01843062|3883777|FG001|Overall Study|Protocol Violation|0
2231886|NCT01843062|3883776|FG000|Overall Study|New treatment following progression|2
2231887|NCT01843062|3883777|FG001|Overall Study|New treatment following progression|0
2231888|NCT01843062|3883776|FG000|Overall Study|Pregnancy|1
2231889|NCT01843062|3883777|FG001|Overall Study|Pregnancy|0
2231890|NCT01843062|3883776|FG000|Overall Study|Adverse Event|2
2231891|NCT01843062|3883777|FG001|Overall Study|Adverse Event|0
2231892|NCT01843062|3883776|FG000|Overall Study|Incorrect randomisation|1
2231893|NCT01843062|3883777|FG001|Overall Study|Incorrect randomisation|0
2231894|NCT01843062|3883776|FG000|Overall Study|Withdrawal by Subject|12
2231895|NCT01843062|3883777|FG001|Overall Study|Withdrawal by Subject|3
2231896|NCT01843062|3883776|FG000|Overall Study|Death|1
2231897|NCT01843062|3883777|FG001|Overall Study|Death|2
2231898|NCT01843062|3883776|FG000|Overall Study|Lost to Follow-up|2
2231899|NCT01843062|3883777|FG001|Overall Study|Lost to Follow-up|4
2231900|NCT01843192|3883786|FG000|Overall Study|Intra-operative exclusions per protocol|2
2231901|NCT01843192|3883787|FG001|Overall Study|Intra-operative exclusions per protocol|6
2231902|NCT01843192|3883788|FG002|Overall Study|Intra-operative exclusions per protocol|2
2231903|NCT01843205|3883796|FG000|First Treatment (11 Days)|Withdrawal by Subject|1
2231904|NCT01843205|3883797|FG001|First Treatment (11 Days)|Withdrawal by Subject|0
2231905|NCT01843348|3883806|FG000|Overall Study|Withdrawal by Subject|4
2231906|NCT01843348|3883807|FG001|Overall Study|Withdrawal by Subject|16
2231907|NCT01843348|3883808|FG002|Overall Study|Withdrawal by Subject|18
2231908|NCT01843348|3883806|FG000|Overall Study|Lost to Follow-up|5
2231909|NCT01843348|3883807|FG001|Overall Study|Lost to Follow-up|4
2231910|NCT01843348|3883808|FG002|Overall Study|Lost to Follow-up|2
2231911|NCT01843348|3883806|FG000|Overall Study|Death|5
2231912|NCT01843348|3883807|FG001|Overall Study|Death|3
2231913|NCT01843348|3883808|FG002|Overall Study|Death|4
2332988|NCT03210961|4057116|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
2332989|NCT03210961|4057117|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
2332990|NCT03210961|4057118|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
2332991|NCT03210961|4057119|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
2332992|NCT03210961|4057120|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
2332993|NCT03210961|4057121|FG008|Overall Study|No Longer Meets Eligibility Criteria|0
2332994|NCT03210961|4057122|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
2332995|NCT03210961|4057123|FG010|Overall Study|No Longer Meets Eligibility Criteria|0
2332996|NCT03210961|4057124|FG011|Overall Study|No Longer Meets Eligibility Criteria|0
2332997|NCT03210961|4057125|FG012|Overall Study|No Longer Meets Eligibility Criteria|0
2332998|NCT03210961|4057126|FG013|Overall Study|No Longer Meets Eligibility Criteria|1
2332999|NCT03210961|4057127|FG014|Overall Study|No Longer Meets Eligibility Criteria|0
2333000|NCT03210961|4057113|FG000|Overall Study|Other|0
2333001|NCT03210961|4057114|FG001|Overall Study|Other|0
2333002|NCT03210961|4057115|FG002|Overall Study|Other|0
2231914|NCT01843348|3883806|FG000|Overall Study|Graft loss/retransplantation|5
2231915|NCT01843348|3883807|FG001|Overall Study|Graft loss/retransplantation|8
2231916|NCT01843348|3883808|FG002|Overall Study|Graft loss/retransplantation|11
2231917|NCT01843348|3883806|FG000|Overall Study|Various reasons|4
2231918|NCT01843348|3883807|FG001|Overall Study|Various reasons|9
2231919|NCT01843348|3883808|FG002|Overall Study|Various reasons|6
2231920|NCT01843374|3883820|FG000|Overall Study|Death|155
2231921|NCT01843374|3883821|FG001|Overall Study|Death|313
2231922|NCT01843374|3883820|FG000|Overall Study|Withdrawal by Subject|14
2231923|NCT01843374|3883821|FG001|Overall Study|Withdrawal by Subject|20
2231924|NCT01843374|3883820|FG000|Overall Study|Withdrawing due to Other reason|20
2231925|NCT01843374|3883821|FG001|Overall Study|Withdrawing due to Other reason|46
2231926|NCT01843660|3883846|FG000|Overall Study|Other|30
2231927|NCT01843673|3883850|FG000|Overall Study|Lack of Efficacy|2
2231928|NCT01843673|3883850|FG000|Overall Study|Withdrawal by Subject|4
2231929|NCT01843777|3883867|FG000|Overall Study|Withdrawal by Subject|1
2231930|NCT01843777|3883868|FG001|Overall Study|Withdrawal by Subject|0
2231931|NCT01843803|3883876|FG000|Overall Study|not a Veteran, did not see provider|1
2231932|NCT01843803|3883877|FG001|Overall Study|not a Veteran, did not see provider|3
2231933|NCT01843842|3883885|FG000|Overall Study|Do not meet inclusion criteria|1
2231934|NCT01843842|3883886|FG001|Overall Study|Do not meet inclusion criteria|1
2231935|NCT01843933|3883903|FG000|Overall Study|Data lost|6
2231936|NCT01843933|3883904|FG001|Overall Study|Data lost|4
2231937|NCT01843972|3883920|FG000|Overall Study|Withdrawal by Subject|0
2231938|NCT01843972|3883921|FG001|Overall Study|Withdrawal by Subject|0
2231939|NCT01843972|3883922|FG002|Overall Study|Withdrawal by Subject|0
2231940|NCT01843972|3883923|FG003|Overall Study|Withdrawal by Subject|0
2231941|NCT01843972|3883924|FG004|Overall Study|Withdrawal by Subject|1
2231942|NCT01843972|3883925|FG005|Overall Study|Withdrawal by Subject|0
2231943|NCT01843972|3883926|FG006|Overall Study|Withdrawal by Subject|0
2231944|NCT01843972|3883927|FG007|Overall Study|Withdrawal by Subject|0
2231945|NCT01843972|3883928|FG008|Overall Study|Withdrawal by Subject|0
2231946|NCT01843972|3883929|FG009|Overall Study|Withdrawal by Subject|0
2231947|NCT01844076|3883969|FG000|Overall Study|Adverse Event|1
2231948|NCT01844076|3883970|FG001|Overall Study|Adverse Event|0
2231949|NCT01844076|3883971|FG002|Overall Study|Adverse Event|0
2231950|NCT01844076|3883972|FG003|Overall Study|Adverse Event|0
2231951|NCT01844076|3883969|FG000|Overall Study|Withdrawal by Subject|1
2231952|NCT01844076|3883970|FG001|Overall Study|Withdrawal by Subject|0
2231953|NCT01844076|3883971|FG002|Overall Study|Withdrawal by Subject|0
2231954|NCT01844076|3883972|FG003|Overall Study|Withdrawal by Subject|0
2231955|NCT01844115|3883984|FG000|Overall Study|Adverse Event|4
2231956|NCT01844115|3883985|FG001|Overall Study|Adverse Event|22
2231957|NCT01844115|3883984|FG000|Overall Study|Lack of Efficacy|1
2231958|NCT01844115|3883985|FG001|Overall Study|Lack of Efficacy|4
2231959|NCT01844115|3883984|FG000|Overall Study|Protocol Violation|12
2231960|NCT01844115|3883985|FG001|Overall Study|Protocol Violation|10
2231961|NCT01844115|3883984|FG000|Overall Study|Withdrawal by Subject|11
2231962|NCT01844115|3883985|FG001|Overall Study|Withdrawal by Subject|11
2231963|NCT01844115|3883984|FG000|Overall Study|Lost to Follow-up|11
2231964|NCT01844115|3883985|FG001|Overall Study|Lost to Follow-up|10
2231965|NCT01844115|3883984|FG000|Overall Study|Pregnancy|0
2231966|NCT01844115|3883985|FG001|Overall Study|Pregnancy|1
2231967|NCT01844284|3884002|FG000|Overall Study|Lost to Follow-up|12
2231968|NCT01844284|3884003|FG001|Overall Study|Lost to Follow-up|7
2231969|NCT01844375|3884011|FG000|Overall Study|Protocol Violation|1
2231970|NCT01844375|3884012|FG001|Overall Study|Protocol Violation|1
2231971|NCT01844531|3884039|FG000|Overall Study|Withdrawal by Subject|0
2231972|NCT01844531|3884040|FG001|Overall Study|Withdrawal by Subject|1
2231973|NCT01844531|3884041|FG002|Overall Study|Withdrawal by Subject|0
2231974|NCT01844531|3884042|FG003|Overall Study|Withdrawal by Subject|0
2231975|NCT01844583|3884054|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8
2231976|NCT01844583|3884055|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10
2231977|NCT01844687|3884066|FG000|Visit 1|Protocol Violation|3
2231978|NCT01844687|3884066|FG000|Visit 1|Lost to Follow-up|5
2231979|NCT01844687|3884066|FG000|Visit 2|Withdrawal by Subject|1
2231980|NCT01844687|3884066|FG000|Visit 2|Protocol Violation|1
2231981|NCT01844687|3884066|FG000|Visit 3|Lost to Follow-up|1
2231982|NCT01844687|3884066|FG000|Visit 3|Withdrawal by Subject|3
2231983|NCT01844687|3884066|FG000|Visit 3|child care problems|1
2231984|NCT01844687|3884066|FG000|Visit 4|Pregnancy|1
2231985|NCT01844687|3884066|FG000|Visit 4|Lost to Follow-up|1
2231986|NCT01844687|3884066|FG000|Visit 4|Withdrawal by Subject|2
2231987|NCT01844700|3884090|FG000|Overall Study|Lack of Efficacy|1
2231988|NCT01844700|3884091|FG001|Overall Study|Lack of Efficacy|0
2231989|NCT01844700|3884090|FG000|Overall Study|refused medication switch|1
2231990|NCT01844700|3884091|FG001|Overall Study|refused medication switch|0
2231991|NCT01844700|3884090|FG000|Overall Study|Withdrawal by Subject|1
2231992|NCT01844700|3884091|FG001|Overall Study|Withdrawal by Subject|0
2231993|NCT01844700|3884090|FG000|Overall Study|stopped taking meds|0
2231994|NCT01844700|3884091|FG001|Overall Study|stopped taking meds|1
2231995|NCT01844765|3884099|FG000|Overall Study|Adverse Event|6
2231996|NCT01844765|3884100|FG001|Overall Study|Adverse Event|8
2231997|NCT01844765|3884099|FG000|Overall Study|Withdrawal by Subject|2
2231998|NCT01844765|3884100|FG001|Overall Study|Withdrawal by Subject|3
2231999|NCT01844765|3884099|FG000|Overall Study|Disease progression|1
2232000|NCT01844765|3884100|FG001|Overall Study|Disease progression|0
2232001|NCT01844765|3884099|FG000|Overall Study|Administrative problems|3
2232002|NCT01844765|3884100|FG001|Overall Study|Administrative problems|4
2232003|NCT01844765|3884099|FG000|Overall Study|Protocol deviation|2
2232004|NCT01844765|3884100|FG001|Overall Study|Protocol deviation|0
2232005|NCT01844765|3884099|FG000|Overall Study|Untreated|1
2232006|NCT01844765|3884100|FG001|Overall Study|Untreated|0
2274420|NCT02296190|3955387|FG004|Overall Study|Patient with Atrial Tachycardia|0
2274421|NCT02296190|3955388|FG005|Overall Study|Patient with Atrial Tachycardia|0
2274422|NCT02296190|3955383|FG000|Overall Study|Blood pressure <100 after sedation|0
2274423|NCT02296190|3955384|FG001|Overall Study|Blood pressure <100 after sedation|0
2274424|NCT02296190|3955385|FG002|Overall Study|Blood pressure <100 after sedation|0
2274425|NCT02296190|3955386|FG003|Overall Study|Blood pressure <100 after sedation|1
2274426|NCT02296190|3955387|FG004|Overall Study|Blood pressure <100 after sedation|0
2274427|NCT02296190|3955388|FG005|Overall Study|Blood pressure <100 after sedation|0
2274428|NCT02296190|3955383|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0
2274429|NCT02296190|3955384|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1
2274430|NCT02296190|3955385|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1
2274431|NCT02296190|3955386|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0
2274432|NCT02296190|3955387|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0
2274433|NCT02296190|3955388|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0
2274434|NCT02296190|3955383|FG000|Overall Study|Patient on antiarrhythmic medication|1
2274435|NCT02296190|3955384|FG001|Overall Study|Patient on antiarrhythmic medication|0
2274436|NCT02296190|3955385|FG002|Overall Study|Patient on antiarrhythmic medication|0
2274437|NCT02296190|3955386|FG003|Overall Study|Patient on antiarrhythmic medication|0
2274438|NCT02296190|3955387|FG004|Overall Study|Patient on antiarrhythmic medication|0
2274439|NCT02296190|3955388|FG005|Overall Study|Patient on antiarrhythmic medication|0
2274440|NCT02296190|3955383|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0
2274441|NCT02296190|3955384|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1
2274442|NCT02296190|3955385|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0
2274443|NCT02296190|3955386|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0
2274444|NCT02296190|3955387|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0
2274445|NCT02296190|3955388|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0
2274446|NCT02296190|3955383|FG000|Overall Study|Lab result not available in time|1
2274447|NCT02296190|3955384|FG001|Overall Study|Lab result not available in time|0
2274448|NCT02296190|3955385|FG002|Overall Study|Lab result not available in time|0
2274449|NCT02296190|3955386|FG003|Overall Study|Lab result not available in time|0
2274450|NCT02296190|3955387|FG004|Overall Study|Lab result not available in time|0
2274451|NCT02296190|3955388|FG005|Overall Study|Lab result not available in time|0
2274452|NCT02296242|3955406|FG000|Overall Study|Death|1
2274453|NCT02296242|3955407|FG001|Overall Study|Death|1
2274454|NCT02296242|3955408|FG002|Overall Study|Death|1
2274455|NCT02296242|3955409|FG003|Overall Study|Death|1
2274456|NCT02296242|3955410|FG004|Overall Study|Death|1
2274457|NCT02296242|3955406|FG000|Overall Study|Withdrawal by Subject|0
2274458|NCT02296242|3955407|FG001|Overall Study|Withdrawal by Subject|0
2274459|NCT02296242|3955408|FG002|Overall Study|Withdrawal by Subject|1
2274460|NCT02296242|3955409|FG003|Overall Study|Withdrawal by Subject|1
2274461|NCT02296242|3955410|FG004|Overall Study|Withdrawal by Subject|3
2274462|NCT02296242|3955406|FG000|Overall Study|Disease Progression|1
2274463|NCT02296242|3955407|FG001|Overall Study|Disease Progression|3
2274464|NCT02296242|3955408|FG002|Overall Study|Disease Progression|2
2274465|NCT02296242|3955409|FG003|Overall Study|Disease Progression|8
2274466|NCT02296242|3955410|FG004|Overall Study|Disease Progression|11
2333003|NCT03210961|4057116|FG003|Overall Study|Other|1
2333004|NCT03210961|4057117|FG004|Overall Study|Other|0
2333005|NCT03210961|4057118|FG005|Overall Study|Other|0
2333006|NCT03210961|4057119|FG006|Overall Study|Other|1
2333007|NCT03210961|4057120|FG007|Overall Study|Other|0
2333008|NCT03210961|4057121|FG008|Overall Study|Other|0
2333009|NCT03210961|4057122|FG009|Overall Study|Other|0
2333010|NCT03210961|4057123|FG010|Overall Study|Other|1
2333011|NCT03210961|4057124|FG011|Overall Study|Other|0
2333012|NCT03210961|4057125|FG012|Overall Study|Other|2
2333013|NCT03210961|4057126|FG013|Overall Study|Other|2
2333014|NCT03210961|4057127|FG014|Overall Study|Other|0
2333015|NCT03211156|4057187|FG000|Overall Study|Withdrawal by Subject|0
2333016|NCT03211156|4057188|FG001|Overall Study|Withdrawal by Subject|2
2333017|NCT03211156|4057187|FG000|Overall Study|Lost to Follow-up|1
2333018|NCT03211156|4057188|FG001|Overall Study|Lost to Follow-up|1
2333019|NCT03211156|4057187|FG000|Overall Study|Adverse Event|1
2333020|NCT03211156|4057188|FG001|Overall Study|Adverse Event|0
2333021|NCT03211858|4057209|FG000|Overall Study|Adverse Event|8
2333022|NCT03211858|4057210|FG001|Overall Study|Adverse Event|6
2333023|NCT03211858|4057209|FG000|Overall Study|Lack of Efficacy|0
2333024|NCT03211858|4057210|FG001|Overall Study|Lack of Efficacy|4
2333025|NCT03211858|4057209|FG000|Overall Study|Poor compliance to protocol|6
2333026|NCT03211858|4057210|FG001|Overall Study|Poor compliance to protocol|2
2333027|NCT03211858|4057209|FG000|Overall Study|Non-serious Hypoglycemia|1
2333028|NCT03211858|4057210|FG001|Overall Study|Non-serious Hypoglycemia|0
2333029|NCT03211858|4057209|FG000|Overall Study|Other than specified above|22
2333030|NCT03211858|4057210|FG001|Overall Study|Other than specified above|21
2333031|NCT03212261|4057220|FG000|Overall Study|Became ineligible d/t tech|2
2232007|NCT01844778|3884114|FG000|Overall Study|Protocol deviation|0
2232008|NCT01844778|3884115|FG001|Overall Study|Protocol deviation|1
2232009|NCT01844778|3884116|FG002|Overall Study|Protocol deviation|2
2232010|NCT01844778|3884114|FG000|Overall Study|Withdrawal by Subject|2
2232011|NCT01844778|3884115|FG001|Overall Study|Withdrawal by Subject|0
2232012|NCT01844778|3884116|FG002|Overall Study|Withdrawal by Subject|0
2232013|NCT01844778|3884114|FG000|Overall Study|Adverse Event|0
2232014|NCT01844778|3884115|FG001|Overall Study|Adverse Event|2
2232015|NCT01844778|3884116|FG002|Overall Study|Adverse Event|2
2232016|NCT01844817|3884130|FG000|Enrolled and Randomized|Withdrawal by Subject|2
2232017|NCT01844817|3884131|FG001|Enrolled and Randomized|Withdrawal by Subject|3
2232018|NCT01844817|3884130|FG000|Treatment|Progressive Disease|27
2232019|NCT01844817|3884131|FG001|Treatment|Progressive Disease|36
2232020|NCT01844817|3884130|FG000|Treatment|Adverse Event|17
2232021|NCT01844817|3884131|FG001|Treatment|Adverse Event|9
2232022|NCT01844817|3884130|FG000|Treatment|Withdrawal by Subject|10
2232023|NCT01844817|3884131|FG001|Treatment|Withdrawal by Subject|6
2232024|NCT01844817|3884130|FG000|Treatment|Death|10
2232025|NCT01844817|3884131|FG001|Treatment|Death|8
2232026|NCT01844817|3884130|FG000|Treatment|Lost to Follow-up|0
2232027|NCT01844817|3884131|FG001|Treatment|Lost to Follow-up|1
2232028|NCT01844817|3884130|FG000|Treatment|Other|0
2232029|NCT01844817|3884131|FG001|Treatment|Other|3
2232030|NCT01844830|3884140|FG000|Overall Study|Withdrawal by Subject|1
2232031|NCT01844830|3884141|FG001|Overall Study|Withdrawal by Subject|0
2232032|NCT01844895|3884147|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
2232033|NCT01844895|3884147|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
2232034|NCT01844895|3884147|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
2232035|NCT01844895|3884147|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1
2232036|NCT01844895|3884147|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
2232037|NCT01844895|3884147|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3
2232038|NCT01844895|3884147|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1
2232039|NCT01845025|3884162|FG000|Overall Study|Adverse Event|6
2232040|NCT01845025|3884163|FG001|Overall Study|Adverse Event|3
2232041|NCT01845025|3884162|FG000|Overall Study|Unsatisfactory therapeutic effect|4
2232042|NCT01845025|3884163|FG001|Overall Study|Unsatisfactory therapeutic effect|2
2232043|NCT01845025|3884162|FG000|Overall Study|Withdrawal by Subject|48
2232044|NCT01845025|3884163|FG001|Overall Study|Withdrawal by Subject|44
2232045|NCT01845025|3884162|FG000|Overall Study|Lost to Follow-up|13
2232046|NCT01845025|3884163|FG001|Overall Study|Lost to Follow-up|13
2232047|NCT01845025|3884162|FG000|Overall Study|Administrative problems|8
2232048|NCT01845025|3884163|FG001|Overall Study|Administrative problems|8
2232049|NCT01845025|3884162|FG000|Overall Study|Death|2
2232050|NCT01845025|3884163|FG001|Overall Study|Death|0
2232051|NCT01845025|3884162|FG000|Overall Study|Protocol deviation|3
2232052|NCT01845025|3884163|FG001|Overall Study|Protocol deviation|6
2232053|NCT01845025|3884162|FG000|Overall Study|Missing|1
2232054|NCT01845025|3884163|FG001|Overall Study|Missing|1
2232055|NCT01845077|3884172|FG000|Washout Period|Lost to Follow-up|0
2232056|NCT01845077|3884173|FG001|Washout Period|Lost to Follow-up|1
2232057|NCT01845077|3884174|FG002|Washout Period|Lost to Follow-up|0
2232058|NCT01845077|3884175|FG003|Washout Period|Lost to Follow-up|1
2232059|NCT01845077|3884176|FG004|Washout Period|Lost to Follow-up|0
2232060|NCT01845077|3884177|FG005|Washout Period|Lost to Follow-up|1
2232061|NCT01845077|3884172|FG000|Washout Period|Adverse Event|1
2232062|NCT01845077|3884173|FG001|Washout Period|Adverse Event|0
2232063|NCT01845077|3884174|FG002|Washout Period|Adverse Event|0
2232064|NCT01845077|3884175|FG003|Washout Period|Adverse Event|0
2232065|NCT01845077|3884176|FG004|Washout Period|Adverse Event|0
2232066|NCT01845077|3884177|FG005|Washout Period|Adverse Event|0
2232067|NCT01845077|3884172|FG000|Washout Period|elevated lab values (not clinic. sign.)|0
2232068|NCT01845077|3884173|FG001|Washout Period|elevated lab values (not clinic. sign.)|0
2232069|NCT01845077|3884174|FG002|Washout Period|elevated lab values (not clinic. sign.)|1
2232070|NCT01845077|3884175|FG003|Washout Period|elevated lab values (not clinic. sign.)|0
2232071|NCT01845077|3884176|FG004|Washout Period|elevated lab values (not clinic. sign.)|0
2232072|NCT01845077|3884177|FG005|Washout Period|elevated lab values (not clinic. sign.)|0
2232073|NCT01845077|3884172|FG000|Washout Period|Protocol Violation|0
2232074|NCT01845077|3884173|FG001|Washout Period|Protocol Violation|0
2232075|NCT01845077|3884174|FG002|Washout Period|Protocol Violation|0
2232076|NCT01845077|3884175|FG003|Washout Period|Protocol Violation|1
2232077|NCT01845077|3884176|FG004|Washout Period|Protocol Violation|1
2232078|NCT01845077|3884177|FG005|Washout Period|Protocol Violation|0
2232079|NCT01845818|3884227|FG000|Overall Study|Withdrawal by Subject|0
2232080|NCT01845818|3884228|FG001|Overall Study|Withdrawal by Subject|1
2232081|NCT01845818|3884227|FG000|Overall Study|Lost to Follow-up|7
2232082|NCT01845818|3884228|FG001|Overall Study|Lost to Follow-up|5
2232083|NCT01845818|3884227|FG000|Overall Study|Administrative Reasons|3
2232084|NCT01845818|3884228|FG001|Overall Study|Administrative Reasons|1
2232085|NCT01845818|3884227|FG000|Overall Study|Serious Adverse Event|1
2232086|NCT01845818|3884228|FG001|Overall Study|Serious Adverse Event|1
2232087|NCT01845818|3884227|FG000|Overall Study|Other|25
2232088|NCT01845818|3884228|FG001|Overall Study|Other|8
2232089|NCT01845818|3884227|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5
2232090|NCT01845818|3884228|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0
2232091|NCT01845818|3884227|FG000|Overall Study|No Follow-Up Data Available|4
2232092|NCT01845818|3884228|FG001|Overall Study|No Follow-Up Data Available|1
2232093|NCT01845831|3884238|FG000|Inpatient Phase|Withdrawal by Subject|1
2232094|NCT01845831|3884239|FG001|Inpatient Phase|Withdrawal by Subject|1
2232095|NCT01845831|3884240|FG002|Inpatient Phase|Withdrawal by Subject|0
2232096|NCT01845831|3884241|FG003|Inpatient Phase|Withdrawal by Subject|0
2232097|NCT01845831|3884242|FG004|Inpatient Phase|Withdrawal by Subject|0
2232098|NCT01845974|3884255|FG000|Overall Study|screen failure|1
2232099|NCT01845974|3884256|FG001|Overall Study|screen failure|0
2232100|NCT01846039|3884262|FG000|Overall Study|Protocol Violation|1
2232101|NCT01846039|3884262|FG000|Overall Study|Subject Withdrew Consent|1
2232102|NCT01846104|3884266|FG000|Overall Study|Withdrawal by Subject|1
2232103|NCT01846208|3884273|FG000|Overall Study|Withdrew prior to treatment|1
2232104|NCT01846208|3884274|FG001|Overall Study|Withdrew prior to treatment|1
2232105|NCT01846208|3884275|FG002|Overall Study|Withdrew prior to treatment|1
2232106|NCT01846208|3884273|FG000|Overall Study|Dosing Symptoms|1
2232107|NCT01846208|3884274|FG001|Overall Study|Dosing Symptoms|2
2232108|NCT01846208|3884275|FG002|Overall Study|Dosing Symptoms|6
2232109|NCT01846208|3884273|FG000|Overall Study|Withdrawal by Subject|5
2232110|NCT01846208|3884274|FG001|Overall Study|Withdrawal by Subject|0
2232111|NCT01846208|3884275|FG002|Overall Study|Withdrawal by Subject|0
2232112|NCT01846208|3884273|FG000|Overall Study|Non-compliance|1
2232113|NCT01846208|3884274|FG001|Overall Study|Non-compliance|1
2232114|NCT01846208|3884275|FG002|Overall Study|Non-compliance|0
2232115|NCT01846208|3884273|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
2232116|NCT01846208|3884274|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
2232117|NCT01846208|3884275|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
2232118|NCT01846208|3884273|FG000|Overall Study|Refused SU OFC|0
2232119|NCT01846208|3884274|FG001|Overall Study|Refused SU OFC|0
2232120|NCT01846208|3884275|FG002|Overall Study|Refused SU OFC|1
2232121|NCT01846221|3884285|FG000|Overall Study|Catheter Failure|2
2232122|NCT01846221|3884286|FG001|Overall Study|Catheter Failure|0
2232123|NCT01846221|3884285|FG000|Overall Study|Age Exclusion|1
2232124|NCT01846221|3884286|FG001|Overall Study|Age Exclusion|0
2232125|NCT01846299|3884294|FG000|Overall Study|Physician Decision|4
2232126|NCT01846299|3884295|FG001|Overall Study|Physician Decision|2
2232127|NCT01846299|3884294|FG000|Overall Study|Protocol deviation|1
2232128|NCT01846299|3884295|FG001|Overall Study|Protocol deviation|0
2232129|NCT01846299|3884294|FG000|Overall Study|Death|1
2232130|NCT01846299|3884295|FG001|Overall Study|Death|2
2232131|NCT01846299|3884294|FG000|Overall Study|Lost to Follow-up|3
2232132|NCT01846299|3884295|FG001|Overall Study|Lost to Follow-up|0
2232133|NCT01846299|3884294|FG000|Overall Study|Withdrawal by Subject|1
2232134|NCT01846299|3884295|FG001|Overall Study|Withdrawal by Subject|6
2232135|NCT01846299|3884294|FG000|Overall Study|Adverse Event|2
2232136|NCT01846299|3884295|FG001|Overall Study|Adverse Event|0
2232137|NCT01846416|3884306|FG000|Treatment Phase|Death|2
2232138|NCT01846416|3884307|FG001|Treatment Phase|Death|9
2232139|NCT01846416|3884308|FG002|Treatment Phase|Death|1
2232140|NCT01846416|3884306|FG000|Treatment Phase|Withdrawal by Subject|2
2232141|NCT01846416|3884307|FG001|Treatment Phase|Withdrawal by Subject|4
2232142|NCT01846416|3884308|FG002|Treatment Phase|Withdrawal by Subject|2
2232143|NCT01846416|3884306|FG000|Treatment Phase|Other|1
2232144|NCT01846416|3884307|FG001|Treatment Phase|Other|5
2232145|NCT01846416|3884308|FG002|Treatment Phase|Other|1
2232146|NCT01846416|3884306|FG000|Treatment Phase|Physician Decision|1
2232147|NCT01846416|3884307|FG001|Treatment Phase|Physician Decision|2
2232148|NCT01846416|3884308|FG002|Treatment Phase|Physician Decision|0
2232149|NCT01846416|3884306|FG000|Treatment Phase|Adverse Event|3
2232150|NCT01846416|3884307|FG001|Treatment Phase|Adverse Event|4
2232151|NCT01846416|3884308|FG002|Treatment Phase|Adverse Event|0
2232152|NCT01846416|3884306|FG000|Treatment Phase|Non-compliance|0
2232153|NCT01846416|3884307|FG001|Treatment Phase|Non-compliance|2
2232154|NCT01846416|3884308|FG002|Treatment Phase|Non-compliance|0
2232155|NCT01846416|3884306|FG000|Treatment Phase|Study Terminated by Sponsor|1
2232156|NCT01846416|3884307|FG001|Treatment Phase|Study Terminated by Sponsor|4
2232157|NCT01846416|3884308|FG002|Treatment Phase|Study Terminated by Sponsor|0
2232158|NCT01846416|3884306|FG000|Treatment Phase|Progressive Disease|21
2232159|NCT01846416|3884307|FG001|Treatment Phase|Progressive Disease|63
2232160|NCT01846416|3884308|FG002|Treatment Phase|Progressive Disease|9
2232161|NCT01846416|3884306|FG000|Survival Follow-up|Death|21
2232162|NCT01846416|3884307|FG001|Survival Follow-up|Death|62
2232163|NCT01846416|3884308|FG002|Survival Follow-up|Death|9
2232164|NCT01846416|3884306|FG000|Survival Follow-up|Lost to Follow-up|0
2232165|NCT01846416|3884307|FG001|Survival Follow-up|Lost to Follow-up|2
2232166|NCT01846416|3884308|FG002|Survival Follow-up|Lost to Follow-up|2
2232167|NCT01846416|3884306|FG000|Survival Follow-up|Withdrawal by Subject|2
2232168|NCT01846416|3884307|FG001|Survival Follow-up|Withdrawal by Subject|7
2232169|NCT01846416|3884308|FG002|Survival Follow-up|Withdrawal by Subject|0
2232170|NCT01846416|3884306|FG000|Survival Follow-up|Study Terminated by Sponsor|2
2232171|NCT01846416|3884307|FG001|Survival Follow-up|Study Terminated by Sponsor|8
2232172|NCT01846416|3884308|FG002|Survival Follow-up|Study Terminated by Sponsor|0
2232173|NCT01846416|3884306|FG000|Survival Follow-up|Other|3
2232174|NCT01846416|3884307|FG001|Survival Follow-up|Other|1
2232175|NCT01846416|3884308|FG002|Survival Follow-up|Other|1
2232176|NCT01846442|3884321|FG000|Overall Study|Adverse Event|2
2232177|NCT01846442|3884322|FG001|Overall Study|Adverse Event|4
2232178|NCT01846442|3884323|FG002|Overall Study|Adverse Event|2
2232179|NCT01846442|3884324|FG003|Overall Study|Adverse Event|1
2232180|NCT01846442|3884321|FG000|Overall Study|Lost to Follow-up|0
2232181|NCT01846442|3884322|FG001|Overall Study|Lost to Follow-up|0
2232182|NCT01846442|3884323|FG002|Overall Study|Lost to Follow-up|1
2232183|NCT01846442|3884324|FG003|Overall Study|Lost to Follow-up|0
2232184|NCT01846442|3884321|FG000|Overall Study|Withdrawal by Subject|3
2232185|NCT01846442|3884322|FG001|Overall Study|Withdrawal by Subject|2
2232186|NCT01846442|3884323|FG002|Overall Study|Withdrawal by Subject|0
2232187|NCT01846442|3884324|FG003|Overall Study|Withdrawal by Subject|1
2232188|NCT01846442|3884321|FG000|Overall Study|Left the city/Lost medication|1
2232189|NCT01846442|3884322|FG001|Overall Study|Left the city/Lost medication|0
2232190|NCT01846442|3884323|FG002|Overall Study|Left the city/Lost medication|1
2232191|NCT01846442|3884324|FG003|Overall Study|Left the city/Lost medication|1
2232192|NCT01846507|3884364|FG000|Overall Study|Lost to Follow-up|4
2232193|NCT01846507|3884364|FG000|Overall Study|Protocol Violation|1
2232194|NCT01846507|3884364|FG000|Overall Study|Missing data|2
2232195|NCT01846611|3884372|FG000|Overall Study|Lost to Follow-up|4
2232196|NCT01846611|3884373|FG001|Overall Study|Lost to Follow-up|6
2232197|NCT01846611|3884372|FG000|Overall Study|Withdrawal by Subject|15
2232198|NCT01846611|3884373|FG001|Overall Study|Withdrawal by Subject|19
2232199|NCT01846611|3884372|FG000|Overall Study|Other|19
2232200|NCT01846611|3884373|FG001|Overall Study|Other|18
2232201|NCT01846624|3884379|FG000|Overall Study|Died during induction, no midostaurin|1
2333032|NCT03212261|4057220|FG000|Overall Study|Tech Trouble- No first study visit|1
2333033|NCT03212261|4057220|FG000|Overall Study|Lost to Follow-up|7
2333034|NCT03212261|4057220|FG000|Overall Study|Family Emergency|1
2333035|NCT03212261|4057220|FG000|Overall Study|Too busy/ No time|5
2333036|NCT03212326|4057225|FG000|Overall Study|Physician Decision|4
2333037|NCT03212365|4057231|FG000|Overall Study|Discharged prior to Xa level|12
2333038|NCT03212365|4057232|FG001|Overall Study|Discharged prior to Xa level|8
2333039|NCT03212365|4057231|FG000|Overall Study|Bled requiring enoxaparin cessation|4
2333040|NCT03212365|4057232|FG001|Overall Study|Bled requiring enoxaparin cessation|2
2036607|NCT00412984|3606857|FG001|Overall Study|Withdrawal by Subject|989
2036608|NCT00412984|3606856|FG000|Overall Study|Lost to Follow-up|51
2036609|NCT00412984|3606857|FG001|Overall Study|Lost to Follow-up|39
2036610|NCT00412984|3606856|FG000|Overall Study|Poor/Noncompliance|57
2036611|NCT00412984|3606857|FG001|Overall Study|Poor/Noncompliance|77
2036612|NCT00412984|3606856|FG000|Overall Study|Pregnancy|1
2036613|NCT00412984|3606857|FG001|Overall Study|Pregnancy|0
2036614|NCT00412984|3606856|FG000|Overall Study|Subject No Longer Meets Study Criteria|87
2036615|NCT00412984|3606857|FG001|Overall Study|Subject No Longer Meets Study Criteria|100
2036616|NCT00412984|3606856|FG000|Overall Study|Administrative Reason by Sponsor|11
2036617|NCT00412984|3606857|FG001|Overall Study|Administrative Reason by Sponsor|8
2036618|NCT00412984|3606856|FG000|Overall Study|Physician Refused to Continue Treatment|81
2036619|NCT00412984|3606857|FG001|Overall Study|Physician Refused to Continue Treatment|89
2036620|NCT00412984|3606856|FG000|Overall Study|Other Reason|80
2036621|NCT00412984|3606857|FG001|Overall Study|Other Reason|92
2036622|NCT00412984|3606856|FG000|Overall Study|Not Reported|11
2036623|NCT00412984|3606857|FG001|Overall Study|Not Reported|12
2036624|NCT00413010|3606865|FG000|Overall Study|Adverse Event|8
2036625|NCT00413010|3606866|FG001|Overall Study|Adverse Event|4
2036626|NCT00413010|3606865|FG000|Overall Study|Laboratory abnormality|0
2036627|NCT00413010|3606866|FG001|Overall Study|Laboratory abnormality|2
2232202|NCT01846741|3884424|FG000|Baseline Visit|Subject did not meet entry criteria|2
2232203|NCT01847092|3884513|FG000|Overall Study|Adverse Event|12
2232204|NCT01847092|3884514|FG001|Overall Study|Adverse Event|3
2232205|NCT01847092|3884513|FG000|Overall Study|Withdrawal by Subject|5
2232206|NCT01847092|3884514|FG001|Overall Study|Withdrawal by Subject|5
2232207|NCT01847092|3884513|FG000|Overall Study|Protocol Specified|8
2232208|NCT01847092|3884514|FG001|Overall Study|Protocol Specified|0
2232209|NCT01847092|3884513|FG000|Overall Study|Physician Decision|1
2232210|NCT01847092|3884514|FG001|Overall Study|Physician Decision|1
2232211|NCT01847092|3884513|FG000|Overall Study|Protocol Violation|0
2232212|NCT01847092|3884514|FG001|Overall Study|Protocol Violation|2
2232213|NCT01847209|3884533|FG000|Overall Study|Withdrawal by Subject|1
2232214|NCT01847209|3884533|FG000|Overall Study|No lung nodule found on intraop CT scan|1
2232215|NCT01847313|3884539|FG000|Overall Study|Death|0
2232216|NCT01847313|3884540|FG001|Overall Study|Death|1
2232217|NCT01847313|3884539|FG000|Overall Study|Withdrawal by Subject|0
2232218|NCT01847313|3884540|FG001|Overall Study|Withdrawal by Subject|1
2232219|NCT01847443|3884550|FG000|Study Period 1|Withdrawal by Subject|0
2232220|NCT01847443|3884551|FG001|Study Period 1|Withdrawal by Subject|1
2232221|NCT01847443|3884552|FG002|Study Period 1|Withdrawal by Subject|0
2232222|NCT01847443|3884553|FG003|Study Period 1|Withdrawal by Subject|0
2232223|NCT01847443|3884550|FG000|Washout Period Before Study Period 2|Adverse Event|1
2232224|NCT01847443|3884551|FG001|Washout Period Before Study Period 2|Adverse Event|1
2232225|NCT01847443|3884552|FG002|Washout Period Before Study Period 2|Adverse Event|0
2232226|NCT01847443|3884553|FG003|Washout Period Before Study Period 2|Adverse Event|0
2232227|NCT01847443|3884550|FG000|Washout Period Before Study Period 2|Other reason|1
2232228|NCT01847443|3884551|FG001|Washout Period Before Study Period 2|Other reason|0
2232229|NCT01847443|3884552|FG002|Washout Period Before Study Period 2|Other reason|0
2232230|NCT01847443|3884553|FG003|Washout Period Before Study Period 2|Other reason|0
2232231|NCT01847443|3884550|FG000|Washout Period Before Study Period 3|Other reason|1
2232232|NCT01847443|3884551|FG001|Washout Period Before Study Period 3|Other reason|0
2232233|NCT01847443|3884552|FG002|Washout Period Before Study Period 3|Other reason|0
2232234|NCT01847443|3884553|FG003|Washout Period Before Study Period 3|Other reason|0
2232235|NCT01847443|3884550|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1
2232236|NCT01847443|3884551|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0
2232237|NCT01847443|3884552|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0
2232238|NCT01847443|3884553|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0
2232239|NCT01847443|3884550|FG000|Washout Period Before Study Period 4|Positive alcohol test|1
2232240|NCT01847443|3884551|FG001|Washout Period Before Study Period 4|Positive alcohol test|0
2232241|NCT01847443|3884552|FG002|Washout Period Before Study Period 4|Positive alcohol test|0
2232242|NCT01847443|3884553|FG003|Washout Period Before Study Period 4|Positive alcohol test|0
2232243|NCT01847755|3884654|FG000|Overall Study|Adverse Event|2
2232244|NCT01847755|3884654|FG000|Overall Study|Withdrawal by Subject|2
2232245|NCT01847755|3884654|FG000|Overall Study|Physician Decision|1
2232246|NCT01847885|3884660|FG000|Initial Enrollment (Consented)|Protocol Violation|1
2232247|NCT01847885|3884661|FG001|Initial Enrollment (Consented)|Protocol Violation|0
2232248|NCT01847885|3884662|FG002|Initial Enrollment (Consented)|Protocol Violation|0
2232249|NCT01847885|3884660|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2
2232250|NCT01847885|3884661|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0
2232251|NCT01847885|3884662|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0
2232252|NCT01847885|3884660|FG000|Initial Enrollment (Consented)|Screen failure|39
2232253|NCT01847885|3884661|FG001|Initial Enrollment (Consented)|Screen failure|0
2232254|NCT01847885|3884662|FG002|Initial Enrollment (Consented)|Screen failure|0
2232255|NCT01847885|3884660|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
2232256|NCT01847885|3884661|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
2232257|NCT01847885|3884662|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
2232258|NCT01847885|3884660|FG000|Randomization|Protocol Violation|0
2232259|NCT01847885|3884661|FG001|Randomization|Protocol Violation|1
2232260|NCT01847885|3884662|FG002|Randomization|Protocol Violation|0
2232261|NCT01847885|3884660|FG000|Randomization|Withdrawal by Subject|0
2232262|NCT01847885|3884661|FG001|Randomization|Withdrawal by Subject|0
2232263|NCT01847885|3884662|FG002|Randomization|Withdrawal by Subject|2
2232264|NCT01847885|3884660|FG000|Randomization|Screen Failure|0
2232265|NCT01847885|3884661|FG001|Randomization|Screen Failure|3
2232266|NCT01847885|3884662|FG002|Randomization|Screen Failure|0
2232267|NCT01848145|3884707|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
2232268|NCT01848145|3884707|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
2232269|NCT01848145|3884707|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
2232270|NCT01848145|3884707|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
2232271|NCT01848145|3884707|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6
2232272|NCT01848145|3884707|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
2232273|NCT01848145|3884707|FG000|Subsequent Infusions: Weeks 3-8|Death|1
2232274|NCT01848210|3884732|FG000|Overall Study|Informed Consent Form Withdrawal|28
2232275|NCT01848210|3884733|FG001|Overall Study|Informed Consent Form Withdrawal|24
2232276|NCT01848210|3884732|FG000|Overall Study|Lost to Follow-up|24
2232277|NCT01848210|3884733|FG001|Overall Study|Lost to Follow-up|12
2232278|NCT01848210|3884732|FG000|Overall Study|Protocol Violation|3
2232279|NCT01848210|3884733|FG001|Overall Study|Protocol Violation|5
2232280|NCT01848210|3884732|FG000|Overall Study|Use of Forbidden Drugs|9
2232281|NCT01848210|3884733|FG001|Overall Study|Use of Forbidden Drugs|10
2232282|NCT01848210|3884732|FG000|Overall Study|Impedition Condition|5
2232283|NCT01848210|3884733|FG001|Overall Study|Impedition Condition|9
2232284|NCT01848210|3884732|FG000|Overall Study|Adverse Event|7
2232285|NCT01848210|3884733|FG001|Overall Study|Adverse Event|9
2232286|NCT01848210|3884732|FG000|Overall Study|Discontinuation Criterion|5
2232287|NCT01848210|3884733|FG001|Overall Study|Discontinuation Criterion|7
2232288|NCT01848210|3884732|FG000|Overall Study|Hypesensitivity|1
2232289|NCT01848210|3884733|FG001|Overall Study|Hypesensitivity|0
2232290|NCT01848210|3884732|FG000|Overall Study|Hepatic Function Alteration|4
2232291|NCT01848210|3884733|FG001|Overall Study|Hepatic Function Alteration|0
2232292|NCT01848210|3884732|FG000|Overall Study|Chronic Venous Insufficiency Course|1
2232293|NCT01848210|3884733|FG001|Overall Study|Chronic Venous Insufficiency Course|2
2232294|NCT01848210|3884732|FG000|Overall Study|Administrative|1
2232295|NCT01848210|3884733|FG001|Overall Study|Administrative|0
2232296|NCT01848288|3884739|FG000|Overall Study|Death|1
2232297|NCT01848288|3884739|FG000|Overall Study|Protocol Violation|1
2232298|NCT01848288|3884739|FG000|Overall Study|Withdrawal by Subject|1
2232299|NCT01848353|3884748|FG000|Phase 1|Withdrawal by Subject|3
2232300|NCT01848353|3884749|FG001|Phase 1|Withdrawal by Subject|1
2232301|NCT01848353|3884750|FG002|Phase 1|Withdrawal by Subject|0
2232302|NCT01848353|3884751|FG003|Phase 1|Withdrawal by Subject|0
2232303|NCT01848353|3884748|FG000|Phase 2|Withdrawal by Subject|3
2232304|NCT01848353|3884749|FG001|Phase 2|Withdrawal by Subject|2
2232305|NCT01848353|3884750|FG002|Phase 2|Withdrawal by Subject|0
2232306|NCT01848353|3884751|FG003|Phase 2|Withdrawal by Subject|0
2232307|NCT01848353|3884748|FG000|Phase 3|Withdrawal by Subject|1
2232308|NCT01848353|3884749|FG001|Phase 3|Withdrawal by Subject|1
2232309|NCT01848353|3884750|FG002|Phase 3|Withdrawal by Subject|0
2232310|NCT01848353|3884751|FG003|Phase 3|Withdrawal by Subject|0
2232311|NCT01848457|3884777|FG000|Overall Study|Death|1
2232312|NCT01848457|3884778|FG001|Overall Study|Death|0
2232313|NCT01848457|3884779|FG002|Overall Study|Death|0
2232314|NCT01848457|3884780|FG003|Overall Study|Death|0
2232315|NCT01848483|3884800|FG000|Overall Study|Death|2
2232316|NCT01848483|3884801|FG001|Overall Study|Death|1
2232317|NCT01848483|3884800|FG000|Overall Study|Lost to Follow-up|6
2232318|NCT01848483|3884801|FG001|Overall Study|Lost to Follow-up|8
2232319|NCT01848483|3884800|FG000|Overall Study|Withdrawal by Subject|1
2232320|NCT01848483|3884801|FG001|Overall Study|Withdrawal by Subject|0
2232321|NCT01848483|3884800|FG000|Overall Study|Incarceration|2
2232322|NCT01848483|3884801|FG001|Overall Study|Incarceration|2
2232323|NCT01848756|3884808|FG000|Overall Study|Adverse Event|1
2232324|NCT01848756|3884808|FG000|Overall Study|Withdrawal by Subject|1
2232325|NCT01848756|3884808|FG000|Overall Study|Enrolled in Error|1
2232326|NCT01848834|3884827|FG000|Overall Study|Adverse Event|3
2232327|NCT01848834|3884828|FG001|Overall Study|Adverse Event|11
2232328|NCT01848834|3884829|FG002|Overall Study|Adverse Event|3
2232329|NCT01848834|3884830|FG003|Overall Study|Adverse Event|5
2232330|NCT01848834|3884831|FG004|Overall Study|Adverse Event|9
2232331|NCT01848834|3884827|FG000|Overall Study|Death|2
2232332|NCT01848834|3884828|FG001|Overall Study|Death|11
2232333|NCT01848834|3884829|FG002|Overall Study|Death|1
2232334|NCT01848834|3884830|FG003|Overall Study|Death|8
2232335|NCT01848834|3884831|FG004|Overall Study|Death|27
2232336|NCT01848834|3884827|FG000|Overall Study|Excluded Medication|5
2232337|NCT01848834|3884828|FG001|Overall Study|Excluded Medication|4
2232338|NCT01848834|3884829|FG002|Overall Study|Excluded Medication|3
2232339|NCT01848834|3884830|FG003|Overall Study|Excluded Medication|6
2333041|NCT03212365|4057231|FG000|Overall Study|Refused study medication|3
2333042|NCT03212365|4057232|FG001|Overall Study|Refused study medication|0
2333043|NCT03212365|4057231|FG000|Overall Study|Initiated heparin infusion on floor|1
2333044|NCT03212365|4057232|FG001|Overall Study|Initiated heparin infusion on floor|1
2333045|NCT03212365|4057231|FG000|Overall Study|Unexpected return to OR|1
2333046|NCT03212365|4057232|FG001|Overall Study|Unexpected return to OR|1
2333047|NCT03212365|4057231|FG000|Overall Study|Medication distribution error|1
2333048|NCT03212365|4057232|FG001|Overall Study|Medication distribution error|0
2333049|NCT03212365|4057231|FG000|Overall Study|Required epidural placement|1
2333050|NCT03212365|4057232|FG001|Overall Study|Required epidural placement|0
2333051|NCT03212365|4057231|FG000|Overall Study|Withdrawal by Subject|0
2333052|NCT03212365|4057232|FG001|Overall Study|Withdrawal by Subject|1
2333053|NCT03212365|4057231|FG000|Overall Study|developed acute renal failure|0
2333054|NCT03212365|4057232|FG001|Overall Study|developed acute renal failure|1
2333055|NCT03212521|4057238|FG000|Overall Study|Adverse Event|1
2333056|NCT03212521|4057238|FG000|Overall Study|Lost to Follow-up|4
2333057|NCT03212521|4057238|FG000|Overall Study|Withdrawal by Subject|1
2333058|NCT03212521|4057238|FG000|Overall Study|Other|1
2333059|NCT03212690|4057260|FG000|Overall Study|Protocol Violation|1
2352798|NCT03736785|4103027|FG001|Overall Study|Adverse Event|1
2352799|NCT03736785|4103028|FG002|Overall Study|Adverse Event|1
2352800|NCT03736785|4103026|FG000|Overall Study|Death|1
2352801|NCT03736785|4103027|FG001|Overall Study|Death|0
2352802|NCT03736785|4103028|FG002|Overall Study|Death|1
2352803|NCT03736785|4103026|FG000|Overall Study|Lost to Follow-up|0
2352804|NCT03736785|4103027|FG001|Overall Study|Lost to Follow-up|2
2352805|NCT03736785|4103028|FG002|Overall Study|Lost to Follow-up|3
2352806|NCT03736785|4103026|FG000|Overall Study|Non compliance with study drug|1
2352807|NCT03736785|4103027|FG001|Overall Study|Non compliance with study drug|1
2352808|NCT03736785|4103028|FG002|Overall Study|Non compliance with study drug|0
2352809|NCT03736785|4103026|FG000|Overall Study|Physician Decision|0
2352810|NCT03736785|4103027|FG001|Overall Study|Physician Decision|1
2352811|NCT03736785|4103028|FG002|Overall Study|Physician Decision|1
2352812|NCT03736785|4103026|FG000|Overall Study|Protocol Violation|1
2352813|NCT03736785|4103027|FG001|Overall Study|Protocol Violation|4
2232340|NCT01848834|3884831|FG004|Overall Study|Excluded Medication|6
2232341|NCT01848834|3884827|FG000|Overall Study|Lost to Follow-up|5
2232342|NCT01848834|3884828|FG001|Overall Study|Lost to Follow-up|5
2232343|NCT01848834|3884829|FG002|Overall Study|Lost to Follow-up|3
2232344|NCT01848834|3884830|FG003|Overall Study|Lost to Follow-up|0
2232345|NCT01848834|3884831|FG004|Overall Study|Lost to Follow-up|3
2232346|NCT01848834|3884827|FG000|Overall Study|Physician Decision|1
2232347|NCT01848834|3884828|FG001|Overall Study|Physician Decision|3
2232348|NCT01848834|3884829|FG002|Overall Study|Physician Decision|4
2232349|NCT01848834|3884830|FG003|Overall Study|Physician Decision|0
2232350|NCT01848834|3884831|FG004|Overall Study|Physician Decision|11
2232351|NCT01848834|3884827|FG000|Overall Study|Protocol Violation|0
2232352|NCT01848834|3884828|FG001|Overall Study|Protocol Violation|0
2232353|NCT01848834|3884829|FG002|Overall Study|Protocol Violation|0
2232354|NCT01848834|3884830|FG003|Overall Study|Protocol Violation|0
2232355|NCT01848834|3884831|FG004|Overall Study|Protocol Violation|1
2232356|NCT01848834|3884827|FG000|Overall Study|Sponsor Decision|1
2232357|NCT01848834|3884828|FG001|Overall Study|Sponsor Decision|1
2232358|NCT01848834|3884829|FG002|Overall Study|Sponsor Decision|0
2232359|NCT01848834|3884830|FG003|Overall Study|Sponsor Decision|1
2232360|NCT01848834|3884831|FG004|Overall Study|Sponsor Decision|1
2232361|NCT01848834|3884827|FG000|Overall Study|Withdrawal by Subject|2
2232362|NCT01848834|3884828|FG001|Overall Study|Withdrawal by Subject|13
2232363|NCT01848834|3884829|FG002|Overall Study|Withdrawal by Subject|10
2232364|NCT01848834|3884830|FG003|Overall Study|Withdrawal by Subject|6
2232365|NCT01848834|3884831|FG004|Overall Study|Withdrawal by Subject|36
2232366|NCT01848938|3884867|FG000|Overall Study|Lost to Follow-up|1
2232367|NCT01848938|3884868|FG001|Overall Study|Lost to Follow-up|1
2232368|NCT01848990|3884886|FG000|Overall Study|Adverse Event|6
2232369|NCT01848990|3884887|FG001|Overall Study|Adverse Event|2
2232370|NCT01848990|3884888|FG002|Overall Study|Adverse Event|0
2232371|NCT01848990|3884886|FG000|Overall Study|Lost to Follow-up|6
2333060|NCT03213210|4057264|FG000|Overall Study|Lost to Follow-up|2
2333061|NCT03213210|4057264|FG000|Overall Study|Study termination|3
2333062|NCT03213366|4057270|FG000|Overall Study|Lost to Follow-up|9
2333063|NCT03213366|4057271|FG001|Overall Study|Lost to Follow-up|4
2333064|NCT03213509|4057296|FG000|Overall Study|Did not consent for verbal autopsy|4
2333065|NCT03213509|4057297|FG001|Overall Study|Did not consent for verbal autopsy|5
2333066|NCT03213626|4057304|FG000|Overall Study|Adverse Event|1
2333067|NCT03213626|4057304|FG000|Overall Study|Progressive Disease|6
2333068|NCT03213938|4057310|FG000|Overall Study|Lost to Follow-up|4
2333069|NCT03213938|4057311|FG001|Overall Study|Lost to Follow-up|3
2333070|NCT03213938|4057310|FG000|Overall Study|Lack of Efficacy|1
2333071|NCT03213938|4057311|FG001|Overall Study|Lack of Efficacy|0
2333072|NCT03213938|4057310|FG000|Overall Study|Decline to participate|5
2333073|NCT03213938|4057311|FG001|Overall Study|Decline to participate|4
2333074|NCT03213938|4057310|FG000|Overall Study|Without reason|4
2333075|NCT03213938|4057311|FG001|Overall Study|Without reason|5
2333076|NCT03214081|4057317|FG000|Overall Study|Case Report Forms Uncollected|9
2333077|NCT03214081|4057317|FG000|Overall Study|Protocol Deviation|54
2333078|NCT03214094|4057321|FG000|Overall Study|Case Report Forms Uncollected|14
2333079|NCT03214094|4057321|FG000|Overall Study|Protocol Deviation|46
2333080|NCT03214198|4057325|FG000|Overall Study|Case Report Forms Uncollected|18
2333081|NCT03214198|4057325|FG000|Overall Study|Protocol Deviation|18
2333082|NCT03214224|4057329|FG000|Overall Study|Protocol Violation|1
2333083|NCT03214224|4057329|FG000|Overall Study|Withdrawal by Subject|2
2333084|NCT03214224|4057329|FG000|Overall Study|Practice controls or therapists|6
2333085|NCT03214367|4057339|FG000|Lead-in Period|Withdrawal by Subject|50
2333086|NCT03214367|4057340|FG001|Lead-in Period|Withdrawal by Subject|0
2333087|NCT03214367|4057341|FG002|Lead-in Period|Withdrawal by Subject|0
2333088|NCT03214367|4057342|FG003|Lead-in Period|Withdrawal by Subject|0
2333089|NCT03214367|4057343|FG004|Lead-in Period|Withdrawal by Subject|2
2333090|NCT03214367|4057344|FG005|Lead-in Period|Withdrawal by Subject|0
2333091|NCT03214367|4057345|FG006|Lead-in Period|Withdrawal by Subject|0
2333092|NCT03214367|4057346|FG007|Lead-in Period|Withdrawal by Subject|0
2333093|NCT03214367|4057339|FG000|Lead-in Period|Adverse Event|3
2333094|NCT03214367|4057340|FG001|Lead-in Period|Adverse Event|0
2333095|NCT03214367|4057341|FG002|Lead-in Period|Adverse Event|0
2333096|NCT03214367|4057342|FG003|Lead-in Period|Adverse Event|0
2333097|NCT03214367|4057343|FG004|Lead-in Period|Adverse Event|0
2333098|NCT03214367|4057344|FG005|Lead-in Period|Adverse Event|0
2333099|NCT03214367|4057345|FG006|Lead-in Period|Adverse Event|0
2333100|NCT03214367|4057346|FG007|Lead-in Period|Adverse Event|0
2333101|NCT03214367|4057339|FG000|Lead-in Period|Lost to Follow-up|12
2333102|NCT03214367|4057340|FG001|Lead-in Period|Lost to Follow-up|0
2333103|NCT03214367|4057341|FG002|Lead-in Period|Lost to Follow-up|0
2333104|NCT03214367|4057342|FG003|Lead-in Period|Lost to Follow-up|0
2333105|NCT03214367|4057343|FG004|Lead-in Period|Lost to Follow-up|0
2333106|NCT03214367|4057344|FG005|Lead-in Period|Lost to Follow-up|0
2333107|NCT03214367|4057345|FG006|Lead-in Period|Lost to Follow-up|0
2333108|NCT03214367|4057346|FG007|Lead-in Period|Lost to Follow-up|0
2333109|NCT03214367|4057339|FG000|Lead-in Period|Sponsor Decision|11
2333110|NCT03214367|4057340|FG001|Lead-in Period|Sponsor Decision|0
2333111|NCT03214367|4057341|FG002|Lead-in Period|Sponsor Decision|0
2333112|NCT03214367|4057342|FG003|Lead-in Period|Sponsor Decision|0
2333113|NCT03214367|4057343|FG004|Lead-in Period|Sponsor Decision|0
2333114|NCT03214367|4057344|FG005|Lead-in Period|Sponsor Decision|0
2232372|NCT01848990|3884887|FG001|Overall Study|Lost to Follow-up|2
2232373|NCT01848990|3884888|FG002|Overall Study|Lost to Follow-up|2
2232374|NCT01848990|3884886|FG000|Overall Study|Protocol Violation|1
2232375|NCT01848990|3884887|FG001|Overall Study|Protocol Violation|1
2232376|NCT01848990|3884888|FG002|Overall Study|Protocol Violation|0
2232377|NCT01848990|3884886|FG000|Overall Study|Withdrawal by Subject|29
2232378|NCT01848990|3884887|FG001|Overall Study|Withdrawal by Subject|10
2232379|NCT01848990|3884888|FG002|Overall Study|Withdrawal by Subject|11
2232380|NCT01848990|3884886|FG000|Overall Study|Physician Decision|1
2232381|NCT01848990|3884887|FG001|Overall Study|Physician Decision|1
2232382|NCT01848990|3884888|FG002|Overall Study|Physician Decision|0
2232383|NCT01848990|3884886|FG000|Overall Study|Non Compliance|1
2232384|NCT01848990|3884887|FG001|Overall Study|Non Compliance|0
2232385|NCT01848990|3884888|FG002|Overall Study|Non Compliance|0
2232386|NCT01848990|3884886|FG000|Overall Study|Death|1
2232387|NCT01848990|3884887|FG001|Overall Study|Death|0
2232388|NCT01848990|3884888|FG002|Overall Study|Death|1
2232389|NCT01848990|3884886|FG000|Overall Study|Other|1
2232390|NCT01848990|3884887|FG001|Overall Study|Other|4
2232391|NCT01848990|3884888|FG002|Overall Study|Other|2
2232392|NCT01849055|3884906|FG000|Overall Study|Withdrawal by Subject|0
2232393|NCT01849055|3884907|FG001|Overall Study|Withdrawal by Subject|0
2232394|NCT01849055|3884908|FG002|Overall Study|Withdrawal by Subject|1
2232395|NCT01849055|3884909|FG003|Overall Study|Withdrawal by Subject|0
2232396|NCT01849055|3884910|FG004|Overall Study|Withdrawal by Subject|0
2232397|NCT01849055|3884911|FG005|Overall Study|Withdrawal by Subject|0
2232398|NCT01849276|3884947|FG000|Followed for Survival for 5 Years|Death|1
2232399|NCT01849276|3884947|FG000|Followed for Survival for 5 Years|Early termination of the study|1
2232400|NCT01849289|3884953|FG000|Overall Study|Adverse Event|3
2232401|NCT01849289|3884954|FG001|Overall Study|Adverse Event|3
2232402|NCT01849289|3884953|FG000|Overall Study|Protocol Violation|3
2232403|NCT01849289|3884954|FG001|Overall Study|Protocol Violation|3
2232404|NCT01849289|3884953|FG000|Overall Study|Withdrawal criteria|1
2232405|NCT01849289|3884954|FG001|Overall Study|Withdrawal criteria|0
2232406|NCT01849289|3884953|FG000|Overall Study|Unclassified|25
2232407|NCT01849289|3884954|FG001|Overall Study|Unclassified|18
2232408|NCT01849458|3884965|FG000|Overall Study|Lost to Follow-up|4
2232409|NCT01849497|3884971|FG000|Overall Study|Withdrawal by Subject|1
2232410|NCT01849497|3884972|FG001|Overall Study|Withdrawal by Subject|2
2232411|NCT01849497|3884971|FG000|Overall Study|Sponsor Decision|0
2232412|NCT01849497|3884972|FG001|Overall Study|Sponsor Decision|1
2232413|NCT01849497|3884971|FG000|Overall Study|Lost to Follow-up|0
2333115|NCT03214367|4057345|FG006|Lead-in Period|Sponsor Decision|0
2036628|NCT00413010|3606865|FG000|Overall Study|Lack of Efficacy|0
2036629|NCT00413010|3606866|FG001|Overall Study|Lack of Efficacy|3
2036630|NCT00413010|3606865|FG000|Overall Study|Lost to Follow-up|3
2036631|NCT00413010|3606866|FG001|Overall Study|Lost to Follow-up|0
2036632|NCT00413010|3606865|FG000|Overall Study|Withdrawal by Subject|7
2036633|NCT00413010|3606866|FG001|Overall Study|Withdrawal by Subject|2
2036634|NCT00413010|3606865|FG000|Overall Study|Due to termination of the study|54
2036635|NCT00413010|3606866|FG001|Overall Study|Due to termination of the study|52
2036636|NCT00413036|3606872|FG000|Overall Study|Adverse Event|44
2036637|NCT00413036|3606872|FG000|Overall Study|Lack of Efficacy|129
2036638|NCT00413036|3606872|FG000|Overall Study|Withdrawal by Subject|7
2036639|NCT00413036|3606872|FG000|Overall Study|Death|9
2036640|NCT00413036|3606872|FG000|Overall Study|Other|26
2232414|NCT01849497|3884972|FG001|Overall Study|Lost to Follow-up|1
2232415|NCT01849562|3884981|FG000|Overall Study|Lost to Follow-up|1
2232416|NCT01849562|3884982|FG001|Overall Study|Lost to Follow-up|0
2232417|NCT01849562|3884983|FG002|Overall Study|Lost to Follow-up|0
2232418|NCT01849562|3884981|FG000|Overall Study|Non-compliance with Study Drug|1
2232419|NCT01849562|3884982|FG001|Overall Study|Non-compliance with Study Drug|0
2232420|NCT01849562|3884983|FG002|Overall Study|Non-compliance with Study Drug|0
2232421|NCT01849588|3885003|FG000|Overall Study|Lack of Efficacy|3
2232422|NCT01849848|3885056|FG000|Overall Study|Physician Decision|1
2232423|NCT01849848|3885056|FG000|Overall Study|Progression of the primary disease|3
2232424|NCT01849874|3885062|FG000|Overall Study|Death|34
2232425|NCT01849874|3885063|FG001|Overall Study|Death|16
2232426|NCT01849874|3885062|FG000|Overall Study|Withdrawal by Subject|4
2232427|NCT01849874|3885063|FG001|Overall Study|Withdrawal by Subject|8
2232428|NCT01849874|3885062|FG000|Overall Study|Lost to Follow-up|0
2232429|NCT01849874|3885063|FG001|Overall Study|Lost to Follow-up|1
2232430|NCT01849874|3885062|FG000|Overall Study|Randomized but Never Treated|1
2232431|NCT01849874|3885063|FG001|Overall Study|Randomized but Never Treated|8
2232432|NCT01849874|3885062|FG000|Overall Study|Ongoing|162
2232433|NCT01849874|3885063|FG001|Overall Study|Ongoing|69
2232434|NCT01850030|3885071|FG000|Overall Study|Adverse Event|64
2232435|NCT01850030|3885072|FG001|Overall Study|Adverse Event|82
2232436|NCT01850030|3885071|FG000|Overall Study|Lack of Efficacy|3
2232437|NCT01850030|3885072|FG001|Overall Study|Lack of Efficacy|1
2232438|NCT01850030|3885071|FG000|Overall Study|Lost to Follow-up|5
2232439|NCT01850030|3885072|FG001|Overall Study|Lost to Follow-up|5
2232440|NCT01850030|3885071|FG000|Overall Study|Withdrawal by Subject|3
2232441|NCT01850030|3885072|FG001|Overall Study|Withdrawal by Subject|4
2232442|NCT01850030|3885071|FG000|Overall Study|Protocol Violation|24
2232443|NCT01850030|3885072|FG001|Overall Study|Protocol Violation|28
2232444|NCT01850030|3885071|FG000|Overall Study|pregnancy not confirmed at visit 4|248
2232445|NCT01850030|3885072|FG001|Overall Study|pregnancy not confirmed at visit 4|249
2232446|NCT01850446|3885093|FG000|Overall Study|Lack of Efficacy|1
2232447|NCT01850446|3885094|FG001|Overall Study|Lack of Efficacy|0
2232448|NCT01850446|3885093|FG000|Overall Study|Withdrawal by Subject|4
2232449|NCT01850446|3885094|FG001|Overall Study|Withdrawal by Subject|0
2232450|NCT01850446|3885093|FG000|Overall Study|Protocol Violation|0
2232451|NCT01850446|3885094|FG001|Overall Study|Protocol Violation|2
2232452|NCT01850524|3885111|FG000|Overall Study|Ongoing on Treatment|57
2232453|NCT01850524|3885112|FG001|Overall Study|Ongoing on Treatment|54
2232454|NCT01850524|3885111|FG000|Overall Study|Adverse Event|96
2232455|NCT01850524|3885112|FG001|Overall Study|Adverse Event|122
2232456|NCT01850524|3885111|FG000|Overall Study|Lost to Follow-up|2
2232457|NCT01850524|3885112|FG001|Overall Study|Lost to Follow-up|0
2232458|NCT01850524|3885111|FG000|Overall Study|Progressive Disease|166
2232459|NCT01850524|3885112|FG001|Overall Study|Progressive Disease|123
2232460|NCT01850524|3885111|FG000|Overall Study|Protocol Violation|1
2232461|NCT01850524|3885112|FG001|Overall Study|Protocol Violation|2
2232462|NCT01850524|3885111|FG000|Overall Study|Withdrawal by Subject|8
2232463|NCT01850524|3885112|FG001|Overall Study|Withdrawal by Subject|19
2232464|NCT01850524|3885111|FG000|Overall Study|Participant Wished to Discontinue Treatment|15
2232465|NCT01850524|3885112|FG001|Overall Study|Participant Wished to Discontinue Treatment|22
2232466|NCT01850524|3885111|FG000|Overall Study|Investigator Decision|4
2232467|NCT01850524|3885112|FG001|Overall Study|Investigator Decision|4
2232468|NCT01850524|3885111|FG000|Overall Study|Participants Removed From Study|0
2232469|NCT01850524|3885112|FG001|Overall Study|Participants Removed From Study|1
2232470|NCT01850524|3885111|FG000|Overall Study|Medical Monitor Decision|0
2232471|NCT01850524|3885112|FG001|Overall Study|Medical Monitor Decision|1
2232472|NCT01850524|3885111|FG000|Overall Study|Participants Decision|2
2232473|NCT01850524|3885112|FG001|Overall Study|Participants Decision|2
2232474|NCT01850524|3885111|FG000|Overall Study|Progressive Disease Per Local Lab|1
2232475|NCT01850524|3885112|FG001|Overall Study|Progressive Disease Per Local Lab|0
2232476|NCT01850524|3885111|FG000|Overall Study|Lack of Improvement|0
2232477|NCT01850524|3885112|FG001|Overall Study|Lack of Improvement|1
2232478|NCT01850524|3885111|FG000|Overall Study|Minimal Response|1
2232479|NCT01850524|3885112|FG001|Overall Study|Minimal Response|0
2232480|NCT01850524|3885111|FG000|Overall Study|Comorbidities|1
2232481|NCT01850524|3885112|FG001|Overall Study|Comorbidities|0
2232482|NCT01850589|3885131|FG000|Overall Study|Withdrawal by Subject|8
2232483|NCT01850589|3885132|FG001|Overall Study|Withdrawal by Subject|0
2232484|NCT01850602|3885140|FG000|Overall Study|Adverse Event|7
2232485|NCT01850602|3885141|FG001|Overall Study|Adverse Event|10
2232486|NCT01850602|3885140|FG000|Overall Study|Physician Decision|2
2232487|NCT01850602|3885141|FG001|Overall Study|Physician Decision|1
2232488|NCT01850602|3885140|FG000|Overall Study|Withdrawal by Subject|2
2232489|NCT01850602|3885141|FG001|Overall Study|Withdrawal by Subject|4
2232490|NCT01850602|3885140|FG000|Overall Study|Decrease in serum calcium|2
2232491|NCT01850602|3885141|FG001|Overall Study|Decrease in serum calcium|3
2232492|NCT01850602|3885140|FG000|Overall Study|Increase in serum ferritin|1
2232493|NCT01850602|3885141|FG001|Overall Study|Increase in serum ferritin|0
2232494|NCT01850615|3885149|FG000|Overall Study|Protocol Violation|4
2232495|NCT01850615|3885150|FG001|Overall Study|Protocol Violation|1
2232496|NCT01850615|3885149|FG000|Overall Study|Adverse Event|2
2232497|NCT01850615|3885150|FG001|Overall Study|Adverse Event|1
2232498|NCT01850615|3885149|FG000|Overall Study|Withdrawal by Subject|3
2232499|NCT01850615|3885150|FG001|Overall Study|Withdrawal by Subject|1
2232500|NCT01850615|3885149|FG000|Overall Study|Lost to Follow-up|0
2232501|NCT01850615|3885150|FG001|Overall Study|Lost to Follow-up|1
2232502|NCT01850615|3885149|FG000|Overall Study|Unclassified|0
2232503|NCT01850615|3885150|FG001|Overall Study|Unclassified|1
2232504|NCT01850641|3885156|FG000|Overall Study|Physician Decision|1
2232505|NCT01850641|3885156|FG000|Overall Study|Decrease in serum phosphorus|1
2232506|NCT01850641|3885156|FG000|Overall Study|Decrease in serum calcium|2
2232507|NCT01850641|3885156|FG000|Overall Study|Increase in serum ferritin|1
2232508|NCT01850823|3885176|FG000|Overall Study|Early Visit Window|0
2232509|NCT01850823|3885177|FG001|Overall Study|Early Visit Window|1
2232510|NCT01850823|3885178|FG002|Overall Study|Early Visit Window|4
2232511|NCT01850823|3885176|FG000|Overall Study|Enrolled in Error|0
2232512|NCT01850823|3885177|FG001|Overall Study|Enrolled in Error|1
2232513|NCT01850823|3885178|FG002|Overall Study|Enrolled in Error|2
2333116|NCT03214367|4057346|FG007|Lead-in Period|Sponsor Decision|0
2333117|NCT03214367|4057339|FG000|Lead-in Period|Physician Decision|12
2333118|NCT03214367|4057340|FG001|Lead-in Period|Physician Decision|0
2333119|NCT03214367|4057341|FG002|Lead-in Period|Physician Decision|0
2333120|NCT03214367|4057342|FG003|Lead-in Period|Physician Decision|0
2333121|NCT03214367|4057343|FG004|Lead-in Period|Physician Decision|0
2333122|NCT03214367|4057344|FG005|Lead-in Period|Physician Decision|0
2333123|NCT03214367|4057345|FG006|Lead-in Period|Physician Decision|0
2333124|NCT03214367|4057346|FG007|Lead-in Period|Physician Decision|0
2333125|NCT03214367|4057339|FG000|Lead-in Period|Protocol Violation|5
2333126|NCT03214367|4057340|FG001|Lead-in Period|Protocol Violation|0
2333127|NCT03214367|4057341|FG002|Lead-in Period|Protocol Violation|0
2333128|NCT03214367|4057342|FG003|Lead-in Period|Protocol Violation|0
2333129|NCT03214367|4057343|FG004|Lead-in Period|Protocol Violation|0
2333130|NCT03214367|4057344|FG005|Lead-in Period|Protocol Violation|0
2333131|NCT03214367|4057345|FG006|Lead-in Period|Protocol Violation|0
2333132|NCT03214367|4057346|FG007|Lead-in Period|Protocol Violation|0
2333133|NCT03214367|4057339|FG000|Lead-in Period|Treatment Interruption|1
2333134|NCT03214367|4057340|FG001|Lead-in Period|Treatment Interruption|0
2333135|NCT03214367|4057341|FG002|Lead-in Period|Treatment Interruption|0
2333136|NCT03214367|4057342|FG003|Lead-in Period|Treatment Interruption|0
2333137|NCT03214367|4057343|FG004|Lead-in Period|Treatment Interruption|0
2333138|NCT03214367|4057344|FG005|Lead-in Period|Treatment Interruption|0
2333139|NCT03214367|4057345|FG006|Lead-in Period|Treatment Interruption|0
2333140|NCT03214367|4057346|FG007|Lead-in Period|Treatment Interruption|0
2333141|NCT03214367|4057339|FG000|Treatment Period|Adverse Event|0
2333142|NCT03214367|4057340|FG001|Treatment Period|Adverse Event|1
2333143|NCT03214367|4057341|FG002|Treatment Period|Adverse Event|4
2333144|NCT03214367|4057342|FG003|Treatment Period|Adverse Event|2
2333145|NCT03214367|4057343|FG004|Treatment Period|Adverse Event|0
2333146|NCT03214367|4057344|FG005|Treatment Period|Adverse Event|0
2333147|NCT03214367|4057345|FG006|Treatment Period|Adverse Event|0
2333148|NCT03214367|4057346|FG007|Treatment Period|Adverse Event|0
2333149|NCT03214367|4057339|FG000|Treatment Period|Death|0
2333150|NCT03214367|4057340|FG001|Treatment Period|Death|1
2333151|NCT03214367|4057341|FG002|Treatment Period|Death|1
2333152|NCT03214367|4057342|FG003|Treatment Period|Death|1
2333153|NCT03214367|4057343|FG004|Treatment Period|Death|0
2333154|NCT03214367|4057344|FG005|Treatment Period|Death|0
2333155|NCT03214367|4057345|FG006|Treatment Period|Death|0
2333156|NCT03214367|4057346|FG007|Treatment Period|Death|0
2333157|NCT03214367|4057339|FG000|Treatment Period|Lost to Follow-up|0
2333158|NCT03214367|4057340|FG001|Treatment Period|Lost to Follow-up|5
2333159|NCT03214367|4057341|FG002|Treatment Period|Lost to Follow-up|3
2333160|NCT03214367|4057342|FG003|Treatment Period|Lost to Follow-up|2
2333161|NCT03214367|4057343|FG004|Treatment Period|Lost to Follow-up|0
2333162|NCT03214367|4057344|FG005|Treatment Period|Lost to Follow-up|2
2333163|NCT03214367|4057345|FG006|Treatment Period|Lost to Follow-up|1
2333164|NCT03214367|4057346|FG007|Treatment Period|Lost to Follow-up|0
2333165|NCT03214367|4057339|FG000|Treatment Period|Sponsor Decision|0
2333166|NCT03214367|4057340|FG001|Treatment Period|Sponsor Decision|3
2333167|NCT03214367|4057341|FG002|Treatment Period|Sponsor Decision|0
2333168|NCT03214367|4057342|FG003|Treatment Period|Sponsor Decision|0
2333169|NCT03214367|4057343|FG004|Treatment Period|Sponsor Decision|0
2333170|NCT03214367|4057344|FG005|Treatment Period|Sponsor Decision|0
2333171|NCT03214367|4057345|FG006|Treatment Period|Sponsor Decision|0
2333172|NCT03214367|4057346|FG007|Treatment Period|Sponsor Decision|0
2333173|NCT03214367|4057339|FG000|Treatment Period|Physician Decision|0
2333174|NCT03214367|4057340|FG001|Treatment Period|Physician Decision|1
2333175|NCT03214367|4057341|FG002|Treatment Period|Physician Decision|2
2333176|NCT03214367|4057342|FG003|Treatment Period|Physician Decision|0
2333177|NCT03214367|4057343|FG004|Treatment Period|Physician Decision|0
2333178|NCT03214367|4057344|FG005|Treatment Period|Physician Decision|0
2036641|NCT00413036|3606872|FG000|Overall Study|Missing|2
2333179|NCT03214367|4057345|FG006|Treatment Period|Physician Decision|0
2232514|NCT01850823|3885176|FG000|Overall Study|Lack of Efficacy|1
2333180|NCT03214367|4057346|FG007|Treatment Period|Physician Decision|0
2232515|NCT01850823|3885177|FG001|Overall Study|Lack of Efficacy|0
2232516|NCT01850823|3885178|FG002|Overall Study|Lack of Efficacy|0
2232517|NCT01850823|3885176|FG000|Overall Study|Lost to Follow-up|0
2232518|NCT01850823|3885177|FG001|Overall Study|Lost to Follow-up|0
2232519|NCT01850823|3885178|FG002|Overall Study|Lost to Follow-up|1
2232520|NCT01850823|3885176|FG000|Overall Study|Restricted Medication|0
2232521|NCT01850823|3885177|FG001|Overall Study|Restricted Medication|0
2232522|NCT01850823|3885178|FG002|Overall Study|Restricted Medication|2
2232523|NCT01850823|3885176|FG000|Overall Study|Significant worstening of SAR|0
2232524|NCT01850823|3885177|FG001|Overall Study|Significant worstening of SAR|1
2232525|NCT01850823|3885178|FG002|Overall Study|Significant worstening of SAR|0
2232526|NCT01850823|3885176|FG000|Overall Study|Withdrawal by Subject|2
2232527|NCT01850823|3885177|FG001|Overall Study|Withdrawal by Subject|0
2232528|NCT01850823|3885178|FG002|Overall Study|Withdrawal by Subject|1
2232529|NCT01851330|3885191|FG000|Overall Study|Lack of Efficacy|10
2232530|NCT01851330|3885192|FG001|Overall Study|Lack of Efficacy|9
2232531|NCT01851330|3885193|FG002|Overall Study|Lack of Efficacy|2
2232532|NCT01851330|3885191|FG000|Overall Study|Lost to Follow-up|1
2232533|NCT01851330|3885192|FG001|Overall Study|Lost to Follow-up|6
2232534|NCT01851330|3885193|FG002|Overall Study|Lost to Follow-up|9
2232535|NCT01851330|3885191|FG000|Overall Study|Withdrew Consent|2
2232536|NCT01851330|3885192|FG001|Overall Study|Withdrew Consent|1
2232537|NCT01851330|3885193|FG002|Overall Study|Withdrew Consent|0
2232538|NCT01851330|3885191|FG000|Overall Study|Investigator's Discretion|0
2232539|NCT01851330|3885192|FG001|Overall Study|Investigator's Discretion|0
2232540|NCT01851330|3885193|FG002|Overall Study|Investigator's Discretion|1
2232541|NCT01851590|3885204|FG000|Overall Study|Withdrawal by Subject|0
2232542|NCT01851590|3885205|FG001|Overall Study|Withdrawal by Subject|0
2232543|NCT01851590|3885206|FG002|Overall Study|Withdrawal by Subject|1
2232544|NCT01851590|3885204|FG000|Overall Study|Adverse Event|0
2232545|NCT01851590|3885205|FG001|Overall Study|Adverse Event|0
2232546|NCT01851590|3885206|FG002|Overall Study|Adverse Event|2
2232547|NCT01851590|3885204|FG000|Overall Study|Lack of Efficacy|0
2232548|NCT01851590|3885205|FG001|Overall Study|Lack of Efficacy|1
2232549|NCT01851590|3885206|FG002|Overall Study|Lack of Efficacy|0
2232550|NCT01851720|3885229|FG000|Overall Study|Lost to Follow-up|0
2232551|NCT01851720|3885230|FG001|Overall Study|Lost to Follow-up|1
2274467|NCT02296242|3955406|FG000|Overall Study|Unacceptable Toxicity|0
2274468|NCT02296242|3955407|FG001|Overall Study|Unacceptable Toxicity|0
2274469|NCT02296242|3955408|FG002|Overall Study|Unacceptable Toxicity|0
2274470|NCT02296242|3955409|FG003|Overall Study|Unacceptable Toxicity|0
2274471|NCT02296242|3955410|FG004|Overall Study|Unacceptable Toxicity|1
2274472|NCT02296242|3955406|FG000|Overall Study|Patient Condition Changed|0
2274473|NCT02296242|3955407|FG001|Overall Study|Patient Condition Changed|0
2274474|NCT02296242|3955408|FG002|Overall Study|Patient Condition Changed|2
2274475|NCT02296242|3955409|FG003|Overall Study|Patient Condition Changed|0
2274476|NCT02296242|3955410|FG004|Overall Study|Patient Condition Changed|1
2274477|NCT02296242|3955406|FG000|Overall Study|At Least 3 Drug Interruptions|0
2274478|NCT02296242|3955407|FG001|Overall Study|At Least 3 Drug Interruptions|0
2274479|NCT02296242|3955408|FG002|Overall Study|At Least 3 Drug Interruptions|1
2274480|NCT02296242|3955409|FG003|Overall Study|At Least 3 Drug Interruptions|1
2274481|NCT02296242|3955410|FG004|Overall Study|At Least 3 Drug Interruptions|1
2274482|NCT02296242|3955406|FG000|Overall Study|Lost to Follow-up|1
2274483|NCT02296242|3955407|FG001|Overall Study|Lost to Follow-up|0
2274484|NCT02296242|3955408|FG002|Overall Study|Lost to Follow-up|0
2274485|NCT02296242|3955409|FG003|Overall Study|Lost to Follow-up|0
2274486|NCT02296242|3955410|FG004|Overall Study|Lost to Follow-up|0
2274487|NCT02296242|3955406|FG000|Overall Study|Need for Hydroxyurea|2
2274488|NCT02296242|3955407|FG001|Overall Study|Need for Hydroxyurea|0
2274489|NCT02296242|3955408|FG002|Overall Study|Need for Hydroxyurea|0
2274490|NCT02296242|3955409|FG003|Overall Study|Need for Hydroxyurea|0
2274491|NCT02296242|3955410|FG004|Overall Study|Need for Hydroxyurea|0
2274492|NCT02296242|3955406|FG000|Overall Study|Screened for Other Protocol|0
2274493|NCT02296242|3955407|FG001|Overall Study|Screened for Other Protocol|1
2274494|NCT02296242|3955408|FG002|Overall Study|Screened for Other Protocol|0
2274495|NCT02296242|3955409|FG003|Overall Study|Screened for Other Protocol|0
2274496|NCT02296242|3955410|FG004|Overall Study|Screened for Other Protocol|0
2274497|NCT02296242|3955406|FG000|Overall Study|Physician Decision|0
2274498|NCT02296242|3955407|FG001|Overall Study|Physician Decision|1
2274499|NCT02296242|3955408|FG002|Overall Study|Physician Decision|0
2274500|NCT02296242|3955409|FG003|Overall Study|Physician Decision|1
2274501|NCT02296242|3955410|FG004|Overall Study|Physician Decision|0
2274502|NCT02296242|3955406|FG000|Overall Study|Alternative Treatment|0
2274503|NCT02296242|3955407|FG001|Overall Study|Alternative Treatment|0
2274504|NCT02296242|3955408|FG002|Overall Study|Alternative Treatment|0
2274505|NCT02296242|3955409|FG003|Overall Study|Alternative Treatment|1
2274506|NCT02296242|3955410|FG004|Overall Study|Alternative Treatment|0
2274507|NCT02296242|3955406|FG000|Overall Study|Adverse Event|0
2274508|NCT02296242|3955407|FG001|Overall Study|Adverse Event|0
2274509|NCT02296242|3955408|FG002|Overall Study|Adverse Event|0
2274510|NCT02296242|3955409|FG003|Overall Study|Adverse Event|1
2274511|NCT02296242|3955410|FG004|Overall Study|Adverse Event|0
2274512|NCT02296242|3955406|FG000|Overall Study|Lack of Efficacy|0
2232552|NCT01851863|3885244|FG000|Overall Study|Did not receive study medication|2
2232553|NCT01851863|3885245|FG001|Overall Study|Did not receive study medication|5
2333181|NCT03214367|4057339|FG000|Treatment Period|Protocol Violation|0
2333182|NCT03214367|4057340|FG001|Treatment Period|Protocol Violation|3
2333183|NCT03214367|4057341|FG002|Treatment Period|Protocol Violation|0
2333184|NCT03214367|4057342|FG003|Treatment Period|Protocol Violation|0
2333185|NCT03214367|4057343|FG004|Treatment Period|Protocol Violation|0
2333186|NCT03214367|4057344|FG005|Treatment Period|Protocol Violation|0
2333187|NCT03214367|4057345|FG006|Treatment Period|Protocol Violation|0
2333188|NCT03214367|4057346|FG007|Treatment Period|Protocol Violation|0
2333189|NCT03214367|4057339|FG000|Treatment Period|Withdrawal by Subject|0
2333190|NCT03214367|4057340|FG001|Treatment Period|Withdrawal by Subject|20
2333191|NCT03214367|4057341|FG002|Treatment Period|Withdrawal by Subject|23
2333192|NCT03214367|4057342|FG003|Treatment Period|Withdrawal by Subject|14
2333193|NCT03214367|4057343|FG004|Treatment Period|Withdrawal by Subject|0
2333194|NCT03214367|4057344|FG005|Treatment Period|Withdrawal by Subject|1
2333195|NCT03214367|4057345|FG006|Treatment Period|Withdrawal by Subject|1
2333196|NCT03214367|4057346|FG007|Treatment Period|Withdrawal by Subject|1
2333197|NCT03214380|4057364|FG000|Lead-in|Adverse Event|3
2333198|NCT03214380|4057365|FG001|Lead-in|Adverse Event|0
2333199|NCT03214380|4057366|FG002|Lead-in|Adverse Event|0
2333200|NCT03214380|4057367|FG003|Lead-in|Adverse Event|1
2333201|NCT03214380|4057368|FG004|Lead-in|Adverse Event|0
2333202|NCT03214380|4057369|FG005|Lead-in|Adverse Event|0
2333203|NCT03214380|4057364|FG000|Lead-in|Lost to Follow-up|4
2333204|NCT03214380|4057365|FG001|Lead-in|Lost to Follow-up|0
2333205|NCT03214380|4057366|FG002|Lead-in|Lost to Follow-up|0
2333206|NCT03214380|4057367|FG003|Lead-in|Lost to Follow-up|1
2333207|NCT03214380|4057368|FG004|Lead-in|Lost to Follow-up|0
2232554|NCT01851863|3885246|FG002|Overall Study|Did not receive study medication|3
2232555|NCT01851863|3885247|FG003|Overall Study|Did not receive study medication|0
2232556|NCT01851863|3885244|FG000|Overall Study|Lost to Follow-up|3
2232557|NCT01851863|3885245|FG001|Overall Study|Lost to Follow-up|4
2232558|NCT01851863|3885246|FG002|Overall Study|Lost to Follow-up|2
2232559|NCT01851863|3885247|FG003|Overall Study|Lost to Follow-up|3
2232560|NCT01852045|3885295|FG000|Overall Study|Adverse Event|1
2232561|NCT01852045|3885296|FG001|Overall Study|Adverse Event|0
2232562|NCT01852045|3885297|FG002|Overall Study|Adverse Event|0
2232563|NCT01852045|3885295|FG000|Overall Study|Lack of Efficacy|3
2232564|NCT01852045|3885296|FG001|Overall Study|Lack of Efficacy|0
2232565|NCT01852045|3885297|FG002|Overall Study|Lack of Efficacy|0
2232566|NCT01852045|3885295|FG000|Overall Study|Lost to Follow-up|0
2232567|NCT01852045|3885296|FG001|Overall Study|Lost to Follow-up|1
2232568|NCT01852045|3885297|FG002|Overall Study|Lost to Follow-up|1
2232569|NCT01852045|3885295|FG000|Overall Study|Withdrawal by Subject|1
2232570|NCT01852045|3885296|FG001|Overall Study|Withdrawal by Subject|0
2232571|NCT01852045|3885297|FG002|Overall Study|Withdrawal by Subject|1
2232572|NCT01852045|3885295|FG000|Overall Study|Other Miscellaneous Reasons|1
2232573|NCT01852045|3885296|FG001|Overall Study|Other Miscellaneous Reasons|3
2232574|NCT01852045|3885297|FG002|Overall Study|Other Miscellaneous Reasons|2
2232575|NCT01852058|3885308|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
2232576|NCT01852058|3885309|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2232577|NCT01852058|3885310|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2232578|NCT01852058|3885311|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2232579|NCT01852058|3885312|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2232580|NCT01852058|3885313|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2232581|NCT01852058|3885314|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2232582|NCT01852058|3885315|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2232583|NCT01852058|3885316|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2232584|NCT01852058|3885317|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2232585|NCT01852058|3885318|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2232586|NCT01852058|3885319|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2232587|NCT01852058|3885308|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2232588|NCT01852058|3885309|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2232589|NCT01852058|3885310|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2232590|NCT01852058|3885311|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2232591|NCT01852058|3885312|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
2232592|NCT01852058|3885313|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2232593|NCT01852058|3885314|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2232594|NCT01852058|3885315|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2232595|NCT01852058|3885316|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2232596|NCT01852058|3885317|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2232597|NCT01852058|3885318|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2232598|NCT01852058|3885319|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2232599|NCT01852058|3885308|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2232600|NCT01852058|3885309|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2232601|NCT01852058|3885310|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2232602|NCT01852058|3885311|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2232603|NCT01852058|3885312|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
2232604|NCT01852058|3885313|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
2232605|NCT01852058|3885314|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2232606|NCT01852058|3885315|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2232607|NCT01852058|3885316|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2232608|NCT01852058|3885317|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2232609|NCT01852058|3885318|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2232610|NCT01852058|3885319|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2232611|NCT01852058|3885308|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2232612|NCT01852058|3885309|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2232613|NCT01852058|3885310|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2232614|NCT01852058|3885311|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2232615|NCT01852058|3885312|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
2232616|NCT01852058|3885313|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2232617|NCT01852058|3885314|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2232618|NCT01852058|3885315|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2232619|NCT01852058|3885316|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2232620|NCT01852058|3885317|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2232621|NCT01852058|3885318|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2232622|NCT01852058|3885319|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2232623|NCT01852058|3885308|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2232624|NCT01852058|3885309|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2232625|NCT01852058|3885310|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2232626|NCT01852058|3885311|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2232627|NCT01852058|3885312|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
2232628|NCT01852058|3885313|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
2232629|NCT01852058|3885314|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2232630|NCT01852058|3885315|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2232631|NCT01852058|3885316|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2232632|NCT01852058|3885317|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2232633|NCT01852058|3885318|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2232634|NCT01852058|3885319|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2232635|NCT01852058|3885308|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2232636|NCT01852058|3885309|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2232637|NCT01852058|3885310|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2232638|NCT01852058|3885311|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
2232639|NCT01852058|3885312|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2232640|NCT01852058|3885313|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2232641|NCT01852058|3885314|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2232642|NCT01852058|3885315|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2232643|NCT01852058|3885316|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2232644|NCT01852058|3885317|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2232645|NCT01852058|3885318|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2232646|NCT01852058|3885319|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2232647|NCT01852058|3885308|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2232648|NCT01852058|3885309|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2232649|NCT01852058|3885310|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2232650|NCT01852058|3885311|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2232651|NCT01852058|3885312|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
2232652|NCT01852058|3885313|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
2232653|NCT01852058|3885314|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2232654|NCT01852058|3885315|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2232655|NCT01852058|3885316|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2232656|NCT01852058|3885317|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2232657|NCT01852058|3885318|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2232658|NCT01852058|3885319|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2232659|NCT01852058|3885308|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2232660|NCT01852058|3885309|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2232661|NCT01852058|3885310|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2232662|NCT01852058|3885311|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2232663|NCT01852058|3885312|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2232664|NCT01852058|3885313|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2232665|NCT01852058|3885314|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2232666|NCT01852058|3885315|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
2232667|NCT01852058|3885316|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2232668|NCT01852058|3885317|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2232669|NCT01852058|3885318|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2232670|NCT01852058|3885319|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2232671|NCT01852058|3885308|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2232672|NCT01852058|3885309|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2232673|NCT01852058|3885310|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2232674|NCT01852058|3885311|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2232675|NCT01852058|3885312|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2232676|NCT01852058|3885313|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2232677|NCT01852058|3885314|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2232678|NCT01852058|3885315|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2232679|NCT01852058|3885316|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
2232680|NCT01852058|3885317|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2232681|NCT01852058|3885318|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2232682|NCT01852058|3885319|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2232683|NCT01852110|3885388|FG000|Overall Study|Adverse Event|12
2232684|NCT01852110|3885389|FG001|Overall Study|Adverse Event|5
2232685|NCT01852110|3885390|FG002|Overall Study|Adverse Event|0
2232686|NCT01852110|3885391|FG003|Overall Study|Adverse Event|0
2232687|NCT01852110|3885392|FG004|Overall Study|Adverse Event|0
2232688|NCT01852110|3885393|FG005|Overall Study|Adverse Event|0
2232689|NCT01852110|3885388|FG000|Overall Study|Lost to Follow-up|1
2232690|NCT01852110|3885389|FG001|Overall Study|Lost to Follow-up|3
2232691|NCT01852110|3885390|FG002|Overall Study|Lost to Follow-up|0
2232692|NCT01852110|3885391|FG003|Overall Study|Lost to Follow-up|0
2232693|NCT01852110|3885392|FG004|Overall Study|Lost to Follow-up|0
2232694|NCT01852110|3885393|FG005|Overall Study|Lost to Follow-up|0
2232695|NCT01852110|3885388|FG000|Overall Study|Non-compliance with Study Drug|2
2232696|NCT01852110|3885389|FG001|Overall Study|Non-compliance with Study Drug|1
2232697|NCT01852110|3885390|FG002|Overall Study|Non-compliance with Study Drug|0
2232698|NCT01852110|3885391|FG003|Overall Study|Non-compliance with Study Drug|0
2232699|NCT01852110|3885392|FG004|Overall Study|Non-compliance with Study Drug|0
2232700|NCT01852110|3885393|FG005|Overall Study|Non-compliance with Study Drug|0
2232701|NCT01852110|3885388|FG000|Overall Study|Physician Decision|1
2232702|NCT01852110|3885389|FG001|Overall Study|Physician Decision|0
2232703|NCT01852110|3885390|FG002|Overall Study|Physician Decision|0
2232704|NCT01852110|3885391|FG003|Overall Study|Physician Decision|0
2232705|NCT01852110|3885392|FG004|Overall Study|Physician Decision|0
2232706|NCT01852110|3885393|FG005|Overall Study|Physician Decision|0
2232707|NCT01852110|3885388|FG000|Overall Study|Protocol Violation|0
2232708|NCT01852110|3885389|FG001|Overall Study|Protocol Violation|1
2232709|NCT01852110|3885390|FG002|Overall Study|Protocol Violation|0
2232710|NCT01852110|3885391|FG003|Overall Study|Protocol Violation|0
2232711|NCT01852110|3885392|FG004|Overall Study|Protocol Violation|0
2232712|NCT01852110|3885393|FG005|Overall Study|Protocol Violation|0
2232713|NCT01852110|3885388|FG000|Overall Study|Study Terminated by Sponsor|30
2232714|NCT01852110|3885389|FG001|Overall Study|Study Terminated by Sponsor|32
2232715|NCT01852110|3885390|FG002|Overall Study|Study Terminated by Sponsor|0
2232716|NCT01852110|3885391|FG003|Overall Study|Study Terminated by Sponsor|0
2232717|NCT01852110|3885392|FG004|Overall Study|Study Terminated by Sponsor|0
2232718|NCT01852110|3885393|FG005|Overall Study|Study Terminated by Sponsor|0
2232719|NCT01852110|3885388|FG000|Overall Study|Withdrawal by Subject|4
2232720|NCT01852110|3885389|FG001|Overall Study|Withdrawal by Subject|4
2333208|NCT03214380|4057369|FG005|Lead-in|Lost to Follow-up|0
2333209|NCT03214380|4057364|FG000|Lead-in|Eligibility Criteria|3
2333210|NCT03214380|4057365|FG001|Lead-in|Eligibility Criteria|0
2333211|NCT03214380|4057366|FG002|Lead-in|Eligibility Criteria|0
2333212|NCT03214380|4057367|FG003|Lead-in|Eligibility Criteria|0
2333213|NCT03214380|4057368|FG004|Lead-in|Eligibility Criteria|0
2333214|NCT03214380|4057369|FG005|Lead-in|Eligibility Criteria|0
2333215|NCT03214380|4057364|FG000|Lead-in|Physician Decision|6
2333216|NCT03214380|4057365|FG001|Lead-in|Physician Decision|0
2333217|NCT03214380|4057366|FG002|Lead-in|Physician Decision|0
2333218|NCT03214380|4057367|FG003|Lead-in|Physician Decision|0
2333219|NCT03214380|4057368|FG004|Lead-in|Physician Decision|0
2333220|NCT03214380|4057369|FG005|Lead-in|Physician Decision|0
2333221|NCT03214380|4057364|FG000|Lead-in|Protocol Deviation|7
2333222|NCT03214380|4057365|FG001|Lead-in|Protocol Deviation|0
2333223|NCT03214380|4057366|FG002|Lead-in|Protocol Deviation|0
2333224|NCT03214380|4057367|FG003|Lead-in|Protocol Deviation|3
2333225|NCT03214380|4057368|FG004|Lead-in|Protocol Deviation|0
2333226|NCT03214380|4057369|FG005|Lead-in|Protocol Deviation|0
2333227|NCT03214380|4057364|FG000|Lead-in|Withdrawal by Subject|41
2333228|NCT03214380|4057365|FG001|Lead-in|Withdrawal by Subject|0
2333229|NCT03214380|4057366|FG002|Lead-in|Withdrawal by Subject|0
2333230|NCT03214380|4057367|FG003|Lead-in|Withdrawal by Subject|14
2333231|NCT03214380|4057368|FG004|Lead-in|Withdrawal by Subject|0
2333232|NCT03214380|4057369|FG005|Lead-in|Withdrawal by Subject|0
2333233|NCT03214380|4057364|FG000|Lead-in|Family Emergency|1
2333234|NCT03214380|4057365|FG001|Lead-in|Family Emergency|0
2333235|NCT03214380|4057366|FG002|Lead-in|Family Emergency|0
2333236|NCT03214380|4057367|FG003|Lead-in|Family Emergency|0
2333237|NCT03214380|4057368|FG004|Lead-in|Family Emergency|0
2333238|NCT03214380|4057369|FG005|Lead-in|Family Emergency|0
2333239|NCT03214380|4057364|FG000|Lead-in|Natural Disaster|9
2333240|NCT03214380|4057365|FG001|Lead-in|Natural Disaster|0
2333241|NCT03214380|4057366|FG002|Lead-in|Natural Disaster|0
2333242|NCT03214380|4057367|FG003|Lead-in|Natural Disaster|0
2333243|NCT03214380|4057368|FG004|Lead-in|Natural Disaster|0
2333244|NCT03214380|4057369|FG005|Lead-in|Natural Disaster|0
2333245|NCT03214380|4057364|FG000|Lead-in|Non Compliance|1
2333246|NCT03214380|4057365|FG001|Lead-in|Non Compliance|0
2333247|NCT03214380|4057366|FG002|Lead-in|Non Compliance|0
2333248|NCT03214380|4057367|FG003|Lead-in|Non Compliance|0
2333249|NCT03214380|4057368|FG004|Lead-in|Non Compliance|0
2333250|NCT03214380|4057369|FG005|Lead-in|Non Compliance|0
2333251|NCT03214380|4057364|FG000|Lead-in|Participant Schedule|2
2333252|NCT03214380|4057365|FG001|Lead-in|Participant Schedule|0
2333253|NCT03214380|4057366|FG002|Lead-in|Participant Schedule|0
2333254|NCT03214380|4057367|FG003|Lead-in|Participant Schedule|0
2333255|NCT03214380|4057368|FG004|Lead-in|Participant Schedule|0
2333256|NCT03214380|4057369|FG005|Lead-in|Participant Schedule|0
2333257|NCT03214380|4057364|FG000|Treatment Period|Adverse Event|0
2333258|NCT03214380|4057365|FG001|Treatment Period|Adverse Event|1
2333259|NCT03214380|4057366|FG002|Treatment Period|Adverse Event|1
2333260|NCT03214380|4057367|FG003|Treatment Period|Adverse Event|0
2333261|NCT03214380|4057368|FG004|Treatment Period|Adverse Event|1
2333262|NCT03214380|4057369|FG005|Treatment Period|Adverse Event|0
2333263|NCT03214380|4057364|FG000|Treatment Period|Non-Compliance with Study Drug|0
2333264|NCT03214380|4057365|FG001|Treatment Period|Non-Compliance with Study Drug|0
2333265|NCT03214380|4057366|FG002|Treatment Period|Non-Compliance with Study Drug|0
2333266|NCT03214380|4057367|FG003|Treatment Period|Non-Compliance with Study Drug|0
2232721|NCT01852110|3885390|FG002|Overall Study|Withdrawal by Subject|0
2232722|NCT01852110|3885391|FG003|Overall Study|Withdrawal by Subject|0
2232723|NCT01852110|3885392|FG004|Overall Study|Withdrawal by Subject|0
2232724|NCT01852110|3885393|FG005|Overall Study|Withdrawal by Subject|0
2232725|NCT01852162|3885409|FG000|Overall Study|Adverse Event|1
2232726|NCT01852162|3885410|FG001|Overall Study|Adverse Event|0
2232727|NCT01852162|3885409|FG000|Overall Study|Withdrawal by Subject|3
2232728|NCT01852162|3885410|FG001|Overall Study|Withdrawal by Subject|1
2232729|NCT01852214|3885435|FG000|Period 1|Adverse Event|1
2232730|NCT01852214|3885436|FG001|Period 1|Adverse Event|2
2232731|NCT01852214|3885435|FG000|Period 1|Withdrawal by Subject|0
2232732|NCT01852214|3885436|FG001|Period 1|Withdrawal by Subject|1
2232733|NCT01852214|3885435|FG000|Washout Period|Withdrawal by Subject|0
2232734|NCT01852214|3885436|FG001|Washout Period|Withdrawal by Subject|1
2232735|NCT01852292|3885445|FG000|Overall Study|Untreated - did not receive study drug|3
2232736|NCT01852292|3885446|FG001|Overall Study|Untreated - did not receive study drug|1
2232737|NCT01852292|3885445|FG000|Overall Study|Death|9
2232738|NCT01852292|3885446|FG001|Overall Study|Death|8
2232739|NCT01852292|3885445|FG000|Overall Study|Patient/guardian decision|8
2232740|NCT01852292|3885446|FG001|Overall Study|Patient/guardian decision|4
2232741|NCT01852292|3885445|FG000|Overall Study|Adverse Event|8
2232742|NCT01852292|3885446|FG001|Overall Study|Adverse Event|11
2232743|NCT01852292|3885445|FG000|Overall Study|Physician Decision|6
2232744|NCT01852292|3885446|FG001|Overall Study|Physician Decision|2
2232745|NCT01852292|3885445|FG000|Overall Study|Protocol Violation|2
2232746|NCT01852292|3885446|FG001|Overall Study|Protocol Violation|0
2232747|NCT01852292|3885445|FG000|Overall Study|Non-compliance with study treatment|1
2232748|NCT01852292|3885446|FG001|Overall Study|Non-compliance with study treatment|0
2232749|NCT01852292|3885445|FG000|Overall Study|Study terminated by Sponsor|0
2232750|NCT01852292|3885446|FG001|Overall Study|Study terminated by Sponsor|1
2232751|NCT01852292|3885445|FG000|Overall Study|Progressive disease|42
2232752|NCT01852292|3885446|FG001|Overall Study|Progressive disease|52
2232753|NCT01852591|3885484|FG000|Overall Study|Withdrawal by Subject|2
2232754|NCT01852591|3885484|FG000|Overall Study|Not Evaluable at Time of Analysis|1
2232755|NCT01852825|3885504|FG000|Overall Study|Withdrawal by Subject|2
2232756|NCT01852825|3885505|FG001|Overall Study|Withdrawal by Subject|0
2232757|NCT01852825|3885506|FG002|Overall Study|Withdrawal by Subject|0
2232758|NCT01852942|3885516|FG000|Overall Study|Physician Decision|1
2232759|NCT01852942|3885517|FG001|Overall Study|Physician Decision|0
2232760|NCT01852942|3885516|FG000|Overall Study|Death|1
2232761|NCT01852942|3885517|FG001|Overall Study|Death|1
2232762|NCT01852942|3885516|FG000|Overall Study|Withdrawal by Subject|2
2232763|NCT01852942|3885517|FG001|Overall Study|Withdrawal by Subject|3
2232764|NCT01852942|3885516|FG000|Overall Study|Lost to Follow-up|1
2232765|NCT01852942|3885517|FG001|Overall Study|Lost to Follow-up|2
2232766|NCT01853046|3885535|FG000|Overall Study|Withdrawal by Subject|1
2232767|NCT01853046|3885536|FG001|Overall Study|Withdrawal by Subject|1
2232768|NCT01853046|3885535|FG000|Overall Study|Adverse Event|4
2232769|NCT01853046|3885536|FG001|Overall Study|Adverse Event|2
2232770|NCT01853046|3885535|FG000|Overall Study|Disease progression|13
2232771|NCT01853046|3885536|FG001|Overall Study|Disease progression|3
2232772|NCT01853072|3885545|FG000|Overall Study|Adverse event prior to treatment|0
2232773|NCT01853072|3885546|FG001|Overall Study|Adverse event prior to treatment|1
2232774|NCT01853072|3885545|FG000|Overall Study|Adverse Event|0
2232775|NCT01853072|3885546|FG001|Overall Study|Adverse Event|3
2232776|NCT01853072|3885545|FG000|Overall Study|Death|1
2232777|NCT01853072|3885546|FG001|Overall Study|Death|4
2232778|NCT01853072|3885545|FG000|Overall Study|Lost to Follow-up|0
2232779|NCT01853072|3885546|FG001|Overall Study|Lost to Follow-up|3
2232780|NCT01853072|3885545|FG000|Overall Study|Non-compliance with study drug|0
2232781|NCT01853072|3885546|FG001|Overall Study|Non-compliance with study drug|1
2232782|NCT01853072|3885545|FG000|Overall Study|Physician Decision|1
2232783|NCT01853072|3885546|FG001|Overall Study|Physician Decision|1
2232784|NCT01853072|3885545|FG000|Overall Study|Withdrawal by Subject|1
2232785|NCT01853072|3885546|FG001|Overall Study|Withdrawal by Subject|2
2232786|NCT01853072|3885545|FG000|Overall Study|Reason not specified|9
2232787|NCT01853072|3885546|FG001|Overall Study|Reason not specified|6
2232788|NCT01853137|3885560|FG000|Overall Study|Lost to Follow-up|4
2232789|NCT01853137|3885561|FG001|Overall Study|Lost to Follow-up|1
2232790|NCT01853228|3885573|FG000|Phase 1|Lack of Efficacy|8
2232791|NCT01853228|3885574|FG001|Phase 1|Lack of Efficacy|0
2232792|NCT01853228|3885573|FG000|Phase 1|Other|1
2232793|NCT01853228|3885574|FG001|Phase 1|Other|0
2232794|NCT01853228|3885573|FG000|Phase 2|Physician Decision|0
2232795|NCT01853228|3885574|FG001|Phase 2|Physician Decision|1
2232796|NCT01853228|3885573|FG000|Phase 2|Proceed To Transplant|0
2232797|NCT01853228|3885574|FG001|Phase 2|Proceed To Transplant|3
2232798|NCT01853228|3885573|FG000|Phase 2|Lack of Efficacy|0
2232799|NCT01853228|3885574|FG001|Phase 2|Lack of Efficacy|4
2232800|NCT01853254|3885579|FG000|Overall Study|Abnormal Laboratory Test|1
2232801|NCT01853254|3885579|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
2232802|NCT01853254|3885579|FG000|Overall Study|Death|1
2232803|NCT01853254|3885579|FG000|Overall Study|Failure to Return|43
2232804|NCT01853254|3885579|FG000|Overall Study|Insufficient Therapeutic Response|22
2232805|NCT01853254|3885579|FG000|Overall Study|Refusal of Treatment|1
2232806|NCT01853254|3885579|FG000|Overall Study|Other Protocol Violation|1
2232807|NCT01853254|3885579|FG000|Overall Study|Withdrawal of Consent|16
2232808|NCT01853254|3885579|FG000|Overall Study|Administrative/Other|16
2232809|NCT01853280|3885585|FG000|Overall Study|Lack of Efficacy|2
2232810|NCT01853280|3885586|FG001|Overall Study|Lack of Efficacy|2
2232811|NCT01853280|3885585|FG000|Overall Study|Lost to Follow-up|0
2232812|NCT01853280|3885586|FG001|Overall Study|Lost to Follow-up|1
2232813|NCT01853280|3885585|FG000|Overall Study|Physician Decision|0
2232814|NCT01853280|3885586|FG001|Overall Study|Physician Decision|1
2232815|NCT01853280|3885585|FG000|Overall Study|Withdrawal by Subject|0
2232816|NCT01853280|3885586|FG001|Overall Study|Withdrawal by Subject|1
2232817|NCT01853280|3885585|FG000|Overall Study|Ineligible|0
2232818|NCT01853280|3885586|FG001|Overall Study|Ineligible|1
2232819|NCT01853384|3885608|FG000|Randomized|Adverse Event|5
2232820|NCT01853384|3885609|FG001|Randomized|Adverse Event|3
2232821|NCT01853384|3885608|FG000|Randomized|Death|1
2333267|NCT03214380|4057368|FG004|Treatment Period|Non-Compliance with Study Drug|1
2333268|NCT03214380|4057369|FG005|Treatment Period|Non-Compliance with Study Drug|0
2333269|NCT03214380|4057364|FG000|Treatment Period|Withdrawal by Subject|0
2333270|NCT03214380|4057365|FG001|Treatment Period|Withdrawal by Subject|10
2333271|NCT03214380|4057366|FG002|Treatment Period|Withdrawal by Subject|8
2333272|NCT03214380|4057367|FG003|Treatment Period|Withdrawal by Subject|0
2333273|NCT03214380|4057368|FG004|Treatment Period|Withdrawal by Subject|7
2333274|NCT03214380|4057369|FG005|Treatment Period|Withdrawal by Subject|11
2333275|NCT03214380|4057364|FG000|Treatment Period|Death|0
2333276|NCT03214380|4057365|FG001|Treatment Period|Death|1
2333277|NCT03214380|4057366|FG002|Treatment Period|Death|2
2333278|NCT03214380|4057367|FG003|Treatment Period|Death|0
2333279|NCT03214380|4057368|FG004|Treatment Period|Death|0
2333280|NCT03214380|4057369|FG005|Treatment Period|Death|0
2333281|NCT03214380|4057364|FG000|Treatment Period|Lost to Follow-up|0
2333282|NCT03214380|4057365|FG001|Treatment Period|Lost to Follow-up|6
2333283|NCT03214380|4057366|FG002|Treatment Period|Lost to Follow-up|3
2333284|NCT03214380|4057367|FG003|Treatment Period|Lost to Follow-up|0
2333285|NCT03214380|4057368|FG004|Treatment Period|Lost to Follow-up|0
2333286|NCT03214380|4057369|FG005|Treatment Period|Lost to Follow-up|0
2333287|NCT03214380|4057364|FG000|Treatment Period|Participant schedule|0
2333288|NCT03214380|4057365|FG001|Treatment Period|Participant schedule|0
2333289|NCT03214380|4057366|FG002|Treatment Period|Participant schedule|1
2333290|NCT03214380|4057367|FG003|Treatment Period|Participant schedule|0
2333291|NCT03214380|4057368|FG004|Treatment Period|Participant schedule|0
2333292|NCT03214380|4057369|FG005|Treatment Period|Participant schedule|0
2333293|NCT03214380|4057364|FG000|Treatment Period|Treatment Interruption|0
2333294|NCT03214380|4057365|FG001|Treatment Period|Treatment Interruption|0
2333295|NCT03214380|4057366|FG002|Treatment Period|Treatment Interruption|1
2036642|NCT00413049|3606878|FG000|Overall Study|Adverse Event|10
2036643|NCT00413049|3606879|FG001|Overall Study|Adverse Event|8
2036644|NCT00413049|3606878|FG000|Overall Study|Withdrawal by Subject|7
2036645|NCT00413049|3606879|FG001|Overall Study|Withdrawal by Subject|5
2036646|NCT00413049|3606878|FG000|Overall Study|Lost to Follow-up|2
2036647|NCT00413049|3606879|FG001|Overall Study|Lost to Follow-up|3
2036648|NCT00413049|3606878|FG000|Overall Study|Protocol Violation|3
2036649|NCT00413049|3606879|FG001|Overall Study|Protocol Violation|1
2036650|NCT00413049|3606878|FG000|Overall Study|Subject no longer requires study drug|0
2036651|NCT00413049|3606879|FG001|Overall Study|Subject no longer requires study drug|1
2036652|NCT00413049|3606878|FG000|Overall Study|Abnormal laboratory value(s)|1
2036653|NCT00413049|3606879|FG001|Overall Study|Abnormal laboratory value(s)|0
2036654|NCT00413049|3606878|FG000|Overall Study|Lack of Efficacy|1
2036655|NCT00413049|3606879|FG001|Overall Study|Lack of Efficacy|0
2195802|NCT01526057|3828463|FG001|Overall Study|Other|0
2195803|NCT01526057|3828464|FG002|Overall Study|Other|1
2195804|NCT01526057|3828462|FG000|Overall Study|Protocol Violation|0
2195805|NCT01526057|3828463|FG001|Overall Study|Protocol Violation|0
2232822|NCT01853384|3885609|FG001|Randomized|Death|2
2232823|NCT01853384|3885608|FG000|Randomized|Lost to Follow-up|1
2232824|NCT01853384|3885609|FG001|Randomized|Lost to Follow-up|1
2232825|NCT01853384|3885608|FG000|Randomized|Withdrawal by Subject|5
2232826|NCT01853384|3885609|FG001|Randomized|Withdrawal by Subject|3
2232827|NCT01853384|3885608|FG000|Randomized|Sponsor Decision|47
2232828|NCT01853384|3885609|FG001|Randomized|Sponsor Decision|34
2232829|NCT01853384|3885608|FG000|Randomized|Other|3
2232830|NCT01853384|3885609|FG001|Randomized|Other|3
2232831|NCT01853384|3885608|FG000|Completed Follow up Visit 1|Early Termination|13
2232832|NCT01853384|3885609|FG001|Completed Follow up Visit 1|Early Termination|9
2232833|NCT01853384|3885608|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1
2232834|NCT01853384|3885609|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0
2232835|NCT01853384|3885608|FG000|Completed Follow up Visit 2|Adverse Event|1
2232836|NCT01853384|3885609|FG001|Completed Follow up Visit 2|Adverse Event|0
2232837|NCT01853384|3885608|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1
2232838|NCT01853384|3885609|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2
2232839|NCT01853384|3885608|FG000|Completed Follow up Visit 2|Death|1
2232840|NCT01853384|3885609|FG001|Completed Follow up Visit 2|Death|0
2232841|NCT01853384|3885608|FG000|Completed Follow up Visit 2|Lost to Follow-up|0
2232842|NCT01853384|3885609|FG001|Completed Follow up Visit 2|Lost to Follow-up|1
2232843|NCT01853397|3885619|FG000|Overall Study|Withdrawal by Subject|0
2232844|NCT01853397|3885620|FG001|Overall Study|Withdrawal by Subject|0
2232845|NCT01853397|3885621|FG002|Overall Study|Withdrawal by Subject|0
2232846|NCT01853397|3885622|FG003|Overall Study|Withdrawal by Subject|1
2232847|NCT01853397|3885619|FG000|Overall Study|Subject Noncompliance|0
2232848|NCT01853397|3885620|FG001|Overall Study|Subject Noncompliance|0
2232849|NCT01853397|3885621|FG002|Overall Study|Subject Noncompliance|0
2232850|NCT01853397|3885622|FG003|Overall Study|Subject Noncompliance|1
2232851|NCT01853462|3885634|FG000|Overall Study|Withdrawal by Subject|1
2232852|NCT01853462|3885635|FG001|Overall Study|Withdrawal by Subject|1
2232853|NCT01853475|3885646|FG000|Overall Study|Withdrawal by Subject|0
2232854|NCT01853475|3885647|FG001|Overall Study|Withdrawal by Subject|1
2232855|NCT01853475|3885648|FG002|Overall Study|Withdrawal by Subject|0
2232856|NCT01853618|3885687|FG000|Overall Study|Bile duct stent blockage/progressive dis|1
2232857|NCT01853618|3885688|FG001|Overall Study|Bile duct stent blockage/progressive dis|0
2232858|NCT01853618|3885689|FG002|Overall Study|Bile duct stent blockage/progressive dis|0
2232859|NCT01853618|3885690|FG003|Overall Study|Bile duct stent blockage/progressive dis|0
2232860|NCT01853618|3885691|FG004|Overall Study|Bile duct stent blockage/progressive dis|0
2232861|NCT01853618|3885687|FG000|Overall Study|Progressive disease|1
2232862|NCT01853618|3885688|FG001|Overall Study|Progressive disease|1
2232863|NCT01853618|3885689|FG002|Overall Study|Progressive disease|1
2232864|NCT01853618|3885690|FG003|Overall Study|Progressive disease|1
2232865|NCT01853618|3885691|FG004|Overall Study|Progressive disease|2
2232866|NCT01853618|3885687|FG000|Overall Study|Physician Decision|0
2232867|NCT01853618|3885688|FG001|Overall Study|Physician Decision|1
2232868|NCT01853618|3885689|FG002|Overall Study|Physician Decision|1
2232869|NCT01853618|3885690|FG003|Overall Study|Physician Decision|0
2232870|NCT01853618|3885691|FG004|Overall Study|Physician Decision|0
2232871|NCT01853618|3885687|FG000|Overall Study|Refused further treatment|0
2232872|NCT01853618|3885688|FG001|Overall Study|Refused further treatment|0
2232873|NCT01853618|3885689|FG002|Overall Study|Refused further treatment|0
2232874|NCT01853618|3885690|FG003|Overall Study|Refused further treatment|0
2232875|NCT01853618|3885691|FG004|Overall Study|Refused further treatment|1
2232876|NCT01853644|3885704|FG000|Registration and Treatment Start|Did not start treatment|1
2232877|NCT01853644|3885704|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2
2232878|NCT01853644|3885704|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
2232879|NCT01853644|3885704|FG000|Reached First Response/Complete 2 Cycles|Other|1
2232880|NCT01853644|3885704|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2
2232881|NCT01853644|3885704|FG000|Continued Treatment After First Response|Adverse Event|2
2232882|NCT01853644|3885704|FG000|Continued Treatment After First Response|Progressive Diseaes|10
2232883|NCT01853696|3885710|FG000|Overall Study|Withdrawal by Subject|1
2333296|NCT03214380|4057367|FG003|Treatment Period|Treatment Interruption|0
2333297|NCT03214380|4057368|FG004|Treatment Period|Treatment Interruption|0
2333298|NCT03214380|4057369|FG005|Treatment Period|Treatment Interruption|0
2333299|NCT03214406|4057383|FG000|Overall Study|did not meet enrollment criteria|9
2333300|NCT03214406|4057384|FG001|Overall Study|did not meet enrollment criteria|13
2333301|NCT03214406|4057383|FG000|Overall Study|Withdrawal by Subject|1
2333302|NCT03214406|4057384|FG001|Overall Study|Withdrawal by Subject|0
2333303|NCT03214406|4057383|FG000|Overall Study|Lost to Follow-up|0
2333304|NCT03214406|4057384|FG001|Overall Study|Lost to Follow-up|2
2333305|NCT03214588|4057393|FG000|Overall Study|Adverse Event|1
2333306|NCT03214588|4057394|FG001|Overall Study|Adverse Event|0
2333307|NCT03214588|4057395|FG002|Overall Study|Adverse Event|2
2333308|NCT03214588|4057393|FG000|Overall Study|Reason Not Specified|0
2333309|NCT03214588|4057394|FG001|Overall Study|Reason Not Specified|1
2232884|NCT01853696|3885711|FG001|Overall Study|Withdrawal by Subject|1
2232885|NCT01853696|3885710|FG000|Overall Study|Lost to Follow-up|5
2232886|NCT01853696|3885711|FG001|Overall Study|Lost to Follow-up|4
2232887|NCT01853839|3885728|FG000|Overall Study|Violated inclusion criteria|2
2232888|NCT01853839|3885728|FG000|Overall Study|Not meet ITT population definition|58
2232889|NCT01853839|3885728|FG000|Overall Study|End of treatment visit too early|33
2232890|NCT01853839|3885728|FG000|Overall Study|Lost to follow-up or no valid BP measure|336
2232891|NCT01853878|3885738|FG000|Overall Study|Recurrence|2
2232892|NCT01853878|3885739|FG001|Overall Study|Recurrence|0
2232893|NCT01853878|3885738|FG000|Overall Study|Adverse Event|2
2232894|NCT01853878|3885739|FG001|Overall Study|Adverse Event|0
2232895|NCT01853878|3885738|FG000|Overall Study|Withdrawal by Subject|3
2232896|NCT01853878|3885739|FG001|Overall Study|Withdrawal by Subject|1
2232897|NCT01853878|3885738|FG000|Overall Study|Migrated/moved from the study area|1
2232898|NCT01853878|3885739|FG001|Overall Study|Migrated/moved from the study area|0
2232899|NCT01853878|3885738|FG000|Overall Study|Other|55
2232900|NCT01853878|3885739|FG001|Overall Study|Other|43
2232901|NCT01854047|3885763|FG000|Overall Study|Lack of Efficacy|1
2232902|NCT01854047|3885764|FG001|Overall Study|Lack of Efficacy|0
2232903|NCT01854047|3885765|FG002|Overall Study|Lack of Efficacy|0
2232904|NCT01854047|3885766|FG003|Overall Study|Lack of Efficacy|0
2232905|NCT01854047|3885767|FG004|Overall Study|Lack of Efficacy|0
2232906|NCT01854047|3885763|FG000|Overall Study|Poor compliance to protocol|3
2232907|NCT01854047|3885764|FG001|Overall Study|Poor compliance to protocol|0
2232908|NCT01854047|3885765|FG002|Overall Study|Poor compliance to protocol|2
2232909|NCT01854047|3885766|FG003|Overall Study|Poor compliance to protocol|0
2232910|NCT01854047|3885767|FG004|Overall Study|Poor compliance to protocol|0
2232911|NCT01854047|3885763|FG000|Overall Study|Adverse Event|5
2232912|NCT01854047|3885764|FG001|Overall Study|Adverse Event|4
2333310|NCT03214588|4057395|FG002|Overall Study|Reason Not Specified|0
2333311|NCT03214640|4057407|FG000|Overall Study|Protocol Violation|1
2333312|NCT03214640|4057408|FG001|Overall Study|Protocol Violation|2
2333313|NCT03214640|4057409|FG002|Overall Study|Protocol Violation|1
2333314|NCT03214640|4057410|FG003|Overall Study|Protocol Violation|4
2333315|NCT03214952|4057420|FG000|Overall Study|Protocol Deviation|45
2333316|NCT03214952|4057420|FG000|Overall Study|Case Report Forms Uncollected|13
2333317|NCT03215667|4057424|FG000|Overall Study|Physician Decision|4
2333318|NCT03215706|4057430|FG000|Randomization|Adverse Event unrelated to study drug|1
2333319|NCT03215706|4057431|FG001|Randomization|Adverse Event unrelated to study drug|0
2333320|NCT03215706|4057430|FG000|Randomization|participant withdrew consent|1
2333321|NCT03215706|4057431|FG001|Randomization|participant withdrew consent|3
2333322|NCT03215706|4057430|FG000|Randomization|no longer meets study criteria|1
2333323|NCT03215706|4057431|FG001|Randomization|no longer meets study criteria|4
2333324|NCT03215706|4057430|FG000|Randomization|other reasons|0
2333325|NCT03215706|4057431|FG001|Randomization|other reasons|2
2333326|NCT03215706|4057430|FG000|Treatment Period|Disease Progression|150
2333327|NCT03215706|4057431|FG001|Treatment Period|Disease Progression|142
2333328|NCT03215706|4057430|FG000|Treatment Period|Study Drug Toxicity|53
2333329|NCT03215706|4057431|FG001|Treatment Period|Study Drug Toxicity|21
2333330|NCT03215706|4057430|FG000|Treatment Period|Death|2
2333331|NCT03215706|4057431|FG001|Treatment Period|Death|1
2333332|NCT03215706|4057430|FG000|Treatment Period|Adverse event unrelated to study drug|24
2333333|NCT03215706|4057431|FG001|Treatment Period|Adverse event unrelated to study drug|23
2333334|NCT03215706|4057430|FG000|Treatment Period|Request to D/C treatment|1
2333335|NCT03215706|4057431|FG001|Treatment Period|Request to D/C treatment|6
2333336|NCT03215706|4057430|FG000|Treatment Period|Participant withdrew consent|3
2333337|NCT03215706|4057431|FG001|Treatment Period|Participant withdrew consent|4
2333338|NCT03215706|4057430|FG000|Treatment Period|Lost to Follow-up|0
2333339|NCT03215706|4057431|FG001|Treatment Period|Lost to Follow-up|1
2333340|NCT03215706|4057430|FG000|Treatment Period|Other Reasons|4
2333341|NCT03215706|4057431|FG001|Treatment Period|Other Reasons|5
2333342|NCT03215706|4057430|FG000|Treatment Period|Ongoing in the treatment period|105
2333343|NCT03215706|4057431|FG001|Treatment Period|Ongoing in the treatment period|43
2333344|NCT03215758|4057439|FG000|Overall Study|Technical Problems|1
2333345|NCT03215758|4057440|FG001|Overall Study|Technical Problems|0
2036656|NCT00413153|3606887|FG000|Overall Study|Withdrawal by Subject|1
2036657|NCT00413153|3606888|FG001|Overall Study|Withdrawal by Subject|1
2036658|NCT00413153|3606887|FG000|Overall Study|Adverse Event|1
2232913|NCT01854047|3885765|FG002|Overall Study|Adverse Event|6
2232914|NCT01854047|3885766|FG003|Overall Study|Adverse Event|10
2232915|NCT01854047|3885767|FG004|Overall Study|Adverse Event|7
2232916|NCT01854047|3885763|FG000|Overall Study|Randomized but not treated|0
2232917|NCT01854047|3885764|FG001|Overall Study|Randomized but not treated|1
2232918|NCT01854047|3885765|FG002|Overall Study|Randomized but not treated|2
2232919|NCT01854047|3885766|FG003|Overall Study|Randomized but not treated|0
2232920|NCT01854047|3885767|FG004|Overall Study|Randomized but not treated|4
2232921|NCT01854047|3885763|FG000|Overall Study|Other than specified above|3
2232922|NCT01854047|3885764|FG001|Overall Study|Other than specified above|3
2232923|NCT01854047|3885765|FG002|Overall Study|Other than specified above|3
2232924|NCT01854047|3885766|FG003|Overall Study|Other than specified above|5
2232925|NCT01854047|3885767|FG004|Overall Study|Other than specified above|8
2232926|NCT01854528|3885835|FG000|Overall Study|Adverse Event|0
2232927|NCT01854528|3885836|FG001|Overall Study|Adverse Event|4
2232928|NCT01854528|3885835|FG000|Overall Study|Withdrawal by Subject|0
2232929|NCT01854528|3885836|FG001|Overall Study|Withdrawal by Subject|2
2232930|NCT01854528|3885835|FG000|Overall Study|Virologic Failure|0
2232931|NCT01854528|3885836|FG001|Overall Study|Virologic Failure|9
2232932|NCT01854645|3885866|FG000|Overall Study|Protocol-Specified Criteria|13
2232933|NCT01854645|3885867|FG001|Overall Study|Protocol-Specified Criteria|10
2232934|NCT01854645|3885868|FG002|Overall Study|Protocol-Specified Criteria|8
2232935|NCT01854645|3885869|FG003|Overall Study|Protocol-Specified Criteria|5
2232936|NCT01854645|3885870|FG004|Overall Study|Protocol-Specified Criteria|7
2232937|NCT01854645|3885866|FG000|Overall Study|Administrative Reasons / Missing|0
2232938|NCT01854645|3885867|FG001|Overall Study|Administrative Reasons / Missing|0
2232939|NCT01854645|3885868|FG002|Overall Study|Administrative Reasons / Missing|0
2232940|NCT01854645|3885869|FG003|Overall Study|Administrative Reasons / Missing|1
2232941|NCT01854645|3885870|FG004|Overall Study|Administrative Reasons / Missing|1
2232942|NCT01854645|3885866|FG000|Overall Study|Protocol Violation|3
2232943|NCT01854645|3885867|FG001|Overall Study|Protocol Violation|0
2232944|NCT01854645|3885868|FG002|Overall Study|Protocol Violation|5
2232945|NCT01854645|3885869|FG003|Overall Study|Protocol Violation|4
2232946|NCT01854645|3885870|FG004|Overall Study|Protocol Violation|1
2232947|NCT01854645|3885866|FG000|Overall Study|Lost to Follow-up|10
2232948|NCT01854645|3885867|FG001|Overall Study|Lost to Follow-up|7
2232949|NCT01854645|3885868|FG002|Overall Study|Lost to Follow-up|8
2232950|NCT01854645|3885869|FG003|Overall Study|Lost to Follow-up|5
2232951|NCT01854645|3885870|FG004|Overall Study|Lost to Follow-up|0
2232952|NCT01854645|3885866|FG000|Overall Study|Physician Decision|1
2232953|NCT01854645|3885867|FG001|Overall Study|Physician Decision|5
2232954|NCT01854645|3885868|FG002|Overall Study|Physician Decision|3
2232955|NCT01854645|3885869|FG003|Overall Study|Physician Decision|3
2232956|NCT01854645|3885870|FG004|Overall Study|Physician Decision|7
2232957|NCT01854645|3885866|FG000|Overall Study|Withdrawal by Subject|31
2232958|NCT01854645|3885867|FG001|Overall Study|Withdrawal by Subject|41
2232959|NCT01854645|3885868|FG002|Overall Study|Withdrawal by Subject|30
2232960|NCT01854645|3885869|FG003|Overall Study|Withdrawal by Subject|21
2232961|NCT01854645|3885870|FG004|Overall Study|Withdrawal by Subject|24
2333346|NCT03215758|4057439|FG000|Overall Study|Protocol deviation|0
2333347|NCT03215758|4057440|FG001|Overall Study|Protocol deviation|1
2333348|NCT03215758|4057439|FG000|Overall Study|Physician Decision|0
2333349|NCT03215758|4057440|FG001|Overall Study|Physician Decision|1
2333350|NCT03215758|4057439|FG000|Overall Study|Death|0
2333351|NCT03215758|4057440|FG001|Overall Study|Death|1
2333352|NCT03215758|4057439|FG000|Overall Study|Adverse Event|1
2333353|NCT03215758|4057440|FG001|Overall Study|Adverse Event|2
2333354|NCT03215758|4057439|FG000|Overall Study|Subject/Guardian Decision|3
2333355|NCT03215758|4057440|FG001|Overall Study|Subject/Guardian Decision|3
2333356|NCT03215771|4057446|FG000|Overall Study|Withdrawal by Subject|2
2333357|NCT03215771|4057446|FG000|Overall Study|Physician Decision|1
2333358|NCT03216226|4057470|FG000|Overall Study|Adverse Event|3
2333359|NCT03216226|4057471|FG001|Overall Study|Adverse Event|0
2333360|NCT03216226|4057470|FG000|Overall Study|Protocol Violation|1
2333361|NCT03216226|4057471|FG001|Overall Study|Protocol Violation|3
2333362|NCT03216226|4057470|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1
2333363|NCT03216226|4057471|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0
2333364|NCT03216226|4057470|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0
2333365|NCT03216226|4057471|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1
2333366|NCT03216226|4057470|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0
2333367|NCT03216226|4057471|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1
2333368|NCT03216265|4057480|FG000|Overall Study|Adverse Event|2
2333369|NCT03216265|4057481|FG001|Overall Study|Adverse Event|0
2333370|NCT03216265|4057482|FG002|Overall Study|Adverse Event|2
2333371|NCT03216265|4057480|FG000|Overall Study|Lost to Follow-up|0
2333372|NCT03216265|4057481|FG001|Overall Study|Lost to Follow-up|1
2333373|NCT03216265|4057482|FG002|Overall Study|Lost to Follow-up|0
2333374|NCT03216265|4057480|FG000|Overall Study|Withdrawal by Subject|0
2333375|NCT03216265|4057481|FG001|Overall Study|Withdrawal by Subject|0
2232962|NCT01854645|3885866|FG000|Overall Study|Lack of Efficacy|7
2232963|NCT01854645|3885867|FG001|Overall Study|Lack of Efficacy|12
2232964|NCT01854645|3885868|FG002|Overall Study|Lack of Efficacy|9
2232965|NCT01854645|3885869|FG003|Overall Study|Lack of Efficacy|3
2232966|NCT01854645|3885870|FG004|Overall Study|Lack of Efficacy|9
2232967|NCT01854645|3885866|FG000|Overall Study|Adverse Event|33
2232968|NCT01854645|3885867|FG001|Overall Study|Adverse Event|31
2232969|NCT01854645|3885868|FG002|Overall Study|Adverse Event|19
2232970|NCT01854645|3885869|FG003|Overall Study|Adverse Event|20
2232971|NCT01854645|3885870|FG004|Overall Study|Adverse Event|11
2232972|NCT01854658|3885886|FG000|Overall Study|Protocol Violation|6
2232973|NCT01854658|3885887|FG001|Overall Study|Protocol Violation|2
2232974|NCT01854658|3885888|FG002|Overall Study|Protocol Violation|2
2232975|NCT01854658|3885889|FG003|Overall Study|Protocol Violation|1
2232976|NCT01854658|3885886|FG000|Overall Study|Physician Decision|7
2232977|NCT01854658|3885887|FG001|Overall Study|Physician Decision|5
2232978|NCT01854658|3885888|FG002|Overall Study|Physician Decision|2
2232979|NCT01854658|3885889|FG003|Overall Study|Physician Decision|4
2232980|NCT01854658|3885886|FG000|Overall Study|Lost to Follow-up|8
2232981|NCT01854658|3885887|FG001|Overall Study|Lost to Follow-up|9
2232982|NCT01854658|3885888|FG002|Overall Study|Lost to Follow-up|8
2232983|NCT01854658|3885889|FG003|Overall Study|Lost to Follow-up|4
2232984|NCT01854658|3885886|FG000|Overall Study|Withdrawal by Subject|28
2232985|NCT01854658|3885887|FG001|Overall Study|Withdrawal by Subject|21
2232986|NCT01854658|3885888|FG002|Overall Study|Withdrawal by Subject|29
2232987|NCT01854658|3885889|FG003|Overall Study|Withdrawal by Subject|15
2232988|NCT01854658|3885886|FG000|Overall Study|Protocol-specified criteria|15
2232989|NCT01854658|3885887|FG001|Overall Study|Protocol-specified criteria|15
2232990|NCT01854658|3885888|FG002|Overall Study|Protocol-specified criteria|10
2232991|NCT01854658|3885889|FG003|Overall Study|Protocol-specified criteria|7
2232992|NCT01854658|3885886|FG000|Overall Study|Lack of Efficacy|3
2232993|NCT01854658|3885887|FG001|Overall Study|Lack of Efficacy|8
2232994|NCT01854658|3885888|FG002|Overall Study|Lack of Efficacy|4
2232995|NCT01854658|3885889|FG003|Overall Study|Lack of Efficacy|7
2232996|NCT01854658|3885886|FG000|Overall Study|Adverse Event|21
2232997|NCT01854658|3885887|FG001|Overall Study|Adverse Event|14
2232998|NCT01854658|3885888|FG002|Overall Study|Adverse Event|23
2232999|NCT01854658|3885889|FG003|Overall Study|Adverse Event|19
2233000|NCT01854658|3885886|FG000|Overall Study|Administrative reasons|5
2233001|NCT01854658|3885887|FG001|Overall Study|Administrative reasons|1
2233002|NCT01854658|3885888|FG002|Overall Study|Administrative reasons|2
2233003|NCT01854658|3885889|FG003|Overall Study|Administrative reasons|2
2233004|NCT01854697|3885904|FG000|Overall Study|Adverse Event|1
2233005|NCT01854697|3885905|FG001|Overall Study|Adverse Event|0
2233006|NCT01854697|3885906|FG002|Overall Study|Adverse Event|0
2233007|NCT01854697|3885907|FG003|Overall Study|Adverse Event|0
2233008|NCT01854697|3885908|FG004|Overall Study|Adverse Event|1
2233009|NCT01854697|3885904|FG000|Overall Study|Lost to Follow-up|4
2233010|NCT01854697|3885905|FG001|Overall Study|Lost to Follow-up|1
2233011|NCT01854697|3885906|FG002|Overall Study|Lost to Follow-up|1
2233012|NCT01854697|3885907|FG003|Overall Study|Lost to Follow-up|2
2233013|NCT01854697|3885908|FG004|Overall Study|Lost to Follow-up|0
2233014|NCT01854697|3885904|FG000|Overall Study|To enter another AbbVie study|1
2233015|NCT01854697|3885905|FG001|Overall Study|To enter another AbbVie study|0
2233016|NCT01854697|3885906|FG002|Overall Study|To enter another AbbVie study|0
2233017|NCT01854697|3885907|FG003|Overall Study|To enter another AbbVie study|0
2233018|NCT01854697|3885908|FG004|Overall Study|To enter another AbbVie study|1
2233019|NCT01854697|3885904|FG000|Overall Study|Withdrew Consent|0
2233020|NCT01854697|3885905|FG001|Overall Study|Withdrew Consent|1
2233021|NCT01854697|3885906|FG002|Overall Study|Withdrew Consent|0
2233022|NCT01854697|3885907|FG003|Overall Study|Withdrew Consent|1
2233023|NCT01854697|3885908|FG004|Overall Study|Withdrew Consent|0
2233024|NCT01854697|3885904|FG000|Overall Study|Other|0
2233025|NCT01854697|3885905|FG001|Overall Study|Other|1
2233026|NCT01854697|3885906|FG002|Overall Study|Other|1
2233027|NCT01854697|3885907|FG003|Overall Study|Other|0
2233028|NCT01854697|3885908|FG004|Overall Study|Other|0
2233029|NCT01854710|3885918|FG000|Overall Study|Withdrawal by Subject|2
2233030|NCT01854710|3885919|FG001|Overall Study|Withdrawal by Subject|1
2233031|NCT01854710|3885920|FG002|Overall Study|Withdrawal by Subject|0
2233032|NCT01854710|3885921|FG003|Overall Study|Withdrawal by Subject|0
2233033|NCT01854710|3885922|FG004|Overall Study|Withdrawal by Subject|0
2233034|NCT01854710|3885923|FG005|Overall Study|Withdrawal by Subject|0
2233035|NCT01854710|3885918|FG000|Overall Study|CRI procedural error|2
2233036|NCT01854710|3885919|FG001|Overall Study|CRI procedural error|2
2233037|NCT01854710|3885920|FG002|Overall Study|CRI procedural error|2
2233038|NCT01854710|3885921|FG003|Overall Study|CRI procedural error|2
2233039|NCT01854710|3885922|FG004|Overall Study|CRI procedural error|2
2233040|NCT01854710|3885923|FG005|Overall Study|CRI procedural error|2
2233041|NCT01854775|3885936|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
2233042|NCT01854775|3885937|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
2233043|NCT01854775|3885938|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0
2233044|NCT01854775|3885936|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1
2233045|NCT01854775|3885937|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0
2233046|NCT01854775|3885938|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0
2233047|NCT01854775|3885936|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
2233048|NCT01854775|3885937|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
2233049|NCT01854775|3885938|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9
2233050|NCT01854775|3885936|FG000|Extension Phase|Pregnancy|3
2233051|NCT01854775|3885937|FG001|Extension Phase|Pregnancy|0
2233052|NCT01854775|3885938|FG002|Extension Phase|Pregnancy|0
2233053|NCT01854775|3885936|FG000|Extension Phase|Investigator's Discretion|1
2233054|NCT01854775|3885937|FG001|Extension Phase|Investigator's Discretion|0
2233055|NCT01854775|3885938|FG002|Extension Phase|Investigator's Discretion|0
2233056|NCT01854775|3885936|FG000|Extension Phase|Non-Compliance with Study Drug|1
2233057|NCT01854775|3885937|FG001|Extension Phase|Non-Compliance with Study Drug|0
2333376|NCT03216265|4057482|FG002|Overall Study|Withdrawal by Subject|1
2333377|NCT03216746|4057521|FG000|Overall Study|Lost to Follow-up|6
2333378|NCT03216746|4057522|FG001|Overall Study|Lost to Follow-up|8
2333379|NCT03216746|4057523|FG002|Overall Study|Lost to Follow-up|5
2333380|NCT03216746|4057524|FG003|Overall Study|Lost to Follow-up|6
2333381|NCT03216850|4057534|FG000|Overall Study|Pre-analytical error|6
2333382|NCT03216954|4057571|FG000|Overall Study|Adverse Event|0
2333383|NCT03216954|4057572|FG001|Overall Study|Adverse Event|0
2333384|NCT03216954|4057573|FG002|Overall Study|Adverse Event|1
2333385|NCT03216954|4057574|FG003|Overall Study|Adverse Event|0
2333386|NCT03216954|4057575|FG004|Overall Study|Adverse Event|1
2333387|NCT03216954|4057571|FG000|Overall Study|Withdrawal by Subject|2
2333388|NCT03216954|4057572|FG001|Overall Study|Withdrawal by Subject|0
2333389|NCT03216954|4057573|FG002|Overall Study|Withdrawal by Subject|0
2333390|NCT03216954|4057574|FG003|Overall Study|Withdrawal by Subject|0
2333391|NCT03216954|4057575|FG004|Overall Study|Withdrawal by Subject|0
2333392|NCT03216954|4057571|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
2333393|NCT03216954|4057572|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1
2333394|NCT03216954|4057573|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
2333395|NCT03216954|4057574|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
2333396|NCT03216954|4057575|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
2333397|NCT03217968|4057583|FG000|Overall Study|Withdrawal by Subject|4
2333398|NCT03217968|4057583|FG000|Overall Study|Lost to Follow-up|1
2333399|NCT03217968|4057583|FG000|Overall Study|Protocol Violation|6
2333400|NCT03218397|4057589|FG000|Overall Study|Prior positive blood culture|8
2333401|NCT03218397|4057590|FG001|Overall Study|Prior positive blood culture|13
2333402|NCT03218397|4057589|FG000|Overall Study|Comfort care|8
2333403|NCT03218397|4057590|FG001|Overall Study|Comfort care|5
2333404|NCT03218397|4057589|FG000|Overall Study|Comfort care and positive blood culture|1
2333405|NCT03218397|4057590|FG001|Overall Study|Comfort care and positive blood culture|0
2333406|NCT03218397|4057589|FG000|Overall Study|Comfort care and mixed culture|0
2333407|NCT03218397|4057590|FG001|Overall Study|Comfort care and mixed culture|1
2333408|NCT03218397|4057589|FG000|Overall Study|Mixed culture|2
2333409|NCT03218397|4057590|FG001|Overall Study|Mixed culture|2
2333410|NCT03218397|4057589|FG000|Overall Study|Inaccessible hospital records|2
2333411|NCT03218397|4057590|FG001|Overall Study|Inaccessible hospital records|5
2333412|NCT03218397|4057589|FG000|Overall Study|No gram-negative bacilli (GNB)|0
2036659|NCT00413153|3606888|FG001|Overall Study|Adverse Event|0
2036660|NCT00413192|3606911|FG000|Overall Study|Disease progression|26
2233058|NCT01854775|3885938|FG002|Extension Phase|Non-Compliance with Study Drug|0
2233059|NCT01854775|3885936|FG000|Extension Phase|Lost to Follow-up|2
2233060|NCT01854775|3885937|FG001|Extension Phase|Lost to Follow-up|0
2233061|NCT01854775|3885938|FG002|Extension Phase|Lost to Follow-up|0
2233062|NCT01854775|3885936|FG000|Extension Phase|Still on Study|32
2233063|NCT01854775|3885937|FG001|Extension Phase|Still on Study|47
2233064|NCT01854775|3885938|FG002|Extension Phase|Still on Study|18
2233065|NCT01854827|3885946|FG000|Overall Study|Death|1
2233066|NCT01854879|3885950|FG000|Overall Study|Could not complete testing within the scheduled time.|1
2233067|NCT01854879|3885950|FG000|Overall Study|screen fail|3
2233068|NCT01854879|3885950|FG000|Overall Study|incomplete data set|1
2233069|NCT01854918|3885960|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
2233070|NCT01854918|3885961|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
2233071|NCT01854918|3885960|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2
2233072|NCT01854918|3885961|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1
2233073|NCT01854918|3885960|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3
2233074|NCT01854918|3885961|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8
2233075|NCT01854918|3885960|FG000|SOC-controlled Period (Year 1)|Death|5
2233076|NCT01854918|3885961|FG001|SOC-controlled Period (Year 1)|Death|5
2233077|NCT01854918|3885960|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
2233078|NCT01854918|3885961|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
2233079|NCT01854918|3885960|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
2233080|NCT01854918|3885961|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
2233081|NCT01854918|3885960|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
2233082|NCT01854918|3885961|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
2233083|NCT01854918|3885960|FG000|All-IP Period (Years 2 and 3)|Death|5
2233084|NCT01854918|3885961|FG001|All-IP Period (Years 2 and 3)|Death|16
2333413|NCT03218397|4057590|FG001|Overall Study|No gram-negative bacilli (GNB)|2
2333414|NCT03218397|4057589|FG000|Overall Study|Randomized during laboratory off hours|2
2233085|NCT01854944|3885977|FG000|Overall Study|Withdrawal by Subject|0
2233086|NCT01854944|3885978|FG001|Overall Study|Withdrawal by Subject|0
2233087|NCT01854944|3885979|FG002|Overall Study|Withdrawal by Subject|1
2233088|NCT01855048|3886007|FG000|Overall Study|Withdrawal by Subject|0
2233089|NCT01855048|3886008|FG001|Overall Study|Withdrawal by Subject|1
2233090|NCT01855048|3886009|FG002|Overall Study|Withdrawal by Subject|0
2233091|NCT01855048|3886010|FG003|Overall Study|Withdrawal by Subject|0
2233092|NCT01855048|3886011|FG004|Overall Study|Withdrawal by Subject|1
2233093|NCT01855048|3886012|FG005|Overall Study|Withdrawal by Subject|0
2233094|NCT01855074|3886036|FG000|Overall Study|Adverse Event|1
2233095|NCT01855074|3886036|FG000|Overall Study|Lost to Follow-up|4
2233096|NCT01855074|3886036|FG000|Overall Study|Withdrawal by Subject|8
2233097|NCT01855074|3886036|FG000|Overall Study|Started but not treated|1
2233098|NCT01855126|3886042|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4
2233099|NCT01855126|3886043|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6
2233100|NCT01855126|3886042|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
2233101|NCT01855126|3886043|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2
2233102|NCT01855243|3886056|FG000|Overall Study|develpoed diabetic ketoacidosis|1
2233103|NCT01855243|3886057|FG001|Overall Study|develpoed diabetic ketoacidosis|0
2233104|NCT01855243|3886058|FG002|Overall Study|develpoed diabetic ketoacidosis|0
2233105|NCT01855399|3886072|FG000|6 Month|Lost to Follow-up|12
2233106|NCT01855399|3886073|FG001|6 Month|Lost to Follow-up|9
2233107|NCT01855399|3886072|FG000|6 Month|Withdrawal by Subject|8
2233108|NCT01855399|3886073|FG001|6 Month|Withdrawal by Subject|6
2233109|NCT01855399|3886072|FG000|12 Month|Lost to Follow-up|7
2233110|NCT01855399|3886073|FG001|12 Month|Lost to Follow-up|11
2233111|NCT01855412|3886082|FG000|Overall Study|Death|77
2233112|NCT01855412|3886083|FG001|Overall Study|Death|123
2233113|NCT01855412|3886084|FG002|Overall Study|Death|30
2233114|NCT01855412|3886082|FG000|Overall Study|Lost to Follow-up|28
2233115|NCT01855412|3886083|FG001|Overall Study|Lost to Follow-up|46
2233116|NCT01855412|3886084|FG002|Overall Study|Lost to Follow-up|15
2233117|NCT01855412|3886082|FG000|Overall Study|Withdrawal by Subject|77
2233118|NCT01855412|3886083|FG001|Overall Study|Withdrawal by Subject|123
2233119|NCT01855412|3886084|FG002|Overall Study|Withdrawal by Subject|24
2233120|NCT01855412|3886082|FG000|Overall Study|Physician Decision|25
2233121|NCT01855412|3886083|FG001|Overall Study|Physician Decision|31
2233122|NCT01855412|3886084|FG002|Overall Study|Physician Decision|3
2233123|NCT01855412|3886082|FG000|Overall Study|Site Closure|4
2233124|NCT01855412|3886083|FG001|Overall Study|Site Closure|18
2233125|NCT01855412|3886084|FG002|Overall Study|Site Closure|1
2233126|NCT01855412|3886082|FG000|Overall Study|Reason not Specified|1
2233127|NCT01855412|3886083|FG001|Overall Study|Reason not Specified|2
2233128|NCT01855412|3886084|FG002|Overall Study|Reason not Specified|3
2233129|NCT01855425|3886098|FG000|Overall Study|Physician Decision|20
2233130|NCT01855750|3886104|FG000|Overall Study|Death|78
2233131|NCT01855750|3886105|FG001|Overall Study|Death|78
2233132|NCT01855750|3886104|FG000|Overall Study|Lost to Follow-up|9
2233133|NCT01855750|3886105|FG001|Overall Study|Lost to Follow-up|23
2233134|NCT01855750|3886104|FG000|Overall Study|Withdrawal by Subject|35
2233135|NCT01855750|3886105|FG001|Overall Study|Withdrawal by Subject|28
2233136|NCT01855750|3886104|FG000|Overall Study|Sponsor ends the study|297
2233137|NCT01855750|3886105|FG001|Overall Study|Sponsor ends the study|290
2233138|NCT01855789|3886111|FG000|1) Baseline up to Week 24|Adverse Event|37
2233139|NCT01855789|3886112|FG001|1) Baseline up to Week 24|Adverse Event|0
2233140|NCT01855789|3886113|FG002|1) Baseline up to Week 24|Adverse Event|0
2233141|NCT01855789|3886114|FG003|1) Baseline up to Week 24|Adverse Event|0
2233142|NCT01855789|3886111|FG000|1) Baseline up to Week 24|Death|2
2233143|NCT01855789|3886112|FG001|1) Baseline up to Week 24|Death|0
2233144|NCT01855789|3886113|FG002|1) Baseline up to Week 24|Death|0
2233145|NCT01855789|3886114|FG003|1) Baseline up to Week 24|Death|0
2233146|NCT01855789|3886111|FG000|1) Baseline up to Week 24|Lack of Efficacy|16
2233147|NCT01855789|3886112|FG001|1) Baseline up to Week 24|Lack of Efficacy|0
2233148|NCT01855789|3886113|FG002|1) Baseline up to Week 24|Lack of Efficacy|0
2233149|NCT01855789|3886114|FG003|1) Baseline up to Week 24|Lack of Efficacy|0
2233150|NCT01855789|3886111|FG000|1) Baseline up to Week 24|Lost to Follow-up|11
2233151|NCT01855789|3886112|FG001|1) Baseline up to Week 24|Lost to Follow-up|0
2233152|NCT01855789|3886113|FG002|1) Baseline up to Week 24|Lost to Follow-up|0
2233153|NCT01855789|3886114|FG003|1) Baseline up to Week 24|Lost to Follow-up|0
2233154|NCT01855789|3886111|FG000|1) Baseline up to Week 24|Protocol Violation|4
2233155|NCT01855789|3886112|FG001|1) Baseline up to Week 24|Protocol Violation|0
2233156|NCT01855789|3886113|FG002|1) Baseline up to Week 24|Protocol Violation|0
2233157|NCT01855789|3886114|FG003|1) Baseline up to Week 24|Protocol Violation|0
2233158|NCT01855789|3886111|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31
2233159|NCT01855789|3886112|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0
2233160|NCT01855789|3886113|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0
2233161|NCT01855789|3886114|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0
2233162|NCT01855789|3886111|FG000|1) Baseline up to Week 24|Physician Decision|4
2233163|NCT01855789|3886112|FG001|1) Baseline up to Week 24|Physician Decision|0
2233164|NCT01855789|3886113|FG002|1) Baseline up to Week 24|Physician Decision|0
2233165|NCT01855789|3886114|FG003|1) Baseline up to Week 24|Physician Decision|0
2233166|NCT01855789|3886111|FG000|1) Baseline up to Week 24|Pregnancy|1
2233167|NCT01855789|3886112|FG001|1) Baseline up to Week 24|Pregnancy|0
2233168|NCT01855789|3886113|FG002|1) Baseline up to Week 24|Pregnancy|0
2233169|NCT01855789|3886114|FG003|1) Baseline up to Week 24|Pregnancy|0
2233170|NCT01855789|3886111|FG000|1) Baseline up to Week 24|Participant Non-compliance|3
2233171|NCT01855789|3886112|FG001|1) Baseline up to Week 24|Participant Non-compliance|0
2233172|NCT01855789|3886113|FG002|1) Baseline up to Week 24|Participant Non-compliance|0
2333415|NCT03218397|4057590|FG001|Overall Study|Randomized during laboratory off hours|1
2333416|NCT03218787|4057618|FG000|Overall Study|Lost to Follow-up|12
2333417|NCT03218787|4057618|FG000|Overall Study|Withdrawal by Subject|72
2333418|NCT03218787|4057618|FG000|Overall Study|Physician Decision|11
2333419|NCT03218787|4057618|FG000|Overall Study|Death|111
2333420|NCT03219216|4057624|FG000|Overall Study|Lost to Follow-up|0
2333421|NCT03219216|4057625|FG001|Overall Study|Lost to Follow-up|1
2333422|NCT03219723|4057656|FG000|Overall Study|Case Report Forms Uncollected|6
2333423|NCT03219723|4057656|FG000|Overall Study|Protocol Deviation|4
2333424|NCT03220217|4057722|FG000|Overall Study|Withdrawal by Subject|0
2333425|NCT03220217|4057723|FG001|Overall Study|Withdrawal by Subject|1
2333426|NCT03220217|4057724|FG002|Overall Study|Withdrawal by Subject|0
2333427|NCT03220217|4057722|FG000|Overall Study|Subject Missed Procedure|0
2333428|NCT03220217|4057723|FG001|Overall Study|Subject Missed Procedure|0
2333429|NCT03220217|4057724|FG002|Overall Study|Subject Missed Procedure|1
2333430|NCT03220737|4057775|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4
2333431|NCT03220737|4057776|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1
2333432|NCT03220737|4057777|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4
2333433|NCT03220737|4057778|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1
2333434|NCT03220737|4057779|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4
2333435|NCT03220737|4057780|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0
2333436|NCT03220737|4057781|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0
2333437|NCT03220737|4057775|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2
2333438|NCT03220737|4057776|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1
2333439|NCT03220737|4057777|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6
2333440|NCT03220737|4057778|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1
2333441|NCT03220737|4057779|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13
2333442|NCT03220737|4057780|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1
2333443|NCT03220737|4057781|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0
2333444|NCT03220737|4057775|FG000|Main Study (Day 1 - 181)|Protocol Violation|0
2333445|NCT03220737|4057776|FG001|Main Study (Day 1 - 181)|Protocol Violation|0
2333446|NCT03220737|4057777|FG002|Main Study (Day 1 - 181)|Protocol Violation|1
2333447|NCT03220737|4057778|FG003|Main Study (Day 1 - 181)|Protocol Violation|1
2333448|NCT03220737|4057779|FG004|Main Study (Day 1 - 181)|Protocol Violation|3
2333449|NCT03220737|4057780|FG005|Main Study (Day 1 - 181)|Protocol Violation|0
2333450|NCT03220737|4057781|FG006|Main Study (Day 1 - 181)|Protocol Violation|1
2333451|NCT03220737|4057775|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
2333452|NCT03220737|4057776|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
2333453|NCT03220737|4057777|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1
2333454|NCT03220737|4057778|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
2333455|NCT03220737|4057779|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
2333456|NCT03220737|4057780|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
2333457|NCT03220737|4057781|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
2333458|NCT03220737|4057775|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
2333459|NCT03220737|4057776|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
2333460|NCT03220737|4057777|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
2333461|NCT03220737|4057778|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
2333462|NCT03220737|4057779|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2
2333463|NCT03220737|4057780|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
2333464|NCT03220737|4057781|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
2333465|NCT03220737|4057775|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1
2333466|NCT03220737|4057776|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
2333467|NCT03220737|4057777|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
2333468|NCT03220737|4057778|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
2333469|NCT03220737|4057779|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
2036661|NCT00413192|3606912|FG001|Overall Study|Disease progression|31
2036662|NCT00413192|3606913|FG002|Overall Study|Disease progression|16
2036663|NCT00413192|3606914|FG003|Overall Study|Disease progression|25
2036664|NCT00413192|3606911|FG000|Overall Study|Toxicity|3
2036665|NCT00413192|3606912|FG001|Overall Study|Toxicity|2
2036666|NCT00413192|3606913|FG002|Overall Study|Toxicity|2
2036667|NCT00413192|3606914|FG003|Overall Study|Toxicity|2
2036668|NCT00413192|3606911|FG000|Overall Study|Withdrawal by Subject|3
2036669|NCT00413192|3606912|FG001|Overall Study|Withdrawal by Subject|5
2036670|NCT00413192|3606913|FG002|Overall Study|Withdrawal by Subject|0
2036671|NCT00413192|3606914|FG003|Overall Study|Withdrawal by Subject|1
2036672|NCT00413192|3606911|FG000|Overall Study|Intercurrent illness|0
2036673|NCT00413192|3606912|FG001|Overall Study|Intercurrent illness|0
2036674|NCT00413192|3606913|FG002|Overall Study|Intercurrent illness|0
2036675|NCT00413192|3606914|FG003|Overall Study|Intercurrent illness|1
2233173|NCT01855789|3886114|FG003|1) Baseline up to Week 24|Participant Non-compliance|0
2233174|NCT01855789|3886111|FG000|1) Baseline up to Week 24|Sponsor Decision|3
2233175|NCT01855789|3886112|FG001|1) Baseline up to Week 24|Sponsor Decision|0
2233176|NCT01855789|3886113|FG002|1) Baseline up to Week 24|Sponsor Decision|0
2233177|NCT01855789|3886114|FG003|1) Baseline up to Week 24|Sponsor Decision|0
2233178|NCT01855789|3886111|FG000|1) Baseline up to Week 24|Other|4
2233179|NCT01855789|3886112|FG001|1) Baseline up to Week 24|Other|0
2233180|NCT01855789|3886113|FG002|1) Baseline up to Week 24|Other|0
2233181|NCT01855789|3886114|FG003|1) Baseline up to Week 24|Other|0
2233182|NCT01855789|3886111|FG000|2) Week 24 up to End of Study|Adverse Event|0
2233183|NCT01855789|3886112|FG001|2) Week 24 up to End of Study|Adverse Event|4
2233184|NCT01855789|3886113|FG002|2) Week 24 up to End of Study|Adverse Event|5
2233185|NCT01855789|3886114|FG003|2) Week 24 up to End of Study|Adverse Event|21
2233186|NCT01855789|3886111|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
2233187|NCT01855789|3886112|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
2233188|NCT01855789|3886113|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
2233189|NCT01855789|3886114|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
2233190|NCT01855789|3886111|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0
2233191|NCT01855789|3886112|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2
2233192|NCT01855789|3886113|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5
2233193|NCT01855789|3886114|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16
2233194|NCT01855789|3886111|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0
2233195|NCT01855789|3886112|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1
2233196|NCT01855789|3886113|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1
2233197|NCT01855789|3886114|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4
2233198|NCT01855789|3886111|FG000|2) Week 24 up to End of Study|Protocol Violation|0
2233199|NCT01855789|3886112|FG001|2) Week 24 up to End of Study|Protocol Violation|0
2233200|NCT01855789|3886113|FG002|2) Week 24 up to End of Study|Protocol Violation|0
2233201|NCT01855789|3886114|FG003|2) Week 24 up to End of Study|Protocol Violation|1
2233202|NCT01855789|3886111|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0
2233203|NCT01855789|3886112|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7
2233204|NCT01855789|3886113|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5
2233205|NCT01855789|3886114|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8
2233206|NCT01855789|3886111|FG000|2) Week 24 up to End of Study|Physician Decision|0
2233207|NCT01855789|3886112|FG001|2) Week 24 up to End of Study|Physician Decision|0
2233208|NCT01855789|3886113|FG002|2) Week 24 up to End of Study|Physician Decision|2
2233209|NCT01855789|3886114|FG003|2) Week 24 up to End of Study|Physician Decision|4
2233210|NCT01855789|3886111|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0
2233211|NCT01855789|3886112|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1
2233212|NCT01855789|3886113|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0
2233213|NCT01855789|3886114|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1
2233214|NCT01855789|3886111|FG000|2) Week 24 up to End of Study|Sponsor Decision|0
2233215|NCT01855789|3886112|FG001|2) Week 24 up to End of Study|Sponsor Decision|0
2233216|NCT01855789|3886113|FG002|2) Week 24 up to End of Study|Sponsor Decision|0
2233217|NCT01855789|3886114|FG003|2) Week 24 up to End of Study|Sponsor Decision|1
2233218|NCT01855789|3886111|FG000|2) Week 24 up to End of Study|Other|0
2233219|NCT01855789|3886112|FG001|2) Week 24 up to End of Study|Other|0
2233220|NCT01855789|3886113|FG002|2) Week 24 up to End of Study|Other|0
2233221|NCT01855789|3886114|FG003|2) Week 24 up to End of Study|Other|1
2233222|NCT01855828|3886120|FG000|Overall Study|Adverse Event|1
2233223|NCT01855828|3886120|FG000|Overall Study|Withdrawal by Subject|1
2233224|NCT01855919|3886131|FG000|Overall Study|Adverse Event|16
2233225|NCT01855919|3886132|FG001|Overall Study|Adverse Event|8
2233226|NCT01855919|3886131|FG000|Overall Study|Lack of Efficacy|1
2333470|NCT03220737|4057780|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
2333471|NCT03220737|4057781|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
2333472|NCT03220737|4057775|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9
2333473|NCT03220737|4057776|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
2333474|NCT03220737|4057777|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
2333475|NCT03220737|4057778|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
2333476|NCT03220737|4057779|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
2333477|NCT03220737|4057780|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
2333478|NCT03220737|4057781|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
2333479|NCT03220737|4057775|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1
2333480|NCT03220737|4057776|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
2333481|NCT03220737|4057777|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
2333482|NCT03220737|4057778|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
2333483|NCT03220737|4057779|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
2333484|NCT03220737|4057780|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
2333485|NCT03220737|4057781|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
2333486|NCT03221387|4057816|FG000|Overall Study|Lost to Follow-up|1
2333487|NCT03221387|4057816|FG000|Overall Study|Lung transplant|1
2333488|NCT03222141|4057848|FG000|Overall Study|Death|15
2233227|NCT01855919|3886132|FG001|Overall Study|Lack of Efficacy|3
2233228|NCT01855919|3886131|FG000|Overall Study|Withdrawal by Subject|4
2233229|NCT01855919|3886132|FG001|Overall Study|Withdrawal by Subject|10
2233230|NCT01855919|3886131|FG000|Overall Study|Entry Criteria Not Met|1
2233231|NCT01855919|3886132|FG001|Overall Study|Entry Criteria Not Met|1
2233232|NCT01855919|3886131|FG000|Overall Study|Protocol Violation|1
2233233|NCT01855919|3886132|FG001|Overall Study|Protocol Violation|4
2233234|NCT01855945|3886151|FG000|Overall Study|Adverse Event|0
2233235|NCT01855945|3886152|FG001|Overall Study|Adverse Event|0
2233236|NCT01855945|3886153|FG002|Overall Study|Adverse Event|0
2233237|NCT01855945|3886154|FG003|Overall Study|Adverse Event|0
2233238|NCT01855945|3886155|FG004|Overall Study|Adverse Event|0
2233239|NCT01855945|3886156|FG005|Overall Study|Adverse Event|0
2233240|NCT01855945|3886157|FG006|Overall Study|Adverse Event|1
2233241|NCT01855945|3886158|FG007|Overall Study|Adverse Event|0
2233242|NCT01855945|3886159|FG008|Overall Study|Adverse Event|0
2233243|NCT01855945|3886160|FG009|Overall Study|Adverse Event|0
2233244|NCT01855945|3886161|FG010|Overall Study|Adverse Event|0
2233245|NCT01855945|3886162|FG011|Overall Study|Adverse Event|0
2233246|NCT01855945|3886151|FG000|Overall Study|Death|0
2233247|NCT01855945|3886152|FG001|Overall Study|Death|0
2233248|NCT01855945|3886153|FG002|Overall Study|Death|0
2233249|NCT01855945|3886154|FG003|Overall Study|Death|0
2233250|NCT01855945|3886155|FG004|Overall Study|Death|0
2233251|NCT01855945|3886156|FG005|Overall Study|Death|0
2233252|NCT01855945|3886157|FG006|Overall Study|Death|2
2233253|NCT01855945|3886158|FG007|Overall Study|Death|0
2233254|NCT01855945|3886159|FG008|Overall Study|Death|0
2233255|NCT01855945|3886160|FG009|Overall Study|Death|0
2233256|NCT01855945|3886161|FG010|Overall Study|Death|0
2233257|NCT01855945|3886162|FG011|Overall Study|Death|0
2233258|NCT01855945|3886151|FG000|Overall Study|Lost to Follow-up|11
2233259|NCT01855945|3886152|FG001|Overall Study|Lost to Follow-up|10
2233260|NCT01855945|3886153|FG002|Overall Study|Lost to Follow-up|7
2233261|NCT01855945|3886154|FG003|Overall Study|Lost to Follow-up|3
2233262|NCT01855945|3886155|FG004|Overall Study|Lost to Follow-up|0
2233263|NCT01855945|3886156|FG005|Overall Study|Lost to Follow-up|3
2233264|NCT01855945|3886157|FG006|Overall Study|Lost to Follow-up|4
2233265|NCT01855945|3886158|FG007|Overall Study|Lost to Follow-up|7
2233266|NCT01855945|3886159|FG008|Overall Study|Lost to Follow-up|2
2233267|NCT01855945|3886160|FG009|Overall Study|Lost to Follow-up|0
2233268|NCT01855945|3886161|FG010|Overall Study|Lost to Follow-up|0
2233269|NCT01855945|3886162|FG011|Overall Study|Lost to Follow-up|2
2233270|NCT01855945|3886151|FG000|Overall Study|Other - Unclassified|1
2233271|NCT01855945|3886152|FG001|Overall Study|Other - Unclassified|1
2233272|NCT01855945|3886153|FG002|Overall Study|Other - Unclassified|1
2333489|NCT03222141|4057848|FG000|Overall Study|Lost to Follow-up|3
2333490|NCT03222349|4057853|FG000|Overall Study|Treatment B not done|5
2333491|NCT03222349|4057854|FG001|Overall Study|Treatment B not done|0
2333492|NCT03222349|4057853|FG000|Overall Study|Lost to Follow-up|1
2333493|NCT03222349|4057854|FG001|Overall Study|Lost to Follow-up|2
2333494|NCT03222349|4057853|FG000|Overall Study|Withdrawal by Subject|1
2333495|NCT03222349|4057854|FG001|Overall Study|Withdrawal by Subject|0
2333496|NCT03222349|4057853|FG000|Overall Study|Treatment A not done|0
2333497|NCT03222349|4057854|FG001|Overall Study|Treatment A not done|5
2333498|NCT03222349|4057853|FG000|Overall Study|Study terminated by sponsor|1
2333499|NCT03222349|4057854|FG001|Overall Study|Study terminated by sponsor|0
2333500|NCT03222583|4057893|FG000|Overall Study|Withdrawal by Subject|3
2333501|NCT03222583|4057894|FG001|Overall Study|Withdrawal by Subject|3
2333502|NCT03222583|4057893|FG000|Overall Study|Lost to Follow-up|1
2333503|NCT03222583|4057894|FG001|Overall Study|Lost to Follow-up|0
2333504|NCT03222583|4057893|FG000|Overall Study|Other|1
2333505|NCT03222583|4057894|FG001|Overall Study|Other|3
2333506|NCT03223909|4057942|FG000|Overall Study|Protocol Violation|48
2333507|NCT03223909|4057943|FG001|Overall Study|Protocol Violation|45
2333508|NCT03223909|4057944|FG002|Overall Study|Protocol Violation|16
2333509|NCT03224130|4057954|FG000|Overall Study|consent issue|0
2333510|NCT03224130|4057955|FG001|Overall Study|consent issue|1
2333511|NCT03224182|4057963|FG000|Overall Study|Study Drug Not Instilled|6
2333512|NCT03224182|4057964|FG001|Overall Study|Study Drug Not Instilled|1
2333513|NCT03224182|4057963|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22
2333514|NCT03224182|4057964|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11
2333515|NCT03224182|4057963|FG000|Overall Study|Withdrew of Consent|4
2333516|NCT03224182|4057964|FG001|Overall Study|Withdrew of Consent|2
2333517|NCT03224182|4057963|FG000|Overall Study|Investigator Decision|3
2333518|NCT03224182|4057964|FG001|Overall Study|Investigator Decision|1
2333519|NCT03224182|4057963|FG000|Overall Study|Sponsor Decision|26
2333520|NCT03224182|4057964|FG001|Overall Study|Sponsor Decision|12
2333521|NCT03224182|4057963|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4
2333522|NCT03224182|4057964|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0
2333523|NCT03224182|4057963|FG000|Overall Study|Lost to Follow-up|1
2333524|NCT03224182|4057964|FG001|Overall Study|Lost to Follow-up|0
2333525|NCT03224182|4057963|FG000|Overall Study|Participant Had Recurrence|11
2333526|NCT03224182|4057964|FG001|Overall Study|Participant Had Recurrence|5
2233273|NCT01855945|3886154|FG003|Overall Study|Other - Unclassified|0
2333527|NCT03224182|4057963|FG000|Overall Study|Death|0
2233274|NCT01855945|3886155|FG004|Overall Study|Other - Unclassified|0
2233275|NCT01855945|3886156|FG005|Overall Study|Other - Unclassified|0
2233276|NCT01855945|3886157|FG006|Overall Study|Other - Unclassified|2
2233277|NCT01855945|3886158|FG007|Overall Study|Other - Unclassified|1
2233278|NCT01855945|3886159|FG008|Overall Study|Other - Unclassified|0
2233279|NCT01855945|3886160|FG009|Overall Study|Other - Unclassified|0
2233280|NCT01855945|3886161|FG010|Overall Study|Other - Unclassified|1
2233281|NCT01855945|3886162|FG011|Overall Study|Other - Unclassified|0
2233282|NCT01855945|3886151|FG000|Overall Study|Withdrawal by Subject|4
2233283|NCT01855945|3886152|FG001|Overall Study|Withdrawal by Subject|0
2233284|NCT01855945|3886153|FG002|Overall Study|Withdrawal by Subject|4
2233285|NCT01855945|3886154|FG003|Overall Study|Withdrawal by Subject|1
2233286|NCT01855945|3886155|FG004|Overall Study|Withdrawal by Subject|1
2233287|NCT01855945|3886156|FG005|Overall Study|Withdrawal by Subject|0
2233288|NCT01855945|3886157|FG006|Overall Study|Withdrawal by Subject|1
2233289|NCT01855945|3886158|FG007|Overall Study|Withdrawal by Subject|0
2233290|NCT01855945|3886159|FG008|Overall Study|Withdrawal by Subject|0
2233291|NCT01855945|3886160|FG009|Overall Study|Withdrawal by Subject|2
2233292|NCT01855945|3886161|FG010|Overall Study|Withdrawal by Subject|4
2233293|NCT01855945|3886162|FG011|Overall Study|Withdrawal by Subject|1
2233294|NCT01855958|3886227|FG000|Overall Study|Withdrawal by Subject|1
2233295|NCT01855958|3886228|FG001|Overall Study|Withdrawal by Subject|0
2233296|NCT01856114|3886250|FG000|Overall Study|Withdrawal by Subject|1
2233297|NCT01856114|3886251|FG001|Overall Study|Withdrawal by Subject|0
2233298|NCT01856114|3886250|FG000|Overall Study|Adverse Event|1
2233299|NCT01856114|3886251|FG001|Overall Study|Adverse Event|0
2233300|NCT01856257|3886264|FG000|Overall Study|Death|2
2233301|NCT01856257|3886265|FG001|Overall Study|Death|0
2233302|NCT01856257|3886266|FG002|Overall Study|Death|0
2233303|NCT01856257|3886267|FG003|Overall Study|Death|0
2233304|NCT01856257|3886264|FG000|Overall Study|Physician Decision|0
2233305|NCT01856257|3886265|FG001|Overall Study|Physician Decision|0
2233306|NCT01856257|3886266|FG002|Overall Study|Physician Decision|0
2233307|NCT01856257|3886267|FG003|Overall Study|Physician Decision|1
2233308|NCT01856257|3886264|FG000|Overall Study|Withdrawal by Subject|1
2233309|NCT01856257|3886265|FG001|Overall Study|Withdrawal by Subject|1
2233310|NCT01856257|3886266|FG002|Overall Study|Withdrawal by Subject|0
2233311|NCT01856257|3886267|FG003|Overall Study|Withdrawal by Subject|0
2233312|NCT01856257|3886264|FG000|Overall Study|Donor complication|0
2233313|NCT01856257|3886265|FG001|Overall Study|Donor complication|0
2233314|NCT01856257|3886266|FG002|Overall Study|Donor complication|0
2233315|NCT01856257|3886267|FG003|Overall Study|Donor complication|1
2233316|NCT01856309|3886280|FG000|Overall Study|Death|4
2233317|NCT01856309|3886281|FG001|Overall Study|Death|6
2233318|NCT01856309|3886282|FG002|Overall Study|Death|11
2233319|NCT01856309|3886283|FG003|Overall Study|Death|6
2233320|NCT01856309|3886280|FG000|Overall Study|Lost to Follow-up|6
2233321|NCT01856309|3886281|FG001|Overall Study|Lost to Follow-up|2
2233322|NCT01856309|3886282|FG002|Overall Study|Lost to Follow-up|4
2233323|NCT01856309|3886283|FG003|Overall Study|Lost to Follow-up|8
2233324|NCT01856309|3886280|FG000|Overall Study|Withdrawal by Subject|11
2233325|NCT01856309|3886281|FG001|Overall Study|Withdrawal by Subject|13
2233326|NCT01856309|3886282|FG002|Overall Study|Withdrawal by Subject|28
2233327|NCT01856309|3886283|FG003|Overall Study|Withdrawal by Subject|26
2233328|NCT01856309|3886280|FG000|Overall Study|Other|227
2233329|NCT01856309|3886281|FG001|Overall Study|Other|225
2333528|NCT03224182|4057964|FG001|Overall Study|Death|1
2333529|NCT03224182|4057963|FG000|Overall Study|Reason not Specified|3
2333530|NCT03224182|4057964|FG001|Overall Study|Reason not Specified|3
2333531|NCT03224182|4057963|FG000|Overall Study|Other|1
2333532|NCT03224182|4057964|FG001|Overall Study|Other|0
2333533|NCT03224234|4057974|FG000|Main Study|Lost to Follow-up|5
2333534|NCT03224234|4057975|FG001|Main Study|Lost to Follow-up|5
2333535|NCT03224325|4058009|FG000|Overall Study|Adverse Event|1
2333536|NCT03224325|4058010|FG001|Overall Study|Adverse Event|0
2333537|NCT03224325|4058011|FG002|Overall Study|Adverse Event|0
2333538|NCT03224325|4058012|FG003|Overall Study|Adverse Event|0
2333539|NCT03224325|4058013|FG004|Overall Study|Adverse Event|0
2333540|NCT03224325|4058014|FG005|Overall Study|Adverse Event|0
2333541|NCT03224325|4058015|FG006|Overall Study|Adverse Event|1
2333542|NCT03224325|4058009|FG000|Overall Study|Withdrawal by Subject|0
2333543|NCT03224325|4058010|FG001|Overall Study|Withdrawal by Subject|0
2333544|NCT03224325|4058011|FG002|Overall Study|Withdrawal by Subject|0
2333545|NCT03224325|4058012|FG003|Overall Study|Withdrawal by Subject|1
2333546|NCT03224325|4058013|FG004|Overall Study|Withdrawal by Subject|0
2333547|NCT03224325|4058014|FG005|Overall Study|Withdrawal by Subject|0
2333548|NCT03224325|4058015|FG006|Overall Study|Withdrawal by Subject|0
2333549|NCT03224598|4058134|FG000|Overall Study|Lost to Follow-up|0
2333550|NCT03224598|4058135|FG001|Overall Study|Lost to Follow-up|2
2333551|NCT03224598|4058136|FG002|Overall Study|Lost to Follow-up|0
2333552|NCT03224598|4058134|FG000|Overall Study|Other|0
2333553|NCT03224598|4058135|FG001|Overall Study|Other|1
2333554|NCT03224598|4058136|FG002|Overall Study|Other|0
2333555|NCT03226249|4058184|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1
2233330|NCT01856309|3886282|FG002|Overall Study|Other|447
2233331|NCT01856309|3886283|FG003|Overall Study|Other|469
2233332|NCT01856309|3886280|FG000|Overall Study|Lack of Efficacy|14
2233333|NCT01856309|3886281|FG001|Overall Study|Lack of Efficacy|9
2233334|NCT01856309|3886282|FG002|Overall Study|Lack of Efficacy|40
2233335|NCT01856309|3886283|FG003|Overall Study|Lack of Efficacy|25
2233336|NCT01856309|3886280|FG000|Overall Study|Adverse Event|31
2233337|NCT01856309|3886281|FG001|Overall Study|Adverse Event|31
2233338|NCT01856309|3886282|FG002|Overall Study|Adverse Event|55
2233339|NCT01856309|3886283|FG003|Overall Study|Adverse Event|65
2233340|NCT01856309|3886280|FG000|Overall Study|Pregnancy|0
2233341|NCT01856309|3886281|FG001|Overall Study|Pregnancy|0
2233342|NCT01856309|3886282|FG002|Overall Study|Pregnancy|0
2233343|NCT01856309|3886283|FG003|Overall Study|Pregnancy|1
2233344|NCT01856309|3886280|FG000|Overall Study|Physician Decision|6
2233345|NCT01856309|3886281|FG001|Overall Study|Physician Decision|1
2233346|NCT01856309|3886282|FG002|Overall Study|Physician Decision|6
2233347|NCT01856309|3886283|FG003|Overall Study|Physician Decision|8
2233348|NCT01856309|3886280|FG000|Overall Study|Noncompliance With Study Drug|0
2233349|NCT01856309|3886281|FG001|Overall Study|Noncompliance With Study Drug|1
2233350|NCT01856309|3886282|FG002|Overall Study|Noncompliance With Study Drug|4
2233351|NCT01856309|3886283|FG003|Overall Study|Noncompliance With Study Drug|1
2233352|NCT01856543|3886308|FG000|Overall Study|Treatment discontinued|6
2233353|NCT01856543|3886309|FG001|Overall Study|Treatment discontinued|3
2233354|NCT01856543|3886308|FG000|Overall Study|Withdrawn before start|7
2233355|NCT01856543|3886309|FG001|Overall Study|Withdrawn before start|3
2233356|NCT01856569|3886316|FG000|Overall Study|Other|1
2233357|NCT01856569|3886316|FG000|Overall Study|Changed Site/Structure|1
2233358|NCT01856569|3886316|FG000|Overall Study|Lost to Follow-up|3
2233359|NCT01856569|3886316|FG000|Overall Study|Did not met inclusion criteria|8
2233360|NCT01856582|3886320|FG000|Overall Study|Died prior to Boost infusion|1
2233361|NCT01856595|3886333|FG000|Overall Study|Withdrawal by Subject|0
2233362|NCT01856595|3886334|FG001|Overall Study|Withdrawal by Subject|1
2233363|NCT01856595|3886335|FG002|Overall Study|Withdrawal by Subject|0
2233364|NCT01856595|3886336|FG003|Overall Study|Withdrawal by Subject|0
2233365|NCT01856595|3886337|FG004|Overall Study|Withdrawal by Subject|0
2233366|NCT01856595|3886338|FG005|Overall Study|Withdrawal by Subject|0
2233367|NCT01856595|3886339|FG006|Overall Study|Withdrawal by Subject|1
2233368|NCT01856595|3886340|FG007|Overall Study|Withdrawal by Subject|0
2233369|NCT01856595|3886341|FG008|Overall Study|Withdrawal by Subject|0
2233370|NCT01856673|3886379|FG000|Overall Study|Withdrawal by Subject|44
2233371|NCT01856673|3886380|FG001|Overall Study|Withdrawal by Subject|50
2233372|NCT01856673|3886381|FG002|Overall Study|Withdrawal by Subject|33
2233373|NCT01856673|3886379|FG000|Overall Study|Lost to Follow-up|31
2233374|NCT01856673|3886380|FG001|Overall Study|Lost to Follow-up|34
2233375|NCT01856673|3886381|FG002|Overall Study|Lost to Follow-up|0
2233376|NCT01856673|3886379|FG000|Overall Study|Unknown reasons|9
2233377|NCT01856673|3886380|FG001|Overall Study|Unknown reasons|0
2233378|NCT01856673|3886381|FG002|Overall Study|Unknown reasons|0
2233379|NCT01856673|3886379|FG000|Overall Study|Psychologist decision|1
2233380|NCT01856673|3886380|FG001|Overall Study|Psychologist decision|0
2233381|NCT01856673|3886381|FG002|Overall Study|Psychologist decision|0
2233382|NCT01856673|3886379|FG000|Overall Study|Paperwork errors|8
2233383|NCT01856673|3886380|FG001|Overall Study|Paperwork errors|0
2233384|NCT01856673|3886381|FG002|Overall Study|Paperwork errors|0
2233385|NCT01856673|3886379|FG000|Overall Study|Death|1
2233386|NCT01856673|3886380|FG001|Overall Study|Death|1
2233387|NCT01856673|3886381|FG002|Overall Study|Death|0
2233388|NCT01856673|3886379|FG000|Overall Study|Protocol Violation|1
2233389|NCT01856673|3886380|FG001|Overall Study|Protocol Violation|0
2233390|NCT01856673|3886381|FG002|Overall Study|Protocol Violation|1
2233391|NCT01856686|3886391|FG000|Overall Study|Lost to Follow-up|5
2233392|NCT01856686|3886392|FG001|Overall Study|Lost to Follow-up|11
2233393|NCT01856790|3886420|FG000|Closed Loop Control|Withdrawal by Subject|2
2233394|NCT01856790|3886420|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
2233395|NCT01856907|3886434|FG000|Overall Study|Pregnancy|0
2233396|NCT01856907|3886435|FG001|Overall Study|Pregnancy|1
2233397|NCT01856907|3886436|FG002|Overall Study|Pregnancy|0
2233398|NCT01856907|3886434|FG000|Overall Study|Pregnancy|0
2333556|NCT03226249|4058184|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29
2333557|NCT03226249|4058184|FG000|Survival Follow-up|Patients still in follow-up.|30
2333558|NCT03226275|4058192|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2333559|NCT03226275|4058193|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2333560|NCT03226275|4058194|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
2333561|NCT03226275|4058195|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2333562|NCT03226275|4058192|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2333563|NCT03226275|4058193|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2333564|NCT03226275|4058194|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2333565|NCT03226275|4058195|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1
2333566|NCT03226353|4058205|FG000|Overall Study|Withdrawal by Subject|1
2333567|NCT03226353|4058205|FG000|Overall Study|Screen Failure|5
2333568|NCT03226392|4058231|FG000|Overall Study|Protocol Deviation|1
2233399|NCT01856907|3886435|FG001|Overall Study|Pregnancy|1
2233400|NCT01856907|3886436|FG002|Overall Study|Pregnancy|0
2233401|NCT01856907|3886434|FG000|Overall Study|Withdrawal by Subject|0
2233402|NCT01856907|3886435|FG001|Overall Study|Withdrawal by Subject|1
2233403|NCT01856907|3886436|FG002|Overall Study|Withdrawal by Subject|0
2233404|NCT01857102|3886451|FG000|Period 1|No longer meets Eligibility Criteria|0
2233405|NCT01857102|3886452|FG001|Period 1|No longer meets Eligibility Criteria|2
2233406|NCT01857102|3886451|FG000|Period 1|Lost to Follow-up|0
2233407|NCT01857102|3886452|FG001|Period 1|Lost to Follow-up|3
2233408|NCT01857102|3886451|FG000|Period 1|Unsatisfactory Lens Fit|1
2233409|NCT01857102|3886452|FG001|Period 1|Unsatisfactory Lens Fit|0
2233410|NCT01857102|3886451|FG000|Period 1|Unsatisfactory Visual Response|1
2233411|NCT01857102|3886452|FG001|Period 1|Unsatisfactory Visual Response|0
2233412|NCT01857102|3886451|FG000|Period 1|Physician Decision|1
2233413|NCT01857102|3886452|FG001|Period 1|Physician Decision|0
2233414|NCT01857102|3886451|FG000|Period 2|Lens Discomfort|1
2233415|NCT01857102|3886452|FG001|Period 2|Lens Discomfort|0
2233416|NCT01857102|3886451|FG000|Period 2|Unsatisfactory Lens Fit|1
2233417|NCT01857102|3886452|FG001|Period 2|Unsatisfactory Lens Fit|0
2233418|NCT01857206|3886462|FG000|Overall Study|ADMINISTRATIVE REASON|0
2233419|NCT01857206|3886463|FG001|Overall Study|ADMINISTRATIVE REASON|1
2233420|NCT01857206|3886462|FG000|Overall Study|Lost to Follow-up|9
2233421|NCT01857206|3886463|FG001|Overall Study|Lost to Follow-up|6
2233422|NCT01857206|3886462|FG000|Overall Study|Unclassified|3
2233423|NCT01857206|3886463|FG001|Overall Study|Unclassified|3
2233424|NCT01857206|3886462|FG000|Overall Study|Withdrawal by Subject|1
2233425|NCT01857206|3886463|FG001|Overall Study|Withdrawal by Subject|0
2274513|NCT02296242|3955407|FG001|Overall Study|Lack of Efficacy|0
2274514|NCT02296242|3955408|FG002|Overall Study|Lack of Efficacy|0
2274515|NCT02296242|3955409|FG003|Overall Study|Lack of Efficacy|0
2274516|NCT02296242|3955410|FG004|Overall Study|Lack of Efficacy|3
2274517|NCT02296320|3955433|FG000|Overall Study|Withdrawal by Subject|4
2274518|NCT02296320|3955434|FG001|Overall Study|Withdrawal by Subject|0
2274519|NCT02296320|3955435|FG002|Overall Study|Withdrawal by Subject|2
2274520|NCT02296320|3955433|FG000|Overall Study|Death|24
2274521|NCT02296320|3955434|FG001|Overall Study|Death|3
2274522|NCT02296320|3955435|FG002|Overall Study|Death|27
2274523|NCT02296320|3955433|FG000|Overall Study|Lost to Follow-up|5
2274524|NCT02296320|3955434|FG001|Overall Study|Lost to Follow-up|2
2274525|NCT02296320|3955435|FG002|Overall Study|Lost to Follow-up|7
2274526|NCT02296320|3955433|FG000|Overall Study|Not treated|2
2274527|NCT02296320|3955434|FG001|Overall Study|Not treated|0
2274528|NCT02296320|3955435|FG002|Overall Study|Not treated|0
2274529|NCT02296320|3955433|FG000|Overall Study|Not - specified|0
2274530|NCT02296320|3955434|FG001|Overall Study|Not - specified|0
2274531|NCT02296320|3955435|FG002|Overall Study|Not - specified|1
2274532|NCT02296424|3955458|FG000|Part 1|New therapy for study indication|0
2274533|NCT02296424|3955459|FG001|Part 1|New therapy for study indication|1
2274534|NCT02296424|3955460|FG002|Part 1|New therapy for study indication|0
2274535|NCT02296424|3955461|FG003|Part 1|New therapy for study indication|0
2274536|NCT02296424|3955458|FG000|Part 1|Protocol Violation|0
2274537|NCT02296424|3955459|FG001|Part 1|Protocol Violation|1
2274538|NCT02296424|3955460|FG002|Part 1|Protocol Violation|0
2274539|NCT02296424|3955461|FG003|Part 1|Protocol Violation|0
2274540|NCT02296424|3955458|FG000|Part 1|Withdrawal by Subject|0
2274541|NCT02296424|3955459|FG001|Part 1|Withdrawal by Subject|2
2274542|NCT02296424|3955460|FG002|Part 1|Withdrawal by Subject|0
2274543|NCT02296424|3955461|FG003|Part 1|Withdrawal by Subject|0
2274544|NCT02296424|3955458|FG000|Part 1|Study terminated by sponsor|0
2274545|NCT02296424|3955459|FG001|Part 1|Study terminated by sponsor|1
2274546|NCT02296424|3955460|FG002|Part 1|Study terminated by sponsor|0
2274547|NCT02296424|3955461|FG003|Part 1|Study terminated by sponsor|0
2274548|NCT02296424|3955458|FG000|Part 1|Adverse Event|2
2274549|NCT02296424|3955459|FG001|Part 1|Adverse Event|11
2274550|NCT02296424|3955460|FG002|Part 1|Adverse Event|0
2274551|NCT02296424|3955461|FG003|Part 1|Adverse Event|0
2274552|NCT02296424|3955458|FG000|Part 1|Lack of Efficacy|5
2274553|NCT02296424|3955459|FG001|Part 1|Lack of Efficacy|17
2274554|NCT02296424|3955460|FG002|Part 1|Lack of Efficacy|0
2274555|NCT02296424|3955461|FG003|Part 1|Lack of Efficacy|0
2274556|NCT02296424|3955458|FG000|Part 1|16 directly started part II|16
2274557|NCT02296424|3955459|FG001|Part 1|16 directly started part II|0
2274558|NCT02296424|3955460|FG002|Part 1|16 directly started part II|0
2274559|NCT02296424|3955461|FG003|Part 1|16 directly started part II|0
2274560|NCT02296424|3955458|FG000|Part 2|Lack of Efficacy|0
2274561|NCT02296424|3955459|FG001|Part 2|Lack of Efficacy|0
2274562|NCT02296424|3955460|FG002|Part 2|Lack of Efficacy|1
2274563|NCT02296424|3955461|FG003|Part 2|Lack of Efficacy|0
2274564|NCT02296424|3955458|FG000|Part 2|Adverse Event|0
2274565|NCT02296424|3955459|FG001|Part 2|Adverse Event|0
2274566|NCT02296424|3955460|FG002|Part 2|Adverse Event|1
2274567|NCT02296424|3955461|FG003|Part 2|Adverse Event|0
2274568|NCT02296424|3955458|FG000|Part 2|Lost to Follow-up|0
2274569|NCT02296424|3955459|FG001|Part 2|Lost to Follow-up|0
2274570|NCT02296424|3955460|FG002|Part 2|Lost to Follow-up|1
2274571|NCT02296424|3955461|FG003|Part 2|Lost to Follow-up|0
2274572|NCT02296476|3955472|FG000|Overall Study|Disease Progression|6
2274573|NCT02296476|3955473|FG001|Overall Study|Disease Progression|4
2274574|NCT02296476|3955474|FG002|Overall Study|Disease Progression|2
2274575|NCT02296840|3955521|FG000|Overall Study|Adverse Event|1
2274576|NCT02296840|3955522|FG001|Overall Study|Adverse Event|1
2233426|NCT01857310|3886517|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315
2233427|NCT01857310|3886518|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282
2233428|NCT01857323|3886524|FG000|Overall Study|Adverse Event|1
2233429|NCT01857323|3886524|FG000|Overall Study|Withdrawal by Subject|3
2233430|NCT01857323|3886524|FG000|Overall Study|Non-compliance|1
2233431|NCT01857323|3886524|FG000|Overall Study|Protocol Violation|6
2233432|NCT01857323|3886524|FG000|Overall Study|Lost to Follow-up|1
2233433|NCT01857323|3886524|FG000|Overall Study|Other|4
2233434|NCT01857323|3886524|FG000|Overall Study|Did not complete 180 doses|48
2233435|NCT01857531|3886535|FG000|Overall Study|Withdrawal by Subject|4
2233436|NCT01857583|3886543|FG000|Overall Study|Adverse Event|0
2233437|NCT01857583|3886544|FG001|Overall Study|Adverse Event|0
2233438|NCT01857583|3886545|FG002|Overall Study|Adverse Event|1
2233439|NCT01857583|3886546|FG003|Overall Study|Adverse Event|1
2233440|NCT01857583|3886543|FG000|Overall Study|Death|0
2233441|NCT01857583|3886544|FG001|Overall Study|Death|1
2233442|NCT01857583|3886545|FG002|Overall Study|Death|1
2233443|NCT01857583|3886546|FG003|Overall Study|Death|0
2233444|NCT01857583|3886543|FG000|Overall Study|Physician Decision|0
2233445|NCT01857583|3886544|FG001|Overall Study|Physician Decision|0
2233446|NCT01857583|3886545|FG002|Overall Study|Physician Decision|0
2233447|NCT01857583|3886546|FG003|Overall Study|Physician Decision|1
2233448|NCT01857583|3886543|FG000|Overall Study|Withdrawal by Subject|1
2233449|NCT01857583|3886544|FG001|Overall Study|Withdrawal by Subject|0
2233450|NCT01857583|3886545|FG002|Overall Study|Withdrawal by Subject|1
2233451|NCT01857583|3886546|FG003|Overall Study|Withdrawal by Subject|2
2233452|NCT01857622|3886559|FG000|Overall Study|Adverse Event|5
2233453|NCT01857622|3886560|FG001|Overall Study|Adverse Event|0
2233454|NCT01857622|3886561|FG002|Overall Study|Adverse Event|2
2233455|NCT01857622|3886559|FG000|Overall Study|Physician Decision|1
2233456|NCT01857622|3886560|FG001|Overall Study|Physician Decision|0
2233457|NCT01857622|3886561|FG002|Overall Study|Physician Decision|0
2233458|NCT01857622|3886559|FG000|Overall Study|Protocol Violation|4
2233459|NCT01857622|3886560|FG001|Overall Study|Protocol Violation|1
2233460|NCT01857622|3886561|FG002|Overall Study|Protocol Violation|0
2333569|NCT03226392|4058232|FG001|Overall Study|Protocol Deviation|0
2333570|NCT03226392|4058231|FG000|Overall Study|Physician Decision|1
2333571|NCT03226392|4058232|FG001|Overall Study|Physician Decision|0
2333572|NCT03226392|4058231|FG000|Overall Study|Lost to Follow-up|1
2333573|NCT03226392|4058232|FG001|Overall Study|Lost to Follow-up|0
2333574|NCT03226392|4058231|FG000|Overall Study|Adverse Event|1
2333575|NCT03226392|4058232|FG001|Overall Study|Adverse Event|0
2333576|NCT03226392|4058231|FG000|Overall Study|Technical Problems|0
2333577|NCT03226392|4058232|FG001|Overall Study|Technical Problems|2
2333578|NCT03226392|4058231|FG000|Overall Study|Subject/Guardian Decision|7
2333579|NCT03226392|4058232|FG001|Overall Study|Subject/Guardian Decision|6
2333580|NCT03226769|4058255|FG000|Overall Study|Withdrawal by Subject|0
2333581|NCT03226769|4058256|FG001|Overall Study|Withdrawal by Subject|1
2333582|NCT03227445|4058271|FG000|Period 1 (28 Days)|Adverse Event|1
2333583|NCT03227445|4058272|FG001|Period 1 (28 Days)|Adverse Event|2
2333584|NCT03227445|4058273|FG002|Period 1 (28 Days)|Adverse Event|0
2333585|NCT03227445|4058274|FG003|Period 1 (28 Days)|Adverse Event|1
2333586|NCT03227445|4058271|FG000|Period 1 (28 Days)|Protocol Violation|1
2333587|NCT03227445|4058272|FG001|Period 1 (28 Days)|Protocol Violation|0
2333588|NCT03227445|4058273|FG002|Period 1 (28 Days)|Protocol Violation|0
2333589|NCT03227445|4058274|FG003|Period 1 (28 Days)|Protocol Violation|0
2333590|NCT03227445|4058271|FG000|Period 1 (28 Days)|Withdrawal by Subject|0
2333591|NCT03227445|4058272|FG001|Period 1 (28 Days)|Withdrawal by Subject|0
2333592|NCT03227445|4058273|FG002|Period 1 (28 Days)|Withdrawal by Subject|1
2333593|NCT03227445|4058274|FG003|Period 1 (28 Days)|Withdrawal by Subject|1
2333594|NCT03227445|4058271|FG000|Period 2 (28 Days)|Adverse Event|1
2333595|NCT03227445|4058272|FG001|Period 2 (28 Days)|Adverse Event|0
2333596|NCT03227445|4058273|FG002|Period 2 (28 Days)|Adverse Event|2
2333597|NCT03227445|4058274|FG003|Period 2 (28 Days)|Adverse Event|1
2333598|NCT03227445|4058271|FG000|Period 2 (28 Days)|Protocol Violation|0
2333599|NCT03227445|4058272|FG001|Period 2 (28 Days)|Protocol Violation|0
2333600|NCT03227445|4058273|FG002|Period 2 (28 Days)|Protocol Violation|0
2333601|NCT03227445|4058274|FG003|Period 2 (28 Days)|Protocol Violation|1
2333602|NCT03227445|4058271|FG000|Period 2 (28 Days)|Withdrawal by Subject|0
2333603|NCT03227445|4058272|FG001|Period 2 (28 Days)|Withdrawal by Subject|1
2333604|NCT03227445|4058273|FG002|Period 2 (28 Days)|Withdrawal by Subject|0
2333605|NCT03227445|4058274|FG003|Period 2 (28 Days)|Withdrawal by Subject|1
2333606|NCT03227692|4058285|FG000|Overall Study|Protocol Violation|1
2333607|NCT03227692|4058286|FG001|Overall Study|Protocol Violation|1
2333608|NCT03227692|4058285|FG000|Overall Study|Lost to Follow-up|4
2333609|NCT03227692|4058286|FG001|Overall Study|Lost to Follow-up|2
2333610|NCT03227692|4058285|FG000|Overall Study|Adverse Event|0
2333611|NCT03227692|4058286|FG001|Overall Study|Adverse Event|2
2333612|NCT03227861|4058292|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4
2333613|NCT03227861|4058292|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1
2333614|NCT03227861|4058292|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1
2333615|NCT03227861|4058292|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1
2333616|NCT03227861|4058292|FG000|Main Study Period (Week 0 to Week 48)|Other|5
2233461|NCT01857622|3886559|FG000|Overall Study|Withdrawal by Subject|1
2333617|NCT03227861|4058292|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55
2333618|NCT03227861|4058292|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16
2333619|NCT03227861|4058292|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6
2333620|NCT03227861|4058292|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1
2333621|NCT03227861|4058292|FG000|Extension Period (Week 48 to Week 96)|Other|2
2333622|NCT03228212|4058307|FG000|Period 1|Adverse Event|1
2333623|NCT03228212|4058308|FG001|Period 1|Adverse Event|0
2333624|NCT03228212|4058307|FG000|Period 1|no longer meets eligibility criteria|0
2333625|NCT03228212|4058308|FG001|Period 1|no longer meets eligibility criteria|1
2333626|NCT03228212|4058307|FG000|Period 2|Lost to Follow-up|1
2333627|NCT03228212|4058308|FG001|Period 2|Lost to Follow-up|0
2333628|NCT03228420|4058316|FG000|Overall Study|Lost to Follow-up|5
2333629|NCT03228420|4058317|FG001|Overall Study|Lost to Follow-up|3
2333630|NCT03228420|4058316|FG000|Overall Study|Withdrawal by Subject|10
2333631|NCT03228420|4058317|FG001|Overall Study|Withdrawal by Subject|0
2333632|NCT03228420|4058316|FG000|Overall Study|Adverse Event|5
2333633|NCT03228420|4058317|FG001|Overall Study|Adverse Event|2
2352814|NCT03736785|4103028|FG002|Overall Study|Protocol Violation|3
2352815|NCT03736785|4103026|FG000|Overall Study|Sponsor Decision|1
2352816|NCT03736785|4103027|FG001|Overall Study|Sponsor Decision|0
2352817|NCT03736785|4103028|FG002|Overall Study|Sponsor Decision|0
2352818|NCT03736785|4103026|FG000|Overall Study|Unknown/Missing data|3
2352819|NCT03736785|4103027|FG001|Overall Study|Unknown/Missing data|2
2352820|NCT03736785|4103028|FG002|Overall Study|Unknown/Missing data|1
2352821|NCT03736785|4103026|FG000|Overall Study|Withdrawal by Subject|9
2352822|NCT03736785|4103027|FG001|Overall Study|Withdrawal by Subject|6
2352823|NCT03736785|4103028|FG002|Overall Study|Withdrawal by Subject|4
2352824|NCT03736031|4103039|FG000|Overall Study|Death|2
2352825|NCT03736031|4103040|FG001|Overall Study|Death|4
2352826|NCT03736031|4103039|FG000|Overall Study|Lost to Follow-up|21
2352827|NCT03736031|4103040|FG001|Overall Study|Lost to Follow-up|2
2352828|NCT03736031|4103039|FG000|Overall Study|Withdrawal by Subject|9
2352829|NCT03736031|4103040|FG001|Overall Study|Withdrawal by Subject|0
2352830|NCT03734991|4103052|FG000|Overall Study|Adverse Event|4
2352831|NCT03734991|4103053|FG001|Overall Study|Adverse Event|0
2352832|NCT03734991|4103052|FG000|Overall Study|Lost to Follow-up|4
2352833|NCT03734991|4103053|FG001|Overall Study|Lost to Follow-up|0
2352834|NCT03734991|4103052|FG000|Overall Study|Physician Decision|0
2352835|NCT03734991|4103053|FG001|Overall Study|Physician Decision|1
2352836|NCT03734991|4103052|FG000|Overall Study|Pregnancy|1
2352837|NCT03734991|4103053|FG001|Overall Study|Pregnancy|0
2352838|NCT03734991|4103052|FG000|Overall Study|Withdrawal by Subject|6
2352839|NCT03734991|4103053|FG001|Overall Study|Withdrawal by Subject|3
2352840|NCT03734991|4103052|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49
2352841|NCT03734991|4103053|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41
2352842|NCT03734991|4103052|FG000|Overall Study|Other|2
2352843|NCT03734991|4103053|FG001|Overall Study|Other|2
2352844|NCT03733899|4103067|FG000|Period 1|Protocol Violation|0
2352845|NCT03733899|4103068|FG001|Period 1|Protocol Violation|0
2352846|NCT03733899|4103069|FG002|Period 1|Protocol Violation|0
2352847|NCT03733899|4103070|FG003|Period 1|Protocol Violation|0
2352848|NCT03733899|4103071|FG004|Period 1|Protocol Violation|0
2352849|NCT03733899|4103072|FG005|Period 1|Protocol Violation|1
2352850|NCT03733899|4103067|FG000|Period 2|Unscuccessful Treatment|0
2352851|NCT03733899|4103068|FG001|Period 2|Unscuccessful Treatment|1
2352852|NCT03733899|4103069|FG002|Period 2|Unscuccessful Treatment|0
2352853|NCT03733899|4103070|FG003|Period 2|Unscuccessful Treatment|0
2352854|NCT03733899|4103071|FG004|Period 2|Unscuccessful Treatment|0
2352855|NCT03733899|4103072|FG005|Period 2|Unscuccessful Treatment|0
2352856|NCT03733899|4103067|FG000|Period 3|Withdrawal by Subject|1
2352857|NCT03733899|4103068|FG001|Period 3|Withdrawal by Subject|0
2352858|NCT03733899|4103069|FG002|Period 3|Withdrawal by Subject|0
2352859|NCT03733899|4103070|FG003|Period 3|Withdrawal by Subject|0
2352860|NCT03733899|4103071|FG004|Period 3|Withdrawal by Subject|0
2352861|NCT03733899|4103072|FG005|Period 3|Withdrawal by Subject|0
2352862|NCT03733470|4103091|FG000|Overall Study|PI Decision|1
2352863|NCT03733470|4103092|FG001|Overall Study|PI Decision|1
2352864|NCT03733301|4103101|FG000|Overall Study|Screen Fail|1
2352865|NCT03733301|4103102|FG001|Overall Study|Screen Fail|0
2352866|NCT03733301|4103103|FG002|Overall Study|Screen Fail|0
2352867|NCT03733301|4103101|FG000|Overall Study|Non-compliance|1
2352868|NCT03733301|4103102|FG001|Overall Study|Non-compliance|0
2352869|NCT03733301|4103103|FG002|Overall Study|Non-compliance|0
2352870|NCT03733301|4103101|FG000|Overall Study|Lack of Efficacy|2
2352871|NCT03733301|4103102|FG001|Overall Study|Lack of Efficacy|3
2352872|NCT03733301|4103103|FG002|Overall Study|Lack of Efficacy|0
2352873|NCT03733301|4103101|FG000|Overall Study|Adverse Event|0
2352874|NCT03733301|4103102|FG001|Overall Study|Adverse Event|1
2352875|NCT03733301|4103103|FG002|Overall Study|Adverse Event|3
2352876|NCT03733301|4103101|FG000|Overall Study|Withdrawal by Subject|3
2352877|NCT03733301|4103102|FG001|Overall Study|Withdrawal by Subject|5
2352878|NCT03733301|4103103|FG002|Overall Study|Withdrawal by Subject|1
2352879|NCT03732638|4103114|FG000|Overall Study|Adverse Event|5
2352880|NCT03732638|4103115|FG001|Overall Study|Adverse Event|2
2352881|NCT03732638|4103114|FG000|Overall Study|Eligibility failure due to baseline laboratory values|8
2233462|NCT01857622|3886560|FG001|Overall Study|Withdrawal by Subject|0
2233463|NCT01857622|3886561|FG002|Overall Study|Withdrawal by Subject|0
2233464|NCT01857869|3886585|FG000|Primary/Challenge Phase|Lost to Follow-up|2
2233465|NCT01857869|3886586|FG001|Primary/Challenge Phase|Lost to Follow-up|0
2233466|NCT01857869|3886587|FG002|Primary/Challenge Phase|Lost to Follow-up|0
2233467|NCT01857869|3886588|FG003|Primary/Challenge Phase|Lost to Follow-up|0
2233468|NCT01857869|3886589|FG004|Primary/Challenge Phase|Lost to Follow-up|0
2233469|NCT01857869|3886590|FG005|Primary/Challenge Phase|Lost to Follow-up|0
2233470|NCT01857869|3886591|FG006|Primary/Challenge Phase|Lost to Follow-up|0
2233471|NCT01857869|3886592|FG007|Primary/Challenge Phase|Lost to Follow-up|0
2233472|NCT01857869|3886593|FG008|Primary/Challenge Phase|Lost to Follow-up|0
2233473|NCT01857869|3886594|FG009|Primary/Challenge Phase|Lost to Follow-up|0
2233474|NCT01857869|3886585|FG000|Primary/Challenge Phase|Pregnancy|1
2233475|NCT01857869|3886586|FG001|Primary/Challenge Phase|Pregnancy|0
2233476|NCT01857869|3886587|FG002|Primary/Challenge Phase|Pregnancy|0
2233477|NCT01857869|3886588|FG003|Primary/Challenge Phase|Pregnancy|0
2233478|NCT01857869|3886589|FG004|Primary/Challenge Phase|Pregnancy|0
2233479|NCT01857869|3886590|FG005|Primary/Challenge Phase|Pregnancy|0
2233480|NCT01857869|3886591|FG006|Primary/Challenge Phase|Pregnancy|0
2233481|NCT01857869|3886592|FG007|Primary/Challenge Phase|Pregnancy|0
2233482|NCT01857869|3886593|FG008|Primary/Challenge Phase|Pregnancy|0
2233483|NCT01857869|3886594|FG009|Primary/Challenge Phase|Pregnancy|0
2233484|NCT01857869|3886585|FG000|Primary/Challenge Phase|Protocol Violation|1
2233485|NCT01857869|3886586|FG001|Primary/Challenge Phase|Protocol Violation|0
2233486|NCT01857869|3886587|FG002|Primary/Challenge Phase|Protocol Violation|0
2233487|NCT01857869|3886588|FG003|Primary/Challenge Phase|Protocol Violation|0
2233488|NCT01857869|3886589|FG004|Primary/Challenge Phase|Protocol Violation|0
2233489|NCT01857869|3886590|FG005|Primary/Challenge Phase|Protocol Violation|0
2233490|NCT01857869|3886591|FG006|Primary/Challenge Phase|Protocol Violation|0
2233491|NCT01857869|3886592|FG007|Primary/Challenge Phase|Protocol Violation|0
2233492|NCT01857869|3886593|FG008|Primary/Challenge Phase|Protocol Violation|0
2233493|NCT01857869|3886594|FG009|Primary/Challenge Phase|Protocol Violation|0
2233494|NCT01857869|3886585|FG000|Primary/Challenge Phase|Other|1
2233495|NCT01857869|3886586|FG001|Primary/Challenge Phase|Other|1
2233496|NCT01857869|3886587|FG002|Primary/Challenge Phase|Other|0
2233497|NCT01857869|3886588|FG003|Primary/Challenge Phase|Other|0
2233498|NCT01857869|3886589|FG004|Primary/Challenge Phase|Other|0
2233499|NCT01857869|3886590|FG005|Primary/Challenge Phase|Other|0
2233500|NCT01857869|3886591|FG006|Primary/Challenge Phase|Other|0
2233501|NCT01857869|3886592|FG007|Primary/Challenge Phase|Other|0
2233502|NCT01857869|3886593|FG008|Primary/Challenge Phase|Other|0
2233503|NCT01857869|3886594|FG009|Primary/Challenge Phase|Other|0
2233504|NCT01857869|3886585|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0
2233505|NCT01857869|3886586|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0
2233506|NCT01857869|3886587|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0
2233507|NCT01857869|3886588|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1
2233508|NCT01857869|3886589|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0
2233509|NCT01857869|3886590|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0
2233510|NCT01857869|3886591|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0
2233511|NCT01857869|3886592|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0
2233512|NCT01857869|3886593|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0
2233513|NCT01857869|3886594|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0
2233514|NCT01857869|3886585|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2233515|NCT01857869|3886586|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2233516|NCT01857869|3886587|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2233517|NCT01857869|3886588|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
2233518|NCT01857869|3886589|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2233519|NCT01857869|3886590|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2233520|NCT01857869|3886591|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2233521|NCT01857869|3886592|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2233522|NCT01857869|3886593|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2333634|NCT03228433|4058329|FG000|Overall Study|Lost to Follow-up|1
2333635|NCT03228433|4058330|FG001|Overall Study|Lost to Follow-up|0
2333636|NCT03228433|4058331|FG002|Overall Study|Lost to Follow-up|0
2333637|NCT03228433|4058332|FG003|Overall Study|Lost to Follow-up|0
2333638|NCT03228433|4058333|FG004|Overall Study|Lost to Follow-up|0
2333639|NCT03228433|4058334|FG005|Overall Study|Lost to Follow-up|0
2333640|NCT03228433|4058329|FG000|Overall Study|Positive alcohol test|0
2333641|NCT03228433|4058330|FG001|Overall Study|Positive alcohol test|0
2333642|NCT03228433|4058331|FG002|Overall Study|Positive alcohol test|0
2333643|NCT03228433|4058332|FG003|Overall Study|Positive alcohol test|1
2333644|NCT03228433|4058333|FG004|Overall Study|Positive alcohol test|0
2333645|NCT03228433|4058334|FG005|Overall Study|Positive alcohol test|0
2333646|NCT03228836|4058356|FG000|Overall Study|Adverse Event|3
2233523|NCT01857869|3886594|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2233524|NCT01857973|3886626|FG000|Overall Study|Subject did not meet required BG range|3
2233525|NCT01857973|3886626|FG000|Overall Study|drop out after 3 failed attempts|1
2233526|NCT01857973|3886626|FG000|Overall Study|Physician Decision|1
2233527|NCT01858194|3886641|FG000|Overall Study|Total Artificial Heart Implant|0
2233528|NCT01858194|3886642|FG001|Overall Study|Total Artificial Heart Implant|1
2233529|NCT01858194|3886641|FG000|Overall Study|Lost to Follow-up|0
2233530|NCT01858194|3886642|FG001|Overall Study|Lost to Follow-up|1
2233531|NCT01858363|3886652|FG000|Overall Study|Death|35
2233532|NCT01858363|3886653|FG001|Overall Study|Death|9
2233533|NCT01858363|3886652|FG000|Overall Study|Withdrawal by Subject|28
2233534|NCT01858363|3886653|FG001|Overall Study|Withdrawal by Subject|14
2233535|NCT01858363|3886652|FG000|Overall Study|Lost to Follow-up|13
2233536|NCT01858363|3886653|FG001|Overall Study|Lost to Follow-up|3
2233537|NCT01858376|3886659|FG000|Overall Study|Dropped d/t lab work not fitting criter|4
2233538|NCT01858389|3886665|FG000|Overall Study|Death|1
2233539|NCT01858389|3886666|FG001|Overall Study|Death|3
2233540|NCT01858389|3886665|FG000|Overall Study|Study terminated by sponsor|0
2233541|NCT01858389|3886666|FG001|Overall Study|Study terminated by sponsor|2
2233542|NCT01858389|3886665|FG000|Overall Study|Withdrawal by Subject|0
2233543|NCT01858389|3886666|FG001|Overall Study|Withdrawal by Subject|1
2233544|NCT01858389|3886665|FG000|Overall Study|Progressive disease|10
2233545|NCT01858389|3886666|FG001|Overall Study|Progressive disease|11
2233546|NCT01858389|3886665|FG000|Overall Study|Other|2
2233547|NCT01858389|3886666|FG001|Overall Study|Other|4
2233548|NCT01858389|3886665|FG000|Overall Study|Adverse Event|3
2233549|NCT01858389|3886666|FG001|Overall Study|Adverse Event|1
2233550|NCT01858389|3886665|FG000|Overall Study|Did not receive treatment|0
2233551|NCT01858389|3886666|FG001|Overall Study|Did not receive treatment|3
2233552|NCT01858532|3886687|FG000|Overall Study|Adverse Event|58
2233553|NCT01858532|3886688|FG001|Overall Study|Adverse Event|50
2233554|NCT01858532|3886689|FG002|Overall Study|Adverse Event|23
2233555|NCT01858532|3886690|FG003|Overall Study|Adverse Event|28
2233556|NCT01858532|3886687|FG000|Overall Study|Withdrew consent|71
2233557|NCT01858532|3886688|FG001|Overall Study|Withdrew consent|93
2233558|NCT01858532|3886689|FG002|Overall Study|Withdrew consent|46
2233559|NCT01858532|3886690|FG003|Overall Study|Withdrew consent|27
2333647|NCT03228836|4058356|FG000|Overall Study|Withdrawal by Subject|1
2333648|NCT03228836|4058356|FG000|Overall Study|Death|1
2333649|NCT03228836|4058356|FG000|Overall Study|Physician Decision|1
2333650|NCT03228836|4058356|FG000|Overall Study|Disease Progression|7
2333651|NCT03228836|4058356|FG000|Overall Study|Other|4
2333652|NCT03229109|4058371|FG000|Overall Study|Withdrawal by Subject|0
2333653|NCT03229109|4058372|FG001|Overall Study|Withdrawal by Subject|0
2333654|NCT03229109|4058373|FG002|Overall Study|Withdrawal by Subject|0
2333655|NCT03229109|4058374|FG003|Overall Study|Withdrawal by Subject|1
2333656|NCT03229486|4058399|FG000|Overall Study|Protocol Violation|0
2333657|NCT03229486|4058400|FG001|Overall Study|Protocol Violation|1
2333658|NCT03229759|4058406|FG000|Overall Study|Screen Failure|30
2333659|NCT03230864|4058419|FG000|Prospective Confirmation (PC) Period|Adverse Event|3
2333660|NCT03230864|4058420|FG001|Prospective Confirmation (PC) Period|Adverse Event|0
2333661|NCT03230864|4058421|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
2333662|NCT03230864|4058422|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
2333663|NCT03230864|4058419|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2333664|NCT03230864|4058420|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2
2333665|NCT03230864|4058421|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2333666|NCT03230864|4058422|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2333667|NCT03230864|4058419|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1
2333668|NCT03230864|4058420|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2
2333669|NCT03230864|4058421|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
2333670|NCT03230864|4058422|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
2333671|NCT03230864|4058419|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
2333672|NCT03230864|4058420|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
2333673|NCT03230864|4058421|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2333674|NCT03230864|4058422|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2333675|NCT03230864|4058419|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
2333676|NCT03230864|4058420|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
2333677|NCT03230864|4058421|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
2333678|NCT03230864|4058422|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
2333679|NCT03230864|4058419|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9
2333680|NCT03230864|4058420|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9
2333681|NCT03230864|4058421|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0
2333682|NCT03230864|4058422|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0
2333683|NCT03230864|4058419|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1
2233560|NCT01858532|3886687|FG000|Overall Study|Lost to Follow-up|17
2233561|NCT01858532|3886688|FG001|Overall Study|Lost to Follow-up|26
2233562|NCT01858532|3886689|FG002|Overall Study|Lost to Follow-up|11
2233563|NCT01858532|3886690|FG003|Overall Study|Lost to Follow-up|14
2233564|NCT01858532|3886687|FG000|Overall Study|Deterioration of medical status|3
2233565|NCT01858532|3886688|FG001|Overall Study|Deterioration of medical status|4
2233566|NCT01858532|3886689|FG002|Overall Study|Deterioration of medical status|3
2233567|NCT01858532|3886690|FG003|Overall Study|Deterioration of medical status|7
2233568|NCT01858532|3886687|FG000|Overall Study|Investigator request|3
2233569|NCT01858532|3886688|FG001|Overall Study|Investigator request|4
2233570|NCT01858532|3886689|FG002|Overall Study|Investigator request|2
2233571|NCT01858532|3886690|FG003|Overall Study|Investigator request|6
2233572|NCT01858532|3886687|FG000|Overall Study|Other, not specified|29
2233573|NCT01858532|3886688|FG001|Overall Study|Other, not specified|15
2233574|NCT01858532|3886689|FG002|Overall Study|Other, not specified|13
2233575|NCT01858532|3886690|FG003|Overall Study|Other, not specified|11
2233576|NCT01858558|3886711|FG000|Overall Study|Death|1
2233577|NCT01858558|3886712|FG001|Overall Study|Death|1
2233578|NCT01858558|3886711|FG000|Overall Study|Lost to Follow-up|1
2233579|NCT01858558|3886712|FG001|Overall Study|Lost to Follow-up|0
2233580|NCT01858558|3886711|FG000|Overall Study|Disease progression|3
2233581|NCT01858558|3886712|FG001|Overall Study|Disease progression|1
2233582|NCT01858558|3886711|FG000|Overall Study|Product contamination|2
2233583|NCT01858558|3886712|FG001|Overall Study|Product contamination|0
2233584|NCT01858558|3886711|FG000|Overall Study|Failed expansion of cell product|2
2233585|NCT01858558|3886712|FG001|Overall Study|Failed expansion of cell product|0
2233586|NCT01858636|3886718|FG000|Overall Study|No Device Deployment Attempted|24
2233587|NCT01858636|3886718|FG000|Overall Study|Physician Decision|1
2233588|NCT01858636|3886718|FG000|Overall Study|Death|1
2233589|NCT01858636|3886718|FG000|Overall Study|Lost to Follow-up|1
2233590|NCT01858636|3886718|FG000|Overall Study|Withdrawal by Subject|1
2233591|NCT01858701|3886723|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
2233592|NCT01858701|3886724|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
2233593|NCT01858701|3886723|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
2233594|NCT01858701|3886724|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
2233595|NCT01858701|3886723|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1
2233596|NCT01858701|3886724|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2
2233597|NCT01858701|3886723|FG000|Period 2, Second 30 Days of Wear|Comfort|0
2233598|NCT01858701|3886724|FG001|Period 2, Second 30 Days of Wear|Comfort|1
2233599|NCT01858766|3886758|FG000|Overall Study|Randomized but Never Treated|0
2233600|NCT01858766|3886759|FG001|Overall Study|Randomized but Never Treated|0
2233601|NCT01858766|3886760|FG002|Overall Study|Randomized but Never Treated|0
2233602|NCT01858766|3886761|FG003|Overall Study|Randomized but Never Treated|0
2233603|NCT01858766|3886762|FG004|Overall Study|Randomized but Never Treated|0
2233604|NCT01858766|3886763|FG005|Overall Study|Randomized but Never Treated|1
2233605|NCT01858766|3886764|FG006|Overall Study|Randomized but Never Treated|0
2233606|NCT01858766|3886765|FG007|Overall Study|Randomized but Never Treated|0
2233607|NCT01858766|3886766|FG008|Overall Study|Randomized but Never Treated|0
2233608|NCT01858766|3886767|FG009|Overall Study|Randomized but Never Treated|0
2233609|NCT01858766|3886768|FG010|Overall Study|Randomized but Never Treated|0
2233610|NCT01858766|3886769|FG011|Overall Study|Randomized but Never Treated|0
2233611|NCT01858766|3886770|FG012|Overall Study|Randomized but Never Treated|0
2233612|NCT01858766|3886771|FG013|Overall Study|Randomized but Never Treated|0
2233613|NCT01858766|3886772|FG014|Overall Study|Randomized but Never Treated|0
2233614|NCT01858766|3886773|FG015|Overall Study|Randomized but Never Treated|0
2233615|NCT01858766|3886774|FG016|Overall Study|Randomized but Never Treated|0
2233616|NCT01858766|3886775|FG017|Overall Study|Randomized but Never Treated|1
2233617|NCT01858766|3886776|FG018|Overall Study|Randomized but Never Treated|0
2233618|NCT01858766|3886758|FG000|Overall Study|Death|0
2233619|NCT01858766|3886759|FG001|Overall Study|Death|0
2233620|NCT01858766|3886760|FG002|Overall Study|Death|1
2233621|NCT01858766|3886761|FG003|Overall Study|Death|0
2233622|NCT01858766|3886762|FG004|Overall Study|Death|0
2233623|NCT01858766|3886763|FG005|Overall Study|Death|0
2233624|NCT01858766|3886764|FG006|Overall Study|Death|0
2233625|NCT01858766|3886765|FG007|Overall Study|Death|0
2233626|NCT01858766|3886766|FG008|Overall Study|Death|0
2233627|NCT01858766|3886767|FG009|Overall Study|Death|0
2233628|NCT01858766|3886768|FG010|Overall Study|Death|0
2233629|NCT01858766|3886769|FG011|Overall Study|Death|0
2233630|NCT01858766|3886770|FG012|Overall Study|Death|0
2233631|NCT01858766|3886771|FG013|Overall Study|Death|0
2233632|NCT01858766|3886772|FG014|Overall Study|Death|0
2233633|NCT01858766|3886773|FG015|Overall Study|Death|0
2233634|NCT01858766|3886774|FG016|Overall Study|Death|0
2233635|NCT01858766|3886775|FG017|Overall Study|Death|0
2233636|NCT01858766|3886776|FG018|Overall Study|Death|0
2233637|NCT01858766|3886758|FG000|Overall Study|Lack of Efficacy|1
2233638|NCT01858766|3886759|FG001|Overall Study|Lack of Efficacy|0
2233639|NCT01858766|3886760|FG002|Overall Study|Lack of Efficacy|0
2233640|NCT01858766|3886761|FG003|Overall Study|Lack of Efficacy|0
2233641|NCT01858766|3886762|FG004|Overall Study|Lack of Efficacy|1
2233642|NCT01858766|3886763|FG005|Overall Study|Lack of Efficacy|2
2233643|NCT01858766|3886764|FG006|Overall Study|Lack of Efficacy|0
2233644|NCT01858766|3886765|FG007|Overall Study|Lack of Efficacy|0
2233645|NCT01858766|3886766|FG008|Overall Study|Lack of Efficacy|0
2233646|NCT01858766|3886767|FG009|Overall Study|Lack of Efficacy|0
2233647|NCT01858766|3886768|FG010|Overall Study|Lack of Efficacy|0
2233648|NCT01858766|3886769|FG011|Overall Study|Lack of Efficacy|3
2233649|NCT01858766|3886770|FG012|Overall Study|Lack of Efficacy|5
2233650|NCT01858766|3886771|FG013|Overall Study|Lack of Efficacy|3
2233651|NCT01858766|3886772|FG014|Overall Study|Lack of Efficacy|5
2233652|NCT01858766|3886773|FG015|Overall Study|Lack of Efficacy|5
2233653|NCT01858766|3886774|FG016|Overall Study|Lack of Efficacy|2
2233654|NCT01858766|3886775|FG017|Overall Study|Lack of Efficacy|3
2233655|NCT01858766|3886776|FG018|Overall Study|Lack of Efficacy|3
2233656|NCT01858766|3886758|FG000|Overall Study|Lost to Follow-up|0
2233657|NCT01858766|3886759|FG001|Overall Study|Lost to Follow-up|0
2233658|NCT01858766|3886760|FG002|Overall Study|Lost to Follow-up|0
2233659|NCT01858766|3886761|FG003|Overall Study|Lost to Follow-up|0
2233660|NCT01858766|3886762|FG004|Overall Study|Lost to Follow-up|0
2233661|NCT01858766|3886763|FG005|Overall Study|Lost to Follow-up|1
2233662|NCT01858766|3886764|FG006|Overall Study|Lost to Follow-up|0
2233663|NCT01858766|3886765|FG007|Overall Study|Lost to Follow-up|2
2233664|NCT01858766|3886766|FG008|Overall Study|Lost to Follow-up|0
2233665|NCT01858766|3886767|FG009|Overall Study|Lost to Follow-up|0
2233666|NCT01858766|3886768|FG010|Overall Study|Lost to Follow-up|0
2233667|NCT01858766|3886769|FG011|Overall Study|Lost to Follow-up|1
2233668|NCT01858766|3886770|FG012|Overall Study|Lost to Follow-up|0
2233669|NCT01858766|3886771|FG013|Overall Study|Lost to Follow-up|0
2233670|NCT01858766|3886772|FG014|Overall Study|Lost to Follow-up|3
2233671|NCT01858766|3886773|FG015|Overall Study|Lost to Follow-up|1
2233672|NCT01858766|3886774|FG016|Overall Study|Lost to Follow-up|1
2233673|NCT01858766|3886775|FG017|Overall Study|Lost to Follow-up|0
2333684|NCT03230864|4058420|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0
2333685|NCT03230864|4058421|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0
2333686|NCT03230864|4058422|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0
2333687|NCT03230864|4058419|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0
2333688|NCT03230864|4058420|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0
2333689|NCT03230864|4058421|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5
2333690|NCT03230864|4058422|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1
2333691|NCT03230864|4058419|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
2333692|NCT03230864|4058420|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
2333693|NCT03230864|4058421|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
2333694|NCT03230864|4058422|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
2333695|NCT03230864|4058419|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0
2333696|NCT03230864|4058420|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0
2333697|NCT03230864|4058421|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2
2333698|NCT03230864|4058422|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0
2333699|NCT03231228|4058434|FG000|Overall Study|Lost to Follow-up|2
2333700|NCT03231228|4058435|FG001|Overall Study|Lost to Follow-up|0
2333701|NCT03231228|4058434|FG000|Overall Study|Physician Decision|1
2333702|NCT03231228|4058435|FG001|Overall Study|Physician Decision|0
2333703|NCT03231371|4058445|FG000|Overall Study|Withdrawal by Subject|1
2333704|NCT03231371|4058445|FG000|Overall Study|chose or were ineligible to have MRI|12
2333705|NCT03231709|4058451|FG000|Treatment Period 1|Reason not Specified|0
2333706|NCT03231709|4058452|FG001|Treatment Period 1|Reason not Specified|1
2333707|NCT03231709|4058451|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0
2333708|NCT03231709|4058452|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1
2333709|NCT03231800|4058464|FG000|Overall Study|Lost to Follow-up|0
2333710|NCT03231800|4058465|FG001|Overall Study|Lost to Follow-up|2
2333711|NCT03231800|4058464|FG000|Overall Study|Protocol Violation|1
2333712|NCT03231800|4058465|FG001|Overall Study|Protocol Violation|1
2333713|NCT03231800|4058464|FG000|Overall Study|reason not provided|2
2333714|NCT03231800|4058465|FG001|Overall Study|reason not provided|0
2333715|NCT03231943|4058487|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2333716|NCT03231943|4058488|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1
2333717|NCT03231943|4058489|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1
2333718|NCT03231943|4058490|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2333719|NCT03231943|4058491|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2333720|NCT03231943|4058492|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2333721|NCT03231943|4058493|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2333722|NCT03231943|4058494|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2333723|NCT03231943|4058495|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2333724|NCT03231943|4058496|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2333725|NCT03231943|4058497|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2333726|NCT03231943|4058498|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2333727|NCT03231943|4058499|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2333728|NCT03231943|4058487|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2333729|NCT03231943|4058488|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
2333730|NCT03231943|4058489|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2333731|NCT03231943|4058490|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2333732|NCT03231943|4058491|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2233674|NCT01858766|3886776|FG018|Overall Study|Lost to Follow-up|1
2233675|NCT01858766|3886758|FG000|Overall Study|Withdrew Consent|0
2233676|NCT01858766|3886759|FG001|Overall Study|Withdrew Consent|0
2233677|NCT01858766|3886760|FG002|Overall Study|Withdrew Consent|0
2233678|NCT01858766|3886761|FG003|Overall Study|Withdrew Consent|0
2233679|NCT01858766|3886762|FG004|Overall Study|Withdrew Consent|0
2233680|NCT01858766|3886763|FG005|Overall Study|Withdrew Consent|0
2233681|NCT01858766|3886764|FG006|Overall Study|Withdrew Consent|0
2233682|NCT01858766|3886765|FG007|Overall Study|Withdrew Consent|0
2233683|NCT01858766|3886766|FG008|Overall Study|Withdrew Consent|0
2233684|NCT01858766|3886767|FG009|Overall Study|Withdrew Consent|0
2233685|NCT01858766|3886768|FG010|Overall Study|Withdrew Consent|0
2233686|NCT01858766|3886769|FG011|Overall Study|Withdrew Consent|1
2233687|NCT01858766|3886770|FG012|Overall Study|Withdrew Consent|0
2233688|NCT01858766|3886771|FG013|Overall Study|Withdrew Consent|0
2233689|NCT01858766|3886772|FG014|Overall Study|Withdrew Consent|0
2233690|NCT01858766|3886773|FG015|Overall Study|Withdrew Consent|0
2233691|NCT01858766|3886774|FG016|Overall Study|Withdrew Consent|0
2233692|NCT01858766|3886775|FG017|Overall Study|Withdrew Consent|0
2233693|NCT01858766|3886776|FG018|Overall Study|Withdrew Consent|0
2233694|NCT01859143|3886826|FG000|Overall Study|Lost to Follow-up|2
2233695|NCT01859143|3886827|FG001|Overall Study|Lost to Follow-up|0
2233696|NCT01859390|3886896|FG000|Overall Study|Insufficient Sputum Collected|1
2233697|NCT01859390|3886897|FG001|Overall Study|Insufficient Sputum Collected|3
2233698|NCT01859390|3886896|FG000|Overall Study|Sample Missing Collection Date|0
2233699|NCT01859390|3886897|FG001|Overall Study|Sample Missing Collection Date|1
2233700|NCT01859390|3886896|FG000|Overall Study|Tube Cracked|0
2233701|NCT01859390|3886897|FG001|Overall Study|Tube Cracked|2
2233702|NCT01859390|3886896|FG000|Overall Study|Shipment Error|0
2333733|NCT03231943|4058492|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2333734|NCT03231943|4058493|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2333735|NCT03231943|4058494|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2333736|NCT03231943|4058495|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2333737|NCT03231943|4058496|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2333738|NCT03231943|4058497|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2333739|NCT03231943|4058498|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2333740|NCT03231943|4058499|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2333741|NCT03231943|4058487|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1
2333742|NCT03231943|4058488|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333743|NCT03231943|4058489|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333744|NCT03231943|4058490|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333745|NCT03231943|4058491|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333746|NCT03231943|4058492|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333747|NCT03231943|4058493|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333748|NCT03231943|4058494|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333749|NCT03231943|4058495|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333750|NCT03231943|4058496|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333751|NCT03231943|4058497|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333752|NCT03231943|4058498|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333753|NCT03231943|4058499|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2333754|NCT03231943|4058487|FG000|Part 2|Adverse Event|0
2333755|NCT03231943|4058488|FG001|Part 2|Adverse Event|0
2333756|NCT03231943|4058489|FG002|Part 2|Adverse Event|0
2333757|NCT03231943|4058490|FG003|Part 2|Adverse Event|0
2333758|NCT03231943|4058491|FG004|Part 2|Adverse Event|0
2333759|NCT03231943|4058492|FG005|Part 2|Adverse Event|0
2333760|NCT03231943|4058493|FG006|Part 2|Adverse Event|0
2333761|NCT03231943|4058494|FG007|Part 2|Adverse Event|0
2333762|NCT03231943|4058495|FG008|Part 2|Adverse Event|0
2333763|NCT03231943|4058496|FG009|Part 2|Adverse Event|0
2333764|NCT03231943|4058497|FG010|Part 2|Adverse Event|1
2333765|NCT03231943|4058498|FG011|Part 2|Adverse Event|0
2333766|NCT03231943|4058499|FG012|Part 2|Adverse Event|0
2333767|NCT03231943|4058487|FG000|Part 2|Withdrawal by Subject|0
2333768|NCT03231943|4058488|FG001|Part 2|Withdrawal by Subject|0
2333769|NCT03231943|4058489|FG002|Part 2|Withdrawal by Subject|0
2333770|NCT03231943|4058490|FG003|Part 2|Withdrawal by Subject|0
2333771|NCT03231943|4058491|FG004|Part 2|Withdrawal by Subject|0
2333772|NCT03231943|4058492|FG005|Part 2|Withdrawal by Subject|0
2333773|NCT03231943|4058493|FG006|Part 2|Withdrawal by Subject|0
2333774|NCT03231943|4058494|FG007|Part 2|Withdrawal by Subject|0
2333775|NCT03231943|4058495|FG008|Part 2|Withdrawal by Subject|0
2333776|NCT03231943|4058496|FG009|Part 2|Withdrawal by Subject|0
2333777|NCT03231943|4058497|FG010|Part 2|Withdrawal by Subject|0
2333778|NCT03231943|4058498|FG011|Part 2|Withdrawal by Subject|1
2333779|NCT03231943|4058499|FG012|Part 2|Withdrawal by Subject|0
2333780|NCT03232281|4058548|FG000|Overall Study|Adverse Event|1
2333781|NCT03232281|4058549|FG001|Overall Study|Adverse Event|1
2333782|NCT03232281|4058548|FG000|Overall Study|Withdrawal by Subject|5
2333783|NCT03232281|4058549|FG001|Overall Study|Withdrawal by Subject|4
2333784|NCT03232281|4058548|FG000|Overall Study|Protocol Deviation|1
2233703|NCT01859390|3886897|FG001|Overall Study|Shipment Error|1
2233704|NCT01859403|3886905|FG000|Primary Endpoint Measure|Lost to Follow-up|0
2233705|NCT01859403|3886906|FG001|Primary Endpoint Measure|Lost to Follow-up|2
2233706|NCT01859403|3886905|FG000|Primary Endpoint Measure|Withdrawal by Subject|1
2333785|NCT03232281|4058549|FG001|Overall Study|Protocol Deviation|1
2233707|NCT01859403|3886906|FG001|Primary Endpoint Measure|Withdrawal by Subject|1
2233708|NCT01859403|3886905|FG000|Primary Endpoint Measure|Physician Decision|0
2233709|NCT01859403|3886906|FG001|Primary Endpoint Measure|Physician Decision|1
2233710|NCT01859403|3886905|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6
2233711|NCT01859403|3886906|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8
2233712|NCT01859494|3886912|FG000|Overall Study|Adverse Event|1
2233713|NCT01859507|3886916|FG000|Overall Study|left the country|4
2233714|NCT01859598|3886921|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742
2233715|NCT01859702|3886935|FG000|Overall Study|Protocol deviation|3
2233716|NCT01859702|3886935|FG000|Overall Study|Adverse Event|2
2233717|NCT01859715|3886942|FG000|Overall Study|No 2nd VAS|16
2233718|NCT01859715|3886943|FG001|Overall Study|No 2nd VAS|8
2233719|NCT01859715|3886944|FG002|Overall Study|No 2nd VAS|23
2233720|NCT01859741|3886962|FG000|Overall Study|Death|3
2233721|NCT01859741|3886963|FG001|Overall Study|Death|2
2233722|NCT01859741|3886964|FG002|Overall Study|Death|4
2233723|NCT01859741|3886965|FG003|Overall Study|Death|3
2233724|NCT01859741|3886966|FG004|Overall Study|Death|5
2233725|NCT01859741|3886967|FG005|Overall Study|Death|4
2233726|NCT01859741|3886968|FG006|Overall Study|Death|51
2233727|NCT01859741|3886969|FG007|Overall Study|Death|51
2233728|NCT01859741|3886962|FG000|Overall Study|Lost to Follow-up|0
2233729|NCT01859741|3886963|FG001|Overall Study|Lost to Follow-up|0
2233730|NCT01859741|3886964|FG002|Overall Study|Lost to Follow-up|0
2233731|NCT01859741|3886965|FG003|Overall Study|Lost to Follow-up|0
2233732|NCT01859741|3886966|FG004|Overall Study|Lost to Follow-up|0
2233733|NCT01859741|3886967|FG005|Overall Study|Lost to Follow-up|1
2233734|NCT01859741|3886968|FG006|Overall Study|Lost to Follow-up|0
2233735|NCT01859741|3886969|FG007|Overall Study|Lost to Follow-up|4
2233736|NCT01859741|3886962|FG000|Overall Study|Withdrawal by Subject|0
2233737|NCT01859741|3886963|FG001|Overall Study|Withdrawal by Subject|1
2233738|NCT01859741|3886964|FG002|Overall Study|Withdrawal by Subject|2
2233739|NCT01859741|3886965|FG003|Overall Study|Withdrawal by Subject|0
2233740|NCT01859741|3886966|FG004|Overall Study|Withdrawal by Subject|0
2233741|NCT01859741|3886967|FG005|Overall Study|Withdrawal by Subject|1
2233742|NCT01859741|3886968|FG006|Overall Study|Withdrawal by Subject|1
2233743|NCT01859741|3886969|FG007|Overall Study|Withdrawal by Subject|1
2233744|NCT01859741|3886962|FG000|Overall Study|Study Terminated by Sponsor|0
2233745|NCT01859741|3886963|FG001|Overall Study|Study Terminated by Sponsor|0
2233746|NCT01859741|3886964|FG002|Overall Study|Study Terminated by Sponsor|0
2233747|NCT01859741|3886965|FG003|Overall Study|Study Terminated by Sponsor|0
2233748|NCT01859741|3886966|FG004|Overall Study|Study Terminated by Sponsor|1
2233749|NCT01859741|3886967|FG005|Overall Study|Study Terminated by Sponsor|0
2233750|NCT01859741|3886968|FG006|Overall Study|Study Terminated by Sponsor|16
2233751|NCT01859741|3886969|FG007|Overall Study|Study Terminated by Sponsor|14
2233752|NCT01859741|3886962|FG000|Overall Study|Other|0
2233753|NCT01859741|3886963|FG001|Overall Study|Other|0
2233754|NCT01859741|3886964|FG002|Overall Study|Other|0
2233755|NCT01859741|3886965|FG003|Overall Study|Other|0
2233756|NCT01859741|3886966|FG004|Overall Study|Other|0
2233757|NCT01859741|3886967|FG005|Overall Study|Other|0
2233758|NCT01859741|3886968|FG006|Overall Study|Other|2
2233759|NCT01859741|3886969|FG007|Overall Study|Other|0
2233760|NCT01859793|3886989|FG000|First Intervention (8 Weeks)|Protocol Violation|2
2233761|NCT01859793|3886990|FG001|First Intervention (8 Weeks)|Protocol Violation|0
2233762|NCT01859793|3886989|FG000|First Intervention (8 Weeks)|Adverse Event|1
2233763|NCT01859793|3886990|FG001|First Intervention (8 Weeks)|Adverse Event|0
2233764|NCT01859793|3886989|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
2233765|NCT01859793|3886990|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
2233766|NCT01859793|3886989|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1
2233767|NCT01859793|3886990|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
2233768|NCT01859923|3887000|FG000|Overall Study|Adverse Event|0
2233769|NCT01859923|3887001|FG001|Overall Study|Adverse Event|0
2233770|NCT01859923|3887002|FG002|Overall Study|Adverse Event|1
2233771|NCT01859923|3887003|FG003|Overall Study|Adverse Event|1
2233772|NCT01859949|3887018|FG000|Overall Study|Family Matters|0
2233773|NCT01859949|3887019|FG001|Overall Study|Family Matters|1
2233774|NCT01859949|3887018|FG000|Overall Study|Physician Decision|2
2333786|NCT03232333|4058555|FG000|Overall Study|Infection or Osteomyelitis|9
2233775|NCT01859949|3887019|FG001|Overall Study|Physician Decision|4
2233776|NCT01859949|3887018|FG000|Overall Study|Withdrawal by Subject|11
2233777|NCT01859949|3887019|FG001|Overall Study|Withdrawal by Subject|10
2233778|NCT01859949|3887018|FG000|Overall Study|Protocol Violation|1
2233779|NCT01859949|3887019|FG001|Overall Study|Protocol Violation|1
2233780|NCT01859949|3887018|FG000|Overall Study|Adverse Event|0
2233781|NCT01859949|3887019|FG001|Overall Study|Adverse Event|1
2233782|NCT01859988|3887031|FG000|Overall Study|Withdrawal by Subject|6
2233783|NCT01859988|3887032|FG001|Overall Study|Withdrawal by Subject|3
2233784|NCT01859988|3887033|FG002|Overall Study|Withdrawal by Subject|4
2233785|NCT01859988|3887034|FG003|Overall Study|Withdrawal by Subject|3
2233786|NCT01859988|3887035|FG004|Overall Study|Withdrawal by Subject|2
2233787|NCT01859988|3887036|FG005|Overall Study|Withdrawal by Subject|2
2233788|NCT01859988|3887031|FG000|Overall Study|Lack of Efficacy|1
2233789|NCT01859988|3887032|FG001|Overall Study|Lack of Efficacy|1
2233790|NCT01859988|3887033|FG002|Overall Study|Lack of Efficacy|5
2233791|NCT01859988|3887034|FG003|Overall Study|Lack of Efficacy|0
2233792|NCT01859988|3887035|FG004|Overall Study|Lack of Efficacy|7
2233793|NCT01859988|3887036|FG005|Overall Study|Lack of Efficacy|9
2233794|NCT01859988|3887031|FG000|Overall Study|Physician Decision|1
2233795|NCT01859988|3887032|FG001|Overall Study|Physician Decision|3
2233796|NCT01859988|3887033|FG002|Overall Study|Physician Decision|1
2333787|NCT03232333|4058555|FG000|Overall Study|Lost to Follow-up|4
2333788|NCT03232333|4058555|FG000|Overall Study|Withdrawal by Subject|2
2333789|NCT03232567|4058563|FG000|Overall Study|Withdrawal by Subject|0
2333790|NCT03232567|4058564|FG001|Overall Study|Withdrawal by Subject|1
2333791|NCT03232567|4058565|FG002|Overall Study|Withdrawal by Subject|0
2333792|NCT03232567|4058566|FG003|Overall Study|Withdrawal by Subject|0
2333793|NCT03232983|4058599|FG000|Period 1|Physician Decision|0
2036676|NCT00413192|3606911|FG000|Overall Study|Intercurrent death|0
2036677|NCT00413192|3606912|FG001|Overall Study|Intercurrent death|1
2036678|NCT00413192|3606913|FG002|Overall Study|Intercurrent death|0
2036679|NCT00413192|3606914|FG003|Overall Study|Intercurrent death|0
2036680|NCT00413192|3606911|FG000|Overall Study|Other|5
2036681|NCT00413192|3606912|FG001|Overall Study|Other|1
2036682|NCT00413192|3606913|FG002|Overall Study|Other|1
2036683|NCT00413192|3606914|FG003|Overall Study|Other|2
2036684|NCT00413192|3606911|FG000|Overall Study|Not treated|0
2036685|NCT00413192|3606912|FG001|Overall Study|Not treated|0
2036686|NCT00413192|3606913|FG002|Overall Study|Not treated|0
2036687|NCT00413192|3606914|FG003|Overall Study|Not treated|1
2036688|NCT00413218|3606926|FG000|Overall Study|Randomized but didn't receive study drug|2
2036689|NCT00413218|3606927|FG001|Overall Study|Randomized but didn't receive study drug|8
2036690|NCT00413218|3606926|FG000|Overall Study|Death|57
2036691|NCT00413218|3606927|FG001|Overall Study|Death|56
2036692|NCT00413218|3606926|FG000|Overall Study|Lost to Follow-up|14
2036693|NCT00413218|3606927|FG001|Overall Study|Lost to Follow-up|17
2036694|NCT00413218|3606926|FG000|Overall Study|Admin|20
2036695|NCT00413218|3606927|FG001|Overall Study|Admin|14
2036696|NCT00413218|3606926|FG000|Overall Study|Missing|1
2036697|NCT00413218|3606927|FG001|Overall Study|Missing|0
2036698|NCT00413218|3606926|FG000|Overall Study|Withdrawal by Subject|9
2036699|NCT00413218|3606927|FG001|Overall Study|Withdrawal by Subject|1
2036700|NCT00413231|3606934|FG000|0 to 30-day Post Treatment|Death|5
2036701|NCT00413231|3606934|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
2036702|NCT00413231|3606934|FG000|30-day to 365-day Post Treatment|Death|13
2036703|NCT00413231|3606934|FG000|365-day to 60-month Post Treatment|Death|36
2036704|NCT00413231|3606934|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5
2036705|NCT00413231|3606934|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4
2036706|NCT00413231|3606934|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1
2036707|NCT00413244|3606941|FG000|Overall Study|Withdrawal by Subject|10
2036708|NCT00413244|3606942|FG001|Overall Study|Withdrawal by Subject|1
2036709|NCT00413283|3606952|FG000|Overall Study|Withdrawal by Subject|1
2036710|NCT00413283|3606953|FG001|Overall Study|Withdrawal by Subject|0
2036711|NCT00413283|3606954|FG002|Overall Study|Withdrawal by Subject|0
2036712|NCT00413283|3606955|FG003|Overall Study|Withdrawal by Subject|1
2036713|NCT00413283|3606952|FG000|Overall Study|Death|0
2036714|NCT00413283|3606953|FG001|Overall Study|Death|0
2036715|NCT00413283|3606954|FG002|Overall Study|Death|1
2036716|NCT00413283|3606955|FG003|Overall Study|Death|1
2036717|NCT00413283|3606952|FG000|Overall Study|Adverse Event|0
2036718|NCT00413283|3606953|FG001|Overall Study|Adverse Event|0
2036719|NCT00413283|3606954|FG002|Overall Study|Adverse Event|0
2036720|NCT00413283|3606955|FG003|Overall Study|Adverse Event|1
2036721|NCT00413283|3606952|FG000|Overall Study|Ineligibility determined|0
2036722|NCT00413283|3606953|FG001|Overall Study|Ineligibility determined|0
2036723|NCT00413283|3606954|FG002|Overall Study|Ineligibility determined|0
2036724|NCT00413283|3606955|FG003|Overall Study|Ineligibility determined|1
2036725|NCT00413283|3606952|FG000|Overall Study|Protocol deviation|0
2036726|NCT00413283|3606953|FG001|Overall Study|Protocol deviation|1
2036727|NCT00413283|3606954|FG002|Overall Study|Protocol deviation|0
2036728|NCT00413283|3606955|FG003|Overall Study|Protocol deviation|0
2036729|NCT00413283|3606952|FG000|Overall Study|Requirement for alternative therapy|0
2036730|NCT00413283|3606953|FG001|Overall Study|Requirement for alternative therapy|2
2036731|NCT00413283|3606954|FG002|Overall Study|Requirement for alternative therapy|0
2036732|NCT00413283|3606955|FG003|Overall Study|Requirement for alternative therapy|0
2036733|NCT00413283|3606952|FG000|Overall Study|Other|0
2036734|NCT00413283|3606953|FG001|Overall Study|Other|0
2036735|NCT00413283|3606954|FG002|Overall Study|Other|1
2036736|NCT00413283|3606955|FG003|Overall Study|Other|0
2036737|NCT00413374|3606976|FG000|Overall Study|Ineligible due to screening criteria.|3
2036738|NCT00413374|3606977|FG001|Overall Study|Ineligible due to screening criteria.|0
2233797|NCT01859988|3887034|FG003|Overall Study|Physician Decision|3
2233798|NCT01859988|3887035|FG004|Overall Study|Physician Decision|4
2233799|NCT01859988|3887036|FG005|Overall Study|Physician Decision|1
2233800|NCT01859988|3887031|FG000|Overall Study|Adverse Event|2
2333794|NCT03232983|4058600|FG001|Period 1|Physician Decision|0
2233801|NCT01859988|3887032|FG001|Overall Study|Adverse Event|1
2233802|NCT01859988|3887033|FG002|Overall Study|Adverse Event|3
2233803|NCT01859988|3887034|FG003|Overall Study|Adverse Event|1
2233804|NCT01859988|3887035|FG004|Overall Study|Adverse Event|2
2333795|NCT03232983|4058601|FG002|Period 1|Physician Decision|1
2233805|NCT01859988|3887036|FG005|Overall Study|Adverse Event|2
2233806|NCT01859988|3887031|FG000|Overall Study|Lost to Follow-up|1
2233807|NCT01859988|3887032|FG001|Overall Study|Lost to Follow-up|2
2233808|NCT01859988|3887033|FG002|Overall Study|Lost to Follow-up|3
2233809|NCT01859988|3887034|FG003|Overall Study|Lost to Follow-up|0
2233810|NCT01859988|3887035|FG004|Overall Study|Lost to Follow-up|3
2233811|NCT01859988|3887036|FG005|Overall Study|Lost to Follow-up|2
2233812|NCT01859988|3887031|FG000|Overall Study|Protocol Violation|0
2233813|NCT01859988|3887032|FG001|Overall Study|Protocol Violation|0
2233814|NCT01859988|3887033|FG002|Overall Study|Protocol Violation|1
2233815|NCT01859988|3887034|FG003|Overall Study|Protocol Violation|0
2233816|NCT01859988|3887035|FG004|Overall Study|Protocol Violation|0
2233817|NCT01859988|3887036|FG005|Overall Study|Protocol Violation|0
2233818|NCT01859988|3887031|FG000|Overall Study|Other than specified above|0
2233819|NCT01859988|3887032|FG001|Overall Study|Other than specified above|2
2233820|NCT01859988|3887033|FG002|Overall Study|Other than specified above|11
2233821|NCT01859988|3887034|FG003|Overall Study|Other than specified above|3
2233822|NCT01859988|3887035|FG004|Overall Study|Other than specified above|5
2233823|NCT01859988|3887036|FG005|Overall Study|Other than specified above|3
2233824|NCT01860079|3887052|FG000|Overall Study|Physician Decision|14
2233825|NCT01860079|3887053|FG001|Overall Study|Physician Decision|22
2233826|NCT01860534|3887096|FG000|ROP #1|Needed treatment for ROP|0
2233827|NCT01860534|3887097|FG001|ROP #1|Needed treatment for ROP|1
2233828|NCT01860534|3887096|FG000|ROP #2|discharged prior to ROP #2|1
2233829|NCT01860534|3887097|FG001|ROP #2|discharged prior to ROP #2|0
2233830|NCT01860677|3887134|FG000|Second Intervention (1 Day)|Lost to Follow-up|7
2233831|NCT01860677|3887135|FG001|Second Intervention (1 Day)|Lost to Follow-up|0
2233832|NCT01860703|3887142|FG000|Overall Study|Adverse Event|1
2233833|NCT01860703|3887143|FG001|Overall Study|Adverse Event|4
2233834|NCT01860703|3887144|FG002|Overall Study|Adverse Event|0
2233835|NCT01860703|3887145|FG003|Overall Study|Adverse Event|2
2233836|NCT01860703|3887142|FG000|Overall Study|Withdrawal by Subject|0
2233837|NCT01860703|3887143|FG001|Overall Study|Withdrawal by Subject|1
2233838|NCT01860703|3887144|FG002|Overall Study|Withdrawal by Subject|0
2233839|NCT01860703|3887145|FG003|Overall Study|Withdrawal by Subject|0
2233840|NCT01860703|3887142|FG000|Overall Study|Personal reason|1
2233841|NCT01860703|3887143|FG001|Overall Study|Personal reason|0
2233842|NCT01860703|3887144|FG002|Overall Study|Personal reason|1
2233843|NCT01860703|3887145|FG003|Overall Study|Personal reason|0
2233844|NCT01860846|3887170|FG000|Overall Study|Lost to Follow-up|33
2233845|NCT01860976|3887202|FG000|Blinded Treatment|Adverse Event|1
2233846|NCT01860976|3887203|FG001|Blinded Treatment|Adverse Event|3
2233847|NCT01860976|3887202|FG000|Blinded Treatment|Lack of Efficacy|5
2233848|NCT01860976|3887203|FG001|Blinded Treatment|Lack of Efficacy|12
2233849|NCT01860976|3887202|FG000|Blinded Treatment|Subject request to discontinue treatment|2
2233850|NCT01860976|3887203|FG001|Blinded Treatment|Subject request to discontinue treatment|3
2233851|NCT01860976|3887202|FG000|Blinded Treatment|Withdrawal by Subject|3
2233852|NCT01860976|3887203|FG001|Blinded Treatment|Withdrawal by Subject|5
2233853|NCT01860976|3887202|FG000|Blinded Treatment|Subject no longer met criteria|1
2233854|NCT01860976|3887203|FG001|Blinded Treatment|Subject no longer met criteria|0
2233855|NCT01860976|3887202|FG000|Blinded Treatment|Entered Open-Label in error|0
2233856|NCT01860976|3887203|FG001|Blinded Treatment|Entered Open-Label in error|1
2233857|NCT01860976|3887202|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76
2233858|NCT01860976|3887203|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89
2233859|NCT01860976|3887202|FG000|Open-Label|Adverse Event|2
2233860|NCT01860976|3887203|FG001|Open-Label|Adverse Event|4
2233861|NCT01860976|3887202|FG000|Open-Label|Lack of Efficacy|16
2233862|NCT01860976|3887203|FG001|Open-Label|Lack of Efficacy|8
2233863|NCT01860976|3887202|FG000|Open-Label|Lost to Follow-up|1
2233864|NCT01860976|3887203|FG001|Open-Label|Lost to Follow-up|2
2233865|NCT01860976|3887202|FG000|Open-Label|Subject request discontinue treatment|4
2233866|NCT01860976|3887203|FG001|Open-Label|Subject request discontinue treatment|3
2233867|NCT01860976|3887202|FG000|Open-Label|Withdrawal by Subject|4
2233868|NCT01860976|3887203|FG001|Open-Label|Withdrawal by Subject|1
2233869|NCT01860976|3887202|FG000|Open-Label|Other Reasons|1
2233870|NCT01860976|3887203|FG001|Open-Label|Other Reasons|1
2233871|NCT01860976|3887202|FG000|Open-Label|Ongoing OL treatment at time of analysis|46
2233872|NCT01860976|3887203|FG001|Open-Label|Ongoing OL treatment at time of analysis|45
2233873|NCT01860976|3887202|FG000|Long Term Extension|Adverse Event|1
2233874|NCT01860976|3887203|FG001|Long Term Extension|Adverse Event|0
2233875|NCT01860976|3887202|FG000|Long Term Extension|Lack of Efficacy|3
2233876|NCT01860976|3887203|FG001|Long Term Extension|Lack of Efficacy|7
2233877|NCT01860976|3887202|FG000|Long Term Extension|Subject request to discontinue treatment|2
2233878|NCT01860976|3887203|FG001|Long Term Extension|Subject request to discontinue treatment|0
2233879|NCT01860976|3887202|FG000|Long Term Extension|Withdrawal by Subject|1
2233880|NCT01860976|3887203|FG001|Long Term Extension|Withdrawal by Subject|0
2233881|NCT01860976|3887202|FG000|Long Term Extension|Ongoing treatment at time of analysis|106
2233882|NCT01860976|3887203|FG001|Long Term Extension|Ongoing treatment at time of analysis|100
2233883|NCT01860989|3887209|FG000|Overall Study|Unsatisfactory therapeutic|5
2233884|NCT01861522|3887254|FG000|Overall Study|Adverse Event|1
2233885|NCT01861522|3887255|FG001|Overall Study|Adverse Event|0
2233886|NCT01861522|3887254|FG000|Overall Study|Withdrawal by Subject|2
2233887|NCT01861522|3887255|FG001|Overall Study|Withdrawal by Subject|0
2233888|NCT01862029|3887335|FG000|Overall Study|Physician Decision|1
2233889|NCT01862250|3887351|FG000|Overall Study|Adverse Event|4
2233890|NCT01862328|3887362|FG000|Overall Study|Progressive Disease|3
2233891|NCT01862328|3887363|FG001|Overall Study|Progressive Disease|11
2233892|NCT01862328|3887364|FG002|Overall Study|Progressive Disease|5
2233893|NCT01862328|3887365|FG003|Overall Study|Progressive Disease|6
2233894|NCT01862328|3887366|FG004|Overall Study|Progressive Disease|7
2233895|NCT01862328|3887367|FG005|Overall Study|Progressive Disease|4
2233896|NCT01862328|3887368|FG006|Overall Study|Progressive Disease|3
2233897|NCT01862328|3887362|FG000|Overall Study|Adverse Event|0
2233898|NCT01862328|3887363|FG001|Overall Study|Adverse Event|4
2233899|NCT01862328|3887364|FG002|Overall Study|Adverse Event|0
2233900|NCT01862328|3887365|FG003|Overall Study|Adverse Event|1
2233901|NCT01862328|3887366|FG004|Overall Study|Adverse Event|0
2233902|NCT01862328|3887367|FG005|Overall Study|Adverse Event|2
2233903|NCT01862328|3887368|FG006|Overall Study|Adverse Event|4
2233904|NCT01862328|3887362|FG000|Overall Study|Other|0
2233905|NCT01862328|3887363|FG001|Overall Study|Other|2
2233906|NCT01862328|3887364|FG002|Overall Study|Other|1
2233907|NCT01862328|3887365|FG003|Overall Study|Other|0
2233908|NCT01862328|3887366|FG004|Overall Study|Other|4
2233909|NCT01862328|3887367|FG005|Overall Study|Other|0
2233910|NCT01862328|3887368|FG006|Overall Study|Other|1
2233911|NCT01862328|3887362|FG000|Overall Study|Withdrawal by Subject|1
2233912|NCT01862328|3887363|FG001|Overall Study|Withdrawal by Subject|1
2233913|NCT01862328|3887364|FG002|Overall Study|Withdrawal by Subject|0
2233914|NCT01862328|3887365|FG003|Overall Study|Withdrawal by Subject|0
2233915|NCT01862328|3887366|FG004|Overall Study|Withdrawal by Subject|1
2233916|NCT01862328|3887367|FG005|Overall Study|Withdrawal by Subject|1
2233917|NCT01862328|3887368|FG006|Overall Study|Withdrawal by Subject|1
2233918|NCT01862328|3887362|FG000|Overall Study|Symptomatic Deterioration|0
2233919|NCT01862328|3887363|FG001|Overall Study|Symptomatic Deterioration|0
2233920|NCT01862328|3887364|FG002|Overall Study|Symptomatic Deterioration|0
2233921|NCT01862328|3887365|FG003|Overall Study|Symptomatic Deterioration|0
2233922|NCT01862328|3887366|FG004|Overall Study|Symptomatic Deterioration|0
2233923|NCT01862328|3887367|FG005|Overall Study|Symptomatic Deterioration|0
2233924|NCT01862328|3887368|FG006|Overall Study|Symptomatic Deterioration|1
2233925|NCT01862484|3887401|FG000|Overall Study|Lack of Efficacy|1
2233926|NCT01862484|3887402|FG001|Overall Study|Lack of Efficacy|1
2233927|NCT01862484|3887401|FG000|Overall Study|Lost to Follow-up|1
2233928|NCT01862484|3887402|FG001|Overall Study|Lost to Follow-up|2
2233929|NCT01862484|3887401|FG000|Overall Study|Protocol Violation|0
2233930|NCT01862484|3887402|FG001|Overall Study|Protocol Violation|2
2233931|NCT01862484|3887401|FG000|Overall Study|Withdrawal by Subject|0
2233932|NCT01862484|3887402|FG001|Overall Study|Withdrawal by Subject|3
2233933|NCT01862640|3887430|FG000|Overall Study|Adverse Event|4
2233934|NCT01862640|3887431|FG001|Overall Study|Adverse Event|10
2233935|NCT01862640|3887432|FG002|Overall Study|Adverse Event|6
2233936|NCT01862640|3887433|FG003|Overall Study|Adverse Event|8
2233937|NCT01862640|3887430|FG000|Overall Study|Participant Met Withdrawal Criteria|1
2233938|NCT01862640|3887431|FG001|Overall Study|Participant Met Withdrawal Criteria|1
2233939|NCT01862640|3887432|FG002|Overall Study|Participant Met Withdrawal Criteria|2
2233940|NCT01862640|3887433|FG003|Overall Study|Participant Met Withdrawal Criteria|1
2233941|NCT01862640|3887430|FG000|Overall Study|Participant Withdrawn by Investigator|0
2233942|NCT01862640|3887431|FG001|Overall Study|Participant Withdrawn by Investigator|1
2233943|NCT01862640|3887432|FG002|Overall Study|Participant Withdrawn by Investigator|1
2233944|NCT01862640|3887433|FG003|Overall Study|Participant Withdrawn by Investigator|1
2233945|NCT01862640|3887430|FG000|Overall Study|Withdrawal by Subject|2
2233946|NCT01862640|3887431|FG001|Overall Study|Withdrawal by Subject|4
2233947|NCT01862640|3887432|FG002|Overall Study|Withdrawal by Subject|8
2233948|NCT01862640|3887433|FG003|Overall Study|Withdrawal by Subject|5
2233949|NCT01862640|3887430|FG000|Overall Study|Protocol Deviation|0
2233950|NCT01862640|3887431|FG001|Overall Study|Protocol Deviation|0
2233951|NCT01862640|3887432|FG002|Overall Study|Protocol Deviation|1
2233952|NCT01862640|3887433|FG003|Overall Study|Protocol Deviation|0
2233953|NCT01862796|3887445|FG000|Overall Study|Prohibited medications|0
2233954|NCT01862796|3887446|FG001|Overall Study|Prohibited medications|0
2233955|NCT01862796|3887447|FG002|Overall Study|Prohibited medications|1
2233956|NCT01862874|3887457|FG000|Overall Study|Randomized not treated|1
2233957|NCT01862874|3887458|FG001|Overall Study|Randomized not treated|0
2233958|NCT01862874|3887457|FG000|Overall Study|Adverse Event|0
2233959|NCT01862874|3887458|FG001|Overall Study|Adverse Event|3
2233960|NCT01862874|3887457|FG000|Overall Study|Lost to Follow-up|26
2233961|NCT01862874|3887458|FG001|Overall Study|Lost to Follow-up|29
2233962|NCT01862874|3887457|FG000|Overall Study|Physician Decision|5
2233963|NCT01862874|3887458|FG001|Overall Study|Physician Decision|3
2233964|NCT01862874|3887457|FG000|Overall Study|Withdrawn by parent/guardian|1
2233965|NCT01862874|3887458|FG001|Overall Study|Withdrawn by parent/guardian|1
2233966|NCT01862874|3887457|FG000|Overall Study|Withdrawal by Subject|46
2233967|NCT01862874|3887458|FG001|Overall Study|Withdrawal by Subject|40
2233968|NCT01862874|3887457|FG000|Overall Study|Death|0
2233969|NCT01862874|3887458|FG001|Overall Study|Death|1
2233970|NCT01862991|3887467|FG000|Overall Study|Lost to Follow-up|2
2233971|NCT01862991|3887468|FG001|Overall Study|Lost to Follow-up|1
2233972|NCT01862991|3887469|FG002|Overall Study|Lost to Follow-up|1
2233973|NCT01862991|3887467|FG000|Overall Study|Protocol Violation|1
2233974|NCT01862991|3887468|FG001|Overall Study|Protocol Violation|0
2233975|NCT01862991|3887469|FG002|Overall Study|Protocol Violation|0
2233976|NCT01863368|3887517|FG000|Phase I, Day 0 to Day 35|Adverse Event|2
2233977|NCT01863368|3887518|FG001|Phase I, Day 0 to Day 35|Adverse Event|4
2233978|NCT01863368|3887517|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1
2233979|NCT01863368|3887518|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0
2233980|NCT01863368|3887517|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
2233981|NCT01863368|3887518|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
2233982|NCT01863368|3887517|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
2233983|NCT01863368|3887518|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
2233984|NCT01863368|3887517|FG000|Phase II, Day 35 to Day 90|Adverse Event|1
2233985|NCT01863368|3887518|FG001|Phase II, Day 35 to Day 90|Adverse Event|0
2233986|NCT01863368|3887517|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1
2233987|NCT01863368|3887518|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0
2233988|NCT01863433|3887525|FG000|Overall Study|Protocol Violation|1
2233989|NCT01863667|3887544|FG000|Overall Study|Adverse Event|1
2233990|NCT01863667|3887545|FG001|Overall Study|Adverse Event|0
2233991|NCT01863667|3887544|FG000|Overall Study|Study terminated by Sponsor|30
2233992|NCT01863667|3887545|FG001|Overall Study|Study terminated by Sponsor|30
2233993|NCT01863667|3887544|FG000|Overall Study|Withdrawal by Subject|2
2233994|NCT01863667|3887545|FG001|Overall Study|Withdrawal by Subject|2
2233995|NCT01863680|3887551|FG000|Overall Study|Adverse Event|17
2333796|NCT03232983|4058602|FG003|Period 1|Physician Decision|0
2333797|NCT03232983|4058599|FG000|Washout Period 2|Physician Decision|0
2333798|NCT03232983|4058600|FG001|Washout Period 2|Physician Decision|0
2333799|NCT03232983|4058601|FG002|Washout Period 2|Physician Decision|1
2333800|NCT03232983|4058602|FG003|Washout Period 2|Physician Decision|0
2333801|NCT03232983|4058599|FG000|Washout Period 2|Withdrawal by Subject|0
2333802|NCT03232983|4058600|FG001|Washout Period 2|Withdrawal by Subject|0
2333803|NCT03232983|4058601|FG002|Washout Period 2|Withdrawal by Subject|0
2333804|NCT03232983|4058602|FG003|Washout Period 2|Withdrawal by Subject|1
2333805|NCT03232983|4058599|FG000|Period 4|Withdrawal by Subject|1
2333806|NCT03232983|4058600|FG001|Period 4|Withdrawal by Subject|0
2333807|NCT03232983|4058601|FG002|Period 4|Withdrawal by Subject|0
2333808|NCT03232983|4058602|FG003|Period 4|Withdrawal by Subject|0
2333809|NCT03233009|4058614|FG000|Overall Study|Lost to Follow-up|1
2333810|NCT03233230|4058652|FG000|Overall Study|Adverse Event|6
2333811|NCT03233230|4058653|FG001|Overall Study|Adverse Event|3
2333812|NCT03233230|4058654|FG002|Overall Study|Adverse Event|6
2333813|NCT03233230|4058655|FG003|Overall Study|Adverse Event|3
2333814|NCT03233230|4058652|FG000|Overall Study|Protocol Violation|1
2333815|NCT03233230|4058653|FG001|Overall Study|Protocol Violation|2
2333816|NCT03233230|4058654|FG002|Overall Study|Protocol Violation|1
2333817|NCT03233230|4058655|FG003|Overall Study|Protocol Violation|1
2333818|NCT03233230|4058652|FG000|Overall Study|Lack of Efficacy|1
2333819|NCT03233230|4058653|FG001|Overall Study|Lack of Efficacy|0
2333820|NCT03233230|4058654|FG002|Overall Study|Lack of Efficacy|0
2333821|NCT03233230|4058655|FG003|Overall Study|Lack of Efficacy|0
2333822|NCT03233230|4058652|FG000|Overall Study|Other|5
2333823|NCT03233230|4058653|FG001|Overall Study|Other|5
2333824|NCT03233230|4058654|FG002|Overall Study|Other|5
2333825|NCT03233230|4058655|FG003|Overall Study|Other|3
2333826|NCT03233230|4058652|FG000|Overall Study|Withdrawal by Subject|2
2333827|NCT03233230|4058653|FG001|Overall Study|Withdrawal by Subject|2
2333828|NCT03233230|4058654|FG002|Overall Study|Withdrawal by Subject|0
2333829|NCT03233230|4058655|FG003|Overall Study|Withdrawal by Subject|1
2333830|NCT03233230|4058652|FG000|Overall Study|Lost to Follow-up|0
2333831|NCT03233230|4058653|FG001|Overall Study|Lost to Follow-up|3
2333832|NCT03233230|4058654|FG002|Overall Study|Lost to Follow-up|0
2333833|NCT03233230|4058655|FG003|Overall Study|Lost to Follow-up|0
2333834|NCT03233308|4058665|FG000|Overall Study|Adverse Event|1
2333835|NCT03233308|4058665|FG000|Overall Study|Protocol Violation|1
2333836|NCT03233438|4058678|FG000|Overall Study|Lost to Follow-up|4
2333837|NCT03233438|4058679|FG001|Overall Study|Lost to Follow-up|9
2333838|NCT03233438|4058678|FG000|Overall Study|Withdrawal by Subject|2
2333839|NCT03233438|4058679|FG001|Overall Study|Withdrawal by Subject|1
2333840|NCT03233438|4058678|FG000|Overall Study|No recording of dalbavancin|0
2333841|NCT03233438|4058679|FG001|Overall Study|No recording of dalbavancin|1
2333842|NCT03233529|4058685|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
2333843|NCT03233529|4058685|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
2333844|NCT03234036|4058718|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
2333845|NCT03234036|4058719|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
2333846|NCT03234036|4058720|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
2333847|NCT03234036|4058721|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
2333848|NCT03234465|4058748|FG000|Overall Study|Adverse Event|4
2333849|NCT03234465|4058749|FG001|Overall Study|Adverse Event|2
2333850|NCT03234465|4058748|FG000|Overall Study|Death|0
2333851|NCT03234465|4058749|FG001|Overall Study|Death|1
2333852|NCT03234465|4058748|FG000|Overall Study|Lost to Follow-up|1
2233996|NCT01863680|3887551|FG000|Overall Study|Risk of OHSS|17
2233997|NCT01863680|3887551|FG000|Overall Study|Spontaneous pregnancy|2
2233998|NCT01863680|3887551|FG000|Overall Study|Withdrawal by Subject|1
2233999|NCT01863680|3887551|FG000|Overall Study|Did not undergo IVF/ET|14
2234000|NCT01863680|3887551|FG000|Overall Study|Other|6
2234001|NCT01863732|3887559|FG000|Overall Study|Adverse Event|2
2234002|NCT01863732|3887560|FG001|Overall Study|Adverse Event|0
2234003|NCT01863732|3887561|FG002|Overall Study|Adverse Event|3
2234004|NCT01863732|3887562|FG003|Overall Study|Adverse Event|3
2234005|NCT01863732|3887559|FG000|Overall Study|Lack of Efficacy|1
2234006|NCT01863732|3887560|FG001|Overall Study|Lack of Efficacy|0
2234007|NCT01863732|3887561|FG002|Overall Study|Lack of Efficacy|2
2234008|NCT01863732|3887562|FG003|Overall Study|Lack of Efficacy|1
2234009|NCT01863732|3887559|FG000|Overall Study|Lost to Follow-up|2
2234010|NCT01863732|3887560|FG001|Overall Study|Lost to Follow-up|2
2234011|NCT01863732|3887561|FG002|Overall Study|Lost to Follow-up|1
2234012|NCT01863732|3887562|FG003|Overall Study|Lost to Follow-up|1
2234013|NCT01863732|3887559|FG000|Overall Study|Physician Decision|1
2234014|NCT01863732|3887560|FG001|Overall Study|Physician Decision|0
2234015|NCT01863732|3887561|FG002|Overall Study|Physician Decision|1
2234016|NCT01863732|3887562|FG003|Overall Study|Physician Decision|0
2234017|NCT01863732|3887559|FG000|Overall Study|Pregnancy|0
2234018|NCT01863732|3887560|FG001|Overall Study|Pregnancy|0
2234019|NCT01863732|3887561|FG002|Overall Study|Pregnancy|0
2234020|NCT01863732|3887562|FG003|Overall Study|Pregnancy|1
2234021|NCT01863732|3887559|FG000|Overall Study|Technical problems|0
2234022|NCT01863732|3887560|FG001|Overall Study|Technical problems|1
2234023|NCT01863732|3887561|FG002|Overall Study|Technical problems|1
2234024|NCT01863732|3887562|FG003|Overall Study|Technical problems|0
2234025|NCT01863732|3887559|FG000|Overall Study|Subject/guardian decision|6
2234026|NCT01863732|3887560|FG001|Overall Study|Subject/guardian decision|9
2234027|NCT01863732|3887561|FG002|Overall Study|Subject/guardian decision|3
2234028|NCT01863732|3887562|FG003|Overall Study|Subject/guardian decision|1
2234029|NCT01863732|3887559|FG000|Overall Study|Death|1
2234030|NCT01863732|3887560|FG001|Overall Study|Death|0
2234031|NCT01863732|3887561|FG002|Overall Study|Death|0
2234032|NCT01863732|3887562|FG003|Overall Study|Death|1
2234033|NCT01863758|3887571|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
2234034|NCT01863758|3887571|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1
2234035|NCT01863771|3887575|FG000|Induction Phase|Adverse Event|9
2234036|NCT01863771|3887576|FG001|Induction Phase|Adverse Event|0
2234037|NCT01863771|3887577|FG002|Induction Phase|Adverse Event|0
2234038|NCT01863771|3887578|FG003|Induction Phase|Adverse Event|0
2234039|NCT01863771|3887575|FG000|Induction Phase|Lack of Efficacy|10
2234040|NCT01863771|3887576|FG001|Induction Phase|Lack of Efficacy|0
2234041|NCT01863771|3887577|FG002|Induction Phase|Lack of Efficacy|0
2234042|NCT01863771|3887578|FG003|Induction Phase|Lack of Efficacy|0
2234043|NCT01863771|3887575|FG000|Induction Phase|Withdrawal by Subject|2
2234044|NCT01863771|3887576|FG001|Induction Phase|Withdrawal by Subject|0
2234045|NCT01863771|3887577|FG002|Induction Phase|Withdrawal by Subject|0
2234046|NCT01863771|3887578|FG003|Induction Phase|Withdrawal by Subject|0
2234047|NCT01863771|3887575|FG000|Maintenance Phase|Adverse Event|0
2234048|NCT01863771|3887576|FG001|Maintenance Phase|Adverse Event|0
2234049|NCT01863771|3887577|FG002|Maintenance Phase|Adverse Event|1
2234050|NCT01863771|3887578|FG003|Maintenance Phase|Adverse Event|1
2234051|NCT01863771|3887575|FG000|Maintenance Phase|Lack of Efficacy|0
2234052|NCT01863771|3887576|FG001|Maintenance Phase|Lack of Efficacy|3
2234053|NCT01863771|3887577|FG002|Maintenance Phase|Lack of Efficacy|7
2234054|NCT01863771|3887578|FG003|Maintenance Phase|Lack of Efficacy|38
2333853|NCT03234465|4058749|FG001|Overall Study|Lost to Follow-up|1
2333854|NCT03234465|4058748|FG000|Overall Study|Withdrawal by Subject|12
2333855|NCT03234465|4058749|FG001|Overall Study|Withdrawal by Subject|27
2333856|NCT03234465|4058748|FG000|Overall Study|Symptomatic deterioration|0
2333857|NCT03234465|4058749|FG001|Overall Study|Symptomatic deterioration|1
2333858|NCT03234465|4058748|FG000|Overall Study|Non-compliance|2
2333859|NCT03234465|4058749|FG001|Overall Study|Non-compliance|0
2333860|NCT03234465|4058748|FG000|Overall Study|Other|14
2333861|NCT03234465|4058749|FG001|Overall Study|Other|8
2333862|NCT03234608|4058757|FG000|Overall Study|Lost to Follow-up|23
2333863|NCT03234608|4058758|FG001|Overall Study|Lost to Follow-up|21
2333864|NCT03235050|4058769|FG000|Overall Study|Adverse Event|0
2333865|NCT03235050|4058770|FG001|Overall Study|Adverse Event|0
2333866|NCT03235050|4058771|FG002|Overall Study|Adverse Event|1
2333867|NCT03235050|4058772|FG003|Overall Study|Adverse Event|4
2333868|NCT03235050|4058773|FG004|Overall Study|Adverse Event|1
2333869|NCT03235050|4058769|FG000|Overall Study|Death|0
2333870|NCT03235050|4058770|FG001|Overall Study|Death|0
2333871|NCT03235050|4058771|FG002|Overall Study|Death|0
2234055|NCT01863771|3887575|FG000|Maintenance Phase|Physician Decision|0
2234056|NCT01863771|3887576|FG001|Maintenance Phase|Physician Decision|0
2234057|NCT01863771|3887577|FG002|Maintenance Phase|Physician Decision|2
2234058|NCT01863771|3887578|FG003|Maintenance Phase|Physician Decision|1
2234059|NCT01863771|3887575|FG000|Maintenance Phase|Pregnancy|0
2234060|NCT01863771|3887576|FG001|Maintenance Phase|Pregnancy|1
2234061|NCT01863771|3887577|FG002|Maintenance Phase|Pregnancy|0
2234062|NCT01863771|3887578|FG003|Maintenance Phase|Pregnancy|0
2234063|NCT01863771|3887575|FG000|Maintenance Phase|Withdrawal by Subject|0
2234064|NCT01863771|3887576|FG001|Maintenance Phase|Withdrawal by Subject|1
2333872|NCT03235050|4058772|FG003|Overall Study|Death|2
2234065|NCT01863771|3887577|FG002|Maintenance Phase|Withdrawal by Subject|2
2234066|NCT01863771|3887578|FG003|Maintenance Phase|Withdrawal by Subject|3
2274577|NCT02296840|3955521|FG000|Overall Study|Protocol Violation|2
2274578|NCT02296840|3955522|FG001|Overall Study|Protocol Violation|1
2274579|NCT02296840|3955521|FG000|Overall Study|Lost to Follow-up|6
2274580|NCT02296840|3955522|FG001|Overall Study|Lost to Follow-up|17
2274581|NCT02296892|3955540|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7
2274582|NCT02296892|3955541|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4
2274583|NCT02296892|3955542|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4
2274584|NCT02296892|3955540|FG000|Overall Study|Lost to Follow-up|5
2274585|NCT02296892|3955541|FG001|Overall Study|Lost to Follow-up|0
2274586|NCT02296892|3955542|FG002|Overall Study|Lost to Follow-up|1
2274587|NCT02296931|3955552|FG000|Overall Study|Protocol Violation|0
2274588|NCT02296931|3955553|FG001|Overall Study|Protocol Violation|2
2274589|NCT02297503|3955575|FG000|Overall Study|Withdrawal by Subject|1
2274590|NCT02297503|3955576|FG001|Overall Study|Withdrawal by Subject|1
2274591|NCT02297503|3955575|FG000|Overall Study|Protocol Violation|1
2274592|NCT02297503|3955576|FG001|Overall Study|Protocol Violation|0
2274593|NCT02297503|3955575|FG000|Overall Study|Pregnancy|0
2274594|NCT02297503|3955576|FG001|Overall Study|Pregnancy|1
2274595|NCT02297503|3955575|FG000|Overall Study|Lost to Follow-up|0
2274596|NCT02297503|3955576|FG001|Overall Study|Lost to Follow-up|1
2274597|NCT02297503|3955575|FG000|Overall Study|Medical reason|0
2274598|NCT02297503|3955576|FG001|Overall Study|Medical reason|1
2274599|NCT02297516|3955593|FG000|Single Treatment Phase (6 Months)|Medical reason|1
2274600|NCT02297516|3955594|FG001|Single Treatment Phase (6 Months)|Medical reason|0
2274601|NCT02297516|3955593|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0
2274602|NCT02297516|3955594|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2
2274603|NCT02297516|3955593|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
2274604|NCT02297516|3955594|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
2274605|NCT02297815|3955609|FG000|Overall Study|Lost to Follow-up|236
2274606|NCT02297815|3955610|FG001|Overall Study|Lost to Follow-up|140
2274607|NCT02297841|3955618|FG000|Overall Study|Withdrawal by Subject|1
2274608|NCT02297841|3955618|FG000|Overall Study|Protocol Violation|7
2274609|NCT02298023|3955625|FG000|Overall Study|Withdrawal by Subject|1
2274610|NCT02298023|3955626|FG001|Overall Study|Withdrawal by Subject|0
2274611|NCT02298023|3955627|FG002|Overall Study|Withdrawal by Subject|0
2274612|NCT02298179|3955650|FG000|Overall Study|Lost to Follow-up|0
2274613|NCT02298179|3955651|FG001|Overall Study|Lost to Follow-up|0
2274614|NCT02298179|3955652|FG002|Overall Study|Lost to Follow-up|1
2274615|NCT02298179|3955653|FG003|Overall Study|Lost to Follow-up|0
2274616|NCT02298179|3955654|FG004|Overall Study|Lost to Follow-up|0
2274617|NCT02298179|3955655|FG005|Overall Study|Lost to Follow-up|0
2274618|NCT02298179|3955656|FG006|Overall Study|Lost to Follow-up|0
2274619|NCT02298179|3955657|FG007|Overall Study|Lost to Follow-up|1
2333873|NCT03235050|4058773|FG004|Overall Study|Death|1
2333874|NCT03235050|4058769|FG000|Overall Study|Lost to Follow-up|1
2333875|NCT03235050|4058770|FG001|Overall Study|Lost to Follow-up|2
2333876|NCT03235050|4058771|FG002|Overall Study|Lost to Follow-up|1
2333877|NCT03235050|4058772|FG003|Overall Study|Lost to Follow-up|2
2333878|NCT03235050|4058773|FG004|Overall Study|Lost to Follow-up|0
2333879|NCT03235050|4058769|FG000|Overall Study|Withdrawal by Subject|3
2333880|NCT03235050|4058770|FG001|Overall Study|Withdrawal by Subject|2
2333881|NCT03235050|4058771|FG002|Overall Study|Withdrawal by Subject|2
2333882|NCT03235050|4058772|FG003|Overall Study|Withdrawal by Subject|5
2333883|NCT03235050|4058773|FG004|Overall Study|Withdrawal by Subject|7
2333884|NCT03235050|4058769|FG000|Overall Study|Other reasons|0
2333885|NCT03235050|4058770|FG001|Overall Study|Other reasons|1
2333886|NCT03235050|4058771|FG002|Overall Study|Other reasons|0
2333887|NCT03235050|4058772|FG003|Overall Study|Other reasons|1
2333888|NCT03235050|4058773|FG004|Overall Study|Other reasons|2
2333889|NCT03235089|4058785|FG000|Overall Study|Lost to Follow-up|1
2333890|NCT03235089|4058786|FG001|Overall Study|Lost to Follow-up|1
2333891|NCT03235089|4058785|FG000|Overall Study|Physician Decision|2
2333892|NCT03235089|4058786|FG001|Overall Study|Physician Decision|2
2333893|NCT03235115|4058793|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2333894|NCT03235115|4058794|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2333895|NCT03235115|4058795|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2333896|NCT03235115|4058796|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2333897|NCT03235115|4058797|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2333898|NCT03235115|4058798|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
2333899|NCT03235154|4058806|FG000|Overall Study|Withdrawal by Subject|1
2333900|NCT03235154|4058806|FG000|Overall Study|Adverse Event|1
2333901|NCT03235154|4058806|FG000|Overall Study|Lost to Follow-up|2
2274620|NCT02298179|3955658|FG008|Overall Study|Lost to Follow-up|0
2274621|NCT02298179|3955659|FG009|Overall Study|Lost to Follow-up|0
2274622|NCT02298179|3955660|FG010|Overall Study|Lost to Follow-up|0
2274623|NCT02298179|3955661|FG011|Overall Study|Lost to Follow-up|0
2274624|NCT02298192|3955689|FG000|Overall Study|Unclassified|3
2274625|NCT02298192|3955690|FG001|Overall Study|Unclassified|2
2274626|NCT02298192|3955689|FG000|Overall Study|Withdrawal criteria|2
2274627|NCT02298192|3955690|FG001|Overall Study|Withdrawal criteria|0
2274628|NCT02298192|3955689|FG000|Overall Study|Withdrawal by Subject|6
2234067|NCT01863849|3887588|FG000|Overall Study|Lost to Follow-up|1
2234068|NCT01863849|3887589|FG001|Overall Study|Lost to Follow-up|0
2234069|NCT01863953|3887599|FG000|Overall Study|Adverse Event|0
2234070|NCT01863953|3887600|FG001|Overall Study|Adverse Event|0
2234071|NCT01863953|3887601|FG002|Overall Study|Adverse Event|1
2234072|NCT01864005|3887611|FG000|Overall Study|Protocol Violation|0
2234073|NCT01864005|3887612|FG001|Overall Study|Protocol Violation|1
2234074|NCT01864005|3887611|FG000|Overall Study|Withdrawal by Subject|0
2234075|NCT01864005|3887612|FG001|Overall Study|Withdrawal by Subject|1
2234076|NCT01864005|3887611|FG000|Overall Study|Incorrect enrolment|1
2234077|NCT01864005|3887612|FG001|Overall Study|Incorrect enrolment|0
2234078|NCT01864005|3887611|FG000|Overall Study|Disease need|1
2234079|NCT01864005|3887612|FG001|Overall Study|Disease need|1
2234080|NCT01864005|3887611|FG000|Overall Study|Need GP IIb/IIIa|1
2234081|NCT01864005|3887612|FG001|Overall Study|Need GP IIb/IIIa|3
2234082|NCT01864148|3887623|FG000|Overall Study|Other|2
2234083|NCT01864148|3887624|FG001|Overall Study|Other|1
2234084|NCT01864148|3887625|FG002|Overall Study|Other|1
2234085|NCT01864148|3887626|FG003|Overall Study|Other|3
2234086|NCT01864148|3887627|FG004|Overall Study|Other|1
2234087|NCT01864148|3887623|FG000|Overall Study|Death|0
2234088|NCT01864148|3887624|FG001|Overall Study|Death|0
2234089|NCT01864148|3887625|FG002|Overall Study|Death|0
2234090|NCT01864148|3887626|FG003|Overall Study|Death|1
2234091|NCT01864148|3887627|FG004|Overall Study|Death|0
2234092|NCT01864148|3887623|FG000|Overall Study|Investigator Decision|5
2234093|NCT01864148|3887624|FG001|Overall Study|Investigator Decision|0
2234094|NCT01864148|3887625|FG002|Overall Study|Investigator Decision|0
2234095|NCT01864148|3887626|FG003|Overall Study|Investigator Decision|4
2234096|NCT01864148|3887627|FG004|Overall Study|Investigator Decision|6
2234097|NCT01864148|3887623|FG000|Overall Study|Withdrawal by Subject|9
2234098|NCT01864148|3887624|FG001|Overall Study|Withdrawal by Subject|2
2234099|NCT01864148|3887625|FG002|Overall Study|Withdrawal by Subject|6
2234100|NCT01864148|3887626|FG003|Overall Study|Withdrawal by Subject|8
2234101|NCT01864148|3887627|FG004|Overall Study|Withdrawal by Subject|8
2234102|NCT01864148|3887623|FG000|Overall Study|Lost to Follow-up|0
2234103|NCT01864148|3887624|FG001|Overall Study|Lost to Follow-up|0
2234104|NCT01864148|3887625|FG002|Overall Study|Lost to Follow-up|0
2234105|NCT01864148|3887626|FG003|Overall Study|Lost to Follow-up|2
2234106|NCT01864148|3887627|FG004|Overall Study|Lost to Follow-up|1
2234107|NCT01864148|3887623|FG000|Overall Study|Adverse Event|4
2234108|NCT01864148|3887624|FG001|Overall Study|Adverse Event|2
2234109|NCT01864148|3887625|FG002|Overall Study|Adverse Event|4
2234110|NCT01864148|3887626|FG003|Overall Study|Adverse Event|7
2234111|NCT01864148|3887627|FG004|Overall Study|Adverse Event|7
2234112|NCT01864148|3887623|FG000|Overall Study|Not Dosed|0
2234113|NCT01864148|3887624|FG001|Overall Study|Not Dosed|0
2234114|NCT01864148|3887625|FG002|Overall Study|Not Dosed|0
2234115|NCT01864148|3887626|FG003|Overall Study|Not Dosed|1
2234116|NCT01864148|3887627|FG004|Overall Study|Not Dosed|0
2234117|NCT01864174|3887646|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
2234118|NCT01864174|3887647|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
2234119|NCT01864174|3887646|FG000|Double Blind - Compliant Randomized|Adverse Event|6
2234120|NCT01864174|3887647|FG001|Double Blind - Compliant Randomized|Adverse Event|1
2234121|NCT01864174|3887646|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
2234122|NCT01864174|3887647|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
2234123|NCT01864174|3887646|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
2234124|NCT01864174|3887647|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
2234125|NCT01864174|3887646|FG000|Double Blind - Compliant Randomized|Death|1
2234126|NCT01864174|3887647|FG001|Double Blind - Compliant Randomized|Death|0
2234127|NCT01864174|3887646|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3
2234128|NCT01864174|3887647|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10
2234129|NCT01864174|3887646|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1
2234130|NCT01864174|3887647|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0
2234131|NCT01864174|3887646|FG000|Double Blind - Compliant Randomized|Other|6
2234132|NCT01864174|3887647|FG001|Double Blind - Compliant Randomized|Other|10
2333902|NCT03235284|4058819|FG000|Overall Study|Adverse Event|1
2333903|NCT03235284|4058820|FG001|Overall Study|Adverse Event|2
2333904|NCT03235284|4058821|FG002|Overall Study|Adverse Event|1
2333905|NCT03235349|4058829|FG000|Overall Study|Adverse Event|1
2234133|NCT01864174|3887646|FG000|Off Treatment Follow-Up|Other|2
2234134|NCT01864174|3887647|FG001|Off Treatment Follow-Up|Other|0
2234135|NCT01864174|3887646|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1
2234136|NCT01864174|3887647|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0
2234137|NCT01864200|3887655|FG000|Overall Study|Lost to Follow-up|1
2234138|NCT01864200|3887656|FG001|Overall Study|Lost to Follow-up|3
2234139|NCT01864200|3887655|FG000|Overall Study|Protocol Violation|1
2234140|NCT01864200|3887656|FG001|Overall Study|Protocol Violation|0
2234141|NCT01864291|3887662|FG000|Overall Study|need for revision surgery|2
2234142|NCT01864525|3887677|FG000|Overall Study|Adverse Event|1
2234143|NCT01864525|3887678|FG001|Overall Study|Adverse Event|0
2234144|NCT01864564|3887690|FG000|Overall Study|Lost to Follow-up|17
2234145|NCT01864564|3887691|FG001|Overall Study|Lost to Follow-up|23
2234146|NCT01864564|3887690|FG000|Overall Study|Withdrawal by Subject|20
2234147|NCT01864564|3887691|FG001|Overall Study|Withdrawal by Subject|11
2234148|NCT01864564|3887690|FG000|Overall Study|Protocol Violation|0
2234149|NCT01864564|3887691|FG001|Overall Study|Protocol Violation|27
2234150|NCT01864564|3887690|FG000|Overall Study|not reported|0
2234151|NCT01864564|3887691|FG001|Overall Study|not reported|34
2234152|NCT01865084|3887700|FG000|Double Blind Period (DB)|Adverse Event|2
2234153|NCT01865084|3887701|FG001|Double Blind Period (DB)|Adverse Event|2
2234154|NCT01865084|3887702|FG002|Double Blind Period (DB)|Adverse Event|1
2234155|NCT01865084|3887700|FG000|Double Blind Period (DB)|Protocol Violation|0
2234156|NCT01865084|3887701|FG001|Double Blind Period (DB)|Protocol Violation|0
2234157|NCT01865084|3887702|FG002|Double Blind Period (DB)|Protocol Violation|1
2234158|NCT01865084|3887700|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
2234159|NCT01865084|3887701|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
2234160|NCT01865084|3887702|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
2234161|NCT01865084|3887700|FG000|Double Blind Period (DB)|Withdrawal by Subject|1
2234162|NCT01865084|3887701|FG001|Double Blind Period (DB)|Withdrawal by Subject|0
2234163|NCT01865084|3887702|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
2234164|NCT01865084|3887700|FG000|Open Label Extension (OLE) Period|Adverse Event|0
2234165|NCT01865084|3887701|FG001|Open Label Extension (OLE) Period|Adverse Event|0
2234166|NCT01865084|3887702|FG002|Open Label Extension (OLE) Period|Adverse Event|1
2234167|NCT01865084|3887700|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0
2234168|NCT01865084|3887701|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0
2234169|NCT01865084|3887702|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2
2234170|NCT01865084|3887700|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0
2234171|NCT01865084|3887701|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1
2234172|NCT01865084|3887702|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0
2234173|NCT01865084|3887700|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
2234174|NCT01865084|3887701|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
2234175|NCT01865084|3887702|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
2234176|NCT01865084|3887700|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
2234177|NCT01865084|3887701|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2
2234178|NCT01865084|3887702|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2
2234179|NCT01865448|3887716|FG000|Overall Study|Adverse Event|1
2234180|NCT01865448|3887717|FG001|Overall Study|Adverse Event|1
2234181|NCT01865448|3887716|FG000|Overall Study|Pregnancy|0
2234182|NCT01865448|3887717|FG001|Overall Study|Pregnancy|1
2234183|NCT01865448|3887716|FG000|Overall Study|dropout unrelated to study|1
2234184|NCT01865448|3887717|FG001|Overall Study|dropout unrelated to study|1
2234185|NCT01865487|3887730|FG000|Overall Study|Lost to Follow-up|0
2234186|NCT01865487|3887731|FG001|Overall Study|Lost to Follow-up|0
2234187|NCT01865487|3887732|FG002|Overall Study|Lost to Follow-up|0
2234188|NCT01865487|3887733|FG003|Overall Study|Lost to Follow-up|1
2234189|NCT01865487|3887734|FG004|Overall Study|Lost to Follow-up|0
2234190|NCT01865487|3887735|FG005|Overall Study|Lost to Follow-up|0
2234191|NCT01865487|3887736|FG006|Overall Study|Lost to Follow-up|1
2234192|NCT01865487|3887737|FG007|Overall Study|Lost to Follow-up|0
2234193|NCT01865487|3887738|FG008|Overall Study|Lost to Follow-up|0
2234194|NCT01865487|3887739|FG009|Overall Study|Lost to Follow-up|0
2234195|NCT01865487|3887730|FG000|Overall Study|Withdrawal by Subject|0
2234196|NCT01865487|3887731|FG001|Overall Study|Withdrawal by Subject|0
2234197|NCT01865487|3887732|FG002|Overall Study|Withdrawal by Subject|0
2234198|NCT01865487|3887733|FG003|Overall Study|Withdrawal by Subject|0
2234199|NCT01865487|3887734|FG004|Overall Study|Withdrawal by Subject|1
2234200|NCT01865487|3887735|FG005|Overall Study|Withdrawal by Subject|0
2234201|NCT01865487|3887736|FG006|Overall Study|Withdrawal by Subject|0
2234202|NCT01865487|3887737|FG007|Overall Study|Withdrawal by Subject|0
2234203|NCT01865487|3887738|FG008|Overall Study|Withdrawal by Subject|0
2234204|NCT01865487|3887739|FG009|Overall Study|Withdrawal by Subject|0
2234205|NCT01865552|3887773|FG000|Period 1|Adverse Event|1
2234206|NCT01865552|3887774|FG001|Period 1|Adverse Event|0
2234207|NCT01865552|3887775|FG002|Period 1|Adverse Event|0
2234208|NCT01865552|3887776|FG003|Period 1|Adverse Event|1
2234209|NCT01865552|3887777|FG004|Period 1|Adverse Event|1
2234210|NCT01865552|3887778|FG005|Period 1|Adverse Event|1
2234211|NCT01865552|3887773|FG000|Period 1|Pathological lab|0
2234212|NCT01865552|3887774|FG001|Period 1|Pathological lab|0
2234213|NCT01865552|3887775|FG002|Period 1|Pathological lab|0
2333906|NCT03235349|4058829|FG000|Overall Study|Other|1
2333907|NCT03235479|4058839|FG000|Overall Study|Lost to Follow-up|8
2333908|NCT03235479|4058840|FG001|Overall Study|Lost to Follow-up|11
2333909|NCT03235479|4058839|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23
2333910|NCT03235479|4058840|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17
2333911|NCT03235479|4058839|FG000|Overall Study|Pregnancy|1
2234214|NCT01865552|3887776|FG003|Period 1|Pathological lab|0
2234215|NCT01865552|3887777|FG004|Period 1|Pathological lab|1
2234216|NCT01865552|3887778|FG005|Period 1|Pathological lab|0
2234217|NCT01865552|3887773|FG000|Period 1|Other|0
2234218|NCT01865552|3887774|FG001|Period 1|Other|0
2234219|NCT01865552|3887775|FG002|Period 1|Other|0
2234220|NCT01865552|3887776|FG003|Period 1|Other|0
2234221|NCT01865552|3887777|FG004|Period 1|Other|1
2234222|NCT01865552|3887778|FG005|Period 1|Other|0
2234223|NCT01865747|3887798|FG000|Overall Study (ITT)|Adverse Event|32
2234224|NCT01865747|3887799|FG001|Overall Study (ITT)|Adverse Event|31
2234225|NCT01865747|3887798|FG000|Overall Study (ITT)|Clinical Deterioration|29
2234226|NCT01865747|3887799|FG001|Overall Study (ITT)|Clinical Deterioration|50
2234227|NCT01865747|3887798|FG000|Overall Study (ITT)|Lack of Efficacy|3
2234228|NCT01865747|3887799|FG001|Overall Study (ITT)|Lack of Efficacy|0
2234229|NCT01865747|3887798|FG000|Overall Study (ITT)|Protocol Violation|1
2234230|NCT01865747|3887799|FG001|Overall Study (ITT)|Protocol Violation|1
2234231|NCT01865747|3887798|FG000|Overall Study (ITT)|Physician Decision|5
2234232|NCT01865747|3887799|FG001|Overall Study (ITT)|Physician Decision|2
2234233|NCT01865747|3887798|FG000|Overall Study (ITT)|Withdrawal by Subject|6
2234234|NCT01865747|3887799|FG001|Overall Study (ITT)|Withdrawal by Subject|11
2234235|NCT01865747|3887798|FG000|Overall Study (ITT)|Sponsor Decision|0
2234236|NCT01865747|3887799|FG001|Overall Study (ITT)|Sponsor Decision|1
2234237|NCT01865747|3887798|FG000|Overall Study (ITT)|Progressive Disease|122
2234238|NCT01865747|3887799|FG001|Overall Study (ITT)|Progressive Disease|158
2234239|NCT01865747|3887798|FG000|Overall Study (ITT)|Reason Not Provided|0
2234240|NCT01865747|3887799|FG001|Overall Study (ITT)|Reason Not Provided|1
2234241|NCT01865747|3887798|FG000|Primary Intent to Treat (PITT)|Adverse Event|21
2234242|NCT01865747|3887799|FG001|Primary Intent to Treat (PITT)|Adverse Event|20
2234243|NCT01865747|3887798|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18
2234244|NCT01865747|3887799|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29
2234245|NCT01865747|3887798|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2
2234246|NCT01865747|3887799|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0
2234247|NCT01865747|3887798|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1
2234248|NCT01865747|3887799|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1
2234249|NCT01865747|3887798|FG000|Primary Intent to Treat (PITT)|Physician Decision|4
2234250|NCT01865747|3887799|FG001|Primary Intent to Treat (PITT)|Physician Decision|2
2234251|NCT01865747|3887798|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
2234252|NCT01865747|3887799|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
2234253|NCT01865747|3887798|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82
2234254|NCT01865747|3887799|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92
2234255|NCT01865747|3887798|FG000|Primary Intent to Treat (PITT)|Other|0
2234256|NCT01865747|3887799|FG001|Primary Intent to Treat (PITT)|Other|1
2234257|NCT01865812|3887805|FG000|Overall Study|Adverse Event|2
2234258|NCT01866098|3887812|FG000|Overall Study|Lost to Follow-up|11
2234259|NCT01866098|3887813|FG001|Overall Study|Lost to Follow-up|18
2234260|NCT01866098|3887814|FG002|Overall Study|Lost to Follow-up|13
2234261|NCT01866098|3887812|FG000|Overall Study|Physician Decision|0
2234262|NCT01866098|3887813|FG001|Overall Study|Physician Decision|1
2234263|NCT01866098|3887814|FG002|Overall Study|Physician Decision|2
2234264|NCT01866098|3887812|FG000|Overall Study|Adverse Event|1
2234265|NCT01866098|3887813|FG001|Overall Study|Adverse Event|5
2234266|NCT01866098|3887814|FG002|Overall Study|Adverse Event|4
2234267|NCT01866098|3887812|FG000|Overall Study|Protocol Violation|1
2234268|NCT01866098|3887813|FG001|Overall Study|Protocol Violation|0
2234269|NCT01866098|3887814|FG002|Overall Study|Protocol Violation|0
2234270|NCT01866098|3887812|FG000|Overall Study|Withdrawal by Subject|1
2234271|NCT01866098|3887813|FG001|Overall Study|Withdrawal by Subject|2
2234272|NCT01866098|3887814|FG002|Overall Study|Withdrawal by Subject|0
2234273|NCT01866098|3887812|FG000|Overall Study|Unrelated Hospitalization|2
2234274|NCT01866098|3887813|FG001|Overall Study|Unrelated Hospitalization|0
2234275|NCT01866098|3887814|FG002|Overall Study|Unrelated Hospitalization|1
2234276|NCT01866098|3887812|FG000|Overall Study|Non-compliance|1
2234277|NCT01866098|3887813|FG001|Overall Study|Non-compliance|0
2234278|NCT01866098|3887814|FG002|Overall Study|Non-compliance|1
2234279|NCT01866098|3887812|FG000|Overall Study|Pregnancy|2
2234280|NCT01866098|3887813|FG001|Overall Study|Pregnancy|0
2234281|NCT01866098|3887814|FG002|Overall Study|Pregnancy|0
2234282|NCT01866098|3887812|FG000|Overall Study|Death|0
2234283|NCT01866098|3887813|FG001|Overall Study|Death|1
2234284|NCT01866098|3887814|FG002|Overall Study|Death|0
2234285|NCT01866293|3887838|FG000|Overall Study|Adverse Event|2
2234286|NCT01866319|3887874|FG000|Overall Study|Adverse Event|12
2234287|NCT01866319|3887875|FG001|Overall Study|Adverse Event|5
2234288|NCT01866319|3887876|FG002|Overall Study|Adverse Event|9
2234289|NCT01866319|3887874|FG000|Overall Study|Clinical progression|3
2234290|NCT01866319|3887875|FG001|Overall Study|Clinical progression|2
2234291|NCT01866319|3887876|FG002|Overall Study|Clinical progression|2
2234292|NCT01866319|3887874|FG000|Overall Study|Death|153
2234293|NCT01866319|3887875|FG001|Overall Study|Death|154
2234294|NCT01866319|3887876|FG002|Overall Study|Death|147
2036739|NCT00413374|3606976|FG000|Overall Study|Adverse Event|1
2234295|NCT01866319|3887874|FG000|Overall Study|Lost to Follow-up|6
2234296|NCT01866319|3887875|FG001|Overall Study|Lost to Follow-up|3
2234297|NCT01866319|3887876|FG002|Overall Study|Lost to Follow-up|8
2234298|NCT01866319|3887874|FG000|Overall Study|Physician Decision|1
2234299|NCT01866319|3887875|FG001|Overall Study|Physician Decision|0
2234300|NCT01866319|3887876|FG002|Overall Study|Physician Decision|1
2234301|NCT01866319|3887874|FG000|Overall Study|Protocol Violation|0
2234302|NCT01866319|3887875|FG001|Overall Study|Protocol Violation|0
2234303|NCT01866319|3887876|FG002|Overall Study|Protocol Violation|1
2234304|NCT01866319|3887874|FG000|Overall Study|Withdrawal by Subject|32
2234305|NCT01866319|3887875|FG001|Overall Study|Withdrawal by Subject|14
2234306|NCT01866319|3887876|FG002|Overall Study|Withdrawal by Subject|12
2234307|NCT01866423|3887891|FG000|Overall Study|Lack of Efficacy|3
2234308|NCT01866423|3887891|FG000|Overall Study|Sponsor Decision|1
2234309|NCT01866826|3887899|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
2234310|NCT01866826|3887900|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
2234311|NCT01866826|3887899|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
2234312|NCT01866826|3887900|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
2234313|NCT01866826|3887899|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
2234314|NCT01866826|3887900|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
2234315|NCT01866917|3887912|FG000|Overall Study|Pharmacist stopped dispensing treatment|4
2234316|NCT01866917|3887913|FG001|Overall Study|Pharmacist stopped dispensing treatment|6
2234317|NCT01867008|3887931|FG000|Overall Study|Withdrawal by Subject|1
2234318|NCT01867021|3887937|FG000|Overall Study|Adverse Event|0
2234319|NCT01867021|3887938|FG001|Overall Study|Adverse Event|1
2234320|NCT01867021|3887937|FG000|Overall Study|Not Eligible|0
2234321|NCT01867021|3887938|FG001|Overall Study|Not Eligible|1
2234322|NCT01867021|3887937|FG000|Overall Study|Death|1
2234323|NCT01867021|3887938|FG001|Overall Study|Death|0
2234324|NCT01867021|3887937|FG000|Overall Study|Lost to Follow-up|0
2234325|NCT01867021|3887938|FG001|Overall Study|Lost to Follow-up|2
2234326|NCT01867021|3887937|FG000|Overall Study|Withdrawal by Subject|1
2234327|NCT01867021|3887938|FG001|Overall Study|Withdrawal by Subject|6
2234328|NCT01867047|3887951|FG000|Overall Study|Lost to Follow-up|3
2234329|NCT01867047|3887952|FG001|Overall Study|Lost to Follow-up|3
2234330|NCT01867047|3887951|FG000|Overall Study|Withdrawal by Subject|2
2234331|NCT01867047|3887952|FG001|Overall Study|Withdrawal by Subject|0
2234332|NCT01867047|3887951|FG000|Overall Study|Physician Decision|2
2234333|NCT01867047|3887952|FG001|Overall Study|Physician Decision|0
2234334|NCT01867047|3887951|FG000|Overall Study|surgery not indicated in protocol|1
2234335|NCT01867047|3887952|FG001|Overall Study|surgery not indicated in protocol|2
2234336|NCT01867086|3887962|FG000|Overall Study|Disease Progression|1
2234337|NCT01867216|3887982|FG000|Overall Study|Withdrawal by Subject|2
2234338|NCT01867216|3887983|FG001|Overall Study|Withdrawal by Subject|0
2234339|NCT01867216|3887984|FG002|Overall Study|Withdrawal by Subject|0
2234340|NCT01867216|3887985|FG003|Overall Study|Withdrawal by Subject|0
2234341|NCT01867216|3887986|FG004|Overall Study|Withdrawal by Subject|1
2234342|NCT01867216|3887987|FG005|Overall Study|Withdrawal by Subject|0
2234343|NCT01867216|3887988|FG006|Overall Study|Withdrawal by Subject|1
2234344|NCT01867216|3887982|FG000|Overall Study|Physician Decision|1
2234345|NCT01867216|3887983|FG001|Overall Study|Physician Decision|0
2234346|NCT01867216|3887984|FG002|Overall Study|Physician Decision|0
2234347|NCT01867216|3887985|FG003|Overall Study|Physician Decision|0
2234348|NCT01867216|3887986|FG004|Overall Study|Physician Decision|0
2234349|NCT01867216|3887987|FG005|Overall Study|Physician Decision|0
2234350|NCT01867216|3887988|FG006|Overall Study|Physician Decision|0
2234351|NCT01867216|3887982|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1
2234352|NCT01867216|3887983|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0
2234353|NCT01867216|3887984|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0
2234354|NCT01867216|3887985|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0
2234355|NCT01867216|3887986|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0
2234356|NCT01867216|3887987|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0
2234357|NCT01867216|3887988|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0
2234358|NCT01867294|3888014|FG000|Overall Study|Withdrawal by Subject|1
2234359|NCT01867294|3888015|FG001|Overall Study|Withdrawal by Subject|1
2234360|NCT01867294|3888016|FG002|Overall Study|Withdrawal by Subject|0
2234361|NCT01867294|3888017|FG003|Overall Study|Withdrawal by Subject|0
2234362|NCT01867307|3888027|FG000|Overall Study|Protocol Violation|2
2234363|NCT01867307|3888028|FG001|Overall Study|Protocol Violation|0
2234364|NCT01867307|3888027|FG000|Overall Study|Other Adverse Event|1
2234365|NCT01867307|3888028|FG001|Overall Study|Other Adverse Event|3
2333912|NCT03235479|4058840|FG001|Overall Study|Pregnancy|0
2333913|NCT03235479|4058839|FG000|Overall Study|Protocol Deviation|1
2333914|NCT03235479|4058840|FG001|Overall Study|Protocol Deviation|3
2333915|NCT03235479|4058839|FG000|Overall Study|Technical Problems|3
2333916|NCT03235479|4058840|FG001|Overall Study|Technical Problems|2
2333917|NCT03235479|4058839|FG000|Overall Study|Withdrawal by Subject|2
2333918|NCT03235479|4058840|FG001|Overall Study|Withdrawal by Subject|2
2333919|NCT03235479|4058839|FG000|Overall Study|Other Reasons|3
2333920|NCT03235479|4058840|FG001|Overall Study|Other Reasons|5
2333921|NCT03235726|4058854|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2333922|NCT03235726|4058855|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2333923|NCT03235726|4058856|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2333924|NCT03235726|4058857|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2333925|NCT03235726|4058858|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
2234366|NCT01867424|3888036|FG000|Overall Study|Patient noncompliance|2
2234367|NCT01867424|3888037|FG001|Overall Study|Patient noncompliance|1
2234368|NCT01867580|3888058|FG000|Overall Study|Withdrawal by Subject|2
2234369|NCT01867580|3888059|FG001|Overall Study|Withdrawal by Subject|3
2234370|NCT01867580|3888058|FG000|Overall Study|Physician Decision|17
2234371|NCT01867580|3888059|FG001|Overall Study|Physician Decision|12
2234372|NCT01867580|3888058|FG000|Overall Study|Lost to Follow-up|3
2234373|NCT01867580|3888059|FG001|Overall Study|Lost to Follow-up|5
2234374|NCT01867580|3888058|FG000|Overall Study|Sponsor terminated study|1
2234375|NCT01867580|3888059|FG001|Overall Study|Sponsor terminated study|0
2234376|NCT01867580|3888058|FG000|Overall Study|Missed follow-up assessment|2
2234377|NCT01867580|3888059|FG001|Overall Study|Missed follow-up assessment|1
2234378|NCT01867580|3888058|FG000|Overall Study|Interruption to therapy|3
2234379|NCT01867580|3888059|FG001|Overall Study|Interruption to therapy|0
2234380|NCT01867580|3888058|FG000|Overall Study|Osteomyelitis|0
2234381|NCT01867580|3888059|FG001|Overall Study|Osteomyelitis|1
2234382|NCT01867580|3888058|FG000|Overall Study|Continuation of therapy|0
2234383|NCT01867580|3888059|FG001|Overall Study|Continuation of therapy|1
2234384|NCT01867580|3888058|FG000|Overall Study|Wound recurrence|0
2234385|NCT01867580|3888059|FG001|Overall Study|Wound recurrence|1
2234386|NCT01867658|3888074|FG000|Overall Study|Withdrawal by Subject|6
2234387|NCT01867658|3888074|FG000|Overall Study|Death|2
2234388|NCT01867658|3888074|FG000|Overall Study|Subject could not be contacted|1
2234389|NCT01867671|3888080|FG000|Overall Study|Adverse Event|5
2234390|NCT01867671|3888081|FG001|Overall Study|Adverse Event|3
2234391|NCT01867671|3888080|FG000|Overall Study|Anaphylaxis|0
2234392|NCT01867671|3888081|FG001|Overall Study|Anaphylaxis|1
2234393|NCT01867671|3888080|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2
2234394|NCT01867671|3888081|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0
2234395|NCT01867671|3888080|FG000|Overall Study|Lost to Follow-up|0
2234396|NCT01867671|3888081|FG001|Overall Study|Lost to Follow-up|1
2234397|NCT01867671|3888080|FG000|Overall Study|Non-compliance with Study Drug|1
2234398|NCT01867671|3888081|FG001|Overall Study|Non-compliance with Study Drug|2
2234399|NCT01867671|3888080|FG000|Overall Study|Withdrawal by Subject|21
2234400|NCT01867671|3888081|FG001|Overall Study|Withdrawal by Subject|21
2234401|NCT01867710|3888091|FG000|Overall Study|Death|25
2234402|NCT01867710|3888092|FG001|Overall Study|Death|15
2234403|NCT01867710|3888093|FG002|Overall Study|Death|27
2234404|NCT01867710|3888094|FG003|Overall Study|Death|20
2234405|NCT01867710|3888091|FG000|Overall Study|Lost to Follow-up|3
2234406|NCT01867710|3888092|FG001|Overall Study|Lost to Follow-up|4
2333926|NCT03235726|4058859|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2333927|NCT03235726|4058860|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2333928|NCT03235726|4058861|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2333929|NCT03235726|4058862|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2333930|NCT03235726|4058863|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2333931|NCT03235726|4058854|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2333932|NCT03235726|4058855|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2333933|NCT03235726|4058856|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2333934|NCT03235726|4058857|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2333935|NCT03235726|4058858|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
2333936|NCT03235726|4058859|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2333937|NCT03235726|4058860|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2333938|NCT03235726|4058861|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2333939|NCT03235726|4058862|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2333940|NCT03235726|4058863|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2333941|NCT03236246|4058918|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8
2333942|NCT03236246|4058919|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7
2333943|NCT03236246|4058918|FG000|24-Week Dose Titration Period|Lost to Follow-up|0
2333944|NCT03236246|4058919|FG001|24-Week Dose Titration Period|Lost to Follow-up|2
2333945|NCT03236246|4058918|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3
2333946|NCT03236246|4058919|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2
2333947|NCT03236246|4058918|FG000|24-Week Dose Titration Period|Investigator Judgement|1
2333948|NCT03236246|4058919|FG001|24-Week Dose Titration Period|Investigator Judgement|1
2333949|NCT03236246|4058918|FG000|24-Week Dose Titration Period|Prohibited Therapy|1
2333950|NCT03236246|4058919|FG001|24-Week Dose Titration Period|Prohibited Therapy|1
2333951|NCT03236246|4058918|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0
2036740|NCT00413374|3606977|FG001|Overall Study|Adverse Event|0
2036741|NCT00413374|3606976|FG000|Overall Study|Lost to Follow-up|1
2036742|NCT00413374|3606977|FG001|Overall Study|Lost to Follow-up|0
2036743|NCT00413374|3606976|FG000|Overall Study|Surgery|1
2036744|NCT00413374|3606977|FG001|Overall Study|Surgery|0
2036745|NCT00413413|3606998|FG000|Single-Blind|Adverse Event|0
2036746|NCT00413413|3606999|FG001|Single-Blind|Adverse Event|9
2036747|NCT00413413|3607000|FG002|Single-Blind|Adverse Event|0
2036748|NCT00413413|3606998|FG000|Single-Blind|Lack of Efficacy|0
2036749|NCT00413413|3606999|FG001|Single-Blind|Lack of Efficacy|5
2036750|NCT00413413|3607000|FG002|Single-Blind|Lack of Efficacy|0
2036751|NCT00413413|3606998|FG000|Single-Blind|Subject no longer requires study drug|0
2036752|NCT00413413|3606999|FG001|Single-Blind|Subject no longer requires study drug|151
2234407|NCT01867710|3888093|FG002|Overall Study|Lost to Follow-up|3
2234408|NCT01867710|3888094|FG003|Overall Study|Lost to Follow-up|2
2234409|NCT01867710|3888091|FG000|Overall Study|Withdrawal of consent|2
2234410|NCT01867710|3888092|FG001|Overall Study|Withdrawal of consent|5
2234411|NCT01867710|3888093|FG002|Overall Study|Withdrawal of consent|1
2234412|NCT01867710|3888094|FG003|Overall Study|Withdrawal of consent|2
2234413|NCT01867710|3888091|FG000|Overall Study|Study Terminated by Sponsor|9
2234414|NCT01867710|3888092|FG001|Overall Study|Study Terminated by Sponsor|13
2234415|NCT01867710|3888093|FG002|Overall Study|Study Terminated by Sponsor|8
2234416|NCT01867710|3888094|FG003|Overall Study|Study Terminated by Sponsor|16
2234417|NCT01867710|3888091|FG000|Overall Study|Biochemical progression|0
2234418|NCT01867710|3888092|FG001|Overall Study|Biochemical progression|1
2234419|NCT01867710|3888093|FG002|Overall Study|Biochemical progression|0
2234420|NCT01867710|3888094|FG003|Overall Study|Biochemical progression|0
2234421|NCT01867710|3888091|FG000|Overall Study|Clinical progression|0
2234422|NCT01867710|3888092|FG001|Overall Study|Clinical progression|0
2234423|NCT01867710|3888093|FG002|Overall Study|Clinical progression|1
2234424|NCT01867710|3888094|FG003|Overall Study|Clinical progression|0
2234425|NCT01867710|3888091|FG000|Overall Study|Disease progression|1
2234426|NCT01867710|3888092|FG001|Overall Study|Disease progression|0
2234427|NCT01867710|3888093|FG002|Overall Study|Disease progression|0
2234428|NCT01867710|3888094|FG003|Overall Study|Disease progression|0
2234429|NCT01867710|3888091|FG000|Overall Study|Patient decision|0
2234430|NCT01867710|3888092|FG001|Overall Study|Patient decision|0
2234431|NCT01867710|3888093|FG002|Overall Study|Patient decision|0
2234432|NCT01867710|3888094|FG003|Overall Study|Patient decision|1
2234433|NCT01867710|3888091|FG000|Overall Study|Patient to follow subsequent treatment|0
2234434|NCT01867710|3888092|FG001|Overall Study|Patient to follow subsequent treatment|1
2234435|NCT01867710|3888093|FG002|Overall Study|Patient to follow subsequent treatment|0
2234436|NCT01867710|3888094|FG003|Overall Study|Patient to follow subsequent treatment|0
2234437|NCT01867710|3888091|FG000|Overall Study|Progressive disease|1
2234438|NCT01867710|3888092|FG001|Overall Study|Progressive disease|0
2234439|NCT01867710|3888093|FG002|Overall Study|Progressive disease|0
2234440|NCT01867710|3888094|FG003|Overall Study|Progressive disease|0
2234441|NCT01867710|3888091|FG000|Overall Study|Protocol Violation|0
2234442|NCT01867710|3888092|FG001|Overall Study|Protocol Violation|0
2234443|NCT01867710|3888093|FG002|Overall Study|Protocol Violation|0
2234444|NCT01867710|3888094|FG003|Overall Study|Protocol Violation|1
2234445|NCT01867710|3888091|FG000|Overall Study|PSA-progression|0
2234446|NCT01867710|3888092|FG001|Overall Study|PSA-progression|1
2234447|NCT01867710|3888093|FG002|Overall Study|PSA-progression|0
2234448|NCT01867710|3888094|FG003|Overall Study|PSA-progression|0
2234449|NCT01867710|3888091|FG000|Overall Study|Study medication no longer effective|0
2234450|NCT01867710|3888092|FG001|Overall Study|Study medication no longer effective|1
2234451|NCT01867710|3888093|FG002|Overall Study|Study medication no longer effective|0
2234452|NCT01867710|3888094|FG003|Overall Study|Study medication no longer effective|0
2234453|NCT01868009|3888104|FG000|Period 1 (5-9 Days)|Adverse Event|0
2234454|NCT01868009|3888105|FG001|Period 1 (5-9 Days)|Adverse Event|2
2234455|NCT01868009|3888104|FG000|Period 2 (5-9 Days)|Adverse Event|1
2234456|NCT01868009|3888105|FG001|Period 2 (5-9 Days)|Adverse Event|0
2234457|NCT01868009|3888104|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
2234458|NCT01868009|3888105|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
2234459|NCT01868022|3888120|FG000|Overall Study|Withdrawal by Subject|0
2234460|NCT01868022|3888121|FG001|Overall Study|Withdrawal by Subject|0
2234461|NCT01868022|3888122|FG002|Overall Study|Withdrawal by Subject|1
2234462|NCT01868022|3888123|FG003|Overall Study|Withdrawal by Subject|1
2234463|NCT01868022|3888124|FG004|Overall Study|Withdrawal by Subject|0
2234464|NCT01868022|3888125|FG005|Overall Study|Withdrawal by Subject|0
2234465|NCT01868022|3888126|FG006|Overall Study|Withdrawal by Subject|0
2234466|NCT01868022|3888127|FG007|Overall Study|Withdrawal by Subject|1
2234467|NCT01868022|3888128|FG008|Overall Study|Withdrawal by Subject|0
2234468|NCT01868022|3888120|FG000|Overall Study|Adverse Event|0
2234469|NCT01868022|3888121|FG001|Overall Study|Adverse Event|0
2234470|NCT01868022|3888122|FG002|Overall Study|Adverse Event|0
2234471|NCT01868022|3888123|FG003|Overall Study|Adverse Event|0
2234472|NCT01868022|3888124|FG004|Overall Study|Adverse Event|2
2234473|NCT01868022|3888125|FG005|Overall Study|Adverse Event|0
2234474|NCT01868022|3888126|FG006|Overall Study|Adverse Event|0
2234475|NCT01868022|3888127|FG007|Overall Study|Adverse Event|2
2234476|NCT01868022|3888128|FG008|Overall Study|Adverse Event|2
2234477|NCT01868022|3888120|FG000|Overall Study|Physician Decision|0
2234478|NCT01868022|3888121|FG001|Overall Study|Physician Decision|0
2234479|NCT01868022|3888122|FG002|Overall Study|Physician Decision|0
2234480|NCT01868022|3888123|FG003|Overall Study|Physician Decision|0
2234481|NCT01868022|3888124|FG004|Overall Study|Physician Decision|0
2234482|NCT01868022|3888125|FG005|Overall Study|Physician Decision|1
2234483|NCT01868022|3888126|FG006|Overall Study|Physician Decision|0
2234484|NCT01868022|3888127|FG007|Overall Study|Physician Decision|2
2234485|NCT01868022|3888128|FG008|Overall Study|Physician Decision|0
2234486|NCT01868022|3888120|FG000|Overall Study|Study closed/terminated|0
2234487|NCT01868022|3888121|FG001|Overall Study|Study closed/terminated|0
2234488|NCT01868022|3888122|FG002|Overall Study|Study closed/terminated|0
2234489|NCT01868022|3888123|FG003|Overall Study|Study closed/terminated|0
2234490|NCT01868022|3888124|FG004|Overall Study|Study closed/terminated|0
2234491|NCT01868022|3888125|FG005|Overall Study|Study closed/terminated|0
2234492|NCT01868022|3888126|FG006|Overall Study|Study closed/terminated|0
2234493|NCT01868022|3888127|FG007|Overall Study|Study closed/terminated|1
2234494|NCT01868022|3888128|FG008|Overall Study|Study closed/terminated|0
2234495|NCT01868022|3888120|FG000|Overall Study|Ongoing|0
2234496|NCT01868022|3888121|FG001|Overall Study|Ongoing|0
2234497|NCT01868022|3888122|FG002|Overall Study|Ongoing|0
2234498|NCT01868022|3888123|FG003|Overall Study|Ongoing|0
2234499|NCT01868022|3888124|FG004|Overall Study|Ongoing|0
2234500|NCT01868022|3888125|FG005|Overall Study|Ongoing|0
2234501|NCT01868022|3888126|FG006|Overall Study|Ongoing|0
2234502|NCT01868022|3888127|FG007|Overall Study|Ongoing|3
2234503|NCT01868022|3888128|FG008|Overall Study|Ongoing|0
2234504|NCT01868035|3888154|FG000|Overall Study|Lost to Follow-up|3
2234505|NCT01868035|3888154|FG000|Overall Study|Withdrawal by Subject|1
2234506|NCT01868035|3888154|FG000|Overall Study|Progressive Disease|2
2234507|NCT01868035|3888154|FG000|Overall Study|Non-compliance|1
2234508|NCT01868074|3888160|FG000|Overall Study|Lost to Follow-up|3
2234509|NCT01868074|3888161|FG001|Overall Study|Lost to Follow-up|2
2234510|NCT01868074|3888160|FG000|Overall Study|Withdrawal by Subject|4
2234511|NCT01868074|3888161|FG001|Overall Study|Withdrawal by Subject|2
2234512|NCT01868165|3888167|FG000|Overall Study|Withdrawal by Subject|36
2234513|NCT01868165|3888167|FG000|Overall Study|Physician Decision|2
2234514|NCT01868165|3888167|FG000|Overall Study|Lost to Follow-up|3
2234515|NCT01868165|3888167|FG000|Overall Study|Death|4
2234516|NCT01868243|3888173|FG000|Overall Study|Death|0
2234517|NCT01868243|3888174|FG001|Overall Study|Death|1
2234518|NCT01868477|3888236|FG000|Overall Study|Adverse Event|2
2234519|NCT01868477|3888237|FG001|Overall Study|Adverse Event|4
2234520|NCT01868477|3888236|FG000|Overall Study|Disease progression|1
2234521|NCT01868477|3888237|FG001|Overall Study|Disease progression|1
2234522|NCT01868477|3888236|FG000|Overall Study|Withdrawal by Subject|1
2234523|NCT01868477|3888237|FG001|Overall Study|Withdrawal by Subject|0
2234524|NCT01868503|3888250|FG000|Overall Study|Withdrawal by Subject|1
2234525|NCT01868503|3888250|FG000|Overall Study|Protocol Violation|1
2234526|NCT01868542|3888258|FG000|Overall Study|Protocol Violation|0
2234527|NCT01868542|3888259|FG001|Overall Study|Protocol Violation|1
2234528|NCT01868542|3888258|FG000|Overall Study|Unclassified|0
2234529|NCT01868542|3888259|FG001|Overall Study|Unclassified|1
2234530|NCT01868594|3888267|FG000|Overall Study|Do not meet inclusion criteria|4
2234531|NCT01868594|3888268|FG001|Overall Study|Do not meet inclusion criteria|3
2333952|NCT03236246|4058919|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1
2333953|NCT03236246|4058918|FG000|24-Week Dose Titration Period|Death|3
2333954|NCT03236246|4058919|FG001|24-Week Dose Titration Period|Death|1
2333955|NCT03236246|4058918|FG000|24-Week Dose Titration Period|Protocol Violation|0
2333956|NCT03236246|4058919|FG001|24-Week Dose Titration Period|Protocol Violation|2
2333957|NCT03236246|4058918|FG000|24-Week Dose Titration Period|Adverse Event|7
2333958|NCT03236246|4058919|FG001|24-Week Dose Titration Period|Adverse Event|8
2333959|NCT03236246|4058918|FG000|24-Week Dose Titration Period|Captured as Other|1
2333960|NCT03236246|4058919|FG001|24-Week Dose Titration Period|Captured as Other|2
2333961|NCT03236246|4058918|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1
2333962|NCT03236246|4058919|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3
2333963|NCT03236246|4058918|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1
2333964|NCT03236246|4058919|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1
2333965|NCT03236246|4058918|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1
2333966|NCT03236246|4058919|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0
2333967|NCT03236246|4058918|FG000|24-Week Dose Maintenance Period|Death|0
2333968|NCT03236246|4058919|FG001|24-Week Dose Maintenance Period|Death|1
2333969|NCT03236246|4058918|FG000|24-Week Dose Maintenance Period|Adverse Event|0
2333970|NCT03236246|4058919|FG001|24-Week Dose Maintenance Period|Adverse Event|1
2333971|NCT03236311|4058927|FG000|Overall Study|Study terminated by sponsor|0
2333972|NCT03236311|4058928|FG001|Overall Study|Study terminated by sponsor|2
2333973|NCT03236311|4058927|FG000|Overall Study|Adverse Event|0
2333974|NCT03236311|4058928|FG001|Overall Study|Adverse Event|1
2333975|NCT03236506|4058937|FG000|Overall Study|Death|1
2333976|NCT03236506|4058938|FG001|Overall Study|Death|1
2333977|NCT03236506|4058939|FG002|Overall Study|Death|1
2333978|NCT03236506|4058937|FG000|Overall Study|Withdrawal by Subject|3
2333979|NCT03236506|4058938|FG001|Overall Study|Withdrawal by Subject|3
2333980|NCT03236506|4058939|FG002|Overall Study|Withdrawal by Subject|4
2333981|NCT03236506|4058937|FG000|Overall Study|Did not initiate treatment|2
2333982|NCT03236506|4058938|FG001|Overall Study|Did not initiate treatment|1
2333983|NCT03236506|4058939|FG002|Overall Study|Did not initiate treatment|2
2333984|NCT03236779|4058949|FG000|Overall Study|Lost to Follow-up|13
2333985|NCT03236779|4058950|FG001|Overall Study|Lost to Follow-up|21
2333986|NCT03237013|4058961|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
2333987|NCT03237013|4058962|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
2333988|NCT03237013|4058963|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
2333989|NCT03237065|4058973|FG000|Overall Study|Adverse Event|0
2333990|NCT03237065|4058974|FG001|Overall Study|Adverse Event|2
2333991|NCT03237065|4058973|FG000|Overall Study|Protocol Violation|0
2234532|NCT01868646|3888287|FG000|Overall Study|Do not meet inclusion criteria|3
2234533|NCT01868646|3888288|FG001|Overall Study|Do not meet inclusion criteria|5
2234534|NCT01868893|3888312|FG000|Overall Study|Adverse Event|2
2234535|NCT01868893|3888312|FG000|Overall Study|Commercial availability of study drug|17
2234536|NCT01868893|3888312|FG000|Overall Study|Neutropenia|1
2234537|NCT01868997|3888320|FG000|Overall Study|Adverse Event|2
2234538|NCT01868997|3888321|FG001|Overall Study|Adverse Event|5
2234539|NCT01868997|3888320|FG000|Overall Study|Lack of Efficacy|2
2234540|NCT01868997|3888321|FG001|Overall Study|Lack of Efficacy|0
2234541|NCT01868997|3888320|FG000|Overall Study|Other|3
2234542|NCT01868997|3888321|FG001|Overall Study|Other|1
2234543|NCT01869192|3888354|FG000|Preoperative Chemotherapy to Surgery|patient choice|2
2234544|NCT01869192|3888355|FG001|Preoperative Chemotherapy to Surgery|patient choice|1
2234545|NCT01869192|3888354|FG000|Postoperative Chemotherapy|Physician Decision|0
2234546|NCT01869192|3888355|FG001|Postoperative Chemotherapy|Physician Decision|2
2234547|NCT01869348|3888363|FG000|Overall Study|Withdrawal by Subject|1
2234548|NCT01869348|3888364|FG001|Overall Study|Withdrawal by Subject|1
2234549|NCT01869699|3888411|FG000|Overall Study|Withdrawal by Subject|1
2234550|NCT01869699|3888412|FG001|Overall Study|Withdrawal by Subject|0
2234551|NCT01869725|3888418|FG000|Overall Study|ineligible after registration|1
2234552|NCT01869725|3888418|FG000|Overall Study|Death|1
2234553|NCT01869725|3888418|FG000|Overall Study|Lost to Follow-up|2
2234554|NCT01869764|3888424|FG000|Overall Study|Withdrawal by Subject|0
2234555|NCT01869764|3888425|FG001|Overall Study|Withdrawal by Subject|2
2234556|NCT01869777|3888431|FG000|Overall Study|Excluded from the analysis, ineligible|1
2234557|NCT01869959|3888439|FG000|Randomization Period|Physician Decision|0
2234558|NCT01869959|3888440|FG001|Randomization Period|Physician Decision|0
2234559|NCT01869959|3888441|FG002|Randomization Period|Physician Decision|0
2234560|NCT01869959|3888442|FG003|Randomization Period|Physician Decision|0
2234561|NCT01869959|3888443|FG004|Randomization Period|Physician Decision|1
2234562|NCT01869959|3888439|FG000|Treatment Period|Adverse Event|1
2234563|NCT01869959|3888440|FG001|Treatment Period|Adverse Event|0
2234564|NCT01869959|3888441|FG002|Treatment Period|Adverse Event|3
2234565|NCT01869959|3888442|FG003|Treatment Period|Adverse Event|1
2234566|NCT01869959|3888443|FG004|Treatment Period|Adverse Event|0
2234567|NCT01869959|3888439|FG000|Treatment Period|Sponsor decision|0
2234568|NCT01869959|3888440|FG001|Treatment Period|Sponsor decision|1
2234569|NCT01869959|3888441|FG002|Treatment Period|Sponsor decision|0
2234570|NCT01869959|3888442|FG003|Treatment Period|Sponsor decision|1
2234571|NCT01869959|3888443|FG004|Treatment Period|Sponsor decision|0
2234572|NCT01869959|3888439|FG000|Treatment Period|Withdrawal by Subject|0
2234573|NCT01869959|3888440|FG001|Treatment Period|Withdrawal by Subject|1
2234574|NCT01869959|3888441|FG002|Treatment Period|Withdrawal by Subject|0
2234575|NCT01869959|3888442|FG003|Treatment Period|Withdrawal by Subject|0
2234576|NCT01869959|3888443|FG004|Treatment Period|Withdrawal by Subject|0
2234577|NCT01870076|3888457|FG000|Overall Study|Withdrawal by Subject|1
2234578|NCT01870076|3888458|FG001|Overall Study|Withdrawal by Subject|0
2234579|NCT01870076|3888459|FG002|Overall Study|Withdrawal by Subject|1
2234580|NCT01870076|3888460|FG003|Overall Study|Withdrawal by Subject|0
2234581|NCT01870297|3888477|FG000|Overall Study|Adverse Event|0
2234582|NCT01870297|3888478|FG001|Overall Study|Adverse Event|0
2234583|NCT01870297|3888479|FG002|Overall Study|Adverse Event|0
2234584|NCT01870297|3888480|FG003|Overall Study|Adverse Event|0
2234585|NCT01870297|3888481|FG004|Overall Study|Adverse Event|2
2234586|NCT01870297|3888482|FG005|Overall Study|Adverse Event|0
2234587|NCT01870297|3888483|FG006|Overall Study|Adverse Event|0
2234588|NCT01870297|3888477|FG000|Overall Study|Lost to Follow-up|0
2234589|NCT01870297|3888478|FG001|Overall Study|Lost to Follow-up|1
2234590|NCT01870297|3888479|FG002|Overall Study|Lost to Follow-up|1
2234591|NCT01870297|3888480|FG003|Overall Study|Lost to Follow-up|0
2234592|NCT01870297|3888481|FG004|Overall Study|Lost to Follow-up|0
2234593|NCT01870297|3888482|FG005|Overall Study|Lost to Follow-up|0
2234594|NCT01870297|3888483|FG006|Overall Study|Lost to Follow-up|0
2234595|NCT01870297|3888477|FG000|Overall Study|Withdrawal by Subject|0
2234596|NCT01870297|3888478|FG001|Overall Study|Withdrawal by Subject|0
2234597|NCT01870297|3888479|FG002|Overall Study|Withdrawal by Subject|0
2234598|NCT01870297|3888480|FG003|Overall Study|Withdrawal by Subject|0
2234599|NCT01870297|3888481|FG004|Overall Study|Withdrawal by Subject|1
2234600|NCT01870297|3888482|FG005|Overall Study|Withdrawal by Subject|1
2234601|NCT01870297|3888483|FG006|Overall Study|Withdrawal by Subject|1
2234602|NCT01870297|3888477|FG000|Overall Study|Sponsor Decision|0
2234603|NCT01870297|3888478|FG001|Overall Study|Sponsor Decision|6
2234604|NCT01870297|3888479|FG002|Overall Study|Sponsor Decision|0
2234605|NCT01870297|3888480|FG003|Overall Study|Sponsor Decision|0
2234606|NCT01870297|3888481|FG004|Overall Study|Sponsor Decision|0
2234607|NCT01870297|3888482|FG005|Overall Study|Sponsor Decision|0
2234608|NCT01870297|3888483|FG006|Overall Study|Sponsor Decision|1
2234609|NCT01870583|3888522|FG000|Overall Study|Protocol Violation|0
2234610|NCT01870583|3888523|FG001|Overall Study|Protocol Violation|5
2234611|NCT01870583|3888524|FG002|Overall Study|Protocol Violation|3
2234612|NCT01870583|3888522|FG000|Overall Study|Lost to Follow-up|11
2234613|NCT01870583|3888523|FG001|Overall Study|Lost to Follow-up|13
2333992|NCT03237065|4058974|FG001|Overall Study|Protocol Violation|1
2333993|NCT03237065|4058973|FG000|Overall Study|Withdrawal by Subject|3
2234614|NCT01870583|3888524|FG002|Overall Study|Lost to Follow-up|5
2234615|NCT01870726|3888548|FG000|Overall Study|Withdrawal of informed consent|0
2333994|NCT03237065|4058974|FG001|Overall Study|Withdrawal by Subject|0
2234616|NCT01870726|3888549|FG001|Overall Study|Withdrawal of informed consent|0
2234617|NCT01870726|3888550|FG002|Overall Study|Withdrawal of informed consent|0
2234618|NCT01870726|3888551|FG003|Overall Study|Withdrawal of informed consent|1
2234619|NCT01870726|3888552|FG004|Overall Study|Withdrawal of informed consent|0
2234620|NCT01870726|3888553|FG005|Overall Study|Withdrawal of informed consent|0
2234621|NCT01870726|3888554|FG006|Overall Study|Withdrawal of informed consent|0
2234622|NCT01870726|3888548|FG000|Overall Study|Withdrawal by Subject|0
2234623|NCT01870726|3888549|FG001|Overall Study|Withdrawal by Subject|1
2234624|NCT01870726|3888550|FG002|Overall Study|Withdrawal by Subject|0
2234625|NCT01870726|3888551|FG003|Overall Study|Withdrawal by Subject|0
2234626|NCT01870726|3888552|FG004|Overall Study|Withdrawal by Subject|0
2234627|NCT01870726|3888553|FG005|Overall Study|Withdrawal by Subject|0
2234628|NCT01870726|3888554|FG006|Overall Study|Withdrawal by Subject|0
2234629|NCT01870726|3888548|FG000|Overall Study|Adverse Event|0
2234630|NCT01870726|3888549|FG001|Overall Study|Adverse Event|0
2234631|NCT01870726|3888550|FG002|Overall Study|Adverse Event|0
2234632|NCT01870726|3888551|FG003|Overall Study|Adverse Event|0
2234633|NCT01870726|3888552|FG004|Overall Study|Adverse Event|1
2234634|NCT01870726|3888553|FG005|Overall Study|Adverse Event|1
2234635|NCT01870726|3888554|FG006|Overall Study|Adverse Event|0
2234636|NCT01870726|3888548|FG000|Overall Study|Progressive disease|5
2234637|NCT01870726|3888549|FG001|Overall Study|Progressive disease|5
2234638|NCT01870726|3888550|FG002|Overall Study|Progressive disease|4
2234639|NCT01870726|3888551|FG003|Overall Study|Progressive disease|5
2234640|NCT01870726|3888552|FG004|Overall Study|Progressive disease|6
2234641|NCT01870726|3888553|FG005|Overall Study|Progressive disease|4
2234642|NCT01870726|3888554|FG006|Overall Study|Progressive disease|10
2234643|NCT01870739|3888581|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0
2234644|NCT01870739|3888582|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1
2234645|NCT01870739|3888581|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0
2234646|NCT01870739|3888582|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1
2234647|NCT01870739|3888581|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3
2234648|NCT01870739|3888582|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2
2234649|NCT01870739|3888581|FG000|Add-on Period (40 Weeks)|Adverse Event|0
2234650|NCT01870739|3888582|FG001|Add-on Period (40 Weeks)|Adverse Event|1
2234651|NCT01870739|3888581|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
2234652|NCT01870739|3888582|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
2234653|NCT01870739|3888581|FG000|Add-on Period (40 Weeks)|Protocol deviation|1
2234654|NCT01870739|3888582|FG001|Add-on Period (40 Weeks)|Protocol deviation|1
2234655|NCT01870739|3888581|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1
2234656|NCT01870739|3888582|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0
2234657|NCT01870778|3888600|FG000|Overall Study|Withdrawal by Subject|8
2234658|NCT01870778|3888601|FG001|Overall Study|Withdrawal by Subject|7
2234659|NCT01870778|3888600|FG000|Overall Study|Lost to Follow-up|0
2234660|NCT01870778|3888601|FG001|Overall Study|Lost to Follow-up|2
2234661|NCT01870843|3888607|FG000|Overall Study|Adverse Event|10
2234662|NCT01870843|3888607|FG000|Overall Study|Lost to Follow-up|24
2234663|NCT01870843|3888607|FG000|Overall Study|Death|1
2234664|NCT01870843|3888607|FG000|Overall Study|Withdrawal by Subject|18
2234665|NCT01870869|3888626|FG000|Overall Study|Implanted with nonstudy device|1
2333995|NCT03237065|4058973|FG000|Overall Study|Lost to Follow-up|1
2333996|NCT03237065|4058974|FG001|Overall Study|Lost to Follow-up|0
2333997|NCT03237065|4058973|FG000|Overall Study|Unable to obtain venous access|0
2333998|NCT03237065|4058974|FG001|Overall Study|Unable to obtain venous access|1
2333999|NCT03237481|4059003|FG000|Overall Study|Lost to Follow-up|1
2334000|NCT03237481|4059004|FG001|Overall Study|Lost to Follow-up|0
2334001|NCT03237481|4059005|FG002|Overall Study|Lost to Follow-up|0
2334002|NCT03237481|4059003|FG000|Overall Study|Protocol Violation|1
2334003|NCT03237481|4059004|FG001|Overall Study|Protocol Violation|0
2334004|NCT03237481|4059005|FG002|Overall Study|Protocol Violation|0
2334005|NCT03237481|4059003|FG000|Overall Study|Withdrawal by Subject|3
2334006|NCT03237481|4059004|FG001|Overall Study|Withdrawal by Subject|2
2334007|NCT03237481|4059005|FG002|Overall Study|Withdrawal by Subject|1
2334008|NCT03237845|4059015|FG000|Overall Study|Adverse Event|0
2334009|NCT03237845|4059016|FG001|Overall Study|Adverse Event|1
2334010|NCT03237845|4059015|FG000|Overall Study|Lost to Follow-up|13
2334011|NCT03237845|4059016|FG001|Overall Study|Lost to Follow-up|10
2334012|NCT03237845|4059015|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26
2334013|NCT03237845|4059016|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31
2334014|NCT03237845|4059015|FG000|Overall Study|Non-Compliance With Study Treatment|0
2334015|NCT03237845|4059016|FG001|Overall Study|Non-Compliance With Study Treatment|1
2334016|NCT03237845|4059015|FG000|Overall Study|Physician Decision|1
2334017|NCT03237845|4059016|FG001|Overall Study|Physician Decision|2
2334018|NCT03237845|4059015|FG000|Overall Study|Pregnancy|1
2334019|NCT03237845|4059016|FG001|Overall Study|Pregnancy|0
2334020|NCT03237845|4059015|FG000|Overall Study|Protocol Deviation|0
2334021|NCT03237845|4059016|FG001|Overall Study|Protocol Deviation|1
2334022|NCT03237845|4059015|FG000|Overall Study|Technical Problems|8
2334023|NCT03237845|4059016|FG001|Overall Study|Technical Problems|1
2334024|NCT03237845|4059015|FG000|Overall Study|Withdrawal by Subject|3
2334025|NCT03237845|4059016|FG001|Overall Study|Withdrawal by Subject|3
2234666|NCT01870869|3888627|FG001|Overall Study|Implanted with nonstudy device|3
2234667|NCT01870869|3888628|FG002|Overall Study|Implanted with nonstudy device|14
2234668|NCT01870869|3888629|FG003|Overall Study|Implanted with nonstudy device|4
2234669|NCT01870869|3888626|FG000|Overall Study|Death|0
2234670|NCT01870869|3888627|FG001|Overall Study|Death|0
2234671|NCT01870869|3888628|FG002|Overall Study|Death|7
2234672|NCT01870869|3888629|FG003|Overall Study|Death|1
2234673|NCT01870869|3888626|FG000|Overall Study|Subject choice|6
2234674|NCT01870869|3888627|FG001|Overall Study|Subject choice|2
2234675|NCT01870869|3888628|FG002|Overall Study|Subject choice|22
2234676|NCT01870869|3888629|FG003|Overall Study|Subject choice|8
2234677|NCT01870869|3888626|FG000|Overall Study|Lost to Follow-up|10
2234678|NCT01870869|3888627|FG001|Overall Study|Lost to Follow-up|2
2234679|NCT01870869|3888628|FG002|Overall Study|Lost to Follow-up|25
2234680|NCT01870869|3888629|FG003|Overall Study|Lost to Follow-up|3
2234681|NCT01870869|3888626|FG000|Overall Study|Reason not Specified|1
2234682|NCT01870869|3888627|FG001|Overall Study|Reason not Specified|2
2234683|NCT01870869|3888628|FG002|Overall Study|Reason not Specified|20
2234684|NCT01870869|3888629|FG003|Overall Study|Reason not Specified|4
2234685|NCT01870869|3888626|FG000|Overall Study|Not evaluable|10
2234686|NCT01870869|3888627|FG001|Overall Study|Not evaluable|5
2234687|NCT01870869|3888628|FG002|Overall Study|Not evaluable|42
2234688|NCT01870869|3888629|FG003|Overall Study|Not evaluable|10
2234689|NCT01870921|3888639|FG000|Overall Study|Subject decision|80
2234690|NCT01870921|3888639|FG000|Overall Study|Severe non-compliance to protocol|7
2234691|NCT01870921|3888639|FG000|Overall Study|Subject Lost to Follow up|2
2234692|NCT01870921|3888639|FG000|Overall Study|Other|1
2234693|NCT01870973|3888645|FG000|Overall Study|Lost to Follow-up|10
2234694|NCT01870973|3888646|FG001|Overall Study|Lost to Follow-up|3
2234695|NCT01870999|3888655|FG000|Overall Study|Adverse Event|0
2234696|NCT01870999|3888656|FG001|Overall Study|Adverse Event|4
2234697|NCT01870999|3888657|FG002|Overall Study|Adverse Event|1
2234698|NCT01870999|3888655|FG000|Overall Study|Subject met withdrawal criteria|3
2234699|NCT01870999|3888656|FG001|Overall Study|Subject met withdrawal criteria|2
2234700|NCT01870999|3888657|FG002|Overall Study|Subject met withdrawal criteria|0
2234701|NCT01870999|3888655|FG000|Overall Study|Subject withdrawn by Investigator|1
2234702|NCT01870999|3888656|FG001|Overall Study|Subject withdrawn by Investigator|0
2234703|NCT01870999|3888657|FG002|Overall Study|Subject withdrawn by Investigator|0
2234704|NCT01870999|3888655|FG000|Overall Study|Withdrawal by Subject|0
2234705|NCT01870999|3888656|FG001|Overall Study|Withdrawal by Subject|2
2234706|NCT01870999|3888657|FG002|Overall Study|Withdrawal by Subject|5
2234707|NCT01870999|3888655|FG000|Overall Study|Protocol Violation|0
2234708|NCT01870999|3888656|FG001|Overall Study|Protocol Violation|0
2234709|NCT01870999|3888657|FG002|Overall Study|Protocol Violation|1
2234710|NCT01871090|3888671|FG000|Overall Study|Interrogation not done in Emergency Room|1
2234711|NCT01871090|3888672|FG001|Overall Study|Interrogation not done in Emergency Room|22
2234712|NCT01871090|3888671|FG000|Overall Study|Interrogation not completed correctly|1
2234713|NCT01871090|3888672|FG001|Overall Study|Interrogation not completed correctly|0
2234714|NCT01871090|3888671|FG000|Overall Study|Subject Non-Compliance|0
2334026|NCT03237845|4059015|FG000|Overall Study|Other Reasons|4
2334027|NCT03237845|4059016|FG001|Overall Study|Other Reasons|0
2334028|NCT03238001|4059026|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
2334029|NCT03238001|4059026|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
2334030|NCT03238001|4059026|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
2334031|NCT03238001|4059026|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
2334032|NCT03238001|4059026|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
2334033|NCT03238001|4059026|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
2334034|NCT03238001|4059026|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
2334035|NCT03238001|4059026|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
2334036|NCT03238352|4059041|FG000|Overall Study|Lost to Follow-up|0
2334037|NCT03238352|4059042|FG001|Overall Study|Lost to Follow-up|2
2334038|NCT03238352|4059043|FG002|Overall Study|Lost to Follow-up|1
2334039|NCT03238352|4059041|FG000|Overall Study|Withdrawal by Subject|0
2334040|NCT03238352|4059042|FG001|Overall Study|Withdrawal by Subject|1
2334041|NCT03238352|4059043|FG002|Overall Study|Withdrawal by Subject|0
2334042|NCT03238417|4059053|FG000|Overall|non-response|955
2334043|NCT03238417|4059054|FG001|Overall|non-response|1920
2334044|NCT03238417|4059053|FG000|Overall|partial completion|48
2334045|NCT03238417|4059054|FG001|Overall|partial completion|68
2036753|NCT00413413|3607000|FG002|Single-Blind|Subject no longer requires study drug|0
2036754|NCT00413413|3606998|FG000|Single-Blind|Protocol Violation|0
2036755|NCT00413413|3606999|FG001|Single-Blind|Protocol Violation|16
2036756|NCT00413413|3607000|FG002|Single-Blind|Protocol Violation|0
2036757|NCT00413413|3606998|FG000|Single-Blind|Withdrawal by Subject|0
2036758|NCT00413413|3606999|FG001|Single-Blind|Withdrawal by Subject|27
2036759|NCT00413413|3607000|FG002|Single-Blind|Withdrawal by Subject|0
2036760|NCT00413413|3606998|FG000|Single-Blind|Lost to Follow-up|0
2036761|NCT00413413|3606999|FG001|Single-Blind|Lost to Follow-up|8
2036762|NCT00413413|3607000|FG002|Single-Blind|Lost to Follow-up|0
2036763|NCT00413413|3606998|FG000|Double-Blind|Adverse Event|6
2036764|NCT00413413|3606999|FG001|Double-Blind|Adverse Event|0
2036765|NCT00413413|3607000|FG002|Double-Blind|Adverse Event|5
2234715|NCT01871090|3888672|FG001|Overall Study|Subject Non-Compliance|1
2234716|NCT01871142|3888678|FG000|Overall Study|Adverse Event|1
2234717|NCT01871285|3888694|FG000|First Intervention (1 Day)|Adverse Event|1
2234718|NCT01871285|3888695|FG001|First Intervention (1 Day)|Adverse Event|0
2234719|NCT01871285|3888696|FG002|First Intervention (1 Day)|Adverse Event|0
2234720|NCT01871285|3888697|FG003|First Intervention (1 Day)|Adverse Event|0
2234721|NCT01871285|3888694|FG000|First Intervention (1 Day)|Lost to Follow-up|0
2234722|NCT01871285|3888695|FG001|First Intervention (1 Day)|Lost to Follow-up|1
2234723|NCT01871285|3888696|FG002|First Intervention (1 Day)|Lost to Follow-up|1
2234724|NCT01871285|3888697|FG003|First Intervention (1 Day)|Lost to Follow-up|0
2234725|NCT01871402|3888709|FG000|Overall Study|Lost to Follow-up|1
2234726|NCT01871402|3888710|FG001|Overall Study|Lost to Follow-up|0
2234727|NCT01871402|3888709|FG000|Overall Study|Withdrawal by Subject|0
2234728|NCT01871402|3888710|FG001|Overall Study|Withdrawal by Subject|2
2234729|NCT01871402|3888709|FG000|Overall Study|Non-compliance|0
2234730|NCT01871402|3888710|FG001|Overall Study|Non-compliance|1
2234731|NCT01871519|3888743|FG000|Overall Study|Death|26
2234732|NCT01871519|3888743|FG000|Overall Study|Lost to Follow-up|15
2234733|NCT01871519|3888743|FG000|Overall Study|Withdrawal by Subject|49
2234734|NCT01871532|3888750|FG000|Overall Study|Withdrawal by Subject|1
2234735|NCT01871532|3888751|FG001|Overall Study|Withdrawal by Subject|2
2274629|NCT02298192|3955690|FG001|Overall Study|Withdrawal by Subject|1
2274630|NCT02298192|3955689|FG000|Overall Study|Lost to Follow-up|2
2274631|NCT02298192|3955690|FG001|Overall Study|Lost to Follow-up|1
2274632|NCT02298192|3955689|FG000|Overall Study|Adverse Event|6
2274633|NCT02298192|3955690|FG001|Overall Study|Adverse Event|2
2274634|NCT02298868|3955742|FG000|Overall Study|Adverse Event|1
2274635|NCT02298868|3955742|FG000|Overall Study|Death|1
2274636|NCT02298868|3955742|FG000|Overall Study|Patient underwent transplant|1
2274637|NCT02298946|3955752|FG000|Overall Study|Did not receive treatment|2
2274638|NCT02298946|3955753|FG001|Overall Study|Did not receive treatment|0
2274639|NCT02298946|3955752|FG000|Overall Study|Unevaluable|2
2274640|NCT02298946|3955753|FG001|Overall Study|Unevaluable|1
2334046|NCT03238417|4059053|FG000|Baseline|Partial completion|17
2334047|NCT03238417|4059054|FG001|Baseline|Partial completion|48
2334048|NCT03238417|4059053|FG000|Baseline|non-response|372
2334049|NCT03238417|4059054|FG001|Baseline|non-response|669
2334050|NCT03238417|4059053|FG000|12-month|non-response|296
2334051|NCT03238417|4059054|FG001|12-month|non-response|669
2334052|NCT03238417|4059053|FG000|12-month|partial completion|23
2334053|NCT03238417|4059054|FG001|12-month|partial completion|37
2334054|NCT03238417|4059053|FG000|24-month|non-response|287
2334055|NCT03238417|4059054|FG001|24-month|non-response|594
2334056|NCT03238417|4059053|FG000|24-month|partial completion|8
2334057|NCT03238417|4059054|FG001|24-month|partial completion|31
2334058|NCT03238651|4059065|FG000|Overall Study|Other|0
2334059|NCT03238651|4059066|FG001|Overall Study|Other|0
2334060|NCT03238651|4059067|FG002|Overall Study|Other|0
2334061|NCT03238651|4059068|FG003|Overall Study|Other|0
2334062|NCT03238651|4059069|FG004|Overall Study|Other|1
2334063|NCT03238651|4059065|FG000|Overall Study|Progressive Disease|2
2334064|NCT03238651|4059066|FG001|Overall Study|Progressive Disease|2
2334065|NCT03238651|4059067|FG002|Overall Study|Progressive Disease|2
2334066|NCT03238651|4059068|FG003|Overall Study|Progressive Disease|2
2334067|NCT03238651|4059069|FG004|Overall Study|Progressive Disease|0
2334068|NCT03238651|4059065|FG000|Overall Study|Withdrawal by Subject|0
2334069|NCT03238651|4059066|FG001|Overall Study|Withdrawal by Subject|1
2334070|NCT03238651|4059067|FG002|Overall Study|Withdrawal by Subject|0
2334071|NCT03238651|4059068|FG003|Overall Study|Withdrawal by Subject|1
2334072|NCT03238651|4059069|FG004|Overall Study|Withdrawal by Subject|0
2334073|NCT03238651|4059065|FG000|Overall Study|Adverse Event|1
2334074|NCT03238651|4059066|FG001|Overall Study|Adverse Event|3
2334075|NCT03238651|4059067|FG002|Overall Study|Adverse Event|2
2334076|NCT03238651|4059068|FG003|Overall Study|Adverse Event|0
2334077|NCT03238651|4059069|FG004|Overall Study|Adverse Event|0
2334078|NCT03238781|4059085|FG000|Overall Study|Adverse Event|1
2334079|NCT03238781|4059086|FG001|Overall Study|Adverse Event|1
2334080|NCT03238781|4059087|FG002|Overall Study|Adverse Event|2
2334081|NCT03238781|4059085|FG000|Overall Study|Lost to Follow-up|2
2334082|NCT03238781|4059086|FG001|Overall Study|Lost to Follow-up|1
2334083|NCT03238781|4059087|FG002|Overall Study|Lost to Follow-up|2
2334084|NCT03238781|4059085|FG000|Overall Study|Withdrawal by Subject|23
2334085|NCT03238781|4059086|FG001|Overall Study|Withdrawal by Subject|14
2334086|NCT03238781|4059087|FG002|Overall Study|Withdrawal by Subject|16
2334087|NCT03238781|4059085|FG000|Overall Study|Decision by sponsor|0
2334088|NCT03238781|4059086|FG001|Overall Study|Decision by sponsor|1
2334089|NCT03238781|4059087|FG002|Overall Study|Decision by sponsor|0
2334090|NCT03238911|4059097|FG000|Overall Study|Withdrawal by Subject|1
2334091|NCT03238911|4059098|FG001|Overall Study|Withdrawal by Subject|2
2334092|NCT03238911|4059097|FG000|Overall Study|Lost to Follow-up|2
2334093|NCT03238911|4059098|FG001|Overall Study|Lost to Follow-up|1
2334094|NCT03238924|4059107|FG000|Overall Study|Withdrawal by Subject|2
2334095|NCT03238924|4059108|FG001|Overall Study|Withdrawal by Subject|2
2334096|NCT03238963|4059116|FG000|Overall Study|Prohibited medication given due to hospital stay|1
2334097|NCT03238963|4059117|FG001|Overall Study|Prohibited medication given due to hospital stay|0
2334098|NCT03238963|4059116|FG000|Overall Study|Withdrawal by Subject|1
2234736|NCT01871545|3888759|FG000|Overall Study|Death|2
2234737|NCT01871545|3888760|FG001|Overall Study|Death|0
2234738|NCT01871545|3888759|FG000|Overall Study|Lack of Efficacy|11
2234739|NCT01871545|3888760|FG001|Overall Study|Lack of Efficacy|2
2234740|NCT01871545|3888759|FG000|Overall Study|Physician Decision|4
2234741|NCT01871545|3888760|FG001|Overall Study|Physician Decision|0
2234742|NCT01871545|3888759|FG000|Overall Study|Withdrawal by Subject|0
2234743|NCT01871545|3888760|FG001|Overall Study|Withdrawal by Subject|1
2234744|NCT01871558|3888771|FG000|Overall Study|Other reason|0
2234745|NCT01871558|3888772|FG001|Overall Study|Other reason|1
2234746|NCT01871558|3888771|FG000|Overall Study|antidiabetic drug prematurely stopped|1
2234747|NCT01871558|3888772|FG001|Overall Study|antidiabetic drug prematurely stopped|1
2234748|NCT01871558|3888771|FG000|Overall Study|Withdrawal by Subject|2
2234749|NCT01871558|3888772|FG001|Overall Study|Withdrawal by Subject|0
2234750|NCT01871805|3888784|FG000|Phase I|Death|7
2234751|NCT01871805|3888785|FG001|Phase I|Death|4
2234752|NCT01871805|3888786|FG002|Phase I|Death|6
2234753|NCT01871805|3888787|FG003|Phase I|Death|2
2234754|NCT01871805|3888788|FG004|Phase I|Death|9
2234755|NCT01871805|3888789|FG005|Phase I|Death|0
2234756|NCT01871805|3888784|FG000|Phase I|Alive in Survival Follow-up|0
2234757|NCT01871805|3888785|FG001|Phase I|Alive in Survival Follow-up|2
2234758|NCT01871805|3888786|FG002|Phase I|Alive in Survival Follow-up|4
2234759|NCT01871805|3888787|FG003|Phase I|Alive in Survival Follow-up|5
2234760|NCT01871805|3888788|FG004|Phase I|Alive in Survival Follow-up|4
2234761|NCT01871805|3888789|FG005|Phase I|Alive in Survival Follow-up|0
2234762|NCT01871805|3888784|FG000|Phase I|Lost to Follow-up|0
2234763|NCT01871805|3888785|FG001|Phase I|Lost to Follow-up|1
2234764|NCT01871805|3888786|FG002|Phase I|Lost to Follow-up|3
2234765|NCT01871805|3888787|FG003|Phase I|Lost to Follow-up|0
2234766|NCT01871805|3888788|FG004|Phase I|Lost to Follow-up|0
2234767|NCT01871805|3888789|FG005|Phase I|Lost to Follow-up|0
2234768|NCT01871805|3888784|FG000|Phase II|Death|0
2234769|NCT01871805|3888785|FG001|Phase II|Death|0
2234770|NCT01871805|3888786|FG002|Phase II|Death|0
2234771|NCT01871805|3888787|FG003|Phase II|Death|0
2234772|NCT01871805|3888788|FG004|Phase II|Death|0
2234773|NCT01871805|3888789|FG005|Phase II|Death|45
2234774|NCT01871805|3888784|FG000|Phase II|Alive in Survival Follow-up|0
2234775|NCT01871805|3888785|FG001|Phase II|Alive in Survival Follow-up|0
2234776|NCT01871805|3888786|FG002|Phase II|Alive in Survival Follow-up|0
2234777|NCT01871805|3888787|FG003|Phase II|Alive in Survival Follow-up|0
2234778|NCT01871805|3888788|FG004|Phase II|Alive in Survival Follow-up|0
2234779|NCT01871805|3888789|FG005|Phase II|Alive in Survival Follow-up|29
2234780|NCT01871805|3888784|FG000|Phase II|Lost to Follow-up|0
2234781|NCT01871805|3888785|FG001|Phase II|Lost to Follow-up|0
2234782|NCT01871805|3888786|FG002|Phase II|Lost to Follow-up|0
2234783|NCT01871805|3888787|FG003|Phase II|Lost to Follow-up|0
2234784|NCT01871805|3888788|FG004|Phase II|Lost to Follow-up|0
2334099|NCT03238963|4059117|FG001|Overall Study|Withdrawal by Subject|1
2334100|NCT03238963|4059116|FG000|Overall Study|Lost to Follow-up|1
2334101|NCT03238963|4059117|FG001|Overall Study|Lost to Follow-up|0
2334102|NCT03238963|4059116|FG000|Overall Study|Protocol Violation|1
2334103|NCT03238963|4059117|FG001|Overall Study|Protocol Violation|1
2334104|NCT03238963|4059116|FG000|Overall Study|Adverse Event|1
2334105|NCT03238963|4059117|FG001|Overall Study|Adverse Event|0
2334106|NCT03239470|4059128|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1
2334107|NCT03239470|4059129|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0
2334108|NCT03239483|4059135|FG000|Overall Study|Lost to Follow-up|1
2334109|NCT03239483|4059136|FG001|Overall Study|Lost to Follow-up|0
2334110|NCT03239483|4059135|FG000|Overall Study|Withdrawal by Subject|1
2334111|NCT03239483|4059136|FG001|Overall Study|Withdrawal by Subject|0
2334112|NCT03239873|4059189|FG000|Overall Study|Lost to Follow-up|15
2334113|NCT03239873|4059190|FG001|Overall Study|Lost to Follow-up|16
2334114|NCT03239873|4059189|FG000|Overall Study|Physician Decision|1
2334115|NCT03239873|4059190|FG001|Overall Study|Physician Decision|0
2334116|NCT03239873|4059189|FG000|Overall Study|Withdrawal by Parent/Guardian|12
2334117|NCT03239873|4059190|FG001|Overall Study|Withdrawal by Parent/Guardian|11
2334118|NCT03239873|4059189|FG000|Overall Study|Withdrawal by Subject|2
2334119|NCT03239873|4059190|FG001|Overall Study|Withdrawal by Subject|0
2334120|NCT03239873|4059189|FG000|Overall Study|Contraindication to study medication|1
2334121|NCT03239873|4059190|FG001|Overall Study|Contraindication to study medication|0
2334122|NCT03239873|4059189|FG000|Overall Study|Protocol Violation|1
2334123|NCT03239873|4059190|FG001|Overall Study|Protocol Violation|0
2334124|NCT03240081|4059198|FG000|Overall Study|Withdrawal by Subject|0
2334125|NCT03240081|4059199|FG001|Overall Study|Withdrawal by Subject|2
2334126|NCT03240081|4059198|FG000|Overall Study|Lost to Follow-up|0
2334127|NCT03240081|4059199|FG001|Overall Study|Lost to Follow-up|1
2334128|NCT03240133|4059208|FG000|Overall Study|Withdrawal by Subject|0
2334129|NCT03240133|4059209|FG001|Overall Study|Withdrawal by Subject|1
2334130|NCT03240133|4059210|FG002|Overall Study|Withdrawal by Subject|0
2334131|NCT03240133|4059208|FG000|Overall Study|Adverse Event|1
2234785|NCT01871805|3888789|FG005|Phase II|Lost to Follow-up|13
2234786|NCT01871870|3888820|FG000|Overall Study|Hardware issues|7
2234787|NCT01871870|3888820|FG000|Overall Study|hyperglycemia|2
2234788|NCT01872078|3888828|FG000|Overall Study|Adverse Event|0
2234789|NCT01872078|3888829|FG001|Overall Study|Adverse Event|0
2234790|NCT01872078|3888830|FG002|Overall Study|Adverse Event|1
2234791|NCT01872078|3888831|FG003|Overall Study|Adverse Event|0
2234792|NCT01872078|3888828|FG000|Overall Study|Dose administration non-compliance|0
2234793|NCT01872078|3888829|FG001|Overall Study|Dose administration non-compliance|0
2234794|NCT01872078|3888830|FG002|Overall Study|Dose administration non-compliance|0
2234795|NCT01872078|3888831|FG003|Overall Study|Dose administration non-compliance|1
2234796|NCT01872078|3888828|FG000|Overall Study|Protocol Violation|0
2234797|NCT01872078|3888829|FG001|Overall Study|Protocol Violation|0
2234798|NCT01872078|3888830|FG002|Overall Study|Protocol Violation|1
2234799|NCT01872078|3888831|FG003|Overall Study|Protocol Violation|0
2234800|NCT01872078|3888828|FG000|Overall Study|Withdrawal by Subject|0
2234801|NCT01872078|3888829|FG001|Overall Study|Withdrawal by Subject|0
2234802|NCT01872078|3888830|FG002|Overall Study|Withdrawal by Subject|1
2234803|NCT01872078|3888831|FG003|Overall Study|Withdrawal by Subject|0
2234804|NCT01872078|3888828|FG000|Overall Study|Patient met exclusion criterion 16.|0
2234805|NCT01872078|3888829|FG001|Overall Study|Patient met exclusion criterion 16.|0
2234806|NCT01872078|3888830|FG002|Overall Study|Patient met exclusion criterion 16.|0
2234807|NCT01872078|3888831|FG003|Overall Study|Patient met exclusion criterion 16.|1
2234808|NCT01872611|3888861|FG000|Overall Study|Adverse Event|3
2234809|NCT01872611|3888862|FG001|Overall Study|Adverse Event|1
2234810|NCT01872611|3888861|FG000|Overall Study|Adverse Event, prior to treatment|0
2234811|NCT01872611|3888862|FG001|Overall Study|Adverse Event, prior to treatment|1
2234812|NCT01872611|3888861|FG000|Overall Study|Death|0
2234813|NCT01872611|3888862|FG001|Overall Study|Death|1
2234814|NCT01872611|3888861|FG000|Overall Study|Death, prior to treatment|0
2234815|NCT01872611|3888862|FG001|Overall Study|Death, prior to treatment|1
2234816|NCT01872611|3888861|FG000|Overall Study|Lost to Follow-up|8
2234817|NCT01872611|3888862|FG001|Overall Study|Lost to Follow-up|1
2234818|NCT01872611|3888861|FG000|Overall Study|Physician Decision|1
2234819|NCT01872611|3888862|FG001|Overall Study|Physician Decision|0
2234820|NCT01872611|3888861|FG000|Overall Study|Withdrawal by Subject|6
2234821|NCT01872611|3888862|FG001|Overall Study|Withdrawal by Subject|1
2234822|NCT01872611|3888861|FG000|Overall Study|Reason not provided|6
2234823|NCT01872611|3888862|FG001|Overall Study|Reason not provided|6
2234824|NCT01872689|3888874|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
2334132|NCT03240133|4059209|FG001|Overall Study|Adverse Event|1
2334133|NCT03240133|4059210|FG002|Overall Study|Adverse Event|0
2334134|NCT03240133|4059208|FG000|Overall Study|Rash|1
2334135|NCT03240133|4059209|FG001|Overall Study|Rash|0
2334136|NCT03240133|4059210|FG002|Overall Study|Rash|0
2334137|NCT03240133|4059208|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1
2334138|NCT03240133|4059209|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0
2334139|NCT03240133|4059210|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0
2334140|NCT03240133|4059208|FG000|Overall Study|Intercurrent illness.|0
2334141|NCT03240133|4059209|FG001|Overall Study|Intercurrent illness.|1
2334142|NCT03240133|4059210|FG002|Overall Study|Intercurrent illness.|0
2334143|NCT03240133|4059208|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
2334144|NCT03240133|4059209|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
2334145|NCT03240133|4059210|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1
2334146|NCT03240575|4059238|FG000|Overall Study|Adverse Event|0
2334147|NCT03240575|4059239|FG001|Overall Study|Adverse Event|2
2334148|NCT03240575|4059240|FG002|Overall Study|Adverse Event|0
2334149|NCT03240575|4059241|FG003|Overall Study|Adverse Event|1
2334150|NCT03240575|4059238|FG000|Overall Study|Withdrawal by Subject|2
2334151|NCT03240575|4059239|FG001|Overall Study|Withdrawal by Subject|11
2334152|NCT03240575|4059240|FG002|Overall Study|Withdrawal by Subject|0
2334153|NCT03240575|4059241|FG003|Overall Study|Withdrawal by Subject|1
2334154|NCT03240575|4059238|FG000|Overall Study|Other|0
2334155|NCT03240575|4059239|FG001|Overall Study|Other|1
2334156|NCT03240575|4059240|FG002|Overall Study|Other|0
2334157|NCT03240575|4059241|FG003|Overall Study|Other|0
2334158|NCT03241342|4059261|FG000|Overall Study|Adverse Event|5
2334159|NCT03241342|4059262|FG001|Overall Study|Adverse Event|8
2334160|NCT03241342|4059263|FG002|Overall Study|Adverse Event|4
2334161|NCT03241342|4059261|FG000|Overall Study|Lack of Efficacy|0
2334162|NCT03241342|4059262|FG001|Overall Study|Lack of Efficacy|0
2334163|NCT03241342|4059263|FG002|Overall Study|Lack of Efficacy|1
2334164|NCT03241342|4059261|FG000|Overall Study|noncompliance with study drug|2
2334165|NCT03241342|4059262|FG001|Overall Study|noncompliance with study drug|1
2334166|NCT03241342|4059263|FG002|Overall Study|noncompliance with study drug|1
2334167|NCT03241342|4059261|FG000|Overall Study|sponsor decision|0
2334168|NCT03241342|4059262|FG001|Overall Study|sponsor decision|1
2334169|NCT03241342|4059263|FG002|Overall Study|sponsor decision|2
2334170|NCT03241342|4059261|FG000|Overall Study|not reported|15
2334171|NCT03241342|4059262|FG001|Overall Study|not reported|21
2334172|NCT03241342|4059263|FG002|Overall Study|not reported|19
2334173|NCT03241368|4059271|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25
2334174|NCT03241368|4059271|FG000|Overall Study|Lost to Follow-up|1
2334175|NCT03241368|4059271|FG000|Overall Study|Physician Decision|6
2334176|NCT03241368|4059271|FG000|Overall Study|Withdrawal by Subject|6
2334177|NCT03241368|4059271|FG000|Overall Study|Protocol Violation|1
2234825|NCT01872689|3888875|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
2234826|NCT01872689|3888876|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
2234827|NCT01872689|3888877|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
2234828|NCT01872689|3888874|FG000|Double-Blind/Placebo-Controlled Period|Other|1
2234829|NCT01872689|3888875|FG001|Double-Blind/Placebo-Controlled Period|Other|1
2234830|NCT01872689|3888876|FG002|Double-Blind/Placebo-Controlled Period|Other|6
2234831|NCT01872689|3888877|FG003|Double-Blind/Placebo-Controlled Period|Other|3
2234832|NCT01872689|3888874|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
2234833|NCT01872689|3888875|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
2234834|NCT01872689|3888876|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
2234835|NCT01872689|3888877|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
2234836|NCT01872689|3888874|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
2234837|NCT01872689|3888875|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
2234838|NCT01872689|3888876|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
2234839|NCT01872689|3888877|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
2234840|NCT01872689|3888874|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0
2234841|NCT01872689|3888875|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3
2234842|NCT01872689|3888876|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3
2234843|NCT01872689|3888877|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1
2234844|NCT01872689|3888874|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
2234845|NCT01872689|3888875|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
2234846|NCT01872689|3888876|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
2234847|NCT01872689|3888877|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
2234848|NCT01872689|3888874|FG000|Double-Blind/Placebo-Controlled Period|Death|3
2234849|NCT01872689|3888875|FG001|Double-Blind/Placebo-Controlled Period|Death|4
2234850|NCT01872689|3888876|FG002|Double-Blind/Placebo-Controlled Period|Death|14
2234851|NCT01872689|3888877|FG003|Double-Blind/Placebo-Controlled Period|Death|9
2234852|NCT01872689|3888874|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6
2234853|NCT01872689|3888875|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3
2234854|NCT01872689|3888876|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10
2234855|NCT01872689|3888877|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7
2234856|NCT01872689|3888874|FG000|Open-Label Period (Only For Monotherapy)|Other|2
2234857|NCT01872689|3888875|FG001|Open-Label Period (Only For Monotherapy)|Other|3
2234858|NCT01872689|3888876|FG002|Open-Label Period (Only For Monotherapy)|Other|0
2234859|NCT01872689|3888877|FG003|Open-Label Period (Only For Monotherapy)|Other|0
2234860|NCT01872689|3888874|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
2234861|NCT01872689|3888875|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
2234862|NCT01872689|3888876|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
2234863|NCT01872689|3888877|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
2234864|NCT01872689|3888874|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0
2234865|NCT01872689|3888875|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1
2234866|NCT01872689|3888876|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0
2234867|NCT01872689|3888877|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0
2234868|NCT01872689|3888874|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
2234869|NCT01872689|3888875|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
2234870|NCT01872689|3888876|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
2234871|NCT01872689|3888877|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
2234872|NCT01872689|3888874|FG000|Open-Label Period (Only For Monotherapy)|Death|5
2234873|NCT01872689|3888875|FG001|Open-Label Period (Only For Monotherapy)|Death|3
2234874|NCT01872689|3888876|FG002|Open-Label Period (Only For Monotherapy)|Death|0
2234875|NCT01872689|3888877|FG003|Open-Label Period (Only For Monotherapy)|Death|0
2234876|NCT01872689|3888874|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2
2234877|NCT01872689|3888875|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1
2234878|NCT01872689|3888876|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0
2234879|NCT01872689|3888877|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0
2234880|NCT01872715|3888890|FG000|Overall Study|Adverse Event|1
2234881|NCT01872715|3888890|FG000|Overall Study|Protocol Violation|1
2234882|NCT01872715|3888890|FG000|Overall Study|Withdrawal by Subject|2
2234883|NCT01872910|3888915|FG000|Overall Study|Lost to Follow-up|2
2234884|NCT01872910|3888916|FG001|Overall Study|Lost to Follow-up|0
2234885|NCT01872910|3888917|FG002|Overall Study|Lost to Follow-up|2
2234886|NCT01872910|3888918|FG003|Overall Study|Lost to Follow-up|0
2234887|NCT01872910|3888919|FG004|Overall Study|Lost to Follow-up|0
2234888|NCT01872910|3888920|FG005|Overall Study|Lost to Follow-up|0
2234889|NCT01873417|3888944|FG000|Overall Study|Did Not Receive Any Study Drug|4
2234890|NCT01873417|3888944|FG000|Overall Study|Adverse Event|24
2234891|NCT01873417|3888944|FG000|Overall Study|Lost to Follow-up|2
2234892|NCT01873417|3888944|FG000|Overall Study|Withdrawal by Subject|2
2234893|NCT01873417|3888944|FG000|Overall Study|Physician Decision|3
2234894|NCT01873495|3888948|FG000|Overall Study|Withdrawal by Subject|1
2234895|NCT01873495|3888948|FG000|Overall Study|Physician Decision|3
2234896|NCT01873495|3888948|FG000|Overall Study|Adverse Event|1
2234897|NCT01873495|3888948|FG000|Overall Study|Removed for Transplantation|1
2234898|NCT01873495|3888948|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
2234899|NCT01873586|3888952|FG000|Overall Study|Lost to Follow-up|3
2234900|NCT01873729|3888959|FG000|Overall Study|Withdrawal by Subject|1
2234901|NCT01873742|3888965|FG000|Overall Study|Lost to Follow-up|68
2234902|NCT01873742|3888966|FG001|Overall Study|Lost to Follow-up|76
2234903|NCT01873859|3888978|FG000|Overall Study|Withdrawal by Subject|0
2234904|NCT01873859|3888979|FG001|Overall Study|Withdrawal by Subject|4
2234905|NCT01873950|3888986|FG000|Period 5|Withdrawal by Subject|0
2234906|NCT01873950|3888987|FG001|Period 5|Withdrawal by Subject|0
2234907|NCT01873950|3888988|FG002|Period 5|Withdrawal by Subject|0
2234908|NCT01873950|3888989|FG003|Period 5|Withdrawal by Subject|1
2334178|NCT03241927|4059303|FG000|Overall Study|study terminated|1
2334179|NCT03241927|4059304|FG001|Overall Study|study terminated|0
2334180|NCT03242018|4059313|FG000|Overall Study|Adverse Event|7
2334181|NCT03242018|4059314|FG001|Overall Study|Adverse Event|7
2334182|NCT03242018|4059315|FG002|Overall Study|Adverse Event|6
2334183|NCT03242018|4059313|FG000|Overall Study|Lost to Follow-up|2
2334184|NCT03242018|4059314|FG001|Overall Study|Lost to Follow-up|2
2334185|NCT03242018|4059315|FG002|Overall Study|Lost to Follow-up|2
2334186|NCT03242018|4059313|FG000|Overall Study|At the Participant's Own Request|5
2334187|NCT03242018|4059314|FG001|Overall Study|At the Participant's Own Request|1
2334188|NCT03242018|4059315|FG002|Overall Study|At the Participant's Own Request|4
2334189|NCT03242018|4059313|FG000|Overall Study|Reason Not Specified|3
2334190|NCT03242018|4059314|FG001|Overall Study|Reason Not Specified|4
2334191|NCT03242018|4059315|FG002|Overall Study|Reason Not Specified|1
2334192|NCT03242018|4059313|FG000|Overall Study|Study Terminated by Sponsor|1
2334193|NCT03242018|4059314|FG001|Overall Study|Study Terminated by Sponsor|0
2334194|NCT03242018|4059315|FG002|Overall Study|Study Terminated by Sponsor|1
2334195|NCT03242252|4059331|FG000|Overall Study|At the Participant's own Request|18
2334196|NCT03242252|4059332|FG001|Overall Study|At the Participant's own Request|10
2334197|NCT03242252|4059333|FG002|Overall Study|At the Participant's own Request|15
2334198|NCT03242252|4059331|FG000|Overall Study|Adverse Event|8
2334199|NCT03242252|4059332|FG001|Overall Study|Adverse Event|6
2334200|NCT03242252|4059333|FG002|Overall Study|Adverse Event|9
2334201|NCT03242252|4059331|FG000|Overall Study|Poor Compliance to Protocol|0
2334202|NCT03242252|4059332|FG001|Overall Study|Poor Compliance to Protocol|2
2334203|NCT03242252|4059333|FG002|Overall Study|Poor Compliance to Protocol|3
2334204|NCT03242252|4059331|FG000|Overall Study|Study Terminated by Sponsor|1
2334205|NCT03242252|4059332|FG001|Overall Study|Study Terminated by Sponsor|0
2334206|NCT03242252|4059333|FG002|Overall Study|Study Terminated by Sponsor|0
2334207|NCT03242252|4059331|FG000|Overall Study|Reason not Specified|4
2334208|NCT03242252|4059332|FG001|Overall Study|Reason not Specified|4
2334209|NCT03242252|4059333|FG002|Overall Study|Reason not Specified|1
2334210|NCT03242252|4059331|FG000|Overall Study|Lost to Follow-up|5
2334211|NCT03242252|4059332|FG001|Overall Study|Lost to Follow-up|1
2334212|NCT03242252|4059333|FG002|Overall Study|Lost to Follow-up|4
2334213|NCT03242434|4059353|FG000|Overall Study|Death|0
2334214|NCT03242434|4059354|FG001|Overall Study|Death|2
2334215|NCT03242759|4059367|FG000|Overall Study|Adverse Event|5
2334216|NCT03242759|4059368|FG001|Overall Study|Adverse Event|1
2334217|NCT03242759|4059367|FG000|Overall Study|Withdrawal by Subject|4
2334218|NCT03242759|4059368|FG001|Overall Study|Withdrawal by Subject|3
2334219|NCT03242759|4059367|FG000|Overall Study|Lost to Follow-up|3
2334220|NCT03242759|4059368|FG001|Overall Study|Lost to Follow-up|1
2334221|NCT03242759|4059367|FG000|Overall Study|Administrative problems|1
2334222|NCT03242759|4059368|FG001|Overall Study|Administrative problems|1
2334223|NCT03242759|4059367|FG000|Overall Study|Death|22
2334224|NCT03242759|4059368|FG001|Overall Study|Death|0
2334225|NCT03242759|4059367|FG000|Overall Study|Change visit schedule|0
2334226|NCT03242759|4059368|FG001|Overall Study|Change visit schedule|1
2334227|NCT03242863|4059374|FG000|Study Week 1|Withdrawal by Subject|0
2334228|NCT03242863|4059375|FG001|Study Week 1|Withdrawal by Subject|1
2334229|NCT03242863|4059376|FG002|Study Week 1|Withdrawal by Subject|0
2334230|NCT03242863|4059377|FG003|Study Week 1|Withdrawal by Subject|0
2334231|NCT03242863|4059378|FG004|Study Week 1|Withdrawal by Subject|3
2334232|NCT03242863|4059379|FG005|Study Week 1|Withdrawal by Subject|0
2334233|NCT03242928|4059389|FG000|Overall Study|Adverse Event|2
2334234|NCT03242928|4059390|FG001|Overall Study|Adverse Event|1
2334235|NCT03242928|4059389|FG000|Overall Study|Lost to Follow-up|2
2334236|NCT03242928|4059390|FG001|Overall Study|Lost to Follow-up|0
2334237|NCT03242928|4059389|FG000|Overall Study|Physician Decision|0
2334238|NCT03242928|4059390|FG001|Overall Study|Physician Decision|1
2334239|NCT03242928|4059389|FG000|Overall Study|Withdrawal by Subject|5
2334240|NCT03242928|4059390|FG001|Overall Study|Withdrawal by Subject|3
2334241|NCT03243084|4059420|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1
2334242|NCT03243084|4059421|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0
2334243|NCT03243305|4059428|FG000|Overall Study|Lost to Follow-up|250
2334244|NCT03243305|4059428|FG000|Overall Study|Withdrawal by Subject|170
2334245|NCT03243305|4059428|FG000|Overall Study|Pregnancy|104
2334246|NCT03243305|4059428|FG000|Overall Study|Non-Compliance with Study Drug|38
2334247|NCT03243305|4059428|FG000|Overall Study|Adverse Event|23
2334248|NCT03243305|4059428|FG000|Overall Study|No sexually active|26
2334249|NCT03243305|4059428|FG000|Overall Study|Physician Decision|22
2334250|NCT03243305|4059428|FG000|Overall Study|Protocol Violation|22
2234909|NCT01873950|3888990|FG004|Period 5|Withdrawal by Subject|0
2234910|NCT01874054|3889013|FG000|Overall Study|Withdrawal by Subject|3
2234911|NCT01874054|3889013|FG000|Overall Study|Study Termination by Sponsor|42
2234912|NCT01874054|3889013|FG000|Overall Study|Lost to Follow-up|5
2234913|NCT01874054|3889013|FG000|Overall Study|Death|5
2234914|NCT01874145|3889039|FG000|Core Period|Non-compliance|1
2234915|NCT01874145|3889040|FG001|Core Period|Non-compliance|0
2234916|NCT01874145|3889039|FG000|Core Period|Protocol Violation|1
2234917|NCT01874145|3889040|FG001|Core Period|Protocol Violation|1
2234918|NCT01874145|3889039|FG000|Core Period|Physician Decision|1
2234919|NCT01874145|3889040|FG001|Core Period|Physician Decision|1
2234920|NCT01874145|3889039|FG000|Core Period|Adverse Event|0
2234921|NCT01874145|3889040|FG001|Core Period|Adverse Event|1
2234922|NCT01874145|3889039|FG000|Core Period|Withdrawal by Subject|0
2234923|NCT01874145|3889040|FG001|Core Period|Withdrawal by Subject|4
2234924|NCT01874145|3889039|FG000|Extension Period|Adverse Event|3
2234925|NCT01874145|3889040|FG001|Extension Period|Adverse Event|2
2234926|NCT01874145|3889039|FG000|Extension Period|Withdrawal by Subject|2
2234927|NCT01874145|3889040|FG001|Extension Period|Withdrawal by Subject|1
2234928|NCT01874145|3889039|FG000|Extension Period|Lost to Follow-up|1
2234929|NCT01874145|3889040|FG001|Extension Period|Lost to Follow-up|1
2234930|NCT01874275|3889061|FG000|Overall Study|Lost to Follow-up|1
2234931|NCT01874275|3889062|FG001|Overall Study|Lost to Follow-up|0
2234932|NCT01874288|3889079|FG000|Overall Study|Withdrawal by Subject|1
2234933|NCT01874288|3889080|FG001|Overall Study|Withdrawal by Subject|0
2234934|NCT01874288|3889081|FG002|Overall Study|Withdrawal by Subject|2
2234935|NCT01874288|3889082|FG003|Overall Study|Withdrawal by Subject|1
2234936|NCT01874288|3889083|FG004|Overall Study|Withdrawal by Subject|1
2234937|NCT01874288|3889079|FG000|Overall Study|Physician Decision|0
2234938|NCT01874288|3889080|FG001|Overall Study|Physician Decision|0
2234939|NCT01874288|3889081|FG002|Overall Study|Physician Decision|0
2234940|NCT01874288|3889082|FG003|Overall Study|Physician Decision|1
2234941|NCT01874288|3889083|FG004|Overall Study|Physician Decision|0
2234942|NCT01874288|3889079|FG000|Overall Study|Progressive disease|2
2234943|NCT01874288|3889080|FG001|Overall Study|Progressive disease|0
2234944|NCT01874288|3889081|FG002|Overall Study|Progressive disease|3
2234945|NCT01874288|3889082|FG003|Overall Study|Progressive disease|5
2234946|NCT01874288|3889083|FG004|Overall Study|Progressive disease|1
2234947|NCT01874340|3889100|FG000|Overall Study|Study terminated by Sponsor|6
2234948|NCT01874340|3889101|FG001|Overall Study|Study terminated by Sponsor|8
2234949|NCT01874340|3889102|FG002|Overall Study|Study terminated by Sponsor|8
2234950|NCT01874340|3889103|FG003|Overall Study|Study terminated by Sponsor|4
2234951|NCT01874340|3889100|FG000|Overall Study|Withdrawal by Subject|0
2234952|NCT01874340|3889101|FG001|Overall Study|Withdrawal by Subject|0
2234953|NCT01874340|3889102|FG002|Overall Study|Withdrawal by Subject|0
2234954|NCT01874340|3889103|FG003|Overall Study|Withdrawal by Subject|1
2234955|NCT01874431|3889125|FG000|Overall Study|Physician Decision|0
2234956|NCT01874431|3889126|FG001|Overall Study|Physician Decision|0
2234957|NCT01874431|3889127|FG002|Overall Study|Physician Decision|1
2234958|NCT01874431|3889128|FG003|Overall Study|Physician Decision|0
2234959|NCT01874431|3889129|FG004|Overall Study|Physician Decision|0
2234960|NCT01874431|3889130|FG005|Overall Study|Physician Decision|0
2234961|NCT01874431|3889131|FG006|Overall Study|Physician Decision|0
2234962|NCT01874431|3889132|FG007|Overall Study|Physician Decision|0
2234963|NCT01874431|3889125|FG000|Overall Study|Adverse Event|5
2234964|NCT01874431|3889126|FG001|Overall Study|Adverse Event|4
2234965|NCT01874431|3889127|FG002|Overall Study|Adverse Event|6
2234966|NCT01874431|3889128|FG003|Overall Study|Adverse Event|5
2234967|NCT01874431|3889129|FG004|Overall Study|Adverse Event|2
2234968|NCT01874431|3889130|FG005|Overall Study|Adverse Event|8
2234969|NCT01874431|3889131|FG006|Overall Study|Adverse Event|2
2234970|NCT01874431|3889132|FG007|Overall Study|Adverse Event|3
2234971|NCT01874431|3889125|FG000|Overall Study|Protocol Violation|1
2234972|NCT01874431|3889126|FG001|Overall Study|Protocol Violation|1
2234973|NCT01874431|3889127|FG002|Overall Study|Protocol Violation|1
2234974|NCT01874431|3889128|FG003|Overall Study|Protocol Violation|0
2234975|NCT01874431|3889129|FG004|Overall Study|Protocol Violation|3
2234976|NCT01874431|3889130|FG005|Overall Study|Protocol Violation|2
2234977|NCT01874431|3889131|FG006|Overall Study|Protocol Violation|1
2234978|NCT01874431|3889132|FG007|Overall Study|Protocol Violation|1
2234979|NCT01874431|3889125|FG000|Overall Study|Non-compliance|0
2234980|NCT01874431|3889126|FG001|Overall Study|Non-compliance|0
2234981|NCT01874431|3889127|FG002|Overall Study|Non-compliance|0
2234982|NCT01874431|3889128|FG003|Overall Study|Non-compliance|0
2234983|NCT01874431|3889129|FG004|Overall Study|Non-compliance|1
2234984|NCT01874431|3889130|FG005|Overall Study|Non-compliance|0
2234985|NCT01874431|3889131|FG006|Overall Study|Non-compliance|1
2234986|NCT01874431|3889132|FG007|Overall Study|Non-compliance|0
2234987|NCT01874431|3889125|FG000|Overall Study|Logistical difficulties|0
2234988|NCT01874431|3889126|FG001|Overall Study|Logistical difficulties|0
2234989|NCT01874431|3889127|FG002|Overall Study|Logistical difficulties|0
2234990|NCT01874431|3889128|FG003|Overall Study|Logistical difficulties|0
2234991|NCT01874431|3889129|FG004|Overall Study|Logistical difficulties|0
2234992|NCT01874431|3889130|FG005|Overall Study|Logistical difficulties|0
2234993|NCT01874431|3889131|FG006|Overall Study|Logistical difficulties|1
2234994|NCT01874431|3889132|FG007|Overall Study|Logistical difficulties|0
2234995|NCT01874431|3889125|FG000|Overall Study|Withdrawal by Subject|0
2234996|NCT01874431|3889126|FG001|Overall Study|Withdrawal by Subject|0
2234997|NCT01874431|3889127|FG002|Overall Study|Withdrawal by Subject|1
2234998|NCT01874431|3889128|FG003|Overall Study|Withdrawal by Subject|2
2234999|NCT01874431|3889129|FG004|Overall Study|Withdrawal by Subject|1
2235000|NCT01874431|3889130|FG005|Overall Study|Withdrawal by Subject|1
2235001|NCT01874431|3889131|FG006|Overall Study|Withdrawal by Subject|3
2235002|NCT01874431|3889132|FG007|Overall Study|Withdrawal by Subject|0
2235003|NCT01874431|3889125|FG000|Overall Study|Sponsor decision|0
2235004|NCT01874431|3889126|FG001|Overall Study|Sponsor decision|0
2235005|NCT01874431|3889127|FG002|Overall Study|Sponsor decision|0
2235006|NCT01874431|3889128|FG003|Overall Study|Sponsor decision|0
2235007|NCT01874431|3889129|FG004|Overall Study|Sponsor decision|1
2235008|NCT01874431|3889130|FG005|Overall Study|Sponsor decision|0
2235009|NCT01874431|3889131|FG006|Overall Study|Sponsor decision|0
2235010|NCT01874431|3889132|FG007|Overall Study|Sponsor decision|0
2235011|NCT01874431|3889125|FG000|Overall Study|Lost to Follow-up|0
2235012|NCT01874431|3889126|FG001|Overall Study|Lost to Follow-up|0
2235013|NCT01874431|3889127|FG002|Overall Study|Lost to Follow-up|1
2235014|NCT01874431|3889128|FG003|Overall Study|Lost to Follow-up|0
2235015|NCT01874431|3889129|FG004|Overall Study|Lost to Follow-up|0
2235016|NCT01874431|3889130|FG005|Overall Study|Lost to Follow-up|0
2235017|NCT01874431|3889131|FG006|Overall Study|Lost to Follow-up|0
2235018|NCT01874431|3889132|FG007|Overall Study|Lost to Follow-up|0
2235019|NCT01874535|3889152|FG000|Overall Study|Lost to Follow-up|10
2235020|NCT01874535|3889153|FG001|Overall Study|Lost to Follow-up|9
2235021|NCT01874535|3889152|FG000|Overall Study|incomplete symptom resolution|45
2235022|NCT01874535|3889153|FG001|Overall Study|incomplete symptom resolution|35
2235023|NCT01874665|3889161|FG000|Overall Study|Adverse Event|6
2334251|NCT03243305|4059428|FG000|Overall Study|Study method no longer primary method|12
2334252|NCT03243305|4059428|FG000|Overall Study|Study Terminated by Sponsor|1
2334253|NCT03243305|4059428|FG000|Overall Study|Early terminations|267
2334254|NCT03243630|4059432|FG000|Overall Study|Protocol Violation|1
2334255|NCT03243630|4059432|FG000|Overall Study|Physician Decision|1
2334256|NCT03244618|4059451|FG000|Overall Study|Lost to Follow-up|3
2334257|NCT03244618|4059452|FG001|Overall Study|Lost to Follow-up|4
2334258|NCT03244618|4059451|FG000|Overall Study|Protocol Violation|4
2334259|NCT03244618|4059452|FG001|Overall Study|Protocol Violation|3
2334260|NCT03244618|4059451|FG000|Overall Study|Withdrawal by Subject|0
2334261|NCT03244618|4059452|FG001|Overall Study|Withdrawal by Subject|2
2352882|NCT03732638|4103115|FG001|Overall Study|Eligibility failure due to baseline laboratory values|13
2352883|NCT03732638|4103114|FG000|Overall Study|Lack of Efficacy|1
2352884|NCT03732638|4103115|FG001|Overall Study|Lack of Efficacy|1
2352885|NCT03732638|4103114|FG000|Overall Study|Lost to Follow-up|19
2352886|NCT03732638|4103115|FG001|Overall Study|Lost to Follow-up|12
2352887|NCT03732638|4103114|FG000|Overall Study|Non-compliance|6
2352888|NCT03732638|4103115|FG001|Overall Study|Non-compliance|5
2352889|NCT03732638|4103114|FG000|Overall Study|Physician Decision|0
2352890|NCT03732638|4103115|FG001|Overall Study|Physician Decision|1
2352891|NCT03732638|4103114|FG000|Overall Study|Protocol deviation|4
2352892|NCT03732638|4103115|FG001|Overall Study|Protocol deviation|5
2352893|NCT03732638|4103114|FG000|Overall Study|Withdrawal by Subject|11
2352894|NCT03732638|4103115|FG001|Overall Study|Withdrawal by Subject|22
2352895|NCT03732248|4103124|FG000|Overall Study|Withdrawal by Subject|1
2352896|NCT03732248|4103125|FG001|Overall Study|Withdrawal by Subject|0
2352897|NCT03731182|4103133|FG000|Overall Study|Lost to Follow-up|2
2352898|NCT03731182|4103134|FG001|Overall Study|Lost to Follow-up|0
2352899|NCT03731182|4103133|FG000|Overall Study|Physician Decision|1
2352900|NCT03731182|4103134|FG001|Overall Study|Physician Decision|0
2352901|NCT03731182|4103133|FG000|Overall Study|Withdrawal By Parent/Guardian|2
2352902|NCT03731182|4103134|FG001|Overall Study|Withdrawal By Parent/Guardian|0
2352903|NCT03730961|4103143|FG000|Overall Study|Adverse Event|0
2352904|NCT03730961|4103144|FG001|Overall Study|Adverse Event|1
2352905|NCT03730103|4103160|FG000|Overall Study|Did not meet inclusion criteria|0
2352906|NCT03730103|4103161|FG001|Overall Study|Did not meet inclusion criteria|5
2235024|NCT01874665|3889162|FG001|Overall Study|Adverse Event|2
2235025|NCT01874665|3889161|FG000|Overall Study|Withdrawal by Subject|4
2235026|NCT01874665|3889162|FG001|Overall Study|Withdrawal by Subject|1
2235027|NCT01874665|3889161|FG000|Overall Study|Physician Decision|3
2235028|NCT01874665|3889162|FG001|Overall Study|Physician Decision|0
2235029|NCT01874665|3889161|FG000|Overall Study|Clinical Progressive Disease|4
2235030|NCT01874665|3889162|FG001|Overall Study|Clinical Progressive Disease|3
2235031|NCT01874665|3889161|FG000|Overall Study|Study Terminated by Sponsor|0
2235032|NCT01874665|3889162|FG001|Overall Study|Study Terminated by Sponsor|2
2235033|NCT01874665|3889161|FG000|Overall Study|Documented Progressive Disease|11
2235034|NCT01874665|3889162|FG001|Overall Study|Documented Progressive Disease|7
2235035|NCT01874665|3889161|FG000|Overall Study|Other|2
2235036|NCT01874665|3889162|FG001|Overall Study|Other|0
2235037|NCT01875237|3889209|FG000|Overall Study|GVDH before DLI|1
2235038|NCT01875237|3889210|FG001|Overall Study|GVDH before DLI|0
2235039|NCT01875237|3889209|FG000|Overall Study|DLI cells could not be produced|1
2235040|NCT01875237|3889210|FG001|Overall Study|DLI cells could not be produced|0
2235041|NCT01875250|3889220|FG000|Overall Study|Adverse Event|2
2235042|NCT01875250|3889221|FG001|Overall Study|Adverse Event|0
2235043|NCT01875367|3889231|FG000|Overall Study|Not complete at least 2 questionaries|4
2235044|NCT01875367|3889232|FG001|Overall Study|Not complete at least 2 questionaries|2
2235045|NCT01875367|3889231|FG000|Overall Study|Not receive study treatment|1
2235046|NCT01875367|3889232|FG001|Overall Study|Not receive study treatment|0
2235047|NCT01875445|3889244|FG000|Overall Study|Lost to Follow-up|5
2235048|NCT01875445|3889245|FG001|Overall Study|Lost to Follow-up|0
2235049|NCT01875445|3889244|FG000|Overall Study|Withdrawal by Subject|2
2235050|NCT01875445|3889245|FG001|Overall Study|Withdrawal by Subject|0
2235051|NCT01875471|3889253|FG000|Overall Study|Adverse Event|0
2235052|NCT01875471|3889254|FG001|Overall Study|Adverse Event|1
2235053|NCT01875471|3889253|FG000|Overall Study|Unsatisfactory Lens Fitting|1
2235054|NCT01875471|3889254|FG001|Overall Study|Unsatisfactory Lens Fitting|0
2235055|NCT01875731|3889271|FG000|Overall Study|Fail to obtain lab sample|1
2235056|NCT01875731|3889272|FG001|Overall Study|Fail to obtain lab sample|0
2235057|NCT01875848|3889286|FG000|Overall Study|Withdrawal by Subject|2
2235058|NCT01875848|3889287|FG001|Overall Study|Withdrawal by Subject|0
2235059|NCT01875874|3889303|FG000|Overall Study|Death|3
2235060|NCT01875991|3889321|FG000|Overall Study|Withdrawal by Subject|6
2235061|NCT01875991|3889322|FG001|Overall Study|Withdrawal by Subject|6
2235062|NCT01875991|3889321|FG000|Overall Study|Sponsor Decision|1
2235063|NCT01875991|3889322|FG001|Overall Study|Sponsor Decision|0
2235064|NCT01876043|3889331|FG000|Overall Study|Death|1
2235065|NCT01876043|3889331|FG000|Overall Study|Withdrawal by Subject|1
2235066|NCT01876082|3889337|FG000|Overall Study|Withdrawal by Subject|0
2235067|NCT01876082|3889338|FG001|Overall Study|Withdrawal by Subject|2
2235068|NCT01876082|3889337|FG000|Overall Study|Protocol Violation|1
2235069|NCT01876082|3889338|FG001|Overall Study|Protocol Violation|0
2235070|NCT01876082|3889337|FG000|Overall Study|Adverse Event|1
2235071|NCT01876082|3889338|FG001|Overall Study|Adverse Event|1
2235072|NCT01876082|3889337|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0
2235073|NCT01876082|3889338|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1
2235074|NCT01876251|3889356|FG000|Overall Study|Clinical progression|1
2235075|NCT01876251|3889357|FG001|Overall Study|Clinical progression|0
2235076|NCT01876251|3889358|FG002|Overall Study|Clinical progression|0
2235077|NCT01876251|3889356|FG000|Overall Study|Death|2
2235078|NCT01876251|3889357|FG001|Overall Study|Death|0
2235079|NCT01876251|3889358|FG002|Overall Study|Death|1
2235080|NCT01876251|3889356|FG000|Overall Study|Participant started new treatment|1
2235081|NCT01876251|3889357|FG001|Overall Study|Participant started new treatment|0
2235082|NCT01876251|3889358|FG002|Overall Study|Participant started new treatment|1
2235083|NCT01876251|3889356|FG000|Overall Study|Participant refused further follow-up|0
2235084|NCT01876251|3889357|FG001|Overall Study|Participant refused further follow-up|0
2235085|NCT01876251|3889358|FG002|Overall Study|Participant refused further follow-up|1
2235086|NCT01876251|3889356|FG000|Overall Study|Study terminated|1
2235087|NCT01876251|3889357|FG001|Overall Study|Study terminated|0
2334262|NCT03244800|4059462|FG000|Overall Study|Adverse Event|0
2334263|NCT03244800|4059463|FG001|Overall Study|Adverse Event|1
2334264|NCT03244800|4059464|FG002|Overall Study|Adverse Event|0
2334265|NCT03244800|4059465|FG003|Overall Study|Adverse Event|1
2334266|NCT03244800|4059462|FG000|Overall Study|Withdrew treatment|0
2334267|NCT03244800|4059463|FG001|Overall Study|Withdrew treatment|0
2334268|NCT03244800|4059464|FG002|Overall Study|Withdrew treatment|0
2334269|NCT03244800|4059465|FG003|Overall Study|Withdrew treatment|1
2334270|NCT03244917|4059484|FG000|Overall Study|Lost to Follow-up|2
2334271|NCT03244917|4059485|FG001|Overall Study|Lost to Follow-up|2
2334272|NCT03245398|4059502|FG000|Overall Study|Travelled to another island|1
2334273|NCT03245398|4059503|FG001|Overall Study|Travelled to another island|0
2334274|NCT03245619|4059537|FG000|Part A (Up to Day 22)|Physician Decision|4
2334275|NCT03245619|4059538|FG001|Part A (Up to Day 22)|Physician Decision|6
2334276|NCT03245619|4059539|FG002|Part A (Up to Day 22)|Physician Decision|6
2334277|NCT03245619|4059540|FG003|Part A (Up to Day 22)|Physician Decision|0
2334278|NCT03245619|4059541|FG004|Part A (Up to Day 22)|Physician Decision|0
2334279|NCT03245619|4059542|FG005|Part A (Up to Day 22)|Physician Decision|0
2334280|NCT03245619|4059543|FG006|Part A (Up to Day 22)|Physician Decision|0
2334281|NCT03245619|4059544|FG007|Part A (Up to Day 22)|Physician Decision|0
2235088|NCT01876251|3889358|FG002|Overall Study|Study terminated|0
2235089|NCT01876251|3889356|FG000|Overall Study|Objective progression or relapse|10
2235090|NCT01876251|3889357|FG001|Overall Study|Objective progression or relapse|3
2235091|NCT01876251|3889358|FG002|Overall Study|Objective progression or relapse|8
2235092|NCT01876368|3889382|FG000|Overall Study|Adverse Event|2
2235093|NCT01876368|3889383|FG001|Overall Study|Adverse Event|5
2235094|NCT01876368|3889382|FG000|Overall Study|Lack of Efficacy|1
2235095|NCT01876368|3889383|FG001|Overall Study|Lack of Efficacy|0
2235096|NCT01876368|3889382|FG000|Overall Study|Lost to Follow-up|0
2235097|NCT01876368|3889383|FG001|Overall Study|Lost to Follow-up|1
2235098|NCT01876368|3889382|FG000|Overall Study|Non-compliance with study treatment|0
2235099|NCT01876368|3889383|FG001|Overall Study|Non-compliance with study treatment|1
2235100|NCT01876368|3889382|FG000|Overall Study|Physician Decision|0
2235101|NCT01876368|3889383|FG001|Overall Study|Physician Decision|2
2235102|NCT01876368|3889382|FG000|Overall Study|Protocol deviation|3
2235103|NCT01876368|3889383|FG001|Overall Study|Protocol deviation|3
2235104|NCT01876368|3889382|FG000|Overall Study|Subject/guardian decision|3
2235105|NCT01876368|3889383|FG001|Overall Study|Subject/guardian decision|1
2235106|NCT01876381|3889389|FG000|Overall Study|Lack of Efficacy|5
2235107|NCT01876381|3889389|FG000|Overall Study|Physician Decision|1
2235108|NCT01876381|3889389|FG000|Overall Study|Withdrawal by Subject|1
2235109|NCT01876420|3889393|FG000|Overall Study|Missed 30 day visit|1
2235110|NCT01876446|3889399|FG000|Overall Study|Death|0
2235111|NCT01876446|3889400|FG001|Overall Study|Death|1
2235112|NCT01876446|3889399|FG000|Overall Study|Withdrawal by Subject|1
2235113|NCT01876446|3889400|FG001|Overall Study|Withdrawal by Subject|2
2235114|NCT01876446|3889399|FG000|Overall Study|Physician Decision|1
2235115|NCT01876446|3889400|FG001|Overall Study|Physician Decision|3
2235116|NCT01876511|3889418|FG000|Overall Study|Disease Progression-clinical/radiologic|11
2235117|NCT01876511|3889419|FG001|Overall Study|Disease Progression-clinical/radiologic|24
2235118|NCT01876511|3889420|FG002|Overall Study|Disease Progression-clinical/radiologic|16
2235119|NCT01876511|3889418|FG000|Overall Study|Death (unrelated)|3
2235120|NCT01876511|3889419|FG001|Overall Study|Death (unrelated)|0
2235121|NCT01876511|3889420|FG002|Overall Study|Death (unrelated)|2
2235122|NCT01876511|3889418|FG000|Overall Study|Drug-related Toxicity|5
2235123|NCT01876511|3889419|FG001|Overall Study|Drug-related Toxicity|1
2235124|NCT01876511|3889420|FG002|Overall Study|Drug-related Toxicity|6
2235125|NCT01876511|3889418|FG000|Overall Study|Patient Decision|3
2235126|NCT01876511|3889419|FG001|Overall Study|Patient Decision|0
2235127|NCT01876511|3889420|FG002|Overall Study|Patient Decision|6
2235128|NCT01876511|3889418|FG000|Overall Study|Physician Decision|1
2235129|NCT01876511|3889419|FG001|Overall Study|Physician Decision|0
2235130|NCT01876511|3889420|FG002|Overall Study|Physician Decision|1
2235131|NCT01876706|3889430|FG000|Overall Study|BPH Intervention|9
2235132|NCT01876706|3889430|FG000|Overall Study|Lost to Follow-up|7
2235133|NCT01876706|3889430|FG000|Overall Study|Withdrawals|6
2235134|NCT01876706|3889430|FG000|Overall Study|Death|3
2235135|NCT01876732|3889434|FG000|Overall Study|MMA was not over 800mg/dL|75
2235136|NCT01876784|3889441|FG000|Overall Study|Withdrawal by Subject|17
2235137|NCT01876784|3889442|FG001|Overall Study|Withdrawal by Subject|2
2235138|NCT01876784|3889441|FG000|Overall Study|Adverse Event|15
2235139|NCT01876784|3889442|FG001|Overall Study|Adverse Event|2
2235140|NCT01876784|3889441|FG000|Overall Study|Protocol Violation|1
2235141|NCT01876784|3889442|FG001|Overall Study|Protocol Violation|0
2235142|NCT01876784|3889441|FG000|Overall Study|Disease progression|37
2235143|NCT01876784|3889442|FG001|Overall Study|Disease progression|67
2235144|NCT01876784|3889441|FG000|Overall Study|Lost to Follow-up|0
2235145|NCT01876784|3889442|FG001|Overall Study|Lost to Follow-up|1
2235146|NCT01876784|3889441|FG000|Overall Study|Death|1
2235147|NCT01876784|3889442|FG001|Overall Study|Death|0
2235148|NCT01876784|3889441|FG000|Overall Study|Randomized but not treated|2
2235149|NCT01876784|3889442|FG001|Overall Study|Randomized but not treated|1
2235150|NCT01876784|3889441|FG000|Overall Study|Other than specified above|5
2235151|NCT01876784|3889442|FG001|Overall Study|Other than specified above|6
2235152|NCT01876784|3889441|FG000|Overall Study|Ongoing|41
2235153|NCT01876784|3889442|FG001|Overall Study|Ongoing|40
2334282|NCT03245619|4059545|FG008|Part A (Up to Day 22)|Physician Decision|0
2036766|NCT00413413|3606998|FG000|Double-Blind|Unsatisfactory therapeutic effect|1
2036767|NCT00413413|3606999|FG001|Double-Blind|Unsatisfactory therapeutic effect|2
2036768|NCT00413413|3607000|FG002|Double-Blind|Unsatisfactory therapeutic effect|1
2036769|NCT00413413|3606998|FG000|Double-Blind|Protocol deviation|1
2036770|NCT00413413|3606999|FG001|Double-Blind|Protocol deviation|2
2036771|NCT00413413|3607000|FG002|Double-Blind|Protocol deviation|1
2036772|NCT00413413|3606998|FG000|Double-Blind|Subject withdrew consent|4
2036773|NCT00413413|3606999|FG001|Double-Blind|Subject withdrew consent|6
2036774|NCT00413413|3607000|FG002|Double-Blind|Subject withdrew consent|9
2036775|NCT00413413|3606998|FG000|Double-Blind|Lost to Follow-up|3
2036776|NCT00413413|3606999|FG001|Double-Blind|Lost to Follow-up|4
2235154|NCT01876810|3889448|FG000|Overall Study|Physician Decision|0
2235155|NCT01876810|3889449|FG001|Overall Study|Physician Decision|1
2235156|NCT01876823|3889458|FG000|Overall Study|Withdrawal by Subject|5
2235157|NCT01876823|3889458|FG000|Overall Study|Physician Decision|2
2235158|NCT01876823|3889458|FG000|Overall Study|Patients moved|2
2235159|NCT01876901|3889464|FG000|Overall Study|Protocol Violation|10
2235160|NCT01876901|3889465|FG001|Overall Study|Protocol Violation|2
2235161|NCT01876901|3889464|FG000|Overall Study|No or other surgical intervention|7
2235162|NCT01876901|3889465|FG001|Overall Study|No or other surgical intervention|5
2235163|NCT01876979|3889483|FG000|Overall Study|Physician Decision|2
2235164|NCT01876979|3889484|FG001|Overall Study|Physician Decision|3
2235165|NCT01877083|3889500|FG000|Treatment Phase|Disease Progression|10
2235166|NCT01877083|3889500|FG000|Treatment Phase|Clinical Progression|1
2235167|NCT01877083|3889500|FG000|Treatment Phase|Adverse Event|6
2235168|NCT01877083|3889500|FG000|Treatment Phase|Withdrawal by Subject|2
2235169|NCT01877083|3889500|FG000|Treatment Phase|Lost to Follow-up|1
2235170|NCT01877083|3889500|FG000|Extension Phase|Disease Progression|3
2235171|NCT01877083|3889500|FG000|Extension Phase|Adverse Event|2
2235172|NCT01877187|3889521|FG000|Overall Study|Death|2
2235173|NCT01877187|3889521|FG000|Overall Study|Withdrawal by Subject|4
2235174|NCT01877187|3889521|FG000|Overall Study|Lost to Follow-up|3
2235175|NCT01877187|3889521|FG000|Overall Study|Declining clinical status|11
2235176|NCT01877187|3889521|FG000|Overall Study|Liver transplant|2
2235177|NCT01877239|3889528|FG000|Overall Study|Adverse Event|4
2235178|NCT01877239|3889528|FG000|Overall Study|Disease Remission|1
2235179|NCT01877239|3889528|FG000|Overall Study|Withdrawal by Subject|4
2334283|NCT03245619|4059546|FG009|Part A (Up to Day 22)|Physician Decision|0
2334284|NCT03245619|4059547|FG010|Part A (Up to Day 22)|Physician Decision|0
2334285|NCT03245619|4059548|FG011|Part A (Up to Day 22)|Physician Decision|0
2334286|NCT03245619|4059549|FG012|Part A (Up to Day 22)|Physician Decision|0
2334287|NCT03245619|4059550|FG013|Part A (Up to Day 22)|Physician Decision|0
2334288|NCT03245619|4059551|FG014|Part A (Up to Day 22)|Physician Decision|0
2334289|NCT03245619|4059552|FG015|Part A (Up to Day 22)|Physician Decision|0
2334290|NCT03245619|4059553|FG016|Part A (Up to Day 22)|Physician Decision|0
2334291|NCT03245723|4059614|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1
2334292|NCT03245723|4059615|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0
2334293|NCT03245723|4059614|FG000|Overall Study|Claustrophobia from wearing the mask|1
2334294|NCT03245723|4059615|FG001|Overall Study|Claustrophobia from wearing the mask|0
2334295|NCT03245723|4059614|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2
2334296|NCT03245723|4059615|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0
2334297|NCT03245723|4059614|FG000|Overall Study|Image acquisition/reconstruction failure|1
2334298|NCT03245723|4059615|FG001|Overall Study|Image acquisition/reconstruction failure|1
2334299|NCT03245736|4059621|FG000|Overall Study|Adverse Event|1
2334300|NCT03245736|4059621|FG000|Overall Study|Progressive Disease|4
2334301|NCT03246061|4059636|FG000|Overall Study|Still in follow-up|15
2334302|NCT03246061|4059637|FG001|Overall Study|Still in follow-up|21
2334303|NCT03246152|4059645|FG000|Overall Study|Lost to Follow-up|2
2334304|NCT03246152|4059645|FG000|Overall Study|Protocol Violation|1
2334305|NCT03246646|4059651|FG000|Overall Study|deemed ineligible and administratively withdrawn|1
2334306|NCT03246646|4059652|FG001|Overall Study|deemed ineligible and administratively withdrawn|0
2334307|NCT03246646|4059651|FG000|Overall Study|Withdrawal by Subject|3
2334308|NCT03246646|4059652|FG001|Overall Study|Withdrawal by Subject|0
2334309|NCT03246646|4059651|FG000|Overall Study|Lost to Follow-up|7
2334310|NCT03246646|4059652|FG001|Overall Study|Lost to Follow-up|0
2334311|NCT03246672|4059658|FG000|Overall Study|Lost to Follow-up|2
2334312|NCT03246724|4059666|FG000|Overall Study|Withdrawal by Subject|5
2334313|NCT03246724|4059667|FG001|Overall Study|Withdrawal by Subject|2
2334314|NCT03246724|4059668|FG002|Overall Study|Withdrawal by Subject|4
2334315|NCT03246724|4059669|FG003|Overall Study|Withdrawal by Subject|2
2334316|NCT03246724|4059666|FG000|Overall Study|Ineligible on day of surgery|7
2334317|NCT03246724|4059667|FG001|Overall Study|Ineligible on day of surgery|2
2334318|NCT03246724|4059668|FG002|Overall Study|Ineligible on day of surgery|0
2334319|NCT03246724|4059669|FG003|Overall Study|Ineligible on day of surgery|3
2334320|NCT03246724|4059666|FG000|Overall Study|Study completed before surgical date|2
2334321|NCT03246724|4059667|FG001|Overall Study|Study completed before surgical date|1
2334322|NCT03246724|4059668|FG002|Overall Study|Study completed before surgical date|8
2334323|NCT03246724|4059669|FG003|Overall Study|Study completed before surgical date|1
2334324|NCT03246724|4059666|FG000|Overall Study|Transferred to other arm|0
2334325|NCT03246724|4059667|FG001|Overall Study|Transferred to other arm|0
2334326|NCT03246724|4059668|FG002|Overall Study|Transferred to other arm|1
2334327|NCT03246724|4059669|FG003|Overall Study|Transferred to other arm|0
2334328|NCT03246724|4059666|FG000|Overall Study|Unable to obtain medication timely|0
2334329|NCT03246724|4059667|FG001|Overall Study|Unable to obtain medication timely|2
2036777|NCT00413413|3607000|FG002|Double-Blind|Lost to Follow-up|2
2036778|NCT00413660|3607039|FG000|Up To Week 12|Adverse Event|1
2036779|NCT00413660|3607040|FG001|Up To Week 12|Adverse Event|3
2036780|NCT00413660|3607041|FG002|Up To Week 12|Adverse Event|1
2036781|NCT00413660|3607042|FG003|Up To Week 12|Adverse Event|4
2036782|NCT00413660|3607043|FG004|Up To Week 12|Adverse Event|6
2036783|NCT00413660|3607044|FG005|Up To Week 12|Adverse Event|4
2036784|NCT00413660|3607045|FG006|Up To Week 12|Adverse Event|1
2036785|NCT00413660|3607046|FG007|Up To Week 12|Adverse Event|0
2036786|NCT00413660|3607047|FG008|Up To Week 12|Adverse Event|0
2036787|NCT00413660|3607048|FG009|Up To Week 12|Adverse Event|0
2036788|NCT00413660|3607049|FG010|Up To Week 12|Adverse Event|0
2036789|NCT00413660|3607039|FG000|Up To Week 12|Lack of Efficacy|2
2036790|NCT00413660|3607040|FG001|Up To Week 12|Lack of Efficacy|0
2235180|NCT01877239|3889528|FG000|Overall Study|Other|2
2235181|NCT01877239|3889528|FG000|Overall Study|Lack of Efficacy|4
2235182|NCT01877239|3889528|FG000|Overall Study|Data not available|35
2235183|NCT01877265|3889532|FG000|Treatment Period 1|Sponsor Decision|0
2235184|NCT01877265|3889533|FG001|Treatment Period 1|Sponsor Decision|0
2235185|NCT01877265|3889534|FG002|Treatment Period 1|Sponsor Decision|1
2235186|NCT01877265|3889535|FG003|Treatment Period 1|Sponsor Decision|0
2235187|NCT01877265|3889536|FG004|Treatment Period 1|Sponsor Decision|0
2235188|NCT01877265|3889537|FG005|Treatment Period 1|Sponsor Decision|0
2235189|NCT01877265|3889532|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2235190|NCT01877265|3889533|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2235191|NCT01877265|3889534|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2235192|NCT01877265|3889535|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2235193|NCT01877265|3889536|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2235194|NCT01877265|3889537|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
2235195|NCT01877265|3889532|FG000|Treatment Period 3|Lost to Follow-up|1
2235196|NCT01877265|3889533|FG001|Treatment Period 3|Lost to Follow-up|0
2235197|NCT01877265|3889534|FG002|Treatment Period 3|Lost to Follow-up|0
2235198|NCT01877265|3889535|FG003|Treatment Period 3|Lost to Follow-up|0
2235199|NCT01877265|3889536|FG004|Treatment Period 3|Lost to Follow-up|0
2235200|NCT01877265|3889537|FG005|Treatment Period 3|Lost to Follow-up|0
2235201|NCT01877278|3889550|FG000|Overall Study|Lost to Follow-up|3
2235202|NCT01877278|3889551|FG001|Overall Study|Lost to Follow-up|3
2235203|NCT01877408|3889559|FG000|Overall Study|Lost to Follow-up|0
2235204|NCT01877408|3889560|FG001|Overall Study|Lost to Follow-up|2
2235205|NCT01877421|3889599|FG000|Phase 2|Lost to Follow-up|0
2235206|NCT01877421|3889600|FG001|Phase 2|Lost to Follow-up|0
2235207|NCT01877421|3889601|FG002|Phase 2|Lost to Follow-up|0
2235208|NCT01877421|3889602|FG003|Phase 2|Lost to Follow-up|0
2235209|NCT01877421|3889603|FG004|Phase 2|Lost to Follow-up|0
2235210|NCT01877421|3889604|FG005|Phase 2|Lost to Follow-up|0
2235211|NCT01877421|3889605|FG006|Phase 2|Lost to Follow-up|1
2235212|NCT01877421|3889606|FG007|Phase 2|Lost to Follow-up|0
2235213|NCT01877421|3889607|FG008|Phase 2|Lost to Follow-up|0
2235214|NCT01877421|3889608|FG009|Phase 2|Lost to Follow-up|0
2235215|NCT01877421|3889609|FG010|Phase 2|Lost to Follow-up|0
2235216|NCT01877421|3889610|FG011|Phase 2|Lost to Follow-up|0
2235217|NCT01877421|3889611|FG012|Phase 2|Lost to Follow-up|0
2235218|NCT01877421|3889612|FG013|Phase 2|Lost to Follow-up|0
2235219|NCT01877421|3889613|FG014|Phase 2|Lost to Follow-up|0
2235220|NCT01877421|3889614|FG015|Phase 2|Lost to Follow-up|0
2235221|NCT01877421|3889615|FG016|Phase 2|Lost to Follow-up|0
2235222|NCT01877421|3889616|FG017|Phase 2|Lost to Follow-up|0
2235223|NCT01877421|3889599|FG000|Phase 2|Withdrawal by Subject|0
2235224|NCT01877421|3889600|FG001|Phase 2|Withdrawal by Subject|0
2235225|NCT01877421|3889601|FG002|Phase 2|Withdrawal by Subject|0
2235226|NCT01877421|3889602|FG003|Phase 2|Withdrawal by Subject|0
2235227|NCT01877421|3889603|FG004|Phase 2|Withdrawal by Subject|0
2235228|NCT01877421|3889604|FG005|Phase 2|Withdrawal by Subject|0
2235229|NCT01877421|3889605|FG006|Phase 2|Withdrawal by Subject|0
2235230|NCT01877421|3889606|FG007|Phase 2|Withdrawal by Subject|0
2235231|NCT01877421|3889607|FG008|Phase 2|Withdrawal by Subject|1
2235232|NCT01877421|3889608|FG009|Phase 2|Withdrawal by Subject|0
2235233|NCT01877421|3889609|FG010|Phase 2|Withdrawal by Subject|1
2235234|NCT01877421|3889610|FG011|Phase 2|Withdrawal by Subject|0
2235235|NCT01877421|3889611|FG012|Phase 2|Withdrawal by Subject|1
2235236|NCT01877421|3889612|FG013|Phase 2|Withdrawal by Subject|0
2235237|NCT01877421|3889613|FG014|Phase 2|Withdrawal by Subject|0
2235238|NCT01877421|3889614|FG015|Phase 2|Withdrawal by Subject|1
2235239|NCT01877421|3889615|FG016|Phase 2|Withdrawal by Subject|0
2235240|NCT01877421|3889616|FG017|Phase 2|Withdrawal by Subject|0
2235241|NCT01877421|3889599|FG000|Phase 2|Protocol Violation|0
2235242|NCT01877421|3889600|FG001|Phase 2|Protocol Violation|0
2235243|NCT01877421|3889601|FG002|Phase 2|Protocol Violation|0
2235244|NCT01877421|3889602|FG003|Phase 2|Protocol Violation|0
2235245|NCT01877421|3889603|FG004|Phase 2|Protocol Violation|0
2235246|NCT01877421|3889604|FG005|Phase 2|Protocol Violation|0
2235247|NCT01877421|3889605|FG006|Phase 2|Protocol Violation|0
2235248|NCT01877421|3889606|FG007|Phase 2|Protocol Violation|0
2235249|NCT01877421|3889607|FG008|Phase 2|Protocol Violation|0
2235250|NCT01877421|3889608|FG009|Phase 2|Protocol Violation|0
2235251|NCT01877421|3889609|FG010|Phase 2|Protocol Violation|1
2235252|NCT01877421|3889610|FG011|Phase 2|Protocol Violation|0
2235253|NCT01877421|3889611|FG012|Phase 2|Protocol Violation|0
2235254|NCT01877421|3889612|FG013|Phase 2|Protocol Violation|0
2235255|NCT01877421|3889613|FG014|Phase 2|Protocol Violation|0
2235256|NCT01877421|3889614|FG015|Phase 2|Protocol Violation|0
2235257|NCT01877421|3889615|FG016|Phase 2|Protocol Violation|0
2235258|NCT01877421|3889616|FG017|Phase 2|Protocol Violation|0
2235259|NCT01877551|3889702|FG000|Overall Study|Physician Decision|0
2235260|NCT01877551|3889703|FG001|Overall Study|Physician Decision|1
2235261|NCT01877668|3889731|FG000|Overall Study|Death|0
2235262|NCT01877668|3889732|FG001|Overall Study|Death|0
2235263|NCT01877668|3889733|FG002|Overall Study|Death|0
2235264|NCT01877668|3889734|FG003|Overall Study|Death|1
2235265|NCT01877668|3889735|FG004|Overall Study|Death|0
2235266|NCT01877668|3889731|FG000|Overall Study|No longer met study criteria|1
2235267|NCT01877668|3889732|FG001|Overall Study|No longer met study criteria|0
2235268|NCT01877668|3889733|FG002|Overall Study|No longer met study criteria|1
2235269|NCT01877668|3889734|FG003|Overall Study|No longer met study criteria|0
2235270|NCT01877668|3889735|FG004|Overall Study|No longer met study criteria|0
2235271|NCT01877668|3889731|FG000|Overall Study|Insufficient clinical response|0
2235272|NCT01877668|3889732|FG001|Overall Study|Insufficient clinical response|1
2235273|NCT01877668|3889733|FG002|Overall Study|Insufficient clinical response|2
2235274|NCT01877668|3889734|FG003|Overall Study|Insufficient clinical response|2
2235275|NCT01877668|3889735|FG004|Overall Study|Insufficient clinical response|0
2334330|NCT03246724|4059668|FG002|Overall Study|Unable to obtain medication timely|2
2334331|NCT03246724|4059669|FG003|Overall Study|Unable to obtain medication timely|1
2334332|NCT03246724|4059666|FG000|Overall Study|Re-consented to participate|0
2334333|NCT03246724|4059667|FG001|Overall Study|Re-consented to participate|0
2334334|NCT03246724|4059668|FG002|Overall Study|Re-consented to participate|0
2334335|NCT03246724|4059669|FG003|Overall Study|Re-consented to participate|1
2334336|NCT03247517|4059693|FG000|Overall Study|Adverse Event|0
2334337|NCT03247517|4059694|FG001|Overall Study|Adverse Event|4
2334338|NCT03247517|4059695|FG002|Overall Study|Adverse Event|2
2334339|NCT03247517|4059693|FG000|Overall Study|Lost to Follow-up|2
2334340|NCT03247517|4059694|FG001|Overall Study|Lost to Follow-up|6
2334341|NCT03247517|4059695|FG002|Overall Study|Lost to Follow-up|4
2334342|NCT03247517|4059693|FG000|Overall Study|Consent withdrawn by caregiver|1
2334343|NCT03247517|4059694|FG001|Overall Study|Consent withdrawn by caregiver|4
2334344|NCT03247517|4059695|FG002|Overall Study|Consent withdrawn by caregiver|7
2334345|NCT03247517|4059693|FG000|Overall Study|Assent/consent withdrawn by subject|2
2334346|NCT03247517|4059694|FG001|Overall Study|Assent/consent withdrawn by subject|3
2334347|NCT03247517|4059695|FG002|Overall Study|Assent/consent withdrawn by subject|1
2334348|NCT03247517|4059693|FG000|Overall Study|Protocol Violation|0
2334349|NCT03247517|4059694|FG001|Overall Study|Protocol Violation|2
2334350|NCT03247517|4059695|FG002|Overall Study|Protocol Violation|0
2334351|NCT03247517|4059693|FG000|Overall Study|Multiple reasons|3
2334352|NCT03247517|4059694|FG001|Overall Study|Multiple reasons|1
2334353|NCT03247517|4059695|FG002|Overall Study|Multiple reasons|0
2334354|NCT03247530|4059706|FG000|Overall Study|Withdrawal by caregiver|19
2334355|NCT03247530|4059707|FG001|Overall Study|Withdrawal by caregiver|8
2334356|NCT03247530|4059708|FG002|Overall Study|Withdrawal by caregiver|10
2334357|NCT03247530|4059706|FG000|Overall Study|Lost to Follow-up|3
2334358|NCT03247530|4059707|FG001|Overall Study|Lost to Follow-up|9
2334359|NCT03247530|4059708|FG002|Overall Study|Lost to Follow-up|6
2334360|NCT03247530|4059706|FG000|Overall Study|Adverse Event|2
2334361|NCT03247530|4059707|FG001|Overall Study|Adverse Event|5
2334362|NCT03247530|4059708|FG002|Overall Study|Adverse Event|2
2334363|NCT03247530|4059706|FG000|Overall Study|Failure to follow procedure|1
2334364|NCT03247530|4059707|FG001|Overall Study|Failure to follow procedure|1
2334365|NCT03247530|4059708|FG002|Overall Study|Failure to follow procedure|1
2334366|NCT03247530|4059706|FG000|Overall Study|Withdrawal by Subject|1
2334367|NCT03247530|4059707|FG001|Overall Study|Withdrawal by Subject|1
2334368|NCT03247530|4059708|FG002|Overall Study|Withdrawal by Subject|0
2334369|NCT03247530|4059706|FG000|Overall Study|Study medication misuse|0
2334370|NCT03247530|4059707|FG001|Overall Study|Study medication misuse|1
2334371|NCT03247530|4059708|FG002|Overall Study|Study medication misuse|0
2334372|NCT03247530|4059706|FG000|Overall Study|Other, multiple categories|1
2334373|NCT03247530|4059707|FG001|Overall Study|Other, multiple categories|3
2334374|NCT03247530|4059708|FG002|Overall Study|Other, multiple categories|1
2334375|NCT03247543|4059722|FG000|Overall Study|Adverse Event|3
2334376|NCT03247543|4059723|FG001|Overall Study|Adverse Event|6
2334377|NCT03247543|4059724|FG002|Overall Study|Adverse Event|4
2334378|NCT03247543|4059722|FG000|Overall Study|Lost to Follow-up|10
2334379|NCT03247543|4059723|FG001|Overall Study|Lost to Follow-up|7
2334380|NCT03247543|4059724|FG002|Overall Study|Lost to Follow-up|8
2334381|NCT03247543|4059722|FG000|Overall Study|Consent withdrawn by caregiver|2
2334382|NCT03247543|4059723|FG001|Overall Study|Consent withdrawn by caregiver|2
2334383|NCT03247543|4059724|FG002|Overall Study|Consent withdrawn by caregiver|9
2334384|NCT03247543|4059722|FG000|Overall Study|Withdrawal by Subject|0
2334385|NCT03247543|4059723|FG001|Overall Study|Withdrawal by Subject|0
2334386|NCT03247543|4059724|FG002|Overall Study|Withdrawal by Subject|1
2334387|NCT03247543|4059722|FG000|Overall Study|Failure to Follow study procedures|1
2334388|NCT03247543|4059723|FG001|Overall Study|Failure to Follow study procedures|3
2334389|NCT03247543|4059724|FG002|Overall Study|Failure to Follow study procedures|1
2334390|NCT03247543|4059722|FG000|Overall Study|Lack of Efficacy|1
2036791|NCT00413660|3607041|FG002|Up To Week 12|Lack of Efficacy|0
2036792|NCT00413660|3607042|FG003|Up To Week 12|Lack of Efficacy|0
2036793|NCT00413660|3607043|FG004|Up To Week 12|Lack of Efficacy|0
2036794|NCT00413660|3607044|FG005|Up To Week 12|Lack of Efficacy|0
2036795|NCT00413660|3607045|FG006|Up To Week 12|Lack of Efficacy|5
2036796|NCT00413660|3607046|FG007|Up To Week 12|Lack of Efficacy|0
2036797|NCT00413660|3607047|FG008|Up To Week 12|Lack of Efficacy|0
2036798|NCT00413660|3607048|FG009|Up To Week 12|Lack of Efficacy|0
2334391|NCT03247543|4059723|FG001|Overall Study|Lack of Efficacy|0
2334392|NCT03247543|4059724|FG002|Overall Study|Lack of Efficacy|0
2334393|NCT03247543|4059722|FG000|Overall Study|Non-compliance with study visits|0
2235276|NCT01877668|3889731|FG000|Overall Study|Lost to Follow-up|0
2235277|NCT01877668|3889732|FG001|Overall Study|Lost to Follow-up|2
2235278|NCT01877668|3889733|FG002|Overall Study|Lost to Follow-up|1
2235279|NCT01877668|3889734|FG003|Overall Study|Lost to Follow-up|0
2235280|NCT01877668|3889735|FG004|Overall Study|Lost to Follow-up|0
2235281|NCT01877668|3889731|FG000|Overall Study|Withdrawal by Subject|2
2235282|NCT01877668|3889732|FG001|Overall Study|Withdrawal by Subject|0
2235283|NCT01877668|3889733|FG002|Overall Study|Withdrawal by Subject|3
2235284|NCT01877668|3889734|FG003|Overall Study|Withdrawal by Subject|2
2235285|NCT01877668|3889735|FG004|Overall Study|Withdrawal by Subject|2
2235286|NCT01877668|3889731|FG000|Overall Study|Other|1
2235287|NCT01877668|3889732|FG001|Overall Study|Other|1
2235288|NCT01877668|3889733|FG002|Overall Study|Other|1
2235289|NCT01877668|3889734|FG003|Overall Study|Other|1
2235290|NCT01877668|3889735|FG004|Overall Study|Other|3
2235291|NCT01877668|3889731|FG000|Overall Study|Protocol Violation|1
2235292|NCT01877668|3889732|FG001|Overall Study|Protocol Violation|1
2235293|NCT01877668|3889733|FG002|Overall Study|Protocol Violation|0
2235294|NCT01877668|3889734|FG003|Overall Study|Protocol Violation|0
2235295|NCT01877668|3889735|FG004|Overall Study|Protocol Violation|3
2235296|NCT01877668|3889731|FG000|Overall Study|Adverse event related to study drug|2
2235297|NCT01877668|3889732|FG001|Overall Study|Adverse event related to study drug|2
2235298|NCT01877668|3889733|FG002|Overall Study|Adverse event related to study drug|2
2235299|NCT01877668|3889734|FG003|Overall Study|Adverse event related to study drug|2
2235300|NCT01877668|3889735|FG004|Overall Study|Adverse event related to study drug|1
2235301|NCT01877668|3889731|FG000|Overall Study|Adverse event unrelated to study drug|4
2235302|NCT01877668|3889732|FG001|Overall Study|Adverse event unrelated to study drug|1
2235303|NCT01877668|3889733|FG002|Overall Study|Adverse event unrelated to study drug|2
2235304|NCT01877668|3889734|FG003|Overall Study|Adverse event unrelated to study drug|0
2235305|NCT01877668|3889735|FG004|Overall Study|Adverse event unrelated to study drug|1
2235306|NCT01877720|3889751|FG000|Overall Study|Adverse Event|1
2235307|NCT01877720|3889752|FG001|Overall Study|Adverse Event|0
2235308|NCT01877915|3889760|FG000|Overall Study|Lost to Follow-up|10
2235309|NCT01877915|3889761|FG001|Overall Study|Lost to Follow-up|9
2235310|NCT01877915|3889760|FG000|Overall Study|Withdrawal by Subject|42
2235311|NCT01877915|3889761|FG001|Overall Study|Withdrawal by Subject|55
2235312|NCT01877915|3889760|FG000|Overall Study|Other|2
2235313|NCT01877915|3889761|FG001|Overall Study|Other|4
2235314|NCT01878084|3889779|FG000|Overall Study|Physician Decision|2
2235315|NCT01878097|3889786|FG000|Baseline|Surveys not fully completed|2497
2235316|NCT01878097|3889787|FG001|Baseline|Surveys not fully completed|1800
2235317|NCT01878097|3889786|FG000|Implementation Year 1|Surveys not fully completed|3202
2235318|NCT01878097|3889787|FG001|Implementation Year 1|Surveys not fully completed|2549
2235319|NCT01878097|3889786|FG000|Implementation Year 2|Surveys not fully completed|3281
2235320|NCT01878097|3889787|FG001|Implementation Year 2|Surveys not fully completed|2841
2235321|NCT01878097|3889786|FG000|Implementation Year 3|Surveys not fully completed|3494
2235322|NCT01878097|3889787|FG001|Implementation Year 3|Surveys not fully completed|2980
2235323|NCT01878097|3889786|FG000|Implementation Year 4|Surveys not fully completed|3604
2235324|NCT01878097|3889787|FG001|Implementation Year 4|Surveys not fully completed|3007
2235325|NCT01878149|3889795|FG000|Overall Study|Did Not Meet Eligibility Criteria|2
2235326|NCT01878149|3889796|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
2235327|NCT01878175|3889802|FG000|Overall Study|Developed contraindicated health problem|2
2235328|NCT01878214|3889809|FG000|Overall Study|Withdrawal by Subject|18
2235329|NCT01878214|3889810|FG001|Overall Study|Withdrawal by Subject|7
2334394|NCT03247543|4059723|FG001|Overall Study|Non-compliance with study visits|1
2334395|NCT03247543|4059724|FG002|Overall Study|Non-compliance with study visits|0
2334396|NCT03247556|4059737|FG000|Overall Study|Adverse Event|1
2334397|NCT03247556|4059738|FG001|Overall Study|Adverse Event|4
2334398|NCT03247556|4059739|FG002|Overall Study|Adverse Event|5
2334399|NCT03247556|4059737|FG000|Overall Study|Lost to Follow-up|5
2334400|NCT03247556|4059738|FG001|Overall Study|Lost to Follow-up|5
2334401|NCT03247556|4059739|FG002|Overall Study|Lost to Follow-up|4
2334402|NCT03247556|4059737|FG000|Overall Study|Consent Withdrawn by Caregiver|4
2334403|NCT03247556|4059738|FG001|Overall Study|Consent Withdrawn by Caregiver|1
2334404|NCT03247556|4059739|FG002|Overall Study|Consent Withdrawn by Caregiver|5
2334405|NCT03247556|4059737|FG000|Overall Study|Assent/consent Withdrawn by Subject|0
2334406|NCT03247556|4059738|FG001|Overall Study|Assent/consent Withdrawn by Subject|2
2334407|NCT03247556|4059739|FG002|Overall Study|Assent/consent Withdrawn by Subject|2
2334408|NCT03247556|4059737|FG000|Overall Study|Protocol Violation|2
2334409|NCT03247556|4059738|FG001|Overall Study|Protocol Violation|0
2334410|NCT03247556|4059739|FG002|Overall Study|Protocol Violation|1
2334411|NCT03247556|4059737|FG000|Overall Study|Subject did not meet inclusion criteria|0
2334412|NCT03247556|4059738|FG001|Overall Study|Subject did not meet inclusion criteria|0
2334413|NCT03247556|4059739|FG002|Overall Study|Subject did not meet inclusion criteria|1
2334414|NCT03247673|4059750|FG000|Overall Study|Withdrawal by Subject|1
2334415|NCT03247673|4059751|FG001|Overall Study|Withdrawal by Subject|0
2334416|NCT03247673|4059752|FG002|Overall Study|Withdrawal by Subject|3
2334417|NCT03247673|4059750|FG000|Overall Study|Lost to Follow-up|0
2334418|NCT03247673|4059751|FG001|Overall Study|Lost to Follow-up|0
2334419|NCT03247673|4059752|FG002|Overall Study|Lost to Follow-up|1
2334420|NCT03247686|4059762|FG000|Overall Study|Withdrawal by Subject|1
2235330|NCT01878214|3889809|FG000|Overall Study|Death|0
2235331|NCT01878214|3889810|FG001|Overall Study|Death|1
2235332|NCT01878214|3889809|FG000|Overall Study|Lost to Follow-up|35
2235333|NCT01878214|3889810|FG001|Overall Study|Lost to Follow-up|36
2235334|NCT01878253|3889816|FG000|Overall Study|Death|1
2235335|NCT01878253|3889816|FG000|Overall Study|SIdus System Removal|3
2235336|NCT01878253|3889816|FG000|Overall Study|Withdrawal by Subject|1
2235337|NCT01878253|3889816|FG000|Overall Study|Lost to Follow-up|2
2235338|NCT01878253|3889816|FG000|Overall Study|Completed Study w/o Follow-up Data|2
2235339|NCT01878292|3889828|FG000|Randomized|Protocol Violation|1
2235340|NCT01878292|3889829|FG001|Randomized|Protocol Violation|0
2235341|NCT01878292|3889830|FG002|Randomized|Protocol Violation|0
2235342|NCT01878292|3889828|FG000|Randomized|Lost to Follow-up|1
2235343|NCT01878292|3889829|FG001|Randomized|Lost to Follow-up|0
2235344|NCT01878292|3889830|FG002|Randomized|Lost to Follow-up|0
2235345|NCT01878292|3889828|FG000|Randomized|Adverse Event|1
2235346|NCT01878292|3889829|FG001|Randomized|Adverse Event|0
2235347|NCT01878292|3889830|FG002|Randomized|Adverse Event|0
2235348|NCT01878292|3889828|FG000|Double-blind Treatment Period|Other Reasons|2
2235349|NCT01878292|3889829|FG001|Double-blind Treatment Period|Other Reasons|0
2235350|NCT01878292|3889830|FG002|Double-blind Treatment Period|Other Reasons|0
2235351|NCT01878292|3889828|FG000|Double-blind Treatment Period|Lost to Follow-up|6
2235352|NCT01878292|3889829|FG001|Double-blind Treatment Period|Lost to Follow-up|3
2235353|NCT01878292|3889830|FG002|Double-blind Treatment Period|Lost to Follow-up|1
2235354|NCT01878292|3889828|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
2235355|NCT01878292|3889829|FG001|Double-blind Treatment Period|Withdrawal by Subject|7
2235356|NCT01878292|3889830|FG002|Double-blind Treatment Period|Withdrawal by Subject|8
2235357|NCT01878292|3889828|FG000|Double-blind Treatment Period|Protocol Violation|3
2235358|NCT01878292|3889829|FG001|Double-blind Treatment Period|Protocol Violation|4
2235359|NCT01878292|3889830|FG002|Double-blind Treatment Period|Protocol Violation|2
2235360|NCT01878292|3889828|FG000|Double-blind Treatment Period|Lack of Efficacy|5
2235361|NCT01878292|3889829|FG001|Double-blind Treatment Period|Lack of Efficacy|3
2235362|NCT01878292|3889830|FG002|Double-blind Treatment Period|Lack of Efficacy|0
2235363|NCT01878292|3889828|FG000|Double-blind Treatment Period|Adverse Event|4
2235364|NCT01878292|3889829|FG001|Double-blind Treatment Period|Adverse Event|9
2235365|NCT01878292|3889830|FG002|Double-blind Treatment Period|Adverse Event|8
2235366|NCT01878292|3889828|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5
2235367|NCT01878292|3889829|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8
2235368|NCT01878292|3889830|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4
2235369|NCT01878383|3889840|FG000|Overall Study|Lost to Follow-up|0
2235370|NCT01878383|3889841|FG001|Overall Study|Lost to Follow-up|1499
2274641|NCT02299076|3955766|FG000|Overall Study|Fraudulent Entries|20
2274642|NCT02299076|3955767|FG001|Overall Study|Fraudulent Entries|14
2274643|NCT02299167|3955811|FG000|Overall Study|patients were excluded from the study|11
2274644|NCT02299336|3955828|FG000|Overall Study|Withdrawal by Subject|11
2274645|NCT02299336|3955828|FG000|Overall Study|Adverse Event|1
2274646|NCT02299336|3955828|FG000|Overall Study|Death|1
2274647|NCT02299336|3955828|FG000|Overall Study|Lost to Follow-up|1
2274648|NCT02299375|3955843|FG000|Overall Study|Adverse Event, serious fatal|1
2274649|NCT02299375|3955844|FG001|Overall Study|Adverse Event, serious fatal|3
2274650|NCT02299375|3955843|FG000|Overall Study|Adverse Event, non-fatal|8
2274651|NCT02299375|3955844|FG001|Overall Study|Adverse Event, non-fatal|9
2274652|NCT02299375|3955843|FG000|Overall Study|Lack of Efficacy|1
2274653|NCT02299375|3955844|FG001|Overall Study|Lack of Efficacy|3
2274654|NCT02299375|3955843|FG000|Overall Study|Protocol Violation|1
2274655|NCT02299375|3955844|FG001|Overall Study|Protocol Violation|3
2274656|NCT02299375|3955843|FG000|Overall Study|Other: Met stopping criteria|1
2274657|NCT02299375|3955844|FG001|Overall Study|Other: Met stopping criteria|0
2274658|NCT02299375|3955843|FG000|Overall Study|Other: Study closed/terminated|66
2274659|NCT02299375|3955844|FG001|Overall Study|Other: Study closed/terminated|55
2274660|NCT02299375|3955843|FG000|Overall Study|Lost to Follow-up|0
2274661|NCT02299375|3955844|FG001|Overall Study|Lost to Follow-up|2
2274662|NCT02299375|3955843|FG000|Overall Study|Physician Decision|1
2274663|NCT02299375|3955844|FG001|Overall Study|Physician Decision|1
2274664|NCT02299375|3955843|FG000|Overall Study|Withdrawal by Subject|1
2274665|NCT02299375|3955844|FG001|Overall Study|Withdrawal by Subject|4
2334421|NCT03247686|4059763|FG001|Overall Study|Withdrawal by Subject|2
2334422|NCT03247816|4059787|FG000|Overall Study|Adverse Event|12
2334423|NCT03247816|4059787|FG000|Overall Study|Physician Decision|3
2334424|NCT03247816|4059787|FG000|Overall Study|Lack of Efficacy|1
2334425|NCT03247816|4059787|FG000|Overall Study|Lost to Follow-up|10
2334426|NCT03247816|4059787|FG000|Overall Study|Missing Feraccru stop date|3
2334427|NCT03248037|4059804|FG000|Overall Study|Withdrawal by Subject|6
2334428|NCT03248037|4059805|FG001|Overall Study|Withdrawal by Subject|9
2334429|NCT03248037|4059804|FG000|Overall Study|Adverse Event|15
2334430|NCT03248037|4059805|FG001|Overall Study|Adverse Event|0
2334431|NCT03248492|4059825|FG000|Overall Study|Ongoing|23
2334432|NCT03248492|4059826|FG001|Overall Study|Ongoing|26
2334433|NCT03248492|4059827|FG002|Overall Study|Ongoing|3
2334434|NCT03248492|4059828|FG003|Overall Study|Ongoing|85
2334435|NCT03248492|4059829|FG004|Overall Study|Ongoing|2
2334436|NCT03248492|4059825|FG000|Overall Study|Progressive disease per RECIST v1.1|16
2235371|NCT01878890|3889911|FG000|Overall Study|Protocol Violation|0
2235372|NCT01878890|3889912|FG001|Overall Study|Protocol Violation|1
2235373|NCT01878890|3889913|FG002|Overall Study|Protocol Violation|0
2235374|NCT01878890|3889914|FG003|Overall Study|Protocol Violation|0
2235375|NCT01879072|3889929|FG000|Overall Study|Withdrawal by Subject|121
2235376|NCT01879072|3889929|FG000|Overall Study|Not Transplanted|30
2235377|NCT01879319|3889944|FG000|Overall Study|Withdrawal by Subject|1
2235378|NCT01879319|3889945|FG001|Overall Study|Withdrawal by Subject|0
2235379|NCT01879319|3889944|FG000|Overall Study|Lost to Follow-up|1
2235380|NCT01879319|3889945|FG001|Overall Study|Lost to Follow-up|5
2235381|NCT01879410|3890000|FG000|Overall Study|Adverse Event|9
2235382|NCT01879410|3890001|FG001|Overall Study|Adverse Event|14
2235383|NCT01879410|3890000|FG000|Overall Study|Lack of Efficacy|4
2235384|NCT01879410|3890001|FG001|Overall Study|Lack of Efficacy|6
2235385|NCT01879410|3890000|FG000|Overall Study|Protocol Violation|1
2235386|NCT01879410|3890001|FG001|Overall Study|Protocol Violation|7
2235387|NCT01879410|3890000|FG000|Overall Study|Lost to Follow-up|2
2235388|NCT01879410|3890001|FG001|Overall Study|Lost to Follow-up|1
2235389|NCT01879410|3890000|FG000|Overall Study|Withdrawal by Subject|7
2235390|NCT01879410|3890001|FG001|Overall Study|Withdrawal by Subject|8
2235391|NCT01879410|3890000|FG000|Overall Study|Randomised in Error|1
2235392|NCT01879410|3890001|FG001|Overall Study|Randomised in Error|2
2235393|NCT01879553|3890013|FG000|Overall Study|Withdrawal by Subject|1
2235394|NCT01879553|3890014|FG001|Overall Study|Withdrawal by Subject|0
2235395|NCT01879579|3890023|FG000|Overall Study|Phone incompatible with texting platform|3
2235396|NCT01879579|3890024|FG001|Overall Study|Phone incompatible with texting platform|0
2235397|NCT01879579|3890023|FG000|Overall Study|Did not enroll in texting platform|1
2235398|NCT01879579|3890024|FG001|Overall Study|Did not enroll in texting platform|0
2235399|NCT01879579|3890023|FG000|Overall Study|Did not initiate insulin treatment|1
2235400|NCT01879579|3890024|FG001|Overall Study|Did not initiate insulin treatment|0
2235401|NCT01879579|3890023|FG000|Overall Study|Phenotypic type 1 diabetes|0
2235402|NCT01879579|3890024|FG001|Overall Study|Phenotypic type 1 diabetes|1
2235403|NCT01879579|3890023|FG000|Overall Study|Discontinued insulin - possible allergy|0
2235404|NCT01879579|3890024|FG001|Overall Study|Discontinued insulin - possible allergy|1
2235405|NCT01879618|3890033|FG000|Overall Study|Does not meet entrance criteria|1
2235406|NCT01879618|3890033|FG000|Overall Study|Withdrawal by Subject|1
2235407|NCT01879618|3890033|FG000|Overall Study|Surgery;changed schedule; not available|8
2235408|NCT01879618|3890033|FG000|Overall Study|Protocol Violation|6
2235409|NCT01879618|3890033|FG000|Overall Study|Adverse Event|5
2235410|NCT01879683|3890037|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1
2235411|NCT01879722|3890051|FG000|Overall Study|Pretreatment Event/Adverse Event|0
2235412|NCT01879722|3890052|FG001|Overall Study|Pretreatment Event/Adverse Event|1
2235413|NCT01879722|3890053|FG002|Overall Study|Pretreatment Event/Adverse Event|0
2235414|NCT01879722|3890054|FG003|Overall Study|Pretreatment Event/Adverse Event|1
2235415|NCT01879722|3890055|FG004|Overall Study|Pretreatment Event/Adverse Event|1
2235416|NCT01879722|3890056|FG005|Overall Study|Pretreatment Event/Adverse Event|0
2235417|NCT01879722|3890057|FG006|Overall Study|Pretreatment Event/Adverse Event|0
2235418|NCT01879722|3890058|FG007|Overall Study|Pretreatment Event/Adverse Event|1
2235419|NCT01879722|3890059|FG008|Overall Study|Pretreatment Event/Adverse Event|1
2235420|NCT01879722|3890060|FG009|Overall Study|Pretreatment Event/Adverse Event|0
2235421|NCT01879722|3890051|FG000|Overall Study|Voluntary Withdrawal|0
2235422|NCT01879722|3890052|FG001|Overall Study|Voluntary Withdrawal|0
2235423|NCT01879722|3890053|FG002|Overall Study|Voluntary Withdrawal|0
2235424|NCT01879722|3890054|FG003|Overall Study|Voluntary Withdrawal|0
2235425|NCT01879722|3890055|FG004|Overall Study|Voluntary Withdrawal|0
2235426|NCT01879722|3890056|FG005|Overall Study|Voluntary Withdrawal|0
2235427|NCT01879722|3890057|FG006|Overall Study|Voluntary Withdrawal|0
2235428|NCT01879722|3890058|FG007|Overall Study|Voluntary Withdrawal|0
2235429|NCT01879722|3890059|FG008|Overall Study|Voluntary Withdrawal|1
2235430|NCT01879722|3890060|FG009|Overall Study|Voluntary Withdrawal|0
2235431|NCT01879852|3890114|FG000|Overall Study|Withdrawal by Subject|2
2235432|NCT01879852|3890115|FG001|Overall Study|Withdrawal by Subject|0
2235433|NCT01880086|3890151|FG000|Overall Study|Lost to Follow-up|1
2235434|NCT01880086|3890152|FG001|Overall Study|Lost to Follow-up|1
2235435|NCT01880424|3890186|FG000|Overall Study|Adverse Event|7
2235436|NCT01880424|3890187|FG001|Overall Study|Adverse Event|6
2235437|NCT01880424|3890186|FG000|Overall Study|Lack of Efficacy|1
2235438|NCT01880424|3890187|FG001|Overall Study|Lack of Efficacy|4
2235439|NCT01880424|3890186|FG000|Overall Study|Lost to Follow-up|3
2235440|NCT01880424|3890187|FG001|Overall Study|Lost to Follow-up|2
2235441|NCT01880424|3890186|FG000|Overall Study|Protocol Violation|11
2235442|NCT01880424|3890187|FG001|Overall Study|Protocol Violation|13
2235443|NCT01880424|3890186|FG000|Overall Study|Withdrawal by Subject|10
2235444|NCT01880424|3890187|FG001|Overall Study|Withdrawal by Subject|30
2235445|NCT01880424|3890186|FG000|Overall Study|Other|1
2235446|NCT01880424|3890187|FG001|Overall Study|Other|0
2235447|NCT01880437|3890196|FG000|Overall Study|Death|12
2235448|NCT01880437|3890197|FG001|Overall Study|Death|4
2235449|NCT01880437|3890198|FG002|Overall Study|Death|17
2235450|NCT01880437|3890196|FG000|Overall Study|Study terminated by Sponsor|3
2235451|NCT01880437|3890197|FG001|Overall Study|Study terminated by Sponsor|0
2235452|NCT01880437|3890198|FG002|Overall Study|Study terminated by Sponsor|2
2235453|NCT01880515|3890210|FG000|Overall Study|Lost to Follow-up|3
2235454|NCT01880515|3890211|FG001|Overall Study|Lost to Follow-up|2
2235455|NCT01880515|3890210|FG000|Overall Study|Disease Progression|5
2235456|NCT01880515|3890211|FG001|Overall Study|Disease Progression|7
2235457|NCT01880528|3890220|FG000|Overall Study|Other|1
2235458|NCT01880528|3890221|FG001|Overall Study|Other|1
2235459|NCT01880554|3890227|FG000|Overall Study|Protocol Violation|14
2235460|NCT01880554|3890227|FG000|Overall Study|Simon's design requirements|2
2235461|NCT01880593|3890234|FG000|Overall Study|Adverse Event|1
2235462|NCT01880593|3890235|FG001|Overall Study|Adverse Event|0
2235463|NCT01880593|3890234|FG000|Overall Study|Lack of Efficacy|1
2235464|NCT01880593|3890235|FG001|Overall Study|Lack of Efficacy|5
2235465|NCT01880593|3890234|FG000|Overall Study|Withdrawal by Subject|6
2235466|NCT01880593|3890235|FG001|Overall Study|Withdrawal by Subject|1
2235467|NCT01880736|3890263|FG000|Overall Study|Adverse Event|0
2235468|NCT01880736|3890264|FG001|Overall Study|Adverse Event|0
2235469|NCT01880736|3890265|FG002|Overall Study|Adverse Event|0
2235470|NCT01880736|3890266|FG003|Overall Study|Adverse Event|1
2235471|NCT01880736|3890263|FG000|Overall Study|Withdrawal Criteria|1
2235472|NCT01880736|3890264|FG001|Overall Study|Withdrawal Criteria|2
2235473|NCT01880736|3890265|FG002|Overall Study|Withdrawal Criteria|1
2235474|NCT01880736|3890266|FG003|Overall Study|Withdrawal Criteria|5
2235475|NCT01881009|3890287|FG000|Summer Camp Session (6 Days)|Unable to wear device|0
2235476|NCT01881009|3890288|FG001|Summer Camp Session (6 Days)|Unable to wear device|1
2235477|NCT01881126|3890319|FG000|Overall Study|Non-compliance|1
2235478|NCT01881126|3890320|FG001|Overall Study|Non-compliance|1
2235479|NCT01881126|3890319|FG000|Overall Study|Adverse Event|0
2235480|NCT01881126|3890320|FG001|Overall Study|Adverse Event|1
2235481|NCT01881230|3890329|FG000|Overall Study|Death|2
2235482|NCT01881230|3890330|FG001|Overall Study|Death|0
2235483|NCT01881230|3890331|FG002|Overall Study|Death|1
2235484|NCT01881230|3890329|FG000|Overall Study|Adverse Event|9
2235485|NCT01881230|3890330|FG001|Overall Study|Adverse Event|13
2235486|NCT01881230|3890331|FG002|Overall Study|Adverse Event|12
2235487|NCT01881230|3890329|FG000|Overall Study|Progressive Disease|31
2235488|NCT01881230|3890330|FG001|Overall Study|Progressive Disease|35
2235489|NCT01881230|3890331|FG002|Overall Study|Progressive Disease|36
2235490|NCT01881230|3890329|FG000|Overall Study|Symptomatic Deterioration|3
2235491|NCT01881230|3890330|FG001|Overall Study|Symptomatic Deterioration|3
2235492|NCT01881230|3890331|FG002|Overall Study|Symptomatic Deterioration|1
2235493|NCT01881230|3890329|FG000|Overall Study|Withdrawal by Subject|6
2235494|NCT01881230|3890330|FG001|Overall Study|Withdrawal by Subject|4
2235495|NCT01881230|3890331|FG002|Overall Study|Withdrawal by Subject|6
2235496|NCT01881230|3890329|FG000|Overall Study|Physician Decision|4
2235497|NCT01881230|3890330|FG001|Overall Study|Physician Decision|3
2235498|NCT01881230|3890331|FG002|Overall Study|Physician Decision|6
2235499|NCT01881230|3890329|FG000|Overall Study|Non-Compliance with Study Drug|1
2235500|NCT01881230|3890330|FG001|Overall Study|Non-Compliance with Study Drug|2
2235501|NCT01881230|3890331|FG002|Overall Study|Non-Compliance with Study Drug|0
2235502|NCT01881230|3890329|FG000|Overall Study|Given Commercially Available Drug|0
2235503|NCT01881230|3890330|FG001|Overall Study|Given Commercially Available Drug|0
2235504|NCT01881230|3890331|FG002|Overall Study|Given Commercially Available Drug|2
2235505|NCT01881230|3890329|FG000|Overall Study|Protocol Violation|1
2235506|NCT01881230|3890330|FG001|Overall Study|Protocol Violation|1
2235507|NCT01881230|3890331|FG002|Overall Study|Protocol Violation|0
2235508|NCT01881230|3890329|FG000|Overall Study|Miscellaneous|3
2235509|NCT01881230|3890330|FG001|Overall Study|Miscellaneous|3
2235510|NCT01881230|3890331|FG002|Overall Study|Miscellaneous|0
2235511|NCT01881230|3890329|FG000|Overall Study|Untreated: Other|0
2235512|NCT01881230|3890330|FG001|Overall Study|Untreated: Other|0
2235513|NCT01881230|3890331|FG002|Overall Study|Untreated: Other|1
2235514|NCT01881230|3890329|FG000|Overall Study|Untreated: Death|0
2235515|NCT01881230|3890330|FG001|Overall Study|Untreated: Death|0
2235516|NCT01881230|3890331|FG002|Overall Study|Untreated: Death|1
2235517|NCT01881230|3890329|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1
2235518|NCT01881230|3890330|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0
2235519|NCT01881230|3890331|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0
2235520|NCT01881620|3890365|FG000|Overall Study|Protocol Violation|4
2235521|NCT01881737|3890369|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
2235522|NCT01881737|3890369|FG000|Overall Study|Withdrawal by Subject|1
2235523|NCT01881737|3890369|FG000|Overall Study|Worsening of baseline behavior|1
2235524|NCT01881750|3890377|FG000|Overall Study|Changes in concomitant therapies|2
2235525|NCT01881750|3890378|FG001|Overall Study|Changes in concomitant therapies|3
2235526|NCT01881750|3890377|FG000|Overall Study|Lost to Follow-up|0
2235527|NCT01881750|3890378|FG001|Overall Study|Lost to Follow-up|1
2235528|NCT01881776|3890389|FG000|Overall Study|Lost to Follow-up|1
2235529|NCT01881776|3890390|FG001|Overall Study|Lost to Follow-up|2
2235530|NCT01881776|3890391|FG002|Overall Study|Lost to Follow-up|1
2235531|NCT01881776|3890389|FG000|Overall Study|Protocol Violation|0
2235532|NCT01881776|3890390|FG001|Overall Study|Protocol Violation|2
2235533|NCT01881776|3890391|FG002|Overall Study|Protocol Violation|1
2235534|NCT01881789|3890405|FG000|Overall Study|Withdrawal by Subject|0
2235535|NCT01881789|3890406|FG001|Overall Study|Withdrawal by Subject|2
2235536|NCT01881789|3890407|FG002|Overall Study|Withdrawal by Subject|1
2235537|NCT01881789|3890408|FG003|Overall Study|Withdrawal by Subject|0
2235538|NCT01881789|3890409|FG004|Overall Study|Withdrawal by Subject|1
2235539|NCT01881789|3890410|FG005|Overall Study|Withdrawal by Subject|1
2235540|NCT01881789|3890405|FG000|Overall Study|Study Terminated by Sponsor|0
2235541|NCT01881789|3890406|FG001|Overall Study|Study Terminated by Sponsor|0
2235542|NCT01881789|3890407|FG002|Overall Study|Study Terminated by Sponsor|0
2235543|NCT01881789|3890408|FG003|Overall Study|Study Terminated by Sponsor|0
2235544|NCT01881789|3890409|FG004|Overall Study|Study Terminated by Sponsor|0
2235545|NCT01881789|3890410|FG005|Overall Study|Study Terminated by Sponsor|1
2235546|NCT01881789|3890405|FG000|Overall Study|Other|3
2235547|NCT01881789|3890406|FG001|Overall Study|Other|5
2235548|NCT01881789|3890407|FG002|Overall Study|Other|2
2235549|NCT01881789|3890408|FG003|Overall Study|Other|3
2235550|NCT01881789|3890409|FG004|Overall Study|Other|1
2235551|NCT01881789|3890410|FG005|Overall Study|Other|1
2235552|NCT01882088|3890449|FG000|Overall Study|Intolerance of esophageal manometry|1
2235553|NCT01882088|3890449|FG000|Overall Study|no possibility to place the catheter|1
2235554|NCT01882088|3890449|FG000|Overall Study|Protocol Violation|1
2235555|NCT01882088|3890449|FG000|Overall Study|inadequate pH-impedance tracings|2
2235556|NCT01882257|3890456|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0
2235557|NCT01882257|3890457|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2
2235558|NCT01882257|3890458|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1
2235559|NCT01882257|3890456|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
2235560|NCT01882257|3890457|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
2235561|NCT01882257|3890458|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
2235562|NCT01882439|3890473|FG000|Overall Study|Adverse event related to study drug|3
2235563|NCT01882439|3890474|FG001|Overall Study|Adverse event related to study drug|8
2235564|NCT01882439|3890475|FG002|Overall Study|Adverse event related to study drug|1
2235565|NCT01882439|3890476|FG003|Overall Study|Adverse event related to study drug|2
2235566|NCT01882439|3890473|FG000|Overall Study|Pregnancy|0
2235567|NCT01882439|3890474|FG001|Overall Study|Pregnancy|1
2235568|NCT01882439|3890475|FG002|Overall Study|Pregnancy|0
2235569|NCT01882439|3890476|FG003|Overall Study|Pregnancy|0
2235570|NCT01882439|3890473|FG000|Overall Study|Protocol Violation|2
2235571|NCT01882439|3890474|FG001|Overall Study|Protocol Violation|2
2235572|NCT01882439|3890475|FG002|Overall Study|Protocol Violation|0
2235573|NCT01882439|3890476|FG003|Overall Study|Protocol Violation|1
2235574|NCT01882439|3890473|FG000|Overall Study|No longer willing to participate|1
2235575|NCT01882439|3890474|FG001|Overall Study|No longer willing to participate|4
2235576|NCT01882439|3890475|FG002|Overall Study|No longer willing to participate|2
2235577|NCT01882439|3890476|FG003|Overall Study|No longer willing to participate|3
2235578|NCT01882439|3890473|FG000|Overall Study|Medication error with no associated AE|0
2235579|NCT01882439|3890474|FG001|Overall Study|Medication error with no associated AE|0
2235580|NCT01882439|3890475|FG002|Overall Study|Medication error with no associated AE|2
2235581|NCT01882439|3890476|FG003|Overall Study|Medication error with no associated AE|0
2235582|NCT01882439|3890473|FG000|Overall Study|Insufficient clinical response|1
2235583|NCT01882439|3890474|FG001|Overall Study|Insufficient clinical response|4
2235584|NCT01882439|3890475|FG002|Overall Study|Insufficient clinical response|4
2235585|NCT01882439|3890476|FG003|Overall Study|Insufficient clinical response|2
2235586|NCT01882439|3890473|FG000|Overall Study|Adverse event unrelated to study drug|2
2235587|NCT01882439|3890474|FG001|Overall Study|Adverse event unrelated to study drug|2
2235588|NCT01882439|3890475|FG002|Overall Study|Adverse event unrelated to study drug|1
2235589|NCT01882439|3890476|FG003|Overall Study|Adverse event unrelated to study drug|1
2235590|NCT01882465|3890491|FG000|Period 1|Lens Discomfort|0
2235591|NCT01882465|3890492|FG001|Period 1|Lens Discomfort|0
2235592|NCT01882465|3890493|FG002|Period 1|Lens Discomfort|0
2235593|NCT01882465|3890494|FG003|Period 1|Lens Discomfort|1
2235594|NCT01882465|3890495|FG004|Period 1|Lens Discomfort|0
2235595|NCT01882465|3890496|FG005|Period 1|Lens Discomfort|0
2235596|NCT01882465|3890497|FG006|Period 1|Lens Discomfort|0
2235597|NCT01882465|3890491|FG000|Period 1|Withdrawal by Subject|0
2235598|NCT01882465|3890492|FG001|Period 1|Withdrawal by Subject|0
2235599|NCT01882465|3890493|FG002|Period 1|Withdrawal by Subject|0
2235600|NCT01882465|3890494|FG003|Period 1|Withdrawal by Subject|0
2235601|NCT01882465|3890495|FG004|Period 1|Withdrawal by Subject|0
2235602|NCT01882465|3890496|FG005|Period 1|Withdrawal by Subject|0
2235603|NCT01882465|3890497|FG006|Period 1|Withdrawal by Subject|1
2235604|NCT01882465|3890491|FG000|Period 2|Protocol Violation|0
2235605|NCT01882465|3890492|FG001|Period 2|Protocol Violation|0
2235606|NCT01882465|3890493|FG002|Period 2|Protocol Violation|0
2235607|NCT01882465|3890494|FG003|Period 2|Protocol Violation|0
2235608|NCT01882465|3890495|FG004|Period 2|Protocol Violation|1
2235609|NCT01882465|3890496|FG005|Period 2|Protocol Violation|0
2235610|NCT01882465|3890497|FG006|Period 2|Protocol Violation|0
2235611|NCT01882647|3890517|FG000|Overall Study|Lost to Follow-up|2
2235612|NCT01882647|3890518|FG001|Overall Study|Lost to Follow-up|2
2235613|NCT01882647|3890517|FG000|Overall Study|Withdrawal by Subject|0
2235614|NCT01882647|3890518|FG001|Overall Study|Withdrawal by Subject|4
2235615|NCT01882803|3890537|FG000|Overall Study|Disease Progression|53
2235616|NCT01882803|3890537|FG000|Overall Study|Adverse Event|22
2235617|NCT01882803|3890537|FG000|Overall Study|Death|7
2235618|NCT01882803|3890537|FG000|Overall Study|Physician Decision|7
2235619|NCT01882803|3890537|FG000|Overall Study|Protocol Violation|1
2235620|NCT01882803|3890537|FG000|Overall Study|Withdrawal by Subject|4
2235621|NCT01882829|3890542|FG000|Overall Study|Adverse Event|4
2235622|NCT01882829|3890542|FG000|Overall Study|Protocol Violation|1
2235623|NCT01882829|3890542|FG000|Overall Study|Withdrawal by Subject|1
2235624|NCT01882907|3890552|FG000|Overall Study|Adverse Event|3
2235625|NCT01882907|3890553|FG001|Overall Study|Adverse Event|1
2235626|NCT01882907|3890552|FG000|Overall Study|Lack of Efficacy|0
2235627|NCT01882907|3890553|FG001|Overall Study|Lack of Efficacy|3
2235628|NCT01882907|3890552|FG000|Overall Study|Lost to Follow-up|1
2235629|NCT01882907|3890553|FG001|Overall Study|Lost to Follow-up|4
2235630|NCT01882907|3890552|FG000|Overall Study|Protocol Violation|10
2235631|NCT01882907|3890553|FG001|Overall Study|Protocol Violation|14
2235632|NCT01882907|3890552|FG000|Overall Study|Withdrawal by Subject|0
2235633|NCT01882907|3890553|FG001|Overall Study|Withdrawal by Subject|6
2235634|NCT01882985|3890561|FG000|Overall Study|Lost to Follow-up|1
2235635|NCT01882985|3890561|FG000|Overall Study|Withdrawal by Subject|1
2235636|NCT01883362|3890571|FG000|Treatment|Adverse Event|1
2334437|NCT03248492|4059826|FG001|Overall Study|Progressive disease per RECIST v1.1|12
2334438|NCT03248492|4059827|FG002|Overall Study|Progressive disease per RECIST v1.1|9
2334439|NCT03248492|4059828|FG003|Overall Study|Progressive disease per RECIST v1.1|22
2334440|NCT03248492|4059829|FG004|Overall Study|Progressive disease per RECIST v1.1|0
2334441|NCT03248492|4059825|FG000|Overall Study|Adverse Event|6
2334442|NCT03248492|4059826|FG001|Overall Study|Adverse Event|6
2334443|NCT03248492|4059827|FG002|Overall Study|Adverse Event|8
2334444|NCT03248492|4059828|FG003|Overall Study|Adverse Event|8
2334445|NCT03248492|4059829|FG004|Overall Study|Adverse Event|1
2334446|NCT03248492|4059825|FG000|Overall Study|Withdrawal by Subject|3
2334447|NCT03248492|4059826|FG001|Overall Study|Withdrawal by Subject|3
2334448|NCT03248492|4059827|FG002|Overall Study|Withdrawal by Subject|0
2334449|NCT03248492|4059828|FG003|Overall Study|Withdrawal by Subject|3
2334450|NCT03248492|4059829|FG004|Overall Study|Withdrawal by Subject|1
2334451|NCT03248492|4059825|FG000|Overall Study|Physician Decision|1
2334452|NCT03248492|4059826|FG001|Overall Study|Physician Decision|0
2334453|NCT03248492|4059827|FG002|Overall Study|Physician Decision|1
2334454|NCT03248492|4059828|FG003|Overall Study|Physician Decision|2
2334455|NCT03248492|4059829|FG004|Overall Study|Physician Decision|0
2334456|NCT03248492|4059825|FG000|Overall Study|Death|1
2334457|NCT03248492|4059826|FG001|Overall Study|Death|0
2334458|NCT03248492|4059827|FG002|Overall Study|Death|0
2334459|NCT03248492|4059828|FG003|Overall Study|Death|6
2334460|NCT03248492|4059829|FG004|Overall Study|Death|0
2334461|NCT03248492|4059825|FG000|Overall Study|Other|0
2334462|NCT03248492|4059826|FG001|Overall Study|Other|1
2334463|NCT03248492|4059827|FG002|Overall Study|Other|0
2334464|NCT03248492|4059828|FG003|Overall Study|Other|4
2334465|NCT03248492|4059829|FG004|Overall Study|Other|0
2334466|NCT03248882|4059854|FG000|Overall Study|Adverse Event|3
2334467|NCT03248882|4059855|FG001|Overall Study|Adverse Event|3
2334468|NCT03248882|4059856|FG002|Overall Study|Adverse Event|2
2334469|NCT03248882|4059857|FG003|Overall Study|Adverse Event|6
2334470|NCT03248882|4059858|FG004|Overall Study|Adverse Event|9
2334471|NCT03248882|4059854|FG000|Overall Study|Lost to Follow-up|0
2334472|NCT03248882|4059855|FG001|Overall Study|Lost to Follow-up|0
2334473|NCT03248882|4059856|FG002|Overall Study|Lost to Follow-up|0
2334474|NCT03248882|4059857|FG003|Overall Study|Lost to Follow-up|0
2334475|NCT03248882|4059858|FG004|Overall Study|Lost to Follow-up|1
2334476|NCT03248882|4059854|FG000|Overall Study|Protocol Violation|2
2334477|NCT03248882|4059855|FG001|Overall Study|Protocol Violation|0
2334478|NCT03248882|4059856|FG002|Overall Study|Protocol Violation|2
2334479|NCT03248882|4059857|FG003|Overall Study|Protocol Violation|0
2334480|NCT03248882|4059858|FG004|Overall Study|Protocol Violation|1
2334481|NCT03248882|4059854|FG000|Overall Study|Withdrawal by Subject|2
2334482|NCT03248882|4059855|FG001|Overall Study|Withdrawal by Subject|2
2334483|NCT03248882|4059856|FG002|Overall Study|Withdrawal by Subject|3
2334484|NCT03248882|4059857|FG003|Overall Study|Withdrawal by Subject|4
2334485|NCT03248882|4059858|FG004|Overall Study|Withdrawal by Subject|2
2334486|NCT03249454|4059917|FG000|Overall Study|Withdrawal by Subject|0
2334487|NCT03249454|4059918|FG001|Overall Study|Withdrawal by Subject|0
2334488|NCT03249454|4059919|FG002|Overall Study|Withdrawal by Subject|0
2334489|NCT03249454|4059920|FG003|Overall Study|Withdrawal by Subject|0
2334490|NCT03249454|4059921|FG004|Overall Study|Withdrawal by Subject|0
2334491|NCT03249454|4059922|FG005|Overall Study|Withdrawal by Subject|0
2334492|NCT03249454|4059923|FG006|Overall Study|Withdrawal by Subject|0
2334493|NCT03249454|4059924|FG007|Overall Study|Withdrawal by Subject|0
2334494|NCT03249454|4059925|FG008|Overall Study|Withdrawal by Subject|0
2334495|NCT03249454|4059926|FG009|Overall Study|Withdrawal by Subject|1
2334496|NCT03249454|4059927|FG010|Overall Study|Withdrawal by Subject|1
2235637|NCT01883362|3890572|FG001|Treatment|Adverse Event|8
2334497|NCT03249909|4059953|FG000|Overall Study|Withdrawal by Subject|3
2235638|NCT01883362|3890571|FG000|Treatment|Withdrawal by Subject|6
2334498|NCT03249909|4059954|FG001|Overall Study|Withdrawal by Subject|0
2334499|NCT03249909|4059955|FG002|Overall Study|Withdrawal by Subject|0
2334500|NCT03249909|4059953|FG000|Overall Study|Adverse Event|3
2235639|NCT01883362|3890572|FG001|Treatment|Withdrawal by Subject|2
2235640|NCT01883362|3890571|FG000|Treatment|Administrative problems|4
2235641|NCT01883362|3890572|FG001|Treatment|Administrative problems|1
2235642|NCT01883362|3890571|FG000|Treatment|Relapse|4
2235643|NCT01883362|3890572|FG001|Treatment|Relapse|2
2235644|NCT01883362|3890571|FG000|Treatment|Randomized, not treated|1
2235645|NCT01883362|3890572|FG001|Treatment|Randomized, not treated|1
2235646|NCT01883362|3890571|FG000|Post Treatment Follow-up|Protocol Violation|0
2235647|NCT01883362|3890572|FG001|Post Treatment Follow-up|Protocol Violation|1
2235648|NCT01883362|3890571|FG000|Post Treatment Follow-up|Withdrawal by Subject|4
2235649|NCT01883362|3890572|FG001|Post Treatment Follow-up|Withdrawal by Subject|3
2235650|NCT01883362|3890571|FG000|Post Treatment Follow-up|Lost to Follow-up|1
2235651|NCT01883362|3890572|FG001|Post Treatment Follow-up|Lost to Follow-up|4
2235652|NCT01883362|3890571|FG000|Post Treatment Follow-up|Administrative problems|2
2235653|NCT01883362|3890572|FG001|Post Treatment Follow-up|Administrative problems|0
2235654|NCT01883362|3890571|FG000|Post Treatment Follow-up|Death|8
2235655|NCT01883362|3890572|FG001|Post Treatment Follow-up|Death|4
2235656|NCT01883362|3890571|FG000|Post Treatment Follow-up|Relapse|1
2235657|NCT01883362|3890572|FG001|Post Treatment Follow-up|Relapse|2
2235658|NCT01883453|3890603|FG000|Overall Study|No episode of common cold|25
2235659|NCT01883453|3890604|FG001|Overall Study|No episode of common cold|23
2235660|NCT01883492|3890612|FG000|Overall Study|Lost to Follow-up|3
2235661|NCT01883492|3890613|FG001|Overall Study|Lost to Follow-up|4
2235662|NCT01883492|3890612|FG000|Overall Study|Surgery on contra-lateral hip|0
2235663|NCT01883492|3890613|FG001|Overall Study|Surgery on contra-lateral hip|1
2235664|NCT01883492|3890612|FG000|Overall Study|Poor X-ray quality|7
2235665|NCT01883492|3890613|FG001|Overall Study|Poor X-ray quality|4
2235666|NCT01883492|3890612|FG000|Overall Study|Withdrawal by Subject|1
2235667|NCT01883492|3890613|FG001|Overall Study|Withdrawal by Subject|0
2235668|NCT01883492|3890612|FG000|Overall Study|inappropriate implant used|1
2235669|NCT01883492|3890613|FG001|Overall Study|inappropriate implant used|1
2235670|NCT01883492|3890612|FG000|Overall Study|bone anatomy did not meet study criteria|1
2235671|NCT01883492|3890613|FG001|Overall Study|bone anatomy did not meet study criteria|1
2235672|NCT01883635|3890621|FG000|Overall Study|Withdrawal by Subject|4
2235673|NCT01883635|3890622|FG001|Overall Study|Withdrawal by Subject|0
2235674|NCT01883895|3890639|FG000|Overall Study|Lost to Follow-up|2
2235675|NCT01884025|3890658|FG000|Overall Study|Lost to Follow-up|3
2235676|NCT01884025|3890659|FG001|Overall Study|Lost to Follow-up|4
2235677|NCT01884311|3890674|FG000|Overall Study|Withdrawal by Subject|3
2235678|NCT01884311|3890674|FG000|Overall Study|withdrew consent due to AEs|1
2235679|NCT01884311|3890674|FG000|Overall Study|Precautionary measure|1
2235680|NCT01884337|3890683|FG000|Treatment|Adverse Event|2
2235681|NCT01884337|3890684|FG001|Treatment|Adverse Event|2
2235682|NCT01884337|3890683|FG000|Treatment|Subj. request to discont. treatment|2
2235683|NCT01884337|3890684|FG001|Treatment|Subj. request to discont. treatment|0
2235684|NCT01884337|3890683|FG000|Follow-up Period|Lost to Follow-up|1
2235685|NCT01884337|3890684|FG001|Follow-up Period|Lost to Follow-up|1
2235686|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
2235687|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
2235688|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
2235689|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6
2235690|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4
2235691|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0
2235692|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
2334501|NCT03249909|4059954|FG001|Overall Study|Adverse Event|0
2334502|NCT03249909|4059955|FG002|Overall Study|Adverse Event|0
2334503|NCT03249909|4059953|FG000|Overall Study|Lost to Follow-up|0
2334504|NCT03249909|4059954|FG001|Overall Study|Lost to Follow-up|1
2334505|NCT03249909|4059955|FG002|Overall Study|Lost to Follow-up|0
2334506|NCT03249935|4059966|FG000|Overall Study|Discharged from facility early|36
2334507|NCT03249935|4059966|FG000|Overall Study|Negative for chlamydia at enrollment|4
2036799|NCT00413660|3607049|FG010|Up To Week 12|Lack of Efficacy|0
2036800|NCT00413660|3607039|FG000|Up To Week 12|Lost to Follow-up|0
2036801|NCT00413660|3607040|FG001|Up To Week 12|Lost to Follow-up|1
2036802|NCT00413660|3607041|FG002|Up To Week 12|Lost to Follow-up|0
2036803|NCT00413660|3607042|FG003|Up To Week 12|Lost to Follow-up|0
2036804|NCT00413660|3607043|FG004|Up To Week 12|Lost to Follow-up|1
2036805|NCT00413660|3607044|FG005|Up To Week 12|Lost to Follow-up|0
2036806|NCT00413660|3607045|FG006|Up To Week 12|Lost to Follow-up|0
2036807|NCT00413660|3607046|FG007|Up To Week 12|Lost to Follow-up|0
2036808|NCT00413660|3607047|FG008|Up To Week 12|Lost to Follow-up|0
2036809|NCT00413660|3607048|FG009|Up To Week 12|Lost to Follow-up|0
2036810|NCT00413660|3607049|FG010|Up To Week 12|Lost to Follow-up|0
2036811|NCT00413660|3607039|FG000|Up To Week 12|Withdrawal by Subject|0
2036812|NCT00413660|3607040|FG001|Up To Week 12|Withdrawal by Subject|2
2036813|NCT00413660|3607041|FG002|Up To Week 12|Withdrawal by Subject|0
2036814|NCT00413660|3607042|FG003|Up To Week 12|Withdrawal by Subject|2
2036815|NCT00413660|3607043|FG004|Up To Week 12|Withdrawal by Subject|0
2036816|NCT00413660|3607044|FG005|Up To Week 12|Withdrawal by Subject|2
2036817|NCT00413660|3607045|FG006|Up To Week 12|Withdrawal by Subject|2
2036818|NCT00413660|3607046|FG007|Up To Week 12|Withdrawal by Subject|0
2036819|NCT00413660|3607047|FG008|Up To Week 12|Withdrawal by Subject|0
2235693|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
2235694|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
2235695|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
2235696|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
2235697|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
2235698|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
2235699|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
2235700|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
2235701|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
2235702|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
2235703|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
2235704|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
2235705|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
2235706|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
2235707|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
2235708|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
2235709|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
2235710|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
2235711|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
2235712|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
2235713|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
2235714|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
2235715|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
2334508|NCT03249935|4059966|FG000|Overall Study|Protocol Violation|5
2334509|NCT03250182|4059972|FG000|Overall Study|Withdrawal by Subject|1
2334510|NCT03251482|4060006|FG000|Overall Study|Withdrawal by Subject|0
2334511|NCT03251482|4060007|FG001|Overall Study|Withdrawal by Subject|1
2334512|NCT03251482|4060008|FG002|Overall Study|Withdrawal by Subject|0
2334513|NCT03251482|4060009|FG003|Overall Study|Withdrawal by Subject|0
2334514|NCT03251482|4060010|FG004|Overall Study|Withdrawal by Subject|0
2334515|NCT03251963|4060028|FG000|Overall Study|inappropriate Xa level timing|6
2334516|NCT03251963|4060029|FG001|Overall Study|inappropriate Xa level timing|3
2334517|NCT03251963|4060028|FG000|Overall Study|no peak Xa level drawn|2
2334518|NCT03251963|4060029|FG001|Overall Study|no peak Xa level drawn|0
2334519|NCT03251963|4060028|FG000|Overall Study|bled prior to Xa level|1
2334520|NCT03251963|4060029|FG001|Overall Study|bled prior to Xa level|2
2334521|NCT03252015|4060039|FG000|Overall Study|Withdrawal by Subject|0
2334522|NCT03252015|4060040|FG001|Overall Study|Withdrawal by Subject|1
2334523|NCT03252015|4060041|FG002|Overall Study|Withdrawal by Subject|1
2334524|NCT03252015|4060042|FG003|Overall Study|Withdrawal by Subject|0
2334525|NCT03252015|4060039|FG000|Overall Study|Adverse Event|1
2334526|NCT03252015|4060040|FG001|Overall Study|Adverse Event|0
2334527|NCT03252015|4060041|FG002|Overall Study|Adverse Event|0
2334528|NCT03252015|4060042|FG003|Overall Study|Adverse Event|1
2334529|NCT03252145|4060068|FG000|Overall Study|Withdrawal by Subject|1
2334530|NCT03252145|4060069|FG001|Overall Study|Withdrawal by Subject|0
2334531|NCT03252145|4060068|FG000|Overall Study|Complicating Disease|1
2334532|NCT03252145|4060069|FG001|Overall Study|Complicating Disease|2
2334533|NCT03253094|4060106|FG000|Overall Study|Adverse Event|2
2334534|NCT03253094|4060107|FG001|Overall Study|Adverse Event|0
2334535|NCT03253094|4060108|FG002|Overall Study|Adverse Event|0
2334536|NCT03253094|4060109|FG003|Overall Study|Adverse Event|0
2334537|NCT03253094|4060110|FG004|Overall Study|Adverse Event|0
2334538|NCT03253094|4060111|FG005|Overall Study|Adverse Event|0
2334539|NCT03253094|4060106|FG000|Overall Study|Lack of Efficacy|0
2334540|NCT03253094|4060107|FG001|Overall Study|Lack of Efficacy|0
2334541|NCT03253094|4060108|FG002|Overall Study|Lack of Efficacy|2
2334542|NCT03253094|4060109|FG003|Overall Study|Lack of Efficacy|1
2334543|NCT03253094|4060110|FG004|Overall Study|Lack of Efficacy|2
2334544|NCT03253094|4060111|FG005|Overall Study|Lack of Efficacy|1
2334545|NCT03253094|4060106|FG000|Overall Study|Lost to Follow-up|0
2334546|NCT03253094|4060107|FG001|Overall Study|Lost to Follow-up|0
2334547|NCT03253094|4060108|FG002|Overall Study|Lost to Follow-up|1
2334548|NCT03253094|4060109|FG003|Overall Study|Lost to Follow-up|1
2334549|NCT03253094|4060110|FG004|Overall Study|Lost to Follow-up|0
2334550|NCT03253094|4060111|FG005|Overall Study|Lost to Follow-up|1
2334551|NCT03253094|4060106|FG000|Overall Study|Physician Decision|1
2334552|NCT03253094|4060107|FG001|Overall Study|Physician Decision|0
2334553|NCT03253094|4060108|FG002|Overall Study|Physician Decision|0
2334554|NCT03253094|4060109|FG003|Overall Study|Physician Decision|1
2334555|NCT03253094|4060110|FG004|Overall Study|Physician Decision|0
2334556|NCT03253094|4060111|FG005|Overall Study|Physician Decision|2
2334557|NCT03253094|4060106|FG000|Overall Study|Withdrawal by Subject|1
2334558|NCT03253094|4060107|FG001|Overall Study|Withdrawal by Subject|2
2334559|NCT03253094|4060108|FG002|Overall Study|Withdrawal by Subject|1
2334560|NCT03253094|4060109|FG003|Overall Study|Withdrawal by Subject|0
2235716|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
2235717|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
2235718|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
2235719|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
2235720|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
2235721|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
2235722|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7
2235723|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3
2235724|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3
2235725|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
2235726|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
2235727|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
2235728|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
2235729|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
2235730|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
2235731|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
2235732|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
2235733|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
2235734|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
2235735|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
2235736|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
2235737|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
2235738|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
2235739|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
2235740|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
2235741|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
2235742|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
2235743|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
2235744|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
2235745|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
2235746|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
2235747|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
2235748|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
2235749|NCT01884350|3890692|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
2235750|NCT01884350|3890693|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
2235751|NCT01884350|3890694|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
2235752|NCT01884545|3890725|FG000|Overall Study|Lost to Follow-up|6
2235753|NCT01884545|3890726|FG001|Overall Study|Lost to Follow-up|4
2235754|NCT01884545|3890727|FG002|Overall Study|Lost to Follow-up|9
2235755|NCT01884545|3890728|FG003|Overall Study|Lost to Follow-up|4
2235756|NCT01884545|3890725|FG000|Overall Study|Patient withdrawn|7
2235757|NCT01884545|3890726|FG001|Overall Study|Patient withdrawn|12
2235758|NCT01884545|3890727|FG002|Overall Study|Patient withdrawn|5
2235759|NCT01884545|3890728|FG003|Overall Study|Patient withdrawn|5
2235760|NCT01884545|3890725|FG000|Overall Study|Non-adherence|0
2235761|NCT01884545|3890726|FG001|Overall Study|Non-adherence|2
2235762|NCT01884545|3890727|FG002|Overall Study|Non-adherence|0
2235763|NCT01884545|3890728|FG003|Overall Study|Non-adherence|0
2235764|NCT01884571|3890738|FG000|Overall Study|Adverse Event|1
2235765|NCT01884571|3890738|FG000|Overall Study|Death|2
2235766|NCT01884571|3890738|FG000|Overall Study|Withdrawal by Subject|2
2235767|NCT01884571|3890738|FG000|Overall Study|Disease progression|3
2235768|NCT01884597|3890745|FG000|Overall Study|Adverse Event|0
2235769|NCT01884597|3890746|FG001|Overall Study|Adverse Event|0
2235770|NCT01884597|3890747|FG002|Overall Study|Adverse Event|1
2235771|NCT01884597|3890745|FG000|Overall Study|Lack of Efficacy|1
2235772|NCT01884597|3890746|FG001|Overall Study|Lack of Efficacy|0
2235773|NCT01884597|3890747|FG002|Overall Study|Lack of Efficacy|0
2235774|NCT01884597|3890745|FG000|Overall Study|Death|0
2235775|NCT01884597|3890746|FG001|Overall Study|Death|1
2235776|NCT01884597|3890747|FG002|Overall Study|Death|0
2235777|NCT01884675|3890763|FG000|Overall Study|Study closed/terminated|3
2235778|NCT01884675|3890764|FG001|Overall Study|Study closed/terminated|2
2235779|NCT01884688|3890772|FG000|Overall Study|Screen Failure|2
2235780|NCT01885000|3890787|FG000|Overall Study|Adverse Event|1
2235781|NCT01885000|3890788|FG001|Overall Study|Adverse Event|0
2235782|NCT01885000|3890787|FG000|Overall Study|Withdrawal by Subject|1
2235783|NCT01885000|3890788|FG001|Overall Study|Withdrawal by Subject|1
2235784|NCT01885000|3890787|FG000|Overall Study|Protocol Violation|0
2235785|NCT01885000|3890788|FG001|Overall Study|Protocol Violation|1
2235786|NCT01885104|3890796|FG000|Overall Study|Withdrawal of Consent|1
2235787|NCT01885104|3890797|FG001|Overall Study|Withdrawal of Consent|0
2235788|NCT01885104|3890796|FG000|Overall Study|Lost to Follow-up|0
2235789|NCT01885104|3890797|FG001|Overall Study|Lost to Follow-up|1
2235790|NCT01885104|3890796|FG000|Overall Study|Physician Decision|1
2235791|NCT01885104|3890797|FG001|Overall Study|Physician Decision|0
2235792|NCT01885182|3890814|FG000|Overall Study|Adverse Event|11
2235793|NCT01885182|3890815|FG001|Overall Study|Adverse Event|13
2235794|NCT01885182|3890814|FG000|Overall Study|Withdrawal by Subject|13
2235795|NCT01885182|3890815|FG001|Overall Study|Withdrawal by Subject|6
2235796|NCT01885182|3890814|FG000|Overall Study|Lost to Follow-up|2
2235797|NCT01885182|3890815|FG001|Overall Study|Lost to Follow-up|2
2235798|NCT01885182|3890814|FG000|Overall Study|Lack of Efficacy|8
2235799|NCT01885182|3890815|FG001|Overall Study|Lack of Efficacy|1
2235800|NCT01885195|3890823|FG000|Overall Study|Adverse Event|29
2235801|NCT01885195|3890823|FG000|Overall Study|Death|1
2235802|NCT01885195|3890823|FG000|Overall Study|Disease Progression|67
2235803|NCT01885195|3890823|FG000|Overall Study|Protocol Deviation|2
2235804|NCT01885195|3890823|FG000|Overall Study|Physician Decision|3
2235805|NCT01885195|3890823|FG000|Overall Study|Patient/guardian decision|8
2235806|NCT01885208|3890829|FG000|Overall Study|Unclassified|32
2235807|NCT01885208|3890830|FG001|Overall Study|Unclassified|38
2235808|NCT01885559|3890838|FG000|Overall Study|Lost to Follow-up|15
2235809|NCT01885559|3890839|FG001|Overall Study|Lost to Follow-up|16
2235810|NCT01885559|3890838|FG000|Overall Study|Less than full participation|9
2235811|NCT01885559|3890839|FG001|Overall Study|Less than full participation|19
2235812|NCT01885559|3890838|FG000|Overall Study|Protocol Violation|0
2235813|NCT01885559|3890839|FG001|Overall Study|Protocol Violation|1
2235814|NCT01885936|3890882|FG000|Overall Study|Withdrawal by Subject|1
2235815|NCT01885936|3890883|FG001|Overall Study|Withdrawal by Subject|0
2235816|NCT01886105|3890889|FG000|Overall Study|Lack of Efficacy|3
2334561|NCT03253094|4060110|FG004|Overall Study|Withdrawal by Subject|3
2334562|NCT03253094|4060111|FG005|Overall Study|Withdrawal by Subject|0
2334563|NCT03253094|4060106|FG000|Overall Study|Other|0
2334564|NCT03253094|4060107|FG001|Overall Study|Other|1
2334565|NCT03253094|4060108|FG002|Overall Study|Other|2
2334566|NCT03253094|4060109|FG003|Overall Study|Other|1
2334567|NCT03253094|4060110|FG004|Overall Study|Other|0
2334568|NCT03253094|4060111|FG005|Overall Study|Other|0
2334569|NCT03254108|4060130|FG000|Overall Study|Adverse Event|0
2334570|NCT03254108|4060131|FG001|Overall Study|Adverse Event|2
2334571|NCT03254108|4060132|FG002|Overall Study|Adverse Event|0
2334572|NCT03254108|4060133|FG003|Overall Study|Adverse Event|1
2334573|NCT03254108|4060134|FG004|Overall Study|Adverse Event|1
2334574|NCT03254108|4060130|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
2334575|NCT03254108|4060131|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
2334576|NCT03254108|4060132|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
2334577|NCT03254108|4060133|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
2334578|NCT03254108|4060134|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2
2334579|NCT03254134|4060148|FG000|Overall Study|Not eligible patients|599
2334580|NCT03254134|4060149|FG001|Overall Study|Not eligible patients|3630
2334581|NCT03254459|4060161|FG000|Overall Study|Adverse Event|7
2334582|NCT03254459|4060162|FG001|Overall Study|Adverse Event|20
2334583|NCT03254459|4060161|FG000|Overall Study|Withdrawal by Subject Consent|3
2334584|NCT03254459|4060162|FG001|Overall Study|Withdrawal by Subject Consent|1
2334585|NCT03254459|4060161|FG000|Overall Study|Lost to Follow-up|0
2334586|NCT03254459|4060162|FG001|Overall Study|Lost to Follow-up|1
2334587|NCT03254459|4060161|FG000|Overall Study|Miscellaneous|0
2334588|NCT03254459|4060162|FG001|Overall Study|Miscellaneous|1
2334589|NCT03254602|4060168|FG000|Overall Study|Lost to Follow-up|4
2334590|NCT03255187|4060178|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
2334591|NCT03255187|4060179|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
2334592|NCT03255187|4060178|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0
2334593|NCT03255187|4060179|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1
2334594|NCT03255291|4060191|FG000|Overall Study|Determined to be ineligible|10
2334595|NCT03255291|4060192|FG001|Overall Study|Determined to be ineligible|12
2334596|NCT03255291|4060193|FG002|Overall Study|Determined to be ineligible|6
2334597|NCT03255291|4060194|FG003|Overall Study|Determined to be ineligible|6
2334598|NCT03255291|4060195|FG004|Overall Study|Determined to be ineligible|5
2334599|NCT03255291|4060196|FG005|Overall Study|Determined to be ineligible|10
2334600|NCT03255291|4060191|FG000|Overall Study|Baseline data collection issues|3
2334601|NCT03255291|4060192|FG001|Overall Study|Baseline data collection issues|0
2334602|NCT03255291|4060193|FG002|Overall Study|Baseline data collection issues|0
2334603|NCT03255291|4060194|FG003|Overall Study|Baseline data collection issues|0
2334604|NCT03255291|4060195|FG004|Overall Study|Baseline data collection issues|2
2334605|NCT03255291|4060196|FG005|Overall Study|Baseline data collection issues|0
2334606|NCT03255382|4060216|FG000|Overall Study|Adverse Event|3
2334607|NCT03255382|4060217|FG001|Overall Study|Adverse Event|0
2334608|NCT03255382|4060216|FG000|Overall Study|Lost to Follow-up|2
2334609|NCT03255382|4060217|FG001|Overall Study|Lost to Follow-up|0
2334610|NCT03255382|4060216|FG000|Overall Study|Withdrawal by Subject|2
2334611|NCT03255382|4060217|FG001|Overall Study|Withdrawal by Subject|0
2334612|NCT03255382|4060216|FG000|Overall Study|Other|6
2334613|NCT03255382|4060217|FG001|Overall Study|Other|0
2334614|NCT03255655|4060226|FG000|Overall Study|Lost to Follow-up|7
2334615|NCT03255655|4060227|FG001|Overall Study|Lost to Follow-up|4
2334616|NCT03255733|4060233|FG000|Overall Study|Lost to Follow-up|4
2235817|NCT01886287|3890898|FG000|Overall Study|Radiographic disease progression|1
2235818|NCT01886287|3890898|FG000|Overall Study|Clinical progression due to disease|1
2235819|NCT01886300|3890902|FG000|Overall Study|Trial terminated by sponsor|16
2235820|NCT01886313|3890908|FG000|Overall Study|Adverse Event|1
2235821|NCT01886313|3890909|FG001|Overall Study|Adverse Event|1
2235822|NCT01886378|3890915|FG000|Overall Study|Adverse Event|1
2235823|NCT01886378|3890915|FG000|Overall Study|Withdrawal by Subject|4
2235824|NCT01886690|3890921|FG000|Overall Study|Protocol Violation|0
2235825|NCT01886690|3890922|FG001|Overall Study|Protocol Violation|1
2235826|NCT01886690|3890921|FG000|Overall Study|Personal Reasons|0
2235827|NCT01886690|3890922|FG001|Overall Study|Personal Reasons|1
2235828|NCT01886716|3890932|FG000|Week 1|Lost to Follow-up|0
2235829|NCT01886716|3890933|FG001|Week 1|Lost to Follow-up|0
2235830|NCT01886716|3890934|FG002|Week 1|Lost to Follow-up|2
2235831|NCT01886716|3890935|FG003|Week 1|Lost to Follow-up|2
2334617|NCT03255824|4060239|FG000|Overall Study|Under-sedation|2
2334618|NCT03255824|4060240|FG001|Overall Study|Under-sedation|1
2334619|NCT03255941|4060254|FG000|Overall Study|Not eligible or refused injection|37
2334620|NCT03255941|4060255|FG001|Overall Study|Not eligible or refused injection|44
2334621|NCT03255941|4060256|FG002|Overall Study|Not eligible or refused injection|5
2334622|NCT03255941|4060257|FG003|Overall Study|Not eligible or refused injection|6
2334623|NCT03255941|4060254|FG000|Overall Study|Did not complete exit interview|1
2334624|NCT03255941|4060255|FG001|Overall Study|Did not complete exit interview|2
2334625|NCT03255941|4060256|FG002|Overall Study|Did not complete exit interview|0
2334626|NCT03255941|4060257|FG003|Overall Study|Did not complete exit interview|0
2334627|NCT03255980|4060283|FG000|Overall Study|Grade =>3 Skin Toxicity|1
2334628|NCT03255980|4060284|FG001|Overall Study|Grade =>3 Skin Toxicity|4
2334629|NCT03255980|4060285|FG002|Overall Study|Grade =>3 Skin Toxicity|6
2334630|NCT03255980|4060286|FG003|Overall Study|Grade =>3 Skin Toxicity|5
2334631|NCT03255980|4060283|FG000|Overall Study|Adverse Event|1
2334632|NCT03255980|4060284|FG001|Overall Study|Adverse Event|1
2334633|NCT03255980|4060285|FG002|Overall Study|Adverse Event|0
2334634|NCT03255980|4060286|FG003|Overall Study|Adverse Event|1
2334635|NCT03255980|4060283|FG000|Overall Study|Lack of compliance to study or assessmen|0
2334636|NCT03255980|4060284|FG001|Overall Study|Lack of compliance to study or assessmen|1
2334637|NCT03255980|4060285|FG002|Overall Study|Lack of compliance to study or assessmen|0
2334638|NCT03255980|4060286|FG003|Overall Study|Lack of compliance to study or assessmen|0
2334639|NCT03255980|4060283|FG000|Overall Study|Lost to Follow-up|1
2334640|NCT03255980|4060284|FG001|Overall Study|Lost to Follow-up|1
2334641|NCT03255980|4060285|FG002|Overall Study|Lost to Follow-up|0
2334642|NCT03255980|4060286|FG003|Overall Study|Lost to Follow-up|3
2334643|NCT03255980|4060283|FG000|Overall Study|Withdrawal by Subject|0
2334644|NCT03255980|4060284|FG001|Overall Study|Withdrawal by Subject|1
2334645|NCT03255980|4060285|FG002|Overall Study|Withdrawal by Subject|0
2334646|NCT03255980|4060286|FG003|Overall Study|Withdrawal by Subject|3
2334647|NCT03256526|4060329|FG000|Overall Study|Adverse Event|1
2334648|NCT03256526|4060330|FG001|Overall Study|Adverse Event|0
2334649|NCT03256526|4060331|FG002|Overall Study|Adverse Event|1
2334650|NCT03256526|4060329|FG000|Overall Study|Lost to Follow-up|1
2334651|NCT03256526|4060330|FG001|Overall Study|Lost to Follow-up|0
2334652|NCT03256526|4060331|FG002|Overall Study|Lost to Follow-up|2
2334653|NCT03256552|4060339|FG000|Overall Study|Protocol Violation|1
2334654|NCT03256552|4060339|FG000|Overall Study|Physician Decision|1
2334655|NCT03256552|4060339|FG000|Overall Study|Adverse Event|1
2334656|NCT03256552|4060339|FG000|Overall Study|Withdrawal by Subject|2
2334657|NCT03256578|4060351|FG000|Overall Study|Excluded Post Randomization|66
2334658|NCT03256578|4060352|FG001|Overall Study|Excluded Post Randomization|56
2334659|NCT03256695|4060358|FG000|Overall Study|Adverse Event|8
2334660|NCT03256695|4060358|FG000|Overall Study|Death|2
2334661|NCT03256695|4060358|FG000|Overall Study|Withdrawal by Subject|14
2334662|NCT03256695|4060358|FG000|Overall Study|Non-compliance with study drug|1
2334663|NCT03256695|4060358|FG000|Overall Study|Lost to Follow-up|3
2334664|NCT03256695|4060358|FG000|Overall Study|Lack of Efficacy|3
2334665|NCT03256695|4060358|FG000|Overall Study|Protocol Violation|5
2334666|NCT03256695|4060358|FG000|Overall Study|Other than specified|3
2334667|NCT03256851|4060368|FG000|Overall Study|Withdrawal by Subject|1
2334668|NCT03256851|4060369|FG001|Overall Study|Withdrawal by Subject|0
2334669|NCT03257358|4060395|FG000|Overall Study|Adverse Event|25
2334670|NCT03257358|4060396|FG001|Overall Study|Adverse Event|12
2334671|NCT03257358|4060395|FG000|Overall Study|Lack of Efficacy|1
2334672|NCT03257358|4060396|FG001|Overall Study|Lack of Efficacy|1
2334673|NCT03257358|4060395|FG000|Overall Study|Lost to Follow-up|12
2334674|NCT03257358|4060396|FG001|Overall Study|Lost to Follow-up|4
2334675|NCT03257358|4060395|FG000|Overall Study|Non-compliance with fingolimod treatment|4
2334676|NCT03257358|4060396|FG001|Overall Study|Non-compliance with fingolimod treatment|2
2334677|NCT03257358|4060395|FG000|Overall Study|Physician Decision|2
2334678|NCT03257358|4060396|FG001|Overall Study|Physician Decision|2
2334679|NCT03257358|4060395|FG000|Overall Study|Protocol Violation|5
2334680|NCT03257358|4060396|FG001|Overall Study|Protocol Violation|3
2334681|NCT03257358|4060395|FG000|Overall Study|Technical problems|4
2334682|NCT03257358|4060396|FG001|Overall Study|Technical problems|1
2334683|NCT03257358|4060395|FG000|Overall Study|Withdrawal by Subject|8
2235832|NCT01886716|3890932|FG000|Week 2|Lost to Follow-up|3
2235833|NCT01886716|3890933|FG001|Week 2|Lost to Follow-up|2
2235834|NCT01886716|3890934|FG002|Week 2|Lost to Follow-up|1
2235835|NCT01886716|3890935|FG003|Week 2|Lost to Follow-up|3
2235836|NCT01886716|3890932|FG000|Week 3|Lost to Follow-up|1
2235837|NCT01886716|3890933|FG001|Week 3|Lost to Follow-up|1
2235838|NCT01886716|3890934|FG002|Week 3|Lost to Follow-up|0
2235839|NCT01886716|3890935|FG003|Week 3|Lost to Follow-up|1
2235840|NCT01886781|3890947|FG000|Overall Study|Protocol Violation|5
2235841|NCT01886781|3890948|FG001|Overall Study|Protocol Violation|0
2235842|NCT01886781|3890947|FG000|Overall Study|Adverse Event|1
2235843|NCT01886781|3890948|FG001|Overall Study|Adverse Event|0
2235844|NCT01886781|3890947|FG000|Overall Study|Lost to Follow-up|5
2235845|NCT01886781|3890948|FG001|Overall Study|Lost to Follow-up|0
2235846|NCT01886781|3890947|FG000|Overall Study|Withdrawal by Subject|2
2235847|NCT01886781|3890948|FG001|Overall Study|Withdrawal by Subject|1
2235848|NCT01886781|3890947|FG000|Overall Study|Worsening of symptoms|1
2235849|NCT01886781|3890948|FG001|Overall Study|Worsening of symptoms|1
2235850|NCT01886833|3890970|FG000|Overall Study|IgA not available from both periods|204
2235851|NCT01887210|3891010|FG000|Overall Study|Withdrawal by Subject|1
2235852|NCT01887210|3891011|FG001|Overall Study|Withdrawal by Subject|3
2235853|NCT01887210|3891010|FG000|Overall Study|Lost to Follow-up|0
2235854|NCT01887210|3891011|FG001|Overall Study|Lost to Follow-up|1
2235855|NCT01887353|3891033|FG000|Overall Study|Study stopped early|4
2235856|NCT01887353|3891034|FG001|Overall Study|Study stopped early|3
2235857|NCT01887418|3891043|FG000|Overall Study|Travelling difficulties|0
2235858|NCT01887418|3891044|FG001|Overall Study|Travelling difficulties|0
2235859|NCT01887418|3891045|FG002|Overall Study|Travelling difficulties|1
2235860|NCT01887600|3891077|FG000|Overall Study|Death|39
2235861|NCT01887600|3891078|FG001|Overall Study|Death|16
2235862|NCT01887600|3891077|FG000|Overall Study|Lack of Efficacy|3
2235863|NCT01887600|3891078|FG001|Overall Study|Lack of Efficacy|26
2235864|NCT01887600|3891077|FG000|Overall Study|Lost to Follow-up|5
2235865|NCT01887600|3891078|FG001|Overall Study|Lost to Follow-up|1
2235866|NCT01887600|3891077|FG000|Overall Study|Physician Decision|7
2235867|NCT01887600|3891078|FG001|Overall Study|Physician Decision|8
2334684|NCT03257358|4060396|FG001|Overall Study|Withdrawal by Subject|3
2334685|NCT03257358|4060395|FG000|Overall Study|Withdrawal of informed consent|9
2334686|NCT03257358|4060396|FG001|Overall Study|Withdrawal of informed consent|5
2334687|NCT03257358|4060395|FG000|Overall Study|New therapy for study indication|1
2334688|NCT03257358|4060396|FG001|Overall Study|New therapy for study indication|0
2334689|NCT03257358|4060395|FG000|Overall Study|No longer requires treatment|0
2334690|NCT03257358|4060396|FG001|Overall Study|No longer requires treatment|1
2334691|NCT03257371|4060402|FG000|Overall Study|Lost to Follow-up|1
2334692|NCT03257410|4060408|FG000|Overall Study|Adverse Event|2
2334693|NCT03257410|4060409|FG001|Overall Study|Adverse Event|3
2334694|NCT03257410|4060408|FG000|Overall Study|Protocol Violation|1
2334695|NCT03257410|4060409|FG001|Overall Study|Protocol Violation|2
2334696|NCT03257410|4060408|FG000|Overall Study|Lost to Follow-up|1
2334697|NCT03257410|4060409|FG001|Overall Study|Lost to Follow-up|0
2334698|NCT03257410|4060408|FG000|Overall Study|Withdrawal by Subject|1
2334699|NCT03257410|4060409|FG001|Overall Study|Withdrawal by Subject|2
2334700|NCT03257410|4060408|FG000|Overall Study|Physician Decision|1
2334701|NCT03257410|4060409|FG001|Overall Study|Physician Decision|1
2334702|NCT03257410|4060408|FG000|Overall Study|Renal transplantation|2
2334703|NCT03257410|4060409|FG001|Overall Study|Renal transplantation|0
2334704|NCT03257410|4060408|FG000|Overall Study|Switch to peritoneal dialysis|1
2334705|NCT03257410|4060409|FG001|Overall Study|Switch to peritoneal dialysis|0
2334706|NCT03257410|4060408|FG000|Overall Study|Death|3
2334707|NCT03257410|4060409|FG001|Overall Study|Death|2
2334708|NCT03257410|4060408|FG000|Overall Study|Change to another dialysis center|2
2334709|NCT03257410|4060409|FG001|Overall Study|Change to another dialysis center|2
2334710|NCT03257410|4060408|FG000|Overall Study|Missing 3 consecutive study treatments|5
2334711|NCT03257410|4060409|FG001|Overall Study|Missing 3 consecutive study treatments|6
2334712|NCT03257410|4060408|FG000|Overall Study|Miscellaneous|2
2334713|NCT03257410|4060409|FG001|Overall Study|Miscellaneous|2
2334714|NCT03257410|4060408|FG000|Overall Study|Other|0
2334715|NCT03257410|4060409|FG001|Overall Study|Other|1
2334716|NCT03257631|4060419|FG000|Overall Study|Death|8
2334717|NCT03257631|4060420|FG001|Overall Study|Death|5
2334718|NCT03257631|4060421|FG002|Overall Study|Death|13
2334719|NCT03257631|4060422|FG003|Overall Study|Death|5
2334720|NCT03257631|4060419|FG000|Overall Study|Progressive Disease|0
2334721|NCT03257631|4060420|FG001|Overall Study|Progressive Disease|0
2334722|NCT03257631|4060421|FG002|Overall Study|Progressive Disease|1
2334723|NCT03257631|4060422|FG003|Overall Study|Progressive Disease|0
2334724|NCT03257631|4060419|FG000|Overall Study|Withdrawal by Parent/Guardian|0
2334725|NCT03257631|4060420|FG001|Overall Study|Withdrawal by Parent/Guardian|2
2334726|NCT03257631|4060421|FG002|Overall Study|Withdrawal by Parent/Guardian|4
2334727|NCT03257631|4060422|FG003|Overall Study|Withdrawal by Parent/Guardian|1
2334728|NCT03257631|4060419|FG000|Overall Study|Lost to Follow-up|0
2334729|NCT03257631|4060420|FG001|Overall Study|Lost to Follow-up|0
2334730|NCT03257631|4060421|FG002|Overall Study|Lost to Follow-up|1
2334731|NCT03257631|4060422|FG003|Overall Study|Lost to Follow-up|0
2334732|NCT03257631|4060419|FG000|Overall Study|Still on Study|3
2334733|NCT03257631|4060420|FG001|Overall Study|Still on Study|2
2235868|NCT01887600|3891077|FG000|Overall Study|Protocol Deviation|3
2235869|NCT01887600|3891078|FG001|Overall Study|Protocol Deviation|0
2235870|NCT01887600|3891077|FG000|Overall Study|Withdrawal by Subject|58
2235871|NCT01887600|3891078|FG001|Overall Study|Withdrawal by Subject|52
2235872|NCT01887600|3891077|FG000|Overall Study|Adverse Event|21
2235873|NCT01887600|3891078|FG001|Overall Study|Adverse Event|9
2235874|NCT01887600|3891077|FG000|Overall Study|Non-compliance with study drug|3
2235875|NCT01887600|3891078|FG001|Overall Study|Non-compliance with study drug|0
2235876|NCT01887600|3891077|FG000|Overall Study|Miscellaneous|6
2235877|NCT01887600|3891078|FG001|Overall Study|Miscellaneous|2
2235878|NCT01887600|3891077|FG000|Overall Study|Progressive Disease|1
2235879|NCT01887600|3891078|FG001|Overall Study|Progressive Disease|0
2235880|NCT01887678|3891087|FG000|Overall Study|Adverse Event|4
2235881|NCT01887678|3891088|FG001|Overall Study|Adverse Event|6
2235882|NCT01887678|3891087|FG000|Overall Study|Exceeded rescue medication dosage|4
2235883|NCT01887678|3891088|FG001|Overall Study|Exceeded rescue medication dosage|5
2235884|NCT01887678|3891087|FG000|Overall Study|Withdrawal of consent|3
2235885|NCT01887678|3891088|FG001|Overall Study|Withdrawal of consent|4
2235886|NCT01887678|3891087|FG000|Overall Study|Lost to Follow-up|4
2235887|NCT01887678|3891088|FG001|Overall Study|Lost to Follow-up|2
2235888|NCT01887678|3891087|FG000|Overall Study|Deterioration of clinical condition|0
2235889|NCT01887678|3891088|FG001|Overall Study|Deterioration of clinical condition|4
2235890|NCT01887678|3891087|FG000|Overall Study|Lack of Efficacy|1
2235891|NCT01887678|3891088|FG001|Overall Study|Lack of Efficacy|2
2235892|NCT01887678|3891087|FG000|Overall Study|Non-compliance|0
2235893|NCT01887678|3891088|FG001|Overall Study|Non-compliance|3
2235894|NCT01887678|3891087|FG000|Overall Study|Specified|1
2235895|NCT01887678|3891088|FG001|Overall Study|Specified|2
2235896|NCT01887717|3891096|FG000|Overall Study|Withdrawal by Subject|1
2235897|NCT01887717|3891097|FG001|Overall Study|Withdrawal by Subject|7
2235898|NCT01887717|3891096|FG000|Overall Study|Physician Decision|0
2235899|NCT01887717|3891097|FG001|Overall Study|Physician Decision|2
2235900|NCT01887717|3891096|FG000|Overall Study|Administrative reasons|5
2235901|NCT01887717|3891097|FG001|Overall Study|Administrative reasons|2
2235902|NCT01887912|3891105|FG000|Overall Study|Serious adverse event|400
2235903|NCT01887912|3891106|FG001|Overall Study|Serious adverse event|198
2235904|NCT01887912|3891105|FG000|Overall Study|Other Adverse Event|34
2235905|NCT01887912|3891106|FG001|Overall Study|Other Adverse Event|15
2235906|NCT01887912|3891105|FG000|Overall Study|Protocol Violation|67
2235907|NCT01887912|3891106|FG001|Overall Study|Protocol Violation|37
2235908|NCT01887912|3891105|FG000|Overall Study|Lost to Follow-up|163
2235909|NCT01887912|3891106|FG001|Overall Study|Lost to Follow-up|74
2235910|NCT01887912|3891105|FG000|Overall Study|Withdrawal by Subject|606
2235911|NCT01887912|3891106|FG001|Overall Study|Withdrawal by Subject|349
2235912|NCT01887912|3891105|FG000|Overall Study|Other|122
2235913|NCT01887912|3891106|FG001|Overall Study|Other|58
2235914|NCT01888003|3891134|FG000|Overall Study|Study Terminated|5
2235915|NCT01888003|3891135|FG001|Overall Study|Study Terminated|6
2235916|NCT01888003|3891136|FG002|Overall Study|Study Terminated|40
2235917|NCT01888367|3891147|FG000|Overall Study|Physician Decision|3
2235918|NCT01888367|3891148|FG001|Overall Study|Physician Decision|4
2235919|NCT01888367|3891149|FG002|Overall Study|Physician Decision|2
2235920|NCT01888367|3891147|FG000|Overall Study|Death|2
2235921|NCT01888367|3891148|FG001|Overall Study|Death|0
2235922|NCT01888367|3891149|FG002|Overall Study|Death|1
2235923|NCT01888367|3891147|FG000|Overall Study|Withdrawal by Subject|1
2235924|NCT01888367|3891148|FG001|Overall Study|Withdrawal by Subject|0
2235925|NCT01888367|3891149|FG002|Overall Study|Withdrawal by Subject|1
2235926|NCT01888367|3891147|FG000|Overall Study|Lost to Follow-up|1
2235927|NCT01888367|3891148|FG001|Overall Study|Lost to Follow-up|1
2235928|NCT01888367|3891149|FG002|Overall Study|Lost to Follow-up|0
2235929|NCT01888367|3891147|FG000|Overall Study|Protocol Violation|0
2235930|NCT01888367|3891148|FG001|Overall Study|Protocol Violation|0
2235931|NCT01888367|3891149|FG002|Overall Study|Protocol Violation|1
2334734|NCT03257631|4060421|FG002|Overall Study|Still on Study|4
2334735|NCT03257631|4060422|FG003|Overall Study|Still on Study|4
2334736|NCT03257657|4060434|FG000|Overall Study|Lost to Follow-up|0
2036820|NCT00413660|3607048|FG009|Up To Week 12|Withdrawal by Subject|0
2036821|NCT00413660|3607049|FG010|Up To Week 12|Withdrawal by Subject|0
2036822|NCT00413660|3607039|FG000|Up To Week 12|Randomized, Not Treated|1
2036823|NCT00413660|3607040|FG001|Up To Week 12|Randomized, Not Treated|0
2036824|NCT00413660|3607041|FG002|Up To Week 12|Randomized, Not Treated|0
2036825|NCT00413660|3607042|FG003|Up To Week 12|Randomized, Not Treated|1
2235932|NCT01888367|3891147|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1
2235933|NCT01888367|3891148|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0
2235934|NCT01888367|3891149|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0
2235935|NCT01888432|3891159|FG000|12-month Analysis (FAS)|Lost to Follow-up|0
2235936|NCT01888432|3891160|FG001|12-month Analysis (FAS)|Lost to Follow-up|2
2235937|NCT01888432|3891159|FG000|12-month Analysis (FAS)|Physician Decision|1
2235938|NCT01888432|3891160|FG001|12-month Analysis (FAS)|Physician Decision|1
2235939|NCT01888432|3891159|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6
2235940|NCT01888432|3891160|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3
2235941|NCT01888432|3891159|FG000|12-month Analysis (FAS)|Death|4
2235942|NCT01888432|3891160|FG001|12-month Analysis (FAS)|Death|3
2235943|NCT01888432|3891159|FG000|24-month Analysis (FAS)|Graft loss|0
2334737|NCT03257657|4060435|FG001|Overall Study|Lost to Follow-up|3
2235944|NCT01888432|3891160|FG001|24-month Analysis (FAS)|Graft loss|1
2235945|NCT01888432|3891159|FG000|24-month Analysis (FAS)|Lost to Follow-up|0
2235946|NCT01888432|3891160|FG001|24-month Analysis (FAS)|Lost to Follow-up|2
2235947|NCT01888432|3891159|FG000|24-month Analysis (FAS)|Physician Decision|2
2235948|NCT01888432|3891160|FG001|24-month Analysis (FAS)|Physician Decision|4
2235949|NCT01888432|3891159|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7
2235950|NCT01888432|3891160|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6
2235951|NCT01888432|3891159|FG000|24-month Analysis (FAS)|Death|8
2235952|NCT01888432|3891160|FG001|24-month Analysis (FAS)|Death|4
2235953|NCT01888432|3891159|FG000|36-month Analysis (Extension)|Death|1
2235954|NCT01888432|3891160|FG001|36-month Analysis (Extension)|Death|0
2235955|NCT01888497|3891176|FG000|Washout Period 1|Withdrawal by Subject|0
2235956|NCT01888497|3891177|FG001|Washout Period 1|Withdrawal by Subject|0
2235957|NCT01888497|3891178|FG002|Washout Period 1|Withdrawal by Subject|1
2235958|NCT01888497|3891179|FG003|Washout Period 1|Withdrawal by Subject|1
2235959|NCT01888497|3891176|FG000|Washout Period 2|Adverse Event|0
2235960|NCT01888497|3891177|FG001|Washout Period 2|Adverse Event|0
2235961|NCT01888497|3891178|FG002|Washout Period 2|Adverse Event|0
2235962|NCT01888497|3891179|FG003|Washout Period 2|Adverse Event|1
2235963|NCT01888497|3891176|FG000|Washout Period 2|Withdrawal by Subject|0
2235964|NCT01888497|3891177|FG001|Washout Period 2|Withdrawal by Subject|0
2235965|NCT01888497|3891178|FG002|Washout Period 2|Withdrawal by Subject|0
2235966|NCT01888497|3891179|FG003|Washout Period 2|Withdrawal by Subject|1
2235967|NCT01888640|3891192|FG000|Overall Study|Lost to Follow-up|1
2235968|NCT01888640|3891193|FG001|Overall Study|Lost to Follow-up|2
2235969|NCT01888640|3891194|FG002|Overall Study|Lost to Follow-up|0
2235970|NCT01888640|3891192|FG000|Overall Study|Withdrawal by Subject|15
2235971|NCT01888640|3891193|FG001|Overall Study|Withdrawal by Subject|11
2235972|NCT01888640|3891194|FG002|Overall Study|Withdrawal by Subject|4
2235973|NCT01888640|3891192|FG000|Overall Study|Minimum dose not met|10
2235974|NCT01888640|3891193|FG001|Overall Study|Minimum dose not met|16
2235975|NCT01888640|3891194|FG002|Overall Study|Minimum dose not met|0
2235976|NCT01888640|3891192|FG000|Overall Study|Given wrong unit (placebo)|1
2235977|NCT01888640|3891193|FG001|Overall Study|Given wrong unit (placebo)|0
2235978|NCT01888640|3891194|FG002|Overall Study|Given wrong unit (placebo)|0
2235979|NCT01888640|3891192|FG000|Overall Study|Excluded for prior TENS|0
2235980|NCT01888640|3891193|FG001|Overall Study|Excluded for prior TENS|1
2235981|NCT01888640|3891194|FG002|Overall Study|Excluded for prior TENS|0
2334738|NCT03257657|4060434|FG000|Overall Study|Withdrawn|0
2334739|NCT03257657|4060435|FG001|Overall Study|Withdrawn|1
2334740|NCT03257657|4060434|FG000|Overall Study|Noted not eligible right after enrolled|0
2334741|NCT03257657|4060435|FG001|Overall Study|Noted not eligible right after enrolled|1
2334742|NCT03257813|4060444|FG000|Overall Study|Protocol Violation|6
2334743|NCT03257813|4060445|FG001|Overall Study|Protocol Violation|3
2334744|NCT03257865|4060456|FG000|Overall Study|Adverse Event|4
2334745|NCT03257865|4060457|FG001|Overall Study|Adverse Event|8
2334746|NCT03257865|4060456|FG000|Overall Study|Lack of Efficacy|1
2334747|NCT03257865|4060457|FG001|Overall Study|Lack of Efficacy|2
2334748|NCT03257865|4060456|FG000|Overall Study|Non-compliance with Study Drug|0
2334749|NCT03257865|4060457|FG001|Overall Study|Non-compliance with Study Drug|2
2334750|NCT03257865|4060456|FG000|Overall Study|Withdrawal by Subject|23
2334751|NCT03257865|4060457|FG001|Overall Study|Withdrawal by Subject|17
2334752|NCT03257865|4060456|FG000|Overall Study|Physician Decision|3
2334753|NCT03257865|4060457|FG001|Overall Study|Physician Decision|1
2334754|NCT03257865|4060456|FG000|Overall Study|Other|0
2334755|NCT03257865|4060457|FG001|Overall Study|Other|1
2334756|NCT03257865|4060456|FG000|Overall Study|Lost to Follow-up|4
2334757|NCT03257865|4060457|FG001|Overall Study|Lost to Follow-up|4
2334758|NCT03257995|4060463|FG000|Overall Study|Adverse Event|0
2334759|NCT03257995|4060464|FG001|Overall Study|Adverse Event|1
2334760|NCT03257995|4060465|FG002|Overall Study|Adverse Event|0
2334761|NCT03257995|4060466|FG003|Overall Study|Adverse Event|0
2334762|NCT03257995|4060467|FG004|Overall Study|Adverse Event|0
2334763|NCT03257995|4060468|FG005|Overall Study|Adverse Event|0
2334764|NCT03257995|4060463|FG000|Overall Study|Protocol deviation|0
2334765|NCT03257995|4060464|FG001|Overall Study|Protocol deviation|0
2334766|NCT03257995|4060465|FG002|Overall Study|Protocol deviation|0
2334767|NCT03257995|4060466|FG003|Overall Study|Protocol deviation|0
2334768|NCT03257995|4060467|FG004|Overall Study|Protocol deviation|0
2334769|NCT03257995|4060468|FG005|Overall Study|Protocol deviation|2
2334770|NCT03258710|4060490|FG000|Overall Study|Adverse Event|1
2334771|NCT03258710|4060490|FG000|Overall Study|Protocol-defined stopping criteria|1
2334772|NCT03258710|4060490|FG000|Overall Study|Physician Decision|1
2334773|NCT03258762|4060496|FG000|Overall Study|Lost to Follow-up|0
2334774|NCT03258762|4060497|FG001|Overall Study|Lost to Follow-up|1
2334775|NCT03258814|4060506|FG000|Overall Study|Early Termination|4
2334776|NCT03258814|4060507|FG001|Overall Study|Early Termination|3
2334777|NCT03258814|4060508|FG002|Overall Study|Early Termination|10
2334778|NCT03259087|4060520|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0
2334779|NCT03259087|4060521|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0
2036826|NCT00413660|3607043|FG004|Up To Week 12|Randomized, Not Treated|0
2334780|NCT03259087|4060522|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0
2334781|NCT03259087|4060523|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0
2235982|NCT01888640|3891192|FG000|Overall Study|Researcher Termination of Participant|0
2235983|NCT01888640|3891193|FG001|Overall Study|Researcher Termination of Participant|1
2235984|NCT01888640|3891194|FG002|Overall Study|Researcher Termination of Participant|1
2235985|NCT01888874|3891212|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
2235986|NCT01888874|3891213|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
2235987|NCT01888874|3891214|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
2235988|NCT01888874|3891215|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4
2235989|NCT01888874|3891216|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
2235990|NCT01888874|3891217|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
2235991|NCT01888874|3891218|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
2235992|NCT01888874|3891212|FG000|Period 1 (Baseline up to Week 12)|Other|1
2235993|NCT01888874|3891213|FG001|Period 1 (Baseline up to Week 12)|Other|0
2235994|NCT01888874|3891214|FG002|Period 1 (Baseline up to Week 12)|Other|1
2235995|NCT01888874|3891215|FG003|Period 1 (Baseline up to Week 12)|Other|1
2334782|NCT03259087|4060524|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1
2334783|NCT03259087|4060520|FG000|Period 2 of Part 2|Adverse Event|0
2334784|NCT03259087|4060521|FG001|Period 2 of Part 2|Adverse Event|0
2334785|NCT03259087|4060522|FG002|Period 2 of Part 2|Adverse Event|0
2334786|NCT03259087|4060523|FG003|Period 2 of Part 2|Adverse Event|0
2334787|NCT03259087|4060524|FG004|Period 2 of Part 2|Adverse Event|1
2334788|NCT03259308|4060577|FG000|Overall Study|Adverse Event|5
2334789|NCT03259308|4060578|FG001|Overall Study|Adverse Event|4
2334790|NCT03259308|4060579|FG002|Overall Study|Adverse Event|1
2334791|NCT03259308|4060577|FG000|Overall Study|Withdrawal by Subject|2
2334792|NCT03259308|4060578|FG001|Overall Study|Withdrawal by Subject|1
2334793|NCT03259308|4060579|FG002|Overall Study|Withdrawal by Subject|3
2334794|NCT03259308|4060577|FG000|Overall Study|Lost to Follow-up|0
2334795|NCT03259308|4060578|FG001|Overall Study|Lost to Follow-up|0
2334796|NCT03259308|4060579|FG002|Overall Study|Lost to Follow-up|1
2334797|NCT03259308|4060577|FG000|Overall Study|Pregnancy|0
2334798|NCT03259308|4060578|FG001|Overall Study|Pregnancy|0
2334799|NCT03259308|4060579|FG002|Overall Study|Pregnancy|1
2334800|NCT03259308|4060577|FG000|Overall Study|Protocol Deviation|0
2334801|NCT03259308|4060578|FG001|Overall Study|Protocol Deviation|3
2334802|NCT03259308|4060579|FG002|Overall Study|Protocol Deviation|0
2334803|NCT03259308|4060577|FG000|Overall Study|Lack of Efficacy|0
2334804|NCT03259308|4060578|FG001|Overall Study|Lack of Efficacy|0
2334805|NCT03259308|4060579|FG002|Overall Study|Lack of Efficacy|1
2334806|NCT03259334|4060590|FG000|Overall Study|Adverse Event|3
2334807|NCT03259334|4060591|FG001|Overall Study|Adverse Event|8
2334808|NCT03259334|4060592|FG002|Overall Study|Adverse Event|5
2334809|NCT03259334|4060590|FG000|Overall Study|Withdrawal by Subject|4
2334810|NCT03259334|4060591|FG001|Overall Study|Withdrawal by Subject|2
2334811|NCT03259334|4060592|FG002|Overall Study|Withdrawal by Subject|4
2334812|NCT03259334|4060590|FG000|Overall Study|Physician Decision|1
2334813|NCT03259334|4060591|FG001|Overall Study|Physician Decision|0
2334814|NCT03259334|4060592|FG002|Overall Study|Physician Decision|0
2334815|NCT03259334|4060590|FG000|Overall Study|Lost to Follow-up|0
2334816|NCT03259334|4060591|FG001|Overall Study|Lost to Follow-up|2
2334817|NCT03259334|4060592|FG002|Overall Study|Lost to Follow-up|1
2334818|NCT03259334|4060590|FG000|Overall Study|Protocol Deviation|0
2334819|NCT03259334|4060591|FG001|Overall Study|Protocol Deviation|3
2334820|NCT03259334|4060592|FG002|Overall Study|Protocol Deviation|2
2334821|NCT03259334|4060590|FG000|Overall Study|Lack of Efficacy|2
2036827|NCT00413660|3607044|FG005|Up To Week 12|Randomized, Not Treated|0
2036828|NCT00413660|3607045|FG006|Up To Week 12|Randomized, Not Treated|0
2036829|NCT00413660|3607046|FG007|Up To Week 12|Randomized, Not Treated|0
2036830|NCT00413660|3607047|FG008|Up To Week 12|Randomized, Not Treated|0
2036831|NCT00413660|3607048|FG009|Up To Week 12|Randomized, Not Treated|0
2036832|NCT00413660|3607049|FG010|Up To Week 12|Randomized, Not Treated|0
2036833|NCT00413660|3607039|FG000|Up To Week 12|Other|3
2036834|NCT00413660|3607040|FG001|Up To Week 12|Other|1
2036835|NCT00413660|3607041|FG002|Up To Week 12|Other|6
2036836|NCT00413660|3607042|FG003|Up To Week 12|Other|1
2036837|NCT00413660|3607043|FG004|Up To Week 12|Other|2
2036838|NCT00413660|3607044|FG005|Up To Week 12|Other|4
2036839|NCT00413660|3607045|FG006|Up To Week 12|Other|3
2036840|NCT00413660|3607046|FG007|Up To Week 12|Other|0
2036841|NCT00413660|3607047|FG008|Up To Week 12|Other|0
2036842|NCT00413660|3607048|FG009|Up To Week 12|Other|0
2036843|NCT00413660|3607049|FG010|Up To Week 12|Other|0
2036844|NCT00413660|3607039|FG000|Post Week 12|Adverse Event|2
2036845|NCT00413660|3607040|FG001|Post Week 12|Adverse Event|0
2036846|NCT00413660|3607041|FG002|Post Week 12|Adverse Event|2
2036847|NCT00413660|3607042|FG003|Post Week 12|Adverse Event|1
2036848|NCT00413660|3607043|FG004|Post Week 12|Adverse Event|4
2036849|NCT00413660|3607044|FG005|Post Week 12|Adverse Event|2
2036850|NCT00413660|3607045|FG006|Post Week 12|Adverse Event|2
2036851|NCT00413660|3607046|FG007|Post Week 12|Adverse Event|0
2036852|NCT00413660|3607047|FG008|Post Week 12|Adverse Event|0
2036853|NCT00413660|3607048|FG009|Post Week 12|Adverse Event|0
2036854|NCT00413660|3607049|FG010|Post Week 12|Adverse Event|0
2334822|NCT03259334|4060591|FG001|Overall Study|Lack of Efficacy|0
2334823|NCT03259334|4060592|FG002|Overall Study|Lack of Efficacy|1
2334824|NCT03259334|4060590|FG000|Overall Study|Randomized but never treated|0
2235996|NCT01888874|3891216|FG004|Period 1 (Baseline up to Week 12)|Other|3
2235997|NCT01888874|3891217|FG005|Period 1 (Baseline up to Week 12)|Other|3
2235998|NCT01888874|3891218|FG006|Period 1 (Baseline up to Week 12)|Other|0
2235999|NCT01888874|3891212|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0
2236000|NCT01888874|3891213|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0
2236001|NCT01888874|3891214|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0
2236002|NCT01888874|3891215|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0
2236003|NCT01888874|3891216|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0
2236004|NCT01888874|3891217|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0
2236005|NCT01888874|3891218|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1
2236006|NCT01888874|3891212|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0
2236007|NCT01888874|3891213|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2
2236008|NCT01888874|3891214|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3
2236009|NCT01888874|3891215|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
2236010|NCT01888874|3891216|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2
2236011|NCT01888874|3891217|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1
2236012|NCT01888874|3891218|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0
2236013|NCT01888874|3891212|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
2236014|NCT01888874|3891213|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
2236015|NCT01888874|3891214|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
2236016|NCT01888874|3891215|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
2236017|NCT01888874|3891216|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1
2236018|NCT01888874|3891217|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
2236019|NCT01888874|3891218|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
2236020|NCT01888874|3891212|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
2334825|NCT03259334|4060591|FG001|Overall Study|Randomized but never treated|2
2334826|NCT03259334|4060592|FG002|Overall Study|Randomized but never treated|0
2334827|NCT03259425|4060600|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1
2334828|NCT03259490|4060606|FG000|Period 1|Withdrawal by Subject|0
2334829|NCT03259490|4060607|FG001|Period 1|Withdrawal by Subject|1
2334830|NCT03259490|4060606|FG000|Period 2|Protocol Violation|1
2334831|NCT03259490|4060607|FG001|Period 2|Protocol Violation|0
2334832|NCT03259555|4060615|FG000|Overall Study|Adverse Event|6
2334833|NCT03259555|4060616|FG001|Overall Study|Adverse Event|4
2334834|NCT03259555|4060615|FG000|Overall Study|Lack of Efficacy|6
2334835|NCT03259555|4060616|FG001|Overall Study|Lack of Efficacy|4
2334836|NCT03259555|4060615|FG000|Overall Study|Lost to Follow-up|0
2334837|NCT03259555|4060616|FG001|Overall Study|Lost to Follow-up|2
2334838|NCT03259555|4060615|FG000|Overall Study|Non-Compliance With Study Drug|1
2334839|NCT03259555|4060616|FG001|Overall Study|Non-Compliance With Study Drug|0
2334840|NCT03259555|4060615|FG000|Overall Study|Progressive Disease|0
2334841|NCT03259555|4060616|FG001|Overall Study|Progressive Disease|2
2334842|NCT03259555|4060615|FG000|Overall Study|Withdrawal by Subject|19
2334843|NCT03259555|4060616|FG001|Overall Study|Withdrawal by Subject|16
2334844|NCT03259555|4060615|FG000|Overall Study|Physician Decision|1
2334845|NCT03259555|4060616|FG001|Overall Study|Physician Decision|2
2334846|NCT03259555|4060615|FG000|Overall Study|Other|1
2334847|NCT03259555|4060616|FG001|Overall Study|Other|0
2334848|NCT03259789|4060625|FG000|Overall Study|Adverse Event|3
2334849|NCT03259789|4060626|FG001|Overall Study|Adverse Event|2
2334850|NCT03259789|4060627|FG002|Overall Study|Adverse Event|1
2334851|NCT03259789|4060625|FG000|Overall Study|Withdrawal by Subject|9
2334852|NCT03259789|4060626|FG001|Overall Study|Withdrawal by Subject|5
2334853|NCT03259789|4060627|FG002|Overall Study|Withdrawal by Subject|1
2334854|NCT03259789|4060625|FG000|Overall Study|Lost to Follow-up|5
2334855|NCT03259789|4060626|FG001|Overall Study|Lost to Follow-up|9
2334856|NCT03259789|4060627|FG002|Overall Study|Lost to Follow-up|4
2334857|NCT03259789|4060625|FG000|Overall Study|Physician Decision|0
2334858|NCT03259789|4060626|FG001|Overall Study|Physician Decision|1
2334859|NCT03259789|4060627|FG002|Overall Study|Physician Decision|0
2334860|NCT03260205|4060641|FG000|Overall Study|Adverse Event|2
2334861|NCT03260205|4060642|FG001|Overall Study|Adverse Event|0
2334862|NCT03260205|4060643|FG002|Overall Study|Adverse Event|2
2334863|NCT03260205|4060644|FG003|Overall Study|Adverse Event|2
2334864|NCT03260205|4060645|FG004|Overall Study|Adverse Event|4
2334865|NCT03260205|4060641|FG000|Overall Study|Lost to Follow-up|2
2334866|NCT03260205|4060642|FG001|Overall Study|Lost to Follow-up|2
2036855|NCT00413660|3607039|FG000|Post Week 12|Lack of Efficacy|0
2036856|NCT00413660|3607040|FG001|Post Week 12|Lack of Efficacy|0
2036857|NCT00413660|3607041|FG002|Post Week 12|Lack of Efficacy|1
2036858|NCT00413660|3607042|FG003|Post Week 12|Lack of Efficacy|0
2036859|NCT00413660|3607043|FG004|Post Week 12|Lack of Efficacy|0
2036860|NCT00413660|3607044|FG005|Post Week 12|Lack of Efficacy|0
2036861|NCT00413660|3607045|FG006|Post Week 12|Lack of Efficacy|0
2036862|NCT00413660|3607046|FG007|Post Week 12|Lack of Efficacy|0
2036863|NCT00413660|3607047|FG008|Post Week 12|Lack of Efficacy|0
2036864|NCT00413660|3607048|FG009|Post Week 12|Lack of Efficacy|1
2036865|NCT00413660|3607049|FG010|Post Week 12|Lack of Efficacy|0
2036866|NCT00413660|3607039|FG000|Post Week 12|Lost to Follow-up|0
2036867|NCT00413660|3607040|FG001|Post Week 12|Lost to Follow-up|1
2236021|NCT01888874|3891213|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1
2236022|NCT01888874|3891214|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
2236023|NCT01888874|3891215|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
2236024|NCT01888874|3891216|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
2236025|NCT01888874|3891217|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
2236026|NCT01888874|3891218|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
2236027|NCT01888874|3891212|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
2236028|NCT01888874|3891213|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
2236029|NCT01888874|3891214|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
2236030|NCT01888874|3891215|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
2236031|NCT01888874|3891216|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
2236032|NCT01888874|3891217|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
2236033|NCT01888874|3891218|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
2236034|NCT01888874|3891212|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
2236035|NCT01888874|3891213|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
2236036|NCT01888874|3891214|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
2236037|NCT01888874|3891215|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
2236038|NCT01888874|3891216|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
2236039|NCT01888874|3891217|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
2236040|NCT01888874|3891218|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
2236041|NCT01888874|3891212|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
2236042|NCT01888874|3891213|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
2236043|NCT01888874|3891214|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
2236044|NCT01888874|3891215|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
2236045|NCT01888874|3891216|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1
2236046|NCT01888874|3891217|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
2236047|NCT01888874|3891218|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
2236048|NCT01888874|3891212|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
2236049|NCT01888874|3891213|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
2236050|NCT01888874|3891214|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2
2236051|NCT01888874|3891215|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
2236052|NCT01888874|3891216|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
2236053|NCT01888874|3891217|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1
2236054|NCT01888874|3891218|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
2236055|NCT01888874|3891212|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0
2236056|NCT01888874|3891213|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0
2236057|NCT01888874|3891214|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1
2236058|NCT01888874|3891215|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0
2236059|NCT01888874|3891216|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0
2236060|NCT01888874|3891217|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0
2236061|NCT01888874|3891218|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0
2236062|NCT01888874|3891212|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2
2334867|NCT03260205|4060643|FG002|Overall Study|Lost to Follow-up|1
2334868|NCT03260205|4060644|FG003|Overall Study|Lost to Follow-up|1
2334869|NCT03260205|4060645|FG004|Overall Study|Lost to Follow-up|5
2334870|NCT03260205|4060641|FG000|Overall Study|Protocol Violation|0
2334871|NCT03260205|4060642|FG001|Overall Study|Protocol Violation|0
2334872|NCT03260205|4060643|FG002|Overall Study|Protocol Violation|2
2334873|NCT03260205|4060644|FG003|Overall Study|Protocol Violation|0
2334874|NCT03260205|4060645|FG004|Overall Study|Protocol Violation|1
2334875|NCT03260205|4060641|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4
2334876|NCT03260205|4060642|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5
2334877|NCT03260205|4060643|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1
2334878|NCT03260205|4060644|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0
2334879|NCT03260205|4060645|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2
2334880|NCT03260205|4060641|FG000|Overall Study|Other: Unspecified|0
2334881|NCT03260205|4060642|FG001|Overall Study|Other: Unspecified|0
2334882|NCT03260205|4060643|FG002|Overall Study|Other: Unspecified|3
2334883|NCT03260205|4060644|FG003|Overall Study|Other: Unspecified|1
2334884|NCT03260205|4060645|FG004|Overall Study|Other: Unspecified|1
2334885|NCT03260205|4060641|FG000|Overall Study|Participant Who Did Not Received AnyDose|1
2334886|NCT03260205|4060642|FG001|Overall Study|Participant Who Did Not Received AnyDose|1
2334887|NCT03260205|4060643|FG002|Overall Study|Participant Who Did Not Received AnyDose|2
2334888|NCT03260205|4060644|FG003|Overall Study|Participant Who Did Not Received AnyDose|3
2334889|NCT03260205|4060645|FG004|Overall Study|Participant Who Did Not Received AnyDose|1
2352907|NCT03728140|4103191|FG000|Overall Study|Abnormal embryo transfer operation|10
2352908|NCT03728140|4103192|FG001|Overall Study|Abnormal embryo transfer operation|7
2352909|NCT03727347|4103211|FG000|Overall Study|Withdrawal by Subject|2
2352910|NCT03727347|4103211|FG000|Overall Study|Lost to Follow-up|1
2352911|NCT03726996|4103224|FG000|Overall Study|Parent's decision|2
2352912|NCT03726996|4103224|FG000|Overall Study|Study early termination|2
2236063|NCT01888874|3891213|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0
2236064|NCT01888874|3891214|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
2236065|NCT01888874|3891215|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2
2236066|NCT01888874|3891216|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1
2236067|NCT01888874|3891217|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1
2236068|NCT01888874|3891218|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3
2236069|NCT01888874|3891212|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
2236070|NCT01888874|3891213|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
2236071|NCT01888874|3891214|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
2236072|NCT01888874|3891215|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
2236073|NCT01888874|3891216|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
2236074|NCT01888874|3891217|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
2236075|NCT01888874|3891218|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
2236076|NCT01888900|3891237|FG000|Overall Study|failed treatment|0
2236077|NCT01888900|3891238|FG001|Overall Study|failed treatment|2
2236078|NCT01888965|3891250|FG000|Overall Study|Adverse Event|5
2236079|NCT01888965|3891250|FG000|Overall Study|Lack of Efficacy|4
2236080|NCT01889069|3891256|FG000|Overall Study|Death|18
2236081|NCT01889069|3891256|FG000|Overall Study|Progression of Disease|14
2236082|NCT01889069|3891256|FG000|Overall Study|Lost to Follow-up|6
2236083|NCT01889069|3891256|FG000|Overall Study|Other|4
2236084|NCT01889069|3891256|FG000|Overall Study|Consent Withdrawal|3
2236085|NCT01889238|3891266|FG000|Overall Study|Treatment ongoing|9
2236086|NCT01889251|3891272|FG000|Overall Study|Adverse Event|1
2236087|NCT01889251|3891273|FG001|Overall Study|Adverse Event|0
2236088|NCT01889602|3891295|FG000|First Intervention|Adverse Event|1
2236089|NCT01889602|3891296|FG001|First Intervention|Adverse Event|1
2236090|NCT01889602|3891297|FG002|First Intervention|Adverse Event|1
2236091|NCT01889602|3891295|FG000|First Intervention|Protocol Violation|0
2236092|NCT01889602|3891296|FG001|First Intervention|Protocol Violation|1
2236093|NCT01889602|3891297|FG002|First Intervention|Protocol Violation|1
2236094|NCT01889602|3891295|FG000|First Intervention|Study ending|0
2236095|NCT01889602|3891296|FG001|First Intervention|Study ending|1
2236096|NCT01889602|3891297|FG002|First Intervention|Study ending|0
2236097|NCT01889602|3891295|FG000|Second Intervention|Adverse Event|0
2236098|NCT01889602|3891296|FG001|Second Intervention|Adverse Event|0
2236099|NCT01889602|3891297|FG002|Second Intervention|Adverse Event|1
2236100|NCT01889602|3891295|FG000|Second Intervention|Study ending|1
2236101|NCT01889602|3891296|FG001|Second Intervention|Study ending|0
2236102|NCT01889602|3891297|FG002|Second Intervention|Study ending|0
2236103|NCT01889602|3891295|FG000|Second Intervention|Withdrawal by Subject|0
2236104|NCT01889602|3891296|FG001|Second Intervention|Withdrawal by Subject|0
2236105|NCT01889602|3891297|FG002|Second Intervention|Withdrawal by Subject|1
2236106|NCT01889602|3891295|FG000|Third Intervention|Protocol Violation|1
2236107|NCT01889602|3891296|FG001|Third Intervention|Protocol Violation|0
2236108|NCT01889602|3891297|FG002|Third Intervention|Protocol Violation|0
2236109|NCT01889602|3891295|FG000|Third Intervention|Withdrawal by Subject|2
2236110|NCT01889602|3891296|FG001|Third Intervention|Withdrawal by Subject|2
2236111|NCT01889602|3891297|FG002|Third Intervention|Withdrawal by Subject|0
2236112|NCT01889862|3891337|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4
2236113|NCT01889862|3891338|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0
2236114|NCT01889862|3891339|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0
2236115|NCT01889862|3891340|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0
2236116|NCT01889862|3891341|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0
2236117|NCT01889862|3891337|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2
2236118|NCT01889862|3891338|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
2236119|NCT01889862|3891339|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
2236120|NCT01889862|3891340|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
2236121|NCT01889862|3891341|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
2236122|NCT01889862|3891337|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4
2236123|NCT01889862|3891338|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
2236124|NCT01889862|3891339|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
2236125|NCT01889862|3891340|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
2236126|NCT01889862|3891341|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
2236127|NCT01889862|3891337|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2
2236128|NCT01889862|3891338|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0
2236129|NCT01889862|3891339|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0
2236130|NCT01889862|3891340|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0
2236131|NCT01889862|3891341|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0
2236132|NCT01889862|3891337|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0
2236133|NCT01889862|3891338|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0
2236134|NCT01889862|3891339|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1
2236135|NCT01889862|3891340|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0
2236136|NCT01889862|3891341|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0
2236137|NCT01889862|3891337|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0
2236138|NCT01889862|3891338|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0
2236139|NCT01889862|3891339|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0
2236140|NCT01889862|3891340|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0
2236141|NCT01889862|3891341|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5
2236142|NCT01889862|3891337|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
2236143|NCT01889862|3891338|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
2236144|NCT01889862|3891339|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
2236145|NCT01889862|3891340|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
2236146|NCT01889862|3891341|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14
2236147|NCT01889862|3891337|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
2236148|NCT01889862|3891338|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
2236149|NCT01889862|3891339|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
2236150|NCT01889862|3891340|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
2236151|NCT01889862|3891341|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4
2236152|NCT01889862|3891337|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0
2236153|NCT01889862|3891338|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0
2236154|NCT01889862|3891339|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0
2236155|NCT01889862|3891340|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0
2236156|NCT01889862|3891341|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5
2236157|NCT01889862|3891337|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0
2236158|NCT01889862|3891338|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0
2236159|NCT01889862|3891339|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0
2236160|NCT01889862|3891340|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0
2236161|NCT01889862|3891341|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2
2236162|NCT01890109|3891389|FG000|Overall Study|Withdrawal by Subject|0
2236163|NCT01890109|3891390|FG001|Overall Study|Withdrawal by Subject|3
2236164|NCT01890109|3891389|FG000|Overall Study|Lost to Follow-up|1
2236165|NCT01890109|3891390|FG001|Overall Study|Lost to Follow-up|2
2236166|NCT01890122|3891401|FG000|Overall Study|Adverse Event|1
2236167|NCT01890122|3891402|FG001|Overall Study|Adverse Event|1
2236168|NCT01890122|3891403|FG002|Overall Study|Adverse Event|1
2236169|NCT01890122|3891404|FG003|Overall Study|Adverse Event|2
2236170|NCT01890122|3891401|FG000|Overall Study|Major Protocol Deviation|3
2236171|NCT01890122|3891402|FG001|Overall Study|Major Protocol Deviation|1
2236172|NCT01890122|3891403|FG002|Overall Study|Major Protocol Deviation|0
2236173|NCT01890122|3891404|FG003|Overall Study|Major Protocol Deviation|1
2236174|NCT01890122|3891401|FG000|Overall Study|Lost to Follow-up|0
2236175|NCT01890122|3891402|FG001|Overall Study|Lost to Follow-up|1
2236176|NCT01890122|3891403|FG002|Overall Study|Lost to Follow-up|2
2236177|NCT01890122|3891404|FG003|Overall Study|Lost to Follow-up|2
2236178|NCT01890122|3891401|FG000|Overall Study|Voluntary Withdrawal|8
2236179|NCT01890122|3891402|FG001|Overall Study|Voluntary Withdrawal|8
2236180|NCT01890122|3891403|FG002|Overall Study|Voluntary Withdrawal|2
2236181|NCT01890122|3891404|FG003|Overall Study|Voluntary Withdrawal|11
2236182|NCT01890122|3891401|FG000|Overall Study|Lack of Efficacy|14
2236183|NCT01890122|3891402|FG001|Overall Study|Lack of Efficacy|24
2236184|NCT01890122|3891403|FG002|Overall Study|Lack of Efficacy|7
2236185|NCT01890122|3891404|FG003|Overall Study|Lack of Efficacy|41
2236186|NCT01890122|3891401|FG000|Overall Study|Reason not Specified|0
2236187|NCT01890122|3891402|FG001|Overall Study|Reason not Specified|1
2236188|NCT01890122|3891403|FG002|Overall Study|Reason not Specified|1
2236189|NCT01890122|3891404|FG003|Overall Study|Reason not Specified|2
2334890|NCT03260868|4060704|FG000|Overall Study|Poor Compliance to Protocol|0
2334891|NCT03260868|4060705|FG001|Overall Study|Poor Compliance to Protocol|2
2334892|NCT03260868|4060704|FG000|Overall Study|Study Terminated By Sponsor|2
2334893|NCT03260868|4060705|FG001|Overall Study|Study Terminated By Sponsor|1
2334894|NCT03260868|4060704|FG000|Overall Study|Other than specified above|1
2334895|NCT03260868|4060705|FG001|Overall Study|Other than specified above|0
2334902|NCT03261037|4060724|FG000|Overall Study|Withdrawal by Subject|2
2334903|NCT03261037|4060725|FG001|Overall Study|Withdrawal by Subject|13
2334904|NCT03261037|4060726|FG002|Overall Study|Withdrawal by Subject|0
2334905|NCT03261037|4060727|FG003|Overall Study|Withdrawal by Subject|18
2334906|NCT03261037|4060724|FG000|Overall Study|Non-compliance with study procedures|0
2334907|NCT03261037|4060725|FG001|Overall Study|Non-compliance with study procedures|2
2334908|NCT03261037|4060726|FG002|Overall Study|Non-compliance with study procedures|0
2334909|NCT03261037|4060727|FG003|Overall Study|Non-compliance with study procedures|6
2334910|NCT03261037|4060724|FG000|Overall Study|Participant moving away and can no longer be in study|0
2334911|NCT03261037|4060725|FG001|Overall Study|Participant moving away and can no longer be in study|1
2334912|NCT03261037|4060726|FG002|Overall Study|Participant moving away and can no longer be in study|0
2334913|NCT03261037|4060727|FG003|Overall Study|Participant moving away and can no longer be in study|0
2334914|NCT03261037|4060724|FG000|Overall Study|Participant came out of study due to investigator discretion|0
2036868|NCT00413660|3607041|FG002|Post Week 12|Lost to Follow-up|1
2036869|NCT00413660|3607042|FG003|Post Week 12|Lost to Follow-up|0
2036870|NCT00413660|3607043|FG004|Post Week 12|Lost to Follow-up|0
2036871|NCT00413660|3607044|FG005|Post Week 12|Lost to Follow-up|0
2036872|NCT00413660|3607045|FG006|Post Week 12|Lost to Follow-up|0
2036873|NCT00413660|3607046|FG007|Post Week 12|Lost to Follow-up|0
2036874|NCT00413660|3607047|FG008|Post Week 12|Lost to Follow-up|0
2036875|NCT00413660|3607048|FG009|Post Week 12|Lost to Follow-up|0
2236190|NCT01890122|3891401|FG000|Overall Study|Randomized but not Treated|1
2236191|NCT01890122|3891402|FG001|Overall Study|Randomized but not Treated|1
2236192|NCT01890122|3891403|FG002|Overall Study|Randomized but not Treated|0
2236193|NCT01890122|3891404|FG003|Overall Study|Randomized but not Treated|0
2236194|NCT01890148|3891414|FG000|Overall Study|Adverse Event|1
2236195|NCT01890265|3891433|FG000|Overall Study|Other (Unspecified reason)|0
2236196|NCT01890265|3891434|FG001|Overall Study|Other (Unspecified reason)|1
2236197|NCT01890265|3891435|FG002|Overall Study|Other (Unspecified reason)|0
2236198|NCT01890265|3891436|FG003|Overall Study|Other (Unspecified reason)|0
2236199|NCT01890265|3891437|FG004|Overall Study|Other (Unspecified reason)|0
2236200|NCT01890265|3891438|FG005|Overall Study|Other (Unspecified reason)|0
2236201|NCT01890265|3891433|FG000|Overall Study|Progressive disease|6
2236202|NCT01890265|3891434|FG001|Overall Study|Progressive disease|6
2236203|NCT01890265|3891435|FG002|Overall Study|Progressive disease|0
2236204|NCT01890265|3891436|FG003|Overall Study|Progressive disease|0
2236205|NCT01890265|3891437|FG004|Overall Study|Progressive disease|0
2236206|NCT01890265|3891438|FG005|Overall Study|Progressive disease|0
2236207|NCT01890265|3891433|FG000|Overall Study|Adverse Event|2
2236208|NCT01890265|3891434|FG001|Overall Study|Adverse Event|1
2236209|NCT01890265|3891435|FG002|Overall Study|Adverse Event|0
2236210|NCT01890265|3891436|FG003|Overall Study|Adverse Event|0
2236211|NCT01890265|3891437|FG004|Overall Study|Adverse Event|0
2236212|NCT01890265|3891438|FG005|Overall Study|Adverse Event|0
2236213|NCT01890265|3891433|FG000|Overall Study|Death|2
2236214|NCT01890265|3891434|FG001|Overall Study|Death|3
2236215|NCT01890265|3891435|FG002|Overall Study|Death|1
2236216|NCT01890265|3891436|FG003|Overall Study|Death|0
2236217|NCT01890265|3891437|FG004|Overall Study|Death|0
2236218|NCT01890265|3891438|FG005|Overall Study|Death|0
2236219|NCT01890265|3891433|FG000|Overall Study|Withdrawal by Subject|0
2236220|NCT01890265|3891434|FG001|Overall Study|Withdrawal by Subject|2
2236221|NCT01890265|3891435|FG002|Overall Study|Withdrawal by Subject|3
2236222|NCT01890265|3891436|FG003|Overall Study|Withdrawal by Subject|0
2236223|NCT01890265|3891437|FG004|Overall Study|Withdrawal by Subject|2
2236224|NCT01890265|3891438|FG005|Overall Study|Withdrawal by Subject|0
2236225|NCT01890421|3891461|FG000|Overall Study|Adverse Event|1
2236226|NCT01890421|3891461|FG000|Overall Study|Other reason|10
2236227|NCT01890434|3891465|FG000|Overall Study|Adverse Event|8
2236228|NCT01890434|3891465|FG000|Overall Study|PCI at external hospital|1
2236229|NCT01890434|3891465|FG000|Overall Study|Assessment discrepancy|1
2236230|NCT01890434|3891465|FG000|Overall Study|CRC didn't contact participant for FU|1
2236231|NCT01890434|3891465|FG000|Overall Study|Could not get whole set of images|1
2236232|NCT01890434|3891465|FG000|Overall Study|Decline to return for GSPECT|1
2236233|NCT01890434|3891465|FG000|Overall Study|GSPECT at rest was not done|1
2236234|NCT01890434|3891465|FG000|Overall Study|Participant didn't complete MRI|1
2236235|NCT01890434|3891465|FG000|Overall Study|Uncontactable by phone|1
2236236|NCT01890434|3891465|FG000|Overall Study|Moved out of position|1
2236237|NCT01890434|3891465|FG000|Overall Study|Unable to contact|1
2236238|NCT01890434|3891465|FG000|Overall Study|Withdrawal by PI for ICA not performed|2
2236239|NCT01890473|3891471|FG000|Overall Study|Lost to Follow-up|1
2236240|NCT01890473|3891472|FG001|Overall Study|Lost to Follow-up|0
2236241|NCT01890473|3891471|FG000|Overall Study|Poor/non-compliance|1
2236242|NCT01890473|3891472|FG001|Overall Study|Poor/non-compliance|0
2236243|NCT01890512|3891480|FG000|Overall Study|Physician Decision|1
2236244|NCT01890512|3891480|FG000|Overall Study|Withdrawal by Subject|1
2236245|NCT01890512|3891480|FG000|Overall Study|Protocol Violation|1
2236246|NCT01890707|3891499|FG000|Overall Study|Lost to Follow-up|1
2236247|NCT01890707|3891500|FG001|Overall Study|Lost to Follow-up|1
2236248|NCT01890746|3891508|FG000|Overall Study|Death|39
2236249|NCT01890746|3891509|FG001|Overall Study|Death|30
2236250|NCT01890746|3891508|FG000|Overall Study|Adverse Event|1
2236251|NCT01890746|3891509|FG001|Overall Study|Adverse Event|0
2236252|NCT01890746|3891508|FG000|Overall Study|Lost to Follow-up|4
2236253|NCT01890746|3891509|FG001|Overall Study|Lost to Follow-up|1
2236254|NCT01890746|3891508|FG000|Overall Study|Physician Decision|3
2236255|NCT01890746|3891509|FG001|Overall Study|Physician Decision|2
2236256|NCT01890746|3891508|FG000|Overall Study|Withdrawal by Subject|5
2236257|NCT01890746|3891509|FG001|Overall Study|Withdrawal by Subject|8
2236258|NCT01890759|3891517|FG000|Overall Study|Protocol Violation|0
2236259|NCT01890759|3891518|FG001|Overall Study|Protocol Violation|2
2334915|NCT03261037|4060725|FG001|Overall Study|Participant came out of study due to investigator discretion|2
2334916|NCT03261037|4060726|FG002|Overall Study|Participant came out of study due to investigator discretion|0
2334917|NCT03261037|4060727|FG003|Overall Study|Participant came out of study due to investigator discretion|0
2334918|NCT03261037|4060724|FG000|Overall Study|Diagnosed but protocol deviation|1
2236260|NCT01890759|3891517|FG000|Overall Study|Lost to Follow-up|0
2236261|NCT01890759|3891518|FG001|Overall Study|Lost to Follow-up|2
2236262|NCT01890759|3891517|FG000|Overall Study|Withdrawal by Subject|2
2236263|NCT01890759|3891518|FG001|Overall Study|Withdrawal by Subject|8
2236264|NCT01890785|3891530|FG000|Third Intervention|Withdrawal by Subject|0
2236265|NCT01890785|3891531|FG001|Third Intervention|Withdrawal by Subject|1
2236266|NCT01890785|3891532|FG002|Third Intervention|Withdrawal by Subject|0
2236267|NCT01890785|3891533|FG003|Third Intervention|Withdrawal by Subject|0
2236268|NCT01890785|3891534|FG004|Third Intervention|Withdrawal by Subject|0
2236269|NCT01890785|3891535|FG005|Third Intervention|Withdrawal by Subject|0
2236270|NCT01890915|3891546|FG000|Overall Study|Adverse Event|1
2236271|NCT01890915|3891547|FG001|Overall Study|Adverse Event|0
2236272|NCT01890915|3891546|FG000|Overall Study|Protocol Violation|2
2236273|NCT01890915|3891547|FG001|Overall Study|Protocol Violation|0
2236274|NCT01890915|3891546|FG000|Overall Study|Equipment Malfunction|0
2236275|NCT01890915|3891547|FG001|Overall Study|Equipment Malfunction|1
2236276|NCT01890967|3891568|FG000|Overall Study|Adverse Event|3
2236277|NCT01890967|3891569|FG001|Overall Study|Adverse Event|3
2236278|NCT01890967|3891570|FG002|Overall Study|Adverse Event|3
2236279|NCT01890967|3891571|FG003|Overall Study|Adverse Event|2
2236280|NCT01890967|3891572|FG004|Overall Study|Adverse Event|1
2236281|NCT01890967|3891573|FG005|Overall Study|Adverse Event|7
2236282|NCT01890967|3891568|FG000|Overall Study|Death|1
2236283|NCT01890967|3891569|FG001|Overall Study|Death|0
2236284|NCT01890967|3891570|FG002|Overall Study|Death|0
2236285|NCT01890967|3891571|FG003|Overall Study|Death|0
2236286|NCT01890967|3891572|FG004|Overall Study|Death|0
2236287|NCT01890967|3891573|FG005|Overall Study|Death|0
2236288|NCT01890967|3891568|FG000|Overall Study|Lost to Follow-up|1
2236289|NCT01890967|3891569|FG001|Overall Study|Lost to Follow-up|1
2236290|NCT01890967|3891570|FG002|Overall Study|Lost to Follow-up|1
2236291|NCT01890967|3891571|FG003|Overall Study|Lost to Follow-up|1
2236292|NCT01890967|3891572|FG004|Overall Study|Lost to Follow-up|0
2236293|NCT01890967|3891573|FG005|Overall Study|Lost to Follow-up|1
2236294|NCT01890967|3891568|FG000|Overall Study|Protocol Violation|0
2236295|NCT01890967|3891569|FG001|Overall Study|Protocol Violation|3
2236296|NCT01890967|3891570|FG002|Overall Study|Protocol Violation|3
2236297|NCT01890967|3891571|FG003|Overall Study|Protocol Violation|2
2236298|NCT01890967|3891572|FG004|Overall Study|Protocol Violation|4
2236299|NCT01890967|3891573|FG005|Overall Study|Protocol Violation|1
2236300|NCT01890967|3891568|FG000|Overall Study|Sponsor Decision|2
2236301|NCT01890967|3891569|FG001|Overall Study|Sponsor Decision|0
2236302|NCT01890967|3891570|FG002|Overall Study|Sponsor Decision|1
2236303|NCT01890967|3891571|FG003|Overall Study|Sponsor Decision|3
2352913|NCT03725852|4103239|FG000|Overall Study|Death|1
2236304|NCT01890967|3891572|FG004|Overall Study|Sponsor Decision|2
2236305|NCT01890967|3891573|FG005|Overall Study|Sponsor Decision|3
2236306|NCT01890967|3891568|FG000|Overall Study|Withdrawal by Subject|3
2236307|NCT01890967|3891569|FG001|Overall Study|Withdrawal by Subject|4
2236308|NCT01890967|3891570|FG002|Overall Study|Withdrawal by Subject|2
2352914|NCT03725852|4103240|FG001|Overall Study|Death|0
2352915|NCT03725852|4103239|FG000|Overall Study|Withdrawal by Subject|1
2352916|NCT03725852|4103240|FG001|Overall Study|Withdrawal by Subject|0
2352917|NCT03725852|4103239|FG000|Overall Study|Travel restrictions due to COVID-19|2
2352918|NCT03725852|4103240|FG001|Overall Study|Travel restrictions due to COVID-19|0
2352919|NCT03725722|4103251|FG000|Overall Study|Lack of Efficacy|2
2352920|NCT03725722|4103252|FG001|Overall Study|Lack of Efficacy|1
2352921|NCT03725722|4103253|FG002|Overall Study|Lack of Efficacy|2
2352922|NCT03725722|4103254|FG003|Overall Study|Lack of Efficacy|0
2352923|NCT03725722|4103255|FG004|Overall Study|Lack of Efficacy|2
2236309|NCT01890967|3891571|FG003|Overall Study|Withdrawal by Subject|3
2236310|NCT01890967|3891572|FG004|Overall Study|Withdrawal by Subject|3
2236311|NCT01890967|3891573|FG005|Overall Study|Withdrawal by Subject|1
2236312|NCT01891357|3891626|FG000|Overall Study|Protocol Violation|3
2236313|NCT01891669|3891640|FG000|Overall Study|Death|0
2236314|NCT01891669|3891641|FG001|Overall Study|Death|0
2236315|NCT01891669|3891642|FG002|Overall Study|Death|0
2236316|NCT01891669|3891643|FG003|Overall Study|Death|0
2236317|NCT01891669|3891644|FG004|Overall Study|Death|0
2236318|NCT01891669|3891645|FG005|Overall Study|Death|0
2236319|NCT01891669|3891646|FG006|Overall Study|Death|0
2236320|NCT01891669|3891647|FG007|Overall Study|Death|1
2236321|NCT01891669|3891648|FG008|Overall Study|Death|0
2236322|NCT01891669|3891649|FG009|Overall Study|Death|1
2236323|NCT01891669|3891640|FG000|Overall Study|Withdrawal by Subject|1
2236324|NCT01891669|3891641|FG001|Overall Study|Withdrawal by Subject|1
2236325|NCT01891669|3891642|FG002|Overall Study|Withdrawal by Subject|0
2236326|NCT01891669|3891643|FG003|Overall Study|Withdrawal by Subject|0
2236327|NCT01891669|3891644|FG004|Overall Study|Withdrawal by Subject|0
2236328|NCT01891669|3891645|FG005|Overall Study|Withdrawal by Subject|0
2236329|NCT01891669|3891646|FG006|Overall Study|Withdrawal by Subject|1
2236330|NCT01891669|3891647|FG007|Overall Study|Withdrawal by Subject|2
2236331|NCT01891669|3891648|FG008|Overall Study|Withdrawal by Subject|1
2236332|NCT01891669|3891649|FG009|Overall Study|Withdrawal by Subject|1
2236333|NCT01891669|3891640|FG000|Overall Study|Other|1
2236334|NCT01891669|3891641|FG001|Overall Study|Other|0
2236335|NCT01891669|3891642|FG002|Overall Study|Other|0
2236336|NCT01891669|3891643|FG003|Overall Study|Other|0
2236337|NCT01891669|3891644|FG004|Overall Study|Other|0
2236338|NCT01891669|3891645|FG005|Overall Study|Other|0
2236339|NCT01891669|3891646|FG006|Overall Study|Other|0
2236340|NCT01891669|3891647|FG007|Overall Study|Other|1
2236341|NCT01891669|3891648|FG008|Overall Study|Other|0
2236342|NCT01891669|3891649|FG009|Overall Study|Other|0
2236343|NCT01891721|3891683|FG000|Overall Study|Lost to Follow-up|10
2236344|NCT01891721|3891684|FG001|Overall Study|Lost to Follow-up|5
2236345|NCT01891721|3891685|FG002|Overall Study|Lost to Follow-up|1
2236346|NCT01891864|3891706|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1
2236347|NCT01891864|3891707|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1
2236348|NCT01891864|3891708|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2236349|NCT01891864|3891709|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2236350|NCT01891864|3891710|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2236351|NCT01891864|3891711|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2236352|NCT01891864|3891706|FG000|Treatment Period 1|Physician Decision|0
2236353|NCT01891864|3891707|FG001|Treatment Period 1|Physician Decision|1
2236354|NCT01891864|3891708|FG002|Treatment Period 1|Physician Decision|0
2236355|NCT01891864|3891709|FG003|Treatment Period 1|Physician Decision|0
2236356|NCT01891864|3891710|FG004|Treatment Period 1|Physician Decision|0
2236357|NCT01891864|3891711|FG005|Treatment Period 1|Physician Decision|0
2236358|NCT01891864|3891706|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0
2236359|NCT01891864|3891707|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1
2236360|NCT01891864|3891708|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0
2236361|NCT01891864|3891709|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0
2236362|NCT01891864|3891710|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0
2236363|NCT01891864|3891711|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0
2236364|NCT01891864|3891706|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4
2236365|NCT01891864|3891707|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4
2236366|NCT01891864|3891708|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2236367|NCT01891864|3891709|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2236368|NCT01891864|3891710|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2236369|NCT01891864|3891711|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2236370|NCT01891864|3891706|FG000|Treatment Period 1|Withdrawal by Subject|2
2236371|NCT01891864|3891707|FG001|Treatment Period 1|Withdrawal by Subject|5
2236372|NCT01891864|3891708|FG002|Treatment Period 1|Withdrawal by Subject|0
2236373|NCT01891864|3891709|FG003|Treatment Period 1|Withdrawal by Subject|0
2236374|NCT01891864|3891710|FG004|Treatment Period 1|Withdrawal by Subject|0
2236375|NCT01891864|3891711|FG005|Treatment Period 1|Withdrawal by Subject|0
2236376|NCT01891864|3891706|FG000|Treatment Period 1|Lost to Follow-up|1
2236377|NCT01891864|3891707|FG001|Treatment Period 1|Lost to Follow-up|0
2236378|NCT01891864|3891708|FG002|Treatment Period 1|Lost to Follow-up|0
2236379|NCT01891864|3891709|FG003|Treatment Period 1|Lost to Follow-up|0
2236380|NCT01891864|3891710|FG004|Treatment Period 1|Lost to Follow-up|0
2236381|NCT01891864|3891711|FG005|Treatment Period 1|Lost to Follow-up|0
2236382|NCT01891864|3891706|FG000|Treatment Period 2|Protocol Violation|0
2236383|NCT01891864|3891707|FG001|Treatment Period 2|Protocol Violation|0
2236384|NCT01891864|3891708|FG002|Treatment Period 2|Protocol Violation|0
2236385|NCT01891864|3891709|FG003|Treatment Period 2|Protocol Violation|1
2236386|NCT01891864|3891710|FG004|Treatment Period 2|Protocol Violation|0
2236387|NCT01891864|3891711|FG005|Treatment Period 2|Protocol Violation|0
2236388|NCT01891864|3891706|FG000|Treatment Period 2|Physician Decision|0
2236389|NCT01891864|3891707|FG001|Treatment Period 2|Physician Decision|0
2236390|NCT01891864|3891708|FG002|Treatment Period 2|Physician Decision|1
2236391|NCT01891864|3891709|FG003|Treatment Period 2|Physician Decision|0
2236392|NCT01891864|3891710|FG004|Treatment Period 2|Physician Decision|0
2236393|NCT01891864|3891711|FG005|Treatment Period 2|Physician Decision|0
2236394|NCT01891864|3891706|FG000|Treatment Period 2|Site Termination|0
2236395|NCT01891864|3891707|FG001|Treatment Period 2|Site Termination|0
2236396|NCT01891864|3891708|FG002|Treatment Period 2|Site Termination|1
2236397|NCT01891864|3891709|FG003|Treatment Period 2|Site Termination|2
2236398|NCT01891864|3891710|FG004|Treatment Period 2|Site Termination|0
2236399|NCT01891864|3891711|FG005|Treatment Period 2|Site Termination|0
2236400|NCT01891864|3891706|FG000|Treatment Period 2|Lack of Efficacy|0
2236401|NCT01891864|3891707|FG001|Treatment Period 2|Lack of Efficacy|0
2236402|NCT01891864|3891708|FG002|Treatment Period 2|Lack of Efficacy|1
2236403|NCT01891864|3891709|FG003|Treatment Period 2|Lack of Efficacy|0
2236404|NCT01891864|3891710|FG004|Treatment Period 2|Lack of Efficacy|1
2236405|NCT01891864|3891711|FG005|Treatment Period 2|Lack of Efficacy|0
2236406|NCT01891864|3891706|FG000|Treatment Period 2|Adverse Event|0
2236407|NCT01891864|3891707|FG001|Treatment Period 2|Adverse Event|0
2236408|NCT01891864|3891708|FG002|Treatment Period 2|Adverse Event|1
2236409|NCT01891864|3891709|FG003|Treatment Period 2|Adverse Event|2
2236410|NCT01891864|3891710|FG004|Treatment Period 2|Adverse Event|0
2236411|NCT01891864|3891711|FG005|Treatment Period 2|Adverse Event|4
2236412|NCT01891864|3891706|FG000|Treatment Period 2|Termination of Site|0
2236413|NCT01891864|3891707|FG001|Treatment Period 2|Termination of Site|0
2236414|NCT01891864|3891708|FG002|Treatment Period 2|Termination of Site|0
2236415|NCT01891864|3891709|FG003|Treatment Period 2|Termination of Site|0
2236416|NCT01891864|3891710|FG004|Treatment Period 2|Termination of Site|2
2236417|NCT01891864|3891711|FG005|Treatment Period 2|Termination of Site|0
2236418|NCT01891864|3891706|FG000|Treatment Period 2|Withdrawal by Subject|0
2236419|NCT01891864|3891707|FG001|Treatment Period 2|Withdrawal by Subject|0
2334919|NCT03261037|4060725|FG001|Overall Study|Diagnosed but protocol deviation|0
2334920|NCT03261037|4060726|FG002|Overall Study|Diagnosed but protocol deviation|0
2334921|NCT03261037|4060727|FG003|Overall Study|Diagnosed but protocol deviation|0
2334922|NCT03261037|4060724|FG000|Overall Study|Participant did not want to continue the study|0
2334923|NCT03261037|4060725|FG001|Overall Study|Participant did not want to continue the study|1
2334924|NCT03261037|4060726|FG002|Overall Study|Participant did not want to continue the study|0
2334925|NCT03261037|4060727|FG003|Overall Study|Participant did not want to continue the study|0
2334926|NCT03261037|4060724|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0
2334927|NCT03261037|4060725|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0
2334928|NCT03261037|4060726|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0
2334929|NCT03261037|4060727|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1
2334930|NCT03261037|4060724|FG000|Overall Study|Participant presented clinical improvement|0
2334931|NCT03261037|4060725|FG001|Overall Study|Participant presented clinical improvement|2
2334932|NCT03261037|4060726|FG002|Overall Study|Participant presented clinical improvement|0
2334933|NCT03261037|4060727|FG003|Overall Study|Participant presented clinical improvement|0
2334934|NCT03261037|4060724|FG000|Overall Study|Technical difficulties|0
2334935|NCT03261037|4060725|FG001|Overall Study|Technical difficulties|0
2334936|NCT03261037|4060726|FG002|Overall Study|Technical difficulties|0
2334937|NCT03261037|4060727|FG003|Overall Study|Technical difficulties|1
2334938|NCT03261037|4060724|FG000|Overall Study|Equipment failed to work|0
2334939|NCT03261037|4060725|FG001|Overall Study|Equipment failed to work|0
2334940|NCT03261037|4060726|FG002|Overall Study|Equipment failed to work|0
2334941|NCT03261037|4060727|FG003|Overall Study|Equipment failed to work|1
2334942|NCT03261037|4060724|FG000|Overall Study|End of study for participant and no follow up|0
2334943|NCT03261037|4060725|FG001|Overall Study|End of study for participant and no follow up|0
2334944|NCT03261037|4060726|FG002|Overall Study|End of study for participant and no follow up|0
2334945|NCT03261037|4060727|FG003|Overall Study|End of study for participant and no follow up|1
2334946|NCT03261037|4060724|FG000|Overall Study|Participant was too weak to continue in study|1
2334947|NCT03261037|4060725|FG001|Overall Study|Participant was too weak to continue in study|0
2334948|NCT03261037|4060726|FG002|Overall Study|Participant was too weak to continue in study|0
2334949|NCT03261037|4060727|FG003|Overall Study|Participant was too weak to continue in study|0
2334950|NCT03261167|4060740|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
2334951|NCT03261167|4060741|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
2334952|NCT03261167|4060740|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
2334953|NCT03261167|4060741|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
2334954|NCT03261167|4060740|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
2334955|NCT03261167|4060741|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
2334956|NCT03261167|4060740|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
2334957|NCT03261167|4060741|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
2334958|NCT03261167|4060740|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
2236420|NCT01891864|3891708|FG002|Treatment Period 2|Withdrawal by Subject|3
2236421|NCT01891864|3891709|FG003|Treatment Period 2|Withdrawal by Subject|4
2236422|NCT01891864|3891710|FG004|Treatment Period 2|Withdrawal by Subject|1
2236423|NCT01891864|3891711|FG005|Treatment Period 2|Withdrawal by Subject|1
2236424|NCT01891864|3891706|FG000|Extension Period|Lack of Efficacy|0
2236425|NCT01891864|3891707|FG001|Extension Period|Lack of Efficacy|0
2236426|NCT01891864|3891708|FG002|Extension Period|Lack of Efficacy|0
2236427|NCT01891864|3891709|FG003|Extension Period|Lack of Efficacy|1
2236428|NCT01891864|3891710|FG004|Extension Period|Lack of Efficacy|1
2236429|NCT01891864|3891711|FG005|Extension Period|Lack of Efficacy|0
2236430|NCT01891864|3891706|FG000|Extension Period|Pregnancy|0
2236431|NCT01891864|3891707|FG001|Extension Period|Pregnancy|0
2236432|NCT01891864|3891708|FG002|Extension Period|Pregnancy|1
2236433|NCT01891864|3891709|FG003|Extension Period|Pregnancy|0
2236434|NCT01891864|3891710|FG004|Extension Period|Pregnancy|0
2236435|NCT01891864|3891711|FG005|Extension Period|Pregnancy|0
2236436|NCT01891864|3891706|FG000|Extension Period|Adverse Event|0
2236437|NCT01891864|3891707|FG001|Extension Period|Adverse Event|0
2236438|NCT01891864|3891708|FG002|Extension Period|Adverse Event|4
2236439|NCT01891864|3891709|FG003|Extension Period|Adverse Event|2
2236440|NCT01891864|3891710|FG004|Extension Period|Adverse Event|2
2236441|NCT01891864|3891711|FG005|Extension Period|Adverse Event|0
2236442|NCT01891864|3891706|FG000|Extension Period|Withdrawal by Subject|0
2236443|NCT01891864|3891707|FG001|Extension Period|Withdrawal by Subject|0
2236444|NCT01891864|3891708|FG002|Extension Period|Withdrawal by Subject|1
2236445|NCT01891864|3891709|FG003|Extension Period|Withdrawal by Subject|2
2236446|NCT01891864|3891710|FG004|Extension Period|Withdrawal by Subject|4
2236447|NCT01891864|3891711|FG005|Extension Period|Withdrawal by Subject|0
2236448|NCT01891864|3891706|FG000|Extension Period|Lost to Follow-up|0
2236449|NCT01891864|3891707|FG001|Extension Period|Lost to Follow-up|0
2236450|NCT01891864|3891708|FG002|Extension Period|Lost to Follow-up|2
2236451|NCT01891864|3891709|FG003|Extension Period|Lost to Follow-up|0
2236452|NCT01891864|3891710|FG004|Extension Period|Lost to Follow-up|0
2236453|NCT01891864|3891711|FG005|Extension Period|Lost to Follow-up|0
2236454|NCT01891890|3891726|FG000|Overall Study|Lost to Follow-up|0
2236455|NCT01891890|3891727|FG001|Overall Study|Lost to Follow-up|0
2236456|NCT01891890|3891728|FG002|Overall Study|Lost to Follow-up|1
2236457|NCT01891890|3891726|FG000|Overall Study|Study ended before endpoint reached|7
2236458|NCT01891890|3891727|FG001|Overall Study|Study ended before endpoint reached|3
2236459|NCT01891890|3891728|FG002|Overall Study|Study ended before endpoint reached|6
2236460|NCT01892020|3891753|FG000|Period 1|Adverse Event|1
2236461|NCT01892020|3891754|FG001|Period 1|Adverse Event|1
2236462|NCT01892020|3891753|FG000|Period 1|Protocol Violation|2
2236463|NCT01892020|3891754|FG001|Period 1|Protocol Violation|4
2236464|NCT01892020|3891753|FG000|Period 1|Unclassified|0
2236465|NCT01892020|3891754|FG001|Period 1|Unclassified|1
2236466|NCT01892020|3891753|FG000|Period 2|Protocol Violation|1
2236467|NCT01892020|3891754|FG001|Period 2|Protocol Violation|0
2236468|NCT01892163|3891762|FG000|Overall Study|Death|1
2236469|NCT01892163|3891763|FG001|Overall Study|Death|1
2236470|NCT01892163|3891762|FG000|Overall Study|Lost to Follow-up|1
2236471|NCT01892163|3891763|FG001|Overall Study|Lost to Follow-up|0
2236472|NCT01892189|3891778|FG000|Washout Period 1 (7 Days)|Adverse Event|0
2236473|NCT01892189|3891779|FG001|Washout Period 1 (7 Days)|Adverse Event|0
2236474|NCT01892189|3891780|FG002|Washout Period 1 (7 Days)|Adverse Event|0
2236475|NCT01892189|3891781|FG003|Washout Period 1 (7 Days)|Adverse Event|0
2236476|NCT01892189|3891782|FG004|Washout Period 1 (7 Days)|Adverse Event|0
2236477|NCT01892189|3891783|FG005|Washout Period 1 (7 Days)|Adverse Event|0
2236478|NCT01892189|3891784|FG006|Washout Period 1 (7 Days)|Adverse Event|0
2236479|NCT01892189|3891785|FG007|Washout Period 1 (7 Days)|Adverse Event|0
2236480|NCT01892189|3891786|FG008|Washout Period 1 (7 Days)|Adverse Event|1
2236481|NCT01892189|3891778|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2236482|NCT01892189|3891779|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2236483|NCT01892189|3891780|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2
2236484|NCT01892189|3891781|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2236485|NCT01892189|3891782|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2236486|NCT01892189|3891783|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2236487|NCT01892189|3891784|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2236488|NCT01892189|3891785|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2236489|NCT01892189|3891786|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2236490|NCT01892189|3891778|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2236491|NCT01892189|3891779|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2236492|NCT01892189|3891780|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2334959|NCT03261167|4060741|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
2334960|NCT03261336|4060753|FG000|Overall Study|Adverse Event|1
2334961|NCT03261947|4060762|FG000|Overall Study|Death|10
2334962|NCT03261947|4060763|FG001|Overall Study|Death|13
2334963|NCT03261947|4060764|FG002|Overall Study|Death|17
2334964|NCT03261947|4060765|FG003|Overall Study|Death|12
2334965|NCT03261947|4060766|FG004|Overall Study|Death|8
2334966|NCT03261947|4060762|FG000|Overall Study|Lost to Follow-up|0
2334967|NCT03261947|4060763|FG001|Overall Study|Lost to Follow-up|0
2334968|NCT03261947|4060764|FG002|Overall Study|Lost to Follow-up|2
2334969|NCT03261947|4060765|FG003|Overall Study|Lost to Follow-up|1
2236493|NCT01892189|3891781|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2334970|NCT03261947|4060766|FG004|Overall Study|Lost to Follow-up|0
2236494|NCT01892189|3891782|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2236495|NCT01892189|3891783|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
2236496|NCT01892189|3891784|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2236497|NCT01892189|3891785|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2236498|NCT01892189|3891786|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2236499|NCT01892293|3891810|FG000|Overall Study|Apheresed but not treated|4
2236500|NCT01892345|3891825|FG000|Overall Study|Adverse Event|0
2236501|NCT01892345|3891826|FG001|Overall Study|Adverse Event|2
2236502|NCT01892345|3891825|FG000|Overall Study|Death|1
2236503|NCT01892345|3891826|FG001|Overall Study|Death|0
2236504|NCT01892345|3891825|FG000|Overall Study|Lost to Follow-up|3
2236505|NCT01892345|3891826|FG001|Overall Study|Lost to Follow-up|0
2236506|NCT01892345|3891825|FG000|Overall Study|Withdrawal by Subject|12
2236507|NCT01892345|3891826|FG001|Overall Study|Withdrawal by Subject|1
2236508|NCT01892436|3891836|FG000|Overall Study|Withdrawal by Subject|8
2236509|NCT01892436|3891837|FG001|Overall Study|Withdrawal by Subject|15
2236510|NCT01892436|3891838|FG002|Overall Study|Withdrawal by Subject|4
2236511|NCT01892436|3891839|FG003|Overall Study|Withdrawal by Subject|4
2236512|NCT01892436|3891836|FG000|Overall Study|Death|1
2236513|NCT01892436|3891837|FG001|Overall Study|Death|1
2236514|NCT01892436|3891838|FG002|Overall Study|Death|0
2236515|NCT01892436|3891839|FG003|Overall Study|Death|0
2236516|NCT01892436|3891836|FG000|Overall Study|Physician Decision|2
2236517|NCT01892436|3891837|FG001|Overall Study|Physician Decision|1
2236518|NCT01892436|3891838|FG002|Overall Study|Physician Decision|0
2236519|NCT01892436|3891839|FG003|Overall Study|Physician Decision|1
2236520|NCT01892436|3891836|FG000|Overall Study|Pregnancy|0
2236521|NCT01892436|3891837|FG001|Overall Study|Pregnancy|2
2236522|NCT01892436|3891838|FG002|Overall Study|Pregnancy|1
2236523|NCT01892436|3891839|FG003|Overall Study|Pregnancy|0
2236524|NCT01892436|3891836|FG000|Overall Study|Technical problems|2
2236525|NCT01892436|3891837|FG001|Overall Study|Technical problems|1
2236526|NCT01892436|3891838|FG002|Overall Study|Technical problems|1
2236527|NCT01892436|3891839|FG003|Overall Study|Technical problems|1
2236528|NCT01892436|3891836|FG000|Overall Study|Lack of Efficacy|1
2236529|NCT01892436|3891837|FG001|Overall Study|Lack of Efficacy|2
2236530|NCT01892436|3891838|FG002|Overall Study|Lack of Efficacy|2
2236531|NCT01892436|3891839|FG003|Overall Study|Lack of Efficacy|2
2236532|NCT01892436|3891836|FG000|Overall Study|Lost to Follow-up|1
2236533|NCT01892436|3891837|FG001|Overall Study|Lost to Follow-up|1
2236534|NCT01892436|3891838|FG002|Overall Study|Lost to Follow-up|1
2236535|NCT01892436|3891839|FG003|Overall Study|Lost to Follow-up|3
2236536|NCT01892436|3891836|FG000|Overall Study|non-compliance with treatment|1
2236537|NCT01892436|3891837|FG001|Overall Study|non-compliance with treatment|0
2236538|NCT01892436|3891838|FG002|Overall Study|non-compliance with treatment|0
2236539|NCT01892436|3891839|FG003|Overall Study|non-compliance with treatment|0
2236540|NCT01892436|3891836|FG000|Overall Study|Adverse Event|7
2236541|NCT01892436|3891837|FG001|Overall Study|Adverse Event|6
2236542|NCT01892436|3891838|FG002|Overall Study|Adverse Event|2
2236543|NCT01892436|3891839|FG003|Overall Study|Adverse Event|3
2236544|NCT01892501|3891849|FG000|Overall Study|Protocol Violation|2
2236545|NCT01892501|3891849|FG000|Overall Study|Puncture not carried out|9
2236546|NCT01892501|3891849|FG000|Overall Study|Radiological monitoring not carried out|5
2236547|NCT01892501|3891849|FG000|Overall Study|Non-contributory histological result|12
2236548|NCT01892540|3891856|FG000|Overall Study|Did not complete PET/MRI|0
2236549|NCT01892540|3891857|FG001|Overall Study|Did not complete PET/MRI|0
2236550|NCT01892540|3891858|FG002|Overall Study|Did not complete PET/MRI|2
2236551|NCT01892540|3891856|FG000|Overall Study|Did not fit in scanner|0
2236552|NCT01892540|3891857|FG001|Overall Study|Did not fit in scanner|0
2236553|NCT01892540|3891858|FG002|Overall Study|Did not fit in scanner|1
2236554|NCT01892657|3891866|FG000|Overall Study|Withdrawal by Subject|6
2236555|NCT01892657|3891866|FG000|Overall Study|Protocol Violation|12
2236556|NCT01893203|3891899|FG000|Overall Study|Withdrawal by Subject|1
2236557|NCT01893281|3891903|FG000|Overall Study|Adverse Event|1
2236558|NCT01893281|3891903|FG000|Overall Study|Protocol Violation|1
2236559|NCT01893281|3891903|FG000|Overall Study|Withdrawal by Subject|1
2236560|NCT01893346|3891911|FG000|Overall Study|Lost to Follow-up|0
2236561|NCT01893346|3891912|FG001|Overall Study|Lost to Follow-up|1
2236562|NCT01893346|3891913|FG002|Overall Study|Lost to Follow-up|0
2236563|NCT01893346|3891914|FG003|Overall Study|Lost to Follow-up|0
2236564|NCT01893346|3891911|FG000|Overall Study|Protocol Violation|1
2236565|NCT01893346|3891912|FG001|Overall Study|Protocol Violation|0
2236566|NCT01893346|3891913|FG002|Overall Study|Protocol Violation|0
2236567|NCT01893346|3891914|FG003|Overall Study|Protocol Violation|0
2236568|NCT01893346|3891911|FG000|Overall Study|Withdrawal by Subject|2
2236569|NCT01893346|3891912|FG001|Overall Study|Withdrawal by Subject|0
2236570|NCT01893346|3891913|FG002|Overall Study|Withdrawal by Subject|0
2236571|NCT01893346|3891914|FG003|Overall Study|Withdrawal by Subject|0
2236572|NCT01893411|3891936|FG000|Overall Study|Protocol Violation|1
2236573|NCT01893411|3891937|FG001|Overall Study|Protocol Violation|0
2236574|NCT01893411|3891938|FG002|Overall Study|Protocol Violation|0
2236575|NCT01893411|3891936|FG000|Overall Study|Physician Decision|1
2236576|NCT01893411|3891937|FG001|Overall Study|Physician Decision|1
2236577|NCT01893411|3891938|FG002|Overall Study|Physician Decision|2
2236578|NCT01893411|3891936|FG000|Overall Study|Lack of Efficacy|2
2236579|NCT01893411|3891937|FG001|Overall Study|Lack of Efficacy|1
2236580|NCT01893411|3891938|FG002|Overall Study|Lack of Efficacy|0
2236581|NCT01893411|3891936|FG000|Overall Study|Other|3
2236582|NCT01893411|3891937|FG001|Overall Study|Other|1
2236583|NCT01893411|3891938|FG002|Overall Study|Other|3
2236584|NCT01893411|3891936|FG000|Overall Study|Adverse Event|1
2236585|NCT01893411|3891937|FG001|Overall Study|Adverse Event|0
2236586|NCT01893411|3891938|FG002|Overall Study|Adverse Event|0
2236587|NCT01893411|3891936|FG000|Overall Study|Withdrawal by Subject|7
2236588|NCT01893411|3891937|FG001|Overall Study|Withdrawal by Subject|4
2236589|NCT01893411|3891938|FG002|Overall Study|Withdrawal by Subject|3
2236590|NCT01893411|3891936|FG000|Overall Study|Lost to Follow-up|2
2236591|NCT01893411|3891937|FG001|Overall Study|Lost to Follow-up|0
2236592|NCT01893411|3891938|FG002|Overall Study|Lost to Follow-up|1
2236593|NCT01893827|3891967|FG000|Overall Study|Lost to Follow-up|19
2236594|NCT01893827|3891968|FG001|Overall Study|Lost to Follow-up|26
2236595|NCT01893905|3891985|FG000|Overall Study|Withdrawal by Subject|1
2236596|NCT01893905|3891986|FG001|Overall Study|Withdrawal by Subject|0
2236597|NCT01893905|3891985|FG000|Overall Study|Adverse Event|9
2236598|NCT01893905|3891986|FG001|Overall Study|Adverse Event|3
2236599|NCT01893905|3891985|FG000|Overall Study|Lack of Efficacy|5
2236600|NCT01893905|3891986|FG001|Overall Study|Lack of Efficacy|7
2236601|NCT01893905|3891985|FG000|Overall Study|Lost to Follow-up|1
2236602|NCT01893905|3891986|FG001|Overall Study|Lost to Follow-up|0
2236603|NCT01893905|3891985|FG000|Overall Study|Protocol Violation|6
2236604|NCT01893905|3891986|FG001|Overall Study|Protocol Violation|1
2236605|NCT01893905|3891985|FG000|Overall Study|Lack of adherence to treatment|2
2236606|NCT01893905|3891986|FG001|Overall Study|Lack of adherence to treatment|0
2236607|NCT01893905|3891985|FG000|Overall Study|Other reason|1
2236608|NCT01893905|3891986|FG001|Overall Study|Other reason|3
2236609|NCT01894022|3892003|FG000|Overall Study|Death|1
2236610|NCT01894022|3892004|FG001|Overall Study|Death|0
2236611|NCT01894022|3892003|FG000|Overall Study|Adverse Event, non-fatal|1
2236612|NCT01894022|3892004|FG001|Overall Study|Adverse Event, non-fatal|0
2236613|NCT01894022|3892003|FG000|Overall Study|Study Closed/terminated|7
2236614|NCT01894022|3892004|FG001|Overall Study|Study Closed/terminated|10
2334971|NCT03261947|4060762|FG000|Overall Study|Withdrawal by Subject|0
2334972|NCT03261947|4060763|FG001|Overall Study|Withdrawal by Subject|0
2334973|NCT03261947|4060764|FG002|Overall Study|Withdrawal by Subject|3
2334974|NCT03261947|4060765|FG003|Overall Study|Withdrawal by Subject|0
2334975|NCT03261947|4060766|FG004|Overall Study|Withdrawal by Subject|1
2334976|NCT03261947|4060762|FG000|Overall Study|Site Terminated by Sponsor|0
2334977|NCT03261947|4060763|FG001|Overall Study|Site Terminated by Sponsor|0
2334978|NCT03261947|4060764|FG002|Overall Study|Site Terminated by Sponsor|4
2334979|NCT03261947|4060765|FG003|Overall Study|Site Terminated by Sponsor|7
2334980|NCT03261947|4060766|FG004|Overall Study|Site Terminated by Sponsor|5
2334981|NCT03261947|4060762|FG000|Overall Study|Reason not Specified|2
2334982|NCT03261947|4060763|FG001|Overall Study|Reason not Specified|0
2334983|NCT03261947|4060764|FG002|Overall Study|Reason not Specified|4
2334984|NCT03261947|4060765|FG003|Overall Study|Reason not Specified|1
2334985|NCT03261947|4060766|FG004|Overall Study|Reason not Specified|3
2334986|NCT03262012|4060803|FG000|Overall Study|Withdrawal by Subject|15
2334987|NCT03262012|4060804|FG001|Overall Study|Withdrawal by Subject|13
2334988|NCT03262012|4060805|FG002|Overall Study|Withdrawal by Subject|8
2334989|NCT03262012|4060806|FG003|Overall Study|Withdrawal by Subject|7
2334990|NCT03262012|4060803|FG000|Overall Study|Adverse Event|10
2334991|NCT03262012|4060804|FG001|Overall Study|Adverse Event|12
2334992|NCT03262012|4060805|FG002|Overall Study|Adverse Event|4
2334993|NCT03262012|4060806|FG003|Overall Study|Adverse Event|6
2334994|NCT03262012|4060803|FG000|Overall Study|Physician Decision|2
2334995|NCT03262012|4060804|FG001|Overall Study|Physician Decision|5
2334996|NCT03262012|4060805|FG002|Overall Study|Physician Decision|1
2334997|NCT03262012|4060806|FG003|Overall Study|Physician Decision|0
2334998|NCT03262012|4060803|FG000|Overall Study|Lack of Efficacy|0
2334999|NCT03262012|4060804|FG001|Overall Study|Lack of Efficacy|5
2335000|NCT03262012|4060805|FG002|Overall Study|Lack of Efficacy|1
2335001|NCT03262012|4060806|FG003|Overall Study|Lack of Efficacy|2
2335002|NCT03262012|4060803|FG000|Overall Study|Protocol Discontinuation Criteria|0
2335003|NCT03262012|4060804|FG001|Overall Study|Protocol Discontinuation Criteria|1
2335004|NCT03262012|4060805|FG002|Overall Study|Protocol Discontinuation Criteria|0
2335005|NCT03262012|4060806|FG003|Overall Study|Protocol Discontinuation Criteria|0
2335006|NCT03262038|4060818|FG000|Overall Study|Withdrawal by Subject|0
2335007|NCT03262038|4060819|FG001|Overall Study|Withdrawal by Subject|1
2335008|NCT03262233|4060829|FG000|Overall Study|Withdrawal by Subject|12
2335009|NCT03262233|4060830|FG001|Overall Study|Withdrawal by Subject|8
2335010|NCT03262233|4060831|FG002|Overall Study|Withdrawal by Subject|21
2335011|NCT03262233|4060832|FG003|Overall Study|Withdrawal by Subject|13
2335012|NCT03262233|4060829|FG000|Overall Study|Declined due to shock|1
2335013|NCT03262233|4060830|FG001|Overall Study|Declined due to shock|2
2335014|NCT03262233|4060831|FG002|Overall Study|Declined due to shock|2
2335015|NCT03262233|4060832|FG003|Overall Study|Declined due to shock|3
2335016|NCT03262233|4060829|FG000|Overall Study|Protocol Violation|5
2335017|NCT03262233|4060830|FG001|Overall Study|Protocol Violation|10
2335018|NCT03262233|4060831|FG002|Overall Study|Protocol Violation|2
2236615|NCT01894100|3892022|FG000|Overall Study|Lost to Follow-up|0
2236616|NCT01894100|3892023|FG001|Overall Study|Lost to Follow-up|1
2236617|NCT01894100|3892022|FG000|Overall Study|Withdrawal by Subject|3
2236618|NCT01894100|3892023|FG001|Overall Study|Withdrawal by Subject|0
2236619|NCT01894152|3892029|FG000|Overall Study|No DMR and no Stent thrombosis|151
2236620|NCT01894230|3892044|FG000|Overall Study|Lost to Follow-up|2
2236621|NCT01894230|3892045|FG001|Overall Study|Lost to Follow-up|2
2236622|NCT01894230|3892044|FG000|Overall Study|Withdrawal by Subject|4
2236623|NCT01894230|3892045|FG001|Overall Study|Withdrawal by Subject|4
2236624|NCT01894230|3892044|FG000|Overall Study|Non-adherent|0
2236625|NCT01894230|3892045|FG001|Overall Study|Non-adherent|1
2236626|NCT01894230|3892044|FG000|Overall Study|Death|1
2236627|NCT01894230|3892045|FG001|Overall Study|Death|0
2236628|NCT01894243|3892054|FG000|Overall Study|Adverse Event|0
2236629|NCT01894243|3892055|FG001|Overall Study|Adverse Event|1
2236630|NCT01894243|3892056|FG002|Overall Study|Adverse Event|2
2236631|NCT01894243|3892054|FG000|Overall Study|Death|0
2236632|NCT01894243|3892055|FG001|Overall Study|Death|0
2236633|NCT01894243|3892056|FG002|Overall Study|Death|3
2335019|NCT03262233|4060832|FG003|Overall Study|Protocol Violation|13
2335020|NCT03262233|4060829|FG000|Overall Study|data collection artifact|0
2335021|NCT03262233|4060830|FG001|Overall Study|data collection artifact|1
2335022|NCT03262233|4060831|FG002|Overall Study|data collection artifact|0
2335023|NCT03262233|4060832|FG003|Overall Study|data collection artifact|0
2335024|NCT03262389|4060843|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1
2335025|NCT03262389|4060843|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1
2335026|NCT03262389|4060843|FG000|Overall Study|opted out of PET/MR|1
2335027|NCT03262441|4060847|FG000|Overall Study|Withdrawal by Subject|1
2335028|NCT03263442|4060853|FG000|Inpatient Phase|Death|1
2335029|NCT03263442|4060854|FG001|Inpatient Phase|Death|0
2335030|NCT03263442|4060853|FG000|Inpatient Phase|Withdrawal by Subject|1
2335031|NCT03263442|4060854|FG001|Inpatient Phase|Withdrawal by Subject|0
2335032|NCT03263442|4060853|FG000|Inpatient Phase|Inadequate Drug Exposure|0
2335033|NCT03263442|4060854|FG001|Inpatient Phase|Inadequate Drug Exposure|1
2335034|NCT03263442|4060853|FG000|1-month Follow-Up|Lost to Follow-up|1
2335035|NCT03263442|4060854|FG001|1-month Follow-Up|Lost to Follow-up|0
2335036|NCT03263442|4060853|FG000|3-month Follow-Up|Lost to Follow-up|1
2335037|NCT03263442|4060854|FG001|3-month Follow-Up|Lost to Follow-up|3
2335038|NCT03263442|4060853|FG000|6-month Follow-Up|Lost to Follow-up|2
2335039|NCT03263442|4060854|FG001|6-month Follow-Up|Lost to Follow-up|2
2335040|NCT03263702|4060864|FG000|Overall Study|Lost to Follow-up|2
2335041|NCT03263702|4060865|FG001|Overall Study|Lost to Follow-up|2
2335042|NCT03263702|4060864|FG000|Overall Study|Withdrawal by Subject|1
2335043|NCT03263702|4060865|FG001|Overall Study|Withdrawal by Subject|2
2335044|NCT03263780|4060871|FG000|Overall Study|Withdrawal by Subject|3
2335045|NCT03263780|4060871|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7
2335046|NCT03264066|4060881|FG000|Overall Study|Adverse Event|1
2335047|NCT03264066|4060882|FG001|Overall Study|Adverse Event|1
2335048|NCT03264066|4060883|FG002|Overall Study|Adverse Event|0
2335049|NCT03264066|4060884|FG003|Overall Study|Adverse Event|0
2335050|NCT03264066|4060885|FG004|Overall Study|Adverse Event|0
2335051|NCT03264066|4060886|FG005|Overall Study|Adverse Event|0
2335052|NCT03264066|4060881|FG000|Overall Study|Death|12
2335053|NCT03264066|4060882|FG001|Overall Study|Death|12
2335054|NCT03264066|4060883|FG002|Overall Study|Death|8
2335055|NCT03264066|4060884|FG003|Overall Study|Death|10
2335056|NCT03264066|4060885|FG004|Overall Study|Death|6
2335057|NCT03264066|4060886|FG005|Overall Study|Death|1
2335058|NCT03264066|4060881|FG000|Overall Study|Lost to Follow-up|1
2335059|NCT03264066|4060882|FG001|Overall Study|Lost to Follow-up|0
2335060|NCT03264066|4060883|FG002|Overall Study|Lost to Follow-up|0
2335061|NCT03264066|4060884|FG003|Overall Study|Lost to Follow-up|0
2335062|NCT03264066|4060885|FG004|Overall Study|Lost to Follow-up|0
2335063|NCT03264066|4060886|FG005|Overall Study|Lost to Follow-up|0
2335064|NCT03264066|4060881|FG000|Overall Study|Progressive Disease|0
2335065|NCT03264066|4060882|FG001|Overall Study|Progressive Disease|2
2335066|NCT03264066|4060883|FG002|Overall Study|Progressive Disease|1
2335067|NCT03264066|4060884|FG003|Overall Study|Progressive Disease|0
2335068|NCT03264066|4060885|FG004|Overall Study|Progressive Disease|0
2335069|NCT03264066|4060886|FG005|Overall Study|Progressive Disease|0
2335070|NCT03264066|4060881|FG000|Overall Study|Study Terminated by Sponsor|5
2335071|NCT03264066|4060882|FG001|Overall Study|Study Terminated by Sponsor|5
2335072|NCT03264066|4060883|FG002|Overall Study|Study Terminated by Sponsor|8
2335073|NCT03264066|4060884|FG003|Overall Study|Study Terminated by Sponsor|5
2335074|NCT03264066|4060885|FG004|Overall Study|Study Terminated by Sponsor|1
2335075|NCT03264066|4060886|FG005|Overall Study|Study Terminated by Sponsor|2
2335076|NCT03264066|4060881|FG000|Overall Study|Withdrawal by Subject|1
2335077|NCT03264066|4060882|FG001|Overall Study|Withdrawal by Subject|0
2335078|NCT03264066|4060883|FG002|Overall Study|Withdrawal by Subject|0
2236634|NCT01894243|3892054|FG000|Overall Study|Lack of Efficacy|3
2236635|NCT01894243|3892055|FG001|Overall Study|Lack of Efficacy|3
2236636|NCT01894243|3892056|FG002|Overall Study|Lack of Efficacy|1
2335079|NCT03264066|4060884|FG003|Overall Study|Withdrawal by Subject|5
2335080|NCT03264066|4060885|FG004|Overall Study|Withdrawal by Subject|0
2236637|NCT01894243|3892054|FG000|Overall Study|Condition under investigation worsened|8
2236638|NCT01894243|3892055|FG001|Overall Study|Condition under investigation worsened|6
2236639|NCT01894243|3892056|FG002|Overall Study|Condition under investigation worsened|2
2236640|NCT01894243|3892054|FG000|Overall Study|Subject decision|1
2236641|NCT01894243|3892055|FG001|Overall Study|Subject decision|0
2236642|NCT01894243|3892056|FG002|Overall Study|Subject decision|0
2236643|NCT01894243|3892054|FG000|Overall Study|Other|1
2236644|NCT01894243|3892055|FG001|Overall Study|Other|0
2236645|NCT01894243|3892056|FG002|Overall Study|Other|0
2236646|NCT01894256|3892074|FG000|Part A|Adverse Event|0
2236647|NCT01894256|3892075|FG001|Part A|Adverse Event|1
2236648|NCT01894256|3892076|FG002|Part A|Adverse Event|0
2236649|NCT01894256|3892074|FG000|Part B|Death|0
2236650|NCT01894256|3892075|FG001|Part B|Death|1
2236651|NCT01894256|3892076|FG002|Part B|Death|1
2236652|NCT01894256|3892074|FG000|Part B|Withdrawal by Subject|0
2236653|NCT01894256|3892075|FG001|Part B|Withdrawal by Subject|1
2236654|NCT01894256|3892076|FG002|Part B|Withdrawal by Subject|0
2236655|NCT01894256|3892074|FG000|Part B|Lack of Efficacy|15
2236656|NCT01894256|3892075|FG001|Part B|Lack of Efficacy|12
2236657|NCT01894256|3892076|FG002|Part B|Lack of Efficacy|13
2236658|NCT01894477|3892089|FG000|Overall Study|Protocol Violation|0
2236659|NCT01894477|3892090|FG001|Overall Study|Protocol Violation|1
2236660|NCT01894477|3892089|FG000|Overall Study|protocol changed due SC changed to cord|0
2236661|NCT01894477|3892090|FG001|Overall Study|protocol changed due SC changed to cord|1
2236662|NCT01894516|3892105|FG000|Period 1 (Baseline up to Week 12)|Other|0
2236663|NCT01894516|3892106|FG001|Period 1 (Baseline up to Week 12)|Other|1
2236664|NCT01894516|3892107|FG002|Period 1 (Baseline up to Week 12)|Other|1
2236665|NCT01894516|3892108|FG003|Period 1 (Baseline up to Week 12)|Other|0
2236666|NCT01894516|3892105|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2
2236667|NCT01894516|3892106|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
2236668|NCT01894516|3892107|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
2236669|NCT01894516|3892108|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
2236670|NCT01894516|3892105|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
2236671|NCT01894516|3892106|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
2236672|NCT01894516|3892107|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
2236673|NCT01894516|3892108|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
2236674|NCT01894516|3892105|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0
2236675|NCT01894516|3892106|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0
2236676|NCT01894516|3892107|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1
2236677|NCT01894516|3892108|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0
2236678|NCT01894516|3892105|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2
2236679|NCT01894516|3892106|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0
2236680|NCT01894516|3892107|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0
2236681|NCT01894516|3892108|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
2236682|NCT01894516|3892105|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
2236683|NCT01894516|3892106|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
2236684|NCT01894516|3892107|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1
2236685|NCT01894516|3892108|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
2236686|NCT01894516|3892105|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0
2236687|NCT01894516|3892106|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2
2236688|NCT01894516|3892107|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
2236689|NCT01894516|3892108|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1
2236690|NCT01894516|3892105|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
2236691|NCT01894516|3892106|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
2236692|NCT01894516|3892107|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
2236693|NCT01894516|3892108|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
2236694|NCT01894568|3892128|FG000|Overall Study|Adverse Event|2
2236695|NCT01894568|3892129|FG001|Overall Study|Adverse Event|3
2236696|NCT01894568|3892128|FG000|Overall Study|Protocol required discontinuation|2
2236697|NCT01894568|3892129|FG001|Overall Study|Protocol required discontinuation|1
2236698|NCT01894568|3892128|FG000|Overall Study|Withdrawal by Subject|5
2236699|NCT01894568|3892129|FG001|Overall Study|Withdrawal by Subject|5
2236700|NCT01894568|3892128|FG000|Overall Study|Physician Decision|1
2236701|NCT01894568|3892129|FG001|Overall Study|Physician Decision|0
2236702|NCT01894568|3892128|FG000|Overall Study|Lost to Follow-up|0
2236703|NCT01894568|3892129|FG001|Overall Study|Lost to Follow-up|1
2236704|NCT01894581|3892138|FG000|Overall Study|Withdrawal by Subject|2
2236705|NCT01894581|3892139|FG001|Overall Study|Withdrawal by Subject|3
2236706|NCT01894581|3892138|FG000|Overall Study|Screen Failure|3
2236707|NCT01894581|3892139|FG001|Overall Study|Screen Failure|4
2236708|NCT01894607|3892145|FG000|Overall Study|Ineligible|1
2236709|NCT01894620|3892151|FG000|Overall Study|Withdrawal by Subject|0
2236710|NCT01894620|3892152|FG001|Overall Study|Withdrawal by Subject|1
2236711|NCT01894776|3892165|FG000|Overall Study|Withdrawal by Subject|1
2236712|NCT01894841|3892171|FG000|Overall Study|Withdrawal by Subject|9
2236713|NCT01894841|3892172|FG001|Overall Study|Withdrawal by Subject|4
2236714|NCT01894841|3892171|FG000|Overall Study|Withdrawn by investigator|2
2236715|NCT01894841|3892172|FG001|Overall Study|Withdrawn by investigator|2
2236716|NCT01894841|3892171|FG000|Overall Study|Lost to Follow-up|7
2236717|NCT01894841|3892172|FG001|Overall Study|Lost to Follow-up|3
2236718|NCT01894919|3892216|FG000|Overall Study|Withdrawal by Subject|1
2236719|NCT01894919|3892217|FG001|Overall Study|Withdrawal by Subject|0
2236720|NCT01894919|3892218|FG002|Overall Study|Withdrawal by Subject|0
2335081|NCT03264066|4060886|FG005|Overall Study|Withdrawal by Subject|0
2335082|NCT03264456|4060935|FG000|Overall Study|Withdrawal by Subject|3
2335083|NCT03264456|4060935|FG000|Overall Study|Lost to Follow-up|1
2335084|NCT03265119|4060941|FG000|Overall Study|Adverse Event|2
2335085|NCT03265119|4060942|FG001|Overall Study|Adverse Event|1
2335086|NCT03265119|4060941|FG000|Overall Study|Lack of Efficacy|3
2335087|NCT03265119|4060942|FG001|Overall Study|Lack of Efficacy|0
2335088|NCT03265119|4060941|FG000|Overall Study|Protocol Violation|1
2335089|NCT03265119|4060942|FG001|Overall Study|Protocol Violation|2
2335090|NCT03265119|4060941|FG000|Overall Study|Withdrawal by Subject|2
2335091|NCT03265119|4060942|FG001|Overall Study|Withdrawal by Subject|4
2335092|NCT03265119|4060941|FG000|Overall Study|Lost to Follow-up|1
2335093|NCT03265119|4060942|FG001|Overall Study|Lost to Follow-up|0
2335094|NCT03265119|4060941|FG000|Overall Study|Lack of Compliance|1
2335095|NCT03265119|4060942|FG001|Overall Study|Lack of Compliance|0
2335096|NCT03265132|4060950|FG000|Overall Study|Adverse Event|0
2335097|NCT03265132|4060951|FG001|Overall Study|Adverse Event|1
2335098|NCT03265132|4060950|FG000|Overall Study|Lack of Efficacy|0
2335099|NCT03265132|4060951|FG001|Overall Study|Lack of Efficacy|2
2335100|NCT03265132|4060950|FG000|Overall Study|Progressive disease|0
2335101|NCT03265132|4060951|FG001|Overall Study|Progressive disease|2
2335102|NCT03265132|4060950|FG000|Overall Study|Withdrawal by Subject|0
2335103|NCT03265132|4060951|FG001|Overall Study|Withdrawal by Subject|1
2335104|NCT03265600|4060961|FG000|Overall Study|Lost to Follow-up|17
2335105|NCT03265600|4060962|FG001|Overall Study|Lost to Follow-up|5
2036876|NCT00413660|3607049|FG010|Post Week 12|Lost to Follow-up|0
2036877|NCT00413660|3607039|FG000|Post Week 12|Withdrawal by Subject|0
2036878|NCT00413660|3607040|FG001|Post Week 12|Withdrawal by Subject|1
2036879|NCT00413660|3607041|FG002|Post Week 12|Withdrawal by Subject|1
2036880|NCT00413660|3607042|FG003|Post Week 12|Withdrawal by Subject|0
2036881|NCT00413660|3607043|FG004|Post Week 12|Withdrawal by Subject|1
2036882|NCT00413660|3607044|FG005|Post Week 12|Withdrawal by Subject|0
2036883|NCT00413660|3607045|FG006|Post Week 12|Withdrawal by Subject|0
2036884|NCT00413660|3607046|FG007|Post Week 12|Withdrawal by Subject|0
2036885|NCT00413660|3607047|FG008|Post Week 12|Withdrawal by Subject|0
2036886|NCT00413660|3607048|FG009|Post Week 12|Withdrawal by Subject|0
2036887|NCT00413660|3607049|FG010|Post Week 12|Withdrawal by Subject|1
2036888|NCT00413660|3607039|FG000|Post Week 12|Other|1
2036889|NCT00413660|3607040|FG001|Post Week 12|Other|2
2036890|NCT00413660|3607041|FG002|Post Week 12|Other|3
2036891|NCT00413660|3607042|FG003|Post Week 12|Other|0
2036892|NCT00413660|3607043|FG004|Post Week 12|Other|1
2036893|NCT00413660|3607044|FG005|Post Week 12|Other|1
2036894|NCT00413660|3607045|FG006|Post Week 12|Other|1
2036895|NCT00413660|3607046|FG007|Post Week 12|Other|0
2036896|NCT00413660|3607047|FG008|Post Week 12|Other|0
2036897|NCT00413660|3607048|FG009|Post Week 12|Other|0
2036898|NCT00413660|3607049|FG010|Post Week 12|Other|0
2036899|NCT00413777|3607081|FG000|Fixed-dose Period|Lost to Follow-up|1
2036900|NCT00413777|3607082|FG001|Fixed-dose Period|Lost to Follow-up|1
2036901|NCT00413777|3607081|FG000|Fixed-dose Period|Adverse Event|2
2036902|NCT00413777|3607082|FG001|Fixed-dose Period|Adverse Event|1
2036903|NCT00413777|3607081|FG000|Fixed-dose Period|Met Withdrawal Criteria|1
2036904|NCT00413777|3607082|FG001|Fixed-dose Period|Met Withdrawal Criteria|0
2036905|NCT00413777|3607081|FG000|Fixed-dose Period|Withdrew Consent|0
2036906|NCT00413777|3607082|FG001|Fixed-dose Period|Withdrew Consent|1
2036907|NCT00413894|3607088|FG000|Overall Study|Withdrawal by Subject|10
2036908|NCT00413894|3607088|FG000|Overall Study|Administrative Reasons|1
2036909|NCT00413894|3607088|FG000|Overall Study|Hb <10 grams/deciliter|12
2036910|NCT00413894|3607088|FG000|Overall Study|Adverse Event|28
2036911|NCT00413894|3607088|FG000|Overall Study|Protocol Violation|11
2036912|NCT00413894|3607088|FG000|Overall Study|Other|18
2036913|NCT00413920|3607097|FG000|Overall Study|Adverse Event|9
2036914|NCT00413920|3607098|FG001|Overall Study|Adverse Event|11
2036915|NCT00413920|3607097|FG000|Overall Study|Lack of Efficacy|11
2036916|NCT00413920|3607098|FG001|Overall Study|Lack of Efficacy|9
2036917|NCT00413920|3607097|FG000|Overall Study|Death|3
2036918|NCT00413920|3607098|FG001|Overall Study|Death|5
2036919|NCT00413920|3607097|FG000|Overall Study|Graft Loss|5
2036920|NCT00413920|3607098|FG001|Overall Study|Graft Loss|3
2036921|NCT00413959|3607104|FG000|Overall Study|Pt had only one cycle.|1
2335106|NCT03265600|4060961|FG000|Overall Study|Withdrawal by Subject|4
2335107|NCT03265600|4060962|FG001|Overall Study|Withdrawal by Subject|2
2036922|NCT00414011|3607108|FG000|Overall Study|Physician Decision|3
2036923|NCT00414011|3607108|FG000|Overall Study|Withdrawal by Subject|2
2036924|NCT00414050|3607117|FG000|Overall Study|Adverse Event|1
2036925|NCT00414050|3607118|FG001|Overall Study|Adverse Event|1
2036926|NCT00414050|3607119|FG002|Overall Study|Adverse Event|1
2036927|NCT00414050|3607120|FG003|Overall Study|Adverse Event|1
2036928|NCT00414050|3607117|FG000|Overall Study|Lost to Follow-up|2
2036929|NCT00414050|3607118|FG001|Overall Study|Lost to Follow-up|2
2036930|NCT00414050|3607119|FG002|Overall Study|Lost to Follow-up|1
2236721|NCT01894919|3892219|FG003|Overall Study|Withdrawal by Subject|0
2236722|NCT01894919|3892220|FG004|Overall Study|Withdrawal by Subject|1
2236723|NCT01894919|3892221|FG005|Overall Study|Withdrawal by Subject|0
2236724|NCT01894919|3892222|FG006|Overall Study|Withdrawal by Subject|0
2236725|NCT01894919|3892223|FG007|Overall Study|Withdrawal by Subject|0
2236726|NCT01894919|3892224|FG008|Overall Study|Withdrawal by Subject|0
2236727|NCT01894919|3892225|FG009|Overall Study|Withdrawal by Subject|1
2236728|NCT01894919|3892226|FG010|Overall Study|Withdrawal by Subject|1
2236729|NCT01894919|3892227|FG011|Overall Study|Withdrawal by Subject|0
2236730|NCT01894919|3892228|FG012|Overall Study|Withdrawal by Subject|0
2236731|NCT01894919|3892216|FG000|Overall Study|Adverse Event|0
2236732|NCT01894919|3892217|FG001|Overall Study|Adverse Event|0
2236733|NCT01894919|3892218|FG002|Overall Study|Adverse Event|0
2236734|NCT01894919|3892219|FG003|Overall Study|Adverse Event|0
2236735|NCT01894919|3892220|FG004|Overall Study|Adverse Event|0
2236736|NCT01894919|3892221|FG005|Overall Study|Adverse Event|0
2236737|NCT01894919|3892222|FG006|Overall Study|Adverse Event|0
2236738|NCT01894919|3892223|FG007|Overall Study|Adverse Event|0
2236739|NCT01894919|3892224|FG008|Overall Study|Adverse Event|0
2236740|NCT01894919|3892225|FG009|Overall Study|Adverse Event|0
2236741|NCT01894919|3892226|FG010|Overall Study|Adverse Event|1
2236742|NCT01894919|3892227|FG011|Overall Study|Adverse Event|0
2236743|NCT01894919|3892228|FG012|Overall Study|Adverse Event|0
2236744|NCT01894919|3892216|FG000|Overall Study|Other-Unspecified|1
2236745|NCT01894919|3892217|FG001|Overall Study|Other-Unspecified|0
2236746|NCT01894919|3892218|FG002|Overall Study|Other-Unspecified|0
2236747|NCT01894919|3892219|FG003|Overall Study|Other-Unspecified|0
2236748|NCT01894919|3892220|FG004|Overall Study|Other-Unspecified|0
2236749|NCT01894919|3892221|FG005|Overall Study|Other-Unspecified|0
2236750|NCT01894919|3892222|FG006|Overall Study|Other-Unspecified|0
2236751|NCT01894919|3892223|FG007|Overall Study|Other-Unspecified|0
2236752|NCT01894919|3892224|FG008|Overall Study|Other-Unspecified|0
2236753|NCT01894919|3892225|FG009|Overall Study|Other-Unspecified|0
2236754|NCT01894919|3892226|FG010|Overall Study|Other-Unspecified|0
2236755|NCT01894919|3892227|FG011|Overall Study|Other-Unspecified|0
2236756|NCT01894919|3892228|FG012|Overall Study|Other-Unspecified|0
2236757|NCT01894919|3892216|FG000|Overall Study|Lost to Follow-up|0
2236758|NCT01894919|3892217|FG001|Overall Study|Lost to Follow-up|0
2236759|NCT01894919|3892218|FG002|Overall Study|Lost to Follow-up|0
2236760|NCT01894919|3892219|FG003|Overall Study|Lost to Follow-up|0
2236761|NCT01894919|3892220|FG004|Overall Study|Lost to Follow-up|2
2236762|NCT01894919|3892221|FG005|Overall Study|Lost to Follow-up|0
2236763|NCT01894919|3892222|FG006|Overall Study|Lost to Follow-up|0
2236764|NCT01894919|3892223|FG007|Overall Study|Lost to Follow-up|0
2236765|NCT01894919|3892224|FG008|Overall Study|Lost to Follow-up|0
2236766|NCT01894919|3892225|FG009|Overall Study|Lost to Follow-up|0
2236767|NCT01894919|3892226|FG010|Overall Study|Lost to Follow-up|0
2236768|NCT01894919|3892227|FG011|Overall Study|Lost to Follow-up|0
2236769|NCT01894919|3892228|FG012|Overall Study|Lost to Follow-up|0
2236770|NCT01894984|3892272|FG000|Overall Study|Other|314
2236771|NCT01894984|3892273|FG001|Overall Study|Other|175
2236772|NCT01895101|3892299|FG000|Overall Study|OPCAB procedure|1
2236773|NCT01895101|3892300|FG001|Overall Study|OPCAB procedure|1
2236774|NCT01895101|3892301|FG002|Overall Study|OPCAB procedure|3
2236775|NCT01895101|3892299|FG000|Overall Study|Withdrawal by Subject|0
2236776|NCT01895101|3892300|FG001|Overall Study|Withdrawal by Subject|1
2236777|NCT01895101|3892301|FG002|Overall Study|Withdrawal by Subject|2
2236778|NCT01895101|3892299|FG000|Overall Study|another study, enrolled in other study|0
2236779|NCT01895101|3892300|FG001|Overall Study|another study, enrolled in other study|1
2236780|NCT01895101|3892301|FG002|Overall Study|another study, enrolled in other study|0
2236781|NCT01895101|3892299|FG000|Overall Study|Death|0
2236782|NCT01895101|3892300|FG001|Overall Study|Death|1
2236783|NCT01895101|3892301|FG002|Overall Study|Death|0
2236784|NCT01895101|3892299|FG000|Overall Study|coagulation disorder|0
2236785|NCT01895101|3892300|FG001|Overall Study|coagulation disorder|1
2236786|NCT01895101|3892301|FG002|Overall Study|coagulation disorder|0
2236787|NCT01895270|3892321|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0
2236788|NCT01895270|3892322|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2
2236789|NCT01895270|3892321|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
2236790|NCT01895270|3892322|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
2236791|NCT01895270|3892321|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3
2236792|NCT01895270|3892322|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1
2236793|NCT01895270|3892321|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0
2236794|NCT01895270|3892322|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1
2236795|NCT01895270|3892321|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
2236796|NCT01895270|3892322|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
2236797|NCT01895270|3892321|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0
2236798|NCT01895270|3892322|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1
2236799|NCT01895270|3892321|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0
2236800|NCT01895270|3892322|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1
2236801|NCT01895309|3892330|FG000|Overall Study|Adverse Event|13
2236802|NCT01895309|3892331|FG001|Overall Study|Adverse Event|17
2236803|NCT01895309|3892330|FG000|Overall Study|Protocol Violation|1
2236804|NCT01895309|3892331|FG001|Overall Study|Protocol Violation|0
2236805|NCT01895309|3892330|FG000|Overall Study|Lack of Efficacy|1
2236806|NCT01895309|3892331|FG001|Overall Study|Lack of Efficacy|3
2236807|NCT01895309|3892330|FG000|Overall Study|Lost to Follow-up|1
2236808|NCT01895309|3892331|FG001|Overall Study|Lost to Follow-up|3
2236809|NCT01895309|3892330|FG000|Overall Study|Physician Decision|15
2236810|NCT01895309|3892331|FG001|Overall Study|Physician Decision|10
2236811|NCT01895309|3892330|FG000|Overall Study|Withdrawal by Subject|9
2236812|NCT01895309|3892331|FG001|Overall Study|Withdrawal by Subject|18
2236813|NCT01895322|3892341|FG000|Overall Study|Adverse Event|1
2236814|NCT01895322|3892341|FG000|Overall Study|Withdrawal by Subject|2
2236815|NCT01895322|3892341|FG000|Overall Study|Protocol Violation|10
2236816|NCT01895335|3892346|FG000|Overall Study|Adverse Event|106
2236817|NCT01895335|3892346|FG000|Overall Study|Lack of Efficacy|53
2236818|NCT01895335|3892346|FG000|Overall Study|Poor Compliance to Protocol|11
2236819|NCT01895335|3892346|FG000|Overall Study|Included But Not treated|1
2236820|NCT01895335|3892346|FG000|Overall Study|Other than Specified Above|44
2236821|NCT01895361|3892353|FG000|Overall Study|Adverse Event|1
2236822|NCT01895361|3892354|FG001|Overall Study|Adverse Event|1
2236823|NCT01895361|3892355|FG002|Overall Study|Adverse Event|3
2236824|NCT01895361|3892353|FG000|Overall Study|Death|2
2236825|NCT01895361|3892354|FG001|Overall Study|Death|1
2236826|NCT01895361|3892355|FG002|Overall Study|Death|2
2236827|NCT01895361|3892353|FG000|Overall Study|Lost to Follow-up|4
2236828|NCT01895361|3892354|FG001|Overall Study|Lost to Follow-up|4
2236829|NCT01895361|3892355|FG002|Overall Study|Lost to Follow-up|6
2236830|NCT01895361|3892353|FG000|Overall Study|Non-compliance with study|1
2236831|NCT01895361|3892354|FG001|Overall Study|Non-compliance with study|3
2236832|NCT01895361|3892355|FG002|Overall Study|Non-compliance with study|1
2236833|NCT01895361|3892353|FG000|Overall Study|Physician Decision|2
2236834|NCT01895361|3892354|FG001|Overall Study|Physician Decision|2
2236835|NCT01895361|3892355|FG002|Overall Study|Physician Decision|2
2236836|NCT01895361|3892353|FG000|Overall Study|Withdrawal by Subject|7
2236837|NCT01895361|3892354|FG001|Overall Study|Withdrawal by Subject|6
2236838|NCT01895361|3892355|FG002|Overall Study|Withdrawal by Subject|6
2236839|NCT01895361|3892353|FG000|Overall Study|Lack of Efficacy|0
2236840|NCT01895361|3892354|FG001|Overall Study|Lack of Efficacy|1
2236841|NCT01895361|3892355|FG002|Overall Study|Lack of Efficacy|0
2236842|NCT01895361|3892353|FG000|Overall Study|Reasons different from categories above|7
2236843|NCT01895361|3892354|FG001|Overall Study|Reasons different from categories above|3
2236844|NCT01895361|3892355|FG002|Overall Study|Reasons different from categories above|4
2236845|NCT01895452|3892365|FG000|Overall Study|Adverse Event|1
2236846|NCT01895452|3892366|FG001|Overall Study|Adverse Event|4
2236847|NCT01895452|3892365|FG000|Overall Study|Lost to Follow-up|1
2236848|NCT01895452|3892366|FG001|Overall Study|Lost to Follow-up|5
2236849|NCT01895452|3892365|FG000|Overall Study|Pregnancy|0
2236850|NCT01895452|3892366|FG001|Overall Study|Pregnancy|1
2236851|NCT01895452|3892365|FG000|Overall Study|Withdrawal by Subject|2
2236852|NCT01895452|3892366|FG001|Overall Study|Withdrawal by Subject|14
2236853|NCT01895452|3892365|FG000|Overall Study|Underlying disease|0
2236854|NCT01895452|3892366|FG001|Overall Study|Underlying disease|3
2236855|NCT01895452|3892365|FG000|Overall Study|Noncompliance with study drug|0
2236856|NCT01895452|3892366|FG001|Overall Study|Noncompliance with study drug|1
2236857|NCT01895543|3892372|FG000|Overall Study|Withdrawal by Subject|43
2236858|NCT01895543|3892372|FG000|Overall Study|Lost to Follow-up|25
2236859|NCT01895543|3892372|FG000|Overall Study|Adverse Event|28
2236860|NCT01895543|3892372|FG000|Overall Study|Subject's substantial non-compliance|6
2236861|NCT01895543|3892372|FG000|Overall Study|Protocol Violation|1
2236862|NCT01895543|3892372|FG000|Overall Study|Physician Decision|2
2236863|NCT01895543|3892372|FG000|Overall Study|Other (Not fulfilling above criteria)|24
2236864|NCT01895608|3892380|FG000|Overall Study|change in health status|0
2236865|NCT01895608|3892381|FG001|Overall Study|change in health status|1
2236866|NCT01895608|3892382|FG002|Overall Study|change in health status|1
2236867|NCT01895608|3892383|FG003|Overall Study|change in health status|0
2236868|NCT01895608|3892380|FG000|Overall Study|Withdrawal by Subject|0
2236869|NCT01895608|3892381|FG001|Overall Study|Withdrawal by Subject|0
2236870|NCT01895608|3892382|FG002|Overall Study|Withdrawal by Subject|2
2236871|NCT01895608|3892383|FG003|Overall Study|Withdrawal by Subject|0
2236872|NCT01895777|3892412|FG000|Overall Study|Adverse Event|1
2236873|NCT01895777|3892413|FG001|Overall Study|Adverse Event|2
2236874|NCT01895777|3892412|FG000|Overall Study|Lost to Follow-up|2
2236875|NCT01895777|3892413|FG001|Overall Study|Lost to Follow-up|0
2236876|NCT01895777|3892412|FG000|Overall Study|Not treated|1
2236877|NCT01895777|3892413|FG001|Overall Study|Not treated|0
2236878|NCT01895777|3892412|FG000|Overall Study|Other reasons|3
2236879|NCT01895777|3892413|FG001|Overall Study|Other reasons|2
2236880|NCT01895777|3892412|FG000|Overall Study|Non-compliance with the CTP|2
2236881|NCT01895777|3892413|FG001|Overall Study|Non-compliance with the CTP|1
2236882|NCT01896050|3892450|FG000|Overall Study|Adverse Event|37
2236883|NCT01896050|3892451|FG001|Overall Study|Adverse Event|2
2236884|NCT01896050|3892450|FG000|Overall Study|Death|1
2236885|NCT01896050|3892451|FG001|Overall Study|Death|0
2236886|NCT01896128|3892475|FG000|Overall Study|Withdrawal by Subject|3
2236887|NCT01896128|3892476|FG001|Overall Study|Withdrawal by Subject|3
2236888|NCT01896193|3892486|FG000|Overall Study|Lack of Efficacy|20
2236889|NCT01896193|3892487|FG001|Overall Study|Lack of Efficacy|11
2236890|NCT01896193|3892486|FG000|Overall Study|Protocol Violation|0
2236891|NCT01896193|3892487|FG001|Overall Study|Protocol Violation|1
2236892|NCT01896193|3892486|FG000|Overall Study|Withdrew Consent|1
2236893|NCT01896193|3892487|FG001|Overall Study|Withdrew Consent|0
2236894|NCT01896232|3892501|FG000|Overall Study|Death|6
2236895|NCT01896232|3892502|FG001|Overall Study|Death|10
2236896|NCT01896232|3892501|FG000|Overall Study|Withdrawal by Subject|32
2236897|NCT01896232|3892502|FG001|Overall Study|Withdrawal by Subject|31
2236898|NCT01896232|3892501|FG000|Overall Study|Sponsor Decision|2
2236899|NCT01896232|3892502|FG001|Overall Study|Sponsor Decision|0
2236900|NCT01896232|3892501|FG000|Overall Study|Lost to Follow-up|9
2236901|NCT01896232|3892502|FG001|Overall Study|Lost to Follow-up|12
2236902|NCT01896271|3892508|FG000|Overall Study|Physician Decision|10
2236903|NCT01896297|3892512|FG000|Overall Study|Died in post treatment phase|1
2236904|NCT01896557|3892534|FG000|Clopidogrel Alone|Adverse Event|1
2236905|NCT01896557|3892535|FG001|Clopidogrel Alone|Adverse Event|0
2236906|NCT01896557|3892534|FG000|Clopidogrel + GI Protector|low adherence|1
2236907|NCT01896557|3892535|FG001|Clopidogrel + GI Protector|low adherence|1
2236908|NCT01896557|3892534|FG000|Clopidogrel + GI Protector|Reading error|1
2236909|NCT01896557|3892535|FG001|Clopidogrel + GI Protector|Reading error|3
2335108|NCT03265600|4060961|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3
2335109|NCT03265600|4060962|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5
2335110|NCT03265938|4060968|FG000|Overall Study|Withdrawal by Subject|1
2335111|NCT03265938|4060968|FG000|Overall Study|Physician Decision|1
2335112|NCT03265938|4060968|FG000|Overall Study|friable mass|6
2335113|NCT03266094|4060973|FG000|Overall Study|Lost to Follow-up|1
2335114|NCT03266094|4060973|FG000|Overall Study|Withdrawal by Subject|1
2335115|NCT03266107|4060979|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1
2036931|NCT00414050|3607120|FG003|Overall Study|Lost to Follow-up|1
2036932|NCT00414050|3607117|FG000|Overall Study|Withdrawal by Subject|5
2036933|NCT00414050|3607118|FG001|Overall Study|Withdrawal by Subject|3
2036934|NCT00414050|3607119|FG002|Overall Study|Withdrawal by Subject|2
2036935|NCT00414050|3607120|FG003|Overall Study|Withdrawal by Subject|4
2036936|NCT00414050|3607117|FG000|Overall Study|Subject discontinued for other reason|1
2036937|NCT00414050|3607118|FG001|Overall Study|Subject discontinued for other reason|2
2036938|NCT00414050|3607119|FG002|Overall Study|Subject discontinued for other reason|2
2036939|NCT00414050|3607120|FG003|Overall Study|Subject discontinued for other reason|1
2036940|NCT00414050|3607117|FG000|Overall Study|Subject Moved|0
2036941|NCT00414050|3607118|FG001|Overall Study|Subject Moved|0
2236910|NCT01896700|3892552|FG000|Overall Study|Adverse Event|4
2236911|NCT01896700|3892553|FG001|Overall Study|Adverse Event|5
2236912|NCT01896700|3892552|FG000|Overall Study|Withdrawal by Subject|0
2236913|NCT01896700|3892553|FG001|Overall Study|Withdrawal by Subject|1
2236914|NCT01896726|3892559|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1
2236915|NCT01896726|3892559|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
2236916|NCT01896856|3892572|FG000|Overall Study|Transportation issues / Non-compliance|0
2236917|NCT01896856|3892573|FG001|Overall Study|Transportation issues / Non-compliance|0
2236918|NCT01896856|3892574|FG002|Overall Study|Transportation issues / Non-compliance|1
2236919|NCT01896856|3892575|FG003|Overall Study|Transportation issues / Non-compliance|0
2236920|NCT01896856|3892576|FG004|Overall Study|Transportation issues / Non-compliance|0
2236921|NCT01896856|3892577|FG005|Overall Study|Transportation issues / Non-compliance|0
2236922|NCT01896869|3892594|FG000|Overall Study|Withdrawal by Subject|0
2236923|NCT01896869|3892595|FG001|Overall Study|Withdrawal by Subject|6
2236924|NCT01896869|3892594|FG000|Overall Study|Lost to Follow-up|1
2236925|NCT01896869|3892595|FG001|Overall Study|Lost to Follow-up|0
2236926|NCT01896895|3892606|FG000|Double-blind MP|Physician Decision|0
2236927|NCT01896895|3892607|FG001|Double-blind MP|Physician Decision|0
2236928|NCT01896895|3892608|FG002|Double-blind MP|Physician Decision|1
2236929|NCT01896895|3892609|FG003|Double-blind MP|Physician Decision|0
2236930|NCT01896895|3892606|FG000|Double-blind MP|Withdrawal by Subject|0
2236931|NCT01896895|3892607|FG001|Double-blind MP|Withdrawal by Subject|2
2236932|NCT01896895|3892608|FG002|Double-blind MP|Withdrawal by Subject|1
2236933|NCT01896895|3892609|FG003|Double-blind MP|Withdrawal by Subject|0
2236934|NCT01896895|3892606|FG000|Double-blind MP|Lost to Follow-up|1
2236935|NCT01896895|3892607|FG001|Double-blind MP|Lost to Follow-up|0
2236936|NCT01896895|3892608|FG002|Double-blind MP|Lost to Follow-up|1
2236937|NCT01896895|3892609|FG003|Double-blind MP|Lost to Follow-up|0
2236938|NCT01896934|3892622|FG000|Overall Study|Adverse Event|1
2236939|NCT01896934|3892622|FG000|Overall Study|Withdrawal by Subject|1
2236940|NCT01896986|3892628|FG000|Overall Study|samples lost|14
2236941|NCT01896986|3892629|FG001|Overall Study|samples lost|23
2236942|NCT01897233|3892653|FG000|Part B (24 Weeks)|Adverse Event|1
2236943|NCT01897233|3892653|FG000|Part B (24 Weeks)|Withdrawal by Subject|2
2236944|NCT01897233|3892653|FG000|Part B (24 Weeks)|Physician Decision|1
2236945|NCT01897493|3892682|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
2236946|NCT01897532|3892691|FG000|Discontinuation From Treatment|Not Treated|7
2236947|NCT01897532|3892692|FG001|Discontinuation From Treatment|Not Treated|5
2236948|NCT01897532|3892691|FG000|Discontinuation From Treatment|Other reason than specified|196
2352924|NCT03725722|4103251|FG000|Overall Study|Adverse Event|2
2236949|NCT01897532|3892692|FG001|Discontinuation From Treatment|Other reason than specified|176
2236950|NCT01897532|3892691|FG000|Discontinuation From Treatment|Withdrawal by Subject|333
2236951|NCT01897532|3892692|FG001|Discontinuation From Treatment|Withdrawal by Subject|281
2236952|NCT01897532|3892691|FG000|Discontinuation From Treatment|Non compliance|24
2236953|NCT01897532|3892692|FG001|Discontinuation From Treatment|Non compliance|15
2236954|NCT01897532|3892691|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402
2236955|NCT01897532|3892692|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362
2236956|NCT01897532|3892691|FG000|Discontinuation From Trial|Not Treated|7
2236957|NCT01897532|3892692|FG001|Discontinuation From Trial|Not Treated|5
2236958|NCT01897532|3892691|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55
2236959|NCT01897532|3892692|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36
2236960|NCT01897714|3892704|FG000|Phase I (Dose Escalation)|Disease progression|3
2236961|NCT01897714|3892705|FG001|Phase I (Dose Escalation)|Disease progression|5
2236962|NCT01897714|3892706|FG002|Phase I (Dose Escalation)|Disease progression|1
2236963|NCT01897714|3892707|FG003|Phase I (Dose Escalation)|Disease progression|3
2236964|NCT01897714|3892708|FG004|Phase I (Dose Escalation)|Disease progression|0
2236965|NCT01897714|3892709|FG005|Phase I (Dose Escalation)|Disease progression|0
2236966|NCT01897714|3892704|FG000|Phase I (Dose Escalation)|Adverse Event|0
2236967|NCT01897714|3892705|FG001|Phase I (Dose Escalation)|Adverse Event|1
2236968|NCT01897714|3892706|FG002|Phase I (Dose Escalation)|Adverse Event|4
2236969|NCT01897714|3892707|FG003|Phase I (Dose Escalation)|Adverse Event|3
2236970|NCT01897714|3892708|FG004|Phase I (Dose Escalation)|Adverse Event|0
2236971|NCT01897714|3892709|FG005|Phase I (Dose Escalation)|Adverse Event|0
2236972|NCT01897714|3892704|FG000|Phase I (Dose Escalation)|Other|0
2236973|NCT01897714|3892705|FG001|Phase I (Dose Escalation)|Other|1
2236974|NCT01897714|3892706|FG002|Phase I (Dose Escalation)|Other|0
2335116|NCT03266107|4060979|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2
2335117|NCT03266107|4060979|FG000|3-Month Follow-up Visit|Lost to Follow-up|1
2335118|NCT03266107|4060979|FG000|12-Month Follow-up Visit|Lost to Follow-up|1
2335119|NCT03266172|4060988|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1
2335120|NCT03266172|4060989|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0
2335121|NCT03266172|4060990|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0
2335122|NCT03266172|4060988|FG000|Part A: Washout Period (7 Days)|Adverse Event|1
2335123|NCT03266172|4060989|FG001|Part A: Washout Period (7 Days)|Adverse Event|0
2335124|NCT03266172|4060990|FG002|Part A: Washout Period (7 Days)|Adverse Event|0
2335125|NCT03266172|4060988|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
2335126|NCT03266172|4060989|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
2335127|NCT03266172|4060990|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
2335128|NCT03266172|4060988|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0
2335129|NCT03266172|4060989|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2
2335130|NCT03266172|4060990|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0
2335131|NCT03266172|4060988|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2335132|NCT03266172|4060989|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2335133|NCT03266172|4060990|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
2335134|NCT03266172|4060988|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2335135|NCT03266172|4060989|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2335136|NCT03266172|4060990|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
2335137|NCT03266588|4061052|FG000|Observational Period|Screen Failure: Eligibility Criteria|439
2335138|NCT03266588|4061053|FG001|Observational Period|Screen Failure: Eligibility Criteria|228
2335139|NCT03266588|4061054|FG002|Observational Period|Screen Failure: Eligibility Criteria|140
2335140|NCT03266588|4061052|FG000|Observational Period|Withdrawal by Subject|44
2335141|NCT03266588|4061053|FG001|Observational Period|Withdrawal by Subject|22
2335142|NCT03266588|4061054|FG002|Observational Period|Withdrawal by Subject|13
2335143|NCT03266588|4061052|FG000|Observational Period|Non-compliance|18
2335144|NCT03266588|4061053|FG001|Observational Period|Non-compliance|12
2335145|NCT03266588|4061054|FG002|Observational Period|Non-compliance|10
2335146|NCT03266588|4061052|FG000|Observational Period|Lost to Follow-up|8
2335147|NCT03266588|4061053|FG001|Observational Period|Lost to Follow-up|12
2335148|NCT03266588|4061054|FG002|Observational Period|Lost to Follow-up|4
2335149|NCT03266588|4061052|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3
2335150|NCT03266588|4061053|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1
2335151|NCT03266588|4061054|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0
2335152|NCT03266588|4061052|FG000|Observational Period|Protocol Deviation|1
2335153|NCT03266588|4061053|FG001|Observational Period|Protocol Deviation|0
2335154|NCT03266588|4061054|FG002|Observational Period|Protocol Deviation|0
2335155|NCT03266588|4061052|FG000|Observational Period|Other Reasons|3
2335156|NCT03266588|4061053|FG001|Observational Period|Other Reasons|0
2335157|NCT03266588|4061054|FG002|Observational Period|Other Reasons|1
2335158|NCT03266588|4061052|FG000|Long-term Treatment Period|Adverse Event|33
2335159|NCT03266588|4061053|FG001|Long-term Treatment Period|Adverse Event|17
2335160|NCT03266588|4061054|FG002|Long-term Treatment Period|Adverse Event|8
2335161|NCT03266588|4061052|FG000|Long-term Treatment Period|Lack of Efficacy|41
2335162|NCT03266588|4061053|FG001|Long-term Treatment Period|Lack of Efficacy|31
2335163|NCT03266588|4061054|FG002|Long-term Treatment Period|Lack of Efficacy|5
2335164|NCT03266588|4061052|FG000|Long-term Treatment Period|Lost to Follow-up|39
2236975|NCT01897714|3892707|FG003|Phase I (Dose Escalation)|Other|0
2236976|NCT01897714|3892708|FG004|Phase I (Dose Escalation)|Other|0
2236977|NCT01897714|3892709|FG005|Phase I (Dose Escalation)|Other|0
2236978|NCT01897714|3892704|FG000|Phase II (MTD)|Withdrawal by Subject|0
2236979|NCT01897714|3892705|FG001|Phase II (MTD)|Withdrawal by Subject|0
2236980|NCT01897714|3892706|FG002|Phase II (MTD)|Withdrawal by Subject|0
2236981|NCT01897714|3892707|FG003|Phase II (MTD)|Withdrawal by Subject|0
2236982|NCT01897714|3892708|FG004|Phase II (MTD)|Withdrawal by Subject|0
2236983|NCT01897714|3892709|FG005|Phase II (MTD)|Withdrawal by Subject|1
2236984|NCT01897714|3892704|FG000|Phase II (MTD)|Lost to Follow-up|0
2236985|NCT01897714|3892705|FG001|Phase II (MTD)|Lost to Follow-up|0
2236986|NCT01897714|3892706|FG002|Phase II (MTD)|Lost to Follow-up|0
2236987|NCT01897714|3892707|FG003|Phase II (MTD)|Lost to Follow-up|0
2236988|NCT01897714|3892708|FG004|Phase II (MTD)|Lost to Follow-up|1
2236989|NCT01897714|3892709|FG005|Phase II (MTD)|Lost to Follow-up|0
2236990|NCT01897714|3892704|FG000|Phase II (MTD)|Death|0
2236991|NCT01897714|3892705|FG001|Phase II (MTD)|Death|0
2236992|NCT01897714|3892706|FG002|Phase II (MTD)|Death|0
2236993|NCT01897714|3892707|FG003|Phase II (MTD)|Death|0
2236994|NCT01897714|3892708|FG004|Phase II (MTD)|Death|25
2236995|NCT01897714|3892709|FG005|Phase II (MTD)|Death|10
2236996|NCT01897714|3892704|FG000|Phase II (MTD)|Study terminated with patient alive|0
2335165|NCT03266588|4061053|FG001|Long-term Treatment Period|Lost to Follow-up|37
2335166|NCT03266588|4061054|FG002|Long-term Treatment Period|Lost to Follow-up|8
2335167|NCT03266588|4061052|FG000|Long-term Treatment Period|Non-Compliance|126
2335168|NCT03266588|4061053|FG001|Long-term Treatment Period|Non-Compliance|57
2335169|NCT03266588|4061054|FG002|Long-term Treatment Period|Non-Compliance|7
2335170|NCT03266588|4061052|FG000|Long-term Treatment Period|Pregnancy|11
2335171|NCT03266588|4061053|FG001|Long-term Treatment Period|Pregnancy|5
2335172|NCT03266588|4061054|FG002|Long-term Treatment Period|Pregnancy|0
2335173|NCT03266588|4061052|FG000|Long-term Treatment Period|Protocol Deviation|17
2335174|NCT03266588|4061053|FG001|Long-term Treatment Period|Protocol Deviation|10
2335175|NCT03266588|4061054|FG002|Long-term Treatment Period|Protocol Deviation|4
2335176|NCT03266588|4061052|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33
2335177|NCT03266588|4061053|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
2335178|NCT03266588|4061054|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
2335179|NCT03266588|4061052|FG000|Long-term Treatment Period|Withdrawal by Subject|100
2335180|NCT03266588|4061053|FG001|Long-term Treatment Period|Withdrawal by Subject|63
2335181|NCT03266588|4061054|FG002|Long-term Treatment Period|Withdrawal by Subject|16
2335182|NCT03266588|4061052|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1
2335183|NCT03266588|4061053|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2
2335184|NCT03266588|4061054|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0
2335185|NCT03266588|4061052|FG000|Long-term Treatment Period|Other Reasons|5
2036942|NCT00414050|3607119|FG002|Overall Study|Subject Moved|0
2036943|NCT00414050|3607120|FG003|Overall Study|Subject Moved|1
2036944|NCT00414076|3607132|FG000|Overall Study|Progression|1
2036945|NCT00414076|3607133|FG001|Overall Study|Progression|2
2036946|NCT00414076|3607132|FG000|Overall Study|Withdrawal by Subject|1
2036947|NCT00414076|3607133|FG001|Overall Study|Withdrawal by Subject|3
2036948|NCT00414076|3607132|FG000|Overall Study|Adverse Event|1
2036949|NCT00414076|3607133|FG001|Overall Study|Adverse Event|0
2036950|NCT00414310|3607169|FG000|Overall Study|Not treated|1
2036951|NCT00414310|3607170|FG001|Overall Study|Not treated|0
2036952|NCT00414388|3607178|FG000|Overall Study|Adverse Event|1
2036953|NCT00414440|3607185|FG000|Core Period|Withdrawal by Subject|70
2036954|NCT00414440|3607186|FG001|Core Period|Withdrawal by Subject|32
2036955|NCT00414440|3607185|FG000|Extension Period|Lost to Follow-up|44
2036956|NCT00414440|3607186|FG001|Extension Period|Lost to Follow-up|52
2036957|NCT00414440|3607185|FG000|Extension Period|Did not consent to continue follow up|61
2036958|NCT00414440|3607186|FG001|Extension Period|Did not consent to continue follow up|54
2036959|NCT00414440|3607185|FG000|Extension Period|Other|1
2036960|NCT00414440|3607186|FG001|Extension Period|Other|1
2036961|NCT00414440|3607185|FG000|Extension Period|Administrative|16
2036962|NCT00414440|3607186|FG001|Extension Period|Administrative|16
2036963|NCT00414440|3607185|FG000|Extension Period|Death|1
2036964|NCT00414440|3607186|FG001|Extension Period|Death|2
2036965|NCT00414440|3607185|FG000|Extension Period|Withdrawal by Subject|9
2036966|NCT00414440|3607186|FG001|Extension Period|Withdrawal by Subject|7
2036967|NCT00414440|3607185|FG000|Extension Period|Not included in follow up period|18
2036968|NCT00414440|3607186|FG001|Extension Period|Not included in follow up period|8
2036969|NCT00414466|3607196|FG000|Overall Study|Adverse Event|0
2036970|NCT00414466|3607197|FG001|Overall Study|Adverse Event|0
2036971|NCT00414466|3607198|FG002|Overall Study|Adverse Event|1
2036972|NCT00414466|3607199|FG003|Overall Study|Adverse Event|1
2036973|NCT00414466|3607196|FG000|Overall Study|Lack of Efficacy|1
2036974|NCT00414466|3607197|FG001|Overall Study|Lack of Efficacy|0
2036975|NCT00414466|3607198|FG002|Overall Study|Lack of Efficacy|0
2036976|NCT00414466|3607199|FG003|Overall Study|Lack of Efficacy|0
2236997|NCT01897714|3892705|FG001|Phase II (MTD)|Study terminated with patient alive|0
2236998|NCT01897714|3892706|FG002|Phase II (MTD)|Study terminated with patient alive|0
2236999|NCT01897714|3892707|FG003|Phase II (MTD)|Study terminated with patient alive|0
2237000|NCT01897714|3892708|FG004|Phase II (MTD)|Study terminated with patient alive|1
2237001|NCT01897714|3892709|FG005|Phase II (MTD)|Study terminated with patient alive|0
2237002|NCT01897714|3892704|FG000|Phase II (MTD)|Other|0
2237003|NCT01897714|3892705|FG001|Phase II (MTD)|Other|0
2237004|NCT01897714|3892706|FG002|Phase II (MTD)|Other|0
2237005|NCT01897714|3892707|FG003|Phase II (MTD)|Other|0
2237006|NCT01897714|3892708|FG004|Phase II (MTD)|Other|3
2237007|NCT01897714|3892709|FG005|Phase II (MTD)|Other|0
2237008|NCT01897727|3892727|FG000|Overall Study|Exclusion: central sleep apnea|0
2237009|NCT01897727|3892728|FG001|Overall Study|Exclusion: central sleep apnea|1
2237010|NCT01897896|3892753|FG000|Overall Study|Death|1
2237011|NCT01897896|3892754|FG001|Overall Study|Death|0
2237012|NCT01897896|3892753|FG000|Overall Study|Adverse Event|11
2237013|NCT01897896|3892754|FG001|Overall Study|Adverse Event|1
2237014|NCT01897896|3892753|FG000|Overall Study|Lost to Follow-up|1
2237015|NCT01897896|3892754|FG001|Overall Study|Lost to Follow-up|0
2237016|NCT01897896|3892753|FG000|Overall Study|Non-compliance with study drug dosing|1
2237017|NCT01897896|3892754|FG001|Overall Study|Non-compliance with study drug dosing|1
2237018|NCT01897896|3892753|FG000|Overall Study|Withdrawal by Subject|7
2237019|NCT01897896|3892754|FG001|Overall Study|Withdrawal by Subject|1
2237020|NCT01897896|3892753|FG000|Overall Study|Require drug that interfere with study|1
2237021|NCT01897896|3892754|FG001|Overall Study|Require drug that interfere with study|4
2237022|NCT01897896|3892753|FG000|Overall Study|Protocol Violation|1
2237023|NCT01897896|3892754|FG001|Overall Study|Protocol Violation|1
2237024|NCT01897896|3892753|FG000|Overall Study|Withdrawal per Investigator's judgement|1
2237025|NCT01897896|3892754|FG001|Overall Study|Withdrawal per Investigator's judgement|1
2237026|NCT01897896|3892753|FG000|Overall Study|Caregiver can no longer participate|0
2237027|NCT01897896|3892754|FG001|Overall Study|Caregiver can no longer participate|2
2237028|NCT01897896|3892753|FG000|Overall Study|Other than specified|2
2237029|NCT01897896|3892754|FG001|Overall Study|Other than specified|1
2237030|NCT01898078|3892773|FG000|Overall Study|Progressive Disease|1
2237031|NCT01898078|3892774|FG001|Overall Study|Progressive Disease|5
2237032|NCT01898078|3892773|FG000|Overall Study|Adverse Event|2
2237033|NCT01898078|3892774|FG001|Overall Study|Adverse Event|1
2237034|NCT01898078|3892773|FG000|Overall Study|Withdrawal by Subject|1
2237035|NCT01898078|3892774|FG001|Overall Study|Withdrawal by Subject|1
2237036|NCT01898078|3892773|FG000|Overall Study|Symptomatic Deterioration|2
2237037|NCT01898078|3892774|FG001|Overall Study|Symptomatic Deterioration|0
2237038|NCT01898078|3892773|FG000|Overall Study|Reason not Specified|0
2237039|NCT01898078|3892774|FG001|Overall Study|Reason not Specified|1
2237040|NCT01898091|3892784|FG000|Overall Study|Lost to Follow-up|1
2237041|NCT01898091|3892785|FG001|Overall Study|Lost to Follow-up|1
2237042|NCT01898091|3892784|FG000|Overall Study|Withdrawal by Subject|1
2237043|NCT01898091|3892785|FG001|Overall Study|Withdrawal by Subject|5
2237044|NCT01898130|3892791|FG000|Treatment|Withdrawal by Subject|2
2237045|NCT01898130|3892791|FG000|Treatment|Progressive Disease|4
2237046|NCT01898130|3892791|FG000|Follow up Until PD or Death|Lost to Follow-up|1
2237047|NCT01898195|3892798|FG000|Smoking Abstinence|Did not have good measurements|35
2237048|NCT01898195|3892799|FG001|Smoking Abstinence|Did not have good measurements|38
2237049|NCT01898195|3892800|FG002|Smoking Abstinence|Did not have good measurements|36
2237050|NCT01898208|3892811|FG000|Overall Study|Positive blood culture|17
2237051|NCT01898208|3892812|FG001|Overall Study|Positive blood culture|23
2237052|NCT01898208|3892813|FG002|Overall Study|Positive blood culture|15
2237053|NCT01898208|3892811|FG000|Overall Study|Death/comfort care within 24 hours|10
2237054|NCT01898208|3892812|FG001|Overall Study|Death/comfort care within 24 hours|9
2237055|NCT01898208|3892813|FG002|Overall Study|Death/comfort care within 24 hours|8
2237056|NCT01898208|3892811|FG000|Overall Study|Negative Gram Stain|6
2237057|NCT01898208|3892812|FG001|Overall Study|Negative Gram Stain|9
2237058|NCT01898208|3892813|FG002|Overall Study|Negative Gram Stain|6
2237059|NCT01898208|3892811|FG000|Overall Study|Non-Blood Specimens in Bottles|3
2237060|NCT01898208|3892812|FG001|Overall Study|Non-Blood Specimens in Bottles|5
2237061|NCT01898208|3892813|FG002|Overall Study|Non-Blood Specimens in Bottles|4
2237062|NCT01898208|3892811|FG000|Overall Study|System/Technical Error|1
2237063|NCT01898208|3892812|FG001|Overall Study|System/Technical Error|2
2237064|NCT01898208|3892813|FG002|Overall Study|System/Technical Error|3
2237065|NCT01898208|3892811|FG000|Overall Study|Lost to Follow-up|3
2237066|NCT01898208|3892812|FG001|Overall Study|Lost to Follow-up|1
2237067|NCT01898208|3892813|FG002|Overall Study|Lost to Follow-up|1
2237068|NCT01898286|3892821|FG000|Overall Study|Withdrawal by Subject|1
2237069|NCT01898286|3892821|FG000|Overall Study|Protocol Violation|1
2237070|NCT01898286|3892821|FG000|Overall Study|Lost to Follow-up|1
2237071|NCT01898299|3892827|FG000|Post Treatment (One Month)|Lost to Follow-up|3
2237072|NCT01898299|3892828|FG001|Post Treatment (One Month)|Lost to Follow-up|4
2237073|NCT01898442|3892849|FG000|Overall Study|Hemolysis/technical problems|1
2237074|NCT01898442|3892850|FG001|Overall Study|Hemolysis/technical problems|2
2237075|NCT01898442|3892851|FG002|Overall Study|Hemolysis/technical problems|2
2237076|NCT01898442|3892849|FG000|Overall Study|Patient vomited pills|0
2237077|NCT01898442|3892850|FG001|Overall Study|Patient vomited pills|0
2237078|NCT01898442|3892851|FG002|Overall Study|Patient vomited pills|1
2237079|NCT01898598|3892861|FG000|Overall Study|Adverse Event|1
2237080|NCT01898598|3892862|FG001|Overall Study|Adverse Event|0
2237081|NCT01898598|3892861|FG000|Overall Study|Withdrawal by Subject|3
2237082|NCT01898598|3892862|FG001|Overall Study|Withdrawal by Subject|0
2237083|NCT01898598|3892861|FG000|Overall Study|Lost to Follow-up|0
2237084|NCT01898598|3892862|FG001|Overall Study|Lost to Follow-up|1
2237085|NCT01898598|3892861|FG000|Overall Study|Other|0
2237086|NCT01898598|3892862|FG001|Overall Study|Other|1
2237087|NCT01898806|3892897|FG000|Overall Study|Withdrawal by Subject|2
2237088|NCT01898806|3892897|FG000|Overall Study|Physician Decision|1
2237089|NCT01898884|3892906|FG000|Multiple Dose Period|Adverse Event|0
2237090|NCT01898884|3892907|FG001|Multiple Dose Period|Adverse Event|0
2237091|NCT01898884|3892908|FG002|Multiple Dose Period|Adverse Event|0
2237092|NCT01898884|3892909|FG003|Multiple Dose Period|Adverse Event|0
2237093|NCT01898884|3892910|FG004|Multiple Dose Period|Adverse Event|0
2237094|NCT01898884|3892911|FG005|Multiple Dose Period|Adverse Event|0
2237095|NCT01898884|3892912|FG006|Multiple Dose Period|Adverse Event|1
2237096|NCT01898884|3892913|FG007|Multiple Dose Period|Adverse Event|0
2237097|NCT01898884|3892914|FG008|Multiple Dose Period|Adverse Event|0
2237098|NCT01898884|3892906|FG000|Multiple Dose Period|Randomized Not Treated|0
2237099|NCT01898884|3892907|FG001|Multiple Dose Period|Randomized Not Treated|0
2237100|NCT01898884|3892908|FG002|Multiple Dose Period|Randomized Not Treated|0
2237101|NCT01898884|3892909|FG003|Multiple Dose Period|Randomized Not Treated|0
2237102|NCT01898884|3892910|FG004|Multiple Dose Period|Randomized Not Treated|0
2237103|NCT01898884|3892911|FG005|Multiple Dose Period|Randomized Not Treated|0
2237104|NCT01898884|3892912|FG006|Multiple Dose Period|Randomized Not Treated|0
2237105|NCT01898884|3892913|FG007|Multiple Dose Period|Randomized Not Treated|0
2237106|NCT01898884|3892914|FG008|Multiple Dose Period|Randomized Not Treated|1
2237107|NCT01898923|3892952|FG000|Overall Study|Lack of Efficacy|5
2237108|NCT01898923|3892953|FG001|Overall Study|Lack of Efficacy|6
2237109|NCT01898923|3892952|FG000|Overall Study|Adverse Event|3
2237110|NCT01898923|3892953|FG001|Overall Study|Adverse Event|1
2237111|NCT01898923|3892952|FG000|Overall Study|Lost to Follow-up|0
2237112|NCT01898923|3892953|FG001|Overall Study|Lost to Follow-up|1
2237113|NCT01898923|3892952|FG000|Overall Study|Withdrawal by Subject|4
2237114|NCT01898923|3892953|FG001|Overall Study|Withdrawal by Subject|7
2237115|NCT01898923|3892952|FG000|Overall Study|Physician Decision|3
2237116|NCT01898923|3892953|FG001|Overall Study|Physician Decision|4
2237117|NCT01898923|3892952|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1
2237118|NCT01898923|3892953|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2
2237119|NCT01899053|3892973|FG000|Overall Study|Progressive Disease|4
2237120|NCT01899053|3892974|FG001|Overall Study|Progressive Disease|0
2237121|NCT01899053|3892975|FG002|Overall Study|Progressive Disease|3
2237122|NCT01899053|3892976|FG003|Overall Study|Progressive Disease|0
2237123|NCT01899053|3892977|FG004|Overall Study|Progressive Disease|3
2237124|NCT01899053|3892978|FG005|Overall Study|Progressive Disease|1
2237125|NCT01899053|3892979|FG006|Overall Study|Progressive Disease|1
2237126|NCT01899053|3892980|FG007|Overall Study|Progressive Disease|1
2237127|NCT01899053|3892981|FG008|Overall Study|Progressive Disease|4
2237128|NCT01899053|3892982|FG009|Overall Study|Progressive Disease|3
2237129|NCT01899053|3892983|FG010|Overall Study|Progressive Disease|12
2237130|NCT01899053|3892984|FG011|Overall Study|Progressive Disease|5
2237131|NCT01899053|3892985|FG012|Overall Study|Progressive Disease|8
2237132|NCT01899053|3892986|FG013|Overall Study|Progressive Disease|17
2335186|NCT03266588|4061053|FG001|Long-term Treatment Period|Other Reasons|0
2335187|NCT03266588|4061054|FG002|Long-term Treatment Period|Other Reasons|0
2335188|NCT03266588|4061052|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
2335189|NCT03266588|4061053|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1
2335190|NCT03266588|4061054|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
2335191|NCT03267212|4061062|FG000|First Intervention|Lost to Follow-up|0
2335192|NCT03267212|4061063|FG001|First Intervention|Lost to Follow-up|2
2335193|NCT03267212|4061062|FG000|First Intervention|Withdrawal by Subject|1
2335194|NCT03267212|4061063|FG001|First Intervention|Withdrawal by Subject|1
2335195|NCT03267212|4061062|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
2335196|NCT03267212|4061063|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
2335197|NCT03267264|4061073|FG000|Overall Study|Withdrawal by Subject|1
2335198|NCT03267264|4061074|FG001|Overall Study|Withdrawal by Subject|0
2335199|NCT03267264|4061075|FG002|Overall Study|Withdrawal by Subject|2
2335200|NCT03267264|4061076|FG003|Overall Study|Withdrawal by Subject|4
2335201|NCT03267511|4061093|FG000|Overall Study|Lost to Follow-up|0
2335202|NCT03267511|4061094|FG001|Overall Study|Lost to Follow-up|0
2335203|NCT03267511|4061095|FG002|Overall Study|Lost to Follow-up|0
2335204|NCT03267511|4061096|FG003|Overall Study|Lost to Follow-up|1
2335205|NCT03267576|4061110|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0
2335206|NCT03267576|4061111|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1
2335207|NCT03267576|4061110|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1
2335208|NCT03267576|4061111|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1
2335209|NCT03267940|4061123|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
2237133|NCT01899053|3892973|FG000|Overall Study|Adverse Event|1
2237134|NCT01899053|3892974|FG001|Overall Study|Adverse Event|1
2237135|NCT01899053|3892975|FG002|Overall Study|Adverse Event|1
2237136|NCT01899053|3892976|FG003|Overall Study|Adverse Event|3
2237137|NCT01899053|3892977|FG004|Overall Study|Adverse Event|1
2237138|NCT01899053|3892978|FG005|Overall Study|Adverse Event|1
2237139|NCT01899053|3892979|FG006|Overall Study|Adverse Event|1
2237140|NCT01899053|3892980|FG007|Overall Study|Adverse Event|0
2237141|NCT01899053|3892981|FG008|Overall Study|Adverse Event|2
2237142|NCT01899053|3892982|FG009|Overall Study|Adverse Event|0
2237143|NCT01899053|3892983|FG010|Overall Study|Adverse Event|3
2237144|NCT01899053|3892984|FG011|Overall Study|Adverse Event|1
2237145|NCT01899053|3892985|FG012|Overall Study|Adverse Event|2
2237146|NCT01899053|3892986|FG013|Overall Study|Adverse Event|2
2237147|NCT01899053|3892973|FG000|Overall Study|Reason Not Specified|0
2237148|NCT01899053|3892974|FG001|Overall Study|Reason Not Specified|0
2237149|NCT01899053|3892975|FG002|Overall Study|Reason Not Specified|0
2237150|NCT01899053|3892976|FG003|Overall Study|Reason Not Specified|0
2237151|NCT01899053|3892977|FG004|Overall Study|Reason Not Specified|0
2237152|NCT01899053|3892978|FG005|Overall Study|Reason Not Specified|0
2237153|NCT01899053|3892979|FG006|Overall Study|Reason Not Specified|1
2237154|NCT01899053|3892980|FG007|Overall Study|Reason Not Specified|0
2237155|NCT01899053|3892981|FG008|Overall Study|Reason Not Specified|0
2237156|NCT01899053|3892982|FG009|Overall Study|Reason Not Specified|0
2237157|NCT01899053|3892983|FG010|Overall Study|Reason Not Specified|0
2237158|NCT01899053|3892984|FG011|Overall Study|Reason Not Specified|0
2237159|NCT01899053|3892985|FG012|Overall Study|Reason Not Specified|1
2237160|NCT01899053|3892986|FG013|Overall Study|Reason Not Specified|0
2237161|NCT01899053|3892973|FG000|Overall Study|Withdrawal by Subject|1
2237162|NCT01899053|3892974|FG001|Overall Study|Withdrawal by Subject|1
2237163|NCT01899053|3892975|FG002|Overall Study|Withdrawal by Subject|2
2237164|NCT01899053|3892976|FG003|Overall Study|Withdrawal by Subject|0
2237165|NCT01899053|3892977|FG004|Overall Study|Withdrawal by Subject|2
2237166|NCT01899053|3892978|FG005|Overall Study|Withdrawal by Subject|0
2237167|NCT01899053|3892979|FG006|Overall Study|Withdrawal by Subject|0
2237168|NCT01899053|3892980|FG007|Overall Study|Withdrawal by Subject|1
2237169|NCT01899053|3892981|FG008|Overall Study|Withdrawal by Subject|0
2237170|NCT01899053|3892982|FG009|Overall Study|Withdrawal by Subject|0
2237171|NCT01899053|3892983|FG010|Overall Study|Withdrawal by Subject|0
2237172|NCT01899053|3892984|FG011|Overall Study|Withdrawal by Subject|0
2237173|NCT01899053|3892985|FG012|Overall Study|Withdrawal by Subject|1
2237174|NCT01899053|3892986|FG013|Overall Study|Withdrawal by Subject|1
2237175|NCT01899053|3892973|FG000|Overall Study|Protocol Violation|0
2237176|NCT01899053|3892974|FG001|Overall Study|Protocol Violation|0
2237177|NCT01899053|3892975|FG002|Overall Study|Protocol Violation|1
2237178|NCT01899053|3892976|FG003|Overall Study|Protocol Violation|0
2237179|NCT01899053|3892977|FG004|Overall Study|Protocol Violation|0
2237180|NCT01899053|3892978|FG005|Overall Study|Protocol Violation|0
2237181|NCT01899053|3892979|FG006|Overall Study|Protocol Violation|0
2237182|NCT01899053|3892980|FG007|Overall Study|Protocol Violation|0
2237183|NCT01899053|3892981|FG008|Overall Study|Protocol Violation|0
2237184|NCT01899053|3892982|FG009|Overall Study|Protocol Violation|0
2237185|NCT01899053|3892983|FG010|Overall Study|Protocol Violation|0
2237186|NCT01899053|3892984|FG011|Overall Study|Protocol Violation|0
2237187|NCT01899053|3892985|FG012|Overall Study|Protocol Violation|0
2237188|NCT01899053|3892986|FG013|Overall Study|Protocol Violation|0
2237189|NCT01899053|3892973|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
2237190|NCT01899053|3892974|FG001|Overall Study|Unsatisfactory Therapeutic Response|1
2237191|NCT01899053|3892975|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
2237192|NCT01899053|3892976|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
2237193|NCT01899053|3892977|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
2237194|NCT01899053|3892978|FG005|Overall Study|Unsatisfactory Therapeutic Response|0
2237195|NCT01899053|3892979|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
2237196|NCT01899053|3892980|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
2237197|NCT01899053|3892981|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
2237198|NCT01899053|3892982|FG009|Overall Study|Unsatisfactory Therapeutic Response|0
2237199|NCT01899053|3892983|FG010|Overall Study|Unsatisfactory Therapeutic Response|1
2237200|NCT01899053|3892984|FG011|Overall Study|Unsatisfactory Therapeutic Response|0
2237201|NCT01899053|3892985|FG012|Overall Study|Unsatisfactory Therapeutic Response|0
2237202|NCT01899053|3892986|FG013|Overall Study|Unsatisfactory Therapeutic Response|0
2237203|NCT01899053|3892973|FG000|Overall Study|Symptomatic Deterioration|0
2237204|NCT01899053|3892974|FG001|Overall Study|Symptomatic Deterioration|0
2237205|NCT01899053|3892975|FG002|Overall Study|Symptomatic Deterioration|0
2237206|NCT01899053|3892976|FG003|Overall Study|Symptomatic Deterioration|0
2237207|NCT01899053|3892977|FG004|Overall Study|Symptomatic Deterioration|0
2237208|NCT01899053|3892978|FG005|Overall Study|Symptomatic Deterioration|1
2237209|NCT01899053|3892979|FG006|Overall Study|Symptomatic Deterioration|0
2237210|NCT01899053|3892980|FG007|Overall Study|Symptomatic Deterioration|1
2237211|NCT01899053|3892981|FG008|Overall Study|Symptomatic Deterioration|0
2237212|NCT01899053|3892982|FG009|Overall Study|Symptomatic Deterioration|0
2237213|NCT01899053|3892983|FG010|Overall Study|Symptomatic Deterioration|0
2237214|NCT01899053|3892984|FG011|Overall Study|Symptomatic Deterioration|1
2237215|NCT01899053|3892985|FG012|Overall Study|Symptomatic Deterioration|2
2237216|NCT01899053|3892986|FG013|Overall Study|Symptomatic Deterioration|0
2237217|NCT01899729|3893039|FG000|Overall Study|Adverse Event|1
2237218|NCT01899729|3893040|FG001|Overall Study|Adverse Event|0
2237219|NCT01899729|3893041|FG002|Overall Study|Adverse Event|0
2237220|NCT01899729|3893042|FG003|Overall Study|Adverse Event|0
2237221|NCT01899729|3893043|FG004|Overall Study|Adverse Event|1
2237222|NCT01899729|3893039|FG000|Overall Study|Withdrawal by Subject|1
2237223|NCT01899729|3893040|FG001|Overall Study|Withdrawal by Subject|2
2335210|NCT03267940|4061124|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
2335211|NCT03267940|4061125|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2335212|NCT03267940|4061126|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2335213|NCT03267940|4061127|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2335214|NCT03267940|4061128|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2335215|NCT03267940|4061123|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2335216|NCT03267940|4061124|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
2335217|NCT03267940|4061125|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2335218|NCT03267940|4061126|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2335219|NCT03267940|4061127|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2335220|NCT03267940|4061128|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2335221|NCT03267940|4061123|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2335222|NCT03267940|4061124|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
2335223|NCT03267940|4061125|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2335224|NCT03267940|4061126|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2335225|NCT03267940|4061127|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2335226|NCT03267940|4061128|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2335227|NCT03267940|4061123|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7
2335228|NCT03267940|4061124|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3
2335229|NCT03267940|4061125|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2335230|NCT03267940|4061126|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2335231|NCT03267940|4061127|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2335232|NCT03267940|4061128|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2335233|NCT03267940|4061123|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2335234|NCT03267940|4061124|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2335235|NCT03267940|4061125|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2335236|NCT03267940|4061126|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
2335237|NCT03267940|4061127|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
2335238|NCT03267940|4061128|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2335239|NCT03267940|4061123|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
2335240|NCT03267940|4061124|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
2335241|NCT03267940|4061125|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
2335242|NCT03267940|4061126|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
2335243|NCT03267940|4061127|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
2335244|NCT03267940|4061128|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
2335245|NCT03267940|4061123|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
2335246|NCT03267940|4061124|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
2335247|NCT03267940|4061125|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
2335248|NCT03267940|4061126|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
2335249|NCT03267940|4061127|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
2335250|NCT03267940|4061128|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
2335251|NCT03267940|4061123|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
2335252|NCT03267940|4061124|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
2335253|NCT03267940|4061125|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
2335254|NCT03267940|4061126|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
2335255|NCT03267940|4061127|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
2335256|NCT03267940|4061128|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
2335257|NCT03267940|4061123|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0
2335258|NCT03267940|4061124|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0
2335259|NCT03267940|4061125|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10
2335260|NCT03267940|4061126|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13
2335261|NCT03267940|4061127|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0
2335262|NCT03267940|4061128|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6
2335263|NCT03268590|4061154|FG000|Overall Study|Previously unknown exclusion criteria|1
2335264|NCT03268746|4061161|FG000|Overall Study|Withdrawal by Subject|1
2335265|NCT03268941|4061176|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2335266|NCT03268941|4061177|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2335267|NCT03268941|4061178|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2335268|NCT03268941|4061179|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
2335269|NCT03268941|4061180|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2335270|NCT03268941|4061181|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2335271|NCT03268941|4061182|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2335272|NCT03268941|4061176|FG000|Part 1 (Days 1 to 9)|Adverse Event|0
2335273|NCT03268941|4061177|FG001|Part 1 (Days 1 to 9)|Adverse Event|0
2335274|NCT03268941|4061178|FG002|Part 1 (Days 1 to 9)|Adverse Event|0
2335275|NCT03268941|4061179|FG003|Part 1 (Days 1 to 9)|Adverse Event|1
2237224|NCT01899729|3893041|FG002|Overall Study|Withdrawal by Subject|0
2237225|NCT01899729|3893042|FG003|Overall Study|Withdrawal by Subject|0
2237226|NCT01899729|3893043|FG004|Overall Study|Withdrawal by Subject|0
2237227|NCT01899729|3893039|FG000|Overall Study|Lack of Efficacy|0
2237228|NCT01899729|3893040|FG001|Overall Study|Lack of Efficacy|0
2237229|NCT01899729|3893041|FG002|Overall Study|Lack of Efficacy|2
2237230|NCT01899729|3893042|FG003|Overall Study|Lack of Efficacy|0
2237231|NCT01899729|3893043|FG004|Overall Study|Lack of Efficacy|1
2237232|NCT01899742|3893057|FG000|Overall Study|Adverse Event|5
2237233|NCT01899742|3893058|FG001|Overall Study|Adverse Event|4
2237234|NCT01899742|3893057|FG000|Overall Study|Lack of Efficacy|1
2237235|NCT01899742|3893058|FG001|Overall Study|Lack of Efficacy|5
2237236|NCT01899742|3893057|FG000|Overall Study|Protocol Violation|2
2237237|NCT01899742|3893058|FG001|Overall Study|Protocol Violation|2
2237238|NCT01899742|3893057|FG000|Overall Study|Withdrawal by Subject|9
2237239|NCT01899742|3893058|FG001|Overall Study|Withdrawal by Subject|5
2237240|NCT01899768|3893064|FG000|Part A|Adverse Event|2
2237241|NCT01899768|3893064|FG000|Part A|Withdrawal by Subject|1
2237242|NCT01899768|3893064|FG000|Part B|Adverse Event|1
2237243|NCT01899768|3893064|FG000|Part B|Withdrawal by Subject|1
2237244|NCT01900054|3893076|FG000|Overall Study|Physician Decision|1
2237245|NCT01900054|3893076|FG000|Overall Study|Withdrawal by Subject|1
2237246|NCT01900314|3893104|FG000|Overall Study|Lost to Follow-up|1
2237247|NCT01900314|3893105|FG001|Overall Study|Lost to Follow-up|0
2237248|NCT01900314|3893104|FG000|Overall Study|Protocol Violation|0
2237249|NCT01900314|3893105|FG001|Overall Study|Protocol Violation|1
2237250|NCT01900314|3893104|FG000|Overall Study|Withdrawal by Subject|3
2237251|NCT01900314|3893105|FG001|Overall Study|Withdrawal by Subject|3
2335276|NCT03268941|4061180|FG004|Part 1 (Days 1 to 9)|Adverse Event|0
2335277|NCT03268941|4061181|FG005|Part 1 (Days 1 to 9)|Adverse Event|0
2335278|NCT03268941|4061182|FG006|Part 1 (Days 1 to 9)|Adverse Event|0
2335279|NCT03268941|4061176|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1
2335280|NCT03268941|4061177|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0
2335281|NCT03268941|4061178|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0
2335282|NCT03268941|4061179|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0
2335283|NCT03268941|4061180|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0
2335284|NCT03268941|4061181|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0
2335285|NCT03268941|4061182|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0
2335286|NCT03268941|4061176|FG000|Part 2: Days 17 to 25|Reason not specified|0
2335287|NCT03268941|4061177|FG001|Part 2: Days 17 to 25|Reason not specified|0
2335288|NCT03268941|4061178|FG002|Part 2: Days 17 to 25|Reason not specified|0
2335289|NCT03268941|4061179|FG003|Part 2: Days 17 to 25|Reason not specified|0
2335290|NCT03268941|4061180|FG004|Part 2: Days 17 to 25|Reason not specified|0
2335291|NCT03268941|4061181|FG005|Part 2: Days 17 to 25|Reason not specified|0
2335292|NCT03268941|4061182|FG006|Part 2: Days 17 to 25|Reason not specified|1
2335293|NCT03268941|4061176|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0
2335294|NCT03268941|4061177|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0
2335295|NCT03268941|4061178|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0
2335296|NCT03268941|4061179|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0
2335297|NCT03268941|4061180|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0
2335298|NCT03268941|4061181|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0
2335299|NCT03268941|4061182|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1
2335300|NCT03269552|4061210|FG000|Overall Study|Adverse Event|2
2335301|NCT03270085|4061217|FG000|Overall Study|Withdrawal by Subject|1
2335302|NCT03270085|4061218|FG001|Overall Study|Withdrawal by Subject|0
2335303|NCT03270644|4061253|FG000|Day 1 Lasmiditan Reference|Physician Decision|1
2335304|NCT03270644|4061253|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1
2335305|NCT03270657|4061264|FG000|Overall Study|Withdrawal by Subject|1
2335306|NCT03271307|4061282|FG000|Overall Study|Lost to Follow-up|0
2335307|NCT03271307|4061283|FG001|Overall Study|Lost to Follow-up|0
2335308|NCT03271307|4061284|FG002|Overall Study|Lost to Follow-up|0
2335309|NCT03271307|4061285|FG003|Overall Study|Lost to Follow-up|28
2335310|NCT03271307|4061286|FG004|Overall Study|Lost to Follow-up|91
2335311|NCT03271528|4061318|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1
2335312|NCT03271528|4061319|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0
2335313|NCT03271528|4061318|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1
2335314|NCT03271528|4061319|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0
2335315|NCT03271528|4061318|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0
2335316|NCT03271528|4061319|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1
2335317|NCT03271528|4061318|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0
2335318|NCT03271528|4061319|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1
2335319|NCT03271528|4061318|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
2335320|NCT03271528|4061319|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
2335321|NCT03271528|4061318|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1
2335322|NCT03271528|4061319|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0
2335323|NCT03271528|4061318|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1
2335324|NCT03271528|4061319|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0
2335325|NCT03273153|4061336|FG000|Overall Study|Remain on Study|161
2237252|NCT01900431|3893127|FG000|Principal Treatment Period (Part A)|Adverse Event|1
2237253|NCT01900431|3893128|FG001|Principal Treatment Period (Part A)|Adverse Event|3
2237254|NCT01900431|3893129|FG002|Principal Treatment Period (Part A)|Adverse Event|0
2237255|NCT01900431|3893127|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6
2237256|NCT01900431|3893128|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6
2237257|NCT01900431|3893129|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0
2237258|NCT01900431|3893127|FG000|Principal Treatment Period (Part A)|Other than specified above|0
2237259|NCT01900431|3893128|FG001|Principal Treatment Period (Part A)|Other than specified above|1
2237260|NCT01900431|3893129|FG002|Principal Treatment Period (Part A)|Other than specified above|0
2237261|NCT01900431|3893127|FG000|Extended Treatment Period (Part B)|Adverse Event|0
2237262|NCT01900431|3893128|FG001|Extended Treatment Period (Part B)|Adverse Event|2
2237263|NCT01900431|3893129|FG002|Extended Treatment Period (Part B)|Adverse Event|0
2237264|NCT01900431|3893127|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1
2237265|NCT01900431|3893128|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7
2237266|NCT01900431|3893129|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0
2237267|NCT01900431|3893127|FG000|Extended Treatment Period (Part B)|Other than specified above|0
2237268|NCT01900431|3893128|FG001|Extended Treatment Period (Part B)|Other than specified above|1
2237269|NCT01900431|3893129|FG002|Extended Treatment Period (Part B)|Other than specified above|0
2237270|NCT01900431|3893127|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0
2237271|NCT01900431|3893128|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0
2237272|NCT01900431|3893129|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2
2237273|NCT01900431|3893127|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
2237274|NCT01900431|3893128|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
2237275|NCT01900431|3893129|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
2237276|NCT01900431|3893127|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
2237277|NCT01900431|3893128|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
2237278|NCT01900431|3893129|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
2237279|NCT01900444|3893137|FG000|Overall Study|Protocol Violation|2
2237280|NCT01900444|3893137|FG000|Overall Study|Lost to Follow-up|1
2237281|NCT01900652|3893152|FG000|Overall Study|Progressive Disease|1
2237282|NCT01900652|3893153|FG001|Overall Study|Progressive Disease|0
2237283|NCT01900652|3893152|FG000|Overall Study|Consent withdrawn by subject|1
2237284|NCT01900652|3893153|FG001|Overall Study|Consent withdrawn by subject|1
2237285|NCT01900652|3893152|FG000|Overall Study|Death|3
2237286|NCT01900652|3893153|FG001|Overall Study|Death|0
2237287|NCT01900652|3893152|FG000|Overall Study|Adverse Event|2
2237288|NCT01900652|3893153|FG001|Overall Study|Adverse Event|1
2237289|NCT01900652|3893152|FG000|Overall Study|Physician Decision|1
2237290|NCT01900652|3893153|FG001|Overall Study|Physician Decision|1
2237291|NCT01900665|3893166|FG000|Placebo Controlled Period|Death|9
2237292|NCT01900665|3893167|FG001|Placebo Controlled Period|Death|16
2237293|NCT01900665|3893166|FG000|Placebo Controlled Period|Adverse Event|48
2237294|NCT01900665|3893167|FG001|Placebo Controlled Period|Adverse Event|39
2237295|NCT01900665|3893166|FG000|Placebo Controlled Period|Protocol Violation|1
2237296|NCT01900665|3893167|FG001|Placebo Controlled Period|Protocol Violation|7
2237297|NCT01900665|3893166|FG000|Placebo Controlled Period|Withdrawal by Subject|33
2237298|NCT01900665|3893167|FG001|Placebo Controlled Period|Withdrawal by Subject|45
2237299|NCT01900665|3893166|FG000|Placebo Controlled Period|Physician Decision|11
2237300|NCT01900665|3893167|FG001|Placebo Controlled Period|Physician Decision|7
2237301|NCT01900665|3893166|FG000|Placebo Controlled Period|Lost to Follow-up|3
2237302|NCT01900665|3893167|FG001|Placebo Controlled Period|Lost to Follow-up|0
2237303|NCT01900665|3893166|FG000|Placebo Controlled Period|Caregiver Decision|33
2237304|NCT01900665|3893167|FG001|Placebo Controlled Period|Caregiver Decision|41
2237305|NCT01900665|3893166|FG000|Placebo Controlled Period|Entry Criteria Not Met|5
2237306|NCT01900665|3893167|FG001|Placebo Controlled Period|Entry Criteria Not Met|9
2335326|NCT03273153|4061337|FG001|Overall Study|Remain on Study|159
2335327|NCT03273153|4061336|FG000|Overall Study|Death|41
2335328|NCT03273153|4061337|FG001|Overall Study|Death|45
2335329|NCT03273153|4061336|FG000|Overall Study|Lost to Follow-up|3
2335330|NCT03273153|4061337|FG001|Overall Study|Lost to Follow-up|3
2335331|NCT03273153|4061336|FG000|Overall Study|Protocol Violation|3
2335332|NCT03273153|4061337|FG001|Overall Study|Protocol Violation|0
2335333|NCT03273153|4061336|FG000|Overall Study|Withdrawal by Subject|16
2335334|NCT03273153|4061337|FG001|Overall Study|Withdrawal by Subject|13
2335335|NCT03273153|4061336|FG000|Overall Study|Symptomatic Deterioration|0
2335336|NCT03273153|4061337|FG001|Overall Study|Symptomatic Deterioration|1
2335337|NCT03273153|4061336|FG000|Overall Study|Other|0
2335338|NCT03273153|4061337|FG001|Overall Study|Other|1
2335339|NCT03273166|4061343|FG000|Overall Study|Withdrawn prior to Completion|31
2335340|NCT03273257|4061350|FG000|Overall Study|Death|0
2335341|NCT03273257|4061351|FG001|Overall Study|Death|1
2335342|NCT03273257|4061350|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
2335343|NCT03273257|4061351|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
2335344|NCT03273257|4061350|FG000|Overall Study|Study terminated|3
2036977|NCT00414466|3607196|FG000|Overall Study|Withdrawn by Sponsor|1
2036978|NCT00414466|3607197|FG001|Overall Study|Withdrawn by Sponsor|0
2036979|NCT00414466|3607198|FG002|Overall Study|Withdrawn by Sponsor|0
2237307|NCT01900665|3893166|FG000|Open Label Period|Adverse Event|16
2237308|NCT01900665|3893167|FG001|Open Label Period|Adverse Event|20
2237309|NCT01900665|3893166|FG000|Open Label Period|Death|5
2237310|NCT01900665|3893167|FG001|Open Label Period|Death|6
2237311|NCT01900665|3893166|FG000|Open Label Period|Lost to Follow-up|1
2237312|NCT01900665|3893167|FG001|Open Label Period|Lost to Follow-up|1
2237313|NCT01900665|3893166|FG000|Open Label Period|Parent/Caregiver Decision|33
2237314|NCT01900665|3893167|FG001|Open Label Period|Parent/Caregiver Decision|34
2237315|NCT01900665|3893166|FG000|Open Label Period|Physician Decision|4
2237316|NCT01900665|3893167|FG001|Open Label Period|Physician Decision|4
2237317|NCT01900665|3893166|FG000|Open Label Period|Protocol Violation|0
2237318|NCT01900665|3893167|FG001|Open Label Period|Protocol Violation|1
2237319|NCT01900665|3893166|FG000|Open Label Period|Sponsor Decision|802
2237320|NCT01900665|3893167|FG001|Open Label Period|Sponsor Decision|765
2237321|NCT01900665|3893166|FG000|Open Label Period|Withdrawal by Subject|20
2237322|NCT01900665|3893167|FG001|Open Label Period|Withdrawal by Subject|28
2237323|NCT01900899|3893192|FG000|Overall Study|Withdrawal by Subject|7
2237324|NCT01900899|3893193|FG001|Overall Study|Withdrawal by Subject|1
2237325|NCT01900899|3893192|FG000|Overall Study|Migrated from study area|2
2237326|NCT01900899|3893193|FG001|Overall Study|Migrated from study area|0
2237327|NCT01901055|3893201|FG000|Randomization But Not Titrated|Did not come to titration study|1
2237328|NCT01901055|3893202|FG001|Randomization But Not Titrated|Did not come to titration study|1
2237329|NCT01901055|3893201|FG000|Randomization But Not Titrated|Physician Decision|0
2237330|NCT01901055|3893202|FG001|Randomization But Not Titrated|Physician Decision|1
2237331|NCT01901055|3893201|FG000|Started Protocol to Week 6|Physician Decision|2
2237332|NCT01901055|3893202|FG001|Started Protocol to Week 6|Physician Decision|1
2237333|NCT01901055|3893201|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0
2237334|NCT01901055|3893202|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2
2237335|NCT01901055|3893201|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1
2237336|NCT01901055|3893202|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0
2237337|NCT01901055|3893201|FG000|Started Protocol to Week 6|Withdrawal by Subject|0
2237338|NCT01901055|3893202|FG001|Started Protocol to Week 6|Withdrawal by Subject|1
2237339|NCT01901055|3893201|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1
2237340|NCT01901055|3893202|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0
2237341|NCT01901055|3893201|FG000|Week 12 Assessment|Withdrawal by Subject|0
2237342|NCT01901055|3893202|FG001|Week 12 Assessment|Withdrawal by Subject|4
2237343|NCT01901055|3893201|FG000|Week 24|Withdrawal by Subject|13
2237344|NCT01901055|3893202|FG001|Week 24|Withdrawal by Subject|19
2237345|NCT01901055|3893201|FG000|Week 24|Physician Decision|1
2237346|NCT01901055|3893202|FG001|Week 24|Physician Decision|0
2237347|NCT01901055|3893201|FG000|Week 36|Withdrawal by Subject|0
2237348|NCT01901055|3893202|FG001|Week 36|Withdrawal by Subject|5
2237349|NCT01901146|3893213|FG000|Neoadjuvant Phase|Death|1
2237350|NCT01901146|3893214|FG001|Neoadjuvant Phase|Death|2
2237351|NCT01901146|3893215|FG002|Neoadjuvant Phase|Death|0
2237352|NCT01901146|3893216|FG003|Neoadjuvant Phase|Death|0
2237353|NCT01901146|3893217|FG004|Neoadjuvant Phase|Death|0
2237354|NCT01901146|3893213|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2
2237355|NCT01901146|3893214|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3
2237356|NCT01901146|3893215|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0
2237357|NCT01901146|3893216|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0
2237358|NCT01901146|3893217|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0
2237359|NCT01901146|3893213|FG000|Neoadjuvant Phase|Lost to Follow-up|0
2237360|NCT01901146|3893214|FG001|Neoadjuvant Phase|Lost to Follow-up|1
2237361|NCT01901146|3893215|FG002|Neoadjuvant Phase|Lost to Follow-up|0
2237362|NCT01901146|3893216|FG003|Neoadjuvant Phase|Lost to Follow-up|0
2237363|NCT01901146|3893217|FG004|Neoadjuvant Phase|Lost to Follow-up|0
2237364|NCT01901146|3893213|FG000|Neoadjuvant Phase|Physician Decision|1
2237365|NCT01901146|3893214|FG001|Neoadjuvant Phase|Physician Decision|2
2237366|NCT01901146|3893215|FG002|Neoadjuvant Phase|Physician Decision|0
2237367|NCT01901146|3893216|FG003|Neoadjuvant Phase|Physician Decision|0
2237368|NCT01901146|3893217|FG004|Neoadjuvant Phase|Physician Decision|0
2237369|NCT01901146|3893213|FG000|Neoadjuvant Phase|Withdrawal by Subject|2
2237370|NCT01901146|3893214|FG001|Neoadjuvant Phase|Withdrawal by Subject|5
2237371|NCT01901146|3893215|FG002|Neoadjuvant Phase|Withdrawal by Subject|0
2237372|NCT01901146|3893216|FG003|Neoadjuvant Phase|Withdrawal by Subject|0
2237373|NCT01901146|3893217|FG004|Neoadjuvant Phase|Withdrawal by Subject|0
2237374|NCT01901146|3893213|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2237375|NCT01901146|3893214|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1
2237376|NCT01901146|3893215|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2237377|NCT01901146|3893216|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2237378|NCT01901146|3893217|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2237379|NCT01901146|3893213|FG000|Adjuvant Phase|Other|0
2237380|NCT01901146|3893214|FG001|Adjuvant Phase|Other|0
2237381|NCT01901146|3893215|FG002|Adjuvant Phase|Other|1
2237382|NCT01901146|3893216|FG003|Adjuvant Phase|Other|0
2237383|NCT01901146|3893217|FG004|Adjuvant Phase|Other|0
2237384|NCT01901146|3893213|FG000|Adjuvant Phase|Death|0
2237385|NCT01901146|3893214|FG001|Adjuvant Phase|Death|0
2237386|NCT01901146|3893215|FG002|Adjuvant Phase|Death|0
2237387|NCT01901146|3893216|FG003|Adjuvant Phase|Death|0
2237388|NCT01901146|3893217|FG004|Adjuvant Phase|Death|3
2237389|NCT01901146|3893213|FG000|Adjuvant Phase|Disease Progression or Recurrence|0
2237390|NCT01901146|3893214|FG001|Adjuvant Phase|Disease Progression or Recurrence|0
2237391|NCT01901146|3893215|FG002|Adjuvant Phase|Disease Progression or Recurrence|12
2237392|NCT01901146|3893216|FG003|Adjuvant Phase|Disease Progression or Recurrence|4
2237393|NCT01901146|3893217|FG004|Adjuvant Phase|Disease Progression or Recurrence|3
2237394|NCT01901146|3893213|FG000|Adjuvant Phase|Physician Decision|0
2237395|NCT01901146|3893214|FG001|Adjuvant Phase|Physician Decision|0
2237396|NCT01901146|3893215|FG002|Adjuvant Phase|Physician Decision|9
2237397|NCT01901146|3893216|FG003|Adjuvant Phase|Physician Decision|2
2237398|NCT01901146|3893217|FG004|Adjuvant Phase|Physician Decision|4
2237399|NCT01901146|3893213|FG000|Adjuvant Phase|Withdrawal by Subject|0
2237400|NCT01901146|3893214|FG001|Adjuvant Phase|Withdrawal by Subject|0
2335345|NCT03273257|4061351|FG001|Overall Study|Study terminated|2
2335346|NCT03273387|4061377|FG000|Overall Study|Death|2
2335347|NCT03273387|4061378|FG001|Overall Study|Death|2
2335348|NCT03273387|4061377|FG000|Overall Study|Withdrawal by Subject|1
2335349|NCT03273387|4061378|FG001|Overall Study|Withdrawal by Subject|1
2335350|NCT03273946|4061412|FG000|Overall Study|Withdrawal by Subject|5
2335351|NCT03273946|4061412|FG000|Overall Study|Unwillingness of the guardian|1
2335352|NCT03273946|4061412|FG000|Overall Study|Participant refused to use the drug|2
2335353|NCT03273946|4061412|FG000|Overall Study|Participant relative refused to use drug|1
2335354|NCT03274076|4061418|FG000|24 Weeks Double Blind|Withdrawal by Subject|0
2335355|NCT03274076|4061419|FG001|24 Weeks Double Blind|Withdrawal by Subject|1
2335356|NCT03274076|4061420|FG002|24 Weeks Double Blind|Withdrawal by Subject|0
2335357|NCT03274076|4061421|FG003|24 Weeks Double Blind|Withdrawal by Subject|0
2335358|NCT03274076|4061418|FG000|24 Weeks Open Label|Adverse Event|0
2335359|NCT03274076|4061419|FG001|24 Weeks Open Label|Adverse Event|0
2335360|NCT03274076|4061420|FG002|24 Weeks Open Label|Adverse Event|2
2335361|NCT03274076|4061421|FG003|24 Weeks Open Label|Adverse Event|0
2335362|NCT03274076|4061418|FG000|24 Weeks Open Label|Withdrawal by Subject|0
2335363|NCT03274076|4061419|FG001|24 Weeks Open Label|Withdrawal by Subject|0
2335364|NCT03274076|4061420|FG002|24 Weeks Open Label|Withdrawal by Subject|0
2335365|NCT03274076|4061421|FG003|24 Weeks Open Label|Withdrawal by Subject|1
2335366|NCT03274440|4061440|FG000|Overall Study|Time commitment too great|1
2335367|NCT03274440|4061441|FG001|Overall Study|Time commitment too great|0
2335368|NCT03274440|4061442|FG002|Overall Study|Time commitment too great|0
2335369|NCT03274440|4061443|FG003|Overall Study|Time commitment too great|1
2335370|NCT03274440|4061444|FG004|Overall Study|Time commitment too great|0
2335371|NCT03274440|4061445|FG005|Overall Study|Time commitment too great|0
2335372|NCT03274453|4061457|FG000|Overall Study|Lost to Follow-up|2
2335373|NCT03274453|4061458|FG001|Overall Study|Lost to Follow-up|5
2335374|NCT03274453|4061459|FG002|Overall Study|Lost to Follow-up|4
2335375|NCT03274453|4061460|FG003|Overall Study|Lost to Follow-up|1
2335376|NCT03274453|4061457|FG000|Overall Study|Physician Decision|2
2335377|NCT03274453|4061458|FG001|Overall Study|Physician Decision|0
2335378|NCT03274453|4061459|FG002|Overall Study|Physician Decision|0
2335379|NCT03274453|4061460|FG003|Overall Study|Physician Decision|3
2335380|NCT03274453|4061457|FG000|Overall Study|Surgery Cancelled|0
2335381|NCT03274453|4061458|FG001|Overall Study|Surgery Cancelled|1
2335382|NCT03274453|4061459|FG002|Overall Study|Surgery Cancelled|0
2335383|NCT03274453|4061460|FG003|Overall Study|Surgery Cancelled|0
2335384|NCT03274466|4061472|FG000|Overall Study|Withdrawal by Subject|7
2335385|NCT03274466|4061473|FG001|Overall Study|Withdrawal by Subject|3
2335386|NCT03274466|4061472|FG000|Overall Study|Protocol Specified Withdrawal|5
2335387|NCT03274466|4061473|FG001|Overall Study|Protocol Specified Withdrawal|11
2335388|NCT03274466|4061472|FG000|Overall Study|Lost to Follow-up|5
2335389|NCT03274466|4061473|FG001|Overall Study|Lost to Follow-up|7
2335390|NCT03274466|4061472|FG000|Overall Study|Subject Non-compliance|0
2335391|NCT03274466|4061473|FG001|Overall Study|Subject Non-compliance|1
2335392|NCT03274466|4061472|FG000|Overall Study|Adverse Event|3
2335393|NCT03274466|4061473|FG001|Overall Study|Adverse Event|3
2335394|NCT03274466|4061472|FG000|Overall Study|Physician Decision|0
2335395|NCT03274466|4061473|FG001|Overall Study|Physician Decision|1
2335396|NCT03274466|4061472|FG000|Overall Study|Protocol Violation|3
2335397|NCT03274466|4061473|FG001|Overall Study|Protocol Violation|3
2335398|NCT03274986|4061506|FG000|Overall Study|Withdrawal by Subject|0
2335399|NCT03274986|4061507|FG001|Overall Study|Withdrawal by Subject|1
2335400|NCT03274986|4061506|FG000|Overall Study|Lost to Follow-up|0
2335401|NCT03274986|4061507|FG001|Overall Study|Lost to Follow-up|1
2335402|NCT03275246|4061527|FG000|Overall Study|Protocol Violation|5
2335403|NCT03275246|4061527|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1
2335404|NCT03275389|4061541|FG000|Overall Study|Lost to Follow-up|10
2335405|NCT03275389|4061542|FG001|Overall Study|Lost to Follow-up|10
2335406|NCT03275389|4061543|FG002|Overall Study|Lost to Follow-up|19
2335407|NCT03275389|4061544|FG003|Overall Study|Lost to Follow-up|12
2335408|NCT03275389|4061545|FG004|Overall Study|Lost to Follow-up|11
2335409|NCT03275389|4061546|FG005|Overall Study|Lost to Follow-up|12
2335410|NCT03275389|4061547|FG006|Overall Study|Lost to Follow-up|21
2335411|NCT03275389|4061548|FG007|Overall Study|Lost to Follow-up|15
2335412|NCT03275389|4061549|FG008|Overall Study|Lost to Follow-up|12
2335413|NCT03275389|4061550|FG009|Overall Study|Lost to Follow-up|14
2237401|NCT01901146|3893215|FG002|Adjuvant Phase|Withdrawal by Subject|4
2237402|NCT01901146|3893216|FG003|Adjuvant Phase|Withdrawal by Subject|1
2237403|NCT01901146|3893217|FG004|Adjuvant Phase|Withdrawal by Subject|4
2237404|NCT01901185|3893226|FG000|Overall Study|Withdrawal by Subject|2
2237405|NCT01901302|3893254|FG000|Overall Study|Adverse Event|2
2237406|NCT01901302|3893255|FG001|Overall Study|Adverse Event|1
2237407|NCT01901302|3893254|FG000|Overall Study|Lack of Efficacy|0
2237408|NCT01901302|3893255|FG001|Overall Study|Lack of Efficacy|2
2237409|NCT01901302|3893254|FG000|Overall Study|Study Terminated by Sponsor|23
2237410|NCT01901302|3893255|FG001|Overall Study|Study Terminated by Sponsor|20
2237411|NCT01901302|3893254|FG000|Overall Study|Withdrawal by Subject|2
2237412|NCT01901302|3893255|FG001|Overall Study|Withdrawal by Subject|0
2237413|NCT01901328|3893263|FG000|Overall Study|Lost to Follow-up|1
2237414|NCT01901328|3893264|FG001|Overall Study|Lost to Follow-up|0
2237415|NCT01901328|3893263|FG000|Overall Study|Physician Decision|0
2237416|NCT01901328|3893264|FG001|Overall Study|Physician Decision|1
2237417|NCT01901328|3893263|FG000|Overall Study|Protocol Violation|1
2237418|NCT01901328|3893264|FG001|Overall Study|Protocol Violation|1
2237419|NCT01901328|3893263|FG000|Overall Study|Study Terminated by Sponsor|19
2237420|NCT01901328|3893264|FG001|Overall Study|Study Terminated by Sponsor|16
2237421|NCT01901328|3893263|FG000|Overall Study|Withdrawal by Subject|1
2237422|NCT01901328|3893264|FG001|Overall Study|Withdrawal by Subject|2
2237423|NCT01901328|3893263|FG000|Overall Study|Lack of Efficacy|0
2237424|NCT01901328|3893264|FG001|Overall Study|Lack of Efficacy|1
2237425|NCT01901341|3893273|FG000|Overall Study|Adverse Event|4
2237426|NCT01901341|3893274|FG001|Overall Study|Adverse Event|2
2237427|NCT01901341|3893273|FG000|Overall Study|Lack of Efficacy|0
2237428|NCT01901341|3893274|FG001|Overall Study|Lack of Efficacy|2
2237429|NCT01901341|3893273|FG000|Overall Study|Lost to Follow-up|0
2237430|NCT01901341|3893274|FG001|Overall Study|Lost to Follow-up|1
2237431|NCT01901341|3893273|FG000|Overall Study|Protocol Violation|2
2237432|NCT01901341|3893274|FG001|Overall Study|Protocol Violation|0
2237433|NCT01901341|3893273|FG000|Overall Study|Study Terminated by Sponsor|13
2237434|NCT01901341|3893274|FG001|Overall Study|Study Terminated by Sponsor|15
2237435|NCT01901341|3893273|FG000|Overall Study|Withdrawal by Subject|1
2237436|NCT01901341|3893274|FG001|Overall Study|Withdrawal by Subject|1
2237437|NCT01901393|3893283|FG000|Overall Study|Adverse Event|1
2237438|NCT01901393|3893284|FG001|Overall Study|Adverse Event|0
2237439|NCT01901419|3893292|FG000|Overall Study|Protocol Violation|2
2237440|NCT01901419|3893293|FG001|Overall Study|Protocol Violation|6
2237441|NCT01901419|3893292|FG000|Overall Study|unavailable researchers|6
2237442|NCT01901419|3893293|FG001|Overall Study|unavailable researchers|3
2237443|NCT01901614|3893315|FG000|Overall Study|Adverse Event|0
2237444|NCT01901614|3893316|FG001|Overall Study|Adverse Event|1
2237445|NCT01901614|3893315|FG000|Overall Study|Lost to Follow-up|1
2237446|NCT01901614|3893316|FG001|Overall Study|Lost to Follow-up|0
2237447|NCT01901614|3893315|FG000|Overall Study|Screen Fail|1
2237448|NCT01901614|3893316|FG001|Overall Study|Screen Fail|0
2237449|NCT01901653|3893335|FG000|Overall Study|Death|2
2237450|NCT01901653|3893336|FG001|Overall Study|Death|1
2237451|NCT01901653|3893337|FG002|Overall Study|Death|8
2237452|NCT01901653|3893338|FG003|Overall Study|Death|3
2237453|NCT01901653|3893339|FG004|Overall Study|Death|2
2237454|NCT01901653|3893340|FG005|Overall Study|Death|2
2237455|NCT01901653|3893341|FG006|Overall Study|Death|6
2237456|NCT01901653|3893342|FG007|Overall Study|Death|9
2237457|NCT01901653|3893343|FG008|Overall Study|Death|1
2237458|NCT01901653|3893344|FG009|Overall Study|Death|16
2237459|NCT01901653|3893345|FG010|Overall Study|Death|2
2237460|NCT01901653|3893346|FG011|Overall Study|Death|15
2237461|NCT01901653|3893347|FG012|Overall Study|Death|4
2237462|NCT01901653|3893335|FG000|Overall Study|Lost to Follow-up|1
2237463|NCT01901653|3893336|FG001|Overall Study|Lost to Follow-up|0
2237464|NCT01901653|3893337|FG002|Overall Study|Lost to Follow-up|2
2237465|NCT01901653|3893338|FG003|Overall Study|Lost to Follow-up|0
2237466|NCT01901653|3893339|FG004|Overall Study|Lost to Follow-up|0
2237467|NCT01901653|3893340|FG005|Overall Study|Lost to Follow-up|1
2237468|NCT01901653|3893341|FG006|Overall Study|Lost to Follow-up|0
2237469|NCT01901653|3893342|FG007|Overall Study|Lost to Follow-up|1
2237470|NCT01901653|3893343|FG008|Overall Study|Lost to Follow-up|0
2237471|NCT01901653|3893344|FG009|Overall Study|Lost to Follow-up|0
2237472|NCT01901653|3893345|FG010|Overall Study|Lost to Follow-up|0
2237473|NCT01901653|3893346|FG011|Overall Study|Lost to Follow-up|0
2237474|NCT01901653|3893347|FG012|Overall Study|Lost to Follow-up|0
2237475|NCT01901653|3893335|FG000|Overall Study|Withdrawal by Subject|0
2237476|NCT01901653|3893336|FG001|Overall Study|Withdrawal by Subject|0
2237477|NCT01901653|3893337|FG002|Overall Study|Withdrawal by Subject|0
2237478|NCT01901653|3893338|FG003|Overall Study|Withdrawal by Subject|0
2237479|NCT01901653|3893339|FG004|Overall Study|Withdrawal by Subject|0
2237480|NCT01901653|3893340|FG005|Overall Study|Withdrawal by Subject|0
2237481|NCT01901653|3893341|FG006|Overall Study|Withdrawal by Subject|1
2237482|NCT01901653|3893342|FG007|Overall Study|Withdrawal by Subject|0
2237483|NCT01901653|3893343|FG008|Overall Study|Withdrawal by Subject|0
2237484|NCT01901653|3893344|FG009|Overall Study|Withdrawal by Subject|0
2237485|NCT01901653|3893345|FG010|Overall Study|Withdrawal by Subject|0
2237486|NCT01901653|3893346|FG011|Overall Study|Withdrawal by Subject|0
2237487|NCT01901653|3893347|FG012|Overall Study|Withdrawal by Subject|0
2237488|NCT01901653|3893335|FG000|Overall Study|Alive at Study Termination by Sponsor|0
2237489|NCT01901653|3893336|FG001|Overall Study|Alive at Study Termination by Sponsor|0
2237490|NCT01901653|3893337|FG002|Overall Study|Alive at Study Termination by Sponsor|1
2237491|NCT01901653|3893338|FG003|Overall Study|Alive at Study Termination by Sponsor|0
2237492|NCT01901653|3893339|FG004|Overall Study|Alive at Study Termination by Sponsor|0
2237493|NCT01901653|3893340|FG005|Overall Study|Alive at Study Termination by Sponsor|0
2237494|NCT01901653|3893341|FG006|Overall Study|Alive at Study Termination by Sponsor|0
2237495|NCT01901653|3893342|FG007|Overall Study|Alive at Study Termination by Sponsor|0
2237496|NCT01901653|3893343|FG008|Overall Study|Alive at Study Termination by Sponsor|0
2237497|NCT01901653|3893344|FG009|Overall Study|Alive at Study Termination by Sponsor|2
2237498|NCT01901653|3893345|FG010|Overall Study|Alive at Study Termination by Sponsor|0
2237499|NCT01901653|3893346|FG011|Overall Study|Alive at Study Termination by Sponsor|1
2237500|NCT01901653|3893347|FG012|Overall Study|Alive at Study Termination by Sponsor|1
2237501|NCT01901848|3893396|FG000|Randomized and Treated|Lost to Follow-up|3
2237502|NCT01901848|3893397|FG001|Randomized and Treated|Lost to Follow-up|6
2237503|NCT01901848|3893396|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10
2237504|NCT01901848|3893397|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0
2237505|NCT01901874|3893403|FG000|Screening Committee Retrospective Review|Protocol Violation|47
2237506|NCT01901874|3893403|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1
2237507|NCT01901874|3893403|FG000|1-Year (365-Day) MAE Evaluation|Death|7
2237508|NCT01901874|3893403|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
2237509|NCT01901874|3893403|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
2237510|NCT01901874|3893403|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
2237511|NCT01902134|3893422|FG000|Overall Study|Adverse Event|3
2237512|NCT01902134|3893423|FG001|Overall Study|Adverse Event|1
2237513|NCT01902134|3893424|FG002|Overall Study|Adverse Event|2
2237514|NCT01902134|3893425|FG003|Overall Study|Adverse Event|1
2237515|NCT01902134|3893426|FG004|Overall Study|Adverse Event|1
2237516|NCT01902134|3893427|FG005|Overall Study|Adverse Event|3
2237517|NCT01902134|3893422|FG000|Overall Study|Lack of Efficacy|0
2237518|NCT01902134|3893423|FG001|Overall Study|Lack of Efficacy|0
2237519|NCT01902134|3893424|FG002|Overall Study|Lack of Efficacy|2
2237520|NCT01902134|3893425|FG003|Overall Study|Lack of Efficacy|0
2237521|NCT01902134|3893426|FG004|Overall Study|Lack of Efficacy|0
2237522|NCT01902134|3893427|FG005|Overall Study|Lack of Efficacy|1
2237523|NCT01902134|3893422|FG000|Overall Study|Physician Decision|0
2237524|NCT01902134|3893423|FG001|Overall Study|Physician Decision|1
2237525|NCT01902134|3893424|FG002|Overall Study|Physician Decision|0
2237526|NCT01902134|3893425|FG003|Overall Study|Physician Decision|0
2237527|NCT01902134|3893426|FG004|Overall Study|Physician Decision|0
2237528|NCT01902134|3893427|FG005|Overall Study|Physician Decision|0
2237529|NCT01902134|3893422|FG000|Overall Study|Protocol Violation|0
2237530|NCT01902134|3893423|FG001|Overall Study|Protocol Violation|0
2237531|NCT01902134|3893424|FG002|Overall Study|Protocol Violation|0
2237532|NCT01902134|3893425|FG003|Overall Study|Protocol Violation|0
2237533|NCT01902134|3893426|FG004|Overall Study|Protocol Violation|0
2237534|NCT01902134|3893427|FG005|Overall Study|Protocol Violation|1
2237535|NCT01902134|3893422|FG000|Overall Study|Withdrawal by Subject|4
2237536|NCT01902134|3893423|FG001|Overall Study|Withdrawal by Subject|8
2237537|NCT01902134|3893424|FG002|Overall Study|Withdrawal by Subject|9
2237538|NCT01902134|3893425|FG003|Overall Study|Withdrawal by Subject|1
2237539|NCT01902134|3893426|FG004|Overall Study|Withdrawal by Subject|5
2237540|NCT01902134|3893427|FG005|Overall Study|Withdrawal by Subject|4
2237541|NCT01902134|3893422|FG000|Overall Study|no compliance|1
2237542|NCT01902134|3893423|FG001|Overall Study|no compliance|0
2237543|NCT01902134|3893424|FG002|Overall Study|no compliance|0
2237544|NCT01902134|3893425|FG003|Overall Study|no compliance|0
2237545|NCT01902134|3893426|FG004|Overall Study|no compliance|0
2237546|NCT01902134|3893427|FG005|Overall Study|no compliance|0
2237547|NCT01902134|3893422|FG000|Overall Study|Other|0
2237548|NCT01902134|3893423|FG001|Overall Study|Other|1
2237549|NCT01902134|3893424|FG002|Overall Study|Other|2
2237550|NCT01902134|3893425|FG003|Overall Study|Other|0
2335414|NCT03275389|4061541|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
2335415|NCT03275389|4061542|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
2335416|NCT03275389|4061543|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
2335417|NCT03275389|4061544|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
2335418|NCT03275389|4061545|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
2335419|NCT03275389|4061546|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
2335420|NCT03275389|4061547|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
2335421|NCT03275389|4061548|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
2335422|NCT03275389|4061549|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
2335423|NCT03275389|4061550|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
2335424|NCT03275389|4061541|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
2335425|NCT03275389|4061542|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
2335426|NCT03275389|4061543|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
2335427|NCT03275389|4061544|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
2335428|NCT03275389|4061545|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
2335429|NCT03275389|4061546|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
2237551|NCT01902134|3893426|FG004|Overall Study|Other|1
2237552|NCT01902134|3893427|FG005|Overall Study|Other|0
2237553|NCT01902173|3893449|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1
2237554|NCT01902173|3893450|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
2237555|NCT01902173|3893451|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
2237556|NCT01902173|3893452|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
2237557|NCT01902173|3893453|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
2237558|NCT01902173|3893454|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
2237559|NCT01902173|3893449|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2
2237560|NCT01902173|3893450|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
2237561|NCT01902173|3893451|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
2237562|NCT01902173|3893452|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
2237563|NCT01902173|3893453|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
2237564|NCT01902173|3893454|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
2237565|NCT01902173|3893449|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
2237566|NCT01902173|3893450|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5
2237567|NCT01902173|3893451|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
2237568|NCT01902173|3893452|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
2237569|NCT01902173|3893453|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
2237570|NCT01902173|3893454|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
2237571|NCT01902173|3893449|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
2237572|NCT01902173|3893450|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1
2237573|NCT01902173|3893451|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
2237574|NCT01902173|3893452|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
2237575|NCT01902173|3893453|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
2237576|NCT01902173|3893454|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
2237577|NCT01902173|3893449|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0
2237578|NCT01902173|3893450|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3
2237579|NCT01902173|3893451|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0
2237580|NCT01902173|3893452|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0
2237581|NCT01902173|3893453|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0
2237582|NCT01902173|3893454|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0
2237583|NCT01902173|3893449|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
2237584|NCT01902173|3893450|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
2237585|NCT01902173|3893451|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3
2237586|NCT01902173|3893452|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
2237587|NCT01902173|3893453|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
2237588|NCT01902173|3893454|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
2237589|NCT01902173|3893449|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
2237590|NCT01902173|3893450|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
2237591|NCT01902173|3893451|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1
2237592|NCT01902173|3893452|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
2237593|NCT01902173|3893453|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
2237594|NCT01902173|3893454|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
2237595|NCT01902173|3893449|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
2237596|NCT01902173|3893450|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
2237597|NCT01902173|3893451|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
2237598|NCT01902173|3893452|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1
2237599|NCT01902173|3893453|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
2237600|NCT01902173|3893454|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
2237601|NCT01902173|3893449|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
2335430|NCT03275389|4061547|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
2335431|NCT03275389|4061548|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
2335432|NCT03275389|4061549|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
2335433|NCT03275389|4061550|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
2335434|NCT03275389|4061541|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2335435|NCT03275389|4061542|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
2335436|NCT03275389|4061543|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2335437|NCT03275389|4061544|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
2335438|NCT03275389|4061545|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2335439|NCT03275389|4061546|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2036980|NCT00414466|3607199|FG003|Overall Study|Withdrawn by Sponsor|0
2036981|NCT00414544|3607225|FG000|Overall Study|Lost to Follow-up|14
2036982|NCT00414596|3607231|FG000|Overall Study|Protocol Violation|2
2036983|NCT00414609|3607237|FG000|Core Study|Adverse Event|9
2237602|NCT01902173|3893450|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
2237603|NCT01902173|3893451|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
2237604|NCT01902173|3893452|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2
2237605|NCT01902173|3893453|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
2237606|NCT01902173|3893454|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
2237607|NCT01902173|3893449|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
2237608|NCT01902173|3893450|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
2237609|NCT01902173|3893451|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
2237610|NCT01902173|3893452|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
2237611|NCT01902173|3893453|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1
2237612|NCT01902173|3893454|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
2237613|NCT01902173|3893449|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
2237614|NCT01902173|3893450|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
2237615|NCT01902173|3893451|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
2237616|NCT01902173|3893452|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
2237617|NCT01902173|3893453|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2
2237618|NCT01902173|3893454|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
2237619|NCT01902173|3893449|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
2237620|NCT01902173|3893450|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
2237621|NCT01902173|3893451|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
2237622|NCT01902173|3893452|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
2237623|NCT01902173|3893453|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
2237624|NCT01902173|3893454|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1
2237625|NCT01902173|3893449|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
2237626|NCT01902173|3893450|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
2335440|NCT03275389|4061547|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
2335441|NCT03275389|4061548|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2335442|NCT03275389|4061549|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2335443|NCT03275389|4061550|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2335444|NCT03275389|4061541|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
2335445|NCT03275389|4061542|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
2335446|NCT03275389|4061543|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
2335447|NCT03275389|4061544|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
2335448|NCT03275389|4061545|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
2335449|NCT03275389|4061546|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
2335450|NCT03275389|4061547|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
2335451|NCT03275389|4061548|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
2335452|NCT03275389|4061549|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
2335453|NCT03275389|4061550|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
2335454|NCT03275389|4061541|FG000|Overall Study|Other|0
2335455|NCT03275389|4061542|FG001|Overall Study|Other|4
2335456|NCT03275389|4061543|FG002|Overall Study|Other|3
2335457|NCT03275389|4061544|FG003|Overall Study|Other|2
2335458|NCT03275389|4061545|FG004|Overall Study|Other|2
2335459|NCT03275389|4061546|FG005|Overall Study|Other|2
2335460|NCT03275389|4061547|FG006|Overall Study|Other|0
2335461|NCT03275389|4061548|FG007|Overall Study|Other|0
2335462|NCT03275389|4061549|FG008|Overall Study|Other|1
2335463|NCT03275389|4061550|FG009|Overall Study|Other|0
2335464|NCT03276026|4061604|FG000|Overall Study|Protocol Violation|1
2335465|NCT03276026|4061605|FG001|Overall Study|Protocol Violation|0
2335466|NCT03276078|4061611|FG000|Overall Study|Adverse Event|1
2335467|NCT03276975|4061635|FG000|Overall Study|Withdrawal by Subject|1
2335468|NCT03276975|4061636|FG001|Overall Study|Withdrawal by Subject|0
2335469|NCT03277352|4061655|FG000|Overall Study|Study Terminated By Sponsor|2
2335470|NCT03277352|4061655|FG000|Overall Study|Withdrawal by Subject|4
2335471|NCT03277352|4061655|FG000|Overall Study|Death|4
2335472|NCT03277794|4061675|FG000|Overall Study|Lost to Follow-up|2
2335473|NCT03277794|4061676|FG001|Overall Study|Lost to Follow-up|4
2335474|NCT03277794|4061675|FG000|Overall Study|Withdrew due to high acuity|1
2335475|NCT03277794|4061676|FG001|Overall Study|Withdrew due to high acuity|0
2335476|NCT03277846|4061685|FG000|Overall Study|Inpatient stay too brief|12
2335477|NCT03277846|4061686|FG001|Overall Study|Inpatient stay too brief|11
2335478|NCT03278028|4061694|FG000|Overall Study|Lost to Follow-up|1
2335479|NCT03278028|4061695|FG001|Overall Study|Lost to Follow-up|0
2335480|NCT03278028|4061694|FG000|Overall Study|Withdrawal by Subject|3
2335481|NCT03278028|4061695|FG001|Overall Study|Withdrawal by Subject|1
2335482|NCT03278028|4061694|FG000|Overall Study|Pregnancy|0
2335483|NCT03278028|4061695|FG001|Overall Study|Pregnancy|1
2335484|NCT03278106|4061719|FG000|Overall Study|No protocol treatment|1
2335485|NCT03278613|4061734|FG000|Overall Study|Lost to Follow-up|3
2335486|NCT03278613|4061735|FG001|Overall Study|Lost to Follow-up|1
2352925|NCT03725722|4103252|FG001|Overall Study|Adverse Event|2
2352926|NCT03725722|4103253|FG002|Overall Study|Adverse Event|1
2352927|NCT03725722|4103254|FG003|Overall Study|Adverse Event|0
2352928|NCT03725722|4103255|FG004|Overall Study|Adverse Event|6
2352929|NCT03725722|4103251|FG000|Overall Study|Withdrawal by Subject|4
2352930|NCT03725722|4103252|FG001|Overall Study|Withdrawal by Subject|1
2352931|NCT03725722|4103253|FG002|Overall Study|Withdrawal by Subject|0
2036984|NCT00414609|3607238|FG001|Core Study|Adverse Event|11
2036985|NCT00414609|3607239|FG002|Core Study|Adverse Event|0
2036986|NCT00414609|3607237|FG000|Core Study|Abnormal laboratory values|0
2352932|NCT03725722|4103254|FG003|Overall Study|Withdrawal by Subject|4
2352933|NCT03725722|4103255|FG004|Overall Study|Withdrawal by Subject|4
2352934|NCT03725722|4103251|FG000|Overall Study|Lost to Follow-up|3
2352935|NCT03725722|4103252|FG001|Overall Study|Lost to Follow-up|1
2352936|NCT03725722|4103253|FG002|Overall Study|Lost to Follow-up|2
2352937|NCT03725722|4103254|FG003|Overall Study|Lost to Follow-up|2
2352938|NCT03725722|4103255|FG004|Overall Study|Lost to Follow-up|1
2237627|NCT01902173|3893451|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
2237628|NCT01902173|3893452|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
2237629|NCT01902173|3893453|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
2237630|NCT01902173|3893454|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3
2237631|NCT01902173|3893449|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0
2237632|NCT01902173|3893450|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0
2237633|NCT01902173|3893451|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0
2237634|NCT01902173|3893452|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0
2237635|NCT01902173|3893453|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0
2237636|NCT01902173|3893454|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1
2237637|NCT01902303|3893473|FG000|Overall Study|Adverse Event|0
2237638|NCT01902303|3893474|FG001|Overall Study|Adverse Event|1
2237639|NCT01902303|3893473|FG000|Overall Study|Lost to Follow-up|0
2237640|NCT01902303|3893474|FG001|Overall Study|Lost to Follow-up|1
2237641|NCT01902303|3893473|FG000|Overall Study|Protocol Violation|2
2237642|NCT01902303|3893474|FG001|Overall Study|Protocol Violation|2
2237643|NCT01902303|3893473|FG000|Overall Study|subject lost investigational product|0
2237644|NCT01902303|3893474|FG001|Overall Study|subject lost investigational product|1
2237645|NCT01902303|3893473|FG000|Overall Study|Did not develop a cold sore|21
2237646|NCT01902303|3893474|FG001|Overall Study|Did not develop a cold sore|19
2237647|NCT01902628|3893491|FG000|Overall Study|Withdrawal of participant's consent|7
2237648|NCT01902628|3893491|FG000|Overall Study|Adverse Event|41
2237649|NCT01902628|3893491|FG000|Overall Study|Lost to Follow-up|35
2237650|NCT01903031|3893527|FG000|Overall Study|Not Able to Attend Clinic|1
2237651|NCT01903031|3893528|FG001|Overall Study|Not Able to Attend Clinic|1
2237652|NCT01903031|3893529|FG002|Overall Study|Not Able to Attend Clinic|0
2237653|NCT01903031|3893527|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1
2237654|NCT01903031|3893528|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0
2237655|NCT01903031|3893529|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0
2237656|NCT01903031|3893527|FG000|Overall Study|Adverse Event|0
2237657|NCT01903031|3893528|FG001|Overall Study|Adverse Event|1
2237658|NCT01903031|3893529|FG002|Overall Study|Adverse Event|0
2237659|NCT01903031|3893527|FG000|Overall Study|Withdrawal by Subject|0
2237660|NCT01903031|3893528|FG001|Overall Study|Withdrawal by Subject|1
2237661|NCT01903031|3893529|FG002|Overall Study|Withdrawal by Subject|1
2237662|NCT01903031|3893527|FG000|Overall Study|Protocol Violation|0
2237663|NCT01903031|3893528|FG001|Overall Study|Protocol Violation|0
2237664|NCT01903031|3893529|FG002|Overall Study|Protocol Violation|2
2237665|NCT01903031|3893527|FG000|Overall Study|Lost to Follow-up|0
2237666|NCT01903031|3893528|FG001|Overall Study|Lost to Follow-up|0
2237667|NCT01903031|3893529|FG002|Overall Study|Lost to Follow-up|1
2237668|NCT01903031|3893527|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0
2237669|NCT01903031|3893528|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0
2237670|NCT01903031|3893529|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1
2237671|NCT01903252|3893560|FG000|Double-Blind Induction|Adverse Event|20
2237672|NCT01903252|3893561|FG001|Double-Blind Induction|Adverse Event|18
2237673|NCT01903252|3893562|FG002|Double-Blind Induction|Adverse Event|0
2237674|NCT01903252|3893563|FG003|Double-Blind Induction|Adverse Event|0
2237675|NCT01903252|3893564|FG004|Double-Blind Induction|Adverse Event|0
2237676|NCT01903252|3893565|FG005|Double-Blind Induction|Adverse Event|0
2237677|NCT01903252|3893560|FG000|Double-Blind Induction|Withdrawal by Subject|10
2237678|NCT01903252|3893561|FG001|Double-Blind Induction|Withdrawal by Subject|13
2237679|NCT01903252|3893562|FG002|Double-Blind Induction|Withdrawal by Subject|0
2237680|NCT01903252|3893563|FG003|Double-Blind Induction|Withdrawal by Subject|0
2237681|NCT01903252|3893564|FG004|Double-Blind Induction|Withdrawal by Subject|0
2237682|NCT01903252|3893565|FG005|Double-Blind Induction|Withdrawal by Subject|0
2237683|NCT01903252|3893560|FG000|Double-Blind Induction|Physician Decision|2
2237684|NCT01903252|3893561|FG001|Double-Blind Induction|Physician Decision|3
2237685|NCT01903252|3893562|FG002|Double-Blind Induction|Physician Decision|0
2237686|NCT01903252|3893563|FG003|Double-Blind Induction|Physician Decision|0
2237687|NCT01903252|3893564|FG004|Double-Blind Induction|Physician Decision|0
2237688|NCT01903252|3893565|FG005|Double-Blind Induction|Physician Decision|0
2237689|NCT01903252|3893560|FG000|Double-Blind Induction|non-compliance,|7
2237690|NCT01903252|3893561|FG001|Double-Blind Induction|non-compliance,|7
2237691|NCT01903252|3893562|FG002|Double-Blind Induction|non-compliance,|0
2237692|NCT01903252|3893563|FG003|Double-Blind Induction|non-compliance,|0
2237693|NCT01903252|3893564|FG004|Double-Blind Induction|non-compliance,|0
2237694|NCT01903252|3893565|FG005|Double-Blind Induction|non-compliance,|0
2237695|NCT01903252|3893560|FG000|Extended Induction, Open-Label|Adverse Event|0
2237696|NCT01903252|3893561|FG001|Extended Induction, Open-Label|Adverse Event|0
2237697|NCT01903252|3893562|FG002|Extended Induction, Open-Label|Adverse Event|17
2237698|NCT01903252|3893563|FG003|Extended Induction, Open-Label|Adverse Event|0
2237699|NCT01903252|3893564|FG004|Extended Induction, Open-Label|Adverse Event|0
2237700|NCT01903252|3893565|FG005|Extended Induction, Open-Label|Adverse Event|0
2237701|NCT01903252|3893560|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0
2237702|NCT01903252|3893561|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0
2237703|NCT01903252|3893562|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5
2237704|NCT01903252|3893563|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0
2335487|NCT03280108|4061773|FG000|Overall Study|Lost to Follow-up|2
2237705|NCT01903252|3893564|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0
2237706|NCT01903252|3893565|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0
2237707|NCT01903252|3893560|FG000|Extended Induction, Open-Label|Physician Decision|0
2237708|NCT01903252|3893561|FG001|Extended Induction, Open-Label|Physician Decision|0
2237709|NCT01903252|3893562|FG002|Extended Induction, Open-Label|Physician Decision|1
2237710|NCT01903252|3893563|FG003|Extended Induction, Open-Label|Physician Decision|0
2237711|NCT01903252|3893564|FG004|Extended Induction, Open-Label|Physician Decision|0
2237712|NCT01903252|3893565|FG005|Extended Induction, Open-Label|Physician Decision|0
2237713|NCT01903252|3893560|FG000|Maintenance, Open-Label|Adverse Event|0
2237714|NCT01903252|3893561|FG001|Maintenance, Open-Label|Adverse Event|0
2237715|NCT01903252|3893562|FG002|Maintenance, Open-Label|Adverse Event|0
2237716|NCT01903252|3893563|FG003|Maintenance, Open-Label|Adverse Event|3
2237717|NCT01903252|3893564|FG004|Maintenance, Open-Label|Adverse Event|9
2237718|NCT01903252|3893565|FG005|Maintenance, Open-Label|Adverse Event|14
2237719|NCT01903252|3893560|FG000|Maintenance, Open-Label|Withdrawal by Subject|0
2237720|NCT01903252|3893561|FG001|Maintenance, Open-Label|Withdrawal by Subject|0
2237721|NCT01903252|3893562|FG002|Maintenance, Open-Label|Withdrawal by Subject|0
2237722|NCT01903252|3893563|FG003|Maintenance, Open-Label|Withdrawal by Subject|1
2237723|NCT01903252|3893564|FG004|Maintenance, Open-Label|Withdrawal by Subject|6
2237724|NCT01903252|3893565|FG005|Maintenance, Open-Label|Withdrawal by Subject|2
2237725|NCT01903252|3893560|FG000|Maintenance, Open-Label|Other|0
2237726|NCT01903252|3893561|FG001|Maintenance, Open-Label|Other|0
2237727|NCT01903252|3893562|FG002|Maintenance, Open-Label|Other|0
2237728|NCT01903252|3893563|FG003|Maintenance, Open-Label|Other|2
2237729|NCT01903252|3893564|FG004|Maintenance, Open-Label|Other|6
2237730|NCT01903252|3893565|FG005|Maintenance, Open-Label|Other|2
2237731|NCT01903356|3893592|FG000|Overall Study|Lost to Follow-up|7
2237732|NCT01903356|3893592|FG000|Overall Study|Violated inclusion/exclusion criteria|5
2237733|NCT01903356|3893592|FG000|Overall Study|Violated the dosage and administration|3
2237734|NCT01903434|3893596|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1
2237735|NCT01903434|3893597|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0
2237736|NCT01903434|3893596|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
2237737|NCT01903434|3893597|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
2237738|NCT01903460|3893607|FG000|Overall Study|Adverse Event|0
2237739|NCT01903460|3893608|FG001|Overall Study|Adverse Event|0
2237740|NCT01903460|3893609|FG002|Overall Study|Adverse Event|0
2237741|NCT01903460|3893610|FG003|Overall Study|Adverse Event|1
2237742|NCT01903525|3893621|FG000|Overall Study|Lost to Follow-up|5
2237743|NCT01903525|3893622|FG001|Overall Study|Lost to Follow-up|9
2237744|NCT01903525|3893621|FG000|Overall Study|Adverse Event|0
2237745|NCT01903525|3893622|FG001|Overall Study|Adverse Event|1
2237746|NCT01903720|3893637|FG000|Overall Study|Inclusion / exclusion criteria not met|6
2237747|NCT01903720|3893637|FG000|Overall Study|Adverse Event|1
2237748|NCT01903720|3893637|FG000|Overall Study|Rescinding of informed consent|2
2237749|NCT01903720|3893637|FG000|Overall Study|Lost to Follow-up|2
2237750|NCT01903720|3893637|FG000|Overall Study|Treatment with alternative drug|1
2237751|NCT01903733|3893645|FG000|Overall Study|Death|23
2237752|NCT01903733|3893646|FG001|Overall Study|Death|54
2237753|NCT01903733|3893647|FG002|Overall Study|Death|30
2237754|NCT01903733|3893648|FG003|Overall Study|Death|98
2237755|NCT01903733|3893645|FG000|Overall Study|Participant refused further follow-up|35
2237756|NCT01903733|3893646|FG001|Overall Study|Participant refused further follow-up|38
2237757|NCT01903733|3893647|FG002|Overall Study|Participant refused further follow-up|13
2237758|NCT01903733|3893648|FG003|Overall Study|Participant refused further follow-up|9
2237759|NCT01903733|3893645|FG000|Overall Study|Lost to Follow-up|18
2237760|NCT01903733|3893646|FG001|Overall Study|Lost to Follow-up|19
2237761|NCT01903733|3893647|FG002|Overall Study|Lost to Follow-up|6
2237762|NCT01903733|3893648|FG003|Overall Study|Lost to Follow-up|9
2237763|NCT01903733|3893645|FG000|Overall Study|Other|10
2237764|NCT01903733|3893646|FG001|Overall Study|Other|15
2237765|NCT01903733|3893647|FG002|Overall Study|Other|12
2237766|NCT01903733|3893648|FG003|Overall Study|Other|3
2237767|NCT01903733|3893645|FG000|Overall Study|Missing|2
2335488|NCT03280108|4061774|FG001|Overall Study|Lost to Follow-up|0
2335489|NCT03280121|4061785|FG000|Overall Study|Physician Decision|1
2335490|NCT03280121|4061785|FG000|Overall Study|Lost to Follow-up|1
2335491|NCT03280121|4061785|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4
2335492|NCT03280264|4061789|FG000|Overall Study|Adverse Event|1
2335493|NCT03280264|4061789|FG000|Overall Study|Physician Decision|1
2335494|NCT03280264|4061789|FG000|Overall Study|Withdrawal by Subject|1
2335495|NCT03280381|4061796|FG000|Overall Study|Physician Decision|0
2335496|NCT03280381|4061797|FG001|Overall Study|Physician Decision|2
2335497|NCT03280537|4061806|FG000|Overall Study|Withdrawal by Subject|2
2335498|NCT03280537|4061807|FG001|Overall Study|Withdrawal by Subject|4
2335499|NCT03280550|4061815|FG000|Overall Study|Withdrawal by Subject|2
2335500|NCT03280550|4061816|FG001|Overall Study|Withdrawal by Subject|2
2335501|NCT03280550|4061815|FG000|Overall Study|Physician Decision|0
2335502|NCT03280550|4061816|FG001|Overall Study|Physician Decision|1
2335503|NCT03280615|4061824|FG000|Overall Study|Lost to Follow-up|1
2335504|NCT03280615|4061825|FG001|Overall Study|Lost to Follow-up|2
2335505|NCT03280615|4061824|FG000|Overall Study|Adverse Event|1
2335506|NCT03280615|4061825|FG001|Overall Study|Adverse Event|1
2237768|NCT01903733|3893646|FG001|Overall Study|Missing|0
2237769|NCT01903733|3893647|FG002|Overall Study|Missing|0
2237770|NCT01903733|3893648|FG003|Overall Study|Missing|0
2237771|NCT01903733|3893645|FG000|Overall Study|Investigator request|18
2237772|NCT01903733|3893646|FG001|Overall Study|Investigator request|0
2237773|NCT01903733|3893647|FG002|Overall Study|Investigator request|0
2237774|NCT01903733|3893648|FG003|Overall Study|Investigator request|0
2237775|NCT01903811|3893687|FG000|Overall Study|No measurable disease|1
2237776|NCT01903811|3893688|FG001|Overall Study|No measurable disease|1
2237777|NCT01903811|3893687|FG000|Overall Study|Incomplete/discontinued prior therapy|1
2237778|NCT01903811|3893688|FG001|Overall Study|Incomplete/discontinued prior therapy|1
2237779|NCT01903811|3893687|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6
2237780|NCT01903811|3893688|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11
2237781|NCT01903811|3893687|FG000|Overall Study|Withdrawal by Subject|0
2237782|NCT01903811|3893688|FG001|Overall Study|Withdrawal by Subject|1
2237783|NCT01903837|3893701|FG000|Part A|Withdrawal by Subject|4
2237784|NCT01903837|3893702|FG001|Part A|Withdrawal by Subject|9
2237785|NCT01903837|3893703|FG002|Part A|Withdrawal by Subject|8
2237786|NCT01903837|3893704|FG003|Part A|Withdrawal by Subject|5
2237787|NCT01903837|3893701|FG000|Part A|Adverse Event|3
2237788|NCT01903837|3893702|FG001|Part A|Adverse Event|6
2237789|NCT01903837|3893703|FG002|Part A|Adverse Event|9
2237790|NCT01903837|3893704|FG003|Part A|Adverse Event|6
2237791|NCT01903837|3893701|FG000|Part A|Lost to Follow-up|9
2237792|NCT01903837|3893702|FG001|Part A|Lost to Follow-up|7
2237793|NCT01903837|3893703|FG002|Part A|Lost to Follow-up|7
2237794|NCT01903837|3893704|FG003|Part A|Lost to Follow-up|2
2237795|NCT01903837|3893701|FG000|Part A|Non-compliance with study drug|1
2237796|NCT01903837|3893702|FG001|Part A|Non-compliance with study drug|4
2237797|NCT01903837|3893703|FG002|Part A|Non-compliance with study drug|4
2237798|NCT01903837|3893704|FG003|Part A|Non-compliance with study drug|0
2335507|NCT03280615|4061824|FG000|Overall Study|Withdrawal by Subject|2
2335508|NCT03280615|4061825|FG001|Overall Study|Withdrawal by Subject|2
2335509|NCT03281304|4061837|FG000|Overall Study|Adverse Event|5
2335510|NCT03281304|4061838|FG001|Overall Study|Adverse Event|2
2335511|NCT03281304|4061837|FG000|Overall Study|Lack of Efficacy|2
2335512|NCT03281304|4061838|FG001|Overall Study|Lack of Efficacy|0
2335513|NCT03281304|4061837|FG000|Overall Study|Pregnancy|1
2335514|NCT03281304|4061838|FG001|Overall Study|Pregnancy|0
2335515|NCT03281304|4061837|FG000|Overall Study|Withdrawal by Subject|5
2335516|NCT03281304|4061838|FG001|Overall Study|Withdrawal by Subject|10
2335517|NCT03281577|4061852|FG000|Overall Study|Adverse Event|0
2335518|NCT03281577|4061853|FG001|Overall Study|Adverse Event|0
2335519|NCT03281577|4061854|FG002|Overall Study|Adverse Event|0
2335520|NCT03281577|4061855|FG003|Overall Study|Adverse Event|1
2335521|NCT03281577|4061852|FG000|Overall Study|Withdrawal by Subject|1
2335522|NCT03281577|4061853|FG001|Overall Study|Withdrawal by Subject|0
2335523|NCT03281577|4061854|FG002|Overall Study|Withdrawal by Subject|0
2335524|NCT03281577|4061855|FG003|Overall Study|Withdrawal by Subject|0
2335525|NCT03281668|4061868|FG000|Overall Study|Physician Decision|1
2335526|NCT03281668|4061868|FG000|Overall Study|scheduling conflict, family circumstance|2
2335527|NCT03281668|4061868|FG000|Overall Study|Withdrawal by Subject|4
2335528|NCT03281668|4061868|FG000|Overall Study|Lost to Follow-up|1
2335529|NCT03281876|4061874|FG000|Overall Study|Adverse Event|4
2335530|NCT03281876|4061875|FG001|Overall Study|Adverse Event|15
2335531|NCT03281876|4061874|FG000|Overall Study|Lost to Follow-up|1
2335532|NCT03281876|4061875|FG001|Overall Study|Lost to Follow-up|4
2335533|NCT03281876|4061874|FG000|Overall Study|Withdrawal by Subject|11
2335534|NCT03281876|4061875|FG001|Overall Study|Withdrawal by Subject|15
2335535|NCT03281876|4061874|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
2335536|NCT03281876|4061875|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
2036987|NCT00414609|3607238|FG001|Core Study|Abnormal laboratory values|1
2036988|NCT00414609|3607239|FG002|Core Study|Abnormal laboratory values|0
2036989|NCT00414609|3607237|FG000|Core Study|Abnormal test procedure results|1
2036990|NCT00414609|3607238|FG001|Core Study|Abnormal test procedure results|1
2036991|NCT00414609|3607239|FG002|Core Study|Abnormal test procedure results|0
2036992|NCT00414609|3607237|FG000|Core Study|Protocol deviation|0
2036993|NCT00414609|3607238|FG001|Core Study|Protocol deviation|1
2036994|NCT00414609|3607239|FG002|Core Study|Protocol deviation|0
2036995|NCT00414609|3607237|FG000|Core Study|Patient withdrew consent|10
2036996|NCT00414609|3607238|FG001|Core Study|Patient withdrew consent|11
2036997|NCT00414609|3607239|FG002|Core Study|Patient withdrew consent|0
2036998|NCT00414609|3607237|FG000|Core Study|Lost to Follow-up|7
2036999|NCT00414609|3607238|FG001|Core Study|Lost to Follow-up|4
2037000|NCT00414609|3607239|FG002|Core Study|Lost to Follow-up|0
2037001|NCT00414609|3607237|FG000|Core Study|Administrative problems|0
2037002|NCT00414609|3607238|FG001|Core Study|Administrative problems|2
2037003|NCT00414609|3607239|FG002|Core Study|Administrative problems|0
2037004|NCT00414609|3607237|FG000|Core Study|Death|7
2037005|NCT00414609|3607238|FG001|Core Study|Death|14
2037006|NCT00414609|3607239|FG002|Core Study|Death|0
2037007|NCT00414609|3607237|FG000|Extension Study|Adverse Event|0
2037008|NCT00414609|3607238|FG001|Extension Study|Adverse Event|0
2037009|NCT00414609|3607239|FG002|Extension Study|Adverse Event|14
2335537|NCT03281876|4061874|FG000|Overall Study|OTHER|5
2237799|NCT01903837|3893701|FG000|Part A|Physician Decision|1
2237800|NCT01903837|3893702|FG001|Part A|Physician Decision|1
2237801|NCT01903837|3893703|FG002|Part A|Physician Decision|0
2237802|NCT01903837|3893704|FG003|Part A|Physician Decision|0
2237803|NCT01903837|3893701|FG000|Part A|Protocol Violation|1
2237804|NCT01903837|3893702|FG001|Part A|Protocol Violation|1
2237805|NCT01903837|3893703|FG002|Part A|Protocol Violation|0
2237806|NCT01903837|3893704|FG003|Part A|Protocol Violation|0
2237807|NCT01903837|3893701|FG000|Part B|Lost to Follow-up|0
2237808|NCT01903837|3893702|FG001|Part B|Lost to Follow-up|3
2237809|NCT01903837|3893703|FG002|Part B|Lost to Follow-up|3
2237810|NCT01903837|3893704|FG003|Part B|Lost to Follow-up|4
2237811|NCT01903837|3893701|FG000|Part B|Withdrawal by Subject|1
2237812|NCT01903837|3893702|FG001|Part B|Withdrawal by Subject|2
2237813|NCT01903837|3893703|FG002|Part B|Withdrawal by Subject|0
2237814|NCT01903837|3893704|FG003|Part B|Withdrawal by Subject|3
2237815|NCT01903837|3893701|FG000|Part B|Adverse Event|3
2237816|NCT01903837|3893702|FG001|Part B|Adverse Event|0
2237817|NCT01903837|3893703|FG002|Part B|Adverse Event|2
2237818|NCT01903837|3893704|FG003|Part B|Adverse Event|0
2237819|NCT01903837|3893701|FG000|Part B|Non-compliance with study drug|2
2237820|NCT01903837|3893702|FG001|Part B|Non-compliance with study drug|0
2237821|NCT01903837|3893703|FG002|Part B|Non-compliance with study drug|0
2237822|NCT01903837|3893704|FG003|Part B|Non-compliance with study drug|1
2237823|NCT01903837|3893701|FG000|Part B|Incarceration|2
2237824|NCT01903837|3893702|FG001|Part B|Incarceration|0
2237825|NCT01903837|3893703|FG002|Part B|Incarceration|0
2237826|NCT01903837|3893704|FG003|Part B|Incarceration|1
2237827|NCT01903837|3893701|FG000|Part B|Physician Decision|1
2237828|NCT01903837|3893702|FG001|Part B|Physician Decision|0
2237829|NCT01903837|3893703|FG002|Part B|Physician Decision|0
2237830|NCT01903837|3893704|FG003|Part B|Physician Decision|2
2237831|NCT01903837|3893701|FG000|Part B|Lack of Efficacy|0
2237832|NCT01903837|3893702|FG001|Part B|Lack of Efficacy|1
2237833|NCT01903837|3893703|FG002|Part B|Lack of Efficacy|0
2237834|NCT01903837|3893704|FG003|Part B|Lack of Efficacy|0
2237835|NCT01903863|3893737|FG000|Overall Study|Physician Decision|2
2237836|NCT01903863|3893738|FG001|Overall Study|Physician Decision|0
2237837|NCT01903876|3893746|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184
2237838|NCT01903876|3893747|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108
2237839|NCT01903876|3893746|FG000|Six-Month Follow-up Period|Lost to Follow-up|91
2237840|NCT01903876|3893747|FG001|Six-Month Follow-up Period|Lost to Follow-up|145
2237841|NCT01903993|3893755|FG000|Overall Study|Death|118
2237842|NCT01903993|3893756|FG001|Overall Study|Death|121
2237843|NCT01903993|3893755|FG000|Overall Study|Withdrawal by Subject|15
2237844|NCT01903993|3893756|FG001|Overall Study|Withdrawal by Subject|4
2237845|NCT01903993|3893755|FG000|Overall Study|Lost to Follow-up|2
2237846|NCT01903993|3893756|FG001|Overall Study|Lost to Follow-up|3
2237847|NCT01903993|3893755|FG000|Overall Study|Study Terminated by Sponsor|8
2237848|NCT01903993|3893756|FG001|Overall Study|Study Terminated by Sponsor|14
2237849|NCT01903993|3893755|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
2335538|NCT03281876|4061875|FG001|Overall Study|OTHER|5
2335539|NCT03282227|4061892|FG000|Overall Study|Exposure Goals Achieved|60
2335540|NCT03282227|4061892|FG000|Overall Study|Non-compliance w/ protocol requirements|79
2335541|NCT03282227|4061892|FG000|Overall Study|Adverse Event|15
2335542|NCT03282227|4061892|FG000|Overall Study|Lost to Follow-up|21
2335543|NCT03282227|4061892|FG000|Overall Study|Withdrawal by Subject|20
2335544|NCT03282227|4061892|FG000|Overall Study|Lack of Efficacy|12
2335545|NCT03282227|4061892|FG000|Overall Study|Sponsor decision|3
2335546|NCT03282227|4061892|FG000|Overall Study|Physician Decision|2
2335547|NCT03282227|4061892|FG000|Overall Study|Pregnancy|2
2335548|NCT03282227|4061892|FG000|Overall Study|Other|1
2335549|NCT03282240|4061899|FG000|Overall Study|Adverse Event|2
2335550|NCT03282240|4061900|FG001|Overall Study|Adverse Event|2
2335551|NCT03282240|4061901|FG002|Overall Study|Adverse Event|0
2335552|NCT03282240|4061899|FG000|Overall Study|Lost to Follow-up|3
2335553|NCT03282240|4061900|FG001|Overall Study|Lost to Follow-up|0
2335554|NCT03282240|4061901|FG002|Overall Study|Lost to Follow-up|0
2335555|NCT03282240|4061899|FG000|Overall Study|Protocol Deviation|4
2335556|NCT03282240|4061900|FG001|Overall Study|Protocol Deviation|1
2335557|NCT03282240|4061901|FG002|Overall Study|Protocol Deviation|2
2335558|NCT03282240|4061899|FG000|Overall Study|Withdrawal by Subject|1
2335559|NCT03282240|4061900|FG001|Overall Study|Withdrawal by Subject|0
2335560|NCT03282240|4061901|FG002|Overall Study|Withdrawal by Subject|1
2335561|NCT03282357|4061912|FG000|Overall Study|Lost to Follow-up|3
2335562|NCT03282357|4061912|FG000|Overall Study|Withdrawal by Subject|4
2335563|NCT03282357|4061912|FG000|Overall Study|Adverse Event|1
2335564|NCT03282357|4061912|FG000|Overall Study|Other|9
2335565|NCT03283098|4061942|FG000|Overall Study|Withdrawal by Subject|0
2335566|NCT03283098|4061943|FG001|Overall Study|Withdrawal by Subject|1
2335567|NCT03283319|4061955|FG000|Overall Study|Lost to Follow-up|5
2237850|NCT01903993|3893756|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
2335568|NCT03283319|4061956|FG001|Overall Study|Lost to Follow-up|4
2335569|NCT03283319|4061957|FG002|Overall Study|Lost to Follow-up|5
2335570|NCT03283319|4061958|FG003|Overall Study|Lost to Follow-up|5
2335571|NCT03283319|4061959|FG004|Overall Study|Lost to Follow-up|4
2237851|NCT01904019|3893763|FG000|1 Year Follow-up|Withdrawal by Subject|4
2237852|NCT01904019|3893763|FG000|1 Year Follow-up|Impossibility to contact patient|5
2237853|NCT01904019|3893763|FG000|3 Year Follow-up|Withdrawal by Subject|1
2237854|NCT01904019|3893763|FG000|3 Year Follow-up|Impossibility to contact patient|14
2237855|NCT01904019|3893763|FG000|5 Year Follow-up|Withdrawal by Subject|2
2237856|NCT01904019|3893763|FG000|5 Year Follow-up|Impossibility to contact patient|4
2237857|NCT01904058|3893771|FG000|Overall Study|Adverse Event|2
2237858|NCT01904058|3893772|FG001|Overall Study|Adverse Event|0
2237859|NCT01904058|3893773|FG002|Overall Study|Adverse Event|0
2237860|NCT01904058|3893774|FG003|Overall Study|Adverse Event|0
2237861|NCT01904058|3893771|FG000|Overall Study|Withdrawal by Subject|1
2237862|NCT01904058|3893772|FG001|Overall Study|Withdrawal by Subject|0
2237863|NCT01904058|3893773|FG002|Overall Study|Withdrawal by Subject|1
2237864|NCT01904058|3893774|FG003|Overall Study|Withdrawal by Subject|0
2237865|NCT01904058|3893771|FG000|Overall Study|Pregnancy|0
2237866|NCT01904058|3893772|FG001|Overall Study|Pregnancy|0
2237867|NCT01904058|3893773|FG002|Overall Study|Pregnancy|0
2237868|NCT01904058|3893774|FG003|Overall Study|Pregnancy|1
2237869|NCT01904149|3893809|FG000|Overall Study|Adverse Event|3
2237870|NCT01904149|3893810|FG001|Overall Study|Adverse Event|4
2237871|NCT01904149|3893811|FG002|Overall Study|Adverse Event|0
2237872|NCT01904149|3893812|FG003|Overall Study|Adverse Event|1
2237873|NCT01904149|3893813|FG004|Overall Study|Adverse Event|1
2237874|NCT01904149|3893814|FG005|Overall Study|Adverse Event|2
2237875|NCT01904149|3893809|FG000|Overall Study|Lack of Efficacy|0
2237876|NCT01904149|3893810|FG001|Overall Study|Lack of Efficacy|3
2237877|NCT01904149|3893811|FG002|Overall Study|Lack of Efficacy|1
2335572|NCT03283319|4061960|FG005|Overall Study|Lost to Follow-up|3
2335573|NCT03283319|4061955|FG000|Overall Study|Withdrawal by Subject|2
2335574|NCT03283319|4061956|FG001|Overall Study|Withdrawal by Subject|2
2335575|NCT03283319|4061957|FG002|Overall Study|Withdrawal by Subject|2
2335576|NCT03283319|4061958|FG003|Overall Study|Withdrawal by Subject|1
2335577|NCT03283319|4061959|FG004|Overall Study|Withdrawal by Subject|0
2335578|NCT03283319|4061960|FG005|Overall Study|Withdrawal by Subject|1
2335579|NCT03283319|4061955|FG000|Overall Study|BARDA regulatory agency or IRB decision|0
2335580|NCT03283319|4061956|FG001|Overall Study|BARDA regulatory agency or IRB decision|0
2335581|NCT03283319|4061957|FG002|Overall Study|BARDA regulatory agency or IRB decision|0
2335582|NCT03283319|4061958|FG003|Overall Study|BARDA regulatory agency or IRB decision|1
2335583|NCT03283319|4061959|FG004|Overall Study|BARDA regulatory agency or IRB decision|0
2335584|NCT03283319|4061960|FG005|Overall Study|BARDA regulatory agency or IRB decision|0
2335585|NCT03283553|4061985|FG000|Patient Participant Flow|Death|5
2335586|NCT03283553|4061986|FG001|Patient Participant Flow|Death|10
2335587|NCT03283553|4061985|FG000|Patient Participant Flow|Withdrawal by Subject|4
2335588|NCT03283553|4061986|FG001|Patient Participant Flow|Withdrawal by Subject|2
2335589|NCT03283553|4061985|FG000|Patient Participant Flow|Lost to Follow-up|1
2335590|NCT03283553|4061986|FG001|Patient Participant Flow|Lost to Follow-up|1
2335591|NCT03283553|4061985|FG000|Care Partner Participant Flow|Withdrawal by Subject|4
2335592|NCT03283553|4061986|FG001|Care Partner Participant Flow|Withdrawal by Subject|3
2335593|NCT03283553|4061985|FG000|Care Partner Participant Flow|Lost to Follow-up|1
2335594|NCT03283553|4061986|FG001|Care Partner Participant Flow|Lost to Follow-up|1
2335595|NCT03283553|4061985|FG000|Care Partner Participant Flow|Discontinued because patient death|5
2335596|NCT03283553|4061986|FG001|Care Partner Participant Flow|Discontinued because patient death|11
2335597|NCT03283696|4061996|FG000|Overall Study|Physician Decision|5
2335598|NCT03283696|4061997|FG001|Overall Study|Physician Decision|6
2335599|NCT03283696|4061996|FG000|Overall Study|Withdrawal by Subject|2
2335600|NCT03283696|4061997|FG001|Overall Study|Withdrawal by Subject|0
2335601|NCT03284229|4062019|FG000|Overall Study|Lost to Follow-up|3
2335602|NCT03284424|4062055|FG000|Overall Study|Death|56
2335603|NCT03284424|4062056|FG001|Overall Study|Death|13
2335604|NCT03284424|4062055|FG000|Overall Study|Lost to Follow-up|1
2335605|NCT03284424|4062056|FG001|Overall Study|Lost to Follow-up|0
2335606|NCT03284424|4062055|FG000|Overall Study|Physician Decision|1
2335607|NCT03284424|4062056|FG001|Overall Study|Physician Decision|0
2335608|NCT03284424|4062055|FG000|Overall Study|Withdrawal by Subject|3
2335609|NCT03284424|4062056|FG001|Overall Study|Withdrawal by Subject|2
2335610|NCT03284424|4062055|FG000|Overall Study|Ongoing in study|44
2335611|NCT03284424|4062056|FG001|Overall Study|Ongoing in study|39
2335612|NCT03284710|4062065|FG000|Overall Study|Withdrawal by Subject|1
2335613|NCT03284710|4062066|FG001|Overall Study|Withdrawal by Subject|0
2335614|NCT03284710|4062067|FG002|Overall Study|Withdrawal by Subject|1
2335615|NCT03284710|4062068|FG003|Overall Study|Withdrawal by Subject|6
2335616|NCT03284710|4062065|FG000|Overall Study|Lost to Follow-up|3
2335617|NCT03284710|4062066|FG001|Overall Study|Lost to Follow-up|3
2335618|NCT03284710|4062067|FG002|Overall Study|Lost to Follow-up|1
2335619|NCT03284710|4062068|FG003|Overall Study|Lost to Follow-up|0
2335620|NCT03284710|4062065|FG000|Overall Study|Physician Decision|1
2335621|NCT03284710|4062066|FG001|Overall Study|Physician Decision|0
2335622|NCT03284710|4062067|FG002|Overall Study|Physician Decision|0
2335623|NCT03284710|4062068|FG003|Overall Study|Physician Decision|0
2237878|NCT01904149|3893812|FG003|Overall Study|Lack of Efficacy|3
2335624|NCT03284710|4062065|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1
2335625|NCT03284710|4062066|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0
2335626|NCT03284710|4062067|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0
2352939|NCT03725722|4103251|FG000|Overall Study|Personal reasons|0
2237879|NCT01904149|3893813|FG004|Overall Study|Lack of Efficacy|3
2237880|NCT01904149|3893814|FG005|Overall Study|Lack of Efficacy|1
2237881|NCT01904149|3893809|FG000|Overall Study|Withdrawal by Subject|1
2237882|NCT01904149|3893810|FG001|Overall Study|Withdrawal by Subject|3
2237883|NCT01904149|3893811|FG002|Overall Study|Withdrawal by Subject|1
2237884|NCT01904149|3893812|FG003|Overall Study|Withdrawal by Subject|0
2237885|NCT01904149|3893813|FG004|Overall Study|Withdrawal by Subject|1
2237886|NCT01904149|3893814|FG005|Overall Study|Withdrawal by Subject|0
2237887|NCT01904149|3893809|FG000|Overall Study|Protocol Violation|0
2237888|NCT01904149|3893810|FG001|Overall Study|Protocol Violation|1
2237889|NCT01904149|3893811|FG002|Overall Study|Protocol Violation|0
2237890|NCT01904149|3893812|FG003|Overall Study|Protocol Violation|0
2237891|NCT01904149|3893813|FG004|Overall Study|Protocol Violation|0
2237892|NCT01904149|3893814|FG005|Overall Study|Protocol Violation|0
2237893|NCT01904149|3893809|FG000|Overall Study|non compliance with study drug|1
2237894|NCT01904149|3893810|FG001|Overall Study|non compliance with study drug|0
2237895|NCT01904149|3893811|FG002|Overall Study|non compliance with study drug|0
2237896|NCT01904149|3893812|FG003|Overall Study|non compliance with study drug|0
2237897|NCT01904149|3893813|FG004|Overall Study|non compliance with study drug|0
2237898|NCT01904149|3893814|FG005|Overall Study|non compliance with study drug|0
2237899|NCT01904383|3893830|FG000|Overall Study|CRF not collected|117
2237900|NCT01904383|3893830|FG000|Overall Study|Reason not listed|147
2237901|NCT01904383|3893830|FG000|Overall Study|Lost to Follow-up|674
2237902|NCT01904383|3893830|FG000|Overall Study|Lack of Efficacy|370
2237903|NCT01904383|3893830|FG000|Overall Study|Improvement|141
2237904|NCT01904383|3893830|FG000|Overall Study|Adverse Event|271
2237905|NCT01904383|3893830|FG000|Overall Study|No patient visit after entry|54
2237906|NCT01904604|3893850|FG000|Overall Study|Withdrew before receiving dosing|0
2237907|NCT01904604|3893851|FG001|Overall Study|Withdrew before receiving dosing|1
2237908|NCT01904604|3893852|FG002|Overall Study|Withdrew before receiving dosing|0
2237909|NCT01904604|3893850|FG000|Overall Study|Non-compliance|1
2237910|NCT01904604|3893851|FG001|Overall Study|Non-compliance|0
2237911|NCT01904604|3893852|FG002|Overall Study|Non-compliance|0
2237912|NCT01904604|3893850|FG000|Overall Study|Anxiety about OFC/Refused OFC|2
2237913|NCT01904604|3893851|FG001|Overall Study|Anxiety about OFC/Refused OFC|0
2237914|NCT01904604|3893852|FG002|Overall Study|Anxiety about OFC/Refused OFC|0
2335627|NCT03284710|4062068|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1
2335628|NCT03284710|4062065|FG000|Overall Study|HIV Infection|0
2335629|NCT03284710|4062066|FG001|Overall Study|HIV Infection|2
2335630|NCT03284710|4062067|FG002|Overall Study|HIV Infection|2
2335631|NCT03284710|4062068|FG003|Overall Study|HIV Infection|1
2335632|NCT03285113|4062092|FG000|Overall Study|Unable to implant leads|2
2335633|NCT03285295|4062101|FG000|Alinity s HBsAg|Protocol Violation|11
2335634|NCT03285295|4062102|FG001|Alinity s HBsAg|Protocol Violation|0
2335635|NCT03285295|4062103|FG002|Alinity s HBsAg|Protocol Violation|0
2335636|NCT03285295|4062104|FG003|Alinity s HBsAg|Protocol Violation|0
2335637|NCT03285295|4062105|FG004|Alinity s HBsAg|Protocol Violation|0
2335638|NCT03285295|4062101|FG000|Alinity s HBsAg|No Result on Comparator Assay|17
2335639|NCT03285295|4062102|FG001|Alinity s HBsAg|No Result on Comparator Assay|0
2335640|NCT03285295|4062103|FG002|Alinity s HBsAg|No Result on Comparator Assay|0
2335641|NCT03285295|4062104|FG003|Alinity s HBsAg|No Result on Comparator Assay|0
2335642|NCT03285295|4062105|FG004|Alinity s HBsAg|No Result on Comparator Assay|0
2335643|NCT03285295|4062101|FG000|Alinity s HBsAg|No Results Generated|74
2335644|NCT03285295|4062102|FG001|Alinity s HBsAg|No Results Generated|6
2335645|NCT03285295|4062103|FG002|Alinity s HBsAg|No Results Generated|0
2335646|NCT03285295|4062104|FG003|Alinity s HBsAg|No Results Generated|0
2335647|NCT03285295|4062105|FG004|Alinity s HBsAg|No Results Generated|0
2335648|NCT03285295|4062101|FG000|Alinity s HTLV I/II|Protocol Violation|6
2335649|NCT03285295|4062102|FG001|Alinity s HTLV I/II|Protocol Violation|0
2335650|NCT03285295|4062103|FG002|Alinity s HTLV I/II|Protocol Violation|0
2335651|NCT03285295|4062104|FG003|Alinity s HTLV I/II|Protocol Violation|0
2335652|NCT03285295|4062105|FG004|Alinity s HTLV I/II|Protocol Violation|0
2335653|NCT03285295|4062101|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15
2335654|NCT03285295|4062102|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0
2335655|NCT03285295|4062103|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0
2335656|NCT03285295|4062104|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0
2335657|NCT03285295|4062105|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0
2335658|NCT03285295|4062101|FG000|Alinity s HTLV I/II|No Results Generated|70
2335659|NCT03285295|4062102|FG001|Alinity s HTLV I/II|No Results Generated|0
2335660|NCT03285295|4062103|FG002|Alinity s HTLV I/II|No Results Generated|0
2335661|NCT03285295|4062104|FG003|Alinity s HTLV I/II|No Results Generated|0
2335662|NCT03285295|4062105|FG004|Alinity s HTLV I/II|No Results Generated|0
2335663|NCT03285295|4062101|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
2335664|NCT03285295|4062102|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2335665|NCT03285295|4062103|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2335666|NCT03285295|4062104|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2335667|NCT03285295|4062105|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2335668|NCT03285295|4062101|FG000|Alinity s Anti-HCV|Protocol Violation|12
2335669|NCT03285295|4062102|FG001|Alinity s Anti-HCV|Protocol Violation|0
2335670|NCT03285295|4062103|FG002|Alinity s Anti-HCV|Protocol Violation|0
2237915|NCT01904604|3893850|FG000|Overall Study|Patch site reactions|1
2237916|NCT01904604|3893851|FG001|Overall Study|Patch site reactions|1
2237917|NCT01904604|3893852|FG002|Overall Study|Patch site reactions|0
2237918|NCT01904604|3893850|FG000|Overall Study|Increased syncope|0
2237919|NCT01904604|3893851|FG001|Overall Study|Increased syncope|1
2237920|NCT01904604|3893852|FG002|Overall Study|Increased syncope|0
2237921|NCT01904604|3893850|FG000|Overall Study|Unrelated illness|0
2237922|NCT01904604|3893851|FG001|Overall Study|Unrelated illness|1
2237923|NCT01904604|3893852|FG002|Overall Study|Unrelated illness|0
2237924|NCT01904604|3893850|FG000|Overall Study|Passed Week 52 OFC|1
2237925|NCT01904604|3893851|FG001|Overall Study|Passed Week 52 OFC|0
2237926|NCT01904604|3893852|FG002|Overall Study|Passed Week 52 OFC|0
2237927|NCT01904604|3893850|FG000|Overall Study|Withdrawal by Subject|1
2237928|NCT01904604|3893851|FG001|Overall Study|Withdrawal by Subject|2
2237929|NCT01904604|3893852|FG002|Overall Study|Withdrawal by Subject|0
2237930|NCT01904604|3893850|FG000|Overall Study|Participant Relocated|1
2237931|NCT01904604|3893851|FG001|Overall Study|Participant Relocated|1
2237932|NCT01904604|3893852|FG002|Overall Study|Participant Relocated|1
2237933|NCT01904604|3893850|FG000|Overall Study|Lost to Follow-up|0
2237934|NCT01904604|3893851|FG001|Overall Study|Lost to Follow-up|0
2237935|NCT01904604|3893852|FG002|Overall Study|Lost to Follow-up|1
2237936|NCT01904721|3893870|FG000|Overall Study|Other Reasons|0
2237937|NCT01904721|3893871|FG001|Overall Study|Other Reasons|0
2237938|NCT01904721|3893872|FG002|Overall Study|Other Reasons|1
2237939|NCT01904721|3893873|FG003|Overall Study|Other Reasons|1
2237940|NCT01904721|3893874|FG004|Overall Study|Other Reasons|2
2237941|NCT01904721|3893875|FG005|Overall Study|Other Reasons|2
2237942|NCT01904721|3893876|FG006|Overall Study|Other Reasons|2
2237943|NCT01904721|3893870|FG000|Overall Study|Personal Reasons|0
2335671|NCT03285295|4062104|FG003|Alinity s Anti-HCV|Protocol Violation|0
2335672|NCT03285295|4062105|FG004|Alinity s Anti-HCV|Protocol Violation|0
2335673|NCT03285295|4062101|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13
2335674|NCT03285295|4062102|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0
2335675|NCT03285295|4062103|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0
2335676|NCT03285295|4062104|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0
2335677|NCT03285295|4062105|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0
2335678|NCT03285295|4062101|FG000|Alinity s Anti-HCV|No Results Generated|71
2335679|NCT03285295|4062102|FG001|Alinity s Anti-HCV|No Results Generated|0
2335680|NCT03285295|4062103|FG002|Alinity s Anti-HCV|No Results Generated|0
2335681|NCT03285295|4062104|FG003|Alinity s Anti-HCV|No Results Generated|0
2335682|NCT03285295|4062105|FG004|Alinity s Anti-HCV|No Results Generated|0
2335683|NCT03285295|4062101|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
2335684|NCT03285295|4062102|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2335685|NCT03285295|4062103|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2335686|NCT03285295|4062104|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2335687|NCT03285295|4062105|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2335688|NCT03285295|4062101|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
2335689|NCT03285295|4062102|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2335690|NCT03285295|4062103|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2335691|NCT03285295|4062104|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2335692|NCT03285295|4062105|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2335693|NCT03285295|4062101|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
2335694|NCT03285295|4062102|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2335695|NCT03285295|4062103|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2335696|NCT03285295|4062104|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2335697|NCT03285295|4062105|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2335698|NCT03285295|4062101|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72
2335699|NCT03285295|4062102|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2335700|NCT03285295|4062103|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2335701|NCT03285295|4062104|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2335702|NCT03285295|4062105|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2335703|NCT03285295|4062101|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
2335704|NCT03285295|4062102|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2335705|NCT03285295|4062103|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2335706|NCT03285295|4062104|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2237944|NCT01904721|3893871|FG001|Overall Study|Personal Reasons|0
2237945|NCT01904721|3893872|FG002|Overall Study|Personal Reasons|0
2237946|NCT01904721|3893873|FG003|Overall Study|Personal Reasons|0
2237947|NCT01904721|3893874|FG004|Overall Study|Personal Reasons|2
2237948|NCT01904721|3893875|FG005|Overall Study|Personal Reasons|3
2237949|NCT01904721|3893876|FG006|Overall Study|Personal Reasons|3
2237950|NCT01904721|3893870|FG000|Overall Study|Lost to Follow-up|0
2237951|NCT01904721|3893871|FG001|Overall Study|Lost to Follow-up|0
2237952|NCT01904721|3893872|FG002|Overall Study|Lost to Follow-up|0
2237953|NCT01904721|3893873|FG003|Overall Study|Lost to Follow-up|0
2237954|NCT01904721|3893874|FG004|Overall Study|Lost to Follow-up|1
2237955|NCT01904721|3893875|FG005|Overall Study|Lost to Follow-up|3
2237956|NCT01904721|3893876|FG006|Overall Study|Lost to Follow-up|1
2237957|NCT01904721|3893870|FG000|Overall Study|Lack of Efficacy|0
2237958|NCT01904721|3893871|FG001|Overall Study|Lack of Efficacy|0
2237959|NCT01904721|3893872|FG002|Overall Study|Lack of Efficacy|0
2237960|NCT01904721|3893873|FG003|Overall Study|Lack of Efficacy|0
2237961|NCT01904721|3893874|FG004|Overall Study|Lack of Efficacy|0
2237962|NCT01904721|3893875|FG005|Overall Study|Lack of Efficacy|0
2237963|NCT01904721|3893876|FG006|Overall Study|Lack of Efficacy|1
2237964|NCT01904721|3893870|FG000|Overall Study|Adverse Event|0
2237965|NCT01904721|3893871|FG001|Overall Study|Adverse Event|0
2237966|NCT01904721|3893872|FG002|Overall Study|Adverse Event|0
2237967|NCT01904721|3893873|FG003|Overall Study|Adverse Event|0
2237968|NCT01904721|3893874|FG004|Overall Study|Adverse Event|3
2237969|NCT01904721|3893875|FG005|Overall Study|Adverse Event|1
2237970|NCT01904721|3893876|FG006|Overall Study|Adverse Event|0
2237971|NCT01904760|3893890|FG000|Overall Study|Protocol Violation|1
2237972|NCT01904760|3893891|FG001|Overall Study|Protocol Violation|0
2237973|NCT01904773|3893897|FG000|Screen|Screen failure|3
2237974|NCT01904773|3893898|FG001|Screen|Screen failure|0
2237975|NCT01904773|3893899|FG002|Screen|Screen failure|0
2237976|NCT01904773|3893900|FG003|Screen|Screen failure|0
2237977|NCT01904773|3893901|FG004|Screen|Screen failure|0
2237978|NCT01904773|3893902|FG005|Screen|Screen failure|0
2237979|NCT01904773|3893903|FG006|Screen|Screen failure|0
2237980|NCT01904773|3893904|FG007|Screen|Screen failure|0
2237981|NCT01904773|3893905|FG008|Screen|Screen failure|0
2237982|NCT01904773|3893897|FG000|Screen|Withdrawal by Subject|1
2237983|NCT01904773|3893898|FG001|Screen|Withdrawal by Subject|0
2237984|NCT01904773|3893899|FG002|Screen|Withdrawal by Subject|0
2237985|NCT01904773|3893900|FG003|Screen|Withdrawal by Subject|0
2237986|NCT01904773|3893901|FG004|Screen|Withdrawal by Subject|0
2237987|NCT01904773|3893902|FG005|Screen|Withdrawal by Subject|0
2237988|NCT01904773|3893903|FG006|Screen|Withdrawal by Subject|0
2237989|NCT01904773|3893904|FG007|Screen|Withdrawal by Subject|0
2237990|NCT01904773|3893905|FG008|Screen|Withdrawal by Subject|0
2237991|NCT01904773|3893897|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
2237992|NCT01904773|3893898|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2237993|NCT01904773|3893899|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2237994|NCT01904773|3893900|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2335707|NCT03285295|4062105|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2335708|NCT03285295|4062101|FG000|Alinity s Anti-HBc|Protocol Violation|8
2335709|NCT03285295|4062102|FG001|Alinity s Anti-HBc|Protocol Violation|0
2335710|NCT03285295|4062103|FG002|Alinity s Anti-HBc|Protocol Violation|0
2335711|NCT03285295|4062104|FG003|Alinity s Anti-HBc|Protocol Violation|0
2335712|NCT03285295|4062105|FG004|Alinity s Anti-HBc|Protocol Violation|0
2335713|NCT03285295|4062101|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13
2335714|NCT03285295|4062102|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1
2335715|NCT03285295|4062103|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0
2335716|NCT03285295|4062104|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0
2335717|NCT03285295|4062105|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0
2335718|NCT03285295|4062101|FG000|Alinity s Anti-HBc|No Results Generated|70
2335719|NCT03285295|4062102|FG001|Alinity s Anti-HBc|No Results Generated|0
2335720|NCT03285295|4062103|FG002|Alinity s Anti-HBc|No Results Generated|0
2335721|NCT03285295|4062104|FG003|Alinity s Anti-HBc|No Results Generated|0
2335722|NCT03285295|4062105|FG004|Alinity s Anti-HBc|No Results Generated|0
2335723|NCT03285295|4062101|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
2335724|NCT03285295|4062102|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2335725|NCT03285295|4062103|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2335726|NCT03285295|4062104|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2335727|NCT03285295|4062105|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2335728|NCT03285295|4062101|FG000|Alinity s Chagas|Protocol Violation|76
2335729|NCT03285295|4062102|FG001|Alinity s Chagas|Protocol Violation|0
2335730|NCT03285295|4062103|FG002|Alinity s Chagas|Protocol Violation|0
2335731|NCT03285295|4062104|FG003|Alinity s Chagas|Protocol Violation|0
2335732|NCT03285295|4062105|FG004|Alinity s Chagas|Protocol Violation|0
2335733|NCT03285295|4062101|FG000|Alinity s Chagas|No Results on Comparator Assay|38
2335734|NCT03285295|4062102|FG001|Alinity s Chagas|No Results on Comparator Assay|0
2335735|NCT03285295|4062103|FG002|Alinity s Chagas|No Results on Comparator Assay|0
2335736|NCT03285295|4062104|FG003|Alinity s Chagas|No Results on Comparator Assay|0
2335737|NCT03285295|4062105|FG004|Alinity s Chagas|No Results on Comparator Assay|0
2335738|NCT03285295|4062101|FG000|Alinity s Chagas|No Results Generated|105
2237995|NCT01904773|3893901|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2237996|NCT01904773|3893902|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2237997|NCT01904773|3893903|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2237998|NCT01904773|3893904|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2237999|NCT01904773|3893905|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2238000|NCT01904773|3893897|FG000|First Intervention|Adverse Event|0
2238001|NCT01904773|3893898|FG001|First Intervention|Adverse Event|0
2238002|NCT01904773|3893899|FG002|First Intervention|Adverse Event|0
2238003|NCT01904773|3893900|FG003|First Intervention|Adverse Event|0
2238004|NCT01904773|3893901|FG004|First Intervention|Adverse Event|0
2238005|NCT01904773|3893902|FG005|First Intervention|Adverse Event|0
2238006|NCT01904773|3893903|FG006|First Intervention|Adverse Event|1
2238007|NCT01904773|3893904|FG007|First Intervention|Adverse Event|0
2238008|NCT01904773|3893905|FG008|First Intervention|Adverse Event|0
2238009|NCT01904773|3893897|FG000|Placebo Washout First Intervention|Condition worsened|0
2238010|NCT01904773|3893898|FG001|Placebo Washout First Intervention|Condition worsened|1
2238011|NCT01904773|3893899|FG002|Placebo Washout First Intervention|Condition worsened|0
2238012|NCT01904773|3893900|FG003|Placebo Washout First Intervention|Condition worsened|0
2238013|NCT01904773|3893901|FG004|Placebo Washout First Intervention|Condition worsened|0
2238014|NCT01904773|3893902|FG005|Placebo Washout First Intervention|Condition worsened|0
2238015|NCT01904773|3893903|FG006|Placebo Washout First Intervention|Condition worsened|0
2238016|NCT01904773|3893904|FG007|Placebo Washout First Intervention|Condition worsened|0
2238017|NCT01904773|3893905|FG008|Placebo Washout First Intervention|Condition worsened|0
2238018|NCT01904773|3893897|FG000|Fifth Intervention|Adverse Event|0
2238019|NCT01904773|3893898|FG001|Fifth Intervention|Adverse Event|0
2238020|NCT01904773|3893899|FG002|Fifth Intervention|Adverse Event|0
2238021|NCT01904773|3893900|FG003|Fifth Intervention|Adverse Event|0
2238022|NCT01904773|3893901|FG004|Fifth Intervention|Adverse Event|0
2238023|NCT01904773|3893902|FG005|Fifth Intervention|Adverse Event|0
2238024|NCT01904773|3893903|FG006|Fifth Intervention|Adverse Event|0
2238025|NCT01904773|3893904|FG007|Fifth Intervention|Adverse Event|1
2238026|NCT01904773|3893905|FG008|Fifth Intervention|Adverse Event|0
2238027|NCT01904773|3893897|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2238028|NCT01904773|3893898|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
2238029|NCT01904773|3893899|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2238030|NCT01904773|3893900|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2238031|NCT01904773|3893901|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2238032|NCT01904773|3893902|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2238033|NCT01904773|3893903|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2238034|NCT01904773|3893904|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2238035|NCT01904773|3893905|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2238036|NCT01904903|3893926|FG000|Overall Study|Withdrawal by Subject|1
2238037|NCT01905267|3893940|FG000|Overall Study|Physician Decision|2
2238038|NCT01905267|3893941|FG001|Overall Study|Physician Decision|2
2238039|NCT01905540|3893972|FG000|Period 3|Other|1
2238040|NCT01905540|3893973|FG001|Period 3|Other|0
2238041|NCT01905540|3893974|FG002|Period 3|Other|1
2238042|NCT01905540|3893975|FG003|Period 3|Other|1
2238043|NCT01905553|3893987|FG000|Period 2|Adverse Event|1
2238044|NCT01905553|3893988|FG001|Period 2|Adverse Event|0
2238045|NCT01905592|3893996|FG000|Overall Study|Disease Progression|51
2238046|NCT01905592|3893997|FG001|Overall Study|Disease Progression|104
2238047|NCT01905592|3893996|FG000|Overall Study|Toxicity|1
2238048|NCT01905592|3893997|FG001|Overall Study|Toxicity|16
2238049|NCT01905592|3893996|FG000|Overall Study|Physician Decision|0
2238050|NCT01905592|3893997|FG001|Overall Study|Physician Decision|2
2238051|NCT01905592|3893996|FG000|Overall Study|New anti-cancer|1
2238052|NCT01905592|3893997|FG001|Overall Study|New anti-cancer|0
2238053|NCT01905592|3893996|FG000|Overall Study|Protocol Violation|0
2238054|NCT01905592|3893997|FG001|Overall Study|Protocol Violation|1
2238055|NCT01905592|3893996|FG000|Overall Study|Sponsor's decision|1
2238056|NCT01905592|3893997|FG001|Overall Study|Sponsor's decision|0
2238057|NCT01905592|3893996|FG000|Overall Study|Not treated|7
2238058|NCT01905592|3893997|FG001|Overall Study|Not treated|3
2238059|NCT01905592|3893996|FG000|Overall Study|Ongoing in Study|0
2238060|NCT01905592|3893997|FG001|Overall Study|Ongoing in Study|7
2238061|NCT01905592|3893996|FG000|Overall Study|Withdrawal by Subject|10
2238062|NCT01905592|3893997|FG001|Overall Study|Withdrawal by Subject|2
2238063|NCT01905657|3894006|FG000|Overall Study|Adverse Event|23
2238064|NCT01905657|3894007|FG001|Overall Study|Adverse Event|17
2238065|NCT01905657|3894008|FG002|Overall Study|Adverse Event|18
2238066|NCT01905657|3894006|FG000|Overall Study|Clinical Progression|103
2238067|NCT01905657|3894007|FG001|Overall Study|Clinical Progression|78
2238068|NCT01905657|3894008|FG002|Overall Study|Clinical Progression|59
2238069|NCT01905657|3894006|FG000|Overall Study|Death|40
2238070|NCT01905657|3894007|FG001|Overall Study|Death|43
2238071|NCT01905657|3894008|FG002|Overall Study|Death|47
2238072|NCT01905657|3894006|FG000|Overall Study|Excluded Medication|13
2238073|NCT01905657|3894007|FG001|Overall Study|Excluded Medication|16
2238074|NCT01905657|3894008|FG002|Overall Study|Excluded Medication|9
2238075|NCT01905657|3894006|FG000|Overall Study|Lost to Follow-up|1
2238076|NCT01905657|3894007|FG001|Overall Study|Lost to Follow-up|2
2238077|NCT01905657|3894008|FG002|Overall Study|Lost to Follow-up|1
2238078|NCT01905657|3894006|FG000|Overall Study|Physician Decision|5
2238079|NCT01905657|3894007|FG001|Overall Study|Physician Decision|8
2238080|NCT01905657|3894008|FG002|Overall Study|Physician Decision|12
2238081|NCT01905657|3894006|FG000|Overall Study|Protocol Violation|2
2238082|NCT01905657|3894007|FG001|Overall Study|Protocol Violation|1
2238083|NCT01905657|3894008|FG002|Overall Study|Protocol Violation|1
2238084|NCT01905657|3894006|FG000|Overall Study|Screen Failure|0
2238085|NCT01905657|3894007|FG001|Overall Study|Screen Failure|1
2238086|NCT01905657|3894008|FG002|Overall Study|Screen Failure|0
2238087|NCT01905657|3894006|FG000|Overall Study|Withdrawal by Subject|15
2238088|NCT01905657|3894007|FG001|Overall Study|Withdrawal by Subject|21
2335739|NCT03285295|4062102|FG001|Alinity s Chagas|No Results Generated|0
2335740|NCT03285295|4062103|FG002|Alinity s Chagas|No Results Generated|0
2335741|NCT03285295|4062104|FG003|Alinity s Chagas|No Results Generated|0
2335742|NCT03285295|4062105|FG004|Alinity s Chagas|No Results Generated|0
2335743|NCT03285295|4062101|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13
2335744|NCT03285295|4062102|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2335745|NCT03285295|4062103|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2335746|NCT03285295|4062104|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2335747|NCT03285295|4062105|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2335748|NCT03285308|4062136|FG000|Overall Study|Adverse Event|3
2335749|NCT03285308|4062137|FG001|Overall Study|Adverse Event|7
2335750|NCT03285308|4062136|FG000|Overall Study|Withdrawal by Subject|8
2335751|NCT03285308|4062137|FG001|Overall Study|Withdrawal by Subject|9
2335752|NCT03285308|4062136|FG000|Overall Study|Lost to Follow-up|3
2335753|NCT03285308|4062137|FG001|Overall Study|Lost to Follow-up|1
2335754|NCT03285308|4062136|FG000|Overall Study|Protocol Deviation|6
2335755|NCT03285308|4062137|FG001|Overall Study|Protocol Deviation|5
2335756|NCT03285308|4062136|FG000|Overall Study|Reason not Specified|0
2335757|NCT03285308|4062137|FG001|Overall Study|Reason not Specified|1
2335758|NCT03285477|4062158|FG000|Treatment and Response Assessment Period|Death|1
2335759|NCT03285477|4062159|FG001|Treatment and Response Assessment Period|Death|0
2335760|NCT03285477|4062158|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1
2335761|NCT03285477|4062159|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0
2037010|NCT00414609|3607237|FG000|Extension Study|Unsatisfactory therapeutic effect|0
2037011|NCT00414609|3607238|FG001|Extension Study|Unsatisfactory therapeutic effect|0
2037012|NCT00414609|3607239|FG002|Extension Study|Unsatisfactory therapeutic effect|2
2037013|NCT00414609|3607237|FG000|Extension Study|Withdrawal by Subject|0
2037014|NCT00414609|3607238|FG001|Extension Study|Withdrawal by Subject|0
2037015|NCT00414609|3607239|FG002|Extension Study|Withdrawal by Subject|13
2037016|NCT00414609|3607237|FG000|Extension Study|Lost to Follow-up|0
2037017|NCT00414609|3607238|FG001|Extension Study|Lost to Follow-up|0
2037018|NCT00414609|3607239|FG002|Extension Study|Lost to Follow-up|10
2037019|NCT00414609|3607237|FG000|Extension Study|Administrative problems|0
2037020|NCT00414609|3607238|FG001|Extension Study|Administrative problems|0
2037021|NCT00414609|3607239|FG002|Extension Study|Administrative problems|1
2037022|NCT00414609|3607237|FG000|Extension Study|Death|0
2037023|NCT00414609|3607238|FG001|Extension Study|Death|0
2037024|NCT00414609|3607239|FG002|Extension Study|Death|17
2037025|NCT00414661|3607261|FG000|Overall Study|Death|2
2037026|NCT00414661|3607262|FG001|Overall Study|Death|5
2037027|NCT00414661|3607263|FG002|Overall Study|Death|0
2037028|NCT00414661|3607264|FG003|Overall Study|Death|0
2037029|NCT00414661|3607261|FG000|Overall Study|Lost to Follow-up|1
2037030|NCT00414661|3607262|FG001|Overall Study|Lost to Follow-up|4
2037031|NCT00414661|3607263|FG002|Overall Study|Lost to Follow-up|0
2037032|NCT00414661|3607264|FG003|Overall Study|Lost to Follow-up|1
2037033|NCT00414661|3607261|FG000|Overall Study|Withdrawal by Subject|5
2037034|NCT00414661|3607262|FG001|Overall Study|Withdrawal by Subject|2
2037035|NCT00414661|3607263|FG002|Overall Study|Withdrawal by Subject|2
2037036|NCT00414661|3607264|FG003|Overall Study|Withdrawal by Subject|2
2037037|NCT00414661|3607261|FG000|Overall Study|Other|6
2238089|NCT01905657|3894008|FG002|Overall Study|Withdrawal by Subject|53
2238090|NCT01905657|3894006|FG000|Overall Study|Sponsor Decision|1
2238091|NCT01905657|3894007|FG001|Overall Study|Sponsor Decision|0
2238092|NCT01905657|3894008|FG002|Overall Study|Sponsor Decision|0
2238093|NCT01905683|3894019|FG000|Overall Study|Protocol Violation|1
2238094|NCT01905683|3894019|FG000|Overall Study|Re-injection criteria not met; others|13
2238095|NCT01905683|3894019|FG000|Overall Study|Physician Decision|1
2238096|NCT01905683|3894019|FG000|Overall Study|Lack of Efficacy|8
2238097|NCT01905683|3894019|FG000|Overall Study|Withdrawal by Subject|20
2238098|NCT01905683|3894019|FG000|Overall Study|Adverse Event|4
2238099|NCT01905683|3894019|FG000|Overall Study|Lost to Follow-up|4
2238100|NCT01905943|3894023|FG000|Overall Study|Withdrawal of consent|90
2238101|NCT01905943|3894023|FG000|Overall Study|Lost to Follow-up|16
2238102|NCT01905943|3894023|FG000|Overall Study|Investigator discretion|7
2238103|NCT01905943|3894023|FG000|Overall Study|Death|186
2238104|NCT01905943|3894023|FG000|Overall Study|Adverse Event|3
2238105|NCT01905943|3894023|FG000|Overall Study|Other|12
2238106|NCT01906008|3894053|FG000|Overall Study|Lost to Follow-up|2
2037038|NCT00414661|3607262|FG001|Overall Study|Other|3
2037039|NCT00414661|3607263|FG002|Overall Study|Other|0
2238107|NCT01906008|3894054|FG001|Overall Study|Lost to Follow-up|0
2238108|NCT01906008|3894053|FG000|Overall Study|Oxaliplatin toxicity|2
2238109|NCT01906008|3894054|FG001|Overall Study|Oxaliplatin toxicity|0
2238110|NCT01906008|3894053|FG000|Overall Study|Protocol Violation|0
2238111|NCT01906008|3894054|FG001|Overall Study|Protocol Violation|1
2238112|NCT01906008|3894053|FG000|Overall Study|Withdrawal by Subject|1
2238113|NCT01906008|3894054|FG001|Overall Study|Withdrawal by Subject|5
2238114|NCT01906008|3894053|FG000|Overall Study|Did not start study med|3
2238115|NCT01906008|3894054|FG001|Overall Study|Did not start study med|4
2238116|NCT01906008|3894053|FG000|Overall Study|Oxaliplatin stops|10
2238117|NCT01906008|3894054|FG001|Overall Study|Oxaliplatin stops|8
2238118|NCT01906008|3894053|FG000|Overall Study|Hospice|1
2238119|NCT01906008|3894054|FG001|Overall Study|Hospice|0
2238120|NCT01906008|3894053|FG000|Overall Study|Physician Decision|3
2238121|NCT01906008|3894054|FG001|Overall Study|Physician Decision|3
2238122|NCT01906008|3894053|FG000|Overall Study|Lack of compliance of study med|5
2238123|NCT01906008|3894054|FG001|Overall Study|Lack of compliance of study med|3
2238124|NCT01906008|3894053|FG000|Overall Study|Adverse Event|0
2238125|NCT01906008|3894054|FG001|Overall Study|Adverse Event|3
2238126|NCT01906346|3894060|FG000|Overall Study|AEs|1
2238127|NCT01906372|3894066|FG000|Overall Study|Withdrawal by Subject|2
2238128|NCT01906476|3894073|FG000|Overall Study|Lost to Follow-up|17
2238129|NCT01906476|3894074|FG001|Overall Study|Lost to Follow-up|16
2238130|NCT01907087|3894119|FG000|Overall Study|Withdrawal by Subject|1
2238131|NCT01907100|3894127|FG000|Overall Study|PD based on modified RECIST criteria|31
2238132|NCT01907100|3894128|FG001|Overall Study|PD based on modified RECIST criteria|32
2238133|NCT01907100|3894129|FG002|Overall Study|PD based on modified RECIST criteria|95
2238134|NCT01907100|3894130|FG003|Overall Study|PD based on modified RECIST criteria|92
2238135|NCT01907100|3894127|FG000|Overall Study|Withdrawal by Subject|2
2238136|NCT01907100|3894128|FG001|Overall Study|Withdrawal by Subject|5
2238137|NCT01907100|3894129|FG002|Overall Study|Withdrawal by Subject|10
2238138|NCT01907100|3894130|FG003|Overall Study|Withdrawal by Subject|13
2238139|NCT01907100|3894127|FG000|Overall Study|Protocol Violation|0
2238140|NCT01907100|3894128|FG001|Overall Study|Protocol Violation|0
2238141|NCT01907100|3894129|FG002|Overall Study|Protocol Violation|1
2238142|NCT01907100|3894130|FG003|Overall Study|Protocol Violation|1
2238143|NCT01907100|3894127|FG000|Overall Study|Lost to Follow-up|0
2238144|NCT01907100|3894128|FG001|Overall Study|Lost to Follow-up|0
2238145|NCT01907100|3894129|FG002|Overall Study|Lost to Follow-up|0
2238146|NCT01907100|3894130|FG003|Overall Study|Lost to Follow-up|1
2238147|NCT01907100|3894127|FG000|Overall Study|Not treated|2
2238148|NCT01907100|3894128|FG001|Overall Study|Not treated|0
2238149|NCT01907100|3894129|FG002|Overall Study|Not treated|1
2238150|NCT01907100|3894130|FG003|Overall Study|Not treated|2
2238151|NCT01907100|3894127|FG000|Overall Study|Other than reasons specified|1
2238152|NCT01907100|3894128|FG001|Overall Study|Other than reasons specified|0
2238153|NCT01907100|3894129|FG002|Overall Study|Other than reasons specified|10
2238154|NCT01907100|3894130|FG003|Overall Study|Other than reasons specified|6
2238155|NCT01907100|3894127|FG000|Overall Study|Adverse event (AE)|6
2238156|NCT01907100|3894128|FG001|Overall Study|Adverse event (AE)|3
2238157|NCT01907100|3894129|FG002|Overall Study|Adverse event (AE)|22
2238158|NCT01907100|3894130|FG003|Overall Study|Adverse event (AE)|23
2238159|NCT01907100|3894127|FG000|Overall Study|Worsening/AE underlying cancer disease|0
2238160|NCT01907100|3894128|FG001|Overall Study|Worsening/AE underlying cancer disease|0
2238161|NCT01907100|3894129|FG002|Overall Study|Worsening/AE underlying cancer disease|8
2238162|NCT01907100|3894130|FG003|Overall Study|Worsening/AE underlying cancer disease|8
2238163|NCT01907217|3894161|FG000|Overall Study|Withdrawal by Subject|0
2238164|NCT01907217|3894162|FG001|Overall Study|Withdrawal by Subject|2
2238165|NCT01907516|3894196|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5
2238166|NCT01907516|3894197|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9
2238167|NCT01907516|3894196|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
2238168|NCT01907516|3894197|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3
2238169|NCT01907516|3894196|FG000|First Intervention (3 Weeks)|Delivered before second arm|3
2238170|NCT01907516|3894197|FG001|First Intervention (3 Weeks)|Delivered before second arm|4
2238171|NCT01907516|3894196|FG000|First Intervention (3 Weeks)|Developed DKA during study|1
2238172|NCT01907516|3894197|FG001|First Intervention (3 Weeks)|Developed DKA during study|0
2238173|NCT01907737|3894208|FG000|Overall Study|Withdrawal by Subject|1
2238174|NCT01907815|3894220|FG000|Overall Study|Withdrawal by Subject|1
2238175|NCT01907815|3894221|FG001|Overall Study|Withdrawal by Subject|0
2238176|NCT01907828|3894231|FG000|Overall Study|Exclusion criteria not met|0
2238177|NCT01907828|3894232|FG001|Overall Study|Exclusion criteria not met|1
2238178|NCT01907828|3894231|FG000|Overall Study|Withdrawal by Subject|3
2238179|NCT01907828|3894232|FG001|Overall Study|Withdrawal by Subject|4
2238180|NCT01907828|3894231|FG000|Overall Study|Lost to Follow-up|3
2238181|NCT01907828|3894232|FG001|Overall Study|Lost to Follow-up|0
2238182|NCT01907828|3894231|FG000|Overall Study|Participant refused 24-month follow-up|1
2238183|NCT01907828|3894232|FG001|Overall Study|Participant refused 24-month follow-up|0
2238184|NCT01907828|3894231|FG000|Overall Study|Participant met exclusion criteria|0
2238185|NCT01907828|3894232|FG001|Overall Study|Participant met exclusion criteria|1
2238186|NCT01907854|3894240|FG000|Overall Study|Protocol Violation|1
2238187|NCT01907854|3894241|FG001|Overall Study|Protocol Violation|1
2238188|NCT01907854|3894240|FG000|Overall Study|Withdrawal by Subject|9
2238189|NCT01907854|3894241|FG001|Overall Study|Withdrawal by Subject|7
2238190|NCT01907854|3894240|FG000|Overall Study|Lost to Follow-up|2
2238191|NCT01907854|3894241|FG001|Overall Study|Lost to Follow-up|2
2238192|NCT01907854|3894240|FG000|Overall Study|Unclassified|4
2238193|NCT01907854|3894241|FG001|Overall Study|Unclassified|3
2238194|NCT01907906|3894249|FG000|Overall Study|Withdrawal by Subject|1
2238195|NCT01907906|3894250|FG001|Overall Study|Withdrawal by Subject|0
2238196|NCT01907906|3894249|FG000|Overall Study|Physician Decision|3
2238197|NCT01907906|3894250|FG001|Overall Study|Physician Decision|1
2335762|NCT03285477|4062158|FG000|Recurrence Follow-up Period|Lost to Follow-up|0
2335763|NCT03285477|4062159|FG001|Recurrence Follow-up Period|Lost to Follow-up|1
2335764|NCT03285477|4062158|FG000|Recurrence Follow-up Period|Withdrawal of consent|1
2335765|NCT03285477|4062159|FG001|Recurrence Follow-up Period|Withdrawal of consent|3
2335766|NCT03285477|4062158|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5
2335767|NCT03285477|4062159|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51
2335768|NCT03285490|4062168|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
2335769|NCT03285490|4062169|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1
2335770|NCT03285490|4062168|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18
2335771|NCT03285490|4062169|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60
2335772|NCT03285594|4062206|FG000|Overall Study|At the Participant's Own Request|10
2335773|NCT03285594|4062207|FG001|Overall Study|At the Participant's Own Request|5
2335774|NCT03285594|4062208|FG002|Overall Study|At the Participant's Own Request|21
2335775|NCT03285594|4062206|FG000|Overall Study|Adverse Event|2
2335776|NCT03285594|4062207|FG001|Overall Study|Adverse Event|2
2335777|NCT03285594|4062208|FG002|Overall Study|Adverse Event|6
2335778|NCT03285594|4062206|FG000|Overall Study|Poor Compliance to Protocol|0
2335779|NCT03285594|4062207|FG001|Overall Study|Poor Compliance to Protocol|0
2335780|NCT03285594|4062208|FG002|Overall Study|Poor Compliance to Protocol|1
2335781|NCT03285594|4062206|FG000|Overall Study|Lost to Follow-up|0
2335782|NCT03285594|4062207|FG001|Overall Study|Lost to Follow-up|0
2335783|NCT03285594|4062208|FG002|Overall Study|Lost to Follow-up|1
2335784|NCT03285594|4062206|FG000|Overall Study|Reason Not Specified|3
2335785|NCT03285594|4062207|FG001|Overall Study|Reason Not Specified|4
2335786|NCT03285594|4062208|FG002|Overall Study|Reason Not Specified|8
2335787|NCT03285646|4062219|FG000|Overall Study|Adverse Event|1
2335788|NCT03285646|4062220|FG001|Overall Study|Adverse Event|0
2335789|NCT03285646|4062219|FG000|Overall Study|Withdrawal by Subject|10
2335790|NCT03285646|4062220|FG001|Overall Study|Withdrawal by Subject|2
2335791|NCT03285646|4062219|FG000|Overall Study|Lost to Follow-up|2
2335792|NCT03285646|4062220|FG001|Overall Study|Lost to Follow-up|1
2335793|NCT03285646|4062219|FG000|Overall Study|Investigator/Sponsor Decision|0
2335794|NCT03285646|4062220|FG001|Overall Study|Investigator/Sponsor Decision|1
2335795|NCT03285711|4062229|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2
2335796|NCT03285711|4062230|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1
2335797|NCT03285711|4062231|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0
2335798|NCT03285711|4062232|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0
2335799|NCT03285711|4062229|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1
2335800|NCT03285711|4062230|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0
2335801|NCT03285711|4062231|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0
2037040|NCT00414661|3607264|FG003|Overall Study|Other|0
2037041|NCT00414726|3607285|FG000|Overall Study|Withdrawal by Subject|0
2037042|NCT00414726|3607286|FG001|Overall Study|Withdrawal by Subject|1
2037043|NCT00414765|3607294|FG000|Overall Study|Adverse Event|5
2037044|NCT00414765|3607295|FG001|Overall Study|Adverse Event|9
2037045|NCT00414765|3607294|FG000|Overall Study|Withdrawal by Subject|1
2037046|NCT00414765|3607295|FG001|Overall Study|Withdrawal by Subject|1
2037047|NCT00414765|3607294|FG000|Overall Study|Disease Progression|0
2037048|NCT00414765|3607295|FG001|Overall Study|Disease Progression|1
2037049|NCT00414908|3607312|FG000|Overall Study|Protocol Violation|1
2037050|NCT00414908|3607313|FG001|Overall Study|Protocol Violation|1
2037051|NCT00414960|3607323|FG000|Overall Study|Adverse Event|4
2037052|NCT00414960|3607324|FG001|Overall Study|Adverse Event|0
2037053|NCT00414960|3607323|FG000|Overall Study|Withdrawal by Subject|3
2037054|NCT00414960|3607324|FG001|Overall Study|Withdrawal by Subject|0
2037055|NCT00414960|3607323|FG000|Overall Study|Physician Decision|0
2037056|NCT00414960|3607324|FG001|Overall Study|Physician Decision|1
2037057|NCT00414973|3607334|FG000|Overall Study|Withdrawal by Subject|14
2037058|NCT00414973|3607335|FG001|Overall Study|Withdrawal by Subject|4
2037059|NCT00414973|3607336|FG002|Overall Study|Withdrawal by Subject|1
2037060|NCT00414973|3607337|FG003|Overall Study|Withdrawal by Subject|0
2037061|NCT00414973|3607334|FG000|Overall Study|Adverse Event|10
2037062|NCT00414973|3607335|FG001|Overall Study|Adverse Event|0
2037063|NCT00414973|3607336|FG002|Overall Study|Adverse Event|1
2037064|NCT00414973|3607337|FG003|Overall Study|Adverse Event|0
2037065|NCT00414973|3607334|FG000|Overall Study|Protocol Violation|3
2037066|NCT00414973|3607335|FG001|Overall Study|Protocol Violation|4
2037067|NCT00414973|3607336|FG002|Overall Study|Protocol Violation|0
2037068|NCT00414973|3607337|FG003|Overall Study|Protocol Violation|0
2037069|NCT00414973|3607334|FG000|Overall Study|Lost to Follow-up|0
2037070|NCT00414973|3607335|FG001|Overall Study|Lost to Follow-up|2
2037071|NCT00414973|3607336|FG002|Overall Study|Lost to Follow-up|0
2037072|NCT00414973|3607337|FG003|Overall Study|Lost to Follow-up|0
2037073|NCT00414973|3607334|FG000|Overall Study|Sponsor Decision|1
2037074|NCT00414973|3607335|FG001|Overall Study|Sponsor Decision|0
2037075|NCT00414973|3607336|FG002|Overall Study|Sponsor Decision|0
2037076|NCT00414973|3607337|FG003|Overall Study|Sponsor Decision|0
2037077|NCT00414973|3607334|FG000|Overall Study|Death|0
2238198|NCT01908101|3894270|FG000|Overall Study|Physician Decision|1
2238199|NCT01908101|3894270|FG000|Overall Study|Withdrawal by Subject|1
2238200|NCT01908101|3894270|FG000|Overall Study|Incorrect Diagnosis|2
2238201|NCT01908101|3894270|FG000|Overall Study|Incorrect Starting Dose|1
2238202|NCT01908101|3894270|FG000|Overall Study|Did not complete the first cycle|4
2238203|NCT01908140|3894285|FG000|Overall Study|Other or Progressive Disease|5
2238204|NCT01908140|3894286|FG001|Overall Study|Other or Progressive Disease|12
2238205|NCT01908140|3894285|FG000|Overall Study|Lack of Efficacy|7
2238206|NCT01908140|3894286|FG001|Overall Study|Lack of Efficacy|5
2238207|NCT01908140|3894285|FG000|Overall Study|Withdrawal by Subject|23
2238208|NCT01908140|3894286|FG001|Overall Study|Withdrawal by Subject|24
2238209|NCT01908140|3894285|FG000|Overall Study|Lost to Follow-up|1
2238210|NCT01908140|3894286|FG001|Overall Study|Lost to Follow-up|6
2238211|NCT01908140|3894285|FG000|Overall Study|Protocol Violation|8
2238212|NCT01908140|3894286|FG001|Overall Study|Protocol Violation|9
2238213|NCT01908140|3894285|FG000|Overall Study|Adverse Event|22
2238214|NCT01908140|3894286|FG001|Overall Study|Adverse Event|23
2238215|NCT01908205|3894294|FG000|Overall Study|Lost to Follow-up|2
2238216|NCT01908205|3894295|FG001|Overall Study|Lost to Follow-up|0
2238217|NCT01908205|3894294|FG000|Overall Study|Withdrawal by Subject|3
2238218|NCT01908205|3894295|FG001|Overall Study|Withdrawal by Subject|1
2238219|NCT01908426|3894316|FG000|Overall Study|Adverse Event|98
2238220|NCT01908426|3894317|FG001|Overall Study|Adverse Event|11
2238221|NCT01908426|3894316|FG000|Overall Study|Clinical Deterioration|72
2238222|NCT01908426|3894317|FG001|Overall Study|Clinical Deterioration|38
2238223|NCT01908426|3894316|FG000|Overall Study|Lack of Efficacy|3
2238224|NCT01908426|3894317|FG001|Overall Study|Lack of Efficacy|0
2238225|NCT01908426|3894316|FG000|Overall Study|Lost to Follow-up|0
2238226|NCT01908426|3894317|FG001|Overall Study|Lost to Follow-up|1
2238227|NCT01908426|3894316|FG000|Overall Study|Physician Decision|3
2238228|NCT01908426|3894317|FG001|Overall Study|Physician Decision|3
2238229|NCT01908426|3894316|FG000|Overall Study|Withdrawal by Subject|11
2238230|NCT01908426|3894317|FG001|Overall Study|Withdrawal by Subject|6
2238231|NCT01908426|3894316|FG000|Overall Study|Progressive Disease|206
2238232|NCT01908426|3894317|FG001|Overall Study|Progressive Disease|152
2238233|NCT01908426|3894316|FG000|Overall Study|Protocol Violation|1
2238234|NCT01908426|3894317|FG001|Overall Study|Protocol Violation|0
2238235|NCT01908426|3894316|FG000|Overall Study|No Study Treatment Given|3
2238236|NCT01908426|3894317|FG001|Overall Study|No Study Treatment Given|0
2238237|NCT01908582|3894339|FG000|Period 2|Physician Decision|1
2238238|NCT01908582|3894339|FG000|Period 2|Withdrawal by Subject|1
2238239|NCT01908634|3894346|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1
2238240|NCT01908634|3894346|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5
2238241|NCT01908699|3894356|FG000|Overall Study|Adverse Event|8
2238242|NCT01908699|3894357|FG001|Overall Study|Adverse Event|12
2238243|NCT01908699|3894356|FG000|Overall Study|Lack of Efficacy|2
2238244|NCT01908699|3894357|FG001|Overall Study|Lack of Efficacy|2
2238245|NCT01908699|3894356|FG000|Overall Study|Lost to Follow-up|2
2238246|NCT01908699|3894357|FG001|Overall Study|Lost to Follow-up|4
2238247|NCT01908699|3894356|FG000|Overall Study|Physician Decision|8
2238248|NCT01908699|3894357|FG001|Overall Study|Physician Decision|8
2238249|NCT01908699|3894356|FG000|Overall Study|Withdrawal by Subject|15
2238250|NCT01908699|3894357|FG001|Overall Study|Withdrawal by Subject|10
2238251|NCT01908699|3894356|FG000|Overall Study|Pregnancy|0
2238252|NCT01908699|3894357|FG001|Overall Study|Pregnancy|1
2238253|NCT01908699|3894356|FG000|Overall Study|Randomized in Error|1
2238254|NCT01908699|3894357|FG001|Overall Study|Randomized in Error|0
2238255|NCT01908699|3894356|FG000|Overall Study|Death|9
2238256|NCT01908699|3894357|FG001|Overall Study|Death|12
2238257|NCT01908699|3894356|FG000|Overall Study|Progressive Disease|30
2238258|NCT01908699|3894357|FG001|Overall Study|Progressive Disease|29
2335802|NCT03285711|4062232|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0
2335803|NCT03285711|4062229|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
2335804|NCT03285711|4062230|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
2335805|NCT03285711|4062231|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
2335806|NCT03285711|4062232|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
2335807|NCT03285711|4062229|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
2335808|NCT03285711|4062230|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
2335809|NCT03285711|4062231|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
2335810|NCT03285711|4062232|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
2335811|NCT03285958|4062248|FG000|Overall Study|Lost to Follow-up|1
2335812|NCT03285958|4062249|FG001|Overall Study|Lost to Follow-up|1
2335813|NCT03285958|4062248|FG000|Overall Study|Withdrawal by Subject|1
2335814|NCT03285958|4062249|FG001|Overall Study|Withdrawal by Subject|0
2335815|NCT03285958|4062248|FG000|Overall Study|Not able to attend required orientation|3
2335816|NCT03285958|4062249|FG001|Overall Study|Not able to attend required orientation|0
2335817|NCT03286218|4062268|FG000|Qualification Phase Period 1|Adverse Event|1
2335818|NCT03286218|4062269|FG001|Qualification Phase Period 1|Adverse Event|0
2238259|NCT01908803|3894382|FG000|Overall Study|Adverse Event|1
2238260|NCT01908803|3894383|FG001|Overall Study|Adverse Event|0
2238261|NCT01908803|3894382|FG000|Overall Study|Physician Decision|0
2238262|NCT01908803|3894383|FG001|Overall Study|Physician Decision|1
2238263|NCT01908803|3894382|FG000|Overall Study|Withdrawal by Subject|1
2238264|NCT01908803|3894383|FG001|Overall Study|Withdrawal by Subject|0
2238265|NCT01908803|3894382|FG000|Overall Study|Randomization Error|1
2238266|NCT01908803|3894383|FG001|Overall Study|Randomization Error|0
2238267|NCT01908803|3894382|FG000|Overall Study|Adverse Event (pre-treatment)|1
2238268|NCT01908803|3894383|FG001|Overall Study|Adverse Event (pre-treatment)|0
2238269|NCT01908816|3894394|FG000|Overall Study|Subject's no longer requires study drug|0
2238270|NCT01908816|3894395|FG001|Overall Study|Subject's no longer requires study drug|0
2238271|NCT01908816|3894396|FG002|Overall Study|Subject's no longer requires study drug|0
2238272|NCT01908816|3894397|FG003|Overall Study|Subject's no longer requires study drug|1
2238273|NCT01908816|3894394|FG000|Overall Study|Protocol deviation|1
2238274|NCT01908816|3894395|FG001|Overall Study|Protocol deviation|2
2238275|NCT01908816|3894396|FG002|Overall Study|Protocol deviation|1
2238276|NCT01908816|3894397|FG003|Overall Study|Protocol deviation|1
2238277|NCT01908816|3894394|FG000|Overall Study|Withdrawal by Subject|0
2238278|NCT01908816|3894395|FG001|Overall Study|Withdrawal by Subject|4
2238279|NCT01908816|3894396|FG002|Overall Study|Withdrawal by Subject|2
2238280|NCT01908816|3894397|FG003|Overall Study|Withdrawal by Subject|2
2238281|NCT01908816|3894394|FG000|Overall Study|Lost to Follow-up|3
2238282|NCT01908816|3894395|FG001|Overall Study|Lost to Follow-up|5
2335819|NCT03286218|4062270|FG002|Qualification Phase Period 1|Adverse Event|0
2335820|NCT03286218|4062271|FG003|Qualification Phase Period 1|Adverse Event|0
2335821|NCT03286218|4062272|FG004|Qualification Phase Period 1|Adverse Event|0
2335822|NCT03286218|4062273|FG005|Qualification Phase Period 1|Adverse Event|0
2335823|NCT03286218|4062274|FG006|Qualification Phase Period 1|Adverse Event|0
2335824|NCT03286218|4062275|FG007|Qualification Phase Period 1|Adverse Event|0
2335825|NCT03286218|4062276|FG008|Qualification Phase Period 1|Adverse Event|0
2335826|NCT03286218|4062277|FG009|Qualification Phase Period 1|Adverse Event|0
2335827|NCT03286218|4062278|FG010|Qualification Phase Period 1|Adverse Event|0
2335828|NCT03286218|4062279|FG011|Qualification Phase Period 1|Adverse Event|0
2335829|NCT03286218|4062268|FG000|Qualification Phase Period 1|Withdrawal by Subject|0
2335830|NCT03286218|4062269|FG001|Qualification Phase Period 1|Withdrawal by Subject|1
2335831|NCT03286218|4062270|FG002|Qualification Phase Period 1|Withdrawal by Subject|0
2335832|NCT03286218|4062271|FG003|Qualification Phase Period 1|Withdrawal by Subject|0
2335833|NCT03286218|4062272|FG004|Qualification Phase Period 1|Withdrawal by Subject|0
2335834|NCT03286218|4062273|FG005|Qualification Phase Period 1|Withdrawal by Subject|0
2335835|NCT03286218|4062274|FG006|Qualification Phase Period 1|Withdrawal by Subject|0
2335836|NCT03286218|4062275|FG007|Qualification Phase Period 1|Withdrawal by Subject|0
2335837|NCT03286218|4062276|FG008|Qualification Phase Period 1|Withdrawal by Subject|0
2335838|NCT03286218|4062277|FG009|Qualification Phase Period 1|Withdrawal by Subject|0
2335839|NCT03286218|4062278|FG010|Qualification Phase Period 1|Withdrawal by Subject|0
2335840|NCT03286218|4062279|FG011|Qualification Phase Period 1|Withdrawal by Subject|0
2335841|NCT03286218|4062268|FG000|Qualification Phase Period 2|Adverse Event|0
2335842|NCT03286218|4062269|FG001|Qualification Phase Period 2|Adverse Event|1
2335843|NCT03286218|4062270|FG002|Qualification Phase Period 2|Adverse Event|0
2335844|NCT03286218|4062271|FG003|Qualification Phase Period 2|Adverse Event|0
2335845|NCT03286218|4062272|FG004|Qualification Phase Period 2|Adverse Event|0
2335846|NCT03286218|4062273|FG005|Qualification Phase Period 2|Adverse Event|0
2335847|NCT03286218|4062274|FG006|Qualification Phase Period 2|Adverse Event|0
2335848|NCT03286218|4062275|FG007|Qualification Phase Period 2|Adverse Event|0
2335849|NCT03286218|4062276|FG008|Qualification Phase Period 2|Adverse Event|0
2335850|NCT03286218|4062277|FG009|Qualification Phase Period 2|Adverse Event|0
2335851|NCT03286218|4062278|FG010|Qualification Phase Period 2|Adverse Event|0
2335852|NCT03286218|4062279|FG011|Qualification Phase Period 2|Adverse Event|0
2335853|NCT03286218|4062268|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14
2335854|NCT03286218|4062269|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15
2335855|NCT03286218|4062270|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0
2037078|NCT00414973|3607335|FG001|Overall Study|Death|0
2037079|NCT00414973|3607336|FG002|Overall Study|Death|1
2037080|NCT00414973|3607337|FG003|Overall Study|Death|0
2037081|NCT00415051|3607347|FG000|Overall Study|Protocol Violation|1
2037082|NCT00415168|3607351|FG000|Overall Study|Death|26
2037083|NCT00415168|3607351|FG000|Overall Study|Lost to Follow-up|3
2037084|NCT00415168|3607351|FG000|Overall Study|Physician Decision|13
2037085|NCT00415168|3607351|FG000|Overall Study|Sponsor Decision|4
2037086|NCT00415168|3607351|FG000|Overall Study|Withdrawal by Subject|6
2037087|NCT00415194|3607357|FG000|Overall Study|Adverse Event|37
2037088|NCT00415194|3607358|FG001|Overall Study|Adverse Event|32
2037089|NCT00415194|3607357|FG000|Overall Study|Entry Criteria Not Met|4
2037090|NCT00415194|3607358|FG001|Overall Study|Entry Criteria Not Met|8
2037091|NCT00415194|3607357|FG000|Overall Study|Lost to Follow-up|1
2037092|NCT00415194|3607358|FG001|Overall Study|Lost to Follow-up|0
2037093|NCT00415194|3607357|FG000|Overall Study|Physician Decision|10
2037094|NCT00415194|3607358|FG001|Overall Study|Physician Decision|16
2037095|NCT00415194|3607357|FG000|Overall Study|Progressive Disease|180
2037096|NCT00415194|3607358|FG001|Overall Study|Progressive Disease|217
2037097|NCT00415194|3607357|FG000|Overall Study|Protocol Violation|4
2037098|NCT00415194|3607358|FG001|Overall Study|Protocol Violation|2
2238283|NCT01908816|3894396|FG002|Overall Study|Lost to Follow-up|4
2238284|NCT01908816|3894397|FG003|Overall Study|Lost to Follow-up|2
2238285|NCT01908816|3894394|FG000|Overall Study|Death|1
2238286|NCT01908816|3894395|FG001|Overall Study|Death|0
2238287|NCT01908816|3894396|FG002|Overall Study|Death|7
2238288|NCT01908816|3894397|FG003|Overall Study|Death|1
2238289|NCT01908816|3894394|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2238290|NCT01908816|3894395|FG001|Overall Study|Unsatisfactory therapeutic effect|13
2238291|NCT01908816|3894396|FG002|Overall Study|Unsatisfactory therapeutic effect|1
2238292|NCT01908816|3894397|FG003|Overall Study|Unsatisfactory therapeutic effect|0
2238293|NCT01908816|3894394|FG000|Overall Study|Early termination|87
2238294|NCT01908816|3894395|FG001|Overall Study|Early termination|60
2238295|NCT01908816|3894396|FG002|Overall Study|Early termination|43
2238296|NCT01908816|3894397|FG003|Overall Study|Early termination|28
2238297|NCT01908829|3894413|FG000|Overall Study|Adverse Event|13
2335856|NCT03286218|4062271|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0
2335857|NCT03286218|4062272|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0
2335858|NCT03286218|4062273|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0
2335859|NCT03286218|4062274|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0
2335860|NCT03286218|4062275|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0
2335861|NCT03286218|4062276|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0
2335862|NCT03286218|4062277|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0
2335863|NCT03286218|4062278|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0
2335864|NCT03286218|4062279|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0
2335865|NCT03286218|4062268|FG000|Qualification Phase Period 2|Lost to Follow-up|0
2335866|NCT03286218|4062269|FG001|Qualification Phase Period 2|Lost to Follow-up|1
2335867|NCT03286218|4062270|FG002|Qualification Phase Period 2|Lost to Follow-up|0
2335868|NCT03286218|4062271|FG003|Qualification Phase Period 2|Lost to Follow-up|0
2335869|NCT03286218|4062272|FG004|Qualification Phase Period 2|Lost to Follow-up|0
2335870|NCT03286218|4062273|FG005|Qualification Phase Period 2|Lost to Follow-up|0
2335871|NCT03286218|4062274|FG006|Qualification Phase Period 2|Lost to Follow-up|0
2335872|NCT03286218|4062275|FG007|Qualification Phase Period 2|Lost to Follow-up|0
2335873|NCT03286218|4062276|FG008|Qualification Phase Period 2|Lost to Follow-up|0
2335874|NCT03286218|4062277|FG009|Qualification Phase Period 2|Lost to Follow-up|0
2335875|NCT03286218|4062278|FG010|Qualification Phase Period 2|Lost to Follow-up|0
2335876|NCT03286218|4062279|FG011|Qualification Phase Period 2|Lost to Follow-up|0
2335877|NCT03286218|4062268|FG000|Qualification Phase Period 2|Protocol Violation|2
2335878|NCT03286218|4062269|FG001|Qualification Phase Period 2|Protocol Violation|0
2335879|NCT03286218|4062270|FG002|Qualification Phase Period 2|Protocol Violation|0
2335880|NCT03286218|4062271|FG003|Qualification Phase Period 2|Protocol Violation|0
2335881|NCT03286218|4062272|FG004|Qualification Phase Period 2|Protocol Violation|0
2335882|NCT03286218|4062273|FG005|Qualification Phase Period 2|Protocol Violation|0
2335883|NCT03286218|4062274|FG006|Qualification Phase Period 2|Protocol Violation|0
2335884|NCT03286218|4062275|FG007|Qualification Phase Period 2|Protocol Violation|0
2335885|NCT03286218|4062276|FG008|Qualification Phase Period 2|Protocol Violation|0
2037099|NCT00415194|3607357|FG000|Overall Study|Withdrawal by Subject|28
2037100|NCT00415194|3607358|FG001|Overall Study|Withdrawal by Subject|21
2037101|NCT00415194|3607357|FG000|Overall Study|Death Due to Study Disease|26
2238298|NCT01908829|3894414|FG001|Overall Study|Adverse Event|11
2238299|NCT01908829|3894415|FG002|Overall Study|Adverse Event|13
2238300|NCT01908829|3894413|FG000|Overall Study|Lost to Follow-up|4
2238301|NCT01908829|3894414|FG001|Overall Study|Lost to Follow-up|2
2238302|NCT01908829|3894415|FG002|Overall Study|Lost to Follow-up|1
2238303|NCT01908829|3894413|FG000|Overall Study|Randomized no double-blind drug received|1
2238304|NCT01908829|3894414|FG001|Overall Study|Randomized no double-blind drug received|0
2238305|NCT01908829|3894415|FG002|Overall Study|Randomized no double-blind drug received|1
2238306|NCT01908829|3894413|FG000|Overall Study|Discontinued (no EoT page)|2
2238307|NCT01908829|3894414|FG001|Overall Study|Discontinued (no EoT page)|0
2238308|NCT01908829|3894415|FG002|Overall Study|Discontinued (no EoT page)|0
2238309|NCT01908829|3894413|FG000|Overall Study|Miscellaneous|0
2238310|NCT01908829|3894414|FG001|Overall Study|Miscellaneous|2
2238311|NCT01908829|3894415|FG002|Overall Study|Miscellaneous|0
2238312|NCT01908829|3894413|FG000|Overall Study|Protocol Violation|2
2238313|NCT01908829|3894414|FG001|Overall Study|Protocol Violation|2
2238314|NCT01908829|3894415|FG002|Overall Study|Protocol Violation|0
2238315|NCT01908829|3894413|FG000|Overall Study|Lack of Efficacy|1
2238316|NCT01908829|3894414|FG001|Overall Study|Lack of Efficacy|3
2238317|NCT01908829|3894415|FG002|Overall Study|Lack of Efficacy|2
2238318|NCT01908829|3894413|FG000|Overall Study|Withdrawal by Subject|26
2238319|NCT01908829|3894414|FG001|Overall Study|Withdrawal by Subject|29
2238320|NCT01908829|3894415|FG002|Overall Study|Withdrawal by Subject|22
2238321|NCT01908907|3894434|FG000|Overall Study|Physician Decision|1
2238322|NCT01908907|3894435|FG001|Overall Study|Physician Decision|0
2238323|NCT01908907|3894434|FG000|Overall Study|Protocol Violation|1
2238324|NCT01908907|3894435|FG001|Overall Study|Protocol Violation|0
2238325|NCT01909336|3894487|FG000|Overall Study|Lost to Follow-up|4
2238326|NCT01909336|3894488|FG001|Overall Study|Lost to Follow-up|2
2238327|NCT01909336|3894489|FG002|Overall Study|Lost to Follow-up|2
2238328|NCT01909336|3894487|FG000|Overall Study|Physician Decision|0
2238329|NCT01909336|3894488|FG001|Overall Study|Physician Decision|1
2238330|NCT01909336|3894489|FG002|Overall Study|Physician Decision|1
2238331|NCT01909453|3894502|FG000|Overall Study|Ongoing|118
2238332|NCT01909453|3894503|FG001|Overall Study|Ongoing|103
2238333|NCT01909453|3894504|FG002|Overall Study|Ongoing|83
2238334|NCT01909453|3894505|FG003|Overall Study|Ongoing|164
2238335|NCT01909453|3894506|FG004|Overall Study|Ongoing|50
2238336|NCT01909453|3894502|FG000|Overall Study|Death|69
2238337|NCT01909453|3894503|FG001|Overall Study|Death|74
2238338|NCT01909453|3894504|FG002|Overall Study|Death|88
2238339|NCT01909453|3894505|FG003|Overall Study|Death|86
2238340|NCT01909453|3894506|FG004|Overall Study|Death|29
2238341|NCT01909453|3894502|FG000|Overall Study|Lost to Follow-up|3
2238342|NCT01909453|3894503|FG001|Overall Study|Lost to Follow-up|4
2238343|NCT01909453|3894504|FG002|Overall Study|Lost to Follow-up|4
2238344|NCT01909453|3894505|FG003|Overall Study|Lost to Follow-up|3
2238345|NCT01909453|3894506|FG004|Overall Study|Lost to Follow-up|3
2238346|NCT01909453|3894502|FG000|Overall Study|Withdrawal by Subject|2
2238347|NCT01909453|3894503|FG001|Overall Study|Withdrawal by Subject|13
2238348|NCT01909453|3894504|FG002|Overall Study|Withdrawal by Subject|16
2238349|NCT01909453|3894505|FG003|Overall Study|Withdrawal by Subject|5
2238350|NCT01909453|3894506|FG004|Overall Study|Withdrawal by Subject|4
2238351|NCT01909466|3894524|FG000|Overall Study|Lost to Follow-up|5
2238352|NCT01909466|3894525|FG001|Overall Study|Lost to Follow-up|7
2238353|NCT01909466|3894524|FG000|Overall Study|Adverse Event|3
2238354|NCT01909466|3894525|FG001|Overall Study|Adverse Event|4
2238355|NCT01909466|3894524|FG000|Overall Study|Met Withdrawal Criteria|0
2238356|NCT01909466|3894525|FG001|Overall Study|Met Withdrawal Criteria|3
2238357|NCT01909466|3894524|FG000|Overall Study|Physician Decision|2
2238358|NCT01909466|3894525|FG001|Overall Study|Physician Decision|0
2238359|NCT01909466|3894524|FG000|Overall Study|Withdrawal by Subject|11
2238360|NCT01909466|3894525|FG001|Overall Study|Withdrawal by Subject|9
2238361|NCT01909466|3894524|FG000|Overall Study|Lack of Efficacy|1
2238362|NCT01909466|3894525|FG001|Overall Study|Lack of Efficacy|0
2238363|NCT01909674|3894531|FG000|Overall Study|Withdrawal by Subject|5
2335886|NCT03286218|4062277|FG009|Qualification Phase Period 2|Protocol Violation|0
2335887|NCT03286218|4062278|FG010|Qualification Phase Period 2|Protocol Violation|0
2335888|NCT03286218|4062279|FG011|Qualification Phase Period 2|Protocol Violation|0
2335889|NCT03286218|4062268|FG000|Qualification Phase Period 2|Withdrawal by Subject|1
2335890|NCT03286218|4062269|FG001|Qualification Phase Period 2|Withdrawal by Subject|2
2335891|NCT03286218|4062270|FG002|Qualification Phase Period 2|Withdrawal by Subject|0
2335892|NCT03286218|4062271|FG003|Qualification Phase Period 2|Withdrawal by Subject|0
2335893|NCT03286218|4062272|FG004|Qualification Phase Period 2|Withdrawal by Subject|0
2335894|NCT03286218|4062273|FG005|Qualification Phase Period 2|Withdrawal by Subject|0
2335895|NCT03286218|4062274|FG006|Qualification Phase Period 2|Withdrawal by Subject|0
2335896|NCT03286218|4062275|FG007|Qualification Phase Period 2|Withdrawal by Subject|0
2335897|NCT03286218|4062276|FG008|Qualification Phase Period 2|Withdrawal by Subject|0
2335898|NCT03286218|4062277|FG009|Qualification Phase Period 2|Withdrawal by Subject|0
2335899|NCT03286218|4062278|FG010|Qualification Phase Period 2|Withdrawal by Subject|0
2335900|NCT03286218|4062279|FG011|Qualification Phase Period 2|Withdrawal by Subject|0
2335901|NCT03286218|4062268|FG000|Treatment Phase Period 1|Withdrawal by Subject|0
2335902|NCT03286218|4062269|FG001|Treatment Phase Period 1|Withdrawal by Subject|0
2335903|NCT03286218|4062270|FG002|Treatment Phase Period 1|Withdrawal by Subject|1
2335904|NCT03286218|4062271|FG003|Treatment Phase Period 1|Withdrawal by Subject|1
2335905|NCT03286218|4062272|FG004|Treatment Phase Period 1|Withdrawal by Subject|0
2335906|NCT03286218|4062273|FG005|Treatment Phase Period 1|Withdrawal by Subject|1
2335907|NCT03286218|4062274|FG006|Treatment Phase Period 1|Withdrawal by Subject|0
2335908|NCT03286218|4062275|FG007|Treatment Phase Period 1|Withdrawal by Subject|0
2335909|NCT03286218|4062276|FG008|Treatment Phase Period 1|Withdrawal by Subject|0
2335910|NCT03286218|4062277|FG009|Treatment Phase Period 1|Withdrawal by Subject|0
2335911|NCT03286218|4062278|FG010|Treatment Phase Period 1|Withdrawal by Subject|0
2335912|NCT03286218|4062279|FG011|Treatment Phase Period 1|Withdrawal by Subject|1
2335913|NCT03286218|4062268|FG000|Treatment Phase Period 4|Withdrawal by Subject|0
2335914|NCT03286218|4062269|FG001|Treatment Phase Period 4|Withdrawal by Subject|0
2335915|NCT03286218|4062270|FG002|Treatment Phase Period 4|Withdrawal by Subject|0
2335916|NCT03286218|4062271|FG003|Treatment Phase Period 4|Withdrawal by Subject|0
2335917|NCT03286218|4062272|FG004|Treatment Phase Period 4|Withdrawal by Subject|0
2335918|NCT03286218|4062273|FG005|Treatment Phase Period 4|Withdrawal by Subject|0
2335919|NCT03286218|4062274|FG006|Treatment Phase Period 4|Withdrawal by Subject|0
2335920|NCT03286218|4062275|FG007|Treatment Phase Period 4|Withdrawal by Subject|0
2335921|NCT03286218|4062276|FG008|Treatment Phase Period 4|Withdrawal by Subject|0
2335922|NCT03286218|4062277|FG009|Treatment Phase Period 4|Withdrawal by Subject|0
2335923|NCT03286218|4062278|FG010|Treatment Phase Period 4|Withdrawal by Subject|0
2335924|NCT03286218|4062279|FG011|Treatment Phase Period 4|Withdrawal by Subject|1
2238364|NCT01909674|3894532|FG001|Overall Study|Withdrawal by Subject|2
2238365|NCT01909778|3894563|FG000|Overall Study|failed screening|1
2238366|NCT01909791|3894572|FG000|Overall Study|Death|9
2238367|NCT01909791|3894573|FG001|Overall Study|Death|8
2238368|NCT01909791|3894574|FG002|Overall Study|Death|4
2238369|NCT01909791|3894572|FG000|Overall Study|Withdrawal by Subject|5
2238370|NCT01909791|3894573|FG001|Overall Study|Withdrawal by Subject|9
2238371|NCT01909791|3894574|FG002|Overall Study|Withdrawal by Subject|13
2238372|NCT01909791|3894572|FG000|Overall Study|Lost to Follow-up|5
2238373|NCT01909791|3894573|FG001|Overall Study|Lost to Follow-up|11
2238374|NCT01909791|3894574|FG002|Overall Study|Lost to Follow-up|10
2238375|NCT01909791|3894572|FG000|Overall Study|Missed Visit|2
2238376|NCT01909791|3894573|FG001|Overall Study|Missed Visit|0
2238377|NCT01909791|3894574|FG002|Overall Study|Missed Visit|1
2238378|NCT01909804|3894599|FG000|Overall Study|Randomized but Never Treated|0
2238379|NCT01909804|3894600|FG001|Overall Study|Randomized but Never Treated|0
2238380|NCT01909804|3894601|FG002|Overall Study|Randomized but Never Treated|0
2238381|NCT01909804|3894602|FG003|Overall Study|Randomized but Never Treated|0
2238382|NCT01909804|3894603|FG004|Overall Study|Randomized but Never Treated|0
2238383|NCT01909804|3894604|FG005|Overall Study|Randomized but Never Treated|0
2238384|NCT01909804|3894605|FG006|Overall Study|Randomized but Never Treated|1
2238385|NCT01909804|3894606|FG007|Overall Study|Randomized but Never Treated|0
2238386|NCT01909804|3894607|FG008|Overall Study|Randomized but Never Treated|0
2238387|NCT01909804|3894608|FG009|Overall Study|Randomized but Never Treated|0
2238388|NCT01909804|3894609|FG010|Overall Study|Randomized but Never Treated|0
2238389|NCT01909804|3894610|FG011|Overall Study|Randomized but Never Treated|1
2238390|NCT01909804|3894599|FG000|Overall Study|Death|0
2238391|NCT01909804|3894600|FG001|Overall Study|Death|0
2238392|NCT01909804|3894601|FG002|Overall Study|Death|0
2238393|NCT01909804|3894602|FG003|Overall Study|Death|0
2238394|NCT01909804|3894603|FG004|Overall Study|Death|0
2238395|NCT01909804|3894604|FG005|Overall Study|Death|0
2238396|NCT01909804|3894605|FG006|Overall Study|Death|0
2238397|NCT01909804|3894606|FG007|Overall Study|Death|0
2238398|NCT01909804|3894607|FG008|Overall Study|Death|0
2238399|NCT01909804|3894608|FG009|Overall Study|Death|0
2238400|NCT01909804|3894609|FG010|Overall Study|Death|1
2238401|NCT01909804|3894610|FG011|Overall Study|Death|0
2238402|NCT01909804|3894599|FG000|Overall Study|Lack of Efficacy|4
2238403|NCT01909804|3894600|FG001|Overall Study|Lack of Efficacy|1
2238404|NCT01909804|3894601|FG002|Overall Study|Lack of Efficacy|0
2238405|NCT01909804|3894602|FG003|Overall Study|Lack of Efficacy|0
2238406|NCT01909804|3894603|FG004|Overall Study|Lack of Efficacy|7
2238407|NCT01909804|3894604|FG005|Overall Study|Lack of Efficacy|3
2238408|NCT01909804|3894605|FG006|Overall Study|Lack of Efficacy|1
2238409|NCT01909804|3894606|FG007|Overall Study|Lack of Efficacy|1
2238410|NCT01909804|3894607|FG008|Overall Study|Lack of Efficacy|0
2238411|NCT01909804|3894608|FG009|Overall Study|Lack of Efficacy|1
2238412|NCT01909804|3894609|FG010|Overall Study|Lack of Efficacy|0
2238413|NCT01909804|3894610|FG011|Overall Study|Lack of Efficacy|1
2238414|NCT01909804|3894599|FG000|Overall Study|Withdrew Consent|0
2238415|NCT01909804|3894600|FG001|Overall Study|Withdrew Consent|0
2238416|NCT01909804|3894601|FG002|Overall Study|Withdrew Consent|0
2335925|NCT03286400|4062310|FG000|Overall Study|Death|10
2335926|NCT03286400|4062310|FG000|Overall Study|Lost to Follow-up|10
2335927|NCT03286400|4062310|FG000|Overall Study|Physician Decision|1
2335928|NCT03286400|4062310|FG000|Overall Study|Scheduling difficulty|4
2335929|NCT03286543|4062325|FG000|Consented|Screen failure before randomization|2
2335930|NCT03286543|4062326|FG001|Consented|Screen failure before randomization|0
2335931|NCT03286543|4062327|FG002|Consented|Screen failure before randomization|0
2335932|NCT03286543|4062325|FG000|Consented|Screen failure before enrollment|4
2335933|NCT03286543|4062326|FG001|Consented|Screen failure before enrollment|0
2335934|NCT03286543|4062327|FG002|Consented|Screen failure before enrollment|0
2335935|NCT03286543|4062325|FG000|Consented|TKA cancelled after enrollment|1
2335936|NCT03286543|4062326|FG001|Consented|TKA cancelled after enrollment|0
2335937|NCT03286543|4062327|FG002|Consented|TKA cancelled after enrollment|0
2335938|NCT03286543|4062325|FG000|Consented|Withdrawn from study|12
2335939|NCT03286543|4062326|FG001|Consented|Withdrawn from study|0
2335940|NCT03286543|4062327|FG002|Consented|Withdrawn from study|0
2335941|NCT03286543|4062325|FG000|Study Enrollment|TKA cancelled after enrollment|0
2335942|NCT03286543|4062326|FG001|Study Enrollment|TKA cancelled after enrollment|0
2335943|NCT03286543|4062327|FG002|Study Enrollment|TKA cancelled after enrollment|1
2335944|NCT03286543|4062325|FG000|Study Enrollment|Withdrawn from study|0
2335945|NCT03286543|4062326|FG001|Study Enrollment|Withdrawn from study|6
2335946|NCT03286543|4062327|FG002|Study Enrollment|Withdrawn from study|6
2335947|NCT03286751|4062333|FG000|Washout Period 1|Withdrawal by Subject|0
2335948|NCT03286751|4062334|FG001|Washout Period 1|Withdrawal by Subject|0
2335949|NCT03286751|4062335|FG002|Washout Period 1|Withdrawal by Subject|0
2335950|NCT03286751|4062336|FG003|Washout Period 1|Withdrawal by Subject|0
2335951|NCT03286751|4062337|FG004|Washout Period 1|Withdrawal by Subject|1
2335952|NCT03286751|4062338|FG005|Washout Period 1|Withdrawal by Subject|0
2335953|NCT03286751|4062333|FG000|Washout Period 2|Personal Reasons|0
2335954|NCT03286751|4062334|FG001|Washout Period 2|Personal Reasons|1
2335955|NCT03286751|4062335|FG002|Washout Period 2|Personal Reasons|0
2335956|NCT03286751|4062336|FG003|Washout Period 2|Personal Reasons|0
2335957|NCT03286751|4062337|FG004|Washout Period 2|Personal Reasons|0
2335958|NCT03286751|4062338|FG005|Washout Period 2|Personal Reasons|0
2335959|NCT03286751|4062333|FG000|Washout Period 5|Adverse Event|0
2335960|NCT03286751|4062334|FG001|Washout Period 5|Adverse Event|0
2238417|NCT01909804|3894602|FG003|Overall Study|Withdrew Consent|0
2238418|NCT01909804|3894603|FG004|Overall Study|Withdrew Consent|1
2238419|NCT01909804|3894604|FG005|Overall Study|Withdrew Consent|1
2238420|NCT01909804|3894605|FG006|Overall Study|Withdrew Consent|0
2238421|NCT01909804|3894606|FG007|Overall Study|Withdrew Consent|0
2238422|NCT01909804|3894607|FG008|Overall Study|Withdrew Consent|0
2238423|NCT01909804|3894608|FG009|Overall Study|Withdrew Consent|0
2238424|NCT01909804|3894609|FG010|Overall Study|Withdrew Consent|0
2238425|NCT01909804|3894610|FG011|Overall Study|Withdrew Consent|0
2238426|NCT01909804|3894599|FG000|Overall Study|Protocol Violation|0
2238427|NCT01909804|3894600|FG001|Overall Study|Protocol Violation|0
2238428|NCT01909804|3894601|FG002|Overall Study|Protocol Violation|0
2238429|NCT01909804|3894602|FG003|Overall Study|Protocol Violation|0
2238430|NCT01909804|3894603|FG004|Overall Study|Protocol Violation|0
2238431|NCT01909804|3894604|FG005|Overall Study|Protocol Violation|0
2238432|NCT01909804|3894605|FG006|Overall Study|Protocol Violation|0
2238433|NCT01909804|3894606|FG007|Overall Study|Protocol Violation|0
2238434|NCT01909804|3894607|FG008|Overall Study|Protocol Violation|0
2238435|NCT01909804|3894608|FG009|Overall Study|Protocol Violation|0
2238436|NCT01909804|3894609|FG010|Overall Study|Protocol Violation|0
2238437|NCT01909804|3894610|FG011|Overall Study|Protocol Violation|1
2238438|NCT01909973|3894634|FG000|Overall Study|Lost to Follow-up|1
2238439|NCT01909973|3894635|FG001|Overall Study|Lost to Follow-up|0
2238440|NCT01910116|3894647|FG000|Overall Study|Adverse Event|0
2238441|NCT01910116|3894648|FG001|Overall Study|Adverse Event|3
2238442|NCT01910116|3894647|FG000|Overall Study|Lack of Efficacy|3
2238443|NCT01910116|3894648|FG001|Overall Study|Lack of Efficacy|4
2238444|NCT01910116|3894647|FG000|Overall Study|Lost to Follow-up|1
2238445|NCT01910116|3894648|FG001|Overall Study|Lost to Follow-up|0
2238446|NCT01910116|3894647|FG000|Overall Study|Protocol Violation|1
2238447|NCT01910116|3894648|FG001|Overall Study|Protocol Violation|2
2238448|NCT01910116|3894647|FG000|Overall Study|Withdrawal by Subject|8
2238449|NCT01910116|3894648|FG001|Overall Study|Withdrawal by Subject|3
2238450|NCT01910116|3894647|FG000|Overall Study|uncertain allocation|1
2238451|NCT01910116|3894648|FG001|Overall Study|uncertain allocation|3
2238452|NCT01910116|3894647|FG000|Overall Study|incomplete data|0
2238453|NCT01910116|3894648|FG001|Overall Study|incomplete data|1
2238454|NCT01910129|3894656|FG000|Randomized Phase 2|Withdrawal by Subject|2
2238455|NCT01910129|3894657|FG001|Randomized Phase 2|Withdrawal by Subject|1
2238456|NCT01910129|3894658|FG002|Randomized Phase 2|Withdrawal by Subject|0
2238457|NCT01910129|3894656|FG000|Randomized Phase 3|Withdrawal by Subject|0
2238458|NCT01910129|3894657|FG001|Randomized Phase 3|Withdrawal by Subject|1
2238459|NCT01910129|3894658|FG002|Randomized Phase 3|Withdrawal by Subject|0
2238460|NCT01910181|3894676|FG000|Overall Study|Death|37
2238461|NCT01910181|3894676|FG000|Overall Study|Lost to Follow-up|3
2238462|NCT01910181|3894676|FG000|Overall Study|Study Terminated by Sponsor|6
2238463|NCT01910298|3894683|FG000|Overall Study|Adverse Event|1
2238464|NCT01910298|3894684|FG001|Overall Study|Adverse Event|0
2238465|NCT01910298|3894683|FG000|Overall Study|Withdrawal by Subject|2
2238466|NCT01910298|3894684|FG001|Overall Study|Withdrawal by Subject|7
2238467|NCT01910298|3894683|FG000|Overall Study|Protocol Deviation|0
2238468|NCT01910298|3894684|FG001|Overall Study|Protocol Deviation|5
2238469|NCT01910298|3894683|FG000|Overall Study|Lost to Follow-up|1
2238470|NCT01910298|3894684|FG001|Overall Study|Lost to Follow-up|1
2238471|NCT01910298|3894683|FG000|Overall Study|Study Terminated by Sponsor|1
2238472|NCT01910298|3894684|FG001|Overall Study|Study Terminated by Sponsor|17
2335961|NCT03286751|4062335|FG002|Washout Period 5|Adverse Event|0
2335962|NCT03286751|4062336|FG003|Washout Period 5|Adverse Event|0
2335963|NCT03286751|4062337|FG004|Washout Period 5|Adverse Event|1
2335964|NCT03286751|4062338|FG005|Washout Period 5|Adverse Event|0
2335965|NCT03287089|4062373|FG000|Overall Study|Lost to Follow-up|0
2335966|NCT03287089|4062374|FG001|Overall Study|Lost to Follow-up|2
2335967|NCT03287089|4062373|FG000|Overall Study|Physician Decision|0
2335968|NCT03287089|4062374|FG001|Overall Study|Physician Decision|2
2335969|NCT03287089|4062373|FG000|Overall Study|Withdrawal by Subject|0
2335970|NCT03287089|4062374|FG001|Overall Study|Withdrawal by Subject|2
2335971|NCT03287219|4062382|FG000|Overall Study|Protocol Violation|0
2335972|NCT03287219|4062383|FG001|Overall Study|Protocol Violation|2
2335973|NCT03287622|4062457|FG000|Overall Study|Withdrawal by Subject|1
2335974|NCT03287622|4062458|FG001|Overall Study|Withdrawal by Subject|0
2335975|NCT03287622|4062457|FG000|Overall Study|Lost to Follow-up|27
2335976|NCT03287622|4062458|FG001|Overall Study|Lost to Follow-up|15
2335977|NCT03287622|4062457|FG000|Overall Study|No prescripion after surgery|28
2335978|NCT03287622|4062458|FG001|Overall Study|No prescripion after surgery|31
2037102|NCT00415194|3607358|FG001|Overall Study|Death Due to Study Disease|29
2037103|NCT00415194|3607357|FG000|Overall Study|Death Due to Study Drug Related AE|11
2037104|NCT00415194|3607358|FG001|Overall Study|Death Due to Study Drug Related AE|1
2037105|NCT00415194|3607357|FG000|Overall Study|Death Due to Procedural Related AE|0
2037106|NCT00415194|3607358|FG001|Overall Study|Death Due to Procedural Related AE|1
2037107|NCT00415194|3607357|FG000|Overall Study|Death Due to AE (Other Causes)|27
2037108|NCT00415194|3607358|FG001|Overall Study|Death Due to AE (Other Causes)|15
2037109|NCT00415363|3607366|FG000|Overall Study|Withdrawal by Subject|4
2238473|NCT01910298|3894683|FG000|Overall Study|Other Miscellaneous Reasons|0
2238474|NCT01910298|3894684|FG001|Overall Study|Other Miscellaneous Reasons|2
2238475|NCT01910519|3894700|FG000|Overall Study|Withdrawal by Subject|2
2238476|NCT01910519|3894701|FG001|Overall Study|Withdrawal by Subject|0
2238477|NCT01910519|3894700|FG000|Overall Study|Adverse Event|2
2238478|NCT01910519|3894701|FG001|Overall Study|Adverse Event|0
2238479|NCT01911260|3894760|FG000|Supplementation Period|transference or evasion of school|7
2238480|NCT01911260|3894761|FG001|Supplementation Period|transference or evasion of school|9
2238481|NCT01911260|3894762|FG002|Supplementation Period|transference or evasion of school|7
2238482|NCT01911260|3894763|FG003|Supplementation Period|transference or evasion of school|6
2238483|NCT01911260|3894760|FG000|Supplementation Period|Adverse Event|2
2238484|NCT01911260|3894761|FG001|Supplementation Period|Adverse Event|0
2238485|NCT01911260|3894762|FG002|Supplementation Period|Adverse Event|1
2238486|NCT01911260|3894763|FG003|Supplementation Period|Adverse Event|0
2238487|NCT01911260|3894760|FG000|Supplementation Period|refused to receive supplement|1
2238488|NCT01911260|3894761|FG001|Supplementation Period|refused to receive supplement|0
2238489|NCT01911260|3894762|FG002|Supplementation Period|refused to receive supplement|1
2238490|NCT01911260|3894763|FG003|Supplementation Period|refused to receive supplement|0
2238491|NCT01911260|3894760|FG000|Supplementation Period|less than 12 weeks supplementation|0
2238492|NCT01911260|3894761|FG001|Supplementation Period|less than 12 weeks supplementation|3
2238493|NCT01911260|3894762|FG002|Supplementation Period|less than 12 weeks supplementation|1
2238494|NCT01911260|3894763|FG003|Supplementation Period|less than 12 weeks supplementation|2
2335979|NCT03287622|4062457|FG000|Overall Study|prolonged Length of stay|2
2335980|NCT03287622|4062458|FG001|Overall Study|prolonged Length of stay|0
2335981|NCT03287622|4062457|FG000|Overall Study|surgery related|0
2335982|NCT03287622|4062458|FG001|Overall Study|surgery related|2
2335983|NCT03287635|4062471|FG000|Overall Study|Lost to Follow-up|5
2335984|NCT03287635|4062471|FG000|Overall Study|Withdrawal by Subject|1
2335985|NCT03287635|4062471|FG000|Overall Study|Physician Decision|1
2335986|NCT03287791|4062483|FG000|Overall Study|Insufficient Therapeutic Response|0
2335987|NCT03287791|4062484|FG001|Overall Study|Insufficient Therapeutic Response|0
2335988|NCT03287791|4062485|FG002|Overall Study|Insufficient Therapeutic Response|1
2335989|NCT03287791|4062483|FG000|Overall Study|Adverse Event|0
2335990|NCT03287791|4062484|FG001|Overall Study|Adverse Event|4
2335991|NCT03287791|4062485|FG002|Overall Study|Adverse Event|3
2335992|NCT03287791|4062483|FG000|Overall Study|Withdrawal by Subject|12
2335993|NCT03287791|4062484|FG001|Overall Study|Withdrawal by Subject|12
2335994|NCT03287791|4062485|FG002|Overall Study|Withdrawal by Subject|17
2335995|NCT03287791|4062483|FG000|Overall Study|Missed more than 6 consecutive doses|3
2335996|NCT03287791|4062484|FG001|Overall Study|Missed more than 6 consecutive doses|2
2335997|NCT03287791|4062485|FG002|Overall Study|Missed more than 6 consecutive doses|2
2335998|NCT03287791|4062483|FG000|Overall Study|Lost to Follow-up|8
2335999|NCT03287791|4062484|FG001|Overall Study|Lost to Follow-up|14
2336000|NCT03287791|4062485|FG002|Overall Study|Lost to Follow-up|11
2336001|NCT03287791|4062483|FG000|Overall Study|Protocol Violation|7
2336002|NCT03287791|4062484|FG001|Overall Study|Protocol Violation|2
2336003|NCT03287791|4062485|FG002|Overall Study|Protocol Violation|1
2336004|NCT03287791|4062483|FG000|Overall Study|Participant was enrolled at 2 sites|1
2336005|NCT03287791|4062484|FG001|Overall Study|Participant was enrolled at 2 sites|0
2336006|NCT03287791|4062485|FG002|Overall Study|Participant was enrolled at 2 sites|1
2336007|NCT03287791|4062483|FG000|Overall Study|Too much time between 2 visits|0
2336008|NCT03287791|4062484|FG001|Overall Study|Too much time between 2 visits|1
2336009|NCT03287791|4062485|FG002|Overall Study|Too much time between 2 visits|0
2336010|NCT03287791|4062483|FG000|Overall Study|Non-compliance|0
2336011|NCT03287791|4062484|FG001|Overall Study|Non-compliance|1
2336012|NCT03287791|4062485|FG002|Overall Study|Non-compliance|0
2336013|NCT03287791|4062483|FG000|Overall Study|Did not meet inclusion criteria|1
2336014|NCT03287791|4062484|FG001|Overall Study|Did not meet inclusion criteria|0
2336015|NCT03287791|4062485|FG002|Overall Study|Did not meet inclusion criteria|0
2336016|NCT03287804|4062493|FG000|Overall Study|Death|1
2336017|NCT03287804|4062493|FG000|Overall Study|Physician Decision|2
2336018|NCT03287804|4062493|FG000|Overall Study|Progressive disease|8
2336019|NCT03287869|4062509|FG000|Overall Study|Adverse Event|14
2336020|NCT03287869|4062510|FG001|Overall Study|Adverse Event|12
2336021|NCT03287869|4062509|FG000|Overall Study|Lack of Efficacy|1
2336022|NCT03287869|4062510|FG001|Overall Study|Lack of Efficacy|0
2336023|NCT03287869|4062509|FG000|Overall Study|Lost to Follow-up|13
2336024|NCT03287869|4062510|FG001|Overall Study|Lost to Follow-up|19
2336025|NCT03287869|4062509|FG000|Overall Study|Non-Compliance With Study Drug|5
2336026|NCT03287869|4062510|FG001|Overall Study|Non-Compliance With Study Drug|9
2336027|NCT03287869|4062509|FG000|Overall Study|Progressive Disease|1
2336028|NCT03287869|4062510|FG001|Overall Study|Progressive Disease|0
2336029|NCT03287869|4062509|FG000|Overall Study|Protocol Deviation|2
2336030|NCT03287869|4062510|FG001|Overall Study|Protocol Deviation|1
2336031|NCT03287869|4062509|FG000|Overall Study|Withdrawal by Subject|36
2336032|NCT03287869|4062510|FG001|Overall Study|Withdrawal by Subject|43
2336033|NCT03287869|4062509|FG000|Overall Study|Early Closure of the Site|0
2336034|NCT03287869|4062510|FG001|Overall Study|Early Closure of the Site|1
2336035|NCT03287869|4062509|FG000|Overall Study|Physician Decision|5
2336036|NCT03287869|4062510|FG001|Overall Study|Physician Decision|5
2336037|NCT03287869|4062509|FG000|Overall Study|Reason not Specified|6
2336038|NCT03287869|4062510|FG001|Overall Study|Reason not Specified|3
2336039|NCT03288714|4062518|FG000|Overall Study|Lost to Follow-up|2
2238495|NCT01911260|3894760|FG000|Follow-up Period|transference or evasion of school|13
2238496|NCT01911260|3894761|FG001|Follow-up Period|transference or evasion of school|20
2238497|NCT01911260|3894762|FG002|Follow-up Period|transference or evasion of school|15
2238498|NCT01911260|3894763|FG003|Follow-up Period|transference or evasion of school|12
2238499|NCT01911273|3894775|FG000|Overall Study|Progression of Disease|1
2238500|NCT01911273|3894776|FG001|Overall Study|Progression of Disease|0
2238501|NCT01911273|3894775|FG000|Overall Study|Withdrawal by Subject|0
2238502|NCT01911273|3894776|FG001|Overall Study|Withdrawal by Subject|2
2238503|NCT01911429|3894820|FG000|Overall Study|Adverse Event|5
2238504|NCT01911429|3894821|FG001|Overall Study|Adverse Event|3
2238505|NCT01911429|3894822|FG002|Overall Study|Adverse Event|9
2238506|NCT01911429|3894820|FG000|Overall Study|Lack of Efficacy|1
2238507|NCT01911429|3894821|FG001|Overall Study|Lack of Efficacy|2
2238508|NCT01911429|3894822|FG002|Overall Study|Lack of Efficacy|4
2238509|NCT01911429|3894820|FG000|Overall Study|Lost to Follow-up|0
2238510|NCT01911429|3894821|FG001|Overall Study|Lost to Follow-up|0
2238511|NCT01911429|3894822|FG002|Overall Study|Lost to Follow-up|1
2238512|NCT01911429|3894820|FG000|Overall Study|Protocol Violation|0
2238513|NCT01911429|3894821|FG001|Overall Study|Protocol Violation|0
2238514|NCT01911429|3894822|FG002|Overall Study|Protocol Violation|1
2238515|NCT01911429|3894820|FG000|Overall Study|Withdrawal by Subject|5
2238516|NCT01911429|3894821|FG001|Overall Study|Withdrawal by Subject|5
2238517|NCT01911429|3894822|FG002|Overall Study|Withdrawal by Subject|4
2238518|NCT01911429|3894820|FG000|Overall Study|Accidental randomization|0
2238519|NCT01911429|3894821|FG001|Overall Study|Accidental randomization|0
2238520|NCT01911429|3894822|FG002|Overall Study|Accidental randomization|1
2238521|NCT01911429|3894820|FG000|Overall Study|subject left study|1
2238522|NCT01911429|3894821|FG001|Overall Study|subject left study|0
2238523|NCT01911429|3894822|FG002|Overall Study|subject left study|0
2238524|NCT01911442|3894833|FG000|Overall Study|Adverse Event|2
2238525|NCT01911442|3894834|FG001|Overall Study|Adverse Event|2
2238526|NCT01911442|3894835|FG002|Overall Study|Adverse Event|4
2238527|NCT01911442|3894833|FG000|Overall Study|Lack of Efficacy|1
2238528|NCT01911442|3894834|FG001|Overall Study|Lack of Efficacy|1
2238529|NCT01911442|3894835|FG002|Overall Study|Lack of Efficacy|1
2238530|NCT01911442|3894833|FG000|Overall Study|Lost to Follow-up|2
2238531|NCT01911442|3894834|FG001|Overall Study|Lost to Follow-up|0
2238532|NCT01911442|3894835|FG002|Overall Study|Lost to Follow-up|1
2238533|NCT01911442|3894833|FG000|Overall Study|Withdrawal by Subject|1
2238534|NCT01911442|3894834|FG001|Overall Study|Withdrawal by Subject|0
2238535|NCT01911442|3894835|FG002|Overall Study|Withdrawal by Subject|6
2238536|NCT01911442|3894833|FG000|Overall Study|Mother's Work Schedule|0
2238537|NCT01911442|3894834|FG001|Overall Study|Mother's Work Schedule|1
2238538|NCT01911442|3894835|FG002|Overall Study|Mother's Work Schedule|0
2238539|NCT01911546|3894847|FG000|Overall Study|Lost to Follow-up|1
2238540|NCT01911546|3894847|FG000|Overall Study|Everolimus was discontinued|5
2238541|NCT01911780|3894869|FG000|Double-blind Period (8 Weeks)|Adverse Event|1
2238542|NCT01911780|3894870|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
2238543|NCT01911780|3894869|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
2238544|NCT01911780|3894870|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
2238545|NCT01911780|3894869|FG000|Double-blind Period (8 Weeks)|Personal reason|1
2238546|NCT01911780|3894870|FG001|Double-blind Period (8 Weeks)|Personal reason|0
2238547|NCT01911780|3894869|FG000|Extension Period (52 Weeks)|Adverse Event|3
2238548|NCT01911780|3894870|FG001|Extension Period (52 Weeks)|Adverse Event|0
2238549|NCT01911780|3894869|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
2238550|NCT01911780|3894870|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
2238551|NCT01911780|3894869|FG000|Extension Period (52 Weeks)|Personal reason|1
2238552|NCT01911780|3894870|FG001|Extension Period (52 Weeks)|Personal reason|1
2238553|NCT01911819|3894883|FG000|Overall Study|Adverse Event|0
2238554|NCT01911819|3894884|FG001|Overall Study|Adverse Event|1
2238555|NCT01911819|3894885|FG002|Overall Study|Adverse Event|0
2238556|NCT01911819|3894883|FG000|Overall Study|Withdrawal by Subject|1
2238557|NCT01911819|3894884|FG001|Overall Study|Withdrawal by Subject|1
2238558|NCT01911819|3894885|FG002|Overall Study|Withdrawal by Subject|0
2238559|NCT01911845|3894893|FG000|Overall Study|Adverse Event|2
2238560|NCT01911845|3894893|FG000|Overall Study|Lost to Follow-up|1
2238561|NCT01911845|3894893|FG000|Overall Study|Other (not specified)|3
2238562|NCT01912222|3894911|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
2238563|NCT01912222|3894912|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
2238564|NCT01912222|3894913|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
2238565|NCT01912222|3894911|FG000|Part B: Treatment Period|Progressive disease|10
2238566|NCT01912222|3894912|FG001|Part B: Treatment Period|Progressive disease|12
2238567|NCT01912222|3894913|FG002|Part B: Treatment Period|Progressive disease|15
2238568|NCT01912222|3894911|FG000|Part B: Treatment Period|Adverse Event|1
2238569|NCT01912222|3894912|FG001|Part B: Treatment Period|Adverse Event|2
2238570|NCT01912222|3894913|FG002|Part B: Treatment Period|Adverse Event|3
2238571|NCT01912222|3894911|FG000|Part B: Treatment Period|Withdrawal by Subject|2
2238572|NCT01912222|3894912|FG001|Part B: Treatment Period|Withdrawal by Subject|1
2238573|NCT01912222|3894913|FG002|Part B: Treatment Period|Withdrawal by Subject|2
2238574|NCT01912287|3894929|FG000|Overall Study|Ineligible|1
2238575|NCT01912287|3894930|FG001|Overall Study|Ineligible|0
2238576|NCT01912287|3894931|FG002|Overall Study|Ineligible|1
2238577|NCT01912287|3894929|FG000|Overall Study|No-show|0
2238578|NCT01912287|3894930|FG001|Overall Study|No-show|0
2238579|NCT01912287|3894931|FG002|Overall Study|No-show|1
2238580|NCT01912287|3894929|FG000|Overall Study|Dissatisfaction with assigned treatment|4
2238581|NCT01912287|3894930|FG001|Overall Study|Dissatisfaction with assigned treatment|2
2238582|NCT01912287|3894931|FG002|Overall Study|Dissatisfaction with assigned treatment|1
2238583|NCT01912287|3894929|FG000|Overall Study|Felt treatment no longer needed|0
2238584|NCT01912287|3894930|FG001|Overall Study|Felt treatment no longer needed|1
2238585|NCT01912287|3894931|FG002|Overall Study|Felt treatment no longer needed|0
2238586|NCT01912287|3894929|FG000|Overall Study|Life circumstances|4
2238587|NCT01912287|3894930|FG001|Overall Study|Life circumstances|2
2238588|NCT01912287|3894931|FG002|Overall Study|Life circumstances|0
2336040|NCT03288714|4062519|FG001|Overall Study|Lost to Follow-up|1
2336041|NCT03288714|4062518|FG000|Overall Study|Non-compliance with study schedule|2
2336042|NCT03288714|4062519|FG001|Overall Study|Non-compliance with study schedule|0
2336043|NCT03288714|4062518|FG000|Overall Study|Withdrawal by Subject|3
2336044|NCT03288714|4062519|FG001|Overall Study|Withdrawal by Subject|1
2336045|NCT03288714|4062518|FG000|Overall Study|Clinical Worsening|2
2336046|NCT03288714|4062519|FG001|Overall Study|Clinical Worsening|1
2336047|NCT03288714|4062518|FG000|Overall Study|Adverse Event|1
2336048|NCT03288714|4062519|FG001|Overall Study|Adverse Event|0
2336049|NCT03288779|4062527|FG000|Overall Study|Withdrawal by Subject|3
2336050|NCT03288987|4062533|FG000|Overall Study|Protocol Violation|10
2336051|NCT03288987|4062534|FG001|Overall Study|Protocol Violation|4
2336052|NCT03289208|4062556|FG000|Overall Study|Adverse Event|1
2336053|NCT03289208|4062557|FG001|Overall Study|Adverse Event|0
2336054|NCT03289208|4062558|FG002|Overall Study|Adverse Event|0
2336055|NCT03289455|4062582|FG000|Overall Study|Death|1
2336056|NCT03289455|4062583|FG001|Overall Study|Death|0
2336057|NCT03289455|4062584|FG002|Overall Study|Death|0
2336058|NCT03289455|4062582|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0
2336059|NCT03289455|4062583|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1
2336060|NCT03289455|4062584|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0
2336061|NCT03289455|4062582|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
2336062|NCT03289455|4062583|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
2336063|NCT03289455|4062584|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1
2336064|NCT03289455|4062582|FG000|Overall Study|Progressive disease|3
2336065|NCT03289455|4062583|FG001|Overall Study|Progressive disease|4
2336066|NCT03289455|4062584|FG002|Overall Study|Progressive disease|5
2336067|NCT03289533|4062603|FG000|Overall Study|Death|12
2336068|NCT03289533|4062603|FG000|Overall Study|Terminated from study by sponsor|10
2336069|NCT03289676|4062609|FG000|Overall Study|Withdrawal by Subject|2
2336070|NCT03289676|4062610|FG001|Overall Study|Withdrawal by Subject|0
2336071|NCT03289676|4062609|FG000|Overall Study|Protocol Violation|2
2336072|NCT03289676|4062610|FG001|Overall Study|Protocol Violation|0
2336073|NCT03289676|4062609|FG000|Overall Study|Lost to Follow-up|0
2336074|NCT03289676|4062610|FG001|Overall Study|Lost to Follow-up|1
2336075|NCT03290300|4062634|FG000|Overall Study|Lost to Follow-up|3
2336076|NCT03291288|4062687|FG000|Drug-drug Interaction Phase|Adverse Event|2
2336077|NCT03291288|4062688|FG001|Drug-drug Interaction Phase|Adverse Event|0
2336078|NCT03291288|4062687|FG000|Drug-drug Interaction Phase|Disease progression|1
2336079|NCT03291288|4062688|FG001|Drug-drug Interaction Phase|Disease progression|0
2336080|NCT03291288|4062687|FG000|Drug-drug Interaction Phase|Other|3
2336081|NCT03291288|4062688|FG001|Drug-drug Interaction Phase|Other|0
2336082|NCT03291288|4062687|FG000|Pexidartinib Only|Ongoing|0
2336083|NCT03291288|4062688|FG001|Pexidartinib Only|Ongoing|2
2336084|NCT03292016|4062717|FG000|Second Washout|Adverse Event|0
2336085|NCT03292016|4062718|FG001|Second Washout|Adverse Event|1
2336086|NCT03292016|4062719|FG002|Second Washout|Adverse Event|0
2336087|NCT03292016|4062720|FG003|Second Washout|Adverse Event|0
2336088|NCT03292016|4062721|FG004|Second Washout|Adverse Event|0
2336089|NCT03292016|4062722|FG005|Second Washout|Adverse Event|0
2336090|NCT03292406|4062733|FG000|Overall Study|Progressive Disease|6
2336091|NCT03292406|4062734|FG001|Overall Study|Progressive Disease|3
2336092|NCT03292406|4062735|FG002|Overall Study|Progressive Disease|4
2336093|NCT03292406|4062733|FG000|Overall Study|Adverse Event|7
2336094|NCT03292406|4062734|FG001|Overall Study|Adverse Event|1
2336095|NCT03292406|4062735|FG002|Overall Study|Adverse Event|4
2336096|NCT03292406|4062733|FG000|Overall Study|Withdrawal by Subject|0
2336097|NCT03292406|4062734|FG001|Overall Study|Withdrawal by Subject|7
2336098|NCT03292406|4062735|FG002|Overall Study|Withdrawal by Subject|2
2336099|NCT03292406|4062733|FG000|Overall Study|Protocol Violation|0
2336100|NCT03292406|4062734|FG001|Overall Study|Protocol Violation|1
2336101|NCT03292406|4062735|FG002|Overall Study|Protocol Violation|1
2336102|NCT03292406|4062733|FG000|Overall Study|Other|0
2336103|NCT03292406|4062734|FG001|Overall Study|Other|1
2336104|NCT03292406|4062735|FG002|Overall Study|Other|2
2238589|NCT01912287|3894929|FG000|Overall Study|Lost Interest|1
2238590|NCT01912287|3894930|FG001|Overall Study|Lost Interest|0
2238591|NCT01912287|3894931|FG002|Overall Study|Lost Interest|0
2336105|NCT03292432|4062745|FG000|Overall Study|Lost to Follow-up|11
2336106|NCT03292432|4062746|FG001|Overall Study|Lost to Follow-up|8
2238592|NCT01912287|3894929|FG000|Overall Study|Uknown reason - subject drop out|5
2238593|NCT01912287|3894930|FG001|Overall Study|Uknown reason - subject drop out|7
2238594|NCT01912287|3894931|FG002|Overall Study|Uknown reason - subject drop out|3
2238595|NCT01912287|3894929|FG000|Overall Study|Missed Assesment|1
2238596|NCT01912287|3894930|FG001|Overall Study|Missed Assesment|1
2238597|NCT01912287|3894931|FG002|Overall Study|Missed Assesment|1
2238598|NCT01912287|3894929|FG000|Overall Study|Scheduling/change in availability|17
2238599|NCT01912287|3894930|FG001|Overall Study|Scheduling/change in availability|10
2238600|NCT01912287|3894931|FG002|Overall Study|Scheduling/change in availability|8
2238601|NCT01912339|3894941|FG000|Blinded (0 to 3 Months)|Declined to participate|1
2238602|NCT01912339|3894942|FG001|Blinded (0 to 3 Months)|Declined to participate|0
2238603|NCT01912339|3894943|FG002|Blinded (0 to 3 Months)|Declined to participate|0
2238604|NCT01912339|3894941|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1
2238605|NCT01912339|3894942|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0
2238606|NCT01912339|3894943|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0
2238607|NCT01912339|3894941|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
2238608|NCT01912339|3894942|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
2238609|NCT01912339|3894943|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
2238610|NCT01912339|3894941|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
2238611|NCT01912339|3894942|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
2238612|NCT01912339|3894943|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
2238613|NCT01912339|3894941|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
2238614|NCT01912339|3894942|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
2238615|NCT01912339|3894943|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
2238616|NCT01912339|3894941|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
2238617|NCT01912339|3894942|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
2238618|NCT01912339|3894943|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
2238619|NCT01912339|3894941|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
2238620|NCT01912339|3894942|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
2238621|NCT01912339|3894943|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
2238622|NCT01912339|3894941|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
2238623|NCT01912339|3894942|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
2238624|NCT01912339|3894943|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
2238625|NCT01912339|3894941|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
2238626|NCT01912339|3894942|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
2238627|NCT01912339|3894943|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
2238628|NCT01912339|3894941|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
2238629|NCT01912339|3894942|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
2238630|NCT01912339|3894943|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
2238631|NCT01912339|3894941|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
2238632|NCT01912339|3894942|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
2238633|NCT01912339|3894943|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
2336107|NCT03292432|4062745|FG000|Overall Study|Death|2
2336108|NCT03292432|4062746|FG001|Overall Study|Death|1
2336109|NCT03292432|4062745|FG000|Overall Study|Withdrawal by Subject|1
2336110|NCT03292432|4062746|FG001|Overall Study|Withdrawal by Subject|2
2336111|NCT03292432|4062745|FG000|Overall Study|Site closed before any data collected|1
2336112|NCT03292432|4062746|FG001|Overall Study|Site closed before any data collected|0
2336113|NCT03292640|4062767|FG000|Overall Study|Withdrawal by Subject|17
2336114|NCT03292640|4062768|FG001|Overall Study|Withdrawal by Subject|16
2336115|NCT03292640|4062767|FG000|Overall Study|Adverse Event|20
2336116|NCT03292640|4062768|FG001|Overall Study|Adverse Event|2
2336117|NCT03292640|4062767|FG000|Overall Study|Lost to Follow-up|24
2336118|NCT03292640|4062768|FG001|Overall Study|Lost to Follow-up|24
2336119|NCT03292653|4062781|FG000|Overall Study|Adverse Event|0
2336120|NCT03292653|4062782|FG001|Overall Study|Adverse Event|0
2336121|NCT03292653|4062783|FG002|Overall Study|Adverse Event|1
2336122|NCT03292653|4062781|FG000|Overall Study|Did not Receive Treatment|1
2336123|NCT03292653|4062782|FG001|Overall Study|Did not Receive Treatment|0
2336124|NCT03292653|4062783|FG002|Overall Study|Did not Receive Treatment|0
2037110|NCT00415363|3607367|FG001|Overall Study|Withdrawal by Subject|4
2037111|NCT00415363|3607366|FG000|Overall Study|Adverse Event|4
2037112|NCT00415363|3607367|FG001|Overall Study|Adverse Event|4
2037113|NCT00415363|3607366|FG000|Overall Study|Lost to Follow-up|2
2037114|NCT00415363|3607367|FG001|Overall Study|Lost to Follow-up|1
2037115|NCT00415363|3607366|FG000|Overall Study|Physician Decision|3
2037116|NCT00415363|3607367|FG001|Overall Study|Physician Decision|1
2037117|NCT00415363|3607366|FG000|Overall Study|Death|16
2238634|NCT01912339|3894941|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
2238635|NCT01912339|3894942|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
2238636|NCT01912339|3894943|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
2238637|NCT01912339|3894941|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
2238638|NCT01912339|3894942|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
2238639|NCT01912339|3894943|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
2336125|NCT03293394|4062842|FG000|Follow-up (6 Months)|Adverse Event|4
2238640|NCT01912456|3894955|FG000|Period 1|Physician Decision|0
2238641|NCT01912456|3894956|FG001|Period 1|Physician Decision|0
2238642|NCT01912456|3894957|FG002|Period 1|Physician Decision|1
2238643|NCT01912456|3894958|FG003|Period 1|Physician Decision|0
2238644|NCT01912456|3894955|FG000|Period 1|non-compliance|1
2238645|NCT01912456|3894956|FG001|Period 1|non-compliance|0
2238646|NCT01912456|3894957|FG002|Period 1|non-compliance|0
2238647|NCT01912456|3894958|FG003|Period 1|non-compliance|1
2238648|NCT01912456|3894955|FG000|Period 1|Adverse Event|1
2238649|NCT01912456|3894956|FG001|Period 1|Adverse Event|0
2238650|NCT01912456|3894957|FG002|Period 1|Adverse Event|0
2238651|NCT01912456|3894958|FG003|Period 1|Adverse Event|1
2238652|NCT01912456|3894955|FG000|Period 1|Withdrawal by Subject|0
2238653|NCT01912456|3894956|FG001|Period 1|Withdrawal by Subject|1
2238654|NCT01912456|3894957|FG002|Period 1|Withdrawal by Subject|1
2238655|NCT01912456|3894958|FG003|Period 1|Withdrawal by Subject|1
2238656|NCT01912456|3894955|FG000|Period 2|Lack of Efficacy|0
2238657|NCT01912456|3894956|FG001|Period 2|Lack of Efficacy|2
2238658|NCT01912456|3894957|FG002|Period 2|Lack of Efficacy|0
2238659|NCT01912456|3894958|FG003|Period 2|Lack of Efficacy|0
2238660|NCT01912456|3894955|FG000|Period 2|Adverse Event|0
2238661|NCT01912456|3894956|FG001|Period 2|Adverse Event|0
2238662|NCT01912456|3894957|FG002|Period 2|Adverse Event|0
2238663|NCT01912456|3894958|FG003|Period 2|Adverse Event|1
2238664|NCT01912599|3894977|FG000|Overall Study|Withdrawal by Subject|0
2238665|NCT01912599|3894978|FG001|Overall Study|Withdrawal by Subject|1
2238666|NCT01912612|3894986|FG000|Overall Study|Adverse Event|4
2238667|NCT01912612|3894987|FG001|Overall Study|Adverse Event|0
2238668|NCT01912612|3894988|FG002|Overall Study|Adverse Event|0
2238669|NCT01912612|3894986|FG000|Overall Study|Withdrew consent|1
2238670|NCT01912612|3894987|FG001|Overall Study|Withdrew consent|0
2238671|NCT01912612|3894988|FG002|Overall Study|Withdrew consent|0
2238672|NCT01912612|3894986|FG000|Overall Study|Study design change|0
2238673|NCT01912612|3894987|FG001|Overall Study|Study design change|0
2238674|NCT01912612|3894988|FG002|Overall Study|Study design change|3
2238675|NCT01912729|3895007|FG000|Overall Study|Withdrawal by Subject|0
2238676|NCT01912729|3895008|FG001|Overall Study|Withdrawal by Subject|1
2238677|NCT01912768|3895016|FG000|Overall Study|Adverse Event|2
2238678|NCT01912768|3895017|FG001|Overall Study|Adverse Event|0
2238679|NCT01912768|3895016|FG000|Overall Study|Lost to Follow-up|2
2238680|NCT01912768|3895017|FG001|Overall Study|Lost to Follow-up|1
2238681|NCT01912768|3895016|FG000|Overall Study|Withdrawal by Subject|5
2238682|NCT01912768|3895017|FG001|Overall Study|Withdrawal by Subject|3
2238683|NCT01912768|3895016|FG000|Overall Study|Randomized in error|1
2238684|NCT01912768|3895017|FG001|Overall Study|Randomized in error|0
2238685|NCT01912781|3895026|FG000|Overall Study|Withdrawal by Subject|2
2238686|NCT01912781|3895027|FG001|Overall Study|Withdrawal by Subject|0
2238687|NCT01912807|3895036|FG000|Overall Study|Did not meet elegibility criteria|6
2238688|NCT01912807|3895037|FG001|Overall Study|Did not meet elegibility criteria|4
2238689|NCT01912807|3895036|FG000|Overall Study|Lost to Follow-up|36
2238690|NCT01912807|3895037|FG001|Overall Study|Lost to Follow-up|37
2238691|NCT01912872|3895047|FG000|Overall Study|Lost to Follow-up|2
2238692|NCT01912872|3895048|FG001|Overall Study|Lost to Follow-up|3
2238693|NCT01912872|3895049|FG002|Overall Study|Lost to Follow-up|5
2238694|NCT01912872|3895050|FG003|Overall Study|Lost to Follow-up|5
2238695|NCT01912872|3895047|FG000|Overall Study|Other unspecified|3
2238696|NCT01912872|3895048|FG001|Overall Study|Other unspecified|1
2238697|NCT01912872|3895049|FG002|Overall Study|Other unspecified|3
2238698|NCT01912872|3895050|FG003|Overall Study|Other unspecified|0
2238699|NCT01912872|3895047|FG000|Overall Study|Informed consent withdrawn|0
2238700|NCT01912872|3895048|FG001|Overall Study|Informed consent withdrawn|0
2238701|NCT01912872|3895049|FG002|Overall Study|Informed consent withdrawn|1
2238702|NCT01912872|3895050|FG003|Overall Study|Informed consent withdrawn|1
2238703|NCT01912872|3895047|FG000|Overall Study|Non-compliance with lab inc/exclusion|0
2238704|NCT01912872|3895048|FG001|Overall Study|Non-compliance with lab inc/exclusion|0
2238705|NCT01912872|3895049|FG002|Overall Study|Non-compliance with lab inc/exclusion|0
2238706|NCT01912872|3895050|FG003|Overall Study|Non-compliance with lab inc/exclusion|1
2238707|NCT01912872|3895047|FG000|Overall Study|Protocol Violation|0
2238708|NCT01912872|3895048|FG001|Overall Study|Protocol Violation|0
2238709|NCT01912872|3895049|FG002|Overall Study|Protocol Violation|1
2238710|NCT01912872|3895050|FG003|Overall Study|Protocol Violation|0
2238711|NCT01912872|3895047|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2238712|NCT01912872|3895048|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2238713|NCT01912872|3895049|FG002|Overall Study|Unsatisfactory therapeutic effect|0
2238714|NCT01912872|3895050|FG003|Overall Study|Unsatisfactory therapeutic effect|2
2238715|NCT01912872|3895047|FG000|Overall Study|Withdrawal of study medication|0
2238716|NCT01912872|3895048|FG001|Overall Study|Withdrawal of study medication|0
2238717|NCT01912872|3895049|FG002|Overall Study|Withdrawal of study medication|0
2238718|NCT01912872|3895050|FG003|Overall Study|Withdrawal of study medication|2
2238719|NCT01912872|3895047|FG000|Overall Study|Missing|0
2238720|NCT01912872|3895048|FG001|Overall Study|Missing|0
2238721|NCT01912872|3895049|FG002|Overall Study|Missing|0
2238722|NCT01912872|3895050|FG003|Overall Study|Missing|1
2238723|NCT01912963|3895064|FG000|Overall Study|Disease Progression (RECIST1.1)|6
2238724|NCT01912963|3895065|FG001|Overall Study|Disease Progression (RECIST1.1)|9
2238725|NCT01912963|3895066|FG002|Overall Study|Disease Progression (RECIST1.1)|5
2238726|NCT01912963|3895064|FG000|Overall Study|Disease Progression (not RECIST1.1)|0
2238727|NCT01912963|3895065|FG001|Overall Study|Disease Progression (not RECIST1.1)|7
2238728|NCT01912963|3895066|FG002|Overall Study|Disease Progression (not RECIST1.1)|1
2238729|NCT01912963|3895064|FG000|Overall Study|Adverse Event|0
2238730|NCT01912963|3895065|FG001|Overall Study|Adverse Event|1
2238731|NCT01912963|3895066|FG002|Overall Study|Adverse Event|1
2238732|NCT01912963|3895064|FG000|Overall Study|Withdrawal by Subject|0
2238733|NCT01912963|3895065|FG001|Overall Study|Withdrawal by Subject|1
2238734|NCT01912963|3895066|FG002|Overall Study|Withdrawal by Subject|0
2238735|NCT01912963|3895064|FG000|Overall Study|Sought treatment locally|0
2238736|NCT01912963|3895065|FG001|Overall Study|Sought treatment locally|1
2238737|NCT01912963|3895066|FG002|Overall Study|Sought treatment locally|0
2238738|NCT01913041|3895074|FG000|Overall Study|Protocol Violation|35
2238739|NCT01913041|3895074|FG000|Overall Study|Withdrawal by Subject|3
2238740|NCT01913041|3895074|FG000|Overall Study|Physician Decision|1
2238741|NCT01913340|3895084|FG000|Overall Study|Death|2
2238742|NCT01913340|3895085|FG001|Overall Study|Death|5
2238743|NCT01913340|3895084|FG000|Overall Study|Lost to Follow-up|1
2238744|NCT01913340|3895085|FG001|Overall Study|Lost to Follow-up|1
2238745|NCT01913353|3895093|FG000|Overall Study|Adverse Event|2
2238746|NCT01913353|3895094|FG001|Overall Study|Adverse Event|0
2238747|NCT01913353|3895093|FG000|Overall Study|Physician Decision|0
2238748|NCT01913353|3895094|FG001|Overall Study|Physician Decision|2
2238749|NCT01913353|3895093|FG000|Overall Study|Withdrawal by Subject|20
2238750|NCT01913353|3895094|FG001|Overall Study|Withdrawal by Subject|6
2238751|NCT01913353|3895093|FG000|Overall Study|multiple reasons|10
2238752|NCT01913353|3895094|FG001|Overall Study|multiple reasons|7
2238753|NCT01913405|3895107|FG000|Overall Study|Withdrawal by Subject|1
2238754|NCT01913405|3895107|FG000|Overall Study|Adverse Event|1
2238755|NCT01913470|3895126|FG000|Overall Study|Lost to Follow-up|0
2238756|NCT01913470|3895127|FG001|Overall Study|Lost to Follow-up|1
2238757|NCT01913470|3895126|FG000|Overall Study|Physician Decision|0
2238758|NCT01913470|3895127|FG001|Overall Study|Physician Decision|1
2238759|NCT01913470|3895126|FG000|Overall Study|Withdrawal by Subject|0
2238760|NCT01913470|3895127|FG001|Overall Study|Withdrawal by Subject|1
2238761|NCT01913483|3895136|FG000|Overall Study|Withdrawal by Subject|1
2238762|NCT01913483|3895137|FG001|Overall Study|Withdrawal by Subject|2
2238763|NCT01913483|3895136|FG000|Overall Study|Lost to Follow-up|6
2238764|NCT01913483|3895137|FG001|Overall Study|Lost to Follow-up|3
2238765|NCT01913483|3895136|FG000|Overall Study|Death|14
2238766|NCT01913483|3895137|FG001|Overall Study|Death|17
2238767|NCT01913639|3895169|FG000|Overall Study|Not Eligible|3
2238768|NCT01914393|3895206|FG000|Overall Study|Protocol Violation|11
2238769|NCT01914393|3895207|FG001|Overall Study|Protocol Violation|3
2238770|NCT01914393|3895208|FG002|Overall Study|Protocol Violation|19
2238771|NCT01914393|3895206|FG000|Overall Study|Lack of Efficacy|11
2238772|NCT01914393|3895207|FG001|Overall Study|Lack of Efficacy|16
2238773|NCT01914393|3895208|FG002|Overall Study|Lack of Efficacy|5
2238774|NCT01914393|3895206|FG000|Overall Study|no reason given|14
2336126|NCT03293394|4062843|FG001|Follow-up (6 Months)|Adverse Event|2
2336127|NCT03293485|4062849|FG000|Overall Study|Death|1
2336128|NCT03293485|4062849|FG000|Overall Study|Screen Failure|2
2336129|NCT03293485|4062849|FG000|Overall Study|Withdrawal by Subject|2
2336130|NCT03293654|4062858|FG000|Overall Study|Lost to Follow-up|0
2336131|NCT03293654|4062859|FG001|Overall Study|Lost to Follow-up|1
2336132|NCT03293654|4062860|FG002|Overall Study|Lost to Follow-up|0
2352940|NCT03725722|4103252|FG001|Overall Study|Personal reasons|0
2352941|NCT03725722|4103253|FG002|Overall Study|Personal reasons|1
2352942|NCT03725722|4103254|FG003|Overall Study|Personal reasons|0
2352943|NCT03725722|4103255|FG004|Overall Study|Personal reasons|1
2352944|NCT03725722|4103251|FG000|Overall Study|COVID-19 situation|0
2352945|NCT03725722|4103252|FG001|Overall Study|COVID-19 situation|1
2352946|NCT03725722|4103253|FG002|Overall Study|COVID-19 situation|0
2352947|NCT03725722|4103254|FG003|Overall Study|COVID-19 situation|0
2352948|NCT03725722|4103255|FG004|Overall Study|COVID-19 situation|0
2352949|NCT03725085|4103276|FG000|Overall Study|Lost to Follow-up|2
2352950|NCT03724981|4103292|FG000|First Device|Protocol Violation|1
2352951|NCT03724981|4103293|FG001|First Device|Protocol Violation|1
2352952|NCT03724968|4103303|FG000|Overall Study|Insurance issues|0
2352953|NCT03724968|4103304|FG001|Overall Study|Insurance issues|1
2352954|NCT03724968|4103303|FG000|Overall Study|Study closed|0
2352955|NCT03724968|4103304|FG001|Overall Study|Study closed|1
2352956|NCT03723070|4103368|FG000|Overall Study|Lost to Follow-up|2
2352957|NCT03723070|4103368|FG000|Overall Study|Physician Decision|1
2352958|NCT03723070|4103368|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6
2352959|NCT03720210|4103372|FG000|Overall Study|Lost to Follow-up|1
2238775|NCT01914393|3895207|FG001|Overall Study|no reason given|8
2238776|NCT01914393|3895208|FG002|Overall Study|no reason given|16
2238777|NCT01914393|3895206|FG000|Overall Study|Adverse Event|29
2238778|NCT01914393|3895207|FG001|Overall Study|Adverse Event|18
2238779|NCT01914393|3895208|FG002|Overall Study|Adverse Event|31
2238780|NCT01914393|3895206|FG000|Overall Study|Withdrawal by Subject|38
2238781|NCT01914393|3895207|FG001|Overall Study|Withdrawal by Subject|20
2238782|NCT01914393|3895208|FG002|Overall Study|Withdrawal by Subject|47
2352960|NCT03718143|4103380|FG000|Overall Study|Death|1
2352961|NCT03718143|4103381|FG001|Overall Study|Death|0
2238783|NCT01914393|3895206|FG000|Overall Study|Lost to Follow-up|12
2238784|NCT01914393|3895207|FG001|Overall Study|Lost to Follow-up|6
2238785|NCT01914393|3895208|FG002|Overall Study|Lost to Follow-up|19
2238786|NCT01914393|3895206|FG000|Overall Study|subject never dosed|0
2238787|NCT01914393|3895207|FG001|Overall Study|subject never dosed|0
2238788|NCT01914393|3895208|FG002|Overall Study|subject never dosed|1
2238789|NCT01914666|3895228|FG000|Treatment Period|Lack of Efficacy|0
2238790|NCT01914666|3895229|FG001|Treatment Period|Lack of Efficacy|0
2238791|NCT01914666|3895230|FG002|Treatment Period|Lack of Efficacy|2
2238792|NCT01914666|3895228|FG000|Treatment Period|Adverse Event|10
2238793|NCT01914666|3895229|FG001|Treatment Period|Adverse Event|4
2238794|NCT01914666|3895230|FG002|Treatment Period|Adverse Event|2
2238795|NCT01914666|3895228|FG000|Treatment Period|Withdrawal by Subject|3
2238796|NCT01914666|3895229|FG001|Treatment Period|Withdrawal by Subject|2
2238797|NCT01914666|3895230|FG002|Treatment Period|Withdrawal by Subject|2
2238798|NCT01914666|3895228|FG000|Treatment Period|Physician Decision|0
2238799|NCT01914666|3895229|FG001|Treatment Period|Physician Decision|0
2238800|NCT01914666|3895230|FG002|Treatment Period|Physician Decision|2
2238801|NCT01914679|3895236|FG000|Overall Study|Lack of Efficacy|1
2238802|NCT01914679|3895236|FG000|Overall Study|Sponsor terminated study|4
2238803|NCT01914757|3895243|FG000|Overall Study|Severe non-compliance to protocol|3
2238804|NCT01914757|3895244|FG001|Overall Study|Severe non-compliance to protocol|1
2238805|NCT01914757|3895245|FG002|Overall Study|Severe non-compliance to protocol|2
2238806|NCT01914757|3895243|FG000|Overall Study|Lost to Follow-up|5
2238807|NCT01914757|3895244|FG001|Overall Study|Lost to Follow-up|8
2238808|NCT01914757|3895245|FG002|Overall Study|Lost to Follow-up|6
2238809|NCT01914757|3895243|FG000|Overall Study|Withdrawal by Subject|15
2238810|NCT01914757|3895244|FG001|Overall Study|Withdrawal by Subject|27
2238811|NCT01914757|3895245|FG002|Overall Study|Withdrawal by Subject|19
2238812|NCT01914757|3895243|FG000|Overall Study|Death|2
2238813|NCT01914757|3895244|FG001|Overall Study|Death|2
2238814|NCT01914757|3895245|FG002|Overall Study|Death|1
2238815|NCT01914757|3895243|FG000|Overall Study|Adverse Event|4
2238816|NCT01914757|3895244|FG001|Overall Study|Adverse Event|3
2238817|NCT01914757|3895245|FG002|Overall Study|Adverse Event|4
2238818|NCT01914757|3895243|FG000|Overall Study|Study specific withdrawal criteria|0
2238819|NCT01914757|3895244|FG001|Overall Study|Study specific withdrawal criteria|1
2238820|NCT01914757|3895245|FG002|Overall Study|Study specific withdrawal criteria|0
2238821|NCT01914757|3895243|FG000|Overall Study|Eligibility criteria not fulfilled|2
2238822|NCT01914757|3895244|FG001|Overall Study|Eligibility criteria not fulfilled|0
2238823|NCT01914757|3895245|FG002|Overall Study|Eligibility criteria not fulfilled|2
2238824|NCT01914757|3895243|FG000|Overall Study|Other reasons|5
2238825|NCT01914757|3895244|FG001|Overall Study|Other reasons|9
2238826|NCT01914757|3895245|FG002|Overall Study|Other reasons|4
2238827|NCT01914926|3895255|FG000|Overall Study|Adverse Event|1
2238828|NCT01914926|3895256|FG001|Overall Study|Adverse Event|0
2238829|NCT01914926|3895255|FG000|Overall Study|uncooperative, agitated and removed|0
2238830|NCT01914926|3895256|FG001|Overall Study|uncooperative, agitated and removed|1
2238831|NCT01915095|3895269|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
2238832|NCT01915095|3895270|FG001|Overall Study|Some subjects were unable to commit to the training study.|0
2238833|NCT01915095|3895271|FG002|Overall Study|Some subjects were unable to commit to the training study.|0
2238834|NCT01915095|3895272|FG003|Overall Study|Some subjects were unable to commit to the training study.|4
2238835|NCT01915095|3895273|FG004|Overall Study|Some subjects were unable to commit to the training study.|6
2238836|NCT01915303|3895328|FG000|Core Phase|Adverse Event|7
2238837|NCT01915303|3895328|FG000|Core Phase|Unsatisfactory therapeutic effect|3
2238838|NCT01915303|3895328|FG000|Core Phase|Death|2
2238839|NCT01915303|3895328|FG000|Core Phase|Protocol Violation|2
2238840|NCT01915303|3895328|FG000|Core Phase|Abnormal lab value|1
2238841|NCT01915303|3895328|FG000|Core Phase|Withdrawal by Subject|1
2238842|NCT01915303|3895328|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
2238843|NCT01915303|3895328|FG000|Extension Phase|Withdrawal by Subject|4
2238844|NCT01915303|3895328|FG000|Extension Phase|Adverse Event|3
2238845|NCT01915303|3895328|FG000|Extension Phase|Death|1
2238846|NCT01915303|3895328|FG000|Extension Phase|Protocol Violation|1
2238847|NCT01915732|3895343|FG000|Overall Study|Withdrawal by Subject|18
2238848|NCT01915732|3895344|FG001|Overall Study|Withdrawal by Subject|18
2238849|NCT01915732|3895343|FG000|Overall Study|Failure to Meet Randomization Criteria|1
2238850|NCT01915732|3895344|FG001|Overall Study|Failure to Meet Randomization Criteria|0
2238851|NCT01915732|3895343|FG000|Overall Study|Adverse Event|12
2238852|NCT01915732|3895344|FG001|Overall Study|Adverse Event|4
2238853|NCT01915732|3895343|FG000|Overall Study|Protocol Violation|5
2238854|NCT01915732|3895344|FG001|Overall Study|Protocol Violation|5
2238855|NCT01915732|3895343|FG000|Overall Study|Lack of Efficacy|6
2238856|NCT01915732|3895344|FG001|Overall Study|Lack of Efficacy|11
2238857|NCT01915732|3895343|FG000|Overall Study|Lost to Follow-up|22
2238858|NCT01915732|3895344|FG001|Overall Study|Lost to Follow-up|26
2238859|NCT01915732|3895343|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1
2238860|NCT01915732|3895344|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0
2238861|NCT01915732|3895343|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1
2238862|NCT01915732|3895344|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0
2238863|NCT01915732|3895343|FG000|Overall Study|Drug Release Error|1
2238864|NCT01915732|3895344|FG001|Overall Study|Drug Release Error|0
2238865|NCT01915732|3895343|FG000|Overall Study|Recovered|1
2238866|NCT01915732|3895344|FG001|Overall Study|Recovered|0
2238867|NCT01915732|3895343|FG000|Overall Study|Pregnancy|1
2238868|NCT01915732|3895344|FG001|Overall Study|Pregnancy|0
2238869|NCT01915732|3895343|FG000|Overall Study|Poor Perceived Efficacy|1
2238870|NCT01915732|3895344|FG001|Overall Study|Poor Perceived Efficacy|0
2238871|NCT01915732|3895343|FG000|Overall Study|Par. Unable to Come to the Hospital|0
2336133|NCT03294317|4062872|FG000|Overall Study|Physician Decision|1
2336134|NCT03294317|4062872|FG000|Overall Study|Withdrawal by Subject|6
2336135|NCT03294317|4062872|FG000|Overall Study|Lost to Follow-up|1
2336136|NCT03294317|4062872|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1
2336137|NCT03294317|4062872|FG000|Overall Study|Failed HB lead implant|8
2336138|NCT03294317|4062872|FG000|Overall Study|Received CRT instead|1
2336139|NCT03294317|4062872|FG000|Overall Study|Exited after lead revision|2
2336140|NCT03294538|4062879|FG000|Overall Study|Adverse Event|0
2336141|NCT03294538|4062880|FG001|Overall Study|Adverse Event|1
2336142|NCT03294538|4062881|FG002|Overall Study|Adverse Event|1
2336143|NCT03294538|4062879|FG000|Overall Study|Lost to Follow-up|1
2336144|NCT03294538|4062880|FG001|Overall Study|Lost to Follow-up|0
2336145|NCT03294538|4062881|FG002|Overall Study|Lost to Follow-up|0
2336146|NCT03294538|4062879|FG000|Overall Study|Outside of Visit Window|4
2336147|NCT03294538|4062880|FG001|Overall Study|Outside of Visit Window|4
2336148|NCT03294538|4062881|FG002|Overall Study|Outside of Visit Window|1
2336149|NCT03294681|4062898|FG000|Overall Study|Withdrawal by Subject|1
2336150|NCT03294941|4062913|FG000|Overall Study|Withdrawal by Subject|0
2336151|NCT03294941|4062914|FG001|Overall Study|Withdrawal by Subject|2
2336152|NCT03295201|4062923|FG000|Overall Study|Lost to Follow-up|1
2336153|NCT03295201|4062924|FG001|Overall Study|Lost to Follow-up|1
2336154|NCT03295201|4062923|FG000|Overall Study|Hospital admission|0
2336155|NCT03295201|4062924|FG001|Overall Study|Hospital admission|1
2037118|NCT00415363|3607367|FG001|Overall Study|Death|12
2037119|NCT00415363|3607366|FG000|Overall Study|Progressive disease|26
2037120|NCT00415363|3607367|FG001|Overall Study|Progressive disease|32
2037121|NCT00415519|3607394|FG000|Overall Study|Adverse Event|1
2037122|NCT00415519|3607395|FG001|Overall Study|Adverse Event|0
2037123|NCT00415519|3607394|FG000|Overall Study|Withdrawal by Subject|2
2037124|NCT00415519|3607395|FG001|Overall Study|Withdrawal by Subject|0
2037125|NCT00415519|3607394|FG000|Overall Study|Patient's convenience|1
2037126|NCT00415519|3607395|FG001|Overall Study|Patient's convenience|0
2037127|NCT00415532|3607403|FG000|Treatment Period|Adverse Event|2
2037128|NCT00415532|3607404|FG001|Treatment Period|Adverse Event|3
2037129|NCT00415532|3607403|FG000|Treatment Period|Death|2
2037130|NCT00415532|3607404|FG001|Treatment Period|Death|1
2037131|NCT00415532|3607403|FG000|Treatment Period|Lost to Follow-up|1
2037132|NCT00415532|3607404|FG001|Treatment Period|Lost to Follow-up|1
2037133|NCT00415532|3607403|FG000|Treatment Period|Protocol Violation|1
2037134|NCT00415532|3607404|FG001|Treatment Period|Protocol Violation|0
2037135|NCT00415532|3607403|FG000|Treatment Period|Withdrawal by Subject|6
2037136|NCT00415532|3607404|FG001|Treatment Period|Withdrawal by Subject|6
2037137|NCT00415532|3607403|FG000|Treatment Period|Other|2
2037138|NCT00415532|3607404|FG001|Treatment Period|Other|2
2336156|NCT03295318|4062942|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1
2238872|NCT01915732|3895344|FG001|Overall Study|Par. Unable to Come to the Hospital|1
2238873|NCT01915732|3895343|FG000|Overall Study|Got Well|0
2238874|NCT01915732|3895344|FG001|Overall Study|Got Well|1
2238875|NCT01915732|3895343|FG000|Overall Study|Par. not Willing to Continue Treatment|0
2238876|NCT01915732|3895344|FG001|Overall Study|Par. not Willing to Continue Treatment|1
2238877|NCT01915732|3895343|FG000|Overall Study|Par. Refused to Hospital Visits|0
2238878|NCT01915732|3895344|FG001|Overall Study|Par. Refused to Hospital Visits|1
2238879|NCT01915732|3895343|FG000|Overall Study|Job Transfer|0
2238880|NCT01915732|3895344|FG001|Overall Study|Job Transfer|1
2238881|NCT01915732|3895343|FG000|Overall Study|Improper Facial Procedure|0
2238882|NCT01915732|3895344|FG001|Overall Study|Improper Facial Procedure|1
2238883|NCT01915732|3895343|FG000|Overall Study|Poor Conscious Effect|0
2238884|NCT01915732|3895344|FG001|Overall Study|Poor Conscious Effect|1
2238885|NCT01915771|3895350|FG000|Day 1|Withdrawal by Subject|1
2238886|NCT01915771|3895350|FG000|Day 15|Withdrawal by Subject|1
2238887|NCT01915849|3895371|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1
2238888|NCT01915849|3895372|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0
2238889|NCT01915849|3895373|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0
2238890|NCT01915849|3895374|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0
2238891|NCT01915849|3895371|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
2238892|NCT01915849|3895372|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2238893|NCT01915849|3895373|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2238894|NCT01915849|3895374|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2336157|NCT03295318|4062943|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0
2336158|NCT03295318|4062944|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0
2336159|NCT03295318|4062942|FG000|Overall Study|Death|1
2336160|NCT03295318|4062943|FG001|Overall Study|Death|1
2336161|NCT03295318|4062944|FG002|Overall Study|Death|1
2336162|NCT03295318|4062942|FG000|Overall Study|Protocol Violation|4
2336163|NCT03295318|4062943|FG001|Overall Study|Protocol Violation|3
2336164|NCT03295318|4062944|FG002|Overall Study|Protocol Violation|3
2336165|NCT03295318|4062942|FG000|Overall Study|Withdrawal by Subject|0
2336166|NCT03295318|4062943|FG001|Overall Study|Withdrawal by Subject|0
2336167|NCT03295318|4062944|FG002|Overall Study|Withdrawal by Subject|1
2336168|NCT03295318|4062942|FG000|Overall Study|Subject discontinued due to travel|0
2336169|NCT03295318|4062943|FG001|Overall Study|Subject discontinued due to travel|1
2336170|NCT03295318|4062944|FG002|Overall Study|Subject discontinued due to travel|0
2336171|NCT03295721|4062978|FG000|Overall Study|Adverse Event|1
2336172|NCT03295721|4062979|FG001|Overall Study|Adverse Event|0
2336173|NCT03295721|4062980|FG002|Overall Study|Adverse Event|0
2336174|NCT03295721|4062978|FG000|Overall Study|Lost to Follow-up|1
2336175|NCT03295721|4062979|FG001|Overall Study|Lost to Follow-up|1
2336176|NCT03295721|4062980|FG002|Overall Study|Lost to Follow-up|1
2336177|NCT03295721|4062978|FG000|Overall Study|Withdrawal by Subject|1
2336178|NCT03295721|4062979|FG001|Overall Study|Withdrawal by Subject|0
2336179|NCT03295721|4062980|FG002|Overall Study|Withdrawal by Subject|1
2336180|NCT03295721|4062978|FG000|Overall Study|Death|0
2336181|NCT03295721|4062979|FG001|Overall Study|Death|0
2336182|NCT03295721|4062980|FG002|Overall Study|Death|1
2336183|NCT03296527|4063028|FG000|Overall Study|Adverse Event|15
2336184|NCT03296527|4063029|FG001|Overall Study|Adverse Event|33
2336185|NCT03296527|4063028|FG000|Overall Study|Protocol Deviation|4
2336186|NCT03296527|4063029|FG001|Overall Study|Protocol Deviation|0
2336187|NCT03296527|4063028|FG000|Overall Study|Subject withdrew consent|3
2336188|NCT03296527|4063029|FG001|Overall Study|Subject withdrew consent|1
2336189|NCT03296527|4063028|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9
2336190|NCT03296527|4063029|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14
2336191|NCT03296527|4063028|FG000|Overall Study|Discontinuations due to withdrawal from trial|2
2336192|NCT03296527|4063029|FG001|Overall Study|Discontinuations due to withdrawal from trial|3
2336193|NCT03296527|4063028|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0
2336194|NCT03296527|4063029|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2
2336195|NCT03296527|4063028|FG000|Overall Study|Discontinuation due to liquid in uterus|1
2336196|NCT03296527|4063029|FG001|Overall Study|Discontinuation due to liquid in uterus|0
2336197|NCT03296527|4063028|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1
2336198|NCT03296527|4063029|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0
2336199|NCT03296566|4063038|FG000|Overall Study|Lost to Follow-up|19
2336200|NCT03296566|4063039|FG001|Overall Study|Lost to Follow-up|46
2336201|NCT03296566|4063038|FG000|Overall Study|Withdrawal by Subject|0
2336202|NCT03296566|4063039|FG001|Overall Study|Withdrawal by Subject|3
2336203|NCT03297021|4063094|FG000|Overall Study|Incomplete/illegible data sheet|4
2336204|NCT03297021|4063095|FG001|Overall Study|Incomplete/illegible data sheet|2
2336205|NCT03297021|4063096|FG002|Overall Study|Incomplete/illegible data sheet|3
2336206|NCT03297021|4063094|FG000|Overall Study|Missing Post-Op Data|1
2336207|NCT03297021|4063095|FG001|Overall Study|Missing Post-Op Data|2
2336208|NCT03297021|4063096|FG002|Overall Study|Missing Post-Op Data|1
2336209|NCT03297216|4063110|FG000|Overall Study|Death|0
2336210|NCT03297216|4063111|FG001|Overall Study|Death|1
2336211|NCT03297216|4063110|FG000|Overall Study|Miscarriage|0
2037139|NCT00415532|3607403|FG000|Treatment Period|Ineligibility determined|1
2238895|NCT01915914|3895384|FG000|Acute Phase|Withdrawal by Subject|4
2238896|NCT01915914|3895385|FG001|Acute Phase|Withdrawal by Subject|0
2238897|NCT01915914|3895386|FG002|Acute Phase|Withdrawal by Subject|0
2238898|NCT01915914|3895387|FG003|Acute Phase|Withdrawal by Subject|0
2238899|NCT01915914|3895384|FG000|Acute Phase|Lost to Follow-up|4
2238900|NCT01915914|3895385|FG001|Acute Phase|Lost to Follow-up|0
2238901|NCT01915914|3895386|FG002|Acute Phase|Lost to Follow-up|0
2238902|NCT01915914|3895387|FG003|Acute Phase|Lost to Follow-up|0
2238903|NCT01915914|3895384|FG000|Acute Phase|Physician Decision|1
2238904|NCT01915914|3895385|FG001|Acute Phase|Physician Decision|0
2238905|NCT01915914|3895386|FG002|Acute Phase|Physician Decision|0
2238906|NCT01915914|3895387|FG003|Acute Phase|Physician Decision|0
2238907|NCT01915914|3895384|FG000|Acute Phase|Accepted Other Topic Therapies|1
2238908|NCT01915914|3895385|FG001|Acute Phase|Accepted Other Topic Therapies|0
2238909|NCT01915914|3895386|FG002|Acute Phase|Accepted Other Topic Therapies|0
2238910|NCT01915914|3895387|FG003|Acute Phase|Accepted Other Topic Therapies|0
2238911|NCT01915914|3895384|FG000|Acute Phase|"Not Achieved treatment success"|1
2238912|NCT01915914|3895385|FG001|Acute Phase|"Not Achieved treatment success"|0
2238913|NCT01915914|3895386|FG002|Acute Phase|"Not Achieved treatment success"|0
2238914|NCT01915914|3895387|FG003|Acute Phase|"Not Achieved treatment success"|0
2238915|NCT01915914|3895384|FG000|Acute Phase|Missing|1
2238916|NCT01915914|3895385|FG001|Acute Phase|Missing|0
2238917|NCT01915914|3895386|FG002|Acute Phase|Missing|0
2238918|NCT01915914|3895387|FG003|Acute Phase|Missing|0
2238919|NCT01915914|3895384|FG000|Maintenance Phase|Withdrawal by Subject|0
2238920|NCT01915914|3895385|FG001|Maintenance Phase|Withdrawal by Subject|1
2238921|NCT01915914|3895386|FG002|Maintenance Phase|Withdrawal by Subject|1
2238922|NCT01915914|3895387|FG003|Maintenance Phase|Withdrawal by Subject|0
2238923|NCT01915914|3895384|FG000|Maintenance Phase|Lost to Follow-up|0
2238924|NCT01915914|3895385|FG001|Maintenance Phase|Lost to Follow-up|4
2238925|NCT01915914|3895386|FG002|Maintenance Phase|Lost to Follow-up|1
2238926|NCT01915914|3895387|FG003|Maintenance Phase|Lost to Follow-up|0
2238927|NCT01915914|3895384|FG000|Maintenance Phase|Missing|0
2238928|NCT01915914|3895385|FG001|Maintenance Phase|Missing|1
2238929|NCT01915914|3895386|FG002|Maintenance Phase|Missing|0
2238930|NCT01915914|3895387|FG003|Maintenance Phase|Missing|0
2238931|NCT01915914|3895384|FG000|Follow-up Phase|Withdrawal by Subject|0
2238932|NCT01915914|3895385|FG001|Follow-up Phase|Withdrawal by Subject|0
2238933|NCT01915914|3895386|FG002|Follow-up Phase|Withdrawal by Subject|0
2238934|NCT01915914|3895387|FG003|Follow-up Phase|Withdrawal by Subject|1
2238935|NCT01915914|3895384|FG000|Follow-up Phase|Physician Decision|0
2238936|NCT01915914|3895385|FG001|Follow-up Phase|Physician Decision|0
2238937|NCT01915914|3895386|FG002|Follow-up Phase|Physician Decision|0
2238938|NCT01915914|3895387|FG003|Follow-up Phase|Physician Decision|1
2238939|NCT01915940|3895407|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39
2238940|NCT01915940|3895408|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0
2238941|NCT01915940|3895409|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0
2238942|NCT01915940|3895407|FG000|Treatment Period|Decision of Participant|0
2238943|NCT01915940|3895408|FG001|Treatment Period|Decision of Participant|1
2238944|NCT01915940|3895409|FG002|Treatment Period|Decision of Participant|3
2336212|NCT03297216|4063111|FG001|Overall Study|Miscarriage|2
2336213|NCT03297216|4063110|FG000|Overall Study|Lost to Follow-up|3
2336214|NCT03297216|4063111|FG001|Overall Study|Lost to Follow-up|2
2336215|NCT03297294|4063126|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30
2336216|NCT03297294|4063127|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31
2336217|NCT03297294|4063128|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2336218|NCT03297294|4063129|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2336219|NCT03297294|4063130|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2336220|NCT03297294|4063126|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
2336221|NCT03297294|4063127|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
2336222|NCT03297294|4063128|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2336223|NCT03297294|4063129|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2336224|NCT03297294|4063130|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2336225|NCT03297294|4063126|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
2336226|NCT03297294|4063127|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1
2336227|NCT03297294|4063128|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0
2336228|NCT03297294|4063129|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
2336229|NCT03297294|4063130|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
2336230|NCT03297294|4063126|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1
2336231|NCT03297294|4063127|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1
2336232|NCT03297294|4063128|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0
2037140|NCT00415532|3607404|FG001|Treatment Period|Ineligibility determined|1
2238945|NCT01915940|3895407|FG000|Treatment Period|Adverse Event|0
2238946|NCT01915940|3895408|FG001|Treatment Period|Adverse Event|9
2238947|NCT01915940|3895409|FG002|Treatment Period|Adverse Event|1
2238948|NCT01915940|3895407|FG000|Treatment Period|Other Miscellaneous Reasons|0
2238949|NCT01915940|3895408|FG001|Treatment Period|Other Miscellaneous Reasons|1
2238950|NCT01915940|3895409|FG002|Treatment Period|Other Miscellaneous Reasons|0
2238951|NCT01916109|3895415|FG000|Overall Study|Withdrawal by Subject|1
2238952|NCT01916226|3895423|FG000|Overall Study|Adverse Event|1
2238953|NCT01916226|3895424|FG001|Overall Study|Adverse Event|0
2238954|NCT01916226|3895425|FG002|Overall Study|Adverse Event|1
2238955|NCT01916226|3895426|FG003|Overall Study|Adverse Event|1
2238956|NCT01916226|3895423|FG000|Overall Study|Lack of Efficacy|0
2238957|NCT01916226|3895424|FG001|Overall Study|Lack of Efficacy|0
2238958|NCT01916226|3895425|FG002|Overall Study|Lack of Efficacy|2
2238959|NCT01916226|3895426|FG003|Overall Study|Lack of Efficacy|1
2238960|NCT01916226|3895423|FG000|Overall Study|Protocol Violation|0
2238961|NCT01916226|3895424|FG001|Overall Study|Protocol Violation|1
2238962|NCT01916226|3895425|FG002|Overall Study|Protocol Violation|0
2238963|NCT01916226|3895426|FG003|Overall Study|Protocol Violation|1
2238964|NCT01916226|3895423|FG000|Overall Study|Physician Decision|0
2238965|NCT01916226|3895424|FG001|Overall Study|Physician Decision|0
2238966|NCT01916226|3895425|FG002|Overall Study|Physician Decision|0
2238967|NCT01916226|3895426|FG003|Overall Study|Physician Decision|1
2238968|NCT01916304|3895437|FG000|Overall Study|Screening failure|17
2238969|NCT01916824|3895483|FG000|Overall Study|Lost to Follow-up|3
2238970|NCT01916824|3895484|FG001|Overall Study|Lost to Follow-up|6
2238971|NCT01916824|3895483|FG000|Overall Study|Physician Decision|2
2238972|NCT01916824|3895484|FG001|Overall Study|Physician Decision|0
2238973|NCT01916824|3895483|FG000|Overall Study|Withdrawal by Subject|2
2238974|NCT01916824|3895484|FG001|Overall Study|Withdrawal by Subject|3
2238975|NCT01917006|3895510|FG000|Randomized-treatment Period|Lost to Follow-up|1
2238976|NCT01917006|3895511|FG001|Randomized-treatment Period|Lost to Follow-up|0
2238977|NCT01917006|3895512|FG002|Randomized-treatment Period|Lost to Follow-up|0
2238978|NCT01917006|3895513|FG003|Randomized-treatment Period|Lost to Follow-up|1
2238979|NCT01917006|3895514|FG004|Randomized-treatment Period|Lost to Follow-up|0
2238980|NCT01917006|3895515|FG005|Randomized-treatment Period|Lost to Follow-up|0
2238981|NCT01917006|3895516|FG006|Randomized-treatment Period|Lost to Follow-up|0
2238982|NCT01917006|3895517|FG007|Randomized-treatment Period|Lost to Follow-up|0
2238983|NCT01917006|3895510|FG000|Randomized-treatment Period|Personal Reasons|0
2238984|NCT01917006|3895511|FG001|Randomized-treatment Period|Personal Reasons|0
2238985|NCT01917006|3895512|FG002|Randomized-treatment Period|Personal Reasons|0
2238986|NCT01917006|3895513|FG003|Randomized-treatment Period|Personal Reasons|0
2238987|NCT01917006|3895514|FG004|Randomized-treatment Period|Personal Reasons|0
2238988|NCT01917006|3895515|FG005|Randomized-treatment Period|Personal Reasons|1
2238989|NCT01917006|3895516|FG006|Randomized-treatment Period|Personal Reasons|0
2238990|NCT01917006|3895517|FG007|Randomized-treatment Period|Personal Reasons|0
2238991|NCT01917006|3895510|FG000|Randomized-treatment Period|Protocol Violation|1
2238992|NCT01917006|3895511|FG001|Randomized-treatment Period|Protocol Violation|0
2238993|NCT01917006|3895512|FG002|Randomized-treatment Period|Protocol Violation|0
2238994|NCT01917006|3895513|FG003|Randomized-treatment Period|Protocol Violation|0
2238995|NCT01917006|3895514|FG004|Randomized-treatment Period|Protocol Violation|0
2238996|NCT01917006|3895515|FG005|Randomized-treatment Period|Protocol Violation|0
2238997|NCT01917006|3895516|FG006|Randomized-treatment Period|Protocol Violation|0
2238998|NCT01917006|3895517|FG007|Randomized-treatment Period|Protocol Violation|0
2238999|NCT01917006|3895510|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0
2239000|NCT01917006|3895511|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0
2239001|NCT01917006|3895512|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0
2239002|NCT01917006|3895513|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0
2239003|NCT01917006|3895514|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0
2239004|NCT01917006|3895515|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0
2239005|NCT01917006|3895516|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1
2239006|NCT01917006|3895517|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0
2239007|NCT01917006|3895510|FG000|Open-label Period|Adverse Event|0
2239008|NCT01917006|3895511|FG001|Open-label Period|Adverse Event|0
2239009|NCT01917006|3895512|FG002|Open-label Period|Adverse Event|0
2239010|NCT01917006|3895513|FG003|Open-label Period|Adverse Event|0
2239011|NCT01917006|3895514|FG004|Open-label Period|Adverse Event|0
2239012|NCT01917006|3895515|FG005|Open-label Period|Adverse Event|0
2239013|NCT01917006|3895516|FG006|Open-label Period|Adverse Event|0
2239014|NCT01917006|3895517|FG007|Open-label Period|Adverse Event|1
2239015|NCT01917006|3895510|FG000|Open-label Period|Lost to Follow-up|0
2239016|NCT01917006|3895511|FG001|Open-label Period|Lost to Follow-up|0
2336233|NCT03297294|4063129|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
2336234|NCT03297294|4063130|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
2336235|NCT03297294|4063126|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
2336236|NCT03297294|4063127|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
2336237|NCT03297294|4063128|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
2336238|NCT03297294|4063129|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1
2336239|NCT03297294|4063130|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
2336240|NCT03297398|4063145|FG000|Overall Study|Sponsor's decision|6
2336241|NCT03297398|4063146|FG001|Overall Study|Sponsor's decision|9
2336242|NCT03297398|4063147|FG002|Overall Study|Sponsor's decision|7
2336243|NCT03297398|4063145|FG000|Overall Study|Adverse Event|1
2336244|NCT03297398|4063146|FG001|Overall Study|Adverse Event|4
2239017|NCT01917006|3895512|FG002|Open-label Period|Lost to Follow-up|0
2239018|NCT01917006|3895513|FG003|Open-label Period|Lost to Follow-up|0
2239019|NCT01917006|3895514|FG004|Open-label Period|Lost to Follow-up|0
2239020|NCT01917006|3895515|FG005|Open-label Period|Lost to Follow-up|0
2239021|NCT01917006|3895516|FG006|Open-label Period|Lost to Follow-up|0
2239022|NCT01917006|3895517|FG007|Open-label Period|Lost to Follow-up|1
2239023|NCT01917084|3895534|FG000|Overall Study|Withdrawal by Subject|1
2239024|NCT01917344|3895560|FG000|Overall Study|Withdrawal by Subject|1
2239025|NCT01917526|3895575|FG000|Overall Study|Protocol Violation|1
2239026|NCT01917526|3895576|FG001|Overall Study|Protocol Violation|1
2239027|NCT01917656|3895584|FG000|Overall Study|Adverse Event|11
2239028|NCT01917656|3895585|FG001|Overall Study|Adverse Event|0
2239029|NCT01917656|3895584|FG000|Overall Study|Withdrawal criteria|8
2239030|NCT01917656|3895585|FG001|Overall Study|Withdrawal criteria|14
2239031|NCT01917656|3895584|FG000|Overall Study|Unclassified|0
2239032|NCT01917656|3895585|FG001|Overall Study|Unclassified|3
2239033|NCT01917656|3895584|FG000|Overall Study|Withdrawal by Subject|4
2239034|NCT01917656|3895585|FG001|Overall Study|Withdrawal by Subject|3
2239035|NCT01917656|3895584|FG000|Overall Study|Lost to Follow-up|3
2239036|NCT01917656|3895585|FG001|Overall Study|Lost to Follow-up|4
2239037|NCT01917747|3895598|FG000|Overall Study|Withdrawal by Subject|1
2239038|NCT01917747|3895599|FG001|Overall Study|Withdrawal by Subject|2
2239039|NCT01917747|3895598|FG000|Overall Study|Lost to Follow-up|18
2239040|NCT01917747|3895599|FG001|Overall Study|Lost to Follow-up|9
2239041|NCT01917968|3895630|FG000|Overall Study|Death|3
2239042|NCT01917968|3895631|FG001|Overall Study|Death|2
2239043|NCT01917968|3895630|FG000|Overall Study|Lost to Follow-up|21
2239044|NCT01917968|3895631|FG001|Overall Study|Lost to Follow-up|39
2239045|NCT01917968|3895630|FG000|Overall Study|Physician Decision|1
2239046|NCT01917968|3895631|FG001|Overall Study|Physician Decision|2
2239047|NCT01917968|3895630|FG000|Overall Study|Withdrawal by Subject|20
2239048|NCT01917968|3895631|FG001|Overall Study|Withdrawal by Subject|35
2239049|NCT01917968|3895630|FG000|Overall Study|Subject Relocation|5
2239050|NCT01917968|3895631|FG001|Overall Study|Subject Relocation|1
2239051|NCT01917968|3895630|FG000|Overall Study|36M Missed Visit|3
2239052|NCT01917968|3895631|FG001|Overall Study|36M Missed Visit|2
2239053|NCT01917968|3895630|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1
2239054|NCT01917968|3895631|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0
2239055|NCT01917968|3895630|FG000|Overall Study|Change in Family Circumstances|0
2239056|NCT01917968|3895631|FG001|Overall Study|Change in Family Circumstances|1
2239057|NCT01917968|3895630|FG000|Overall Study|No Data Available|0
2239058|NCT01917968|3895631|FG001|Overall Study|No Data Available|2
2239059|NCT01918085|3895658|FG000|Test Period 1: Strata Strip|Adverse Event|0
2239060|NCT01918085|3895659|FG001|Test Period 1: Strata Strip|Adverse Event|1
2239061|NCT01918306|3895674|FG000|Overall Study|progresive disease|4
2239062|NCT01918306|3895675|FG001|Overall Study|progresive disease|0
2239063|NCT01918306|3895676|FG002|Overall Study|progresive disease|1
2239064|NCT01918306|3895677|FG003|Overall Study|progresive disease|1
2239065|NCT01918306|3895674|FG000|Overall Study|Withdrawal by Subject|0
2239066|NCT01918306|3895675|FG001|Overall Study|Withdrawal by Subject|0
2239067|NCT01918306|3895676|FG002|Overall Study|Withdrawal by Subject|0
2239068|NCT01918306|3895677|FG003|Overall Study|Withdrawal by Subject|2
2239069|NCT01918306|3895674|FG000|Overall Study|neutropenia|1
2239070|NCT01918306|3895675|FG001|Overall Study|neutropenia|0
2239071|NCT01918306|3895676|FG002|Overall Study|neutropenia|0
2239072|NCT01918306|3895677|FG003|Overall Study|neutropenia|0
2239073|NCT01918306|3895674|FG000|Overall Study|Lack of Efficacy|1
2239074|NCT01918306|3895675|FG001|Overall Study|Lack of Efficacy|0
2239075|NCT01918306|3895676|FG002|Overall Study|Lack of Efficacy|0
2239076|NCT01918306|3895677|FG003|Overall Study|Lack of Efficacy|0
2239077|NCT01918306|3895674|FG000|Overall Study|progress disease, crossover|0
2239078|NCT01918306|3895675|FG001|Overall Study|progress disease, crossover|0
2239079|NCT01918306|3895676|FG002|Overall Study|progress disease, crossover|1
2239080|NCT01918306|3895677|FG003|Overall Study|progress disease, crossover|0
2239081|NCT01918332|3895701|FG000|Overall Study|Adverse Event|0
2239082|NCT01918332|3895702|FG001|Overall Study|Adverse Event|0
2239083|NCT01918332|3895703|FG002|Overall Study|Adverse Event|0
2239084|NCT01918332|3895704|FG003|Overall Study|Adverse Event|1
2239085|NCT01918332|3895701|FG000|Overall Study|Withdrawal by Subject|2
2239086|NCT01918332|3895702|FG001|Overall Study|Withdrawal by Subject|3
2239087|NCT01918332|3895703|FG002|Overall Study|Withdrawal by Subject|2
2239088|NCT01918332|3895704|FG003|Overall Study|Withdrawal by Subject|3
2239089|NCT01918332|3895701|FG000|Overall Study|Protocol Violation|6
2239090|NCT01918332|3895702|FG001|Overall Study|Protocol Violation|2
2239091|NCT01918332|3895703|FG002|Overall Study|Protocol Violation|6
2239092|NCT01918332|3895704|FG003|Overall Study|Protocol Violation|3
2239093|NCT01918332|3895701|FG000|Overall Study|lipid result by central lab did not meet|0
2239094|NCT01918332|3895702|FG001|Overall Study|lipid result by central lab did not meet|0
2239095|NCT01918332|3895703|FG002|Overall Study|lipid result by central lab did not meet|1
2336245|NCT03297398|4063147|FG002|Overall Study|Adverse Event|4
2336246|NCT03297398|4063145|FG000|Overall Study|Withdrawal by Subject|1
2336247|NCT03297398|4063146|FG001|Overall Study|Withdrawal by Subject|2
2336248|NCT03297398|4063147|FG002|Overall Study|Withdrawal by Subject|2
2336249|NCT03297398|4063145|FG000|Overall Study|Protocol Violation|0
2336250|NCT03297398|4063146|FG001|Overall Study|Protocol Violation|2
2336251|NCT03297398|4063147|FG002|Overall Study|Protocol Violation|0
2239096|NCT01918332|3895704|FG003|Overall Study|lipid result by central lab did not meet|0
2239097|NCT01918371|3895716|FG000|Overall Study|Missing Data|1
2239098|NCT01918371|3895717|FG001|Overall Study|Missing Data|1
2239099|NCT01918774|3895727|FG000|Overall Study|Lost prior to first CBTw session|4
2239100|NCT01918774|3895727|FG000|Overall Study|Lost to Follow-up|1
2239101|NCT01919112|3895743|FG000|Secondary Analysis-day 30|Death|1
2239102|NCT01919112|3895744|FG001|Secondary Analysis-day 30|Death|1
2239103|NCT01919112|3895745|FG002|Secondary Analysis-day 30|Death|1
2239104|NCT01919112|3895743|FG000|Secondary Analysis-day 30|Lost to Follow-up|1
2239105|NCT01919112|3895744|FG001|Secondary Analysis-day 30|Lost to Follow-up|0
2239106|NCT01919112|3895745|FG002|Secondary Analysis-day 30|Lost to Follow-up|0
2239107|NCT01919164|3895758|FG000|Overall Study|Adverse Event|6
2239108|NCT01919164|3895759|FG001|Overall Study|Adverse Event|4
2239109|NCT01919164|3895760|FG002|Overall Study|Adverse Event|9
2239110|NCT01919164|3895761|FG003|Overall Study|Adverse Event|3
2239111|NCT01919164|3895762|FG004|Overall Study|Adverse Event|2
2239112|NCT01919164|3895758|FG000|Overall Study|Lost to Follow-up|2
2239113|NCT01919164|3895759|FG001|Overall Study|Lost to Follow-up|2
2239114|NCT01919164|3895760|FG002|Overall Study|Lost to Follow-up|2
2239115|NCT01919164|3895761|FG003|Overall Study|Lost to Follow-up|0
2239116|NCT01919164|3895762|FG004|Overall Study|Lost to Follow-up|4
2239117|NCT01919164|3895758|FG000|Overall Study|Death|1
2239118|NCT01919164|3895759|FG001|Overall Study|Death|0
2239119|NCT01919164|3895760|FG002|Overall Study|Death|0
2239120|NCT01919164|3895761|FG003|Overall Study|Death|0
2239121|NCT01919164|3895762|FG004|Overall Study|Death|0
2239122|NCT01919164|3895758|FG000|Overall Study|Protocol Violation|6
2239123|NCT01919164|3895759|FG001|Overall Study|Protocol Violation|0
2239124|NCT01919164|3895760|FG002|Overall Study|Protocol Violation|3
2336252|NCT03297398|4063145|FG000|Overall Study|Physician Decision|0
2336253|NCT03297398|4063146|FG001|Overall Study|Physician Decision|0
2336254|NCT03297398|4063147|FG002|Overall Study|Physician Decision|1
2336255|NCT03297398|4063145|FG000|Overall Study|Lost to Follow-up|0
2336256|NCT03297398|4063146|FG001|Overall Study|Lost to Follow-up|0
2336257|NCT03297398|4063147|FG002|Overall Study|Lost to Follow-up|1
2336258|NCT03298412|4063195|FG000|Run-in Period|Other, Not Specified|1
2336259|NCT03298412|4063195|FG000|Run-in Period|Disease Progression|1
2336260|NCT03298412|4063195|FG000|Run-in Period|Ineligibility Determined|1
2336261|NCT03298412|4063195|FG000|Run-in Period|Decision by Sponsor|6
2336262|NCT03298984|4063224|FG000|Overall Study|Physician Decision|1
2336263|NCT03298984|4063225|FG001|Overall Study|Physician Decision|0
2336264|NCT03298984|4063226|FG002|Overall Study|Physician Decision|0
2336265|NCT03298984|4063227|FG003|Overall Study|Physician Decision|6
2336266|NCT03298984|4063224|FG000|Overall Study|Lack of Efficacy|0
2336267|NCT03298984|4063225|FG001|Overall Study|Lack of Efficacy|1
2336268|NCT03298984|4063226|FG002|Overall Study|Lack of Efficacy|1
2336269|NCT03298984|4063227|FG003|Overall Study|Lack of Efficacy|4
2336270|NCT03298984|4063224|FG000|Overall Study|Relapsed disease (following remission)|0
2336271|NCT03298984|4063225|FG001|Overall Study|Relapsed disease (following remission)|0
2336272|NCT03298984|4063226|FG002|Overall Study|Relapsed disease (following remission)|1
2336273|NCT03298984|4063227|FG003|Overall Study|Relapsed disease (following remission)|1
2336274|NCT03298984|4063224|FG000|Overall Study|Adverse Event|0
2336275|NCT03298984|4063225|FG001|Overall Study|Adverse Event|0
2336276|NCT03298984|4063226|FG002|Overall Study|Adverse Event|0
2336277|NCT03298984|4063227|FG003|Overall Study|Adverse Event|1
2336278|NCT03298984|4063224|FG000|Overall Study|Death|0
2336279|NCT03298984|4063225|FG001|Overall Study|Death|0
2336280|NCT03298984|4063226|FG002|Overall Study|Death|0
2336281|NCT03298984|4063227|FG003|Overall Study|Death|2
2336282|NCT03298984|4063224|FG000|Overall Study|Insurance Company Decision|0
2336283|NCT03298984|4063225|FG001|Overall Study|Insurance Company Decision|0
2336284|NCT03298984|4063226|FG002|Overall Study|Insurance Company Decision|0
2336285|NCT03298984|4063227|FG003|Overall Study|Insurance Company Decision|1
2336286|NCT03299049|4063240|FG000|Overall Study|On-going|486
2336287|NCT03299049|4063241|FG001|Overall Study|On-going|481
2336288|NCT03299049|4063240|FG000|Overall Study|Withdrawal by Subject|6
2336289|NCT03299049|4063241|FG001|Overall Study|Withdrawal by Subject|21
2336290|NCT03299049|4063240|FG000|Overall Study|Physician Decision|5
2336291|NCT03299049|4063241|FG001|Overall Study|Physician Decision|1
2336292|NCT03299049|4063240|FG000|Overall Study|Lost to Follow-up|2
2336293|NCT03299049|4063241|FG001|Overall Study|Lost to Follow-up|0
2336294|NCT03299049|4063240|FG000|Overall Study|Pregnancy|1
2336295|NCT03299049|4063241|FG001|Overall Study|Pregnancy|3
2336296|NCT03299049|4063240|FG000|Overall Study|Protocol Violation|1
2037141|NCT00415532|3607403|FG000|Treatment Period|Noncompliance|1
2037142|NCT00415532|3607404|FG001|Treatment Period|Noncompliance|1
2037143|NCT00415532|3607403|FG000|Treatment Period|Requirement for alternative therapy|1
2037144|NCT00415532|3607404|FG001|Treatment Period|Requirement for alternative therapy|0
2037145|NCT00415532|3607403|FG000|Safety Follow Up Period|Adverse Event|1
2239125|NCT01919164|3895761|FG003|Overall Study|Protocol Violation|2
2336297|NCT03299049|4063241|FG001|Overall Study|Protocol Violation|1
2336298|NCT03299049|4063240|FG000|Overall Study|Lack of Efficacy|9
2239126|NCT01919164|3895762|FG004|Overall Study|Protocol Violation|2
2239127|NCT01919164|3895758|FG000|Overall Study|Disease progression|2
2239128|NCT01919164|3895759|FG001|Overall Study|Disease progression|2
2239129|NCT01919164|3895760|FG002|Overall Study|Disease progression|1
2239130|NCT01919164|3895761|FG003|Overall Study|Disease progression|2
2239131|NCT01919164|3895762|FG004|Overall Study|Disease progression|1
2239132|NCT01919164|3895758|FG000|Overall Study|Withdrew consent|13
2239133|NCT01919164|3895759|FG001|Overall Study|Withdrew consent|13
2239134|NCT01919164|3895760|FG002|Overall Study|Withdrew consent|14
2239135|NCT01919164|3895761|FG003|Overall Study|Withdrew consent|14
2239136|NCT01919164|3895762|FG004|Overall Study|Withdrew consent|9
2239137|NCT01919164|3895758|FG000|Overall Study|Other Un-specified|13
2239138|NCT01919164|3895759|FG001|Overall Study|Other Un-specified|9
2239139|NCT01919164|3895760|FG002|Overall Study|Other Un-specified|8
2239140|NCT01919164|3895761|FG003|Overall Study|Other Un-specified|7
2239141|NCT01919164|3895762|FG004|Overall Study|Other Un-specified|15
2239142|NCT01919190|3895776|FG000|Overall Study|Intra-op findings, etc.|3
2239143|NCT01919190|3895777|FG001|Overall Study|Intra-op findings, etc.|0
2239144|NCT01919229|3895800|FG000|Overall Study|Subject/guardian decision|0
2239145|NCT01919229|3895801|FG001|Overall Study|Subject/guardian decision|0
2239146|NCT01919229|3895802|FG002|Overall Study|Subject/guardian decision|1
2239147|NCT01919307|3895810|FG000|Overall Study|Withdrawal by Subject|9
2239148|NCT01919398|3895817|FG000|Overall Study|Progressive Disease|0
2239149|NCT01919398|3895818|FG001|Overall Study|Progressive Disease|0
2239150|NCT01919398|3895819|FG002|Overall Study|Progressive Disease|4
2239151|NCT01919411|3895829|FG000|Overall Study|Lost to Follow-up|2
2239152|NCT01919411|3895830|FG001|Overall Study|Lost to Follow-up|4
2239153|NCT01919411|3895829|FG000|Overall Study|Physician Decision|1
2239154|NCT01919411|3895830|FG001|Overall Study|Physician Decision|0
2239155|NCT01919411|3895829|FG000|Overall Study|Protocol Violation|2
2239156|NCT01919411|3895830|FG001|Overall Study|Protocol Violation|1
2239157|NCT01919489|3895855|FG000|Overall Study|Rejected the need of injections|4
2239158|NCT01919489|3895856|FG001|Overall Study|Rejected the need of injections|7
2239159|NCT01919489|3895855|FG000|Overall Study|Adverse Event|10
2239160|NCT01919489|3895856|FG001|Overall Study|Adverse Event|0
2239161|NCT01919489|3895855|FG000|Overall Study|Hospital readmission|2
2239162|NCT01919489|3895856|FG001|Overall Study|Hospital readmission|9
2239163|NCT01919489|3895855|FG000|Overall Study|Death|2
2239164|NCT01919489|3895856|FG001|Overall Study|Death|1
2239165|NCT01919489|3895855|FG000|Overall Study|Lost to Follow-up|38
2239166|NCT01919489|3895856|FG001|Overall Study|Lost to Follow-up|27
2239167|NCT01919723|3895883|FG000|Overall Study|Blood Samples Hemolyzed|2
2239168|NCT01919723|3895884|FG001|Overall Study|Blood Samples Hemolyzed|2
2239169|NCT01919801|3895892|FG000|Overall Study|Withdrawal by Subject|1
2239170|NCT01919801|3895893|FG001|Overall Study|Withdrawal by Subject|0
2239171|NCT01919801|3895892|FG000|Overall Study|Physician Decision|0
2239172|NCT01919801|3895893|FG001|Overall Study|Physician Decision|1
2239173|NCT01919801|3895892|FG000|Overall Study|Lost to Follow-up|0
2239174|NCT01919801|3895893|FG001|Overall Study|Lost to Follow-up|1
2239175|NCT01919801|3895892|FG000|Overall Study|Other|0
2239176|NCT01919801|3895893|FG001|Overall Study|Other|1
2239177|NCT01919814|3895899|FG000|Overall Study|Adverse Event|1
2239178|NCT01919814|3895900|FG001|Overall Study|Adverse Event|0
2239179|NCT01919814|3895899|FG000|Overall Study|Protocol Violation|1
2239180|NCT01919814|3895900|FG001|Overall Study|Protocol Violation|0
2239181|NCT01919814|3895899|FG000|Overall Study|Withdrawal by Subject|1
2239182|NCT01919814|3895900|FG001|Overall Study|Withdrawal by Subject|0
2239183|NCT01919970|3895908|FG000|Overall Study|Withdrawal by Subject|3
2239184|NCT01919970|3895909|FG001|Overall Study|Withdrawal by Subject|0
2239185|NCT01920061|3895939|FG000|Overall Study|Death|1
2239186|NCT01920061|3895940|FG001|Overall Study|Death|1
2239187|NCT01920061|3895941|FG002|Overall Study|Death|0
2239188|NCT01920061|3895942|FG003|Overall Study|Death|1
2239189|NCT01920061|3895943|FG004|Overall Study|Death|1
2239190|NCT01920061|3895944|FG005|Overall Study|Death|0
2239191|NCT01920061|3895945|FG006|Overall Study|Death|0
2239192|NCT01920061|3895946|FG007|Overall Study|Death|1
2239193|NCT01920061|3895947|FG008|Overall Study|Death|0
2239194|NCT01920061|3895948|FG009|Overall Study|Death|1
2239195|NCT01920061|3895949|FG010|Overall Study|Death|0
2239196|NCT01920061|3895950|FG011|Overall Study|Death|1
2239197|NCT01920061|3895951|FG012|Overall Study|Death|0
2239198|NCT01920061|3895952|FG013|Overall Study|Death|2
2239199|NCT01920061|3895953|FG014|Overall Study|Death|0
2239200|NCT01920061|3895954|FG015|Overall Study|Death|0
2239201|NCT01920061|3895955|FG016|Overall Study|Death|0
2239202|NCT01920061|3895956|FG017|Overall Study|Death|0
2239203|NCT01920061|3895957|FG018|Overall Study|Death|1
2239204|NCT01920061|3895958|FG019|Overall Study|Death|0
2239205|NCT01920061|3895939|FG000|Overall Study|Lost to Follow-up|0
2239206|NCT01920061|3895940|FG001|Overall Study|Lost to Follow-up|2
2239207|NCT01920061|3895941|FG002|Overall Study|Lost to Follow-up|0
2336299|NCT03299049|4063241|FG001|Overall Study|Lack of Efficacy|3
2239208|NCT01920061|3895942|FG003|Overall Study|Lost to Follow-up|0
2239209|NCT01920061|3895943|FG004|Overall Study|Lost to Follow-up|0
2239210|NCT01920061|3895944|FG005|Overall Study|Lost to Follow-up|0
2239211|NCT01920061|3895945|FG006|Overall Study|Lost to Follow-up|1
2239212|NCT01920061|3895946|FG007|Overall Study|Lost to Follow-up|0
2239213|NCT01920061|3895947|FG008|Overall Study|Lost to Follow-up|0
2239214|NCT01920061|3895948|FG009|Overall Study|Lost to Follow-up|0
2239215|NCT01920061|3895949|FG010|Overall Study|Lost to Follow-up|3
2239216|NCT01920061|3895950|FG011|Overall Study|Lost to Follow-up|0
2239217|NCT01920061|3895951|FG012|Overall Study|Lost to Follow-up|0
2239218|NCT01920061|3895952|FG013|Overall Study|Lost to Follow-up|0
2239219|NCT01920061|3895953|FG014|Overall Study|Lost to Follow-up|0
2239220|NCT01920061|3895954|FG015|Overall Study|Lost to Follow-up|0
2239221|NCT01920061|3895955|FG016|Overall Study|Lost to Follow-up|0
2336300|NCT03299049|4063240|FG000|Overall Study|Adverse Event|12
2336301|NCT03299049|4063241|FG001|Overall Study|Adverse Event|13
2336302|NCT03299101|4063254|FG000|Overall Study|Lost to Follow-up|1
2336303|NCT03299101|4063254|FG000|Overall Study|Withdrawal by Subject|5
2336304|NCT03299101|4063254|FG000|Overall Study|Surgery was changed|3
2336305|NCT03299101|4063254|FG000|Overall Study|Not enough time to complete prehab|1
2336306|NCT03299244|4063260|FG000|Overall Study|Withdrawal by Subject|34
2336307|NCT03299244|4063261|FG001|Overall Study|Withdrawal by Subject|29
2336308|NCT03299244|4063260|FG000|Overall Study|Decision by Sponsor|4
2336309|NCT03299244|4063261|FG001|Overall Study|Decision by Sponsor|5
2336310|NCT03299244|4063260|FG000|Overall Study|Death|9
2336311|NCT03299244|4063261|FG001|Overall Study|Death|4
2336312|NCT03299686|4063270|FG000|Treatment Epoch|Subject/Guardian Decision|2
2336313|NCT03299686|4063271|FG001|Treatment Epoch|Subject/Guardian Decision|0
2336314|NCT03299686|4063270|FG000|Treatment Epoch|Physician Decision|1
2336315|NCT03299686|4063271|FG001|Treatment Epoch|Physician Decision|0
2336316|NCT03299686|4063270|FG000|Treatment Epoch|Adverse Event|8
2336317|NCT03299686|4063271|FG001|Treatment Epoch|Adverse Event|4
2336318|NCT03299686|4063270|FG000|Follow-up Epoch|Subject/Guardian Decision|0
2336319|NCT03299686|4063271|FG001|Follow-up Epoch|Subject/Guardian Decision|1
2336320|NCT03299881|4063279|FG000|Overall Study|Study Termination|17
2336321|NCT03299881|4063280|FG001|Overall Study|Study Termination|13
2336322|NCT03300050|4063291|FG000|Overall Study|Lost to Follow-up|2
2336323|NCT03300050|4063292|FG001|Overall Study|Lost to Follow-up|1
2336324|NCT03300050|4063293|FG002|Overall Study|Lost to Follow-up|0
2336325|NCT03300050|4063294|FG003|Overall Study|Lost to Follow-up|0
2336326|NCT03300050|4063295|FG004|Overall Study|Lost to Follow-up|1
2336327|NCT03300050|4063291|FG000|Overall Study|Withdrawal by Subject|1
2336328|NCT03300050|4063292|FG001|Overall Study|Withdrawal by Subject|1
2336329|NCT03300050|4063293|FG002|Overall Study|Withdrawal by Subject|1
2336330|NCT03300050|4063294|FG003|Overall Study|Withdrawal by Subject|0
2037146|NCT00415532|3607404|FG001|Safety Follow Up Period|Adverse Event|3
2037147|NCT00415532|3607403|FG000|Safety Follow Up Period|Death|3
2037148|NCT00415532|3607404|FG001|Safety Follow Up Period|Death|0
2037149|NCT00415532|3607403|FG000|Safety Follow Up Period|Withdrawal by Subject|2
2037150|NCT00415532|3607404|FG001|Safety Follow Up Period|Withdrawal by Subject|3
2037151|NCT00415532|3607403|FG000|Safety Follow Up Period|Other|1
2037152|NCT00415532|3607404|FG001|Safety Follow Up Period|Other|4
2239222|NCT01920061|3895956|FG017|Overall Study|Lost to Follow-up|1
2239223|NCT01920061|3895957|FG018|Overall Study|Lost to Follow-up|4
2239224|NCT01920061|3895958|FG019|Overall Study|Lost to Follow-up|3
2239225|NCT01920061|3895939|FG000|Overall Study|Other|1
2239226|NCT01920061|3895940|FG001|Overall Study|Other|1
2239227|NCT01920061|3895941|FG002|Overall Study|Other|2
2239228|NCT01920061|3895942|FG003|Overall Study|Other|1
2239229|NCT01920061|3895943|FG004|Overall Study|Other|0
2239230|NCT01920061|3895944|FG005|Overall Study|Other|1
2239231|NCT01920061|3895945|FG006|Overall Study|Other|0
2239232|NCT01920061|3895946|FG007|Overall Study|Other|0
2336331|NCT03300050|4063295|FG004|Overall Study|Withdrawal by Subject|0
2336332|NCT03300050|4063291|FG000|Overall Study|Death|0
2336333|NCT03300050|4063292|FG001|Overall Study|Death|0
2336334|NCT03300050|4063293|FG002|Overall Study|Death|1
2336335|NCT03300050|4063294|FG003|Overall Study|Death|0
2336336|NCT03300050|4063295|FG004|Overall Study|Death|0
2336337|NCT03300050|4063291|FG000|Overall Study|Not Eligible at Randomization|0
2336338|NCT03300050|4063292|FG001|Overall Study|Not Eligible at Randomization|0
2336339|NCT03300050|4063293|FG002|Overall Study|Not Eligible at Randomization|1
2336340|NCT03300050|4063294|FG003|Overall Study|Not Eligible at Randomization|1
2336341|NCT03300050|4063295|FG004|Overall Study|Not Eligible at Randomization|0
2336342|NCT03300570|4063318|FG000|Overall Study|Adverse Event|0
2336343|NCT03300570|4063319|FG001|Overall Study|Adverse Event|1
2336344|NCT03300570|4063318|FG000|Overall Study|Withdrawal by Subject|1
2336345|NCT03300570|4063319|FG001|Overall Study|Withdrawal by Subject|0
2336346|NCT03300570|4063318|FG000|Overall Study|Inadequate bowel prep|1
2336347|NCT03300570|4063319|FG001|Overall Study|Inadequate bowel prep|0
2336348|NCT03301155|4063350|FG000|Overall Study|Сompliance with exclusion criteria|8
2336349|NCT03301155|4063351|FG001|Overall Study|Сompliance with exclusion criteria|7
2336350|NCT03301623|4063398|FG000|Overall Study|Death|3
2336351|NCT03301623|4063399|FG001|Overall Study|Death|1
2336352|NCT03301623|4063398|FG000|Overall Study|Withdrawal by Subject|11
2336353|NCT03301623|4063399|FG001|Overall Study|Withdrawal by Subject|13
2336354|NCT03301623|4063398|FG000|Overall Study|Lost to Follow-up|3
2336355|NCT03301623|4063399|FG001|Overall Study|Lost to Follow-up|1
2336356|NCT03301649|4063408|FG000|Overall Study|Need alternate therapy due to live lice|17
2336357|NCT03301649|4063409|FG001|Overall Study|Need alternate therapy due to live lice|25
2336358|NCT03301649|4063410|FG002|Overall Study|Need alternate therapy due to live lice|81
2336359|NCT03301649|4063408|FG000|Overall Study|Lost to Follow-up|11
2336360|NCT03301649|4063409|FG001|Overall Study|Lost to Follow-up|11
2336361|NCT03301649|4063410|FG002|Overall Study|Lost to Follow-up|3
2239233|NCT01920061|3895947|FG008|Overall Study|Other|0
2336362|NCT03301649|4063408|FG000|Overall Study|Protocol Violation|0
2239234|NCT01920061|3895948|FG009|Overall Study|Other|1
2239235|NCT01920061|3895949|FG010|Overall Study|Other|1
2239236|NCT01920061|3895950|FG011|Overall Study|Other|2
2239237|NCT01920061|3895951|FG012|Overall Study|Other|1
2239238|NCT01920061|3895952|FG013|Overall Study|Other|4
2239239|NCT01920061|3895953|FG014|Overall Study|Other|0
2239240|NCT01920061|3895954|FG015|Overall Study|Other|1
2239241|NCT01920061|3895955|FG016|Overall Study|Other|1
2239242|NCT01920061|3895956|FG017|Overall Study|Other|0
2239243|NCT01920061|3895957|FG018|Overall Study|Other|1
2239244|NCT01920061|3895958|FG019|Overall Study|Other|1
2239245|NCT01920061|3895939|FG000|Overall Study|Participant refused further follow-up|0
2239246|NCT01920061|3895940|FG001|Overall Study|Participant refused further follow-up|0
2239247|NCT01920061|3895941|FG002|Overall Study|Participant refused further follow-up|0
2239248|NCT01920061|3895942|FG003|Overall Study|Participant refused further follow-up|0
2239249|NCT01920061|3895943|FG004|Overall Study|Participant refused further follow-up|1
2239250|NCT01920061|3895944|FG005|Overall Study|Participant refused further follow-up|1
2239251|NCT01920061|3895945|FG006|Overall Study|Participant refused further follow-up|0
2239252|NCT01920061|3895946|FG007|Overall Study|Participant refused further follow-up|0
2239253|NCT01920061|3895947|FG008|Overall Study|Participant refused further follow-up|1
2239254|NCT01920061|3895948|FG009|Overall Study|Participant refused further follow-up|0
2239255|NCT01920061|3895949|FG010|Overall Study|Participant refused further follow-up|1
2239256|NCT01920061|3895950|FG011|Overall Study|Participant refused further follow-up|0
2239257|NCT01920061|3895951|FG012|Overall Study|Participant refused further follow-up|1
2239258|NCT01920061|3895952|FG013|Overall Study|Participant refused further follow-up|0
2239259|NCT01920061|3895953|FG014|Overall Study|Participant refused further follow-up|1
2239260|NCT01920061|3895954|FG015|Overall Study|Participant refused further follow-up|2
2239261|NCT01920061|3895955|FG016|Overall Study|Participant refused further follow-up|1
2239262|NCT01920061|3895956|FG017|Overall Study|Participant refused further follow-up|1
2239263|NCT01920061|3895957|FG018|Overall Study|Participant refused further follow-up|0
2239264|NCT01920061|3895958|FG019|Overall Study|Participant refused further follow-up|0
2239265|NCT01920152|3896023|FG000|Overall Study|Withdrawal by Subject|1
2239266|NCT01920152|3896024|FG001|Overall Study|Withdrawal by Subject|2
2239267|NCT01920178|3896032|FG000|Overall Study|Lost to Follow-up|2
2239268|NCT01920178|3896033|FG001|Overall Study|Lost to Follow-up|1
2239269|NCT01920477|3896054|FG000|Overall Study|Adverse Event|0
2239270|NCT01920477|3896055|FG001|Overall Study|Adverse Event|1
2239271|NCT01920477|3896054|FG000|Overall Study|Lack of Efficacy|1
2239272|NCT01920477|3896055|FG001|Overall Study|Lack of Efficacy|0
2239273|NCT01920477|3896054|FG000|Overall Study|Study closed/terminated|14
2239274|NCT01920477|3896055|FG001|Overall Study|Study closed/terminated|15
2239275|NCT01920477|3896054|FG000|Overall Study|Withdrawal by Subject|0
2239276|NCT01920477|3896055|FG001|Overall Study|Withdrawal by Subject|1
2239277|NCT01920555|3896066|FG000|Overall Study|Physician Decision|1
2239278|NCT01920555|3896067|FG001|Overall Study|Physician Decision|2
2239279|NCT01920555|3896068|FG002|Overall Study|Physician Decision|1
2239280|NCT01920555|3896069|FG003|Overall Study|Physician Decision|2
2239281|NCT01920555|3896070|FG004|Overall Study|Physician Decision|0
2239282|NCT01920555|3896066|FG000|Overall Study|Lack of Efficacy|2
2239283|NCT01920555|3896067|FG001|Overall Study|Lack of Efficacy|0
2239284|NCT01920555|3896068|FG002|Overall Study|Lack of Efficacy|0
2239285|NCT01920555|3896069|FG003|Overall Study|Lack of Efficacy|0
2239286|NCT01920555|3896070|FG004|Overall Study|Lack of Efficacy|0
2239287|NCT01920555|3896066|FG000|Overall Study|Travel Difficulties|1
2239288|NCT01920555|3896067|FG001|Overall Study|Travel Difficulties|1
2239289|NCT01920555|3896068|FG002|Overall Study|Travel Difficulties|0
2239290|NCT01920555|3896069|FG003|Overall Study|Travel Difficulties|0
2239291|NCT01920555|3896070|FG004|Overall Study|Travel Difficulties|1
2239292|NCT01920555|3896066|FG000|Overall Study|Lost to Follow-up|0
2239293|NCT01920555|3896067|FG001|Overall Study|Lost to Follow-up|1
2239294|NCT01920555|3896068|FG002|Overall Study|Lost to Follow-up|0
2239295|NCT01920555|3896069|FG003|Overall Study|Lost to Follow-up|1
2239296|NCT01920555|3896070|FG004|Overall Study|Lost to Follow-up|0
2239297|NCT01920568|3896084|FG000|Overall Study|Adverse Event|27
2239298|NCT01920568|3896085|FG001|Overall Study|Adverse Event|8
2239299|NCT01920568|3896084|FG000|Overall Study|Protocol Violation|5
2239300|NCT01920568|3896085|FG001|Overall Study|Protocol Violation|3
2239301|NCT01920568|3896084|FG000|Overall Study|Lost to Follow-up|2
2239302|NCT01920568|3896085|FG001|Overall Study|Lost to Follow-up|2
2239303|NCT01920568|3896084|FG000|Overall Study|Physician Decision|13
2239304|NCT01920568|3896085|FG001|Overall Study|Physician Decision|4
2239305|NCT01920568|3896084|FG000|Overall Study|Withdrawal by Subject|79
2239306|NCT01920568|3896085|FG001|Overall Study|Withdrawal by Subject|55
2239307|NCT01920568|3896084|FG000|Overall Study|Death due to disease progression|25
2239308|NCT01920568|3896085|FG001|Overall Study|Death due to disease progression|12
2239309|NCT01920594|3896094|FG000|Overall Study|Adverse Event|4
2239310|NCT01920594|3896095|FG001|Overall Study|Adverse Event|2
2239311|NCT01920594|3896094|FG000|Overall Study|Lost to Follow-up|1
2239312|NCT01920594|3896095|FG001|Overall Study|Lost to Follow-up|0
2239313|NCT01920594|3896094|FG000|Overall Study|Recovery|2
2239314|NCT01920594|3896095|FG001|Overall Study|Recovery|0
2239315|NCT01920594|3896094|FG000|Overall Study|Investigator discretion|0
2239316|NCT01920594|3896095|FG001|Overall Study|Investigator discretion|1
2239317|NCT01920711|3896103|FG000|Overall Study|Death|347
2239318|NCT01920711|3896104|FG001|Overall Study|Death|356
2239319|NCT01920711|3896103|FG000|Overall Study|Lost to Follow-up|13
2239320|NCT01920711|3896104|FG001|Overall Study|Lost to Follow-up|14
2239321|NCT01920711|3896103|FG000|Overall Study|Withdrawal by Subject|4
2239322|NCT01920711|3896104|FG001|Overall Study|Withdrawal by Subject|3
2239323|NCT01920854|3896131|FG000|Overall Study|Withdrawal by Subject|1
2239324|NCT01920854|3896132|FG001|Overall Study|Withdrawal by Subject|0
2239325|NCT01920854|3896133|FG002|Overall Study|Withdrawal by Subject|0
2239326|NCT01920854|3896134|FG003|Overall Study|Withdrawal by Subject|0
2239327|NCT01920854|3896135|FG004|Overall Study|Withdrawal by Subject|1
2239328|NCT01920854|3896136|FG005|Overall Study|Withdrawal by Subject|0
2239329|NCT01920854|3896137|FG006|Overall Study|Withdrawal by Subject|1
2239330|NCT01920893|3896174|FG000|Overall Study|Adverse Event|5
2239331|NCT01920893|3896175|FG001|Overall Study|Adverse Event|2
2239332|NCT01920893|3896174|FG000|Overall Study|Lack of Efficacy|2
2239333|NCT01920893|3896175|FG001|Overall Study|Lack of Efficacy|0
2239334|NCT01920958|3896182|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5
2239335|NCT01921101|3896188|FG000|Overall Study|Death|16
2239336|NCT01921101|3896189|FG001|Overall Study|Death|6
2239337|NCT01921179|3896206|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
2239338|NCT01921179|3896207|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
2239339|NCT01921179|3896206|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
2239340|NCT01921179|3896207|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
2239341|NCT01921205|3896216|FG000|Overall Study|Adverse Event|12
2239342|NCT01921205|3896217|FG001|Overall Study|Adverse Event|7
2239343|NCT01921205|3896216|FG000|Overall Study|Lack of Efficacy|1
2239344|NCT01921205|3896217|FG001|Overall Study|Lack of Efficacy|0
2239345|NCT01921205|3896216|FG000|Overall Study|Protocol Violation|1
2239346|NCT01921205|3896217|FG001|Overall Study|Protocol Violation|3
2239347|NCT01921205|3896216|FG000|Overall Study|Lost to Follow-up|1
2239348|NCT01921205|3896217|FG001|Overall Study|Lost to Follow-up|1
2239349|NCT01921205|3896216|FG000|Overall Study|Withdrawal by Subject|6
2239350|NCT01921205|3896217|FG001|Overall Study|Withdrawal by Subject|5
2239351|NCT01921205|3896216|FG000|Overall Study|Use Of Prohibited Medication|0
2239352|NCT01921205|3896217|FG001|Overall Study|Use Of Prohibited Medication|1
2239353|NCT01921205|3896216|FG000|Overall Study|The Excessive Use Of Rescue Medication|0
2239354|NCT01921205|3896217|FG001|Overall Study|The Excessive Use Of Rescue Medication|1
2239355|NCT01921205|3896216|FG000|Overall Study|Non Compliance Of The Parent|0
2239356|NCT01921205|3896217|FG001|Overall Study|Non Compliance Of The Parent|1
2239357|NCT01921205|3896216|FG000|Overall Study|Non Compliance Of Child|0
2239358|NCT01921205|3896217|FG001|Overall Study|Non Compliance Of Child|1
2239359|NCT01921257|3896223|FG000|Overall Study|Adverse Event|1
2239360|NCT01921257|3896223|FG000|Overall Study|Protocol Violation|1
2239361|NCT01921257|3896223|FG000|Overall Study|Withdrawal by Subject|1
2239362|NCT01921270|3896228|FG000|Overall Study|Withdrawal by Subject|1
2239363|NCT01921348|3896247|FG000|Overall Study|Withdrawal by Subject|1
2239364|NCT01921348|3896248|FG001|Overall Study|Withdrawal by Subject|0
2239365|NCT01921348|3896247|FG000|Overall Study|Lost to Follow-up|0
2239366|NCT01921348|3896248|FG001|Overall Study|Lost to Follow-up|2
2239367|NCT01921387|3896254|FG000|Overall Study|Adverse Event|1
2239368|NCT01921517|3896265|FG000|Overall Study|Lost to Follow-up|5
2239369|NCT01921517|3896266|FG001|Overall Study|Lost to Follow-up|0
2239370|NCT01921517|3896265|FG000|Overall Study|Newly diagnosed health concern|2
2239371|NCT01921517|3896266|FG001|Overall Study|Newly diagnosed health concern|0
2239372|NCT01921517|3896265|FG000|Overall Study|Physician Decision|0
2239373|NCT01921517|3896266|FG001|Overall Study|Physician Decision|2
2239374|NCT01921517|3896265|FG000|Overall Study|Withdrawal by Subject|7
2239375|NCT01921517|3896266|FG001|Overall Study|Withdrawal by Subject|3
2239376|NCT01921517|3896265|FG000|Overall Study|Subject missed final imaging|1
2239377|NCT01921517|3896266|FG001|Overall Study|Subject missed final imaging|4
2239378|NCT01921829|3896293|FG000|Overall Study|Withdrawal by Subject|0
2239379|NCT01921829|3896294|FG001|Overall Study|Withdrawal by Subject|1
2239380|NCT01922011|3896327|FG000|Overall Study|Protocol Violation|0
2239381|NCT01922011|3896328|FG001|Overall Study|Protocol Violation|1
2239382|NCT01922011|3896327|FG000|Overall Study|Physician Decision|0
2239383|NCT01922011|3896328|FG001|Overall Study|Physician Decision|1
2239384|NCT01922011|3896327|FG000|Overall Study|Parent/Guardian Decision|3
2239385|NCT01922011|3896328|FG001|Overall Study|Parent/Guardian Decision|0
2239386|NCT01922011|3896327|FG000|Overall Study|Lost to Follow-up|0
2239387|NCT01922011|3896328|FG001|Overall Study|Lost to Follow-up|1
2239388|NCT01922011|3896327|FG000|Overall Study|Missed Test-of-Cure Visit|0
2239389|NCT01922011|3896328|FG001|Overall Study|Missed Test-of-Cure Visit|2
2239390|NCT01922011|3896327|FG000|Overall Study|Not Treated|1
2239391|NCT01922011|3896328|FG001|Overall Study|Not Treated|0
2336363|NCT03301649|4063409|FG001|Overall Study|Protocol Violation|1
2336364|NCT03301649|4063410|FG002|Overall Study|Protocol Violation|1
2336365|NCT03301649|4063408|FG000|Overall Study|Withdrawal by Subject|10
2336366|NCT03301649|4063409|FG001|Overall Study|Withdrawal by Subject|4
2336367|NCT03301649|4063410|FG002|Overall Study|Withdrawal by Subject|0
2336368|NCT03301649|4063408|FG000|Overall Study|Other than specified|5
2336369|NCT03301649|4063409|FG001|Overall Study|Other than specified|3
2239392|NCT01922011|3896327|FG000|Overall Study|Lack of willing home health agency|1
2239393|NCT01922011|3896328|FG001|Overall Study|Lack of willing home health agency|0
2239394|NCT01922011|3896327|FG000|Overall Study|Randomized in error|1
2239395|NCT01922011|3896328|FG001|Overall Study|Randomized in error|0
2239396|NCT01922037|3896351|FG000|Overall Study|Withdrawal by Subject|2
2239397|NCT01922037|3896352|FG001|Overall Study|Withdrawal by Subject|44
2239398|NCT01922037|3896351|FG000|Overall Study|Adverse Event|1
2239399|NCT01922037|3896352|FG001|Overall Study|Adverse Event|7
2239400|NCT01922037|3896351|FG000|Overall Study|Death|0
2239401|NCT01922037|3896352|FG001|Overall Study|Death|5
2239402|NCT01922037|3896351|FG000|Overall Study|Pregnancy|0
2239403|NCT01922037|3896352|FG001|Overall Study|Pregnancy|2
2239404|NCT01922037|3896351|FG000|Overall Study|Participant non-compliance|4
2239405|NCT01922037|3896352|FG001|Overall Study|Participant non-compliance|46
2239406|NCT01922037|3896351|FG000|Overall Study|Investigator/Sponsor decision|1
2239407|NCT01922037|3896352|FG001|Overall Study|Investigator/Sponsor decision|4
2239408|NCT01922037|3896351|FG000|Overall Study|Other unspecified|2
2239409|NCT01922037|3896352|FG001|Overall Study|Other unspecified|66
2239410|NCT01922089|3896419|FG000|Overall Study|Adverse Event|18
2239411|NCT01922089|3896420|FG001|Overall Study|Adverse Event|13
2239412|NCT01922089|3896419|FG000|Overall Study|Protocol Deviation|10
2239413|NCT01922089|3896420|FG001|Overall Study|Protocol Deviation|7
2239414|NCT01922089|3896419|FG000|Overall Study|Withdrawal by Subject|3
2239415|NCT01922089|3896420|FG001|Overall Study|Withdrawal by Subject|4
2239416|NCT01922089|3896419|FG000|Overall Study|administrative problems|4
2239417|NCT01922089|3896420|FG001|Overall Study|administrative problems|1
2239418|NCT01922089|3896419|FG000|Overall Study|Physician Decision|2
2239419|NCT01922089|3896420|FG001|Overall Study|Physician Decision|3
2239420|NCT01922089|3896419|FG000|Overall Study|Death|2
2239421|NCT01922089|3896420|FG001|Overall Study|Death|1
2239422|NCT01922089|3896419|FG000|Overall Study|Lost to Follow-up|0
2239423|NCT01922089|3896420|FG001|Overall Study|Lost to Follow-up|1
2239424|NCT01922102|3896429|FG000|Overall Study|Withdrawal by Subject|7
2239425|NCT01922102|3896430|FG001|Overall Study|Withdrawal by Subject|3
2239426|NCT01922102|3896431|FG002|Overall Study|Withdrawal by Subject|7
2239427|NCT01922102|3896429|FG000|Overall Study|Physician Decision|0
2239428|NCT01922102|3896430|FG001|Overall Study|Physician Decision|2
2239429|NCT01922102|3896431|FG002|Overall Study|Physician Decision|1
2239430|NCT01922102|3896429|FG000|Overall Study|Adverse Event|1
2239431|NCT01922102|3896430|FG001|Overall Study|Adverse Event|2
2239432|NCT01922102|3896431|FG002|Overall Study|Adverse Event|0
2239433|NCT01922102|3896429|FG000|Overall Study|Lost to Follow-up|1
2239434|NCT01922102|3896430|FG001|Overall Study|Lost to Follow-up|0
2239435|NCT01922102|3896431|FG002|Overall Study|Lost to Follow-up|0
2239436|NCT01922102|3896429|FG000|Overall Study|Administrative problems|0
2239437|NCT01922102|3896430|FG001|Overall Study|Administrative problems|2
2239438|NCT01922102|3896431|FG002|Overall Study|Administrative problems|0
2239439|NCT01922258|3896458|FG000|Overall Study|Lost to Follow-up|1
2239440|NCT01922258|3896459|FG001|Overall Study|Lost to Follow-up|1
2239441|NCT01922258|3896458|FG000|Overall Study|Adverse Event|9
2239442|NCT01922258|3896459|FG001|Overall Study|Adverse Event|2
2239443|NCT01922258|3896458|FG000|Overall Study|Met Withdrawal Criteria|0
2239444|NCT01922258|3896459|FG001|Overall Study|Met Withdrawal Criteria|4
2239445|NCT01922258|3896458|FG000|Overall Study|Withdrawn by the Investigator|1
2239446|NCT01922258|3896459|FG001|Overall Study|Withdrawn by the Investigator|4
2239447|NCT01922258|3896458|FG000|Overall Study|Withdrawal by participant|5
2239448|NCT01922258|3896459|FG001|Overall Study|Withdrawal by participant|5
2239449|NCT01922271|3896467|FG000|WASHOUT Period|Withdrawal by Subject|1
2239450|NCT01922271|3896468|FG001|WASHOUT Period|Withdrawal by Subject|0
2239451|NCT01922349|3896491|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0
2239452|NCT01922349|3896492|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0
2239453|NCT01922349|3896493|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0
2336370|NCT03301649|4063410|FG002|Overall Study|Other than specified|0
2336371|NCT03301714|4063421|FG000|Overall Study|Lost to Follow-up|10
2336372|NCT03301714|4063422|FG001|Overall Study|Lost to Follow-up|4
2336373|NCT03301714|4063423|FG002|Overall Study|Lost to Follow-up|4
2336374|NCT03301714|4063421|FG000|Overall Study|Did not receive allocated intervention|0
2336375|NCT03301714|4063422|FG001|Overall Study|Did not receive allocated intervention|2
2336376|NCT03301714|4063423|FG002|Overall Study|Did not receive allocated intervention|3
2336377|NCT03301740|4063436|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
2336378|NCT03301740|4063437|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
2336379|NCT03301740|4063436|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
2336380|NCT03301740|4063437|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
2336381|NCT03301831|4063452|FG000|Overall Study|Lost to Follow-up|5
2336382|NCT03301831|4063453|FG001|Overall Study|Lost to Follow-up|3
2336383|NCT03301831|4063452|FG000|Overall Study|Protocol Violation|4
2239454|NCT01922349|3896494|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1
2239455|NCT01922739|3896530|FG000|Titration/Adjustment Period|Adverse Event|3
2239456|NCT01922739|3896530|FG000|Titration/Adjustment Period|Withdrawal by Subject|5
2239457|NCT01922739|3896530|FG000|Titration/Adjustment Period|Lost to Follow-up|1
2239458|NCT01922739|3896530|FG000|Titration/Adjustment Period|Lack of Efficacy|3
2239459|NCT01922739|3896530|FG000|Open-label Treatment Period|Adverse Event|6
2239460|NCT01922739|3896530|FG000|Open-label Treatment Period|Withdrawal by Subject|14
2239461|NCT01922739|3896530|FG000|Open-label Treatment Period|Noncompliance to study medication|3
2239462|NCT01922739|3896530|FG000|Open-label Treatment Period|Protocol Violation|5
2239463|NCT01922739|3896530|FG000|Open-label Treatment Period|Pregnancy|1
2239464|NCT01922739|3896530|FG000|Open-label Treatment Period|Noncompliance to study procedures|1
2239465|NCT01922739|3896530|FG000|Open-label Treatment Period|Lost to Follow-up|2
2239466|NCT01922739|3896530|FG000|Open-label Treatment Period|Physician Decision|1
2239467|NCT01922739|3896530|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1
2239468|NCT01922934|3896548|FG000|Eligible Patients|Death|0
2239469|NCT01922934|3896549|FG001|Eligible Patients|Death|7
2239470|NCT01922934|3896548|FG000|Eligible Patients|Physician Decision|17
2239471|NCT01922934|3896549|FG001|Eligible Patients|Physician Decision|0
2239472|NCT01922934|3896548|FG000|Eligible Patients|Did not meet inclusion criteria|36
2239473|NCT01922934|3896549|FG001|Eligible Patients|Did not meet inclusion criteria|81
2239474|NCT01922934|3896548|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
2239475|NCT01922934|3896549|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
2239476|NCT01922934|3896548|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
2239477|NCT01922934|3896549|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
2239478|NCT01922934|3896548|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
2239479|NCT01922934|3896549|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
2239480|NCT01923181|3896584|FG000|Overall Study|Protocol Violation|2
2239481|NCT01923181|3896585|FG001|Overall Study|Protocol Violation|2
2239482|NCT01923181|3896586|FG002|Overall Study|Protocol Violation|0
2239483|NCT01923181|3896587|FG003|Overall Study|Protocol Violation|2
2239484|NCT01923181|3896588|FG004|Overall Study|Protocol Violation|2
2239485|NCT01923181|3896589|FG005|Overall Study|Protocol Violation|1
2239486|NCT01923181|3896590|FG006|Overall Study|Protocol Violation|1
2239487|NCT01923181|3896591|FG007|Overall Study|Protocol Violation|2
2239488|NCT01923181|3896592|FG008|Overall Study|Protocol Violation|1
2239489|NCT01923181|3896584|FG000|Overall Study|Withdrawal by Subject|0
2239490|NCT01923181|3896585|FG001|Overall Study|Withdrawal by Subject|1
2239491|NCT01923181|3896586|FG002|Overall Study|Withdrawal by Subject|0
2239492|NCT01923181|3896587|FG003|Overall Study|Withdrawal by Subject|1
2239493|NCT01923181|3896588|FG004|Overall Study|Withdrawal by Subject|4
2239494|NCT01923181|3896589|FG005|Overall Study|Withdrawal by Subject|2
2239495|NCT01923181|3896590|FG006|Overall Study|Withdrawal by Subject|4
2239496|NCT01923181|3896591|FG007|Overall Study|Withdrawal by Subject|3
2239497|NCT01923181|3896592|FG008|Overall Study|Withdrawal by Subject|1
2239498|NCT01923181|3896584|FG000|Overall Study|Other|1
2239499|NCT01923181|3896585|FG001|Overall Study|Other|0
2239500|NCT01923181|3896586|FG002|Overall Study|Other|0
2239501|NCT01923181|3896587|FG003|Overall Study|Other|1
2239502|NCT01923181|3896588|FG004|Overall Study|Other|0
2239503|NCT01923181|3896589|FG005|Overall Study|Other|0
2239504|NCT01923181|3896590|FG006|Overall Study|Other|0
2239505|NCT01923181|3896591|FG007|Overall Study|Other|0
2239506|NCT01923181|3896592|FG008|Overall Study|Other|0
2239507|NCT01923181|3896584|FG000|Overall Study|Lost to Follow-up|0
2239508|NCT01923181|3896585|FG001|Overall Study|Lost to Follow-up|3
2239509|NCT01923181|3896586|FG002|Overall Study|Lost to Follow-up|2
2239510|NCT01923181|3896587|FG003|Overall Study|Lost to Follow-up|1
2239511|NCT01923181|3896588|FG004|Overall Study|Lost to Follow-up|2
2239512|NCT01923181|3896589|FG005|Overall Study|Lost to Follow-up|1
2239513|NCT01923181|3896590|FG006|Overall Study|Lost to Follow-up|3
2239514|NCT01923181|3896591|FG007|Overall Study|Lost to Follow-up|3
2239515|NCT01923181|3896592|FG008|Overall Study|Lost to Follow-up|1
2239516|NCT01923285|3896617|FG000|Overall Study|Withdrawal by Subject|7
2239517|NCT01923285|3896618|FG001|Overall Study|Withdrawal by Subject|6
2239518|NCT01923311|3896626|FG000|Overall Study|Pregnancy|1
2239519|NCT01923311|3896627|FG001|Overall Study|Pregnancy|0
2239520|NCT01923311|3896626|FG000|Overall Study|Investigator's Discretion|1
2239521|NCT01923311|3896627|FG001|Overall Study|Investigator's Discretion|0
2239522|NCT01923311|3896626|FG000|Overall Study|Non-Compliance with Study Drug|2
2239523|NCT01923311|3896627|FG001|Overall Study|Non-Compliance with Study Drug|1
2239524|NCT01923311|3896626|FG000|Overall Study|Withdrew Consent|1
2239525|NCT01923311|3896627|FG001|Overall Study|Withdrew Consent|0
2239526|NCT01923311|3896626|FG000|Overall Study|Study Terminated by Sponsor|12
2239527|NCT01923311|3896627|FG001|Overall Study|Study Terminated by Sponsor|0
2239528|NCT01923363|3896634|FG000|Overall Study|Protocol Violation|1
2336384|NCT03301831|4063453|FG001|Overall Study|Protocol Violation|0
2336385|NCT03301831|4063452|FG000|Overall Study|Withdrawal by Subject|11
2336386|NCT03301831|4063453|FG001|Overall Study|Withdrawal by Subject|0
2336387|NCT03301844|4063461|FG000|Overall Study|suspected colon cancer|1
2336388|NCT03301844|4063462|FG001|Overall Study|suspected colon cancer|1
2336389|NCT03302234|4063479|FG000|Overall Study|Death|137
2336390|NCT03302234|4063480|FG001|Overall Study|Death|135
2336391|NCT03302234|4063479|FG000|Overall Study|Withdrawal by Subject|1
2336392|NCT03302234|4063480|FG001|Overall Study|Withdrawal by Subject|1
2336393|NCT03302234|4063479|FG000|Overall Study|Laryngeal carcinoma|0
2336394|NCT03302234|4063480|FG001|Overall Study|Laryngeal carcinoma|1
2336395|NCT03302559|4063491|FG000|Overall Study|Adverse Event|2
2336396|NCT03302559|4063491|FG000|Overall Study|Lost to Follow-up|1
2336397|NCT03302559|4063491|FG000|Overall Study|Withdrew Consent|3
2239529|NCT01923389|3896640|FG000|Overall Study|Protocol Violation|1
2239530|NCT01923389|3896641|FG001|Overall Study|Protocol Violation|0
2239531|NCT01923428|3896652|FG000|Overall Study|Adverse Event|8
2239532|NCT01923428|3896653|FG001|Overall Study|Adverse Event|6
2239533|NCT01923428|3896654|FG002|Overall Study|Adverse Event|3
2239534|NCT01923428|3896655|FG003|Overall Study|Adverse Event|3
2239535|NCT01923428|3896652|FG000|Overall Study|Withdrawal by Subject|5
2239536|NCT01923428|3896653|FG001|Overall Study|Withdrawal by Subject|3
2239537|NCT01923428|3896654|FG002|Overall Study|Withdrawal by Subject|0
2239538|NCT01923428|3896655|FG003|Overall Study|Withdrawal by Subject|4
2239539|NCT01923428|3896652|FG000|Overall Study|Lost to Follow-up|2
2239540|NCT01923428|3896653|FG001|Overall Study|Lost to Follow-up|1
2239541|NCT01923428|3896654|FG002|Overall Study|Lost to Follow-up|5
2239542|NCT01923428|3896655|FG003|Overall Study|Lost to Follow-up|0
2239543|NCT01923428|3896652|FG000|Overall Study|Protocol Violation|3
2239544|NCT01923428|3896653|FG001|Overall Study|Protocol Violation|0
2239545|NCT01923428|3896654|FG002|Overall Study|Protocol Violation|2
2239546|NCT01923428|3896655|FG003|Overall Study|Protocol Violation|1
2239547|NCT01923428|3896652|FG000|Overall Study|Non Compliance to treatment|1
2239548|NCT01923428|3896653|FG001|Overall Study|Non Compliance to treatment|2
2239549|NCT01923428|3896654|FG002|Overall Study|Non Compliance to treatment|0
2336398|NCT03302936|4063524|FG000|Overall Study|Protocol Violation|3
2336399|NCT03302936|4063525|FG001|Overall Study|Protocol Violation|4
2336400|NCT03302975|4063535|FG000|Overall Study|Lost to Follow-up|4
2336401|NCT03303079|4063542|FG000|Overall Study|Adverse Event|0
2336402|NCT03303079|4063543|FG001|Overall Study|Adverse Event|1
2336403|NCT03303079|4063544|FG002|Overall Study|Adverse Event|3
2336404|NCT03303079|4063542|FG000|Overall Study|Protocol Violation|5
2336405|NCT03303079|4063543|FG001|Overall Study|Protocol Violation|4
2336406|NCT03303079|4063544|FG002|Overall Study|Protocol Violation|7
2336407|NCT03303079|4063542|FG000|Overall Study|Withdrawal by Subject|2
2336408|NCT03303079|4063543|FG001|Overall Study|Withdrawal by Subject|4
2336409|NCT03303079|4063544|FG002|Overall Study|Withdrawal by Subject|2
2336410|NCT03303079|4063542|FG000|Overall Study|Other than specified|0
2336411|NCT03303079|4063543|FG001|Overall Study|Other than specified|2
2336412|NCT03303079|4063544|FG002|Overall Study|Other than specified|0
2336413|NCT03303092|4063555|FG000|Overall Study|Adverse Event|1
2336414|NCT03303092|4063556|FG001|Overall Study|Adverse Event|0
2336415|NCT03303092|4063557|FG002|Overall Study|Adverse Event|1
2336416|NCT03303092|4063555|FG000|Overall Study|Protocol Violation|1
2336417|NCT03303092|4063556|FG001|Overall Study|Protocol Violation|5
2336418|NCT03303092|4063557|FG002|Overall Study|Protocol Violation|1
2336419|NCT03303092|4063555|FG000|Overall Study|Withdrawal by Subject|1
2336420|NCT03303092|4063556|FG001|Overall Study|Withdrawal by Subject|1
2336421|NCT03303092|4063557|FG002|Overall Study|Withdrawal by Subject|3
2336422|NCT03303105|4063567|FG000|Overall Study|Adverse Event|0
2336423|NCT03303105|4063568|FG001|Overall Study|Adverse Event|2
2336424|NCT03303105|4063567|FG000|Overall Study|Lack of Efficacy|1
2336425|NCT03303105|4063568|FG001|Overall Study|Lack of Efficacy|0
2336426|NCT03303105|4063567|FG000|Overall Study|Protocol Violation|1
2336427|NCT03303105|4063568|FG001|Overall Study|Protocol Violation|0
2336428|NCT03303105|4063567|FG000|Overall Study|Withdrawal by Subject|0
2336429|NCT03303105|4063568|FG001|Overall Study|Withdrawal by Subject|2
2336430|NCT03303417|4063597|FG000|Overall Study|Withdrawal by Subject|1
2336431|NCT03303417|4063598|FG001|Overall Study|Withdrawal by Subject|1
2336432|NCT03303521|4063606|FG000|Overall Study|Withdrawal by Subject|2
2336433|NCT03303521|4063607|FG001|Overall Study|Withdrawal by Subject|0
2336434|NCT03303521|4063606|FG000|Overall Study|Death|1
2336435|NCT03303521|4063607|FG001|Overall Study|Death|0
2336436|NCT03303521|4063606|FG000|Overall Study|Kidney transplantation|0
2336437|NCT03303521|4063607|FG001|Overall Study|Kidney transplantation|1
2336438|NCT03303521|4063606|FG000|Overall Study|Investigational product discontinuation|0
2336439|NCT03303521|4063607|FG001|Overall Study|Investigational product discontinuation|1
2336440|NCT03303521|4063606|FG000|Overall Study|Transferred to non-study dialysis center|1
2336441|NCT03303521|4063607|FG001|Overall Study|Transferred to non-study dialysis center|0
2336442|NCT03303521|4063606|FG000|Overall Study|Non-comliance to study protocol|0
2336443|NCT03303521|4063607|FG001|Overall Study|Non-comliance to study protocol|1
2336444|NCT03303521|4063606|FG000|Overall Study|Adverse Event|1
2336445|NCT03303521|4063607|FG001|Overall Study|Adverse Event|0
2336446|NCT03304184|4063682|FG000|Overall Study|Withdrawal by Subject|1
2336447|NCT03304184|4063683|FG001|Overall Study|Withdrawal by Subject|2
2336448|NCT03304522|4063692|FG000|Overall Study|Adverse Event|0
2336449|NCT03304522|4063693|FG001|Overall Study|Adverse Event|4
2336450|NCT03304522|4063692|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
2336451|NCT03304522|4063693|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
2336452|NCT03304522|4063692|FG000|Overall Study|Withdrawal of consent (for other reason)|0
2336453|NCT03304522|4063693|FG001|Overall Study|Withdrawal of consent (for other reason)|2
2195806|NCT01526057|3828464|FG002|Overall Study|Protocol Violation|1
2336454|NCT03304522|4063692|FG000|Overall Study|Other|0
2336455|NCT03304522|4063693|FG001|Overall Study|Other|1
2336456|NCT03304626|4063701|FG000|Overall Study|Adverse Event|1
2336457|NCT03304626|4063702|FG001|Overall Study|Adverse Event|0
2336458|NCT03304626|4063701|FG000|Overall Study|Lack of Efficacy|1
2239550|NCT01923428|3896655|FG003|Overall Study|Non Compliance to treatment|1
2239551|NCT01923428|3896652|FG000|Overall Study|Lack of Efficacy|0
2239552|NCT01923428|3896653|FG001|Overall Study|Lack of Efficacy|0
2239553|NCT01923428|3896654|FG002|Overall Study|Lack of Efficacy|1
2239554|NCT01923428|3896655|FG003|Overall Study|Lack of Efficacy|1
2239555|NCT01923467|3896665|FG000|Overall Study|Lost to Follow-up|62
2239556|NCT01923467|3896665|FG000|Overall Study|Subject non-interest|479
2239557|NCT01923740|3896671|FG000|Overall Study|Lost to Follow-up|4
2239558|NCT01923740|3896672|FG001|Overall Study|Lost to Follow-up|9
2239559|NCT01923740|3896671|FG000|Overall Study|Withdrawal by Subject|2
2239560|NCT01923740|3896672|FG001|Overall Study|Withdrawal by Subject|0
2239561|NCT01923896|3896689|FG000|Overall Study|Adverse Event|1
2239562|NCT01923896|3896690|FG001|Overall Study|Adverse Event|0
2239563|NCT01924182|3896715|FG000|Overall Study|Withdrawal by Subject|1
2239564|NCT01924182|3896716|FG001|Overall Study|Withdrawal by Subject|0
2239565|NCT01924299|3896724|FG000|Period 2|Withdrawal by Subject|1
2239566|NCT01924299|3896725|FG001|Period 2|Withdrawal by Subject|0
2239567|NCT01924299|3896724|FG000|Period 2|Adverse Event|0
2239568|NCT01924299|3896725|FG001|Period 2|Adverse Event|1
2239569|NCT01924364|3896737|FG000|Overall Study|Physician Decision|3
2239570|NCT01924429|3896763|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3
2239571|NCT01924429|3896764|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
2239572|NCT01924533|3896783|FG000|Overall Study|Death|181
2239573|NCT01924533|3896784|FG001|Overall Study|Death|200
2239574|NCT01924533|3896783|FG000|Overall Study|Lost to Follow-up|0
2239575|NCT01924533|3896784|FG001|Overall Study|Lost to Follow-up|1
2239576|NCT01924533|3896783|FG000|Overall Study|Withdrawal by Subject|7
2239577|NCT01924533|3896784|FG001|Overall Study|Withdrawal by Subject|3
2239578|NCT01924533|3896783|FG000|Overall Study|Other Eligibility criteria|1
2239579|NCT01924533|3896784|FG001|Overall Study|Other Eligibility criteria|1
2239580|NCT01924689|3896810|FG000|Overall Study|Death|0
2239581|NCT01924689|3896811|FG001|Overall Study|Death|1
2239582|NCT01924689|3896812|FG002|Overall Study|Death|0
2239583|NCT01924689|3896813|FG003|Overall Study|Death|1
2239584|NCT01924689|3896814|FG004|Overall Study|Death|0
2239585|NCT01924689|3896815|FG005|Overall Study|Death|0
2239586|NCT01924689|3896810|FG000|Overall Study|Disease progression|0
2239587|NCT01924689|3896811|FG001|Overall Study|Disease progression|0
2336459|NCT03304626|4063702|FG001|Overall Study|Lack of Efficacy|1
2336460|NCT03304873|4063711|FG000|Overall Study|Lost to Follow-up|1
2336461|NCT03304873|4063712|FG001|Overall Study|Lost to Follow-up|8
2336462|NCT03305081|4063720|FG000|Overall Study|Lost to Follow-up|10
2336463|NCT03305081|4063721|FG001|Overall Study|Lost to Follow-up|15
2336464|NCT03305419|4063744|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2336465|NCT03305419|4063745|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
2336466|NCT03305419|4063746|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2336467|NCT03305419|4063747|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2336468|NCT03305419|4063748|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2336469|NCT03305419|4063749|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2336470|NCT03305419|4063750|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2336471|NCT03305419|4063751|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2336472|NCT03305419|4063744|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
2336473|NCT03305419|4063745|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2336474|NCT03305419|4063746|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2336475|NCT03305419|4063747|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2336476|NCT03305419|4063748|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2336477|NCT03305419|4063749|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2336478|NCT03305419|4063750|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2336479|NCT03305419|4063751|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2336480|NCT03305419|4063744|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
2336481|NCT03305419|4063745|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2336482|NCT03305419|4063746|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2336483|NCT03305419|4063747|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2336484|NCT03305419|4063748|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2336485|NCT03305419|4063749|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2336486|NCT03305419|4063750|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2336487|NCT03305419|4063751|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2336488|NCT03305419|4063744|FG000|Part B (14 Days)|Adverse Event|0
2336489|NCT03305419|4063745|FG001|Part B (14 Days)|Adverse Event|0
2336490|NCT03305419|4063746|FG002|Part B (14 Days)|Adverse Event|0
2336491|NCT03305419|4063747|FG003|Part B (14 Days)|Adverse Event|0
2336492|NCT03305419|4063748|FG004|Part B (14 Days)|Adverse Event|1
2336493|NCT03305419|4063749|FG005|Part B (14 Days)|Adverse Event|2
2336494|NCT03305419|4063750|FG006|Part B (14 Days)|Adverse Event|4
2336495|NCT03305419|4063751|FG007|Part B (14 Days)|Adverse Event|0
2336496|NCT03305419|4063744|FG000|Part B (14 Days)|Physician Decision|0
2336497|NCT03305419|4063745|FG001|Part B (14 Days)|Physician Decision|0
2336498|NCT03305419|4063746|FG002|Part B (14 Days)|Physician Decision|0
2239588|NCT01924689|3896812|FG002|Overall Study|Disease progression|2
2239589|NCT01924689|3896813|FG003|Overall Study|Disease progression|0
2239590|NCT01924689|3896814|FG004|Overall Study|Disease progression|3
2239591|NCT01924689|3896815|FG005|Overall Study|Disease progression|2
2239592|NCT01924689|3896810|FG000|Overall Study|New therapy or study|3
2239593|NCT01924689|3896811|FG001|Overall Study|New therapy or study|2
2239594|NCT01924689|3896812|FG002|Overall Study|New therapy or study|1
2239595|NCT01924689|3896813|FG003|Overall Study|New therapy or study|4
2239596|NCT01924689|3896814|FG004|Overall Study|New therapy or study|2
2239597|NCT01924689|3896815|FG005|Overall Study|New therapy or study|0
2239598|NCT01924689|3896810|FG000|Overall Study|Withdrawal of consent|0
2239599|NCT01924689|3896811|FG001|Overall Study|Withdrawal of consent|0
2239600|NCT01924689|3896812|FG002|Overall Study|Withdrawal of consent|1
2239601|NCT01924689|3896813|FG003|Overall Study|Withdrawal of consent|1
2239602|NCT01924689|3896814|FG004|Overall Study|Withdrawal of consent|0
2239603|NCT01924689|3896815|FG005|Overall Study|Withdrawal of consent|0
2239604|NCT01924689|3896810|FG000|Overall Study|Other|0
2239605|NCT01924689|3896811|FG001|Overall Study|Other|0
2239606|NCT01924689|3896812|FG002|Overall Study|Other|0
2239607|NCT01924689|3896813|FG003|Overall Study|Other|0
2239608|NCT01924689|3896814|FG004|Overall Study|Other|1
2239609|NCT01924689|3896815|FG005|Overall Study|Other|0
2239610|NCT01924754|3896836|FG000|Overall Study|Lost to Follow-up|1
2239611|NCT01924754|3896837|FG001|Overall Study|Lost to Follow-up|2
2239612|NCT01924754|3896838|FG002|Overall Study|Lost to Follow-up|1
2239613|NCT01924754|3896836|FG000|Overall Study|Pregnancy|0
2239614|NCT01924754|3896837|FG001|Overall Study|Pregnancy|1
2239615|NCT01924754|3896838|FG002|Overall Study|Pregnancy|2
2239616|NCT01924767|3896854|FG000|Overall Study|Adverse Event|1
2239617|NCT01924767|3896855|FG001|Overall Study|Adverse Event|0
2239618|NCT01924767|3896856|FG002|Overall Study|Adverse Event|1
2239619|NCT01924767|3896857|FG003|Overall Study|Adverse Event|0
2239620|NCT01924767|3896858|FG004|Overall Study|Adverse Event|0
2239621|NCT01924806|3896877|FG000|Overall Study|Physician Decision|2
2239622|NCT01924806|3896878|FG001|Overall Study|Physician Decision|1
2239623|NCT01924845|3896884|FG000|Overall Study|Adverse Event|3
2239624|NCT01924845|3896884|FG000|Overall Study|Withdrawal by Subject|2
2239625|NCT01924845|3896884|FG000|Overall Study|Protocol Violation|1
2239626|NCT01925014|3896919|FG000|Overall Study|Inappropriate enrollment|4
2239627|NCT01925014|3896920|FG001|Overall Study|Inappropriate enrollment|6
2239628|NCT01925014|3896919|FG000|Overall Study|Withdrawal by Subject|5
2239629|NCT01925014|3896920|FG001|Overall Study|Withdrawal by Subject|13
2239630|NCT01925170|3896933|FG000|Overall Study|Unverified cancer status|53
2239631|NCT01925183|3896941|FG000|Overall Study|Adverse Event|1
2239632|NCT01925183|3896942|FG001|Overall Study|Adverse Event|0
2239633|NCT01925209|3896952|FG000|Treatment Epoch|Physician Decision|1
2239634|NCT01925209|3896953|FG001|Treatment Epoch|Physician Decision|0
2239635|NCT01925209|3896954|FG002|Treatment Epoch|Physician Decision|0
2239636|NCT01925209|3896955|FG003|Treatment Epoch|Physician Decision|0
2239637|NCT01925209|3896952|FG000|Treatment Epoch|Non-compliance with study treatment|0
2239638|NCT01925209|3896953|FG001|Treatment Epoch|Non-compliance with study treatment|0
2239639|NCT01925209|3896954|FG002|Treatment Epoch|Non-compliance with study treatment|0
2239640|NCT01925209|3896955|FG003|Treatment Epoch|Non-compliance with study treatment|1
2239641|NCT01925209|3896952|FG000|Treatment Epoch|Death|1
2239642|NCT01925209|3896953|FG001|Treatment Epoch|Death|0
2239643|NCT01925209|3896954|FG002|Treatment Epoch|Death|0
2239644|NCT01925209|3896955|FG003|Treatment Epoch|Death|0
2239645|NCT01925209|3896952|FG000|Treatment Epoch|Protocol deviation|0
2239646|NCT01925209|3896953|FG001|Treatment Epoch|Protocol deviation|0
2239647|NCT01925209|3896954|FG002|Treatment Epoch|Protocol deviation|1
2239648|NCT01925209|3896955|FG003|Treatment Epoch|Protocol deviation|1
2239649|NCT01925209|3896952|FG000|Treatment Epoch|Withdrawal by Subject|4
2239650|NCT01925209|3896953|FG001|Treatment Epoch|Withdrawal by Subject|3
2239651|NCT01925209|3896954|FG002|Treatment Epoch|Withdrawal by Subject|3
2336499|NCT03305419|4063747|FG003|Part B (14 Days)|Physician Decision|0
2336500|NCT03305419|4063748|FG004|Part B (14 Days)|Physician Decision|2
2336501|NCT03305419|4063749|FG005|Part B (14 Days)|Physician Decision|8
2336502|NCT03305419|4063750|FG006|Part B (14 Days)|Physician Decision|1
2336503|NCT03305419|4063751|FG007|Part B (14 Days)|Physician Decision|0
2336504|NCT03305575|4063776|FG000|Overall Study|Physician Decision|1
2336505|NCT03305575|4063777|FG001|Overall Study|Physician Decision|0
2336506|NCT03305666|4063789|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2
2336507|NCT03305666|4063790|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0
2336508|NCT03305731|4063796|FG000|Overall Study|Protocol Violation|1
2336509|NCT03305770|4063802|FG000|Overall Study|Physician Decision - prior to dispense|0
2336510|NCT03305770|4063803|FG001|Overall Study|Physician Decision - prior to dispense|1
2336511|NCT03305770|4063802|FG000|Overall Study|Subject moved|1
2336512|NCT03305770|4063803|FG001|Overall Study|Subject moved|0
2336513|NCT03305809|4063815|FG000|Overall Study|Adverse Event|2
2336514|NCT03305809|4063816|FG001|Overall Study|Adverse Event|2
2336515|NCT03305809|4063817|FG002|Overall Study|Adverse Event|6
2239652|NCT01925209|3896955|FG003|Treatment Epoch|Withdrawal by Subject|2
2239653|NCT01925209|3896952|FG000|Treatment Epoch|Adverse Event|3
2336516|NCT03305809|4063818|FG003|Overall Study|Adverse Event|6
2336517|NCT03305809|4063815|FG000|Overall Study|Death|0
2239654|NCT01925209|3896953|FG001|Treatment Epoch|Adverse Event|5
2239655|NCT01925209|3896954|FG002|Treatment Epoch|Adverse Event|3
2239656|NCT01925209|3896955|FG003|Treatment Epoch|Adverse Event|1
2239657|NCT01925209|3896952|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0
2239658|NCT01925209|3896953|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1
2239659|NCT01925209|3896954|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1
2239660|NCT01925209|3896955|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2
2239661|NCT01925209|3896952|FG000|Maintenance Treatment Epoch|Adverse Event|0
2239662|NCT01925209|3896953|FG001|Maintenance Treatment Epoch|Adverse Event|0
2239663|NCT01925209|3896954|FG002|Maintenance Treatment Epoch|Adverse Event|1
2239664|NCT01925209|3896955|FG003|Maintenance Treatment Epoch|Adverse Event|0
2239665|NCT01925209|3896952|FG000|Follow-up|Adverse Event|1
2239666|NCT01925209|3896953|FG001|Follow-up|Adverse Event|4
2239667|NCT01925209|3896954|FG002|Follow-up|Adverse Event|0
2239668|NCT01925209|3896955|FG003|Follow-up|Adverse Event|1
2239669|NCT01925209|3896952|FG000|Follow-up|Physician Decision|0
2239670|NCT01925209|3896953|FG001|Follow-up|Physician Decision|0
2239671|NCT01925209|3896954|FG002|Follow-up|Physician Decision|1
2239672|NCT01925209|3896955|FG003|Follow-up|Physician Decision|0
2239673|NCT01925209|3896952|FG000|Follow-up|Non-compliance with study treatment|0
2239674|NCT01925209|3896953|FG001|Follow-up|Non-compliance with study treatment|0
2239675|NCT01925209|3896954|FG002|Follow-up|Non-compliance with study treatment|0
2239676|NCT01925209|3896955|FG003|Follow-up|Non-compliance with study treatment|1
2239677|NCT01925209|3896952|FG000|Follow-up|Withdrawal by Subject|0
2239678|NCT01925209|3896953|FG001|Follow-up|Withdrawal by Subject|2
2239679|NCT01925209|3896954|FG002|Follow-up|Withdrawal by Subject|0
2239680|NCT01925209|3896955|FG003|Follow-up|Withdrawal by Subject|2
2239681|NCT01925274|3896968|FG000|Overall Study|Death|1
2239682|NCT01925274|3896969|FG001|Overall Study|Death|0
2239683|NCT01925274|3896970|FG002|Overall Study|Death|0
2239684|NCT01925274|3896968|FG000|Overall Study|Lost to Follow-up|0
2239685|NCT01925274|3896969|FG001|Overall Study|Lost to Follow-up|1
2239686|NCT01925274|3896970|FG002|Overall Study|Lost to Follow-up|0
2239687|NCT01925274|3896968|FG000|Overall Study|Withdrawal by Subject|1
2239688|NCT01925274|3896969|FG001|Overall Study|Withdrawal by Subject|2
2336518|NCT03305809|4063816|FG001|Overall Study|Death|0
2336519|NCT03305809|4063817|FG002|Overall Study|Death|1
2336520|NCT03305809|4063818|FG003|Overall Study|Death|1
2336521|NCT03305809|4063815|FG000|Overall Study|Lost to Follow-up|1
2336522|NCT03305809|4063816|FG001|Overall Study|Lost to Follow-up|2
2336523|NCT03305809|4063817|FG002|Overall Study|Lost to Follow-up|0
2336524|NCT03305809|4063818|FG003|Overall Study|Lost to Follow-up|0
2336525|NCT03305809|4063815|FG000|Overall Study|Sponsor Decision|1
2336526|NCT03305809|4063816|FG001|Overall Study|Sponsor Decision|0
2336527|NCT03305809|4063817|FG002|Overall Study|Sponsor Decision|1
2336528|NCT03305809|4063818|FG003|Overall Study|Sponsor Decision|8
2336529|NCT03305809|4063815|FG000|Overall Study|Physician Decision|0
2336530|NCT03305809|4063816|FG001|Overall Study|Physician Decision|0
2336531|NCT03305809|4063817|FG002|Overall Study|Physician Decision|2
2336532|NCT03305809|4063818|FG003|Overall Study|Physician Decision|4
2336533|NCT03305809|4063815|FG000|Overall Study|Progressive Disease|0
2336534|NCT03305809|4063816|FG001|Overall Study|Progressive Disease|0
2336535|NCT03305809|4063817|FG002|Overall Study|Progressive Disease|1
2336536|NCT03305809|4063818|FG003|Overall Study|Progressive Disease|0
2336537|NCT03305809|4063815|FG000|Overall Study|Protocol Violation|1
2336538|NCT03305809|4063816|FG001|Overall Study|Protocol Violation|0
2336539|NCT03305809|4063817|FG002|Overall Study|Protocol Violation|2
2336540|NCT03305809|4063818|FG003|Overall Study|Protocol Violation|3
2336541|NCT03305809|4063815|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0
2336542|NCT03305809|4063816|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0
2336543|NCT03305809|4063817|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0
2037153|NCT00415532|3607403|FG000|Safety Follow Up Period|Ineligibility determined|1
2037154|NCT00415532|3607404|FG001|Safety Follow Up Period|Ineligibility determined|1
2037155|NCT00415532|3607403|FG000|Safety Follow Up Period|Noncompliance|1
2037156|NCT00415532|3607404|FG001|Safety Follow Up Period|Noncompliance|0
2037157|NCT00415532|3607403|FG000|Safety Follow Up Period|Requirement for alternative therapy|0
2037158|NCT00415532|3607404|FG001|Safety Follow Up Period|Requirement for alternative therapy|1
2037159|NCT00415597|3607410|FG000|Enrollment|Withdrawal by Subject|1
2037160|NCT00415597|3607410|FG000|Enrollment|Protocol Violation|1
2037161|NCT00415597|3607410|FG000|Treatment|Adverse Event|110
2037162|NCT00415597|3607410|FG000|Treatment|Lack of Efficacy|39
2037163|NCT00415597|3607410|FG000|Treatment|Protocol Violation|67
2037164|NCT00415597|3607410|FG000|Treatment|Physician Decision|3
2037165|NCT00415597|3607410|FG000|Treatment|Withdrawal by Subject|51
2037166|NCT00415597|3607410|FG000|Treatment|Lost to Follow-up|28
2037167|NCT00415597|3607410|FG000|Treatment|Drug Screen|2
2037168|NCT00415597|3607410|FG000|Treatment|Administrative|3
2037169|NCT00415597|3607410|FG000|Treatment|Sponsor Decision|1
2037170|NCT00415597|3607410|FG000|Treatment|Multiple Reasons|1
2037171|NCT00415610|3607417|FG000|Overall Study|Death|3
2037172|NCT00415610|3607418|FG001|Overall Study|Death|2
2037173|NCT00415610|3607419|FG002|Overall Study|Death|5
2037174|NCT00415636|3607433|FG000|Overall Study|Symptomatic deterioration|1
2037175|NCT00415636|3607434|FG001|Overall Study|Symptomatic deterioration|0
2239689|NCT01925274|3896970|FG002|Overall Study|Withdrawal by Subject|0
2239690|NCT01925274|3896968|FG000|Overall Study|Study terminated by sponsor|4
2239691|NCT01925274|3896969|FG001|Overall Study|Study terminated by sponsor|0
2239692|NCT01925274|3896970|FG002|Overall Study|Study terminated by sponsor|0
2239693|NCT01925274|3896968|FG000|Overall Study|Protocol amendment|1
2239694|NCT01925274|3896969|FG001|Overall Study|Protocol amendment|3
2239695|NCT01925274|3896970|FG002|Overall Study|Protocol amendment|6
2239696|NCT01925339|3896982|FG000|Overall Study|Adverse Event|2
2239697|NCT01925339|3896983|FG001|Overall Study|Adverse Event|0
2239698|NCT01925417|3897006|FG000|Overall Study|Withdrawal by Subject|2
2239699|NCT01925417|3897006|FG000|Overall Study|Death|1
2239700|NCT01925612|3897025|FG000|Overall Study|Progressive Disease|1
2239701|NCT01925612|3897026|FG001|Overall Study|Progressive Disease|1
2239702|NCT01925612|3897027|FG002|Overall Study|Progressive Disease|1
2239703|NCT01925612|3897028|FG003|Overall Study|Progressive Disease|0
2239704|NCT01925612|3897029|FG004|Overall Study|Progressive Disease|0
2239705|NCT01925612|3897025|FG000|Overall Study|Adverse Event|3
2239706|NCT01925612|3897026|FG001|Overall Study|Adverse Event|3
2239707|NCT01925612|3897027|FG002|Overall Study|Adverse Event|0
2239708|NCT01925612|3897028|FG003|Overall Study|Adverse Event|1
2239709|NCT01925612|3897029|FG004|Overall Study|Adverse Event|2
2239710|NCT01925703|3897045|FG000|Overall Study|Physician Decision|1
2239711|NCT01925703|3897045|FG000|Overall Study|Lost to Follow-up|2
2239712|NCT01925703|3897045|FG000|Overall Study|Discharge prior to full iron repletion|1
2239713|NCT01925768|3897051|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2239714|NCT01925768|3897052|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2239715|NCT01925768|3897051|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2239716|NCT01925768|3897052|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
2239717|NCT01925768|3897051|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
2239718|NCT01925768|3897052|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
2239719|NCT01925768|3897051|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
2239720|NCT01925768|3897052|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
2239721|NCT01925768|3897051|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
2239722|NCT01925768|3897052|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
2239723|NCT01925768|3897051|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
2239724|NCT01925768|3897052|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
2239725|NCT01925768|3897051|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
2239726|NCT01925768|3897052|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
2239727|NCT01925768|3897051|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
2239728|NCT01925768|3897052|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
2239729|NCT01925768|3897051|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
2239730|NCT01925768|3897052|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
2239731|NCT01925768|3897051|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0
2239732|NCT01925768|3897052|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1
2239733|NCT01925768|3897051|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
2239734|NCT01925768|3897052|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
2239735|NCT01925950|3897073|FG000|Part 2|Withdrawal by Subject|1
2239736|NCT01925950|3897074|FG001|Part 2|Withdrawal by Subject|0
2239737|NCT01925989|3897082|FG000|Period 1|Sponsor Decision|1
2239738|NCT01925989|3897083|FG001|Period 1|Sponsor Decision|1
2239739|NCT01925989|3897084|FG002|Period 1|Sponsor Decision|0
2239740|NCT01925989|3897082|FG000|Period 1|Withdrawal by Subject|0
2239741|NCT01925989|3897083|FG001|Period 1|Withdrawal by Subject|1
2239742|NCT01925989|3897084|FG002|Period 1|Withdrawal by Subject|0
2239743|NCT01926015|3897098|FG000|Overall Study|Withdrawal by parent/guardian|0
2239744|NCT01926015|3897099|FG001|Overall Study|Withdrawal by parent/guardian|1
2239745|NCT01926015|3897098|FG000|Overall Study|Randomized not treated|2
2239746|NCT01926015|3897099|FG001|Overall Study|Randomized not treated|0
2239747|NCT01926028|3897108|FG000|Overall Study|Lost to Follow-up|7
2239748|NCT01926028|3897109|FG001|Overall Study|Lost to Follow-up|6
2239749|NCT01926028|3897110|FG002|Overall Study|Lost to Follow-up|0
2239750|NCT01926028|3897108|FG000|Overall Study|Physician Decision|1
2239751|NCT01926028|3897109|FG001|Overall Study|Physician Decision|5
2239752|NCT01926028|3897110|FG002|Overall Study|Physician Decision|0
2239753|NCT01926028|3897108|FG000|Overall Study|Withdrawal by Subject|9
2239754|NCT01926028|3897109|FG001|Overall Study|Withdrawal by Subject|9
2239755|NCT01926028|3897110|FG002|Overall Study|Withdrawal by Subject|2
2239756|NCT01926028|3897108|FG000|Overall Study|Non compliance or other reasons|4
2239757|NCT01926028|3897109|FG001|Overall Study|Non compliance or other reasons|2
2239758|NCT01926028|3897110|FG002|Overall Study|Non compliance or other reasons|0
2239759|NCT01926119|3897119|FG000|Overall Study|Withdrawal by Subject|1
2239760|NCT01926444|3897127|FG000|Overall Study|Colonoscopy not performed|0
2239761|NCT01926444|3897128|FG001|Overall Study|Colonoscopy not performed|0
2239762|NCT01926444|3897129|FG002|Overall Study|Colonoscopy not performed|4
2239763|NCT01926444|3897130|FG003|Overall Study|Colonoscopy not performed|2
2239764|NCT01926509|3897157|FG000|Overall Study|vital sign met discontinuation criteria|1
2239765|NCT01926509|3897158|FG001|Overall Study|vital sign met discontinuation criteria|0
2239766|NCT01926509|3897159|FG002|Overall Study|vital sign met discontinuation criteria|0
2336544|NCT03305809|4063818|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2
2239767|NCT01926509|3897160|FG003|Overall Study|vital sign met discontinuation criteria|0
2239768|NCT01926626|3897170|FG000|Overall Study|Withdrawal by Subject|15
2239769|NCT01926626|3897170|FG000|Overall Study|Lost to Follow-up|7
2239770|NCT01926782|3897180|FG000|Overall Study|Participant moved|2
2239771|NCT01926782|3897181|FG001|Overall Study|Participant moved|0
2239772|NCT01926782|3897182|FG002|Overall Study|Participant moved|1
2239773|NCT01926782|3897183|FG003|Overall Study|Participant moved|1
2239774|NCT01926782|3897184|FG004|Overall Study|Participant moved|0
2239775|NCT01926782|3897185|FG005|Overall Study|Participant moved|3
2239776|NCT01926782|3897180|FG000|Overall Study|Physician Decision|0
2239777|NCT01926782|3897181|FG001|Overall Study|Physician Decision|2
2239778|NCT01926782|3897182|FG002|Overall Study|Physician Decision|1
2239779|NCT01926782|3897183|FG003|Overall Study|Physician Decision|1
2239780|NCT01926782|3897184|FG004|Overall Study|Physician Decision|0
2239781|NCT01926782|3897185|FG005|Overall Study|Physician Decision|0
2239782|NCT01926782|3897180|FG000|Overall Study|Other than specified|2
2239783|NCT01926782|3897181|FG001|Overall Study|Other than specified|3
2239784|NCT01926782|3897182|FG002|Overall Study|Other than specified|5
2239785|NCT01926782|3897183|FG003|Overall Study|Other than specified|12
2239786|NCT01926782|3897184|FG004|Overall Study|Other than specified|4
2239787|NCT01926782|3897185|FG005|Overall Study|Other than specified|11
2239788|NCT01926782|3897180|FG000|Overall Study|Adverse Event|13
2239789|NCT01926782|3897181|FG001|Overall Study|Adverse Event|4
2239790|NCT01926782|3897182|FG002|Overall Study|Adverse Event|17
2239791|NCT01926782|3897183|FG003|Overall Study|Adverse Event|4
2239792|NCT01926782|3897184|FG004|Overall Study|Adverse Event|3
2239793|NCT01926782|3897185|FG005|Overall Study|Adverse Event|14
2239794|NCT01926782|3897180|FG000|Overall Study|Poor compliance to protocol|5
2239795|NCT01926782|3897181|FG001|Overall Study|Poor compliance to protocol|3
2239796|NCT01926782|3897182|FG002|Overall Study|Poor compliance to protocol|8
2239797|NCT01926782|3897183|FG003|Overall Study|Poor compliance to protocol|0
2239798|NCT01926782|3897184|FG004|Overall Study|Poor compliance to protocol|1
2239799|NCT01926782|3897185|FG005|Overall Study|Poor compliance to protocol|6
2239800|NCT01926782|3897180|FG000|Overall Study|Randomized and not treated|0
2239801|NCT01926782|3897181|FG001|Overall Study|Randomized and not treated|0
2239802|NCT01926782|3897182|FG002|Overall Study|Randomized and not treated|0
2239803|NCT01926782|3897183|FG003|Overall Study|Randomized and not treated|1
2239804|NCT01926782|3897184|FG004|Overall Study|Randomized and not treated|0
2239805|NCT01926782|3897185|FG005|Overall Study|Randomized and not treated|0
2239806|NCT01926782|3897180|FG000|Overall Study|Withdrawal by Subject|6
2239807|NCT01926782|3897181|FG001|Overall Study|Withdrawal by Subject|1
2239808|NCT01926782|3897182|FG002|Overall Study|Withdrawal by Subject|8
2239809|NCT01926782|3897183|FG003|Overall Study|Withdrawal by Subject|1
2239810|NCT01926782|3897184|FG004|Overall Study|Withdrawal by Subject|0
2239811|NCT01926782|3897185|FG005|Overall Study|Withdrawal by Subject|5
2239812|NCT01926782|3897180|FG000|Overall Study|Related to study drug administration|0
2239813|NCT01926782|3897181|FG001|Overall Study|Related to study drug administration|0
2239814|NCT01926782|3897182|FG002|Overall Study|Related to study drug administration|0
2239815|NCT01926782|3897183|FG003|Overall Study|Related to study drug administration|0
2239816|NCT01926782|3897184|FG004|Overall Study|Related to study drug administration|0
2239817|NCT01926782|3897185|FG005|Overall Study|Related to study drug administration|2
2239818|NCT01926886|3897200|FG000|Overall Study|Administrative/other|1
2239819|NCT01926886|3897201|FG001|Overall Study|Administrative/other|0
2239820|NCT01926886|3897200|FG000|Overall Study|Adverse event/intercurrent illness|4
2239821|NCT01926886|3897201|FG001|Overall Study|Adverse event/intercurrent illness|0
2239822|NCT01926886|3897200|FG000|Overall Study|Disease progression/recurrence|4
2239823|NCT01926886|3897201|FG001|Overall Study|Disease progression/recurrence|0
2239824|NCT01926886|3897200|FG000|Overall Study|Withdrawal by Subject|15
2239825|NCT01926886|3897201|FG001|Overall Study|Withdrawal by Subject|0
2239826|NCT01926886|3897200|FG000|Overall Study|Failure to return|3
2239827|NCT01926886|3897201|FG001|Overall Study|Failure to return|0
2239828|NCT01926886|3897200|FG000|Overall Study|Recurrence of disease|1
2239829|NCT01926886|3897201|FG001|Overall Study|Recurrence of disease|0
2239830|NCT01926886|3897200|FG000|Overall Study|Progression of disease|2
2239831|NCT01926886|3897201|FG001|Overall Study|Progression of disease|0
2239832|NCT01926886|3897200|FG000|Overall Study|Death|1
2239833|NCT01926886|3897201|FG001|Overall Study|Death|0
2239834|NCT01926886|3897200|FG000|Overall Study|Did not cooperate|1
2239835|NCT01926886|3897201|FG001|Overall Study|Did not cooperate|0
2239836|NCT01927055|3897219|FG000|Open-label|Adverse Event|6
2239837|NCT01927055|3897220|FG001|Open-label|Adverse Event|0
2239838|NCT01927055|3897221|FG002|Open-label|Adverse Event|0
2239839|NCT01927055|3897219|FG000|Open-label|Withdrawal by Subject|1
2239840|NCT01927055|3897220|FG001|Open-label|Withdrawal by Subject|0
2239841|NCT01927055|3897221|FG002|Open-label|Withdrawal by Subject|0
2239842|NCT01927055|3897219|FG000|Open-label|Study Stopped|4
2239843|NCT01927055|3897220|FG001|Open-label|Study Stopped|0
2239844|NCT01927055|3897221|FG002|Open-label|Study Stopped|0
2239845|NCT01927055|3897219|FG000|Open-label|Supine Hypertension|4
2239846|NCT01927055|3897220|FG001|Open-label|Supine Hypertension|0
2239847|NCT01927055|3897221|FG002|Open-label|Supine Hypertension|0
2239848|NCT01927055|3897219|FG000|Open-label|Difficulty attending study visits|1
2336545|NCT03305809|4063815|FG000|Overall Study|Withdrawal by Subject|2
2239849|NCT01927055|3897220|FG001|Open-label|Difficulty attending study visits|0
2239850|NCT01927055|3897221|FG002|Open-label|Difficulty attending study visits|0
2239851|NCT01927055|3897219|FG000|Double-Blind|Adverse Event|0
2239852|NCT01927055|3897220|FG001|Double-Blind|Adverse Event|1
2239853|NCT01927055|3897221|FG002|Double-Blind|Adverse Event|1
2239854|NCT01927055|3897219|FG000|Double-Blind|Protocol Violation|0
2239855|NCT01927055|3897220|FG001|Double-Blind|Protocol Violation|0
2239856|NCT01927055|3897221|FG002|Double-Blind|Protocol Violation|1
2239857|NCT01927055|3897219|FG000|Double-Blind|Withdrawal by Subject|0
2239858|NCT01927055|3897220|FG001|Double-Blind|Withdrawal by Subject|2
2239859|NCT01927055|3897221|FG002|Double-Blind|Withdrawal by Subject|3
2239860|NCT01927055|3897219|FG000|Double-Blind|Study Stopped|0
2239861|NCT01927055|3897220|FG001|Double-Blind|Study Stopped|7
2239862|NCT01927055|3897221|FG002|Double-Blind|Study Stopped|7
2239863|NCT01927055|3897219|FG000|Double-Blind|Supine Hypertension|0
2239864|NCT01927055|3897220|FG001|Double-Blind|Supine Hypertension|0
2239865|NCT01927055|3897221|FG002|Double-Blind|Supine Hypertension|1
2239866|NCT01927055|3897219|FG000|Double-Blind|Extended Vacation|0
2239867|NCT01927055|3897220|FG001|Double-Blind|Extended Vacation|1
2239868|NCT01927055|3897221|FG002|Double-Blind|Extended Vacation|0
2239869|NCT01927341|3897237|FG000|Phase 1b|Lost to Follow-up|1
2239870|NCT01927341|3897238|FG001|Phase 1b|Lost to Follow-up|0
2239871|NCT01927341|3897239|FG002|Phase 1b|Lost to Follow-up|0
2239872|NCT01927341|3897240|FG003|Phase 1b|Lost to Follow-up|0
2239873|NCT01927341|3897241|FG004|Phase 1b|Lost to Follow-up|0
2239874|NCT01927341|3897237|FG000|Phase 1b|Death|2
2239875|NCT01927341|3897238|FG001|Phase 1b|Death|0
2239876|NCT01927341|3897239|FG002|Phase 1b|Death|0
2336546|NCT03305809|4063816|FG001|Overall Study|Withdrawal by Subject|4
2336547|NCT03305809|4063817|FG002|Overall Study|Withdrawal by Subject|5
2336548|NCT03305809|4063818|FG003|Overall Study|Withdrawal by Subject|2
2336549|NCT03305809|4063815|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0
2336550|NCT03305809|4063816|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0
2336551|NCT03305809|4063817|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1
2336552|NCT03305809|4063818|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1
2336553|NCT03306043|4063847|FG000|Overall Study|Adverse Event|1
2336554|NCT03306043|4063847|FG000|Overall Study|Lost to Follow-up|1
2336555|NCT03306043|4063847|FG000|Overall Study|Withdrawal by Subject|2
2336556|NCT03306277|4063855|FG000|Overall Study|Death|1
2336557|NCT03306277|4063855|FG000|Overall Study|Adverse Event|1
2336558|NCT03306277|4063855|FG000|Overall Study|Withdrawal by Subject|1
2336559|NCT03306433|4063880|FG000|Overall Study|Lost to Follow-up|3
2336560|NCT03306433|4063880|FG000|Overall Study|Patient did not have teeth extracted|1
2336561|NCT03306433|4063880|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3
2352962|NCT03718143|4103382|FG002|Overall Study|Death|0
2352963|NCT03718143|4103380|FG000|Overall Study|Progression of Disease|1
2352964|NCT03718143|4103381|FG001|Overall Study|Progression of Disease|0
2352965|NCT03718143|4103382|FG002|Overall Study|Progression of Disease|0
2352966|NCT03718143|4103380|FG000|Overall Study|Withdrawal of Informed Consent|1
2352967|NCT03718143|4103381|FG001|Overall Study|Withdrawal of Informed Consent|2
2352968|NCT03718143|4103382|FG002|Overall Study|Withdrawal of Informed Consent|1
2352969|NCT03709576|4103390|FG000|Overall Study|progression prior to enrollment|1
2352970|NCT03704636|4103395|FG000|Overall Study|Inadequate Venous Flow|3
2352971|NCT03694821|4103419|FG000|Overall Study|Study terminated|4
2352972|NCT03694821|4103420|FG001|Overall Study|Study terminated|8
2352973|NCT03694821|4103421|FG002|Overall Study|Study terminated|4
2352974|NCT03686969|4103431|FG000|Overall Study|Study terminated|1
2352975|NCT03686969|4103432|FG001|Overall Study|Study terminated|0
2352976|NCT03682367|4103440|FG000|Overall Study|Protocol Violation|2
2352977|NCT03682367|4103441|FG001|Overall Study|Protocol Violation|1
2352978|NCT03682367|4103440|FG000|Overall Study|Closed Study Early|0
2352979|NCT03682367|4103441|FG001|Overall Study|Closed Study Early|3
2352980|NCT03680911|4103449|FG000|At Home Treatment|Study Termination|3
2352981|NCT03680911|4103450|FG001|At Home Treatment|Study Termination|0
2352982|NCT03680911|4103449|FG000|At Home Treatment|Lost to Follow-up|0
2352983|NCT03680911|4103450|FG001|At Home Treatment|Lost to Follow-up|1
2352984|NCT03680911|4103449|FG000|At Home Treatment|Withdrawal by Subject|0
2352985|NCT03680911|4103450|FG001|At Home Treatment|Withdrawal by Subject|2
2352986|NCT03680911|4103449|FG000|Visit 3 (4 Month Follow up)|Study Termination|0
2352987|NCT03680911|4103450|FG001|Visit 3 (4 Month Follow up)|Study Termination|1
2352988|NCT03656692|4103456|FG000|Overall Study|Worsening of disease activity|2
2352989|NCT03656692|4103456|FG000|Overall Study|Physician Decision|1
2352990|NCT03648983|4103460|FG000|Overall Study|Study was terminated due to PI departure|95
2352991|NCT03643159|4103467|FG000|Overall Study|Adverse Event|1
2352992|NCT03643159|4103467|FG000|Overall Study|Withdrawal by Subject|1
2352993|NCT03630120|4103485|FG000|Overall Study|Disease progression|0
2352994|NCT03630120|4103486|FG001|Overall Study|Disease progression|1
2352995|NCT03630120|4103487|FG002|Overall Study|Disease progression|1
2352996|NCT03630120|4103488|FG003|Overall Study|Disease progression|1
2352997|NCT03615144|4103519|FG000|Overall Study|Participant no longer eligible for this protocol|1
2352998|NCT03615144|4103520|FG001|Overall Study|Participant no longer eligible for this protocol|0
2352999|NCT03605303|4103526|FG000|Period 1|Study Terminated|2
2353000|NCT03605303|4103527|FG001|Period 1|Study Terminated|1
2239877|NCT01927341|3897240|FG003|Phase 1b|Death|0
2239878|NCT01927341|3897241|FG004|Phase 1b|Death|0
2239879|NCT01927341|3897237|FG000|Phase 1b|Follow-up completed|7
2239880|NCT01927341|3897238|FG001|Phase 1b|Follow-up completed|0
2239881|NCT01927341|3897239|FG002|Phase 1b|Follow-up completed|0
2239882|NCT01927341|3897240|FG003|Phase 1b|Follow-up completed|0
2239883|NCT01927341|3897241|FG004|Phase 1b|Follow-up completed|0
2239884|NCT01927341|3897237|FG000|Phase 2|Lost to Follow-up|0
2239885|NCT01927341|3897238|FG001|Phase 2|Lost to Follow-up|1
2239886|NCT01927341|3897239|FG002|Phase 2|Lost to Follow-up|0
2239887|NCT01927341|3897240|FG003|Phase 2|Lost to Follow-up|0
2239888|NCT01927341|3897241|FG004|Phase 2|Lost to Follow-up|0
2239889|NCT01927341|3897237|FG000|Phase 2|Participant withdrew consent|0
2239890|NCT01927341|3897238|FG001|Phase 2|Participant withdrew consent|2
2239891|NCT01927341|3897239|FG002|Phase 2|Participant withdrew consent|1
2239892|NCT01927341|3897240|FG003|Phase 2|Participant withdrew consent|2
2239893|NCT01927341|3897241|FG004|Phase 2|Participant withdrew consent|3
2239894|NCT01927341|3897237|FG000|Phase 2|Death|0
2239895|NCT01927341|3897238|FG001|Phase 2|Death|4
2239896|NCT01927341|3897239|FG002|Phase 2|Death|0
2239897|NCT01927341|3897240|FG003|Phase 2|Death|3
2239898|NCT01927341|3897241|FG004|Phase 2|Death|2
2239899|NCT01927341|3897237|FG000|Phase 2|New cancer therapy|0
2239900|NCT01927341|3897238|FG001|Phase 2|New cancer therapy|1
2239901|NCT01927341|3897239|FG002|Phase 2|New cancer therapy|0
2239902|NCT01927341|3897240|FG003|Phase 2|New cancer therapy|4
2239903|NCT01927341|3897241|FG004|Phase 2|New cancer therapy|1
2239904|NCT01927341|3897237|FG000|Phase 2|Disease progression|0
2239905|NCT01927341|3897238|FG001|Phase 2|Disease progression|1
2239906|NCT01927341|3897239|FG002|Phase 2|Disease progression|1
2239907|NCT01927341|3897240|FG003|Phase 2|Disease progression|1
2239908|NCT01927341|3897241|FG004|Phase 2|Disease progression|0
2239909|NCT01927341|3897237|FG000|Phase 2|Follow-up completed|0
2239910|NCT01927341|3897238|FG001|Phase 2|Follow-up completed|6
2239911|NCT01927341|3897239|FG002|Phase 2|Follow-up completed|3
2239912|NCT01927341|3897240|FG003|Phase 2|Follow-up completed|5
2239913|NCT01927341|3897241|FG004|Phase 2|Follow-up completed|2
2239914|NCT01927367|3897259|FG000|Overall Study|Withdrawal by Subject|7
2239915|NCT01927367|3897260|FG001|Overall Study|Withdrawal by Subject|4
2239916|NCT01927367|3897259|FG000|Overall Study|No baseline data|0
2239917|NCT01927367|3897260|FG001|Overall Study|No baseline data|1
2239918|NCT01927497|3897268|FG000|Overall Study|Death|0
2239919|NCT01927497|3897269|FG001|Overall Study|Death|1
2336562|NCT03307174|4063935|FG000|Overall Study|Unplanned ICU Administrion|5
2336563|NCT03307174|4063936|FG001|Overall Study|Unplanned ICU Administrion|3
2336564|NCT03307174|4063935|FG000|Overall Study|Aborted Surgery|1
2336565|NCT03307174|4063936|FG001|Overall Study|Aborted Surgery|2
2336566|NCT03307174|4063935|FG000|Overall Study|Hypotension|6
2336567|NCT03307174|4063936|FG001|Overall Study|Hypotension|0
2336568|NCT03307174|4063935|FG000|Overall Study|Nonfunctional epidural|1
2336569|NCT03307174|4063936|FG001|Overall Study|Nonfunctional epidural|1
2336570|NCT03307174|4063935|FG000|Overall Study|Planned epidural removal|1
2336571|NCT03307174|4063936|FG001|Overall Study|Planned epidural removal|0
2336572|NCT03307174|4063935|FG000|Overall Study|Intrathecal catheter placement|0
2336573|NCT03307174|4063936|FG001|Overall Study|Intrathecal catheter placement|1
2336574|NCT03307252|4063953|FG000|Part 2, Period 1|Treatment not received|0
2336575|NCT03307252|4063954|FG001|Part 2, Period 1|Treatment not received|0
2336576|NCT03307252|4063955|FG002|Part 2, Period 1|Treatment not received|0
2336577|NCT03307252|4063956|FG003|Part 2, Period 1|Treatment not received|0
2336578|NCT03307252|4063957|FG004|Part 2, Period 1|Treatment not received|0
2336579|NCT03307252|4063958|FG005|Part 2, Period 1|Treatment not received|1
2336580|NCT03307252|4063959|FG006|Part 2, Period 1|Treatment not received|0
2336581|NCT03307252|4063960|FG007|Part 2, Period 1|Treatment not received|0
2336582|NCT03307252|4063961|FG008|Part 2, Period 1|Treatment not received|0
2336583|NCT03307252|4063962|FG009|Part 2, Period 1|Treatment not received|0
2336584|NCT03307252|4063963|FG010|Part 2, Period 1|Treatment not received|0
2336585|NCT03307252|4063953|FG000|Part 2, Period 3|Other than listed|0
2336586|NCT03307252|4063954|FG001|Part 2, Period 3|Other than listed|0
2336587|NCT03307252|4063955|FG002|Part 2, Period 3|Other than listed|0
2336588|NCT03307252|4063956|FG003|Part 2, Period 3|Other than listed|0
2336589|NCT03307252|4063957|FG004|Part 2, Period 3|Other than listed|1
2336590|NCT03307252|4063958|FG005|Part 2, Period 3|Other than listed|0
2336591|NCT03307252|4063959|FG006|Part 2, Period 3|Other than listed|0
2336592|NCT03307252|4063960|FG007|Part 2, Period 3|Other than listed|0
2336593|NCT03307252|4063961|FG008|Part 2, Period 3|Other than listed|0
2336594|NCT03307252|4063962|FG009|Part 2, Period 3|Other than listed|0
2239920|NCT01927497|3897268|FG000|Overall Study|Protocol Violation|2
2239921|NCT01927497|3897269|FG001|Overall Study|Protocol Violation|0
2336595|NCT03307252|4063963|FG010|Part 2, Period 3|Other than listed|0
2336596|NCT03307252|4063953|FG000|Part 2, Period 4|Other than listed|0
2336597|NCT03307252|4063954|FG001|Part 2, Period 4|Other than listed|0
2336598|NCT03307252|4063955|FG002|Part 2, Period 4|Other than listed|0
2336599|NCT03307252|4063956|FG003|Part 2, Period 4|Other than listed|0
2336600|NCT03307252|4063957|FG004|Part 2, Period 4|Other than listed|0
2336601|NCT03307252|4063958|FG005|Part 2, Period 4|Other than listed|0
2336602|NCT03307252|4063959|FG006|Part 2, Period 4|Other than listed|1
2239922|NCT01927562|3897275|FG000|Overall Study|Lost to Follow-up|30
2239923|NCT01927562|3897275|FG000|Overall Study|Withdrawal by Subject|3
2239924|NCT01927562|3897275|FG000|Overall Study|Physician Decision|5
2239925|NCT01927627|3897287|FG000|Overall Study|Adverse Event|3
2239926|NCT01927627|3897287|FG000|Overall Study|Lack of Efficacy|1
2239927|NCT01927627|3897287|FG000|Overall Study|Financial Concerns|1
2239928|NCT01927757|3897295|FG000|Overall Study|Withdrawal by Subject|14
2239929|NCT01927757|3897295|FG000|Overall Study|Lost to Follow-up|2
2239930|NCT01927757|3897295|FG000|Overall Study|Decision by Sponsor|2
2239931|NCT01927757|3897295|FG000|Overall Study|Other|1
2239932|NCT01927757|3897295|FG000|Overall Study|Ethical Reasons|4
2239933|NCT01927861|3897305|FG000|Extension Phase (104 Weeks)|Adverse Event|0
2239934|NCT01927861|3897306|FG001|Extension Phase (104 Weeks)|Adverse Event|2
2239935|NCT01927861|3897305|FG000|Extension Phase (104 Weeks)|Unclassified|0
2239936|NCT01927861|3897306|FG001|Extension Phase (104 Weeks)|Unclassified|1
2239937|NCT01928225|3897341|FG000|Overall Study|Pregnancy|1
2239938|NCT01928225|3897342|FG001|Overall Study|Pregnancy|0
2239939|NCT01928225|3897341|FG000|Overall Study|basaloid cervical cancer|1
2239940|NCT01928225|3897342|FG001|Overall Study|basaloid cervical cancer|0
2239941|NCT01928225|3897341|FG000|Overall Study|Lost to Follow-up|1
2239942|NCT01928225|3897342|FG001|Overall Study|Lost to Follow-up|3
2239943|NCT01928329|3897360|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1
2239944|NCT01928329|3897361|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3
2239945|NCT01928329|3897360|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0
2239946|NCT01928329|3897361|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1
2239947|NCT01928329|3897360|FG000|Overall Study|Adverse Event|5
2239948|NCT01928329|3897361|FG001|Overall Study|Adverse Event|3
2239949|NCT01928329|3897360|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4
2239950|NCT01928329|3897361|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1
2239951|NCT01928329|3897360|FG000|Overall Study|Withdrawal by Subject|1
2239952|NCT01928329|3897361|FG001|Overall Study|Withdrawal by Subject|5
2239953|NCT01928329|3897360|FG000|Overall Study|Physician Decision|1
2239954|NCT01928329|3897361|FG001|Overall Study|Physician Decision|1
2239955|NCT01928381|3897367|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
2239956|NCT01928381|3897368|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2239957|NCT01928381|3897369|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2239958|NCT01928381|3897370|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2239959|NCT01928381|3897371|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2239960|NCT01928381|3897372|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2239961|NCT01928381|3897373|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2239962|NCT01928381|3897367|FG000|Part 1 - Pain Training|Pain training criteria not met|29
2239963|NCT01928381|3897368|FG001|Part 1 - Pain Training|Pain training criteria not met|0
2239964|NCT01928381|3897369|FG002|Part 1 - Pain Training|Pain training criteria not met|0
2239965|NCT01928381|3897370|FG003|Part 1 - Pain Training|Pain training criteria not met|0
2239966|NCT01928381|3897371|FG004|Part 1 - Pain Training|Pain training criteria not met|0
2239967|NCT01928381|3897372|FG005|Part 1 - Pain Training|Pain training criteria not met|0
2239968|NCT01928381|3897373|FG006|Part 1 - Pain Training|Pain training criteria not met|0
2239969|NCT01928381|3897367|FG000|Part 1 - Pain Training|Withdrawal by Subject|1
2239970|NCT01928381|3897368|FG001|Part 1 - Pain Training|Withdrawal by Subject|0
2239971|NCT01928381|3897369|FG002|Part 1 - Pain Training|Withdrawal by Subject|0
2239972|NCT01928381|3897370|FG003|Part 1 - Pain Training|Withdrawal by Subject|0
2239973|NCT01928381|3897371|FG004|Part 1 - Pain Training|Withdrawal by Subject|0
2239974|NCT01928381|3897372|FG005|Part 1 - Pain Training|Withdrawal by Subject|0
2239975|NCT01928381|3897373|FG006|Part 1 - Pain Training|Withdrawal by Subject|0
2239976|NCT01928381|3897367|FG000|Part 1 - Pain Training|Lost to Follow-up|4
2336603|NCT03307252|4063960|FG007|Part 2, Period 4|Other than listed|0
2336604|NCT03307252|4063961|FG008|Part 2, Period 4|Other than listed|0
2336605|NCT03307252|4063962|FG009|Part 2, Period 4|Other than listed|0
2336606|NCT03307252|4063963|FG010|Part 2, Period 4|Other than listed|0
2336607|NCT03307252|4063953|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2336608|NCT03307252|4063954|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2336609|NCT03307252|4063955|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2336610|NCT03307252|4063956|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2336611|NCT03307252|4063957|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2336612|NCT03307252|4063958|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2336613|NCT03307252|4063959|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2336614|NCT03307252|4063960|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2336615|NCT03307252|4063961|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2336616|NCT03307252|4063962|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2336617|NCT03307252|4063963|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
2336618|NCT03307785|4063990|FG000|Part A: Up to 28.5 Months|Disease progression|2
2336619|NCT03307785|4063991|FG001|Part A: Up to 28.5 Months|Disease progression|0
2336620|NCT03307785|4063992|FG002|Part A: Up to 28.5 Months|Disease progression|0
2037176|NCT00415636|3607435|FG002|Overall Study|Symptomatic deterioration|1
2239977|NCT01928381|3897368|FG001|Part 1 - Pain Training|Lost to Follow-up|0
2239978|NCT01928381|3897369|FG002|Part 1 - Pain Training|Lost to Follow-up|0
2239979|NCT01928381|3897370|FG003|Part 1 - Pain Training|Lost to Follow-up|0
2239980|NCT01928381|3897371|FG004|Part 1 - Pain Training|Lost to Follow-up|0
2239981|NCT01928381|3897372|FG005|Part 1 - Pain Training|Lost to Follow-up|0
2239982|NCT01928381|3897373|FG006|Part 1 - Pain Training|Lost to Follow-up|0
2239983|NCT01928381|3897367|FG000|Part 1 - Pain Training|Protocol Violation|1
2239984|NCT01928381|3897368|FG001|Part 1 - Pain Training|Protocol Violation|0
2239985|NCT01928381|3897369|FG002|Part 1 - Pain Training|Protocol Violation|0
2239986|NCT01928381|3897370|FG003|Part 1 - Pain Training|Protocol Violation|0
2239987|NCT01928381|3897371|FG004|Part 1 - Pain Training|Protocol Violation|0
2239988|NCT01928381|3897372|FG005|Part 1 - Pain Training|Protocol Violation|0
2239989|NCT01928381|3897373|FG006|Part 1 - Pain Training|Protocol Violation|0
2239990|NCT01928381|3897367|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1
2239991|NCT01928381|3897368|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2239992|NCT01928381|3897369|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2239993|NCT01928381|3897370|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2239994|NCT01928381|3897371|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2239995|NCT01928381|3897372|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2239996|NCT01928381|3897373|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2239997|NCT01928381|3897367|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
2239998|NCT01928381|3897368|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2239999|NCT01928381|3897369|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2240000|NCT01928381|3897370|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2240001|NCT01928381|3897371|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2240002|NCT01928381|3897372|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2240003|NCT01928381|3897373|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2240004|NCT01928381|3897367|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
2240005|NCT01928381|3897368|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2240006|NCT01928381|3897369|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2240007|NCT01928381|3897370|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2240008|NCT01928381|3897371|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2240009|NCT01928381|3897372|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2240010|NCT01928381|3897373|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2240011|NCT01928381|3897367|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
2240012|NCT01928381|3897368|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2240013|NCT01928381|3897369|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2240014|NCT01928381|3897370|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2240015|NCT01928381|3897371|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2240016|NCT01928381|3897372|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2240017|NCT01928381|3897373|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2240018|NCT01928381|3897367|FG000|Part 2 - First Intervention|Withdrawal by Subject|0
2240019|NCT01928381|3897368|FG001|Part 2 - First Intervention|Withdrawal by Subject|0
2240020|NCT01928381|3897369|FG002|Part 2 - First Intervention|Withdrawal by Subject|1
2240021|NCT01928381|3897370|FG003|Part 2 - First Intervention|Withdrawal by Subject|0
2240022|NCT01928381|3897371|FG004|Part 2 - First Intervention|Withdrawal by Subject|0
2240023|NCT01928381|3897372|FG005|Part 2 - First Intervention|Withdrawal by Subject|0
2240024|NCT01928381|3897373|FG006|Part 2 - First Intervention|Withdrawal by Subject|0
2240025|NCT01928381|3897367|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0
2240026|NCT01928381|3897368|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0
2240027|NCT01928381|3897369|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1
2240028|NCT01928381|3897370|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0
2240029|NCT01928381|3897371|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0
2240030|NCT01928381|3897372|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0
2240031|NCT01928381|3897373|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0
2240032|NCT01928381|3897367|FG000|Part 2 - First Intervention|Eligibility criterion not met|0
2240033|NCT01928381|3897368|FG001|Part 2 - First Intervention|Eligibility criterion not met|0
2240034|NCT01928381|3897369|FG002|Part 2 - First Intervention|Eligibility criterion not met|0
2240035|NCT01928381|3897370|FG003|Part 2 - First Intervention|Eligibility criterion not met|0
2240036|NCT01928381|3897371|FG004|Part 2 - First Intervention|Eligibility criterion not met|0
2240037|NCT01928381|3897372|FG005|Part 2 - First Intervention|Eligibility criterion not met|1
2240038|NCT01928381|3897373|FG006|Part 2 - First Intervention|Eligibility criterion not met|1
2240039|NCT01928381|3897367|FG000|Part 2 - First Intervention|Lost to Follow-up|0
2240040|NCT01928381|3897368|FG001|Part 2 - First Intervention|Lost to Follow-up|0
2240041|NCT01928381|3897369|FG002|Part 2 - First Intervention|Lost to Follow-up|0
2240042|NCT01928381|3897370|FG003|Part 2 - First Intervention|Lost to Follow-up|1
2240043|NCT01928381|3897371|FG004|Part 2 - First Intervention|Lost to Follow-up|0
2240044|NCT01928381|3897372|FG005|Part 2 - First Intervention|Lost to Follow-up|0
2240045|NCT01928381|3897373|FG006|Part 2 - First Intervention|Lost to Follow-up|0
2240046|NCT01928381|3897367|FG000|Washout First Intervention|Protocol Violation|0
2240047|NCT01928381|3897368|FG001|Washout First Intervention|Protocol Violation|0
2240048|NCT01928381|3897369|FG002|Washout First Intervention|Protocol Violation|0
2240049|NCT01928381|3897370|FG003|Washout First Intervention|Protocol Violation|0
2240050|NCT01928381|3897371|FG004|Washout First Intervention|Protocol Violation|1
2240051|NCT01928381|3897372|FG005|Washout First Intervention|Protocol Violation|0
2240052|NCT01928381|3897373|FG006|Washout First Intervention|Protocol Violation|0
2240053|NCT01928381|3897367|FG000|Part 2 - Second Intervention|Lost to Follow-up|0
2240054|NCT01928381|3897368|FG001|Part 2 - Second Intervention|Lost to Follow-up|1
2240055|NCT01928381|3897369|FG002|Part 2 - Second Intervention|Lost to Follow-up|0
2240056|NCT01928381|3897370|FG003|Part 2 - Second Intervention|Lost to Follow-up|1
2240057|NCT01928381|3897371|FG004|Part 2 - Second Intervention|Lost to Follow-up|0
2240058|NCT01928381|3897372|FG005|Part 2 - Second Intervention|Lost to Follow-up|0
2240059|NCT01928381|3897373|FG006|Part 2 - Second Intervention|Lost to Follow-up|0
2240060|NCT01928381|3897367|FG000|Part 2 - Post Third Intervention|Protocol Violation|0
2240061|NCT01928381|3897368|FG001|Part 2 - Post Third Intervention|Protocol Violation|0
2240062|NCT01928381|3897369|FG002|Part 2 - Post Third Intervention|Protocol Violation|1
2240063|NCT01928381|3897370|FG003|Part 2 - Post Third Intervention|Protocol Violation|0
2240064|NCT01928381|3897371|FG004|Part 2 - Post Third Intervention|Protocol Violation|0
2240065|NCT01928381|3897372|FG005|Part 2 - Post Third Intervention|Protocol Violation|0
2240066|NCT01928381|3897373|FG006|Part 2 - Post Third Intervention|Protocol Violation|0
2336621|NCT03307785|4063993|FG003|Part A: Up to 28.5 Months|Disease progression|0
2336622|NCT03307785|4063994|FG004|Part A: Up to 28.5 Months|Disease progression|0
2336623|NCT03307785|4063995|FG005|Part A: Up to 28.5 Months|Disease progression|0
2336624|NCT03307785|4063996|FG006|Part A: Up to 28.5 Months|Disease progression|0
2336625|NCT03307785|4063997|FG007|Part A: Up to 28.5 Months|Disease progression|0
2336626|NCT03307785|4063998|FG008|Part A: Up to 28.5 Months|Disease progression|0
2336627|NCT03307785|4063999|FG009|Part A: Up to 28.5 Months|Disease progression|0
2336628|NCT03307785|4064000|FG010|Part A: Up to 28.5 Months|Disease progression|0
2336629|NCT03307785|4063990|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7
2336630|NCT03307785|4063991|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1
2336631|NCT03307785|4063992|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0
2037177|NCT00415636|3607436|FG003|Overall Study|Symptomatic deterioration|2
2037178|NCT00415636|3607437|FG004|Overall Study|Symptomatic deterioration|0
2037179|NCT00415636|3607438|FG005|Overall Study|Symptomatic deterioration|1
2037180|NCT00415636|3607433|FG000|Overall Study|Adverse Event|0
2037181|NCT00415636|3607434|FG001|Overall Study|Adverse Event|0
2037182|NCT00415636|3607435|FG002|Overall Study|Adverse Event|0
2037183|NCT00415636|3607436|FG003|Overall Study|Adverse Event|1
2037184|NCT00415636|3607437|FG004|Overall Study|Adverse Event|1
2037185|NCT00415636|3607438|FG005|Overall Study|Adverse Event|0
2037186|NCT00415636|3607433|FG000|Overall Study|Withdrawal by Subject|0
2037187|NCT00415636|3607434|FG001|Overall Study|Withdrawal by Subject|0
2037188|NCT00415636|3607435|FG002|Overall Study|Withdrawal by Subject|0
2037189|NCT00415636|3607436|FG003|Overall Study|Withdrawal by Subject|0
2037190|NCT00415636|3607437|FG004|Overall Study|Withdrawal by Subject|1
2037191|NCT00415636|3607438|FG005|Overall Study|Withdrawal by Subject|0
2037192|NCT00415636|3607433|FG000|Overall Study|Disease progression|0
2037193|NCT00415636|3607434|FG001|Overall Study|Disease progression|0
2037194|NCT00415636|3607435|FG002|Overall Study|Disease progression|0
2037195|NCT00415636|3607436|FG003|Overall Study|Disease progression|3
2037196|NCT00415636|3607437|FG004|Overall Study|Disease progression|0
2037197|NCT00415636|3607438|FG005|Overall Study|Disease progression|1
2037198|NCT00415909|3607478|FG000|Overall Study|Withdrawal by Subject|2
2037199|NCT00415909|3607478|FG000|Overall Study|Death|1
2037200|NCT00416078|3607484|FG000|Overall Study|Death|3
2037201|NCT00416078|3607485|FG001|Overall Study|Death|4
2037202|NCT00416078|3607484|FG000|Overall Study|Withdrawal by Subject|3
2037203|NCT00416078|3607485|FG001|Overall Study|Withdrawal by Subject|2
2037204|NCT00416078|3607484|FG000|Overall Study|Physician Decision|1
2037205|NCT00416078|3607485|FG001|Overall Study|Physician Decision|0
2037206|NCT00416078|3607484|FG000|Overall Study|Lost to Follow-up|4
2037207|NCT00416078|3607485|FG001|Overall Study|Lost to Follow-up|2
2037208|NCT00416195|3607508|FG000|Overall Study|Adverse Event|1
2037209|NCT00416195|3607509|FG001|Overall Study|Adverse Event|2
2037210|NCT00416195|3607508|FG000|Overall Study|Protocol Violation|1
2037211|NCT00416195|3607509|FG001|Overall Study|Protocol Violation|1
2037212|NCT00416195|3607508|FG000|Overall Study|Other|0
2037213|NCT00416195|3607509|FG001|Overall Study|Other|1
2037214|NCT00416312|3607515|FG000|Overall Study|tumors not visible on imaging|2
2037215|NCT00416455|3607521|FG000|Overall Study|PET / CT not done|3
2037216|NCT00416455|3607522|FG001|Overall Study|PET / CT not done|5
2037217|NCT00416455|3607521|FG000|Overall Study|PET / CT poor quality|2
2037218|NCT00416455|3607522|FG001|Overall Study|PET / CT poor quality|1
2037219|NCT00416455|3607521|FG000|Overall Study|Inadequate pathology|11
2037220|NCT00416455|3607522|FG001|Overall Study|Inadequate pathology|2
2037221|NCT00416520|3607550|FG000|Open-label Period|Adverse Event|28
2037222|NCT00416520|3607551|FG001|Open-label Period|Adverse Event|10
2037223|NCT00416520|3607552|FG002|Open-label Period|Adverse Event|0
2037224|NCT00416520|3607553|FG003|Open-label Period|Adverse Event|0
2037225|NCT00416520|3607550|FG000|Open-label Period|Death|2
2037226|NCT00416520|3607551|FG001|Open-label Period|Death|1
2037227|NCT00416520|3607552|FG002|Open-label Period|Death|0
2037228|NCT00416520|3607553|FG003|Open-label Period|Death|0
2037229|NCT00416520|3607550|FG000|Open-label Period|Lack of Efficacy|8
2240067|NCT01928394|3897406|FG000|Treatment Period|Disease progression|17
2240068|NCT01928394|3897407|FG001|Treatment Period|Disease progression|2
2240069|NCT01928394|3897408|FG002|Treatment Period|Disease progression|12
2240070|NCT01928394|3897409|FG003|Treatment Period|Disease progression|48
2240071|NCT01928394|3897410|FG004|Treatment Period|Disease progression|3
2240072|NCT01928394|3897411|FG005|Treatment Period|Disease progression|25
2240073|NCT01928394|3897412|FG006|Treatment Period|Disease progression|38
2240074|NCT01928394|3897413|FG007|Treatment Period|Disease progression|16
2240075|NCT01928394|3897414|FG008|Treatment Period|Disease progression|3
2240076|NCT01928394|3897415|FG009|Treatment Period|Disease progression|11
2240077|NCT01928394|3897416|FG010|Treatment Period|Disease progression|22
2240078|NCT01928394|3897417|FG011|Treatment Period|Disease progression|73
2240079|NCT01928394|3897418|FG012|Treatment Period|Disease progression|38
2240080|NCT01928394|3897419|FG013|Treatment Period|Disease progression|118
2240081|NCT01928394|3897420|FG014|Treatment Period|Disease progression|59
2240082|NCT01928394|3897421|FG015|Treatment Period|Disease progression|1
2240083|NCT01928394|3897422|FG016|Treatment Period|Disease progression|43
2240084|NCT01928394|3897423|FG017|Treatment Period|Disease progression|56
2240085|NCT01928394|3897424|FG018|Treatment Period|Disease progression|50
2240086|NCT01928394|3897425|FG019|Treatment Period|Disease progression|71
2240087|NCT01928394|3897426|FG020|Treatment Period|Disease progression|30
2240088|NCT01928394|3897427|FG021|Treatment Period|Disease progression|31
2240089|NCT01928394|3897428|FG022|Treatment Period|Disease progression|31
2240090|NCT01928394|3897406|FG000|Treatment Period|Study drug toxicity|1
2240091|NCT01928394|3897407|FG001|Treatment Period|Study drug toxicity|1
2240092|NCT01928394|3897408|FG002|Treatment Period|Study drug toxicity|3
2240093|NCT01928394|3897409|FG003|Treatment Period|Study drug toxicity|3
2240094|NCT01928394|3897410|FG004|Treatment Period|Study drug toxicity|0
2240095|NCT01928394|3897411|FG005|Treatment Period|Study drug toxicity|9
2240096|NCT01928394|3897412|FG006|Treatment Period|Study drug toxicity|7
2240097|NCT01928394|3897413|FG007|Treatment Period|Study drug toxicity|1
2240098|NCT01928394|3897414|FG008|Treatment Period|Study drug toxicity|0
2240099|NCT01928394|3897415|FG009|Treatment Period|Study drug toxicity|5
2240100|NCT01928394|3897416|FG010|Treatment Period|Study drug toxicity|2
2240101|NCT01928394|3897417|FG011|Treatment Period|Study drug toxicity|3
2240102|NCT01928394|3897418|FG012|Treatment Period|Study drug toxicity|7
2240103|NCT01928394|3897419|FG013|Treatment Period|Study drug toxicity|5
2240104|NCT01928394|3897420|FG014|Treatment Period|Study drug toxicity|12
2240105|NCT01928394|3897421|FG015|Treatment Period|Study drug toxicity|0
2240106|NCT01928394|3897422|FG016|Treatment Period|Study drug toxicity|3
2240107|NCT01928394|3897423|FG017|Treatment Period|Study drug toxicity|3
2240108|NCT01928394|3897424|FG018|Treatment Period|Study drug toxicity|12
2240109|NCT01928394|3897425|FG019|Treatment Period|Study drug toxicity|15
2240110|NCT01928394|3897426|FG020|Treatment Period|Study drug toxicity|4
2240111|NCT01928394|3897427|FG021|Treatment Period|Study drug toxicity|7
2240112|NCT01928394|3897428|FG022|Treatment Period|Study drug toxicity|4
2240113|NCT01928394|3897406|FG000|Treatment Period|AE unrelated to study drug|0
2240114|NCT01928394|3897407|FG001|Treatment Period|AE unrelated to study drug|0
2240115|NCT01928394|3897408|FG002|Treatment Period|AE unrelated to study drug|2
2240116|NCT01928394|3897409|FG003|Treatment Period|AE unrelated to study drug|3
2240117|NCT01928394|3897410|FG004|Treatment Period|AE unrelated to study drug|0
2240118|NCT01928394|3897411|FG005|Treatment Period|AE unrelated to study drug|5
2240119|NCT01928394|3897412|FG006|Treatment Period|AE unrelated to study drug|1
2240120|NCT01928394|3897413|FG007|Treatment Period|AE unrelated to study drug|0
2240121|NCT01928394|3897414|FG008|Treatment Period|AE unrelated to study drug|0
2240122|NCT01928394|3897415|FG009|Treatment Period|AE unrelated to study drug|2
2240123|NCT01928394|3897416|FG010|Treatment Period|AE unrelated to study drug|0
2240124|NCT01928394|3897417|FG011|Treatment Period|AE unrelated to study drug|12
2240125|NCT01928394|3897418|FG012|Treatment Period|AE unrelated to study drug|6
2240126|NCT01928394|3897419|FG013|Treatment Period|AE unrelated to study drug|13
2240127|NCT01928394|3897420|FG014|Treatment Period|AE unrelated to study drug|6
2240128|NCT01928394|3897421|FG015|Treatment Period|AE unrelated to study drug|1
2240129|NCT01928394|3897422|FG016|Treatment Period|AE unrelated to study drug|1
2240130|NCT01928394|3897423|FG017|Treatment Period|AE unrelated to study drug|6
2240131|NCT01928394|3897424|FG018|Treatment Period|AE unrelated to study drug|3
2240132|NCT01928394|3897425|FG019|Treatment Period|AE unrelated to study drug|5
2240133|NCT01928394|3897426|FG020|Treatment Period|AE unrelated to study drug|1
2240134|NCT01928394|3897427|FG021|Treatment Period|AE unrelated to study drug|1
2240135|NCT01928394|3897428|FG022|Treatment Period|AE unrelated to study drug|0
2240136|NCT01928394|3897406|FG000|Treatment Period|Participant request to stop therapy|0
2240137|NCT01928394|3897407|FG001|Treatment Period|Participant request to stop therapy|0
2240138|NCT01928394|3897408|FG002|Treatment Period|Participant request to stop therapy|0
2240139|NCT01928394|3897409|FG003|Treatment Period|Participant request to stop therapy|0
2240140|NCT01928394|3897410|FG004|Treatment Period|Participant request to stop therapy|0
2240141|NCT01928394|3897411|FG005|Treatment Period|Participant request to stop therapy|3
2240142|NCT01928394|3897412|FG006|Treatment Period|Participant request to stop therapy|3
2240143|NCT01928394|3897413|FG007|Treatment Period|Participant request to stop therapy|0
2240144|NCT01928394|3897414|FG008|Treatment Period|Participant request to stop therapy|0
2240145|NCT01928394|3897415|FG009|Treatment Period|Participant request to stop therapy|0
2240146|NCT01928394|3897416|FG010|Treatment Period|Participant request to stop therapy|3
2240147|NCT01928394|3897417|FG011|Treatment Period|Participant request to stop therapy|2
2240148|NCT01928394|3897418|FG012|Treatment Period|Participant request to stop therapy|1
2240149|NCT01928394|3897419|FG013|Treatment Period|Participant request to stop therapy|2
2240150|NCT01928394|3897420|FG014|Treatment Period|Participant request to stop therapy|4
2240151|NCT01928394|3897421|FG015|Treatment Period|Participant request to stop therapy|0
2240152|NCT01928394|3897422|FG016|Treatment Period|Participant request to stop therapy|1
2336632|NCT03307785|4063993|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0
2336633|NCT03307785|4063994|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0
2336634|NCT03307785|4063995|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0
2336635|NCT03307785|4063996|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0
2336636|NCT03307785|4063997|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0
2336637|NCT03307785|4063998|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0
2336638|NCT03307785|4063999|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0
2336639|NCT03307785|4064000|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0
2336640|NCT03307785|4063990|FG000|Part A: Up to 28.5 Months|Death|4
2336641|NCT03307785|4063991|FG001|Part A: Up to 28.5 Months|Death|4
2336642|NCT03307785|4063992|FG002|Part A: Up to 28.5 Months|Death|0
2336643|NCT03307785|4063993|FG003|Part A: Up to 28.5 Months|Death|0
2336644|NCT03307785|4063994|FG004|Part A: Up to 28.5 Months|Death|0
2336645|NCT03307785|4063995|FG005|Part A: Up to 28.5 Months|Death|0
2336646|NCT03307785|4063996|FG006|Part A: Up to 28.5 Months|Death|0
2336647|NCT03307785|4063997|FG007|Part A: Up to 28.5 Months|Death|0
2336648|NCT03307785|4063998|FG008|Part A: Up to 28.5 Months|Death|0
2336649|NCT03307785|4063999|FG009|Part A: Up to 28.5 Months|Death|0
2336650|NCT03307785|4064000|FG010|Part A: Up to 28.5 Months|Death|0
2336651|NCT03307785|4063990|FG000|Part A: Up to 28.5 Months|Physician Decision|3
2336652|NCT03307785|4063991|FG001|Part A: Up to 28.5 Months|Physician Decision|1
2336653|NCT03307785|4063992|FG002|Part A: Up to 28.5 Months|Physician Decision|0
2336654|NCT03307785|4063993|FG003|Part A: Up to 28.5 Months|Physician Decision|0
2336655|NCT03307785|4063994|FG004|Part A: Up to 28.5 Months|Physician Decision|0
2336656|NCT03307785|4063995|FG005|Part A: Up to 28.5 Months|Physician Decision|0
2336657|NCT03307785|4063996|FG006|Part A: Up to 28.5 Months|Physician Decision|0
2336658|NCT03307785|4063997|FG007|Part A: Up to 28.5 Months|Physician Decision|0
2336659|NCT03307785|4063998|FG008|Part A: Up to 28.5 Months|Physician Decision|0
2336660|NCT03307785|4063999|FG009|Part A: Up to 28.5 Months|Physician Decision|0
2336661|NCT03307785|4064000|FG010|Part A: Up to 28.5 Months|Physician Decision|0
2336662|NCT03307785|4063990|FG000|Part B: Up to 28.5 Months|Disease progression|0
2336663|NCT03307785|4063991|FG001|Part B: Up to 28.5 Months|Disease progression|0
2336664|NCT03307785|4063992|FG002|Part B: Up to 28.5 Months|Disease progression|1
2336665|NCT03307785|4063993|FG003|Part B: Up to 28.5 Months|Disease progression|0
2336666|NCT03307785|4063994|FG004|Part B: Up to 28.5 Months|Disease progression|0
2336667|NCT03307785|4063995|FG005|Part B: Up to 28.5 Months|Disease progression|0
2336668|NCT03307785|4063996|FG006|Part B: Up to 28.5 Months|Disease progression|0
2336669|NCT03307785|4063997|FG007|Part B: Up to 28.5 Months|Disease progression|0
2336670|NCT03307785|4063998|FG008|Part B: Up to 28.5 Months|Disease progression|0
2336671|NCT03307785|4063999|FG009|Part B: Up to 28.5 Months|Disease progression|0
2336672|NCT03307785|4064000|FG010|Part B: Up to 28.5 Months|Disease progression|0
2336673|NCT03307785|4063990|FG000|Part B: Up to 28.5 Months|Physician Decision|0
2336674|NCT03307785|4063991|FG001|Part B: Up to 28.5 Months|Physician Decision|0
2336675|NCT03307785|4063992|FG002|Part B: Up to 28.5 Months|Physician Decision|1
2336676|NCT03307785|4063993|FG003|Part B: Up to 28.5 Months|Physician Decision|0
2336677|NCT03307785|4063994|FG004|Part B: Up to 28.5 Months|Physician Decision|0
2336678|NCT03307785|4063995|FG005|Part B: Up to 28.5 Months|Physician Decision|0
2336679|NCT03307785|4063996|FG006|Part B: Up to 28.5 Months|Physician Decision|0
2336680|NCT03307785|4063997|FG007|Part B: Up to 28.5 Months|Physician Decision|0
2336681|NCT03307785|4063998|FG008|Part B: Up to 28.5 Months|Physician Decision|0
2336682|NCT03307785|4063999|FG009|Part B: Up to 28.5 Months|Physician Decision|0
2336683|NCT03307785|4064000|FG010|Part B: Up to 28.5 Months|Physician Decision|0
2336684|NCT03307785|4063990|FG000|Part B: Up to 28.5 Months|Death|0
2336685|NCT03307785|4063991|FG001|Part B: Up to 28.5 Months|Death|0
2336686|NCT03307785|4063992|FG002|Part B: Up to 28.5 Months|Death|7
2336687|NCT03307785|4063993|FG003|Part B: Up to 28.5 Months|Death|0
2336688|NCT03307785|4063994|FG004|Part B: Up to 28.5 Months|Death|0
2336689|NCT03307785|4063995|FG005|Part B: Up to 28.5 Months|Death|0
2336690|NCT03307785|4063996|FG006|Part B: Up to 28.5 Months|Death|0
2336691|NCT03307785|4063997|FG007|Part B: Up to 28.5 Months|Death|0
2336692|NCT03307785|4063998|FG008|Part B: Up to 28.5 Months|Death|0
2336693|NCT03307785|4063999|FG009|Part B: Up to 28.5 Months|Death|0
2336694|NCT03307785|4064000|FG010|Part B: Up to 28.5 Months|Death|0
2336695|NCT03307785|4063990|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0
2336696|NCT03307785|4063991|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0
2336697|NCT03307785|4063992|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1
2336698|NCT03307785|4063993|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0
2336699|NCT03307785|4063994|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0
2240153|NCT01928394|3897423|FG017|Treatment Period|Participant request to stop therapy|3
2240154|NCT01928394|3897424|FG018|Treatment Period|Participant request to stop therapy|1
2240155|NCT01928394|3897425|FG019|Treatment Period|Participant request to stop therapy|1
2240156|NCT01928394|3897426|FG020|Treatment Period|Participant request to stop therapy|3
2240157|NCT01928394|3897427|FG021|Treatment Period|Participant request to stop therapy|1
2240158|NCT01928394|3897428|FG022|Treatment Period|Participant request to stop therapy|3
2240159|NCT01928394|3897406|FG000|Treatment Period|Participant withdrew consent|0
2240160|NCT01928394|3897407|FG001|Treatment Period|Participant withdrew consent|0
2240161|NCT01928394|3897408|FG002|Treatment Period|Participant withdrew consent|1
2240162|NCT01928394|3897409|FG003|Treatment Period|Participant withdrew consent|1
2240163|NCT01928394|3897410|FG004|Treatment Period|Participant withdrew consent|0
2240164|NCT01928394|3897411|FG005|Treatment Period|Participant withdrew consent|1
2240165|NCT01928394|3897412|FG006|Treatment Period|Participant withdrew consent|0
2240166|NCT01928394|3897413|FG007|Treatment Period|Participant withdrew consent|1
2240167|NCT01928394|3897414|FG008|Treatment Period|Participant withdrew consent|0
2240168|NCT01928394|3897415|FG009|Treatment Period|Participant withdrew consent|0
2240169|NCT01928394|3897416|FG010|Treatment Period|Participant withdrew consent|1
2240170|NCT01928394|3897417|FG011|Treatment Period|Participant withdrew consent|1
2240171|NCT01928394|3897418|FG012|Treatment Period|Participant withdrew consent|1
2240172|NCT01928394|3897419|FG013|Treatment Period|Participant withdrew consent|0
2240173|NCT01928394|3897420|FG014|Treatment Period|Participant withdrew consent|2
2240174|NCT01928394|3897421|FG015|Treatment Period|Participant withdrew consent|0
2240175|NCT01928394|3897422|FG016|Treatment Period|Participant withdrew consent|2
2240176|NCT01928394|3897423|FG017|Treatment Period|Participant withdrew consent|1
2240177|NCT01928394|3897424|FG018|Treatment Period|Participant withdrew consent|1
2240178|NCT01928394|3897425|FG019|Treatment Period|Participant withdrew consent|1
2240179|NCT01928394|3897426|FG020|Treatment Period|Participant withdrew consent|0
2240180|NCT01928394|3897427|FG021|Treatment Period|Participant withdrew consent|2
2240181|NCT01928394|3897428|FG022|Treatment Period|Participant withdrew consent|0
2240182|NCT01928394|3897406|FG000|Treatment Period|Poor/non-compliance|0
2240183|NCT01928394|3897407|FG001|Treatment Period|Poor/non-compliance|0
2240184|NCT01928394|3897408|FG002|Treatment Period|Poor/non-compliance|0
2240185|NCT01928394|3897409|FG003|Treatment Period|Poor/non-compliance|1
2240186|NCT01928394|3897410|FG004|Treatment Period|Poor/non-compliance|0
2240187|NCT01928394|3897411|FG005|Treatment Period|Poor/non-compliance|0
2240188|NCT01928394|3897412|FG006|Treatment Period|Poor/non-compliance|0
2240189|NCT01928394|3897413|FG007|Treatment Period|Poor/non-compliance|0
2240190|NCT01928394|3897414|FG008|Treatment Period|Poor/non-compliance|0
2240191|NCT01928394|3897415|FG009|Treatment Period|Poor/non-compliance|0
2240192|NCT01928394|3897416|FG010|Treatment Period|Poor/non-compliance|0
2240193|NCT01928394|3897417|FG011|Treatment Period|Poor/non-compliance|0
2240194|NCT01928394|3897418|FG012|Treatment Period|Poor/non-compliance|1
2240195|NCT01928394|3897419|FG013|Treatment Period|Poor/non-compliance|0
2240196|NCT01928394|3897420|FG014|Treatment Period|Poor/non-compliance|1
2240197|NCT01928394|3897421|FG015|Treatment Period|Poor/non-compliance|0
2336700|NCT03307785|4063995|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0
2336701|NCT03307785|4063996|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0
2336702|NCT03307785|4063997|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0
2336703|NCT03307785|4063998|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0
2336704|NCT03307785|4063999|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0
2336705|NCT03307785|4064000|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0
2336706|NCT03307785|4063990|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
2336707|NCT03307785|4063991|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
2336708|NCT03307785|4063992|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4
2336709|NCT03307785|4063993|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
2336710|NCT03307785|4063994|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
2336711|NCT03307785|4063995|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
2336712|NCT03307785|4063996|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
2336713|NCT03307785|4063997|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
2336714|NCT03307785|4063998|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
2336715|NCT03307785|4063999|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
2336716|NCT03307785|4064000|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
2336717|NCT03307785|4063990|FG000|Part C: Up to 22.5 Months|Disease progression|0
2336718|NCT03307785|4063991|FG001|Part C: Up to 22.5 Months|Disease progression|0
2336719|NCT03307785|4063992|FG002|Part C: Up to 22.5 Months|Disease progression|0
2336720|NCT03307785|4063993|FG003|Part C: Up to 22.5 Months|Disease progression|0
2336721|NCT03307785|4063994|FG004|Part C: Up to 22.5 Months|Disease progression|1
2336722|NCT03307785|4063995|FG005|Part C: Up to 22.5 Months|Disease progression|0
2336723|NCT03307785|4063996|FG006|Part C: Up to 22.5 Months|Disease progression|0
2336724|NCT03307785|4063997|FG007|Part C: Up to 22.5 Months|Disease progression|0
2336725|NCT03307785|4063998|FG008|Part C: Up to 22.5 Months|Disease progression|0
2336726|NCT03307785|4063999|FG009|Part C: Up to 22.5 Months|Disease progression|0
2336727|NCT03307785|4064000|FG010|Part C: Up to 22.5 Months|Disease progression|0
2336728|NCT03307785|4063990|FG000|Part C: Up to 22.5 Months|Physician Decision|0
2240198|NCT01928394|3897422|FG016|Treatment Period|Poor/non-compliance|0
2240199|NCT01928394|3897423|FG017|Treatment Period|Poor/non-compliance|1
2240200|NCT01928394|3897424|FG018|Treatment Period|Poor/non-compliance|0
2240201|NCT01928394|3897425|FG019|Treatment Period|Poor/non-compliance|1
2240202|NCT01928394|3897426|FG020|Treatment Period|Poor/non-compliance|0
2240203|NCT01928394|3897427|FG021|Treatment Period|Poor/non-compliance|0
2240204|NCT01928394|3897428|FG022|Treatment Period|Poor/non-compliance|0
2240205|NCT01928394|3897406|FG000|Treatment Period|other reason|0
2240206|NCT01928394|3897407|FG001|Treatment Period|other reason|0
2240207|NCT01928394|3897408|FG002|Treatment Period|other reason|0
2240208|NCT01928394|3897409|FG003|Treatment Period|other reason|0
2240209|NCT01928394|3897410|FG004|Treatment Period|other reason|0
2240210|NCT01928394|3897411|FG005|Treatment Period|other reason|0
2240211|NCT01928394|3897412|FG006|Treatment Period|other reason|0
2240212|NCT01928394|3897413|FG007|Treatment Period|other reason|0
2240213|NCT01928394|3897414|FG008|Treatment Period|other reason|0
2240214|NCT01928394|3897415|FG009|Treatment Period|other reason|0
2240215|NCT01928394|3897416|FG010|Treatment Period|other reason|1
2240216|NCT01928394|3897417|FG011|Treatment Period|other reason|1
2240217|NCT01928394|3897418|FG012|Treatment Period|other reason|1
2240218|NCT01928394|3897419|FG013|Treatment Period|other reason|0
2240219|NCT01928394|3897420|FG014|Treatment Period|other reason|1
2240220|NCT01928394|3897421|FG015|Treatment Period|other reason|0
2240221|NCT01928394|3897422|FG016|Treatment Period|other reason|0
2240222|NCT01928394|3897423|FG017|Treatment Period|other reason|0
2240223|NCT01928394|3897424|FG018|Treatment Period|other reason|2
2240224|NCT01928394|3897425|FG019|Treatment Period|other reason|2
2240225|NCT01928394|3897426|FG020|Treatment Period|other reason|0
2240226|NCT01928394|3897427|FG021|Treatment Period|other reason|0
2240227|NCT01928394|3897428|FG022|Treatment Period|other reason|0
2240228|NCT01928394|3897406|FG000|Treatment Period|Maximum clinical benefit|0
2240229|NCT01928394|3897407|FG001|Treatment Period|Maximum clinical benefit|0
2240230|NCT01928394|3897408|FG002|Treatment Period|Maximum clinical benefit|0
2240231|NCT01928394|3897409|FG003|Treatment Period|Maximum clinical benefit|0
2240232|NCT01928394|3897410|FG004|Treatment Period|Maximum clinical benefit|0
2240233|NCT01928394|3897411|FG005|Treatment Period|Maximum clinical benefit|0
2240234|NCT01928394|3897412|FG006|Treatment Period|Maximum clinical benefit|0
2240235|NCT01928394|3897413|FG007|Treatment Period|Maximum clinical benefit|0
2240236|NCT01928394|3897414|FG008|Treatment Period|Maximum clinical benefit|0
2240237|NCT01928394|3897415|FG009|Treatment Period|Maximum clinical benefit|0
2240238|NCT01928394|3897416|FG010|Treatment Period|Maximum clinical benefit|1
2240239|NCT01928394|3897417|FG011|Treatment Period|Maximum clinical benefit|1
2240240|NCT01928394|3897418|FG012|Treatment Period|Maximum clinical benefit|0
2240241|NCT01928394|3897419|FG013|Treatment Period|Maximum clinical benefit|0
2240242|NCT01928394|3897420|FG014|Treatment Period|Maximum clinical benefit|1
2240243|NCT01928394|3897421|FG015|Treatment Period|Maximum clinical benefit|0
2240244|NCT01928394|3897422|FG016|Treatment Period|Maximum clinical benefit|0
2240245|NCT01928394|3897423|FG017|Treatment Period|Maximum clinical benefit|1
2240246|NCT01928394|3897424|FG018|Treatment Period|Maximum clinical benefit|1
2240247|NCT01928394|3897425|FG019|Treatment Period|Maximum clinical benefit|0
2240248|NCT01928394|3897426|FG020|Treatment Period|Maximum clinical benefit|2
2240249|NCT01928394|3897427|FG021|Treatment Period|Maximum clinical benefit|0
2240250|NCT01928394|3897428|FG022|Treatment Period|Maximum clinical benefit|0
2240251|NCT01928394|3897406|FG000|Treatment Period|Lost to Follow-up|0
2240252|NCT01928394|3897407|FG001|Treatment Period|Lost to Follow-up|0
2240253|NCT01928394|3897408|FG002|Treatment Period|Lost to Follow-up|0
2240254|NCT01928394|3897409|FG003|Treatment Period|Lost to Follow-up|0
2240255|NCT01928394|3897410|FG004|Treatment Period|Lost to Follow-up|0
2240256|NCT01928394|3897411|FG005|Treatment Period|Lost to Follow-up|0
2240257|NCT01928394|3897412|FG006|Treatment Period|Lost to Follow-up|0
2240258|NCT01928394|3897413|FG007|Treatment Period|Lost to Follow-up|0
2240259|NCT01928394|3897414|FG008|Treatment Period|Lost to Follow-up|0
2240260|NCT01928394|3897415|FG009|Treatment Period|Lost to Follow-up|0
2240261|NCT01928394|3897416|FG010|Treatment Period|Lost to Follow-up|0
2240262|NCT01928394|3897417|FG011|Treatment Period|Lost to Follow-up|0
2240263|NCT01928394|3897418|FG012|Treatment Period|Lost to Follow-up|0
2240264|NCT01928394|3897419|FG013|Treatment Period|Lost to Follow-up|0
2240265|NCT01928394|3897420|FG014|Treatment Period|Lost to Follow-up|0
2240266|NCT01928394|3897421|FG015|Treatment Period|Lost to Follow-up|0
2240267|NCT01928394|3897422|FG016|Treatment Period|Lost to Follow-up|0
2240268|NCT01928394|3897423|FG017|Treatment Period|Lost to Follow-up|0
2240269|NCT01928394|3897424|FG018|Treatment Period|Lost to Follow-up|0
2240270|NCT01928394|3897425|FG019|Treatment Period|Lost to Follow-up|0
2240271|NCT01928394|3897426|FG020|Treatment Period|Lost to Follow-up|0
2240272|NCT01928394|3897427|FG021|Treatment Period|Lost to Follow-up|0
2240273|NCT01928394|3897428|FG022|Treatment Period|Lost to Follow-up|1
2240274|NCT01928394|3897406|FG000|Treatment Period|Death|0
2240275|NCT01928394|3897407|FG001|Treatment Period|Death|0
2240276|NCT01928394|3897408|FG002|Treatment Period|Death|0
2240277|NCT01928394|3897409|FG003|Treatment Period|Death|0
2240278|NCT01928394|3897410|FG004|Treatment Period|Death|0
2240279|NCT01928394|3897411|FG005|Treatment Period|Death|0
2240280|NCT01928394|3897412|FG006|Treatment Period|Death|0
2240281|NCT01928394|3897413|FG007|Treatment Period|Death|0
2240282|NCT01928394|3897414|FG008|Treatment Period|Death|0
2240283|NCT01928394|3897415|FG009|Treatment Period|Death|0
2240284|NCT01928394|3897416|FG010|Treatment Period|Death|0
2240285|NCT01928394|3897417|FG011|Treatment Period|Death|0
2240286|NCT01928394|3897418|FG012|Treatment Period|Death|0
2240287|NCT01928394|3897419|FG013|Treatment Period|Death|1
2240288|NCT01928394|3897420|FG014|Treatment Period|Death|2
2240289|NCT01928394|3897421|FG015|Treatment Period|Death|0
2240290|NCT01928394|3897422|FG016|Treatment Period|Death|0
2240291|NCT01928394|3897423|FG017|Treatment Period|Death|0
2240292|NCT01928394|3897424|FG018|Treatment Period|Death|0
2240293|NCT01928394|3897425|FG019|Treatment Period|Death|0
2240294|NCT01928394|3897426|FG020|Treatment Period|Death|0
2240295|NCT01928394|3897427|FG021|Treatment Period|Death|0
2240296|NCT01928394|3897428|FG022|Treatment Period|Death|0
2240297|NCT01928394|3897406|FG000|Follow-up Period|Participant withdrew consent|3
2240298|NCT01928394|3897407|FG001|Follow-up Period|Participant withdrew consent|0
2240299|NCT01928394|3897408|FG002|Follow-up Period|Participant withdrew consent|1
2240300|NCT01928394|3897409|FG003|Follow-up Period|Participant withdrew consent|4
2240301|NCT01928394|3897410|FG004|Follow-up Period|Participant withdrew consent|0
2240302|NCT01928394|3897411|FG005|Follow-up Period|Participant withdrew consent|2
2240303|NCT01928394|3897412|FG006|Follow-up Period|Participant withdrew consent|5
2240304|NCT01928394|3897413|FG007|Follow-up Period|Participant withdrew consent|1
2240305|NCT01928394|3897414|FG008|Follow-up Period|Participant withdrew consent|0
2240306|NCT01928394|3897415|FG009|Follow-up Period|Participant withdrew consent|0
2240307|NCT01928394|3897416|FG010|Follow-up Period|Participant withdrew consent|5
2240308|NCT01928394|3897417|FG011|Follow-up Period|Participant withdrew consent|8
2240309|NCT01928394|3897418|FG012|Follow-up Period|Participant withdrew consent|2
2240310|NCT01928394|3897419|FG013|Follow-up Period|Participant withdrew consent|12
2240311|NCT01928394|3897420|FG014|Follow-up Period|Participant withdrew consent|7
2240312|NCT01928394|3897421|FG015|Follow-up Period|Participant withdrew consent|0
2240313|NCT01928394|3897422|FG016|Follow-up Period|Participant withdrew consent|5
2240314|NCT01928394|3897423|FG017|Follow-up Period|Participant withdrew consent|3
2240315|NCT01928394|3897424|FG018|Follow-up Period|Participant withdrew consent|2
2336729|NCT03307785|4063991|FG001|Part C: Up to 22.5 Months|Physician Decision|0
2336730|NCT03307785|4063992|FG002|Part C: Up to 22.5 Months|Physician Decision|0
2336731|NCT03307785|4063993|FG003|Part C: Up to 22.5 Months|Physician Decision|3
2336732|NCT03307785|4063994|FG004|Part C: Up to 22.5 Months|Physician Decision|1
2336733|NCT03307785|4063995|FG005|Part C: Up to 22.5 Months|Physician Decision|0
2336734|NCT03307785|4063996|FG006|Part C: Up to 22.5 Months|Physician Decision|0
2336735|NCT03307785|4063997|FG007|Part C: Up to 22.5 Months|Physician Decision|0
2336736|NCT03307785|4063998|FG008|Part C: Up to 22.5 Months|Physician Decision|0
2336737|NCT03307785|4063999|FG009|Part C: Up to 22.5 Months|Physician Decision|0
2336738|NCT03307785|4064000|FG010|Part C: Up to 22.5 Months|Physician Decision|0
2336739|NCT03307785|4063990|FG000|Part C: Up to 22.5 Months|Death|0
2336740|NCT03307785|4063991|FG001|Part C: Up to 22.5 Months|Death|0
2336741|NCT03307785|4063992|FG002|Part C: Up to 22.5 Months|Death|0
2336742|NCT03307785|4063993|FG003|Part C: Up to 22.5 Months|Death|1
2336743|NCT03307785|4063994|FG004|Part C: Up to 22.5 Months|Death|4
2336744|NCT03307785|4063995|FG005|Part C: Up to 22.5 Months|Death|0
2336745|NCT03307785|4063996|FG006|Part C: Up to 22.5 Months|Death|0
2336746|NCT03307785|4063997|FG007|Part C: Up to 22.5 Months|Death|0
2336747|NCT03307785|4063998|FG008|Part C: Up to 22.5 Months|Death|0
2336748|NCT03307785|4063999|FG009|Part C: Up to 22.5 Months|Death|0
2336749|NCT03307785|4064000|FG010|Part C: Up to 22.5 Months|Death|0
2336750|NCT03307785|4063990|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0
2336751|NCT03307785|4063991|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0
2037230|NCT00416520|3607551|FG001|Open-label Period|Lack of Efficacy|1
2037231|NCT00416520|3607552|FG002|Open-label Period|Lack of Efficacy|0
2037232|NCT00416520|3607553|FG003|Open-label Period|Lack of Efficacy|0
2037233|NCT00416520|3607550|FG000|Open-label Period|Protocol Violation|3
2037234|NCT00416520|3607551|FG001|Open-label Period|Protocol Violation|3
2037235|NCT00416520|3607552|FG002|Open-label Period|Protocol Violation|0
2037236|NCT00416520|3607553|FG003|Open-label Period|Protocol Violation|0
2037237|NCT00416520|3607550|FG000|Open-label Period|Withdrawal by Subject|16
2037238|NCT00416520|3607551|FG001|Open-label Period|Withdrawal by Subject|5
2037239|NCT00416520|3607552|FG002|Open-label Period|Withdrawal by Subject|0
2037240|NCT00416520|3607553|FG003|Open-label Period|Withdrawal by Subject|0
2037241|NCT00416520|3607550|FG000|Open-label Period|Other Reasons|3
2037242|NCT00416520|3607551|FG001|Open-label Period|Other Reasons|12
2037243|NCT00416520|3607552|FG002|Open-label Period|Other Reasons|0
2037244|NCT00416520|3607553|FG003|Open-label Period|Other Reasons|0
2037245|NCT00416520|3607550|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0
2037246|NCT00416520|3607551|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0
2037247|NCT00416520|3607552|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0
2037248|NCT00416520|3607553|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1
2037249|NCT00416520|3607550|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
2240316|NCT01928394|3897425|FG019|Follow-up Period|Participant withdrew consent|7
2037250|NCT00416520|3607551|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
2037251|NCT00416520|3607552|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
2037252|NCT00416520|3607553|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
2240317|NCT01928394|3897426|FG020|Follow-up Period|Participant withdrew consent|4
2240318|NCT01928394|3897427|FG021|Follow-up Period|Participant withdrew consent|6
2240319|NCT01928394|3897428|FG022|Follow-up Period|Participant withdrew consent|2
2240320|NCT01928394|3897406|FG000|Follow-up Period|Death|0
2240321|NCT01928394|3897407|FG001|Follow-up Period|Death|0
2240322|NCT01928394|3897408|FG002|Follow-up Period|Death|2
2240323|NCT01928394|3897409|FG003|Follow-up Period|Death|6
2240324|NCT01928394|3897410|FG004|Follow-up Period|Death|0
2240325|NCT01928394|3897411|FG005|Follow-up Period|Death|6
2240326|NCT01928394|3897412|FG006|Follow-up Period|Death|6
2240327|NCT01928394|3897413|FG007|Follow-up Period|Death|2
2240328|NCT01928394|3897414|FG008|Follow-up Period|Death|1
2240329|NCT01928394|3897415|FG009|Follow-up Period|Death|2
2240330|NCT01928394|3897416|FG010|Follow-up Period|Death|4
2240331|NCT01928394|3897417|FG011|Follow-up Period|Death|12
2240332|NCT01928394|3897418|FG012|Follow-up Period|Death|11
2240333|NCT01928394|3897419|FG013|Follow-up Period|Death|25
2240334|NCT01928394|3897420|FG014|Follow-up Period|Death|18
2240335|NCT01928394|3897421|FG015|Follow-up Period|Death|0
2240336|NCT01928394|3897422|FG016|Follow-up Period|Death|6
2240337|NCT01928394|3897423|FG017|Follow-up Period|Death|5
2240338|NCT01928394|3897424|FG018|Follow-up Period|Death|13
2240339|NCT01928394|3897425|FG019|Follow-up Period|Death|13
2240340|NCT01928394|3897426|FG020|Follow-up Period|Death|5
2240341|NCT01928394|3897427|FG021|Follow-up Period|Death|3
2240342|NCT01928394|3897428|FG022|Follow-up Period|Death|2
2240343|NCT01928394|3897406|FG000|Follow-up Period|other reason|0
2336752|NCT03307785|4063992|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0
2336753|NCT03307785|4063993|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1
2336754|NCT03307785|4063994|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0
2336755|NCT03307785|4063995|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0
2336756|NCT03307785|4063996|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0
2336757|NCT03307785|4063997|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0
2336758|NCT03307785|4063998|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0
2336759|NCT03307785|4063999|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0
2336760|NCT03307785|4064000|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0
2336761|NCT03307785|4063990|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
2336762|NCT03307785|4063991|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
2336763|NCT03307785|4063992|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
2336764|NCT03307785|4063993|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
2336765|NCT03307785|4063994|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
2336766|NCT03307785|4063995|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
2336767|NCT03307785|4063996|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
2336768|NCT03307785|4063997|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
2336769|NCT03307785|4063998|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
2336770|NCT03307785|4063999|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
2336771|NCT03307785|4064000|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
2336772|NCT03307785|4063990|FG000|Part D: Up to 9.5 Months|Physician Decision|0
2336773|NCT03307785|4063991|FG001|Part D: Up to 9.5 Months|Physician Decision|0
2336774|NCT03307785|4063992|FG002|Part D: Up to 9.5 Months|Physician Decision|0
2336775|NCT03307785|4063993|FG003|Part D: Up to 9.5 Months|Physician Decision|0
2336776|NCT03307785|4063994|FG004|Part D: Up to 9.5 Months|Physician Decision|0
2336777|NCT03307785|4063995|FG005|Part D: Up to 9.5 Months|Physician Decision|1
2336778|NCT03307785|4063996|FG006|Part D: Up to 9.5 Months|Physician Decision|0
2336779|NCT03307785|4063997|FG007|Part D: Up to 9.5 Months|Physician Decision|0
2336780|NCT03307785|4063998|FG008|Part D: Up to 9.5 Months|Physician Decision|0
2037253|NCT00416520|3607550|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0
2037254|NCT00416520|3607551|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0
2037255|NCT00416520|3607552|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1
2037256|NCT00416520|3607553|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1
2037257|NCT00416598|3607576|FG000|Induction & Intensification|Adverse Event|38
2037258|NCT00416598|3607576|FG000|Induction & Intensification|Death|32
2037259|NCT00416598|3607576|FG000|Induction & Intensification|Withdrawal by Subject|46
2037260|NCT00416598|3607576|FG000|Induction & Intensification|Alternative Treatment|135
2037261|NCT00416598|3607576|FG000|Induction & Intensification|Physician discretion/other medical issue|45
2037262|NCT00416598|3607576|FG000|Induction & Intensification|Relapse/progression|29
2037263|NCT00416598|3607576|FG000|Induction & Intensification|Failed induction|87
2037264|NCT00416598|3607576|FG000|Decitabine Maintenance|Adverse Event|5
2037265|NCT00416598|3607576|FG000|Decitabine Maintenance|Withdrawal by Subject|18
2037266|NCT00416598|3607576|FG000|Decitabine Maintenance|Progression/relapse|38
2037267|NCT00416598|3607576|FG000|Decitabine Maintenance|Alternative treatment|2
2037268|NCT00416598|3607576|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9
2240344|NCT01928394|3897407|FG001|Follow-up Period|other reason|0
2240345|NCT01928394|3897408|FG002|Follow-up Period|other reason|0
2240346|NCT01928394|3897409|FG003|Follow-up Period|other reason|0
2240347|NCT01928394|3897410|FG004|Follow-up Period|other reason|0
2240348|NCT01928394|3897411|FG005|Follow-up Period|other reason|0
2240349|NCT01928394|3897412|FG006|Follow-up Period|other reason|1
2240350|NCT01928394|3897413|FG007|Follow-up Period|other reason|3
2240351|NCT01928394|3897414|FG008|Follow-up Period|other reason|0
2240352|NCT01928394|3897415|FG009|Follow-up Period|other reason|0
2240353|NCT01928394|3897416|FG010|Follow-up Period|other reason|2
2240354|NCT01928394|3897417|FG011|Follow-up Period|other reason|1
2240355|NCT01928394|3897418|FG012|Follow-up Period|other reason|0
2240356|NCT01928394|3897419|FG013|Follow-up Period|other reason|1
2240357|NCT01928394|3897420|FG014|Follow-up Period|other reason|4
2240358|NCT01928394|3897421|FG015|Follow-up Period|other reason|0
2240359|NCT01928394|3897422|FG016|Follow-up Period|other reason|2
2240360|NCT01928394|3897423|FG017|Follow-up Period|other reason|0
2240361|NCT01928394|3897424|FG018|Follow-up Period|other reason|1
2240362|NCT01928394|3897425|FG019|Follow-up Period|other reason|1
2240363|NCT01928394|3897426|FG020|Follow-up Period|other reason|0
2240364|NCT01928394|3897427|FG021|Follow-up Period|other reason|0
2240365|NCT01928394|3897428|FG022|Follow-up Period|other reason|1
2240366|NCT01928394|3897406|FG000|Follow-up Period|Lost to Follow-up|0
2240367|NCT01928394|3897407|FG001|Follow-up Period|Lost to Follow-up|0
2240368|NCT01928394|3897408|FG002|Follow-up Period|Lost to Follow-up|0
2240369|NCT01928394|3897409|FG003|Follow-up Period|Lost to Follow-up|0
2240370|NCT01928394|3897410|FG004|Follow-up Period|Lost to Follow-up|0
2240371|NCT01928394|3897411|FG005|Follow-up Period|Lost to Follow-up|0
2240372|NCT01928394|3897412|FG006|Follow-up Period|Lost to Follow-up|0
2240373|NCT01928394|3897413|FG007|Follow-up Period|Lost to Follow-up|0
2240374|NCT01928394|3897414|FG008|Follow-up Period|Lost to Follow-up|0
2240375|NCT01928394|3897415|FG009|Follow-up Period|Lost to Follow-up|0
2240376|NCT01928394|3897416|FG010|Follow-up Period|Lost to Follow-up|0
2240377|NCT01928394|3897417|FG011|Follow-up Period|Lost to Follow-up|1
2240378|NCT01928394|3897418|FG012|Follow-up Period|Lost to Follow-up|1
2240379|NCT01928394|3897419|FG013|Follow-up Period|Lost to Follow-up|0
2240380|NCT01928394|3897420|FG014|Follow-up Period|Lost to Follow-up|1
2240381|NCT01928394|3897421|FG015|Follow-up Period|Lost to Follow-up|0
2240382|NCT01928394|3897422|FG016|Follow-up Period|Lost to Follow-up|1
2240383|NCT01928394|3897423|FG017|Follow-up Period|Lost to Follow-up|0
2240384|NCT01928394|3897424|FG018|Follow-up Period|Lost to Follow-up|0
2240385|NCT01928394|3897425|FG019|Follow-up Period|Lost to Follow-up|0
2240386|NCT01928394|3897426|FG020|Follow-up Period|Lost to Follow-up|0
2240387|NCT01928394|3897427|FG021|Follow-up Period|Lost to Follow-up|0
2240388|NCT01928394|3897428|FG022|Follow-up Period|Lost to Follow-up|1
2240389|NCT01928433|3897479|FG000|Overall Study|Adverse Event|5
2240390|NCT01928433|3897480|FG001|Overall Study|Adverse Event|2
2240391|NCT01928433|3897481|FG002|Overall Study|Adverse Event|5
2240392|NCT01928433|3897479|FG000|Overall Study|Protocol Violation|0
2240393|NCT01928433|3897480|FG001|Overall Study|Protocol Violation|0
2240394|NCT01928433|3897481|FG002|Overall Study|Protocol Violation|2
2240395|NCT01928433|3897479|FG000|Overall Study|Lack of Efficacy|5
2336781|NCT03307785|4063999|FG009|Part D: Up to 9.5 Months|Physician Decision|0
2336782|NCT03307785|4064000|FG010|Part D: Up to 9.5 Months|Physician Decision|0
2336783|NCT03307785|4063990|FG000|Part D: Up to 9.5 Months|Death|0
2336784|NCT03307785|4063991|FG001|Part D: Up to 9.5 Months|Death|0
2336785|NCT03307785|4063992|FG002|Part D: Up to 9.5 Months|Death|0
2336786|NCT03307785|4063993|FG003|Part D: Up to 9.5 Months|Death|0
2336787|NCT03307785|4063994|FG004|Part D: Up to 9.5 Months|Death|0
2336788|NCT03307785|4063995|FG005|Part D: Up to 9.5 Months|Death|1
2336789|NCT03307785|4063996|FG006|Part D: Up to 9.5 Months|Death|0
2336790|NCT03307785|4063997|FG007|Part D: Up to 9.5 Months|Death|0
2336791|NCT03307785|4063998|FG008|Part D: Up to 9.5 Months|Death|0
2336792|NCT03307785|4063999|FG009|Part D: Up to 9.5 Months|Death|0
2336793|NCT03307785|4064000|FG010|Part D: Up to 9.5 Months|Death|0
2336794|NCT03307785|4063990|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0
2336795|NCT03307785|4063991|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0
2336796|NCT03307785|4063992|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0
2336797|NCT03307785|4063993|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0
2037269|NCT00416624|3607584|FG000|Overall Study|Withdrawal by Subject|1
2037270|NCT00416624|3607585|FG001|Overall Study|Withdrawal by Subject|6
2037271|NCT00416624|3607586|FG002|Overall Study|Withdrawal by Subject|4
2037272|NCT00416624|3607587|FG003|Overall Study|Withdrawal by Subject|9
2037273|NCT00416624|3607584|FG000|Overall Study|Death|4
2037274|NCT00416624|3607585|FG001|Overall Study|Death|7
2037275|NCT00416624|3607586|FG002|Overall Study|Death|7
2037276|NCT00416624|3607587|FG003|Overall Study|Death|1
2037277|NCT00416624|3607584|FG000|Overall Study|Adverse Event|8
2037278|NCT00416624|3607585|FG001|Overall Study|Adverse Event|3
2037279|NCT00416624|3607586|FG002|Overall Study|Adverse Event|2
2037280|NCT00416624|3607587|FG003|Overall Study|Adverse Event|2
2037281|NCT00416624|3607584|FG000|Overall Study|Other|8
2240396|NCT01928433|3897480|FG001|Overall Study|Lack of Efficacy|4
2240397|NCT01928433|3897481|FG002|Overall Study|Lack of Efficacy|4
2240398|NCT01928433|3897479|FG000|Overall Study|Withdrawal by Subject|0
2240399|NCT01928433|3897480|FG001|Overall Study|Withdrawal by Subject|4
2240400|NCT01928433|3897481|FG002|Overall Study|Withdrawal by Subject|0
2240401|NCT01928433|3897479|FG000|Overall Study|Negative screening urine culture|7
2240402|NCT01928433|3897480|FG001|Overall Study|Negative screening urine culture|6
2240403|NCT01928433|3897481|FG002|Overall Study|Negative screening urine culture|10
2240404|NCT01928433|3897479|FG000|Overall Study|Lost to Follow-up|0
2240405|NCT01928433|3897480|FG001|Overall Study|Lost to Follow-up|2
2240406|NCT01928433|3897481|FG002|Overall Study|Lost to Follow-up|3
2240407|NCT01928433|3897479|FG000|Overall Study|Other reasons|3
2240408|NCT01928433|3897480|FG001|Overall Study|Other reasons|3
2240409|NCT01928433|3897481|FG002|Overall Study|Other reasons|4
2240410|NCT01928472|3897507|FG000|Overall Study|Death|0
2240411|NCT01928472|3897508|FG001|Overall Study|Death|0
2240412|NCT01928472|3897509|FG002|Overall Study|Death|1
2240413|NCT01928472|3897510|FG003|Overall Study|Death|0
2240414|NCT01928472|3897507|FG000|Overall Study|Withdrawal by Subject|4
2240415|NCT01928472|3897508|FG001|Overall Study|Withdrawal by Subject|4
2240416|NCT01928472|3897509|FG002|Overall Study|Withdrawal by Subject|1
2240417|NCT01928472|3897510|FG003|Overall Study|Withdrawal by Subject|2
2240418|NCT01928472|3897507|FG000|Overall Study|Lost to Follow-up|2
2240419|NCT01928472|3897508|FG001|Overall Study|Lost to Follow-up|3
2240420|NCT01928472|3897509|FG002|Overall Study|Lost to Follow-up|4
2240421|NCT01928472|3897510|FG003|Overall Study|Lost to Follow-up|0
2240422|NCT01928472|3897507|FG000|Overall Study|Administrative Reason|2
2240423|NCT01928472|3897508|FG001|Overall Study|Administrative Reason|1
2240424|NCT01928472|3897509|FG002|Overall Study|Administrative Reason|0
2240425|NCT01928472|3897510|FG003|Overall Study|Administrative Reason|0
2240426|NCT01928472|3897507|FG000|Overall Study|Unclassified|0
2240427|NCT01928472|3897508|FG001|Overall Study|Unclassified|0
2240428|NCT01928472|3897509|FG002|Overall Study|Unclassified|1
2240429|NCT01928472|3897510|FG003|Overall Study|Unclassified|0
2240430|NCT01928485|3897523|FG000|Overall Study|Physician Decision|0
2240431|NCT01928485|3897524|FG001|Overall Study|Physician Decision|1
2240432|NCT01928719|3897578|FG000|Overall Study|Lost to Follow-up|26
2240433|NCT01928719|3897579|FG001|Overall Study|Lost to Follow-up|11
2240434|NCT01928719|3897578|FG000|Overall Study|Withdrawal by Subject|22
2336798|NCT03307785|4063994|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0
2336799|NCT03307785|4063995|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1
2336800|NCT03307785|4063996|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0
2336801|NCT03307785|4063997|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0
2336802|NCT03307785|4063998|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0
2336803|NCT03307785|4063999|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0
2336804|NCT03307785|4064000|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0
2336805|NCT03307785|4063990|FG000|Part E: Up to 4.4 Months|Death|0
2336806|NCT03307785|4063991|FG001|Part E: Up to 4.4 Months|Death|0
2336807|NCT03307785|4063992|FG002|Part E: Up to 4.4 Months|Death|0
2336808|NCT03307785|4063993|FG003|Part E: Up to 4.4 Months|Death|0
2336809|NCT03307785|4063994|FG004|Part E: Up to 4.4 Months|Death|0
2336810|NCT03307785|4063995|FG005|Part E: Up to 4.4 Months|Death|0
2336811|NCT03307785|4063996|FG006|Part E: Up to 4.4 Months|Death|1
2336812|NCT03307785|4063997|FG007|Part E: Up to 4.4 Months|Death|0
2336813|NCT03307785|4063998|FG008|Part E: Up to 4.4 Months|Death|0
2336814|NCT03307785|4063999|FG009|Part E: Up to 4.4 Months|Death|0
2336815|NCT03307785|4064000|FG010|Part E: Up to 4.4 Months|Death|0
2336816|NCT03307785|4063990|FG000|Part E: Up to 4.4 Months|Physician Decision|0
2336817|NCT03307785|4063991|FG001|Part E: Up to 4.4 Months|Physician Decision|0
2336818|NCT03307785|4063992|FG002|Part E: Up to 4.4 Months|Physician Decision|0
2336819|NCT03307785|4063993|FG003|Part E: Up to 4.4 Months|Physician Decision|0
2336820|NCT03307785|4063994|FG004|Part E: Up to 4.4 Months|Physician Decision|0
2336821|NCT03307785|4063995|FG005|Part E: Up to 4.4 Months|Physician Decision|0
2336822|NCT03307785|4063996|FG006|Part E: Up to 4.4 Months|Physician Decision|1
2336823|NCT03307785|4063997|FG007|Part E: Up to 4.4 Months|Physician Decision|0
2336824|NCT03307785|4063998|FG008|Part E: Up to 4.4 Months|Physician Decision|0
2336825|NCT03307785|4063999|FG009|Part E: Up to 4.4 Months|Physician Decision|0
2336826|NCT03307785|4064000|FG010|Part E: Up to 4.4 Months|Physician Decision|0
2336827|NCT03307785|4063990|FG000|Part F: Up to 3.5 Months|Physician Decision|0
2336828|NCT03307785|4063991|FG001|Part F: Up to 3.5 Months|Physician Decision|0
2336829|NCT03307785|4063992|FG002|Part F: Up to 3.5 Months|Physician Decision|0
2336830|NCT03307785|4063993|FG003|Part F: Up to 3.5 Months|Physician Decision|0
2336831|NCT03307785|4063994|FG004|Part F: Up to 3.5 Months|Physician Decision|0
2336832|NCT03307785|4063995|FG005|Part F: Up to 3.5 Months|Physician Decision|0
2336833|NCT03307785|4063996|FG006|Part F: Up to 3.5 Months|Physician Decision|0
2336834|NCT03307785|4063997|FG007|Part F: Up to 3.5 Months|Physician Decision|1
2336835|NCT03307785|4063998|FG008|Part F: Up to 3.5 Months|Physician Decision|0
2336836|NCT03307785|4063999|FG009|Part F: Up to 3.5 Months|Physician Decision|0
2336837|NCT03307785|4064000|FG010|Part F: Up to 3.5 Months|Physician Decision|0
2336838|NCT03307837|4064027|FG000|Overall Study|Withdrawal by Subject|0
2336839|NCT03307837|4064028|FG001|Overall Study|Withdrawal by Subject|0
2336840|NCT03307837|4064029|FG002|Overall Study|Withdrawal by Subject|1
2336841|NCT03307837|4064030|FG003|Overall Study|Withdrawal by Subject|0
2336842|NCT03307837|4064031|FG004|Overall Study|Withdrawal by Subject|0
2336843|NCT03307837|4064032|FG005|Overall Study|Withdrawal by Subject|1
2336844|NCT03307837|4064027|FG000|Overall Study|Lost to Follow-up|1
2336845|NCT03307837|4064028|FG001|Overall Study|Lost to Follow-up|1
2336846|NCT03307837|4064029|FG002|Overall Study|Lost to Follow-up|0
2336847|NCT03307837|4064030|FG003|Overall Study|Lost to Follow-up|0
2240435|NCT01928719|3897579|FG001|Overall Study|Withdrawal by Subject|7
2240436|NCT01928719|3897578|FG000|Overall Study|Protocol Violation|3
2240437|NCT01928719|3897579|FG001|Overall Study|Protocol Violation|1
2240438|NCT01928719|3897578|FG000|Overall Study|Adverse Event|1
2240439|NCT01928719|3897579|FG001|Overall Study|Adverse Event|0
2240440|NCT01928758|3897589|FG000|Overall Study|Lost to Follow-up|14
2240441|NCT01928758|3897590|FG001|Overall Study|Lost to Follow-up|9
2240442|NCT01928758|3897589|FG000|Overall Study|Withdrawal by Subject|5
2240443|NCT01928758|3897590|FG001|Overall Study|Withdrawal by Subject|2
2240444|NCT01928758|3897589|FG000|Overall Study|Adverse Event|3
2240445|NCT01928758|3897590|FG001|Overall Study|Adverse Event|5
2240446|NCT01928758|3897589|FG000|Overall Study|Protocol Violation|3
2240447|NCT01928758|3897590|FG001|Overall Study|Protocol Violation|4
2240448|NCT01928771|3897600|FG000|Overall Study|Adverse Event|6
2240449|NCT01928771|3897601|FG001|Overall Study|Adverse Event|5
2240450|NCT01928771|3897602|FG002|Overall Study|Adverse Event|1
2240451|NCT01928771|3897600|FG000|Overall Study|Death|2
2240452|NCT01928771|3897601|FG001|Overall Study|Death|2
2240453|NCT01928771|3897602|FG002|Overall Study|Death|2
2240454|NCT01928771|3897600|FG000|Overall Study|Lost to Follow-up|5
2240455|NCT01928771|3897601|FG001|Overall Study|Lost to Follow-up|6
2240456|NCT01928771|3897602|FG002|Overall Study|Lost to Follow-up|3
2240457|NCT01928771|3897600|FG000|Overall Study|Withdrawal by Subject|20
2240458|NCT01928771|3897601|FG001|Overall Study|Withdrawal by Subject|15
2240459|NCT01928771|3897602|FG002|Overall Study|Withdrawal by Subject|17
2240460|NCT01928771|3897600|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
2240461|NCT01928771|3897601|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
2240462|NCT01928771|3897602|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
2240463|NCT01928771|3897600|FG000|Overall Study|Other Reasons|9
2240464|NCT01928771|3897601|FG001|Overall Study|Other Reasons|9
2240465|NCT01928771|3897602|FG002|Overall Study|Other Reasons|14
2240466|NCT01928771|3897600|FG000|Overall Study|Severe Non-Compliance to Protocol|4
2240467|NCT01928771|3897601|FG001|Overall Study|Severe Non-Compliance to Protocol|2
2240468|NCT01928771|3897602|FG002|Overall Study|Severe Non-Compliance to Protocol|2
2240469|NCT01928862|3897635|FG000|Overall Study|Lost to Follow-up|1
2240470|NCT01928862|3897636|FG001|Overall Study|Lost to Follow-up|0
2240471|NCT01928862|3897637|FG002|Overall Study|Lost to Follow-up|0
2240472|NCT01928862|3897638|FG003|Overall Study|Lost to Follow-up|0
2240473|NCT01928862|3897639|FG004|Overall Study|Lost to Follow-up|1
2240474|NCT01928927|3897654|FG000|Overall Study|Lost to Follow-up|1
2240475|NCT01928927|3897655|FG001|Overall Study|Lost to Follow-up|0
2240476|NCT01928927|3897654|FG000|Overall Study|Withdrawal by Subject|1
2240477|NCT01928927|3897655|FG001|Overall Study|Withdrawal by Subject|1
2240478|NCT01928940|3897667|FG000|Overall Study|Adverse Event|0
2240479|NCT01928940|3897668|FG001|Overall Study|Adverse Event|1
2240480|NCT01929018|3897677|FG000|Overall Study|Lost to Follow-up|1
2240481|NCT01929018|3897678|FG001|Overall Study|Lost to Follow-up|0
2240482|NCT01929018|3897677|FG000|Overall Study|Hospitalization|0
2240483|NCT01929018|3897678|FG001|Overall Study|Hospitalization|1
2240484|NCT01929031|3897688|FG000|Overall Study|Adverse Event|3
2240485|NCT01929031|3897689|FG001|Overall Study|Adverse Event|1
2240486|NCT01929031|3897690|FG002|Overall Study|Adverse Event|1
2240487|NCT01929031|3897691|FG003|Overall Study|Adverse Event|0
2240488|NCT01929031|3897692|FG004|Overall Study|Adverse Event|0
2240489|NCT01929031|3897693|FG005|Overall Study|Adverse Event|0
2240490|NCT01929031|3897688|FG000|Overall Study|Protocol Violation|1
2240491|NCT01929031|3897689|FG001|Overall Study|Protocol Violation|0
2240492|NCT01929031|3897690|FG002|Overall Study|Protocol Violation|0
2240493|NCT01929031|3897691|FG003|Overall Study|Protocol Violation|0
2240494|NCT01929031|3897692|FG004|Overall Study|Protocol Violation|0
2240495|NCT01929031|3897693|FG005|Overall Study|Protocol Violation|1
2240496|NCT01929031|3897688|FG000|Overall Study|Reason other than specified above|0
2240497|NCT01929031|3897689|FG001|Overall Study|Reason other than specified above|1
2240498|NCT01929031|3897690|FG002|Overall Study|Reason other than specified above|0
2240499|NCT01929031|3897691|FG003|Overall Study|Reason other than specified above|0
2240500|NCT01929031|3897692|FG004|Overall Study|Reason other than specified above|1
2240501|NCT01929031|3897693|FG005|Overall Study|Reason other than specified above|0
2240502|NCT01929044|3897705|FG000|Overall Study|Adverse Event|1
2240503|NCT01929044|3897706|FG001|Overall Study|Adverse Event|0
2240504|NCT01929044|3897705|FG000|Overall Study|Protocol Violation|9
2240505|NCT01929044|3897706|FG001|Overall Study|Protocol Violation|14
2240506|NCT01929044|3897705|FG000|Overall Study|Not Treated|1
2240507|NCT01929044|3897706|FG001|Overall Study|Not Treated|3
2240508|NCT01929083|3897723|FG000|Intervention 1|Lost to Follow-up|2
2240509|NCT01929083|3897724|FG001|Intervention 1|Lost to Follow-up|0
2240510|NCT01929083|3897723|FG000|Intervention 1|Nonadherent to study medications|1
2240511|NCT01929083|3897724|FG001|Intervention 1|Nonadherent to study medications|0
2240512|NCT01929083|3897723|FG000|Intervention 2|Adverse Event|0
2240513|NCT01929083|3897724|FG001|Intervention 2|Adverse Event|1
2240514|NCT01929109|3897735|FG000|Period 1 (All Groups)|Deviation from protocol|0
2240515|NCT01929109|3897736|FG001|Period 1 (All Groups)|Deviation from protocol|0
2240516|NCT01929109|3897737|FG002|Period 1 (All Groups)|Deviation from protocol|1
2240517|NCT01929109|3897738|FG003|Period 1 (All Groups)|Deviation from protocol|0
2240518|NCT01929109|3897739|FG004|Period 1 (All Groups)|Deviation from protocol|0
2240519|NCT01929135|3897756|FG000|Overall Study|Lost to Follow-up|1
2240520|NCT01929135|3897757|FG001|Overall Study|Lost to Follow-up|1
2240521|NCT01929226|3897767|FG000|Overall Study|Lost to Follow-up|4
2240522|NCT01929226|3897768|FG001|Overall Study|Lost to Follow-up|0
2240523|NCT01929226|3897767|FG000|Overall Study|Withdrawal by Subject|1
2240524|NCT01929226|3897768|FG001|Overall Study|Withdrawal by Subject|1
2240525|NCT01929317|3897781|FG000|Dose Increase Effect Verification Phase|Adverse Event|5
2240526|NCT01929317|3897782|FG001|Dose Increase Effect Verification Phase|Adverse Event|1
2240527|NCT01929317|3897781|FG000|Dose Increase Effect Verification Phase|Physician Decision|1
2240528|NCT01929317|3897782|FG001|Dose Increase Effect Verification Phase|Physician Decision|0
2240529|NCT01929317|3897781|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
2240530|NCT01929317|3897782|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
2240531|NCT01929317|3897781|FG000|Long-term Phase|Adverse Event|5
2240532|NCT01929317|3897782|FG001|Long-term Phase|Adverse Event|1
2240533|NCT01929317|3897781|FG000|Long-term Phase|Physician Decision|3
2240534|NCT01929317|3897782|FG001|Long-term Phase|Physician Decision|0
2240535|NCT01929317|3897781|FG000|Long-term Phase|Withdrawal by Subject|4
2240536|NCT01929317|3897782|FG001|Long-term Phase|Withdrawal by Subject|0
2240537|NCT01929317|3897781|FG000|Long-term Phase|Protocol Violation|1
2240538|NCT01929317|3897782|FG001|Long-term Phase|Protocol Violation|0
2240539|NCT01929317|3897781|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1
2240540|NCT01929317|3897782|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0
2240541|NCT01929317|3897781|FG000|Long-term Phase|Study Closed/Terminated|5
2240542|NCT01929317|3897782|FG001|Long-term Phase|Study Closed/Terminated|3
2240543|NCT01929343|3897797|FG000|Overall Study|Physician Decision|0
2240544|NCT01929343|3897798|FG001|Overall Study|Physician Decision|2
2240545|NCT01929343|3897799|FG002|Overall Study|Physician Decision|0
2240546|NCT01929343|3897797|FG000|Overall Study|Withdrawal by Subject|1
2336848|NCT03307837|4064031|FG004|Overall Study|Lost to Follow-up|0
2336849|NCT03307837|4064032|FG005|Overall Study|Lost to Follow-up|1
2336850|NCT03308825|4064107|FG000|Overall Study|Lost to Follow-up|2
2336851|NCT03308825|4064108|FG001|Overall Study|Lost to Follow-up|2
2336852|NCT03308825|4064109|FG002|Overall Study|Lost to Follow-up|1
2336853|NCT03308825|4064110|FG003|Overall Study|Lost to Follow-up|0
2336854|NCT03308825|4064107|FG000|Overall Study|Protocol Violation|0
2336855|NCT03308825|4064108|FG001|Overall Study|Protocol Violation|2
2336856|NCT03308825|4064109|FG002|Overall Study|Protocol Violation|0
2336857|NCT03308825|4064110|FG003|Overall Study|Protocol Violation|0
2336858|NCT03308942|4064129|FG000|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
2336859|NCT03308942|4064130|FG001|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
2336860|NCT03308942|4064131|FG002|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
2336861|NCT03308942|4064132|FG003|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|0
2336862|NCT03308942|4064133|FG004|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|0
2336863|NCT03308942|4064129|FG000|Stage 1 (up to a Maximum of 29 Months)|Death|8
2336864|NCT03308942|4064130|FG001|Stage 1 (up to a Maximum of 29 Months)|Death|15
2336865|NCT03308942|4064131|FG002|Stage 1 (up to a Maximum of 29 Months)|Death|1
2336866|NCT03308942|4064132|FG003|Stage 1 (up to a Maximum of 29 Months)|Death|0
2336867|NCT03308942|4064133|FG004|Stage 1 (up to a Maximum of 29 Months)|Death|0
2336868|NCT03308942|4064129|FG000|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|7
2336869|NCT03308942|4064130|FG001|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|4
2336870|NCT03308942|4064131|FG002|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
2336871|NCT03308942|4064132|FG003|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
2336872|NCT03308942|4064133|FG004|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
2336873|NCT03308942|4064129|FG000|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
2336874|NCT03308942|4064130|FG001|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
2336875|NCT03308942|4064131|FG002|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
2336876|NCT03308942|4064132|FG003|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|3
2336877|NCT03308942|4064133|FG004|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
2336878|NCT03308942|4064129|FG000|Stage 2 (up to a Maximum of 17 Months)|Death|0
2336879|NCT03308942|4064130|FG001|Stage 2 (up to a Maximum of 17 Months)|Death|0
2336880|NCT03308942|4064131|FG002|Stage 2 (up to a Maximum of 17 Months)|Death|0
2336881|NCT03308942|4064132|FG003|Stage 2 (up to a Maximum of 17 Months)|Death|4
2336882|NCT03308942|4064133|FG004|Stage 2 (up to a Maximum of 17 Months)|Death|0
2336883|NCT03308942|4064129|FG000|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
2336884|NCT03308942|4064130|FG001|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
2336885|NCT03308942|4064131|FG002|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
2336886|NCT03308942|4064132|FG003|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|5
2336887|NCT03308942|4064133|FG004|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
2336888|NCT03308968|4064149|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3
2336889|NCT03308968|4064150|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1
2336890|NCT03308968|4064151|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4
2037282|NCT00416624|3607585|FG001|Overall Study|Other|11
2037283|NCT00416624|3607586|FG002|Overall Study|Other|5
2037284|NCT00416624|3607587|FG003|Overall Study|Other|5
2037285|NCT00416624|3607584|FG000|Overall Study|Cancel|1
2037286|NCT00416624|3607585|FG001|Overall Study|Cancel|0
2037287|NCT00416624|3607586|FG002|Overall Study|Cancel|0
2037288|NCT00416624|3607587|FG003|Overall Study|Cancel|0
2240547|NCT01929343|3897798|FG001|Overall Study|Withdrawal by Subject|0
2240548|NCT01929343|3897799|FG002|Overall Study|Withdrawal by Subject|0
2240549|NCT01929395|3897810|FG000|Overall Study|Did not complete - non-related toxicity|1
2240550|NCT01929395|3897811|FG001|Overall Study|Did not complete - non-related toxicity|0
2240551|NCT01929395|3897812|FG002|Overall Study|Did not complete - non-related toxicity|0
2240552|NCT01929395|3897810|FG000|Overall Study|Withdrawal by Subject|0
2240553|NCT01929395|3897811|FG001|Overall Study|Withdrawal by Subject|1
2240554|NCT01929395|3897812|FG002|Overall Study|Withdrawal by Subject|0
2240555|NCT01929395|3897810|FG000|Overall Study|Screen Fail|0
2240556|NCT01929395|3897811|FG001|Overall Study|Screen Fail|0
2240557|NCT01929395|3897812|FG002|Overall Study|Screen Fail|1
2240558|NCT01929408|3897820|FG000|Overall Study|received HCT as initial treatment|8
2336891|NCT03308968|4064149|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
2336892|NCT03308968|4064150|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
2336893|NCT03308968|4064151|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
2336894|NCT03308968|4064149|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6
2336895|NCT03308968|4064150|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0
2336896|NCT03308968|4064151|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2
2336897|NCT03308968|4064149|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
2336898|NCT03308968|4064150|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
2336899|NCT03308968|4064151|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
2336900|NCT03308968|4064149|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
2336901|NCT03308968|4064150|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
2336902|NCT03308968|4064151|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
2336903|NCT03308968|4064149|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
2336904|NCT03308968|4064150|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
2336905|NCT03308968|4064151|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
2336906|NCT03308968|4064149|FG000|Double-Blind Period (12 Weeks)|Other than specified|1
2336907|NCT03308968|4064150|FG001|Double-Blind Period (12 Weeks)|Other than specified|0
2336908|NCT03308968|4064151|FG002|Double-Blind Period (12 Weeks)|Other than specified|2
2336909|NCT03308968|4064149|FG000|Open-Label Period (12 Weeks)|Other than specified|1
2336910|NCT03308968|4064150|FG001|Open-Label Period (12 Weeks)|Other than specified|2
2336911|NCT03308968|4064151|FG002|Open-Label Period (12 Weeks)|Other than specified|1
2336912|NCT03308968|4064149|FG000|Open-Label Period (12 Weeks)|Adverse Event|4
2336913|NCT03308968|4064150|FG001|Open-Label Period (12 Weeks)|Adverse Event|1
2336914|NCT03308968|4064151|FG002|Open-Label Period (12 Weeks)|Adverse Event|1
2336915|NCT03308968|4064149|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
2336916|NCT03308968|4064150|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
2336917|NCT03308968|4064151|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
2336918|NCT03308968|4064149|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0
2336919|NCT03308968|4064150|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1
2336920|NCT03308968|4064151|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1
2336921|NCT03308968|4064149|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
2336922|NCT03308968|4064150|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
2336923|NCT03308968|4064151|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
2336924|NCT03308968|4064149|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0
2336925|NCT03308968|4064150|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1
2336926|NCT03308968|4064151|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1
2336927|NCT03308968|4064149|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1
2336928|NCT03308968|4064150|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2
2336929|NCT03308968|4064151|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0
2336930|NCT03309020|4064164|FG000|Overall Study|Death|1
2336931|NCT03309020|4064165|FG001|Overall Study|Death|0
2336932|NCT03309020|4064164|FG000|Overall Study|Did not undergo surgery|2
2336933|NCT03309020|4064165|FG001|Overall Study|Did not undergo surgery|1
2336934|NCT03309202|4064177|FG000|Overall Study|Lost to Follow-up|1
2336935|NCT03309202|4064178|FG001|Overall Study|Lost to Follow-up|0
2336936|NCT03309202|4064179|FG002|Overall Study|Lost to Follow-up|0
2336937|NCT03309202|4064180|FG003|Overall Study|Lost to Follow-up|0
2336938|NCT03309605|4064211|FG000|Overall Study|Adverse Event|0
2336939|NCT03309605|4064212|FG001|Overall Study|Adverse Event|0
2336940|NCT03309605|4064213|FG002|Overall Study|Adverse Event|0
2336941|NCT03309605|4064214|FG003|Overall Study|Adverse Event|1
2336942|NCT03309605|4064215|FG004|Overall Study|Adverse Event|0
2336943|NCT03309605|4064216|FG005|Overall Study|Adverse Event|0
2336944|NCT03309605|4064217|FG006|Overall Study|Adverse Event|2
2336945|NCT03309605|4064218|FG007|Overall Study|Adverse Event|1
2336946|NCT03309605|4064211|FG000|Overall Study|Withdrawal by Subject|0
2336947|NCT03309605|4064212|FG001|Overall Study|Withdrawal by Subject|0
2336948|NCT03309605|4064213|FG002|Overall Study|Withdrawal by Subject|0
2336949|NCT03309605|4064214|FG003|Overall Study|Withdrawal by Subject|0
2336950|NCT03309605|4064215|FG004|Overall Study|Withdrawal by Subject|1
2336951|NCT03309605|4064216|FG005|Overall Study|Withdrawal by Subject|0
2336952|NCT03309605|4064217|FG006|Overall Study|Withdrawal by Subject|1
2336953|NCT03309605|4064218|FG007|Overall Study|Withdrawal by Subject|1
2336954|NCT03309696|4064238|FG000|Overall Study|Analysis of TEP data could not be completed|0
2336955|NCT03309696|4064239|FG001|Overall Study|Analysis of TEP data could not be completed|5
2240559|NCT01929681|3897845|FG000|Overall Study|Withdrawal by Subject|1
2240560|NCT01929681|3897846|FG001|Overall Study|Withdrawal by Subject|0
2240561|NCT01929681|3897845|FG000|Overall Study|Physician Decision|1
2240562|NCT01929681|3897846|FG001|Overall Study|Physician Decision|1
2240563|NCT01929707|3897852|FG000|Intervention Period 1|Lost to Follow-up|0
2336956|NCT03309696|4064240|FG002|Overall Study|Analysis of TEP data could not be completed|0
2336957|NCT03309696|4064241|FG003|Overall Study|Analysis of TEP data could not be completed|0
2336958|NCT03309943|4064270|FG000|Overall Study|Withdrawal by Subject|0
2336959|NCT03309943|4064271|FG001|Overall Study|Withdrawal by Subject|1
2336960|NCT03309943|4064270|FG000|Overall Study|Inappropriate behavior towards staff|0
2336961|NCT03309943|4064271|FG001|Overall Study|Inappropriate behavior towards staff|1
2336962|NCT03310021|4064297|FG000|Overall Study|Withdrawal by Subject|0
2336963|NCT03310021|4064298|FG001|Overall Study|Withdrawal by Subject|0
2336964|NCT03310021|4064299|FG002|Overall Study|Withdrawal by Subject|0
2336965|NCT03310021|4064300|FG003|Overall Study|Withdrawal by Subject|0
2336966|NCT03310021|4064301|FG004|Overall Study|Withdrawal by Subject|0
2336967|NCT03310021|4064302|FG005|Overall Study|Withdrawal by Subject|0
2336968|NCT03310021|4064303|FG006|Overall Study|Withdrawal by Subject|1
2336969|NCT03310021|4064304|FG007|Overall Study|Withdrawal by Subject|0
2336970|NCT03310021|4064305|FG008|Overall Study|Withdrawal by Subject|0
2336971|NCT03310021|4064306|FG009|Overall Study|Withdrawal by Subject|0
2336972|NCT03310021|4064307|FG010|Overall Study|Withdrawal by Subject|0
2336973|NCT03310021|4064308|FG011|Overall Study|Withdrawal by Subject|0
2336974|NCT03310021|4064309|FG012|Overall Study|Withdrawal by Subject|0
2336975|NCT03310021|4064310|FG013|Overall Study|Withdrawal by Subject|0
2336976|NCT03310021|4064311|FG014|Overall Study|Withdrawal by Subject|0
2336977|NCT03310021|4064312|FG015|Overall Study|Withdrawal by Subject|0
2336978|NCT03310021|4064313|FG016|Overall Study|Withdrawal by Subject|0
2336979|NCT03310021|4064314|FG017|Overall Study|Withdrawal by Subject|0
2336980|NCT03310021|4064315|FG018|Overall Study|Withdrawal by Subject|0
2336981|NCT03310021|4064316|FG019|Overall Study|Withdrawal by Subject|0
2336982|NCT03310021|4064297|FG000|Overall Study|Lost to Follow-up|0
2336983|NCT03310021|4064298|FG001|Overall Study|Lost to Follow-up|0
2336984|NCT03310021|4064299|FG002|Overall Study|Lost to Follow-up|0
2336985|NCT03310021|4064300|FG003|Overall Study|Lost to Follow-up|0
2336986|NCT03310021|4064301|FG004|Overall Study|Lost to Follow-up|0
2336987|NCT03310021|4064302|FG005|Overall Study|Lost to Follow-up|0
2336988|NCT03310021|4064303|FG006|Overall Study|Lost to Follow-up|0
2336989|NCT03310021|4064304|FG007|Overall Study|Lost to Follow-up|0
2336990|NCT03310021|4064305|FG008|Overall Study|Lost to Follow-up|0
2336991|NCT03310021|4064306|FG009|Overall Study|Lost to Follow-up|0
2336992|NCT03310021|4064307|FG010|Overall Study|Lost to Follow-up|1
2336993|NCT03310021|4064308|FG011|Overall Study|Lost to Follow-up|0
2336994|NCT03310021|4064309|FG012|Overall Study|Lost to Follow-up|0
2336995|NCT03310021|4064310|FG013|Overall Study|Lost to Follow-up|0
2336996|NCT03310021|4064311|FG014|Overall Study|Lost to Follow-up|0
2336997|NCT03310021|4064312|FG015|Overall Study|Lost to Follow-up|0
2336998|NCT03310021|4064313|FG016|Overall Study|Lost to Follow-up|0
2336999|NCT03310021|4064314|FG017|Overall Study|Lost to Follow-up|0
2337000|NCT03310021|4064315|FG018|Overall Study|Lost to Follow-up|0
2337001|NCT03310021|4064316|FG019|Overall Study|Lost to Follow-up|0
2337002|NCT03310268|4064361|FG000|Overall Study|(Not specified)|1
2337003|NCT03310268|4064362|FG001|Overall Study|(Not specified)|5
2337004|NCT03310268|4064363|FG002|Overall Study|(Not specified)|0
2337005|NCT03310411|4064371|FG000|Period 1|Adverse Event|0
2337006|NCT03310411|4064372|FG001|Period 1|Adverse Event|0
2337007|NCT03310411|4064373|FG002|Period 1|Adverse Event|0
2337008|NCT03310411|4064374|FG003|Period 1|Adverse Event|1
2337009|NCT03310580|4064409|FG000|Overall Study|Adverse Event|0
2337010|NCT03310580|4064410|FG001|Overall Study|Adverse Event|1
2337011|NCT03310580|4064411|FG002|Overall Study|Adverse Event|0
2337012|NCT03310723|4064422|FG000|Overall Study|Withdrawal by Subject|0
2337013|NCT03310723|4064423|FG001|Overall Study|Withdrawal by Subject|1
2337014|NCT03310723|4064422|FG000|Overall Study|Protocol Violation|0
2337015|NCT03310723|4064423|FG001|Overall Study|Protocol Violation|2
2337016|NCT03310775|4064431|FG000|Overall Study|Lost to Follow-up|2
2337017|NCT03310775|4064432|FG001|Overall Study|Lost to Follow-up|3
2337018|NCT03310775|4064431|FG000|Overall Study|aggravation of depression|0
2337019|NCT03310775|4064432|FG001|Overall Study|aggravation of depression|1
2337020|NCT03310970|4064438|FG000|Overall Study|Withdrawal by Subject|0
2337021|NCT03310970|4064439|FG001|Overall Study|Withdrawal by Subject|1
2337022|NCT03311230|4064450|FG000|Overall Study|Withdrawal by Subject|1
2337023|NCT03311230|4064451|FG001|Overall Study|Withdrawal by Subject|4
2337024|NCT03311230|4064452|FG002|Overall Study|Withdrawal by Subject|2
2337025|NCT03311230|4064453|FG003|Overall Study|Withdrawal by Subject|7
2337026|NCT03311230|4064450|FG000|Overall Study|Unrelated injury|0
2337027|NCT03311230|4064451|FG001|Overall Study|Unrelated injury|1
2337028|NCT03311230|4064452|FG002|Overall Study|Unrelated injury|0
2337029|NCT03311230|4064453|FG003|Overall Study|Unrelated injury|0
2337030|NCT03311373|4064463|FG000|Overall Study|Adverse Event|1
2337031|NCT03311373|4064463|FG000|Overall Study|Protocol Discontinuation Criteria|3
2337032|NCT03311373|4064463|FG000|Overall Study|Lost to Follow-up|1
2337033|NCT03311373|4064463|FG000|Overall Study|Physician Decision|1
2337034|NCT03311373|4064463|FG000|Overall Study|Withdrawal by Subject|3
2240564|NCT01929707|3897853|FG001|Intervention Period 1|Lost to Follow-up|0
2240565|NCT01929707|3897854|FG002|Intervention Period 1|Lost to Follow-up|0
2240566|NCT01929707|3897855|FG003|Intervention Period 1|Lost to Follow-up|1
2240567|NCT01929707|3897856|FG004|Intervention Period 1|Lost to Follow-up|0
2240568|NCT01929707|3897857|FG005|Intervention Period 1|Lost to Follow-up|0
2240569|NCT01929707|3897858|FG006|Intervention Period 1|Lost to Follow-up|0
2240570|NCT01929707|3897859|FG007|Intervention Period 1|Lost to Follow-up|0
2240571|NCT01929707|3897852|FG000|Intervention Period 1|Withdrawal by Subject|0
2240572|NCT01929707|3897853|FG001|Intervention Period 1|Withdrawal by Subject|0
2240573|NCT01929707|3897854|FG002|Intervention Period 1|Withdrawal by Subject|0
2240574|NCT01929707|3897855|FG003|Intervention Period 1|Withdrawal by Subject|2
2240575|NCT01929707|3897856|FG004|Intervention Period 1|Withdrawal by Subject|0
2240576|NCT01929707|3897857|FG005|Intervention Period 1|Withdrawal by Subject|0
2240577|NCT01929707|3897858|FG006|Intervention Period 1|Withdrawal by Subject|0
2240578|NCT01929707|3897859|FG007|Intervention Period 1|Withdrawal by Subject|0
2240579|NCT01929707|3897852|FG000|Intervention Period 2|Withdrawal by Subject|0
2240580|NCT01929707|3897853|FG001|Intervention Period 2|Withdrawal by Subject|0
2240581|NCT01929707|3897854|FG002|Intervention Period 2|Withdrawal by Subject|0
2240582|NCT01929707|3897855|FG003|Intervention Period 2|Withdrawal by Subject|0
2240583|NCT01929707|3897856|FG004|Intervention Period 2|Withdrawal by Subject|0
2240584|NCT01929707|3897857|FG005|Intervention Period 2|Withdrawal by Subject|2
2240585|NCT01929707|3897858|FG006|Intervention Period 2|Withdrawal by Subject|0
2240586|NCT01929707|3897859|FG007|Intervention Period 2|Withdrawal by Subject|0
2240587|NCT01929863|3897884|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
2337035|NCT03311646|4064473|FG000|Overall Study|Physician Decision|1
2337036|NCT03311646|4064473|FG000|Overall Study|Withdrawal by Subject|5
2337037|NCT03311646|4064473|FG000|Overall Study|Lost to Follow-up|5
2337038|NCT03311646|4064473|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4
2037289|NCT00416715|3607597|FG000|Overall Study|Not evaluable for joint aches|7
2037290|NCT00416715|3607597|FG000|Overall Study|Vitamin D levels not evaluable|8
2037291|NCT00416884|3607608|FG000|Overall Study|Study terminated due to low accrual|1
2037292|NCT00416949|3607612|FG000|Overall Study|Patients refused to participate|5
2037293|NCT00417027|3607619|FG000|Overall Study|Protocol Violation|0
2037294|NCT00417027|3607620|FG001|Overall Study|Protocol Violation|5
2037295|NCT00417027|3607621|FG002|Overall Study|Protocol Violation|5
2037296|NCT00417079|3607631|FG000|Overall Study|Disease progression|267
2037297|NCT00417079|3607632|FG001|Overall Study|Disease progression|180
2037298|NCT00417079|3607631|FG000|Overall Study|Adverse Event|32
2037299|NCT00417079|3607632|FG001|Overall Study|Adverse Event|67
2037300|NCT00417079|3607631|FG000|Overall Study|Non-compliance to protocol|0
2037301|NCT00417079|3607632|FG001|Overall Study|Non-compliance to protocol|1
2037302|NCT00417079|3607631|FG000|Overall Study|Lost to Follow-up|2
2037303|NCT00417079|3607632|FG001|Overall Study|Lost to Follow-up|0
2037304|NCT00417079|3607631|FG000|Overall Study|Withdrawal by Subject|17
2037305|NCT00417079|3607632|FG001|Overall Study|Withdrawal by Subject|8
2037306|NCT00417079|3607631|FG000|Overall Study|Not treated|6
2037307|NCT00417079|3607632|FG001|Overall Study|Not treated|7
2037308|NCT00417079|3607631|FG000|Overall Study|Screened failure|2
2037309|NCT00417079|3607632|FG001|Overall Study|Screened failure|1
2037310|NCT00417079|3607631|FG000|Overall Study|Investigator's decision|1
2037311|NCT00417079|3607632|FG001|Overall Study|Investigator's decision|4
2037312|NCT00417079|3607631|FG000|Overall Study|Non-confirmed Disease progression|1
2037313|NCT00417079|3607632|FG001|Overall Study|Non-confirmed Disease progression|1
2037314|NCT00417079|3607631|FG000|Overall Study|Clinical deterioration|1
2037315|NCT00417079|3607632|FG001|Overall Study|Clinical deterioration|0
2037316|NCT00417079|3607631|FG000|Overall Study|Screening error|2
2037317|NCT00417079|3607632|FG001|Overall Study|Screening error|1
2037318|NCT00417079|3607631|FG000|Overall Study|Withdrawal by subject's family|0
2037319|NCT00417079|3607632|FG001|Overall Study|Withdrawal by subject's family|1
2037320|NCT00417079|3607631|FG000|Overall Study|Patient unable to come to the clinic|0
2037321|NCT00417079|3607632|FG001|Overall Study|Patient unable to come to the clinic|1
2037322|NCT00417079|3607631|FG000|Overall Study|abnormal liver function tests|0
2037323|NCT00417079|3607632|FG001|Overall Study|abnormal liver function tests|1
2037324|NCT00417170|3607640|FG000|Overall Study|Adverse Event|1
2037325|NCT00417170|3607641|FG001|Overall Study|Adverse Event|1
2037326|NCT00417170|3607640|FG000|Overall Study|Withdrawal by Subject|1
2037327|NCT00417170|3607641|FG001|Overall Study|Withdrawal by Subject|1
2037328|NCT00417170|3607640|FG000|Overall Study|Lost to Follow-up|0
2037329|NCT00417170|3607641|FG001|Overall Study|Lost to Follow-up|1
2037330|NCT00417482|3607665|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14
2037331|NCT00417482|3607666|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8
2037332|NCT00417482|3607667|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24
2037333|NCT00417482|3607665|FG000|Phase B 1st 16 Weeks|Adverse Event|2
2037334|NCT00417482|3607666|FG001|Phase B 1st 16 Weeks|Adverse Event|0
2037335|NCT00417482|3607667|FG002|Phase B 1st 16 Weeks|Adverse Event|1
2037336|NCT00417482|3607665|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
2037337|NCT00417482|3607666|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
2037338|NCT00417482|3607667|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
2037339|NCT00417482|3607665|FG000|Phase B 1st 16 Weeks|Death|1
2037340|NCT00417482|3607666|FG001|Phase B 1st 16 Weeks|Death|0
2240588|NCT01929863|3897885|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
2240589|NCT01929863|3897884|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
2240590|NCT01929863|3897885|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
2240591|NCT01929863|3897884|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
2240592|NCT01929863|3897885|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
2240593|NCT01929876|3897896|FG000|Period 2|Non-Compliance|1
2240594|NCT01929980|3897904|FG000|Overall Study|Physician Decision|1
2240595|NCT01929993|3897910|FG000|Overall Study|Protocol Violation|4
2240596|NCT01929993|3897911|FG001|Overall Study|Protocol Violation|6
2240597|NCT01929993|3897910|FG000|Overall Study|Absent CIN, invasion present or artifact|26
2240598|NCT01929993|3897911|FG001|Overall Study|Absent CIN, invasion present or artifact|22
2240599|NCT01930045|3897917|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0
2240600|NCT01930045|3897918|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0
2240601|NCT01930045|3897919|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0
2240602|NCT01930045|3897920|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0
2240603|NCT01930045|3897921|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0
2240604|NCT01930045|3897922|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1
2240605|NCT01930045|3897917|FG000|Pause (up to 37 Days)|Protocol Violation|0
2240606|NCT01930045|3897918|FG001|Pause (up to 37 Days)|Protocol Violation|0
2240607|NCT01930045|3897919|FG002|Pause (up to 37 Days)|Protocol Violation|0
2240608|NCT01930045|3897920|FG003|Pause (up to 37 Days)|Protocol Violation|0
2240609|NCT01930045|3897921|FG004|Pause (up to 37 Days)|Protocol Violation|0
2240610|NCT01930045|3897922|FG005|Pause (up to 37 Days)|Protocol Violation|1
2240611|NCT01930162|3897946|FG000|Overall Study|Abnormal test procedure result(s)|4
2240612|NCT01930162|3897946|FG000|Overall Study|Death|1
2240613|NCT01930175|3897954|FG000|Core Study|Lost to Follow-up|0
2240614|NCT01930175|3897955|FG001|Core Study|Lost to Follow-up|1
2240615|NCT01930175|3897956|FG002|Core Study|Lost to Follow-up|0
2240616|NCT01930175|3897954|FG000|Core Study|Adverse Event|0
2240617|NCT01930175|3897955|FG001|Core Study|Adverse Event|0
2240618|NCT01930175|3897956|FG002|Core Study|Adverse Event|1
2240619|NCT01930188|3897968|FG000|Overall Study|unclassified|4
2240620|NCT01930188|3897969|FG001|Overall Study|unclassified|5
2240621|NCT01930188|3897970|FG002|Overall Study|unclassified|3
2240622|NCT01930188|3897968|FG000|Overall Study|Missing follow-up information|2
2240623|NCT01930188|3897969|FG001|Overall Study|Missing follow-up information|2
2240624|NCT01930188|3897970|FG002|Overall Study|Missing follow-up information|3
2240625|NCT01930188|3897968|FG000|Overall Study|Lost to Follow-up|5
2240626|NCT01930188|3897969|FG001|Overall Study|Lost to Follow-up|2
2240627|NCT01930188|3897970|FG002|Overall Study|Lost to Follow-up|2
2240628|NCT01930188|3897968|FG000|Overall Study|Death|2
2240629|NCT01930188|3897969|FG001|Overall Study|Death|1
2240630|NCT01930188|3897970|FG002|Overall Study|Death|3
2240631|NCT01930188|3897968|FG000|Overall Study|Withdrawal by Subject|9
2240632|NCT01930188|3897969|FG001|Overall Study|Withdrawal by Subject|11
2240633|NCT01930188|3897970|FG002|Overall Study|Withdrawal by Subject|8
2240634|NCT01930214|3897982|FG000|Overall Study|Death|4
2240635|NCT01930214|3897983|FG001|Overall Study|Death|4
2240636|NCT01930214|3897984|FG002|Overall Study|Death|11
2240637|NCT01930214|3897982|FG000|Overall Study|Lost to Follow-up|12
2240638|NCT01930214|3897983|FG001|Overall Study|Lost to Follow-up|13
2240639|NCT01930214|3897984|FG002|Overall Study|Lost to Follow-up|12
2240640|NCT01930214|3897982|FG000|Overall Study|Voluntary withdrawal of infomed consent|2
2240641|NCT01930214|3897983|FG001|Overall Study|Voluntary withdrawal of infomed consent|4
2240642|NCT01930214|3897984|FG002|Overall Study|Voluntary withdrawal of infomed consent|2
2240643|NCT01930214|3897982|FG000|Overall Study|Physician Decision|2
2240644|NCT01930214|3897983|FG001|Overall Study|Physician Decision|0
2240645|NCT01930214|3897984|FG002|Overall Study|Physician Decision|0
2240646|NCT01930799|3898026|FG000|Overall Study|Withdrawal by Subject|3
2240647|NCT01930799|3898026|FG000|Overall Study|Lost to Follow-up|5
2240648|NCT01930890|3898034|FG000|Overall Study|Study Termination|14
2240649|NCT01930890|3898035|FG001|Overall Study|Study Termination|28
2240650|NCT01930890|3898036|FG002|Overall Study|Study Termination|13
2240651|NCT01930890|3898037|FG003|Overall Study|Study Termination|25
2240652|NCT01930890|3898034|FG000|Overall Study|Death|0
2240653|NCT01930890|3898035|FG001|Overall Study|Death|0
2337039|NCT03311659|4064478|FG000|Overall Study|Protocol Violation|1
2337040|NCT03311724|4064486|FG000|Overall Study|Physician Decision|0
2337041|NCT03311724|4064487|FG001|Overall Study|Physician Decision|0
2337042|NCT03311724|4064488|FG002|Overall Study|Physician Decision|0
2337043|NCT03311724|4064489|FG003|Overall Study|Physician Decision|1
2337044|NCT03311724|4064486|FG000|Overall Study|Protocol Violation|1
2337045|NCT03311724|4064487|FG001|Overall Study|Protocol Violation|0
2337046|NCT03311724|4064488|FG002|Overall Study|Protocol Violation|1
2337047|NCT03311724|4064489|FG003|Overall Study|Protocol Violation|0
2337048|NCT03311724|4064486|FG000|Overall Study|Withdrawal by Subject|1
2240654|NCT01930890|3898036|FG002|Overall Study|Death|0
2240655|NCT01930890|3898037|FG003|Overall Study|Death|1
2240656|NCT01930890|3898034|FG000|Overall Study|Investigator Decision|0
2240657|NCT01930890|3898035|FG001|Overall Study|Investigator Decision|1
2240658|NCT01930890|3898036|FG002|Overall Study|Investigator Decision|0
2240659|NCT01930890|3898037|FG003|Overall Study|Investigator Decision|0
2240660|NCT01930890|3898034|FG000|Overall Study|Consent Withdrawn|0
2240661|NCT01930890|3898035|FG001|Overall Study|Consent Withdrawn|3
2240662|NCT01930890|3898036|FG002|Overall Study|Consent Withdrawn|0
2240663|NCT01930890|3898037|FG003|Overall Study|Consent Withdrawn|1
2240664|NCT01930890|3898034|FG000|Overall Study|Adverse Event|0
2240665|NCT01930890|3898035|FG001|Overall Study|Adverse Event|1
2240666|NCT01930890|3898036|FG002|Overall Study|Adverse Event|0
2240667|NCT01930890|3898037|FG003|Overall Study|Adverse Event|0
2240668|NCT01931059|3898049|FG000|Day 1|Pregnancy|0
2240669|NCT01931059|3898050|FG001|Day 1|Pregnancy|1
2240670|NCT01931059|3898049|FG000|Day3|Lost to Follow-up|1
2240671|NCT01931059|3898050|FG001|Day3|Lost to Follow-up|0
2240672|NCT01931150|3898064|FG000|Overall Study|Withdrawal by Subject|1
2240673|NCT01931150|3898065|FG001|Overall Study|Withdrawal by Subject|2
2240674|NCT01931202|3898078|FG000|Overall Study|Withdrawal by Subject|0
2240675|NCT01931202|3898079|FG001|Overall Study|Withdrawal by Subject|0
2240676|NCT01931202|3898080|FG002|Overall Study|Withdrawal by Subject|2
2240677|NCT01931202|3898078|FG000|Overall Study|Lost to Follow-up|0
2240678|NCT01931202|3898079|FG001|Overall Study|Lost to Follow-up|5
2240679|NCT01931202|3898080|FG002|Overall Study|Lost to Follow-up|2
2240680|NCT01931397|3898091|FG000|Overall Study|Physician Decision|2
2240681|NCT01931397|3898091|FG000|Overall Study|Withdrawal by Subject|8
2240682|NCT01931397|3898091|FG000|Overall Study|moved out of state|1
2240683|NCT01931462|3898099|FG000|Overall Study|Withdrawal by Subject|1
2240684|NCT01931475|3898105|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20
2240685|NCT01931475|3898106|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10
2240686|NCT01931475|3898105|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
2240687|NCT01931475|3898106|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
2240688|NCT01931475|3898105|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
2240689|NCT01931475|3898106|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
2240690|NCT01931475|3898105|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
2240691|NCT01931475|3898106|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
2240692|NCT01931475|3898105|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0
2240693|NCT01931475|3898106|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1
2240694|NCT01931475|3898105|FG000|Period 2: Extension Treatment Phase|Adverse Event|0
2240695|NCT01931475|3898106|FG001|Period 2: Extension Treatment Phase|Adverse Event|8
2240696|NCT01931475|3898105|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1
2240697|NCT01931475|3898106|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0
2240698|NCT01931475|3898105|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
2240699|NCT01931475|3898106|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
2240700|NCT01931475|3898105|FG000|Period 2: Extension Treatment Phase|Physician Decision|1
2240701|NCT01931475|3898106|FG001|Period 2: Extension Treatment Phase|Physician Decision|1
2240702|NCT01931475|3898105|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
2240703|NCT01931475|3898106|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
2240704|NCT01931475|3898105|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1
2240705|NCT01931475|3898106|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1
2240706|NCT01931566|3898133|FG000|Overall Study|Randomized But Not Treated|6
2240707|NCT01931566|3898134|FG001|Overall Study|Randomized But Not Treated|9
2240708|NCT01931566|3898135|FG002|Overall Study|Randomized But Not Treated|14
2240709|NCT01931566|3898133|FG000|Overall Study|Adverse Event|37
2240710|NCT01931566|3898134|FG001|Overall Study|Adverse Event|167
2240711|NCT01931566|3898135|FG002|Overall Study|Adverse Event|132
2337049|NCT03311724|4064487|FG001|Overall Study|Withdrawal by Subject|1
2337050|NCT03311724|4064488|FG002|Overall Study|Withdrawal by Subject|0
2337051|NCT03311724|4064489|FG003|Overall Study|Withdrawal by Subject|0
2337052|NCT03311724|4064486|FG000|Overall Study|Lost to Follow-up|1
2337053|NCT03311724|4064487|FG001|Overall Study|Lost to Follow-up|0
2337054|NCT03311724|4064488|FG002|Overall Study|Lost to Follow-up|0
2337055|NCT03311724|4064489|FG003|Overall Study|Lost to Follow-up|0
2337056|NCT03311724|4064486|FG000|Overall Study|Sponsor Decision|0
2337057|NCT03311724|4064487|FG001|Overall Study|Sponsor Decision|0
2337058|NCT03311724|4064488|FG002|Overall Study|Sponsor Decision|1
2337059|NCT03311724|4064489|FG003|Overall Study|Sponsor Decision|0
2337060|NCT03311841|4064507|FG000|14-day Wash-out|Adverse Event|0
2337061|NCT03311841|4064508|FG001|14-day Wash-out|Adverse Event|1
2337062|NCT03311841|4064509|FG002|14-day Wash-out|Adverse Event|0
2337063|NCT03311841|4064510|FG003|14-day Wash-out|Adverse Event|0
2337064|NCT03311841|4064511|FG004|14-day Wash-out|Adverse Event|0
2337065|NCT03311841|4064507|FG000|14-day Wash-out|Non-Compliance With Study Drug|0
2337066|NCT03311841|4064508|FG001|14-day Wash-out|Non-Compliance With Study Drug|0
2337067|NCT03311841|4064509|FG002|14-day Wash-out|Non-Compliance With Study Drug|0
2337068|NCT03311841|4064510|FG003|14-day Wash-out|Non-Compliance With Study Drug|1
2337069|NCT03311841|4064511|FG004|14-day Wash-out|Non-Compliance With Study Drug|0
2337070|NCT03312114|4064550|FG000|Overall Study|All the five enrolled dropped out of the|5
2337071|NCT03312218|4064557|FG000|Overall Study|Never signed in to access the app|54
2337072|NCT03312218|4064558|FG001|Overall Study|Never signed in to access the app|58
2337073|NCT03312231|4064569|FG000|Overall Study|Lost to Follow-up|2
2337074|NCT03312231|4064570|FG001|Overall Study|Lost to Follow-up|6
2337075|NCT03312231|4064571|FG002|Overall Study|Lost to Follow-up|1
2337076|NCT03312231|4064572|FG003|Overall Study|Lost to Follow-up|3
2337077|NCT03312231|4064573|FG004|Overall Study|Lost to Follow-up|1
2337078|NCT03312231|4064569|FG000|Overall Study|Withdrawal by Subject|0
2240712|NCT01931566|3898133|FG000|Overall Study|Major Protocol Deviation|5
2240713|NCT01931566|3898134|FG001|Overall Study|Major Protocol Deviation|14
2240714|NCT01931566|3898135|FG002|Overall Study|Major Protocol Deviation|21
2240715|NCT01931566|3898133|FG000|Overall Study|Lost to Follow-up|3
2240716|NCT01931566|3898134|FG001|Overall Study|Lost to Follow-up|26
2240717|NCT01931566|3898135|FG002|Overall Study|Lost to Follow-up|23
2240718|NCT01931566|3898133|FG000|Overall Study|Voluntary Withdrawal|78
2240719|NCT01931566|3898134|FG001|Overall Study|Voluntary Withdrawal|245
2240720|NCT01931566|3898135|FG002|Overall Study|Voluntary Withdrawal|225
2240721|NCT01931566|3898133|FG000|Overall Study|Study Termination|289
2240722|NCT01931566|3898134|FG001|Overall Study|Study Termination|968
2240723|NCT01931566|3898135|FG002|Overall Study|Study Termination|1037
2240724|NCT01931566|3898133|FG000|Overall Study|Reason Not Specified|11
2240725|NCT01931566|3898134|FG001|Overall Study|Reason Not Specified|47
2240726|NCT01931566|3898135|FG002|Overall Study|Reason Not Specified|53
2240727|NCT01931566|3898133|FG000|Overall Study|Missing|0
2240728|NCT01931566|3898134|FG001|Overall Study|Missing|0
2240729|NCT01931566|3898135|FG002|Overall Study|Missing|1
2240730|NCT01931670|3898147|FG000|Treatment Period|Exclusionary Medication Received|1
2240731|NCT01931670|3898148|FG001|Treatment Period|Exclusionary Medication Received|1
2240732|NCT01931670|3898149|FG002|Treatment Period|Exclusionary Medication Received|1
2240733|NCT01931670|3898147|FG000|Treatment Period|Surgery/Invasive Intervention|4
2240734|NCT01931670|3898148|FG001|Treatment Period|Surgery/Invasive Intervention|2
2240735|NCT01931670|3898149|FG002|Treatment Period|Surgery/Invasive Intervention|0
2240736|NCT01931670|3898147|FG000|Treatment Period|Subject Noncompliant|4
2240737|NCT01931670|3898148|FG001|Treatment Period|Subject Noncompliant|9
2240738|NCT01931670|3898149|FG002|Treatment Period|Subject Noncompliant|5
2240739|NCT01931670|3898147|FG000|Treatment Period|Adverse Event|19
2240740|NCT01931670|3898148|FG001|Treatment Period|Adverse Event|8
2240741|NCT01931670|3898149|FG002|Treatment Period|Adverse Event|21
2240742|NCT01931670|3898147|FG000|Treatment Period|Lack of Efficacy|11
2240743|NCT01931670|3898148|FG001|Treatment Period|Lack of Efficacy|2
2240744|NCT01931670|3898149|FG002|Treatment Period|Lack of Efficacy|2
2240745|NCT01931670|3898147|FG000|Treatment Period|Pregnancy|7
2240746|NCT01931670|3898148|FG001|Treatment Period|Pregnancy|2
2240747|NCT01931670|3898149|FG002|Treatment Period|Pregnancy|0
2240748|NCT01931670|3898147|FG000|Treatment Period|Other|8
2240749|NCT01931670|3898148|FG001|Treatment Period|Other|7
2240750|NCT01931670|3898149|FG002|Treatment Period|Other|2
2240751|NCT01931670|3898147|FG000|Treatment Period|Consent Withdrawn by Subject|17
2240752|NCT01931670|3898148|FG001|Treatment Period|Consent Withdrawn by Subject|12
2240753|NCT01931670|3898149|FG002|Treatment Period|Consent Withdrawn by Subject|7
2240754|NCT01931670|3898147|FG000|Treatment Period|Lost to Follow-up|19
2240755|NCT01931670|3898148|FG001|Treatment Period|Lost to Follow-up|5
2240756|NCT01931670|3898149|FG002|Treatment Period|Lost to Follow-up|7
2240757|NCT01931670|3898147|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
2240758|NCT01931670|3898148|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
2240759|NCT01931670|3898149|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
2240760|NCT01931670|3898147|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
2240761|NCT01931670|3898148|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
2240762|NCT01931670|3898149|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
2240763|NCT01931670|3898147|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
2240764|NCT01931670|3898148|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
2240765|NCT01931670|3898149|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
2240766|NCT01931670|3898147|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6
2240767|NCT01931670|3898148|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3
2240768|NCT01931670|3898149|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3
2240769|NCT01931670|3898147|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
2240770|NCT01931670|3898148|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
2240771|NCT01931670|3898149|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
2240772|NCT01931670|3898147|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
2240773|NCT01931670|3898148|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
2240774|NCT01931670|3898149|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
2240775|NCT01931735|3898167|FG000|Randomized Phase|Lost to Follow-up|2
2240776|NCT01931735|3898168|FG001|Randomized Phase|Lost to Follow-up|2
2240777|NCT01931735|3898169|FG002|Randomized Phase|Lost to Follow-up|5
2240778|NCT01931735|3898170|FG003|Randomized Phase|Lost to Follow-up|0
2240779|NCT01931735|3898167|FG000|Observational Non-Randomized Phase|Adverse Event|0
2240780|NCT01931735|3898168|FG001|Observational Non-Randomized Phase|Adverse Event|0
2240781|NCT01931735|3898169|FG002|Observational Non-Randomized Phase|Adverse Event|0
2240782|NCT01931735|3898170|FG003|Observational Non-Randomized Phase|Adverse Event|1
2337079|NCT03312231|4064570|FG001|Overall Study|Withdrawal by Subject|3
2337080|NCT03312231|4064571|FG002|Overall Study|Withdrawal by Subject|1
2337081|NCT03312231|4064572|FG003|Overall Study|Withdrawal by Subject|0
2337082|NCT03312231|4064573|FG004|Overall Study|Withdrawal by Subject|0
2337083|NCT03312231|4064569|FG000|Overall Study|Death|0
2337084|NCT03312231|4064570|FG001|Overall Study|Death|1
2240783|NCT01931735|3898167|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0
2240784|NCT01931735|3898168|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0
2240785|NCT01931735|3898169|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0
2240786|NCT01931735|3898170|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1
2240787|NCT01931839|3898187|FG000|Overall Study|Death|0
2240788|NCT01931839|3898188|FG001|Overall Study|Death|1
2240789|NCT01931839|3898189|FG002|Overall Study|Death|2
2240790|NCT01931839|3898190|FG003|Overall Study|Death|0
2240791|NCT01931839|3898191|FG004|Overall Study|Death|0
2240792|NCT01931839|3898192|FG005|Overall Study|Death|0
2240793|NCT01931839|3898193|FG006|Overall Study|Death|0
2240794|NCT01931839|3898187|FG000|Overall Study|Physician Decision|1
2240795|NCT01931839|3898188|FG001|Overall Study|Physician Decision|0
2240796|NCT01931839|3898189|FG002|Overall Study|Physician Decision|1
2240797|NCT01931839|3898190|FG003|Overall Study|Physician Decision|0
2240798|NCT01931839|3898191|FG004|Overall Study|Physician Decision|0
2240799|NCT01931839|3898192|FG005|Overall Study|Physician Decision|0
2240800|NCT01931839|3898193|FG006|Overall Study|Physician Decision|1
2240801|NCT01931839|3898187|FG000|Overall Study|Withdrawal of consent|0
2240802|NCT01931839|3898188|FG001|Overall Study|Withdrawal of consent|0
2240803|NCT01931839|3898189|FG002|Overall Study|Withdrawal of consent|0
2240804|NCT01931839|3898190|FG003|Overall Study|Withdrawal of consent|0
2240805|NCT01931839|3898191|FG004|Overall Study|Withdrawal of consent|1
2240806|NCT01931839|3898192|FG005|Overall Study|Withdrawal of consent|0
2240807|NCT01931839|3898193|FG006|Overall Study|Withdrawal of consent|0
2240808|NCT01931839|3898187|FG000|Overall Study|Adverse Event|9
2240809|NCT01931839|3898188|FG001|Overall Study|Adverse Event|4
2240810|NCT01931839|3898189|FG002|Overall Study|Adverse Event|1
2240811|NCT01931839|3898190|FG003|Overall Study|Adverse Event|3
2240812|NCT01931839|3898191|FG004|Overall Study|Adverse Event|0
2240813|NCT01931839|3898192|FG005|Overall Study|Adverse Event|0
2240814|NCT01931839|3898193|FG006|Overall Study|Adverse Event|1
2240815|NCT01931839|3898187|FG000|Overall Study|Withdrawal of consent (not due to AE)|11
2240816|NCT01931839|3898188|FG001|Overall Study|Withdrawal of consent (not due to AE)|8
2240817|NCT01931839|3898189|FG002|Overall Study|Withdrawal of consent (not due to AE)|13
2240818|NCT01931839|3898190|FG003|Overall Study|Withdrawal of consent (not due to AE)|3
2240819|NCT01931839|3898191|FG004|Overall Study|Withdrawal of consent (not due to AE)|0
2240820|NCT01931839|3898192|FG005|Overall Study|Withdrawal of consent (not due to AE)|2
2240821|NCT01931839|3898193|FG006|Overall Study|Withdrawal of consent (not due to AE)|2
2240822|NCT01931839|3898187|FG000|Overall Study|Other non-compliance|15
2240823|NCT01931839|3898188|FG001|Overall Study|Other non-compliance|9
2240824|NCT01931839|3898189|FG002|Overall Study|Other non-compliance|12
2240825|NCT01931839|3898190|FG003|Overall Study|Other non-compliance|3
2240826|NCT01931839|3898191|FG004|Overall Study|Other non-compliance|0
2240827|NCT01931839|3898192|FG005|Overall Study|Other non-compliance|3
2240828|NCT01931839|3898193|FG006|Overall Study|Other non-compliance|0
2240829|NCT01931839|3898187|FG000|Overall Study|Lost to Follow-up|1
2240830|NCT01931839|3898188|FG001|Overall Study|Lost to Follow-up|2
2240831|NCT01931839|3898189|FG002|Overall Study|Lost to Follow-up|4
2240832|NCT01931839|3898190|FG003|Overall Study|Lost to Follow-up|5
2240833|NCT01931839|3898191|FG004|Overall Study|Lost to Follow-up|0
2240834|NCT01931839|3898192|FG005|Overall Study|Lost to Follow-up|0
2240835|NCT01931839|3898193|FG006|Overall Study|Lost to Follow-up|0
2240836|NCT01931839|3898187|FG000|Overall Study|Other|4
2240837|NCT01931839|3898188|FG001|Overall Study|Other|2
2240838|NCT01931839|3898189|FG002|Overall Study|Other|6
2240839|NCT01931839|3898190|FG003|Overall Study|Other|0
2337085|NCT03312231|4064571|FG002|Overall Study|Death|1
2337086|NCT03312231|4064572|FG003|Overall Study|Death|0
2337087|NCT03312231|4064573|FG004|Overall Study|Death|0
2337088|NCT03312231|4064569|FG000|Overall Study|Study Vaccination not Received|1
2337089|NCT03312231|4064570|FG001|Overall Study|Study Vaccination not Received|1
2337090|NCT03312231|4064571|FG002|Overall Study|Study Vaccination not Received|1
2337091|NCT03312231|4064572|FG003|Overall Study|Study Vaccination not Received|0
2337092|NCT03312231|4064573|FG004|Overall Study|Study Vaccination not Received|0
2337093|NCT03312543|4064604|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
2337094|NCT03312543|4064605|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
2337095|NCT03312543|4064604|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
2337096|NCT03312543|4064605|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
2337097|NCT03312543|4064604|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
2337098|NCT03312543|4064605|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
2337099|NCT03312543|4064604|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1
2240840|NCT01931839|3898191|FG004|Overall Study|Other|0
2240841|NCT01931839|3898192|FG005|Overall Study|Other|0
2240842|NCT01931839|3898193|FG006|Overall Study|Other|0
2240843|NCT01931865|3898213|FG000|Overall Study|Lost to Follow-up|2
2240844|NCT01931865|3898213|FG000|Overall Study|Withdrawal by Subject|2
2240845|NCT01931956|3898233|FG000|Overall Study|Death|42
2240846|NCT01931956|3898234|FG001|Overall Study|Death|7
2240847|NCT01931956|3898235|FG002|Overall Study|Death|379
2240848|NCT01931956|3898236|FG003|Overall Study|Death|96
2240849|NCT01931956|3898233|FG000|Overall Study|Withdrawal by Subject|5
2240850|NCT01931956|3898234|FG001|Overall Study|Withdrawal by Subject|0
2240851|NCT01931956|3898235|FG002|Overall Study|Withdrawal by Subject|70
2240852|NCT01931956|3898236|FG003|Overall Study|Withdrawal by Subject|30
2240853|NCT01931956|3898233|FG000|Overall Study|Lost to Follow-up|2
2240854|NCT01931956|3898234|FG001|Overall Study|Lost to Follow-up|0
2240855|NCT01931956|3898235|FG002|Overall Study|Lost to Follow-up|11
2240856|NCT01931956|3898236|FG003|Overall Study|Lost to Follow-up|7
2240857|NCT01931956|3898233|FG000|Overall Study|Expected|2
2240858|NCT01931956|3898234|FG001|Overall Study|Expected|0
2240859|NCT01931956|3898235|FG002|Overall Study|Expected|6
2240860|NCT01931956|3898236|FG003|Overall Study|Expected|0
2240861|NCT01931956|3898233|FG000|Overall Study|Not due|0
2240862|NCT01931956|3898234|FG001|Overall Study|Not due|0
2240863|NCT01931956|3898235|FG002|Overall Study|Not due|21
2240864|NCT01931956|3898236|FG003|Overall Study|Not due|0
2240865|NCT01931995|3898261|FG000|First Intervention (1 Day)|Withdrawal by Subject|2
2240866|NCT01931995|3898262|FG001|First Intervention (1 Day)|Withdrawal by Subject|2
2240867|NCT01931995|3898261|FG000|First Intervention (1 Day)|Physician Decision|1
2240868|NCT01931995|3898262|FG001|First Intervention (1 Day)|Physician Decision|1
2240869|NCT01931995|3898261|FG000|First Intervention (1 Day)|Lost to Follow-up|1
2240870|NCT01931995|3898262|FG001|First Intervention (1 Day)|Lost to Follow-up|1
2240871|NCT01932294|3898294|FG000|Overall Study|Death|43
2240872|NCT01932294|3898294|FG000|Overall Study|Lost to Follow-up|8
2240873|NCT01932294|3898294|FG000|Overall Study|VAD Implantation|20
2240874|NCT01932294|3898294|FG000|Overall Study|Heart Transplantation|16
2240875|NCT01932294|3898294|FG000|Overall Study|Transferred to other hospitals|12
2240876|NCT01932437|3898301|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2240877|NCT01932437|3898302|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2240878|NCT01932437|3898303|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2240879|NCT01932437|3898304|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2240880|NCT01932437|3898305|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2240881|NCT01932437|3898306|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
2240882|NCT01932697|3898338|FG000|Overall Study|Received a different amount of tx|1
2240883|NCT01932697|3898339|FG001|Overall Study|Received a different amount of tx|0
2240884|NCT01932697|3898338|FG000|Overall Study|Ineligible|1
2240885|NCT01932697|3898339|FG001|Overall Study|Ineligible|0
2337100|NCT03312543|4064605|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1
2337101|NCT03312543|4064604|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1
2337102|NCT03312543|4064605|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1
2337103|NCT03312543|4064604|FG000|Regression (Week 12 to Week 24)|Death|0
2337104|NCT03312543|4064605|FG001|Regression (Week 12 to Week 24)|Death|1
2337105|NCT03312933|4064615|FG000|Overall Study|Protocol Violation|15
2337106|NCT03312933|4064615|FG000|Overall Study|Lost to Follow-up|36
2337107|NCT03312933|4064615|FG000|Overall Study|Withdrawal by Subject|3
2337108|NCT03313037|4064621|FG000|Overall Study|Protocol Violation|4
2337109|NCT03313037|4064622|FG001|Overall Study|Protocol Violation|1
2337110|NCT03313037|4064621|FG000|Overall Study|Other|1
2337111|NCT03313037|4064622|FG001|Overall Study|Other|1
2337112|NCT03313037|4064621|FG000|Overall Study|Withdrawal by Subject|4
2337113|NCT03313037|4064622|FG001|Overall Study|Withdrawal by Subject|3
2337114|NCT03313037|4064621|FG000|Overall Study|No longer meets eligibility criteria|1
2337115|NCT03313037|4064622|FG001|Overall Study|No longer meets eligibility criteria|7
2337116|NCT03313037|4064621|FG000|Overall Study|Lost to Follow-up|9
2337117|NCT03313037|4064622|FG001|Overall Study|Lost to Follow-up|8
2337118|NCT03313037|4064621|FG000|Overall Study|Randomized but not treated|1
2337119|NCT03313037|4064622|FG001|Overall Study|Randomized but not treated|0
2337120|NCT03313050|4064632|FG000|Stage 2: 12 Months|Adverse Event|0
2337121|NCT03313050|4064633|FG001|Stage 2: 12 Months|Adverse Event|0
2337122|NCT03313050|4064634|FG002|Stage 2: 12 Months|Adverse Event|0
2337123|NCT03313050|4064635|FG003|Stage 2: 12 Months|Adverse Event|1
2337124|NCT03313050|4064632|FG000|Stage 2: 12 Months|Death|0
2337125|NCT03313050|4064633|FG001|Stage 2: 12 Months|Death|0
2337126|NCT03313050|4064634|FG002|Stage 2: 12 Months|Death|3
2337127|NCT03313050|4064635|FG003|Stage 2: 12 Months|Death|0
2337128|NCT03313050|4064632|FG000|Stage 2: 12 Months|Lost to Follow-up|0
2337129|NCT03313050|4064633|FG001|Stage 2: 12 Months|Lost to Follow-up|0
2337130|NCT03313050|4064634|FG002|Stage 2: 12 Months|Lost to Follow-up|1
2337131|NCT03313050|4064635|FG003|Stage 2: 12 Months|Lost to Follow-up|5
2337132|NCT03313050|4064632|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
2337133|NCT03313050|4064633|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
2337134|NCT03313050|4064634|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
2337135|NCT03313050|4064635|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3
2337136|NCT03313050|4064632|FG000|Stage 2: 12 Months|Protocol deviation|0
2337137|NCT03313050|4064633|FG001|Stage 2: 12 Months|Protocol deviation|0
2337138|NCT03313050|4064634|FG002|Stage 2: 12 Months|Protocol deviation|7
2337139|NCT03313050|4064635|FG003|Stage 2: 12 Months|Protocol deviation|7
2337140|NCT03313050|4064632|FG000|Stage 2: 12 Months|Withdrawal by Subject|0
2337141|NCT03313050|4064633|FG001|Stage 2: 12 Months|Withdrawal by Subject|0
2337142|NCT03313050|4064634|FG002|Stage 2: 12 Months|Withdrawal by Subject|0
2337143|NCT03313050|4064635|FG003|Stage 2: 12 Months|Withdrawal by Subject|3
2337144|NCT03313050|4064632|FG000|Stage 2: 12 Months|Other|0
2337145|NCT03313050|4064633|FG001|Stage 2: 12 Months|Other|0
2337146|NCT03313050|4064634|FG002|Stage 2: 12 Months|Other|0
2337147|NCT03313050|4064635|FG003|Stage 2: 12 Months|Other|1
2240886|NCT01932762|3898351|FG000|Overall Study|Withdrawal by Subject|1
2240887|NCT01932762|3898352|FG001|Overall Study|Withdrawal by Subject|2
2240888|NCT01932762|3898353|FG002|Overall Study|Withdrawal by Subject|0
2240889|NCT01932762|3898354|FG003|Overall Study|Withdrawal by Subject|0
2240890|NCT01932762|3898351|FG000|Overall Study|Lost to Follow-up|4
2240891|NCT01932762|3898352|FG001|Overall Study|Lost to Follow-up|0
2240892|NCT01932762|3898353|FG002|Overall Study|Lost to Follow-up|0
2240893|NCT01932762|3898354|FG003|Overall Study|Lost to Follow-up|1
2240894|NCT01932762|3898351|FG000|Overall Study|Physician Decision|1
2240895|NCT01932762|3898352|FG001|Overall Study|Physician Decision|0
2240896|NCT01932762|3898353|FG002|Overall Study|Physician Decision|0
2240897|NCT01932762|3898354|FG003|Overall Study|Physician Decision|0
2240898|NCT01932788|3898366|FG000|Overall Study|Protocol Violation|18
2240899|NCT01932788|3898367|FG001|Overall Study|Protocol Violation|0
2240900|NCT01932788|3898366|FG000|Overall Study|Lost to Follow-up|18
2240901|NCT01932788|3898367|FG001|Overall Study|Lost to Follow-up|46
2240902|NCT01932788|3898366|FG000|Overall Study|Lack of Efficacy|2
2240903|NCT01932788|3898367|FG001|Overall Study|Lack of Efficacy|0
2240904|NCT01932788|3898366|FG000|Overall Study|Withdrawal by Subject|0
2240905|NCT01932788|3898367|FG001|Overall Study|Withdrawal by Subject|5
2240906|NCT01932970|3898373|FG000|Overall Study|Withdrawal by Subject|5
2240907|NCT01932970|3898373|FG000|Overall Study|Death|1
2240908|NCT01932970|3898373|FG000|Overall Study|Lost to Follow-up|2
2240909|NCT01932970|3898373|FG000|Overall Study|Protocol Specified Criteria|10
2240910|NCT01932996|3898379|FG000|Overall Study|Protocol Violation|2
2240911|NCT01932996|3898380|FG001|Overall Study|Protocol Violation|0
2240912|NCT01933048|3898388|FG000|Overall Study|Lost to Follow-up|15
2337148|NCT03313076|4064649|FG000|Overall Study|Withdrawal by Subject|2
2337149|NCT03313076|4064650|FG001|Overall Study|Withdrawal by Subject|0
2337150|NCT03313076|4064651|FG002|Overall Study|Withdrawal by Subject|0
2337151|NCT03313076|4064652|FG003|Overall Study|Withdrawal by Subject|0
2337152|NCT03313076|4064649|FG000|Overall Study|Lost to Follow-up|0
2337153|NCT03313076|4064650|FG001|Overall Study|Lost to Follow-up|2
2337154|NCT03313076|4064651|FG002|Overall Study|Lost to Follow-up|2
2337155|NCT03313076|4064652|FG003|Overall Study|Lost to Follow-up|2
2337156|NCT03313310|4064670|FG000|Phase 2|Lost to Follow-up|4
2337157|NCT03313310|4064671|FG001|Phase 2|Lost to Follow-up|0
2337158|NCT03313310|4064670|FG000|Phase 3|Lost to Follow-up|0
2337159|NCT03313310|4064671|FG001|Phase 3|Lost to Follow-up|1
2337160|NCT03314233|4064677|FG000|Overall Study|No longer eligible at time of delivery|1
2337161|NCT03314519|4064683|FG000|Overall Study|Protocol Violation|3
2337162|NCT03314519|4064684|FG001|Overall Study|Protocol Violation|2
2337163|NCT03314662|4064693|FG000|Overall Study|Withdrawal by Subject|1
2337164|NCT03314662|4064694|FG001|Overall Study|Withdrawal by Subject|1
2337165|NCT03314662|4064695|FG002|Overall Study|Withdrawal by Subject|1
2337166|NCT03314662|4064693|FG000|Overall Study|Lost to Follow-up|5
2337167|NCT03314662|4064694|FG001|Overall Study|Lost to Follow-up|4
2337168|NCT03314662|4064695|FG002|Overall Study|Lost to Follow-up|4
2337169|NCT03314662|4064693|FG000|Overall Study|Death|2
2337170|NCT03314662|4064694|FG001|Overall Study|Death|0
2337171|NCT03314662|4064695|FG002|Overall Study|Death|0
2337172|NCT03314857|4064720|FG000|Overall Study|Death|4
2337173|NCT03314857|4064720|FG000|Overall Study|Physician Decision|1
2337174|NCT03315208|4064739|FG000|Overall Study|Lost to Follow-up|11
2337175|NCT03315208|4064740|FG001|Overall Study|Lost to Follow-up|6
2337176|NCT03315208|4064739|FG000|Overall Study|Withdrawal by Subject|2
2337177|NCT03315208|4064740|FG001|Overall Study|Withdrawal by Subject|0
2337178|NCT03315286|4064749|FG000|Overall Study|Lost to Follow-up|0
2337179|NCT03315286|4064750|FG001|Overall Study|Lost to Follow-up|3
2337180|NCT03315286|4064749|FG000|Overall Study|Withdrawal by Subject|1
2337181|NCT03315286|4064750|FG001|Overall Study|Withdrawal by Subject|0
2337182|NCT03315286|4064749|FG000|Overall Study|Protocol Violation|0
2337183|NCT03315286|4064750|FG001|Overall Study|Protocol Violation|1
2337184|NCT03315689|4064775|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1
2337185|NCT03315689|4064776|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0
2337186|NCT03315689|4064775|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0
2337187|NCT03315689|4064776|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2
2337188|NCT03315689|4064775|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0
2337189|NCT03315689|4064776|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1
2337190|NCT03315793|4064798|FG000|Overall Study|Adverse Event|4
2337191|NCT03315793|4064799|FG001|Overall Study|Adverse Event|2
2337192|NCT03315793|4064798|FG000|Overall Study|Protocol Deviation|1
2240913|NCT01933048|3898389|FG001|Overall Study|Lost to Follow-up|18
2240914|NCT01933048|3898388|FG000|Overall Study|personal reasons|1
2240915|NCT01933048|3898389|FG001|Overall Study|personal reasons|1
2240916|NCT01933048|3898388|FG000|Overall Study|Protocol Violation|7
2337193|NCT03315793|4064799|FG001|Overall Study|Protocol Deviation|0
2337194|NCT03315793|4064798|FG000|Overall Study|Difficult for regular visit|0
2240917|NCT01933048|3898389|FG001|Overall Study|Protocol Violation|8
2240918|NCT01933048|3898388|FG000|Overall Study|Physician Decision|1
2240919|NCT01933048|3898389|FG001|Overall Study|Physician Decision|0
2240920|NCT01933048|3898388|FG000|Overall Study|unknown reasons|1
2240921|NCT01933048|3898389|FG001|Overall Study|unknown reasons|1
2240922|NCT01933113|3898398|FG000|Overall Study|Fractured nonfunctioning lead.|1
2240923|NCT01933217|3898404|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1
2240924|NCT01933217|3898405|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3
2240925|NCT01933217|3898404|FG000|Randomization (4 Weeks)|Lost to Follow-up|1
2240926|NCT01933217|3898405|FG001|Randomization (4 Weeks)|Lost to Follow-up|1
2240927|NCT01933334|3898428|FG000|Overall Study|Adverse Event|5
2240928|NCT01933334|3898429|FG001|Overall Study|Adverse Event|1
2240929|NCT01933334|3898428|FG000|Overall Study|Withdrawal by Subject|0
2240930|NCT01933334|3898429|FG001|Overall Study|Withdrawal by Subject|1
2240931|NCT01933594|3898472|FG000|Overall Study|Lost to Follow-up|1
2240932|NCT01933594|3898473|FG001|Overall Study|Lost to Follow-up|0
2240933|NCT01933594|3898474|FG002|Overall Study|Lost to Follow-up|0
2240934|NCT01933594|3898475|FG003|Overall Study|Lost to Follow-up|0
2240935|NCT01933594|3898476|FG004|Overall Study|Lost to Follow-up|1
2240936|NCT01933594|3898477|FG005|Overall Study|Lost to Follow-up|0
2240937|NCT01933594|3898472|FG000|Overall Study|Ineligible for subsequent study step|0
2240938|NCT01933594|3898473|FG001|Overall Study|Ineligible for subsequent study step|0
2240939|NCT01933594|3898474|FG002|Overall Study|Ineligible for subsequent study step|0
2240940|NCT01933594|3898475|FG003|Overall Study|Ineligible for subsequent study step|0
2240941|NCT01933594|3898476|FG004|Overall Study|Ineligible for subsequent study step|1
2240942|NCT01933594|3898477|FG005|Overall Study|Ineligible for subsequent study step|0
2240943|NCT01933672|3898495|FG000|Metformin Run-in Period|Adverse Event|1
2240944|NCT01933672|3898496|FG001|Metformin Run-in Period|Adverse Event|0
2240945|NCT01933672|3898497|FG002|Metformin Run-in Period|Adverse Event|0
2240946|NCT01933672|3898498|FG003|Metformin Run-in Period|Adverse Event|0
2240947|NCT01933672|3898499|FG004|Metformin Run-in Period|Adverse Event|0
2240948|NCT01933672|3898500|FG005|Metformin Run-in Period|Adverse Event|0
2240949|NCT01933672|3898501|FG006|Metformin Run-in Period|Adverse Event|0
2240950|NCT01933672|3898495|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4
2240951|NCT01933672|3898496|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0
2240952|NCT01933672|3898497|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0
2337195|NCT03315793|4064799|FG001|Overall Study|Difficult for regular visit|1
2337196|NCT03316131|4064816|FG000|Treatment Period 2|Protocol deviation|1
2337197|NCT03316131|4064817|FG001|Treatment Period 2|Protocol deviation|0
2337198|NCT03316170|4064825|FG000|Overall Study|Death|1
2337199|NCT03316170|4064826|FG001|Overall Study|Death|0
2337200|NCT03316170|4064825|FG000|Overall Study|Lost to Follow-up|6
2337201|NCT03316170|4064826|FG001|Overall Study|Lost to Follow-up|7
2337202|NCT03316547|4064845|FG000|Overall Study|Death|3
2337203|NCT03316547|4064846|FG001|Overall Study|Death|1
2337204|NCT03316547|4064845|FG000|Overall Study|Lost to Follow-up|6
2337205|NCT03316547|4064846|FG001|Overall Study|Lost to Follow-up|6
2337206|NCT03316547|4064845|FG000|Overall Study|Withdrawal by Subject|3
2337207|NCT03316547|4064846|FG001|Overall Study|Withdrawal by Subject|2
2337208|NCT03316547|4064845|FG000|Overall Study|Transfer to another hospital|6
2337209|NCT03316547|4064846|FG001|Overall Study|Transfer to another hospital|4
2337210|NCT03316911|4064865|FG000|Overall Study|Lost to Follow-up|33
2337211|NCT03316911|4064866|FG001|Overall Study|Lost to Follow-up|29
2337212|NCT03317379|4064915|FG000|Overall Study|Lost to Follow-up|0
2337213|NCT03317379|4064916|FG001|Overall Study|Lost to Follow-up|3
2337214|NCT03317379|4064917|FG002|Overall Study|Lost to Follow-up|2
2337215|NCT03318315|4064941|FG000|Overall Study|Lost to Follow-up|3
2337216|NCT03318315|4064942|FG001|Overall Study|Lost to Follow-up|2
2337217|NCT03318315|4064943|FG002|Overall Study|Lost to Follow-up|1
2337218|NCT03318315|4064941|FG000|Overall Study|Protocol Violation|1
2337219|NCT03318315|4064942|FG001|Overall Study|Protocol Violation|1
2337220|NCT03318315|4064943|FG002|Overall Study|Protocol Violation|1
2337221|NCT03318315|4064941|FG000|Overall Study|Withdrawal by Subject|0
2337222|NCT03318315|4064942|FG001|Overall Study|Withdrawal by Subject|0
2337223|NCT03318315|4064943|FG002|Overall Study|Withdrawal by Subject|2
2240953|NCT01933672|3898498|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0
2240954|NCT01933672|3898499|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0
2240955|NCT01933672|3898500|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0
2240956|NCT01933672|3898501|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0
2240957|NCT01933672|3898495|FG000|Metformin Run-in Period|Other|5
2240958|NCT01933672|3898496|FG001|Metformin Run-in Period|Other|0
2240959|NCT01933672|3898497|FG002|Metformin Run-in Period|Other|0
2240960|NCT01933672|3898498|FG003|Metformin Run-in Period|Other|0
2240961|NCT01933672|3898499|FG004|Metformin Run-in Period|Other|0
2240962|NCT01933672|3898500|FG005|Metformin Run-in Period|Other|0
2240963|NCT01933672|3898501|FG006|Metformin Run-in Period|Other|0
2240964|NCT01933672|3898495|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2240965|NCT01933672|3898496|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2240966|NCT01933672|3898497|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2240967|NCT01933672|3898498|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2240968|NCT01933672|3898499|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1
2240969|NCT01933672|3898500|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2240970|NCT01933672|3898501|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2240971|NCT01933672|3898495|FG000|First Intervention Period (12-16 Days)|Other|0
2240972|NCT01933672|3898496|FG001|First Intervention Period (12-16 Days)|Other|0
2240973|NCT01933672|3898497|FG002|First Intervention Period (12-16 Days)|Other|1
2240974|NCT01933672|3898498|FG003|First Intervention Period (12-16 Days)|Other|0
2240975|NCT01933672|3898499|FG004|First Intervention Period (12-16 Days)|Other|0
2240976|NCT01933672|3898500|FG005|First Intervention Period (12-16 Days)|Other|1
2240977|NCT01933672|3898501|FG006|First Intervention Period (12-16 Days)|Other|0
2240978|NCT01933672|3898495|FG000|Second Intervention Period (12-16 Days)|Other|0
2240979|NCT01933672|3898496|FG001|Second Intervention Period (12-16 Days)|Other|1
2240980|NCT01933672|3898497|FG002|Second Intervention Period (12-16 Days)|Other|1
2240981|NCT01933672|3898498|FG003|Second Intervention Period (12-16 Days)|Other|0
2240982|NCT01933672|3898499|FG004|Second Intervention Period (12-16 Days)|Other|0
2240983|NCT01933672|3898500|FG005|Second Intervention Period (12-16 Days)|Other|0
2240984|NCT01933672|3898501|FG006|Second Intervention Period (12-16 Days)|Other|0
2240985|NCT01933672|3898495|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2240986|NCT01933672|3898496|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2240987|NCT01933672|3898497|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2240988|NCT01933672|3898498|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
2240989|NCT01933672|3898499|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2240990|NCT01933672|3898500|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2240991|NCT01933672|3898501|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2240992|NCT01933672|3898495|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2240993|NCT01933672|3898496|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
2240994|NCT01933672|3898497|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2240995|NCT01933672|3898498|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2240996|NCT01933672|3898499|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2240997|NCT01933672|3898500|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2240998|NCT01933672|3898501|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2240999|NCT01933789|3898532|FG000|Overall Study|Death|0
2241000|NCT01933789|3898533|FG001|Overall Study|Death|0
2241001|NCT01933789|3898534|FG002|Overall Study|Death|0
2241002|NCT01933789|3898535|FG003|Overall Study|Death|0
2037341|NCT00417482|3607667|FG002|Phase B 1st 16 Weeks|Death|0
2037342|NCT00417482|3607665|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1
2037343|NCT00417482|3607666|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12
2037344|NCT00417482|3607667|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2
2037345|NCT00417482|3607665|FG000|Phase B 2nd 16 Weeks|Adverse Event|0
2037346|NCT00417482|3607666|FG001|Phase B 2nd 16 Weeks|Adverse Event|0
2037347|NCT00417482|3607667|FG002|Phase B 2nd 16 Weeks|Adverse Event|1
2037348|NCT00417482|3607665|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1
2037349|NCT00417482|3607666|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0
2037350|NCT00417482|3607667|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0
2037351|NCT00417482|3607665|FG000|Phase B 2nd 16 Weeks|Death|1
2037352|NCT00417482|3607666|FG001|Phase B 2nd 16 Weeks|Death|1
2037353|NCT00417482|3607667|FG002|Phase B 2nd 16 Weeks|Death|0
2037354|NCT00417612|3607683|FG000|Overall Study|Errant diagnosis|0
2037355|NCT00417612|3607684|FG001|Overall Study|Errant diagnosis|1
2037356|NCT00417612|3607683|FG000|Overall Study|Adverse Event|2
2037357|NCT00417612|3607684|FG001|Overall Study|Adverse Event|0
2037358|NCT00417612|3607683|FG000|Overall Study|Protocol Violation|0
2037359|NCT00417612|3607684|FG001|Overall Study|Protocol Violation|2
2037360|NCT00417612|3607683|FG000|Overall Study|Lost to Follow-up|1
2037361|NCT00417612|3607684|FG001|Overall Study|Lost to Follow-up|0
2037362|NCT00417885|3607703|FG000|Overall Study|Adverse Event|1
2037363|NCT00417885|3607703|FG000|Overall Study|Objective Progression or Relapse|3
2037364|NCT00417885|3607703|FG000|Overall Study|Transferred to Another Sunitinib Study|2
2241003|NCT01933789|3898536|FG004|Overall Study|Death|21
2241004|NCT01933789|3898537|FG005|Overall Study|Death|32
2241005|NCT01933789|3898538|FG006|Overall Study|Death|0
2241006|NCT01933789|3898539|FG007|Overall Study|Death|0
2241007|NCT01933789|3898540|FG008|Overall Study|Death|0
2241008|NCT01933789|3898532|FG000|Overall Study|Lost to Follow-up|0
2241009|NCT01933789|3898533|FG001|Overall Study|Lost to Follow-up|0
2241010|NCT01933789|3898534|FG002|Overall Study|Lost to Follow-up|0
2241011|NCT01933789|3898535|FG003|Overall Study|Lost to Follow-up|1
2241012|NCT01933789|3898536|FG004|Overall Study|Lost to Follow-up|8
2241013|NCT01933789|3898537|FG005|Overall Study|Lost to Follow-up|9
2241014|NCT01933789|3898538|FG006|Overall Study|Lost to Follow-up|1
2241015|NCT01933789|3898539|FG007|Overall Study|Lost to Follow-up|4
2241016|NCT01933789|3898540|FG008|Overall Study|Lost to Follow-up|0
2241017|NCT01933789|3898532|FG000|Overall Study|Withdrawal by Subject|2
2241018|NCT01933789|3898533|FG001|Overall Study|Withdrawal by Subject|1
2241019|NCT01933789|3898534|FG002|Overall Study|Withdrawal by Subject|0
2241020|NCT01933789|3898535|FG003|Overall Study|Withdrawal by Subject|0
2241021|NCT01933789|3898536|FG004|Overall Study|Withdrawal by Subject|17
2241022|NCT01933789|3898537|FG005|Overall Study|Withdrawal by Subject|16
2241023|NCT01933789|3898538|FG006|Overall Study|Withdrawal by Subject|1
2241024|NCT01933789|3898539|FG007|Overall Study|Withdrawal by Subject|4
2241025|NCT01933789|3898540|FG008|Overall Study|Withdrawal by Subject|0
2241026|NCT01933789|3898532|FG000|Overall Study|Became Ineligible|4
2241027|NCT01933789|3898533|FG001|Overall Study|Became Ineligible|0
2241028|NCT01933789|3898534|FG002|Overall Study|Became Ineligible|0
2241029|NCT01933789|3898535|FG003|Overall Study|Became Ineligible|0
2241030|NCT01933789|3898536|FG004|Overall Study|Became Ineligible|13
2241031|NCT01933789|3898537|FG005|Overall Study|Became Ineligible|10
2241032|NCT01933789|3898538|FG006|Overall Study|Became Ineligible|13
2241033|NCT01933789|3898539|FG007|Overall Study|Became Ineligible|6
2241034|NCT01933789|3898540|FG008|Overall Study|Became Ineligible|0
2241035|NCT01933880|3898562|FG000|Overall Study|Withdrawal by Subject|5
2241036|NCT01933880|3898563|FG001|Overall Study|Withdrawal by Subject|0
2241037|NCT01933880|3898562|FG000|Overall Study|Lack of Efficacy|1
2241038|NCT01933880|3898563|FG001|Overall Study|Lack of Efficacy|0
2241039|NCT01933880|3898562|FG000|Overall Study|Concomitant medication Interference|0
2241040|NCT01933880|3898563|FG001|Overall Study|Concomitant medication Interference|1
2241041|NCT01933880|3898562|FG000|Overall Study|Followup exceeded 4 days to visit window|19
2241042|NCT01933880|3898563|FG001|Overall Study|Followup exceeded 4 days to visit window|0
2241043|NCT01933880|3898562|FG000|Overall Study|Other|4
2241044|NCT01933880|3898563|FG001|Overall Study|Other|0
2241045|NCT01933880|3898562|FG000|Overall Study|Protocol Violation|1
2241046|NCT01933880|3898563|FG001|Overall Study|Protocol Violation|0
2241047|NCT01933919|3898576|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0
2241048|NCT01933919|3898577|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1
2241049|NCT01933919|3898576|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
2241050|NCT01933919|3898577|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
2241051|NCT01933919|3898576|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
2241052|NCT01933919|3898577|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
2241053|NCT01933919|3898576|FG000|Open-label Long-term Phase|Adverse Event|2
2241054|NCT01933919|3898577|FG001|Open-label Long-term Phase|Adverse Event|0
2241055|NCT01933919|3898576|FG000|Open-label Long-term Phase|Withdrawal by Subject|3
2241056|NCT01933919|3898577|FG001|Open-label Long-term Phase|Withdrawal by Subject|4
2241057|NCT01933919|3898576|FG000|Open-label Long-term Phase|Lost to Follow-up|1
2241058|NCT01933919|3898577|FG001|Open-label Long-term Phase|Lost to Follow-up|0
2241059|NCT01933919|3898576|FG000|Open-label Long-term Phase|Other|1
2241060|NCT01933919|3898577|FG001|Open-label Long-term Phase|Other|2
2241061|NCT01934010|3898611|FG000|Overall Study|Adverse Event|1
2241062|NCT01934010|3898612|FG001|Overall Study|Adverse Event|1
2241063|NCT01934010|3898613|FG002|Overall Study|Adverse Event|0
2241064|NCT01934010|3898611|FG000|Overall Study|Withdrawal by Subject|15
2241065|NCT01934010|3898612|FG001|Overall Study|Withdrawal by Subject|6
2241066|NCT01934010|3898613|FG002|Overall Study|Withdrawal by Subject|2
2241067|NCT01934010|3898611|FG000|Overall Study|Lost to Follow-up|7
2241068|NCT01934010|3898612|FG001|Overall Study|Lost to Follow-up|4
2241069|NCT01934010|3898613|FG002|Overall Study|Lost to Follow-up|0
2241070|NCT01934140|3898632|FG000|Persistence Phase (Year 6-10)|Other|24
2241071|NCT01934140|3898633|FG001|Persistence Phase (Year 6-10)|Other|6
2241072|NCT01934140|3898632|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5
2241073|NCT01934140|3898633|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2
2241074|NCT01934140|3898632|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
2241075|NCT01934140|3898633|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
2241076|NCT01934140|3898632|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
2241077|NCT01934140|3898633|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
2241078|NCT01934140|3898632|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
2241079|NCT01934140|3898633|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
2241080|NCT01934140|3898632|FG000|Booster Phase (6 Months)|Lost to Follow-up|1
2241081|NCT01934140|3898633|FG001|Booster Phase (6 Months)|Lost to Follow-up|0
2241082|NCT01934140|3898632|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2
2241083|NCT01934140|3898633|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1
2241084|NCT01934140|3898632|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2
2241085|NCT01934140|3898633|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2
2241086|NCT01934192|3898645|FG000|Overall Study|Protocol Violation|0
2241087|NCT01934192|3898646|FG001|Overall Study|Protocol Violation|0
2241088|NCT01934192|3898647|FG002|Overall Study|Protocol Violation|0
2241089|NCT01934192|3898648|FG003|Overall Study|Protocol Violation|1
2241090|NCT01934192|3898645|FG000|Overall Study|Other: reached stopping criteria|6
2037365|NCT00417963|3607707|FG000|Overall Study|Lost to Follow-up|3
2037366|NCT00417963|3607707|FG000|Overall Study|Withdrawal by Subject|18
2037367|NCT00417963|3607707|FG000|Overall Study|Death|17
2037368|NCT00417963|3607707|FG000|Overall Study|Study device could not be deployed|3
2037369|NCT00417976|3607716|FG000|Overall Study|Non compliance unrelated to toxicity|1
2037370|NCT00417976|3607716|FG000|Overall Study|Treatment -related toxicity|2
2037371|NCT00417989|3607723|FG000|Overall Study|Withdrawal by Subject|13
2037372|NCT00417989|3607724|FG001|Overall Study|Withdrawal by Subject|13
2037373|NCT00417989|3607723|FG000|Overall Study|Lost to Follow-up|1
2037374|NCT00417989|3607724|FG001|Overall Study|Lost to Follow-up|6
2037375|NCT00417989|3607723|FG000|Overall Study|Protocol Violation|1
2241091|NCT01934192|3898646|FG001|Overall Study|Other: reached stopping criteria|5
2241092|NCT01934192|3898647|FG002|Overall Study|Other: reached stopping criteria|1
2241093|NCT01934192|3898648|FG003|Overall Study|Other: reached stopping criteria|0
2241094|NCT01934192|3898645|FG000|Overall Study|Physician Decision|3
2241095|NCT01934192|3898646|FG001|Overall Study|Physician Decision|2
2241096|NCT01934192|3898647|FG002|Overall Study|Physician Decision|0
2241097|NCT01934192|3898648|FG003|Overall Study|Physician Decision|0
2241098|NCT01934218|3898671|FG000|Double-blind Phase|Adverse Event|8
2241099|NCT01934218|3898672|FG001|Double-blind Phase|Adverse Event|8
2241100|NCT01934218|3898671|FG000|Double-blind Phase|Lack of Efficacy|6
2241101|NCT01934218|3898672|FG001|Double-blind Phase|Lack of Efficacy|7
2241102|NCT01934218|3898671|FG000|Double-blind Phase|Lost to Follow-up|7
2241103|NCT01934218|3898672|FG001|Double-blind Phase|Lost to Follow-up|14
2241104|NCT01934218|3898671|FG000|Double-blind Phase|Physician Decision|1
2241105|NCT01934218|3898672|FG001|Double-blind Phase|Physician Decision|2
2241106|NCT01934218|3898671|FG000|Double-blind Phase|Protocol Violation|4
2241107|NCT01934218|3898672|FG001|Double-blind Phase|Protocol Violation|0
2241108|NCT01934218|3898671|FG000|Double-blind Phase|Withdrawal by Subject|16
2241109|NCT01934218|3898672|FG001|Double-blind Phase|Withdrawal by Subject|13
2241110|NCT01934218|3898671|FG000|Double-blind Phase|Noncompliance with Study Protocol|5
2241111|NCT01934218|3898672|FG001|Double-blind Phase|Noncompliance with Study Protocol|8
2241112|NCT01934218|3898671|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1
2241113|NCT01934218|3898672|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2
2241114|NCT01934218|3898671|FG000|Open-Label Phase|Adverse Event|2
2241115|NCT01934218|3898672|FG001|Open-Label Phase|Adverse Event|4
2241116|NCT01934218|3898671|FG000|Open-Label Phase|Lack of Efficacy|1
2241117|NCT01934218|3898672|FG001|Open-Label Phase|Lack of Efficacy|4
2241118|NCT01934218|3898671|FG000|Open-Label Phase|Lost to Follow-up|4
2241119|NCT01934218|3898672|FG001|Open-Label Phase|Lost to Follow-up|2
2241120|NCT01934218|3898671|FG000|Open-Label Phase|Physician Decision|1
2241121|NCT01934218|3898672|FG001|Open-Label Phase|Physician Decision|0
2241122|NCT01934218|3898671|FG000|Open-Label Phase|Protocol Violation|1
2241123|NCT01934218|3898672|FG001|Open-Label Phase|Protocol Violation|0
2241124|NCT01934218|3898671|FG000|Open-Label Phase|Withdrawal by Subject|13
2241125|NCT01934218|3898672|FG001|Open-Label Phase|Withdrawal by Subject|11
2241126|NCT01934218|3898671|FG000|Open-Label Phase|Noncompliance with Study Protocol|4
2241127|NCT01934218|3898672|FG001|Open-Label Phase|Noncompliance with Study Protocol|2
2241128|NCT01934218|3898671|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0
2241129|NCT01934218|3898672|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1
2241130|NCT01934335|3898684|FG000|Overall Study|Withdrawal by Subject|1
2241131|NCT01934335|3898685|FG001|Overall Study|Withdrawal by Subject|1
2241132|NCT01934556|3898702|FG000|Overall Study|Withdrawal by Subject|0
2241133|NCT01934556|3898703|FG001|Overall Study|Withdrawal by Subject|1
2241134|NCT01934556|3898704|FG002|Overall Study|Withdrawal by Subject|1
2241135|NCT01934556|3898702|FG000|Overall Study|Lost to Follow-up|4
2241136|NCT01934556|3898703|FG001|Overall Study|Lost to Follow-up|10
2337304|NCT03318783|4065002|FG000|Overall Study|Withdrawal by Subject|0
2337305|NCT03318783|4065003|FG001|Overall Study|Withdrawal by Subject|1
2337306|NCT03318783|4065002|FG000|Overall Study|Death|0
2337307|NCT03318783|4065003|FG001|Overall Study|Death|1
2337308|NCT03319212|4065046|FG000|Overall Study|Discontinued as moving out of local area|0
2337309|NCT03319212|4065047|FG001|Overall Study|Discontinued as moving out of local area|1
2337310|NCT03319212|4065046|FG000|Overall Study|Adverse Event|2
2337311|NCT03319212|4065047|FG001|Overall Study|Adverse Event|2
2337312|NCT03319212|4065046|FG000|Overall Study|Withdrawal by Subject|0
2337313|NCT03319212|4065047|FG001|Overall Study|Withdrawal by Subject|1
2337314|NCT03319212|4065046|FG000|Overall Study|Lost to Follow-up|0
2337315|NCT03319212|4065047|FG001|Overall Study|Lost to Follow-up|1
2337316|NCT03319212|4065046|FG000|Overall Study|Physician Decision|1
2337317|NCT03319212|4065047|FG001|Overall Study|Physician Decision|0
2337318|NCT03319719|4065061|FG000|Overall Study|Lost to Follow-up|1
2337319|NCT03319953|4065075|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1
2337320|NCT03319953|4065076|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
2037376|NCT00417989|3607724|FG001|Overall Study|Protocol Violation|0
2037377|NCT00417989|3607723|FG000|Overall Study|Death|0
2037378|NCT00417989|3607724|FG001|Overall Study|Death|1
2037379|NCT00417989|3607723|FG000|Overall Study|Physician Decision|5
2037380|NCT00417989|3607724|FG001|Overall Study|Physician Decision|2
2037381|NCT00418184|3607764|FG000|Double-blind Phase|Withdrawal by Subject|22
2037382|NCT00418184|3607765|FG001|Double-blind Phase|Withdrawal by Subject|9
2241137|NCT01934556|3898704|FG002|Overall Study|Lost to Follow-up|7
2241138|NCT01934556|3898702|FG000|Overall Study|Death|1
2241139|NCT01934556|3898703|FG001|Overall Study|Death|5
2241140|NCT01934556|3898704|FG002|Overall Study|Death|2
2241141|NCT01934790|3898718|FG000|Treatment|Adverse Event|3
2241142|NCT01934790|3898718|FG000|Treatment|Clinical progression|6
2241143|NCT01934790|3898718|FG000|Treatment|Radiological progression|4
2241144|NCT01934790|3898718|FG000|Treatment|Withdrawal by Subject|2
2241145|NCT01934790|3898718|FG000|Treatment|Study drug never administered|1
2241146|NCT01934790|3898718|FG000|Active Follow up|Death|20
2241147|NCT01934790|3898718|FG000|Active Follow up|Physician Decision|2
2241148|NCT01934790|3898718|FG000|Active Follow up|Progressive disease|1
2241149|NCT01934790|3898718|FG000|Active Follow up|Other reason|1
2241150|NCT01934894|3898724|FG000|Overall Study|Adverse Event|1
2241151|NCT01934894|3898725|FG001|Overall Study|Adverse Event|2
2241152|NCT01934894|3898724|FG000|Overall Study|Death|2
2241153|NCT01934894|3898725|FG001|Overall Study|Death|0
2241154|NCT01934894|3898724|FG000|Overall Study|Withdrawal by Subject|0
2241155|NCT01934894|3898725|FG001|Overall Study|Withdrawal by Subject|1
2241156|NCT01934894|3898724|FG000|Overall Study|Progressive Disease|3
2241157|NCT01934894|3898725|FG001|Overall Study|Progressive Disease|2
2241158|NCT01934972|3898736|FG000|Overall Study|Withdrawal by Subject|9
2337321|NCT03319953|4065077|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
2337322|NCT03319953|4065078|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
2337323|NCT03319953|4065075|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0
2337324|NCT03319953|4065076|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0
2337325|NCT03319953|4065077|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1
2337326|NCT03319953|4065078|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1
2337327|NCT03320057|4065086|FG000|Overall Study|Lost to Follow-up|4
2337328|NCT03320057|4065087|FG001|Overall Study|Lost to Follow-up|17
2337329|NCT03320057|4065086|FG000|Overall Study|Did not take mifepristone or misoprostol|2
2337330|NCT03320057|4065087|FG001|Overall Study|Did not take mifepristone or misoprostol|0
2337331|NCT03320369|4065097|FG000|Overall Study|Adverse Event|1
2337332|NCT03320369|4065097|FG000|Overall Study|Withdrawal by Subject|2
2337333|NCT03320564|4065101|FG000|Overall Study|Protocol Violation|1
2337334|NCT03320824|4065107|FG000|Overall Study|Withdrawal by Subject|8
2337335|NCT03320824|4065108|FG001|Overall Study|Withdrawal by Subject|1
2337336|NCT03320824|4065107|FG000|Overall Study|Lost to Follow-up|10
2337337|NCT03320824|4065108|FG001|Overall Study|Lost to Follow-up|1
2337338|NCT03320824|4065107|FG000|Overall Study|moved out of state|0
2337339|NCT03320824|4065108|FG001|Overall Study|moved out of state|1
2337340|NCT03320824|4065107|FG000|Overall Study|could not complete final visit|0
2337341|NCT03320824|4065108|FG001|Overall Study|could not complete final visit|1
2337342|NCT03320850|4065124|FG000|Overall Study|Lost to Follow-up|0
2337343|NCT03320850|4065125|FG001|Overall Study|Lost to Follow-up|0
2337344|NCT03320850|4065126|FG002|Overall Study|Lost to Follow-up|0
2337345|NCT03320850|4065127|FG003|Overall Study|Lost to Follow-up|0
2337346|NCT03320850|4065128|FG004|Overall Study|Lost to Follow-up|1
2337347|NCT03320850|4065129|FG005|Overall Study|Lost to Follow-up|2
2337348|NCT03320850|4065130|FG006|Overall Study|Lost to Follow-up|2
2337349|NCT03320850|4065131|FG007|Overall Study|Lost to Follow-up|0
2337350|NCT03320850|4065132|FG008|Overall Study|Lost to Follow-up|6
2337351|NCT03320850|4065133|FG009|Overall Study|Lost to Follow-up|4
2337352|NCT03320850|4065124|FG000|Overall Study|Withdrawal by Subject|0
2337353|NCT03320850|4065125|FG001|Overall Study|Withdrawal by Subject|0
2337354|NCT03320850|4065126|FG002|Overall Study|Withdrawal by Subject|0
2337355|NCT03320850|4065127|FG003|Overall Study|Withdrawal by Subject|0
2337356|NCT03320850|4065128|FG004|Overall Study|Withdrawal by Subject|1
2337357|NCT03320850|4065129|FG005|Overall Study|Withdrawal by Subject|2
2337358|NCT03320850|4065130|FG006|Overall Study|Withdrawal by Subject|4
2337359|NCT03320850|4065131|FG007|Overall Study|Withdrawal by Subject|5
2337360|NCT03320850|4065132|FG008|Overall Study|Withdrawal by Subject|2
2337361|NCT03320850|4065133|FG009|Overall Study|Withdrawal by Subject|1
2337362|NCT03320850|4065124|FG000|Overall Study|Lack of Efficacy|0
2337363|NCT03320850|4065125|FG001|Overall Study|Lack of Efficacy|0
2337364|NCT03320850|4065126|FG002|Overall Study|Lack of Efficacy|0
2337365|NCT03320850|4065127|FG003|Overall Study|Lack of Efficacy|1
2337366|NCT03320850|4065128|FG004|Overall Study|Lack of Efficacy|0
2337367|NCT03320850|4065129|FG005|Overall Study|Lack of Efficacy|1
2337368|NCT03320850|4065130|FG006|Overall Study|Lack of Efficacy|0
2037383|NCT00418184|3607764|FG000|Double-blind Phase|Adverse Event|2
2037384|NCT00418184|3607765|FG001|Double-blind Phase|Adverse Event|1
2037385|NCT00418184|3607764|FG000|Double-blind Phase|Poor compliance|3
2037386|NCT00418184|3607765|FG001|Double-blind Phase|Poor compliance|1
2037387|NCT00418314|3607781|FG000|Overall Study|Withdrawal by Subject|1
2037388|NCT00418314|3607782|FG001|Overall Study|Withdrawal by Subject|2
2037389|NCT00418379|3607791|FG000|Year 1|Adverse Event|9
2037390|NCT00418379|3607792|FG001|Year 1|Adverse Event|15
2037391|NCT00418379|3607793|FG002|Year 1|Adverse Event|3
2037392|NCT00418379|3607791|FG000|Year 1|Withdrawal by Subject|7
2037393|NCT00418379|3607792|FG001|Year 1|Withdrawal by Subject|8
2241159|NCT01934972|3898737|FG001|Overall Study|Withdrawal by Subject|6
2037394|NCT00418379|3607793|FG002|Year 1|Withdrawal by Subject|5
2337369|NCT03320850|4065131|FG007|Overall Study|Lack of Efficacy|2
2337370|NCT03320850|4065132|FG008|Overall Study|Lack of Efficacy|0
2241160|NCT01935700|3898767|FG000|Overall Study|Withdrawal by Subject|1
2241161|NCT01935700|3898768|FG001|Overall Study|Withdrawal by Subject|0
2241162|NCT01935700|3898767|FG000|Overall Study|Physician Decision|4
2241163|NCT01935700|3898768|FG001|Overall Study|Physician Decision|0
2241164|NCT01936181|3898808|FG000|Randomised, Double-blind|Adverse Event|27
2241165|NCT01936181|3898809|FG001|Randomised, Double-blind|Adverse Event|21
2241166|NCT01936181|3898810|FG002|Randomised, Double-blind|Adverse Event|0
2241167|NCT01936181|3898811|FG003|Randomised, Double-blind|Adverse Event|0
2241168|NCT01936181|3898808|FG000|Randomised, Double-blind|Protocol Violation|1
2241169|NCT01936181|3898809|FG001|Randomised, Double-blind|Protocol Violation|5
2241170|NCT01936181|3898810|FG002|Randomised, Double-blind|Protocol Violation|0
2241171|NCT01936181|3898811|FG003|Randomised, Double-blind|Protocol Violation|0
2241172|NCT01936181|3898808|FG000|Randomised, Double-blind|Lack of Efficacy|5
2241173|NCT01936181|3898809|FG001|Randomised, Double-blind|Lack of Efficacy|6
2241174|NCT01936181|3898810|FG002|Randomised, Double-blind|Lack of Efficacy|0
2241175|NCT01936181|3898811|FG003|Randomised, Double-blind|Lack of Efficacy|0
2241176|NCT01936181|3898808|FG000|Randomised, Double-blind|Lost to Follow-up|0
2241177|NCT01936181|3898809|FG001|Randomised, Double-blind|Lost to Follow-up|1
2241178|NCT01936181|3898810|FG002|Randomised, Double-blind|Lost to Follow-up|0
2241179|NCT01936181|3898811|FG003|Randomised, Double-blind|Lost to Follow-up|0
2241180|NCT01936181|3898808|FG000|Randomised, Double-blind|Pregnancy|0
2241181|NCT01936181|3898809|FG001|Randomised, Double-blind|Pregnancy|1
2241182|NCT01936181|3898810|FG002|Randomised, Double-blind|Pregnancy|0
2241183|NCT01936181|3898811|FG003|Randomised, Double-blind|Pregnancy|0
2241184|NCT01936181|3898808|FG000|Randomised, Double-blind|Physician Decision|4
2241185|NCT01936181|3898809|FG001|Randomised, Double-blind|Physician Decision|4
2241186|NCT01936181|3898810|FG002|Randomised, Double-blind|Physician Decision|0
2241187|NCT01936181|3898811|FG003|Randomised, Double-blind|Physician Decision|0
2241188|NCT01936181|3898808|FG000|Randomised, Double-blind|Withdrawal by Subject|23
2241189|NCT01936181|3898809|FG001|Randomised, Double-blind|Withdrawal by Subject|26
2241190|NCT01936181|3898810|FG002|Randomised, Double-blind|Withdrawal by Subject|0
2241191|NCT01936181|3898811|FG003|Randomised, Double-blind|Withdrawal by Subject|0
2241192|NCT01936181|3898808|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
2241193|NCT01936181|3898809|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
2241194|NCT01936181|3898810|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
2241195|NCT01936181|3898811|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
2241196|NCT01936181|3898808|FG000|Transition-extension|Adverse Event|3
2241197|NCT01936181|3898809|FG001|Transition-extension|Adverse Event|0
2241198|NCT01936181|3898810|FG002|Transition-extension|Adverse Event|3
2241199|NCT01936181|3898811|FG003|Transition-extension|Adverse Event|1
2241200|NCT01936181|3898808|FG000|Transition-extension|Lost to Follow-up|3
2241201|NCT01936181|3898809|FG001|Transition-extension|Lost to Follow-up|0
2241202|NCT01936181|3898810|FG002|Transition-extension|Lost to Follow-up|1
2241203|NCT01936181|3898811|FG003|Transition-extension|Lost to Follow-up|2
2241204|NCT01936181|3898808|FG000|Transition-extension|Physician Decision|2
2241205|NCT01936181|3898809|FG001|Transition-extension|Physician Decision|0
2241206|NCT01936181|3898810|FG002|Transition-extension|Physician Decision|0
2241207|NCT01936181|3898811|FG003|Transition-extension|Physician Decision|1
2241208|NCT01936181|3898808|FG000|Transition-extension|Withdrawal by Subject|7
2241209|NCT01936181|3898809|FG001|Transition-extension|Withdrawal by Subject|0
2241210|NCT01936181|3898810|FG002|Transition-extension|Withdrawal by Subject|2
2241211|NCT01936181|3898811|FG003|Transition-extension|Withdrawal by Subject|1
2241212|NCT01936623|3898888|FG000|Overall Study|Lost to Follow-up|0
2241213|NCT01936623|3898889|FG001|Overall Study|Lost to Follow-up|5
2241214|NCT01936649|3898895|FG000|Overall Study|Withdrawal by Subject|4
2241215|NCT01936649|3898895|FG000|Overall Study|Physician Decision|2
2241216|NCT01936649|3898895|FG000|Overall Study|Protocol Violation|2
2241217|NCT01936649|3898895|FG000|Overall Study|Other than specified above|5
2241218|NCT01936857|3898921|FG000|Overall Study|Sent to prison or 06 center|11
2241219|NCT01936857|3898922|FG001|Overall Study|Sent to prison or 06 center|12
2241220|NCT01936857|3898921|FG000|Overall Study|Lost to Follow-up|10
2241221|NCT01936857|3898922|FG001|Overall Study|Lost to Follow-up|7
2241222|NCT01936857|3898921|FG000|Overall Study|Death|7
2241223|NCT01936857|3898922|FG001|Overall Study|Death|3
2241224|NCT01936857|3898921|FG000|Overall Study|Moved|2
2241225|NCT01936857|3898922|FG001|Overall Study|Moved|1
2241226|NCT01936857|3898921|FG000|Overall Study|Withdrawal by Subject|1
2241227|NCT01936857|3898922|FG001|Overall Study|Withdrawal by Subject|0
2241228|NCT01936857|3898921|FG000|Overall Study|Side effect of medication|1
2241229|NCT01936857|3898922|FG001|Overall Study|Side effect of medication|0
2241230|NCT01936857|3898921|FG000|Overall Study|Other|2
2241231|NCT01936857|3898922|FG001|Overall Study|Other|2
2241232|NCT01936870|3898928|FG000|Overall Study|No Visit After Treatment|176
2241233|NCT01936870|3898928|FG000|Overall Study|Protocol Violation|12
2241234|NCT01936870|3898928|FG000|Overall Study|No Drug Administration|1
2337371|NCT03320850|4065133|FG009|Overall Study|Lack of Efficacy|3
2337372|NCT03320850|4065124|FG000|Overall Study|Failure to Meet Randomization Criteria|0
2337373|NCT03320850|4065125|FG001|Overall Study|Failure to Meet Randomization Criteria|0
2337374|NCT03320850|4065126|FG002|Overall Study|Failure to Meet Randomization Criteria|0
2241235|NCT01936948|3898953|FG000|Overall Study|no 30-day follow-up data|0
2337375|NCT03320850|4065127|FG003|Overall Study|Failure to Meet Randomization Criteria|0
2337376|NCT03320850|4065128|FG004|Overall Study|Failure to Meet Randomization Criteria|0
2337377|NCT03320850|4065129|FG005|Overall Study|Failure to Meet Randomization Criteria|1
2337378|NCT03320850|4065130|FG006|Overall Study|Failure to Meet Randomization Criteria|0
2337379|NCT03320850|4065131|FG007|Overall Study|Failure to Meet Randomization Criteria|0
2337380|NCT03320850|4065132|FG008|Overall Study|Failure to Meet Randomization Criteria|0
2337381|NCT03320850|4065133|FG009|Overall Study|Failure to Meet Randomization Criteria|0
2337382|NCT03320850|4065124|FG000|Overall Study|Adverse Event|0
2337383|NCT03320850|4065125|FG001|Overall Study|Adverse Event|0
2337384|NCT03320850|4065126|FG002|Overall Study|Adverse Event|0
2337385|NCT03320850|4065127|FG003|Overall Study|Adverse Event|0
2337386|NCT03320850|4065128|FG004|Overall Study|Adverse Event|0
2337387|NCT03320850|4065129|FG005|Overall Study|Adverse Event|2
2337388|NCT03320850|4065130|FG006|Overall Study|Adverse Event|1
2337389|NCT03320850|4065131|FG007|Overall Study|Adverse Event|0
2337390|NCT03320850|4065132|FG008|Overall Study|Adverse Event|2
2337391|NCT03320850|4065133|FG009|Overall Study|Adverse Event|0
2337392|NCT03320850|4065124|FG000|Overall Study|Reason Not Specified|0
2337393|NCT03320850|4065125|FG001|Overall Study|Reason Not Specified|0
2337394|NCT03320850|4065126|FG002|Overall Study|Reason Not Specified|0
2337395|NCT03320850|4065127|FG003|Overall Study|Reason Not Specified|0
2337396|NCT03320850|4065128|FG004|Overall Study|Reason Not Specified|0
2337397|NCT03320850|4065129|FG005|Overall Study|Reason Not Specified|1
2337398|NCT03320850|4065130|FG006|Overall Study|Reason Not Specified|0
2337399|NCT03320850|4065131|FG007|Overall Study|Reason Not Specified|0
2337400|NCT03320850|4065132|FG008|Overall Study|Reason Not Specified|0
2337401|NCT03320850|4065133|FG009|Overall Study|Reason Not Specified|1
2337402|NCT03320941|4065165|FG000|Overall Study|subject/guardian decision|0
2337403|NCT03320941|4065166|FG001|Overall Study|subject/guardian decision|0
2337404|NCT03320941|4065167|FG002|Overall Study|subject/guardian decision|0
2337405|NCT03320941|4065168|FG003|Overall Study|subject/guardian decision|1
2337406|NCT03320941|4065169|FG004|Overall Study|subject/guardian decision|0
2337407|NCT03321006|4065183|FG000|Overall Study|Death|1
2337408|NCT03321006|4065184|FG001|Overall Study|Death|0
2337409|NCT03321006|4065183|FG000|Overall Study|Lack of Efficacy|1
2337410|NCT03321006|4065184|FG001|Overall Study|Lack of Efficacy|0
2337411|NCT03321396|4065203|FG000|Overall Study|Physician Decision|1
2337412|NCT03321721|4065210|FG000|Overall Study|Lost to Follow-up|4
2337413|NCT03321721|4065211|FG001|Overall Study|Lost to Follow-up|8
2337414|NCT03321721|4065212|FG002|Overall Study|Lost to Follow-up|11
2337415|NCT03322293|4065224|FG000|Overall Study|Lost to Follow-up|0
2337416|NCT03322293|4065225|FG001|Overall Study|Lost to Follow-up|0
2337417|NCT03322293|4065226|FG002|Overall Study|Lost to Follow-up|1
2337418|NCT03322423|4065234|FG000|Period 1|Subject no longer eligible|0
2337419|NCT03322423|4065235|FG001|Period 1|Subject no longer eligible|1
2337420|NCT03322423|4065234|FG000|Period 1|Withdrawal by Subject|0
2337421|NCT03322423|4065235|FG001|Period 1|Withdrawal by Subject|1
2337422|NCT03322423|4065234|FG000|Period 1|Incorrect Lens Dispensed|1
2337423|NCT03322423|4065235|FG001|Period 1|Incorrect Lens Dispensed|0
2337424|NCT03322423|4065234|FG000|Period 1|Unsatisfactory Lens Fitting|1
2337425|NCT03322423|4065235|FG001|Period 1|Unsatisfactory Lens Fitting|0
2337426|NCT03322423|4065234|FG000|Period 2|Dispensed incorrect lens in left eye|0
2337427|NCT03322423|4065235|FG001|Period 2|Dispensed incorrect lens in left eye|1
2337428|NCT03322423|4065234|FG000|Period 2|Protocol Violation|1
2337429|NCT03322423|4065235|FG001|Period 2|Protocol Violation|0
2337430|NCT03322423|4065234|FG000|Period 2|Subject not eligible for Pytergiumectomy|0
2337431|NCT03322423|4065235|FG001|Period 2|Subject not eligible for Pytergiumectomy|1
2353001|NCT03600740|4103533|FG000|Overall Study|Surgical plan was altered-subject not eligible|1
2353002|NCT03598140|4103539|FG000|Overall Study|enrolled but didn't start|1
2353003|NCT03598140|4103540|FG001|Overall Study|enrolled but didn't start|0
2353004|NCT03598036|4103548|FG000|Overall Study|Withdrawal by Subject|1
2037395|NCT00418379|3607791|FG000|Year 1|Any other reason not above-mentioned|2
2037396|NCT00418379|3607792|FG001|Year 1|Any other reason not above-mentioned|5
2037397|NCT00418379|3607793|FG002|Year 1|Any other reason not above-mentioned|7
2037398|NCT00418379|3607791|FG000|Year 2|Adverse Event|5
2037399|NCT00418379|3607792|FG001|Year 2|Adverse Event|2
2037400|NCT00418379|3607793|FG002|Year 2|Adverse Event|1
2037401|NCT00418379|3607791|FG000|Year 2|Withdrawal by Subject|1
2037402|NCT00418379|3607792|FG001|Year 2|Withdrawal by Subject|1
2037403|NCT00418379|3607793|FG002|Year 2|Withdrawal by Subject|3
2037404|NCT00418379|3607791|FG000|Year 2|Any other reason not above-mentioned|2
2037405|NCT00418379|3607792|FG001|Year 2|Any other reason not above-mentioned|1
2037406|NCT00418379|3607793|FG002|Year 2|Any other reason not above-mentioned|6
2037407|NCT00418379|3607791|FG000|Year 3|Withdrawal by Subject|1
2037408|NCT00418379|3607792|FG001|Year 3|Withdrawal by Subject|1
2353005|NCT03598036|4103549|FG001|Overall Study|Withdrawal by Subject|0
2353006|NCT03590743|4103568|FG000|Overall Study|Withdrawal by Subject|0
2353007|NCT03590743|4103569|FG001|Overall Study|Withdrawal by Subject|1
2353008|NCT03580382|4103577|FG000|Overall Study|Early Termination of Study|0
2353009|NCT03580382|4103578|FG001|Overall Study|Early Termination of Study|3
2353010|NCT03571646|4103595|FG000|Overall Study|Adverse Event|1
2241236|NCT01936948|3898954|FG001|Overall Study|no 30-day follow-up data|3
2241237|NCT01936948|3898955|FG002|Overall Study|no 30-day follow-up data|3
2241238|NCT01936948|3898956|FG003|Overall Study|no 30-day follow-up data|3
2241239|NCT01937117|3898971|FG000|Overall Study|Disease Progression|7
2241240|NCT01937117|3898971|FG000|Overall Study|Physician Decision|4
2241241|NCT01937117|3898971|FG000|Overall Study|Adverse Event|2
2241242|NCT01937130|3898979|FG000|Overall Study|Withdrawal by Subject|0
2241243|NCT01937130|3898980|FG001|Overall Study|Withdrawal by Subject|0
2241244|NCT01937130|3898981|FG002|Overall Study|Withdrawal by Subject|0
2241245|NCT01937130|3898982|FG003|Overall Study|Withdrawal by Subject|1
2241246|NCT01937130|3898979|FG000|Overall Study|Adverse Event|0
2241247|NCT01937130|3898980|FG001|Overall Study|Adverse Event|1
2241248|NCT01937130|3898981|FG002|Overall Study|Adverse Event|0
2241249|NCT01937130|3898982|FG003|Overall Study|Adverse Event|1
2241250|NCT01937130|3898979|FG000|Overall Study|Death|1
2241251|NCT01937130|3898980|FG001|Overall Study|Death|1
2241252|NCT01937130|3898981|FG002|Overall Study|Death|1
2241253|NCT01937130|3898982|FG003|Overall Study|Death|0
2241254|NCT01937130|3898979|FG000|Overall Study|Lost to Follow-up|2
2241255|NCT01937130|3898980|FG001|Overall Study|Lost to Follow-up|0
2241256|NCT01937130|3898981|FG002|Overall Study|Lost to Follow-up|2
2241257|NCT01937130|3898982|FG003|Overall Study|Lost to Follow-up|0
2241258|NCT01937130|3898979|FG000|Overall Study|Physician Decision|0
2241259|NCT01937130|3898980|FG001|Overall Study|Physician Decision|1
2241260|NCT01937130|3898981|FG002|Overall Study|Physician Decision|0
2241261|NCT01937130|3898982|FG003|Overall Study|Physician Decision|0
2241262|NCT01937130|3898979|FG000|Overall Study|Patients unable to swallow|0
2241263|NCT01937130|3898980|FG001|Overall Study|Patients unable to swallow|1
2241264|NCT01937130|3898981|FG002|Overall Study|Patients unable to swallow|0
2241265|NCT01937130|3898982|FG003|Overall Study|Patients unable to swallow|0
2241266|NCT01937130|3898979|FG000|Overall Study|Patient lost to FU due to death|2
2241267|NCT01937130|3898980|FG001|Overall Study|Patient lost to FU due to death|0
2241268|NCT01937130|3898981|FG002|Overall Study|Patient lost to FU due to death|0
2241269|NCT01937130|3898982|FG003|Overall Study|Patient lost to FU due to death|0
2241270|NCT01937299|3899007|FG000|Overall Study|Adverse Event|13
2241271|NCT01937299|3899008|FG001|Overall Study|Adverse Event|0
2241272|NCT01937299|3899007|FG000|Overall Study|Lack of Efficacy|0
2241273|NCT01937299|3899008|FG001|Overall Study|Lack of Efficacy|4
2241274|NCT01937299|3899007|FG000|Overall Study|Withdrawal by Subject|1
2241275|NCT01937299|3899008|FG001|Overall Study|Withdrawal by Subject|0
2241276|NCT01937312|3899017|FG000|Overall Study|Adverse Event|10
2241277|NCT01937312|3899018|FG001|Overall Study|Adverse Event|1
2241278|NCT01937312|3899017|FG000|Overall Study|Lack of Efficacy|0
2241279|NCT01937312|3899018|FG001|Overall Study|Lack of Efficacy|1
2241280|NCT01937312|3899017|FG000|Overall Study|Withdrawal of subject prior to treatment|1
2241281|NCT01937312|3899018|FG001|Overall Study|Withdrawal of subject prior to treatment|1
2241282|NCT01937351|3899027|FG000|Overall Study|Withdrawal by Subject|4
2241283|NCT01937351|3899028|FG001|Overall Study|Withdrawal by Subject|2
2241284|NCT01937351|3899027|FG000|Overall Study|Death|1
2241285|NCT01937351|3899028|FG001|Overall Study|Death|0
2241286|NCT01937351|3899027|FG000|Overall Study|Not treated w device, per protocol fail|4
2241287|NCT01937351|3899028|FG001|Overall Study|Not treated w device, per protocol fail|0
2241288|NCT01937364|3899035|FG000|Overall Study|Adverse Event|2
2241289|NCT01937364|3899036|FG001|Overall Study|Adverse Event|1
2241290|NCT01937390|3899042|FG000|Overall Study|Death|2
2241291|NCT01937390|3899042|FG000|Overall Study|Lost to Follow-up|7
2241292|NCT01937390|3899042|FG000|Overall Study|Withdrawal by Subject|5
2241293|NCT01937390|3899042|FG000|Overall Study|Fail to return|21
2241294|NCT01937559|3899059|FG000|Overall Study|Physician Decision|3
2241295|NCT01937559|3899060|FG001|Overall Study|Physician Decision|3
2241296|NCT01937559|3899061|FG002|Overall Study|Physician Decision|0
2241297|NCT01937559|3899059|FG000|Overall Study|Withdrawal by Subject|6
2241298|NCT01937559|3899060|FG001|Overall Study|Withdrawal by Subject|4
2241299|NCT01937559|3899061|FG002|Overall Study|Withdrawal by Subject|0
2241300|NCT01937559|3899059|FG000|Overall Study|screen fail|2
2241301|NCT01937559|3899060|FG001|Overall Study|screen fail|4
2241302|NCT01937559|3899061|FG002|Overall Study|screen fail|0
2241303|NCT01937715|3899089|FG000|Overall Study|Death|0
2241304|NCT01937715|3899090|FG001|Overall Study|Death|0
2241305|NCT01937715|3899091|FG002|Overall Study|Death|0
2241306|NCT01937715|3899092|FG003|Overall Study|Death|1
2241307|NCT01937715|3899093|FG004|Overall Study|Death|0
2241308|NCT01937715|3899089|FG000|Overall Study|Withdrawal by Subject|0
2241309|NCT01937715|3899090|FG001|Overall Study|Withdrawal by Subject|1
2241310|NCT01937715|3899091|FG002|Overall Study|Withdrawal by Subject|0
2241311|NCT01937715|3899092|FG003|Overall Study|Withdrawal by Subject|0
2241312|NCT01937715|3899093|FG004|Overall Study|Withdrawal by Subject|2
2241313|NCT01937715|3899089|FG000|Overall Study|Other|0
2241314|NCT01937715|3899090|FG001|Overall Study|Other|0
2241315|NCT01937715|3899091|FG002|Overall Study|Other|0
2241316|NCT01937715|3899092|FG003|Overall Study|Other|3
2241317|NCT01937715|3899093|FG004|Overall Study|Other|0
2241318|NCT01937871|3899108|FG000|Overall Study|Adverse Event|6
2241319|NCT01937871|3899109|FG001|Overall Study|Adverse Event|6
2241320|NCT01937871|3899110|FG002|Overall Study|Adverse Event|2
2241321|NCT01937871|3899108|FG000|Overall Study|Lost to Follow-up|8
2241322|NCT01937871|3899109|FG001|Overall Study|Lost to Follow-up|2
2241323|NCT01937871|3899110|FG002|Overall Study|Lost to Follow-up|4
2241324|NCT01937871|3899108|FG000|Overall Study|Withdrawal by Subject|9
2337432|NCT03322462|4065241|FG000|Overall Study|Technical difficulties|2
2337433|NCT03322462|4065241|FG000|Overall Study|Other|1
2337434|NCT03322514|4065249|FG000|Overall Study|Withdrawal by Subject|1
2337435|NCT03322514|4065250|FG001|Overall Study|Withdrawal by Subject|1
2337436|NCT03323086|4065276|FG000|Overall Study|Lost to Follow-up|3
2337437|NCT03323086|4065277|FG001|Overall Study|Lost to Follow-up|2
2337438|NCT03323164|4065285|FG000|Overall Study|Poor quality imaging/scans|2
2337439|NCT03323164|4065286|FG001|Overall Study|Poor quality imaging/scans|2
2337440|NCT03323736|4065308|FG000|Overall Study|Screen Failure|14
2337441|NCT03323736|4065309|FG001|Overall Study|Screen Failure|9
2337442|NCT03323736|4065310|FG002|Overall Study|Screen Failure|1
2337443|NCT03323736|4065308|FG000|Overall Study|Withdrawal Before Treatment|3
2337444|NCT03323736|4065309|FG001|Overall Study|Withdrawal Before Treatment|1
2337445|NCT03323736|4065310|FG002|Overall Study|Withdrawal Before Treatment|1
2337446|NCT03323736|4065308|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2
2337447|NCT03323736|4065309|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2
2337448|NCT03323736|4065310|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0
2337449|NCT03324581|4065346|FG000|Overall Study|Adverse Event|18
2337450|NCT03324581|4065347|FG001|Overall Study|Adverse Event|11
2337451|NCT03324581|4065348|FG002|Overall Study|Adverse Event|7
2337452|NCT03324581|4065346|FG000|Overall Study|Lack of Efficacy|0
2337453|NCT03324581|4065347|FG001|Overall Study|Lack of Efficacy|1
2337454|NCT03324581|4065348|FG002|Overall Study|Lack of Efficacy|0
2337455|NCT03324581|4065346|FG000|Overall Study|Lost to Follow-up|5
2337456|NCT03324581|4065347|FG001|Overall Study|Lost to Follow-up|3
2337457|NCT03324581|4065348|FG002|Overall Study|Lost to Follow-up|6
2337458|NCT03324581|4065346|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
2337459|NCT03324581|4065347|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
2337460|NCT03324581|4065348|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0
2337461|NCT03324581|4065346|FG000|Overall Study|Physician Decision|0
2337462|NCT03324581|4065347|FG001|Overall Study|Physician Decision|1
2337463|NCT03324581|4065348|FG002|Overall Study|Physician Decision|2
2337464|NCT03324581|4065346|FG000|Overall Study|Protocol Deviation|8
2037409|NCT00418379|3607793|FG002|Year 3|Withdrawal by Subject|2
2241325|NCT01937871|3899109|FG001|Overall Study|Withdrawal by Subject|6
2241326|NCT01937871|3899110|FG002|Overall Study|Withdrawal by Subject|4
2241327|NCT01937871|3899108|FG000|Overall Study|Physician Decision|0
2241328|NCT01937871|3899109|FG001|Overall Study|Physician Decision|1
2241329|NCT01937871|3899110|FG002|Overall Study|Physician Decision|0
2241330|NCT01937871|3899108|FG000|Overall Study|Entry Criteria Not Met|1
2241331|NCT01937871|3899109|FG001|Overall Study|Entry Criteria Not Met|2
2241332|NCT01937871|3899110|FG002|Overall Study|Entry Criteria Not Met|1
2241333|NCT01937884|3899123|FG000|Overall Study|Withdrawal by Subject|1
2241334|NCT01937884|3899124|FG001|Overall Study|Withdrawal by Subject|0
2241335|NCT01938001|3899151|FG000|Overall Study|Withdrawal by Subject|25
2241336|NCT01938001|3899152|FG001|Overall Study|Withdrawal by Subject|17
2241337|NCT01938001|3899151|FG000|Overall Study|Non-compliant|1
2241338|NCT01938001|3899152|FG001|Overall Study|Non-compliant|0
2241339|NCT01938001|3899151|FG000|Overall Study|Participant Moved|0
2241340|NCT01938001|3899152|FG001|Overall Study|Participant Moved|1
2241341|NCT01938001|3899151|FG000|Overall Study|Lost to Follow-up|1
2241342|NCT01938001|3899152|FG001|Overall Study|Lost to Follow-up|3
2241343|NCT01938001|3899151|FG000|Overall Study|Death|16
2241344|NCT01938001|3899152|FG001|Overall Study|Death|26
2241345|NCT01938391|3899216|FG000|6 Month Follow up|Withdrawal by Subject|1
2241346|NCT01938391|3899216|FG000|12 Month Follow up|Physician Decision|1
2241347|NCT01938391|3899216|FG000|12 Month Follow up|Withdrawal by Subject|1
2241348|NCT01938430|3899234|FG000|Overall Study|Randomized but Not Treated|0
2241349|NCT01938430|3899235|FG001|Overall Study|Randomized but Not Treated|0
2241350|NCT01938430|3899236|FG002|Overall Study|Randomized but Not Treated|0
2241351|NCT01938430|3899237|FG003|Overall Study|Randomized but Not Treated|0
2241352|NCT01938430|3899238|FG004|Overall Study|Randomized but Not Treated|0
2241353|NCT01938430|3899239|FG005|Overall Study|Randomized but Not Treated|0
2241354|NCT01938430|3899240|FG006|Overall Study|Randomized but Not Treated|0
2241355|NCT01938430|3899241|FG007|Overall Study|Randomized but Not Treated|0
2241356|NCT01938430|3899242|FG008|Overall Study|Randomized but Not Treated|0
2241357|NCT01938430|3899243|FG009|Overall Study|Randomized but Not Treated|0
2241358|NCT01938430|3899244|FG010|Overall Study|Randomized but Not Treated|1
2241359|NCT01938430|3899245|FG011|Overall Study|Randomized but Not Treated|0
2241360|NCT01938430|3899246|FG012|Overall Study|Randomized but Not Treated|0
2241361|NCT01938430|3899247|FG013|Overall Study|Randomized but Not Treated|1
2241362|NCT01938430|3899234|FG000|Overall Study|Adverse Event|0
2241363|NCT01938430|3899235|FG001|Overall Study|Adverse Event|0
2241364|NCT01938430|3899236|FG002|Overall Study|Adverse Event|0
2241365|NCT01938430|3899237|FG003|Overall Study|Adverse Event|0
2241366|NCT01938430|3899238|FG004|Overall Study|Adverse Event|0
2241367|NCT01938430|3899239|FG005|Overall Study|Adverse Event|0
2241368|NCT01938430|3899240|FG006|Overall Study|Adverse Event|1
2241369|NCT01938430|3899241|FG007|Overall Study|Adverse Event|0
2337465|NCT03324581|4065347|FG001|Overall Study|Protocol Deviation|9
2337466|NCT03324581|4065348|FG002|Overall Study|Protocol Deviation|4
2241370|NCT01938430|3899242|FG008|Overall Study|Adverse Event|0
2241371|NCT01938430|3899243|FG009|Overall Study|Adverse Event|0
2241372|NCT01938430|3899244|FG010|Overall Study|Adverse Event|0
2241373|NCT01938430|3899245|FG011|Overall Study|Adverse Event|0
2241374|NCT01938430|3899246|FG012|Overall Study|Adverse Event|0
2241375|NCT01938430|3899247|FG013|Overall Study|Adverse Event|0
2241376|NCT01938430|3899234|FG000|Overall Study|Death|1
2241377|NCT01938430|3899235|FG001|Overall Study|Death|2
2241378|NCT01938430|3899236|FG002|Overall Study|Death|2
2241379|NCT01938430|3899237|FG003|Overall Study|Death|1
2241380|NCT01938430|3899238|FG004|Overall Study|Death|0
2241381|NCT01938430|3899239|FG005|Overall Study|Death|0
2241382|NCT01938430|3899240|FG006|Overall Study|Death|1
2241383|NCT01938430|3899241|FG007|Overall Study|Death|1
2241384|NCT01938430|3899242|FG008|Overall Study|Death|2
2241385|NCT01938430|3899243|FG009|Overall Study|Death|3
2241386|NCT01938430|3899244|FG010|Overall Study|Death|0
2241387|NCT01938430|3899245|FG011|Overall Study|Death|0
2241388|NCT01938430|3899246|FG012|Overall Study|Death|0
2241389|NCT01938430|3899247|FG013|Overall Study|Death|0
2241390|NCT01938430|3899234|FG000|Overall Study|Investigator's Discretion|0
2241391|NCT01938430|3899235|FG001|Overall Study|Investigator's Discretion|0
2241392|NCT01938430|3899236|FG002|Overall Study|Investigator's Discretion|1
2241393|NCT01938430|3899237|FG003|Overall Study|Investigator's Discretion|0
2241394|NCT01938430|3899238|FG004|Overall Study|Investigator's Discretion|0
2241395|NCT01938430|3899239|FG005|Overall Study|Investigator's Discretion|0
2241396|NCT01938430|3899240|FG006|Overall Study|Investigator's Discretion|0
2241397|NCT01938430|3899241|FG007|Overall Study|Investigator's Discretion|0
2241398|NCT01938430|3899242|FG008|Overall Study|Investigator's Discretion|0
2241399|NCT01938430|3899243|FG009|Overall Study|Investigator's Discretion|0
2241400|NCT01938430|3899244|FG010|Overall Study|Investigator's Discretion|0
2241401|NCT01938430|3899245|FG011|Overall Study|Investigator's Discretion|0
2241402|NCT01938430|3899246|FG012|Overall Study|Investigator's Discretion|0
2241403|NCT01938430|3899247|FG013|Overall Study|Investigator's Discretion|0
2241404|NCT01938430|3899234|FG000|Overall Study|Lack of Efficacy|3
2241405|NCT01938430|3899235|FG001|Overall Study|Lack of Efficacy|1
2241406|NCT01938430|3899236|FG002|Overall Study|Lack of Efficacy|1
2241407|NCT01938430|3899237|FG003|Overall Study|Lack of Efficacy|1
2241408|NCT01938430|3899238|FG004|Overall Study|Lack of Efficacy|0
2241409|NCT01938430|3899239|FG005|Overall Study|Lack of Efficacy|0
2241410|NCT01938430|3899240|FG006|Overall Study|Lack of Efficacy|0
2241411|NCT01938430|3899241|FG007|Overall Study|Lack of Efficacy|0
2241412|NCT01938430|3899242|FG008|Overall Study|Lack of Efficacy|1
2241413|NCT01938430|3899243|FG009|Overall Study|Lack of Efficacy|0
2241414|NCT01938430|3899244|FG010|Overall Study|Lack of Efficacy|2
2241415|NCT01938430|3899245|FG011|Overall Study|Lack of Efficacy|1
2241416|NCT01938430|3899246|FG012|Overall Study|Lack of Efficacy|0
2241417|NCT01938430|3899247|FG013|Overall Study|Lack of Efficacy|0
2241418|NCT01938430|3899234|FG000|Overall Study|Lost to Follow-up|0
2241419|NCT01938430|3899235|FG001|Overall Study|Lost to Follow-up|0
2241420|NCT01938430|3899236|FG002|Overall Study|Lost to Follow-up|1
2241421|NCT01938430|3899237|FG003|Overall Study|Lost to Follow-up|0
2241422|NCT01938430|3899238|FG004|Overall Study|Lost to Follow-up|0
2241423|NCT01938430|3899239|FG005|Overall Study|Lost to Follow-up|1
2241424|NCT01938430|3899240|FG006|Overall Study|Lost to Follow-up|0
2241425|NCT01938430|3899241|FG007|Overall Study|Lost to Follow-up|0
2241426|NCT01938430|3899242|FG008|Overall Study|Lost to Follow-up|0
2241427|NCT01938430|3899243|FG009|Overall Study|Lost to Follow-up|0
2337467|NCT03324581|4065346|FG000|Overall Study|Withdrawal by Subject|6
2337468|NCT03324581|4065347|FG001|Overall Study|Withdrawal by Subject|8
2337469|NCT03324581|4065348|FG002|Overall Study|Withdrawal by Subject|6
2337470|NCT03324581|4065346|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
2337471|NCT03324581|4065347|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1
2337472|NCT03324581|4065348|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
2337473|NCT03325010|4065365|FG000|Overall Study|Adverse Event|3
2337474|NCT03325010|4065366|FG001|Overall Study|Adverse Event|8
2337475|NCT03325010|4065365|FG000|Overall Study|Protocol Violation|1
2337476|NCT03325010|4065366|FG001|Overall Study|Protocol Violation|8
2337477|NCT03325010|4065365|FG000|Overall Study|Withdrawal by Subject|1
2337478|NCT03325010|4065366|FG001|Overall Study|Withdrawal by Subject|3
2337479|NCT03325010|4065365|FG000|Overall Study|Lost to Follow-up|1
2337480|NCT03325010|4065366|FG001|Overall Study|Lost to Follow-up|0
2337481|NCT03325010|4065365|FG000|Overall Study|Physician Decision|1
2337482|NCT03325010|4065366|FG001|Overall Study|Physician Decision|1
2337483|NCT03325010|4065365|FG000|Overall Study|Lack of Efficacy|2
2337484|NCT03325010|4065366|FG001|Overall Study|Lack of Efficacy|0
2337485|NCT03325556|4065372|FG000|Open-label Period|Lack of Response in OL period|70
2337486|NCT03325556|4065373|FG001|Open-label Period|Lack of Response in OL period|0
2241428|NCT01938430|3899244|FG010|Overall Study|Lost to Follow-up|0
2241429|NCT01938430|3899245|FG011|Overall Study|Lost to Follow-up|0
2241430|NCT01938430|3899246|FG012|Overall Study|Lost to Follow-up|0
2241431|NCT01938430|3899247|FG013|Overall Study|Lost to Follow-up|0
2241432|NCT01938430|3899234|FG000|Overall Study|Withdrew Consent|0
2241433|NCT01938430|3899235|FG001|Overall Study|Withdrew Consent|0
2241434|NCT01938430|3899236|FG002|Overall Study|Withdrew Consent|0
2241435|NCT01938430|3899237|FG003|Overall Study|Withdrew Consent|0
2241436|NCT01938430|3899238|FG004|Overall Study|Withdrew Consent|0
2241437|NCT01938430|3899239|FG005|Overall Study|Withdrew Consent|0
2241438|NCT01938430|3899240|FG006|Overall Study|Withdrew Consent|0
2241439|NCT01938430|3899241|FG007|Overall Study|Withdrew Consent|0
2241440|NCT01938430|3899242|FG008|Overall Study|Withdrew Consent|1
2241441|NCT01938430|3899243|FG009|Overall Study|Withdrew Consent|0
2241442|NCT01938430|3899244|FG010|Overall Study|Withdrew Consent|0
2241443|NCT01938430|3899245|FG011|Overall Study|Withdrew Consent|0
2241444|NCT01938430|3899246|FG012|Overall Study|Withdrew Consent|0
2241445|NCT01938430|3899247|FG013|Overall Study|Withdrew Consent|0
2241446|NCT01938573|3899302|FG000|Overall Study|Lack of Efficacy|1
2241447|NCT01938573|3899303|FG001|Overall Study|Lack of Efficacy|0
2241448|NCT01938573|3899302|FG000|Overall Study|Operation at other hospital|1
2241449|NCT01938573|3899303|FG001|Overall Study|Operation at other hospital|0
2241450|NCT01938625|3899310|FG000|Overall Study|Withdrawal by Subject|0
2241451|NCT01938625|3899311|FG001|Overall Study|Withdrawal by Subject|1
2241452|NCT01938625|3899310|FG000|Overall Study|Adverse Event|0
2241453|NCT01938625|3899311|FG001|Overall Study|Adverse Event|1
2241454|NCT01938846|3899329|FG000|Overall Study|Progressive disease|26
2241455|NCT01938846|3899330|FG001|Overall Study|Progressive disease|18
2241456|NCT01938846|3899331|FG002|Overall Study|Progressive disease|16
2241457|NCT01938846|3899329|FG000|Overall Study|Adverse Event|8
2241458|NCT01938846|3899330|FG001|Overall Study|Adverse Event|4
2241459|NCT01938846|3899331|FG002|Overall Study|Adverse Event|3
2241460|NCT01938846|3899329|FG000|Overall Study|Withdrawal by Subject|2
2337487|NCT03325556|4065374|FG002|Open-label Period|Lack of Response in OL period|0
2337488|NCT03325556|4065372|FG000|Open-label Period|Adverse Event|27
2337489|NCT03325556|4065373|FG001|Open-label Period|Adverse Event|0
2337490|NCT03325556|4065374|FG002|Open-label Period|Adverse Event|0
2337491|NCT03325556|4065372|FG000|Open-label Period|Death|1
2337492|NCT03325556|4065373|FG001|Open-label Period|Death|0
2337493|NCT03325556|4065374|FG002|Open-label Period|Death|0
2337494|NCT03325556|4065372|FG000|Open-label Period|Lost to Follow-up|1
2337495|NCT03325556|4065373|FG001|Open-label Period|Lost to Follow-up|0
2337496|NCT03325556|4065374|FG002|Open-label Period|Lost to Follow-up|0
2337497|NCT03325556|4065372|FG000|Open-label Period|Non-compliance with study drug|5
2337498|NCT03325556|4065373|FG001|Open-label Period|Non-compliance with study drug|0
2337499|NCT03325556|4065374|FG002|Open-label Period|Non-compliance with study drug|0
2337500|NCT03325556|4065372|FG000|Open-label Period|Use of prohibited medication|1
2337501|NCT03325556|4065373|FG001|Open-label Period|Use of prohibited medication|0
2337502|NCT03325556|4065374|FG002|Open-label Period|Use of prohibited medication|0
2337503|NCT03325556|4065372|FG000|Open-label Period|Protocol Violation|4
2337504|NCT03325556|4065373|FG001|Open-label Period|Protocol Violation|0
2337505|NCT03325556|4065374|FG002|Open-label Period|Protocol Violation|0
2337506|NCT03325556|4065372|FG000|Open-label Period|Withdrawal by Subject|17
2337507|NCT03325556|4065373|FG001|Open-label Period|Withdrawal by Subject|0
2337508|NCT03325556|4065374|FG002|Open-label Period|Withdrawal by Subject|0
2337509|NCT03325556|4065372|FG000|Open-label Period|Not otherwise specified|8
2337510|NCT03325556|4065373|FG001|Open-label Period|Not otherwise specified|0
2337511|NCT03325556|4065374|FG002|Open-label Period|Not otherwise specified|0
2337512|NCT03325556|4065372|FG000|Open-label Period|Administrative discont. at study termination|41
2337513|NCT03325556|4065373|FG001|Open-label Period|Administrative discont. at study termination|0
2337514|NCT03325556|4065374|FG002|Open-label Period|Administrative discont. at study termination|0
2337515|NCT03325556|4065372|FG000|Double-blind Period|Relapse|0
2337516|NCT03325556|4065373|FG001|Double-blind Period|Relapse|15
2337517|NCT03325556|4065374|FG002|Double-blind Period|Relapse|34
2337518|NCT03325556|4065372|FG000|Double-blind Period|Adverse Event|0
2337519|NCT03325556|4065373|FG001|Double-blind Period|Adverse Event|3
2337520|NCT03325556|4065374|FG002|Double-blind Period|Adverse Event|1
2337521|NCT03325556|4065372|FG000|Double-blind Period|Noncompliance with study drug|0
2337522|NCT03325556|4065373|FG001|Double-blind Period|Noncompliance with study drug|0
2337523|NCT03325556|4065374|FG002|Double-blind Period|Noncompliance with study drug|1
2337524|NCT03325556|4065372|FG000|Double-blind Period|Use of prohibited medication|0
2337525|NCT03325556|4065373|FG001|Double-blind Period|Use of prohibited medication|1
2337526|NCT03325556|4065374|FG002|Double-blind Period|Use of prohibited medication|0
2337527|NCT03325556|4065372|FG000|Double-blind Period|Physician Decision|0
2337528|NCT03325556|4065373|FG001|Double-blind Period|Physician Decision|0
2337529|NCT03325556|4065374|FG002|Double-blind Period|Physician Decision|1
2337530|NCT03325556|4065372|FG000|Double-blind Period|Withdrawal by Subject|0
2337531|NCT03325556|4065373|FG001|Double-blind Period|Withdrawal by Subject|6
2337532|NCT03325556|4065374|FG002|Double-blind Period|Withdrawal by Subject|4
2337533|NCT03325556|4065372|FG000|Double-blind Period|Not otherwise specified|0
2337534|NCT03325556|4065373|FG001|Double-blind Period|Not otherwise specified|1
2337535|NCT03325556|4065374|FG002|Double-blind Period|Not otherwise specified|5
2337536|NCT03325556|4065372|FG000|Double-blind Period|Administrative discont. at study termination|0
2337537|NCT03325556|4065373|FG001|Double-blind Period|Administrative discont. at study termination|35
2337538|NCT03325556|4065374|FG002|Double-blind Period|Administrative discont. at study termination|31
2337539|NCT03325673|4065383|FG000|Overall Study|Adverse Event|4
2337540|NCT03325673|4065384|FG001|Overall Study|Adverse Event|0
2241461|NCT01938846|3899330|FG001|Overall Study|Withdrawal by Subject|2
2241462|NCT01938846|3899331|FG002|Overall Study|Withdrawal by Subject|1
2241463|NCT01938846|3899329|FG000|Overall Study|Other than listed|5
2241464|NCT01938846|3899330|FG001|Overall Study|Other than listed|1
2241465|NCT01938846|3899331|FG002|Overall Study|Other than listed|4
2241466|NCT01939002|3899381|FG000|Overall Study|Adverse Event|13
2241467|NCT01939002|3899382|FG001|Overall Study|Adverse Event|13
2241468|NCT01939002|3899381|FG000|Overall Study|Withdrawal by Subject|5
2241469|NCT01939002|3899382|FG001|Overall Study|Withdrawal by Subject|3
2241470|NCT01939002|3899381|FG000|Overall Study|Other|1
2241471|NCT01939002|3899382|FG001|Overall Study|Other|2
2241472|NCT01939028|3899393|FG000|Overall Study|Withdrawal by Subject|5
2241473|NCT01939028|3899393|FG000|Overall Study|Physician Decision|7
2241474|NCT01939158|3899410|FG000|Overall Study|Adverse Event|1
2241475|NCT01939158|3899411|FG001|Overall Study|Adverse Event|0
2241476|NCT01939158|3899412|FG002|Overall Study|Adverse Event|0
2241477|NCT01939158|3899413|FG003|Overall Study|Adverse Event|0
2241478|NCT01939158|3899410|FG000|Overall Study|Withdrawal by Subject|22
2241479|NCT01939158|3899411|FG001|Overall Study|Withdrawal by Subject|25
2241480|NCT01939158|3899412|FG002|Overall Study|Withdrawal by Subject|15
2241481|NCT01939158|3899413|FG003|Overall Study|Withdrawal by Subject|17
2241482|NCT01939158|3899410|FG000|Overall Study|Migrated/moved from study area|5
2241483|NCT01939158|3899411|FG001|Overall Study|Migrated/moved from study area|7
2241484|NCT01939158|3899412|FG002|Overall Study|Migrated/moved from study area|3
2241485|NCT01939158|3899413|FG003|Overall Study|Migrated/moved from study area|6
2241486|NCT01939158|3899410|FG000|Overall Study|Lost to Follow-up|18
2241487|NCT01939158|3899411|FG001|Overall Study|Lost to Follow-up|17
2241488|NCT01939158|3899412|FG002|Overall Study|Lost to Follow-up|17
2241489|NCT01939158|3899413|FG003|Overall Study|Lost to Follow-up|17
2241490|NCT01939158|3899410|FG000|Overall Study|Death|0
2241491|NCT01939158|3899411|FG001|Overall Study|Death|0
2241492|NCT01939158|3899412|FG002|Overall Study|Death|1
2241493|NCT01939158|3899413|FG003|Overall Study|Death|1
2241494|NCT01939158|3899410|FG000|Overall Study|No longer meets eligibility criteria|0
2241495|NCT01939158|3899411|FG001|Overall Study|No longer meets eligibility criteria|0
2241496|NCT01939158|3899412|FG002|Overall Study|No longer meets eligibility criteria|1
2241497|NCT01939158|3899413|FG003|Overall Study|No longer meets eligibility criteria|0
2241498|NCT01939158|3899410|FG000|Overall Study|Other|1
2241499|NCT01939158|3899411|FG001|Overall Study|Other|3
2241500|NCT01939158|3899412|FG002|Overall Study|Other|4
2241501|NCT01939158|3899413|FG003|Overall Study|Other|3
2241502|NCT01939197|3899434|FG000|Overall Study|Withdrawal by Subject|1
2241503|NCT01939197|3899435|FG001|Overall Study|Withdrawal by Subject|0
2241504|NCT01939197|3899436|FG002|Overall Study|Withdrawal by Subject|0
2241505|NCT01939197|3899437|FG003|Overall Study|Withdrawal by Subject|0
2241506|NCT01939197|3899438|FG004|Overall Study|Withdrawal by Subject|1
2241507|NCT01939197|3899439|FG005|Overall Study|Withdrawal by Subject|0
2241508|NCT01939197|3899440|FG006|Overall Study|Withdrawal by Subject|0
2241509|NCT01939197|3899434|FG000|Overall Study|Lost to Follow-up|0
2241510|NCT01939197|3899435|FG001|Overall Study|Lost to Follow-up|1
2241511|NCT01939197|3899436|FG002|Overall Study|Lost to Follow-up|0
2241512|NCT01939197|3899437|FG003|Overall Study|Lost to Follow-up|1
2241513|NCT01939197|3899438|FG004|Overall Study|Lost to Follow-up|3
2241514|NCT01939197|3899439|FG005|Overall Study|Lost to Follow-up|1
2241515|NCT01939197|3899440|FG006|Overall Study|Lost to Follow-up|2
2241516|NCT01939314|3899493|FG000|Overall Study|Withdrawal by Subject|3
2241517|NCT01939314|3899494|FG001|Overall Study|Withdrawal by Subject|1
2241518|NCT01939314|3899493|FG000|Overall Study|Protocol Violation|1
2241519|NCT01939314|3899494|FG001|Overall Study|Protocol Violation|0
2241520|NCT01939314|3899493|FG000|Overall Study|Pregnancy|0
2241521|NCT01939314|3899494|FG001|Overall Study|Pregnancy|1
2241522|NCT01939314|3899493|FG000|Overall Study|Lost to Follow-up|5
2241523|NCT01939314|3899494|FG001|Overall Study|Lost to Follow-up|6
2241524|NCT01939353|3899502|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3
2241525|NCT01939353|3899502|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1
2241526|NCT01939353|3899502|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2
2241527|NCT01939353|3899502|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1
2241528|NCT01939353|3899502|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1
2241529|NCT01939366|3899511|FG000|Overall Study|Adverse Event|8
2241530|NCT01939366|3899512|FG001|Overall Study|Adverse Event|17
2241531|NCT01939366|3899513|FG002|Overall Study|Adverse Event|30
2241532|NCT01939366|3899514|FG003|Overall Study|Adverse Event|8
2241533|NCT01939366|3899515|FG004|Overall Study|Adverse Event|5
2241534|NCT01939366|3899511|FG000|Overall Study|Lack of Efficacy|2
2241535|NCT01939366|3899512|FG001|Overall Study|Lack of Efficacy|1
2241536|NCT01939366|3899513|FG002|Overall Study|Lack of Efficacy|1
2241537|NCT01939366|3899514|FG003|Overall Study|Lack of Efficacy|1
2241538|NCT01939366|3899515|FG004|Overall Study|Lack of Efficacy|3
2241539|NCT01939366|3899511|FG000|Overall Study|Lost to Follow-up|1
2241540|NCT01939366|3899512|FG001|Overall Study|Lost to Follow-up|1
2241541|NCT01939366|3899513|FG002|Overall Study|Lost to Follow-up|0
2241542|NCT01939366|3899514|FG003|Overall Study|Lost to Follow-up|0
2241543|NCT01939366|3899515|FG004|Overall Study|Lost to Follow-up|0
2241544|NCT01939366|3899511|FG000|Overall Study|Withdrawal by Subject|1
2241545|NCT01939366|3899512|FG001|Overall Study|Withdrawal by Subject|0
2241546|NCT01939366|3899513|FG002|Overall Study|Withdrawal by Subject|2
2241547|NCT01939366|3899514|FG003|Overall Study|Withdrawal by Subject|2
2241548|NCT01939366|3899515|FG004|Overall Study|Withdrawal by Subject|3
2241549|NCT01939366|3899511|FG000|Overall Study|Inclusion criteria not met|0
2241550|NCT01939366|3899512|FG001|Overall Study|Inclusion criteria not met|1
2241551|NCT01939366|3899513|FG002|Overall Study|Inclusion criteria not met|1
2241552|NCT01939366|3899514|FG003|Overall Study|Inclusion criteria not met|0
2241553|NCT01939366|3899515|FG004|Overall Study|Inclusion criteria not met|1
2241554|NCT01939366|3899511|FG000|Overall Study|Other|0
2241555|NCT01939366|3899512|FG001|Overall Study|Other|0
2241556|NCT01939366|3899513|FG002|Overall Study|Other|2
2241557|NCT01939366|3899514|FG003|Overall Study|Other|2
2241558|NCT01939366|3899515|FG004|Overall Study|Other|1
2241559|NCT01939366|3899511|FG000|Overall Study|Protocol Violation|0
2241560|NCT01939366|3899512|FG001|Overall Study|Protocol Violation|0
2241561|NCT01939366|3899513|FG002|Overall Study|Protocol Violation|0
2241562|NCT01939366|3899514|FG003|Overall Study|Protocol Violation|1
2241563|NCT01939366|3899515|FG004|Overall Study|Protocol Violation|0
2241564|NCT01939366|3899511|FG000|Overall Study|Sponsor decision|0
2241565|NCT01939366|3899512|FG001|Overall Study|Sponsor decision|0
2241566|NCT01939366|3899513|FG002|Overall Study|Sponsor decision|0
2241567|NCT01939366|3899514|FG003|Overall Study|Sponsor decision|0
2241568|NCT01939366|3899515|FG004|Overall Study|Sponsor decision|2
2241569|NCT01939366|3899511|FG000|Overall Study|GCP non-compliance at site|2
2241570|NCT01939366|3899512|FG001|Overall Study|GCP non-compliance at site|3
2241571|NCT01939366|3899513|FG002|Overall Study|GCP non-compliance at site|2
2241572|NCT01939366|3899514|FG003|Overall Study|GCP non-compliance at site|3
2241573|NCT01939366|3899515|FG004|Overall Study|GCP non-compliance at site|3
2241574|NCT01939496|3899539|FG000|Overall Study|Adverse Event|2
2241575|NCT01939496|3899540|FG001|Overall Study|Adverse Event|0
2241576|NCT01939496|3899541|FG002|Overall Study|Adverse Event|0
2241577|NCT01939496|3899539|FG000|Overall Study|Lost to Follow-up|1
2241578|NCT01939496|3899540|FG001|Overall Study|Lost to Follow-up|1
2241579|NCT01939496|3899541|FG002|Overall Study|Lost to Follow-up|0
2241580|NCT01939496|3899539|FG000|Overall Study|Physician Decision|1
2241581|NCT01939496|3899540|FG001|Overall Study|Physician Decision|0
2241582|NCT01939496|3899541|FG002|Overall Study|Physician Decision|0
2241583|NCT01939496|3899539|FG000|Overall Study|Protocol Violation|3
2241584|NCT01939496|3899540|FG001|Overall Study|Protocol Violation|0
2241585|NCT01939496|3899541|FG002|Overall Study|Protocol Violation|0
2241586|NCT01939496|3899539|FG000|Overall Study|Withdrawal by Subject|0
2241587|NCT01939496|3899540|FG001|Overall Study|Withdrawal by Subject|1
2241588|NCT01939496|3899541|FG002|Overall Study|Withdrawal by Subject|1
2241589|NCT01939496|3899539|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0
2241590|NCT01939496|3899540|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1
2241591|NCT01939496|3899541|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0
2241592|NCT01939496|3899539|FG000|Overall Study|Other|2
2241593|NCT01939496|3899540|FG001|Overall Study|Other|0
2241594|NCT01939496|3899541|FG002|Overall Study|Other|1
2241595|NCT01939548|3899552|FG000|Overall Study|Non compliance|0
2241596|NCT01939548|3899553|FG001|Overall Study|Non compliance|2
2241597|NCT01939548|3899554|FG002|Overall Study|Non compliance|0
2241598|NCT01939548|3899552|FG000|Overall Study|Study Terminated by Sponsor|17
2241599|NCT01939548|3899553|FG001|Overall Study|Study Terminated by Sponsor|19
2241600|NCT01939548|3899554|FG002|Overall Study|Study Terminated by Sponsor|12
2241601|NCT01939548|3899552|FG000|Overall Study|Insufficient Clinical Response|1
2241602|NCT01939548|3899553|FG001|Overall Study|Insufficient Clinical Response|0
2241603|NCT01939548|3899554|FG002|Overall Study|Insufficient Clinical Response|0
2241604|NCT01939548|3899552|FG000|Overall Study|Did Not Meet Entrance Criteria|1
2241605|NCT01939548|3899553|FG001|Overall Study|Did Not Meet Entrance Criteria|0
2337541|NCT03325881|4065403|FG000|Overall Study|Protocol Violation|0
2337542|NCT03325881|4065404|FG001|Overall Study|Protocol Violation|1
2337543|NCT03325881|4065403|FG000|Overall Study|Withdrawal by Subject|0
2337544|NCT03325881|4065404|FG001|Overall Study|Withdrawal by Subject|2
2337545|NCT03325881|4065403|FG000|Overall Study|Lack of Efficacy|2
2337546|NCT03325881|4065404|FG001|Overall Study|Lack of Efficacy|0
2337547|NCT03325881|4065403|FG000|Overall Study|Not treated|1
2337548|NCT03325881|4065404|FG001|Overall Study|Not treated|0
2337549|NCT03325894|4065414|FG000|Overall Study|Adverse Event|2
2337550|NCT03325894|4065415|FG001|Overall Study|Adverse Event|3
2337551|NCT03325894|4065414|FG000|Overall Study|Protocol Violation|1
2337552|NCT03325894|4065415|FG001|Overall Study|Protocol Violation|2
2337553|NCT03325894|4065414|FG000|Overall Study|Withdrawal by Subject|10
2337554|NCT03325894|4065415|FG001|Overall Study|Withdrawal by Subject|6
2337555|NCT03325894|4065414|FG000|Overall Study|Lost to Follow-up|4
2337556|NCT03325894|4065415|FG001|Overall Study|Lost to Follow-up|9
2337557|NCT03325894|4065414|FG000|Overall Study|Lack of Efficacy|8
2337558|NCT03325894|4065415|FG001|Overall Study|Lack of Efficacy|14
2337559|NCT03325894|4065414|FG000|Overall Study|Study Terminated by Sponsor|38
2337560|NCT03325894|4065415|FG001|Overall Study|Study Terminated by Sponsor|43
2337561|NCT03325894|4065414|FG000|Overall Study|Other (Not received Treatment)|1
2337562|NCT03325894|4065415|FG001|Overall Study|Other (Not received Treatment)|0
2337563|NCT03326323|4065424|FG000|Overall Study|Unable to receive ANH protocol|3
2337564|NCT03326518|4065431|FG000|Overall Study|Protocol Violation|1
2337565|NCT03326518|4065432|FG001|Overall Study|Protocol Violation|0
2241606|NCT01939548|3899554|FG002|Overall Study|Did Not Meet Entrance Criteria|0
2241607|NCT01939548|3899552|FG000|Overall Study|Withdrawal by Subject|4
2241608|NCT01939548|3899553|FG001|Overall Study|Withdrawal by Subject|4
2241609|NCT01939548|3899554|FG002|Overall Study|Withdrawal by Subject|1
2241610|NCT01939548|3899552|FG000|Overall Study|Protocol Violation|7
2241611|NCT01939548|3899553|FG001|Overall Study|Protocol Violation|6
2241612|NCT01939548|3899554|FG002|Overall Study|Protocol Violation|5
2241613|NCT01939548|3899552|FG000|Overall Study|Lost to Follow-up|5
2241614|NCT01939548|3899553|FG001|Overall Study|Lost to Follow-up|5
2241615|NCT01939548|3899554|FG002|Overall Study|Lost to Follow-up|3
2241616|NCT01939548|3899552|FG000|Overall Study|Adverse Event|2
2241617|NCT01939548|3899553|FG001|Overall Study|Adverse Event|9
2241618|NCT01939548|3899554|FG002|Overall Study|Adverse Event|7
2241619|NCT01939548|3899552|FG000|Overall Study|Death|0
2241620|NCT01939548|3899553|FG001|Overall Study|Death|0
2241621|NCT01939548|3899554|FG002|Overall Study|Death|1
2241622|NCT01939548|3899552|FG000|Overall Study|Participant dropped|0
2241623|NCT01939548|3899553|FG001|Overall Study|Participant dropped|0
2241624|NCT01939548|3899554|FG002|Overall Study|Participant dropped|1
2241625|NCT01939548|3899552|FG000|Overall Study|Participant unwilling to continue|0
2241626|NCT01939548|3899553|FG001|Overall Study|Participant unwilling to continue|1
2241627|NCT01939548|3899554|FG002|Overall Study|Participant unwilling to continue|0
2241628|NCT01939548|3899552|FG000|Overall Study|Participant withdrew consent|0
2241629|NCT01939548|3899553|FG001|Overall Study|Participant withdrew consent|2
2241630|NCT01939548|3899554|FG002|Overall Study|Participant withdrew consent|0
2241631|NCT01939548|3899552|FG000|Overall Study|Did not complete follow-up|0
2241632|NCT01939548|3899553|FG001|Overall Study|Did not complete follow-up|1
2241633|NCT01939548|3899554|FG002|Overall Study|Did not complete follow-up|0
2241634|NCT01939899|3899567|FG000|Lead-in Dose Finding Phase|Death|0
2241635|NCT01939899|3899568|FG001|Lead-in Dose Finding Phase|Death|3
2241636|NCT01939899|3899569|FG002|Lead-in Dose Finding Phase|Death|1
2241637|NCT01939899|3899570|FG003|Lead-in Dose Finding Phase|Death|0
2241638|NCT01939899|3899571|FG004|Lead-in Dose Finding Phase|Death|0
2241639|NCT01939899|3899567|FG000|Lead-in Dose Finding Phase|Disease Progression|2
2241640|NCT01939899|3899568|FG001|Lead-in Dose Finding Phase|Disease Progression|4
2241641|NCT01939899|3899569|FG002|Lead-in Dose Finding Phase|Disease Progression|3
2241642|NCT01939899|3899570|FG003|Lead-in Dose Finding Phase|Disease Progression|0
2241643|NCT01939899|3899571|FG004|Lead-in Dose Finding Phase|Disease Progression|0
2241644|NCT01939899|3899567|FG000|Lead-in Dose Finding Phase|Other|0
2241645|NCT01939899|3899568|FG001|Lead-in Dose Finding Phase|Other|0
2241646|NCT01939899|3899569|FG002|Lead-in Dose Finding Phase|Other|1
2241647|NCT01939899|3899570|FG003|Lead-in Dose Finding Phase|Other|0
2241648|NCT01939899|3899571|FG004|Lead-in Dose Finding Phase|Other|0
2241649|NCT01939899|3899567|FG000|Phase 2|Withdrawal by Subject|0
2241650|NCT01939899|3899568|FG001|Phase 2|Withdrawal by Subject|0
2241651|NCT01939899|3899569|FG002|Phase 2|Withdrawal by Subject|0
2241652|NCT01939899|3899570|FG003|Phase 2|Withdrawal by Subject|2
2241653|NCT01939899|3899571|FG004|Phase 2|Withdrawal by Subject|0
2241654|NCT01939899|3899567|FG000|Phase 2|Disease Progression|0
2241655|NCT01939899|3899568|FG001|Phase 2|Disease Progression|0
2241656|NCT01939899|3899569|FG002|Phase 2|Disease Progression|0
2241657|NCT01939899|3899570|FG003|Phase 2|Disease Progression|9
2241658|NCT01939899|3899571|FG004|Phase 2|Disease Progression|1
2241659|NCT01939977|3899597|FG000|Overall Study|Adverse Event|4
2241660|NCT01939977|3899598|FG001|Overall Study|Adverse Event|3
2241661|NCT01939977|3899597|FG000|Overall Study|Lack of Efficacy|3
2241662|NCT01939977|3899598|FG001|Overall Study|Lack of Efficacy|0
2241663|NCT01939977|3899597|FG000|Overall Study|Physician Decision|1
2241664|NCT01939977|3899598|FG001|Overall Study|Physician Decision|1
2241665|NCT01939977|3899597|FG000|Overall Study|Withdrawal by Subject|0
2241666|NCT01939977|3899598|FG001|Overall Study|Withdrawal by Subject|2
2241667|NCT01939977|3899597|FG000|Overall Study|Did not meet inclusion criteria|1
2241668|NCT01939977|3899598|FG001|Overall Study|Did not meet inclusion criteria|0
2241669|NCT01939977|3899597|FG000|Overall Study|Did not receive study medication|0
2241670|NCT01939977|3899598|FG001|Overall Study|Did not receive study medication|1
2241671|NCT01940120|3899604|FG000|Overall Study|Death|40
2241672|NCT01940120|3899604|FG000|Overall Study|Withdrawal by Subject|8
2337566|NCT03326518|4065433|FG002|Overall Study|Protocol Violation|0
2337567|NCT03326518|4065431|FG000|Overall Study|Withdrawal by Subject|1
2337568|NCT03326518|4065432|FG001|Overall Study|Withdrawal by Subject|0
2337569|NCT03326518|4065433|FG002|Overall Study|Withdrawal by Subject|0
2337570|NCT03326518|4065431|FG000|Overall Study|Lost to Follow-up|1
2337571|NCT03326518|4065432|FG001|Overall Study|Lost to Follow-up|0
2337572|NCT03326518|4065433|FG002|Overall Study|Lost to Follow-up|1
2337573|NCT03326856|4065450|FG000|Overall Study|Lost to Follow-up|1
2337574|NCT03326856|4065451|FG001|Overall Study|Lost to Follow-up|1
2337575|NCT03326856|4065452|FG002|Overall Study|Lost to Follow-up|0
2337576|NCT03326856|4065453|FG003|Overall Study|Lost to Follow-up|0
2241673|NCT01940354|3899637|FG000|Overall Study|Withdrawal by Subject|4
2241674|NCT01940354|3899638|FG001|Overall Study|Withdrawal by Subject|2
2241675|NCT01940471|3899646|FG000|Double-Blind Phase|Randomized but Never Treated|1
2241676|NCT01940471|3899647|FG001|Double-Blind Phase|Randomized but Never Treated|1
2241677|NCT01940471|3899646|FG000|Double-Blind Phase|Withdrew Consent|13
2241678|NCT01940471|3899647|FG001|Double-Blind Phase|Withdrew Consent|7
2241679|NCT01940471|3899646|FG000|Double-Blind Phase|Adverse Event|1
2241680|NCT01940471|3899647|FG001|Double-Blind Phase|Adverse Event|2
2241681|NCT01940471|3899646|FG000|Double-Blind Phase|Lost to Follow-up|3
2241682|NCT01940471|3899647|FG001|Double-Blind Phase|Lost to Follow-up|2
2241683|NCT01940471|3899646|FG000|Double-Blind Phase|Pregnancy|2
2241684|NCT01940471|3899647|FG001|Double-Blind Phase|Pregnancy|1
2241685|NCT01940471|3899646|FG000|Double-Blind Phase|Investigator's Discretion|5
2241686|NCT01940471|3899647|FG001|Double-Blind Phase|Investigator's Discretion|0
2241687|NCT01940471|3899646|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
2241688|NCT01940471|3899647|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
2241689|NCT01940471|3899646|FG000|Double-Blind Phase|Protocol-Specified Criteria|1
2241690|NCT01940471|3899647|FG001|Double-Blind Phase|Protocol-Specified Criteria|0
2241691|NCT01940471|3899646|FG000|Double-Blind Phase|Death|1
2241692|NCT01940471|3899647|FG001|Double-Blind Phase|Death|0
2241693|NCT01940471|3899646|FG000|Double-Blind Phase|Lack of Efficacy|1
2241694|NCT01940471|3899647|FG001|Double-Blind Phase|Lack of Efficacy|0
2241695|NCT01940471|3899646|FG000|Double-Blind Phase|Protocol Violation|0
2241696|NCT01940471|3899647|FG001|Double-Blind Phase|Protocol Violation|1
2241697|NCT01940471|3899646|FG000|Double-Blind Phase|Still in Double-Blind Phase|539
2241698|NCT01940471|3899647|FG001|Double-Blind Phase|Still in Double-Blind Phase|270
2241699|NCT01940471|3899646|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14
2241700|NCT01940471|3899647|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8
2241701|NCT01940484|3899654|FG000|Overall Study|Withdrawal by Subject|3
2241702|NCT01940484|3899654|FG000|Overall Study|Underwent transplantation|4
2241703|NCT01940484|3899654|FG000|Overall Study|Death|2
2241704|NCT01940484|3899654|FG000|Overall Study|Adverse Event|1
2241705|NCT01940497|3899660|FG000|Overall Study|Adverse Event/Intercurrent Illness|11
2241706|NCT01940497|3899661|FG001|Overall Study|Adverse Event/Intercurrent Illness|8
2241707|NCT01940497|3899660|FG000|Overall Study|Recurrence of Disease Postsurgery|1
2241708|NCT01940497|3899661|FG001|Overall Study|Recurrence of Disease Postsurgery|3
2241709|NCT01940497|3899660|FG000|Overall Study|Violation of Entry Criteria|1
2241710|NCT01940497|3899661|FG001|Overall Study|Violation of Entry Criteria|1
2241711|NCT01940497|3899660|FG000|Overall Study|Refused Treatment|1
2241712|NCT01940497|3899661|FG001|Overall Study|Refused Treatment|3
2241713|NCT01940497|3899660|FG000|Overall Study|Withdrew Consent|6
2241714|NCT01940497|3899661|FG001|Overall Study|Withdrew Consent|2
2241715|NCT01940497|3899660|FG000|Overall Study|Administrative/Other|1
2241716|NCT01940497|3899661|FG001|Overall Study|Administrative/Other|1
2241717|NCT01940705|3899700|FG000|Overall Study|Lost to Follow-up|1
2241718|NCT01940705|3899701|FG001|Overall Study|Lost to Follow-up|3
2337577|NCT03326856|4065454|FG004|Overall Study|Lost to Follow-up|0
2337578|NCT03327220|4065537|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1
2337579|NCT03327220|4065538|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2
2337580|NCT03327220|4065537|FG000|Overall Study|Investigator Decision|2
2337581|NCT03327220|4065538|FG001|Overall Study|Investigator Decision|0
2337582|NCT03327220|4065537|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0
2337583|NCT03327220|4065538|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1
2337584|NCT03327220|4065537|FG000|Overall Study|Fungal infection|1
2337585|NCT03327220|4065538|FG001|Overall Study|Fungal infection|0
2037410|NCT00418379|3607791|FG000|Year 3|Any other reason not above-mentioned|2
2037411|NCT00418379|3607792|FG001|Year 3|Any other reason not above-mentioned|1
2037412|NCT00418379|3607793|FG002|Year 3|Any other reason not above-mentioned|1
2037413|NCT00418379|3607791|FG000|Year 4|Adverse Event|0
2037414|NCT00418379|3607792|FG001|Year 4|Adverse Event|1
2037415|NCT00418379|3607793|FG002|Year 4|Adverse Event|0
2037416|NCT00418379|3607791|FG000|Year 4|Withdrawal by Subject|2
2037417|NCT00418379|3607792|FG001|Year 4|Withdrawal by Subject|3
2037418|NCT00418379|3607793|FG002|Year 4|Withdrawal by Subject|2
2037419|NCT00418379|3607791|FG000|Year 4|Any other reason not above-mentioned|1
2037420|NCT00418379|3607792|FG001|Year 4|Any other reason not above-mentioned|1
2037421|NCT00418379|3607793|FG002|Year 4|Any other reason not above-mentioned|0
2037422|NCT00418379|3607791|FG000|Year 5|Adverse Event|0
2037423|NCT00418379|3607792|FG001|Year 5|Adverse Event|1
2037424|NCT00418379|3607793|FG002|Year 5|Adverse Event|0
2037425|NCT00418379|3607791|FG000|Year 5|Any other reason not above-mentioned|2
2037426|NCT00418379|3607792|FG001|Year 5|Any other reason not above-mentioned|4
2037427|NCT00418379|3607793|FG002|Year 5|Any other reason not above-mentioned|3
2037428|NCT00418522|3607812|FG000|Overall Study|Adverse Event|7
2037429|NCT00418522|3607813|FG001|Overall Study|Adverse Event|1
2037430|NCT00418522|3607812|FG000|Overall Study|Lack of Efficacy|1
2037431|NCT00418522|3607813|FG001|Overall Study|Lack of Efficacy|3
2037432|NCT00418522|3607812|FG000|Overall Study|Lost to Follow-up|10
2037433|NCT00418522|3607813|FG001|Overall Study|Lost to Follow-up|4
2037434|NCT00418522|3607812|FG000|Overall Study|Withdrawal by Subject|31
2037435|NCT00418522|3607813|FG001|Overall Study|Withdrawal by Subject|7
2037436|NCT00418522|3607812|FG000|Overall Study|Other|27
2241719|NCT01940705|3899702|FG002|Overall Study|Lost to Follow-up|2
2241720|NCT01940705|3899703|FG003|Overall Study|Lost to Follow-up|2
2241721|NCT01940705|3899700|FG000|Overall Study|Withdrawal by Subject|2
2241722|NCT01940705|3899701|FG001|Overall Study|Withdrawal by Subject|2
2241723|NCT01940705|3899702|FG002|Overall Study|Withdrawal by Subject|3
2241724|NCT01940705|3899703|FG003|Overall Study|Withdrawal by Subject|2
2241725|NCT01940705|3899700|FG000|Overall Study|Intervention not given|0
2241726|NCT01940705|3899701|FG001|Overall Study|Intervention not given|3
2241727|NCT01940705|3899702|FG002|Overall Study|Intervention not given|3
2241728|NCT01940705|3899703|FG003|Overall Study|Intervention not given|0
2241729|NCT01940705|3899700|FG000|Overall Study|Withdrawal by team - hearing aid change|1
2241730|NCT01940705|3899701|FG001|Overall Study|Withdrawal by team - hearing aid change|0
2241731|NCT01940705|3899702|FG002|Overall Study|Withdrawal by team - hearing aid change|0
2241732|NCT01940705|3899703|FG003|Overall Study|Withdrawal by team - hearing aid change|0
2241733|NCT01940887|3899718|FG000|Year 1|Protocol Violation|0
2241734|NCT01940887|3899719|FG001|Year 1|Protocol Violation|1
2241735|NCT01940887|3899718|FG000|Year 1|Physician Decision|7
2241736|NCT01940887|3899719|FG001|Year 1|Physician Decision|3
2241737|NCT01940887|3899718|FG000|Year 1|Death|5
2241738|NCT01940887|3899719|FG001|Year 1|Death|3
2241739|NCT01940887|3899718|FG000|Year 1|Adverse Event|7
2241740|NCT01940887|3899719|FG001|Year 1|Adverse Event|6
2241741|NCT01940887|3899718|FG000|Year 1|Withdrawal by Subject|18
2241742|NCT01940887|3899719|FG001|Year 1|Withdrawal by Subject|9
2241743|NCT01940887|3899718|FG000|Year 1|Lost to Follow-up|2
2241744|NCT01940887|3899719|FG001|Year 1|Lost to Follow-up|1
2241745|NCT01940887|3899718|FG000|Year 2|Physician Decision|8
2241746|NCT01940887|3899719|FG001|Year 2|Physician Decision|1
2241747|NCT01940887|3899718|FG000|Year 2|Death|0
2241748|NCT01940887|3899719|FG001|Year 2|Death|2
2241749|NCT01940887|3899718|FG000|Year 2|Sponsor Decision, early termination|192
2241750|NCT01940887|3899719|FG001|Year 2|Sponsor Decision, early termination|203
2241751|NCT01940887|3899718|FG000|Year 2|Adverse Event|8
2241752|NCT01940887|3899719|FG001|Year 2|Adverse Event|2
2241753|NCT01940887|3899718|FG000|Year 2|Withdrawal by Subject|8
2241754|NCT01940887|3899719|FG001|Year 2|Withdrawal by Subject|8
2241755|NCT01940887|3899718|FG000|Year 2|Lost to Follow-up|1
2241756|NCT01940887|3899719|FG001|Year 2|Lost to Follow-up|6
2241757|NCT01940900|3899727|FG000|Overall Study|Physician Decision|4
2241758|NCT01940900|3899728|FG001|Overall Study|Physician Decision|0
2241759|NCT01940900|3899727|FG000|Overall Study|Adverse Event|10
2241760|NCT01940900|3899728|FG001|Overall Study|Adverse Event|15
2241761|NCT01940900|3899727|FG000|Overall Study|Withdrawal by Subject|11
2241762|NCT01940900|3899728|FG001|Overall Study|Withdrawal by Subject|15
2241763|NCT01940900|3899727|FG000|Overall Study|Lost to Follow-up|1
2241764|NCT01940900|3899728|FG001|Overall Study|Lost to Follow-up|0
2241765|NCT01940900|3899727|FG000|Overall Study|Sponsor Decision|1
2241766|NCT01940900|3899728|FG001|Overall Study|Sponsor Decision|0
2337586|NCT03327220|4065537|FG000|Overall Study|Discharged to Rehabilitation|0
2337587|NCT03327220|4065538|FG001|Overall Study|Discharged to Rehabilitation|1
2337588|NCT03327220|4065537|FG000|Overall Study|Missing|1
2337589|NCT03327220|4065538|FG001|Overall Study|Missing|0
2337590|NCT03327402|4065544|FG000|Overall Study|Withdrawal by Subject|1
2337591|NCT03327402|4065544|FG000|Overall Study|Other (Visit Out-Of-Window)|1
2337592|NCT03328182|4065558|FG000|Overall Study|Withdrawal by Subject|1
2337593|NCT03328182|4065558|FG000|Overall Study|Protocol Violation|2
2337594|NCT03328182|4065558|FG000|Overall Study|No Product Evaluated|1
2337595|NCT03328325|4065571|FG000|Overall Study|Lost to Follow-up|4
2337596|NCT03328325|4065571|FG000|Overall Study|Physician Decision|1
2337597|NCT03328325|4065571|FG000|Overall Study|Withdrawal by Subject|3
2337598|NCT03328325|4065571|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3
2337599|NCT03328832|4065581|FG000|Overall Study|Lost to Follow-up|0
2337600|NCT03328832|4065582|FG001|Overall Study|Lost to Follow-up|1
2337601|NCT03328897|4065591|FG000|Randomized-treatment Epoch|Adverse Event|4
2337602|NCT03328897|4065592|FG001|Randomized-treatment Epoch|Adverse Event|1
2337603|NCT03328897|4065593|FG002|Randomized-treatment Epoch|Adverse Event|1
2337604|NCT03328897|4065591|FG000|Randomized-treatment Epoch|Lost to Follow-up|0
2337605|NCT03328897|4065592|FG001|Randomized-treatment Epoch|Lost to Follow-up|1
2337606|NCT03328897|4065593|FG002|Randomized-treatment Epoch|Lost to Follow-up|0
2337607|NCT03328897|4065591|FG000|Randomized-treatment Epoch|Pregnancy|3
2337608|NCT03328897|4065592|FG001|Randomized-treatment Epoch|Pregnancy|0
2337609|NCT03328897|4065593|FG002|Randomized-treatment Epoch|Pregnancy|0
2337610|NCT03328897|4065591|FG000|Randomized-treatment Epoch|Patient/guardian decision|8
2337611|NCT03328897|4065592|FG001|Randomized-treatment Epoch|Patient/guardian decision|3
2337612|NCT03328897|4065593|FG002|Randomized-treatment Epoch|Patient/guardian decision|1
2337613|NCT03328897|4065591|FG000|Randomized-treatment Epoch|Lack of Efficacy|1
2337614|NCT03328897|4065592|FG001|Randomized-treatment Epoch|Lack of Efficacy|0
2337615|NCT03328897|4065593|FG002|Randomized-treatment Epoch|Lack of Efficacy|0
2037437|NCT00418522|3607813|FG001|Overall Study|Other|23
2037438|NCT00418522|3607812|FG000|Overall Study|Randomized but did not receive treatment|7
2037439|NCT00418522|3607813|FG001|Overall Study|Randomized but did not receive treatment|4
2037440|NCT00418561|3607822|FG000|Overall Study|Participant's (guardian's) decision|0
2037441|NCT00418561|3607823|FG001|Overall Study|Participant's (guardian's) decision|1
2037442|NCT00418561|3607824|FG002|Overall Study|Participant's (guardian's) decision|0
2037443|NCT00418665|3607844|FG000|Treatment Period|Ineligibility determined|1
2037444|NCT00418665|3607845|FG001|Treatment Period|Ineligibility determined|1
2037445|NCT00418665|3607846|FG002|Treatment Period|Ineligibility determined|0
2241767|NCT01940900|3899727|FG000|Overall Study|subject non-compliance|1
2241768|NCT01940900|3899728|FG001|Overall Study|subject non-compliance|1
2241769|NCT01940900|3899727|FG000|Overall Study|other|1
2241770|NCT01940900|3899728|FG001|Overall Study|other|0
2241771|NCT01940939|3899736|FG000|Overall Study|Withdrawal by Subject|2
2241772|NCT01940939|3899737|FG001|Overall Study|Withdrawal by Subject|8
2241773|NCT01941030|3899745|FG000|Overall Study|Death|3
2241774|NCT01941030|3899746|FG001|Overall Study|Death|2
2241775|NCT01941030|3899745|FG000|Overall Study|Lost to Follow-up|6
2241776|NCT01941030|3899746|FG001|Overall Study|Lost to Follow-up|5
2241777|NCT01941030|3899745|FG000|Overall Study|Withdrawal by Subject|4
2241778|NCT01941030|3899746|FG001|Overall Study|Withdrawal by Subject|6
2241779|NCT01941095|3899752|FG000|Overall Study|Insufficient therapeutic response|13
2241780|NCT01941095|3899752|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2
2241781|NCT01941095|3899752|FG000|Overall Study|Adverse Event|11
2241782|NCT01941095|3899752|FG000|Overall Study|Physician Decision|3
2241783|NCT01941095|3899752|FG000|Overall Study|Withdrawal by Subject|17
2241784|NCT01941095|3899752|FG000|Overall Study|Lost to Follow-up|10
2241785|NCT01941186|3899759|FG000|Follow-up|Lost to Follow-up|1
2241786|NCT01941186|3899760|FG001|Follow-up|Lost to Follow-up|0
2241787|NCT01941498|3899805|FG000|Overall Study|Relocated out of state|1
2241788|NCT01941537|3899826|FG000|Overall Study|Lack of Efficacy|1
2241789|NCT01941537|3899827|FG001|Overall Study|Lack of Efficacy|2
2241790|NCT01941537|3899826|FG000|Overall Study|Lost to Follow-up|1
2241791|NCT01941537|3899827|FG001|Overall Study|Lost to Follow-up|0
2241792|NCT01941537|3899826|FG000|Overall Study|Pregnancy|1
2241793|NCT01941537|3899827|FG001|Overall Study|Pregnancy|0
2241794|NCT01941537|3899826|FG000|Overall Study|Adverse Event|1
2241795|NCT01941537|3899827|FG001|Overall Study|Adverse Event|0
2241796|NCT01941537|3899826|FG000|Overall Study|Withdrawal by Subject|0
2241797|NCT01941537|3899827|FG001|Overall Study|Withdrawal by Subject|1
2241798|NCT01941940|3899872|FG000|Overall Study|Adverse Event|11
2241799|NCT01941940|3899872|FG000|Overall Study|Lost to Follow-up|2
2241800|NCT01941940|3899872|FG000|Overall Study|Physician Decision|2
2241801|NCT01941940|3899872|FG000|Overall Study|Withdrawal by Subject|15
2241802|NCT01941940|3899872|FG000|Overall Study|Death|1
2241803|NCT01941940|3899872|FG000|Overall Study|Other|1
2241804|NCT01941940|3899872|FG000|Overall Study|Other|1
2241805|NCT01942148|3899876|FG000|Overall Study|Adverse Event|4
2241806|NCT01942148|3899876|FG000|Overall Study|Lack of Efficacy|2
2241807|NCT01942148|3899876|FG000|Overall Study|Physician Decision|11
2241808|NCT01942148|3899876|FG000|Overall Study|Protocol Violation|1
2241809|NCT01942148|3899876|FG000|Overall Study|Withdrawal by Subject|8
2241810|NCT01942148|3899876|FG000|Overall Study|Use of the prohibition medicine|1
2241811|NCT01942161|3899883|FG000|Overall Study|Adverse Event|1
2241812|NCT01942161|3899884|FG001|Overall Study|Adverse Event|2
2241813|NCT01942161|3899885|FG002|Overall Study|Adverse Event|5
2241814|NCT01942161|3899883|FG000|Overall Study|Physician Decision|3
2241815|NCT01942161|3899884|FG001|Overall Study|Physician Decision|1
2241816|NCT01942161|3899885|FG002|Overall Study|Physician Decision|0
2241817|NCT01942161|3899883|FG000|Overall Study|Protocol Violation|1
2241818|NCT01942161|3899884|FG001|Overall Study|Protocol Violation|0
2241819|NCT01942161|3899885|FG002|Overall Study|Protocol Violation|0
2241820|NCT01942161|3899883|FG000|Overall Study|Withdrawal by Subject|3
2241821|NCT01942161|3899884|FG001|Overall Study|Withdrawal by Subject|3
2241822|NCT01942161|3899885|FG002|Overall Study|Withdrawal by Subject|1
2241823|NCT01942486|3899893|FG000|Overall Study|Lost to Follow-up|27
2241824|NCT01942590|3899899|FG000|Overall Study|Withdrawal by Subject|0
2241825|NCT01942590|3899900|FG001|Overall Study|Withdrawal by Subject|1
2241826|NCT01942590|3899899|FG000|Overall Study|Adverse Event|1
2241827|NCT01942590|3899900|FG001|Overall Study|Adverse Event|0
2241828|NCT01942733|3899955|FG000|Overall Study|Lost to Follow-up|1
2241829|NCT01942733|3899955|FG000|Overall Study|Non-compliance with IMP|1
2241830|NCT01942733|3899955|FG000|Overall Study|Administrative|1
2241831|NCT01942785|3899959|FG000|Overall Study|Adverse Event|2
2241832|NCT01942785|3899959|FG000|Overall Study|Withdrawal by Subject|1
2241833|NCT01942785|3899959|FG000|Overall Study|Protocol Violation|1
2241834|NCT01942993|3899965|FG000|Overall Study|Lost to Follow-up|1
2241835|NCT01942993|3899965|FG000|Overall Study|Physician Decision|1
2241836|NCT01943292|3899997|FG000|Overall Study|Withdrawal by Subject|1
2241837|NCT01943292|3899998|FG001|Overall Study|Withdrawal by Subject|0
2241838|NCT01943292|3899999|FG002|Overall Study|Withdrawal by Subject|0
2241839|NCT01943435|3900016|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4
2241840|NCT01943435|3900017|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12
2241841|NCT01943435|3900018|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3
2241842|NCT01943435|3900016|FG000|Intervention Period|Withdrawal by Subject|3
2241843|NCT01943435|3900017|FG001|Intervention Period|Withdrawal by Subject|3
2241844|NCT01943435|3900018|FG002|Intervention Period|Withdrawal by Subject|4
2241845|NCT01943435|3900016|FG000|2 Month Follow up|Lost to Follow-up|2
2241846|NCT01943435|3900017|FG001|2 Month Follow up|Lost to Follow-up|3
2241847|NCT01943435|3900018|FG002|2 Month Follow up|Lost to Follow-up|0
2241848|NCT01943435|3900016|FG000|6 Month Follow up|Lost to Follow-up|12
2241849|NCT01943435|3900017|FG001|6 Month Follow up|Lost to Follow-up|7
2241850|NCT01943435|3900018|FG002|6 Month Follow up|Lost to Follow-up|15
2241851|NCT01943539|3900052|FG000|Overall Study|Non-compliance with at-home intervention|4
2241852|NCT01943539|3900053|FG001|Overall Study|Non-compliance with at-home intervention|0
2241853|NCT01943552|3900062|FG000|Overall Study|Adverse Event|3
2241854|NCT01943552|3900063|FG001|Overall Study|Adverse Event|2
2241855|NCT01943552|3900062|FG000|Overall Study|Withdrawal by Subject|6
2241856|NCT01943552|3900063|FG001|Overall Study|Withdrawal by Subject|6
2241857|NCT01943552|3900062|FG000|Overall Study|Other Reasons|16
2241858|NCT01943552|3900063|FG001|Overall Study|Other Reasons|17
2337616|NCT03328897|4065591|FG000|Follow-up Epoch|Adverse Event|4
2337617|NCT03328897|4065592|FG001|Follow-up Epoch|Adverse Event|0
2337618|NCT03328897|4065593|FG002|Follow-up Epoch|Adverse Event|1
2337619|NCT03328897|4065591|FG000|Follow-up Epoch|Lack of Efficacy|1
2337620|NCT03328897|4065592|FG001|Follow-up Epoch|Lack of Efficacy|1
2337621|NCT03328897|4065593|FG002|Follow-up Epoch|Lack of Efficacy|1
2337622|NCT03328897|4065591|FG000|Follow-up Epoch|Lost to Follow-up|0
2337623|NCT03328897|4065592|FG001|Follow-up Epoch|Lost to Follow-up|1
2337624|NCT03328897|4065593|FG002|Follow-up Epoch|Lost to Follow-up|0
2337625|NCT03328897|4065591|FG000|Follow-up Epoch|Pregnancy|1
2337626|NCT03328897|4065592|FG001|Follow-up Epoch|Pregnancy|0
2337627|NCT03328897|4065593|FG002|Follow-up Epoch|Pregnancy|0
2337628|NCT03328897|4065591|FG000|Follow-up Epoch|Patient/guardian decision|2
2337629|NCT03328897|4065592|FG001|Follow-up Epoch|Patient/guardian decision|1
2337630|NCT03328897|4065593|FG002|Follow-up Epoch|Patient/guardian decision|0
2337631|NCT03329196|4065608|FG000|Overall Study|Adverse Event|10
2241859|NCT01943591|3900084|FG000|Overall Study|Lost to Follow-up|3
2241860|NCT01943591|3900085|FG001|Overall Study|Lost to Follow-up|4
2241861|NCT01943591|3900084|FG000|Overall Study|Death|2
2241862|NCT01943591|3900085|FG001|Overall Study|Death|7
2241863|NCT01943799|3900095|FG000|Overall Study|Lost to Follow-up|0
2241864|NCT01943799|3900096|FG001|Overall Study|Lost to Follow-up|1
2241865|NCT01943799|3900097|FG002|Overall Study|Lost to Follow-up|1
2241866|NCT01943799|3900098|FG003|Overall Study|Lost to Follow-up|0
2241867|NCT01943799|3900095|FG000|Overall Study|Protocol Violation|1
2241868|NCT01943799|3900096|FG001|Overall Study|Protocol Violation|0
2241869|NCT01943799|3900097|FG002|Overall Study|Protocol Violation|0
2241870|NCT01943799|3900098|FG003|Overall Study|Protocol Violation|0
2241871|NCT01943799|3900095|FG000|Overall Study|Withdrawal by Subject|4
2337632|NCT03329196|4065609|FG001|Overall Study|Adverse Event|5
2337633|NCT03329196|4065608|FG000|Overall Study|Physician Decision|2
2337634|NCT03329196|4065609|FG001|Overall Study|Physician Decision|2
2337635|NCT03329196|4065608|FG000|Overall Study|Withdrawal by Subject|11
2337636|NCT03329196|4065609|FG001|Overall Study|Withdrawal by Subject|3
2337637|NCT03329196|4065608|FG000|Overall Study|Hepatic function abnormalities|0
2337638|NCT03329196|4065609|FG001|Overall Study|Hepatic function abnormalities|1
2337639|NCT03329196|4065608|FG000|Overall Study|Conducting rescue therapy before Week 24|2
2337640|NCT03329196|4065609|FG001|Overall Study|Conducting rescue therapy before Week 24|1
2337641|NCT03329196|4065608|FG000|Overall Study|Difficult to control Hb|2
2337642|NCT03329196|4065609|FG001|Overall Study|Difficult to control Hb|3
2337643|NCT03329196|4065608|FG000|Overall Study|Dialysis or renal transplant|13
2337644|NCT03329196|4065609|FG001|Overall Study|Dialysis or renal transplant|15
2337645|NCT03329573|4065629|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
2337646|NCT03329573|4065630|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
2337647|NCT03329573|4065631|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
2337648|NCT03329573|4065632|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
2337649|NCT03329573|4065629|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
2337650|NCT03329573|4065630|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
2337651|NCT03329573|4065631|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
2337652|NCT03329573|4065632|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
2337653|NCT03329573|4065629|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
2337654|NCT03329573|4065630|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
2337655|NCT03329573|4065631|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
2337656|NCT03329573|4065632|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
2337657|NCT03329573|4065629|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
2337658|NCT03329573|4065630|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
2337659|NCT03329573|4065631|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
2337660|NCT03329573|4065632|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
2337661|NCT03329690|4065647|FG000|Overall Study|Progressive disease per RECIST|67
2337662|NCT03329690|4065648|FG001|Overall Study|Progressive disease per RECIST|42
2337663|NCT03329690|4065649|FG002|Overall Study|Progressive disease per RECIST|5
2337664|NCT03329690|4065650|FG003|Overall Study|Progressive disease per RECIST|16
2337665|NCT03329690|4065651|FG004|Overall Study|Progressive disease per RECIST|19
2337666|NCT03329690|4065647|FG000|Overall Study|Clinical progression|6
2337667|NCT03329690|4065648|FG001|Overall Study|Clinical progression|4
2337668|NCT03329690|4065649|FG002|Overall Study|Clinical progression|1
2337669|NCT03329690|4065650|FG003|Overall Study|Clinical progression|1
2337670|NCT03329690|4065651|FG004|Overall Study|Clinical progression|0
2337671|NCT03329690|4065647|FG000|Overall Study|Adverse Event|19
2337672|NCT03329690|4065648|FG001|Overall Study|Adverse Event|4
2037446|NCT00418665|3607844|FG000|Treatment Period|Adverse Event|2
2037447|NCT00418665|3607845|FG001|Treatment Period|Adverse Event|2
2037448|NCT00418665|3607846|FG002|Treatment Period|Adverse Event|0
2241872|NCT01943799|3900096|FG001|Overall Study|Withdrawal by Subject|2
2241873|NCT01943799|3900097|FG002|Overall Study|Withdrawal by Subject|1
2241874|NCT01943799|3900098|FG003|Overall Study|Withdrawal by Subject|0
2241875|NCT01943825|3900112|FG000|Overall Study|Lost to Follow-up|9
2241876|NCT01943825|3900113|FG001|Overall Study|Lost to Follow-up|3
2241877|NCT01943825|3900114|FG002|Overall Study|Lost to Follow-up|12
2241878|NCT01943825|3900115|FG003|Overall Study|Lost to Follow-up|8
2241879|NCT01943825|3900112|FG000|Overall Study|Withdrawal by Subject|1
2241880|NCT01943825|3900113|FG001|Overall Study|Withdrawal by Subject|0
2241881|NCT01943825|3900114|FG002|Overall Study|Withdrawal by Subject|3
2241882|NCT01943825|3900115|FG003|Overall Study|Withdrawal by Subject|2
2241883|NCT01943825|3900112|FG000|Overall Study|Other than specified above|0
2241884|NCT01943825|3900113|FG001|Overall Study|Other than specified above|1
2241885|NCT01943825|3900114|FG002|Overall Study|Other than specified above|0
2241886|NCT01943825|3900115|FG003|Overall Study|Other than specified above|1
2241887|NCT01943851|3900147|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241888|NCT01943851|3900148|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241889|NCT01943851|3900149|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241890|NCT01943851|3900150|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
2241891|NCT01943851|3900151|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241892|NCT01943851|3900152|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241893|NCT01943851|3900153|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
2241894|NCT01943851|3900154|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
2241895|NCT01943851|3900155|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
2241896|NCT01943851|3900156|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241897|NCT01943851|3900157|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241898|NCT01943851|3900158|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241899|NCT01943851|3900159|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241900|NCT01943851|3900160|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241901|NCT01943851|3900161|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241902|NCT01943851|3900162|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241903|NCT01943851|3900163|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241904|NCT01943851|3900164|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
2241905|NCT01943851|3900147|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241906|NCT01943851|3900148|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241907|NCT01943851|3900149|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241908|NCT01943851|3900150|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241909|NCT01943851|3900151|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
2241910|NCT01943851|3900152|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241911|NCT01943851|3900153|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241912|NCT01943851|3900154|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
2241913|NCT01943851|3900155|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241914|NCT01943851|3900156|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241915|NCT01943851|3900157|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241916|NCT01943851|3900158|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241917|NCT01943851|3900159|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241918|NCT01943851|3900160|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241919|NCT01943851|3900161|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241920|NCT01943851|3900162|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241921|NCT01943851|3900163|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241922|NCT01943851|3900164|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
2241923|NCT01943851|3900147|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241924|NCT01943851|3900148|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241925|NCT01943851|3900149|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241926|NCT01943851|3900150|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241927|NCT01943851|3900151|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241928|NCT01943851|3900152|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241929|NCT01943851|3900153|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2337673|NCT03329690|4065649|FG002|Overall Study|Adverse Event|0
2337674|NCT03329690|4065650|FG003|Overall Study|Adverse Event|1
2337675|NCT03329690|4065651|FG004|Overall Study|Adverse Event|2
2337676|NCT03329690|4065647|FG000|Overall Study|Death|2
2337677|NCT03329690|4065648|FG001|Overall Study|Death|0
2337678|NCT03329690|4065649|FG002|Overall Study|Death|0
2337679|NCT03329690|4065650|FG003|Overall Study|Death|1
2337680|NCT03329690|4065651|FG004|Overall Study|Death|0
2337681|NCT03329690|4065647|FG000|Overall Study|Withdrawal by Subject|2
2337682|NCT03329690|4065648|FG001|Overall Study|Withdrawal by Subject|3
2337683|NCT03329690|4065649|FG002|Overall Study|Withdrawal by Subject|0
2337684|NCT03329690|4065650|FG003|Overall Study|Withdrawal by Subject|1
2337685|NCT03329690|4065651|FG004|Overall Study|Withdrawal by Subject|0
2337686|NCT03329690|4065647|FG000|Overall Study|Physician Decision|1
2337687|NCT03329690|4065648|FG001|Overall Study|Physician Decision|0
2337688|NCT03329690|4065649|FG002|Overall Study|Physician Decision|0
2337689|NCT03329690|4065650|FG003|Overall Study|Physician Decision|0
2337690|NCT03329690|4065651|FG004|Overall Study|Physician Decision|1
2337691|NCT03329690|4065647|FG000|Overall Study|Did not receive treatment|1
2337692|NCT03329690|4065648|FG001|Overall Study|Did not receive treatment|0
2337693|NCT03329690|4065649|FG002|Overall Study|Did not receive treatment|0
2037449|NCT00418665|3607844|FG000|Treatment Period|Withdrawal by Subject|0
2037450|NCT00418665|3607845|FG001|Treatment Period|Withdrawal by Subject|3
2037451|NCT00418665|3607846|FG002|Treatment Period|Withdrawal by Subject|1
2037452|NCT00418665|3607844|FG000|Treatment Period|Requirement for alternative therapy|1
2241930|NCT01943851|3900154|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241931|NCT01943851|3900155|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241932|NCT01943851|3900156|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241933|NCT01943851|3900157|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241934|NCT01943851|3900158|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241935|NCT01943851|3900159|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241936|NCT01943851|3900160|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1
2241937|NCT01943851|3900161|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241938|NCT01943851|3900162|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241939|NCT01943851|3900163|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241940|NCT01943851|3900164|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
2241941|NCT01943851|3900147|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241942|NCT01943851|3900148|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241943|NCT01943851|3900149|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241944|NCT01943851|3900150|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241945|NCT01943851|3900151|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241946|NCT01943851|3900152|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241947|NCT01943851|3900153|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241948|NCT01943851|3900154|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241949|NCT01943851|3900155|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241950|NCT01943851|3900156|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241951|NCT01943851|3900157|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241952|NCT01943851|3900158|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241953|NCT01943851|3900159|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241954|NCT01943851|3900160|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241955|NCT01943851|3900161|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241956|NCT01943851|3900162|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2
2241957|NCT01943851|3900163|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241958|NCT01943851|3900164|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
2241959|NCT01943851|3900147|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241960|NCT01943851|3900148|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241961|NCT01943851|3900149|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241962|NCT01943851|3900150|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241963|NCT01943851|3900151|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241964|NCT01943851|3900152|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241965|NCT01943851|3900153|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241966|NCT01943851|3900154|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241967|NCT01943851|3900155|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241968|NCT01943851|3900156|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241969|NCT01943851|3900157|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241970|NCT01943851|3900158|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241971|NCT01943851|3900159|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241972|NCT01943851|3900160|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241973|NCT01943851|3900161|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
2241974|NCT01943851|3900162|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4
2241975|NCT01943851|3900163|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3
2241976|NCT01943851|3900164|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1
2241977|NCT01943916|3900209|FG000|Overall Study|Technically invalid images|10
2337694|NCT03329690|4065650|FG003|Overall Study|Did not receive treatment|1
2337695|NCT03329690|4065651|FG004|Overall Study|Did not receive treatment|0
2337696|NCT03329846|4065671|FG000|Overall Study|Disease progression|4
2337697|NCT03329846|4065672|FG001|Overall Study|Disease progression|6
2337698|NCT03329846|4065671|FG000|Overall Study|Study drug toxicity|1
2337699|NCT03329846|4065672|FG001|Overall Study|Study drug toxicity|0
2337700|NCT03329846|4065671|FG000|Overall Study|Participant request to discontinue treatment|0
2337701|NCT03329846|4065672|FG001|Overall Study|Participant request to discontinue treatment|1
2337702|NCT03329846|4065671|FG000|Overall Study|Participant withdrew consent|1
2337703|NCT03329846|4065672|FG001|Overall Study|Participant withdrew consent|0
2337704|NCT03329846|4065671|FG000|Overall Study|Other reasons|2
2337705|NCT03329846|4065672|FG001|Overall Study|Other reasons|2
2337706|NCT03329885|4065684|FG000|Overall Study|Sponsor discontinued the study early|0
2337707|NCT03329885|4065685|FG001|Overall Study|Sponsor discontinued the study early|0
2337708|NCT03329885|4065686|FG002|Overall Study|Sponsor discontinued the study early|0
2337709|NCT03329885|4065687|FG003|Overall Study|Sponsor discontinued the study early|0
2337710|NCT03329885|4065688|FG004|Overall Study|Sponsor discontinued the study early|0
2337711|NCT03329885|4065689|FG005|Overall Study|Sponsor discontinued the study early|0
2337712|NCT03329885|4065690|FG006|Overall Study|Sponsor discontinued the study early|1
2337713|NCT03329885|4065691|FG007|Overall Study|Sponsor discontinued the study early|1
2337714|NCT03329885|4065692|FG008|Overall Study|Sponsor discontinued the study early|0
2337715|NCT03329989|4065725|FG000|Overall Study|Withdrawal by Subject|9
2241978|NCT01943916|3900209|FG000|Overall Study|Enrollment Failure|23
2241979|NCT01943916|3900209|FG000|Overall Study|Pilot Phase exclusion|100
2241980|NCT01943916|3900209|FG000|Overall Study|Quality Assurance Reader Fail|130
2241981|NCT01943916|3900209|FG000|Overall Study|Technical Failure|39
2241982|NCT01943916|3900209|FG000|Overall Study|Protocol Deviation No Biopsy|25
2241983|NCT01943916|3900209|FG000|Overall Study|No Truth Panel Review|38
2241984|NCT01943916|3900209|FG000|Overall Study|Protocol Deviation|1
2337716|NCT03329989|4065725|FG000|Overall Study|Lost to Follow-up|8
2337717|NCT03329989|4065725|FG000|Overall Study|Adverse Event|5
2337718|NCT03329989|4065725|FG000|Overall Study|Protocol Violation|1
2337719|NCT03330002|4065729|FG000|Overall Study|Lost to Follow-up|15
2337720|NCT03330002|4065729|FG000|Overall Study|Death|7
2337721|NCT03330119|4065741|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166
2337722|NCT03330119|4065742|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282
2337723|NCT03330236|4065750|FG000|Overall Study|Death|2
2337724|NCT03330236|4065751|FG001|Overall Study|Death|1
2337725|NCT03330236|4065750|FG000|Overall Study|Withdrawal by Subject|2
2337726|NCT03330236|4065751|FG001|Overall Study|Withdrawal by Subject|4
2337727|NCT03330236|4065750|FG000|Overall Study|Lost to Follow-up|0
2337728|NCT03330236|4065751|FG001|Overall Study|Lost to Follow-up|2
2337729|NCT03330236|4065750|FG000|Overall Study|Physician Decision|2
2337730|NCT03330236|4065751|FG001|Overall Study|Physician Decision|0
2337731|NCT03330236|4065750|FG000|Overall Study|Protocol Violation|4
2337732|NCT03330236|4065751|FG001|Overall Study|Protocol Violation|3
2337733|NCT03330236|4065750|FG000|Overall Study|SedLine malfunction/blinding|19
2337734|NCT03330236|4065751|FG001|Overall Study|SedLine malfunction/blinding|14
2337735|NCT03330236|4065750|FG000|Overall Study|Volatile anesthetics used|11
2337736|NCT03330236|4065751|FG001|Overall Study|Volatile anesthetics used|8
2337737|NCT03330236|4065750|FG000|Overall Study|Surgery aborted/converted to open|60
2337738|NCT03330236|4065751|FG001|Overall Study|Surgery aborted/converted to open|52
2337739|NCT03330288|4065788|FG000|Overall Study|Other reason|1
2337740|NCT03330288|4065789|FG001|Overall Study|Other reason|1
2337741|NCT03330288|4065788|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1
2337742|NCT03330288|4065789|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0
2337743|NCT03330288|4065788|FG000|Overall Study|Adverse Event|1
2337744|NCT03330288|4065789|FG001|Overall Study|Adverse Event|0
2337745|NCT03330288|4065788|FG000|Overall Study|Withdrawal by Subject|1
2337746|NCT03330288|4065789|FG001|Overall Study|Withdrawal by Subject|0
2337747|NCT03330288|4065788|FG000|Overall Study|Lost to Follow-up|26
2337748|NCT03330288|4065789|FG001|Overall Study|Lost to Follow-up|7
2337749|NCT03331042|4065820|FG000|Overall Study|Protocol Violation|1
2337750|NCT03331042|4065821|FG001|Overall Study|Protocol Violation|0
2337751|NCT03331042|4065822|FG002|Overall Study|Protocol Violation|0
2337752|NCT03331042|4065823|FG003|Overall Study|Protocol Violation|0
2337753|NCT03331042|4065820|FG000|Overall Study|Physician Decision|0
2337754|NCT03331042|4065821|FG001|Overall Study|Physician Decision|0
2337755|NCT03331042|4065822|FG002|Overall Study|Physician Decision|1
2337756|NCT03331042|4065823|FG003|Overall Study|Physician Decision|0
2337757|NCT03331042|4065820|FG000|Overall Study|Lost to Follow-up|0
2337758|NCT03331042|4065821|FG001|Overall Study|Lost to Follow-up|0
2337759|NCT03331042|4065822|FG002|Overall Study|Lost to Follow-up|0
2337760|NCT03331042|4065823|FG003|Overall Study|Lost to Follow-up|1
2337761|NCT03331315|4065850|FG000|Overall Study|Physician Decision|18
2337762|NCT03331315|4065851|FG001|Overall Study|Physician Decision|14
2337763|NCT03331666|4065861|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
2337764|NCT03331666|4065862|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
2337765|NCT03332160|4065888|FG000|Overall Study|Withdrawal by Subject|1
2337766|NCT03332160|4065889|FG001|Overall Study|Withdrawal by Subject|1
2337767|NCT03332160|4065888|FG000|Overall Study|Adverse Event|0
2337768|NCT03332160|4065889|FG001|Overall Study|Adverse Event|1
2337769|NCT03332160|4065888|FG000|Overall Study|Developed Exclusion Criteria|0
2337770|NCT03332160|4065889|FG001|Overall Study|Developed Exclusion Criteria|1
2337771|NCT03332160|4065888|FG000|Overall Study|Non-adherence to treatment|0
2337772|NCT03332160|4065889|FG001|Overall Study|Non-adherence to treatment|2
2337773|NCT03332212|4065900|FG000|Overall Study|Not treated|0
2337774|NCT03332212|4065901|FG001|Overall Study|Not treated|1
2337775|NCT03332212|4065902|FG002|Overall Study|Not treated|0
2337776|NCT03332212|4065903|FG003|Overall Study|Not treated|0
2337777|NCT03332212|4065900|FG000|Overall Study|Adverse Event|0
2337778|NCT03332212|4065901|FG001|Overall Study|Adverse Event|0
2337779|NCT03332212|4065902|FG002|Overall Study|Adverse Event|0
2337780|NCT03332212|4065903|FG003|Overall Study|Adverse Event|1
2337781|NCT03332212|4065900|FG000|Overall Study|worsening of disease under study|1
2337782|NCT03332212|4065901|FG001|Overall Study|worsening of disease under study|1
2337783|NCT03332212|4065902|FG002|Overall Study|worsening of disease under study|0
2337784|NCT03332212|4065903|FG003|Overall Study|worsening of disease under study|0
2337785|NCT03332628|4065924|FG000|Overall Study|Physician Decision|2
2337786|NCT03332771|4065933|FG000|Overall Study|Adverse Event|6
2337787|NCT03332771|4065934|FG001|Overall Study|Adverse Event|4
2337788|NCT03332771|4065935|FG002|Overall Study|Adverse Event|1
2337789|NCT03332771|4065936|FG003|Overall Study|Adverse Event|3
2337790|NCT03332771|4065933|FG000|Overall Study|Poor Compliance to Protocol|0
2241985|NCT01944046|3900220|FG000|Randomized to DB|Adverse Event|5
2241986|NCT01944046|3900221|FG001|Randomized to DB|Adverse Event|2
2241987|NCT01944046|3900220|FG000|Randomized to DB|Clinical Worsening|3
2241988|NCT01944046|3900221|FG001|Randomized to DB|Clinical Worsening|2
2241989|NCT01944046|3900220|FG000|Randomized to DB|Lost to Follow-up|3
2241990|NCT01944046|3900221|FG001|Randomized to DB|Lost to Follow-up|3
2241991|NCT01944046|3900220|FG000|Randomized to DB|Withdrawal by Subject|2
2241992|NCT01944046|3900221|FG001|Randomized to DB|Withdrawal by Subject|4
2241993|NCT01944046|3900220|FG000|Randomized to DB|Physician Decision|1
2241994|NCT01944046|3900221|FG001|Randomized to DB|Physician Decision|2
2241995|NCT01944046|3900220|FG000|Randomized to DB|Did not have baseline ABC-SW|2
2241996|NCT01944046|3900221|FG001|Randomized to DB|Did not have baseline ABC-SW|0
2337791|NCT03332771|4065934|FG001|Overall Study|Poor Compliance to Protocol|1
2337792|NCT03332771|4065935|FG002|Overall Study|Poor Compliance to Protocol|0
2337793|NCT03332771|4065936|FG003|Overall Study|Poor Compliance to Protocol|1
2337794|NCT03332771|4065933|FG000|Overall Study|Lost to Follow-up|2
2337795|NCT03332771|4065934|FG001|Overall Study|Lost to Follow-up|2
2337796|NCT03332771|4065935|FG002|Overall Study|Lost to Follow-up|1
2337797|NCT03332771|4065936|FG003|Overall Study|Lost to Follow-up|2
2337798|NCT03332771|4065933|FG000|Overall Study|At the Participant's own request|20
2337799|NCT03332771|4065934|FG001|Overall Study|At the Participant's own request|26
2337800|NCT03332771|4065935|FG002|Overall Study|At the Participant's own request|14
2337801|NCT03332771|4065936|FG003|Overall Study|At the Participant's own request|23
2337802|NCT03332771|4065933|FG000|Overall Study|Reason Not Specified|6
2337803|NCT03332771|4065934|FG001|Overall Study|Reason Not Specified|18
2337804|NCT03332771|4065935|FG002|Overall Study|Reason Not Specified|16
2337805|NCT03332771|4065936|FG003|Overall Study|Reason Not Specified|19
2337806|NCT03332784|4065966|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337807|NCT03332784|4065967|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
2337808|NCT03332784|4065968|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337809|NCT03332784|4065969|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337810|NCT03332784|4065970|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337811|NCT03332784|4065971|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337812|NCT03332784|4065972|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337813|NCT03332784|4065973|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337814|NCT03332784|4065974|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337815|NCT03332784|4065975|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337816|NCT03332784|4065976|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337817|NCT03332784|4065977|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337818|NCT03332784|4065978|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337819|NCT03332784|4065979|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337820|NCT03332784|4065980|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
2337821|NCT03332784|4065981|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337822|NCT03332784|4065982|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337823|NCT03332784|4065983|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2037453|NCT00418665|3607845|FG001|Treatment Period|Requirement for alternative therapy|0
2037454|NCT00418665|3607846|FG002|Treatment Period|Requirement for alternative therapy|0
2037455|NCT00418665|3607844|FG000|Treatment Period|Physician Decision|1
2037456|NCT00418665|3607845|FG001|Treatment Period|Physician Decision|0
2037457|NCT00418665|3607846|FG002|Treatment Period|Physician Decision|3
2037458|NCT00418665|3607844|FG000|Treatment Extension|Adverse Event|1
2037459|NCT00418665|3607845|FG001|Treatment Extension|Adverse Event|0
2037460|NCT00418665|3607846|FG002|Treatment Extension|Adverse Event|0
2037461|NCT00418665|3607844|FG000|Treatment Extension|Withdrawal by Subject|1
2037462|NCT00418665|3607845|FG001|Treatment Extension|Withdrawal by Subject|0
2037463|NCT00418665|3607846|FG002|Treatment Extension|Withdrawal by Subject|0
2037464|NCT00418665|3607844|FG000|Treatment Extension|Requirement for alternative therapy|2
2037465|NCT00418665|3607845|FG001|Treatment Extension|Requirement for alternative therapy|2
2037466|NCT00418665|3607846|FG002|Treatment Extension|Requirement for alternative therapy|0
2037467|NCT00418665|3607844|FG000|Treatment Extension|Physician Decision|2
2037468|NCT00418665|3607845|FG001|Treatment Extension|Physician Decision|2
2037469|NCT00418665|3607846|FG002|Treatment Extension|Physician Decision|1
2241997|NCT01944046|3900220|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5
2241998|NCT01944046|3900221|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6
2241999|NCT01944046|3900220|FG000|Open Label Eligible and Consented|Lost to Follow-up|3
2242000|NCT01944046|3900221|FG001|Open Label Eligible and Consented|Lost to Follow-up|5
2242001|NCT01944046|3900220|FG000|Open Label Eligible and Consented|Adverse Event|6
2242002|NCT01944046|3900221|FG001|Open Label Eligible and Consented|Adverse Event|1
2242003|NCT01944046|3900220|FG000|Open Label Eligible and Consented|Clinical Worsening|4
2242004|NCT01944046|3900221|FG001|Open Label Eligible and Consented|Clinical Worsening|2
2242005|NCT01944046|3900220|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1
2242006|NCT01944046|3900221|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0
2242007|NCT01944098|3900233|FG000|Overall Study|Physician Decision|1
2242008|NCT01944098|3900234|FG001|Overall Study|Physician Decision|0
2242009|NCT01944462|3900285|FG000|PPPP Educational Program|Lost to Follow-up|60
2242010|NCT01944631|3900292|FG000|Overall Study|Adverse Event|1
2242011|NCT01944631|3900293|FG001|Overall Study|Adverse Event|0
2242012|NCT01944631|3900292|FG000|Overall Study|Lost to Follow-up|3
2242013|NCT01944631|3900293|FG001|Overall Study|Lost to Follow-up|1
2242014|NCT01944631|3900292|FG000|Overall Study|Withdrawal by Subject|0
2242015|NCT01944631|3900293|FG001|Overall Study|Withdrawal by Subject|1
2242016|NCT01944670|3900308|FG000|Overall Study|Lost to Follow-up|2
2242017|NCT01944722|3900314|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
2242018|NCT01944722|3900314|FG000|Overall Study|Specimen Shipping Issues|34
2242019|NCT01944722|3900314|FG000|Overall Study|Improper Storage/Transport|5
2242020|NCT01944722|3900314|FG000|Overall Study|Insufficient Volume for Test|1
2242021|NCT01944722|3900314|FG000|Overall Study|Missing Specimens|3
2242022|NCT01944722|3900314|FG000|Overall Study|Specimens Mislabeled|2
2242023|NCT01944722|3900314|FG000|Overall Study|Withdrawal by Subject|8
2242024|NCT01944722|3900314|FG000|Overall Study|NILM Subjects <30 years old|8106
2242025|NCT01944722|3900314|FG000|Overall Study|Unsatisfactory Cytology Result|63
2242026|NCT01944722|3900314|FG000|Overall Study|>ASCUS Cytology|1122
2242027|NCT01944774|3900326|FG000|Overall Study|Withdrawal by Subject|2
2242028|NCT01944774|3900327|FG001|Overall Study|Withdrawal by Subject|3
2242029|NCT01944774|3900328|FG002|Overall Study|Withdrawal by Subject|3
2242030|NCT01944774|3900326|FG000|Overall Study|Adverse Event|3
2242031|NCT01944774|3900327|FG001|Overall Study|Adverse Event|2
2242032|NCT01944774|3900328|FG002|Overall Study|Adverse Event|3
2242033|NCT01944774|3900326|FG000|Overall Study|Lack of Efficacy|1
2242034|NCT01944774|3900327|FG001|Overall Study|Lack of Efficacy|2
2242035|NCT01944774|3900328|FG002|Overall Study|Lack of Efficacy|2
2242036|NCT01944774|3900326|FG000|Overall Study|Lost to Follow-up|0
2242037|NCT01944774|3900327|FG001|Overall Study|Lost to Follow-up|1
2242038|NCT01944774|3900328|FG002|Overall Study|Lost to Follow-up|0
2242039|NCT01944839|3900341|FG000|Overall Study|Physician Decision|2
2242040|NCT01944839|3900342|FG001|Overall Study|Physician Decision|2
2242041|NCT01944839|3900341|FG000|Overall Study|Protocol Violation|0
2242042|NCT01944839|3900342|FG001|Overall Study|Protocol Violation|1
2242043|NCT01944839|3900341|FG000|Overall Study|Adverse Event|10
2242044|NCT01944839|3900342|FG001|Overall Study|Adverse Event|5
2242045|NCT01944839|3900341|FG000|Overall Study|Withdrawal by Subject|9
2242046|NCT01944839|3900342|FG001|Overall Study|Withdrawal by Subject|17
2242047|NCT01944839|3900341|FG000|Overall Study|Lost to Follow-up|1
2242048|NCT01944839|3900342|FG001|Overall Study|Lost to Follow-up|0
2242049|NCT01944839|3900341|FG000|Overall Study|Subject non-compliance|0
2242050|NCT01944839|3900342|FG001|Overall Study|Subject non-compliance|3
2242051|NCT01944969|3900368|FG000|Overall Study|Adverse Event|1
2242052|NCT01944969|3900368|FG000|Overall Study|Lack of Efficacy|1
2242053|NCT01944969|3900368|FG000|Overall Study|Non-compliance with IMP|1
2242054|NCT01944969|3900368|FG000|Overall Study|Administrative or other reasons|23
2242055|NCT01945034|3900377|FG000|Overall Study|Medication Error|0
2242056|NCT01945034|3900378|FG001|Overall Study|Medication Error|1
2242057|NCT01945034|3900379|FG002|Overall Study|Medication Error|0
2242058|NCT01945034|3900377|FG000|Overall Study|Withdrawal by Subject|0
2242059|NCT01945034|3900378|FG001|Overall Study|Withdrawal by Subject|3
2242060|NCT01945034|3900379|FG002|Overall Study|Withdrawal by Subject|1
2242061|NCT01945034|3900377|FG000|Overall Study|Other|0
2242062|NCT01945034|3900378|FG001|Overall Study|Other|1
2242063|NCT01945034|3900379|FG002|Overall Study|Other|3
2242064|NCT01945034|3900377|FG000|Overall Study|Lost to Follow-up|0
2242065|NCT01945034|3900378|FG001|Overall Study|Lost to Follow-up|0
2242066|NCT01945034|3900379|FG002|Overall Study|Lost to Follow-up|2
2242067|NCT01945034|3900377|FG000|Overall Study|Protocol Violation|1
2242068|NCT01945034|3900378|FG001|Overall Study|Protocol Violation|0
2242069|NCT01945034|3900379|FG002|Overall Study|Protocol Violation|1
2242070|NCT01945086|3900390|FG000|Overall Study|Withdrawal by Subject|1
2242071|NCT01945086|3900391|FG001|Overall Study|Withdrawal by Subject|0
2242072|NCT01945086|3900392|FG002|Overall Study|Withdrawal by Subject|1
2242073|NCT01945086|3900390|FG000|Overall Study|Adverse Event|0
2337824|NCT03332784|4065984|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337825|NCT03332784|4065985|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
2337826|NCT03333109|4066046|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0
2242074|NCT01945086|3900391|FG001|Overall Study|Adverse Event|0
2242075|NCT01945086|3900392|FG002|Overall Study|Adverse Event|1
2242076|NCT01945216|3900418|FG000|Overall Study|Case report forms (CRF) uncollected|52
2242077|NCT01945216|3900418|FG000|Overall Study|Protocol Violation|42
2242078|NCT01945216|3900418|FG000|Overall Study|CRF not assured by investigators|5
2242079|NCT01945242|3900428|FG000|Overall Study|Physician Decision|3
2242080|NCT01945242|3900429|FG001|Overall Study|Physician Decision|3
2242081|NCT01945281|3900438|FG000|Overall Study|Adverse Event|1
2242082|NCT01945281|3900439|FG001|Overall Study|Adverse Event|0
2242083|NCT01945281|3900438|FG000|Overall Study|Death|3
2242084|NCT01945281|3900439|FG001|Overall Study|Death|3
2242085|NCT01945281|3900438|FG000|Overall Study|Physician Decision|1
2242086|NCT01945281|3900439|FG001|Overall Study|Physician Decision|1
2242087|NCT01945281|3900438|FG000|Overall Study|Technical Problems|1
2242088|NCT01945281|3900439|FG001|Overall Study|Technical Problems|0
2242089|NCT01945489|3900462|FG000|Cycle 1|Adverse Event|2
2242090|NCT01945489|3900463|FG001|Cycle 1|Adverse Event|0
2242091|NCT01945489|3900462|FG000|Cycle 1|Lost to Follow-up|4
2242092|NCT01945489|3900463|FG001|Cycle 1|Lost to Follow-up|0
2242093|NCT01945489|3900462|FG000|Cycle 1|Personal Reasons|4
2242094|NCT01945489|3900463|FG001|Cycle 1|Personal Reasons|2
2242095|NCT01945489|3900462|FG000|Cycle 1|Protocol Violation|0
2242096|NCT01945489|3900463|FG001|Cycle 1|Protocol Violation|1
2242097|NCT01945489|3900462|FG000|Cycle 1|Other Miscellaneous Reasons|3
2242098|NCT01945489|3900463|FG001|Cycle 1|Other Miscellaneous Reasons|1
2242099|NCT01945489|3900462|FG000|Cycle 2|Adverse Event|1
2242100|NCT01945489|3900463|FG001|Cycle 2|Adverse Event|0
2242101|NCT01945489|3900462|FG000|Cycle 2|Lost to Follow-up|0
2242102|NCT01945489|3900463|FG001|Cycle 2|Lost to Follow-up|1
2242103|NCT01945580|3900472|FG000|Overall Study|Withdrawal by Subject|13
2242104|NCT01945580|3900473|FG001|Overall Study|Withdrawal by Subject|35
2242105|NCT01945580|3900472|FG000|Overall Study|Physician Decision|3
2242106|NCT01945580|3900473|FG001|Overall Study|Physician Decision|2
2242107|NCT01945580|3900472|FG000|Overall Study|Lost to Follow-up|26
2242108|NCT01945580|3900473|FG001|Overall Study|Lost to Follow-up|39
2242109|NCT01945580|3900472|FG000|Overall Study|Death|7
2242110|NCT01945580|3900473|FG001|Overall Study|Death|2
2242111|NCT01945580|3900472|FG000|Overall Study|Patient moved out of state|0
2242112|NCT01945580|3900473|FG001|Overall Study|Patient moved out of state|1
2242113|NCT01945580|3900472|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1
2242114|NCT01945580|3900473|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0
2242115|NCT01945580|3900472|FG000|Overall Study|Family illness - unable to return|0
2242116|NCT01945580|3900473|FG001|Overall Study|Family illness - unable to return|1
2242117|NCT01945580|3900472|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0
2242118|NCT01945580|3900473|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1
2242119|NCT01945580|3900472|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0
2242120|NCT01945580|3900473|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1
2242121|NCT01945580|3900472|FG000|Overall Study|Noncompliance with 36 month visit|1
2242122|NCT01945580|3900473|FG001|Overall Study|Noncompliance with 36 month visit|0
2242123|NCT01945580|3900472|FG000|Overall Study|The patient moved.|1
2242124|NCT01945580|3900473|FG001|Overall Study|The patient moved.|0
2242125|NCT01945580|3900472|FG000|Overall Study|No data available|0
2242126|NCT01945580|3900473|FG001|Overall Study|No data available|2
2242127|NCT01945593|3900487|FG000|Overall Study|Adverse Event|0
2242128|NCT01945593|3900488|FG001|Overall Study|Adverse Event|0
2242129|NCT01945593|3900489|FG002|Overall Study|Adverse Event|0
2242130|NCT01945593|3900490|FG003|Overall Study|Adverse Event|5
2242131|NCT01945593|3900487|FG000|Overall Study|Physician Decision|0
2242132|NCT01945593|3900488|FG001|Overall Study|Physician Decision|0
2242133|NCT01945593|3900489|FG002|Overall Study|Physician Decision|1
2242134|NCT01945593|3900490|FG003|Overall Study|Physician Decision|1
2242135|NCT01945593|3900487|FG000|Overall Study|Withdrawal by Subject|0
2242136|NCT01945593|3900488|FG001|Overall Study|Withdrawal by Subject|2
2242137|NCT01945593|3900489|FG002|Overall Study|Withdrawal by Subject|0
2242138|NCT01945593|3900490|FG003|Overall Study|Withdrawal by Subject|4
2242139|NCT01945593|3900487|FG000|Overall Study|Protocol Violation|0
2242140|NCT01945593|3900488|FG001|Overall Study|Protocol Violation|2
2242141|NCT01945593|3900489|FG002|Overall Study|Protocol Violation|1
2242142|NCT01945593|3900490|FG003|Overall Study|Protocol Violation|3
2242143|NCT01945593|3900487|FG000|Overall Study|Death|0
2242144|NCT01945593|3900488|FG001|Overall Study|Death|0
2242145|NCT01945593|3900489|FG002|Overall Study|Death|1
2242146|NCT01945593|3900490|FG003|Overall Study|Death|0
2242147|NCT01945593|3900487|FG000|Overall Study|Other: Terminated|0
2242148|NCT01945593|3900488|FG001|Overall Study|Other: Terminated|0
2242149|NCT01945593|3900489|FG002|Overall Study|Other: Terminated|0
2242150|NCT01945593|3900490|FG003|Overall Study|Other: Terminated|1
2242151|NCT01945593|3900487|FG000|Overall Study|Other: Surgical Procedure|0
2242152|NCT01945593|3900488|FG001|Overall Study|Other: Surgical Procedure|2
2242153|NCT01945593|3900489|FG002|Overall Study|Other: Surgical Procedure|0
2242154|NCT01945593|3900490|FG003|Overall Study|Other: Surgical Procedure|6
2242155|NCT01945593|3900487|FG000|Overall Study|Other: Screen Failure|0
2242156|NCT01945593|3900488|FG001|Overall Study|Other: Screen Failure|2
2242157|NCT01945593|3900489|FG002|Overall Study|Other: Screen Failure|0
2242158|NCT01945593|3900490|FG003|Overall Study|Other: Screen Failure|0
2242159|NCT01945710|3900512|FG000|Overall Study|Progressive Disease|5
2242160|NCT01945710|3900513|FG001|Overall Study|Progressive Disease|4
2242161|NCT01945710|3900514|FG002|Overall Study|Progressive Disease|3
2242162|NCT01945710|3900515|FG003|Overall Study|Progressive Disease|2
2242163|NCT01945710|3900516|FG004|Overall Study|Progressive Disease|7
2242164|NCT01945710|3900517|FG005|Overall Study|Progressive Disease|3
2242165|NCT01945710|3900518|FG006|Overall Study|Progressive Disease|19
2242166|NCT01945710|3900512|FG000|Overall Study|Adverse Event|0
2242167|NCT01945710|3900513|FG001|Overall Study|Adverse Event|1
2242168|NCT01945710|3900514|FG002|Overall Study|Adverse Event|0
2242169|NCT01945710|3900515|FG003|Overall Study|Adverse Event|0
2242170|NCT01945710|3900516|FG004|Overall Study|Adverse Event|0
2242171|NCT01945710|3900517|FG005|Overall Study|Adverse Event|0
2242172|NCT01945710|3900518|FG006|Overall Study|Adverse Event|0
2242173|NCT01945710|3900512|FG000|Overall Study|Other|2
2242174|NCT01945710|3900513|FG001|Overall Study|Other|0
2242175|NCT01945710|3900514|FG002|Overall Study|Other|3
2242176|NCT01945710|3900515|FG003|Overall Study|Other|1
2242177|NCT01945710|3900516|FG004|Overall Study|Other|1
2242178|NCT01945710|3900517|FG005|Overall Study|Other|0
2242179|NCT01945710|3900518|FG006|Overall Study|Other|4
2242180|NCT01945710|3900512|FG000|Overall Study|Withdrawal by Subject|0
2242181|NCT01945710|3900513|FG001|Overall Study|Withdrawal by Subject|1
2242182|NCT01945710|3900514|FG002|Overall Study|Withdrawal by Subject|1
2242183|NCT01945710|3900515|FG003|Overall Study|Withdrawal by Subject|0
2242184|NCT01945710|3900516|FG004|Overall Study|Withdrawal by Subject|1
2242185|NCT01945710|3900517|FG005|Overall Study|Withdrawal by Subject|0
2242186|NCT01945710|3900518|FG006|Overall Study|Withdrawal by Subject|0
2242187|NCT01945866|3900538|FG000|Overall Study|Eyes did not complete or were dropped|2
2242188|NCT01945866|3900539|FG001|Overall Study|Eyes did not complete or were dropped|0
2242189|NCT01945944|3900548|FG000|Overall Study|Adverse Event|0
2242190|NCT01945944|3900549|FG001|Overall Study|Adverse Event|2
2242191|NCT01945944|3900548|FG000|Overall Study|Physician Decision|1
2242192|NCT01945944|3900549|FG001|Overall Study|Physician Decision|0
2242193|NCT01945944|3900548|FG000|Overall Study|Withdrawal by Subject|0
2242194|NCT01945944|3900549|FG001|Overall Study|Withdrawal by Subject|1
2242195|NCT01945996|3900574|FG000|Overall Study|Lost to Follow-up|3
2242196|NCT01945996|3900575|FG001|Overall Study|Lost to Follow-up|5
2242197|NCT01946152|3900596|FG000|Overall Study|Adverse Event|1
2242198|NCT01946152|3900597|FG001|Overall Study|Adverse Event|0
2242199|NCT01946152|3900598|FG002|Overall Study|Adverse Event|0
2242200|NCT01946152|3900599|FG003|Overall Study|Adverse Event|0
2242201|NCT01946152|3900596|FG000|Overall Study|Withdrawal by Subject|0
2242202|NCT01946152|3900597|FG001|Overall Study|Withdrawal by Subject|2
2242203|NCT01946152|3900598|FG002|Overall Study|Withdrawal by Subject|0
2242204|NCT01946152|3900599|FG003|Overall Study|Withdrawal by Subject|0
2242205|NCT01946152|3900596|FG000|Overall Study|Progression|0
2242206|NCT01946152|3900597|FG001|Overall Study|Progression|1
2242207|NCT01946152|3900598|FG002|Overall Study|Progression|4
2242208|NCT01946152|3900599|FG003|Overall Study|Progression|7
2242209|NCT01946152|3900596|FG000|Overall Study|Physician Decision|0
2242210|NCT01946152|3900597|FG001|Overall Study|Physician Decision|0
2242211|NCT01946152|3900598|FG002|Overall Study|Physician Decision|1
2242212|NCT01946152|3900599|FG003|Overall Study|Physician Decision|0
2242213|NCT01946152|3900596|FG000|Overall Study|Second malignancy|0
2242214|NCT01946152|3900597|FG001|Overall Study|Second malignancy|0
2242215|NCT01946152|3900598|FG002|Overall Study|Second malignancy|1
2242216|NCT01946152|3900599|FG003|Overall Study|Second malignancy|0
2242217|NCT01946152|3900596|FG000|Overall Study|Adverse Event|0
2242218|NCT01946152|3900597|FG001|Overall Study|Adverse Event|0
2242219|NCT01946152|3900598|FG002|Overall Study|Adverse Event|0
2242220|NCT01946152|3900599|FG003|Overall Study|Adverse Event|1
2242221|NCT01946165|3900613|FG000|Overall Study|Physician Decision|2
2242222|NCT01946165|3900614|FG001|Overall Study|Physician Decision|0
2242223|NCT01946165|3900613|FG000|Overall Study|Withdrawal by Subject|0
2242224|NCT01946165|3900614|FG001|Overall Study|Withdrawal by Subject|2
2337827|NCT03333109|4066047|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0
2337828|NCT03333109|4066048|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2
2337829|NCT03333109|4066046|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
2337830|NCT03333109|4066047|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
2337831|NCT03333109|4066048|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1
2337832|NCT03333109|4066046|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4
2337833|NCT03333109|4066047|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0
2337834|NCT03333109|4066048|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1
2337835|NCT03333109|4066046|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1
2337836|NCT03333109|4066047|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0
2337837|NCT03333109|4066048|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0
2337838|NCT03333109|4066046|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9
2337839|NCT03333109|4066047|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6
2337840|NCT03333109|4066048|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5
2337841|NCT03333109|4066046|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
2242225|NCT01946178|3900621|FG000|Overall Study|Pregnancy|1
2242226|NCT01946178|3900621|FG000|Overall Study|Lost to Follow-up|1
2242227|NCT01946191|3900631|FG000|Allocation|Did not complete orientation|1
2242228|NCT01946191|3900632|FG001|Allocation|Did not complete orientation|1
2242229|NCT01946191|3900631|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4
2242230|NCT01946191|3900632|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2
2242231|NCT01946191|3900631|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0
2242232|NCT01946191|3900632|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1
2242233|NCT01946191|3900631|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13
2242234|NCT01946191|3900632|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15
2242235|NCT01946282|3900648|FG000|Year 1|Did not return FIT kit|4186
2242236|NCT01946282|3900649|FG001|Year 1|Did not return FIT kit|608
2242237|NCT01946282|3900650|FG002|Year 1|Did not return FIT kit|654
2242238|NCT01946282|3900648|FG000|Year 2|Did not return FIT kit|803
2242239|NCT01946282|3900649|FG001|Year 2|Did not return FIT kit|131
2242240|NCT01946282|3900650|FG002|Year 2|Did not return FIT kit|115
2242241|NCT01946282|3900648|FG000|Year 3|Did not return FIT kit|288
2242242|NCT01946282|3900649|FG001|Year 3|Did not return FIT kit|43
2242243|NCT01946282|3900650|FG002|Year 3|Did not return FIT kit|30
2242244|NCT01946412|3900660|FG000|Overall Study|Adverse Event|1
2242245|NCT01946412|3900660|FG000|Overall Study|Non-Compliance|1
2242246|NCT01946412|3900660|FG000|Overall Study|Continued with commercial Kalydeco|2
2242247|NCT01946412|3900660|FG000|Overall Study|Difficulty in swallowing|1
2242248|NCT01946425|3900668|FG000|Overall Study|Protocol Violation|1
2242249|NCT01946425|3900669|FG001|Overall Study|Protocol Violation|0
2242250|NCT01946425|3900668|FG000|Overall Study|Withdrawal by Subject|1
2242251|NCT01946425|3900669|FG001|Overall Study|Withdrawal by Subject|0
2242252|NCT01946438|3900680|FG000|Overall Study|Adverse Event|0
2242253|NCT01946438|3900681|FG001|Overall Study|Adverse Event|0
2242254|NCT01946438|3900682|FG002|Overall Study|Adverse Event|0
2242255|NCT01946438|3900683|FG003|Overall Study|Adverse Event|1
2242256|NCT01946438|3900680|FG000|Overall Study|Serious Adverse event|1
2242257|NCT01946438|3900681|FG001|Overall Study|Serious Adverse event|0
2242258|NCT01946438|3900682|FG002|Overall Study|Serious Adverse event|0
2242259|NCT01946438|3900683|FG003|Overall Study|Serious Adverse event|0
2242260|NCT01946438|3900680|FG000|Overall Study|Protocol Violation|0
2242261|NCT01946438|3900681|FG001|Overall Study|Protocol Violation|0
2242262|NCT01946438|3900682|FG002|Overall Study|Protocol Violation|1
2242263|NCT01946438|3900683|FG003|Overall Study|Protocol Violation|0
2242264|NCT01946438|3900680|FG000|Overall Study|Withdrawal by Subject|1
2242265|NCT01946438|3900681|FG001|Overall Study|Withdrawal by Subject|0
2242266|NCT01946438|3900682|FG002|Overall Study|Withdrawal by Subject|0
2242267|NCT01946438|3900683|FG003|Overall Study|Withdrawal by Subject|0
2242268|NCT01946529|3900702|FG000|End of Window Therapy (2 Courses)|Physician Decision|0
2242269|NCT01946529|3900703|FG001|End of Window Therapy (2 Courses)|Physician Decision|1
2242270|NCT01946529|3900704|FG002|End of Window Therapy (2 Courses)|Physician Decision|0
2242271|NCT01946529|3900702|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1
2242272|NCT01946529|3900703|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16
2242273|NCT01946529|3900704|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6
2242274|NCT01946802|3900711|FG000|Overall Study|Death|1
2242275|NCT01946802|3900711|FG000|Overall Study|Withdrawal by Subject|2
2242276|NCT01946802|3900711|FG000|Overall Study|Combined septic shock|1
2242277|NCT01946802|3900711|FG000|Overall Study|Protocol Violation|1
2242278|NCT01946880|3900717|FG000|Overall Study|Lost to Follow-up|1
2242279|NCT01946880|3900718|FG001|Overall Study|Lost to Follow-up|0
2242280|NCT01946880|3900717|FG000|Overall Study|Physician Decision|1
2242281|NCT01946880|3900718|FG001|Overall Study|Physician Decision|1
2242282|NCT01946880|3900717|FG000|Overall Study|Withdrawal by Subject|3
2242283|NCT01946880|3900718|FG001|Overall Study|Withdrawal by Subject|2
2242284|NCT01946880|3900717|FG000|Overall Study|Met Primary Endpoint|1
2242285|NCT01946880|3900718|FG001|Overall Study|Met Primary Endpoint|0
2242286|NCT01946880|3900717|FG000|Overall Study|Personal and Family Issues|1
2242287|NCT01946880|3900718|FG001|Overall Study|Personal and Family Issues|0
2242288|NCT01947127|3900726|FG000|Overall Study|Protocol Violation|18
2242289|NCT01947127|3900727|FG001|Overall Study|Protocol Violation|38
2242290|NCT01947127|3900726|FG000|Overall Study|Withdrawal by Subject|1
2242291|NCT01947127|3900727|FG001|Overall Study|Withdrawal by Subject|1
2242292|NCT01947127|3900726|FG000|Overall Study|Data loss|4
2242293|NCT01947127|3900727|FG001|Overall Study|Data loss|4
2242294|NCT01947283|3900747|FG000|Overall Study|Death|1
2242295|NCT01947283|3900748|FG001|Overall Study|Death|1
2242296|NCT01947283|3900749|FG002|Overall Study|Death|1
2242297|NCT01947283|3900750|FG003|Overall Study|Death|0
2242298|NCT01947283|3900751|FG004|Overall Study|Death|0
2242299|NCT01947283|3900752|FG005|Overall Study|Death|0
2242300|NCT01947283|3900753|FG006|Overall Study|Death|0
2242301|NCT01947283|3900747|FG000|Overall Study|Lost to Follow-up|4
2242302|NCT01947283|3900748|FG001|Overall Study|Lost to Follow-up|6
2242303|NCT01947283|3900749|FG002|Overall Study|Lost to Follow-up|5
2242304|NCT01947283|3900750|FG003|Overall Study|Lost to Follow-up|5
2242305|NCT01947283|3900751|FG004|Overall Study|Lost to Follow-up|0
2242306|NCT01947283|3900752|FG005|Overall Study|Lost to Follow-up|2
2242307|NCT01947283|3900753|FG006|Overall Study|Lost to Follow-up|5
2242308|NCT01947283|3900747|FG000|Overall Study|Withdrawal by Subject|10
2242309|NCT01947283|3900748|FG001|Overall Study|Withdrawal by Subject|8
2242310|NCT01947283|3900749|FG002|Overall Study|Withdrawal by Subject|4
2242311|NCT01947283|3900750|FG003|Overall Study|Withdrawal by Subject|1
2242312|NCT01947283|3900751|FG004|Overall Study|Withdrawal by Subject|0
2242313|NCT01947283|3900752|FG005|Overall Study|Withdrawal by Subject|0
2242314|NCT01947283|3900753|FG006|Overall Study|Withdrawal by Subject|2
2242315|NCT01947283|3900747|FG000|Overall Study|No Clinical Recording|12
2242316|NCT01947283|3900748|FG001|Overall Study|No Clinical Recording|6
2242317|NCT01947283|3900749|FG002|Overall Study|No Clinical Recording|8
2242318|NCT01947283|3900750|FG003|Overall Study|No Clinical Recording|10
2242319|NCT01947283|3900751|FG004|Overall Study|No Clinical Recording|0
2242320|NCT01947283|3900752|FG005|Overall Study|No Clinical Recording|0
2242321|NCT01947283|3900753|FG006|Overall Study|No Clinical Recording|0
2242322|NCT01947283|3900747|FG000|Overall Study|Non-coding Clinical Recording language|0
2242323|NCT01947283|3900748|FG001|Overall Study|Non-coding Clinical Recording language|0
2242324|NCT01947283|3900749|FG002|Overall Study|Non-coding Clinical Recording language|0
2242325|NCT01947283|3900750|FG003|Overall Study|Non-coding Clinical Recording language|1
2242326|NCT01947283|3900751|FG004|Overall Study|Non-coding Clinical Recording language|0
2242327|NCT01947283|3900752|FG005|Overall Study|Non-coding Clinical Recording language|0
2242328|NCT01947283|3900753|FG006|Overall Study|Non-coding Clinical Recording language|0
2242329|NCT01947283|3900747|FG000|Overall Study|Missing Follow-up Assessment|2
2242330|NCT01947283|3900748|FG001|Overall Study|Missing Follow-up Assessment|2
2242331|NCT01947283|3900749|FG002|Overall Study|Missing Follow-up Assessment|3
2242332|NCT01947283|3900750|FG003|Overall Study|Missing Follow-up Assessment|0
2242333|NCT01947283|3900751|FG004|Overall Study|Missing Follow-up Assessment|0
2242334|NCT01947283|3900752|FG005|Overall Study|Missing Follow-up Assessment|2
2242335|NCT01947283|3900753|FG006|Overall Study|Missing Follow-up Assessment|0
2242336|NCT01947283|3900747|FG000|Overall Study|No patients were enrolled in study|0
2242337|NCT01947283|3900748|FG001|Overall Study|No patients were enrolled in study|0
2242338|NCT01947283|3900749|FG002|Overall Study|No patients were enrolled in study|0
2242339|NCT01947283|3900750|FG003|Overall Study|No patients were enrolled in study|0
2242340|NCT01947283|3900751|FG004|Overall Study|No patients were enrolled in study|0
2242341|NCT01947283|3900752|FG005|Overall Study|No patients were enrolled in study|3
2242342|NCT01947283|3900753|FG006|Overall Study|No patients were enrolled in study|1
2337842|NCT03333109|4066047|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0
2337843|NCT03333109|4066048|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
2337844|NCT03333109|4066046|FG000|Safety Follow-up Period|Lost to Follow-up|6
2337845|NCT03333109|4066047|FG001|Safety Follow-up Period|Lost to Follow-up|2
2337846|NCT03333109|4066048|FG002|Safety Follow-up Period|Lost to Follow-up|1
2337847|NCT03333109|4066046|FG000|Safety Follow-up Period|Withdrawal by Subject|7
2337848|NCT03333109|4066047|FG001|Safety Follow-up Period|Withdrawal by Subject|2
2337849|NCT03333109|4066048|FG002|Safety Follow-up Period|Withdrawal by Subject|12
2337850|NCT03333876|4066077|FG000|Screening Period|Screen Failure|4
2337851|NCT03333876|4066077|FG000|Nasal Dilator|Bed Partner Lost to follow up|6
2337852|NCT03333876|4066077|FG000|Mandibular Advancement|Adverse Event|2
2337853|NCT03333876|4066077|FG000|Mandibular Advancement|Product Damage|2
2337854|NCT03333941|4066090|FG000|Overall Study|Lost to Follow-up|10
2337855|NCT03333941|4066090|FG000|Overall Study|Death|2
2337856|NCT03333941|4066090|FG000|Overall Study|Adverse Event|1
2337857|NCT03334175|4066096|FG000|Overall Study|Lost to Follow-up|0
2337858|NCT03334175|4066097|FG001|Overall Study|Lost to Follow-up|1
2337859|NCT03334188|4066105|FG000|Overall Study|Withdrawal by Subject|0
2337860|NCT03334188|4066106|FG001|Overall Study|Withdrawal by Subject|1
2337861|NCT03334188|4066105|FG000|Overall Study|Death|1
2337862|NCT03334188|4066106|FG001|Overall Study|Death|0
2337863|NCT03334188|4066105|FG000|Overall Study|Never had qualifying clinic visit|7
2337864|NCT03334188|4066106|FG001|Overall Study|Never had qualifying clinic visit|7
2337865|NCT03334214|4066115|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
2037470|NCT00418665|3607844|FG000|Treatment Extension|Death|0
2037471|NCT00418665|3607845|FG001|Treatment Extension|Death|0
2037472|NCT00418665|3607846|FG002|Treatment Extension|Death|1
2037473|NCT00418691|3607857|FG000|Overall Study|Lost to Follow-up|1
2037474|NCT00418691|3607858|FG001|Overall Study|Lost to Follow-up|2
2037475|NCT00418691|3607859|FG002|Overall Study|Lost to Follow-up|3
2037476|NCT00418691|3607857|FG000|Overall Study|Started new medication voiding entry|0
2037477|NCT00418691|3607858|FG001|Overall Study|Started new medication voiding entry|0
2037478|NCT00418691|3607859|FG002|Overall Study|Started new medication voiding entry|1
2037479|NCT00418691|3607857|FG000|Overall Study|Progressive Disease|1
2037480|NCT00418691|3607858|FG001|Overall Study|Progressive Disease|0
2037481|NCT00418691|3607859|FG002|Overall Study|Progressive Disease|1
2037482|NCT00418717|3607867|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1
2037483|NCT00418717|3607867|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2
2037484|NCT00418886|3607873|FG000|Overall Study|discontinue treatment survival follow up|90
2037485|NCT00418886|3607874|FG001|Overall Study|discontinue treatment survival follow up|91
2037486|NCT00418886|3607873|FG000|Overall Study|Death|122
2037487|NCT00418886|3607874|FG001|Overall Study|Death|147
2037488|NCT00418886|3607873|FG000|Overall Study|Withdrawal by Subject|9
2037489|NCT00418886|3607874|FG001|Overall Study|Withdrawal by Subject|10
2037490|NCT00418886|3607873|FG000|Overall Study|Lost to Follow-up|4
2037491|NCT00418886|3607874|FG001|Overall Study|Lost to Follow-up|6
2037492|NCT00418886|3607873|FG000|Overall Study|withdrawn due to other reason|1
2242343|NCT01947491|3900783|FG000|Overall Study|Lost to Follow-up|5
2242344|NCT01947491|3900784|FG001|Overall Study|Lost to Follow-up|3
2242345|NCT01947491|3900785|FG002|Overall Study|Lost to Follow-up|1
2242346|NCT01947491|3900786|FG003|Overall Study|Lost to Follow-up|2
2242347|NCT01947491|3900783|FG000|Overall Study|Lack of Efficacy|1
2242348|NCT01947491|3900784|FG001|Overall Study|Lack of Efficacy|0
2242349|NCT01947491|3900785|FG002|Overall Study|Lack of Efficacy|0
2242350|NCT01947491|3900786|FG003|Overall Study|Lack of Efficacy|1
2242351|NCT01947491|3900783|FG000|Overall Study|Protocol Violation|1
2242352|NCT01947491|3900784|FG001|Overall Study|Protocol Violation|0
2242353|NCT01947491|3900785|FG002|Overall Study|Protocol Violation|0
2242354|NCT01947491|3900786|FG003|Overall Study|Protocol Violation|0
2242355|NCT01947491|3900783|FG000|Overall Study|Withdrawal by Subject|1
2242356|NCT01947491|3900784|FG001|Overall Study|Withdrawal by Subject|1
2242357|NCT01947491|3900785|FG002|Overall Study|Withdrawal by Subject|1
2242358|NCT01947491|3900786|FG003|Overall Study|Withdrawal by Subject|0
2242359|NCT01947491|3900783|FG000|Overall Study|Worsening of condition|0
2242360|NCT01947491|3900784|FG001|Overall Study|Worsening of condition|1
2242361|NCT01947491|3900785|FG002|Overall Study|Worsening of condition|0
2242362|NCT01947491|3900786|FG003|Overall Study|Worsening of condition|0
2242363|NCT01947491|3900783|FG000|Overall Study|Adverse Event|0
2242364|NCT01947491|3900784|FG001|Overall Study|Adverse Event|1
2242365|NCT01947491|3900785|FG002|Overall Study|Adverse Event|0
2242366|NCT01947491|3900786|FG003|Overall Study|Adverse Event|2
2242367|NCT01947517|3900798|FG000|Overall Study|Withdrawal by Subject|1
2242368|NCT01947517|3900799|FG001|Overall Study|Withdrawal by Subject|1
2242369|NCT01947582|3900805|FG000|Overall Study|Withdrawal by Subject|1
2242370|NCT01947855|3900825|FG000|Overall Study|Withdrawal by Subject|1
2242371|NCT01947855|3900826|FG001|Overall Study|Withdrawal by Subject|0
2242372|NCT01947855|3900827|FG002|Overall Study|Withdrawal by Subject|0
2242373|NCT01947894|3900838|FG000|Overall Study|Other|3
2242374|NCT01947894|3900839|FG001|Overall Study|Other|4
2242375|NCT01947894|3900840|FG002|Overall Study|Other|3
2242376|NCT01947894|3900838|FG000|Overall Study|Withdrawal by Subject|12
2242377|NCT01947894|3900839|FG001|Overall Study|Withdrawal by Subject|4
2242378|NCT01947894|3900840|FG002|Overall Study|Withdrawal by Subject|1
2242379|NCT01947894|3900838|FG000|Overall Study|Death|12
2242380|NCT01947894|3900839|FG001|Overall Study|Death|1
2242381|NCT01947894|3900840|FG002|Overall Study|Death|0
2242382|NCT01947894|3900838|FG000|Overall Study|Physician Decision|2
2242383|NCT01947894|3900839|FG001|Overall Study|Physician Decision|0
2242384|NCT01947894|3900840|FG002|Overall Study|Physician Decision|0
2242385|NCT01947894|3900838|FG000|Overall Study|Adverse Event|5
2242386|NCT01947894|3900839|FG001|Overall Study|Adverse Event|1
2242387|NCT01947894|3900840|FG002|Overall Study|Adverse Event|0
2242388|NCT01947894|3900838|FG000|Overall Study|Switched to other growth hormone brand|53
2242389|NCT01947894|3900839|FG001|Overall Study|Switched to other growth hormone brand|8
2242390|NCT01947894|3900840|FG002|Overall Study|Switched to other growth hormone brand|23
2242391|NCT01948050|3900880|FG000|Overall Study|Withdrawal by Subject|0
2242392|NCT01948050|3900881|FG001|Overall Study|Withdrawal by Subject|1
2242393|NCT01948063|3900889|FG000|Overall Study|Boston MCI halted research protocol|0
2242394|NCT01948063|3900890|FG001|Overall Study|Boston MCI halted research protocol|1
2242395|NCT01948063|3900889|FG000|Overall Study|Discovered an enrollment in other study|0
2242396|NCT01948063|3900890|FG001|Overall Study|Discovered an enrollment in other study|1
2242397|NCT01948063|3900889|FG000|Overall Study|Blood samples were accidentally thawed|1
2242398|NCT01948063|3900890|FG001|Overall Study|Blood samples were accidentally thawed|0
2242399|NCT01948076|3900898|FG000|Overall Study|Withdrawal by Subject|0
2242400|NCT01948076|3900899|FG001|Overall Study|Withdrawal by Subject|1
2242401|NCT01948193|3900911|FG000|Overall Study|Serious event|2
2242402|NCT01948193|3900911|FG000|Overall Study|Lost to Follow-up|7
2242403|NCT01948258|3900916|FG000|Overall Study|Pregnancy|41
2242404|NCT01948258|3900916|FG000|Overall Study|Did not complete by cut-off date|35
2242405|NCT01948258|3900916|FG000|Overall Study|Lost to Follow-up|27
2242406|NCT01948258|3900916|FG000|Overall Study|Withdrawal by SPD|8
2242407|NCT01948258|3900916|FG000|Overall Study|Withdrawal by Subject|6
2242408|NCT01948258|3900916|FG000|Overall Study|Health Care Professional|43
2242409|NCT01948258|3900916|FG000|Overall Study|Removed from statistical analysis|2
2242410|NCT01948427|3900956|FG000|Overall Study|Serious Adverse Event|3
2242411|NCT01948427|3900957|FG001|Overall Study|Serious Adverse Event|0
2242412|NCT01948427|3900958|FG002|Overall Study|Serious Adverse Event|0
2242413|NCT01948427|3900959|FG003|Overall Study|Serious Adverse Event|0
2242414|NCT01948427|3900960|FG004|Overall Study|Serious Adverse Event|1
2242415|NCT01948427|3900956|FG000|Overall Study|Investigator Request|0
2242416|NCT01948427|3900957|FG001|Overall Study|Investigator Request|8
2242417|NCT01948427|3900958|FG002|Overall Study|Investigator Request|0
2242418|NCT01948427|3900959|FG003|Overall Study|Investigator Request|0
2337866|NCT03334214|4066116|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
2337867|NCT03334214|4066115|FG000|Overall Study|Withdrawal by Subject|0
2337868|NCT03334214|4066116|FG001|Overall Study|Withdrawal by Subject|1
2337869|NCT03334214|4066115|FG000|Overall Study|Other|1
2337870|NCT03334214|4066116|FG001|Overall Study|Other|0
2337871|NCT03334396|4066131|FG000|Overall Study|Adverse Event|1
2242419|NCT01948427|3900960|FG004|Overall Study|Investigator Request|6
2242420|NCT01948427|3900956|FG000|Overall Study|Lost to Follow-up|1
2242421|NCT01948427|3900957|FG001|Overall Study|Lost to Follow-up|0
2242422|NCT01948427|3900958|FG002|Overall Study|Lost to Follow-up|0
2242423|NCT01948427|3900959|FG003|Overall Study|Lost to Follow-up|0
2242424|NCT01948427|3900960|FG004|Overall Study|Lost to Follow-up|4
2242425|NCT01948427|3900956|FG000|Overall Study|Withdrawal by Subject|2
2242426|NCT01948427|3900957|FG001|Overall Study|Withdrawal by Subject|0
2242427|NCT01948427|3900958|FG002|Overall Study|Withdrawal by Subject|0
2242428|NCT01948427|3900959|FG003|Overall Study|Withdrawal by Subject|0
2242429|NCT01948427|3900960|FG004|Overall Study|Withdrawal by Subject|1
2242430|NCT01948427|3900956|FG000|Overall Study|Other, Not Specified|1
2242431|NCT01948427|3900957|FG001|Overall Study|Other, Not Specified|9
2242432|NCT01948427|3900958|FG002|Overall Study|Other, Not Specified|0
2242433|NCT01948427|3900959|FG003|Overall Study|Other, Not Specified|0
2242434|NCT01948427|3900960|FG004|Overall Study|Other, Not Specified|2
2242435|NCT01948791|3900985|FG000|Overall Study|Adverse Event|12
2242436|NCT01948791|3900985|FG000|Overall Study|Lack of Efficacy|3
2242437|NCT01948791|3900985|FG000|Overall Study|Protocol Violation|2
2242438|NCT01948791|3900985|FG000|Overall Study|Withdrawal by Subject|5
2242439|NCT01948791|3900985|FG000|Overall Study|Lost to Follow-up|6
2242440|NCT01948791|3900985|FG000|Overall Study|Management issues|1
2242441|NCT01948791|3900985|FG000|Overall Study|Others|7
2242442|NCT01948791|3900985|FG000|Overall Study|Screening failure|35
2242443|NCT01948830|3900991|FG000|Overall Study|Physician Decision|1
2242444|NCT01948830|3900992|FG001|Overall Study|Physician Decision|3
2242445|NCT01948830|3900991|FG000|Overall Study|Protocol deviation|1
2242446|NCT01948830|3900992|FG001|Overall Study|Protocol deviation|2
2242447|NCT01948830|3900991|FG000|Overall Study|Lost to Follow-up|5
2242448|NCT01948830|3900992|FG001|Overall Study|Lost to Follow-up|4
2242449|NCT01948830|3900991|FG000|Overall Study|Withdrawal by Subject|14
2242450|NCT01948830|3900992|FG001|Overall Study|Withdrawal by Subject|17
2242451|NCT01948830|3900991|FG000|Overall Study|Adverse Event|9
2242452|NCT01948830|3900992|FG001|Overall Study|Adverse Event|2
2242453|NCT01948830|3900991|FG000|Overall Study|Death|3
2242454|NCT01948830|3900992|FG001|Overall Study|Death|4
2242455|NCT01948908|3901001|FG000|Overall Study|Protocol Violation|1
2242456|NCT01948908|3901002|FG001|Overall Study|Protocol Violation|0
2242457|NCT01948908|3901003|FG002|Overall Study|Protocol Violation|2
2242458|NCT01949051|3901041|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1
2242459|NCT01949051|3901042|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0
2242460|NCT01949051|3901043|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0
2242461|NCT01949051|3901044|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1
2242462|NCT01949051|3901045|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0
2242463|NCT01949051|3901046|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0
2337872|NCT03334396|4066132|FG001|Overall Study|Adverse Event|0
2337873|NCT03334396|4066133|FG002|Overall Study|Adverse Event|1
2337874|NCT03334396|4066134|FG003|Overall Study|Adverse Event|0
2337875|NCT03334396|4066135|FG004|Overall Study|Adverse Event|0
2337876|NCT03334396|4066136|FG005|Overall Study|Adverse Event|0
2337877|NCT03334396|4066137|FG006|Overall Study|Adverse Event|0
2337878|NCT03334396|4066138|FG007|Overall Study|Adverse Event|0
2337879|NCT03334396|4066131|FG000|Overall Study|Lack of Efficacy|10
2337880|NCT03334396|4066132|FG001|Overall Study|Lack of Efficacy|4
2337881|NCT03334396|4066133|FG002|Overall Study|Lack of Efficacy|1
2337882|NCT03334396|4066134|FG003|Overall Study|Lack of Efficacy|3
2337883|NCT03334396|4066135|FG004|Overall Study|Lack of Efficacy|1
2337884|NCT03334396|4066136|FG005|Overall Study|Lack of Efficacy|0
2337885|NCT03334396|4066137|FG006|Overall Study|Lack of Efficacy|0
2337886|NCT03334396|4066138|FG007|Overall Study|Lack of Efficacy|1
2337887|NCT03334396|4066131|FG000|Overall Study|Lost to Follow-up|0
2337888|NCT03334396|4066132|FG001|Overall Study|Lost to Follow-up|0
2337889|NCT03334396|4066133|FG002|Overall Study|Lost to Follow-up|1
2337890|NCT03334396|4066134|FG003|Overall Study|Lost to Follow-up|0
2337891|NCT03334396|4066135|FG004|Overall Study|Lost to Follow-up|0
2337892|NCT03334396|4066136|FG005|Overall Study|Lost to Follow-up|0
2337893|NCT03334396|4066137|FG006|Overall Study|Lost to Follow-up|1
2337894|NCT03334396|4066138|FG007|Overall Study|Lost to Follow-up|0
2337895|NCT03334396|4066131|FG000|Overall Study|Physician Decision|1
2337896|NCT03334396|4066132|FG001|Overall Study|Physician Decision|0
2337897|NCT03334396|4066133|FG002|Overall Study|Physician Decision|0
2337898|NCT03334396|4066134|FG003|Overall Study|Physician Decision|0
2337899|NCT03334396|4066135|FG004|Overall Study|Physician Decision|0
2337900|NCT03334396|4066136|FG005|Overall Study|Physician Decision|0
2337901|NCT03334396|4066137|FG006|Overall Study|Physician Decision|0
2337902|NCT03334396|4066138|FG007|Overall Study|Physician Decision|0
2337903|NCT03334396|4066131|FG000|Overall Study|Withdrawal by Subject|10
2337904|NCT03334396|4066132|FG001|Overall Study|Withdrawal by Subject|5
2337905|NCT03334396|4066133|FG002|Overall Study|Withdrawal by Subject|7
2337906|NCT03334396|4066134|FG003|Overall Study|Withdrawal by Subject|2
2337907|NCT03334396|4066135|FG004|Overall Study|Withdrawal by Subject|2
2337908|NCT03334396|4066136|FG005|Overall Study|Withdrawal by Subject|1
2242464|NCT01949051|3901041|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1
2242465|NCT01949051|3901042|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2242466|NCT01949051|3901043|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2337909|NCT03334396|4066137|FG006|Overall Study|Withdrawal by Subject|2
2242467|NCT01949051|3901044|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2242468|NCT01949051|3901045|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2242469|NCT01949051|3901046|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2242470|NCT01949051|3901041|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0
2242471|NCT01949051|3901042|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0
2242472|NCT01949051|3901043|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0
2242473|NCT01949051|3901044|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0
2242474|NCT01949051|3901045|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0
2242475|NCT01949051|3901046|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1
2242476|NCT01949051|3901041|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2242477|NCT01949051|3901042|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1
2242478|NCT01949051|3901043|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2242479|NCT01949051|3901044|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2242480|NCT01949051|3901045|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2242481|NCT01949051|3901046|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2242482|NCT01949051|3901041|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2242483|NCT01949051|3901042|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2242484|NCT01949051|3901043|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
2242485|NCT01949051|3901044|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2242486|NCT01949051|3901045|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2242487|NCT01949051|3901046|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2242488|NCT01949090|3901059|FG000|Overall Study|Serious Adverse Event|0
2242489|NCT01949090|3901060|FG001|Overall Study|Serious Adverse Event|1
2242490|NCT01949090|3901061|FG002|Overall Study|Serious Adverse Event|2
2242491|NCT01949090|3901062|FG003|Overall Study|Serious Adverse Event|0
2242492|NCT01949090|3901063|FG004|Overall Study|Serious Adverse Event|1
2242493|NCT01949090|3901059|FG000|Overall Study|Withdrawal by Subject|2
2242494|NCT01949090|3901060|FG001|Overall Study|Withdrawal by Subject|0
2242495|NCT01949090|3901061|FG002|Overall Study|Withdrawal by Subject|0
2242496|NCT01949090|3901062|FG003|Overall Study|Withdrawal by Subject|0
2242497|NCT01949090|3901063|FG004|Overall Study|Withdrawal by Subject|1
2242498|NCT01949090|3901059|FG000|Overall Study|Protocol non-compliance|0
2242499|NCT01949090|3901060|FG001|Overall Study|Protocol non-compliance|0
2242500|NCT01949090|3901061|FG002|Overall Study|Protocol non-compliance|0
2242501|NCT01949090|3901062|FG003|Overall Study|Protocol non-compliance|0
2242502|NCT01949090|3901063|FG004|Overall Study|Protocol non-compliance|1
2242503|NCT01949090|3901059|FG000|Overall Study|Lost to Follow-up|2
2242504|NCT01949090|3901060|FG001|Overall Study|Lost to Follow-up|1
2242505|NCT01949090|3901061|FG002|Overall Study|Lost to Follow-up|0
2242506|NCT01949090|3901062|FG003|Overall Study|Lost to Follow-up|1
2242507|NCT01949090|3901063|FG004|Overall Study|Lost to Follow-up|1
2242508|NCT01949116|3901078|FG000|Overall Study|Death|2
2242509|NCT01949116|3901079|FG001|Overall Study|Death|0
2242510|NCT01949116|3901078|FG000|Overall Study|Lost to Follow-up|1
2337910|NCT03334396|4066138|FG007|Overall Study|Withdrawal by Subject|0
2337911|NCT03334396|4066131|FG000|Overall Study|Pregnancy|0
2337912|NCT03334396|4066132|FG001|Overall Study|Pregnancy|1
2337913|NCT03334396|4066133|FG002|Overall Study|Pregnancy|0
2337914|NCT03334396|4066134|FG003|Overall Study|Pregnancy|0
2337915|NCT03334396|4066135|FG004|Overall Study|Pregnancy|0
2337916|NCT03334396|4066136|FG005|Overall Study|Pregnancy|0
2337917|NCT03334396|4066137|FG006|Overall Study|Pregnancy|0
2337918|NCT03334396|4066138|FG007|Overall Study|Pregnancy|0
2337919|NCT03334396|4066131|FG000|Overall Study|Ineligible|0
2337920|NCT03334396|4066132|FG001|Overall Study|Ineligible|1
2337921|NCT03334396|4066133|FG002|Overall Study|Ineligible|0
2337922|NCT03334396|4066134|FG003|Overall Study|Ineligible|0
2337923|NCT03334396|4066135|FG004|Overall Study|Ineligible|0
2337924|NCT03334396|4066136|FG005|Overall Study|Ineligible|0
2337925|NCT03334396|4066137|FG006|Overall Study|Ineligible|0
2337926|NCT03334396|4066138|FG007|Overall Study|Ineligible|0
2337927|NCT03334396|4066131|FG000|Overall Study|Started New Job|1
2337928|NCT03334396|4066132|FG001|Overall Study|Started New Job|0
2337929|NCT03334396|4066133|FG002|Overall Study|Started New Job|0
2337930|NCT03334396|4066134|FG003|Overall Study|Started New Job|0
2337931|NCT03334396|4066135|FG004|Overall Study|Started New Job|0
2337932|NCT03334396|4066136|FG005|Overall Study|Started New Job|0
2337933|NCT03334396|4066137|FG006|Overall Study|Started New Job|0
2337934|NCT03334396|4066138|FG007|Overall Study|Started New Job|0
2337935|NCT03334422|4066159|FG000|Overall Study|Adverse Event|1
2337936|NCT03334422|4066160|FG001|Overall Study|Adverse Event|3
2337937|NCT03334422|4066161|FG002|Overall Study|Adverse Event|2
2337938|NCT03334422|4066162|FG003|Overall Study|Adverse Event|2
2337939|NCT03334422|4066159|FG000|Overall Study|Lack of Efficacy|10
2337940|NCT03334422|4066160|FG001|Overall Study|Lack of Efficacy|2
2337941|NCT03334422|4066161|FG002|Overall Study|Lack of Efficacy|7
2337942|NCT03334422|4066162|FG003|Overall Study|Lack of Efficacy|3
2337943|NCT03334422|4066159|FG000|Overall Study|Withdrawal by Subject|8
2337944|NCT03334422|4066160|FG001|Overall Study|Withdrawal by Subject|3
2337945|NCT03334422|4066161|FG002|Overall Study|Withdrawal by Subject|1
2337946|NCT03334422|4066162|FG003|Overall Study|Withdrawal by Subject|0
2337947|NCT03334422|4066159|FG000|Overall Study|Lost to Follow-up|0
2337948|NCT03334422|4066160|FG001|Overall Study|Lost to Follow-up|0
2337949|NCT03334422|4066161|FG002|Overall Study|Lost to Follow-up|0
2242511|NCT01949116|3901079|FG001|Overall Study|Lost to Follow-up|3
2242512|NCT01949116|3901078|FG000|Overall Study|Withdrawal by Subject|5
2242513|NCT01949116|3901079|FG001|Overall Study|Withdrawal by Subject|3
2242514|NCT01949142|3901091|FG000|Overall Study|Withdrawal of consent|1
2242515|NCT01949142|3901092|FG001|Overall Study|Withdrawal of consent|0
2242516|NCT01949142|3901091|FG000|Overall Study|Lost to Follow-up|1
2242517|NCT01949142|3901092|FG001|Overall Study|Lost to Follow-up|1
2242518|NCT01949142|3901091|FG000|Overall Study|Parent changed their mind|1
2242519|NCT01949142|3901092|FG001|Overall Study|Parent changed their mind|0
2242520|NCT01949155|3901101|FG000|Overall Study|Lost to Follow-up|1
2337950|NCT03334422|4066162|FG003|Overall Study|Lost to Follow-up|1
2337951|NCT03334422|4066159|FG000|Overall Study|Inability to obtain laboratory samples|0
2337952|NCT03334422|4066160|FG001|Overall Study|Inability to obtain laboratory samples|1
2337953|NCT03334422|4066161|FG002|Overall Study|Inability to obtain laboratory samples|0
2337954|NCT03334422|4066162|FG003|Overall Study|Inability to obtain laboratory samples|0
2337955|NCT03334422|4066159|FG000|Overall Study|Pregnancy|0
2337956|NCT03334422|4066160|FG001|Overall Study|Pregnancy|1
2337957|NCT03334422|4066161|FG002|Overall Study|Pregnancy|0
2337958|NCT03334422|4066162|FG003|Overall Study|Pregnancy|0
2337959|NCT03334448|4066177|FG000|Washout|Personal Reason|0
2337960|NCT03334448|4066178|FG001|Washout|Personal Reason|1
2337961|NCT03334448|4066179|FG002|Washout|Personal Reason|0
2337962|NCT03334448|4066180|FG003|Washout|Personal Reason|0
2337963|NCT03334448|4066177|FG000|Washout|Protocol Violation|0
2337964|NCT03334448|4066178|FG001|Washout|Protocol Violation|0
2337965|NCT03334448|4066179|FG002|Washout|Protocol Violation|0
2037493|NCT00418886|3607874|FG001|Overall Study|withdrawn due to other reason|0
2037494|NCT00418886|3607873|FG000|Overall Study|randomised but no treatment received|0
2037495|NCT00418886|3607874|FG001|Overall Study|randomised but no treatment received|1
2037496|NCT00418938|3607882|FG000|Overall Study|Reimbursement|1
2037497|NCT00418938|3607883|FG001|Overall Study|Reimbursement|0
2037498|NCT00418938|3607882|FG000|Overall Study|Administrative decision|3
2037499|NCT00418938|3607883|FG001|Overall Study|Administrative decision|3
2037500|NCT00418938|3607882|FG000|Overall Study|Withdrawal by Subject|16
2037501|NCT00418938|3607883|FG001|Overall Study|Withdrawal by Subject|15
2037502|NCT00418938|3607882|FG000|Overall Study|Lost to Follow-up|1
2037503|NCT00418938|3607883|FG001|Overall Study|Lost to Follow-up|3
2037504|NCT00418938|3607882|FG000|Overall Study|Adverse Event|1
2037505|NCT00418938|3607883|FG001|Overall Study|Adverse Event|1
2037506|NCT00418938|3607882|FG000|Overall Study|On-going|1
2037507|NCT00418938|3607883|FG001|Overall Study|On-going|1
2037508|NCT00418938|3607882|FG000|Overall Study|Ineligibility Determined|1
2037509|NCT00418938|3607883|FG001|Overall Study|Ineligibility Determined|0
2195807|NCT01526148|3828474|FG000|Overall Study|Adverse Event|6
2195808|NCT01526148|3828475|FG001|Overall Study|Adverse Event|5
2195809|NCT01526148|3828474|FG000|Overall Study|Lost to Follow-up|3
2195810|NCT01526148|3828475|FG001|Overall Study|Lost to Follow-up|6
2195811|NCT01526148|3828474|FG000|Overall Study|Withdrawal by Subject|2
2195812|NCT01526148|3828475|FG001|Overall Study|Withdrawal by Subject|0
2195813|NCT01526148|3828474|FG000|Overall Study|Unstable Medical Condition|1
2195814|NCT01526148|3828475|FG001|Overall Study|Unstable Medical Condition|0
2195815|NCT01526148|3828474|FG000|Overall Study|Unable to discontinue concomitant med|1
2195816|NCT01526148|3828475|FG001|Overall Study|Unable to discontinue concomitant med|0
2195817|NCT01526148|3828474|FG000|Overall Study|Moved out of state|1
2195818|NCT01526148|3828475|FG001|Overall Study|Moved out of state|0
2195819|NCT01526148|3828474|FG000|Overall Study|Incarcerated|0
2195820|NCT01526148|3828475|FG001|Overall Study|Incarcerated|2
2195821|NCT01526551|3828533|FG000|Overall Study|Lack of returned parental consent form|424
2195822|NCT01526733|3828558|FG000|Phase 1|Protocol Violation|1
2195823|NCT01526733|3828559|FG001|Phase 1|Protocol Violation|0
2195824|NCT01526733|3828558|FG000|Phase 1|Withdrawal by Subject|1
2195825|NCT01526733|3828559|FG001|Phase 1|Withdrawal by Subject|1
2195826|NCT01526785|3828566|FG000|Overall Study|Study Terminated by Sponsor|8
2195827|NCT01526785|3828566|FG000|Overall Study|Death|2
2195828|NCT01526785|3828566|FG000|Overall Study|Physician Decision|1
2195829|NCT01526785|3828566|FG000|Overall Study|Withdrawal by Subject|2
2195830|NCT01526889|3828572|FG000|Treatment Period|Adverse Event|2
2195831|NCT01526889|3828573|FG001|Treatment Period|Adverse Event|0
2195832|NCT01526889|3828572|FG000|Treatment Extension Period|Administrative problems|1
2195833|NCT01526889|3828573|FG001|Treatment Extension Period|Administrative problems|0
2195834|NCT01526928|3828592|FG000|Overall Study|Progressive Disease|35
2195835|NCT01526928|3828593|FG001|Overall Study|Progressive Disease|17
2195836|NCT01526928|3828594|FG002|Overall Study|Progressive Disease|150
2195837|NCT01526928|3828595|FG003|Overall Study|Progressive Disease|182
2195838|NCT01526928|3828596|FG004|Overall Study|Progressive Disease|76
2195839|NCT01526928|3828597|FG005|Overall Study|Progressive Disease|4
2195840|NCT01526928|3828592|FG000|Overall Study|Adverse Event|2
2195841|NCT01526928|3828593|FG001|Overall Study|Adverse Event|1
2195842|NCT01526928|3828594|FG002|Overall Study|Adverse Event|29
2195843|NCT01526928|3828595|FG003|Overall Study|Adverse Event|40
2195844|NCT01526928|3828596|FG004|Overall Study|Adverse Event|13
2195845|NCT01526928|3828597|FG005|Overall Study|Adverse Event|2
2195846|NCT01526928|3828592|FG000|Overall Study|Death|0
2242521|NCT01949155|3901102|FG001|Overall Study|Lost to Follow-up|0
2337966|NCT03334448|4066180|FG003|Washout|Protocol Violation|1
2242522|NCT01949155|3901101|FG000|Overall Study|Protocol Violation|1
2242523|NCT01949155|3901102|FG001|Overall Study|Protocol Violation|0
2242524|NCT01949480|3901124|FG000|Overall Study|Physician Decision|5
2242525|NCT01949480|3901125|FG001|Overall Study|Physician Decision|8
2242526|NCT01949532|3901133|FG000|Overall Study|On-study at the Data Cut-off Date|3
2242527|NCT01949532|3901134|FG001|Overall Study|On-study at the Data Cut-off Date|3
2242528|NCT01949662|3901159|FG000|Overall Study|Death|9
2242529|NCT01949662|3901160|FG001|Overall Study|Death|7
2242530|NCT01949662|3901159|FG000|Overall Study|Discharged before an agitation event|8
2242531|NCT01949662|3901160|FG001|Overall Study|Discharged before an agitation event|3
2242532|NCT01949662|3901159|FG000|Overall Study|Dropped out|1
2242533|NCT01949662|3901160|FG001|Overall Study|Dropped out|3
2242534|NCT01949662|3901159|FG000|Overall Study|Ineligible|0
2242535|NCT01949662|3901160|FG001|Overall Study|Ineligible|1
2242536|NCT01949870|3901174|FG000|Overall Study|Lack of Efficacy|2
2242537|NCT01949870|3901174|FG000|Overall Study|Adverse Event|1
2242538|NCT01949870|3901174|FG000|Overall Study|Study termination|1
2242539|NCT01949870|3901174|FG000|Overall Study|Eligibility requirements not fulfilled|2
2242540|NCT01950013|3901181|FG000|Overall Study|Withdrawal by Subject|0
2242541|NCT01950013|3901182|FG001|Overall Study|Withdrawal by Subject|2
2242542|NCT01950013|3901183|FG002|Overall Study|Withdrawal by Subject|0
2242543|NCT01950169|3901212|FG000|Overall Study|Withdrawal by Subject|2
2242544|NCT01950169|3901213|FG001|Overall Study|Withdrawal by Subject|8
2242545|NCT01950169|3901214|FG002|Overall Study|Withdrawal by Subject|1
2242546|NCT01950169|3901212|FG000|Overall Study|Death|1
2242547|NCT01950169|3901213|FG001|Overall Study|Death|0
2242548|NCT01950169|3901214|FG002|Overall Study|Death|0
2242549|NCT01950273|3901234|FG000|Overall Study|Protocol Violation|1
2242550|NCT01950273|3901235|FG001|Overall Study|Protocol Violation|0
2242551|NCT01950273|3901234|FG000|Overall Study|Withdrawal by Subject|2
2242552|NCT01950273|3901235|FG001|Overall Study|Withdrawal by Subject|0
2242553|NCT01950273|3901234|FG000|Overall Study|Other not defined above|1
2242554|NCT01950273|3901235|FG001|Overall Study|Other not defined above|0
2242555|NCT01950364|3901256|FG000|Overall Study|Adverse Event|3
2242556|NCT01950364|3901257|FG001|Overall Study|Adverse Event|0
2242557|NCT01950364|3901256|FG000|Overall Study|Stem Cell Transplant|2
2242558|NCT01950364|3901257|FG001|Overall Study|Stem Cell Transplant|6
2242559|NCT01950364|3901256|FG000|Overall Study|Disease Progression|5
2242560|NCT01950364|3901257|FG001|Overall Study|Disease Progression|2
2242561|NCT01950364|3901256|FG000|Overall Study|Withdrawal by Subject|0
2242562|NCT01950364|3901257|FG001|Overall Study|Withdrawal by Subject|1
2242563|NCT01950364|3901256|FG000|Overall Study|Protocol Violation|0
2242564|NCT01950364|3901257|FG001|Overall Study|Protocol Violation|1
2242565|NCT01950741|3901267|FG000|Overall Study|Lost to Follow-up|1
2242566|NCT01950741|3901267|FG000|Overall Study|Death|1
2242567|NCT01950741|3901267|FG000|Overall Study|Withdrawal by Subject|1
2337967|NCT03334630|4066188|FG000|Overall Study|Withdrawal by Subject|7
2337968|NCT03334630|4066189|FG001|Overall Study|Withdrawal by Subject|7
2337969|NCT03334630|4066188|FG000|Overall Study|Lost to Follow-up|3
2337970|NCT03334630|4066189|FG001|Overall Study|Lost to Follow-up|1
2337971|NCT03334630|4066188|FG000|Overall Study|Adverse Event|0
2337972|NCT03334630|4066189|FG001|Overall Study|Adverse Event|1
2337973|NCT03334630|4066188|FG000|Overall Study|Physician Decision|1
2337974|NCT03334630|4066189|FG001|Overall Study|Physician Decision|1
2337975|NCT03334630|4066188|FG000|Overall Study|Enrollment closed|2
2337976|NCT03334630|4066189|FG001|Overall Study|Enrollment closed|1
2337977|NCT03334630|4066188|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0
2337978|NCT03334630|4066189|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1
2337979|NCT03334630|4066188|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1
2337980|NCT03334630|4066189|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1
2337981|NCT03334695|4066197|FG000|Overall Study|Lost to Follow-up|3
2337982|NCT03334695|4066198|FG001|Overall Study|Lost to Follow-up|3
2337983|NCT03334695|4066197|FG000|Overall Study|Physician Decision|1
2337984|NCT03334695|4066198|FG001|Overall Study|Physician Decision|2
2337985|NCT03334695|4066197|FG000|Overall Study|Protocol Violation|0
2337986|NCT03334695|4066198|FG001|Overall Study|Protocol Violation|1
2337987|NCT03334721|4066208|FG000|Overall Study|Withdrawal by Subject|1
2337988|NCT03334721|4066209|FG001|Overall Study|Withdrawal by Subject|0
2337989|NCT03334721|4066208|FG000|Overall Study|No longer met inclusion/exclusion criter|1
2337990|NCT03334721|4066209|FG001|Overall Study|No longer met inclusion/exclusion criter|0
2337991|NCT03334747|4066241|FG000|Treatment Phase|Technical problems|0
2337992|NCT03334747|4066242|FG001|Treatment Phase|Technical problems|0
2337993|NCT03334747|4066243|FG002|Treatment Phase|Technical problems|0
2337994|NCT03334747|4066244|FG003|Treatment Phase|Technical problems|0
2337995|NCT03334747|4066245|FG004|Treatment Phase|Technical problems|1
2337996|NCT03334747|4066246|FG005|Treatment Phase|Technical problems|0
2337997|NCT03334747|4066247|FG006|Treatment Phase|Technical problems|0
2337998|NCT03334747|4066248|FG007|Treatment Phase|Technical problems|0
2337999|NCT03334747|4066249|FG008|Treatment Phase|Technical problems|0
2338000|NCT03334747|4066241|FG000|Treatment Phase|Subject/guardian decision|1
2338001|NCT03334747|4066242|FG001|Treatment Phase|Subject/guardian decision|0
2338002|NCT03334747|4066243|FG002|Treatment Phase|Subject/guardian decision|0
2338003|NCT03334747|4066244|FG003|Treatment Phase|Subject/guardian decision|0
2242568|NCT01950819|3901278|FG000|Overall Study|Graft Loss|35
2242569|NCT01950819|3901279|FG001|Overall Study|Graft Loss|30
2242570|NCT01950819|3901278|FG000|Overall Study|Death|29
2242571|NCT01950819|3901279|FG001|Overall Study|Death|34
2242572|NCT01950819|3901278|FG000|Overall Study|Subject / Gardian decision|54
2242573|NCT01950819|3901279|FG001|Overall Study|Subject / Gardian decision|51
2242574|NCT01950819|3901278|FG000|Overall Study|technical problems|2
2242575|NCT01950819|3901279|FG001|Overall Study|technical problems|0
2242576|NCT01950819|3901278|FG000|Overall Study|Pregnancy|0
2242577|NCT01950819|3901279|FG001|Overall Study|Pregnancy|2
2242578|NCT01950819|3901278|FG000|Overall Study|Lost to Follow-up|9
2242579|NCT01950819|3901279|FG001|Overall Study|Lost to Follow-up|17
2242580|NCT01951092|3901291|FG000|Overall Study|Lost to Follow-up|10
2242581|NCT01951092|3901291|FG000|Overall Study|Incarceration|1
2338004|NCT03334747|4066245|FG004|Treatment Phase|Subject/guardian decision|0
2338005|NCT03334747|4066246|FG005|Treatment Phase|Subject/guardian decision|1
2338006|NCT03334747|4066247|FG006|Treatment Phase|Subject/guardian decision|0
2338007|NCT03334747|4066248|FG007|Treatment Phase|Subject/guardian decision|0
2338008|NCT03334747|4066249|FG008|Treatment Phase|Subject/guardian decision|0
2338009|NCT03334747|4066241|FG000|Follow-Up Phase|Subject/guardian decision|0
2338010|NCT03334747|4066242|FG001|Follow-Up Phase|Subject/guardian decision|0
2338011|NCT03334747|4066243|FG002|Follow-Up Phase|Subject/guardian decision|0
2338012|NCT03334747|4066244|FG003|Follow-Up Phase|Subject/guardian decision|0
2338013|NCT03334747|4066245|FG004|Follow-Up Phase|Subject/guardian decision|0
2338014|NCT03334747|4066246|FG005|Follow-Up Phase|Subject/guardian decision|0
2338015|NCT03334747|4066247|FG006|Follow-Up Phase|Subject/guardian decision|1
2338016|NCT03334747|4066248|FG007|Follow-Up Phase|Subject/guardian decision|0
2338017|NCT03334747|4066249|FG008|Follow-Up Phase|Subject/guardian decision|1
2338018|NCT03334903|4066291|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1
2338019|NCT03334903|4066292|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0
2338020|NCT03334903|4066291|FG000|Overall Study|Protocol Violation|1
2338021|NCT03334903|4066292|FG001|Overall Study|Protocol Violation|3
2338022|NCT03334903|4066291|FG000|Overall Study|Surgery postponed|1
2338023|NCT03334903|4066292|FG001|Overall Study|Surgery postponed|0
2338024|NCT03334903|4066291|FG000|Overall Study|Adverse Event|1
2338025|NCT03334903|4066292|FG001|Overall Study|Adverse Event|1
2338026|NCT03334903|4066291|FG000|Overall Study|Withdrawal by Subject|0
2338027|NCT03334903|4066292|FG001|Overall Study|Withdrawal by Subject|1
2338028|NCT03335150|4066300|FG000|Overall Study|Withdrawal by Subject|10
2338029|NCT03335150|4066301|FG001|Overall Study|Withdrawal by Subject|4
2338030|NCT03335150|4066300|FG000|Overall Study|Adverse Event|0
2338031|NCT03335150|4066301|FG001|Overall Study|Adverse Event|1
2338032|NCT03335566|4066377|FG000|Overall Study|Adverse Event|0
2338033|NCT03335566|4066378|FG001|Overall Study|Adverse Event|1
2338034|NCT03335566|4066377|FG000|Overall Study|Lost to Follow-up|1
2338035|NCT03335566|4066378|FG001|Overall Study|Lost to Follow-up|0
2037510|NCT00419003|3607926|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6
2037511|NCT00419003|3607927|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6
2037512|NCT00419003|3607926|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
2037513|NCT00419003|3607927|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
2037514|NCT00419094|3607938|FG000|Overall Study|Adverse Event|3
2037515|NCT00419094|3607939|FG001|Overall Study|Adverse Event|7
2037516|NCT00419094|3607938|FG000|Overall Study|Lack of Efficacy|1
2037517|NCT00419094|3607939|FG001|Overall Study|Lack of Efficacy|0
2037518|NCT00419094|3607938|FG000|Overall Study|Lost to Follow-up|0
2037519|NCT00419094|3607939|FG001|Overall Study|Lost to Follow-up|2
2037520|NCT00419094|3607938|FG000|Overall Study|Protocol Violation|1
2037521|NCT00419094|3607939|FG001|Overall Study|Protocol Violation|14
2037522|NCT00419094|3607938|FG000|Overall Study|Withdrawal of consent|1
2037523|NCT00419094|3607939|FG001|Overall Study|Withdrawal of consent|5
2037524|NCT00419094|3607938|FG000|Overall Study|Other: Error determining exit criteria|1
2037525|NCT00419094|3607939|FG001|Overall Study|Other: Error determining exit criteria|0
2037526|NCT00419094|3607938|FG000|Overall Study|Other: Patient non-compliant|0
2037527|NCT00419094|3607939|FG001|Overall Study|Other: Patient non-compliant|1
2037528|NCT00419094|3607938|FG000|Overall Study|Other: No contact for extended period|0
2037529|NCT00419094|3607939|FG001|Overall Study|Other: No contact for extended period|1
2037530|NCT00419120|3607945|FG000|Long Term Follow up Period|study ongoing|10
2037531|NCT00419159|3607951|FG000|Overall Study|Adverse Event|7
2037532|NCT00419159|3607952|FG001|Overall Study|Adverse Event|15
2037533|NCT00419159|3607951|FG000|Overall Study|Abnormal laboratory value(s)|0
2037534|NCT00419159|3607952|FG001|Overall Study|Abnormal laboratory value(s)|2
2037535|NCT00419159|3607951|FG000|Overall Study|Subject's no longer requires study drug|0
2037536|NCT00419159|3607952|FG001|Overall Study|Subject's no longer requires study drug|1
2037537|NCT00419159|3607951|FG000|Overall Study|Protocol Violation|1
2037538|NCT00419159|3607952|FG001|Overall Study|Protocol Violation|0
2037539|NCT00419159|3607951|FG000|Overall Study|Withdrawal by Subject|10
2037540|NCT00419159|3607952|FG001|Overall Study|Withdrawal by Subject|3
2037541|NCT00419159|3607951|FG000|Overall Study|Lost to Follow-up|0
2242582|NCT01951092|3901291|FG000|Overall Study|Transfer of Care|1
2242583|NCT01951105|3901298|FG000|Overall Study|Adverse Event|0
2242584|NCT01951105|3901299|FG001|Overall Study|Adverse Event|5
2242585|NCT01951105|3901300|FG002|Overall Study|Adverse Event|0
2242586|NCT01951105|3901298|FG000|Overall Study|Lost to Follow-up|0
2242587|NCT01951105|3901299|FG001|Overall Study|Lost to Follow-up|1
2242588|NCT01951105|3901300|FG002|Overall Study|Lost to Follow-up|0
2242589|NCT01951105|3901298|FG000|Overall Study|Protocol Violation|1
2242590|NCT01951105|3901299|FG001|Overall Study|Protocol Violation|1
2242591|NCT01951105|3901300|FG002|Overall Study|Protocol Violation|1
2242592|NCT01951105|3901298|FG000|Overall Study|Withdrawal by Subject|0
2242593|NCT01951105|3901299|FG001|Overall Study|Withdrawal by Subject|3
2242594|NCT01951105|3901300|FG002|Overall Study|Withdrawal by Subject|1
2242595|NCT01951157|3901326|FG000|Overall Study|Progressive Disease|12
2242596|NCT01951157|3901327|FG001|Overall Study|Progressive Disease|13
2242597|NCT01951157|3901328|FG002|Overall Study|Progressive Disease|10
2242598|NCT01951157|3901326|FG000|Overall Study|Treatment-unrelated AE|1
2242599|NCT01951157|3901327|FG001|Overall Study|Treatment-unrelated AE|0
2242600|NCT01951157|3901328|FG002|Overall Study|Treatment-unrelated AE|3
2242601|NCT01951157|3901326|FG000|Overall Study|Study Termination|0
2242602|NCT01951157|3901327|FG001|Overall Study|Study Termination|0
2242603|NCT01951157|3901328|FG002|Overall Study|Study Termination|1
2242604|NCT01951157|3901326|FG000|Overall Study|Physician Decision|5
2242605|NCT01951157|3901327|FG001|Overall Study|Physician Decision|3
2242606|NCT01951157|3901328|FG002|Overall Study|Physician Decision|2
2242607|NCT01951157|3901326|FG000|Overall Study|Non-treatmentrelated death|2
2242608|NCT01951157|3901327|FG001|Overall Study|Non-treatmentrelated death|2
2242609|NCT01951157|3901328|FG002|Overall Study|Non-treatmentrelated death|2
2242610|NCT01951157|3901326|FG000|Overall Study|No treated|0
2242611|NCT01951157|3901327|FG001|Overall Study|No treated|1
2242612|NCT01951157|3901328|FG002|Overall Study|No treated|0
2242613|NCT01951157|3901326|FG000|Overall Study|Treatment-related AE|2
2242614|NCT01951157|3901327|FG001|Overall Study|Treatment-related AE|0
2242615|NCT01951157|3901328|FG002|Overall Study|Treatment-related AE|4
2242616|NCT01951157|3901326|FG000|Overall Study|Consent withdrawn by subject|0
2242617|NCT01951157|3901327|FG001|Overall Study|Consent withdrawn by subject|1
2242618|NCT01951157|3901328|FG002|Overall Study|Consent withdrawn by subject|3
2242619|NCT01951157|3901326|FG000|Overall Study|Treatment-related death|0
2242620|NCT01951157|3901327|FG001|Overall Study|Treatment-related death|2
2242621|NCT01951157|3901328|FG002|Overall Study|Treatment-related death|0
2242622|NCT01951170|3901337|FG000|Overall Study|Investigator decision|1
2242623|NCT01951261|3901343|FG000|Overall Study|Death|1
2242624|NCT01951261|3901344|FG001|Overall Study|Death|0
2242625|NCT01951261|3901343|FG000|Overall Study|Lost to Follow-up|4
2242626|NCT01951261|3901344|FG001|Overall Study|Lost to Follow-up|3
2242627|NCT01951261|3901343|FG000|Overall Study|Protocol Violation|4
2242628|NCT01951261|3901344|FG001|Overall Study|Protocol Violation|3
2242629|NCT01951417|3901384|FG000|Overall Study|Withdrawal by Subject|1
2242630|NCT01951417|3901384|FG000|Overall Study|Protocol Violation|2
2242631|NCT01951417|3901384|FG000|Overall Study|Lost to Follow-up|6
2242632|NCT01951573|3901392|FG000|Washout Period|Adverse Event|0
2242633|NCT01951573|3901393|FG001|Washout Period|Adverse Event|1
2242634|NCT01951586|3901401|FG000|Overall Study|Death|61
2242635|NCT01951586|3901402|FG001|Overall Study|Death|120
2242636|NCT01951586|3901401|FG000|Overall Study|Withdrawal by Subject|8
2242637|NCT01951586|3901402|FG001|Overall Study|Withdrawal by Subject|17
2242638|NCT01951586|3901401|FG000|Overall Study|Lost to Follow-up|0
2242639|NCT01951586|3901402|FG001|Overall Study|Lost to Follow-up|1
2242640|NCT01951586|3901401|FG000|Overall Study|Sponsor Decision|9
2242641|NCT01951586|3901402|FG001|Overall Study|Sponsor Decision|10
2242642|NCT01951625|3901414|FG000|Treatment Period|Protocol Violation|2
2242643|NCT01951625|3901415|FG001|Treatment Period|Protocol Violation|0
2242644|NCT01951625|3901416|FG002|Treatment Period|Protocol Violation|1
2242645|NCT01951625|3901417|FG003|Treatment Period|Protocol Violation|3
2242646|NCT01951625|3901418|FG004|Treatment Period|Protocol Violation|2
2242647|NCT01951625|3901414|FG000|Treatment Period|Physician Decision|0
2242648|NCT01951625|3901415|FG001|Treatment Period|Physician Decision|0
2242649|NCT01951625|3901416|FG002|Treatment Period|Physician Decision|0
2242650|NCT01951625|3901417|FG003|Treatment Period|Physician Decision|0
2242651|NCT01951625|3901418|FG004|Treatment Period|Physician Decision|1
2242652|NCT01951625|3901414|FG000|Treatment Period|Protocol driven decision point|0
2242653|NCT01951625|3901415|FG001|Treatment Period|Protocol driven decision point|5
2242654|NCT01951625|3901416|FG002|Treatment Period|Protocol driven decision point|0
2242655|NCT01951625|3901417|FG003|Treatment Period|Protocol driven decision point|2
2242656|NCT01951625|3901418|FG004|Treatment Period|Protocol driven decision point|1
2242657|NCT01951625|3901414|FG000|Treatment Period|Non compliance with study drug|1
2242658|NCT01951625|3901415|FG001|Treatment Period|Non compliance with study drug|2
2242659|NCT01951625|3901416|FG002|Treatment Period|Non compliance with study drug|2
2242660|NCT01951625|3901417|FG003|Treatment Period|Non compliance with study drug|0
2242661|NCT01951625|3901418|FG004|Treatment Period|Non compliance with study drug|0
2242662|NCT01951625|3901414|FG000|Treatment Period|Death|3
2242663|NCT01951625|3901415|FG001|Treatment Period|Death|2
2242664|NCT01951625|3901416|FG002|Treatment Period|Death|2
2242665|NCT01951625|3901417|FG003|Treatment Period|Death|1
2242666|NCT01951625|3901418|FG004|Treatment Period|Death|2
2242667|NCT01951625|3901414|FG000|Treatment Period|Adverse Event|7
2242668|NCT01951625|3901415|FG001|Treatment Period|Adverse Event|10
2242669|NCT01951625|3901416|FG002|Treatment Period|Adverse Event|9
2242670|NCT01951625|3901417|FG003|Treatment Period|Adverse Event|8
2242671|NCT01951625|3901418|FG004|Treatment Period|Adverse Event|8
2242672|NCT01951625|3901414|FG000|Treatment Period|Withdrawal by Subject|5
2242673|NCT01951625|3901415|FG001|Treatment Period|Withdrawal by Subject|2
2242674|NCT01951625|3901416|FG002|Treatment Period|Withdrawal by Subject|1
2242675|NCT01951625|3901417|FG003|Treatment Period|Withdrawal by Subject|7
2242676|NCT01951625|3901418|FG004|Treatment Period|Withdrawal by Subject|3
2242677|NCT01951625|3901414|FG000|Treatment Period|Lost to Follow-up|1
2242678|NCT01951625|3901415|FG001|Treatment Period|Lost to Follow-up|0
2242679|NCT01951625|3901416|FG002|Treatment Period|Lost to Follow-up|0
2242680|NCT01951625|3901417|FG003|Treatment Period|Lost to Follow-up|1
2338036|NCT03335566|4066377|FG000|Overall Study|Technical Problems|1
2338037|NCT03335566|4066378|FG001|Overall Study|Technical Problems|0
2338038|NCT03335566|4066377|FG000|Overall Study|Protocol Violation|1
2338039|NCT03335566|4066378|FG001|Overall Study|Protocol Violation|0
2338040|NCT03335566|4066377|FG000|Overall Study|Other than specified above|1
2338041|NCT03335566|4066378|FG001|Overall Study|Other than specified above|2
2338042|NCT03336502|4066407|FG000|Overall Study|Physician Decision|0
2338043|NCT03336502|4066408|FG001|Overall Study|Physician Decision|1
2338044|NCT03336502|4066407|FG000|Overall Study|Prohibited Drugs|1
2338045|NCT03336502|4066408|FG001|Overall Study|Prohibited Drugs|1
2338046|NCT03336502|4066407|FG000|Overall Study|Death|1
2338047|NCT03336502|4066408|FG001|Overall Study|Death|2
2338048|NCT03336502|4066407|FG000|Overall Study|Adverse Event|2
2338049|NCT03336502|4066408|FG001|Overall Study|Adverse Event|5
2338050|NCT03337139|4066429|FG000|Phase I|Withdrawal by Subject|10
2338051|NCT03337139|4066430|FG001|Phase I|Withdrawal by Subject|0
2338052|NCT03337152|4066438|FG000|Overall Study|Physician Decision|1
2338053|NCT03337152|4066439|FG001|Overall Study|Physician Decision|0
2338054|NCT03337152|4066438|FG000|Overall Study|Lost to Follow-up|1
2338055|NCT03337152|4066439|FG001|Overall Study|Lost to Follow-up|3
2338056|NCT03337152|4066438|FG000|Overall Study|Adverse Event|3
2338057|NCT03337152|4066439|FG001|Overall Study|Adverse Event|1
2338058|NCT03337152|4066438|FG000|Overall Study|Stopped drug dosing due to study halt|6
2338059|NCT03337152|4066439|FG001|Overall Study|Stopped drug dosing due to study halt|7
2353011|NCT03571646|4103596|FG001|Overall Study|Adverse Event|0
2353012|NCT03571646|4103595|FG000|Overall Study|Withdrawal by Subject|1
2353013|NCT03571646|4103596|FG001|Overall Study|Withdrawal by Subject|1
2353014|NCT03543358|4103619|FG000|Overall Study|Death|1
2353015|NCT03543358|4103620|FG001|Overall Study|Death|0
2353016|NCT03543358|4103619|FG000|Overall Study|Disease Progression|1
2353017|NCT03543358|4103620|FG001|Overall Study|Disease Progression|0
2353018|NCT03543358|4103619|FG000|Overall Study|Parent Study Closure|1
2353019|NCT03543358|4103620|FG001|Overall Study|Parent Study Closure|0
2353020|NCT03509207|4103648|FG000|Overall Study|Death|2
2353021|NCT03500341|4103665|FG000|Overall Study|Withdrawn prior to Completion|2
2353022|NCT03500159|4103671|FG000|Overall Study|Study Terminated|2
2353023|NCT03500159|4103672|FG001|Overall Study|Study Terminated|1
2353024|NCT03477903|4103698|FG000|Overall Study|Study Terminated by Sponsor|1
2353025|NCT03469258|4103702|FG000|Overall Study|Upon surgery, did not meet criteria|4
2353026|NCT03466658|4103706|FG000|Overall Study|Withdrawal by Subject|3
2353027|NCT03465891|4103714|FG000|Overall Study|Withdrawal by Subject|0
2353028|NCT03465891|4103715|FG001|Overall Study|Withdrawal by Subject|1
2353029|NCT03465891|4103714|FG000|Overall Study|Disease progression|1
2353030|NCT03465891|4103715|FG001|Overall Study|Disease progression|0
2353031|NCT03387059|4103793|FG000|Overall Study|Study termination|5
2353032|NCT03387059|4103794|FG001|Overall Study|Study termination|4
2353033|NCT03379233|4103811|FG000|Overall Study|Technical issues with Concept 2 inhalers|1
2037542|NCT00419159|3607952|FG001|Overall Study|Lost to Follow-up|1
2037543|NCT00419159|3607951|FG000|Overall Study|Death|2
2037544|NCT00419159|3607952|FG001|Overall Study|Death|2
2037545|NCT00419159|3607951|FG000|Overall Study|Disease progression|79
2242681|NCT01951625|3901418|FG004|Treatment Period|Lost to Follow-up|0
2242682|NCT01951625|3901414|FG000|Follow Up Period|Non-compliance with study drug|1
2242683|NCT01951625|3901415|FG001|Follow Up Period|Non-compliance with study drug|0
2242684|NCT01951625|3901416|FG002|Follow Up Period|Non-compliance with study drug|0
2242685|NCT01951625|3901417|FG003|Follow Up Period|Non-compliance with study drug|0
2242686|NCT01951625|3901418|FG004|Follow Up Period|Non-compliance with study drug|0
2242687|NCT01951625|3901414|FG000|Follow Up Period|Death|1
2242688|NCT01951625|3901415|FG001|Follow Up Period|Death|3
2242689|NCT01951625|3901416|FG002|Follow Up Period|Death|2
2242690|NCT01951625|3901417|FG003|Follow Up Period|Death|2
2242691|NCT01951625|3901418|FG004|Follow Up Period|Death|1
2242692|NCT01951625|3901414|FG000|Follow Up Period|Logistical difficulties|1
2242693|NCT01951625|3901415|FG001|Follow Up Period|Logistical difficulties|2
2242694|NCT01951625|3901416|FG002|Follow Up Period|Logistical difficulties|0
2242695|NCT01951625|3901417|FG003|Follow Up Period|Logistical difficulties|0
2242696|NCT01951625|3901418|FG004|Follow Up Period|Logistical difficulties|0
2242697|NCT01951625|3901414|FG000|Follow Up Period|Adverse Event|0
2242698|NCT01951625|3901415|FG001|Follow Up Period|Adverse Event|3
2242699|NCT01951625|3901416|FG002|Follow Up Period|Adverse Event|2
2353034|NCT03379233|4103812|FG001|Overall Study|Technical issues with Concept 2 inhalers|6
2353035|NCT03361228|4103828|FG000|Overall Study|Other|1
2242700|NCT01951625|3901417|FG003|Follow Up Period|Adverse Event|3
2242701|NCT01951625|3901418|FG004|Follow Up Period|Adverse Event|5
2242702|NCT01951625|3901414|FG000|Follow Up Period|Withdrawal by Subject|4
2242703|NCT01951625|3901415|FG001|Follow Up Period|Withdrawal by Subject|1
2242704|NCT01951625|3901416|FG002|Follow Up Period|Withdrawal by Subject|0
2242705|NCT01951625|3901417|FG003|Follow Up Period|Withdrawal by Subject|5
2242706|NCT01951625|3901418|FG004|Follow Up Period|Withdrawal by Subject|3
2242707|NCT01951625|3901414|FG000|Follow Up Period|Lost to Follow-up|1
2242708|NCT01951625|3901415|FG001|Follow Up Period|Lost to Follow-up|0
2242709|NCT01951625|3901416|FG002|Follow Up Period|Lost to Follow-up|0
2242710|NCT01951625|3901417|FG003|Follow Up Period|Lost to Follow-up|1
2242711|NCT01951625|3901418|FG004|Follow Up Period|Lost to Follow-up|1
2242712|NCT01951638|3901436|FG000|Treatment Period|Protocol Violation|0
2242713|NCT01951638|3901437|FG001|Treatment Period|Protocol Violation|0
2242714|NCT01951638|3901438|FG002|Treatment Period|Protocol Violation|0
2242715|NCT01951638|3901439|FG003|Treatment Period|Protocol Violation|2
2242716|NCT01951638|3901440|FG004|Treatment Period|Protocol Violation|0
2242717|NCT01951638|3901436|FG000|Treatment Period|Protocol-driven decision point|1
2242718|NCT01951638|3901437|FG001|Treatment Period|Protocol-driven decision point|3
2242719|NCT01951638|3901438|FG002|Treatment Period|Protocol-driven decision point|0
2242720|NCT01951638|3901439|FG003|Treatment Period|Protocol-driven decision point|0
2242721|NCT01951638|3901440|FG004|Treatment Period|Protocol-driven decision point|0
2338060|NCT03337308|4066451|FG000|Overall Study|Adverse Event|2
2338061|NCT03337308|4066452|FG001|Overall Study|Adverse Event|3
2338062|NCT03337308|4066453|FG002|Overall Study|Adverse Event|3
2338063|NCT03337308|4066454|FG003|Overall Study|Adverse Event|1
2338064|NCT03337308|4066451|FG000|Overall Study|Lost to Follow-up|1
2338065|NCT03337308|4066452|FG001|Overall Study|Lost to Follow-up|2
2338066|NCT03337308|4066453|FG002|Overall Study|Lost to Follow-up|0
2338067|NCT03337308|4066454|FG003|Overall Study|Lost to Follow-up|0
2338068|NCT03337308|4066451|FG000|Overall Study|Withdrawal by Subject|2
2338069|NCT03337308|4066452|FG001|Overall Study|Withdrawal by Subject|1
2338070|NCT03337308|4066453|FG002|Overall Study|Withdrawal by Subject|2
2338071|NCT03337308|4066454|FG003|Overall Study|Withdrawal by Subject|1
2338072|NCT03337308|4066451|FG000|Overall Study|Protocol Violation|0
2338073|NCT03337308|4066452|FG001|Overall Study|Protocol Violation|1
2338074|NCT03337308|4066453|FG002|Overall Study|Protocol Violation|0
2338075|NCT03337308|4066454|FG003|Overall Study|Protocol Violation|0
2338076|NCT03337477|4066466|FG000|Overall Study|not categorized into the listed ones|11
2338077|NCT03337477|4066467|FG001|Overall Study|not categorized into the listed ones|9
2338078|NCT03337477|4066466|FG000|Overall Study|Withdrawal by Subject|0
2338079|NCT03337477|4066467|FG001|Overall Study|Withdrawal by Subject|1
2338080|NCT03337477|4066466|FG000|Overall Study|Death|0
2338081|NCT03337477|4066467|FG001|Overall Study|Death|1
2338082|NCT03337477|4066466|FG000|Overall Study|Lost to Follow-up|0
2338083|NCT03337477|4066467|FG001|Overall Study|Lost to Follow-up|2
2338084|NCT03337490|4066478|FG000|Overall Study|Withdrawal by Subject|1
2338085|NCT03337490|4066479|FG001|Overall Study|Withdrawal by Subject|0
2338086|NCT03337490|4066480|FG002|Overall Study|Withdrawal by Subject|0
2338087|NCT03337490|4066478|FG000|Overall Study|Lack of Efficacy|10
2338088|NCT03337490|4066479|FG001|Overall Study|Lack of Efficacy|12
2338089|NCT03337490|4066480|FG002|Overall Study|Lack of Efficacy|35
2338090|NCT03337490|4066478|FG000|Overall Study|Physician Decision|0
2338091|NCT03337490|4066479|FG001|Overall Study|Physician Decision|1
2338092|NCT03337490|4066480|FG002|Overall Study|Physician Decision|0
2338093|NCT03337490|4066478|FG000|Overall Study|Lost to Follow-up|0
2338094|NCT03337490|4066479|FG001|Overall Study|Lost to Follow-up|1
2338095|NCT03337490|4066480|FG002|Overall Study|Lost to Follow-up|0
2338096|NCT03337542|4066488|FG000|Overall Study|Withdrew Consent|17
2338097|NCT03337542|4066488|FG000|Overall Study|Allergic Adverse Event|1
2338098|NCT03337542|4066488|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1
2338099|NCT03337542|4066488|FG000|Overall Study|Lost to Follow-up|1
2338100|NCT03337542|4066488|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1
2338101|NCT03338010|4066495|FG000|Overall Study|Withdrawal by Subject|14
2338102|NCT03338010|4066496|FG001|Overall Study|Withdrawal by Subject|8
2338103|NCT03338010|4066495|FG000|Overall Study|Lost to Follow-up|4
2338104|NCT03338010|4066496|FG001|Overall Study|Lost to Follow-up|2
2338105|NCT03338010|4066495|FG000|Overall Study|Adverse Event|3
2338106|NCT03338010|4066496|FG001|Overall Study|Adverse Event|2
2338107|NCT03338010|4066495|FG000|Overall Study|Physician Decision|2
2338108|NCT03338010|4066496|FG001|Overall Study|Physician Decision|2
2338109|NCT03338010|4066495|FG000|Overall Study|Non-Compliance with Study Drug|0
2338110|NCT03338010|4066496|FG001|Overall Study|Non-Compliance with Study Drug|3
2338111|NCT03338010|4066495|FG000|Overall Study|Protocol Violation|0
2338112|NCT03338010|4066496|FG001|Overall Study|Protocol Violation|1
2338113|NCT03338023|4066504|FG000|Overall Study|Withdrawal by Subject|3
2338114|NCT03338023|4066505|FG001|Overall Study|Withdrawal by Subject|4
2338115|NCT03338023|4066504|FG000|Overall Study|Protocol Violation|3
2338116|NCT03338023|4066505|FG001|Overall Study|Protocol Violation|3
2338117|NCT03338023|4066504|FG000|Overall Study|Lost to Follow-up|2
2338118|NCT03338023|4066505|FG001|Overall Study|Lost to Follow-up|1
2338119|NCT03338023|4066504|FG000|Overall Study|Physician Decision|1
2338120|NCT03338023|4066505|FG001|Overall Study|Physician Decision|2
2338121|NCT03338062|4066528|FG000|Overall Study|Alternative Therapy|1
2338122|NCT03338062|4066529|FG001|Overall Study|Alternative Therapy|0
2338123|NCT03338296|4066538|FG000|Overall Study|Adverse Event|0
2242722|NCT01951638|3901436|FG000|Treatment Period|Logistical difficulties|0
2242723|NCT01951638|3901437|FG001|Treatment Period|Logistical difficulties|1
2242724|NCT01951638|3901438|FG002|Treatment Period|Logistical difficulties|1
2242725|NCT01951638|3901439|FG003|Treatment Period|Logistical difficulties|0
2242726|NCT01951638|3901440|FG004|Treatment Period|Logistical difficulties|0
2242727|NCT01951638|3901436|FG000|Treatment Period|Withdrawal by Subject|9
2242728|NCT01951638|3901437|FG001|Treatment Period|Withdrawal by Subject|6
2242729|NCT01951638|3901438|FG002|Treatment Period|Withdrawal by Subject|4
2242730|NCT01951638|3901439|FG003|Treatment Period|Withdrawal by Subject|5
2242731|NCT01951638|3901440|FG004|Treatment Period|Withdrawal by Subject|4
2242732|NCT01951638|3901436|FG000|Treatment Period|Death|0
2242733|NCT01951638|3901437|FG001|Treatment Period|Death|0
2242734|NCT01951638|3901438|FG002|Treatment Period|Death|0
2242735|NCT01951638|3901439|FG003|Treatment Period|Death|3
2242736|NCT01951638|3901440|FG004|Treatment Period|Death|1
2242737|NCT01951638|3901436|FG000|Treatment Period|Adverse Event|3
2242738|NCT01951638|3901437|FG001|Treatment Period|Adverse Event|4
2242739|NCT01951638|3901438|FG002|Treatment Period|Adverse Event|8
2242740|NCT01951638|3901439|FG003|Treatment Period|Adverse Event|6
2242741|NCT01951638|3901440|FG004|Treatment Period|Adverse Event|5
2242742|NCT01951638|3901436|FG000|Follow-up Period|Protocol Violation|0
2242743|NCT01951638|3901437|FG001|Follow-up Period|Protocol Violation|0
2242744|NCT01951638|3901438|FG002|Follow-up Period|Protocol Violation|0
2242745|NCT01951638|3901439|FG003|Follow-up Period|Protocol Violation|1
2242746|NCT01951638|3901440|FG004|Follow-up Period|Protocol Violation|0
2242747|NCT01951638|3901436|FG000|Follow-up Period|Logistical difficulties|0
2242748|NCT01951638|3901437|FG001|Follow-up Period|Logistical difficulties|2
2242749|NCT01951638|3901438|FG002|Follow-up Period|Logistical difficulties|0
2242750|NCT01951638|3901439|FG003|Follow-up Period|Logistical difficulties|0
2242751|NCT01951638|3901440|FG004|Follow-up Period|Logistical difficulties|1
2242752|NCT01951638|3901436|FG000|Follow-up Period|Withdrawal by Subject|1
2242753|NCT01951638|3901437|FG001|Follow-up Period|Withdrawal by Subject|5
2242754|NCT01951638|3901438|FG002|Follow-up Period|Withdrawal by Subject|2
2242755|NCT01951638|3901439|FG003|Follow-up Period|Withdrawal by Subject|1
2242756|NCT01951638|3901440|FG004|Follow-up Period|Withdrawal by Subject|2
2242757|NCT01951638|3901436|FG000|Follow-up Period|Lost to Follow-up|0
2242758|NCT01951638|3901437|FG001|Follow-up Period|Lost to Follow-up|1
2242759|NCT01951638|3901438|FG002|Follow-up Period|Lost to Follow-up|0
2242760|NCT01951638|3901439|FG003|Follow-up Period|Lost to Follow-up|1
2242761|NCT01951638|3901440|FG004|Follow-up Period|Lost to Follow-up|0
2242762|NCT01951638|3901436|FG000|Follow-up Period|Death|1
2242763|NCT01951638|3901437|FG001|Follow-up Period|Death|0
2242764|NCT01951638|3901438|FG002|Follow-up Period|Death|1
2242765|NCT01951638|3901439|FG003|Follow-up Period|Death|4
2242766|NCT01951638|3901440|FG004|Follow-up Period|Death|1
2242767|NCT01951638|3901436|FG000|Follow-up Period|Adverse Event|0
2242768|NCT01951638|3901437|FG001|Follow-up Period|Adverse Event|1
2242769|NCT01951638|3901438|FG002|Follow-up Period|Adverse Event|2
2242770|NCT01951638|3901439|FG003|Follow-up Period|Adverse Event|1
2242771|NCT01951638|3901440|FG004|Follow-up Period|Adverse Event|1
2242772|NCT01951703|3901463|FG000|First Intervention|Withdrawal by Subject|1
2242773|NCT01951703|3901464|FG001|First Intervention|Withdrawal by Subject|0
2242774|NCT01951703|3901463|FG000|First Intervention|Subject was not compliant|1
2242775|NCT01951703|3901464|FG001|First Intervention|Subject was not compliant|1
2242776|NCT01951703|3901463|FG000|First Intervention|Physician Decision|1
2242777|NCT01951703|3901464|FG001|First Intervention|Physician Decision|0
2242778|NCT01951703|3901463|FG000|Second Intervention|Protocol Violation|0
2242779|NCT01951703|3901464|FG001|Second Intervention|Protocol Violation|1
2242780|NCT01951703|3901463|FG000|Second Intervention|Unsatisfactory Lens fitting|0
2242781|NCT01951703|3901464|FG001|Second Intervention|Unsatisfactory Lens fitting|1
2242782|NCT01952015|3901511|FG000|Induction|Protocol Violation|1
2242783|NCT01952015|3901511|FG000|Maintenance|Adverse Event|2
2242784|NCT01952015|3901511|FG000|Treatment Period 3|Physician Decision|9
2242785|NCT01952041|3901529|FG000|Overall Study|Lost to Follow-up|9
2242786|NCT01952041|3901530|FG001|Overall Study|Lost to Follow-up|16
2242787|NCT01952041|3901529|FG000|Overall Study|Withdrawal by Subject|7
2242788|NCT01952041|3901530|FG001|Overall Study|Withdrawal by Subject|5
2242789|NCT01952041|3901529|FG000|Overall Study|Death|1
2242790|NCT01952041|3901530|FG001|Overall Study|Death|0
2242791|NCT01952054|3901536|FG000|Overall Study|Physician Decision|1
2242792|NCT01952080|3901544|FG000|Overall Study|Withdrawal by Subject|0
2242793|NCT01952080|3901545|FG001|Overall Study|Withdrawal by Subject|0
2242794|NCT01952080|3901546|FG002|Overall Study|Withdrawal by Subject|0
2242795|NCT01952080|3901547|FG003|Overall Study|Withdrawal by Subject|1
2242796|NCT01952080|3901544|FG000|Overall Study|Protocol Non-compliance|0
2242797|NCT01952080|3901545|FG001|Overall Study|Protocol Non-compliance|1
2242798|NCT01952080|3901546|FG002|Overall Study|Protocol Non-compliance|0
2242799|NCT01952080|3901547|FG003|Overall Study|Protocol Non-compliance|0
2242800|NCT01952145|3901559|FG000|Overall Study|Protocol Violation|2
2242801|NCT01952145|3901560|FG001|Overall Study|Protocol Violation|1
2242802|NCT01952145|3901559|FG000|Overall Study|Death|0
2242803|NCT01952145|3901560|FG001|Overall Study|Death|1
2242804|NCT01952145|3901559|FG000|Overall Study|Adverse Event|9
2242805|NCT01952145|3901560|FG001|Overall Study|Adverse Event|0
2242806|NCT01952145|3901559|FG000|Overall Study|Withdrawal Criteria|16
2242807|NCT01952145|3901560|FG001|Overall Study|Withdrawal Criteria|11
2242808|NCT01952145|3901559|FG000|Overall Study|Unclassified|1
2242809|NCT01952145|3901560|FG001|Overall Study|Unclassified|1
2242810|NCT01952366|3901572|FG000|Overall Study|Death|22
2242811|NCT01952366|3901572|FG000|Overall Study|Withdrawal by Subject|9
2242812|NCT01952574|3901615|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9
2242813|NCT01952574|3901616|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3
2242814|NCT01952574|3901617|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3
2242815|NCT01952574|3901618|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4
2242816|NCT01952574|3901619|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
2242817|NCT01952574|3901620|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0
2242818|NCT01952574|3901621|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0
2242819|NCT01952574|3901615|FG000|Double-blind Treatment Phase|Sponsor Decision|6
2242820|NCT01952574|3901616|FG001|Double-blind Treatment Phase|Sponsor Decision|0
2242821|NCT01952574|3901617|FG002|Double-blind Treatment Phase|Sponsor Decision|5
2242822|NCT01952574|3901618|FG003|Double-blind Treatment Phase|Sponsor Decision|2
2242823|NCT01952574|3901619|FG004|Double-blind Treatment Phase|Sponsor Decision|0
2242824|NCT01952574|3901620|FG005|Double-blind Treatment Phase|Sponsor Decision|0
2242825|NCT01952574|3901621|FG006|Double-blind Treatment Phase|Sponsor Decision|0
2338124|NCT03338296|4066539|FG001|Overall Study|Adverse Event|1
2338125|NCT03338296|4066538|FG000|Overall Study|Withdrawal by Subject|14
2338126|NCT03338296|4066539|FG001|Overall Study|Withdrawal by Subject|13
2338127|NCT03338296|4066538|FG000|Overall Study|Lost to Follow-up|10
2338128|NCT03338296|4066539|FG001|Overall Study|Lost to Follow-up|10
2338129|NCT03338296|4066538|FG000|Overall Study|Study Terminated by Sponsor|77
2338130|NCT03338296|4066539|FG001|Overall Study|Study Terminated by Sponsor|76
2338131|NCT03338296|4066538|FG000|Overall Study|Other|2
2338132|NCT03338296|4066539|FG001|Overall Study|Other|7
2338133|NCT03338296|4066538|FG000|Overall Study|Missing|0
2338134|NCT03338296|4066539|FG001|Overall Study|Missing|1
2338135|NCT03338400|4066547|FG000|Overall Study|Lost to Follow-up|1
2338136|NCT03338400|4066548|FG001|Overall Study|Lost to Follow-up|2
2338137|NCT03338569|4066581|FG000|Overall Study|Physician Decision|8
2338138|NCT03338569|4066582|FG001|Overall Study|Physician Decision|3
2338139|NCT03338569|4066581|FG000|Overall Study|Withdrawal by Subject|0
2338140|NCT03338569|4066582|FG001|Overall Study|Withdrawal by Subject|1
2338141|NCT03338569|4066581|FG000|Overall Study|Lost to Follow-up|0
2338142|NCT03338569|4066582|FG001|Overall Study|Lost to Follow-up|1
2338143|NCT03338673|4066590|FG000|Overall Study|Lost to Follow-up|1
2338144|NCT03338673|4066591|FG001|Overall Study|Lost to Follow-up|1
2338145|NCT03338816|4066615|FG000|6-Month Double-blind Period|Adverse Event|0
2338146|NCT03338816|4066616|FG001|6-Month Double-blind Period|Adverse Event|1
2338147|NCT03338816|4066615|FG000|Open-Label Extension Period|Ongoing in Study|46
2338148|NCT03338816|4066616|FG001|Open-Label Extension Period|Ongoing in Study|47
2338149|NCT03338855|4066624|FG000|Overall Study|Withdrawn as birth control pill stopped|1
2037546|NCT00419159|3607952|FG001|Overall Study|Disease progression|76
2037547|NCT00419263|3607969|FG000|Overall Study|Lost to Follow-up|2
2037548|NCT00419263|3607970|FG001|Overall Study|Lost to Follow-up|1
2037549|NCT00419263|3607971|FG002|Overall Study|Lost to Follow-up|1
2037550|NCT00419263|3607969|FG000|Overall Study|Randomized in Error, Not Treated|1
2037551|NCT00419263|3607970|FG001|Overall Study|Randomized in Error, Not Treated|1
2037552|NCT00419263|3607971|FG002|Overall Study|Randomized in Error, Not Treated|0
2037553|NCT00419263|3607969|FG000|Overall Study|Adverse Event|0
2037554|NCT00419263|3607970|FG001|Overall Study|Adverse Event|0
2037555|NCT00419263|3607971|FG002|Overall Study|Adverse Event|1
2037556|NCT00419263|3607969|FG000|Overall Study|Withdrawal by Subject|0
2037557|NCT00419263|3607970|FG001|Overall Study|Withdrawal by Subject|0
2037558|NCT00419263|3607971|FG002|Overall Study|Withdrawal by Subject|1
2037559|NCT00419341|3607989|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8
2037560|NCT00419341|3607989|FG000|Wash in/Wash Out Period|Adverse Event|2
2037561|NCT00419341|3607989|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1
2037562|NCT00419341|3607989|FG000|Efficacy Period|Withdrawal by Subject|6
2037563|NCT00419341|3607989|FG000|Efficacy Period|Protocol Violation|1
2037564|NCT00419341|3607989|FG000|Efficacy Period|Lost to Follow-up|1
2037565|NCT00419341|3607989|FG000|Efficacy Period|Non-compliance|1
2037566|NCT00419341|3607989|FG000|Efficacy Period|Termination of study site|1
2037567|NCT00419380|3607997|FG000|Overall Study|Lack of Efficacy|1
2037568|NCT00419380|3607998|FG001|Overall Study|Lack of Efficacy|7
2037569|NCT00419380|3607997|FG000|Overall Study|Physician Decision|0
2037570|NCT00419380|3607998|FG001|Overall Study|Physician Decision|1
2037571|NCT00419380|3607997|FG000|Overall Study|Lost to Follow-up|0
2037572|NCT00419380|3607998|FG001|Overall Study|Lost to Follow-up|1
2037573|NCT00419380|3607997|FG000|Overall Study|Withdrawal by Subject|0
2037574|NCT00419380|3607998|FG001|Overall Study|Withdrawal by Subject|1
2037575|NCT00419393|3608004|FG000|Overall Study|Adverse Event|5
2037576|NCT00419393|3608004|FG000|Overall Study|Protocol Violation|5
2037577|NCT00419393|3608004|FG000|Overall Study|Withdrawal by Subject|7
2037578|NCT00419393|3608004|FG000|Overall Study|Other: Sponsor request|3
2037579|NCT00419393|3608004|FG000|Overall Study|Other: Subject had temporal lobectomy|1
2037580|NCT00419393|3608004|FG000|Overall Study|Other: Site closure|1
2037581|NCT00419393|3608004|FG000|Overall Study|Other: Other health problems|1
2037582|NCT00419393|3608004|FG000|Overall Study|Other: Investigator decision|1
2242826|NCT01952574|3901615|FG000|Double-blind Treatment Phase|Lost to Follow-up|2
2242827|NCT01952574|3901616|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
2242828|NCT01952574|3901617|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
2242829|NCT01952574|3901618|FG003|Double-blind Treatment Phase|Lost to Follow-up|0
2242830|NCT01952574|3901619|FG004|Double-blind Treatment Phase|Lost to Follow-up|0
2242831|NCT01952574|3901620|FG005|Double-blind Treatment Phase|Lost to Follow-up|0
2242832|NCT01952574|3901621|FG006|Double-blind Treatment Phase|Lost to Follow-up|0
2242833|NCT01952574|3901615|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
2242834|NCT01952574|3901616|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
2242835|NCT01952574|3901617|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
2242836|NCT01952574|3901618|FG003|Open-label Treatment Phase|Withdrawal by Subject|0
2242837|NCT01952574|3901619|FG004|Open-label Treatment Phase|Withdrawal by Subject|121
2242838|NCT01952574|3901620|FG005|Open-label Treatment Phase|Withdrawal by Subject|0
2242839|NCT01952574|3901621|FG006|Open-label Treatment Phase|Withdrawal by Subject|0
2242840|NCT01952574|3901615|FG000|Open-label Treatment Phase|Decision by Sponsor|0
2242841|NCT01952574|3901616|FG001|Open-label Treatment Phase|Decision by Sponsor|0
2242842|NCT01952574|3901617|FG002|Open-label Treatment Phase|Decision by Sponsor|0
2242843|NCT01952574|3901618|FG003|Open-label Treatment Phase|Decision by Sponsor|0
2242844|NCT01952574|3901619|FG004|Open-label Treatment Phase|Decision by Sponsor|17
2242845|NCT01952574|3901620|FG005|Open-label Treatment Phase|Decision by Sponsor|0
2242846|NCT01952574|3901621|FG006|Open-label Treatment Phase|Decision by Sponsor|0
2242847|NCT01952574|3901615|FG000|Open-label Treatment Phase|Missing|0
2242848|NCT01952574|3901616|FG001|Open-label Treatment Phase|Missing|0
2242849|NCT01952574|3901617|FG002|Open-label Treatment Phase|Missing|0
2242850|NCT01952574|3901618|FG003|Open-label Treatment Phase|Missing|0
2242851|NCT01952574|3901619|FG004|Open-label Treatment Phase|Missing|4
2242852|NCT01952574|3901620|FG005|Open-label Treatment Phase|Missing|0
2242853|NCT01952574|3901621|FG006|Open-label Treatment Phase|Missing|0
2242854|NCT01952574|3901615|FG000|Open-label Treatment Phase|Lost to Follow-up|0
2242855|NCT01952574|3901616|FG001|Open-label Treatment Phase|Lost to Follow-up|0
2242856|NCT01952574|3901617|FG002|Open-label Treatment Phase|Lost to Follow-up|0
2242857|NCT01952574|3901618|FG003|Open-label Treatment Phase|Lost to Follow-up|0
2242858|NCT01952574|3901619|FG004|Open-label Treatment Phase|Lost to Follow-up|19
2242859|NCT01952574|3901620|FG005|Open-label Treatment Phase|Lost to Follow-up|0
2242860|NCT01952574|3901621|FG006|Open-label Treatment Phase|Lost to Follow-up|0
2242861|NCT01952574|3901615|FG000|Open-label Treatment Phase|Death|0
2242862|NCT01952574|3901616|FG001|Open-label Treatment Phase|Death|0
2242863|NCT01952574|3901617|FG002|Open-label Treatment Phase|Death|0
2242864|NCT01952574|3901618|FG003|Open-label Treatment Phase|Death|0
2242865|NCT01952574|3901619|FG004|Open-label Treatment Phase|Death|1
2242866|NCT01952574|3901620|FG005|Open-label Treatment Phase|Death|0
2242867|NCT01952574|3901621|FG006|Open-label Treatment Phase|Death|0
2242868|NCT01952574|3901615|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0
2242869|NCT01952574|3901616|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0
2242870|NCT01952574|3901617|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0
2242871|NCT01952574|3901618|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0
2242872|NCT01952574|3901619|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0
2242873|NCT01952574|3901620|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1
2242874|NCT01952574|3901621|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0
2242875|NCT01952574|3901615|FG000|Clinical Home Use Substudy|Decision by Sponsor|0
2242876|NCT01952574|3901616|FG001|Clinical Home Use Substudy|Decision by Sponsor|0
2242877|NCT01952574|3901617|FG002|Clinical Home Use Substudy|Decision by Sponsor|0
2242878|NCT01952574|3901618|FG003|Clinical Home Use Substudy|Decision by Sponsor|0
2242879|NCT01952574|3901619|FG004|Clinical Home Use Substudy|Decision by Sponsor|0
2242880|NCT01952574|3901620|FG005|Clinical Home Use Substudy|Decision by Sponsor|2
2242881|NCT01952574|3901621|FG006|Clinical Home Use Substudy|Decision by Sponsor|1
2242882|NCT01952665|3901661|FG000|Overall Study|Physician Decision|3
2242883|NCT01952665|3901662|FG001|Overall Study|Physician Decision|2
2242884|NCT01952665|3901661|FG000|Overall Study|Lost to Follow-up|1
2242885|NCT01952665|3901662|FG001|Overall Study|Lost to Follow-up|2
2242886|NCT01952665|3901661|FG000|Overall Study|Adverse Event|2
2242887|NCT01952665|3901662|FG001|Overall Study|Adverse Event|1
2242888|NCT01952665|3901661|FG000|Overall Study|Protocol Violation|0
2242889|NCT01952665|3901662|FG001|Overall Study|Protocol Violation|1
2242890|NCT01952691|3901690|FG000|Overall Study|Lost to Follow-up|2
2242891|NCT01952834|3901694|FG000|Overall Study|Adverse Event|1
2242892|NCT01953003|3901701|FG000|Overall Study|Not treated|0
2242893|NCT01953003|3901702|FG001|Overall Study|Not treated|1
2242894|NCT01953003|3901701|FG000|Overall Study|Progressive disease|35
2242895|NCT01953003|3901702|FG001|Overall Study|Progressive disease|45
2242896|NCT01953003|3901701|FG000|Overall Study|Related Adverse events|7
2242897|NCT01953003|3901702|FG001|Overall Study|Related Adverse events|2
2242898|NCT01953003|3901701|FG000|Overall Study|Non-related adverse events|0
2242899|NCT01953003|3901702|FG001|Overall Study|Non-related adverse events|2
2242900|NCT01953003|3901701|FG000|Overall Study|Protocol Violation|0
2242901|NCT01953003|3901702|FG001|Overall Study|Protocol Violation|1
2242902|NCT01953003|3901701|FG000|Overall Study|Withdrawal by Subject|14
2242903|NCT01953003|3901702|FG001|Overall Study|Withdrawal by Subject|4
2242904|NCT01953224|3901725|FG000|Overall Study|Lost to Follow-up|1
2242905|NCT01953224|3901726|FG001|Overall Study|Lost to Follow-up|1
2242906|NCT01953224|3901725|FG000|Overall Study|Withdrawal by Subject|1
2242907|NCT01953224|3901726|FG001|Overall Study|Withdrawal by Subject|2
2242908|NCT01953328|3901749|FG000|Overall Study|Withdrawal by Subject|0
2242909|NCT01953328|3901750|FG001|Overall Study|Withdrawal by Subject|0
2242910|NCT01953328|3901751|FG002|Overall Study|Withdrawal by Subject|0
2242911|NCT01953328|3901752|FG003|Overall Study|Withdrawal by Subject|0
2242912|NCT01953328|3901753|FG004|Overall Study|Withdrawal by Subject|1
2242913|NCT01953328|3901754|FG005|Overall Study|Withdrawal by Subject|0
2242914|NCT01953328|3901755|FG006|Overall Study|Withdrawal by Subject|0
2242915|NCT01953328|3901756|FG007|Overall Study|Withdrawal by Subject|0
2242916|NCT01953328|3901749|FG000|Overall Study|Lost to Follow-up|0
2242917|NCT01953328|3901750|FG001|Overall Study|Lost to Follow-up|0
2242918|NCT01953328|3901751|FG002|Overall Study|Lost to Follow-up|0
2242919|NCT01953328|3901752|FG003|Overall Study|Lost to Follow-up|0
2242920|NCT01953328|3901753|FG004|Overall Study|Lost to Follow-up|1
2242921|NCT01953328|3901754|FG005|Overall Study|Lost to Follow-up|0
2242922|NCT01953328|3901755|FG006|Overall Study|Lost to Follow-up|0
2242923|NCT01953328|3901756|FG007|Overall Study|Lost to Follow-up|0
2242924|NCT01953354|3901776|FG000|Overall Study|Withdrawal by Subject|0
2242925|NCT01953354|3901777|FG001|Overall Study|Withdrawal by Subject|1
2242926|NCT01953354|3901776|FG000|Overall Study|Decision of Sponsor|0
2242927|NCT01953354|3901777|FG001|Overall Study|Decision of Sponsor|1
2242928|NCT01953354|3901776|FG000|Overall Study|Disease Exacerbation|1
2242929|NCT01953354|3901777|FG001|Overall Study|Disease Exacerbation|0
2242930|NCT01953601|3901808|FG000|Part 1 (Base Study)|Adverse Event|24
2242931|NCT01953601|3901809|FG001|Part 1 (Base Study)|Adverse Event|37
2242932|NCT01953601|3901810|FG002|Part 1 (Base Study)|Adverse Event|15
2242933|NCT01953601|3901808|FG000|Part 1 (Base Study)|Death|2
2242934|NCT01953601|3901809|FG001|Part 1 (Base Study)|Death|0
2242935|NCT01953601|3901810|FG002|Part 1 (Base Study)|Death|3
2242936|NCT01953601|3901808|FG000|Part 1 (Base Study)|Lack of Efficacy|3
2242937|NCT01953601|3901809|FG001|Part 1 (Base Study)|Lack of Efficacy|1
2242938|NCT01953601|3901810|FG002|Part 1 (Base Study)|Lack of Efficacy|4
2242939|NCT01953601|3901808|FG000|Part 1 (Base Study)|Lost to Follow-up|1
2242940|NCT01953601|3901809|FG001|Part 1 (Base Study)|Lost to Follow-up|3
2242941|NCT01953601|3901810|FG002|Part 1 (Base Study)|Lost to Follow-up|6
2242942|NCT01953601|3901808|FG000|Part 1 (Base Study)|Non-compliance with study drug|0
2242943|NCT01953601|3901809|FG001|Part 1 (Base Study)|Non-compliance with study drug|3
2242944|NCT01953601|3901810|FG002|Part 1 (Base Study)|Non-compliance with study drug|1
2338150|NCT03338855|4066625|FG001|Overall Study|Withdrawn as birth control pill stopped|0
2338151|NCT03338894|4066631|FG000|Overall Study|not able able to attend 9 or more classes|10
2338152|NCT03338998|4066637|FG000|Treatment Period|Withdrawal by Subject|1
2338153|NCT03338998|4066638|FG001|Treatment Period|Withdrawal by Subject|1
2338154|NCT03338998|4066637|FG000|Treatment Period|Adverse Event|0
2338155|NCT03338998|4066638|FG001|Treatment Period|Adverse Event|2
2338156|NCT03338998|4066637|FG000|Treatment Period|Protocol deviation|1
2338157|NCT03338998|4066638|FG001|Treatment Period|Protocol deviation|0
2338158|NCT03338998|4066637|FG000|Treatment Period|Physician Decision|2
2338159|NCT03338998|4066638|FG001|Treatment Period|Physician Decision|0
2338160|NCT03338998|4066637|FG000|Treatment Period|Subject failed swallow test|4
2338161|NCT03338998|4066638|FG001|Treatment Period|Subject failed swallow test|0
2338162|NCT03338998|4066637|FG000|Safety Follow-Up Period|Adverse Event|0
2338163|NCT03338998|4066638|FG001|Safety Follow-Up Period|Adverse Event|1
2338164|NCT03338998|4066637|FG000|Safety Follow-Up Period|Protocol deviation|1
2338165|NCT03338998|4066638|FG001|Safety Follow-Up Period|Protocol deviation|0
2338166|NCT03338998|4066637|FG000|Safety Follow-Up Period|Lost to Follow-up|1
2338167|NCT03338998|4066638|FG001|Safety Follow-Up Period|Lost to Follow-up|0
2338168|NCT03339219|4066658|FG000|Overall Study|Death|12
2338169|NCT03339219|4066658|FG000|Overall Study|Site Terminated by Sponsor|22
2338170|NCT03339219|4066658|FG000|Overall Study|Withdrawal by Subject|1
2338171|NCT03339297|4066664|FG000|Overall Study|Relapse of Hematologic Disease|1
2037583|NCT00419562|3608023|FG000|Overall Study|Lost to Follow-up|12
2037584|NCT00419562|3608024|FG001|Overall Study|Lost to Follow-up|13
2037585|NCT00419562|3608023|FG000|Overall Study|Withdrawal by Subject|20
2037586|NCT00419562|3608024|FG001|Overall Study|Withdrawal by Subject|18
2037587|NCT00419562|3608023|FG000|Overall Study|Participant Institutionalized|1
2037588|NCT00419562|3608024|FG001|Overall Study|Participant Institutionalized|0
2037589|NCT00419744|3608037|FG000|Overall Study|Adverse Event|39
2037590|NCT00419744|3608038|FG001|Overall Study|Adverse Event|40
2037591|NCT00419744|3608039|FG002|Overall Study|Adverse Event|50
2037592|NCT00419744|3608037|FG000|Overall Study|Withdrawal by Subject|45
2037593|NCT00419744|3608038|FG001|Overall Study|Withdrawal by Subject|49
2037594|NCT00419744|3608039|FG002|Overall Study|Withdrawal by Subject|52
2037595|NCT00419744|3608037|FG000|Overall Study|Lost to Follow-up|8
2037596|NCT00419744|3608038|FG001|Overall Study|Lost to Follow-up|10
2037597|NCT00419744|3608039|FG002|Overall Study|Lost to Follow-up|6
2037598|NCT00419744|3608037|FG000|Overall Study|Protocol Violation|4
2037599|NCT00419744|3608038|FG001|Overall Study|Protocol Violation|7
2037600|NCT00419744|3608039|FG002|Overall Study|Protocol Violation|8
2037601|NCT00419744|3608037|FG000|Overall Study|Randomized in error|9
2037602|NCT00419744|3608038|FG001|Overall Study|Randomized in error|6
2037603|NCT00419744|3608039|FG002|Overall Study|Randomized in error|7
2037604|NCT00419744|3608037|FG000|Overall Study|Moving out of state|2
2242945|NCT01953601|3901808|FG000|Part 1 (Base Study)|Physician Decision|3
2242946|NCT01953601|3901809|FG001|Part 1 (Base Study)|Physician Decision|7
2242947|NCT01953601|3901810|FG002|Part 1 (Base Study)|Physician Decision|4
2242948|NCT01953601|3901808|FG000|Part 1 (Base Study)|Screen failure|1
2242949|NCT01953601|3901809|FG001|Part 1 (Base Study)|Screen failure|0
2242950|NCT01953601|3901810|FG002|Part 1 (Base Study)|Screen failure|1
2242951|NCT01953601|3901808|FG000|Part 1 (Base Study)|Site discontinued study participation|2
2242952|NCT01953601|3901809|FG001|Part 1 (Base Study)|Site discontinued study participation|0
2242953|NCT01953601|3901810|FG002|Part 1 (Base Study)|Site discontinued study participation|0
2242954|NCT01953601|3901808|FG000|Part 1 (Base Study)|Study terminated by sponsor|174
2242955|NCT01953601|3901809|FG001|Part 1 (Base Study)|Study terminated by sponsor|169
2242956|NCT01953601|3901810|FG002|Part 1 (Base Study)|Study terminated by sponsor|179
2242957|NCT01953601|3901808|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
2242958|NCT01953601|3901809|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
2242959|NCT01953601|3901810|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
2242960|NCT01953601|3901808|FG000|Part 1 (Base Study)|Subject moved|2
2242961|NCT01953601|3901809|FG001|Part 1 (Base Study)|Subject moved|2
2242962|NCT01953601|3901810|FG002|Part 1 (Base Study)|Subject moved|1
2242963|NCT01953601|3901808|FG000|Part 1 (Base Study)|Withdrawal by Subject|32
2242964|NCT01953601|3901809|FG001|Part 1 (Base Study)|Withdrawal by Subject|23
2242965|NCT01953601|3901810|FG002|Part 1 (Base Study)|Withdrawal by Subject|22
2242966|NCT01953601|3901808|FG000|Part 2 (Extension Study)|Adverse Event|1
2242967|NCT01953601|3901809|FG001|Part 2 (Extension Study)|Adverse Event|1
2242968|NCT01953601|3901810|FG002|Part 2 (Extension Study)|Adverse Event|10
2242969|NCT01953601|3901808|FG000|Part 2 (Extension Study)|Death|0
2242970|NCT01953601|3901809|FG001|Part 2 (Extension Study)|Death|3
2242971|NCT01953601|3901810|FG002|Part 2 (Extension Study)|Death|0
2242972|NCT01953601|3901808|FG000|Part 2 (Extension Study)|Lack of Efficacy|2
2242973|NCT01953601|3901809|FG001|Part 2 (Extension Study)|Lack of Efficacy|0
2242974|NCT01953601|3901810|FG002|Part 2 (Extension Study)|Lack of Efficacy|0
2242975|NCT01953601|3901808|FG000|Part 2 (Extension Study)|Lost to Follow-up|2
2242976|NCT01953601|3901809|FG001|Part 2 (Extension Study)|Lost to Follow-up|1
2242977|NCT01953601|3901810|FG002|Part 2 (Extension Study)|Lost to Follow-up|1
2242978|NCT01953601|3901808|FG000|Part 2 (Extension Study)|Physician Decision|2
2242979|NCT01953601|3901809|FG001|Part 2 (Extension Study)|Physician Decision|0
2242980|NCT01953601|3901810|FG002|Part 2 (Extension Study)|Physician Decision|2
2242981|NCT01953601|3901808|FG000|Part 2 (Extension Study)|Site discontinued study participation|0
2242982|NCT01953601|3901809|FG001|Part 2 (Extension Study)|Site discontinued study participation|1
2242983|NCT01953601|3901810|FG002|Part 2 (Extension Study)|Site discontinued study participation|1
2242984|NCT01953601|3901808|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185
2242985|NCT01953601|3901809|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178
2242986|NCT01953601|3901810|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187
2242987|NCT01953601|3901808|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
2242988|NCT01953601|3901809|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
2242989|NCT01953601|3901810|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
2242990|NCT01953601|3901808|FG000|Part 2 (Extension Study)|Subject moved|0
2242991|NCT01953601|3901809|FG001|Part 2 (Extension Study)|Subject moved|0
2242992|NCT01953601|3901810|FG002|Part 2 (Extension Study)|Subject moved|1
2242993|NCT01953601|3901808|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5
2242994|NCT01953601|3901809|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4
2242995|NCT01953601|3901810|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2
2242996|NCT01953692|3901830|FG000|Overall Study|Adverse Event|5
2242997|NCT01953692|3901831|FG001|Overall Study|Adverse Event|2
2242998|NCT01953692|3901832|FG002|Overall Study|Adverse Event|4
2242999|NCT01953692|3901833|FG003|Overall Study|Adverse Event|2
2243000|NCT01953692|3901834|FG004|Overall Study|Adverse Event|1
2243001|NCT01953692|3901835|FG005|Overall Study|Adverse Event|2
2243002|NCT01953692|3901836|FG006|Overall Study|Adverse Event|0
2243003|NCT01953692|3901837|FG007|Overall Study|Adverse Event|0
2243004|NCT01953692|3901838|FG008|Overall Study|Adverse Event|0
2243005|NCT01953692|3901830|FG000|Overall Study|Clinical Progression|0
2243006|NCT01953692|3901831|FG001|Overall Study|Clinical Progression|15
2243007|NCT01953692|3901832|FG002|Overall Study|Clinical Progression|7
2243008|NCT01953692|3901833|FG003|Overall Study|Clinical Progression|5
2243009|NCT01953692|3901834|FG004|Overall Study|Clinical Progression|0
2243010|NCT01953692|3901835|FG005|Overall Study|Clinical Progression|7
2243011|NCT01953692|3901836|FG006|Overall Study|Clinical Progression|20
2243012|NCT01953692|3901837|FG007|Overall Study|Clinical Progression|3
2243013|NCT01953692|3901838|FG008|Overall Study|Clinical Progression|3
2243014|NCT01953692|3901830|FG000|Overall Study|Death|5
2243015|NCT01953692|3901831|FG001|Overall Study|Death|0
2243016|NCT01953692|3901832|FG002|Overall Study|Death|2
2243017|NCT01953692|3901833|FG003|Overall Study|Death|2
2243018|NCT01953692|3901834|FG004|Overall Study|Death|1
2243019|NCT01953692|3901835|FG005|Overall Study|Death|3
2243020|NCT01953692|3901836|FG006|Overall Study|Death|6
2243021|NCT01953692|3901837|FG007|Overall Study|Death|2
2243022|NCT01953692|3901838|FG008|Overall Study|Death|1
2243023|NCT01953692|3901830|FG000|Overall Study|Excluded Medication|1
2243024|NCT01953692|3901831|FG001|Overall Study|Excluded Medication|0
2243025|NCT01953692|3901832|FG002|Overall Study|Excluded Medication|0
2243026|NCT01953692|3901833|FG003|Overall Study|Excluded Medication|0
2243027|NCT01953692|3901834|FG004|Overall Study|Excluded Medication|0
2243028|NCT01953692|3901835|FG005|Overall Study|Excluded Medication|0
2243029|NCT01953692|3901836|FG006|Overall Study|Excluded Medication|0
2243030|NCT01953692|3901837|FG007|Overall Study|Excluded Medication|0
2243031|NCT01953692|3901838|FG008|Overall Study|Excluded Medication|0
2243032|NCT01953692|3901830|FG000|Overall Study|Lost to Follow-up|1
2243033|NCT01953692|3901831|FG001|Overall Study|Lost to Follow-up|0
2243034|NCT01953692|3901832|FG002|Overall Study|Lost to Follow-up|3
2243035|NCT01953692|3901833|FG003|Overall Study|Lost to Follow-up|1
2243036|NCT01953692|3901834|FG004|Overall Study|Lost to Follow-up|0
2243037|NCT01953692|3901835|FG005|Overall Study|Lost to Follow-up|1
2243038|NCT01953692|3901836|FG006|Overall Study|Lost to Follow-up|0
2243039|NCT01953692|3901837|FG007|Overall Study|Lost to Follow-up|0
2243040|NCT01953692|3901838|FG008|Overall Study|Lost to Follow-up|0
2243041|NCT01953692|3901830|FG000|Overall Study|Physician Decision|11
2243042|NCT01953692|3901831|FG001|Overall Study|Physician Decision|4
2243043|NCT01953692|3901832|FG002|Overall Study|Physician Decision|2
2243044|NCT01953692|3901833|FG003|Overall Study|Physician Decision|2
2243045|NCT01953692|3901834|FG004|Overall Study|Physician Decision|1
2243046|NCT01953692|3901835|FG005|Overall Study|Physician Decision|2
2243047|NCT01953692|3901836|FG006|Overall Study|Physician Decision|4
2243048|NCT01953692|3901837|FG007|Overall Study|Physician Decision|1
2243049|NCT01953692|3901838|FG008|Overall Study|Physician Decision|0
2243050|NCT01953692|3901830|FG000|Overall Study|Protocol Violation|0
2243051|NCT01953692|3901831|FG001|Overall Study|Protocol Violation|2
2243052|NCT01953692|3901832|FG002|Overall Study|Protocol Violation|1
2243053|NCT01953692|3901833|FG003|Overall Study|Protocol Violation|0
2243054|NCT01953692|3901834|FG004|Overall Study|Protocol Violation|0
2243055|NCT01953692|3901835|FG005|Overall Study|Protocol Violation|0
2243056|NCT01953692|3901836|FG006|Overall Study|Protocol Violation|0
2243057|NCT01953692|3901837|FG007|Overall Study|Protocol Violation|1
2243058|NCT01953692|3901838|FG008|Overall Study|Protocol Violation|0
2243059|NCT01953692|3901830|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
2243060|NCT01953692|3901831|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
2243061|NCT01953692|3901832|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
2243062|NCT01953692|3901833|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
2243063|NCT01953692|3901834|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
2338172|NCT03339297|4066665|FG001|Overall Study|Relapse of Hematologic Disease|0
2338173|NCT03339297|4066664|FG000|Overall Study|Death|10
2338174|NCT03339297|4066665|FG001|Overall Study|Death|7
2338175|NCT03339297|4066664|FG000|Overall Study|Hepatic Candidosis|1
2338176|NCT03339297|4066665|FG001|Overall Study|Hepatic Candidosis|0
2338177|NCT03339297|4066664|FG000|Overall Study|Adverse Event, Serious Fatal|0
2338178|NCT03339297|4066665|FG001|Overall Study|Adverse Event, Serious Fatal|2
2338179|NCT03339297|4066664|FG000|Overall Study|Consent Withdrawn by Participant|3
2338180|NCT03339297|4066665|FG001|Overall Study|Consent Withdrawn by Participant|3
2338181|NCT03339297|4066664|FG000|Overall Study|Disease Relapse|2
2338182|NCT03339297|4066665|FG001|Overall Study|Disease Relapse|0
2338183|NCT03339297|4066664|FG000|Overall Study|Physician Decision|1
2338184|NCT03339297|4066665|FG001|Overall Study|Physician Decision|1
2338185|NCT03339297|4066664|FG000|Overall Study|Relapse of Disease New Transplant Performed|1
2338186|NCT03339297|4066665|FG001|Overall Study|Relapse of Disease New Transplant Performed|0
2338187|NCT03339297|4066664|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1
2338188|NCT03339297|4066665|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0
2338189|NCT03339297|4066664|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1
2338190|NCT03339297|4066665|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0
2338191|NCT03339297|4066664|FG000|Overall Study|Adverse Event, Non-fatal|1
2338192|NCT03339297|4066665|FG001|Overall Study|Adverse Event, Non-fatal|0
2338193|NCT03339297|4066664|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0
2338194|NCT03339297|4066665|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1
2338195|NCT03339297|4066664|FG000|Overall Study|Patient Was Not Eligible|1
2338196|NCT03339297|4066665|FG001|Overall Study|Patient Was Not Eligible|0
2338197|NCT03339453|4066673|FG000|First Visit of Glucagon Treatment|Adverse Event|0
2338198|NCT03339453|4066674|FG001|First Visit of Glucagon Treatment|Adverse Event|1
2338199|NCT03339583|4066695|FG000|First Intervention (14 Days)|Adverse Event|1
2338200|NCT03339583|4066696|FG001|First Intervention (14 Days)|Adverse Event|0
2037605|NCT00419744|3608038|FG001|Overall Study|Moving out of state|0
2037606|NCT00419744|3608039|FG002|Overall Study|Moving out of state|1
2037607|NCT00419744|3608037|FG000|Overall Study|Physician Decision|10
2037608|NCT00419744|3608038|FG001|Overall Study|Physician Decision|5
2037609|NCT00419744|3608039|FG002|Overall Study|Physician Decision|6
2037610|NCT00419744|3608037|FG000|Overall Study|Spirometry mouthpiece issues|0
2037611|NCT00419744|3608038|FG001|Overall Study|Spirometry mouthpiece issues|1
2037612|NCT00419744|3608039|FG002|Overall Study|Spirometry mouthpiece issues|2
2037613|NCT00419744|3608037|FG000|Overall Study|Incorrect medication kit dispensed|0
2037614|NCT00419744|3608038|FG001|Overall Study|Incorrect medication kit dispensed|0
2037615|NCT00419744|3608039|FG002|Overall Study|Incorrect medication kit dispensed|1
2037616|NCT00419757|3608049|FG000|Overall Study|Adverse Event|1
2037617|NCT00419757|3608050|FG001|Overall Study|Adverse Event|4
2243064|NCT01953692|3901835|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
2243065|NCT01953692|3901836|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
2243066|NCT01953692|3901837|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2
2243067|NCT01953692|3901838|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
2243068|NCT01953692|3901830|FG000|Overall Study|Withdrawal by Subject|4
2243069|NCT01953692|3901831|FG001|Overall Study|Withdrawal by Subject|2
2243070|NCT01953692|3901832|FG002|Overall Study|Withdrawal by Subject|1
2243071|NCT01953692|3901833|FG003|Overall Study|Withdrawal by Subject|2
2243072|NCT01953692|3901834|FG004|Overall Study|Withdrawal by Subject|0
2243073|NCT01953692|3901835|FG005|Overall Study|Withdrawal by Subject|3
2243074|NCT01953692|3901836|FG006|Overall Study|Withdrawal by Subject|2
2243075|NCT01953692|3901837|FG007|Overall Study|Withdrawal by Subject|1
2243076|NCT01953692|3901838|FG008|Overall Study|Withdrawal by Subject|1
2243077|NCT01953783|3901868|FG000|Overall Study|Progressive disease|2
2243078|NCT01953913|3901882|FG000|Overall Study|Disease Progression|349
2243079|NCT01953913|3901882|FG000|Overall Study|Worsening of underlying cancer|22
2243080|NCT01953913|3901882|FG000|Overall Study|Adverse Event|20
2243081|NCT01953913|3901882|FG000|Overall Study|Protocol Violation|6
2243082|NCT01953913|3901882|FG000|Overall Study|Lost to Follow-up|4
2243083|NCT01953913|3901882|FG000|Overall Study|Withdrawal by Subject|32
2243084|NCT01953913|3901882|FG000|Overall Study|Other than listed|108
2243085|NCT01953913|3901882|FG000|Overall Study|Not Treated|1
2243086|NCT01954017|3901889|FG000|Overall Study|Adverse Event|0
2243087|NCT01954017|3901890|FG001|Overall Study|Adverse Event|0
2243088|NCT01954017|3901891|FG002|Overall Study|Adverse Event|1
2243089|NCT01954017|3901889|FG000|Overall Study|Death|2
2243090|NCT01954017|3901890|FG001|Overall Study|Death|1
2243091|NCT01954017|3901891|FG002|Overall Study|Death|1
2243092|NCT01954017|3901889|FG000|Overall Study|Withdrawal by Subject|0
2243093|NCT01954017|3901890|FG001|Overall Study|Withdrawal by Subject|1
2243094|NCT01954017|3901891|FG002|Overall Study|Withdrawal by Subject|0
2243095|NCT01954017|3901889|FG000|Overall Study|Protocol Violation|0
2243096|NCT01954017|3901890|FG001|Overall Study|Protocol Violation|3
2243097|NCT01954017|3901891|FG002|Overall Study|Protocol Violation|2
2243098|NCT01954017|3901889|FG000|Overall Study|Necrotizing enterocolitis|1
2243099|NCT01954017|3901890|FG001|Overall Study|Necrotizing enterocolitis|0
2243100|NCT01954017|3901891|FG002|Overall Study|Necrotizing enterocolitis|1
2243101|NCT01954017|3901889|FG000|Overall Study|Enteral intake stopped >7 days|0
2243102|NCT01954017|3901890|FG001|Overall Study|Enteral intake stopped >7 days|1
2243103|NCT01954017|3901891|FG002|Overall Study|Enteral intake stopped >7 days|1
2243104|NCT01954017|3901889|FG000|Overall Study|All other reasons|2
2243105|NCT01954017|3901890|FG001|Overall Study|All other reasons|2
2243106|NCT01954017|3901891|FG002|Overall Study|All other reasons|7
2243107|NCT01954056|3901927|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
2243108|NCT01954056|3901928|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
2243109|NCT01954082|3901936|FG000|Overall Study|Study Suspension|42
2243110|NCT01954082|3901937|FG001|Overall Study|Study Suspension|36
2243111|NCT01954082|3901936|FG000|Overall Study|Adverse Event|10
2243112|NCT01954082|3901937|FG001|Overall Study|Adverse Event|4
2243113|NCT01954082|3901936|FG000|Overall Study|Intolerance|0
2243114|NCT01954082|3901937|FG001|Overall Study|Intolerance|1
2243115|NCT01954082|3901936|FG000|Overall Study|Non-compliance|6
2243116|NCT01954082|3901937|FG001|Overall Study|Non-compliance|4
2243117|NCT01954082|3901936|FG000|Overall Study|Physician Decision|2
2243118|NCT01954082|3901937|FG001|Overall Study|Physician Decision|0
2243119|NCT01954082|3901936|FG000|Overall Study|Parent Decision|1
2243120|NCT01954082|3901937|FG001|Overall Study|Parent Decision|0
2243121|NCT01954082|3901936|FG000|Overall Study|Withdrawal by Subject|0
2243122|NCT01954082|3901937|FG001|Overall Study|Withdrawal by Subject|1
2243123|NCT01954082|3901936|FG000|Overall Study|Discontinued Early Prior to Transfer|3
2243124|NCT01954082|3901937|FG001|Overall Study|Discontinued Early Prior to Transfer|2
2243125|NCT01954082|3901936|FG000|Overall Study|Redirection of Care|0
2338201|NCT03339583|4066695|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0
2338202|NCT03339583|4066696|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1
2338203|NCT03339583|4066695|FG000|Second Intervention (14 Days)|Adverse Event|0
2338204|NCT03339583|4066696|FG001|Second Intervention (14 Days)|Adverse Event|1
2338205|NCT03339583|4066695|FG000|Follow-up (14 Days)|Physician Decision|6
2338206|NCT03339583|4066696|FG001|Follow-up (14 Days)|Physician Decision|3
2338207|NCT03339713|4066706|FG000|Overall Study|Lost to Follow-up|2
2338208|NCT03339713|4066707|FG001|Overall Study|Lost to Follow-up|1
2338209|NCT03339713|4066706|FG000|Overall Study|Protocol Violation|1
2338210|NCT03339713|4066707|FG001|Overall Study|Protocol Violation|0
2338211|NCT03339713|4066706|FG000|Overall Study|Withdrawal by Subject|1
2338212|NCT03339713|4066707|FG001|Overall Study|Withdrawal by Subject|1
2338213|NCT03339726|4066718|FG000|Overall Study|Withdrawal by Subject|1
2338214|NCT03339726|4066719|FG001|Overall Study|Withdrawal by Subject|0
2338215|NCT03339726|4066720|FG002|Overall Study|Withdrawal by Subject|0
2243126|NCT01954082|3901937|FG001|Overall Study|Redirection of Care|2
2243127|NCT01954082|3901936|FG000|Overall Study|Miscalculation of Final Dose Day|0
2243128|NCT01954082|3901937|FG001|Overall Study|Miscalculation of Final Dose Day|3
2243129|NCT01954082|3901936|FG000|Overall Study|Comfort Care|0
2243130|NCT01954082|3901937|FG001|Overall Study|Comfort Care|1
2243131|NCT01954082|3901936|FG000|Overall Study|Infant Moved|0
2243132|NCT01954082|3901937|FG001|Overall Study|Infant Moved|1
2243133|NCT01954082|3901936|FG000|Overall Study|Randomized not Treated|4
2243134|NCT01954082|3901937|FG001|Overall Study|Randomized not Treated|2
2243135|NCT01954121|3901945|FG000|Overall Study|Lack of Efficacy|94
2243136|NCT01954121|3901946|FG001|Overall Study|Lack of Efficacy|41
2243137|NCT01954121|3901945|FG000|Overall Study|Protocol Violation|0
2243138|NCT01954121|3901946|FG001|Overall Study|Protocol Violation|2
2243139|NCT01954121|3901945|FG000|Overall Study|Lost to Follow-up|5
2243140|NCT01954121|3901946|FG001|Overall Study|Lost to Follow-up|6
2243141|NCT01954121|3901945|FG000|Overall Study|Withdrawal by Subject|18
2243142|NCT01954121|3901946|FG001|Overall Study|Withdrawal by Subject|12
2243143|NCT01954121|3901945|FG000|Overall Study|Pregnancy|1
2243144|NCT01954121|3901946|FG001|Overall Study|Pregnancy|1
2243145|NCT01954121|3901945|FG000|Overall Study|AE, serious fatal|1
2243146|NCT01954121|3901946|FG001|Overall Study|AE, serious fatal|0
2243147|NCT01954121|3901945|FG000|Overall Study|AE, non-serious non-fatal|5
2243148|NCT01954121|3901946|FG001|Overall Study|AE, non-serious non-fatal|22
2243149|NCT01954121|3901945|FG000|Overall Study|SAE, non-fatal|1
2243150|NCT01954121|3901946|FG001|Overall Study|SAE, non-fatal|4
2243151|NCT01954121|3901945|FG000|Overall Study|Non-compliant with study procedures|1
2243152|NCT01954121|3901946|FG001|Overall Study|Non-compliant with study procedures|0
2243153|NCT01954121|3901945|FG000|Overall Study|Non-compliant patient|1
2243154|NCT01954121|3901946|FG001|Overall Study|Non-compliant patient|1
2243155|NCT01954121|3901945|FG000|Overall Study|Subject did not follow instructions|0
2243156|NCT01954121|3901946|FG001|Overall Study|Subject did not follow instructions|2
2243157|NCT01954251|3901954|FG000|Overall Study|Adverse Event|5
2243158|NCT01954251|3901955|FG001|Overall Study|Adverse Event|7
2243159|NCT01954251|3901954|FG000|Overall Study|Lost to Follow-up|6
2243160|NCT01954251|3901955|FG001|Overall Study|Lost to Follow-up|6
2243161|NCT01954251|3901954|FG000|Overall Study|Withdrawal by Subject|2
2243162|NCT01954251|3901955|FG001|Overall Study|Withdrawal by Subject|6
2243163|NCT01954342|3901983|FG000|Overall Study|Missing data from 13-16week study visit|0
2243164|NCT01954342|3901984|FG001|Overall Study|Missing data from 13-16week study visit|0
2243165|NCT01954342|3901985|FG002|Overall Study|Missing data from 13-16week study visit|0
2243166|NCT01954342|3901986|FG003|Overall Study|Missing data from 13-16week study visit|1
2243167|NCT01954342|3901983|FG000|Overall Study|Miscarriage|0
2243168|NCT01954342|3901984|FG001|Overall Study|Miscarriage|0
2243169|NCT01954342|3901985|FG002|Overall Study|Miscarriage|0
2243170|NCT01954342|3901986|FG003|Overall Study|Miscarriage|3
2243171|NCT01954342|3901983|FG000|Overall Study|Lost to Follow-up|0
2243172|NCT01954342|3901984|FG001|Overall Study|Lost to Follow-up|0
2243173|NCT01954342|3901985|FG002|Overall Study|Lost to Follow-up|0
2243174|NCT01954342|3901986|FG003|Overall Study|Lost to Follow-up|5
2338216|NCT03339726|4066718|FG000|Overall Study|Lost to Follow-up|0
2338217|NCT03339726|4066719|FG001|Overall Study|Lost to Follow-up|1
2338218|NCT03339726|4066720|FG002|Overall Study|Lost to Follow-up|0
2338219|NCT03339999|4066732|FG000|Overall Study|Adverse Event|1
2338220|NCT03339999|4066733|FG001|Overall Study|Adverse Event|2
2338221|NCT03339999|4066734|FG002|Overall Study|Adverse Event|2
2338222|NCT03339999|4066735|FG003|Overall Study|Adverse Event|1
2338223|NCT03339999|4066732|FG000|Overall Study|Lack of Efficacy|0
2338224|NCT03339999|4066733|FG001|Overall Study|Lack of Efficacy|1
2338225|NCT03339999|4066734|FG002|Overall Study|Lack of Efficacy|0
2338226|NCT03339999|4066735|FG003|Overall Study|Lack of Efficacy|0
2338227|NCT03339999|4066732|FG000|Overall Study|Lost to Follow-up|0
2338228|NCT03339999|4066733|FG001|Overall Study|Lost to Follow-up|0
2338229|NCT03339999|4066734|FG002|Overall Study|Lost to Follow-up|0
2338230|NCT03339999|4066735|FG003|Overall Study|Lost to Follow-up|1
2338231|NCT03339999|4066732|FG000|Overall Study|Study Terminated by Sponsor|6
2338232|NCT03339999|4066733|FG001|Overall Study|Study Terminated by Sponsor|3
2338233|NCT03339999|4066734|FG002|Overall Study|Study Terminated by Sponsor|4
2338234|NCT03339999|4066735|FG003|Overall Study|Study Terminated by Sponsor|3
2338235|NCT03340025|4066750|FG000|Overall Study|Lost to Follow-up|2
2338236|NCT03340025|4066751|FG001|Overall Study|Lost to Follow-up|2
2338237|NCT03340961|4066835|FG000|Overall Study|Adverse Event|1
2338238|NCT03340961|4066836|FG001|Overall Study|Adverse Event|3
2338239|NCT03340961|4066837|FG002|Overall Study|Adverse Event|2
2338240|NCT03340961|4066838|FG003|Overall Study|Adverse Event|4
2338241|NCT03340961|4066835|FG000|Overall Study|Lost to Follow-up|0
2338242|NCT03340961|4066836|FG001|Overall Study|Lost to Follow-up|1
2338243|NCT03340961|4066837|FG002|Overall Study|Lost to Follow-up|0
2338244|NCT03340961|4066838|FG003|Overall Study|Lost to Follow-up|1
2338245|NCT03340961|4066835|FG000|Overall Study|Withdrawal by Subject|3
2338246|NCT03340961|4066836|FG001|Overall Study|Withdrawal by Subject|2
2338247|NCT03340961|4066837|FG002|Overall Study|Withdrawal by Subject|4
2338248|NCT03340961|4066838|FG003|Overall Study|Withdrawal by Subject|7
2338249|NCT03340961|4066835|FG000|Overall Study|Use of prohibited treatment|0
2338250|NCT03340961|4066836|FG001|Overall Study|Use of prohibited treatment|3
2338251|NCT03340961|4066837|FG002|Overall Study|Use of prohibited treatment|2
2243175|NCT01954342|3901983|FG000|Overall Study|Preterm delivery|0
2243176|NCT01954342|3901984|FG001|Overall Study|Preterm delivery|0
2243177|NCT01954342|3901985|FG002|Overall Study|Preterm delivery|0
2243178|NCT01954342|3901986|FG003|Overall Study|Preterm delivery|3
2243179|NCT01954342|3901983|FG000|Overall Study|Pre-eclampsia|0
2243180|NCT01954342|3901984|FG001|Overall Study|Pre-eclampsia|0
2243181|NCT01954342|3901985|FG002|Overall Study|Pre-eclampsia|0
2243182|NCT01954342|3901986|FG003|Overall Study|Pre-eclampsia|4
2243183|NCT01954342|3901983|FG000|Overall Study|Unreliable Data|0
2243184|NCT01954342|3901984|FG001|Overall Study|Unreliable Data|0
2243185|NCT01954342|3901985|FG002|Overall Study|Unreliable Data|0
2243186|NCT01954342|3901986|FG003|Overall Study|Unreliable Data|2
2243187|NCT01954394|3901998|FG000|Overall Study|Enrolled but not treated|1
2243188|NCT01954394|3901999|FG001|Overall Study|Enrolled but not treated|0
2243189|NCT01954394|3901998|FG000|Overall Study|Adverse Event|10
2243190|NCT01954394|3901999|FG001|Overall Study|Adverse Event|23
2243191|NCT01954394|3901998|FG000|Overall Study|Poor compliance to protocol|7
2243192|NCT01954394|3901999|FG001|Overall Study|Poor compliance to protocol|7
2243193|NCT01954394|3901998|FG000|Overall Study|Participant Moved|0
2243194|NCT01954394|3901999|FG001|Overall Study|Participant Moved|4
2243195|NCT01954394|3901998|FG000|Overall Study|Related to Study Drug administration|2
2243196|NCT01954394|3901999|FG001|Overall Study|Related to Study Drug administration|2
2243197|NCT01954394|3901998|FG000|Overall Study|Other than specified above|10
2243198|NCT01954394|3901999|FG001|Overall Study|Other than specified above|21
2243199|NCT01954745|3902020|FG000|Overall Study|Radiological Progression|11
2243200|NCT01954745|3902020|FG000|Overall Study|Clinical Progression|5
2243201|NCT01954745|3902020|FG000|Overall Study|Adverse Event|2
2243202|NCT01954745|3902020|FG000|Overall Study|Death|1
2243203|NCT01954771|3902027|FG000|Overall Study|Missing HbA1c of end-point|1
2243204|NCT01954771|3902028|FG001|Overall Study|Missing HbA1c of end-point|1
2243205|NCT01954771|3902029|FG002|Overall Study|Missing HbA1c of end-point|0
2243206|NCT01954771|3902027|FG000|Overall Study|Missing CGMS of end-point|1
2243207|NCT01954771|3902028|FG001|Overall Study|Missing CGMS of end-point|1
2243208|NCT01954771|3902029|FG002|Overall Study|Missing CGMS of end-point|0
2243209|NCT01954771|3902027|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5
2243210|NCT01954771|3902028|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1
2243211|NCT01954771|3902029|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3
2243212|NCT01954927|3902042|FG000|Overall Study|Withdrawal by Subject|3
2243213|NCT01954927|3902043|FG001|Overall Study|Withdrawal by Subject|1
2243214|NCT01955005|3902051|FG000|Overall Study|Withdrawal by Subject|3
2243215|NCT01955005|3902052|FG001|Overall Study|Withdrawal by Subject|5
2243216|NCT01955044|3902061|FG000|Overall Study|Death|1
2243217|NCT01955044|3902062|FG001|Overall Study|Death|1
2243218|NCT01955044|3902063|FG002|Overall Study|Death|0
2243219|NCT01955083|3902073|FG000|Overall Study|Lost to Follow-up|1
2243220|NCT01955083|3902074|FG001|Overall Study|Lost to Follow-up|1
2243221|NCT01955122|3902106|FG000|Overall Study|Physician Decision|5
2243222|NCT01955122|3902107|FG001|Overall Study|Physician Decision|5
2243223|NCT01955161|3902122|FG000|Overall Study|Withdrawal before treatment|2
2243224|NCT01955161|3902123|FG001|Overall Study|Withdrawal before treatment|0
2243225|NCT01955161|3902124|FG002|Overall Study|Withdrawal before treatment|1
2243226|NCT01955161|3902122|FG000|Overall Study|Adverse Event|10
2243227|NCT01955161|3902123|FG001|Overall Study|Adverse Event|14
2243228|NCT01955161|3902124|FG002|Overall Study|Adverse Event|15
2243229|NCT01955161|3902122|FG000|Overall Study|Death|1
2243230|NCT01955161|3902123|FG001|Overall Study|Death|1
2243231|NCT01955161|3902124|FG002|Overall Study|Death|3
2243232|NCT01955161|3902122|FG000|Overall Study|Withdrawal by Subject|9
2243233|NCT01955161|3902123|FG001|Overall Study|Withdrawal by Subject|8
2243234|NCT01955161|3902124|FG002|Overall Study|Withdrawal by Subject|12
2243235|NCT01955161|3902122|FG000|Overall Study|Protocol Violation|2
2243236|NCT01955161|3902123|FG001|Overall Study|Protocol Violation|0
2243237|NCT01955161|3902124|FG002|Overall Study|Protocol Violation|0
2243238|NCT01955161|3902122|FG000|Overall Study|Other reason: physician decision|0
2243239|NCT01955161|3902123|FG001|Overall Study|Other reason: physician decision|1
2243240|NCT01955161|3902124|FG002|Overall Study|Other reason: physician decision|1
2243241|NCT01955161|3902122|FG000|Overall Study|Other reason: disallowed medication|1
2243242|NCT01955161|3902123|FG001|Overall Study|Other reason: disallowed medication|0
2243243|NCT01955161|3902124|FG002|Overall Study|Other reason: disallowed medication|1
2243244|NCT01955161|3902122|FG000|Overall Study|Other reason: caregiver unavailable|1
2243245|NCT01955161|3902123|FG001|Overall Study|Other reason: caregiver unavailable|0
2243246|NCT01955161|3902124|FG002|Overall Study|Other reason: caregiver unavailable|0
2243247|NCT01955161|3902122|FG000|Overall Study|Other reason: moved to nursing home|0
2243248|NCT01955161|3902123|FG001|Overall Study|Other reason: moved to nursing home|1
2243249|NCT01955161|3902124|FG002|Overall Study|Other reason: moved to nursing home|0
2243250|NCT01955161|3902122|FG000|Overall Study|Other reason: insufficient compliance|0
2338252|NCT03340961|4066838|FG003|Overall Study|Use of prohibited treatment|4
2338253|NCT03340961|4066835|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0
2338254|NCT03340961|4066836|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1
2338255|NCT03340961|4066837|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0
2338256|NCT03340961|4066838|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1
2338257|NCT03340961|4066835|FG000|Overall Study|Subject developed an exclusion criterion|0
2338258|NCT03340961|4066836|FG001|Overall Study|Subject developed an exclusion criterion|1
2338259|NCT03340961|4066837|FG002|Overall Study|Subject developed an exclusion criterion|0
2338260|NCT03340961|4066838|FG003|Overall Study|Subject developed an exclusion criterion|0
2338261|NCT03340961|4066835|FG000|Overall Study|Protocol Violation|1
2243251|NCT01955161|3902123|FG001|Overall Study|Other reason: insufficient compliance|0
2243252|NCT01955161|3902124|FG002|Overall Study|Other reason: insufficient compliance|1
2243253|NCT01955161|3902122|FG000|Overall Study|Other reason: primary biliary cirrhosis|1
2243254|NCT01955161|3902123|FG001|Overall Study|Other reason: primary biliary cirrhosis|0
2243255|NCT01955161|3902124|FG002|Overall Study|Other reason: primary biliary cirrhosis|0
2243256|NCT01955161|3902122|FG000|Overall Study|Other reason: patient's will|0
2243257|NCT01955161|3902123|FG001|Overall Study|Other reason: patient's will|0
2243258|NCT01955161|3902124|FG002|Overall Study|Other reason: patient's will|1
2243259|NCT01955707|3902216|FG000|Overall Study|Adverse Event|1
2243260|NCT01955707|3902217|FG001|Overall Study|Adverse Event|2
2243261|NCT01955707|3902216|FG000|Overall Study|Lost to Follow-up|2
2243262|NCT01955707|3902217|FG001|Overall Study|Lost to Follow-up|1
2243263|NCT01955707|3902216|FG000|Overall Study|Withdrawal by Subject|0
2243264|NCT01955707|3902217|FG001|Overall Study|Withdrawal by Subject|3
2243265|NCT01955707|3902216|FG000|Overall Study|Death|13
2243266|NCT01955707|3902217|FG001|Overall Study|Death|14
2243267|NCT01955707|3902216|FG000|Overall Study|Other|4
2243268|NCT01955707|3902217|FG001|Overall Study|Other|2
2243269|NCT01955733|3902277|FG000|Period 1|Lost to Follow-up|1
2243270|NCT01955733|3902278|FG001|Period 1|Lost to Follow-up|0
2243271|NCT01955733|3902279|FG002|Period 1|Lost to Follow-up|0
2243272|NCT01955733|3902277|FG000|Period 2|Adverse Event|1
2243273|NCT01955733|3902278|FG001|Period 2|Adverse Event|0
2243274|NCT01955733|3902279|FG002|Period 2|Adverse Event|0
2243275|NCT01955733|3902277|FG000|Period 2|Physician Decision|0
2243276|NCT01955733|3902278|FG001|Period 2|Physician Decision|0
2243277|NCT01955733|3902279|FG002|Period 2|Physician Decision|1
2243278|NCT01955733|3902277|FG000|Period 2|Withdrawal by Subject|1
2243279|NCT01955733|3902278|FG001|Period 2|Withdrawal by Subject|3
2243280|NCT01955733|3902279|FG002|Period 2|Withdrawal by Subject|2
2243281|NCT01955733|3902277|FG000|Period 2|Study terminated by sponsor|8
2243282|NCT01955733|3902278|FG001|Period 2|Study terminated by sponsor|14
2243283|NCT01955733|3902279|FG002|Period 2|Study terminated by sponsor|16
2338262|NCT03340961|4066836|FG001|Overall Study|Protocol Violation|0
2338263|NCT03340961|4066837|FG002|Overall Study|Protocol Violation|1
2338264|NCT03340961|4066838|FG003|Overall Study|Protocol Violation|0
2338265|NCT03340961|4066835|FG000|Overall Study|Adverse Event|1
2338266|NCT03340961|4066836|FG001|Overall Study|Adverse Event|1
2338267|NCT03340961|4066837|FG002|Overall Study|Adverse Event|0
2338268|NCT03340961|4066838|FG003|Overall Study|Adverse Event|0
2338269|NCT03340961|4066835|FG000|Overall Study|Lack of Efficacy|0
2338270|NCT03340961|4066836|FG001|Overall Study|Lack of Efficacy|0
2338271|NCT03340961|4066837|FG002|Overall Study|Lack of Efficacy|0
2338272|NCT03340961|4066838|FG003|Overall Study|Lack of Efficacy|1
2338273|NCT03341273|4066850|FG000|Overall Study|Lost to Follow-up|7
2338274|NCT03341273|4066851|FG001|Overall Study|Lost to Follow-up|7
2338275|NCT03341273|4066850|FG000|Overall Study|Withdrawal by Subject|4
2338276|NCT03341273|4066851|FG001|Overall Study|Withdrawal by Subject|2
2338277|NCT03341273|4066850|FG000|Overall Study|Physician Decision|1
2338278|NCT03341273|4066851|FG001|Overall Study|Physician Decision|0
2338279|NCT03341273|4066850|FG000|Overall Study|Protocol Violation|0
2338280|NCT03341273|4066851|FG001|Overall Study|Protocol Violation|1
2338281|NCT03341273|4066850|FG000|Overall Study|Enrolled but Treatment Not Administered|6
2338282|NCT03341273|4066851|FG001|Overall Study|Enrolled but Treatment Not Administered|1
2338283|NCT03341273|4066850|FG000|Overall Study|Became ineligible after enrollment|1
2338284|NCT03341273|4066851|FG001|Overall Study|Became ineligible after enrollment|0
2338285|NCT03341273|4066850|FG000|Overall Study|Not Eligible at Enrollment|0
2338286|NCT03341273|4066851|FG001|Overall Study|Not Eligible at Enrollment|1
2338287|NCT03341273|4066850|FG000|Overall Study|Participant incarcerated|1
2338288|NCT03341273|4066851|FG001|Overall Study|Participant incarcerated|0
2338289|NCT03341299|4066857|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0
2338290|NCT03341299|4066858|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0
2338291|NCT03341299|4066859|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1
2338292|NCT03341299|4066860|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0
2338293|NCT03341312|4066872|FG000|Period 1|Withdrawal by Subject|0
2338294|NCT03341312|4066873|FG001|Period 1|Withdrawal by Subject|1
2338295|NCT03341312|4066874|FG002|Period 1|Withdrawal by Subject|0
2338296|NCT03341312|4066875|FG003|Period 1|Withdrawal by Subject|0
2338297|NCT03341507|4066887|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34
2338298|NCT03341533|4066893|FG000|Overall Study|Withdrawal by Subject|1
2338299|NCT03341533|4066894|FG001|Overall Study|Withdrawal by Subject|1
2338300|NCT03341533|4066893|FG000|Overall Study|Not eligible after randomization|2
2338301|NCT03341533|4066894|FG001|Overall Study|Not eligible after randomization|1
2338302|NCT03341637|4066906|FG000|Overall Study|Lost to Follow-up|1
2338303|NCT03341637|4066907|FG001|Overall Study|Lost to Follow-up|0
2338304|NCT03341637|4066906|FG000|Overall Study|Withdrawal by Subject|3
2338305|NCT03341637|4066907|FG001|Overall Study|Withdrawal by Subject|3
2338306|NCT03341637|4066906|FG000|Overall Study|Reason not Specified|1
2338307|NCT03341637|4066907|FG001|Overall Study|Reason not Specified|1
2338308|NCT03341923|4066937|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0
2338309|NCT03341923|4066938|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1
2338310|NCT03342053|4066957|FG000|Overall Study|Adverse Event|2
2243284|NCT01955733|3902277|FG000|Period 2|Lost to Follow-up|2
2243285|NCT01955733|3902278|FG001|Period 2|Lost to Follow-up|0
2243286|NCT01955733|3902279|FG002|Period 2|Lost to Follow-up|0
2243287|NCT01955733|3902277|FG000|Period 2|Other not defined above|0
2243288|NCT01955733|3902278|FG001|Period 2|Other not defined above|2
2243289|NCT01955733|3902279|FG002|Period 2|Other not defined above|2
2338311|NCT03342053|4066958|FG001|Overall Study|Adverse Event|0
2338312|NCT03342053|4066957|FG000|Overall Study|Withdrawal by Subject|0
2338313|NCT03342053|4066958|FG001|Overall Study|Withdrawal by Subject|1
2338314|NCT03342404|4066966|FG000|Overall Study|Withdrawal by Subject|9
2338315|NCT03342404|4066967|FG001|Overall Study|Withdrawal by Subject|10
2338316|NCT03342404|4066966|FG000|Overall Study|Lack of Efficacy|1
2338317|NCT03342404|4066967|FG001|Overall Study|Lack of Efficacy|17
2338318|NCT03342404|4066966|FG000|Overall Study|Adverse Event|3
2338319|NCT03342404|4066967|FG001|Overall Study|Adverse Event|4
2338320|NCT03342404|4066966|FG000|Overall Study|Noncompliance with study drug|1
2338321|NCT03342404|4066967|FG001|Overall Study|Noncompliance with study drug|0
2338322|NCT03342404|4066966|FG000|Overall Study|Other reasons|1
2338323|NCT03342404|4066967|FG001|Overall Study|Other reasons|0
2338324|NCT03342469|4066975|FG000|Overall Study|Withdrawal by Subject|0
2338325|NCT03342469|4066976|FG001|Overall Study|Withdrawal by Subject|1
2338326|NCT03342469|4066977|FG002|Overall Study|Withdrawal by Subject|0
2338327|NCT03342469|4066978|FG003|Overall Study|Withdrawal by Subject|0
2338328|NCT03342560|4066989|FG000|Overall Study|Lost to Follow-up|2
2338329|NCT03342690|4066997|FG000|Overall Study|Missing Information|9
2338330|NCT03342690|4066997|FG000|Overall Study|Protocol Violation|16
2338331|NCT03342898|4067004|FG000|Overall Study|Adverse Event|3
2338332|NCT03342898|4067005|FG001|Overall Study|Adverse Event|1
2338333|NCT03342898|4067006|FG002|Overall Study|Adverse Event|0
2338334|NCT03342898|4067004|FG000|Overall Study|Lost to Follow-up|44
2338335|NCT03342898|4067005|FG001|Overall Study|Lost to Follow-up|40
2338336|NCT03342898|4067006|FG002|Overall Study|Lost to Follow-up|42
2338337|NCT03342898|4067004|FG000|Overall Study|Withdrawal of Consent|5
2338338|NCT03342898|4067005|FG001|Overall Study|Withdrawal of Consent|9
2338339|NCT03342898|4067006|FG002|Overall Study|Withdrawal of Consent|11
2338340|NCT03342898|4067004|FG000|Overall Study|Death|0
2338341|NCT03342898|4067005|FG001|Overall Study|Death|1
2338342|NCT03342898|4067006|FG002|Overall Study|Death|1
2338343|NCT03342898|4067004|FG000|Overall Study|Reason not Specified|2
2338344|NCT03342898|4067005|FG001|Overall Study|Reason not Specified|2
2338345|NCT03342898|4067006|FG002|Overall Study|Reason not Specified|0
2338346|NCT03342963|4067018|FG000|Overall Study|Adverse Event|1
2338347|NCT03342963|4067019|FG001|Overall Study|Adverse Event|2
2338348|NCT03342963|4067020|FG002|Overall Study|Adverse Event|0
2338349|NCT03342963|4067021|FG003|Overall Study|Adverse Event|0
2338350|NCT03342963|4067018|FG000|Overall Study|Withdrawal by Subject|1
2338351|NCT03342963|4067019|FG001|Overall Study|Withdrawal by Subject|0
2338352|NCT03342963|4067020|FG002|Overall Study|Withdrawal by Subject|0
2338353|NCT03342963|4067021|FG003|Overall Study|Withdrawal by Subject|0
2338354|NCT03343067|4067034|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
2338355|NCT03343067|4067035|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
2338356|NCT03343067|4067036|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
2338357|NCT03343639|4067055|FG000|Overall Study|Withdrawal by Subject|10
2338358|NCT03343639|4067056|FG001|Overall Study|Withdrawal by Subject|6
2338359|NCT03343639|4067055|FG000|Overall Study|Lost to Follow-up|4
2338360|NCT03343639|4067056|FG001|Overall Study|Lost to Follow-up|5
2338361|NCT03343639|4067055|FG000|Overall Study|Protocol Violation|0
2338362|NCT03343639|4067056|FG001|Overall Study|Protocol Violation|1
2338363|NCT03343704|4067064|FG000|Overall Study|Refused to complete follow up|0
2338364|NCT03343704|4067065|FG001|Overall Study|Refused to complete follow up|1
2338365|NCT03343704|4067064|FG000|Overall Study|Death|0
2338366|NCT03343704|4067065|FG001|Overall Study|Death|1
2338367|NCT03343704|4067064|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1
2338368|NCT03343704|4067065|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0
2037618|NCT00419757|3608049|FG000|Overall Study|Lost to Follow-up|1
2037619|NCT00419757|3608050|FG001|Overall Study|Lost to Follow-up|4
2037620|NCT00419757|3608049|FG000|Overall Study|Withdrawal by Subject|7
2037621|NCT00419757|3608050|FG001|Overall Study|Withdrawal by Subject|1
2037622|NCT00419757|3608049|FG000|Overall Study|Protocol Violation|2
2037623|NCT00419757|3608050|FG001|Overall Study|Protocol Violation|3
2037624|NCT00419757|3608049|FG000|Overall Study|Study specific discontinuation criteria|4
2037625|NCT00419757|3608050|FG001|Overall Study|Study specific discontinuation criteria|8
2037626|NCT00419757|3608049|FG000|Overall Study|Multiple reasons|3
2037627|NCT00419757|3608050|FG001|Overall Study|Multiple reasons|1
2037628|NCT00419770|3608060|FG000|Overall Study|Withdrawal by Subject|5
2037629|NCT00419770|3608061|FG001|Overall Study|Withdrawal by Subject|1
2037630|NCT00419926|3608069|FG000|Overall Study|Withdrawal by Subject|7
2037631|NCT00419926|3608070|FG001|Overall Study|Withdrawal by Subject|3
2037632|NCT00419926|3608069|FG000|Overall Study|Administrative Problem|4
2037633|NCT00419926|3608070|FG001|Overall Study|Administrative Problem|4
2037634|NCT00419926|3608069|FG000|Overall Study|Lost to Follow-up|1
2243290|NCT01956123|3902323|FG000|COS Cycle 2|Protocol Violation|8
2243291|NCT01956123|3902324|FG001|COS Cycle 2|Protocol Violation|3
2338369|NCT03344172|4067075|FG000|Overall Study|Received <1 dose of treatment|1
2243292|NCT01956123|3902325|FG002|COS Cycle 2|Protocol Violation|0
2243293|NCT01956123|3902326|FG003|COS Cycle 2|Protocol Violation|0
2243294|NCT01956123|3902323|FG000|COS Cycle 2|Adverse Event|3
2243295|NCT01956123|3902324|FG001|COS Cycle 2|Adverse Event|4
2243296|NCT01956123|3902325|FG002|COS Cycle 2|Adverse Event|0
2243297|NCT01956123|3902326|FG003|COS Cycle 2|Adverse Event|0
2243298|NCT01956123|3902323|FG000|COS Cycle 2|Personal Reasons|2
2243299|NCT01956123|3902324|FG001|COS Cycle 2|Personal Reasons|0
2243300|NCT01956123|3902325|FG002|COS Cycle 2|Personal Reasons|0
2243301|NCT01956123|3902326|FG003|COS Cycle 2|Personal Reasons|0
2243302|NCT01956123|3902323|FG000|COS Cycle 2|Withdrawal by Subject|1
2243303|NCT01956123|3902324|FG001|COS Cycle 2|Withdrawal by Subject|0
2243304|NCT01956123|3902325|FG002|COS Cycle 2|Withdrawal by Subject|0
2243305|NCT01956123|3902326|FG003|COS Cycle 2|Withdrawal by Subject|0
2243306|NCT01956123|3902323|FG000|COS Cycle 3|Protocol Violation|0
2243307|NCT01956123|3902324|FG001|COS Cycle 3|Protocol Violation|0
2243308|NCT01956123|3902325|FG002|COS Cycle 3|Protocol Violation|2
2243309|NCT01956123|3902326|FG003|COS Cycle 3|Protocol Violation|1
2243310|NCT01956123|3902323|FG000|COS Cycle 3|Adverse Event|0
2243311|NCT01956123|3902324|FG001|COS Cycle 3|Adverse Event|0
2243312|NCT01956123|3902325|FG002|COS Cycle 3|Adverse Event|3
2243313|NCT01956123|3902326|FG003|COS Cycle 3|Adverse Event|0
2243314|NCT01956123|3902323|FG000|COS Cycle 3|Personal Reasons|0
2243315|NCT01956123|3902324|FG001|COS Cycle 3|Personal Reasons|0
2243316|NCT01956123|3902325|FG002|COS Cycle 3|Personal Reasons|1
2243317|NCT01956123|3902326|FG003|COS Cycle 3|Personal Reasons|0
2243318|NCT01956123|3902323|FG000|COS Cycle 3|Withdrawal by Subject|0
2243319|NCT01956123|3902324|FG001|COS Cycle 3|Withdrawal by Subject|0
2243320|NCT01956123|3902325|FG002|COS Cycle 3|Withdrawal by Subject|0
2243321|NCT01956123|3902326|FG003|COS Cycle 3|Withdrawal by Subject|1
2243322|NCT01956240|3902339|FG000|Overall Study|Lost to Follow-up|6
2243323|NCT01956240|3902340|FG001|Overall Study|Lost to Follow-up|20
2243324|NCT01956240|3902339|FG000|Overall Study|Adverse Event|17
2243325|NCT01956240|3902340|FG001|Overall Study|Adverse Event|4
2243326|NCT01956773|3902365|FG000|Overall Study|Lost to Follow-up|628
2243327|NCT01956773|3902366|FG001|Overall Study|Lost to Follow-up|1
2243328|NCT01957111|3902379|FG000|Overall Study|Withdrawal by Subject|1
2243329|NCT01957111|3902380|FG001|Overall Study|Withdrawal by Subject|1
2243330|NCT01957137|3902386|FG000|Randomized Portion|Adverse Event|1
2243331|NCT01957137|3902386|FG000|Randomized Portion|Withdrawal by Subject|1
2243332|NCT01957150|3902400|FG000|Overall Study|Adverse Event|23
2243333|NCT01957150|3902401|FG001|Overall Study|Adverse Event|20
2243334|NCT01957150|3902400|FG000|Overall Study|Withdrawal by Subject|13
2243335|NCT01957150|3902401|FG001|Overall Study|Withdrawal by Subject|17
2243336|NCT01957150|3902400|FG000|Overall Study|Physician Decision|3
2243337|NCT01957150|3902401|FG001|Overall Study|Physician Decision|6
2243338|NCT01957150|3902400|FG000|Overall Study|Lost to Follow-up|4
2243339|NCT01957150|3902401|FG001|Overall Study|Lost to Follow-up|4
2243340|NCT01957150|3902400|FG000|Overall Study|Protocol Violation|1
2243341|NCT01957150|3902401|FG001|Overall Study|Protocol Violation|0
2243342|NCT01957150|3902400|FG000|Overall Study|Lack of Efficacy|11
2243343|NCT01957150|3902401|FG001|Overall Study|Lack of Efficacy|11
2243344|NCT01957163|3902410|FG000|Overall Study|Adverse Event|5
2243345|NCT01957163|3902411|FG001|Overall Study|Adverse Event|2
2243346|NCT01957163|3902412|FG002|Overall Study|Adverse Event|4
2243347|NCT01957163|3902410|FG000|Overall Study|Lack of Efficacy|5
2338370|NCT03344172|4067076|FG001|Overall Study|Received <1 dose of treatment|0
2338371|NCT03344640|4067092|FG000|Overall Study|Adverse Event|1
2338372|NCT03344640|4067093|FG001|Overall Study|Adverse Event|0
2338373|NCT03344640|4067092|FG000|Overall Study|Physician Decision|1
2338374|NCT03344640|4067093|FG001|Overall Study|Physician Decision|1
2338375|NCT03344640|4067092|FG000|Overall Study|Withdrawal by Subject|1
2338376|NCT03344640|4067093|FG001|Overall Study|Withdrawal by Subject|2
2338377|NCT03344640|4067092|FG000|Follow-up Epoch|Withdrawal by Subject|0
2338378|NCT03344640|4067093|FG001|Follow-up Epoch|Withdrawal by Subject|2
2338379|NCT03345407|4067136|FG000|Overall Study|Withdrawal by Subject|11
2338380|NCT03345407|4067137|FG001|Overall Study|Withdrawal by Subject|1
2338381|NCT03345407|4067138|FG002|Overall Study|Withdrawal by Subject|5
2338382|NCT03345407|4067139|FG003|Overall Study|Withdrawal by Subject|6
2338383|NCT03345407|4067140|FG004|Overall Study|Withdrawal by Subject|3
2338384|NCT03345407|4067141|FG005|Overall Study|Withdrawal by Subject|6
2338385|NCT03345407|4067142|FG006|Overall Study|Withdrawal by Subject|16
2338386|NCT03345407|4067136|FG000|Overall Study|Physician Decision|3
2338387|NCT03345407|4067137|FG001|Overall Study|Physician Decision|1
2338388|NCT03345407|4067138|FG002|Overall Study|Physician Decision|0
2338389|NCT03345407|4067139|FG003|Overall Study|Physician Decision|0
2338390|NCT03345407|4067140|FG004|Overall Study|Physician Decision|1
2338391|NCT03345407|4067141|FG005|Overall Study|Physician Decision|2
2338392|NCT03345407|4067142|FG006|Overall Study|Physician Decision|3
2338393|NCT03345407|4067136|FG000|Overall Study|Lost to Follow-up|2
2338394|NCT03345407|4067137|FG001|Overall Study|Lost to Follow-up|0
2338395|NCT03345407|4067138|FG002|Overall Study|Lost to Follow-up|1
2338396|NCT03345407|4067139|FG003|Overall Study|Lost to Follow-up|0
2338397|NCT03345407|4067140|FG004|Overall Study|Lost to Follow-up|1
2243348|NCT01957163|3902411|FG001|Overall Study|Lack of Efficacy|4
2243349|NCT01957163|3902412|FG002|Overall Study|Lack of Efficacy|9
2338398|NCT03345407|4067141|FG005|Overall Study|Lost to Follow-up|2
2243350|NCT01957163|3902410|FG000|Overall Study|Protocol Violation|1
2243351|NCT01957163|3902411|FG001|Overall Study|Protocol Violation|2
2243352|NCT01957163|3902412|FG002|Overall Study|Protocol Violation|0
2243353|NCT01957163|3902410|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0
2243354|NCT01957163|3902411|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0
2243355|NCT01957163|3902412|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1
2243356|NCT01957163|3902410|FG000|Overall Study|Lost to Follow-up|0
2243357|NCT01957163|3902411|FG001|Overall Study|Lost to Follow-up|1
2243358|NCT01957163|3902412|FG002|Overall Study|Lost to Follow-up|0
2243359|NCT01957163|3902410|FG000|Overall Study|Withdrawal by Subject|4
2243360|NCT01957163|3902411|FG001|Overall Study|Withdrawal by Subject|2
2243361|NCT01957163|3902412|FG002|Overall Study|Withdrawal by Subject|4
2243362|NCT01957202|3902420|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243363|NCT01957202|3902421|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
2243364|NCT01957202|3902422|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243365|NCT01957202|3902423|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243366|NCT01957202|3902424|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243367|NCT01957202|3902425|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243368|NCT01957202|3902426|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243369|NCT01957202|3902427|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243370|NCT01957202|3902428|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243371|NCT01957202|3902429|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243372|NCT01957202|3902430|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243373|NCT01957202|3902431|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243374|NCT01957202|3902432|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243375|NCT01957202|3902433|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243376|NCT01957202|3902434|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243377|NCT01957202|3902435|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243378|NCT01957202|3902436|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
2243379|NCT01957202|3902437|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2243380|NCT01957202|3902420|FG000|Treatment Period 3 (8 Days)|Adverse Event|0
2243381|NCT01957202|3902421|FG001|Treatment Period 3 (8 Days)|Adverse Event|0
2243382|NCT01957202|3902422|FG002|Treatment Period 3 (8 Days)|Adverse Event|0
2243383|NCT01957202|3902423|FG003|Treatment Period 3 (8 Days)|Adverse Event|0
2243384|NCT01957202|3902424|FG004|Treatment Period 3 (8 Days)|Adverse Event|0
2243385|NCT01957202|3902425|FG005|Treatment Period 3 (8 Days)|Adverse Event|0
2243386|NCT01957202|3902426|FG006|Treatment Period 3 (8 Days)|Adverse Event|0
2243387|NCT01957202|3902427|FG007|Treatment Period 3 (8 Days)|Adverse Event|0
2243388|NCT01957202|3902428|FG008|Treatment Period 3 (8 Days)|Adverse Event|0
2243389|NCT01957202|3902429|FG009|Treatment Period 3 (8 Days)|Adverse Event|0
2243390|NCT01957202|3902430|FG010|Treatment Period 3 (8 Days)|Adverse Event|0
2243391|NCT01957202|3902431|FG011|Treatment Period 3 (8 Days)|Adverse Event|0
2243392|NCT01957202|3902432|FG012|Treatment Period 3 (8 Days)|Adverse Event|0
2243393|NCT01957202|3902433|FG013|Treatment Period 3 (8 Days)|Adverse Event|0
2243394|NCT01957202|3902434|FG014|Treatment Period 3 (8 Days)|Adverse Event|0
2243395|NCT01957202|3902435|FG015|Treatment Period 3 (8 Days)|Adverse Event|0
2243396|NCT01957202|3902436|FG016|Treatment Period 3 (8 Days)|Adverse Event|1
2243397|NCT01957202|3902437|FG017|Treatment Period 3 (8 Days)|Adverse Event|0
2243398|NCT01957215|3902449|FG000|Overall Study|Adverse Event|2
2243399|NCT01957215|3902450|FG001|Overall Study|Adverse Event|2
2243400|NCT01957215|3902449|FG000|Overall Study|Lost to Follow-up|3
2243401|NCT01957215|3902450|FG001|Overall Study|Lost to Follow-up|3
2243402|NCT01957215|3902449|FG000|Overall Study|Protocol Violation|1
2243403|NCT01957215|3902450|FG001|Overall Study|Protocol Violation|2
2243404|NCT01957215|3902449|FG000|Overall Study|Withdrawal by Subject|7
2243405|NCT01957215|3902450|FG001|Overall Study|Withdrawal by Subject|5
2243406|NCT01957397|3902473|FG000|Test Period 1|sudden leakage/small bag|1
2243407|NCT01957397|3902474|FG001|Test Period 1|sudden leakage/small bag|1
2243408|NCT01957397|3902473|FG000|Test Period 1|Withdrawal by Subject|1
2243409|NCT01957397|3902474|FG001|Test Period 1|Withdrawal by Subject|0
2243410|NCT01957397|3902473|FG000|Test Period 2|Adverse Event|0
2243411|NCT01957397|3902474|FG001|Test Period 2|Adverse Event|1
2243412|NCT01957397|3902473|FG000|Test Period 3|Adverse Event|1
2243413|NCT01957397|3902474|FG001|Test Period 3|Adverse Event|2
2243414|NCT01957397|3902473|FG000|Test Period 3|the adhesive did not work|1
2243415|NCT01957397|3902474|FG001|Test Period 3|the adhesive did not work|0
2338399|NCT03345407|4067142|FG006|Overall Study|Lost to Follow-up|3
2338400|NCT03345407|4067136|FG000|Overall Study|Protocol-defined stopping criteria|9
2338401|NCT03345407|4067137|FG001|Overall Study|Protocol-defined stopping criteria|0
2338402|NCT03345407|4067138|FG002|Overall Study|Protocol-defined stopping criteria|0
2338403|NCT03345407|4067139|FG003|Overall Study|Protocol-defined stopping criteria|0
2338404|NCT03345407|4067140|FG004|Overall Study|Protocol-defined stopping criteria|2
2338405|NCT03345407|4067141|FG005|Overall Study|Protocol-defined stopping criteria|1
2338406|NCT03345407|4067142|FG006|Overall Study|Protocol-defined stopping criteria|1
2338407|NCT03345407|4067136|FG000|Overall Study|Protocol Violation|2
2338408|NCT03345407|4067137|FG001|Overall Study|Protocol Violation|0
2338409|NCT03345407|4067138|FG002|Overall Study|Protocol Violation|0
2338410|NCT03345407|4067139|FG003|Overall Study|Protocol Violation|0
2338411|NCT03345407|4067140|FG004|Overall Study|Protocol Violation|1
2338412|NCT03345407|4067141|FG005|Overall Study|Protocol Violation|0
2338413|NCT03345407|4067142|FG006|Overall Study|Protocol Violation|3
2243416|NCT01957462|3902488|FG000|Test Period 1|Withdrawal by Subject|1
2243417|NCT01957462|3902489|FG001|Test Period 1|Withdrawal by Subject|0
2243418|NCT01957462|3902488|FG000|Test Period 1|Adverse Event|1
2243419|NCT01957462|3902489|FG001|Test Period 1|Adverse Event|0
2243420|NCT01957475|3902495|FG000|Test Period 1|Withdrawal by Subject|1
2243421|NCT01957475|3902496|FG001|Test Period 1|Withdrawal by Subject|0
2243422|NCT01957475|3902495|FG000|Test Period 1|Other|1
2243423|NCT01957475|3902496|FG001|Test Period 1|Other|0
2243424|NCT01957475|3902495|FG000|Test Period 1|Lack of Efficacy|0
2243425|NCT01957475|3902496|FG001|Test Period 1|Lack of Efficacy|1
2243426|NCT01957475|3902495|FG000|Test Period 2|Adverse Event|1
2243427|NCT01957475|3902496|FG001|Test Period 2|Adverse Event|0
2243428|NCT01957488|3902502|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2
2243429|NCT01957488|3902503|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0
2243430|NCT01957488|3902504|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1
2243431|NCT01957488|3902505|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1
2243432|NCT01957488|3902506|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0
2243433|NCT01957488|3902507|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0
2243434|NCT01957488|3902502|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1
2243435|NCT01957488|3902503|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2
2243436|NCT01957488|3902504|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2
2243437|NCT01957488|3902505|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1
2243438|NCT01957488|3902506|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0
2243439|NCT01957488|3902507|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3
2243440|NCT01957488|3902502|FG000|Test Period 1 (2 Weeks)|Adverse Event|0
2243441|NCT01957488|3902503|FG001|Test Period 1 (2 Weeks)|Adverse Event|1
2243442|NCT01957488|3902504|FG002|Test Period 1 (2 Weeks)|Adverse Event|1
2243443|NCT01957488|3902505|FG003|Test Period 1 (2 Weeks)|Adverse Event|0
2243444|NCT01957488|3902506|FG004|Test Period 1 (2 Weeks)|Adverse Event|1
2243445|NCT01957488|3902507|FG005|Test Period 1 (2 Weeks)|Adverse Event|0
2243446|NCT01957488|3902502|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
2243447|NCT01957488|3902503|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
2243448|NCT01957488|3902504|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
2243449|NCT01957488|3902505|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
2243450|NCT01957488|3902506|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
2243451|NCT01957488|3902507|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2
2243452|NCT01957488|3902502|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
2243453|NCT01957488|3902503|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
2243454|NCT01957488|3902504|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
2243455|NCT01957488|3902505|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
2243456|NCT01957488|3902506|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1
2243457|NCT01957488|3902507|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
2243458|NCT01957488|3902502|FG000|Test Period 1 (2 Weeks)|screen failure|0
2243459|NCT01957488|3902503|FG001|Test Period 1 (2 Weeks)|screen failure|0
2243460|NCT01957488|3902504|FG002|Test Period 1 (2 Weeks)|screen failure|0
2243461|NCT01957488|3902505|FG003|Test Period 1 (2 Weeks)|screen failure|0
2243462|NCT01957488|3902506|FG004|Test Period 1 (2 Weeks)|screen failure|0
2243463|NCT01957488|3902507|FG005|Test Period 1 (2 Weeks)|screen failure|1
2243464|NCT01957488|3902502|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2
2243465|NCT01957488|3902503|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0
2243466|NCT01957488|3902504|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1
2243467|NCT01957488|3902505|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1
2243468|NCT01957488|3902506|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0
2243469|NCT01957488|3902507|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0
2243470|NCT01957488|3902502|FG000|Test Period 2 (2 Weeks)|Other|1
2243471|NCT01957488|3902503|FG001|Test Period 2 (2 Weeks)|Other|0
2243472|NCT01957488|3902504|FG002|Test Period 2 (2 Weeks)|Other|0
2243473|NCT01957488|3902505|FG003|Test Period 2 (2 Weeks)|Other|0
2243474|NCT01957488|3902506|FG004|Test Period 2 (2 Weeks)|Other|0
2243475|NCT01957488|3902507|FG005|Test Period 2 (2 Weeks)|Other|0
2243476|NCT01957488|3902502|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
2243477|NCT01957488|3902503|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1
2243478|NCT01957488|3902504|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
2243479|NCT01957488|3902505|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
2243480|NCT01957488|3902506|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
2243481|NCT01957488|3902507|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
2243482|NCT01957488|3902502|FG000|Test Period 2 (2 Weeks)|Adverse Event|0
2243483|NCT01957488|3902503|FG001|Test Period 2 (2 Weeks)|Adverse Event|0
2243484|NCT01957488|3902504|FG002|Test Period 2 (2 Weeks)|Adverse Event|0
2243485|NCT01957488|3902505|FG003|Test Period 2 (2 Weeks)|Adverse Event|0
2243486|NCT01957488|3902506|FG004|Test Period 2 (2 Weeks)|Adverse Event|2
2243487|NCT01957488|3902507|FG005|Test Period 2 (2 Weeks)|Adverse Event|0
2243488|NCT01957488|3902502|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
2243489|NCT01957488|3902503|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
2243490|NCT01957488|3902504|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
2243491|NCT01957488|3902505|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
2243492|NCT01957488|3902506|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
2338414|NCT03345407|4067136|FG000|Overall Study|Lack of Efficacy|1
2243493|NCT01957488|3902507|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1
2243494|NCT01957488|3902502|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1
2243495|NCT01957488|3902503|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
2243496|NCT01957488|3902504|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
2243497|NCT01957488|3902505|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
2243498|NCT01957488|3902506|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
2243499|NCT01957488|3902507|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
2243500|NCT01957488|3902502|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0
2243501|NCT01957488|3902503|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1
2243502|NCT01957488|3902504|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0
2243503|NCT01957488|3902505|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0
2243504|NCT01957488|3902506|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0
2243505|NCT01957488|3902507|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0
2243506|NCT01957553|3902515|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
2243507|NCT01957553|3902516|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
2243508|NCT01957553|3902515|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2
2243509|NCT01957553|3902516|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0
2243510|NCT01957553|3902515|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
2243511|NCT01957553|3902516|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
2243512|NCT01957553|3902515|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1
2243513|NCT01957553|3902516|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0
2243514|NCT01957553|3902515|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1
2243515|NCT01957553|3902516|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3
2243516|NCT01957553|3902515|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
2243517|NCT01957553|3902516|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
2243518|NCT01957553|3902515|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
2243519|NCT01957553|3902516|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
2243520|NCT01957553|3902515|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
2243521|NCT01957553|3902516|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
2243522|NCT01957553|3902515|FG000|Test Period 2 (21 +- 1 Days)|Other|1
2243523|NCT01957553|3902516|FG001|Test Period 2 (21 +- 1 Days)|Other|0
2243524|NCT01957579|3902526|FG000|Overall Study|Withdrawal of concent|0
2243525|NCT01957579|3902527|FG001|Overall Study|Withdrawal of concent|1
2243526|NCT01957579|3902528|FG002|Overall Study|Withdrawal of concent|0
2243527|NCT01957579|3902529|FG003|Overall Study|Withdrawal of concent|0
2243528|NCT01957579|3902526|FG000|Overall Study|Death|0
2243529|NCT01957579|3902527|FG001|Overall Study|Death|0
2243530|NCT01957579|3902528|FG002|Overall Study|Death|2
2243531|NCT01957579|3902529|FG003|Overall Study|Death|0
2243532|NCT01957644|3902561|FG000|Overall Study|Adverse Event|4
2243533|NCT01957644|3902562|FG001|Overall Study|Adverse Event|2
2243534|NCT01957644|3902563|FG002|Overall Study|Adverse Event|0
2243535|NCT01957644|3902564|FG003|Overall Study|Adverse Event|0
2243536|NCT01957644|3902565|FG004|Overall Study|Adverse Event|1
2243537|NCT01957644|3902561|FG000|Overall Study|Progressive disease / relapse|0
2243538|NCT01957644|3902562|FG001|Overall Study|Progressive disease / relapse|1
2243539|NCT01957644|3902563|FG002|Overall Study|Progressive disease / relapse|0
2243540|NCT01957644|3902564|FG003|Overall Study|Progressive disease / relapse|1
2243541|NCT01957644|3902565|FG004|Overall Study|Progressive disease / relapse|0
2243542|NCT01957644|3902561|FG000|Overall Study|Other reason|1
2243543|NCT01957644|3902562|FG001|Overall Study|Other reason|2
2243544|NCT01957644|3902563|FG002|Overall Study|Other reason|1
2243545|NCT01957644|3902564|FG003|Overall Study|Other reason|1
2243546|NCT01957644|3902565|FG004|Overall Study|Other reason|0
2243547|NCT01957644|3902561|FG000|Overall Study|Withdrawal by Subject|1
2243548|NCT01957644|3902562|FG001|Overall Study|Withdrawal by Subject|0
2243549|NCT01957644|3902563|FG002|Overall Study|Withdrawal by Subject|0
2243550|NCT01957644|3902564|FG003|Overall Study|Withdrawal by Subject|0
2243551|NCT01957644|3902565|FG004|Overall Study|Withdrawal by Subject|0
2243552|NCT01957644|3902561|FG000|Overall Study|Protocol Violation|0
2243553|NCT01957644|3902562|FG001|Overall Study|Protocol Violation|1
2243554|NCT01957644|3902563|FG002|Overall Study|Protocol Violation|0
2243555|NCT01957644|3902564|FG003|Overall Study|Protocol Violation|0
2243556|NCT01957644|3902565|FG004|Overall Study|Protocol Violation|0
2243557|NCT01957709|3902583|FG000|Overall Study|Patient refused to complete post-tx bx|1
2243558|NCT01957787|3902591|FG000|Overall Study|Death|18
2243559|NCT01957787|3902591|FG000|Overall Study|Lost to Follow-up|3
2243560|NCT01957787|3902591|FG000|Overall Study|Withdrawal by Subject|3
2243561|NCT01957787|3902591|FG000|Overall Study|Entered Hospice or Similar Program|2
2243562|NCT01957787|3902591|FG000|Overall Study|Index Tumor(s) Resected|2
2243563|NCT01957787|3902591|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2
2243564|NCT01957787|3902591|FG000|Overall Study|Local therapy, not cryoablation|6
2243565|NCT01957865|3902598|FG000|Overall Study|Found HIV negative|0
2243566|NCT01957865|3902599|FG001|Overall Study|Found HIV negative|0
2243567|NCT01957865|3902600|FG002|Overall Study|Found HIV negative|1
2243568|NCT01957865|3902598|FG000|Overall Study|Lost to Follow-up|0
2243569|NCT01957865|3902599|FG001|Overall Study|Lost to Follow-up|2
2243570|NCT01957865|3902600|FG002|Overall Study|Lost to Follow-up|2
2243571|NCT01958008|3902625|FG000|Overall Study|Worsening of disease under study|0
2243572|NCT01958008|3902626|FG001|Overall Study|Worsening of disease under study|0
2243573|NCT01958008|3902627|FG002|Overall Study|Worsening of disease under study|1
2243574|NCT01958008|3902628|FG003|Overall Study|Worsening of disease under study|0
2243575|NCT01958008|3902625|FG000|Overall Study|Other adverse event|1
2243576|NCT01958008|3902626|FG001|Overall Study|Other adverse event|0
2243577|NCT01958008|3902627|FG002|Overall Study|Other adverse event|0
2243578|NCT01958008|3902628|FG003|Overall Study|Other adverse event|0
2243579|NCT01958060|3902647|FG000|Overall Study|Not treated|2
2243580|NCT01958060|3902648|FG001|Overall Study|Not treated|0
2243581|NCT01958060|3902649|FG002|Overall Study|Not treated|0
2243582|NCT01958060|3902650|FG003|Overall Study|Not treated|0
2243583|NCT01958060|3902651|FG004|Overall Study|Not treated|1
2243584|NCT01958060|3902652|FG005|Overall Study|Not treated|0
2243585|NCT01958125|3902699|FG000|Overall Study|Missing diary data|2
2243586|NCT01958125|3902700|FG001|Overall Study|Missing diary data|6
2243587|NCT01958125|3902699|FG000|Overall Study|No headache attacks|0
2243588|NCT01958125|3902700|FG001|Overall Study|No headache attacks|2
2243589|NCT01958164|3902708|FG000|Overall Study|Adverse Event|0
2243590|NCT01958164|3902709|FG001|Overall Study|Adverse Event|2
2243591|NCT01958164|3902708|FG000|Overall Study|Lost to Follow-up|2
2243592|NCT01958164|3902709|FG001|Overall Study|Lost to Follow-up|3
2243593|NCT01958281|3902718|FG000|Overall Study|Lack of Efficacy|5
2243594|NCT01958281|3902719|FG001|Overall Study|Lack of Efficacy|2
2243595|NCT01958281|3902720|FG002|Overall Study|Lack of Efficacy|0
2243596|NCT01958281|3902718|FG000|Overall Study|Adverse Event|0
2243597|NCT01958281|3902719|FG001|Overall Study|Adverse Event|2
2243598|NCT01958281|3902720|FG002|Overall Study|Adverse Event|0
2243599|NCT01958281|3902718|FG000|Overall Study|Withdrew Consent|1
2243600|NCT01958281|3902719|FG001|Overall Study|Withdrew Consent|0
2243601|NCT01958281|3902720|FG002|Overall Study|Withdrew Consent|0
2243602|NCT01958294|3902729|FG000|Overall Study|Clinical Circumstances|2
2243603|NCT01958437|3902755|FG000|Overall Study|Incidental MRI findings|0
2243604|NCT01958437|3902756|FG001|Overall Study|Incidental MRI findings|0
2243605|NCT01958437|3902757|FG002|Overall Study|Incidental MRI findings|1
2243606|NCT01958437|3902758|FG003|Overall Study|Incidental MRI findings|1
2243607|NCT01958476|3902777|FG000|Overall Study|Parent requested exclusion from analysis|1
2243608|NCT01958476|3902778|FG001|Overall Study|Parent requested exclusion from analysis|0
2243609|NCT01958489|3902784|FG000|Period 2|Adverse Event|0
2243610|NCT01958489|3902785|FG001|Period 2|Adverse Event|1
2243611|NCT01958619|3902809|FG000|Overall Study|Protocol Violation|2
2243612|NCT01958619|3902810|FG001|Overall Study|Protocol Violation|0
2243613|NCT01958619|3902811|FG002|Overall Study|Protocol Violation|1
2243614|NCT01958619|3902812|FG003|Overall Study|Protocol Violation|0
2243615|NCT01958671|3902840|FG000|Overall Study|Adverse Event|1
2243616|NCT01958671|3902841|FG001|Overall Study|Adverse Event|1
2243617|NCT01958671|3902842|FG002|Overall Study|Adverse Event|5
2243618|NCT01958671|3902840|FG000|Overall Study|Death|1
2243619|NCT01958671|3902841|FG001|Overall Study|Death|0
2243620|NCT01958671|3902842|FG002|Overall Study|Death|0
2243621|NCT01958671|3902840|FG000|Overall Study|Excluded medication|0
2243622|NCT01958671|3902841|FG001|Overall Study|Excluded medication|0
2243623|NCT01958671|3902842|FG002|Overall Study|Excluded medication|1
2338415|NCT03345407|4067137|FG001|Overall Study|Lack of Efficacy|1
2338416|NCT03345407|4067138|FG002|Overall Study|Lack of Efficacy|1
2338417|NCT03345407|4067139|FG003|Overall Study|Lack of Efficacy|1
2338418|NCT03345407|4067140|FG004|Overall Study|Lack of Efficacy|1
2338419|NCT03345407|4067141|FG005|Overall Study|Lack of Efficacy|0
2338420|NCT03345407|4067142|FG006|Overall Study|Lack of Efficacy|3
2338421|NCT03345407|4067136|FG000|Overall Study|Adverse Event|4
2338422|NCT03345407|4067137|FG001|Overall Study|Adverse Event|0
2338423|NCT03345407|4067138|FG002|Overall Study|Adverse Event|5
2338424|NCT03345407|4067139|FG003|Overall Study|Adverse Event|4
2338425|NCT03345407|4067140|FG004|Overall Study|Adverse Event|6
2338426|NCT03345407|4067141|FG005|Overall Study|Adverse Event|5
2338427|NCT03345407|4067142|FG006|Overall Study|Adverse Event|16
2338428|NCT03345472|4067164|FG000|Implant to 3 Months|Withdrawal by Subject|2
2338429|NCT03345472|4067164|FG000|Implant to 3 Months|Physician Decision|1
2338430|NCT03345472|4067164|FG000|Implant to 3 Months|Adverse Event|1
2037635|NCT00419926|3608070|FG001|Overall Study|Lost to Follow-up|2
2037636|NCT00419926|3608069|FG000|Overall Study|Death|2
2037637|NCT00419926|3608070|FG001|Overall Study|Death|1
2037638|NCT00419952|3608078|FG000|Overall Study|Adverse Event|8
2037639|NCT00419952|3608079|FG001|Overall Study|Adverse Event|10
2037640|NCT00419952|3608078|FG000|Overall Study|Withdrawal by Subject|44
2037641|NCT00419952|3608079|FG001|Overall Study|Withdrawal by Subject|43
2037642|NCT00419952|3608078|FG000|Overall Study|Lost to Follow-up|43
2037643|NCT00419952|3608079|FG001|Overall Study|Lost to Follow-up|34
2037644|NCT00419952|3608078|FG000|Overall Study|Protocol Violation|32
2037645|NCT00419952|3608079|FG001|Overall Study|Protocol Violation|24
2037646|NCT00419952|3608078|FG000|Overall Study|Pregnancy|4
2037647|NCT00419952|3608079|FG001|Overall Study|Pregnancy|2
2037648|NCT00419952|3608078|FG000|Overall Study|Physician Decision|1
2243624|NCT01958671|3902840|FG000|Overall Study|Hyperglycemia|0
2243625|NCT01958671|3902841|FG001|Overall Study|Hyperglycemia|0
2243626|NCT01958671|3902842|FG002|Overall Study|Hyperglycemia|2
2243627|NCT01958671|3902840|FG000|Overall Study|Lost to Follow-up|7
2243628|NCT01958671|3902841|FG001|Overall Study|Lost to Follow-up|11
2243629|NCT01958671|3902842|FG002|Overall Study|Lost to Follow-up|7
2338431|NCT03345472|4067164|FG000|3 Months to 12 Months|Physician Decision|3
2243630|NCT01958671|3902840|FG000|Overall Study|Non-compliance with study drug|1
2243631|NCT01958671|3902841|FG001|Overall Study|Non-compliance with study drug|1
2243632|NCT01958671|3902842|FG002|Overall Study|Non-compliance with study drug|1
2243633|NCT01958671|3902840|FG000|Overall Study|Pregnancy|0
2243634|NCT01958671|3902841|FG001|Overall Study|Pregnancy|0
2243635|NCT01958671|3902842|FG002|Overall Study|Pregnancy|1
2243636|NCT01958671|3902840|FG000|Overall Study|Protocol Violation|0
2243637|NCT01958671|3902841|FG001|Overall Study|Protocol Violation|1
2243638|NCT01958671|3902842|FG002|Overall Study|Protocol Violation|0
2243639|NCT01958671|3902840|FG000|Overall Study|Study site terminated by sponsor|1
2243640|NCT01958671|3902841|FG001|Overall Study|Study site terminated by sponsor|0
2243641|NCT01958671|3902842|FG002|Overall Study|Study site terminated by sponsor|1
2243642|NCT01958671|3902840|FG000|Overall Study|Participant moved|0
2243643|NCT01958671|3902841|FG001|Overall Study|Participant moved|0
2243644|NCT01958671|3902842|FG002|Overall Study|Participant moved|1
2243645|NCT01958671|3902840|FG000|Overall Study|Withdrawal by Subject|8
2243646|NCT01958671|3902841|FG001|Overall Study|Withdrawal by Subject|10
2243647|NCT01958671|3902842|FG002|Overall Study|Withdrawal by Subject|13
2243648|NCT01958827|3902858|FG000|Overall Study|Adverse Event|3
2243649|NCT01958827|3902858|FG000|Overall Study|Lack of Efficacy|6
2243650|NCT01958827|3902858|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1
2243651|NCT01958918|3902864|FG000|Overall Study|Death|1
2243652|NCT01958918|3902865|FG001|Overall Study|Death|3
2243653|NCT01958918|3902864|FG000|Overall Study|Lost to Follow-up|4
2243654|NCT01958918|3902865|FG001|Overall Study|Lost to Follow-up|7
2243655|NCT01958918|3902864|FG000|Overall Study|Withdrawal by Subject|13
2243656|NCT01958918|3902865|FG001|Overall Study|Withdrawal by Subject|8
2243657|NCT01958918|3902864|FG000|Overall Study|Lack of Efficacy|13
2243658|NCT01958918|3902865|FG001|Overall Study|Lack of Efficacy|10
2243659|NCT01958918|3902864|FG000|Overall Study|Adverse Event|12
2243660|NCT01958918|3902865|FG001|Overall Study|Adverse Event|12
2243661|NCT01958918|3902864|FG000|Overall Study|administrative problems|0
2243662|NCT01958918|3902865|FG001|Overall Study|administrative problems|2
2243663|NCT01959035|3902871|FG000|Overall Study|Adverse Event|5
2243664|NCT01959035|3902871|FG000|Overall Study|Withdrawal by Subject|4
2243665|NCT01959035|3902871|FG000|Overall Study|Lost to Follow-up|1
2243666|NCT01959035|3902871|FG000|Overall Study|Other (no primary reason given)|1
2243667|NCT01959165|3902889|FG000|Overall Study|Adverse Event|0
2243668|NCT01959165|3902890|FG001|Overall Study|Adverse Event|0
2243669|NCT01959165|3902891|FG002|Overall Study|Adverse Event|0
2243670|NCT01959165|3902892|FG003|Overall Study|Adverse Event|1
2243671|NCT01959165|3902889|FG000|Overall Study|Lack of Efficacy|1
2243672|NCT01959165|3902890|FG001|Overall Study|Lack of Efficacy|0
2243673|NCT01959165|3902891|FG002|Overall Study|Lack of Efficacy|0
2243674|NCT01959165|3902892|FG003|Overall Study|Lack of Efficacy|0
2243675|NCT01959165|3902889|FG000|Overall Study|overdose|0
2243676|NCT01959165|3902890|FG001|Overall Study|overdose|0
2243677|NCT01959165|3902891|FG002|Overall Study|overdose|0
2243678|NCT01959165|3902892|FG003|Overall Study|overdose|1
2243679|NCT01959165|3902889|FG000|Overall Study|Welfare recipient|0
2243680|NCT01959165|3902890|FG001|Overall Study|Welfare recipient|1
2243681|NCT01959165|3902891|FG002|Overall Study|Welfare recipient|0
2243682|NCT01959165|3902892|FG003|Overall Study|Welfare recipient|0
2243683|NCT01959230|3902911|FG000|Overall Study|Failure to follow study procedures|0
2243684|NCT01959230|3902912|FG001|Overall Study|Failure to follow study procedures|1
2243685|NCT01959230|3902911|FG000|Overall Study|Administrative reasons|2
2243686|NCT01959230|3902912|FG001|Overall Study|Administrative reasons|0
2243687|NCT01959230|3902911|FG000|Overall Study|Withdrawal by Subject|2
2243688|NCT01959230|3902912|FG001|Overall Study|Withdrawal by Subject|0
2243689|NCT01959243|3902920|FG000|Overall Study|Investigator Decision|3
2243690|NCT01959243|3902921|FG001|Overall Study|Investigator Decision|0
2243691|NCT01959243|3902920|FG000|Overall Study|Adverse Event|5
2243692|NCT01959243|3902921|FG001|Overall Study|Adverse Event|2
2243693|NCT01959243|3902920|FG000|Overall Study|Administrative reasons|2
2243694|NCT01959243|3902921|FG001|Overall Study|Administrative reasons|1
2243695|NCT01959243|3902920|FG000|Overall Study|Lost to Follow-up|3
2243696|NCT01959243|3902921|FG001|Overall Study|Lost to Follow-up|1
2243697|NCT01959334|3902929|FG000|Second Dose|Adverse Event|1
2243698|NCT01959334|3902930|FG001|Second Dose|Adverse Event|0
2243699|NCT01959334|3902929|FG000|Third Dose|Adverse Event|0
2243700|NCT01959334|3902930|FG001|Third Dose|Adverse Event|1
2243701|NCT01959347|3902938|FG000|Overall Study|Protocol Violation|9
2243702|NCT01959347|3902939|FG001|Overall Study|Protocol Violation|7
2243703|NCT01959412|3902945|FG000|Overall Study|Protocol deviation|1
2243704|NCT01959412|3902946|FG001|Overall Study|Protocol deviation|1
2243705|NCT01959412|3902947|FG002|Overall Study|Protocol deviation|0
2243706|NCT01959412|3902948|FG003|Overall Study|Protocol deviation|1
2243707|NCT01959412|3902949|FG004|Overall Study|Protocol deviation|3
2243708|NCT01959412|3902950|FG005|Overall Study|Protocol deviation|0
2243709|NCT01959412|3902945|FG000|Overall Study|Adverse Event|0
2243710|NCT01959412|3902946|FG001|Overall Study|Adverse Event|0
2243711|NCT01959412|3902947|FG002|Overall Study|Adverse Event|0
2243712|NCT01959412|3902948|FG003|Overall Study|Adverse Event|1
2243713|NCT01959412|3902949|FG004|Overall Study|Adverse Event|0
2243714|NCT01959412|3902950|FG005|Overall Study|Adverse Event|0
2243715|NCT01959425|3902966|FG000|Overall Study|Withdrawal by Subject|5
2243716|NCT01959425|3902967|FG001|Overall Study|Withdrawal by Subject|4
2243717|NCT01959425|3902966|FG000|Overall Study|Lost to Follow-up|1
2243718|NCT01959425|3902967|FG001|Overall Study|Lost to Follow-up|0
2243719|NCT01959425|3902966|FG000|Overall Study|Discontinued Subjects|6
2243720|NCT01959425|3902967|FG001|Overall Study|Discontinued Subjects|4
2243721|NCT01959503|3902997|FG000|Overall Study|Death|2
2243722|NCT01959503|3902998|FG001|Overall Study|Death|1
2243723|NCT01959503|3902997|FG000|Overall Study|Randomized but not treated|1
2243724|NCT01959503|3902998|FG001|Overall Study|Randomized but not treated|1
2243725|NCT01959516|3903004|FG000|Epoch 1|Adverse Event|4
2243726|NCT01959516|3903005|FG001|Epoch 1|Adverse Event|1
2243727|NCT01959516|3903004|FG000|Epoch 1|unsatisfactory therapeutic effect|1
2243728|NCT01959516|3903005|FG001|Epoch 1|unsatisfactory therapeutic effect|0
2243729|NCT01959516|3903004|FG000|Epoch 1|Subject withdrew consent|3
2243730|NCT01959516|3903005|FG001|Epoch 1|Subject withdrew consent|2
2243731|NCT01959516|3903004|FG000|Epoch 1|Administrative problems|1
2243732|NCT01959516|3903005|FG001|Epoch 1|Administrative problems|0
2243733|NCT01959516|3903004|FG000|Epoch 1|Use of prohibited treatment|1
2243734|NCT01959516|3903005|FG001|Epoch 1|Use of prohibited treatment|0
2243735|NCT01959516|3903004|FG000|Epoch 1|Moderate or severe COPD exacerbation|0
2243736|NCT01959516|3903005|FG001|Epoch 1|Moderate or severe COPD exacerbation|1
2243737|NCT01959516|3903004|FG000|Epoch 1|Protocol deviation|0
2243738|NCT01959516|3903005|FG001|Epoch 1|Protocol deviation|1
2243739|NCT01959516|3903004|FG000|Epoch 2|unsatisfactory therapeutic effect|1
2243740|NCT01959516|3903005|FG001|Epoch 2|unsatisfactory therapeutic effect|0
2243741|NCT01959516|3903004|FG000|Epoch 2|Subject withdrew consent|1
2243742|NCT01959516|3903005|FG001|Epoch 2|Subject withdrew consent|0
2243743|NCT01959516|3903004|FG000|Epoch 2|Moderate or severe COPD exacerbation|0
2243744|NCT01959516|3903005|FG001|Epoch 2|Moderate or severe COPD exacerbation|1
2243745|NCT01959529|3903013|FG000|Overall Study|Adverse event (not hypoglycaemia)|0
2243746|NCT01959529|3903014|FG001|Overall Study|Adverse event (not hypoglycaemia)|1
2243747|NCT01959529|3903013|FG000|Overall Study|Lost to Follow-up|4
2243748|NCT01959529|3903014|FG001|Overall Study|Lost to Follow-up|1
2243749|NCT01959529|3903013|FG000|Overall Study|Other|70
2338432|NCT03345472|4067164|FG000|3 Months to 12 Months|Lost to Follow-up|2
2338433|NCT03345472|4067164|FG000|3 Months to 12 Months|Withdrawal by Subject|1
2338434|NCT03345472|4067164|FG000|3 Months to 12 Months|Adverse Event|1
2338435|NCT03345472|4067164|FG000|3 Months to 12 Months|Death|1
2338436|NCT03345914|4067171|FG000|Overall Study|Transition to another study at week 16|80
2338437|NCT03345914|4067172|FG001|Overall Study|Transition to another study at week 16|86
2338438|NCT03345914|4067173|FG002|Overall Study|Transition to another study at week 16|78
2338439|NCT03345914|4067171|FG000|Overall Study|Transition to OLE during follow-up|37
2338440|NCT03345914|4067172|FG001|Overall Study|Transition to OLE during follow-up|33
2338441|NCT03345914|4067173|FG002|Overall Study|Transition to OLE during follow-up|39
2338442|NCT03345914|4067171|FG000|Overall Study|Physician Decision|0
2338443|NCT03345914|4067172|FG001|Overall Study|Physician Decision|1
2338444|NCT03345914|4067173|FG002|Overall Study|Physician Decision|1
2338445|NCT03345914|4067171|FG000|Overall Study|Withdrawal by Subject|5
2338446|NCT03345914|4067172|FG001|Overall Study|Withdrawal by Subject|1
2338447|NCT03345914|4067173|FG002|Overall Study|Withdrawal by Subject|2
2338448|NCT03345914|4067171|FG000|Overall Study|Other|1
2338449|NCT03345914|4067172|FG001|Overall Study|Other|1
2338450|NCT03345914|4067173|FG002|Overall Study|Other|1
2338451|NCT03345914|4067171|FG000|Overall Study|Ongoing|0
2338452|NCT03345914|4067172|FG001|Overall Study|Ongoing|0
2338453|NCT03345914|4067173|FG002|Overall Study|Ongoing|1
2338454|NCT03345979|4067183|FG000|Overall Study|Withdrawal by Subject|20
2338455|NCT03345979|4067184|FG001|Overall Study|Withdrawal by Subject|31
2338456|NCT03345979|4067183|FG000|Overall Study|Adverse Event|10
2338457|NCT03345979|4067184|FG001|Overall Study|Adverse Event|11
2338458|NCT03345979|4067183|FG000|Overall Study|Lost to Follow-up|8
2338459|NCT03345979|4067184|FG001|Overall Study|Lost to Follow-up|9
2338460|NCT03345979|4067183|FG000|Overall Study|Lack of Efficacy|4
2338461|NCT03345979|4067184|FG001|Overall Study|Lack of Efficacy|2
2338462|NCT03345979|4067183|FG000|Overall Study|Protocol Violation|1
2338463|NCT03345979|4067184|FG001|Overall Study|Protocol Violation|3
2338464|NCT03345979|4067183|FG000|Overall Study|Physician Decision|0
2338465|NCT03345979|4067184|FG001|Overall Study|Physician Decision|2
2338466|NCT03346057|4067194|FG000|Overall Study|Death|1
2338467|NCT03346057|4067195|FG001|Overall Study|Death|2
2338468|NCT03346057|4067196|FG002|Overall Study|Death|0
2338469|NCT03346057|4067197|FG003|Overall Study|Death|0
2338470|NCT03346057|4067194|FG000|Overall Study|Lost to Follow-up|0
2338471|NCT03346057|4067195|FG001|Overall Study|Lost to Follow-up|2
2338472|NCT03346057|4067196|FG002|Overall Study|Lost to Follow-up|1
2338473|NCT03346057|4067197|FG003|Overall Study|Lost to Follow-up|0
2338474|NCT03346057|4067194|FG000|Overall Study|Ineligible For Study - Not Treated|0
2243750|NCT01959529|3903014|FG001|Overall Study|Other|68
2338475|NCT03346057|4067195|FG001|Overall Study|Ineligible For Study - Not Treated|1
2338476|NCT03346057|4067196|FG002|Overall Study|Ineligible For Study - Not Treated|0
2338477|NCT03346057|4067197|FG003|Overall Study|Ineligible For Study - Not Treated|0
2338478|NCT03346057|4067194|FG000|Overall Study|Renal Insufficiency - Not Treated|1
2338479|NCT03346057|4067195|FG001|Overall Study|Renal Insufficiency - Not Treated|0
2243751|NCT01959529|3903013|FG000|Overall Study|Hypoglycaemia|1
2243752|NCT01959529|3903014|FG001|Overall Study|Hypoglycaemia|1
2243753|NCT01959529|3903013|FG000|Overall Study|Lack of glycaemic control|1
2243754|NCT01959529|3903014|FG001|Overall Study|Lack of glycaemic control|1
2243755|NCT01959581|3903025|FG000|Overall Study|Lost to Follow-up|5
2243756|NCT01959607|3903031|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
2243757|NCT01959607|3903032|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
2243758|NCT01959607|3903033|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
2243759|NCT01959607|3903034|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
2243760|NCT01959672|3903043|FG000|Overall Study|Death|1
2243761|NCT01959698|3903061|FG000|Overall Study|Adverse Event|0
2243762|NCT01959698|3903062|FG001|Overall Study|Adverse Event|0
2243763|NCT01959698|3903063|FG002|Overall Study|Adverse Event|0
2243764|NCT01959698|3903064|FG003|Overall Study|Adverse Event|0
2243765|NCT01959698|3903065|FG004|Overall Study|Adverse Event|0
2243766|NCT01959698|3903066|FG005|Overall Study|Adverse Event|0
2243767|NCT01959698|3903067|FG006|Overall Study|Adverse Event|1
2243768|NCT01959698|3903061|FG000|Overall Study|Physician Decision|1
2243769|NCT01959698|3903062|FG001|Overall Study|Physician Decision|0
2243770|NCT01959698|3903063|FG002|Overall Study|Physician Decision|1
2243771|NCT01959698|3903064|FG003|Overall Study|Physician Decision|2
2243772|NCT01959698|3903065|FG004|Overall Study|Physician Decision|0
2243773|NCT01959698|3903066|FG005|Overall Study|Physician Decision|3
2243774|NCT01959698|3903067|FG006|Overall Study|Physician Decision|3
2243775|NCT01959841|3903087|FG000|Overall Study|Adverse Event|1
2243776|NCT01959841|3903088|FG001|Overall Study|Adverse Event|3
2243777|NCT01959841|3903089|FG002|Overall Study|Adverse Event|2
2243778|NCT01959841|3903087|FG000|Overall Study|Lack of Efficacy|5
2243779|NCT01959841|3903088|FG001|Overall Study|Lack of Efficacy|0
2243780|NCT01959841|3903089|FG002|Overall Study|Lack of Efficacy|0
2243781|NCT01959841|3903087|FG000|Overall Study|Lost to Follow-up|1
2243782|NCT01959841|3903088|FG001|Overall Study|Lost to Follow-up|1
2243783|NCT01959841|3903089|FG002|Overall Study|Lost to Follow-up|0
2243784|NCT01959841|3903087|FG000|Overall Study|Physician Decision|0
2243785|NCT01959841|3903088|FG001|Overall Study|Physician Decision|2
2243786|NCT01959841|3903089|FG002|Overall Study|Physician Decision|3
2243787|NCT01959841|3903087|FG000|Overall Study|Protocol Violation|16
2243788|NCT01959841|3903088|FG001|Overall Study|Protocol Violation|23
2243789|NCT01959841|3903089|FG002|Overall Study|Protocol Violation|16
2243790|NCT01959841|3903087|FG000|Overall Study|Withdrawal by Subject|7
2243791|NCT01959841|3903088|FG001|Overall Study|Withdrawal by Subject|7
2243792|NCT01959841|3903089|FG002|Overall Study|Withdrawal by Subject|5
2243793|NCT01959841|3903087|FG000|Overall Study|Clinical laboratory value|2
2243794|NCT01959841|3903088|FG001|Overall Study|Clinical laboratory value|6
2243795|NCT01959841|3903089|FG002|Overall Study|Clinical laboratory value|6
2243796|NCT01959841|3903087|FG000|Overall Study|Platelet count below on day1 or 4|11
2243797|NCT01959841|3903088|FG001|Overall Study|Platelet count below on day1 or 4|15
2243798|NCT01959841|3903089|FG002|Overall Study|Platelet count below on day1 or 4|11
2243799|NCT01959880|3903101|FG000|Overall Study|Withdrawal by Subject|11
2243800|NCT01959880|3903102|FG001|Overall Study|Withdrawal by Subject|13
2243801|NCT01959880|3903103|FG002|Overall Study|Withdrawal by Subject|8
2243802|NCT01959880|3903104|FG003|Overall Study|Withdrawal by Subject|7
2243803|NCT01959880|3903101|FG000|Overall Study|Death|1
2243804|NCT01959880|3903102|FG001|Overall Study|Death|10
2243805|NCT01959880|3903103|FG002|Overall Study|Death|1
2243806|NCT01959880|3903104|FG003|Overall Study|Death|2
2243807|NCT01959880|3903101|FG000|Overall Study|Lost to Follow-up|95
2243808|NCT01959880|3903102|FG001|Overall Study|Lost to Follow-up|18
2243809|NCT01959880|3903103|FG002|Overall Study|Lost to Follow-up|15
2243810|NCT01959880|3903104|FG003|Overall Study|Lost to Follow-up|8
2243811|NCT01959880|3903101|FG000|Overall Study|Explantation w/o study device reimplant.|22
2243812|NCT01959880|3903102|FG001|Overall Study|Explantation w/o study device reimplant.|17
2243813|NCT01959880|3903103|FG002|Overall Study|Explantation w/o study device reimplant.|5
2243814|NCT01959880|3903104|FG003|Overall Study|Explantation w/o study device reimplant.|12
2243815|NCT01959880|3903101|FG000|Overall Study|Study completed early-FDA approved|1003
2243816|NCT01959880|3903102|FG001|Overall Study|Study completed early-FDA approved|311
2243817|NCT01959880|3903103|FG002|Overall Study|Study completed early-FDA approved|179
2243818|NCT01959880|3903104|FG003|Overall Study|Study completed early-FDA approved|152
2243819|NCT01959919|3903114|FG000|Overall Study|Did not meet the eligibility criteria|2
2243820|NCT01959932|3903121|FG000|Overall Study|Withdrawal by Subject|1
2243821|NCT01959932|3903122|FG001|Overall Study|Withdrawal by Subject|0
2243822|NCT01959932|3903123|FG002|Overall Study|Withdrawal by Subject|0
2243823|NCT01960114|3903166|FG000|Overall Study|Adverse Event|1
2243824|NCT01960114|3903167|FG001|Overall Study|Adverse Event|0
2243825|NCT01960114|3903166|FG000|Overall Study|Could not swallow study medication|0
2243826|NCT01960114|3903167|FG001|Overall Study|Could not swallow study medication|1
2243827|NCT01960140|3903173|FG000|Period 2 (Days 3-18)|Adverse Event|2
2243828|NCT01960257|3903181|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12
2243829|NCT01960257|3903182|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
2243830|NCT01960257|3903183|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
2243831|NCT01960257|3903181|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3
2243832|NCT01960257|3903182|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
2243833|NCT01960257|3903183|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
2243834|NCT01960257|3903181|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1
2243835|NCT01960257|3903182|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0
2243836|NCT01960257|3903183|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0
2243837|NCT01960296|3903195|FG000|Overall Study|Postponed surgery|1
2243838|NCT01960296|3903196|FG001|Overall Study|Postponed surgery|0
2243839|NCT01960296|3903195|FG000|Overall Study|Received different procedure|1
2243840|NCT01960296|3903196|FG001|Overall Study|Received different procedure|3
2243841|NCT01960348|3903204|FG000|Overall Study|Adverse event, not serious|2
2243842|NCT01960348|3903205|FG001|Overall Study|Adverse event, not serious|2
2243843|NCT01960348|3903204|FG000|Overall Study|Adverse event, serious fatal|6
2243844|NCT01960348|3903205|FG001|Overall Study|Adverse event, serious fatal|5
2243845|NCT01960348|3903204|FG000|Overall Study|Adverse event, serious non-fatal|0
2243846|NCT01960348|3903205|FG001|Overall Study|Adverse event, serious non-fatal|3
2243847|NCT01960348|3903204|FG000|Overall Study|Withdrawal by Subject|1
2243848|NCT01960348|3903205|FG001|Overall Study|Withdrawal by Subject|11
2243849|NCT01960348|3903204|FG000|Overall Study|Physician Decision|0
2243850|NCT01960348|3903205|FG001|Overall Study|Physician Decision|1
2243851|NCT01960348|3903204|FG000|Overall Study|Protocol Violation|1
2243852|NCT01960348|3903205|FG001|Overall Study|Protocol Violation|0
2243853|NCT01960413|3903226|FG000|Overall Study|Withdrawal by Subject|1
2243854|NCT01960413|3903227|FG001|Overall Study|Withdrawal by Subject|1
2243855|NCT01960413|3903226|FG000|Overall Study|Physician Decision|1
2243856|NCT01960413|3903227|FG001|Overall Study|Physician Decision|0
2243857|NCT01960413|3903226|FG000|Overall Study|Lost to Follow-up|2
2338480|NCT03346057|4067196|FG002|Overall Study|Renal Insufficiency - Not Treated|0
2338481|NCT03346057|4067197|FG003|Overall Study|Renal Insufficiency - Not Treated|0
2338482|NCT03346057|4067194|FG000|Overall Study|Physician Decision|3
2338483|NCT03346057|4067195|FG001|Overall Study|Physician Decision|2
2338484|NCT03346057|4067196|FG002|Overall Study|Physician Decision|0
2338485|NCT03346057|4067197|FG003|Overall Study|Physician Decision|2
2338486|NCT03346057|4067194|FG000|Overall Study|Randomization Mistake - Not Treated|1
2338487|NCT03346057|4067195|FG001|Overall Study|Randomization Mistake - Not Treated|1
2338488|NCT03346057|4067196|FG002|Overall Study|Randomization Mistake - Not Treated|0
2338489|NCT03346057|4067197|FG003|Overall Study|Randomization Mistake - Not Treated|0
2338490|NCT03346057|4067194|FG000|Overall Study|Withdrawal by Subject|1
2338491|NCT03346057|4067195|FG001|Overall Study|Withdrawal by Subject|0
2338492|NCT03346057|4067196|FG002|Overall Study|Withdrawal by Subject|0
2338493|NCT03346057|4067197|FG003|Overall Study|Withdrawal by Subject|0
2338494|NCT03346070|4067212|FG000|Overall Study|Death|0
2338495|NCT03346070|4067213|FG001|Overall Study|Death|0
2338496|NCT03346070|4067214|FG002|Overall Study|Death|0
2338497|NCT03346070|4067215|FG003|Overall Study|Death|0
2338498|NCT03346070|4067216|FG004|Overall Study|Death|1
2037649|NCT00419952|3608079|FG001|Overall Study|Physician Decision|3
2037650|NCT00419952|3608078|FG000|Overall Study|Incorrectly enrolled|10
2037651|NCT00419952|3608079|FG001|Overall Study|Incorrectly enrolled|3
2037652|NCT00419952|3608078|FG000|Overall Study|Intake of prohibited medication|2
2243858|NCT01960413|3903227|FG001|Overall Study|Lost to Follow-up|0
2243859|NCT01960725|3903259|FG000|Overall Study|Lost to Follow-up|4
2243860|NCT01960725|3903260|FG001|Overall Study|Lost to Follow-up|3
2243861|NCT01960725|3903259|FG000|Overall Study|Withdrawal by Subject|1
2243862|NCT01960725|3903260|FG001|Overall Study|Withdrawal by Subject|0
2243863|NCT01960725|3903259|FG000|Overall Study|unable to obtain blood sample|1
2243864|NCT01960725|3903260|FG001|Overall Study|unable to obtain blood sample|2
2243865|NCT01960790|3903266|FG000|Overall Study|Survey forms could not be recovered|3
2243866|NCT01960790|3903266|FG000|Overall Study|Treat with Humira outside survey period|3
2243867|NCT01960790|3903266|FG000|Overall Study|Transferred to another hospital|4
2243868|NCT01960790|3903266|FG000|Overall Study|Unevaluable for safety|1
2243869|NCT01960816|3903270|FG000|Overall Study|Lost to Follow-up|1
2243870|NCT01960842|3903274|FG000|Overall Study|Adverse Event|1
2243871|NCT01960842|3903274|FG000|Overall Study|Withdrawal by Subject|2
2243872|NCT01960855|3903283|FG000|Overall Study|Subject noncompliant|1
2243873|NCT01960855|3903284|FG001|Overall Study|Subject noncompliant|0
2243874|NCT01960855|3903285|FG002|Overall Study|Subject noncompliant|0
2243875|NCT01960855|3903286|FG003|Overall Study|Subject noncompliant|0
2243876|NCT01960855|3903287|FG004|Overall Study|Subject noncompliant|0
2243877|NCT01960855|3903283|FG000|Overall Study|Adverse Event|2
2243878|NCT01960855|3903284|FG001|Overall Study|Adverse Event|0
2243879|NCT01960855|3903285|FG002|Overall Study|Adverse Event|6
2243880|NCT01960855|3903286|FG003|Overall Study|Adverse Event|2
2243881|NCT01960855|3903287|FG004|Overall Study|Adverse Event|2
2243882|NCT01960855|3903283|FG000|Overall Study|Lack of Efficacy|1
2243883|NCT01960855|3903284|FG001|Overall Study|Lack of Efficacy|1
2243884|NCT01960855|3903285|FG002|Overall Study|Lack of Efficacy|0
2243885|NCT01960855|3903286|FG003|Overall Study|Lack of Efficacy|0
2243886|NCT01960855|3903287|FG004|Overall Study|Lack of Efficacy|0
2243887|NCT01960855|3903283|FG000|Overall Study|Other|2
2243888|NCT01960855|3903284|FG001|Overall Study|Other|1
2338499|NCT03346070|4067212|FG000|Overall Study|Lost to Follow-up|0
2338500|NCT03346070|4067213|FG001|Overall Study|Lost to Follow-up|1
2338501|NCT03346070|4067214|FG002|Overall Study|Lost to Follow-up|2
2338502|NCT03346070|4067215|FG003|Overall Study|Lost to Follow-up|0
2338503|NCT03346070|4067216|FG004|Overall Study|Lost to Follow-up|0
2338504|NCT03346070|4067212|FG000|Overall Study|Physician Decision|0
2338505|NCT03346070|4067213|FG001|Overall Study|Physician Decision|0
2338506|NCT03346070|4067214|FG002|Overall Study|Physician Decision|0
2243889|NCT01960855|3903285|FG002|Overall Study|Other|1
2243890|NCT01960855|3903286|FG003|Overall Study|Other|1
2243891|NCT01960855|3903287|FG004|Overall Study|Other|0
2243892|NCT01960855|3903283|FG000|Overall Study|Consent withdrawn by subject|3
2243893|NCT01960855|3903284|FG001|Overall Study|Consent withdrawn by subject|1
2243894|NCT01960855|3903285|FG002|Overall Study|Consent withdrawn by subject|2
2243895|NCT01960855|3903286|FG003|Overall Study|Consent withdrawn by subject|1
2243896|NCT01960855|3903287|FG004|Overall Study|Consent withdrawn by subject|1
2243897|NCT01960855|3903283|FG000|Overall Study|Lost to Follow-up|2
2243898|NCT01960855|3903284|FG001|Overall Study|Lost to Follow-up|1
2243899|NCT01960855|3903285|FG002|Overall Study|Lost to Follow-up|0
2243900|NCT01960855|3903286|FG003|Overall Study|Lost to Follow-up|0
2243901|NCT01960855|3903287|FG004|Overall Study|Lost to Follow-up|2
2243902|NCT01960907|3903301|FG000|Overall Study|Death|4
2243903|NCT01960907|3903302|FG001|Overall Study|Death|3
2243904|NCT01960907|3903301|FG000|Overall Study|Withdrawal by Subject|32
2243905|NCT01960907|3903302|FG001|Overall Study|Withdrawal by Subject|42
2243906|NCT01960998|3903313|FG000|Overall Study|Lost to Follow-up|3
2243907|NCT01960998|3903314|FG001|Overall Study|Lost to Follow-up|7
2243908|NCT01960998|3903313|FG000|Overall Study|Death|0
2243909|NCT01960998|3903314|FG001|Overall Study|Death|1
2243910|NCT01960998|3903313|FG000|Overall Study|Withdrawal by Subject|8
2243911|NCT01960998|3903314|FG001|Overall Study|Withdrawal by Subject|2
2243912|NCT01960998|3903313|FG000|Overall Study|lost computer access|0
2243913|NCT01960998|3903314|FG001|Overall Study|lost computer access|1
2243914|NCT01961115|3903329|FG000|Overall Study|Disease Progression|1
2243915|NCT01961115|3903330|FG001|Overall Study|Disease Progression|0
2243916|NCT01961115|3903331|FG002|Overall Study|Disease Progression|3
2243917|NCT01961115|3903329|FG000|Overall Study|Adverse Event|1
2243918|NCT01961115|3903330|FG001|Overall Study|Adverse Event|0
2243919|NCT01961115|3903331|FG002|Overall Study|Adverse Event|1
2243920|NCT01961297|3903349|FG000|Overall Study|unconfirmed diagnosis of SD|2
2243921|NCT01961297|3903350|FG001|Overall Study|unconfirmed diagnosis of SD|1
2243922|NCT01961323|3903356|FG000|Overall Study|Withdrawal by Subject|7
2243923|NCT01961323|3903356|FG000|Overall Study|Lost to Follow-up|8
2243924|NCT01961323|3903356|FG000|Overall Study|screen failure|34
2243925|NCT01961349|3903363|FG000|Overall Study|Withdrawal by Subject|1
2243926|NCT01961349|3903364|FG001|Overall Study|Withdrawal by Subject|4
2243927|NCT01961349|3903365|FG002|Overall Study|Withdrawal by Subject|0
2243928|NCT01961349|3903363|FG000|Overall Study|Adverse Event|0
2243929|NCT01961349|3903364|FG001|Overall Study|Adverse Event|0
2243930|NCT01961349|3903365|FG002|Overall Study|Adverse Event|1
2243931|NCT01961349|3903363|FG000|Overall Study|registration error, personal reason etc|2
2243932|NCT01961349|3903364|FG001|Overall Study|registration error, personal reason etc|2
2338507|NCT03346070|4067215|FG003|Overall Study|Physician Decision|1
2338508|NCT03346070|4067216|FG004|Overall Study|Physician Decision|1
2338509|NCT03346070|4067212|FG000|Overall Study|Withdrawal by Subject|1
2338510|NCT03346070|4067213|FG001|Overall Study|Withdrawal by Subject|0
2338511|NCT03346070|4067214|FG002|Overall Study|Withdrawal by Subject|0
2338512|NCT03346070|4067215|FG003|Overall Study|Withdrawal by Subject|1
2338513|NCT03346070|4067216|FG004|Overall Study|Withdrawal by Subject|0
2338514|NCT03346070|4067212|FG000|Overall Study|Study medication not received as planned|2
2338515|NCT03346070|4067213|FG001|Overall Study|Study medication not received as planned|3
2338516|NCT03346070|4067214|FG002|Overall Study|Study medication not received as planned|2
2338517|NCT03346070|4067215|FG003|Overall Study|Study medication not received as planned|3
2338518|NCT03346070|4067216|FG004|Overall Study|Study medication not received as planned|2
2338519|NCT03346070|4067212|FG000|Overall Study|Screen Failure|0
2338520|NCT03346070|4067213|FG001|Overall Study|Screen Failure|0
2338521|NCT03346070|4067214|FG002|Overall Study|Screen Failure|0
2338522|NCT03346070|4067215|FG003|Overall Study|Screen Failure|1
2338523|NCT03346070|4067216|FG004|Overall Study|Screen Failure|1
2338524|NCT03346759|4067241|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2
2338525|NCT03346759|4067242|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3
2338526|NCT03346759|4067241|FG000|First Menstrual Cycle|Withdrawal by Subject|1
2338527|NCT03346759|4067242|FG001|First Menstrual Cycle|Withdrawal by Subject|0
2338528|NCT03346759|4067241|FG000|Second Menstrual Cycle|Lost to Follow-up|1
2338529|NCT03346759|4067242|FG001|Second Menstrual Cycle|Lost to Follow-up|0
2338530|NCT03347188|4067269|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
2338531|NCT03347188|4067270|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
2338532|NCT03347188|4067269|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4
2338533|NCT03347188|4067270|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8
2338534|NCT03347188|4067269|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7
2338535|NCT03347188|4067270|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4
2338536|NCT03347188|4067269|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
2243933|NCT01961349|3903365|FG002|Overall Study|registration error, personal reason etc|1
2243934|NCT01961544|3903381|FG000|Overall Study|Protocol Violation|1
2243935|NCT01961544|3903381|FG000|Overall Study|Withdrawal by Subject|7
2243936|NCT01961544|3903381|FG000|Overall Study|Adverse Event|1
2243937|NCT01961544|3903381|FG000|Overall Study|Physician Decision|2
2243938|NCT01961544|3903381|FG000|Overall Study|Poor Tolerance|1
2243939|NCT01961544|3903381|FG000|Overall Study|Aggravation of Steral Pain|1
2243940|NCT01961609|3903387|FG000|Initiation|Missing|3
2243941|NCT01961609|3903388|FG001|Initiation|Missing|2
2243942|NCT01961609|3903389|FG002|Initiation|Missing|0
2243943|NCT01961609|3903390|FG003|Initiation|Missing|0
2243944|NCT01961609|3903387|FG000|Initiation|Protocol deviation|1
2243945|NCT01961609|3903388|FG001|Initiation|Protocol deviation|0
2243946|NCT01961609|3903389|FG002|Initiation|Protocol deviation|0
2243947|NCT01961609|3903390|FG003|Initiation|Protocol deviation|0
2243948|NCT01961609|3903387|FG000|Initiation|Death|0
2243949|NCT01961609|3903388|FG001|Initiation|Death|1
2243950|NCT01961609|3903389|FG002|Initiation|Death|0
2243951|NCT01961609|3903390|FG003|Initiation|Death|0
2243952|NCT01961609|3903387|FG000|Initiation|Administrative problems|1
2243953|NCT01961609|3903388|FG001|Initiation|Administrative problems|0
2243954|NCT01961609|3903389|FG002|Initiation|Administrative problems|0
2243955|NCT01961609|3903390|FG003|Initiation|Administrative problems|0
2243956|NCT01961609|3903387|FG000|Initiation|Withdrawal by Subject|1
2243957|NCT01961609|3903388|FG001|Initiation|Withdrawal by Subject|2
2243958|NCT01961609|3903389|FG002|Initiation|Withdrawal by Subject|0
2243959|NCT01961609|3903390|FG003|Initiation|Withdrawal by Subject|0
2243960|NCT01961609|3903387|FG000|Initiation|Lack of Efficacy|2
2243961|NCT01961609|3903388|FG001|Initiation|Lack of Efficacy|1
2243962|NCT01961609|3903389|FG002|Initiation|Lack of Efficacy|0
2243963|NCT01961609|3903390|FG003|Initiation|Lack of Efficacy|0
2243964|NCT01961609|3903387|FG000|Initiation|Abnormal lab values|0
2243965|NCT01961609|3903388|FG001|Initiation|Abnormal lab values|1
2243966|NCT01961609|3903389|FG002|Initiation|Abnormal lab values|0
2243967|NCT01961609|3903390|FG003|Initiation|Abnormal lab values|0
2243968|NCT01961609|3903387|FG000|Initiation|Adverse Event|3
2243969|NCT01961609|3903388|FG001|Initiation|Adverse Event|5
2243970|NCT01961609|3903389|FG002|Initiation|Adverse Event|0
2243971|NCT01961609|3903390|FG003|Initiation|Adverse Event|0
2243972|NCT01961609|3903387|FG000|Initiation|Randomized but not treated|1
2243973|NCT01961609|3903388|FG001|Initiation|Randomized but not treated|1
2243974|NCT01961609|3903389|FG002|Initiation|Randomized but not treated|0
2243975|NCT01961609|3903390|FG003|Initiation|Randomized but not treated|0
2243976|NCT01961609|3903387|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
2243977|NCT01961609|3903388|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
2243978|NCT01961609|3903389|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
2243979|NCT01961609|3903390|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
2243980|NCT01961609|3903387|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
2243981|NCT01961609|3903388|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
2243982|NCT01961609|3903389|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
2243983|NCT01961609|3903390|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
2338537|NCT03347188|4067270|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
2338538|NCT03347188|4067269|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1
2338539|NCT03347188|4067270|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2
2338540|NCT03347188|4067269|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26
2338541|NCT03347188|4067270|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28
2338542|NCT03347188|4067269|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1
2338543|NCT03347188|4067270|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0
2338544|NCT03347188|4067269|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0
2338545|NCT03347188|4067270|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1
2338546|NCT03347279|4067278|FG000|Overall Study|Withdrawal by Subject|8
2338547|NCT03347279|4067279|FG001|Overall Study|Withdrawal by Subject|15
2338548|NCT03347279|4067278|FG000|Overall Study|Death|0
2338549|NCT03347279|4067279|FG001|Overall Study|Death|2
2338550|NCT03347279|4067278|FG000|Overall Study|Lost to Follow-up|5
2338551|NCT03347279|4067279|FG001|Overall Study|Lost to Follow-up|2
2338552|NCT03347279|4067278|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3
2338553|NCT03347279|4067279|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4
2338554|NCT03347695|4067287|FG000|Overall Study|Death|0
2338555|NCT03347695|4067288|FG001|Overall Study|Death|4
2338556|NCT03347695|4067287|FG000|Overall Study|Lost to Follow-up|0
2338557|NCT03347695|4067288|FG001|Overall Study|Lost to Follow-up|1
2338558|NCT03349034|4067307|FG000|Overall Study|catheters dislodged during transport|2
2338559|NCT03349034|4067308|FG001|Overall Study|catheters dislodged during transport|0
2338560|NCT03349034|4067307|FG000|Overall Study|intubated for >48 hrs following surgery|1
2338561|NCT03349034|4067308|FG001|Overall Study|intubated for >48 hrs following surgery|1
2338562|NCT03349034|4067307|FG000|Overall Study|soft tissue flap used|1
2338563|NCT03349034|4067308|FG001|Overall Study|soft tissue flap used|0
2338564|NCT03349034|4067307|FG000|Overall Study|Other|0
2338565|NCT03349034|4067308|FG001|Overall Study|Other|1
2243984|NCT01961609|3903387|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
2243985|NCT01961609|3903388|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
2243986|NCT01961609|3903389|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
2243987|NCT01961609|3903390|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
2243988|NCT01961609|3903387|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
2243989|NCT01961609|3903388|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
2243990|NCT01961609|3903389|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
2243991|NCT01961609|3903390|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
2243992|NCT01961609|3903387|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
2243993|NCT01961609|3903388|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
2243994|NCT01961609|3903389|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
2243995|NCT01961609|3903390|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
2243996|NCT01961609|3903387|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
2243997|NCT01961609|3903388|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
2243998|NCT01961609|3903389|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
2243999|NCT01961609|3903390|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
2244000|NCT01961609|3903387|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
2244001|NCT01961609|3903388|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
2244002|NCT01961609|3903389|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
2244003|NCT01961609|3903390|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
2244004|NCT01961609|3903387|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
2244005|NCT01961609|3903388|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
2244006|NCT01961609|3903389|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
2244007|NCT01961609|3903390|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
2244008|NCT01961609|3903387|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
2244009|NCT01961609|3903388|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
2244010|NCT01961609|3903389|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
2244011|NCT01961609|3903390|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
2244012|NCT01961609|3903387|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
2244013|NCT01961609|3903388|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
2244014|NCT01961609|3903389|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
2244015|NCT01961609|3903390|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
2338566|NCT03349060|4067319|FG000|Overall Study|Adverse Event|9
2338567|NCT03349060|4067320|FG001|Overall Study|Adverse Event|9
2338568|NCT03349060|4067321|FG002|Overall Study|Adverse Event|7
2338569|NCT03349060|4067319|FG000|Overall Study|Lack of Efficacy|1
2338570|NCT03349060|4067320|FG001|Overall Study|Lack of Efficacy|0
2338571|NCT03349060|4067321|FG002|Overall Study|Lack of Efficacy|2
2338572|NCT03349060|4067319|FG000|Overall Study|Lost to Follow-up|2
2338573|NCT03349060|4067320|FG001|Overall Study|Lost to Follow-up|1
2338574|NCT03349060|4067321|FG002|Overall Study|Lost to Follow-up|1
2338575|NCT03349060|4067319|FG000|Overall Study|Protocol Violation|2
2338576|NCT03349060|4067320|FG001|Overall Study|Protocol Violation|2
2338577|NCT03349060|4067321|FG002|Overall Study|Protocol Violation|1
2338578|NCT03349060|4067319|FG000|Overall Study|Withdrawal by Subject|5
2338579|NCT03349060|4067320|FG001|Overall Study|Withdrawal by Subject|3
2338580|NCT03349060|4067321|FG002|Overall Study|Withdrawal by Subject|4
2338581|NCT03349060|4067319|FG000|Overall Study|Medication error,no linked adverse event|0
2338582|NCT03349060|4067320|FG001|Overall Study|Medication error,no linked adverse event|0
2338583|NCT03349060|4067321|FG002|Overall Study|Medication error,no linked adverse event|1
2338584|NCT03349060|4067319|FG000|Overall Study|Withdrawal By Parent/Guardian|0
2338585|NCT03349060|4067320|FG001|Overall Study|Withdrawal By Parent/Guardian|1
2338586|NCT03349060|4067321|FG002|Overall Study|Withdrawal By Parent/Guardian|0
2338587|NCT03349060|4067319|FG000|Overall Study|Other|2
2338588|NCT03349060|4067320|FG001|Overall Study|Other|1
2338589|NCT03349060|4067321|FG002|Overall Study|Other|0
2338590|NCT03349099|4067331|FG000|Overall Study|Physician Decision|3
2338591|NCT03349099|4067332|FG001|Overall Study|Physician Decision|4
2338592|NCT03349099|4067331|FG000|Overall Study|Stone migrated from the kidney|1
2338593|NCT03349099|4067332|FG001|Overall Study|Stone migrated from the kidney|0
2338594|NCT03349333|4067338|FG000|Overall Study|Progression of Disease|36
2338595|NCT03349333|4067338|FG000|Overall Study|Adverse Event|11
2338596|NCT03349333|4067338|FG000|Overall Study|Other|6
2338597|NCT03349333|4067338|FG000|Overall Study|Withdrawal by Subject|5
2338598|NCT03349333|4067338|FG000|Overall Study|Conditions interfere with participation|2
2338599|NCT03349333|4067338|FG000|Overall Study|Physician Decision|2
2338600|NCT03349333|4067338|FG000|Overall Study|3-week lapse between pralatrexate doses|1
2338601|NCT03349333|4067338|FG000|Overall Study|Patients in treatment less than 24 month|8
2338602|NCT03349437|4067342|FG000|Screening|Screen Fail|4
2338603|NCT03349437|4067343|FG001|Screening|Screen Fail|0
2338604|NCT03349437|4067344|FG002|Screening|Screen Fail|0
2338605|NCT03349437|4067342|FG000|Screening|Withdrawn|1
2338606|NCT03349437|4067343|FG001|Screening|Withdrawn|0
2338607|NCT03349437|4067344|FG002|Screening|Withdrawn|0
2338608|NCT03349515|4067353|FG000|Overall Study|Lack of Efficacy|2
2338609|NCT03349515|4067354|FG001|Overall Study|Lack of Efficacy|0
2338610|NCT03349515|4067353|FG000|Overall Study|Physician Decision|3
2338611|NCT03349515|4067354|FG001|Overall Study|Physician Decision|1
2338612|NCT03349710|4067396|FG000|Treatment Period|Death|0
2338613|NCT03349710|4067397|FG001|Treatment Period|Death|0
2338614|NCT03349710|4067398|FG002|Treatment Period|Death|1
2338615|NCT03349710|4067399|FG003|Treatment Period|Death|0
2338616|NCT03349710|4067396|FG000|Treatment Period|Disease Progression|0
2338617|NCT03349710|4067397|FG001|Treatment Period|Disease Progression|2
2338618|NCT03349710|4067398|FG002|Treatment Period|Disease Progression|0
2338619|NCT03349710|4067399|FG003|Treatment Period|Disease Progression|1
2244016|NCT01961609|3903387|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
2244017|NCT01961609|3903388|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
2244018|NCT01961609|3903389|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
2244019|NCT01961609|3903390|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
2244020|NCT01961609|3903387|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
2244021|NCT01961609|3903388|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
2244022|NCT01961609|3903389|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
2244023|NCT01961609|3903390|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
2244024|NCT01961687|3903407|FG000|Overall Study|Lost to Follow-up|19
2244025|NCT01961687|3903407|FG000|Overall Study|Re-operation|17
2244026|NCT01961687|3903407|FG000|Overall Study|Death|7
2244027|NCT01961687|3903407|FG000|Overall Study|Withdrawal by Subject|6
2244028|NCT01961687|3903407|FG000|Overall Study|Adverse Event|6
2244029|NCT01961687|3903407|FG000|Overall Study|Moved to area without study site|2
2244030|NCT01961687|3903407|FG000|Overall Study|Sponsor decision|2
2244031|NCT01961687|3903407|FG000|Overall Study|Physician Decision|1
2244032|NCT01961687|3903407|FG000|Overall Study|Unable to meet follow-up requirements|1
2244033|NCT01961882|3903413|FG000|Overall Study|Adverse Event|3
2244034|NCT01961882|3903414|FG001|Overall Study|Adverse Event|2
2244035|NCT01961882|3903413|FG000|Overall Study|Physician Decision|1
2244036|NCT01961882|3903414|FG001|Overall Study|Physician Decision|0
2244037|NCT01961882|3903413|FG000|Overall Study|Withdrawal by Subject|4
2244038|NCT01961882|3903414|FG001|Overall Study|Withdrawal by Subject|1
2338620|NCT03349710|4067396|FG000|Treatment Period|Study Drug Toxicity|1
2338621|NCT03349710|4067397|FG001|Treatment Period|Study Drug Toxicity|0
2338622|NCT03349710|4067398|FG002|Treatment Period|Study Drug Toxicity|1
2338623|NCT03349710|4067399|FG003|Treatment Period|Study Drug Toxicity|1
2338624|NCT03349710|4067396|FG000|Treatment Period|Adverse event unrelated to Study Drug|2
2338625|NCT03349710|4067397|FG001|Treatment Period|Adverse event unrelated to Study Drug|1
2338626|NCT03349710|4067398|FG002|Treatment Period|Adverse event unrelated to Study Drug|1
2338627|NCT03349710|4067399|FG003|Treatment Period|Adverse event unrelated to Study Drug|1
2338628|NCT03349710|4067396|FG000|Treatment Period|admin reason by sponsor|0
2338629|NCT03349710|4067397|FG001|Treatment Period|admin reason by sponsor|7
2338630|NCT03349710|4067398|FG002|Treatment Period|admin reason by sponsor|0
2338631|NCT03349710|4067399|FG003|Treatment Period|admin reason by sponsor|19
2338632|NCT03349710|4067396|FG000|Treatment Period|Other Reason|2
2338633|NCT03349710|4067397|FG001|Treatment Period|Other Reason|0
2338634|NCT03349710|4067398|FG002|Treatment Period|Other Reason|2
2338635|NCT03349710|4067399|FG003|Treatment Period|Other Reason|1
2338636|NCT03349710|4067396|FG000|Treatment Period|completed|6
2338637|NCT03349710|4067397|FG001|Treatment Period|completed|0
2338638|NCT03349710|4067398|FG002|Treatment Period|completed|18
2338639|NCT03349710|4067399|FG003|Treatment Period|completed|1
2338640|NCT03349710|4067396|FG000|Treatment Period|participant request to discontinue|0
2338641|NCT03349710|4067397|FG001|Treatment Period|participant request to discontinue|0
2338642|NCT03349710|4067398|FG002|Treatment Period|participant request to discontinue|4
2338643|NCT03349710|4067399|FG003|Treatment Period|participant request to discontinue|0
2338644|NCT03349710|4067396|FG000|Treatment Period|participant withdrew consent|1
2338645|NCT03349710|4067397|FG001|Treatment Period|participant withdrew consent|0
2338646|NCT03349710|4067398|FG002|Treatment Period|participant withdrew consent|0
2338647|NCT03349710|4067399|FG003|Treatment Period|participant withdrew consent|0
2338648|NCT03350256|4067422|FG000|Overall Study|Inclusion/exclusion violation|4
2338649|NCT03350256|4067422|FG000|Overall Study|Recommended for other therapies|2
2338650|NCT03350256|4067422|FG000|Overall Study|Protocol Violation|3
2338651|NCT03350256|4067422|FG000|Overall Study|Non compliance|2
2338652|NCT03350256|4067422|FG000|Overall Study|Denial by insurance|1
2338653|NCT03350256|4067422|FG000|Overall Study|Adverse Event|2
2338654|NCT03350256|4067422|FG000|Overall Study|Trial failure|12
2338655|NCT03350256|4067422|FG000|Overall Study|Did not proceed to permanent implant|3
2338656|NCT03350256|4067422|FG000|Overall Study|Withdrawal by Subject|3
2338657|NCT03350256|4067422|FG000|Overall Study|Subject moving out of state|1
2338658|NCT03350256|4067422|FG000|Overall Study|Lost to Follow-up|1
2338659|NCT03350256|4067422|FG000|Overall Study|Lack of Efficacy|2
2338660|NCT03350672|4067433|FG000|Overall Study|Withdrawal by Subject|7
2338661|NCT03350672|4067434|FG001|Overall Study|Withdrawal by Subject|0
2338662|NCT03350672|4067435|FG002|Overall Study|Withdrawal by Subject|0
2338663|NCT03351114|4067472|FG000|Overall Study|Withdrawal by Subject|1
2338664|NCT03351231|4067476|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1
2338665|NCT03351231|4067476|FG000|Combination Therapy Period|Disease progression|2
2338666|NCT03351231|4067476|FG000|Combination Therapy Period|Study drug toxicity|1
2338667|NCT03351231|4067476|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1
2338668|NCT03351231|4067476|FG000|Safety Follow-Up Period|Participant withdrew consent|1
2338669|NCT03351231|4067476|FG000|Safety Follow-Up Period|Other reason|2
2338670|NCT03351335|4067483|FG000|Overall Study|Failure to maintain inclusion/exclusion|0
2338671|NCT03351335|4067484|FG001|Overall Study|Failure to maintain inclusion/exclusion|0
2338672|NCT03351335|4067485|FG002|Overall Study|Failure to maintain inclusion/exclusion|4
2353036|NCT03361228|4103829|FG001|Overall Study|Other|1
2353037|NCT03361228|4103828|FG000|Overall Study|Death|3
2353038|NCT03361228|4103829|FG001|Overall Study|Death|0
2244039|NCT01961882|3903413|FG000|Overall Study|Relapse of AML|39
2244040|NCT01961882|3903414|FG001|Overall Study|Relapse of AML|37
2244041|NCT01961882|3903413|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2
2244042|NCT01961882|3903414|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2
2244043|NCT01961882|3903413|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1
2244044|NCT01961882|3903414|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0
2244045|NCT01962103|3903444|FG000|Phase 1|Adverse Event|4
2244046|NCT01962103|3903445|FG001|Phase 1|Adverse Event|0
2244047|NCT01962103|3903446|FG002|Phase 1|Adverse Event|2
2244048|NCT01962103|3903447|FG003|Phase 1|Adverse Event|1
2244049|NCT01962103|3903448|FG004|Phase 1|Adverse Event|2
2244050|NCT01962103|3903449|FG005|Phase 1|Adverse Event|2
2244051|NCT01962103|3903450|FG006|Phase 1|Adverse Event|0
2244052|NCT01962103|3903451|FG007|Phase 1|Adverse Event|0
2244053|NCT01962103|3903452|FG008|Phase 1|Adverse Event|0
2244054|NCT01962103|3903444|FG000|Phase 1|Progressive Disease|8
2244055|NCT01962103|3903445|FG001|Phase 1|Progressive Disease|6
2244056|NCT01962103|3903446|FG002|Phase 1|Progressive Disease|8
2244057|NCT01962103|3903447|FG003|Phase 1|Progressive Disease|4
2244058|NCT01962103|3903448|FG004|Phase 1|Progressive Disease|5
2244059|NCT01962103|3903449|FG005|Phase 1|Progressive Disease|4
2244060|NCT01962103|3903450|FG006|Phase 1|Progressive Disease|0
2244061|NCT01962103|3903451|FG007|Phase 1|Progressive Disease|0
2244062|NCT01962103|3903452|FG008|Phase 1|Progressive Disease|0
2244063|NCT01962103|3903444|FG000|Phase 1|Withdrawal by Subject|0
2244064|NCT01962103|3903445|FG001|Phase 1|Withdrawal by Subject|0
2244065|NCT01962103|3903446|FG002|Phase 1|Withdrawal by Subject|0
2244066|NCT01962103|3903447|FG003|Phase 1|Withdrawal by Subject|2
2244067|NCT01962103|3903448|FG004|Phase 1|Withdrawal by Subject|0
2244068|NCT01962103|3903449|FG005|Phase 1|Withdrawal by Subject|0
2244069|NCT01962103|3903450|FG006|Phase 1|Withdrawal by Subject|0
2244070|NCT01962103|3903451|FG007|Phase 1|Withdrawal by Subject|0
2338673|NCT03351478|4067496|FG000|Overall Study|At the subject's own request|11
2338674|NCT03351478|4067497|FG001|Overall Study|At the subject's own request|12
2338675|NCT03351478|4067498|FG002|Overall Study|At the subject's own request|5
2338676|NCT03351478|4067496|FG000|Overall Study|Adverse Event|1
2338677|NCT03351478|4067497|FG001|Overall Study|Adverse Event|2
2338678|NCT03351478|4067498|FG002|Overall Study|Adverse Event|1
2338679|NCT03351478|4067496|FG000|Overall Study|Poor compliance to protocol|1
2338680|NCT03351478|4067497|FG001|Overall Study|Poor compliance to protocol|0
2338681|NCT03351478|4067498|FG002|Overall Study|Poor compliance to protocol|0
2338682|NCT03351478|4067496|FG000|Overall Study|Reason not Specified|1
2338683|NCT03351478|4067497|FG001|Overall Study|Reason not Specified|3
2338684|NCT03351478|4067498|FG002|Overall Study|Reason not Specified|0
2338685|NCT03351478|4067496|FG000|Overall Study|Lost to Follow-up|0
2338686|NCT03351478|4067497|FG001|Overall Study|Lost to Follow-up|0
2338687|NCT03351478|4067498|FG002|Overall Study|Lost to Follow-up|1
2338688|NCT03351608|4067511|FG000|Overall Study|Lost to Follow-up|0
2338689|NCT03351608|4067512|FG001|Overall Study|Lost to Follow-up|1
2338690|NCT03351608|4067513|FG002|Overall Study|Lost to Follow-up|1
2338691|NCT03351608|4067514|FG003|Overall Study|Lost to Follow-up|1
2338692|NCT03351608|4067515|FG004|Overall Study|Lost to Follow-up|1
2338693|NCT03351608|4067511|FG000|Overall Study|Physician Decision|1
2338694|NCT03351608|4067512|FG001|Overall Study|Physician Decision|0
2338695|NCT03351608|4067513|FG002|Overall Study|Physician Decision|0
2338696|NCT03351608|4067514|FG003|Overall Study|Physician Decision|2
2338697|NCT03351608|4067515|FG004|Overall Study|Physician Decision|1
2338698|NCT03351608|4067511|FG000|Overall Study|Randomized by mistake, no treatment given|0
2338699|NCT03351608|4067512|FG001|Overall Study|Randomized by mistake, no treatment given|0
2338700|NCT03351608|4067513|FG002|Overall Study|Randomized by mistake, no treatment given|0
2338701|NCT03351608|4067514|FG003|Overall Study|Randomized by mistake, no treatment given|1
2338702|NCT03351608|4067515|FG004|Overall Study|Randomized by mistake, no treatment given|0
2338703|NCT03351608|4067511|FG000|Overall Study|Withdrawal by parent/guardian|0
2338704|NCT03351608|4067512|FG001|Overall Study|Withdrawal by parent/guardian|0
2338705|NCT03351608|4067513|FG002|Overall Study|Withdrawal by parent/guardian|1
2037653|NCT00419952|3608079|FG001|Overall Study|Intake of prohibited medication|2
2037654|NCT00419952|3608078|FG000|Overall Study|Occurence of 2 or more exacerbations|2
2037655|NCT00419952|3608079|FG001|Overall Study|Occurence of 2 or more exacerbations|0
2037656|NCT00419952|3608078|FG000|Overall Study|Diary or medication non-compliance|2
2037657|NCT00419952|3608079|FG001|Overall Study|Diary or medication non-compliance|4
2037658|NCT00419952|3608078|FG000|Overall Study|Abnormal ECG|1
2037659|NCT00419952|3608079|FG001|Overall Study|Abnormal ECG|0
2244071|NCT01962103|3903452|FG008|Phase 1|Withdrawal by Subject|0
2244072|NCT01962103|3903444|FG000|Phase 1|Withdrawal by Parent/Guardian|0
2244073|NCT01962103|3903445|FG001|Phase 1|Withdrawal by Parent/Guardian|0
2244074|NCT01962103|3903446|FG002|Phase 1|Withdrawal by Parent/Guardian|2
2244075|NCT01962103|3903447|FG003|Phase 1|Withdrawal by Parent/Guardian|1
2244076|NCT01962103|3903448|FG004|Phase 1|Withdrawal by Parent/Guardian|0
2244077|NCT01962103|3903449|FG005|Phase 1|Withdrawal by Parent/Guardian|0
2244078|NCT01962103|3903450|FG006|Phase 1|Withdrawal by Parent/Guardian|0
2338706|NCT03351608|4067514|FG003|Overall Study|Withdrawal by parent/guardian|1
2338707|NCT03351608|4067515|FG004|Overall Study|Withdrawal by parent/guardian|0
2338708|NCT03351608|4067511|FG000|Overall Study|Other|0
2244079|NCT01962103|3903451|FG007|Phase 1|Withdrawal by Parent/Guardian|0
2244080|NCT01962103|3903452|FG008|Phase 1|Withdrawal by Parent/Guardian|0
2244081|NCT01962103|3903444|FG000|Phase 1|Physician Decision|0
2244082|NCT01962103|3903445|FG001|Phase 1|Physician Decision|0
2244083|NCT01962103|3903446|FG002|Phase 1|Physician Decision|0
2244084|NCT01962103|3903447|FG003|Phase 1|Physician Decision|1
2244085|NCT01962103|3903448|FG004|Phase 1|Physician Decision|0
2244086|NCT01962103|3903449|FG005|Phase 1|Physician Decision|0
2244087|NCT01962103|3903450|FG006|Phase 1|Physician Decision|0
2244088|NCT01962103|3903451|FG007|Phase 1|Physician Decision|0
2244089|NCT01962103|3903452|FG008|Phase 1|Physician Decision|0
2244090|NCT01962103|3903444|FG000|Phase 1|Symptomatic Deterioration|3
2244091|NCT01962103|3903445|FG001|Phase 1|Symptomatic Deterioration|2
2244092|NCT01962103|3903446|FG002|Phase 1|Symptomatic Deterioration|2
2244093|NCT01962103|3903447|FG003|Phase 1|Symptomatic Deterioration|2
2244094|NCT01962103|3903448|FG004|Phase 1|Symptomatic Deterioration|1
2244095|NCT01962103|3903449|FG005|Phase 1|Symptomatic Deterioration|1
2244096|NCT01962103|3903450|FG006|Phase 1|Symptomatic Deterioration|0
2244097|NCT01962103|3903451|FG007|Phase 1|Symptomatic Deterioration|0
2244098|NCT01962103|3903452|FG008|Phase 1|Symptomatic Deterioration|0
2244099|NCT01962103|3903444|FG000|Phase 1|Miscellaneous|1
2244100|NCT01962103|3903445|FG001|Phase 1|Miscellaneous|0
2244101|NCT01962103|3903446|FG002|Phase 1|Miscellaneous|0
2244102|NCT01962103|3903447|FG003|Phase 1|Miscellaneous|0
2244103|NCT01962103|3903448|FG004|Phase 1|Miscellaneous|0
2244104|NCT01962103|3903449|FG005|Phase 1|Miscellaneous|0
2244105|NCT01962103|3903450|FG006|Phase 1|Miscellaneous|0
2244106|NCT01962103|3903451|FG007|Phase 1|Miscellaneous|0
2244107|NCT01962103|3903452|FG008|Phase 1|Miscellaneous|0
2244108|NCT01962103|3903444|FG000|Phase 2|Adverse Event|0
2244109|NCT01962103|3903445|FG001|Phase 2|Adverse Event|0
2244110|NCT01962103|3903446|FG002|Phase 2|Adverse Event|0
2244111|NCT01962103|3903447|FG003|Phase 2|Adverse Event|0
2244112|NCT01962103|3903448|FG004|Phase 2|Adverse Event|0
2244113|NCT01962103|3903449|FG005|Phase 2|Adverse Event|0
2244114|NCT01962103|3903450|FG006|Phase 2|Adverse Event|1
2244115|NCT01962103|3903451|FG007|Phase 2|Adverse Event|0
2244116|NCT01962103|3903452|FG008|Phase 2|Adverse Event|3
2244117|NCT01962103|3903444|FG000|Phase 2|Progressive Disease|0
2244118|NCT01962103|3903445|FG001|Phase 2|Progressive Disease|0
2244119|NCT01962103|3903446|FG002|Phase 2|Progressive Disease|0
2244120|NCT01962103|3903447|FG003|Phase 2|Progressive Disease|0
2244121|NCT01962103|3903448|FG004|Phase 2|Progressive Disease|0
2244122|NCT01962103|3903449|FG005|Phase 2|Progressive Disease|0
2244123|NCT01962103|3903450|FG006|Phase 2|Progressive Disease|11
2244124|NCT01962103|3903451|FG007|Phase 2|Progressive Disease|12
2244125|NCT01962103|3903452|FG008|Phase 2|Progressive Disease|11
2244126|NCT01962103|3903444|FG000|Phase 2|Symptomatic Deterioration|0
2244127|NCT01962103|3903445|FG001|Phase 2|Symptomatic Deterioration|0
2244128|NCT01962103|3903446|FG002|Phase 2|Symptomatic Deterioration|0
2244129|NCT01962103|3903447|FG003|Phase 2|Symptomatic Deterioration|0
2244130|NCT01962103|3903448|FG004|Phase 2|Symptomatic Deterioration|0
2244131|NCT01962103|3903449|FG005|Phase 2|Symptomatic Deterioration|0
2244132|NCT01962103|3903450|FG006|Phase 2|Symptomatic Deterioration|2
2244133|NCT01962103|3903451|FG007|Phase 2|Symptomatic Deterioration|2
2244134|NCT01962103|3903452|FG008|Phase 2|Symptomatic Deterioration|0
2244135|NCT01962207|3903476|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2
2244136|NCT01962207|3903477|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1
2244137|NCT01962207|3903478|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5
2244138|NCT01962207|3903479|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2
2244139|NCT01962207|3903476|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2
2244140|NCT01962207|3903477|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0
2244141|NCT01962207|3903478|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4
2244142|NCT01962207|3903479|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0
2244143|NCT01962207|3903476|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4
2244144|NCT01962207|3903477|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5
2244145|NCT01962207|3903478|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18
2244146|NCT01962207|3903479|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4
2244147|NCT01962207|3903476|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
2244148|NCT01962207|3903477|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
2244149|NCT01962207|3903478|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
2244150|NCT01962207|3903479|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
2244151|NCT01962207|3903476|FG000|Persistence Phase (5 Years)|Adverse Event|0
2244152|NCT01962207|3903477|FG001|Persistence Phase (5 Years)|Adverse Event|0
2244153|NCT01962207|3903478|FG002|Persistence Phase (5 Years)|Adverse Event|1
2244154|NCT01962207|3903479|FG003|Persistence Phase (5 Years)|Adverse Event|0
2244155|NCT01962207|3903476|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
2244156|NCT01962207|3903477|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
2244157|NCT01962207|3903478|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
2244158|NCT01962207|3903479|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
2244159|NCT01962298|3903498|FG000|Overall Study|Protocol Violation|1
2244160|NCT01962298|3903499|FG001|Overall Study|Protocol Violation|0
2244161|NCT01962298|3903500|FG002|Overall Study|Protocol Violation|1
2244162|NCT01962298|3903501|FG003|Overall Study|Protocol Violation|1
2244163|NCT01962298|3903502|FG004|Overall Study|Protocol Violation|0
2244164|NCT01962298|3903498|FG000|Overall Study|Data quality insufficient|2
2244165|NCT01962298|3903499|FG001|Overall Study|Data quality insufficient|0
2244166|NCT01962298|3903500|FG002|Overall Study|Data quality insufficient|3
2244167|NCT01962298|3903501|FG003|Overall Study|Data quality insufficient|1
2244168|NCT01962298|3903502|FG004|Overall Study|Data quality insufficient|4
2244169|NCT01962298|3903498|FG000|Overall Study|Insufficient data|0
2244170|NCT01962298|3903499|FG001|Overall Study|Insufficient data|2
2244171|NCT01962298|3903500|FG002|Overall Study|Insufficient data|1
2244172|NCT01962298|3903501|FG003|Overall Study|Insufficient data|0
2338709|NCT03351608|4067512|FG001|Overall Study|Other|1
2338710|NCT03351608|4067513|FG002|Overall Study|Other|1
2338711|NCT03351608|4067514|FG003|Overall Study|Other|3
2338712|NCT03351608|4067515|FG004|Overall Study|Other|0
2338713|NCT03351738|4067571|FG000|Overall Study|Withdrawal by Subject|0
2338714|NCT03351738|4067572|FG001|Overall Study|Withdrawal by Subject|1
2338715|NCT03351738|4067573|FG002|Overall Study|Withdrawal by Subject|0
2338716|NCT03351738|4067574|FG003|Overall Study|Withdrawal by Subject|1
2338717|NCT03351738|4067575|FG004|Overall Study|Withdrawal by Subject|0
2338718|NCT03351738|4067576|FG005|Overall Study|Withdrawal by Subject|0
2338719|NCT03352414|4067614|FG000|Overall Study|Ineligible by operative criteria|12
2338720|NCT03352414|4067615|FG001|Overall Study|Ineligible by operative criteria|10
2338721|NCT03352453|4067625|FG000|Overall Study|Miscellaneous Reasons|1
2338722|NCT03352453|4067626|FG001|Overall Study|Miscellaneous Reasons|2
2338723|NCT03352453|4067625|FG000|Overall Study|Lack of Efficacy|1
2338724|NCT03352453|4067626|FG001|Overall Study|Lack of Efficacy|0
2338725|NCT03352453|4067625|FG000|Overall Study|Withdrawal by Subject|8
2338726|NCT03352453|4067626|FG001|Overall Study|Withdrawal by Subject|14
2037660|NCT00420004|3608088|FG000|Overall Study|Adverse Event|4
2037661|NCT00420004|3608089|FG001|Overall Study|Adverse Event|1
2037662|NCT00420004|3608090|FG002|Overall Study|Adverse Event|1
2037663|NCT00420004|3608088|FG000|Overall Study|Lack of Efficacy|5
2037664|NCT00420004|3608089|FG001|Overall Study|Lack of Efficacy|4
2037665|NCT00420004|3608090|FG002|Overall Study|Lack of Efficacy|1
2037666|NCT00420004|3608088|FG000|Overall Study|Lost to Follow-up|31
2037667|NCT00420004|3608089|FG001|Overall Study|Lost to Follow-up|12
2037668|NCT00420004|3608090|FG002|Overall Study|Lost to Follow-up|10
2037669|NCT00420004|3608088|FG000|Overall Study|Entry Criteria Not Met|0
2037670|NCT00420004|3608089|FG001|Overall Study|Entry Criteria Not Met|1
2037671|NCT00420004|3608090|FG002|Overall Study|Entry Criteria Not Met|0
2037672|NCT00420004|3608088|FG000|Overall Study|Physician Decision|14
2037673|NCT00420004|3608089|FG001|Overall Study|Physician Decision|4
2244173|NCT01962298|3903502|FG004|Overall Study|Insufficient data|1
2244174|NCT01962298|3903498|FG000|Overall Study|Incorrect data recorded|0
2244175|NCT01962298|3903499|FG001|Overall Study|Incorrect data recorded|1
2244176|NCT01962298|3903500|FG002|Overall Study|Incorrect data recorded|0
2244177|NCT01962298|3903501|FG003|Overall Study|Incorrect data recorded|0
2244178|NCT01962298|3903502|FG004|Overall Study|Incorrect data recorded|0
2244179|NCT01962298|3903498|FG000|Overall Study|Physician Decision|0
2244180|NCT01962298|3903499|FG001|Overall Study|Physician Decision|1
2244181|NCT01962298|3903500|FG002|Overall Study|Physician Decision|0
2244182|NCT01962298|3903501|FG003|Overall Study|Physician Decision|0
2244183|NCT01962298|3903502|FG004|Overall Study|Physician Decision|1
2244184|NCT01962441|3903526|FG000|Randomized Period|Randomized but Never Treated|4
2244185|NCT01962441|3903527|FG001|Randomized Period|Randomized but Never Treated|2
2244186|NCT01962441|3903528|FG002|Randomized Period|Randomized but Never Treated|3
2037674|NCT00420004|3608090|FG002|Overall Study|Physician Decision|2
2244187|NCT01962441|3903526|FG000|Randomized Period|Lost to Follow-up|2
2244188|NCT01962441|3903527|FG001|Randomized Period|Lost to Follow-up|4
2244189|NCT01962441|3903528|FG002|Randomized Period|Lost to Follow-up|4
2338727|NCT03352453|4067625|FG000|Overall Study|Study Terminated by Sponsor|2
2244190|NCT01962441|3903526|FG000|Randomized Period|Withdrew Consent|3
2244191|NCT01962441|3903527|FG001|Randomized Period|Withdrew Consent|3
2244192|NCT01962441|3903528|FG002|Randomized Period|Withdrew Consent|2
2244193|NCT01962441|3903526|FG000|Randomized Period|Adverse Event|1
2244194|NCT01962441|3903527|FG001|Randomized Period|Adverse Event|1
2244195|NCT01962441|3903528|FG002|Randomized Period|Adverse Event|0
2244196|NCT01962441|3903526|FG000|Randomized Period|Death|0
2244197|NCT01962441|3903527|FG001|Randomized Period|Death|0
2244198|NCT01962441|3903528|FG002|Randomized Period|Death|2
2244199|NCT01962441|3903526|FG000|Randomized Period|Protocol Violation|0
2244200|NCT01962441|3903527|FG001|Randomized Period|Protocol Violation|1
2244201|NCT01962441|3903528|FG002|Randomized Period|Protocol Violation|0
2244202|NCT01962441|3903526|FG000|Retreatment Substudy|Lack of Efficacy|1
2244203|NCT01962441|3903527|FG001|Retreatment Substudy|Lack of Efficacy|0
2244204|NCT01962441|3903528|FG002|Retreatment Substudy|Lack of Efficacy|0
2244205|NCT01962441|3903526|FG000|Retreatment Substudy|Lost to Follow-up|1
2244206|NCT01962441|3903527|FG001|Retreatment Substudy|Lost to Follow-up|0
2244207|NCT01962441|3903528|FG002|Retreatment Substudy|Lost to Follow-up|0
2244208|NCT01962493|3903539|FG000|Overall Study|Adverse Event|1
2244209|NCT01962493|3903540|FG001|Overall Study|Adverse Event|2
2244210|NCT01962493|3903539|FG000|Overall Study|Protocol Violation|0
2244211|NCT01962493|3903540|FG001|Overall Study|Protocol Violation|1
2244212|NCT01962493|3903539|FG000|Overall Study|Withdrawal by Subject|4
2244213|NCT01962493|3903540|FG001|Overall Study|Withdrawal by Subject|2
2338728|NCT03352453|4067626|FG001|Overall Study|Study Terminated by Sponsor|1
2338729|NCT03352453|4067625|FG000|Overall Study|Protocol Deviation|1
2338730|NCT03352453|4067626|FG001|Overall Study|Protocol Deviation|0
2338731|NCT03352453|4067625|FG000|Overall Study|Lost to Follow-up|7
2338732|NCT03352453|4067626|FG001|Overall Study|Lost to Follow-up|6
2338733|NCT03352453|4067625|FG000|Overall Study|Adverse Event|2
2338734|NCT03352453|4067626|FG001|Overall Study|Adverse Event|9
2338735|NCT03352713|4067641|FG000|Overall Study|Lost to Follow-up|8
2338736|NCT03352713|4067641|FG000|Overall Study|Withdrawn by investigator|5
2338737|NCT03352713|4067641|FG000|Overall Study|Completed 0 EMAs|8
2338738|NCT03352713|4067641|FG000|Overall Study|Device incompatible/stolen|5
2338739|NCT03353220|4067645|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4
2338740|NCT03353220|4067646|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7
2338741|NCT03353740|4067656|FG000|Overall Study|Images for these participants not viable|52
2338742|NCT03354429|4067680|FG000|Overall Study|Withdrawal by Subject|8
2338743|NCT03354429|4067681|FG001|Overall Study|Withdrawal by Subject|7
2338744|NCT03354429|4067680|FG000|Overall Study|Lost to Follow-up|1
2338745|NCT03354429|4067681|FG001|Overall Study|Lost to Follow-up|0
2338746|NCT03354637|4067699|FG000|Double-blind Period|Protocol Violation|2
2338747|NCT03354637|4067700|FG001|Double-blind Period|Protocol Violation|0
2338748|NCT03354637|4067701|FG002|Double-blind Period|Protocol Violation|0
2338749|NCT03354637|4067699|FG000|Double-blind Period|Adverse Event|1
2338750|NCT03354637|4067700|FG001|Double-blind Period|Adverse Event|2
2338751|NCT03354637|4067701|FG002|Double-blind Period|Adverse Event|0
2338752|NCT03354637|4067699|FG000|Double-blind Period|Lost to Follow-up|3
2338753|NCT03354637|4067700|FG001|Double-blind Period|Lost to Follow-up|4
2338754|NCT03354637|4067701|FG002|Double-blind Period|Lost to Follow-up|3
2338755|NCT03354637|4067699|FG000|Double-blind Period|Withdrawal by Subject|10
2338756|NCT03354637|4067700|FG001|Double-blind Period|Withdrawal by Subject|6
2338757|NCT03354637|4067701|FG002|Double-blind Period|Withdrawal by Subject|4
2338758|NCT03354637|4067699|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1
2338759|NCT03354637|4067700|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1
2338760|NCT03354637|4067701|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0
2338761|NCT03354637|4067699|FG000|Open Label Extension|Adverse Event|0
2338762|NCT03354637|4067700|FG001|Open Label Extension|Adverse Event|0
2338763|NCT03354637|4067701|FG002|Open Label Extension|Adverse Event|1
2338764|NCT03354637|4067699|FG000|Open Label Extension|Lost to Follow-up|0
2338765|NCT03354637|4067700|FG001|Open Label Extension|Lost to Follow-up|0
2338766|NCT03354637|4067701|FG002|Open Label Extension|Lost to Follow-up|2
2338767|NCT03354637|4067699|FG000|Open Label Extension|Withdrawal by Subject|0
2338768|NCT03354637|4067700|FG001|Open Label Extension|Withdrawal by Subject|0
2338769|NCT03354637|4067701|FG002|Open Label Extension|Withdrawal by Subject|5
2338770|NCT03354637|4067699|FG000|Open Label Extension|Study Terminated by Sponsor|0
2338771|NCT03354637|4067700|FG001|Open Label Extension|Study Terminated by Sponsor|0
2338772|NCT03354637|4067701|FG002|Open Label Extension|Study Terminated by Sponsor|17
2338773|NCT03354637|4067699|FG000|Open Label Extension|Subject Noncompliance|0
2338774|NCT03354637|4067700|FG001|Open Label Extension|Subject Noncompliance|0
2338775|NCT03354637|4067701|FG002|Open Label Extension|Subject Noncompliance|1
2338776|NCT03354637|4067699|FG000|Open Label Extension|Lack of Efficacy|0
2338777|NCT03354637|4067700|FG001|Open Label Extension|Lack of Efficacy|0
2338778|NCT03354637|4067701|FG002|Open Label Extension|Lack of Efficacy|1
2338779|NCT03354637|4067699|FG000|Open Label Extension|Physician Decision|0
2338780|NCT03354637|4067700|FG001|Open Label Extension|Physician Decision|0
2338781|NCT03354637|4067701|FG002|Open Label Extension|Physician Decision|1
2338782|NCT03354663|4067710|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
2338783|NCT03354663|4067710|FG000|Enrollment to Catheter Insertion|Adverse Event|1
2244214|NCT01962896|3903582|FG000|Overall Study|Lack of Efficacy|4
2244215|NCT01962922|3903589|FG000|PK Portion Day 7|Withdrawal by Subject|3
2244216|NCT01962922|3903590|FG001|PK Portion Day 7|Withdrawal by Subject|0
2244217|NCT01962922|3903589|FG000|PK Portion Day 7|non-compliance|1
2244218|NCT01962922|3903590|FG001|PK Portion Day 7|non-compliance|0
2244219|NCT01962922|3903589|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
2244220|NCT01962922|3903590|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
2244221|NCT01962922|3903589|FG000|Extendion Portion (up to Month 6)|Physician Decision|1
2244222|NCT01962922|3903590|FG001|Extendion Portion (up to Month 6)|Physician Decision|0
2244223|NCT01962987|3903612|FG000|Overall Study|Adverse Event|4
2244224|NCT01962987|3903613|FG001|Overall Study|Adverse Event|4
2244225|NCT01962987|3903614|FG002|Overall Study|Adverse Event|0
2244226|NCT01962987|3903612|FG000|Overall Study|Lost to Follow-up|0
2244227|NCT01962987|3903613|FG001|Overall Study|Lost to Follow-up|0
2244228|NCT01962987|3903614|FG002|Overall Study|Lost to Follow-up|1
2244229|NCT01962987|3903612|FG000|Overall Study|Non compliance with dosing requirements|4
2244230|NCT01962987|3903613|FG001|Overall Study|Non compliance with dosing requirements|2
2244231|NCT01962987|3903614|FG002|Overall Study|Non compliance with dosing requirements|0
2244232|NCT01962987|3903612|FG000|Overall Study|Miscellaneous|1
2244233|NCT01962987|3903613|FG001|Overall Study|Miscellaneous|9
2244234|NCT01962987|3903614|FG002|Overall Study|Miscellaneous|2
2244235|NCT01962987|3903612|FG000|Overall Study|Restricted medication|5
2244236|NCT01962987|3903613|FG001|Overall Study|Restricted medication|1
2244237|NCT01962987|3903614|FG002|Overall Study|Restricted medication|1
2244238|NCT01962987|3903612|FG000|Overall Study|Serious Adverse Event|1
2244239|NCT01962987|3903613|FG001|Overall Study|Serious Adverse Event|0
2244240|NCT01962987|3903614|FG002|Overall Study|Serious Adverse Event|0
2244241|NCT01962987|3903612|FG000|Overall Study|Withdrawal by Subject|11
2244242|NCT01962987|3903613|FG001|Overall Study|Withdrawal by Subject|10
2244243|NCT01962987|3903614|FG002|Overall Study|Withdrawal by Subject|6
2244244|NCT01962987|3903612|FG000|Overall Study|Randomized in Error|4
2244245|NCT01962987|3903613|FG001|Overall Study|Randomized in Error|2
2244246|NCT01962987|3903614|FG002|Overall Study|Randomized in Error|2
2244247|NCT01963117|3903648|FG000|Overall Study|Death|1
2244248|NCT01963260|3903702|FG000|Overall Study|Withdrawal by Subject|2
2244249|NCT01963260|3903703|FG001|Overall Study|Withdrawal by Subject|0
2244250|NCT01963260|3903704|FG002|Overall Study|Withdrawal by Subject|0
2244251|NCT01963260|3903705|FG003|Overall Study|Withdrawal by Subject|1
2244252|NCT01963260|3903706|FG004|Overall Study|Withdrawal by Subject|2
2244253|NCT01963260|3903707|FG005|Overall Study|Withdrawal by Subject|0
2244254|NCT01963260|3903708|FG006|Overall Study|Withdrawal by Subject|0
2244255|NCT01963260|3903709|FG007|Overall Study|Withdrawal by Subject|0
2244256|NCT01963260|3903710|FG008|Overall Study|Withdrawal by Subject|0
2244257|NCT01963260|3903711|FG009|Overall Study|Withdrawal by Subject|0
2244258|NCT01963403|3903742|FG000|Overall Study|Lost to Follow-up|2
2244259|NCT01963403|3903743|FG001|Overall Study|Lost to Follow-up|3
2244260|NCT01963403|3903742|FG000|Overall Study|Implant removal|0
2244261|NCT01963403|3903743|FG001|Overall Study|Implant removal|1
2244262|NCT01963611|3903760|FG000|Overall Study|Adverse Event|1
2244263|NCT01963611|3903761|FG001|Overall Study|Adverse Event|1
2244264|NCT01963611|3903762|FG002|Overall Study|Adverse Event|3
2244265|NCT01963611|3903763|FG003|Overall Study|Adverse Event|4
2244266|NCT01963611|3903764|FG004|Overall Study|Adverse Event|3
2244267|NCT01963611|3903760|FG000|Overall Study|Protocol Violation|0
2244268|NCT01963611|3903761|FG001|Overall Study|Protocol Violation|0
2244269|NCT01963611|3903762|FG002|Overall Study|Protocol Violation|0
2244270|NCT01963611|3903763|FG003|Overall Study|Protocol Violation|1
2244271|NCT01963611|3903764|FG004|Overall Study|Protocol Violation|0
2244272|NCT01963611|3903760|FG000|Overall Study|Lack of Efficacy|0
2244273|NCT01963611|3903761|FG001|Overall Study|Lack of Efficacy|0
2244274|NCT01963611|3903762|FG002|Overall Study|Lack of Efficacy|0
2244275|NCT01963611|3903763|FG003|Overall Study|Lack of Efficacy|1
2244276|NCT01963611|3903764|FG004|Overall Study|Lack of Efficacy|0
2244277|NCT01963611|3903760|FG000|Overall Study|Withdrawal by Subject|3
2244278|NCT01963611|3903761|FG001|Overall Study|Withdrawal by Subject|2
2244279|NCT01963611|3903762|FG002|Overall Study|Withdrawal by Subject|1
2244280|NCT01963611|3903763|FG003|Overall Study|Withdrawal by Subject|1
2244281|NCT01963611|3903764|FG004|Overall Study|Withdrawal by Subject|3
2244282|NCT01963611|3903760|FG000|Overall Study|Other|47
2244283|NCT01963611|3903761|FG001|Overall Study|Other|46
2244284|NCT01963611|3903762|FG002|Overall Study|Other|48
2244285|NCT01963611|3903763|FG003|Overall Study|Other|45
2244286|NCT01963611|3903764|FG004|Overall Study|Other|45
2244287|NCT01963676|3903779|FG000|Overall Study|Withdrawal by Subject|1
2244288|NCT01963676|3903780|FG001|Overall Study|Withdrawal by Subject|0
2244289|NCT01963767|3903788|FG000|Overall Study|Withdrawal by Subject|4
2244290|NCT01963767|3903789|FG001|Overall Study|Withdrawal by Subject|2
2244291|NCT01963767|3903788|FG000|Overall Study|Adverse Event|2
2244292|NCT01963767|3903789|FG001|Overall Study|Adverse Event|0
2244293|NCT01964105|3903847|FG000|Overall Study|Lost to Follow-up|2
2244294|NCT01964105|3903848|FG001|Overall Study|Lost to Follow-up|13
2244295|NCT01964105|3903849|FG002|Overall Study|Lost to Follow-up|0
2244296|NCT01964222|3903859|FG000|Overall Study|Lost to Follow-up|7
2244297|NCT01964222|3903860|FG001|Overall Study|Lost to Follow-up|5
2244298|NCT01964222|3903859|FG000|Overall Study|Withdrawal by Subject|6
2244299|NCT01964222|3903860|FG001|Overall Study|Withdrawal by Subject|6
2244300|NCT01964222|3903859|FG000|Overall Study|Screening Failure|2
2244301|NCT01964222|3903860|FG001|Overall Study|Screening Failure|0
2244302|NCT01964300|3903868|FG000|Overall Study|Ineligible after enrollment|0
2244303|NCT01964300|3903869|FG001|Overall Study|Ineligible after enrollment|1
2244304|NCT01964300|3903868|FG000|Overall Study|Adverse Event|1
2244305|NCT01964300|3903869|FG001|Overall Study|Adverse Event|1
2338784|NCT03354663|4067710|FG000|Completed 30-day Visit|Withdrawal by Subject|1
2338785|NCT03354663|4067710|FG000|Completed 30-day Visit|Missed Visit|1
2338786|NCT03355326|4067729|FG000|Overall Study|Protocol Violation|3
2338787|NCT03355326|4067730|FG001|Overall Study|Protocol Violation|3
2338788|NCT03355742|4067736|FG000|Overall Study|Lost to Follow-up|4
2338789|NCT03355742|4067736|FG000|Overall Study|Withdrawal by Subject|29
2338790|NCT03355742|4067736|FG000|Overall Study|Physician Decision|6
2338791|NCT03355742|4067736|FG000|Overall Study|Death|55
2338792|NCT03355742|4067736|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5
2338793|NCT03356145|4067746|FG000|Overall Study|Withdrawal by Subject|2
2338794|NCT03356145|4067747|FG001|Overall Study|Withdrawal by Subject|1
2338795|NCT03356145|4067746|FG000|Overall Study|Did not meet inclusion criteria|1
2338796|NCT03356145|4067747|FG001|Overall Study|Did not meet inclusion criteria|0
2338797|NCT03356977|4067753|FG000|Overall Study|Lost to Follow-up|3
2338798|NCT03356977|4067753|FG000|Overall Study|Withdrawal by parent/guardian|2
2037675|NCT00420004|3608088|FG000|Overall Study|Protocol Violation|5
2037676|NCT00420004|3608089|FG001|Overall Study|Protocol Violation|4
2037677|NCT00420004|3608090|FG002|Overall Study|Protocol Violation|3
2037678|NCT00420004|3608088|FG000|Overall Study|Withdrawal by Subject|67
2037679|NCT00420004|3608089|FG001|Overall Study|Withdrawal by Subject|42
2037680|NCT00420004|3608090|FG002|Overall Study|Withdrawal by Subject|14
2037681|NCT00420004|3608088|FG000|Overall Study|Sponsor Decision|3
2037682|NCT00420004|3608089|FG001|Overall Study|Sponsor Decision|3
2037683|NCT00420004|3608090|FG002|Overall Study|Sponsor Decision|1
2037684|NCT00420056|3608111|FG000|Overall Study|Objective progression or relapse|17
2244306|NCT01964300|3903868|FG000|Overall Study|Lack of Efficacy|3
2244307|NCT01964300|3903869|FG001|Overall Study|Lack of Efficacy|5
2244308|NCT01964300|3903868|FG000|Overall Study|Withdrawal by Subject|0
2244309|NCT01964300|3903869|FG001|Overall Study|Withdrawal by Subject|1
2244310|NCT01964300|3903868|FG000|Overall Study|To receive alternative therapy|1
2244311|NCT01964300|3903869|FG001|Overall Study|To receive alternative therapy|2
2244312|NCT01964300|3903868|FG000|Overall Study|Enlargement of cyst requiring drainage|1
2244313|NCT01964300|3903869|FG001|Overall Study|Enlargement of cyst requiring drainage|0
2244314|NCT01964300|3903868|FG000|Overall Study|Weight criteria not met|0
2244315|NCT01964300|3903869|FG001|Overall Study|Weight criteria not met|1
2244316|NCT01964326|3903875|FG000|Overall Study|Adverse Event|48
2244317|NCT01964326|3903875|FG000|Overall Study|Death|2
2244318|NCT01964326|3903875|FG000|Overall Study|Protocol Violation|4
2244319|NCT01964326|3903875|FG000|Overall Study|Lost to Follow-up|88
2244320|NCT01964326|3903875|FG000|Overall Study|Withdrawal by Subject|87
2244321|NCT01964326|3903875|FG000|Overall Study|Pregnancy|1
2244322|NCT01964326|3903875|FG000|Overall Study|No Longer Meets Eligibility Criteria|1
2244323|NCT01964326|3903875|FG000|Overall Study|Physician Decision|55
2244324|NCT01964326|3903875|FG000|Overall Study|Investigator Discretion|1
2244325|NCT01964326|3903875|FG000|Overall Study|Other|9
2244326|NCT01964326|3903875|FG000|Overall Study|Did not meet eligibility criteria|1
2244327|NCT01964352|3903883|FG000|Overall Study|Adverse Event|13
2244328|NCT01964352|3903884|FG001|Overall Study|Adverse Event|3
2244329|NCT01964352|3903885|FG002|Overall Study|Adverse Event|4
2244330|NCT01964352|3903886|FG003|Overall Study|Adverse Event|3
2244331|NCT01964352|3903883|FG000|Overall Study|Lack of Efficacy|6
2244332|NCT01964352|3903884|FG001|Overall Study|Lack of Efficacy|0
2244333|NCT01964352|3903885|FG002|Overall Study|Lack of Efficacy|0
2244334|NCT01964352|3903886|FG003|Overall Study|Lack of Efficacy|0
2244335|NCT01964352|3903883|FG000|Overall Study|Protocol Violation|2
2244336|NCT01964352|3903884|FG001|Overall Study|Protocol Violation|4
2244337|NCT01964352|3903885|FG002|Overall Study|Protocol Violation|0
2244338|NCT01964352|3903886|FG003|Overall Study|Protocol Violation|2
2244339|NCT01964352|3903883|FG000|Overall Study|Lost to Follow-up|1
2244340|NCT01964352|3903884|FG001|Overall Study|Lost to Follow-up|0
2244341|NCT01964352|3903885|FG002|Overall Study|Lost to Follow-up|0
2244342|NCT01964352|3903886|FG003|Overall Study|Lost to Follow-up|1
2244343|NCT01964352|3903883|FG000|Overall Study|Withdrawal by Subject|4
2244344|NCT01964352|3903884|FG001|Overall Study|Withdrawal by Subject|2
2244345|NCT01964352|3903885|FG002|Overall Study|Withdrawal by Subject|1
2244346|NCT01964352|3903886|FG003|Overall Study|Withdrawal by Subject|0
2244347|NCT01964352|3903883|FG000|Overall Study|Other than stated above|0
2244348|NCT01964352|3903884|FG001|Overall Study|Other than stated above|2
2244349|NCT01964352|3903885|FG002|Overall Study|Other than stated above|1
2244350|NCT01964352|3903886|FG003|Overall Study|Other than stated above|2
2244351|NCT01964378|3903898|FG000|Overall Study|Disc. due to death before first dosing|0
2244352|NCT01964378|3903899|FG001|Overall Study|Disc. due to death before first dosing|1
2244353|NCT01964378|3903898|FG000|Overall Study|Disc. due to AE before first dosing|1
2244354|NCT01964378|3903899|FG001|Overall Study|Disc. due to AE before first dosing|0
2244355|NCT01964378|3903898|FG000|Overall Study|Death|3
2244356|NCT01964378|3903899|FG001|Overall Study|Death|2
2244357|NCT01964378|3903898|FG000|Overall Study|Adverse Event|12
2244358|NCT01964378|3903899|FG001|Overall Study|Adverse Event|5
2244359|NCT01964378|3903898|FG000|Overall Study|Lack of Efficacy|0
2244360|NCT01964378|3903899|FG001|Overall Study|Lack of Efficacy|1
2244361|NCT01964378|3903898|FG000|Overall Study|Protocol Violation|0
2244362|NCT01964378|3903899|FG001|Overall Study|Protocol Violation|1
2244363|NCT01964378|3903898|FG000|Overall Study|Lost to Follow-up|0
2244364|NCT01964378|3903899|FG001|Overall Study|Lost to Follow-up|1
2244365|NCT01964378|3903898|FG000|Overall Study|Withdrawal by Subject|7
2244366|NCT01964378|3903899|FG001|Overall Study|Withdrawal by Subject|5
2244367|NCT01964378|3903898|FG000|Overall Study|Inclusion/exclusion criteria not met|1
2244368|NCT01964378|3903899|FG001|Overall Study|Inclusion/exclusion criteria not met|3
2244369|NCT01964378|3903898|FG000|Overall Study|Other|1
2244370|NCT01964378|3903899|FG001|Overall Study|Other|2
2244371|NCT01964430|3903907|FG000|Overall Study|Adverse Event|71
2244372|NCT01964430|3903908|FG001|Overall Study|Adverse Event|37
2244373|NCT01964430|3903907|FG000|Overall Study|Withdrawal by Subject|36
2244374|NCT01964430|3903908|FG001|Overall Study|Withdrawal by Subject|27
2244375|NCT01964430|3903907|FG000|Overall Study|Death|1
2244376|NCT01964430|3903908|FG001|Overall Study|Death|3
2244377|NCT01964430|3903907|FG000|Overall Study|Protocol Deviation|0
2244378|NCT01964430|3903908|FG001|Overall Study|Protocol Deviation|1
2244379|NCT01964430|3903907|FG000|Overall Study|Physician Decision|5
2244380|NCT01964430|3903908|FG001|Overall Study|Physician Decision|4
2244381|NCT01964430|3903907|FG000|Overall Study|Disease Relapse|28
2244382|NCT01964430|3903908|FG001|Overall Study|Disease Relapse|38
2244383|NCT01964430|3903907|FG000|Overall Study|Miscellaneous|1
2244384|NCT01964430|3903908|FG001|Overall Study|Miscellaneous|3
2244385|NCT01964430|3903907|FG000|Overall Study|Randomized but not Treated|3
2244386|NCT01964430|3903908|FG001|Overall Study|Randomized but not Treated|11
2244387|NCT01964521|3903914|FG000|Overall Study|Lost to Follow-up|4
2244388|NCT01964547|3903921|FG000|Overall Study|Adverse Event|8
2244389|NCT01964547|3903922|FG001|Overall Study|Adverse Event|2
2244390|NCT01964547|3903921|FG000|Overall Study|Withdrawal by Subject|4
2244391|NCT01964547|3903922|FG001|Overall Study|Withdrawal by Subject|7
2244392|NCT01964547|3903921|FG000|Overall Study|Lost to Follow-up|0
2244393|NCT01964547|3903922|FG001|Overall Study|Lost to Follow-up|1
2244394|NCT01964547|3903921|FG000|Overall Study|Withdrawal by Investigator|0
2244395|NCT01964547|3903922|FG001|Overall Study|Withdrawal by Investigator|1
2244396|NCT01964716|3903930|FG000|Overall Study|Withdrawal by Subject|2
2244397|NCT01964716|3903931|FG001|Overall Study|Withdrawal by Subject|3
2244398|NCT01964716|3903930|FG000|Overall Study|Lost to Follow-up|1
2244399|NCT01964716|3903931|FG001|Overall Study|Lost to Follow-up|2
2244400|NCT01964716|3903930|FG000|Overall Study|No longer met eligibility criteria|1
2244401|NCT01964716|3903931|FG001|Overall Study|No longer met eligibility criteria|1
2244402|NCT01964716|3903930|FG000|Overall Study|Death|1
2244403|NCT01964716|3903931|FG001|Overall Study|Death|0
2244404|NCT01964755|3903945|FG000|Overall Study|Death|2
2244405|NCT01964898|3903951|FG000|Overall Study|ineligible post-randomization|1
2244406|NCT01964898|3903952|FG001|Overall Study|ineligible post-randomization|1
2244407|NCT01964898|3903951|FG000|Overall Study|did not receive the allocated interventi|2
2244408|NCT01964898|3903952|FG001|Overall Study|did not receive the allocated interventi|1
2244409|NCT01964898|3903951|FG000|Overall Study|Lost to Follow-up|3
2244410|NCT01964898|3903952|FG001|Overall Study|Lost to Follow-up|5
2244411|NCT01964898|3903951|FG000|Overall Study|Withdrawal by Subject|1
2244412|NCT01964898|3903952|FG001|Overall Study|Withdrawal by Subject|0
2244413|NCT01964924|3903958|FG000|Trametinib Monotherapy|Progression|19
2244414|NCT01964924|3903959|FG001|Trametinib Monotherapy|Progression|0
2244415|NCT01964950|3903970|FG000|Overall Study|Protocol Violation|25
2244416|NCT01964963|3903977|FG000|Overall Study|Case Report Forms Uncollected|888
2244417|NCT01964963|3903977|FG000|Overall Study|Protocol Deviation|50
2244418|NCT01964963|3903977|FG000|Overall Study|Data Reliability was not Assured|5
2244419|NCT01964976|3903983|FG000|Overall Study|Protocol Violation|31
2244420|NCT01965158|3904007|FG000|Overall Study|Adverse Event|14
2244421|NCT01965158|3904008|FG001|Overall Study|Adverse Event|5
2244422|NCT01965158|3904007|FG000|Overall Study|Withdrawal by Subject|16
2244423|NCT01965158|3904008|FG001|Overall Study|Withdrawal by Subject|24
2244424|NCT01965158|3904007|FG000|Overall Study|Lost to Follow-up|7
2244425|NCT01965158|3904008|FG001|Overall Study|Lost to Follow-up|5
2244426|NCT01965158|3904007|FG000|Overall Study|Protocol Violation|1
2244427|NCT01965158|3904008|FG001|Overall Study|Protocol Violation|1
2244428|NCT01965158|3904007|FG000|Overall Study|Other - Miscellaneous|3
2244429|NCT01965158|3904008|FG001|Overall Study|Other - Miscellaneous|0
2244430|NCT01965262|3904014|FG000|Second Intervention (7 Days)|Discontinued|0
2244431|NCT01965262|3904015|FG001|Second Intervention (7 Days)|Discontinued|1
2244432|NCT01965262|3904014|FG000|Second Intervention (7 Days)|Poor lens fit|0
2244433|NCT01965262|3904015|FG001|Second Intervention (7 Days)|Poor lens fit|9
2244434|NCT01965262|3904014|FG000|Second Intervention (7 Days)|Poor visual acuity|1
2244435|NCT01965262|3904015|FG001|Second Intervention (7 Days)|Poor visual acuity|0
2244436|NCT01965327|3904042|FG000|Overall Study|Physician Decision|2
2244437|NCT01965431|3904055|FG000|Overall Study|Adverse Event|0
2244438|NCT01965431|3904056|FG001|Overall Study|Adverse Event|1
2244439|NCT01965431|3904057|FG002|Overall Study|Adverse Event|0
2244440|NCT01965431|3904058|FG003|Overall Study|Adverse Event|0
2244441|NCT01965431|3904059|FG004|Overall Study|Adverse Event|0
2244442|NCT01965431|3904060|FG005|Overall Study|Adverse Event|0
2244443|NCT01965431|3904055|FG000|Overall Study|Other than stated above|6
2244444|NCT01965431|3904056|FG001|Overall Study|Other than stated above|5
2244445|NCT01965431|3904057|FG002|Overall Study|Other than stated above|6
2244446|NCT01965431|3904058|FG003|Overall Study|Other than stated above|6
2244447|NCT01965431|3904059|FG004|Overall Study|Other than stated above|6
2244448|NCT01965431|3904060|FG005|Overall Study|Other than stated above|6
2244449|NCT01965535|3904072|FG000|Overall Study|Lack of Efficacy|2
2244450|NCT01965535|3904073|FG001|Overall Study|Lack of Efficacy|1
2244451|NCT01965600|3904086|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
2244452|NCT01965600|3904087|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
2244453|NCT01965600|3904088|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
2244454|NCT01965600|3904089|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
2244455|NCT01965600|3904086|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
2244456|NCT01965600|3904087|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
2244457|NCT01965600|3904088|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
2244458|NCT01965600|3904089|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
2244459|NCT01965600|3904086|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
2244460|NCT01965600|3904087|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
2244461|NCT01965600|3904088|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
2244462|NCT01965600|3904089|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
2244463|NCT01965600|3904086|FG000|Washout Period of Approximately 15 Days|Adverse Event|0
2244464|NCT01965600|3904087|FG001|Washout Period of Approximately 15 Days|Adverse Event|0
2244465|NCT01965600|3904088|FG002|Washout Period of Approximately 15 Days|Adverse Event|0
2244466|NCT01965600|3904089|FG003|Washout Period of Approximately 15 Days|Adverse Event|1
2244467|NCT01965600|3904086|FG000|Second Intervention|Study terminated by Sponsor|0
2244468|NCT01965600|3904087|FG001|Second Intervention|Study terminated by Sponsor|0
2244469|NCT01965600|3904088|FG002|Second Intervention|Study terminated by Sponsor|2
2244470|NCT01965600|3904089|FG003|Second Intervention|Study terminated by Sponsor|2
2244471|NCT01965652|3904099|FG000|Overall Study|Adverse Event|40
2244472|NCT01965652|3904100|FG001|Overall Study|Adverse Event|37
2244473|NCT01965652|3904099|FG000|Overall Study|Withdrawal by Subject|62
2244474|NCT01965652|3904100|FG001|Overall Study|Withdrawal by Subject|69
2244475|NCT01965652|3904099|FG000|Overall Study|Lost to Follow-up|53
2244476|NCT01965652|3904100|FG001|Overall Study|Lost to Follow-up|40
2244477|NCT01965652|3904099|FG000|Overall Study|Protocol Violation|34
2244478|NCT01965652|3904100|FG001|Overall Study|Protocol Violation|38
2244479|NCT01965652|3904099|FG000|Overall Study|Death|3
2244480|NCT01965652|3904100|FG001|Overall Study|Death|4
2244481|NCT01965652|3904099|FG000|Overall Study|Other - Miscellaneous|18
2244482|NCT01965652|3904100|FG001|Overall Study|Other - Miscellaneous|21
2244483|NCT01965652|3904099|FG000|Overall Study|Pregnancy|0
2244484|NCT01965652|3904100|FG001|Overall Study|Pregnancy|1
2244485|NCT01965834|3904123|FG000|Overall Study|Lack of Efficacy|4
2244486|NCT01965860|3904130|FG000|Overall Study|Pregnancy|1
2244487|NCT01965860|3904131|FG001|Overall Study|Pregnancy|0
2244488|NCT01965860|3904132|FG002|Overall Study|Pregnancy|1
2244489|NCT01965860|3904130|FG000|Overall Study|Logistics|1
2244490|NCT01965860|3904131|FG001|Overall Study|Logistics|0
2244491|NCT01965860|3904132|FG002|Overall Study|Logistics|0
2244492|NCT01965938|3904147|FG000|Overall Study|Withdrawal by Subject|1
2244493|NCT01965938|3904148|FG001|Overall Study|Withdrawal by Subject|0
2244494|NCT01966003|3904158|FG000|Overall Study|Death|43
2244495|NCT01966003|3904159|FG001|Overall Study|Death|36
2244496|NCT01966003|3904158|FG000|Overall Study|Protocol Violation|6
2244497|NCT01966003|3904159|FG001|Overall Study|Protocol Violation|4
2244498|NCT01966003|3904158|FG000|Overall Study|Lost to Follow-up|4
2244499|NCT01966003|3904159|FG001|Overall Study|Lost to Follow-up|3
2244500|NCT01966003|3904158|FG000|Overall Study|Physician Decision|12
2244501|NCT01966003|3904159|FG001|Overall Study|Physician Decision|13
2244502|NCT01966003|3904158|FG000|Overall Study|Withdrawal by Subject|29
2244503|NCT01966003|3904159|FG001|Overall Study|Withdrawal by Subject|19
2244504|NCT01966003|3904158|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131
2244505|NCT01966003|3904159|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127
2244506|NCT01966003|3904158|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44
2244507|NCT01966003|3904159|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67
2244508|NCT01966003|3904158|FG000|Overall Study|Other|1
2244509|NCT01966003|3904159|FG001|Overall Study|Other|1
2244510|NCT01966042|3904165|FG000|Overall Study|Death|2
2244511|NCT01966068|3904171|FG000|Overall Study|Withdrawal by Subject|57
2244512|NCT01966068|3904171|FG000|Overall Study|Lost to Follow-up|81
2244513|NCT01966107|3904178|FG000|Overall Study|excluded from FAS|21
2244514|NCT01966107|3904179|FG001|Overall Study|excluded from FAS|20
2244515|NCT01966107|3904178|FG000|Overall Study|discontinued treatment|345
2244516|NCT01966107|3904179|FG001|Overall Study|discontinued treatment|372
2244517|NCT01966107|3904178|FG000|Overall Study|due to study closure|164
2244518|NCT01966107|3904179|FG001|Overall Study|due to study closure|186
2244519|NCT01966107|3904178|FG000|Overall Study|withdrew from the study|272
2244520|NCT01966107|3904179|FG001|Overall Study|withdrew from the study|303
2244521|NCT01966120|3904187|FG000|Overall Study|Withdrawal by Subject|0
2244522|NCT01966120|3904188|FG001|Overall Study|Withdrawal by Subject|5
2244523|NCT01966120|3904187|FG000|Overall Study|Lost to Follow-up|1
2244524|NCT01966120|3904188|FG001|Overall Study|Lost to Follow-up|1
2244525|NCT01966432|3904235|FG000|Overall Study|Lost to Follow-up|3
2244526|NCT01966432|3904236|FG001|Overall Study|Lost to Follow-up|2
2244527|NCT01966432|3904237|FG002|Overall Study|Lost to Follow-up|5
2244528|NCT01966432|3904235|FG000|Overall Study|Withdrawal by Subject|1
2244529|NCT01966432|3904236|FG001|Overall Study|Withdrawal by Subject|3
2244530|NCT01966432|3904237|FG002|Overall Study|Withdrawal by Subject|0
2244531|NCT01966432|3904235|FG000|Overall Study|Subject Incarcerated|0
2244532|NCT01966432|3904236|FG001|Overall Study|Subject Incarcerated|0
2244533|NCT01966432|3904237|FG002|Overall Study|Subject Incarcerated|1
2244534|NCT01966432|3904235|FG000|Overall Study|SBIRT program ended|1
2244535|NCT01966432|3904236|FG001|Overall Study|SBIRT program ended|8
2244536|NCT01966432|3904237|FG002|Overall Study|SBIRT program ended|20
2244537|NCT01966445|3904253|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2244538|NCT01966445|3904254|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2244539|NCT01966445|3904255|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2244540|NCT01966445|3904256|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
2244541|NCT01966445|3904257|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2244542|NCT01966445|3904258|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
2244543|NCT01966445|3904259|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2244544|NCT01966445|3904253|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2244545|NCT01966445|3904254|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
2244546|NCT01966445|3904255|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2244547|NCT01966445|3904256|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
2244548|NCT01966445|3904257|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
2338799|NCT03357341|4067759|FG000|Overall Study|Withdrawal by Subject|3
2338800|NCT03357341|4067760|FG001|Overall Study|Withdrawal by Subject|6
2338801|NCT03357341|4067759|FG000|Overall Study|Lost to Follow-up|4
2338802|NCT03357341|4067760|FG001|Overall Study|Lost to Follow-up|5
2338803|NCT03357341|4067759|FG000|Overall Study|Death|0
2338804|NCT03357341|4067760|FG001|Overall Study|Death|1
2338805|NCT03357471|4067782|FG000|Overall Study|Adverse Event|1
2338806|NCT03357471|4067783|FG001|Overall Study|Adverse Event|0
2338807|NCT03357471|4067782|FG000|Overall Study|Lost to Follow-up|1
2338808|NCT03357471|4067783|FG001|Overall Study|Lost to Follow-up|0
2338809|NCT03357731|4067798|FG000|Overall Study|Withdrew consent due to personal reasons|0
2338810|NCT03357731|4067799|FG001|Overall Study|Withdrew consent due to personal reasons|0
2338811|NCT03357731|4067800|FG002|Overall Study|Withdrew consent due to personal reasons|0
2338812|NCT03357731|4067801|FG003|Overall Study|Withdrew consent due to personal reasons|0
2338813|NCT03357731|4067802|FG004|Overall Study|Withdrew consent due to personal reasons|1
2338814|NCT03357731|4067803|FG005|Overall Study|Withdrew consent due to personal reasons|0
2338815|NCT03357731|4067798|FG000|Overall Study|Acute bradycardia and hypotension|0
2338816|NCT03357731|4067799|FG001|Overall Study|Acute bradycardia and hypotension|0
2338817|NCT03357731|4067800|FG002|Overall Study|Acute bradycardia and hypotension|0
2338818|NCT03357731|4067801|FG003|Overall Study|Acute bradycardia and hypotension|1
2338819|NCT03357731|4067802|FG004|Overall Study|Acute bradycardia and hypotension|0
2338820|NCT03357731|4067803|FG005|Overall Study|Acute bradycardia and hypotension|0
2338821|NCT03357731|4067798|FG000|Overall Study|Adverse Event|0
2338822|NCT03357731|4067799|FG001|Overall Study|Adverse Event|0
2338823|NCT03357731|4067800|FG002|Overall Study|Adverse Event|0
2338824|NCT03357731|4067801|FG003|Overall Study|Adverse Event|0
2338825|NCT03357731|4067802|FG004|Overall Study|Adverse Event|0
2338826|NCT03357731|4067803|FG005|Overall Study|Adverse Event|1
2338827|NCT03357731|4067798|FG000|Overall Study|Hypotension|0
2338828|NCT03357731|4067799|FG001|Overall Study|Hypotension|0
2338829|NCT03357731|4067800|FG002|Overall Study|Hypotension|1
2338830|NCT03357731|4067801|FG003|Overall Study|Hypotension|1
2338831|NCT03357731|4067802|FG004|Overall Study|Hypotension|0
2338832|NCT03357731|4067803|FG005|Overall Study|Hypotension|0
2338833|NCT03357731|4067798|FG000|Overall Study|Lost to Follow-up|0
2338834|NCT03357731|4067799|FG001|Overall Study|Lost to Follow-up|0
2338835|NCT03357731|4067800|FG002|Overall Study|Lost to Follow-up|0
2338836|NCT03357731|4067801|FG003|Overall Study|Lost to Follow-up|1
2338837|NCT03357731|4067802|FG004|Overall Study|Lost to Follow-up|0
2338838|NCT03357731|4067803|FG005|Overall Study|Lost to Follow-up|0
2338839|NCT03358147|4067816|FG000|Overall Study|Withdrawal by Subject|13
2338840|NCT03358147|4067817|FG001|Overall Study|Withdrawal by Subject|19
2338841|NCT03358147|4067818|FG002|Overall Study|Withdrawal by Subject|16
2037685|NCT00420095|3608117|FG000|Overall Study|Adverse Event|1
2037686|NCT00420095|3608118|FG001|Overall Study|Adverse Event|0
2037687|NCT00420095|3608117|FG000|Overall Study|Protocol Violation|1
2037688|NCT00420095|3608118|FG001|Overall Study|Protocol Violation|1
2037689|NCT00420095|3608117|FG000|Overall Study|Lost to Follow-up|1
2244549|NCT01966445|3904258|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2244550|NCT01966445|3904259|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2338842|NCT03358147|4067819|FG003|Overall Study|Withdrawal by Subject|10
2037690|NCT00420095|3608118|FG001|Overall Study|Lost to Follow-up|0
2244551|NCT01966445|3904253|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2244552|NCT01966445|3904254|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
2244553|NCT01966445|3904255|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
2244554|NCT01966445|3904256|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2244555|NCT01966445|3904257|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
2244556|NCT01966445|3904258|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2244557|NCT01966445|3904259|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2244558|NCT01966445|3904253|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2244559|NCT01966445|3904254|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2244560|NCT01966445|3904255|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2244561|NCT01966445|3904256|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2244562|NCT01966445|3904257|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2244563|NCT01966445|3904258|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2244564|NCT01966445|3904259|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
2244565|NCT01966445|3904253|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2244566|NCT01966445|3904254|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2244567|NCT01966445|3904255|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2244568|NCT01966445|3904256|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2244569|NCT01966445|3904257|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2244570|NCT01966445|3904258|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2244571|NCT01966445|3904259|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
2244572|NCT01967069|3904378|FG000|Overall Study|Adverse Event|2
2244573|NCT01967069|3904379|FG001|Overall Study|Adverse Event|2
2244574|NCT01967069|3904378|FG000|Overall Study|Lost to Follow-up|5
2244575|NCT01967069|3904379|FG001|Overall Study|Lost to Follow-up|2
2244576|NCT01967069|3904378|FG000|Overall Study|Withdrawal by Subject|1
2244577|NCT01967069|3904379|FG001|Overall Study|Withdrawal by Subject|3
2244578|NCT01967069|3904378|FG000|Overall Study|Lack of Efficacy|0
2244579|NCT01967069|3904379|FG001|Overall Study|Lack of Efficacy|1
2244580|NCT01967134|3904401|FG000|Overall Study|Lost to Follow-up|0
2244581|NCT01967134|3904402|FG001|Overall Study|Lost to Follow-up|1
2244582|NCT01967134|3904403|FG002|Overall Study|Lost to Follow-up|0
2244583|NCT01967147|3904413|FG000|Overall Study|Adverse Event|5
2244584|NCT01967147|3904414|FG001|Overall Study|Adverse Event|2
2244585|NCT01967147|3904413|FG000|Overall Study|Lack of Efficacy|1
2244586|NCT01967147|3904414|FG001|Overall Study|Lack of Efficacy|4
2244587|NCT01967147|3904413|FG000|Overall Study|Lost to Follow-up|1
2244588|NCT01967147|3904414|FG001|Overall Study|Lost to Follow-up|2
2244589|NCT01967147|3904413|FG000|Overall Study|Withdrawal by Subject|2
2244590|NCT01967147|3904414|FG001|Overall Study|Withdrawal by Subject|4
2244591|NCT01967147|3904413|FG000|Overall Study|Non-compliance with Study Drug|0
2244592|NCT01967147|3904414|FG001|Overall Study|Non-compliance with Study Drug|3
2244593|NCT01967147|3904413|FG000|Overall Study|Other|4
2244594|NCT01967147|3904414|FG001|Overall Study|Other|5
2244595|NCT01967173|3904429|FG000|Overall Study|Lost to Follow-up|5
2244596|NCT01967173|3904430|FG001|Overall Study|Lost to Follow-up|3
2244597|NCT01967173|3904431|FG002|Overall Study|Lost to Follow-up|2
2244598|NCT01967173|3904432|FG003|Overall Study|Lost to Follow-up|4
2244599|NCT01967173|3904433|FG004|Overall Study|Lost to Follow-up|8
2244600|NCT01967173|3904434|FG005|Overall Study|Lost to Follow-up|12
2244601|NCT01967173|3904435|FG006|Overall Study|Lost to Follow-up|6
2244602|NCT01967173|3904436|FG007|Overall Study|Lost to Follow-up|8
2244603|NCT01967173|3904429|FG000|Overall Study|Physician Decision|2
2244604|NCT01967173|3904430|FG001|Overall Study|Physician Decision|0
2244605|NCT01967173|3904431|FG002|Overall Study|Physician Decision|2
2244606|NCT01967173|3904432|FG003|Overall Study|Physician Decision|1
2244607|NCT01967173|3904433|FG004|Overall Study|Physician Decision|1
2244608|NCT01967173|3904434|FG005|Overall Study|Physician Decision|1
2244609|NCT01967173|3904435|FG006|Overall Study|Physician Decision|1
2244610|NCT01967173|3904436|FG007|Overall Study|Physician Decision|0
2244611|NCT01967173|3904429|FG000|Overall Study|Lack of Efficacy|2
2244612|NCT01967173|3904430|FG001|Overall Study|Lack of Efficacy|0
2244613|NCT01967173|3904431|FG002|Overall Study|Lack of Efficacy|2
2244614|NCT01967173|3904432|FG003|Overall Study|Lack of Efficacy|2
2244615|NCT01967173|3904433|FG004|Overall Study|Lack of Efficacy|0
2244616|NCT01967173|3904434|FG005|Overall Study|Lack of Efficacy|1
2244617|NCT01967173|3904435|FG006|Overall Study|Lack of Efficacy|0
2244618|NCT01967173|3904436|FG007|Overall Study|Lack of Efficacy|2
2244619|NCT01967173|3904429|FG000|Overall Study|Pregnancy|0
2244620|NCT01967173|3904430|FG001|Overall Study|Pregnancy|0
2244621|NCT01967173|3904431|FG002|Overall Study|Pregnancy|0
2244622|NCT01967173|3904432|FG003|Overall Study|Pregnancy|0
2244623|NCT01967173|3904433|FG004|Overall Study|Pregnancy|0
2244624|NCT01967173|3904434|FG005|Overall Study|Pregnancy|0
2244625|NCT01967173|3904435|FG006|Overall Study|Pregnancy|1
2244626|NCT01967173|3904436|FG007|Overall Study|Pregnancy|1
2244627|NCT01967173|3904429|FG000|Overall Study|Adverse Event|0
2244628|NCT01967173|3904430|FG001|Overall Study|Adverse Event|0
2244629|NCT01967173|3904431|FG002|Overall Study|Adverse Event|0
2244630|NCT01967173|3904432|FG003|Overall Study|Adverse Event|0
2244631|NCT01967173|3904433|FG004|Overall Study|Adverse Event|0
2244632|NCT01967173|3904434|FG005|Overall Study|Adverse Event|0
2244633|NCT01967173|3904435|FG006|Overall Study|Adverse Event|0
2244634|NCT01967173|3904436|FG007|Overall Study|Adverse Event|1
2244635|NCT01967173|3904429|FG000|Overall Study|Withdrawal by Subject|15
2244636|NCT01967173|3904430|FG001|Overall Study|Withdrawal by Subject|14
2244637|NCT01967173|3904431|FG002|Overall Study|Withdrawal by Subject|10
2244638|NCT01967173|3904432|FG003|Overall Study|Withdrawal by Subject|7
2244639|NCT01967173|3904433|FG004|Overall Study|Withdrawal by Subject|8
2244640|NCT01967173|3904434|FG005|Overall Study|Withdrawal by Subject|9
2244641|NCT01967173|3904435|FG006|Overall Study|Withdrawal by Subject|10
2338843|NCT03358147|4067820|FG004|Overall Study|Withdrawal by Subject|5
2338844|NCT03358147|4067816|FG000|Overall Study|Adverse Event|3
2338845|NCT03358147|4067817|FG001|Overall Study|Adverse Event|9
2338846|NCT03358147|4067818|FG002|Overall Study|Adverse Event|7
2338847|NCT03358147|4067819|FG003|Overall Study|Adverse Event|5
2338848|NCT03358147|4067820|FG004|Overall Study|Adverse Event|2
2338849|NCT03358147|4067816|FG000|Overall Study|Lost to Follow-up|4
2338850|NCT03358147|4067817|FG001|Overall Study|Lost to Follow-up|3
2338851|NCT03358147|4067818|FG002|Overall Study|Lost to Follow-up|7
2338852|NCT03358147|4067819|FG003|Overall Study|Lost to Follow-up|6
2338853|NCT03358147|4067820|FG004|Overall Study|Lost to Follow-up|4
2338854|NCT03358147|4067816|FG000|Overall Study|Major Protocol Deviation|11
2338855|NCT03358147|4067817|FG001|Overall Study|Major Protocol Deviation|3
2338856|NCT03358147|4067818|FG002|Overall Study|Major Protocol Deviation|2
2338857|NCT03358147|4067819|FG003|Overall Study|Major Protocol Deviation|3
2338858|NCT03358147|4067820|FG004|Overall Study|Major Protocol Deviation|1
2338859|NCT03358147|4067816|FG000|Overall Study|Protocol specified criteria|2
2338860|NCT03358147|4067817|FG001|Overall Study|Protocol specified criteria|3
2338861|NCT03358147|4067818|FG002|Overall Study|Protocol specified criteria|0
2338862|NCT03358147|4067819|FG003|Overall Study|Protocol specified criteria|3
2338863|NCT03358147|4067820|FG004|Overall Study|Protocol specified criteria|1
2338864|NCT03358147|4067816|FG000|Overall Study|Physician Decision|1
2338865|NCT03358147|4067817|FG001|Overall Study|Physician Decision|0
2338866|NCT03358147|4067818|FG002|Overall Study|Physician Decision|1
2338867|NCT03358147|4067819|FG003|Overall Study|Physician Decision|6
2338868|NCT03358147|4067820|FG004|Overall Study|Physician Decision|1
2338869|NCT03358147|4067816|FG000|Overall Study|Administrative reasons|0
2338870|NCT03358147|4067817|FG001|Overall Study|Administrative reasons|1
2338871|NCT03358147|4067818|FG002|Overall Study|Administrative reasons|0
2338872|NCT03358147|4067819|FG003|Overall Study|Administrative reasons|3
2338873|NCT03358147|4067820|FG004|Overall Study|Administrative reasons|0
2338874|NCT03358147|4067816|FG000|Overall Study|Lack of Efficacy|0
2338875|NCT03358147|4067817|FG001|Overall Study|Lack of Efficacy|1
2338876|NCT03358147|4067818|FG002|Overall Study|Lack of Efficacy|1
2338877|NCT03358147|4067819|FG003|Overall Study|Lack of Efficacy|0
2338878|NCT03358147|4067820|FG004|Overall Study|Lack of Efficacy|0
2338879|NCT03358238|4067834|FG000|Overall Study|Withdrawal by Subject|0
2338880|NCT03358238|4067835|FG001|Overall Study|Withdrawal by Subject|1
2338881|NCT03358290|4067857|FG000|Overall Study|Study discontinued by Sponsor|0
2338882|NCT03358290|4067858|FG001|Overall Study|Study discontinued by Sponsor|1
2338883|NCT03358290|4067859|FG002|Overall Study|Study discontinued by Sponsor|1
2338884|NCT03358290|4067860|FG003|Overall Study|Study discontinued by Sponsor|0
2338885|NCT03358290|4067861|FG004|Overall Study|Study discontinued by Sponsor|0
2338886|NCT03358290|4067857|FG000|Overall Study|Adverse Event|0
2338887|NCT03358290|4067858|FG001|Overall Study|Adverse Event|0
2338888|NCT03358290|4067859|FG002|Overall Study|Adverse Event|1
2338889|NCT03358290|4067860|FG003|Overall Study|Adverse Event|2
2338890|NCT03358290|4067861|FG004|Overall Study|Adverse Event|0
2338891|NCT03358290|4067857|FG000|Overall Study|Withdrawal by Subject|0
2338892|NCT03358290|4067858|FG001|Overall Study|Withdrawal by Subject|0
2338893|NCT03358290|4067859|FG002|Overall Study|Withdrawal by Subject|0
2338894|NCT03358290|4067860|FG003|Overall Study|Withdrawal by Subject|0
2338895|NCT03358290|4067861|FG004|Overall Study|Withdrawal by Subject|1
2338896|NCT03358329|4067873|FG000|Overall Study|Lost to Follow-up|2
2338897|NCT03358329|4067873|FG000|Overall Study|Withdrawal by Subject|2
2338898|NCT03358407|4067898|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
2338899|NCT03358407|4067899|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
2338900|NCT03358407|4067900|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1
2338901|NCT03358407|4067901|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
2338902|NCT03358407|4067902|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
2338903|NCT03358407|4067903|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
2338904|NCT03358407|4067904|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
2338905|NCT03358407|4067905|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
2338906|NCT03358407|4067906|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
2338907|NCT03358407|4067907|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
2338908|NCT03358407|4067898|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
2338909|NCT03358407|4067899|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
2338910|NCT03358407|4067900|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
2338911|NCT03358407|4067901|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
2338912|NCT03358407|4067902|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1
2338913|NCT03358407|4067903|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
2244642|NCT01967173|3904436|FG007|Overall Study|Withdrawal by Subject|12
2244643|NCT01967225|3904452|FG000|Overall Study|Adverse Event|3
2244644|NCT01967225|3904453|FG001|Overall Study|Adverse Event|1
2244645|NCT01967225|3904452|FG000|Overall Study|Withdrawal by Subject|2
2244646|NCT01967225|3904453|FG001|Overall Study|Withdrawal by Subject|1
2244647|NCT01967225|3904452|FG000|Overall Study|Lack of Efficacy|1
2244648|NCT01967225|3904453|FG001|Overall Study|Lack of Efficacy|1
2244649|NCT01967225|3904452|FG000|Overall Study|Switching to other therapy|2
2244650|NCT01967225|3904453|FG001|Overall Study|Switching to other therapy|0
2244651|NCT01967225|3904452|FG000|Overall Study|Protocol driven decision point|1
2244652|NCT01967225|3904453|FG001|Overall Study|Protocol driven decision point|0
2244653|NCT01967225|3904452|FG000|Overall Study|Logistical difficulties|1
2244654|NCT01967225|3904453|FG001|Overall Study|Logistical difficulties|0
2244655|NCT01967225|3904452|FG000|Overall Study|Protocol Violation|2
2244656|NCT01967225|3904453|FG001|Overall Study|Protocol Violation|0
2244657|NCT01967277|3904463|FG000|Overall Study|Lost to Follow-up|1
2244658|NCT01967277|3904464|FG001|Overall Study|Lost to Follow-up|2
2244659|NCT01967277|3904463|FG000|Overall Study|Unrelated illness|0
2244660|NCT01967277|3904464|FG001|Overall Study|Unrelated illness|1
2244661|NCT01967537|3904498|FG000|Overall Study|Withdrawal by Subject|52
2244662|NCT01967537|3904498|FG000|Overall Study|Refuse treatment|2
2244663|NCT01967537|3904498|FG000|Overall Study|Lost to Follow-up|6
2244664|NCT01967550|3904504|FG000|Overall Study|Withdrawal by Subject|1
2244665|NCT01967550|3904505|FG001|Overall Study|Withdrawal by Subject|0
2244666|NCT01967550|3904504|FG000|Overall Study|Adverse Event|2
2244667|NCT01967550|3904505|FG001|Overall Study|Adverse Event|0
2244668|NCT01967550|3904504|FG000|Overall Study|Protocol Violation|2
2244669|NCT01967550|3904505|FG001|Overall Study|Protocol Violation|1
2244670|NCT01967550|3904504|FG000|Overall Study|Non Compliance|0
2244671|NCT01967550|3904505|FG001|Overall Study|Non Compliance|1
2244672|NCT01967576|3904511|FG000|Overall Study|Withdrawal by Subject|3
2244673|NCT01967576|3904511|FG000|Overall Study|Progressed/Removed from treatment|1
2244674|NCT01967576|3904511|FG000|Overall Study|Study closing at site|1
2244675|NCT01967576|3904511|FG000|Overall Study|Adverse Event|1
2244676|NCT01967576|3904511|FG000|Overall Study|Refused further treatment|1
2244677|NCT01967628|3904517|FG000|Overall Study|Withdrawal by Subject|2
2244678|NCT01967628|3904518|FG001|Overall Study|Withdrawal by Subject|0
2244679|NCT01967628|3904517|FG000|Overall Study|Unable to complete bronchoscopy|4
2244680|NCT01967628|3904518|FG001|Overall Study|Unable to complete bronchoscopy|6
2244681|NCT01967628|3904517|FG000|Overall Study|Lost to Follow-up|1
2244682|NCT01967628|3904518|FG001|Overall Study|Lost to Follow-up|0
2244683|NCT01967628|3904517|FG000|Overall Study|Low protein concentration in sample|20
2244684|NCT01967628|3904518|FG001|Overall Study|Low protein concentration in sample|25
2244685|NCT01967706|3904531|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
2244686|NCT01967706|3904532|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
2244687|NCT01967706|3904533|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
2244688|NCT01967706|3904534|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
2244689|NCT01967719|3904545|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
2244690|NCT01967719|3904546|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
2244691|NCT01967719|3904547|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
2244692|NCT01967719|3904548|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
2244693|NCT01967719|3904545|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0
2244694|NCT01967719|3904546|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1
2244695|NCT01967719|3904547|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0
2244696|NCT01967719|3904548|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0
2244697|NCT01967732|3904560|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
2244698|NCT01967732|3904561|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
2244699|NCT01967732|3904562|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
2244700|NCT01967732|3904563|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
2244701|NCT01967732|3904560|FG000|First Intervention (Day 1)|Poor venous access|0
2244702|NCT01967732|3904561|FG001|First Intervention (Day 1)|Poor venous access|1
2244703|NCT01967732|3904562|FG002|First Intervention (Day 1)|Poor venous access|0
2244704|NCT01967732|3904563|FG003|First Intervention (Day 1)|Poor venous access|0
2244705|NCT01967888|3904586|FG000|Overall Study|Lost to Follow-up|6
2338914|NCT03358407|4067904|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
2338915|NCT03358407|4067905|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
2338916|NCT03358407|4067906|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
2338917|NCT03358407|4067907|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
2338918|NCT03358407|4067898|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
2338919|NCT03358407|4067899|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
2338920|NCT03358407|4067900|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
2338921|NCT03358407|4067901|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
2338922|NCT03358407|4067902|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
2338923|NCT03358407|4067903|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1
2338924|NCT03358407|4067904|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
2244706|NCT01967888|3904587|FG001|Overall Study|Lost to Follow-up|4
2244707|NCT01967888|3904586|FG000|Overall Study|Withdrawal by Subject|1
2244708|NCT01967888|3904587|FG001|Overall Study|Withdrawal by Subject|1
2244709|NCT01967888|3904586|FG000|Overall Study|Did Not Have Transplant|1
2244710|NCT01967888|3904587|FG001|Overall Study|Did Not Have Transplant|0
2244711|NCT01967888|3904586|FG000|Overall Study|Research visit not done, data recorded|1
2244712|NCT01967888|3904587|FG001|Overall Study|Research visit not done, data recorded|0
2244713|NCT01967888|3904586|FG000|Overall Study|Subject excluded after randomization|1
2244714|NCT01967888|3904587|FG001|Overall Study|Subject excluded after randomization|0
2244715|NCT01967888|3904586|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0
2244716|NCT01967888|3904587|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1
2244717|NCT01967888|3904586|FG000|Overall Study|Subject Unable To Comply With Final Day|0
2244718|NCT01967888|3904587|FG001|Overall Study|Subject Unable To Comply With Final Day|1
2244719|NCT01967940|3904596|FG000|Part 2|Enrolled in Part 2 and Never Treated|0
2244720|NCT01967940|3904597|FG001|Part 2|Enrolled in Part 2 and Never Treated|0
2244721|NCT01967940|3904598|FG002|Part 2|Enrolled in Part 2 and Never Treated|0
2244722|NCT01967940|3904599|FG003|Part 2|Enrolled in Part 2 and Never Treated|1
2244723|NCT01967940|3904596|FG000|Part 2|Adverse Event|0
2244724|NCT01967940|3904597|FG001|Part 2|Adverse Event|0
2244725|NCT01967940|3904598|FG002|Part 2|Adverse Event|0
2244726|NCT01967940|3904599|FG003|Part 2|Adverse Event|1
2244727|NCT01967940|3904596|FG000|Part 2|Unknown Reason|0
2244728|NCT01967940|3904597|FG001|Part 2|Unknown Reason|0
2244729|NCT01967940|3904598|FG002|Part 2|Unknown Reason|0
2244730|NCT01967940|3904599|FG003|Part 2|Unknown Reason|1
2244731|NCT01968031|3904612|FG000|Overall Study|Adverse Event|13
2244732|NCT01968031|3904613|FG001|Overall Study|Adverse Event|10
2244733|NCT01968031|3904614|FG002|Overall Study|Adverse Event|22
2244734|NCT01968031|3904612|FG000|Overall Study|Withdrawal by Subject|3
2244735|NCT01968031|3904613|FG001|Overall Study|Withdrawal by Subject|7
2244736|NCT01968031|3904614|FG002|Overall Study|Withdrawal by Subject|3
2244737|NCT01968031|3904612|FG000|Overall Study|Did not meet entry criteria|1
2244738|NCT01968031|3904613|FG001|Overall Study|Did not meet entry criteria|1
2244739|NCT01968031|3904614|FG002|Overall Study|Did not meet entry criteria|1
2244740|NCT01968031|3904612|FG000|Overall Study|Noncompliance|0
2244741|NCT01968031|3904613|FG001|Overall Study|Noncompliance|0
2244742|NCT01968031|3904614|FG002|Overall Study|Noncompliance|2
2244743|NCT01968031|3904612|FG000|Overall Study|Failed inclusion criteria|0
2244744|NCT01968031|3904613|FG001|Overall Study|Failed inclusion criteria|2
2244745|NCT01968031|3904614|FG002|Overall Study|Failed inclusion criteria|0
2244746|NCT01968031|3904612|FG000|Overall Study|Death|0
2244747|NCT01968031|3904613|FG001|Overall Study|Death|0
2244748|NCT01968031|3904614|FG002|Overall Study|Death|1
2244749|NCT01968031|3904612|FG000|Overall Study|Prohibited concomitant medication|1
2244750|NCT01968031|3904613|FG001|Overall Study|Prohibited concomitant medication|0
2244751|NCT01968031|3904614|FG002|Overall Study|Prohibited concomitant medication|0
2244752|NCT01968070|3904646|FG000|Period 1|Withdrawal by Subject|0
2244753|NCT01968070|3904647|FG001|Period 1|Withdrawal by Subject|1
2244754|NCT01968070|3904648|FG002|Period 1|Withdrawal by Subject|0
2244755|NCT01968070|3904649|FG003|Period 1|Withdrawal by Subject|0
2244756|NCT01968070|3904650|FG004|Period 1|Withdrawal by Subject|0
2244757|NCT01968070|3904651|FG005|Period 1|Withdrawal by Subject|0
2244758|NCT01968070|3904652|FG006|Period 1|Withdrawal by Subject|1
2244759|NCT01968070|3904653|FG007|Period 1|Withdrawal by Subject|0
2244760|NCT01968070|3904654|FG008|Period 1|Withdrawal by Subject|0
2244761|NCT01968070|3904655|FG009|Period 1|Withdrawal by Subject|0
2244762|NCT01968070|3904656|FG010|Period 1|Withdrawal by Subject|0
2244763|NCT01968070|3904657|FG011|Period 1|Withdrawal by Subject|0
2244764|NCT01968070|3904658|FG012|Period 1|Withdrawal by Subject|0
2244765|NCT01968070|3904659|FG013|Period 1|Withdrawal by Subject|0
2244766|NCT01968070|3904660|FG014|Period 1|Withdrawal by Subject|0
2244767|NCT01968070|3904661|FG015|Period 1|Withdrawal by Subject|1
2244768|NCT01968070|3904662|FG016|Period 1|Withdrawal by Subject|0
2244769|NCT01968070|3904663|FG017|Period 1|Withdrawal by Subject|0
2244770|NCT01968070|3904646|FG000|Period 1|Protocol Violation|0
2244771|NCT01968070|3904647|FG001|Period 1|Protocol Violation|0
2244772|NCT01968070|3904648|FG002|Period 1|Protocol Violation|0
2244773|NCT01968070|3904649|FG003|Period 1|Protocol Violation|1
2244774|NCT01968070|3904650|FG004|Period 1|Protocol Violation|1
2244775|NCT01968070|3904651|FG005|Period 1|Protocol Violation|0
2244776|NCT01968070|3904652|FG006|Period 1|Protocol Violation|0
2244777|NCT01968070|3904653|FG007|Period 1|Protocol Violation|0
2244778|NCT01968070|3904654|FG008|Period 1|Protocol Violation|0
2244779|NCT01968070|3904655|FG009|Period 1|Protocol Violation|0
2244780|NCT01968070|3904656|FG010|Period 1|Protocol Violation|0
2244781|NCT01968070|3904657|FG011|Period 1|Protocol Violation|0
2244782|NCT01968070|3904658|FG012|Period 1|Protocol Violation|0
2244783|NCT01968070|3904659|FG013|Period 1|Protocol Violation|0
2244784|NCT01968070|3904660|FG014|Period 1|Protocol Violation|0
2244785|NCT01968070|3904661|FG015|Period 1|Protocol Violation|0
2244786|NCT01968070|3904662|FG016|Period 1|Protocol Violation|0
2244787|NCT01968070|3904663|FG017|Period 1|Protocol Violation|0
2244788|NCT01968070|3904646|FG000|Period 1|Lost to Follow-up|0
2244789|NCT01968070|3904647|FG001|Period 1|Lost to Follow-up|0
2244790|NCT01968070|3904648|FG002|Period 1|Lost to Follow-up|0
2244791|NCT01968070|3904649|FG003|Period 1|Lost to Follow-up|1
2244792|NCT01968070|3904650|FG004|Period 1|Lost to Follow-up|0
2244793|NCT01968070|3904651|FG005|Period 1|Lost to Follow-up|0
2244794|NCT01968070|3904652|FG006|Period 1|Lost to Follow-up|0
2244795|NCT01968070|3904653|FG007|Period 1|Lost to Follow-up|0
2244796|NCT01968070|3904654|FG008|Period 1|Lost to Follow-up|0
2244797|NCT01968070|3904655|FG009|Period 1|Lost to Follow-up|0
2244798|NCT01968070|3904656|FG010|Period 1|Lost to Follow-up|0
2244799|NCT01968070|3904657|FG011|Period 1|Lost to Follow-up|0
2244800|NCT01968070|3904658|FG012|Period 1|Lost to Follow-up|0
2244801|NCT01968070|3904659|FG013|Period 1|Lost to Follow-up|0
2244802|NCT01968070|3904660|FG014|Period 1|Lost to Follow-up|0
2244803|NCT01968070|3904661|FG015|Period 1|Lost to Follow-up|0
2244804|NCT01968070|3904662|FG016|Period 1|Lost to Follow-up|0
2244805|NCT01968070|3904663|FG017|Period 1|Lost to Follow-up|0
2244806|NCT01968070|3904646|FG000|Period 1|Adverse Event|0
2244807|NCT01968070|3904647|FG001|Period 1|Adverse Event|0
2244808|NCT01968070|3904648|FG002|Period 1|Adverse Event|0
2244809|NCT01968070|3904649|FG003|Period 1|Adverse Event|0
2244810|NCT01968070|3904650|FG004|Period 1|Adverse Event|0
2244811|NCT01968070|3904651|FG005|Period 1|Adverse Event|0
2244812|NCT01968070|3904652|FG006|Period 1|Adverse Event|1
2244813|NCT01968070|3904653|FG007|Period 1|Adverse Event|0
2244814|NCT01968070|3904654|FG008|Period 1|Adverse Event|0
2244815|NCT01968070|3904655|FG009|Period 1|Adverse Event|0
2244816|NCT01968070|3904656|FG010|Period 1|Adverse Event|0
2244817|NCT01968070|3904657|FG011|Period 1|Adverse Event|0
2338925|NCT03358407|4067905|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2
2338926|NCT03358407|4067906|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
2338927|NCT03358407|4067907|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
2338928|NCT03358407|4067898|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
2338929|NCT03358407|4067899|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
2338930|NCT03358407|4067900|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
2338931|NCT03358407|4067901|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
2338932|NCT03358407|4067902|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
2338933|NCT03358407|4067903|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
2338934|NCT03358407|4067904|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
2338935|NCT03358407|4067905|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
2338936|NCT03358407|4067906|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
2338937|NCT03358407|4067907|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
2338938|NCT03358407|4067898|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
2338939|NCT03358407|4067899|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
2338940|NCT03358407|4067900|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
2338941|NCT03358407|4067901|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
2338942|NCT03358407|4067902|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
2338943|NCT03358407|4067903|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
2338944|NCT03358407|4067904|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
2338945|NCT03358407|4067905|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
2338946|NCT03358407|4067906|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
2338947|NCT03358407|4067907|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
2338948|NCT03358407|4067898|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
2338949|NCT03358407|4067899|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
2338950|NCT03358407|4067900|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
2338951|NCT03358407|4067901|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
2338952|NCT03358407|4067902|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
2338953|NCT03358407|4067903|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
2338954|NCT03358407|4067904|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
2338955|NCT03358407|4067905|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6
2338956|NCT03358407|4067906|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
2353039|NCT03359174|4103844|FG000|Overall Study|Adverse Event|1
2037691|NCT00420199|3608135|FG000|Overall Study|Participant no longer met study criteria|1
2037692|NCT00420199|3608136|FG001|Overall Study|Participant no longer met study criteria|0
2037693|NCT00420212|3608150|FG000|Overall Study|Adverse Event|22
2037694|NCT00420212|3608151|FG001|Overall Study|Adverse Event|40
2037695|NCT00420212|3608152|FG002|Overall Study|Adverse Event|36
2037696|NCT00420212|3608150|FG000|Overall Study|Lost to Follow-up|9
2037697|NCT00420212|3608151|FG001|Overall Study|Lost to Follow-up|11
2037698|NCT00420212|3608152|FG002|Overall Study|Lost to Follow-up|11
2037699|NCT00420212|3608150|FG000|Overall Study|Withdrawal by Subject|31
2037700|NCT00420212|3608151|FG001|Overall Study|Withdrawal by Subject|22
2037701|NCT00420212|3608152|FG002|Overall Study|Withdrawal by Subject|19
2037702|NCT00420212|3608150|FG000|Overall Study|Physician Decision|4
2037703|NCT00420212|3608151|FG001|Overall Study|Physician Decision|4
2037704|NCT00420212|3608152|FG002|Overall Study|Physician Decision|3
2037705|NCT00420212|3608150|FG000|Overall Study|Protocol Violation|4
2037706|NCT00420212|3608151|FG001|Overall Study|Protocol Violation|4
2037707|NCT00420212|3608152|FG002|Overall Study|Protocol Violation|8
2037708|NCT00420212|3608150|FG000|Overall Study|Death|0
2244818|NCT01968070|3904658|FG012|Period 1|Adverse Event|0
2244819|NCT01968070|3904659|FG013|Period 1|Adverse Event|0
2244820|NCT01968070|3904660|FG014|Period 1|Adverse Event|0
2244821|NCT01968070|3904661|FG015|Period 1|Adverse Event|0
2244822|NCT01968070|3904662|FG016|Period 1|Adverse Event|0
2244823|NCT01968070|3904663|FG017|Period 1|Adverse Event|0
2244824|NCT01968070|3904646|FG000|Period 1|Physician Decision|0
2244825|NCT01968070|3904647|FG001|Period 1|Physician Decision|0
2244826|NCT01968070|3904648|FG002|Period 1|Physician Decision|0
2244827|NCT01968070|3904649|FG003|Period 1|Physician Decision|0
2244828|NCT01968070|3904650|FG004|Period 1|Physician Decision|0
2244829|NCT01968070|3904651|FG005|Period 1|Physician Decision|0
2244830|NCT01968070|3904652|FG006|Period 1|Physician Decision|0
2244831|NCT01968070|3904653|FG007|Period 1|Physician Decision|0
2244832|NCT01968070|3904654|FG008|Period 1|Physician Decision|0
2244833|NCT01968070|3904655|FG009|Period 1|Physician Decision|0
2244834|NCT01968070|3904656|FG010|Period 1|Physician Decision|0
2244835|NCT01968070|3904657|FG011|Period 1|Physician Decision|1
2244836|NCT01968070|3904658|FG012|Period 1|Physician Decision|0
2244837|NCT01968070|3904659|FG013|Period 1|Physician Decision|0
2244838|NCT01968070|3904660|FG014|Period 1|Physician Decision|0
2244839|NCT01968070|3904661|FG015|Period 1|Physician Decision|0
2244840|NCT01968070|3904662|FG016|Period 1|Physician Decision|0
2244841|NCT01968070|3904663|FG017|Period 1|Physician Decision|0
2244842|NCT01968070|3904646|FG000|Period 2|Withdrawal by Subject|0
2244843|NCT01968070|3904647|FG001|Period 2|Withdrawal by Subject|0
2244844|NCT01968070|3904648|FG002|Period 2|Withdrawal by Subject|0
2244845|NCT01968070|3904649|FG003|Period 2|Withdrawal by Subject|0
2244846|NCT01968070|3904650|FG004|Period 2|Withdrawal by Subject|1
2244847|NCT01968070|3904651|FG005|Period 2|Withdrawal by Subject|0
2244848|NCT01968070|3904652|FG006|Period 2|Withdrawal by Subject|0
2244849|NCT01968070|3904653|FG007|Period 2|Withdrawal by Subject|0
2244850|NCT01968070|3904654|FG008|Period 2|Withdrawal by Subject|0
2244851|NCT01968070|3904655|FG009|Period 2|Withdrawal by Subject|0
2244852|NCT01968070|3904656|FG010|Period 2|Withdrawal by Subject|0
2244853|NCT01968070|3904657|FG011|Period 2|Withdrawal by Subject|0
2244854|NCT01968070|3904658|FG012|Period 2|Withdrawal by Subject|0
2244855|NCT01968070|3904659|FG013|Period 2|Withdrawal by Subject|0
2244856|NCT01968070|3904660|FG014|Period 2|Withdrawal by Subject|0
2244857|NCT01968070|3904661|FG015|Period 2|Withdrawal by Subject|0
2244858|NCT01968070|3904662|FG016|Period 2|Withdrawal by Subject|0
2244859|NCT01968070|3904663|FG017|Period 2|Withdrawal by Subject|0
2338957|NCT03358407|4067907|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
2338958|NCT03358472|4067938|FG000|Overall Study|Death|6
2338959|NCT03358472|4067939|FG001|Overall Study|Death|3
2338960|NCT03358472|4067940|FG002|Overall Study|Death|10
2338961|NCT03358472|4067938|FG000|Overall Study|Physician Decision|0
2338962|NCT03358472|4067939|FG001|Overall Study|Physician Decision|1
2338963|NCT03358472|4067940|FG002|Overall Study|Physician Decision|0
2338964|NCT03358472|4067938|FG000|Overall Study|Withdrawal by Subject|0
2338965|NCT03358472|4067939|FG001|Overall Study|Withdrawal by Subject|0
2338966|NCT03358472|4067940|FG002|Overall Study|Withdrawal by Subject|1
2338967|NCT03358472|4067938|FG000|Overall Study|On-going at clinical cut off date|9
2338968|NCT03358472|4067939|FG001|Overall Study|On-going at clinical cut off date|6
2338969|NCT03358472|4067940|FG002|Overall Study|On-going at clinical cut off date|5
2338970|NCT03359395|4067959|FG000|First Intervention A / B|Withdrawal by Subject|1
2338971|NCT03359395|4067960|FG001|First Intervention A / B|Withdrawal by Subject|0
2338972|NCT03359395|4067959|FG000|First Intervention A / B|Lost to Follow-up|2
2338973|NCT03359395|4067960|FG001|First Intervention A / B|Lost to Follow-up|3
2338974|NCT03359395|4067959|FG000|Second Intervention B/A|Exclusion criteria|0
2338975|NCT03359395|4067960|FG001|Second Intervention B/A|Exclusion criteria|1
2338976|NCT03359395|4067959|FG000|Second Intervention B/A|Lost to Follow-up|3
2338977|NCT03359395|4067960|FG001|Second Intervention B/A|Lost to Follow-up|2
2338978|NCT03359473|4067970|FG000|Overall Study|Adverse Event|0
2338979|NCT03359473|4067971|FG001|Overall Study|Adverse Event|2
2338980|NCT03359473|4067972|FG002|Overall Study|Adverse Event|5
2338981|NCT03359473|4067973|FG003|Overall Study|Adverse Event|3
2338982|NCT03359473|4067970|FG000|Overall Study|Lost to Follow-up|0
2338983|NCT03359473|4067971|FG001|Overall Study|Lost to Follow-up|1
2338984|NCT03359473|4067972|FG002|Overall Study|Lost to Follow-up|0
2338985|NCT03359473|4067973|FG003|Overall Study|Lost to Follow-up|0
2338986|NCT03359473|4067970|FG000|Overall Study|Physician Decision|0
2338987|NCT03359473|4067971|FG001|Overall Study|Physician Decision|1
2338988|NCT03359473|4067972|FG002|Overall Study|Physician Decision|0
2338989|NCT03359473|4067973|FG003|Overall Study|Physician Decision|1
2338990|NCT03359473|4067970|FG000|Overall Study|Withdrawal by Subject|1
2338991|NCT03359473|4067971|FG001|Overall Study|Withdrawal by Subject|2
2338992|NCT03359473|4067972|FG002|Overall Study|Withdrawal by Subject|1
2338993|NCT03359473|4067973|FG003|Overall Study|Withdrawal by Subject|0
2338994|NCT03359473|4067970|FG000|Overall Study|Protocol-defined stopping criteria|1
2338995|NCT03359473|4067971|FG001|Overall Study|Protocol-defined stopping criteria|0
2338996|NCT03359473|4067972|FG002|Overall Study|Protocol-defined stopping criteria|0
2338997|NCT03359473|4067973|FG003|Overall Study|Protocol-defined stopping criteria|1
2338998|NCT03359590|4067986|FG000|First Intervention|Withdrawal by Subject|1
2338999|NCT03359590|4067987|FG001|First Intervention|Withdrawal by Subject|1
2339000|NCT03359590|4067986|FG000|First Intervention|Protocol Violation|0
2339001|NCT03359590|4067987|FG001|First Intervention|Protocol Violation|1
2339002|NCT03359850|4068004|FG000|PK Phase (Up to Day 8)|Physician Decision|0
2244860|NCT01968213|3904712|FG000|Overall Study|Ongoing|90
2244861|NCT01968213|3904713|FG001|Overall Study|Ongoing|9
2244862|NCT01968434|3904793|FG000|Overall Study|Lost to Follow-up|3
2244863|NCT01968434|3904794|FG001|Overall Study|Lost to Follow-up|6
2244864|NCT01968551|3904812|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
2244865|NCT01968551|3904813|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
2244866|NCT01968551|3904814|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
2244867|NCT01968551|3904812|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0
2339003|NCT03359850|4068005|FG001|PK Phase (Up to Day 8)|Physician Decision|1
2339004|NCT03359850|4068004|FG000|PK Phase (Up to Day 8)|Adverse Event|1
2339005|NCT03359850|4068005|FG001|PK Phase (Up to Day 8)|Adverse Event|0
2339006|NCT03359850|4068004|FG000|Extension Phase (Up to 28 Months)|Death|2
2339007|NCT03359850|4068005|FG001|Extension Phase (Up to 28 Months)|Death|4
2339008|NCT03359850|4068004|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1
2339009|NCT03359850|4068005|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2
2339010|NCT03359850|4068004|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5
2339011|NCT03359850|4068005|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0
2339012|NCT03360071|4068019|FG000|Overall Study|Lost to Follow-up|1
2339013|NCT03360071|4068020|FG001|Overall Study|Lost to Follow-up|0
2339014|NCT03360344|4068048|FG000|Overall Study|Withdrawal by Subject|0
2339015|NCT03360344|4068049|FG001|Overall Study|Withdrawal by Subject|1
2339016|NCT03360344|4068050|FG002|Overall Study|Withdrawal by Subject|1
2339017|NCT03360747|4068058|FG000|Overall Study|Voluntary Withdrawal|1
2339018|NCT03361137|4068067|FG000|Overall Study|Reason not specified|1
2339019|NCT03361137|4068068|FG001|Overall Study|Reason not specified|0
2339020|NCT03361137|4068069|FG002|Overall Study|Reason not specified|0
2339021|NCT03361137|4068070|FG003|Overall Study|Reason not specified|0
2339022|NCT03361137|4068071|FG004|Overall Study|Reason not specified|0
2339023|NCT03361176|4068087|FG000|Overall Study|Lost to Follow-up|1
2339024|NCT03361176|4068088|FG001|Overall Study|Lost to Follow-up|2
2339025|NCT03361176|4068087|FG000|Overall Study|Adverse Event|0
2339026|NCT03361176|4068088|FG001|Overall Study|Adverse Event|2
2339027|NCT03361176|4068087|FG000|Overall Study|Withdrawal by Subject|0
2339028|NCT03361176|4068088|FG001|Overall Study|Withdrawal by Subject|1
2339029|NCT03361293|4068096|FG000|Overall Study|Lost to Follow-up|0
2339030|NCT03361293|4068097|FG001|Overall Study|Lost to Follow-up|2
2339031|NCT03361293|4068096|FG000|Overall Study|Withdrawal by Subject|1
2339032|NCT03361293|4068097|FG001|Overall Study|Withdrawal by Subject|3
2339033|NCT03361423|4068105|FG000|Overall Study|Withdrawal by Subject|4
2339034|NCT03361423|4068106|FG001|Overall Study|Withdrawal by Subject|3
2339035|NCT03361423|4068105|FG000|Overall Study|Did not treat|19
2339036|NCT03361423|4068106|FG001|Overall Study|Did not treat|18
2339037|NCT03361423|4068105|FG000|Overall Study|Started >60 minutes from migraine onset|0
2339038|NCT03361423|4068106|FG001|Overall Study|Started >60 minutes from migraine onset|1
2339039|NCT03361423|4068105|FG000|Overall Study|Missing data|4
2339040|NCT03361423|4068106|FG001|Overall Study|Missing data|1
2339041|NCT03361605|4068112|FG000|Overall Study|Analyzable data not available|3
2339042|NCT03363321|4068153|FG000|Overall Study|Withdrawal by Subject|0
2339043|NCT03363321|4068154|FG001|Overall Study|Withdrawal by Subject|1
2339044|NCT03363321|4068155|FG002|Overall Study|Withdrawal by Subject|0
2339045|NCT03363321|4068156|FG003|Overall Study|Withdrawal by Subject|1
2339046|NCT03363321|4068157|FG004|Overall Study|Withdrawal by Subject|0
2339047|NCT03363776|4068173|FG000|Overall Study|Progressive disease|2
2339048|NCT03363776|4068174|FG001|Overall Study|Progressive disease|3
2339049|NCT03363776|4068175|FG002|Overall Study|Progressive disease|1
2339050|NCT03363776|4068173|FG000|Overall Study|Study drug toxicity|0
2339051|NCT03363776|4068174|FG001|Overall Study|Study drug toxicity|0
2339052|NCT03363776|4068175|FG002|Overall Study|Study drug toxicity|1
2339053|NCT03363776|4068173|FG000|Overall Study|Death|1
2037709|NCT00420212|3608151|FG001|Overall Study|Death|0
2037710|NCT00420212|3608152|FG002|Overall Study|Death|1
2037711|NCT00420212|3608150|FG000|Overall Study|Other-Unspecified|21
2037712|NCT00420212|3608151|FG001|Overall Study|Other-Unspecified|14
2037713|NCT00420212|3608152|FG002|Overall Study|Other-Unspecified|18
2037714|NCT00420238|3608165|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1
2037715|NCT00420238|3608166|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0
2037716|NCT00420238|3608165|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
2037717|NCT00420238|3608166|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
2244868|NCT01968551|3904813|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1
2244869|NCT01968551|3904814|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0
2244870|NCT01968551|3904812|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1
2244871|NCT01968551|3904813|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1
2244872|NCT01968551|3904814|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3
2244873|NCT01968551|3904812|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0
2244874|NCT01968551|3904813|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0
2244875|NCT01968551|3904814|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2
2244876|NCT01968551|3904812|FG000|Extension Phase|Adverse Event|0
2244877|NCT01968551|3904813|FG001|Extension Phase|Adverse Event|0
2339054|NCT03363776|4068174|FG001|Overall Study|Death|0
2339055|NCT03363776|4068175|FG002|Overall Study|Death|0
2339056|NCT03363906|4068215|FG000|Period 1 (Reference or Test)|Adverse Event|1
2244878|NCT01968551|3904814|FG002|Extension Phase|Adverse Event|2
2244879|NCT01968551|3904812|FG000|Extension Phase|Death|0
2244880|NCT01968551|3904813|FG001|Extension Phase|Death|1
2244881|NCT01968551|3904814|FG002|Extension Phase|Death|0
2244882|NCT01968551|3904812|FG000|Extension Phase|Withdrew Consent|0
2244883|NCT01968551|3904813|FG001|Extension Phase|Withdrew Consent|0
2244884|NCT01968551|3904814|FG002|Extension Phase|Withdrew Consent|1
2244885|NCT01968551|3904812|FG000|Extension Phase|Lost to Follow-up|1
2244886|NCT01968551|3904813|FG001|Extension Phase|Lost to Follow-up|0
2244887|NCT01968551|3904814|FG002|Extension Phase|Lost to Follow-up|1
2244888|NCT01968694|3904828|FG000|Washout (1 Month)|Lost to Follow-up|0
2244889|NCT01968694|3904829|FG001|Washout (1 Month)|Lost to Follow-up|1
2244890|NCT01968707|3904845|FG000|Overall Study|Did not meet treatment day baseline|49
2244891|NCT01968707|3904846|FG001|Overall Study|Did not meet treatment day baseline|12
2244892|NCT01968707|3904847|FG002|Overall Study|Did not meet treatment day baseline|41
2244893|NCT01968707|3904848|FG003|Overall Study|Did not meet treatment day baseline|44
2244894|NCT01968707|3904849|FG004|Overall Study|Did not meet treatment day baseline|36
2244895|NCT01968707|3904850|FG005|Overall Study|Did not meet treatment day baseline|11
2339057|NCT03363906|4068216|FG001|Period 1 (Reference or Test)|Adverse Event|2
2339058|NCT03363906|4068215|FG000|Period 2 (Test or Reference)|Adverse Event|2
2339059|NCT03363906|4068216|FG001|Period 2 (Test or Reference)|Adverse Event|0
2339060|NCT03363906|4068215|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1
2339061|NCT03363906|4068216|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1
2339062|NCT03363906|4068215|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1
2339063|NCT03363906|4068216|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0
2339064|NCT03364023|4068222|FG000|Overall Study|Lost to Follow-up|3
2339065|NCT03364023|4068222|FG000|Overall Study|Death|14
2339066|NCT03364036|4068226|FG000|Overall Study|Adverse Event|1
2339067|NCT03364036|4068226|FG000|Overall Study|Lost to Follow-up|1
2339068|NCT03364036|4068226|FG000|Overall Study|Withdrew Consent|1
2339069|NCT03364036|4068226|FG000|Overall Study|Protocol Non-Compliance|1
2339070|NCT03364036|4068226|FG000|Overall Study|Other|2
2339071|NCT03364049|4068234|FG000|Overall Study|Death|6
2339072|NCT03364049|4068235|FG001|Overall Study|Death|4
2339073|NCT03364049|4068236|FG002|Overall Study|Death|5
2339074|NCT03364049|4068237|FG003|Overall Study|Death|14
2339075|NCT03364049|4068234|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
2339076|NCT03364049|4068235|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1
2339077|NCT03364049|4068236|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
2339078|NCT03364049|4068237|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
2339079|NCT03364049|4068234|FG000|Overall Study|Withdrawal by Subject|0
2339080|NCT03364049|4068235|FG001|Overall Study|Withdrawal by Subject|1
2339081|NCT03364049|4068236|FG002|Overall Study|Withdrawal by Subject|1
2339082|NCT03364049|4068237|FG003|Overall Study|Withdrawal by Subject|1
2339083|NCT03364192|4068247|FG000|Overall Study|Ineligible|10
2339084|NCT03364192|4068247|FG000|Overall Study|Withdrawal by Subject|5
2339085|NCT03364192|4068247|FG000|Overall Study|Lost to Follow-up|1
2339086|NCT03364309|4068255|FG000|Induction Period|Adverse Event|4
2339087|NCT03364309|4068256|FG001|Induction Period|Adverse Event|0
2339088|NCT03364309|4068257|FG002|Induction Period|Adverse Event|1
2339089|NCT03364309|4068258|FG003|Induction Period|Adverse Event|0
2339090|NCT03364309|4068259|FG004|Induction Period|Adverse Event|0
2339091|NCT03364309|4068260|FG005|Induction Period|Adverse Event|0
2339092|NCT03364309|4068261|FG006|Induction Period|Adverse Event|0
2339093|NCT03364309|4068262|FG007|Induction Period|Adverse Event|0
2339094|NCT03364309|4068263|FG008|Induction Period|Adverse Event|0
2339095|NCT03364309|4068264|FG009|Induction Period|Adverse Event|0
2339096|NCT03364309|4068265|FG010|Induction Period|Adverse Event|0
2339097|NCT03364309|4068266|FG011|Induction Period|Adverse Event|0
2339098|NCT03364309|4068267|FG012|Induction Period|Adverse Event|0
2339099|NCT03364309|4068268|FG013|Induction Period|Adverse Event|0
2339100|NCT03364309|4068269|FG014|Induction Period|Adverse Event|0
2339101|NCT03364309|4068270|FG015|Induction Period|Adverse Event|0
2339102|NCT03364309|4068271|FG016|Induction Period|Adverse Event|0
2339103|NCT03364309|4068272|FG017|Induction Period|Adverse Event|0
2339104|NCT03364309|4068273|FG018|Induction Period|Adverse Event|0
2339105|NCT03364309|4068255|FG000|Induction Period|Withdrawal by Subject|1
2339106|NCT03364309|4068256|FG001|Induction Period|Withdrawal by Subject|3
2339107|NCT03364309|4068257|FG002|Induction Period|Withdrawal by Subject|0
2339108|NCT03364309|4068258|FG003|Induction Period|Withdrawal by Subject|0
2339109|NCT03364309|4068259|FG004|Induction Period|Withdrawal by Subject|0
2339110|NCT03364309|4068260|FG005|Induction Period|Withdrawal by Subject|0
2339111|NCT03364309|4068261|FG006|Induction Period|Withdrawal by Subject|0
2339112|NCT03364309|4068262|FG007|Induction Period|Withdrawal by Subject|0
2339113|NCT03364309|4068263|FG008|Induction Period|Withdrawal by Subject|0
2339114|NCT03364309|4068264|FG009|Induction Period|Withdrawal by Subject|0
2339115|NCT03364309|4068265|FG010|Induction Period|Withdrawal by Subject|0
2339116|NCT03364309|4068266|FG011|Induction Period|Withdrawal by Subject|0
2339117|NCT03364309|4068267|FG012|Induction Period|Withdrawal by Subject|0
2339118|NCT03364309|4068268|FG013|Induction Period|Withdrawal by Subject|0
2339119|NCT03364309|4068269|FG014|Induction Period|Withdrawal by Subject|0
2244896|NCT01968707|3904851|FG006|Overall Study|Did not meet treatment day baseline|34
2244897|NCT01968707|3904852|FG007|Overall Study|Did not meet treatment day baseline|35
2244898|NCT01968811|3904885|FG000|Overall Study|Protocol Violation|4
2244899|NCT01968811|3904885|FG000|Overall Study|post op.ref. of subject to other hospita|1
2244900|NCT01968954|3904891|FG000|Overall Study|Adverse Event|6
2244901|NCT01968954|3904892|FG001|Overall Study|Adverse Event|3
2244902|NCT01968954|3904891|FG000|Overall Study|Death|1
2244903|NCT01968954|3904892|FG001|Overall Study|Death|2
2244904|NCT01968954|3904891|FG000|Overall Study|Lost to Follow-up|6
2244905|NCT01968954|3904892|FG001|Overall Study|Lost to Follow-up|4
2244906|NCT01968954|3904891|FG000|Overall Study|Withdrawal by Subject|20
2244907|NCT01968954|3904892|FG001|Overall Study|Withdrawal by Subject|23
2244908|NCT01968954|3904891|FG000|Overall Study|Other|7
2244909|NCT01968954|3904892|FG001|Overall Study|Other|8
2244910|NCT01968954|3904891|FG000|Overall Study|Protocol Violation|0
2244911|NCT01968954|3904892|FG001|Overall Study|Protocol Violation|1
2244912|NCT01968954|3904891|FG000|Overall Study|Did not met inclusion criteria|0
2244913|NCT01968954|3904892|FG001|Overall Study|Did not met inclusion criteria|2
2244914|NCT01968967|3904901|FG000|Treatment Period|Other|22
2244915|NCT01968967|3904902|FG001|Treatment Period|Other|22
2244916|NCT01968967|3904903|FG002|Treatment Period|Other|0
2244917|NCT01968967|3904904|FG003|Treatment Period|Other|0
2244918|NCT01968967|3904905|FG004|Treatment Period|Other|0
2244919|NCT01968967|3904901|FG000|Treatment Period|Withdrawal by Subject|71
2244920|NCT01968967|3904902|FG001|Treatment Period|Withdrawal by Subject|61
2244921|NCT01968967|3904903|FG002|Treatment Period|Withdrawal by Subject|0
2244922|NCT01968967|3904904|FG003|Treatment Period|Withdrawal by Subject|0
2244923|NCT01968967|3904905|FG004|Treatment Period|Withdrawal by Subject|0
2244924|NCT01968967|3904901|FG000|Treatment Period|Did Not Meet Entrance Criteria|2
2244925|NCT01968967|3904902|FG001|Treatment Period|Did Not Meet Entrance Criteria|3
2244926|NCT01968967|3904903|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
2244927|NCT01968967|3904904|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
2244928|NCT01968967|3904905|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
2244929|NCT01968967|3904901|FG000|Treatment Period|Lost to Follow-up|26
2244930|NCT01968967|3904902|FG001|Treatment Period|Lost to Follow-up|31
2244931|NCT01968967|3904903|FG002|Treatment Period|Lost to Follow-up|0
2244932|NCT01968967|3904904|FG003|Treatment Period|Lost to Follow-up|0
2244933|NCT01968967|3904905|FG004|Treatment Period|Lost to Follow-up|0
2244934|NCT01968967|3904901|FG000|Treatment Period|Protocol Violation|1
2244935|NCT01968967|3904902|FG001|Treatment Period|Protocol Violation|2
2244936|NCT01968967|3904903|FG002|Treatment Period|Protocol Violation|0
2244937|NCT01968967|3904904|FG003|Treatment Period|Protocol Violation|0
2244938|NCT01968967|3904905|FG004|Treatment Period|Protocol Violation|0
2244939|NCT01968967|3904901|FG000|Treatment Period|Adverse Event|9
2244940|NCT01968967|3904902|FG001|Treatment Period|Adverse Event|8
2244941|NCT01968967|3904903|FG002|Treatment Period|Adverse Event|0
2244942|NCT01968967|3904904|FG003|Treatment Period|Adverse Event|0
2244943|NCT01968967|3904905|FG004|Treatment Period|Adverse Event|0
2244944|NCT01968967|3904901|FG000|Treatment Period|Death|9
2244945|NCT01968967|3904902|FG001|Treatment Period|Death|2
2244946|NCT01968967|3904903|FG002|Treatment Period|Death|0
2244947|NCT01968967|3904904|FG003|Treatment Period|Death|0
2244948|NCT01968967|3904905|FG004|Treatment Period|Death|0
2244949|NCT01968967|3904901|FG000|Treatment Period|Randomized Not Treated|6
2244950|NCT01968967|3904902|FG001|Treatment Period|Randomized Not Treated|5
2244951|NCT01968967|3904903|FG002|Treatment Period|Randomized Not Treated|0
2244952|NCT01968967|3904904|FG003|Treatment Period|Randomized Not Treated|0
2244953|NCT01968967|3904905|FG004|Treatment Period|Randomized Not Treated|0
2244954|NCT01968967|3904901|FG000|Extension Period|Withdrew Consent|0
2244955|NCT01968967|3904902|FG001|Extension Period|Withdrew Consent|0
2244956|NCT01968967|3904903|FG002|Extension Period|Withdrew Consent|2
2244957|NCT01968967|3904904|FG003|Extension Period|Withdrew Consent|0
2244958|NCT01968967|3904905|FG004|Extension Period|Withdrew Consent|5
2244959|NCT01968980|3904921|FG000|Overall Study|Death|0
2244960|NCT01968980|3904922|FG001|Overall Study|Death|1
2244961|NCT01968980|3904921|FG000|Overall Study|Adverse Event|1
2244962|NCT01968980|3904922|FG001|Overall Study|Adverse Event|3
2244963|NCT01968980|3904921|FG000|Overall Study|Does not meet entry criteria|1
2244964|NCT01968980|3904922|FG001|Overall Study|Does not meet entry criteria|3
2244965|NCT01968980|3904921|FG000|Overall Study|Withdrawal by Subject|13
2244966|NCT01968980|3904922|FG001|Overall Study|Withdrawal by Subject|5
2244967|NCT01968980|3904921|FG000|Overall Study|Other unspecified|1
2244968|NCT01968980|3904922|FG001|Overall Study|Other unspecified|2
2244969|NCT01969058|3904931|FG000|Overall Study|Withdrawal by Subject|2
2244970|NCT01969058|3904932|FG001|Overall Study|Withdrawal by Subject|0
2244971|NCT01969058|3904931|FG000|Overall Study|Adverse Event|1
2244972|NCT01969058|3904932|FG001|Overall Study|Adverse Event|0
2244973|NCT01969084|3904940|FG000|Overall Study|Adverse Event|0
2244974|NCT01969084|3904941|FG001|Overall Study|Adverse Event|1
2244975|NCT01969500|3904998|FG000|Overall Study|Death|0
2244976|NCT01969500|3904999|FG001|Overall Study|Death|1
2244977|NCT01969500|3904998|FG000|Overall Study|extended hospitalization|1
2244978|NCT01969500|3904999|FG001|Overall Study|extended hospitalization|1
2244979|NCT01969721|3905018|FG000|Overall Study|Adverse Event|3
2244980|NCT01969721|3905019|FG001|Overall Study|Adverse Event|8
2244981|NCT01969721|3905020|FG002|Overall Study|Adverse Event|3
2244982|NCT01969721|3905021|FG003|Overall Study|Adverse Event|2
2244983|NCT01969721|3905018|FG000|Overall Study|Lack of Efficacy|0
2244984|NCT01969721|3905019|FG001|Overall Study|Lack of Efficacy|0
2244985|NCT01969721|3905020|FG002|Overall Study|Lack of Efficacy|1
2244986|NCT01969721|3905021|FG003|Overall Study|Lack of Efficacy|0
2244987|NCT01969721|3905018|FG000|Overall Study|Non compliant with protocol|1
2244988|NCT01969721|3905019|FG001|Overall Study|Non compliant with protocol|1
2244989|NCT01969721|3905020|FG002|Overall Study|Non compliant with protocol|0
2244990|NCT01969721|3905021|FG003|Overall Study|Non compliant with protocol|2
2244991|NCT01969721|3905018|FG000|Overall Study|Other not defined above|0
2244992|NCT01969721|3905019|FG001|Overall Study|Other not defined above|2
2244993|NCT01969721|3905020|FG002|Overall Study|Other not defined above|0
2244994|NCT01969721|3905021|FG003|Overall Study|Other not defined above|0
2244995|NCT01969721|3905018|FG000|Overall Study|Discontinued during washout periods.|0
2244996|NCT01969721|3905019|FG001|Overall Study|Discontinued during washout periods.|1
2244997|NCT01969721|3905020|FG002|Overall Study|Discontinued during washout periods.|1
2244998|NCT01969721|3905021|FG003|Overall Study|Discontinued during washout periods.|2
2244999|NCT01969799|3905050|FG000|Overall Study|Adverse Event|0
2245000|NCT01969799|3905051|FG001|Overall Study|Adverse Event|1
2245001|NCT01969799|3905050|FG000|Overall Study|Death|16
2245002|NCT01969799|3905051|FG001|Overall Study|Death|11
2245003|NCT01969799|3905050|FG000|Overall Study|Lost to Follow-up|0
2245004|NCT01969799|3905051|FG001|Overall Study|Lost to Follow-up|2
2245005|NCT01969799|3905050|FG000|Overall Study|Physician Decision|1
2245006|NCT01969799|3905051|FG001|Overall Study|Physician Decision|0
2245007|NCT01969851|3905069|FG000|Overall Study|Adverse Event|0
2245008|NCT01969851|3905070|FG001|Overall Study|Adverse Event|0
2339120|NCT03364309|4068270|FG015|Induction Period|Withdrawal by Subject|0
2339121|NCT03364309|4068271|FG016|Induction Period|Withdrawal by Subject|0
2339122|NCT03364309|4068272|FG017|Induction Period|Withdrawal by Subject|0
2339123|NCT03364309|4068273|FG018|Induction Period|Withdrawal by Subject|0
2339124|NCT03364309|4068255|FG000|Induction Period|Lost to Follow-up|1
2339125|NCT03364309|4068256|FG001|Induction Period|Lost to Follow-up|0
2037718|NCT00420238|3608165|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
2037719|NCT00420238|3608166|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
2037720|NCT00420238|3608165|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
2037721|NCT00420238|3608166|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
2037722|NCT00420238|3608165|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
2037723|NCT00420238|3608166|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
2037724|NCT00420238|3608165|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
2037725|NCT00420238|3608166|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
2037726|NCT00420290|3608180|FG000|Overall Study|Adverse Event|3
2037727|NCT00420290|3608181|FG001|Overall Study|Adverse Event|1
2037728|NCT00420290|3608180|FG000|Overall Study|Withdrawal by Subject|0
2037729|NCT00420290|3608181|FG001|Overall Study|Withdrawal by Subject|2
2037730|NCT00420290|3608180|FG000|Overall Study|did not meet inclusion/exclusion|1
2037731|NCT00420290|3608181|FG001|Overall Study|did not meet inclusion/exclusion|1
2037732|NCT00420303|3608189|FG000|Overall Study|Serious Adverse Event|1
2037733|NCT00420303|3608190|FG001|Overall Study|Serious Adverse Event|0
2037734|NCT00420303|3608189|FG000|Overall Study|Lack of Efficacy|0
2037735|NCT00420303|3608190|FG001|Overall Study|Lack of Efficacy|3
2037736|NCT00420303|3608189|FG000|Overall Study|Physician Decision|0
2037737|NCT00420303|3608190|FG001|Overall Study|Physician Decision|1
2037738|NCT00420316|3608198|FG000|Overall Study|Withdrawal by Subject|0
2037739|NCT00420316|3608199|FG001|Overall Study|Withdrawal by Subject|1
2037740|NCT00420316|3608198|FG000|Overall Study|Lost to Follow-up|12
2037741|NCT00420316|3608199|FG001|Overall Study|Lost to Follow-up|8
2037742|NCT00420342|3608208|FG000|Overall Study|Lost to Follow-up|1
2037743|NCT00420342|3608209|FG001|Overall Study|Lost to Follow-up|0
2037744|NCT00420342|3608210|FG002|Overall Study|Lost to Follow-up|1
2037745|NCT00420342|3608208|FG000|Overall Study|Withdrawal by Subject|0
2037746|NCT00420342|3608209|FG001|Overall Study|Withdrawal by Subject|2
2037747|NCT00420342|3608210|FG002|Overall Study|Withdrawal by Subject|0
2037748|NCT00420381|3608218|FG000|Overall Study|Protocol Violation|1
2037749|NCT00420407|3608224|FG000|Overall Study|Lost to Follow-up|0
2037750|NCT00420407|3608225|FG001|Overall Study|Lost to Follow-up|3
2037751|NCT00420407|3608224|FG000|Overall Study|Physician Decision|2
2037752|NCT00420407|3608225|FG001|Overall Study|Physician Decision|1
2037753|NCT00420407|3608224|FG000|Overall Study|subject identified as detainee|1
2037754|NCT00420407|3608225|FG001|Overall Study|subject identified as detainee|0
2037755|NCT00420407|3608224|FG000|Overall Study|subject identified as Jehovah's witness|1
2037756|NCT00420407|3608225|FG001|Overall Study|subject identified as Jehovah's witness|0
2037757|NCT00420407|3608224|FG000|Overall Study|Withdrawal by Subject|0
2037758|NCT00420407|3608225|FG001|Overall Study|Withdrawal by Subject|2
2037759|NCT00420420|3608234|FG000|Overall Study|Adverse Event|5
2037760|NCT00420420|3608235|FG001|Overall Study|Adverse Event|3
2037761|NCT00420420|3608234|FG000|Overall Study|Protocol Violation|1
2037762|NCT00420420|3608235|FG001|Overall Study|Protocol Violation|1
2037763|NCT00420420|3608234|FG000|Overall Study|Withdrawal by Subject|1
2037764|NCT00420420|3608235|FG001|Overall Study|Withdrawal by Subject|0
2245009|NCT01969851|3905071|FG002|Overall Study|Adverse Event|3
2245010|NCT01969851|3905069|FG000|Overall Study|Lack of Efficacy|0
2245011|NCT01969851|3905070|FG001|Overall Study|Lack of Efficacy|3
2245012|NCT01969851|3905071|FG002|Overall Study|Lack of Efficacy|1
2245013|NCT01969851|3905069|FG000|Overall Study|Withdrawal by Subject|1
2245014|NCT01969851|3905070|FG001|Overall Study|Withdrawal by Subject|0
2245015|NCT01969851|3905071|FG002|Overall Study|Withdrawal by Subject|1
2245016|NCT01969851|3905069|FG000|Overall Study|No effective dose in Titration period|0
2245017|NCT01969851|3905070|FG001|Overall Study|No effective dose in Titration period|0
2245018|NCT01969851|3905071|FG002|Overall Study|No effective dose in Titration period|1
2245019|NCT01969851|3905069|FG000|Overall Study|Sponsor decision|0
2245020|NCT01969851|3905070|FG001|Overall Study|Sponsor decision|0
2245021|NCT01969851|3905071|FG002|Overall Study|Sponsor decision|1
2245022|NCT01970007|3905083|FG000|Overall Study|Death|5
2245023|NCT01970007|3905083|FG000|Overall Study|Withdrawal by Subject|23
2245024|NCT01970007|3905083|FG000|Overall Study|Lost to Follow-up|24
2245025|NCT01970007|3905083|FG000|Overall Study|"Other endpoint"|3
2245026|NCT01970241|3905098|FG000|Overall Study|Withdrawal by Subject|2
2245027|NCT01970241|3905099|FG001|Overall Study|Withdrawal by Subject|0
2245028|NCT01970241|3905098|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15
2245029|NCT01970241|3905099|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8
2245030|NCT01970371|3905110|FG000|Overall Study|Death|8
2245031|NCT01970371|3905111|FG001|Overall Study|Death|13
2245032|NCT01970371|3905112|FG002|Overall Study|Death|12
2245033|NCT01970371|3905110|FG000|Overall Study|Lost to Follow-up|0
2245034|NCT01970371|3905111|FG001|Overall Study|Lost to Follow-up|0
2245035|NCT01970371|3905112|FG002|Overall Study|Lost to Follow-up|1
2245036|NCT01970397|3905124|FG000|Overall Study|Adverse Event|0
2245037|NCT01970397|3905125|FG001|Overall Study|Adverse Event|1
2245038|NCT01970397|3905124|FG000|Overall Study|Lost to Follow-up|0
2245039|NCT01970397|3905125|FG001|Overall Study|Lost to Follow-up|1
2245040|NCT01970397|3905124|FG000|Overall Study|Personal Reasons|1
2245041|NCT01970397|3905125|FG001|Overall Study|Personal Reasons|2
2245042|NCT01970397|3905124|FG000|Overall Study|Protocol Violation|1
2245043|NCT01970397|3905125|FG001|Overall Study|Protocol Violation|1
2245044|NCT01970475|3905133|FG000|Overall Study|Withdrawal by Subject|11
2245045|NCT01970475|3905134|FG001|Overall Study|Withdrawal by Subject|6
2245046|NCT01970475|3905133|FG000|Overall Study|Adverse Event|7
2245047|NCT01970475|3905134|FG001|Overall Study|Adverse Event|3
2245048|NCT01970475|3905133|FG000|Overall Study|Lost to Follow-up|2
2245049|NCT01970475|3905134|FG001|Overall Study|Lost to Follow-up|2
2245050|NCT01970475|3905133|FG000|Overall Study|Protocol Violation|1
2245051|NCT01970475|3905134|FG001|Overall Study|Protocol Violation|0
2245052|NCT01970488|3905142|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1
2245053|NCT01970488|3905143|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2
2245054|NCT01970488|3905144|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0
2245055|NCT01970488|3905145|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0
2245056|NCT01970488|3905146|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0
2245057|NCT01970488|3905142|FG000|Part 1: Through Week 16|Protocol Violation|1
2245058|NCT01970488|3905143|FG001|Part 1: Through Week 16|Protocol Violation|2
2245059|NCT01970488|3905144|FG002|Part 1: Through Week 16|Protocol Violation|0
2245060|NCT01970488|3905145|FG003|Part 1: Through Week 16|Protocol Violation|0
2245061|NCT01970488|3905146|FG004|Part 1: Through Week 16|Protocol Violation|0
2245062|NCT01970488|3905142|FG000|Part 1: Through Week 16|Adverse Event|6
2245063|NCT01970488|3905143|FG001|Part 1: Through Week 16|Adverse Event|5
2245064|NCT01970488|3905144|FG002|Part 1: Through Week 16|Adverse Event|0
2245065|NCT01970488|3905145|FG003|Part 1: Through Week 16|Adverse Event|0
2245066|NCT01970488|3905146|FG004|Part 1: Through Week 16|Adverse Event|0
2245067|NCT01970488|3905142|FG000|Part 1: Through Week 16|Withdrawal by Subject|3
2245068|NCT01970488|3905143|FG001|Part 1: Through Week 16|Withdrawal by Subject|2
2245069|NCT01970488|3905144|FG002|Part 1: Through Week 16|Withdrawal by Subject|0
2245070|NCT01970488|3905145|FG003|Part 1: Through Week 16|Withdrawal by Subject|0
2245071|NCT01970488|3905146|FG004|Part 1: Through Week 16|Withdrawal by Subject|0
2245072|NCT01970488|3905142|FG000|Part 1: Through Week 16|Lost to Follow-up|0
2245073|NCT01970488|3905143|FG001|Part 1: Through Week 16|Lost to Follow-up|2
2245074|NCT01970488|3905144|FG002|Part 1: Through Week 16|Lost to Follow-up|0
2245075|NCT01970488|3905145|FG003|Part 1: Through Week 16|Lost to Follow-up|0
2245076|NCT01970488|3905146|FG004|Part 1: Through Week 16|Lost to Follow-up|0
2245077|NCT01970488|3905142|FG000|Part 2: Post Week 16|Physician Decision|0
2245078|NCT01970488|3905143|FG001|Part 2: Post Week 16|Physician Decision|0
2245079|NCT01970488|3905144|FG002|Part 2: Post Week 16|Physician Decision|0
2245080|NCT01970488|3905145|FG003|Part 2: Post Week 16|Physician Decision|0
2245081|NCT01970488|3905146|FG004|Part 2: Post Week 16|Physician Decision|1
2245082|NCT01970488|3905142|FG000|Part 2: Post Week 16|Non-compliance|0
2245083|NCT01970488|3905143|FG001|Part 2: Post Week 16|Non-compliance|0
2245084|NCT01970488|3905144|FG002|Part 2: Post Week 16|Non-compliance|1
2245085|NCT01970488|3905145|FG003|Part 2: Post Week 16|Non-compliance|0
2245086|NCT01970488|3905146|FG004|Part 2: Post Week 16|Non-compliance|0
2245087|NCT01970488|3905142|FG000|Part 2: Post Week 16|Lack of Efficacy|0
2245088|NCT01970488|3905143|FG001|Part 2: Post Week 16|Lack of Efficacy|0
2245089|NCT01970488|3905144|FG002|Part 2: Post Week 16|Lack of Efficacy|2
2245090|NCT01970488|3905145|FG003|Part 2: Post Week 16|Lack of Efficacy|3
2245091|NCT01970488|3905146|FG004|Part 2: Post Week 16|Lack of Efficacy|1
2245092|NCT01970488|3905142|FG000|Part 2: Post Week 16|Adverse Event|0
2245093|NCT01970488|3905143|FG001|Part 2: Post Week 16|Adverse Event|0
2245094|NCT01970488|3905144|FG002|Part 2: Post Week 16|Adverse Event|5
2245095|NCT01970488|3905145|FG003|Part 2: Post Week 16|Adverse Event|1
2245096|NCT01970488|3905146|FG004|Part 2: Post Week 16|Adverse Event|1
2245097|NCT01970488|3905142|FG000|Part 2: Post Week 16|Withdrawal by Subject|0
2245098|NCT01970488|3905143|FG001|Part 2: Post Week 16|Withdrawal by Subject|0
2245099|NCT01970488|3905144|FG002|Part 2: Post Week 16|Withdrawal by Subject|8
2245100|NCT01970488|3905145|FG003|Part 2: Post Week 16|Withdrawal by Subject|3
2245101|NCT01970488|3905146|FG004|Part 2: Post Week 16|Withdrawal by Subject|3
2245102|NCT01970488|3905142|FG000|Part 2: Post Week 16|Lost to Follow-up|0
2245103|NCT01970488|3905143|FG001|Part 2: Post Week 16|Lost to Follow-up|0
2245104|NCT01970488|3905144|FG002|Part 2: Post Week 16|Lost to Follow-up|1
2245105|NCT01970488|3905145|FG003|Part 2: Post Week 16|Lost to Follow-up|1
2245106|NCT01970488|3905146|FG004|Part 2: Post Week 16|Lost to Follow-up|2
2245107|NCT01970527|3905163|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
2245108|NCT01970527|3905164|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
2245109|NCT01970527|3905163|FG000|Treatment|Disease progression|0
2245110|NCT01970527|3905164|FG001|Treatment|Disease progression|1
2245111|NCT01970527|3905163|FG000|Treatment|Participant did not tolerate Ipilimumab|0
2245112|NCT01970527|3905164|FG001|Treatment|Participant did not tolerate Ipilimumab|1
2245113|NCT01970527|3905163|FG000|Treatment|Death|0
2245114|NCT01970527|3905164|FG001|Treatment|Death|1
2245115|NCT01970527|3905163|FG000|Follow-up Clinic Visit|Disease progression|1
2245116|NCT01970527|3905164|FG001|Follow-up Clinic Visit|Disease progression|1
2245117|NCT01970527|3905163|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0
2245118|NCT01970527|3905164|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1
2245119|NCT01970527|3905163|FG000|Follow-up Clinic Visit|Lost to Follow-up|0
2245120|NCT01970527|3905164|FG001|Follow-up Clinic Visit|Lost to Follow-up|1
2245121|NCT01970540|3905176|FG000|Overall Study|Non-treatment-related AE|0
2245122|NCT01970540|3905177|FG001|Overall Study|Non-treatment-related AE|0
2245123|NCT01970540|3905178|FG002|Overall Study|Non-treatment-related AE|1
2245124|NCT01970540|3905176|FG000|Overall Study|Progressive disease|55
2245125|NCT01970540|3905177|FG001|Overall Study|Progressive disease|23
2245126|NCT01970540|3905178|FG002|Overall Study|Progressive disease|10
2245127|NCT01970540|3905176|FG000|Overall Study|Treatment delay over protocol|0
2245128|NCT01970540|3905177|FG001|Overall Study|Treatment delay over protocol|0
2245129|NCT01970540|3905178|FG002|Overall Study|Treatment delay over protocol|1
2245130|NCT01970540|3905176|FG000|Overall Study|Physician Decision|7
2245131|NCT01970540|3905177|FG001|Overall Study|Physician Decision|2
2245132|NCT01970540|3905178|FG002|Overall Study|Physician Decision|0
2245133|NCT01970540|3905176|FG000|Overall Study|Clinical progression|0
2245134|NCT01970540|3905177|FG001|Overall Study|Clinical progression|1
2245135|NCT01970540|3905178|FG002|Overall Study|Clinical progression|1
2245136|NCT01970540|3905176|FG000|Overall Study|End of study|2
2245137|NCT01970540|3905177|FG001|Overall Study|End of study|0
2245138|NCT01970540|3905178|FG002|Overall Study|End of study|2
2245139|NCT01970540|3905176|FG000|Overall Study|Adverse Event|0
2245140|NCT01970540|3905177|FG001|Overall Study|Adverse Event|2
2245141|NCT01970540|3905178|FG002|Overall Study|Adverse Event|1
2245142|NCT01970540|3905176|FG000|Overall Study|Treatment-related AE|4
2245143|NCT01970540|3905177|FG001|Overall Study|Treatment-related AE|0
2339126|NCT03364309|4068257|FG002|Induction Period|Lost to Follow-up|0
2339127|NCT03364309|4068258|FG003|Induction Period|Lost to Follow-up|0
2339128|NCT03364309|4068259|FG004|Induction Period|Lost to Follow-up|0
2339129|NCT03364309|4068260|FG005|Induction Period|Lost to Follow-up|0
2339130|NCT03364309|4068261|FG006|Induction Period|Lost to Follow-up|0
2339131|NCT03364309|4068262|FG007|Induction Period|Lost to Follow-up|0
2339132|NCT03364309|4068263|FG008|Induction Period|Lost to Follow-up|0
2339133|NCT03364309|4068264|FG009|Induction Period|Lost to Follow-up|0
2339134|NCT03364309|4068265|FG010|Induction Period|Lost to Follow-up|0
2339135|NCT03364309|4068266|FG011|Induction Period|Lost to Follow-up|0
2339136|NCT03364309|4068267|FG012|Induction Period|Lost to Follow-up|0
2339137|NCT03364309|4068268|FG013|Induction Period|Lost to Follow-up|0
2339138|NCT03364309|4068269|FG014|Induction Period|Lost to Follow-up|0
2339139|NCT03364309|4068270|FG015|Induction Period|Lost to Follow-up|0
2339140|NCT03364309|4068271|FG016|Induction Period|Lost to Follow-up|0
2339141|NCT03364309|4068272|FG017|Induction Period|Lost to Follow-up|0
2339142|NCT03364309|4068273|FG018|Induction Period|Lost to Follow-up|0
2339143|NCT03364309|4068255|FG000|Induction Period|Physician Decision|0
2339144|NCT03364309|4068256|FG001|Induction Period|Physician Decision|1
2339145|NCT03364309|4068257|FG002|Induction Period|Physician Decision|0
2245144|NCT01970540|3905178|FG002|Overall Study|Treatment-related AE|2
2245145|NCT01970540|3905176|FG000|Overall Study|Withdrawal by Subject|4
2245146|NCT01970540|3905177|FG001|Overall Study|Withdrawal by Subject|0
2245147|NCT01970540|3905178|FG002|Overall Study|Withdrawal by Subject|1
2245148|NCT01970540|3905176|FG000|Overall Study|Clinical deterioration|1
2245149|NCT01970540|3905177|FG001|Overall Study|Clinical deterioration|0
2245150|NCT01970540|3905178|FG002|Overall Study|Clinical deterioration|0
2245151|NCT01970592|3905197|FG000|Overall Study|Withdrawal by Subject|4
2245152|NCT01970592|3905197|FG000|Overall Study|Physician Decision|1
2245153|NCT01970592|3905197|FG000|Overall Study|Adverse Event|1
2245154|NCT01970878|3905209|FG000|Overall Study|Withdrawal by Subject|11
2245155|NCT01970878|3905210|FG001|Overall Study|Withdrawal by Subject|10
2245156|NCT01970878|3905211|FG002|Overall Study|Withdrawal by Subject|14
2245157|NCT01970878|3905212|FG003|Overall Study|Withdrawal by Subject|7
2245158|NCT01970878|3905209|FG000|Overall Study|Lost to Follow-up|1
2245159|NCT01970878|3905210|FG001|Overall Study|Lost to Follow-up|3
2245160|NCT01970878|3905211|FG002|Overall Study|Lost to Follow-up|2
2245161|NCT01970878|3905212|FG003|Overall Study|Lost to Follow-up|4
2245162|NCT01970878|3905209|FG000|Overall Study|Administrative Reasons|1
2245163|NCT01970878|3905210|FG001|Overall Study|Administrative Reasons|0
2245164|NCT01970878|3905211|FG002|Overall Study|Administrative Reasons|0
2245165|NCT01970878|3905212|FG003|Overall Study|Administrative Reasons|4
2245166|NCT01970878|3905209|FG000|Overall Study|Lack of Efficacy|2
2245167|NCT01970878|3905210|FG001|Overall Study|Lack of Efficacy|1
2245168|NCT01970878|3905211|FG002|Overall Study|Lack of Efficacy|2
2245169|NCT01970878|3905212|FG003|Overall Study|Lack of Efficacy|0
2245170|NCT01970878|3905209|FG000|Overall Study|Adverse Event|12
2245171|NCT01970878|3905210|FG001|Overall Study|Adverse Event|7
2245172|NCT01970878|3905211|FG002|Overall Study|Adverse Event|4
2245173|NCT01970878|3905212|FG003|Overall Study|Adverse Event|3
2245174|NCT01970878|3905209|FG000|Overall Study|Protocol Specified Criteria|10
2245175|NCT01970878|3905210|FG001|Overall Study|Protocol Specified Criteria|4
2245176|NCT01970878|3905211|FG002|Overall Study|Protocol Specified Criteria|3
2245177|NCT01970878|3905212|FG003|Overall Study|Protocol Specified Criteria|6
2245178|NCT01970878|3905209|FG000|Overall Study|Physician Decision|0
2245179|NCT01970878|3905210|FG001|Overall Study|Physician Decision|1
2245180|NCT01970878|3905211|FG002|Overall Study|Physician Decision|1
2245181|NCT01970878|3905212|FG003|Overall Study|Physician Decision|0
2245182|NCT01970878|3905209|FG000|Overall Study|No Completion Status|0
2245183|NCT01970878|3905210|FG001|Overall Study|No Completion Status|1
2245184|NCT01970878|3905211|FG002|Overall Study|No Completion Status|0
2245185|NCT01970878|3905212|FG003|Overall Study|No Completion Status|0
2245186|NCT01970982|3905232|FG000|Overall Study|Withdrawal by Subject|0
2245187|NCT01970982|3905233|FG001|Overall Study|Withdrawal by Subject|0
2245188|NCT01970982|3905234|FG002|Overall Study|Withdrawal by Subject|2
2245189|NCT01970995|3905246|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2245190|NCT01970995|3905247|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2245191|NCT01970995|3905248|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2245192|NCT01970995|3905246|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1
2245193|NCT01970995|3905247|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0
2245194|NCT01970995|3905248|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1
2245195|NCT01971203|3905263|FG000|Overall Study|Protocol Violation|3
2245196|NCT01971203|3905264|FG001|Overall Study|Protocol Violation|2
2245197|NCT01971203|3905263|FG000|Overall Study|Withdrawal by Subject|5
2245198|NCT01971203|3905264|FG001|Overall Study|Withdrawal by Subject|6
2245199|NCT01971203|3905263|FG000|Overall Study|Adverse Event|1
2245200|NCT01971203|3905264|FG001|Overall Study|Adverse Event|0
2245201|NCT01971346|3905279|FG000|Overall Study|Protocol Violation|3
2245202|NCT01971346|3905279|FG000|Overall Study|Lost to Follow-up|2
2245203|NCT01971346|3905279|FG000|Overall Study|Withdrawal by Subject|2
2245204|NCT01971346|3905279|FG000|Overall Study|Physician Decision|1
2245205|NCT01971476|3905310|FG000|Cohort 1: 2 to <12 Years|Other not defined|3
2245206|NCT01971476|3905311|FG001|Cohort 1: 2 to <12 Years|Other not defined|3
2245207|NCT01971476|3905312|FG002|Cohort 1: 2 to <12 Years|Other not defined|6
2245208|NCT01971476|3905310|FG000|Cohort 2: 12 to <18 Years|Other not defined|6
2245209|NCT01971476|3905311|FG001|Cohort 2: 12 to <18 Years|Other not defined|3
2245210|NCT01971476|3905312|FG002|Cohort 2: 12 to <18 Years|Other not defined|0
2245211|NCT01971476|3905310|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0
2245212|NCT01971476|3905311|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1
2245213|NCT01971476|3905312|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0
2245214|NCT01971554|3905333|FG000|Overall Study|Lost to Follow-up|1
2245215|NCT01971554|3905334|FG001|Overall Study|Lost to Follow-up|0
2245216|NCT01971554|3905335|FG002|Overall Study|Lost to Follow-up|0
2245217|NCT01971554|3905336|FG003|Overall Study|Lost to Follow-up|0
2245218|NCT01971567|3905348|FG000|Overall Study|Withdrawal by Subject|3
2245219|NCT01971567|3905349|FG001|Overall Study|Withdrawal by Subject|2
2245220|NCT01971567|3905348|FG000|Overall Study|Lost to Follow-up|1
2245221|NCT01971567|3905349|FG001|Overall Study|Lost to Follow-up|0
2245222|NCT01971645|3905374|FG000|Overall Study|Adverse Event|1
2245223|NCT01971645|3905375|FG001|Overall Study|Adverse Event|0
2245224|NCT01971645|3905376|FG002|Overall Study|Adverse Event|0
2339146|NCT03364309|4068258|FG003|Induction Period|Physician Decision|0
2339147|NCT03364309|4068259|FG004|Induction Period|Physician Decision|0
2339148|NCT03364309|4068260|FG005|Induction Period|Physician Decision|0
2339149|NCT03364309|4068261|FG006|Induction Period|Physician Decision|0
2245225|NCT01971645|3905374|FG000|Overall Study|Lost to Follow-up|1
2245226|NCT01971645|3905375|FG001|Overall Study|Lost to Follow-up|0
2245227|NCT01971645|3905376|FG002|Overall Study|Lost to Follow-up|1
2245228|NCT01971645|3905374|FG000|Overall Study|Protocol Violation|0
2245229|NCT01971645|3905375|FG001|Overall Study|Protocol Violation|0
2245230|NCT01971645|3905376|FG002|Overall Study|Protocol Violation|1
2245231|NCT01971723|3905386|FG000|Overall Study|Withdrawal by Subject|1
2245232|NCT01971723|3905387|FG001|Overall Study|Withdrawal by Subject|1
2245233|NCT01971723|3905386|FG000|Overall Study|Protocol Violation|1
2245234|NCT01971723|3905387|FG001|Overall Study|Protocol Violation|2
2245235|NCT01972074|3905409|FG000|Overall Study|Adverse Event|4
2245236|NCT01972074|3905410|FG001|Overall Study|Adverse Event|1
2245237|NCT01972074|3905411|FG002|Overall Study|Adverse Event|0
2245238|NCT01972074|3905409|FG000|Overall Study|Lack of Efficacy|1
2245239|NCT01972074|3905410|FG001|Overall Study|Lack of Efficacy|1
2245240|NCT01972074|3905411|FG002|Overall Study|Lack of Efficacy|0
2245241|NCT01972074|3905409|FG000|Overall Study|Lost to Follow-up|0
2245242|NCT01972074|3905410|FG001|Overall Study|Lost to Follow-up|1
2245243|NCT01972074|3905411|FG002|Overall Study|Lost to Follow-up|1
2245244|NCT01972074|3905409|FG000|Overall Study|Withdrawal by Subject|1
2245245|NCT01972074|3905410|FG001|Overall Study|Withdrawal by Subject|1
2245246|NCT01972074|3905411|FG002|Overall Study|Withdrawal by Subject|1
2245247|NCT01972074|3905409|FG000|Overall Study|Scanner Unavailable|0
2245248|NCT01972074|3905410|FG001|Overall Study|Scanner Unavailable|0
2245249|NCT01972074|3905411|FG002|Overall Study|Scanner Unavailable|1
2245250|NCT01972152|3905418|FG000|First Treatment Visit|Lost to Follow-up|0
2245251|NCT01972152|3905419|FG001|First Treatment Visit|Lost to Follow-up|1
2245252|NCT01972152|3905420|FG002|First Treatment Visit|Lost to Follow-up|0
2245253|NCT01972152|3905421|FG003|First Treatment Visit|Lost to Follow-up|0
2339150|NCT03364309|4068262|FG007|Induction Period|Physician Decision|0
2339151|NCT03364309|4068263|FG008|Induction Period|Physician Decision|0
2339152|NCT03364309|4068264|FG009|Induction Period|Physician Decision|0
2339153|NCT03364309|4068265|FG010|Induction Period|Physician Decision|0
2339154|NCT03364309|4068266|FG011|Induction Period|Physician Decision|0
2339155|NCT03364309|4068267|FG012|Induction Period|Physician Decision|0
2339156|NCT03364309|4068268|FG013|Induction Period|Physician Decision|0
2339157|NCT03364309|4068269|FG014|Induction Period|Physician Decision|0
2339158|NCT03364309|4068270|FG015|Induction Period|Physician Decision|0
2339159|NCT03364309|4068271|FG016|Induction Period|Physician Decision|0
2339160|NCT03364309|4068272|FG017|Induction Period|Physician Decision|0
2339161|NCT03364309|4068273|FG018|Induction Period|Physician Decision|0
2339162|NCT03364309|4068255|FG000|Maintenance Period|Withdrawal by Subject|0
2339163|NCT03364309|4068256|FG001|Maintenance Period|Withdrawal by Subject|0
2339164|NCT03364309|4068257|FG002|Maintenance Period|Withdrawal by Subject|0
2339165|NCT03364309|4068258|FG003|Maintenance Period|Withdrawal by Subject|1
2339166|NCT03364309|4068259|FG004|Maintenance Period|Withdrawal by Subject|3
2339167|NCT03364309|4068260|FG005|Maintenance Period|Withdrawal by Subject|1
2339168|NCT03364309|4068261|FG006|Maintenance Period|Withdrawal by Subject|3
2339169|NCT03364309|4068262|FG007|Maintenance Period|Withdrawal by Subject|0
2339170|NCT03364309|4068263|FG008|Maintenance Period|Withdrawal by Subject|1
2339171|NCT03364309|4068264|FG009|Maintenance Period|Withdrawal by Subject|1
2339172|NCT03364309|4068265|FG010|Maintenance Period|Withdrawal by Subject|2
2339173|NCT03364309|4068266|FG011|Maintenance Period|Withdrawal by Subject|0
2339174|NCT03364309|4068267|FG012|Maintenance Period|Withdrawal by Subject|0
2339175|NCT03364309|4068268|FG013|Maintenance Period|Withdrawal by Subject|0
2339176|NCT03364309|4068269|FG014|Maintenance Period|Withdrawal by Subject|0
2339177|NCT03364309|4068270|FG015|Maintenance Period|Withdrawal by Subject|0
2339178|NCT03364309|4068271|FG016|Maintenance Period|Withdrawal by Subject|0
2339179|NCT03364309|4068272|FG017|Maintenance Period|Withdrawal by Subject|0
2339180|NCT03364309|4068273|FG018|Maintenance Period|Withdrawal by Subject|0
2339181|NCT03364309|4068255|FG000|Maintenance Period|Adverse Event|0
2339182|NCT03364309|4068256|FG001|Maintenance Period|Adverse Event|0
2339183|NCT03364309|4068257|FG002|Maintenance Period|Adverse Event|0
2339184|NCT03364309|4068258|FG003|Maintenance Period|Adverse Event|0
2339185|NCT03364309|4068259|FG004|Maintenance Period|Adverse Event|2
2339186|NCT03364309|4068260|FG005|Maintenance Period|Adverse Event|0
2339187|NCT03364309|4068261|FG006|Maintenance Period|Adverse Event|3
2339188|NCT03364309|4068262|FG007|Maintenance Period|Adverse Event|0
2339189|NCT03364309|4068263|FG008|Maintenance Period|Adverse Event|1
2339190|NCT03364309|4068264|FG009|Maintenance Period|Adverse Event|0
2339191|NCT03364309|4068265|FG010|Maintenance Period|Adverse Event|2
2339192|NCT03364309|4068266|FG011|Maintenance Period|Adverse Event|0
2339193|NCT03364309|4068267|FG012|Maintenance Period|Adverse Event|0
2339194|NCT03364309|4068268|FG013|Maintenance Period|Adverse Event|0
2339195|NCT03364309|4068269|FG014|Maintenance Period|Adverse Event|0
2339196|NCT03364309|4068270|FG015|Maintenance Period|Adverse Event|0
2339197|NCT03364309|4068271|FG016|Maintenance Period|Adverse Event|0
2339198|NCT03364309|4068272|FG017|Maintenance Period|Adverse Event|0
2339199|NCT03364309|4068273|FG018|Maintenance Period|Adverse Event|0
2339200|NCT03364309|4068255|FG000|Maintenance Period|Relapsed|0
2339201|NCT03364309|4068256|FG001|Maintenance Period|Relapsed|0
2339202|NCT03364309|4068257|FG002|Maintenance Period|Relapsed|0
2339203|NCT03364309|4068258|FG003|Maintenance Period|Relapsed|43
2339204|NCT03364309|4068259|FG004|Maintenance Period|Relapsed|7
2339205|NCT03364309|4068260|FG005|Maintenance Period|Relapsed|45
2339206|NCT03364309|4068261|FG006|Maintenance Period|Relapsed|10
2339207|NCT03364309|4068262|FG007|Maintenance Period|Relapsed|2
2339208|NCT03364309|4068263|FG008|Maintenance Period|Relapsed|0
2339209|NCT03364309|4068264|FG009|Maintenance Period|Relapsed|0
2245254|NCT01972152|3905422|FG004|First Treatment Visit|Lost to Follow-up|0
2245255|NCT01972152|3905423|FG005|First Treatment Visit|Lost to Follow-up|0
2245256|NCT01972152|3905418|FG000|Second Treatment Visit|Protocol Violation|0
2245257|NCT01972152|3905419|FG001|Second Treatment Visit|Protocol Violation|1
2245258|NCT01972152|3905420|FG002|Second Treatment Visit|Protocol Violation|0
2245259|NCT01972152|3905421|FG003|Second Treatment Visit|Protocol Violation|0
2245260|NCT01972152|3905422|FG004|Second Treatment Visit|Protocol Violation|0
2245261|NCT01972152|3905423|FG005|Second Treatment Visit|Protocol Violation|0
2245262|NCT01972308|3905449|FG000|Overall Study|Withdrawal by Subject|0
2245263|NCT01972308|3905450|FG001|Overall Study|Withdrawal by Subject|1
2245264|NCT01972308|3905449|FG000|Overall Study|Lost to Follow-up|4
2245265|NCT01972308|3905450|FG001|Overall Study|Lost to Follow-up|6
2245266|NCT01972308|3905449|FG000|Overall Study|Death|4
2245267|NCT01972308|3905450|FG001|Overall Study|Death|1
2245268|NCT01972438|3905460|FG000|Baseline-Month 3 Crossover Period|Death|1
2245269|NCT01972438|3905461|FG001|Baseline-Month 3 Crossover Period|Death|0
2245270|NCT01972438|3905460|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
2245271|NCT01972438|3905461|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
2245272|NCT01972438|3905460|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0
2245273|NCT01972438|3905461|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1
2245274|NCT01972438|3905460|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
2245275|NCT01972438|3905461|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
2245276|NCT01972438|3905460|FG000|Months 3-6 Crossover Period|Early Study Closure|0
2245277|NCT01972438|3905461|FG001|Months 3-6 Crossover Period|Early Study Closure|1
2245278|NCT01972438|3905460|FG000|Months 6-12 Study Period|Death|1
2245279|NCT01972438|3905461|FG001|Months 6-12 Study Period|Death|0
2245280|NCT01972438|3905460|FG000|Months 6-12 Study Period|Early Study Closure|2
2245281|NCT01972438|3905461|FG001|Months 6-12 Study Period|Early Study Closure|2
2245282|NCT01972438|3905460|FG000|Post Month 12 Study Period|Early Study Closure|3
2245283|NCT01972438|3905461|FG001|Post Month 12 Study Period|Early Study Closure|4
2245284|NCT01972464|3905471|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
2245285|NCT01972464|3905472|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
2245286|NCT01972464|3905471|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
2245287|NCT01972464|3905472|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
2245288|NCT01972464|3905471|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
2245289|NCT01972464|3905472|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
2245290|NCT01972464|3905471|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
2245291|NCT01972464|3905472|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
2245292|NCT01972529|3905492|FG000|Overall Study|Adverse Event|0
2245293|NCT01972529|3905493|FG001|Overall Study|Adverse Event|1
2245294|NCT01972529|3905494|FG002|Overall Study|Adverse Event|0
2245295|NCT01972529|3905495|FG003|Overall Study|Adverse Event|0
2245296|NCT01972529|3905492|FG000|Overall Study|Lost to Follow-up|1
2245297|NCT01972529|3905493|FG001|Overall Study|Lost to Follow-up|0
2245298|NCT01972529|3905494|FG002|Overall Study|Lost to Follow-up|0
2245299|NCT01972529|3905495|FG003|Overall Study|Lost to Follow-up|0
2245300|NCT01972529|3905492|FG000|Overall Study|Participant Choice|0
2245301|NCT01972529|3905493|FG001|Overall Study|Participant Choice|1
2245302|NCT01972529|3905494|FG002|Overall Study|Participant Choice|0
2245303|NCT01972529|3905495|FG003|Overall Study|Participant Choice|0
2245304|NCT01972529|3905492|FG000|Overall Study|Withdrawl of Consent|1
2245305|NCT01972529|3905493|FG001|Overall Study|Withdrawl of Consent|2
2245306|NCT01972529|3905494|FG002|Overall Study|Withdrawl of Consent|0
2245307|NCT01972529|3905495|FG003|Overall Study|Withdrawl of Consent|1
2245308|NCT01972529|3905492|FG000|Overall Study|Other|0
2245309|NCT01972529|3905493|FG001|Overall Study|Other|0
2245310|NCT01972529|3905494|FG002|Overall Study|Other|0
2245311|NCT01972529|3905495|FG003|Overall Study|Other|2
2245312|NCT01972529|3905492|FG000|Overall Study|Not treated|0
2245313|NCT01972529|3905493|FG001|Overall Study|Not treated|1
2245314|NCT01972529|3905494|FG002|Overall Study|Not treated|2
2245315|NCT01972529|3905495|FG003|Overall Study|Not treated|1
2245316|NCT01972568|3905509|FG000|Overall Study|Other events|3
2245317|NCT01972568|3905510|FG001|Overall Study|Other events|0
2245318|NCT01972568|3905511|FG002|Overall Study|Other events|0
2245319|NCT01972568|3905509|FG000|Overall Study|Lack of Efficacy|0
2245320|NCT01972568|3905510|FG001|Overall Study|Lack of Efficacy|1
2245321|NCT01972568|3905511|FG002|Overall Study|Lack of Efficacy|2
2339210|NCT03364309|4068265|FG010|Maintenance Period|Relapsed|0
2339211|NCT03364309|4068266|FG011|Maintenance Period|Relapsed|0
2339212|NCT03364309|4068267|FG012|Maintenance Period|Relapsed|0
2339213|NCT03364309|4068268|FG013|Maintenance Period|Relapsed|0
2339214|NCT03364309|4068269|FG014|Maintenance Period|Relapsed|0
2339215|NCT03364309|4068270|FG015|Maintenance Period|Relapsed|0
2339216|NCT03364309|4068271|FG016|Maintenance Period|Relapsed|0
2339217|NCT03364309|4068272|FG017|Maintenance Period|Relapsed|0
2339218|NCT03364309|4068273|FG018|Maintenance Period|Relapsed|0
2339219|NCT03364309|4068255|FG000|Maintenance Period|Lack of Efficacy|0
2339220|NCT03364309|4068256|FG001|Maintenance Period|Lack of Efficacy|0
2339221|NCT03364309|4068257|FG002|Maintenance Period|Lack of Efficacy|0
2245322|NCT01972568|3905509|FG000|Overall Study|Protocol Violation|1
2245323|NCT01972568|3905510|FG001|Overall Study|Protocol Violation|2
2245324|NCT01972568|3905511|FG002|Overall Study|Protocol Violation|2
2245325|NCT01972568|3905509|FG000|Overall Study|Withdrawal by Subject|6
2245326|NCT01972568|3905510|FG001|Overall Study|Withdrawal by Subject|3
2245327|NCT01972568|3905511|FG002|Overall Study|Withdrawal by Subject|7
2245328|NCT01972568|3905509|FG000|Overall Study|Lost to Follow-up|1
2245329|NCT01972568|3905510|FG001|Overall Study|Lost to Follow-up|0
2245330|NCT01972568|3905511|FG002|Overall Study|Lost to Follow-up|0
2245331|NCT01972568|3905509|FG000|Overall Study|Adverse Event|5
2245332|NCT01972568|3905510|FG001|Overall Study|Adverse Event|6
2245333|NCT01972568|3905511|FG002|Overall Study|Adverse Event|5
2245334|NCT01972659|3905521|FG000|Overall Study|Protocol Violation|2
2245335|NCT01972659|3905522|FG001|Overall Study|Protocol Violation|2
2245336|NCT01972659|3905521|FG000|Overall Study|problems realted to acceleromyograph|2
2245337|NCT01972659|3905522|FG001|Overall Study|problems realted to acceleromyograph|1
2245338|NCT01972724|3905531|FG000|Double-Blind|Rescue Criteria Met|1
2245339|NCT01972724|3905532|FG001|Double-Blind|Rescue Criteria Met|0
2245340|NCT01972724|3905533|FG002|Double-Blind|Rescue Criteria Met|0
2245341|NCT01972724|3905531|FG000|Double-Blind|Adverse Event|1
2245342|NCT01972724|3905532|FG001|Double-Blind|Adverse Event|0
2245343|NCT01972724|3905533|FG002|Double-Blind|Adverse Event|0
2245344|NCT01972724|3905531|FG000|Double-Blind|Withdrawal of Consent|2
2245345|NCT01972724|3905532|FG001|Double-Blind|Withdrawal of Consent|1
2245346|NCT01972724|3905533|FG002|Double-Blind|Withdrawal of Consent|0
2245347|NCT01972724|3905531|FG000|Double-Blind|Significant Protocol Deviation|5
2245348|NCT01972724|3905532|FG001|Double-Blind|Significant Protocol Deviation|8
2245349|NCT01972724|3905533|FG002|Double-Blind|Significant Protocol Deviation|0
2245350|NCT01972724|3905531|FG000|Open-Label|Withdrew Consent|0
2245351|NCT01972724|3905532|FG001|Open-Label|Withdrew Consent|0
2245352|NCT01972724|3905533|FG002|Open-Label|Withdrew Consent|3
2245353|NCT01972724|3905531|FG000|Open-Label|Significant Protocol Deviation|0
2245354|NCT01972724|3905532|FG001|Open-Label|Significant Protocol Deviation|0
2245355|NCT01972724|3905533|FG002|Open-Label|Significant Protocol Deviation|2
2245356|NCT01972776|3905547|FG000|Part 1|Withdrawal by Subject|0
2245357|NCT01972776|3905548|FG001|Part 1|Withdrawal by Subject|0
2245358|NCT01972776|3905549|FG002|Part 1|Withdrawal by Subject|1
2245359|NCT01972776|3905550|FG003|Part 1|Withdrawal by Subject|0
2245360|NCT01972776|3905551|FG004|Part 1|Withdrawal by Subject|0
2245361|NCT01972776|3905552|FG005|Part 1|Withdrawal by Subject|0
2245362|NCT01972776|3905547|FG000|Part 1|Adverse Event|0
2245363|NCT01972776|3905548|FG001|Part 1|Adverse Event|0
2245364|NCT01972776|3905549|FG002|Part 1|Adverse Event|1
2245365|NCT01972776|3905550|FG003|Part 1|Adverse Event|1
2245366|NCT01972776|3905551|FG004|Part 1|Adverse Event|0
2245367|NCT01972776|3905552|FG005|Part 1|Adverse Event|0
2245368|NCT01972776|3905547|FG000|Part 2|Adverse Event|0
2245369|NCT01972776|3905548|FG001|Part 2|Adverse Event|0
2245370|NCT01972776|3905549|FG002|Part 2|Adverse Event|0
2245371|NCT01972776|3905550|FG003|Part 2|Adverse Event|0
2245372|NCT01972776|3905551|FG004|Part 2|Adverse Event|3
2245373|NCT01972776|3905552|FG005|Part 2|Adverse Event|0
2245374|NCT01972776|3905547|FG000|Part 2|Administrative problems|0
2245375|NCT01972776|3905548|FG001|Part 2|Administrative problems|0
2245376|NCT01972776|3905549|FG002|Part 2|Administrative problems|0
2245377|NCT01972776|3905550|FG003|Part 2|Administrative problems|0
2245378|NCT01972776|3905551|FG004|Part 2|Administrative problems|10
2245379|NCT01972776|3905552|FG005|Part 2|Administrative problems|7
2245380|NCT01972789|3905568|FG000|Overall Study|Adverse Event|11
2245381|NCT01972789|3905569|FG001|Overall Study|Adverse Event|4
2245382|NCT01972789|3905568|FG000|Overall Study|Subject withdrew consent|14
2245383|NCT01972789|3905569|FG001|Overall Study|Subject withdrew consent|12
2245384|NCT01972789|3905568|FG000|Overall Study|Lost to Follow-up|4
2245385|NCT01972789|3905569|FG001|Overall Study|Lost to Follow-up|7
2245386|NCT01972789|3905568|FG000|Overall Study|Death|7
2245387|NCT01972789|3905569|FG001|Overall Study|Death|5
2245388|NCT01972789|3905568|FG000|Overall Study|Protocol deviation|1
2245389|NCT01972789|3905569|FG001|Overall Study|Protocol deviation|0
2245390|NCT01972789|3905568|FG000|Overall Study|Physician Decision|3
2245391|NCT01972789|3905569|FG001|Overall Study|Physician Decision|2
2245392|NCT01972841|3905581|FG000|Overall Study|Randomized but Never Received Treatment|2
2245393|NCT01972841|3905582|FG001|Overall Study|Randomized but Never Received Treatment|5
2245394|NCT01972841|3905583|FG002|Overall Study|Randomized but Never Received Treatment|4
2245395|NCT01972841|3905584|FG003|Overall Study|Randomized but Never Received Treatment|2
2245396|NCT01972841|3905585|FG004|Overall Study|Randomized but Never Received Treatment|6
2245397|NCT01972841|3905586|FG005|Overall Study|Randomized but Never Received Treatment|13
2245398|NCT01972841|3905581|FG000|Overall Study|Adverse Event|13
2245399|NCT01972841|3905582|FG001|Overall Study|Adverse Event|8
2245400|NCT01972841|3905583|FG002|Overall Study|Adverse Event|12
2245401|NCT01972841|3905584|FG003|Overall Study|Adverse Event|9
2245402|NCT01972841|3905585|FG004|Overall Study|Adverse Event|21
2245403|NCT01972841|3905586|FG005|Overall Study|Adverse Event|26
2245404|NCT01972841|3905581|FG000|Overall Study|Lack of Efficacy|1
2245405|NCT01972841|3905582|FG001|Overall Study|Lack of Efficacy|0
2245406|NCT01972841|3905583|FG002|Overall Study|Lack of Efficacy|0
2245407|NCT01972841|3905584|FG003|Overall Study|Lack of Efficacy|2
2245408|NCT01972841|3905585|FG004|Overall Study|Lack of Efficacy|4
2245409|NCT01972841|3905586|FG005|Overall Study|Lack of Efficacy|1
2245410|NCT01972841|3905581|FG000|Overall Study|Lost to Follow-up|4
2245411|NCT01972841|3905582|FG001|Overall Study|Lost to Follow-up|2
2245412|NCT01972841|3905583|FG002|Overall Study|Lost to Follow-up|4
2245413|NCT01972841|3905584|FG003|Overall Study|Lost to Follow-up|2
2245414|NCT01972841|3905585|FG004|Overall Study|Lost to Follow-up|9
2245415|NCT01972841|3905586|FG005|Overall Study|Lost to Follow-up|3
2245416|NCT01972841|3905581|FG000|Overall Study|Protocol Violation|2
2339222|NCT03364309|4068258|FG003|Maintenance Period|Lack of Efficacy|0
2339223|NCT03364309|4068259|FG004|Maintenance Period|Lack of Efficacy|0
2339224|NCT03364309|4068260|FG005|Maintenance Period|Lack of Efficacy|0
2339225|NCT03364309|4068261|FG006|Maintenance Period|Lack of Efficacy|0
2339226|NCT03364309|4068262|FG007|Maintenance Period|Lack of Efficacy|0
2339227|NCT03364309|4068263|FG008|Maintenance Period|Lack of Efficacy|1
2339228|NCT03364309|4068264|FG009|Maintenance Period|Lack of Efficacy|3
2339229|NCT03364309|4068265|FG010|Maintenance Period|Lack of Efficacy|2
2339230|NCT03364309|4068266|FG011|Maintenance Period|Lack of Efficacy|0
2339231|NCT03364309|4068267|FG012|Maintenance Period|Lack of Efficacy|0
2339232|NCT03364309|4068268|FG013|Maintenance Period|Lack of Efficacy|0
2339233|NCT03364309|4068269|FG014|Maintenance Period|Lack of Efficacy|0
2339234|NCT03364309|4068270|FG015|Maintenance Period|Lack of Efficacy|0
2339235|NCT03364309|4068271|FG016|Maintenance Period|Lack of Efficacy|0
2339236|NCT03364309|4068272|FG017|Maintenance Period|Lack of Efficacy|0
2339237|NCT03364309|4068273|FG018|Maintenance Period|Lack of Efficacy|0
2339238|NCT03364309|4068255|FG000|Maintenance Period|Death|0
2339239|NCT03364309|4068256|FG001|Maintenance Period|Death|0
2339240|NCT03364309|4068257|FG002|Maintenance Period|Death|0
2339241|NCT03364309|4068258|FG003|Maintenance Period|Death|0
2339242|NCT03364309|4068259|FG004|Maintenance Period|Death|0
2339243|NCT03364309|4068260|FG005|Maintenance Period|Death|0
2339244|NCT03364309|4068261|FG006|Maintenance Period|Death|0
2339245|NCT03364309|4068262|FG007|Maintenance Period|Death|0
2339246|NCT03364309|4068263|FG008|Maintenance Period|Death|1
2339247|NCT03364309|4068264|FG009|Maintenance Period|Death|0
2339248|NCT03364309|4068265|FG010|Maintenance Period|Death|0
2339249|NCT03364309|4068266|FG011|Maintenance Period|Death|0
2339250|NCT03364309|4068267|FG012|Maintenance Period|Death|0
2339251|NCT03364309|4068268|FG013|Maintenance Period|Death|0
2037765|NCT00420420|3608234|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1
2037766|NCT00420420|3608235|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0
2245417|NCT01972841|3905582|FG001|Overall Study|Protocol Violation|2
2245418|NCT01972841|3905583|FG002|Overall Study|Protocol Violation|3
2245419|NCT01972841|3905584|FG003|Overall Study|Protocol Violation|5
2245420|NCT01972841|3905585|FG004|Overall Study|Protocol Violation|9
2245421|NCT01972841|3905586|FG005|Overall Study|Protocol Violation|4
2245422|NCT01972841|3905581|FG000|Overall Study|Withdrawal by participants|21
2245423|NCT01972841|3905582|FG001|Overall Study|Withdrawal by participants|27
2245424|NCT01972841|3905583|FG002|Overall Study|Withdrawal by participants|23
2245425|NCT01972841|3905584|FG003|Overall Study|Withdrawal by participants|16
2245426|NCT01972841|3905585|FG004|Overall Study|Withdrawal by participants|33
2245427|NCT01972841|3905586|FG005|Overall Study|Withdrawal by participants|34
2245428|NCT01972841|3905581|FG000|Overall Study|Miscellaneous|0
2245429|NCT01972841|3905582|FG001|Overall Study|Miscellaneous|0
2245430|NCT01972841|3905583|FG002|Overall Study|Miscellaneous|4
2339252|NCT03364309|4068269|FG014|Maintenance Period|Death|0
2339253|NCT03364309|4068270|FG015|Maintenance Period|Death|0
2339254|NCT03364309|4068271|FG016|Maintenance Period|Death|0
2339255|NCT03364309|4068272|FG017|Maintenance Period|Death|0
2339256|NCT03364309|4068273|FG018|Maintenance Period|Death|0
2339257|NCT03364309|4068255|FG000|Maintenance Period|Lost to Follow-up|0
2339258|NCT03364309|4068256|FG001|Maintenance Period|Lost to Follow-up|0
2339259|NCT03364309|4068257|FG002|Maintenance Period|Lost to Follow-up|0
2339260|NCT03364309|4068258|FG003|Maintenance Period|Lost to Follow-up|0
2339261|NCT03364309|4068259|FG004|Maintenance Period|Lost to Follow-up|0
2339262|NCT03364309|4068260|FG005|Maintenance Period|Lost to Follow-up|0
2339263|NCT03364309|4068261|FG006|Maintenance Period|Lost to Follow-up|0
2339264|NCT03364309|4068262|FG007|Maintenance Period|Lost to Follow-up|0
2339265|NCT03364309|4068263|FG008|Maintenance Period|Lost to Follow-up|1
2339266|NCT03364309|4068264|FG009|Maintenance Period|Lost to Follow-up|0
2339267|NCT03364309|4068265|FG010|Maintenance Period|Lost to Follow-up|0
2339268|NCT03364309|4068266|FG011|Maintenance Period|Lost to Follow-up|0
2339269|NCT03364309|4068267|FG012|Maintenance Period|Lost to Follow-up|0
2339270|NCT03364309|4068268|FG013|Maintenance Period|Lost to Follow-up|0
2339271|NCT03364309|4068269|FG014|Maintenance Period|Lost to Follow-up|0
2339272|NCT03364309|4068270|FG015|Maintenance Period|Lost to Follow-up|0
2339273|NCT03364309|4068271|FG016|Maintenance Period|Lost to Follow-up|0
2339274|NCT03364309|4068272|FG017|Maintenance Period|Lost to Follow-up|0
2339275|NCT03364309|4068273|FG018|Maintenance Period|Lost to Follow-up|0
2339276|NCT03364309|4068255|FG000|Maintenance Period|Miscellaneous|0
2339277|NCT03364309|4068256|FG001|Maintenance Period|Miscellaneous|0
2339278|NCT03364309|4068257|FG002|Maintenance Period|Miscellaneous|0
2339279|NCT03364309|4068258|FG003|Maintenance Period|Miscellaneous|0
2339280|NCT03364309|4068259|FG004|Maintenance Period|Miscellaneous|0
2339281|NCT03364309|4068260|FG005|Maintenance Period|Miscellaneous|0
2245431|NCT01972841|3905584|FG003|Overall Study|Miscellaneous|1
2339282|NCT03364309|4068261|FG006|Maintenance Period|Miscellaneous|0
2339283|NCT03364309|4068262|FG007|Maintenance Period|Miscellaneous|0
2245432|NCT01972841|3905585|FG004|Overall Study|Miscellaneous|0
2245433|NCT01972841|3905586|FG005|Overall Study|Miscellaneous|4
2245434|NCT01972841|3905581|FG000|Overall Study|Did not have end of treatment page|0
2245435|NCT01972841|3905582|FG001|Overall Study|Did not have end of treatment page|0
2245436|NCT01972841|3905583|FG002|Overall Study|Did not have end of treatment page|0
2245437|NCT01972841|3905584|FG003|Overall Study|Did not have end of treatment page|0
2245438|NCT01972841|3905585|FG004|Overall Study|Did not have end of treatment page|1
2245439|NCT01972841|3905586|FG005|Overall Study|Did not have end of treatment page|0
2245440|NCT01973218|3905621|FG000|Overall Study|Adverse Event|1
2245441|NCT01973218|3905622|FG001|Overall Study|Adverse Event|0
2245442|NCT01973218|3905621|FG000|Overall Study|Withdrawal by Subject|1
2245443|NCT01973218|3905622|FG001|Overall Study|Withdrawal by Subject|0
2245444|NCT01973231|3905632|FG000|Overall Study|Protocol Violation|1
2245445|NCT01973231|3905633|FG001|Overall Study|Protocol Violation|1
2245446|NCT01973231|3905632|FG000|Overall Study|Lost to Follow-up|1
2245447|NCT01973231|3905633|FG001|Overall Study|Lost to Follow-up|1
2245448|NCT01973231|3905632|FG000|Overall Study|unclassified|2
2245449|NCT01973231|3905633|FG001|Overall Study|unclassified|1
2245450|NCT01973231|3905632|FG000|Overall Study|Withdrawal by Subject|7
2245451|NCT01973231|3905633|FG001|Overall Study|Withdrawal by Subject|9
2245452|NCT01973283|3905639|FG000|Overall Study|Lost to Follow-up|4
2245453|NCT01973387|3905681|FG000|Overall Study|Adverse Event|14
2245454|NCT01973387|3905682|FG001|Overall Study|Adverse Event|4
2245455|NCT01973387|3905681|FG000|Overall Study|Withdrawal by Subject|7
2245456|NCT01973387|3905682|FG001|Overall Study|Withdrawal by Subject|4
2245457|NCT01973387|3905681|FG000|Overall Study|Study terminated by sponsor|63
2245458|NCT01973387|3905682|FG001|Overall Study|Study terminated by sponsor|0
2245459|NCT01973387|3905681|FG000|Overall Study|Progressive disease or relapse|16
2339284|NCT03364309|4068263|FG008|Maintenance Period|Miscellaneous|1
2339285|NCT03364309|4068264|FG009|Maintenance Period|Miscellaneous|0
2339286|NCT03364309|4068265|FG010|Maintenance Period|Miscellaneous|0
2339287|NCT03364309|4068266|FG011|Maintenance Period|Miscellaneous|0
2339288|NCT03364309|4068267|FG012|Maintenance Period|Miscellaneous|0
2339289|NCT03364309|4068268|FG013|Maintenance Period|Miscellaneous|0
2339290|NCT03364309|4068269|FG014|Maintenance Period|Miscellaneous|0
2339291|NCT03364309|4068270|FG015|Maintenance Period|Miscellaneous|0
2339292|NCT03364309|4068271|FG016|Maintenance Period|Miscellaneous|0
2339293|NCT03364309|4068272|FG017|Maintenance Period|Miscellaneous|0
2339294|NCT03364309|4068273|FG018|Maintenance Period|Miscellaneous|0
2339295|NCT03364309|4068255|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339296|NCT03364309|4068256|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339297|NCT03364309|4068257|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339298|NCT03364309|4068258|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339299|NCT03364309|4068259|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339300|NCT03364309|4068260|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339301|NCT03364309|4068261|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339302|NCT03364309|4068262|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339303|NCT03364309|4068263|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339304|NCT03364309|4068264|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339305|NCT03364309|4068265|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339306|NCT03364309|4068266|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339307|NCT03364309|4068267|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339308|NCT03364309|4068268|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
2339309|NCT03364309|4068269|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
2339310|NCT03364309|4068270|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
2339311|NCT03364309|4068271|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339312|NCT03364309|4068272|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339313|NCT03364309|4068273|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
2339314|NCT03364309|4068255|FG000|Re-treatment (Maintenance) Period|Adverse Event|0
2339315|NCT03364309|4068256|FG001|Re-treatment (Maintenance) Period|Adverse Event|0
2339316|NCT03364309|4068257|FG002|Re-treatment (Maintenance) Period|Adverse Event|0
2339317|NCT03364309|4068258|FG003|Re-treatment (Maintenance) Period|Adverse Event|0
2339318|NCT03364309|4068259|FG004|Re-treatment (Maintenance) Period|Adverse Event|0
2339319|NCT03364309|4068260|FG005|Re-treatment (Maintenance) Period|Adverse Event|0
2339320|NCT03364309|4068261|FG006|Re-treatment (Maintenance) Period|Adverse Event|0
2339321|NCT03364309|4068262|FG007|Re-treatment (Maintenance) Period|Adverse Event|0
2339322|NCT03364309|4068263|FG008|Re-treatment (Maintenance) Period|Adverse Event|0
2339323|NCT03364309|4068264|FG009|Re-treatment (Maintenance) Period|Adverse Event|0
2339324|NCT03364309|4068265|FG010|Re-treatment (Maintenance) Period|Adverse Event|0
2339325|NCT03364309|4068266|FG011|Re-treatment (Maintenance) Period|Adverse Event|0
2339326|NCT03364309|4068267|FG012|Re-treatment (Maintenance) Period|Adverse Event|0
2339327|NCT03364309|4068268|FG013|Re-treatment (Maintenance) Period|Adverse Event|0
2339328|NCT03364309|4068269|FG014|Re-treatment (Maintenance) Period|Adverse Event|1
2339329|NCT03364309|4068270|FG015|Re-treatment (Maintenance) Period|Adverse Event|0
2339330|NCT03364309|4068271|FG016|Re-treatment (Maintenance) Period|Adverse Event|0
2339331|NCT03364309|4068272|FG017|Re-treatment (Maintenance) Period|Adverse Event|0
2339332|NCT03364309|4068273|FG018|Re-treatment (Maintenance) Period|Adverse Event|0
2339333|NCT03364309|4068255|FG000|Re-treatment (Maintenance) Period|Relapse|0
2245460|NCT01973387|3905682|FG001|Overall Study|Progressive disease or relapse|5
2245461|NCT01973387|3905681|FG000|Overall Study|Death|4
2245462|NCT01973387|3905682|FG001|Overall Study|Death|3
2245463|NCT01973387|3905681|FG000|Overall Study|Randomized, not treated|2
2245464|NCT01973387|3905682|FG001|Overall Study|Randomized, not treated|2
2245465|NCT01973439|3905698|FG000|Overall Study|Lost samples from one PK Day|2
2245466|NCT01973439|3905698|FG000|Overall Study|Vomiting after commencing once daily|1
2245467|NCT01973439|3905698|FG000|Overall Study|PK curve incomplete|2
2245468|NCT01973491|3905702|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
2245469|NCT01973491|3905702|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
2245470|NCT01973491|3905702|FG000|Treatment Period (16 Weeks)|Adverse Event|1
2245471|NCT01973569|3905709|FG000|Overall Study|Adverse Event|9
2245472|NCT01973569|3905710|FG001|Overall Study|Adverse Event|2
2245473|NCT01973569|3905711|FG002|Overall Study|Adverse Event|4
2245474|NCT01973569|3905709|FG000|Overall Study|Protocol Violation|2
2245475|NCT01973569|3905710|FG001|Overall Study|Protocol Violation|1
2245476|NCT01973569|3905711|FG002|Overall Study|Protocol Violation|3
2245477|NCT01973569|3905709|FG000|Overall Study|Withdrawal by Subject|7
2245478|NCT01973569|3905710|FG001|Overall Study|Withdrawal by Subject|5
2245479|NCT01973569|3905711|FG002|Overall Study|Withdrawal by Subject|2
2245480|NCT01973569|3905709|FG000|Overall Study|Invasive dental treatment|3
2245481|NCT01973569|3905710|FG001|Overall Study|Invasive dental treatment|5
2245482|NCT01973569|3905711|FG002|Overall Study|Invasive dental treatment|6
2245483|NCT01973569|3905709|FG000|Overall Study|Prohibited concomitant d|1
2245484|NCT01973569|3905710|FG001|Overall Study|Prohibited concomitant d|5
2245485|NCT01973569|3905711|FG002|Overall Study|Prohibited concomitant d|0
2245486|NCT01973569|3905709|FG000|Overall Study|Disease progression|0
2245487|NCT01973569|3905710|FG001|Overall Study|Disease progression|3
2245488|NCT01973569|3905711|FG002|Overall Study|Disease progression|0
2245489|NCT01973569|3905709|FG000|Overall Study|Other|1
2245490|NCT01973569|3905710|FG001|Overall Study|Other|1
2245491|NCT01973569|3905711|FG002|Overall Study|Other|0
2245492|NCT01973569|3905709|FG000|Overall Study|Did not receive study drug|6
2245493|NCT01973569|3905710|FG001|Overall Study|Did not receive study drug|3
2245494|NCT01973569|3905711|FG002|Overall Study|Did not receive study drug|3
2245495|NCT01973595|3905723|FG000|Washout|Withdrawal by Subject|1
2245496|NCT01973595|3905724|FG001|Washout|Withdrawal by Subject|0
2245497|NCT01973595|3905725|FG002|Washout|Withdrawal by Subject|1
2245498|NCT01973595|3905726|FG003|Washout|Withdrawal by Subject|0
2245499|NCT01973998|3905773|FG000|Overall Study|Death|2
2245500|NCT01973998|3905774|FG001|Overall Study|Death|2
2245501|NCT01974141|3905808|FG000|Overall Study|Other Reasons|28
2245502|NCT01974141|3905809|FG001|Overall Study|Other Reasons|18
2245503|NCT01974141|3905808|FG000|Overall Study|Protocol Violation|2
2245504|NCT01974141|3905809|FG001|Overall Study|Protocol Violation|6
2245505|NCT01974141|3905808|FG000|Overall Study|Personal Reasons|21
2245506|NCT01974141|3905809|FG001|Overall Study|Personal Reasons|20
2245507|NCT01974141|3905808|FG000|Overall Study|Lost to Follow-up|38
2245508|NCT01974141|3905809|FG001|Overall Study|Lost to Follow-up|29
2245509|NCT01974141|3905808|FG000|Overall Study|Pregnancy|3
2245510|NCT01974141|3905809|FG001|Overall Study|Pregnancy|3
2245511|NCT01974141|3905808|FG000|Overall Study|Lack of Efficacy|0
2245512|NCT01974141|3905809|FG001|Overall Study|Lack of Efficacy|1
2245513|NCT01974141|3905808|FG000|Overall Study|Adverse Event|4
2245514|NCT01974141|3905809|FG001|Overall Study|Adverse Event|5
2245515|NCT01974323|3905826|FG000|Overall Study|Other Reasons|25
2245516|NCT01974323|3905827|FG001|Overall Study|Other Reasons|28
2245517|NCT01974323|3905826|FG000|Overall Study|Protocol Violation|2
2245518|NCT01974323|3905827|FG001|Overall Study|Protocol Violation|2
2245519|NCT01974323|3905826|FG000|Overall Study|Personal Reasons|15
2245520|NCT01974323|3905827|FG001|Overall Study|Personal Reasons|19
2245521|NCT01974323|3905826|FG000|Overall Study|Lost to Follow-up|45
2245522|NCT01974323|3905827|FG001|Overall Study|Lost to Follow-up|40
2245523|NCT01974323|3905826|FG000|Overall Study|Pregnancy|2
2245524|NCT01974323|3905827|FG001|Overall Study|Pregnancy|1
2245525|NCT01974323|3905826|FG000|Overall Study|Lack of Efficacy|1
2245526|NCT01974323|3905827|FG001|Overall Study|Lack of Efficacy|1
2245527|NCT01974323|3905826|FG000|Overall Study|Adverse Event|2
2245528|NCT01974323|3905827|FG001|Overall Study|Adverse Event|2
2339334|NCT03364309|4068256|FG001|Re-treatment (Maintenance) Period|Relapse|0
2339335|NCT03364309|4068257|FG002|Re-treatment (Maintenance) Period|Relapse|0
2339336|NCT03364309|4068258|FG003|Re-treatment (Maintenance) Period|Relapse|0
2339337|NCT03364309|4068259|FG004|Re-treatment (Maintenance) Period|Relapse|0
2339338|NCT03364309|4068260|FG005|Re-treatment (Maintenance) Period|Relapse|0
2339339|NCT03364309|4068261|FG006|Re-treatment (Maintenance) Period|Relapse|0
2339340|NCT03364309|4068262|FG007|Re-treatment (Maintenance) Period|Relapse|0
2339341|NCT03364309|4068263|FG008|Re-treatment (Maintenance) Period|Relapse|0
2339342|NCT03364309|4068264|FG009|Re-treatment (Maintenance) Period|Relapse|0
2339343|NCT03364309|4068265|FG010|Re-treatment (Maintenance) Period|Relapse|0
2339344|NCT03364309|4068266|FG011|Re-treatment (Maintenance) Period|Relapse|0
2339345|NCT03364309|4068267|FG012|Re-treatment (Maintenance) Period|Relapse|1
2339346|NCT03364309|4068268|FG013|Re-treatment (Maintenance) Period|Relapse|0
2339347|NCT03364309|4068269|FG014|Re-treatment (Maintenance) Period|Relapse|0
2339348|NCT03364309|4068270|FG015|Re-treatment (Maintenance) Period|Relapse|1
2339349|NCT03364309|4068271|FG016|Re-treatment (Maintenance) Period|Relapse|0
2245529|NCT01974752|3905973|FG000|Overall Study|Death|33
2245530|NCT01974752|3905974|FG001|Overall Study|Death|11
2245531|NCT01974752|3905973|FG000|Overall Study|Lost to Follow-up|2
2245532|NCT01974752|3905974|FG001|Overall Study|Lost to Follow-up|0
2245533|NCT01974752|3905973|FG000|Overall Study|Withdrawal by Subject|2
2245534|NCT01974752|3905974|FG001|Overall Study|Withdrawal by Subject|3
2245535|NCT01974752|3905973|FG000|Overall Study|Other Eligibility Criteria|0
2245536|NCT01974752|3905974|FG001|Overall Study|Other Eligibility Criteria|1
2245537|NCT01974817|3905980|FG000|Overall Study|Death|4
2245538|NCT01974817|3905980|FG000|Overall Study|Lost to Follow-up|2
2245539|NCT01974817|3905980|FG000|Overall Study|Protocol Violation|2
2245540|NCT01974895|3905986|FG000|Overall Study|Protocol Violation|1
2245541|NCT01974895|3905987|FG001|Overall Study|Protocol Violation|0
2245542|NCT01974895|3905986|FG000|Overall Study|Lost to Follow-up|4
2245543|NCT01974895|3905987|FG001|Overall Study|Lost to Follow-up|6
2245544|NCT01974895|3905986|FG000|Overall Study|Withdrawal by Subject|0
2245545|NCT01974895|3905987|FG001|Overall Study|Withdrawal by Subject|1
2245546|NCT01974895|3905986|FG000|Overall Study|Other (Missed Visit)|1
2245547|NCT01974895|3905987|FG001|Overall Study|Other (Missed Visit)|0
2245548|NCT01974895|3905986|FG000|Overall Study|Other (Reason unknown)|9
2245549|NCT01974895|3905987|FG001|Overall Study|Other (Reason unknown)|8
2245550|NCT01975220|3906006|FG000|Test Period 1|Not treated|0
2245551|NCT01975220|3906007|FG001|Test Period 1|Not treated|1
2245552|NCT01975220|3906008|FG002|Test Period 1|Not treated|0
2245553|NCT01975220|3906009|FG003|Test Period 1|Not treated|0
2245554|NCT01975220|3906010|FG004|Test Period 1|Not treated|0
2245555|NCT01975220|3906011|FG005|Test Period 1|Not treated|0
2245556|NCT01975246|3906028|FG000|Overall Study|Adverse Event|2
2245557|NCT01975246|3906029|FG001|Overall Study|Adverse Event|1
2245558|NCT01975246|3906028|FG000|Overall Study|Lack of Efficacy|1
2245559|NCT01975246|3906029|FG001|Overall Study|Lack of Efficacy|0
2245560|NCT01975246|3906028|FG000|Overall Study|Protocol Violation|1
2245561|NCT01975246|3906029|FG001|Overall Study|Protocol Violation|0
2245562|NCT01975246|3906028|FG000|Overall Study|Other than stated|0
2245563|NCT01975246|3906029|FG001|Overall Study|Other than stated|1
2245564|NCT01975285|3906037|FG000|Overall Study|Failed Block and follow up|2
2245565|NCT01975285|3906038|FG001|Overall Study|Failed Block and follow up|2
2245566|NCT01975376|3906046|FG000|Overall Study|Adverse Event|5
2245567|NCT01975376|3906047|FG001|Overall Study|Adverse Event|5
2245568|NCT01975376|3906046|FG000|Overall Study|Death|65
2245569|NCT01975376|3906047|FG001|Overall Study|Death|72
2245570|NCT01975376|3906046|FG000|Overall Study|Lost to Follow-up|70
2245571|NCT01975376|3906047|FG001|Overall Study|Lost to Follow-up|66
2245572|NCT01975376|3906046|FG000|Overall Study|Withdrew consent|68
2245573|NCT01975376|3906047|FG001|Overall Study|Withdrew consent|62
2245574|NCT01975376|3906046|FG000|Overall Study|Other|2
2245575|NCT01975376|3906047|FG001|Overall Study|Other|4
2245576|NCT01975376|3906046|FG000|Overall Study|Randomized, Not Treated|16
2245577|NCT01975376|3906047|FG001|Overall Study|Randomized, Not Treated|8
2245578|NCT01975389|3906055|FG000|Overall Study|Adverse Event|10
2245579|NCT01975389|3906056|FG001|Overall Study|Adverse Event|6
2245580|NCT01975389|3906055|FG000|Overall Study|Death|61
2245581|NCT01975389|3906056|FG001|Overall Study|Death|54
2245582|NCT01975389|3906055|FG000|Overall Study|Lost to Follow-up|81
2245583|NCT01975389|3906056|FG001|Overall Study|Lost to Follow-up|86
2245584|NCT01975389|3906055|FG000|Overall Study|Withdrawal by Subject|90
2245585|NCT01975389|3906056|FG001|Overall Study|Withdrawal by Subject|76
2245586|NCT01975389|3906055|FG000|Overall Study|Other|6
2245587|NCT01975389|3906056|FG001|Overall Study|Other|9
2245588|NCT01975389|3906055|FG000|Overall Study|Randomized, not treated|4
2245589|NCT01975389|3906056|FG001|Overall Study|Randomized, not treated|5
2245590|NCT01975428|3906064|FG000|Overall Study|Lost to Follow-up|17
2245591|NCT01975428|3906065|FG001|Overall Study|Lost to Follow-up|4
2245592|NCT01975428|3906064|FG000|Overall Study|Withdrawal by Subject|3
2245593|NCT01975428|3906065|FG001|Overall Study|Withdrawal by Subject|10
2245594|NCT01975675|3906092|FG000|Overall Study|Death|0
2245595|NCT01975675|3906093|FG001|Overall Study|Death|1
2245596|NCT01975675|3906094|FG002|Overall Study|Death|0
2245597|NCT01975675|3906095|FG003|Overall Study|Death|0
2245598|NCT01975701|3906105|FG000|Overall Study|Lost to Follow-up|1
2245599|NCT01975701|3906105|FG000|Overall Study|Death|23
2245600|NCT01975701|3906105|FG000|Overall Study|Physician Decision|1
2245601|NCT01975831|3906118|FG000|Overall Study|Adverse Event|1
2245602|NCT01975831|3906119|FG001|Overall Study|Adverse Event|2
2245603|NCT01975831|3906120|FG002|Overall Study|Adverse Event|2
2245604|NCT01975831|3906121|FG003|Overall Study|Adverse Event|0
2245605|NCT01975831|3906122|FG004|Overall Study|Adverse Event|1
2245606|NCT01975831|3906123|FG005|Overall Study|Adverse Event|1
2245607|NCT01975831|3906124|FG006|Overall Study|Adverse Event|3
2245608|NCT01975831|3906125|FG007|Overall Study|Adverse Event|4
2245609|NCT01975831|3906126|FG008|Overall Study|Adverse Event|1
2245610|NCT01975831|3906118|FG000|Overall Study|Death|1
2245611|NCT01975831|3906119|FG001|Overall Study|Death|1
2245612|NCT01975831|3906120|FG002|Overall Study|Death|0
2245613|NCT01975831|3906121|FG003|Overall Study|Death|0
2245614|NCT01975831|3906122|FG004|Overall Study|Death|1
2245615|NCT01975831|3906123|FG005|Overall Study|Death|0
2245616|NCT01975831|3906124|FG006|Overall Study|Death|1
2245617|NCT01975831|3906125|FG007|Overall Study|Death|0
2245618|NCT01975831|3906126|FG008|Overall Study|Death|0
2245619|NCT01975831|3906118|FG000|Overall Study|Progressive Disease|1
2245620|NCT01975831|3906119|FG001|Overall Study|Progressive Disease|3
2245621|NCT01975831|3906120|FG002|Overall Study|Progressive Disease|2
2245622|NCT01975831|3906121|FG003|Overall Study|Progressive Disease|4
2245623|NCT01975831|3906122|FG004|Overall Study|Progressive Disease|13
2245624|NCT01975831|3906123|FG005|Overall Study|Progressive Disease|9
2245625|NCT01975831|3906124|FG006|Overall Study|Progressive Disease|10
2245626|NCT01975831|3906125|FG007|Overall Study|Progressive Disease|8
2245627|NCT01975831|3906126|FG008|Overall Study|Progressive Disease|10
2245628|NCT01975831|3906118|FG000|Overall Study|Withdrawal by Subject|0
2245629|NCT01975831|3906119|FG001|Overall Study|Withdrawal by Subject|3
2245630|NCT01975831|3906120|FG002|Overall Study|Withdrawal by Subject|0
2245631|NCT01975831|3906121|FG003|Overall Study|Withdrawal by Subject|0
2245632|NCT01975831|3906122|FG004|Overall Study|Withdrawal by Subject|3
2245633|NCT01975831|3906123|FG005|Overall Study|Withdrawal by Subject|1
2245634|NCT01975831|3906124|FG006|Overall Study|Withdrawal by Subject|1
2245635|NCT01975831|3906125|FG007|Overall Study|Withdrawal by Subject|0
2245636|NCT01975831|3906126|FG008|Overall Study|Withdrawal by Subject|0
2245637|NCT01975831|3906118|FG000|Overall Study|Physician Decision|0
2245638|NCT01975831|3906119|FG001|Overall Study|Physician Decision|0
2339350|NCT03364309|4068272|FG017|Re-treatment (Maintenance) Period|Relapse|0
2339351|NCT03364309|4068273|FG018|Re-treatment (Maintenance) Period|Relapse|0
2339352|NCT03364309|4068255|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0
2339353|NCT03364309|4068256|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0
2339354|NCT03364309|4068257|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0
2339355|NCT03364309|4068258|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0
2339356|NCT03364309|4068259|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
2339357|NCT03364309|4068260|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0
2339358|NCT03364309|4068261|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0
2037767|NCT00420511|3608249|FG000|Overall Study|Adverse Event|1
2037768|NCT00420511|3608250|FG001|Overall Study|Adverse Event|1
2037769|NCT00420511|3608249|FG000|Overall Study|Lost to Follow-up|1
2037770|NCT00420511|3608250|FG001|Overall Study|Lost to Follow-up|0
2037771|NCT00420628|3608260|FG000|Overall Study|Withdrawn by parent or gaurdian|5
2037772|NCT00420628|3608261|FG001|Overall Study|Withdrawn by parent or gaurdian|2
2037773|NCT00420628|3608260|FG000|Overall Study|Lost to Follow-up|3
2037774|NCT00420628|3608261|FG001|Overall Study|Lost to Follow-up|2
2037775|NCT00420628|3608260|FG000|Overall Study|Adverse Event|1
2037776|NCT00420628|3608261|FG001|Overall Study|Adverse Event|0
2037777|NCT00420641|3608270|FG000|Overall Study|Adverse Event|3
2037778|NCT00420641|3608271|FG001|Overall Study|Adverse Event|25
2037779|NCT00420641|3608272|FG002|Overall Study|Adverse Event|10
2037780|NCT00420641|3608270|FG000|Overall Study|Lost to Follow-up|2
2037781|NCT00420641|3608271|FG001|Overall Study|Lost to Follow-up|4
2037782|NCT00420641|3608272|FG002|Overall Study|Lost to Follow-up|2
2037783|NCT00420641|3608270|FG000|Overall Study|Protocol Violation|8
2037784|NCT00420641|3608271|FG001|Overall Study|Protocol Violation|8
2037785|NCT00420641|3608272|FG002|Overall Study|Protocol Violation|7
2037786|NCT00420641|3608270|FG000|Overall Study|Withdrawal by Subject|15
2245639|NCT01975831|3906120|FG002|Overall Study|Physician Decision|0
2245640|NCT01975831|3906121|FG003|Overall Study|Physician Decision|0
2245641|NCT01975831|3906122|FG004|Overall Study|Physician Decision|0
2245642|NCT01975831|3906123|FG005|Overall Study|Physician Decision|1
2245643|NCT01975831|3906124|FG006|Overall Study|Physician Decision|0
2245644|NCT01975831|3906125|FG007|Overall Study|Physician Decision|1
2245645|NCT01975831|3906126|FG008|Overall Study|Physician Decision|0
2245646|NCT01975831|3906118|FG000|Overall Study|Initiation of Subsequent Therapy|0
2245647|NCT01975831|3906119|FG001|Overall Study|Initiation of Subsequent Therapy|0
2245648|NCT01975831|3906120|FG002|Overall Study|Initiation of Subsequent Therapy|0
2245649|NCT01975831|3906121|FG003|Overall Study|Initiation of Subsequent Therapy|0
2245650|NCT01975831|3906122|FG004|Overall Study|Initiation of Subsequent Therapy|0
2245651|NCT01975831|3906123|FG005|Overall Study|Initiation of Subsequent Therapy|1
2245652|NCT01975831|3906124|FG006|Overall Study|Initiation of Subsequent Therapy|0
2245653|NCT01975831|3906125|FG007|Overall Study|Initiation of Subsequent Therapy|2
2245654|NCT01975831|3906126|FG008|Overall Study|Initiation of Subsequent Therapy|0
2245655|NCT01975831|3906118|FG000|Overall Study|Entered Hospice|0
2245656|NCT01975831|3906119|FG001|Overall Study|Entered Hospice|0
2245657|NCT01975831|3906120|FG002|Overall Study|Entered Hospice|0
2245658|NCT01975831|3906121|FG003|Overall Study|Entered Hospice|0
2245659|NCT01975831|3906122|FG004|Overall Study|Entered Hospice|0
2245660|NCT01975831|3906123|FG005|Overall Study|Entered Hospice|1
2245661|NCT01975831|3906124|FG006|Overall Study|Entered Hospice|0
2245662|NCT01975831|3906125|FG007|Overall Study|Entered Hospice|0
2245663|NCT01975831|3906126|FG008|Overall Study|Entered Hospice|0
2245664|NCT01975831|3906118|FG000|Overall Study|Unable to Treat Within Protocol Windows|0
2245665|NCT01975831|3906119|FG001|Overall Study|Unable to Treat Within Protocol Windows|0
2245666|NCT01975831|3906120|FG002|Overall Study|Unable to Treat Within Protocol Windows|0
2245667|NCT01975831|3906121|FG003|Overall Study|Unable to Treat Within Protocol Windows|0
2245668|NCT01975831|3906122|FG004|Overall Study|Unable to Treat Within Protocol Windows|0
2245669|NCT01975831|3906123|FG005|Overall Study|Unable to Treat Within Protocol Windows|0
2245670|NCT01975831|3906124|FG006|Overall Study|Unable to Treat Within Protocol Windows|1
2245671|NCT01975831|3906125|FG007|Overall Study|Unable to Treat Within Protocol Windows|0
2245672|NCT01975831|3906126|FG008|Overall Study|Unable to Treat Within Protocol Windows|1
2245673|NCT01975948|3906177|FG000|Overall Study|Withdrawal by Subject|17
2245674|NCT01975948|3906178|FG001|Overall Study|Withdrawal by Subject|21
2245675|NCT01975948|3906179|FG002|Overall Study|Withdrawal by Subject|7
2245676|NCT01975948|3906180|FG003|Overall Study|Withdrawal by Subject|6
2245677|NCT01976104|3906198|FG000|Overall Study|Adverse Event|0
2245678|NCT01976104|3906199|FG001|Overall Study|Adverse Event|0
2245679|NCT01976104|3906200|FG002|Overall Study|Adverse Event|1
2245680|NCT01976104|3906201|FG003|Overall Study|Adverse Event|0
2245681|NCT01976104|3906198|FG000|Overall Study|Lost to Follow-up|3
2245682|NCT01976104|3906199|FG001|Overall Study|Lost to Follow-up|0
2245683|NCT01976104|3906200|FG002|Overall Study|Lost to Follow-up|1
2245684|NCT01976104|3906201|FG003|Overall Study|Lost to Follow-up|1
2245685|NCT01976104|3906198|FG000|Overall Study|Subject Choice|0
2245686|NCT01976104|3906199|FG001|Overall Study|Subject Choice|1
2245687|NCT01976104|3906200|FG002|Overall Study|Subject Choice|0
2245688|NCT01976104|3906201|FG003|Overall Study|Subject Choice|1
2245689|NCT01976104|3906198|FG000|Overall Study|Withdrawal by Subject|3
2245690|NCT01976104|3906199|FG001|Overall Study|Withdrawal by Subject|0
2245691|NCT01976104|3906200|FG002|Overall Study|Withdrawal by Subject|0
2245692|NCT01976104|3906201|FG003|Overall Study|Withdrawal by Subject|1
2339359|NCT03364309|4068262|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0
2339360|NCT03364309|4068263|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0
2339361|NCT03364309|4068264|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0
2339362|NCT03364309|4068265|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0
2339363|NCT03364309|4068266|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0
2339364|NCT03364309|4068267|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0
2339365|NCT03364309|4068268|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0
2339366|NCT03364309|4068269|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0
2339367|NCT03364309|4068270|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0
2339368|NCT03364309|4068271|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3
2339369|NCT03364309|4068272|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19
2339370|NCT03364309|4068273|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1
2339371|NCT03364309|4068255|FG000|Post-Treatment Followup Period|Adverse Event|0
2339372|NCT03364309|4068256|FG001|Post-Treatment Followup Period|Adverse Event|0
2339373|NCT03364309|4068257|FG002|Post-Treatment Followup Period|Adverse Event|0
2339374|NCT03364309|4068258|FG003|Post-Treatment Followup Period|Adverse Event|0
2339375|NCT03364309|4068259|FG004|Post-Treatment Followup Period|Adverse Event|0
2339376|NCT03364309|4068260|FG005|Post-Treatment Followup Period|Adverse Event|0
2339377|NCT03364309|4068261|FG006|Post-Treatment Followup Period|Adverse Event|0
2339378|NCT03364309|4068262|FG007|Post-Treatment Followup Period|Adverse Event|0
2339379|NCT03364309|4068263|FG008|Post-Treatment Followup Period|Adverse Event|0
2339380|NCT03364309|4068264|FG009|Post-Treatment Followup Period|Adverse Event|0
2339381|NCT03364309|4068265|FG010|Post-Treatment Followup Period|Adverse Event|0
2339382|NCT03364309|4068266|FG011|Post-Treatment Followup Period|Adverse Event|0
2339383|NCT03364309|4068267|FG012|Post-Treatment Followup Period|Adverse Event|0
2339384|NCT03364309|4068268|FG013|Post-Treatment Followup Period|Adverse Event|0
2339385|NCT03364309|4068269|FG014|Post-Treatment Followup Period|Adverse Event|0
2339386|NCT03364309|4068270|FG015|Post-Treatment Followup Period|Adverse Event|0
2037787|NCT00420641|3608271|FG001|Overall Study|Withdrawal by Subject|21
2037788|NCT00420641|3608272|FG002|Overall Study|Withdrawal by Subject|14
2037789|NCT00420641|3608270|FG000|Overall Study|Lack of Efficacy|6
2037790|NCT00420641|3608271|FG001|Overall Study|Lack of Efficacy|5
2037791|NCT00420641|3608272|FG002|Overall Study|Lack of Efficacy|4
2037792|NCT00420641|3608270|FG000|Overall Study|Non-compliance|7
2037793|NCT00420641|3608271|FG001|Overall Study|Non-compliance|5
2037794|NCT00420641|3608272|FG002|Overall Study|Non-compliance|4
2037795|NCT00420641|3608270|FG000|Overall Study|Other|4
2037796|NCT00420641|3608271|FG001|Overall Study|Other|4
2037797|NCT00420641|3608272|FG002|Overall Study|Other|3
2037798|NCT00420745|3608282|FG000|Overall Study|Adverse Event|2
2037799|NCT00420745|3608283|FG001|Overall Study|Adverse Event|2
2037800|NCT00420745|3608282|FG000|Overall Study|Lost to Follow-up|10
2037801|NCT00420745|3608283|FG001|Overall Study|Lost to Follow-up|2
2037802|NCT00420745|3608282|FG000|Overall Study|Protocol Violation|1
2037803|NCT00420745|3608283|FG001|Overall Study|Protocol Violation|0
2037804|NCT00420745|3608282|FG000|Overall Study|Physician Decision|1
2037805|NCT00420745|3608283|FG001|Overall Study|Physician Decision|1
2037806|NCT00420745|3608282|FG000|Overall Study|Recurrent pneumonia & bronchitis|0
2037807|NCT00420745|3608283|FG001|Overall Study|Recurrent pneumonia & bronchitis|1
2037808|NCT00420745|3608282|FG000|Overall Study|Age limit exceeded for Dose 2|1
2037809|NCT00420745|3608283|FG001|Overall Study|Age limit exceeded for Dose 2|0
2037810|NCT00420784|3608302|FG000|Overall Study|Adverse Event|11
2037811|NCT00420784|3608303|FG001|Overall Study|Adverse Event|29
2037812|NCT00420784|3608304|FG002|Overall Study|Adverse Event|10
2037813|NCT00420784|3608305|FG003|Overall Study|Adverse Event|5
2037814|NCT00420784|3608302|FG000|Overall Study|Withdrawal by Subject|0
2245693|NCT01976104|3906198|FG000|Overall Study|Other|0
2245694|NCT01976104|3906199|FG001|Overall Study|Other|1
2245695|NCT01976104|3906200|FG002|Overall Study|Other|0
2245696|NCT01976104|3906201|FG003|Overall Study|Other|0
2245697|NCT01976299|3906214|FG000|Overall Study|Withdrawal by Subject|3
2245698|NCT01976299|3906215|FG001|Overall Study|Withdrawal by Subject|1
2245699|NCT01976299|3906214|FG000|Overall Study|Death|4
2245700|NCT01976299|3906215|FG001|Overall Study|Death|2
2245701|NCT01976299|3906214|FG000|Overall Study|Lost to Follow-up|7
2245702|NCT01976299|3906215|FG001|Overall Study|Lost to Follow-up|1
2245703|NCT01976299|3906214|FG000|Overall Study|See clarification above in comments|9
2245704|NCT01976299|3906215|FG001|Overall Study|See clarification above in comments|2
2245705|NCT01976312|3906223|FG000|Overall Study|Pregnancy|0
2245706|NCT01976312|3906224|FG001|Overall Study|Pregnancy|1
2245707|NCT01976312|3906223|FG000|Overall Study|Lost to Follow-up|2
2245708|NCT01976312|3906224|FG001|Overall Study|Lost to Follow-up|0
2245709|NCT01976312|3906223|FG000|Overall Study|Withdrawal by Subject|7
2245710|NCT01976312|3906224|FG001|Overall Study|Withdrawal by Subject|2
2245711|NCT01976312|3906223|FG000|Overall Study|Adverse Event|6
2245712|NCT01976312|3906224|FG001|Overall Study|Adverse Event|6
2245713|NCT01976312|3906223|FG000|Overall Study|Protocol Violation|2
2245714|NCT01976312|3906224|FG001|Overall Study|Protocol Violation|0
2245715|NCT01976338|3906233|FG000|Overall Study|Physician Decision|0
2245716|NCT01976338|3906234|FG001|Overall Study|Physician Decision|1
2245717|NCT01976338|3906233|FG000|Overall Study|Lost to Follow-up|3
2245718|NCT01976338|3906234|FG001|Overall Study|Lost to Follow-up|0
2245719|NCT01976338|3906233|FG000|Overall Study|Withdrawal by Subject|5
2245720|NCT01976338|3906234|FG001|Overall Study|Withdrawal by Subject|2
2245721|NCT01976338|3906233|FG000|Overall Study|Adverse Event|5
2245722|NCT01976338|3906234|FG001|Overall Study|Adverse Event|1
2245723|NCT01976364|3906241|FG000|Main Study (36 Months)|Adverse Event|63
2245724|NCT01976364|3906242|FG001|Main Study (36 Months)|Adverse Event|0
2245725|NCT01976364|3906243|FG002|Main Study (36 Months)|Adverse Event|0
2245726|NCT01976364|3906241|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5
2245727|NCT01976364|3906242|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0
2245728|NCT01976364|3906243|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0
2245729|NCT01976364|3906241|FG000|Main Study (36 Months)|Other|13
2245730|NCT01976364|3906242|FG001|Main Study (36 Months)|Other|0
2245731|NCT01976364|3906243|FG002|Main Study (36 Months)|Other|0
2245732|NCT01976364|3906241|FG000|Main Study (36 Months)|No longer met eligibility criteria|2
2245733|NCT01976364|3906242|FG001|Main Study (36 Months)|No longer met eligibility criteria|0
2245734|NCT01976364|3906243|FG002|Main Study (36 Months)|No longer met eligibility criteria|0
2245735|NCT01976364|3906241|FG000|Main Study (36 Months)|Medication error|1
2245736|NCT01976364|3906242|FG001|Main Study (36 Months)|Medication error|0
2245737|NCT01976364|3906243|FG002|Main Study (36 Months)|Medication error|0
2245738|NCT01976364|3906241|FG000|Main Study (36 Months)|Lost to Follow-up|10
2245739|NCT01976364|3906242|FG001|Main Study (36 Months)|Lost to Follow-up|0
2245740|NCT01976364|3906243|FG002|Main Study (36 Months)|Lost to Follow-up|0
2245741|NCT01976364|3906241|FG000|Main Study (36 Months)|Lack of Efficacy|40
2245742|NCT01976364|3906242|FG001|Main Study (36 Months)|Lack of Efficacy|0
2245743|NCT01976364|3906243|FG002|Main Study (36 Months)|Lack of Efficacy|0
2245744|NCT01976364|3906241|FG000|Main Study (36 Months)|Protocol Violation|13
2245745|NCT01976364|3906242|FG001|Main Study (36 Months)|Protocol Violation|0
2245746|NCT01976364|3906243|FG002|Main Study (36 Months)|Protocol Violation|0
2245747|NCT01976364|3906241|FG000|Main Study (36 Months)|Withdrawal by Subject|69
2245748|NCT01976364|3906242|FG001|Main Study (36 Months)|Withdrawal by Subject|0
2245749|NCT01976364|3906243|FG002|Main Study (36 Months)|Withdrawal by Subject|0
2245750|NCT01976364|3906241|FG000|Main Study (36 Months)|Death|5
2245751|NCT01976364|3906242|FG001|Main Study (36 Months)|Death|0
2245752|NCT01976364|3906243|FG002|Main Study (36 Months)|Death|0
2245753|NCT01976364|3906241|FG000|Sub-study (12 Months)|Lost to Follow-up|0
2245754|NCT01976364|3906242|FG001|Sub-study (12 Months)|Lost to Follow-up|1
2245755|NCT01976364|3906243|FG002|Sub-study (12 Months)|Lost to Follow-up|0
2245756|NCT01976364|3906241|FG000|Sub-study (12 Months)|Withdrawal by Subject|0
2245757|NCT01976364|3906242|FG001|Sub-study (12 Months)|Withdrawal by Subject|0
2245758|NCT01976364|3906243|FG002|Sub-study (12 Months)|Withdrawal by Subject|1
2245759|NCT01976364|3906241|FG000|Sub-study (12 Months)|Protocol Violation|0
2245760|NCT01976364|3906242|FG001|Sub-study (12 Months)|Protocol Violation|1
2245761|NCT01976364|3906243|FG002|Sub-study (12 Months)|Protocol Violation|1
2245762|NCT01976364|3906241|FG000|Sub-study (12 Months)|Adverse Event|0
2245763|NCT01976364|3906242|FG001|Sub-study (12 Months)|Adverse Event|4
2245764|NCT01976364|3906243|FG002|Sub-study (12 Months)|Adverse Event|3
2245765|NCT01976507|3906279|FG000|Overall Study|Adverse Event|6
2245766|NCT01976507|3906279|FG000|Overall Study|ablation not done, drug not given|1
2245767|NCT01976624|3906294|FG000|Overall Study|Participants contraindicated|2
2245768|NCT01976624|3906294|FG000|Overall Study|Participants age less than 19 years|12
2245769|NCT01976663|3906302|FG000|Overall Study|Completed 18 mos but no repeat treatment|24
2245770|NCT01976663|3906302|FG000|Overall Study|Personal Reasons|6
2245771|NCT01976663|3906302|FG000|Overall Study|Withdrawal by Subject|4
2245772|NCT01976663|3906302|FG000|Overall Study|Screen Failure|3
2245773|NCT01976663|3906302|FG000|Overall Study|Adverse Event|2
2245774|NCT01976663|3906302|FG000|Overall Study|Lost to Follow-up|3
2245775|NCT01976728|3906314|FG000|Overall Study|Subject missed multiple doses of IMP|1
2245776|NCT01976728|3906315|FG001|Overall Study|Subject missed multiple doses of IMP|0
2245777|NCT01976728|3906316|FG002|Overall Study|Subject missed multiple doses of IMP|0
2245778|NCT01976728|3906317|FG003|Overall Study|Subject missed multiple doses of IMP|0
2245779|NCT01976741|3906353|FG000|Overall Study|Withdrawal by Subject|1
2245780|NCT01976741|3906354|FG001|Overall Study|Withdrawal by Subject|0
2245781|NCT01976741|3906355|FG002|Overall Study|Withdrawal by Subject|1
2245782|NCT01976741|3906356|FG003|Overall Study|Withdrawal by Subject|1
2245783|NCT01976741|3906357|FG004|Overall Study|Withdrawal by Subject|0
2245784|NCT01976741|3906358|FG005|Overall Study|Withdrawal by Subject|0
2245785|NCT01976741|3906359|FG006|Overall Study|Withdrawal by Subject|1
2245786|NCT01976741|3906360|FG007|Overall Study|Withdrawal by Subject|4
2245787|NCT01976741|3906361|FG008|Overall Study|Withdrawal by Subject|0
2245788|NCT01976741|3906362|FG009|Overall Study|Withdrawal by Subject|0
2245789|NCT01976741|3906353|FG000|Overall Study|Adverse Event|0
2245790|NCT01976741|3906354|FG001|Overall Study|Adverse Event|0
2245791|NCT01976741|3906355|FG002|Overall Study|Adverse Event|2
2245792|NCT01976741|3906356|FG003|Overall Study|Adverse Event|0
2245793|NCT01976741|3906357|FG004|Overall Study|Adverse Event|0
2245794|NCT01976741|3906358|FG005|Overall Study|Adverse Event|0
2245795|NCT01976741|3906359|FG006|Overall Study|Adverse Event|3
2245796|NCT01976741|3906360|FG007|Overall Study|Adverse Event|8
2245797|NCT01976741|3906361|FG008|Overall Study|Adverse Event|1
2245798|NCT01976741|3906362|FG009|Overall Study|Adverse Event|4
2245799|NCT01976806|3906398|FG000|Overall Study|Lost to Follow-up|1
2245800|NCT01976806|3906399|FG001|Overall Study|Lost to Follow-up|4
2245801|NCT01976806|3906398|FG000|Overall Study|Adverse Event|1
2245802|NCT01976806|3906399|FG001|Overall Study|Adverse Event|1
2245803|NCT01976806|3906398|FG000|Overall Study|Withdrawal by Subject|1
2245804|NCT01976806|3906399|FG001|Overall Study|Withdrawal by Subject|1
2245805|NCT01976845|3906417|FG000|Overall Study|Physician Decision|8
2245806|NCT01976845|3906418|FG001|Overall Study|Physician Decision|8
2245807|NCT01976845|3906419|FG002|Overall Study|Physician Decision|3
2245808|NCT01977040|3906451|FG000|Overall Study|Vasa previa not confirmed|2
2245809|NCT01977092|3906461|FG000|Overall Study|Death|3
2245810|NCT01977092|3906462|FG001|Overall Study|Death|4
2245811|NCT01977092|3906461|FG000|Overall Study|Lost to Follow-up|23
2245812|NCT01977092|3906462|FG001|Overall Study|Lost to Follow-up|14
2245813|NCT01977092|3906461|FG000|Overall Study|Withdrawal by Subject|2
2245814|NCT01977092|3906462|FG001|Overall Study|Withdrawal by Subject|1
2245815|NCT01977092|3906461|FG000|Overall Study|In prison|3
2245816|NCT01977092|3906462|FG001|Overall Study|In prison|11
2245817|NCT01977222|3906468|FG000|Overall Study|Withdrawal by Subject|1
2245818|NCT01977352|3906474|FG000|Overall Study|Lost to Follow-up|1
2245819|NCT01977352|3906475|FG001|Overall Study|Lost to Follow-up|2
2245820|NCT01977456|3906481|FG000|Overall Study|Death|5
2245821|NCT01977482|3906491|FG000|Overall Study|Adverse Event|0
2245822|NCT01977482|3906492|FG001|Overall Study|Adverse Event|1
2245823|NCT01977482|3906493|FG002|Overall Study|Adverse Event|1
2245824|NCT01977482|3906494|FG003|Overall Study|Adverse Event|0
2245825|NCT01977482|3906495|FG004|Overall Study|Adverse Event|2
2245826|NCT01977482|3906496|FG005|Overall Study|Adverse Event|0
2245827|NCT01977482|3906491|FG000|Overall Study|Lost to Follow-up|1
2245828|NCT01977482|3906492|FG001|Overall Study|Lost to Follow-up|0
2245829|NCT01977482|3906493|FG002|Overall Study|Lost to Follow-up|0
2245830|NCT01977482|3906494|FG003|Overall Study|Lost to Follow-up|0
2245831|NCT01977482|3906495|FG004|Overall Study|Lost to Follow-up|0
2245832|NCT01977482|3906496|FG005|Overall Study|Lost to Follow-up|0
2245833|NCT01977482|3906491|FG000|Overall Study|Physician Decision|0
2245834|NCT01977482|3906492|FG001|Overall Study|Physician Decision|1
2245835|NCT01977482|3906493|FG002|Overall Study|Physician Decision|0
2245836|NCT01977482|3906494|FG003|Overall Study|Physician Decision|0
2245837|NCT01977482|3906495|FG004|Overall Study|Physician Decision|0
2245838|NCT01977482|3906496|FG005|Overall Study|Physician Decision|0
2245839|NCT01977482|3906491|FG000|Overall Study|Protocol Violation|0
2245840|NCT01977482|3906492|FG001|Overall Study|Protocol Violation|0
2245841|NCT01977482|3906493|FG002|Overall Study|Protocol Violation|1
2245842|NCT01977482|3906494|FG003|Overall Study|Protocol Violation|0
2245843|NCT01977482|3906495|FG004|Overall Study|Protocol Violation|0
2245844|NCT01977482|3906496|FG005|Overall Study|Protocol Violation|0
2339387|NCT03364309|4068271|FG016|Post-Treatment Followup Period|Adverse Event|2
2339388|NCT03364309|4068272|FG017|Post-Treatment Followup Period|Adverse Event|6
2339389|NCT03364309|4068273|FG018|Post-Treatment Followup Period|Adverse Event|1
2339390|NCT03364309|4068255|FG000|Post-Treatment Followup Period|Lost to Follow-up|0
2339391|NCT03364309|4068256|FG001|Post-Treatment Followup Period|Lost to Follow-up|0
2339392|NCT03364309|4068257|FG002|Post-Treatment Followup Period|Lost to Follow-up|0
2339393|NCT03364309|4068258|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
2339394|NCT03364309|4068259|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
2339395|NCT03364309|4068260|FG005|Post-Treatment Followup Period|Lost to Follow-up|0
2339396|NCT03364309|4068261|FG006|Post-Treatment Followup Period|Lost to Follow-up|0
2339397|NCT03364309|4068262|FG007|Post-Treatment Followup Period|Lost to Follow-up|0
2339398|NCT03364309|4068263|FG008|Post-Treatment Followup Period|Lost to Follow-up|0
2339399|NCT03364309|4068264|FG009|Post-Treatment Followup Period|Lost to Follow-up|0
2339400|NCT03364309|4068265|FG010|Post-Treatment Followup Period|Lost to Follow-up|0
2339401|NCT03364309|4068266|FG011|Post-Treatment Followup Period|Lost to Follow-up|0
2245845|NCT01977482|3906491|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0
2245846|NCT01977482|3906492|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3
2245847|NCT01977482|3906493|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2
2245848|NCT01977482|3906494|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1
2245849|NCT01977482|3906495|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0
2245850|NCT01977482|3906496|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0
2245851|NCT01977482|3906491|FG000|Overall Study|Withdrawal by Subject|2
2245852|NCT01977482|3906492|FG001|Overall Study|Withdrawal by Subject|4
2245853|NCT01977482|3906493|FG002|Overall Study|Withdrawal by Subject|1
2245854|NCT01977482|3906494|FG003|Overall Study|Withdrawal by Subject|3
2245855|NCT01977482|3906495|FG004|Overall Study|Withdrawal by Subject|1
2245856|NCT01977482|3906496|FG005|Overall Study|Withdrawal by Subject|5
2245857|NCT01977573|3906528|FG000|Overall Study|Adverse Event|7
2245858|NCT01977573|3906529|FG001|Overall Study|Adverse Event|0
2245859|NCT01977573|3906530|FG002|Overall Study|Adverse Event|2
2245860|NCT01977573|3906531|FG003|Overall Study|Adverse Event|1
2245861|NCT01977573|3906528|FG000|Overall Study|Lost to Follow-up|1
2245862|NCT01977573|3906529|FG001|Overall Study|Lost to Follow-up|0
2245863|NCT01977573|3906530|FG002|Overall Study|Lost to Follow-up|0
2245864|NCT01977573|3906531|FG003|Overall Study|Lost to Follow-up|1
2245865|NCT01977573|3906528|FG000|Overall Study|Physician Decision|1
2245866|NCT01977573|3906529|FG001|Overall Study|Physician Decision|0
2245867|NCT01977573|3906530|FG002|Overall Study|Physician Decision|0
2245868|NCT01977573|3906531|FG003|Overall Study|Physician Decision|0
2245869|NCT01977573|3906528|FG000|Overall Study|Protocol Violation|3
2245870|NCT01977573|3906529|FG001|Overall Study|Protocol Violation|1
2245871|NCT01977573|3906530|FG002|Overall Study|Protocol Violation|0
2245872|NCT01977573|3906531|FG003|Overall Study|Protocol Violation|0
2245873|NCT01977573|3906528|FG000|Overall Study|Reached Defined Stopping Criteria|2
2245874|NCT01977573|3906529|FG001|Overall Study|Reached Defined Stopping Criteria|1
2245875|NCT01977573|3906530|FG002|Overall Study|Reached Defined Stopping Criteria|1
2245876|NCT01977573|3906531|FG003|Overall Study|Reached Defined Stopping Criteria|0
2245877|NCT01977573|3906528|FG000|Overall Study|Withdrawal by Subject|6
2245878|NCT01977573|3906529|FG001|Overall Study|Withdrawal by Subject|1
2245879|NCT01977573|3906530|FG002|Overall Study|Withdrawal by Subject|1
2245880|NCT01977573|3906531|FG003|Overall Study|Withdrawal by Subject|1
2245881|NCT01977612|3906553|FG000|Overall Study|Lost to Follow-up|1
2245882|NCT01977612|3906554|FG001|Overall Study|Lost to Follow-up|1
2245883|NCT01977625|3906560|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3
2245884|NCT01977625|3906561|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0
2245885|NCT01977625|3906560|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2245886|NCT01977625|3906561|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
2245887|NCT01977651|3906569|FG000|4 Month Treatment Period|Adverse Event|34
2245888|NCT01977651|3906569|FG000|4 Month Treatment Period|Death|3
2245889|NCT01977651|3906569|FG000|4 Month Treatment Period|Progressive Disease|43
2245890|NCT01977651|3906569|FG000|4 Month Treatment Period|Withdrawal by Subject|17
2245891|NCT01977651|3906569|FG000|4 Month Treatment Period|Physician Decision|4
2245892|NCT01977651|3906569|FG000|1 Year Extension Period|Adverse Event|14
2245893|NCT01977651|3906569|FG000|1 Year Extension Period|Death|10
2245894|NCT01977651|3906569|FG000|1 Year Extension Period|Lost to Follow-up|2
2245895|NCT01977651|3906569|FG000|1 Year Extension Period|Progressive Disease|86
2245896|NCT01977651|3906569|FG000|1 Year Extension Period|Withdrawal by Subject|11
2245897|NCT01977651|3906569|FG000|1 Year Extension Period|Physician Decision|6
2245898|NCT01977651|3906569|FG000|1 Year Extension Period|Miscellaneous|1
2245899|NCT01977651|3906569|FG000|Post 1 Year Extension Period|Adverse Event|5
2245900|NCT01977651|3906569|FG000|Post 1 Year Extension Period|Death|13
2245901|NCT01977651|3906569|FG000|Post 1 Year Extension Period|Progressive Disease|60
2245902|NCT01977651|3906569|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13
2245903|NCT01977651|3906569|FG000|Post 1 Year Extension Period|Physician Decision|4
2245904|NCT01977651|3906569|FG000|Post 1 Year Extension Period|Miscellaneous|49
2245905|NCT01977677|3906576|FG000|Overall Study|Unrelated Adverse Event|0
2245906|NCT01977677|3906577|FG001|Overall Study|Unrelated Adverse Event|0
2245907|NCT01977677|3906578|FG002|Overall Study|Unrelated Adverse Event|1
2245908|NCT01977690|3906588|FG000|Overall Study|Withdrawal by Subject|0
2245909|NCT01977690|3906589|FG001|Overall Study|Withdrawal by Subject|4
2245910|NCT01977794|3906606|FG000|Overall Study|Adverse Event|2
2245911|NCT01977794|3906607|FG001|Overall Study|Adverse Event|2
2245912|NCT01977794|3906606|FG000|Overall Study|Lost to Follow-up|2
2245913|NCT01977794|3906607|FG001|Overall Study|Lost to Follow-up|1
2245914|NCT01977794|3906606|FG000|Overall Study|Protocol Violation|1
2245915|NCT01977794|3906607|FG001|Overall Study|Protocol Violation|0
2245916|NCT01977794|3906606|FG000|Overall Study|Death|1
2245917|NCT01977794|3906607|FG001|Overall Study|Death|1
2245918|NCT01977794|3906606|FG000|Overall Study|Withdrew consent|2
2245919|NCT01977794|3906607|FG001|Overall Study|Withdrew consent|1
2245920|NCT01977794|3906606|FG000|Overall Study|Other|0
2245921|NCT01977794|3906607|FG001|Overall Study|Other|1
2245922|NCT01977820|3906615|FG000|Overall Study|Sponsor terminated the study|1
2339402|NCT03364309|4068267|FG012|Post-Treatment Followup Period|Lost to Follow-up|0
2339403|NCT03364309|4068268|FG013|Post-Treatment Followup Period|Lost to Follow-up|0
2339404|NCT03364309|4068269|FG014|Post-Treatment Followup Period|Lost to Follow-up|0
2339405|NCT03364309|4068270|FG015|Post-Treatment Followup Period|Lost to Follow-up|0
2245923|NCT01977820|3906616|FG001|Overall Study|Sponsor terminated the study|1
2245924|NCT01977846|3906624|FG000|Total Study - Prospective|Death|0
2245925|NCT01977846|3906625|FG001|Total Study - Prospective|Death|1
2245926|NCT01977846|3906624|FG000|Total Study - Prospective|Lost to Follow-up|0
2245927|NCT01977846|3906625|FG001|Total Study - Prospective|Lost to Follow-up|8
2245928|NCT01977846|3906624|FG000|Total Study - Prospective|Withdrawal by Subject|0
2245929|NCT01977846|3906625|FG001|Total Study - Prospective|Withdrawal by Subject|13
2245930|NCT01977846|3906624|FG000|Total Study - Prospective|Not available at time of visit|0
2245931|NCT01977846|3906625|FG001|Total Study - Prospective|Not available at time of visit|5
2245932|NCT01977846|3906624|FG000|Total Study - Prospective|No show|0
2245933|NCT01977846|3906625|FG001|Total Study - Prospective|No show|1
2245934|NCT01977846|3906624|FG000|Total Study - Prospective|Protocol Violation|0
2245935|NCT01977846|3906625|FG001|Total Study - Prospective|Protocol Violation|1
2245936|NCT01977898|3906634|FG000|Overall Study|Non functioning catheter|1
2245937|NCT01977898|3906635|FG001|Overall Study|Non functioning catheter|1
2245938|NCT01977937|3906643|FG000|Overall Study|Withdrawal by Subject|2
2245939|NCT01977937|3906644|FG001|Overall Study|Withdrawal by Subject|1
2245940|NCT01977937|3906643|FG000|Overall Study|Adverse Event|1
2245941|NCT01977937|3906644|FG001|Overall Study|Adverse Event|0
2245942|NCT01977937|3906643|FG000|Overall Study|Physician Decision|0
2245943|NCT01977937|3906644|FG001|Overall Study|Physician Decision|1
2245944|NCT01978093|3906652|FG000|Overall Study|Death|1
2245945|NCT01978093|3906653|FG001|Overall Study|Death|0
2245946|NCT01978093|3906652|FG000|Overall Study|Adverse Event|0
2245947|NCT01978093|3906653|FG001|Overall Study|Adverse Event|5
2245948|NCT01978093|3906652|FG000|Overall Study|Protocol Violation|8
2245949|NCT01978093|3906653|FG001|Overall Study|Protocol Violation|2
2245950|NCT01978093|3906652|FG000|Overall Study|Withdrawal by Subject|29
2245951|NCT01978093|3906653|FG001|Overall Study|Withdrawal by Subject|25
2245952|NCT01978093|3906652|FG000|Overall Study|Lost to Follow-up|11
2245953|NCT01978093|3906653|FG001|Overall Study|Lost to Follow-up|15
2245954|NCT01978093|3906652|FG000|Overall Study|Migrated/moved from study area|11
2245955|NCT01978093|3906653|FG001|Overall Study|Migrated/moved from study area|13
2245956|NCT01978093|3906652|FG000|Overall Study|Loss of kaiser coverage|4
2245957|NCT01978093|3906653|FG001|Overall Study|Loss of kaiser coverage|10
2245958|NCT01978093|3906652|FG000|Overall Study|Lost kaiser health plan unable to contac|1
2245959|NCT01978093|3906653|FG001|Overall Study|Lost kaiser health plan unable to contac|0
2245960|NCT01978093|3906652|FG000|Overall Study|Mother lost custody of child|0
2245961|NCT01978093|3906653|FG001|Overall Study|Mother lost custody of child|1
2245962|NCT01978093|3906652|FG000|Overall Study|Child was in care of grandmother|0
2245963|NCT01978093|3906653|FG001|Overall Study|Child was in care of grandmother|1
2245964|NCT01978093|3906652|FG000|Overall Study|N/A for vaccine administration|0
2245965|NCT01978093|3906653|FG001|Overall Study|N/A for vaccine administration|1
2245966|NCT01978119|3906662|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
2245967|NCT01978119|3906663|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
2245968|NCT01978119|3906662|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2245969|NCT01978119|3906663|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2245970|NCT01978119|3906662|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2245971|NCT01978119|3906663|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
2245972|NCT01978145|3906669|FG000|Treatment Period 1|Adverse Event|1
2245973|NCT01978145|3906670|FG001|Treatment Period 1|Adverse Event|9
2245974|NCT01978145|3906669|FG000|Treatment Period 1|Physician Decision|1
2245975|NCT01978145|3906670|FG001|Treatment Period 1|Physician Decision|0
2245976|NCT01978145|3906669|FG000|Treatment Period 1|Withdrawal by Subject|5
2245977|NCT01978145|3906670|FG001|Treatment Period 1|Withdrawal by Subject|4
2245978|NCT01978145|3906669|FG000|Treatment Period 1|Par. reached defined stopping criteria|2
2245979|NCT01978145|3906670|FG001|Treatment Period 1|Par. reached defined stopping criteria|3
2245980|NCT01978145|3906669|FG000|Washout Period 1|Adverse Event|0
2245981|NCT01978145|3906670|FG001|Washout Period 1|Adverse Event|1
2245982|NCT01978145|3906669|FG000|Washout Period 1|Withdrawal by Subject|1
2245983|NCT01978145|3906670|FG001|Washout Period 1|Withdrawal by Subject|1
2245984|NCT01978145|3906669|FG000|Washout Period 1|Par. reached defined stopping criteria|0
2245985|NCT01978145|3906670|FG001|Washout Period 1|Par. reached defined stopping criteria|1
2339406|NCT03364309|4068271|FG016|Post-Treatment Followup Period|Lost to Follow-up|0
2339407|NCT03364309|4068272|FG017|Post-Treatment Followup Period|Lost to Follow-up|2
2339408|NCT03364309|4068273|FG018|Post-Treatment Followup Period|Lost to Follow-up|0
2339409|NCT03364309|4068255|FG000|Post-Treatment Followup Period|Miscellaneous|0
2339410|NCT03364309|4068256|FG001|Post-Treatment Followup Period|Miscellaneous|0
2339411|NCT03364309|4068257|FG002|Post-Treatment Followup Period|Miscellaneous|0
2339412|NCT03364309|4068258|FG003|Post-Treatment Followup Period|Miscellaneous|0
2339413|NCT03364309|4068259|FG004|Post-Treatment Followup Period|Miscellaneous|0
2339414|NCT03364309|4068260|FG005|Post-Treatment Followup Period|Miscellaneous|0
2339415|NCT03364309|4068261|FG006|Post-Treatment Followup Period|Miscellaneous|0
2339416|NCT03364309|4068262|FG007|Post-Treatment Followup Period|Miscellaneous|0
2339417|NCT03364309|4068263|FG008|Post-Treatment Followup Period|Miscellaneous|0
2339418|NCT03364309|4068264|FG009|Post-Treatment Followup Period|Miscellaneous|0
2339419|NCT03364309|4068265|FG010|Post-Treatment Followup Period|Miscellaneous|0
2339420|NCT03364309|4068266|FG011|Post-Treatment Followup Period|Miscellaneous|0
2245986|NCT01978145|3906669|FG000|Treatment Period 2|Adverse Event|3
2245987|NCT01978145|3906670|FG001|Treatment Period 2|Adverse Event|3
2245988|NCT01978145|3906669|FG000|Treatment Period 2|Protocol Violation|0
2245989|NCT01978145|3906670|FG001|Treatment Period 2|Protocol Violation|1
2245990|NCT01978145|3906669|FG000|Treatment Period 2|Lost to Follow-up|1
2245991|NCT01978145|3906670|FG001|Treatment Period 2|Lost to Follow-up|1
2245992|NCT01978145|3906669|FG000|Treatment Period 2|Withdrawal by Subject|7
2245993|NCT01978145|3906670|FG001|Treatment Period 2|Withdrawal by Subject|4
2245994|NCT01978145|3906669|FG000|Treatment Period 2|Par. reached defined stopping criteria|8
2245995|NCT01978145|3906670|FG001|Treatment Period 2|Par. reached defined stopping criteria|5
2245996|NCT01978184|3906678|FG000|Overall Study|Progressive disease|5
2245997|NCT01978184|3906679|FG001|Overall Study|Progressive disease|5
2245998|NCT01978184|3906678|FG000|Overall Study|Other than PDA|2
2245999|NCT01978184|3906679|FG001|Overall Study|Other than PDA|2
2246000|NCT01978184|3906678|FG000|Overall Study|Physician Decision|0
2246001|NCT01978184|3906679|FG001|Overall Study|Physician Decision|3
2246002|NCT01978184|3906678|FG000|Overall Study|Noncompliance|1
2246003|NCT01978184|3906679|FG001|Overall Study|Noncompliance|2
2246004|NCT01978184|3906678|FG000|Overall Study|Death|1
2246005|NCT01978184|3906679|FG001|Overall Study|Death|0
2246006|NCT01978184|3906678|FG000|Overall Study|Withdrew- toxicities or physical decline|4
2246007|NCT01978184|3906679|FG001|Overall Study|Withdrew- toxicities or physical decline|8
2246008|NCT01978236|3906685|FG000|Overall Study|Discontinued due to study close|2
2246009|NCT01978262|3906689|FG000|Overall Study|Withdrawal by Subject|9
2246010|NCT01978262|3906689|FG000|Overall Study|Lost to Follow-up|2
2246011|NCT01978912|3906757|FG000|Overall Study|Adverse Event|0
2246012|NCT01978912|3906758|FG001|Overall Study|Adverse Event|1
2246013|NCT01978912|3906759|FG002|Overall Study|Adverse Event|0
2246014|NCT01978912|3906760|FG003|Overall Study|Adverse Event|0
2246015|NCT01978912|3906757|FG000|Overall Study|Lost to Follow-up|1
2246016|NCT01978912|3906758|FG001|Overall Study|Lost to Follow-up|1
2246017|NCT01978912|3906759|FG002|Overall Study|Lost to Follow-up|0
2246018|NCT01978912|3906760|FG003|Overall Study|Lost to Follow-up|1
2246019|NCT01978912|3906757|FG000|Overall Study|Withdrawal by Subject|1
2246020|NCT01978912|3906758|FG001|Overall Study|Withdrawal by Subject|0
2246021|NCT01978912|3906759|FG002|Overall Study|Withdrawal by Subject|2
2246022|NCT01978912|3906760|FG003|Overall Study|Withdrawal by Subject|2
2246023|NCT01978912|3906757|FG000|Overall Study|Lumbar Surgery|1
2246024|NCT01978912|3906758|FG001|Overall Study|Lumbar Surgery|0
2339421|NCT03364309|4068267|FG012|Post-Treatment Followup Period|Miscellaneous|0
2339422|NCT03364309|4068268|FG013|Post-Treatment Followup Period|Miscellaneous|0
2339423|NCT03364309|4068269|FG014|Post-Treatment Followup Period|Miscellaneous|0
2339424|NCT03364309|4068270|FG015|Post-Treatment Followup Period|Miscellaneous|0
2339425|NCT03364309|4068271|FG016|Post-Treatment Followup Period|Miscellaneous|0
2339426|NCT03364309|4068272|FG017|Post-Treatment Followup Period|Miscellaneous|4
2339427|NCT03364309|4068273|FG018|Post-Treatment Followup Period|Miscellaneous|0
2339428|NCT03364335|4068302|FG000|Overall Study|Adverse Event|3
2339429|NCT03364335|4068303|FG001|Overall Study|Adverse Event|4
2339430|NCT03364335|4068304|FG002|Overall Study|Adverse Event|1
2339431|NCT03364335|4068305|FG003|Overall Study|Adverse Event|2
2339432|NCT03364335|4068306|FG004|Overall Study|Adverse Event|0
2339433|NCT03364335|4068302|FG000|Overall Study|Lost to Follow-up|7
2339434|NCT03364335|4068303|FG001|Overall Study|Lost to Follow-up|7
2339435|NCT03364335|4068304|FG002|Overall Study|Lost to Follow-up|10
2339436|NCT03364335|4068305|FG003|Overall Study|Lost to Follow-up|11
2339437|NCT03364335|4068306|FG004|Overall Study|Lost to Follow-up|11
2339438|NCT03364608|4068318|FG000|Overall Study|Withdrawal by Subject|4
2339439|NCT03364608|4068318|FG000|Overall Study|Protocol Violation|2
2339440|NCT03364608|4068318|FG000|Overall Study|Lost to Follow-up|2
2339441|NCT03364673|4068330|FG000|Overall Study|Withdrawal by Subject|2
2339442|NCT03364673|4068330|FG000|Overall Study|Injury unrelated to study|3
2339443|NCT03364738|4068334|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6
2339444|NCT03364738|4068334|FG000|Overall Study|Withdrawal by Subject|1
2339445|NCT03364738|4068334|FG000|Overall Study|Adverse Event|1
2339446|NCT03364751|4068343|FG000|Overall Study|Withdrawal by Subject|1
2339447|NCT03364751|4068344|FG001|Overall Study|Withdrawal by Subject|0
2339448|NCT03364751|4068345|FG002|Overall Study|Withdrawal by Subject|0
2339449|NCT03364751|4068346|FG003|Overall Study|Withdrawal by Subject|0
2339450|NCT03364751|4068343|FG000|Overall Study|Lost to Follow-up|0
2339451|NCT03364751|4068344|FG001|Overall Study|Lost to Follow-up|1
2037815|NCT00420784|3608303|FG001|Overall Study|Withdrawal by Subject|1
2037816|NCT00420784|3608304|FG002|Overall Study|Withdrawal by Subject|0
2037817|NCT00420784|3608305|FG003|Overall Study|Withdrawal by Subject|0
2037818|NCT00420784|3608302|FG000|Overall Study|Lost to Follow-up|0
2037819|NCT00420784|3608303|FG001|Overall Study|Lost to Follow-up|0
2037820|NCT00420784|3608304|FG002|Overall Study|Lost to Follow-up|2
2037821|NCT00420784|3608305|FG003|Overall Study|Lost to Follow-up|1
2037822|NCT00420784|3608302|FG000|Overall Study|Virologic Stopping Rule|17
2037823|NCT00420784|3608303|FG001|Overall Study|Virologic Stopping Rule|26
2246025|NCT01978912|3906759|FG002|Overall Study|Lumbar Surgery|1
2246026|NCT01978912|3906760|FG003|Overall Study|Lumbar Surgery|0
2246027|NCT01978912|3906757|FG000|Overall Study|Intradiscal Steroid Injection|0
2246028|NCT01978912|3906758|FG001|Overall Study|Intradiscal Steroid Injection|1
2246029|NCT01978912|3906759|FG002|Overall Study|Intradiscal Steroid Injection|0
2246030|NCT01978912|3906760|FG003|Overall Study|Intradiscal Steroid Injection|0
2246031|NCT01979016|3906772|FG000|Overall Study|Withdrawal by Subject|2
2246032|NCT01979016|3906773|FG001|Overall Study|Withdrawal by Subject|0
2246033|NCT01979016|3906772|FG000|Overall Study|Adverse Event|0
2246034|NCT01979016|3906773|FG001|Overall Study|Adverse Event|1
2246035|NCT01979185|3906813|FG000|Period 2|Other|0
2246036|NCT01979185|3906814|FG001|Period 2|Other|1
2246037|NCT01979523|3906849|FG000|Overall Study|Withdrawal by Subject|1
2246038|NCT01979523|3906850|FG001|Overall Study|Withdrawal by Subject|0
2246039|NCT01979614|3906859|FG000|Overall Study|Adverse Event|1
2246040|NCT01979614|3906860|FG001|Overall Study|Adverse Event|1
2246041|NCT01979835|3906866|FG000|Primary Outcome SA Measurment|failed insertion|18
2246042|NCT01979835|3906866|FG000|Follow-up|Lost to Follow-up|32
2246043|NCT01979952|3906872|FG000|Overall Study|Adverse Event|4
2246044|NCT01979952|3906873|FG001|Overall Study|Adverse Event|5
2246045|NCT01979952|3906872|FG000|Overall Study|Protocol Violation|1
2246046|NCT01979952|3906873|FG001|Overall Study|Protocol Violation|0
2246047|NCT01979952|3906872|FG000|Overall Study|Withdrawal by Subject|2
2246048|NCT01979952|3906873|FG001|Overall Study|Withdrawal by Subject|1
2246049|NCT01979952|3906872|FG000|Overall Study|Other than specified above|1
2246050|NCT01979952|3906873|FG001|Overall Study|Other than specified above|0
2246051|NCT01980056|3906882|FG000|Overall Study|Death|1
2246052|NCT01980056|3906883|FG001|Overall Study|Death|1
2246053|NCT01980056|3906884|FG002|Overall Study|Death|0
2246054|NCT01980095|3906898|FG000|Overall Study|Lost to Follow-up|6
2246055|NCT01980095|3906899|FG001|Overall Study|Lost to Follow-up|7
2246056|NCT01980095|3906898|FG000|Overall Study|Withdrawal by Subject|2
2246057|NCT01980095|3906899|FG001|Overall Study|Withdrawal by Subject|3
2246058|NCT01980095|3906898|FG000|Overall Study|Poor compliance|5
2246059|NCT01980095|3906899|FG001|Overall Study|Poor compliance|0
2246060|NCT01980095|3906898|FG000|Overall Study|Safety issue|0
2246061|NCT01980095|3906899|FG001|Overall Study|Safety issue|1
2246062|NCT01980095|3906898|FG000|Overall Study|Study drug discontinued|1
2246063|NCT01980095|3906899|FG001|Overall Study|Study drug discontinued|0
2246064|NCT01980095|3906898|FG000|Overall Study|Randomized by mistake|1
2246065|NCT01980095|3906899|FG001|Overall Study|Randomized by mistake|0
2246066|NCT01980628|3906938|FG000|Overall Study|Adverse Event|12
2246067|NCT01980628|3906938|FG000|Overall Study|Physician Decision|5
2246068|NCT01980628|3906938|FG000|Overall Study|Withdrawal by Subject|4
2246069|NCT01980628|3906938|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42
2246070|NCT01980706|3906955|FG000|Overall Study|Withdrawal by Subject|9
2246071|NCT01980706|3906956|FG001|Overall Study|Withdrawal by Subject|6
2246072|NCT01980706|3906957|FG002|Overall Study|Withdrawal by Subject|2
2246073|NCT01980706|3906955|FG000|Overall Study|Adverse Event|1
2246074|NCT01980706|3906956|FG001|Overall Study|Adverse Event|2
2246075|NCT01980706|3906957|FG002|Overall Study|Adverse Event|5
2246076|NCT01980706|3906955|FG000|Overall Study|Lost to Follow-up|3
2246077|NCT01980706|3906956|FG001|Overall Study|Lost to Follow-up|4
2246078|NCT01980706|3906957|FG002|Overall Study|Lost to Follow-up|3
2246079|NCT01980706|3906955|FG000|Overall Study|miscellaneous|4
2246080|NCT01980706|3906956|FG001|Overall Study|miscellaneous|5
2246081|NCT01980706|3906957|FG002|Overall Study|miscellaneous|3
2246082|NCT01980888|3906976|FG000|Overall Study|Study Terminated by Sponsor|116
2246083|NCT01980888|3906977|FG001|Overall Study|Study Terminated by Sponsor|122
2246084|NCT01980888|3906976|FG000|Overall Study|Withdrew Consent|17
2339452|NCT03364751|4068345|FG002|Overall Study|Lost to Follow-up|0
2339453|NCT03364751|4068346|FG003|Overall Study|Lost to Follow-up|0
2339454|NCT03365011|4068362|FG000|Overall Study|Withdrawal by Subject|1
2339455|NCT03365011|4068363|FG001|Overall Study|Withdrawal by Subject|2
2339456|NCT03365934|4068386|FG000|Overall Study|Adverse Event|1
2339457|NCT03365934|4068386|FG000|Overall Study|Withdrawal by Subject|1
2339458|NCT03366428|4068410|FG000|Overall Study|Progressive disease per RECIST v1.1|15
2339459|NCT03366428|4068410|FG000|Overall Study|Adverse Event|2
2339460|NCT03366428|4068410|FG000|Overall Study|Clinical progression|1
2339461|NCT03366428|4068410|FG000|Overall Study|Withdrawal by Subject|1
2339462|NCT03367793|4068422|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
2339463|NCT03367793|4068423|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
2339464|NCT03367793|4068424|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1
2339465|NCT03367793|4068425|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
2246085|NCT01980888|3906977|FG001|Overall Study|Withdrew Consent|6
2246086|NCT01980888|3906976|FG000|Overall Study|Investigator's Discretion|8
2246087|NCT01980888|3906977|FG001|Overall Study|Investigator's Discretion|3
2246088|NCT01980888|3906976|FG000|Overall Study|Non-Compliance with Study Drug|3
2246089|NCT01980888|3906977|FG001|Overall Study|Non-Compliance with Study Drug|2
2246090|NCT01980992|3906990|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
2246091|NCT01980992|3906991|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
2246092|NCT01980992|3906990|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
2246093|NCT01980992|3906991|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
2246094|NCT01980992|3906990|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1
2246095|NCT01980992|3906991|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0
2246096|NCT01980992|3906990|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
2246097|NCT01980992|3906991|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
2246098|NCT01980992|3906990|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
2246099|NCT01980992|3906991|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
2246100|NCT01980992|3906990|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
2246101|NCT01980992|3906991|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
2246102|NCT01981109|3907013|FG000|Overall Study|Death|36
2246103|NCT01981109|3907013|FG000|Overall Study|Withdrawal by Subject|40
2246104|NCT01981109|3907013|FG000|Overall Study|Lost to Follow-up|9
2246105|NCT01981109|3907013|FG000|Overall Study|No Discontinuation Documentation|37
2246106|NCT01981109|3907013|FG000|Overall Study|Study Termination|100
2246107|NCT01981109|3907013|FG000|Overall Study|No data available|2
2246108|NCT01981122|3907020|FG000|Overall Study|Withdrawal by Subject|0
2246109|NCT01981122|3907021|FG001|Overall Study|Withdrawal by Subject|2
2246110|NCT01981122|3907020|FG000|Overall Study|Protocol Violation|0
2246111|NCT01981122|3907021|FG001|Overall Study|Protocol Violation|1
2246112|NCT01981122|3907020|FG000|Overall Study|Lost to Follow-up|0
2246113|NCT01981122|3907021|FG001|Overall Study|Lost to Follow-up|1
2246114|NCT01981122|3907020|FG000|Overall Study|Investigator Or Dendreon Discretion|0
2246115|NCT01981122|3907021|FG001|Overall Study|Investigator Or Dendreon Discretion|1
2246116|NCT01981122|3907020|FG000|Overall Study|Death|14
2246117|NCT01981122|3907021|FG001|Overall Study|Death|15
2246118|NCT01981187|3907027|FG000|Overall Study|Participant/guardian decision|2
2246119|NCT01981187|3907027|FG000|Overall Study|Physician Decision|1
2246120|NCT01981187|3907027|FG000|Overall Study|Disease progression|2
2246121|NCT01981187|3907027|FG000|Overall Study|Adverse Event|7
2246122|NCT01981356|3907033|FG000|Overall Study|Lost to Follow-up|4
2246123|NCT01981356|3907034|FG001|Overall Study|Lost to Follow-up|1
2246124|NCT01981356|3907033|FG000|Overall Study|Withdrawal by Subject|1
2246125|NCT01981356|3907034|FG001|Overall Study|Withdrawal by Subject|1
2246126|NCT01981356|3907033|FG000|Overall Study|Protocol Violation|2
2246127|NCT01981356|3907034|FG001|Overall Study|Protocol Violation|0
2339466|NCT03367793|4068426|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
2339467|NCT03367793|4068427|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
2339468|NCT03368170|4068444|FG000|Overall Study|Adverse Event|2
2339469|NCT03368170|4068445|FG001|Overall Study|Adverse Event|1
2339470|NCT03368807|4068460|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3
2339471|NCT03368807|4068460|FG000|Period 1 (Blinded CGM)|Protocol Violation|1
2339472|NCT03368807|4068460|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1
2339473|NCT03368807|4068460|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1
2339474|NCT03368859|4068468|FG000|Overall Study|Withdrew Consent|5
2339475|NCT03368859|4068469|FG001|Overall Study|Withdrew Consent|4
2339476|NCT03368859|4068468|FG000|Overall Study|Death|12
2339477|NCT03368859|4068469|FG001|Overall Study|Death|6
2339478|NCT03368859|4068468|FG000|Overall Study|Study terminated by Sponsor|18
2339479|NCT03368859|4068469|FG001|Overall Study|Study terminated by Sponsor|23
2339480|NCT03368859|4068468|FG000|Overall Study|Other|1
2339481|NCT03368859|4068469|FG001|Overall Study|Other|1
2339482|NCT03369236|4068503|FG000|Double-blind Treatment Period|Accidental unblinding|0
2339483|NCT03369236|4068504|FG001|Double-blind Treatment Period|Accidental unblinding|1
2339484|NCT03369236|4068503|FG000|Open-label Extension Period|Lack of Efficacy|2
2339485|NCT03369236|4068504|FG001|Open-label Extension Period|Lack of Efficacy|1
2339486|NCT03369236|4068503|FG000|Open-label Extension Period|Adverse Event|0
2339487|NCT03369236|4068504|FG001|Open-label Extension Period|Adverse Event|1
2339488|NCT03369236|4068503|FG000|Open-label Extension Period|Sponsor decision to close study|3
2339489|NCT03369236|4068504|FG001|Open-label Extension Period|Sponsor decision to close study|4
2339490|NCT03369418|4068533|FG000|Overall Study|Withdrawal by Subject|3
2339491|NCT03369418|4068534|FG001|Overall Study|Withdrawal by Subject|3
2339492|NCT03369704|4068542|FG000|Treatment Epoch|technical problems|1
2339493|NCT03369704|4068543|FG001|Treatment Epoch|technical problems|0
2339494|NCT03369704|4068542|FG000|Treatment Epoch|Protocol Violation|1
2339495|NCT03369704|4068543|FG001|Treatment Epoch|Protocol Violation|0
2339496|NCT03369704|4068542|FG000|Treatment Epoch|Lost to Follow-up|0
2339497|NCT03369704|4068543|FG001|Treatment Epoch|Lost to Follow-up|1
2339498|NCT03369704|4068542|FG000|Treatment Epoch|Lack of Efficacy|0
2339499|NCT03369704|4068543|FG001|Treatment Epoch|Lack of Efficacy|2
2339500|NCT03369704|4068542|FG000|Treatment Epoch|Adverse Event|2
2339501|NCT03369704|4068543|FG001|Treatment Epoch|Adverse Event|0
2339502|NCT03369704|4068542|FG000|Follow-up Epoch|Lost to Follow-up|1
2339503|NCT03369704|4068543|FG001|Follow-up Epoch|Lost to Follow-up|0
2339504|NCT03369951|4068553|FG000|Overall Study|Withdrawal by Subject|3
2339505|NCT03369951|4068553|FG000|Overall Study|Death|1
2339506|NCT03369951|4068553|FG000|Overall Study|Lost to Follow-up|1
2339507|NCT03369951|4068553|FG000|Overall Study|Protocol Violation|1
2339508|NCT03370289|4068570|FG000|Overall Study|Screen Failure|1
2339509|NCT03370289|4068570|FG000|Overall Study|Sample Size Sufficient|4
2339510|NCT03370302|4068580|FG000|Dose Escalation Phase|Other|0
2339511|NCT03370302|4068581|FG001|Dose Escalation Phase|Other|1
2339512|NCT03370302|4068582|FG002|Dose Escalation Phase|Other|1
2339513|NCT03370302|4068583|FG003|Dose Escalation Phase|Other|0
2339514|NCT03370302|4068584|FG004|Dose Escalation Phase|Other|0
2339515|NCT03370302|4068585|FG005|Dose Escalation Phase|Other|0
2339516|NCT03370302|4068580|FG000|Dose Escalation Phase|Withdrawal by Subject|0
2339517|NCT03370302|4068581|FG001|Dose Escalation Phase|Withdrawal by Subject|1
2246128|NCT01981473|3907044|FG000|Overall Study|Incorrect diagnosis of RA|0
2246129|NCT01981473|3907045|FG001|Overall Study|Incorrect diagnosis of RA|0
2246130|NCT01981473|3907046|FG002|Overall Study|Incorrect diagnosis of RA|1
2246131|NCT01981473|3907044|FG000|Overall Study|Received treatment for < 6 months|0
2246132|NCT01981473|3907045|FG001|Overall Study|Received treatment for < 6 months|0
2246133|NCT01981473|3907046|FG002|Overall Study|Received treatment for < 6 months|1
2246134|NCT01981473|3907044|FG000|Overall Study|Received treatment for >24 months|2
2246135|NCT01981473|3907045|FG001|Overall Study|Received treatment for >24 months|0
2246136|NCT01981473|3907046|FG002|Overall Study|Received treatment for >24 months|6
2246137|NCT01981616|3907074|FG000|Overall Study|Adverse Event|0
2246138|NCT01981616|3907075|FG001|Overall Study|Adverse Event|1
2246139|NCT01981616|3907074|FG000|Overall Study|Protocol Violation|1
2246140|NCT01981616|3907075|FG001|Overall Study|Protocol Violation|0
2246141|NCT01981954|3907108|FG000|Titration Period|Protocol Deviation|1
2246142|NCT01981954|3907108|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1
2246143|NCT01982292|3907144|FG000|Overall Study|Adverse Event|2
2246144|NCT01982292|3907145|FG001|Overall Study|Adverse Event|0
2246145|NCT01982292|3907144|FG000|Overall Study|Death|1
2246146|NCT01982292|3907145|FG001|Overall Study|Death|0
2246147|NCT01982292|3907144|FG000|Overall Study|Lost to Follow-up|2
2246148|NCT01982292|3907145|FG001|Overall Study|Lost to Follow-up|0
2246149|NCT01982292|3907144|FG000|Overall Study|Non-Compliance With Study Treatment|1
2246150|NCT01982292|3907145|FG001|Overall Study|Non-Compliance With Study Treatment|0
2246151|NCT01982292|3907144|FG000|Overall Study|Protocol Deviation|1
2246152|NCT01982292|3907145|FG001|Overall Study|Protocol Deviation|0
2246153|NCT01982292|3907144|FG000|Overall Study|Patient/Guardian Decision|3
2246154|NCT01982292|3907145|FG001|Overall Study|Patient/Guardian Decision|1
2246155|NCT01982292|3907144|FG000|Overall Study|Technical Problems|2
2246156|NCT01982292|3907145|FG001|Overall Study|Technical Problems|0
2246157|NCT01982331|3907153|FG000|Received Vaccination 2|Adverse Event|1
2246158|NCT01982331|3907154|FG001|Received Vaccination 2|Adverse Event|2
2246159|NCT01982331|3907153|FG000|Received Vaccination 2|Withdrawal by Subject|0
2246160|NCT01982331|3907154|FG001|Received Vaccination 2|Withdrawal by Subject|1
2246161|NCT01982331|3907153|FG000|Completed Study (Day 112)|Withdrawal by Subject|2
2246162|NCT01982331|3907154|FG001|Completed Study (Day 112)|Withdrawal by Subject|0
2246163|NCT01982435|3907162|FG000|Overall Study|Adverse Event|1
2246164|NCT01982435|3907163|FG001|Overall Study|Adverse Event|0
2246165|NCT01982448|3907171|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
2246166|NCT01982448|3907172|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2
2246167|NCT01982448|3907171|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1
2246168|NCT01982448|3907172|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0
2246169|NCT01982448|3907171|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0
2246170|NCT01982448|3907172|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2
2246171|NCT01982448|3907171|FG000|Preoperative Chemotherapy|Lost to Follow-up|0
2246172|NCT01982448|3907172|FG001|Preoperative Chemotherapy|Lost to Follow-up|1
2246173|NCT01982682|3907190|FG000|Overall Study|Physician Decision|1
2246174|NCT01982773|3907206|FG000|Overall Study|Withdrawal by Subject|1
2246175|NCT01982773|3907207|FG001|Overall Study|Withdrawal by Subject|3
2246176|NCT01982773|3907206|FG000|Overall Study|Lost to Follow-up|7
2246177|NCT01982773|3907207|FG001|Overall Study|Lost to Follow-up|1
2246178|NCT01982812|3907224|FG000|Overall Study|Death|1
2246179|NCT01982812|3907225|FG001|Overall Study|Death|5
2246180|NCT01982812|3907224|FG000|Overall Study|Adverse Event|0
2246181|NCT01982812|3907225|FG001|Overall Study|Adverse Event|5
2246182|NCT01982942|3907233|FG000|Overall Study|Adverse Event|10
2246183|NCT01982942|3907234|FG001|Overall Study|Adverse Event|5
2246184|NCT01982942|3907233|FG000|Overall Study|Lost to Follow-up|4
2246185|NCT01982942|3907234|FG001|Overall Study|Lost to Follow-up|3
2246186|NCT01982942|3907233|FG000|Overall Study|Multiple sclerosis progression|3
2246187|NCT01982942|3907234|FG001|Overall Study|Multiple sclerosis progression|2
2246188|NCT01982942|3907233|FG000|Overall Study|Wanted to try therapy not permitted|1
2246189|NCT01982942|3907234|FG001|Overall Study|Wanted to try therapy not permitted|0
2246190|NCT01982942|3907233|FG000|Overall Study|Subject declined future visits|0
2246191|NCT01982942|3907234|FG001|Overall Study|Subject declined future visits|1
2246192|NCT01982942|3907233|FG000|Overall Study|Left geographical area|2
2246193|NCT01982942|3907234|FG001|Overall Study|Left geographical area|0
2246194|NCT01982942|3907233|FG000|Overall Study|Too many pills|1
2246195|NCT01982942|3907234|FG001|Overall Study|Too many pills|0
2246196|NCT01982942|3907233|FG000|Overall Study|MS Relapse|0
2246197|NCT01982942|3907234|FG001|Overall Study|MS Relapse|1
2246198|NCT01982942|3907233|FG000|Overall Study|Chose to join a stem cell trial|0
2246199|NCT01982942|3907234|FG001|Overall Study|Chose to join a stem cell trial|1
2246200|NCT01982942|3907233|FG000|Overall Study|Subject bedridden, rapidly declining|0
2246201|NCT01982942|3907234|FG001|Overall Study|Subject bedridden, rapidly declining|1
2246202|NCT01982955|3907245|FG000|Overall Study|Randomized but not treated|0
2246203|NCT01982955|3907246|FG001|Overall Study|Randomized but not treated|0
2246204|NCT01982955|3907247|FG002|Overall Study|Randomized but not treated|0
2246205|NCT01982955|3907248|FG003|Overall Study|Randomized but not treated|1
2246206|NCT01982955|3907249|FG004|Overall Study|Randomized but not treated|0
2246207|NCT01982955|3907245|FG000|Overall Study|Ongoing|0
2246208|NCT01982955|3907246|FG001|Overall Study|Ongoing|0
2246209|NCT01982955|3907247|FG002|Overall Study|Ongoing|4
2246210|NCT01982955|3907248|FG003|Overall Study|Ongoing|0
2246211|NCT01982955|3907249|FG004|Overall Study|Ongoing|0
2246212|NCT01983111|3907290|FG000|Overall Study|Withdrawal by Subject|8
2246213|NCT01983111|3907291|FG001|Overall Study|Withdrawal by Subject|6
2246214|NCT01983111|3907290|FG000|Overall Study|Adverse Event|4
2246215|NCT01983111|3907291|FG001|Overall Study|Adverse Event|0
2246216|NCT01983111|3907290|FG000|Overall Study|Protocol Violation|0
2246217|NCT01983111|3907291|FG001|Overall Study|Protocol Violation|1
2246218|NCT01983254|3907310|FG000|Overall Study|Death|6
2246219|NCT01983254|3907311|FG001|Overall Study|Death|6
2246220|NCT01983254|3907310|FG000|Overall Study|Lost to Follow-up|17
2246221|NCT01983254|3907311|FG001|Overall Study|Lost to Follow-up|16
2246222|NCT01983254|3907310|FG000|Overall Study|too ill|11
2246223|NCT01983254|3907311|FG001|Overall Study|too ill|8
2246224|NCT01983293|3907319|FG000|Overall Study|Withdrawal by Subject|29
2246225|NCT01983293|3907320|FG001|Overall Study|Withdrawal by Subject|15
2246226|NCT01983293|3907319|FG000|Overall Study|Missing 12-month visit|3
2246227|NCT01983293|3907320|FG001|Overall Study|Missing 12-month visit|3
2246228|NCT01983293|3907319|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1
2246229|NCT01983293|3907320|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1
2246230|NCT01983683|3907355|FG000|Overall Study|Withdrawal by Subject|14
2246231|NCT01983683|3907356|FG001|Overall Study|Withdrawal by Subject|18
2246232|NCT01983683|3907355|FG000|Overall Study|Death|11
2246233|NCT01983683|3907356|FG001|Overall Study|Death|15
2246234|NCT01983683|3907355|FG000|Overall Study|Physician Decision|8
2246235|NCT01983683|3907356|FG001|Overall Study|Physician Decision|9
2246236|NCT01983683|3907355|FG000|Overall Study|Lost to Follow-up|4
2246237|NCT01983683|3907356|FG001|Overall Study|Lost to Follow-up|8
2246238|NCT01983683|3907355|FG000|Overall Study|Sponsor Decision|1
2246239|NCT01983683|3907356|FG001|Overall Study|Sponsor Decision|1
2246240|NCT01983930|3907409|FG000|Overall Study|Withdrawal by Subject|9
2246241|NCT01983930|3907410|FG001|Overall Study|Withdrawal by Subject|8
2246242|NCT01983930|3907409|FG000|Overall Study|Adverse Event|0
2246243|NCT01983930|3907410|FG001|Overall Study|Adverse Event|1
2246244|NCT01983969|3907420|FG000|Overall Study|Disease Progression|0
2246245|NCT01983969|3907421|FG001|Overall Study|Disease Progression|1
2246246|NCT01983969|3907422|FG002|Overall Study|Disease Progression|0
2246247|NCT01984164|3907436|FG000|Overall Study|Withdrawal by Subject|4
2246248|NCT01984164|3907437|FG001|Overall Study|Withdrawal by Subject|3
2246249|NCT01984164|3907436|FG000|Overall Study|Adverse Event|5
2246250|NCT01984164|3907437|FG001|Overall Study|Adverse Event|19
2246251|NCT01984164|3907436|FG000|Overall Study|Lost to Follow-up|1
2246252|NCT01984164|3907437|FG001|Overall Study|Lost to Follow-up|3
2246253|NCT01984229|3907445|FG000|Safety Follow-up Period|Adverse Event|1
2246254|NCT01984229|3907446|FG001|Safety Follow-up Period|Adverse Event|1
2246255|NCT01984229|3907445|FG000|Safety Follow-up Period|Lost to Follow-up|1
2246256|NCT01984229|3907446|FG001|Safety Follow-up Period|Lost to Follow-up|0
2246257|NCT01984242|3907461|FG000|Overall Study|Death|52
2246258|NCT01984242|3907462|FG001|Overall Study|Death|50
2246259|NCT01984242|3907463|FG002|Overall Study|Death|52
2246260|NCT01984242|3907461|FG000|Overall Study|Withdrawal by Subject|5
2246261|NCT01984242|3907462|FG001|Overall Study|Withdrawal by Subject|3
2246262|NCT01984242|3907463|FG002|Overall Study|Withdrawal by Subject|10
2246263|NCT01984242|3907461|FG000|Overall Study|Physician Decision|0
2246264|NCT01984242|3907462|FG001|Overall Study|Physician Decision|0
2246265|NCT01984242|3907463|FG002|Overall Study|Physician Decision|1
2246266|NCT01984242|3907461|FG000|Overall Study|Lost to Follow-up|4
2246267|NCT01984242|3907462|FG001|Overall Study|Lost to Follow-up|0
2246268|NCT01984242|3907463|FG002|Overall Study|Lost to Follow-up|3
2246269|NCT01984242|3907461|FG000|Overall Study|Sponsor Decision|1
2246270|NCT01984242|3907462|FG001|Overall Study|Sponsor Decision|0
2246271|NCT01984242|3907463|FG002|Overall Study|Sponsor Decision|0
2246272|NCT01984242|3907461|FG000|Overall Study|Non-Compliance|1
2246273|NCT01984242|3907462|FG001|Overall Study|Non-Compliance|0
2246274|NCT01984242|3907463|FG002|Overall Study|Non-Compliance|0
2246275|NCT01984242|3907461|FG000|Overall Study|Study terminated by Sponsor|38
2246276|NCT01984242|3907462|FG001|Overall Study|Study terminated by Sponsor|50
2246277|NCT01984242|3907463|FG002|Overall Study|Study terminated by Sponsor|34
2246278|NCT01984242|3907461|FG000|Overall Study|Disease Progression|0
2246279|NCT01984242|3907462|FG001|Overall Study|Disease Progression|0
2246280|NCT01984242|3907463|FG002|Overall Study|Disease Progression|1
2246281|NCT01984294|3907482|FG000|Overall Study|Randomized but Never Treated|0
2246282|NCT01984294|3907483|FG001|Overall Study|Randomized but Never Treated|0
2246283|NCT01984294|3907484|FG002|Overall Study|Randomized but Never Treated|1
2246284|NCT01984294|3907482|FG000|Overall Study|Lack of Efficacy|4
2339518|NCT03370302|4068582|FG002|Dose Escalation Phase|Withdrawal by Subject|2
2339519|NCT03370302|4068583|FG003|Dose Escalation Phase|Withdrawal by Subject|0
2339520|NCT03370302|4068584|FG004|Dose Escalation Phase|Withdrawal by Subject|0
2339521|NCT03370302|4068585|FG005|Dose Escalation Phase|Withdrawal by Subject|2
2339522|NCT03370302|4068580|FG000|Dose Escalation Phase|Adverse Event|1
2339523|NCT03370302|4068581|FG001|Dose Escalation Phase|Adverse Event|0
2246285|NCT01984294|3907483|FG001|Overall Study|Lack of Efficacy|2
2246286|NCT01984294|3907484|FG002|Overall Study|Lack of Efficacy|6
2246287|NCT01984294|3907482|FG000|Overall Study|Adverse Event|0
2246288|NCT01984294|3907483|FG001|Overall Study|Adverse Event|1
2246289|NCT01984294|3907484|FG002|Overall Study|Adverse Event|0
2246290|NCT01984424|3907509|FG000|Overall Study|Withdrawal by Subject|3
2246291|NCT01984424|3907510|FG001|Overall Study|Withdrawal by Subject|5
2246292|NCT01984424|3907509|FG000|Overall Study|Sponsor Decision|0
2246293|NCT01984424|3907510|FG001|Overall Study|Sponsor Decision|1
2246294|NCT01984424|3907509|FG000|Overall Study|Lost to Follow-up|0
2246295|NCT01984424|3907510|FG001|Overall Study|Lost to Follow-up|1
2339524|NCT03370302|4068582|FG002|Dose Escalation Phase|Adverse Event|2
2339525|NCT03370302|4068583|FG003|Dose Escalation Phase|Adverse Event|0
2037824|NCT00420784|3608304|FG002|Overall Study|Virologic Stopping Rule|41
2037825|NCT00420784|3608305|FG003|Overall Study|Virologic Stopping Rule|67
2037826|NCT00420784|3608302|FG000|Overall Study|Other|1
2037827|NCT00420784|3608303|FG001|Overall Study|Other|2
2037828|NCT00420784|3608304|FG002|Overall Study|Other|0
2037829|NCT00420784|3608305|FG003|Overall Study|Other|5
2037830|NCT00420849|3608316|FG000|Overall Study|Lack of Efficacy|154
2037831|NCT00420849|3608316|FG000|Overall Study|Adverse Event|107
2037832|NCT00420849|3608316|FG000|Overall Study|Withdrawal by Subject|28
2037833|NCT00420849|3608316|FG000|Overall Study|Death|18
2037834|NCT00420849|3608316|FG000|Overall Study|Other|14
2037835|NCT00420849|3608316|FG000|Overall Study|Transplant|8
2037836|NCT00420849|3608316|FG000|Overall Study|Protocol Violation|1
2037837|NCT00420849|3608316|FG000|Overall Study|Lost to Follow-up|1
2037838|NCT00420927|3608330|FG000|Period 1|Adverse Event|19
2037839|NCT00420927|3608331|FG001|Period 1|Adverse Event|15
2037840|NCT00420927|3608332|FG002|Period 1|Adverse Event|0
2037841|NCT00420927|3608333|FG003|Period 1|Adverse Event|0
2037842|NCT00420927|3608334|FG004|Period 1|Adverse Event|0
2037843|NCT00420927|3608335|FG005|Period 1|Adverse Event|0
2037844|NCT00420927|3608336|FG006|Period 1|Adverse Event|0
2037845|NCT00420927|3608330|FG000|Period 1|Withdrawal by Subject|7
2037846|NCT00420927|3608331|FG001|Period 1|Withdrawal by Subject|12
2037847|NCT00420927|3608332|FG002|Period 1|Withdrawal by Subject|0
2037848|NCT00420927|3608333|FG003|Period 1|Withdrawal by Subject|0
2037849|NCT00420927|3608334|FG004|Period 1|Withdrawal by Subject|0
2037850|NCT00420927|3608335|FG005|Period 1|Withdrawal by Subject|0
2037851|NCT00420927|3608336|FG006|Period 1|Withdrawal by Subject|0
2037852|NCT00420927|3608330|FG000|Period 1|Lost to Follow-up|8
2037853|NCT00420927|3608331|FG001|Period 1|Lost to Follow-up|6
2037854|NCT00420927|3608332|FG002|Period 1|Lost to Follow-up|0
2037855|NCT00420927|3608333|FG003|Period 1|Lost to Follow-up|0
2037856|NCT00420927|3608334|FG004|Period 1|Lost to Follow-up|0
2037857|NCT00420927|3608335|FG005|Period 1|Lost to Follow-up|0
2037858|NCT00420927|3608336|FG006|Period 1|Lost to Follow-up|0
2037859|NCT00420927|3608330|FG000|Period 1|Lack of efficacy/Loss of efficacy|1
2037860|NCT00420927|3608331|FG001|Period 1|Lack of efficacy/Loss of efficacy|6
2037861|NCT00420927|3608332|FG002|Period 1|Lack of efficacy/Loss of efficacy|0
2037862|NCT00420927|3608333|FG003|Period 1|Lack of efficacy/Loss of efficacy|0
2037863|NCT00420927|3608334|FG004|Period 1|Lack of efficacy/Loss of efficacy|0
2037864|NCT00420927|3608335|FG005|Period 1|Lack of efficacy/Loss of efficacy|0
2037865|NCT00420927|3608336|FG006|Period 1|Lack of efficacy/Loss of efficacy|0
2037866|NCT00420927|3608330|FG000|Period 1|Death|2
2037867|NCT00420927|3608331|FG001|Period 1|Death|0
2037868|NCT00420927|3608332|FG002|Period 1|Death|0
2037869|NCT00420927|3608333|FG003|Period 1|Death|0
2037870|NCT00420927|3608334|FG004|Period 1|Death|0
2037871|NCT00420927|3608335|FG005|Period 1|Death|0
2037872|NCT00420927|3608336|FG006|Period 1|Death|0
2037873|NCT00420927|3608330|FG000|Period 1|Subject moved/relocated|0
2037874|NCT00420927|3608331|FG001|Period 1|Subject moved/relocated|2
2037875|NCT00420927|3608332|FG002|Period 1|Subject moved/relocated|0
2037876|NCT00420927|3608333|FG003|Period 1|Subject moved/relocated|0
2037877|NCT00420927|3608334|FG004|Period 1|Subject moved/relocated|0
2037878|NCT00420927|3608335|FG005|Period 1|Subject moved/relocated|0
2037879|NCT00420927|3608336|FG006|Period 1|Subject moved/relocated|0
2037880|NCT00420927|3608330|FG000|Period 1|Noncompliant with study drug|1
2246296|NCT01984684|3907522|FG000|Overall Study|Lost to Follow-up|25
2246297|NCT01984684|3907523|FG001|Overall Study|Lost to Follow-up|24
2037881|NCT00420927|3608331|FG001|Period 1|Noncompliant with study drug|1
2037882|NCT00420927|3608332|FG002|Period 1|Noncompliant with study drug|0
2037883|NCT00420927|3608333|FG003|Period 1|Noncompliant with study drug|0
2037884|NCT00420927|3608334|FG004|Period 1|Noncompliant with study drug|0
2037885|NCT00420927|3608335|FG005|Period 1|Noncompliant with study drug|0
2037886|NCT00420927|3608336|FG006|Period 1|Noncompliant with study drug|0
2037887|NCT00420927|3608330|FG000|Period 1|Randomization error|1
2037888|NCT00420927|3608331|FG001|Period 1|Randomization error|0
2037889|NCT00420927|3608332|FG002|Period 1|Randomization error|0
2037890|NCT00420927|3608333|FG003|Period 1|Randomization error|0
2037891|NCT00420927|3608334|FG004|Period 1|Randomization error|0
2037892|NCT00420927|3608335|FG005|Period 1|Randomization error|0
2037893|NCT00420927|3608336|FG006|Period 1|Randomization error|0
2037894|NCT00420927|3608330|FG000|Period 1|Suspected tuberculosis/positive test|1
2037895|NCT00420927|3608331|FG001|Period 1|Suspected tuberculosis/positive test|1
2037896|NCT00420927|3608332|FG002|Period 1|Suspected tuberculosis/positive test|0
2037897|NCT00420927|3608333|FG003|Period 1|Suspected tuberculosis/positive test|0
2037898|NCT00420927|3608334|FG004|Period 1|Suspected tuberculosis/positive test|0
2246298|NCT01984684|3907522|FG000|Overall Study|Adverse Event|8
2246299|NCT01984684|3907523|FG001|Overall Study|Adverse Event|12
2246300|NCT01984684|3907522|FG000|Overall Study|Withdrawal by Subject|9
2246301|NCT01984684|3907523|FG001|Overall Study|Withdrawal by Subject|9
2246302|NCT01984684|3907522|FG000|Overall Study|Lack of Efficacy|3
2246303|NCT01984684|3907523|FG001|Overall Study|Lack of Efficacy|6
2246304|NCT01984684|3907522|FG000|Overall Study|Physician Decision|4
2246305|NCT01984684|3907523|FG001|Overall Study|Physician Decision|2
2246306|NCT01984684|3907522|FG000|Overall Study|Protocol Violation|4
2246307|NCT01984684|3907523|FG001|Overall Study|Protocol Violation|2
2246308|NCT01984684|3907522|FG000|Overall Study|Death|0
2246309|NCT01984684|3907523|FG001|Overall Study|Death|1
2246310|NCT01984684|3907522|FG000|Overall Study|Noncompliance with study drug|2
2246311|NCT01984684|3907523|FG001|Overall Study|Noncompliance with study drug|1
2246312|NCT01984684|3907522|FG000|Overall Study|Subject incarcerated|1
2246313|NCT01984684|3907523|FG001|Overall Study|Subject incarcerated|0
2246314|NCT01984684|3907522|FG000|Overall Study|Study drug not available at site|1
2246315|NCT01984684|3907523|FG001|Overall Study|Study drug not available at site|1
2246316|NCT01984684|3907522|FG000|Overall Study|Subject had inadequate IV access|0
2246317|NCT01984684|3907523|FG001|Overall Study|Subject had inadequate IV access|1
2246318|NCT01984697|3907534|FG000|Overall Study|Adverse Event|0
2246319|NCT01984697|3907535|FG001|Overall Study|Adverse Event|0
2246320|NCT01984697|3907536|FG002|Overall Study|Adverse Event|2
2246321|NCT01984697|3907537|FG003|Overall Study|Adverse Event|0
2246322|NCT01984697|3907538|FG004|Overall Study|Adverse Event|0
2246323|NCT01984697|3907534|FG000|Overall Study|Lost to Follow-up|14
2246324|NCT01984697|3907535|FG001|Overall Study|Lost to Follow-up|5
2246325|NCT01984697|3907536|FG002|Overall Study|Lost to Follow-up|10
2246326|NCT01984697|3907537|FG003|Overall Study|Lost to Follow-up|6
2339526|NCT03370302|4068584|FG004|Dose Escalation Phase|Adverse Event|0
2339527|NCT03370302|4068585|FG005|Dose Escalation Phase|Adverse Event|0
2339528|NCT03370302|4068580|FG000|Dose Escalation Phase|Progressive Disease|2
2339529|NCT03370302|4068581|FG001|Dose Escalation Phase|Progressive Disease|4
2339530|NCT03370302|4068582|FG002|Dose Escalation Phase|Progressive Disease|2
2339531|NCT03370302|4068583|FG003|Dose Escalation Phase|Progressive Disease|0
2339532|NCT03370302|4068584|FG004|Dose Escalation Phase|Progressive Disease|3
2339533|NCT03370302|4068585|FG005|Dose Escalation Phase|Progressive Disease|1
2339534|NCT03370302|4068580|FG000|Dose Expansion Phase|Progressive Disease|0
2339535|NCT03370302|4068581|FG001|Dose Expansion Phase|Progressive Disease|0
2339536|NCT03370302|4068582|FG002|Dose Expansion Phase|Progressive Disease|0
2339537|NCT03370302|4068583|FG003|Dose Expansion Phase|Progressive Disease|6
2339538|NCT03370302|4068584|FG004|Dose Expansion Phase|Progressive Disease|0
2339539|NCT03370302|4068585|FG005|Dose Expansion Phase|Progressive Disease|0
2339540|NCT03370419|4068603|FG000|Overall Study|Lost to Follow-up|16
2339541|NCT03370471|4068609|FG000|Overall Study|Withdrawal by Subject|6
2339542|NCT03370471|4068610|FG001|Overall Study|Withdrawal by Subject|1
2339543|NCT03370471|4068609|FG000|Overall Study|Unable to access veins for blood draw|0
2339544|NCT03370471|4068610|FG001|Overall Study|Unable to access veins for blood draw|1
2339545|NCT03370471|4068609|FG000|Overall Study|Screen fail|1
2339546|NCT03370471|4068610|FG001|Overall Study|Screen fail|0
2353040|NCT03348904|4103855|FG000|Overall Study|Administrative reason by the sponsor|0
2353041|NCT03348904|4103856|FG001|Overall Study|Administrative reason by the sponsor|1
2353042|NCT03348904|4103857|FG002|Overall Study|Administrative reason by the sponsor|0
2353043|NCT03345901|4103865|FG000|Overall Study|The study was terminated|18
2353044|NCT03344562|4103872|FG000|Overall Study|Withdrawal by Subject|2
2353045|NCT03344562|4103873|FG001|Overall Study|Withdrawal by Subject|0
2353046|NCT03342638|4103881|FG000|Overall Study|Withdrawal by Subject|1
2353047|NCT03342638|4103882|FG001|Overall Study|Withdrawal by Subject|0
2353048|NCT03342638|4103881|FG000|Overall Study|Physician Decision|0
2353049|NCT03342638|4103882|FG001|Overall Study|Physician Decision|1
2353050|NCT03339401|4103899|FG000|Overall Study|Death|2
2353051|NCT03339401|4103900|FG001|Overall Study|Death|1
2353052|NCT03339401|4103899|FG000|Overall Study|Withdrawal by Subject|2
2353053|NCT03339401|4103900|FG001|Overall Study|Withdrawal by Subject|0
2353054|NCT03339401|4103899|FG000|Overall Study|Study terminated|4
2353055|NCT03339401|4103900|FG001|Overall Study|Study terminated|3
2353056|NCT03339401|4103899|FG000|Overall Study|Investigator Decision|1
2353057|NCT03339401|4103900|FG001|Overall Study|Investigator Decision|0
2353058|NCT03339245|4103908|FG000|Overall Study|Adverse Event|1
2353059|NCT03339245|4103909|FG001|Overall Study|Adverse Event|1
2353060|NCT03339245|4103908|FG000|Overall Study|Withdrawal by Subject|1
2353061|NCT03339245|4103909|FG001|Overall Study|Withdrawal by Subject|0
2353062|NCT03329404|4103921|FG000|Overall Study|The study was suspended.|1
2353063|NCT03329404|4103922|FG001|Overall Study|The study was suspended.|4
2246327|NCT01984697|3907538|FG004|Overall Study|Lost to Follow-up|21
2353064|NCT03326869|4103930|FG000|Overall Study|Study data has been lost to natural disa|1
2353065|NCT03326869|4103931|FG001|Overall Study|Study data has been lost to natural disa|1
2353066|NCT03305055|4103956|FG000|Overall Study|Withdrawal by Subject|0
2353067|NCT03305055|4103957|FG001|Overall Study|Withdrawal by Subject|1
2353068|NCT03305055|4103956|FG000|Overall Study|Adverse Event|1
2353069|NCT03305055|4103957|FG001|Overall Study|Adverse Event|1
2353070|NCT03303469|4103963|FG000|Overall Study|Lost to Follow-up|2
2353071|NCT03302247|4103967|FG000|Overall Study|the study has closed prematurely|2
2246328|NCT01984697|3907534|FG000|Overall Study|Physician Decision|3
2246329|NCT01984697|3907535|FG001|Overall Study|Physician Decision|0
2246330|NCT01984697|3907536|FG002|Overall Study|Physician Decision|0
2246331|NCT01984697|3907537|FG003|Overall Study|Physician Decision|1
2246332|NCT01984697|3907538|FG004|Overall Study|Physician Decision|0
2246333|NCT01984697|3907534|FG000|Overall Study|Protocol Violation|8
2246334|NCT01984697|3907535|FG001|Overall Study|Protocol Violation|5
2246335|NCT01984697|3907536|FG002|Overall Study|Protocol Violation|3
2246336|NCT01984697|3907537|FG003|Overall Study|Protocol Violation|2
2246337|NCT01984697|3907538|FG004|Overall Study|Protocol Violation|0
2246338|NCT01984697|3907534|FG000|Overall Study|Withdrawal by Subject|15
2246339|NCT01984697|3907535|FG001|Overall Study|Withdrawal by Subject|21
2246340|NCT01984697|3907536|FG002|Overall Study|Withdrawal by Subject|13
2246341|NCT01984697|3907537|FG003|Overall Study|Withdrawal by Subject|11
2246342|NCT01984697|3907538|FG004|Overall Study|Withdrawal by Subject|13
2246343|NCT01984697|3907534|FG000|Overall Study|Missed last follow-up visit|1
2246344|NCT01984697|3907535|FG001|Overall Study|Missed last follow-up visit|0
2246345|NCT01984697|3907536|FG002|Overall Study|Missed last follow-up visit|0
2246346|NCT01984697|3907537|FG003|Overall Study|Missed last follow-up visit|0
2246347|NCT01984697|3907538|FG004|Overall Study|Missed last follow-up visit|0
2246348|NCT01984697|3907534|FG000|Overall Study|Death|0
2246349|NCT01984697|3907535|FG001|Overall Study|Death|0
2246350|NCT01984697|3907536|FG002|Overall Study|Death|0
2246351|NCT01984697|3907537|FG003|Overall Study|Death|1
2246352|NCT01984697|3907538|FG004|Overall Study|Death|0
2246353|NCT01984697|3907534|FG000|Overall Study|Pregnancy|2
2246354|NCT01984697|3907535|FG001|Overall Study|Pregnancy|0
2246355|NCT01984697|3907536|FG002|Overall Study|Pregnancy|1
2246356|NCT01984697|3907537|FG003|Overall Study|Pregnancy|0
2246357|NCT01984697|3907538|FG004|Overall Study|Pregnancy|1
2246358|NCT01984892|3907550|FG000|Overall Study|Progressive disease|7
2246359|NCT01985126|3907556|FG000|Overall Study|Death|15
2246360|NCT01985126|3907557|FG001|Overall Study|Death|69
2246361|NCT01985126|3907556|FG000|Overall Study|Lost to Follow-up|0
2246362|NCT01985126|3907557|FG001|Overall Study|Lost to Follow-up|8
2246363|NCT01985126|3907556|FG000|Overall Study|Study Terminated By Sponsor|1
2246364|NCT01985126|3907557|FG001|Overall Study|Study Terminated By Sponsor|22
2246365|NCT01985126|3907556|FG000|Overall Study|Withdrawal by Subject|2
2246366|NCT01985126|3907557|FG001|Overall Study|Withdrawal by Subject|7
2246367|NCT01985321|3907565|FG000|Overall Study|Protocol Violation|4
2246368|NCT01985321|3907566|FG001|Overall Study|Protocol Violation|3
2246369|NCT01985321|3907565|FG000|Overall Study|Withdrawal by Subject|1
2246370|NCT01985321|3907566|FG001|Overall Study|Withdrawal by Subject|0
2246371|NCT01985321|3907565|FG000|Overall Study|Lost to Follow-up|5
2246372|NCT01985321|3907566|FG001|Overall Study|Lost to Follow-up|2
2246373|NCT01985321|3907565|FG000|Overall Study|Subject treated wrong type of sore|1
2246374|NCT01985321|3907566|FG001|Overall Study|Subject treated wrong type of sore|0
2246375|NCT01985334|3907580|FG000|Overall Study|Administrative problems|1
2246376|NCT01985334|3907581|FG001|Overall Study|Administrative problems|1
2246377|NCT01985334|3907582|FG002|Overall Study|Administrative problems|0
2246378|NCT01985334|3907583|FG003|Overall Study|Administrative problems|2
2246379|NCT01985334|3907584|FG004|Overall Study|Administrative problems|0
2246380|NCT01985334|3907585|FG005|Overall Study|Administrative problems|1
2246381|NCT01985334|3907586|FG006|Overall Study|Administrative problems|1
2246382|NCT01985334|3907587|FG007|Overall Study|Administrative problems|3
2246383|NCT01985334|3907580|FG000|Overall Study|Death|1
2246384|NCT01985334|3907581|FG001|Overall Study|Death|0
2246385|NCT01985334|3907582|FG002|Overall Study|Death|0
2246386|NCT01985334|3907583|FG003|Overall Study|Death|3
2246387|NCT01985334|3907584|FG004|Overall Study|Death|0
2246388|NCT01985334|3907585|FG005|Overall Study|Death|0
2246389|NCT01985334|3907586|FG006|Overall Study|Death|1
2246390|NCT01985334|3907587|FG007|Overall Study|Death|2
2246391|NCT01985334|3907580|FG000|Overall Study|Worsening of disease|0
2246392|NCT01985334|3907581|FG001|Overall Study|Worsening of disease|0
2246393|NCT01985334|3907582|FG002|Overall Study|Worsening of disease|0
2246394|NCT01985334|3907583|FG003|Overall Study|Worsening of disease|1
2246395|NCT01985334|3907584|FG004|Overall Study|Worsening of disease|0
2246396|NCT01985334|3907585|FG005|Overall Study|Worsening of disease|3
2246397|NCT01985334|3907586|FG006|Overall Study|Worsening of disease|0
2246398|NCT01985334|3907587|FG007|Overall Study|Worsening of disease|1
2246399|NCT01985334|3907580|FG000|Overall Study|Other|2
2246400|NCT01985334|3907581|FG001|Overall Study|Other|9
2246401|NCT01985334|3907582|FG002|Overall Study|Other|7
2246402|NCT01985334|3907583|FG003|Overall Study|Other|17
2246403|NCT01985334|3907584|FG004|Overall Study|Other|4
2246404|NCT01985334|3907585|FG005|Overall Study|Other|8
2246405|NCT01985334|3907586|FG006|Overall Study|Other|4
2246406|NCT01985334|3907587|FG007|Overall Study|Other|7
2246407|NCT01985334|3907580|FG000|Overall Study|Protocol deviation|6
2246408|NCT01985334|3907581|FG001|Overall Study|Protocol deviation|31
2246409|NCT01985334|3907582|FG002|Overall Study|Protocol deviation|25
2246410|NCT01985334|3907583|FG003|Overall Study|Protocol deviation|84
2246411|NCT01985334|3907584|FG004|Overall Study|Protocol deviation|17
2246412|NCT01985334|3907585|FG005|Overall Study|Protocol deviation|47
2246413|NCT01985334|3907586|FG006|Overall Study|Protocol deviation|15
2246414|NCT01985334|3907587|FG007|Overall Study|Protocol deviation|42
2246415|NCT01985334|3907580|FG000|Overall Study|Moderate / severe COPD exacerbation|5
2246416|NCT01985334|3907581|FG001|Overall Study|Moderate / severe COPD exacerbation|14
2246417|NCT01985334|3907582|FG002|Overall Study|Moderate / severe COPD exacerbation|12
2246418|NCT01985334|3907583|FG003|Overall Study|Moderate / severe COPD exacerbation|40
2246419|NCT01985334|3907584|FG004|Overall Study|Moderate / severe COPD exacerbation|6
2246420|NCT01985334|3907585|FG005|Overall Study|Moderate / severe COPD exacerbation|40
2246421|NCT01985334|3907586|FG006|Overall Study|Moderate / severe COPD exacerbation|8
2246422|NCT01985334|3907587|FG007|Overall Study|Moderate / severe COPD exacerbation|19
2246423|NCT01985334|3907580|FG000|Overall Study|Subject withdrawal of consent|3
2246424|NCT01985334|3907581|FG001|Overall Study|Subject withdrawal of consent|6
2246425|NCT01985334|3907582|FG002|Overall Study|Subject withdrawal of consent|2
2246426|NCT01985334|3907583|FG003|Overall Study|Subject withdrawal of consent|28
2246427|NCT01985334|3907584|FG004|Overall Study|Subject withdrawal of consent|4
2246428|NCT01985334|3907585|FG005|Overall Study|Subject withdrawal of consent|19
2246429|NCT01985334|3907586|FG006|Overall Study|Subject withdrawal of consent|0
2246430|NCT01985334|3907587|FG007|Overall Study|Subject withdrawal of consent|20
2246431|NCT01985334|3907580|FG000|Overall Study|Adverse Event|0
2246432|NCT01985334|3907581|FG001|Overall Study|Adverse Event|8
2246433|NCT01985334|3907582|FG002|Overall Study|Adverse Event|2
2246434|NCT01985334|3907583|FG003|Overall Study|Adverse Event|26
2246435|NCT01985334|3907584|FG004|Overall Study|Adverse Event|3
2246436|NCT01985334|3907585|FG005|Overall Study|Adverse Event|18
2246437|NCT01985334|3907586|FG006|Overall Study|Adverse Event|3
2246438|NCT01985334|3907587|FG007|Overall Study|Adverse Event|15
2246439|NCT01985334|3907580|FG000|Overall Study|Other|4
2246440|NCT01985334|3907581|FG001|Overall Study|Other|2
2246441|NCT01985334|3907582|FG002|Overall Study|Other|3
2246442|NCT01985334|3907583|FG003|Overall Study|Other|10
2246443|NCT01985334|3907584|FG004|Overall Study|Other|1
2246444|NCT01985334|3907585|FG005|Overall Study|Other|6
2246445|NCT01985334|3907586|FG006|Overall Study|Other|2
2246446|NCT01985334|3907587|FG007|Overall Study|Other|2
2246447|NCT01985334|3907580|FG000|Overall Study|Medication non-compliance|0
2246448|NCT01985334|3907581|FG001|Overall Study|Medication non-compliance|4
2246449|NCT01985334|3907582|FG002|Overall Study|Medication non-compliance|1
2246450|NCT01985334|3907583|FG003|Overall Study|Medication non-compliance|6
2246451|NCT01985334|3907584|FG004|Overall Study|Medication non-compliance|2
2246452|NCT01985334|3907585|FG005|Overall Study|Medication non-compliance|3
2246453|NCT01985334|3907586|FG006|Overall Study|Medication non-compliance|1
2246454|NCT01985334|3907587|FG007|Overall Study|Medication non-compliance|3
2246455|NCT01985334|3907580|FG000|Overall Study|Use of prohibited treatment|1
2246456|NCT01985334|3907581|FG001|Overall Study|Use of prohibited treatment|4
2246457|NCT01985334|3907582|FG002|Overall Study|Use of prohibited treatment|1
2246458|NCT01985334|3907583|FG003|Overall Study|Use of prohibited treatment|2
2246459|NCT01985334|3907584|FG004|Overall Study|Use of prohibited treatment|1
2246460|NCT01985334|3907585|FG005|Overall Study|Use of prohibited treatment|6
2246461|NCT01985334|3907586|FG006|Overall Study|Use of prohibited treatment|2
2246462|NCT01985334|3907587|FG007|Overall Study|Use of prohibited treatment|0
2246463|NCT01985334|3907580|FG000|Overall Study|Investigator decision|0
2246464|NCT01985334|3907581|FG001|Overall Study|Investigator decision|3
2246465|NCT01985334|3907582|FG002|Overall Study|Investigator decision|0
2246466|NCT01985334|3907583|FG003|Overall Study|Investigator decision|7
2246467|NCT01985334|3907584|FG004|Overall Study|Investigator decision|1
2246468|NCT01985334|3907585|FG005|Overall Study|Investigator decision|1
2246469|NCT01985334|3907586|FG006|Overall Study|Investigator decision|0
2246470|NCT01985334|3907587|FG007|Overall Study|Investigator decision|4
2246471|NCT01985334|3907580|FG000|Overall Study|Lost to Follow-up|0
2246472|NCT01985334|3907581|FG001|Overall Study|Lost to Follow-up|2
2246473|NCT01985334|3907582|FG002|Overall Study|Lost to Follow-up|0
2246474|NCT01985334|3907583|FG003|Overall Study|Lost to Follow-up|3
2246475|NCT01985334|3907584|FG004|Overall Study|Lost to Follow-up|1
2246476|NCT01985334|3907585|FG005|Overall Study|Lost to Follow-up|4
2246477|NCT01985334|3907586|FG006|Overall Study|Lost to Follow-up|0
2246478|NCT01985334|3907587|FG007|Overall Study|Lost to Follow-up|3
2246479|NCT01985360|3907621|FG000|Overall Study|Withdrawal by Subject|4
2246480|NCT01985360|3907622|FG001|Overall Study|Withdrawal by Subject|0
2339547|NCT03370770|4068618|FG000|Overall Study|Patient was followed in another hospital center|1
2339548|NCT03370770|4068618|FG000|Overall Study|Progressive Disease|98
2339549|NCT03370770|4068618|FG000|Overall Study|Adverse Event|2
2339550|NCT03370770|4068618|FG000|Overall Study|Death|5
2339551|NCT03371355|4068626|FG000|Overall Study|Investigator judgment|0
2339552|NCT03371355|4068627|FG001|Overall Study|Investigator judgment|0
2339553|NCT03371355|4068628|FG002|Overall Study|Investigator judgment|1
2339554|NCT03371355|4068629|FG003|Overall Study|Investigator judgment|1
2339555|NCT03371355|4068626|FG000|Overall Study|Voluntary withdrawal|1
2246481|NCT01985360|3907621|FG000|Overall Study|Lost to Follow-up|5
2246482|NCT01985360|3907622|FG001|Overall Study|Lost to Follow-up|3
2246483|NCT01986010|3907710|FG000|Overall Study|Adverse Event|0
2246484|NCT01986010|3907711|FG001|Overall Study|Adverse Event|1
2246485|NCT01986010|3907712|FG002|Overall Study|Adverse Event|0
2246486|NCT01986010|3907713|FG003|Overall Study|Adverse Event|0
2246487|NCT01986010|3907714|FG004|Overall Study|Adverse Event|0
2339556|NCT03371355|4068627|FG001|Overall Study|Voluntary withdrawal|0
2246488|NCT01986010|3907715|FG005|Overall Study|Adverse Event|0
2246489|NCT01986010|3907716|FG006|Overall Study|Adverse Event|0
2246490|NCT01986010|3907717|FG007|Overall Study|Adverse Event|0
2246491|NCT01986010|3907718|FG008|Overall Study|Adverse Event|0
2246492|NCT01986010|3907719|FG009|Overall Study|Adverse Event|0
2246493|NCT01986010|3907720|FG010|Overall Study|Adverse Event|0
2246494|NCT01986010|3907721|FG011|Overall Study|Adverse Event|0
2246495|NCT01986010|3907722|FG012|Overall Study|Adverse Event|0
2246496|NCT01986010|3907723|FG013|Overall Study|Adverse Event|0
2246497|NCT01986010|3907724|FG014|Overall Study|Adverse Event|0
2246498|NCT01986010|3907725|FG015|Overall Study|Adverse Event|1
2246499|NCT01986010|3907726|FG016|Overall Study|Adverse Event|0
2246500|NCT01986010|3907710|FG000|Overall Study|Lost to Follow-up|2
2246501|NCT01986010|3907711|FG001|Overall Study|Lost to Follow-up|1
2246502|NCT01986010|3907712|FG002|Overall Study|Lost to Follow-up|2
2246503|NCT01986010|3907713|FG003|Overall Study|Lost to Follow-up|2
2246504|NCT01986010|3907714|FG004|Overall Study|Lost to Follow-up|2
2246505|NCT01986010|3907715|FG005|Overall Study|Lost to Follow-up|2
2246506|NCT01986010|3907716|FG006|Overall Study|Lost to Follow-up|0
2246507|NCT01986010|3907717|FG007|Overall Study|Lost to Follow-up|0
2246508|NCT01986010|3907718|FG008|Overall Study|Lost to Follow-up|4
2246509|NCT01986010|3907719|FG009|Overall Study|Lost to Follow-up|2
2246510|NCT01986010|3907720|FG010|Overall Study|Lost to Follow-up|0
2246511|NCT01986010|3907721|FG011|Overall Study|Lost to Follow-up|1
2246512|NCT01986010|3907722|FG012|Overall Study|Lost to Follow-up|1
2246513|NCT01986010|3907723|FG013|Overall Study|Lost to Follow-up|1
2246514|NCT01986010|3907724|FG014|Overall Study|Lost to Follow-up|2
2246515|NCT01986010|3907725|FG015|Overall Study|Lost to Follow-up|0
2246516|NCT01986010|3907726|FG016|Overall Study|Lost to Follow-up|0
2246517|NCT01986010|3907710|FG000|Overall Study|Physician Decision|0
2246518|NCT01986010|3907711|FG001|Overall Study|Physician Decision|0
2246519|NCT01986010|3907712|FG002|Overall Study|Physician Decision|0
2246520|NCT01986010|3907713|FG003|Overall Study|Physician Decision|0
2246521|NCT01986010|3907714|FG004|Overall Study|Physician Decision|0
2246522|NCT01986010|3907715|FG005|Overall Study|Physician Decision|0
2246523|NCT01986010|3907716|FG006|Overall Study|Physician Decision|0
2246524|NCT01986010|3907717|FG007|Overall Study|Physician Decision|0
2339557|NCT03371355|4068628|FG002|Overall Study|Voluntary withdrawal|1
2339558|NCT03371355|4068629|FG003|Overall Study|Voluntary withdrawal|2
2339559|NCT03371355|4068626|FG000|Overall Study|Adverse Event|0
2339560|NCT03371355|4068627|FG001|Overall Study|Adverse Event|1
2339561|NCT03371355|4068628|FG002|Overall Study|Adverse Event|2
2339562|NCT03371355|4068629|FG003|Overall Study|Adverse Event|3
2339563|NCT03371355|4068626|FG000|Overall Study|Reason not Specified|0
2339564|NCT03371355|4068627|FG001|Overall Study|Reason not Specified|1
2339565|NCT03371355|4068628|FG002|Overall Study|Reason not Specified|0
2339566|NCT03371355|4068629|FG003|Overall Study|Reason not Specified|1
2339567|NCT03371381|4068643|FG000|Overall Study|Death|5
2339568|NCT03371381|4068643|FG000|Overall Study|Study terminated by sponsor|3
2339569|NCT03371381|4068643|FG000|Overall Study|Other|4
2037899|NCT00420927|3608335|FG005|Period 1|Suspected tuberculosis/positive test|0
2037900|NCT00420927|3608336|FG006|Period 1|Suspected tuberculosis/positive test|0
2037901|NCT00420927|3608330|FG000|Period 1|Study site closure|0
2037902|NCT00420927|3608331|FG001|Period 1|Study site closure|1
2037903|NCT00420927|3608332|FG002|Period 1|Study site closure|0
2037904|NCT00420927|3608333|FG003|Period 1|Study site closure|0
2037905|NCT00420927|3608334|FG004|Period 1|Study site closure|0
2037906|NCT00420927|3608335|FG005|Period 1|Study site closure|0
2037907|NCT00420927|3608336|FG006|Period 1|Study site closure|0
2037908|NCT00420927|3608330|FG000|Period 1|Subject received new diagnosis|0
2037909|NCT00420927|3608331|FG001|Period 1|Subject received new diagnosis|2
2037910|NCT00420927|3608332|FG002|Period 1|Subject received new diagnosis|0
2037911|NCT00420927|3608333|FG003|Period 1|Subject received new diagnosis|0
2037912|NCT00420927|3608334|FG004|Period 1|Subject received new diagnosis|0
2037913|NCT00420927|3608335|FG005|Period 1|Subject received new diagnosis|0
2037914|NCT00420927|3608336|FG006|Period 1|Subject received new diagnosis|0
2037915|NCT00420927|3608330|FG000|Period 1|Received wrong treatment/incorrect dose|0
2037916|NCT00420927|3608331|FG001|Period 1|Received wrong treatment/incorrect dose|1
2037917|NCT00420927|3608332|FG002|Period 1|Received wrong treatment/incorrect dose|0
2037918|NCT00420927|3608333|FG003|Period 1|Received wrong treatment/incorrect dose|0
2037919|NCT00420927|3608334|FG004|Period 1|Received wrong treatment/incorrect dose|0
2037920|NCT00420927|3608335|FG005|Period 1|Received wrong treatment/incorrect dose|0
2037921|NCT00420927|3608336|FG006|Period 1|Received wrong treatment/incorrect dose|0
2037922|NCT00420927|3608330|FG000|Period 1|Failed to meet entry criteria|8
2037923|NCT00420927|3608331|FG001|Period 1|Failed to meet entry criteria|7
2037924|NCT00420927|3608332|FG002|Period 1|Failed to meet entry criteria|0
2037925|NCT00420927|3608333|FG003|Period 1|Failed to meet entry criteria|0
2246525|NCT01986010|3907718|FG008|Overall Study|Physician Decision|0
2339570|NCT03371459|4068647|FG000|Washout|Lost to Follow-up|0
2037926|NCT00420927|3608334|FG004|Period 1|Failed to meet entry criteria|0
2037927|NCT00420927|3608335|FG005|Period 1|Failed to meet entry criteria|0
2037928|NCT00420927|3608336|FG006|Period 1|Failed to meet entry criteria|0
2037929|NCT00420927|3608330|FG000|Period 1|Took prohibited medication|1
2037930|NCT00420927|3608331|FG001|Period 1|Took prohibited medication|3
2037931|NCT00420927|3608332|FG002|Period 1|Took prohibited medication|0
2246526|NCT01986010|3907719|FG009|Overall Study|Physician Decision|0
2246527|NCT01986010|3907720|FG010|Overall Study|Physician Decision|0
2246528|NCT01986010|3907721|FG011|Overall Study|Physician Decision|0
2246529|NCT01986010|3907722|FG012|Overall Study|Physician Decision|0
2246530|NCT01986010|3907723|FG013|Overall Study|Physician Decision|0
2246531|NCT01986010|3907724|FG014|Overall Study|Physician Decision|1
2246532|NCT01986010|3907725|FG015|Overall Study|Physician Decision|0
2246533|NCT01986010|3907726|FG016|Overall Study|Physician Decision|0
2246534|NCT01986010|3907710|FG000|Overall Study|Withdrawal by Subject|2
2246535|NCT01986010|3907711|FG001|Overall Study|Withdrawal by Subject|2
2246536|NCT01986010|3907712|FG002|Overall Study|Withdrawal by Subject|3
2246537|NCT01986010|3907713|FG003|Overall Study|Withdrawal by Subject|0
2246538|NCT01986010|3907714|FG004|Overall Study|Withdrawal by Subject|2
2246539|NCT01986010|3907715|FG005|Overall Study|Withdrawal by Subject|4
2246540|NCT01986010|3907716|FG006|Overall Study|Withdrawal by Subject|0
2246541|NCT01986010|3907717|FG007|Overall Study|Withdrawal by Subject|0
2246542|NCT01986010|3907718|FG008|Overall Study|Withdrawal by Subject|0
2246543|NCT01986010|3907719|FG009|Overall Study|Withdrawal by Subject|0
2246544|NCT01986010|3907720|FG010|Overall Study|Withdrawal by Subject|0
2246545|NCT01986010|3907721|FG011|Overall Study|Withdrawal by Subject|2
2246546|NCT01986010|3907722|FG012|Overall Study|Withdrawal by Subject|0
2246547|NCT01986010|3907723|FG013|Overall Study|Withdrawal by Subject|1
2246548|NCT01986010|3907724|FG014|Overall Study|Withdrawal by Subject|2
2246549|NCT01986010|3907725|FG015|Overall Study|Withdrawal by Subject|0
2246550|NCT01986010|3907726|FG016|Overall Study|Withdrawal by Subject|0
2246551|NCT01986010|3907710|FG000|Overall Study|Status Not Recorded|2
2246552|NCT01986010|3907711|FG001|Overall Study|Status Not Recorded|4
2246553|NCT01986010|3907712|FG002|Overall Study|Status Not Recorded|2
2246554|NCT01986010|3907713|FG003|Overall Study|Status Not Recorded|0
2246555|NCT01986010|3907714|FG004|Overall Study|Status Not Recorded|1
2246556|NCT01986010|3907715|FG005|Overall Study|Status Not Recorded|2
2246557|NCT01986010|3907716|FG006|Overall Study|Status Not Recorded|0
2246558|NCT01986010|3907717|FG007|Overall Study|Status Not Recorded|0
2246559|NCT01986010|3907718|FG008|Overall Study|Status Not Recorded|2
2246560|NCT01986010|3907719|FG009|Overall Study|Status Not Recorded|1
2246561|NCT01986010|3907720|FG010|Overall Study|Status Not Recorded|7
2246562|NCT01986010|3907721|FG011|Overall Study|Status Not Recorded|7
2246563|NCT01986010|3907722|FG012|Overall Study|Status Not Recorded|9
2246564|NCT01986010|3907723|FG013|Overall Study|Status Not Recorded|9
2246565|NCT01986010|3907724|FG014|Overall Study|Status Not Recorded|5
2246566|NCT01986010|3907725|FG015|Overall Study|Status Not Recorded|10
2246567|NCT01986010|3907726|FG016|Overall Study|Status Not Recorded|4
2246568|NCT01986062|3907774|FG000|Overall Study|Lost to Follow-up|1
2246569|NCT01986062|3907775|FG001|Overall Study|Lost to Follow-up|0
2246570|NCT01986062|3907774|FG000|Overall Study|Withdrawal by Subject|0
2246571|NCT01986062|3907775|FG001|Overall Study|Withdrawal by Subject|1
2246572|NCT01986114|3907797|FG000|Overall Study|Adverse Event|59
2246573|NCT01986114|3907797|FG000|Overall Study|Lack of Efficacy|23
2246574|NCT01986114|3907797|FG000|Overall Study|Withdrawal by Subject|58
2246575|NCT01986114|3907797|FG000|Overall Study|Noncompliance|3
2246576|NCT01986114|3907797|FG000|Overall Study|Protocol Violation|1
2246577|NCT01986114|3907797|FG000|Overall Study|Lost to Follow-up|5
2246578|NCT01986114|3907797|FG000|Overall Study|Other reason|7
2246579|NCT01986140|3907805|FG000|Overall Study|Withdrawal by Subject|31
2246580|NCT01986140|3907806|FG001|Overall Study|Withdrawal by Subject|25
2246581|NCT01986140|3907805|FG000|Overall Study|alternative treatment|1
2246582|NCT01986140|3907806|FG001|Overall Study|alternative treatment|1
2246583|NCT01986140|3907805|FG000|Overall Study|found not eligible|3
2246584|NCT01986140|3907806|FG001|Overall Study|found not eligible|0
2246585|NCT01986140|3907805|FG000|Overall Study|Adverse Event|0
2246586|NCT01986140|3907806|FG001|Overall Study|Adverse Event|1
2246587|NCT01986140|3907805|FG000|Overall Study|progression disease|0
2246588|NCT01986140|3907806|FG001|Overall Study|progression disease|1
2246589|NCT01986231|3907812|FG000|Overall Study|Adverse Event|1
2246590|NCT01986348|3907820|FG000|Overall Study|Death|8
2246591|NCT01986348|3907821|FG001|Overall Study|Death|22
2246592|NCT01986348|3907822|FG002|Overall Study|Death|10
2246593|NCT01986348|3907823|FG003|Overall Study|Death|21
2246594|NCT01986348|3907820|FG000|Overall Study|Lost to Follow-up|0
2246595|NCT01986348|3907821|FG001|Overall Study|Lost to Follow-up|0
2246596|NCT01986348|3907822|FG002|Overall Study|Lost to Follow-up|0
2246597|NCT01986348|3907823|FG003|Overall Study|Lost to Follow-up|2
2246598|NCT01986348|3907820|FG000|Overall Study|Physician Decision|0
2246599|NCT01986348|3907821|FG001|Overall Study|Physician Decision|0
2246600|NCT01986348|3907822|FG002|Overall Study|Physician Decision|0
2246601|NCT01986348|3907823|FG003|Overall Study|Physician Decision|1
2246602|NCT01986348|3907820|FG000|Overall Study|Progressive Disease|0
2246603|NCT01986348|3907821|FG001|Overall Study|Progressive Disease|0
2246604|NCT01986348|3907822|FG002|Overall Study|Progressive Disease|2
2246605|NCT01986348|3907823|FG003|Overall Study|Progressive Disease|0
2246606|NCT01986348|3907820|FG000|Overall Study|Withdrawal by Participant|0
2246607|NCT01986348|3907821|FG001|Overall Study|Withdrawal by Participant|1
2246608|NCT01986348|3907822|FG002|Overall Study|Withdrawal by Participant|2
2246609|NCT01986348|3907823|FG003|Overall Study|Withdrawal by Participant|1
2246610|NCT01986348|3907820|FG000|Overall Study|Study Terminated by Sponsor|0
2246611|NCT01986348|3907821|FG001|Overall Study|Study Terminated by Sponsor|0
2246612|NCT01986348|3907822|FG002|Overall Study|Study Terminated by Sponsor|0
2246613|NCT01986348|3907823|FG003|Overall Study|Study Terminated by Sponsor|3
2246614|NCT01986348|3907820|FG000|Overall Study|Other-unspecified|0
2246615|NCT01986348|3907821|FG001|Overall Study|Other-unspecified|1
2246616|NCT01986348|3907822|FG002|Overall Study|Other-unspecified|0
2246617|NCT01986348|3907823|FG003|Overall Study|Other-unspecified|2
2246618|NCT01986647|3907849|FG000|Overall Study|Lost to Follow-up|4
2246619|NCT01986647|3907850|FG001|Overall Study|Lost to Follow-up|1
2246620|NCT01986647|3907851|FG002|Overall Study|Lost to Follow-up|4
2246621|NCT01986647|3907852|FG003|Overall Study|Lost to Follow-up|4
2246622|NCT01986647|3907849|FG000|Overall Study|Withdrawal by Subject|1
2246623|NCT01986647|3907850|FG001|Overall Study|Withdrawal by Subject|3
2246624|NCT01986647|3907851|FG002|Overall Study|Withdrawal by Subject|2
2246625|NCT01986647|3907852|FG003|Overall Study|Withdrawal by Subject|3
2246626|NCT01986647|3907849|FG000|Overall Study|Health|5
2246627|NCT01986647|3907850|FG001|Overall Study|Health|3
2246628|NCT01986647|3907851|FG002|Overall Study|Health|6
2246629|NCT01986647|3907852|FG003|Overall Study|Health|4
2246630|NCT01986829|3907888|FG000|Overall Study|Death|1
2246631|NCT01986855|3907898|FG000|Overall Study|Adverse Event|1
2339571|NCT03371459|4068648|FG001|Washout|Lost to Follow-up|1
2339572|NCT03371732|4068656|FG000|Overall Study|Withdrawal by Subject|9
2339573|NCT03371732|4068657|FG001|Overall Study|Withdrawal by Subject|3
2339574|NCT03371732|4068656|FG000|Overall Study|Refusal to continue|3
2339575|NCT03371732|4068657|FG001|Overall Study|Refusal to continue|4
2339576|NCT03372083|4068669|FG000|Overall Study|Adverse Event|3
2339577|NCT03372083|4068669|FG000|Overall Study|Physician Decision|1
2339578|NCT03372083|4068669|FG000|Overall Study|Withdrawal by Subject|1
2339579|NCT03372096|4068673|FG000|Overall Study|Study Closed|8
2339580|NCT03372369|4068682|FG000|Qualification Period|Withdrawal by Subject|16
2339581|NCT03372369|4068683|FG001|Qualification Period|Withdrawal by Subject|13
2339582|NCT03372369|4068682|FG000|Qualification Period|Inconsistent Eligibility Results|10
2339583|NCT03372369|4068683|FG001|Qualification Period|Inconsistent Eligibility Results|9
2339584|NCT03372369|4068682|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3
2339585|NCT03372369|4068683|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3
2339586|NCT03372551|4068713|FG000|First Intervention (1 Week)|Withdrawal by Subject|1
2339587|NCT03372551|4068714|FG001|First Intervention (1 Week)|Withdrawal by Subject|0
2339588|NCT03372603|4068727|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
2339589|NCT03372603|4068728|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
2339590|NCT03372603|4068727|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
2339591|NCT03372603|4068728|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
2339592|NCT03373383|4068769|FG000|Treatment Period: Wk0-16|Adverse Event|7
2339593|NCT03373383|4068770|FG001|Treatment Period: Wk0-16|Adverse Event|6
2339594|NCT03373383|4068771|FG002|Treatment Period: Wk0-16|Adverse Event|11
2339595|NCT03373383|4068772|FG003|Treatment Period: Wk0-16|Adverse Event|15
2339596|NCT03373383|4068773|FG004|Treatment Period: Wk0-16|Adverse Event|21
2037932|NCT00420927|3608333|FG003|Period 1|Took prohibited medication|0
2037933|NCT00420927|3608334|FG004|Period 1|Took prohibited medication|0
2037934|NCT00420927|3608335|FG005|Period 1|Took prohibited medication|0
2037935|NCT00420927|3608336|FG006|Period 1|Took prohibited medication|0
2037936|NCT00420927|3608330|FG000|Period 2|Adverse Event|0
2037937|NCT00420927|3608331|FG001|Period 2|Adverse Event|0
2037938|NCT00420927|3608332|FG002|Period 2|Adverse Event|7
2037939|NCT00420927|3608333|FG003|Period 2|Adverse Event|3
2037940|NCT00420927|3608334|FG004|Period 2|Adverse Event|17
2037941|NCT00420927|3608335|FG005|Period 2|Adverse Event|6
2037942|NCT00420927|3608336|FG006|Period 2|Adverse Event|20
2037943|NCT00420927|3608330|FG000|Period 2|Withdrawal by Subject|0
2037944|NCT00420927|3608331|FG001|Period 2|Withdrawal by Subject|0
2037945|NCT00420927|3608332|FG002|Period 2|Withdrawal by Subject|1
2037946|NCT00420927|3608333|FG003|Period 2|Withdrawal by Subject|3
2037947|NCT00420927|3608334|FG004|Period 2|Withdrawal by Subject|11
2037948|NCT00420927|3608335|FG005|Period 2|Withdrawal by Subject|2
2037949|NCT00420927|3608336|FG006|Period 2|Withdrawal by Subject|12
2037950|NCT00420927|3608330|FG000|Period 2|Lost to Follow-up|0
2037951|NCT00420927|3608331|FG001|Period 2|Lost to Follow-up|0
2037952|NCT00420927|3608332|FG002|Period 2|Lost to Follow-up|2
2037953|NCT00420927|3608333|FG003|Period 2|Lost to Follow-up|2
2037954|NCT00420927|3608334|FG004|Period 2|Lost to Follow-up|6
2037955|NCT00420927|3608335|FG005|Period 2|Lost to Follow-up|3
2037956|NCT00420927|3608336|FG006|Period 2|Lost to Follow-up|9
2037957|NCT00420927|3608330|FG000|Period 2|Lack of efficacy/Loss of efficacy|0
2246632|NCT01986855|3907899|FG001|Overall Study|Adverse Event|0
2246633|NCT01986855|3907900|FG002|Overall Study|Adverse Event|0
2246634|NCT01986855|3907898|FG000|Overall Study|Death|3
2246635|NCT01986855|3907899|FG001|Overall Study|Death|4
2246636|NCT01986855|3907900|FG002|Overall Study|Death|4
2246637|NCT01986855|3907898|FG000|Overall Study|Lost to Follow-up|2
2246638|NCT01986855|3907899|FG001|Overall Study|Lost to Follow-up|1
2246639|NCT01986855|3907900|FG002|Overall Study|Lost to Follow-up|0
2037958|NCT00420927|3608331|FG001|Period 2|Lack of efficacy/Loss of efficacy|0
2037959|NCT00420927|3608332|FG002|Period 2|Lack of efficacy/Loss of efficacy|2
2037960|NCT00420927|3608333|FG003|Period 2|Lack of efficacy/Loss of efficacy|1
2037961|NCT00420927|3608334|FG004|Period 2|Lack of efficacy/Loss of efficacy|6
2246640|NCT01986855|3907898|FG000|Overall Study|Screen Failure|0
2246641|NCT01986855|3907899|FG001|Overall Study|Screen Failure|1
2246642|NCT01986855|3907900|FG002|Overall Study|Screen Failure|0
2246643|NCT01986855|3907898|FG000|Overall Study|Participant Moved|0
2246644|NCT01986855|3907899|FG001|Overall Study|Participant Moved|0
2246645|NCT01986855|3907900|FG002|Overall Study|Participant Moved|2
2246646|NCT01986855|3907898|FG000|Overall Study|Withdrawal by Subject|7
2246647|NCT01986855|3907899|FG001|Overall Study|Withdrawal by Subject|8
2246648|NCT01986855|3907900|FG002|Overall Study|Withdrawal by Subject|5
2246649|NCT01986881|3907911|FG000|Overall Study|Death|228
2246650|NCT01986881|3907912|FG001|Overall Study|Death|233
2246651|NCT01986881|3907913|FG002|Overall Study|Death|247
2246652|NCT01986881|3907911|FG000|Overall Study|Lost to Follow-up|51
2246653|NCT01986881|3907912|FG001|Overall Study|Lost to Follow-up|44
2246654|NCT01986881|3907913|FG002|Overall Study|Lost to Follow-up|55
2246655|NCT01986881|3907911|FG000|Overall Study|Physician Decision|7
2246656|NCT01986881|3907912|FG001|Overall Study|Physician Decision|4
2246657|NCT01986881|3907913|FG002|Overall Study|Physician Decision|6
2246658|NCT01986881|3907911|FG000|Overall Study|Study Site Terminated by Sponsor|2
2246659|NCT01986881|3907912|FG001|Overall Study|Study Site Terminated by Sponsor|2
2246660|NCT01986881|3907913|FG002|Overall Study|Study Site Terminated by Sponsor|3
2246661|NCT01986881|3907911|FG000|Overall Study|Withdrawal by Subject|41
2246662|NCT01986881|3907912|FG001|Overall Study|Withdrawal by Subject|60
2246663|NCT01986881|3907913|FG002|Overall Study|Withdrawal by Subject|45
2246664|NCT01986881|3907911|FG000|Overall Study|Subject Moved|0
2246665|NCT01986881|3907912|FG001|Overall Study|Subject Moved|1
2246666|NCT01986881|3907913|FG002|Overall Study|Subject Moved|0
2246667|NCT01986881|3907911|FG000|Overall Study|Other|1
2246668|NCT01986881|3907912|FG001|Overall Study|Other|2
2246669|NCT01986881|3907913|FG002|Overall Study|Other|2
2246670|NCT01986907|3907944|FG000|Overall Study|Adverse Event|11
2246671|NCT01986907|3907944|FG000|Overall Study|Unsatisfactory therapeutic effect|24
2246672|NCT01986907|3907944|FG000|Overall Study|Protocol Violation|4
2246673|NCT01986907|3907944|FG000|Overall Study|Withdrawal by Subject|76
2246674|NCT01986907|3907944|FG000|Overall Study|Lost to Follow-up|38
2246675|NCT01986907|3907944|FG000|Overall Study|Death|9
2246676|NCT01986920|3907951|FG000|A- 101 25%|Withdrawal by Subject|1
2246677|NCT01986920|3907952|FG001|A- 101 25%|Withdrawal by Subject|0
2246678|NCT01986920|3907953|FG002|A- 101 25%|Withdrawal by Subject|0
2246679|NCT01986920|3907954|FG003|A- 101 25%|Withdrawal by Subject|0
2246680|NCT01986920|3907951|FG000|A-101 32.5%|Withdrawal by Subject|0
2246681|NCT01986920|3907952|FG001|A-101 32.5%|Withdrawal by Subject|1
2246682|NCT01986920|3907953|FG002|A-101 32.5%|Withdrawal by Subject|0
2246683|NCT01986920|3907954|FG003|A-101 32.5%|Withdrawal by Subject|0
2246684|NCT01986920|3907951|FG000|A-101 40%|Withdrawal by Subject|0
2246685|NCT01986920|3907952|FG001|A-101 40%|Withdrawal by Subject|0
2246686|NCT01986920|3907953|FG002|A-101 40%|Withdrawal by Subject|1
2246687|NCT01986920|3907954|FG003|A-101 40%|Withdrawal by Subject|0
2246688|NCT01986920|3907951|FG000|Placebo|Withdrawal by Subject|0
2246689|NCT01986920|3907952|FG001|Placebo|Withdrawal by Subject|0
2246690|NCT01986920|3907953|FG002|Placebo|Withdrawal by Subject|0
2246691|NCT01986920|3907954|FG003|Placebo|Withdrawal by Subject|1
2246692|NCT01986985|3907973|FG000|Overall Study|Withdrawal by Subject|4
2246693|NCT01986985|3907973|FG000|Overall Study|Scan not completed due to malfunction|3
2246694|NCT01987102|3907988|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
2246695|NCT01987102|3907989|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
2246696|NCT01987102|3907988|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
2246697|NCT01987102|3907989|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
2246698|NCT01987102|3907988|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
2246699|NCT01987102|3907989|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
2246700|NCT01987102|3907988|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
2246701|NCT01987102|3907989|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
2246702|NCT01987102|3907988|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
2246703|NCT01987102|3907989|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
2246704|NCT01987102|3907988|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
2246705|NCT01987102|3907989|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
2246706|NCT01987232|3908020|FG000|Overall Study|Ongoing in Study|0
2246707|NCT01987232|3908021|FG001|Overall Study|Ongoing in Study|0
2246708|NCT01987232|3908022|FG002|Overall Study|Ongoing in Study|0
2246709|NCT01987232|3908023|FG003|Overall Study|Ongoing in Study|1
2246710|NCT01987232|3908024|FG004|Overall Study|Ongoing in Study|0
2246711|NCT01987427|3908100|FG000|Overall Study|Adverse Event|4
2246712|NCT01987427|3908101|FG001|Overall Study|Adverse Event|2
2246713|NCT01987427|3908102|FG002|Overall Study|Adverse Event|8
2246714|NCT01987427|3908100|FG000|Overall Study|Lost to Follow-up|6
2246715|NCT01987427|3908101|FG001|Overall Study|Lost to Follow-up|6
2246716|NCT01987427|3908102|FG002|Overall Study|Lost to Follow-up|9
2246717|NCT01987427|3908100|FG000|Overall Study|Withdrawal by Subject|2
2246718|NCT01987427|3908101|FG001|Overall Study|Withdrawal by Subject|1
2246719|NCT01987427|3908102|FG002|Overall Study|Withdrawal by Subject|3
2246720|NCT01987427|3908100|FG000|Overall Study|Lack of Efficacy|1
2246721|NCT01987427|3908101|FG001|Overall Study|Lack of Efficacy|0
2246722|NCT01987427|3908102|FG002|Overall Study|Lack of Efficacy|0
2246723|NCT01987427|3908100|FG000|Overall Study|Other|1
2246724|NCT01987427|3908101|FG001|Overall Study|Other|1
2246725|NCT01987427|3908102|FG002|Overall Study|Other|0
2246726|NCT01987453|3908113|FG000|Overall Study|Death|0
2246727|NCT01987453|3908114|FG001|Overall Study|Death|0
2246728|NCT01987453|3908115|FG002|Overall Study|Death|1
2246729|NCT01987453|3908113|FG000|Overall Study|Lack of Efficacy|1
2246730|NCT01987453|3908114|FG001|Overall Study|Lack of Efficacy|12
2246731|NCT01987453|3908115|FG002|Overall Study|Lack of Efficacy|0
2246732|NCT01987479|3908127|FG000|Overall Study|Protocol Violation|1
2246733|NCT01987479|3908127|FG000|Overall Study|Physician Decision|2
2246734|NCT01987479|3908127|FG000|Overall Study|Participant/legal guardian decision|1
2246735|NCT01987479|3908127|FG000|Overall Study|Other|5
2246736|NCT01987479|3908127|FG000|Overall Study|Lost to Follow-up|1
2246737|NCT01987479|3908127|FG000|Overall Study|Adverse Event|7
2246738|NCT01987505|3908133|FG000|Overall Study|Other|9
2246739|NCT01987505|3908133|FG000|Overall Study|Withdrawal by Subject|2
2246740|NCT01987505|3908133|FG000|Overall Study|Other Reason|2
2246741|NCT01987505|3908133|FG000|Overall Study|Lost to Follow-up|15
2246742|NCT01987505|3908133|FG000|Overall Study|Investigator Decision|2
2246743|NCT01987505|3908133|FG000|Overall Study|Death|4
2246744|NCT01987557|3908142|FG000|Overall Study|Protocol Violation|1
2246745|NCT01987557|3908143|FG001|Overall Study|Protocol Violation|0
2246746|NCT01987557|3908144|FG002|Overall Study|Protocol Violation|1
2246747|NCT01987557|3908142|FG000|Overall Study|Withdrawal by Subject|2
2246748|NCT01987557|3908143|FG001|Overall Study|Withdrawal by Subject|1
2246749|NCT01987557|3908144|FG002|Overall Study|Withdrawal by Subject|2
2246750|NCT01987557|3908142|FG000|Overall Study|Adverse Event|0
2246751|NCT01987557|3908143|FG001|Overall Study|Adverse Event|2
2246752|NCT01987557|3908144|FG002|Overall Study|Adverse Event|0
2246753|NCT01987596|3908163|FG000|Overall Study|Physician Decision|1
2246754|NCT01987596|3908164|FG001|Overall Study|Physician Decision|0
2246755|NCT01987596|3908163|FG000|Overall Study|Progressive Disease; missing all period|0
2246756|NCT01987596|3908164|FG001|Overall Study|Progressive Disease; missing all period|1
2246757|NCT01987609|3908176|FG000|Overall Study|Adverse Event|1
2246758|NCT01987765|3908194|FG000|Overall Study|Protocol Violation|65
2246759|NCT01987765|3908194|FG000|Overall Study|Lost to Follow-up|37
2246760|NCT01987817|3908200|FG000|Overall Study|Adverse Event|4
2246761|NCT01987817|3908201|FG001|Overall Study|Adverse Event|0
2246762|NCT01987817|3908200|FG000|Overall Study|Withdrawal by Subject|1
2246763|NCT01987817|3908201|FG001|Overall Study|Withdrawal by Subject|1
2246764|NCT01987817|3908200|FG000|Overall Study|Physician Decision|1
2246765|NCT01987817|3908201|FG001|Overall Study|Physician Decision|0
2246766|NCT01987830|3908208|FG000|Overall Study|Never received baseline scan|1
2246767|NCT01987895|3908214|FG000|Overall Study|Withdrawal by Subject|12
2246768|NCT01987895|3908215|FG001|Overall Study|Withdrawal by Subject|7
2246769|NCT01987895|3908214|FG000|Overall Study|Physician Decision|8
2246770|NCT01987895|3908215|FG001|Overall Study|Physician Decision|10
2246771|NCT01987895|3908214|FG000|Overall Study|Death|7
2246772|NCT01987895|3908215|FG001|Overall Study|Death|7
2246773|NCT01987895|3908214|FG000|Overall Study|Lost to Follow-up|3
2246774|NCT01987895|3908215|FG001|Overall Study|Lost to Follow-up|5
2246775|NCT01987895|3908214|FG000|Overall Study|randomized before giving IC|0
2246776|NCT01987895|3908215|FG001|Overall Study|randomized before giving IC|1
2246777|NCT01987908|3908221|FG000|Placebo Lead-in Period|Adverse Event|2
2246778|NCT01987908|3908222|FG001|Placebo Lead-in Period|Adverse Event|0
2246779|NCT01987908|3908223|FG002|Placebo Lead-in Period|Adverse Event|0
2246780|NCT01987908|3908221|FG000|Placebo Lead-in Period|Physician Decision|2
2246781|NCT01987908|3908222|FG001|Placebo Lead-in Period|Physician Decision|0
2246782|NCT01987908|3908223|FG002|Placebo Lead-in Period|Physician Decision|0
2246783|NCT01987908|3908221|FG000|Placebo Lead-in Period|Withdrawal by Subject|1
2246784|NCT01987908|3908222|FG001|Placebo Lead-in Period|Withdrawal by Subject|0
2246785|NCT01987908|3908223|FG002|Placebo Lead-in Period|Withdrawal by Subject|0
2246786|NCT01987908|3908221|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
2246787|NCT01987908|3908222|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
2246788|NCT01987908|3908223|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
2246789|NCT01987908|3908221|FG000|Treatment Period|Adverse Event|0
2246790|NCT01987908|3908222|FG001|Treatment Period|Adverse Event|1
2246791|NCT01987908|3908223|FG002|Treatment Period|Adverse Event|1
2246792|NCT01987908|3908221|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
2246793|NCT01987908|3908222|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
2246794|NCT01987908|3908223|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
2246795|NCT01987908|3908221|FG000|Post-Treatment Observation Period|Other: Bad Veins|0
2246796|NCT01987908|3908222|FG001|Post-Treatment Observation Period|Other: Bad Veins|1
2246797|NCT01987908|3908223|FG002|Post-Treatment Observation Period|Other: Bad Veins|0
2339597|NCT03373383|4068769|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2
2339598|NCT03373383|4068770|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
2339599|NCT03373383|4068771|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
2339600|NCT03373383|4068772|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0
2339601|NCT03373383|4068773|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0
2339602|NCT03373383|4068769|FG000|Treatment Period: Wk0-16|Protocol Violation|0
2339603|NCT03373383|4068770|FG001|Treatment Period: Wk0-16|Protocol Violation|4
2339604|NCT03373383|4068771|FG002|Treatment Period: Wk0-16|Protocol Violation|2
2246798|NCT01987960|3908249|FG000|Period 1|Adverse Event|24
2246799|NCT01987960|3908250|FG001|Period 1|Adverse Event|0
2246800|NCT01987960|3908251|FG002|Period 1|Adverse Event|0
2246801|NCT01987960|3908252|FG003|Period 1|Adverse Event|0
2246802|NCT01987960|3908249|FG000|Period 1|Lack of Efficacy|4
2246803|NCT01987960|3908250|FG001|Period 1|Lack of Efficacy|0
2246804|NCT01987960|3908251|FG002|Period 1|Lack of Efficacy|0
2246805|NCT01987960|3908252|FG003|Period 1|Lack of Efficacy|0
2339605|NCT03373383|4068772|FG003|Treatment Period: Wk0-16|Protocol Violation|1
2339606|NCT03373383|4068773|FG004|Treatment Period: Wk0-16|Protocol Violation|0
2339607|NCT03373383|4068769|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2
2339608|NCT03373383|4068770|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0
2339609|NCT03373383|4068771|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0
2339610|NCT03373383|4068772|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0
2339611|NCT03373383|4068773|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0
2339612|NCT03373383|4068769|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2
2339613|NCT03373383|4068770|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3
2339614|NCT03373383|4068771|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2
2339615|NCT03373383|4068772|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3
2339616|NCT03373383|4068773|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3
2339617|NCT03373383|4068769|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0
2339618|NCT03373383|4068770|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1
2339619|NCT03373383|4068771|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0
2339620|NCT03373383|4068772|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0
2339621|NCT03373383|4068773|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0
2339622|NCT03373383|4068769|FG000|Treatment Period: Wk0-16|By opinion of investigator|0
2339623|NCT03373383|4068770|FG001|Treatment Period: Wk0-16|By opinion of investigator|0
2037962|NCT00420927|3608335|FG005|Period 2|Lack of efficacy/Loss of efficacy|2
2037963|NCT00420927|3608336|FG006|Period 2|Lack of efficacy/Loss of efficacy|6
2037964|NCT00420927|3608330|FG000|Period 2|Received wrong treatment/incorrect dose|0
2037965|NCT00420927|3608331|FG001|Period 2|Received wrong treatment/incorrect dose|0
2037966|NCT00420927|3608332|FG002|Period 2|Received wrong treatment/incorrect dose|0
2037967|NCT00420927|3608333|FG003|Period 2|Received wrong treatment/incorrect dose|0
2037968|NCT00420927|3608334|FG004|Period 2|Received wrong treatment/incorrect dose|0
2037969|NCT00420927|3608335|FG005|Period 2|Received wrong treatment/incorrect dose|0
2037970|NCT00420927|3608336|FG006|Period 2|Received wrong treatment/incorrect dose|1
2037971|NCT00420927|3608330|FG000|Period 2|Subject unable to find transportation|0
2037972|NCT00420927|3608331|FG001|Period 2|Subject unable to find transportation|0
2037973|NCT00420927|3608332|FG002|Period 2|Subject unable to find transportation|0
2037974|NCT00420927|3608333|FG003|Period 2|Subject unable to find transportation|0
2037975|NCT00420927|3608334|FG004|Period 2|Subject unable to find transportation|0
2037976|NCT00420927|3608335|FG005|Period 2|Subject unable to find transportation|0
2037977|NCT00420927|3608336|FG006|Period 2|Subject unable to find transportation|1
2037978|NCT00420927|3608330|FG000|Period 2|Physician Decision|0
2037979|NCT00420927|3608331|FG001|Period 2|Physician Decision|0
2037980|NCT00420927|3608332|FG002|Period 2|Physician Decision|0
2037981|NCT00420927|3608333|FG003|Period 2|Physician Decision|0
2037982|NCT00420927|3608334|FG004|Period 2|Physician Decision|1
2037983|NCT00420927|3608335|FG005|Period 2|Physician Decision|1
2246806|NCT01987960|3908249|FG000|Period 1|Non-compliance with IMP|6
2246807|NCT01987960|3908250|FG001|Period 1|Non-compliance with IMP|0
2246808|NCT01987960|3908251|FG002|Period 1|Non-compliance with IMP|0
2246809|NCT01987960|3908252|FG003|Period 1|Non-compliance with IMP|0
2246810|NCT01987960|3908249|FG000|Period 1|Protocol Violation|12
2246811|NCT01987960|3908250|FG001|Period 1|Protocol Violation|0
2246812|NCT01987960|3908251|FG002|Period 1|Protocol Violation|0
2246813|NCT01987960|3908252|FG003|Period 1|Protocol Violation|0
2246814|NCT01987960|3908249|FG000|Period 1|Withdrawal by Subject|21
2246815|NCT01987960|3908250|FG001|Period 1|Withdrawal by Subject|0
2246816|NCT01987960|3908251|FG002|Period 1|Withdrawal by Subject|0
2246817|NCT01987960|3908252|FG003|Period 1|Withdrawal by Subject|0
2246818|NCT01987960|3908249|FG000|Period 1|Lost to Follow-up|40
2246819|NCT01987960|3908250|FG001|Period 1|Lost to Follow-up|0
2246820|NCT01987960|3908251|FG002|Period 1|Lost to Follow-up|0
2246821|NCT01987960|3908252|FG003|Period 1|Lost to Follow-up|0
2246822|NCT01987960|3908249|FG000|Period 1|administrative or other reason|75
2246823|NCT01987960|3908250|FG001|Period 1|administrative or other reason|0
2246824|NCT01987960|3908251|FG002|Period 1|administrative or other reason|0
2246825|NCT01987960|3908252|FG003|Period 1|administrative or other reason|0
2246826|NCT01987960|3908249|FG000|Period 1|Withdrawal of consent before treatment|4
2246827|NCT01987960|3908250|FG001|Period 1|Withdrawal of consent before treatment|0
2246828|NCT01987960|3908251|FG002|Period 1|Withdrawal of consent before treatment|0
2246829|NCT01987960|3908252|FG003|Period 1|Withdrawal of consent before treatment|0
2246830|NCT01987960|3908249|FG000|Period 2|Adverse Event|0
2246831|NCT01987960|3908250|FG001|Period 2|Adverse Event|0
2246832|NCT01987960|3908251|FG002|Period 2|Adverse Event|1
2246833|NCT01987960|3908252|FG003|Period 2|Adverse Event|0
2246834|NCT01987960|3908249|FG000|Period 2|Withdrawal by Subject|0
2246835|NCT01987960|3908250|FG001|Period 2|Withdrawal by Subject|0
2246836|NCT01987960|3908251|FG002|Period 2|Withdrawal by Subject|1
2246837|NCT01987960|3908252|FG003|Period 2|Withdrawal by Subject|0
2246838|NCT01987960|3908249|FG000|Period 2|Administrative or other reason|0
2246839|NCT01987960|3908250|FG001|Period 2|Administrative or other reason|5
2246840|NCT01987960|3908251|FG002|Period 2|Administrative or other reason|7
2246841|NCT01987960|3908252|FG003|Period 2|Administrative or other reason|0
2246842|NCT01987960|3908249|FG000|Period 3|Adverse Event|0
2246843|NCT01987960|3908250|FG001|Period 3|Adverse Event|0
2246844|NCT01987960|3908251|FG002|Period 3|Adverse Event|0
2246845|NCT01987960|3908252|FG003|Period 3|Adverse Event|7
2246846|NCT01987960|3908249|FG000|Period 3|Non-compliance with IMP|0
2246847|NCT01987960|3908250|FG001|Period 3|Non-compliance with IMP|0
2246848|NCT01987960|3908251|FG002|Period 3|Non-compliance with IMP|0
2246849|NCT01987960|3908252|FG003|Period 3|Non-compliance with IMP|1
2246850|NCT01987960|3908249|FG000|Period 3|Protocol Violation|0
2246851|NCT01987960|3908250|FG001|Period 3|Protocol Violation|0
2246852|NCT01987960|3908251|FG002|Period 3|Protocol Violation|0
2246853|NCT01987960|3908252|FG003|Period 3|Protocol Violation|6
2246854|NCT01987960|3908249|FG000|Period 3|Withdrawal by Subject|0
2246855|NCT01987960|3908250|FG001|Period 3|Withdrawal by Subject|0
2246856|NCT01987960|3908251|FG002|Period 3|Withdrawal by Subject|0
2246857|NCT01987960|3908252|FG003|Period 3|Withdrawal by Subject|9
2246858|NCT01987960|3908249|FG000|Period 3|Lost to Follow-up|0
2246859|NCT01987960|3908250|FG001|Period 3|Lost to Follow-up|0
2339624|NCT03373383|4068771|FG002|Treatment Period: Wk0-16|By opinion of investigator|0
2339625|NCT03373383|4068772|FG003|Treatment Period: Wk0-16|By opinion of investigator|1
2339626|NCT03373383|4068773|FG004|Treatment Period: Wk0-16|By opinion of investigator|0
2339627|NCT03373383|4068769|FG000|Treatment Period: Wk0-16|Sponsor decision|0
2339628|NCT03373383|4068770|FG001|Treatment Period: Wk0-16|Sponsor decision|0
2339629|NCT03373383|4068771|FG002|Treatment Period: Wk0-16|Sponsor decision|0
2339630|NCT03373383|4068772|FG003|Treatment Period: Wk0-16|Sponsor decision|1
2339631|NCT03373383|4068773|FG004|Treatment Period: Wk0-16|Sponsor decision|0
2339632|NCT03373383|4068769|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1
2339633|NCT03373383|4068770|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
2339634|NCT03373383|4068771|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
2339635|NCT03373383|4068772|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
2339636|NCT03373383|4068773|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
2339637|NCT03374189|4068835|FG000|Overall Study|Lost to Follow-up|1
2339638|NCT03374189|4068836|FG001|Overall Study|Lost to Follow-up|0
2339639|NCT03374358|4068844|FG000|Overall Study|Withdrawal by Subject|0
2339640|NCT03374358|4068845|FG001|Overall Study|Withdrawal by Subject|2
2339641|NCT03374488|4068853|FG000|Overall Study|Death|13
2339642|NCT03374488|4068854|FG001|Overall Study|Death|13
2339643|NCT03374488|4068853|FG000|Overall Study|Withdrawal by Subject|3
2339644|NCT03374488|4068854|FG001|Overall Study|Withdrawal by Subject|1
2339645|NCT03374488|4068853|FG000|Overall Study|Physician Decision|3
2339646|NCT03374488|4068854|FG001|Overall Study|Physician Decision|0
2339647|NCT03374995|4068876|FG000|Overall Study|Withdrawal by Subject|0
2339648|NCT03374995|4068877|FG001|Overall Study|Withdrawal by Subject|1
2339649|NCT03376321|4068917|FG000|Overall Study|Other|5
2339650|NCT03376321|4068918|FG001|Overall Study|Other|1
2339651|NCT03376321|4068917|FG000|Overall Study|Withdrawal by Subject|8
2339652|NCT03376321|4068918|FG001|Overall Study|Withdrawal by Subject|14
2339653|NCT03376321|4068917|FG000|Overall Study|Lost to Follow-up|1
2339654|NCT03376321|4068918|FG001|Overall Study|Lost to Follow-up|7
2246860|NCT01987960|3908251|FG002|Period 3|Lost to Follow-up|0
2246861|NCT01987960|3908252|FG003|Period 3|Lost to Follow-up|5
2246862|NCT01987960|3908249|FG000|Period 3|Administrative or other reason|0
2246863|NCT01987960|3908250|FG001|Period 3|Administrative or other reason|0
2246864|NCT01987960|3908251|FG002|Period 3|Administrative or other reason|0
2246865|NCT01987960|3908252|FG003|Period 3|Administrative or other reason|43
2246866|NCT01987986|3908266|FG000|Overall Study|Lost to Follow-up|1
2246867|NCT01987986|3908267|FG001|Overall Study|Lost to Follow-up|0
2246868|NCT01987986|3908268|FG002|Overall Study|Lost to Follow-up|0
2246869|NCT01987986|3908269|FG003|Overall Study|Lost to Follow-up|0
2246870|NCT01987986|3908266|FG000|Overall Study|Adverse Event|1
2246871|NCT01987986|3908267|FG001|Overall Study|Adverse Event|0
2246872|NCT01987986|3908268|FG002|Overall Study|Adverse Event|2
2246873|NCT01987986|3908269|FG003|Overall Study|Adverse Event|0
2246874|NCT01988012|3908279|FG000|Overall Study|Adverse Event|5
2246875|NCT01988012|3908279|FG000|Overall Study|Insufficient Therapeutic Response|3
2246876|NCT01988012|3908279|FG000|Overall Study|Patient Withdrawal of Consent|4
2246877|NCT01988012|3908279|FG000|Overall Study|Lost to Follow-up|1
2246878|NCT01988012|3908279|FG000|Overall Study|Physician Decision|1
2246879|NCT01988012|3908279|FG000|Overall Study|Protocol Violation|1
2246880|NCT01988090|3908285|FG000|Start Treament After Randomization|Withdrawal by Subject|2
2246881|NCT01988090|3908286|FG001|Start Treament After Randomization|Withdrawal by Subject|3
2246882|NCT01988090|3908285|FG000|Start Treament After Randomization|Protocol Violation|0
2246883|NCT01988090|3908286|FG001|Start Treament After Randomization|Protocol Violation|1
2246884|NCT01988090|3908285|FG000|Complete Study After Start|Withdrawal by Subject|2
2246885|NCT01988090|3908286|FG001|Complete Study After Start|Withdrawal by Subject|0
2246886|NCT01988090|3908285|FG000|Complete Study After Start|Protocol Violation|1
2246887|NCT01988090|3908286|FG001|Complete Study After Start|Protocol Violation|1
2246888|NCT01988103|3908295|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3
2246889|NCT01988103|3908296|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10
2246890|NCT01988103|3908297|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6
2246891|NCT01988103|3908298|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0
2246892|NCT01988103|3908299|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0
2246893|NCT01988103|3908295|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
2246894|NCT01988103|3908296|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
2246895|NCT01988103|3908297|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
2246896|NCT01988103|3908298|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
2246897|NCT01988103|3908299|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
2246898|NCT01988103|3908295|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
2246899|NCT01988103|3908296|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
2246900|NCT01988103|3908297|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
2246901|NCT01988103|3908298|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
2246902|NCT01988103|3908299|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
2246903|NCT01988103|3908295|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
2246904|NCT01988103|3908296|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
2246905|NCT01988103|3908297|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
2246906|NCT01988103|3908298|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
2246907|NCT01988103|3908299|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
2246908|NCT01988103|3908295|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
2246909|NCT01988103|3908296|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
2339655|NCT03376321|4068917|FG000|Overall Study|Death|4
2339656|NCT03376321|4068918|FG001|Overall Study|Death|0
2339657|NCT03376321|4068917|FG000|Overall Study|Randomized, not treated|5
2339658|NCT03376321|4068918|FG001|Overall Study|Randomized, not treated|3
2339659|NCT03376516|4068924|FG000|Overall Study|Not treated|1
2339660|NCT03376516|4068924|FG000|Overall Study|Consent withdrawn|1
2339661|NCT03377556|4068961|FG000|Overall Study|Adverse Event|5
2339662|NCT03377556|4068961|FG000|Overall Study|Refusal unrelated to adverse events|1
2339663|NCT03377556|4068961|FG000|Overall Study|Progression/relapse|38
2339664|NCT03377556|4068961|FG000|Overall Study|Death|3
2339665|NCT03377634|4068967|FG000|Study Period|Adverse Event|1
2339666|NCT03377634|4068968|FG001|Study Period|Adverse Event|0
2339667|NCT03377634|4068967|FG000|Study Period|Withdrawal by Subject|1
2339668|NCT03377634|4068968|FG001|Study Period|Withdrawal by Subject|0
2339669|NCT03378635|4068986|FG000|Overall Study|Adverse Event|1
2339670|NCT03378635|4068987|FG001|Overall Study|Adverse Event|0
2339671|NCT03378635|4068988|FG002|Overall Study|Adverse Event|0
2339672|NCT03378635|4068986|FG000|Overall Study|Withdrawal by Subject|1
2339673|NCT03378635|4068987|FG001|Overall Study|Withdrawal by Subject|0
2339674|NCT03378635|4068988|FG002|Overall Study|Withdrawal by Subject|0
2339675|NCT03379259|4069021|FG000|Overall Study|Commenced new anti-cancer therapy|1
2339676|NCT03379259|4069022|FG001|Overall Study|Commenced new anti-cancer therapy|0
2339677|NCT03379259|4069023|FG002|Overall Study|Commenced new anti-cancer therapy|0
2339678|NCT03379259|4069024|FG003|Overall Study|Commenced new anti-cancer therapy|0
2339679|NCT03379259|4069025|FG004|Overall Study|Commenced new anti-cancer therapy|0
2339680|NCT03379259|4069026|FG005|Overall Study|Commenced new anti-cancer therapy|0
2339681|NCT03379259|4069021|FG000|Overall Study|Death|0
2339682|NCT03379259|4069022|FG001|Overall Study|Death|1
2339683|NCT03379259|4069023|FG002|Overall Study|Death|2
2246910|NCT01988103|3908297|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
2246911|NCT01988103|3908298|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
2246912|NCT01988103|3908299|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
2246913|NCT01988103|3908295|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
2246914|NCT01988103|3908296|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
2246915|NCT01988103|3908297|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
2246916|NCT01988103|3908298|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
2246917|NCT01988103|3908299|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
2246918|NCT01988103|3908295|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
2246919|NCT01988103|3908296|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
2246920|NCT01988103|3908297|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
2246921|NCT01988103|3908298|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
2246922|NCT01988103|3908299|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
2246923|NCT01988402|3908346|FG000|Overall Study|Adverse Event|1
2246924|NCT01988402|3908347|FG001|Overall Study|Adverse Event|2
2246925|NCT01988402|3908346|FG000|Overall Study|Withdrawal by Subject|1
2246926|NCT01988402|3908347|FG001|Overall Study|Withdrawal by Subject|0
2246927|NCT01988493|3908364|FG000|Overall Study|Randomized but not treated|0
2246928|NCT01988493|3908365|FG001|Overall Study|Randomized but not treated|0
2246929|NCT01988493|3908366|FG002|Overall Study|Randomized but not treated|0
2246930|NCT01988493|3908367|FG003|Overall Study|Randomized but not treated|0
2246931|NCT01988493|3908368|FG004|Overall Study|Randomized but not treated|1
2246932|NCT01988493|3908364|FG000|Overall Study|Ongoing|0
2246933|NCT01988493|3908365|FG001|Overall Study|Ongoing|0
2246934|NCT01988493|3908366|FG002|Overall Study|Ongoing|0
2246935|NCT01988493|3908367|FG003|Overall Study|Ongoing|2
2246936|NCT01988493|3908368|FG004|Overall Study|Ongoing|0
2246937|NCT01988662|3908382|FG000|Overall Study|Subject/guardian decision|1
2246938|NCT01988662|3908383|FG001|Overall Study|Subject/guardian decision|1
2246939|NCT01988662|3908382|FG000|Overall Study|Adverse Event|3
2246940|NCT01988662|3908383|FG001|Overall Study|Adverse Event|1
2246941|NCT01988779|3908392|FG000|Overall Study|Withdrawal by Subject|2
2246942|NCT01988779|3908393|FG001|Overall Study|Withdrawal by Subject|2
2246943|NCT01988779|3908392|FG000|Overall Study|Protocol Violation|1
2246944|NCT01988779|3908393|FG001|Overall Study|Protocol Violation|0
2246945|NCT01989156|3908431|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
2246946|NCT01989156|3908432|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2246947|NCT01989156|3908433|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
2246948|NCT01989156|3908431|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0
2246949|NCT01989156|3908432|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0
2246950|NCT01989156|3908433|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1
2246951|NCT01989156|3908431|FG000|Confinement Period (Population at Day 5)|Adverse Event|0
2246952|NCT01989156|3908432|FG001|Confinement Period (Population at Day 5)|Adverse Event|0
2246953|NCT01989156|3908433|FG002|Confinement Period (Population at Day 5)|Adverse Event|1
2246954|NCT01989156|3908431|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2
2246955|NCT01989156|3908432|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2
2246956|NCT01989156|3908433|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2
2246957|NCT01989156|3908431|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3
2246958|NCT01989156|3908432|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2
2246959|NCT01989156|3908433|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0
2246960|NCT01989156|3908431|FG000|End of Study (Population at Day 90)|Physician Decision|1
2246961|NCT01989156|3908432|FG001|End of Study (Population at Day 90)|Physician Decision|0
2246962|NCT01989156|3908433|FG002|End of Study (Population at Day 90)|Physician Decision|1
2246963|NCT01989156|3908431|FG000|End of Study (Population at Day 90)|Moved out of state|1
2246964|NCT01989156|3908432|FG001|End of Study (Population at Day 90)|Moved out of state|0
2246965|NCT01989156|3908433|FG002|End of Study (Population at Day 90)|Moved out of state|0
2246966|NCT01989156|3908431|FG000|End of Study (Population at Day 90)|Employment Conflict|0
2246967|NCT01989156|3908432|FG001|End of Study (Population at Day 90)|Employment Conflict|1
2246968|NCT01989156|3908433|FG002|End of Study (Population at Day 90)|Employment Conflict|0
2339684|NCT03379259|4069024|FG003|Overall Study|Death|1
2339685|NCT03379259|4069025|FG004|Overall Study|Death|4
2339686|NCT03379259|4069026|FG005|Overall Study|Death|2
2339687|NCT03379259|4069021|FG000|Overall Study|Withdrawal by Subject|0
2339688|NCT03379259|4069022|FG001|Overall Study|Withdrawal by Subject|0
2339689|NCT03379259|4069023|FG002|Overall Study|Withdrawal by Subject|1
2339690|NCT03379259|4069024|FG003|Overall Study|Withdrawal by Subject|0
2339691|NCT03379259|4069025|FG004|Overall Study|Withdrawal by Subject|2
2339692|NCT03379259|4069026|FG005|Overall Study|Withdrawal by Subject|0
2339693|NCT03379259|4069021|FG000|Overall Study|Study terminated by sponsor|0
2339694|NCT03379259|4069022|FG001|Overall Study|Study terminated by sponsor|0
2339695|NCT03379259|4069023|FG002|Overall Study|Study terminated by sponsor|0
2339696|NCT03379259|4069024|FG003|Overall Study|Study terminated by sponsor|1
2339697|NCT03379259|4069025|FG004|Overall Study|Study terminated by sponsor|1
2037984|NCT00420927|3608336|FG006|Period 2|Physician Decision|0
2037985|NCT00420927|3608330|FG000|Period 2|Sponsor decision|0
2246969|NCT01989169|3908443|FG000|Period 2|Adverse Event|0
2246970|NCT01989169|3908444|FG001|Period 2|Adverse Event|1
2246971|NCT01989208|3908459|FG000|200 mg (7 Days)|Protocol Violation|0
2246972|NCT01989208|3908460|FG001|200 mg (7 Days)|Protocol Violation|1
2246973|NCT01989455|3908487|FG000|Overall Study|Adverse Event|0
2246974|NCT01989455|3908488|FG001|Overall Study|Adverse Event|1
2246975|NCT01989455|3908489|FG002|Overall Study|Adverse Event|0
2246976|NCT01989455|3908490|FG003|Overall Study|Adverse Event|0
2246977|NCT01989455|3908491|FG004|Overall Study|Adverse Event|0
2246978|NCT01989455|3908487|FG000|Overall Study|Withdrawal by Subject|0
2246979|NCT01989455|3908488|FG001|Overall Study|Withdrawal by Subject|1
2246980|NCT01989455|3908489|FG002|Overall Study|Withdrawal by Subject|0
2246981|NCT01989455|3908490|FG003|Overall Study|Withdrawal by Subject|0
2246982|NCT01989455|3908491|FG004|Overall Study|Withdrawal by Subject|0
2246983|NCT01989455|3908487|FG000|Overall Study|Technical problems with infusion|0
2246984|NCT01989455|3908488|FG001|Overall Study|Technical problems with infusion|0
2246985|NCT01989455|3908489|FG002|Overall Study|Technical problems with infusion|1
2246986|NCT01989455|3908490|FG003|Overall Study|Technical problems with infusion|0
2246987|NCT01989455|3908491|FG004|Overall Study|Technical problems with infusion|1
2246988|NCT01989468|3908510|FG000|Overall Study|Adverse Event|10
2246989|NCT01989468|3908511|FG001|Overall Study|Adverse Event|15
2246990|NCT01989468|3908512|FG002|Overall Study|Adverse Event|4
2246991|NCT01989468|3908513|FG003|Overall Study|Adverse Event|5
2246992|NCT01989468|3908514|FG004|Overall Study|Adverse Event|4
2246993|NCT01989468|3908510|FG000|Overall Study|Lack of Efficacy|11
2246994|NCT01989468|3908511|FG001|Overall Study|Lack of Efficacy|11
2246995|NCT01989468|3908512|FG002|Overall Study|Lack of Efficacy|7
2246996|NCT01989468|3908513|FG003|Overall Study|Lack of Efficacy|4
2246997|NCT01989468|3908514|FG004|Overall Study|Lack of Efficacy|2
2246998|NCT01989468|3908510|FG000|Overall Study|Lost to Follow-up|5
2246999|NCT01989468|3908511|FG001|Overall Study|Lost to Follow-up|2
2247000|NCT01989468|3908512|FG002|Overall Study|Lost to Follow-up|0
2247001|NCT01989468|3908513|FG003|Overall Study|Lost to Follow-up|1
2247002|NCT01989468|3908514|FG004|Overall Study|Lost to Follow-up|1
2247003|NCT01989468|3908510|FG000|Overall Study|Physician Decision|4
2247004|NCT01989468|3908511|FG001|Overall Study|Physician Decision|1
2247005|NCT01989468|3908512|FG002|Overall Study|Physician Decision|0
2247006|NCT01989468|3908513|FG003|Overall Study|Physician Decision|1
2247007|NCT01989468|3908514|FG004|Overall Study|Physician Decision|0
2247008|NCT01989468|3908510|FG000|Overall Study|Pregnancy|0
2247009|NCT01989468|3908511|FG001|Overall Study|Pregnancy|1
2247010|NCT01989468|3908512|FG002|Overall Study|Pregnancy|0
2247011|NCT01989468|3908513|FG003|Overall Study|Pregnancy|0
2247012|NCT01989468|3908514|FG004|Overall Study|Pregnancy|0
2247013|NCT01989468|3908510|FG000|Overall Study|Technical Problems|3
2247014|NCT01989468|3908511|FG001|Overall Study|Technical Problems|1
2247015|NCT01989468|3908512|FG002|Overall Study|Technical Problems|3
2247016|NCT01989468|3908513|FG003|Overall Study|Technical Problems|1
2247017|NCT01989468|3908514|FG004|Overall Study|Technical Problems|0
2247018|NCT01989468|3908510|FG000|Overall Study|Subject Guardian Decision|11
2247019|NCT01989468|3908511|FG001|Overall Study|Subject Guardian Decision|6
2247020|NCT01989468|3908512|FG002|Overall Study|Subject Guardian Decision|4
2247021|NCT01989468|3908513|FG003|Overall Study|Subject Guardian Decision|4
2247022|NCT01989468|3908514|FG004|Overall Study|Subject Guardian Decision|1
2247023|NCT01989468|3908510|FG000|Overall Study|Death|3
2247024|NCT01989468|3908511|FG001|Overall Study|Death|0
2247025|NCT01989468|3908512|FG002|Overall Study|Death|1
2339698|NCT03379259|4069026|FG005|Overall Study|Study terminated by sponsor|4
2339699|NCT03379259|4069021|FG000|Overall Study|Disease progression|0
2339700|NCT03379259|4069022|FG001|Overall Study|Disease progression|0
2339701|NCT03379259|4069023|FG002|Overall Study|Disease progression|0
2339702|NCT03379259|4069024|FG003|Overall Study|Disease progression|1
2339703|NCT03379259|4069025|FG004|Overall Study|Disease progression|0
2339704|NCT03379259|4069026|FG005|Overall Study|Disease progression|1
2339705|NCT03379259|4069021|FG000|Overall Study|Lost to Follow-up|0
2339706|NCT03379259|4069022|FG001|Overall Study|Lost to Follow-up|0
2339707|NCT03379259|4069023|FG002|Overall Study|Lost to Follow-up|0
2339708|NCT03379259|4069024|FG003|Overall Study|Lost to Follow-up|0
2339709|NCT03379259|4069025|FG004|Overall Study|Lost to Follow-up|1
2339710|NCT03379259|4069026|FG005|Overall Study|Lost to Follow-up|0
2339711|NCT03379259|4069021|FG000|Overall Study|Deteriorating condition|0
2339712|NCT03379259|4069022|FG001|Overall Study|Deteriorating condition|0
2339713|NCT03379259|4069023|FG002|Overall Study|Deteriorating condition|0
2339714|NCT03379259|4069024|FG003|Overall Study|Deteriorating condition|0
2339715|NCT03379259|4069025|FG004|Overall Study|Deteriorating condition|1
2339716|NCT03379259|4069026|FG005|Overall Study|Deteriorating condition|0
2339717|NCT03379376|4069043|FG000|Overall Study|Lost to Follow-up|2
2339718|NCT03379376|4069043|FG000|Overall Study|Did not wish to complete follow up|1
2247026|NCT01989468|3908513|FG003|Overall Study|Death|0
2247027|NCT01989468|3908514|FG004|Overall Study|Death|0
2247028|NCT01989546|3908527|FG000|Overall Study|Clinical Progression|1
2247029|NCT01989546|3908527|FG000|Overall Study|Disease progression on study|8
2247030|NCT01989572|3908537|FG000|Overall Study|Lack of Efficacy|35
2247031|NCT01989572|3908538|FG001|Overall Study|Lack of Efficacy|48
2247032|NCT01989572|3908539|FG002|Overall Study|Lack of Efficacy|48
2247033|NCT01989572|3908540|FG003|Overall Study|Lack of Efficacy|43
2247034|NCT01989572|3908541|FG004|Overall Study|Lack of Efficacy|71
2247035|NCT01989572|3908542|FG005|Overall Study|Lack of Efficacy|79
2247036|NCT01989572|3908537|FG000|Overall Study|Adverse Event|2
2247037|NCT01989572|3908538|FG001|Overall Study|Adverse Event|1
2247038|NCT01989572|3908539|FG002|Overall Study|Adverse Event|3
2247039|NCT01989572|3908540|FG003|Overall Study|Adverse Event|0
2247040|NCT01989572|3908541|FG004|Overall Study|Adverse Event|3
2247041|NCT01989572|3908542|FG005|Overall Study|Adverse Event|0
2247042|NCT01989572|3908537|FG000|Overall Study|Death|0
2247043|NCT01989572|3908538|FG001|Overall Study|Death|0
2247044|NCT01989572|3908539|FG002|Overall Study|Death|0
2247045|NCT01989572|3908540|FG003|Overall Study|Death|0
2247046|NCT01989572|3908541|FG004|Overall Study|Death|1
2247047|NCT01989572|3908542|FG005|Overall Study|Death|0
2247048|NCT01989572|3908537|FG000|Overall Study|Withdrawal by Subject|4
2247049|NCT01989572|3908538|FG001|Overall Study|Withdrawal by Subject|1
2247050|NCT01989572|3908539|FG002|Overall Study|Withdrawal by Subject|5
2339719|NCT03379376|4069043|FG000|Overall Study|Overwhelmed, didn't want to continue|1
2339720|NCT03379376|4069043|FG000|Overall Study|Death|1
2339721|NCT03379753|4069096|FG000|Overall Study|Withdrawal by Subject|2
2339722|NCT03379753|4069097|FG001|Overall Study|Withdrawal by Subject|1
2339723|NCT03379753|4069096|FG000|Overall Study|not having correct procedure|1
2339724|NCT03379753|4069097|FG001|Overall Study|not having correct procedure|2
2037986|NCT00420927|3608331|FG001|Period 2|Sponsor decision|0
2037987|NCT00420927|3608332|FG002|Period 2|Sponsor decision|1
2037988|NCT00420927|3608333|FG003|Period 2|Sponsor decision|0
2037989|NCT00420927|3608334|FG004|Period 2|Sponsor decision|0
2037990|NCT00420927|3608335|FG005|Period 2|Sponsor decision|0
2037991|NCT00420927|3608336|FG006|Period 2|Sponsor decision|1
2037992|NCT00420927|3608330|FG000|Period 2|Randomization error|0
2037993|NCT00420927|3608331|FG001|Period 2|Randomization error|0
2037994|NCT00420927|3608332|FG002|Period 2|Randomization error|0
2037995|NCT00420927|3608333|FG003|Period 2|Randomization error|0
2037996|NCT00420927|3608334|FG004|Period 2|Randomization error|1
2037997|NCT00420927|3608335|FG005|Period 2|Randomization error|1
2037998|NCT00420927|3608336|FG006|Period 2|Randomization error|0
2037999|NCT00420927|3608330|FG000|Period 2|Noncompliant with study drug|0
2038000|NCT00420927|3608331|FG001|Period 2|Noncompliant with study drug|0
2038001|NCT00420927|3608332|FG002|Period 2|Noncompliant with study drug|0
2038002|NCT00420927|3608333|FG003|Period 2|Noncompliant with study drug|1
2038003|NCT00420927|3608334|FG004|Period 2|Noncompliant with study drug|0
2038004|NCT00420927|3608335|FG005|Period 2|Noncompliant with study drug|0
2038005|NCT00420927|3608336|FG006|Period 2|Noncompliant with study drug|2
2038006|NCT00420927|3608330|FG000|Period 2|Methotrexate intolerance|0
2038007|NCT00420927|3608331|FG001|Period 2|Methotrexate intolerance|0
2038008|NCT00420927|3608332|FG002|Period 2|Methotrexate intolerance|0
2038009|NCT00420927|3608333|FG003|Period 2|Methotrexate intolerance|0
2038010|NCT00420927|3608334|FG004|Period 2|Methotrexate intolerance|0
2038011|NCT00420927|3608335|FG005|Period 2|Methotrexate intolerance|0
2038012|NCT00420927|3608336|FG006|Period 2|Methotrexate intolerance|1
2038013|NCT00420927|3608330|FG000|Period 2|Took prohibited medication|0
2038014|NCT00420927|3608331|FG001|Period 2|Took prohibited medication|0
2038015|NCT00420927|3608332|FG002|Period 2|Took prohibited medication|0
2038016|NCT00420927|3608333|FG003|Period 2|Took prohibited medication|0
2038017|NCT00420927|3608334|FG004|Period 2|Took prohibited medication|1
2038018|NCT00420927|3608335|FG005|Period 2|Took prohibited medication|0
2038019|NCT00420927|3608336|FG006|Period 2|Took prohibited medication|0
2038020|NCT00421148|3608380|FG000|Overall Study|Lost to Follow-up|0
2038021|NCT00421148|3608381|FG001|Overall Study|Lost to Follow-up|0
2038022|NCT00421148|3608382|FG002|Overall Study|Lost to Follow-up|0
2038023|NCT00421148|3608383|FG003|Overall Study|Lost to Follow-up|0
2038024|NCT00421148|3608384|FG004|Overall Study|Lost to Follow-up|0
2038025|NCT00421148|3608385|FG005|Overall Study|Lost to Follow-up|0
2038026|NCT00421148|3608386|FG006|Overall Study|Lost to Follow-up|0
2038027|NCT00421148|3608387|FG007|Overall Study|Lost to Follow-up|0
2038028|NCT00421148|3608388|FG008|Overall Study|Lost to Follow-up|0
2038029|NCT00421148|3608389|FG009|Overall Study|Lost to Follow-up|0
2038030|NCT00421148|3608390|FG010|Overall Study|Lost to Follow-up|0
2038031|NCT00421148|3608391|FG011|Overall Study|Lost to Follow-up|0
2038032|NCT00421148|3608392|FG012|Overall Study|Lost to Follow-up|0
2038033|NCT00421148|3608393|FG013|Overall Study|Lost to Follow-up|0
2038034|NCT00421148|3608394|FG014|Overall Study|Lost to Follow-up|0
2038035|NCT00421148|3608395|FG015|Overall Study|Lost to Follow-up|0
2038036|NCT00421148|3608396|FG016|Overall Study|Lost to Follow-up|0
2038037|NCT00421148|3608397|FG017|Overall Study|Lost to Follow-up|1
2038038|NCT00421148|3608398|FG018|Overall Study|Lost to Follow-up|0
2038039|NCT00421148|3608399|FG019|Overall Study|Lost to Follow-up|0
2038040|NCT00421148|3608380|FG000|Overall Study|Withdrawal by Subject|0
2038041|NCT00421148|3608381|FG001|Overall Study|Withdrawal by Subject|0
2038042|NCT00421148|3608382|FG002|Overall Study|Withdrawal by Subject|0
2038043|NCT00421148|3608383|FG003|Overall Study|Withdrawal by Subject|0
2247051|NCT01989572|3908540|FG003|Overall Study|Withdrawal by Subject|1
2247052|NCT01989572|3908541|FG004|Overall Study|Withdrawal by Subject|12
2247053|NCT01989572|3908542|FG005|Overall Study|Withdrawal by Subject|4
2247054|NCT01989572|3908537|FG000|Overall Study|complicating disease|1
2247055|NCT01989572|3908538|FG001|Overall Study|complicating disease|1
2247056|NCT01989572|3908539|FG002|Overall Study|complicating disease|2
2247057|NCT01989572|3908540|FG003|Overall Study|complicating disease|0
2247058|NCT01989572|3908541|FG004|Overall Study|complicating disease|1
2247059|NCT01989572|3908542|FG005|Overall Study|complicating disease|0
2247060|NCT01989572|3908537|FG000|Overall Study|error|2
2247061|NCT01989572|3908538|FG001|Overall Study|error|1
2247062|NCT01989572|3908539|FG002|Overall Study|error|1
2247063|NCT01989572|3908540|FG003|Overall Study|error|1
2247064|NCT01989572|3908541|FG004|Overall Study|error|1
2247065|NCT01989572|3908542|FG005|Overall Study|error|1
2247066|NCT01989572|3908537|FG000|Overall Study|maximum dose reached|0
2247067|NCT01989572|3908538|FG001|Overall Study|maximum dose reached|1
2247068|NCT01989572|3908539|FG002|Overall Study|maximum dose reached|0
2247069|NCT01989572|3908540|FG003|Overall Study|maximum dose reached|0
2247070|NCT01989572|3908541|FG004|Overall Study|maximum dose reached|1
2247071|NCT01989572|3908542|FG005|Overall Study|maximum dose reached|0
2247072|NCT01989572|3908537|FG000|Overall Study|unknown/not specify|3
2247073|NCT01989572|3908538|FG001|Overall Study|unknown/not specify|4
2247074|NCT01989572|3908539|FG002|Overall Study|unknown/not specify|1
2247075|NCT01989572|3908540|FG003|Overall Study|unknown/not specify|3
2247076|NCT01989572|3908541|FG004|Overall Study|unknown/not specify|3
2247077|NCT01989572|3908542|FG005|Overall Study|unknown/not specify|5
2247078|NCT01989572|3908537|FG000|Overall Study|not start protocol therapy|5
2247079|NCT01989572|3908538|FG001|Overall Study|not start protocol therapy|1
2247080|NCT01989572|3908539|FG002|Overall Study|not start protocol therapy|2
2247081|NCT01989572|3908540|FG003|Overall Study|not start protocol therapy|3
2247082|NCT01989572|3908541|FG004|Overall Study|not start protocol therapy|4
2247083|NCT01989572|3908542|FG005|Overall Study|not start protocol therapy|18
2247084|NCT01989572|3908537|FG000|Overall Study|alternative therapy|3
2247085|NCT01989572|3908538|FG001|Overall Study|alternative therapy|0
2247086|NCT01989572|3908539|FG002|Overall Study|alternative therapy|0
2247087|NCT01989572|3908540|FG003|Overall Study|alternative therapy|0
2247088|NCT01989572|3908541|FG004|Overall Study|alternative therapy|1
2247089|NCT01989572|3908542|FG005|Overall Study|alternative therapy|3
2247090|NCT01989689|3908562|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
2247091|NCT01989689|3908563|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
2247092|NCT01989689|3908562|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
2247093|NCT01989689|3908563|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
2247094|NCT01989754|3908573|FG000|Overall Study|Withdrawal by Subject|10
2247095|NCT01989754|3908574|FG001|Overall Study|Withdrawal by Subject|14
2247096|NCT01989754|3908573|FG000|Overall Study|Lost to Follow-up|28
2247097|NCT01989754|3908574|FG001|Overall Study|Lost to Follow-up|20
2247098|NCT01989754|3908573|FG000|Overall Study|Closed Site|1
2247099|NCT01989754|3908574|FG001|Overall Study|Closed Site|1
2247100|NCT01990261|3908602|FG000|Overall Study|Death Before Treatment Start|2
2247101|NCT01990261|3908602|FG000|Overall Study|Death due to Disease Progression (PD)|10
2247102|NCT01990261|3908602|FG000|Overall Study|Death From other Causes|1
2247103|NCT01990261|3908602|FG000|Overall Study|Disease Progression (PD)|8
2247104|NCT01990261|3908602|FG000|Overall Study|PD Before Treatment Start|1
2339725|NCT03379753|4069096|FG000|Overall Study|No primary outcome|12
2339726|NCT03379753|4069097|FG001|Overall Study|No primary outcome|22
2339727|NCT03380091|4069119|FG000|Overall Study|Withdrawal by Subject|2
2339728|NCT03380091|4069120|FG001|Overall Study|Withdrawal by Subject|1
2339729|NCT03380390|4069128|FG000|Overall Study|Adverse Event|3
2339730|NCT03380429|4069137|FG000|Overall Study|Physician Decision|0
2339731|NCT03380429|4069138|FG001|Overall Study|Physician Decision|1
2339732|NCT03380429|4069139|FG002|Overall Study|Physician Decision|0
2339733|NCT03380429|4069140|FG003|Overall Study|Physician Decision|1
2339734|NCT03380429|4069141|FG004|Overall Study|Physician Decision|1
2339735|NCT03380429|4069137|FG000|Overall Study|Withdrawal by Subject|3
2339736|NCT03380429|4069138|FG001|Overall Study|Withdrawal by Subject|3
2339737|NCT03380429|4069139|FG002|Overall Study|Withdrawal by Subject|5
2339738|NCT03380429|4069140|FG003|Overall Study|Withdrawal by Subject|2
2339739|NCT03380429|4069141|FG004|Overall Study|Withdrawal by Subject|1
2339740|NCT03380429|4069137|FG000|Overall Study|Lost to Follow-up|0
2339741|NCT03380429|4069138|FG001|Overall Study|Lost to Follow-up|2
2339742|NCT03380429|4069139|FG002|Overall Study|Lost to Follow-up|4
2339743|NCT03380429|4069140|FG003|Overall Study|Lost to Follow-up|3
2339744|NCT03380429|4069141|FG004|Overall Study|Lost to Follow-up|1
2339745|NCT03380429|4069137|FG000|Overall Study|Protocol Violation|1
2339746|NCT03380429|4069138|FG001|Overall Study|Protocol Violation|0
2339747|NCT03380429|4069139|FG002|Overall Study|Protocol Violation|1
2247105|NCT01990261|3908602|FG000|Overall Study|Dossier not Approved|1
2247106|NCT01990261|3908602|FG000|Overall Study|Lost to Follow-up|2
2247107|NCT01990300|3908606|FG000|Overall Study|Case Report Forms Uncollected|89
2247108|NCT01990300|3908606|FG000|Overall Study|Protocol Deviation|53
2247109|NCT01990313|3908610|FG000|Overall Study|Lost to Follow-up|1
2247110|NCT01990339|3908614|FG000|Overall Study|Data Not Available|49
2247111|NCT01990339|3908614|FG000|Overall Study|Voluntary Withdrawal|1402
2247112|NCT01990339|3908614|FG000|Overall Study|Lost to Follow-up|861
2247113|NCT01990495|3908620|FG000|Overall Study|Physician Decision|5
2247114|NCT01990495|3908621|FG001|Overall Study|Physician Decision|4
2247115|NCT01990534|3908629|FG000|Overall Study|Death|22
2247116|NCT01990534|3908629|FG000|Overall Study|Progressive disease|3
2339748|NCT03380429|4069140|FG003|Overall Study|Protocol Violation|0
2247117|NCT01990534|3908629|FG000|Overall Study|Protocol Violation|1
2247118|NCT01990534|3908629|FG000|Overall Study|Withdrawal of Informed Consent|2
2247119|NCT01990534|3908629|FG000|Overall Study|Symptomatic Deterioration|1
2247120|NCT01990534|3908629|FG000|Overall Study|Withdrawal by Subject|3
2247121|NCT01990534|3908629|FG000|Overall Study|Reason not Specified|2
2247122|NCT01990534|3908629|FG000|Overall Study|Lost to Follow-up|1
2247123|NCT01990560|3908633|FG000|Overall Study|Withdrawal by Subject|1
2247124|NCT01990573|3908640|FG000|Overall Study|Physician Decision|0
2247125|NCT01990573|3908641|FG001|Overall Study|Physician Decision|0
2247126|NCT01990573|3908642|FG002|Overall Study|Physician Decision|1
2247127|NCT01990612|3908652|FG000|Overall Study|Lost to Follow-up|2
2247128|NCT01990612|3908653|FG001|Overall Study|Lost to Follow-up|1
2247129|NCT01990612|3908652|FG000|Overall Study|Withdrawal by Subject|5
2247130|NCT01990612|3908653|FG001|Overall Study|Withdrawal by Subject|2
2247131|NCT01990664|3908661|FG000|Overall Study|Lost to Follow-up|2
2247132|NCT01990664|3908662|FG001|Overall Study|Lost to Follow-up|6
2247133|NCT01990664|3908661|FG000|Overall Study|Withdrawal by Subject|2
2247134|NCT01990664|3908662|FG001|Overall Study|Withdrawal by Subject|3
2247135|NCT01990664|3908661|FG000|Overall Study|Protocol Violation|1
2247136|NCT01990664|3908662|FG001|Overall Study|Protocol Violation|0
2247137|NCT01990664|3908661|FG000|Overall Study|Lens Discomfort|1
2247138|NCT01990664|3908662|FG001|Overall Study|Lens Discomfort|1
2247139|NCT01990664|3908661|FG000|Overall Study|Lens Handling Difficulties|1
2247140|NCT01990664|3908662|FG001|Overall Study|Lens Handling Difficulties|0
2247141|NCT01990664|3908661|FG000|Overall Study|Unsatisfactory Visual Response|0
2247142|NCT01990664|3908662|FG001|Overall Study|Unsatisfactory Visual Response|1
2247143|NCT01990742|3908688|FG000|Overall Study|Withdrawal by facility|407
2247144|NCT01990742|3908689|FG001|Overall Study|Withdrawal by facility|1083
2247145|NCT01990742|3908688|FG000|Overall Study|Facility closed|0
2247146|NCT01990742|3908689|FG001|Overall Study|Facility closed|270
2247147|NCT01990768|3908698|FG000|Intervention Started|Found to be ineligible|14
2247148|NCT01990768|3908699|FG001|Intervention Started|Found to be ineligible|13
2247149|NCT01990768|3908700|FG002|Intervention Started|Found to be ineligible|11
2339749|NCT03380429|4069141|FG004|Overall Study|Protocol Violation|1
2339750|NCT03380429|4069137|FG000|Overall Study|Lack of Efficacy|0
2339751|NCT03380429|4069138|FG001|Overall Study|Lack of Efficacy|0
2339752|NCT03380429|4069139|FG002|Overall Study|Lack of Efficacy|0
2339753|NCT03380429|4069140|FG003|Overall Study|Lack of Efficacy|2
2339754|NCT03380429|4069141|FG004|Overall Study|Lack of Efficacy|1
2339755|NCT03380429|4069137|FG000|Overall Study|Adverse Event|1
2339756|NCT03380429|4069138|FG001|Overall Study|Adverse Event|1
2339757|NCT03380429|4069139|FG002|Overall Study|Adverse Event|1
2339758|NCT03380429|4069140|FG003|Overall Study|Adverse Event|2
2339759|NCT03380429|4069141|FG004|Overall Study|Adverse Event|0
2339760|NCT03381196|4069186|FG000|Overall Study|Withdrawal by Subject|7
2339761|NCT03381196|4069187|FG001|Overall Study|Withdrawal by Subject|7
2339762|NCT03381196|4069186|FG000|Overall Study|Other|0
2339763|NCT03381196|4069187|FG001|Overall Study|Other|1
2339764|NCT03381196|4069186|FG000|Overall Study|Lost to Follow-up|5
2339765|NCT03381196|4069187|FG001|Overall Study|Lost to Follow-up|4
2339766|NCT03381196|4069186|FG000|Overall Study|Death|0
2339767|NCT03381196|4069187|FG001|Overall Study|Death|1
2339768|NCT03381196|4069186|FG000|Overall Study|Adverse Event|1
2339769|NCT03381196|4069187|FG001|Overall Study|Adverse Event|0
2339770|NCT03381196|4069186|FG000|Overall Study|Randomized, not treated|3
2339771|NCT03381196|4069187|FG001|Overall Study|Randomized, not treated|6
2339772|NCT03381248|4069195|FG000|Overall Study|Withdrawal by Subject|5
2339773|NCT03381248|4069196|FG001|Overall Study|Withdrawal by Subject|3
2339774|NCT03381248|4069195|FG000|Overall Study|Lost to Follow-up|3
2339775|NCT03381248|4069196|FG001|Overall Study|Lost to Follow-up|2
2339776|NCT03381248|4069195|FG000|Overall Study|Lack of Efficacy|1
2339777|NCT03381248|4069196|FG001|Overall Study|Lack of Efficacy|0
2339778|NCT03381248|4069195|FG000|Overall Study|Adverse Event|2
2339779|NCT03381248|4069196|FG001|Overall Study|Adverse Event|0
2339780|NCT03381248|4069195|FG000|Overall Study|Protocol Violation|2
2339781|NCT03381248|4069196|FG001|Overall Study|Protocol Violation|1
2339782|NCT03381339|4069204|FG000|Overall Study|Protocol Violation|4
2038044|NCT00421148|3608384|FG004|Overall Study|Withdrawal by Subject|0
2038045|NCT00421148|3608385|FG005|Overall Study|Withdrawal by Subject|0
2038046|NCT00421148|3608386|FG006|Overall Study|Withdrawal by Subject|0
2038047|NCT00421148|3608387|FG007|Overall Study|Withdrawal by Subject|0
2038048|NCT00421148|3608388|FG008|Overall Study|Withdrawal by Subject|0
2038049|NCT00421148|3608389|FG009|Overall Study|Withdrawal by Subject|0
2038050|NCT00421148|3608390|FG010|Overall Study|Withdrawal by Subject|0
2038051|NCT00421148|3608391|FG011|Overall Study|Withdrawal by Subject|0
2038052|NCT00421148|3608392|FG012|Overall Study|Withdrawal by Subject|0
2038053|NCT00421148|3608393|FG013|Overall Study|Withdrawal by Subject|0
2247150|NCT01990768|3908698|FG000|Intervention Started|Study drug issue or kit malfunction|9
2247151|NCT01990768|3908699|FG001|Intervention Started|Study drug issue or kit malfunction|6
2247152|NCT01990768|3908700|FG002|Intervention Started|Study drug issue or kit malfunction|7
2247153|NCT01990768|3908698|FG000|Intervention Started|Patient became ineligible due to vitals|5
2339783|NCT03381339|4069205|FG001|Overall Study|Protocol Violation|3
2339784|NCT03381339|4069204|FG000|Overall Study|Lost to Follow-up|0
2339785|NCT03381339|4069205|FG001|Overall Study|Lost to Follow-up|1
2247154|NCT01990768|3908699|FG001|Intervention Started|Patient became ineligible due to vitals|5
2247155|NCT01990768|3908700|FG002|Intervention Started|Patient became ineligible due to vitals|2
2247156|NCT01990768|3908698|FG000|Intervention Started|Not enough time for EMS to enroll|4
2247157|NCT01990768|3908699|FG001|Intervention Started|Not enough time for EMS to enroll|3
2247158|NCT01990768|3908700|FG002|Intervention Started|Not enough time for EMS to enroll|0
2247159|NCT01990768|3908698|FG000|Intervention Started|Patient care priority|1
2247160|NCT01990768|3908699|FG001|Intervention Started|Patient care priority|2
2247161|NCT01990768|3908700|FG002|Intervention Started|Patient care priority|3
2247162|NCT01990768|3908698|FG000|Intervention Started|IV lost|2
2247163|NCT01990768|3908699|FG001|Intervention Started|IV lost|2
2247164|NCT01990768|3908700|FG002|Intervention Started|IV lost|2
2247165|NCT01990768|3908698|FG000|Intervention Started|Required CPR|1
2247166|NCT01990768|3908699|FG001|Intervention Started|Required CPR|1
2247167|NCT01990768|3908700|FG002|Intervention Started|Required CPR|0
2247168|NCT01990768|3908698|FG000|Intervention Started|Seizure or hx of seizure|0
2247169|NCT01990768|3908699|FG001|Intervention Started|Seizure or hx of seizure|0
2247170|NCT01990768|3908700|FG002|Intervention Started|Seizure or hx of seizure|2
2247171|NCT01990768|3908698|FG000|Intervention Started|Discovered to be pregnant|0
2247172|NCT01990768|3908699|FG001|Intervention Started|Discovered to be pregnant|1
2247173|NCT01990768|3908700|FG002|Intervention Started|Discovered to be pregnant|0
2247174|NCT01990768|3908698|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4
2247175|NCT01990768|3908699|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11
2247176|NCT01990768|3908700|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10
2247177|NCT01990768|3908698|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
2247178|NCT01990768|3908699|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
2247179|NCT01990768|3908700|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
2247180|NCT01990768|3908698|FG000|Prehospital Study Drug Infusion|Required CPR|2
2247181|NCT01990768|3908699|FG001|Prehospital Study Drug Infusion|Required CPR|6
2247182|NCT01990768|3908700|FG002|Prehospital Study Drug Infusion|Required CPR|0
2247183|NCT01990768|3908698|FG000|Prehospital Study Drug Infusion|Other safety concern|2
2247184|NCT01990768|3908699|FG001|Prehospital Study Drug Infusion|Other safety concern|1
2247185|NCT01990768|3908700|FG002|Prehospital Study Drug Infusion|Other safety concern|1
2247186|NCT01990768|3908698|FG000|Prehospital Study Drug Infusion|Death|3
2247187|NCT01990768|3908699|FG001|Prehospital Study Drug Infusion|Death|1
2247188|NCT01990768|3908700|FG002|Prehospital Study Drug Infusion|Death|1
2247189|NCT01990768|3908698|FG000|Prehospital Study Drug Infusion|Discharged|2
2247190|NCT01990768|3908699|FG001|Prehospital Study Drug Infusion|Discharged|1
2247191|NCT01990768|3908700|FG002|Prehospital Study Drug Infusion|Discharged|0
2247192|NCT01990768|3908698|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1
2247193|NCT01990768|3908699|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0
2247194|NCT01990768|3908700|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0
2247195|NCT01990768|3908698|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0
2247196|NCT01990768|3908699|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0
2247197|NCT01990768|3908700|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1
2247198|NCT01990768|3908698|FG000|Prehospital Study Drug Infusion|Unknown if completed|1
2247199|NCT01990768|3908699|FG001|Prehospital Study Drug Infusion|Unknown if completed|4
2247200|NCT01990768|3908700|FG002|Prehospital Study Drug Infusion|Unknown if completed|2
2247201|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Discharged|19
2247202|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Discharged|18
2247203|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Discharged|13
2247204|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14
2247205|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17
2247206|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10
2247207|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
2247208|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
2247209|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
2247210|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12
2247211|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11
2247212|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6
2247213|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11
2247214|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4
2247215|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7
2247216|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
2247217|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
2247218|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
2247219|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
2247220|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
2247221|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
2247222|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Required CPR|3
2247223|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Required CPR|7
2247224|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Required CPR|1
2247225|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Other safety concern|4
2247226|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Other safety concern|2
2247227|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Other safety concern|3
2247228|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4
2247229|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0
2247230|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3
2247231|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1
2247232|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1
2247233|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1
2247234|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
2247235|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
2247236|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
2247237|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0
2247238|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1
2247239|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2
2339786|NCT03382262|4069237|FG000|Overall Study|Physician Decision|0
2339787|NCT03382262|4069238|FG001|Overall Study|Physician Decision|0
2339788|NCT03382262|4069239|FG002|Overall Study|Physician Decision|1
2339789|NCT03382262|4069240|FG003|Overall Study|Physician Decision|0
2339790|NCT03382262|4069237|FG000|Overall Study|Withdrawal by Subject|0
2339791|NCT03382262|4069238|FG001|Overall Study|Withdrawal by Subject|0
2339792|NCT03382262|4069239|FG002|Overall Study|Withdrawal by Subject|0
2339793|NCT03382262|4069240|FG003|Overall Study|Withdrawal by Subject|1
2339794|NCT03382418|4069253|FG000|Overall Study|Withdrawal by Subject|1
2339795|NCT03382418|4069254|FG001|Overall Study|Withdrawal by Subject|0
2339796|NCT03382418|4069255|FG002|Overall Study|Withdrawal by Subject|0
2339797|NCT03382418|4069253|FG000|Overall Study|Lost to Follow-up|2
2339798|NCT03382418|4069254|FG001|Overall Study|Lost to Follow-up|3
2339799|NCT03382418|4069255|FG002|Overall Study|Lost to Follow-up|0
2339800|NCT03382821|4069284|FG000|Overall Study|Did not receive allocated intervention.|0
2339801|NCT03382821|4069285|FG001|Overall Study|Did not receive allocated intervention.|3
2339802|NCT03382899|4069298|FG000|Overall Study|Ineligibility Determined|0
2339803|NCT03382899|4069299|FG001|Overall Study|Ineligibility Determined|1
2339804|NCT03382899|4069298|FG000|Overall Study|Lost to Follow-up|0
2339805|NCT03382899|4069299|FG001|Overall Study|Lost to Follow-up|1
2339806|NCT03382899|4069298|FG000|Overall Study|Sponsor's decision|31
2339807|NCT03382899|4069299|FG001|Overall Study|Sponsor's decision|28
2339808|NCT03382899|4069298|FG000|Overall Study|Withdrawal by Subject|0
2339809|NCT03382899|4069299|FG001|Overall Study|Withdrawal by Subject|5
2339810|NCT03382912|4069307|FG000|Overall Study|Physician Decision|0
2339811|NCT03382912|4069308|FG001|Overall Study|Physician Decision|1
2339812|NCT03382912|4069307|FG000|Overall Study|Sponsor Decision|6
2038054|NCT00421148|3608394|FG014|Overall Study|Withdrawal by Subject|0
2038055|NCT00421148|3608395|FG015|Overall Study|Withdrawal by Subject|0
2038056|NCT00421148|3608396|FG016|Overall Study|Withdrawal by Subject|0
2038057|NCT00421148|3608397|FG017|Overall Study|Withdrawal by Subject|1
2038058|NCT00421148|3608398|FG018|Overall Study|Withdrawal by Subject|0
2038059|NCT00421148|3608399|FG019|Overall Study|Withdrawal by Subject|0
2038060|NCT00421148|3608380|FG000|Overall Study|Protocol Violation|0
2038061|NCT00421148|3608381|FG001|Overall Study|Protocol Violation|0
2038062|NCT00421148|3608382|FG002|Overall Study|Protocol Violation|0
2038063|NCT00421148|3608383|FG003|Overall Study|Protocol Violation|0
2038064|NCT00421148|3608384|FG004|Overall Study|Protocol Violation|0
2038065|NCT00421148|3608385|FG005|Overall Study|Protocol Violation|1
2038066|NCT00421148|3608386|FG006|Overall Study|Protocol Violation|0
2038067|NCT00421148|3608387|FG007|Overall Study|Protocol Violation|0
2038068|NCT00421148|3608388|FG008|Overall Study|Protocol Violation|0
2038069|NCT00421148|3608389|FG009|Overall Study|Protocol Violation|0
2038070|NCT00421148|3608390|FG010|Overall Study|Protocol Violation|0
2038071|NCT00421148|3608391|FG011|Overall Study|Protocol Violation|0
2038072|NCT00421148|3608392|FG012|Overall Study|Protocol Violation|0
2038073|NCT00421148|3608393|FG013|Overall Study|Protocol Violation|0
2038074|NCT00421148|3608394|FG014|Overall Study|Protocol Violation|0
2038075|NCT00421148|3608395|FG015|Overall Study|Protocol Violation|0
2038076|NCT00421148|3608396|FG016|Overall Study|Protocol Violation|0
2038077|NCT00421148|3608397|FG017|Overall Study|Protocol Violation|0
2038078|NCT00421148|3608398|FG018|Overall Study|Protocol Violation|1
2038079|NCT00421148|3608399|FG019|Overall Study|Protocol Violation|0
2038080|NCT00421174|3608443|FG000|Overall Study|Withdrawal by Subject|0
2038081|NCT00421174|3608444|FG001|Overall Study|Withdrawal by Subject|1
2038082|NCT00421174|3608443|FG000|Overall Study|Ineligible due to infection|2
2038083|NCT00421174|3608444|FG001|Overall Study|Ineligible due to infection|0
2038084|NCT00421304|3608453|FG000|Overall Study|Lost to Follow-up|5
2038085|NCT00421304|3608454|FG001|Overall Study|Lost to Follow-up|2
2038086|NCT00421304|3608455|FG002|Overall Study|Lost to Follow-up|5
2038087|NCT00421304|3608453|FG000|Overall Study|Withdrawal by Subject|2
2038088|NCT00421304|3608454|FG001|Overall Study|Withdrawal by Subject|2
2038089|NCT00421304|3608455|FG002|Overall Study|Withdrawal by Subject|2
2339813|NCT03382912|4069308|FG001|Overall Study|Sponsor Decision|6
2339814|NCT03382912|4069307|FG000|Overall Study|Withdrawal by Subject|0
2339815|NCT03382912|4069308|FG001|Overall Study|Withdrawal by Subject|5
2247240|NCT01990768|3908698|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0
2247241|NCT01990768|3908699|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0
2247242|NCT01990768|3908700|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1
2247243|NCT01990768|3908698|FG000|6-Month Follow-up|Withdrawal by Subject|25
2247244|NCT01990768|3908699|FG001|6-Month Follow-up|Withdrawal by Subject|25
2247245|NCT01990768|3908700|FG002|6-Month Follow-up|Withdrawal by Subject|26
2247246|NCT01990768|3908698|FG000|6-Month Follow-up|Calls unreturned or refused contact|4
2247247|NCT01990768|3908699|FG001|6-Month Follow-up|Calls unreturned or refused contact|15
2247248|NCT01990768|3908700|FG002|6-Month Follow-up|Calls unreturned or refused contact|20
2247249|NCT01990768|3908698|FG000|6-Month Follow-up|No contact information|5
2247250|NCT01990768|3908699|FG001|6-Month Follow-up|No contact information|6
2247251|NCT01990768|3908700|FG002|6-Month Follow-up|No contact information|5
2247252|NCT01990768|3908698|FG000|6-Month Follow-up|Homeless|4
2247253|NCT01990768|3908699|FG001|6-Month Follow-up|Homeless|3
2247254|NCT01990768|3908700|FG002|6-Month Follow-up|Homeless|6
2247255|NCT01990768|3908698|FG000|6-Month Follow-up|Prisoner at time of enrollment|0
2247256|NCT01990768|3908699|FG001|6-Month Follow-up|Prisoner at time of enrollment|0
2247257|NCT01990768|3908700|FG002|6-Month Follow-up|Prisoner at time of enrollment|1
2247258|NCT01990768|3908698|FG000|6-Month Follow-up|Prisoner at time of follow-up|0
2247259|NCT01990768|3908699|FG001|6-Month Follow-up|Prisoner at time of follow-up|2
2247260|NCT01990768|3908700|FG002|6-Month Follow-up|Prisoner at time of follow-up|0
2247261|NCT01990768|3908698|FG000|6-Month Follow-up|Patient at psychiatric hospital|1
2247262|NCT01990768|3908699|FG001|6-Month Follow-up|Patient at psychiatric hospital|0
2247263|NCT01990768|3908700|FG002|6-Month Follow-up|Patient at psychiatric hospital|0
2247264|NCT01990859|3908805|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
2247265|NCT01990859|3908805|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
2247266|NCT01990950|3908814|FG000|Overall Study|Death|3
2247267|NCT01990950|3908814|FG000|Overall Study|Lost to Follow-up|2
2247268|NCT01990950|3908814|FG000|Overall Study|Withdrawal by Subject|6
2247269|NCT01991197|3908820|FG000|Overall Study|Lost to Follow-up|1
2247270|NCT01991197|3908821|FG001|Overall Study|Lost to Follow-up|1
2247271|NCT01991197|3908820|FG000|Overall Study|Physician Decision|0
2247272|NCT01991197|3908821|FG001|Overall Study|Physician Decision|2
2247273|NCT01991197|3908820|FG000|Overall Study|Withdrawal by Subject|2
2247274|NCT01991197|3908821|FG001|Overall Study|Withdrawal by Subject|0
2339816|NCT03383146|4069316|FG000|Overall Study|Screen Failure|1
2339817|NCT03383146|4069317|FG001|Overall Study|Screen Failure|0
2339818|NCT03383146|4069316|FG000|Overall Study|Adverse Event|6
2339819|NCT03383146|4069317|FG001|Overall Study|Adverse Event|18
2339820|NCT03383146|4069316|FG000|Overall Study|Lack of Efficacy|0
2339821|NCT03383146|4069317|FG001|Overall Study|Lack of Efficacy|3
2339822|NCT03383146|4069316|FG000|Overall Study|Withdrawal by Subject|20
2339823|NCT03383146|4069317|FG001|Overall Study|Withdrawal by Subject|36
2339824|NCT03383146|4069316|FG000|Overall Study|Lost to Follow-up|5
2339825|NCT03383146|4069317|FG001|Overall Study|Lost to Follow-up|15
2339826|NCT03383146|4069316|FG000|Overall Study|Death|0
2339827|NCT03383146|4069317|FG001|Overall Study|Death|2
2038090|NCT00421304|3608453|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1
2038091|NCT00421304|3608454|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0
2038092|NCT00421304|3608455|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0
2038093|NCT00421304|3608453|FG000|Overall Study|Did not attend Day 360 visit|0
2038094|NCT00421304|3608454|FG001|Overall Study|Did not attend Day 360 visit|0
2038095|NCT00421304|3608455|FG002|Overall Study|Did not attend Day 360 visit|1
2038096|NCT00421343|3608465|FG000|Overall Study|Death|1
2038097|NCT00421343|3608465|FG000|Overall Study|Withdrawal by Subject|2
2038098|NCT00421343|3608465|FG000|Overall Study|Lost to Follow-up|3
2038099|NCT00421408|3608471|FG000|Overall Study|Lost to Follow-up|30
2038100|NCT00421408|3608472|FG001|Overall Study|Lost to Follow-up|20
2038101|NCT00421408|3608471|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12
2038102|NCT00421408|3608472|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25
2038103|NCT00421707|3608489|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1
2038104|NCT00421707|3608490|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5
2038105|NCT00421707|3608489|FG000|Period 1: Treatment Period 1|Adverse Event|7
2038106|NCT00421707|3608490|FG001|Period 1: Treatment Period 1|Adverse Event|2
2038107|NCT00421707|3608489|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2
2038108|NCT00421707|3608490|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2
2038109|NCT00421707|3608489|FG000|Period 1: Treatment Period 1|Protocol Violation|1
2038110|NCT00421707|3608490|FG001|Period 1: Treatment Period 1|Protocol Violation|0
2038111|NCT00421707|3608489|FG000|Period 2: Washout|Adverse Event|1
2247275|NCT01991314|3908834|FG000|Overall Study|Adverse Event|5
2247276|NCT01991314|3908835|FG001|Overall Study|Adverse Event|1
2247277|NCT01991314|3908834|FG000|Overall Study|Lost to Follow-up|6
2247278|NCT01991314|3908835|FG001|Overall Study|Lost to Follow-up|10
2247279|NCT01991470|3908841|FG000|Enlite 1 Period|Withdrawal by Subject|18
2247280|NCT01991470|3908841|FG000|Enlite 1 Period|Adverse Event|1
2247281|NCT01991470|3908841|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1
2247282|NCT01991470|3908841|FG000|Enlite 3 Period|Lost to Follow-up|1
2247283|NCT01991470|3908841|FG000|Enlite 3 Period|Physician Decision|2
2247284|NCT01991470|3908841|FG000|Enlite 3 Period|Physician Decision|8
2339828|NCT03383146|4069316|FG000|Overall Study|Physician Decision|0
2247285|NCT01991470|3908841|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
2247286|NCT01991483|3908857|FG000|Dose Level 600 mg|Withdrawal by Subject|0
2247287|NCT01991483|3908858|FG001|Dose Level 600 mg|Withdrawal by Subject|0
2247288|NCT01991483|3908859|FG002|Dose Level 600 mg|Withdrawal by Subject|1
2247289|NCT01991483|3908860|FG003|Dose Level 600 mg|Withdrawal by Subject|0
2247290|NCT01991483|3908857|FG000|Dose Level 600 mg|Physician Decision|0
2247291|NCT01991483|3908858|FG001|Dose Level 600 mg|Physician Decision|0
2247292|NCT01991483|3908859|FG002|Dose Level 600 mg|Physician Decision|1
2247293|NCT01991483|3908860|FG003|Dose Level 600 mg|Physician Decision|0
2247294|NCT01991483|3908857|FG000|Dose Level 1000 mg|Protocol Violation|0
2247295|NCT01991483|3908858|FG001|Dose Level 1000 mg|Protocol Violation|0
2247296|NCT01991483|3908859|FG002|Dose Level 1000 mg|Protocol Violation|0
2247297|NCT01991483|3908860|FG003|Dose Level 1000 mg|Protocol Violation|1
2247298|NCT01991743|3908890|FG000|Overall Study|external cephalic version not performed|0
2247299|NCT01991743|3908891|FG001|Overall Study|external cephalic version not performed|0
2247300|NCT01991743|3908892|FG002|Overall Study|external cephalic version not performed|1
2247301|NCT01991743|3908893|FG003|Overall Study|external cephalic version not performed|0
2247302|NCT01991795|3908905|FG000|Overall Study|Lost to Follow-up|6
2247303|NCT01991795|3908906|FG001|Overall Study|Lost to Follow-up|4
2247304|NCT01991795|3908905|FG000|Overall Study|Withdrawal by Subject|117
2247305|NCT01991795|3908906|FG001|Overall Study|Withdrawal by Subject|94
2247306|NCT01991795|3908905|FG000|Overall Study|Site prematurely closed by sponsor|26
2247307|NCT01991795|3908906|FG001|Overall Study|Site prematurely closed by sponsor|25
2247308|NCT01991977|3908936|FG000|Overall Study|Withdrew prior to receiving treatment|7
2247309|NCT01991977|3908936|FG000|Overall Study|Withdrew after start of treatment|5
2247310|NCT01992094|3908965|FG000|Overall Study|ADMINISTRATIVE REASON|6
2247311|NCT01992094|3908966|FG001|Overall Study|ADMINISTRATIVE REASON|7
2247312|NCT01992094|3908967|FG002|Overall Study|ADMINISTRATIVE REASON|1
2247313|NCT01992094|3908965|FG000|Overall Study|Adverse Event|1
2247314|NCT01992094|3908966|FG001|Overall Study|Adverse Event|0
2247315|NCT01992094|3908967|FG002|Overall Study|Adverse Event|0
2247316|NCT01992094|3908965|FG000|Overall Study|Death|5
2247317|NCT01992094|3908966|FG001|Overall Study|Death|5
2247318|NCT01992094|3908967|FG002|Overall Study|Death|2
2247319|NCT01992094|3908965|FG000|Overall Study|Lost to Follow-up|26
2247320|NCT01992094|3908966|FG001|Overall Study|Lost to Follow-up|9
2247321|NCT01992094|3908967|FG002|Overall Study|Lost to Follow-up|13
2247322|NCT01992094|3908965|FG000|Overall Study|OTHER|4
2247323|NCT01992094|3908966|FG001|Overall Study|OTHER|0
2247324|NCT01992094|3908967|FG002|Overall Study|OTHER|0
2247325|NCT01992094|3908965|FG000|Overall Study|Protocol Violation|1
2247326|NCT01992094|3908966|FG001|Overall Study|Protocol Violation|0
2247327|NCT01992094|3908967|FG002|Overall Study|Protocol Violation|1
2247328|NCT01992094|3908965|FG000|Overall Study|Withdrawal by Subject|7
2247329|NCT01992094|3908966|FG001|Overall Study|Withdrawal by Subject|3
2247330|NCT01992094|3908967|FG002|Overall Study|Withdrawal by Subject|4
2247331|NCT01992107|3908994|FG000|Overall Study|Administrative reasons|2
2247332|NCT01992107|3908995|FG001|Overall Study|Administrative reasons|0
2247333|NCT01992107|3908996|FG002|Overall Study|Administrative reasons|0
2247334|NCT01992107|3908994|FG000|Overall Study|Adverse Event|0
2247335|NCT01992107|3908995|FG001|Overall Study|Adverse Event|1
2247336|NCT01992107|3908996|FG002|Overall Study|Adverse Event|0
2247337|NCT01992107|3908994|FG000|Overall Study|Lost to Follow-up|46
2247338|NCT01992107|3908995|FG001|Overall Study|Lost to Follow-up|22
2247339|NCT01992107|3908996|FG002|Overall Study|Lost to Follow-up|26
2247340|NCT01992107|3908994|FG000|Overall Study|noncompliance and were unavailable|7
2247341|NCT01992107|3908995|FG001|Overall Study|noncompliance and were unavailable|3
2247342|NCT01992107|3908996|FG002|Overall Study|noncompliance and were unavailable|2
2247343|NCT01992107|3908994|FG000|Overall Study|Withdrawal by Subject|13
2247344|NCT01992107|3908995|FG001|Overall Study|Withdrawal by Subject|7
2247345|NCT01992107|3908996|FG002|Overall Study|Withdrawal by Subject|8
2247346|NCT01992159|3909025|FG000|Overall Study|Withdrawal by Subject|4
2247347|NCT01992159|3909026|FG001|Overall Study|Withdrawal by Subject|7
2247348|NCT01992159|3909027|FG002|Overall Study|Withdrawal by Subject|0
2247349|NCT01992159|3909028|FG003|Overall Study|Withdrawal by Subject|3
2247350|NCT01992159|3909025|FG000|Overall Study|Adverse Event|0
2247351|NCT01992159|3909026|FG001|Overall Study|Adverse Event|1
2247352|NCT01992159|3909027|FG002|Overall Study|Adverse Event|0
2247353|NCT01992159|3909028|FG003|Overall Study|Adverse Event|1
2247354|NCT01992159|3909025|FG000|Overall Study|Death|0
2247355|NCT01992159|3909026|FG001|Overall Study|Death|0
2247356|NCT01992159|3909027|FG002|Overall Study|Death|1
2247357|NCT01992159|3909028|FG003|Overall Study|Death|0
2247358|NCT01992536|3909093|FG000|Overall Study|Administrative Reason|0
2247359|NCT01992536|3909094|FG001|Overall Study|Administrative Reason|0
2247360|NCT01992536|3909095|FG002|Overall Study|Administrative Reason|0
2247361|NCT01992536|3909096|FG003|Overall Study|Administrative Reason|0
2247362|NCT01992536|3909097|FG004|Overall Study|Administrative Reason|0
2247363|NCT01992536|3909098|FG005|Overall Study|Administrative Reason|0
2247364|NCT01992536|3909099|FG006|Overall Study|Administrative Reason|7
2247365|NCT01992536|3909100|FG007|Overall Study|Administrative Reason|0
2247366|NCT01992536|3909101|FG008|Overall Study|Administrative Reason|0
2247367|NCT01992536|3909102|FG009|Overall Study|Administrative Reason|0
2247368|NCT01992536|3909093|FG000|Overall Study|Lost to Follow-up|4
2247369|NCT01992536|3909094|FG001|Overall Study|Lost to Follow-up|2
2247370|NCT01992536|3909095|FG002|Overall Study|Lost to Follow-up|1
2247371|NCT01992536|3909096|FG003|Overall Study|Lost to Follow-up|0
2247372|NCT01992536|3909097|FG004|Overall Study|Lost to Follow-up|0
2247373|NCT01992536|3909098|FG005|Overall Study|Lost to Follow-up|1
2247374|NCT01992536|3909099|FG006|Overall Study|Lost to Follow-up|0
2247375|NCT01992536|3909100|FG007|Overall Study|Lost to Follow-up|0
2247376|NCT01992536|3909101|FG008|Overall Study|Lost to Follow-up|1
2247377|NCT01992536|3909102|FG009|Overall Study|Lost to Follow-up|1
2247378|NCT01992536|3909093|FG000|Overall Study|Withdrawal by Subject|0
2247379|NCT01992536|3909094|FG001|Overall Study|Withdrawal by Subject|1
2247380|NCT01992536|3909095|FG002|Overall Study|Withdrawal by Subject|0
2247381|NCT01992536|3909096|FG003|Overall Study|Withdrawal by Subject|2
2247382|NCT01992536|3909097|FG004|Overall Study|Withdrawal by Subject|0
2247383|NCT01992536|3909098|FG005|Overall Study|Withdrawal by Subject|0
2247384|NCT01992536|3909099|FG006|Overall Study|Withdrawal by Subject|0
2247385|NCT01992536|3909100|FG007|Overall Study|Withdrawal by Subject|0
2247386|NCT01992536|3909101|FG008|Overall Study|Withdrawal by Subject|0
2247387|NCT01992536|3909102|FG009|Overall Study|Withdrawal by Subject|0
2247388|NCT01992549|3909144|FG000|Overall Study|Lost to Follow-up|2
2247389|NCT01992549|3909144|FG000|Overall Study|Serious Adverse Event|1
2247390|NCT01992549|3909144|FG000|Overall Study|Product Switch to Extend Half Life|1
2247391|NCT01992757|3909154|FG000|Overall Study|2 patients excluded due to FFP given.|2
2247392|NCT01993017|3909174|FG000|Overall Study|Death|23
2247393|NCT01993017|3909175|FG001|Overall Study|Death|26
2247394|NCT01993017|3909176|FG002|Overall Study|Death|18
2247395|NCT01993017|3909174|FG000|Overall Study|Could not be contacted|43
2247396|NCT01993017|3909175|FG001|Overall Study|Could not be contacted|42
2247397|NCT01993017|3909176|FG002|Overall Study|Could not be contacted|38
2247398|NCT01993017|3909174|FG000|Overall Study|Dropped out|19
2247399|NCT01993017|3909175|FG001|Overall Study|Dropped out|6
2247400|NCT01993017|3909176|FG002|Overall Study|Dropped out|11
2247401|NCT01993017|3909174|FG000|Overall Study|Other reasons|17
2247402|NCT01993017|3909175|FG001|Overall Study|Other reasons|11
2247403|NCT01993017|3909176|FG002|Overall Study|Other reasons|7
2247404|NCT01993017|3909174|FG000|Overall Study|Ineligible after randomization|4
2247405|NCT01993017|3909175|FG001|Overall Study|Ineligible after randomization|5
2247406|NCT01993017|3909176|FG002|Overall Study|Ineligible after randomization|5
2247407|NCT01993030|3909187|FG000|Overall Study|Adverse Event|0
2247408|NCT01993030|3909188|FG001|Overall Study|Adverse Event|4
2247409|NCT01993186|3909217|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1
2247410|NCT01993186|3909218|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
2247411|NCT01993186|3909217|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
2247412|NCT01993186|3909218|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
2247413|NCT01993186|3909217|FG000|Open-Label Extension Period|Other, Not Specified|0
2247414|NCT01993186|3909218|FG001|Open-Label Extension Period|Other, Not Specified|1
2247415|NCT01993186|3909217|FG000|Open-Label Extension Period|Adverse Event|1
2247416|NCT01993186|3909218|FG001|Open-Label Extension Period|Adverse Event|0
2247417|NCT01993186|3909217|FG000|Open-Label Extension Period|Principal Investigator Decision|1
2247418|NCT01993186|3909218|FG001|Open-Label Extension Period|Principal Investigator Decision|0
2247419|NCT01993186|3909217|FG000|Open-Label Extension Period|Withdrawal by Subject|4
2247420|NCT01993186|3909218|FG001|Open-Label Extension Period|Withdrawal by Subject|5
2247421|NCT01993186|3909217|FG000|Open-Label Extension Period|Subject Non-Compliance|1
2247422|NCT01993186|3909218|FG001|Open-Label Extension Period|Subject Non-Compliance|0
2247423|NCT01993329|3909235|FG000|Period 2|Adverse Event|0
2247424|NCT01993329|3909236|FG001|Period 2|Adverse Event|0
2247425|NCT01993329|3909237|FG002|Period 2|Adverse Event|0
2247426|NCT01993329|3909238|FG003|Period 2|Adverse Event|0
2247427|NCT01993329|3909239|FG004|Period 2|Adverse Event|0
2247428|NCT01993329|3909240|FG005|Period 2|Adverse Event|1
2247429|NCT01993329|3909235|FG000|Wash-out|Personal reasons|0
2247430|NCT01993329|3909236|FG001|Wash-out|Personal reasons|1
2247431|NCT01993329|3909237|FG002|Wash-out|Personal reasons|0
2247432|NCT01993329|3909238|FG003|Wash-out|Personal reasons|0
2247433|NCT01993329|3909239|FG004|Wash-out|Personal reasons|0
2247434|NCT01993329|3909240|FG005|Wash-out|Personal reasons|0
2247435|NCT01993615|3909254|FG000|Overall Study|Death|1
2247436|NCT01993615|3909255|FG001|Overall Study|Death|0
2247437|NCT01993667|3909263|FG000|Overall Study|Insufficient data to analyze|16
2247438|NCT01993667|3909264|FG001|Overall Study|Insufficient data to analyze|16
2247439|NCT01993667|3909263|FG000|Overall Study|Insufficient altitude reached|3
2247440|NCT01993667|3909264|FG001|Overall Study|Insufficient altitude reached|1
2247441|NCT01993667|3909263|FG000|Overall Study|Lost to Follow-up|2
2247442|NCT01993667|3909264|FG001|Overall Study|Lost to Follow-up|2
2247443|NCT01993823|3909272|FG000|Overall Study|Requested by the patient|6
2247444|NCT01993823|3909273|FG001|Overall Study|Requested by the patient|11
2247445|NCT01993823|3909272|FG000|Overall Study|Protocol Violation|0
2247446|NCT01993823|3909273|FG001|Overall Study|Protocol Violation|1
2247447|NCT01993823|3909272|FG000|Overall Study|Lost to Follow-up|1
2247448|NCT01993823|3909273|FG001|Overall Study|Lost to Follow-up|4
2247449|NCT01993836|3909282|FG000|Overall Study|Surgery Cancelled|3
2247450|NCT01993836|3909283|FG001|Overall Study|Surgery Cancelled|0
2247451|NCT01993836|3909284|FG002|Overall Study|Surgery Cancelled|0
2247452|NCT01993836|3909282|FG000|Overall Study|Physician Decision|2
2247453|NCT01993836|3909283|FG001|Overall Study|Physician Decision|1
2247454|NCT01993836|3909284|FG002|Overall Study|Physician Decision|0
2247455|NCT01993836|3909282|FG000|Overall Study|Death|0
2247456|NCT01993836|3909283|FG001|Overall Study|Death|2
2247457|NCT01993836|3909284|FG002|Overall Study|Death|0
2247458|NCT01993836|3909282|FG000|Overall Study|Withdrawal by Subject|12
2247459|NCT01993836|3909283|FG001|Overall Study|Withdrawal by Subject|10
2247460|NCT01993836|3909284|FG002|Overall Study|Withdrawal by Subject|5
2247461|NCT01993888|3909315|FG000|Overall Study|Death|1
2247462|NCT01993888|3909316|FG001|Overall Study|Death|1
2247463|NCT01993888|3909315|FG000|Overall Study|Lost to Follow-up|1
2247464|NCT01993888|3909316|FG001|Overall Study|Lost to Follow-up|1
2247465|NCT01993888|3909315|FG000|Overall Study|Withdrawal by Subject|0
2247466|NCT01993888|3909316|FG001|Overall Study|Withdrawal by Subject|1
2247467|NCT01993927|3909322|FG000|Overall Study|Case Report Forms Uncollected|18
2247468|NCT01993927|3909322|FG000|Overall Study|Protocol Violation|11
2247469|NCT01993940|3909328|FG000|Overall Study|Adverse Event|16
2247470|NCT01993940|3909329|FG001|Overall Study|Adverse Event|11
2247471|NCT01993940|3909328|FG000|Overall Study|Withdrawal by Subject|15
2247472|NCT01993940|3909329|FG001|Overall Study|Withdrawal by Subject|19
2247473|NCT01993940|3909328|FG000|Overall Study|Lost to Follow-up|2
2247474|NCT01993940|3909329|FG001|Overall Study|Lost to Follow-up|5
2247475|NCT01993940|3909328|FG000|Overall Study|Protocol Violation|5
2247476|NCT01993940|3909329|FG001|Overall Study|Protocol Violation|8
2339829|NCT03383146|4069317|FG001|Overall Study|Physician Decision|1
2339830|NCT03383146|4069316|FG000|Overall Study|Protocol Deviation|1
2339831|NCT03383146|4069317|FG001|Overall Study|Protocol Deviation|8
2339832|NCT03383146|4069316|FG000|Overall Study|Study Terminated by the Sponsor|48
2339833|NCT03383146|4069317|FG001|Overall Study|Study Terminated by the Sponsor|95
2339834|NCT03383146|4069316|FG000|Overall Study|Reason not Specified|4
2339835|NCT03383146|4069317|FG001|Overall Study|Reason not Specified|6
2339836|NCT03383614|4069379|FG000|Overall Study|Withdrawal by Subject|0
2339837|NCT03383614|4069380|FG001|Overall Study|Withdrawal by Subject|1
2339838|NCT03383614|4069381|FG002|Overall Study|Withdrawal by Subject|0
2339839|NCT03383614|4069382|FG003|Overall Study|Withdrawal by Subject|0
2339840|NCT03383692|4069403|FG000|Overall Study|Progressive disease as per RECIST|3
2339841|NCT03383692|4069404|FG001|Overall Study|Progressive disease as per RECIST|3
2339842|NCT03383692|4069403|FG000|Overall Study|Clinical progression|0
2339843|NCT03383692|4069404|FG001|Overall Study|Clinical progression|1
2339844|NCT03383692|4069403|FG000|Overall Study|Adverse Event|3
2339845|NCT03383692|4069404|FG001|Overall Study|Adverse Event|0
2339846|NCT03383783|4069416|FG000|Overall Study|Withdrawal by Subject|2
2339847|NCT03383887|4069432|FG000|Overall Study|Lost to Follow-up|0
2339848|NCT03383887|4069433|FG001|Overall Study|Lost to Follow-up|1
2339849|NCT03384316|4069453|FG000|Overall Study|Screen failure|0
2339850|NCT03384316|4069454|FG001|Overall Study|Screen failure|1
2339851|NCT03384693|4069471|FG000|Overall Study|Adverse Event|3
2339852|NCT03384745|4069481|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
2339853|NCT03384745|4069482|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
2339854|NCT03384745|4069483|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1
2339855|NCT03384745|4069484|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2
2339856|NCT03384745|4069485|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
2339857|NCT03384745|4069486|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
2339858|NCT03384745|4069481|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
2339859|NCT03384745|4069482|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
2339860|NCT03384745|4069483|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
2339861|NCT03384745|4069484|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
2339862|NCT03384745|4069485|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3
2339863|NCT03384745|4069486|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1
2339864|NCT03384745|4069481|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
2339865|NCT03384745|4069482|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
2339866|NCT03384745|4069483|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
2339867|NCT03384745|4069484|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
2339868|NCT03384745|4069485|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
2339869|NCT03384745|4069486|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
2339870|NCT03384745|4069481|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
2339871|NCT03384745|4069482|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
2339872|NCT03384745|4069483|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1
2339873|NCT03384745|4069484|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
2339874|NCT03384745|4069485|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
2339875|NCT03384745|4069486|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
2339876|NCT03384745|4069481|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0
2247477|NCT01993940|3909328|FG000|Overall Study|Death|1
2247478|NCT01993940|3909329|FG001|Overall Study|Death|0
2247479|NCT01993940|3909328|FG000|Overall Study|Other - Miscellaneous|1
2247480|NCT01993940|3909329|FG001|Overall Study|Other - Miscellaneous|1
2247481|NCT01994226|3909353|FG000|Overall Study|Protocol Violation|13
2247482|NCT01994226|3909354|FG001|Overall Study|Protocol Violation|10
2247483|NCT01994226|3909353|FG000|Overall Study|Early Cessation of treatment|6
2247484|NCT01994226|3909354|FG001|Overall Study|Early Cessation of treatment|11
2247485|NCT01994291|3909363|FG000|Overall Study|Adverse Event|4
2247486|NCT01994291|3909364|FG001|Overall Study|Adverse Event|1
2247487|NCT01994291|3909365|FG002|Overall Study|Adverse Event|3
2247488|NCT01994291|3909363|FG000|Overall Study|Lost to Follow-up|1
2247489|NCT01994291|3909364|FG001|Overall Study|Lost to Follow-up|1
2247490|NCT01994291|3909365|FG002|Overall Study|Lost to Follow-up|0
2247491|NCT01994291|3909363|FG000|Overall Study|Does not meet entrance criteria|1
2247492|NCT01994291|3909364|FG001|Overall Study|Does not meet entrance criteria|0
2247493|NCT01994291|3909365|FG002|Overall Study|Does not meet entrance criteria|0
2247494|NCT01994291|3909363|FG000|Overall Study|Medication error without associated AE|1
2247495|NCT01994291|3909364|FG001|Overall Study|Medication error without associated AE|0
2247496|NCT01994291|3909365|FG002|Overall Study|Medication error without associated AE|1
2247497|NCT01994291|3909363|FG000|Overall Study|Protocol Violation|1
2247498|NCT01994291|3909364|FG001|Overall Study|Protocol Violation|0
2247499|NCT01994291|3909365|FG002|Overall Study|Protocol Violation|0
2247500|NCT01994291|3909363|FG000|Overall Study|Withdrawal by Subject|6
2247501|NCT01994291|3909364|FG001|Overall Study|Withdrawal by Subject|3
2247502|NCT01994291|3909365|FG002|Overall Study|Withdrawal by Subject|5
2247503|NCT01994291|3909363|FG000|Overall Study|Other|1
2247504|NCT01994291|3909364|FG001|Overall Study|Other|2
2247505|NCT01994291|3909365|FG002|Overall Study|Other|0
2247506|NCT01994395|3909376|FG000|Overall Study|Withdrawal by Subject|1
2247507|NCT01994395|3909377|FG001|Overall Study|Withdrawal by Subject|2
2247508|NCT01994590|3909398|FG000|Overall Study|Adverse Event|1
2247509|NCT01994590|3909398|FG000|Overall Study|Trial Terminated|1
2247510|NCT01994629|3909404|FG000|Overall Study|Withdrawal by Subject|1
2247511|NCT01994629|3909405|FG001|Overall Study|Withdrawal by Subject|0
2247512|NCT01994629|3909404|FG000|Overall Study|Lost to Follow-up|0
2247513|NCT01994629|3909405|FG001|Overall Study|Lost to Follow-up|3
2247514|NCT01994720|3909413|FG000|Overall Study|Withdrawal by Subject|46
2247515|NCT01994720|3909414|FG001|Overall Study|Withdrawal by Subject|56
2339877|NCT03384745|4069482|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0
2339878|NCT03384745|4069483|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0
2339879|NCT03384745|4069484|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1
2339880|NCT03384745|4069485|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1
2339881|NCT03384745|4069486|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0
2339882|NCT03384745|4069481|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
2339883|NCT03384745|4069482|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
2339884|NCT03384745|4069483|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
2339885|NCT03384745|4069484|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
2339886|NCT03384745|4069485|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1
2339887|NCT03384745|4069486|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
2339888|NCT03384745|4069481|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
2339889|NCT03384745|4069482|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
2339890|NCT03384745|4069483|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
2339891|NCT03384745|4069484|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
2339892|NCT03384745|4069485|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
2339893|NCT03384745|4069486|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
2339894|NCT03384745|4069481|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
2339895|NCT03384745|4069482|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
2339896|NCT03384745|4069483|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3
2339897|NCT03384745|4069484|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
2339898|NCT03384745|4069485|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
2339899|NCT03384745|4069486|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
2339900|NCT03384745|4069481|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
2339901|NCT03384745|4069482|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
2339902|NCT03384745|4069483|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
2038112|NCT00421707|3608490|FG001|Period 2: Washout|Adverse Event|1
2038113|NCT00421707|3608489|FG000|Period 2: Washout|Withdrawal by Subject|0
2038114|NCT00421707|3608490|FG001|Period 2: Washout|Withdrawal by Subject|1
2038115|NCT00421707|3608489|FG000|Period 2: Washout|Lost to Follow-up|0
2038116|NCT00421707|3608490|FG001|Period 2: Washout|Lost to Follow-up|1
2038117|NCT00421707|3608489|FG000|Period 2: Washout|Other: Pregnancy|0
2038118|NCT00421707|3608490|FG001|Period 2: Washout|Other: Pregnancy|1
2038119|NCT00421707|3608489|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1
2038120|NCT00421707|3608490|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1
2038121|NCT00421707|3608489|FG000|Period 3:Treatment Period 2|Protocol Violation|1
2038122|NCT00421707|3608490|FG001|Period 3:Treatment Period 2|Protocol Violation|0
2038123|NCT00421707|3608489|FG000|Period 3:Treatment Period 2|Adverse Event|0
2038124|NCT00421707|3608490|FG001|Period 3:Treatment Period 2|Adverse Event|2
2038125|NCT00421733|3608502|FG000|Overall Study|Adverse Event|4
2038126|NCT00421733|3608503|FG001|Overall Study|Adverse Event|9
2038127|NCT00421733|3608504|FG002|Overall Study|Adverse Event|2
2038128|NCT00421733|3608502|FG000|Overall Study|Lost to Follow-up|1
2038129|NCT00421733|3608503|FG001|Overall Study|Lost to Follow-up|2
2038130|NCT00421733|3608504|FG002|Overall Study|Lost to Follow-up|4
2038131|NCT00421733|3608502|FG000|Overall Study|Withdrawal by Subject|1
2247516|NCT01994837|3909444|FG000|Overall Study|Progressive disease per protocol|23
2247517|NCT01994837|3909444|FG000|Overall Study|Adv event related to progressive disease|3
2247518|NCT01994837|3909444|FG000|Overall Study|Fatal progressive disease|2
2247519|NCT01994837|3909444|FG000|Overall Study|Adverse event not related to progression|1
2247520|NCT01994837|3909444|FG000|Overall Study|Chose palliative care|1
2247521|NCT01994837|3909444|FG000|Overall Study|Proceeded to transplant|1
2247522|NCT01994837|3909444|FG000|Overall Study|Removed from study due to no response|1
2247523|NCT01994850|3909448|FG000|Overall Study|Physician Decision|1
2247524|NCT01994850|3909448|FG000|Overall Study|Withdrawal by Subject|1
2247525|NCT01994863|3909452|FG000|Period 1|Adverse Event|4
2247526|NCT01994863|3909453|FG001|Period 1|Adverse Event|0
2247527|NCT01994863|3909452|FG000|Period 1|Withdrawal by Subject|1
2247528|NCT01994863|3909453|FG001|Period 1|Withdrawal by Subject|0
2247529|NCT01994863|3909452|FG000|Period 1|Trial stopped by sponsor|1
2247530|NCT01994863|3909453|FG001|Period 1|Trial stopped by sponsor|3
2247531|NCT01994863|3909452|FG000|Period 1|Lack of Efficacy|1
2247532|NCT01994863|3909453|FG001|Period 1|Lack of Efficacy|0
2247533|NCT01994863|3909452|FG000|Period 2|Adverse Event|0
2247534|NCT01994863|3909453|FG001|Period 2|Adverse Event|1
2247535|NCT01994863|3909452|FG000|Period 2|Lack of Efficacy|0
2247536|NCT01994863|3909453|FG001|Period 2|Lack of Efficacy|2
2247537|NCT01994863|3909452|FG000|Period 2|Withdrawal by Subject|1
2247538|NCT01994863|3909453|FG001|Period 2|Withdrawal by Subject|1
2247539|NCT01994876|3909459|FG000|Test Period 1|Withdrawal by Subject|0
2247540|NCT01994876|3909460|FG001|Test Period 1|Withdrawal by Subject|1
2247541|NCT01994876|3909459|FG000|Test Period 1|Adverse Event|0
2247542|NCT01994876|3909460|FG001|Test Period 1|Adverse Event|1
2247543|NCT01994876|3909459|FG000|Test Period 2|Adverse Event|1
2247544|NCT01994876|3909460|FG001|Test Period 2|Adverse Event|0
2247545|NCT01994876|3909459|FG000|Test Period 2|Protocol Violation|0
2247546|NCT01994876|3909460|FG001|Test Period 2|Protocol Violation|1
2247547|NCT01994889|3909471|FG000|Overall Study|Adverse Event|5
2247548|NCT01994889|3909472|FG001|Overall Study|Adverse Event|12
2247549|NCT01994889|3909473|FG002|Overall Study|Adverse Event|11
2247550|NCT01994889|3909471|FG000|Overall Study|Cardiac Device Implantation|0
2247551|NCT01994889|3909472|FG001|Overall Study|Cardiac Device Implantation|2
2247552|NCT01994889|3909473|FG002|Overall Study|Cardiac Device Implantation|0
2247553|NCT01994889|3909471|FG000|Overall Study|Organ Transplantation|1
2247554|NCT01994889|3909472|FG001|Overall Study|Organ Transplantation|5
2247555|NCT01994889|3909473|FG002|Overall Study|Organ Transplantation|5
2247556|NCT01994889|3909471|FG000|Overall Study|No longer willing to participate|8
2247557|NCT01994889|3909472|FG001|Overall Study|No longer willing to participate|17
2247558|NCT01994889|3909473|FG002|Overall Study|No longer willing to participate|37
2339903|NCT03384745|4069484|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
2339904|NCT03384745|4069485|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
2339905|NCT03384745|4069486|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
2339906|NCT03384745|4069481|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
2339907|NCT03384745|4069482|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
2339908|NCT03384745|4069483|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
2339909|NCT03384745|4069484|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2
2339910|NCT03384745|4069485|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
2339911|NCT03384745|4069486|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
2339912|NCT03384745|4069481|FG000|Response Assess/Dose Hold (W24-W48)|Death|0
2339913|NCT03384745|4069482|FG001|Response Assess/Dose Hold (W24-W48)|Death|1
2339914|NCT03384745|4069483|FG002|Response Assess/Dose Hold (W24-W48)|Death|0
2339915|NCT03384745|4069484|FG003|Response Assess/Dose Hold (W24-W48)|Death|0
2339916|NCT03384745|4069485|FG004|Response Assess/Dose Hold (W24-W48)|Death|0
2339917|NCT03384745|4069486|FG005|Response Assess/Dose Hold (W24-W48)|Death|0
2339918|NCT03384940|4069509|FG000|Overall Study|Progressive disease|36
2339919|NCT03384940|4069510|FG001|Overall Study|Progressive disease|11
2339920|NCT03384940|4069511|FG002|Overall Study|Progressive disease|13
2339921|NCT03384940|4069509|FG000|Overall Study|Clinical progression|4
2339922|NCT03384940|4069510|FG001|Overall Study|Clinical progression|0
2339923|NCT03384940|4069511|FG002|Overall Study|Clinical progression|3
2339924|NCT03384940|4069509|FG000|Overall Study|Adverse Event|7
2339925|NCT03384940|4069510|FG001|Overall Study|Adverse Event|1
2339926|NCT03384940|4069511|FG002|Overall Study|Adverse Event|1
2339927|NCT03384940|4069509|FG000|Overall Study|Withdrawal by Subject|3
2339928|NCT03384940|4069510|FG001|Overall Study|Withdrawal by Subject|1
2339929|NCT03384940|4069511|FG002|Overall Study|Withdrawal by Subject|0
2339930|NCT03384940|4069509|FG000|Overall Study|Physician Decision|1
2339931|NCT03384940|4069510|FG001|Overall Study|Physician Decision|1
2339932|NCT03384940|4069511|FG002|Overall Study|Physician Decision|0
2339933|NCT03384940|4069509|FG000|Overall Study|Death|2
2339934|NCT03384940|4069510|FG001|Overall Study|Death|1
2339935|NCT03384940|4069511|FG002|Overall Study|Death|0
2339936|NCT03384940|4069509|FG000|Overall Study|Other|0
2339937|NCT03384940|4069510|FG001|Overall Study|Other|0
2247559|NCT01994889|3909471|FG000|Overall Study|Lost to Follow-up|0
2247560|NCT01994889|3909472|FG001|Overall Study|Lost to Follow-up|1
2247561|NCT01994889|3909473|FG002|Overall Study|Lost to Follow-up|0
2247562|NCT01994889|3909471|FG000|Overall Study|Protocol Violation|0
2339938|NCT03384940|4069511|FG002|Overall Study|Other|1
2353072|NCT03302247|4103967|FG000|Overall Study|Death|1
2247563|NCT01994889|3909472|FG001|Overall Study|Protocol Violation|1
2247564|NCT01994889|3909473|FG002|Overall Study|Protocol Violation|1
2247565|NCT01994889|3909471|FG000|Overall Study|Death|14
2247566|NCT01994889|3909472|FG001|Overall Study|Death|25
2247567|NCT01994889|3909473|FG002|Overall Study|Death|38
2247568|NCT01994902|3909480|FG000|Test Period 1|Withdrawal by Subject|3
2247569|NCT01994902|3909481|FG001|Test Period 1|Withdrawal by Subject|0
2247570|NCT01994902|3909480|FG000|Test Period 1|device deficiency with adverse event|0
2247571|NCT01994902|3909481|FG001|Test Period 1|device deficiency with adverse event|1
2247572|NCT01994902|3909480|FG000|Test Period 1|Adverse Event|2
2247573|NCT01994902|3909481|FG001|Test Period 1|Adverse Event|1
2247574|NCT01994902|3909480|FG000|Test Period 1|Lack of Efficacy|0
2247575|NCT01994902|3909481|FG001|Test Period 1|Lack of Efficacy|1
2247576|NCT01994902|3909480|FG000|Test Period 1|bag too small|1
2247577|NCT01994902|3909481|FG001|Test Period 1|bag too small|0
2247578|NCT01994902|3909480|FG000|Test Period 2|Withdrawal by Subject|0
2247579|NCT01994902|3909481|FG001|Test Period 2|Withdrawal by Subject|2
2247580|NCT01994902|3909480|FG000|Test Period 2|Lack of Efficacy|0
2247581|NCT01994902|3909481|FG001|Test Period 2|Lack of Efficacy|1
2247582|NCT01994902|3909480|FG000|Test Period 2|Other|0
2247583|NCT01994902|3909481|FG001|Test Period 2|Other|3
2247584|NCT01994954|3909489|FG000|Overall Study|Death|1
2247585|NCT01994954|3909490|FG001|Overall Study|Death|0
2247586|NCT01994954|3909489|FG000|Overall Study|Withdrawal by Subject|9
2247587|NCT01994954|3909490|FG001|Overall Study|Withdrawal by Subject|14
2247588|NCT01994954|3909489|FG000|Overall Study|Physician Decision|2
2247589|NCT01994954|3909490|FG001|Overall Study|Physician Decision|2
2247590|NCT01994954|3909489|FG000|Overall Study|Lost to Follow-up|8
2247591|NCT01994954|3909490|FG001|Overall Study|Lost to Follow-up|10
2247592|NCT01994954|3909489|FG000|Overall Study|6 Month Follow-up Not Complete|5
2247593|NCT01994954|3909490|FG001|Overall Study|6 Month Follow-up Not Complete|4
2247594|NCT01995071|3909544|FG000|Overall Study|Adverse Event|0
2247595|NCT01995071|3909545|FG001|Overall Study|Adverse Event|0
2247596|NCT01995071|3909546|FG002|Overall Study|Adverse Event|0
2247597|NCT01995071|3909547|FG003|Overall Study|Adverse Event|0
2247598|NCT01995071|3909548|FG004|Overall Study|Adverse Event|0
2247599|NCT01995071|3909549|FG005|Overall Study|Adverse Event|0
2247600|NCT01995071|3909550|FG006|Overall Study|Adverse Event|1
2247601|NCT01995071|3909551|FG007|Overall Study|Adverse Event|0
2247602|NCT01995071|3909552|FG008|Overall Study|Adverse Event|0
2247603|NCT01995071|3909553|FG009|Overall Study|Adverse Event|0
2247604|NCT01995071|3909554|FG010|Overall Study|Adverse Event|0
2247605|NCT01995071|3909555|FG011|Overall Study|Adverse Event|0
2247606|NCT01995071|3909544|FG000|Overall Study|Moved|0
2247607|NCT01995071|3909545|FG001|Overall Study|Moved|0
2247608|NCT01995071|3909546|FG002|Overall Study|Moved|1
2247609|NCT01995071|3909547|FG003|Overall Study|Moved|0
2247610|NCT01995071|3909548|FG004|Overall Study|Moved|1
2247611|NCT01995071|3909549|FG005|Overall Study|Moved|0
2247612|NCT01995071|3909550|FG006|Overall Study|Moved|0
2247613|NCT01995071|3909551|FG007|Overall Study|Moved|0
2247614|NCT01995071|3909552|FG008|Overall Study|Moved|0
2247615|NCT01995071|3909553|FG009|Overall Study|Moved|0
2247616|NCT01995071|3909554|FG010|Overall Study|Moved|1
2247617|NCT01995071|3909555|FG011|Overall Study|Moved|0
2247618|NCT01995071|3909544|FG000|Overall Study|Lost to Follow-up|1
2247619|NCT01995071|3909545|FG001|Overall Study|Lost to Follow-up|0
2247620|NCT01995071|3909546|FG002|Overall Study|Lost to Follow-up|0
2247621|NCT01995071|3909547|FG003|Overall Study|Lost to Follow-up|0
2247622|NCT01995071|3909548|FG004|Overall Study|Lost to Follow-up|0
2247623|NCT01995071|3909549|FG005|Overall Study|Lost to Follow-up|0
2247624|NCT01995071|3909550|FG006|Overall Study|Lost to Follow-up|0
2247625|NCT01995071|3909551|FG007|Overall Study|Lost to Follow-up|1
2247626|NCT01995071|3909552|FG008|Overall Study|Lost to Follow-up|1
2247627|NCT01995071|3909553|FG009|Overall Study|Lost to Follow-up|0
2247628|NCT01995071|3909554|FG010|Overall Study|Lost to Follow-up|0
2247629|NCT01995071|3909555|FG011|Overall Study|Lost to Follow-up|0
2247630|NCT01995071|3909544|FG000|Overall Study|Incarcerated|0
2247631|NCT01995071|3909545|FG001|Overall Study|Incarcerated|0
2247632|NCT01995071|3909546|FG002|Overall Study|Incarcerated|0
2247633|NCT01995071|3909547|FG003|Overall Study|Incarcerated|0
2247634|NCT01995071|3909548|FG004|Overall Study|Incarcerated|0
2247635|NCT01995071|3909549|FG005|Overall Study|Incarcerated|0
2247636|NCT01995071|3909550|FG006|Overall Study|Incarcerated|0
2247637|NCT01995071|3909551|FG007|Overall Study|Incarcerated|1
2247638|NCT01995071|3909552|FG008|Overall Study|Incarcerated|0
2247639|NCT01995071|3909553|FG009|Overall Study|Incarcerated|0
2247640|NCT01995071|3909554|FG010|Overall Study|Incarcerated|0
2247641|NCT01995071|3909555|FG011|Overall Study|Incarcerated|0
2247642|NCT01995136|3909596|FG000|Overall Study|Change in residence|1
2247643|NCT01995201|3909602|FG000|From Baseline Until Week 24|Adverse Event|4
2247644|NCT01995201|3909603|FG001|From Baseline Until Week 24|Adverse Event|15
2247645|NCT01995201|3909604|FG002|From Baseline Until Week 24|Adverse Event|0
2247646|NCT01995201|3909605|FG003|From Baseline Until Week 24|Adverse Event|0
2247647|NCT01995201|3909606|FG004|From Baseline Until Week 24|Adverse Event|0
2247648|NCT01995201|3909607|FG005|From Baseline Until Week 24|Adverse Event|0
2247649|NCT01995201|3909608|FG006|From Baseline Until Week 24|Adverse Event|0
2247650|NCT01995201|3909602|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2247651|NCT01995201|3909603|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
2247652|NCT01995201|3909604|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2339939|NCT03384966|4069531|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1
2339940|NCT03384966|4069532|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0
2339941|NCT03384966|4069533|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0
2339942|NCT03384966|4069531|FG000|Follow-up Period|Adverse Event|1
2339943|NCT03384966|4069532|FG001|Follow-up Period|Adverse Event|0
2339944|NCT03384966|4069533|FG002|Follow-up Period|Adverse Event|0
2339945|NCT03386032|4069553|FG000|Overall Study|Lack of Efficacy|6
2339946|NCT03386032|4069554|FG001|Overall Study|Lack of Efficacy|2
2339947|NCT03386032|4069555|FG002|Overall Study|Lack of Efficacy|0
2339948|NCT03386032|4069553|FG000|Overall Study|Adverse Event|2
2339949|NCT03386032|4069554|FG001|Overall Study|Adverse Event|2
2339950|NCT03386032|4069555|FG002|Overall Study|Adverse Event|0
2339951|NCT03386032|4069553|FG000|Overall Study|Withdrawal by Subject|1
2339952|NCT03386032|4069554|FG001|Overall Study|Withdrawal by Subject|0
2339953|NCT03386032|4069555|FG002|Overall Study|Withdrawal by Subject|0
2339954|NCT03386032|4069553|FG000|Overall Study|Lost to Follow-up|9
2339955|NCT03386032|4069554|FG001|Overall Study|Lost to Follow-up|3
2339956|NCT03386032|4069555|FG002|Overall Study|Lost to Follow-up|0
2339957|NCT03386344|4069575|FG000|Overall Study|Adverse Event|6
2339958|NCT03386344|4069576|FG001|Overall Study|Adverse Event|3
2339959|NCT03386344|4069577|FG002|Overall Study|Adverse Event|1
2339960|NCT03386344|4069575|FG000|Overall Study|Poor Compliance to Protocol|0
2339961|NCT03386344|4069576|FG001|Overall Study|Poor Compliance to Protocol|1
2339962|NCT03386344|4069577|FG002|Overall Study|Poor Compliance to Protocol|0
2339963|NCT03386344|4069575|FG000|Overall Study|Study Terminated by Sponsor|101
2339964|NCT03386344|4069576|FG001|Overall Study|Study Terminated by Sponsor|102
2339965|NCT03386344|4069577|FG002|Overall Study|Study Terminated by Sponsor|106
2339966|NCT03386344|4069575|FG000|Overall Study|Lost to Follow-up|3
2339967|NCT03386344|4069576|FG001|Overall Study|Lost to Follow-up|2
2339968|NCT03386344|4069577|FG002|Overall Study|Lost to Follow-up|1
2339969|NCT03386344|4069575|FG000|Overall Study|At the Participant's own Request|7
2339970|NCT03386344|4069576|FG001|Overall Study|At the Participant's own Request|7
2339971|NCT03386344|4069577|FG002|Overall Study|At the Participant's own Request|8
2339972|NCT03386344|4069575|FG000|Overall Study|Reason not Specified|0
2339973|NCT03386344|4069576|FG001|Overall Study|Reason not Specified|1
2339974|NCT03386344|4069577|FG002|Overall Study|Reason not Specified|0
2339975|NCT03386435|4069587|FG000|Overall Study|Protocol Violation|5
2339976|NCT03386435|4069588|FG001|Overall Study|Protocol Violation|7
2339977|NCT03386448|4069596|FG000|Overall Study|Adverse Event|0
2339978|NCT03386448|4069597|FG001|Overall Study|Adverse Event|2
2339979|NCT03386474|4069605|FG000|Overall Study|Death|1
2339980|NCT03386474|4069606|FG001|Overall Study|Death|0
2339981|NCT03386474|4069605|FG000|Overall Study|Adverse Event|0
2339982|NCT03386474|4069606|FG001|Overall Study|Adverse Event|1
2339983|NCT03386994|4069620|FG000|Overall Study|Lung transplant|1
2339984|NCT03386994|4069620|FG000|Overall Study|Adverse Event|14
2339985|NCT03386994|4069620|FG000|Overall Study|Lost to Follow-up|4
2339986|NCT03386994|4069620|FG000|Overall Study|Withdrawal by Subject|3
2339987|NCT03386994|4069620|FG000|Overall Study|Death|16
2339988|NCT03387020|4069638|FG000|Overall Study|Adverse Event|0
2339989|NCT03387020|4069639|FG001|Overall Study|Adverse Event|2
2339990|NCT03387020|4069640|FG002|Overall Study|Adverse Event|0
2339991|NCT03387020|4069638|FG000|Overall Study|Withdrawal by Subject|2
2339992|NCT03387020|4069639|FG001|Overall Study|Withdrawal by Subject|0
2339993|NCT03387020|4069640|FG002|Overall Study|Withdrawal by Subject|0
2339994|NCT03387046|4069664|FG000|Overall Study|Adverse Event|1
2339995|NCT03387046|4069665|FG001|Overall Study|Adverse Event|1
2339996|NCT03387462|4069685|FG000|Overall Study|Lost to Follow-up|1
2353073|NCT03300024|4103973|FG000|Overall Study|Physician Decision|4
2353074|NCT03300024|4103974|FG001|Overall Study|Physician Decision|6
2038132|NCT00421733|3608503|FG001|Overall Study|Withdrawal by Subject|2
2038133|NCT00421733|3608504|FG002|Overall Study|Withdrawal by Subject|7
2038134|NCT00421733|3608502|FG000|Overall Study|Death|0
2038135|NCT00421733|3608503|FG001|Overall Study|Death|3
2038136|NCT00421733|3608504|FG002|Overall Study|Death|0
2038137|NCT00421733|3608502|FG000|Overall Study|Required dialysis|1
2038138|NCT00421733|3608503|FG001|Overall Study|Required dialysis|0
2038139|NCT00421733|3608504|FG002|Overall Study|Required dialysis|0
2247653|NCT01995201|3909605|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2247654|NCT01995201|3909606|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2247655|NCT01995201|3909607|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2038140|NCT00421733|3608502|FG000|Overall Study|Administrative|2
2038141|NCT00421733|3608503|FG001|Overall Study|Administrative|0
2247656|NCT01995201|3909608|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2247657|NCT01995201|3909602|FG000|From Baseline Until Week 24|Death|0
2247658|NCT01995201|3909603|FG001|From Baseline Until Week 24|Death|1
2247659|NCT01995201|3909604|FG002|From Baseline Until Week 24|Death|0
2247660|NCT01995201|3909605|FG003|From Baseline Until Week 24|Death|0
2247661|NCT01995201|3909606|FG004|From Baseline Until Week 24|Death|0
2247662|NCT01995201|3909607|FG005|From Baseline Until Week 24|Death|0
2247663|NCT01995201|3909608|FG006|From Baseline Until Week 24|Death|0
2247664|NCT01995201|3909602|FG000|From Baseline Until Week 24|Lack of Efficacy|2
2247665|NCT01995201|3909603|FG001|From Baseline Until Week 24|Lack of Efficacy|5
2247666|NCT01995201|3909604|FG002|From Baseline Until Week 24|Lack of Efficacy|0
2247667|NCT01995201|3909605|FG003|From Baseline Until Week 24|Lack of Efficacy|0
2247668|NCT01995201|3909606|FG004|From Baseline Until Week 24|Lack of Efficacy|0
2247669|NCT01995201|3909607|FG005|From Baseline Until Week 24|Lack of Efficacy|0
2247670|NCT01995201|3909608|FG006|From Baseline Until Week 24|Lack of Efficacy|0
2247671|NCT01995201|3909602|FG000|From Baseline Until Week 24|Lost to Follow-up|2
2247672|NCT01995201|3909603|FG001|From Baseline Until Week 24|Lost to Follow-up|3
2247673|NCT01995201|3909604|FG002|From Baseline Until Week 24|Lost to Follow-up|0
2247674|NCT01995201|3909605|FG003|From Baseline Until Week 24|Lost to Follow-up|0
2247675|NCT01995201|3909606|FG004|From Baseline Until Week 24|Lost to Follow-up|0
2247676|NCT01995201|3909607|FG005|From Baseline Until Week 24|Lost to Follow-up|0
2247677|NCT01995201|3909608|FG006|From Baseline Until Week 24|Lost to Follow-up|0
2247678|NCT01995201|3909602|FG000|From Baseline Until Week 24|Withdrawal by Subject|2
2247679|NCT01995201|3909603|FG001|From Baseline Until Week 24|Withdrawal by Subject|8
2247680|NCT01995201|3909604|FG002|From Baseline Until Week 24|Withdrawal by Subject|0
2247681|NCT01995201|3909605|FG003|From Baseline Until Week 24|Withdrawal by Subject|0
2247682|NCT01995201|3909606|FG004|From Baseline Until Week 24|Withdrawal by Subject|0
2247683|NCT01995201|3909607|FG005|From Baseline Until Week 24|Withdrawal by Subject|0
2247684|NCT01995201|3909608|FG006|From Baseline Until Week 24|Withdrawal by Subject|0
2247685|NCT01995201|3909602|FG000|From Baseline Until Week 24|Physician Decision|0
2247686|NCT01995201|3909603|FG001|From Baseline Until Week 24|Physician Decision|2
2247687|NCT01995201|3909604|FG002|From Baseline Until Week 24|Physician Decision|0
2247688|NCT01995201|3909605|FG003|From Baseline Until Week 24|Physician Decision|0
2247689|NCT01995201|3909606|FG004|From Baseline Until Week 24|Physician Decision|0
2247690|NCT01995201|3909607|FG005|From Baseline Until Week 24|Physician Decision|0
2247691|NCT01995201|3909608|FG006|From Baseline Until Week 24|Physician Decision|0
2247692|NCT01995201|3909602|FG000|From Baseline Until Week 24|Protocol Violation|0
2247693|NCT01995201|3909603|FG001|From Baseline Until Week 24|Protocol Violation|9
2247694|NCT01995201|3909604|FG002|From Baseline Until Week 24|Protocol Violation|0
2247695|NCT01995201|3909605|FG003|From Baseline Until Week 24|Protocol Violation|0
2247696|NCT01995201|3909606|FG004|From Baseline Until Week 24|Protocol Violation|0
2247697|NCT01995201|3909607|FG005|From Baseline Until Week 24|Protocol Violation|0
2247698|NCT01995201|3909608|FG006|From Baseline Until Week 24|Protocol Violation|0
2247699|NCT01995201|3909602|FG000|From Week 24 Until Week 48|Adverse Event|0
2247700|NCT01995201|3909603|FG001|From Week 24 Until Week 48|Adverse Event|0
2247701|NCT01995201|3909604|FG002|From Week 24 Until Week 48|Adverse Event|2
2247702|NCT01995201|3909605|FG003|From Week 24 Until Week 48|Adverse Event|1
2247703|NCT01995201|3909606|FG004|From Week 24 Until Week 48|Adverse Event|1
2247704|NCT01995201|3909607|FG005|From Week 24 Until Week 48|Adverse Event|3
2247705|NCT01995201|3909608|FG006|From Week 24 Until Week 48|Adverse Event|1
2247706|NCT01995201|3909602|FG000|From Week 24 Until Week 48|Death|0
2247707|NCT01995201|3909603|FG001|From Week 24 Until Week 48|Death|0
2247708|NCT01995201|3909604|FG002|From Week 24 Until Week 48|Death|0
2247709|NCT01995201|3909605|FG003|From Week 24 Until Week 48|Death|0
2247710|NCT01995201|3909606|FG004|From Week 24 Until Week 48|Death|0
2247711|NCT01995201|3909607|FG005|From Week 24 Until Week 48|Death|2
2247712|NCT01995201|3909608|FG006|From Week 24 Until Week 48|Death|0
2339997|NCT03387683|4069691|FG000|Overall Study|In receipt of disallowed medication|1
2339998|NCT03387683|4069692|FG001|Overall Study|In receipt of disallowed medication|0
2339999|NCT03387683|4069691|FG000|Overall Study|Did not receive treatment|1
2340000|NCT03387683|4069692|FG001|Overall Study|Did not receive treatment|0
2340001|NCT03388164|4069709|FG000|Overall Study|Withdrawal by Subject|3
2340002|NCT03388164|4069710|FG001|Overall Study|Withdrawal by Subject|1
2340003|NCT03389308|4069743|FG000|Overall Study|Withdrawal by Subject|5
2340004|NCT03389308|4069743|FG000|Overall Study|Lost to Follow-up|3
2340005|NCT03389308|4069743|FG000|Overall Study|Adverse Event|2
2340006|NCT03389308|4069743|FG000|Overall Study|Sponsor Request|2
2340007|NCT03389555|4069749|FG000|Overall Study|Protocol Violation|1
2340008|NCT03389555|4069750|FG001|Overall Study|Protocol Violation|3
2340009|NCT03389555|4069749|FG000|Overall Study|Death|1
2340010|NCT03389555|4069750|FG001|Overall Study|Death|0
2340011|NCT03389893|4069779|FG000|Randomized Double Blind Period|Withdrawal by Subject|1
2340012|NCT03389893|4069780|FG001|Randomized Double Blind Period|Withdrawal by Subject|0
2340013|NCT03389893|4069781|FG002|Randomized Double Blind Period|Withdrawal by Subject|0
2340014|NCT03389893|4069782|FG003|Randomized Double Blind Period|Withdrawal by Subject|0
2340015|NCT03389893|4069779|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0
2340016|NCT03389893|4069780|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0
2340017|NCT03389893|4069781|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2
2247713|NCT01995201|3909602|FG000|From Week 24 Until Week 48|Lack of Efficacy|0
2247714|NCT01995201|3909603|FG001|From Week 24 Until Week 48|Lack of Efficacy|0
2247715|NCT01995201|3909604|FG002|From Week 24 Until Week 48|Lack of Efficacy|1
2247716|NCT01995201|3909605|FG003|From Week 24 Until Week 48|Lack of Efficacy|0
2247717|NCT01995201|3909606|FG004|From Week 24 Until Week 48|Lack of Efficacy|0
2247718|NCT01995201|3909607|FG005|From Week 24 Until Week 48|Lack of Efficacy|2
2247719|NCT01995201|3909608|FG006|From Week 24 Until Week 48|Lack of Efficacy|1
2247720|NCT01995201|3909602|FG000|From Week 24 Until Week 48|Lost to Follow-up|0
2247721|NCT01995201|3909603|FG001|From Week 24 Until Week 48|Lost to Follow-up|0
2247722|NCT01995201|3909604|FG002|From Week 24 Until Week 48|Lost to Follow-up|0
2247723|NCT01995201|3909605|FG003|From Week 24 Until Week 48|Lost to Follow-up|0
2247724|NCT01995201|3909606|FG004|From Week 24 Until Week 48|Lost to Follow-up|1
2247725|NCT01995201|3909607|FG005|From Week 24 Until Week 48|Lost to Follow-up|1
2247726|NCT01995201|3909608|FG006|From Week 24 Until Week 48|Lost to Follow-up|0
2247727|NCT01995201|3909602|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0
2247728|NCT01995201|3909603|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0
2247729|NCT01995201|3909604|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1
2247730|NCT01995201|3909605|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0
2247731|NCT01995201|3909606|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1
2247732|NCT01995201|3909607|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0
2247733|NCT01995201|3909608|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0
2247734|NCT01995201|3909602|FG000|From Week 24 Until Week 48|Physician Decision|0
2247735|NCT01995201|3909603|FG001|From Week 24 Until Week 48|Physician Decision|0
2247736|NCT01995201|3909604|FG002|From Week 24 Until Week 48|Physician Decision|0
2247737|NCT01995201|3909605|FG003|From Week 24 Until Week 48|Physician Decision|0
2247738|NCT01995201|3909606|FG004|From Week 24 Until Week 48|Physician Decision|1
2340018|NCT03389893|4069782|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1
2340019|NCT03389893|4069779|FG000|Open Label Extension and Follow-Up|Physician Decision|0
2340020|NCT03389893|4069780|FG001|Open Label Extension and Follow-Up|Physician Decision|0
2340021|NCT03389893|4069781|FG002|Open Label Extension and Follow-Up|Physician Decision|1
2340022|NCT03389893|4069782|FG003|Open Label Extension and Follow-Up|Physician Decision|0
2340023|NCT03389893|4069779|FG000|Open Label Extension and Follow-Up|Participant Moved|0
2340024|NCT03389893|4069780|FG001|Open Label Extension and Follow-Up|Participant Moved|0
2340025|NCT03389893|4069781|FG002|Open Label Extension and Follow-Up|Participant Moved|1
2340026|NCT03389893|4069782|FG003|Open Label Extension and Follow-Up|Participant Moved|0
2340027|NCT03390101|4069791|FG000|Weeks 0-12|Withdrawal by Subject|0
2340028|NCT03390101|4069792|FG001|Weeks 0-12|Withdrawal by Subject|1
2340029|NCT03390101|4069793|FG002|Weeks 0-12|Withdrawal by Subject|1
2340030|NCT03390101|4069791|FG000|Weeks 0-12|Lost to Follow-up|0
2340031|NCT03390101|4069792|FG001|Weeks 0-12|Lost to Follow-up|1
2340032|NCT03390101|4069793|FG002|Weeks 0-12|Lost to Follow-up|0
2340033|NCT03390101|4069791|FG000|Weeks 12-54|Withdrawal by Subject|0
2340034|NCT03390101|4069792|FG001|Weeks 12-54|Withdrawal by Subject|3
2340035|NCT03390101|4069793|FG002|Weeks 12-54|Withdrawal by Subject|1
2340036|NCT03390101|4069791|FG000|Weeks 12-54|Pregnancy|1
2340037|NCT03390101|4069792|FG001|Weeks 12-54|Pregnancy|0
2340038|NCT03390101|4069793|FG002|Weeks 12-54|Pregnancy|0
2340039|NCT03390101|4069791|FG000|Weeks 12-54|Adverse Event|2
2340040|NCT03390101|4069792|FG001|Weeks 12-54|Adverse Event|1
2340041|NCT03390101|4069793|FG002|Weeks 12-54|Adverse Event|1
2340042|NCT03390166|4069812|FG000|Overall Study|Death|0
2340043|NCT03390166|4069813|FG001|Overall Study|Death|1
2340044|NCT03390166|4069812|FG000|Overall Study|Lost to Follow-up|6
2340045|NCT03390166|4069813|FG001|Overall Study|Lost to Follow-up|4
2340046|NCT03390166|4069812|FG000|Overall Study|Physician Decision|2
2340047|NCT03390166|4069813|FG001|Overall Study|Physician Decision|1
2340048|NCT03390166|4069812|FG000|Overall Study|Move from study area|3
2340049|NCT03390166|4069813|FG001|Overall Study|Move from study area|2
2340050|NCT03390166|4069812|FG000|Overall Study|To militarycamp for conscript|1
2340051|NCT03390166|4069813|FG001|Overall Study|To militarycamp for conscript|0
2340052|NCT03390166|4069812|FG000|Overall Study|To drug therapy course|0
2340053|NCT03390166|4069813|FG001|Overall Study|To drug therapy course|1
2340054|NCT03390166|4069812|FG000|Overall Study|Move to work oversea|0
2340055|NCT03390166|4069813|FG001|Overall Study|Move to work oversea|1
2340056|NCT03390426|4069827|FG000|Overall Study|Protocol Violation|0
2340057|NCT03390426|4069828|FG001|Overall Study|Protocol Violation|1
2340058|NCT03391765|4069861|FG000|Overall Study|Adverse Event|2
2340059|NCT03391765|4069862|FG001|Overall Study|Adverse Event|0
2340060|NCT03391765|4069863|FG002|Overall Study|Adverse Event|0
2340061|NCT03391765|4069864|FG003|Overall Study|Adverse Event|2
2340062|NCT03391765|4069861|FG000|Overall Study|Withdrew consent|5
2340063|NCT03391765|4069862|FG001|Overall Study|Withdrew consent|7
2340064|NCT03391765|4069863|FG002|Overall Study|Withdrew consent|2
2340065|NCT03391765|4069864|FG003|Overall Study|Withdrew consent|5
2340066|NCT03391765|4069861|FG000|Overall Study|Other, not specified|44
2340067|NCT03391765|4069862|FG001|Overall Study|Other, not specified|38
2340068|NCT03391765|4069863|FG002|Overall Study|Other, not specified|21
2340069|NCT03391765|4069864|FG003|Overall Study|Other, not specified|16
2340070|NCT03392168|4069891|FG000|Period 2: Cohort 2|Lost to Follow-up|0
2340071|NCT03392168|4069892|FG001|Period 2: Cohort 2|Lost to Follow-up|1
2247739|NCT01995201|3909607|FG005|From Week 24 Until Week 48|Physician Decision|0
2247740|NCT01995201|3909608|FG006|From Week 24 Until Week 48|Physician Decision|0
2247741|NCT01995201|3909602|FG000|From Week 24 Until Week 48|Protocol Violation|0
2247742|NCT01995201|3909603|FG001|From Week 24 Until Week 48|Protocol Violation|0
2247743|NCT01995201|3909604|FG002|From Week 24 Until Week 48|Protocol Violation|1
2247744|NCT01995201|3909605|FG003|From Week 24 Until Week 48|Protocol Violation|0
2247745|NCT01995201|3909606|FG004|From Week 24 Until Week 48|Protocol Violation|2
2247746|NCT01995201|3909607|FG005|From Week 24 Until Week 48|Protocol Violation|0
2340072|NCT03392168|4069893|FG002|Period 2: Cohort 2|Lost to Follow-up|1
2340073|NCT03392168|4069894|FG003|Period 2: Cohort 2|Lost to Follow-up|1
2340074|NCT03392168|4069891|FG000|Period 2: Cohort 2|Other|0
2340075|NCT03392168|4069892|FG001|Period 2: Cohort 2|Other|1
2340076|NCT03392168|4069893|FG002|Period 2: Cohort 2|Other|0
2340077|NCT03392168|4069894|FG003|Period 2: Cohort 2|Other|0
2340078|NCT03392194|4069905|FG000|Overall Study|Withdrawal by Subject|1
2340079|NCT03392194|4069906|FG001|Overall Study|Withdrawal by Subject|2
2340080|NCT03392194|4069905|FG000|Overall Study|Conflicts with personal schedule|1
2340081|NCT03392194|4069906|FG001|Overall Study|Conflicts with personal schedule|0
2340082|NCT03393000|4069928|FG000|Overall Study|Death|11
2340083|NCT03393000|4069928|FG000|Overall Study|Withdrawal by Subject|2
2340084|NCT03393000|4069928|FG000|Overall Study|Physician Decision|1
2353075|NCT03283709|4103984|FG000|Overall Study|trial terminated|0
2353076|NCT03283709|4103985|FG001|Overall Study|trial terminated|1
2353077|NCT03263806|4104020|FG000|Overall Study|Elevated Troponin (failed screen)|1
2353078|NCT03263806|4104021|FG001|Overall Study|Elevated Troponin (failed screen)|0
2353079|NCT03263806|4104020|FG000|Overall Study|Withdrawal by Subject|0
2353080|NCT03263806|4104021|FG001|Overall Study|Withdrawal by Subject|1
2353081|NCT03263806|4104020|FG000|Overall Study|Study Termination|5
2353082|NCT03263806|4104021|FG001|Overall Study|Study Termination|6
2353083|NCT03261531|4104027|FG000|Overall Study|Withdrawal by Subject|4
2353084|NCT03219372|4104046|FG000|Overall Study|Withdrawal by Subject|1
2353085|NCT03219372|4104047|FG001|Overall Study|Withdrawal by Subject|0
2353086|NCT03217175|4104053|FG000|Overall Study|Physician Decision|4
2353087|NCT03217175|4104054|FG001|Overall Study|Physician Decision|1
2353088|NCT03223662|4104081|FG000|Overall Study|Physician Decision|1
2353089|NCT03223662|4104081|FG000|Overall Study|Study closure|1
2353090|NCT03212144|4104087|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1
2353091|NCT03212144|4104088|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0
2353092|NCT03212144|4104087|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1
2353093|NCT03212144|4104088|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1
2353094|NCT03204539|4104104|FG000|Overall Study|Loss of funding|0
2353095|NCT03204539|4104105|FG001|Overall Study|Loss of funding|1
2353096|NCT03206216|4104113|FG000|Overall Study|Withdrawal by Subject|0
2353097|NCT03206216|4104114|FG001|Overall Study|Withdrawal by Subject|1
2353098|NCT03195660|4104120|FG000|Overall Study|The study was terminated|2
2353099|NCT03166618|4104130|FG000|Overall Study|Study was Terminated|0
2353100|NCT03166618|4104131|FG001|Overall Study|Study was Terminated|1
2353101|NCT03169530|4104139|FG000|Overall Study|Study ended by NIH|15
2353102|NCT03169530|4104140|FG001|Overall Study|Study ended by NIH|17
2353103|NCT03151226|4104155|FG000|Overall Study|Withdrawal by Subject|2
2353104|NCT03151226|4104155|FG000|Overall Study|not wear device correctly|1
2353105|NCT03168906|4104170|FG000|Overall Study|Lack of Efficacy|6
2353106|NCT03168906|4104171|FG001|Overall Study|Lack of Efficacy|6
2353107|NCT03178201|4104178|FG000|Overall Study|Off study|5
2353108|NCT03172026|4104184|FG000|Overall Study|Withdrawal by Subject|1
2353109|NCT03172026|4104185|FG001|Overall Study|Withdrawal by Subject|0
2353110|NCT03172026|4104184|FG000|Overall Study|COVID restrictions|1
2353111|NCT03172026|4104185|FG001|Overall Study|COVID restrictions|0
2353112|NCT03152526|4104194|FG000|Overall Study|Withdrawal by Subject|0
2353113|NCT03152526|4104195|FG001|Overall Study|Withdrawal by Subject|1
2353114|NCT03123393|4104230|FG000|Overall Study|Study Terminated by Sponsor|6
2353115|NCT03123393|4104231|FG001|Overall Study|Study Terminated by Sponsor|9
2353116|NCT03123393|4104230|FG000|Overall Study|Withdrawal by Subject|2
2353117|NCT03123393|4104231|FG001|Overall Study|Withdrawal by Subject|1
2353118|NCT03123393|4104230|FG000|Overall Study|Reason not Specified|13
2353119|NCT03123393|4104231|FG001|Overall Study|Reason not Specified|13
2353120|NCT03119662|4104243|FG000|Overall Study|Withdrawal by Subject|0
2353121|NCT03119662|4104244|FG001|Overall Study|Withdrawal by Subject|1
2353122|NCT03120676|4104259|FG000|Overall Study|Not treated|1
2353123|NCT03113071|4104284|FG000|Overall Study|Withdrawal by Subject|1
2353124|NCT03113071|4104285|FG001|Overall Study|Withdrawal by Subject|0
2353125|NCT03110900|4104293|FG000|Overall Study|Sponsor withdrew|1
2353126|NCT03110900|4104294|FG001|Overall Study|Sponsor withdrew|1
2353127|NCT03078868|4104300|FG000|Overall Study|Physician Decision|3
2353128|NCT03065933|4104313|FG000|Overall Study|study terminated|5
2353129|NCT03070002|4104317|FG000|Follow up for 2 Years|Death|1
2353130|NCT03058705|4104321|FG000|Overall Study|Withdrawal by Subject|2
2353131|NCT03058705|4104321|FG000|Overall Study|Physician Decision|2
2353132|NCT03053518|4104343|FG000|Overall Study|Withdrawal by Subject|3
2353133|NCT03053518|4104343|FG000|Overall Study|Lost to Follow-up|2
2353134|NCT03053518|4104343|FG000|Overall Study|Ineligible|5
2353135|NCT03050398|4104347|FG000|Overall Study|Study terminated by sponsor|8
2353136|NCT03029832|4104365|FG000|Overall Study|Safety Follow-Up Completed|2
2247747|NCT01995201|3909608|FG006|From Week 24 Until Week 48|Protocol Violation|0
2247748|NCT01995266|3909629|FG000|Overall Study|Death|1
2247749|NCT01995266|3909629|FG000|Overall Study|Lack of Efficacy|6
2247750|NCT01995266|3909629|FG000|Overall Study|Adverse Event|2
2247751|NCT01995357|3909633|FG000|Period 5|Lack of Efficacy|1
2247752|NCT01995357|3909634|FG001|Period 5|Lack of Efficacy|0
2247753|NCT01995357|3909635|FG002|Period 5|Lack of Efficacy|0
2247754|NCT01995357|3909636|FG003|Period 5|Lack of Efficacy|0
2247755|NCT01995357|3909637|FG004|Period 5|Lack of Efficacy|0
2247756|NCT01995357|3909638|FG005|Period 5|Lack of Efficacy|0
2247757|NCT01995357|3909633|FG000|Period 5|Adverse Event|1
2247758|NCT01995357|3909634|FG001|Period 5|Adverse Event|0
2247759|NCT01995357|3909635|FG002|Period 5|Adverse Event|1
2247760|NCT01995357|3909636|FG003|Period 5|Adverse Event|0
2247761|NCT01995357|3909637|FG004|Period 5|Adverse Event|0
2247762|NCT01995357|3909638|FG005|Period 5|Adverse Event|0
2247763|NCT01995461|3909654|FG000|Overall Study|Death|1
2247764|NCT01995461|3909654|FG000|Overall Study|Lost to Follow-up|2
2247765|NCT01995461|3909654|FG000|Overall Study|Withdrawal by Subject|2
2247766|NCT01995513|3909667|FG000|Open Label Treatment Period|Other|9
2247767|NCT01995513|3909668|FG001|Open Label Treatment Period|Other|0
2247768|NCT01995513|3909669|FG002|Open Label Treatment Period|Other|0
2247769|NCT01995513|3909667|FG000|Open Label Treatment Period|Withdrawal by Subject|14
2247770|NCT01995513|3909668|FG001|Open Label Treatment Period|Withdrawal by Subject|0
2247771|NCT01995513|3909669|FG002|Open Label Treatment Period|Withdrawal by Subject|0
2247772|NCT01995513|3909667|FG000|Open Label Treatment Period|Protocol Violation|1
2247773|NCT01995513|3909668|FG001|Open Label Treatment Period|Protocol Violation|0
2247774|NCT01995513|3909669|FG002|Open Label Treatment Period|Protocol Violation|0
2247775|NCT01995513|3909667|FG000|Open Label Treatment Period|Disease Progression|64
2247776|NCT01995513|3909668|FG001|Open Label Treatment Period|Disease Progression|0
2247777|NCT01995513|3909669|FG002|Open Label Treatment Period|Disease Progression|0
2247778|NCT01995513|3909667|FG000|Open Label Treatment Period|No PSA response at week 13|43
2247779|NCT01995513|3909668|FG001|Open Label Treatment Period|No PSA response at week 13|0
2247780|NCT01995513|3909669|FG002|Open Label Treatment Period|No PSA response at week 13|0
2247781|NCT01995513|3909667|FG000|Open Label Treatment Period|Adverse Event|35
2247782|NCT01995513|3909668|FG001|Open Label Treatment Period|Adverse Event|0
2247783|NCT01995513|3909669|FG002|Open Label Treatment Period|Adverse Event|0
2247784|NCT01995513|3909667|FG000|Open Label Treatment Period|Death|8
2247785|NCT01995513|3909668|FG001|Open Label Treatment Period|Death|0
2247786|NCT01995513|3909669|FG002|Open Label Treatment Period|Death|0
2247787|NCT01995513|3909667|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
2247788|NCT01995513|3909668|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
2247789|NCT01995513|3909669|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
2247790|NCT01995513|3909667|FG000|Double Blind Treatment Period|Adverse Event|0
2247791|NCT01995513|3909668|FG001|Double Blind Treatment Period|Adverse Event|12
2247792|NCT01995513|3909669|FG002|Double Blind Treatment Period|Adverse Event|5
2247793|NCT01995513|3909667|FG000|Double Blind Treatment Period|Other|0
2247794|NCT01995513|3909668|FG001|Double Blind Treatment Period|Other|1
2247795|NCT01995513|3909669|FG002|Double Blind Treatment Period|Other|2
2247796|NCT01995513|3909667|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
2247797|NCT01995513|3909668|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
2247798|NCT01995513|3909669|FG002|Double Blind Treatment Period|Withdrawal by Subject|6
2247799|NCT01995513|3909667|FG000|Double Blind Treatment Period|Death|0
2247800|NCT01995513|3909668|FG001|Double Blind Treatment Period|Death|0
2247801|NCT01995513|3909669|FG002|Double Blind Treatment Period|Death|1
2247802|NCT01995513|3909667|FG000|Double Blind Treatment Period|Disease Progression|0
2247803|NCT01995513|3909668|FG001|Double Blind Treatment Period|Disease Progression|82
2247804|NCT01995513|3909669|FG002|Double Blind Treatment Period|Disease Progression|93
2247805|NCT01995513|3909667|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
2247806|NCT01995513|3909668|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
2247807|NCT01995513|3909669|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
2247808|NCT01995526|3909679|FG000|Overall Study|Physician Decision|1
2247809|NCT01995539|3909683|FG000|Overall Study|Screening Failure|1
2247810|NCT01995539|3909683|FG000|Overall Study|Withdrawal by Investigator|15
2247811|NCT01995539|3909683|FG000|Overall Study|Withdrawal by Subject|11
2247812|NCT01995539|3909683|FG000|Overall Study|Lost to Follow-up|5
2247813|NCT01995539|3909683|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1
2247814|NCT01995552|3909687|FG000|Overall Study|Protocol Violation|1
2247815|NCT01995552|3909687|FG000|Overall Study|Lack of Efficacy|15
2247816|NCT01995552|3909687|FG000|Overall Study|Death|1
2247817|NCT01995825|3909695|FG000|Overall Study|Withdrawal by Subject|1
2247818|NCT01995825|3909696|FG001|Overall Study|Withdrawal by Subject|0
2247819|NCT01995838|3909709|FG000|Overall Study|Lost to Follow-up|0
2247820|NCT01995838|3909710|FG001|Overall Study|Lost to Follow-up|1
2247821|NCT01995838|3909711|FG002|Overall Study|Lost to Follow-up|0
2247822|NCT01995838|3909712|FG003|Overall Study|Lost to Follow-up|0
2247823|NCT01995838|3909713|FG004|Overall Study|Lost to Follow-up|0
2247824|NCT01995838|3909714|FG005|Overall Study|Lost to Follow-up|0
2247825|NCT01995838|3909715|FG006|Overall Study|Lost to Follow-up|1
2247826|NCT01995838|3909709|FG000|Overall Study|Participant choice|2
2247827|NCT01995838|3909710|FG001|Overall Study|Participant choice|0
2247828|NCT01995838|3909711|FG002|Overall Study|Participant choice|0
2247829|NCT01995838|3909712|FG003|Overall Study|Participant choice|0
2247830|NCT01995838|3909713|FG004|Overall Study|Participant choice|0
2247831|NCT01995838|3909714|FG005|Overall Study|Participant choice|1
2247832|NCT01995838|3909715|FG006|Overall Study|Participant choice|1
2247833|NCT01995838|3909709|FG000|Overall Study|Adverse Event|0
2247834|NCT01995838|3909710|FG001|Overall Study|Adverse Event|0
2247835|NCT01995838|3909711|FG002|Overall Study|Adverse Event|0
2247836|NCT01995838|3909712|FG003|Overall Study|Adverse Event|0
2247837|NCT01995838|3909713|FG004|Overall Study|Adverse Event|0
2247838|NCT01995838|3909714|FG005|Overall Study|Adverse Event|0
2340085|NCT03393806|4069975|FG000|Overall Study|Physician Decision|1
2340086|NCT03393806|4069976|FG001|Overall Study|Physician Decision|0
2340087|NCT03394391|4069985|FG000|Overall Study|Lost to Follow-up|1
2340088|NCT03394391|4069986|FG001|Overall Study|Lost to Follow-up|2
2340089|NCT03394508|4069994|FG000|Overall Study|Protocol Violation|0
2340090|NCT03394508|4069995|FG001|Overall Study|Protocol Violation|3
2340091|NCT03394508|4069994|FG000|Overall Study|Lost to Follow-up|1
2340092|NCT03394508|4069995|FG001|Overall Study|Lost to Follow-up|0
2340093|NCT03394885|4070009|FG000|Overall Study|Adverse Event|4
2340094|NCT03394885|4070009|FG000|Overall Study|Lack of Efficacy|1
2340095|NCT03394885|4070009|FG000|Overall Study|Physician Decision|1
2340096|NCT03394885|4070009|FG000|Overall Study|Withdrawal by Subject|8
2340097|NCT03394885|4070009|FG000|Overall Study|Alternative Therapy|1
2340098|NCT03394924|4070016|FG000|Overall Study|Adverse Event|0
2340099|NCT03394924|4070017|FG001|Overall Study|Adverse Event|5
2340100|NCT03394924|4070018|FG002|Overall Study|Adverse Event|0
2340101|NCT03394924|4070016|FG000|Overall Study|Withdrawal by Subject|2
2340102|NCT03394924|4070017|FG001|Overall Study|Withdrawal by Subject|0
2340103|NCT03394924|4070018|FG002|Overall Study|Withdrawal by Subject|0
2340104|NCT03394924|4070016|FG000|Overall Study|Lost to Follow-up|0
2340105|NCT03394924|4070017|FG001|Overall Study|Lost to Follow-up|1
2340106|NCT03394924|4070018|FG002|Overall Study|Lost to Follow-up|0
2340107|NCT03394924|4070016|FG000|Overall Study|Did not meet all inclusion criteria|1
2340108|NCT03394924|4070017|FG001|Overall Study|Did not meet all inclusion criteria|0
2340109|NCT03394924|4070018|FG002|Overall Study|Did not meet all inclusion criteria|0
2340110|NCT03395353|4070028|FG000|Overall Study|Adverse Event|20
2340111|NCT03395353|4070028|FG000|Overall Study|Protocol Violation|1
2340112|NCT03395353|4070028|FG000|Overall Study|Lack of Efficacy|3
2340113|NCT03395353|4070028|FG000|Overall Study|Withdrawal by Subject|24
2340114|NCT03395353|4070028|FG000|Overall Study|Discontinued visit|1
2340115|NCT03395353|4070028|FG000|Overall Study|Refrain from visit due to COVID-19|1
2340116|NCT03395353|4070028|FG000|Overall Study|Physician Decision|4
2340117|NCT03395353|4070028|FG000|Overall Study|Early termination of overall study|33
2340118|NCT03396835|4070069|FG000|Overall Study|Withdrawn prior to completion|1
2340119|NCT03396835|4070069|FG000|Overall Study|Did not meet criteria for data analysis|1
2340120|NCT03396913|4070075|FG000|Overall Study|Lost to Follow-up|0
2340121|NCT03396913|4070076|FG001|Overall Study|Lost to Follow-up|6
2340122|NCT03397771|4070113|FG000|Overall Study|2 erroneously randomized, never treated|3
2340123|NCT03397771|4070114|FG001|Overall Study|2 erroneously randomized, never treated|1
2340124|NCT03397771|4070113|FG000|Overall Study|Withdrawal by Subject|1
2340125|NCT03397771|4070114|FG001|Overall Study|Withdrawal by Subject|3
2340126|NCT03397771|4070113|FG000|Overall Study|Protocol Violation|2
2340127|NCT03397771|4070114|FG001|Overall Study|Protocol Violation|2
2340128|NCT03397771|4070113|FG000|Overall Study|Adverse Event|2
2340129|NCT03397771|4070114|FG001|Overall Study|Adverse Event|1
2340130|NCT03398356|4070192|FG000|Before Treatment|Lost to Follow-up|1
2340131|NCT03398356|4070193|FG001|Before Treatment|Lost to Follow-up|2
2340132|NCT03398356|4070194|FG002|Before Treatment|Lost to Follow-up|0
2340133|NCT03398356|4070192|FG000|Before Treatment|drug intolerance|2
2340134|NCT03398356|4070193|FG001|Before Treatment|drug intolerance|1
2340135|NCT03398356|4070194|FG002|Before Treatment|drug intolerance|0
2340136|NCT03398356|4070192|FG000|Before Treatment|Withdrawal by Subject|0
2340137|NCT03398356|4070193|FG001|Before Treatment|Withdrawal by Subject|5
2340138|NCT03398356|4070194|FG002|Before Treatment|Withdrawal by Subject|0
2038142|NCT00421733|3608504|FG002|Overall Study|Administrative|0
2038143|NCT00421733|3608502|FG000|Overall Study|Did not satisfy entry criteria|1
2038144|NCT00421733|3608503|FG001|Overall Study|Did not satisfy entry criteria|3
2038145|NCT00421733|3608504|FG002|Overall Study|Did not satisfy entry criteria|2
2038146|NCT00421733|3608502|FG000|Overall Study|Sponsor request|1
2247839|NCT01995838|3909715|FG006|Overall Study|Adverse Event|1
2340139|NCT03398356|4070192|FG000|Before Treatment|Physician Decision|0
2340140|NCT03398356|4070193|FG001|Before Treatment|Physician Decision|0
2340141|NCT03398356|4070194|FG002|Before Treatment|Physician Decision|11
2340142|NCT03398356|4070192|FG000|After 6 Weeks of Treatment|Physician Decision|0
2340143|NCT03398356|4070193|FG001|After 6 Weeks of Treatment|Physician Decision|2
2340144|NCT03398356|4070194|FG002|After 6 Weeks of Treatment|Physician Decision|0
2340145|NCT03399786|4070249|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1
2340146|NCT03399786|4070250|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
2340147|NCT03399786|4070251|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
2340148|NCT03399786|4070252|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
2247840|NCT01995838|3909709|FG000|Overall Study|Withdrawal by Subject|0
2247841|NCT01995838|3909710|FG001|Overall Study|Withdrawal by Subject|0
2247842|NCT01995838|3909711|FG002|Overall Study|Withdrawal by Subject|0
2247843|NCT01995838|3909712|FG003|Overall Study|Withdrawal by Subject|0
2247844|NCT01995838|3909713|FG004|Overall Study|Withdrawal by Subject|1
2247845|NCT01995838|3909714|FG005|Overall Study|Withdrawal by Subject|0
2247846|NCT01995838|3909715|FG006|Overall Study|Withdrawal by Subject|0
2247847|NCT01995838|3909709|FG000|Overall Study|Other|3
2247848|NCT01995838|3909710|FG001|Overall Study|Other|1
2247849|NCT01995838|3909711|FG002|Overall Study|Other|0
2247850|NCT01995838|3909712|FG003|Overall Study|Other|2
2247851|NCT01995838|3909713|FG004|Overall Study|Other|1
2247852|NCT01995838|3909714|FG005|Overall Study|Other|1
2247853|NCT01995838|3909715|FG006|Overall Study|Other|2
2247854|NCT01996033|3909732|FG000|Overall Study|Death|1
2247855|NCT01996033|3909732|FG000|Overall Study|Physician Decision|1
2247856|NCT01996033|3909732|FG000|Overall Study|Withdrawal by Subject|4
2247857|NCT01996033|3909732|FG000|Overall Study|Lost to Follow-up|3
2247858|NCT01996241|3909738|FG000|Overall Study|Lost to Follow-up|252
2247859|NCT01996241|3909739|FG001|Overall Study|Lost to Follow-up|235
2247860|NCT01996254|3909749|FG000|Overall Study|Change in Eligibility|0
2247861|NCT01996254|3909750|FG001|Overall Study|Change in Eligibility|2
2247862|NCT01996254|3909751|FG002|Overall Study|Change in Eligibility|0
2247863|NCT01996254|3909749|FG000|Overall Study|Withdrawal by Subject|0
2247864|NCT01996254|3909750|FG001|Overall Study|Withdrawal by Subject|3
2247865|NCT01996254|3909751|FG002|Overall Study|Withdrawal by Subject|4
2247866|NCT01996254|3909749|FG000|Overall Study|Lost to Follow-up|1
2247867|NCT01996254|3909750|FG001|Overall Study|Lost to Follow-up|0
2247868|NCT01996254|3909751|FG002|Overall Study|Lost to Follow-up|4
2247869|NCT01996319|3909763|FG000|Overall Study|Protocol Violation|1
2247870|NCT01996319|3909764|FG001|Overall Study|Protocol Violation|0
2247871|NCT01996319|3909763|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5
2247872|NCT01996319|3909764|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1
2247873|NCT01996319|3909763|FG000|Overall Study|Adverse Event|2
2247874|NCT01996319|3909764|FG001|Overall Study|Adverse Event|2
2247875|NCT01996332|3909770|FG000|Overall Study|Adverse Event|117
2247876|NCT01996332|3909770|FG000|Overall Study|Lack of Efficacy|1245
2247877|NCT01996332|3909770|FG000|Overall Study|Death|264
2247878|NCT01996332|3909770|FG000|Overall Study|Protocol Violation|9
2247879|NCT01996332|3909770|FG000|Overall Study|Withdrawal by Subject|71
2247880|NCT01996332|3909770|FG000|Overall Study|Other|20
2247881|NCT01996332|3909770|FG000|Overall Study|Clinical Deterioration|28
2247882|NCT01996332|3909770|FG000|Overall Study|Physician Decision|17
2247883|NCT01996332|3909770|FG000|Overall Study|Lost to Follow-up|34
2247884|NCT01996592|3909774|FG000|Overall Study|no response to text/no diary entry|32
2247885|NCT01996592|3909774|FG000|Overall Study|change in surgical date|4
2247886|NCT01996592|3909774|FG000|Overall Study|Withdrawal by Subject|5
2247887|NCT01996592|3909774|FG000|Overall Study|change in mode of delivery|4
2247888|NCT01996709|3909810|FG000|Overall Study|Withdrawal by Subject|1
2247889|NCT01996709|3909811|FG001|Overall Study|Withdrawal by Subject|0
2247890|NCT01996709|3909810|FG000|Overall Study|Lost to Follow-up|3
2247891|NCT01996709|3909811|FG001|Overall Study|Lost to Follow-up|0
2247892|NCT01996709|3909810|FG000|Overall Study|Subject Non-Compliant|1
2247893|NCT01996709|3909811|FG001|Overall Study|Subject Non-Compliant|0
2247894|NCT01996709|3909810|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
2247895|NCT01996709|3909811|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
2340149|NCT03399786|4070249|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
2340150|NCT03399786|4070250|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
2340151|NCT03399786|4070251|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1
2340152|NCT03399786|4070252|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
2340153|NCT03399786|4070249|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0
2340154|NCT03399786|4070250|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0
2340155|NCT03399786|4070251|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0
2340156|NCT03399786|4070252|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1
2340157|NCT03400033|4070262|FG000|Overall Study|Withdrawal by Subject|1
2340158|NCT03400033|4070263|FG001|Overall Study|Withdrawal by Subject|2
2340159|NCT03400787|4070318|FG000|Overall Study|Lost to Follow-up|1
2340160|NCT03400787|4070319|FG001|Overall Study|Lost to Follow-up|0
2340161|NCT03400787|4070318|FG000|Overall Study|Death|1
2340162|NCT03400787|4070319|FG001|Overall Study|Death|0
2340163|NCT03400787|4070318|FG000|Overall Study|Protocol Violation|0
2340164|NCT03400787|4070319|FG001|Overall Study|Protocol Violation|2
2340165|NCT03400787|4070318|FG000|Overall Study|Unblinded before 3-month follow-upa-|0
2340166|NCT03400787|4070319|FG001|Overall Study|Unblinded before 3-month follow-upa-|6
2340167|NCT03400852|4070336|FG000|Blinded Treatment Period|Physician Decision|0
2340168|NCT03400852|4070337|FG001|Blinded Treatment Period|Physician Decision|1
2340169|NCT03400852|4070338|FG002|Blinded Treatment Period|Physician Decision|0
2247896|NCT01996748|3909823|FG000|Overall Study|Personal reason|1
2340170|NCT03400852|4070336|FG000|Blinded Treatment Period|Adverse Event|1
2340171|NCT03400852|4070337|FG001|Blinded Treatment Period|Adverse Event|1
2340172|NCT03400852|4070338|FG002|Blinded Treatment Period|Adverse Event|0
2247897|NCT01996748|3909824|FG001|Overall Study|Personal reason|0
2247898|NCT01996748|3909823|FG000|Overall Study|Physician Decision|2
2247899|NCT01996748|3909824|FG001|Overall Study|Physician Decision|0
2247900|NCT01996748|3909823|FG000|Overall Study|Adverse Event|1
2247901|NCT01996748|3909824|FG001|Overall Study|Adverse Event|4
2247902|NCT01996748|3909823|FG000|Overall Study|Withdrawal by Subject|0
2247903|NCT01996748|3909824|FG001|Overall Study|Withdrawal by Subject|1
2247904|NCT01996748|3909823|FG000|Overall Study|Lost to Follow-up|4
2247905|NCT01996748|3909824|FG001|Overall Study|Lost to Follow-up|1
2247906|NCT01996826|3909843|FG000|Overall Study|Lost to Follow-up|6
2247907|NCT01996826|3909844|FG001|Overall Study|Lost to Follow-up|2
2247908|NCT01996826|3909843|FG000|Overall Study|Physician Decision|1
2247909|NCT01996826|3909844|FG001|Overall Study|Physician Decision|1
2247910|NCT01996904|3909865|FG000|Overall Study|Lost to Follow-up|38
2247911|NCT01996904|3909866|FG001|Overall Study|Lost to Follow-up|27
2247912|NCT01997281|3909908|FG000|Overall Study|Withdrawal by Subject|1
2247913|NCT01997281|3909909|FG001|Overall Study|Withdrawal by Subject|0
2247914|NCT01997333|3909917|FG000|Randomization and Treatment|Disease Progression|70
2247915|NCT01997333|3909918|FG001|Randomization and Treatment|Disease Progression|159
2247916|NCT01997333|3909917|FG000|Randomization and Treatment|Adverse Event|10
2247917|NCT01997333|3909918|FG001|Randomization and Treatment|Adverse Event|32
2247918|NCT01997333|3909917|FG000|Randomization and Treatment|Physician Decision|0
2247919|NCT01997333|3909918|FG001|Randomization and Treatment|Physician Decision|4
2247920|NCT01997333|3909917|FG000|Randomization and Treatment|Withdrawal by Subject|6
2247921|NCT01997333|3909918|FG001|Randomization and Treatment|Withdrawal by Subject|3
2247922|NCT01997333|3909917|FG000|Randomization and Treatment|Did not receive treatment|17
2247923|NCT01997333|3909918|FG001|Randomization and Treatment|Did not receive treatment|5
2247924|NCT01997333|3909917|FG000|Survival Follow up|Withdrawal by Subject|15
2247925|NCT01997333|3909918|FG001|Survival Follow up|Withdrawal by Subject|6
2247926|NCT01997333|3909917|FG000|Survival Follow up|Lost to Follow-up|0
2247927|NCT01997333|3909918|FG001|Survival Follow up|Lost to Follow-up|6
2247928|NCT01997333|3909917|FG000|Survival Follow up|Various|1
2247929|NCT01997333|3909918|FG001|Survival Follow up|Various|2
2247930|NCT01997892|3909982|FG000|Overall Study|Physician Decision|2
2247931|NCT01997892|3909982|FG000|Overall Study|Lost to Follow-up|6
2247932|NCT01997892|3909982|FG000|Overall Study|Death|14
2247933|NCT01997892|3909982|FG000|Overall Study|Renal transplant|8
2247934|NCT01997892|3909982|FG000|Overall Study|Other|3
2340173|NCT03400852|4070336|FG000|Blinded Treatment Period|Study terminated by sponsor|8
2340174|NCT03400852|4070337|FG001|Blinded Treatment Period|Study terminated by sponsor|4
2340175|NCT03400852|4070338|FG002|Blinded Treatment Period|Study terminated by sponsor|0
2340176|NCT03400852|4070336|FG000|Open Label Period|Physician Decision|0
2340177|NCT03400852|4070337|FG001|Open Label Period|Physician Decision|0
2340178|NCT03400852|4070338|FG002|Open Label Period|Physician Decision|1
2340179|NCT03400852|4070336|FG000|Open Label Period|Study terminated by sponsor|0
2340180|NCT03400852|4070337|FG001|Open Label Period|Study terminated by sponsor|0
2340181|NCT03400852|4070338|FG002|Open Label Period|Study terminated by sponsor|21
2340182|NCT03400956|4070349|FG000|Treatment Period 1|Adverse Event|0
2340183|NCT03400956|4070350|FG001|Treatment Period 1|Adverse Event|1
2340184|NCT03400956|4070351|FG002|Treatment Period 1|Adverse Event|0
2340185|NCT03400956|4070349|FG000|Treatment Period 1|Lost to Follow-up|0
2340186|NCT03400956|4070350|FG001|Treatment Period 1|Lost to Follow-up|0
2340187|NCT03400956|4070351|FG002|Treatment Period 1|Lost to Follow-up|1
2340188|NCT03400956|4070349|FG000|Treatment Period 1|Protocol Violation|0
2340189|NCT03400956|4070350|FG001|Treatment Period 1|Protocol Violation|2
2340190|NCT03400956|4070351|FG002|Treatment Period 1|Protocol Violation|0
2340191|NCT03400956|4070349|FG000|Treatment Period 1|Study terminated by sponsor|3
2340192|NCT03400956|4070350|FG001|Treatment Period 1|Study terminated by sponsor|1
2340193|NCT03400956|4070351|FG002|Treatment Period 1|Study terminated by sponsor|1
2340194|NCT03400956|4070349|FG000|Treatment Period 1|Withdrawal by Subject|0
2340195|NCT03400956|4070350|FG001|Treatment Period 1|Withdrawal by Subject|2
2340196|NCT03400956|4070351|FG002|Treatment Period 1|Withdrawal by Subject|4
2340197|NCT03400956|4070349|FG000|Treatment Period 1|Other|1
2340198|NCT03400956|4070350|FG001|Treatment Period 1|Other|2
2340199|NCT03400956|4070351|FG002|Treatment Period 1|Other|3
2038147|NCT00421733|3608503|FG001|Overall Study|Sponsor request|0
2038148|NCT00421733|3608504|FG002|Overall Study|Sponsor request|3
2038149|NCT00421733|3608502|FG000|Overall Study|Protocol deviation|4
2038150|NCT00421733|3608503|FG001|Overall Study|Protocol deviation|7
2038151|NCT00421733|3608504|FG002|Overall Study|Protocol deviation|2
2247935|NCT01997892|3909982|FG000|Overall Study|Study completion data not recorded|35
2247936|NCT01998243|3909997|FG000|Overall Study|Pregnancy|0
2247937|NCT01998243|3909998|FG001|Overall Study|Pregnancy|1
2247938|NCT01998243|3909997|FG000|Overall Study|Protocol Violation|5
2247939|NCT01998243|3909998|FG001|Overall Study|Protocol Violation|2
2247940|NCT01998243|3909997|FG000|Overall Study|Withdrawal by Subject|3
2247941|NCT01998243|3909998|FG001|Overall Study|Withdrawal by Subject|4
2247942|NCT01998399|3910021|FG000|Overall Study|Lost to Follow-up|1
2247943|NCT01998399|3910022|FG001|Overall Study|Lost to Follow-up|3
2247944|NCT01998399|3910021|FG000|Overall Study|Death|4
2340200|NCT03400956|4070349|FG000|Post-treatment Period 1|Adverse Event|0
2247945|NCT01998399|3910022|FG001|Overall Study|Death|2
2340201|NCT03400956|4070350|FG001|Post-treatment Period 1|Adverse Event|0
2247946|NCT01998399|3910021|FG000|Overall Study|Study stopped before dosing completed|3
2247947|NCT01998399|3910022|FG001|Overall Study|Study stopped before dosing completed|3
2247948|NCT01998399|3910021|FG000|Overall Study|Withdrawal by Subject|0
2247949|NCT01998399|3910022|FG001|Overall Study|Withdrawal by Subject|1
2247950|NCT01998477|3910043|FG000|Overall Study|Lost to Follow-up|4
2247951|NCT01998477|3910044|FG001|Overall Study|Lost to Follow-up|5
2247952|NCT01998477|3910043|FG000|Overall Study|Withdrawal by Subject|6
2247953|NCT01998477|3910044|FG001|Overall Study|Withdrawal by Subject|0
2247954|NCT01998581|3910077|FG000|Overall Study|Refused repeat treatment|20
2247955|NCT01998581|3910078|FG001|Overall Study|Refused repeat treatment|4
2247956|NCT01998581|3910077|FG000|Overall Study|Protocol Violation|1
2247957|NCT01998581|3910078|FG001|Overall Study|Protocol Violation|0
2247958|NCT01998581|3910077|FG000|Overall Study|Withdrawal by Subject|8
2247959|NCT01998581|3910078|FG001|Overall Study|Withdrawal by Subject|1
2247960|NCT01998581|3910077|FG000|Overall Study|Lost to Follow-up|12
2247961|NCT01998581|3910078|FG001|Overall Study|Lost to Follow-up|4
2247962|NCT01998581|3910077|FG000|Overall Study|Adverse Event|1
2247963|NCT01998581|3910078|FG001|Overall Study|Adverse Event|1
2247964|NCT01998581|3910077|FG000|Overall Study|Other reasons|3
2247965|NCT01998581|3910078|FG001|Overall Study|Other reasons|2
2247966|NCT01998581|3910077|FG000|Overall Study|Randomized but withdrew before treatment|1
2247967|NCT01998581|3910078|FG001|Overall Study|Randomized but withdrew before treatment|0
2247968|NCT01998633|3910087|FG000|Overall Study|Death|1
2247969|NCT01998737|3910097|FG000|Overall Study|Corrupted database|23
2247970|NCT01998737|3910098|FG001|Overall Study|Corrupted database|0
2247971|NCT01998880|3910106|FG000|Overall Study|Adverse Events or Intercurrent Illness|16
2247972|NCT01998880|3910107|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
2247973|NCT01998880|3910106|FG000|Overall Study|Disease Progression|1
2247974|NCT01998880|3910107|FG001|Overall Study|Disease Progression|8
2247975|NCT01998880|3910106|FG000|Overall Study|Withdrew Consent|2
2247976|NCT01998880|3910107|FG001|Overall Study|Withdrew Consent|1
2247977|NCT01998880|3910106|FG000|Overall Study|Death|3
2247978|NCT01998880|3910107|FG001|Overall Study|Death|6
2247979|NCT01998880|3910106|FG000|Overall Study|Insufficient Therapeutic Response|1
2247980|NCT01998880|3910107|FG001|Overall Study|Insufficient Therapeutic Response|5
2247981|NCT01998880|3910106|FG000|Overall Study|Administrative/Other|1
2247982|NCT01998880|3910107|FG001|Overall Study|Administrative/Other|1
2247983|NCT01998880|3910106|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
2247984|NCT01998880|3910107|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
2247985|NCT01998880|3910106|FG000|Overall Study|Violation of Selection Criteria at Entry|0
2247986|NCT01998880|3910107|FG001|Overall Study|Violation of Selection Criteria at Entry|1
2340202|NCT03400956|4070351|FG002|Post-treatment Period 1|Adverse Event|1
2340203|NCT03400956|4070349|FG000|Post-treatment Period 1|Physician Decision|2
2340204|NCT03400956|4070350|FG001|Post-treatment Period 1|Physician Decision|3
2340205|NCT03400956|4070351|FG002|Post-treatment Period 1|Physician Decision|0
2340206|NCT03400956|4070349|FG000|Post-treatment Period 1|Study terminated by sponsor|11
2340207|NCT03400956|4070350|FG001|Post-treatment Period 1|Study terminated by sponsor|10
2340208|NCT03400956|4070351|FG002|Post-treatment Period 1|Study terminated by sponsor|11
2340209|NCT03400956|4070349|FG000|Post-treatment Period 1|Withdrawal by Subject|5
2340210|NCT03400956|4070350|FG001|Post-treatment Period 1|Withdrawal by Subject|0
2340211|NCT03400956|4070351|FG002|Post-treatment Period 1|Withdrawal by Subject|0
2340212|NCT03400956|4070349|FG000|Post-treatment Period 1|Other|4
2340213|NCT03400956|4070350|FG001|Post-treatment Period 1|Other|3
2340214|NCT03400956|4070351|FG002|Post-treatment Period 1|Other|4
2340215|NCT03400956|4070349|FG000|Treatment Period 2|Adverse Event|2
2340216|NCT03400956|4070350|FG001|Treatment Period 2|Adverse Event|1
2340217|NCT03400956|4070351|FG002|Treatment Period 2|Adverse Event|1
2340218|NCT03400956|4070349|FG000|Treatment Period 2|Lost to Follow-up|1
2340219|NCT03400956|4070350|FG001|Treatment Period 2|Lost to Follow-up|1
2340220|NCT03400956|4070351|FG002|Treatment Period 2|Lost to Follow-up|0
2340221|NCT03400956|4070349|FG000|Treatment Period 2|Withdrawal by Subject|0
2340222|NCT03400956|4070350|FG001|Treatment Period 2|Withdrawal by Subject|0
2340223|NCT03400956|4070351|FG002|Treatment Period 2|Withdrawal by Subject|3
2340224|NCT03400956|4070349|FG000|Treatment Period 2|Other|1
2340225|NCT03400956|4070350|FG001|Treatment Period 2|Other|1
2340226|NCT03400956|4070351|FG002|Treatment Period 2|Other|0
2340227|NCT03400956|4070349|FG000|Follow-up Period|Withdrawal by Subject|0
2038152|NCT00421889|3608525|FG000|Overall Study|Adverse Event|1
2247987|NCT01998880|3910106|FG000|Overall Study|Did Not Receive Treatment|3
2247988|NCT01998880|3910107|FG001|Overall Study|Did Not Receive Treatment|2
2247989|NCT01998893|3910113|FG000|Overall Study|Adverse Event|2
2247990|NCT01998893|3910113|FG000|Overall Study|Death|1
2247991|NCT01998893|3910113|FG000|Overall Study|Lost to Follow-up|8
2247992|NCT01998893|3910113|FG000|Overall Study|Physician Decision|2
2247993|NCT01998893|3910113|FG000|Overall Study|Protocol Violation|2
2247994|NCT01998893|3910113|FG000|Overall Study|Withdrawal by Subject|1
2247995|NCT01998893|3910113|FG000|Overall Study|Transformation to high-grade lymphoma|1
2247996|NCT01998906|3910120|FG000|Overall Study|Participants ongoing in follow-up|77
2247997|NCT01998906|3910121|FG001|Overall Study|Participants ongoing in follow-up|60
2247998|NCT01998906|3910122|FG002|Overall Study|Participants ongoing in follow-up|58
2247999|NCT01998906|3910120|FG000|Overall Study|Death|21
2248000|NCT01998906|3910121|FG001|Overall Study|Death|30
2248001|NCT01998906|3910122|FG002|Overall Study|Death|17
2248002|NCT01998906|3910120|FG000|Overall Study|Lack of Efficacy|10
2248003|NCT01998906|3910121|FG001|Overall Study|Lack of Efficacy|9
2248004|NCT01998906|3910122|FG002|Overall Study|Lack of Efficacy|8
2248005|NCT01998906|3910120|FG000|Overall Study|Failure to return|0
2248006|NCT01998906|3910121|FG001|Overall Study|Failure to return|2
2248007|NCT01998906|3910122|FG002|Overall Study|Failure to return|4
2248008|NCT01998906|3910120|FG000|Overall Study|Violation of Selection Criteria|0
2248009|NCT01998906|3910121|FG001|Overall Study|Violation of Selection Criteria|0
2248010|NCT01998906|3910122|FG002|Overall Study|Violation of Selection Criteria|1
2248011|NCT01998906|3910120|FG000|Overall Study|Withdrawal by Subject|1
2248012|NCT01998906|3910121|FG001|Overall Study|Withdrawal by Subject|4
2248013|NCT01998906|3910122|FG002|Overall Study|Withdrawal by Subject|3
2248014|NCT01998906|3910120|FG000|Overall Study|Administrative/Other|2
2248015|NCT01998906|3910121|FG001|Overall Study|Administrative/Other|1
2248016|NCT01998906|3910122|FG002|Overall Study|Administrative/Other|3
2248017|NCT01998906|3910120|FG000|Overall Study|Other|3
2248018|NCT01998906|3910121|FG001|Overall Study|Other|8
2248019|NCT01998906|3910122|FG002|Overall Study|Other|4
2248020|NCT01998919|3910135|FG000|Overall Study|Death|2
2248021|NCT01998919|3910136|FG001|Overall Study|Death|2
2248022|NCT01998919|3910135|FG000|Overall Study|Adverse Event|0
2248023|NCT01998919|3910136|FG001|Overall Study|Adverse Event|5
2248024|NCT01998919|3910135|FG000|Overall Study|Disease progression|31
2248025|NCT01998919|3910136|FG001|Overall Study|Disease progression|22
2248026|NCT01998919|3910135|FG000|Overall Study|Withdrawal by Subject|2
2248027|NCT01998919|3910136|FG001|Overall Study|Withdrawal by Subject|4
2248028|NCT01998919|3910135|FG000|Overall Study|Lost to Follow-up|2
2248029|NCT01998919|3910136|FG001|Overall Study|Lost to Follow-up|0
2248030|NCT01998919|3910135|FG000|Overall Study|Other|5
2248031|NCT01998919|3910136|FG001|Overall Study|Other|2
2248032|NCT01998958|3910149|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248033|NCT01998958|3910150|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1
2248034|NCT01998958|3910151|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248035|NCT01998958|3910152|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248036|NCT01998958|3910153|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248037|NCT01998958|3910154|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248038|NCT01998958|3910155|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248039|NCT01998958|3910156|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248040|NCT01998958|3910157|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248041|NCT01998958|3910158|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248042|NCT01998958|3910159|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248043|NCT01998958|3910160|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248044|NCT01998958|3910161|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248045|NCT01998958|3910162|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248046|NCT01998958|3910163|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248047|NCT01998958|3910164|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248048|NCT01998958|3910165|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248049|NCT01998958|3910166|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248050|NCT01998958|3910167|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248051|NCT01998958|3910168|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248052|NCT01998958|3910169|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248053|NCT01998958|3910170|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248054|NCT01998958|3910171|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248055|NCT01998958|3910172|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248056|NCT01998958|3910173|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248057|NCT01998958|3910174|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248058|NCT01998958|3910175|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248059|NCT01998958|3910176|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248060|NCT01998958|3910177|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248061|NCT01998958|3910178|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248062|NCT01998958|3910179|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248063|NCT01998958|3910180|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0
2248064|NCT01998958|3910149|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0
2248065|NCT01998958|3910150|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1
2248066|NCT01998958|3910151|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0
2248067|NCT01998958|3910152|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0
2248068|NCT01998958|3910153|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0
2248069|NCT01998958|3910154|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0
2248070|NCT01998958|3910155|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0
2248071|NCT01998958|3910156|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0
2248072|NCT01998958|3910157|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0
2248073|NCT01998958|3910158|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0
2248074|NCT01998958|3910159|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0
2248075|NCT01998958|3910160|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0
2248076|NCT01998958|3910161|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0
2248077|NCT01998958|3910162|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0
2248078|NCT01998958|3910163|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0
2248079|NCT01998958|3910164|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0
2248080|NCT01998958|3910165|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0
2340228|NCT03400956|4070350|FG001|Follow-up Period|Withdrawal by Subject|0
2340229|NCT03400956|4070351|FG002|Follow-up Period|Withdrawal by Subject|1
2340230|NCT03400956|4070349|FG000|Follow-up Period|Other|0
2340231|NCT03400956|4070350|FG001|Follow-up Period|Other|0
2340232|NCT03400956|4070351|FG002|Follow-up Period|Other|1
2340233|NCT03401229|4070364|FG000|Overall Study|Lost to Follow-up|2
2340234|NCT03401229|4070365|FG001|Overall Study|Lost to Follow-up|1
2340235|NCT03401229|4070364|FG000|Overall Study|Other|1
2340236|NCT03401229|4070365|FG001|Overall Study|Other|3
2340237|NCT03401229|4070364|FG000|Overall Study|Adverse Event|8
2340238|NCT03401229|4070365|FG001|Overall Study|Adverse Event|6
2340239|NCT03401229|4070364|FG000|Overall Study|Withdrawal by Subject|29
2340240|NCT03401229|4070365|FG001|Overall Study|Withdrawal by Subject|26
2340241|NCT03401229|4070364|FG000|Overall Study|COVID-19|0
2340242|NCT03401229|4070365|FG001|Overall Study|COVID-19|1
2340243|NCT03401450|4070373|FG000|Overall Study|Lost to Follow-up|4
2340244|NCT03401450|4070374|FG001|Overall Study|Lost to Follow-up|6
2340245|NCT03401450|4070373|FG000|Overall Study|Anesthesia plan changed|2
2340246|NCT03401450|4070374|FG001|Overall Study|Anesthesia plan changed|2
2340247|NCT03401450|4070373|FG000|Overall Study|Did not complete medication diary|4
2340248|NCT03401450|4070374|FG001|Overall Study|Did not complete medication diary|2
2340249|NCT03401450|4070373|FG000|Overall Study|post surgery medication change|2
2340250|NCT03401450|4070374|FG001|Overall Study|post surgery medication change|1
2340251|NCT03401450|4070373|FG000|Overall Study|Cancelled surgery|0
2340252|NCT03401450|4070374|FG001|Overall Study|Cancelled surgery|2
2340253|NCT03402126|4070389|FG000|Overall Study|Lost to Follow-up|6
2038153|NCT00421889|3608526|FG001|Overall Study|Adverse Event|0
2038154|NCT00421889|3608527|FG002|Overall Study|Adverse Event|1
2038155|NCT00421889|3608528|FG003|Overall Study|Adverse Event|1
2038156|NCT00421889|3608529|FG004|Overall Study|Adverse Event|1
2038157|NCT00421889|3608530|FG005|Overall Study|Adverse Event|4
2038158|NCT00421889|3608531|FG006|Overall Study|Adverse Event|1
2038159|NCT00421889|3608532|FG007|Overall Study|Adverse Event|0
2038160|NCT00421889|3608533|FG008|Overall Study|Adverse Event|2
2038161|NCT00421889|3608525|FG000|Overall Study|Withdrawal by Subject|1
2038162|NCT00421889|3608526|FG001|Overall Study|Withdrawal by Subject|3
2038163|NCT00421889|3608527|FG002|Overall Study|Withdrawal by Subject|0
2038164|NCT00421889|3608528|FG003|Overall Study|Withdrawal by Subject|0
2038165|NCT00421889|3608529|FG004|Overall Study|Withdrawal by Subject|2
2038166|NCT00421889|3608530|FG005|Overall Study|Withdrawal by Subject|0
2038167|NCT00421889|3608531|FG006|Overall Study|Withdrawal by Subject|0
2038168|NCT00421889|3608532|FG007|Overall Study|Withdrawal by Subject|0
2038169|NCT00421889|3608533|FG008|Overall Study|Withdrawal by Subject|0
2038170|NCT00421889|3608525|FG000|Overall Study|Death|0
2038171|NCT00421889|3608526|FG001|Overall Study|Death|0
2038172|NCT00421889|3608527|FG002|Overall Study|Death|0
2038173|NCT00421889|3608528|FG003|Overall Study|Death|0
2038174|NCT00421889|3608529|FG004|Overall Study|Death|1
2038175|NCT00421889|3608530|FG005|Overall Study|Death|1
2038176|NCT00421889|3608531|FG006|Overall Study|Death|0
2038177|NCT00421889|3608532|FG007|Overall Study|Death|0
2038178|NCT00421889|3608533|FG008|Overall Study|Death|0
2038179|NCT00421889|3608525|FG000|Overall Study|Progressive disease|3
2038180|NCT00421889|3608526|FG001|Overall Study|Progressive disease|2
2038181|NCT00421889|3608527|FG002|Overall Study|Progressive disease|2
2038182|NCT00421889|3608528|FG003|Overall Study|Progressive disease|3
2038183|NCT00421889|3608529|FG004|Overall Study|Progressive disease|2
2038184|NCT00421889|3608530|FG005|Overall Study|Progressive disease|21
2038185|NCT00421889|3608531|FG006|Overall Study|Progressive disease|3
2038186|NCT00421889|3608532|FG007|Overall Study|Progressive disease|1
2038187|NCT00421889|3608533|FG008|Overall Study|Progressive disease|5
2038188|NCT00421889|3608525|FG000|Overall Study|Patient/Investigator request|0
2248081|NCT01998958|3910166|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0
2248082|NCT01998958|3910167|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0
2248083|NCT01998958|3910168|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0
2248084|NCT01998958|3910169|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0
2248085|NCT01998958|3910170|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0
2248086|NCT01998958|3910171|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0
2038189|NCT00421889|3608526|FG001|Overall Study|Patient/Investigator request|0
2038190|NCT00421889|3608527|FG002|Overall Study|Patient/Investigator request|0
2038191|NCT00421889|3608528|FG003|Overall Study|Patient/Investigator request|0
2248087|NCT01998958|3910172|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0
2248088|NCT01998958|3910173|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0
2248089|NCT01998958|3910174|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0
2248090|NCT01998958|3910175|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0
2248091|NCT01998958|3910176|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0
2248092|NCT01998958|3910177|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0
2248093|NCT01998958|3910178|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0
2248094|NCT01998958|3910179|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0
2248095|NCT01998958|3910180|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0
2248096|NCT01998958|3910149|FG000|Period 1 (Panel A and B)|Adverse Event|0
2248097|NCT01998958|3910150|FG001|Period 1 (Panel A and B)|Adverse Event|1
2248098|NCT01998958|3910151|FG002|Period 1 (Panel A and B)|Adverse Event|0
2248099|NCT01998958|3910152|FG003|Period 1 (Panel A and B)|Adverse Event|0
2248100|NCT01998958|3910153|FG004|Period 1 (Panel A and B)|Adverse Event|0
2248101|NCT01998958|3910154|FG005|Period 1 (Panel A and B)|Adverse Event|0
2248102|NCT01998958|3910155|FG006|Period 1 (Panel A and B)|Adverse Event|0
2248103|NCT01998958|3910156|FG007|Period 1 (Panel A and B)|Adverse Event|0
2248104|NCT01998958|3910157|FG008|Period 1 (Panel A and B)|Adverse Event|0
2248105|NCT01998958|3910158|FG009|Period 1 (Panel A and B)|Adverse Event|0
2248106|NCT01998958|3910159|FG010|Period 1 (Panel A and B)|Adverse Event|0
2248107|NCT01998958|3910160|FG011|Period 1 (Panel A and B)|Adverse Event|0
2248108|NCT01998958|3910161|FG012|Period 1 (Panel A and B)|Adverse Event|0
2248109|NCT01998958|3910162|FG013|Period 1 (Panel A and B)|Adverse Event|0
2248110|NCT01998958|3910163|FG014|Period 1 (Panel A and B)|Adverse Event|0
2248111|NCT01998958|3910164|FG015|Period 1 (Panel A and B)|Adverse Event|0
2248112|NCT01998958|3910165|FG016|Period 1 (Panel A and B)|Adverse Event|0
2248113|NCT01998958|3910166|FG017|Period 1 (Panel A and B)|Adverse Event|0
2248114|NCT01998958|3910167|FG018|Period 1 (Panel A and B)|Adverse Event|0
2248115|NCT01998958|3910168|FG019|Period 1 (Panel A and B)|Adverse Event|0
2248116|NCT01998958|3910169|FG020|Period 1 (Panel A and B)|Adverse Event|0
2248117|NCT01998958|3910170|FG021|Period 1 (Panel A and B)|Adverse Event|0
2248118|NCT01998958|3910171|FG022|Period 1 (Panel A and B)|Adverse Event|0
2248119|NCT01998958|3910172|FG023|Period 1 (Panel A and B)|Adverse Event|0
2248120|NCT01998958|3910173|FG024|Period 1 (Panel A and B)|Adverse Event|0
2248121|NCT01998958|3910174|FG025|Period 1 (Panel A and B)|Adverse Event|0
2248122|NCT01998958|3910175|FG026|Period 1 (Panel A and B)|Adverse Event|0
2248123|NCT01998958|3910176|FG027|Period 1 (Panel A and B)|Adverse Event|0
2248124|NCT01998958|3910177|FG028|Period 1 (Panel A and B)|Adverse Event|0
2248125|NCT01998958|3910178|FG029|Period 1 (Panel A and B)|Adverse Event|0
2248126|NCT01998958|3910179|FG030|Period 1 (Panel A and B)|Adverse Event|0
2248127|NCT01998958|3910180|FG031|Period 1 (Panel A and B)|Adverse Event|0
2248128|NCT01998958|3910149|FG000|Period 1 (Panel A and B)|Other|1
2248129|NCT01998958|3910150|FG001|Period 1 (Panel A and B)|Other|0
2340254|NCT03402126|4070389|FG000|Overall Study|Protocol Violation|10
2340255|NCT03402126|4070389|FG000|Overall Study|Sponsor request/Study termination|29
2340256|NCT03402126|4070389|FG000|Overall Study|Study product no longer in use|1
2340257|NCT03402126|4070389|FG000|Overall Study|Technical problems|1
2340258|NCT03402126|4070389|FG000|Overall Study|Withdrawal by Subject|6
2340259|NCT03402126|4070389|FG000|Overall Study|Physician Decision|2
2340260|NCT03402126|4070389|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3
2340261|NCT03402126|4070389|FG000|Overall Study|Death|4
2340262|NCT03402386|4070406|FG000|Overall Study|Adverse Event|3
2340263|NCT03402386|4070406|FG000|Overall Study|Physician Decision|1
2340264|NCT03402386|4070406|FG000|Overall Study|Difficult to control Hb|2
2340265|NCT03402750|4070425|FG000|Overall Study|Lost to Follow-up|2
2340266|NCT03402750|4070426|FG001|Overall Study|Lost to Follow-up|1
2340267|NCT03402893|4070432|FG000|Overall Study|Withdrawal by Subject|1
2340268|NCT03403036|4070458|FG000|Overall Study|Lack of Efficacy|5
2340269|NCT03403192|4070466|FG000|Overall Study|Lost to Follow-up|1
2340270|NCT03403192|4070467|FG001|Overall Study|Lost to Follow-up|2
2340271|NCT03403192|4070468|FG002|Overall Study|Lost to Follow-up|0
2340272|NCT03403192|4070469|FG003|Overall Study|Lost to Follow-up|0
2340273|NCT03403192|4070466|FG000|Overall Study|Unable to respond|0
2340274|NCT03403192|4070467|FG001|Overall Study|Unable to respond|1
2340275|NCT03403192|4070468|FG002|Overall Study|Unable to respond|0
2340276|NCT03403192|4070469|FG003|Overall Study|Unable to respond|0
2340277|NCT03403192|4070466|FG000|Overall Study|Incomplete|3
2340278|NCT03403192|4070467|FG001|Overall Study|Incomplete|1
2340279|NCT03403192|4070468|FG002|Overall Study|Incomplete|3
2340280|NCT03403192|4070469|FG003|Overall Study|Incomplete|6
2340281|NCT03403374|4070544|FG000|Overall Study|Lost to Follow-up|1
2340282|NCT03403400|4070551|FG000|Overall Study|Lost to Follow-up|1
2340283|NCT03403400|4070552|FG001|Overall Study|Lost to Follow-up|0
2340284|NCT03403400|4070553|FG002|Overall Study|Lost to Follow-up|1
2340285|NCT03403400|4070551|FG000|Overall Study|Hospitalization|1
2340286|NCT03403400|4070552|FG001|Overall Study|Hospitalization|0
2340287|NCT03403400|4070553|FG002|Overall Study|Hospitalization|0
2340288|NCT03403400|4070551|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0
2340289|NCT03403400|4070552|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0
2340290|NCT03403400|4070553|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1
2340291|NCT03403413|4070576|FG000|Overall Study|Lack of Efficacy|2
2340292|NCT03403426|4070582|FG000|Overall Study|Death|1
2340293|NCT03403426|4070582|FG000|Overall Study|Lost to Follow-up|2
2340294|NCT03403751|4070684|FG000|Overall Study|Death|5
2248130|NCT01998958|3910151|FG002|Period 1 (Panel A and B)|Other|0
2248131|NCT01998958|3910152|FG003|Period 1 (Panel A and B)|Other|0
2248132|NCT01998958|3910153|FG004|Period 1 (Panel A and B)|Other|0
2248133|NCT01998958|3910154|FG005|Period 1 (Panel A and B)|Other|0
2248134|NCT01998958|3910155|FG006|Period 1 (Panel A and B)|Other|0
2248135|NCT01998958|3910156|FG007|Period 1 (Panel A and B)|Other|0
2248136|NCT01998958|3910157|FG008|Period 1 (Panel A and B)|Other|0
2248137|NCT01998958|3910158|FG009|Period 1 (Panel A and B)|Other|0
2248138|NCT01998958|3910159|FG010|Period 1 (Panel A and B)|Other|0
2248139|NCT01998958|3910160|FG011|Period 1 (Panel A and B)|Other|0
2248140|NCT01998958|3910161|FG012|Period 1 (Panel A and B)|Other|0
2248141|NCT01998958|3910162|FG013|Period 1 (Panel A and B)|Other|0
2248142|NCT01998958|3910163|FG014|Period 1 (Panel A and B)|Other|0
2248143|NCT01998958|3910164|FG015|Period 1 (Panel A and B)|Other|0
2248144|NCT01998958|3910165|FG016|Period 1 (Panel A and B)|Other|0
2248145|NCT01998958|3910166|FG017|Period 1 (Panel A and B)|Other|0
2248146|NCT01998958|3910167|FG018|Period 1 (Panel A and B)|Other|0
2248147|NCT01998958|3910168|FG019|Period 1 (Panel A and B)|Other|0
2248148|NCT01998958|3910169|FG020|Period 1 (Panel A and B)|Other|0
2248149|NCT01998958|3910170|FG021|Period 1 (Panel A and B)|Other|0
2248150|NCT01998958|3910171|FG022|Period 1 (Panel A and B)|Other|0
2248151|NCT01998958|3910172|FG023|Period 1 (Panel A and B)|Other|0
2248152|NCT01998958|3910173|FG024|Period 1 (Panel A and B)|Other|0
2248153|NCT01998958|3910174|FG025|Period 1 (Panel A and B)|Other|0
2248154|NCT01998958|3910175|FG026|Period 1 (Panel A and B)|Other|0
2248155|NCT01998958|3910176|FG027|Period 1 (Panel A and B)|Other|0
2248156|NCT01998958|3910177|FG028|Period 1 (Panel A and B)|Other|0
2248157|NCT01998958|3910178|FG029|Period 1 (Panel A and B)|Other|0
2248158|NCT01998958|3910179|FG030|Period 1 (Panel A and B)|Other|0
2248159|NCT01998958|3910180|FG031|Period 1 (Panel A and B)|Other|0
2340295|NCT03403751|4070685|FG001|Overall Study|Death|6
2340296|NCT03403751|4070684|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2
2340297|NCT03403751|4070685|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2
2340298|NCT03404206|4070702|FG000|Overall Study|Withdrawal by Subject|1
2340299|NCT03404206|4070703|FG001|Overall Study|Withdrawal by Subject|1
2340300|NCT03404206|4070704|FG002|Overall Study|Withdrawal by Subject|0
2340301|NCT03404206|4070702|FG000|Overall Study|Lost to Follow-up|3
2340302|NCT03404206|4070703|FG001|Overall Study|Lost to Follow-up|1
2340303|NCT03404206|4070704|FG002|Overall Study|Lost to Follow-up|0
2340304|NCT03404674|4070749|FG000|Overall Study|Inability to Attend Future Visits|0
2340305|NCT03404674|4070750|FG001|Overall Study|Inability to Attend Future Visits|1
2340306|NCT03404674|4070751|FG002|Overall Study|Inability to Attend Future Visits|1
2340307|NCT03404674|4070752|FG003|Overall Study|Inability to Attend Future Visits|0
2340308|NCT03404674|4070753|FG004|Overall Study|Inability to Attend Future Visits|0
2340309|NCT03404674|4070754|FG005|Overall Study|Inability to Attend Future Visits|0
2340310|NCT03404674|4070749|FG000|Overall Study|Behavioral Problems|0
2340311|NCT03404674|4070750|FG001|Overall Study|Behavioral Problems|0
2340312|NCT03404674|4070751|FG002|Overall Study|Behavioral Problems|1
2340313|NCT03404674|4070752|FG003|Overall Study|Behavioral Problems|0
2340314|NCT03404674|4070753|FG004|Overall Study|Behavioral Problems|0
2038192|NCT00421889|3608529|FG004|Overall Study|Patient/Investigator request|0
2038193|NCT00421889|3608530|FG005|Overall Study|Patient/Investigator request|9
2038194|NCT00421889|3608531|FG006|Overall Study|Patient/Investigator request|0
2038195|NCT00421889|3608532|FG007|Overall Study|Patient/Investigator request|1
2038196|NCT00421889|3608533|FG008|Overall Study|Patient/Investigator request|3
2038197|NCT00421889|3608525|FG000|Overall Study|Lost to Follow-up|0
2038198|NCT00421889|3608526|FG001|Overall Study|Lost to Follow-up|0
2038199|NCT00421889|3608527|FG002|Overall Study|Lost to Follow-up|0
2038200|NCT00421889|3608528|FG003|Overall Study|Lost to Follow-up|0
2038201|NCT00421889|3608529|FG004|Overall Study|Lost to Follow-up|0
2038202|NCT00421889|3608530|FG005|Overall Study|Lost to Follow-up|0
2038203|NCT00421889|3608531|FG006|Overall Study|Lost to Follow-up|0
2038204|NCT00421889|3608532|FG007|Overall Study|Lost to Follow-up|0
2038205|NCT00421889|3608533|FG008|Overall Study|Lost to Follow-up|1
2248160|NCT01998958|3910149|FG000|Period 2 (Panel A and B)|Adverse Event|0
2248161|NCT01998958|3910150|FG001|Period 2 (Panel A and B)|Adverse Event|0
2248162|NCT01998958|3910151|FG002|Period 2 (Panel A and B)|Adverse Event|0
2248163|NCT01998958|3910152|FG003|Period 2 (Panel A and B)|Adverse Event|0
2248164|NCT01998958|3910153|FG004|Period 2 (Panel A and B)|Adverse Event|0
2248165|NCT01998958|3910154|FG005|Period 2 (Panel A and B)|Adverse Event|0
2248166|NCT01998958|3910155|FG006|Period 2 (Panel A and B)|Adverse Event|0
2248167|NCT01998958|3910156|FG007|Period 2 (Panel A and B)|Adverse Event|0
2248168|NCT01998958|3910157|FG008|Period 2 (Panel A and B)|Adverse Event|0
2248169|NCT01998958|3910158|FG009|Period 2 (Panel A and B)|Adverse Event|0
2248170|NCT01998958|3910159|FG010|Period 2 (Panel A and B)|Adverse Event|1
2248171|NCT01998958|3910160|FG011|Period 2 (Panel A and B)|Adverse Event|0
2248172|NCT01998958|3910161|FG012|Period 2 (Panel A and B)|Adverse Event|0
2248173|NCT01998958|3910162|FG013|Period 2 (Panel A and B)|Adverse Event|0
2248174|NCT01998958|3910163|FG014|Period 2 (Panel A and B)|Adverse Event|1
2248175|NCT01998958|3910164|FG015|Period 2 (Panel A and B)|Adverse Event|0
2340315|NCT03404674|4070754|FG005|Overall Study|Behavioral Problems|0
2340316|NCT03404674|4070749|FG000|Overall Study|Started a Medication that Precluded Eligibility|0
2340317|NCT03404674|4070750|FG001|Overall Study|Started a Medication that Precluded Eligibility|0
2248176|NCT01998958|3910165|FG016|Period 2 (Panel A and B)|Adverse Event|0
2248177|NCT01998958|3910166|FG017|Period 2 (Panel A and B)|Adverse Event|0
2248178|NCT01998958|3910167|FG018|Period 2 (Panel A and B)|Adverse Event|0
2248179|NCT01998958|3910168|FG019|Period 2 (Panel A and B)|Adverse Event|0
2248180|NCT01998958|3910169|FG020|Period 2 (Panel A and B)|Adverse Event|0
2248181|NCT01998958|3910170|FG021|Period 2 (Panel A and B)|Adverse Event|0
2248182|NCT01998958|3910171|FG022|Period 2 (Panel A and B)|Adverse Event|0
2248183|NCT01998958|3910172|FG023|Period 2 (Panel A and B)|Adverse Event|0
2248184|NCT01998958|3910173|FG024|Period 2 (Panel A and B)|Adverse Event|0
2248185|NCT01998958|3910174|FG025|Period 2 (Panel A and B)|Adverse Event|0
2248186|NCT01998958|3910175|FG026|Period 2 (Panel A and B)|Adverse Event|0
2248187|NCT01998958|3910176|FG027|Period 2 (Panel A and B)|Adverse Event|0
2248188|NCT01998958|3910177|FG028|Period 2 (Panel A and B)|Adverse Event|0
2248189|NCT01998958|3910178|FG029|Period 2 (Panel A and B)|Adverse Event|0
2248190|NCT01998958|3910179|FG030|Period 2 (Panel A and B)|Adverse Event|0
2248191|NCT01998958|3910180|FG031|Period 2 (Panel A and B)|Adverse Event|0
2248192|NCT01998958|3910149|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248193|NCT01998958|3910150|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248194|NCT01998958|3910151|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248195|NCT01998958|3910152|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248196|NCT01998958|3910153|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248197|NCT01998958|3910154|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248198|NCT01998958|3910155|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248199|NCT01998958|3910156|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248200|NCT01998958|3910157|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248201|NCT01998958|3910158|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248202|NCT01998958|3910159|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248203|NCT01998958|3910160|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248204|NCT01998958|3910161|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248205|NCT01998958|3910162|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248206|NCT01998958|3910163|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1
2248207|NCT01998958|3910164|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248208|NCT01998958|3910165|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248209|NCT01998958|3910166|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248210|NCT01998958|3910167|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1
2248211|NCT01998958|3910168|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248212|NCT01998958|3910169|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248213|NCT01998958|3910170|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248214|NCT01998958|3910171|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248215|NCT01998958|3910172|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248216|NCT01998958|3910173|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248217|NCT01998958|3910174|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248218|NCT01998958|3910175|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248219|NCT01998958|3910176|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248220|NCT01998958|3910177|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248221|NCT01998958|3910178|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248222|NCT01998958|3910179|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0
2340318|NCT03404674|4070751|FG002|Overall Study|Started a Medication that Precluded Eligibility|0
2340319|NCT03404674|4070752|FG003|Overall Study|Started a Medication that Precluded Eligibility|1
2340320|NCT03404674|4070753|FG004|Overall Study|Started a Medication that Precluded Eligibility|0
2340321|NCT03404674|4070754|FG005|Overall Study|Started a Medication that Precluded Eligibility|1
2340322|NCT03404843|4070771|FG000|Overall Study|Study difficulties unrelated to Tx|4
2340323|NCT03404843|4070772|FG001|Overall Study|Study difficulties unrelated to Tx|1
2353137|NCT03029832|4104366|FG001|Overall Study|Safety Follow-Up Completed|0
2353138|NCT03029832|4104365|FG000|Overall Study|Death due to Disease Progression|1
2353139|NCT03029832|4104366|FG001|Overall Study|Death due to Disease Progression|0
2353140|NCT03029832|4104365|FG000|Overall Study|Study Terminated By Sponsor|1
2353141|NCT03029832|4104366|FG001|Overall Study|Study Terminated By Sponsor|1
2353142|NCT03010423|4104401|FG000|Overall Study|Study termination|8
2353143|NCT02991430|4104417|FG000|Treatment Period 1|Adverse Event|1
2353144|NCT02991430|4104418|FG001|Treatment Period 1|Adverse Event|0
2353145|NCT02991430|4104419|FG002|Treatment Period 1|Adverse Event|2
2353146|NCT02991430|4104417|FG000|Treatment Period 1|Withdrawal by Subject|0
2353147|NCT02991430|4104418|FG001|Treatment Period 1|Withdrawal by Subject|4
2353148|NCT02991430|4104419|FG002|Treatment Period 1|Withdrawal by Subject|0
2353149|NCT02991430|4104417|FG000|Treatment Period 2|Study Termination|6
2353150|NCT02991430|4104418|FG001|Treatment Period 2|Study Termination|3
2353151|NCT02991430|4104419|FG002|Treatment Period 2|Study Termination|3
2353152|NCT02991430|4104417|FG000|Treatment Period 2|Lost to Follow-up|0
2353153|NCT02991430|4104418|FG001|Treatment Period 2|Lost to Follow-up|0
2353154|NCT02991430|4104419|FG002|Treatment Period 2|Lost to Follow-up|1
2353155|NCT02991430|4104417|FG000|Post-treatment Observation Period|Study Termination|3
2353156|NCT02991430|4104418|FG001|Post-treatment Observation Period|Study Termination|6
2353157|NCT02991430|4104419|FG002|Post-treatment Observation Period|Study Termination|5
2353158|NCT02978833|4104452|FG000|Overall Study|Study terminated|1
2353159|NCT02978833|4104453|FG001|Overall Study|Study terminated|1
2353160|NCT02966223|4104490|FG000|Overall Study|Physician Decision|3
2248223|NCT01998958|3910180|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0
2248224|NCT01998958|3910149|FG000|Open Label Phase (Optional)|Adverse Event|0
2248225|NCT01998958|3910150|FG001|Open Label Phase (Optional)|Adverse Event|0
2248226|NCT01998958|3910151|FG002|Open Label Phase (Optional)|Adverse Event|0
2248227|NCT01998958|3910152|FG003|Open Label Phase (Optional)|Adverse Event|0
2248228|NCT01998958|3910153|FG004|Open Label Phase (Optional)|Adverse Event|0
2248229|NCT01998958|3910154|FG005|Open Label Phase (Optional)|Adverse Event|0
2248230|NCT01998958|3910155|FG006|Open Label Phase (Optional)|Adverse Event|0
2248231|NCT01998958|3910156|FG007|Open Label Phase (Optional)|Adverse Event|0
2248232|NCT01998958|3910157|FG008|Open Label Phase (Optional)|Adverse Event|0
2248233|NCT01998958|3910158|FG009|Open Label Phase (Optional)|Adverse Event|0
2248234|NCT01998958|3910159|FG010|Open Label Phase (Optional)|Adverse Event|0
2248235|NCT01998958|3910160|FG011|Open Label Phase (Optional)|Adverse Event|0
2248236|NCT01998958|3910161|FG012|Open Label Phase (Optional)|Adverse Event|0
2248237|NCT01998958|3910162|FG013|Open Label Phase (Optional)|Adverse Event|0
2248238|NCT01998958|3910163|FG014|Open Label Phase (Optional)|Adverse Event|0
2248239|NCT01998958|3910164|FG015|Open Label Phase (Optional)|Adverse Event|0
2248240|NCT01998958|3910165|FG016|Open Label Phase (Optional)|Adverse Event|0
2248241|NCT01998958|3910166|FG017|Open Label Phase (Optional)|Adverse Event|0
2248242|NCT01998958|3910167|FG018|Open Label Phase (Optional)|Adverse Event|0
2248243|NCT01998958|3910168|FG019|Open Label Phase (Optional)|Adverse Event|0
2248244|NCT01998958|3910169|FG020|Open Label Phase (Optional)|Adverse Event|0
2248245|NCT01998958|3910170|FG021|Open Label Phase (Optional)|Adverse Event|0
2248246|NCT01998958|3910171|FG022|Open Label Phase (Optional)|Adverse Event|0
2248247|NCT01998958|3910172|FG023|Open Label Phase (Optional)|Adverse Event|1
2248248|NCT01998958|3910173|FG024|Open Label Phase (Optional)|Adverse Event|0
2248249|NCT01998958|3910174|FG025|Open Label Phase (Optional)|Adverse Event|0
2248250|NCT01998958|3910175|FG026|Open Label Phase (Optional)|Adverse Event|0
2248251|NCT01998958|3910176|FG027|Open Label Phase (Optional)|Adverse Event|0
2248252|NCT01998958|3910177|FG028|Open Label Phase (Optional)|Adverse Event|0
2248253|NCT01998958|3910178|FG029|Open Label Phase (Optional)|Adverse Event|0
2248254|NCT01998958|3910179|FG030|Open Label Phase (Optional)|Adverse Event|0
2248255|NCT01998958|3910180|FG031|Open Label Phase (Optional)|Adverse Event|0
2248256|NCT01998958|3910149|FG000|Open Label Phase (Optional)|Other|0
2340324|NCT03405818|4070800|FG000|Overall Study|Withdrawal by Subject|4
2340325|NCT03405818|4070800|FG000|Overall Study|Lost to Follow-up|4
2340326|NCT03405935|4070804|FG000|Overall Study|Adverse Event|3
2340327|NCT03405935|4070804|FG000|Overall Study|Death|2
2340328|NCT03405935|4070804|FG000|Overall Study|Withdrawal by Subject|1
2340329|NCT03405935|4070804|FG000|Overall Study|Lost to Follow-up|2
2340330|NCT03406260|4070814|FG000|Period 1|Adverse Event|0
2340331|NCT03406260|4070815|FG001|Period 1|Adverse Event|0
2340332|NCT03406260|4070816|FG002|Period 1|Adverse Event|0
2340333|NCT03406260|4070817|FG003|Period 1|Adverse Event|0
2340334|NCT03406260|4070818|FG004|Period 1|Adverse Event|1
2340335|NCT03406260|4070819|FG005|Period 1|Adverse Event|0
2340336|NCT03406962|4070885|FG000|Overall Study|Death|2
2340337|NCT03406962|4070885|FG000|Overall Study|Adverse Event|1
2038206|NCT00421928|3608560|FG000|Overall Study|Adverse Event|61
2038207|NCT00421928|3608561|FG001|Overall Study|Adverse Event|140
2038208|NCT00421928|3608562|FG002|Overall Study|Adverse Event|22
2038209|NCT00421928|3608560|FG000|Overall Study|Lost to Follow-up|5
2038210|NCT00421928|3608561|FG001|Overall Study|Lost to Follow-up|0
2038211|NCT00421928|3608562|FG002|Overall Study|Lost to Follow-up|3
2038212|NCT00421928|3608560|FG000|Overall Study|Withdrawal by Subject|50
2038213|NCT00421928|3608561|FG001|Overall Study|Withdrawal by Subject|48
2038214|NCT00421928|3608562|FG002|Overall Study|Withdrawal by Subject|43
2038215|NCT00421928|3608560|FG000|Overall Study|Lack of Efficacy|15
2038216|NCT00421928|3608561|FG001|Overall Study|Lack of Efficacy|7
2038217|NCT00421928|3608562|FG002|Overall Study|Lack of Efficacy|35
2038218|NCT00421928|3608560|FG000|Overall Study|Study drug non-compliant|6
2038219|NCT00421928|3608561|FG001|Overall Study|Study drug non-compliant|7
2038220|NCT00421928|3608562|FG002|Overall Study|Study drug non-compliant|4
2038221|NCT00421928|3608560|FG000|Overall Study|All other|26
2038222|NCT00421928|3608561|FG001|Overall Study|All other|21
2038223|NCT00421928|3608562|FG002|Overall Study|All other|27
2038224|NCT00421928|3608560|FG000|Overall Study|Death|0
2248257|NCT01998958|3910150|FG001|Open Label Phase (Optional)|Other|0
2248258|NCT01998958|3910151|FG002|Open Label Phase (Optional)|Other|0
2248259|NCT01998958|3910152|FG003|Open Label Phase (Optional)|Other|0
2248260|NCT01998958|3910153|FG004|Open Label Phase (Optional)|Other|0
2248261|NCT01998958|3910154|FG005|Open Label Phase (Optional)|Other|0
2248262|NCT01998958|3910155|FG006|Open Label Phase (Optional)|Other|0
2248263|NCT01998958|3910156|FG007|Open Label Phase (Optional)|Other|0
2248264|NCT01998958|3910157|FG008|Open Label Phase (Optional)|Other|0
2248265|NCT01998958|3910158|FG009|Open Label Phase (Optional)|Other|0
2248266|NCT01998958|3910159|FG010|Open Label Phase (Optional)|Other|0
2248267|NCT01998958|3910160|FG011|Open Label Phase (Optional)|Other|0
2248268|NCT01998958|3910161|FG012|Open Label Phase (Optional)|Other|0
2248269|NCT01998958|3910162|FG013|Open Label Phase (Optional)|Other|0
2248270|NCT01998958|3910163|FG014|Open Label Phase (Optional)|Other|0
2248271|NCT01998958|3910164|FG015|Open Label Phase (Optional)|Other|0
2248272|NCT01998958|3910165|FG016|Open Label Phase (Optional)|Other|0
2340338|NCT03407118|4070899|FG000|Period 2|Withdrawal by Subject|1
2038225|NCT00421928|3608561|FG001|Overall Study|Death|1
2340339|NCT03407118|4070900|FG001|Period 2|Withdrawal by Subject|0
2248273|NCT01998958|3910166|FG017|Open Label Phase (Optional)|Other|0
2248274|NCT01998958|3910167|FG018|Open Label Phase (Optional)|Other|0
2248275|NCT01998958|3910168|FG019|Open Label Phase (Optional)|Other|0
2248276|NCT01998958|3910169|FG020|Open Label Phase (Optional)|Other|0
2248277|NCT01998958|3910170|FG021|Open Label Phase (Optional)|Other|0
2248278|NCT01998958|3910171|FG022|Open Label Phase (Optional)|Other|5
2248279|NCT01998958|3910172|FG023|Open Label Phase (Optional)|Other|1
2248280|NCT01998958|3910173|FG024|Open Label Phase (Optional)|Other|0
2248281|NCT01998958|3910174|FG025|Open Label Phase (Optional)|Other|0
2248282|NCT01998958|3910175|FG026|Open Label Phase (Optional)|Other|0
2248283|NCT01998958|3910176|FG027|Open Label Phase (Optional)|Other|0
2248284|NCT01998958|3910177|FG028|Open Label Phase (Optional)|Other|0
2248285|NCT01998958|3910178|FG029|Open Label Phase (Optional)|Other|0
2248286|NCT01998958|3910179|FG030|Open Label Phase (Optional)|Other|0
2248287|NCT01998958|3910180|FG031|Open Label Phase (Optional)|Other|0
2248288|NCT01998958|3910149|FG000|Open Label Phase (Optional)|Lost to Follow-up|0
2248289|NCT01998958|3910150|FG001|Open Label Phase (Optional)|Lost to Follow-up|0
2248290|NCT01998958|3910151|FG002|Open Label Phase (Optional)|Lost to Follow-up|0
2248291|NCT01998958|3910152|FG003|Open Label Phase (Optional)|Lost to Follow-up|0
2248292|NCT01998958|3910153|FG004|Open Label Phase (Optional)|Lost to Follow-up|0
2248293|NCT01998958|3910154|FG005|Open Label Phase (Optional)|Lost to Follow-up|0
2248294|NCT01998958|3910155|FG006|Open Label Phase (Optional)|Lost to Follow-up|0
2248295|NCT01998958|3910156|FG007|Open Label Phase (Optional)|Lost to Follow-up|0
2248296|NCT01998958|3910157|FG008|Open Label Phase (Optional)|Lost to Follow-up|0
2248297|NCT01998958|3910158|FG009|Open Label Phase (Optional)|Lost to Follow-up|0
2248298|NCT01998958|3910159|FG010|Open Label Phase (Optional)|Lost to Follow-up|0
2248299|NCT01998958|3910160|FG011|Open Label Phase (Optional)|Lost to Follow-up|0
2248300|NCT01998958|3910161|FG012|Open Label Phase (Optional)|Lost to Follow-up|0
2248301|NCT01998958|3910162|FG013|Open Label Phase (Optional)|Lost to Follow-up|0
2248302|NCT01998958|3910163|FG014|Open Label Phase (Optional)|Lost to Follow-up|0
2248303|NCT01998958|3910164|FG015|Open Label Phase (Optional)|Lost to Follow-up|0
2248304|NCT01998958|3910165|FG016|Open Label Phase (Optional)|Lost to Follow-up|0
2248305|NCT01998958|3910166|FG017|Open Label Phase (Optional)|Lost to Follow-up|0
2248306|NCT01998958|3910167|FG018|Open Label Phase (Optional)|Lost to Follow-up|0
2248307|NCT01998958|3910168|FG019|Open Label Phase (Optional)|Lost to Follow-up|0
2248308|NCT01998958|3910169|FG020|Open Label Phase (Optional)|Lost to Follow-up|0
2248309|NCT01998958|3910170|FG021|Open Label Phase (Optional)|Lost to Follow-up|0
2248310|NCT01998958|3910171|FG022|Open Label Phase (Optional)|Lost to Follow-up|1
2248311|NCT01998958|3910172|FG023|Open Label Phase (Optional)|Lost to Follow-up|0
2248312|NCT01998958|3910173|FG024|Open Label Phase (Optional)|Lost to Follow-up|0
2248313|NCT01998958|3910174|FG025|Open Label Phase (Optional)|Lost to Follow-up|0
2248314|NCT01998958|3910175|FG026|Open Label Phase (Optional)|Lost to Follow-up|0
2248315|NCT01998958|3910176|FG027|Open Label Phase (Optional)|Lost to Follow-up|0
2248316|NCT01998958|3910177|FG028|Open Label Phase (Optional)|Lost to Follow-up|0
2248317|NCT01998958|3910178|FG029|Open Label Phase (Optional)|Lost to Follow-up|0
2248318|NCT01998958|3910179|FG030|Open Label Phase (Optional)|Lost to Follow-up|0
2248319|NCT01998958|3910180|FG031|Open Label Phase (Optional)|Lost to Follow-up|0
2248320|NCT01998958|3910149|FG000|Open Label Phase (Optional)|Lack of Efficacy|0
2248321|NCT01998958|3910150|FG001|Open Label Phase (Optional)|Lack of Efficacy|0
2248322|NCT01998958|3910151|FG002|Open Label Phase (Optional)|Lack of Efficacy|0
2248323|NCT01998958|3910152|FG003|Open Label Phase (Optional)|Lack of Efficacy|0
2248324|NCT01998958|3910153|FG004|Open Label Phase (Optional)|Lack of Efficacy|0
2248325|NCT01998958|3910154|FG005|Open Label Phase (Optional)|Lack of Efficacy|0
2248326|NCT01998958|3910155|FG006|Open Label Phase (Optional)|Lack of Efficacy|0
2248327|NCT01998958|3910156|FG007|Open Label Phase (Optional)|Lack of Efficacy|0
2248328|NCT01998958|3910157|FG008|Open Label Phase (Optional)|Lack of Efficacy|0
2248329|NCT01998958|3910158|FG009|Open Label Phase (Optional)|Lack of Efficacy|0
2248330|NCT01998958|3910159|FG010|Open Label Phase (Optional)|Lack of Efficacy|0
2248331|NCT01998958|3910160|FG011|Open Label Phase (Optional)|Lack of Efficacy|0
2248332|NCT01998958|3910161|FG012|Open Label Phase (Optional)|Lack of Efficacy|0
2248333|NCT01998958|3910162|FG013|Open Label Phase (Optional)|Lack of Efficacy|0
2248334|NCT01998958|3910163|FG014|Open Label Phase (Optional)|Lack of Efficacy|0
2248335|NCT01998958|3910164|FG015|Open Label Phase (Optional)|Lack of Efficacy|0
2248336|NCT01998958|3910165|FG016|Open Label Phase (Optional)|Lack of Efficacy|0
2248337|NCT01998958|3910166|FG017|Open Label Phase (Optional)|Lack of Efficacy|0
2248338|NCT01998958|3910167|FG018|Open Label Phase (Optional)|Lack of Efficacy|0
2248339|NCT01998958|3910168|FG019|Open Label Phase (Optional)|Lack of Efficacy|0
2248340|NCT01998958|3910169|FG020|Open Label Phase (Optional)|Lack of Efficacy|0
2248341|NCT01998958|3910170|FG021|Open Label Phase (Optional)|Lack of Efficacy|1
2248342|NCT01998958|3910171|FG022|Open Label Phase (Optional)|Lack of Efficacy|2
2248343|NCT01998958|3910172|FG023|Open Label Phase (Optional)|Lack of Efficacy|0
2248344|NCT01998958|3910173|FG024|Open Label Phase (Optional)|Lack of Efficacy|0
2248345|NCT01998958|3910174|FG025|Open Label Phase (Optional)|Lack of Efficacy|0
2248346|NCT01998958|3910175|FG026|Open Label Phase (Optional)|Lack of Efficacy|0
2248347|NCT01998958|3910176|FG027|Open Label Phase (Optional)|Lack of Efficacy|0
2248348|NCT01998958|3910177|FG028|Open Label Phase (Optional)|Lack of Efficacy|0
2248349|NCT01998958|3910178|FG029|Open Label Phase (Optional)|Lack of Efficacy|0
2248350|NCT01998958|3910179|FG030|Open Label Phase (Optional)|Lack of Efficacy|0
2248351|NCT01998958|3910180|FG031|Open Label Phase (Optional)|Lack of Efficacy|0
2248352|NCT01998958|3910149|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0
2248353|NCT01998958|3910150|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0
2248354|NCT01998958|3910151|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0
2248355|NCT01998958|3910152|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0
2248356|NCT01998958|3910153|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0
2248357|NCT01998958|3910154|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0
2248358|NCT01998958|3910155|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0
2248359|NCT01998958|3910156|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0
2248360|NCT01998958|3910157|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0
2248361|NCT01998958|3910158|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0
2248362|NCT01998958|3910159|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0
2248363|NCT01998958|3910160|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0
2248364|NCT01998958|3910161|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0
2248365|NCT01998958|3910162|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0
2248366|NCT01998958|3910163|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0
2248367|NCT01998958|3910164|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0
2248368|NCT01998958|3910165|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0
2248369|NCT01998958|3910166|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0
2248370|NCT01998958|3910167|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0
2248371|NCT01998958|3910168|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0
2248372|NCT01998958|3910169|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0
2248373|NCT01998958|3910170|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2
2248374|NCT01998958|3910171|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1
2248375|NCT01998958|3910172|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2
2248376|NCT01998958|3910173|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0
2248377|NCT01998958|3910174|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0
2248378|NCT01998958|3910175|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0
2248379|NCT01998958|3910176|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0
2248380|NCT01998958|3910177|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0
2248381|NCT01998958|3910178|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0
2340340|NCT03407170|4070906|FG000|Overall Study|Adverse Event|1
2340341|NCT03407430|4070916|FG000|Washout|Protocol Violation|1
2340342|NCT03407430|4070917|FG001|Washout|Protocol Violation|0
2340343|NCT03407482|4070930|FG000|Overall Study|Adverse Event|12
2340344|NCT03407482|4070930|FG000|Overall Study|Disease Relapse|1
2340345|NCT03407482|4070930|FG000|Overall Study|Lost to Follow-up|1
2340346|NCT03407482|4070930|FG000|Overall Study|Non-Compliance With Study Drug|1
2340347|NCT03407482|4070930|FG000|Overall Study|Pregnancy|2
2340348|NCT03407482|4070930|FG000|Overall Study|Protocol Violation|1
2340349|NCT03407482|4070930|FG000|Overall Study|Study Terminated By Sponsor|106
2340350|NCT03407482|4070930|FG000|Overall Study|Withdrawal by Subject|6
2340351|NCT03407482|4070930|FG000|Overall Study|Data Entry Error|1
2340352|NCT03408483|4070990|FG000|Overall Study|Physician Decision|3
2340353|NCT03408483|4070991|FG001|Overall Study|Physician Decision|3
2340354|NCT03408483|4070990|FG000|Overall Study|Lost to Follow-up|3
2340355|NCT03408483|4070991|FG001|Overall Study|Lost to Follow-up|0
2340356|NCT03408639|4070999|FG000|Overall Study|Death|5
2340357|NCT03408639|4071000|FG001|Overall Study|Death|5
2340358|NCT03408639|4070999|FG000|Overall Study|Lost to Follow-up|1
2340359|NCT03408639|4071000|FG001|Overall Study|Lost to Follow-up|4
2340360|NCT03408639|4070999|FG000|Overall Study|Withdrawal by Subject|2
2340361|NCT03408639|4071000|FG001|Overall Study|Withdrawal by Subject|7
2340362|NCT03408639|4070999|FG000|Overall Study|Physician Decision|3
2340363|NCT03408639|4071000|FG001|Overall Study|Physician Decision|6
2340364|NCT03409107|4071038|FG000|Overall Study|Withdrawal by Subject|4
2340365|NCT03409107|4071039|FG001|Overall Study|Withdrawal by Subject|2
2340366|NCT03409107|4071038|FG000|Overall Study|Physician Decision|1
2340367|NCT03409107|4071039|FG001|Overall Study|Physician Decision|0
2340368|NCT03409107|4071038|FG000|Overall Study|Lost to Follow-up|7
2340369|NCT03409107|4071039|FG001|Overall Study|Lost to Follow-up|2
2340370|NCT03409107|4071038|FG000|Overall Study|Adverse Event|5
2340371|NCT03409107|4071039|FG001|Overall Study|Adverse Event|3
2340372|NCT03409731|4071045|FG000|Overall Study|Withdrawal by Subject|1
2340373|NCT03409731|4071045|FG000|Overall Study|Death|2
2340374|NCT03409796|4071051|FG000|Overall Study|Adverse Event|2
2340375|NCT03409796|4071052|FG001|Overall Study|Adverse Event|0
2340376|NCT03409796|4071051|FG000|Overall Study|Other|0
2340377|NCT03409796|4071052|FG001|Overall Study|Other|1
2340378|NCT03410056|4071062|FG000|Overall Study|Decision by Sponsor|0
2340379|NCT03410056|4071063|FG001|Overall Study|Decision by Sponsor|0
2340380|NCT03410056|4071064|FG002|Overall Study|Decision by Sponsor|3
2340381|NCT03410056|4071065|FG003|Overall Study|Decision by Sponsor|0
2340382|NCT03410056|4071066|FG004|Overall Study|Decision by Sponsor|0
2340383|NCT03410056|4071067|FG005|Overall Study|Decision by Sponsor|0
2340384|NCT03410056|4071068|FG006|Overall Study|Decision by Sponsor|0
2038226|NCT00421928|3608562|FG002|Overall Study|Death|0
2038227|NCT00421993|3608574|FG000|Overall Study|Withdrawal by Subject|22
2038228|NCT00421993|3608575|FG001|Overall Study|Withdrawal by Subject|23
2038229|NCT00421993|3608576|FG002|Overall Study|Withdrawal by Subject|23
2038230|NCT00421993|3608577|FG003|Overall Study|Withdrawal by Subject|24
2248382|NCT01998958|3910179|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0
2248383|NCT01998958|3910180|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0
2248384|NCT01998984|3910234|FG000|Overall Study|Adverse Event|0
2248385|NCT01998984|3910235|FG001|Overall Study|Adverse Event|0
2248386|NCT01998984|3910236|FG002|Overall Study|Adverse Event|0
2248387|NCT01998984|3910237|FG003|Overall Study|Adverse Event|1
2248388|NCT01998984|3910234|FG000|Overall Study|Lost to Follow-up|0
2248389|NCT01998984|3910235|FG001|Overall Study|Lost to Follow-up|1
2248390|NCT01998984|3910236|FG002|Overall Study|Lost to Follow-up|0
2248391|NCT01998984|3910237|FG003|Overall Study|Lost to Follow-up|1
2248392|NCT01998984|3910234|FG000|Overall Study|Withdrawal by Subject|0
2248393|NCT01998984|3910235|FG001|Overall Study|Withdrawal by Subject|0
2248394|NCT01998984|3910236|FG002|Overall Study|Withdrawal by Subject|1
2248395|NCT01998984|3910237|FG003|Overall Study|Withdrawal by Subject|0
2248396|NCT01998984|3910234|FG000|Overall Study|Other|0
2248397|NCT01998984|3910235|FG001|Overall Study|Other|0
2248398|NCT01998984|3910236|FG002|Overall Study|Other|0
2248399|NCT01998984|3910237|FG003|Overall Study|Other|1
2248400|NCT01999114|3910252|FG000|Overall Study|Adverse Event|8
2248401|NCT01999114|3910253|FG001|Overall Study|Adverse Event|7
2248402|NCT01999114|3910254|FG002|Overall Study|Adverse Event|2
2248403|NCT01999114|3910255|FG003|Overall Study|Adverse Event|2
2248404|NCT01999114|3910256|FG004|Overall Study|Adverse Event|1
2248405|NCT01999114|3910252|FG000|Overall Study|Withdrawal by Subject|0
2248406|NCT01999114|3910253|FG001|Overall Study|Withdrawal by Subject|0
2248407|NCT01999114|3910254|FG002|Overall Study|Withdrawal by Subject|1
2248408|NCT01999114|3910255|FG003|Overall Study|Withdrawal by Subject|0
2248409|NCT01999114|3910256|FG004|Overall Study|Withdrawal by Subject|1
2248410|NCT01999114|3910252|FG000|Overall Study|Lost to Follow-up|0
2248411|NCT01999114|3910253|FG001|Overall Study|Lost to Follow-up|0
2248412|NCT01999114|3910254|FG002|Overall Study|Lost to Follow-up|1
2248413|NCT01999114|3910255|FG003|Overall Study|Lost to Follow-up|0
2248414|NCT01999114|3910256|FG004|Overall Study|Lost to Follow-up|0
2248415|NCT01999114|3910252|FG000|Overall Study|Administrative|0
2248416|NCT01999114|3910253|FG001|Overall Study|Administrative|0
2248417|NCT01999114|3910254|FG002|Overall Study|Administrative|1
2248418|NCT01999114|3910255|FG003|Overall Study|Administrative|1
2248419|NCT01999114|3910256|FG004|Overall Study|Administrative|2
2248420|NCT01999218|3910302|FG000|Overall Study|Hyperglycemia|18
2248421|NCT01999218|3910303|FG001|Overall Study|Hyperglycemia|17
2248422|NCT01999218|3910304|FG002|Overall Study|Hyperglycemia|17
2248423|NCT01999218|3910302|FG000|Overall Study|Lack of Efficacy|1
2248424|NCT01999218|3910303|FG001|Overall Study|Lack of Efficacy|0
2248425|NCT01999218|3910304|FG002|Overall Study|Lack of Efficacy|1
2248426|NCT01999218|3910302|FG000|Overall Study|Lost to Follow-up|22
2248427|NCT01999218|3910303|FG001|Overall Study|Lost to Follow-up|17
2248428|NCT01999218|3910304|FG002|Overall Study|Lost to Follow-up|18
2248429|NCT01999218|3910302|FG000|Overall Study|Non-Compliance With Study Drug|6
2248430|NCT01999218|3910303|FG001|Overall Study|Non-Compliance With Study Drug|4
2248431|NCT01999218|3910304|FG002|Overall Study|Non-Compliance With Study Drug|1
2248432|NCT01999218|3910302|FG000|Overall Study|Physician Decision|1
2248433|NCT01999218|3910303|FG001|Overall Study|Physician Decision|4
2248434|NCT01999218|3910304|FG002|Overall Study|Physician Decision|6
2248435|NCT01999218|3910302|FG000|Overall Study|Protocol Violation|4
2248436|NCT01999218|3910303|FG001|Overall Study|Protocol Violation|5
2248437|NCT01999218|3910304|FG002|Overall Study|Protocol Violation|4
2248438|NCT01999218|3910302|FG000|Overall Study|Screen failure|0
2248439|NCT01999218|3910303|FG001|Overall Study|Screen failure|1
2248440|NCT01999218|3910304|FG002|Overall Study|Screen failure|0
2248441|NCT01999218|3910302|FG000|Overall Study|Study Terminated By Sponsor|7
2248442|NCT01999218|3910303|FG001|Overall Study|Study Terminated By Sponsor|5
2248443|NCT01999218|3910304|FG002|Overall Study|Study Terminated By Sponsor|12
2248444|NCT01999218|3910302|FG000|Overall Study|Participant moves|2
2248445|NCT01999218|3910303|FG001|Overall Study|Participant moves|5
2248446|NCT01999218|3910304|FG002|Overall Study|Participant moves|3
2248447|NCT01999218|3910302|FG000|Overall Study|Withdrawal by Subject|28
2248448|NCT01999218|3910303|FG001|Overall Study|Withdrawal by Subject|29
2248449|NCT01999218|3910304|FG002|Overall Study|Withdrawal by Subject|34
2248450|NCT01999218|3910302|FG000|Overall Study|Creatinine/eGFR|0
2248451|NCT01999218|3910303|FG001|Overall Study|Creatinine/eGFR|0
2248452|NCT01999218|3910304|FG002|Overall Study|Creatinine/eGFR|1
2248453|NCT01999218|3910302|FG000|Overall Study|Death|7
2248454|NCT01999218|3910303|FG001|Overall Study|Death|1
2248455|NCT01999218|3910304|FG002|Overall Study|Death|2
2248456|NCT01999218|3910302|FG000|Overall Study|Excluded Medication|1
2248457|NCT01999218|3910303|FG001|Overall Study|Excluded Medication|1
2248458|NCT01999218|3910304|FG002|Overall Study|Excluded Medication|2
2248459|NCT01999218|3910302|FG000|Overall Study|Adverse Event|9
2248460|NCT01999218|3910303|FG001|Overall Study|Adverse Event|7
2248461|NCT01999218|3910304|FG002|Overall Study|Adverse Event|7
2248462|NCT01999218|3910302|FG000|Overall Study|Treated but excluded at 1 trial site|3
2248463|NCT01999218|3910303|FG001|Overall Study|Treated but excluded at 1 trial site|5
2248464|NCT01999218|3910304|FG002|Overall Study|Treated but excluded at 1 trial site|2
2248465|NCT01999322|3910333|FG000|Overall Study|Adverse Event|1
2248466|NCT01999322|3910334|FG001|Overall Study|Adverse Event|0
2248467|NCT01999335|3910345|FG000|Overall Study|Discontinued before receiving treatment|0
2248468|NCT01999335|3910346|FG001|Overall Study|Discontinued before receiving treatment|0
2248469|NCT01999335|3910347|FG002|Overall Study|Discontinued before receiving treatment|0
2248470|NCT01999335|3910348|FG003|Overall Study|Discontinued before receiving treatment|0
2248471|NCT01999335|3910349|FG004|Overall Study|Discontinued before receiving treatment|2
2248472|NCT01999465|3910385|FG000|Overall Study|Lost to Follow-up|0
2248473|NCT01999465|3910386|FG001|Overall Study|Lost to Follow-up|2
2248474|NCT01999465|3910385|FG000|Overall Study|Protocol Violation|0
2248475|NCT01999465|3910386|FG001|Overall Study|Protocol Violation|1
2248476|NCT01999868|3910424|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
2248477|NCT01999868|3910425|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
2248478|NCT01999868|3910426|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5
2248479|NCT01999868|3910424|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
2248480|NCT01999868|3910425|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
2248481|NCT01999868|3910426|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0
2248482|NCT01999868|3910424|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3
2248483|NCT01999868|3910425|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4
2248484|NCT01999868|3910426|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0
2248485|NCT01999868|3910424|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
2248486|NCT01999868|3910425|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1
2248487|NCT01999868|3910426|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
2248488|NCT01999868|3910424|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
2248489|NCT01999868|3910425|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2
2248490|NCT01999868|3910426|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
2248491|NCT01999868|3910424|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1
2248492|NCT01999868|3910425|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2
2248493|NCT01999868|3910426|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0
2248494|NCT01999868|3910424|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8
2248495|NCT01999868|3910425|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1
2248496|NCT01999868|3910426|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0
2248497|NCT01999868|3910424|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1
2248498|NCT01999868|3910425|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
2248499|NCT01999868|3910426|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
2248500|NCT01999868|3910424|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4
2248501|NCT01999868|3910425|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
2248502|NCT01999868|3910426|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
2248503|NCT01999868|3910424|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
2248504|NCT01999868|3910425|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1
2248505|NCT01999868|3910426|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
2248506|NCT01999868|3910424|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
2248507|NCT01999868|3910425|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1
2248508|NCT01999868|3910426|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
2248509|NCT01999868|3910424|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1
2248510|NCT01999868|3910425|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2
2248511|NCT01999868|3910426|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0
2248512|NCT01999868|3910424|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10
2248513|NCT01999868|3910425|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19
2248514|NCT01999868|3910426|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0
2248515|NCT01999868|3910424|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
2248516|NCT01999868|3910425|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2
2248517|NCT01999868|3910426|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
2248518|NCT01999868|3910424|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12
2248519|NCT01999868|3910425|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4
2248520|NCT01999868|3910426|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0
2248521|NCT01999894|3910434|FG000|Overall Study|Adverse Event|9
2248522|NCT01999894|3910434|FG000|Overall Study|Lack of Efficacy|5
2248523|NCT01999894|3910434|FG000|Overall Study|Protocol Violation|1
2248524|NCT01999894|3910434|FG000|Overall Study|Withdrawal by Subject|7
2248525|NCT01999894|3910434|FG000|Overall Study|Lost to Follow-up|10
2248526|NCT01999894|3910434|FG000|Overall Study|Other Reason|3
2248527|NCT01999894|3910434|FG000|Overall Study|Inclusion/exclusion criteria not met|1
2248528|NCT01999946|3910451|FG000|Overall Study|Participant not released from jail|2
2248529|NCT01999946|3910452|FG001|Overall Study|Participant not released from jail|2
2248530|NCT01999946|3910453|FG002|Overall Study|Participant not released from jail|0
2248531|NCT01999946|3910451|FG000|Overall Study|Not included in primary outcome analysis|0
2248532|NCT01999946|3910452|FG001|Overall Study|Not included in primary outcome analysis|0
2248533|NCT01999946|3910453|FG002|Overall Study|Not included in primary outcome analysis|79
2248534|NCT01999972|3910466|FG000|Dose Escalation Part|Participant refused further follow-up|1
2248535|NCT01999972|3910467|FG001|Dose Escalation Part|Participant refused further follow-up|0
2340385|NCT03410056|4071062|FG000|Overall Study|Withdrawal by Subject|0
2248536|NCT01999972|3910468|FG002|Dose Escalation Part|Participant refused further follow-up|1
2248537|NCT01999972|3910469|FG003|Dose Escalation Part|Participant refused further follow-up|1
2248538|NCT01999972|3910470|FG004|Dose Escalation Part|Participant refused further follow-up|0
2248539|NCT01999972|3910471|FG005|Dose Escalation Part|Participant refused further follow-up|0
2248540|NCT01999972|3910466|FG000|Dose Escalation Part|Death|0
2248541|NCT01999972|3910467|FG001|Dose Escalation Part|Death|1
2248542|NCT01999972|3910468|FG002|Dose Escalation Part|Death|0
2248543|NCT01999972|3910469|FG003|Dose Escalation Part|Death|0
2248544|NCT01999972|3910470|FG004|Dose Escalation Part|Death|0
2248545|NCT01999972|3910471|FG005|Dose Escalation Part|Death|0
2248546|NCT01999972|3910466|FG000|Dose Escalation Part|Enrolled but not treated|0
2248547|NCT01999972|3910467|FG001|Dose Escalation Part|Enrolled but not treated|0
2248548|NCT01999972|3910468|FG002|Dose Escalation Part|Enrolled but not treated|1
2248549|NCT01999972|3910469|FG003|Dose Escalation Part|Enrolled but not treated|1
2248550|NCT01999972|3910470|FG004|Dose Escalation Part|Enrolled but not treated|0
2248551|NCT01999972|3910471|FG005|Dose Escalation Part|Enrolled but not treated|0
2248552|NCT01999972|3910466|FG000|Dose Escalation Part|Disease progression|3
2248553|NCT01999972|3910467|FG001|Dose Escalation Part|Disease progression|2
2248554|NCT01999972|3910468|FG002|Dose Escalation Part|Disease progression|3
2248555|NCT01999972|3910469|FG003|Dose Escalation Part|Disease progression|6
2248556|NCT01999972|3910470|FG004|Dose Escalation Part|Disease progression|0
2248557|NCT01999972|3910471|FG005|Dose Escalation Part|Disease progression|0
2248558|NCT01999972|3910466|FG000|Dose Escalation Part|Adverse Event|0
2248559|NCT01999972|3910467|FG001|Dose Escalation Part|Adverse Event|0
2248560|NCT01999972|3910468|FG002|Dose Escalation Part|Adverse Event|0
2248561|NCT01999972|3910469|FG003|Dose Escalation Part|Adverse Event|2
2248562|NCT01999972|3910470|FG004|Dose Escalation Part|Adverse Event|0
2248563|NCT01999972|3910471|FG005|Dose Escalation Part|Adverse Event|0
2248564|NCT01999972|3910466|FG000|Dose Escalation Part|Global deterioration of health status|1
2248565|NCT01999972|3910467|FG001|Dose Escalation Part|Global deterioration of health status|0
2248566|NCT01999972|3910468|FG002|Dose Escalation Part|Global deterioration of health status|0
2248567|NCT01999972|3910469|FG003|Dose Escalation Part|Global deterioration of health status|1
2248568|NCT01999972|3910470|FG004|Dose Escalation Part|Global deterioration of health status|0
2248569|NCT01999972|3910471|FG005|Dose Escalation Part|Global deterioration of health status|0
2248570|NCT01999972|3910466|FG000|Dose Expansion Part|Death|0
2248571|NCT01999972|3910467|FG001|Dose Expansion Part|Death|0
2248572|NCT01999972|3910468|FG002|Dose Expansion Part|Death|0
2248573|NCT01999972|3910469|FG003|Dose Expansion Part|Death|0
2248574|NCT01999972|3910470|FG004|Dose Expansion Part|Death|2
2248575|NCT01999972|3910471|FG005|Dose Expansion Part|Death|1
2248576|NCT01999972|3910466|FG000|Dose Expansion Part|Disease progression|0
2248577|NCT01999972|3910467|FG001|Dose Expansion Part|Disease progression|0
2248578|NCT01999972|3910468|FG002|Dose Expansion Part|Disease progression|0
2248579|NCT01999972|3910469|FG003|Dose Expansion Part|Disease progression|0
2248580|NCT01999972|3910470|FG004|Dose Expansion Part|Disease progression|9
2248581|NCT01999972|3910471|FG005|Dose Expansion Part|Disease progression|3
2248582|NCT01999972|3910466|FG000|Dose Expansion Part|Sponsor decision|0
2248583|NCT01999972|3910467|FG001|Dose Expansion Part|Sponsor decision|0
2248584|NCT01999972|3910468|FG002|Dose Expansion Part|Sponsor decision|0
2248585|NCT01999972|3910469|FG003|Dose Expansion Part|Sponsor decision|0
2248586|NCT01999972|3910470|FG004|Dose Expansion Part|Sponsor decision|1
2248587|NCT01999972|3910471|FG005|Dose Expansion Part|Sponsor decision|0
2248588|NCT01999972|3910466|FG000|Dose Expansion Part|Adverse Event|0
2248589|NCT01999972|3910467|FG001|Dose Expansion Part|Adverse Event|0
2248590|NCT01999972|3910468|FG002|Dose Expansion Part|Adverse Event|0
2248591|NCT01999972|3910469|FG003|Dose Expansion Part|Adverse Event|0
2248592|NCT01999972|3910470|FG004|Dose Expansion Part|Adverse Event|4
2248593|NCT01999972|3910471|FG005|Dose Expansion Part|Adverse Event|2
2248594|NCT01999972|3910466|FG000|Dose Expansion Part|Participant's non-compliance|0
2248595|NCT01999972|3910467|FG001|Dose Expansion Part|Participant's non-compliance|0
2248596|NCT01999972|3910468|FG002|Dose Expansion Part|Participant's non-compliance|0
2248597|NCT01999972|3910469|FG003|Dose Expansion Part|Participant's non-compliance|0
2248598|NCT01999972|3910470|FG004|Dose Expansion Part|Participant's non-compliance|0
2248599|NCT01999972|3910471|FG005|Dose Expansion Part|Participant's non-compliance|1
2248600|NCT01999972|3910466|FG000|Dose Expansion Part|Participant refused further follow-up|0
2248601|NCT01999972|3910467|FG001|Dose Expansion Part|Participant refused further follow-up|0
2248602|NCT01999972|3910468|FG002|Dose Expansion Part|Participant refused further follow-up|0
2248603|NCT01999972|3910469|FG003|Dose Expansion Part|Participant refused further follow-up|0
2248604|NCT01999972|3910470|FG004|Dose Expansion Part|Participant refused further follow-up|4
2248605|NCT01999972|3910471|FG005|Dose Expansion Part|Participant refused further follow-up|0
2248606|NCT01999972|3910466|FG000|Dose Expansion Part|Changed to standard of care|0
2248607|NCT01999972|3910467|FG001|Dose Expansion Part|Changed to standard of care|0
2248608|NCT01999972|3910468|FG002|Dose Expansion Part|Changed to standard of care|0
2248609|NCT01999972|3910469|FG003|Dose Expansion Part|Changed to standard of care|0
2248610|NCT01999972|3910470|FG004|Dose Expansion Part|Changed to standard of care|1
2248611|NCT01999972|3910471|FG005|Dose Expansion Part|Changed to standard of care|0
2248612|NCT02000115|3910498|FG000|Overall Study|Death|56
2248613|NCT02000115|3910499|FG001|Overall Study|Death|45
2248614|NCT02000115|3910500|FG002|Overall Study|Death|0
2248615|NCT02000115|3910501|FG003|Overall Study|Death|0
2248616|NCT02000115|3910498|FG000|Overall Study|Missed Visit|6
2248617|NCT02000115|3910499|FG001|Overall Study|Missed Visit|8
2248618|NCT02000115|3910500|FG002|Overall Study|Missed Visit|1
2248619|NCT02000115|3910501|FG003|Overall Study|Missed Visit|0
2248620|NCT02000115|3910498|FG000|Overall Study|Protocol Violation|2
2248621|NCT02000115|3910499|FG001|Overall Study|Protocol Violation|1
2248622|NCT02000115|3910500|FG002|Overall Study|Protocol Violation|0
2248623|NCT02000115|3910501|FG003|Overall Study|Protocol Violation|0
2248624|NCT02000115|3910498|FG000|Overall Study|Physician Decision|2
2248625|NCT02000115|3910499|FG001|Overall Study|Physician Decision|0
2248626|NCT02000115|3910500|FG002|Overall Study|Physician Decision|0
2248627|NCT02000115|3910501|FG003|Overall Study|Physician Decision|0
2248628|NCT02000115|3910498|FG000|Overall Study|Withdrawal by Subject|11
2248629|NCT02000115|3910499|FG001|Overall Study|Withdrawal by Subject|11
2248630|NCT02000115|3910500|FG002|Overall Study|Withdrawal by Subject|0
2248631|NCT02000115|3910501|FG003|Overall Study|Withdrawal by Subject|0
2248632|NCT02000115|3910498|FG000|Overall Study|Lost to Follow-up|0
2248633|NCT02000115|3910499|FG001|Overall Study|Lost to Follow-up|1
2248634|NCT02000115|3910500|FG002|Overall Study|Lost to Follow-up|0
2248635|NCT02000115|3910501|FG003|Overall Study|Lost to Follow-up|0
2248636|NCT02000115|3910498|FG000|Overall Study|Non-compliance|2
2248637|NCT02000115|3910499|FG001|Overall Study|Non-compliance|1
2248638|NCT02000115|3910500|FG002|Overall Study|Non-compliance|0
2248639|NCT02000115|3910501|FG003|Overall Study|Non-compliance|0
2248640|NCT02000115|3910498|FG000|Overall Study|Withdrawn on day of randomization|0
2248641|NCT02000115|3910499|FG001|Overall Study|Withdrawn on day of randomization|1
2248642|NCT02000115|3910500|FG002|Overall Study|Withdrawn on day of randomization|0
2248643|NCT02000115|3910501|FG003|Overall Study|Withdrawn on day of randomization|0
2248644|NCT02000115|3910498|FG000|Overall Study|Still on Study|0
2248645|NCT02000115|3910499|FG001|Overall Study|Still on Study|0
2248646|NCT02000115|3910500|FG002|Overall Study|Still on Study|0
2248647|NCT02000115|3910501|FG003|Overall Study|Still on Study|53
2248648|NCT02000440|3910523|FG000|Overall Study|Adverse Event|3
2248649|NCT02000440|3910523|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1
2248650|NCT02000531|3910529|FG000|Overall Study|Lost to Follow-up|1
2248651|NCT02000531|3910530|FG001|Overall Study|Lost to Follow-up|0
2248652|NCT02000531|3910529|FG000|Overall Study|Discontinued due to data cut-off|3
2248653|NCT02000531|3910530|FG001|Overall Study|Discontinued due to data cut-off|8
2248654|NCT02000622|3910547|FG000|Overall Study|Withdrawal by Subject|5
2248655|NCT02000622|3910548|FG001|Overall Study|Withdrawal by Subject|7
2248656|NCT02000622|3910547|FG000|Overall Study|Lost to Follow-up|4
2248657|NCT02000622|3910548|FG001|Overall Study|Lost to Follow-up|0
2248658|NCT02000622|3910547|FG000|Overall Study|Death|159
2340386|NCT03410056|4071063|FG001|Overall Study|Withdrawal by Subject|2
2340387|NCT03410056|4071064|FG002|Overall Study|Withdrawal by Subject|5
2340388|NCT03410056|4071065|FG003|Overall Study|Withdrawal by Subject|5
2340389|NCT03410056|4071066|FG004|Overall Study|Withdrawal by Subject|0
2340390|NCT03410056|4071067|FG005|Overall Study|Withdrawal by Subject|0
2340391|NCT03410056|4071068|FG006|Overall Study|Withdrawal by Subject|0
2340392|NCT03411902|4071112|FG000|Overall Study|Lost to Follow-up|3
2340393|NCT03411902|4071113|FG001|Overall Study|Lost to Follow-up|0
2340394|NCT03412019|4071121|FG000|Overall Study|Withdrawal by Subject|1
2340395|NCT03412019|4071122|FG001|Overall Study|Withdrawal by Subject|1
2340396|NCT03412084|4071130|FG000|Overall Study|Withdrawal by Subject|2
2340397|NCT03412084|4071131|FG001|Overall Study|Withdrawal by Subject|0
2340398|NCT03412084|4071130|FG000|Overall Study|Participant moved|1
2340399|NCT03412084|4071131|FG001|Overall Study|Participant moved|0
2340400|NCT03412084|4071130|FG000|Overall Study|Lost to Follow-up|1
2340401|NCT03412084|4071131|FG001|Overall Study|Lost to Follow-up|1
2340402|NCT03412734|4071139|FG000|Overall Study|Incorrect labeling of samples|2
2340403|NCT03412734|4071140|FG001|Overall Study|Incorrect labeling of samples|0
2340404|NCT03412734|4071139|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1
2340405|NCT03412734|4071140|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0
2340406|NCT03412929|4071146|FG000|Overall Study|Protocol Violation|3
2340407|NCT03414047|4071163|FG000|Overall Study|Adverse Event|0
2340408|NCT03414047|4071164|FG001|Overall Study|Adverse Event|0
2340409|NCT03414047|4071165|FG002|Overall Study|Adverse Event|1
2340410|NCT03414047|4071166|FG003|Overall Study|Adverse Event|1
2340411|NCT03414047|4071163|FG000|Overall Study|Physician Decision|1
2340412|NCT03414047|4071164|FG001|Overall Study|Physician Decision|0
2340413|NCT03414047|4071165|FG002|Overall Study|Physician Decision|0
2340414|NCT03414047|4071166|FG003|Overall Study|Physician Decision|1
2038231|NCT00421993|3608574|FG000|Overall Study|Lost to Follow-up|18
2248659|NCT02000622|3910548|FG001|Overall Study|Death|73
2248660|NCT02000622|3910547|FG000|Overall Study|Withdrawn due to site closure|1
2248661|NCT02000622|3910548|FG001|Overall Study|Withdrawn due to site closure|0
2248662|NCT02000752|3910556|FG000|Overall Study|Dystocic delivery|19
2248663|NCT02000752|3910557|FG001|Overall Study|Dystocic delivery|8
2248664|NCT02000752|3910556|FG000|Overall Study|Shift Changes|12
2248665|NCT02000752|3910557|FG001|Overall Study|Shift Changes|5
2248666|NCT02000817|3910567|FG000|Overall Study|Withdrawal by Subject|2
2248667|NCT02000817|3910568|FG001|Overall Study|Withdrawal by Subject|0
2248668|NCT02000817|3910569|FG002|Overall Study|Withdrawal by Subject|0
2248669|NCT02000817|3910570|FG003|Overall Study|Withdrawal by Subject|0
2248670|NCT02000817|3910567|FG000|Overall Study|Adverse Event|0
2248671|NCT02000817|3910568|FG001|Overall Study|Adverse Event|1
2248672|NCT02000817|3910569|FG002|Overall Study|Adverse Event|0
2248673|NCT02000817|3910570|FG003|Overall Study|Adverse Event|0
2248674|NCT02000817|3910567|FG000|Overall Study|Lost to Follow-up|0
2248675|NCT02000817|3910568|FG001|Overall Study|Lost to Follow-up|0
2248676|NCT02000817|3910569|FG002|Overall Study|Lost to Follow-up|1
2248677|NCT02000817|3910570|FG003|Overall Study|Lost to Follow-up|0
2248678|NCT02000921|3910595|FG000|Overall Study|Withdrawal by Subject|3
2248679|NCT02000921|3910596|FG001|Overall Study|Withdrawal by Subject|10
2248680|NCT02000921|3910597|FG002|Overall Study|Withdrawal by Subject|5
2248681|NCT02000921|3910595|FG000|Overall Study|Lost to Follow-up|2
2248682|NCT02000921|3910596|FG001|Overall Study|Lost to Follow-up|4
2248683|NCT02000921|3910597|FG002|Overall Study|Lost to Follow-up|5
2248684|NCT02000921|3910595|FG000|Overall Study|Physician Decision|0
2248685|NCT02000921|3910596|FG001|Overall Study|Physician Decision|2
2248686|NCT02000921|3910597|FG002|Overall Study|Physician Decision|0
2248687|NCT02001051|3910624|FG000|Overall Study|Deemed not eligible following enrollment|0
2248688|NCT02001051|3910625|FG001|Overall Study|Deemed not eligible following enrollment|1
2248689|NCT02001064|3910633|FG000|Overall Study|Withdrawal by Subject|2
2248690|NCT02001064|3910634|FG001|Overall Study|Withdrawal by Subject|1
2340415|NCT03414047|4071163|FG000|Overall Study|Withdrawal by Subject|1
2340416|NCT03414047|4071164|FG001|Overall Study|Withdrawal by Subject|0
2340417|NCT03414047|4071165|FG002|Overall Study|Withdrawal by Subject|2
2340418|NCT03414047|4071166|FG003|Overall Study|Withdrawal by Subject|0
2340419|NCT03414359|4071179|FG000|Overall Study|Lack of Efficacy|1
2340420|NCT03414359|4071180|FG001|Overall Study|Lack of Efficacy|1
2340421|NCT03414359|4071179|FG000|Overall Study|Protocol Violation|0
2340422|NCT03414359|4071180|FG001|Overall Study|Protocol Violation|1
2340423|NCT03415178|4071195|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
2340424|NCT03415178|4071196|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
2340425|NCT03415178|4071195|FG000|Single Arm Period (up to Week 16)|Adverse Event|0
2340426|NCT03415178|4071196|FG001|Single Arm Period (up to Week 16)|Adverse Event|1
2340427|NCT03416127|4071229|FG000|Overall Study|Withdrawal by Subject|0
2340428|NCT03416127|4071230|FG001|Overall Study|Withdrawal by Subject|1
2340429|NCT03416127|4071231|FG002|Overall Study|Withdrawal by Subject|1
2340430|NCT03417024|4071280|FG000|Overall Study|Study Termination prior to follow-up|11
2340431|NCT03417024|4071280|FG000|Overall Study|Physician Decision|2
2340432|NCT03417141|4071284|FG000|Overall Study|Withdrawal by Subject|1
2340433|NCT03417141|4071284|FG000|Overall Study|Protocol Violation|3
2038232|NCT00421993|3608575|FG001|Overall Study|Lost to Follow-up|19
2038233|NCT00421993|3608576|FG002|Overall Study|Lost to Follow-up|22
2038234|NCT00421993|3608577|FG003|Overall Study|Lost to Follow-up|20
2038235|NCT00421993|3608574|FG000|Overall Study|Adverse Event|11
2038236|NCT00421993|3608575|FG001|Overall Study|Adverse Event|1
2038237|NCT00421993|3608576|FG002|Overall Study|Adverse Event|6
2038238|NCT00421993|3608577|FG003|Overall Study|Adverse Event|4
2038239|NCT00421993|3608574|FG000|Overall Study|Protocol Violation|2
2038240|NCT00421993|3608575|FG001|Overall Study|Protocol Violation|2
2038241|NCT00421993|3608576|FG002|Overall Study|Protocol Violation|0
2038242|NCT00421993|3608577|FG003|Overall Study|Protocol Violation|1
2038243|NCT00421993|3608574|FG000|Overall Study|Lack of Efficacy|0
2038244|NCT00421993|3608575|FG001|Overall Study|Lack of Efficacy|3
2038245|NCT00421993|3608576|FG002|Overall Study|Lack of Efficacy|0
2038246|NCT00421993|3608577|FG003|Overall Study|Lack of Efficacy|5
2038247|NCT00421993|3608574|FG000|Overall Study|Pregnancy|0
2038248|NCT00421993|3608575|FG001|Overall Study|Pregnancy|1
2038249|NCT00421993|3608576|FG002|Overall Study|Pregnancy|1
2038250|NCT00421993|3608577|FG003|Overall Study|Pregnancy|2
2038251|NCT00421993|3608574|FG000|Overall Study|Subject transportation issues|0
2038252|NCT00421993|3608575|FG001|Overall Study|Subject transportation issues|0
2340434|NCT03417219|4071290|FG000|Overall Study|Lost to Follow-up|0
2340435|NCT03417219|4071291|FG001|Overall Study|Lost to Follow-up|3
2340436|NCT03417505|4071301|FG000|First Lens Type (30 Days)|Lost to Follow-up|1
2340437|NCT03417505|4071302|FG001|First Lens Type (30 Days)|Lost to Follow-up|1
2340438|NCT03417830|4071352|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1
2340439|NCT03417830|4071353|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0
2340440|NCT03418324|4071390|FG000|Overall Study|Death|0
2340441|NCT03418324|4071391|FG001|Overall Study|Death|1
2340442|NCT03418324|4071390|FG000|Overall Study|Physician Decision|1
2340443|NCT03418324|4071391|FG001|Overall Study|Physician Decision|1
2340444|NCT03418376|4071401|FG000|Overall Study|Musculoskeletal injury|1
2340445|NCT03418376|4071402|FG001|Overall Study|Musculoskeletal injury|2
2340446|NCT03418376|4071403|FG002|Overall Study|Musculoskeletal injury|1
2340447|NCT03418376|4071404|FG003|Overall Study|Musculoskeletal injury|0
2340448|NCT03418376|4071401|FG000|Overall Study|Personal reasons|0
2340449|NCT03418376|4071402|FG001|Overall Study|Personal reasons|2
2340450|NCT03418376|4071403|FG002|Overall Study|Personal reasons|2
2340451|NCT03418376|4071404|FG003|Overall Study|Personal reasons|1
2340452|NCT03418376|4071401|FG000|Overall Study|Exacerbation|0
2340453|NCT03418376|4071402|FG001|Overall Study|Exacerbation|1
2340454|NCT03418376|4071403|FG002|Overall Study|Exacerbation|0
2038253|NCT00421993|3608576|FG002|Overall Study|Subject transportation issues|0
2248691|NCT02001181|3910642|FG000|Overall Study|Adverse Event|0
2248692|NCT02001181|3910643|FG001|Overall Study|Adverse Event|2
2248693|NCT02001181|3910642|FG000|Overall Study|Lost to Follow-up|1
2248694|NCT02001181|3910643|FG001|Overall Study|Lost to Follow-up|0
2248695|NCT02001181|3910642|FG000|Overall Study|Withdrawal by Subject|0
2248696|NCT02001181|3910643|FG001|Overall Study|Withdrawal by Subject|1
2248697|NCT02001194|3910653|FG000|Intervention Period (13 Weeks)|No longer interested|1
2248698|NCT02001194|3910654|FG001|Intervention Period (13 Weeks)|No longer interested|0
2248699|NCT02001194|3910655|FG002|Intervention Period (13 Weeks)|No longer interested|2
2248700|NCT02001194|3910656|FG003|Intervention Period (13 Weeks)|No longer interested|2
2248701|NCT02001194|3910653|FG000|Follow-Up Period (13 Weeks)|No longer interested|3
2248702|NCT02001194|3910654|FG001|Follow-Up Period (13 Weeks)|No longer interested|2
2248703|NCT02001194|3910655|FG002|Follow-Up Period (13 Weeks)|No longer interested|1
2248704|NCT02001194|3910656|FG003|Follow-Up Period (13 Weeks)|No longer interested|0
2248705|NCT02001558|3910668|FG000|Overall Study|Lost to Follow-up|8
2248706|NCT02001558|3910669|FG001|Overall Study|Lost to Follow-up|14
2248707|NCT02001688|3910678|FG000|Overall Study|Withdrawal by Subject|0
2248708|NCT02001688|3910679|FG001|Overall Study|Withdrawal by Subject|0
2248709|NCT02001688|3910680|FG002|Overall Study|Withdrawal by Subject|1
2248710|NCT02001688|3910678|FG000|Overall Study|Adverse Event|0
2248711|NCT02001688|3910679|FG001|Overall Study|Adverse Event|1
2248712|NCT02001688|3910680|FG002|Overall Study|Adverse Event|0
2248713|NCT02001987|3910698|FG000|Core Study Period (24 Weeks)|Adverse Event|9
2248714|NCT02001987|3910698|FG000|Core Study Period (24 Weeks)|Death|1
2248715|NCT02001987|3910698|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
2248716|NCT02001987|3910698|FG000|Core Study Period (24 Weeks)|Physician Decision|1
2248717|NCT02001987|3910698|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4
2248718|NCT02001987|3910698|FG000|Core Study Period (24 Weeks)|Protocol Violation|3
2248719|NCT02001987|3910698|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3
2248720|NCT02001987|3910698|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2
2248721|NCT02001987|3910698|FG000|LTE Period (52 Weeks)|Physician Decision|2
2248722|NCT02001987|3910698|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1
2248723|NCT02001987|3910698|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1
2248724|NCT02001987|3910698|FG000|LTE Period (52 Weeks)|Other|3
2248725|NCT02002091|3910709|FG000|Screening|Lost to Follow-up|10
2248726|NCT02002091|3910710|FG001|Screening|Lost to Follow-up|12
2248727|NCT02002091|3910709|FG000|Screening|Death|3
2248728|NCT02002091|3910710|FG001|Screening|Death|2
2248729|NCT02002182|3910747|FG000|Overall Study|Withdraw from study|3
2248730|NCT02002182|3910748|FG001|Overall Study|Withdraw from study|1
2248731|NCT02002182|3910747|FG000|Overall Study|Health Reasons|1
2248732|NCT02002182|3910748|FG001|Overall Study|Health Reasons|0
2248733|NCT02002182|3910747|FG000|Overall Study|Death|1
2248734|NCT02002182|3910748|FG001|Overall Study|Death|0
2248735|NCT02002221|3910765|FG000|Overall Study|Adverse Event|2
2248736|NCT02002221|3910766|FG001|Overall Study|Adverse Event|1
2248737|NCT02002221|3910765|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2248738|NCT02002221|3910766|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2248739|NCT02002221|3910765|FG000|Overall Study|Patient withdrew consent|0
2248740|NCT02002221|3910766|FG001|Overall Study|Patient withdrew consent|1
2248741|NCT02002533|3910789|FG000|Overall Study|Withdrawal by Subject|6
2248742|NCT02002533|3910790|FG001|Overall Study|Withdrawal by Subject|13
2248743|NCT02002533|3910789|FG000|Overall Study|Protocol Violation|0
2248744|NCT02002533|3910790|FG001|Overall Study|Protocol Violation|1
2248745|NCT02002533|3910789|FG000|Overall Study|Adverse Event|0
2248746|NCT02002533|3910790|FG001|Overall Study|Adverse Event|3
2248747|NCT02002533|3910789|FG000|Overall Study|Lost to Follow-up|0
2248748|NCT02002533|3910790|FG001|Overall Study|Lost to Follow-up|1
2248749|NCT02002689|3910807|FG000|Overall Study|Disease Progression|7
2248750|NCT02002689|3910807|FG000|Overall Study|Adverse Event|3
2248751|NCT02002884|3910851|FG000|Main Period (MP)|Other|0
2248752|NCT02002884|3910852|FG001|Main Period (MP)|Other|3
2248753|NCT02002884|3910853|FG002|Main Period (MP)|Other|3
2248754|NCT02002884|3910854|FG003|Main Period (MP)|Other|0
2248755|NCT02002884|3910851|FG000|Main Period (MP)|Adverse Event|0
2248756|NCT02002884|3910852|FG001|Main Period (MP)|Adverse Event|1
2248757|NCT02002884|3910853|FG002|Main Period (MP)|Adverse Event|1
2248758|NCT02002884|3910854|FG003|Main Period (MP)|Adverse Event|0
2248759|NCT02002884|3910851|FG000|Main Period (MP)|Withdrawal by Subject|6
2248760|NCT02002884|3910852|FG001|Main Period (MP)|Withdrawal by Subject|2
2248761|NCT02002884|3910853|FG002|Main Period (MP)|Withdrawal by Subject|2
2248762|NCT02002884|3910854|FG003|Main Period (MP)|Withdrawal by Subject|0
2248763|NCT02002884|3910851|FG000|Main Period (MP)|Lost to Follow-up|0
2248764|NCT02002884|3910852|FG001|Main Period (MP)|Lost to Follow-up|0
2248765|NCT02002884|3910853|FG002|Main Period (MP)|Lost to Follow-up|2
2248766|NCT02002884|3910854|FG003|Main Period (MP)|Lost to Follow-up|0
2248767|NCT02002884|3910851|FG000|Open-Label Extension Period (OLEX)|Other|0
2248768|NCT02002884|3910852|FG001|Open-Label Extension Period (OLEX)|Other|0
2248769|NCT02002884|3910853|FG002|Open-Label Extension Period (OLEX)|Other|0
2248770|NCT02002884|3910854|FG003|Open-Label Extension Period (OLEX)|Other|24
2248771|NCT02002884|3910851|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0
2248772|NCT02002884|3910852|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0
2248773|NCT02002884|3910853|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0
2340455|NCT03418376|4071404|FG003|Overall Study|Exacerbation|0
2340456|NCT03418545|4071416|FG000|Overall Study|Withdrawal by Participant|2
2340457|NCT03418545|4071417|FG001|Overall Study|Withdrawal by Participant|4
2340458|NCT03418545|4071416|FG000|Overall Study|Lost to Follow-up|3
2340459|NCT03418545|4071417|FG001|Overall Study|Lost to Follow-up|5
2340460|NCT03418545|4071416|FG000|Overall Study|Reason Not Specified|0
2340461|NCT03418545|4071417|FG001|Overall Study|Reason Not Specified|1
2340462|NCT03418545|4071416|FG000|Overall Study|Missing Completion Status|0
2340463|NCT03418545|4071417|FG001|Overall Study|Missing Completion Status|1
2340464|NCT03418571|4071428|FG000|Overall Study|Consent withdrawn by legal guardian|1
2340465|NCT03418571|4071429|FG001|Overall Study|Consent withdrawn by legal guardian|0
2340466|NCT03419403|4071464|FG000|Overall Study|Withdrawal by Subject|5
2340467|NCT03419403|4071465|FG001|Overall Study|Withdrawal by Subject|2
2340468|NCT03419403|4071466|FG002|Overall Study|Withdrawal by Subject|5
2340469|NCT03419403|4071467|FG003|Overall Study|Withdrawal by Subject|1
2340470|NCT03419403|4071464|FG000|Overall Study|Progressive disease (per protocol)|0
2340471|NCT03419403|4071465|FG001|Overall Study|Progressive disease (per protocol)|2
2340472|NCT03419403|4071466|FG002|Overall Study|Progressive disease (per protocol)|2
2340473|NCT03419403|4071467|FG003|Overall Study|Progressive disease (per protocol)|0
2340474|NCT03419403|4071464|FG000|Overall Study|Other, not specified|6
2340475|NCT03419403|4071465|FG001|Overall Study|Other, not specified|4
2340476|NCT03419403|4071466|FG002|Overall Study|Other, not specified|5
2340477|NCT03419403|4071467|FG003|Overall Study|Other, not specified|1
2340478|NCT03419403|4071464|FG000|Overall Study|Left study due to COVID-19 restrictions|1
2340479|NCT03419403|4071465|FG001|Overall Study|Left study due to COVID-19 restrictions|1
2340480|NCT03419403|4071466|FG002|Overall Study|Left study due to COVID-19 restrictions|0
2340481|NCT03419403|4071467|FG003|Overall Study|Left study due to COVID-19 restrictions|0
2340482|NCT03419598|4071492|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2
2340483|NCT03419962|4071507|FG000|Overall Study|Change to other medication|1
2340484|NCT03419962|4071507|FG000|Overall Study|Refusal of continuing with trial drug|1
2340485|NCT03419962|4071507|FG000|Overall Study|Lost to Follow-up|3
2340486|NCT03419962|4071507|FG000|Overall Study|Difficulty in inhaling the doses|1
2340487|NCT03419962|4071507|FG000|Overall Study|Missing completion data|31
2340488|NCT03420300|4071511|FG000|Overall Study|Death|2
2340489|NCT03421379|4071554|FG000|Period 1|Withdrawal by Subject|0
2340490|NCT03421379|4071555|FG001|Period 1|Withdrawal by Subject|1
2340491|NCT03421379|4071554|FG000|Period 1|Physician Decision|1
2340492|NCT03421379|4071555|FG001|Period 1|Physician Decision|1
2340493|NCT03421379|4071554|FG000|Period 1|Did not receive treatment|1
2340494|NCT03421379|4071555|FG001|Period 1|Did not receive treatment|2
2340495|NCT03421431|4071564|FG000|Overall Study|Adverse Event|2
2340496|NCT03421431|4071565|FG001|Overall Study|Adverse Event|1
2340497|NCT03421431|4071566|FG002|Overall Study|Adverse Event|12
2340498|NCT03421431|4071564|FG000|Overall Study|Lost to Follow-up|1
2340499|NCT03421431|4071565|FG001|Overall Study|Lost to Follow-up|1
2340500|NCT03421431|4071566|FG002|Overall Study|Lost to Follow-up|1
2340501|NCT03421431|4071564|FG000|Overall Study|Withdrawal by Subject|3
2340502|NCT03421431|4071565|FG001|Overall Study|Withdrawal by Subject|2
2340503|NCT03421431|4071566|FG002|Overall Study|Withdrawal by Subject|1
2340504|NCT03421431|4071564|FG000|Overall Study|Protocol Violation|0
2340505|NCT03421431|4071565|FG001|Overall Study|Protocol Violation|1
2340506|NCT03421431|4071566|FG002|Overall Study|Protocol Violation|0
2340507|NCT03421431|4071564|FG000|Overall Study|Participant met Stopping Rules|0
2340508|NCT03421431|4071565|FG001|Overall Study|Participant met Stopping Rules|1
2340509|NCT03421431|4071566|FG002|Overall Study|Participant met Stopping Rules|0
2340510|NCT03421730|4071576|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2340511|NCT03421730|4071577|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
2340512|NCT03421730|4071578|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2340513|NCT03421730|4071579|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2340514|NCT03421730|4071580|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2340515|NCT03421730|4071581|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2340516|NCT03421730|4071582|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2340517|NCT03421730|4071583|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2340518|NCT03421730|4071584|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2340519|NCT03421730|4071585|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2340520|NCT03421730|4071586|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2340521|NCT03421730|4071587|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2340522|NCT03421730|4071576|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2340523|NCT03421730|4071577|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2340524|NCT03421730|4071578|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2340525|NCT03421730|4071579|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2340526|NCT03421730|4071580|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
2353161|NCT02966223|4104490|FG000|Overall Study|Withdrawal by Subject|11
2248774|NCT02002884|3910854|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1
2248775|NCT02002884|3910851|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0
2248776|NCT02002884|3910852|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0
2248777|NCT02002884|3910853|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0
2248778|NCT02002884|3910854|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5
2248779|NCT02002884|3910851|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
2248780|NCT02002884|3910852|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
2248781|NCT02002884|3910853|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
2248782|NCT02002884|3910854|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10
2248783|NCT02002884|3910851|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
2248784|NCT02002884|3910852|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
2248785|NCT02002884|3910853|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
2248786|NCT02002884|3910854|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10
2248787|NCT02002975|3910868|FG000|Overall Study|Case Report Forms Uncollected|135
2248788|NCT02002975|3910868|FG000|Overall Study|Protocol Deviation|437
2248789|NCT02003014|3910872|FG000|Overall Study|Case report forms uncollected|9
2248790|NCT02003014|3910872|FG000|Overall Study|Treatment started after contract period|1
2248791|NCT02003014|3910872|FG000|Overall Study|Patient did not visit the study site|5
2248792|NCT02003014|3910872|FG000|Overall Study|Investigator's transfer|4
2248793|NCT02003183|3910887|FG000|Overall Study|Lost to Follow-up|0
2248794|NCT02003183|3910888|FG001|Overall Study|Lost to Follow-up|2
2248795|NCT02003365|3910901|FG000|Overall Study|Lost to Follow-up|0
2248796|NCT02003365|3910902|FG001|Overall Study|Lost to Follow-up|0
2248797|NCT02003365|3910903|FG002|Overall Study|Lost to Follow-up|1
2248798|NCT02003391|3910913|FG000|Overall Study|Withdrawal by Subject|2
2248799|NCT02003391|3910914|FG001|Overall Study|Withdrawal by Subject|1
2248800|NCT02003391|3910913|FG000|Overall Study|Protocol Violation|0
2248801|NCT02003391|3910914|FG001|Overall Study|Protocol Violation|1
2248802|NCT02003391|3910913|FG000|Overall Study|Adverse Event|1
2340527|NCT03421730|4071581|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2340528|NCT03421730|4071582|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2340529|NCT03421730|4071583|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2340530|NCT03421730|4071584|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2340531|NCT03421730|4071585|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2340532|NCT03421730|4071586|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2340533|NCT03421730|4071587|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2340534|NCT03422159|4071612|FG000|Overall Study|Exclusion due to terminal disease|2
2340535|NCT03422159|4071613|FG001|Overall Study|Exclusion due to terminal disease|1
2340536|NCT03422172|4071621|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1
2340537|NCT03422172|4071621|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1
2340538|NCT03422172|4071621|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3
2340539|NCT03422250|4071634|FG000|Intervention|Adverse Event|0
2340540|NCT03422250|4071635|FG001|Intervention|Adverse Event|1
2340541|NCT03422250|4071636|FG002|Intervention|Adverse Event|0
2340542|NCT03422250|4071637|FG003|Intervention|Adverse Event|1
2340543|NCT03422250|4071634|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1
2340544|NCT03422250|4071635|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
2340545|NCT03422250|4071636|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2
2340546|NCT03422250|4071637|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
2340547|NCT03422250|4071634|FG000|Follow-up|Withdrawal by Subject|0
2340548|NCT03422250|4071635|FG001|Follow-up|Withdrawal by Subject|0
2340549|NCT03422250|4071636|FG002|Follow-up|Withdrawal by Subject|0
2340550|NCT03422250|4071637|FG003|Follow-up|Withdrawal by Subject|1
2340551|NCT03422250|4071634|FG000|Follow-up|Adverse Event|0
2340552|NCT03422250|4071635|FG001|Follow-up|Adverse Event|0
2340553|NCT03422250|4071636|FG002|Follow-up|Adverse Event|0
2340554|NCT03422250|4071637|FG003|Follow-up|Adverse Event|1
2340555|NCT03423173|4071657|FG000|Overall Study|Randomized but not vaccinated|1
2340556|NCT03423173|4071658|FG001|Overall Study|Randomized but not vaccinated|0
2340557|NCT03423173|4071659|FG002|Overall Study|Randomized but not vaccinated|2
2340558|NCT03423173|4071660|FG003|Overall Study|Randomized but not vaccinated|1
2340559|NCT03423173|4071657|FG000|Overall Study|Adverse Event|1
2340560|NCT03423173|4071658|FG001|Overall Study|Adverse Event|1
2340561|NCT03423173|4071659|FG002|Overall Study|Adverse Event|1
2340562|NCT03423173|4071660|FG003|Overall Study|Adverse Event|1
2340563|NCT03423173|4071657|FG000|Overall Study|Lost to Follow-up|10
2340564|NCT03423173|4071658|FG001|Overall Study|Lost to Follow-up|19
2340565|NCT03423173|4071659|FG002|Overall Study|Lost to Follow-up|17
2340566|NCT03423173|4071660|FG003|Overall Study|Lost to Follow-up|22
2340567|NCT03423173|4071657|FG000|Overall Study|Withdrawal of consent|4
2340568|NCT03423173|4071658|FG001|Overall Study|Withdrawal of consent|10
2340569|NCT03423173|4071659|FG002|Overall Study|Withdrawal of consent|4
2340570|NCT03423173|4071660|FG003|Overall Study|Withdrawal of consent|5
2340571|NCT03423173|4071657|FG000|Overall Study|Death|1
2340572|NCT03423173|4071658|FG001|Overall Study|Death|0
2340573|NCT03423173|4071659|FG002|Overall Study|Death|0
2340574|NCT03423173|4071660|FG003|Overall Study|Death|0
2340575|NCT03423173|4071657|FG000|Overall Study|Reason not Specified|2
2248803|NCT02003391|3910914|FG001|Overall Study|Adverse Event|0
2248804|NCT02003534|3910935|FG000|Overall Study|Lost to Follow-up|47
2248805|NCT02003573|3910942|FG000|Overall Study|Progressive disease|2
2248806|NCT02003573|3910943|FG001|Overall Study|Progressive disease|0
2248807|NCT02003573|3910944|FG002|Overall Study|Progressive disease|1
2248808|NCT02003573|3910942|FG000|Overall Study|Other Adverse event|0
2248809|NCT02003573|3910943|FG001|Overall Study|Other Adverse event|1
2248810|NCT02003573|3910944|FG002|Overall Study|Other Adverse event|1
2248811|NCT02003573|3910942|FG000|Overall Study|Refuse to take trial medication|0
2248812|NCT02003573|3910943|FG001|Overall Study|Refuse to take trial medication|1
2248813|NCT02003573|3910944|FG002|Overall Study|Refuse to take trial medication|1
2248814|NCT02003573|3910942|FG000|Overall Study|Other than specified|1
2248815|NCT02003573|3910943|FG001|Overall Study|Other than specified|2
2248816|NCT02003573|3910944|FG002|Overall Study|Other than specified|3
2248817|NCT02003638|3910965|FG000|Overall Study|Withdrawal by Subject|1
2248818|NCT02003638|3910966|FG001|Overall Study|Withdrawal by Subject|0
2248819|NCT02003898|3910972|FG000|Overall Study|Death|3
2248820|NCT02003898|3910972|FG000|Overall Study|Lost to Follow-up|12
2248821|NCT02003898|3910972|FG000|Overall Study|Withdrawal by Subject|52
2248822|NCT02003963|3910987|FG000|Overall Study|Lost to Follow-up|2
2248823|NCT02003963|3910988|FG001|Overall Study|Lost to Follow-up|1
2248824|NCT02004093|3910998|FG000|Overall Study|Death|2
2248825|NCT02004093|3910999|FG001|Overall Study|Death|1
2248826|NCT02004093|3910998|FG000|Overall Study|Lack of Efficacy|66
2248827|NCT02004093|3910999|FG001|Overall Study|Lack of Efficacy|62
2248828|NCT02004093|3910998|FG000|Overall Study|Protocol Violation|0
2248829|NCT02004093|3910999|FG001|Overall Study|Protocol Violation|1
2248830|NCT02004093|3910998|FG000|Overall Study|Lost to Follow-up|0
2248831|NCT02004093|3910999|FG001|Overall Study|Lost to Follow-up|1
2248832|NCT02004093|3910998|FG000|Overall Study|Withdrawal by Subject|3
2248833|NCT02004093|3910999|FG001|Overall Study|Withdrawal by Subject|7
2248834|NCT02004093|3910998|FG000|Overall Study|Other|3
2248835|NCT02004093|3910999|FG001|Overall Study|Other|1
2248836|NCT02004236|3911021|FG000|Overall Study|Lack of Efficacy|0
2248837|NCT02004236|3911022|FG001|Overall Study|Lack of Efficacy|0
2248838|NCT02004236|3911023|FG002|Overall Study|Lack of Efficacy|16
2248839|NCT02004262|3911038|FG000|Overall Study|Death|67
2248840|NCT02004262|3911039|FG001|Overall Study|Death|64
2248841|NCT02004262|3911040|FG002|Overall Study|Death|66
2248842|NCT02004262|3911041|FG003|Overall Study|Death|28
2248843|NCT02004262|3911042|FG004|Overall Study|Death|29
2248844|NCT02004262|3911043|FG005|Overall Study|Death|22
2248845|NCT02004262|3911038|FG000|Overall Study|Withdrawal by Subject|1
2248846|NCT02004262|3911039|FG001|Overall Study|Withdrawal by Subject|0
2340576|NCT03423173|4071658|FG001|Overall Study|Reason not Specified|5
2340577|NCT03423173|4071659|FG002|Overall Study|Reason not Specified|3
2340578|NCT03423173|4071660|FG003|Overall Study|Reason not Specified|1
2340579|NCT03423238|4071681|FG000|Overall Study|Lost to Follow-up|1
2340580|NCT03423238|4071682|FG001|Overall Study|Lost to Follow-up|0
2340581|NCT03423238|4071681|FG000|Overall Study|Withdrawal by Subject|1
2340582|NCT03423238|4071682|FG001|Overall Study|Withdrawal by Subject|0
2340583|NCT03424044|4071698|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2340584|NCT03424044|4071699|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2340585|NCT03424044|4071700|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
2340586|NCT03424044|4071701|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2340587|NCT03424044|4071702|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2340588|NCT03424044|4071703|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2340589|NCT03424044|4071704|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2340590|NCT03424044|4071705|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2340591|NCT03424044|4071706|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2340592|NCT03424044|4071698|FG000|First Intervention (76 Hours)|Adverse Event|0
2340593|NCT03424044|4071699|FG001|First Intervention (76 Hours)|Adverse Event|0
2340594|NCT03424044|4071700|FG002|First Intervention (76 Hours)|Adverse Event|0
2340595|NCT03424044|4071701|FG003|First Intervention (76 Hours)|Adverse Event|0
2340596|NCT03424044|4071702|FG004|First Intervention (76 Hours)|Adverse Event|1
2038254|NCT00421993|3608577|FG003|Overall Study|Subject transportation issues|1
2038255|NCT00422058|3608602|FG000|Double-Blind, Week 0-20|Adverse Event|3
2038256|NCT00422058|3608603|FG001|Double-Blind, Week 0-20|Adverse Event|4
2038257|NCT00422058|3608604|FG002|Double-Blind, Week 0-20|Adverse Event|5
2038258|NCT00422058|3608605|FG003|Double-Blind, Week 0-20|Adverse Event|9
2038259|NCT00422058|3608606|FG004|Double-Blind, Week 0-20|Adverse Event|5
2038260|NCT00422058|3608607|FG005|Double-Blind, Week 0-20|Adverse Event|3
2038261|NCT00422058|3608602|FG000|Double-Blind, Week 0-20|Protocol Violation|3
2038262|NCT00422058|3608603|FG001|Double-Blind, Week 0-20|Protocol Violation|2
2038263|NCT00422058|3608604|FG002|Double-Blind, Week 0-20|Protocol Violation|2
2038264|NCT00422058|3608605|FG003|Double-Blind, Week 0-20|Protocol Violation|3
2038265|NCT00422058|3608606|FG004|Double-Blind, Week 0-20|Protocol Violation|2
2038266|NCT00422058|3608607|FG005|Double-Blind, Week 0-20|Protocol Violation|2
2248847|NCT02004262|3911040|FG002|Overall Study|Withdrawal by Subject|4
2248848|NCT02004262|3911041|FG003|Overall Study|Withdrawal by Subject|0
2248849|NCT02004262|3911042|FG004|Overall Study|Withdrawal by Subject|1
2248850|NCT02004262|3911043|FG005|Overall Study|Withdrawal by Subject|3
2248851|NCT02004262|3911038|FG000|Overall Study|Lost to Follow-up|1
2248852|NCT02004262|3911039|FG001|Overall Study|Lost to Follow-up|1
2248853|NCT02004262|3911040|FG002|Overall Study|Lost to Follow-up|0
2248854|NCT02004262|3911041|FG003|Overall Study|Lost to Follow-up|0
2248855|NCT02004262|3911042|FG004|Overall Study|Lost to Follow-up|0
2248856|NCT02004262|3911043|FG005|Overall Study|Lost to Follow-up|0
2248857|NCT02004262|3911038|FG000|Overall Study|Study Terminated by Sponsor|4
2248858|NCT02004262|3911039|FG001|Overall Study|Study Terminated by Sponsor|3
2248859|NCT02004262|3911040|FG002|Overall Study|Study Terminated by Sponsor|2
2248860|NCT02004262|3911041|FG003|Overall Study|Study Terminated by Sponsor|1
2248861|NCT02004262|3911042|FG004|Overall Study|Study Terminated by Sponsor|1
2248862|NCT02004262|3911043|FG005|Overall Study|Study Terminated by Sponsor|5
2248863|NCT02004353|3911066|FG000|Overall Study|Voluntary participation|1334
2248864|NCT02004847|3911103|FG000|Overall Study|Protocol Violation|1
2248865|NCT02004847|3911104|FG001|Overall Study|Protocol Violation|1
2248866|NCT02004873|3911119|FG000|Overall Study|Implant unsuccessful|6
2248867|NCT02004873|3911119|FG000|Overall Study|Awaiting 6-month visit|390
2248868|NCT02004873|3911119|FG000|Overall Study|Missed 6-month visit|4
2248869|NCT02004873|3911119|FG000|Overall Study|Death|23
2248870|NCT02004873|3911119|FG000|Overall Study|Withdrawal by Subject|1
2248871|NCT02004886|3911130|FG000|Overall Study|Adverse Event|0
2248872|NCT02004886|3911131|FG001|Overall Study|Adverse Event|1
2248873|NCT02004886|3911132|FG002|Overall Study|Adverse Event|0
2248874|NCT02004886|3911133|FG003|Overall Study|Adverse Event|0
2248875|NCT02004886|3911130|FG000|Overall Study|Unable to attend future visits|1
2248876|NCT02004886|3911131|FG001|Overall Study|Unable to attend future visits|0
2248877|NCT02004886|3911132|FG002|Overall Study|Unable to attend future visits|0
2248878|NCT02004886|3911133|FG003|Overall Study|Unable to attend future visits|0
2248879|NCT02005029|3911162|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1
2248880|NCT02005029|3911163|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0
2248881|NCT02005211|3911194|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2248882|NCT02005211|3911195|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2248883|NCT02005211|3911196|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2248884|NCT02005211|3911197|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2248885|NCT02005211|3911198|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
2248886|NCT02005211|3911199|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2248887|NCT02005211|3911200|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2248888|NCT02005250|3911225|FG000|Overall Study|Lost to Follow-up|15
2248889|NCT02005250|3911226|FG001|Overall Study|Lost to Follow-up|5
2248890|NCT02005276|3911236|FG000|Overall Study|No longer interested|5
2248891|NCT02005276|3911237|FG001|Overall Study|No longer interested|2
2248892|NCT02005276|3911238|FG002|Overall Study|No longer interested|3
2248893|NCT02005276|3911239|FG003|Overall Study|No longer interested|3
2248894|NCT02005484|3911264|FG000|Overall Study|Death|1
2248895|NCT02005484|3911264|FG000|Overall Study|Disease progression|1
2248896|NCT02005484|3911264|FG000|Overall Study|Changed to a Different Study|1
2340597|NCT03424044|4071703|FG005|First Intervention (76 Hours)|Adverse Event|0
2340598|NCT03424044|4071704|FG006|First Intervention (76 Hours)|Adverse Event|0
2340599|NCT03424044|4071705|FG007|First Intervention (76 Hours)|Adverse Event|0
2340600|NCT03424044|4071706|FG008|First Intervention (76 Hours)|Adverse Event|0
2340601|NCT03424044|4071698|FG000|First Intervention (76 Hours)|device issues|0
2340602|NCT03424044|4071699|FG001|First Intervention (76 Hours)|device issues|0
2340603|NCT03424044|4071700|FG002|First Intervention (76 Hours)|device issues|0
2340604|NCT03424044|4071701|FG003|First Intervention (76 Hours)|device issues|0
2340605|NCT03424044|4071702|FG004|First Intervention (76 Hours)|device issues|0
2340606|NCT03424044|4071703|FG005|First Intervention (76 Hours)|device issues|0
2340607|NCT03424044|4071704|FG006|First Intervention (76 Hours)|device issues|1
2340608|NCT03424044|4071705|FG007|First Intervention (76 Hours)|device issues|1
2340609|NCT03424044|4071706|FG008|First Intervention (76 Hours)|device issues|1
2340610|NCT03424044|4071698|FG000|Third Intervention (76 Hours)|Adverse Event|1
2340611|NCT03424044|4071699|FG001|Third Intervention (76 Hours)|Adverse Event|0
2340612|NCT03424044|4071700|FG002|Third Intervention (76 Hours)|Adverse Event|0
2340613|NCT03424044|4071701|FG003|Third Intervention (76 Hours)|Adverse Event|0
2340614|NCT03424044|4071702|FG004|Third Intervention (76 Hours)|Adverse Event|0
2340615|NCT03424044|4071703|FG005|Third Intervention (76 Hours)|Adverse Event|0
2340616|NCT03424044|4071704|FG006|Third Intervention (76 Hours)|Adverse Event|1
2340617|NCT03424044|4071705|FG007|Third Intervention (76 Hours)|Adverse Event|0
2340618|NCT03424044|4071706|FG008|Third Intervention (76 Hours)|Adverse Event|0
2340619|NCT03424044|4071698|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0
2340620|NCT03424044|4071699|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0
2340621|NCT03424044|4071700|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0
2340622|NCT03424044|4071701|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1
2340623|NCT03424044|4071702|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0
2340624|NCT03424044|4071703|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0
2340625|NCT03424044|4071704|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0
2340626|NCT03424044|4071705|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0
2038267|NCT00422058|3608602|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2
2248897|NCT02005484|3911264|FG000|Overall Study|Sponsor decision|1
2248898|NCT02005562|3911287|FG000|Overall Study|Death|2
2248899|NCT02005562|3911288|FG001|Overall Study|Death|2
2248900|NCT02005562|3911287|FG000|Overall Study|Graft loss|7
2248901|NCT02005562|3911288|FG001|Overall Study|Graft loss|6
2248902|NCT02005562|3911287|FG000|Overall Study|Withdrawal by Subject|2
2248903|NCT02005562|3911288|FG001|Overall Study|Withdrawal by Subject|2
2248904|NCT02005562|3911287|FG000|Overall Study|No transplant|1
2248905|NCT02005562|3911288|FG001|Overall Study|No transplant|4
2248906|NCT02005562|3911287|FG000|Overall Study|Physician Decision|0
2248907|NCT02005562|3911288|FG001|Overall Study|Physician Decision|1
2248908|NCT02005627|3911305|FG000|Overall Study|Lost to Follow-up|1
2248909|NCT02005627|3911306|FG001|Overall Study|Lost to Follow-up|2
2248910|NCT02005627|3911305|FG000|Overall Study|Withdrawal by Subject|1
2248911|NCT02005627|3911306|FG001|Overall Study|Withdrawal by Subject|2
2248912|NCT02005692|3911326|FG000|Overall Study|Protocol Violation|1
2248913|NCT02005692|3911326|FG000|Overall Study|Withdrawal by Subject|1
2248914|NCT02005692|3911326|FG000|Overall Study|Discharged earlier than anticipated|5
2248915|NCT02005887|3911333|FG000|Overall Study|Protocol Violation|0
2248916|NCT02005887|3911334|FG001|Overall Study|Protocol Violation|2
2248917|NCT02006121|3911355|FG000|Double Blind Phase|Adverse Event|6
2248918|NCT02006121|3911356|FG001|Double Blind Phase|Adverse Event|0
2248919|NCT02006121|3911355|FG000|Double Blind Phase|Lack of Efficacy|1
2248920|NCT02006121|3911356|FG001|Double Blind Phase|Lack of Efficacy|16
2248921|NCT02006121|3911355|FG000|Double Blind Phase|Withdrawal by Subject|3
2248922|NCT02006121|3911356|FG001|Double Blind Phase|Withdrawal by Subject|4
2248923|NCT02006121|3911355|FG000|Double Blind Phase|Non-compliance with study drug|1
2248924|NCT02006121|3911356|FG001|Double Blind Phase|Non-compliance with study drug|3
2248925|NCT02006121|3911355|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1
2248926|NCT02006121|3911356|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0
2248927|NCT02006121|3911355|FG000|Double Blind Phase|Inconvenience of infusion system|0
2248928|NCT02006121|3911356|FG001|Double Blind Phase|Inconvenience of infusion system|1
2248929|NCT02006121|3911355|FG000|Open Label Phase|Adverse Event|15
2248930|NCT02006121|3911356|FG001|Open Label Phase|Adverse Event|0
2248931|NCT02006121|3911355|FG000|Open Label Phase|Lack of Efficacy|2
2248932|NCT02006121|3911356|FG001|Open Label Phase|Lack of Efficacy|0
2248933|NCT02006121|3911355|FG000|Open Label Phase|Protocol Violation|2
2248934|NCT02006121|3911356|FG001|Open Label Phase|Protocol Violation|0
2248935|NCT02006121|3911355|FG000|Open Label Phase|Withdrawal by Subject|3
2248936|NCT02006121|3911356|FG001|Open Label Phase|Withdrawal by Subject|0
2248937|NCT02006121|3911355|FG000|Open Label Phase|Non-compliance with study drug|3
2248938|NCT02006121|3911356|FG001|Open Label Phase|Non-compliance with study drug|0
2248939|NCT02006472|3911413|FG000|Period 1 (Through Week 26)|Protocol Violation|1
2248940|NCT02006472|3911414|FG001|Period 1 (Through Week 26)|Protocol Violation|1
2248941|NCT02006472|3911415|FG002|Period 1 (Through Week 26)|Protocol Violation|1
2248942|NCT02006472|3911416|FG003|Period 1 (Through Week 26)|Protocol Violation|1
2248943|NCT02006472|3911417|FG004|Period 1 (Through Week 26)|Protocol Violation|0
2248944|NCT02006472|3911413|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0
2248945|NCT02006472|3911414|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0
2248946|NCT02006472|3911415|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1
2248947|NCT02006472|3911416|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0
2248948|NCT02006472|3911417|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0
2248949|NCT02006472|3911413|FG000|Period 1 (Through Week 26)|Noncompliance|2
2248950|NCT02006472|3911414|FG001|Period 1 (Through Week 26)|Noncompliance|1
2248951|NCT02006472|3911415|FG002|Period 1 (Through Week 26)|Noncompliance|1
2248952|NCT02006472|3911416|FG003|Period 1 (Through Week 26)|Noncompliance|0
2248953|NCT02006472|3911417|FG004|Period 1 (Through Week 26)|Noncompliance|0
2248954|NCT02006472|3911413|FG000|Period 1 (Through Week 26)|Other|1
2248955|NCT02006472|3911414|FG001|Period 1 (Through Week 26)|Other|5
2248956|NCT02006472|3911415|FG002|Period 1 (Through Week 26)|Other|0
2248957|NCT02006472|3911416|FG003|Period 1 (Through Week 26)|Other|2
2248958|NCT02006472|3911417|FG004|Period 1 (Through Week 26)|Other|3
2248959|NCT02006472|3911413|FG000|Period 1 (Through Week 26)|Adverse Event|5
2248960|NCT02006472|3911414|FG001|Period 1 (Through Week 26)|Adverse Event|6
2248961|NCT02006472|3911415|FG002|Period 1 (Through Week 26)|Adverse Event|11
2248962|NCT02006472|3911416|FG003|Period 1 (Through Week 26)|Adverse Event|11
2248963|NCT02006472|3911417|FG004|Period 1 (Through Week 26)|Adverse Event|14
2248964|NCT02006472|3911413|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3
2248965|NCT02006472|3911414|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9
2248966|NCT02006472|3911415|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3
2248967|NCT02006472|3911416|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0
2248968|NCT02006472|3911417|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3
2248969|NCT02006472|3911413|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1
2340627|NCT03424044|4071706|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0
2340628|NCT03424239|4071740|FG000|Overall Study|Withdrawal by Subject|2
2340629|NCT03424265|4071746|FG000|Overall Study|screening failure|1
2340630|NCT03424265|4071747|FG001|Overall Study|screening failure|0
2340631|NCT03424265|4071746|FG000|Overall Study|Withdrawal by Subject|0
2340632|NCT03424265|4071747|FG001|Overall Study|Withdrawal by Subject|2
2340633|NCT03425188|4071777|FG000|Overall Study|Withdrawal by Subject|1
2340634|NCT03425253|4071782|FG000|Overall Study|Adverse Event|2
2248970|NCT02006472|3911414|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0
2248971|NCT02006472|3911415|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0
2248972|NCT02006472|3911416|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1
2248973|NCT02006472|3911417|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1
2248974|NCT02006472|3911413|FG000|Period 2 (Through Week 52)|Noncompliance|1
2248975|NCT02006472|3911414|FG001|Period 2 (Through Week 52)|Noncompliance|0
2248976|NCT02006472|3911415|FG002|Period 2 (Through Week 52)|Noncompliance|0
2248977|NCT02006472|3911416|FG003|Period 2 (Through Week 52)|Noncompliance|0
2248978|NCT02006472|3911417|FG004|Period 2 (Through Week 52)|Noncompliance|0
2248979|NCT02006472|3911413|FG000|Period 2 (Through Week 52)|Adverse Event|1
2248980|NCT02006472|3911414|FG001|Period 2 (Through Week 52)|Adverse Event|4
2248981|NCT02006472|3911415|FG002|Period 2 (Through Week 52)|Adverse Event|5
2248982|NCT02006472|3911416|FG003|Period 2 (Through Week 52)|Adverse Event|1
2248983|NCT02006472|3911417|FG004|Period 2 (Through Week 52)|Adverse Event|1
2248984|NCT02006472|3911413|FG000|Period 2 (Through Week 52)|Other|0
2248985|NCT02006472|3911414|FG001|Period 2 (Through Week 52)|Other|1
2248986|NCT02006472|3911415|FG002|Period 2 (Through Week 52)|Other|0
2248987|NCT02006472|3911416|FG003|Period 2 (Through Week 52)|Other|1
2248988|NCT02006472|3911417|FG004|Period 2 (Through Week 52)|Other|0
2248989|NCT02006472|3911413|FG000|Period 2 (Through Week 52)|Not treated|0
2248990|NCT02006472|3911414|FG001|Period 2 (Through Week 52)|Not treated|0
2248991|NCT02006472|3911415|FG002|Period 2 (Through Week 52)|Not treated|2
2248992|NCT02006472|3911416|FG003|Period 2 (Through Week 52)|Not treated|0
2248993|NCT02006472|3911417|FG004|Period 2 (Through Week 52)|Not treated|0
2248994|NCT02006472|3911413|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2
2248995|NCT02006472|3911414|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1
2248996|NCT02006472|3911415|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2
2248997|NCT02006472|3911416|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0
2248998|NCT02006472|3911417|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0
2248999|NCT02006472|3911413|FG000|Period 2 (Through Week 52)|Sponsor decision|0
2249000|NCT02006472|3911414|FG001|Period 2 (Through Week 52)|Sponsor decision|0
2249001|NCT02006472|3911415|FG002|Period 2 (Through Week 52)|Sponsor decision|1
2249002|NCT02006472|3911416|FG003|Period 2 (Through Week 52)|Sponsor decision|0
2249003|NCT02006472|3911417|FG004|Period 2 (Through Week 52)|Sponsor decision|0
2249004|NCT02006576|3911437|FG000|Overall Study|Withdrawal by Subject|4
2249005|NCT02006576|3911438|FG001|Overall Study|Withdrawal by Subject|6
2249006|NCT02006576|3911439|FG002|Overall Study|Withdrawal by Subject|2
2249007|NCT02006576|3911437|FG000|Overall Study|Death|0
2249008|NCT02006576|3911438|FG001|Overall Study|Death|0
2249009|NCT02006576|3911439|FG002|Overall Study|Death|1
2249010|NCT02006576|3911437|FG000|Overall Study|Lost to Follow-up|1
2249011|NCT02006576|3911438|FG001|Overall Study|Lost to Follow-up|0
2249012|NCT02006576|3911439|FG002|Overall Study|Lost to Follow-up|1
2249013|NCT02006576|3911437|FG000|Overall Study|Screen Failure, too sick, other|13
2249014|NCT02006576|3911438|FG001|Overall Study|Screen Failure, too sick, other|1
2249015|NCT02006576|3911439|FG002|Overall Study|Screen Failure, too sick, other|13
2249016|NCT02006628|3911449|FG000|Overall Study|Adverse Event|1
2249017|NCT02006628|3911450|FG001|Overall Study|Adverse Event|1
2249018|NCT02006628|3911449|FG000|Overall Study|Withdrawal by Subject|2
2249019|NCT02006628|3911450|FG001|Overall Study|Withdrawal by Subject|1
2249020|NCT02006641|3911459|FG000|Overall Study|Withdrawal before treatment|2
2249021|NCT02006641|3911460|FG001|Overall Study|Withdrawal before treatment|5
2249022|NCT02006641|3911461|FG002|Overall Study|Withdrawal before treatment|3
2249023|NCT02006641|3911459|FG000|Overall Study|Adverse Event|15
2249024|NCT02006641|3911460|FG001|Overall Study|Adverse Event|11
2249025|NCT02006641|3911461|FG002|Overall Study|Adverse Event|15
2249026|NCT02006641|3911459|FG000|Overall Study|Protocol Violation|0
2249027|NCT02006641|3911460|FG001|Overall Study|Protocol Violation|2
2249028|NCT02006641|3911461|FG002|Overall Study|Protocol Violation|2
2249029|NCT02006641|3911459|FG000|Overall Study|Lost to Follow-up|0
2249030|NCT02006641|3911460|FG001|Overall Study|Lost to Follow-up|1
2249031|NCT02006641|3911461|FG002|Overall Study|Lost to Follow-up|0
2249032|NCT02006641|3911459|FG000|Overall Study|Withdrawal by Subject|7
2249033|NCT02006641|3911460|FG001|Overall Study|Withdrawal by Subject|12
2249034|NCT02006641|3911461|FG002|Overall Study|Withdrawal by Subject|11
2249035|NCT02006641|3911459|FG000|Overall Study|Other reason: patient didn't show up|1
2249036|NCT02006641|3911460|FG001|Overall Study|Other reason: patient didn't show up|0
2249037|NCT02006641|3911461|FG002|Overall Study|Other reason: patient didn't show up|0
2249038|NCT02006641|3911459|FG000|Overall Study|Other reason:patient didn't want to come|0
2249039|NCT02006641|3911460|FG001|Overall Study|Other reason:patient didn't want to come|0
2249040|NCT02006641|3911461|FG002|Overall Study|Other reason:patient didn't want to come|1
2340635|NCT03425253|4071782|FG000|Overall Study|Lost to Follow-up|3
2340636|NCT03425253|4071782|FG000|Overall Study|Withdrew Consent|6
2340637|NCT03425253|4071782|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5
2340638|NCT03425396|4071792|FG000|Overall Study|Lost to Follow-up|2
2340639|NCT03425396|4071793|FG001|Overall Study|Lost to Follow-up|5
2340640|NCT03425396|4071794|FG002|Overall Study|Lost to Follow-up|2
2340641|NCT03425396|4071795|FG003|Overall Study|Lost to Follow-up|0
2340642|NCT03425396|4071796|FG004|Overall Study|Lost to Follow-up|0
2249041|NCT02006641|3911459|FG000|Overall Study|Other reason: patient has moved|1
2249042|NCT02006641|3911460|FG001|Overall Study|Other reason: patient has moved|0
2249043|NCT02006641|3911461|FG002|Overall Study|Other reason: patient has moved|1
2249044|NCT02006641|3911459|FG000|Overall Study|Other reason: caregiver in hospital|0
2249045|NCT02006641|3911460|FG001|Overall Study|Other reason: caregiver in hospital|1
2249046|NCT02006641|3911461|FG002|Overall Study|Other reason: caregiver in hospital|0
2249047|NCT02006641|3911459|FG000|Overall Study|Other reason: patient's wife has died|0
2249048|NCT02006641|3911460|FG001|Overall Study|Other reason: patient's wife has died|0
2249049|NCT02006641|3911461|FG002|Overall Study|Other reason: patient's wife has died|1
2249050|NCT02006641|3911459|FG000|Overall Study|Other reason: hospitalisation|0
2249051|NCT02006641|3911460|FG001|Overall Study|Other reason: hospitalisation|1
2249052|NCT02006641|3911461|FG002|Overall Study|Other reason: hospitalisation|0
2249053|NCT02006641|3911459|FG000|Overall Study|Other reason: caregiver impossibility|0
2249054|NCT02006641|3911460|FG001|Overall Study|Other reason: caregiver impossibility|0
2249055|NCT02006641|3911461|FG002|Overall Study|Other reason: caregiver impossibility|1
2249056|NCT02006641|3911459|FG000|Overall Study|Other reason: protocol non-compliance|0
2249057|NCT02006641|3911460|FG001|Overall Study|Other reason: protocol non-compliance|0
2249058|NCT02006641|3911461|FG002|Overall Study|Other reason: protocol non-compliance|1
2249059|NCT02006654|3911471|FG000|Overall Study|Withdrawal before treatment|4
2249060|NCT02006654|3911472|FG001|Overall Study|Withdrawal before treatment|2
2249061|NCT02006654|3911471|FG000|Overall Study|Adverse Event|16
2249062|NCT02006654|3911472|FG001|Overall Study|Adverse Event|17
2249063|NCT02006654|3911471|FG000|Overall Study|Death|1
2249064|NCT02006654|3911472|FG001|Overall Study|Death|0
2249065|NCT02006654|3911471|FG000|Overall Study|Withdrawal by Subject|14
2249066|NCT02006654|3911472|FG001|Overall Study|Withdrawal by Subject|12
2249067|NCT02006654|3911471|FG000|Overall Study|Protocol Violation|5
2249068|NCT02006654|3911472|FG001|Overall Study|Protocol Violation|8
2249069|NCT02006654|3911471|FG000|Overall Study|Lost to Follow-up|1
2249070|NCT02006654|3911472|FG001|Overall Study|Lost to Follow-up|0
2249071|NCT02006654|3911471|FG000|Overall Study|patient's will|2
2249072|NCT02006654|3911472|FG001|Overall Study|patient's will|1
2249073|NCT02006654|3911471|FG000|Overall Study|insufficient compliance|1
2249074|NCT02006654|3911472|FG001|Overall Study|insufficient compliance|0
2249075|NCT02006654|3911471|FG000|Overall Study|worsening cognitive condition|0
2249076|NCT02006654|3911472|FG001|Overall Study|worsening cognitive condition|1
2249077|NCT02006654|3911471|FG000|Overall Study|faecal incontinence|0
2249078|NCT02006654|3911472|FG001|Overall Study|faecal incontinence|1
2249079|NCT02006654|3911471|FG000|Overall Study|mood disorder|0
2249080|NCT02006654|3911472|FG001|Overall Study|mood disorder|1
2249081|NCT02006654|3911471|FG000|Overall Study|disallowed medication|1
2249082|NCT02006654|3911472|FG001|Overall Study|disallowed medication|0
2249083|NCT02006654|3911471|FG000|Overall Study|moving out of state|0
2249084|NCT02006654|3911472|FG001|Overall Study|moving out of state|1
2249085|NCT02006667|3911479|FG000|Overall Study|Adverse Event|3
2249086|NCT02006667|3911479|FG000|Overall Study|Death|2
2249087|NCT02006667|3911479|FG000|Overall Study|Withdrawal by Subject|1
2249088|NCT02006693|3911485|FG000|Overall Study|No Reason Specified|6
2249089|NCT02006693|3911486|FG001|Overall Study|No Reason Specified|8
2249090|NCT02006693|3911485|FG000|Overall Study|Another Glaucoma-related Surgery|12
2249091|NCT02006693|3911486|FG001|Overall Study|Another Glaucoma-related Surgery|1
2249092|NCT02006693|3911485|FG000|Overall Study|XEN Implant Explantation|0
2249093|NCT02006693|3911486|FG001|Overall Study|XEN Implant Explantation|1
2249094|NCT02006693|3911485|FG000|Overall Study|Death|2
2249095|NCT02006693|3911486|FG001|Overall Study|Death|2
2249096|NCT02006693|3911485|FG000|Overall Study|Lost to Follow-up|4
2249097|NCT02006693|3911486|FG001|Overall Study|Lost to Follow-up|1
2249098|NCT02006693|3911485|FG000|Overall Study|Patient Decision|4
2249099|NCT02006693|3911486|FG001|Overall Study|Patient Decision|0
2249100|NCT02006706|3911492|FG000|Overall Study|Lost to Follow-up|1
2249101|NCT02006719|3911498|FG000|Overall Study|Withdrawal by Subject|10
2249102|NCT02006719|3911499|FG001|Overall Study|Withdrawal by Subject|2
2249103|NCT02006719|3911498|FG000|Overall Study|Lost to Follow-up|5
2249104|NCT02006719|3911499|FG001|Overall Study|Lost to Follow-up|1
2249105|NCT02006719|3911498|FG000|Overall Study|Protocol Violation|2
2249106|NCT02006719|3911499|FG001|Overall Study|Protocol Violation|0
2249107|NCT02006719|3911498|FG000|Overall Study|Adverse Event|1
2249108|NCT02006719|3911499|FG001|Overall Study|Adverse Event|1
2249109|NCT02006719|3911498|FG000|Overall Study|Other/Unknown|0
2249110|NCT02006719|3911499|FG001|Overall Study|Other/Unknown|1
2340643|NCT03425396|4071792|FG000|Overall Study|Withdrawal by Subject|0
2249111|NCT02006732|3911509|FG000|Overall Study|Adverse Event|10
2249112|NCT02006732|3911510|FG001|Overall Study|Adverse Event|7
2249113|NCT02006732|3911511|FG002|Overall Study|Adverse Event|4
2249114|NCT02006732|3911512|FG003|Overall Study|Adverse Event|2
2249115|NCT02006732|3911509|FG000|Overall Study|Lack of Efficacy|6
2249116|NCT02006732|3911510|FG001|Overall Study|Lack of Efficacy|3
2249117|NCT02006732|3911511|FG002|Overall Study|Lack of Efficacy|1
2249118|NCT02006732|3911512|FG003|Overall Study|Lack of Efficacy|1
2249119|NCT02006732|3911509|FG000|Overall Study|Protocol Violation|1
2249120|NCT02006732|3911510|FG001|Overall Study|Protocol Violation|1
2249121|NCT02006732|3911511|FG002|Overall Study|Protocol Violation|0
2249122|NCT02006732|3911512|FG003|Overall Study|Protocol Violation|0
2249123|NCT02006732|3911509|FG000|Overall Study|Lost to Follow-up|0
2249124|NCT02006732|3911510|FG001|Overall Study|Lost to Follow-up|1
2249125|NCT02006732|3911511|FG002|Overall Study|Lost to Follow-up|0
2249126|NCT02006732|3911512|FG003|Overall Study|Lost to Follow-up|0
2249127|NCT02006732|3911509|FG000|Overall Study|Withdrawal by Subject|3
2249128|NCT02006732|3911510|FG001|Overall Study|Withdrawal by Subject|0
2249129|NCT02006732|3911511|FG002|Overall Study|Withdrawal by Subject|4
2249130|NCT02006732|3911512|FG003|Overall Study|Withdrawal by Subject|1
2249131|NCT02006758|3911522|FG000|Overall Study|Protocol Violation|1
2249132|NCT02006758|3911522|FG000|Overall Study|Death|1
2249133|NCT02006758|3911522|FG000|Overall Study|Lost to Follow-up|4
2249134|NCT02006758|3911522|FG000|Overall Study|Withdrawal by Subject|4
2249135|NCT02006758|3911522|FG000|Overall Study|Procedurally excluded|1
2249136|NCT02006758|3911522|FG000|Overall Study|Other|2
2249137|NCT02006979|3911557|FG000|Overall Study|Withdrawal by Subject|1
2249138|NCT02006979|3911558|FG001|Overall Study|Withdrawal by Subject|1
2249139|NCT02006979|3911557|FG000|Overall Study|Protocol Violation|0
2249140|NCT02006979|3911558|FG001|Overall Study|Protocol Violation|1
2249141|NCT02007070|3911564|FG000|Overall Study|Adverse Event|4
2249142|NCT02007070|3911564|FG000|Overall Study|Clinical Progression|4
2249143|NCT02007070|3911564|FG000|Overall Study|Death|1
2249144|NCT02007070|3911564|FG000|Overall Study|Protocol Violation|2
2249145|NCT02007070|3911564|FG000|Overall Study|Physician Decision|1
2249146|NCT02007070|3911564|FG000|Overall Study|Progressive Disease|21
2249147|NCT02007096|3911570|FG000|Overall Study|medication not available|2
2249148|NCT02007096|3911571|FG001|Overall Study|medication not available|0
2249149|NCT02007096|3911570|FG000|Overall Study|did not inject saline|0
2249150|NCT02007096|3911571|FG001|Overall Study|did not inject saline|3
2249151|NCT02007096|3911570|FG000|Overall Study|did not follow postoperative protocol|8
2249152|NCT02007096|3911571|FG001|Overall Study|did not follow postoperative protocol|11
2249153|NCT02007096|3911570|FG000|Overall Study|converted to open surgery|1
2249154|NCT02007096|3911571|FG001|Overall Study|converted to open surgery|1
2249155|NCT02007096|3911570|FG000|Overall Study|no mesh placed|0
2249156|NCT02007096|3911571|FG001|Overall Study|no mesh placed|1
2249157|NCT02007109|3911577|FG000|Overall Study|Diary not returned or excluded|102
2249158|NCT02007109|3911577|FG000|Overall Study|Excluded - Age<7yo|9
2249159|NCT02007252|3911590|FG000|Overall Study|Administrative problems|3
2249160|NCT02007252|3911591|FG001|Overall Study|Administrative problems|7
2249161|NCT02007252|3911590|FG000|Overall Study|Abnormal laboratory value(s)|1
2249162|NCT02007252|3911591|FG001|Overall Study|Abnormal laboratory value(s)|0
2249163|NCT02007252|3911590|FG000|Overall Study|Adverse Event|7
2249164|NCT02007252|3911591|FG001|Overall Study|Adverse Event|4
2249165|NCT02007278|3911599|FG000|Overall Study|Failure to comply with an eligibility|0
2249166|NCT02007278|3911600|FG001|Overall Study|Failure to comply with an eligibility|1
2249167|NCT02007278|3911599|FG000|Overall Study|Ingestion of drugs not allowed in study|0
2249168|NCT02007278|3911600|FG001|Overall Study|Ingestion of drugs not allowed in study|1
2249169|NCT02007278|3911599|FG000|Overall Study|Incorrect medication administration|1
2249170|NCT02007278|3911600|FG001|Overall Study|Incorrect medication administration|0
2249171|NCT02007278|3911599|FG000|Overall Study|Mis-randomization|1
2249172|NCT02007278|3911600|FG001|Overall Study|Mis-randomization|1
2249173|NCT02007434|3911634|FG000|Overall Study|Lost to Follow-up|0
2249174|NCT02007434|3911635|FG001|Overall Study|Lost to Follow-up|1
2249175|NCT02007434|3911636|FG002|Overall Study|Lost to Follow-up|0
2249176|NCT02007434|3911637|FG003|Overall Study|Lost to Follow-up|0
2249177|NCT02007434|3911638|FG004|Overall Study|Lost to Follow-up|0
2249178|NCT02007434|3911639|FG005|Overall Study|Lost to Follow-up|0
2249179|NCT02007434|3911640|FG006|Overall Study|Lost to Follow-up|0
2249180|NCT02007434|3911641|FG007|Overall Study|Lost to Follow-up|0
2249181|NCT02007434|3911634|FG000|Overall Study|Non-compliance|1
2249182|NCT02007434|3911635|FG001|Overall Study|Non-compliance|0
2249183|NCT02007434|3911636|FG002|Overall Study|Non-compliance|1
2249184|NCT02007434|3911637|FG003|Overall Study|Non-compliance|0
2249185|NCT02007434|3911638|FG004|Overall Study|Non-compliance|0
2249186|NCT02007434|3911639|FG005|Overall Study|Non-compliance|0
2249187|NCT02007434|3911640|FG006|Overall Study|Non-compliance|0
2249188|NCT02007434|3911641|FG007|Overall Study|Non-compliance|0
2249189|NCT02007512|3911664|FG000|Double Blind Treatment Period|Adverse Event|4
2249190|NCT02007512|3911665|FG001|Double Blind Treatment Period|Adverse Event|2
2249191|NCT02007512|3911666|FG002|Double Blind Treatment Period|Adverse Event|6
2249192|NCT02007512|3911667|FG003|Double Blind Treatment Period|Adverse Event|2
2249193|NCT02007512|3911664|FG000|Double Blind Treatment Period|Death|1
2249194|NCT02007512|3911665|FG001|Double Blind Treatment Period|Death|0
2249195|NCT02007512|3911666|FG002|Double Blind Treatment Period|Death|0
2249196|NCT02007512|3911667|FG003|Double Blind Treatment Period|Death|0
2249197|NCT02007512|3911664|FG000|Double Blind Treatment Period|Disease progression|44
2249198|NCT02007512|3911665|FG001|Double Blind Treatment Period|Disease progression|49
2249199|NCT02007512|3911666|FG002|Double Blind Treatment Period|Disease progression|45
2249200|NCT02007512|3911667|FG003|Double Blind Treatment Period|Disease progression|51
2249201|NCT02007512|3911664|FG000|Double Blind Treatment Period|Withdrawal by Subject|4
2249202|NCT02007512|3911665|FG001|Double Blind Treatment Period|Withdrawal by Subject|2
2249203|NCT02007512|3911666|FG002|Double Blind Treatment Period|Withdrawal by Subject|3
2249204|NCT02007512|3911667|FG003|Double Blind Treatment Period|Withdrawal by Subject|3
2249205|NCT02007512|3911664|FG000|Double Blind Treatment Period|Protocol Violation|0
2249206|NCT02007512|3911665|FG001|Double Blind Treatment Period|Protocol Violation|0
2249207|NCT02007512|3911666|FG002|Double Blind Treatment Period|Protocol Violation|0
2249208|NCT02007512|3911667|FG003|Double Blind Treatment Period|Protocol Violation|1
2249209|NCT02007512|3911664|FG000|Double Blind Treatment Period|Other|0
2249210|NCT02007512|3911665|FG001|Double Blind Treatment Period|Other|0
2249211|NCT02007512|3911666|FG002|Double Blind Treatment Period|Other|1
2249212|NCT02007512|3911667|FG003|Double Blind Treatment Period|Other|2
2249213|NCT02007512|3911664|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
2249214|NCT02007512|3911665|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
2249215|NCT02007512|3911666|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
2249216|NCT02007512|3911667|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
2249217|NCT02007512|3911664|FG000|Open Label Treatment Period|Adverse Event|0
2249218|NCT02007512|3911665|FG001|Open Label Treatment Period|Adverse Event|1
2249219|NCT02007512|3911666|FG002|Open Label Treatment Period|Adverse Event|0
2249220|NCT02007512|3911667|FG003|Open Label Treatment Period|Adverse Event|0
2249221|NCT02007512|3911664|FG000|Open Label Treatment Period|Other|0
2249222|NCT02007512|3911665|FG001|Open Label Treatment Period|Other|0
2249223|NCT02007512|3911666|FG002|Open Label Treatment Period|Other|0
2249224|NCT02007512|3911667|FG003|Open Label Treatment Period|Other|1
2249225|NCT02007512|3911664|FG000|Open Label Treatment Period|Disease progression|0
2249226|NCT02007512|3911665|FG001|Open Label Treatment Period|Disease progression|17
2249227|NCT02007512|3911666|FG002|Open Label Treatment Period|Disease progression|0
2249228|NCT02007512|3911667|FG003|Open Label Treatment Period|Disease progression|11
2249229|NCT02007512|3911664|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
2249230|NCT02007512|3911665|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
2249231|NCT02007512|3911666|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
2249232|NCT02007512|3911667|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
2249233|NCT02007577|3911682|FG000|Overall Study|Adverse Event|1
2249234|NCT02007577|3911683|FG001|Overall Study|Adverse Event|0
2340644|NCT03425396|4071793|FG001|Overall Study|Withdrawal by Subject|1
2038268|NCT00422058|3608603|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1
2038269|NCT00422058|3608604|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1
2038270|NCT00422058|3608605|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0
2038271|NCT00422058|3608606|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0
2038272|NCT00422058|3608607|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1
2038273|NCT00422058|3608602|FG000|Double-Blind, Week 0-20|Other|11
2038274|NCT00422058|3608603|FG001|Double-Blind, Week 0-20|Other|3
2038275|NCT00422058|3608604|FG002|Double-Blind, Week 0-20|Other|8
2038276|NCT00422058|3608605|FG003|Double-Blind, Week 0-20|Other|8
2038277|NCT00422058|3608606|FG004|Double-Blind, Week 0-20|Other|4
2038278|NCT00422058|3608607|FG005|Double-Blind, Week 0-20|Other|10
2038279|NCT00422058|3608602|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12
2038280|NCT00422058|3608603|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17
2038281|NCT00422058|3608604|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15
2038282|NCT00422058|3608605|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8
2038283|NCT00422058|3608606|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10
2038284|NCT00422058|3608607|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12
2038285|NCT00422058|3608602|FG000|Open-Label Extension, Week 20-104|Adverse Event|3
2038286|NCT00422058|3608603|FG001|Open-Label Extension, Week 20-104|Adverse Event|4
2038287|NCT00422058|3608604|FG002|Open-Label Extension, Week 20-104|Adverse Event|7
2038288|NCT00422058|3608605|FG003|Open-Label Extension, Week 20-104|Adverse Event|4
2038289|NCT00422058|3608606|FG004|Open-Label Extension, Week 20-104|Adverse Event|4
2038290|NCT00422058|3608607|FG005|Open-Label Extension, Week 20-104|Adverse Event|0
2038291|NCT00422058|3608602|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1
2038292|NCT00422058|3608603|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2
2038293|NCT00422058|3608604|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3
2038294|NCT00422058|3608605|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1
2038295|NCT00422058|3608606|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5
2038296|NCT00422058|3608607|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3
2038297|NCT00422058|3608602|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3
2249235|NCT02007577|3911682|FG000|Overall Study|Withdrawal by Subject|0
2249236|NCT02007577|3911683|FG001|Overall Study|Withdrawal by Subject|1
2249237|NCT02007720|3911691|FG000|Overall Study|Withdrawal by Subject|9
2249238|NCT02007720|3911692|FG001|Overall Study|Withdrawal by Subject|11
2249239|NCT02007720|3911691|FG000|Overall Study|study terminated by sponsor|58
2249240|NCT02007720|3911692|FG001|Overall Study|study terminated by sponsor|54
2249241|NCT02007720|3911691|FG000|Overall Study|technical problem|4
2249242|NCT02007720|3911692|FG001|Overall Study|technical problem|2
2249243|NCT02007720|3911691|FG000|Overall Study|patient followd less than 165 days|11
2249244|NCT02007720|3911692|FG001|Overall Study|patient followd less than 165 days|5
2340645|NCT03425396|4071794|FG002|Overall Study|Withdrawal by Subject|0
2340646|NCT03425396|4071795|FG003|Overall Study|Withdrawal by Subject|1
2340647|NCT03425396|4071796|FG004|Overall Study|Withdrawal by Subject|0
2340648|NCT03425396|4071792|FG000|Overall Study|Other|0
2340649|NCT03425396|4071793|FG001|Overall Study|Other|1
2340650|NCT03425396|4071794|FG002|Overall Study|Other|1
2249245|NCT02007954|3911703|FG000|Overall Study|Received liver transplant|3
2249246|NCT02007954|3911703|FG000|Overall Study|Switch in treatment modality|2
2249247|NCT02007954|3911703|FG000|Overall Study|Disease progression and unrelated AE|1
2249248|NCT02007954|3911703|FG000|Overall Study|Death|1
2249249|NCT02008227|3911722|FG000|Overall Study|Lost to Follow-up|7
2249250|NCT02008227|3911723|FG001|Overall Study|Lost to Follow-up|9
2249251|NCT02008227|3911722|FG000|Overall Study|Death|494
2249252|NCT02008227|3911723|FG001|Overall Study|Death|485
2249253|NCT02008227|3911722|FG000|Overall Study|Withdrawal by Subject|67
2249254|NCT02008227|3911723|FG001|Overall Study|Withdrawal by Subject|36
2249255|NCT02008227|3911722|FG000|Overall Study|Study Terminated By Sponsor|44
2249256|NCT02008227|3911723|FG001|Overall Study|Study Terminated By Sponsor|83
2249257|NCT02008318|3911732|FG000|Overall Study|Adverse Event|4
2249258|NCT02008318|3911733|FG001|Overall Study|Adverse Event|0
2249259|NCT02008318|3911732|FG000|Overall Study|Physician Decision|2
2249260|NCT02008318|3911733|FG001|Overall Study|Physician Decision|0
2249261|NCT02008318|3911732|FG000|Overall Study|Progressive Disease|2
2249262|NCT02008318|3911733|FG001|Overall Study|Progressive Disease|0
2249263|NCT02008318|3911732|FG000|Overall Study|Protocol Violation|1
2249264|NCT02008318|3911733|FG001|Overall Study|Protocol Violation|1
2249265|NCT02008318|3911732|FG000|Overall Study|Withdrawal by Subject|3
2249266|NCT02008318|3911733|FG001|Overall Study|Withdrawal by Subject|0
2249267|NCT02008526|3911745|FG000|Overall Study|Death|0
2249268|NCT02008526|3911746|FG001|Overall Study|Death|2
2249269|NCT02008526|3911747|FG002|Overall Study|Death|1
2249270|NCT02008526|3911745|FG000|Overall Study|Withdrawal by Subject|3
2249271|NCT02008526|3911746|FG001|Overall Study|Withdrawal by Subject|3
2249272|NCT02008526|3911747|FG002|Overall Study|Withdrawal by Subject|2
2249273|NCT02008526|3911745|FG000|Overall Study|Lost to Follow-up|5
2249274|NCT02008526|3911746|FG001|Overall Study|Lost to Follow-up|9
2249275|NCT02008526|3911747|FG002|Overall Study|Lost to Follow-up|6
2249276|NCT02008565|3911759|FG000|Overall Study|Protocol Violation|1
2249277|NCT02008565|3911760|FG001|Overall Study|Protocol Violation|1
2249278|NCT02008565|3911761|FG002|Overall Study|Protocol Violation|2
2249279|NCT02008565|3911762|FG003|Overall Study|Protocol Violation|0
2340651|NCT03425396|4071795|FG003|Overall Study|Other|0
2340652|NCT03425396|4071796|FG004|Overall Study|Other|1
2353162|NCT02966223|4104490|FG000|Overall Study|Lost to Follow-up|1
2353163|NCT02965846|4104497|FG000|Overall Study|Lost to Follow-up|1
2353164|NCT02965846|4104498|FG001|Overall Study|Lost to Follow-up|0
2353165|NCT02965846|4104499|FG002|Overall Study|Lost to Follow-up|0
2353166|NCT02965846|4104497|FG000|Overall Study|Withdrawal by Subject|0
2353167|NCT02965846|4104498|FG001|Overall Study|Withdrawal by Subject|1
2353168|NCT02965846|4104499|FG002|Overall Study|Withdrawal by Subject|0
2353169|NCT02965846|4104497|FG000|Overall Study|Study Terminated By Sponsor|4
2353170|NCT02965846|4104498|FG001|Overall Study|Study Terminated By Sponsor|4
2353171|NCT02965846|4104499|FG002|Overall Study|Study Terminated By Sponsor|0
2353172|NCT02965846|4104497|FG000|Overall Study|Participants not randomized|0
2353173|NCT02965846|4104498|FG001|Overall Study|Participants not randomized|0
2353174|NCT02965846|4104499|FG002|Overall Study|Participants not randomized|33
2353175|NCT02956005|4104520|FG000|Overall Study|Not eligible|1
2353176|NCT02956005|4104520|FG000|Overall Study|Withdrawal by Subject|3
2353177|NCT02956005|4104520|FG000|Overall Study|Physician Decision|12
2353178|NCT02940223|4104535|FG000|Overall Study|Failed Requirement|2
2353179|NCT02940223|4104536|FG001|Overall Study|Failed Requirement|0
2353180|NCT02954159|4104544|FG000|Overall Study|Study ended prematurely due to low enrol|1
2353181|NCT02954159|4104545|FG001|Overall Study|Study ended prematurely due to low enrol|0
2353182|NCT02954159|4104544|FG000|Overall Study|Withdrawal by Subject|0
2353183|NCT02954159|4104545|FG001|Overall Study|Withdrawal by Subject|1
2353184|NCT02954952|4104554|FG000|Overall Study|Withdrawal by Subject|1
2353185|NCT02954952|4104555|FG001|Overall Study|Withdrawal by Subject|0
2353186|NCT02954952|4104556|FG002|Overall Study|Withdrawal by Subject|0
2353187|NCT02954952|4104554|FG000|Overall Study|No data collected|0
2353188|NCT02954952|4104555|FG001|Overall Study|No data collected|1
2353189|NCT02954952|4104556|FG002|Overall Study|No data collected|0
2353190|NCT02947022|4104568|FG000|Overall Study|Study Stopped|1
2353191|NCT02950480|4104583|FG000|Overall Study|Withdrawal by Subject|1
2353192|NCT02950480|4104584|FG001|Overall Study|Withdrawal by Subject|0
2353193|NCT02949947|4104592|FG000|Overall Study|Non Compliance|0
2353194|NCT02949947|4104593|FG001|Overall Study|Non Compliance|1
2353195|NCT02949947|4104592|FG000|Overall Study|Insurance change|1
2353196|NCT02949947|4104593|FG001|Overall Study|Insurance change|0
2353197|NCT02947100|4104599|FG000|Overall Study|study terminated early|3
2353198|NCT02947100|4104599|FG000|Overall Study|did not meet inclusion criteria|1
2353199|NCT02908516|4104620|FG000|Overall Study|Study Terminated|3
2353200|NCT02908516|4104621|FG001|Overall Study|Study Terminated|3
2353201|NCT02923830|4104629|FG000|Overall Study|Physician Decision|13
2353202|NCT02923830|4104630|FG001|Overall Study|Physician Decision|15
2353203|NCT02920450|4104636|FG000|Overall Study|Death|1
2353204|NCT02920450|4104637|FG001|Overall Study|Death|0
2353205|NCT02920450|4104638|FG002|Overall Study|Death|0
2353206|NCT02920450|4104639|FG003|Overall Study|Death|0
2353207|NCT02920450|4104636|FG000|Overall Study|Withdrawal by Subject|1
2353208|NCT02920450|4104637|FG001|Overall Study|Withdrawal by Subject|0
2249280|NCT02008773|3911796|FG000|Overall Study|Adverse Event|3
2249281|NCT02008773|3911797|FG001|Overall Study|Adverse Event|3
2249282|NCT02008773|3911798|FG002|Overall Study|Adverse Event|1
2249283|NCT02008773|3911799|FG003|Overall Study|Adverse Event|2
2249284|NCT02008773|3911796|FG000|Overall Study|Medication Non-compliance|2
2249285|NCT02008773|3911797|FG001|Overall Study|Medication Non-compliance|1
2249286|NCT02008773|3911798|FG002|Overall Study|Medication Non-compliance|3
2249287|NCT02008773|3911799|FG003|Overall Study|Medication Non-compliance|2
2249288|NCT02008773|3911796|FG000|Overall Study|Withdrawal by Subject|8
2249289|NCT02008773|3911797|FG001|Overall Study|Withdrawal by Subject|4
2249290|NCT02008773|3911798|FG002|Overall Study|Withdrawal by Subject|7
2249291|NCT02008773|3911799|FG003|Overall Study|Withdrawal by Subject|6
2249292|NCT02008773|3911796|FG000|Overall Study|Lost to Follow-up|0
2249293|NCT02008773|3911797|FG001|Overall Study|Lost to Follow-up|1
2249294|NCT02008773|3911798|FG002|Overall Study|Lost to Follow-up|3
2249295|NCT02008773|3911799|FG003|Overall Study|Lost to Follow-up|2
2249296|NCT02008877|3911807|FG000|Overall Study|Inevaluable|0
2249297|NCT02008877|3911808|FG001|Overall Study|Inevaluable|1
2249298|NCT02008877|3911809|FG002|Overall Study|Inevaluable|0
2249299|NCT02008890|3911821|FG000|Period 1|Withdrawal by Subject|7
2249300|NCT02008890|3911822|FG001|Period 1|Withdrawal by Subject|7
2249301|NCT02008890|3911823|FG002|Period 1|Withdrawal by Subject|5
2249302|NCT02008890|3911824|FG003|Period 1|Withdrawal by Subject|0
2249303|NCT02008890|3911825|FG004|Period 1|Withdrawal by Subject|0
2249304|NCT02008890|3911821|FG000|Period 1|Pregnancy|1
2249305|NCT02008890|3911822|FG001|Period 1|Pregnancy|0
2249306|NCT02008890|3911823|FG002|Period 1|Pregnancy|0
2249307|NCT02008890|3911824|FG003|Period 1|Pregnancy|0
2249308|NCT02008890|3911825|FG004|Period 1|Pregnancy|0
2249309|NCT02008890|3911821|FG000|Period 1|Physician Decision|1
2249310|NCT02008890|3911822|FG001|Period 1|Physician Decision|0
2249311|NCT02008890|3911823|FG002|Period 1|Physician Decision|1
2249312|NCT02008890|3911824|FG003|Period 1|Physician Decision|0
2249313|NCT02008890|3911825|FG004|Period 1|Physician Decision|0
2249314|NCT02008890|3911821|FG000|Period 1|Adverse Event|6
2249315|NCT02008890|3911822|FG001|Period 1|Adverse Event|8
2249316|NCT02008890|3911823|FG002|Period 1|Adverse Event|6
2249317|NCT02008890|3911824|FG003|Period 1|Adverse Event|0
2249318|NCT02008890|3911825|FG004|Period 1|Adverse Event|0
2249319|NCT02008890|3911821|FG000|Period 2|Adverse Event|12
2249320|NCT02008890|3911822|FG001|Period 2|Adverse Event|7
2249321|NCT02008890|3911823|FG002|Period 2|Adverse Event|0
2249322|NCT02008890|3911824|FG003|Period 2|Adverse Event|5
2249323|NCT02008890|3911825|FG004|Period 2|Adverse Event|5
2249324|NCT02008890|3911821|FG000|Period 2|Withdrawal by Subject|11
2249325|NCT02008890|3911822|FG001|Period 2|Withdrawal by Subject|8
2249326|NCT02008890|3911823|FG002|Period 2|Withdrawal by Subject|0
2249327|NCT02008890|3911824|FG003|Period 2|Withdrawal by Subject|7
2249328|NCT02008890|3911825|FG004|Period 2|Withdrawal by Subject|2
2249329|NCT02008890|3911821|FG000|Period 2|Physician Decision|4
2249330|NCT02008890|3911822|FG001|Period 2|Physician Decision|0
2249331|NCT02008890|3911823|FG002|Period 2|Physician Decision|0
2249332|NCT02008890|3911824|FG003|Period 2|Physician Decision|2
2249333|NCT02008890|3911825|FG004|Period 2|Physician Decision|1
2249334|NCT02008890|3911821|FG000|Period 2|Lost to Follow-up|0
2249335|NCT02008890|3911822|FG001|Period 2|Lost to Follow-up|0
2249336|NCT02008890|3911823|FG002|Period 2|Lost to Follow-up|1
2249337|NCT02008890|3911824|FG003|Period 2|Lost to Follow-up|0
2249338|NCT02008890|3911825|FG004|Period 2|Lost to Follow-up|0
2249339|NCT02008890|3911821|FG000|Extension Period|Withdrawal by Subject|3
2249340|NCT02008890|3911822|FG001|Extension Period|Withdrawal by Subject|2
2249341|NCT02008890|3911823|FG002|Extension Period|Withdrawal by Subject|0
2249342|NCT02008890|3911824|FG003|Extension Period|Withdrawal by Subject|4
2249343|NCT02008890|3911825|FG004|Extension Period|Withdrawal by Subject|2
2249344|NCT02008890|3911821|FG000|Extension Period|Lost to Follow-up|1
2340653|NCT03426267|4071821|FG000|Overall Study|Physician Decision|1
2340654|NCT03426267|4071822|FG001|Overall Study|Physician Decision|4
2340655|NCT03426267|4071821|FG000|Overall Study|Lost to Follow-up|1
2340656|NCT03426267|4071822|FG001|Overall Study|Lost to Follow-up|0
2340657|NCT03426267|4071821|FG000|Overall Study|Withdrawal by Subject|4
2340658|NCT03426267|4071822|FG001|Overall Study|Withdrawal by Subject|10
2340659|NCT03426267|4071821|FG000|Overall Study|Protocol Violation|1
2340660|NCT03426267|4071822|FG001|Overall Study|Protocol Violation|3
2340661|NCT03426267|4071821|FG000|Overall Study|Adverse Event|9
2340662|NCT03426267|4071822|FG001|Overall Study|Adverse Event|27
2340663|NCT03426267|4071821|FG000|Overall Study|Prohibited Treatment Intake|2
2340664|NCT03426267|4071822|FG001|Overall Study|Prohibited Treatment Intake|3
2340665|NCT03426267|4071821|FG000|Overall Study|Lack of Efficacy|0
2340666|NCT03426267|4071822|FG001|Overall Study|Lack of Efficacy|25
2340667|NCT03426267|4071821|FG000|Overall Study|other|3
2340668|NCT03426267|4071822|FG001|Overall Study|other|0
2340669|NCT03426345|4071830|FG000|Overall Study|Adverse Event|4
2340670|NCT03426345|4071831|FG001|Overall Study|Adverse Event|4
2340671|NCT03426345|4071830|FG000|Overall Study|Lack of Efficacy|1
2249345|NCT02008890|3911822|FG001|Extension Period|Lost to Follow-up|0
2249346|NCT02008890|3911823|FG002|Extension Period|Lost to Follow-up|0
2249347|NCT02008890|3911824|FG003|Extension Period|Lost to Follow-up|0
2249348|NCT02008890|3911825|FG004|Extension Period|Lost to Follow-up|0
2249349|NCT02008890|3911821|FG000|Extension Period|Adverse Event|1
2249350|NCT02008890|3911822|FG001|Extension Period|Adverse Event|3
2249351|NCT02008890|3911823|FG002|Extension Period|Adverse Event|0
2249352|NCT02008890|3911824|FG003|Extension Period|Adverse Event|0
2249353|NCT02008890|3911825|FG004|Extension Period|Adverse Event|2
2249354|NCT02008916|3911843|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
2249355|NCT02008916|3911844|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
2249356|NCT02008916|3911845|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
2249357|NCT02008916|3911843|FG000|Week 16 - 156|Adverse Event|4
2249358|NCT02008916|3911844|FG001|Week 16 - 156|Adverse Event|2
2249359|NCT02008916|3911845|FG002|Week 16 - 156|Adverse Event|3
2249360|NCT02008916|3911843|FG000|Week 16 - 156|Withdrawal by Subject|7
2249361|NCT02008916|3911844|FG001|Week 16 - 156|Withdrawal by Subject|3
2249362|NCT02008916|3911845|FG002|Week 16 - 156|Withdrawal by Subject|5
2249363|NCT02008916|3911843|FG000|Week 16 - 156|No longer requires treatment|0
2249364|NCT02008916|3911844|FG001|Week 16 - 156|No longer requires treatment|1
2249365|NCT02008916|3911845|FG002|Week 16 - 156|No longer requires treatment|0
2249366|NCT02008916|3911843|FG000|Week 16 - 156|Lost to Follow-up|5
2249367|NCT02008916|3911844|FG001|Week 16 - 156|Lost to Follow-up|0
2249368|NCT02008916|3911845|FG002|Week 16 - 156|Lost to Follow-up|0
2249369|NCT02008916|3911843|FG000|Week 16 - 156|Lack of Efficacy|3
2249370|NCT02008916|3911844|FG001|Week 16 - 156|Lack of Efficacy|5
2249371|NCT02008916|3911845|FG002|Week 16 - 156|Lack of Efficacy|2
2249372|NCT02008916|3911843|FG000|Week 16 - 156|Pregnancy|0
2249373|NCT02008916|3911844|FG001|Week 16 - 156|Pregnancy|1
2249374|NCT02008916|3911845|FG002|Week 16 - 156|Pregnancy|0
2249375|NCT02008916|3911843|FG000|Week 16 - 156|Physician Decision|0
2249376|NCT02008916|3911844|FG001|Week 16 - 156|Physician Decision|1
2249377|NCT02008916|3911845|FG002|Week 16 - 156|Physician Decision|0
2249378|NCT02009046|3911863|FG000|Overall Study|Lost to Follow-up|256
2249379|NCT02009046|3911864|FG001|Overall Study|Lost to Follow-up|206
2249380|NCT02009163|3911878|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
2249381|NCT02009163|3911879|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
2249382|NCT02009163|3911880|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
2249383|NCT02009163|3911878|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29
2249384|NCT02009163|3911879|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0
2249385|NCT02009163|3911880|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0
2249386|NCT02009163|3911878|FG000|Open-label Period (Non-randomized)|Adverse Event|22
2249387|NCT02009163|3911879|FG001|Open-label Period (Non-randomized)|Adverse Event|0
2340672|NCT03426345|4071831|FG001|Overall Study|Lack of Efficacy|0
2340673|NCT03426345|4071830|FG000|Overall Study|Withdrawal by Subject|5
2340674|NCT03426345|4071831|FG001|Overall Study|Withdrawal by Subject|6
2340675|NCT03426345|4071830|FG000|Overall Study|Lost to Follow-up|3
2340676|NCT03426345|4071831|FG001|Overall Study|Lost to Follow-up|1
2340677|NCT03426345|4071830|FG000|Overall Study|Protocol Deviation|3
2340678|NCT03426345|4071831|FG001|Overall Study|Protocol Deviation|4
2340679|NCT03426345|4071830|FG000|Overall Study|Reason Not Specified|1
2340680|NCT03426345|4071831|FG001|Overall Study|Reason Not Specified|2
2340681|NCT03426345|4071830|FG000|Overall Study|Missing Completion Status|1
2340682|NCT03426345|4071831|FG001|Overall Study|Missing Completion Status|0
2340683|NCT03426436|4071838|FG000|Overall Study|Incorrect lead placement|12
2340684|NCT03426436|4071838|FG000|Overall Study|Withdrawal by Subject|2
2340685|NCT03426436|4071838|FG000|Overall Study|Consent issue|1
2340686|NCT03426436|4071838|FG000|Overall Study|ECGs not saved|4
2340687|NCT03426631|4071848|FG000|Overall Study|Lost to Follow-up|0
2340688|NCT03426631|4071849|FG001|Overall Study|Lost to Follow-up|1
2340689|NCT03426787|4071855|FG000|Overall Study|Withdrawal by Subject|6
2340690|NCT03426787|4071855|FG000|Overall Study|Lost to Follow-up|7
2340691|NCT03426787|4071855|FG000|Overall Study|Unrelated to intervention death|1
2340692|NCT03426995|4071884|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340693|NCT03426995|4071885|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340694|NCT03426995|4071886|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1
2340695|NCT03426995|4071887|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340696|NCT03426995|4071888|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340697|NCT03426995|4071889|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340698|NCT03426995|4071890|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340699|NCT03426995|4071891|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340700|NCT03426995|4071892|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340701|NCT03426995|4071893|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340702|NCT03426995|4071894|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340703|NCT03426995|4071895|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340704|NCT03426995|4071896|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340705|NCT03426995|4071897|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340706|NCT03426995|4071898|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340707|NCT03426995|4071899|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340708|NCT03426995|4071900|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2340709|NCT03426995|4071901|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2249388|NCT02009163|3911880|FG002|Open-label Period (Non-randomized)|Adverse Event|0
2249389|NCT02009163|3911878|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20
2249390|NCT02009163|3911879|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0
2249391|NCT02009163|3911880|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0
2249392|NCT02009163|3911878|FG000|Open-label Period (Non-randomized)|Protocol Violation|10
2249393|NCT02009163|3911879|FG001|Open-label Period (Non-randomized)|Protocol Violation|0
2249394|NCT02009163|3911880|FG002|Open-label Period (Non-randomized)|Protocol Violation|0
2249395|NCT02009163|3911878|FG000|Open-label Period (Non-randomized)|Pregnancy|1
2249396|NCT02009163|3911879|FG001|Open-label Period (Non-randomized)|Pregnancy|0
2249397|NCT02009163|3911880|FG002|Open-label Period (Non-randomized)|Pregnancy|0
2249398|NCT02009163|3911878|FG000|Open-label Period (Non-randomized)|Other|13
2249399|NCT02009163|3911879|FG001|Open-label Period (Non-randomized)|Other|0
2249400|NCT02009163|3911880|FG002|Open-label Period (Non-randomized)|Other|0
2249401|NCT02009163|3911878|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0
2249402|NCT02009163|3911879|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25
2249403|NCT02009163|3911880|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9
2249404|NCT02009163|3911878|FG000|Randomized-withdrawal Period|Lost to Follow-up|0
2249405|NCT02009163|3911879|FG001|Randomized-withdrawal Period|Lost to Follow-up|13
2249406|NCT02009163|3911880|FG002|Randomized-withdrawal Period|Lost to Follow-up|6
2249407|NCT02009163|3911878|FG000|Randomized-withdrawal Period|Adverse Event|0
2249408|NCT02009163|3911879|FG001|Randomized-withdrawal Period|Adverse Event|0
2249409|NCT02009163|3911880|FG002|Randomized-withdrawal Period|Adverse Event|6
2249410|NCT02009163|3911878|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0
2249411|NCT02009163|3911879|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40
2249412|NCT02009163|3911880|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5
2249413|NCT02009163|3911878|FG000|Randomized-withdrawal Period|Protocol Violation|0
2249414|NCT02009163|3911879|FG001|Randomized-withdrawal Period|Protocol Violation|1
2249415|NCT02009163|3911880|FG002|Randomized-withdrawal Period|Protocol Violation|2
2340710|NCT03426995|4071902|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
2038298|NCT00422058|3608603|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2
2038299|NCT00422058|3608604|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5
2038300|NCT00422058|3608605|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2
2038301|NCT00422058|3608606|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0
2038302|NCT00422058|3608607|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1
2038303|NCT00422058|3608602|FG000|Open-Label Extension, Week 20-104|Other|13
2038304|NCT00422058|3608603|FG001|Open-Label Extension, Week 20-104|Other|14
2038305|NCT00422058|3608604|FG002|Open-Label Extension, Week 20-104|Other|6
2038306|NCT00422058|3608605|FG003|Open-Label Extension, Week 20-104|Other|13
2038307|NCT00422058|3608606|FG004|Open-Label Extension, Week 20-104|Other|16
2038308|NCT00422058|3608607|FG005|Open-Label Extension, Week 20-104|Other|18
2038309|NCT00422084|3608623|FG000|Overall Study|Adverse Event|21
2038310|NCT00422084|3608624|FG001|Overall Study|Adverse Event|7
2038311|NCT00422084|3608623|FG000|Overall Study|Withdrawal by Subject|12
2038312|NCT00422084|3608624|FG001|Overall Study|Withdrawal by Subject|9
2038313|NCT00422084|3608623|FG000|Overall Study|Lost to Follow-up|14
2249416|NCT02009163|3911878|FG000|Randomized-withdrawal Period|Pregnancy|0
2249417|NCT02009163|3911879|FG001|Randomized-withdrawal Period|Pregnancy|0
2249418|NCT02009163|3911880|FG002|Randomized-withdrawal Period|Pregnancy|2
2249419|NCT02009163|3911878|FG000|Randomized-withdrawal Period|Other|0
2249420|NCT02009163|3911879|FG001|Randomized-withdrawal Period|Other|9
2249421|NCT02009163|3911880|FG002|Randomized-withdrawal Period|Other|5
2249422|NCT02009332|3911896|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
2249423|NCT02009332|3911897|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1
2249424|NCT02009332|3911898|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
2249425|NCT02009332|3911899|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
2249426|NCT02009332|3911900|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
2249427|NCT02009332|3911901|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
2249428|NCT02009332|3911896|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
2249429|NCT02009332|3911897|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
2249430|NCT02009332|3911898|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
2249431|NCT02009332|3911899|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
2249432|NCT02009332|3911900|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1
2249433|NCT02009332|3911901|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
2249434|NCT02009332|3911896|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
2249435|NCT02009332|3911897|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
2249436|NCT02009332|3911898|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
2249437|NCT02009332|3911899|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
2249438|NCT02009332|3911900|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
2249439|NCT02009332|3911901|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1
2249440|NCT02009397|3911915|FG000|Overall Study|Protocol Violation|6
2249441|NCT02009397|3911915|FG000|Overall Study|Death|8
2249442|NCT02009397|3911915|FG000|Overall Study|Lost to Follow-up|6
2249443|NCT02009696|3911928|FG000|Overall Study|Withdrawal by Subject|2
2249444|NCT02009722|3911934|FG000|Overall Study|Protocol Violation|1
2249445|NCT02009722|3911935|FG001|Overall Study|Protocol Violation|2
2249446|NCT02009722|3911934|FG000|Overall Study|Did not receive intervention|0
2249447|NCT02009722|3911935|FG001|Overall Study|Did not receive intervention|1
2249448|NCT02009865|3911943|FG000|Overall Study|Adverse Event|0
2249449|NCT02009865|3911944|FG001|Overall Study|Adverse Event|2
2249450|NCT02009865|3911943|FG000|Overall Study|Protocol Violation|0
2249451|NCT02009865|3911944|FG001|Overall Study|Protocol Violation|2
2249452|NCT02009865|3911943|FG000|Overall Study|Withdrawal by Subject|1
2249453|NCT02009865|3911944|FG001|Overall Study|Withdrawal by Subject|1
2249454|NCT02009878|3911953|FG000|Overall Study|Participant Met Withdrawal Criteria|0
2249455|NCT02009878|3911954|FG001|Overall Study|Participant Met Withdrawal Criteria|1
2249456|NCT02009878|3911955|FG002|Overall Study|Participant Met Withdrawal Criteria|0
2249457|NCT02009930|3911963|FG000|Overall Study|withdrawn|5
2249458|NCT02010255|3912031|FG000|Overall Study|Death|0
2249459|NCT02010255|3912032|FG001|Overall Study|Death|1
2249460|NCT02010255|3912033|FG002|Overall Study|Death|4
2249461|NCT02010255|3912034|FG003|Overall Study|Death|4
2249462|NCT02010255|3912035|FG004|Overall Study|Death|2
2249463|NCT02010255|3912036|FG005|Overall Study|Death|0
2249464|NCT02010255|3912037|FG006|Overall Study|Death|1
2249465|NCT02010255|3912038|FG007|Overall Study|Death|1
2249466|NCT02010255|3912039|FG008|Overall Study|Death|1
2249467|NCT02010255|3912040|FG009|Overall Study|Death|0
2249468|NCT02010255|3912041|FG010|Overall Study|Death|1
2249469|NCT02010255|3912042|FG011|Overall Study|Death|1
2249470|NCT02010255|3912043|FG012|Overall Study|Death|0
2249471|NCT02010255|3912044|FG013|Overall Study|Death|0
2340711|NCT03426995|4071884|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340712|NCT03426995|4071885|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340713|NCT03426995|4071886|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340714|NCT03426995|4071887|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340715|NCT03426995|4071888|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340716|NCT03426995|4071889|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1
2340717|NCT03426995|4071890|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340718|NCT03426995|4071891|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340719|NCT03426995|4071892|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340720|NCT03426995|4071893|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340721|NCT03426995|4071894|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340722|NCT03426995|4071895|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340723|NCT03426995|4071896|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340724|NCT03426995|4071897|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340725|NCT03426995|4071898|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340726|NCT03426995|4071899|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340727|NCT03426995|4071900|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340728|NCT03426995|4071901|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340729|NCT03426995|4071902|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
2340730|NCT03426995|4071884|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340731|NCT03426995|4071885|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340732|NCT03426995|4071886|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2249472|NCT02010255|3912031|FG000|Overall Study|Lack of Efficacy|4
2249473|NCT02010255|3912032|FG001|Overall Study|Lack of Efficacy|1
2249474|NCT02010255|3912033|FG002|Overall Study|Lack of Efficacy|2
2249475|NCT02010255|3912034|FG003|Overall Study|Lack of Efficacy|1
2249476|NCT02010255|3912035|FG004|Overall Study|Lack of Efficacy|1
2249477|NCT02010255|3912036|FG005|Overall Study|Lack of Efficacy|0
2249478|NCT02010255|3912037|FG006|Overall Study|Lack of Efficacy|0
2249479|NCT02010255|3912038|FG007|Overall Study|Lack of Efficacy|0
2249480|NCT02010255|3912039|FG008|Overall Study|Lack of Efficacy|0
2249481|NCT02010255|3912040|FG009|Overall Study|Lack of Efficacy|0
2249482|NCT02010255|3912041|FG010|Overall Study|Lack of Efficacy|1
2249483|NCT02010255|3912042|FG011|Overall Study|Lack of Efficacy|0
2249484|NCT02010255|3912043|FG012|Overall Study|Lack of Efficacy|0
2249485|NCT02010255|3912044|FG013|Overall Study|Lack of Efficacy|0
2249486|NCT02010255|3912031|FG000|Overall Study|Withdrew Consent|1
2249487|NCT02010255|3912032|FG001|Overall Study|Withdrew Consent|0
2249488|NCT02010255|3912033|FG002|Overall Study|Withdrew Consent|0
2249489|NCT02010255|3912034|FG003|Overall Study|Withdrew Consent|1
2249490|NCT02010255|3912035|FG004|Overall Study|Withdrew Consent|0
2249491|NCT02010255|3912036|FG005|Overall Study|Withdrew Consent|0
2249492|NCT02010255|3912037|FG006|Overall Study|Withdrew Consent|0
2249493|NCT02010255|3912038|FG007|Overall Study|Withdrew Consent|0
2249494|NCT02010255|3912039|FG008|Overall Study|Withdrew Consent|0
2249495|NCT02010255|3912040|FG009|Overall Study|Withdrew Consent|0
2249496|NCT02010255|3912041|FG010|Overall Study|Withdrew Consent|0
2249497|NCT02010255|3912042|FG011|Overall Study|Withdrew Consent|0
2249498|NCT02010255|3912043|FG012|Overall Study|Withdrew Consent|0
2249499|NCT02010255|3912044|FG013|Overall Study|Withdrew Consent|0
2249500|NCT02010255|3912031|FG000|Overall Study|Adverse Event|1
2249501|NCT02010255|3912032|FG001|Overall Study|Adverse Event|0
2249502|NCT02010255|3912033|FG002|Overall Study|Adverse Event|0
2249503|NCT02010255|3912034|FG003|Overall Study|Adverse Event|0
2249504|NCT02010255|3912035|FG004|Overall Study|Adverse Event|0
2249505|NCT02010255|3912036|FG005|Overall Study|Adverse Event|0
2249506|NCT02010255|3912037|FG006|Overall Study|Adverse Event|0
2249507|NCT02010255|3912038|FG007|Overall Study|Adverse Event|0
2249508|NCT02010255|3912039|FG008|Overall Study|Adverse Event|0
2249509|NCT02010255|3912040|FG009|Overall Study|Adverse Event|0
2249510|NCT02010255|3912041|FG010|Overall Study|Adverse Event|0
2249511|NCT02010255|3912042|FG011|Overall Study|Adverse Event|0
2249512|NCT02010255|3912043|FG012|Overall Study|Adverse Event|0
2249513|NCT02010255|3912044|FG013|Overall Study|Adverse Event|0
2249514|NCT02010255|3912031|FG000|Overall Study|Lost to Follow-up|0
2249515|NCT02010255|3912032|FG001|Overall Study|Lost to Follow-up|0
2249516|NCT02010255|3912033|FG002|Overall Study|Lost to Follow-up|1
2249517|NCT02010255|3912034|FG003|Overall Study|Lost to Follow-up|0
2249518|NCT02010255|3912035|FG004|Overall Study|Lost to Follow-up|1
2249519|NCT02010255|3912036|FG005|Overall Study|Lost to Follow-up|0
2249520|NCT02010255|3912037|FG006|Overall Study|Lost to Follow-up|0
2249521|NCT02010255|3912038|FG007|Overall Study|Lost to Follow-up|0
2249522|NCT02010255|3912039|FG008|Overall Study|Lost to Follow-up|0
2340733|NCT03426995|4071887|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340734|NCT03426995|4071888|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
2340735|NCT03426995|4071889|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
2340736|NCT03426995|4071890|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340737|NCT03426995|4071891|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340738|NCT03426995|4071892|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340739|NCT03426995|4071893|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340740|NCT03426995|4071894|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340741|NCT03426995|4071895|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340742|NCT03426995|4071896|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340743|NCT03426995|4071897|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340744|NCT03426995|4071898|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340745|NCT03426995|4071899|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340746|NCT03426995|4071900|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340747|NCT03426995|4071901|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340748|NCT03426995|4071902|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
2340749|NCT03426995|4071884|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340750|NCT03426995|4071885|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340751|NCT03426995|4071886|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340752|NCT03426995|4071887|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340753|NCT03426995|4071888|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340754|NCT03426995|4071889|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340755|NCT03426995|4071890|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340756|NCT03426995|4071891|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340757|NCT03426995|4071892|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340758|NCT03426995|4071893|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2353209|NCT02920450|4104638|FG002|Overall Study|Withdrawal by Subject|0
2249523|NCT02010255|3912040|FG009|Overall Study|Lost to Follow-up|0
2249524|NCT02010255|3912041|FG010|Overall Study|Lost to Follow-up|0
2249525|NCT02010255|3912042|FG011|Overall Study|Lost to Follow-up|0
2249526|NCT02010255|3912043|FG012|Overall Study|Lost to Follow-up|0
2249527|NCT02010255|3912044|FG013|Overall Study|Lost to Follow-up|0
2249528|NCT02010255|3912031|FG000|Overall Study|Randomized but Not Treated|0
2340759|NCT03426995|4071894|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1
2340760|NCT03426995|4071895|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340761|NCT03426995|4071896|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340762|NCT03426995|4071897|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340763|NCT03426995|4071898|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340764|NCT03426995|4071899|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340765|NCT03426995|4071900|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2038314|NCT00422084|3608624|FG001|Overall Study|Lost to Follow-up|9
2038315|NCT00422084|3608623|FG000|Overall Study|Protocol Violation|4
2038316|NCT00422084|3608624|FG001|Overall Study|Protocol Violation|1
2038317|NCT00422084|3608623|FG000|Overall Study|Lack of Efficacy|40
2038318|NCT00422084|3608624|FG001|Overall Study|Lack of Efficacy|42
2038319|NCT00422084|3608623|FG000|Overall Study|P. vivax infection|3
2038320|NCT00422084|3608624|FG001|Overall Study|P. vivax infection|6
2038321|NCT00422084|3608623|FG000|Overall Study|Cyesis|1
2038322|NCT00422084|3608624|FG001|Overall Study|Cyesis|0
2038323|NCT00422084|3608623|FG000|Overall Study|Withdrawn from study accidentally|1
2038324|NCT00422084|3608624|FG001|Overall Study|Withdrawn from study accidentally|0
2038325|NCT00422084|3608623|FG000|Overall Study|Non-compliance|1
2038326|NCT00422084|3608624|FG001|Overall Study|Non-compliance|0
2038327|NCT00422084|3608623|FG000|Overall Study|Re-location|0
2038328|NCT00422084|3608624|FG001|Overall Study|Re-location|1
2038329|NCT00422084|3608623|FG000|Overall Study|Not defined|1
2038330|NCT00422084|3608624|FG001|Overall Study|Not defined|1
2249529|NCT02010255|3912032|FG001|Overall Study|Randomized but Not Treated|0
2249530|NCT02010255|3912033|FG002|Overall Study|Randomized but Not Treated|0
2249531|NCT02010255|3912034|FG003|Overall Study|Randomized but Not Treated|0
2249532|NCT02010255|3912035|FG004|Overall Study|Randomized but Not Treated|0
2249533|NCT02010255|3912036|FG005|Overall Study|Randomized but Not Treated|0
2249534|NCT02010255|3912037|FG006|Overall Study|Randomized but Not Treated|0
2249535|NCT02010255|3912038|FG007|Overall Study|Randomized but Not Treated|0
2249536|NCT02010255|3912039|FG008|Overall Study|Randomized but Not Treated|0
2249537|NCT02010255|3912040|FG009|Overall Study|Randomized but Not Treated|0
2249538|NCT02010255|3912041|FG010|Overall Study|Randomized but Not Treated|0
2249539|NCT02010255|3912042|FG011|Overall Study|Randomized but Not Treated|0
2249540|NCT02010255|3912043|FG012|Overall Study|Randomized but Not Treated|0
2249541|NCT02010255|3912044|FG013|Overall Study|Randomized but Not Treated|1
2249542|NCT02010567|3912113|FG000|Overall Study|Adverse Event|0
2249543|NCT02010567|3912114|FG001|Overall Study|Adverse Event|0
2249544|NCT02010567|3912115|FG002|Overall Study|Adverse Event|1
2249545|NCT02010567|3912116|FG003|Overall Study|Adverse Event|0
2249546|NCT02010567|3912117|FG004|Overall Study|Adverse Event|1
2249547|NCT02010632|3912127|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
2249548|NCT02010632|3912128|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
2249549|NCT02010684|3912140|FG000|Overall Study|Lost to Follow-up|8
2249550|NCT02010684|3912141|FG001|Overall Study|Lost to Follow-up|18
2249551|NCT02010684|3912140|FG000|Overall Study|Withdrawal by Subject|4
2249552|NCT02010684|3912141|FG001|Overall Study|Withdrawal by Subject|5
2249553|NCT02010775|3912165|FG000|Overall Study|Adverse Event|0
2249554|NCT02010775|3912166|FG001|Overall Study|Adverse Event|0
2249555|NCT02010775|3912167|FG002|Overall Study|Adverse Event|0
2249556|NCT02010775|3912168|FG003|Overall Study|Adverse Event|0
2249557|NCT02010775|3912169|FG004|Overall Study|Adverse Event|1
2249558|NCT02010775|3912165|FG000|Overall Study|Pregnancy|0
2249559|NCT02010775|3912166|FG001|Overall Study|Pregnancy|0
2249560|NCT02010775|3912167|FG002|Overall Study|Pregnancy|2
2249561|NCT02010775|3912168|FG003|Overall Study|Pregnancy|0
2249562|NCT02010775|3912169|FG004|Overall Study|Pregnancy|0
2249563|NCT02010775|3912165|FG000|Overall Study|Lost to Follow-up|2
2249564|NCT02010775|3912166|FG001|Overall Study|Lost to Follow-up|0
2249565|NCT02010775|3912167|FG002|Overall Study|Lost to Follow-up|0
2249566|NCT02010775|3912168|FG003|Overall Study|Lost to Follow-up|1
2249567|NCT02010775|3912169|FG004|Overall Study|Lost to Follow-up|1
2249568|NCT02010775|3912165|FG000|Overall Study|Personal Reasons|3
2249569|NCT02010775|3912166|FG001|Overall Study|Personal Reasons|3
2249570|NCT02010775|3912167|FG002|Overall Study|Personal Reasons|1
2249571|NCT02010775|3912168|FG003|Overall Study|Personal Reasons|2
2249572|NCT02010775|3912169|FG004|Overall Study|Personal Reasons|4
2249573|NCT02011113|3912194|FG000|Overall Study|Adverse Event|4
2249574|NCT02011113|3912194|FG000|Overall Study|Disease Progression (DP)|16
2038331|NCT00422097|3608636|FG000|Dose Level 2|Still on treatment|0
2038332|NCT00422097|3608637|FG001|Dose Level 2|Still on treatment|1
2038333|NCT00422097|3608638|FG002|Dose Level 2|Still on treatment|0
2249575|NCT02011113|3912194|FG000|Overall Study|Death|1
2249576|NCT02011113|3912194|FG000|Overall Study|Insufficient effect of Pomalidomide|1
2249577|NCT02011113|3912194|FG000|Overall Study|Investigator's judgement- DP|3
2249578|NCT02011113|3912194|FG000|Overall Study|Study terminated by sponsor|11
2249579|NCT02011386|3912199|FG000|Overall Study|Non-compliance|2
2249580|NCT02011386|3912199|FG000|Overall Study|Lack of Efficacy|3
2249581|NCT02011893|3912255|FG000|Enrollment to Randomization|Adverse Event|2
2249582|NCT02011893|3912256|FG001|Enrollment to Randomization|Adverse Event|0
2249583|NCT02011893|3912257|FG002|Enrollment to Randomization|Adverse Event|0
2249584|NCT02011893|3912255|FG000|Enrollment to Randomization|Physician Decision|10
2249585|NCT02011893|3912256|FG001|Enrollment to Randomization|Physician Decision|0
2249586|NCT02011893|3912257|FG002|Enrollment to Randomization|Physician Decision|0
2249587|NCT02011893|3912255|FG000|Enrollment to Randomization|Withdrawal by Subject|21
2249588|NCT02011893|3912256|FG001|Enrollment to Randomization|Withdrawal by Subject|0
2249589|NCT02011893|3912257|FG002|Enrollment to Randomization|Withdrawal by Subject|0
2249590|NCT02011893|3912255|FG000|Enrollment to Randomization|Screening Failure|29
2249591|NCT02011893|3912256|FG001|Enrollment to Randomization|Screening Failure|0
2249592|NCT02011893|3912257|FG002|Enrollment to Randomization|Screening Failure|0
2249593|NCT02011893|3912255|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
2249594|NCT02011893|3912256|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
2249595|NCT02011893|3912257|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
2249596|NCT02011893|3912255|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2
2249597|NCT02011893|3912256|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0
2249598|NCT02011893|3912257|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0
2249599|NCT02011893|3912255|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
2249600|NCT02011893|3912256|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
2249601|NCT02011893|3912257|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
2249602|NCT02011893|3912255|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
2249603|NCT02011893|3912256|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
2249604|NCT02011893|3912257|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
2249605|NCT02011893|3912255|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
2249606|NCT02011893|3912256|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
2249607|NCT02011893|3912257|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
2249608|NCT02011945|3912265|FG000|Overall Study|Participant requested to Discontinue|0
2249609|NCT02011945|3912266|FG001|Overall Study|Participant requested to Discontinue|1
2249610|NCT02011945|3912267|FG002|Overall Study|Participant requested to Discontinue|1
2249611|NCT02011945|3912265|FG000|Overall Study|Adverse Event unrelated to Drug|0
2249612|NCT02011945|3912266|FG001|Overall Study|Adverse Event unrelated to Drug|2
2249613|NCT02011945|3912267|FG002|Overall Study|Adverse Event unrelated to Drug|1
2249614|NCT02011945|3912265|FG000|Overall Study|Study Drug Toxicity|0
2249615|NCT02011945|3912266|FG001|Overall Study|Study Drug Toxicity|0
2249616|NCT02011945|3912267|FG002|Overall Study|Study Drug Toxicity|1
2249617|NCT02011945|3912265|FG000|Overall Study|Treatment Failure|0
2249618|NCT02011945|3912266|FG001|Overall Study|Treatment Failure|7
2249619|NCT02011945|3912267|FG002|Overall Study|Treatment Failure|6
2249620|NCT02011945|3912265|FG000|Overall Study|No Longer Meets Study Criteria|1
2249621|NCT02011945|3912266|FG001|Overall Study|No Longer Meets Study Criteria|0
2249622|NCT02011945|3912267|FG002|Overall Study|No Longer Meets Study Criteria|0
2249623|NCT02011945|3912265|FG000|Overall Study|Proceeded to stem cell transplant|0
2249624|NCT02011945|3912266|FG001|Overall Study|Proceeded to stem cell transplant|0
2249625|NCT02011945|3912267|FG002|Overall Study|Proceeded to stem cell transplant|1
2249626|NCT02011945|3912265|FG000|Overall Study|Sub-Optimal Response to dasatinib|1
2249627|NCT02011945|3912266|FG001|Overall Study|Sub-Optimal Response to dasatinib|0
2249628|NCT02011945|3912267|FG002|Overall Study|Sub-Optimal Response to dasatinib|0
2249629|NCT02012218|3912289|FG000|Overall Study|Withdrawal by Subject|1
2249630|NCT02012218|3912290|FG001|Overall Study|Withdrawal by Subject|0
2249631|NCT02012218|3912291|FG002|Overall Study|Withdrawal by Subject|1
2249632|NCT02012218|3912292|FG003|Overall Study|Withdrawal by Subject|1
2249633|NCT02012218|3912293|FG004|Overall Study|Withdrawal by Subject|1
2249634|NCT02012218|3912289|FG000|Overall Study|Adverse Event|1
2249635|NCT02012218|3912290|FG001|Overall Study|Adverse Event|0
2249636|NCT02012218|3912291|FG002|Overall Study|Adverse Event|0
2249637|NCT02012218|3912292|FG003|Overall Study|Adverse Event|1
2249638|NCT02012218|3912293|FG004|Overall Study|Adverse Event|0
2249639|NCT02012218|3912289|FG000|Overall Study|Lost to Follow-up|0
2249640|NCT02012218|3912290|FG001|Overall Study|Lost to Follow-up|1
2249641|NCT02012218|3912291|FG002|Overall Study|Lost to Follow-up|1
2249642|NCT02012218|3912292|FG003|Overall Study|Lost to Follow-up|0
2249643|NCT02012218|3912293|FG004|Overall Study|Lost to Follow-up|0
2249644|NCT02012218|3912289|FG000|Overall Study|Protocol Specified|1
2249645|NCT02012218|3912290|FG001|Overall Study|Protocol Specified|0
2249646|NCT02012218|3912291|FG002|Overall Study|Protocol Specified|0
2249647|NCT02012218|3912292|FG003|Overall Study|Protocol Specified|0
2249648|NCT02012218|3912293|FG004|Overall Study|Protocol Specified|0
2249649|NCT02012218|3912289|FG000|Overall Study|Protocol Deviation|1
2340766|NCT03426995|4071901|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340767|NCT03426995|4071902|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
2340768|NCT03426995|4071884|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340769|NCT03426995|4071885|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340770|NCT03426995|4071886|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340771|NCT03426995|4071887|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340772|NCT03426995|4071888|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340773|NCT03426995|4071889|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340774|NCT03426995|4071890|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340775|NCT03426995|4071891|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1
2340776|NCT03426995|4071892|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340777|NCT03426995|4071893|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2249650|NCT02012218|3912290|FG001|Overall Study|Protocol Deviation|0
2249651|NCT02012218|3912291|FG002|Overall Study|Protocol Deviation|0
2249652|NCT02012218|3912292|FG003|Overall Study|Protocol Deviation|0
2249653|NCT02012218|3912293|FG004|Overall Study|Protocol Deviation|0
2249654|NCT02012452|3912334|FG000|Overall Study|Lost to Follow-up|2
2249655|NCT02012452|3912335|FG001|Overall Study|Lost to Follow-up|1
2249656|NCT02012452|3912334|FG000|Overall Study|Withdrawal by Subject|4
2249657|NCT02012452|3912335|FG001|Overall Study|Withdrawal by Subject|0
2249658|NCT02012491|3912343|FG000|Overall Study|Lost to Follow-up|1
2249659|NCT02012491|3912344|FG001|Overall Study|Lost to Follow-up|0
2249660|NCT02012491|3912343|FG000|Overall Study|Protocol Violation|0
2249661|NCT02012491|3912344|FG001|Overall Study|Protocol Violation|1
2249662|NCT02012491|3912343|FG000|Overall Study|Withdrawal by Subject|1
2249663|NCT02012491|3912344|FG001|Overall Study|Withdrawal by Subject|0
2249664|NCT02012686|3912373|FG000|Overall Study|muscle contraction|0
2249665|NCT02012686|3912374|FG001|Overall Study|muscle contraction|1
2249666|NCT02012686|3912373|FG000|Overall Study|electrocardiography monitoring noise|0
2249667|NCT02012686|3912374|FG001|Overall Study|electrocardiography monitoring noise|1
2249668|NCT02012959|3912380|FG000|Treatment Phase A|Adverse Event|2
2249669|NCT02012959|3912381|FG001|Treatment Phase A|Adverse Event|0
2249670|NCT02012959|3912382|FG002|Treatment Phase A|Adverse Event|0
2249671|NCT02012959|3912383|FG003|Treatment Phase A|Adverse Event|0
2249672|NCT02012959|3912384|FG004|Treatment Phase A|Adverse Event|0
2249673|NCT02013037|3912394|FG000|Overall Study|Death|6
2249674|NCT02013037|3912394|FG000|Overall Study|Withdrawal by Subject|1
2249675|NCT02013037|3912394|FG000|Overall Study|Awaiting Transplantation|7
2249676|NCT02013037|3912394|FG000|Overall Study|Transplanted without DSA|2
2249677|NCT02013206|3912427|FG000|Overall Study|Progressive disease (PD)|14
2249678|NCT02013206|3912428|FG001|Overall Study|Progressive disease (PD)|17
2249679|NCT02013206|3912427|FG000|Overall Study|Symptomatic deterioration|3
2249680|NCT02013206|3912428|FG001|Overall Study|Symptomatic deterioration|1
2249681|NCT02013206|3912427|FG000|Overall Study|Adverse Event|1
2249682|NCT02013206|3912428|FG001|Overall Study|Adverse Event|0
2249683|NCT02013206|3912427|FG000|Overall Study|Patient refusal|2
2249684|NCT02013206|3912428|FG001|Overall Study|Patient refusal|0
2249685|NCT02013206|3912427|FG000|Overall Study|Patient non-compliance|1
2249686|NCT02013206|3912428|FG001|Overall Study|Patient non-compliance|0
2249687|NCT02013206|3912427|FG000|Overall Study|Death|1
2249688|NCT02013206|3912428|FG001|Overall Study|Death|2
2249689|NCT02013206|3912427|FG000|Overall Study|Other reasons off treatment|5
2249690|NCT02013206|3912428|FG001|Overall Study|Other reasons off treatment|2
2249691|NCT02013375|3912451|FG000|Overall Study|Did not engraft|1
2249692|NCT02013375|3912451|FG000|Overall Study|Did not engraft|1
2249693|NCT02013388|3912464|FG000|Overall Study|work emergency|1
2249694|NCT02013388|3912465|FG001|Overall Study|work emergency|0
2249695|NCT02013388|3912466|FG002|Overall Study|work emergency|0
2249696|NCT02013388|3912467|FG003|Overall Study|work emergency|0
2249697|NCT02013388|3912468|FG004|Overall Study|work emergency|1
2249698|NCT02013388|3912469|FG005|Overall Study|work emergency|0
2249699|NCT02013388|3912470|FG006|Overall Study|work emergency|0
2249700|NCT02013388|3912471|FG007|Overall Study|work emergency|0
2249701|NCT02013531|3912493|FG000|Overall Study|Lost to Follow-up|3
2249702|NCT02013531|3912493|FG000|Overall Study|Met Withdrawal Criteria|1
2249703|NCT02013531|3912493|FG000|Overall Study|Withdrawal by Subject|1
2249704|NCT02013544|3912499|FG000|Overall Study|Adverse Event|5
2249705|NCT02013544|3912500|FG001|Overall Study|Adverse Event|5
2249706|NCT02013544|3912499|FG000|Overall Study|Lost to Follow-up|2
2249707|NCT02013544|3912500|FG001|Overall Study|Lost to Follow-up|3
2249708|NCT02013544|3912499|FG000|Overall Study|Withdrawal by Subject|2
2249709|NCT02013544|3912500|FG001|Overall Study|Withdrawal by Subject|8
2249710|NCT02013544|3912499|FG000|Overall Study|Physician Decision|0
2249711|NCT02013544|3912500|FG001|Overall Study|Physician Decision|1
2249712|NCT02013544|3912499|FG000|Overall Study|Entry criteria not met/non-compliance|2
2249713|NCT02013544|3912500|FG001|Overall Study|Entry criteria not met/non-compliance|3
2249714|NCT02013609|3912506|FG000|Overall Study|Withdrawal by Subject|9
2249715|NCT02013609|3912506|FG000|Overall Study|Lost to Follow-up|3
2249716|NCT02013609|3912506|FG000|Overall Study|Adverse Event|3
2249717|NCT02013609|3912506|FG000|Overall Study|Met Withdrawal Criteria|3
2249718|NCT02013622|3912510|FG000|Overall Study|Lost to Follow-up|10
2249719|NCT02013622|3912510|FG000|Overall Study|Adverse Event|3
2249720|NCT02013622|3912510|FG000|Overall Study|Met Withdrawal Criteria|3
2249721|NCT02013622|3912510|FG000|Overall Study|Withdrawal by Subject|6
2249722|NCT02013622|3912510|FG000|Overall Study|Protocol Deviation|1
2249723|NCT02013622|3912510|FG000|Overall Study|Lack of Efficacy|1
2249724|NCT02013674|3912516|FG000|Overall Study|Death|0
2249725|NCT02013674|3912517|FG001|Overall Study|Death|1
2249726|NCT02013674|3912516|FG000|Overall Study|Lost to Follow-up|1
2249727|NCT02013674|3912517|FG001|Overall Study|Lost to Follow-up|0
2249728|NCT02013687|3912527|FG000|Overall Study|Lost to Follow-up|0
2249729|NCT02013687|3912528|FG001|Overall Study|Lost to Follow-up|0
2249730|NCT02013687|3912529|FG002|Overall Study|Lost to Follow-up|1
2249731|NCT02013687|3912530|FG003|Overall Study|Lost to Follow-up|0
2249732|NCT02013687|3912527|FG000|Overall Study|Protocol Violation|0
2249733|NCT02013687|3912528|FG001|Overall Study|Protocol Violation|0
2249734|NCT02013687|3912529|FG002|Overall Study|Protocol Violation|0
2249735|NCT02013687|3912530|FG003|Overall Study|Protocol Violation|1
2249736|NCT02013687|3912527|FG000|Overall Study|Withdrawal by Subject|0
2249737|NCT02013687|3912528|FG001|Overall Study|Withdrawal by Subject|0
2249738|NCT02013687|3912529|FG002|Overall Study|Withdrawal by Subject|0
2249739|NCT02013687|3912530|FG003|Overall Study|Withdrawal by Subject|1
2249740|NCT02013687|3912527|FG000|Overall Study|Missed visits due to patient travel|0
2249741|NCT02013687|3912528|FG001|Overall Study|Missed visits due to patient travel|0
2249742|NCT02013687|3912529|FG002|Overall Study|Missed visits due to patient travel|1
2249743|NCT02013687|3912530|FG003|Overall Study|Missed visits due to patient travel|0
2249744|NCT02013765|3912544|FG000|Overall Study|Trial was terminated by sponsor|1
2249745|NCT02013778|3912548|FG000|Overall Study|Death|4
2249746|NCT02013778|3912548|FG000|Overall Study|Withdrawal by Subject|1
2249747|NCT02013778|3912548|FG000|Overall Study|Physician Decision|1
2249748|NCT02013778|3912548|FG000|Overall Study|Adverse Event|1
2249749|NCT02013791|3912561|FG000|Period 1|Lost to Follow-up|0
2249750|NCT02013791|3912562|FG001|Period 1|Lost to Follow-up|0
2249751|NCT02013791|3912563|FG002|Period 1|Lost to Follow-up|0
2249752|NCT02013791|3912564|FG003|Period 1|Lost to Follow-up|1
2249753|NCT02013791|3912565|FG004|Period 1|Lost to Follow-up|0
2249754|NCT02013791|3912566|FG005|Period 1|Lost to Follow-up|0
2249755|NCT02013791|3912567|FG006|Period 1|Lost to Follow-up|1
2340778|NCT03426995|4071894|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340779|NCT03426995|4071895|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340780|NCT03426995|4071896|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2038334|NCT00422097|3608639|FG003|Dose Level 2|Still on treatment|0
2038335|NCT00422097|3608640|FG004|Dose Level 2|Still on treatment|0
2038336|NCT00422097|3608641|FG005|Dose Level 2|Still on treatment|0
2038337|NCT00422097|3608642|FG006|Dose Level 2|Still on treatment|0
2038338|NCT00422097|3608643|FG007|Dose Level 2|Still on treatment|0
2038339|NCT00422162|3608669|FG000|Overall Study|Adverse Event|11
2038340|NCT00422162|3608670|FG001|Overall Study|Adverse Event|9
2038341|NCT00422162|3608669|FG000|Overall Study|Lack of Efficacy|4
2038342|NCT00422162|3608670|FG001|Overall Study|Lack of Efficacy|10
2038343|NCT00422162|3608669|FG000|Overall Study|Withdrawal by Subject|7
2038344|NCT00422162|3608670|FG001|Overall Study|Withdrawal by Subject|6
2038345|NCT00422162|3608669|FG000|Overall Study|Lost to Follow-up|1
2038346|NCT00422162|3608670|FG001|Overall Study|Lost to Follow-up|2
2038347|NCT00422162|3608669|FG000|Overall Study|Non-Compliant with Protocol|1
2038348|NCT00422162|3608670|FG001|Overall Study|Non-Compliant with Protocol|1
2038349|NCT00422162|3608669|FG000|Overall Study|Other|0
2038350|NCT00422162|3608670|FG001|Overall Study|Other|1
2038351|NCT00422162|3608669|FG000|Overall Study|Didn't Receive Treatment|0
2038352|NCT00422162|3608670|FG001|Overall Study|Didn't Receive Treatment|1
2038353|NCT00422227|3608693|FG000|Overall Study|Adverse Event|3
2038354|NCT00422227|3608694|FG001|Overall Study|Adverse Event|8
2038355|NCT00422227|3608693|FG000|Overall Study|Lost to Follow-up|1
2038356|NCT00422227|3608694|FG001|Overall Study|Lost to Follow-up|3
2038357|NCT00422227|3608693|FG000|Overall Study|Withdrawal by Subject|0
2249756|NCT02013791|3912568|FG007|Period 1|Lost to Follow-up|1
2249757|NCT02013791|3912569|FG008|Period 1|Lost to Follow-up|0
2249758|NCT02013791|3912561|FG000|Period 1|Other Miscellaneous Reasons|0
2249759|NCT02013791|3912562|FG001|Period 1|Other Miscellaneous Reasons|2
2249760|NCT02013791|3912563|FG002|Period 1|Other Miscellaneous Reasons|0
2249761|NCT02013791|3912564|FG003|Period 1|Other Miscellaneous Reasons|0
2249762|NCT02013791|3912565|FG004|Period 1|Other Miscellaneous Reasons|0
2249763|NCT02013791|3912566|FG005|Period 1|Other Miscellaneous Reasons|0
2249764|NCT02013791|3912567|FG006|Period 1|Other Miscellaneous Reasons|0
2249765|NCT02013791|3912568|FG007|Period 1|Other Miscellaneous Reasons|0
2249766|NCT02013791|3912569|FG008|Period 1|Other Miscellaneous Reasons|0
2249767|NCT02013817|3912590|FG000|Overall Study|Adverse Event|12
2249768|NCT02013817|3912590|FG000|Overall Study|Withdrawal by Subject|4
2249769|NCT02013817|3912590|FG000|Overall Study|Death|2
2249770|NCT02013817|3912590|FG000|Overall Study|Other|9
2249771|NCT02013830|3912594|FG000|Overall Study|Adverse Event|3
2249772|NCT02013830|3912594|FG000|Overall Study|Death|1
2249773|NCT02013830|3912594|FG000|Overall Study|Insufficient therapeutic response|25
2249774|NCT02013830|3912594|FG000|Overall Study|Refused treatment|1
2249775|NCT02014116|3912615|FG000|Overall Study|Progressive Disease|3
2249776|NCT02014116|3912616|FG001|Overall Study|Progressive Disease|4
2340781|NCT03426995|4071897|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2249777|NCT02014116|3912617|FG002|Overall Study|Progressive Disease|2
2249778|NCT02014116|3912618|FG003|Overall Study|Progressive Disease|6
2249779|NCT02014116|3912619|FG004|Overall Study|Progressive Disease|1
2249780|NCT02014116|3912620|FG005|Overall Study|Progressive Disease|13
2249781|NCT02014116|3912621|FG006|Overall Study|Progressive Disease|1
2249782|NCT02014116|3912622|FG007|Overall Study|Progressive Disease|3
2249783|NCT02014116|3912623|FG008|Overall Study|Progressive Disease|7
2249784|NCT02014116|3912615|FG000|Overall Study|Adverse Event|0
2249785|NCT02014116|3912616|FG001|Overall Study|Adverse Event|0
2249786|NCT02014116|3912617|FG002|Overall Study|Adverse Event|0
2249787|NCT02014116|3912618|FG003|Overall Study|Adverse Event|0
2249788|NCT02014116|3912619|FG004|Overall Study|Adverse Event|1
2249789|NCT02014116|3912620|FG005|Overall Study|Adverse Event|0
2249790|NCT02014116|3912621|FG006|Overall Study|Adverse Event|0
2249791|NCT02014116|3912622|FG007|Overall Study|Adverse Event|1
2249792|NCT02014116|3912623|FG008|Overall Study|Adverse Event|0
2249793|NCT02014116|3912615|FG000|Overall Study|Lost to Follow-up|0
2249794|NCT02014116|3912616|FG001|Overall Study|Lost to Follow-up|0
2249795|NCT02014116|3912617|FG002|Overall Study|Lost to Follow-up|0
2249796|NCT02014116|3912618|FG003|Overall Study|Lost to Follow-up|0
2249797|NCT02014116|3912619|FG004|Overall Study|Lost to Follow-up|0
2249798|NCT02014116|3912620|FG005|Overall Study|Lost to Follow-up|1
2249799|NCT02014116|3912621|FG006|Overall Study|Lost to Follow-up|0
2249800|NCT02014116|3912622|FG007|Overall Study|Lost to Follow-up|0
2249801|NCT02014116|3912623|FG008|Overall Study|Lost to Follow-up|1
2249802|NCT02014116|3912615|FG000|Overall Study|Death|0
2249803|NCT02014116|3912616|FG001|Overall Study|Death|0
2249804|NCT02014116|3912617|FG002|Overall Study|Death|0
2249805|NCT02014116|3912618|FG003|Overall Study|Death|0
2249806|NCT02014116|3912619|FG004|Overall Study|Death|0
2249807|NCT02014116|3912620|FG005|Overall Study|Death|0
2249808|NCT02014116|3912621|FG006|Overall Study|Death|0
2249809|NCT02014116|3912622|FG007|Overall Study|Death|1
2249810|NCT02014116|3912623|FG008|Overall Study|Death|1
2249811|NCT02014116|3912615|FG000|Overall Study|Withdrawal by Subject|0
2249812|NCT02014116|3912616|FG001|Overall Study|Withdrawal by Subject|0
2249813|NCT02014116|3912617|FG002|Overall Study|Withdrawal by Subject|1
2249814|NCT02014116|3912618|FG003|Overall Study|Withdrawal by Subject|1
2249815|NCT02014116|3912619|FG004|Overall Study|Withdrawal by Subject|0
2249816|NCT02014116|3912620|FG005|Overall Study|Withdrawal by Subject|1
2249817|NCT02014116|3912621|FG006|Overall Study|Withdrawal by Subject|0
2249818|NCT02014116|3912622|FG007|Overall Study|Withdrawal by Subject|0
2249819|NCT02014116|3912623|FG008|Overall Study|Withdrawal by Subject|0
2249820|NCT02014116|3912615|FG000|Overall Study|Withdrawal Caregiver Decision|0
2249821|NCT02014116|3912616|FG001|Overall Study|Withdrawal Caregiver Decision|0
2249822|NCT02014116|3912617|FG002|Overall Study|Withdrawal Caregiver Decision|0
2249823|NCT02014116|3912618|FG003|Overall Study|Withdrawal Caregiver Decision|0
2249824|NCT02014116|3912619|FG004|Overall Study|Withdrawal Caregiver Decision|0
2249825|NCT02014116|3912620|FG005|Overall Study|Withdrawal Caregiver Decision|1
2249826|NCT02014116|3912621|FG006|Overall Study|Withdrawal Caregiver Decision|0
2249827|NCT02014116|3912622|FG007|Overall Study|Withdrawal Caregiver Decision|0
2249828|NCT02014116|3912623|FG008|Overall Study|Withdrawal Caregiver Decision|0
2249829|NCT02014116|3912615|FG000|Overall Study|Physician Decision|0
2340782|NCT03426995|4071898|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340783|NCT03426995|4071899|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340784|NCT03426995|4071900|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340785|NCT03426995|4071901|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340786|NCT03426995|4071902|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
2340787|NCT03426995|4071884|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340788|NCT03426995|4071885|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340789|NCT03426995|4071886|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340790|NCT03426995|4071887|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340791|NCT03426995|4071888|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340792|NCT03426995|4071889|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340793|NCT03426995|4071890|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340794|NCT03426995|4071891|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340795|NCT03426995|4071892|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340796|NCT03426995|4071893|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340797|NCT03426995|4071894|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340798|NCT03426995|4071895|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340799|NCT03426995|4071896|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340800|NCT03426995|4071897|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340801|NCT03426995|4071898|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8
2340802|NCT03426995|4071899|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9
2340803|NCT03426995|4071900|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2353210|NCT02920450|4104639|FG003|Overall Study|Withdrawal by Subject|0
2249830|NCT02014116|3912616|FG001|Overall Study|Physician Decision|0
2249831|NCT02014116|3912617|FG002|Overall Study|Physician Decision|0
2249832|NCT02014116|3912618|FG003|Overall Study|Physician Decision|0
2249833|NCT02014116|3912619|FG004|Overall Study|Physician Decision|0
2249834|NCT02014116|3912620|FG005|Overall Study|Physician Decision|0
2249835|NCT02014116|3912621|FG006|Overall Study|Physician Decision|0
2249836|NCT02014116|3912622|FG007|Overall Study|Physician Decision|0
2249837|NCT02014116|3912623|FG008|Overall Study|Physician Decision|1
2249838|NCT02014272|3912659|FG000|Intervention Period 1|Withdrawal by Subject|1
2249839|NCT02014272|3912660|FG001|Intervention Period 1|Withdrawal by Subject|0
2249840|NCT02014272|3912659|FG000|Intervention Period 1|Adverse Event|0
2249841|NCT02014272|3912660|FG001|Intervention Period 1|Adverse Event|1
2249842|NCT02014376|3912682|FG000|Overall Study|Adverse Event|1
2249843|NCT02014376|3912683|FG001|Overall Study|Adverse Event|1
2249844|NCT02014376|3912684|FG002|Overall Study|Adverse Event|0
2249845|NCT02014376|3912682|FG000|Overall Study|Lost to Follow-up|2
2249846|NCT02014376|3912683|FG001|Overall Study|Lost to Follow-up|0
2249847|NCT02014376|3912684|FG002|Overall Study|Lost to Follow-up|0
2249848|NCT02014402|3912696|FG000|Overall Study|Adverse Event|1
2249849|NCT02014402|3912697|FG001|Overall Study|Adverse Event|0
2249850|NCT02014402|3912698|FG002|Overall Study|Adverse Event|0
2249851|NCT02014402|3912699|FG003|Overall Study|Adverse Event|0
2249852|NCT02014402|3912696|FG000|Overall Study|Withdrawal by Subject|1
2249853|NCT02014402|3912697|FG001|Overall Study|Withdrawal by Subject|2
2249854|NCT02014402|3912698|FG002|Overall Study|Withdrawal by Subject|2
2249855|NCT02014402|3912699|FG003|Overall Study|Withdrawal by Subject|1
2249856|NCT02014402|3912696|FG000|Overall Study|Subject did not have transportation|0
2249857|NCT02014402|3912697|FG001|Overall Study|Subject did not have transportation|1
2249858|NCT02014402|3912698|FG002|Overall Study|Subject did not have transportation|0
2249859|NCT02014402|3912699|FG003|Overall Study|Subject did not have transportation|0
2249860|NCT02014402|3912696|FG000|Overall Study|Lost to Follow-up|0
2249861|NCT02014402|3912697|FG001|Overall Study|Lost to Follow-up|0
2249862|NCT02014402|3912698|FG002|Overall Study|Lost to Follow-up|1
2249863|NCT02014402|3912699|FG003|Overall Study|Lost to Follow-up|2
2249864|NCT02014441|3912716|FG000|Overall Study|Withdrawal by Subject|12
2249865|NCT02014467|3912724|FG000|Overall Study|Adverse Event|4
2249866|NCT02014467|3912725|FG001|Overall Study|Adverse Event|0
2249867|NCT02014467|3912724|FG000|Overall Study|Protocol Violation|3
2249868|NCT02014467|3912725|FG001|Overall Study|Protocol Violation|0
2249869|NCT02014467|3912724|FG000|Overall Study|Physician Decision|2
2249870|NCT02014467|3912725|FG001|Overall Study|Physician Decision|3
2249871|NCT02014467|3912724|FG000|Overall Study|Withdrawal by Subject|16
2249872|NCT02014467|3912725|FG001|Overall Study|Withdrawal by Subject|4
2249873|NCT02014480|3912731|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2249874|NCT02014480|3912732|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2249875|NCT02014480|3912733|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1
2249876|NCT02014480|3912734|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2249877|NCT02014480|3912735|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2249878|NCT02014480|3912736|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2249879|NCT02014480|3912731|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2249880|NCT02014480|3912732|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2249881|NCT02014480|3912733|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2249882|NCT02014480|3912734|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
2249883|NCT02014480|3912735|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2249884|NCT02014480|3912736|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2249885|NCT02014480|3912731|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2249886|NCT02014480|3912732|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2249887|NCT02014480|3912733|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
2249888|NCT02014480|3912734|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2249889|NCT02014480|3912735|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2249890|NCT02014480|3912736|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2249891|NCT02014480|3912731|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1
2249892|NCT02014480|3912732|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1
2249893|NCT02014480|3912733|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2
2249894|NCT02014480|3912734|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
2249895|NCT02014480|3912735|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
2249896|NCT02014480|3912736|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
2249897|NCT02014480|3912731|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2249898|NCT02014480|3912732|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
2249899|NCT02014480|3912733|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2249900|NCT02014480|3912734|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2249901|NCT02014480|3912735|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2249902|NCT02014480|3912736|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2249903|NCT02014480|3912731|FG000|Treatment Period 3 (14 Days)|Adverse Event|0
2249904|NCT02014480|3912732|FG001|Treatment Period 3 (14 Days)|Adverse Event|0
2249905|NCT02014480|3912733|FG002|Treatment Period 3 (14 Days)|Adverse Event|1
2340804|NCT03426995|4071901|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340805|NCT03426995|4071902|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
2340806|NCT03426995|4071884|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2249906|NCT02014480|3912734|FG003|Treatment Period 3 (14 Days)|Adverse Event|0
2249907|NCT02014480|3912735|FG004|Treatment Period 3 (14 Days)|Adverse Event|0
2249908|NCT02014480|3912736|FG005|Treatment Period 3 (14 Days)|Adverse Event|1
2249909|NCT02014480|3912731|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2249910|NCT02014480|3912732|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2249911|NCT02014480|3912733|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2249912|NCT02014480|3912734|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2249913|NCT02014480|3912735|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2249914|NCT02014480|3912736|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1
2249915|NCT02014584|3912758|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0
2249916|NCT02014584|3912759|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1
2249917|NCT02014584|3912760|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0
2249918|NCT02014584|3912761|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0
2249919|NCT02014584|3912762|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0
2249920|NCT02014584|3912763|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0
2249921|NCT02014584|3912758|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
2249922|NCT02014584|3912759|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
2249923|NCT02014584|3912760|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2249924|NCT02014584|3912761|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2249925|NCT02014584|3912762|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2249926|NCT02014584|3912763|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2249927|NCT02014584|3912758|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2249928|NCT02014584|3912759|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2249929|NCT02014584|3912760|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2
2249930|NCT02014584|3912761|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2249931|NCT02014584|3912762|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2249932|NCT02014584|3912763|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2249933|NCT02014584|3912758|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2249934|NCT02014584|3912759|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2249935|NCT02014584|3912760|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
2249936|NCT02014584|3912761|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
2249937|NCT02014584|3912762|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2249938|NCT02014584|3912763|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2249939|NCT02014584|3912758|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2249940|NCT02014584|3912759|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2249941|NCT02014584|3912760|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2249942|NCT02014584|3912761|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2249943|NCT02014584|3912762|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
2249944|NCT02014584|3912763|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2249945|NCT02014597|3912777|FG000|Overall Study|Unable to record log contrast sensitivity|2
2249946|NCT02014597|3912778|FG001|Overall Study|Unable to record log contrast sensitivity|1
2249947|NCT02014740|3912786|FG000|Overall Study|Lost to Follow-up|4
2249948|NCT02014740|3912787|FG001|Overall Study|Lost to Follow-up|4
2249949|NCT02014740|3912786|FG000|Overall Study|Withdrawal by Subject|2
2249950|NCT02014740|3912787|FG001|Overall Study|Withdrawal by Subject|1
2249951|NCT02015039|3912795|FG000|Overall Study|Not eligible|0
2249952|NCT02015039|3912796|FG001|Overall Study|Not eligible|1
2249953|NCT02015065|3912805|FG000|Overall Study|Death on study|1
2249954|NCT02015065|3912806|FG001|Overall Study|Death on study|2
2249955|NCT02015065|3912807|FG002|Overall Study|Death on study|1
2249956|NCT02015104|3912817|FG000|Overall Study|Withdrew consent after first dose drug|1
2249957|NCT02015104|3912818|FG001|Overall Study|Withdrew consent after first dose drug|0
2249958|NCT02015104|3912817|FG000|Overall Study|Withdrew consent prior to treatment|0
2249959|NCT02015104|3912818|FG001|Overall Study|Withdrew consent prior to treatment|1
2249960|NCT02015195|3912834|FG000|Overall Study|Adverse Event|0
2249961|NCT02015195|3912835|FG001|Overall Study|Adverse Event|0
2249962|NCT02015195|3912836|FG002|Overall Study|Adverse Event|0
2249963|NCT02015195|3912837|FG003|Overall Study|Adverse Event|1
2249964|NCT02015195|3912838|FG004|Overall Study|Adverse Event|0
2249965|NCT02015195|3912839|FG005|Overall Study|Adverse Event|0
2249966|NCT02015195|3912840|FG006|Overall Study|Adverse Event|0
2249967|NCT02015221|3912857|FG000|Overall Study|Withdrawal by Subject|8
2249968|NCT02015221|3912858|FG001|Overall Study|Withdrawal by Subject|6
2249969|NCT02015221|3912857|FG000|Overall Study|Lost to Follow-up|1
2249970|NCT02015221|3912858|FG001|Overall Study|Lost to Follow-up|0
2249971|NCT02015390|3912877|FG000|Overall Study|Lost to Follow-up|1
2249972|NCT02015390|3912878|FG001|Overall Study|Lost to Follow-up|0
2249973|NCT02015390|3912877|FG000|Overall Study|Adverse Event|0
2249974|NCT02015390|3912878|FG001|Overall Study|Adverse Event|3
2249975|NCT02015390|3912877|FG000|Overall Study|Physician Decision|0
2340807|NCT03426995|4071885|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2249976|NCT02015390|3912878|FG001|Overall Study|Physician Decision|1
2249977|NCT02015481|3912892|FG000|Overall Study|Death|1
2249978|NCT02015520|3912901|FG000|Overall Study|Lack of Efficacy|1
2249979|NCT02015520|3912902|FG001|Overall Study|Lack of Efficacy|0
2249980|NCT02015520|3912903|FG002|Overall Study|Lack of Efficacy|3
2249981|NCT02015520|3912904|FG003|Overall Study|Lack of Efficacy|2
2249982|NCT02015520|3912901|FG000|Overall Study|Adverse Event|0
2249983|NCT02015520|3912902|FG001|Overall Study|Adverse Event|0
2249984|NCT02015520|3912903|FG002|Overall Study|Adverse Event|0
2249985|NCT02015520|3912904|FG003|Overall Study|Adverse Event|1
2249986|NCT02015520|3912901|FG000|Overall Study|Withdrawal by Subject|2
2249987|NCT02015520|3912902|FG001|Overall Study|Withdrawal by Subject|2
2249988|NCT02015520|3912903|FG002|Overall Study|Withdrawal by Subject|1
2249989|NCT02015520|3912904|FG003|Overall Study|Withdrawal by Subject|0
2249990|NCT02015520|3912901|FG000|Overall Study|Death|1
2249991|NCT02015520|3912902|FG001|Overall Study|Death|0
2249992|NCT02015520|3912903|FG002|Overall Study|Death|0
2249993|NCT02015520|3912904|FG003|Overall Study|Death|0
2249994|NCT02015520|3912901|FG000|Overall Study|Lost to Follow-up|0
2249995|NCT02015520|3912902|FG001|Overall Study|Lost to Follow-up|0
2249996|NCT02015520|3912903|FG002|Overall Study|Lost to Follow-up|1
2249997|NCT02015520|3912904|FG003|Overall Study|Lost to Follow-up|0
2249998|NCT02015520|3912901|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1
2249999|NCT02015520|3912902|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1
2250000|NCT02015520|3912903|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2
2250001|NCT02015520|3912904|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1
2250002|NCT02015520|3912901|FG000|Overall Study|Subject no Longer Meets Study Criteria|0
2250003|NCT02015520|3912902|FG001|Overall Study|Subject no Longer Meets Study Criteria|1
2250004|NCT02015520|3912903|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
2250005|NCT02015520|3912904|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
2250006|NCT02015546|3912917|FG000|Overall Study|Withdrawal by Subject|1
2250007|NCT02015546|3912918|FG001|Overall Study|Withdrawal by Subject|1
2250008|NCT02015546|3912919|FG002|Overall Study|Withdrawal by Subject|1
2250009|NCT02015546|3912917|FG000|Overall Study|Screem Failure|2
2250010|NCT02015546|3912918|FG001|Overall Study|Screem Failure|1
2250011|NCT02015546|3912919|FG002|Overall Study|Screem Failure|3
2250012|NCT02015637|3912929|FG000|Overall Study|Lost to Follow-up|3
2250013|NCT02015637|3912930|FG001|Overall Study|Lost to Follow-up|5
2250014|NCT02015637|3912929|FG000|Overall Study|Adverse Event|3
2250015|NCT02015637|3912930|FG001|Overall Study|Adverse Event|0
2250016|NCT02015637|3912929|FG000|Overall Study|Did not take study drug|2
2250017|NCT02015637|3912930|FG001|Overall Study|Did not take study drug|0
2250018|NCT02015676|3912939|FG000|Overall Study|Adverse Event|2
2250019|NCT02015676|3912940|FG001|Overall Study|Adverse Event|18
2250020|NCT02015676|3912941|FG002|Overall Study|Adverse Event|0
2250021|NCT02015676|3912939|FG000|Overall Study|Lack of Efficacy|2
2250022|NCT02015676|3912940|FG001|Overall Study|Lack of Efficacy|4
2250023|NCT02015676|3912941|FG002|Overall Study|Lack of Efficacy|0
2250024|NCT02015676|3912939|FG000|Overall Study|Protocol Violation|1
2250025|NCT02015676|3912940|FG001|Overall Study|Protocol Violation|0
2250026|NCT02015676|3912941|FG002|Overall Study|Protocol Violation|0
2250027|NCT02015676|3912939|FG000|Overall Study|Withdrawal by Subject|1
2250028|NCT02015676|3912940|FG001|Overall Study|Withdrawal by Subject|7
2250029|NCT02015676|3912941|FG002|Overall Study|Withdrawal by Subject|1
2250030|NCT02015676|3912939|FG000|Overall Study|Administrative reasons|0
2250031|NCT02015676|3912940|FG001|Overall Study|Administrative reasons|3
2250032|NCT02015676|3912941|FG002|Overall Study|Administrative reasons|1
2250033|NCT02015676|3912939|FG000|Overall Study|Death|0
2250034|NCT02015676|3912940|FG001|Overall Study|Death|1
2250035|NCT02015676|3912941|FG002|Overall Study|Death|0
2250036|NCT02015676|3912939|FG000|Overall Study|Disease progression|3
2250037|NCT02015676|3912940|FG001|Overall Study|Disease progression|1
2250038|NCT02015676|3912941|FG002|Overall Study|Disease progression|1
2250039|NCT02015754|3912945|FG000|Overall Study|Disease progression|5
2250040|NCT02015754|3912945|FG000|Overall Study|Change in treatment modality|5
2250041|NCT02015754|3912945|FG000|Overall Study|Lost to Follow-up|1
2340808|NCT03426995|4071886|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340809|NCT03426995|4071887|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340810|NCT03426995|4071888|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340811|NCT03426995|4071889|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340812|NCT03426995|4071890|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340813|NCT03426995|4071891|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340814|NCT03426995|4071892|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340815|NCT03426995|4071893|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340816|NCT03426995|4071894|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340817|NCT03426995|4071895|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340818|NCT03426995|4071896|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340819|NCT03426995|4071897|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340820|NCT03426995|4071898|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1
2340821|NCT03426995|4071899|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3
2340822|NCT03426995|4071900|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340823|NCT03426995|4071901|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340824|NCT03426995|4071902|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
2340825|NCT03427073|4071957|FG000|Overall Study|Disease Progression|1
2340826|NCT03427073|4071958|FG001|Overall Study|Disease Progression|1
2340827|NCT03427073|4071959|FG002|Overall Study|Disease Progression|1
2340828|NCT03427073|4071960|FG003|Overall Study|Disease Progression|3
2340829|NCT03427073|4071961|FG004|Overall Study|Disease Progression|3
2340830|NCT03427073|4071962|FG005|Overall Study|Disease Progression|4
2340831|NCT03427073|4071963|FG006|Overall Study|Disease Progression|2
2250042|NCT02015793|3912951|FG000|Overall Study|Adverse Event|3
2250043|NCT02015793|3912952|FG001|Overall Study|Adverse Event|3
2250044|NCT02015793|3912951|FG000|Overall Study|Withdrawal by Subject|1
2250045|NCT02015793|3912952|FG001|Overall Study|Withdrawal by Subject|1
2250046|NCT02015819|3912968|FG000|Overall Study|Rickham catheter was misaligned|0
2250047|NCT02015819|3912969|FG001|Overall Study|Rickham catheter was misaligned|0
2250048|NCT02015819|3912970|FG002|Overall Study|Rickham catheter was misaligned|0
2250049|NCT02015819|3912971|FG003|Overall Study|Rickham catheter was misaligned|1
2250050|NCT02016105|3912987|FG000|TREATMENT PERIOD 1|Protocol Violation|2
2250051|NCT02016105|3912988|FG001|TREATMENT PERIOD 1|Protocol Violation|8
2250052|NCT02016105|3912989|FG002|TREATMENT PERIOD 1|Protocol Violation|0
2250053|NCT02016105|3912990|FG003|TREATMENT PERIOD 1|Protocol Violation|0
2250054|NCT02016105|3912991|FG004|TREATMENT PERIOD 1|Protocol Violation|0
2250055|NCT02016105|3912992|FG005|TREATMENT PERIOD 1|Protocol Violation|0
2250056|NCT02016105|3912987|FG000|TREATMENT PERIOD 1|Physician Decision|0
2250057|NCT02016105|3912988|FG001|TREATMENT PERIOD 1|Physician Decision|2
2250058|NCT02016105|3912989|FG002|TREATMENT PERIOD 1|Physician Decision|0
2250059|NCT02016105|3912990|FG003|TREATMENT PERIOD 1|Physician Decision|0
2250060|NCT02016105|3912991|FG004|TREATMENT PERIOD 1|Physician Decision|0
2250061|NCT02016105|3912992|FG005|TREATMENT PERIOD 1|Physician Decision|0
2250062|NCT02016105|3912987|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4
2250063|NCT02016105|3912988|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2
2250064|NCT02016105|3912989|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0
2250065|NCT02016105|3912990|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0
2250066|NCT02016105|3912991|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0
2250067|NCT02016105|3912992|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0
2250068|NCT02016105|3912987|FG000|TREATMENT PERIOD 1|Pregnancy|0
2250069|NCT02016105|3912988|FG001|TREATMENT PERIOD 1|Pregnancy|1
2250070|NCT02016105|3912989|FG002|TREATMENT PERIOD 1|Pregnancy|0
2250071|NCT02016105|3912990|FG003|TREATMENT PERIOD 1|Pregnancy|0
2250072|NCT02016105|3912991|FG004|TREATMENT PERIOD 1|Pregnancy|0
2250073|NCT02016105|3912992|FG005|TREATMENT PERIOD 1|Pregnancy|0
2250074|NCT02016105|3912987|FG000|TREATMENT PERIOD 1|Adverse Event|3
2250075|NCT02016105|3912988|FG001|TREATMENT PERIOD 1|Adverse Event|5
2250076|NCT02016105|3912989|FG002|TREATMENT PERIOD 1|Adverse Event|0
2250077|NCT02016105|3912990|FG003|TREATMENT PERIOD 1|Adverse Event|0
2250078|NCT02016105|3912991|FG004|TREATMENT PERIOD 1|Adverse Event|0
2250079|NCT02016105|3912992|FG005|TREATMENT PERIOD 1|Adverse Event|0
2250080|NCT02016105|3912987|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15
2250081|NCT02016105|3912988|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11
2340832|NCT03427073|4071964|FG007|Overall Study|Disease Progression|3
2340833|NCT03427073|4071957|FG000|Overall Study|Physician Decision|0
2340834|NCT03427073|4071958|FG001|Overall Study|Physician Decision|0
2340835|NCT03427073|4071959|FG002|Overall Study|Physician Decision|0
2340836|NCT03427073|4071960|FG003|Overall Study|Physician Decision|0
2340837|NCT03427073|4071961|FG004|Overall Study|Physician Decision|0
2340838|NCT03427073|4071962|FG005|Overall Study|Physician Decision|0
2038358|NCT00422227|3608694|FG001|Overall Study|Withdrawal by Subject|4
2038359|NCT00422292|3608715|FG000|Overall Study|Serious adverse events|1
2038360|NCT00422292|3608716|FG001|Overall Study|Serious adverse events|4
2038361|NCT00422292|3608717|FG002|Overall Study|Serious adverse events|0
2038362|NCT00422292|3608718|FG003|Overall Study|Serious adverse events|0
2038363|NCT00422292|3608715|FG000|Overall Study|Adverse Event|1
2038364|NCT00422292|3608716|FG001|Overall Study|Adverse Event|0
2038365|NCT00422292|3608717|FG002|Overall Study|Adverse Event|1
2038366|NCT00422292|3608718|FG003|Overall Study|Adverse Event|0
2038367|NCT00422292|3608715|FG000|Overall Study|Protocol Violation|4
2038368|NCT00422292|3608716|FG001|Overall Study|Protocol Violation|25
2038369|NCT00422292|3608717|FG002|Overall Study|Protocol Violation|8
2038370|NCT00422292|3608718|FG003|Overall Study|Protocol Violation|5
2038371|NCT00422292|3608715|FG000|Overall Study|Lost to Follow-up|6
2038372|NCT00422292|3608716|FG001|Overall Study|Lost to Follow-up|12
2038373|NCT00422292|3608717|FG002|Overall Study|Lost to Follow-up|6
2038374|NCT00422292|3608718|FG003|Overall Study|Lost to Follow-up|6
2038375|NCT00422292|3608715|FG000|Overall Study|Withdrawal by Subject|6
2038376|NCT00422292|3608716|FG001|Overall Study|Withdrawal by Subject|25
2038377|NCT00422292|3608717|FG002|Overall Study|Withdrawal by Subject|7
2038378|NCT00422292|3608718|FG003|Overall Study|Withdrawal by Subject|13
2038379|NCT00422383|3608733|FG000|Overall Study|Adverse Event|5
2038380|NCT00422383|3608734|FG001|Overall Study|Adverse Event|3
2038381|NCT00422383|3608735|FG002|Overall Study|Adverse Event|1
2038382|NCT00422383|3608736|FG003|Overall Study|Adverse Event|1
2038383|NCT00422383|3608737|FG004|Overall Study|Adverse Event|0
2250082|NCT02016105|3912989|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0
2250083|NCT02016105|3912990|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0
2250084|NCT02016105|3912991|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0
2250085|NCT02016105|3912992|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0
2250086|NCT02016105|3912987|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6
2250087|NCT02016105|3912988|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4
2250088|NCT02016105|3912989|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0
2250089|NCT02016105|3912990|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0
2340839|NCT03427073|4071963|FG006|Overall Study|Physician Decision|1
2340840|NCT03427073|4071964|FG007|Overall Study|Physician Decision|1
2340841|NCT03427268|4071991|FG000|Overall Study|Progressive disease|25
2250090|NCT02016105|3912991|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0
2250091|NCT02016105|3912992|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0
2250092|NCT02016105|3912987|FG000|TREATMENT PERIOD 2|Non compliance study medication|0
2250093|NCT02016105|3912988|FG001|TREATMENT PERIOD 2|Non compliance study medication|0
2250094|NCT02016105|3912989|FG002|TREATMENT PERIOD 2|Non compliance study medication|0
2250095|NCT02016105|3912990|FG003|TREATMENT PERIOD 2|Non compliance study medication|0
2250096|NCT02016105|3912991|FG004|TREATMENT PERIOD 2|Non compliance study medication|0
2250097|NCT02016105|3912992|FG005|TREATMENT PERIOD 2|Non compliance study medication|1
2250098|NCT02016105|3912987|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0
2250099|NCT02016105|3912988|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0
2250100|NCT02016105|3912989|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2
2250101|NCT02016105|3912990|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6
2250102|NCT02016105|3912991|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3
2250103|NCT02016105|3912992|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2
2250104|NCT02016105|3912987|FG000|TREATMENT PERIOD 2|Pregnancy|0
2250105|NCT02016105|3912988|FG001|TREATMENT PERIOD 2|Pregnancy|0
2250106|NCT02016105|3912989|FG002|TREATMENT PERIOD 2|Pregnancy|0
2250107|NCT02016105|3912990|FG003|TREATMENT PERIOD 2|Pregnancy|0
2250108|NCT02016105|3912991|FG004|TREATMENT PERIOD 2|Pregnancy|0
2250109|NCT02016105|3912992|FG005|TREATMENT PERIOD 2|Pregnancy|1
2250110|NCT02016105|3912987|FG000|TREATMENT PERIOD 2|Death|0
2250111|NCT02016105|3912988|FG001|TREATMENT PERIOD 2|Death|0
2250112|NCT02016105|3912989|FG002|TREATMENT PERIOD 2|Death|0
2250113|NCT02016105|3912990|FG003|TREATMENT PERIOD 2|Death|0
2250114|NCT02016105|3912991|FG004|TREATMENT PERIOD 2|Death|0
2250115|NCT02016105|3912992|FG005|TREATMENT PERIOD 2|Death|1
2250116|NCT02016105|3912987|FG000|TREATMENT PERIOD 2|Adverse Event|0
2250117|NCT02016105|3912988|FG001|TREATMENT PERIOD 2|Adverse Event|0
2250118|NCT02016105|3912989|FG002|TREATMENT PERIOD 2|Adverse Event|0
2250119|NCT02016105|3912990|FG003|TREATMENT PERIOD 2|Adverse Event|4
2250120|NCT02016105|3912991|FG004|TREATMENT PERIOD 2|Adverse Event|0
2250121|NCT02016105|3912992|FG005|TREATMENT PERIOD 2|Adverse Event|1
2250122|NCT02016105|3912987|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0
2250123|NCT02016105|3912988|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0
2250124|NCT02016105|3912989|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3
2250125|NCT02016105|3912990|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1
2250126|NCT02016105|3912991|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1
2250127|NCT02016105|3912992|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7
2250128|NCT02016105|3912987|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0
2250129|NCT02016105|3912988|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0
2250130|NCT02016105|3912989|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1
2250131|NCT02016105|3912990|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0
2250132|NCT02016105|3912991|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0
2250133|NCT02016105|3912992|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1
2250134|NCT02016105|3912987|FG000|EXTENSION PERIOD|New therapy for study indication|0
2250135|NCT02016105|3912988|FG001|EXTENSION PERIOD|New therapy for study indication|0
2250136|NCT02016105|3912989|FG002|EXTENSION PERIOD|New therapy for study indication|0
2250137|NCT02016105|3912990|FG003|EXTENSION PERIOD|New therapy for study indication|0
2250138|NCT02016105|3912991|FG004|EXTENSION PERIOD|New therapy for study indication|1
2250139|NCT02016105|3912992|FG005|EXTENSION PERIOD|New therapy for study indication|1
2250140|NCT02016105|3912987|FG000|EXTENSION PERIOD|Lack of Efficacy|0
2250141|NCT02016105|3912988|FG001|EXTENSION PERIOD|Lack of Efficacy|0
2250142|NCT02016105|3912989|FG002|EXTENSION PERIOD|Lack of Efficacy|1
2250143|NCT02016105|3912990|FG003|EXTENSION PERIOD|Lack of Efficacy|3
2250144|NCT02016105|3912991|FG004|EXTENSION PERIOD|Lack of Efficacy|1
2250145|NCT02016105|3912992|FG005|EXTENSION PERIOD|Lack of Efficacy|1
2250146|NCT02016105|3912987|FG000|EXTENSION PERIOD|Adverse Event|0
2250147|NCT02016105|3912988|FG001|EXTENSION PERIOD|Adverse Event|0
2250148|NCT02016105|3912989|FG002|EXTENSION PERIOD|Adverse Event|2
2250149|NCT02016105|3912990|FG003|EXTENSION PERIOD|Adverse Event|0
2250150|NCT02016105|3912991|FG004|EXTENSION PERIOD|Adverse Event|1
2340842|NCT03427268|4071991|FG000|Overall Study|Never treated|2
2340843|NCT03427268|4071991|FG000|Overall Study|Compassionate use|1
2340844|NCT03427268|4071991|FG000|Overall Study|Withdrawal by Subject|1
2340845|NCT03427268|4071991|FG000|Overall Study|Adverse Event|3
2340846|NCT03427619|4071995|FG000|Overall Study|Physician Decision|3
2340847|NCT03427619|4071995|FG000|Overall Study|Withdrawal by Subject|4
2340848|NCT03427619|4071995|FG000|Overall Study|Lost to Follow-up|5
2340849|NCT03427619|4071995|FG000|Overall Study|Administrative|4
2340850|NCT03427619|4071995|FG000|Overall Study|Other|2
2340851|NCT03427619|4071995|FG000|Overall Study|Unknown or Missing Completion Status|48
2340852|NCT03427892|4071999|FG000|Overall Study|Lost to Follow-up|2
2340853|NCT03428100|4072011|FG000|Overall Study|Adverse Event|1
2340854|NCT03428100|4072012|FG001|Overall Study|Adverse Event|0
2340855|NCT03428100|4072013|FG002|Overall Study|Adverse Event|3
2250151|NCT02016105|3912992|FG005|EXTENSION PERIOD|Adverse Event|0
2250152|NCT02016105|3912987|FG000|EXTENSION PERIOD|Withdrawal by Subject|0
2340856|NCT03428100|4072014|FG003|Overall Study|Adverse Event|1
2340857|NCT03428100|4072011|FG000|Overall Study|Lack of Efficacy|16
2340858|NCT03428100|4072012|FG001|Overall Study|Lack of Efficacy|10
2340859|NCT03428100|4072013|FG002|Overall Study|Lack of Efficacy|7
2340860|NCT03428100|4072014|FG003|Overall Study|Lack of Efficacy|6
2340861|NCT03428100|4072011|FG000|Overall Study|Protocol Deviation|0
2340862|NCT03428100|4072012|FG001|Overall Study|Protocol Deviation|2
2250153|NCT02016105|3912988|FG001|EXTENSION PERIOD|Withdrawal by Subject|0
2250154|NCT02016105|3912989|FG002|EXTENSION PERIOD|Withdrawal by Subject|2
2250155|NCT02016105|3912990|FG003|EXTENSION PERIOD|Withdrawal by Subject|2
2250156|NCT02016105|3912991|FG004|EXTENSION PERIOD|Withdrawal by Subject|2
2250157|NCT02016105|3912992|FG005|EXTENSION PERIOD|Withdrawal by Subject|2
2250158|NCT02016105|3912987|FG000|EXTENSION PERIOD|Non-compliance with study indication|0
2250159|NCT02016105|3912988|FG001|EXTENSION PERIOD|Non-compliance with study indication|0
2250160|NCT02016105|3912989|FG002|EXTENSION PERIOD|Non-compliance with study indication|0
2250161|NCT02016105|3912990|FG003|EXTENSION PERIOD|Non-compliance with study indication|0
2250162|NCT02016105|3912991|FG004|EXTENSION PERIOD|Non-compliance with study indication|1
2250163|NCT02016105|3912992|FG005|EXTENSION PERIOD|Non-compliance with study indication|0
2250164|NCT02016105|3912987|FG000|EXTENSION PERIOD|Lost to Follow-up|0
2250165|NCT02016105|3912988|FG001|EXTENSION PERIOD|Lost to Follow-up|0
2250166|NCT02016105|3912989|FG002|EXTENSION PERIOD|Lost to Follow-up|0
2250167|NCT02016105|3912990|FG003|EXTENSION PERIOD|Lost to Follow-up|0
2250168|NCT02016105|3912991|FG004|EXTENSION PERIOD|Lost to Follow-up|0
2250169|NCT02016105|3912992|FG005|EXTENSION PERIOD|Lost to Follow-up|2
2250170|NCT02016170|3913009|FG000|Overall Study|Adverse Event|1
2250171|NCT02016170|3913010|FG001|Overall Study|Adverse Event|1
2250172|NCT02016170|3913011|FG002|Overall Study|Adverse Event|0
2250173|NCT02016170|3913009|FG000|Overall Study|Protocol Violation|1
2250174|NCT02016170|3913010|FG001|Overall Study|Protocol Violation|0
2250175|NCT02016170|3913011|FG002|Overall Study|Protocol Violation|0
2250176|NCT02016183|3913018|FG000|Overall Study|Case Report Forms Uncollected|13
2250177|NCT02016183|3913018|FG000|Overall Study|Protocol Violation|52
2250178|NCT02016300|3913037|FG000|Overall Study|Lost to Follow-up|0
2250179|NCT02016300|3913038|FG001|Overall Study|Lost to Follow-up|3
2250180|NCT02016482|3913046|FG000|Period A|Adverse Event|3
2250181|NCT02016482|3913047|FG001|Period A|Adverse Event|5
2250182|NCT02016482|3913046|FG000|Period A|Withdrawal by Subject|3
2250183|NCT02016482|3913047|FG001|Period A|Withdrawal by Subject|4
2250184|NCT02016482|3913046|FG000|Period A|Lost to Follow-up|3
2250185|NCT02016482|3913047|FG001|Period A|Lost to Follow-up|3
2250186|NCT02016482|3913046|FG000|Period A|Lack of Efficacy|2
2250187|NCT02016482|3913047|FG001|Period A|Lack of Efficacy|1
2250188|NCT02016482|3913046|FG000|Period A|Other|3
2250189|NCT02016482|3913047|FG001|Period A|Other|0
2250190|NCT02016482|3913046|FG000|Period A|Protocol Violation|0
2250191|NCT02016482|3913047|FG001|Period A|Protocol Violation|1
2250192|NCT02016482|3913046|FG000|Period A|Required Alternative/Prohibited Therapy|0
2250193|NCT02016482|3913047|FG001|Period A|Required Alternative/Prohibited Therapy|1
2250194|NCT02016482|3913046|FG000|Period B|Withdrawal by Subject|1
2250195|NCT02016482|3913047|FG001|Period B|Withdrawal by Subject|1
2250196|NCT02016482|3913046|FG000|Period B|Lost to Follow-up|2
2250197|NCT02016482|3913047|FG001|Period B|Lost to Follow-up|0
2340863|NCT03428100|4072013|FG002|Overall Study|Protocol Deviation|2
2340864|NCT03428100|4072014|FG003|Overall Study|Protocol Deviation|0
2340865|NCT03428100|4072011|FG000|Overall Study|Withdrawal by Subject|4
2340866|NCT03428100|4072012|FG001|Overall Study|Withdrawal by Subject|0
2340867|NCT03428100|4072013|FG002|Overall Study|Withdrawal by Subject|0
2340868|NCT03428100|4072014|FG003|Overall Study|Withdrawal by Subject|0
2340869|NCT03428100|4072011|FG000|Overall Study|Physician Decision|0
2340870|NCT03428100|4072012|FG001|Overall Study|Physician Decision|1
2340871|NCT03428100|4072013|FG002|Overall Study|Physician Decision|0
2340872|NCT03428100|4072014|FG003|Overall Study|Physician Decision|0
2340873|NCT03428152|4072036|FG000|Overall Study|Physician Decision|4
2340874|NCT03428152|4072037|FG001|Overall Study|Physician Decision|2
2340875|NCT03428152|4072036|FG000|Overall Study|Protocol Violation|3
2340876|NCT03428152|4072037|FG001|Overall Study|Protocol Violation|5
2340877|NCT03428152|4072036|FG000|Overall Study|Lack of Efficacy|0
2340878|NCT03428152|4072037|FG001|Overall Study|Lack of Efficacy|4
2340879|NCT03428360|4072060|FG000|Overall Study|Informed consent withdrawn|5
2340880|NCT03428360|4072060|FG000|Overall Study|Withdrawal by Subject|4
2340881|NCT03428360|4072060|FG000|Overall Study|Lost to Follow-up|5
2340882|NCT03428360|4072060|FG000|Overall Study|Physician Decision|2
2340883|NCT03428360|4072060|FG000|Overall Study|Informed consent withdrawn|5
2340884|NCT03428360|4072060|FG000|Overall Study|Study terminated by sponsor|10
2340885|NCT03428360|4072060|FG000|Overall Study|Non-compliant with study|1
2038384|NCT00422383|3608733|FG000|Overall Study|Lack of Efficacy|4
2038385|NCT00422383|3608734|FG001|Overall Study|Lack of Efficacy|4
2038386|NCT00422383|3608735|FG002|Overall Study|Lack of Efficacy|2
2038387|NCT00422383|3608736|FG003|Overall Study|Lack of Efficacy|1
2038388|NCT00422383|3608737|FG004|Overall Study|Lack of Efficacy|1
2038389|NCT00422383|3608733|FG000|Overall Study|Lost to Follow-up|0
2038390|NCT00422383|3608734|FG001|Overall Study|Lost to Follow-up|1
2038391|NCT00422383|3608735|FG002|Overall Study|Lost to Follow-up|0
2038392|NCT00422383|3608736|FG003|Overall Study|Lost to Follow-up|0
2038393|NCT00422383|3608737|FG004|Overall Study|Lost to Follow-up|1
2250198|NCT02016482|3913046|FG000|Period B|Lack of Efficacy|6
2250199|NCT02016482|3913047|FG001|Period B|Lack of Efficacy|4
2250200|NCT02016482|3913046|FG000|Period B|Other|4
2340886|NCT03428360|4072060|FG000|Overall Study|Non-compliant with study drug|3
2340887|NCT03428360|4072060|FG000|Overall Study|Death|3
2340888|NCT03428360|4072060|FG000|Overall Study|Adverse Event|1
2340889|NCT03428360|4072060|FG000|Overall Study|Not on antiepileptic drug|1
2250201|NCT02016482|3913047|FG001|Period B|Other|0
2250202|NCT02016482|3913046|FG000|Period B|Required Alternative/Prohibited Therapy|0
2250203|NCT02016482|3913047|FG001|Period B|Required Alternative/Prohibited Therapy|2
2250204|NCT02016625|3913107|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0
2250205|NCT02016625|3913108|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1
2250206|NCT02016625|3913107|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
2250207|NCT02016625|3913108|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
2250208|NCT02016625|3913107|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
2250209|NCT02016625|3913108|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
2250210|NCT02016690|3913124|FG000|Overall Study|Excluded from SAS: Enrollment violation|2
2250211|NCT02016690|3913124|FG000|Overall Study|Excluded from SAS: Duplication|2
2250212|NCT02016690|3913124|FG000|Overall Study|Excluded from SAS: Early treatment|2
2250213|NCT02016690|3913124|FG000|Overall Study|Excluded from SAS: Ineligible for study|2
2250214|NCT02016690|3913124|FG000|Overall Study|Did not meet inclusion criteria|13
2250215|NCT02016690|3913124|FG000|Overall Study|Hospitalized for RSV at study start|3
2250216|NCT02016716|3913131|FG000|Overall Study|Withdrawal by Subject|5
2250217|NCT02016716|3913132|FG001|Overall Study|Withdrawal by Subject|5
2250218|NCT02016716|3913133|FG002|Overall Study|Withdrawal by Subject|5
2250219|NCT02016716|3913131|FG000|Overall Study|Protocol-specified Criteria|0
2250220|NCT02016716|3913132|FG001|Overall Study|Protocol-specified Criteria|1
2250221|NCT02016716|3913133|FG002|Overall Study|Protocol-specified Criteria|0
2250222|NCT02016716|3913131|FG000|Overall Study|Lost to Follow-up|1
2250223|NCT02016716|3913132|FG001|Overall Study|Lost to Follow-up|2
2250224|NCT02016716|3913133|FG002|Overall Study|Lost to Follow-up|1
2250225|NCT02016755|3913142|FG000|Overall Study|Major amputation of index limb|2
2250226|NCT02016755|3913142|FG000|Overall Study|Adverse Event|2
2250227|NCT02016755|3913142|FG000|Overall Study|Physician Decision|1
2250228|NCT02016755|3913142|FG000|Overall Study|Death|2
2250229|NCT02016898|3913169|FG000|Overall Study|Death|1
2250230|NCT02016898|3913170|FG001|Overall Study|Death|1
2250231|NCT02016898|3913169|FG000|Overall Study|Lost to Follow-up|4
2250232|NCT02016898|3913170|FG001|Overall Study|Lost to Follow-up|4
2250233|NCT02017015|3913181|FG000|Overall Study|Adverse Event|9
2250234|NCT02017015|3913181|FG000|Overall Study|Withdrawal by Subject|21
2250235|NCT02017015|3913181|FG000|Overall Study|Death|4
2250236|NCT02017015|3913181|FG000|Overall Study|Progressive Disease|31
2250237|NCT02017015|3913181|FG000|Overall Study|Non-compliance with study drug|2
2250238|NCT02017015|3913181|FG000|Overall Study|Physician Decision|2
2340890|NCT03428750|4072070|FG000|Overall Study|Withdrawal by Subject|11
2340891|NCT03428750|4072071|FG001|Overall Study|Withdrawal by Subject|10
2340892|NCT03428750|4072070|FG000|Overall Study|Lost to Follow-up|3
2340893|NCT03428750|4072071|FG001|Overall Study|Lost to Follow-up|9
2340894|NCT03428750|4072070|FG000|Overall Study|Adverse Event|9
2340895|NCT03428750|4072071|FG001|Overall Study|Adverse Event|1
2340896|NCT03428750|4072070|FG000|Overall Study|Protocol Violation|1
2340897|NCT03428750|4072071|FG001|Overall Study|Protocol Violation|0
2340898|NCT03428750|4072070|FG000|Overall Study|Administrative|0
2340899|NCT03428750|4072071|FG001|Overall Study|Administrative|1
2340900|NCT03428815|4072102|FG000|Overall Study|Lost to Follow-up|2
2340901|NCT03428815|4072103|FG001|Overall Study|Lost to Follow-up|2
2340902|NCT03428815|4072102|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5
2340903|NCT03428815|4072103|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2
2340904|NCT03428815|4072102|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3
2340905|NCT03428815|4072103|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1
2340906|NCT03428997|4072109|FG000|Overall Study|Sponsor decision.|1
2340907|NCT03428997|4072109|FG000|Overall Study|Withdrawal by Subject|3
2340908|NCT03428997|4072109|FG000|Overall Study|Lost to Follow-up|4
2340909|NCT03429556|4072134|FG000|Overall Study|Lost to Follow-up|0
2340910|NCT03429556|4072135|FG001|Overall Study|Lost to Follow-up|1
2340911|NCT03429556|4072136|FG002|Overall Study|Lost to Follow-up|0
2340912|NCT03429556|4072137|FG003|Overall Study|Lost to Follow-up|0
2340913|NCT03430245|4072165|FG000|Overall Study|Withdrawal by Subject|6
2340914|NCT03430245|4072165|FG000|Overall Study|Lost to Follow-up|1
2340915|NCT03430856|4072182|FG000|Overall Study|Adverse Event|0
2340916|NCT03430856|4072183|FG001|Overall Study|Adverse Event|1
2340917|NCT03430856|4072184|FG002|Overall Study|Adverse Event|0
2340918|NCT03430856|4072182|FG000|Overall Study|Rescue criteria|1
2340919|NCT03430856|4072183|FG001|Overall Study|Rescue criteria|1
2340920|NCT03430856|4072184|FG002|Overall Study|Rescue criteria|0
2340921|NCT03430856|4072182|FG000|Overall Study|Voluntary withdrawal of consent|1
2038394|NCT00422383|3608733|FG000|Overall Study|Protocol Violation|1
2038395|NCT00422383|3608734|FG001|Overall Study|Protocol Violation|1
2038396|NCT00422383|3608735|FG002|Overall Study|Protocol Violation|1
2038397|NCT00422383|3608736|FG003|Overall Study|Protocol Violation|0
2038398|NCT00422383|3608737|FG004|Overall Study|Protocol Violation|0
2038399|NCT00422383|3608733|FG000|Overall Study|Withdrawal by Subject|5
2038400|NCT00422383|3608734|FG001|Overall Study|Withdrawal by Subject|5
2038401|NCT00422383|3608735|FG002|Overall Study|Withdrawal by Subject|0
2250239|NCT02017171|3913199|FG000|Overall Study|Death|10
2250240|NCT02017171|3913200|FG001|Overall Study|Death|4
2250241|NCT02017171|3913199|FG000|Overall Study|Withdrawal by Subject|23
2250242|NCT02017171|3913200|FG001|Overall Study|Withdrawal by Subject|17
2250243|NCT02017171|3913199|FG000|Overall Study|Lost to Follow-up|21
2250244|NCT02017171|3913200|FG001|Overall Study|Lost to Follow-up|20
2250245|NCT02017171|3913199|FG000|Overall Study|ESKD|6
2250246|NCT02017171|3913200|FG001|Overall Study|ESKD|2
2250247|NCT02017171|3913199|FG000|Overall Study|Miscellaneous|2
2250248|NCT02017171|3913200|FG001|Overall Study|Miscellaneous|3
2250249|NCT02017223|3913223|FG000|Overall Study|Algorithm problems|2
2250250|NCT02017444|3913242|FG000|Overall Study|Physician Decision|1
2250251|NCT02017444|3913243|FG001|Overall Study|Physician Decision|0
2250252|NCT02017444|3913242|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1
2250253|NCT02017444|3913243|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0
2250254|NCT02017535|3913253|FG000|Overall Study|Withdrawal by Subject|1
2250255|NCT02017535|3913254|FG001|Overall Study|Withdrawal by Subject|0
2250256|NCT02017535|3913255|FG002|Overall Study|Withdrawal by Subject|0
2250257|NCT02017535|3913256|FG003|Overall Study|Withdrawal by Subject|0
2250258|NCT02017860|3913275|FG000|Overall Study|Adverse Event|1
2250259|NCT02017860|3913275|FG000|Overall Study|Withdrawal by Subject|1
2250260|NCT02017899|3913285|FG000|Overall Study|Withdrawal by Subject|0
2250261|NCT02017899|3913286|FG001|Overall Study|Withdrawal by Subject|0
2250262|NCT02017899|3913287|FG002|Overall Study|Withdrawal by Subject|0
2250263|NCT02017899|3913288|FG003|Overall Study|Withdrawal by Subject|1
2250264|NCT02017899|3913289|FG004|Overall Study|Withdrawal by Subject|1
2250265|NCT02017899|3913290|FG005|Overall Study|Withdrawal by Subject|0
2250266|NCT02018042|3913304|FG000|Overall Study|Withdrawal by Subject|1
2340922|NCT03430856|4072183|FG001|Overall Study|Voluntary withdrawal of consent|1
2340923|NCT03430856|4072184|FG002|Overall Study|Voluntary withdrawal of consent|1
2340924|NCT03430986|4072197|FG000|24-week Control Period|Adverse Event|1
2340925|NCT03430986|4072198|FG001|24-week Control Period|Adverse Event|0
2340926|NCT03430986|4072197|FG000|24-week Control Period|Lost to Follow-up|2
2340927|NCT03430986|4072198|FG001|24-week Control Period|Lost to Follow-up|2
2340928|NCT03430986|4072197|FG000|24-week Control Period|Withdrawal by Participant|5
2340929|NCT03430986|4072198|FG001|24-week Control Period|Withdrawal by Participant|0
2340930|NCT03430986|4072197|FG000|24-week Control Period|Protocol Deviation|0
2340931|NCT03430986|4072198|FG001|24-week Control Period|Protocol Deviation|2
2340932|NCT03430986|4072197|FG000|24-week Post-Control Period|Lost to Follow-up|1
2340933|NCT03430986|4072198|FG001|24-week Post-Control Period|Lost to Follow-up|1
2340934|NCT03430986|4072197|FG000|24-week Post-Control Period|Withdrawal by Participant|0
2340935|NCT03430986|4072198|FG001|24-week Post-Control Period|Withdrawal by Participant|1
2340936|NCT03431337|4072230|FG000|Overall Study|Lost to Follow-up|21
2340937|NCT03431337|4072231|FG001|Overall Study|Lost to Follow-up|19
2340938|NCT03431337|4072230|FG000|Overall Study|Withdrawal by Subject|8
2340939|NCT03431337|4072231|FG001|Overall Study|Withdrawal by Subject|3
2340940|NCT03431441|4072241|FG000|Overall Study|Withdrawal by Subject|2
2340941|NCT03431441|4072241|FG000|Overall Study|Adverse Event|2
2340942|NCT03431441|4072241|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1
2340943|NCT03431857|4072245|FG000|Overall Study|Death|6
2340944|NCT03431857|4072245|FG000|Overall Study|Lost to Follow-up|41
2340945|NCT03431857|4072245|FG000|Overall Study|Adverse Event|6
2340946|NCT03431857|4072245|FG000|Overall Study|Withdrawal by Subject|1
2340947|NCT03432390|4072251|FG000|Apnea Period|Protocol Violation|2
2340948|NCT03432390|4072252|FG001|Apnea Period|Protocol Violation|2
2340949|NCT03432533|4072260|FG000|Overall Study|Lost to Follow-up|1
2340950|NCT03432533|4072261|FG001|Overall Study|Lost to Follow-up|2
2340951|NCT03432533|4072260|FG000|Overall Study|Withdrawal by Subject|14
2340952|NCT03432533|4072261|FG001|Overall Study|Withdrawal by Subject|9
2340953|NCT03432858|4072270|FG000|Overall Study|Protocol Violation|2
2340954|NCT03432858|4072271|FG001|Overall Study|Protocol Violation|1
2340955|NCT03432858|4072272|FG002|Overall Study|Protocol Violation|9
2340956|NCT03432858|4072270|FG000|Overall Study|Withdrawal by Subject|0
2340957|NCT03432858|4072271|FG001|Overall Study|Withdrawal by Subject|1
2340958|NCT03432858|4072272|FG002|Overall Study|Withdrawal by Subject|1
2340959|NCT03432858|4072270|FG000|Overall Study|Procedure canceled/rescheduled|0
2340960|NCT03432858|4072271|FG001|Overall Study|Procedure canceled/rescheduled|9
2340961|NCT03432858|4072272|FG002|Overall Study|Procedure canceled/rescheduled|6
2340962|NCT03432858|4072270|FG000|Overall Study|Required postop mobilization with splinting|0
2340963|NCT03432858|4072271|FG001|Overall Study|Required postop mobilization with splinting|0
2340964|NCT03432858|4072272|FG002|Overall Study|Required postop mobilization with splinting|1
2340965|NCT03433482|4072284|FG000|Overall Study|Lost to Follow-up|1
2340966|NCT03433482|4072285|FG001|Overall Study|Lost to Follow-up|0
2340967|NCT03433482|4072286|FG002|Overall Study|Lost to Follow-up|1
2340968|NCT03433482|4072287|FG003|Overall Study|Lost to Follow-up|1
2340969|NCT03433482|4072284|FG000|Overall Study|Withdrawal by Subject|0
2340970|NCT03433482|4072285|FG001|Overall Study|Withdrawal by Subject|0
2340971|NCT03433482|4072286|FG002|Overall Study|Withdrawal by Subject|1
2340972|NCT03433482|4072287|FG003|Overall Study|Withdrawal by Subject|0
2340973|NCT03433482|4072284|FG000|Overall Study|Unknown reason|0
2340974|NCT03433482|4072285|FG001|Overall Study|Unknown reason|0
2340975|NCT03433482|4072286|FG002|Overall Study|Unknown reason|2
2340976|NCT03433482|4072287|FG003|Overall Study|Unknown reason|0
2340977|NCT03433677|4072299|FG000|Period 1|Protocol Violation|1
2340978|NCT03433677|4072300|FG001|Period 1|Protocol Violation|0
2250267|NCT02018458|3913323|FG000|Overall Study|Death|4
2250268|NCT02018562|3913329|FG000|Overall Study|Withdrawal by Subject|2
2250269|NCT02018562|3913330|FG001|Overall Study|Withdrawal by Subject|0
2250270|NCT02018562|3913329|FG000|Overall Study|Discharged prior to study completion|1
2250271|NCT02018562|3913330|FG001|Overall Study|Discharged prior to study completion|0
2250272|NCT02018822|3913373|FG000|Overall Study|filling replaced by crown|0
2250273|NCT02018822|3913374|FG001|Overall Study|filling replaced by crown|1
2250274|NCT02018822|3913375|FG002|Overall Study|filling replaced by crown|0
2250275|NCT02018822|3913373|FG000|Overall Study|Physician Decision|0
2250276|NCT02018822|3913374|FG001|Overall Study|Physician Decision|1
2250277|NCT02018822|3913375|FG002|Overall Study|Physician Decision|1
2250278|NCT02018822|3913373|FG000|Overall Study|Lost to Follow-up|6
2250279|NCT02018822|3913374|FG001|Overall Study|Lost to Follow-up|6
2250280|NCT02018822|3913375|FG002|Overall Study|Lost to Follow-up|5
2250281|NCT02018887|3913394|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1
2250282|NCT02018887|3913395|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2250283|NCT02018887|3913396|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2250284|NCT02018887|3913397|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2250285|NCT02018887|3913398|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2250286|NCT02018887|3913399|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2250287|NCT02018887|3913400|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2250288|NCT02018887|3913401|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2250289|NCT02018887|3913402|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2250290|NCT02018887|3913403|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2250291|NCT02018887|3913404|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2250292|NCT02018887|3913394|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0
2250293|NCT02018887|3913395|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0
2250294|NCT02018887|3913396|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0
2250295|NCT02018887|3913397|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0
2250296|NCT02018887|3913398|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1
2250297|NCT02018887|3913399|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0
2250298|NCT02018887|3913400|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1
2250299|NCT02018887|3913401|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4
2250300|NCT02018887|3913402|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0
2250301|NCT02018887|3913403|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0
2250302|NCT02018887|3913404|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0
2250303|NCT02018887|3913394|FG000|Part C: Cohort 8 Overall|Adverse Event|0
2250304|NCT02018887|3913395|FG001|Part C: Cohort 8 Overall|Adverse Event|0
2250305|NCT02018887|3913396|FG002|Part C: Cohort 8 Overall|Adverse Event|0
2250306|NCT02018887|3913397|FG003|Part C: Cohort 8 Overall|Adverse Event|0
2250307|NCT02018887|3913398|FG004|Part C: Cohort 8 Overall|Adverse Event|0
2250308|NCT02018887|3913399|FG005|Part C: Cohort 8 Overall|Adverse Event|0
2250309|NCT02018887|3913400|FG006|Part C: Cohort 8 Overall|Adverse Event|0
2250310|NCT02018887|3913401|FG007|Part C: Cohort 8 Overall|Adverse Event|0
2250311|NCT02018887|3913402|FG008|Part C: Cohort 8 Overall|Adverse Event|1
2250312|NCT02018887|3913403|FG009|Part C: Cohort 8 Overall|Adverse Event|3
2250313|NCT02018887|3913404|FG010|Part C: Cohort 8 Overall|Adverse Event|0
2250314|NCT02018887|3913394|FG000|Part C: Cohort 8 Overall|Physician Decision|0
2250315|NCT02018887|3913395|FG001|Part C: Cohort 8 Overall|Physician Decision|0
2250316|NCT02018887|3913396|FG002|Part C: Cohort 8 Overall|Physician Decision|0
2250317|NCT02018887|3913397|FG003|Part C: Cohort 8 Overall|Physician Decision|0
2250318|NCT02018887|3913398|FG004|Part C: Cohort 8 Overall|Physician Decision|0
2250319|NCT02018887|3913399|FG005|Part C: Cohort 8 Overall|Physician Decision|0
2250320|NCT02018887|3913400|FG006|Part C: Cohort 8 Overall|Physician Decision|0
2250321|NCT02018887|3913401|FG007|Part C: Cohort 8 Overall|Physician Decision|0
2250322|NCT02018887|3913402|FG008|Part C: Cohort 8 Overall|Physician Decision|2
2250323|NCT02018887|3913403|FG009|Part C: Cohort 8 Overall|Physician Decision|0
2250324|NCT02018887|3913404|FG010|Part C: Cohort 8 Overall|Physician Decision|1
2250325|NCT02019108|3913476|FG000|Overall Study|Lost to Follow-up|5
2250326|NCT02019108|3913477|FG001|Overall Study|Lost to Follow-up|7
2250327|NCT02019264|3913485|FG000|Overall Study|Not treated|6
2250328|NCT02019264|3913486|FG001|Overall Study|Not treated|4
2250329|NCT02019264|3913485|FG000|Overall Study|Lost to Follow-up|50
2250330|NCT02019264|3913486|FG001|Overall Study|Lost to Follow-up|47
2250331|NCT02019264|3913485|FG000|Overall Study|Withdrawal by Subject|142
2250332|NCT02019264|3913486|FG001|Overall Study|Withdrawal by Subject|117
2250333|NCT02019264|3913485|FG000|Overall Study|Administrative reason|36
2250334|NCT02019264|3913486|FG001|Overall Study|Administrative reason|28
2250335|NCT02019264|3913485|FG000|Overall Study|Missing|14
2250336|NCT02019264|3913486|FG001|Overall Study|Missing|11
2250337|NCT02019277|3913492|FG000|Overall Study|Withdrawal by Subject|3
2250338|NCT02019277|3913492|FG000|Overall Study|Death|7
2250339|NCT02019277|3913492|FG000|Overall Study|Did no Cooperate|1
2250340|NCT02019277|3913492|FG000|Overall Study|Adverse Event|1
2250341|NCT02019420|3913498|FG000|Overall Study|Did not receive study drug|2
2250342|NCT02019420|3913499|FG001|Overall Study|Did not receive study drug|2
2250343|NCT02019420|3913498|FG000|Overall Study|Withdrawal by Subject|1
2250344|NCT02019420|3913499|FG001|Overall Study|Withdrawal by Subject|3
2250345|NCT02019420|3913498|FG000|Overall Study|At request of sponsor or investigator|0
2250346|NCT02019420|3913499|FG001|Overall Study|At request of sponsor or investigator|1
2250347|NCT02019420|3913498|FG000|Overall Study|Death|104
2250348|NCT02019420|3913499|FG001|Overall Study|Death|99
2250349|NCT02019420|3913498|FG000|Overall Study|Transferred to other care facility|1
2250350|NCT02019420|3913499|FG001|Overall Study|Transferred to other care facility|1
2250351|NCT02019472|3913508|FG000|Overall Study|Adverse Event|14
2250352|NCT02019472|3913509|FG001|Overall Study|Adverse Event|23
2250353|NCT02019472|3913510|FG002|Overall Study|Adverse Event|17
2250354|NCT02019472|3913508|FG000|Overall Study|Death|0
2250355|NCT02019472|3913509|FG001|Overall Study|Death|1
2250356|NCT02019472|3913510|FG002|Overall Study|Death|1
2250357|NCT02019472|3913508|FG000|Overall Study|Lack of Efficacy|7
2250358|NCT02019472|3913509|FG001|Overall Study|Lack of Efficacy|4
2250359|NCT02019472|3913510|FG002|Overall Study|Lack of Efficacy|4
2250360|NCT02019472|3913508|FG000|Overall Study|Lost to Follow-up|0
2250361|NCT02019472|3913509|FG001|Overall Study|Lost to Follow-up|2
2250362|NCT02019472|3913510|FG002|Overall Study|Lost to Follow-up|1
2250363|NCT02019472|3913508|FG000|Overall Study|Physician Decision|1
2250364|NCT02019472|3913509|FG001|Overall Study|Physician Decision|2
2250365|NCT02019472|3913510|FG002|Overall Study|Physician Decision|0
2250366|NCT02019472|3913508|FG000|Overall Study|Pregnancy|1
2250367|NCT02019472|3913509|FG001|Overall Study|Pregnancy|2
2250368|NCT02019472|3913510|FG002|Overall Study|Pregnancy|2
2250369|NCT02019472|3913508|FG000|Overall Study|Withdrawal by Subject|11
2250370|NCT02019472|3913509|FG001|Overall Study|Withdrawal by Subject|10
2250371|NCT02019472|3913510|FG002|Overall Study|Withdrawal by Subject|11
2250372|NCT02019472|3913508|FG000|Overall Study|Other|3
2250373|NCT02019472|3913509|FG001|Overall Study|Other|8
2250374|NCT02019472|3913510|FG002|Overall Study|Other|6
2250375|NCT02019550|3913524|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
2250376|NCT02019550|3913525|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1
2250377|NCT02019602|3913546|FG000|Screening Period|Ineligibility|4
2250378|NCT02019602|3913547|FG001|Screening Period|Ineligibility|0
2250379|NCT02019602|3913546|FG000|Screening Period|Adverse Event|1
2340979|NCT03433677|4072299|FG000|Period 2|Withdrawal by Subject|1
2340980|NCT03433677|4072300|FG001|Period 2|Withdrawal by Subject|1
2340981|NCT03433703|4072307|FG000|Overall Study|Study terminated by Sponsor|2
2340982|NCT03433755|4072315|FG000|Overall Study|Lost to Follow-up|1
2340983|NCT03433755|4072316|FG001|Overall Study|Lost to Follow-up|0
2340984|NCT03433755|4072317|FG002|Overall Study|Lost to Follow-up|0
2340985|NCT03433755|4072318|FG003|Overall Study|Lost to Follow-up|0
2340986|NCT03433755|4072315|FG000|Overall Study|Decision by Sponsor|1
2340987|NCT03433755|4072316|FG001|Overall Study|Decision by Sponsor|0
2340988|NCT03433755|4072317|FG002|Overall Study|Decision by Sponsor|0
2340989|NCT03433755|4072318|FG003|Overall Study|Decision by Sponsor|0
2340990|NCT03434119|4072345|FG000|Overall Study|Randomized but not treated|1
2340991|NCT03434119|4072346|FG001|Overall Study|Randomized but not treated|0
2340992|NCT03434119|4072345|FG000|Overall Study|Adverse Event|1
2340993|NCT03434119|4072346|FG001|Overall Study|Adverse Event|0
2340994|NCT03434119|4072345|FG000|Overall Study|Poor Compliance to Protocol|0
2340995|NCT03434119|4072346|FG001|Overall Study|Poor Compliance to Protocol|1
2340996|NCT03434119|4072345|FG000|Overall Study|Study Terminated by Sponsor|91
2340997|NCT03434119|4072346|FG001|Overall Study|Study Terminated by Sponsor|102
2340998|NCT03434119|4072345|FG000|Overall Study|Withdrawal by Subject|7
2340999|NCT03434119|4072346|FG001|Overall Study|Withdrawal by Subject|5
2341000|NCT03434119|4072345|FG000|Overall Study|Other than specified|7
2341001|NCT03434119|4072346|FG001|Overall Study|Other than specified|5
2038402|NCT00422383|3608736|FG003|Overall Study|Withdrawal by Subject|0
2038403|NCT00422383|3608737|FG004|Overall Study|Withdrawal by Subject|1
2038404|NCT00422422|3608755|FG000|Overall Study|Lack of Efficacy|1
2038405|NCT00422422|3608755|FG000|Overall Study|Protocol Violation|1
2038406|NCT00422422|3608755|FG000|Overall Study|Withdrawal by Subject|2
2038407|NCT00422422|3608755|FG000|Overall Study|SAE, non-fatal|1
2038408|NCT00422422|3608755|FG000|Overall Study|AE, non-serious non-fatal|5
2038409|NCT00422461|3608769|FG000|Overall Study|Adverse Event|1
2038410|NCT00422461|3608770|FG001|Overall Study|Adverse Event|2
2038411|NCT00422461|3608771|FG002|Overall Study|Adverse Event|1
2038412|NCT00422461|3608772|FG003|Overall Study|Adverse Event|1
2250380|NCT02019602|3913547|FG001|Screening Period|Adverse Event|0
2250381|NCT02019667|3913554|FG000|First Intervention (6 Months)|Adverse Event|0
2250382|NCT02019667|3913555|FG001|First Intervention (6 Months)|Adverse Event|1
2250383|NCT02019667|3913554|FG000|2nd Intervention (6 Months)|Adverse Event|0
2250384|NCT02019667|3913555|FG001|2nd Intervention (6 Months)|Adverse Event|1
2250385|NCT02019667|3913554|FG000|2nd Intervention (6 Months)|Physician Decision|0
2250386|NCT02019667|3913555|FG001|2nd Intervention (6 Months)|Physician Decision|1
2250387|NCT02019719|3913568|FG000|Overall Study|Adverse Event|1
2250388|NCT02019719|3913569|FG001|Overall Study|Adverse Event|0
2250389|NCT02019719|3913570|FG002|Overall Study|Adverse Event|0
2250390|NCT02019719|3913571|FG003|Overall Study|Adverse Event|1
2250391|NCT02019719|3913572|FG004|Overall Study|Adverse Event|1
2250392|NCT02019719|3913568|FG000|Overall Study|Protocol Violation|1
2250393|NCT02019719|3913569|FG001|Overall Study|Protocol Violation|1
2250394|NCT02019719|3913570|FG002|Overall Study|Protocol Violation|0
2250395|NCT02019719|3913571|FG003|Overall Study|Protocol Violation|0
2341002|NCT03434249|4072354|FG000|Overall Study|Adverse Event|1
2341003|NCT03434249|4072355|FG001|Overall Study|Adverse Event|0
2341004|NCT03434249|4072354|FG000|Overall Study|Lost to Follow-up|0
2341005|NCT03434249|4072355|FG001|Overall Study|Lost to Follow-up|1
2250396|NCT02019719|3913572|FG004|Overall Study|Protocol Violation|0
2250397|NCT02019719|3913568|FG000|Overall Study|Protocol defined stopping criteria|2
2250398|NCT02019719|3913569|FG001|Overall Study|Protocol defined stopping criteria|0
2250399|NCT02019719|3913570|FG002|Overall Study|Protocol defined stopping criteria|0
2250400|NCT02019719|3913571|FG003|Overall Study|Protocol defined stopping criteria|1
2250401|NCT02019719|3913572|FG004|Overall Study|Protocol defined stopping criteria|1
2250402|NCT02019719|3913568|FG000|Overall Study|Physician Decision|2
2250403|NCT02019719|3913569|FG001|Overall Study|Physician Decision|0
2250404|NCT02019719|3913570|FG002|Overall Study|Physician Decision|0
2250405|NCT02019719|3913571|FG003|Overall Study|Physician Decision|0
2250406|NCT02019719|3913572|FG004|Overall Study|Physician Decision|0
2250407|NCT02019927|3913619|FG000|Overall Study|Lost to Follow-up|2
2250408|NCT02019927|3913620|FG001|Overall Study|Lost to Follow-up|4
2250409|NCT02019927|3913621|FG002|Overall Study|Lost to Follow-up|1
2250410|NCT02019927|3913622|FG003|Overall Study|Lost to Follow-up|2
2250411|NCT02019927|3913623|FG004|Overall Study|Lost to Follow-up|3
2250412|NCT02019927|3913624|FG005|Overall Study|Lost to Follow-up|1
2250413|NCT02019979|3913646|FG000|Overall Study|study terminated|14
2250414|NCT02020031|3913661|FG000|Overall Study|Physician Decision|1
2250415|NCT02020031|3913662|FG001|Overall Study|Physician Decision|1
2250416|NCT02020512|3913717|FG000|Overall Study|Adverse Event|1
2250417|NCT02020512|3913717|FG000|Overall Study|Lost to Follow-up|3
2250418|NCT02020512|3913717|FG000|Overall Study|Protocol Violation|4
2250419|NCT02020577|3913723|FG000|Overall Study|Progressive disease|3
2250420|NCT02020577|3913724|FG001|Overall Study|Progressive disease|38
2250421|NCT02020577|3913723|FG000|Overall Study|Other AE or clinical progression|0
2250422|NCT02020577|3913724|FG001|Overall Study|Other AE or clinical progression|15
2250423|NCT02020577|3913723|FG000|Overall Study|Withdrawal by Subject|0
2250424|NCT02020577|3913724|FG001|Overall Study|Withdrawal by Subject|1
2250425|NCT02020577|3913723|FG000|Overall Study|Other than stated above|0
2250426|NCT02020577|3913724|FG001|Overall Study|Other than stated above|1
2250427|NCT02020616|3913743|FG000|Overall Study|Adverse Event|0
2250428|NCT02020616|3913744|FG001|Overall Study|Adverse Event|0
2250429|NCT02020616|3913745|FG002|Overall Study|Adverse Event|0
2250430|NCT02020616|3913746|FG003|Overall Study|Adverse Event|0
2250431|NCT02020616|3913747|FG004|Overall Study|Adverse Event|0
2250432|NCT02020616|3913748|FG005|Overall Study|Adverse Event|1
2250433|NCT02020616|3913749|FG006|Overall Study|Adverse Event|1
2250434|NCT02020616|3913743|FG000|Overall Study|Physician Decision|0
2250435|NCT02020616|3913744|FG001|Overall Study|Physician Decision|0
2250436|NCT02020616|3913745|FG002|Overall Study|Physician Decision|0
2250437|NCT02020616|3913746|FG003|Overall Study|Physician Decision|0
2250438|NCT02020616|3913747|FG004|Overall Study|Physician Decision|0
2250439|NCT02020616|3913748|FG005|Overall Study|Physician Decision|1
2250440|NCT02020616|3913749|FG006|Overall Study|Physician Decision|2
2250441|NCT02020616|3913743|FG000|Overall Study|Withdrawal by Subject|0
2250442|NCT02020616|3913744|FG001|Overall Study|Withdrawal by Subject|0
2250443|NCT02020616|3913745|FG002|Overall Study|Withdrawal by Subject|1
2250444|NCT02020616|3913746|FG003|Overall Study|Withdrawal by Subject|0
2250445|NCT02020616|3913747|FG004|Overall Study|Withdrawal by Subject|0
2250446|NCT02020616|3913748|FG005|Overall Study|Withdrawal by Subject|1
2250447|NCT02020616|3913749|FG006|Overall Study|Withdrawal by Subject|1
2250448|NCT02020616|3913743|FG000|Overall Study|Lost to Follow-up|0
2341006|NCT03434249|4072354|FG000|Overall Study|Non-compliance of family|2
2341007|NCT03434249|4072355|FG001|Overall Study|Non-compliance of family|1
2341008|NCT03434249|4072354|FG000|Overall Study|Difficulties in completing daily diary|2
2341009|NCT03434249|4072355|FG001|Overall Study|Difficulties in completing daily diary|1
2341010|NCT03434834|4072365|FG000|Overall Study|unable to swallow OCT probe|16
2341011|NCT03434977|4072371|FG000|Washout Period (at Least 6 Days)|Adverse Event|0
2341012|NCT03434977|4072372|FG001|Washout Period (at Least 6 Days)|Adverse Event|1
2341013|NCT03435055|4072378|FG000|Screening|Physician Decision|2
2341014|NCT03435055|4072378|FG000|Received Intervention|Did not complete nitrous administration|3
2341015|NCT03435081|4072392|FG000|Overall Study|Lack of Efficacy|6
2341016|NCT03435081|4072393|FG001|Overall Study|Lack of Efficacy|5
2341017|NCT03435081|4072394|FG002|Overall Study|Lack of Efficacy|0
2341018|NCT03435081|4072392|FG000|Overall Study|Adverse Event|2
2341019|NCT03435081|4072393|FG001|Overall Study|Adverse Event|2
2341020|NCT03435081|4072394|FG002|Overall Study|Adverse Event|2
2341021|NCT03435081|4072392|FG000|Overall Study|Withdrawal by Subject|8
2341022|NCT03435081|4072393|FG001|Overall Study|Withdrawal by Subject|7
2341023|NCT03435081|4072394|FG002|Overall Study|Withdrawal by Subject|10
2341024|NCT03435081|4072392|FG000|Overall Study|Lost to Follow-up|3
2341025|NCT03435081|4072393|FG001|Overall Study|Lost to Follow-up|1
2341026|NCT03435081|4072394|FG002|Overall Study|Lost to Follow-up|4
2341027|NCT03435081|4072392|FG000|Overall Study|Pregnancy|1
2341028|NCT03435081|4072393|FG001|Overall Study|Pregnancy|0
2341029|NCT03435081|4072394|FG002|Overall Study|Pregnancy|0
2250449|NCT02020616|3913744|FG001|Overall Study|Lost to Follow-up|1
2250450|NCT02020616|3913745|FG002|Overall Study|Lost to Follow-up|0
2250451|NCT02020616|3913746|FG003|Overall Study|Lost to Follow-up|1
2341030|NCT03435081|4072392|FG000|Overall Study|Non-compliance|1
2341031|NCT03435081|4072393|FG001|Overall Study|Non-compliance|0
2341032|NCT03435081|4072394|FG002|Overall Study|Non-compliance|2
2341033|NCT03435081|4072392|FG000|Overall Study|Inadequate Response|0
2341034|NCT03435081|4072393|FG001|Overall Study|Inadequate Response|1
2250452|NCT02020616|3913747|FG004|Overall Study|Lost to Follow-up|1
2250453|NCT02020616|3913748|FG005|Overall Study|Lost to Follow-up|1
2250454|NCT02020616|3913749|FG006|Overall Study|Lost to Follow-up|0
2250455|NCT02020616|3913743|FG000|Overall Study|Early Termination Criteria Met|0
2250456|NCT02020616|3913744|FG001|Overall Study|Early Termination Criteria Met|0
2250457|NCT02020616|3913745|FG002|Overall Study|Early Termination Criteria Met|1
2250458|NCT02020616|3913746|FG003|Overall Study|Early Termination Criteria Met|0
2250459|NCT02020616|3913747|FG004|Overall Study|Early Termination Criteria Met|0
2250460|NCT02020616|3913748|FG005|Overall Study|Early Termination Criteria Met|1
2250461|NCT02020616|3913749|FG006|Overall Study|Early Termination Criteria Met|0
2250462|NCT02020616|3913743|FG000|Overall Study|Randomized in Error|0
2250463|NCT02020616|3913744|FG001|Overall Study|Randomized in Error|0
2250464|NCT02020616|3913745|FG002|Overall Study|Randomized in Error|0
2250465|NCT02020616|3913746|FG003|Overall Study|Randomized in Error|1
2250466|NCT02020616|3913747|FG004|Overall Study|Randomized in Error|0
2250467|NCT02020616|3913748|FG005|Overall Study|Randomized in Error|0
2250468|NCT02020616|3913749|FG006|Overall Study|Randomized in Error|0
2250469|NCT02020616|3913743|FG000|Overall Study|Lack of Efficacy|0
2250470|NCT02020616|3913744|FG001|Overall Study|Lack of Efficacy|0
2250471|NCT02020616|3913745|FG002|Overall Study|Lack of Efficacy|0
2250472|NCT02020616|3913746|FG003|Overall Study|Lack of Efficacy|0
2250473|NCT02020616|3913747|FG004|Overall Study|Lack of Efficacy|1
2250474|NCT02020616|3913748|FG005|Overall Study|Lack of Efficacy|0
2250475|NCT02020616|3913749|FG006|Overall Study|Lack of Efficacy|0
2250476|NCT02020863|3913788|FG000|Overall Study|Discovery of Metastatic disease|4
2250477|NCT02020863|3913788|FG000|Overall Study|Team chose not to place an a line|1
2250478|NCT02020889|3913794|FG000|Overall Study|Adverse Event|0
2250479|NCT02020889|3913795|FG001|Overall Study|Adverse Event|1
2250480|NCT02020889|3913794|FG000|Overall Study|Lack of Efficacy|1
2250481|NCT02020889|3913795|FG001|Overall Study|Lack of Efficacy|0
2250482|NCT02020889|3913794|FG000|Overall Study|Lost to Follow-up|1
2250483|NCT02020889|3913795|FG001|Overall Study|Lost to Follow-up|0
2250484|NCT02020889|3913794|FG000|Overall Study|Physician Decision|2
2250485|NCT02020889|3913795|FG001|Overall Study|Physician Decision|0
2250486|NCT02020889|3913794|FG000|Overall Study|Withdrawal by Subject|3
2250487|NCT02020889|3913795|FG001|Overall Study|Withdrawal by Subject|2
2250488|NCT02020941|3913801|FG000|Overall Study|Adverse Event|1
2250489|NCT02020941|3913801|FG000|Overall Study|Physician Decision|2
2250490|NCT02020941|3913801|FG000|Overall Study|Withdrawal by Subject|1
2250491|NCT02020941|3913801|FG000|Overall Study|Disease Progression|4
2250492|NCT02020967|3913807|FG000|Overall Study|Withdrawal by Subject|51
2250493|NCT02021292|3913825|FG000|Overall Study|Physician Decision|0
2250494|NCT02021292|3913826|FG001|Overall Study|Physician Decision|1
2250495|NCT02021292|3913825|FG000|Overall Study|Lost to Follow-up|0
2250496|NCT02021292|3913826|FG001|Overall Study|Lost to Follow-up|1
2250497|NCT02021292|3913825|FG000|Overall Study|Death|0
2250498|NCT02021292|3913826|FG001|Overall Study|Death|1
2250499|NCT02021318|3913836|FG000|Overall Study|Adverse Event|2
2250500|NCT02021318|3913837|FG001|Overall Study|Adverse Event|1
2250501|NCT02021318|3913836|FG000|Overall Study|Death|33
2250502|NCT02021318|3913837|FG001|Overall Study|Death|34
2250503|NCT02021318|3913836|FG000|Overall Study|Lost to Follow-up|3
2250504|NCT02021318|3913837|FG001|Overall Study|Lost to Follow-up|3
2250505|NCT02021318|3913836|FG000|Overall Study|Progressive Disease|0
2341035|NCT03435081|4072394|FG002|Overall Study|Inadequate Response|0
2341036|NCT03435081|4072392|FG000|Overall Study|Withdrawal Due to Caregiver Circumstance|0
2341037|NCT03435081|4072393|FG001|Overall Study|Withdrawal Due to Caregiver Circumstance|0
2341038|NCT03435081|4072394|FG002|Overall Study|Withdrawal Due to Caregiver Circumstance|1
2341039|NCT03435211|4072412|FG000|Overall Study|Unable to achieve minimum desaturation level|1
2341040|NCT03435224|4072416|FG000|Overall Study|Unable to achieve a minimum desaturation level|4
2038413|NCT00422461|3608769|FG000|Overall Study|Other|0
2038414|NCT00422461|3608770|FG001|Overall Study|Other|0
2038415|NCT00422461|3608771|FG002|Overall Study|Other|0
2038416|NCT00422461|3608772|FG003|Overall Study|Other|2
2038417|NCT00422461|3608769|FG000|Overall Study|Participants no longer willing to participate in study|1
2038418|NCT00422461|3608770|FG001|Overall Study|Participants no longer willing to participate in study|0
2038419|NCT00422461|3608771|FG002|Overall Study|Participants no longer willing to participate in study|0
2038420|NCT00422461|3608772|FG003|Overall Study|Participants no longer willing to participate in study|0
2038421|NCT00422461|3608769|FG000|Overall Study|Randomized but not treated|1
2038422|NCT00422461|3608770|FG001|Overall Study|Randomized but not treated|1
2038423|NCT00422461|3608771|FG002|Overall Study|Randomized but not treated|0
2038424|NCT00422461|3608772|FG003|Overall Study|Randomized but not treated|0
2038425|NCT00422513|3608784|FG000|Overall Study|Lack of Efficacy|4
2038426|NCT00422513|3608785|FG001|Overall Study|Lack of Efficacy|5
2038427|NCT00422513|3608784|FG000|Overall Study|Protocol Violation|23
2038428|NCT00422513|3608785|FG001|Overall Study|Protocol Violation|7
2038429|NCT00422513|3608784|FG000|Overall Study|Refused Treatment|4
2038430|NCT00422513|3608785|FG001|Overall Study|Refused Treatment|2
2038431|NCT00422513|3608784|FG000|Overall Study|Withdrawal by Subject|2
2038432|NCT00422513|3608785|FG001|Overall Study|Withdrawal by Subject|1
2038433|NCT00422513|3608784|FG000|Overall Study|early termination of the study|67
2038434|NCT00422513|3608785|FG001|Overall Study|early termination of the study|80
2038435|NCT00422513|3608784|FG000|Overall Study|Adverse Event|4
2250506|NCT02021318|3913837|FG001|Overall Study|Progressive Disease|1
2250507|NCT02021318|3913836|FG000|Overall Study|Withdrawal by Subject|30
2250508|NCT02021318|3913837|FG001|Overall Study|Withdrawal by Subject|18
2250509|NCT02021318|3913836|FG000|Overall Study|Physician Decision|3
2250510|NCT02021318|3913837|FG001|Overall Study|Physician Decision|3
2250511|NCT02021318|3913836|FG000|Overall Study|Miscellaneous|2
2250512|NCT02021318|3913837|FG001|Overall Study|Miscellaneous|3
2250513|NCT02021331|3913846|FG000|Overall Study|Adverse Event|0
2250514|NCT02021331|3913847|FG001|Overall Study|Adverse Event|2
2250515|NCT02021565|3913861|FG000|Baseline Through Intervention|Death|0
2250516|NCT02021565|3913862|FG001|Baseline Through Intervention|Death|1
2250517|NCT02021565|3913861|FG000|Baseline Through Intervention|Withdrawal by Subject|8
2250518|NCT02021565|3913862|FG001|Baseline Through Intervention|Withdrawal by Subject|8
2250519|NCT02021565|3913861|FG000|Baseline Through Intervention|Protocol Violation|0
2250520|NCT02021565|3913862|FG001|Baseline Through Intervention|Protocol Violation|7
2250521|NCT02021565|3913861|FG000|Baseline Through Intervention|Lost to Follow-up|4
2250522|NCT02021565|3913862|FG001|Baseline Through Intervention|Lost to Follow-up|2
2250523|NCT02021565|3913861|FG000|3-month Follow-up|Death|3
2250524|NCT02021565|3913862|FG001|3-month Follow-up|Death|0
2250525|NCT02021565|3913861|FG000|3-month Follow-up|Withdrawal by Subject|4
2250526|NCT02021565|3913862|FG001|3-month Follow-up|Withdrawal by Subject|0
2250527|NCT02021565|3913861|FG000|3-month Follow-up|Protocol Violation|3
2250528|NCT02021565|3913862|FG001|3-month Follow-up|Protocol Violation|2
2250529|NCT02021643|3913876|FG000|Overall Study|Enrolled but Never Treated|1
2250530|NCT02021643|3913877|FG001|Overall Study|Enrolled but Never Treated|0
2250531|NCT02021643|3913878|FG002|Overall Study|Enrolled but Never Treated|0
2250532|NCT02021643|3913879|FG003|Overall Study|Enrolled but Never Treated|0
2250533|NCT02021643|3913876|FG000|Overall Study|Adverse Event|0
2250534|NCT02021643|3913877|FG001|Overall Study|Adverse Event|1
2250535|NCT02021643|3913878|FG002|Overall Study|Adverse Event|0
2250536|NCT02021643|3913879|FG003|Overall Study|Adverse Event|0
2250537|NCT02021643|3913876|FG000|Overall Study|Death|0
2250538|NCT02021643|3913877|FG001|Overall Study|Death|1
2250539|NCT02021643|3913878|FG002|Overall Study|Death|0
2250540|NCT02021643|3913879|FG003|Overall Study|Death|0
2250541|NCT02021643|3913876|FG000|Overall Study|Investigator's Discretion|1
2250542|NCT02021643|3913877|FG001|Overall Study|Investigator's Discretion|0
2250543|NCT02021643|3913878|FG002|Overall Study|Investigator's Discretion|0
2250544|NCT02021643|3913879|FG003|Overall Study|Investigator's Discretion|0
2250545|NCT02021643|3913876|FG000|Overall Study|Lack of Efficacy|7
2250546|NCT02021643|3913877|FG001|Overall Study|Lack of Efficacy|6
2250547|NCT02021643|3913878|FG002|Overall Study|Lack of Efficacy|0
2250548|NCT02021643|3913879|FG003|Overall Study|Lack of Efficacy|12
2250549|NCT02021643|3913876|FG000|Overall Study|Lost to Follow-up|0
2250550|NCT02021643|3913877|FG001|Overall Study|Lost to Follow-up|1
2250551|NCT02021643|3913878|FG002|Overall Study|Lost to Follow-up|0
2250552|NCT02021643|3913879|FG003|Overall Study|Lost to Follow-up|0
2250553|NCT02021643|3913876|FG000|Overall Study|Withdrew Consent|0
2250554|NCT02021643|3913877|FG001|Overall Study|Withdrew Consent|1
2250555|NCT02021643|3913878|FG002|Overall Study|Withdrew Consent|0
2250556|NCT02021643|3913879|FG003|Overall Study|Withdrew Consent|0
2250557|NCT02021656|3913895|FG000|Overall Study|Adverse Event|1
2250558|NCT02021656|3913895|FG000|Overall Study|Lack of Efficacy|2
2250559|NCT02021656|3913895|FG000|Overall Study|Lost to Follow-up|1
2250560|NCT02021656|3913895|FG000|Overall Study|Withdrew Consent|2
2250561|NCT02021812|3913912|FG000|Overall Study|Death|8
2250562|NCT02021812|3913912|FG000|Overall Study|Withdrawal by Subject|3
2250563|NCT02021812|3913912|FG000|Overall Study|Lost to Follow-up|1
2250564|NCT02021812|3913912|FG000|Overall Study|Refuse to return, COVD 19, in hospice, and didn't return for visit|4
2250565|NCT02021812|3913912|FG000|Overall Study|Still in study|6
2250566|NCT02022007|3913942|FG000|Overall Study|Withdrawal by Subject|1
2250567|NCT02022007|3913943|FG001|Overall Study|Withdrawal by Subject|1
2250568|NCT02022007|3913944|FG002|Overall Study|Withdrawal by Subject|1
2250569|NCT02022007|3913942|FG000|Overall Study|Noncompliant|0
2250570|NCT02022007|3913943|FG001|Overall Study|Noncompliant|0
2250571|NCT02022007|3913944|FG002|Overall Study|Noncompliant|1
2250572|NCT02022033|3913956|FG000|Overall Study|Physician Decision|1
2250573|NCT02022657|3913975|FG000|Overall Study|Withdrawal by Subject|2
2250574|NCT02022657|3913976|FG001|Overall Study|Withdrawal by Subject|0
2250575|NCT02022657|3913977|FG002|Overall Study|Withdrawal by Subject|1
2250576|NCT02022657|3913978|FG003|Overall Study|Withdrawal by Subject|0
2250577|NCT02022657|3913979|FG004|Overall Study|Withdrawal by Subject|0
2250578|NCT02022657|3913980|FG005|Overall Study|Withdrawal by Subject|0
2250579|NCT02022657|3913975|FG000|Overall Study|Physician Decision|0
2250580|NCT02022657|3913976|FG001|Overall Study|Physician Decision|0
2250581|NCT02022657|3913977|FG002|Overall Study|Physician Decision|0
2250582|NCT02022657|3913978|FG003|Overall Study|Physician Decision|0
2250583|NCT02022657|3913979|FG004|Overall Study|Physician Decision|0
2250584|NCT02022657|3913980|FG005|Overall Study|Physician Decision|1
2250585|NCT02022670|3913989|FG000|Overall Study|Adverse Event|1
2250586|NCT02022670|3913990|FG001|Overall Study|Adverse Event|0
2250587|NCT02022670|3913991|FG002|Overall Study|Adverse Event|1
2250588|NCT02022748|3914012|FG000|Overall Study|Adverse Event|1
2250589|NCT02022748|3914013|FG001|Overall Study|Adverse Event|1
2250590|NCT02022748|3914014|FG002|Overall Study|Adverse Event|0
2250591|NCT02022748|3914012|FG000|Overall Study|Withdrawal by Subject|0
2250592|NCT02022748|3914013|FG001|Overall Study|Withdrawal by Subject|1
2250593|NCT02022748|3914014|FG002|Overall Study|Withdrawal by Subject|0
2250594|NCT02023099|3914029|FG000|Overall Study|Non-fatal Adverse Event (AE)|0
2250595|NCT02023099|3914030|FG001|Overall Study|Non-fatal Adverse Event (AE)|0
2250596|NCT02023099|3914031|FG002|Overall Study|Non-fatal Adverse Event (AE)|1
2250597|NCT02023099|3914029|FG000|Overall Study|Withdrawn Consent|3
2250598|NCT02023099|3914030|FG001|Overall Study|Withdrawn Consent|0
2250599|NCT02023099|3914031|FG002|Overall Study|Withdrawn Consent|1
2250600|NCT02023099|3914029|FG000|Overall Study|Non-treatment-emergent Fatal AE|0
2250601|NCT02023099|3914030|FG001|Overall Study|Non-treatment-emergent Fatal AE|0
2250602|NCT02023099|3914031|FG002|Overall Study|Non-treatment-emergent Fatal AE|1
2250603|NCT02023112|3914041|FG000|Overall Study|Withdrawal by Subject|2
2250604|NCT02023112|3914042|FG001|Overall Study|Withdrawal by Subject|1
2250605|NCT02023151|3914066|FG000|Overall Study|Lost to Follow-up|4
2250606|NCT02023242|3914072|FG000|Overall Study|Lost to Follow-up|3
2250607|NCT02023242|3914073|FG001|Overall Study|Lost to Follow-up|1
2250608|NCT02023242|3914072|FG000|Overall Study|Death|0
2250609|NCT02023242|3914073|FG001|Overall Study|Death|1
2341041|NCT03435497|4072422|FG000|Overall Study|Lost to Follow-up|1
2341042|NCT03435497|4072423|FG001|Overall Study|Lost to Follow-up|0
2341043|NCT03435497|4072422|FG000|Overall Study|Death|1
2341044|NCT03435497|4072423|FG001|Overall Study|Death|0
2341045|NCT03435497|4072422|FG000|Overall Study|Withdrawal by Subject|0
2341046|NCT03435497|4072423|FG001|Overall Study|Withdrawal by Subject|4
2341047|NCT03435497|4072422|FG000|Overall Study|Wrong survey administered|0
2341048|NCT03435497|4072423|FG001|Overall Study|Wrong survey administered|2
2341049|NCT03435692|4072453|FG000|Overall Study|Lack of Efficacy|2
2341050|NCT03435692|4072454|FG001|Overall Study|Lack of Efficacy|2
2341051|NCT03435692|4072455|FG002|Overall Study|Lack of Efficacy|0
2341052|NCT03436082|4072478|FG000|Overall Study|Did not undergo procedure|1
2341053|NCT03436082|4072479|FG001|Overall Study|Did not undergo procedure|0
2341054|NCT03436420|4072496|FG000|Overall Study|Lack of Efficacy|3
2341055|NCT03436732|4072502|FG000|Overall Study|Not treated-enrolled in different study|1
2341056|NCT03436732|4072503|FG001|Overall Study|Not treated-enrolled in different study|0
2341057|NCT03436732|4072502|FG000|Overall Study|Off study after cycle 1|1
2341058|NCT03436732|4072503|FG001|Overall Study|Off study after cycle 1|0
2341059|NCT03436732|4072502|FG000|Overall Study|Adverse Event|2
2341060|NCT03436732|4072503|FG001|Overall Study|Adverse Event|0
2341061|NCT03436732|4072502|FG000|Overall Study|Death|0
2341062|NCT03436732|4072503|FG001|Overall Study|Death|1
2341063|NCT03437265|4072539|FG000|Overall Study|Protocol Violation|6
2341064|NCT03437278|4072546|FG000|Overall Study|Adverse Event|0
2341065|NCT03437278|4072547|FG001|Overall Study|Adverse Event|0
2341066|NCT03437278|4072548|FG002|Overall Study|Adverse Event|1
2341067|NCT03437278|4072546|FG000|Overall Study|Progressive disease|1
2341068|NCT03437278|4072547|FG001|Overall Study|Progressive disease|0
2341069|NCT03437278|4072548|FG002|Overall Study|Progressive disease|0
2341070|NCT03437278|4072546|FG000|Overall Study|Physician Decision|1
2341071|NCT03437278|4072547|FG001|Overall Study|Physician Decision|0
2341072|NCT03437278|4072548|FG002|Overall Study|Physician Decision|1
2341073|NCT03437447|4072561|FG000|Treatment Period 1|Withdrawal by Subject|0
2341074|NCT03437447|4072562|FG001|Treatment Period 1|Withdrawal by Subject|0
2341075|NCT03437447|4072563|FG002|Treatment Period 1|Withdrawal by Subject|1
2341076|NCT03437512|4072573|FG000|Randomized|Withdrawal by Subject|0
2341077|NCT03437512|4072574|FG001|Randomized|Withdrawal by Subject|2
2341078|NCT03437512|4072573|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2
2341079|NCT03437512|4072574|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1
2341080|NCT03437577|4072592|FG000|Pre-Randomization|Withdrawal by Subject|0
2341081|NCT03437577|4072593|FG001|Pre-Randomization|Withdrawal by Subject|0
2341082|NCT03437577|4072594|FG002|Pre-Randomization|Withdrawal by Subject|10
2341083|NCT03437577|4072592|FG000|Post-Randomization|Physician Decision|0
2341084|NCT03437577|4072593|FG001|Post-Randomization|Physician Decision|2
2341085|NCT03437577|4072594|FG002|Post-Randomization|Physician Decision|0
2341086|NCT03437733|4072602|FG000|Overall Study|Eligibility criteria not met|0
2341087|NCT03437733|4072603|FG001|Overall Study|Eligibility criteria not met|3
2341088|NCT03438006|4072612|FG000|Overall Study|Adverse Event|1
2341089|NCT03438006|4072612|FG000|Overall Study|Lost to Follow-up|67
2341090|NCT03438006|4072612|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47
2341091|NCT03438006|4072612|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3
2341092|NCT03438383|4072628|FG000|Overall Study|Protocol Violation|9
2341093|NCT03438383|4072629|FG001|Overall Study|Protocol Violation|3
2341094|NCT03438396|4072635|FG000|Overall Study|Ongoing on study treatment|4
2341095|NCT03438396|4072635|FG000|Overall Study|Ongoing in survival follow-up|33
2341096|NCT03438396|4072635|FG000|Overall Study|Withdrawal by Subject|4
2341097|NCT03438396|4072635|FG000|Overall Study|Lost to Follow-up|2
2341098|NCT03438396|4072635|FG000|Overall Study|Death|58
2341099|NCT03438396|4072635|FG000|Overall Study|Not treated|1
2341100|NCT03438539|4072645|FG000|Overall Study|Lost to Follow-up|8
2341101|NCT03438539|4072646|FG001|Overall Study|Lost to Follow-up|4
2341102|NCT03438539|4072647|FG002|Overall Study|Lost to Follow-up|10
2341103|NCT03438539|4072648|FG003|Overall Study|Lost to Follow-up|9
2341104|NCT03438539|4072649|FG004|Overall Study|Lost to Follow-up|3
2250610|NCT02023268|3914081|FG000|Overall Study|Lack of Efficacy|0
2250611|NCT02023268|3914082|FG001|Overall Study|Lack of Efficacy|1
2250612|NCT02023268|3914081|FG000|Overall Study|Adverse Event|0
2250613|NCT02023268|3914082|FG001|Overall Study|Adverse Event|2
2250614|NCT02023268|3914081|FG000|Overall Study|Withdrawal by Subject|0
2250615|NCT02023268|3914082|FG001|Overall Study|Withdrawal by Subject|1
2250616|NCT02023697|3914110|FG000|Treatment Period|Radiological progression|13
2250617|NCT02023697|3914111|FG001|Treatment Period|Radiological progression|17
2250618|NCT02023697|3914112|FG002|Treatment Period|Radiological progression|26
2250619|NCT02023697|3914110|FG000|Treatment Period|Never Treated|5
2250620|NCT02023697|3914111|FG001|Treatment Period|Never Treated|6
2250621|NCT02023697|3914112|FG002|Treatment Period|Never Treated|10
2250622|NCT02023697|3914110|FG000|Treatment Period|Adverse Event|13
2250623|NCT02023697|3914111|FG001|Treatment Period|Adverse Event|25
2250624|NCT02023697|3914112|FG002|Treatment Period|Adverse Event|23
2250625|NCT02023697|3914110|FG000|Treatment Period|Logistical difficulties|1
2250626|NCT02023697|3914111|FG001|Treatment Period|Logistical difficulties|1
2250627|NCT02023697|3914112|FG002|Treatment Period|Logistical difficulties|1
2250628|NCT02023697|3914110|FG000|Treatment Period|Clinical progression|10
2250629|NCT02023697|3914111|FG001|Treatment Period|Clinical progression|8
2250630|NCT02023697|3914112|FG002|Treatment Period|Clinical progression|28
2250631|NCT02023697|3914110|FG000|Treatment Period|Withdrawal by Subject|4
2250632|NCT02023697|3914111|FG001|Treatment Period|Withdrawal by Subject|5
2250633|NCT02023697|3914112|FG002|Treatment Period|Withdrawal by Subject|13
2250634|NCT02023697|3914110|FG000|Treatment Period|Safety outcome reached|0
2250635|NCT02023697|3914111|FG001|Treatment Period|Safety outcome reached|1
2250636|NCT02023697|3914112|FG002|Treatment Period|Safety outcome reached|0
2250637|NCT02023697|3914110|FG000|Treatment Period|Physician Decision|0
2250638|NCT02023697|3914111|FG001|Treatment Period|Physician Decision|0
2250639|NCT02023697|3914112|FG002|Treatment Period|Physician Decision|1
2250640|NCT02023697|3914110|FG000|Active Follow-up Period|Withdrawal by Subject|5
2250641|NCT02023697|3914111|FG001|Active Follow-up Period|Withdrawal by Subject|13
2250642|NCT02023697|3914112|FG002|Active Follow-up Period|Withdrawal by Subject|7
2250643|NCT02023697|3914110|FG000|Active Follow-up Period|Lost to Follow-up|1
2250644|NCT02023697|3914111|FG001|Active Follow-up Period|Lost to Follow-up|1
2250645|NCT02023697|3914112|FG002|Active Follow-up Period|Lost to Follow-up|1
2250646|NCT02023697|3914110|FG000|Active Follow-up Period|Deterioration of general condition|1
2250647|NCT02023697|3914111|FG001|Active Follow-up Period|Deterioration of general condition|1
2250648|NCT02023697|3914112|FG002|Active Follow-up Period|Deterioration of general condition|1
2250649|NCT02023697|3914110|FG000|Active Follow-up Period|Other unspecified|2
2250650|NCT02023697|3914111|FG001|Active Follow-up Period|Other unspecified|0
2250651|NCT02023697|3914112|FG002|Active Follow-up Period|Other unspecified|1
2250652|NCT02023697|3914110|FG000|Active Follow-up Period|Clinical progression|0
2250653|NCT02023697|3914111|FG001|Active Follow-up Period|Clinical progression|2
2250654|NCT02023697|3914112|FG002|Active Follow-up Period|Clinical progression|1
2250655|NCT02023697|3914110|FG000|Active Follow-up Period|Radiological progression|0
2250656|NCT02023697|3914111|FG001|Active Follow-up Period|Radiological progression|0
2250657|NCT02023697|3914112|FG002|Active Follow-up Period|Radiological progression|1
2250658|NCT02023697|3914110|FG000|Active Follow-up Period|Death|83
2250659|NCT02023697|3914111|FG001|Active Follow-up Period|Death|82
2250660|NCT02023697|3914112|FG002|Active Follow-up Period|Death|87
2250661|NCT02023697|3914110|FG000|Long-term Follow-up Period|Death|9
2250662|NCT02023697|3914111|FG001|Long-term Follow-up Period|Death|6
2250663|NCT02023697|3914112|FG002|Long-term Follow-up Period|Death|4
2250664|NCT02023697|3914110|FG000|Long-term Follow-up Period|Withdrawal by Subject|6
2250665|NCT02023697|3914111|FG001|Long-term Follow-up Period|Withdrawal by Subject|3
2250666|NCT02023697|3914112|FG002|Long-term Follow-up Period|Withdrawal by Subject|0
2250667|NCT02023697|3914110|FG000|Long-term Follow-up Period|Lost to Follow-up|1
2250668|NCT02023697|3914111|FG001|Long-term Follow-up Period|Lost to Follow-up|0
2250669|NCT02023697|3914112|FG002|Long-term Follow-up Period|Lost to Follow-up|1
2250670|NCT02023697|3914110|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6
2250671|NCT02023697|3914111|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9
2250672|NCT02023697|3914112|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6
2250673|NCT02023697|3914110|FG000|Long-term Follow-up Period|Technical problems|0
2250674|NCT02023697|3914111|FG001|Long-term Follow-up Period|Technical problems|0
2250675|NCT02023697|3914112|FG002|Long-term Follow-up Period|Technical problems|1
2250676|NCT02023697|3914110|FG000|Long-term Follow-up Period|Other unspecified|6
2250677|NCT02023697|3914111|FG001|Long-term Follow-up Period|Other unspecified|3
2341105|NCT03438539|4072650|FG005|Overall Study|Lost to Follow-up|8
2341106|NCT03439072|4072673|FG000|Overall Study|Withdrawal by Subject|2
2341107|NCT03439072|4072674|FG001|Overall Study|Withdrawal by Subject|3
2341108|NCT03439072|4072673|FG000|Overall Study|Physician Decision|0
2341109|NCT03439072|4072674|FG001|Overall Study|Physician Decision|1
2341110|NCT03439124|4072682|FG000|Overall Study|Adverse Event|2
2341111|NCT03439124|4072683|FG001|Overall Study|Adverse Event|0
2341112|NCT03439124|4072682|FG000|Overall Study|Lost to Follow-up|1
2341113|NCT03439124|4072683|FG001|Overall Study|Lost to Follow-up|0
2341114|NCT03439124|4072682|FG000|Overall Study|Other reasons|1
2341115|NCT03439124|4072683|FG001|Overall Study|Other reasons|0
2250678|NCT02023697|3914112|FG002|Long-term Follow-up Period|Other unspecified|5
2250679|NCT02023866|3914131|FG000|Overall Study|Non-compliance|2
2250680|NCT02023866|3914131|FG000|Overall Study|Adverse Event|3
2250681|NCT02023866|3914131|FG000|Overall Study|Withdrawal by Subject|1
2250682|NCT02023879|3914138|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
2250683|NCT02023879|3914139|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
2250684|NCT02023879|3914140|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
2250685|NCT02023879|3914138|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
2250686|NCT02023879|3914139|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
2250687|NCT02023879|3914140|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
2250688|NCT02023879|3914138|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
2250689|NCT02023879|3914139|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
2250690|NCT02023879|3914140|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
2250691|NCT02023879|3914138|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
2250692|NCT02023879|3914139|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
2250693|NCT02023879|3914140|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
2250694|NCT02023879|3914138|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
2250695|NCT02023879|3914139|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
2250696|NCT02023879|3914140|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
2250697|NCT02023879|3914138|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
2250698|NCT02023879|3914139|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
2250699|NCT02023879|3914140|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
2250700|NCT02023879|3914138|FG000|Extension Open Label Treatment|Adverse Event|1
2250701|NCT02023879|3914139|FG001|Extension Open Label Treatment|Adverse Event|7
2250702|NCT02023879|3914140|FG002|Extension Open Label Treatment|Adverse Event|3
2250703|NCT02023879|3914138|FG000|Extension Open Label Treatment|Poor compliance to protocol|1
2250704|NCT02023879|3914139|FG001|Extension Open Label Treatment|Poor compliance to protocol|1
2250705|NCT02023879|3914140|FG002|Extension Open Label Treatment|Poor compliance to protocol|0
2250706|NCT02023879|3914138|FG000|Extension Open Label Treatment|Participant moved|1
2250707|NCT02023879|3914139|FG001|Extension Open Label Treatment|Participant moved|2
2250708|NCT02023879|3914140|FG002|Extension Open Label Treatment|Participant moved|0
2250709|NCT02023879|3914138|FG000|Extension Open Label Treatment|Other than specified above|2
2250710|NCT02023879|3914139|FG001|Extension Open Label Treatment|Other than specified above|7
2250711|NCT02023879|3914140|FG002|Extension Open Label Treatment|Other than specified above|2
2250712|NCT02024698|3914285|FG000|First Intervention (7 Days)|Withdrawal by Subject|0
2250713|NCT02024698|3914286|FG001|First Intervention (7 Days)|Withdrawal by Subject|1
2250714|NCT02024750|3914312|FG000|Overall Study|Withdrawal by Subject|2
2250715|NCT02024750|3914313|FG001|Overall Study|Withdrawal by Subject|1
2250716|NCT02024867|3914321|FG000|Overall Study|Protocol Violation|3
2250717|NCT02024867|3914322|FG001|Overall Study|Protocol Violation|3
2250718|NCT02024867|3914321|FG000|Overall Study|Lost to Follow-up|6
2250719|NCT02024867|3914322|FG001|Overall Study|Lost to Follow-up|4
2250720|NCT02024932|3914334|FG000|Overall Study|Adverse Event|2
2250721|NCT02024932|3914335|FG001|Overall Study|Adverse Event|3
2250722|NCT02024932|3914336|FG002|Overall Study|Adverse Event|0
2250723|NCT02024932|3914337|FG003|Overall Study|Adverse Event|0
2250724|NCT02024932|3914338|FG004|Overall Study|Adverse Event|2
2250725|NCT02024932|3914339|FG005|Overall Study|Adverse Event|0
2250726|NCT02024932|3914334|FG000|Overall Study|Abnormal laboratory value|0
2250727|NCT02024932|3914335|FG001|Overall Study|Abnormal laboratory value|0
2250728|NCT02024932|3914336|FG002|Overall Study|Abnormal laboratory value|0
2250729|NCT02024932|3914337|FG003|Overall Study|Abnormal laboratory value|2
2250730|NCT02024932|3914338|FG004|Overall Study|Abnormal laboratory value|0
2250731|NCT02024932|3914339|FG005|Overall Study|Abnormal laboratory value|0
2250732|NCT02024971|3914359|FG000|Overall Study|Data Not Available|30
2250733|NCT02024971|3914359|FG000|Overall Study|Lost to Follow-up|6
2250734|NCT02025179|3914381|FG000|Overall Study|Lost to Follow-up|0
2250735|NCT02025179|3914382|FG001|Overall Study|Lost to Follow-up|0
2250736|NCT02025179|3914383|FG002|Overall Study|Lost to Follow-up|1
2250737|NCT02025205|3914393|FG000|Overall Study|Withdrawal by Subject|1
2250738|NCT02025205|3914394|FG001|Overall Study|Withdrawal by Subject|1
2250739|NCT02025205|3914393|FG000|Overall Study|Protocol Violation|2
2250740|NCT02025205|3914394|FG001|Overall Study|Protocol Violation|1
2250741|NCT02025205|3914393|FG000|Overall Study|Death|0
2250742|NCT02025205|3914394|FG001|Overall Study|Death|1
2250743|NCT02025530|3914422|FG000|Overall Study|No longer met elligibility criteria|5
2250744|NCT02025530|3914423|FG001|Overall Study|No longer met elligibility criteria|1
2250745|NCT02025621|3914431|FG000|Overall Study|Withdrawal by Subject|1
2250746|NCT02025621|3914432|FG001|Overall Study|Withdrawal by Subject|0
2250747|NCT02025621|3914431|FG000|Overall Study|Death|0
2250748|NCT02025621|3914432|FG001|Overall Study|Death|1
2250749|NCT02025621|3914431|FG000|Overall Study|No longer eligible|10
2250750|NCT02025621|3914432|FG001|Overall Study|No longer eligible|15
2250751|NCT02025621|3914431|FG000|Overall Study|Surgery initiated before infusion|3
2341116|NCT03439137|4072691|FG000|Overall Study|Adverse Event|16
2250752|NCT02025621|3914432|FG001|Overall Study|Surgery initiated before infusion|3
2250753|NCT02025725|3914453|FG000|Overall Study|Adverse Event|5
2250754|NCT02025725|3914454|FG001|Overall Study|Adverse Event|0
2250755|NCT02025725|3914453|FG000|Overall Study|Lost to Follow-up|2
2250756|NCT02025725|3914454|FG001|Overall Study|Lost to Follow-up|0
2250757|NCT02025725|3914453|FG000|Overall Study|Protocol Violation|1
2250758|NCT02025725|3914454|FG001|Overall Study|Protocol Violation|1
2250759|NCT02025725|3914453|FG000|Overall Study|Withdrawal by Subject|3
2250760|NCT02025725|3914454|FG001|Overall Study|Withdrawal by Subject|2
2250761|NCT02025725|3914453|FG000|Overall Study|Post-dose QTcB > 270 msec|0
2250762|NCT02025725|3914454|FG001|Overall Study|Post-dose QTcB > 270 msec|1
2250763|NCT02025751|3914464|FG000|Overall Study|Lost to Follow-up|1
2250764|NCT02025751|3914465|FG001|Overall Study|Lost to Follow-up|0
2250765|NCT02025751|3914464|FG000|Overall Study|Adverse Event|0
2250766|NCT02025751|3914465|FG001|Overall Study|Adverse Event|1
2250767|NCT02025751|3914464|FG000|Overall Study|Physician Decision|0
2250768|NCT02025751|3914465|FG001|Overall Study|Physician Decision|1
2250769|NCT02025751|3914464|FG000|Overall Study|Withdrawal by Subject|0
2250770|NCT02025751|3914465|FG001|Overall Study|Withdrawal by Subject|1
2250771|NCT02025907|3914483|FG000|Overall Study|Lack of Efficacy|1
2250772|NCT02025907|3914484|FG001|Overall Study|Lack of Efficacy|0
2250773|NCT02025907|3914483|FG000|Overall Study|Withdrawal by Subject|15
2250774|NCT02025907|3914484|FG001|Overall Study|Withdrawal by Subject|8
2250775|NCT02025907|3914483|FG000|Overall Study|Protocol Violation|2
2250776|NCT02025907|3914484|FG001|Overall Study|Protocol Violation|0
2250777|NCT02025907|3914483|FG000|Overall Study|Physician Decision|2
2250778|NCT02025907|3914484|FG001|Overall Study|Physician Decision|0
2250779|NCT02025907|3914483|FG000|Overall Study|Lost to Follow-up|2
2250780|NCT02025907|3914484|FG001|Overall Study|Lost to Follow-up|2
2250781|NCT02025907|3914483|FG000|Overall Study|Adverse Event|3
2250782|NCT02025907|3914484|FG001|Overall Study|Adverse Event|1
2250783|NCT02025907|3914483|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2
2250784|NCT02025907|3914484|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1
2250785|NCT02025985|3914495|FG000|Overall Study|Consent withdrawn|0
2250786|NCT02025985|3914496|FG001|Overall Study|Consent withdrawn|0
2250787|NCT02025985|3914497|FG002|Overall Study|Consent withdrawn|1
2250788|NCT02025985|3914498|FG003|Overall Study|Consent withdrawn|0
2250789|NCT02025985|3914499|FG004|Overall Study|Consent withdrawn|0
2250790|NCT02025985|3914495|FG000|Overall Study|Termination of study by Sponsor|4
2250791|NCT02025985|3914496|FG001|Overall Study|Termination of study by Sponsor|3
2250792|NCT02025985|3914497|FG002|Overall Study|Termination of study by Sponsor|1
2250793|NCT02025985|3914498|FG003|Overall Study|Termination of study by Sponsor|1
2250794|NCT02025985|3914499|FG004|Overall Study|Termination of study by Sponsor|3
2250795|NCT02025985|3914495|FG000|Overall Study|Death|21
2250796|NCT02025985|3914496|FG001|Overall Study|Death|20
2250797|NCT02025985|3914497|FG002|Overall Study|Death|23
2250798|NCT02025985|3914498|FG003|Overall Study|Death|20
2250799|NCT02025985|3914499|FG004|Overall Study|Death|17
2250800|NCT02026011|3914515|FG000|Allocation 1 (First Set of Medication)|Side Effects|6
2250801|NCT02026011|3914516|FG001|Allocation 1 (First Set of Medication)|Side Effects|0
2250802|NCT02026011|3914515|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
2250803|NCT02026011|3914516|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
2250804|NCT02026011|3914515|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
2250805|NCT02026011|3914516|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
2250806|NCT02026011|3914515|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
2250807|NCT02026011|3914516|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
2250808|NCT02026063|3914527|FG000|Overall Study|Physician Decision|0
2250809|NCT02026063|3914528|FG001|Overall Study|Physician Decision|10
2250810|NCT02026063|3914527|FG000|Overall Study|Noncompliance with Study Drug|1
2250811|NCT02026063|3914528|FG001|Overall Study|Noncompliance with Study Drug|1
2250812|NCT02026063|3914527|FG000|Overall Study|Withdrawal of Consent|1
2250813|NCT02026063|3914528|FG001|Overall Study|Withdrawal of Consent|6
2250814|NCT02026063|3914527|FG000|Overall Study|Adverse Event|5
2250815|NCT02026063|3914528|FG001|Overall Study|Adverse Event|20
2250816|NCT02026063|3914527|FG000|Overall Study|Lack of Efficacy|0
2250817|NCT02026063|3914528|FG001|Overall Study|Lack of Efficacy|4
2250818|NCT02026063|3914527|FG000|Overall Study|Lost to Follow-up|0
2250819|NCT02026063|3914528|FG001|Overall Study|Lost to Follow-up|1
2341117|NCT03439137|4072692|FG001|Overall Study|Adverse Event|12
2341118|NCT03439137|4072691|FG000|Overall Study|Physician Decision|0
2341119|NCT03439137|4072692|FG001|Overall Study|Physician Decision|5
2341120|NCT03439137|4072691|FG000|Overall Study|Withdrawal by Subject|14
2341121|NCT03439137|4072692|FG001|Overall Study|Withdrawal by Subject|4
2341122|NCT03439137|4072691|FG000|Overall Study|Conducting rescue therapy|2
2341123|NCT03439137|4072692|FG001|Overall Study|Conducting rescue therapy|1
2341124|NCT03439137|4072691|FG000|Overall Study|Difficult to control Hb|10
2250820|NCT02026063|3914527|FG000|Overall Study|Reason not Specified|2
2250821|NCT02026063|3914528|FG001|Overall Study|Reason not Specified|7
2250822|NCT02026141|3914537|FG000|Overall Study|Protocol Violation|0
2250823|NCT02026141|3914538|FG001|Overall Study|Protocol Violation|1
2250824|NCT02026258|3914564|FG000|Randomized|Did not start treatment|2
2250825|NCT02026258|3914565|FG001|Randomized|Did not start treatment|1
2250826|NCT02026258|3914564|FG000|Randomized|Change in treatment plan|1
2341125|NCT03439137|4072692|FG001|Overall Study|Difficult to control Hb|2
2250827|NCT02026258|3914565|FG001|Randomized|Change in treatment plan|0
2341126|NCT03439137|4072691|FG000|Overall Study|Initiation of a renal transplant|0
2341127|NCT03439137|4072692|FG001|Overall Study|Initiation of a renal transplant|2
2341128|NCT03439189|4072698|FG000|Overall Study|Protocol Violation|19
2341129|NCT03439189|4072698|FG000|Overall Study|Lack of Efficacy|63
2341130|NCT03440320|4072716|FG000|Overall Study|Withdrawal by Subject|0
2341131|NCT03440320|4072717|FG001|Overall Study|Withdrawal by Subject|1
2341132|NCT03440411|4072729|FG000|Overall Study|Adverse Event|0
2341133|NCT03440411|4072730|FG001|Overall Study|Adverse Event|0
2341134|NCT03440411|4072731|FG002|Overall Study|Adverse Event|1
2341135|NCT03440411|4072732|FG003|Overall Study|Adverse Event|0
2341136|NCT03440411|4072729|FG000|Overall Study|PD|2
2341137|NCT03440411|4072730|FG001|Overall Study|PD|1
2341138|NCT03440411|4072731|FG002|Overall Study|PD|1
2341139|NCT03440411|4072732|FG003|Overall Study|PD|1
2341140|NCT03440411|4072729|FG000|Overall Study|Withdrawal by Subject|1
2341141|NCT03440411|4072730|FG001|Overall Study|Withdrawal by Subject|0
2341142|NCT03440411|4072731|FG002|Overall Study|Withdrawal by Subject|0
2341143|NCT03440411|4072732|FG003|Overall Study|Withdrawal by Subject|0
2341144|NCT03440411|4072729|FG000|Overall Study|Closed study by sponsor|0
2341145|NCT03440411|4072730|FG001|Overall Study|Closed study by sponsor|0
2341146|NCT03440411|4072731|FG002|Overall Study|Closed study by sponsor|0
2341147|NCT03440411|4072732|FG003|Overall Study|Closed study by sponsor|1
2341148|NCT03440918|4072776|FG000|Overall Study|Protocol Violation|0
2341149|NCT03440918|4072777|FG001|Overall Study|Protocol Violation|16
2341150|NCT03440944|4072785|FG000|Overall Study|Physician Decision|1
2341151|NCT03440944|4072786|FG001|Overall Study|Physician Decision|0
2341152|NCT03440944|4072785|FG000|Overall Study|No Acceptable Vasculature|0
2341153|NCT03440944|4072786|FG001|Overall Study|No Acceptable Vasculature|1
2341154|NCT03441789|4072878|FG000|Overall Study|Withdrawal by Subject|1
2341155|NCT03441789|4072879|FG001|Overall Study|Withdrawal by Subject|1
2341156|NCT03441789|4072878|FG000|Overall Study|Adverse Event|0
2341157|NCT03441789|4072879|FG001|Overall Study|Adverse Event|1
2341158|NCT03441789|4072878|FG000|Overall Study|Protocol Violation|0
2341159|NCT03441789|4072879|FG001|Overall Study|Protocol Violation|1
2341160|NCT03441789|4072878|FG000|Overall Study|Lost to Follow-up|0
2341161|NCT03441789|4072879|FG001|Overall Study|Lost to Follow-up|1
2341162|NCT03441984|4072887|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2341163|NCT03441984|4072888|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2341164|NCT03441984|4072889|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
2341165|NCT03441984|4072890|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2341166|NCT03441984|4072891|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2341167|NCT03441984|4072892|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2341168|NCT03441984|4072893|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2341169|NCT03441984|4072894|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2341170|NCT03441984|4072895|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2341171|NCT03441984|4072896|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2341172|NCT03441984|4072897|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2341173|NCT03441984|4072898|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2341174|NCT03442296|4072926|FG000|3 Month Follow-up|Death|3
2341175|NCT03442296|4072927|FG001|3 Month Follow-up|Death|1
2341176|NCT03442296|4072926|FG000|3 Month Follow-up|Lost to Follow-up|1
2341177|NCT03442296|4072927|FG001|3 Month Follow-up|Lost to Follow-up|1
2341178|NCT03442296|4072926|FG000|3 Month Follow-up|Withdrawal by Subject|1
2341179|NCT03442296|4072927|FG001|3 Month Follow-up|Withdrawal by Subject|0
2341180|NCT03442296|4072926|FG000|3 Month Follow-up|Obtained Hearing Aids|0
2341181|NCT03442296|4072927|FG001|3 Month Follow-up|Obtained Hearing Aids|1
2341182|NCT03442296|4072926|FG000|12 Month Follow-up|Incomplete measurement|1
2341183|NCT03442296|4072927|FG001|12 Month Follow-up|Incomplete measurement|1
2341184|NCT03442569|4072933|FG000|Overall Study|Subject was ineligible after enrollment|1
2353211|NCT02920177|4104648|FG000|Overall Study|Withdrawal by Subject|1
2353212|NCT02920177|4104649|FG001|Overall Study|Withdrawal by Subject|1
2353213|NCT02920177|4104648|FG000|Overall Study|Physician Decision|1
2353214|NCT02920177|4104649|FG001|Overall Study|Physician Decision|0
2353215|NCT02920177|4104648|FG000|Overall Study|Lost to Follow-up|0
2353216|NCT02920177|4104649|FG001|Overall Study|Lost to Follow-up|1
2353217|NCT02926638|4104657|FG000|Overall Study|Progression|2
2353218|NCT02926638|4104658|FG001|Overall Study|Progression|5
2353219|NCT02926638|4104657|FG000|Overall Study|Ineligible|1
2353220|NCT02926638|4104658|FG001|Overall Study|Ineligible|0
2353221|NCT02926638|4104657|FG000|Overall Study|Not protocol specified|1
2353222|NCT02926638|4104658|FG001|Overall Study|Not protocol specified|0
2353223|NCT02920242|4104667|FG000|Overall Study|Withdrawal by Subject|1
2353224|NCT02920242|4104668|FG001|Overall Study|Withdrawal by Subject|0
2353225|NCT02920242|4104669|FG002|Overall Study|Withdrawal by Subject|1
2353226|NCT02920242|4104667|FG000|Overall Study|Did not meet inc./exc. criteria|1
2353227|NCT02920242|4104668|FG001|Overall Study|Did not meet inc./exc. criteria|0
2353228|NCT02920242|4104669|FG002|Overall Study|Did not meet inc./exc. criteria|0
2353229|NCT02899728|4104701|FG000|Overall Study|Withdrawal by Subject|1
2353230|NCT02899728|4104702|FG001|Overall Study|Withdrawal by Subject|1
2250828|NCT02026258|3914564|FG000|Randomized|Presence of periodontal disease|1
2250829|NCT02026258|3914565|FG001|Randomized|Presence of periodontal disease|1
2250830|NCT02026258|3914564|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1
2250831|NCT02026258|3914565|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1
2250832|NCT02026258|3914564|FG000|Recieved Allocated Intervention|Lost to Follow-up|0
2250833|NCT02026258|3914565|FG001|Recieved Allocated Intervention|Lost to Follow-up|1
2250834|NCT02027025|3914606|FG000|Overall Study|Adverse Event|0
2250835|NCT02027025|3914607|FG001|Overall Study|Adverse Event|1
2250836|NCT02027025|3914608|FG002|Overall Study|Adverse Event|1
2250837|NCT02027025|3914606|FG000|Overall Study|Protocol Violation|1
2250838|NCT02027025|3914607|FG001|Overall Study|Protocol Violation|0
2250839|NCT02027025|3914608|FG002|Overall Study|Protocol Violation|0
2250840|NCT02027025|3914606|FG000|Overall Study|Lost to Follow-up|0
2250841|NCT02027025|3914607|FG001|Overall Study|Lost to Follow-up|2
2250842|NCT02027025|3914608|FG002|Overall Study|Lost to Follow-up|0
2250843|NCT02027025|3914606|FG000|Overall Study|Withdrawal by Subject|0
2250844|NCT02027025|3914607|FG001|Overall Study|Withdrawal by Subject|1
2250845|NCT02027025|3914608|FG002|Overall Study|Withdrawal by Subject|0
2250846|NCT02027025|3914606|FG000|Overall Study|Sponsor's decision|0
2250847|NCT02027025|3914607|FG001|Overall Study|Sponsor's decision|1
2250848|NCT02027025|3914608|FG002|Overall Study|Sponsor's decision|0
2250849|NCT02027311|3914629|FG000|Overall Study|Protocol Violation|3
2250850|NCT02027311|3914630|FG001|Overall Study|Protocol Violation|2
2250851|NCT02027376|3914638|FG000|Overall Study|Death|1
2250852|NCT02027376|3914639|FG001|Overall Study|Death|0
2250853|NCT02027376|3914640|FG002|Overall Study|Death|0
2250854|NCT02027402|3914652|FG000|Overall Study|Withdrawal by Subject|4
2250855|NCT02027402|3914653|FG001|Overall Study|Withdrawal by Subject|1
2250856|NCT02027428|3914663|FG000|Induction|Never treated|7
2250857|NCT02027428|3914664|FG001|Induction|Never treated|0
2341185|NCT03442595|4072939|FG000|Overall Study|Lost to Follow-up|94
2341186|NCT03442595|4072940|FG001|Overall Study|Lost to Follow-up|0
2341187|NCT03442777|4072963|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8
2353231|NCT02875067|4104708|FG000|Overall Study|Withdrawal by Subject|1
2038436|NCT00422513|3608785|FG001|Overall Study|Adverse Event|4
2038437|NCT00422513|3608784|FG000|Overall Study|Death|3
2038438|NCT00422513|3608785|FG001|Overall Study|Death|7
2038439|NCT00422591|3608791|FG000|Overall Study|Physician Decision|4
2250858|NCT02027428|3914665|FG002|Induction|Never treated|0
2250859|NCT02027428|3914663|FG000|Induction|Progressive disease|77
2250860|NCT02027428|3914664|FG001|Induction|Progressive disease|0
2250861|NCT02027428|3914665|FG002|Induction|Progressive disease|0
2250862|NCT02027428|3914663|FG000|Induction|Adverse Event|51
2250863|NCT02027428|3914664|FG001|Induction|Adverse Event|0
2250864|NCT02027428|3914665|FG002|Induction|Adverse Event|0
2250865|NCT02027428|3914663|FG000|Induction|Withdrawal by Subject|22
2250866|NCT02027428|3914664|FG001|Induction|Withdrawal by Subject|0
2250867|NCT02027428|3914665|FG002|Induction|Withdrawal by Subject|0
2250868|NCT02027428|3914663|FG000|Induction|Death|21
2250869|NCT02027428|3914664|FG001|Induction|Death|0
2250870|NCT02027428|3914665|FG002|Induction|Death|0
2250871|NCT02027428|3914663|FG000|Induction|Symptomatic deterioration|16
2250872|NCT02027428|3914664|FG001|Induction|Symptomatic deterioration|0
2250873|NCT02027428|3914665|FG002|Induction|Symptomatic deterioration|0
2250874|NCT02027428|3914663|FG000|Induction|Study terminated by sponsor|12
2250875|NCT02027428|3914664|FG001|Induction|Study terminated by sponsor|0
2250876|NCT02027428|3914665|FG002|Induction|Study terminated by sponsor|0
2250877|NCT02027428|3914663|FG000|Induction|Protocol Violation|1
2250878|NCT02027428|3914664|FG001|Induction|Protocol Violation|0
2250879|NCT02027428|3914665|FG002|Induction|Protocol Violation|0
2250880|NCT02027428|3914663|FG000|Induction|Miscellaneous|14
2250881|NCT02027428|3914664|FG001|Induction|Miscellaneous|0
2250882|NCT02027428|3914665|FG002|Induction|Miscellaneous|0
2250883|NCT02027428|3914663|FG000|Induction|Induction Treatment Ongoing|4
2250884|NCT02027428|3914664|FG001|Induction|Induction Treatment Ongoing|0
2250885|NCT02027428|3914665|FG002|Induction|Induction Treatment Ongoing|0
2250886|NCT02027428|3914663|FG000|Maintenance|Death|0
2250887|NCT02027428|3914664|FG001|Maintenance|Death|3
2250888|NCT02027428|3914665|FG002|Maintenance|Death|2
2250889|NCT02027428|3914663|FG000|Maintenance|Adverse Event|0
2250890|NCT02027428|3914664|FG001|Maintenance|Adverse Event|21
2250891|NCT02027428|3914665|FG002|Maintenance|Adverse Event|1
2250892|NCT02027428|3914663|FG000|Maintenance|Progressive disease|0
2250893|NCT02027428|3914664|FG001|Maintenance|Progressive disease|84
2250894|NCT02027428|3914665|FG002|Maintenance|Progressive disease|47
2250895|NCT02027428|3914663|FG000|Maintenance|Symptomatic deterioration|0
2250896|NCT02027428|3914664|FG001|Maintenance|Symptomatic deterioration|4
2250897|NCT02027428|3914665|FG002|Maintenance|Symptomatic deterioration|1
2250898|NCT02027428|3914663|FG000|Maintenance|Withdrawal by Subject|0
2250899|NCT02027428|3914664|FG001|Maintenance|Withdrawal by Subject|6
2250900|NCT02027428|3914665|FG002|Maintenance|Withdrawal by Subject|5
2250901|NCT02027428|3914663|FG000|Maintenance|Protocol Violation|0
2250902|NCT02027428|3914664|FG001|Maintenance|Protocol Violation|0
2250903|NCT02027428|3914665|FG002|Maintenance|Protocol Violation|1
2250904|NCT02027428|3914663|FG000|Maintenance|Other|0
2250905|NCT02027428|3914664|FG001|Maintenance|Other|6
2250906|NCT02027428|3914665|FG002|Maintenance|Other|3
2250907|NCT02027428|3914663|FG000|Survival Follow-up|Death|0
2250908|NCT02027428|3914664|FG001|Survival Follow-up|Death|78
2250909|NCT02027428|3914665|FG002|Survival Follow-up|Death|45
2250910|NCT02027428|3914663|FG000|Survival Follow-up|Lost to Follow-up|0
2250911|NCT02027428|3914664|FG001|Survival Follow-up|Lost to Follow-up|1
2250912|NCT02027428|3914665|FG002|Survival Follow-up|Lost to Follow-up|1
2250913|NCT02027545|3914690|FG000|Overall Study|Failed to sign HIPAA|0
2250914|NCT02027545|3914691|FG001|Overall Study|Failed to sign HIPAA|2
2250915|NCT02027545|3914690|FG000|Overall Study|Failed to attend study visit|2
2250916|NCT02027545|3914691|FG001|Overall Study|Failed to attend study visit|0
2250917|NCT02027558|3914699|FG000|Overall Study|Death|0
2250918|NCT02027558|3914700|FG001|Overall Study|Death|1
2250919|NCT02027558|3914699|FG000|Overall Study|Withdrawal by Subject|2
2250920|NCT02027558|3914700|FG001|Overall Study|Withdrawal by Subject|0
2250921|NCT02027558|3914699|FG000|Overall Study|Lost to Follow-up|4
2250922|NCT02027558|3914700|FG001|Overall Study|Lost to Follow-up|1
2250923|NCT02027558|3914699|FG000|Overall Study|Refused assessment|3
2250924|NCT02027558|3914700|FG001|Overall Study|Refused assessment|0
2250925|NCT02027623|3914710|FG000|Overall Study|Lost to Follow-up|3
2250926|NCT02027623|3914711|FG001|Overall Study|Lost to Follow-up|3
2250927|NCT02027623|3914710|FG000|Overall Study|Withdrawal by Subject|6
2250928|NCT02027623|3914711|FG001|Overall Study|Withdrawal by Subject|9
2250929|NCT02027701|3914718|FG000|Overall Study|Adverse Event|3
2250930|NCT02027701|3914718|FG000|Overall Study|Lack of Efficacy|8
2250931|NCT02027701|3914718|FG000|Overall Study|Physician Decision|2
2250932|NCT02027701|3914718|FG000|Overall Study|Withdrawal by Subject|3
2250933|NCT02027844|3914727|FG000|Overall Study|Withdrawal by Subject|3
2250934|NCT02027844|3914728|FG001|Overall Study|Withdrawal by Subject|2
2250935|NCT02027844|3914729|FG002|Overall Study|Withdrawal by Subject|1
2250936|NCT02027844|3914727|FG000|Overall Study|Lost to Follow-up|0
2250937|NCT02027844|3914728|FG001|Overall Study|Lost to Follow-up|2
2250938|NCT02027844|3914729|FG002|Overall Study|Lost to Follow-up|1
2250939|NCT02027844|3914727|FG000|Overall Study|Protocol Violation|0
2250940|NCT02027844|3914728|FG001|Overall Study|Protocol Violation|2
2250941|NCT02027844|3914729|FG002|Overall Study|Protocol Violation|0
2250942|NCT02027844|3914727|FG000|Overall Study|Incomlete data|2
2250943|NCT02027844|3914728|FG001|Overall Study|Incomlete data|0
2250944|NCT02027844|3914729|FG002|Overall Study|Incomlete data|0
2250945|NCT02028065|3914753|FG000|Randomization Through Start Treatment|Not treated|1
2250946|NCT02028065|3914754|FG001|Randomization Through Start Treatment|Not treated|3
2250947|NCT02028065|3914755|FG002|Randomization Through Start Treatment|Not treated|3
2250948|NCT02028065|3914753|FG000|Treatment Through Study Completion|Lost to Follow-up|2
2250949|NCT02028065|3914754|FG001|Treatment Through Study Completion|Lost to Follow-up|4
2250950|NCT02028065|3914755|FG002|Treatment Through Study Completion|Lost to Follow-up|6
2250951|NCT02028065|3914753|FG000|Treatment Through Study Completion|Physician Decision|1
2250952|NCT02028065|3914754|FG001|Treatment Through Study Completion|Physician Decision|0
2250953|NCT02028065|3914755|FG002|Treatment Through Study Completion|Physician Decision|0
2250954|NCT02028065|3914753|FG000|Treatment Through Study Completion|Protocol Violation|1
2250955|NCT02028065|3914754|FG001|Treatment Through Study Completion|Protocol Violation|4
2250956|NCT02028065|3914755|FG002|Treatment Through Study Completion|Protocol Violation|0
2250957|NCT02028065|3914753|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
2250958|NCT02028065|3914754|FG001|Treatment Through Study Completion|Withdrawal by Subject|4
2250959|NCT02028065|3914755|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
2250960|NCT02028065|3914753|FG000|Treatment Through Study Completion|Adverse Event|3
2250961|NCT02028065|3914754|FG001|Treatment Through Study Completion|Adverse Event|3
2250962|NCT02028065|3914755|FG002|Treatment Through Study Completion|Adverse Event|5
2250963|NCT02028169|3914763|FG000|Overall Study|Lost to Follow-up|21
2250964|NCT02028169|3914763|FG000|Overall Study|Lack of Efficacy|2
2250965|NCT02028169|3914763|FG000|Overall Study|Withdrawal by Subject|2
2250966|NCT02028169|3914763|FG000|Overall Study|Adverse Event|1
2250967|NCT02028169|3914763|FG000|Overall Study|Cessation of Drug|1
2250968|NCT02028169|3914763|FG000|Overall Study|Concomitant Medication Usage|1
2250969|NCT02028182|3914767|FG000|Overall Study|Protocol Violation|2
2250970|NCT02028715|3914854|FG000|Overall Study|Adverse Event|2
2250971|NCT02028715|3914855|FG001|Overall Study|Adverse Event|2
2250972|NCT02028715|3914854|FG000|Overall Study|Physician Decision|1
2250973|NCT02028715|3914855|FG001|Overall Study|Physician Decision|0
2250974|NCT02028715|3914854|FG000|Overall Study|Did not complete satisfaction surveys|2
2250975|NCT02028715|3914855|FG001|Overall Study|Did not complete satisfaction surveys|2
2250976|NCT02028767|3914870|FG000|Treatment Period 2|Non compliant with protocol|1
2250977|NCT02028767|3914871|FG001|Treatment Period 2|Non compliant with protocol|0
2250978|NCT02028767|3914870|FG000|Treatment Period 2|Reason other than those specified above|1
2250979|NCT02028767|3914871|FG001|Treatment Period 2|Reason other than those specified above|0
2250980|NCT02028871|3914946|FG000|Overall Study|Positive urine drug screen|1
2250981|NCT02028871|3914947|FG001|Overall Study|Positive urine drug screen|1
2250982|NCT02028871|3914946|FG000|Overall Study|Withdrawal by Subject|1
2250983|NCT02028871|3914947|FG001|Overall Study|Withdrawal by Subject|2
2250984|NCT02028871|3914946|FG000|Overall Study|IV placement difficulty|1
2250985|NCT02028871|3914947|FG001|Overall Study|IV placement difficulty|0
2250986|NCT02028871|3914946|FG000|Overall Study|Current Illness|1
2250987|NCT02028871|3914947|FG001|Overall Study|Current Illness|0
2250988|NCT02029235|3914976|FG000|Overall Study|Non-compliance with study meds or diary|4
2250989|NCT02029235|3914977|FG001|Overall Study|Non-compliance with study meds or diary|1
2250990|NCT02029274|3914987|FG000|Overall Study|Adverse Event|1
2250991|NCT02029274|3914988|FG001|Overall Study|Adverse Event|0
2250992|NCT02029274|3914989|FG002|Overall Study|Adverse Event|2
2250993|NCT02029274|3914990|FG003|Overall Study|Adverse Event|2
2250994|NCT02029417|3915004|FG000|Overall Study|Death|1
2250995|NCT02029417|3915004|FG000|Overall Study|Adverse Event|1
2250996|NCT02029521|3915023|FG000|Overall Study|Protocol Violation|1
2250997|NCT02029521|3915024|FG001|Overall Study|Protocol Violation|0
2250998|NCT02029521|3915023|FG000|Overall Study|Withdrawal by Subject|1
2250999|NCT02029521|3915024|FG001|Overall Study|Withdrawal by Subject|1
2251000|NCT02029638|3915036|FG000|Overall Study|Death|0
2251001|NCT02029638|3915037|FG001|Overall Study|Death|0
2251002|NCT02029638|3915038|FG002|Overall Study|Death|1
2251003|NCT02029638|3915036|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2
2251004|NCT02029638|3915037|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0
2251005|NCT02029638|3915038|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0
2251006|NCT02029976|3915083|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12
2251007|NCT02029976|3915084|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8
2251008|NCT02029976|3915083|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8
2251009|NCT02029976|3915084|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4
2251010|NCT02029976|3915083|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
2251011|NCT02029976|3915084|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
2251012|NCT02029976|3915083|FG000|YR-2 Follow Up vs Baseline|Moved from area|0
2251013|NCT02029976|3915084|FG001|YR-2 Follow Up vs Baseline|Moved from area|2
2251014|NCT02029989|3915092|FG000|Overall Study|Withdrawal by Subject|1
2251015|NCT02029989|3915093|FG001|Overall Study|Withdrawal by Subject|0
2251016|NCT02029989|3915092|FG000|Overall Study|Withdrawal: Fear of needles|1
2251017|NCT02029989|3915093|FG001|Overall Study|Withdrawal: Fear of needles|0
2251018|NCT02029989|3915092|FG000|Overall Study|Change of location|2
2251019|NCT02029989|3915093|FG001|Overall Study|Change of location|3
2251020|NCT02029989|3915092|FG000|Overall Study|Physician Decision|2
2251021|NCT02029989|3915093|FG001|Overall Study|Physician Decision|0
2251022|NCT02029989|3915092|FG000|Overall Study|Lost to Follow-up|9
2251023|NCT02029989|3915093|FG001|Overall Study|Lost to Follow-up|7
2251024|NCT02029989|3915092|FG000|Overall Study|Death|0
2251025|NCT02029989|3915093|FG001|Overall Study|Death|1
2251026|NCT02029989|3915092|FG000|Overall Study|Protocol Violation|1
2251027|NCT02029989|3915093|FG001|Overall Study|Protocol Violation|0
2251028|NCT02030002|3915099|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1
2251029|NCT02030002|3915099|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4
2251030|NCT02030002|3915099|FG000|Follow-up|Lost to Follow-up|2
2251031|NCT02030041|3915108|FG000|Overall Study|Withdrawal by Subject|2
2251032|NCT02030041|3915109|FG001|Overall Study|Withdrawal by Subject|2
2251033|NCT02030041|3915110|FG002|Overall Study|Withdrawal by Subject|1
2341188|NCT03442777|4072964|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13
2341189|NCT03442777|4072965|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7
2341190|NCT03442829|4072973|FG000|Overall Study|Scheduling clash|3
2341191|NCT03442829|4072974|FG001|Overall Study|Scheduling clash|1
2341192|NCT03442829|4072973|FG000|Overall Study|Illness unrelated to study|1
2341193|NCT03442829|4072974|FG001|Overall Study|Illness unrelated to study|1
2341194|NCT03443024|4072998|FG000|Overall Study|Adverse Event|2
2341195|NCT03443024|4072999|FG001|Overall Study|Adverse Event|4
2341196|NCT03443024|4073000|FG002|Overall Study|Adverse Event|3
2341197|NCT03443024|4073001|FG003|Overall Study|Adverse Event|1
2341198|NCT03443024|4072998|FG000|Overall Study|Lost to Follow-up|9
2341199|NCT03443024|4072999|FG001|Overall Study|Lost to Follow-up|9
2341200|NCT03443024|4073000|FG002|Overall Study|Lost to Follow-up|7
2341201|NCT03443024|4073001|FG003|Overall Study|Lost to Follow-up|5
2341202|NCT03443024|4072998|FG000|Overall Study|Withdrawal by Subject|8
2341203|NCT03443024|4072999|FG001|Overall Study|Withdrawal by Subject|15
2341204|NCT03443024|4073000|FG002|Overall Study|Withdrawal by Subject|9
2341205|NCT03443024|4073001|FG003|Overall Study|Withdrawal by Subject|23
2341206|NCT03443024|4072998|FG000|Overall Study|Physician Decision|1
2341207|NCT03443024|4072999|FG001|Overall Study|Physician Decision|2
2341208|NCT03443024|4073000|FG002|Overall Study|Physician Decision|0
2341209|NCT03443024|4073001|FG003|Overall Study|Physician Decision|1
2341210|NCT03443024|4072998|FG000|Overall Study|Sponsor Decision|1
2341211|NCT03443024|4072999|FG001|Overall Study|Sponsor Decision|1
2341212|NCT03443024|4073000|FG002|Overall Study|Sponsor Decision|0
2341213|NCT03443024|4073001|FG003|Overall Study|Sponsor Decision|0
2341214|NCT03443024|4072998|FG000|Overall Study|Protocol Deviation|0
2341215|NCT03443024|4072999|FG001|Overall Study|Protocol Deviation|0
2341216|NCT03443024|4073000|FG002|Overall Study|Protocol Deviation|0
2341217|NCT03443024|4073001|FG003|Overall Study|Protocol Deviation|2
2341218|NCT03443414|4073027|FG000|Overall Study|Adverse Event|6
2341219|NCT03443414|4073028|FG001|Overall Study|Adverse Event|0
2341220|NCT03443414|4073029|FG002|Overall Study|Adverse Event|4
2341221|NCT03443414|4073030|FG003|Overall Study|Adverse Event|2
2251034|NCT02030119|3915139|FG000|Overall Study|Withdrawal by Subject|3
2251035|NCT02030119|3915140|FG001|Overall Study|Withdrawal by Subject|1
2251036|NCT02030119|3915141|FG002|Overall Study|Withdrawal by Subject|5
2251037|NCT02030119|3915142|FG003|Overall Study|Withdrawal by Subject|3
2251038|NCT02030119|3915139|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0
2251039|NCT02030119|3915140|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1
2251040|NCT02030119|3915141|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1
2251041|NCT02030119|3915142|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0
2251042|NCT02030405|3915165|FG000|Overall Study|Withdrawal by Subject|1
2251043|NCT02030405|3915165|FG000|Overall Study|Lost to Follow-up|1
2251044|NCT02030535|3915170|FG000|Washout Period 1 (21 Days)|Adverse Event|1
2251045|NCT02030600|3915190|FG000|Treatment Period 1|Adverse Event|5
2251046|NCT02030600|3915191|FG001|Treatment Period 1|Adverse Event|7
2251047|NCT02030600|3915190|FG000|Treatment Period 1|Lack of Efficacy|0
2251048|NCT02030600|3915191|FG001|Treatment Period 1|Lack of Efficacy|1
2251049|NCT02030600|3915190|FG000|Treatment Period 1|Lost to Follow-up|11
2251050|NCT02030600|3915191|FG001|Treatment Period 1|Lost to Follow-up|3
2251051|NCT02030600|3915190|FG000|Treatment Period 1|Protocol Violation|22
2251052|NCT02030600|3915191|FG001|Treatment Period 1|Protocol Violation|17
2251053|NCT02030600|3915190|FG000|Treatment Period 1|Withdrawal by Subject|13
2251054|NCT02030600|3915191|FG001|Treatment Period 1|Withdrawal by Subject|17
2251055|NCT02030600|3915190|FG000|Treatment Period 1|Casebook Unsigned|1
2251056|NCT02030600|3915191|FG001|Treatment Period 1|Casebook Unsigned|0
2251057|NCT02030600|3915190|FG000|Treatment Period 1|Unclassified|1
2251058|NCT02030600|3915191|FG001|Treatment Period 1|Unclassified|0
2251059|NCT02030600|3915190|FG000|Treatment Period 2|Adverse Event|4
2251060|NCT02030600|3915191|FG001|Treatment Period 2|Adverse Event|4
2251061|NCT02030600|3915190|FG000|Treatment Period 2|Lack of Efficacy|2
2251062|NCT02030600|3915191|FG001|Treatment Period 2|Lack of Efficacy|1
2251063|NCT02030600|3915190|FG000|Treatment Period 2|Lost to Follow-up|4
2251064|NCT02030600|3915191|FG001|Treatment Period 2|Lost to Follow-up|2
2251065|NCT02030600|3915190|FG000|Treatment Period 2|Protocol Violation|1
2251066|NCT02030600|3915191|FG001|Treatment Period 2|Protocol Violation|2
2251067|NCT02030600|3915190|FG000|Treatment Period 2|Withdrawal by Subject|13
2341222|NCT03443414|4073031|FG004|Overall Study|Adverse Event|3
2341223|NCT03443414|4073027|FG000|Overall Study|Withdrawal by Subject|3
2341224|NCT03443414|4073028|FG001|Overall Study|Withdrawal by Subject|2
2341225|NCT03443414|4073029|FG002|Overall Study|Withdrawal by Subject|2
2341226|NCT03443414|4073030|FG003|Overall Study|Withdrawal by Subject|2
2341227|NCT03443414|4073031|FG004|Overall Study|Withdrawal by Subject|1
2341228|NCT03443414|4073027|FG000|Overall Study|Death|0
2341229|NCT03443414|4073028|FG001|Overall Study|Death|1
2341230|NCT03443414|4073029|FG002|Overall Study|Death|0
2341231|NCT03443414|4073030|FG003|Overall Study|Death|1
2341232|NCT03443414|4073031|FG004|Overall Study|Death|0
2341233|NCT03443414|4073027|FG000|Overall Study|Reason not specified|2
2341234|NCT03443414|4073028|FG001|Overall Study|Reason not specified|0
2341235|NCT03443414|4073029|FG002|Overall Study|Reason not specified|0
2341236|NCT03443414|4073030|FG003|Overall Study|Reason not specified|0
2341237|NCT03443414|4073031|FG004|Overall Study|Reason not specified|1
2341238|NCT03443427|4073045|FG000|Overall Study|Adverse Event|2
2341239|NCT03443427|4073046|FG001|Overall Study|Adverse Event|3
2341240|NCT03443427|4073045|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
2341241|NCT03443427|4073046|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
2341242|NCT03443427|4073045|FG000|Overall Study|Other|4
2341243|NCT03443427|4073046|FG001|Overall Study|Other|6
2341244|NCT03443713|4073055|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0
2341245|NCT03443713|4073056|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0
2341246|NCT03443713|4073057|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1
2341247|NCT03444155|4073080|FG000|First Intervention (6 Weeks)|Adverse Event|1
2038440|NCT00422591|3608791|FG000|Overall Study|Withdrawal by Subject|2
2038441|NCT00422734|3608810|FG000|Overall Study|Physician Decision|1
2038442|NCT00422734|3608811|FG001|Overall Study|Physician Decision|1
2038443|NCT00422734|3608810|FG000|Overall Study|Protocol Violation|1
2038444|NCT00422734|3608811|FG001|Overall Study|Protocol Violation|6
2038445|NCT00422734|3608810|FG000|Overall Study|Withdrawal by Subject|12
2038446|NCT00422734|3608811|FG001|Overall Study|Withdrawal by Subject|8
2038447|NCT00422734|3608810|FG000|Overall Study|Adverse Event|0
2038448|NCT00422734|3608811|FG001|Overall Study|Adverse Event|3
2038449|NCT00422734|3608810|FG000|Overall Study|Partner Decision|0
2038450|NCT00422734|3608811|FG001|Overall Study|Partner Decision|3
2038451|NCT00422799|3608817|FG000|Overall Study|Withdrawal by Subject|6
2038452|NCT00422799|3608817|FG000|Overall Study|Adverse Event|7
2251068|NCT02030600|3915191|FG001|Treatment Period 2|Withdrawal by Subject|9
2251069|NCT02030600|3915190|FG000|Treatment Period 2|Unclassified|1
2251070|NCT02030600|3915191|FG001|Treatment Period 2|Unclassified|0
2251071|NCT02030821|3915203|FG000|Overall Study|Physician Decision|2
2251072|NCT02030821|3915204|FG001|Overall Study|Physician Decision|2
2251073|NCT02030821|3915205|FG002|Overall Study|Physician Decision|5
2251074|NCT02030821|3915206|FG003|Overall Study|Physician Decision|2
2251075|NCT02030834|3915219|FG000|Overall Study|Death|4
2251076|NCT02030834|3915220|FG001|Overall Study|Death|0
2251077|NCT02030834|3915221|FG002|Overall Study|Death|0
2251078|NCT02030834|3915219|FG000|Overall Study|Manufacturing failure|2
2251079|NCT02030834|3915220|FG001|Overall Study|Manufacturing failure|0
2251080|NCT02030834|3915221|FG002|Overall Study|Manufacturing failure|1
2251081|NCT02030834|3915219|FG000|Overall Study|Disease progression|2
2251082|NCT02030834|3915220|FG001|Overall Study|Disease progression|0
2251083|NCT02030834|3915221|FG002|Overall Study|Disease progression|2
2251084|NCT02030834|3915219|FG000|Overall Study|Lost to Follow-up|1
2251085|NCT02030834|3915220|FG001|Overall Study|Lost to Follow-up|0
2251086|NCT02030834|3915221|FG002|Overall Study|Lost to Follow-up|0
2251087|NCT02030834|3915219|FG000|Overall Study|Withdrawal by Subject|1
2251088|NCT02030834|3915220|FG001|Overall Study|Withdrawal by Subject|0
2251089|NCT02030834|3915221|FG002|Overall Study|Withdrawal by Subject|0
2251090|NCT02030834|3915219|FG000|Overall Study|Lack of funding|1
2251091|NCT02030834|3915220|FG001|Overall Study|Lack of funding|0
2251092|NCT02030834|3915221|FG002|Overall Study|Lack of funding|0
2251093|NCT02030847|3915229|FG000|Overall Study|Death|10
2251094|NCT02030847|3915229|FG000|Overall Study|Disease Progression|15
2251095|NCT02030847|3915229|FG000|Overall Study|New Cancer Therapy|8
2251096|NCT02030847|3915229|FG000|Overall Study|Physician Decision|3
2251097|NCT02030847|3915229|FG000|Overall Study|Withdrawal by Subject|1
2251098|NCT02031146|3915247|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0
2251099|NCT02031146|3915248|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0
2251100|NCT02031146|3915249|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0
2251101|NCT02031146|3915250|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100
2251102|NCT02031146|3915251|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26
2251103|NCT02031146|3915252|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4
2251104|NCT02031146|3915253|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5
2251105|NCT02031237|3915265|FG000|Overall Study|Death|1
2251106|NCT02031237|3915266|FG001|Overall Study|Death|5
2251107|NCT02031237|3915267|FG002|Overall Study|Death|0
2251108|NCT02031237|3915265|FG000|Overall Study|Physician Decision|0
2251109|NCT02031237|3915266|FG001|Overall Study|Physician Decision|1
2251110|NCT02031237|3915267|FG002|Overall Study|Physician Decision|0
2251111|NCT02031237|3915265|FG000|Overall Study|Withdrawal by Subject|2
2251112|NCT02031237|3915266|FG001|Overall Study|Withdrawal by Subject|2
2251113|NCT02031237|3915267|FG002|Overall Study|Withdrawal by Subject|0
2251114|NCT02031237|3915265|FG000|Overall Study|Protocol Violation|2
2251115|NCT02031237|3915266|FG001|Overall Study|Protocol Violation|6
2251116|NCT02031237|3915267|FG002|Overall Study|Protocol Violation|0
2251117|NCT02031237|3915265|FG000|Overall Study|Alternate Treatment Given|0
2251118|NCT02031237|3915266|FG001|Overall Study|Alternate Treatment Given|0
2251119|NCT02031237|3915267|FG002|Overall Study|Alternate Treatment Given|3
2341248|NCT03444155|4073081|FG001|First Intervention (6 Weeks)|Adverse Event|0
2341249|NCT03444584|4073089|FG000|Overall Study|Withdrawal by Subject|0
2341250|NCT03444584|4073090|FG001|Overall Study|Withdrawal by Subject|1
2341251|NCT03444584|4073089|FG000|Overall Study|Other|0
2341252|NCT03444584|4073090|FG001|Overall Study|Other|1
2341253|NCT03444766|4073097|FG000|Overall Study|Other Reasons|2
2341254|NCT03444766|4073097|FG000|Overall Study|Participant Withdrew Consent|5
2341255|NCT03444766|4073097|FG000|Overall Study|Lost to Follow-up|2
2341256|NCT03444766|4073097|FG000|Overall Study|Death|2
2341257|NCT03444766|4073097|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6
2341258|NCT03444766|4073097|FG000|Overall Study|Disease Progression|49
2341259|NCT03445065|4073113|FG000|Overall Study|Withdrawal by Subject|3
2341260|NCT03445065|4073114|FG001|Overall Study|Withdrawal by Subject|6
2341261|NCT03445065|4073115|FG002|Overall Study|Withdrawal by Subject|2
2341262|NCT03445065|4073116|FG003|Overall Study|Withdrawal by Subject|2
2341263|NCT03445065|4073113|FG000|Overall Study|Other|4
2341264|NCT03445065|4073114|FG001|Overall Study|Other|3
2341265|NCT03445065|4073115|FG002|Overall Study|Other|3
2341266|NCT03445065|4073116|FG003|Overall Study|Other|1
2341267|NCT03446781|4073223|FG000|Overall Study|Lost to Follow-up|11
2341268|NCT03446781|4073224|FG001|Overall Study|Lost to Follow-up|5
2341269|NCT03446781|4073223|FG000|Overall Study|Withdrawal by Subject|9
2341270|NCT03446781|4073224|FG001|Overall Study|Withdrawal by Subject|7
2341271|NCT03446781|4073223|FG000|Overall Study|Adverse Event|8
2341272|NCT03446781|4073224|FG001|Overall Study|Adverse Event|2
2341273|NCT03446781|4073223|FG000|Overall Study|Protocol Violation|0
2341274|NCT03446781|4073224|FG001|Overall Study|Protocol Violation|3
2341275|NCT03446885|4073265|FG000|Overall Study|Lost to Follow-up|1
2341276|NCT03446885|4073266|FG001|Overall Study|Lost to Follow-up|0
2341277|NCT03446885|4073265|FG000|Overall Study|Did not complete entire visit|1
2341278|NCT03446885|4073266|FG001|Overall Study|Did not complete entire visit|0
2341279|NCT03447249|4073285|FG000|Overall Study|Adverse Event|1
2341280|NCT03447249|4073286|FG001|Overall Study|Adverse Event|0
2341281|NCT03447249|4073285|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
2341282|NCT03447249|4073286|FG001|Overall Study|Withdrawal of consent (not due to AE)|0
2341283|NCT03447249|4073285|FG000|Overall Study|Other|3
2341284|NCT03447249|4073286|FG001|Overall Study|Other|0
2341285|NCT03447314|4073312|FG000|Part 1 (Up to 27 Months)|Death|6
2341286|NCT03447314|4073313|FG001|Part 1 (Up to 27 Months)|Death|5
2341287|NCT03447314|4073314|FG002|Part 1 (Up to 27 Months)|Death|3
2341288|NCT03447314|4073315|FG003|Part 1 (Up to 27 Months)|Death|3
2341289|NCT03447314|4073316|FG004|Part 1 (Up to 27 Months)|Death|0
2251120|NCT02031276|3915277|FG000|Period 1 Double-blind IV|Adverse Event|6
2251121|NCT02031276|3915278|FG001|Period 1 Double-blind IV|Adverse Event|5
2251122|NCT02031276|3915279|FG002|Period 1 Double-blind IV|Adverse Event|1
2251123|NCT02031276|3915277|FG000|Period 1 Double-blind IV|Other|0
2251124|NCT02031276|3915278|FG001|Period 1 Double-blind IV|Other|1
2251125|NCT02031276|3915279|FG002|Period 1 Double-blind IV|Other|0
2251126|NCT02031276|3915277|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1
2251127|NCT02031276|3915278|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0
2251128|NCT02031276|3915279|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0
2251129|NCT02031276|3915277|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
2251130|NCT02031276|3915278|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
2251131|NCT02031276|3915279|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
2251132|NCT02031276|3915277|FG000|Period 2 Open-label Risankizumab IV|Other|0
2251133|NCT02031276|3915278|FG001|Period 2 Open-label Risankizumab IV|Other|2
2251134|NCT02031276|3915279|FG002|Period 2 Open-label Risankizumab IV|Other|1
2251135|NCT02031276|3915277|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0
2251136|NCT02031276|3915278|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2
2251137|NCT02031276|3915279|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0
2251138|NCT02031276|3915277|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2
2251139|NCT02031276|3915278|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0
2341290|NCT03447314|4073317|FG005|Part 1 (Up to 27 Months)|Death|4
2341291|NCT03447314|4073318|FG006|Part 1 (Up to 27 Months)|Death|3
2341292|NCT03447314|4073319|FG007|Part 1 (Up to 27 Months)|Death|0
2341293|NCT03447314|4073320|FG008|Part 1 (Up to 27 Months)|Death|0
2341294|NCT03447314|4073321|FG009|Part 1 (Up to 27 Months)|Death|0
2341295|NCT03447314|4073322|FG010|Part 1 (Up to 27 Months)|Death|4
2341296|NCT03447314|4073323|FG011|Part 1 (Up to 27 Months)|Death|2
2341297|NCT03447314|4073324|FG012|Part 1 (Up to 27 Months)|Death|0
2341298|NCT03447314|4073325|FG013|Part 1 (Up to 27 Months)|Death|0
2341299|NCT03447314|4073326|FG014|Part 1 (Up to 27 Months)|Death|0
2341300|NCT03447314|4073327|FG015|Part 1 (Up to 27 Months)|Death|0
2341301|NCT03447314|4073328|FG016|Part 1 (Up to 27 Months)|Death|0
2341302|NCT03447314|4073329|FG017|Part 1 (Up to 27 Months)|Death|0
2341303|NCT03447314|4073312|FG000|Part 1 (Up to 27 Months)|Ongoing in the study|2
2341304|NCT03447314|4073313|FG001|Part 1 (Up to 27 Months)|Ongoing in the study|1
2341305|NCT03447314|4073314|FG002|Part 1 (Up to 27 Months)|Ongoing in the study|3
2341306|NCT03447314|4073315|FG003|Part 1 (Up to 27 Months)|Ongoing in the study|1
2341307|NCT03447314|4073316|FG004|Part 1 (Up to 27 Months)|Ongoing in the study|2
2341308|NCT03447314|4073317|FG005|Part 1 (Up to 27 Months)|Ongoing in the study|1
2341309|NCT03447314|4073318|FG006|Part 1 (Up to 27 Months)|Ongoing in the study|2
2341310|NCT03447314|4073319|FG007|Part 1 (Up to 27 Months)|Ongoing in the study|0
2341311|NCT03447314|4073320|FG008|Part 1 (Up to 27 Months)|Ongoing in the study|0
2341312|NCT03447314|4073321|FG009|Part 1 (Up to 27 Months)|Ongoing in the study|0
2341313|NCT03447314|4073322|FG010|Part 1 (Up to 27 Months)|Ongoing in the study|3
2341314|NCT03447314|4073323|FG011|Part 1 (Up to 27 Months)|Ongoing in the study|4
2341315|NCT03447314|4073324|FG012|Part 1 (Up to 27 Months)|Ongoing in the study|0
2341316|NCT03447314|4073325|FG013|Part 1 (Up to 27 Months)|Ongoing in the study|0
2341317|NCT03447314|4073326|FG014|Part 1 (Up to 27 Months)|Ongoing in the study|0
2341318|NCT03447314|4073327|FG015|Part 1 (Up to 27 Months)|Ongoing in the study|0
2341319|NCT03447314|4073328|FG016|Part 1 (Up to 27 Months)|Ongoing in the study|0
2341320|NCT03447314|4073329|FG017|Part 1 (Up to 27 Months)|Ongoing in the study|0
2341321|NCT03447314|4073312|FG000|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
2341322|NCT03447314|4073313|FG001|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341323|NCT03447314|4073314|FG002|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
2341324|NCT03447314|4073315|FG003|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341325|NCT03447314|4073316|FG004|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341326|NCT03447314|4073317|FG005|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
2341327|NCT03447314|4073318|FG006|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341328|NCT03447314|4073319|FG007|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341329|NCT03447314|4073320|FG008|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341330|NCT03447314|4073321|FG009|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341331|NCT03447314|4073322|FG010|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341332|NCT03447314|4073323|FG011|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341333|NCT03447314|4073324|FG012|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341334|NCT03447314|4073325|FG013|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2038453|NCT00422903|3608840|FG000|Overall Study|Disease Progression|3
2038454|NCT00422903|3608841|FG001|Overall Study|Disease Progression|1
2038455|NCT00422903|3608840|FG000|Overall Study|Adverse Event|0
2038456|NCT00422903|3608841|FG001|Overall Study|Adverse Event|2
2038457|NCT00422903|3608840|FG000|Overall Study|Informed Consent Withdrawn|1
2038458|NCT00422903|3608841|FG001|Overall Study|Informed Consent Withdrawn|2
2038459|NCT00423046|3608849|FG000|Overall Study|Other|340
2038460|NCT00423046|3608850|FG001|Overall Study|Other|345
2038461|NCT00423085|3608861|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21
2038462|NCT00423085|3608862|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38
2038463|NCT00423085|3608863|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34
2038464|NCT00423085|3608864|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0
2038465|NCT00423085|3608861|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
2251140|NCT02031276|3915279|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0
2251141|NCT02031276|3915277|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
2251142|NCT02031276|3915278|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
2251143|NCT02031276|3915279|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
2251144|NCT02031276|3915277|FG000|Period 3 Open-label Risankizumab SC|Other|0
2251145|NCT02031276|3915278|FG001|Period 3 Open-label Risankizumab SC|Other|0
2251146|NCT02031276|3915279|FG002|Period 3 Open-label Risankizumab SC|Other|1
2251147|NCT02031302|3915293|FG000|Overall Study|Death|115
2251148|NCT02031302|3915294|FG001|Overall Study|Death|0
2251149|NCT02031302|3915293|FG000|Overall Study|Not treated with study valve system|18
2251150|NCT02031302|3915294|FG001|Overall Study|Not treated with study valve system|0
2251151|NCT02031302|3915293|FG000|Overall Study|Missed Follow Up|27
2251152|NCT02031302|3915294|FG001|Overall Study|Missed Follow Up|0
2251153|NCT02031302|3915293|FG000|Overall Study|Lost to Follow-up|4
2251154|NCT02031302|3915294|FG001|Overall Study|Lost to Follow-up|0
2251155|NCT02031432|3915301|FG000|Overall Study|Protocol Violation|1
2251156|NCT02031432|3915301|FG000|Overall Study|Lack of Efficacy|5
2251157|NCT02031432|3915301|FG000|Overall Study|Cancer Progression|2
2251158|NCT02031432|3915301|FG000|Overall Study|Withdrawn as forbidden meds required|1
2251159|NCT02031432|3915301|FG000|Overall Study|Adverse Event|8
2251160|NCT02031432|3915301|FG000|Overall Study|Withdrawal by Subject|5
2251161|NCT02031432|3915301|FG000|Overall Study|Lost to Follow-up|1
2251162|NCT02031432|3915301|FG000|Overall Study|Inclusion/Exclusion criteria not met|5
2251163|NCT02031432|3915301|FG000|Overall Study|Death|10
2251164|NCT02031458|3915308|FG000|May 8, 2015 to January 11, 2019|Death|89
2251165|NCT02031458|3915309|FG001|May 8, 2015 to January 11, 2019|Death|193
2251166|NCT02031458|3915310|FG002|May 8, 2015 to January 11, 2019|Death|198
2251167|NCT02031458|3915308|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
2251168|NCT02031458|3915309|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
2251169|NCT02031458|3915310|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
2251170|NCT02031458|3915308|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
2251171|NCT02031458|3915309|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
2251172|NCT02031458|3915310|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
2251173|NCT02031458|3915308|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2
2251174|NCT02031458|3915309|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3
2251175|NCT02031458|3915310|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3
2251176|NCT02031458|3915308|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7
2251177|NCT02031458|3915309|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4
2251178|NCT02031458|3915310|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0
2251179|NCT02031458|3915308|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
2251180|NCT02031458|3915309|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
2251181|NCT02031458|3915310|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
2251182|NCT02031458|3915308|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
2251183|NCT02031458|3915309|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
2251184|NCT02031458|3915310|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
2251185|NCT02031458|3915308|FG000|Baseline to May 8, 2015|Death|36
2251186|NCT02031458|3915309|FG001|Baseline to May 8, 2015|Death|87
2251187|NCT02031458|3915310|FG002|Baseline to May 8, 2015|Death|100
2251188|NCT02031458|3915308|FG000|Baseline to May 8, 2015|Protocol Violation|7
2251189|NCT02031458|3915309|FG001|Baseline to May 8, 2015|Protocol Violation|4
2251190|NCT02031458|3915310|FG002|Baseline to May 8, 2015|Protocol Violation|0
2251191|NCT02031458|3915308|FG000|Baseline to May 8, 2015|Physician Decision|0
2251192|NCT02031458|3915309|FG001|Baseline to May 8, 2015|Physician Decision|1
2251193|NCT02031458|3915310|FG002|Baseline to May 8, 2015|Physician Decision|0
2251194|NCT02031458|3915308|FG000|Baseline to May 8, 2015|Unknown Reason|0
2251195|NCT02031458|3915309|FG001|Baseline to May 8, 2015|Unknown Reason|1
2251196|NCT02031458|3915310|FG002|Baseline to May 8, 2015|Unknown Reason|2
2251197|NCT02031458|3915308|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6
2251198|NCT02031458|3915309|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9
2251199|NCT02031458|3915310|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3
2251200|NCT02031458|3915308|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46
2251201|NCT02031458|3915309|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83
2251202|NCT02031458|3915310|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73
2251203|NCT02031458|3915308|FG000|Baseline to May 8, 2015|On Treatment|43
2251204|NCT02031458|3915309|FG001|Baseline to May 8, 2015|On Treatment|81
2251205|NCT02031458|3915310|FG002|Baseline to May 8, 2015|On Treatment|73
2251206|NCT02031458|3915308|FG000|Baseline to May 8, 2015|Lost to Follow-up|1
2251207|NCT02031458|3915309|FG001|Baseline to May 8, 2015|Lost to Follow-up|1
2251208|NCT02031458|3915310|FG002|Baseline to May 8, 2015|Lost to Follow-up|2
2251209|NCT02031471|3915320|FG000|24 Week Treatment Period|Adverse Event|6
2251210|NCT02031471|3915320|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2
2251211|NCT02031471|3915320|FG000|24 Week Treatment Period|Protocol Violation|1
2251212|NCT02031471|3915320|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1
2251213|NCT02031471|3915320|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1
2251214|NCT02031471|3915320|FG000|Long Term Extension (LTE) Period|Adverse Event|1
2251215|NCT02031471|3915320|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
2251216|NCT02031536|3915326|FG000|Overall Study|ineligible|1
2251217|NCT02031536|3915327|FG001|Overall Study|ineligible|0
2251218|NCT02031640|3915351|FG000|Screening Period|Adverse Event|1
2251219|NCT02031640|3915352|FG001|Screening Period|Adverse Event|0
2251220|NCT02031640|3915353|FG002|Screening Period|Adverse Event|0
2251221|NCT02031640|3915354|FG003|Screening Period|Adverse Event|0
2251222|NCT02031640|3915355|FG004|Screening Period|Adverse Event|0
2251223|NCT02031640|3915356|FG005|Screening Period|Adverse Event|0
2251224|NCT02031640|3915351|FG000|Screening Period|Withdrawal by Subject|29
2251225|NCT02031640|3915352|FG001|Screening Period|Withdrawal by Subject|0
2251226|NCT02031640|3915353|FG002|Screening Period|Withdrawal by Subject|0
2251227|NCT02031640|3915354|FG003|Screening Period|Withdrawal by Subject|0
2251228|NCT02031640|3915355|FG004|Screening Period|Withdrawal by Subject|0
2251229|NCT02031640|3915356|FG005|Screening Period|Withdrawal by Subject|0
2251230|NCT02031640|3915351|FG000|Screening Period|Inclusion criteria not met|312
2251231|NCT02031640|3915352|FG001|Screening Period|Inclusion criteria not met|0
2251232|NCT02031640|3915353|FG002|Screening Period|Inclusion criteria not met|0
2341335|NCT03447314|4073326|FG014|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341336|NCT03447314|4073327|FG015|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341337|NCT03447314|4073328|FG016|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341338|NCT03447314|4073329|FG017|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
2341339|NCT03447314|4073312|FG000|Part 1 (Up to 27 Months)|Disease progression|0
2341340|NCT03447314|4073313|FG001|Part 1 (Up to 27 Months)|Disease progression|0
2341341|NCT03447314|4073314|FG002|Part 1 (Up to 27 Months)|Disease progression|1
2341342|NCT03447314|4073315|FG003|Part 1 (Up to 27 Months)|Disease progression|0
2341343|NCT03447314|4073316|FG004|Part 1 (Up to 27 Months)|Disease progression|0
2341344|NCT03447314|4073317|FG005|Part 1 (Up to 27 Months)|Disease progression|0
2341345|NCT03447314|4073318|FG006|Part 1 (Up to 27 Months)|Disease progression|0
2341346|NCT03447314|4073319|FG007|Part 1 (Up to 27 Months)|Disease progression|0
2341347|NCT03447314|4073320|FG008|Part 1 (Up to 27 Months)|Disease progression|0
2341348|NCT03447314|4073321|FG009|Part 1 (Up to 27 Months)|Disease progression|0
2341349|NCT03447314|4073322|FG010|Part 1 (Up to 27 Months)|Disease progression|0
2341350|NCT03447314|4073323|FG011|Part 1 (Up to 27 Months)|Disease progression|0
2341351|NCT03447314|4073324|FG012|Part 1 (Up to 27 Months)|Disease progression|0
2341352|NCT03447314|4073325|FG013|Part 1 (Up to 27 Months)|Disease progression|0
2341353|NCT03447314|4073326|FG014|Part 1 (Up to 27 Months)|Disease progression|0
2341354|NCT03447314|4073327|FG015|Part 1 (Up to 27 Months)|Disease progression|0
2341355|NCT03447314|4073328|FG016|Part 1 (Up to 27 Months)|Disease progression|0
2341356|NCT03447314|4073329|FG017|Part 1 (Up to 27 Months)|Disease progression|0
2341357|NCT03447314|4073312|FG000|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341358|NCT03447314|4073313|FG001|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341359|NCT03447314|4073314|FG002|Part 1 (Up to 27 Months)|Lost to Follow-up|1
2341360|NCT03447314|4073315|FG003|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341361|NCT03447314|4073316|FG004|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341362|NCT03447314|4073317|FG005|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341363|NCT03447314|4073318|FG006|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341364|NCT03447314|4073319|FG007|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341365|NCT03447314|4073320|FG008|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341366|NCT03447314|4073321|FG009|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341367|NCT03447314|4073322|FG010|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341368|NCT03447314|4073323|FG011|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341369|NCT03447314|4073324|FG012|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341370|NCT03447314|4073325|FG013|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341371|NCT03447314|4073326|FG014|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341372|NCT03447314|4073327|FG015|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341373|NCT03447314|4073328|FG016|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341374|NCT03447314|4073329|FG017|Part 1 (Up to 27 Months)|Lost to Follow-up|0
2341375|NCT03447353|4073370|FG000|Overall Study|Failure at Screening Visit|2
2341376|NCT03447353|4073370|FG000|Overall Study|Lost to Follow-up|4
2341377|NCT03447353|4073370|FG000|Overall Study|Scheduling Conflicts|3
2341378|NCT03447353|4073370|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
2341379|NCT03447730|4073383|FG000|Overall Study|Adverse Event|0
2341380|NCT03447730|4073384|FG001|Overall Study|Adverse Event|2
2341381|NCT03447730|4073385|FG002|Overall Study|Adverse Event|0
2341382|NCT03447821|4073396|FG000|Overall Study|Withdrawal by Subject|1
2341383|NCT03447821|4073397|FG001|Overall Study|Withdrawal by Subject|1
2341384|NCT03447821|4073398|FG002|Overall Study|Withdrawal by Subject|0
2341385|NCT03447821|4073396|FG000|Overall Study|Lost to Follow-up|0
2341386|NCT03447821|4073397|FG001|Overall Study|Lost to Follow-up|0
2341387|NCT03447821|4073398|FG002|Overall Study|Lost to Follow-up|1
2341388|NCT03448224|4073417|FG000|Overall Study|Provided same answer to every question|1
2341389|NCT03448224|4073418|FG001|Overall Study|Provided same answer to every question|0
2341390|NCT03448406|4073426|FG000|Overall Study|Noncompliance of scheduled visits|1
2341391|NCT03448406|4073427|FG001|Overall Study|Noncompliance of scheduled visits|2
2251233|NCT02031640|3915354|FG003|Screening Period|Inclusion criteria not met|0
2341392|NCT03448406|4073426|FG000|Overall Study|Withdrawal by Subject|1
2341393|NCT03448406|4073427|FG001|Overall Study|Withdrawal by Subject|2
2341394|NCT03448406|4073426|FG000|Overall Study|Protocol Violation|1
2251234|NCT02031640|3915355|FG004|Screening Period|Inclusion criteria not met|0
2251235|NCT02031640|3915356|FG005|Screening Period|Inclusion criteria not met|0
2251236|NCT02031640|3915351|FG000|Screening Period|Exclusion criteria met|30
2251237|NCT02031640|3915352|FG001|Screening Period|Exclusion criteria met|0
2251238|NCT02031640|3915353|FG002|Screening Period|Exclusion criteria met|0
2251239|NCT02031640|3915354|FG003|Screening Period|Exclusion criteria met|0
2251240|NCT02031640|3915355|FG004|Screening Period|Exclusion criteria met|0
2251241|NCT02031640|3915356|FG005|Screening Period|Exclusion criteria met|0
2251242|NCT02031640|3915351|FG000|Screening Period|Lost to Follow-up|14
2251243|NCT02031640|3915352|FG001|Screening Period|Lost to Follow-up|0
2251244|NCT02031640|3915353|FG002|Screening Period|Lost to Follow-up|0
2251245|NCT02031640|3915354|FG003|Screening Period|Lost to Follow-up|0
2251246|NCT02031640|3915355|FG004|Screening Period|Lost to Follow-up|0
2251247|NCT02031640|3915356|FG005|Screening Period|Lost to Follow-up|0
2251248|NCT02031640|3915351|FG000|Screening Period|Enrollment closed|26
2251249|NCT02031640|3915352|FG001|Screening Period|Enrollment closed|0
2251250|NCT02031640|3915353|FG002|Screening Period|Enrollment closed|0
2251251|NCT02031640|3915354|FG003|Screening Period|Enrollment closed|0
2251252|NCT02031640|3915355|FG004|Screening Period|Enrollment closed|0
2251253|NCT02031640|3915356|FG005|Screening Period|Enrollment closed|0
2251254|NCT02031640|3915351|FG000|Run-In Period|Adverse Event|4
2251255|NCT02031640|3915352|FG001|Run-In Period|Adverse Event|0
2251256|NCT02031640|3915353|FG002|Run-In Period|Adverse Event|0
2251257|NCT02031640|3915354|FG003|Run-In Period|Adverse Event|0
2251258|NCT02031640|3915355|FG004|Run-In Period|Adverse Event|0
2251259|NCT02031640|3915356|FG005|Run-In Period|Adverse Event|0
2251260|NCT02031640|3915351|FG000|Run-In Period|Withdrawal by Subject|17
2251261|NCT02031640|3915352|FG001|Run-In Period|Withdrawal by Subject|0
2251262|NCT02031640|3915353|FG002|Run-In Period|Withdrawal by Subject|0
2251263|NCT02031640|3915354|FG003|Run-In Period|Withdrawal by Subject|0
2251264|NCT02031640|3915355|FG004|Run-In Period|Withdrawal by Subject|0
2251265|NCT02031640|3915356|FG005|Run-In Period|Withdrawal by Subject|0
2251266|NCT02031640|3915351|FG000|Run-In Period|Inclusion criteria not met|38
2251267|NCT02031640|3915352|FG001|Run-In Period|Inclusion criteria not met|0
2251268|NCT02031640|3915353|FG002|Run-In Period|Inclusion criteria not met|0
2251269|NCT02031640|3915354|FG003|Run-In Period|Inclusion criteria not met|0
2251270|NCT02031640|3915355|FG004|Run-In Period|Inclusion criteria not met|0
2251271|NCT02031640|3915356|FG005|Run-In Period|Inclusion criteria not met|0
2251272|NCT02031640|3915351|FG000|Run-In Period|Exclusion criteria met|8
2251273|NCT02031640|3915352|FG001|Run-In Period|Exclusion criteria met|0
2251274|NCT02031640|3915353|FG002|Run-In Period|Exclusion criteria met|0
2251275|NCT02031640|3915354|FG003|Run-In Period|Exclusion criteria met|0
2251276|NCT02031640|3915355|FG004|Run-In Period|Exclusion criteria met|0
2251277|NCT02031640|3915356|FG005|Run-In Period|Exclusion criteria met|0
2251278|NCT02031640|3915351|FG000|Run-In Period|Randomization criteria not met|85
2251279|NCT02031640|3915352|FG001|Run-In Period|Randomization criteria not met|0
2251280|NCT02031640|3915353|FG002|Run-In Period|Randomization criteria not met|0
2251281|NCT02031640|3915354|FG003|Run-In Period|Randomization criteria not met|0
2251282|NCT02031640|3915355|FG004|Run-In Period|Randomization criteria not met|0
2251283|NCT02031640|3915356|FG005|Run-In Period|Randomization criteria not met|0
2251284|NCT02031640|3915351|FG000|Run-In Period|Various administrative reasons|17
2251285|NCT02031640|3915352|FG001|Run-In Period|Various administrative reasons|0
2251286|NCT02031640|3915353|FG002|Run-In Period|Various administrative reasons|0
2251287|NCT02031640|3915354|FG003|Run-In Period|Various administrative reasons|0
2251288|NCT02031640|3915355|FG004|Run-In Period|Various administrative reasons|0
2251289|NCT02031640|3915356|FG005|Run-In Period|Various administrative reasons|0
2251290|NCT02031640|3915351|FG000|Double-blind Treatment Period|Protocol deviation|0
2251291|NCT02031640|3915352|FG001|Double-blind Treatment Period|Protocol deviation|2
2251292|NCT02031640|3915353|FG002|Double-blind Treatment Period|Protocol deviation|0
2251293|NCT02031640|3915354|FG003|Double-blind Treatment Period|Protocol deviation|1
2251294|NCT02031640|3915355|FG004|Double-blind Treatment Period|Protocol deviation|3
2251295|NCT02031640|3915356|FG005|Double-blind Treatment Period|Protocol deviation|1
2251296|NCT02031640|3915351|FG000|Double-blind Treatment Period|Lack of Efficacy|0
2251297|NCT02031640|3915352|FG001|Double-blind Treatment Period|Lack of Efficacy|14
2251298|NCT02031640|3915353|FG002|Double-blind Treatment Period|Lack of Efficacy|3
2251299|NCT02031640|3915354|FG003|Double-blind Treatment Period|Lack of Efficacy|2
2251300|NCT02031640|3915355|FG004|Double-blind Treatment Period|Lack of Efficacy|5
2251301|NCT02031640|3915356|FG005|Double-blind Treatment Period|Lack of Efficacy|1
2251302|NCT02031640|3915351|FG000|Double-blind Treatment Period|Non-compliance|0
2251303|NCT02031640|3915352|FG001|Double-blind Treatment Period|Non-compliance|1
2251304|NCT02031640|3915353|FG002|Double-blind Treatment Period|Non-compliance|0
2251305|NCT02031640|3915354|FG003|Double-blind Treatment Period|Non-compliance|1
2251306|NCT02031640|3915355|FG004|Double-blind Treatment Period|Non-compliance|1
2251307|NCT02031640|3915356|FG005|Double-blind Treatment Period|Non-compliance|0
2251308|NCT02031640|3915351|FG000|Double-blind Treatment Period|Adverse Event|0
2341395|NCT03448406|4073427|FG001|Overall Study|Protocol Violation|0
2341396|NCT03448406|4073426|FG000|Overall Study|Adverse Event|8
2341397|NCT03448406|4073427|FG001|Overall Study|Adverse Event|9
2341398|NCT03448419|4073435|FG000|Overall Study|Adverse Event|10
2251309|NCT02031640|3915352|FG001|Double-blind Treatment Period|Adverse Event|0
2251310|NCT02031640|3915353|FG002|Double-blind Treatment Period|Adverse Event|0
2251311|NCT02031640|3915354|FG003|Double-blind Treatment Period|Adverse Event|2
2251312|NCT02031640|3915355|FG004|Double-blind Treatment Period|Adverse Event|0
2251313|NCT02031640|3915356|FG005|Double-blind Treatment Period|Adverse Event|0
2251314|NCT02031640|3915351|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
2251315|NCT02031640|3915352|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
2251316|NCT02031640|3915353|FG002|Double-blind Treatment Period|Withdrawal by Subject|3
2251317|NCT02031640|3915354|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
2251318|NCT02031640|3915355|FG004|Double-blind Treatment Period|Withdrawal by Subject|1
2251319|NCT02031640|3915356|FG005|Double-blind Treatment Period|Withdrawal by Subject|1
2251320|NCT02031640|3915351|FG000|Double-blind Treatment Period|Lost to Follow-up|0
2251321|NCT02031640|3915352|FG001|Double-blind Treatment Period|Lost to Follow-up|3
2251322|NCT02031640|3915353|FG002|Double-blind Treatment Period|Lost to Follow-up|0
2251323|NCT02031640|3915354|FG003|Double-blind Treatment Period|Lost to Follow-up|0
2251324|NCT02031640|3915355|FG004|Double-blind Treatment Period|Lost to Follow-up|1
2251325|NCT02031640|3915356|FG005|Double-blind Treatment Period|Lost to Follow-up|0
2251326|NCT02031679|3915377|FG000|Overall Study|Protocol Violation|0
2251327|NCT02031679|3915378|FG001|Overall Study|Protocol Violation|1
2251328|NCT02031679|3915377|FG000|Overall Study|Lack of Efficacy|0
2251329|NCT02031679|3915378|FG001|Overall Study|Lack of Efficacy|1
2251330|NCT02032173|3915395|FG000|Overall Study|Discontinuation due to sponsor decision|31
2251331|NCT02032238|3915418|FG000|Overall Study|Lost to Follow-up|2
2251332|NCT02032238|3915419|FG001|Overall Study|Lost to Follow-up|0
2251333|NCT02032407|3915425|FG000|Overall Study|Lost to Follow-up|2
2251334|NCT02032407|3915425|FG000|Overall Study|Pregnancy|1
2251335|NCT02032407|3915425|FG000|Overall Study|Other Miscellaneous Reasons|2
2251336|NCT02032706|3915471|FG000|Overall Study|Did not qualify|5
2251337|NCT02032706|3915471|FG000|Overall Study|Protocol Violation|1
2251338|NCT02032875|3915499|FG000|Treatment Period|Adverse Event|1
2251339|NCT02032875|3915500|FG001|Treatment Period|Adverse Event|0
2251340|NCT02032875|3915499|FG000|Treatment Period|Liver transplant, No extension needed|0
2251341|NCT02032875|3915500|FG001|Treatment Period|Liver transplant, No extension needed|1
2251342|NCT02032875|3915499|FG000|Treatment Period|Liver transplant, Treatment extension|0
2251343|NCT02032875|3915500|FG001|Treatment Period|Liver transplant, Treatment extension|3
2251344|NCT02032875|3915499|FG000|Follow-up Period|Death|0
2251345|NCT02032875|3915500|FG001|Follow-up Period|Death|1
2251346|NCT02032875|3915499|FG000|Follow-up Period|Virologic Relapse|3
2251347|NCT02032875|3915500|FG001|Follow-up Period|Virologic Relapse|10
2251348|NCT02032888|3915510|FG000|Treatment Period|Poor compliance/noncompliance|1
2251349|NCT02032888|3915511|FG001|Treatment Period|Poor compliance/noncompliance|1
2251350|NCT02032888|3915512|FG002|Treatment Period|Poor compliance/noncompliance|0
2251351|NCT02032888|3915510|FG000|Treatment Period|Other|1
2251352|NCT02032888|3915511|FG001|Treatment Period|Other|1
2251353|NCT02032888|3915512|FG002|Treatment Period|Other|0
2251354|NCT02032888|3915510|FG000|Follow-up Period|Lost to Follow-up|1
2251355|NCT02032888|3915511|FG001|Follow-up Period|Lost to Follow-up|1
2251356|NCT02032888|3915512|FG002|Follow-up Period|Lost to Follow-up|0
2251357|NCT02032888|3915510|FG000|Follow-up Period|Death|1
2341399|NCT03448419|4073436|FG001|Overall Study|Adverse Event|9
2341400|NCT03448419|4073435|FG000|Overall Study|Lost to Follow-up|0
2341401|NCT03448419|4073436|FG001|Overall Study|Lost to Follow-up|2
2341402|NCT03448419|4073435|FG000|Overall Study|Withdrawal by Subject|3
2341403|NCT03448419|4073436|FG001|Overall Study|Withdrawal by Subject|1
2341404|NCT03448419|4073435|FG000|Overall Study|Not treated|0
2341405|NCT03448419|4073436|FG001|Overall Study|Not treated|1
2341406|NCT03448419|4073435|FG000|Overall Study|Patient did not attend all visits|0
2341407|NCT03448419|4073436|FG001|Overall Study|Patient did not attend all visits|2
2341408|NCT03448419|4073435|FG000|Overall Study|Withdrawn by Sponsor|0
2341409|NCT03448419|4073436|FG001|Overall Study|Withdrawn by Sponsor|1
2341410|NCT03448536|4073446|FG000|Overall Study|Protocol Violation|2
2341411|NCT03448536|4073447|FG001|Overall Study|Protocol Violation|0
2341412|NCT03448536|4073446|FG000|Overall Study|Pregnancy|1
2341413|NCT03448536|4073447|FG001|Overall Study|Pregnancy|0
2341414|NCT03448536|4073446|FG000|Overall Study|Withdrawal by Subject|1
2341415|NCT03448536|4073447|FG001|Overall Study|Withdrawal by Subject|2
2341416|NCT03448536|4073446|FG000|Overall Study|Lost to Follow-up|3
2341417|NCT03448536|4073447|FG001|Overall Study|Lost to Follow-up|2
2341418|NCT03448536|4073446|FG000|Overall Study|Inadequate pain reporter|1
2341419|NCT03448536|4073447|FG001|Overall Study|Inadequate pain reporter|0
2341420|NCT03448536|4073446|FG000|Overall Study|Other|3
2341421|NCT03448536|4073447|FG001|Overall Study|Other|0
2341422|NCT03448536|4073446|FG000|Overall Study|Physician Decision|1
2341423|NCT03448536|4073447|FG001|Overall Study|Physician Decision|0
2341424|NCT03449030|4073463|FG000|Overall Study|Withdrawal by Subject|0
2341425|NCT03449030|4073464|FG001|Overall Study|Withdrawal by Subject|0
2341426|NCT03449030|4073465|FG002|Overall Study|Withdrawal by Subject|0
2341427|NCT03449030|4073466|FG003|Overall Study|Withdrawal by Subject|1
2341428|NCT03449030|4073467|FG004|Overall Study|Withdrawal by Subject|1
2251358|NCT02032888|3915511|FG001|Follow-up Period|Death|1
2251359|NCT02032888|3915512|FG002|Follow-up Period|Death|0
2341429|NCT03449030|4073468|FG005|Overall Study|Withdrawal by Subject|1
2251360|NCT02032888|3915510|FG000|Follow-up Period|Other|1
2251361|NCT02032888|3915511|FG001|Follow-up Period|Other|0
2251362|NCT02032888|3915512|FG002|Follow-up Period|Other|0
2251363|NCT02032901|3915531|FG000|Treatment Period (12 Weeks)|Pregnancy|1
2251364|NCT02032901|3915532|FG001|Treatment Period (12 Weeks)|Pregnancy|0
2251365|NCT02032901|3915531|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
2251366|NCT02032901|3915532|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
2251367|NCT02033369|3915596|FG000|Overall Study|Physician Decision|1
2251368|NCT02033369|3915597|FG001|Overall Study|Physician Decision|2
2251369|NCT02033369|3915596|FG000|Overall Study|Not a good demographic match|0
2251370|NCT02033369|3915597|FG001|Overall Study|Not a good demographic match|2
2251371|NCT02033369|3915596|FG000|Overall Study|Withdrawal by Subject|1
2251372|NCT02033369|3915597|FG001|Overall Study|Withdrawal by Subject|1
2251373|NCT02033369|3915596|FG000|Overall Study|Lost to Follow-up|1
2251374|NCT02033369|3915597|FG001|Overall Study|Lost to Follow-up|0
2251375|NCT02033369|3915596|FG000|Overall Study|Protocol Violation|2
2251376|NCT02033369|3915597|FG001|Overall Study|Protocol Violation|0
2251377|NCT02033759|3915635|FG000|Overall Study|Withdrawal by Subject|2
2251378|NCT02033759|3915636|FG001|Overall Study|Withdrawal by Subject|1
2251379|NCT02033759|3915635|FG000|Overall Study|Protocol Violation|1
2251380|NCT02033759|3915636|FG001|Overall Study|Protocol Violation|1
2251381|NCT02033850|3915644|FG000|Overall Study|Death|1
2251382|NCT02033850|3915645|FG001|Overall Study|Death|0
2251383|NCT02033850|3915644|FG000|Overall Study|unrelated medical reason|1
2251384|NCT02033850|3915645|FG001|Overall Study|unrelated medical reason|1
2251385|NCT02033889|3915663|FG000|Overall Study|Adverse Event|3
2251386|NCT02033889|3915664|FG001|Overall Study|Adverse Event|1
2251387|NCT02033889|3915665|FG002|Overall Study|Adverse Event|3
2251388|NCT02033889|3915663|FG000|Overall Study|Death|3
2251389|NCT02033889|3915664|FG001|Overall Study|Death|1
2251390|NCT02033889|3915665|FG002|Overall Study|Death|2
2251391|NCT02033889|3915663|FG000|Overall Study|Excluded Medication|1
2251392|NCT02033889|3915664|FG001|Overall Study|Excluded Medication|1
2251393|NCT02033889|3915665|FG002|Overall Study|Excluded Medication|0
2251394|NCT02033889|3915663|FG000|Overall Study|Lost to Follow-up|8
2251395|NCT02033889|3915664|FG001|Overall Study|Lost to Follow-up|5
2251396|NCT02033889|3915665|FG002|Overall Study|Lost to Follow-up|6
2251397|NCT02033889|3915663|FG000|Overall Study|Non-Compliance With Study Drug|1
2251398|NCT02033889|3915664|FG001|Overall Study|Non-Compliance With Study Drug|0
2251399|NCT02033889|3915665|FG002|Overall Study|Non-Compliance With Study Drug|0
2251400|NCT02033889|3915663|FG000|Overall Study|Physician Decision|0
2251401|NCT02033889|3915664|FG001|Overall Study|Physician Decision|1
2251402|NCT02033889|3915665|FG002|Overall Study|Physician Decision|1
2251403|NCT02033889|3915663|FG000|Overall Study|Participant moved|0
2251404|NCT02033889|3915664|FG001|Overall Study|Participant moved|1
2251405|NCT02033889|3915665|FG002|Overall Study|Participant moved|0
2251406|NCT02033889|3915663|FG000|Overall Study|Withdrawal by Subject|18
2251407|NCT02033889|3915664|FG001|Overall Study|Withdrawal by Subject|10
2251408|NCT02033889|3915665|FG002|Overall Study|Withdrawal by Subject|13
2251409|NCT02034006|3915684|FG000|Overall Study|Withdrawal by Subject|7
2251410|NCT02034006|3915684|FG000|Overall Study|Lost to Follow-up|5
2251411|NCT02034006|3915684|FG000|Overall Study|Death|1
2251412|NCT02034006|3915684|FG000|Overall Study|Pregnancy|1
2251413|NCT02034058|3915700|FG000|Overall Study|Death|3
2251414|NCT02034162|3915706|FG000|Double-blind|Lost to Follow-up|3
2251415|NCT02034162|3915707|FG001|Double-blind|Lost to Follow-up|0
2251416|NCT02034162|3915708|FG002|Double-blind|Lost to Follow-up|0
2251417|NCT02034162|3915706|FG000|Double-blind|Physician Decision|1
2251418|NCT02034162|3915707|FG001|Double-blind|Physician Decision|0
2251419|NCT02034162|3915708|FG002|Double-blind|Physician Decision|0
2251420|NCT02034162|3915706|FG000|Double-blind|Protocol Violation|0
2251421|NCT02034162|3915707|FG001|Double-blind|Protocol Violation|1
2251422|NCT02034162|3915708|FG002|Double-blind|Protocol Violation|0
2341430|NCT03449030|4073469|FG006|Overall Study|Withdrawal by Subject|1
2341431|NCT03449030|4073470|FG007|Overall Study|Withdrawal by Subject|2
2341432|NCT03449030|4073471|FG008|Overall Study|Withdrawal by Subject|0
2341433|NCT03449030|4073472|FG009|Overall Study|Withdrawal by Subject|0
2341434|NCT03449030|4073463|FG000|Overall Study|Symptomatic Deterioration|0
2341435|NCT03449030|4073464|FG001|Overall Study|Symptomatic Deterioration|1
2341436|NCT03449030|4073465|FG002|Overall Study|Symptomatic Deterioration|0
2341437|NCT03449030|4073466|FG003|Overall Study|Symptomatic Deterioration|0
2341438|NCT03449030|4073467|FG004|Overall Study|Symptomatic Deterioration|0
2341439|NCT03449030|4073468|FG005|Overall Study|Symptomatic Deterioration|1
2341440|NCT03449030|4073469|FG006|Overall Study|Symptomatic Deterioration|1
2341441|NCT03449030|4073470|FG007|Overall Study|Symptomatic Deterioration|0
2341442|NCT03449030|4073471|FG008|Overall Study|Symptomatic Deterioration|2
2341443|NCT03449030|4073472|FG009|Overall Study|Symptomatic Deterioration|0
2251423|NCT02034162|3915706|FG000|Double-blind|Withdrawal by Subject|5
2251424|NCT02034162|3915707|FG001|Double-blind|Withdrawal by Subject|7
2251425|NCT02034162|3915708|FG002|Double-blind|Withdrawal by Subject|0
2251426|NCT02034409|3915725|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4
2251427|NCT02034409|3915726|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0
2251428|NCT02034409|3915725|FG000|Sham-Controlled Treatment Period|Adverse Event|1
2341444|NCT03449030|4073463|FG000|Overall Study|Progressive Disease|1
2251429|NCT02034409|3915726|FG001|Sham-Controlled Treatment Period|Adverse Event|1
2251430|NCT02034409|3915725|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0
2251431|NCT02034409|3915726|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1
2251432|NCT02034409|3915725|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8
2251433|NCT02034409|3915726|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8
2251434|NCT02034409|3915725|FG000|Sham-Controlled Treatment Period|Physician Decision|1
2251435|NCT02034409|3915726|FG001|Sham-Controlled Treatment Period|Physician Decision|3
2251436|NCT02034409|3915725|FG000|Sham-Controlled Treatment Period|misrandomized|2
2251437|NCT02034409|3915726|FG001|Sham-Controlled Treatment Period|misrandomized|2
2251438|NCT02034435|3915734|FG000|Overall Study|Withdrawal by Subject|1
2251439|NCT02034435|3915735|FG001|Overall Study|Withdrawal by Subject|0
2251440|NCT02034435|3915736|FG002|Overall Study|Withdrawal by Subject|0
2251441|NCT02034435|3915737|FG003|Overall Study|Withdrawal by Subject|0
2251442|NCT02034435|3915734|FG000|Overall Study|Illness|0
2251443|NCT02034435|3915735|FG001|Overall Study|Illness|2
2251444|NCT02034435|3915736|FG002|Overall Study|Illness|0
2251445|NCT02034435|3915737|FG003|Overall Study|Illness|0
2251446|NCT02034435|3915734|FG000|Overall Study|Inadequate IV access|1
2251447|NCT02034435|3915735|FG001|Overall Study|Inadequate IV access|0
2251448|NCT02034435|3915736|FG002|Overall Study|Inadequate IV access|0
2251449|NCT02034435|3915737|FG003|Overall Study|Inadequate IV access|1
2251450|NCT02034474|3915749|FG000|Overall Study|Adverse Event|3
2251451|NCT02034474|3915750|FG001|Overall Study|Adverse Event|2
2251452|NCT02034474|3915749|FG000|Overall Study|Withdrawal by Subject|1
2251453|NCT02034474|3915750|FG001|Overall Study|Withdrawal by Subject|2
2251454|NCT02034513|3915760|FG000|Overall Study|Adverse Event|11
2251455|NCT02034513|3915761|FG001|Overall Study|Adverse Event|10
2251456|NCT02034513|3915760|FG000|Overall Study|Lack of Efficacy|0
2251457|NCT02034513|3915761|FG001|Overall Study|Lack of Efficacy|1
2251458|NCT02034513|3915760|FG000|Overall Study|Lost to Follow-up|6
2251459|NCT02034513|3915761|FG001|Overall Study|Lost to Follow-up|7
2251460|NCT02034513|3915760|FG000|Overall Study|Pregnancy|0
2251461|NCT02034513|3915761|FG001|Overall Study|Pregnancy|3
2251462|NCT02034513|3915760|FG000|Overall Study|Protocol Violation|7
2251463|NCT02034513|3915761|FG001|Overall Study|Protocol Violation|10
2251464|NCT02034513|3915760|FG000|Overall Study|Withdrawal by Subject|25
2251465|NCT02034513|3915761|FG001|Overall Study|Withdrawal by Subject|25
2251466|NCT02034513|3915760|FG000|Overall Study|Unclassified|0
2251467|NCT02034513|3915761|FG001|Overall Study|Unclassified|1
2251468|NCT02034552|3915772|FG000|Overall Study|Never treated|3
2251469|NCT02034552|3915773|FG001|Overall Study|Never treated|2
2251470|NCT02034552|3915774|FG002|Overall Study|Never treated|0
2251471|NCT02034552|3915772|FG000|Overall Study|Radiological progression|3
2251472|NCT02034552|3915773|FG001|Overall Study|Radiological progression|5
2251473|NCT02034552|3915774|FG002|Overall Study|Radiological progression|4
2251474|NCT02034552|3915772|FG000|Overall Study|AE not assoc. with disease progression|1
2251475|NCT02034552|3915773|FG001|Overall Study|AE not assoc. with disease progression|4
2251476|NCT02034552|3915774|FG002|Overall Study|AE not assoc. with disease progression|2
2251477|NCT02034552|3915772|FG000|Overall Study|AE associated with disease progression|0
2251478|NCT02034552|3915773|FG001|Overall Study|AE associated with disease progression|1
2251479|NCT02034552|3915774|FG002|Overall Study|AE associated with disease progression|0
2251480|NCT02034552|3915772|FG000|Overall Study|Withdrawal by Subject|2
2251481|NCT02034552|3915773|FG001|Overall Study|Withdrawal by Subject|1
2251482|NCT02034552|3915774|FG002|Overall Study|Withdrawal by Subject|1
2251483|NCT02034552|3915772|FG000|Overall Study|Non-compliance with study drug|0
2251484|NCT02034552|3915773|FG001|Overall Study|Non-compliance with study drug|0
2251485|NCT02034552|3915774|FG002|Overall Study|Non-compliance with study drug|1
2251486|NCT02034552|3915772|FG000|Overall Study|Clinical progression|5
2251487|NCT02034552|3915773|FG001|Overall Study|Clinical progression|7
2251488|NCT02034552|3915774|FG002|Overall Study|Clinical progression|9
2251489|NCT02034565|3915782|FG000|Overall Study|Adverse Event|1
2251490|NCT02034565|3915783|FG001|Overall Study|Adverse Event|0
2251491|NCT02034591|3915805|FG000|Overall Study|Withdrawal by Subject|0
2251492|NCT02034591|3915806|FG001|Overall Study|Withdrawal by Subject|0
2251493|NCT02034591|3915807|FG002|Overall Study|Withdrawal by Subject|0
2251494|NCT02034591|3915808|FG003|Overall Study|Withdrawal by Subject|0
2251495|NCT02034591|3915809|FG004|Overall Study|Withdrawal by Subject|1
2251496|NCT02034591|3915810|FG005|Overall Study|Withdrawal by Subject|0
2251497|NCT02034708|3915821|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
2251498|NCT02034708|3915822|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
2251499|NCT02034708|3915821|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
2251500|NCT02034708|3915822|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
2251501|NCT02034708|3915821|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
2251502|NCT02034708|3915822|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
2251503|NCT02034708|3915821|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3
2251504|NCT02034708|3915822|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2
2251505|NCT02034799|3915835|FG000|Overall Study|Withdrawal by Subject|0
2251506|NCT02034799|3915836|FG001|Overall Study|Withdrawal by Subject|2
2251507|NCT02034799|3915835|FG000|Overall Study|Lost to Follow-up|0
2251508|NCT02034799|3915836|FG001|Overall Study|Lost to Follow-up|1
2251509|NCT02034799|3915835|FG000|Overall Study|Death|2
2251510|NCT02034799|3915836|FG001|Overall Study|Death|1
2251511|NCT02034877|3915844|FG000|Overall Study|Lost to Follow-up|0
2251512|NCT02034877|3915845|FG001|Overall Study|Lost to Follow-up|3
2251513|NCT02034877|3915844|FG000|Overall Study|No Longer Willing to Participate|0
2251514|NCT02034877|3915845|FG001|Overall Study|No Longer Willing to Participate|3
2251515|NCT02034916|3915853|FG000|Overall Study|Death|39
2251516|NCT02034916|3915854|FG001|Overall Study|Death|28
2251517|NCT02034916|3915853|FG000|Overall Study|Withdrawal by Subject|2
2251518|NCT02034916|3915854|FG001|Overall Study|Withdrawal by Subject|1
2251519|NCT02034916|3915853|FG000|Overall Study|Lost to Follow-up|4
2251520|NCT02034916|3915854|FG001|Overall Study|Lost to Follow-up|1
2251521|NCT02034916|3915853|FG000|Overall Study|Study terminated by sponsor|4
2251522|NCT02034916|3915854|FG001|Overall Study|Study terminated by sponsor|5
2251523|NCT02035202|3915864|FG000|Overall Study|Lost to Follow-up|8
2251524|NCT02035202|3915865|FG001|Overall Study|Lost to Follow-up|16
2251525|NCT02035202|3915866|FG002|Overall Study|Lost to Follow-up|2
2251526|NCT02035267|3915878|FG000|Overall Study|Withdrawal consent-subject convenience|0
2251527|NCT02035267|3915879|FG001|Overall Study|Withdrawal consent-subject convenience|0
2251528|NCT02035267|3915880|FG002|Overall Study|Withdrawal consent-subject convenience|1
2251529|NCT02035267|3915881|FG003|Overall Study|Withdrawal consent-subject convenience|0
2251530|NCT02035267|3915878|FG000|Overall Study|Adverse Event|0
2251531|NCT02035267|3915879|FG001|Overall Study|Adverse Event|0
2251532|NCT02035267|3915880|FG002|Overall Study|Adverse Event|1
2251533|NCT02035267|3915881|FG003|Overall Study|Adverse Event|0
2341445|NCT03449030|4073464|FG001|Overall Study|Progressive Disease|0
2341446|NCT03449030|4073465|FG002|Overall Study|Progressive Disease|1
2341447|NCT03449030|4073466|FG003|Overall Study|Progressive Disease|4
2341448|NCT03449030|4073467|FG004|Overall Study|Progressive Disease|5
2341449|NCT03449030|4073468|FG005|Overall Study|Progressive Disease|3
2341450|NCT03449030|4073469|FG006|Overall Study|Progressive Disease|0
2341451|NCT03449030|4073470|FG007|Overall Study|Progressive Disease|1
2341452|NCT03449030|4073471|FG008|Overall Study|Progressive Disease|1
2341453|NCT03449030|4073472|FG009|Overall Study|Progressive Disease|1
2341454|NCT03449030|4073463|FG000|Overall Study|Adverse Event|0
2341455|NCT03449030|4073464|FG001|Overall Study|Adverse Event|0
2341456|NCT03449030|4073465|FG002|Overall Study|Adverse Event|0
2341457|NCT03449030|4073466|FG003|Overall Study|Adverse Event|0
2341458|NCT03449030|4073467|FG004|Overall Study|Adverse Event|0
2341459|NCT03449030|4073468|FG005|Overall Study|Adverse Event|2
2341460|NCT03449030|4073469|FG006|Overall Study|Adverse Event|0
2341461|NCT03449030|4073470|FG007|Overall Study|Adverse Event|0
2038466|NCT00423085|3608862|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
2038467|NCT00423085|3608863|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
2038468|NCT00423085|3608864|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
2038469|NCT00423085|3608861|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
2038470|NCT00423085|3608862|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
2038471|NCT00423085|3608863|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
2038472|NCT00423085|3608864|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
2038473|NCT00423085|3608861|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8
2038474|NCT00423085|3608862|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3
2038475|NCT00423085|3608863|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7
2038476|NCT00423085|3608864|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0
2038477|NCT00423085|3608861|FG000|24-Week Double-Blind Treatment Phase|Death|1
2038478|NCT00423085|3608862|FG001|24-Week Double-Blind Treatment Phase|Death|1
2038479|NCT00423085|3608863|FG002|24-Week Double-Blind Treatment Phase|Death|0
2038480|NCT00423085|3608864|FG003|24-Week Double-Blind Treatment Phase|Death|0
2038481|NCT00423085|3608861|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
2038482|NCT00423085|3608862|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
2038483|NCT00423085|3608863|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
2038484|NCT00423085|3608864|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
2038485|NCT00423085|3608861|FG000|52-Week Open-Label Extension Phase|Adverse Event|0
2038486|NCT00423085|3608862|FG001|52-Week Open-Label Extension Phase|Adverse Event|0
2038487|NCT00423085|3608863|FG002|52-Week Open-Label Extension Phase|Adverse Event|0
2038488|NCT00423085|3608864|FG003|52-Week Open-Label Extension Phase|Adverse Event|97
2038489|NCT00423085|3608861|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
2038490|NCT00423085|3608862|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
2038491|NCT00423085|3608863|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
2038492|NCT00423085|3608864|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
2038493|NCT00423085|3608861|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
2038494|NCT00423085|3608862|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
2251534|NCT02035267|3915878|FG000|Overall Study|Lost to Follow-up|0
2251535|NCT02035267|3915879|FG001|Overall Study|Lost to Follow-up|0
2251536|NCT02035267|3915880|FG002|Overall Study|Lost to Follow-up|0
2251537|NCT02035267|3915881|FG003|Overall Study|Lost to Follow-up|1
2251538|NCT02035267|3915878|FG000|Overall Study|Other unspecified|0
2341462|NCT03449030|4073471|FG008|Overall Study|Adverse Event|0
2341463|NCT03449030|4073472|FG009|Overall Study|Adverse Event|0
2341464|NCT03449030|4073463|FG000|Overall Study|Death|0
2251539|NCT02035267|3915879|FG001|Overall Study|Other unspecified|1
2251540|NCT02035267|3915880|FG002|Overall Study|Other unspecified|0
2251541|NCT02035267|3915881|FG003|Overall Study|Other unspecified|0
2341465|NCT03449030|4073464|FG001|Overall Study|Death|0
2341466|NCT03449030|4073465|FG002|Overall Study|Death|0
2341467|NCT03449030|4073466|FG003|Overall Study|Death|0
2038495|NCT00423085|3608863|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
2038496|NCT00423085|3608864|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
2038497|NCT00423085|3608861|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0
2038498|NCT00423085|3608862|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0
2038499|NCT00423085|3608863|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0
2038500|NCT00423085|3608864|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9
2038501|NCT00423085|3608861|FG000|52-Week Open-Label Extension Phase|Death|0
2038502|NCT00423085|3608862|FG001|52-Week Open-Label Extension Phase|Death|0
2038503|NCT00423085|3608863|FG002|52-Week Open-Label Extension Phase|Death|0
2038504|NCT00423085|3608864|FG003|52-Week Open-Label Extension Phase|Death|2
2038505|NCT00423098|3608876|FG000|Overall Study|Adverse Event|1
2038506|NCT00423098|3608877|FG001|Overall Study|Adverse Event|2
2038507|NCT00423098|3608876|FG000|Overall Study|Unsatisfactory therapeutic effect|0
2038508|NCT00423098|3608877|FG001|Overall Study|Unsatisfactory therapeutic effect|1
2038509|NCT00423098|3608876|FG000|Overall Study|Administrative problems|0
2038510|NCT00423098|3608877|FG001|Overall Study|Administrative problems|1
2038511|NCT00423098|3608876|FG000|Overall Study|Death|2
2038512|NCT00423098|3608877|FG001|Overall Study|Death|0
2038513|NCT00423137|3608887|FG000|Overall Study|Lost to Follow-up|0
2038514|NCT00423137|3608888|FG001|Overall Study|Lost to Follow-up|0
2341468|NCT03449030|4073467|FG004|Overall Study|Death|1
2251542|NCT02035332|3915893|FG000|Overall Study|Procedure Aborted due to Uterine Width|1
2251543|NCT02035475|3915902|FG000|Overall Study|Withdrawal by Subject|4
2251544|NCT02035475|3915902|FG000|Overall Study|Physician Decision|1
2251545|NCT02035475|3915902|FG000|Overall Study|Equipment Error|1
2251546|NCT02035553|3915910|FG000|Overall Study|Death (See All-Cause Mortality Table)|0
2251547|NCT02035553|3915911|FG001|Overall Study|Death (See All-Cause Mortality Table)|1
2251548|NCT02035553|3915910|FG000|Overall Study|Adverse Event|10
2251549|NCT02035553|3915911|FG001|Overall Study|Adverse Event|6
2251550|NCT02035553|3915910|FG000|Overall Study|Physician Decision|3
2251551|NCT02035553|3915911|FG001|Overall Study|Physician Decision|2
2251552|NCT02035553|3915910|FG000|Overall Study|Lack of Efficacy|1
2251553|NCT02035553|3915911|FG001|Overall Study|Lack of Efficacy|1
2251554|NCT02035553|3915910|FG000|Overall Study|Withdrawal by Subject|4
2251555|NCT02035553|3915911|FG001|Overall Study|Withdrawal by Subject|7
2251556|NCT02035553|3915910|FG000|Overall Study|Non-compliance with Study Drug|0
2251557|NCT02035553|3915911|FG001|Overall Study|Non-compliance with Study Drug|1
2251558|NCT02035553|3915910|FG000|Overall Study|Lost to Follow-up|0
2251559|NCT02035553|3915911|FG001|Overall Study|Lost to Follow-up|1
2251560|NCT02035553|3915910|FG000|Overall Study|Other Reason|0
2251561|NCT02035553|3915911|FG001|Overall Study|Other Reason|4
2251562|NCT02035696|3915921|FG000|Overall Study|Lost to Follow-up|0
2251563|NCT02035696|3915922|FG001|Overall Study|Lost to Follow-up|3
2251564|NCT02035696|3915923|FG002|Overall Study|Lost to Follow-up|1
2251565|NCT02035696|3915924|FG003|Overall Study|Lost to Follow-up|2
2251566|NCT02035696|3915921|FG000|Overall Study|Withdrawal by Subject|3
2251567|NCT02035696|3915922|FG001|Overall Study|Withdrawal by Subject|0
2251568|NCT02035696|3915923|FG002|Overall Study|Withdrawal by Subject|2
2251569|NCT02035696|3915924|FG003|Overall Study|Withdrawal by Subject|1
2251570|NCT02035748|3915938|FG000|Overall Study|Adverse Event|5
2251571|NCT02035748|3915938|FG000|Overall Study|Death|3
2251572|NCT02035748|3915938|FG000|Overall Study|Lost to Follow-up|2
2251573|NCT02035748|3915938|FG000|Overall Study|Physician Decision|3
2251574|NCT02035748|3915938|FG000|Overall Study|Withdrawal by Subject|6
2251575|NCT02035748|3915938|FG000|Overall Study|Progressive Disease|1
2251576|NCT02036294|3915945|FG000|Overall Study|Death|7
2251577|NCT02036294|3915946|FG001|Overall Study|Death|8
2251578|NCT02036294|3915945|FG000|Overall Study|Withdrawal by Subject|2
2251579|NCT02036294|3915946|FG001|Overall Study|Withdrawal by Subject|3
2251580|NCT02036502|3915976|FG000|Part 1:Dose Determination/Escalation|Death|3
2251581|NCT02036502|3915977|FG001|Part 1:Dose Determination/Escalation|Death|2
2251582|NCT02036502|3915978|FG002|Part 1:Dose Determination/Escalation|Death|0
2251583|NCT02036502|3915979|FG003|Part 1:Dose Determination/Escalation|Death|0
2251584|NCT02036502|3915980|FG004|Part 1:Dose Determination/Escalation|Death|0
2251585|NCT02036502|3915981|FG005|Part 1:Dose Determination/Escalation|Death|0
2251586|NCT02036502|3915982|FG006|Part 1:Dose Determination/Escalation|Death|0
2251587|NCT02036502|3915983|FG007|Part 1:Dose Determination/Escalation|Death|0
2251588|NCT02036502|3915976|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3
2251589|NCT02036502|3915977|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
2251590|NCT02036502|3915978|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
2251591|NCT02036502|3915979|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
2251592|NCT02036502|3915980|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
2251593|NCT02036502|3915981|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
2251594|NCT02036502|3915982|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
2251595|NCT02036502|3915983|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
2251596|NCT02036502|3915976|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0
2251597|NCT02036502|3915977|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1
2251598|NCT02036502|3915978|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0
2251599|NCT02036502|3915979|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0
2251600|NCT02036502|3915980|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0
2251601|NCT02036502|3915981|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0
2251602|NCT02036502|3915982|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0
2251603|NCT02036502|3915983|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0
2251604|NCT02036502|3915976|FG000|Part 1:Dose Determination/Escalation|Not treated|0
2251605|NCT02036502|3915977|FG001|Part 1:Dose Determination/Escalation|Not treated|1
2251606|NCT02036502|3915978|FG002|Part 1:Dose Determination/Escalation|Not treated|0
2251607|NCT02036502|3915979|FG003|Part 1:Dose Determination/Escalation|Not treated|0
2251608|NCT02036502|3915980|FG004|Part 1:Dose Determination/Escalation|Not treated|0
2251609|NCT02036502|3915981|FG005|Part 1:Dose Determination/Escalation|Not treated|0
2251610|NCT02036502|3915982|FG006|Part 1:Dose Determination/Escalation|Not treated|0
2251611|NCT02036502|3915983|FG007|Part 1:Dose Determination/Escalation|Not treated|0
2251612|NCT02036502|3915976|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
2251613|NCT02036502|3915977|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
2251614|NCT02036502|3915978|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2
2251615|NCT02036502|3915979|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
2251616|NCT02036502|3915980|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
2251617|NCT02036502|3915981|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
2251618|NCT02036502|3915982|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
2251619|NCT02036502|3915983|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
2251620|NCT02036502|3915976|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0
2251621|NCT02036502|3915977|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0
2251622|NCT02036502|3915978|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3
2251623|NCT02036502|3915979|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0
2251624|NCT02036502|3915980|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0
2251625|NCT02036502|3915981|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0
2251626|NCT02036502|3915982|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0
2251627|NCT02036502|3915983|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0
2251628|NCT02036502|3915976|FG000|Part 2:Dose Confirmation|Death|0
2251629|NCT02036502|3915977|FG001|Part 2:Dose Confirmation|Death|0
2251630|NCT02036502|3915978|FG002|Part 2:Dose Confirmation|Death|1
2251631|NCT02036502|3915979|FG003|Part 2:Dose Confirmation|Death|0
2251632|NCT02036502|3915980|FG004|Part 2:Dose Confirmation|Death|0
2251633|NCT02036502|3915981|FG005|Part 2:Dose Confirmation|Death|0
2251634|NCT02036502|3915982|FG006|Part 2:Dose Confirmation|Death|0
2251635|NCT02036502|3915983|FG007|Part 2:Dose Confirmation|Death|0
2251636|NCT02036502|3915976|FG000|Part 2:Dose Confirmation|Not treated|0
2251637|NCT02036502|3915977|FG001|Part 2:Dose Confirmation|Not treated|0
2251638|NCT02036502|3915978|FG002|Part 2:Dose Confirmation|Not treated|0
2251639|NCT02036502|3915979|FG003|Part 2:Dose Confirmation|Not treated|1
2341469|NCT03449030|4073468|FG005|Overall Study|Death|0
2341470|NCT03449030|4073469|FG006|Overall Study|Death|0
2341471|NCT03449030|4073470|FG007|Overall Study|Death|0
2341472|NCT03449030|4073471|FG008|Overall Study|Death|0
2341473|NCT03449030|4073472|FG009|Overall Study|Death|0
2341474|NCT03449134|4073498|FG000|52-Week Treatment Period|Death|2
2341475|NCT03449134|4073499|FG001|52-Week Treatment Period|Death|1
2341476|NCT03449134|4073500|FG002|52-Week Treatment Period|Death|0
2341477|NCT03449134|4073498|FG000|52-Week Treatment Period|Lost to Follow-up|2
2341478|NCT03449134|4073499|FG001|52-Week Treatment Period|Lost to Follow-up|1
2341479|NCT03449134|4073500|FG002|52-Week Treatment Period|Lost to Follow-up|1
2341480|NCT03449134|4073498|FG000|52-Week Treatment Period|Physician Decision|2
2341481|NCT03449134|4073499|FG001|52-Week Treatment Period|Physician Decision|3
2341482|NCT03449134|4073500|FG002|52-Week Treatment Period|Physician Decision|3
2341483|NCT03449134|4073498|FG000|52-Week Treatment Period|Screen Failure|1
2341484|NCT03449134|4073499|FG001|52-Week Treatment Period|Screen Failure|0
2341485|NCT03449134|4073500|FG002|52-Week Treatment Period|Screen Failure|1
2341486|NCT03449134|4073498|FG000|52-Week Treatment Period|Withdrawal by Subject|37
2341487|NCT03449134|4073499|FG001|52-Week Treatment Period|Withdrawal by Subject|39
2341488|NCT03449134|4073500|FG002|52-Week Treatment Period|Withdrawal by Subject|55
2341489|NCT03449134|4073498|FG000|52-Week Treatment Period|Site Closure|1
2341490|NCT03449134|4073499|FG001|52-Week Treatment Period|Site Closure|0
2341491|NCT03449134|4073500|FG002|52-Week Treatment Period|Site Closure|0
2341492|NCT03449147|4073514|FG000|52-week Treatment Period|Death|0
2341493|NCT03449147|4073515|FG001|52-week Treatment Period|Death|1
2341494|NCT03449147|4073516|FG002|52-week Treatment Period|Death|0
2341495|NCT03449147|4073514|FG000|52-week Treatment Period|Lost to Follow-up|6
2341496|NCT03449147|4073515|FG001|52-week Treatment Period|Lost to Follow-up|2
2038515|NCT00423137|3608889|FG002|Overall Study|Lost to Follow-up|1
2038516|NCT00423137|3608890|FG003|Overall Study|Lost to Follow-up|0
2038517|NCT00423137|3608887|FG000|Overall Study|Protocol Violation|0
2038518|NCT00423137|3608888|FG001|Overall Study|Protocol Violation|0
2038519|NCT00423137|3608889|FG002|Overall Study|Protocol Violation|0
2038520|NCT00423137|3608890|FG003|Overall Study|Protocol Violation|1
2038521|NCT00423137|3608887|FG000|Overall Study|Adverse Event Study disease worse|1
2038522|NCT00423137|3608888|FG001|Overall Study|Adverse Event Study disease worse|0
2038523|NCT00423137|3608889|FG002|Overall Study|Adverse Event Study disease worse|3
2038524|NCT00423137|3608890|FG003|Overall Study|Adverse Event Study disease worse|1
2038525|NCT00423137|3608887|FG000|Overall Study|Adverse Event Other|0
2038526|NCT00423137|3608888|FG001|Overall Study|Adverse Event Other|0
2038527|NCT00423137|3608889|FG002|Overall Study|Adverse Event Other|2
2038528|NCT00423137|3608890|FG003|Overall Study|Adverse Event Other|0
2038529|NCT00423150|3608903|FG000|Overall Study|Adverse Event|11
2038530|NCT00423150|3608903|FG000|Overall Study|Progression of disease being studied|69
2038531|NCT00423150|3608903|FG000|Overall Study|Withdrawal by Subject|1
2038532|NCT00423150|3608903|FG000|Overall Study|Non-compliance with protocol|1
2038533|NCT00423150|3608903|FG000|Overall Study|Administrative|4
2038534|NCT00423189|3608910|FG000|Overall Study|Death|0
2251640|NCT02036502|3915980|FG004|Part 2:Dose Confirmation|Not treated|0
2251641|NCT02036502|3915981|FG005|Part 2:Dose Confirmation|Not treated|0
2251642|NCT02036502|3915982|FG006|Part 2:Dose Confirmation|Not treated|0
2251643|NCT02036502|3915983|FG007|Part 2:Dose Confirmation|Not treated|0
2251644|NCT02036502|3915976|FG000|Part 3:Dose Expansion|Adverse Event|0
2251645|NCT02036502|3915977|FG001|Part 3:Dose Expansion|Adverse Event|0
2251646|NCT02036502|3915978|FG002|Part 3:Dose Expansion|Adverse Event|0
2251647|NCT02036502|3915979|FG003|Part 3:Dose Expansion|Adverse Event|0
2251648|NCT02036502|3915980|FG004|Part 3:Dose Expansion|Adverse Event|0
2251649|NCT02036502|3915981|FG005|Part 3:Dose Expansion|Adverse Event|4
2251650|NCT02036502|3915982|FG006|Part 3:Dose Expansion|Adverse Event|0
2341497|NCT03449147|4073516|FG002|52-week Treatment Period|Lost to Follow-up|5
2341498|NCT03449147|4073514|FG000|52-week Treatment Period|Other|0
2251651|NCT02036502|3915983|FG007|Part 3:Dose Expansion|Adverse Event|2
2251652|NCT02036502|3915976|FG000|Part 3:Dose Expansion|Death|0
2251653|NCT02036502|3915977|FG001|Part 3:Dose Expansion|Death|0
2251654|NCT02036502|3915978|FG002|Part 3:Dose Expansion|Death|0
2251655|NCT02036502|3915979|FG003|Part 3:Dose Expansion|Death|0
2251656|NCT02036502|3915980|FG004|Part 3:Dose Expansion|Death|0
2251657|NCT02036502|3915981|FG005|Part 3:Dose Expansion|Death|24
2251658|NCT02036502|3915982|FG006|Part 3:Dose Expansion|Death|0
2251659|NCT02036502|3915983|FG007|Part 3:Dose Expansion|Death|3
2251660|NCT02036502|3915976|FG000|Part 3:Dose Expansion|Lost to Follow-up|0
2251661|NCT02036502|3915977|FG001|Part 3:Dose Expansion|Lost to Follow-up|0
2251662|NCT02036502|3915978|FG002|Part 3:Dose Expansion|Lost to Follow-up|0
2251663|NCT02036502|3915979|FG003|Part 3:Dose Expansion|Lost to Follow-up|0
2251664|NCT02036502|3915980|FG004|Part 3:Dose Expansion|Lost to Follow-up|0
2251665|NCT02036502|3915981|FG005|Part 3:Dose Expansion|Lost to Follow-up|0
2251666|NCT02036502|3915982|FG006|Part 3:Dose Expansion|Lost to Follow-up|0
2251667|NCT02036502|3915983|FG007|Part 3:Dose Expansion|Lost to Follow-up|1
2251668|NCT02036502|3915976|FG000|Part 3:Dose Expansion|Physician Decision|0
2251669|NCT02036502|3915977|FG001|Part 3:Dose Expansion|Physician Decision|0
2251670|NCT02036502|3915978|FG002|Part 3:Dose Expansion|Physician Decision|0
2251671|NCT02036502|3915979|FG003|Part 3:Dose Expansion|Physician Decision|0
2251672|NCT02036502|3915980|FG004|Part 3:Dose Expansion|Physician Decision|0
2251673|NCT02036502|3915981|FG005|Part 3:Dose Expansion|Physician Decision|1
2251674|NCT02036502|3915982|FG006|Part 3:Dose Expansion|Physician Decision|0
2251675|NCT02036502|3915983|FG007|Part 3:Dose Expansion|Physician Decision|0
2251676|NCT02036502|3915976|FG000|Part 3:Dose Expansion|Progressive Disease|0
2251677|NCT02036502|3915977|FG001|Part 3:Dose Expansion|Progressive Disease|0
2251678|NCT02036502|3915978|FG002|Part 3:Dose Expansion|Progressive Disease|0
2251679|NCT02036502|3915979|FG003|Part 3:Dose Expansion|Progressive Disease|0
2251680|NCT02036502|3915980|FG004|Part 3:Dose Expansion|Progressive Disease|0
2251681|NCT02036502|3915981|FG005|Part 3:Dose Expansion|Progressive Disease|1
2251682|NCT02036502|3915982|FG006|Part 3:Dose Expansion|Progressive Disease|0
2251683|NCT02036502|3915983|FG007|Part 3:Dose Expansion|Progressive Disease|0
2251684|NCT02036502|3915976|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0
2251685|NCT02036502|3915977|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0
2251686|NCT02036502|3915978|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0
2251687|NCT02036502|3915979|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0
2251688|NCT02036502|3915980|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0
2251689|NCT02036502|3915981|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11
2251690|NCT02036502|3915982|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0
2251691|NCT02036502|3915983|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2
2251692|NCT02036502|3915976|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0
2251693|NCT02036502|3915977|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0
2251694|NCT02036502|3915978|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0
2251695|NCT02036502|3915979|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0
2251696|NCT02036502|3915980|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0
2251697|NCT02036502|3915981|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4
2251698|NCT02036502|3915982|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1
2251699|NCT02036502|3915983|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2
2251700|NCT02036502|3915976|FG000|Part 3:Dose Expansion|Not Treated|0
2251701|NCT02036502|3915977|FG001|Part 3:Dose Expansion|Not Treated|0
2251702|NCT02036502|3915978|FG002|Part 3:Dose Expansion|Not Treated|0
2251703|NCT02036502|3915979|FG003|Part 3:Dose Expansion|Not Treated|0
2251704|NCT02036502|3915980|FG004|Part 3:Dose Expansion|Not Treated|0
2251705|NCT02036502|3915981|FG005|Part 3:Dose Expansion|Not Treated|2
2251706|NCT02036502|3915982|FG006|Part 3:Dose Expansion|Not Treated|0
2251707|NCT02036502|3915983|FG007|Part 3:Dose Expansion|Not Treated|0
2341499|NCT03449147|4073515|FG001|52-week Treatment Period|Other|1
2341500|NCT03449147|4073516|FG002|52-week Treatment Period|Other|2
2341501|NCT03449147|4073514|FG000|52-week Treatment Period|Physician Decision|1
2341502|NCT03449147|4073515|FG001|52-week Treatment Period|Physician Decision|0
2341503|NCT03449147|4073516|FG002|52-week Treatment Period|Physician Decision|3
2341504|NCT03449147|4073514|FG000|52-week Treatment Period|Screen Failure|1
2341505|NCT03449147|4073515|FG001|52-week Treatment Period|Screen Failure|2
2341506|NCT03449147|4073516|FG002|52-week Treatment Period|Screen Failure|0
2341507|NCT03449147|4073514|FG000|52-week Treatment Period|Withdrawal by Subject|46
2341508|NCT03449147|4073515|FG001|52-week Treatment Period|Withdrawal by Subject|68
2341509|NCT03449147|4073516|FG002|52-week Treatment Period|Withdrawal by Subject|74
2341510|NCT03449147|4073514|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1
2341511|NCT03449147|4073515|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
2341512|NCT03449147|4073516|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
2341513|NCT03449147|4073514|FG000|12-Week Off-Treatment Durability Period|Other|0
2341514|NCT03449147|4073515|FG001|12-Week Off-Treatment Durability Period|Other|1
2341515|NCT03449147|4073516|FG002|12-Week Off-Treatment Durability Period|Other|0
2341516|NCT03449446|4073564|FG000|Overall Study|Randomized but Never Treated|0
2341517|NCT03449446|4073565|FG001|Overall Study|Randomized but Never Treated|0
2341518|NCT03449446|4073566|FG002|Overall Study|Randomized but Never Treated|1
2341519|NCT03449446|4073567|FG003|Overall Study|Randomized but Never Treated|1
2341520|NCT03449446|4073568|FG004|Overall Study|Randomized but Never Treated|1
2251708|NCT02036515|3916006|FG000|Overall Study|Adverse Event|1
2251709|NCT02036515|3916007|FG001|Overall Study|Adverse Event|1
2251710|NCT02036515|3916008|FG002|Overall Study|Adverse Event|2
2251711|NCT02036515|3916006|FG000|Overall Study|Lost to Follow-up|0
2251712|NCT02036515|3916007|FG001|Overall Study|Lost to Follow-up|2
2251713|NCT02036515|3916008|FG002|Overall Study|Lost to Follow-up|0
2251714|NCT02036515|3916006|FG000|Overall Study|Non-compliance with study drug|0
2251715|NCT02036515|3916007|FG001|Overall Study|Non-compliance with study drug|0
2251716|NCT02036515|3916008|FG002|Overall Study|Non-compliance with study drug|2
2251717|NCT02036515|3916006|FG000|Overall Study|Screen failure|0
2251718|NCT02036515|3916007|FG001|Overall Study|Screen failure|2
2251719|NCT02036515|3916008|FG002|Overall Study|Screen failure|0
2251720|NCT02036515|3916006|FG000|Overall Study|Withdrawal by Subject|4
2251721|NCT02036515|3916007|FG001|Overall Study|Withdrawal by Subject|7
2251722|NCT02036515|3916008|FG002|Overall Study|Withdrawal by Subject|9
2251723|NCT02036515|3916006|FG000|Overall Study|Hyperglycemia|0
2251724|NCT02036515|3916007|FG001|Overall Study|Hyperglycemia|0
2251725|NCT02036515|3916008|FG002|Overall Study|Hyperglycemia|1
2251726|NCT02036580|3916023|FG000|Overall Study|Withdrawal by Subject|0
2251727|NCT02036580|3916024|FG001|Overall Study|Withdrawal by Subject|1
2251728|NCT02036580|3916025|FG002|Overall Study|Withdrawal by Subject|0
2251729|NCT02036580|3916023|FG000|Overall Study|Adverse Event|1
2251730|NCT02036580|3916024|FG001|Overall Study|Adverse Event|0
2251731|NCT02036580|3916025|FG002|Overall Study|Adverse Event|0
2251732|NCT02036645|3916045|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2251733|NCT02036645|3916046|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2251734|NCT02036645|3916047|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2341521|NCT03449446|4073569|FG005|Overall Study|Randomized but Never Treated|0
2341522|NCT03449446|4073570|FG006|Overall Study|Randomized but Never Treated|0
2341523|NCT03449446|4073564|FG000|Overall Study|Unknown Reason|33
2341524|NCT03449446|4073565|FG001|Overall Study|Unknown Reason|1
2341525|NCT03449446|4073566|FG002|Overall Study|Unknown Reason|1
2341526|NCT03449446|4073567|FG003|Overall Study|Unknown Reason|1
2341527|NCT03449446|4073568|FG004|Overall Study|Unknown Reason|2
2341528|NCT03449446|4073569|FG005|Overall Study|Unknown Reason|2
2341529|NCT03449446|4073570|FG006|Overall Study|Unknown Reason|0
2341530|NCT03449446|4073564|FG000|Overall Study|Withdrew Consent|1
2341531|NCT03449446|4073565|FG001|Overall Study|Withdrew Consent|3
2341532|NCT03449446|4073566|FG002|Overall Study|Withdrew Consent|1
2341533|NCT03449446|4073567|FG003|Overall Study|Withdrew Consent|4
2341534|NCT03449446|4073568|FG004|Overall Study|Withdrew Consent|4
2341535|NCT03449446|4073569|FG005|Overall Study|Withdrew Consent|4
2341536|NCT03449446|4073570|FG006|Overall Study|Withdrew Consent|1
2341537|NCT03449446|4073564|FG000|Overall Study|Adverse Event|1
2341538|NCT03449446|4073565|FG001|Overall Study|Adverse Event|2
2341539|NCT03449446|4073566|FG002|Overall Study|Adverse Event|1
2341540|NCT03449446|4073567|FG003|Overall Study|Adverse Event|0
2341541|NCT03449446|4073568|FG004|Overall Study|Adverse Event|0
2341542|NCT03449446|4073569|FG005|Overall Study|Adverse Event|2
2341543|NCT03449446|4073570|FG006|Overall Study|Adverse Event|0
2341544|NCT03449446|4073564|FG000|Overall Study|Lost to Follow-up|0
2341545|NCT03449446|4073565|FG001|Overall Study|Lost to Follow-up|0
2341546|NCT03449446|4073566|FG002|Overall Study|Lost to Follow-up|2
2341547|NCT03449446|4073567|FG003|Overall Study|Lost to Follow-up|1
2341548|NCT03449446|4073568|FG004|Overall Study|Lost to Follow-up|3
2341549|NCT03449446|4073569|FG005|Overall Study|Lost to Follow-up|0
2341550|NCT03449446|4073570|FG006|Overall Study|Lost to Follow-up|0
2341551|NCT03449446|4073564|FG000|Overall Study|Investigator's Discretion|0
2341552|NCT03449446|4073565|FG001|Overall Study|Investigator's Discretion|1
2341553|NCT03449446|4073566|FG002|Overall Study|Investigator's Discretion|1
2341554|NCT03449446|4073567|FG003|Overall Study|Investigator's Discretion|2
2341555|NCT03449446|4073568|FG004|Overall Study|Investigator's Discretion|0
2341556|NCT03449446|4073569|FG005|Overall Study|Investigator's Discretion|0
2341557|NCT03449446|4073570|FG006|Overall Study|Investigator's Discretion|0
2341558|NCT03449446|4073564|FG000|Overall Study|Non Compliance with Study Drug|1
2341559|NCT03449446|4073565|FG001|Overall Study|Non Compliance with Study Drug|0
2341560|NCT03449446|4073566|FG002|Overall Study|Non Compliance with Study Drug|0
2341561|NCT03449446|4073567|FG003|Overall Study|Non Compliance with Study Drug|0
2341562|NCT03449446|4073568|FG004|Overall Study|Non Compliance with Study Drug|0
2341563|NCT03449446|4073569|FG005|Overall Study|Non Compliance with Study Drug|0
2341564|NCT03449446|4073570|FG006|Overall Study|Non Compliance with Study Drug|0
2341565|NCT03449446|4073564|FG000|Overall Study|Protocol Violation|0
2341566|NCT03449446|4073565|FG001|Overall Study|Protocol Violation|0
2341567|NCT03449446|4073566|FG002|Overall Study|Protocol Violation|0
2341568|NCT03449446|4073567|FG003|Overall Study|Protocol Violation|0
2341569|NCT03449446|4073568|FG004|Overall Study|Protocol Violation|1
2341570|NCT03449446|4073569|FG005|Overall Study|Protocol Violation|1
2341571|NCT03449446|4073570|FG006|Overall Study|Protocol Violation|0
2341572|NCT03449446|4073564|FG000|Overall Study|Death|0
2341573|NCT03449446|4073565|FG001|Overall Study|Death|0
2341574|NCT03449446|4073566|FG002|Overall Study|Death|0
2251735|NCT02036645|3916048|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2251736|NCT02036645|3916049|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2251737|NCT02036645|3916050|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2251738|NCT02036645|3916051|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1
2251739|NCT02036645|3916052|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2251740|NCT02036645|3916053|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2251741|NCT02036645|3916054|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2251742|NCT02036645|3916055|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2251743|NCT02036645|3916056|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2251744|NCT02036645|3916045|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2251745|NCT02036645|3916046|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2251746|NCT02036645|3916047|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2251747|NCT02036645|3916048|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
2251748|NCT02036645|3916049|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2251749|NCT02036645|3916050|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2251750|NCT02036645|3916051|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2251751|NCT02036645|3916052|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2251752|NCT02036645|3916053|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2251753|NCT02036645|3916054|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2251754|NCT02036645|3916055|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2251755|NCT02036645|3916056|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2251756|NCT02036775|3916094|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2251757|NCT02036775|3916095|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2251758|NCT02036775|3916096|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2251759|NCT02036775|3916097|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2251760|NCT02036775|3916098|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2251761|NCT02036775|3916099|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
2251762|NCT02036853|3916113|FG000|Overall Study|Adverse Event|0
2251763|NCT02036853|3916114|FG001|Overall Study|Adverse Event|2
2251764|NCT02036853|3916113|FG000|Overall Study|Lack of Efficacy|0
2251765|NCT02036853|3916114|FG001|Overall Study|Lack of Efficacy|2
2341575|NCT03449446|4073567|FG003|Overall Study|Death|0
2341576|NCT03449446|4073568|FG004|Overall Study|Death|1
2341577|NCT03449446|4073569|FG005|Overall Study|Death|0
2341578|NCT03449446|4073570|FG006|Overall Study|Death|0
2341579|NCT03449758|4073586|FG000|Overall Study|Major protocol deviation|1
2038535|NCT00423189|3608911|FG001|Overall Study|Death|1
2038536|NCT00423189|3608912|FG002|Overall Study|Death|0
2038537|NCT00423267|3608927|FG000|Period A|Withdrawal by Subject|0
2038538|NCT00423267|3608928|FG001|Period A|Withdrawal by Subject|1
2038539|NCT00423267|3608927|FG000|Period A|Non-compliance with protocol|1
2038540|NCT00423267|3608928|FG001|Period A|Non-compliance with protocol|0
2038541|NCT00423267|3608927|FG000|Period A|Administrative|1
2038542|NCT00423267|3608928|FG001|Period A|Administrative|0
2038543|NCT00423293|3608936|FG000|Overall Study|Ineligible / No protocol treatment|11
2038544|NCT00423319|3608942|FG000|Overall Study|Death|2
2038545|NCT00423319|3608943|FG001|Overall Study|Death|0
2038546|NCT00423319|3608942|FG000|Overall Study|Adverse Event|93
2038547|NCT00423319|3608943|FG001|Overall Study|Adverse Event|112
2038548|NCT00423319|3608942|FG000|Overall Study|Withdrawal by Subject|86
2038549|NCT00423319|3608943|FG001|Overall Study|Withdrawal by Subject|99
2038550|NCT00423319|3608942|FG000|Overall Study|Lost to Follow-up|4
2038551|NCT00423319|3608943|FG001|Overall Study|Lost to Follow-up|3
2038552|NCT00423319|3608942|FG000|Overall Study|Poor compliance or noncompliance|1
2038553|NCT00423319|3608943|FG001|Overall Study|Poor compliance or noncompliance|1
2038554|NCT00423319|3608942|FG000|Overall Study|No longer meets study criteria|15
2038555|NCT00423319|3608943|FG001|Overall Study|No longer meets study criteria|15
2038556|NCT00423319|3608942|FG000|Overall Study|Other|23
2038557|NCT00423319|3608943|FG001|Overall Study|Other|22
2038558|NCT00423332|3608952|FG000|Overall Study|Adverse Event|6
2038559|NCT00423332|3608953|FG001|Overall Study|Adverse Event|2
2038560|NCT00423332|3608952|FG000|Overall Study|Withdrawal by Subject|1
2038561|NCT00423332|3608953|FG001|Overall Study|Withdrawal by Subject|0
2038562|NCT00423332|3608952|FG000|Overall Study|Condition under investigation worsened|1
2038563|NCT00423332|3608953|FG001|Overall Study|Condition under investigation worsened|1
2038564|NCT00423332|3608952|FG000|Overall Study|Progressive at Week 6|0
2038565|NCT00423332|3608953|FG001|Overall Study|Progressive at Week 6|1
2038566|NCT00423332|3608952|FG000|Overall Study|Unblinded before 12 weeks|1
2038567|NCT00423332|3608953|FG001|Overall Study|Unblinded before 12 weeks|3
2038568|NCT00423449|3608978|FG000|Overall Study|Clinical Adverse Event|1
2038569|NCT00423449|3608979|FG001|Overall Study|Clinical Adverse Event|0
2038570|NCT00423449|3608980|FG002|Overall Study|Clinical Adverse Event|1
2038571|NCT00423449|3608981|FG003|Overall Study|Clinical Adverse Event|8
2038572|NCT00423449|3608982|FG004|Overall Study|Clinical Adverse Event|2
2038573|NCT00423449|3608978|FG000|Overall Study|Death|1
2038574|NCT00423449|3608979|FG001|Overall Study|Death|0
2038575|NCT00423449|3608980|FG002|Overall Study|Death|2
2038576|NCT00423449|3608981|FG003|Overall Study|Death|1
2038577|NCT00423449|3608982|FG004|Overall Study|Death|1
2038578|NCT00423449|3608978|FG000|Overall Study|Progressive Disease|1
2038579|NCT00423449|3608979|FG001|Overall Study|Progressive Disease|3
2038580|NCT00423449|3608980|FG002|Overall Study|Progressive Disease|8
2038581|NCT00423449|3608981|FG003|Overall Study|Progressive Disease|11
2038582|NCT00423449|3608982|FG004|Overall Study|Progressive Disease|4
2251766|NCT02036853|3916113|FG000|Overall Study|Physician Decision|0
2251767|NCT02036853|3916114|FG001|Overall Study|Physician Decision|1
2251768|NCT02036853|3916113|FG000|Overall Study|Withdrawal by Subject|0
2251769|NCT02036853|3916114|FG001|Overall Study|Withdrawal by Subject|1
2251770|NCT02037165|3916136|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2251771|NCT02037165|3916137|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2251772|NCT02037165|3916138|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2251773|NCT02037165|3916139|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2251774|NCT02037165|3916140|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1
2251775|NCT02037256|3916181|FG000|Overall Study|Protocol Violation|0
2251776|NCT02037256|3916182|FG001|Overall Study|Protocol Violation|1
2251777|NCT02037256|3916181|FG000|Overall Study|Withdrawn prior to Velcade|0
2251778|NCT02037256|3916182|FG001|Overall Study|Withdrawn prior to Velcade|2
2251779|NCT02037295|3916194|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
2251780|NCT02037295|3916195|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
2251781|NCT02037295|3916196|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
2251782|NCT02037295|3916197|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
2251783|NCT02037477|3916232|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0
2251784|NCT02037477|3916233|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0
2251785|NCT02037477|3916234|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1
2251786|NCT02037477|3916235|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0
2251787|NCT02037568|3916256|FG000|Overall Study|Withdrawal by Subject|17
2251788|NCT02037568|3916257|FG001|Overall Study|Withdrawal by Subject|24
2251789|NCT02037568|3916256|FG000|Overall Study|Lost to Follow-up|16
2251790|NCT02037568|3916257|FG001|Overall Study|Lost to Follow-up|13
2251791|NCT02037568|3916256|FG000|Overall Study|Screen Failure|3
2251792|NCT02037568|3916257|FG001|Overall Study|Screen Failure|1
2251793|NCT02037568|3916256|FG000|Overall Study|Patient did not receive transplant|0
2251794|NCT02037568|3916257|FG001|Overall Study|Patient did not receive transplant|1
2251795|NCT02037984|3916301|FG000|Overall Study|Lack of Efficacy|0
2251796|NCT02037984|3916302|FG001|Overall Study|Lack of Efficacy|0
2251797|NCT02037984|3916303|FG002|Overall Study|Lack of Efficacy|3
2251798|NCT02037984|3916304|FG003|Overall Study|Lack of Efficacy|10
2251799|NCT02037984|3916305|FG004|Overall Study|Lack of Efficacy|2
2251800|NCT02037984|3916306|FG005|Overall Study|Lack of Efficacy|2
2251801|NCT02037984|3916307|FG006|Overall Study|Lack of Efficacy|4
2251802|NCT02037984|3916308|FG007|Overall Study|Lack of Efficacy|3
2251803|NCT02037984|3916301|FG000|Overall Study|Lost to Follow-up|1
2251804|NCT02037984|3916302|FG001|Overall Study|Lost to Follow-up|0
2251805|NCT02037984|3916303|FG002|Overall Study|Lost to Follow-up|3
2341580|NCT03449758|4073586|FG000|Overall Study|Treatment inefficacy|5
2341581|NCT03449758|4073586|FG000|Overall Study|Adverse Event|9
2341582|NCT03449758|4073586|FG000|Overall Study|Consent withdrawal|1
2341583|NCT03449758|4073586|FG000|Overall Study|Other unspecified reason|3
2341584|NCT03449979|4073595|FG000|Overall Study|Technical difficulty|0
2341585|NCT03449979|4073596|FG001|Overall Study|Technical difficulty|0
2341586|NCT03449979|4073597|FG002|Overall Study|Technical difficulty|0
2341587|NCT03449979|4073598|FG003|Overall Study|Technical difficulty|1
2341588|NCT03450070|4073608|FG000|Overall Study|Withdrawal by Subject|8
2341589|NCT03451071|4073639|FG000|First Vaccine|Withdrawal by Subject|1
2341590|NCT03451071|4073639|FG000|Second Vaccine|Lost to Follow-up|19
2341591|NCT03451071|4073639|FG000|Third Vaccine|Lost to Follow-up|22
2341592|NCT03451071|4073639|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4
2341593|NCT03451084|4073647|FG000|Overall Study|Withdrawal by Subject|2
2341594|NCT03451084|4073648|FG001|Overall Study|Withdrawal by Subject|1
2341595|NCT03451084|4073649|FG002|Overall Study|Withdrawal by Subject|2
2341596|NCT03451084|4073650|FG003|Overall Study|Withdrawal by Subject|1
2341597|NCT03451084|4073647|FG000|Overall Study|Disease recurrence|0
2341598|NCT03451084|4073648|FG001|Overall Study|Disease recurrence|2
2341599|NCT03451084|4073649|FG002|Overall Study|Disease recurrence|0
2341600|NCT03451084|4073650|FG003|Overall Study|Disease recurrence|0
2341601|NCT03451084|4073647|FG000|Overall Study|Lack of Efficacy|0
2341602|NCT03451084|4073648|FG001|Overall Study|Lack of Efficacy|3
2341603|NCT03451084|4073649|FG002|Overall Study|Lack of Efficacy|0
2341604|NCT03451084|4073650|FG003|Overall Study|Lack of Efficacy|1
2341605|NCT03451084|4073647|FG000|Overall Study|Death|1
2341606|NCT03451084|4073648|FG001|Overall Study|Death|0
2341607|NCT03451084|4073649|FG002|Overall Study|Death|2
2341608|NCT03451084|4073650|FG003|Overall Study|Death|0
2341609|NCT03451084|4073647|FG000|Overall Study|Physician Decision|0
2341610|NCT03451084|4073648|FG001|Overall Study|Physician Decision|0
2341611|NCT03451084|4073649|FG002|Overall Study|Physician Decision|2
2341612|NCT03451084|4073650|FG003|Overall Study|Physician Decision|2
2341613|NCT03451084|4073647|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3
2341614|NCT03451084|4073648|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
2341615|NCT03451084|4073649|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
2341616|NCT03451084|4073650|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2
2341617|NCT03451721|4073660|FG000|Overall Study|Death|1
2341618|NCT03451773|4073666|FG000|Overall Study|Death on study|1
2251806|NCT02037984|3916304|FG003|Overall Study|Lost to Follow-up|5
2251807|NCT02037984|3916305|FG004|Overall Study|Lost to Follow-up|2
2251808|NCT02037984|3916306|FG005|Overall Study|Lost to Follow-up|2
2251809|NCT02037984|3916307|FG006|Overall Study|Lost to Follow-up|2
2251810|NCT02037984|3916308|FG007|Overall Study|Lost to Follow-up|4
2251811|NCT02037984|3916301|FG000|Overall Study|Physician Decision|0
2251812|NCT02037984|3916302|FG001|Overall Study|Physician Decision|0
2251813|NCT02037984|3916303|FG002|Overall Study|Physician Decision|0
2251814|NCT02037984|3916304|FG003|Overall Study|Physician Decision|0
2251815|NCT02037984|3916305|FG004|Overall Study|Physician Decision|0
2251816|NCT02037984|3916306|FG005|Overall Study|Physician Decision|0
2251817|NCT02037984|3916307|FG006|Overall Study|Physician Decision|1
2251818|NCT02037984|3916308|FG007|Overall Study|Physician Decision|0
2251819|NCT02037984|3916301|FG000|Overall Study|Protocol Violation|0
2251820|NCT02037984|3916302|FG001|Overall Study|Protocol Violation|0
2251821|NCT02037984|3916303|FG002|Overall Study|Protocol Violation|0
2251822|NCT02037984|3916304|FG003|Overall Study|Protocol Violation|0
2251823|NCT02037984|3916305|FG004|Overall Study|Protocol Violation|0
2251824|NCT02037984|3916306|FG005|Overall Study|Protocol Violation|1
2251825|NCT02037984|3916307|FG006|Overall Study|Protocol Violation|2
2251826|NCT02037984|3916308|FG007|Overall Study|Protocol Violation|0
2251827|NCT02037984|3916301|FG000|Overall Study|Technical Problems|0
2251828|NCT02037984|3916302|FG001|Overall Study|Technical Problems|0
2251829|NCT02037984|3916303|FG002|Overall Study|Technical Problems|3
2251830|NCT02037984|3916304|FG003|Overall Study|Technical Problems|3
2251831|NCT02037984|3916305|FG004|Overall Study|Technical Problems|2
2251832|NCT02037984|3916306|FG005|Overall Study|Technical Problems|3
2251833|NCT02037984|3916307|FG006|Overall Study|Technical Problems|4
2251834|NCT02037984|3916308|FG007|Overall Study|Technical Problems|2
2251835|NCT02037984|3916301|FG000|Overall Study|Withdrawal by Parent/Guardian|0
2251836|NCT02037984|3916302|FG001|Overall Study|Withdrawal by Parent/Guardian|0
2251837|NCT02037984|3916303|FG002|Overall Study|Withdrawal by Parent/Guardian|3
2251838|NCT02037984|3916304|FG003|Overall Study|Withdrawal by Parent/Guardian|2
2251839|NCT02037984|3916305|FG004|Overall Study|Withdrawal by Parent/Guardian|5
2251840|NCT02037984|3916306|FG005|Overall Study|Withdrawal by Parent/Guardian|1
2251841|NCT02037984|3916307|FG006|Overall Study|Withdrawal by Parent/Guardian|4
2251842|NCT02037984|3916308|FG007|Overall Study|Withdrawal by Parent/Guardian|2
2251843|NCT02037984|3916301|FG000|Overall Study|Withdrawal by Subject|0
2251844|NCT02037984|3916302|FG001|Overall Study|Withdrawal by Subject|0
2251845|NCT02037984|3916303|FG002|Overall Study|Withdrawal by Subject|0
2251846|NCT02037984|3916304|FG003|Overall Study|Withdrawal by Subject|1
2251847|NCT02037984|3916305|FG004|Overall Study|Withdrawal by Subject|1
2251848|NCT02037984|3916306|FG005|Overall Study|Withdrawal by Subject|3
2251849|NCT02037984|3916307|FG006|Overall Study|Withdrawal by Subject|0
2251850|NCT02037984|3916308|FG007|Overall Study|Withdrawal by Subject|1
2251851|NCT02038010|3916336|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
2251852|NCT02038010|3916337|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
2251853|NCT02038010|3916338|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
2251854|NCT02038010|3916339|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
2251855|NCT02038010|3916336|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
2251856|NCT02038010|3916337|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
2251857|NCT02038010|3916338|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
2251858|NCT02038010|3916339|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
2251859|NCT02038010|3916336|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
2251860|NCT02038010|3916337|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
2251861|NCT02038010|3916338|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
2251862|NCT02038010|3916339|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
2251863|NCT02038010|3916336|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
2251864|NCT02038010|3916337|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
2251865|NCT02038010|3916338|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
2251866|NCT02038010|3916339|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
2251867|NCT02038010|3916336|FG000|Follow Up|Death|4
2251868|NCT02038010|3916337|FG001|Follow Up|Death|3
2251869|NCT02038010|3916338|FG002|Follow Up|Death|0
2251870|NCT02038010|3916339|FG003|Follow Up|Death|0
2251871|NCT02038010|3916336|FG000|Follow Up|Other|3
2251872|NCT02038010|3916337|FG001|Follow Up|Other|0
2251873|NCT02038010|3916338|FG002|Follow Up|Other|0
2251874|NCT02038010|3916339|FG003|Follow Up|Other|0
2251875|NCT02038036|3916355|FG000|Core Study|Adverse Event|7
2251876|NCT02038036|3916356|FG001|Core Study|Adverse Event|7
2251877|NCT02038036|3916355|FG000|Core Study|Death|1
2251878|NCT02038036|3916356|FG001|Core Study|Death|1
2251879|NCT02038036|3916355|FG000|Core Study|Disease progression|2
2251880|NCT02038036|3916356|FG001|Core Study|Disease progression|2
2251881|NCT02038036|3916355|FG000|Core Study|Lost to Follow-up|0
2251882|NCT02038036|3916356|FG001|Core Study|Lost to Follow-up|1
2251883|NCT02038036|3916355|FG000|Core Study|Physician Decision|2
2251884|NCT02038036|3916356|FG001|Core Study|Physician Decision|1
2251885|NCT02038036|3916355|FG000|Core Study|Subject/guardian decision|0
2251886|NCT02038036|3916356|FG001|Core Study|Subject/guardian decision|1
2251887|NCT02038036|3916355|FG000|Core Study|Withdrawal by Subject|3
2251888|NCT02038036|3916356|FG001|Core Study|Withdrawal by Subject|1
2251889|NCT02038036|3916355|FG000|Crossover Period|Withdrawal by Subject|0
2251890|NCT02038036|3916356|FG001|Crossover Period|Withdrawal by Subject|3
2251891|NCT02038036|3916355|FG000|Crossover Period|Adverse Event|0
2251892|NCT02038036|3916356|FG001|Crossover Period|Adverse Event|9
2251893|NCT02038036|3916355|FG000|Crossover Period|Death|0
2251894|NCT02038036|3916356|FG001|Crossover Period|Death|2
2251895|NCT02038036|3916355|FG000|Crossover Period|Disease progression|0
2251896|NCT02038036|3916356|FG001|Crossover Period|Disease progression|3
2251897|NCT02038036|3916355|FG000|Crossover Period|Lost to Follow-up|0
2251898|NCT02038036|3916356|FG001|Crossover Period|Lost to Follow-up|1
2251899|NCT02038036|3916355|FG000|Crossover Period|Physician Decision|0
2251900|NCT02038036|3916356|FG001|Crossover Period|Physician Decision|2
2341619|NCT03451773|4073667|FG001|Overall Study|Death on study|5
2341620|NCT03451773|4073666|FG000|Overall Study|Death during follow-up period|0
2341621|NCT03451773|4073667|FG001|Overall Study|Death during follow-up period|1
2341622|NCT03452189|4073711|FG000|First Intervention (3 Months)|Adverse Event|1
2341623|NCT03452189|4073712|FG001|First Intervention (3 Months)|Adverse Event|0
2341624|NCT03452189|4073711|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4
2341625|NCT03452189|4073712|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0
2341626|NCT03452527|4073729|FG000|Overall Study|Withdrawal by Subject|1
2341627|NCT03452527|4073730|FG001|Overall Study|Withdrawal by Subject|1
2038583|NCT00423449|3608978|FG000|Overall Study|Laboratory Adverse Event|0
2038584|NCT00423449|3608979|FG001|Overall Study|Laboratory Adverse Event|1
2038585|NCT00423449|3608980|FG002|Overall Study|Laboratory Adverse Event|2
2038586|NCT00423449|3608981|FG003|Overall Study|Laboratory Adverse Event|0
2038587|NCT00423449|3608982|FG004|Overall Study|Laboratory Adverse Event|0
2038588|NCT00423449|3608978|FG000|Overall Study|Other|0
2038589|NCT00423449|3608979|FG001|Overall Study|Other|0
2038590|NCT00423449|3608980|FG002|Overall Study|Other|0
2038591|NCT00423449|3608981|FG003|Overall Study|Other|1
2038592|NCT00423449|3608982|FG004|Overall Study|Other|0
2038593|NCT00423449|3608978|FG000|Overall Study|Protocol Violation|0
2038594|NCT00423449|3608979|FG001|Overall Study|Protocol Violation|0
2038595|NCT00423449|3608980|FG002|Overall Study|Protocol Violation|2
2038596|NCT00423449|3608981|FG003|Overall Study|Protocol Violation|1
2038597|NCT00423449|3608982|FG004|Overall Study|Protocol Violation|0
2038598|NCT00423592|3608995|FG000|Overall Study|Adverse Event (through Week 12)|2
2038599|NCT00423592|3608995|FG000|Overall Study|Adverse Event (post Week 12)|5
2038600|NCT00423605|3608999|FG000|Overall Study|Adverse Event|129
2038601|NCT00423605|3608999|FG000|Overall Study|Withdrawal by Subject|36
2038602|NCT00423605|3608999|FG000|Overall Study|Lost to Follow-up|15
2038603|NCT00423605|3608999|FG000|Overall Study|Lack of Efficacy|38
2038604|NCT00423605|3608999|FG000|Overall Study|Sponsor Decision|3
2038605|NCT00423605|3608999|FG000|Overall Study|Physician Decision|8
2038606|NCT00423605|3608999|FG000|Overall Study|Protocol Violation|7
2038607|NCT00423605|3608999|FG000|Overall Study|Not one of the pre-specified options|5
2038608|NCT00423657|3609005|FG000|Overall Study|Withdrew consent|10
2038609|NCT00423657|3609006|FG001|Overall Study|Withdrew consent|8
2038610|NCT00423657|3609005|FG000|Overall Study|Non-compliance|0
2038611|NCT00423657|3609006|FG001|Overall Study|Non-compliance|1
2038612|NCT00423657|3609005|FG000|Overall Study|Other|15
2038613|NCT00423657|3609006|FG001|Overall Study|Other|16
2038614|NCT00423657|3609005|FG000|Overall Study|Request of sponsor/investigator|1
2038615|NCT00423657|3609006|FG001|Overall Study|Request of sponsor/investigator|0
2038616|NCT00423670|3609019|FG000|Treatment Period|Switched to Arm 8 at TW 24|36
2038617|NCT00423670|3609020|FG001|Treatment Period|Switched to Arm 8 at TW 24|0
2038618|NCT00423670|3609021|FG002|Treatment Period|Switched to Arm 8 at TW 24|0
2038619|NCT00423670|3609022|FG003|Treatment Period|Switched to Arm 8 at TW 24|0
2038620|NCT00423670|3609023|FG004|Treatment Period|Switched to Arm 8 at TW 24|0
2038621|NCT00423670|3609024|FG005|Treatment Period|Switched to Arm 8 at TW 24|0
2038622|NCT00423670|3609025|FG006|Treatment Period|Switched to Arm 8 at TW 24|0
2038623|NCT00423670|3609026|FG007|Treatment Period|Switched to Arm 8 at TW 24|0
2038624|NCT00423670|3609019|FG000|Treatment Period|Adverse Event|8
2038625|NCT00423670|3609020|FG001|Treatment Period|Adverse Event|12
2038626|NCT00423670|3609021|FG002|Treatment Period|Adverse Event|15
2038627|NCT00423670|3609022|FG003|Treatment Period|Adverse Event|20
2038628|NCT00423670|3609023|FG004|Treatment Period|Adverse Event|9
2038629|NCT00423670|3609024|FG005|Treatment Period|Adverse Event|4
2038630|NCT00423670|3609025|FG006|Treatment Period|Adverse Event|7
2038631|NCT00423670|3609026|FG007|Treatment Period|Adverse Event|2
2038632|NCT00423670|3609019|FG000|Treatment Period|Protocol-defined clinical event|0
2038633|NCT00423670|3609020|FG001|Treatment Period|Protocol-defined clinical event|7
2038634|NCT00423670|3609021|FG002|Treatment Period|Protocol-defined clinical event|4
2038635|NCT00423670|3609022|FG003|Treatment Period|Protocol-defined clinical event|12
2038636|NCT00423670|3609023|FG004|Treatment Period|Protocol-defined clinical event|5
2038637|NCT00423670|3609024|FG005|Treatment Period|Protocol-defined clinical event|4
2038638|NCT00423670|3609025|FG006|Treatment Period|Protocol-defined clinical event|16
2038639|NCT00423670|3609026|FG007|Treatment Period|Protocol-defined clinical event|15
2038640|NCT00423670|3609019|FG000|Treatment Period|Lost to Follow-up|2
2251901|NCT02038049|3916367|FG000|Overall Study|Lost to Follow-up|1
2038641|NCT00423670|3609020|FG001|Treatment Period|Lost to Follow-up|1
2038642|NCT00423670|3609021|FG002|Treatment Period|Lost to Follow-up|3
2038643|NCT00423670|3609022|FG003|Treatment Period|Lost to Follow-up|1
2251902|NCT02038049|3916368|FG001|Overall Study|Lost to Follow-up|0
2251903|NCT02038075|3916380|FG000|Overall Study|Withdrawal by Subject|3
2251904|NCT02038075|3916381|FG001|Overall Study|Withdrawal by Subject|0
2341628|NCT03452527|4073729|FG000|Overall Study|Study Terminated|2
2341629|NCT03452527|4073730|FG001|Overall Study|Study Terminated|3
2341630|NCT03452943|4073738|FG000|Titration Period (7 Weeks)|Adverse Event|1
2341631|NCT03452943|4073739|FG001|Titration Period (7 Weeks)|Adverse Event|1
2341632|NCT03452943|4073738|FG000|Titration Period (7 Weeks)|Protocol Violation|0
2341633|NCT03452943|4073739|FG001|Titration Period (7 Weeks)|Protocol Violation|1
2341634|NCT03452943|4073738|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3
2341635|NCT03452943|4073739|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2
2341636|NCT03452943|4073738|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1
2341637|NCT03452943|4073739|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0
2341638|NCT03452943|4073738|FG000|Maintenance Period (5 Weeks)|Adverse Event|1
2341639|NCT03452943|4073739|FG001|Maintenance Period (5 Weeks)|Adverse Event|0
2341640|NCT03452943|4073738|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2
2341641|NCT03452943|4073739|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0
2341642|NCT03453151|4073766|FG000|Overall Study|Withdrawal by Subject|1
2341643|NCT03453151|4073766|FG000|Overall Study|Physician Decision|3
2341644|NCT03454412|4073798|FG000|Baseline Assesment|Physician Decision|12
2341645|NCT03455543|4073840|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2
2341646|NCT03455543|4073841|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5
2341647|NCT03455543|4073842|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0
2341648|NCT03455543|4073840|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7
2341649|NCT03455543|4073841|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2
2341650|NCT03455543|4073842|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0
2341651|NCT03455543|4073840|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2
2341652|NCT03455543|4073841|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
2341653|NCT03455543|4073842|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
2341654|NCT03455543|4073840|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
2341655|NCT03455543|4073841|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
2341656|NCT03455543|4073842|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3
2341657|NCT03455543|4073840|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
2341658|NCT03455543|4073841|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
2341659|NCT03455543|4073842|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20
2341660|NCT03455543|4073840|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
2341661|NCT03455543|4073841|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
2341662|NCT03455543|4073842|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7
2341663|NCT03455543|4073840|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
2341664|NCT03455543|4073841|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
2341665|NCT03455543|4073842|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4
2341666|NCT03455543|4073840|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
2341667|NCT03455543|4073841|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
2341668|NCT03455543|4073842|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2
2341669|NCT03455543|4073840|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
2341670|NCT03455543|4073841|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
2341671|NCT03455543|4073842|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1
2341672|NCT03456700|4073859|FG000|Overall Study|Withdrawal by Subject|1
2341673|NCT03456856|4073863|FG000|Overall Study|Lost to Follow-up|2
2341674|NCT03456856|4073863|FG000|Overall Study|Withdrawal by Subject|1
2341675|NCT03456960|4073873|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2341676|NCT03456960|4073874|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2341677|NCT03456960|4073875|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
2341678|NCT03456960|4073876|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
2341679|NCT03456960|4073877|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2341680|NCT03456960|4073878|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2341681|NCT03456960|4073873|FG000|Period 2 (1 Day)|Adverse Event|1
2341682|NCT03456960|4073874|FG001|Period 2 (1 Day)|Adverse Event|0
2341683|NCT03456960|4073875|FG002|Period 2 (1 Day)|Adverse Event|0
2341684|NCT03456960|4073876|FG003|Period 2 (1 Day)|Adverse Event|1
2341685|NCT03456960|4073877|FG004|Period 2 (1 Day)|Adverse Event|0
2341686|NCT03456960|4073878|FG005|Period 2 (1 Day)|Adverse Event|0
2341687|NCT03457103|4073896|FG000|Overall Study|illness/hospitalization|4
2341688|NCT03457103|4073897|FG001|Overall Study|illness/hospitalization|2
2341689|NCT03457103|4073896|FG000|Overall Study|Lost to Follow-up|2
2341690|NCT03457103|4073897|FG001|Overall Study|Lost to Follow-up|1
2341691|NCT03457103|4073896|FG000|Overall Study|Withdrawal by Subject|1
2341692|NCT03457103|4073897|FG001|Overall Study|Withdrawal by Subject|2
2341693|NCT03457103|4073896|FG000|Overall Study|financial/ insurance issues|1
2341694|NCT03457103|4073897|FG001|Overall Study|financial/ insurance issues|1
2341695|NCT03457636|4073912|FG000|Overall Study|Lost to Follow-up|2
2341696|NCT03457727|4073920|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
2341697|NCT03457727|4073921|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
2341698|NCT03457727|4073922|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
2341699|NCT03457727|4073923|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
2251905|NCT02038543|3916407|FG000|Overall Study|Screen Failure|0
2251906|NCT02038543|3916408|FG001|Overall Study|Screen Failure|0
2251907|NCT02038543|3916409|FG002|Overall Study|Screen Failure|0
2251908|NCT02038543|3916410|FG003|Overall Study|Screen Failure|1
2251909|NCT02038543|3916407|FG000|Overall Study|Withdrawal by Subject|0
2251910|NCT02038543|3916408|FG001|Overall Study|Withdrawal by Subject|0
2251911|NCT02038543|3916409|FG002|Overall Study|Withdrawal by Subject|0
2251912|NCT02038543|3916410|FG003|Overall Study|Withdrawal by Subject|1
2251913|NCT02038647|3916427|FG000|Overall Study|Progressive Disease|50
2251914|NCT02038647|3916428|FG001|Overall Study|Progressive Disease|59
2251915|NCT02038647|3916427|FG000|Overall Study|Adverse Event|18
2251916|NCT02038647|3916428|FG001|Overall Study|Adverse Event|10
2251917|NCT02038647|3916427|FG000|Overall Study|Symptomatic Deterioration|7
2251918|NCT02038647|3916428|FG001|Overall Study|Symptomatic Deterioration|7
2251919|NCT02038647|3916427|FG000|Overall Study|Withdrawal by Subject|5
2251920|NCT02038647|3916428|FG001|Overall Study|Withdrawal by Subject|2
2251921|NCT02038647|3916427|FG000|Overall Study|Not Reported|0
2251922|NCT02038647|3916428|FG001|Overall Study|Not Reported|1
2251923|NCT02038647|3916427|FG000|Overall Study|Ongoing at Datacut|9
2251924|NCT02038647|3916428|FG001|Overall Study|Ongoing at Datacut|10
2251925|NCT02038764|3916439|FG000|Overall Study|Adverse Event|0
2251926|NCT02038764|3916440|FG001|Overall Study|Adverse Event|0
2251927|NCT02038764|3916441|FG002|Overall Study|Adverse Event|1
2251928|NCT02038764|3916442|FG003|Overall Study|Adverse Event|0
2251929|NCT02038764|3916443|FG004|Overall Study|Adverse Event|0
2251930|NCT02038764|3916439|FG000|Overall Study|Lost to Follow-up|0
2251931|NCT02038764|3916440|FG001|Overall Study|Lost to Follow-up|1
2251932|NCT02038764|3916441|FG002|Overall Study|Lost to Follow-up|0
2251933|NCT02038764|3916442|FG003|Overall Study|Lost to Follow-up|0
2251934|NCT02038764|3916443|FG004|Overall Study|Lost to Follow-up|0
2251935|NCT02038764|3916439|FG000|Overall Study|Withdrawal by Subject|0
2251936|NCT02038764|3916440|FG001|Overall Study|Withdrawal by Subject|0
2251937|NCT02038764|3916441|FG002|Overall Study|Withdrawal by Subject|0
2251938|NCT02038764|3916442|FG003|Overall Study|Withdrawal by Subject|0
2251939|NCT02038764|3916443|FG004|Overall Study|Withdrawal by Subject|1
2251940|NCT02038764|3916439|FG000|Overall Study|Other|1
2251941|NCT02038764|3916440|FG001|Overall Study|Other|0
2251942|NCT02038764|3916441|FG002|Overall Study|Other|1
2251943|NCT02038764|3916442|FG003|Overall Study|Other|0
2251944|NCT02038764|3916443|FG004|Overall Study|Other|0
2251945|NCT02038790|3916459|FG000|Day 0 - First Treatment|Withdrawal by Subject|1
2251946|NCT02038790|3916460|FG001|Day 0 - First Treatment|Withdrawal by Subject|1
2251947|NCT02038829|3916467|FG000|Washout Period 1|Death|0
2251948|NCT02038829|3916468|FG001|Washout Period 1|Death|0
2251949|NCT02038829|3916469|FG002|Washout Period 1|Death|0
2251950|NCT02038829|3916470|FG003|Washout Period 1|Death|0
2341700|NCT03458702|4073959|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
2341701|NCT03458702|4073960|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
2341702|NCT03458702|4073959|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
2341703|NCT03458702|4073960|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
2341704|NCT03459040|4073970|FG000|Overall Study|Death|8
2341705|NCT03459040|4073970|FG000|Overall Study|Withdrawal by Subject|1
2341706|NCT03459196|4073982|FG000|Overall Study|Subject didn't receive study catheter|2
2341707|NCT03461146|4074043|FG000|Overall Study|Adverse Event|2
2341708|NCT03461146|4074043|FG000|Overall Study|Physician Decision|1
2341709|NCT03461289|4074047|FG000|Overall Study|Death|1
2341710|NCT03461757|4074053|FG000|Overall Study|Adverse Event|1
2341711|NCT03461757|4074054|FG001|Overall Study|Adverse Event|0
2341712|NCT03461757|4074053|FG000|Overall Study|Lost to Follow-up|13
2341713|NCT03461757|4074054|FG001|Overall Study|Lost to Follow-up|7
2341714|NCT03461757|4074053|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28
2341715|NCT03461757|4074054|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25
2341716|NCT03461757|4074053|FG000|Overall Study|Non-compliance with study treatment|0
2341717|NCT03461757|4074054|FG001|Overall Study|Non-compliance with study treatment|1
2341718|NCT03461757|4074053|FG000|Overall Study|Pregnancy|2
2341719|NCT03461757|4074054|FG001|Overall Study|Pregnancy|0
2341720|NCT03461757|4074053|FG000|Overall Study|Protocol Violation|1
2341721|NCT03461757|4074054|FG001|Overall Study|Protocol Violation|1
2341722|NCT03461757|4074053|FG000|Overall Study|Withdrawal by Subject|7
2341723|NCT03461757|4074054|FG001|Overall Study|Withdrawal by Subject|7
2341724|NCT03461757|4074053|FG000|Overall Study|Other Reasons|1
2341725|NCT03461757|4074054|FG001|Overall Study|Other Reasons|4
2341726|NCT03462082|4074069|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0
2341727|NCT03462082|4074070|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0
2341728|NCT03462082|4074071|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0
2341729|NCT03462082|4074072|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0
2341730|NCT03462082|4074073|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0
2341731|NCT03462082|4074074|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0
2341732|NCT03462082|4074075|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1
2341733|NCT03462082|4074076|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2
2341734|NCT03462576|4074089|FG000|Overall Study|Protocol Violation|5
2251951|NCT02038829|3916471|FG004|Washout Period 1|Death|1
2251952|NCT02038829|3916472|FG005|Washout Period 1|Death|0
2251953|NCT02038829|3916473|FG006|Washout Period 1|Death|0
2251954|NCT02038829|3916474|FG007|Washout Period 1|Death|0
2251955|NCT02038829|3916475|FG008|Washout Period 1|Death|0
2251956|NCT02038829|3916476|FG009|Washout Period 1|Death|0
2251957|NCT02038829|3916477|FG010|Washout Period 1|Death|0
2251958|NCT02038829|3916478|FG011|Washout Period 1|Death|0
2251959|NCT02038829|3916467|FG000|Treatment Period 2|Adverse Event|0
2251960|NCT02038829|3916468|FG001|Treatment Period 2|Adverse Event|0
2251961|NCT02038829|3916469|FG002|Treatment Period 2|Adverse Event|0
2251962|NCT02038829|3916470|FG003|Treatment Period 2|Adverse Event|0
2251963|NCT02038829|3916471|FG004|Treatment Period 2|Adverse Event|0
2251964|NCT02038829|3916472|FG005|Treatment Period 2|Adverse Event|0
2251965|NCT02038829|3916473|FG006|Treatment Period 2|Adverse Event|0
2251966|NCT02038829|3916474|FG007|Treatment Period 2|Adverse Event|0
2251967|NCT02038829|3916475|FG008|Treatment Period 2|Adverse Event|0
2251968|NCT02038829|3916476|FG009|Treatment Period 2|Adverse Event|0
2251969|NCT02038829|3916477|FG010|Treatment Period 2|Adverse Event|1
2251970|NCT02038829|3916478|FG011|Treatment Period 2|Adverse Event|0
2251971|NCT02038829|3916467|FG000|Treatment Period 2|Withdrawal by Subject|1
2251972|NCT02038829|3916468|FG001|Treatment Period 2|Withdrawal by Subject|0
2251973|NCT02038829|3916469|FG002|Treatment Period 2|Withdrawal by Subject|0
2251974|NCT02038829|3916470|FG003|Treatment Period 2|Withdrawal by Subject|0
2251975|NCT02038829|3916471|FG004|Treatment Period 2|Withdrawal by Subject|0
2251976|NCT02038829|3916472|FG005|Treatment Period 2|Withdrawal by Subject|0
2251977|NCT02038829|3916473|FG006|Treatment Period 2|Withdrawal by Subject|0
2251978|NCT02038829|3916474|FG007|Treatment Period 2|Withdrawal by Subject|0
2251979|NCT02038829|3916475|FG008|Treatment Period 2|Withdrawal by Subject|0
2251980|NCT02038829|3916476|FG009|Treatment Period 2|Withdrawal by Subject|0
2251981|NCT02038829|3916477|FG010|Treatment Period 2|Withdrawal by Subject|0
2251982|NCT02038829|3916478|FG011|Treatment Period 2|Withdrawal by Subject|0
2251983|NCT02038829|3916467|FG000|Washout Period 2|Adverse Event|0
2251984|NCT02038829|3916468|FG001|Washout Period 2|Adverse Event|0
2251985|NCT02038829|3916469|FG002|Washout Period 2|Adverse Event|0
2251986|NCT02038829|3916470|FG003|Washout Period 2|Adverse Event|0
2251987|NCT02038829|3916471|FG004|Washout Period 2|Adverse Event|0
2251988|NCT02038829|3916472|FG005|Washout Period 2|Adverse Event|0
2251989|NCT02038829|3916473|FG006|Washout Period 2|Adverse Event|0
2251990|NCT02038829|3916474|FG007|Washout Period 2|Adverse Event|0
2251991|NCT02038829|3916475|FG008|Washout Period 2|Adverse Event|1
2251992|NCT02038829|3916476|FG009|Washout Period 2|Adverse Event|0
2251993|NCT02038829|3916477|FG010|Washout Period 2|Adverse Event|0
2251994|NCT02038829|3916478|FG011|Washout Period 2|Adverse Event|0
2251995|NCT02038829|3916467|FG000|Washout Period 2|Withdrawal by Subject|0
2251996|NCT02038829|3916468|FG001|Washout Period 2|Withdrawal by Subject|0
2251997|NCT02038829|3916469|FG002|Washout Period 2|Withdrawal by Subject|0
2251998|NCT02038829|3916470|FG003|Washout Period 2|Withdrawal by Subject|0
2251999|NCT02038829|3916471|FG004|Washout Period 2|Withdrawal by Subject|0
2252000|NCT02038829|3916472|FG005|Washout Period 2|Withdrawal by Subject|1
2252001|NCT02038829|3916473|FG006|Washout Period 2|Withdrawal by Subject|0
2252002|NCT02038829|3916474|FG007|Washout Period 2|Withdrawal by Subject|0
2252003|NCT02038829|3916475|FG008|Washout Period 2|Withdrawal by Subject|0
2252004|NCT02038829|3916476|FG009|Washout Period 2|Withdrawal by Subject|0
2252005|NCT02038829|3916477|FG010|Washout Period 2|Withdrawal by Subject|0
2252006|NCT02038829|3916478|FG011|Washout Period 2|Withdrawal by Subject|0
2252007|NCT02038829|3916467|FG000|Treatment Period 4|Adverse Event|0
2252008|NCT02038829|3916468|FG001|Treatment Period 4|Adverse Event|1
2252009|NCT02038829|3916469|FG002|Treatment Period 4|Adverse Event|0
2252010|NCT02038829|3916470|FG003|Treatment Period 4|Adverse Event|0
2252011|NCT02038829|3916471|FG004|Treatment Period 4|Adverse Event|0
2252012|NCT02038829|3916472|FG005|Treatment Period 4|Adverse Event|0
2252013|NCT02038829|3916473|FG006|Treatment Period 4|Adverse Event|0
2252014|NCT02038829|3916474|FG007|Treatment Period 4|Adverse Event|0
2252015|NCT02038829|3916475|FG008|Treatment Period 4|Adverse Event|0
2252016|NCT02038829|3916476|FG009|Treatment Period 4|Adverse Event|0
2252017|NCT02038829|3916477|FG010|Treatment Period 4|Adverse Event|0
2252018|NCT02038829|3916478|FG011|Treatment Period 4|Adverse Event|0
2252019|NCT02038829|3916467|FG000|Washout Period 4|Adverse Event|0
2252020|NCT02038829|3916468|FG001|Washout Period 4|Adverse Event|0
2252021|NCT02038829|3916469|FG002|Washout Period 4|Adverse Event|0
2252022|NCT02038829|3916470|FG003|Washout Period 4|Adverse Event|0
2252023|NCT02038829|3916471|FG004|Washout Period 4|Adverse Event|0
2252024|NCT02038829|3916472|FG005|Washout Period 4|Adverse Event|0
2252025|NCT02038829|3916473|FG006|Washout Period 4|Adverse Event|1
2252026|NCT02038829|3916474|FG007|Washout Period 4|Adverse Event|0
2252027|NCT02038829|3916475|FG008|Washout Period 4|Adverse Event|0
2252028|NCT02038829|3916476|FG009|Washout Period 4|Adverse Event|0
2252029|NCT02038829|3916477|FG010|Washout Period 4|Adverse Event|0
2252030|NCT02038829|3916478|FG011|Washout Period 4|Adverse Event|0
2252031|NCT02038829|3916467|FG000|Treatment Period 6|Adverse Event|0
2252032|NCT02038829|3916468|FG001|Treatment Period 6|Adverse Event|0
2252033|NCT02038829|3916469|FG002|Treatment Period 6|Adverse Event|1
2252034|NCT02038829|3916470|FG003|Treatment Period 6|Adverse Event|0
2252035|NCT02038829|3916471|FG004|Treatment Period 6|Adverse Event|0
2252036|NCT02038829|3916472|FG005|Treatment Period 6|Adverse Event|0
2252037|NCT02038829|3916473|FG006|Treatment Period 6|Adverse Event|0
2252038|NCT02038829|3916474|FG007|Treatment Period 6|Adverse Event|0
2252039|NCT02038829|3916475|FG008|Treatment Period 6|Adverse Event|0
2252040|NCT02038829|3916476|FG009|Treatment Period 6|Adverse Event|0
2252041|NCT02038829|3916477|FG010|Treatment Period 6|Adverse Event|0
2252042|NCT02038829|3916478|FG011|Treatment Period 6|Adverse Event|0
2252043|NCT02038881|3916496|FG000|Overall Study|Withdrawal by Subject|0
2252044|NCT02038881|3916497|FG001|Overall Study|Withdrawal by Subject|0
2252045|NCT02038881|3916498|FG002|Overall Study|Withdrawal by Subject|1
2252046|NCT02038881|3916496|FG000|Overall Study|Lost to Follow-up|2
2252047|NCT02038881|3916497|FG001|Overall Study|Lost to Follow-up|0
2252048|NCT02038881|3916498|FG002|Overall Study|Lost to Follow-up|0
2252049|NCT02038881|3916496|FG000|Overall Study|incarcerated|1
2252050|NCT02038881|3916497|FG001|Overall Study|incarcerated|0
2252051|NCT02038881|3916498|FG002|Overall Study|incarcerated|0
2252052|NCT02038907|3916539|FG000|Overall Study|Protocol Violation|0
2252053|NCT02038907|3916540|FG001|Overall Study|Protocol Violation|0
2252054|NCT02038907|3916541|FG002|Overall Study|Protocol Violation|0
2252055|NCT02038907|3916542|FG003|Overall Study|Protocol Violation|0
2252056|NCT02038907|3916543|FG004|Overall Study|Protocol Violation|0
2252057|NCT02038907|3916544|FG005|Overall Study|Protocol Violation|0
2252058|NCT02038907|3916545|FG006|Overall Study|Protocol Violation|0
2252059|NCT02038907|3916546|FG007|Overall Study|Protocol Violation|0
2341735|NCT03462576|4074090|FG001|Overall Study|Protocol Violation|11
2341736|NCT03462576|4074091|FG002|Overall Study|Protocol Violation|7
2341737|NCT03462576|4074089|FG000|Overall Study|Device Malfunction|0
2341738|NCT03462576|4074090|FG001|Overall Study|Device Malfunction|0
2341739|NCT03462576|4074091|FG002|Overall Study|Device Malfunction|1
2341740|NCT03462680|4074101|FG000|Overall Study|Withdrawal by Subject|3
2341741|NCT03462680|4074102|FG001|Overall Study|Withdrawal by Subject|5
2341742|NCT03463031|4074130|FG000|Overall Study|Withdrawal by Subject|4
2341743|NCT03463031|4074131|FG001|Overall Study|Withdrawal by Subject|2
2341744|NCT03463031|4074130|FG000|Overall Study|Investigator/Sponsor Decision|0
2341745|NCT03463031|4074131|FG001|Overall Study|Investigator/Sponsor Decision|1
2341746|NCT03463031|4074130|FG000|Overall Study|Lost to Follow-up|1
2341747|NCT03463031|4074131|FG001|Overall Study|Lost to Follow-up|1
2341748|NCT03463031|4074130|FG000|Overall Study|Adverse Event|4
2341749|NCT03463031|4074131|FG001|Overall Study|Adverse Event|1
2341750|NCT03463031|4074130|FG000|Overall Study|Use of prohibited medication by subject|1
2341751|NCT03463031|4074131|FG001|Overall Study|Use of prohibited medication by subject|0
2038644|NCT00423670|3609023|FG004|Treatment Period|Lost to Follow-up|6
2038645|NCT00423670|3609024|FG005|Treatment Period|Lost to Follow-up|0
2038646|NCT00423670|3609025|FG006|Treatment Period|Lost to Follow-up|3
2252060|NCT02038907|3916547|FG008|Overall Study|Protocol Violation|0
2252061|NCT02038907|3916548|FG009|Overall Study|Protocol Violation|0
2252062|NCT02038907|3916549|FG010|Overall Study|Protocol Violation|1
2252063|NCT02038907|3916550|FG011|Overall Study|Protocol Violation|0
2252064|NCT02038907|3916551|FG012|Overall Study|Protocol Violation|0
2252065|NCT02038907|3916552|FG013|Overall Study|Protocol Violation|0
2252066|NCT02038907|3916539|FG000|Overall Study|Withdrawal by Subject|0
2252067|NCT02038907|3916540|FG001|Overall Study|Withdrawal by Subject|0
2252068|NCT02038907|3916541|FG002|Overall Study|Withdrawal by Subject|0
2252069|NCT02038907|3916542|FG003|Overall Study|Withdrawal by Subject|0
2252070|NCT02038907|3916543|FG004|Overall Study|Withdrawal by Subject|0
2252071|NCT02038907|3916544|FG005|Overall Study|Withdrawal by Subject|0
2252072|NCT02038907|3916545|FG006|Overall Study|Withdrawal by Subject|0
2252073|NCT02038907|3916546|FG007|Overall Study|Withdrawal by Subject|0
2252074|NCT02038907|3916547|FG008|Overall Study|Withdrawal by Subject|0
2252075|NCT02038907|3916548|FG009|Overall Study|Withdrawal by Subject|0
2252076|NCT02038907|3916549|FG010|Overall Study|Withdrawal by Subject|1
2252077|NCT02038907|3916550|FG011|Overall Study|Withdrawal by Subject|0
2252078|NCT02038907|3916551|FG012|Overall Study|Withdrawal by Subject|0
2252079|NCT02038907|3916552|FG013|Overall Study|Withdrawal by Subject|0
2252080|NCT02038920|3916586|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
2252081|NCT02038920|3916587|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
2252082|NCT02038920|3916588|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2252083|NCT02038920|3916589|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2252084|NCT02038920|3916590|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2252085|NCT02038920|3916591|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2252086|NCT02038920|3916586|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
2252087|NCT02038920|3916587|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2252088|NCT02038920|3916588|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2252089|NCT02038920|3916589|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2252090|NCT02038920|3916590|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2252091|NCT02038920|3916591|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2252092|NCT02038920|3916586|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
2252093|NCT02038920|3916587|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
2252094|NCT02038920|3916588|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2252095|NCT02038920|3916589|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2252096|NCT02038920|3916590|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2252097|NCT02038920|3916591|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2252098|NCT02038920|3916586|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
2353232|NCT02875067|4104708|FG000|Overall Study|Withdrawal by Termination of Study|5
2252099|NCT02038920|3916587|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
2252100|NCT02038920|3916588|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
2252101|NCT02038920|3916589|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
2252102|NCT02038920|3916590|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
2252103|NCT02038920|3916591|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
2252104|NCT02038920|3916586|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2252105|NCT02038920|3916587|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2252106|NCT02038920|3916588|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
2252107|NCT02038920|3916589|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2252108|NCT02038920|3916590|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2252109|NCT02038920|3916591|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2252110|NCT02038920|3916586|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
2252111|NCT02038920|3916587|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
2252112|NCT02038920|3916588|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
2252113|NCT02038920|3916589|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
2252114|NCT02038920|3916590|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
2252115|NCT02038920|3916591|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
2252116|NCT02038920|3916586|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2252117|NCT02038920|3916587|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2252118|NCT02038920|3916588|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2252119|NCT02038920|3916589|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2252120|NCT02038920|3916590|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2252121|NCT02038920|3916591|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
2252122|NCT02038920|3916586|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2252123|NCT02038920|3916587|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2252124|NCT02038920|3916588|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2252125|NCT02038920|3916589|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2252126|NCT02038920|3916590|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2252127|NCT02038920|3916591|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
2252128|NCT02038920|3916586|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2252129|NCT02038920|3916587|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2252130|NCT02038920|3916588|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2252131|NCT02038920|3916589|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2252132|NCT02038920|3916590|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2252133|NCT02038920|3916591|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
2252134|NCT02038920|3916586|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2252135|NCT02038920|3916587|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2252136|NCT02038920|3916588|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2252137|NCT02038920|3916589|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2252138|NCT02038920|3916590|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2252139|NCT02038920|3916591|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1
2252140|NCT02038920|3916586|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2341752|NCT03464383|4074173|FG000|Overall Study|Lost to Follow-up|1
2341753|NCT03464383|4074174|FG001|Overall Study|Lost to Follow-up|0
2341754|NCT03464383|4074175|FG002|Overall Study|Lost to Follow-up|0
2341755|NCT03464383|4074173|FG000|Overall Study|Withdrawal by Subject|0
2341756|NCT03464383|4074174|FG001|Overall Study|Withdrawal by Subject|1
2341757|NCT03464383|4074175|FG002|Overall Study|Withdrawal by Subject|0
2341758|NCT03464422|4074184|FG000|Overall Study|Lost to Follow-up|2
2341759|NCT03464422|4074184|FG000|Overall Study|Withdrawal by Subject|2
2341760|NCT03465436|4074194|FG000|Period 1|Protocol Violation|0
2341761|NCT03465436|4074195|FG001|Period 1|Protocol Violation|0
2341762|NCT03465436|4074196|FG002|Period 1|Protocol Violation|1
2341763|NCT03465436|4074197|FG003|Period 1|Protocol Violation|0
2341764|NCT03465436|4074194|FG000|Period 2|Protocol Violation|0
2341765|NCT03465436|4074195|FG001|Period 2|Protocol Violation|1
2341766|NCT03465436|4074196|FG002|Period 2|Protocol Violation|0
2341767|NCT03465436|4074197|FG003|Period 2|Protocol Violation|0
2341768|NCT03465436|4074194|FG000|Period 3|Protocol Violation|1
2341769|NCT03465436|4074195|FG001|Period 3|Protocol Violation|1
2341770|NCT03465436|4074196|FG002|Period 3|Protocol Violation|0
2341771|NCT03465436|4074197|FG003|Period 3|Protocol Violation|0
2341772|NCT03465436|4074194|FG000|Period 4|Protocol Violation|0
2341773|NCT03465436|4074195|FG001|Period 4|Protocol Violation|0
2341774|NCT03465436|4074196|FG002|Period 4|Protocol Violation|1
2341775|NCT03465436|4074197|FG003|Period 4|Protocol Violation|0
2341776|NCT03465709|4074209|FG000|Overall Study|Study/Site Terminated by Sponsor|14
2341777|NCT03465709|4074209|FG000|Overall Study|Withdrawal by Subject|3
2341778|NCT03465722|4074217|FG000|End of Treatment|Patient Refused Treatment|3
2341779|NCT03465722|4074218|FG001|End of Treatment|Patient Refused Treatment|1
2341780|NCT03465722|4074217|FG000|End of Treatment|Withdrawal by Subject|6
2341781|NCT03465722|4074218|FG001|End of Treatment|Withdrawal by Subject|1
2341782|NCT03465722|4074217|FG000|End of Treatment|Adverse Event|30
2341783|NCT03465722|4074218|FG001|End of Treatment|Adverse Event|23
2252141|NCT02038920|3916587|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2252142|NCT02038920|3916588|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2252143|NCT02038920|3916589|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2252144|NCT02038920|3916590|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2252145|NCT02038920|3916591|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
2252146|NCT02038920|3916586|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2252147|NCT02038920|3916587|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2252148|NCT02038920|3916588|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2252149|NCT02038920|3916589|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2252150|NCT02038920|3916590|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2252151|NCT02038920|3916591|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
2252152|NCT02038933|3916610|FG000|Overall Study|Disease progression|104
2252153|NCT02038933|3916610|FG000|Overall Study|Study drug toxicity|6
2252154|NCT02038933|3916610|FG000|Overall Study|Adverse event unrelated to study drug|6
2252155|NCT02038933|3916610|FG000|Overall Study|Participant request to discontinue treatment|2
2252156|NCT02038933|3916610|FG000|Overall Study|Lost to Follow-up|1
2252157|NCT02038933|3916610|FG000|Overall Study|Other reasons|2
2252158|NCT02038959|3916617|FG000|Overall Study|Withdrawal by Subject|6
2252159|NCT02038959|3916618|FG001|Overall Study|Withdrawal by Subject|8
2252160|NCT02039219|3916635|FG000|Treatment|Withdrawal by Subject|1
2252161|NCT02039219|3916636|FG001|Treatment|Withdrawal by Subject|0
2252162|NCT02039219|3916635|FG000|Treatment|Adverse Event|0
2252163|NCT02039219|3916636|FG001|Treatment|Adverse Event|1
2252164|NCT02039219|3916635|FG000|Treatment|Physician Decision|1
2252165|NCT02039219|3916636|FG001|Treatment|Physician Decision|0
2252166|NCT02039219|3916635|FG000|Treatment|Lost to Follow-up|0
2252167|NCT02039219|3916636|FG001|Treatment|Lost to Follow-up|1
2252168|NCT02039219|3916635|FG000|Treatment|Protocol Violation|1
2252169|NCT02039219|3916636|FG001|Treatment|Protocol Violation|0
2252170|NCT02039219|3916635|FG000|Treatment|Death|1
2252171|NCT02039219|3916636|FG001|Treatment|Death|0
2252172|NCT02039219|3916635|FG000|Follow up|Adverse Event|0
2252173|NCT02039219|3916636|FG001|Follow up|Adverse Event|1
2252174|NCT02039375|3916642|FG000|Overall Study|Lost to Follow-up|2
2252175|NCT02039414|3916648|FG000|Overall Study|Delivered|1
2252176|NCT02039414|3916649|FG001|Overall Study|Delivered|1
2252177|NCT02039414|3916648|FG000|Overall Study|Lost to Follow-up|2
2252178|NCT02039414|3916649|FG001|Overall Study|Lost to Follow-up|0
2252179|NCT02039414|3916648|FG000|Overall Study|Protocol Violation|3
2252180|NCT02039414|3916649|FG001|Overall Study|Protocol Violation|1
2252181|NCT02039427|3916659|FG000|Overall Study|Duration of surgery > 3h|1
2252182|NCT02039427|3916660|FG001|Overall Study|Duration of surgery > 3h|1
2252183|NCT02039427|3916661|FG002|Overall Study|Duration of surgery > 3h|0
2252184|NCT02039427|3916662|FG003|Overall Study|Duration of surgery > 3h|0
2252185|NCT02039427|3916659|FG000|Overall Study|Withdrawal on concent|0
2252186|NCT02039427|3916660|FG001|Overall Study|Withdrawal on concent|0
2252187|NCT02039427|3916661|FG002|Overall Study|Withdrawal on concent|0
2252188|NCT02039427|3916662|FG003|Overall Study|Withdrawal on concent|1
2252189|NCT02039427|3916659|FG000|Overall Study|Cancellation of surgery|0
2252190|NCT02039427|3916660|FG001|Overall Study|Cancellation of surgery|0
2252191|NCT02039427|3916661|FG002|Overall Study|Cancellation of surgery|1
2252192|NCT02039427|3916662|FG003|Overall Study|Cancellation of surgery|0
2252193|NCT02039427|3916659|FG000|Overall Study|Loss of follow - up|1
2252194|NCT02039427|3916660|FG001|Overall Study|Loss of follow - up|0
2252195|NCT02039427|3916661|FG002|Overall Study|Loss of follow - up|2
2252196|NCT02039427|3916662|FG003|Overall Study|Loss of follow - up|4
2252197|NCT02039427|3916659|FG000|Overall Study|Steroid Use|1
2252198|NCT02039427|3916660|FG001|Overall Study|Steroid Use|0
2252199|NCT02039427|3916661|FG002|Overall Study|Steroid Use|0
2252200|NCT02039427|3916662|FG003|Overall Study|Steroid Use|0
2252201|NCT02039505|3916679|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
2252202|NCT02039505|3916680|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
2252203|NCT02039505|3916681|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
2252204|NCT02039505|3916682|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2252205|NCT02039505|3916683|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2252206|NCT02039505|3916684|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2252207|NCT02039505|3916685|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2252208|NCT02039505|3916679|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
2341784|NCT03465722|4074217|FG000|End of Treatment|Disease Progression (Confirmed by Central Review)|102
2341785|NCT03465722|4074218|FG001|End of Treatment|Disease Progression (Confirmed by Central Review)|101
2341786|NCT03465722|4074217|FG000|End of Treatment|Clinical Progression|17
2341787|NCT03465722|4074218|FG001|End of Treatment|Clinical Progression|5
2341788|NCT03465722|4074217|FG000|End of Treatment|Physician Decision|4
2341789|NCT03465722|4074218|FG001|End of Treatment|Physician Decision|5
2341790|NCT03465722|4074217|FG000|End of Treatment|Lost to Follow-up|3
2341791|NCT03465722|4074218|FG001|End of Treatment|Lost to Follow-up|1
2341792|NCT03465722|4074217|FG000|End of Treatment|Administrative/Other|6
2341793|NCT03465722|4074218|FG001|End of Treatment|Administrative/Other|3
2341794|NCT03465722|4074217|FG000|End of Treatment|Treatment Ongoing|68
2341795|NCT03465722|4074218|FG001|End of Treatment|Treatment Ongoing|94
2252209|NCT02039505|3916680|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
2252210|NCT02039505|3916681|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
2252211|NCT02039505|3916682|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2252212|NCT02039505|3916683|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2252213|NCT02039505|3916684|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2252214|NCT02039505|3916685|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2252215|NCT02039505|3916679|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
2252216|NCT02039505|3916680|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2252217|NCT02039505|3916681|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2252218|NCT02039505|3916682|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2252219|NCT02039505|3916683|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2252220|NCT02039505|3916684|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2252221|NCT02039505|3916685|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2252222|NCT02039505|3916679|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2252223|NCT02039505|3916680|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2252224|NCT02039505|3916681|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2252225|NCT02039505|3916682|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
2252226|NCT02039505|3916683|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
2252227|NCT02039505|3916684|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
2252228|NCT02039505|3916685|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2252229|NCT02039505|3916679|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2252230|NCT02039505|3916680|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2252231|NCT02039505|3916681|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2252232|NCT02039505|3916682|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
2252233|NCT02039505|3916683|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
2252234|NCT02039505|3916684|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
2252235|NCT02039505|3916685|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2252236|NCT02039505|3916679|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2252237|NCT02039505|3916680|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2252238|NCT02039505|3916681|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2252239|NCT02039505|3916682|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
2252240|NCT02039505|3916683|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
2252241|NCT02039505|3916684|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
2252242|NCT02039505|3916685|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2252243|NCT02039505|3916679|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2252244|NCT02039505|3916680|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2252245|NCT02039505|3916681|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2252246|NCT02039505|3916682|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
2252247|NCT02039505|3916683|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2252248|NCT02039505|3916684|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2252249|NCT02039505|3916685|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2252250|NCT02039505|3916679|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2252251|NCT02039505|3916680|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2252252|NCT02039505|3916681|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2252253|NCT02039505|3916682|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2252254|NCT02039505|3916683|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2252255|NCT02039505|3916684|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2252256|NCT02039505|3916685|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
2252257|NCT02039505|3916679|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2252258|NCT02039505|3916680|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2252259|NCT02039505|3916681|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2252260|NCT02039505|3916682|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2252261|NCT02039505|3916683|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2252262|NCT02039505|3916684|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2252263|NCT02039505|3916685|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
2252264|NCT02039505|3916679|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2252265|NCT02039505|3916680|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2252266|NCT02039505|3916681|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2252267|NCT02039505|3916682|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2252268|NCT02039505|3916683|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2252269|NCT02039505|3916684|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2252270|NCT02039505|3916685|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
2252271|NCT02039505|3916679|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2252272|NCT02039505|3916680|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2252273|NCT02039505|3916681|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2252274|NCT02039505|3916682|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2353233|NCT02860169|4104723|FG000|Part A|Withdrawal by Subject|1
2252275|NCT02039505|3916683|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2252276|NCT02039505|3916684|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2252277|NCT02039505|3916685|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
2252278|NCT02039674|3916719|FG000|Overall Study|Adverse Event|0
2252279|NCT02039674|3916720|FG001|Overall Study|Adverse Event|0
2252280|NCT02039674|3916721|FG002|Overall Study|Adverse Event|1
2252281|NCT02039674|3916722|FG003|Overall Study|Adverse Event|1
2252282|NCT02039674|3916723|FG004|Overall Study|Adverse Event|0
2252283|NCT02039674|3916724|FG005|Overall Study|Adverse Event|0
2252284|NCT02039674|3916725|FG006|Overall Study|Adverse Event|0
2252285|NCT02039674|3916726|FG007|Overall Study|Adverse Event|0
2252286|NCT02039674|3916727|FG008|Overall Study|Adverse Event|2
2252287|NCT02039674|3916728|FG009|Overall Study|Adverse Event|0
2252288|NCT02039674|3916729|FG010|Overall Study|Adverse Event|0
2252289|NCT02039674|3916730|FG011|Overall Study|Adverse Event|2
2252290|NCT02039674|3916731|FG012|Overall Study|Adverse Event|2
2252291|NCT02039674|3916732|FG013|Overall Study|Adverse Event|1
2252292|NCT02039674|3916719|FG000|Overall Study|Death|0
2252293|NCT02039674|3916720|FG001|Overall Study|Death|0
2252294|NCT02039674|3916721|FG002|Overall Study|Death|1
2252295|NCT02039674|3916722|FG003|Overall Study|Death|2
2252296|NCT02039674|3916723|FG004|Overall Study|Death|0
2252297|NCT02039674|3916724|FG005|Overall Study|Death|0
2252298|NCT02039674|3916725|FG006|Overall Study|Death|0
2252299|NCT02039674|3916726|FG007|Overall Study|Death|0
2252300|NCT02039674|3916727|FG008|Overall Study|Death|0
2252301|NCT02039674|3916728|FG009|Overall Study|Death|0
2252302|NCT02039674|3916729|FG010|Overall Study|Death|1
2252303|NCT02039674|3916730|FG011|Overall Study|Death|1
2252304|NCT02039674|3916731|FG012|Overall Study|Death|0
2252305|NCT02039674|3916732|FG013|Overall Study|Death|8
2252306|NCT02039674|3916719|FG000|Overall Study|Excluded Medication|1
2252307|NCT02039674|3916720|FG001|Overall Study|Excluded Medication|1
2252308|NCT02039674|3916721|FG002|Overall Study|Excluded Medication|0
2252309|NCT02039674|3916722|FG003|Overall Study|Excluded Medication|1
2252310|NCT02039674|3916723|FG004|Overall Study|Excluded Medication|0
2252311|NCT02039674|3916724|FG005|Overall Study|Excluded Medication|1
2252312|NCT02039674|3916725|FG006|Overall Study|Excluded Medication|0
2252313|NCT02039674|3916726|FG007|Overall Study|Excluded Medication|0
2252314|NCT02039674|3916727|FG008|Overall Study|Excluded Medication|2
2252315|NCT02039674|3916728|FG009|Overall Study|Excluded Medication|2
2252316|NCT02039674|3916729|FG010|Overall Study|Excluded Medication|4
2252317|NCT02039674|3916730|FG011|Overall Study|Excluded Medication|2
2252318|NCT02039674|3916731|FG012|Overall Study|Excluded Medication|4
2252319|NCT02039674|3916732|FG013|Overall Study|Excluded Medication|3
2252320|NCT02039674|3916719|FG000|Overall Study|Lost to Follow-up|0
2252321|NCT02039674|3916720|FG001|Overall Study|Lost to Follow-up|0
2252322|NCT02039674|3916721|FG002|Overall Study|Lost to Follow-up|0
2252323|NCT02039674|3916722|FG003|Overall Study|Lost to Follow-up|0
2252324|NCT02039674|3916723|FG004|Overall Study|Lost to Follow-up|0
2252325|NCT02039674|3916724|FG005|Overall Study|Lost to Follow-up|0
2252326|NCT02039674|3916725|FG006|Overall Study|Lost to Follow-up|0
2252327|NCT02039674|3916726|FG007|Overall Study|Lost to Follow-up|0
2252328|NCT02039674|3916727|FG008|Overall Study|Lost to Follow-up|0
2252329|NCT02039674|3916728|FG009|Overall Study|Lost to Follow-up|0
2252330|NCT02039674|3916729|FG010|Overall Study|Lost to Follow-up|0
2252331|NCT02039674|3916730|FG011|Overall Study|Lost to Follow-up|0
2252332|NCT02039674|3916731|FG012|Overall Study|Lost to Follow-up|1
2252333|NCT02039674|3916732|FG013|Overall Study|Lost to Follow-up|0
2252334|NCT02039674|3916719|FG000|Overall Study|Physician Decision|0
2252335|NCT02039674|3916720|FG001|Overall Study|Physician Decision|0
2252336|NCT02039674|3916721|FG002|Overall Study|Physician Decision|0
2252337|NCT02039674|3916722|FG003|Overall Study|Physician Decision|0
2252338|NCT02039674|3916723|FG004|Overall Study|Physician Decision|0
2252339|NCT02039674|3916724|FG005|Overall Study|Physician Decision|0
2252340|NCT02039674|3916725|FG006|Overall Study|Physician Decision|0
2252341|NCT02039674|3916726|FG007|Overall Study|Physician Decision|0
2252342|NCT02039674|3916727|FG008|Overall Study|Physician Decision|0
2252343|NCT02039674|3916728|FG009|Overall Study|Physician Decision|0
2252344|NCT02039674|3916729|FG010|Overall Study|Physician Decision|0
2252345|NCT02039674|3916730|FG011|Overall Study|Physician Decision|1
2252346|NCT02039674|3916731|FG012|Overall Study|Physician Decision|0
2252347|NCT02039674|3916732|FG013|Overall Study|Physician Decision|0
2252348|NCT02039674|3916719|FG000|Overall Study|Progressive Disease|6
2252349|NCT02039674|3916720|FG001|Overall Study|Progressive Disease|7
2252350|NCT02039674|3916721|FG002|Overall Study|Progressive Disease|6
2252351|NCT02039674|3916722|FG003|Overall Study|Progressive Disease|7
2252352|NCT02039674|3916723|FG004|Overall Study|Progressive Disease|8
2252353|NCT02039674|3916724|FG005|Overall Study|Progressive Disease|10
2252354|NCT02039674|3916725|FG006|Overall Study|Progressive Disease|1
2252355|NCT02039674|3916726|FG007|Overall Study|Progressive Disease|3
2252356|NCT02039674|3916727|FG008|Overall Study|Progressive Disease|7
2252357|NCT02039674|3916728|FG009|Overall Study|Progressive Disease|2
2252358|NCT02039674|3916729|FG010|Overall Study|Progressive Disease|0
2252359|NCT02039674|3916730|FG011|Overall Study|Progressive Disease|17
2252360|NCT02039674|3916731|FG012|Overall Study|Progressive Disease|18
2252361|NCT02039674|3916732|FG013|Overall Study|Progressive Disease|16
2252362|NCT02039674|3916719|FG000|Overall Study|Withdrawal by Subject|0
2252363|NCT02039674|3916720|FG001|Overall Study|Withdrawal by Subject|2
2252364|NCT02039674|3916721|FG002|Overall Study|Withdrawal by Subject|1
2252365|NCT02039674|3916722|FG003|Overall Study|Withdrawal by Subject|0
2252366|NCT02039674|3916723|FG004|Overall Study|Withdrawal by Subject|1
2252367|NCT02039674|3916724|FG005|Overall Study|Withdrawal by Subject|0
2252368|NCT02039674|3916725|FG006|Overall Study|Withdrawal by Subject|0
2252369|NCT02039674|3916726|FG007|Overall Study|Withdrawal by Subject|0
2252370|NCT02039674|3916727|FG008|Overall Study|Withdrawal by Subject|0
2341796|NCT03465722|4074217|FG000|End of Treatment|Randomized But Not Treated|1
2341797|NCT03465722|4074218|FG001|End of Treatment|Randomized But Not Treated|2
2341798|NCT03465722|4074217|FG000|End of Study|Withdrawal by Subject|17
2341799|NCT03465722|4074218|FG001|End of Study|Withdrawal by Subject|7
2341800|NCT03465722|4074217|FG000|End of Study|Death|57
2341801|NCT03465722|4074218|FG001|End of Study|Death|57
2341802|NCT03465722|4074217|FG000|End of Study|Lost to Follow-up|5
2341803|NCT03465722|4074218|FG001|End of Study|Lost to Follow-up|2
2341804|NCT03465722|4074217|FG000|End of Study|Administrative/Other|4
2341805|NCT03465722|4074218|FG001|End of Study|Administrative/Other|2
2341806|NCT03465722|4074217|FG000|End of Study|On Treatment or in Follow Up|157
2341807|NCT03465722|4074218|FG001|End of Study|On Treatment or in Follow Up|168
2341808|NCT03465878|4074226|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
2341809|NCT03465878|4074227|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1
2341810|NCT03465878|4074228|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
2341811|NCT03465878|4074229|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
2341812|NCT03465878|4074226|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
2341813|NCT03465878|4074227|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
2341814|NCT03465878|4074228|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
2341815|NCT03465878|4074229|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1
2341816|NCT03465878|4074226|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0
2341817|NCT03465878|4074227|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0
2341818|NCT03465878|4074228|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0
2341819|NCT03465878|4074229|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1
2341820|NCT03465904|4074257|FG000|Overall Study|Withdrawal by Subject|9
2341821|NCT03465904|4074258|FG001|Overall Study|Withdrawal by Subject|5
2341822|NCT03465904|4074257|FG000|Overall Study|Lost to Follow-up|10
2341823|NCT03465904|4074258|FG001|Overall Study|Lost to Follow-up|9
2341824|NCT03465904|4074257|FG000|Overall Study|Protocol Violation|8
2341825|NCT03465904|4074258|FG001|Overall Study|Protocol Violation|5
2341826|NCT03465904|4074257|FG000|Overall Study|Ineligible for mITT analysis|62
2341827|NCT03465904|4074258|FG001|Overall Study|Ineligible for mITT analysis|47
2341828|NCT03466060|4074293|FG000|Period 1|Test Lens Damage|0
2341829|NCT03466060|4074294|FG001|Period 1|Test Lens Damage|2
2341830|NCT03466060|4074295|FG002|Period 1|Test Lens Damage|0
2341831|NCT03466060|4074296|FG003|Period 1|Test Lens Damage|0
2341832|NCT03466060|4074297|FG004|Period 1|Test Lens Damage|0
2341833|NCT03466060|4074298|FG005|Period 1|Test Lens Damage|0
2341834|NCT03466060|4074293|FG000|Period 1|Withdrawal by Subject|0
2341835|NCT03466060|4074294|FG001|Period 1|Withdrawal by Subject|0
2341836|NCT03466060|4074295|FG002|Period 1|Withdrawal by Subject|2
2341837|NCT03466060|4074296|FG003|Period 1|Withdrawal by Subject|0
2341838|NCT03466060|4074297|FG004|Period 1|Withdrawal by Subject|0
2341839|NCT03466060|4074298|FG005|Period 1|Withdrawal by Subject|0
2341840|NCT03466060|4074293|FG000|Period 1|Lost to Follow-up|0
2341841|NCT03466060|4074294|FG001|Period 1|Lost to Follow-up|0
2341842|NCT03466060|4074295|FG002|Period 1|Lost to Follow-up|0
2341843|NCT03466060|4074296|FG003|Period 1|Lost to Follow-up|1
2341844|NCT03466060|4074297|FG004|Period 1|Lost to Follow-up|0
2341845|NCT03466060|4074298|FG005|Period 1|Lost to Follow-up|0
2341846|NCT03466060|4074293|FG000|Period 1|Grade 2 Conjunctivitis|0
2341847|NCT03466060|4074294|FG001|Period 1|Grade 2 Conjunctivitis|0
2341848|NCT03466060|4074295|FG002|Period 1|Grade 2 Conjunctivitis|1
2341849|NCT03466060|4074296|FG003|Period 1|Grade 2 Conjunctivitis|0
2341850|NCT03466060|4074297|FG004|Period 1|Grade 2 Conjunctivitis|0
2341851|NCT03466060|4074298|FG005|Period 1|Grade 2 Conjunctivitis|0
2341852|NCT03466060|4074293|FG000|Period 2|Lens Handling Difficulties|0
2341853|NCT03466060|4074294|FG001|Period 2|Lens Handling Difficulties|0
2341854|NCT03466060|4074295|FG002|Period 2|Lens Handling Difficulties|1
2341855|NCT03466060|4074296|FG003|Period 2|Lens Handling Difficulties|0
2341856|NCT03466060|4074297|FG004|Period 2|Lens Handling Difficulties|0
2341857|NCT03466060|4074298|FG005|Period 2|Lens Handling Difficulties|0
2341858|NCT03466073|4074318|FG000|Overall Study|Death|1
2341859|NCT03466073|4074319|FG001|Overall Study|Death|0
2341860|NCT03466073|4074320|FG002|Overall Study|Death|0
2341861|NCT03466073|4074321|FG003|Overall Study|Death|0
2341862|NCT03466073|4074322|FG004|Overall Study|Death|0
2341863|NCT03466073|4074323|FG005|Overall Study|Death|1
2341864|NCT03466086|4074344|FG000|Period 1|Sponsor decision due to study timeline|1
2341865|NCT03466086|4074345|FG001|Period 1|Sponsor decision due to study timeline|0
2341866|NCT03466086|4074344|FG000|Period 1|Withdrawal by Subject|1
2341867|NCT03466086|4074345|FG001|Period 1|Withdrawal by Subject|0
2341868|NCT03466099|4074354|FG000|Overall Study|Adverse Event|1
2341869|NCT03466099|4074355|FG001|Overall Study|Adverse Event|1
2252371|NCT02039674|3916728|FG009|Overall Study|Withdrawal by Subject|2
2252372|NCT02039674|3916729|FG010|Overall Study|Withdrawal by Subject|1
2252373|NCT02039674|3916730|FG011|Overall Study|Withdrawal by Subject|3
2252374|NCT02039674|3916731|FG012|Overall Study|Withdrawal by Subject|5
2252375|NCT02039674|3916732|FG013|Overall Study|Withdrawal by Subject|2
2252376|NCT02039674|3916719|FG000|Overall Study|Ongoing in Study|5
2252377|NCT02039674|3916720|FG001|Overall Study|Ongoing in Study|2
2252378|NCT02039674|3916721|FG002|Overall Study|Ongoing in Study|3
2252379|NCT02039674|3916722|FG003|Overall Study|Ongoing in Study|2
2252380|NCT02039674|3916723|FG004|Overall Study|Ongoing in Study|3
2252381|NCT02039674|3916724|FG005|Overall Study|Ongoing in Study|1
2252382|NCT02039674|3916725|FG006|Overall Study|Ongoing in Study|2
2252383|NCT02039674|3916726|FG007|Overall Study|Ongoing in Study|0
2252384|NCT02039674|3916727|FG008|Overall Study|Ongoing in Study|1
2252385|NCT02039674|3916728|FG009|Overall Study|Ongoing in Study|6
2252386|NCT02039674|3916729|FG010|Overall Study|Ongoing in Study|1
2252387|NCT02039674|3916730|FG011|Overall Study|Ongoing in Study|34
2252388|NCT02039674|3916731|FG012|Overall Study|Ongoing in Study|33
2252389|NCT02039674|3916732|FG013|Overall Study|Ongoing in Study|3
2252390|NCT02039687|3916769|FG000|Overall Study|Adverse Event|0
2252391|NCT02039687|3916770|FG001|Overall Study|Adverse Event|0
2252392|NCT02039687|3916771|FG002|Overall Study|Adverse Event|1
2252393|NCT02039687|3916772|FG003|Overall Study|Adverse Event|0
2252394|NCT02039687|3916769|FG000|Overall Study|Withdrawal by Subject|0
2252395|NCT02039687|3916770|FG001|Overall Study|Withdrawal by Subject|1
2252396|NCT02039687|3916771|FG002|Overall Study|Withdrawal by Subject|0
2252397|NCT02039687|3916772|FG003|Overall Study|Withdrawal by Subject|0
2252398|NCT02039687|3916769|FG000|Overall Study|treatment assignment could not be confir|0
2252399|NCT02039687|3916770|FG001|Overall Study|treatment assignment could not be confir|0
2252400|NCT02039687|3916771|FG002|Overall Study|treatment assignment could not be confir|2
2252401|NCT02039687|3916772|FG003|Overall Study|treatment assignment could not be confir|0
2252402|NCT02039778|3916791|FG000|Overall Study|Death|2
2252403|NCT02039778|3916791|FG000|Overall Study|Withdrawal by Subject|1
2252404|NCT02039778|3916791|FG000|Overall Study|Never started the protocol treatment|1
2252405|NCT02039856|3916805|FG000|Overall Study|Death|5
2252406|NCT02039856|3916806|FG001|Overall Study|Death|3
2252407|NCT02039856|3916805|FG000|Overall Study|Partial survey completion|61
2252408|NCT02039856|3916806|FG001|Overall Study|Partial survey completion|26
2252409|NCT02039856|3916805|FG000|Overall Study|Lost to Follow-up|388
2252410|NCT02039856|3916806|FG001|Overall Study|Lost to Follow-up|206
2341870|NCT03466099|4074356|FG002|Overall Study|Adverse Event|1
2341871|NCT03466099|4074354|FG000|Overall Study|Withdrawal by Subject|2
2341872|NCT03466099|4074355|FG001|Overall Study|Withdrawal by Subject|3
2341873|NCT03466099|4074356|FG002|Overall Study|Withdrawal by Subject|1
2341874|NCT03466099|4074354|FG000|Overall Study|Use of rescue medication|8
2341875|NCT03466099|4074355|FG001|Overall Study|Use of rescue medication|9
2341876|NCT03466099|4074356|FG002|Overall Study|Use of rescue medication|13
2341877|NCT03466099|4074354|FG000|Overall Study|Rescued without meeting criteria|4
2341878|NCT03466099|4074355|FG001|Overall Study|Rescued without meeting criteria|1
2341879|NCT03466099|4074356|FG002|Overall Study|Rescued without meeting criteria|1
2341880|NCT03466099|4074354|FG000|Overall Study|Subject compliance|2
2341881|NCT03466099|4074355|FG001|Overall Study|Subject compliance|0
2341882|NCT03466099|4074356|FG002|Overall Study|Subject compliance|0
2341883|NCT03466099|4074354|FG000|Overall Study|Worsening disease|0
2341884|NCT03466099|4074355|FG001|Overall Study|Worsening disease|0
2038647|NCT00423670|3609026|FG007|Treatment Period|Lost to Follow-up|1
2038648|NCT00423670|3609019|FG000|Treatment Period|Subject withdrew (not treatment related)|3
2038649|NCT00423670|3609020|FG001|Treatment Period|Subject withdrew (not treatment related)|9
2038650|NCT00423670|3609021|FG002|Treatment Period|Subject withdrew (not treatment related)|4
2038651|NCT00423670|3609022|FG003|Treatment Period|Subject withdrew (not treatment related)|4
2038652|NCT00423670|3609023|FG004|Treatment Period|Subject withdrew (not treatment related)|5
2038653|NCT00423670|3609024|FG005|Treatment Period|Subject withdrew (not treatment related)|0
2038654|NCT00423670|3609025|FG006|Treatment Period|Subject withdrew (not treatment related)|3
2038655|NCT00423670|3609026|FG007|Treatment Period|Subject withdrew (not treatment related)|0
2038656|NCT00423670|3609019|FG000|Treatment Period|Investigator decision|0
2252411|NCT02039856|3916805|FG000|Overall Study|Withdrawal by Subject|1573
2252412|NCT02039856|3916806|FG001|Overall Study|Withdrawal by Subject|618
2252413|NCT02039908|3916814|FG000|Phase 1-Summer|Withdrawal by Subject|7
2252414|NCT02039908|3916815|FG001|Phase 1-Summer|Withdrawal by Subject|6
2252415|NCT02039908|3916816|FG002|Phase 1-Summer|Withdrawal by Subject|0
2252416|NCT02039908|3916817|FG003|Phase 1-Summer|Withdrawal by Subject|0
2252417|NCT02039908|3916814|FG000|Phase 1-Summer|Protocol Violation|6
2252418|NCT02039908|3916815|FG001|Phase 1-Summer|Protocol Violation|0
2252419|NCT02039908|3916816|FG002|Phase 1-Summer|Protocol Violation|0
2252420|NCT02039908|3916817|FG003|Phase 1-Summer|Protocol Violation|0
2252421|NCT02039908|3916814|FG000|Phase 2-School Year|Lost to Follow-up|0
2252422|NCT02039908|3916815|FG001|Phase 2-School Year|Lost to Follow-up|0
2252423|NCT02039908|3916816|FG002|Phase 2-School Year|Lost to Follow-up|1
2252424|NCT02039908|3916817|FG003|Phase 2-School Year|Lost to Follow-up|3
2252425|NCT02039908|3916814|FG000|Phase 2-School Year|Protocol Violation|0
2252426|NCT02039908|3916815|FG001|Phase 2-School Year|Protocol Violation|0
2252427|NCT02039908|3916816|FG002|Phase 2-School Year|Protocol Violation|3
2252428|NCT02039908|3916817|FG003|Phase 2-School Year|Protocol Violation|0
2252429|NCT02039908|3916814|FG000|Phase 2-School Year|Withdrawal by Subject|0
2252430|NCT02039908|3916815|FG001|Phase 2-School Year|Withdrawal by Subject|0
2252431|NCT02039908|3916816|FG002|Phase 2-School Year|Withdrawal by Subject|8
2252432|NCT02039908|3916817|FG003|Phase 2-School Year|Withdrawal by Subject|5
2252433|NCT02040090|3916862|FG000|Overall Study|Adverse Event|2
2252434|NCT02040090|3916863|FG001|Overall Study|Adverse Event|0
2252435|NCT02040090|3916862|FG000|Overall Study|Physician Decision|1
2252436|NCT02040090|3916863|FG001|Overall Study|Physician Decision|0
2252437|NCT02040090|3916862|FG000|Overall Study|Withdrawal by Subject|0
2252438|NCT02040090|3916863|FG001|Overall Study|Withdrawal by Subject|1
2252439|NCT02040090|3916862|FG000|Overall Study|Lost to Follow-up|0
2252440|NCT02040090|3916863|FG001|Overall Study|Lost to Follow-up|1
2252441|NCT02040259|3916877|FG000|Overall Study|Death|280
2252442|NCT02040259|3916877|FG000|Overall Study|Lost to Follow-up|76
2252443|NCT02040259|3916877|FG000|Overall Study|Assessment not completed|3
2252444|NCT02040259|3916877|FG000|Overall Study|Withdrawal by Subject|4
2252445|NCT02040428|3916900|FG000|Overall Study|Death|4
2252446|NCT02040428|3916901|FG001|Overall Study|Death|3
2341885|NCT03466099|4074356|FG002|Overall Study|Worsening disease|1
2341886|NCT03467217|4074380|FG000|Overall Study|Trial stopped early|5
2341887|NCT03467217|4074381|FG001|Overall Study|Trial stopped early|2
2341888|NCT03467217|4074380|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5
2341889|NCT03467217|4074381|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2
2341890|NCT03467217|4074380|FG000|Overall Study|Lost to Follow-up|0
2341891|NCT03467217|4074381|FG001|Overall Study|Lost to Follow-up|2
2341892|NCT03467425|4074412|FG000|Overall Study|Adverse Event|9
2341893|NCT03467425|4074413|FG001|Overall Study|Adverse Event|9
2341894|NCT03467425|4074412|FG000|Overall Study|Lack of Efficacy|3
2341895|NCT03467425|4074413|FG001|Overall Study|Lack of Efficacy|1
2341896|NCT03467425|4074412|FG000|Overall Study|Protocol Violation|0
2341897|NCT03467425|4074413|FG001|Overall Study|Protocol Violation|1
2341898|NCT03467425|4074412|FG000|Overall Study|Lost to Follow-up|18
2341899|NCT03467425|4074413|FG001|Overall Study|Lost to Follow-up|25
2341900|NCT03467425|4074412|FG000|Overall Study|Physician Decision|2
2341901|NCT03467425|4074413|FG001|Overall Study|Physician Decision|1
2341902|NCT03467425|4074412|FG000|Overall Study|Withdrawal by Subject|15
2341903|NCT03467425|4074413|FG001|Overall Study|Withdrawal by Subject|17
2341904|NCT03467763|4074435|FG000|Overall Study|Lost to Follow-up|1
2341905|NCT03467763|4074435|FG000|Overall Study|Protocol Violation|2
2341906|NCT03467945|4074445|FG000|Treatment Period 2|Withdrawal by Subject|0
2341907|NCT03467945|4074446|FG001|Treatment Period 2|Withdrawal by Subject|1
2341908|NCT03467945|4074447|FG002|Treatment Period 2|Withdrawal by Subject|0
2341909|NCT03467945|4074448|FG003|Treatment Period 2|Withdrawal by Subject|0
2341910|NCT03467945|4074445|FG000|Treatment Period 3|Withdrawal by Subject|1
2341911|NCT03467945|4074446|FG001|Treatment Period 3|Withdrawal by Subject|0
2341912|NCT03467945|4074447|FG002|Treatment Period 3|Withdrawal by Subject|2
2341913|NCT03467945|4074448|FG003|Treatment Period 3|Withdrawal by Subject|1
2341914|NCT03467971|4074461|FG000|Treatment Period 2|Withdrawal by Subject|0
2341915|NCT03467971|4074462|FG001|Treatment Period 2|Withdrawal by Subject|1
2341916|NCT03468543|4074480|FG000|Overall Study|Protocol stopping rules met|3
2341917|NCT03468855|4074495|FG000|Overall Study|Adverse Event|2
2341918|NCT03468855|4074495|FG000|Overall Study|Lost to Follow-up|5
2341919|NCT03468855|4074495|FG000|Overall Study|Withdrawal by Subject|3
2341920|NCT03468855|4074495|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1
2341921|NCT03469336|4074517|FG000|Overall Study|Adverse Event|1
2341922|NCT03469349|4074529|FG000|Overall Study|Withdrawal by Subject|1
2341923|NCT03469349|4074530|FG001|Overall Study|Withdrawal by Subject|3
2341924|NCT03469349|4074529|FG000|Overall Study|Progressive Disease|0
2341925|NCT03469349|4074530|FG001|Overall Study|Progressive Disease|1
2341926|NCT03469349|4074529|FG000|Overall Study|Lost to Follow-up|2
2341927|NCT03469349|4074530|FG001|Overall Study|Lost to Follow-up|2
2341928|NCT03469349|4074529|FG000|Overall Study|Adverse Event|2
2341929|NCT03469349|4074530|FG001|Overall Study|Adverse Event|4
2341930|NCT03470194|4074542|FG000|Overall Study|Lost to Follow-up|11
2252447|NCT02040428|3916900|FG000|Overall Study|Withdrawal by Subject|1
2341931|NCT03470194|4074543|FG001|Overall Study|Lost to Follow-up|17
2341932|NCT03470545|4074555|FG000|Overall Study|Death|0
2252448|NCT02040428|3916901|FG001|Overall Study|Withdrawal by Subject|1
2252449|NCT02040532|3916907|FG000|Overall Study|Lost to Follow-up|1
2252450|NCT02040532|3916907|FG000|Overall Study|Physician Decision|4
2252451|NCT02040532|3916907|FG000|Overall Study|Adverse Event|4
2252452|NCT02040532|3916907|FG000|Overall Study|Withdrawal by Subject|3
2341933|NCT03470545|4074556|FG001|Overall Study|Death|1
2341934|NCT03470545|4074555|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1
2341935|NCT03470545|4074556|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0
2341936|NCT03470545|4074555|FG000|Overall Study|Adverse Event|2
2341937|NCT03470545|4074556|FG001|Overall Study|Adverse Event|0
2341938|NCT03470545|4074555|FG000|Overall Study|Withdrawal by Subject|1
2341939|NCT03470545|4074556|FG001|Overall Study|Withdrawal by Subject|1
2341940|NCT03470545|4074555|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0
2341941|NCT03470545|4074556|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1
2341942|NCT03471078|4074579|FG000|Overall Study|Withdrawal by Subject|9
2341943|NCT03471078|4074580|FG001|Overall Study|Withdrawal by Subject|1
2038657|NCT00423670|3609020|FG001|Treatment Period|Investigator decision|0
2038658|NCT00423670|3609021|FG002|Treatment Period|Investigator decision|0
2038659|NCT00423670|3609022|FG003|Treatment Period|Investigator decision|0
2038660|NCT00423670|3609023|FG004|Treatment Period|Investigator decision|0
2038661|NCT00423670|3609024|FG005|Treatment Period|Investigator decision|0
2038662|NCT00423670|3609025|FG006|Treatment Period|Investigator decision|0
2038663|NCT00423670|3609026|FG007|Treatment Period|Investigator decision|1
2038664|NCT00423670|3609019|FG000|Treatment Period|Non-compliance with protocol|3
2038665|NCT00423670|3609020|FG001|Treatment Period|Non-compliance with protocol|1
2038666|NCT00423670|3609021|FG002|Treatment Period|Non-compliance with protocol|1
2038667|NCT00423670|3609022|FG003|Treatment Period|Non-compliance with protocol|3
2038668|NCT00423670|3609023|FG004|Treatment Period|Non-compliance with protocol|2
2038669|NCT00423670|3609024|FG005|Treatment Period|Non-compliance with protocol|0
2038670|NCT00423670|3609025|FG006|Treatment Period|Non-compliance with protocol|2
2038671|NCT00423670|3609026|FG007|Treatment Period|Non-compliance with protocol|2
2038672|NCT00423670|3609019|FG000|Follow-up Period|Lost to Follow-up|0
2038673|NCT00423670|3609020|FG001|Follow-up Period|Lost to Follow-up|12
2038674|NCT00423670|3609021|FG002|Follow-up Period|Lost to Follow-up|8
2038675|NCT00423670|3609022|FG003|Follow-up Period|Lost to Follow-up|3
2038676|NCT00423670|3609023|FG004|Follow-up Period|Lost to Follow-up|1
2038677|NCT00423670|3609024|FG005|Follow-up Period|Lost to Follow-up|0
2038678|NCT00423670|3609025|FG006|Follow-up Period|Lost to Follow-up|5
2038679|NCT00423670|3609026|FG007|Follow-up Period|Lost to Follow-up|0
2038680|NCT00423670|3609019|FG000|Follow-up Period|Subject withdrew (not treatment related)|1
2038681|NCT00423670|3609020|FG001|Follow-up Period|Subject withdrew (not treatment related)|4
2038682|NCT00423670|3609021|FG002|Follow-up Period|Subject withdrew (not treatment related)|2
2038683|NCT00423670|3609022|FG003|Follow-up Period|Subject withdrew (not treatment related)|1
2038684|NCT00423670|3609023|FG004|Follow-up Period|Subject withdrew (not treatment related)|1
2195847|NCT01526928|3828593|FG001|Overall Study|Death|0
2195848|NCT01526928|3828594|FG002|Overall Study|Death|3
2195849|NCT01526928|3828595|FG003|Overall Study|Death|0
2195850|NCT01526928|3828596|FG004|Overall Study|Death|0
2195851|NCT01526928|3828597|FG005|Overall Study|Death|0
2195852|NCT01526928|3828592|FG000|Overall Study|Withdrawal by Subject|1
2195853|NCT01526928|3828593|FG001|Overall Study|Withdrawal by Subject|0
2195854|NCT01526928|3828594|FG002|Overall Study|Withdrawal by Subject|13
2195855|NCT01526928|3828595|FG003|Overall Study|Withdrawal by Subject|11
2195856|NCT01526928|3828596|FG004|Overall Study|Withdrawal by Subject|3
2195857|NCT01526928|3828597|FG005|Overall Study|Withdrawal by Subject|0
2195858|NCT01526928|3828592|FG000|Overall Study|Physician Decision|0
2195859|NCT01526928|3828593|FG001|Overall Study|Physician Decision|0
2195860|NCT01526928|3828594|FG002|Overall Study|Physician Decision|2
2195861|NCT01526928|3828595|FG003|Overall Study|Physician Decision|5
2195862|NCT01526928|3828596|FG004|Overall Study|Physician Decision|0
2195863|NCT01526928|3828597|FG005|Overall Study|Physician Decision|0
2195864|NCT01526928|3828592|FG000|Overall Study|Other Reason|0
2195865|NCT01526928|3828593|FG001|Overall Study|Other Reason|1
2195866|NCT01526928|3828594|FG002|Overall Study|Other Reason|11
2195867|NCT01526928|3828595|FG003|Overall Study|Other Reason|4
2195868|NCT01526928|3828596|FG004|Overall Study|Other Reason|1
2195869|NCT01526928|3828597|FG005|Overall Study|Other Reason|0
2195870|NCT01526928|3828592|FG000|Overall Study|Lost to Follow-up|0
2195871|NCT01526928|3828593|FG001|Overall Study|Lost to Follow-up|0
2195872|NCT01526928|3828594|FG002|Overall Study|Lost to Follow-up|0
2195873|NCT01526928|3828595|FG003|Overall Study|Lost to Follow-up|1
2195874|NCT01526928|3828596|FG004|Overall Study|Lost to Follow-up|0
2195875|NCT01526928|3828597|FG005|Overall Study|Lost to Follow-up|0
2195876|NCT01526928|3828592|FG000|Overall Study|Protocol Deviation|0
2195877|NCT01526928|3828593|FG001|Overall Study|Protocol Deviation|0
2195878|NCT01526928|3828594|FG002|Overall Study|Protocol Deviation|0
2195879|NCT01526928|3828595|FG003|Overall Study|Protocol Deviation|2
2195880|NCT01526928|3828596|FG004|Overall Study|Protocol Deviation|0
2195881|NCT01526928|3828597|FG005|Overall Study|Protocol Deviation|0
2195882|NCT01526928|3828592|FG000|Overall Study|Missing|0
2252453|NCT02040766|3916929|FG000|Overall Study|Adverse Event|1
2252454|NCT02040766|3916930|FG001|Overall Study|Adverse Event|1
2252455|NCT02040766|3916931|FG002|Overall Study|Adverse Event|1
2252456|NCT02040766|3916932|FG003|Overall Study|Adverse Event|0
2252457|NCT02040766|3916933|FG004|Overall Study|Adverse Event|2
2252458|NCT02040766|3916929|FG000|Overall Study|Withdrawal by Subject|4
2252459|NCT02040766|3916930|FG001|Overall Study|Withdrawal by Subject|3
2252460|NCT02040766|3916931|FG002|Overall Study|Withdrawal by Subject|2
2252461|NCT02040766|3916932|FG003|Overall Study|Withdrawal by Subject|3
2252462|NCT02040766|3916933|FG004|Overall Study|Withdrawal by Subject|2
2252463|NCT02040766|3916929|FG000|Overall Study|Non-compliance|0
2252464|NCT02040766|3916930|FG001|Overall Study|Non-compliance|1
2252465|NCT02040766|3916931|FG002|Overall Study|Non-compliance|0
2252466|NCT02040766|3916932|FG003|Overall Study|Non-compliance|0
2252467|NCT02040766|3916933|FG004|Overall Study|Non-compliance|0
2252468|NCT02040766|3916929|FG000|Overall Study|Protocol Violation|2
2252469|NCT02040766|3916930|FG001|Overall Study|Protocol Violation|1
2252470|NCT02040766|3916931|FG002|Overall Study|Protocol Violation|2
2252471|NCT02040766|3916932|FG003|Overall Study|Protocol Violation|3
2252472|NCT02040766|3916933|FG004|Overall Study|Protocol Violation|0
2252473|NCT02040766|3916929|FG000|Overall Study|Lost to Follow-up|4
2252474|NCT02040766|3916930|FG001|Overall Study|Lost to Follow-up|1
2341944|NCT03471078|4074579|FG000|Overall Study|Adverse Event|4
2341945|NCT03471078|4074580|FG001|Overall Study|Adverse Event|1
2341946|NCT03471078|4074579|FG000|Overall Study|Physician Decision|3
2341947|NCT03471078|4074580|FG001|Overall Study|Physician Decision|2
2341948|NCT03471078|4074579|FG000|Overall Study|Death|2
2341949|NCT03471078|4074580|FG001|Overall Study|Death|0
2341950|NCT03471078|4074579|FG000|Overall Study|Other|3
2341951|NCT03471078|4074580|FG001|Overall Study|Other|2
2341952|NCT03471871|4074597|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2341953|NCT03471871|4074598|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2341954|NCT03471871|4074599|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
2341955|NCT03471871|4074600|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2341956|NCT03471871|4074601|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2341957|NCT03471871|4074597|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
2341958|NCT03471871|4074598|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
2341959|NCT03471871|4074599|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
2341960|NCT03471871|4074600|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
2341961|NCT03471871|4074601|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
2341962|NCT03471871|4074597|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2341963|NCT03471871|4074598|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2341964|NCT03471871|4074599|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2341965|NCT03471871|4074600|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2341966|NCT03471871|4074601|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
2341967|NCT03471871|4074597|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2341968|NCT03471871|4074598|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2341969|NCT03471871|4074599|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2341970|NCT03471871|4074600|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2341971|NCT03471871|4074601|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
2341972|NCT03471871|4074597|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2341973|NCT03471871|4074598|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2341974|NCT03471871|4074599|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2341975|NCT03471871|4074600|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
2341976|NCT03471871|4074601|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2341977|NCT03472014|4074622|FG000|Overall Study|Lost to Follow-up|4
2341978|NCT03472326|4074637|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0
2341979|NCT03472326|4074638|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0
2341980|NCT03472326|4074639|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1
2341981|NCT03472326|4074640|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2
2341982|NCT03472326|4074637|FG000|Part 2: Combination Therapy|Pregnancy|0
2341983|NCT03472326|4074638|FG001|Part 2: Combination Therapy|Pregnancy|0
2341984|NCT03472326|4074639|FG002|Part 2: Combination Therapy|Pregnancy|0
2341985|NCT03472326|4074640|FG003|Part 2: Combination Therapy|Pregnancy|1
2341986|NCT03472521|4074660|FG000|Overall Study|Lost to Follow-up|3
2341987|NCT03472521|4074661|FG001|Overall Study|Lost to Follow-up|2
2341988|NCT03472521|4074660|FG000|Overall Study|Discontinued intervention|3
2341989|NCT03472521|4074661|FG001|Overall Study|Discontinued intervention|1
2341990|NCT03472534|4074667|FG000|Overall Study|Withdrawal by Subject|9
2341991|NCT03472534|4074667|FG000|Overall Study|Adverse Event|2
2341992|NCT03472547|4074671|FG000|Overall Study|Withdrawal by Subject|30
2341993|NCT03472885|4074675|FG000|Overall Study|Adverse Event|1
2341994|NCT03473197|4074687|FG000|Overall Study|Adverse Event|4
2341995|NCT03473197|4074687|FG000|Overall Study|Lost to Follow-up|1
2341996|NCT03473197|4074687|FG000|Overall Study|Withdrawal by Subject|5
2341997|NCT03473236|4074701|FG000|Overall Study|Withdrawal by Subject|0
2341998|NCT03473236|4074702|FG001|Overall Study|Withdrawal by Subject|0
2252475|NCT02040766|3916931|FG002|Overall Study|Lost to Follow-up|3
2252476|NCT02040766|3916932|FG003|Overall Study|Lost to Follow-up|1
2252477|NCT02040766|3916933|FG004|Overall Study|Lost to Follow-up|4
2252478|NCT02040766|3916929|FG000|Overall Study|Not reported|1
2252479|NCT02040766|3916930|FG001|Overall Study|Not reported|0
2252480|NCT02040766|3916931|FG002|Overall Study|Not reported|0
2252481|NCT02040766|3916932|FG003|Overall Study|Not reported|0
2252482|NCT02040766|3916933|FG004|Overall Study|Not reported|0
2252483|NCT02040766|3916929|FG000|Overall Study|Lack of Efficacy|6
2252484|NCT02040766|3916930|FG001|Overall Study|Lack of Efficacy|3
2252485|NCT02040766|3916931|FG002|Overall Study|Lack of Efficacy|4
2252486|NCT02040766|3916932|FG003|Overall Study|Lack of Efficacy|6
2252487|NCT02040766|3916933|FG004|Overall Study|Lack of Efficacy|5
2252488|NCT02040779|3916949|FG000|Overall Study|Adverse Event|1
2252489|NCT02040779|3916950|FG001|Overall Study|Adverse Event|0
2252490|NCT02040779|3916951|FG002|Overall Study|Adverse Event|0
2252491|NCT02040779|3916949|FG000|Overall Study|Withdrawal by Subject|4
2252492|NCT02040779|3916950|FG001|Overall Study|Withdrawal by Subject|1
2252493|NCT02040779|3916951|FG002|Overall Study|Withdrawal by Subject|3
2252494|NCT02040779|3916949|FG000|Overall Study|Non-compliance|0
2252495|NCT02040779|3916950|FG001|Overall Study|Non-compliance|1
2252496|NCT02040779|3916951|FG002|Overall Study|Non-compliance|0
2252497|NCT02040779|3916949|FG000|Overall Study|Protocol Violation|2
2252498|NCT02040779|3916950|FG001|Overall Study|Protocol Violation|1
2252499|NCT02040779|3916951|FG002|Overall Study|Protocol Violation|0
2252500|NCT02040779|3916949|FG000|Overall Study|Lost to Follow-up|1
2252501|NCT02040779|3916950|FG001|Overall Study|Lost to Follow-up|2
2252502|NCT02040779|3916951|FG002|Overall Study|Lost to Follow-up|1
2252503|NCT02040779|3916949|FG000|Overall Study|Lack of Efficacy|4
2252504|NCT02040779|3916950|FG001|Overall Study|Lack of Efficacy|2
2252505|NCT02040779|3916951|FG002|Overall Study|Lack of Efficacy|0
2252506|NCT02040805|3916961|FG000|Overall Study|Lost to Follow-up|14
2252507|NCT02040805|3916962|FG001|Overall Study|Lost to Follow-up|9
2252508|NCT02040805|3916961|FG000|Overall Study|Withdrawal by Subject|28
2252509|NCT02040805|3916962|FG001|Overall Study|Withdrawal by Subject|41
2252510|NCT02040844|3916971|FG000|Overall Study|Adverse Event|0
2252511|NCT02040844|3916972|FG001|Overall Study|Adverse Event|0
2252512|NCT02040844|3916973|FG002|Overall Study|Adverse Event|1
2252513|NCT02040844|3916971|FG000|Overall Study|Withdrawal by Subject|16
2252514|NCT02040844|3916972|FG001|Overall Study|Withdrawal by Subject|22
2252515|NCT02040844|3916973|FG002|Overall Study|Withdrawal by Subject|25
2252516|NCT02040844|3916971|FG000|Overall Study|Lost to Follow-up|12
2252517|NCT02040844|3916972|FG001|Overall Study|Lost to Follow-up|9
2252518|NCT02040844|3916973|FG002|Overall Study|Lost to Follow-up|13
2252519|NCT02040844|3916971|FG000|Overall Study|Missing|13
2252520|NCT02040844|3916972|FG001|Overall Study|Missing|3
2252521|NCT02040844|3916973|FG002|Overall Study|Missing|2
2252522|NCT02040844|3916971|FG000|Overall Study|Non-specified|8
2252523|NCT02040844|3916972|FG001|Overall Study|Non-specified|2
2252524|NCT02040844|3916973|FG002|Overall Study|Non-specified|5
2252525|NCT02040844|3916971|FG000|Overall Study|Concomitant medication|1
2252526|NCT02040844|3916972|FG001|Overall Study|Concomitant medication|3
2252527|NCT02040844|3916973|FG002|Overall Study|Concomitant medication|1
2252528|NCT02040857|3916981|FG000|Overall Study|Adverse Event|14
2252529|NCT02040857|3916981|FG000|Overall Study|Physician Decision|5
2252530|NCT02040857|3916981|FG000|Overall Study|Withdrawal by Subject|31
2252531|NCT02040857|3916981|FG000|Overall Study|patient non-compliance|3
2341999|NCT03473236|4074703|FG002|Overall Study|Withdrawal by Subject|0
2342000|NCT03473236|4074704|FG003|Overall Study|Withdrawal by Subject|0
2342001|NCT03473236|4074705|FG004|Overall Study|Withdrawal by Subject|0
2342002|NCT03473236|4074706|FG005|Overall Study|Withdrawal by Subject|1
2342003|NCT03473236|4074707|FG006|Overall Study|Withdrawal by Subject|0
2342004|NCT03473236|4074708|FG007|Overall Study|Withdrawal by Subject|0
2342005|NCT03473236|4074709|FG008|Overall Study|Withdrawal by Subject|1
2342006|NCT03473236|4074710|FG009|Overall Study|Withdrawal by Subject|0
2342007|NCT03473301|4074743|FG000|Overall Study|Protocol Violation|4
2342008|NCT03473301|4074744|FG001|Overall Study|Protocol Violation|0
2342009|NCT03473301|4074745|FG002|Overall Study|Protocol Violation|0
2342010|NCT03473301|4074743|FG000|Overall Study|Withdrawal by Subject|0
2342011|NCT03473301|4074744|FG001|Overall Study|Withdrawal by Subject|1
2342012|NCT03473301|4074745|FG002|Overall Study|Withdrawal by Subject|0
2342013|NCT03473301|4074743|FG000|Overall Study|Missed study visit due to pandemic restrictions|7
2342014|NCT03473301|4074744|FG001|Overall Study|Missed study visit due to pandemic restrictions|5
2342015|NCT03473301|4074745|FG002|Overall Study|Missed study visit due to pandemic restrictions|6
2342016|NCT03473808|4074764|FG000|Overall Study|Withdrawal by Subject|1
2342017|NCT03474081|4074774|FG000|Overall Study|Adverse Event|6
2342018|NCT03474081|4074775|FG001|Overall Study|Adverse Event|3
2342019|NCT03474081|4074774|FG000|Overall Study|Lost to Follow-up|2
2342020|NCT03474081|4074775|FG001|Overall Study|Lost to Follow-up|1
2342021|NCT03474081|4074774|FG000|Overall Study|Physician Decision|3
2342022|NCT03474081|4074775|FG001|Overall Study|Physician Decision|2
2342023|NCT03474081|4074774|FG000|Overall Study|Withdrawal by Subject|5
2342024|NCT03474081|4074775|FG001|Overall Study|Withdrawal by Subject|7
2252532|NCT02040857|3916981|FG000|Overall Study|Lost to Follow-up|2
2252533|NCT02040857|3916981|FG000|Overall Study|recurrence|4
2342025|NCT03474081|4074774|FG000|Overall Study|Investigator site closed|1
2252534|NCT02040857|3916981|FG000|Overall Study|ineligible|1
2252535|NCT02040870|3916988|FG000|Overall Study|Completed treatment phase|6
2252536|NCT02040870|3916988|FG000|Overall Study|Adverse Event|7
2252537|NCT02040870|3916988|FG000|Overall Study|Progressive disease|58
2252538|NCT02040870|3916988|FG000|Overall Study|Physician Decision|6
2252539|NCT02040870|3916988|FG000|Overall Study|Subject/guardian decision|10
2252540|NCT02040870|3916988|FG000|Overall Study|Lost to Follow-up|3
2252541|NCT02040870|3916988|FG000|Overall Study|Death|13
2252542|NCT02041091|3916994|FG000|Treatment|Adverse Event|3
2252543|NCT02041091|3916995|FG001|Treatment|Adverse Event|3
2252544|NCT02041091|3916994|FG000|Treatment|Withdrawal by Subject|2
2252545|NCT02041091|3916995|FG001|Treatment|Withdrawal by Subject|4
2252546|NCT02041091|3916994|FG000|Treatment|Physician Decision|1
2252547|NCT02041091|3916995|FG001|Treatment|Physician Decision|0
2252548|NCT02041091|3916994|FG000|Treatment|Sponsor Decision|15
2252549|NCT02041091|3916995|FG001|Treatment|Sponsor Decision|16
2252550|NCT02041091|3916994|FG000|Treatment|Lost to Follow-up|1
2252551|NCT02041091|3916995|FG001|Treatment|Lost to Follow-up|0
2252552|NCT02041091|3916994|FG000|Optional Safety Extension Period|Adverse Event|4
2252553|NCT02041091|3916995|FG001|Optional Safety Extension Period|Adverse Event|2
2252554|NCT02041091|3916994|FG000|Optional Safety Extension Period|Withdrawal by Subject|5
2252555|NCT02041091|3916995|FG001|Optional Safety Extension Period|Withdrawal by Subject|2
2252556|NCT02041091|3916994|FG000|Optional Safety Extension Period|Protocol Violation|2
2252557|NCT02041091|3916995|FG001|Optional Safety Extension Period|Protocol Violation|0
2252558|NCT02041091|3916994|FG000|Optional Safety Extension Period|Physician Decision|2
2252559|NCT02041091|3916995|FG001|Optional Safety Extension Period|Physician Decision|1
2252560|NCT02041091|3916994|FG000|Optional Safety Extension Period|Sponsor Decision|70
2252561|NCT02041091|3916995|FG001|Optional Safety Extension Period|Sponsor Decision|74
2252562|NCT02041091|3916994|FG000|Optional Safety Extension Period|Lost to Follow-up|2
2252563|NCT02041091|3916995|FG001|Optional Safety Extension Period|Lost to Follow-up|3
2252564|NCT02041104|3917009|FG000|Overall Study|Lost to Follow-up|1
2252565|NCT02041104|3917010|FG001|Overall Study|Lost to Follow-up|4
2252566|NCT02041104|3917009|FG000|Overall Study|discomfort during OGTT|0
2252567|NCT02041104|3917010|FG001|Overall Study|discomfort during OGTT|3
2252568|NCT02041286|3917043|FG000|Overall Study|Adverse Event|1
2252569|NCT02041299|3917051|FG000|Overall Study|Adverse Event|9
2252570|NCT02041299|3917052|FG001|Overall Study|Adverse Event|3
2252571|NCT02041299|3917051|FG000|Overall Study|Lost to Follow-up|4
2252572|NCT02041299|3917052|FG001|Overall Study|Lost to Follow-up|1
2252573|NCT02041299|3917051|FG000|Overall Study|Physician Decision|1
2252574|NCT02041299|3917052|FG001|Overall Study|Physician Decision|1
2252575|NCT02041299|3917051|FG000|Overall Study|Withdrawal by Subject|13
2252576|NCT02041299|3917052|FG001|Overall Study|Withdrawal by Subject|7
2252577|NCT02041299|3917051|FG000|Overall Study|Protocol Violation|11
2252578|NCT02041299|3917052|FG001|Overall Study|Protocol Violation|4
2252579|NCT02041299|3917051|FG000|Overall Study|Termination of the study|7
2252580|NCT02041299|3917052|FG001|Overall Study|Termination of the study|3
2252581|NCT02041299|3917051|FG000|Overall Study|Required bone marrow transplant|0
2252582|NCT02041299|3917052|FG001|Overall Study|Required bone marrow transplant|1
2252583|NCT02041299|3917051|FG000|Overall Study|Patient stopped dosing on unknown date|1
2252584|NCT02041299|3917052|FG001|Overall Study|Patient stopped dosing on unknown date|0
2252585|NCT02041429|3917083|FG000|Overall Study|Progressive Disease|2
2252586|NCT02041429|3917084|FG001|Overall Study|Progressive Disease|2
2252587|NCT02041429|3917085|FG002|Overall Study|Progressive Disease|3
2252588|NCT02041429|3917086|FG003|Overall Study|Progressive Disease|2
2252589|NCT02041429|3917083|FG000|Overall Study|Toxicity|0
2252590|NCT02041429|3917084|FG001|Overall Study|Toxicity|1
2252591|NCT02041429|3917085|FG002|Overall Study|Toxicity|4
2252592|NCT02041429|3917086|FG003|Overall Study|Toxicity|2
2252593|NCT02041429|3917083|FG000|Overall Study|Withdrawal by Subject|0
2252594|NCT02041429|3917084|FG001|Overall Study|Withdrawal by Subject|1
2252595|NCT02041429|3917085|FG002|Overall Study|Withdrawal by Subject|0
2252596|NCT02041429|3917086|FG003|Overall Study|Withdrawal by Subject|0
2252597|NCT02041429|3917083|FG000|Overall Study|On Maintenance Therapy|1
2252598|NCT02041429|3917084|FG001|Overall Study|On Maintenance Therapy|0
2252599|NCT02041429|3917085|FG002|Overall Study|On Maintenance Therapy|0
2252600|NCT02041429|3917086|FG003|Overall Study|On Maintenance Therapy|2
2252601|NCT02041494|3917103|FG000|Overall Study|Death|1
2252602|NCT02041494|3917104|FG001|Overall Study|Death|3
2252603|NCT02041494|3917103|FG000|Overall Study|Lost to Follow-up|2
2252604|NCT02041494|3917104|FG001|Overall Study|Lost to Follow-up|6
2252605|NCT02041494|3917103|FG000|Overall Study|study terminated|16
2252606|NCT02041494|3917104|FG001|Overall Study|study terminated|11
2252607|NCT02041520|3917113|FG000|Overall Study|Adverse Event|2
2252608|NCT02041520|3917114|FG001|Overall Study|Adverse Event|1
2252609|NCT02041520|3917113|FG000|Overall Study|Withdrawal by Subject|3
2252610|NCT02041520|3917114|FG001|Overall Study|Withdrawal by Subject|4
2252611|NCT02041520|3917113|FG000|Overall Study|Protocol Violation|1
2252612|NCT02041520|3917114|FG001|Overall Study|Protocol Violation|0
2252613|NCT02041520|3917113|FG000|Overall Study|Lost to Follow-up|0
2252614|NCT02041520|3917114|FG001|Overall Study|Lost to Follow-up|1
2252615|NCT02041520|3917113|FG000|Overall Study|Hypothiroidism identified during follow-|0
2252616|NCT02041520|3917114|FG001|Overall Study|Hypothiroidism identified during follow-|1
2252617|NCT02041533|3917124|FG000|Overall Study|Disease Progression|168
2252618|NCT02041533|3917125|FG001|Overall Study|Disease Progression|142
2252619|NCT02041533|3917124|FG000|Overall Study|Study drug toxicity|27
2252620|NCT02041533|3917125|FG001|Overall Study|Study drug toxicity|30
2252621|NCT02041533|3917124|FG000|Overall Study|Death|1
2252622|NCT02041533|3917125|FG001|Overall Study|Death|0
2252623|NCT02041533|3917124|FG000|Overall Study|Adverse Event unrelated to study drug|20
2252624|NCT02041533|3917125|FG001|Overall Study|Adverse Event unrelated to study drug|21
2252625|NCT02041533|3917124|FG000|Overall Study|Subject request to discontinue treatment|5
2252626|NCT02041533|3917125|FG001|Overall Study|Subject request to discontinue treatment|9
2252627|NCT02041533|3917124|FG000|Overall Study|Withdrawal by Subject|2
2252628|NCT02041533|3917125|FG001|Overall Study|Withdrawal by Subject|1
2342026|NCT03474081|4074775|FG001|Overall Study|Investigator site closed|0
2342027|NCT03475056|4074805|FG000|Overall Study|Lost to Follow-up|0
2342028|NCT03475056|4074806|FG001|Overall Study|Lost to Follow-up|1
2342029|NCT03475056|4074805|FG000|Overall Study|Moved from Area|0
2038685|NCT00423670|3609024|FG005|Follow-up Period|Subject withdrew (not treatment related)|0
2038686|NCT00423670|3609025|FG006|Follow-up Period|Subject withdrew (not treatment related)|1
2038687|NCT00423670|3609026|FG007|Follow-up Period|Subject withdrew (not treatment related)|1
2038688|NCT00423670|3609019|FG000|Follow-up Period|Non-compliance with protocol|2
2038689|NCT00423670|3609020|FG001|Follow-up Period|Non-compliance with protocol|0
2038690|NCT00423670|3609021|FG002|Follow-up Period|Non-compliance with protocol|1
2038691|NCT00423670|3609022|FG003|Follow-up Period|Non-compliance with protocol|1
2038692|NCT00423670|3609023|FG004|Follow-up Period|Non-compliance with protocol|0
2038693|NCT00423670|3609024|FG005|Follow-up Period|Non-compliance with protocol|0
2038694|NCT00423670|3609025|FG006|Follow-up Period|Non-compliance with protocol|3
2038695|NCT00423670|3609026|FG007|Follow-up Period|Non-compliance with protocol|2
2038696|NCT00423722|3609060|FG000|Overall Study|Death|4
2038697|NCT00423722|3609061|FG001|Overall Study|Death|4
2038698|NCT00423722|3609060|FG000|Overall Study|Declined to participate|2
2038699|NCT00423722|3609061|FG001|Overall Study|Declined to participate|3
2038700|NCT00423722|3609060|FG000|Overall Study|Unable to complete questionnaires|4
2038701|NCT00423722|3609061|FG001|Overall Study|Unable to complete questionnaires|4
2038702|NCT00423722|3609060|FG000|Overall Study|Withdrawal by Subject|4
2038703|NCT00423722|3609061|FG001|Overall Study|Withdrawal by Subject|2
2038704|NCT00423735|3609076|FG000|Overall Study|Ineligible / No protocol treatment|8
2038705|NCT00423735|3609077|FG001|Overall Study|Ineligible / No protocol treatment|6
2038706|NCT00423735|3609078|FG002|Overall Study|Ineligible / No protocol treatment|0
2038707|NCT00423800|3609090|FG000|Overall Study|Protocol Violation|0
2038708|NCT00423800|3609091|FG001|Overall Study|Protocol Violation|1
2038709|NCT00423813|3609101|FG000|Overall Study|Adverse Event|11
2038710|NCT00423813|3609102|FG001|Overall Study|Adverse Event|30
2038711|NCT00423813|3609103|FG002|Overall Study|Adverse Event|40
2038712|NCT00423813|3609101|FG000|Overall Study|Withdrawal by Subject|6
2038713|NCT00423813|3609102|FG001|Overall Study|Withdrawal by Subject|8
2038714|NCT00423813|3609103|FG002|Overall Study|Withdrawal by Subject|5
2038715|NCT00423813|3609101|FG000|Overall Study|Lost to Follow-up|5
2038716|NCT00423813|3609102|FG001|Overall Study|Lost to Follow-up|4
2038717|NCT00423813|3609103|FG002|Overall Study|Lost to Follow-up|4
2038718|NCT00423813|3609101|FG000|Overall Study|Lack of Efficacy|23
2038719|NCT00423813|3609102|FG001|Overall Study|Lack of Efficacy|18
2038720|NCT00423813|3609103|FG002|Overall Study|Lack of Efficacy|19
2038721|NCT00423813|3609101|FG000|Overall Study|Physician Decision|2
2038722|NCT00423813|3609102|FG001|Overall Study|Physician Decision|0
2038723|NCT00423813|3609103|FG002|Overall Study|Physician Decision|0
2038724|NCT00423813|3609101|FG000|Overall Study|Sponsor Decision|0
2038725|NCT00423813|3609102|FG001|Overall Study|Sponsor Decision|1
2038726|NCT00423813|3609103|FG002|Overall Study|Sponsor Decision|0
2038727|NCT00423813|3609101|FG000|Overall Study|Protocol Violation|9
2038728|NCT00423813|3609102|FG001|Overall Study|Protocol Violation|4
2038729|NCT00423813|3609103|FG002|Overall Study|Protocol Violation|4
2038730|NCT00423813|3609101|FG000|Overall Study|Pregnancy|0
2038731|NCT00423813|3609102|FG001|Overall Study|Pregnancy|0
2038732|NCT00423813|3609103|FG002|Overall Study|Pregnancy|1
2038733|NCT00423813|3609101|FG000|Overall Study|Subject started night shift work|1
2195883|NCT01526928|3828593|FG001|Overall Study|Missing|0
2195884|NCT01526928|3828594|FG002|Overall Study|Missing|1
2195885|NCT01526928|3828595|FG003|Overall Study|Missing|0
2195886|NCT01526928|3828596|FG004|Overall Study|Missing|2
2195887|NCT01526928|3828597|FG005|Overall Study|Missing|0
2195888|NCT01527006|3828655|FG000|Core Study|Adverse Event|0
2195889|NCT01527006|3828656|FG001|Core Study|Adverse Event|2
2195890|NCT01527006|3828655|FG000|Core Study|Lost to Follow-up|0
2195891|NCT01527006|3828656|FG001|Core Study|Lost to Follow-up|1
2195892|NCT01527006|3828655|FG000|Core Study|Subject Choice|1
2195893|NCT01527006|3828656|FG001|Core Study|Subject Choice|0
2195894|NCT01527006|3828655|FG000|Core Study|Inadequate Therapeutic Effect|1
2195895|NCT01527006|3828656|FG001|Core Study|Inadequate Therapeutic Effect|0
2195896|NCT01527006|3828655|FG000|Core Study|Withdrawal by Subject|0
2195897|NCT01527006|3828656|FG001|Core Study|Withdrawal by Subject|1
2195898|NCT01527006|3828655|FG000|Core Study|Other|0
2195899|NCT01527006|3828656|FG001|Core Study|Other|2
2195900|NCT01527006|3828655|FG000|Extension Phase|Adverse Event|4
2195901|NCT01527006|3828656|FG001|Extension Phase|Adverse Event|2
2252629|NCT02041533|3917124|FG000|Overall Study|Maximum clinical benefit|0
2252630|NCT02041533|3917125|FG001|Overall Study|Maximum clinical benefit|18
2252631|NCT02041533|3917124|FG000|Overall Study|Poor/non-compliance|1
2252632|NCT02041533|3917125|FG001|Overall Study|Poor/non-compliance|0
2252633|NCT02041533|3917124|FG000|Overall Study|Other reasons|0
2252634|NCT02041533|3917125|FG001|Overall Study|Other reasons|1
2252635|NCT02041533|3917124|FG000|Overall Study|Completed max number of chemo cycles|0
2252636|NCT02041533|3917125|FG001|Overall Study|Completed max number of chemo cycles|29
2252637|NCT02041533|3917124|FG000|Overall Study|Randomized, not treated|4
2252638|NCT02041533|3917125|FG001|Overall Study|Randomized, not treated|7
2252639|NCT02041702|3917133|FG000|Overall Study|Lost to Follow-up|1
2252640|NCT02041702|3917134|FG001|Overall Study|Lost to Follow-up|6
2252641|NCT02041702|3917133|FG000|Overall Study|Death|4
2252642|NCT02041702|3917134|FG001|Overall Study|Death|0
2252643|NCT02041702|3917133|FG000|Overall Study|Withdrawal by Subject|4
2252644|NCT02041702|3917134|FG001|Overall Study|Withdrawal by Subject|3
2252645|NCT02041702|3917133|FG000|Overall Study|Patient not confirmed as MRI compatible|1
2252646|NCT02041702|3917134|FG001|Overall Study|Patient not confirmed as MRI compatible|0
2252647|NCT02041702|3917133|FG000|Overall Study|Cardiac Resynchronization Therapy|1
2252648|NCT02041702|3917134|FG001|Overall Study|Cardiac Resynchronization Therapy|0
2252649|NCT02041923|3917142|FG000|Overall Study|Lost to Follow-up|26
2252650|NCT02041923|3917143|FG001|Overall Study|Lost to Follow-up|30
2252651|NCT02041962|3917153|FG000|Overall Study|Lost Aetna Coverage|43
2252652|NCT02041962|3917154|FG001|Overall Study|Lost Aetna Coverage|40
2252653|NCT02041962|3917153|FG000|Overall Study|Death|1
2252654|NCT02041962|3917154|FG001|Overall Study|Death|1
2252655|NCT02041962|3917153|FG000|Overall Study|Lost to Follow-up|37
2252656|NCT02041962|3917154|FG001|Overall Study|Lost to Follow-up|32
2252657|NCT02041962|3917153|FG000|Overall Study|Withdrawal by Subject|0
2252658|NCT02041962|3917154|FG001|Overall Study|Withdrawal by Subject|11
2252659|NCT02042014|3917160|FG000|Overall Study|Adverse Event|1
2252660|NCT02042014|3917160|FG000|Overall Study|Physician Decision|7
2252661|NCT02042183|3917181|FG000|Overall Study|Physician Decision|7
2252662|NCT02042183|3917182|FG001|Overall Study|Physician Decision|2
2252663|NCT02042183|3917181|FG000|Overall Study|Lack of Efficacy|4
2252664|NCT02042183|3917182|FG001|Overall Study|Lack of Efficacy|3
2252665|NCT02042183|3917181|FG000|Overall Study|Non-compliance with Study Drug|2
2252666|NCT02042183|3917182|FG001|Overall Study|Non-compliance with Study Drug|3
2252667|NCT02042183|3917181|FG000|Overall Study|Adverse Event|17
2252668|NCT02042183|3917182|FG001|Overall Study|Adverse Event|6
2252669|NCT02042183|3917181|FG000|Overall Study|Other|3
2252670|NCT02042183|3917182|FG001|Overall Study|Other|3
2252671|NCT02042183|3917181|FG000|Overall Study|Withdrawal by Subject|21
2252672|NCT02042183|3917182|FG001|Overall Study|Withdrawal by Subject|16
2252673|NCT02042183|3917181|FG000|Overall Study|Site Terminated by Sponsor|2
2252674|NCT02042183|3917182|FG001|Overall Study|Site Terminated by Sponsor|1
2252675|NCT02042183|3917181|FG000|Overall Study|Lost to Follow-up|9
2252676|NCT02042183|3917182|FG001|Overall Study|Lost to Follow-up|2
2252677|NCT02042404|3917194|FG000|Overall Study|Death|1
2252678|NCT02042404|3917195|FG001|Overall Study|Death|0
2252679|NCT02042404|3917194|FG000|Overall Study|Unrelated Adverse Event|3
2252680|NCT02042404|3917195|FG001|Overall Study|Unrelated Adverse Event|0
2252681|NCT02042404|3917194|FG000|Overall Study|Inability to meet time requirements|1
2252682|NCT02042404|3917195|FG001|Overall Study|Inability to meet time requirements|0
2252683|NCT02042443|3917204|FG000|Overall Study|Adverse Event|2
2252684|NCT02042443|3917205|FG001|Overall Study|Adverse Event|1
2252685|NCT02042443|3917204|FG000|Overall Study|Withdrawal by Subject|0
2252686|NCT02042443|3917205|FG001|Overall Study|Withdrawal by Subject|1
2252687|NCT02042443|3917204|FG000|Overall Study|Progression|21
2252688|NCT02042443|3917205|FG001|Overall Study|Progression|17
2252689|NCT02042443|3917204|FG000|Overall Study|not protocol specified|1
2252690|NCT02042443|3917205|FG001|Overall Study|not protocol specified|1
2252691|NCT02042443|3917204|FG000|Overall Study|Not eligible/not analyzable|3
2252692|NCT02042443|3917205|FG001|Overall Study|Not eligible/not analyzable|6
2252693|NCT02043015|3917234|FG000|Overall Study|Lost to Follow-up|4
2252694|NCT02043015|3917234|FG000|Overall Study|Withdrawal by Subject|4
2252695|NCT02043015|3917234|FG000|Overall Study|Removed once target enrollment reached|15
2252696|NCT02043015|3917234|FG000|Overall Study|Participant moved away from study city|4
2252697|NCT02043015|3917234|FG000|Overall Study|Incarceration|1
2252698|NCT02043132|3917242|FG000|Overall Study|Lost to Follow-up|1
2252699|NCT02043132|3917243|FG001|Overall Study|Lost to Follow-up|1
2252700|NCT02043132|3917242|FG000|Overall Study|screen failures|4
2252701|NCT02043132|3917243|FG001|Overall Study|screen failures|8
2252702|NCT02043301|3917271|FG000|Overall Study|Discontinued|0
2252703|NCT02043301|3917272|FG001|Overall Study|Discontinued|1
2252704|NCT02043301|3917273|FG002|Overall Study|Discontinued|0
2252705|NCT02043366|3917287|FG000|Overall Study|Lost to Follow-up|2
2252706|NCT02043366|3917288|FG001|Overall Study|Lost to Follow-up|2
2252707|NCT02043366|3917289|FG002|Overall Study|Lost to Follow-up|2
2252708|NCT02043366|3917290|FG003|Overall Study|Lost to Follow-up|2
2252709|NCT02043366|3917291|FG004|Overall Study|Lost to Follow-up|2
2252710|NCT02043366|3917292|FG005|Overall Study|Lost to Follow-up|2
2252711|NCT02043509|3917319|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61
2252712|NCT02043509|3917320|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47
2252713|NCT02043509|3917319|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4
2252714|NCT02043509|3917320|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0
2252715|NCT02043509|3917319|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67
2252716|NCT02043509|3917320|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67
2252717|NCT02043509|3917319|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7
2252718|NCT02043509|3917320|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5
2252719|NCT02043548|3917328|FG000|Overall Study|Lack of Efficacy|1
2252720|NCT02043548|3917329|FG001|Overall Study|Lack of Efficacy|0
2252721|NCT02043548|3917328|FG000|Overall Study|Adverse Event|0
2252722|NCT02043548|3917329|FG001|Overall Study|Adverse Event|1
2252723|NCT02043782|3917358|FG000|Period 1|Adverse Event|0
2252724|NCT02043782|3917359|FG001|Period 1|Adverse Event|0
2252725|NCT02043782|3917360|FG002|Period 1|Adverse Event|1
2252726|NCT02043782|3917361|FG003|Period 1|Adverse Event|0
2252727|NCT02043782|3917362|FG004|Period 1|Adverse Event|0
2252728|NCT02043782|3917363|FG005|Period 1|Adverse Event|0
2252729|NCT02043899|3917380|FG000|Overall Study|Adverse Event|3
2252730|NCT02043899|3917380|FG000|Overall Study|Physician Decision|1
2252731|NCT02043899|3917380|FG000|Overall Study|Withdrawal by Subject|2
2252732|NCT02043899|3917380|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5
2252733|NCT02043899|3917380|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12
2252734|NCT02043899|3917380|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2
2252735|NCT02043899|3917380|FG000|Overall Study|Clinical progression necessitating urgent treatment|1
2252736|NCT02043899|3917380|FG000|Overall Study|Treatment delayed|1
2252737|NCT02043938|3917384|FG000|Overall Study|Withdrawal by Subject|7
2252738|NCT02043938|3917384|FG000|Overall Study|Unable to place EEG sensors on patient|1
2252739|NCT02043938|3917384|FG000|Overall Study|No show by subject|1
2252740|NCT02043938|3917384|FG000|Overall Study|Investigator decision|1
2252741|NCT02044094|3917391|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
2252742|NCT02044094|3917391|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
2342030|NCT03475056|4074806|FG001|Overall Study|Moved from Area|2
2342031|NCT03475316|4074815|FG000|6 Month Intervention|Adverse Event|2
2342032|NCT03475316|4074816|FG001|6 Month Intervention|Adverse Event|1
2342033|NCT03475316|4074815|FG000|6 Month Intervention|Withdrawal by Subject|2
2342034|NCT03475316|4074816|FG001|6 Month Intervention|Withdrawal by Subject|0
2342035|NCT03475316|4074815|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1
2342036|NCT03475316|4074816|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3
2342037|NCT03475316|4074815|FG000|9 Months|Study stopped due to COVID pandemic|3
2342038|NCT03475316|4074816|FG001|9 Months|Study stopped due to COVID pandemic|4
2342039|NCT03475875|4074822|FG000|Period 1|Lost to Follow-up|1
2342040|NCT03475875|4074823|FG001|Period 1|Lost to Follow-up|0
2342041|NCT03475875|4074822|FG000|Period 1|Adverse Event|2
2342042|NCT03475875|4074823|FG001|Period 1|Adverse Event|1
2342043|NCT03475875|4074822|FG000|Period 2|Adverse Event|3
2342044|NCT03475875|4074823|FG001|Period 2|Adverse Event|0
2342045|NCT03475875|4074822|FG000|Period 2|Protocol Violation|0
2342046|NCT03475875|4074823|FG001|Period 2|Protocol Violation|1
2342047|NCT03476798|4074865|FG000|Overall Study|Death|1
2342048|NCT03476798|4074865|FG000|Overall Study|Withdrawal by Subject|2
2342049|NCT03476798|4074865|FG000|Overall Study|Protocol Violation|2
2342050|NCT03477838|4074909|FG000|Overall Study|Lost to Follow-up|14
2342051|NCT03478371|4074927|FG000|Overall Study|non-compliance|1
2342052|NCT03478371|4074927|FG000|Overall Study|Lost to Follow-up|4
2342053|NCT03478644|4074939|FG000|Phase 2|Withdrawal by Subject|2
2342054|NCT03478644|4074940|FG001|Phase 2|Withdrawal by Subject|1
2342055|NCT03478644|4074939|FG000|Phase 2|Lost to Follow-up|1
2342056|NCT03478644|4074940|FG001|Phase 2|Lost to Follow-up|0
2342057|NCT03478657|4074948|FG000|Overall Study|Withdrawal by Subject|0
2342058|NCT03478657|4074949|FG001|Overall Study|Withdrawal by Subject|1
2342059|NCT03478683|4074957|FG000|Overall Study|Adverse Event|5
2342060|NCT03478683|4074958|FG001|Overall Study|Adverse Event|3
2342061|NCT03478683|4074957|FG000|Overall Study|Lost to Follow-up|0
2342062|NCT03478683|4074958|FG001|Overall Study|Lost to Follow-up|5
2342063|NCT03478683|4074957|FG000|Overall Study|Physician Decision|1
2342064|NCT03478683|4074958|FG001|Overall Study|Physician Decision|3
2342065|NCT03478683|4074957|FG000|Overall Study|Withdrawal by Subject|7
2342066|NCT03478683|4074958|FG001|Overall Study|Withdrawal by Subject|7
2342067|NCT03478696|4074966|FG000|Overall Study|Adverse Event|1
2342068|NCT03478696|4074967|FG001|Overall Study|Adverse Event|5
2342069|NCT03478696|4074966|FG000|Overall Study|Lost to Follow-up|1
2342070|NCT03478696|4074967|FG001|Overall Study|Lost to Follow-up|0
2342071|NCT03478696|4074966|FG000|Overall Study|Physician Decision|6
2342072|NCT03478696|4074967|FG001|Overall Study|Physician Decision|3
2342073|NCT03478696|4074966|FG000|Overall Study|Withdrawal by Subject|9
2342074|NCT03478696|4074967|FG001|Overall Study|Withdrawal by Subject|4
2342075|NCT03478787|4074975|FG000|Overall Study|Adverse Event|5
2342076|NCT03478787|4074976|FG001|Overall Study|Adverse Event|1
2342077|NCT03478787|4074975|FG000|Overall Study|Protocol Violation|3
2342078|NCT03478787|4074976|FG001|Overall Study|Protocol Violation|0
2342079|NCT03478787|4074975|FG000|Overall Study|Lack of Efficacy|7
2342080|NCT03478787|4074976|FG001|Overall Study|Lack of Efficacy|1
2342081|NCT03478787|4074975|FG000|Overall Study|Lost to Follow-up|9
2252743|NCT02044094|3917391|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
2252744|NCT02044094|3917391|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
2252745|NCT02044094|3917391|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
2252746|NCT02044094|3917391|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
2252747|NCT02044094|3917391|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
2252748|NCT02044094|3917391|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
2252749|NCT02044159|3917408|FG000|Overall Study|Consent declined (deferred consent)|2
2252750|NCT02044159|3917409|FG001|Overall Study|Consent declined (deferred consent)|4
2252751|NCT02044159|3917408|FG000|Overall Study|No longer eligible, drug not given|1
2252752|NCT02044159|3917409|FG001|Overall Study|No longer eligible, drug not given|0
2252753|NCT02044159|3917408|FG000|Overall Study|Nurse declined to give study drug|1
2252754|NCT02044159|3917409|FG001|Overall Study|Nurse declined to give study drug|0
2252755|NCT02044458|3917467|FG000|Overall Study|Protocol Violation|3
2252756|NCT02044458|3917468|FG001|Overall Study|Protocol Violation|8
2252757|NCT02044510|3917476|FG000|Overall Study|Adverse Event|1
2252758|NCT02044510|3917477|FG001|Overall Study|Adverse Event|2
2252759|NCT02044874|3917515|FG000|Overall Study|Adverse Event|5
2252760|NCT02044874|3917516|FG001|Overall Study|Adverse Event|6
2252761|NCT02044874|3917517|FG002|Overall Study|Adverse Event|6
2252762|NCT02044874|3917515|FG000|Overall Study|Withdrawal by Subject|8
2252763|NCT02044874|3917516|FG001|Overall Study|Withdrawal by Subject|16
2252764|NCT02044874|3917517|FG002|Overall Study|Withdrawal by Subject|23
2252765|NCT02044874|3917515|FG000|Overall Study|Physician Decision|0
2252766|NCT02044874|3917516|FG001|Overall Study|Physician Decision|2
2252767|NCT02044874|3917517|FG002|Overall Study|Physician Decision|1
2252768|NCT02044874|3917515|FG000|Overall Study|Lost to Follow-up|10
2252769|NCT02044874|3917516|FG001|Overall Study|Lost to Follow-up|27
2252770|NCT02044874|3917517|FG002|Overall Study|Lost to Follow-up|21
2252771|NCT02044874|3917515|FG000|Overall Study|Sponsor Decision|0
2252772|NCT02044874|3917516|FG001|Overall Study|Sponsor Decision|1
2252773|NCT02044874|3917517|FG002|Overall Study|Sponsor Decision|1
2252774|NCT02044874|3917515|FG000|Overall Study|Other|7
2252775|NCT02044874|3917516|FG001|Overall Study|Other|3
2252776|NCT02044874|3917517|FG002|Overall Study|Other|8
2252777|NCT02045095|3917536|FG000|Overall Study|Other|0
2252778|NCT02045095|3917537|FG001|Overall Study|Other|0
2252779|NCT02045095|3917538|FG002|Overall Study|Other|1
2252780|NCT02045095|3917539|FG003|Overall Study|Other|0
2252781|NCT02045095|3917540|FG004|Overall Study|Other|0
2252782|NCT02045095|3917541|FG005|Overall Study|Other|2
2252783|NCT02045095|3917542|FG006|Overall Study|Other|0
2252784|NCT02045095|3917536|FG000|Overall Study|Progressive Disease|3
2252785|NCT02045095|3917537|FG001|Overall Study|Progressive Disease|3
2252786|NCT02045095|3917538|FG002|Overall Study|Progressive Disease|2
2252787|NCT02045095|3917539|FG003|Overall Study|Progressive Disease|4
2252788|NCT02045095|3917540|FG004|Overall Study|Progressive Disease|2
2252789|NCT02045095|3917541|FG005|Overall Study|Progressive Disease|4
2252790|NCT02045095|3917542|FG006|Overall Study|Progressive Disease|1
2252791|NCT02045095|3917536|FG000|Overall Study|Withdrawal by Subject|0
2252792|NCT02045095|3917537|FG001|Overall Study|Withdrawal by Subject|0
2252793|NCT02045095|3917538|FG002|Overall Study|Withdrawal by Subject|0
2252794|NCT02045095|3917539|FG003|Overall Study|Withdrawal by Subject|0
2252795|NCT02045095|3917540|FG004|Overall Study|Withdrawal by Subject|3
2252796|NCT02045095|3917541|FG005|Overall Study|Withdrawal by Subject|0
2252797|NCT02045095|3917542|FG006|Overall Study|Withdrawal by Subject|0
2252798|NCT02045095|3917536|FG000|Overall Study|Adverse Event|0
2252799|NCT02045095|3917537|FG001|Overall Study|Adverse Event|1
2252800|NCT02045095|3917538|FG002|Overall Study|Adverse Event|1
2252801|NCT02045095|3917539|FG003|Overall Study|Adverse Event|0
2252802|NCT02045095|3917540|FG004|Overall Study|Adverse Event|0
2252803|NCT02045095|3917541|FG005|Overall Study|Adverse Event|2
2252804|NCT02045095|3917542|FG006|Overall Study|Adverse Event|0
2252805|NCT02045212|3917577|FG000|Overall Study|Adverse Event|0
2252806|NCT02045212|3917578|FG001|Overall Study|Adverse Event|1
2252807|NCT02045212|3917577|FG000|Overall Study|Withdrawal by Subject|1
2252808|NCT02045212|3917578|FG001|Overall Study|Withdrawal by Subject|0
2252809|NCT02045212|3917577|FG000|Overall Study|Finished 13 weeks, chose not to extend|1
2252810|NCT02045212|3917578|FG001|Overall Study|Finished 13 weeks, chose not to extend|0
2252811|NCT02045433|3917618|FG000|Overall Study|Withdrawal by Subject|1
2252812|NCT02045732|3917633|FG000|Overall Study|At the discretion of the investigator|1
2252813|NCT02045732|3917634|FG001|Overall Study|At the discretion of the investigator|1
2252814|NCT02045836|3917642|FG000|Overall Study|Adverse Event|4
2252815|NCT02045836|3917643|FG001|Overall Study|Adverse Event|4
2252816|NCT02045836|3917642|FG000|Overall Study|Withdrawal by Subject|1
2252817|NCT02045836|3917643|FG001|Overall Study|Withdrawal by Subject|1
2252818|NCT02045836|3917642|FG000|Overall Study|Lost to Follow-up|4
2252819|NCT02045836|3917643|FG001|Overall Study|Lost to Follow-up|7
2252820|NCT02045836|3917642|FG000|Overall Study|Migrated from study area|0
2252821|NCT02045836|3917643|FG001|Overall Study|Migrated from study area|2
2342082|NCT03478787|4074976|FG001|Overall Study|Lost to Follow-up|5
2342083|NCT03478787|4074975|FG000|Overall Study|Withdrawal by Subject|2
2342084|NCT03478787|4074976|FG001|Overall Study|Withdrawal by Subject|6
2342085|NCT03478787|4074975|FG000|Overall Study|Other, Not Specified|3
2252822|NCT02045862|3917653|FG000|Overall Study|Death|0
2252823|NCT02045862|3917654|FG001|Overall Study|Death|0
2252824|NCT02045862|3917655|FG002|Overall Study|Death|1
2252825|NCT02045862|3917653|FG000|Overall Study|Miscellaneous|5
2252826|NCT02045862|3917654|FG001|Overall Study|Miscellaneous|0
2252827|NCT02045862|3917655|FG002|Overall Study|Miscellaneous|8
2252828|NCT02045862|3917653|FG000|Overall Study|Withdrawal by Patient|18
2252829|NCT02045862|3917654|FG001|Overall Study|Withdrawal by Patient|27
2252830|NCT02045862|3917655|FG002|Overall Study|Withdrawal by Patient|57
2252831|NCT02045862|3917653|FG000|Overall Study|Protocol Violation|0
2252832|NCT02045862|3917654|FG001|Overall Study|Protocol Violation|0
2252833|NCT02045862|3917655|FG002|Overall Study|Protocol Violation|6
2252834|NCT02045862|3917653|FG000|Overall Study|Lack of Efficacy|8
2252835|NCT02045862|3917654|FG001|Overall Study|Lack of Efficacy|4
2252836|NCT02045862|3917655|FG002|Overall Study|Lack of Efficacy|13
2252837|NCT02045862|3917653|FG000|Overall Study|Randomized but not Received Study Drug|0
2252838|NCT02045862|3917654|FG001|Overall Study|Randomized but not Received Study Drug|2
2252839|NCT02045862|3917655|FG002|Overall Study|Randomized but not Received Study Drug|8
2252840|NCT02045862|3917653|FG000|Overall Study|Adverse Event|7
2252841|NCT02045862|3917654|FG001|Overall Study|Adverse Event|5
2252842|NCT02045862|3917655|FG002|Overall Study|Adverse Event|27
2252843|NCT02045862|3917653|FG000|Overall Study|Lost to Follow-up|1
2252844|NCT02045862|3917654|FG001|Overall Study|Lost to Follow-up|2
2252845|NCT02045862|3917655|FG002|Overall Study|Lost to Follow-up|6
2252846|NCT02045875|3917665|FG000|Overall Study|Lost to Follow-up|3
2252847|NCT02045875|3917666|FG001|Overall Study|Lost to Follow-up|0
2252848|NCT02045875|3917665|FG000|Overall Study|Withdrawal by Subject|4
2252849|NCT02045875|3917666|FG001|Overall Study|Withdrawal by Subject|3
2252850|NCT02045979|3917675|FG000|Overall Study|Informed Consent Withdrawn|2
2252851|NCT02045979|3917676|FG001|Overall Study|Informed Consent Withdrawn|0
2252852|NCT02045979|3917677|FG002|Overall Study|Informed Consent Withdrawn|1
2252853|NCT02045979|3917675|FG000|Overall Study|not specified above|0
2252854|NCT02045979|3917676|FG001|Overall Study|not specified above|1
2252855|NCT02045979|3917677|FG002|Overall Study|not specified above|0
2252856|NCT02046070|3917701|FG000|Overall Study|Progressive Disease|18
2252857|NCT02046070|3917702|FG001|Overall Study|Progressive Disease|11
2252858|NCT02046070|3917703|FG002|Overall Study|Progressive Disease|40
2252859|NCT02046070|3917701|FG000|Overall Study|Adverse Event|8
2252860|NCT02046070|3917702|FG001|Overall Study|Adverse Event|10
2252861|NCT02046070|3917703|FG002|Overall Study|Adverse Event|17
2252862|NCT02046070|3917701|FG000|Overall Study|Withdrawal by Subject|1
2252863|NCT02046070|3917702|FG001|Overall Study|Withdrawal by Subject|2
2252864|NCT02046070|3917703|FG002|Overall Study|Withdrawal by Subject|6
2252865|NCT02046070|3917701|FG000|Overall Study|Study Terminated by Sponsor|1
2252866|NCT02046070|3917702|FG001|Overall Study|Study Terminated by Sponsor|1
2342086|NCT03478787|4074976|FG001|Overall Study|Other, Not Specified|0
2342087|NCT03478891|4074985|FG000|Overall Study|Enrolled, but product never administered|0
2342088|NCT03478891|4074986|FG001|Overall Study|Enrolled, but product never administered|0
2342089|NCT03478891|4074987|FG002|Overall Study|Enrolled, but product never administered|1
2342090|NCT03478891|4074985|FG000|Overall Study|Moved from area|0
2342091|NCT03478891|4074986|FG001|Overall Study|Moved from area|0
2342092|NCT03478891|4074987|FG002|Overall Study|Moved from area|1
2342093|NCT03478891|4074985|FG000|Overall Study|Lost to Follow-up|1
2342094|NCT03478891|4074986|FG001|Overall Study|Lost to Follow-up|0
2342095|NCT03478891|4074987|FG002|Overall Study|Lost to Follow-up|1
2342096|NCT03478930|4075012|FG000|Overall Study|Adverse Event|0
2342097|NCT03478930|4075013|FG001|Overall Study|Adverse Event|1
2342098|NCT03478930|4075012|FG000|Overall Study|Lack of Efficacy|3
2342099|NCT03478930|4075013|FG001|Overall Study|Lack of Efficacy|3
2342100|NCT03478930|4075012|FG000|Overall Study|Withdrawal by Subject|6
2342101|NCT03478930|4075013|FG001|Overall Study|Withdrawal by Subject|5
2342102|NCT03478969|4075022|FG000|Overall Study|Withdrawal by Subject|4
2342103|NCT03478969|4075023|FG001|Overall Study|Withdrawal by Subject|7
2342104|NCT03478969|4075024|FG002|Overall Study|Withdrawal by Subject|6
2342105|NCT03478969|4075022|FG000|Overall Study|Adverse Event|2
2342106|NCT03478969|4075023|FG001|Overall Study|Adverse Event|0
2342107|NCT03478969|4075024|FG002|Overall Study|Adverse Event|1
2342108|NCT03478969|4075022|FG000|Overall Study|Pregnancy|1
2342109|NCT03478969|4075023|FG001|Overall Study|Pregnancy|0
2342110|NCT03478969|4075024|FG002|Overall Study|Pregnancy|0
2342111|NCT03478969|4075022|FG000|Overall Study|Personal Reasons|1
2342112|NCT03478969|4075023|FG001|Overall Study|Personal Reasons|0
2342113|NCT03478969|4075024|FG002|Overall Study|Personal Reasons|1
2342114|NCT03478969|4075022|FG000|Overall Study|Covid-19|1
2342115|NCT03478969|4075023|FG001|Overall Study|Covid-19|4
2342116|NCT03478969|4075024|FG002|Overall Study|Covid-19|3
2342117|NCT03478969|4075022|FG000|Overall Study|Multiple Reasons|0
2342118|NCT03478969|4075023|FG001|Overall Study|Multiple Reasons|1
2342119|NCT03478969|4075024|FG002|Overall Study|Multiple Reasons|1
2342120|NCT03478969|4075022|FG000|Overall Study|Eligibility Criteria|0
2342121|NCT03478969|4075023|FG001|Overall Study|Eligibility Criteria|0
2342122|NCT03478969|4075024|FG002|Overall Study|Eligibility Criteria|5
2342123|NCT03478969|4075022|FG000|Overall Study|Lost to Follow-up|0
2252867|NCT02046070|3917703|FG002|Overall Study|Study Terminated by Sponsor|1
2252868|NCT02046070|3917701|FG000|Overall Study|Reason not Specified|4
2252869|NCT02046070|3917702|FG001|Overall Study|Reason not Specified|4
2252870|NCT02046070|3917703|FG002|Overall Study|Reason not Specified|6
2252871|NCT02046122|3917711|FG000|Overall Study|Physician Decision|8
2252872|NCT02046122|3917711|FG000|Overall Study|Withdrawal by Subject|1
2252873|NCT02046148|3917726|FG000|Overall Study|Lost to Follow-up|1
2252874|NCT02046148|3917727|FG001|Overall Study|Lost to Follow-up|1
2252875|NCT02046148|3917726|FG000|Overall Study|Withdrawal by Subject|0
2252876|NCT02046148|3917727|FG001|Overall Study|Withdrawal by Subject|2
2252877|NCT02046174|3917733|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1
2252878|NCT02046174|3917734|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0
2252879|NCT02046369|3917862|FG000|Overall Study|Adverse Event|3
2252880|NCT02046369|3917863|FG001|Overall Study|Adverse Event|3
2252881|NCT02046369|3917862|FG000|Overall Study|Lack of Efficacy|3
2252882|NCT02046369|3917863|FG001|Overall Study|Lack of Efficacy|3
2252883|NCT02046369|3917862|FG000|Overall Study|Lost to Follow-up|3
2252884|NCT02046369|3917863|FG001|Overall Study|Lost to Follow-up|3
2252885|NCT02046369|3917862|FG000|Overall Study|Protocol Violation|1
2252886|NCT02046369|3917863|FG001|Overall Study|Protocol Violation|2
2252887|NCT02046369|3917862|FG000|Overall Study|Withdrawal by Subject|3
2252888|NCT02046369|3917863|FG001|Overall Study|Withdrawal by Subject|6
2252889|NCT02046369|3917862|FG000|Overall Study|never received study drug|0
2252890|NCT02046369|3917863|FG001|Overall Study|never received study drug|1
2252891|NCT02046369|3917862|FG000|Overall Study|non compliance|1
2252892|NCT02046369|3917863|FG001|Overall Study|non compliance|0
2252893|NCT02046564|3917889|FG000|Overall Study|Adverse Event|6
2252894|NCT02046564|3917890|FG001|Overall Study|Adverse Event|3
2252895|NCT02046564|3917889|FG000|Overall Study|Physician Decision|0
2252896|NCT02046564|3917890|FG001|Overall Study|Physician Decision|1
2252897|NCT02046564|3917889|FG000|Overall Study|Protocol Violation|3
2252898|NCT02046564|3917890|FG001|Overall Study|Protocol Violation|1
2252899|NCT02046564|3917889|FG000|Overall Study|Withdrawal by Subject|4
2252900|NCT02046564|3917890|FG001|Overall Study|Withdrawal by Subject|10
2252901|NCT02046564|3917889|FG000|Overall Study|Subject met withdrawal criteria|2
2252902|NCT02046564|3917890|FG001|Overall Study|Subject met withdrawal criteria|5
2252903|NCT02046603|3917898|FG000|Overall Study|Other|11
2252904|NCT02046603|3917899|FG001|Overall Study|Other|66
2252905|NCT02046603|3917898|FG000|Overall Study|Protocol Violation|0
2252906|NCT02046603|3917899|FG001|Overall Study|Protocol Violation|1
2252907|NCT02046603|3917898|FG000|Overall Study|Participant/legal guardian decision|1
2252908|NCT02046603|3917899|FG001|Overall Study|Participant/legal guardian decision|3
2252909|NCT02046603|3917898|FG000|Overall Study|Physician Decision|2
2252910|NCT02046603|3917899|FG001|Overall Study|Physician Decision|1
2252911|NCT02046603|3917898|FG000|Overall Study|Lost to Follow-up|1
2252912|NCT02046603|3917899|FG001|Overall Study|Lost to Follow-up|2
2252913|NCT02046603|3917898|FG000|Overall Study|Death|0
2252914|NCT02046603|3917899|FG001|Overall Study|Death|1
2252915|NCT02046603|3917898|FG000|Overall Study|Adverse Event|0
2252916|NCT02046603|3917899|FG001|Overall Study|Adverse Event|1
2252917|NCT02046616|3917906|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
2252918|NCT02046616|3917906|FG000|24-Week Treatment Period|Any Other Adverse Event|13
2252919|NCT02046616|3917906|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1
2252920|NCT02046616|3917906|FG000|24-Week Treatment Period|Physician Decision|3
2252921|NCT02046616|3917906|FG000|24-Week Treatment Period|Other|1
2252922|NCT02046616|3917906|FG000|8-Week FU Period|Lost to Follow-up|1
2252923|NCT02046993|3917955|FG000|Overall Study|Withdrawal by Subject|2
2252924|NCT02046993|3917956|FG001|Overall Study|Withdrawal by Subject|10
2252925|NCT02046993|3917955|FG000|Overall Study|Lost to Follow-up|1
2252926|NCT02046993|3917956|FG001|Overall Study|Lost to Follow-up|1
2252927|NCT02047045|3917977|FG000|Baseline|Withdrawal by Subject|3
2252928|NCT02047045|3917978|FG001|Baseline|Withdrawal by Subject|2
2252929|NCT02047045|3917977|FG000|Treatment Period (8 Weeks )|Adverse Event|3
2252930|NCT02047045|3917978|FG001|Treatment Period (8 Weeks )|Adverse Event|1
2252931|NCT02047045|3917977|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1
2252932|NCT02047045|3917978|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3
2252933|NCT02047045|3917977|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3
2252934|NCT02047045|3917978|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5
2252935|NCT02047045|3917977|FG000|Treatment Period (8 Weeks )|moved far away out of work|3
2252936|NCT02047045|3917978|FG001|Treatment Period (8 Weeks )|moved far away out of work|0
2252937|NCT02047045|3917977|FG000|Treatment Period (8 Weeks )|no reason was given|1
2252938|NCT02047045|3917978|FG001|Treatment Period (8 Weeks )|no reason was given|0
2252939|NCT02047045|3917977|FG000|Treatment Period (8 Weeks )|refused to take drugs|0
2252940|NCT02047045|3917978|FG001|Treatment Period (8 Weeks )|refused to take drugs|5
2252941|NCT02047045|3917977|FG000|Treatment Period (8 Weeks )|for safety considerations|0
2252942|NCT02047045|3917978|FG001|Treatment Period (8 Weeks )|for safety considerations|1
2252943|NCT02047045|3917977|FG000|Follow-up Period (24 Weeks)|Adverse Event|1
2252944|NCT02047045|3917978|FG001|Follow-up Period (24 Weeks)|Adverse Event|1
2252945|NCT02047110|3917988|FG000|DB Treatment Period up to Week 24|Adverse Event|1
2252946|NCT02047110|3917989|FG001|DB Treatment Period up to Week 24|Adverse Event|0
2252947|NCT02047110|3917990|FG002|DB Treatment Period up to Week 24|Adverse Event|0
2252948|NCT02047110|3917991|FG003|DB Treatment Period up to Week 24|Adverse Event|0
2342124|NCT03478969|4075023|FG001|Overall Study|Lost to Follow-up|0
2252949|NCT02047110|3917988|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1
2252950|NCT02047110|3917989|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0
2252951|NCT02047110|3917990|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0
2252952|NCT02047110|3917991|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0
2252953|NCT02047110|3917988|FG000|DB Treatment Period up to Week 24|Protocol Violation|1
2252954|NCT02047110|3917989|FG001|DB Treatment Period up to Week 24|Protocol Violation|0
2252955|NCT02047110|3917990|FG002|DB Treatment Period up to Week 24|Protocol Violation|0
2252956|NCT02047110|3917991|FG003|DB Treatment Period up to Week 24|Protocol Violation|0
2252957|NCT02047110|3917988|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1
2252958|NCT02047110|3917989|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0
2252959|NCT02047110|3917990|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0
2252960|NCT02047110|3917991|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1
2252961|NCT02047110|3917988|FG000|DB Treatment Period up to Week 24|Other than specified|1
2252962|NCT02047110|3917989|FG001|DB Treatment Period up to Week 24|Other than specified|2
2252963|NCT02047110|3917990|FG002|DB Treatment Period up to Week 24|Other than specified|3
2252964|NCT02047110|3917991|FG003|DB Treatment Period up to Week 24|Other than specified|1
2252965|NCT02047110|3917988|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
2252966|NCT02047110|3917989|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
2252967|NCT02047110|3917990|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
2252968|NCT02047110|3917991|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
2252969|NCT02047110|3917988|FG000|DB (Week 12 up to Week 24)|Other than specified|0
2252970|NCT02047110|3917989|FG001|DB (Week 12 up to Week 24)|Other than specified|1
2252971|NCT02047110|3917990|FG002|DB (Week 12 up to Week 24)|Other than specified|1
2252972|NCT02047110|3917991|FG003|DB (Week 12 up to Week 24)|Other than specified|0
2252973|NCT02047110|3917988|FG000|Escape Treatment Period|Withdrawal by Subject|1
2252974|NCT02047110|3917989|FG001|Escape Treatment Period|Withdrawal by Subject|2
2252975|NCT02047110|3917990|FG002|Escape Treatment Period|Withdrawal by Subject|1
2252976|NCT02047110|3917991|FG003|Escape Treatment Period|Withdrawal by Subject|1
2252977|NCT02047110|3917988|FG000|Escape Treatment Period|Adverse Event|1
2252978|NCT02047110|3917989|FG001|Escape Treatment Period|Adverse Event|2
2252979|NCT02047110|3917990|FG002|Escape Treatment Period|Adverse Event|2
2252980|NCT02047110|3917991|FG003|Escape Treatment Period|Adverse Event|0
2252981|NCT02047110|3917988|FG000|Escape Treatment Period|Other than specified|1
2252982|NCT02047110|3917989|FG001|Escape Treatment Period|Other than specified|2
2252983|NCT02047110|3917990|FG002|Escape Treatment Period|Other than specified|0
2252984|NCT02047110|3917991|FG003|Escape Treatment Period|Other than specified|1
2342125|NCT03478969|4075024|FG002|Overall Study|Lost to Follow-up|1
2342126|NCT03479216|4075053|FG000|Overall Study|Withdrawal by Subject|3
2342127|NCT03479216|4075054|FG001|Overall Study|Withdrawal by Subject|2
2038734|NCT00423813|3609102|FG001|Overall Study|Subject started night shift work|0
2038735|NCT00423813|3609103|FG002|Overall Study|Subject started night shift work|0
2038736|NCT00423813|3609101|FG000|Overall Study|Will start exclusionary medications|0
2038737|NCT00423813|3609102|FG001|Overall Study|Will start exclusionary medications|1
2038738|NCT00423813|3609103|FG002|Overall Study|Will start exclusionary medications|0
2038739|NCT00423813|3609101|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0
2038740|NCT00423813|3609102|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0
2038741|NCT00423813|3609103|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1
2038742|NCT00423852|3609111|FG000|Overall Study|Removed pior to the high-dose portion|3
2038743|NCT00423891|3609127|FG000|Enrolled|Withdrawal by Subject|0
2038744|NCT00423891|3609128|FG001|Enrolled|Withdrawal by Subject|0
2038745|NCT00423891|3609129|FG002|Enrolled|Withdrawal by Subject|1
2038746|NCT00423891|3609127|FG000|Enrolled|Lost to Follow-up|0
2038747|NCT00423891|3609128|FG001|Enrolled|Lost to Follow-up|0
2038748|NCT00423891|3609129|FG002|Enrolled|Lost to Follow-up|1
2038749|NCT00423891|3609127|FG000|Enrolled|No longer met criteria|11
2038750|NCT00423891|3609128|FG001|Enrolled|No longer met criteria|2
2038751|NCT00423891|3609129|FG002|Enrolled|No longer met criteria|1
2038752|NCT00423891|3609127|FG000|Treatment|Withdrawal by Subject|1
2038753|NCT00423891|3609128|FG001|Treatment|Withdrawal by Subject|0
2038754|NCT00423891|3609129|FG002|Treatment|Withdrawal by Subject|0
2038755|NCT00423891|3609127|FG000|Treatment|Lost to Follow-up|1
2038756|NCT00423891|3609128|FG001|Treatment|Lost to Follow-up|0
2038757|NCT00423891|3609129|FG002|Treatment|Lost to Follow-up|0
2038758|NCT00423891|3609127|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0
2038759|NCT00423891|3609128|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3
2038760|NCT00423891|3609129|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2
2038761|NCT00423891|3609127|FG000|Post-Dosing Follow Up|Lost to Follow-up|2
2038762|NCT00423891|3609128|FG001|Post-Dosing Follow Up|Lost to Follow-up|0
2038763|NCT00423891|3609129|FG002|Post-Dosing Follow Up|Lost to Follow-up|0
2195902|NCT01527006|3828655|FG000|Extension Phase|Lost to Follow-up|0
2195903|NCT01527006|3828656|FG001|Extension Phase|Lost to Follow-up|1
2195904|NCT01527006|3828655|FG000|Extension Phase|Subject Choice|1
2195905|NCT01527006|3828656|FG001|Extension Phase|Subject Choice|1
2195906|NCT01527006|3828655|FG000|Extension Phase|Inadequate therapeutic effect|1
2195907|NCT01527006|3828656|FG001|Extension Phase|Inadequate therapeutic effect|1
2195908|NCT01527006|3828655|FG000|Extension Phase|Other|0
2195909|NCT01527006|3828656|FG001|Extension Phase|Other|3
2195910|NCT01527110|3828681|FG000|Overall Study|Adverse Event|1
2252985|NCT02047110|3917988|FG000|OLE Treatment Period|Other than specified|0
2252986|NCT02047110|3917989|FG001|OLE Treatment Period|Other than specified|0
2252987|NCT02047110|3917990|FG002|OLE Treatment Period|Other than specified|1
2252988|NCT02047110|3917991|FG003|OLE Treatment Period|Other than specified|0
2252989|NCT02047227|3918010|FG000|Overall Study|Adverse Event|2
2252990|NCT02047227|3918011|FG001|Overall Study|Adverse Event|4
2252991|NCT02047227|3918010|FG000|Overall Study|Lost to Follow-up|0
2252992|NCT02047227|3918011|FG001|Overall Study|Lost to Follow-up|3
2252993|NCT02047227|3918010|FG000|Overall Study|Protocol Violation|1
2252994|NCT02047227|3918011|FG001|Overall Study|Protocol Violation|0
2252995|NCT02047227|3918010|FG000|Overall Study|Spontaneous pregnancy|1
2252996|NCT02047227|3918011|FG001|Overall Study|Spontaneous pregnancy|0
2252997|NCT02047227|3918010|FG000|Overall Study|Lack of ovarian response to stimulation|35
2252998|NCT02047227|3918011|FG001|Overall Study|Lack of ovarian response to stimulation|32
2252999|NCT02047227|3918010|FG000|Overall Study|No oocytes retrieved|21
2253000|NCT02047227|3918011|FG001|Overall Study|No oocytes retrieved|20
2253001|NCT02047227|3918010|FG000|Overall Study|No fertilization|61
2253002|NCT02047227|3918011|FG001|Overall Study|No fertilization|51
2253003|NCT02047227|3918010|FG000|Overall Study|Intention to freeze all embryos|1
2253004|NCT02047227|3918011|FG001|Overall Study|Intention to freeze all embryos|0
2253005|NCT02047227|3918010|FG000|Overall Study|All embryos discarded|12
2253006|NCT02047227|3918011|FG001|Overall Study|All embryos discarded|11
2253007|NCT02047227|3918010|FG000|Overall Study|Other|10
2253008|NCT02047227|3918011|FG001|Overall Study|Other|9
2253009|NCT02047253|3918017|FG000|Overall Study|Lost to Follow-up|8
2253010|NCT02047318|3918025|FG000|Core Study Period|Did not consent to 52-week follow- up|8
2253011|NCT02047318|3918025|FG000|Core Study Period|Adverse Event|1
2253012|NCT02047318|3918025|FG000|Core Study Period|Withdrawal by caregiver|3
2253013|NCT02047318|3918025|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1
2253014|NCT02047604|3918065|FG000|Overall Study|Withdrawal by Subject|0
2253015|NCT02047604|3918066|FG001|Overall Study|Withdrawal by Subject|0
2253016|NCT02047604|3918067|FG002|Overall Study|Withdrawal by Subject|0
2253017|NCT02047604|3918068|FG003|Overall Study|Withdrawal by Subject|0
2253018|NCT02047604|3918069|FG004|Overall Study|Withdrawal by Subject|1
2253019|NCT02047604|3918070|FG005|Overall Study|Withdrawal by Subject|1
2253020|NCT02047734|3918094|FG000|Overall Study|Adverse Event|18
2253021|NCT02047734|3918095|FG001|Overall Study|Adverse Event|13
2253022|NCT02047734|3918096|FG002|Overall Study|Adverse Event|13
2253023|NCT02047734|3918094|FG000|Overall Study|Lack of Efficacy|4
2253024|NCT02047734|3918095|FG001|Overall Study|Lack of Efficacy|5
2253025|NCT02047734|3918096|FG002|Overall Study|Lack of Efficacy|1
2253026|NCT02047734|3918094|FG000|Overall Study|Protocol Violation|3
2253027|NCT02047734|3918095|FG001|Overall Study|Protocol Violation|1
2253028|NCT02047734|3918096|FG002|Overall Study|Protocol Violation|1
2253029|NCT02047734|3918094|FG000|Overall Study|Lost to Follow-up|1
2253030|NCT02047734|3918095|FG001|Overall Study|Lost to Follow-up|4
2253031|NCT02047734|3918096|FG002|Overall Study|Lost to Follow-up|0
2253032|NCT02047734|3918094|FG000|Overall Study|Death|0
2253033|NCT02047734|3918095|FG001|Overall Study|Death|1
2253034|NCT02047734|3918096|FG002|Overall Study|Death|0
2253035|NCT02047734|3918094|FG000|Overall Study|Withdrawal by Subject|30
2253036|NCT02047734|3918095|FG001|Overall Study|Withdrawal by Subject|31
2253037|NCT02047734|3918096|FG002|Overall Study|Withdrawal by Subject|19
2253038|NCT02047734|3918094|FG000|Overall Study|Physician Decision|7
2253039|NCT02047734|3918095|FG001|Overall Study|Physician Decision|6
2253040|NCT02047734|3918096|FG002|Overall Study|Physician Decision|5
2253041|NCT02047734|3918094|FG000|Overall Study|Miscellaneous|2
2253042|NCT02047734|3918095|FG001|Overall Study|Miscellaneous|4
2253043|NCT02047734|3918096|FG002|Overall Study|Miscellaneous|6
2253044|NCT02047734|3918094|FG000|Overall Study|Did Not Receive Study Drug|2
2253045|NCT02047734|3918095|FG001|Overall Study|Did Not Receive Study Drug|4
2253046|NCT02047734|3918096|FG002|Overall Study|Did Not Receive Study Drug|1
2253047|NCT02047903|3918104|FG000|Overall Study|Adverse Event|14
2253048|NCT02047903|3918104|FG000|Overall Study|Serious adverse event|10
2253049|NCT02047903|3918104|FG000|Overall Study|Withdrawal by Subject|16
2253050|NCT02047903|3918104|FG000|Overall Study|Lost to Follow-up|4
2253051|NCT02047903|3918104|FG000|Overall Study|Reason not listed|6
2253052|NCT02047903|3918104|FG000|Overall Study|Not Treated|9
2253053|NCT02048072|3918133|FG000|Overall Study|Adverse Event|3
2253054|NCT02048072|3918133|FG000|Overall Study|Lost to Follow-up|1
2253055|NCT02048241|3918139|FG000|Overall Study|Withdrawal by Subject|0
2253056|NCT02048241|3918140|FG001|Overall Study|Withdrawal by Subject|1
2253057|NCT02048722|3918155|FG000|2 Cycles of Treatment|Adverse Event|2
2253058|NCT02048722|3918155|FG000|2 Cycles of Treatment|Withdrawal by Subject|4
2253059|NCT02048722|3918155|FG000|2 Cycles of Treatment|Progressive Disease|2
2253060|NCT02048722|3918155|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10
2253061|NCT02048722|3918155|FG000|Follow up for 5 Years|Death|22
2253062|NCT02048722|3918155|FG000|Follow up for 5 Years|Withdrawal by Subject|3
2253063|NCT02048722|3918155|FG000|Follow up for 5 Years|Still in follow up|4
2253064|NCT02048826|3918161|FG000|Overall Study|Withdrawal by Subject|1
2253065|NCT02048826|3918162|FG001|Overall Study|Withdrawal by Subject|0
2253066|NCT02049437|3918215|FG000|Period 1|Adverse Event|1
2253067|NCT02049437|3918216|FG001|Period 1|Adverse Event|1
2253068|NCT02049437|3918215|FG000|Period 1|Adverse Event|1
2253069|NCT02049437|3918216|FG001|Period 1|Adverse Event|0
2253070|NCT02049450|3918222|FG000|Overall Study|Adverse Event|2
2253071|NCT02049450|3918222|FG000|Overall Study|Withdrawal by Subject|1
2253072|NCT02049450|3918222|FG000|Overall Study|Patients/guardian decision|1
2253073|NCT02049814|3918253|FG000|Overall Study|Reason not Specified|4
2253074|NCT02049814|3918254|FG001|Overall Study|Reason not Specified|3
2253075|NCT02049814|3918253|FG000|Overall Study|Pregnancy|1
2253076|NCT02049814|3918254|FG001|Overall Study|Pregnancy|0
2253077|NCT02049814|3918253|FG000|Overall Study|Lost to Follow-up|2
2253078|NCT02049814|3918254|FG001|Overall Study|Lost to Follow-up|3
2253079|NCT02049814|3918253|FG000|Overall Study|Serious Protocol Violation|5
2253080|NCT02049814|3918254|FG001|Overall Study|Serious Protocol Violation|7
2253081|NCT02049814|3918253|FG000|Overall Study|Study Termination|0
2253082|NCT02049814|3918254|FG001|Overall Study|Study Termination|1
2253083|NCT02049814|3918253|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8
2253084|NCT02049814|3918254|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5
2253085|NCT02049814|3918253|FG000|Overall Study|Voluntary withdrawal|9
2253086|NCT02049814|3918254|FG001|Overall Study|Voluntary withdrawal|8
2253087|NCT02049866|3918260|FG000|Overall Study|Withdrawal by Subject|1
2253088|NCT02049944|3918277|FG000|Overall Study|Protocol Violation|2
2253089|NCT02049957|3918290|FG000|Overall Study|Progressive Disease|5
2253090|NCT02049957|3918291|FG001|Overall Study|Progressive Disease|4
2253091|NCT02049957|3918292|FG002|Overall Study|Progressive Disease|2
2342128|NCT03479216|4075053|FG000|Overall Study|Physician Decision|2
2342129|NCT03479216|4075054|FG001|Overall Study|Physician Decision|3
2342130|NCT03480009|4075072|FG000|Overall Study|Lost to Follow-up|4
2342131|NCT03480009|4075073|FG001|Overall Study|Lost to Follow-up|5
2342132|NCT03480009|4075074|FG002|Overall Study|Lost to Follow-up|4
2342133|NCT03480009|4075075|FG003|Overall Study|Lost to Follow-up|0
2342134|NCT03480022|4075090|FG000|Overall Study|Pregnancy|2
2342135|NCT03480022|4075091|FG001|Overall Study|Pregnancy|0
2342136|NCT03480022|4075090|FG000|Overall Study|Adverse Event|6
2342137|NCT03480022|4075091|FG001|Overall Study|Adverse Event|0
2342138|NCT03480022|4075090|FG000|Overall Study|Lack of Efficacy|0
2342139|NCT03480022|4075091|FG001|Overall Study|Lack of Efficacy|2
2342140|NCT03480022|4075090|FG000|Overall Study|Physician Decision|0
2342141|NCT03480022|4075091|FG001|Overall Study|Physician Decision|1
2342142|NCT03480022|4075090|FG000|Overall Study|Withdrawal by Subject|2
2342143|NCT03480022|4075091|FG001|Overall Study|Withdrawal by Subject|0
2342144|NCT03480022|4075090|FG000|Overall Study|Medication concerns|1
2342145|NCT03480022|4075091|FG001|Overall Study|Medication concerns|0
2342146|NCT03480022|4075090|FG000|Overall Study|Family member COVID exposure|0
2342147|NCT03480022|4075091|FG001|Overall Study|Family member COVID exposure|1
2342148|NCT03480152|4075108|FG000|Phase I|Signed consent. Died before treatment.|1
2342149|NCT03480152|4075109|FG001|Phase I|Signed consent. Died before treatment.|0
2342150|NCT03480152|4075110|FG002|Phase I|Signed consent. Died before treatment.|0
2342151|NCT03480243|4075118|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1
2342152|NCT03480243|4075118|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1
2342153|NCT03480425|4075131|FG000|Overall Study|Force transducer technical failure|1
2342154|NCT03480750|4075147|FG000|Overall Study|Withdrawal by Subject|0
2342155|NCT03480750|4075148|FG001|Overall Study|Withdrawal by Subject|1
2342156|NCT03480750|4075149|FG002|Overall Study|Withdrawal by Subject|0
2342157|NCT03480750|4075150|FG003|Overall Study|Withdrawal by Subject|0
2342158|NCT03480750|4075151|FG004|Overall Study|Withdrawal by Subject|0
2342159|NCT03480750|4075152|FG005|Overall Study|Withdrawal by Subject|0
2342160|NCT03480750|4075147|FG000|Overall Study|The interruption in Trientine shippment|0
2342161|NCT03480750|4075148|FG001|Overall Study|The interruption in Trientine shippment|0
2342162|NCT03480750|4075149|FG002|Overall Study|The interruption in Trientine shippment|0
2342163|NCT03480750|4075150|FG003|Overall Study|The interruption in Trientine shippment|0
2342164|NCT03480750|4075151|FG004|Overall Study|The interruption in Trientine shippment|0
2342165|NCT03480750|4075152|FG005|Overall Study|The interruption in Trientine shippment|1
2353234|NCT02860169|4104723|FG000|Part A|Other (Screening failure)|6
2353235|NCT02860169|4104723|FG000|Part A|Other (Survey not completed)|3
2353236|NCT02860169|4104723|FG000|Part A|Other (did not completed consent)|1
2353237|NCT02860169|4104723|FG000|Part B|Other (Screening failure)|10
2353238|NCT02860169|4104723|FG000|Part B|Withdrawal by Subject|1
2353239|NCT02860169|4104723|FG000|Part C|Other (Screening failure)|1
2353240|NCT02865395|4104732|FG000|Overall Study|Physician Decision|6
2353241|NCT02865395|4104733|FG001|Overall Study|Physician Decision|10
2353242|NCT02865395|4104734|FG002|Overall Study|Physician Decision|7
2353243|NCT02868892|4104742|FG000|Overall Study|Investigator left site and no follow-up|6
2353244|NCT02865083|4104748|FG000|Overall Study|Early Termination|3
2353245|NCT02865083|4104749|FG001|Overall Study|Early Termination|1
2253092|NCT02049957|3918293|FG003|Overall Study|Progressive Disease|2
2253093|NCT02049957|3918294|FG004|Overall Study|Progressive Disease|6
2253094|NCT02049957|3918295|FG005|Overall Study|Progressive Disease|35
2253095|NCT02049957|3918296|FG006|Overall Study|Progressive Disease|7
2253096|NCT02049957|3918297|FG007|Overall Study|Progressive Disease|26
2253097|NCT02049957|3918298|FG008|Overall Study|Progressive Disease|6
2253098|NCT02049957|3918290|FG000|Overall Study|Adverse Event|1
2253099|NCT02049957|3918291|FG001|Overall Study|Adverse Event|1
2253100|NCT02049957|3918292|FG002|Overall Study|Adverse Event|1
2253101|NCT02049957|3918293|FG003|Overall Study|Adverse Event|0
2253102|NCT02049957|3918294|FG004|Overall Study|Adverse Event|0
2253103|NCT02049957|3918295|FG005|Overall Study|Adverse Event|5
2253104|NCT02049957|3918296|FG006|Overall Study|Adverse Event|0
2253105|NCT02049957|3918297|FG007|Overall Study|Adverse Event|6
2253106|NCT02049957|3918298|FG008|Overall Study|Adverse Event|1
2253107|NCT02049957|3918290|FG000|Overall Study|Study Terminated by Sponsor|0
2253108|NCT02049957|3918291|FG001|Overall Study|Study Terminated by Sponsor|1
2253109|NCT02049957|3918292|FG002|Overall Study|Study Terminated by Sponsor|0
2253110|NCT02049957|3918293|FG003|Overall Study|Study Terminated by Sponsor|0
2253111|NCT02049957|3918294|FG004|Overall Study|Study Terminated by Sponsor|0
2253112|NCT02049957|3918295|FG005|Overall Study|Study Terminated by Sponsor|0
2253113|NCT02049957|3918296|FG006|Overall Study|Study Terminated by Sponsor|1
2253114|NCT02049957|3918297|FG007|Overall Study|Study Terminated by Sponsor|0
2253115|NCT02049957|3918298|FG008|Overall Study|Study Terminated by Sponsor|0
2253116|NCT02049957|3918290|FG000|Overall Study|Withdrawal by Subject|0
2253117|NCT02049957|3918291|FG001|Overall Study|Withdrawal by Subject|0
2253118|NCT02049957|3918292|FG002|Overall Study|Withdrawal by Subject|0
2253119|NCT02049957|3918293|FG003|Overall Study|Withdrawal by Subject|1
2253120|NCT02049957|3918294|FG004|Overall Study|Withdrawal by Subject|0
2253121|NCT02049957|3918295|FG005|Overall Study|Withdrawal by Subject|2
2253122|NCT02049957|3918296|FG006|Overall Study|Withdrawal by Subject|0
2253123|NCT02049957|3918297|FG007|Overall Study|Withdrawal by Subject|3
2253124|NCT02049957|3918298|FG008|Overall Study|Withdrawal by Subject|1
2253125|NCT02049957|3918290|FG000|Overall Study|Physician Decision|0
2253126|NCT02049957|3918291|FG001|Overall Study|Physician Decision|0
2253127|NCT02049957|3918292|FG002|Overall Study|Physician Decision|0
2253128|NCT02049957|3918293|FG003|Overall Study|Physician Decision|0
2253129|NCT02049957|3918294|FG004|Overall Study|Physician Decision|0
2253130|NCT02049957|3918295|FG005|Overall Study|Physician Decision|1
2253131|NCT02049957|3918296|FG006|Overall Study|Physician Decision|0
2253132|NCT02049957|3918297|FG007|Overall Study|Physician Decision|0
2253133|NCT02049957|3918298|FG008|Overall Study|Physician Decision|0
2253134|NCT02050048|3918320|FG000|Overall Study|Lost to Follow-up|0
2253135|NCT02050048|3918321|FG001|Overall Study|Lost to Follow-up|1
2253136|NCT02050048|3918320|FG000|Overall Study|Death|1
2253137|NCT02050048|3918321|FG001|Overall Study|Death|0
2253138|NCT02050048|3918320|FG000|Overall Study|Ineligible after ERCP|4
2253139|NCT02050048|3918321|FG001|Overall Study|Ineligible after ERCP|1
2253140|NCT02050321|3918327|FG000|Overall Study|Withdrawal by Subject|1
2253141|NCT02050321|3918327|FG000|Overall Study|Adverse Event|1
2253142|NCT02050373|3918343|FG000|Overall Study|Adverse Event|4
2253143|NCT02050373|3918344|FG001|Overall Study|Adverse Event|7
2253144|NCT02050373|3918343|FG000|Overall Study|Death|3
2253145|NCT02050373|3918344|FG001|Overall Study|Death|3
2253146|NCT02051296|3918367|FG000|Overall Study|Lost to Follow-up|1
2253147|NCT02051296|3918368|FG001|Overall Study|Lost to Follow-up|2
2253148|NCT02051296|3918367|FG000|Overall Study|withdraw prior to treatment|7
2253149|NCT02051296|3918368|FG001|Overall Study|withdraw prior to treatment|7
2342166|NCT03480763|4075177|FG000|Overall Study|Withdrawal by Subject|18
2342167|NCT03480763|4075178|FG001|Overall Study|Withdrawal by Subject|10
2342168|NCT03480763|4075177|FG000|Overall Study|Lost to Follow-up|4
2342169|NCT03480763|4075178|FG001|Overall Study|Lost to Follow-up|7
2342170|NCT03480763|4075177|FG000|Overall Study|non-study pneumococcal vaccine|1
2342171|NCT03480763|4075178|FG001|Overall Study|non-study pneumococcal vaccine|0
2342172|NCT03480763|4075177|FG000|Overall Study|oncological treatment|0
2342173|NCT03480763|4075178|FG001|Overall Study|oncological treatment|2
2342174|NCT03480763|4075177|FG000|Overall Study|pain with vaccination|1
2342175|NCT03480763|4075178|FG001|Overall Study|pain with vaccination|0
2342176|NCT03480802|4075192|FG000|Overall Study|Lost to Follow-up|5
2342177|NCT03480802|4075193|FG001|Overall Study|Lost to Follow-up|1
2342178|NCT03480802|4075192|FG000|Overall Study|Withdrawal by Subject|2
2342179|NCT03480802|4075193|FG001|Overall Study|Withdrawal by Subject|1
2342180|NCT03480802|4075192|FG000|Overall Study|Relocated|0
2342181|NCT03480802|4075193|FG001|Overall Study|Relocated|1
2342182|NCT03480841|4075201|FG000|Overall Study|Lost to Follow-up|2
2342183|NCT03480932|4075221|FG000|Overall Study|Death|1
2342184|NCT03480932|4075222|FG001|Overall Study|Death|1
2342185|NCT03480932|4075223|FG002|Overall Study|Death|0
2342186|NCT03480932|4075221|FG000|Overall Study|Lost to Follow-up|0
2342187|NCT03480932|4075222|FG001|Overall Study|Lost to Follow-up|2
2342188|NCT03480932|4075223|FG002|Overall Study|Lost to Follow-up|3
2342189|NCT03480932|4075221|FG000|Overall Study|Incarcerated|2
2342190|NCT03480932|4075222|FG001|Overall Study|Incarcerated|2
2342191|NCT03480932|4075223|FG002|Overall Study|Incarcerated|2
2342192|NCT03481309|4075246|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1
2342193|NCT03481309|4075247|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0
2342194|NCT03481309|4075248|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0
2342195|NCT03481309|4075249|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0
2342196|NCT03481309|4075250|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0
2342197|NCT03481309|4075251|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0
2253150|NCT02051764|3918424|FG000|Overall Study|Study terminated by sponsor|0
2253151|NCT02051764|3918425|FG001|Overall Study|Study terminated by sponsor|7
2253152|NCT02052011|3918458|FG000|Overall Study|Lost to Follow-up|3
2253153|NCT02052011|3918459|FG001|Overall Study|Lost to Follow-up|0
2253154|NCT02052011|3918458|FG000|Overall Study|Withdrawal by Subject|1
2253155|NCT02052011|3918459|FG001|Overall Study|Withdrawal by Subject|2
2253156|NCT02052310|3918476|FG000|Overall Study|Death|64
2253157|NCT02052310|3918477|FG001|Overall Study|Death|54
2253158|NCT02052310|3918476|FG000|Overall Study|Withdrawal by Subject|37
2253159|NCT02052310|3918477|FG001|Overall Study|Withdrawal by Subject|49
2253160|NCT02052310|3918476|FG000|Overall Study|Other than specified|32
2253161|NCT02052310|3918477|FG001|Overall Study|Other than specified|29
2253162|NCT02052310|3918476|FG000|Overall Study|Adverse Event|29
2253163|NCT02052310|3918477|FG001|Overall Study|Adverse Event|22
2253164|NCT02052310|3918476|FG000|Overall Study|Kidney Transplant|23
2253165|NCT02052310|3918477|FG001|Overall Study|Kidney Transplant|29
2253166|NCT02052310|3918476|FG000|Overall Study|Physician Decision|14
2253167|NCT02052310|3918477|FG001|Overall Study|Physician Decision|7
2253168|NCT02052310|3918476|FG000|Overall Study|Lack of Efficacy|6
2253169|NCT02052310|3918477|FG001|Overall Study|Lack of Efficacy|1
2253170|NCT02052310|3918476|FG000|Overall Study|Site Terminated by Sponsor|5
2253171|NCT02052310|3918477|FG001|Overall Study|Site Terminated by Sponsor|13
2253172|NCT02052310|3918476|FG000|Overall Study|Lost to Follow-up|4
2253173|NCT02052310|3918477|FG001|Overall Study|Lost to Follow-up|2
2253174|NCT02052310|3918476|FG000|Overall Study|Protocol Violation|1
2253175|NCT02052310|3918477|FG001|Overall Study|Protocol Violation|6
2253176|NCT02052414|3918483|FG000|Overall Study|Adverse Event|12
2253177|NCT02052414|3918483|FG000|Overall Study|Lack of Efficacy|2
2253178|NCT02052414|3918483|FG000|Overall Study|Withdrawal by Subject|3
2253179|NCT02052440|3918490|FG000|Overall Study|Withdrawal by Subject|0
2253180|NCT02052440|3918491|FG001|Overall Study|Withdrawal by Subject|1
2253181|NCT02052466|3918497|FG000|Overall Study|Withdrawal by Subject|1
2253182|NCT02052466|3918497|FG000|Overall Study|Acromial fracture|1
2253183|NCT02052596|3918519|FG000|Active Phase|Adverse Event|3
2253184|NCT02052596|3918520|FG001|Active Phase|Adverse Event|2
2253185|NCT02052596|3918519|FG000|Active Phase|Lost to Follow-up|8
2253186|NCT02052596|3918520|FG001|Active Phase|Lost to Follow-up|11
2253187|NCT02052596|3918519|FG000|Active Phase|Protocol Violation|1
2253188|NCT02052596|3918520|FG001|Active Phase|Protocol Violation|2
2253189|NCT02052596|3918519|FG000|Active Phase|Withdrawal by Subject|3
2253190|NCT02052596|3918520|FG001|Active Phase|Withdrawal by Subject|4
2253191|NCT02052596|3918519|FG000|Active Phase|Enrolled in error|1
2253192|NCT02052596|3918520|FG001|Active Phase|Enrolled in error|0
2253193|NCT02052596|3918519|FG000|Active Phase|Lost due to Crohn's disease|0
2253194|NCT02052596|3918520|FG001|Active Phase|Lost due to Crohn's disease|1
2253195|NCT02052596|3918519|FG000|Safety Phase|Adverse Event|6
2253196|NCT02052596|3918520|FG001|Safety Phase|Adverse Event|3
2253197|NCT02052596|3918519|FG000|Safety Phase|Lost to Follow-up|11
2253198|NCT02052596|3918520|FG001|Safety Phase|Lost to Follow-up|18
2253199|NCT02052596|3918519|FG000|Safety Phase|Protocol Violation|1
2253200|NCT02052596|3918520|FG001|Safety Phase|Protocol Violation|2
2253201|NCT02052596|3918519|FG000|Safety Phase|Withdrawal by Subject|8
2253202|NCT02052596|3918520|FG001|Safety Phase|Withdrawal by Subject|11
2253203|NCT02052596|3918519|FG000|Safety Phase|Enrolled in error|1
2253204|NCT02052596|3918520|FG001|Safety Phase|Enrolled in error|0
2253205|NCT02052596|3918519|FG000|Safety Phase|Lost due to Crohn's disease|0
2253206|NCT02052596|3918520|FG001|Safety Phase|Lost due to Crohn's disease|1
2253207|NCT02052960|3918567|FG000|Overall Study|Adverse Event|19
2253208|NCT02052960|3918568|FG001|Overall Study|Adverse Event|17
2253209|NCT02052960|3918567|FG000|Overall Study|Protocol Violation|4
2342198|NCT03481725|4075270|FG000|Overall Study|Withdrawal by Subject|1
2342199|NCT03481725|4075271|FG001|Overall Study|Withdrawal by Subject|0
2342200|NCT03481816|4075281|FG000|Starting Dose|Refused further vaccines after 1 dose|1
2342201|NCT03481816|4075282|FG001|Starting Dose|Refused further vaccines after 1 dose|0
2342202|NCT03481816|4075281|FG000|Dose Expansion|Off treatment due to progressive disease|0
2342203|NCT03481816|4075282|FG001|Dose Expansion|Off treatment due to progressive disease|5
2342204|NCT03481816|4075281|FG000|Dose Expansion|Withdrawal by Subject|0
2342205|NCT03481816|4075282|FG001|Dose Expansion|Withdrawal by Subject|2
2342206|NCT03481816|4075281|FG000|Dose Expansion|Physician Decision|0
2342207|NCT03481816|4075282|FG001|Dose Expansion|Physician Decision|5
2342208|NCT03482011|4075292|FG000|Induction Period (16 Weeks)|Adverse Event|1
2342209|NCT03482011|4075293|FG001|Induction Period (16 Weeks)|Adverse Event|3
2342210|NCT03482011|4075294|FG002|Induction Period (16 Weeks)|Adverse Event|0
2342211|NCT03482011|4075295|FG003|Induction Period (16 Weeks)|Adverse Event|0
2342212|NCT03482011|4075296|FG004|Induction Period (16 Weeks)|Adverse Event|0
2342213|NCT03482011|4075297|FG005|Induction Period (16 Weeks)|Adverse Event|0
2342214|NCT03482011|4075298|FG006|Induction Period (16 Weeks)|Adverse Event|0
2342215|NCT03482011|4075299|FG007|Induction Period (16 Weeks)|Adverse Event|0
2038764|NCT00423917|3609139|FG000|Overall Study|Cancel|2
2038765|NCT00423917|3609139|FG000|Overall Study|Ineligible|1
2253210|NCT02052960|3918568|FG001|Overall Study|Protocol Violation|3
2253211|NCT02052960|3918567|FG000|Overall Study|Withdrawal by Subject|6
2253212|NCT02052960|3918568|FG001|Overall Study|Withdrawal by Subject|11
2253213|NCT02052960|3918567|FG000|Overall Study|Other|25
2253214|NCT02052960|3918568|FG001|Overall Study|Other|15
2253215|NCT02053168|3918581|FG000|Overall Study|Withdrawal by Subject|1
2253216|NCT02053168|3918581|FG000|Overall Study|Physician Decision|1
2253217|NCT02053168|3918581|FG000|Overall Study|Lost to Follow-up|1
2253218|NCT02053493|3918608|FG000|Overall Study|Withdrawal by Subject|1
2253219|NCT02053493|3918609|FG001|Overall Study|Withdrawal by Subject|1
2253220|NCT02053610|3918617|FG000|Overall Study|Adverse Event/Intercurrent Illness|25
2253221|NCT02053610|3918618|FG001|Overall Study|Adverse Event/Intercurrent Illness|43
2253222|NCT02053610|3918617|FG000|Overall Study|Withdrew Consent|2
2253223|NCT02053610|3918618|FG001|Overall Study|Withdrew Consent|9
2253224|NCT02053610|3918617|FG000|Overall Study|Death|5
2253225|NCT02053610|3918618|FG001|Overall Study|Death|5
2253226|NCT02053610|3918617|FG000|Overall Study|Administrative/Other|1
2253227|NCT02053610|3918618|FG001|Overall Study|Administrative/Other|1
2253228|NCT02053610|3918617|FG000|Overall Study|Disease Progression|2
2253229|NCT02053610|3918618|FG001|Overall Study|Disease Progression|3
2253230|NCT02053610|3918617|FG000|Overall Study|Refused treatment/Did not cooperate|1
2253231|NCT02053610|3918618|FG001|Overall Study|Refused treatment/Did not cooperate|3
2253232|NCT02053610|3918617|FG000|Overall Study|Did not Receive Treatment|4
2253233|NCT02053610|3918618|FG001|Overall Study|Did not Receive Treatment|2
2253234|NCT02053610|3918617|FG000|Overall Study|Insufficient Therapeutic Response|1
2253235|NCT02053610|3918618|FG001|Overall Study|Insufficient Therapeutic Response|1
2253236|NCT02053610|3918617|FG000|Overall Study|Violation of Selection Criteria|1
2253237|NCT02053610|3918618|FG001|Overall Study|Violation of Selection Criteria|0
2253238|NCT02053753|3918626|FG000|Overall Study|Withdrawal by Subject|2
2253239|NCT02053753|3918627|FG001|Overall Study|Withdrawal by Subject|4
2253240|NCT02053753|3918626|FG000|Overall Study|Decision by Sponsor|1
2253241|NCT02053753|3918627|FG001|Overall Study|Decision by Sponsor|1
2253242|NCT02053753|3918626|FG000|Overall Study|Lost to Follow-up|4
2253243|NCT02053753|3918627|FG001|Overall Study|Lost to Follow-up|3
2253244|NCT02054130|3918637|FG000|Overall Study|Withdrawal by Subject|4
2253245|NCT02054130|3918638|FG001|Overall Study|Withdrawal by Subject|4
2253246|NCT02054130|3918639|FG002|Overall Study|Withdrawal by Subject|7
2253247|NCT02054130|3918640|FG003|Overall Study|Withdrawal by Subject|10
2253248|NCT02054130|3918637|FG000|Overall Study|Death|0
2253249|NCT02054130|3918638|FG001|Overall Study|Death|1
2253250|NCT02054130|3918639|FG002|Overall Study|Death|0
2253251|NCT02054130|3918640|FG003|Overall Study|Death|0
2253252|NCT02054130|3918637|FG000|Overall Study|Lost to Follow-up|0
2253253|NCT02054130|3918638|FG001|Overall Study|Lost to Follow-up|0
2253254|NCT02054130|3918639|FG002|Overall Study|Lost to Follow-up|1
2253255|NCT02054130|3918640|FG003|Overall Study|Lost to Follow-up|2
2253256|NCT02054130|3918637|FG000|Overall Study|Missed dose|4
2253257|NCT02054130|3918638|FG001|Overall Study|Missed dose|6
2253258|NCT02054130|3918639|FG002|Overall Study|Missed dose|7
2253259|NCT02054130|3918640|FG003|Overall Study|Missed dose|10
2253260|NCT02054325|3918664|FG000|Overall Study|Lost to Follow-up|8
2253261|NCT02054325|3918665|FG001|Overall Study|Lost to Follow-up|5
2253262|NCT02054481|3918684|FG000|Overall Study|Adverse Event|1
2253263|NCT02054481|3918685|FG001|Overall Study|Adverse Event|1
2253264|NCT02054481|3918686|FG002|Overall Study|Adverse Event|0
2253265|NCT02054481|3918687|FG003|Overall Study|Adverse Event|1
2253266|NCT02054481|3918684|FG000|Overall Study|Lost to Follow-up|1
2253267|NCT02054481|3918685|FG001|Overall Study|Lost to Follow-up|0
2253268|NCT02054481|3918686|FG002|Overall Study|Lost to Follow-up|0
2253269|NCT02054481|3918687|FG003|Overall Study|Lost to Follow-up|0
2253270|NCT02054481|3918684|FG000|Overall Study|Other reason|2
2253271|NCT02054481|3918685|FG001|Overall Study|Other reason|1
2253272|NCT02054481|3918686|FG002|Overall Study|Other reason|2
2253273|NCT02054481|3918687|FG003|Overall Study|Other reason|0
2342216|NCT03482011|4075292|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3
2342217|NCT03482011|4075293|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1
2342218|NCT03482011|4075294|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
2342219|NCT03482011|4075295|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
2342220|NCT03482011|4075296|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
2342221|NCT03482011|4075297|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
2342222|NCT03482011|4075298|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
2342223|NCT03482011|4075299|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
2342224|NCT03482011|4075292|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0
2342225|NCT03482011|4075293|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1
2342226|NCT03482011|4075294|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0
2342227|NCT03482011|4075295|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0
2342228|NCT03482011|4075296|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0
2342229|NCT03482011|4075297|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0
2342230|NCT03482011|4075298|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0
2342231|NCT03482011|4075299|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0
2342232|NCT03482011|4075292|FG000|Induction Period (16 Weeks)|Screen Failure|0
2342233|NCT03482011|4075293|FG001|Induction Period (16 Weeks)|Screen Failure|1
2342234|NCT03482011|4075294|FG002|Induction Period (16 Weeks)|Screen Failure|0
2342235|NCT03482011|4075295|FG003|Induction Period (16 Weeks)|Screen Failure|0
2342236|NCT03482011|4075296|FG004|Induction Period (16 Weeks)|Screen Failure|0
2342237|NCT03482011|4075297|FG005|Induction Period (16 Weeks)|Screen Failure|0
2342238|NCT03482011|4075298|FG006|Induction Period (16 Weeks)|Screen Failure|0
2253274|NCT02054520|3918704|FG000|Overall Study|Adverse Event|1
2253275|NCT02054520|3918705|FG001|Overall Study|Adverse Event|4
2253276|NCT02054520|3918706|FG002|Overall Study|Adverse Event|2
2253277|NCT02054520|3918707|FG003|Overall Study|Adverse Event|1
2253278|NCT02054520|3918708|FG004|Overall Study|Adverse Event|1
2253279|NCT02054520|3918709|FG005|Overall Study|Adverse Event|0
2253280|NCT02054520|3918704|FG000|Overall Study|Lack of Efficacy|7
2253281|NCT02054520|3918705|FG001|Overall Study|Lack of Efficacy|0
2253282|NCT02054520|3918706|FG002|Overall Study|Lack of Efficacy|2
2253283|NCT02054520|3918707|FG003|Overall Study|Lack of Efficacy|1
2253284|NCT02054520|3918708|FG004|Overall Study|Lack of Efficacy|3
2253285|NCT02054520|3918709|FG005|Overall Study|Lack of Efficacy|2
2253286|NCT02054520|3918704|FG000|Overall Study|Withdrawal by Subject|1
2253287|NCT02054520|3918705|FG001|Overall Study|Withdrawal by Subject|0
2253288|NCT02054520|3918706|FG002|Overall Study|Withdrawal by Subject|0
2253289|NCT02054520|3918707|FG003|Overall Study|Withdrawal by Subject|2
2253290|NCT02054520|3918708|FG004|Overall Study|Withdrawal by Subject|1
2253291|NCT02054520|3918709|FG005|Overall Study|Withdrawal by Subject|0
2253292|NCT02054520|3918704|FG000|Overall Study|Physician Decision|0
2253293|NCT02054520|3918705|FG001|Overall Study|Physician Decision|1
2253294|NCT02054520|3918706|FG002|Overall Study|Physician Decision|0
2253295|NCT02054520|3918707|FG003|Overall Study|Physician Decision|1
2253296|NCT02054520|3918708|FG004|Overall Study|Physician Decision|0
2253297|NCT02054520|3918709|FG005|Overall Study|Physician Decision|1
2253298|NCT02054520|3918704|FG000|Overall Study|Study terminated by Sponsor|0
2253299|NCT02054520|3918705|FG001|Overall Study|Study terminated by Sponsor|0
2253300|NCT02054520|3918706|FG002|Overall Study|Study terminated by Sponsor|2
2253301|NCT02054520|3918707|FG003|Overall Study|Study terminated by Sponsor|1
2342239|NCT03482011|4075299|FG007|Induction Period (16 Weeks)|Screen Failure|0
2342240|NCT03482011|4075292|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
2342241|NCT03482011|4075293|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5
2342242|NCT03482011|4075294|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
2342243|NCT03482011|4075295|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
2342244|NCT03482011|4075296|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
2342245|NCT03482011|4075297|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
2342246|NCT03482011|4075298|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
2342247|NCT03482011|4075299|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
2342248|NCT03482011|4075292|FG000|Maintenance Period (36 Weeks)|Adverse Event|0
2342249|NCT03482011|4075293|FG001|Maintenance Period (36 Weeks)|Adverse Event|0
2342250|NCT03482011|4075294|FG002|Maintenance Period (36 Weeks)|Adverse Event|0
2342251|NCT03482011|4075295|FG003|Maintenance Period (36 Weeks)|Adverse Event|0
2342252|NCT03482011|4075296|FG004|Maintenance Period (36 Weeks)|Adverse Event|0
2342253|NCT03482011|4075297|FG005|Maintenance Period (36 Weeks)|Adverse Event|1
2342254|NCT03482011|4075298|FG006|Maintenance Period (36 Weeks)|Adverse Event|1
2342255|NCT03482011|4075299|FG007|Maintenance Period (36 Weeks)|Adverse Event|4
2342256|NCT03482011|4075292|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0
2342257|NCT03482011|4075293|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0
2342258|NCT03482011|4075294|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1
2342259|NCT03482011|4075295|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2
2342260|NCT03482011|4075296|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1
2342261|NCT03482011|4075297|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1
2342262|NCT03482011|4075298|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0
2342263|NCT03482011|4075299|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9
2342264|NCT03482011|4075292|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2342265|NCT03482011|4075293|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2342266|NCT03482011|4075294|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2342267|NCT03482011|4075295|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2342268|NCT03482011|4075296|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2
2342269|NCT03482011|4075297|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2038766|NCT00423930|3609143|FG000|Overall Study|Withdrawal by Subject|2
2038767|NCT00423943|3609149|FG000|Overall Study|Withdrawal by Subject|3
2038768|NCT00423943|3609150|FG001|Overall Study|Withdrawal by Subject|1
2038769|NCT00424021|3609160|FG000|NCT00046319 Study Period|Adverse Event|1
2038770|NCT00424021|3609161|FG001|NCT00046319 Study Period|Adverse Event|0
2038771|NCT00424021|3609162|FG002|NCT00046319 Study Period|Adverse Event|1
2038772|NCT00424021|3609163|FG003|NCT00046319 Study Period|Adverse Event|1
2038773|NCT00424021|3609160|FG000|NCT00046319 Study Period|Withdrawal by Subject|0
2038774|NCT00424021|3609161|FG001|NCT00046319 Study Period|Withdrawal by Subject|1
2038775|NCT00424021|3609162|FG002|NCT00046319 Study Period|Withdrawal by Subject|0
2038776|NCT00424021|3609163|FG003|NCT00046319 Study Period|Withdrawal by Subject|0
2038777|NCT00424021|3609160|FG000|NCT00046319 Study Period|Sponsor discretion|0
2038778|NCT00424021|3609161|FG001|NCT00046319 Study Period|Sponsor discretion|1
2038779|NCT00424021|3609162|FG002|NCT00046319 Study Period|Sponsor discretion|0
2038780|NCT00424021|3609163|FG003|NCT00046319 Study Period|Sponsor discretion|0
2038781|NCT00424021|3609160|FG000|NCT00046319 Study Period|Lost to Follow-up|0
2038782|NCT00424021|3609161|FG001|NCT00046319 Study Period|Lost to Follow-up|1
2253302|NCT02054520|3918708|FG004|Overall Study|Study terminated by Sponsor|0
2253303|NCT02054520|3918709|FG005|Overall Study|Study terminated by Sponsor|0
2253304|NCT02054702|3918729|FG000|Overall Study|Lost to Follow-up|3
2253305|NCT02054702|3918730|FG001|Overall Study|Lost to Follow-up|5
2253306|NCT02054702|3918729|FG000|Overall Study|Adverse Event|3
2253307|NCT02054702|3918730|FG001|Overall Study|Adverse Event|1
2253308|NCT02054702|3918729|FG000|Overall Study|Met Withdrawal Criteria|4
2253309|NCT02054702|3918730|FG001|Overall Study|Met Withdrawal Criteria|1
2253310|NCT02054702|3918729|FG000|Overall Study|Physician Decision|0
2253311|NCT02054702|3918730|FG001|Overall Study|Physician Decision|1
2253312|NCT02054702|3918729|FG000|Overall Study|Withdrawal by Subject|14
2253313|NCT02054702|3918730|FG001|Overall Study|Withdrawal by Subject|4
2253314|NCT02054715|3918738|FG000|Baseline/Follow-up 1|Refused|1
2253315|NCT02054715|3918739|FG001|Baseline/Follow-up 1|Refused|3
2253316|NCT02054715|3918738|FG000|Baseline/Follow-up 1|Medical|0
2253317|NCT02054715|3918739|FG001|Baseline/Follow-up 1|Medical|1
2253318|NCT02054715|3918738|FG000|Baseline/Follow-up 1|Changed MD/Facility|0
2253319|NCT02054715|3918739|FG001|Baseline/Follow-up 1|Changed MD/Facility|1
2253320|NCT02054715|3918738|FG000|Baseline/Follow-up 1|Disliked Procedure|0
2253321|NCT02054715|3918739|FG001|Baseline/Follow-up 1|Disliked Procedure|1
2253322|NCT02054715|3918738|FG000|Baseline/Follow-up 1|No Reason|0
2253323|NCT02054715|3918739|FG001|Baseline/Follow-up 1|No Reason|1
2253324|NCT02054715|3918738|FG000|Baseline/Follow-up 1|Overwhelmed|2
2253325|NCT02054715|3918739|FG001|Baseline/Follow-up 1|Overwhelmed|0
2253326|NCT02054715|3918738|FG000|Baseline/Follow-up 1|Ineligible|3
2253327|NCT02054715|3918739|FG001|Baseline/Follow-up 1|Ineligible|0
2253328|NCT02054715|3918738|FG000|Baseline/Follow-up 1|Hospitalization|1
2253329|NCT02054715|3918739|FG001|Baseline/Follow-up 1|Hospitalization|0
2253330|NCT02054715|3918738|FG000|Baseline/Follow-up 1|Changed Mind|1
2253331|NCT02054715|3918739|FG001|Baseline/Follow-up 1|Changed Mind|0
2253332|NCT02054715|3918738|FG000|Follow-up 2|Lost to Followup|3
2253333|NCT02054715|3918739|FG001|Follow-up 2|Lost to Followup|1
2253334|NCT02054715|3918738|FG000|Follow-up 2|Refused|3
2253335|NCT02054715|3918739|FG001|Follow-up 2|Refused|2
2253336|NCT02054715|3918738|FG000|Follow-up 2|Followup Not Completed|3
2253337|NCT02054715|3918739|FG001|Follow-up 2|Followup Not Completed|4
2253338|NCT02054715|3918738|FG000|Follow-up 2|Ineligible|4
2253339|NCT02054715|3918739|FG001|Follow-up 2|Ineligible|5
2253340|NCT02054715|3918738|FG000|Follow-up 2|Death|3
2253341|NCT02054715|3918739|FG001|Follow-up 2|Death|3
2253342|NCT02054715|3918738|FG000|Follow-up 2|Hospitalization|0
2253343|NCT02054715|3918739|FG001|Follow-up 2|Hospitalization|2
2253344|NCT02054715|3918738|FG000|Follow-up 2|Changed MD/Facility|0
2253345|NCT02054715|3918739|FG001|Follow-up 2|Changed MD/Facility|1
2253346|NCT02054715|3918738|FG000|Follow-up 2|Changed Mind|0
2253347|NCT02054715|3918739|FG001|Follow-up 2|Changed Mind|1
2253348|NCT02054715|3918738|FG000|Follow-up 2|No Reason|2
2253349|NCT02054715|3918739|FG001|Follow-up 2|No Reason|0
2253350|NCT02054715|3918738|FG000|Follow-up 2|Treatment Change or Delay|1
2253351|NCT02054715|3918739|FG001|Follow-up 2|Treatment Change or Delay|0
2253352|NCT02054897|3918770|FG000|Overall Study|Withdrawal by Subject|2
2253353|NCT02054897|3918771|FG001|Overall Study|Withdrawal by Subject|0
2253354|NCT02054897|3918772|FG002|Overall Study|Withdrawal by Subject|2
2253355|NCT02054897|3918770|FG000|Overall Study|Missing follow-up information|3
2342270|NCT03482011|4075298|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2342271|NCT03482011|4075299|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1
2342272|NCT03482011|4075292|FG000|Maintenance Period (36 Weeks)|Physician Decision|0
2342273|NCT03482011|4075293|FG001|Maintenance Period (36 Weeks)|Physician Decision|0
2342274|NCT03482011|4075294|FG002|Maintenance Period (36 Weeks)|Physician Decision|0
2342275|NCT03482011|4075295|FG003|Maintenance Period (36 Weeks)|Physician Decision|1
2342276|NCT03482011|4075296|FG004|Maintenance Period (36 Weeks)|Physician Decision|0
2342277|NCT03482011|4075297|FG005|Maintenance Period (36 Weeks)|Physician Decision|1
2342278|NCT03482011|4075298|FG006|Maintenance Period (36 Weeks)|Physician Decision|1
2342279|NCT03482011|4075299|FG007|Maintenance Period (36 Weeks)|Physician Decision|1
2342280|NCT03482011|4075292|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2342281|NCT03482011|4075293|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2342282|NCT03482011|4075294|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2342283|NCT03482011|4075295|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
2342284|NCT03482011|4075296|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
2342285|NCT03482011|4075297|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
2342286|NCT03482011|4075298|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
2342287|NCT03482011|4075299|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
2342288|NCT03482011|4075292|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
2342289|NCT03482011|4075293|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
2342290|NCT03482011|4075294|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
2342291|NCT03482011|4075295|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2
2342292|NCT03482011|4075296|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
2342293|NCT03482011|4075297|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
2342294|NCT03482011|4075298|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
2342295|NCT03482011|4075299|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5
2342296|NCT03482011|4075292|FG000|Follow-up Period (12 Weeks)|Adverse Event|0
2253356|NCT02054897|3918771|FG001|Overall Study|Missing follow-up information|5
2253357|NCT02054897|3918772|FG002|Overall Study|Missing follow-up information|3
2253358|NCT02054897|3918770|FG000|Overall Study|Lost to Follow-up|4
2253359|NCT02054897|3918771|FG001|Overall Study|Lost to Follow-up|2
2253360|NCT02054897|3918772|FG002|Overall Study|Lost to Follow-up|7
2253361|NCT02054897|3918770|FG000|Overall Study|Randomized but not exposed|1
2253362|NCT02054897|3918771|FG001|Overall Study|Randomized but not exposed|0
2253363|NCT02054897|3918772|FG002|Overall Study|Randomized but not exposed|0
2253364|NCT02055118|3918783|FG000|Overall Study|Withdrawal by Subject|0
2253365|NCT02055118|3918784|FG001|Overall Study|Withdrawal by Subject|2
2253366|NCT02055118|3918785|FG002|Overall Study|Withdrawal by Subject|0
2253367|NCT02055157|3918798|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
2253368|NCT02055157|3918799|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1
2253369|NCT02055157|3918800|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
2253370|NCT02055157|3918801|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
2253371|NCT02055157|3918798|FG000|Initial 6 Months|Adverse Event|0
2253372|NCT02055157|3918799|FG001|Initial 6 Months|Adverse Event|0
2253373|NCT02055157|3918800|FG002|Initial 6 Months|Adverse Event|0
2253374|NCT02055157|3918801|FG003|Initial 6 Months|Adverse Event|1
2253375|NCT02055157|3918798|FG000|Initial 6 Months|Consent withdrawn by subject|1
2253376|NCT02055157|3918799|FG001|Initial 6 Months|Consent withdrawn by subject|0
2253377|NCT02055157|3918800|FG002|Initial 6 Months|Consent withdrawn by subject|0
2253378|NCT02055157|3918801|FG003|Initial 6 Months|Consent withdrawn by subject|0
2253379|NCT02055157|3918798|FG000|18-month Extension|Investigator decision|0
2253380|NCT02055157|3918799|FG001|18-month Extension|Investigator decision|1
2253381|NCT02055157|3918800|FG002|18-month Extension|Investigator decision|0
2253382|NCT02055157|3918801|FG003|18-month Extension|Investigator decision|0
2253383|NCT02055157|3918798|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1
2253384|NCT02055157|3918799|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0
2253385|NCT02055157|3918800|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0
2253386|NCT02055157|3918801|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0
2253387|NCT02055352|3918824|FG000|Overall Study|Adverse Event|0
2253388|NCT02055352|3918825|FG001|Overall Study|Adverse Event|1
2253389|NCT02055352|3918824|FG000|Overall Study|Non-eligible|0
2253390|NCT02055352|3918825|FG001|Overall Study|Non-eligible|1
2253391|NCT02055352|3918824|FG000|Overall Study|Poor compliance|1
2253392|NCT02055352|3918825|FG001|Overall Study|Poor compliance|1
2253393|NCT02055352|3918824|FG000|Overall Study|Death|1
2253394|NCT02055352|3918825|FG001|Overall Study|Death|2
2253395|NCT02055352|3918824|FG000|Overall Study|Patient decision|1
2253396|NCT02055352|3918825|FG001|Overall Study|Patient decision|1
2253397|NCT02055352|3918824|FG000|Overall Study|Use of prohibited treatment|0
2253398|NCT02055352|3918825|FG001|Overall Study|Use of prohibited treatment|3
2253399|NCT02055352|3918824|FG000|Overall Study|AE, study drug would be detrimental|1
2253400|NCT02055352|3918825|FG001|Overall Study|AE, study drug would be detrimental|3
2253401|NCT02055352|3918824|FG000|Overall Study|Withdrawal of informed consent|1
2253402|NCT02055352|3918825|FG001|Overall Study|Withdrawal of informed consent|0
2253403|NCT02055352|3918824|FG000|Overall Study|Reason unknown|1
2253404|NCT02055352|3918825|FG001|Overall Study|Reason unknown|5
2253405|NCT02055365|3918831|FG000|Overall Study|Prematurely Withdrawn|1
2253406|NCT02055820|3918896|FG000|Phase I: Dose-Finding|Death|1
2253407|NCT02055820|3918897|FG001|Phase I: Dose-Finding|Death|0
2253408|NCT02055820|3918898|FG002|Phase I: Dose-Finding|Death|1
2253409|NCT02055820|3918899|FG003|Phase I: Dose-Finding|Death|2
2253410|NCT02055820|3918900|FG004|Phase I: Dose-Finding|Death|0
2253411|NCT02055820|3918901|FG005|Phase I: Dose-Finding|Death|1
2253412|NCT02055820|3918902|FG006|Phase I: Dose-Finding|Death|1
2253413|NCT02055820|3918903|FG007|Phase I: Dose-Finding|Death|0
2253414|NCT02055820|3918904|FG008|Phase I: Dose-Finding|Death|0
2253415|NCT02055820|3918905|FG009|Phase I: Dose-Finding|Death|0
2253416|NCT02055820|3918896|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0
2253417|NCT02055820|3918897|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0
2253418|NCT02055820|3918898|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0
2253419|NCT02055820|3918899|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0
2253420|NCT02055820|3918900|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0
2253421|NCT02055820|3918901|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1
2253422|NCT02055820|3918902|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0
2253423|NCT02055820|3918903|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0
2253424|NCT02055820|3918904|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0
2253425|NCT02055820|3918905|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0
2253426|NCT02055820|3918896|FG000|Phase I: Dose-Finding|Lost to Follow-up|0
2253427|NCT02055820|3918897|FG001|Phase I: Dose-Finding|Lost to Follow-up|0
2253428|NCT02055820|3918898|FG002|Phase I: Dose-Finding|Lost to Follow-up|0
2253429|NCT02055820|3918899|FG003|Phase I: Dose-Finding|Lost to Follow-up|1
2253430|NCT02055820|3918900|FG004|Phase I: Dose-Finding|Lost to Follow-up|0
2253431|NCT02055820|3918901|FG005|Phase I: Dose-Finding|Lost to Follow-up|0
2253432|NCT02055820|3918902|FG006|Phase I: Dose-Finding|Lost to Follow-up|1
2253433|NCT02055820|3918903|FG007|Phase I: Dose-Finding|Lost to Follow-up|0
2253434|NCT02055820|3918904|FG008|Phase I: Dose-Finding|Lost to Follow-up|0
2253435|NCT02055820|3918905|FG009|Phase I: Dose-Finding|Lost to Follow-up|0
2253436|NCT02055820|3918896|FG000|Phase II: Expansion|Death|0
2253437|NCT02055820|3918897|FG001|Phase II: Expansion|Death|0
2253438|NCT02055820|3918898|FG002|Phase II: Expansion|Death|0
2342297|NCT03482011|4075293|FG001|Follow-up Period (12 Weeks)|Adverse Event|0
2342298|NCT03482011|4075294|FG002|Follow-up Period (12 Weeks)|Adverse Event|0
2253439|NCT02055820|3918899|FG003|Phase II: Expansion|Death|0
2253440|NCT02055820|3918900|FG004|Phase II: Expansion|Death|33
2253441|NCT02055820|3918901|FG005|Phase II: Expansion|Death|0
2253442|NCT02055820|3918902|FG006|Phase II: Expansion|Death|0
2253443|NCT02055820|3918903|FG007|Phase II: Expansion|Death|0
2253444|NCT02055820|3918904|FG008|Phase II: Expansion|Death|0
2253445|NCT02055820|3918905|FG009|Phase II: Expansion|Death|0
2253446|NCT02055820|3918896|FG000|Phase II: Expansion|Lost to Follow-up|0
2253447|NCT02055820|3918897|FG001|Phase II: Expansion|Lost to Follow-up|0
2253448|NCT02055820|3918898|FG002|Phase II: Expansion|Lost to Follow-up|0
2253449|NCT02055820|3918899|FG003|Phase II: Expansion|Lost to Follow-up|0
2253450|NCT02055820|3918900|FG004|Phase II: Expansion|Lost to Follow-up|4
2253451|NCT02055820|3918901|FG005|Phase II: Expansion|Lost to Follow-up|0
2253452|NCT02055820|3918902|FG006|Phase II: Expansion|Lost to Follow-up|0
2253453|NCT02055820|3918903|FG007|Phase II: Expansion|Lost to Follow-up|0
2253454|NCT02055820|3918904|FG008|Phase II: Expansion|Lost to Follow-up|0
2253455|NCT02055820|3918905|FG009|Phase II: Expansion|Lost to Follow-up|0
2253456|NCT02055820|3918896|FG000|Phase II: Expansion|Withdrawal by Subject|0
2253457|NCT02055820|3918897|FG001|Phase II: Expansion|Withdrawal by Subject|0
2253458|NCT02055820|3918898|FG002|Phase II: Expansion|Withdrawal by Subject|0
2253459|NCT02055820|3918899|FG003|Phase II: Expansion|Withdrawal by Subject|0
2253460|NCT02055820|3918900|FG004|Phase II: Expansion|Withdrawal by Subject|12
2253461|NCT02055820|3918901|FG005|Phase II: Expansion|Withdrawal by Subject|0
2253462|NCT02055820|3918902|FG006|Phase II: Expansion|Withdrawal by Subject|0
2253463|NCT02055820|3918903|FG007|Phase II: Expansion|Withdrawal by Subject|0
2253464|NCT02055820|3918904|FG008|Phase II: Expansion|Withdrawal by Subject|0
2253465|NCT02055820|3918905|FG009|Phase II: Expansion|Withdrawal by Subject|0
2253466|NCT02055898|3918949|FG000|First Intervention (5 Days)|Physician Decision|2
2253467|NCT02055898|3918950|FG001|First Intervention (5 Days)|Physician Decision|0
2253468|NCT02055898|3918949|FG000|First Intervention (5 Days)|Withdrawal by Subject|0
2342299|NCT03482011|4075295|FG003|Follow-up Period (12 Weeks)|Adverse Event|0
2342300|NCT03482011|4075296|FG004|Follow-up Period (12 Weeks)|Adverse Event|0
2342301|NCT03482011|4075297|FG005|Follow-up Period (12 Weeks)|Adverse Event|0
2342302|NCT03482011|4075298|FG006|Follow-up Period (12 Weeks)|Adverse Event|1
2342303|NCT03482011|4075299|FG007|Follow-up Period (12 Weeks)|Adverse Event|4
2342304|NCT03482011|4075292|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0
2342305|NCT03482011|4075293|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0
2342306|NCT03482011|4075294|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1
2342307|NCT03482011|4075295|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3
2342308|NCT03482011|4075296|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0
2342309|NCT03482011|4075297|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0
2342310|NCT03482011|4075298|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0
2342311|NCT03482011|4075299|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6
2342312|NCT03482011|4075292|FG000|Follow-up Period (12 Weeks)|Physician Decision|0
2342313|NCT03482011|4075293|FG001|Follow-up Period (12 Weeks)|Physician Decision|0
2342314|NCT03482011|4075294|FG002|Follow-up Period (12 Weeks)|Physician Decision|0
2342315|NCT03482011|4075295|FG003|Follow-up Period (12 Weeks)|Physician Decision|0
2342316|NCT03482011|4075296|FG004|Follow-up Period (12 Weeks)|Physician Decision|0
2342317|NCT03482011|4075297|FG005|Follow-up Period (12 Weeks)|Physician Decision|0
2342318|NCT03482011|4075298|FG006|Follow-up Period (12 Weeks)|Physician Decision|0
2342319|NCT03482011|4075299|FG007|Follow-up Period (12 Weeks)|Physician Decision|1
2342320|NCT03482011|4075292|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0
2342321|NCT03482011|4075293|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0
2342322|NCT03482011|4075294|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0
2342323|NCT03482011|4075295|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0
2342324|NCT03482011|4075296|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0
2342325|NCT03482011|4075297|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0
2342326|NCT03482011|4075298|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0
2342327|NCT03482011|4075299|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1
2342328|NCT03482453|4075336|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2342329|NCT03482453|4075337|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2342330|NCT03482453|4075338|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2342331|NCT03482453|4075339|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2342332|NCT03482453|4075340|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2038783|NCT00424021|3609162|FG002|NCT00046319 Study Period|Lost to Follow-up|0
2038784|NCT00424021|3609163|FG003|NCT00046319 Study Period|Lost to Follow-up|0
2038785|NCT00424021|3609160|FG000|AMB-220-E Study Period|Adverse Event|1
2038786|NCT00424021|3609161|FG001|AMB-220-E Study Period|Adverse Event|1
2038787|NCT00424021|3609162|FG002|AMB-220-E Study Period|Adverse Event|3
2038788|NCT00424021|3609163|FG003|AMB-220-E Study Period|Adverse Event|7
2038789|NCT00424021|3609160|FG000|AMB-220-E Study Period|Death|0
2038790|NCT00424021|3609161|FG001|AMB-220-E Study Period|Death|0
2038791|NCT00424021|3609162|FG002|AMB-220-E Study Period|Death|1
2038792|NCT00424021|3609163|FG003|AMB-220-E Study Period|Death|1
2038793|NCT00424021|3609160|FG000|AMB-220-E Study Period|Lost to Follow-up|0
2038794|NCT00424021|3609161|FG001|AMB-220-E Study Period|Lost to Follow-up|1
2038795|NCT00424021|3609162|FG002|AMB-220-E Study Period|Lost to Follow-up|1
2038796|NCT00424021|3609163|FG003|AMB-220-E Study Period|Lost to Follow-up|1
2038797|NCT00424021|3609160|FG000|AMB-220-E Study Period|Physician Decision|0
2253469|NCT02055898|3918950|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
2253470|NCT02055976|3918965|FG000|Overall Study|Other|0
2253471|NCT02055976|3918966|FG001|Overall Study|Other|0
2253472|NCT02055976|3918967|FG002|Overall Study|Other|1
2253473|NCT02055976|3918968|FG003|Overall Study|Other|0
2253474|NCT02055976|3918969|FG004|Overall Study|Other|0
2253475|NCT02055976|3918970|FG005|Overall Study|Other|0
2253476|NCT02055976|3918971|FG006|Overall Study|Other|0
2253477|NCT02055976|3918972|FG007|Overall Study|Other|0
2253478|NCT02055976|3918973|FG008|Overall Study|Other|0
2253479|NCT02055976|3918965|FG000|Overall Study|Adverse Event|0
2253480|NCT02055976|3918966|FG001|Overall Study|Adverse Event|0
2253481|NCT02055976|3918967|FG002|Overall Study|Adverse Event|0
2253482|NCT02055976|3918968|FG003|Overall Study|Adverse Event|0
2253483|NCT02055976|3918969|FG004|Overall Study|Adverse Event|0
2253484|NCT02055976|3918970|FG005|Overall Study|Adverse Event|1
2253485|NCT02055976|3918971|FG006|Overall Study|Adverse Event|1
2253486|NCT02055976|3918972|FG007|Overall Study|Adverse Event|0
2253487|NCT02055976|3918973|FG008|Overall Study|Adverse Event|0
2253488|NCT02055976|3918965|FG000|Overall Study|Does not meet entrance criteria|0
2253489|NCT02055976|3918966|FG001|Overall Study|Does not meet entrance criteria|0
2253490|NCT02055976|3918967|FG002|Overall Study|Does not meet entrance criteria|0
2253491|NCT02055976|3918968|FG003|Overall Study|Does not meet entrance criteria|0
2253492|NCT02055976|3918969|FG004|Overall Study|Does not meet entrance criteria|0
2253493|NCT02055976|3918970|FG005|Overall Study|Does not meet entrance criteria|0
2253494|NCT02055976|3918971|FG006|Overall Study|Does not meet entrance criteria|1
2253495|NCT02055976|3918972|FG007|Overall Study|Does not meet entrance criteria|0
2253496|NCT02055976|3918973|FG008|Overall Study|Does not meet entrance criteria|0
2253497|NCT02055976|3918965|FG000|Overall Study|Lost to Follow-up|0
2253498|NCT02055976|3918966|FG001|Overall Study|Lost to Follow-up|0
2253499|NCT02055976|3918967|FG002|Overall Study|Lost to Follow-up|0
2253500|NCT02055976|3918968|FG003|Overall Study|Lost to Follow-up|1
2253501|NCT02055976|3918969|FG004|Overall Study|Lost to Follow-up|0
2253502|NCT02055976|3918970|FG005|Overall Study|Lost to Follow-up|0
2253503|NCT02055976|3918971|FG006|Overall Study|Lost to Follow-up|0
2253504|NCT02055976|3918972|FG007|Overall Study|Lost to Follow-up|0
2253505|NCT02055976|3918973|FG008|Overall Study|Lost to Follow-up|0
2253506|NCT02056288|3919011|FG000|In-Hospital Data|Surgery cancelled|1
2253507|NCT02056288|3919012|FG001|In-Hospital Data|Surgery cancelled|0
2253508|NCT02056288|3919011|FG000|In-Hospital Data|Protocol Violation|3
2253509|NCT02056288|3919012|FG001|In-Hospital Data|Protocol Violation|0
2253510|NCT02056288|3919011|FG000|In-Hospital Data|Physician Decision|1
2253511|NCT02056288|3919012|FG001|In-Hospital Data|Physician Decision|0
2253512|NCT02056288|3919011|FG000|48-Hour Post-Discharge Data|Did not return diary|14
2253513|NCT02056288|3919012|FG001|48-Hour Post-Discharge Data|Did not return diary|20
2253514|NCT02056301|3919020|FG000|Overall Study|Protocol Violation|1
2253515|NCT02056301|3919021|FG001|Overall Study|Protocol Violation|2
2253516|NCT02056301|3919020|FG000|Overall Study|Surgical complications req. 2nd surgery|1
2253517|NCT02056301|3919021|FG001|Overall Study|Surgical complications req. 2nd surgery|0
2253518|NCT02056301|3919020|FG000|Overall Study|Withdrawal by Subject|0
2253519|NCT02056301|3919021|FG001|Overall Study|Withdrawal by Subject|1
2253520|NCT02056301|3919020|FG000|Overall Study|Issues with epidural|0
2253521|NCT02056301|3919021|FG001|Overall Study|Issues with epidural|3
2253522|NCT02056340|3919029|FG000|Overall Study|Lost to Follow-up|5
2253523|NCT02056340|3919030|FG001|Overall Study|Lost to Follow-up|5
2253524|NCT02056340|3919029|FG000|Overall Study|Withdrawal by Subject|2
2253525|NCT02056340|3919030|FG001|Overall Study|Withdrawal by Subject|6
2253526|NCT02056392|3919042|FG000|Overall Study|Lost to Follow-up|0
2253527|NCT02056392|3919043|FG001|Overall Study|Lost to Follow-up|1
2253528|NCT02056392|3919044|FG002|Overall Study|Lost to Follow-up|2
2253529|NCT02056392|3919045|FG003|Overall Study|Lost to Follow-up|0
2253530|NCT02056392|3919046|FG004|Overall Study|Lost to Follow-up|0
2253531|NCT02056392|3919047|FG005|Overall Study|Lost to Follow-up|0
2253532|NCT02056392|3919042|FG000|Overall Study|Protocol Violation|1
2253533|NCT02056392|3919043|FG001|Overall Study|Protocol Violation|0
2253534|NCT02056392|3919044|FG002|Overall Study|Protocol Violation|1
2253535|NCT02056392|3919045|FG003|Overall Study|Protocol Violation|0
2253536|NCT02056392|3919046|FG004|Overall Study|Protocol Violation|0
2253537|NCT02056392|3919047|FG005|Overall Study|Protocol Violation|0
2253538|NCT02056392|3919042|FG000|Overall Study|Withdrawal by Subject|1
2253539|NCT02056392|3919043|FG001|Overall Study|Withdrawal by Subject|0
2253540|NCT02056392|3919044|FG002|Overall Study|Withdrawal by Subject|0
2253541|NCT02056392|3919045|FG003|Overall Study|Withdrawal by Subject|0
2253542|NCT02056392|3919046|FG004|Overall Study|Withdrawal by Subject|1
2253543|NCT02056392|3919047|FG005|Overall Study|Withdrawal by Subject|0
2253544|NCT02056626|3919070|FG000|Overall Study|patient did not follow directions|3
2253545|NCT02056626|3919071|FG001|Overall Study|patient did not follow directions|1
2253546|NCT02056626|3919072|FG002|Overall Study|patient did not follow directions|0
2253547|NCT02056626|3919073|FG003|Overall Study|patient did not follow directions|0
2253548|NCT02056652|3919096|FG000|Overall Study|Withdrawal by Subject|1
2253549|NCT02056652|3919097|FG001|Overall Study|Withdrawal by Subject|0
2253550|NCT02056652|3919096|FG000|Overall Study|Lost to Follow-up|0
2253551|NCT02056652|3919097|FG001|Overall Study|Lost to Follow-up|3
2253552|NCT02056834|3919103|FG000|Overall Study|Lost to Follow-up|7
2253553|NCT02057068|3919119|FG000|Overall Study|Withdrawal by Subject|2
2253554|NCT02057068|3919120|FG001|Overall Study|Withdrawal by Subject|2
2253555|NCT02057068|3919119|FG000|Overall Study|Caregiver (CG) Health|0
2253556|NCT02057068|3919120|FG001|Overall Study|Caregiver (CG) Health|2
2253557|NCT02057068|3919119|FG000|Overall Study|Carepartner (CP) Health|4
2253558|NCT02057068|3919120|FG001|Overall Study|Carepartner (CP) Health|2
2253559|NCT02057068|3919119|FG000|Overall Study|Lost to Follow-up|2
2253560|NCT02057068|3919120|FG001|Overall Study|Lost to Follow-up|2
2253561|NCT02057198|3919140|FG000|Overall Study|Death|0
2253562|NCT02057198|3919141|FG001|Overall Study|Death|0
2253563|NCT02057198|3919142|FG002|Overall Study|Death|1
2253564|NCT02057198|3919140|FG000|Overall Study|Discharged early; lost to followup|0
2253565|NCT02057198|3919141|FG001|Overall Study|Discharged early; lost to followup|1
2253566|NCT02057198|3919142|FG002|Overall Study|Discharged early; lost to followup|0
2253567|NCT02057250|3919154|FG000|AID Assessment Phase|Adverse Event|3
2253568|NCT02057250|3919155|FG001|AID Assessment Phase|Adverse Event|2
2253569|NCT02057250|3919156|FG002|AID Assessment Phase|Adverse Event|6
2253570|NCT02057250|3919157|FG003|AID Assessment Phase|Adverse Event|1
2253571|NCT02057250|3919158|FG004|AID Assessment Phase|Adverse Event|0
2253572|NCT02057250|3919154|FG000|AID Assessment Phase|Other than specified above|1
2253573|NCT02057250|3919155|FG001|AID Assessment Phase|Other than specified above|1
2253574|NCT02057250|3919156|FG002|AID Assessment Phase|Other than specified above|1
2253575|NCT02057250|3919157|FG003|AID Assessment Phase|Other than specified above|1
2253576|NCT02057250|3919158|FG004|AID Assessment Phase|Other than specified above|0
2253577|NCT02057250|3919154|FG000|Extension Phase|Adverse Event|0
2253578|NCT02057250|3919155|FG001|Extension Phase|Adverse Event|0
2253579|NCT02057250|3919156|FG002|Extension Phase|Adverse Event|0
2253580|NCT02057250|3919157|FG003|Extension Phase|Adverse Event|0
2253581|NCT02057250|3919158|FG004|Extension Phase|Adverse Event|15
2253582|NCT02057250|3919154|FG000|Extension Phase|Lack of Efficacy|0
2253583|NCT02057250|3919155|FG001|Extension Phase|Lack of Efficacy|0
2253584|NCT02057250|3919156|FG002|Extension Phase|Lack of Efficacy|0
2253585|NCT02057250|3919157|FG003|Extension Phase|Lack of Efficacy|0
2253586|NCT02057250|3919158|FG004|Extension Phase|Lack of Efficacy|10
2253587|NCT02057250|3919154|FG000|Extension Phase|Entered in this period but not treated|0
2253588|NCT02057250|3919155|FG001|Extension Phase|Entered in this period but not treated|0
2253589|NCT02057250|3919156|FG002|Extension Phase|Entered in this period but not treated|0
2253590|NCT02057250|3919157|FG003|Extension Phase|Entered in this period but not treated|0
2253591|NCT02057250|3919158|FG004|Extension Phase|Entered in this period but not treated|4
2253592|NCT02057250|3919154|FG000|Extension Phase|Other than specified above|0
2253593|NCT02057250|3919155|FG001|Extension Phase|Other than specified above|0
2253594|NCT02057250|3919156|FG002|Extension Phase|Other than specified above|0
2253595|NCT02057250|3919157|FG003|Extension Phase|Other than specified above|0
2253596|NCT02057250|3919158|FG004|Extension Phase|Other than specified above|7
2253597|NCT02057393|3919170|FG000|Overall Study|Withdrawal by Subject|1
2253598|NCT02057393|3919170|FG000|Overall Study|Patient did not meet criteria|1
2253599|NCT02057406|3919177|FG000|Overall Study|Physician Decision|0
2253600|NCT02057406|3919178|FG001|Overall Study|Physician Decision|0
2253601|NCT02057406|3919179|FG002|Overall Study|Physician Decision|2
2253602|NCT02057406|3919177|FG000|Overall Study|Withdrawal by Subject|0
2253603|NCT02057406|3919178|FG001|Overall Study|Withdrawal by Subject|2
2253604|NCT02057406|3919179|FG002|Overall Study|Withdrawal by Subject|0
2253605|NCT02057406|3919177|FG000|Overall Study|Lost to Follow-up|0
2253606|NCT02057406|3919178|FG001|Overall Study|Lost to Follow-up|0
2253607|NCT02057406|3919179|FG002|Overall Study|Lost to Follow-up|1
2253608|NCT02057406|3919177|FG000|Overall Study|Death|1
2253609|NCT02057406|3919178|FG001|Overall Study|Death|0
2253610|NCT02057406|3919179|FG002|Overall Study|Death|0
2253611|NCT02057406|3919177|FG000|Overall Study|Protocol Violation|0
2253612|NCT02057406|3919178|FG001|Overall Study|Protocol Violation|1
2253613|NCT02057406|3919179|FG002|Overall Study|Protocol Violation|0
2253614|NCT02057406|3919177|FG000|Overall Study|Patient transportation issues|0
2253615|NCT02057406|3919178|FG001|Overall Study|Patient transportation issues|0
2253616|NCT02057406|3919179|FG002|Overall Study|Patient transportation issues|1
2253617|NCT02057458|3919187|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0
2253618|NCT02057458|3919188|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1
2253619|NCT02057458|3919189|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0
2253620|NCT02057458|3919187|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
2253621|NCT02057458|3919188|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
2253622|NCT02057458|3919189|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
2253623|NCT02057458|3919187|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
2253624|NCT02057458|3919188|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
2253625|NCT02057458|3919189|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
2253626|NCT02057523|3919219|FG000|Overall Study|Withdrawal by Subject|1
2253627|NCT02057523|3919219|FG000|Overall Study|Lack of Efficacy|1
2253628|NCT02057549|3919225|FG000|Overall Study|Lost to Follow-up|1
2253629|NCT02057549|3919226|FG001|Overall Study|Lost to Follow-up|0
2253630|NCT02057549|3919225|FG000|Overall Study|Physician Decision|1
2253631|NCT02057549|3919226|FG001|Overall Study|Physician Decision|0
2253632|NCT02057549|3919225|FG000|Overall Study|Withdrawal by Subject|1
2253633|NCT02057549|3919226|FG001|Overall Study|Withdrawal by Subject|0
2253634|NCT02057575|3919236|FG000|Overall Study|Adverse Event|0
2253635|NCT02057575|3919237|FG001|Overall Study|Adverse Event|2
2253636|NCT02057575|3919238|FG002|Overall Study|Adverse Event|0
2253637|NCT02057575|3919239|FG003|Overall Study|Adverse Event|1
2253638|NCT02057575|3919236|FG000|Overall Study|Withdrawal by Subject|1
2253639|NCT02057575|3919237|FG001|Overall Study|Withdrawal by Subject|0
2253640|NCT02057575|3919238|FG002|Overall Study|Withdrawal by Subject|0
2253641|NCT02057575|3919239|FG003|Overall Study|Withdrawal by Subject|0
2253642|NCT02057575|3919236|FG000|Overall Study|Dissallowed Concurrent Medication|0
2253643|NCT02057575|3919237|FG001|Overall Study|Dissallowed Concurrent Medication|1
2253644|NCT02057575|3919238|FG002|Overall Study|Dissallowed Concurrent Medication|0
2253645|NCT02057575|3919239|FG003|Overall Study|Dissallowed Concurrent Medication|0
2253646|NCT02057575|3919236|FG000|Overall Study|Protocol Violation|0
2253647|NCT02057575|3919237|FG001|Overall Study|Protocol Violation|1
2253648|NCT02057575|3919238|FG002|Overall Study|Protocol Violation|0
2253649|NCT02057575|3919239|FG003|Overall Study|Protocol Violation|0
2253650|NCT02057666|3919261|FG000|Double Blind Treatment Period|Withdrawal by Subject|8
2253651|NCT02057666|3919262|FG001|Double Blind Treatment Period|Withdrawal by Subject|5
2253652|NCT02057666|3919261|FG000|Double Blind Treatment Period|Poor tolerability|7
2253653|NCT02057666|3919262|FG001|Double Blind Treatment Period|Poor tolerability|2
2253654|NCT02057666|3919261|FG000|Double Blind Treatment Period|Symptomatic disease progression|8
2253655|NCT02057666|3919262|FG001|Double Blind Treatment Period|Symptomatic disease progression|3
2253656|NCT02057666|3919261|FG000|Double Blind Treatment Period|Physician Decision|1
2253657|NCT02057666|3919262|FG001|Double Blind Treatment Period|Physician Decision|0
2253658|NCT02057666|3919261|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1
2253659|NCT02057666|3919262|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0
2253660|NCT02057666|3919261|FG000|Double Blind Treatment Period|Subject planning to withdraw|1
2253661|NCT02057666|3919262|FG001|Double Blind Treatment Period|Subject planning to withdraw|0
2253662|NCT02057666|3919261|FG000|Double Blind Treatment Period|Sponsor's request|70
2253663|NCT02057666|3919262|FG001|Double Blind Treatment Period|Sponsor's request|34
2253664|NCT02057666|3919261|FG000|Open-Label Treatment Period|Poor tolerability|0
2253665|NCT02057666|3919262|FG001|Open-Label Treatment Period|Poor tolerability|1
2253666|NCT02057666|3919261|FG000|Open-Label Treatment Period|Symptomatic disease progression|0
2253667|NCT02057666|3919262|FG001|Open-Label Treatment Period|Symptomatic disease progression|1
2253668|NCT02057666|3919261|FG000|Open-Label Treatment Period|Sponsor's request|0
2253669|NCT02057666|3919262|FG001|Open-Label Treatment Period|Sponsor's request|4
2253670|NCT02057692|3919272|FG000|Overall Study|Adverse Event|1
2253671|NCT02057692|3919273|FG001|Overall Study|Adverse Event|0
2253672|NCT02057692|3919274|FG002|Overall Study|Adverse Event|0
2253673|NCT02057692|3919275|FG003|Overall Study|Adverse Event|0
2253674|NCT02057692|3919272|FG000|Overall Study|Lost to Follow-up|0
2253675|NCT02057692|3919273|FG001|Overall Study|Lost to Follow-up|0
2253676|NCT02057692|3919274|FG002|Overall Study|Lost to Follow-up|0
2253677|NCT02057692|3919275|FG003|Overall Study|Lost to Follow-up|1
2253678|NCT02057718|3919293|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0
2253679|NCT02057718|3919294|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2
2253680|NCT02057718|3919293|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1
2253681|NCT02057718|3919294|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0
2253682|NCT02057718|3919293|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0
2253683|NCT02057718|3919294|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1
2253684|NCT02057718|3919293|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0
2253685|NCT02057718|3919294|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3
2253686|NCT02057718|3919293|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
2253687|NCT02057718|3919294|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
2253688|NCT02057718|3919293|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0
2253689|NCT02057718|3919294|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1
2253690|NCT02057718|3919293|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0
2253691|NCT02057718|3919294|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1
2253692|NCT02057718|3919293|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1
2253693|NCT02057718|3919294|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3
2253694|NCT02057718|3919293|FG000|Optional Follow-up Treatment Period|Progressive disease|0
2253695|NCT02057718|3919294|FG001|Optional Follow-up Treatment Period|Progressive disease|1
2253696|NCT02057718|3919293|FG000|Optional Follow-up Treatment Period|Adverse Event|1
2253697|NCT02057718|3919294|FG001|Optional Follow-up Treatment Period|Adverse Event|2
2253698|NCT02057718|3919293|FG000|Optional Follow-up Treatment Period|Liver Transplant|0
2253699|NCT02057718|3919294|FG001|Optional Follow-up Treatment Period|Liver Transplant|2
2253700|NCT02057757|3919302|FG000|Overall Study|Withdrawal by Subject|3
2253701|NCT02057757|3919303|FG001|Overall Study|Withdrawal by Subject|5
2253702|NCT02057757|3919302|FG000|Overall Study|Death|2
2253703|NCT02057757|3919303|FG001|Overall Study|Death|0
2253704|NCT02057757|3919302|FG000|Overall Study|Lost to Follow-up|8
2342333|NCT03482453|4075341|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2342334|NCT03482453|4075342|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2253705|NCT02057757|3919303|FG001|Overall Study|Lost to Follow-up|3
2253706|NCT02057757|3919302|FG000|Overall Study|Non-compliance|1
2253707|NCT02057757|3919303|FG001|Overall Study|Non-compliance|0
2253708|NCT02057835|3919323|FG000|Overall Study|Withdrawal by Subject|0
2253709|NCT02057835|3919324|FG001|Overall Study|Withdrawal by Subject|2
2253710|NCT02057835|3919325|FG002|Overall Study|Withdrawal by Subject|0
2253711|NCT02057835|3919326|FG003|Overall Study|Withdrawal by Subject|0
2253712|NCT02057835|3919327|FG004|Overall Study|Withdrawal by Subject|0
2253713|NCT02057835|3919328|FG005|Overall Study|Withdrawal by Subject|0
2253714|NCT02057835|3919329|FG006|Overall Study|Withdrawal by Subject|0
2253715|NCT02057835|3919330|FG007|Overall Study|Withdrawal by Subject|0
2253716|NCT02057835|3919331|FG008|Overall Study|Withdrawal by Subject|0
2253717|NCT02057835|3919332|FG009|Overall Study|Withdrawal by Subject|0
2253718|NCT02058069|3919378|FG000|Overall Study|Exclusion due to implant size|5
2253719|NCT02058069|3919378|FG000|Overall Study|Withdrawal by Subject|6
2253720|NCT02058095|3919384|FG000|Overall Study|Adverse Event|1
2253721|NCT02058095|3919385|FG001|Overall Study|Adverse Event|0
2253722|NCT02058108|3919393|FG000|Overall Study|Abnormal Laboratory Values|0
2253723|NCT02058108|3919394|FG001|Overall Study|Abnormal Laboratory Values|1
2253724|NCT02058108|3919393|FG000|Overall Study|Unsatisfactory therapeutic effect|37
2253725|NCT02058108|3919394|FG001|Overall Study|Unsatisfactory therapeutic effect|4
2253726|NCT02058108|3919393|FG000|Overall Study|No longer requires study drug|0
2253727|NCT02058108|3919394|FG001|Overall Study|No longer requires study drug|1
2253728|NCT02058108|3919393|FG000|Overall Study|Withdrawal by Subject|1
2253729|NCT02058108|3919394|FG001|Overall Study|Withdrawal by Subject|0
2253730|NCT02058108|3919393|FG000|Overall Study|Administrative problems|3
2253731|NCT02058108|3919394|FG001|Overall Study|Administrative problems|3
2253732|NCT02058108|3919393|FG000|Overall Study|Protocol Violation|0
2253733|NCT02058108|3919394|FG001|Overall Study|Protocol Violation|1
2253734|NCT02058147|3919405|FG000|Overall Study|Randomized but not treated|0
2253735|NCT02058147|3919406|FG001|Overall Study|Randomized but not treated|0
2253736|NCT02058147|3919407|FG002|Overall Study|Randomized but not treated|1
2253737|NCT02058147|3919405|FG000|Overall Study|Adverse Event|12
2253738|NCT02058147|3919406|FG001|Overall Study|Adverse Event|9
2253739|NCT02058147|3919407|FG002|Overall Study|Adverse Event|21
2253740|NCT02058147|3919405|FG000|Overall Study|Lack of Efficacy|1
2253741|NCT02058147|3919406|FG001|Overall Study|Lack of Efficacy|0
2253742|NCT02058147|3919407|FG002|Overall Study|Lack of Efficacy|3
2253743|NCT02058147|3919405|FG000|Overall Study|Poor compliance to protocol|8
2253744|NCT02058147|3919406|FG001|Overall Study|Poor compliance to protocol|9
2253745|NCT02058147|3919407|FG002|Overall Study|Poor compliance to protocol|4
2253746|NCT02058147|3919405|FG000|Overall Study|Other than specified|8
2253747|NCT02058147|3919406|FG001|Overall Study|Other than specified|9
2253748|NCT02058147|3919407|FG002|Overall Study|Other than specified|0
2253749|NCT02058160|3919417|FG000|Overall Study|Randomized but not treated|2
2253750|NCT02058160|3919418|FG001|Overall Study|Randomized but not treated|4
2253751|NCT02058160|3919417|FG000|Overall Study|Poor compliance to protocol|4
2253752|NCT02058160|3919418|FG001|Overall Study|Poor compliance to protocol|1
2253753|NCT02058160|3919417|FG000|Overall Study|Adverse Event|12
2253754|NCT02058160|3919418|FG001|Overall Study|Adverse Event|3
2253755|NCT02058160|3919417|FG000|Overall Study|Lost to Follow-up|1
2253756|NCT02058160|3919418|FG001|Overall Study|Lost to Follow-up|0
2253757|NCT02058160|3919417|FG000|Overall Study|Other than specified above|12
2253758|NCT02058160|3919418|FG001|Overall Study|Other than specified above|6
2253759|NCT02058290|3919435|FG000|Overall Study|Protocol Violation|2
2253760|NCT02058290|3919436|FG001|Overall Study|Protocol Violation|1
2253761|NCT02058290|3919435|FG000|Overall Study|Physician Decision|1
2253762|NCT02058290|3919436|FG001|Overall Study|Physician Decision|0
2253763|NCT02058290|3919435|FG000|Overall Study|Didn't meet intraoperative criteria|8
2253764|NCT02058290|3919436|FG001|Overall Study|Didn't meet intraoperative criteria|7
2253765|NCT02058290|3919435|FG000|Overall Study|Withdrawal by Subject|0
2253766|NCT02058290|3919436|FG001|Overall Study|Withdrawal by Subject|1
2253767|NCT02058368|3919444|FG000|Overall Study|Adverse Event|15
2253768|NCT02058368|3919445|FG001|Overall Study|Adverse Event|20
2253769|NCT02058368|3919444|FG000|Overall Study|Lack of Efficacy|0
2253770|NCT02058368|3919445|FG001|Overall Study|Lack of Efficacy|1
2253771|NCT02058368|3919444|FG000|Overall Study|Protocol Violation|0
2253772|NCT02058368|3919445|FG001|Overall Study|Protocol Violation|4
2253773|NCT02058368|3919444|FG000|Overall Study|Lost to Follow-up|2
2253774|NCT02058368|3919445|FG001|Overall Study|Lost to Follow-up|0
2253775|NCT02058368|3919444|FG000|Overall Study|Physician Decision|2
2253776|NCT02058368|3919445|FG001|Overall Study|Physician Decision|3
2253777|NCT02058368|3919444|FG000|Overall Study|Withdrawal by Subject|22
2253778|NCT02058368|3919445|FG001|Overall Study|Withdrawal by Subject|26
2253779|NCT02058498|3919451|FG000|Overall Study|Withdrawal by Subject|4
2253780|NCT02058563|3919461|FG000|Overall Study|Lost to Follow-up|26
2253781|NCT02058563|3919462|FG001|Overall Study|Lost to Follow-up|22
2253782|NCT02058563|3919461|FG000|Overall Study|Other (vaccinated later as new subject)|1
2253783|NCT02058563|3919462|FG001|Overall Study|Other (vaccinated later as new subject)|0
2253784|NCT02058563|3919461|FG000|Overall Study|Consent Withdrawal|1
2253785|NCT02058563|3919462|FG001|Overall Study|Consent Withdrawal|1
2253786|NCT02058563|3919461|FG000|Overall Study|Other (patient incarcerated)|0
2253787|NCT02058563|3919462|FG001|Overall Study|Other (patient incarcerated)|1
2253788|NCT02058589|3919470|FG000|Overall Study|Serious Adverse Event|1
2253789|NCT02058589|3919471|FG001|Overall Study|Serious Adverse Event|1
2253790|NCT02058589|3919470|FG000|Overall Study|Non-Serious Adverse Event|1
2253791|NCT02058589|3919471|FG001|Overall Study|Non-Serious Adverse Event|0
2253792|NCT02058589|3919470|FG000|Overall Study|Withdrawal by Subject|0
2253793|NCT02058589|3919471|FG001|Overall Study|Withdrawal by Subject|1
2253794|NCT02058628|3919481|FG000|Overall Study|Adverse Event|1
2253795|NCT02058628|3919482|FG001|Overall Study|Adverse Event|0
2253796|NCT02058628|3919481|FG000|Overall Study|Withdrawal by Subject|2
2253797|NCT02058628|3919482|FG001|Overall Study|Withdrawal by Subject|2
2342335|NCT03482453|4075343|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2342336|NCT03482453|4075344|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2342337|NCT03482453|4075345|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2342338|NCT03482453|4075346|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
2342339|NCT03482453|4075347|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2342340|NCT03482635|4075401|FG000|Overall Study|Lack of Efficacy|0
2342341|NCT03482635|4075402|FG001|Overall Study|Lack of Efficacy|0
2342342|NCT03482635|4075403|FG002|Overall Study|Lack of Efficacy|1
2342343|NCT03482635|4075404|FG003|Overall Study|Lack of Efficacy|3
2195911|NCT01527149|3828685|FG000|Overall Study|Death|2
2195912|NCT01527357|3828700|FG000|Overall Study|Death|8
2195913|NCT01527357|3828701|FG001|Overall Study|Death|2
2195914|NCT01527357|3828700|FG000|Overall Study|Lost to Follow-up|6
2195915|NCT01527357|3828701|FG001|Overall Study|Lost to Follow-up|4
2195916|NCT01527357|3828700|FG000|Overall Study|Withdrew Consent|1
2342344|NCT03482635|4075401|FG000|Overall Study|Adverse Event|2
2342345|NCT03482635|4075402|FG001|Overall Study|Adverse Event|2
2342346|NCT03482635|4075403|FG002|Overall Study|Adverse Event|0
2342347|NCT03482635|4075404|FG003|Overall Study|Adverse Event|3
2342348|NCT03482635|4075401|FG000|Overall Study|Withdrawal by Subject|2
2342349|NCT03482635|4075402|FG001|Overall Study|Withdrawal by Subject|1
2342350|NCT03482635|4075403|FG002|Overall Study|Withdrawal by Subject|0
2342351|NCT03482635|4075404|FG003|Overall Study|Withdrawal by Subject|1
2342352|NCT03482635|4075401|FG000|Overall Study|Withdrawn by Principle Investigator|1
2342353|NCT03482635|4075402|FG001|Overall Study|Withdrawn by Principle Investigator|0
2342354|NCT03482635|4075403|FG002|Overall Study|Withdrawn by Principle Investigator|0
2342355|NCT03482635|4075404|FG003|Overall Study|Withdrawn by Principle Investigator|0
2342356|NCT03482635|4075401|FG000|Overall Study|Not treated|0
2342357|NCT03482635|4075402|FG001|Overall Study|Not treated|0
2342358|NCT03482635|4075403|FG002|Overall Study|Not treated|0
2342359|NCT03482635|4075404|FG003|Overall Study|Not treated|1
2342360|NCT03482882|4075423|FG000|Overall Study|Adverse Event|3
2342361|NCT03482882|4075423|FG000|Overall Study|Lost to Follow-up|1
2342362|NCT03482882|4075423|FG000|Overall Study|Protocol Violation|2
2342363|NCT03482882|4075423|FG000|Overall Study|Not further specified|1
2342364|NCT03483623|4075442|FG000|Overall Study|43 complete sets achieved|1
2342365|NCT03483961|4075485|FG000|Overall Study|Lost to Follow-up|7
2342366|NCT03483961|4075486|FG001|Overall Study|Lost to Follow-up|6
2342367|NCT03483961|4075487|FG002|Overall Study|Lost to Follow-up|6
2342368|NCT03483961|4075488|FG003|Overall Study|Lost to Follow-up|6
2038798|NCT00424021|3609161|FG001|AMB-220-E Study Period|Physician Decision|0
2038799|NCT00424021|3609162|FG002|AMB-220-E Study Period|Physician Decision|0
2038800|NCT00424021|3609163|FG003|AMB-220-E Study Period|Physician Decision|1
2038801|NCT00424047|3609182|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
2038802|NCT00424047|3609183|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
2038803|NCT00424047|3609182|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
2038804|NCT00424047|3609183|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
2038805|NCT00424047|3609182|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
2038806|NCT00424047|3609183|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
2038807|NCT00424047|3609182|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
2038808|NCT00424047|3609183|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
2038809|NCT00424047|3609182|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11
2038810|NCT00424047|3609183|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10
2038811|NCT00424047|3609182|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2
2038812|NCT00424047|3609183|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1
2038813|NCT00424047|3609182|FG000|On Study at Time of Unblinding|Adverse Event|22
2038814|NCT00424047|3609183|FG001|On Study at Time of Unblinding|Adverse Event|12
2038815|NCT00424047|3609182|FG000|On Study at Time of Unblinding|Progression of disease|92
2038816|NCT00424047|3609183|FG001|On Study at Time of Unblinding|Progression of disease|128
2038817|NCT00424047|3609182|FG000|On Study at Time of Unblinding|Lack of Efficacy|1
2038818|NCT00424047|3609183|FG001|On Study at Time of Unblinding|Lack of Efficacy|3
2038819|NCT00424047|3609182|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24
2038820|NCT00424047|3609183|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9
2038821|NCT00424047|3609182|FG000|On Study at Time of Unblinding|Death|11
2038822|NCT00424047|3609183|FG001|On Study at Time of Unblinding|Death|11
2038823|NCT00424047|3609182|FG000|On Study at Time of Unblinding|Other|5
2195917|NCT01527357|3828701|FG001|Overall Study|Withdrew Consent|1
2253798|NCT02058628|3919481|FG000|Overall Study|Lost to Follow-up|2
2342369|NCT03483961|4075489|FG004|Overall Study|Lost to Follow-up|6
2342370|NCT03483961|4075490|FG005|Overall Study|Lost to Follow-up|4
2253799|NCT02058628|3919482|FG001|Overall Study|Lost to Follow-up|4
2253800|NCT02058628|3919481|FG000|Overall Study|Not in time schedule|0
2253801|NCT02058628|3919482|FG001|Overall Study|Not in time schedule|1
2253802|NCT02058628|3919481|FG000|Overall Study|The visit date was not in timeline|0
2253803|NCT02058628|3919482|FG001|Overall Study|The visit date was not in timeline|1
2253804|NCT02058628|3919481|FG000|Overall Study|A lot of time for study for participant|1
2253805|NCT02058628|3919482|FG001|Overall Study|A lot of time for study for participant|0
2253806|NCT02058628|3919481|FG000|Overall Study|Non compliance|1
2253807|NCT02058628|3919482|FG001|Overall Study|Non compliance|0
2253808|NCT02058836|3919493|FG000|Overall Study|Withdrawal by Subject|1
2253809|NCT02058836|3919494|FG001|Overall Study|Withdrawal by Subject|1
2253810|NCT02058849|3919502|FG000|Overall Study|Hospitalization|1
2253811|NCT02058849|3919503|FG001|Overall Study|Hospitalization|1
2342371|NCT03483961|4075491|FG006|Overall Study|Lost to Follow-up|4
2342372|NCT03483961|4075492|FG007|Overall Study|Lost to Follow-up|11
2342373|NCT03483961|4075493|FG008|Overall Study|Lost to Follow-up|1
2342374|NCT03483961|4075494|FG009|Overall Study|Lost to Follow-up|0
2342375|NCT03483961|4075485|FG000|Overall Study|Withdrawal by Subject|3
2342376|NCT03483961|4075486|FG001|Overall Study|Withdrawal by Subject|4
2342377|NCT03483961|4075487|FG002|Overall Study|Withdrawal by Subject|5
2342378|NCT03483961|4075488|FG003|Overall Study|Withdrawal by Subject|3
2342379|NCT03483961|4075489|FG004|Overall Study|Withdrawal by Subject|4
2342380|NCT03483961|4075490|FG005|Overall Study|Withdrawal by Subject|2
2342381|NCT03483961|4075491|FG006|Overall Study|Withdrawal by Subject|1
2342382|NCT03483961|4075492|FG007|Overall Study|Withdrawal by Subject|2
2342383|NCT03483961|4075493|FG008|Overall Study|Withdrawal by Subject|1
2342384|NCT03483961|4075494|FG009|Overall Study|Withdrawal by Subject|0
2342385|NCT03483961|4075485|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1
2342386|NCT03483961|4075486|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
2342387|NCT03483961|4075487|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
2342388|NCT03483961|4075488|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
2342389|NCT03483961|4075489|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
2342390|NCT03483961|4075490|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
2342391|NCT03483961|4075491|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
2342392|NCT03483961|4075492|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
2342393|NCT03483961|4075493|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
2342394|NCT03483961|4075494|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
2342395|NCT03483961|4075485|FG000|Overall Study|Adverse Event|0
2342396|NCT03483961|4075486|FG001|Overall Study|Adverse Event|0
2342397|NCT03483961|4075487|FG002|Overall Study|Adverse Event|1
2342398|NCT03483961|4075488|FG003|Overall Study|Adverse Event|0
2342399|NCT03483961|4075489|FG004|Overall Study|Adverse Event|0
2342400|NCT03483961|4075490|FG005|Overall Study|Adverse Event|0
2342401|NCT03483961|4075491|FG006|Overall Study|Adverse Event|0
2342402|NCT03483961|4075492|FG007|Overall Study|Adverse Event|0
2342403|NCT03483961|4075493|FG008|Overall Study|Adverse Event|0
2342404|NCT03483961|4075494|FG009|Overall Study|Adverse Event|0
2342405|NCT03484273|4075515|FG000|Overall Study|Equipment Malfunction|1
2342406|NCT03484273|4075515|FG000|Overall Study|Data excluded from analysis|1
2342407|NCT03484429|4075529|FG000|Overall Study|Withdrawal by Subject|1
2342408|NCT03484429|4075530|FG001|Overall Study|Withdrawal by Subject|0
2342409|NCT03484429|4075529|FG000|Overall Study|Adverse Event|2
2342410|NCT03484429|4075530|FG001|Overall Study|Adverse Event|0
2342411|NCT03485222|4075538|FG000|Overall Study|Death|0
2342412|NCT03485222|4075539|FG001|Overall Study|Death|1
2038824|NCT00424047|3609183|FG001|On Study at Time of Unblinding|Other|4
2038825|NCT00424047|3609182|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
2038826|NCT00424047|3609183|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
2038827|NCT00424047|3609182|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0
2038828|NCT00424047|3609183|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1
2038829|NCT00424047|3609182|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12
2038830|NCT00424047|3609183|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4
2038831|NCT00424047|3609182|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
2038832|NCT00424047|3609183|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
2038833|NCT00424047|3609182|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
2038834|NCT00424047|3609183|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
2253812|NCT02058849|3919502|FG000|Overall Study|Death|1
2253813|NCT02058849|3919503|FG001|Overall Study|Death|0
2253814|NCT02058849|3919502|FG000|Overall Study|Lost to Follow-up|1
2253815|NCT02058849|3919503|FG001|Overall Study|Lost to Follow-up|0
2253816|NCT02058849|3919502|FG000|Overall Study|Withdrawal by Subject|4
2253817|NCT02058849|3919503|FG001|Overall Study|Withdrawal by Subject|0
2253818|NCT02058940|3919509|FG000|Overall Study|Discharged from Critical Care Unit|1
2253819|NCT02058966|3919513|FG000|Open-Label Methamphetamine|Adverse Event|1
2253820|NCT02058966|3919513|FG000|First Intervention|Withdrawal by Subject|1
2253821|NCT02058992|3919525|FG000|Overall Study|Lost to Follow-up|4
2253822|NCT02058992|3919525|FG000|Overall Study|Protocol Violation|92
2253823|NCT02058992|3919525|FG000|Overall Study|CRF Uncollected|20
2253824|NCT02059005|3919531|FG000|Overall Study|Death|1
2253825|NCT02059005|3919532|FG001|Overall Study|Death|3
2253826|NCT02059005|3919531|FG000|Overall Study|Lost to Follow-up|19
2253827|NCT02059005|3919532|FG001|Overall Study|Lost to Follow-up|19
2253828|NCT02059005|3919531|FG000|Overall Study|Incarceration|0
2253829|NCT02059005|3919532|FG001|Overall Study|Incarceration|1
2253830|NCT02059005|3919531|FG000|Overall Study|Inpatient|0
2253831|NCT02059005|3919532|FG001|Overall Study|Inpatient|1
2253832|NCT02059135|3919556|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
2253833|NCT02059135|3919557|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
2253834|NCT02059135|3919556|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
2253835|NCT02059135|3919557|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
2253836|NCT02059135|3919556|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0
2253837|NCT02059135|3919557|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1
2253838|NCT02059135|3919556|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
2253839|NCT02059135|3919557|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
2253840|NCT02059135|3919556|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
2253841|NCT02059135|3919557|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
2253842|NCT02059135|3919556|FG000|Neonatal Follow-up (Safety Population)|Death|3
2253843|NCT02059135|3919557|FG001|Neonatal Follow-up (Safety Population)|Death|2
2253844|NCT02059135|3919556|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
2253845|NCT02059135|3919557|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
2253846|NCT02059135|3919556|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
2253847|NCT02059135|3919557|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
2253848|NCT02059148|3919565|FG000|Treatment 1|Protocol Violation|0
2253849|NCT02059148|3919566|FG001|Treatment 1|Protocol Violation|0
2253850|NCT02059148|3919567|FG002|Treatment 1|Protocol Violation|0
2253851|NCT02059148|3919568|FG003|Treatment 1|Protocol Violation|0
2253852|NCT02059148|3919569|FG004|Treatment 1|Protocol Violation|0
2253853|NCT02059148|3919570|FG005|Treatment 1|Protocol Violation|1
2253854|NCT02059161|3919583|FG000|Overall Study|Pregnancy|0
2253855|NCT02059161|3919584|FG001|Overall Study|Pregnancy|2
2253856|NCT02059161|3919583|FG000|Overall Study|Adverse Event|2
2253857|NCT02059161|3919584|FG001|Overall Study|Adverse Event|6
2253858|NCT02059161|3919583|FG000|Overall Study|Lost to Follow-up|20
2253859|NCT02059161|3919584|FG001|Overall Study|Lost to Follow-up|12
2253860|NCT02059161|3919583|FG000|Overall Study|Physician Decision|4
2253861|NCT02059161|3919584|FG001|Overall Study|Physician Decision|4
2253862|NCT02059161|3919583|FG000|Overall Study|Protocol Violation|1
2253863|NCT02059161|3919584|FG001|Overall Study|Protocol Violation|1
2253864|NCT02059161|3919583|FG000|Overall Study|Withdrawal by Subject|16
2253865|NCT02059161|3919584|FG001|Overall Study|Withdrawal by Subject|13
2253866|NCT02059161|3919583|FG000|Overall Study|Randomized in error, no study drug|0
2253867|NCT02059161|3919584|FG001|Overall Study|Randomized in error, no study drug|1
2253868|NCT02059161|3919583|FG000|Overall Study|Non-compliance with study drug|6
2253869|NCT02059161|3919584|FG001|Overall Study|Non-compliance with study drug|2
2253870|NCT02059174|3919590|FG000|Period 1|Withdrawal by Subject|0
2253871|NCT02059174|3919591|FG001|Period 1|Withdrawal by Subject|2
2253872|NCT02059174|3919590|FG000|Period 2|Withdrawal by Subject|0
2253873|NCT02059174|3919591|FG001|Period 2|Withdrawal by Subject|2
2253874|NCT02059174|3919590|FG000|Period 2|Protocol Violation|1
2342413|NCT03485222|4075538|FG000|Overall Study|Lost to Follow-up|2
2342414|NCT03485222|4075539|FG001|Overall Study|Lost to Follow-up|1
2342415|NCT03485495|4075547|FG000|Overall Study|Non-compliance with inclusion criteria|1
2342416|NCT03485495|4075548|FG001|Overall Study|Non-compliance with inclusion criteria|0
2342417|NCT03485911|4075557|FG000|Overall Study|Withdrawal by Subject|0
2342418|NCT03485911|4075558|FG001|Overall Study|Withdrawal by Subject|2
2342419|NCT03485911|4075559|FG002|Overall Study|Withdrawal by Subject|2
2342420|NCT03485911|4075557|FG000|Overall Study|Adverse Event|1
2342421|NCT03485911|4075558|FG001|Overall Study|Adverse Event|0
2342422|NCT03485911|4075559|FG002|Overall Study|Adverse Event|1
2342423|NCT03485911|4075557|FG000|Overall Study|High frequency of HAE attacks|0
2342424|NCT03485911|4075558|FG001|Overall Study|High frequency of HAE attacks|0
2342425|NCT03485911|4075559|FG002|Overall Study|High frequency of HAE attacks|1
2342426|NCT03485950|4075569|FG000|Overall Study|Adverse Event|1
2342427|NCT03485950|4075570|FG001|Overall Study|Adverse Event|0
2342428|NCT03485950|4075569|FG000|Overall Study|Death|3
2342429|NCT03485950|4075570|FG001|Overall Study|Death|2
2342430|NCT03485950|4075569|FG000|Overall Study|Withdrawal by Subject|3
2342431|NCT03485950|4075570|FG001|Overall Study|Withdrawal by Subject|0
2342432|NCT03486392|4075585|FG000|Overall Study|Lost to Follow-up|0
2342433|NCT03486392|4075586|FG001|Overall Study|Lost to Follow-up|0
2342434|NCT03486392|4075587|FG002|Overall Study|Lost to Follow-up|8
2342435|NCT03486392|4075588|FG003|Overall Study|Lost to Follow-up|5
2342436|NCT03486392|4075589|FG004|Overall Study|Lost to Follow-up|2
2342437|NCT03486392|4075585|FG000|Overall Study|Withdrawal by Subject|3
2342438|NCT03486392|4075586|FG001|Overall Study|Withdrawal by Subject|0
2253875|NCT02059174|3919591|FG001|Period 2|Protocol Violation|0
2253876|NCT02059174|3919590|FG000|Period 3|Physician Decision|1
2253877|NCT02059174|3919591|FG001|Period 3|Physician Decision|0
2253878|NCT02059187|3919599|FG000|Overall Study|Adverse Event|0
2253879|NCT02059187|3919600|FG001|Overall Study|Adverse Event|3
2253880|NCT02059187|3919599|FG000|Overall Study|Death|1
2253881|NCT02059187|3919600|FG001|Overall Study|Death|1
2253882|NCT02059187|3919599|FG000|Overall Study|Lost to Follow-up|9
2253883|NCT02059187|3919600|FG001|Overall Study|Lost to Follow-up|8
2253884|NCT02059187|3919599|FG000|Overall Study|Non-compliance with study drug|1
2253885|NCT02059187|3919600|FG001|Overall Study|Non-compliance with study drug|0
2253886|NCT02059187|3919599|FG000|Overall Study|Physician Decision|1
2253887|NCT02059187|3919600|FG001|Overall Study|Physician Decision|2
2253888|NCT02059187|3919599|FG000|Overall Study|Protocol Violation|1
2253889|NCT02059187|3919600|FG001|Overall Study|Protocol Violation|0
2253890|NCT02059187|3919599|FG000|Overall Study|Withdrawal by Subject|12
2253891|NCT02059187|3919600|FG001|Overall Study|Withdrawal by Subject|8
2253892|NCT02059239|3919620|FG000|Overall Study|Progressive Disease after Bendamustine|1
2253893|NCT02059239|3919621|FG001|Overall Study|Progressive Disease after Bendamustine|3
2253894|NCT02059239|3919620|FG000|Overall Study|Physician Decision|1
2253895|NCT02059239|3919621|FG001|Overall Study|Physician Decision|0
2253896|NCT02059278|3919630|FG000|Overall Study|Adverse Event|1
2253897|NCT02059278|3919631|FG001|Overall Study|Adverse Event|1
2253898|NCT02059278|3919630|FG000|Overall Study|Lost to Follow-up|1
2253899|NCT02059278|3919631|FG001|Overall Study|Lost to Follow-up|0
2253900|NCT02059278|3919630|FG000|Overall Study|Withdrawal by Subject|0
2253901|NCT02059278|3919631|FG001|Overall Study|Withdrawal by Subject|3
2253902|NCT02059278|3919630|FG000|Overall Study|Ran out of IP and decided to discontinue|1
2253903|NCT02059278|3919631|FG001|Overall Study|Ran out of IP and decided to discontinue|0
2253904|NCT02059291|3919646|FG000|Epoch 2|Lack of Efficacy|0
2253905|NCT02059291|3919647|FG001|Epoch 2|Lack of Efficacy|0
2253906|NCT02059291|3919648|FG002|Epoch 2|Lack of Efficacy|0
2253907|NCT02059291|3919649|FG003|Epoch 2|Lack of Efficacy|1
2253908|NCT02059291|3919650|FG004|Epoch 2|Lack of Efficacy|0
2253909|NCT02059291|3919651|FG005|Epoch 2|Lack of Efficacy|1
2253910|NCT02059291|3919652|FG006|Epoch 2|Lack of Efficacy|0
2253911|NCT02059291|3919653|FG007|Epoch 2|Lack of Efficacy|0
2253912|NCT02059291|3919654|FG008|Epoch 2|Lack of Efficacy|0
2253913|NCT02059291|3919655|FG009|Epoch 2|Lack of Efficacy|0
2253914|NCT02059291|3919656|FG010|Epoch 2|Lack of Efficacy|0
2253915|NCT02059291|3919657|FG011|Epoch 2|Lack of Efficacy|0
2253916|NCT02059291|3919658|FG012|Epoch 2|Lack of Efficacy|0
2253917|NCT02059291|3919659|FG013|Epoch 2|Lack of Efficacy|0
2253918|NCT02059291|3919660|FG014|Epoch 2|Lack of Efficacy|0
2253919|NCT02059291|3919661|FG015|Epoch 2|Lack of Efficacy|0
2253920|NCT02059291|3919662|FG016|Epoch 2|Lack of Efficacy|0
2342439|NCT03486392|4075587|FG002|Overall Study|Withdrawal by Subject|6
2342440|NCT03486392|4075588|FG003|Overall Study|Withdrawal by Subject|4
2342441|NCT03486392|4075589|FG004|Overall Study|Withdrawal by Subject|1
2342442|NCT03486392|4075585|FG000|Overall Study|Death|0
2342443|NCT03486392|4075586|FG001|Overall Study|Death|0
2342444|NCT03486392|4075587|FG002|Overall Study|Death|0
2342445|NCT03486392|4075588|FG003|Overall Study|Death|0
2342446|NCT03486392|4075589|FG004|Overall Study|Death|1
2342447|NCT03486834|4075604|FG000|Overall Study|Withdrawal by Subject|46
2342448|NCT03486834|4075605|FG001|Overall Study|Withdrawal by Subject|46
2342449|NCT03486834|4075606|FG002|Overall Study|Withdrawal by Subject|52
2342450|NCT03486834|4075604|FG000|Overall Study|Adverse Event|8
2342451|NCT03486834|4075605|FG001|Overall Study|Adverse Event|7
2342452|NCT03486834|4075606|FG002|Overall Study|Adverse Event|0
2342453|NCT03486834|4075604|FG000|Overall Study|Lost to Follow-up|41
2342454|NCT03486834|4075605|FG001|Overall Study|Lost to Follow-up|24
2342455|NCT03486834|4075606|FG002|Overall Study|Lost to Follow-up|39
2342456|NCT03486834|4075604|FG000|Overall Study|Non-compliance with Study Drug|2
2342457|NCT03486834|4075605|FG001|Overall Study|Non-compliance with Study Drug|2
2342458|NCT03486834|4075606|FG002|Overall Study|Non-compliance with Study Drug|0
2342459|NCT03486834|4075604|FG000|Overall Study|Physician Decision|5
2342460|NCT03486834|4075605|FG001|Overall Study|Physician Decision|2
2342461|NCT03486834|4075606|FG002|Overall Study|Physician Decision|3
2342462|NCT03486834|4075604|FG000|Overall Study|Pregnancy|10
2342463|NCT03486834|4075605|FG001|Overall Study|Pregnancy|12
2342464|NCT03486834|4075606|FG002|Overall Study|Pregnancy|12
2038835|NCT00424177|3609194|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
2038836|NCT00424177|3609194|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
2038837|NCT00424177|3609194|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
2038838|NCT00424177|3609194|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
2038839|NCT00424177|3609194|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
2038840|NCT00424177|3609194|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
2038841|NCT00424177|3609194|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
2038842|NCT00424177|3609194|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
2038843|NCT00424177|3609194|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
2038844|NCT00424177|3609194|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
2253921|NCT02059291|3919663|FG017|Epoch 2|Lack of Efficacy|0
2253922|NCT02059291|3919664|FG018|Epoch 2|Lack of Efficacy|0
2253923|NCT02059291|3919665|FG019|Epoch 2|Lack of Efficacy|0
2253924|NCT02059291|3919666|FG020|Epoch 2|Lack of Efficacy|0
2253925|NCT02059291|3919667|FG021|Epoch 2|Lack of Efficacy|0
2253926|NCT02059291|3919668|FG022|Epoch 2|Lack of Efficacy|0
2253927|NCT02059291|3919669|FG023|Epoch 2|Lack of Efficacy|0
2253928|NCT02059291|3919670|FG024|Epoch 2|Lack of Efficacy|0
2253929|NCT02059291|3919646|FG000|Epoch 2|Adverse Event|0
2253930|NCT02059291|3919647|FG001|Epoch 2|Adverse Event|0
2253931|NCT02059291|3919648|FG002|Epoch 2|Adverse Event|1
2253932|NCT02059291|3919649|FG003|Epoch 2|Adverse Event|1
2253933|NCT02059291|3919650|FG004|Epoch 2|Adverse Event|0
2253934|NCT02059291|3919651|FG005|Epoch 2|Adverse Event|0
2253935|NCT02059291|3919652|FG006|Epoch 2|Adverse Event|0
2253936|NCT02059291|3919653|FG007|Epoch 2|Adverse Event|1
2253937|NCT02059291|3919654|FG008|Epoch 2|Adverse Event|1
2253938|NCT02059291|3919655|FG009|Epoch 2|Adverse Event|0
2253939|NCT02059291|3919656|FG010|Epoch 2|Adverse Event|0
2253940|NCT02059291|3919657|FG011|Epoch 2|Adverse Event|0
2253941|NCT02059291|3919658|FG012|Epoch 2|Adverse Event|0
2253942|NCT02059291|3919659|FG013|Epoch 2|Adverse Event|0
2253943|NCT02059291|3919660|FG014|Epoch 2|Adverse Event|0
2253944|NCT02059291|3919661|FG015|Epoch 2|Adverse Event|0
2253945|NCT02059291|3919662|FG016|Epoch 2|Adverse Event|0
2253946|NCT02059291|3919663|FG017|Epoch 2|Adverse Event|0
2253947|NCT02059291|3919664|FG018|Epoch 2|Adverse Event|0
2253948|NCT02059291|3919665|FG019|Epoch 2|Adverse Event|0
2253949|NCT02059291|3919666|FG020|Epoch 2|Adverse Event|0
2253950|NCT02059291|3919667|FG021|Epoch 2|Adverse Event|0
2253951|NCT02059291|3919668|FG022|Epoch 2|Adverse Event|0
2253952|NCT02059291|3919669|FG023|Epoch 2|Adverse Event|0
2253953|NCT02059291|3919670|FG024|Epoch 2|Adverse Event|0
2253954|NCT02059291|3919646|FG000|Epoch 2|Withdrawal by Subject|0
2253955|NCT02059291|3919647|FG001|Epoch 2|Withdrawal by Subject|1
2253956|NCT02059291|3919648|FG002|Epoch 2|Withdrawal by Subject|0
2253957|NCT02059291|3919649|FG003|Epoch 2|Withdrawal by Subject|0
2253958|NCT02059291|3919650|FG004|Epoch 2|Withdrawal by Subject|0
2253959|NCT02059291|3919651|FG005|Epoch 2|Withdrawal by Subject|1
2253960|NCT02059291|3919652|FG006|Epoch 2|Withdrawal by Subject|0
2253961|NCT02059291|3919653|FG007|Epoch 2|Withdrawal by Subject|0
2253962|NCT02059291|3919654|FG008|Epoch 2|Withdrawal by Subject|1
2253963|NCT02059291|3919655|FG009|Epoch 2|Withdrawal by Subject|0
2253964|NCT02059291|3919656|FG010|Epoch 2|Withdrawal by Subject|0
2253965|NCT02059291|3919657|FG011|Epoch 2|Withdrawal by Subject|0
2253966|NCT02059291|3919658|FG012|Epoch 2|Withdrawal by Subject|0
2253967|NCT02059291|3919659|FG013|Epoch 2|Withdrawal by Subject|0
2253968|NCT02059291|3919660|FG014|Epoch 2|Withdrawal by Subject|0
2253969|NCT02059291|3919661|FG015|Epoch 2|Withdrawal by Subject|0
2253970|NCT02059291|3919662|FG016|Epoch 2|Withdrawal by Subject|0
2253971|NCT02059291|3919663|FG017|Epoch 2|Withdrawal by Subject|0
2253972|NCT02059291|3919664|FG018|Epoch 2|Withdrawal by Subject|0
2253973|NCT02059291|3919665|FG019|Epoch 2|Withdrawal by Subject|0
2253974|NCT02059291|3919666|FG020|Epoch 2|Withdrawal by Subject|0
2253975|NCT02059291|3919667|FG021|Epoch 2|Withdrawal by Subject|0
2253976|NCT02059291|3919668|FG022|Epoch 2|Withdrawal by Subject|0
2253977|NCT02059291|3919669|FG023|Epoch 2|Withdrawal by Subject|0
2253978|NCT02059291|3919670|FG024|Epoch 2|Withdrawal by Subject|0
2253979|NCT02059291|3919646|FG000|Epoch 3|Physician Decision|0
2342465|NCT03486834|4075604|FG000|Overall Study|Protocol Deviation|2
2342466|NCT03486834|4075605|FG001|Overall Study|Protocol Deviation|3
2342467|NCT03486834|4075606|FG002|Overall Study|Protocol Deviation|3
2342468|NCT03486834|4075604|FG000|Overall Study|Withdrawal by Parent/Guardian|1
2342469|NCT03486834|4075605|FG001|Overall Study|Withdrawal by Parent/Guardian|2
2342470|NCT03486834|4075606|FG002|Overall Study|Withdrawal by Parent/Guardian|2
2342471|NCT03486834|4075604|FG000|Overall Study|Randomized but not treated|4
2342472|NCT03486834|4075605|FG001|Overall Study|Randomized but not treated|4
2342473|NCT03486834|4075606|FG002|Overall Study|Randomized but not treated|1
2342474|NCT03487445|4075701|FG000|Randomization|Not treated for administrative reasons|1
2342475|NCT03487445|4075702|FG001|Randomization|Not treated for administrative reasons|0
2342476|NCT03487549|4075710|FG000|Overall Study|Protocol Violation|0
2342477|NCT03487549|4075711|FG001|Overall Study|Protocol Violation|1
2342478|NCT03487549|4075710|FG000|Overall Study|Lost to Follow-up|2
2342479|NCT03487549|4075711|FG001|Overall Study|Lost to Follow-up|1
2342480|NCT03487549|4075710|FG000|Overall Study|Withdrawal by Subject|2
2342481|NCT03487549|4075711|FG001|Overall Study|Withdrawal by Subject|0
2342482|NCT03487848|4075730|FG000|Overall Study|Lost to Follow-up|1
2342483|NCT03488108|4075736|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0
2342484|NCT03488108|4075737|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
2342485|NCT03488108|4075736|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
2342486|NCT03488108|4075737|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
2342487|NCT03488225|4075745|FG000|Overall Study|Off Protocol Therapy|2
2342488|NCT03488225|4075745|FG000|Overall Study|Stem Cell Transplant|2
2342489|NCT03488238|4075749|FG000|Overall Study|Equipment malfunction|1
2342490|NCT03488238|4075749|FG000|Overall Study|Adverse Event|1
2342491|NCT03488927|4075769|FG000|Overall Study|Withdrawal by Subject|44
2342492|NCT03488927|4075770|FG001|Overall Study|Withdrawal by Subject|118
2342493|NCT03488927|4075771|FG002|Overall Study|Withdrawal by Subject|217
2253980|NCT02059291|3919647|FG001|Epoch 3|Physician Decision|0
2253981|NCT02059291|3919648|FG002|Epoch 3|Physician Decision|0
2253982|NCT02059291|3919649|FG003|Epoch 3|Physician Decision|0
2253983|NCT02059291|3919650|FG004|Epoch 3|Physician Decision|0
2253984|NCT02059291|3919651|FG005|Epoch 3|Physician Decision|0
2253985|NCT02059291|3919652|FG006|Epoch 3|Physician Decision|0
2253986|NCT02059291|3919653|FG007|Epoch 3|Physician Decision|0
2253987|NCT02059291|3919654|FG008|Epoch 3|Physician Decision|0
2253988|NCT02059291|3919655|FG009|Epoch 3|Physician Decision|0
2253989|NCT02059291|3919656|FG010|Epoch 3|Physician Decision|0
2253990|NCT02059291|3919657|FG011|Epoch 3|Physician Decision|0
2253991|NCT02059291|3919658|FG012|Epoch 3|Physician Decision|0
2253992|NCT02059291|3919659|FG013|Epoch 3|Physician Decision|1
2253993|NCT02059291|3919660|FG014|Epoch 3|Physician Decision|0
2253994|NCT02059291|3919661|FG015|Epoch 3|Physician Decision|1
2253995|NCT02059291|3919662|FG016|Epoch 3|Physician Decision|0
2253996|NCT02059291|3919663|FG017|Epoch 3|Physician Decision|0
2253997|NCT02059291|3919664|FG018|Epoch 3|Physician Decision|0
2342494|NCT03489304|4075779|FG000|Overall Study|Lost to Follow-up|4
2342495|NCT03489343|4075790|FG000|Overall Study|Documented progressive disease|1
2342496|NCT03489343|4075791|FG001|Overall Study|Documented progressive disease|0
2342497|NCT03489343|4075792|FG002|Overall Study|Documented progressive disease|3
2342498|NCT03489343|4075793|FG003|Overall Study|Documented progressive disease|1
2342499|NCT03489343|4075794|FG004|Overall Study|Documented progressive disease|3
2342500|NCT03489343|4075795|FG005|Overall Study|Documented progressive disease|5
2342501|NCT03489343|4075796|FG006|Overall Study|Documented progressive disease|4
2342502|NCT03489343|4075790|FG000|Overall Study|Adverse Event|0
2342503|NCT03489343|4075791|FG001|Overall Study|Adverse Event|1
2342504|NCT03489343|4075792|FG002|Overall Study|Adverse Event|0
2342505|NCT03489343|4075793|FG003|Overall Study|Adverse Event|0
2342506|NCT03489343|4075794|FG004|Overall Study|Adverse Event|0
2342507|NCT03489343|4075795|FG005|Overall Study|Adverse Event|1
2342508|NCT03489343|4075796|FG006|Overall Study|Adverse Event|0
2342509|NCT03489343|4075790|FG000|Overall Study|Withdrawal by Subject|0
2342510|NCT03489343|4075791|FG001|Overall Study|Withdrawal by Subject|0
2342511|NCT03489343|4075792|FG002|Overall Study|Withdrawal by Subject|0
2342512|NCT03489343|4075793|FG003|Overall Study|Withdrawal by Subject|1
2342513|NCT03489343|4075794|FG004|Overall Study|Withdrawal by Subject|0
2342514|NCT03489343|4075795|FG005|Overall Study|Withdrawal by Subject|1
2342515|NCT03489343|4075796|FG006|Overall Study|Withdrawal by Subject|1
2342516|NCT03489343|4075790|FG000|Overall Study|Clinical progression|0
2342517|NCT03489343|4075791|FG001|Overall Study|Clinical progression|0
2342518|NCT03489343|4075792|FG002|Overall Study|Clinical progression|0
2342519|NCT03489343|4075793|FG003|Overall Study|Clinical progression|1
2342520|NCT03489343|4075794|FG004|Overall Study|Clinical progression|0
2342521|NCT03489343|4075795|FG005|Overall Study|Clinical progression|0
2342522|NCT03489343|4075796|FG006|Overall Study|Clinical progression|1
2342523|NCT03489369|4075816|FG000|Overall Study|Documented Progressive Disease|3
2342524|NCT03489369|4075817|FG001|Overall Study|Documented Progressive Disease|2
2342525|NCT03489369|4075818|FG002|Overall Study|Documented Progressive Disease|3
2342526|NCT03489369|4075819|FG003|Overall Study|Documented Progressive Disease|6
2342527|NCT03489369|4075816|FG000|Overall Study|Clinical Progression (Worsening of Clini|0
2342528|NCT03489369|4075817|FG001|Overall Study|Clinical Progression (Worsening of Clini|1
2342529|NCT03489369|4075818|FG002|Overall Study|Clinical Progression (Worsening of Clini|0
2342530|NCT03489369|4075819|FG003|Overall Study|Clinical Progression (Worsening of Clini|0
2342531|NCT03489551|4075829|FG000|Overall Study|Withdrawal by Subject|2
2342532|NCT03489720|4075835|FG000|Overall Study|Withdrawal by Subject|2
2342533|NCT03489720|4075836|FG001|Overall Study|Withdrawal by Subject|0
2342534|NCT03489863|4075857|FG000|Overall Study|Withdrawal by Subject|0
2342535|NCT03489863|4075858|FG001|Overall Study|Withdrawal by Subject|1
2342536|NCT03490032|4075875|FG000|Overall Study|family issue (child custody)|1
2342537|NCT03490032|4075876|FG001|Overall Study|family issue (child custody)|0
2342538|NCT03490032|4075877|FG002|Overall Study|family issue (child custody)|0
2342539|NCT03490981|4075910|FG000|Overall Study|Lost to Follow-up|1
2342540|NCT03490981|4075911|FG001|Overall Study|Lost to Follow-up|2
2342541|NCT03491150|4075919|FG000|Overall Study|Adverse Event|1
2342542|NCT03491150|4075920|FG001|Overall Study|Adverse Event|0
2342543|NCT03491150|4075919|FG000|Overall Study|Study Terminated by Sponsor|74
2342544|NCT03491150|4075920|FG001|Overall Study|Study Terminated by Sponsor|70
2342545|NCT03491150|4075919|FG000|Overall Study|Other|0
2342546|NCT03491150|4075920|FG001|Overall Study|Other|1
2342547|NCT03491150|4075919|FG000|Overall Study|Withdrawal by Subject|1
2342548|NCT03491150|4075920|FG001|Overall Study|Withdrawal by Subject|2
2038845|NCT00424190|3609208|FG000|Overall Study|Withdrew consent|3
2038846|NCT00424190|3609209|FG001|Overall Study|Withdrew consent|4
2038847|NCT00424190|3609208|FG000|Overall Study|Death|3
2038848|NCT00424190|3609209|FG001|Overall Study|Death|0
2038849|NCT00424190|3609208|FG000|Overall Study|Noncompliance|1
2038850|NCT00424190|3609209|FG001|Overall Study|Noncompliance|2
2038851|NCT00424190|3609208|FG000|Overall Study|Request of sponsor or investigator|0
2038852|NCT00424190|3609209|FG001|Overall Study|Request of sponsor or investigator|2
2038853|NCT00424190|3609208|FG000|Overall Study|Diagnosis of osteomyelitis|0
2038854|NCT00424190|3609209|FG001|Overall Study|Diagnosis of osteomyelitis|1
2253998|NCT02059291|3919665|FG019|Epoch 3|Physician Decision|0
2253999|NCT02059291|3919666|FG020|Epoch 3|Physician Decision|0
2254000|NCT02059291|3919667|FG021|Epoch 3|Physician Decision|0
2254001|NCT02059291|3919668|FG022|Epoch 3|Physician Decision|0
2254002|NCT02059291|3919669|FG023|Epoch 3|Physician Decision|0
2254003|NCT02059291|3919670|FG024|Epoch 3|Physician Decision|0
2254004|NCT02059291|3919646|FG000|Epoch 3|Adverse Event|0
2254005|NCT02059291|3919647|FG001|Epoch 3|Adverse Event|0
2254006|NCT02059291|3919648|FG002|Epoch 3|Adverse Event|0
2254007|NCT02059291|3919649|FG003|Epoch 3|Adverse Event|0
2254008|NCT02059291|3919650|FG004|Epoch 3|Adverse Event|0
2254009|NCT02059291|3919651|FG005|Epoch 3|Adverse Event|0
2254010|NCT02059291|3919652|FG006|Epoch 3|Adverse Event|0
2254011|NCT02059291|3919653|FG007|Epoch 3|Adverse Event|0
2254012|NCT02059291|3919654|FG008|Epoch 3|Adverse Event|0
2254013|NCT02059291|3919655|FG009|Epoch 3|Adverse Event|0
2254014|NCT02059291|3919656|FG010|Epoch 3|Adverse Event|0
2254015|NCT02059291|3919657|FG011|Epoch 3|Adverse Event|0
2254016|NCT02059291|3919658|FG012|Epoch 3|Adverse Event|0
2254017|NCT02059291|3919659|FG013|Epoch 3|Adverse Event|0
2254018|NCT02059291|3919660|FG014|Epoch 3|Adverse Event|0
2254019|NCT02059291|3919661|FG015|Epoch 3|Adverse Event|1
2254020|NCT02059291|3919662|FG016|Epoch 3|Adverse Event|0
2254021|NCT02059291|3919663|FG017|Epoch 3|Adverse Event|0
2254022|NCT02059291|3919664|FG018|Epoch 3|Adverse Event|0
2254023|NCT02059291|3919665|FG019|Epoch 3|Adverse Event|0
2254024|NCT02059291|3919666|FG020|Epoch 3|Adverse Event|0
2254025|NCT02059291|3919667|FG021|Epoch 3|Adverse Event|0
2254026|NCT02059291|3919668|FG022|Epoch 3|Adverse Event|0
2254027|NCT02059291|3919669|FG023|Epoch 3|Adverse Event|0
2254028|NCT02059291|3919670|FG024|Epoch 3|Adverse Event|0
2254029|NCT02059291|3919646|FG000|Epoch 3|Lack of Efficacy|0
2254030|NCT02059291|3919647|FG001|Epoch 3|Lack of Efficacy|0
2254031|NCT02059291|3919648|FG002|Epoch 3|Lack of Efficacy|0
2254032|NCT02059291|3919649|FG003|Epoch 3|Lack of Efficacy|0
2342549|NCT03491553|4075936|FG000|Main Study (Up to Week 48)|Adverse Event|0
2342550|NCT03491553|4075937|FG001|Main Study (Up to Week 48)|Adverse Event|0
2342551|NCT03491553|4075938|FG002|Main Study (Up to Week 48)|Adverse Event|0
2342552|NCT03491553|4075939|FG003|Main Study (Up to Week 48)|Adverse Event|1
2342553|NCT03491553|4075940|FG004|Main Study (Up to Week 48)|Adverse Event|0
2342554|NCT03491553|4075941|FG005|Main Study (Up to Week 48)|Adverse Event|0
2342555|NCT03491553|4075936|FG000|Main Study (Up to Week 48)|Withdrew Consent|1
2342556|NCT03491553|4075937|FG001|Main Study (Up to Week 48)|Withdrew Consent|1
2342557|NCT03491553|4075938|FG002|Main Study (Up to Week 48)|Withdrew Consent|0
2342558|NCT03491553|4075939|FG003|Main Study (Up to Week 48)|Withdrew Consent|0
2342559|NCT03491553|4075940|FG004|Main Study (Up to Week 48)|Withdrew Consent|0
2342560|NCT03491553|4075941|FG005|Main Study (Up to Week 48)|Withdrew Consent|0
2342561|NCT03492281|4075994|FG000|Overall Study|Withdrawal by Subject|21
2342562|NCT03492281|4075995|FG001|Overall Study|Withdrawal by Subject|14
2342563|NCT03492281|4075996|FG002|Overall Study|Withdrawal by Subject|13
2342564|NCT03492281|4075994|FG000|Overall Study|Lost to Follow-up|14
2342565|NCT03492281|4075995|FG001|Overall Study|Lost to Follow-up|15
2342566|NCT03492281|4075996|FG002|Overall Study|Lost to Follow-up|10
2342567|NCT03492281|4075994|FG000|Overall Study|Adverse Event|6
2342568|NCT03492281|4075995|FG001|Overall Study|Adverse Event|8
2342569|NCT03492281|4075996|FG002|Overall Study|Adverse Event|13
2342570|NCT03492281|4075994|FG000|Overall Study|Lack of Efficacy|3
2342571|NCT03492281|4075995|FG001|Overall Study|Lack of Efficacy|0
2342572|NCT03492281|4075996|FG002|Overall Study|Lack of Efficacy|1
2342573|NCT03492281|4075994|FG000|Overall Study|Physician Decision|1
2342574|NCT03492281|4075995|FG001|Overall Study|Physician Decision|0
2342575|NCT03492281|4075996|FG002|Overall Study|Physician Decision|3
2342576|NCT03492281|4075994|FG000|Overall Study|Protocol Violation|0
2342577|NCT03492281|4075995|FG001|Overall Study|Protocol Violation|2
2342578|NCT03492281|4075996|FG002|Overall Study|Protocol Violation|1
2342579|NCT03492281|4075994|FG000|Overall Study|Withdrawn Due to Sponsor|1
2342580|NCT03492281|4075995|FG001|Overall Study|Withdrawn Due to Sponsor|0
2342581|NCT03492281|4075996|FG002|Overall Study|Withdrawn Due to Sponsor|1
2342582|NCT03492281|4075994|FG000|Overall Study|Death|0
2342583|NCT03492281|4075995|FG001|Overall Study|Death|0
2342584|NCT03492281|4075996|FG002|Overall Study|Death|1
2342585|NCT03492281|4075994|FG000|Overall Study|Captured as Other in Database|8
2342586|NCT03492281|4075995|FG001|Overall Study|Captured as Other in Database|6
2342587|NCT03492281|4075996|FG002|Overall Study|Captured as Other in Database|3
2342588|NCT03492554|4076046|FG000|Overall Study|Protocol Violation|0
2342589|NCT03492554|4076047|FG001|Overall Study|Protocol Violation|14
2342590|NCT03493386|4076056|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2038855|NCT00424190|3609208|FG000|Overall Study|Other|15
2038856|NCT00424190|3609209|FG001|Overall Study|Other|21
2038857|NCT00424255|3609217|FG000|Overall Study|Death|115
2038858|NCT00424255|3609218|FG001|Overall Study|Death|111
2038859|NCT00424255|3609217|FG000|Overall Study|Lost to Follow-up|26
2038860|NCT00424255|3609218|FG001|Overall Study|Lost to Follow-up|20
2038861|NCT00424255|3609217|FG000|Overall Study|Protocol Violation|0
2038862|NCT00424255|3609218|FG001|Overall Study|Protocol Violation|1
2353246|NCT02865122|4104758|FG000|Overall Study|Adverse Event|1
2038863|NCT00424255|3609217|FG000|Overall Study|Withdrawal by Subject|34
2254033|NCT02059291|3919650|FG004|Epoch 3|Lack of Efficacy|0
2254034|NCT02059291|3919651|FG005|Epoch 3|Lack of Efficacy|0
2254035|NCT02059291|3919652|FG006|Epoch 3|Lack of Efficacy|0
2254036|NCT02059291|3919653|FG007|Epoch 3|Lack of Efficacy|0
2254037|NCT02059291|3919654|FG008|Epoch 3|Lack of Efficacy|0
2254038|NCT02059291|3919655|FG009|Epoch 3|Lack of Efficacy|0
2254039|NCT02059291|3919656|FG010|Epoch 3|Lack of Efficacy|0
2254040|NCT02059291|3919657|FG011|Epoch 3|Lack of Efficacy|0
2254041|NCT02059291|3919658|FG012|Epoch 3|Lack of Efficacy|0
2254042|NCT02059291|3919659|FG013|Epoch 3|Lack of Efficacy|0
2254043|NCT02059291|3919660|FG014|Epoch 3|Lack of Efficacy|0
2254044|NCT02059291|3919661|FG015|Epoch 3|Lack of Efficacy|3
2254045|NCT02059291|3919662|FG016|Epoch 3|Lack of Efficacy|0
2254046|NCT02059291|3919663|FG017|Epoch 3|Lack of Efficacy|0
2254047|NCT02059291|3919664|FG018|Epoch 3|Lack of Efficacy|0
2254048|NCT02059291|3919665|FG019|Epoch 3|Lack of Efficacy|0
2254049|NCT02059291|3919666|FG020|Epoch 3|Lack of Efficacy|0
2254050|NCT02059291|3919667|FG021|Epoch 3|Lack of Efficacy|0
2254051|NCT02059291|3919668|FG022|Epoch 3|Lack of Efficacy|0
2254052|NCT02059291|3919669|FG023|Epoch 3|Lack of Efficacy|0
2254053|NCT02059291|3919670|FG024|Epoch 3|Lack of Efficacy|0
2254054|NCT02059291|3919646|FG000|Epoch 3|Withdrawal by Subject|0
2254055|NCT02059291|3919647|FG001|Epoch 3|Withdrawal by Subject|0
2254056|NCT02059291|3919648|FG002|Epoch 3|Withdrawal by Subject|0
2254057|NCT02059291|3919649|FG003|Epoch 3|Withdrawal by Subject|0
2254058|NCT02059291|3919650|FG004|Epoch 3|Withdrawal by Subject|0
2254059|NCT02059291|3919651|FG005|Epoch 3|Withdrawal by Subject|0
2254060|NCT02059291|3919652|FG006|Epoch 3|Withdrawal by Subject|0
2254061|NCT02059291|3919653|FG007|Epoch 3|Withdrawal by Subject|0
2254062|NCT02059291|3919654|FG008|Epoch 3|Withdrawal by Subject|0
2254063|NCT02059291|3919655|FG009|Epoch 3|Withdrawal by Subject|0
2254064|NCT02059291|3919656|FG010|Epoch 3|Withdrawal by Subject|0
2254065|NCT02059291|3919657|FG011|Epoch 3|Withdrawal by Subject|0
2254066|NCT02059291|3919658|FG012|Epoch 3|Withdrawal by Subject|0
2254067|NCT02059291|3919659|FG013|Epoch 3|Withdrawal by Subject|0
2254068|NCT02059291|3919660|FG014|Epoch 3|Withdrawal by Subject|0
2254069|NCT02059291|3919661|FG015|Epoch 3|Withdrawal by Subject|1
2254070|NCT02059291|3919662|FG016|Epoch 3|Withdrawal by Subject|0
2254071|NCT02059291|3919663|FG017|Epoch 3|Withdrawal by Subject|0
2254072|NCT02059291|3919664|FG018|Epoch 3|Withdrawal by Subject|0
2254073|NCT02059291|3919665|FG019|Epoch 3|Withdrawal by Subject|0
2254074|NCT02059291|3919666|FG020|Epoch 3|Withdrawal by Subject|0
2254075|NCT02059291|3919667|FG021|Epoch 3|Withdrawal by Subject|0
2254076|NCT02059291|3919668|FG022|Epoch 3|Withdrawal by Subject|0
2254077|NCT02059291|3919669|FG023|Epoch 3|Withdrawal by Subject|0
2254078|NCT02059291|3919670|FG024|Epoch 3|Withdrawal by Subject|0
2254079|NCT02059291|3919646|FG000|Epoch 4|Adverse Event|0
2254080|NCT02059291|3919647|FG001|Epoch 4|Adverse Event|0
2254081|NCT02059291|3919648|FG002|Epoch 4|Adverse Event|0
2254082|NCT02059291|3919649|FG003|Epoch 4|Adverse Event|0
2254083|NCT02059291|3919650|FG004|Epoch 4|Adverse Event|0
2254084|NCT02059291|3919651|FG005|Epoch 4|Adverse Event|0
2254085|NCT02059291|3919652|FG006|Epoch 4|Adverse Event|0
2254086|NCT02059291|3919653|FG007|Epoch 4|Adverse Event|0
2254087|NCT02059291|3919654|FG008|Epoch 4|Adverse Event|0
2254088|NCT02059291|3919655|FG009|Epoch 4|Adverse Event|0
2254089|NCT02059291|3919656|FG010|Epoch 4|Adverse Event|0
2254090|NCT02059291|3919657|FG011|Epoch 4|Adverse Event|0
2254091|NCT02059291|3919658|FG012|Epoch 4|Adverse Event|0
2254092|NCT02059291|3919659|FG013|Epoch 4|Adverse Event|0
2254093|NCT02059291|3919660|FG014|Epoch 4|Adverse Event|0
2254094|NCT02059291|3919661|FG015|Epoch 4|Adverse Event|0
2254095|NCT02059291|3919662|FG016|Epoch 4|Adverse Event|1
2254096|NCT02059291|3919663|FG017|Epoch 4|Adverse Event|0
2254097|NCT02059291|3919664|FG018|Epoch 4|Adverse Event|0
2254098|NCT02059291|3919665|FG019|Epoch 4|Adverse Event|0
2254099|NCT02059291|3919666|FG020|Epoch 4|Adverse Event|0
2254100|NCT02059291|3919667|FG021|Epoch 4|Adverse Event|0
2254101|NCT02059291|3919668|FG022|Epoch 4|Adverse Event|1
2254102|NCT02059291|3919669|FG023|Epoch 4|Adverse Event|0
2254103|NCT02059291|3919670|FG024|Epoch 4|Adverse Event|0
2254104|NCT02059291|3919646|FG000|Epoch 4|Pregnancy|0
2254105|NCT02059291|3919647|FG001|Epoch 4|Pregnancy|0
2254106|NCT02059291|3919648|FG002|Epoch 4|Pregnancy|0
2254107|NCT02059291|3919649|FG003|Epoch 4|Pregnancy|0
2254108|NCT02059291|3919650|FG004|Epoch 4|Pregnancy|0
2254109|NCT02059291|3919651|FG005|Epoch 4|Pregnancy|0
2254110|NCT02059291|3919652|FG006|Epoch 4|Pregnancy|0
2254111|NCT02059291|3919653|FG007|Epoch 4|Pregnancy|0
2254112|NCT02059291|3919654|FG008|Epoch 4|Pregnancy|0
2254113|NCT02059291|3919655|FG009|Epoch 4|Pregnancy|0
2254114|NCT02059291|3919656|FG010|Epoch 4|Pregnancy|0
2254115|NCT02059291|3919657|FG011|Epoch 4|Pregnancy|0
2254116|NCT02059291|3919658|FG012|Epoch 4|Pregnancy|0
2254117|NCT02059291|3919659|FG013|Epoch 4|Pregnancy|0
2254118|NCT02059291|3919660|FG014|Epoch 4|Pregnancy|0
2254119|NCT02059291|3919661|FG015|Epoch 4|Pregnancy|0
2254120|NCT02059291|3919662|FG016|Epoch 4|Pregnancy|1
2254121|NCT02059291|3919663|FG017|Epoch 4|Pregnancy|0
2254122|NCT02059291|3919664|FG018|Epoch 4|Pregnancy|0
2254123|NCT02059291|3919665|FG019|Epoch 4|Pregnancy|0
2254124|NCT02059291|3919666|FG020|Epoch 4|Pregnancy|0
2254125|NCT02059291|3919667|FG021|Epoch 4|Pregnancy|0
2254126|NCT02059291|3919668|FG022|Epoch 4|Pregnancy|0
2254127|NCT02059291|3919669|FG023|Epoch 4|Pregnancy|0
2254128|NCT02059291|3919670|FG024|Epoch 4|Pregnancy|0
2254129|NCT02059291|3919646|FG000|Epoch 4|Withdrawal by Subject|0
2254130|NCT02059291|3919647|FG001|Epoch 4|Withdrawal by Subject|0
2254131|NCT02059291|3919648|FG002|Epoch 4|Withdrawal by Subject|0
2254132|NCT02059291|3919649|FG003|Epoch 4|Withdrawal by Subject|0
2254133|NCT02059291|3919650|FG004|Epoch 4|Withdrawal by Subject|0
2254134|NCT02059291|3919651|FG005|Epoch 4|Withdrawal by Subject|0
2254135|NCT02059291|3919652|FG006|Epoch 4|Withdrawal by Subject|0
2254136|NCT02059291|3919653|FG007|Epoch 4|Withdrawal by Subject|0
2254137|NCT02059291|3919654|FG008|Epoch 4|Withdrawal by Subject|0
2254138|NCT02059291|3919655|FG009|Epoch 4|Withdrawal by Subject|0
2254139|NCT02059291|3919656|FG010|Epoch 4|Withdrawal by Subject|0
2254140|NCT02059291|3919657|FG011|Epoch 4|Withdrawal by Subject|0
2254141|NCT02059291|3919658|FG012|Epoch 4|Withdrawal by Subject|0
2254142|NCT02059291|3919659|FG013|Epoch 4|Withdrawal by Subject|0
2254143|NCT02059291|3919660|FG014|Epoch 4|Withdrawal by Subject|0
2342591|NCT03493386|4076057|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2342592|NCT03493386|4076058|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2342593|NCT03493386|4076059|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2342594|NCT03493542|4076078|FG000|Overall Study|Ongoing|2
2342595|NCT03493542|4076079|FG001|Overall Study|Ongoing|3
2342596|NCT03493542|4076078|FG000|Overall Study|Withdrawal by parent or guardian|3
2342597|NCT03493542|4076079|FG001|Overall Study|Withdrawal by parent or guardian|0
2342598|NCT03493542|4076078|FG000|Overall Study|Withdrawal by Subject|2
2342599|NCT03493542|4076079|FG001|Overall Study|Withdrawal by Subject|6
2342600|NCT03493698|4076089|FG000|Treatment Period C|Adverse Event|1
2342601|NCT03493698|4076089|FG000|Treatment Period C|Withdrawal by Subject|1
2342602|NCT03494725|4076127|FG000|Overall Study|Withdrawal by Subject|0
2342603|NCT03494725|4076128|FG001|Overall Study|Withdrawal by Subject|2
2342604|NCT03494725|4076127|FG000|Overall Study|Antibiotic use|1
2342605|NCT03494725|4076128|FG001|Overall Study|Antibiotic use|0
2342606|NCT03494816|4076140|FG000|Overall Study|Protocol Violation|2
2342607|NCT03494816|4076140|FG000|Overall Study|Physician Decision|2
2342608|NCT03494816|4076140|FG000|Overall Study|Did not start trial treatment|1
2342609|NCT03494816|4076140|FG000|Overall Study|Adverse Event|1
2342610|NCT03494985|4076152|FG000|Overall Study|Adverse Event|3
2342611|NCT03494985|4076153|FG001|Overall Study|Adverse Event|2
2342612|NCT03494985|4076154|FG002|Overall Study|Adverse Event|3
2342613|NCT03494985|4076155|FG003|Overall Study|Adverse Event|0
2342614|NCT03494985|4076152|FG000|Overall Study|Other (Withdrawal of consent)|2
2342615|NCT03494985|4076153|FG001|Overall Study|Other (Withdrawal of consent)|3
2342616|NCT03494985|4076154|FG002|Overall Study|Other (Withdrawal of consent)|2
2342617|NCT03494985|4076155|FG003|Overall Study|Other (Withdrawal of consent)|5
2342618|NCT03494985|4076152|FG000|Overall Study|Other (Not specified)|0
2342619|NCT03494985|4076153|FG001|Overall Study|Other (Not specified)|1
2342620|NCT03494985|4076154|FG002|Overall Study|Other (Not specified)|1
2342621|NCT03494985|4076155|FG003|Overall Study|Other (Not specified)|0
2342622|NCT03495102|4076168|FG000|Overall Study|Adverse Event|5
2342623|NCT03495102|4076169|FG001|Overall Study|Adverse Event|7
2342624|NCT03495102|4076170|FG002|Overall Study|Adverse Event|10
2342625|NCT03495102|4076168|FG000|Overall Study|Death|3
2342626|NCT03495102|4076169|FG001|Overall Study|Death|4
2342627|NCT03495102|4076170|FG002|Overall Study|Death|4
2342628|NCT03495102|4076168|FG000|Overall Study|Lost to Follow-up|15
2342629|NCT03495102|4076169|FG001|Overall Study|Lost to Follow-up|16
2342630|NCT03495102|4076170|FG002|Overall Study|Lost to Follow-up|17
2342631|NCT03495102|4076168|FG000|Overall Study|Physician Decision|2
2038864|NCT00424255|3609218|FG001|Overall Study|Withdrawal by Subject|38
2038865|NCT00424255|3609217|FG000|Overall Study|Physician Decision|3
2038866|NCT00424255|3609218|FG001|Overall Study|Physician Decision|7
2038867|NCT00424255|3609217|FG000|Overall Study|Cognitive Disturbance|1
2038868|NCT00424255|3609218|FG001|Overall Study|Cognitive Disturbance|0
2038869|NCT00424255|3609217|FG000|Overall Study|Non-compliance by Participants|1
2038870|NCT00424255|3609218|FG001|Overall Study|Non-compliance by Participants|0
2038871|NCT00424255|3609217|FG000|Overall Study|Fatigue|1
2038872|NCT00424255|3609218|FG001|Overall Study|Fatigue|0
2038873|NCT00424255|3609217|FG000|Overall Study|Disease Progression|0
2038874|NCT00424255|3609218|FG001|Overall Study|Disease Progression|2
2038875|NCT00424255|3609217|FG000|Overall Study|Sponsor Terminated Study|161
2038876|NCT00424255|3609218|FG001|Overall Study|Sponsor Terminated Study|167
2038877|NCT00424294|3609235|FG000|Overall Study|Adverse Event|4
2038878|NCT00424294|3609236|FG001|Overall Study|Adverse Event|10
2038879|NCT00424294|3609235|FG000|Overall Study|Lack of Efficacy|2
2038880|NCT00424294|3609236|FG001|Overall Study|Lack of Efficacy|1
2038881|NCT00424294|3609235|FG000|Overall Study|Withdrawal by Subject|1
2038882|NCT00424294|3609236|FG001|Overall Study|Withdrawal by Subject|2
2038883|NCT00424294|3609235|FG000|Overall Study|Other|0
2038884|NCT00424294|3609236|FG001|Overall Study|Other|2
2038885|NCT00424294|3609235|FG000|Overall Study|Randomized but not Treated|1
2038886|NCT00424294|3609236|FG001|Overall Study|Randomized but not Treated|0
2038887|NCT00424346|3609246|FG000|Core Study|Adverse Event|5
2038888|NCT00424346|3609247|FG001|Core Study|Adverse Event|3
2038889|NCT00424346|3609248|FG002|Core Study|Adverse Event|1
2038890|NCT00424346|3609249|FG003|Core Study|Adverse Event|1
2038891|NCT00424346|3609246|FG000|Core Study|Abnormal Laboratory Values|0
2254144|NCT02059291|3919661|FG015|Epoch 4|Withdrawal by Subject|0
2254145|NCT02059291|3919662|FG016|Epoch 4|Withdrawal by Subject|0
2254146|NCT02059291|3919663|FG017|Epoch 4|Withdrawal by Subject|0
2254147|NCT02059291|3919664|FG018|Epoch 4|Withdrawal by Subject|0
2254148|NCT02059291|3919665|FG019|Epoch 4|Withdrawal by Subject|0
2254149|NCT02059291|3919666|FG020|Epoch 4|Withdrawal by Subject|1
2254150|NCT02059291|3919667|FG021|Epoch 4|Withdrawal by Subject|0
2254151|NCT02059291|3919668|FG022|Epoch 4|Withdrawal by Subject|0
2254152|NCT02059291|3919669|FG023|Epoch 4|Withdrawal by Subject|0
2254153|NCT02059291|3919670|FG024|Epoch 4|Withdrawal by Subject|0
2254154|NCT02059291|3919646|FG000|Epoch 4|Lack of Efficacy|0
2254155|NCT02059291|3919647|FG001|Epoch 4|Lack of Efficacy|0
2254156|NCT02059291|3919648|FG002|Epoch 4|Lack of Efficacy|0
2254157|NCT02059291|3919649|FG003|Epoch 4|Lack of Efficacy|0
2254158|NCT02059291|3919650|FG004|Epoch 4|Lack of Efficacy|0
2254159|NCT02059291|3919651|FG005|Epoch 4|Lack of Efficacy|0
2254160|NCT02059291|3919652|FG006|Epoch 4|Lack of Efficacy|0
2254161|NCT02059291|3919653|FG007|Epoch 4|Lack of Efficacy|0
2254162|NCT02059291|3919654|FG008|Epoch 4|Lack of Efficacy|0
2254163|NCT02059291|3919655|FG009|Epoch 4|Lack of Efficacy|0
2254164|NCT02059291|3919656|FG010|Epoch 4|Lack of Efficacy|0
2254165|NCT02059291|3919657|FG011|Epoch 4|Lack of Efficacy|0
2254166|NCT02059291|3919658|FG012|Epoch 4|Lack of Efficacy|0
2254167|NCT02059291|3919659|FG013|Epoch 4|Lack of Efficacy|0
2254168|NCT02059291|3919660|FG014|Epoch 4|Lack of Efficacy|0
2254169|NCT02059291|3919661|FG015|Epoch 4|Lack of Efficacy|0
2254170|NCT02059291|3919662|FG016|Epoch 4|Lack of Efficacy|0
2254171|NCT02059291|3919663|FG017|Epoch 4|Lack of Efficacy|0
2254172|NCT02059291|3919664|FG018|Epoch 4|Lack of Efficacy|0
2254173|NCT02059291|3919665|FG019|Epoch 4|Lack of Efficacy|0
2254174|NCT02059291|3919666|FG020|Epoch 4|Lack of Efficacy|0
2254175|NCT02059291|3919667|FG021|Epoch 4|Lack of Efficacy|0
2254176|NCT02059291|3919668|FG022|Epoch 4|Lack of Efficacy|0
2254177|NCT02059291|3919669|FG023|Epoch 4|Lack of Efficacy|1
2254178|NCT02059291|3919670|FG024|Epoch 4|Lack of Efficacy|0
2254179|NCT02059395|3919700|FG000|Overall Study|Lost to Follow-up|2
2254180|NCT02059395|3919701|FG001|Overall Study|Lost to Follow-up|4
2254181|NCT02059408|3919710|FG000|Overall Study|Did not get tested|0
2254182|NCT02059408|3919711|FG001|Overall Study|Did not get tested|330
2254183|NCT02059408|3919712|FG002|Overall Study|Did not get tested|358
2254184|NCT02059434|3919731|FG000|Washout Between Periods 1 and 2|Physician Decision|0
2254185|NCT02059434|3919732|FG001|Washout Between Periods 1 and 2|Physician Decision|0
2254186|NCT02059434|3919733|FG002|Washout Between Periods 1 and 2|Physician Decision|0
2254187|NCT02059434|3919734|FG003|Washout Between Periods 1 and 2|Physician Decision|0
2254188|NCT02059434|3919735|FG004|Washout Between Periods 1 and 2|Physician Decision|0
2254189|NCT02059434|3919736|FG005|Washout Between Periods 1 and 2|Physician Decision|0
2254190|NCT02059434|3919737|FG006|Washout Between Periods 1 and 2|Physician Decision|0
2254191|NCT02059434|3919738|FG007|Washout Between Periods 1 and 2|Physician Decision|1
2254192|NCT02059434|3919739|FG008|Washout Between Periods 1 and 2|Physician Decision|0
2254193|NCT02059434|3919731|FG000|Washout Between Periods 4 and 5|Adverse Event|0
2254194|NCT02059434|3919732|FG001|Washout Between Periods 4 and 5|Adverse Event|0
2254195|NCT02059434|3919733|FG002|Washout Between Periods 4 and 5|Adverse Event|0
2254196|NCT02059434|3919734|FG003|Washout Between Periods 4 and 5|Adverse Event|0
2254197|NCT02059434|3919735|FG004|Washout Between Periods 4 and 5|Adverse Event|0
2254198|NCT02059434|3919736|FG005|Washout Between Periods 4 and 5|Adverse Event|0
2254199|NCT02059434|3919737|FG006|Washout Between Periods 4 and 5|Adverse Event|0
2254200|NCT02059434|3919738|FG007|Washout Between Periods 4 and 5|Adverse Event|0
2254201|NCT02059434|3919739|FG008|Washout Between Periods 4 and 5|Adverse Event|1
2254202|NCT02059434|3919731|FG000|Washout Between Periods 6 and 7|Physician Decision|0
2254203|NCT02059434|3919732|FG001|Washout Between Periods 6 and 7|Physician Decision|0
2254204|NCT02059434|3919733|FG002|Washout Between Periods 6 and 7|Physician Decision|0
2254205|NCT02059434|3919734|FG003|Washout Between Periods 6 and 7|Physician Decision|0
2254206|NCT02059434|3919735|FG004|Washout Between Periods 6 and 7|Physician Decision|0
2254207|NCT02059434|3919736|FG005|Washout Between Periods 6 and 7|Physician Decision|0
2254208|NCT02059434|3919737|FG006|Washout Between Periods 6 and 7|Physician Decision|0
2254209|NCT02059434|3919738|FG007|Washout Between Periods 6 and 7|Physician Decision|0
2254210|NCT02059434|3919739|FG008|Washout Between Periods 6 and 7|Physician Decision|1
2254211|NCT02059434|3919731|FG000|Washout Between Periods 7 and 8|Adverse Event|0
2254212|NCT02059434|3919732|FG001|Washout Between Periods 7 and 8|Adverse Event|0
2254213|NCT02059434|3919733|FG002|Washout Between Periods 7 and 8|Adverse Event|0
2254214|NCT02059434|3919734|FG003|Washout Between Periods 7 and 8|Adverse Event|0
2342632|NCT03495102|4076169|FG001|Overall Study|Physician Decision|0
2342633|NCT03495102|4076170|FG002|Overall Study|Physician Decision|2
2342634|NCT03495102|4076168|FG000|Overall Study|Withdrawal by Subject|25
2342635|NCT03495102|4076169|FG001|Overall Study|Withdrawal by Subject|36
2342636|NCT03495102|4076170|FG002|Overall Study|Withdrawal by Subject|18
2342637|NCT03495102|4076168|FG000|Overall Study|Protocol Violation|1
2342638|NCT03495102|4076169|FG001|Overall Study|Protocol Violation|1
2342639|NCT03495102|4076170|FG002|Overall Study|Protocol Violation|0
2342640|NCT03495102|4076168|FG000|Overall Study|Site Closure|3
2342641|NCT03495102|4076169|FG001|Overall Study|Site Closure|1
2342642|NCT03495102|4076170|FG002|Overall Study|Site Closure|2
2342643|NCT03495102|4076168|FG000|Overall Study|Non-compliance|1
2254215|NCT02059434|3919735|FG004|Washout Between Periods 7 and 8|Adverse Event|0
2254216|NCT02059434|3919736|FG005|Washout Between Periods 7 and 8|Adverse Event|0
2254217|NCT02059434|3919737|FG006|Washout Between Periods 7 and 8|Adverse Event|0
2254218|NCT02059434|3919738|FG007|Washout Between Periods 7 and 8|Adverse Event|0
2342644|NCT03495102|4076169|FG001|Overall Study|Non-compliance|0
2254219|NCT02059434|3919739|FG008|Washout Between Periods 7 and 8|Adverse Event|1
2254220|NCT02059434|3919731|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2254221|NCT02059434|3919732|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2254222|NCT02059434|3919733|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2254223|NCT02059434|3919734|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2254224|NCT02059434|3919735|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2254225|NCT02059434|3919736|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2254226|NCT02059434|3919737|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2254227|NCT02059434|3919738|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2254228|NCT02059434|3919739|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1
2254229|NCT02059980|3919820|FG000|Overall Study|Lost to Follow-up|2
2254230|NCT02059980|3919821|FG001|Overall Study|Lost to Follow-up|1
2254231|NCT02060370|3919850|FG000|Overall Study|Physician Decision|1
2254232|NCT02060383|3919859|FG000|Core Phase|Unsatisfactory therapeutic effect|1
2254233|NCT02060383|3919860|FG001|Core Phase|Unsatisfactory therapeutic effect|5
2254234|NCT02060383|3919861|FG002|Core Phase|Unsatisfactory therapeutic effect|0
2254235|NCT02060383|3919862|FG003|Core Phase|Unsatisfactory therapeutic effect|0
2254236|NCT02060383|3919863|FG004|Core Phase|Unsatisfactory therapeutic effect|0
2254237|NCT02060383|3919859|FG000|Core Phase|Adverse Event|2
2254238|NCT02060383|3919860|FG001|Core Phase|Adverse Event|0
2254239|NCT02060383|3919861|FG002|Core Phase|Adverse Event|0
2254240|NCT02060383|3919862|FG003|Core Phase|Adverse Event|2
2254241|NCT02060383|3919863|FG004|Core Phase|Adverse Event|6
2254242|NCT02060383|3919859|FG000|Core Phase|Administrative problems|0
2254243|NCT02060383|3919860|FG001|Core Phase|Administrative problems|1
2342645|NCT03495102|4076170|FG002|Overall Study|Non-compliance|0
2342646|NCT03495102|4076168|FG000|Overall Study|Participant Duplicated at Another Site|0
2342647|NCT03495102|4076169|FG001|Overall Study|Participant Duplicated at Another Site|0
2342648|NCT03495102|4076170|FG002|Overall Study|Participant Duplicated at Another Site|1
2342649|NCT03495102|4076168|FG000|Overall Study|Primary Care Physician Recommendation|0
2342650|NCT03495102|4076169|FG001|Overall Study|Primary Care Physician Recommendation|1
2342651|NCT03495102|4076170|FG002|Overall Study|Primary Care Physician Recommendation|0
2342652|NCT03495102|4076168|FG000|Overall Study|Relocated to Another Country|0
2342653|NCT03495102|4076169|FG001|Overall Study|Relocated to Another Country|1
2342654|NCT03495102|4076170|FG002|Overall Study|Relocated to Another Country|0
2342655|NCT03495102|4076168|FG000|Overall Study|Participant was in Rehabilitation|1
2342656|NCT03495102|4076169|FG001|Overall Study|Participant was in Rehabilitation|0
2342657|NCT03495102|4076170|FG002|Overall Study|Participant was in Rehabilitation|0
2342658|NCT03495817|4076187|FG000|26 Week Open Label|Adverse Event|3
2342659|NCT03495817|4076187|FG000|26 Week Open Label|Withdrawal by Subject|4
2342660|NCT03495817|4076187|FG000|26 Week Open Label|Lost to Follow-up|1
2342661|NCT03495817|4076187|FG000|26 Week Extension|Lost to Follow-up|2
2342662|NCT03495869|4076199|FG000|Overall Study|Lost to Follow-up|4
2342663|NCT03495869|4076200|FG001|Overall Study|Lost to Follow-up|17
2342664|NCT03495869|4076201|FG002|Overall Study|Lost to Follow-up|8
2342665|NCT03495869|4076202|FG003|Overall Study|Lost to Follow-up|14
2342666|NCT03495869|4076199|FG000|Overall Study|Withdrawal by Subject|0
2342667|NCT03495869|4076200|FG001|Overall Study|Withdrawal by Subject|3
2342668|NCT03495869|4076201|FG002|Overall Study|Withdrawal by Subject|0
2342669|NCT03495869|4076202|FG003|Overall Study|Withdrawal by Subject|3
2342670|NCT03495869|4076199|FG000|Overall Study|Dropped from study|0
2342671|NCT03495869|4076200|FG001|Overall Study|Dropped from study|7
2342672|NCT03495869|4076201|FG002|Overall Study|Dropped from study|2
2342673|NCT03495869|4076202|FG003|Overall Study|Dropped from study|4
2342674|NCT03495908|4076214|FG000|Overall Study|Withdrawal by Subject|3
2342675|NCT03495908|4076215|FG001|Overall Study|Withdrawal by Subject|1
2342676|NCT03495908|4076214|FG000|Overall Study|Lost to Follow-up|1
2342677|NCT03495908|4076215|FG001|Overall Study|Lost to Follow-up|4
2342678|NCT03495908|4076214|FG000|Overall Study|Adverse Event|0
2342679|NCT03495908|4076215|FG001|Overall Study|Adverse Event|2
2342680|NCT03495908|4076214|FG000|Overall Study|Death|1
2342681|NCT03495908|4076215|FG001|Overall Study|Death|0
2342682|NCT03495908|4076214|FG000|Overall Study|Physician Decision|5
2342683|NCT03495908|4076215|FG001|Overall Study|Physician Decision|4
2342684|NCT03495908|4076214|FG000|Overall Study|No documented reason|0
2342685|NCT03495908|4076215|FG001|Overall Study|No documented reason|2
2342686|NCT03496298|4076234|FG000|Overall Study|Adverse Event|49
2342687|NCT03496298|4076235|FG001|Overall Study|Adverse Event|68
2342688|NCT03496298|4076236|FG002|Overall Study|Adverse Event|79
2342689|NCT03496298|4076234|FG000|Overall Study|Study terminated by Sponsor|1050
2342690|NCT03496298|4076235|FG001|Overall Study|Study terminated by Sponsor|1063
2342691|NCT03496298|4076236|FG002|Overall Study|Study terminated by Sponsor|1071
2342692|NCT03496298|4076234|FG000|Overall Study|Physician decision (other than Adverse event)|12
2342693|NCT03496298|4076235|FG001|Overall Study|Physician decision (other than Adverse event)|17
2254244|NCT02060383|3919861|FG002|Core Phase|Administrative problems|0
2254245|NCT02060383|3919862|FG003|Core Phase|Administrative problems|0
2254246|NCT02060383|3919863|FG004|Core Phase|Administrative problems|0
2254247|NCT02060383|3919859|FG000|Core Phase|Protocol Violation|0
2254248|NCT02060383|3919860|FG001|Core Phase|Protocol Violation|0
2254249|NCT02060383|3919861|FG002|Core Phase|Protocol Violation|0
2254250|NCT02060383|3919862|FG003|Core Phase|Protocol Violation|1
2254251|NCT02060383|3919863|FG004|Core Phase|Protocol Violation|0
2254252|NCT02060383|3919859|FG000|Core Phase|Withdrawal by Subject|0
2254253|NCT02060383|3919860|FG001|Core Phase|Withdrawal by Subject|0
2254254|NCT02060383|3919861|FG002|Core Phase|Withdrawal by Subject|0
2254255|NCT02060383|3919862|FG003|Core Phase|Withdrawal by Subject|4
2254256|NCT02060383|3919863|FG004|Core Phase|Withdrawal by Subject|2
2254257|NCT02060383|3919859|FG000|Extension Phase|Unsatisfactory therapeutic effect|1
2254258|NCT02060383|3919860|FG001|Extension Phase|Unsatisfactory therapeutic effect|1
2254259|NCT02060383|3919861|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
2254260|NCT02060383|3919862|FG003|Extension Phase|Unsatisfactory therapeutic effect|2
2254261|NCT02060383|3919863|FG004|Extension Phase|Unsatisfactory therapeutic effect|2
2254262|NCT02060383|3919859|FG000|Extension Phase|Adverse Event|1
2254263|NCT02060383|3919860|FG001|Extension Phase|Adverse Event|1
2254264|NCT02060383|3919861|FG002|Extension Phase|Adverse Event|2
2254265|NCT02060383|3919862|FG003|Extension Phase|Adverse Event|0
2254266|NCT02060383|3919863|FG004|Extension Phase|Adverse Event|1
2254267|NCT02060383|3919859|FG000|Extension Phase|Withdrawal by Subject|0
2254268|NCT02060383|3919860|FG001|Extension Phase|Withdrawal by Subject|1
2254269|NCT02060383|3919861|FG002|Extension Phase|Withdrawal by Subject|0
2254270|NCT02060383|3919862|FG003|Extension Phase|Withdrawal by Subject|0
2254271|NCT02060383|3919863|FG004|Extension Phase|Withdrawal by Subject|2
2254272|NCT02060383|3919859|FG000|Extension Phase|Administrative problems|1
2254273|NCT02060383|3919860|FG001|Extension Phase|Administrative problems|0
2254274|NCT02060383|3919861|FG002|Extension Phase|Administrative problems|0
2254275|NCT02060383|3919862|FG003|Extension Phase|Administrative problems|0
2254276|NCT02060383|3919863|FG004|Extension Phase|Administrative problems|0
2254277|NCT02060383|3919859|FG000|Extension Phase|Death|0
2254278|NCT02060383|3919860|FG001|Extension Phase|Death|0
2254279|NCT02060383|3919861|FG002|Extension Phase|Death|1
2254280|NCT02060383|3919862|FG003|Extension Phase|Death|0
2254281|NCT02060383|3919863|FG004|Extension Phase|Death|1
2254282|NCT02060383|3919859|FG000|Extension Phase|Protocol Violation|0
2254283|NCT02060383|3919860|FG001|Extension Phase|Protocol Violation|0
2254284|NCT02060383|3919861|FG002|Extension Phase|Protocol Violation|0
2254285|NCT02060383|3919862|FG003|Extension Phase|Protocol Violation|0
2254286|NCT02060383|3919863|FG004|Extension Phase|Protocol Violation|1
2254287|NCT02060903|3919916|FG000|Overall Study|Lost to Follow-up|4
2254288|NCT02060903|3919917|FG001|Overall Study|Lost to Follow-up|0
2254289|NCT02060903|3919916|FG000|Overall Study|Withdrawal by Subject|0
2254290|NCT02060903|3919917|FG001|Overall Study|Withdrawal by Subject|7
2254291|NCT02061202|3919925|FG000|Overall Study|Lost to Follow-up|1
2254292|NCT02061202|3919926|FG001|Overall Study|Lost to Follow-up|1
2254293|NCT02061280|3919934|FG000|Overall Study|Protocol Violation|12
2254294|NCT02061280|3919935|FG001|Overall Study|Protocol Violation|8
2254295|NCT02061280|3919934|FG000|Overall Study|moved out of state|0
2254296|NCT02061280|3919935|FG001|Overall Study|moved out of state|1
2254297|NCT02061280|3919934|FG000|Overall Study|Withdrawal by Subject|1
2254298|NCT02061280|3919935|FG001|Overall Study|Withdrawal by Subject|2
2254299|NCT02061280|3919934|FG000|Overall Study|Lost to Follow-up|5
2254300|NCT02061280|3919935|FG001|Overall Study|Lost to Follow-up|1
2254301|NCT02061540|3919994|FG000|Overall Study|Adverse Event|2
2254302|NCT02061540|3919994|FG000|Overall Study|Withdrawal by Subject|2
2342694|NCT03496298|4076236|FG002|Overall Study|Physician decision (other than Adverse event)|10
2342695|NCT03496298|4076234|FG000|Overall Study|Withdrawal by Subject|176
2342696|NCT03496298|4076235|FG001|Overall Study|Withdrawal by Subject|154
2342697|NCT03496298|4076236|FG002|Overall Study|Withdrawal by Subject|151
2342698|NCT03496298|4076234|FG000|Overall Study|Other|29
2342699|NCT03496298|4076235|FG001|Overall Study|Other|20
2342700|NCT03496298|4076236|FG002|Overall Study|Other|23
2342701|NCT03496298|4076234|FG000|Overall Study|Randomized and not treated|1
2342702|NCT03496298|4076235|FG001|Overall Study|Randomized and not treated|1
2342703|NCT03496298|4076236|FG002|Overall Study|Randomized and not treated|1
2342704|NCT03497039|4076308|FG000|Overall Study|Withdrawal by Subject|1
2342705|NCT03497039|4076309|FG001|Overall Study|Withdrawal by Subject|0
2342706|NCT03497039|4076308|FG000|Overall Study|Protocol Violation|0
2342707|NCT03497039|4076309|FG001|Overall Study|Protocol Violation|1
2342708|NCT03497130|4076317|FG000|Overall Study|Lost to Follow-up|1
2342709|NCT03497130|4076318|FG001|Overall Study|Lost to Follow-up|1
2342710|NCT03497429|4076326|FG000|Overall Study|Progressive disease|3
2342711|NCT03497429|4076327|FG001|Overall Study|Progressive disease|4
2342712|NCT03497429|4076326|FG000|Overall Study|Adverse Event|0
2342713|NCT03497429|4076327|FG001|Overall Study|Adverse Event|2
2342714|NCT03498287|4076398|FG000|Overall Study|Withdrawal by Subject|3
2342715|NCT03498287|4076399|FG001|Overall Study|Withdrawal by Subject|0
2342716|NCT03498287|4076398|FG000|Overall Study|Protocol Violation|0
2342717|NCT03498287|4076399|FG001|Overall Study|Protocol Violation|4
2342718|NCT03498287|4076398|FG000|Overall Study|Adverse Event|0
2342719|NCT03498287|4076399|FG001|Overall Study|Adverse Event|1
2342720|NCT03498560|4076415|FG000|Overall Study|Found Ineligible|2
2342721|NCT03498560|4076415|FG000|Overall Study|Withdrawal by Subject|14
2254303|NCT02061592|3920005|FG000|Period 1|Withdrawal by Subject|1
2254304|NCT02061592|3920006|FG001|Period 1|Withdrawal by Subject|0
2254305|NCT02061592|3920005|FG000|Period 1|Protocol Violation|1
2254306|NCT02061592|3920006|FG001|Period 1|Protocol Violation|0
2254307|NCT02061592|3920005|FG000|Period 2|Lost to Follow-up|0
2254308|NCT02061592|3920006|FG001|Period 2|Lost to Follow-up|1
2254309|NCT02061813|3920045|FG000|Overall Study|Withdrawal by Subject|1
2254310|NCT02061813|3920045|FG000|Overall Study|Protocol Violation|2
2254311|NCT02062151|3920065|FG000|Overall Study|screen failure|1
2254312|NCT02062385|3920090|FG000|Overall Study|Adverse Event|19
2254313|NCT02062385|3920091|FG001|Overall Study|Adverse Event|13
2254314|NCT02062385|3920092|FG002|Overall Study|Adverse Event|1
2254315|NCT02062385|3920093|FG003|Overall Study|Adverse Event|0
2254316|NCT02062385|3920090|FG000|Overall Study|Protocol Violation|1
2254317|NCT02062385|3920091|FG001|Overall Study|Protocol Violation|0
2254318|NCT02062385|3920092|FG002|Overall Study|Protocol Violation|0
2254319|NCT02062385|3920093|FG003|Overall Study|Protocol Violation|0
2254320|NCT02062385|3920090|FG000|Overall Study|Incomplete EPI by database lock|2
2254321|NCT02062385|3920091|FG001|Overall Study|Incomplete EPI by database lock|0
2254322|NCT02062385|3920092|FG002|Overall Study|Incomplete EPI by database lock|0
2254323|NCT02062385|3920093|FG003|Overall Study|Incomplete EPI by database lock|0
2254324|NCT02062385|3920090|FG000|Overall Study|Moved|10
2254325|NCT02062385|3920091|FG001|Overall Study|Moved|11
2254326|NCT02062385|3920092|FG002|Overall Study|Moved|1
2254327|NCT02062385|3920093|FG003|Overall Study|Moved|0
2254328|NCT02062385|3920090|FG000|Overall Study|Withdrawn by parent/guardian|46
2254329|NCT02062385|3920091|FG001|Overall Study|Withdrawn by parent/guardian|41
2254330|NCT02062385|3920092|FG002|Overall Study|Withdrawn by parent/guardian|9
2254331|NCT02062385|3920093|FG003|Overall Study|Withdrawn by parent/guardian|8
2254332|NCT02062385|3920090|FG000|Overall Study|Death|0
2254333|NCT02062385|3920091|FG001|Overall Study|Death|0
2254334|NCT02062385|3920092|FG002|Overall Study|Death|0
2254335|NCT02062385|3920093|FG003|Overall Study|Death|1
2254336|NCT02062385|3920090|FG000|Overall Study|Lost to Follow-up|0
2254337|NCT02062385|3920091|FG001|Overall Study|Lost to Follow-up|0
2254338|NCT02062385|3920092|FG002|Overall Study|Lost to Follow-up|1
2254339|NCT02062385|3920093|FG003|Overall Study|Lost to Follow-up|0
2254340|NCT02062398|3920101|FG000|Overall Study|Implant removal|1
2254341|NCT02062437|3920105|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31
2254342|NCT02062437|3920105|FG000|Overall Study|Patient not available for the 2y visit|18
2254343|NCT02062437|3920105|FG000|Overall Study|Death|2
2254344|NCT02062437|3920105|FG000|Overall Study|Pt. couldn't come due to med. condition|1
2254345|NCT02062450|3920111|FG000|Overall Study|No follow-up visit|124
2254346|NCT02062632|3920179|FG000|Overall Study|No treatment data|1
2342722|NCT03498560|4076415|FG000|Overall Study|Lost to Follow-up|4
2342723|NCT03498560|4076415|FG000|Overall Study|Death|1
2353247|NCT02865122|4104759|FG001|Overall Study|Adverse Event|0
2353248|NCT02865122|4104760|FG002|Overall Study|Adverse Event|0
2353249|NCT02865915|4104770|FG000|Overall Study|Pregnancy|1
2353250|NCT02865915|4104771|FG001|Overall Study|Pregnancy|0
2353251|NCT02865915|4104770|FG000|Overall Study|Withdrawal by Subject|1
2353252|NCT02865915|4104771|FG001|Overall Study|Withdrawal by Subject|1
2353253|NCT02865915|4104770|FG000|Overall Study|Adverse Event|0
2353254|NCT02865915|4104771|FG001|Overall Study|Adverse Event|4
2353255|NCT02865915|4104770|FG000|Overall Study|Lost to Follow-up|0
2353256|NCT02865915|4104771|FG001|Overall Study|Lost to Follow-up|1
2353257|NCT02865915|4104770|FG000|Overall Study|Protocol Violation|0
2353258|NCT02865915|4104771|FG001|Overall Study|Protocol Violation|1
2353259|NCT02865915|4104770|FG000|Overall Study|Study terminated by sponsor|23
2353260|NCT02865915|4104771|FG001|Overall Study|Study terminated by sponsor|18
2353261|NCT02865915|4104770|FG000|Overall Study|Dosing group discontinued|0
2353262|NCT02865915|4104771|FG001|Overall Study|Dosing group discontinued|5
2353263|NCT02855411|4104777|FG000|Overall Study|Study terminated by sponsor|21
2353264|NCT02855411|4104777|FG000|Overall Study|Does not meet entrance criteria|14
2353265|NCT02828124|4104793|FG000|Overall Study|Disease Progression|1
2353266|NCT02828124|4104794|FG001|Overall Study|Disease Progression|2
2353267|NCT02828124|4104795|FG002|Overall Study|Disease Progression|1
2353268|NCT02828124|4104796|FG003|Overall Study|Disease Progression|4
2353269|NCT02828124|4104793|FG000|Overall Study|AE Unrelated to Study Drug|0
2353270|NCT02828124|4104794|FG001|Overall Study|AE Unrelated to Study Drug|0
2353271|NCT02828124|4104795|FG002|Overall Study|AE Unrelated to Study Drug|0
2353272|NCT02828124|4104796|FG003|Overall Study|AE Unrelated to Study Drug|1
2353273|NCT02828124|4104793|FG000|Overall Study|Subject Withdrew Consent|0
2353274|NCT02828124|4104794|FG001|Overall Study|Subject Withdrew Consent|0
2353275|NCT02828124|4104795|FG002|Overall Study|Subject Withdrew Consent|0
2353276|NCT02828124|4104796|FG003|Overall Study|Subject Withdrew Consent|1
2353277|NCT02825043|4104815|FG000|Overall Study|Lost to Follow-up|4
2353278|NCT02819804|4104819|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
2353279|NCT02809118|4104826|FG000|Overall Study|Withdrawal by Subject|0
2353280|NCT02809118|4104827|FG001|Overall Study|Withdrawal by Subject|1
2353281|NCT02809118|4104828|FG002|Overall Study|Withdrawal by Subject|1
2353282|NCT02806960|4104864|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3
2254347|NCT02062645|3920183|FG000|Overall Study|Adverse Event|2
2254348|NCT02062645|3920183|FG000|Overall Study|Protocol Violation|8
2353283|NCT02806960|4104865|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3
2254349|NCT02062645|3920183|FG000|Overall Study|Lost to Follow-up|5
2254350|NCT02062658|3920187|FG000|Overall Study|Withdrawal by Subject|1
2254351|NCT02062658|3920187|FG000|Overall Study|Lack of Efficacy|1
2254352|NCT02062879|3920215|FG000|Overall Study|Withdrawal by Subject|4
2254353|NCT02062879|3920216|FG001|Overall Study|Withdrawal by Subject|1
2254354|NCT02063217|3920265|FG000|Overall Study|Withdrawal by Subject|1
2254355|NCT02063217|3920266|FG001|Overall Study|Withdrawal by Subject|0
2254356|NCT02063217|3920267|FG002|Overall Study|Withdrawal by Subject|0
2254357|NCT02063659|3920304|FG000|Double-Blind Treatment Period|Adverse Event|1
2254358|NCT02063659|3920305|FG001|Double-Blind Treatment Period|Adverse Event|2
2254359|NCT02063659|3920306|FG002|Double-Blind Treatment Period|Adverse Event|0
2254360|NCT02063659|3920307|FG003|Double-Blind Treatment Period|Adverse Event|0
2254361|NCT02063659|3920304|FG000|Double-Blind Treatment Period|Physician Decision|1
2254362|NCT02063659|3920305|FG001|Double-Blind Treatment Period|Physician Decision|0
2254363|NCT02063659|3920306|FG002|Double-Blind Treatment Period|Physician Decision|0
2254364|NCT02063659|3920307|FG003|Double-Blind Treatment Period|Physician Decision|0
2254365|NCT02063659|3920304|FG000|Double-Blind Treatment Period|Withdrawal of consent|0
2254366|NCT02063659|3920305|FG001|Double-Blind Treatment Period|Withdrawal of consent|1
2254367|NCT02063659|3920306|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
2254368|NCT02063659|3920307|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
2254369|NCT02063659|3920304|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
2254370|NCT02063659|3920305|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
2254371|NCT02063659|3920306|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
2254372|NCT02063659|3920307|FG003|Open-Label Extension Period (OLE)|Physician Decision|1
2254373|NCT02063659|3920304|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2254374|NCT02063659|3920305|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2254375|NCT02063659|3920306|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2254376|NCT02063659|3920307|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
2254377|NCT02063659|3920304|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2254378|NCT02063659|3920305|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2254379|NCT02063659|3920306|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2254380|NCT02063659|3920307|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1
2254381|NCT02063659|3920304|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
2254382|NCT02063659|3920305|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
2254383|NCT02063659|3920306|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
2254384|NCT02063659|3920307|FG003|Open-Label Extension Period (OLE)|Adverse Event|7
2254385|NCT02063659|3920304|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
2254386|NCT02063659|3920305|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
2254387|NCT02063659|3920306|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
2254388|NCT02063659|3920307|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
2254389|NCT02063672|3920323|FG000|Overall Study|Ongoing Follow-up|27
2254390|NCT02063672|3920324|FG001|Overall Study|Ongoing Follow-up|14
2254391|NCT02063672|3920323|FG000|Overall Study|Death|5
2254392|NCT02063672|3920324|FG001|Overall Study|Death|3
2254393|NCT02063672|3920323|FG000|Overall Study|Lost to Follow-up|1
2254394|NCT02063672|3920324|FG001|Overall Study|Lost to Follow-up|3
2254395|NCT02063672|3920323|FG000|Overall Study|Withdrawal by Subject|2
2254396|NCT02063672|3920324|FG001|Overall Study|Withdrawal by Subject|2
2254397|NCT02063698|3920332|FG000|Overall Study|did not complete booklet for days 2-8|1
2254398|NCT02063698|3920333|FG001|Overall Study|did not complete booklet for days 2-8|2
2254399|NCT02063737|3920341|FG000|Overall Study|Lost to Follow-up|11
2254400|NCT02063737|3920342|FG001|Overall Study|Lost to Follow-up|4
2254401|NCT02063828|3920351|FG000|Overall Study|Withdrawal by Subject|4
2254402|NCT02063828|3920352|FG001|Overall Study|Withdrawal by Subject|6
2254403|NCT02063828|3920353|FG002|Overall Study|Withdrawal by Subject|3
2254404|NCT02063828|3920351|FG000|Overall Study|Death|0
2254405|NCT02063828|3920352|FG001|Overall Study|Death|0
2254406|NCT02063828|3920353|FG002|Overall Study|Death|1
2254407|NCT02063854|3920368|FG000|Overall Study|Pretreatment Event/Adverse Event|13
2254408|NCT02063854|3920369|FG001|Overall Study|Pretreatment Event/Adverse Event|10
2254409|NCT02063854|3920370|FG002|Overall Study|Pretreatment Event/Adverse Event|13
2254410|NCT02063854|3920371|FG003|Overall Study|Pretreatment Event/Adverse Event|8
2254411|NCT02063854|3920372|FG004|Overall Study|Pretreatment Event/Adverse Event|7
2254412|NCT02063854|3920373|FG005|Overall Study|Pretreatment Event/Adverse Event|18
2254413|NCT02063854|3920374|FG006|Overall Study|Pretreatment Event/Adverse Event|4
2254414|NCT02063854|3920368|FG000|Overall Study|Major Protocol Deviation|0
2254415|NCT02063854|3920369|FG001|Overall Study|Major Protocol Deviation|0
2254416|NCT02063854|3920370|FG002|Overall Study|Major Protocol Deviation|3
2254417|NCT02063854|3920371|FG003|Overall Study|Major Protocol Deviation|0
2254418|NCT02063854|3920372|FG004|Overall Study|Major Protocol Deviation|0
2254419|NCT02063854|3920373|FG005|Overall Study|Major Protocol Deviation|0
2254420|NCT02063854|3920374|FG006|Overall Study|Major Protocol Deviation|0
2254421|NCT02063854|3920368|FG000|Overall Study|Voluntary Withdrawal|2
2254422|NCT02063854|3920369|FG001|Overall Study|Voluntary Withdrawal|0
2254423|NCT02063854|3920370|FG002|Overall Study|Voluntary Withdrawal|8
2254424|NCT02063854|3920371|FG003|Overall Study|Voluntary Withdrawal|1
2254425|NCT02063854|3920372|FG004|Overall Study|Voluntary Withdrawal|3
2254426|NCT02063854|3920373|FG005|Overall Study|Voluntary Withdrawal|6
2254427|NCT02063854|3920374|FG006|Overall Study|Voluntary Withdrawal|1
2254428|NCT02063854|3920368|FG000|Overall Study|Surgical Dental Work Performed/Planned|5
2254429|NCT02063854|3920369|FG001|Overall Study|Surgical Dental Work Performed/Planned|2
2254430|NCT02063854|3920370|FG002|Overall Study|Surgical Dental Work Performed/Planned|6
2254431|NCT02063854|3920371|FG003|Overall Study|Surgical Dental Work Performed/Planned|1
2254432|NCT02063854|3920372|FG004|Overall Study|Surgical Dental Work Performed/Planned|1
2254433|NCT02063854|3920373|FG005|Overall Study|Surgical Dental Work Performed/Planned|6
2254434|NCT02063854|3920374|FG006|Overall Study|Surgical Dental Work Performed/Planned|1
2254435|NCT02063854|3920368|FG000|Overall Study|Reason Not Specified|1
2254436|NCT02063854|3920369|FG001|Overall Study|Reason Not Specified|0
2254437|NCT02063854|3920370|FG002|Overall Study|Reason Not Specified|0
2254438|NCT02063854|3920371|FG003|Overall Study|Reason Not Specified|0
2254439|NCT02063854|3920372|FG004|Overall Study|Reason Not Specified|0
2254440|NCT02063854|3920373|FG005|Overall Study|Reason Not Specified|0
2254441|NCT02063854|3920374|FG006|Overall Study|Reason Not Specified|0
2254442|NCT02063854|3920368|FG000|Overall Study|Did Not Receive Study Drug|0
2342724|NCT03499028|4076422|FG000|Overall Study|Lost to Follow-up|12
2342725|NCT03499028|4076423|FG001|Overall Study|Lost to Follow-up|9
2342726|NCT03499028|4076422|FG000|Overall Study|Withdrawal by Subject|5
2342727|NCT03499028|4076423|FG001|Overall Study|Withdrawal by Subject|8
2342728|NCT03499028|4076422|FG000|Overall Study|Unplanned SNF discharge|5
2342729|NCT03499028|4076423|FG001|Overall Study|Unplanned SNF discharge|8
2342730|NCT03499067|4076431|FG000|First Intervention|Physician Decision|2
2342731|NCT03499067|4076432|FG001|First Intervention|Physician Decision|1
2342732|NCT03499067|4076431|FG000|First Intervention|Withdrawal by Subject|3
2342733|NCT03499067|4076432|FG001|First Intervention|Withdrawal by Subject|6
2342734|NCT03499353|4076438|FG000|Treatment|Adverse Event|3
2342735|NCT03499353|4076438|FG000|Treatment|Progressive Disease|10
2342736|NCT03499353|4076438|FG000|Treatment|Other|1
2342737|NCT03499353|4076438|FG000|Treatment|Withdrawal by Subject|2
2342738|NCT03499353|4076438|FG000|Long-Term Follow-up|Death|2
2342739|NCT03499353|4076438|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55
2342740|NCT03499353|4076438|FG000|Long-Term Follow-up|Withdrawal by Subject|1
2342741|NCT03499873|4076445|FG000|Overall Study|Withdrawal by Subject|4
2342742|NCT03499873|4076446|FG001|Overall Study|Withdrawal by Subject|6
2342743|NCT03499873|4076447|FG002|Overall Study|Withdrawal by Subject|1
2342744|NCT03499873|4076445|FG000|Overall Study|Subjects condition worsened|0
2342745|NCT03499873|4076446|FG001|Overall Study|Subjects condition worsened|3
2342746|NCT03499873|4076447|FG002|Overall Study|Subjects condition worsened|11
2342747|NCT03499873|4076445|FG000|Overall Study|Adverse Event|8
2342748|NCT03499873|4076446|FG001|Overall Study|Adverse Event|3
2342749|NCT03499873|4076447|FG002|Overall Study|Adverse Event|6
2342750|NCT03499873|4076445|FG000|Overall Study|Physician Decision|1
2342751|NCT03499873|4076446|FG001|Overall Study|Physician Decision|0
2342752|NCT03499873|4076447|FG002|Overall Study|Physician Decision|0
2342753|NCT03499873|4076445|FG000|Overall Study|Administrative reasons|0
2342754|NCT03499873|4076446|FG001|Overall Study|Administrative reasons|1
2342755|NCT03499873|4076447|FG002|Overall Study|Administrative reasons|0
2342756|NCT03499873|4076445|FG000|Overall Study|Concomitant therapy|5
2342757|NCT03499873|4076446|FG001|Overall Study|Concomitant therapy|4
2342758|NCT03499873|4076447|FG002|Overall Study|Concomitant therapy|7
2342759|NCT03499873|4076445|FG000|Overall Study|Miscellaneous|1
2342760|NCT03499873|4076446|FG001|Overall Study|Miscellaneous|2
2342761|NCT03499873|4076447|FG002|Overall Study|Miscellaneous|2
2342762|NCT03499873|4076445|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1
2342763|NCT03499873|4076446|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1
2342764|NCT03499873|4076447|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0
2342765|NCT03500094|4076455|FG000|Overall Study|Withdrawal by Subject|1
2342766|NCT03500094|4076455|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1
2342767|NCT03500094|4076455|FG000|Overall Study|Lost to Follow-up|1
2342768|NCT03500198|4076463|FG000|Overall Study|Lost to Follow-up|0
2342769|NCT03500198|4076464|FG001|Overall Study|Lost to Follow-up|1
2342770|NCT03500211|4076474|FG000|Overall Study|Withdrawal by Subject|1
2342771|NCT03500211|4076475|FG001|Overall Study|Withdrawal by Subject|1
2038892|NCT00424346|3609247|FG001|Core Study|Abnormal Laboratory Values|1
2038893|NCT00424346|3609248|FG002|Core Study|Abnormal Laboratory Values|0
2038894|NCT00424346|3609249|FG003|Core Study|Abnormal Laboratory Values|0
2038895|NCT00424346|3609246|FG000|Core Study|Lack of Efficacy|1
2038896|NCT00424346|3609247|FG001|Core Study|Lack of Efficacy|3
2038897|NCT00424346|3609248|FG002|Core Study|Lack of Efficacy|0
2038898|NCT00424346|3609249|FG003|Core Study|Lack of Efficacy|4
2038899|NCT00424346|3609246|FG000|Core Study|Withdrawal by Subject|1
2038900|NCT00424346|3609247|FG001|Core Study|Withdrawal by Subject|0
2038901|NCT00424346|3609248|FG002|Core Study|Withdrawal by Subject|0
2038902|NCT00424346|3609249|FG003|Core Study|Withdrawal by Subject|2
2038903|NCT00424346|3609246|FG000|Core Study|Lost to Follow-up|1
2038904|NCT00424346|3609247|FG001|Core Study|Lost to Follow-up|1
2038905|NCT00424346|3609248|FG002|Core Study|Lost to Follow-up|0
2038906|NCT00424346|3609249|FG003|Core Study|Lost to Follow-up|0
2038907|NCT00424346|3609246|FG000|Core Study|Administrative Problems|1
2038908|NCT00424346|3609247|FG001|Core Study|Administrative Problems|0
2254443|NCT02063854|3920369|FG001|Overall Study|Did Not Receive Study Drug|0
2254444|NCT02063854|3920370|FG002|Overall Study|Did Not Receive Study Drug|0
2254445|NCT02063854|3920371|FG003|Overall Study|Did Not Receive Study Drug|0
2254446|NCT02063854|3920372|FG004|Overall Study|Did Not Receive Study Drug|0
2254447|NCT02063854|3920373|FG005|Overall Study|Did Not Receive Study Drug|1
2254448|NCT02063854|3920374|FG006|Overall Study|Did Not Receive Study Drug|0
2254449|NCT02063880|3920403|FG000|Overall Study|Death|21
2254450|NCT02063880|3920404|FG001|Overall Study|Death|18
2254451|NCT02063880|3920403|FG000|Overall Study|Lost to Follow-up|7
2254452|NCT02063880|3920404|FG001|Overall Study|Lost to Follow-up|7
2254453|NCT02063880|3920403|FG000|Overall Study|Ineligible|0
2254454|NCT02063880|3920404|FG001|Overall Study|Ineligible|2
2254455|NCT02063984|3920412|FG000|Overall Study|Lost to Follow-up|6
2254456|NCT02063984|3920413|FG001|Overall Study|Lost to Follow-up|5
2254457|NCT02064166|3920425|FG000|Overall Study|Adverse Event|1
2254458|NCT02064166|3920426|FG001|Overall Study|Adverse Event|0
2254459|NCT02064205|3920454|FG000|Overall Study|Withdrawal by Subject|1
2254460|NCT02064231|3920470|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5
2254461|NCT02064231|3920471|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3
2254462|NCT02064231|3920472|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0
2254463|NCT02064231|3920473|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0
2254464|NCT02064231|3920470|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1
2254465|NCT02064231|3920471|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1
2254466|NCT02064231|3920472|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0
2254467|NCT02064231|3920473|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0
2254468|NCT02064231|3920470|FG000|First Test Period (Test A or Test C)|Adverse Event|1
2254469|NCT02064231|3920471|FG001|First Test Period (Test A or Test C)|Adverse Event|0
2254470|NCT02064231|3920472|FG002|First Test Period (Test A or Test C)|Adverse Event|1
2254471|NCT02064231|3920473|FG003|First Test Period (Test A or Test C)|Adverse Event|0
2254472|NCT02064231|3920470|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1
2254473|NCT02064231|3920471|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1
2254474|NCT02064231|3920472|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0
2254475|NCT02064231|3920473|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0
2254476|NCT02064439|3920497|FG000|Overall Study|Adverse Event|51
2254477|NCT02064439|3920498|FG001|Overall Study|Adverse Event|47
2254478|NCT02064439|3920499|FG002|Overall Study|Adverse Event|46
2254479|NCT02064439|3920497|FG000|Overall Study|Death|0
2254480|NCT02064439|3920498|FG001|Overall Study|Death|2
2254481|NCT02064439|3920499|FG002|Overall Study|Death|3
2254482|NCT02064439|3920497|FG000|Overall Study|Withdrawal by Subject|29
2254483|NCT02064439|3920498|FG001|Overall Study|Withdrawal by Subject|18
2254484|NCT02064439|3920499|FG002|Overall Study|Withdrawal by Subject|26
2254485|NCT02064439|3920497|FG000|Overall Study|Protocol Violation|3
2254486|NCT02064439|3920498|FG001|Overall Study|Protocol Violation|5
2254487|NCT02064439|3920499|FG002|Overall Study|Protocol Violation|3
2254488|NCT02064439|3920497|FG000|Overall Study|Lost to Follow-up|1
2254489|NCT02064439|3920498|FG001|Overall Study|Lost to Follow-up|3
2254490|NCT02064439|3920499|FG002|Overall Study|Lost to Follow-up|4
2254491|NCT02064439|3920497|FG000|Overall Study|Non-compliance with study medication|21
2254492|NCT02064439|3920498|FG001|Overall Study|Non-compliance with study medication|19
2254493|NCT02064439|3920499|FG002|Overall Study|Non-compliance with study medication|23
2254494|NCT02064439|3920497|FG000|Overall Study|Physician Decision|0
2254495|NCT02064439|3920498|FG001|Overall Study|Physician Decision|1
2254496|NCT02064439|3920499|FG002|Overall Study|Physician Decision|1
2254497|NCT02064439|3920497|FG000|Overall Study|Logistical difficulties|6
2254498|NCT02064439|3920498|FG001|Overall Study|Logistical difficulties|5
2254499|NCT02064439|3920499|FG002|Overall Study|Logistical difficulties|2
2254500|NCT02064439|3920497|FG000|Overall Study|Efficacy outcome reached|18
2254501|NCT02064439|3920498|FG001|Overall Study|Efficacy outcome reached|16
2254502|NCT02064439|3920499|FG002|Overall Study|Efficacy outcome reached|57
2254503|NCT02064439|3920497|FG000|Overall Study|Safety outcome reached|12
2254504|NCT02064439|3920498|FG001|Overall Study|Safety outcome reached|20
2254505|NCT02064439|3920499|FG002|Overall Study|Safety outcome reached|10
2254506|NCT02064439|3920497|FG000|Overall Study|Other|2
2254507|NCT02064439|3920498|FG001|Overall Study|Other|2
2254508|NCT02064439|3920499|FG002|Overall Study|Other|7
2342772|NCT03500224|4076481|FG000|Overall Study|Withdrawal by Subject|2
2342773|NCT03500419|4076500|FG000|Overall Study|Withdrawal by Subject|2
2342774|NCT03500419|4076501|FG001|Overall Study|Withdrawal by Subject|25
2342775|NCT03500679|4076509|FG000|Overall Study|Lost to Follow-up|6
2342776|NCT03500679|4076510|FG001|Overall Study|Lost to Follow-up|3
2342777|NCT03500679|4076509|FG000|Overall Study|Withdrawal by Subject|3
2342778|NCT03500679|4076510|FG001|Overall Study|Withdrawal by Subject|0
2342779|NCT03500692|4076516|FG000|Overall Study|Death|76
2342780|NCT03500692|4076516|FG000|Overall Study|Missed visit|30
2342781|NCT03500692|4076516|FG000|Overall Study|Termination Reasons|3
2342782|NCT03501277|4076593|FG000|Intervention Period 1 (4 Days)|Other|0
2342783|NCT03501277|4076594|FG001|Intervention Period 1 (4 Days)|Other|0
2342784|NCT03501277|4076595|FG002|Intervention Period 1 (4 Days)|Other|1
2342785|NCT03501277|4076596|FG003|Intervention Period 1 (4 Days)|Other|0
2342786|NCT03501277|4076593|FG000|Intervention Period 1 (4 Days)|Adverse Event|0
2254509|NCT02064816|3920513|FG000|Overall Study|Adverse Event|3
2254510|NCT02064816|3920514|FG001|Overall Study|Adverse Event|2
2254511|NCT02064816|3920513|FG000|Overall Study|Withdrawal by Subject|2
2254512|NCT02064816|3920514|FG001|Overall Study|Withdrawal by Subject|1
2254513|NCT02064816|3920513|FG000|Overall Study|Lost to Follow-up|2
2254514|NCT02064816|3920514|FG001|Overall Study|Lost to Follow-up|1
2254515|NCT02064816|3920513|FG000|Overall Study|Therapeutic failure|0
2254516|NCT02064816|3920514|FG001|Overall Study|Therapeutic failure|1
2254517|NCT02064816|3920513|FG000|Overall Study|Other|1
2254518|NCT02064816|3920514|FG001|Overall Study|Other|3
2254519|NCT02064868|3920569|FG000|Overall Study|Lost to Follow-up|14
2254520|NCT02064868|3920570|FG001|Overall Study|Lost to Follow-up|8
2254521|NCT02064868|3920569|FG000|Overall Study|Physician Decision|1
2254522|NCT02064868|3920570|FG001|Overall Study|Physician Decision|0
2254523|NCT02064868|3920569|FG000|Overall Study|Withdrawal by Subject|14
2254524|NCT02064868|3920570|FG001|Overall Study|Withdrawal by Subject|3
2254525|NCT02064868|3920569|FG000|Overall Study|Technical Problems or Missing|5
2254526|NCT02064868|3920570|FG001|Overall Study|Technical Problems or Missing|2
2254527|NCT02064894|3920579|FG000|Overall Study|Withdrawal by Subject|43
2254528|NCT02064894|3920580|FG001|Overall Study|Withdrawal by Subject|102
2254529|NCT02064894|3920581|FG002|Overall Study|Withdrawal by Subject|115
2254530|NCT02064920|3920600|FG000|Overall Study|Adverse Event|0
2254531|NCT02064920|3920601|FG001|Overall Study|Adverse Event|4
2254532|NCT02064920|3920600|FG000|Overall Study|Physician Decision|0
2254533|NCT02064920|3920601|FG001|Overall Study|Physician Decision|1
2254534|NCT02064920|3920600|FG000|Overall Study|Technical Problems|0
2254535|NCT02064920|3920601|FG001|Overall Study|Technical Problems|1
2254536|NCT02064920|3920600|FG000|Overall Study|Withdrawal by Subject|1
2254537|NCT02064920|3920601|FG001|Overall Study|Withdrawal by Subject|3
2254538|NCT02065245|3920636|FG000|Infusion 1|Lost to Follow-up|0
2254539|NCT02065245|3920637|FG001|Infusion 1|Lost to Follow-up|0
2254540|NCT02065245|3920638|FG002|Infusion 1|Lost to Follow-up|0
2254541|NCT02065245|3920639|FG003|Infusion 1|Lost to Follow-up|0
2254542|NCT02065245|3920640|FG004|Infusion 1|Lost to Follow-up|0
2254543|NCT02065245|3920641|FG005|Infusion 1|Lost to Follow-up|0
2254544|NCT02065245|3920642|FG006|Infusion 1|Lost to Follow-up|1
2254545|NCT02065245|3920636|FG000|Infusion 1|Death|0
2254546|NCT02065245|3920637|FG001|Infusion 1|Death|0
2254547|NCT02065245|3920638|FG002|Infusion 1|Death|1
2254548|NCT02065245|3920639|FG003|Infusion 1|Death|0
2254549|NCT02065245|3920640|FG004|Infusion 1|Death|1
2254550|NCT02065245|3920641|FG005|Infusion 1|Death|0
2254551|NCT02065245|3920642|FG006|Infusion 1|Death|0
2254552|NCT02065245|3920636|FG000|Infusion 2|Death|0
2254553|NCT02065245|3920637|FG001|Infusion 2|Death|0
2254554|NCT02065245|3920638|FG002|Infusion 2|Death|0
2254555|NCT02065245|3920639|FG003|Infusion 2|Death|0
2342787|NCT03501277|4076594|FG001|Intervention Period 1 (4 Days)|Adverse Event|0
2342788|NCT03501277|4076595|FG002|Intervention Period 1 (4 Days)|Adverse Event|0
2342789|NCT03501277|4076596|FG003|Intervention Period 1 (4 Days)|Adverse Event|1
2342790|NCT03501277|4076593|FG000|Intervention Period 2 (4 Days)|Adverse Event|0
2342791|NCT03501277|4076594|FG001|Intervention Period 2 (4 Days)|Adverse Event|0
2342792|NCT03501277|4076595|FG002|Intervention Period 2 (4 Days)|Adverse Event|0
2342793|NCT03501277|4076596|FG003|Intervention Period 2 (4 Days)|Adverse Event|1
2342794|NCT03501277|4076593|FG000|Intervention Period 3 (4 Days)|Adverse Event|0
2342795|NCT03501277|4076594|FG001|Intervention Period 3 (4 Days)|Adverse Event|0
2342796|NCT03501277|4076595|FG002|Intervention Period 3 (4 Days)|Adverse Event|0
2342797|NCT03501277|4076596|FG003|Intervention Period 3 (4 Days)|Adverse Event|1
2038909|NCT00424346|3609248|FG002|Core Study|Administrative Problems|1
2038910|NCT00424346|3609249|FG003|Core Study|Administrative Problems|0
2038911|NCT00424346|3609246|FG000|Core Study|Protocol Violation|0
2038912|NCT00424346|3609247|FG001|Core Study|Protocol Violation|0
2038913|NCT00424346|3609248|FG002|Core Study|Protocol Violation|2
2038914|NCT00424346|3609249|FG003|Core Study|Protocol Violation|0
2038915|NCT00424346|3609246|FG000|Extension Phase|Adverse Event|0
2038916|NCT00424346|3609247|FG001|Extension Phase|Adverse Event|9
2038917|NCT00424346|3609248|FG002|Extension Phase|Adverse Event|5
2038918|NCT00424346|3609249|FG003|Extension Phase|Adverse Event|4
2038919|NCT00424346|3609246|FG000|Extension Phase|Lack of Efficacy|0
2038920|NCT00424346|3609247|FG001|Extension Phase|Lack of Efficacy|16
2038921|NCT00424346|3609248|FG002|Extension Phase|Lack of Efficacy|14
2038922|NCT00424346|3609249|FG003|Extension Phase|Lack of Efficacy|11
2038923|NCT00424346|3609246|FG000|Extension Phase|Withdrawal by Subject|0
2038924|NCT00424346|3609247|FG001|Extension Phase|Withdrawal by Subject|5
2038925|NCT00424346|3609248|FG002|Extension Phase|Withdrawal by Subject|3
2038926|NCT00424346|3609249|FG003|Extension Phase|Withdrawal by Subject|4
2254556|NCT02065245|3920640|FG004|Infusion 2|Death|0
2254557|NCT02065245|3920641|FG005|Infusion 2|Death|0
2254558|NCT02065245|3920642|FG006|Infusion 2|Death|1
2254559|NCT02065245|3920636|FG000|Infusion 3|Lost to Follow-up|1
2254560|NCT02065245|3920637|FG001|Infusion 3|Lost to Follow-up|1
2254561|NCT02065245|3920638|FG002|Infusion 3|Lost to Follow-up|0
2254562|NCT02065245|3920639|FG003|Infusion 3|Lost to Follow-up|0
2254563|NCT02065245|3920640|FG004|Infusion 3|Lost to Follow-up|0
2254564|NCT02065245|3920641|FG005|Infusion 3|Lost to Follow-up|0
2254565|NCT02065245|3920642|FG006|Infusion 3|Lost to Follow-up|0
2254566|NCT02065336|3920666|FG000|Extension Phase|Study Terminated by Sponsor|0
2254567|NCT02065336|3920667|FG001|Extension Phase|Study Terminated by Sponsor|0
2254568|NCT02065336|3920668|FG002|Extension Phase|Study Terminated by Sponsor|0
2254569|NCT02065336|3920669|FG003|Extension Phase|Study Terminated by Sponsor|0
2254570|NCT02065336|3920670|FG004|Extension Phase|Study Terminated by Sponsor|0
2254571|NCT02065336|3920671|FG005|Extension Phase|Study Terminated by Sponsor|0
2254572|NCT02065336|3920672|FG006|Extension Phase|Study Terminated by Sponsor|0
2254573|NCT02065336|3920673|FG007|Extension Phase|Study Terminated by Sponsor|0
2254574|NCT02065336|3920674|FG008|Extension Phase|Study Terminated by Sponsor|2
2254575|NCT02065336|3920675|FG009|Extension Phase|Study Terminated by Sponsor|8
2254576|NCT02065518|3920727|FG000|Overall Study|Lost to Follow-up|3
2254577|NCT02065518|3920728|FG001|Overall Study|Lost to Follow-up|4
2254578|NCT02065518|3920729|FG002|Overall Study|Lost to Follow-up|0
2254579|NCT02065518|3920730|FG003|Overall Study|Lost to Follow-up|3
2254580|NCT02065518|3920727|FG000|Overall Study|Withdrawal by Subject|3
2254581|NCT02065518|3920728|FG001|Overall Study|Withdrawal by Subject|4
2254582|NCT02065518|3920729|FG002|Overall Study|Withdrawal by Subject|9
2254583|NCT02065518|3920730|FG003|Overall Study|Withdrawal by Subject|2
2254584|NCT02065557|3920743|FG000|Induction Period|Withdrawal by Subject|2
2254585|NCT02065557|3920744|FG001|Induction Period|Withdrawal by Subject|1
2254586|NCT02065557|3920745|FG002|Induction Period|Withdrawal by Subject|0
2254587|NCT02065557|3920746|FG003|Induction Period|Withdrawal by Subject|0
2254588|NCT02065557|3920747|FG004|Induction Period|Withdrawal by Subject|0
2254589|NCT02065557|3920748|FG005|Induction Period|Withdrawal by Subject|0
2254590|NCT02065557|3920743|FG000|Induction Period|Lack of Efficacy|2
2254591|NCT02065557|3920744|FG001|Induction Period|Lack of Efficacy|1
2254592|NCT02065557|3920745|FG002|Induction Period|Lack of Efficacy|1
2254593|NCT02065557|3920746|FG003|Induction Period|Lack of Efficacy|0
2254594|NCT02065557|3920747|FG004|Induction Period|Lack of Efficacy|0
2254595|NCT02065557|3920748|FG005|Induction Period|Lack of Efficacy|0
2254596|NCT02065557|3920743|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1
2254597|NCT02065557|3920744|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1
2254598|NCT02065557|3920745|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1
2254599|NCT02065557|3920746|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0
2254600|NCT02065557|3920747|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0
2254601|NCT02065557|3920748|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0
2254602|NCT02065557|3920743|FG000|Induction Period|Non-Responder at Week 8|4
2254603|NCT02065557|3920744|FG001|Induction Period|Non-Responder at Week 8|4
2254604|NCT02065557|3920745|FG002|Induction Period|Non-Responder at Week 8|0
2254605|NCT02065557|3920746|FG003|Induction Period|Non-Responder at Week 8|0
2254606|NCT02065557|3920747|FG004|Induction Period|Non-Responder at Week 8|0
2254607|NCT02065557|3920748|FG005|Induction Period|Non-Responder at Week 8|0
2254608|NCT02065557|3920743|FG000|Induction Period|Adverse Event|1
2254609|NCT02065557|3920744|FG001|Induction Period|Adverse Event|1
2254610|NCT02065557|3920745|FG002|Induction Period|Adverse Event|0
2342798|NCT03502070|4076617|FG000|Overall Study|Withdrawal by Subject|1
2342799|NCT03502070|4076617|FG000|Overall Study|Screen Failure|1
2342800|NCT03502616|4076627|FG000|Up to Week 16|Withdrawal by Subject|1
2342801|NCT03502616|4076628|FG001|Up to Week 16|Withdrawal by Subject|2
2342802|NCT03502616|4076627|FG000|Up to Week 16|Lost to Follow-up|0
2342803|NCT03502616|4076628|FG001|Up to Week 16|Lost to Follow-up|1
2342804|NCT03502616|4076627|FG000|Up to Week 16|Randomized, but not treated|1
2342805|NCT03502616|4076628|FG001|Up to Week 16|Randomized, but not treated|0
2342806|NCT03502616|4076627|FG000|Week 16 to Week 48|Withdrawal by Subject|6
2342807|NCT03502616|4076628|FG001|Week 16 to Week 48|Withdrawal by Subject|6
2342808|NCT03502616|4076627|FG000|Week 16 to Week 48|Lost to Follow-up|1
2342809|NCT03502616|4076628|FG001|Week 16 to Week 48|Lost to Follow-up|0
2342810|NCT03502681|4076638|FG000|Overall Study|Adverse Event|1
2342811|NCT03502681|4076639|FG001|Overall Study|Adverse Event|1
2342812|NCT03502681|4076638|FG000|Overall Study|Disease Progression|2
2342813|NCT03502681|4076639|FG001|Overall Study|Disease Progression|1
2342814|NCT03502798|4076646|FG000|Overall Study|equipment failure|0
2342815|NCT03502798|4076647|FG001|Overall Study|equipment failure|7
2342816|NCT03503162|4076675|FG000|Overall Study|did not meet eligibility|1
2342817|NCT03503188|4076681|FG000|Overall Study|Non eligible in the sub study|0
2342818|NCT03503188|4076682|FG001|Overall Study|Non eligible in the sub study|1
2342819|NCT03504189|4076710|FG000|Overall Study|Withdrawal by Subject|1
2342820|NCT03504189|4076710|FG000|Overall Study|Screening Failure|1
2342821|NCT03504189|4076710|FG000|Overall Study|Device Failure|2
2342822|NCT03504852|4076726|FG000|Overall Study|Withdrawal of informed consent|2
2342823|NCT03504852|4076727|FG001|Overall Study|Withdrawal of informed consent|1
2342824|NCT03504852|4076728|FG002|Overall Study|Withdrawal of informed consent|0
2342825|NCT03504852|4076726|FG000|Overall Study|Withdrawal by Subject|5
2342826|NCT03504852|4076727|FG001|Overall Study|Withdrawal by Subject|5
2342827|NCT03504852|4076728|FG002|Overall Study|Withdrawal by Subject|1
2342828|NCT03504852|4076726|FG000|Overall Study|Lost to Follow-up|4
2342829|NCT03504852|4076727|FG001|Overall Study|Lost to Follow-up|1
2342830|NCT03504852|4076728|FG002|Overall Study|Lost to Follow-up|0
2342831|NCT03504852|4076726|FG000|Overall Study|New therapy for study indication|1
2038927|NCT00424346|3609246|FG000|Extension Phase|Lost to Follow-up|0
2038928|NCT00424346|3609247|FG001|Extension Phase|Lost to Follow-up|2
2342832|NCT03504852|4076727|FG001|Overall Study|New therapy for study indication|0
2254611|NCT02065557|3920746|FG003|Induction Period|Adverse Event|0
2254612|NCT02065557|3920747|FG004|Induction Period|Adverse Event|0
2254613|NCT02065557|3920748|FG005|Induction Period|Adverse Event|0
2254614|NCT02065557|3920743|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0
2254615|NCT02065557|3920744|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0
2254616|NCT02065557|3920745|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0
2254617|NCT02065557|3920746|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1
2254618|NCT02065557|3920747|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1
2254619|NCT02065557|3920748|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0
2254620|NCT02065557|3920743|FG000|Maintenance Period|Withdrawal by Subject|0
2254621|NCT02065557|3920744|FG001|Maintenance Period|Withdrawal by Subject|0
2254622|NCT02065557|3920745|FG002|Maintenance Period|Withdrawal by Subject|0
2254623|NCT02065557|3920746|FG003|Maintenance Period|Withdrawal by Subject|0
2254624|NCT02065557|3920747|FG004|Maintenance Period|Withdrawal by Subject|2
2254625|NCT02065557|3920748|FG005|Maintenance Period|Withdrawal by Subject|1
2254626|NCT02065557|3920743|FG000|Maintenance Period|Lack of Efficacy|0
2254627|NCT02065557|3920744|FG001|Maintenance Period|Lack of Efficacy|0
2254628|NCT02065557|3920745|FG002|Maintenance Period|Lack of Efficacy|0
2254629|NCT02065557|3920746|FG003|Maintenance Period|Lack of Efficacy|0
2254630|NCT02065557|3920747|FG004|Maintenance Period|Lack of Efficacy|5
2254631|NCT02065557|3920748|FG005|Maintenance Period|Lack of Efficacy|2
2254632|NCT02065557|3920743|FG000|Maintenance Period|Subject Non-Compliance|0
2254633|NCT02065557|3920744|FG001|Maintenance Period|Subject Non-Compliance|0
2254634|NCT02065557|3920745|FG002|Maintenance Period|Subject Non-Compliance|0
2254635|NCT02065557|3920746|FG003|Maintenance Period|Subject Non-Compliance|0
2254636|NCT02065557|3920747|FG004|Maintenance Period|Subject Non-Compliance|0
2254637|NCT02065557|3920748|FG005|Maintenance Period|Subject Non-Compliance|1
2254638|NCT02065570|3920775|FG000|Induction Study|Adverse Event|5
2254639|NCT02065570|3920776|FG001|Induction Study|Adverse Event|12
2254640|NCT02065570|3920777|FG002|Induction Study|Adverse Event|0
2254641|NCT02065570|3920778|FG003|Induction Study|Adverse Event|0
2254642|NCT02065570|3920775|FG000|Induction Study|Withdrawal by Subject|2
2254643|NCT02065570|3920776|FG001|Induction Study|Withdrawal by Subject|3
2254644|NCT02065570|3920777|FG002|Induction Study|Withdrawal by Subject|0
2254645|NCT02065570|3920778|FG003|Induction Study|Withdrawal by Subject|0
2254646|NCT02065570|3920775|FG000|Induction Study|Lost to Follow-up|1
2254647|NCT02065570|3920776|FG001|Induction Study|Lost to Follow-up|1
2254648|NCT02065570|3920777|FG002|Induction Study|Lost to Follow-up|0
2254649|NCT02065570|3920778|FG003|Induction Study|Lost to Follow-up|0
2254650|NCT02065570|3920775|FG000|Induction Study|Other, Not Specified|6
2254651|NCT02065570|3920776|FG001|Induction Study|Other, Not Specified|5
2254652|NCT02065570|3920777|FG002|Induction Study|Other, Not Specified|0
2254653|NCT02065570|3920778|FG003|Induction Study|Other, Not Specified|0
2254654|NCT02065570|3920775|FG000|Maintenance Study|Adverse Event|0
2254655|NCT02065570|3920776|FG001|Maintenance Study|Adverse Event|0
2254656|NCT02065570|3920777|FG002|Maintenance Study|Adverse Event|8
2254657|NCT02065570|3920778|FG003|Maintenance Study|Adverse Event|8
2254658|NCT02065570|3920775|FG000|Maintenance Study|Withdrawal by Subject|0
2254659|NCT02065570|3920776|FG001|Maintenance Study|Withdrawal by Subject|0
2254660|NCT02065570|3920777|FG002|Maintenance Study|Withdrawal by Subject|1
2254661|NCT02065570|3920778|FG003|Maintenance Study|Withdrawal by Subject|4
2254662|NCT02065570|3920775|FG000|Maintenance Study|Lost to Follow-up|0
2254663|NCT02065570|3920776|FG001|Maintenance Study|Lost to Follow-up|0
2254664|NCT02065570|3920777|FG002|Maintenance Study|Lost to Follow-up|2
2254665|NCT02065570|3920778|FG003|Maintenance Study|Lost to Follow-up|2
2254666|NCT02065570|3920775|FG000|Maintenance Study|Other, Not Specified|0
2254667|NCT02065570|3920776|FG001|Maintenance Study|Other, Not Specified|0
2254668|NCT02065570|3920777|FG002|Maintenance Study|Other, Not Specified|11
2342833|NCT03504852|4076728|FG002|Overall Study|New therapy for study indication|0
2342834|NCT03504852|4076726|FG000|Overall Study|Lack of Efficacy|1
2342835|NCT03504852|4076727|FG001|Overall Study|Lack of Efficacy|2
2342836|NCT03504852|4076728|FG002|Overall Study|Lack of Efficacy|0
2342837|NCT03504852|4076726|FG000|Overall Study|Death|0
2342838|NCT03504852|4076727|FG001|Overall Study|Death|1
2342839|NCT03504852|4076728|FG002|Overall Study|Death|0
2342840|NCT03504852|4076726|FG000|Overall Study|Adverse Event|4
2342841|NCT03504852|4076727|FG001|Overall Study|Adverse Event|8
2342842|NCT03504852|4076728|FG002|Overall Study|Adverse Event|2
2342843|NCT03504917|4076740|FG000|Blinded Treatment Period|Protocol Violation|1
2342844|NCT03504917|4076741|FG001|Blinded Treatment Period|Protocol Violation|0
2342845|NCT03504917|4076740|FG000|Blinded Treatment Period|Withdrawal by Subject|12
2342846|NCT03504917|4076741|FG001|Blinded Treatment Period|Withdrawal by Subject|9
2342847|NCT03504917|4076740|FG000|Blinded Treatment Period|Lack of Efficacy|1
2342848|NCT03504917|4076741|FG001|Blinded Treatment Period|Lack of Efficacy|1
2342849|NCT03504917|4076740|FG000|Blinded Treatment Period|Lost to Follow-up|1
2342850|NCT03504917|4076741|FG001|Blinded Treatment Period|Lost to Follow-up|4
2342851|NCT03504917|4076740|FG000|Blinded Treatment Period|Adverse Event|4
2342852|NCT03504917|4076741|FG001|Blinded Treatment Period|Adverse Event|4
2342853|NCT03504917|4076740|FG000|Blinded Treatment Period|Physician Decision|1
2342854|NCT03504917|4076741|FG001|Blinded Treatment Period|Physician Decision|0
2254669|NCT02065570|3920778|FG003|Maintenance Study|Other, Not Specified|5
2254670|NCT02065622|3920791|FG000|Induction Study|Adverse Event|13
2254671|NCT02065622|3920792|FG001|Induction Study|Adverse Event|19
2254672|NCT02065622|3920793|FG002|Induction Study|Adverse Event|0
2254673|NCT02065622|3920794|FG003|Induction Study|Adverse Event|0
2254674|NCT02065622|3920795|FG004|Induction Study|Adverse Event|0
2254675|NCT02065622|3920791|FG000|Induction Study|Withdrawal by Subject|3
2254676|NCT02065622|3920792|FG001|Induction Study|Withdrawal by Subject|5
2254677|NCT02065622|3920793|FG002|Induction Study|Withdrawal by Subject|0
2254678|NCT02065622|3920794|FG003|Induction Study|Withdrawal by Subject|0
2254679|NCT02065622|3920795|FG004|Induction Study|Withdrawal by Subject|0
2254680|NCT02065622|3920791|FG000|Induction Study|Lost to Follow-up|1
2254681|NCT02065622|3920792|FG001|Induction Study|Lost to Follow-up|0
2254682|NCT02065622|3920793|FG002|Induction Study|Lost to Follow-up|0
2254683|NCT02065622|3920794|FG003|Induction Study|Lost to Follow-up|0
2254684|NCT02065622|3920795|FG004|Induction Study|Lost to Follow-up|0
2254685|NCT02065622|3920791|FG000|Induction Study|Lack of Efficacy|22
2254686|NCT02065622|3920792|FG001|Induction Study|Lack of Efficacy|27
2254687|NCT02065622|3920793|FG002|Induction Study|Lack of Efficacy|0
2254688|NCT02065622|3920794|FG003|Induction Study|Lack of Efficacy|0
2254689|NCT02065622|3920795|FG004|Induction Study|Lack of Efficacy|0
2254690|NCT02065622|3920791|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4
2254691|NCT02065622|3920792|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5
2254692|NCT02065622|3920793|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0
2254693|NCT02065622|3920794|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0
2254694|NCT02065622|3920795|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0
2254695|NCT02065622|3920791|FG000|Induction Study|Subject Noncompliance|1
2254696|NCT02065622|3920792|FG001|Induction Study|Subject Noncompliance|1
2254697|NCT02065622|3920793|FG002|Induction Study|Subject Noncompliance|0
2254698|NCT02065622|3920794|FG003|Induction Study|Subject Noncompliance|0
2254699|NCT02065622|3920795|FG004|Induction Study|Subject Noncompliance|0
2254700|NCT02065622|3920791|FG000|Induction Study|Other, Not Specified|3
2254701|NCT02065622|3920792|FG001|Induction Study|Other, Not Specified|2
2254702|NCT02065622|3920793|FG002|Induction Study|Other, Not Specified|0
2254703|NCT02065622|3920794|FG003|Induction Study|Other, Not Specified|0
2254704|NCT02065622|3920795|FG004|Induction Study|Other, Not Specified|0
2254705|NCT02065622|3920791|FG000|Maintenance Study|Adverse Event|0
2254706|NCT02065622|3920792|FG001|Maintenance Study|Adverse Event|0
2254707|NCT02065622|3920793|FG002|Maintenance Study|Adverse Event|25
2254708|NCT02065622|3920794|FG003|Maintenance Study|Adverse Event|22
2254709|NCT02065622|3920795|FG004|Maintenance Study|Adverse Event|11
2254710|NCT02065622|3920791|FG000|Maintenance Study|Withdrawal by Subject|0
2254711|NCT02065622|3920792|FG001|Maintenance Study|Withdrawal by Subject|0
2254712|NCT02065622|3920793|FG002|Maintenance Study|Withdrawal by Subject|11
2254713|NCT02065622|3920794|FG003|Maintenance Study|Withdrawal by Subject|5
2254714|NCT02065622|3920795|FG004|Maintenance Study|Withdrawal by Subject|7
2254715|NCT02065622|3920791|FG000|Maintenance Study|Lost to Follow-up|0
2254716|NCT02065622|3920792|FG001|Maintenance Study|Lost to Follow-up|0
2254717|NCT02065622|3920793|FG002|Maintenance Study|Lost to Follow-up|4
2254718|NCT02065622|3920794|FG003|Maintenance Study|Lost to Follow-up|1
2254719|NCT02065622|3920795|FG004|Maintenance Study|Lost to Follow-up|1
2254720|NCT02065622|3920791|FG000|Maintenance Study|Lack of Efficacy|0
2254721|NCT02065622|3920792|FG001|Maintenance Study|Lack of Efficacy|0
2254722|NCT02065622|3920793|FG002|Maintenance Study|Lack of Efficacy|70
2254723|NCT02065622|3920794|FG003|Maintenance Study|Lack of Efficacy|55
2254724|NCT02065622|3920795|FG004|Maintenance Study|Lack of Efficacy|19
2254725|NCT02065622|3920791|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0
2254726|NCT02065622|3920792|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0
2254727|NCT02065622|3920793|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7
2254728|NCT02065622|3920794|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3
2254729|NCT02065622|3920795|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4
2254730|NCT02065622|3920791|FG000|Maintenance Study|Subject Non-Compliance|0
2254731|NCT02065622|3920792|FG001|Maintenance Study|Subject Non-Compliance|0
2254732|NCT02065622|3920793|FG002|Maintenance Study|Subject Non-Compliance|1
2254733|NCT02065622|3920794|FG003|Maintenance Study|Subject Non-Compliance|3
2254734|NCT02065622|3920795|FG004|Maintenance Study|Subject Non-Compliance|2
2254735|NCT02065622|3920791|FG000|Maintenance Study|Other, Not Specified|0
2254736|NCT02065622|3920792|FG001|Maintenance Study|Other, Not Specified|0
2254737|NCT02065622|3920793|FG002|Maintenance Study|Other, Not Specified|6
2254738|NCT02065622|3920794|FG003|Maintenance Study|Other, Not Specified|14
2254739|NCT02065622|3920795|FG004|Maintenance Study|Other, Not Specified|2
2254740|NCT02065622|3920791|FG000|Maintenance Study|Unknown Reason|0
2254741|NCT02065622|3920792|FG001|Maintenance Study|Unknown Reason|0
2254742|NCT02065622|3920793|FG002|Maintenance Study|Unknown Reason|0
2254743|NCT02065622|3920794|FG003|Maintenance Study|Unknown Reason|1
2254744|NCT02065622|3920795|FG004|Maintenance Study|Unknown Reason|0
2254745|NCT02065713|3920821|FG000|Overall Study|Adverse Event|0
2254746|NCT02065713|3920822|FG001|Overall Study|Adverse Event|1
2254747|NCT02065713|3920821|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2254748|NCT02065713|3920822|FG001|Overall Study|Unsatisfactory therapeutic effect|0
2254749|NCT02065791|3920830|FG000|Overall Study|Closed Site|1
2254750|NCT02065791|3920831|FG001|Overall Study|Closed Site|1
2254751|NCT02065791|3920830|FG000|Overall Study|Withdrawal by Subject|11
2254752|NCT02065791|3920831|FG001|Overall Study|Withdrawal by Subject|5
2254753|NCT02065791|3920830|FG000|Overall Study|Lost to Follow-up|13
2254754|NCT02065791|3920831|FG001|Overall Study|Lost to Follow-up|9
2254755|NCT02065895|3920837|FG000|Overall Study|Protocol Violation|1
2254756|NCT02065895|3920838|FG001|Overall Study|Protocol Violation|0
2254757|NCT02065895|3920839|FG002|Overall Study|Protocol Violation|0
2254758|NCT02065895|3920840|FG003|Overall Study|Protocol Violation|1
2254759|NCT02065895|3920841|FG004|Overall Study|Protocol Violation|0
2254760|NCT02065895|3920842|FG005|Overall Study|Protocol Violation|0
2254761|NCT02065895|3920837|FG000|Overall Study|Scheduling conflicts|0
2254762|NCT02065895|3920838|FG001|Overall Study|Scheduling conflicts|1
2254763|NCT02065895|3920839|FG002|Overall Study|Scheduling conflicts|0
2254764|NCT02065895|3920840|FG003|Overall Study|Scheduling conflicts|0
2254765|NCT02065895|3920841|FG004|Overall Study|Scheduling conflicts|0
2254766|NCT02065895|3920842|FG005|Overall Study|Scheduling conflicts|0
2254767|NCT02066051|3920859|FG000|Overall Study|Subject developed active GVHD|1
2254768|NCT02066129|3920865|FG000|Overall Study|Lost to Follow-up|13
2254769|NCT02066129|3920866|FG001|Overall Study|Lost to Follow-up|12
2254770|NCT02066129|3920865|FG000|Overall Study|Withdrawal by Subject|7
2254771|NCT02066129|3920866|FG001|Overall Study|Withdrawal by Subject|10
2254772|NCT02066129|3920865|FG000|Overall Study|Lack of Efficacy|8
2254773|NCT02066129|3920866|FG001|Overall Study|Lack of Efficacy|10
2342855|NCT03504917|4076740|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1
2342856|NCT03504917|4076741|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3
2342857|NCT03504917|4076740|FG000|Blinded Treatment Period|Study terminated by sponsor|39
2342858|NCT03504917|4076741|FG001|Blinded Treatment Period|Study terminated by sponsor|34
2342859|NCT03504917|4076740|FG000|Blinded Treatment Period|Non-compliance with study drug|0
2342860|NCT03504917|4076741|FG001|Blinded Treatment Period|Non-compliance with study drug|1
2342861|NCT03504917|4076740|FG000|Open Label Extension Treatment Period|The participant left the study site|0
2342862|NCT03504917|4076741|FG001|Open Label Extension Treatment Period|The participant left the study site|1
2342863|NCT03504917|4076740|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8
2342864|NCT03504917|4076741|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2
2342865|NCT03504917|4076740|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1
2342866|NCT03504917|4076741|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4
2342867|NCT03504917|4076740|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3
2342868|NCT03504917|4076741|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1
2342869|NCT03504917|4076740|FG000|Open Label Extension Treatment Period|Adverse Event|7
2342870|NCT03504917|4076741|FG001|Open Label Extension Treatment Period|Adverse Event|0
2342871|NCT03504917|4076740|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0
2342872|NCT03504917|4076741|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1
2342873|NCT03504917|4076740|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81
2342874|NCT03504917|4076741|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88
2342875|NCT03505021|4076755|FG000|Overall Study|Protocol Violation|1
2342876|NCT03505021|4076756|FG001|Overall Study|Protocol Violation|0
2342877|NCT03505021|4076755|FG000|Overall Study|Death|9
2342878|NCT03505021|4076756|FG001|Overall Study|Death|8
2342879|NCT03505021|4076755|FG000|Overall Study|Consent withdrawn by subject|6
2342880|NCT03505021|4076756|FG001|Overall Study|Consent withdrawn by subject|1
2342881|NCT03505021|4076755|FG000|Overall Study|Lost to Follow-up|5
2342882|NCT03505021|4076756|FG001|Overall Study|Lost to Follow-up|3
2342883|NCT03505021|4076755|FG000|Overall Study|Adverse Event|26
2342884|NCT03505021|4076756|FG001|Overall Study|Adverse Event|9
2342885|NCT03505021|4076755|FG000|Overall Study|Disease progression|33
2342886|NCT03505021|4076756|FG001|Overall Study|Disease progression|17
2342887|NCT03505021|4076755|FG000|Overall Study|Other|11
2342888|NCT03505021|4076756|FG001|Overall Study|Other|5
2342889|NCT03505021|4076755|FG000|Overall Study|Personal reason|21
2342890|NCT03505021|4076756|FG001|Overall Study|Personal reason|12
2342891|NCT03505593|4076783|FG000|Overall Study|Withdrawal by Subject|1
2342892|NCT03505593|4076783|FG000|Overall Study|Died before procedure|1
2342893|NCT03505593|4076783|FG000|Overall Study|Anatomical abnormality|1
2342894|NCT03505593|4076783|FG000|Overall Study|Unable to pass through esophagus|1
2342895|NCT03505593|4076783|FG000|Overall Study|Obstruction by Endotracheal tube|1
2342896|NCT03505749|4076789|FG000|Overall Study|Lost to Follow-up|7
2342897|NCT03505749|4076790|FG001|Overall Study|Lost to Follow-up|11
2342898|NCT03505749|4076789|FG000|Overall Study|Withdrawal by Subject|6
2342899|NCT03505749|4076790|FG001|Overall Study|Withdrawal by Subject|0
2342900|NCT03505749|4076789|FG000|Overall Study|Discharged from treatment|3
2342901|NCT03505749|4076790|FG001|Overall Study|Discharged from treatment|6
2342902|NCT03506425|4076820|FG000|Overall Study|Adverse Event|1
2342903|NCT03506425|4076821|FG001|Overall Study|Adverse Event|3
2342904|NCT03506425|4076822|FG002|Overall Study|Adverse Event|0
2342905|NCT03506425|4076820|FG000|Overall Study|Death|1
2342906|NCT03506425|4076821|FG001|Overall Study|Death|0
2342907|NCT03506425|4076822|FG002|Overall Study|Death|0
2342908|NCT03506425|4076820|FG000|Overall Study|Withdrawal by Subject|0
2342909|NCT03506425|4076821|FG001|Overall Study|Withdrawal by Subject|0
2342910|NCT03506425|4076822|FG002|Overall Study|Withdrawal by Subject|1
2254774|NCT02066129|3920865|FG000|Overall Study|Physician Decision|1
2254775|NCT02066129|3920866|FG001|Overall Study|Physician Decision|1
2254776|NCT02066233|3920874|FG000|EG Scan II (Day 1)|difficulty intubating subject|6
2254777|NCT02066233|3920875|FG001|EG Scan II (Day 1)|difficulty intubating subject|6
2254778|NCT02066298|3920887|FG000|Overall Study|Lost to Follow-up|3
2254779|NCT02066298|3920888|FG001|Overall Study|Lost to Follow-up|2
2254780|NCT02066298|3920889|FG002|Overall Study|Lost to Follow-up|3
2254781|NCT02066298|3920890|FG003|Overall Study|Lost to Follow-up|2
2254782|NCT02066298|3920891|FG004|Overall Study|Lost to Follow-up|3
2254783|NCT02066298|3920892|FG005|Overall Study|Lost to Follow-up|4
2254784|NCT02066298|3920887|FG000|Overall Study|Withdrawal by Subject|6
2254785|NCT02066298|3920888|FG001|Overall Study|Withdrawal by Subject|6
2254786|NCT02066298|3920889|FG002|Overall Study|Withdrawal by Subject|6
2254787|NCT02066298|3920890|FG003|Overall Study|Withdrawal by Subject|4
2254788|NCT02066298|3920891|FG004|Overall Study|Withdrawal by Subject|5
2254789|NCT02066298|3920892|FG005|Overall Study|Withdrawal by Subject|8
2254790|NCT02066298|3920887|FG000|Overall Study|Physician Decision|0
2254791|NCT02066298|3920888|FG001|Overall Study|Physician Decision|0
2254792|NCT02066298|3920889|FG002|Overall Study|Physician Decision|1
2254793|NCT02066298|3920890|FG003|Overall Study|Physician Decision|0
2254794|NCT02066298|3920891|FG004|Overall Study|Physician Decision|1
2254795|NCT02066298|3920892|FG005|Overall Study|Physician Decision|0
2254796|NCT02066311|3920904|FG000|Overall Study|Adverse Event|4
2254797|NCT02066311|3920904|FG000|Overall Study|Withdrawal by Subject|1
2254798|NCT02066389|3920914|FG000|Overall Study|Adverse Event|1
2254799|NCT02066389|3920915|FG001|Overall Study|Adverse Event|1
2254800|NCT02066389|3920916|FG002|Overall Study|Adverse Event|1
2254801|NCT02066389|3920917|FG003|Overall Study|Adverse Event|1
2254802|NCT02066389|3920918|FG004|Overall Study|Adverse Event|5
2254803|NCT02066389|3920919|FG005|Overall Study|Adverse Event|1
2254804|NCT02066389|3920914|FG000|Overall Study|Withdrawal by Subject|4
2254805|NCT02066389|3920915|FG001|Overall Study|Withdrawal by Subject|0
2254806|NCT02066389|3920916|FG002|Overall Study|Withdrawal by Subject|5
2254807|NCT02066389|3920917|FG003|Overall Study|Withdrawal by Subject|1
2254808|NCT02066389|3920918|FG004|Overall Study|Withdrawal by Subject|1
2254809|NCT02066389|3920919|FG005|Overall Study|Withdrawal by Subject|2
2254810|NCT02066389|3920914|FG000|Overall Study|Lost to Follow-up|0
2254811|NCT02066389|3920915|FG001|Overall Study|Lost to Follow-up|0
2254812|NCT02066389|3920916|FG002|Overall Study|Lost to Follow-up|0
2254813|NCT02066389|3920917|FG003|Overall Study|Lost to Follow-up|1
2254814|NCT02066389|3920918|FG004|Overall Study|Lost to Follow-up|1
2254815|NCT02066389|3920919|FG005|Overall Study|Lost to Follow-up|1
2254816|NCT02066389|3920914|FG000|Overall Study|Randomized in Error|0
2254817|NCT02066389|3920915|FG001|Overall Study|Randomized in Error|0
2254818|NCT02066389|3920916|FG002|Overall Study|Randomized in Error|0
2254819|NCT02066389|3920917|FG003|Overall Study|Randomized in Error|0
2254820|NCT02066389|3920918|FG004|Overall Study|Randomized in Error|0
2254821|NCT02066389|3920919|FG005|Overall Study|Randomized in Error|1
2254822|NCT02066402|3920935|FG000|Overall Study|Adverse Event|1
2254823|NCT02066402|3920936|FG001|Overall Study|Adverse Event|2
2254824|NCT02066402|3920935|FG000|Overall Study|Lost to Follow-up|11
2254825|NCT02066402|3920936|FG001|Overall Study|Lost to Follow-up|8
2254826|NCT02066402|3920935|FG000|Overall Study|Withdrawal by Subject|14
2254827|NCT02066402|3920936|FG001|Overall Study|Withdrawal by Subject|11
2254828|NCT02066402|3920935|FG000|Overall Study|Progressive disease-clinical progression|0
2254829|NCT02066402|3920936|FG001|Overall Study|Progressive disease-clinical progression|1
2254830|NCT02066402|3920935|FG000|Overall Study|Protocol driven decision point|0
2254831|NCT02066402|3920936|FG001|Overall Study|Protocol driven decision point|1
2254832|NCT02066415|3920945|FG000|Overall Study|Decision by Sponsor|5
2254833|NCT02066415|3920946|FG001|Overall Study|Decision by Sponsor|4
2254834|NCT02066415|3920947|FG002|Overall Study|Decision by Sponsor|2
2254835|NCT02066415|3920945|FG000|Overall Study|Withdrawal by Subject|9
2254836|NCT02066415|3920946|FG001|Overall Study|Withdrawal by Subject|1
2254837|NCT02066415|3920947|FG002|Overall Study|Withdrawal by Subject|4
2254838|NCT02066415|3920945|FG000|Overall Study|Lost to Follow-up|7
2254839|NCT02066415|3920946|FG001|Overall Study|Lost to Follow-up|2
2254840|NCT02066415|3920947|FG002|Overall Study|Lost to Follow-up|2
2254841|NCT02066467|3920955|FG000|Overall Study|Did not undergo implant procedure|24
2254842|NCT02066467|3920955|FG000|Overall Study|Attempted to implant withoput success|43
2254843|NCT02066467|3920955|FG000|Overall Study|Consent ineligible|1
2254844|NCT02066467|3920955|FG000|Overall Study|Death|54
2254845|NCT02066467|3920955|FG000|Overall Study|Lost to Follow-up|51
2254846|NCT02066467|3920955|FG000|Overall Study|Adverse Event|20
2254847|NCT02066467|3920955|FG000|Overall Study|Withdrawal by Subject|16
2254848|NCT02066467|3920955|FG000|Overall Study|Physician Decision|2
2254849|NCT02066467|3920955|FG000|Overall Study|Not defined|4
2254850|NCT02066922|3921008|FG000|Overall Study|Adverse Event|1
2254851|NCT02067533|3921054|FG000|Overall Study|Lost to Follow-up|4
2254852|NCT02067533|3921055|FG001|Overall Study|Lost to Follow-up|2
2254853|NCT02067663|3921076|FG000|Overall Study|Lost to Follow-up|13
2254854|NCT02067663|3921077|FG001|Overall Study|Lost to Follow-up|14
2254855|NCT02067676|3921089|FG000|Overall Study|Withdrawal by Subject|1
2254856|NCT02067676|3921090|FG001|Overall Study|Withdrawal by Subject|0
2254857|NCT02067676|3921091|FG002|Overall Study|Withdrawal by Subject|0
2342911|NCT03506477|4076833|FG000|Overall Study|Withdrawal by Subject|1
2254858|NCT02067676|3921092|FG003|Overall Study|Withdrawal by Subject|0
2254859|NCT02067676|3921093|FG004|Overall Study|Withdrawal by Subject|0
2254860|NCT02067676|3921094|FG005|Overall Study|Withdrawal by Subject|0
2254861|NCT02067728|3921115|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
2254862|NCT02067728|3921116|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
2254863|NCT02067728|3921115|FG000|6 Month Follow up Survey|Lost to Follow-up|48
2254864|NCT02067728|3921116|FG001|6 Month Follow up Survey|Lost to Follow-up|60
2254865|NCT02067728|3921115|FG000|6 Month Measurements|Unable to attend|114
2254866|NCT02067728|3921116|FG001|6 Month Measurements|Unable to attend|97
2254867|NCT02068118|3921142|FG000|18-month Comparative Study Period|Death|90
2254868|NCT02068118|3921143|FG001|18-month Comparative Study Period|Death|97
2254869|NCT02068118|3921142|FG000|18-month Comparative Study Period|Withdrawal by Subject|23
2254870|NCT02068118|3921143|FG001|18-month Comparative Study Period|Withdrawal by Subject|52
2254871|NCT02068118|3921142|FG000|18-month Comparative Study Period|Lost to Follow-up|6
2254872|NCT02068118|3921143|FG001|18-month Comparative Study Period|Lost to Follow-up|7
2254873|NCT02068118|3921142|FG000|18-month Comparative Study Period|Heart transplant|9
2254874|NCT02068118|3921143|FG001|18-month Comparative Study Period|Heart transplant|15
2254875|NCT02068118|3921142|FG000|18-month Comparative Study Period|Inclusion in another protocol|0
2254876|NCT02068118|3921143|FG001|18-month Comparative Study Period|Inclusion in another protocol|2
2254877|NCT02068118|3921142|FG000|18-month Comparative Study Period|Hemiplegia|0
2254878|NCT02068118|3921143|FG001|18-month Comparative Study Period|Hemiplegia|1
2254879|NCT02068118|3921142|FG000|18-month Comparative Study Period|Alzheimer's disease|0
2254880|NCT02068118|3921143|FG001|18-month Comparative Study Period|Alzheimer's disease|1
2254881|NCT02068118|3921142|FG000|18-month Comparative Study Period|Move|0
2254882|NCT02068118|3921143|FG001|18-month Comparative Study Period|Move|1
2254883|NCT02068118|3921142|FG000|18-month Comparative Study Period|Hearing loss|0
2254884|NCT02068118|3921143|FG001|18-month Comparative Study Period|Hearing loss|1
2254885|NCT02068118|3921142|FG000|Extension Period|Death|0
2254886|NCT02068118|3921143|FG001|Extension Period|Death|2
2254887|NCT02068118|3921142|FG000|Extension Period|Withdrawal by Subject|1
2254888|NCT02068118|3921143|FG001|Extension Period|Withdrawal by Subject|0
2254889|NCT02068118|3921142|FG000|Extension Period|Heart transplant|1
2254890|NCT02068118|3921143|FG001|Extension Period|Heart transplant|0
2254891|NCT02068118|3921142|FG000|Extension Period|Wrong device use|0
2254892|NCT02068118|3921143|FG001|Extension Period|Wrong device use|1
2342912|NCT03506477|4076834|FG001|Overall Study|Withdrawal by Subject|0
2342913|NCT03508050|4076875|FG000|Overall Study|Pleural adhesions|1
2342914|NCT03508050|4076876|FG001|Overall Study|Pleural adhesions|0
2342915|NCT03508050|4076875|FG000|Overall Study|Mucus plug|1
2342916|NCT03508050|4076876|FG001|Overall Study|Mucus plug|0
2342917|NCT03508050|4076875|FG000|Overall Study|Negative biopsy, surgery cancelled|3
2342918|NCT03508050|4076876|FG001|Overall Study|Negative biopsy, surgery cancelled|1
2342919|NCT03508050|4076875|FG000|Overall Study|Sustained desaturation|0
2342920|NCT03508050|4076876|FG001|Overall Study|Sustained desaturation|1
2342921|NCT03508609|4076883|FG000|Overall Study|Withdrawal by Subject|1
2342922|NCT03508830|4076904|FG000|Overall Study|Withdrawal by Subject|3
2342923|NCT03508830|4076905|FG001|Overall Study|Withdrawal by Subject|4
2342924|NCT03508830|4076904|FG000|Overall Study|Physician Decision|2
2342925|NCT03508830|4076905|FG001|Overall Study|Physician Decision|2
2342926|NCT03508843|4076911|FG000|Overall Study|Withdrawal by Subject|1
2342927|NCT03508843|4076911|FG000|Overall Study|technical difficulties|2
2342928|NCT03509350|4076917|FG000|Overall Study|Withdrawal by Subject|0
2342929|NCT03509350|4076918|FG001|Overall Study|Withdrawal by Subject|2
2342930|NCT03509675|4076926|FG000|First Intervention (7 Days)|Lost to Follow-up|3
2342931|NCT03509675|4076927|FG001|First Intervention (7 Days)|Lost to Follow-up|3
2342932|NCT03509675|4076926|FG000|First Intervention (7 Days)|Lack of Efficacy|2
2342933|NCT03509675|4076927|FG001|First Intervention (7 Days)|Lack of Efficacy|1
2342934|NCT03509675|4076926|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1
2342935|NCT03509675|4076927|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0
2342936|NCT03509675|4076926|FG000|Second Intervention )7 Days)|Lost Rinse B|1
2342937|NCT03509675|4076927|FG001|Second Intervention )7 Days)|Lost Rinse B|0
2342938|NCT03509948|4076948|FG000|Overall Study|Protocol Violation|0
2342939|NCT03509948|4076949|FG001|Overall Study|Protocol Violation|1
2342940|NCT03510182|4076959|FG000|Overall Study|Withdrawal by Subject|2
2342941|NCT03510273|4076977|FG000|Overall Study|Withdrawal by Subject|2
2342942|NCT03510273|4076977|FG000|Overall Study|Care outside study, ineligible to cont.|3
2342943|NCT03510273|4076977|FG000|Overall Study|Moved away from study area|4
2342944|NCT03510455|4076985|FG000|Overall Study|Physician Decision|1
2342945|NCT03510663|4077018|FG000|Overall Study|Withdrawal by Subject|0
2342946|NCT03510663|4077019|FG001|Overall Study|Withdrawal by Subject|1
2342947|NCT03510663|4077020|FG002|Overall Study|Withdrawal by Subject|0
2342948|NCT03510663|4077021|FG003|Overall Study|Withdrawal by Subject|0
2342949|NCT03510663|4077022|FG004|Overall Study|Withdrawal by Subject|0
2342950|NCT03510663|4077023|FG005|Overall Study|Withdrawal by Subject|0
2342951|NCT03510663|4077024|FG006|Overall Study|Withdrawal by Subject|0
2342952|NCT03510663|4077025|FG007|Overall Study|Withdrawal by Subject|0
2342953|NCT03510715|4077037|FG000|Overall Study|Adverse Event|1
2342954|NCT03510715|4077038|FG001|Overall Study|Adverse Event|0
2342955|NCT03510910|4077047|FG000|Overall Study|Incomplete Survey|2
2254893|NCT02068222|3921155|FG000|Overall Study|Lost to Follow-up|1
2254894|NCT02068352|3921162|FG000|Overall Study|Lost to Follow-up|0
2254895|NCT02068352|3921163|FG001|Overall Study|Lost to Follow-up|2
2254896|NCT02068352|3921164|FG002|Overall Study|Lost to Follow-up|0
2254897|NCT02068352|3921162|FG000|Overall Study|Adverse Event|4
2254898|NCT02068352|3921163|FG001|Overall Study|Adverse Event|2
2254899|NCT02068352|3921164|FG002|Overall Study|Adverse Event|7
2254900|NCT02068352|3921162|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
2254901|NCT02068352|3921163|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1
2254902|NCT02068352|3921164|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
2254903|NCT02068352|3921162|FG000|Overall Study|Participant Withdrew Consent to Participate|6
2254904|NCT02068352|3921163|FG001|Overall Study|Participant Withdrew Consent to Participate|3
2254905|NCT02068352|3921164|FG002|Overall Study|Participant Withdrew Consent to Participate|1
2254906|NCT02068352|3921162|FG000|Overall Study|Protocol Deviation|0
2254907|NCT02068352|3921163|FG001|Overall Study|Protocol Deviation|0
2254908|NCT02068352|3921164|FG002|Overall Study|Protocol Deviation|1
2254909|NCT02068443|3921175|FG000|Overall Study|Pretreatment Event/Adverse Event|0
2254910|NCT02068443|3921176|FG001|Overall Study|Pretreatment Event/Adverse Event|5
2254911|NCT02068443|3921177|FG002|Overall Study|Pretreatment Event/Adverse Event|2
2254912|NCT02068443|3921175|FG000|Overall Study|Voluntary Withdrawal|4
2254913|NCT02068443|3921176|FG001|Overall Study|Voluntary Withdrawal|0
2254914|NCT02068443|3921177|FG002|Overall Study|Voluntary Withdrawal|1
2254915|NCT02068443|3921175|FG000|Overall Study|Lack of Efficacy|2
2254916|NCT02068443|3921176|FG001|Overall Study|Lack of Efficacy|1
2254917|NCT02068443|3921177|FG002|Overall Study|Lack of Efficacy|0
2254918|NCT02068443|3921175|FG000|Overall Study|Other Reason Not Specified|1
2254919|NCT02068443|3921176|FG001|Overall Study|Other Reason Not Specified|0
2254920|NCT02068443|3921177|FG002|Overall Study|Other Reason Not Specified|0
2342956|NCT03510910|4077048|FG001|Overall Study|Incomplete Survey|3
2342957|NCT03511053|4077063|FG000|Overall Study|Withdrawal by Subject|1
2342958|NCT03511105|4077069|FG000|Overall Study|Adverse Event|1
2342959|NCT03511105|4077070|FG001|Overall Study|Adverse Event|0
2342960|NCT03511105|4077069|FG000|Overall Study|Withdrew consent|1
2342961|NCT03511105|4077070|FG001|Overall Study|Withdrew consent|0
2342962|NCT03511326|4077077|FG000|Overall Study|Withdrawal by Subject|1
2342963|NCT03511378|4077083|FG000|Overall Study|Withdrawal by Subject|2
2342964|NCT03511378|4077084|FG001|Overall Study|Withdrawal by Subject|2
2342965|NCT03511378|4077083|FG000|Overall Study|Patient not coming or schedule visit|1
2342966|NCT03511378|4077084|FG001|Overall Study|Patient not coming or schedule visit|0
2342967|NCT03512028|4077121|FG000|Overall Study|Withdrawal by Subject|2
2342968|NCT03512028|4077122|FG001|Overall Study|Withdrawal by Subject|0
2342969|NCT03512028|4077121|FG000|Overall Study|Protocol Violation|2
2342970|NCT03512028|4077122|FG001|Overall Study|Protocol Violation|0
2342971|NCT03512288|4077151|FG000|Overall Study|Adverse Event|1
2342972|NCT03512288|4077152|FG001|Overall Study|Adverse Event|0
2342973|NCT03512288|4077151|FG000|Overall Study|Lost to Follow-up|12
2342974|NCT03512288|4077152|FG001|Overall Study|Lost to Follow-up|15
2342975|NCT03512288|4077151|FG000|Overall Study|Physician Decision|0
2342976|NCT03512288|4077152|FG001|Overall Study|Physician Decision|2
2342977|NCT03512288|4077151|FG000|Overall Study|Protocol Violation|6
2342978|NCT03512288|4077152|FG001|Overall Study|Protocol Violation|4
2342979|NCT03512288|4077151|FG000|Overall Study|Medication error without associated adverse event|1
2342980|NCT03512288|4077152|FG001|Overall Study|Medication error without associated adverse event|0
2342981|NCT03512288|4077151|FG000|Overall Study|No longer met eligibility criteria|5
2342982|NCT03512288|4077152|FG001|Overall Study|No longer met eligibility criteria|2
2342983|NCT03512288|4077151|FG000|Overall Study|Withdrawal by parent/guardian|14
2342984|NCT03512288|4077152|FG001|Overall Study|Withdrawal by parent/guardian|18
2342985|NCT03512288|4077151|FG000|Overall Study|Other|1
2342986|NCT03512288|4077152|FG001|Overall Study|Other|1
2342987|NCT03512288|4077151|FG000|Overall Study|Randomized but not treated|1
2342988|NCT03512288|4077152|FG001|Overall Study|Randomized but not treated|1
2342989|NCT03512353|4077158|FG000|Overall Study|Sponsor Decision|3
2342990|NCT03512353|4077158|FG000|Overall Study|Death|1
2342991|NCT03513588|4077178|FG000|Overall Study|Lost to Follow-up|0
2342992|NCT03513588|4077179|FG001|Overall Study|Lost to Follow-up|1
2342993|NCT03513588|4077180|FG002|Overall Study|Lost to Follow-up|1
2342994|NCT03513588|4077178|FG000|Overall Study|Study dosing paused by sponsor|1
2342995|NCT03513588|4077179|FG001|Overall Study|Study dosing paused by sponsor|1
2342996|NCT03513588|4077180|FG002|Overall Study|Study dosing paused by sponsor|0
2342997|NCT03513588|4077178|FG000|Overall Study|Death|0
2342998|NCT03513588|4077179|FG001|Overall Study|Death|0
2342999|NCT03513588|4077180|FG002|Overall Study|Death|1
2343000|NCT03514641|4077232|FG000|603A: 0-12 Week Study Period|Protocol Violation|3
2343001|NCT03514641|4077233|FG001|603A: 0-12 Week Study Period|Protocol Violation|3
2343002|NCT03514641|4077234|FG002|603A: 0-12 Week Study Period|Protocol Violation|0
2343003|NCT03514641|4077235|FG003|603A: 0-12 Week Study Period|Protocol Violation|0
2343004|NCT03514641|4077232|FG000|603A: 0-12 Week Study Period|Adverse Event|5
2343005|NCT03514641|4077233|FG001|603A: 0-12 Week Study Period|Adverse Event|2
2343006|NCT03514641|4077234|FG002|603A: 0-12 Week Study Period|Adverse Event|0
2343007|NCT03514641|4077235|FG003|603A: 0-12 Week Study Period|Adverse Event|0
2343008|NCT03514641|4077232|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7
2254921|NCT02068495|3921185|FG000|Overall Study|Case Report Forms Uncollected|60
2254922|NCT02068495|3921185|FG000|Overall Study|Protocol Deviation|49
2254923|NCT02068508|3921189|FG000|Overall Study|Case report forms uncollected|27
2254924|NCT02068508|3921189|FG000|Overall Study|Patient did not visit the study site|1
2254925|NCT02068508|3921189|FG000|Overall Study|Protocol Violation|4
2254926|NCT02068599|3921196|FG000|Overall Study|Adverse Event|4
2343009|NCT03514641|4077233|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5
2343010|NCT03514641|4077234|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0
2343011|NCT03514641|4077235|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0
2343012|NCT03514641|4077232|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10
2343013|NCT03514641|4077233|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9
2343014|NCT03514641|4077234|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0
2343015|NCT03514641|4077235|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0
2343016|NCT03514641|4077232|FG000|603A: 0-12 Week Study Period|Physician Decision|1
2343017|NCT03514641|4077233|FG001|603A: 0-12 Week Study Period|Physician Decision|0
2343018|NCT03514641|4077234|FG002|603A: 0-12 Week Study Period|Physician Decision|0
2343019|NCT03514641|4077235|FG003|603A: 0-12 Week Study Period|Physician Decision|0
2343020|NCT03514641|4077232|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1
2343021|NCT03514641|4077233|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0
2038929|NCT00424346|3609248|FG002|Extension Phase|Lost to Follow-up|0
2038930|NCT00424346|3609249|FG003|Extension Phase|Lost to Follow-up|0
2038931|NCT00424346|3609246|FG000|Extension Phase|Administrative Problems|0
2038932|NCT00424346|3609247|FG001|Extension Phase|Administrative Problems|69
2038933|NCT00424346|3609248|FG002|Extension Phase|Administrative Problems|32
2038934|NCT00424346|3609249|FG003|Extension Phase|Administrative Problems|35
2038935|NCT00424346|3609246|FG000|Extension Phase|Death|0
2038936|NCT00424346|3609247|FG001|Extension Phase|Death|0
2038937|NCT00424346|3609248|FG002|Extension Phase|Death|0
2038938|NCT00424346|3609249|FG003|Extension Phase|Death|1
2038939|NCT00424346|3609246|FG000|Extension Phase|Protocol Violation|0
2038940|NCT00424346|3609247|FG001|Extension Phase|Protocol Violation|1
2038941|NCT00424346|3609248|FG002|Extension Phase|Protocol Violation|1
2038942|NCT00424346|3609249|FG003|Extension Phase|Protocol Violation|0
2038943|NCT00424372|3609262|FG000|Overall Study|Death|1
2038944|NCT00424372|3609262|FG000|Overall Study|Adverse Event|18
2038945|NCT00424372|3609262|FG000|Overall Study|Lack of Efficacy|6
2038946|NCT00424372|3609262|FG000|Overall Study|Withdrawal by Subject|4
2038947|NCT00424372|3609262|FG000|Overall Study|Protocol Violation|1
2038948|NCT00424372|3609262|FG000|Overall Study|Health deterioration|1
2038949|NCT00424385|3609266|FG000|Cohort 0|Withdrawal by Subject|5
2038950|NCT00424385|3609266|FG000|Cohort 0|Physician Decision|1
2038951|NCT00424385|3609266|FG000|Cohort 1|Withdrawal by Subject|1
2038952|NCT00424398|3609275|FG000|Overall Study|Withdrawal by Subject|2
2038953|NCT00424398|3609276|FG001|Overall Study|Withdrawal by Subject|1
2038954|NCT00424398|3609277|FG002|Overall Study|Withdrawal by Subject|0
2038955|NCT00424398|3609275|FG000|Overall Study|Subject met exclusion criteria|1
2038956|NCT00424398|3609276|FG001|Overall Study|Subject met exclusion criteria|0
2038957|NCT00424398|3609277|FG002|Overall Study|Subject met exclusion criteria|0
2038958|NCT00424463|3609288|FG000|Overall Study|Adverse Event|2
2038959|NCT00424463|3609289|FG001|Overall Study|Adverse Event|3
2038960|NCT00424463|3609290|FG002|Overall Study|Adverse Event|2
2038961|NCT00424463|3609288|FG000|Overall Study|Physician Decision|0
2038962|NCT00424463|3609289|FG001|Overall Study|Physician Decision|2
2038963|NCT00424463|3609290|FG002|Overall Study|Physician Decision|2
2038964|NCT00424463|3609288|FG000|Overall Study|Withdrawal by Subject|4
2038965|NCT00424463|3609289|FG001|Overall Study|Withdrawal by Subject|2
2038966|NCT00424463|3609290|FG002|Overall Study|Withdrawal by Subject|5
2038967|NCT00424463|3609288|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
2038968|NCT00424463|3609289|FG001|Overall Study|Tracheotomy due to worsening of ALS|7
2038969|NCT00424463|3609290|FG002|Overall Study|Tracheotomy due to worsening of ALS|6
2038970|NCT00424463|3609288|FG000|Overall Study|Patient's convenience|0
2038971|NCT00424463|3609289|FG001|Overall Study|Patient's convenience|0
2038972|NCT00424463|3609290|FG002|Overall Study|Patient's convenience|1
2038973|NCT00424476|3609301|FG000|Overall Study|Withdrawal by Subject|7
2038974|NCT00424476|3609302|FG001|Overall Study|Withdrawal by Subject|6
2038975|NCT00424476|3609303|FG002|Overall Study|Withdrawal by Subject|3
2038976|NCT00424476|3609301|FG000|Overall Study|Adverse Event|19
2038977|NCT00424476|3609302|FG001|Overall Study|Adverse Event|16
2038978|NCT00424476|3609303|FG002|Overall Study|Adverse Event|15
2038979|NCT00424476|3609301|FG000|Overall Study|Lack of Efficacy|16
2038980|NCT00424476|3609302|FG001|Overall Study|Lack of Efficacy|12
2038981|NCT00424476|3609303|FG002|Overall Study|Lack of Efficacy|12
2038982|NCT00424476|3609301|FG000|Overall Study|Lack of Compliance|1
2038983|NCT00424476|3609302|FG001|Overall Study|Lack of Compliance|1
2038984|NCT00424476|3609303|FG002|Overall Study|Lack of Compliance|1
2038985|NCT00424476|3609301|FG000|Overall Study|Lost to Follow-up|4
2038986|NCT00424476|3609302|FG001|Overall Study|Lost to Follow-up|6
2038987|NCT00424476|3609303|FG002|Overall Study|Lost to Follow-up|3
2038988|NCT00424476|3609301|FG000|Overall Study|Protocol Violation|7
2038989|NCT00424476|3609302|FG001|Overall Study|Protocol Violation|2
2038990|NCT00424476|3609303|FG002|Overall Study|Protocol Violation|3
2038991|NCT00424476|3609301|FG000|Overall Study|Physician Decision|3
2254927|NCT02068599|3921197|FG001|Overall Study|Adverse Event|1
2254928|NCT02068599|3921198|FG002|Overall Study|Adverse Event|1
2254929|NCT02068599|3921196|FG000|Overall Study|Withdrawal by Subject|2
2254930|NCT02068599|3921197|FG001|Overall Study|Withdrawal by Subject|7
2254931|NCT02068599|3921198|FG002|Overall Study|Withdrawal by Subject|5
2254932|NCT02068599|3921196|FG000|Overall Study|Protocol Violation|4
2254933|NCT02068599|3921197|FG001|Overall Study|Protocol Violation|2
2254934|NCT02068599|3921198|FG002|Overall Study|Protocol Violation|3
2254935|NCT02068599|3921196|FG000|Overall Study|Lost to Follow-up|1
2254936|NCT02068599|3921197|FG001|Overall Study|Lost to Follow-up|0
2254937|NCT02068599|3921198|FG002|Overall Study|Lost to Follow-up|0
2254938|NCT02068599|3921196|FG000|Overall Study|Lack of Efficacy|0
2254939|NCT02068599|3921197|FG001|Overall Study|Lack of Efficacy|0
2254940|NCT02068599|3921198|FG002|Overall Study|Lack of Efficacy|3
2254941|NCT02068599|3921196|FG000|Overall Study|Noncompliance|0
2254942|NCT02068599|3921197|FG001|Overall Study|Noncompliance|0
2254943|NCT02068599|3921198|FG002|Overall Study|Noncompliance|1
2254944|NCT02068768|3921265|FG000|Overall Study|Lost to Follow-up|5
2254945|NCT02068768|3921265|FG000|Overall Study|Early Termination by Sponsor|2
2254946|NCT02068885|3921295|FG000|Overall Study|Withdrew|3
2254947|NCT02068885|3921296|FG001|Overall Study|Withdrew|5
2254948|NCT02068885|3921297|FG002|Overall Study|Withdrew|8
2254949|NCT02069015|3921308|FG000|Overall Study|Lost to Follow-up|39
2254950|NCT02069015|3921309|FG001|Overall Study|Lost to Follow-up|32
2254951|NCT02069015|3921308|FG000|Overall Study|Withdrawal by Subject|1
2254952|NCT02069015|3921309|FG001|Overall Study|Withdrawal by Subject|1
2254953|NCT02069093|3921320|FG000|Overall Study|Disease progression|14
2254954|NCT02069093|3921320|FG000|Overall Study|New cancer therapy|1
2254955|NCT02069093|3921320|FG000|Overall Study|Death|1
2254956|NCT02069093|3921320|FG000|Overall Study|Administrative problems|1
2254957|NCT02069093|3921320|FG000|Overall Study|Withdrawal by Subject|2
2254958|NCT02069093|3921320|FG000|Overall Study|Abnormal laboratory values|1
2254959|NCT02069093|3921320|FG000|Overall Study|Adverse Event|10
2254960|NCT02069379|3921358|FG000|Baseline Measurements|Lost to Follow-up|1
2254961|NCT02069379|3921359|FG001|Baseline Measurements|Lost to Follow-up|0
2254962|NCT02069379|3921360|FG002|Baseline Measurements|Lost to Follow-up|0
2254963|NCT02069379|3921361|FG003|Baseline Measurements|Lost to Follow-up|0
2254964|NCT02069379|3921358|FG000|Baseline Measurements|Ineligible based on initial assessments|2
2254965|NCT02069379|3921359|FG001|Baseline Measurements|Ineligible based on initial assessments|0
2254966|NCT02069379|3921360|FG002|Baseline Measurements|Ineligible based on initial assessments|0
2254967|NCT02069379|3921361|FG003|Baseline Measurements|Ineligible based on initial assessments|2
2254968|NCT02069379|3921358|FG000|First Treatment Arm|Lost to Follow-up|0
2254969|NCT02069379|3921359|FG001|First Treatment Arm|Lost to Follow-up|1
2254970|NCT02069379|3921360|FG002|First Treatment Arm|Lost to Follow-up|1
2254971|NCT02069379|3921361|FG003|First Treatment Arm|Lost to Follow-up|0
2254972|NCT02069379|3921358|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0
2254973|NCT02069379|3921359|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
2254974|NCT02069379|3921360|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0
2254975|NCT02069379|3921361|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0
2254976|NCT02069379|3921358|FG000|Washout Period (4 Weeks)|Unrelated event|0
2254977|NCT02069379|3921359|FG001|Washout Period (4 Weeks)|Unrelated event|1
2254978|NCT02069379|3921360|FG002|Washout Period (4 Weeks)|Unrelated event|0
2254979|NCT02069379|3921361|FG003|Washout Period (4 Weeks)|Unrelated event|0
2254980|NCT02069379|3921358|FG000|Second Treatment Arm|Lost to Follow-up|0
2254981|NCT02069379|3921359|FG001|Second Treatment Arm|Lost to Follow-up|0
2254982|NCT02069379|3921360|FG002|Second Treatment Arm|Lost to Follow-up|1
2254983|NCT02069379|3921361|FG003|Second Treatment Arm|Lost to Follow-up|0
2254984|NCT02069392|3921373|FG000|Overall Study|Withdrawal by Subject|4
2254985|NCT02069392|3921374|FG001|Overall Study|Withdrawal by Subject|2
2254986|NCT02070380|3921441|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
2254987|NCT02070380|3921442|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
2254988|NCT02070380|3921443|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
2254989|NCT02070380|3921444|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
2254990|NCT02070380|3921441|FG000|Second Injection|Image sets missing or technically inadeq|0
2254991|NCT02070380|3921442|FG001|Second Injection|Image sets missing or technically inadeq|1
2254992|NCT02070380|3921443|FG002|Second Injection|Image sets missing or technically inadeq|0
2254993|NCT02070380|3921444|FG003|Second Injection|Image sets missing or technically inadeq|0
2254994|NCT02070380|3921441|FG000|Second Injection|Protocol Violation|0
2254995|NCT02070380|3921442|FG001|Second Injection|Protocol Violation|1
2254996|NCT02070380|3921443|FG002|Second Injection|Protocol Violation|1
2254997|NCT02070380|3921444|FG003|Second Injection|Protocol Violation|5
2254998|NCT02070484|3921458|FG000|Overall Study|Withdrawal by Subject|1
2254999|NCT02070484|3921459|FG001|Overall Study|Withdrawal by Subject|0
2255000|NCT02070588|3921468|FG000|Overall Study|Withdrawal by Subject|29
2255001|NCT02070588|3921469|FG001|Overall Study|Withdrawal by Subject|1
2343022|NCT03514641|4077234|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0
2255002|NCT02070588|3921470|FG002|Overall Study|Withdrawal by Subject|0
2255003|NCT02070588|3921468|FG000|Overall Study|Writhdrawal due to early termination|9
2255004|NCT02070588|3921469|FG001|Overall Study|Writhdrawal due to early termination|0
2255005|NCT02070588|3921470|FG002|Overall Study|Writhdrawal due to early termination|0
2255006|NCT02070588|3921468|FG000|Overall Study|Adverse Event|1
2255007|NCT02070588|3921469|FG001|Overall Study|Adverse Event|0
2255008|NCT02070588|3921470|FG002|Overall Study|Adverse Event|0
2255009|NCT02070744|3921501|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0
2255010|NCT02070744|3921502|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0
2255011|NCT02070744|3921503|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0
2255012|NCT02070744|3921504|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1
2255013|NCT02070744|3921505|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0
2255014|NCT02070744|3921501|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2255015|NCT02070744|3921502|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2255016|NCT02070744|3921503|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2255017|NCT02070744|3921504|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2255018|NCT02070744|3921505|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2
2255019|NCT02070744|3921501|FG000|OLE Phase (48 Weeks)|Other|0
2255020|NCT02070744|3921502|FG001|OLE Phase (48 Weeks)|Other|0
2255021|NCT02070744|3921503|FG002|OLE Phase (48 Weeks)|Other|0
2255022|NCT02070744|3921504|FG003|OLE Phase (48 Weeks)|Other|0
2255023|NCT02070744|3921505|FG004|OLE Phase (48 Weeks)|Other|1
2255024|NCT02070757|3921522|FG000|Overall Study|Adverse Event|107
2255025|NCT02070757|3921523|FG001|Overall Study|Adverse Event|99
2255026|NCT02070757|3921522|FG000|Overall Study|Lost to Follow-up|7
2255027|NCT02070757|3921523|FG001|Overall Study|Lost to Follow-up|4
2255028|NCT02070757|3921522|FG000|Overall Study|Protocol Violation|0
2255029|NCT02070757|3921523|FG001|Overall Study|Protocol Violation|4
2343023|NCT03514641|4077235|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0
2343024|NCT03514641|4077232|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
2343025|NCT03514641|4077233|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1
2343026|NCT03514641|4077234|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
2343027|NCT03514641|4077235|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
2343028|NCT03514641|4077232|FG000|603B: 24-36 Week Study Period|Protocol Violation|0
2343029|NCT03514641|4077233|FG001|603B: 24-36 Week Study Period|Protocol Violation|0
2343030|NCT03514641|4077234|FG002|603B: 24-36 Week Study Period|Protocol Violation|0
2343031|NCT03514641|4077235|FG003|603B: 24-36 Week Study Period|Protocol Violation|2
2343032|NCT03514641|4077232|FG000|603B: 24-36 Week Study Period|Adverse Event|0
2343033|NCT03514641|4077233|FG001|603B: 24-36 Week Study Period|Adverse Event|0
2343034|NCT03514641|4077234|FG002|603B: 24-36 Week Study Period|Adverse Event|3
2343035|NCT03514641|4077235|FG003|603B: 24-36 Week Study Period|Adverse Event|1
2343036|NCT03514641|4077232|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0
2343037|NCT03514641|4077233|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0
2343038|NCT03514641|4077234|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2
2343039|NCT03514641|4077235|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3
2343040|NCT03514641|4077232|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0
2343041|NCT03514641|4077233|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0
2343042|NCT03514641|4077234|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6
2343043|NCT03514641|4077235|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6
2343044|NCT03514641|4077232|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
2343045|NCT03514641|4077233|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
2343046|NCT03514641|4077234|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
2343047|NCT03514641|4077235|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
2343048|NCT03515824|4077268|FG000|Overall Study|Death|3
2343049|NCT03515824|4077269|FG001|Overall Study|Death|2
2343050|NCT03515824|4077270|FG002|Overall Study|Death|6
2343051|NCT03515824|4077271|FG003|Overall Study|Death|0
2343052|NCT03515824|4077268|FG000|Overall Study|Lost to Follow-up|0
2343053|NCT03515824|4077269|FG001|Overall Study|Lost to Follow-up|1
2343054|NCT03515824|4077270|FG002|Overall Study|Lost to Follow-up|1
2343055|NCT03515824|4077271|FG003|Overall Study|Lost to Follow-up|0
2343056|NCT03515824|4077268|FG000|Overall Study|Study terminated by sponsor|0
2343057|NCT03515824|4077269|FG001|Overall Study|Study terminated by sponsor|1
2343058|NCT03515824|4077270|FG002|Overall Study|Study terminated by sponsor|6
2343059|NCT03515824|4077271|FG003|Overall Study|Study terminated by sponsor|0
2343060|NCT03515824|4077268|FG000|Overall Study|Status not recorded|0
2343061|NCT03515824|4077269|FG001|Overall Study|Status not recorded|0
2343062|NCT03515824|4077270|FG002|Overall Study|Status not recorded|2
2343063|NCT03515824|4077271|FG003|Overall Study|Status not recorded|0
2343064|NCT03515941|4077281|FG000|Overall Study|Adverse Event|1
2343065|NCT03515941|4077282|FG001|Overall Study|Adverse Event|0
2343066|NCT03517436|4077298|FG000|Overall Study|Death|3
2343067|NCT03517436|4077298|FG000|Overall Study|Withdrawal by Subject|4
2343068|NCT03517436|4077298|FG000|Overall Study|Did not receive study valve.|1
2343069|NCT03517566|4077307|FG000|Overall Study|Adverse Event|5
2343070|NCT03517566|4077308|FG001|Overall Study|Adverse Event|2
2343071|NCT03517566|4077309|FG002|Overall Study|Adverse Event|2
2343072|NCT03517566|4077310|FG003|Overall Study|Adverse Event|8
2343073|NCT03517566|4077311|FG004|Overall Study|Adverse Event|7
2343074|NCT03517566|4077307|FG000|Overall Study|Lack of Efficacy|3
2255030|NCT02070757|3921522|FG000|Overall Study|Withdrawal by Subject|1
2255031|NCT02070757|3921523|FG001|Overall Study|Withdrawal by Subject|3
2255032|NCT02070757|3921522|FG000|Overall Study|Investigator Decision|0
2255033|NCT02070757|3921523|FG001|Overall Study|Investigator Decision|2
2255034|NCT02070757|3921522|FG000|Overall Study|Discharged from Study Hospital|2
2255035|NCT02070757|3921523|FG001|Overall Study|Discharged from Study Hospital|2
2255036|NCT02070965|3921532|FG000|Overall Study|Lost to Follow-up|0
2255037|NCT02070965|3921533|FG001|Overall Study|Lost to Follow-up|1
2255038|NCT02070965|3921534|FG002|Overall Study|Lost to Follow-up|0
2255039|NCT02070965|3921532|FG000|Overall Study|Withdrawal by Subject|1
2255040|NCT02070965|3921533|FG001|Overall Study|Withdrawal by Subject|1
2255041|NCT02070965|3921534|FG002|Overall Study|Withdrawal by Subject|1
2255042|NCT02070965|3921532|FG000|Overall Study|Subject moved|1
2255043|NCT02070965|3921533|FG001|Overall Study|Subject moved|0
2255044|NCT02070965|3921534|FG002|Overall Study|Subject moved|0
2255045|NCT02070978|3921545|FG000|Overall Study|Adverse Event|6
2255046|NCT02070978|3921546|FG001|Overall Study|Adverse Event|2
2255047|NCT02070978|3921547|FG002|Overall Study|Adverse Event|0
2255048|NCT02070978|3921545|FG000|Overall Study|Lost to Follow-up|1
2255049|NCT02070978|3921546|FG001|Overall Study|Lost to Follow-up|3
2255050|NCT02070978|3921547|FG002|Overall Study|Lost to Follow-up|4
2255051|NCT02070978|3921545|FG000|Overall Study|Withdrawal by Subject|3
2255052|NCT02070978|3921546|FG001|Overall Study|Withdrawal by Subject|5
2255053|NCT02070978|3921547|FG002|Overall Study|Withdrawal by Subject|3
2255054|NCT02070978|3921545|FG000|Overall Study|Protocol Violation|1
2255055|NCT02070978|3921546|FG001|Overall Study|Protocol Violation|0
2255056|NCT02070978|3921547|FG002|Overall Study|Protocol Violation|3
2255057|NCT02070978|3921545|FG000|Overall Study|Lack of Efficacy|0
2255058|NCT02070978|3921546|FG001|Overall Study|Lack of Efficacy|1
2255059|NCT02070978|3921547|FG002|Overall Study|Lack of Efficacy|0
2255060|NCT02070978|3921545|FG000|Overall Study|Death|0
2255061|NCT02070978|3921546|FG001|Overall Study|Death|0
2255062|NCT02070978|3921547|FG002|Overall Study|Death|2
2255063|NCT02070978|3921545|FG000|Overall Study|Un-specified|3
2255064|NCT02070978|3921546|FG001|Overall Study|Un-specified|2
2255065|NCT02070978|3921547|FG002|Overall Study|Un-specified|2
2255066|NCT02070978|3921545|FG000|Overall Study|Terminated by Sponsor|33
2255067|NCT02070978|3921546|FG001|Overall Study|Terminated by Sponsor|40
2255068|NCT02070978|3921547|FG002|Overall Study|Terminated by Sponsor|39
2255069|NCT02070991|3921557|FG000|Overall Study|Death|2
2255070|NCT02070991|3921558|FG001|Overall Study|Death|0
2255071|NCT02070991|3921557|FG000|Overall Study|Withdrawal by Subject|1
2255072|NCT02070991|3921558|FG001|Overall Study|Withdrawal by Subject|0
2255073|NCT02071082|3921566|FG000|Overall Study|Enrolled and Never Treated|1
2255074|NCT02071082|3921567|FG001|Overall Study|Enrolled and Never Treated|1
2255075|NCT02071082|3921566|FG000|Overall Study|Adverse Event|0
2255076|NCT02071082|3921567|FG001|Overall Study|Adverse Event|1
2255077|NCT02071082|3921566|FG000|Overall Study|Withdrew Consent|0
2255078|NCT02071082|3921567|FG001|Overall Study|Withdrew Consent|4
2255079|NCT02071082|3921566|FG000|Overall Study|Lost to Follow-up|1
2255080|NCT02071082|3921567|FG001|Overall Study|Lost to Follow-up|1
2255081|NCT02071225|3921591|FG000|Overall Study|Withdrawal of Consent|2
2255082|NCT02071225|3921591|FG000|Overall Study|Protocol Deviation|1
2255083|NCT02071225|3921591|FG000|Overall Study|Lost to Follow-up|2
2255084|NCT02071225|3921591|FG000|Overall Study|Death|25
2255085|NCT02071290|3921597|FG000|Overall Study|Death|1
2255086|NCT02071290|3921598|FG001|Overall Study|Death|0
2255087|NCT02071290|3921597|FG000|Overall Study|Withdrawal by Subject|0
2255088|NCT02071290|3921598|FG001|Overall Study|Withdrawal by Subject|1
2255089|NCT02071290|3921597|FG000|Overall Study|Protocol Violation|3
2255090|NCT02071290|3921598|FG001|Overall Study|Protocol Violation|5
2255091|NCT02071290|3921597|FG000|Overall Study|Physician Decision|0
2255092|NCT02071290|3921598|FG001|Overall Study|Physician Decision|1
2255093|NCT02071706|3921613|FG000|Overall Study|Adverse Event|1
2255094|NCT02071706|3921613|FG000|Overall Study|Withdrawal by Subject|2
2255095|NCT02071771|3921617|FG000|Period 1: First 10 Days|Unacceptable lens fit|1
2255096|NCT02071771|3921618|FG001|Period 1: First 10 Days|Unacceptable lens fit|0
2255097|NCT02071771|3921617|FG000|Period 1: First 10 Days|Unavailable lens power|1
2255098|NCT02071771|3921618|FG001|Period 1: First 10 Days|Unavailable lens power|0
2255099|NCT02071849|3921656|FG000|6-month Primary Endpoint|Did not receive device|4
2255100|NCT02071849|3921656|FG000|6-month Primary Endpoint|Adverse Event|1
2255101|NCT02071849|3921656|FG000|2-year Extended Follow-up|Adverse Event|1
2255102|NCT02072096|3921675|FG000|Overall Study|Lack of Efficacy|18
2255103|NCT02072096|3921676|FG001|Overall Study|Lack of Efficacy|29
2255104|NCT02072096|3921675|FG000|Overall Study|Protocol Violation|7
2255105|NCT02072096|3921676|FG001|Overall Study|Protocol Violation|7
2255106|NCT02072096|3921675|FG000|Overall Study|Withdrawal by Subject|5
2255107|NCT02072096|3921676|FG001|Overall Study|Withdrawal by Subject|7
2255108|NCT02072096|3921675|FG000|Overall Study|Adverse Event|5
2255109|NCT02072096|3921676|FG001|Overall Study|Adverse Event|2
2255110|NCT02072096|3921675|FG000|Overall Study|No Reason Provided|4
2255111|NCT02072096|3921676|FG001|Overall Study|No Reason Provided|2
2255112|NCT02072096|3921675|FG000|Overall Study|Death|2
2255113|NCT02072096|3921676|FG001|Overall Study|Death|0
2255114|NCT02072096|3921675|FG000|Overall Study|Physician Decision|0
2255115|NCT02072096|3921676|FG001|Overall Study|Physician Decision|1
2255116|NCT02072096|3921675|FG000|Overall Study|Study Terminated by Sponsor|43
2255117|NCT02072096|3921676|FG001|Overall Study|Study Terminated by Sponsor|30
2255118|NCT02072096|3921675|FG000|Overall Study|Lost to Follow-up|1
2255119|NCT02072096|3921676|FG001|Overall Study|Lost to Follow-up|0
2255120|NCT02072174|3921685|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14
2255121|NCT02072174|3921686|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15
2255122|NCT02072174|3921685|FG000|Overall Study|Protocol Violation|16
2255123|NCT02072174|3921686|FG001|Overall Study|Protocol Violation|23
2255124|NCT02072174|3921685|FG000|Overall Study|Physician Decision|0
2255125|NCT02072174|3921686|FG001|Overall Study|Physician Decision|1
2255126|NCT02072174|3921685|FG000|Overall Study|Non-compliance with protocol requirement|2
2255127|NCT02072174|3921686|FG001|Overall Study|Non-compliance with protocol requirement|0
2255128|NCT02072226|3921700|FG000|Overall Study|Lost to Follow-up|11
2343075|NCT03517566|4077308|FG001|Overall Study|Lack of Efficacy|2
2343076|NCT03517566|4077309|FG002|Overall Study|Lack of Efficacy|1
2343077|NCT03517566|4077310|FG003|Overall Study|Lack of Efficacy|1
2343078|NCT03517566|4077311|FG004|Overall Study|Lack of Efficacy|4
2343079|NCT03517566|4077307|FG000|Overall Study|Lost to Follow-up|3
2343080|NCT03517566|4077308|FG001|Overall Study|Lost to Follow-up|1
2343081|NCT03517566|4077309|FG002|Overall Study|Lost to Follow-up|1
2343082|NCT03517566|4077310|FG003|Overall Study|Lost to Follow-up|1
2343083|NCT03517566|4077311|FG004|Overall Study|Lost to Follow-up|0
2343084|NCT03517566|4077307|FG000|Overall Study|Physician Decision|1
2343085|NCT03517566|4077308|FG001|Overall Study|Physician Decision|1
2343086|NCT03517566|4077309|FG002|Overall Study|Physician Decision|0
2343087|NCT03517566|4077310|FG003|Overall Study|Physician Decision|1
2343088|NCT03517566|4077311|FG004|Overall Study|Physician Decision|0
2343089|NCT03517566|4077307|FG000|Overall Study|Pregnancy|0
2343090|NCT03517566|4077308|FG001|Overall Study|Pregnancy|1
2343091|NCT03517566|4077309|FG002|Overall Study|Pregnancy|0
2343092|NCT03517566|4077310|FG003|Overall Study|Pregnancy|0
2343093|NCT03517566|4077311|FG004|Overall Study|Pregnancy|0
2343094|NCT03517566|4077307|FG000|Overall Study|Protocol Deviation|0
2343095|NCT03517566|4077308|FG001|Overall Study|Protocol Deviation|1
2343096|NCT03517566|4077309|FG002|Overall Study|Protocol Deviation|0
2343097|NCT03517566|4077310|FG003|Overall Study|Protocol Deviation|1
2343098|NCT03517566|4077311|FG004|Overall Study|Protocol Deviation|1
2343099|NCT03517566|4077307|FG000|Overall Study|Study terminated by Sponsor|11
2343100|NCT03517566|4077308|FG001|Overall Study|Study terminated by Sponsor|5
2343101|NCT03517566|4077309|FG002|Overall Study|Study terminated by Sponsor|6
2343102|NCT03517566|4077310|FG003|Overall Study|Study terminated by Sponsor|14
2343103|NCT03517566|4077311|FG004|Overall Study|Study terminated by Sponsor|12
2343104|NCT03517566|4077307|FG000|Overall Study|Subject Decision /Guardian Decision|9
2343105|NCT03517566|4077308|FG001|Overall Study|Subject Decision /Guardian Decision|8
2343106|NCT03517566|4077309|FG002|Overall Study|Subject Decision /Guardian Decision|5
2343107|NCT03517566|4077310|FG003|Overall Study|Subject Decision /Guardian Decision|8
2343108|NCT03517566|4077311|FG004|Overall Study|Subject Decision /Guardian Decision|8
2343109|NCT03518008|4077324|FG000|Period 2, Second Week of Wear|Family emergency|0
2343110|NCT03518008|4077325|FG001|Period 2, Second Week of Wear|Family emergency|1
2343111|NCT03518125|4077337|FG000|Overall Study|Lost to Follow-up|0
2343112|NCT03518125|4077338|FG001|Overall Study|Lost to Follow-up|2
2343113|NCT03518125|4077339|FG002|Overall Study|Lost to Follow-up|0
2343114|NCT03518125|4077340|FG003|Overall Study|Lost to Follow-up|0
2343115|NCT03518125|4077341|FG004|Overall Study|Lost to Follow-up|3
2343116|NCT03518125|4077342|FG005|Overall Study|Lost to Follow-up|5
2343117|NCT03518125|4077337|FG000|Overall Study|Physician Decision|0
2343118|NCT03518125|4077338|FG001|Overall Study|Physician Decision|1
2343119|NCT03518125|4077339|FG002|Overall Study|Physician Decision|0
2343120|NCT03518125|4077340|FG003|Overall Study|Physician Decision|0
2343121|NCT03518125|4077341|FG004|Overall Study|Physician Decision|0
2343122|NCT03518125|4077342|FG005|Overall Study|Physician Decision|0
2343123|NCT03518125|4077337|FG000|Overall Study|Withdrawal by Subject|1
2343124|NCT03518125|4077338|FG001|Overall Study|Withdrawal by Subject|1
2343125|NCT03518125|4077339|FG002|Overall Study|Withdrawal by Subject|0
2343126|NCT03518125|4077340|FG003|Overall Study|Withdrawal by Subject|1
2343127|NCT03518125|4077341|FG004|Overall Study|Withdrawal by Subject|1
2343128|NCT03518125|4077342|FG005|Overall Study|Withdrawal by Subject|3
2343129|NCT03518125|4077337|FG000|Overall Study|Missed Day 394 Visit|1
2343130|NCT03518125|4077338|FG001|Overall Study|Missed Day 394 Visit|0
2343131|NCT03518125|4077339|FG002|Overall Study|Missed Day 394 Visit|0
2343132|NCT03518125|4077340|FG003|Overall Study|Missed Day 394 Visit|0
2343133|NCT03518125|4077341|FG004|Overall Study|Missed Day 394 Visit|0
2343134|NCT03518125|4077342|FG005|Overall Study|Missed Day 394 Visit|0
2343135|NCT03518658|4077359|FG000|Overall Study|Other|51
2343136|NCT03518658|4077360|FG001|Overall Study|Other|0
2343137|NCT03518840|4077368|FG000|Overall Study|Lost to Follow-up|6
2343138|NCT03519087|4077377|FG000|Clinic Evaluation|Physician Decision|15
2343139|NCT03519087|4077378|FG001|Clinic Evaluation|Physician Decision|18
2343140|NCT03519087|4077379|FG002|Clinic Evaluation|Physician Decision|0
2343141|NCT03519087|4077380|FG003|Clinic Evaluation|Physician Decision|0
2343142|NCT03519087|4077381|FG004|Clinic Evaluation|Physician Decision|0
2343143|NCT03519087|4077377|FG000|Clinic Evaluation|Protocol Violation|1
2343144|NCT03519087|4077378|FG001|Clinic Evaluation|Protocol Violation|0
2343145|NCT03519087|4077379|FG002|Clinic Evaluation|Protocol Violation|0
2343146|NCT03519087|4077380|FG003|Clinic Evaluation|Protocol Violation|0
2343147|NCT03519087|4077381|FG004|Clinic Evaluation|Protocol Violation|0
2343148|NCT03519087|4077377|FG000|Re-randomization for Treatment|Withdrawal by Subject|25
2343149|NCT03519087|4077378|FG001|Re-randomization for Treatment|Withdrawal by Subject|29
2255129|NCT02072226|3921701|FG001|Overall Study|Lost to Follow-up|7
2255130|NCT02072226|3921700|FG000|Overall Study|Patient Non-compliance|2
2255131|NCT02072226|3921701|FG001|Overall Study|Patient Non-compliance|3
2255132|NCT02072226|3921700|FG000|Overall Study|Death|1
2255133|NCT02072226|3921701|FG001|Overall Study|Death|0
2255134|NCT02072226|3921700|FG000|Overall Study|Patient Withdrawal of Consent|1
2255135|NCT02072226|3921701|FG001|Overall Study|Patient Withdrawal of Consent|0
2255136|NCT02072434|3921714|FG000|Overall Study|Protocol Violation|10
2255137|NCT02072434|3921715|FG001|Overall Study|Protocol Violation|9
2255138|NCT02072434|3921714|FG000|Overall Study|Physician Decision|5
2255139|NCT02072434|3921715|FG001|Overall Study|Physician Decision|10
2255140|NCT02072434|3921714|FG000|Overall Study|Adverse event, serious fatal|1
2255141|NCT02072434|3921715|FG001|Overall Study|Adverse event, serious fatal|6
2255142|NCT02072434|3921714|FG000|Overall Study|Adverse Event|7
2255143|NCT02072434|3921715|FG001|Overall Study|Adverse Event|6
2255144|NCT02072434|3921714|FG000|Overall Study|Withdrawal by Subject|17
2255145|NCT02072434|3921715|FG001|Overall Study|Withdrawal by Subject|29
2255146|NCT02072434|3921714|FG000|Overall Study|Other|14
2255147|NCT02072434|3921715|FG001|Overall Study|Other|29
2255148|NCT02072434|3921714|FG000|Overall Study|Lost to Follow-up|0
2255149|NCT02072434|3921715|FG001|Overall Study|Lost to Follow-up|1
2255150|NCT02072668|3921721|FG000|Second Intervention|Lost to Follow-up|1
2255151|NCT02072668|3921722|FG001|Second Intervention|Lost to Follow-up|0
2343150|NCT03519087|4077379|FG002|Re-randomization for Treatment|Withdrawal by Subject|0
2343151|NCT03519087|4077380|FG003|Re-randomization for Treatment|Withdrawal by Subject|0
2343152|NCT03519087|4077381|FG004|Re-randomization for Treatment|Withdrawal by Subject|0
2343153|NCT03519087|4077377|FG000|Re-randomization for Treatment|Not appropriate|2
2343154|NCT03519087|4077378|FG001|Re-randomization for Treatment|Not appropriate|3
2343155|NCT03519087|4077379|FG002|Re-randomization for Treatment|Not appropriate|0
2343156|NCT03519087|4077380|FG003|Re-randomization for Treatment|Not appropriate|0
2343157|NCT03519087|4077381|FG004|Re-randomization for Treatment|Not appropriate|0
2343158|NCT03519087|4077377|FG000|Laboratory Testing|Lost to Follow-up|0
2038992|NCT00424476|3609302|FG001|Overall Study|Physician Decision|2
2038993|NCT00424476|3609303|FG002|Overall Study|Physician Decision|3
2038994|NCT00424476|3609301|FG000|Overall Study|Other|4
2038995|NCT00424476|3609302|FG001|Overall Study|Other|3
2038996|NCT00424476|3609303|FG002|Overall Study|Other|9
2038997|NCT00424489|3609311|FG000|Overall Study|Death|3
2038998|NCT00424515|3609321|FG000|Overall Study|Progressive Disease|10
2038999|NCT00424515|3609322|FG001|Overall Study|Progressive Disease|11
2039000|NCT00424515|3609321|FG000|Overall Study|Adverse Event|0
2039001|NCT00424515|3609322|FG001|Overall Study|Adverse Event|1
2039002|NCT00424515|3609321|FG000|Overall Study|Intercurrent Illness|0
2039003|NCT00424515|3609322|FG001|Overall Study|Intercurrent Illness|1
2039004|NCT00424515|3609321|FG000|Overall Study|Withdrawal by Subject|1
2039005|NCT00424515|3609322|FG001|Overall Study|Withdrawal by Subject|0
2039006|NCT00424528|3609331|FG000|Overall Study|Adverse Event|2
2039007|NCT00424528|3609332|FG001|Overall Study|Adverse Event|1
2039008|NCT00424528|3609333|FG002|Overall Study|Adverse Event|2
2039009|NCT00424528|3609331|FG000|Overall Study|Protocol Violation|1
2039010|NCT00424528|3609332|FG001|Overall Study|Protocol Violation|1
2039011|NCT00424528|3609333|FG002|Overall Study|Protocol Violation|0
2039012|NCT00424528|3609331|FG000|Overall Study|Lost to Follow-up|0
2039013|NCT00424528|3609332|FG001|Overall Study|Lost to Follow-up|1
2039014|NCT00424528|3609333|FG002|Overall Study|Lost to Follow-up|0
2039015|NCT00424528|3609331|FG000|Overall Study|noncompliance with study requirements|2
2039016|NCT00424528|3609332|FG001|Overall Study|noncompliance with study requirements|1
2039017|NCT00424528|3609333|FG002|Overall Study|noncompliance with study requirements|2
2255152|NCT02072824|3921733|FG000|Overall Study|Insufficient clinical response|1
2255153|NCT02072824|3921734|FG001|Overall Study|Insufficient clinical response|0
2255154|NCT02072824|3921735|FG002|Overall Study|Insufficient clinical response|1
2255155|NCT02072824|3921733|FG000|Overall Study|No longer willing to participate|1
2255156|NCT02072824|3921734|FG001|Overall Study|No longer willing to participate|0
2255157|NCT02072824|3921735|FG002|Overall Study|No longer willing to participate|1
2255158|NCT02072824|3921733|FG000|Overall Study|Medication error|0
2255159|NCT02072824|3921734|FG001|Overall Study|Medication error|1
2255160|NCT02072824|3921735|FG002|Overall Study|Medication error|0
2255161|NCT02072824|3921733|FG000|Overall Study|Adverse Event|0
2255162|NCT02072824|3921734|FG001|Overall Study|Adverse Event|0
2255163|NCT02072824|3921735|FG002|Overall Study|Adverse Event|1
2255164|NCT02072941|3921749|FG000|Overall Study|Withdrawal by Subject|29
2039018|NCT00424593|3609352|FG000|Acute Double-Blind Period|Adverse Event|16
2039019|NCT00424593|3609353|FG001|Acute Double-Blind Period|Adverse Event|7
2039020|NCT00424593|3609352|FG000|Acute Double-Blind Period|Withdrawal by Subject|11
2039021|NCT00424593|3609353|FG001|Acute Double-Blind Period|Withdrawal by Subject|10
2039022|NCT00424593|3609352|FG000|Acute Double-Blind Period|Protocol Violation|2
2039023|NCT00424593|3609353|FG001|Acute Double-Blind Period|Protocol Violation|2
2039024|NCT00424593|3609352|FG000|Acute Double-Blind Period|Physician Decision|1
2039025|NCT00424593|3609353|FG001|Acute Double-Blind Period|Physician Decision|2
2039026|NCT00424593|3609352|FG000|Acute Double-Blind Period|Lost to Follow-up|1
2039027|NCT00424593|3609353|FG001|Acute Double-Blind Period|Lost to Follow-up|1
2039028|NCT00424593|3609352|FG000|Acute Double-Blind Period|Lack of Efficacy|0
2255165|NCT02072941|3921750|FG001|Overall Study|Withdrawal by Subject|21
2255166|NCT02072941|3921749|FG000|Overall Study|Lost to Follow-up|4
2255167|NCT02072941|3921750|FG001|Overall Study|Lost to Follow-up|4
2255168|NCT02072941|3921749|FG000|Overall Study|Death|3
2255169|NCT02072941|3921750|FG001|Overall Study|Death|2
2255170|NCT02072941|3921749|FG000|Overall Study|Removed by Study Staff|2
2255171|NCT02072941|3921750|FG001|Overall Study|Removed by Study Staff|2
2255172|NCT02072980|3921756|FG000|Period 2, Second Wear|Adverse Event|0
2255173|NCT02072980|3921757|FG001|Period 2, Second Wear|Adverse Event|1
2255174|NCT02073565|3921825|FG000|Cohort A|Withdrawal by Subject|1
2255175|NCT02073565|3921826|FG001|Cohort A|Withdrawal by Subject|0
2255176|NCT02073565|3921825|FG000|Cohort B|Withdrawal by Subject|1
2255177|NCT02073565|3921826|FG001|Cohort B|Withdrawal by Subject|2
2255178|NCT02073565|3921825|FG000|Cohort C|Withdrawal by Subject|0
2255179|NCT02073565|3921826|FG001|Cohort C|Withdrawal by Subject|2
2255180|NCT02073565|3921825|FG000|Cohort C|Lost to Follow-up|0
2255181|NCT02073565|3921826|FG001|Cohort C|Lost to Follow-up|2
2255182|NCT02073643|3921832|FG000|Overall Study|Lost to Follow-up|24
2255183|NCT02073656|3921836|FG000|Primary Study|Lost to Follow-up|6
2255184|NCT02073656|3921836|FG000|Primary Study|Death|1
2255185|NCT02073656|3921836|FG000|Primary Study|Withdrew Consent|1
2255186|NCT02073682|3921844|FG000|Overall Study|Low Creatinine Clearance|1
2255187|NCT02073682|3921845|FG001|Overall Study|Low Creatinine Clearance|2
2255188|NCT02073682|3921844|FG000|Overall Study|Death|86
2255189|NCT02073682|3921845|FG001|Overall Study|Death|100
2255190|NCT02073682|3921844|FG000|Overall Study|Cancer Cured|10
2255191|NCT02073682|3921845|FG001|Overall Study|Cancer Cured|15
2255192|NCT02073682|3921844|FG000|Overall Study|ID: Patient Noncompliance|1
2255193|NCT02073682|3921845|FG001|Overall Study|ID: Patient Noncompliance|2
2255194|NCT02073682|3921844|FG000|Overall Study|ID: Palliative Treatment Only|10
2255195|NCT02073682|3921845|FG001|Overall Study|ID: Palliative Treatment Only|7
2255196|NCT02073682|3921844|FG000|Overall Study|Prohibited Concomitant Medication Use|0
2255197|NCT02073682|3921845|FG001|Overall Study|Prohibited Concomitant Medication Use|1
2255198|NCT02073682|3921844|FG000|Overall Study|Platelet Count <50,000/mL|1
2255199|NCT02073682|3921845|FG001|Overall Study|Platelet Count <50,000/mL|2
2255200|NCT02073682|3921844|FG000|Overall Study|Surgery/Medical Procedure|3
2255201|NCT02073682|3921845|FG001|Overall Study|Surgery/Medical Procedure|1
2255202|NCT02073682|3921844|FG000|Overall Study|Withdrawal by Subject|6
2255203|NCT02073682|3921845|FG001|Overall Study|Withdrawal by Subject|8
2255204|NCT02073682|3921844|FG000|Overall Study|Start of New Chemotherapy Regimen|6
2255205|NCT02073682|3921845|FG001|Overall Study|Start of New Chemotherapy Regimen|3
2255206|NCT02073682|3921844|FG000|Overall Study|Cancer Progression|53
2255207|NCT02073682|3921845|FG001|Overall Study|Cancer Progression|33
2255208|NCT02073682|3921844|FG000|Overall Study|Protocol Violation|1
2255209|NCT02073682|3921845|FG001|Overall Study|Protocol Violation|0
2255210|NCT02073682|3921844|FG000|Overall Study|Adverse Event|79
2255211|NCT02073682|3921845|FG001|Overall Study|Adverse Event|62
2255212|NCT02073682|3921844|FG000|Overall Study|No reason provided|11
2255213|NCT02073682|3921845|FG001|Overall Study|No reason provided|9
2255214|NCT02073682|3921844|FG000|Overall Study|PD: Inconvenience of Dosing|21
2255215|NCT02073682|3921845|FG001|Overall Study|PD: Inconvenience of Dosing|78
2255216|NCT02073682|3921844|FG000|Overall Study|Lost to Follow-up|1
2255217|NCT02073682|3921845|FG001|Overall Study|Lost to Follow-up|1
2255218|NCT02073682|3921844|FG000|Overall Study|ID: Benefit/Risk Judgment|32
2255219|NCT02073682|3921845|FG001|Overall Study|ID: Benefit/Risk Judgment|46
2255220|NCT02073929|3921862|FG000|Overall Study|Lost to Follow-up|2
2255221|NCT02073929|3921863|FG001|Overall Study|Lost to Follow-up|1
2255222|NCT02073929|3921862|FG000|Overall Study|Adverse Event|2
2255223|NCT02073929|3921863|FG001|Overall Study|Adverse Event|1
2255224|NCT02073929|3921862|FG000|Overall Study|Withdrawal by Subject|0
2255225|NCT02073929|3921863|FG001|Overall Study|Withdrawal by Subject|1
2255226|NCT02074059|3921875|FG000|Overall Study|Death|0
2255227|NCT02074059|3921876|FG001|Overall Study|Death|0
2255228|NCT02074059|3921877|FG002|Overall Study|Death|0
2255229|NCT02074059|3921878|FG003|Overall Study|Death|0
2255230|NCT02074059|3921879|FG004|Overall Study|Death|1
2255231|NCT02074059|3921880|FG005|Overall Study|Death|1
2255232|NCT02074514|3921929|FG000|Overall Study|Lack of Efficacy|3
2255233|NCT02074514|3921930|FG001|Overall Study|Lack of Efficacy|2
2255234|NCT02074514|3921929|FG000|Overall Study|Lost to Follow-up|0
2255235|NCT02074514|3921930|FG001|Overall Study|Lost to Follow-up|1
2255236|NCT02074514|3921929|FG000|Overall Study|Withdrew Consent|0
2255237|NCT02074514|3921930|FG001|Overall Study|Withdrew Consent|1
2255238|NCT02074553|3921942|FG000|Intervention Period 1|Family Emergency|0
2255239|NCT02074553|3921943|FG001|Intervention Period 1|Family Emergency|0
2255240|NCT02074553|3921944|FG002|Intervention Period 1|Family Emergency|0
2255241|NCT02074553|3921945|FG003|Intervention Period 1|Family Emergency|1
2255242|NCT02074553|3921946|FG004|Intervention Period 1|Family Emergency|0
2255243|NCT02074553|3921947|FG005|Intervention Period 1|Family Emergency|0
2255244|NCT02074553|3921948|FG006|Intervention Period 1|Family Emergency|0
2255245|NCT02074553|3921949|FG007|Intervention Period 1|Family Emergency|0
2255246|NCT02074553|3921942|FG000|Washout Period 1|Adverse Event|1
2255247|NCT02074553|3921943|FG001|Washout Period 1|Adverse Event|0
2255248|NCT02074553|3921944|FG002|Washout Period 1|Adverse Event|0
2255249|NCT02074553|3921945|FG003|Washout Period 1|Adverse Event|0
2255250|NCT02074553|3921946|FG004|Washout Period 1|Adverse Event|0
2255251|NCT02074553|3921947|FG005|Washout Period 1|Adverse Event|0
2255252|NCT02074553|3921948|FG006|Washout Period 1|Adverse Event|0
2255253|NCT02074553|3921949|FG007|Washout Period 1|Adverse Event|0
2255254|NCT02074553|3921942|FG000|Washout Period 1|Physician Decision|0
2255255|NCT02074553|3921943|FG001|Washout Period 1|Physician Decision|0
2255256|NCT02074553|3921944|FG002|Washout Period 1|Physician Decision|0
2255257|NCT02074553|3921945|FG003|Washout Period 1|Physician Decision|1
2255258|NCT02074553|3921946|FG004|Washout Period 1|Physician Decision|0
2255259|NCT02074553|3921947|FG005|Washout Period 1|Physician Decision|0
2255260|NCT02074553|3921948|FG006|Washout Period 1|Physician Decision|0
2255261|NCT02074553|3921949|FG007|Washout Period 1|Physician Decision|0
2255262|NCT02074553|3921942|FG000|Washout Period 1|Other|0
2255263|NCT02074553|3921943|FG001|Washout Period 1|Other|0
2255264|NCT02074553|3921944|FG002|Washout Period 1|Other|0
2255265|NCT02074553|3921945|FG003|Washout Period 1|Other|0
2255266|NCT02074553|3921946|FG004|Washout Period 1|Other|0
2255267|NCT02074553|3921947|FG005|Washout Period 1|Other|1
2255268|NCT02074553|3921948|FG006|Washout Period 1|Other|0
2255269|NCT02074553|3921949|FG007|Washout Period 1|Other|0
2255270|NCT02074553|3921942|FG000|Washout Period 2|Adverse Event|0
2255271|NCT02074553|3921943|FG001|Washout Period 2|Adverse Event|0
2255272|NCT02074553|3921944|FG002|Washout Period 2|Adverse Event|0
2255273|NCT02074553|3921945|FG003|Washout Period 2|Adverse Event|0
2255274|NCT02074553|3921946|FG004|Washout Period 2|Adverse Event|0
2255275|NCT02074553|3921947|FG005|Washout Period 2|Adverse Event|0
2255276|NCT02074553|3921948|FG006|Washout Period 2|Adverse Event|1
2255277|NCT02074553|3921949|FG007|Washout Period 2|Adverse Event|0
2255278|NCT02074553|3921942|FG000|Washout Period 2|Physician Decision|0
2255279|NCT02074553|3921943|FG001|Washout Period 2|Physician Decision|0
2255280|NCT02074553|3921944|FG002|Washout Period 2|Physician Decision|0
2255281|NCT02074553|3921945|FG003|Washout Period 2|Physician Decision|0
2255282|NCT02074553|3921946|FG004|Washout Period 2|Physician Decision|0
2255283|NCT02074553|3921947|FG005|Washout Period 2|Physician Decision|1
2255284|NCT02074553|3921948|FG006|Washout Period 2|Physician Decision|0
2255285|NCT02074553|3921949|FG007|Washout Period 2|Physician Decision|0
2255286|NCT02074553|3921942|FG000|Washout Period 2|Lost to Follow-up|0
2255287|NCT02074553|3921943|FG001|Washout Period 2|Lost to Follow-up|0
2255288|NCT02074553|3921944|FG002|Washout Period 2|Lost to Follow-up|1
2255289|NCT02074553|3921945|FG003|Washout Period 2|Lost to Follow-up|0
2255290|NCT02074553|3921946|FG004|Washout Period 2|Lost to Follow-up|0
2255291|NCT02074553|3921947|FG005|Washout Period 2|Lost to Follow-up|0
2255292|NCT02074553|3921948|FG006|Washout Period 2|Lost to Follow-up|0
2255293|NCT02074553|3921949|FG007|Washout Period 2|Lost to Follow-up|0
2343159|NCT03519087|4077378|FG001|Laboratory Testing|Lost to Follow-up|0
2343160|NCT03519087|4077379|FG002|Laboratory Testing|Lost to Follow-up|2
2343161|NCT03519087|4077380|FG003|Laboratory Testing|Lost to Follow-up|3
2343162|NCT03519087|4077381|FG004|Laboratory Testing|Lost to Follow-up|6
2343163|NCT03519087|4077377|FG000|Laboratory Testing|Protocol Violation|0
2343164|NCT03519087|4077378|FG001|Laboratory Testing|Protocol Violation|0
2343165|NCT03519087|4077379|FG002|Laboratory Testing|Protocol Violation|0
2343166|NCT03519087|4077380|FG003|Laboratory Testing|Protocol Violation|1
2343167|NCT03519087|4077381|FG004|Laboratory Testing|Protocol Violation|0
2343168|NCT03519204|4077399|FG000|Overall Study|Lost to Follow-up|3
2343169|NCT03519204|4077400|FG001|Overall Study|Lost to Follow-up|8
2343170|NCT03519204|4077399|FG000|Overall Study|Withdrawal by Subject|9
2343171|NCT03519204|4077400|FG001|Overall Study|Withdrawal by Subject|7
2343172|NCT03519204|4077399|FG000|Overall Study|Other Miscellaneous Reasons|1
2343173|NCT03519204|4077400|FG001|Overall Study|Other Miscellaneous Reasons|0
2353284|NCT02806960|4104866|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3
2353285|NCT02806960|4104867|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3
2353286|NCT02815397|4104877|FG000|Overall Study|Physician Decision|2
2353287|NCT02802592|4104881|FG000|Overall Study|Study terminated due to loss of funding|4
2353288|NCT02730793|4104906|FG000|Overall Study|Physician Decision|0
2353289|NCT02730793|4104907|FG001|Overall Study|Physician Decision|1
2353290|NCT02730793|4104906|FG000|Overall Study|Withdrawal by Subject|0
2353291|NCT02730793|4104907|FG001|Overall Study|Withdrawal by Subject|1
2353292|NCT02760602|4104924|FG000|Overall Study|Withdrawal by Subject|1
2353293|NCT02760602|4104925|FG001|Overall Study|Withdrawal by Subject|0
2353294|NCT02760602|4104924|FG000|Overall Study|Terminated by sponsor|12
2353295|NCT02760602|4104925|FG001|Overall Study|Terminated by sponsor|13
2353296|NCT02757521|4104933|FG000|Overall Study|Adverse Event|1
2353297|NCT02757521|4104934|FG001|Overall Study|Adverse Event|0
2353298|NCT02725671|4104987|FG000|Overall Study|Lost to Follow-up|1
2353299|NCT02732327|4105008|FG000|Overall Study|Protocol Violation|0
2353300|NCT02732327|4105009|FG001|Overall Study|Protocol Violation|1
2353301|NCT02726399|4105015|FG000|Overall Study|Participant Non-Compliance|1
2353302|NCT02726399|4105015|FG000|Overall Study|Adverse Event|2
2353303|NCT02726399|4105015|FG000|Overall Study|Progression of disease|4
2353304|NCT02720510|4105021|FG000|Overall Study|Study Terminated by the sponsor|2
2353305|NCT02720510|4105022|FG001|Overall Study|Study Terminated by the sponsor|0
2353306|NCT02720510|4105021|FG000|Overall Study|Adverse Event|0
2353307|NCT02720510|4105022|FG001|Overall Study|Adverse Event|1
2353308|NCT02720510|4105021|FG000|Overall Study|Physician Decision|1
2353309|NCT02720510|4105022|FG001|Overall Study|Physician Decision|2
2255294|NCT02074553|3921942|FG000|Washout Period 3|Physician Decision|0
2255295|NCT02074553|3921943|FG001|Washout Period 3|Physician Decision|0
2255296|NCT02074553|3921944|FG002|Washout Period 3|Physician Decision|0
2255297|NCT02074553|3921945|FG003|Washout Period 3|Physician Decision|0
2255298|NCT02074553|3921946|FG004|Washout Period 3|Physician Decision|0
2255299|NCT02074553|3921947|FG005|Washout Period 3|Physician Decision|0
2255300|NCT02074553|3921948|FG006|Washout Period 3|Physician Decision|0
2255301|NCT02074553|3921949|FG007|Washout Period 3|Physician Decision|1
2255302|NCT02074982|3921987|FG000|Overall Study|Adverse Event|15
2255303|NCT02074982|3921988|FG001|Overall Study|Adverse Event|7
2255304|NCT02074982|3921987|FG000|Overall Study|Lack of Efficacy|6
2255305|NCT02074982|3921988|FG001|Overall Study|Lack of Efficacy|1
2255306|NCT02074982|3921987|FG000|Overall Study|Lost to Follow-up|9
2255307|NCT02074982|3921988|FG001|Overall Study|Lost to Follow-up|10
2255308|NCT02074982|3921987|FG000|Overall Study|Non-compliance with study treatment|0
2255309|NCT02074982|3921988|FG001|Overall Study|Non-compliance with study treatment|2
2255310|NCT02074982|3921987|FG000|Overall Study|Physician Decision|1
2255311|NCT02074982|3921988|FG001|Overall Study|Physician Decision|1
2255312|NCT02074982|3921987|FG000|Overall Study|Pregnancy|1
2255313|NCT02074982|3921988|FG001|Overall Study|Pregnancy|2
2255314|NCT02074982|3921987|FG000|Overall Study|Protocol deviation|4
2255315|NCT02074982|3921988|FG001|Overall Study|Protocol deviation|3
2255316|NCT02074982|3921987|FG000|Overall Study|Technical problems|0
2255317|NCT02074982|3921988|FG001|Overall Study|Technical problems|2
2255318|NCT02074982|3921987|FG000|Overall Study|Subject/guardian decision|15
2255319|NCT02074982|3921988|FG001|Overall Study|Subject/guardian decision|24
2255320|NCT02074982|3921987|FG000|Overall Study|Death|0
2255321|NCT02074982|3921988|FG001|Overall Study|Death|2
2255322|NCT02075008|3922000|FG000|Overall Study|Technical problems|1
2255323|NCT02075008|3922000|FG000|Overall Study|Pregnancy|1
2255324|NCT02075008|3922000|FG000|Overall Study|Physician Decision|1
2255325|NCT02075008|3922000|FG000|Overall Study|Lost to Follow-up|1
2255326|NCT02075008|3922000|FG000|Overall Study|Lack of Efficacy|1
2255327|NCT02075008|3922000|FG000|Overall Study|Death|1
2255328|NCT02075008|3922000|FG000|Overall Study|Adverse Event|5
2255329|NCT02075008|3922000|FG000|Overall Study|Withdrawal by Subject|6
2255330|NCT02075008|3922000|FG000|Overall Study|Study terminated by Sponsor|159
2255331|NCT02075047|3922006|FG000|Treatment Phase (4 Weeks)|Adverse Event|14
2255332|NCT02075047|3922007|FG001|Treatment Phase (4 Weeks)|Adverse Event|4
2255333|NCT02075047|3922006|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2
2255334|NCT02075047|3922007|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2
2255335|NCT02075047|3922006|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0
2255336|NCT02075047|3922007|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1
2255337|NCT02075047|3922006|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1
2255338|NCT02075047|3922007|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0
2255339|NCT02075047|3922006|FG000|Treatment Phase (4 Weeks)|Screen Failure|1
2255340|NCT02075047|3922007|FG001|Treatment Phase (4 Weeks)|Screen Failure|0
2255341|NCT02075047|3922006|FG000|Treatment Phase (4 Weeks)|Other|1
2255342|NCT02075047|3922007|FG001|Treatment Phase (4 Weeks)|Other|1
2255343|NCT02075047|3922006|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4
2255344|NCT02075047|3922007|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2
2255345|NCT02075047|3922006|FG000|Follow up Phase (5 Weeks)|Adverse Event|14
2255346|NCT02075047|3922007|FG001|Follow up Phase (5 Weeks)|Adverse Event|4
2255347|NCT02075047|3922006|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2
2255348|NCT02075047|3922007|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2
2255349|NCT02075047|3922006|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0
2255350|NCT02075047|3922007|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1
2255351|NCT02075047|3922006|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1
2255352|NCT02075047|3922007|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0
2343174|NCT03519516|4077433|FG000|Overall Study|Adverse Event|0
2343175|NCT03519516|4077434|FG001|Overall Study|Adverse Event|1
2343176|NCT03519854|4077458|FG000|Overall Study|Technical Error|0
2343177|NCT03519854|4077459|FG001|Overall Study|Technical Error|0
2343178|NCT03519854|4077460|FG002|Overall Study|Technical Error|1
2343179|NCT03519854|4077461|FG003|Overall Study|Technical Error|0
2343180|NCT03519854|4077462|FG004|Overall Study|Technical Error|0
2343181|NCT03519854|4077463|FG005|Overall Study|Technical Error|0
2343182|NCT03519854|4077464|FG006|Overall Study|Technical Error|0
2343183|NCT03519854|4077465|FG007|Overall Study|Technical Error|0
2343184|NCT03519854|4077466|FG008|Overall Study|Technical Error|0
2343185|NCT03519854|4077467|FG009|Overall Study|Technical Error|0
2343186|NCT03519854|4077468|FG010|Overall Study|Technical Error|0
2343187|NCT03519854|4077469|FG011|Overall Study|Technical Error|0
2343188|NCT03519854|4077470|FG012|Overall Study|Technical Error|0
2343189|NCT03519854|4077471|FG013|Overall Study|Technical Error|0
2343190|NCT03519854|4077472|FG014|Overall Study|Technical Error|0
2343191|NCT03519854|4077473|FG015|Overall Study|Technical Error|0
2343192|NCT03519854|4077474|FG016|Overall Study|Technical Error|0
2343193|NCT03519854|4077475|FG017|Overall Study|Technical Error|0
2343194|NCT03519867|4077523|FG000|Overall Study|Adverse Event|1
2343195|NCT03519867|4077524|FG001|Overall Study|Adverse Event|1
2343196|NCT03519867|4077525|FG002|Overall Study|Adverse Event|0
2255353|NCT02075047|3922006|FG000|Follow up Phase (5 Weeks)|Screen Failure|1
2255354|NCT02075047|3922007|FG001|Follow up Phase (5 Weeks)|Screen Failure|0
2255355|NCT02075047|3922006|FG000|Follow up Phase (5 Weeks)|Other|1
2255356|NCT02075047|3922007|FG001|Follow up Phase (5 Weeks)|Other|2
2255357|NCT02075047|3922006|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7
2255358|NCT02075047|3922007|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4
2255359|NCT02075073|3922016|FG000|Overall Study|Withdrawal by Subject|0
2255360|NCT02075073|3922017|FG001|Overall Study|Withdrawal by Subject|1
2255361|NCT02075073|3922018|FG002|Overall Study|Withdrawal by Subject|0
2255362|NCT02075203|3922038|FG000|Overall Study|Withdrawal by Subject|1
2255363|NCT02075203|3922039|FG001|Overall Study|Withdrawal by Subject|0
2255364|NCT02075203|3922040|FG002|Overall Study|Withdrawal by Subject|1
2255365|NCT02075203|3922038|FG000|Overall Study|Adverse Event|1
2255366|NCT02075203|3922039|FG001|Overall Study|Adverse Event|0
2255367|NCT02075203|3922040|FG002|Overall Study|Adverse Event|0
2255368|NCT02075203|3922038|FG000|Overall Study|participant refused to use contraception|1
2255369|NCT02075203|3922039|FG001|Overall Study|participant refused to use contraception|0
2255370|NCT02075203|3922040|FG002|Overall Study|participant refused to use contraception|0
2255371|NCT02075255|3922051|FG000|Overall Study|Study specific withdrawal criteria|0
2255372|NCT02075255|3922052|FG001|Overall Study|Study specific withdrawal criteria|1
2255373|NCT02075255|3922053|FG002|Overall Study|Study specific withdrawal criteria|1
2255374|NCT02075255|3922051|FG000|Overall Study|Withdrawal by Subject|4
2255375|NCT02075255|3922052|FG001|Overall Study|Withdrawal by Subject|1
2255376|NCT02075255|3922053|FG002|Overall Study|Withdrawal by Subject|0
2255377|NCT02075255|3922051|FG000|Overall Study|Lost to Follow-up|0
2255378|NCT02075255|3922052|FG001|Overall Study|Lost to Follow-up|0
2255379|NCT02075255|3922053|FG002|Overall Study|Lost to Follow-up|1
2255380|NCT02075255|3922051|FG000|Overall Study|Adverse Event|0
2255381|NCT02075255|3922052|FG001|Overall Study|Adverse Event|0
2255382|NCT02075255|3922053|FG002|Overall Study|Adverse Event|1
2255383|NCT02075255|3922051|FG000|Overall Study|Death|0
2255384|NCT02075255|3922052|FG001|Overall Study|Death|2
2255385|NCT02075255|3922053|FG002|Overall Study|Death|0
2255386|NCT02075320|3922061|FG000|Overall Study|Withdrawal by Subject|2
2255387|NCT02075463|3922065|FG000|Overall Study|Adverse Event|3
2255388|NCT02075463|3922065|FG000|Overall Study|Par. reached stopping criteria|4
2255389|NCT02075463|3922065|FG000|Overall Study|Withdrawal by Subject|1
2255390|NCT02075476|3922072|FG000|Overall Study|Death|2
2255391|NCT02075476|3922073|FG001|Overall Study|Death|2
2255392|NCT02075476|3922072|FG000|Overall Study|Lost to Follow-up|1
2255393|NCT02075476|3922073|FG001|Overall Study|Lost to Follow-up|3
2255394|NCT02075515|3922082|FG000|Overall Study|Serious Adverse Event|1
2255395|NCT02075515|3922083|FG001|Overall Study|Serious Adverse Event|1
2255396|NCT02075515|3922084|FG002|Overall Study|Serious Adverse Event|1
2255397|NCT02075515|3922082|FG000|Overall Study|Non-Serious Adverse Event|0
2255398|NCT02075515|3922083|FG001|Overall Study|Non-Serious Adverse Event|1
2255399|NCT02075515|3922084|FG002|Overall Study|Non-Serious Adverse Event|0
2255400|NCT02075515|3922082|FG000|Overall Study|Withdrawal by Subject|2
2255401|NCT02075515|3922083|FG001|Overall Study|Withdrawal by Subject|0
2255402|NCT02075515|3922084|FG002|Overall Study|Withdrawal by Subject|1
2255403|NCT02075515|3922082|FG000|Overall Study|Lost to Follow-up|1
2255404|NCT02075515|3922083|FG001|Overall Study|Lost to Follow-up|3
2255405|NCT02075515|3922084|FG002|Overall Study|Lost to Follow-up|6
2255406|NCT02075541|3922095|FG000|Overall Study|Serious Adverse Event|1
2255407|NCT02075541|3922096|FG001|Overall Study|Serious Adverse Event|4
2255408|NCT02075541|3922095|FG000|Overall Study|Protocol Violation|1
2255409|NCT02075541|3922096|FG001|Overall Study|Protocol Violation|0
2255410|NCT02075541|3922095|FG000|Overall Study|Withdrawal by Subject|1
2255411|NCT02075541|3922096|FG001|Overall Study|Withdrawal by Subject|3
2255412|NCT02075541|3922095|FG000|Overall Study|Sponsor study termination|0
2255413|NCT02075541|3922096|FG001|Overall Study|Sponsor study termination|1
2255414|NCT02075541|3922095|FG000|Overall Study|Other- unable to perform study procedure|1
2255415|NCT02075541|3922096|FG001|Overall Study|Other- unable to perform study procedure|0
2255416|NCT02075554|3922102|FG000|Overall Study|Lost to Follow-up|7
2255417|NCT02075554|3922102|FG000|Overall Study|Withdrawal by Subject|5
2255418|NCT02075554|3922102|FG000|Overall Study|Physician Decision|3
2255419|NCT02075606|3922106|FG000|Overall Study|Adverse Event|5
2255420|NCT02075606|3922106|FG000|Overall Study|Withdrawal by Subject|1
2255421|NCT02075606|3922106|FG000|Overall Study|Death|1
2255422|NCT02075606|3922106|FG000|Overall Study|Investigator's decision|1
2255423|NCT02075606|3922106|FG000|Overall Study|Symptom management|1
2255424|NCT02075606|3922106|FG000|Overall Study|Increasing Symptoms|1
2255425|NCT02075632|3922117|FG000|Overall Study|Adverse Event|1
2255426|NCT02075632|3922118|FG001|Overall Study|Adverse Event|1
2255427|NCT02075632|3922117|FG000|Overall Study|Lost to Follow-up|0
2255428|NCT02075632|3922118|FG001|Overall Study|Lost to Follow-up|3
2255429|NCT02075632|3922117|FG000|Overall Study|Withdrawal by Subject|0
2255430|NCT02075632|3922118|FG001|Overall Study|Withdrawal by Subject|1
2255431|NCT02075658|3922126|FG000|Overall Study|Physician Decision|2
2255432|NCT02075658|3922127|FG001|Overall Study|Physician Decision|2
2255433|NCT02076022|3922135|FG000|Overall Study|Withdrawal by Subject|2
2255434|NCT02076022|3922136|FG001|Overall Study|Withdrawal by Subject|0
2255435|NCT02076113|3922177|FG000|Overall Study|Lost to Follow-up|4
2255436|NCT02076113|3922178|FG001|Overall Study|Lost to Follow-up|1
2255437|NCT02076113|3922177|FG000|Overall Study|Withdrawal by Subject|2
2255438|NCT02076113|3922178|FG001|Overall Study|Withdrawal by Subject|3
2255439|NCT02076113|3922177|FG000|Overall Study|Death|1
2255440|NCT02076113|3922178|FG001|Overall Study|Death|3
2255441|NCT02076165|3922197|FG000|Overall Study|Lost to Follow-up|7
2255442|NCT02076165|3922198|FG001|Overall Study|Lost to Follow-up|5
2255443|NCT02076165|3922197|FG000|Overall Study|Refused follow-up assessment|1
2255444|NCT02076165|3922198|FG001|Overall Study|Refused follow-up assessment|1
2255445|NCT02076334|3922221|FG000|Overall Study|Protocol Violation|1
2255446|NCT02076334|3922222|FG001|Overall Study|Protocol Violation|0
2255447|NCT02076334|3922223|FG002|Overall Study|Protocol Violation|0
2255448|NCT02076334|3922224|FG003|Overall Study|Protocol Violation|0
2255449|NCT02076334|3922221|FG000|Overall Study|Lost to Follow-up|0
2255450|NCT02076334|3922222|FG001|Overall Study|Lost to Follow-up|1
2255451|NCT02076334|3922223|FG002|Overall Study|Lost to Follow-up|1
2255452|NCT02076334|3922224|FG003|Overall Study|Lost to Follow-up|0
2255453|NCT02076334|3922221|FG000|Overall Study|muscle soreness|0
2255454|NCT02076334|3922222|FG001|Overall Study|muscle soreness|0
2255455|NCT02076334|3922223|FG002|Overall Study|muscle soreness|0
2255456|NCT02076334|3922224|FG003|Overall Study|muscle soreness|1
2343197|NCT03519867|4077526|FG003|Overall Study|Adverse Event|0
2343198|NCT03519867|4077527|FG004|Overall Study|Adverse Event|0
2343199|NCT03519867|4077528|FG005|Overall Study|Adverse Event|0
2343200|NCT03519867|4077529|FG006|Overall Study|Adverse Event|0
2343201|NCT03519867|4077530|FG007|Overall Study|Adverse Event|0
2343202|NCT03519867|4077531|FG008|Overall Study|Adverse Event|0
2343203|NCT03519867|4077532|FG009|Overall Study|Adverse Event|0
2343204|NCT03519867|4077523|FG000|Overall Study|Protocol Violation|0
2343205|NCT03519867|4077524|FG001|Overall Study|Protocol Violation|0
2343206|NCT03519867|4077525|FG002|Overall Study|Protocol Violation|0
2343207|NCT03519867|4077526|FG003|Overall Study|Protocol Violation|0
2343208|NCT03519867|4077527|FG004|Overall Study|Protocol Violation|0
2343209|NCT03519867|4077528|FG005|Overall Study|Protocol Violation|1
2343210|NCT03519867|4077529|FG006|Overall Study|Protocol Violation|0
2343211|NCT03519867|4077530|FG007|Overall Study|Protocol Violation|0
2343212|NCT03519867|4077531|FG008|Overall Study|Protocol Violation|0
2343213|NCT03519867|4077532|FG009|Overall Study|Protocol Violation|0
2343214|NCT03519867|4077523|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0
2343215|NCT03519867|4077524|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0
2343216|NCT03519867|4077525|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0
2343217|NCT03519867|4077526|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0
2343218|NCT03519867|4077527|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0
2343219|NCT03519867|4077528|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0
2343220|NCT03519867|4077529|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1
2343221|NCT03519867|4077530|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0
2343222|NCT03519867|4077531|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0
2343223|NCT03519867|4077532|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0
2343224|NCT03519867|4077523|FG000|Overall Study|Admin. of other reversal agent|1
2343225|NCT03519867|4077524|FG001|Overall Study|Admin. of other reversal agent|1
2343226|NCT03519867|4077525|FG002|Overall Study|Admin. of other reversal agent|0
2343227|NCT03519867|4077526|FG003|Overall Study|Admin. of other reversal agent|0
2343228|NCT03519867|4077527|FG004|Overall Study|Admin. of other reversal agent|0
2343229|NCT03519867|4077528|FG005|Overall Study|Admin. of other reversal agent|1
2343230|NCT03519867|4077529|FG006|Overall Study|Admin. of other reversal agent|0
2343231|NCT03519867|4077530|FG007|Overall Study|Admin. of other reversal agent|0
2343232|NCT03519867|4077531|FG008|Overall Study|Admin. of other reversal agent|0
2343233|NCT03519867|4077532|FG009|Overall Study|Admin. of other reversal agent|0
2343234|NCT03519867|4077523|FG000|Overall Study|Reason not provided|1
2343235|NCT03519867|4077524|FG001|Overall Study|Reason not provided|1
2343236|NCT03519867|4077525|FG002|Overall Study|Reason not provided|1
2343237|NCT03519867|4077526|FG003|Overall Study|Reason not provided|1
2343238|NCT03519867|4077527|FG004|Overall Study|Reason not provided|0
2343239|NCT03519867|4077528|FG005|Overall Study|Reason not provided|1
2343240|NCT03519867|4077529|FG006|Overall Study|Reason not provided|0
2343241|NCT03519867|4077530|FG007|Overall Study|Reason not provided|1
2343242|NCT03519867|4077531|FG008|Overall Study|Reason not provided|1
2343243|NCT03519867|4077532|FG009|Overall Study|Reason not provided|0
2343244|NCT03519919|4077554|FG000|Overall Study|Withdrawal by Subject|1
2343245|NCT03519919|4077554|FG000|Overall Study|Lack of Efficacy|1
2343246|NCT03519919|4077554|FG000|Overall Study|Screen Failure|1
2343247|NCT03519932|4077584|FG000|First Intervention|Adverse Event|1
2343248|NCT03519932|4077585|FG001|First Intervention|Adverse Event|3
2343249|NCT03520387|4077628|FG000|Pre-Randomization|Withdrawal by Subject|1
2343250|NCT03520387|4077629|FG001|Pre-Randomization|Withdrawal by Subject|0
2343251|NCT03520387|4077630|FG002|Pre-Randomization|Withdrawal by Subject|0
2343252|NCT03520387|4077631|FG003|Pre-Randomization|Withdrawal by Subject|0
2343253|NCT03520387|4077632|FG004|Pre-Randomization|Withdrawal by Subject|0
2343254|NCT03520387|4077628|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2
2343255|NCT03520387|4077629|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
2343256|NCT03520387|4077630|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
2255457|NCT02077140|3922325|FG000|Overall Study|Lost to Follow-up|4
2255458|NCT02077140|3922326|FG001|Overall Study|Lost to Follow-up|1
2255459|NCT02077140|3922327|FG002|Overall Study|Lost to Follow-up|2
2255460|NCT02077140|3922328|FG003|Overall Study|Lost to Follow-up|2
2255461|NCT02077140|3922329|FG004|Overall Study|Lost to Follow-up|3
2255462|NCT02077140|3922325|FG000|Overall Study|Withdrawal by Subject|0
2255463|NCT02077140|3922326|FG001|Overall Study|Withdrawal by Subject|1
2255464|NCT02077140|3922327|FG002|Overall Study|Withdrawal by Subject|0
2255465|NCT02077140|3922328|FG003|Overall Study|Withdrawal by Subject|2
2255466|NCT02077140|3922329|FG004|Overall Study|Withdrawal by Subject|2
2255467|NCT02077374|3922346|FG000|Overall Study|Withdrawal by Subject|0
2255468|NCT02077374|3922347|FG001|Overall Study|Withdrawal by Subject|1
2255469|NCT02077374|3922346|FG000|Overall Study|Protocol Violation|0
2255470|NCT02077374|3922347|FG001|Overall Study|Protocol Violation|1
2255471|NCT02077465|3922358|FG000|Overall Study|Withdrew Consent|0
2255472|NCT02077465|3922359|FG001|Overall Study|Withdrew Consent|1
2255473|NCT02077465|3922358|FG000|Overall Study|Lost to Follow-up|1
2255474|NCT02077465|3922359|FG001|Overall Study|Lost to Follow-up|0
2255475|NCT02078102|3922367|FG000|Overall Study|Adverse Event|1
2255476|NCT02078102|3922368|FG001|Overall Study|Adverse Event|0
2255477|NCT02078102|3922367|FG000|Overall Study|Withdrawal by Subject|1
2255478|NCT02078102|3922368|FG001|Overall Study|Withdrawal by Subject|0
2255479|NCT02078102|3922367|FG000|Overall Study|Physician Decision|0
2255480|NCT02078102|3922368|FG001|Overall Study|Physician Decision|1
2255481|NCT02078219|3922394|FG000|Overall Study|Other|2
2255482|NCT02078219|3922395|FG001|Overall Study|Other|2
2255483|NCT02078219|3922396|FG002|Overall Study|Other|3
2255484|NCT02078219|3922397|FG003|Overall Study|Other|0
2255485|NCT02078219|3922398|FG004|Overall Study|Other|1
2255486|NCT02078219|3922394|FG000|Overall Study|Withdrawal by Subject|0
2255487|NCT02078219|3922395|FG001|Overall Study|Withdrawal by Subject|1
2255488|NCT02078219|3922396|FG002|Overall Study|Withdrawal by Subject|0
2255489|NCT02078219|3922397|FG003|Overall Study|Withdrawal by Subject|1
2255490|NCT02078219|3922398|FG004|Overall Study|Withdrawal by Subject|1
2255491|NCT02078219|3922394|FG000|Overall Study|Protocol Violation|0
2255492|NCT02078219|3922395|FG001|Overall Study|Protocol Violation|0
2255493|NCT02078219|3922396|FG002|Overall Study|Protocol Violation|0
2255494|NCT02078219|3922397|FG003|Overall Study|Protocol Violation|1
2255495|NCT02078219|3922398|FG004|Overall Study|Protocol Violation|0
2255496|NCT02078219|3922394|FG000|Overall Study|Death|0
2255497|NCT02078219|3922395|FG001|Overall Study|Death|0
2255498|NCT02078219|3922396|FG002|Overall Study|Death|0
2255499|NCT02078219|3922397|FG003|Overall Study|Death|1
2255500|NCT02078219|3922398|FG004|Overall Study|Death|0
2343257|NCT03520387|4077631|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
2343258|NCT03520387|4077632|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
2343259|NCT03520400|4077645|FG000|Overall Study|Physician Decision|15
2343260|NCT03520400|4077646|FG001|Overall Study|Physician Decision|7
2343261|NCT03520920|4077655|FG000|Overall Study|Death|13
2343262|NCT03520920|4077656|FG001|Overall Study|Death|1
2343263|NCT03520920|4077657|FG002|Overall Study|Death|0
2343264|NCT03520920|4077655|FG000|Overall Study|Withdrawal by Subject|2
2343265|NCT03520920|4077656|FG001|Overall Study|Withdrawal by Subject|1
2343266|NCT03520920|4077657|FG002|Overall Study|Withdrawal by Subject|0
2343267|NCT03520920|4077655|FG000|Overall Study|Study Terminated by the Sponsor|5
2343268|NCT03520920|4077656|FG001|Overall Study|Study Terminated by the Sponsor|14
2343269|NCT03520920|4077657|FG002|Overall Study|Study Terminated by the Sponsor|5
2343270|NCT03520959|4077673|FG000|Overall Study|Study terminated by Sponsor|0
2343271|NCT03520959|4077674|FG001|Overall Study|Study terminated by Sponsor|1
2343272|NCT03521115|4077700|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56
2343273|NCT03521115|4077701|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40
2343274|NCT03521115|4077700|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3
2343275|NCT03521115|4077701|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1
2343276|NCT03521141|4077716|FG000|Overall Study|Death|1
2343277|NCT03521141|4077717|FG001|Overall Study|Death|0
2343278|NCT03521141|4077718|FG002|Overall Study|Death|1
2343279|NCT03521193|4077728|FG000|Overall Study|Withdrawal by Subject|8
2343280|NCT03521193|4077729|FG001|Overall Study|Withdrawal by Subject|0
2343281|NCT03521193|4077728|FG000|Overall Study|non compliant to ASA treatment|8
2343282|NCT03521193|4077729|FG001|Overall Study|non compliant to ASA treatment|0
2343283|NCT03521635|4077764|FG000|Overall Study|Adverse Event|1
2343284|NCT03521635|4077765|FG001|Overall Study|Adverse Event|1
2343285|NCT03521635|4077764|FG000|Overall Study|Refused to complete study visit|1
2343286|NCT03521635|4077765|FG001|Overall Study|Refused to complete study visit|0
2343287|NCT03521635|4077764|FG000|Overall Study|Refused to continue trial medication|2
2343288|NCT03521635|4077765|FG001|Overall Study|Refused to continue trial medication|2
2343289|NCT03521635|4077764|FG000|Overall Study|Lost to Follow-up|0
2343290|NCT03521635|4077765|FG001|Overall Study|Lost to Follow-up|1
2343291|NCT03521635|4077764|FG000|Overall Study|Meet exclusion criteria|0
2039029|NCT00424593|3609353|FG001|Acute Double-Blind Period|Lack of Efficacy|1
2255501|NCT02078219|3922394|FG000|Overall Study|Adverse Event|1
2255502|NCT02078219|3922395|FG001|Overall Study|Adverse Event|1
2343292|NCT03521635|4077765|FG001|Overall Study|Meet exclusion criteria|1
2343293|NCT03521635|4077764|FG000|Overall Study|Patient not taken study medicine|0
2255503|NCT02078219|3922396|FG002|Overall Study|Adverse Event|3
2255504|NCT02078219|3922397|FG003|Overall Study|Adverse Event|1
2255505|NCT02078219|3922398|FG004|Overall Study|Adverse Event|0
2255506|NCT02078713|3922452|FG000|Overall Study|Lost to Follow-up|49
2255507|NCT02078713|3922453|FG001|Overall Study|Lost to Follow-up|55
2255508|NCT02078713|3922454|FG002|Overall Study|Lost to Follow-up|0
2255509|NCT02078713|3922455|FG003|Overall Study|Lost to Follow-up|0
2255510|NCT02078713|3922452|FG000|Overall Study|Pregnant at baseline|3
2255511|NCT02078713|3922453|FG001|Overall Study|Pregnant at baseline|5
2255512|NCT02078713|3922454|FG002|Overall Study|Pregnant at baseline|0
2343294|NCT03521635|4077765|FG001|Overall Study|Patient not taken study medicine|1
2343295|NCT03521791|4077773|FG000|Overall Study|Protocol Violation|7
2343296|NCT03521791|4077774|FG001|Overall Study|Protocol Violation|17
2343297|NCT03521817|4077782|FG000|Overall Study|Protocol Violation|0
2343298|NCT03521817|4077783|FG001|Overall Study|Protocol Violation|1
2343299|NCT03522506|4077812|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2343300|NCT03522506|4077813|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2343301|NCT03522506|4077814|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2343302|NCT03522506|4077815|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2343303|NCT03522506|4077812|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0
2343304|NCT03522506|4077813|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0
2343305|NCT03522506|4077814|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0
2343306|NCT03522506|4077815|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1
2343307|NCT03522675|4077829|FG000|Overall Study|Screen fail|1
2343308|NCT03522675|4077829|FG000|Overall Study|Non-reactive to histamine|1
2343309|NCT03522948|4077837|FG000|Overall Study|Lost to Follow-up|1
2343310|NCT03523715|4077843|FG000|Overall Study|Lost to Follow-up|11
2343311|NCT03523715|4077844|FG001|Overall Study|Lost to Follow-up|14
2343312|NCT03523715|4077843|FG000|Overall Study|Did not meet inclusion criteria|1
2343313|NCT03523715|4077844|FG001|Overall Study|Did not meet inclusion criteria|0
2343314|NCT03523715|4077843|FG000|Overall Study|Internally inconsistent reporting|0
2343315|NCT03523715|4077844|FG001|Overall Study|Internally inconsistent reporting|2
2343316|NCT03523871|4077850|FG000|Overall Study|Death|1
2343317|NCT03524157|4077870|FG000|Overall Study|cytology not readable|0
2343318|NCT03524157|4077871|FG001|Overall Study|cytology not readable|0
2343319|NCT03524157|4077872|FG002|Overall Study|cytology not readable|1
2343320|NCT03525119|4077892|FG000|Overall Study|Adverse Event|0
2343321|NCT03525119|4077893|FG001|Overall Study|Adverse Event|1
2343322|NCT03525119|4077894|FG002|Overall Study|Adverse Event|0
2343323|NCT03525119|4077892|FG000|Overall Study|Lost to Follow-up|32
2255513|NCT02078713|3922455|FG003|Overall Study|Pregnant at baseline|0
2343324|NCT03525119|4077893|FG001|Overall Study|Lost to Follow-up|33
2343325|NCT03525119|4077894|FG002|Overall Study|Lost to Follow-up|37
2255514|NCT02078713|3922452|FG000|Overall Study|Enrolled twice|0
2255515|NCT02078713|3922453|FG001|Overall Study|Enrolled twice|1
2255516|NCT02078713|3922454|FG002|Overall Study|Enrolled twice|0
2255517|NCT02078713|3922455|FG003|Overall Study|Enrolled twice|0
2255518|NCT02078752|3922486|FG000|Overall Study|Death|0
2255519|NCT02078752|3922487|FG001|Overall Study|Death|3
2255520|NCT02078752|3922488|FG002|Overall Study|Death|0
2255521|NCT02078752|3922489|FG003|Overall Study|Death|0
2255522|NCT02078752|3922490|FG004|Overall Study|Death|0
2255523|NCT02078752|3922491|FG005|Overall Study|Death|1
2255524|NCT02078752|3922492|FG006|Overall Study|Death|0
2255525|NCT02078752|3922493|FG007|Overall Study|Death|1
2255526|NCT02078752|3922494|FG008|Overall Study|Death|0
2255527|NCT02078752|3922495|FG009|Overall Study|Death|4
2255528|NCT02078752|3922486|FG000|Overall Study|Lost to Follow-up|1
2255529|NCT02078752|3922487|FG001|Overall Study|Lost to Follow-up|0
2255530|NCT02078752|3922488|FG002|Overall Study|Lost to Follow-up|0
2255531|NCT02078752|3922489|FG003|Overall Study|Lost to Follow-up|1
2255532|NCT02078752|3922490|FG004|Overall Study|Lost to Follow-up|0
2255533|NCT02078752|3922491|FG005|Overall Study|Lost to Follow-up|0
2255534|NCT02078752|3922492|FG006|Overall Study|Lost to Follow-up|0
2255535|NCT02078752|3922493|FG007|Overall Study|Lost to Follow-up|0
2255536|NCT02078752|3922494|FG008|Overall Study|Lost to Follow-up|0
2255537|NCT02078752|3922495|FG009|Overall Study|Lost to Follow-up|0
2255538|NCT02078752|3922486|FG000|Overall Study|Withdrawal by Subject|1
2255539|NCT02078752|3922487|FG001|Overall Study|Withdrawal by Subject|1
2255540|NCT02078752|3922488|FG002|Overall Study|Withdrawal by Subject|1
2255541|NCT02078752|3922489|FG003|Overall Study|Withdrawal by Subject|1
2255542|NCT02078752|3922490|FG004|Overall Study|Withdrawal by Subject|0
2255543|NCT02078752|3922491|FG005|Overall Study|Withdrawal by Subject|3
2255544|NCT02078752|3922492|FG006|Overall Study|Withdrawal by Subject|2
2255545|NCT02078752|3922493|FG007|Overall Study|Withdrawal by Subject|1
2255546|NCT02078752|3922494|FG008|Overall Study|Withdrawal by Subject|0
2255547|NCT02078752|3922495|FG009|Overall Study|Withdrawal by Subject|1
2255548|NCT02078752|3922486|FG000|Overall Study|Other|0
2255549|NCT02078752|3922487|FG001|Overall Study|Other|3
2255550|NCT02078752|3922488|FG002|Overall Study|Other|0
2255551|NCT02078752|3922489|FG003|Overall Study|Other|0
2255552|NCT02078752|3922490|FG004|Overall Study|Other|1
2255553|NCT02078752|3922491|FG005|Overall Study|Other|0
2343326|NCT03525119|4077892|FG000|Overall Study|Withdrawal by Subject|5
2039030|NCT00424593|3609352|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19
2039031|NCT00424593|3609353|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0
2039032|NCT00424593|3609352|FG000|Dose-Blind Extension Period|Adverse Event|18
2039033|NCT00424593|3609353|FG001|Dose-Blind Extension Period|Adverse Event|0
2039034|NCT00424593|3609352|FG000|Dose-Blind Extension Period|Lack of Efficacy|9
2039035|NCT00424593|3609353|FG001|Dose-Blind Extension Period|Lack of Efficacy|0
2039036|NCT00424593|3609352|FG000|Dose-Blind Extension Period|Protocol Violation|9
2039037|NCT00424593|3609353|FG001|Dose-Blind Extension Period|Protocol Violation|0
2039038|NCT00424593|3609352|FG000|Dose-Blind Extension Period|Lost to Follow-up|6
2039039|NCT00424593|3609353|FG001|Dose-Blind Extension Period|Lost to Follow-up|0
2039040|NCT00424593|3609352|FG000|Dose-Blind Extension Period|Physician Decision|3
2039041|NCT00424593|3609353|FG001|Dose-Blind Extension Period|Physician Decision|0
2195918|NCT01527357|3828700|FG000|Overall Study|Non-compliance|0
2195919|NCT01527357|3828701|FG001|Overall Study|Non-compliance|1
2195920|NCT01527357|3828700|FG000|Overall Study|No Day 29 Visit|0
2195921|NCT01527357|3828701|FG001|Overall Study|No Day 29 Visit|1
2195922|NCT01527357|3828700|FG000|Overall Study|Did Not Receive Treatment|2
2195923|NCT01527357|3828701|FG001|Overall Study|Did Not Receive Treatment|0
2195924|NCT01527370|3828707|FG000|Overall Study|Withdrawal by Subject|4
2195925|NCT01527370|3828707|FG000|Overall Study|Physician Decision|1
2195926|NCT01527370|3828707|FG000|Overall Study|Death|1
2195927|NCT01527383|3828713|FG000|Overall Study|Adverse Event|5
2195928|NCT01527383|3828714|FG001|Overall Study|Adverse Event|0
2195929|NCT01527383|3828713|FG000|Overall Study|Lost to Follow-up|3
2195930|NCT01527383|3828714|FG001|Overall Study|Lost to Follow-up|0
2195931|NCT01527383|3828713|FG000|Overall Study|Physician Decision|2
2195932|NCT01527383|3828714|FG001|Overall Study|Physician Decision|0
2195933|NCT01527383|3828713|FG000|Overall Study|Pregnancy|1
2195934|NCT01527383|3828714|FG001|Overall Study|Pregnancy|0
2195935|NCT01527383|3828713|FG000|Overall Study|Protocol Violation|1
2195936|NCT01527383|3828714|FG001|Overall Study|Protocol Violation|0
2195937|NCT01527383|3828713|FG000|Overall Study|Screen failure|1
2255554|NCT02078752|3922492|FG006|Overall Study|Other|0
2255555|NCT02078752|3922493|FG007|Overall Study|Other|1
2255556|NCT02078752|3922494|FG008|Overall Study|Other|0
2255557|NCT02078752|3922495|FG009|Overall Study|Other|0
2255558|NCT02078752|3922486|FG000|Overall Study|Study terminated by sponsor|0
2255559|NCT02078752|3922487|FG001|Overall Study|Study terminated by sponsor|0
2255560|NCT02078752|3922488|FG002|Overall Study|Study terminated by sponsor|0
2255561|NCT02078752|3922489|FG003|Overall Study|Study terminated by sponsor|0
2255562|NCT02078752|3922490|FG004|Overall Study|Study terminated by sponsor|0
2255563|NCT02078752|3922491|FG005|Overall Study|Study terminated by sponsor|0
2255564|NCT02078752|3922492|FG006|Overall Study|Study terminated by sponsor|0
2255565|NCT02078752|3922493|FG007|Overall Study|Study terminated by sponsor|0
2255566|NCT02078752|3922494|FG008|Overall Study|Study terminated by sponsor|0
2255567|NCT02078752|3922495|FG009|Overall Study|Study terminated by sponsor|5
2255568|NCT02078817|3922526|FG000|Overall Study|Withdrawal by Subject|1
2255569|NCT02078960|3922537|FG000|Treatment Period|Other|0
2255570|NCT02078960|3922538|FG001|Treatment Period|Other|0
2255571|NCT02078960|3922539|FG002|Treatment Period|Other|1
2255572|NCT02078960|3922537|FG000|Treatment Period|Lack of Efficacy|0
2255573|NCT02078960|3922538|FG001|Treatment Period|Lack of Efficacy|1
2255574|NCT02078960|3922539|FG002|Treatment Period|Lack of Efficacy|0
2255575|NCT02078960|3922537|FG000|Treatment Period|Disease progression - accelerated phase|0
2255576|NCT02078960|3922538|FG001|Treatment Period|Disease progression - accelerated phase|1
2255577|NCT02078960|3922539|FG002|Treatment Period|Disease progression - accelerated phase|0
2255578|NCT02078960|3922537|FG000|Treatment Period|Disease progression - blast phase|1
2255579|NCT02078960|3922538|FG001|Treatment Period|Disease progression - blast phase|0
2255580|NCT02078960|3922539|FG002|Treatment Period|Disease progression - blast phase|0
2255581|NCT02078960|3922537|FG000|Treatment Period|Withdrawal by Subject|0
2255582|NCT02078960|3922538|FG001|Treatment Period|Withdrawal by Subject|1
2255583|NCT02078960|3922539|FG002|Treatment Period|Withdrawal by Subject|1
2255584|NCT02078960|3922537|FG000|Treatment Period|Adverse Event|1
2255585|NCT02078960|3922538|FG001|Treatment Period|Adverse Event|0
2255586|NCT02078960|3922539|FG002|Treatment Period|Adverse Event|0
2255587|NCT02078960|3922537|FG000|Treatment Period|Death|0
2255588|NCT02078960|3922538|FG001|Treatment Period|Death|0
2255589|NCT02078960|3922539|FG002|Treatment Period|Death|1
2255590|NCT02078960|3922537|FG000|Follow-up Period|Death|2
2255591|NCT02078960|3922538|FG001|Follow-up Period|Death|0
2255592|NCT02078960|3922539|FG002|Follow-up Period|Death|0
2255593|NCT02078960|3922537|FG000|Follow-up Period|Lost to Follow-up|0
2255594|NCT02078960|3922538|FG001|Follow-up Period|Lost to Follow-up|1
2255595|NCT02078960|3922539|FG002|Follow-up Period|Lost to Follow-up|0
2255596|NCT02079038|3922561|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6
2255597|NCT02079038|3922562|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5
2255598|NCT02079038|3922561|FG000|Modified Intent to Treat Population|Death|1
2255599|NCT02079038|3922562|FG001|Modified Intent to Treat Population|Death|0
2255600|NCT02079038|3922561|FG000|Completed 6 Months|Lost to Follow-up|2
2255601|NCT02079038|3922562|FG001|Completed 6 Months|Lost to Follow-up|1
2255602|NCT02079077|3922570|FG000|Overall Study|Lost to Follow-up|5
2255603|NCT02079077|3922571|FG001|Overall Study|Lost to Follow-up|7
2255604|NCT02079077|3922570|FG000|Overall Study|Became STIs Positive|1
2255605|NCT02079077|3922571|FG001|Overall Study|Became STIs Positive|2
2255606|NCT02079246|3922577|FG000|OLEX|Withdrawal before treatment|1
2255607|NCT02079246|3922578|FG001|OLEX|Withdrawal before treatment|0
2255608|NCT02079246|3922577|FG000|OLEX|Death|11
2343327|NCT03525119|4077893|FG001|Overall Study|Withdrawal by Subject|4
2343328|NCT03525119|4077894|FG002|Overall Study|Withdrawal by Subject|2
2343329|NCT03525119|4077892|FG000|Overall Study|Reason not Specified|2
2343330|NCT03525119|4077893|FG001|Overall Study|Reason not Specified|1
2343331|NCT03525119|4077894|FG002|Overall Study|Reason not Specified|2
2343332|NCT03525119|4077892|FG000|Overall Study|Randomized but not Vaccinated|1
2343333|NCT03525119|4077893|FG001|Overall Study|Randomized but not Vaccinated|0
2343334|NCT03525119|4077894|FG002|Overall Study|Randomized but not Vaccinated|2
2343335|NCT03525444|4077915|FG000|Overall Study|Adverse Event|0
2343336|NCT03525444|4077916|FG001|Overall Study|Adverse Event|1
2343337|NCT03525444|4077915|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
2343338|NCT03525444|4077916|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
2343339|NCT03525444|4077915|FG000|Overall Study|Other|0
2343340|NCT03525444|4077916|FG001|Overall Study|Other|1
2343341|NCT03525678|4077935|FG000|Overall Study|Ongoing at the time of interim analysis|60
2343342|NCT03525678|4077936|FG001|Overall Study|Ongoing at the time of interim analysis|65
2343343|NCT03525678|4077937|FG002|Overall Study|Ongoing at the time of interim analysis|21
2343344|NCT03525678|4077935|FG000|Overall Study|Withdrawal by Subject|3
2343345|NCT03525678|4077936|FG001|Overall Study|Withdrawal by Subject|1
2343346|NCT03525678|4077937|FG002|Overall Study|Withdrawal by Subject|0
2343347|NCT03525678|4077935|FG000|Overall Study|Physician Decision|1
2343348|NCT03525678|4077936|FG001|Overall Study|Physician Decision|2
2343349|NCT03525678|4077937|FG002|Overall Study|Physician Decision|0
2343350|NCT03525678|4077935|FG000|Overall Study|Lost to Follow-up|1
2343351|NCT03525678|4077936|FG001|Overall Study|Lost to Follow-up|0
2343352|NCT03525678|4077937|FG002|Overall Study|Lost to Follow-up|0
2343353|NCT03525678|4077935|FG000|Overall Study|Death|32
2343354|NCT03525678|4077936|FG001|Overall Study|Death|31
2343355|NCT03525678|4077937|FG002|Overall Study|Death|4
2343356|NCT03525834|4077945|FG000|Overall Study|Progressive disease|1
2343357|NCT03526458|4077959|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
2343358|NCT03526458|4077960|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
2343359|NCT03526458|4077959|FG000|Overall Study|Stone passed, surgery cancelled|2
2255609|NCT02079246|3922578|FG001|OLEX|Death|0
2255610|NCT02079246|3922577|FG000|OLEX|Adverse Event|66
2255611|NCT02079246|3922578|FG001|OLEX|Adverse Event|0
2255612|NCT02079246|3922577|FG000|OLEX|Withdrawal by Subject|60
2255613|NCT02079246|3922578|FG001|OLEX|Withdrawal by Subject|0
2255614|NCT02079246|3922577|FG000|OLEX|Lost to Follow-up|6
2255615|NCT02079246|3922578|FG001|OLEX|Lost to Follow-up|0
2255616|NCT02079246|3922577|FG000|OLEX|Protocol Violation|6
2255617|NCT02079246|3922578|FG001|OLEX|Protocol Violation|0
2255618|NCT02079246|3922577|FG000|OLEX|Lack of Efficacy|3
2255619|NCT02079246|3922578|FG001|OLEX|Lack of Efficacy|0
2255620|NCT02079246|3922577|FG000|OLEX|Results of the lead-in studies|58
2255621|NCT02079246|3922578|FG001|OLEX|Results of the lead-in studies|0
2255622|NCT02079246|3922577|FG000|OLEX|Other: Disallowed medication|8
2255623|NCT02079246|3922578|FG001|OLEX|Other: Disallowed medication|0
2255624|NCT02079246|3922577|FG000|OLEX|Other: Insufficient compliance|2
2255625|NCT02079246|3922578|FG001|OLEX|Other: Insufficient compliance|0
2255626|NCT02079246|3922577|FG000|OLEX|Other: Caregiver unavailable|3
2255627|NCT02079246|3922578|FG001|OLEX|Other: Caregiver unavailable|0
2255628|NCT02079246|3922577|FG000|OLEX|Other: Coordinator decision|1
2255629|NCT02079246|3922578|FG001|OLEX|Other: Coordinator decision|0
2255630|NCT02079246|3922577|FG000|OLEX|Other: Worsening of condition|1
2255631|NCT02079246|3922578|FG001|OLEX|Other: Worsening of condition|0
2255632|NCT02079246|3922577|FG000|OLEX|Other: Moved to nursing home|1
2255633|NCT02079246|3922578|FG001|OLEX|Other: Moved to nursing home|0
2255634|NCT02079246|3922577|FG000|OLEX|Other: Withdrawal of caregiver consent|1
2255635|NCT02079246|3922578|FG001|OLEX|Other: Withdrawal of caregiver consent|0
2255636|NCT02079246|3922577|FG000|OLEX-MEM|Adverse Event|0
2255637|NCT02079246|3922578|FG001|OLEX-MEM|Adverse Event|6
2255638|NCT02079246|3922577|FG000|OLEX-MEM|Withdrawal by Subject|0
2255639|NCT02079246|3922578|FG001|OLEX-MEM|Withdrawal by Subject|7
2255640|NCT02079246|3922577|FG000|OLEX-MEM|Protocol Violation|0
2255641|NCT02079246|3922578|FG001|OLEX-MEM|Protocol Violation|2
2255642|NCT02079246|3922577|FG000|OLEX-MEM|Lost to Follow-up|0
2255643|NCT02079246|3922578|FG001|OLEX-MEM|Lost to Follow-up|1
2255644|NCT02079246|3922577|FG000|OLEX-MEM|Other: Moved to nursing home|0
2255645|NCT02079246|3922578|FG001|OLEX-MEM|Other: Moved to nursing home|3
2255646|NCT02079519|3922596|FG000|Overall Study|Disease Progression|9
2255647|NCT02079519|3922596|FG000|Overall Study|Adverse Event|1
2255648|NCT02079532|3922600|FG000|Overall Study|Adverse Event|7
2255649|NCT02079532|3922600|FG000|Overall Study|Additional or changed therapy|2
2255650|NCT02079532|3922600|FG000|Overall Study|Lack of Efficacy|9
2255651|NCT02079532|3922600|FG000|Overall Study|Protocol Violation|3
2255652|NCT02079532|3922600|FG000|Overall Study|Withdrawal by Subject|1
2255653|NCT02079532|3922600|FG000|Overall Study|Administrative problems|1
2255654|NCT02079532|3922600|FG000|Overall Study|Inclusion into ReFIRST|3
2343360|NCT03526458|4077960|FG001|Overall Study|Stone passed, surgery cancelled|1
2343361|NCT03526458|4077959|FG000|Overall Study|Withdrawal by Subject|1
2343362|NCT03526458|4077960|FG001|Overall Study|Withdrawal by Subject|0
2343363|NCT03526458|4077959|FG000|Overall Study|Physician Decision|2
2343364|NCT03526458|4077960|FG001|Overall Study|Physician Decision|1
2343365|NCT03526458|4077959|FG000|Overall Study|Lack of equipment|1
2343366|NCT03526458|4077960|FG001|Overall Study|Lack of equipment|1
2343367|NCT03526861|4077969|FG000|Initial Treatment Period|Not dosed|1
2343368|NCT03526861|4077970|FG001|Initial Treatment Period|Not dosed|1
2343369|NCT03526861|4077971|FG002|Initial Treatment Period|Not dosed|1
2343370|NCT03526861|4077972|FG003|Initial Treatment Period|Not dosed|0
2343371|NCT03526861|4077973|FG004|Initial Treatment Period|Not dosed|0
2343372|NCT03526861|4077974|FG005|Initial Treatment Period|Not dosed|0
2343373|NCT03526861|4077975|FG006|Initial Treatment Period|Not dosed|0
2343374|NCT03526861|4077976|FG007|Initial Treatment Period|Not dosed|0
2343375|NCT03526861|4077977|FG008|Initial Treatment Period|Not dosed|0
2343376|NCT03526861|4077969|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3
2343377|NCT03526861|4077970|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
2343378|NCT03526861|4077971|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5
2343379|NCT03526861|4077972|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343380|NCT03526861|4077973|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343381|NCT03526861|4077974|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343382|NCT03526861|4077975|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343383|NCT03526861|4077976|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343384|NCT03526861|4077977|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343385|NCT03526861|4077969|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3
2343386|NCT03526861|4077970|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5
2343387|NCT03526861|4077971|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8
2343388|NCT03526861|4077972|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0
2343389|NCT03526861|4077973|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0
2343390|NCT03526861|4077974|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0
2343391|NCT03526861|4077975|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0
2343392|NCT03526861|4077976|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0
2343393|NCT03526861|4077977|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0
2255655|NCT02079532|3922600|FG000|Overall Study|Other|3
2255656|NCT02079610|3922606|FG000|Overall Study|Withdrawal by Subject|1
2255657|NCT02079610|3922607|FG001|Overall Study|Withdrawal by Subject|1
2255658|NCT02079636|3922628|FG000|Overall Study|Death|2
2255659|NCT02079636|3922629|FG001|Overall Study|Death|1
2255660|NCT02079636|3922630|FG002|Overall Study|Death|0
2255661|NCT02079636|3922631|FG003|Overall Study|Death|5
2255662|NCT02079636|3922632|FG004|Overall Study|Death|1
2255663|NCT02079636|3922633|FG005|Overall Study|Death|2
2255664|NCT02079636|3922634|FG006|Overall Study|Death|1
2255665|NCT02079636|3922635|FG007|Overall Study|Death|0
2255666|NCT02079636|3922636|FG008|Overall Study|Death|0
2255667|NCT02079636|3922637|FG009|Overall Study|Death|0
2255668|NCT02079636|3922638|FG010|Overall Study|Death|0
2255669|NCT02079636|3922639|FG011|Overall Study|Death|1
2255670|NCT02079636|3922640|FG012|Overall Study|Death|1
2255671|NCT02079636|3922641|FG013|Overall Study|Death|0
2255672|NCT02079636|3922642|FG014|Overall Study|Death|2
2343394|NCT03526861|4077969|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343395|NCT03526861|4077970|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343396|NCT03526861|4077971|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343397|NCT03526861|4077972|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
2343398|NCT03526861|4077973|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
2343399|NCT03526861|4077974|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343400|NCT03526861|4077975|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
2343401|NCT03526861|4077976|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343402|NCT03526861|4077977|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343403|NCT03526861|4077969|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0
2343404|NCT03526861|4077970|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0
2343405|NCT03526861|4077971|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0
2343406|NCT03526861|4077972|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6
2343407|NCT03526861|4077973|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5
2343408|NCT03526861|4077974|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4
2343409|NCT03526861|4077975|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5
2343410|NCT03526861|4077976|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2
2343411|NCT03526861|4077977|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0
2343412|NCT03526861|4077969|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343413|NCT03526861|4077970|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343414|NCT03526861|4077971|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343415|NCT03526861|4077972|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
2343416|NCT03526861|4077973|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343417|NCT03526861|4077974|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343418|NCT03526861|4077975|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343419|NCT03526861|4077976|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343420|NCT03526861|4077977|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343421|NCT03526861|4077969|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343422|NCT03526861|4077970|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343423|NCT03526861|4077971|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343424|NCT03526861|4077972|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343425|NCT03526861|4077973|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343426|NCT03526861|4077974|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343427|NCT03526861|4077975|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343428|NCT03526861|4077976|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
2343429|NCT03526861|4077977|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19
2343430|NCT03526861|4077969|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
2195938|NCT01527383|3828714|FG001|Overall Study|Screen failure|0
2195939|NCT01527383|3828713|FG000|Overall Study|Participant moved|0
2195940|NCT01527383|3828714|FG001|Overall Study|Participant moved|1
2195941|NCT01527383|3828713|FG000|Overall Study|Withdrawal by Subject|2
2195942|NCT01527383|3828714|FG001|Overall Study|Withdrawal by Subject|3
2195943|NCT01527487|3828722|FG000|Overall Study|MD Discretion/Lack of Efficacy|3
2195944|NCT01527487|3828723|FG001|Overall Study|MD Discretion/Lack of Efficacy|4
2195945|NCT01527487|3828722|FG000|Overall Study|Disease Progression|4
2195946|NCT01527487|3828723|FG001|Overall Study|Disease Progression|1
2255673|NCT02079636|3922628|FG000|Overall Study|Adverse Event|1
2255674|NCT02079636|3922629|FG001|Overall Study|Adverse Event|1
2255675|NCT02079636|3922630|FG002|Overall Study|Adverse Event|0
2255676|NCT02079636|3922631|FG003|Overall Study|Adverse Event|1
2255677|NCT02079636|3922632|FG004|Overall Study|Adverse Event|1
2255678|NCT02079636|3922633|FG005|Overall Study|Adverse Event|2
2255679|NCT02079636|3922634|FG006|Overall Study|Adverse Event|0
2255680|NCT02079636|3922635|FG007|Overall Study|Adverse Event|0
2255681|NCT02079636|3922636|FG008|Overall Study|Adverse Event|0
2255682|NCT02079636|3922637|FG009|Overall Study|Adverse Event|0
2255683|NCT02079636|3922638|FG010|Overall Study|Adverse Event|0
2255684|NCT02079636|3922639|FG011|Overall Study|Adverse Event|0
2255685|NCT02079636|3922640|FG012|Overall Study|Adverse Event|0
2255686|NCT02079636|3922641|FG013|Overall Study|Adverse Event|0
2255687|NCT02079636|3922642|FG014|Overall Study|Adverse Event|0
2255688|NCT02079636|3922628|FG000|Overall Study|Progressive disease|0
2255689|NCT02079636|3922629|FG001|Overall Study|Progressive disease|0
2255690|NCT02079636|3922630|FG002|Overall Study|Progressive disease|0
2255691|NCT02079636|3922631|FG003|Overall Study|Progressive disease|2
2255692|NCT02079636|3922632|FG004|Overall Study|Progressive disease|0
2255693|NCT02079636|3922633|FG005|Overall Study|Progressive disease|0
2255694|NCT02079636|3922634|FG006|Overall Study|Progressive disease|0
2255695|NCT02079636|3922635|FG007|Overall Study|Progressive disease|0
2255696|NCT02079636|3922636|FG008|Overall Study|Progressive disease|0
2255697|NCT02079636|3922637|FG009|Overall Study|Progressive disease|0
2255698|NCT02079636|3922638|FG010|Overall Study|Progressive disease|0
2255699|NCT02079636|3922639|FG011|Overall Study|Progressive disease|0
2255700|NCT02079636|3922640|FG012|Overall Study|Progressive disease|1
2255701|NCT02079636|3922641|FG013|Overall Study|Progressive disease|0
2255702|NCT02079636|3922642|FG014|Overall Study|Progressive disease|0
2255703|NCT02079636|3922628|FG000|Overall Study|Withdrawal by Subject|0
2255704|NCT02079636|3922629|FG001|Overall Study|Withdrawal by Subject|0
2255705|NCT02079636|3922630|FG002|Overall Study|Withdrawal by Subject|0
2255706|NCT02079636|3922631|FG003|Overall Study|Withdrawal by Subject|4
2255707|NCT02079636|3922632|FG004|Overall Study|Withdrawal by Subject|0
2255708|NCT02079636|3922633|FG005|Overall Study|Withdrawal by Subject|1
2255709|NCT02079636|3922634|FG006|Overall Study|Withdrawal by Subject|0
2255710|NCT02079636|3922635|FG007|Overall Study|Withdrawal by Subject|0
2255711|NCT02079636|3922636|FG008|Overall Study|Withdrawal by Subject|0
2255712|NCT02079636|3922637|FG009|Overall Study|Withdrawal by Subject|2
2255713|NCT02079636|3922638|FG010|Overall Study|Withdrawal by Subject|1
2255714|NCT02079636|3922639|FG011|Overall Study|Withdrawal by Subject|1
2255715|NCT02079636|3922640|FG012|Overall Study|Withdrawal by Subject|1
2255716|NCT02079636|3922641|FG013|Overall Study|Withdrawal by Subject|0
2255717|NCT02079636|3922642|FG014|Overall Study|Withdrawal by Subject|2
2255718|NCT02079636|3922628|FG000|Overall Study|Physician Decision|0
2255719|NCT02079636|3922629|FG001|Overall Study|Physician Decision|0
2255720|NCT02079636|3922630|FG002|Overall Study|Physician Decision|0
2255721|NCT02079636|3922631|FG003|Overall Study|Physician Decision|0
2255722|NCT02079636|3922632|FG004|Overall Study|Physician Decision|0
2255723|NCT02079636|3922633|FG005|Overall Study|Physician Decision|1
2255724|NCT02079636|3922634|FG006|Overall Study|Physician Decision|0
2255725|NCT02079636|3922635|FG007|Overall Study|Physician Decision|0
2255726|NCT02079636|3922636|FG008|Overall Study|Physician Decision|0
2255727|NCT02079636|3922637|FG009|Overall Study|Physician Decision|1
2255728|NCT02079636|3922638|FG010|Overall Study|Physician Decision|1
2255729|NCT02079636|3922639|FG011|Overall Study|Physician Decision|0
2255730|NCT02079636|3922640|FG012|Overall Study|Physician Decision|0
2255731|NCT02079636|3922641|FG013|Overall Study|Physician Decision|0
2255732|NCT02079636|3922642|FG014|Overall Study|Physician Decision|1
2255733|NCT02079636|3922628|FG000|Overall Study|Lost to Follow-up|0
2255734|NCT02079636|3922629|FG001|Overall Study|Lost to Follow-up|0
2255735|NCT02079636|3922630|FG002|Overall Study|Lost to Follow-up|0
2255736|NCT02079636|3922631|FG003|Overall Study|Lost to Follow-up|0
2255737|NCT02079636|3922632|FG004|Overall Study|Lost to Follow-up|0
2255738|NCT02079636|3922633|FG005|Overall Study|Lost to Follow-up|0
2255739|NCT02079636|3922634|FG006|Overall Study|Lost to Follow-up|0
2255740|NCT02079636|3922635|FG007|Overall Study|Lost to Follow-up|1
2255741|NCT02079636|3922636|FG008|Overall Study|Lost to Follow-up|0
2255742|NCT02079636|3922637|FG009|Overall Study|Lost to Follow-up|0
2255743|NCT02079636|3922638|FG010|Overall Study|Lost to Follow-up|0
2255744|NCT02079636|3922639|FG011|Overall Study|Lost to Follow-up|0
2255745|NCT02079636|3922640|FG012|Overall Study|Lost to Follow-up|0
2255746|NCT02079636|3922641|FG013|Overall Study|Lost to Follow-up|0
2255747|NCT02079636|3922642|FG014|Overall Study|Lost to Follow-up|0
2255748|NCT02079649|3922710|FG000|Overall Study|Lost to Follow-up|0
2255749|NCT02079649|3922711|FG001|Overall Study|Lost to Follow-up|0
2255750|NCT02079649|3922712|FG002|Overall Study|Lost to Follow-up|0
2255751|NCT02079649|3922713|FG003|Overall Study|Lost to Follow-up|1
2255752|NCT02079649|3922710|FG000|Overall Study|Withdrawal by Subject|0
2255753|NCT02079649|3922711|FG001|Overall Study|Withdrawal by Subject|0
2255754|NCT02079649|3922712|FG002|Overall Study|Withdrawal by Subject|0
2255755|NCT02079649|3922713|FG003|Overall Study|Withdrawal by Subject|1
2255756|NCT02079649|3922710|FG000|Overall Study|Randomization error (prior to treatment)|1
2255757|NCT02079649|3922711|FG001|Overall Study|Randomization error (prior to treatment)|0
2255758|NCT02079649|3922712|FG002|Overall Study|Randomization error (prior to treatment)|1
2255759|NCT02079649|3922713|FG003|Overall Study|Randomization error (prior to treatment)|0
2255760|NCT02079805|3922726|FG000|Overall Study|Pretreatment Event/Adverse Event|0
2255761|NCT02079805|3922727|FG001|Overall Study|Pretreatment Event/Adverse Event|1
2343431|NCT03526861|4077970|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
2343432|NCT03526861|4077971|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
2343433|NCT03526861|4077972|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
2343434|NCT03526861|4077973|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
2343435|NCT03526861|4077974|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
2343436|NCT03526861|4077975|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
2343437|NCT03526861|4077976|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
2343438|NCT03526861|4077977|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1
2343439|NCT03526861|4077969|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343440|NCT03526861|4077970|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343441|NCT03526861|4077971|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343442|NCT03526861|4077972|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343443|NCT03526861|4077973|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343444|NCT03526861|4077974|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343445|NCT03526861|4077975|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343446|NCT03526861|4077976|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
2343447|NCT03526861|4077977|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8
2343448|NCT03527160|4077999|FG000|Overall Study|No urine collected|13
2343449|NCT03527160|4077999|FG000|Overall Study|No clinical serum creatinine collected|6
2343450|NCT03527160|4077999|FG000|Overall Study|Did not meet inclusion|2
2343451|NCT03527173|4078008|FG000|Overall Study|Lost to Follow-up|4
2343452|NCT03527173|4078009|FG001|Overall Study|Lost to Follow-up|2
2343453|NCT03527173|4078008|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
2343454|NCT03527173|4078009|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
2343455|NCT03527173|4078008|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
2343456|NCT03527173|4078009|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
2343457|NCT03527173|4078008|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
2343458|NCT03527173|4078009|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
2343459|NCT03527550|4078017|FG000|Overall Study|Lost to Follow-up|4
2343460|NCT03527550|4078018|FG001|Overall Study|Lost to Follow-up|2
2343461|NCT03527550|4078017|FG000|Overall Study|Withdrawal by Subject|4
2343462|NCT03527550|4078018|FG001|Overall Study|Withdrawal by Subject|1
2343463|NCT03527550|4078017|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1
2343464|NCT03527550|4078018|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0
2343465|NCT03527745|4078052|FG000|Overall Study|Lost to Follow-up|3
2343466|NCT03527745|4078053|FG001|Overall Study|Lost to Follow-up|6
2343467|NCT03527745|4078054|FG002|Overall Study|Lost to Follow-up|7
2343468|NCT03527745|4078055|FG003|Overall Study|Lost to Follow-up|9
2343469|NCT03527745|4078056|FG004|Overall Study|Lost to Follow-up|0
2343470|NCT03527745|4078057|FG005|Overall Study|Lost to Follow-up|2
2343471|NCT03527745|4078058|FG006|Overall Study|Lost to Follow-up|3
2343472|NCT03527745|4078059|FG007|Overall Study|Lost to Follow-up|2
2343473|NCT03527745|4078060|FG008|Overall Study|Lost to Follow-up|3
2343474|NCT03527745|4078061|FG009|Overall Study|Lost to Follow-up|2
2343475|NCT03527745|4078062|FG010|Overall Study|Lost to Follow-up|1
2343476|NCT03527745|4078063|FG011|Overall Study|Lost to Follow-up|1
2343477|NCT03527745|4078064|FG012|Overall Study|Lost to Follow-up|0
2343478|NCT03527745|4078065|FG013|Overall Study|Lost to Follow-up|0
2343479|NCT03527745|4078066|FG014|Overall Study|Lost to Follow-up|0
2343480|NCT03527745|4078067|FG015|Overall Study|Lost to Follow-up|0
2343481|NCT03527745|4078068|FG016|Overall Study|Lost to Follow-up|1
2343482|NCT03527745|4078069|FG017|Overall Study|Lost to Follow-up|0
2343483|NCT03527745|4078070|FG018|Overall Study|Lost to Follow-up|0
2343484|NCT03527745|4078071|FG019|Overall Study|Lost to Follow-up|1
2343485|NCT03527745|4078072|FG020|Overall Study|Lost to Follow-up|1
2343486|NCT03527745|4078073|FG021|Overall Study|Lost to Follow-up|5
2343487|NCT03527745|4078074|FG022|Overall Study|Lost to Follow-up|6
2343488|NCT03527745|4078075|FG023|Overall Study|Lost to Follow-up|8
2343489|NCT03527745|4078076|FG024|Overall Study|Lost to Follow-up|1
2343490|NCT03527745|4078077|FG025|Overall Study|Lost to Follow-up|3
2343491|NCT03527966|4078135|FG000|Overall Study|Lost to Follow-up|3
2343492|NCT03527966|4078136|FG001|Overall Study|Lost to Follow-up|0
2343493|NCT03528174|4078142|FG000|Overall Study|Adverse Event|1
2343494|NCT03528174|4078142|FG000|Overall Study|sensors dislodged|1
2255762|NCT02079805|3922726|FG000|Overall Study|Voluntary Withdrawal|0
2255763|NCT02079805|3922727|FG001|Overall Study|Voluntary Withdrawal|1
2255764|NCT02079844|3922736|FG000|Treatment Period 1|Voluntary Withdrawal|0
2255765|NCT02079844|3922737|FG001|Treatment Period 1|Voluntary Withdrawal|0
2255766|NCT02079844|3922738|FG002|Treatment Period 1|Voluntary Withdrawal|2
2255767|NCT02079844|3922736|FG000|Treatment Period 2|Voluntary Withdrawal|0
2255768|NCT02079844|3922737|FG001|Treatment Period 2|Voluntary Withdrawal|1
2255769|NCT02079844|3922738|FG002|Treatment Period 2|Voluntary Withdrawal|0
2255770|NCT02079909|3922752|FG000|Overall Study|Adverse Event|23
2255771|NCT02079909|3922753|FG001|Overall Study|Adverse Event|23
2255772|NCT02079909|3922754|FG002|Overall Study|Adverse Event|7
2255773|NCT02079909|3922752|FG000|Overall Study|Withdrawal by Subject|9
2255774|NCT02079909|3922753|FG001|Overall Study|Withdrawal by Subject|17
2255775|NCT02079909|3922754|FG002|Overall Study|Withdrawal by Subject|4
2255776|NCT02079909|3922752|FG000|Overall Study|Lost to Follow-up|2
2255777|NCT02079909|3922753|FG001|Overall Study|Lost to Follow-up|3
2255778|NCT02079909|3922754|FG002|Overall Study|Lost to Follow-up|1
2255779|NCT02079909|3922752|FG000|Overall Study|Death|2
2255780|NCT02079909|3922753|FG001|Overall Study|Death|2
2255781|NCT02079909|3922754|FG002|Overall Study|Death|0
2255782|NCT02079909|3922752|FG000|Overall Study|Lack of Efficacy|0
2255783|NCT02079909|3922753|FG001|Overall Study|Lack of Efficacy|0
2255784|NCT02079909|3922754|FG002|Overall Study|Lack of Efficacy|1
2255785|NCT02079909|3922752|FG000|Overall Study|Protocol Violation|0
2255786|NCT02079909|3922753|FG001|Overall Study|Protocol Violation|1
2255787|NCT02079909|3922754|FG002|Overall Study|Protocol Violation|1
2255788|NCT02079909|3922752|FG000|Overall Study|Physician Decision|0
2255789|NCT02079909|3922753|FG001|Overall Study|Physician Decision|1
2255790|NCT02079909|3922754|FG002|Overall Study|Physician Decision|1
2255791|NCT02079909|3922752|FG000|Overall Study|Relocation etc.|2
2255792|NCT02079909|3922753|FG001|Overall Study|Relocation etc.|2
2255793|NCT02079909|3922754|FG002|Overall Study|Relocation etc.|3
2255794|NCT02080091|3922772|FG000|Overall Study|Study Terminated|22
2255795|NCT02080091|3922772|FG000|Overall Study|Death|1
2255796|NCT02080091|3922772|FG000|Overall Study|Withdrawal by Subject|1
2255797|NCT02080091|3922772|FG000|Overall Study|Other|1
2255798|NCT02080221|3922780|FG000|Overall Study|Withdrawal by Subject|1
2255799|NCT02080221|3922780|FG000|Overall Study|Clinical Progression of Disease|1
2255800|NCT02080260|3922784|FG000|Overall Study|Death|18
2255801|NCT02080260|3922784|FG000|Overall Study|Withdrawal by Subject|1
2255802|NCT02080364|3922810|FG000|Baseline Period|Protocol Violation|2
2255803|NCT02080364|3922811|FG001|Baseline Period|Protocol Violation|1
2255804|NCT02080364|3922812|FG002|Baseline Period|Protocol Violation|0
2255805|NCT02080364|3922813|FG003|Baseline Period|Protocol Violation|0
2255806|NCT02080364|3922810|FG000|Baseline Period|Other|0
2255807|NCT02080364|3922811|FG001|Baseline Period|Other|1
2255808|NCT02080364|3922812|FG002|Baseline Period|Other|1
2255809|NCT02080364|3922813|FG003|Baseline Period|Other|0
2255810|NCT02080364|3922810|FG000|Treatment Period|Adverse Event|10
2255811|NCT02080364|3922811|FG001|Treatment Period|Adverse Event|15
2255812|NCT02080364|3922812|FG002|Treatment Period|Adverse Event|11
2255813|NCT02080364|3922813|FG003|Treatment Period|Adverse Event|14
2255814|NCT02080364|3922810|FG000|Treatment Period|Lost to Follow-up|2
2255815|NCT02080364|3922811|FG001|Treatment Period|Lost to Follow-up|3
2255816|NCT02080364|3922812|FG002|Treatment Period|Lost to Follow-up|5
2255817|NCT02080364|3922813|FG003|Treatment Period|Lost to Follow-up|0
2255818|NCT02080364|3922810|FG000|Treatment Period|Protocol Violation|5
2255819|NCT02080364|3922811|FG001|Treatment Period|Protocol Violation|3
2255820|NCT02080364|3922812|FG002|Treatment Period|Protocol Violation|5
2255821|NCT02080364|3922813|FG003|Treatment Period|Protocol Violation|1
2255822|NCT02080364|3922810|FG000|Treatment Period|Withdrawal by Subject|16
2255823|NCT02080364|3922811|FG001|Treatment Period|Withdrawal by Subject|16
2255824|NCT02080364|3922812|FG002|Treatment Period|Withdrawal by Subject|15
2255825|NCT02080364|3922813|FG003|Treatment Period|Withdrawal by Subject|10
2255826|NCT02080364|3922810|FG000|Treatment Period|Study Terminated by Sponsor|0
2255827|NCT02080364|3922811|FG001|Treatment Period|Study Terminated by Sponsor|0
2255828|NCT02080364|3922812|FG002|Treatment Period|Study Terminated by Sponsor|180
2255829|NCT02080364|3922813|FG003|Treatment Period|Study Terminated by Sponsor|183
2255830|NCT02080364|3922810|FG000|Treatment Period|Other|14
2255831|NCT02080364|3922811|FG001|Treatment Period|Other|12
2255832|NCT02080364|3922812|FG002|Treatment Period|Other|21
2255833|NCT02080364|3922813|FG003|Treatment Period|Other|16
2255834|NCT02080403|3922825|FG000|Overall Study|Adverse Event|5
2255835|NCT02080403|3922826|FG001|Overall Study|Adverse Event|1
2255836|NCT02080403|3922825|FG000|Overall Study|Death|0
2255837|NCT02080403|3922826|FG001|Overall Study|Death|2
2255838|NCT02080403|3922825|FG000|Overall Study|Lost to Follow-up|2
2255839|NCT02080403|3922826|FG001|Overall Study|Lost to Follow-up|0
2255840|NCT02080403|3922825|FG000|Overall Study|Pregnancy|0
2255841|NCT02080403|3922826|FG001|Overall Study|Pregnancy|1
2255842|NCT02080403|3922825|FG000|Overall Study|Protocol Violation|3
2255843|NCT02080403|3922826|FG001|Overall Study|Protocol Violation|7
2255844|NCT02080403|3922825|FG000|Overall Study|Withdrawal by Subject|5
2255845|NCT02080403|3922826|FG001|Overall Study|Withdrawal by Subject|1
2255846|NCT02080481|3922867|FG000|Overall Study|Never received a block.|1
2255847|NCT02080481|3922868|FG001|Overall Study|Never received a block.|0
2255848|NCT02080832|3922924|FG000|Overall Study|Excluded from analysis by MRI|9
2255849|NCT02080832|3922925|FG001|Overall Study|Excluded from analysis by MRI|10
2255850|NCT02080832|3922926|FG002|Overall Study|Excluded from analysis by MRI|14
2255851|NCT02080832|3922924|FG000|Overall Study|Lost to Follow-up|0
2255852|NCT02080832|3922925|FG001|Overall Study|Lost to Follow-up|2
2255853|NCT02080832|3922926|FG002|Overall Study|Lost to Follow-up|2
2255854|NCT02080871|3922936|FG000|Overall Study|Death|1
2255855|NCT02080871|3922936|FG000|Overall Study|Lost to Follow-up|1
2255856|NCT02081001|3922942|FG000|Overall Study|Adverse Event|0
2255857|NCT02081001|3922943|FG001|Overall Study|Adverse Event|0
2255858|NCT02081001|3922944|FG002|Overall Study|Adverse Event|0
2255859|NCT02081001|3922945|FG003|Overall Study|Adverse Event|0
2255860|NCT02081001|3922946|FG004|Overall Study|Adverse Event|1
2255861|NCT02081001|3922947|FG005|Overall Study|Adverse Event|0
2255862|NCT02081001|3922948|FG006|Overall Study|Adverse Event|0
2255863|NCT02081001|3922949|FG007|Overall Study|Adverse Event|0
2255864|NCT02081001|3922950|FG008|Overall Study|Adverse Event|0
2255865|NCT02081001|3922951|FG009|Overall Study|Adverse Event|0
2255866|NCT02081001|3922952|FG010|Overall Study|Adverse Event|0
2255867|NCT02081001|3922953|FG011|Overall Study|Adverse Event|0
2255868|NCT02081079|3922990|FG000|Overall Study|Lack of Efficacy|3
2255869|NCT02081079|3922991|FG001|Overall Study|Lack of Efficacy|2
2255870|NCT02081079|3922990|FG000|Overall Study|Lost to Follow-up|1
2255871|NCT02081079|3922991|FG001|Overall Study|Lost to Follow-up|0
2255872|NCT02081196|3923001|FG000|Overall Study|Lost to Follow-up|1
2255873|NCT02081417|3923027|FG000|Overall Study|Lost to Follow-up|26
2255874|NCT02081417|3923028|FG001|Overall Study|Lost to Follow-up|23
2255875|NCT02081417|3923027|FG000|Overall Study|Moved Away|1
2255876|NCT02081417|3923028|FG001|Overall Study|Moved Away|2
2255877|NCT02081417|3923027|FG000|Overall Study|Incarcerated|2
2255878|NCT02081417|3923028|FG001|Overall Study|Incarcerated|2
2255879|NCT02081417|3923027|FG000|Overall Study|Death|4
2255880|NCT02081417|3923028|FG001|Overall Study|Death|3
2255881|NCT02081417|3923027|FG000|Overall Study|Withdrawal by Subject|4
2255882|NCT02081417|3923028|FG001|Overall Study|Withdrawal by Subject|0
2255883|NCT02081417|3923027|FG000|Overall Study|Admitted to Residential Treatment|2
2255884|NCT02081417|3923028|FG001|Overall Study|Admitted to Residential Treatment|0
2255885|NCT02081417|3923027|FG000|Overall Study|Did not start treatment|17
2255886|NCT02081417|3923028|FG001|Overall Study|Did not start treatment|21
2255887|NCT02081534|3923059|FG000|Overall Study|Adverse Event|5
2255888|NCT02081534|3923060|FG001|Overall Study|Adverse Event|4
2255889|NCT02081534|3923061|FG002|Overall Study|Adverse Event|3
2255890|NCT02081534|3923062|FG003|Overall Study|Adverse Event|10
2255891|NCT02081534|3923063|FG004|Overall Study|Adverse Event|2
2255892|NCT02081534|3923064|FG005|Overall Study|Adverse Event|8
2255893|NCT02081534|3923065|FG006|Overall Study|Adverse Event|2
2255894|NCT02081534|3923059|FG000|Overall Study|Withdrawal by Subject|0
2255895|NCT02081534|3923060|FG001|Overall Study|Withdrawal by Subject|1
2255896|NCT02081534|3923061|FG002|Overall Study|Withdrawal by Subject|1
2255897|NCT02081534|3923062|FG003|Overall Study|Withdrawal by Subject|1
2255898|NCT02081534|3923063|FG004|Overall Study|Withdrawal by Subject|1
2255899|NCT02081534|3923064|FG005|Overall Study|Withdrawal by Subject|0
2255900|NCT02081534|3923065|FG006|Overall Study|Withdrawal by Subject|1
2255901|NCT02081534|3923059|FG000|Overall Study|Protocol Violation|0
2255902|NCT02081534|3923060|FG001|Overall Study|Protocol Violation|3
2255903|NCT02081534|3923061|FG002|Overall Study|Protocol Violation|0
2255904|NCT02081534|3923062|FG003|Overall Study|Protocol Violation|0
2255905|NCT02081534|3923063|FG004|Overall Study|Protocol Violation|0
2255906|NCT02081534|3923064|FG005|Overall Study|Protocol Violation|0
2255907|NCT02081534|3923065|FG006|Overall Study|Protocol Violation|1
2255908|NCT02081534|3923059|FG000|Overall Study|Lost to Follow-up|0
2255909|NCT02081534|3923060|FG001|Overall Study|Lost to Follow-up|0
2255910|NCT02081534|3923061|FG002|Overall Study|Lost to Follow-up|0
2255911|NCT02081534|3923062|FG003|Overall Study|Lost to Follow-up|2
2255912|NCT02081534|3923063|FG004|Overall Study|Lost to Follow-up|1
2255913|NCT02081534|3923064|FG005|Overall Study|Lost to Follow-up|1
2255914|NCT02081534|3923065|FG006|Overall Study|Lost to Follow-up|0
2255915|NCT02081586|3923089|FG000|Overall Study|Lost to Follow-up|0
2255916|NCT02081586|3923090|FG001|Overall Study|Lost to Follow-up|1
2255917|NCT02081586|3923091|FG002|Overall Study|Lost to Follow-up|0
2255918|NCT02081586|3923092|FG003|Overall Study|Lost to Follow-up|1
2255919|NCT02081586|3923089|FG000|Overall Study|Head injury not related to study|0
2255920|NCT02081586|3923090|FG001|Overall Study|Head injury not related to study|0
2255921|NCT02081586|3923091|FG002|Overall Study|Head injury not related to study|1
2255922|NCT02081586|3923092|FG003|Overall Study|Head injury not related to study|0
2255923|NCT02081599|3923106|FG000|Period 1：Double-blind Period|Adverse Event|3
2255924|NCT02081599|3923107|FG001|Period 1：Double-blind Period|Adverse Event|0
2255925|NCT02081599|3923106|FG000|Period 1：Double-blind Period|Lack of Efficacy|2
2255926|NCT02081599|3923107|FG001|Period 1：Double-blind Period|Lack of Efficacy|1
2255927|NCT02081599|3923106|FG000|Period 1：Double-blind Period|Physician Decision|1
2255928|NCT02081599|3923107|FG001|Period 1：Double-blind Period|Physician Decision|0
2255929|NCT02081599|3923106|FG000|Period 1：Double-blind Period|Protocol Violation|0
2255930|NCT02081599|3923107|FG001|Period 1：Double-blind Period|Protocol Violation|1
2255931|NCT02081599|3923106|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1
2255932|NCT02081599|3923107|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0
2255933|NCT02081599|3923106|FG000|Period 1：Double-blind Period|stopping criteria|1
2255934|NCT02081599|3923107|FG001|Period 1：Double-blind Period|stopping criteria|0
2255935|NCT02081599|3923106|FG000|Period 2：Open-label Period|Adverse Event|1
2255936|NCT02081599|3923107|FG001|Period 2：Open-label Period|Adverse Event|0
2255937|NCT02081599|3923106|FG000|Period 2：Open-label Period|Lack of Efficacy|2
2255938|NCT02081599|3923107|FG001|Period 2：Open-label Period|Lack of Efficacy|4
2255939|NCT02081599|3923106|FG000|Period 2：Open-label Period|Physician Decision|1
2255940|NCT02081599|3923107|FG001|Period 2：Open-label Period|Physician Decision|0
2255941|NCT02081599|3923106|FG000|Period 2：Open-label Period|Withdrawal by Subject|2
2255942|NCT02081599|3923107|FG001|Period 2：Open-label Period|Withdrawal by Subject|0
2255943|NCT02081677|3923132|FG000|Overall Study|Adverse Event|0
2255944|NCT02081677|3923133|FG001|Overall Study|Adverse Event|0
2255945|NCT02081677|3923134|FG002|Overall Study|Adverse Event|1
2255946|NCT02081677|3923135|FG003|Overall Study|Adverse Event|0
2255947|NCT02081677|3923132|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
2255948|NCT02081677|3923133|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
2255949|NCT02081677|3923134|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
2343495|NCT03528369|4078149|FG000|Overall Study|Withdrawal by Subject|2
2343496|NCT03528369|4078150|FG001|Overall Study|Withdrawal by Subject|0
2343497|NCT03528369|4078151|FG002|Overall Study|Withdrawal by Subject|0
2343498|NCT03528369|4078149|FG000|Overall Study|Lost to Follow-up|1
2343499|NCT03528369|4078150|FG001|Overall Study|Lost to Follow-up|0
2343500|NCT03528369|4078151|FG002|Overall Study|Lost to Follow-up|0
2343501|NCT03528369|4078149|FG000|Overall Study|Adverse Event|0
2343502|NCT03528369|4078150|FG001|Overall Study|Adverse Event|1
2343503|NCT03528369|4078151|FG002|Overall Study|Adverse Event|0
2343504|NCT03528551|4078171|FG000|Overall Study|Lost to Follow-up|0
2343505|NCT03528551|4078172|FG001|Overall Study|Lost to Follow-up|1
2195947|NCT01527487|3828722|FG000|Overall Study|Adverse Event|1
2195948|NCT01527487|3828723|FG001|Overall Study|Adverse Event|1
2195949|NCT01527487|3828722|FG000|Overall Study|Death|0
2195950|NCT01527487|3828723|FG001|Overall Study|Death|1
2195951|NCT01527500|3828738|FG000|Part A|Administrative|11
2195952|NCT01527500|3828739|FG001|Part A|Administrative|7
2195953|NCT01527500|3828738|FG000|Part A|Adverse Event|4
2195954|NCT01527500|3828739|FG001|Part A|Adverse Event|2
2195955|NCT01527500|3828738|FG000|Part A|Death|4
2195956|NCT01527500|3828739|FG001|Part A|Death|1
2195957|NCT01527500|3828738|FG000|Part A|Lost to Follow-up|0
2195958|NCT01527500|3828739|FG001|Part A|Lost to Follow-up|1
2195959|NCT01527500|3828738|FG000|Part A|Protocol Deviation|9
2195960|NCT01527500|3828739|FG001|Part A|Protocol Deviation|2
2195961|NCT01527500|3828738|FG000|Part A|Withdrawal by Subject|2
2195962|NCT01527500|3828739|FG001|Part A|Withdrawal by Subject|0
2195963|NCT01527500|3828738|FG000|Part B|Adverse Event|1
2195964|NCT01527500|3828739|FG001|Part B|Adverse Event|0
2195965|NCT01527682|3828766|FG000|Overall Study|Protocol Violation|8
2195966|NCT01528033|3828772|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8
2195967|NCT01528033|3828773|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7
2195968|NCT01528033|3828772|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
2195969|NCT01528033|3828773|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
2195970|NCT01528033|3828772|FG000|Primary Endpoint Assessment ITT|Death|2
2255950|NCT02081677|3923135|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
2255951|NCT02081677|3923132|FG000|Overall Study|Not comfortable with lens care system|1
2255952|NCT02081677|3923133|FG001|Overall Study|Not comfortable with lens care system|0
2255953|NCT02081677|3923134|FG002|Overall Study|Not comfortable with lens care system|0
2255954|NCT02081677|3923135|FG003|Overall Study|Not comfortable with lens care system|0
2255955|NCT02081677|3923132|FG000|Overall Study|Unsatisfactory Lens Fitting|0
2255956|NCT02081677|3923133|FG001|Overall Study|Unsatisfactory Lens Fitting|1
2255957|NCT02081677|3923134|FG002|Overall Study|Unsatisfactory Lens Fitting|0
2255958|NCT02081677|3923135|FG003|Overall Study|Unsatisfactory Lens Fitting|0
2255959|NCT02081690|3923145|FG000|Overall Study|Death|3
2255960|NCT02081690|3923145|FG000|Overall Study|Physician Decision|3
2255961|NCT02081690|3923145|FG000|Overall Study|Withdrawal by Subject|1
2255962|NCT02081846|3923194|FG000|Overall Study|Withdrawal by Subject|1
2255963|NCT02081846|3923195|FG001|Overall Study|Withdrawal by Subject|0
2255964|NCT02081846|3923194|FG000|Overall Study|invalid consent|1
2255965|NCT02081846|3923195|FG001|Overall Study|invalid consent|0
2255966|NCT02081859|3923203|FG000|Overall Study|No fertilization|2
2255967|NCT02081859|3923204|FG001|Overall Study|No fertilization|2
2255968|NCT02081859|3923203|FG000|Overall Study|No sperm|1
2255969|NCT02081859|3923204|FG001|Overall Study|No sperm|0
2255970|NCT02081859|3923203|FG000|Overall Study|Unanticipated freeze all cycle|2
2255971|NCT02081859|3923204|FG001|Overall Study|Unanticipated freeze all cycle|6
2195971|NCT01528033|3828773|FG001|Primary Endpoint Assessment ITT|Death|2
2255972|NCT02081859|3923203|FG000|Overall Study|< 4 embryos|27
2255973|NCT02081859|3923204|FG001|Overall Study|< 4 embryos|23
2255974|NCT02081859|3923203|FG000|Overall Study|Other reasons|2
2255975|NCT02081859|3923204|FG001|Overall Study|Other reasons|0
2255976|NCT02082158|3923246|FG000|Overall Study|Withdrawal by Subject|0
2343506|NCT03528551|4078173|FG002|Overall Study|Lost to Follow-up|0
2343507|NCT03528551|4078171|FG000|Overall Study|Transferred to other arm/group|2
2255977|NCT02082158|3923247|FG001|Overall Study|Withdrawal by Subject|0
2255978|NCT02082158|3923248|FG002|Overall Study|Withdrawal by Subject|0
2255979|NCT02082158|3923249|FG003|Overall Study|Withdrawal by Subject|0
2255980|NCT02082158|3923250|FG004|Overall Study|Withdrawal by Subject|1
2255981|NCT02082158|3923251|FG005|Overall Study|Withdrawal by Subject|0
2255982|NCT02082158|3923246|FG000|Overall Study|Failed Fit-testing|8
2255983|NCT02082158|3923247|FG001|Overall Study|Failed Fit-testing|8
2255984|NCT02082158|3923248|FG002|Overall Study|Failed Fit-testing|14
2255985|NCT02082158|3923249|FG003|Overall Study|Failed Fit-testing|4
2255986|NCT02082158|3923250|FG004|Overall Study|Failed Fit-testing|3
2255987|NCT02082158|3923251|FG005|Overall Study|Failed Fit-testing|7
2255988|NCT02082184|3923273|FG000|Overall Study|Adverse Event|1
2255989|NCT02082184|3923274|FG001|Overall Study|Adverse Event|0
2255990|NCT02082184|3923273|FG000|Overall Study|Medical diagnosis|1
2255991|NCT02082184|3923274|FG001|Overall Study|Medical diagnosis|2
2255992|NCT02082184|3923273|FG000|Overall Study|Device associated symptoms|5
2255993|NCT02082184|3923274|FG001|Overall Study|Device associated symptoms|0
2255994|NCT02082184|3923273|FG000|Overall Study|Withdrawal by Subject|3
2255995|NCT02082184|3923274|FG001|Overall Study|Withdrawal by Subject|2
2255996|NCT02082184|3923273|FG000|Overall Study|Protocol Violation|0
2255997|NCT02082184|3923274|FG001|Overall Study|Protocol Violation|6
2255998|NCT02082184|3923273|FG000|Overall Study|Lost to Follow-up|0
2255999|NCT02082184|3923274|FG001|Overall Study|Lost to Follow-up|2
2256000|NCT02082184|3923273|FG000|Overall Study|Subject non-compliance|0
2256001|NCT02082184|3923274|FG001|Overall Study|Subject non-compliance|1
2256002|NCT02082210|3923286|FG000|Overall Study|Death|0
2256003|NCT02082210|3923287|FG001|Overall Study|Death|0
2256004|NCT02082210|3923288|FG002|Overall Study|Death|1
2256005|NCT02082210|3923289|FG003|Overall Study|Death|1
2256006|NCT02082210|3923290|FG004|Overall Study|Death|1
2256007|NCT02082210|3923291|FG005|Overall Study|Death|0
2256008|NCT02082210|3923286|FG000|Overall Study|Withdrawal by Subject|0
2256009|NCT02082210|3923287|FG001|Overall Study|Withdrawal by Subject|0
2256010|NCT02082210|3923288|FG002|Overall Study|Withdrawal by Subject|0
2256011|NCT02082210|3923289|FG003|Overall Study|Withdrawal by Subject|1
2256012|NCT02082210|3923290|FG004|Overall Study|Withdrawal by Subject|2
2256013|NCT02082210|3923291|FG005|Overall Study|Withdrawal by Subject|2
2256014|NCT02082210|3923286|FG000|Overall Study|Clinical Progression|0
2256015|NCT02082210|3923287|FG001|Overall Study|Clinical Progression|0
2256016|NCT02082210|3923288|FG002|Overall Study|Clinical Progression|0
2256017|NCT02082210|3923289|FG003|Overall Study|Clinical Progression|1
2256018|NCT02082210|3923290|FG004|Overall Study|Clinical Progression|0
2256019|NCT02082210|3923291|FG005|Overall Study|Clinical Progression|0
2256020|NCT02082210|3923286|FG000|Overall Study|No Post-Baseline Tumor Assesment|0
2256021|NCT02082210|3923287|FG001|Overall Study|No Post-Baseline Tumor Assesment|0
2256022|NCT02082210|3923288|FG002|Overall Study|No Post-Baseline Tumor Assesment|1
2256023|NCT02082210|3923289|FG003|Overall Study|No Post-Baseline Tumor Assesment|2
2256024|NCT02082210|3923290|FG004|Overall Study|No Post-Baseline Tumor Assesment|0
2256025|NCT02082210|3923291|FG005|Overall Study|No Post-Baseline Tumor Assesment|0
2256026|NCT02082210|3923286|FG000|Overall Study|Physician Decision|0
2256027|NCT02082210|3923287|FG001|Overall Study|Physician Decision|0
2256028|NCT02082210|3923288|FG002|Overall Study|Physician Decision|1
2256029|NCT02082210|3923289|FG003|Overall Study|Physician Decision|1
2256030|NCT02082210|3923290|FG004|Overall Study|Physician Decision|0
2256031|NCT02082210|3923291|FG005|Overall Study|Physician Decision|0
2256032|NCT02082262|3923317|FG000|Overall Study|Withdrawal by Subject|3
2256033|NCT02082262|3923317|FG000|Overall Study|Adverse Event|48
2256034|NCT02082340|3923327|FG000|Overall Study|Lost to Follow-up|1
2256035|NCT02082340|3923328|FG001|Overall Study|Lost to Follow-up|1
2256036|NCT02082483|3923345|FG000|Overall Study|Lost to Follow-up|1
2256037|NCT02082483|3923346|FG001|Overall Study|Lost to Follow-up|1
2256038|NCT02082483|3923345|FG000|Overall Study|Withdrawal by Subject|2
2256039|NCT02082483|3923346|FG001|Overall Study|Withdrawal by Subject|1
2256040|NCT02082483|3923345|FG000|Overall Study|Physician Decision|1
2256041|NCT02082483|3923346|FG001|Overall Study|Physician Decision|1
2256042|NCT02082483|3923345|FG000|Overall Study|Death|2
2256043|NCT02082483|3923346|FG001|Overall Study|Death|3
2256044|NCT02082522|3923355|FG000|Overall Study|Sponsor termination|5
2256045|NCT02082522|3923356|FG001|Overall Study|Sponsor termination|3
2256046|NCT02082522|3923355|FG000|Overall Study|Withdrawal by Subject|2
2256047|NCT02082522|3923356|FG001|Overall Study|Withdrawal by Subject|4
2256048|NCT02082522|3923355|FG000|Overall Study|Death|1
2256049|NCT02082522|3923356|FG001|Overall Study|Death|0
2256050|NCT02082522|3923355|FG000|Overall Study|Lost to Follow-up|1
2256051|NCT02082522|3923356|FG001|Overall Study|Lost to Follow-up|0
2256052|NCT02082522|3923355|FG000|Overall Study|Physician Decision|3
2256053|NCT02082522|3923356|FG001|Overall Study|Physician Decision|1
2256054|NCT02082522|3923355|FG000|Overall Study|Disease progression|2
2256055|NCT02082522|3923356|FG001|Overall Study|Disease progression|2
2256056|NCT02082522|3923355|FG000|Overall Study|Chemotherapy change|1
2256057|NCT02082522|3923356|FG001|Overall Study|Chemotherapy change|3
2256058|NCT02082912|3923399|FG000|Overall Study|Physician Decision|0
2256059|NCT02082912|3923400|FG001|Overall Study|Physician Decision|1
2256060|NCT02082977|3923416|FG000|Part 1 (Up to 3.2 Years)|Death|1
2256061|NCT02082977|3923417|FG001|Part 1 (Up to 3.2 Years)|Death|0
2256062|NCT02082977|3923418|FG002|Part 1 (Up to 3.2 Years)|Death|0
2256063|NCT02082977|3923419|FG003|Part 1 (Up to 3.2 Years)|Death|0
2256064|NCT02082977|3923420|FG004|Part 1 (Up to 3.2 Years)|Death|0
2256065|NCT02082977|3923421|FG005|Part 1 (Up to 3.2 Years)|Death|1
2256066|NCT02082977|3923422|FG006|Part 1 (Up to 3.2 Years)|Death|2
2256067|NCT02082977|3923423|FG007|Part 1 (Up to 3.2 Years)|Death|0
2256068|NCT02082977|3923424|FG008|Part 1 (Up to 3.2 Years)|Death|1
2256069|NCT02082977|3923425|FG009|Part 1 (Up to 3.2 Years)|Death|0
2256070|NCT02082977|3923416|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2256071|NCT02082977|3923417|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2256072|NCT02082977|3923418|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2256073|NCT02082977|3923419|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2256074|NCT02082977|3923420|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2256075|NCT02082977|3923421|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2256076|NCT02082977|3923422|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2256077|NCT02082977|3923423|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
2343508|NCT03528551|4078172|FG001|Overall Study|Transferred to other arm/group|3
2343509|NCT03528551|4078173|FG002|Overall Study|Transferred to other arm/group|0
2343510|NCT03528551|4078171|FG000|Overall Study|Withdrawal by parent/guardian|0
2343511|NCT03528551|4078172|FG001|Overall Study|Withdrawal by parent/guardian|5
2343512|NCT03528551|4078173|FG002|Overall Study|Withdrawal by parent/guardian|0
2343513|NCT03528551|4078171|FG000|Overall Study|Protocol Violation|0
2343514|NCT03528551|4078172|FG001|Overall Study|Protocol Violation|3
2343515|NCT03528551|4078173|FG002|Overall Study|Protocol Violation|0
2343516|NCT03528551|4078171|FG000|Overall Study|Withdrawal by Subject|0
2343517|NCT03528551|4078172|FG001|Overall Study|Withdrawal by Subject|7
2343518|NCT03528551|4078173|FG002|Overall Study|Withdrawal by Subject|0
2343519|NCT03528577|4078182|FG000|Sequence 1|Failed Spirometry|1
2343520|NCT03528577|4078182|FG000|Sequence 1|Restricted medication|1
2343521|NCT03528577|4078182|FG000|Sequence 2|Adverse Event|1
2343522|NCT03528577|4078182|FG000|Sequence 2|Withdrawal by Subject|1
2343523|NCT03528577|4078182|FG000|Sequence 2|Failed Spirometry|1
2343524|NCT03528577|4078182|FG000|Sequence 3|Failed Spirometry|1
2343525|NCT03528577|4078182|FG000|Sequence 4|Failed Spirometry|2
2343526|NCT03528577|4078182|FG000|Sequence 4|Adverse Event|1
2343527|NCT03529162|4078191|FG000|Overall Study|Lost to Follow-up|2
2343528|NCT03529162|4078192|FG001|Overall Study|Lost to Follow-up|2
2343529|NCT03529409|4078203|FG000|Randomized|Lost to Follow-up|0
2343530|NCT03529409|4078204|FG001|Randomized|Lost to Follow-up|0
2343531|NCT03529409|4078205|FG002|Randomized|Lost to Follow-up|4
2343532|NCT03529409|4078203|FG000|Randomized|Excluded|0
2343533|NCT03529409|4078204|FG001|Randomized|Excluded|0
2343534|NCT03529409|4078205|FG002|Randomized|Excluded|1
2343535|NCT03529409|4078203|FG000|Post-treatment Assessment|Death|1
2343536|NCT03529409|4078204|FG001|Post-treatment Assessment|Death|0
2343537|NCT03529409|4078205|FG002|Post-treatment Assessment|Death|0
2343538|NCT03529409|4078203|FG000|Post-treatment Assessment|Lost to Follow-up|1
2343539|NCT03529409|4078204|FG001|Post-treatment Assessment|Lost to Follow-up|1
2343540|NCT03529409|4078205|FG002|Post-treatment Assessment|Lost to Follow-up|0
2343541|NCT03529409|4078203|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2
2343542|NCT03529409|4078204|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4
2343543|NCT03529409|4078205|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0
2343544|NCT03529409|4078203|FG000|Follow-up Assessment|Death|1
2343545|NCT03529409|4078204|FG001|Follow-up Assessment|Death|0
2343546|NCT03529409|4078205|FG002|Follow-up Assessment|Death|0
2343547|NCT03529409|4078203|FG000|Follow-up Assessment|Withdrawal by Subject|0
2343548|NCT03529409|4078204|FG001|Follow-up Assessment|Withdrawal by Subject|1
2343549|NCT03529409|4078205|FG002|Follow-up Assessment|Withdrawal by Subject|0
2343550|NCT03529773|4078262|FG000|Overall Study|Adverse Event|0
2343551|NCT03529773|4078263|FG001|Overall Study|Adverse Event|0
2343552|NCT03529773|4078264|FG002|Overall Study|Adverse Event|0
2343553|NCT03529773|4078265|FG003|Overall Study|Adverse Event|0
2343554|NCT03529773|4078266|FG004|Overall Study|Adverse Event|0
2343555|NCT03529773|4078267|FG005|Overall Study|Adverse Event|0
2343556|NCT03529773|4078268|FG006|Overall Study|Adverse Event|0
2343557|NCT03529773|4078269|FG007|Overall Study|Adverse Event|0
2343558|NCT03529773|4078270|FG008|Overall Study|Adverse Event|0
2343559|NCT03529773|4078271|FG009|Overall Study|Adverse Event|0
2343560|NCT03529773|4078272|FG010|Overall Study|Adverse Event|0
2343561|NCT03529773|4078273|FG011|Overall Study|Adverse Event|0
2343562|NCT03529773|4078274|FG012|Overall Study|Adverse Event|0
2343563|NCT03529773|4078275|FG013|Overall Study|Adverse Event|0
2343564|NCT03529773|4078276|FG014|Overall Study|Adverse Event|0
2343565|NCT03529773|4078277|FG015|Overall Study|Adverse Event|0
2343566|NCT03529773|4078278|FG016|Overall Study|Adverse Event|0
2343567|NCT03529773|4078279|FG017|Overall Study|Adverse Event|0
2343568|NCT03529773|4078280|FG018|Overall Study|Adverse Event|0
2195972|NCT01528033|3828772|FG000|Primary Endpoint Assessment ITT|Physician Decision|2
2195973|NCT01528033|3828773|FG001|Primary Endpoint Assessment ITT|Physician Decision|1
2343569|NCT03529773|4078281|FG019|Overall Study|Adverse Event|0
2343570|NCT03529773|4078282|FG020|Overall Study|Adverse Event|0
2343571|NCT03529773|4078283|FG021|Overall Study|Adverse Event|0
2343572|NCT03529773|4078284|FG022|Overall Study|Adverse Event|0
2256078|NCT02082977|3923424|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2256079|NCT02082977|3923425|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2256080|NCT02082977|3923416|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2256081|NCT02082977|3923417|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2256082|NCT02082977|3923418|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2256083|NCT02082977|3923419|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2256084|NCT02082977|3923420|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2256085|NCT02082977|3923421|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
2256086|NCT02082977|3923422|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2256087|NCT02082977|3923423|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2256088|NCT02082977|3923424|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2256089|NCT02082977|3923425|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2256090|NCT02082977|3923416|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0
2256091|NCT02082977|3923417|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0
2256092|NCT02082977|3923418|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0
2256093|NCT02082977|3923419|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0
2256094|NCT02082977|3923420|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1
2256095|NCT02082977|3923421|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1
2256096|NCT02082977|3923422|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4
2256097|NCT02082977|3923423|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1
2256098|NCT02082977|3923424|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2
2256099|NCT02082977|3923425|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0
2256100|NCT02082977|3923416|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2256101|NCT02082977|3923417|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2256102|NCT02082977|3923418|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2256103|NCT02082977|3923419|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2256104|NCT02082977|3923420|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2256105|NCT02082977|3923421|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2256106|NCT02082977|3923422|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2256107|NCT02082977|3923423|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
2256108|NCT02082977|3923424|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2256109|NCT02082977|3923425|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2256110|NCT02083185|3923473|FG000|Overall Study|Lost to Follow-up|0
2256111|NCT02083185|3923474|FG001|Overall Study|Lost to Follow-up|3
2256112|NCT02083185|3923475|FG002|Overall Study|Lost to Follow-up|0
2256113|NCT02083185|3923473|FG000|Overall Study|Withdrawal by Subject|9
2256114|NCT02083185|3923474|FG001|Overall Study|Withdrawal by Subject|15
2256115|NCT02083185|3923475|FG002|Overall Study|Withdrawal by Subject|1
2256116|NCT02083185|3923473|FG000|Overall Study|Death|2
2256117|NCT02083185|3923474|FG001|Overall Study|Death|2
2256118|NCT02083185|3923475|FG002|Overall Study|Death|1
2256119|NCT02083185|3923473|FG000|Overall Study|Reason not Specified|9
2256120|NCT02083185|3923474|FG001|Overall Study|Reason not Specified|6
2256121|NCT02083185|3923475|FG002|Overall Study|Reason not Specified|5
2256122|NCT02083185|3923473|FG000|Overall Study|Study Terminated by Sponsor|0
2256123|NCT02083185|3923474|FG001|Overall Study|Study Terminated by Sponsor|1
2256124|NCT02083185|3923475|FG002|Overall Study|Study Terminated by Sponsor|0
2256125|NCT02083185|3923473|FG000|Overall Study|Did not Receive Study Drug|0
2256126|NCT02083185|3923474|FG001|Overall Study|Did not Receive Study Drug|2
2256127|NCT02083185|3923475|FG002|Overall Study|Did not Receive Study Drug|0
2256128|NCT02083380|3923495|FG000|Overall Study|Lack of Efficacy|68
2256129|NCT02083380|3923496|FG001|Overall Study|Lack of Efficacy|79
2256130|NCT02083380|3923497|FG002|Overall Study|Lack of Efficacy|64
2256131|NCT02083380|3923495|FG000|Overall Study|Withdrawal by Subject|9
2256132|NCT02083380|3923496|FG001|Overall Study|Withdrawal by Subject|3
2256133|NCT02083380|3923497|FG002|Overall Study|Withdrawal by Subject|7
2256134|NCT02083380|3923495|FG000|Overall Study|Physician Decision|1
2256135|NCT02083380|3923496|FG001|Overall Study|Physician Decision|6
2256136|NCT02083380|3923497|FG002|Overall Study|Physician Decision|3
2256137|NCT02083380|3923495|FG000|Overall Study|Adverse Event|0
2256138|NCT02083380|3923496|FG001|Overall Study|Adverse Event|0
2256139|NCT02083380|3923497|FG002|Overall Study|Adverse Event|1
2256140|NCT02083380|3923495|FG000|Overall Study|Lost to Follow-up|5
2256141|NCT02083380|3923496|FG001|Overall Study|Lost to Follow-up|3
2256142|NCT02083380|3923497|FG002|Overall Study|Lost to Follow-up|3
2256143|NCT02083380|3923495|FG000|Overall Study|Other|8
2256144|NCT02083380|3923496|FG001|Overall Study|Other|4
2256145|NCT02083380|3923497|FG002|Overall Study|Other|6
2256146|NCT02083653|3923526|FG000|Overall Study|Randomized but not Treated|0
2256147|NCT02083653|3923527|FG001|Overall Study|Randomized but not Treated|2
2256148|NCT02083653|3923528|FG002|Overall Study|Randomized but not Treated|7
2256149|NCT02083653|3923526|FG000|Overall Study|Adverse Event|12
2256150|NCT02083653|3923527|FG001|Overall Study|Adverse Event|5
2256151|NCT02083653|3923528|FG002|Overall Study|Adverse Event|4
2256152|NCT02083653|3923526|FG000|Overall Study|Lost to Follow-up|1
2256153|NCT02083653|3923527|FG001|Overall Study|Lost to Follow-up|0
2256154|NCT02083653|3923528|FG002|Overall Study|Lost to Follow-up|0
2343573|NCT03529773|4078285|FG023|Overall Study|Adverse Event|0
2256155|NCT02083653|3923526|FG000|Overall Study|Death|2
2256156|NCT02083653|3923527|FG001|Overall Study|Death|2
2256157|NCT02083653|3923528|FG002|Overall Study|Death|2
2256158|NCT02083653|3923526|FG000|Overall Study|Progressive Disease|65
2256159|NCT02083653|3923527|FG001|Overall Study|Progressive Disease|73
2256160|NCT02083653|3923528|FG002|Overall Study|Progressive Disease|63
2256161|NCT02083653|3923526|FG000|Overall Study|Withdrawal by Subject|2
2256162|NCT02083653|3923527|FG001|Overall Study|Withdrawal by Subject|1
2256163|NCT02083653|3923528|FG002|Overall Study|Withdrawal by Subject|2
2256164|NCT02083653|3923526|FG000|Overall Study|Other Events|0
2256165|NCT02083653|3923527|FG001|Overall Study|Other Events|2
2256166|NCT02083653|3923528|FG002|Overall Study|Other Events|2
2256167|NCT02083653|3923526|FG000|Overall Study|Reason Missing|0
2256168|NCT02083653|3923527|FG001|Overall Study|Reason Missing|0
2256169|NCT02083653|3923528|FG002|Overall Study|Reason Missing|4
2256170|NCT02083783|3923555|FG000|Overall Study|Withdrawal by Subject|1
2256171|NCT02083783|3923556|FG001|Overall Study|Withdrawal by Subject|0
2343574|NCT03529773|4078286|FG024|Overall Study|Adverse Event|0
2343575|NCT03529773|4078287|FG025|Overall Study|Adverse Event|0
2343576|NCT03529773|4078288|FG026|Overall Study|Adverse Event|0
2343577|NCT03529773|4078289|FG027|Overall Study|Adverse Event|0
2343578|NCT03529773|4078290|FG028|Overall Study|Adverse Event|0
2343579|NCT03529773|4078291|FG029|Overall Study|Adverse Event|0
2343580|NCT03529773|4078292|FG030|Overall Study|Adverse Event|1
2343581|NCT03529773|4078293|FG031|Overall Study|Adverse Event|0
2343582|NCT03529773|4078294|FG032|Overall Study|Adverse Event|0
2343583|NCT03529773|4078295|FG033|Overall Study|Adverse Event|0
2343584|NCT03529773|4078296|FG034|Overall Study|Adverse Event|0
2343585|NCT03529773|4078297|FG035|Overall Study|Adverse Event|1
2343586|NCT03529773|4078298|FG036|Overall Study|Adverse Event|0
2343587|NCT03529773|4078299|FG037|Overall Study|Adverse Event|0
2343588|NCT03529773|4078300|FG038|Overall Study|Adverse Event|0
2343589|NCT03529773|4078301|FG039|Overall Study|Adverse Event|1
2343590|NCT03529773|4078262|FG000|Overall Study|Death|0
2343591|NCT03529773|4078263|FG001|Overall Study|Death|0
2343592|NCT03529773|4078264|FG002|Overall Study|Death|0
2343593|NCT03529773|4078265|FG003|Overall Study|Death|0
2343594|NCT03529773|4078266|FG004|Overall Study|Death|0
2343595|NCT03529773|4078267|FG005|Overall Study|Death|0
2343596|NCT03529773|4078268|FG006|Overall Study|Death|0
2343597|NCT03529773|4078269|FG007|Overall Study|Death|0
2343598|NCT03529773|4078270|FG008|Overall Study|Death|0
2343599|NCT03529773|4078271|FG009|Overall Study|Death|0
2343600|NCT03529773|4078272|FG010|Overall Study|Death|0
2343601|NCT03529773|4078273|FG011|Overall Study|Death|0
2343602|NCT03529773|4078274|FG012|Overall Study|Death|1
2343603|NCT03529773|4078275|FG013|Overall Study|Death|0
2343604|NCT03529773|4078276|FG014|Overall Study|Death|0
2343605|NCT03529773|4078277|FG015|Overall Study|Death|0
2343606|NCT03529773|4078278|FG016|Overall Study|Death|0
2343607|NCT03529773|4078279|FG017|Overall Study|Death|0
2343608|NCT03529773|4078280|FG018|Overall Study|Death|0
2343609|NCT03529773|4078281|FG019|Overall Study|Death|1
2343610|NCT03529773|4078282|FG020|Overall Study|Death|0
2343611|NCT03529773|4078283|FG021|Overall Study|Death|0
2343612|NCT03529773|4078284|FG022|Overall Study|Death|1
2343613|NCT03529773|4078285|FG023|Overall Study|Death|0
2343614|NCT03529773|4078286|FG024|Overall Study|Death|0
2343615|NCT03529773|4078287|FG025|Overall Study|Death|0
2343616|NCT03529773|4078288|FG026|Overall Study|Death|0
2343617|NCT03529773|4078289|FG027|Overall Study|Death|0
2343618|NCT03529773|4078290|FG028|Overall Study|Death|0
2343619|NCT03529773|4078291|FG029|Overall Study|Death|0
2343620|NCT03529773|4078292|FG030|Overall Study|Death|0
2343621|NCT03529773|4078293|FG031|Overall Study|Death|0
2343622|NCT03529773|4078294|FG032|Overall Study|Death|0
2343623|NCT03529773|4078295|FG033|Overall Study|Death|1
2343624|NCT03529773|4078296|FG034|Overall Study|Death|1
2343625|NCT03529773|4078297|FG035|Overall Study|Death|0
2343626|NCT03529773|4078298|FG036|Overall Study|Death|1
2343627|NCT03529773|4078299|FG037|Overall Study|Death|0
2343628|NCT03529773|4078300|FG038|Overall Study|Death|0
2343629|NCT03529773|4078301|FG039|Overall Study|Death|0
2343630|NCT03529773|4078262|FG000|Overall Study|Lost to Follow-up|0
2343631|NCT03529773|4078263|FG001|Overall Study|Lost to Follow-up|0
2343632|NCT03529773|4078264|FG002|Overall Study|Lost to Follow-up|1
2343633|NCT03529773|4078265|FG003|Overall Study|Lost to Follow-up|0
2343634|NCT03529773|4078266|FG004|Overall Study|Lost to Follow-up|1
2343635|NCT03529773|4078267|FG005|Overall Study|Lost to Follow-up|1
2343636|NCT03529773|4078268|FG006|Overall Study|Lost to Follow-up|0
2343637|NCT03529773|4078269|FG007|Overall Study|Lost to Follow-up|0
2343638|NCT03529773|4078270|FG008|Overall Study|Lost to Follow-up|0
2343639|NCT03529773|4078271|FG009|Overall Study|Lost to Follow-up|0
2343640|NCT03529773|4078272|FG010|Overall Study|Lost to Follow-up|0
2343641|NCT03529773|4078273|FG011|Overall Study|Lost to Follow-up|0
2343642|NCT03529773|4078274|FG012|Overall Study|Lost to Follow-up|0
2343643|NCT03529773|4078275|FG013|Overall Study|Lost to Follow-up|1
2343644|NCT03529773|4078276|FG014|Overall Study|Lost to Follow-up|4
2343645|NCT03529773|4078277|FG015|Overall Study|Lost to Follow-up|1
2343646|NCT03529773|4078278|FG016|Overall Study|Lost to Follow-up|1
2343647|NCT03529773|4078279|FG017|Overall Study|Lost to Follow-up|0
2343648|NCT03529773|4078280|FG018|Overall Study|Lost to Follow-up|1
2343649|NCT03529773|4078281|FG019|Overall Study|Lost to Follow-up|1
2343650|NCT03529773|4078282|FG020|Overall Study|Lost to Follow-up|2
2343651|NCT03529773|4078283|FG021|Overall Study|Lost to Follow-up|4
2256172|NCT02083926|3923586|FG000|Overall Study|Withdrawal by Subject|1
2256173|NCT02083926|3923587|FG001|Overall Study|Withdrawal by Subject|0
2256174|NCT02083965|3923596|FG000|Treatment Period|Other|1
2256175|NCT02083965|3923597|FG001|Treatment Period|Other|0
2256176|NCT02084056|3923607|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
2256177|NCT02084056|3923608|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2256178|NCT02084056|3923609|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2256179|NCT02084056|3923610|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2256180|NCT02084056|3923607|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1
2256181|NCT02084056|3923608|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2256182|NCT02084056|3923609|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2256183|NCT02084056|3923610|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2256184|NCT02084082|3923631|FG000|Washout Period 1 (35 Days)|Adverse Event|0
2256185|NCT02084082|3923632|FG001|Washout Period 1 (35 Days)|Adverse Event|0
2256186|NCT02084082|3923633|FG002|Washout Period 1 (35 Days)|Adverse Event|1
2256187|NCT02084082|3923634|FG003|Washout Period 1 (35 Days)|Adverse Event|1
2256188|NCT02084082|3923631|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2256189|NCT02084082|3923632|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2256190|NCT02084082|3923633|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2256191|NCT02084082|3923634|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1
2256192|NCT02084134|3923646|FG000|Overall Study|Protocol Violation|4
2256193|NCT02084134|3923647|FG001|Overall Study|Protocol Violation|2
2256194|NCT02084134|3923646|FG000|Overall Study|Death|0
2256195|NCT02084134|3923647|FG001|Overall Study|Death|1
2256196|NCT02084238|3923657|FG000|Overall Study|Lost to Follow-up|2
2256197|NCT02085135|3923713|FG000|Overall Study|Adverse Event|4
2256198|NCT02085135|3923714|FG001|Overall Study|Adverse Event|7
2256199|NCT02085135|3923713|FG000|Overall Study|Lost to Follow-up|2
2256200|NCT02085135|3923714|FG001|Overall Study|Lost to Follow-up|2
2256201|NCT02085135|3923713|FG000|Overall Study|Withdrawal by Subject|3
2256202|NCT02085135|3923714|FG001|Overall Study|Withdrawal by Subject|0
2256203|NCT02085135|3923713|FG000|Overall Study|Lack of Efficacy|2
2256204|NCT02085135|3923714|FG001|Overall Study|Lack of Efficacy|0
2256205|NCT02085161|3923724|FG000|Overall Study|Not Treated|1
2256206|NCT02085161|3923725|FG001|Overall Study|Not Treated|0
2256207|NCT02085161|3923726|FG002|Overall Study|Not Treated|0
2256208|NCT02085161|3923727|FG003|Overall Study|Not Treated|0
2256209|NCT02085161|3923724|FG000|Overall Study|Adverse Event|8
2256210|NCT02085161|3923725|FG001|Overall Study|Adverse Event|5
2256211|NCT02085161|3923726|FG002|Overall Study|Adverse Event|4
2256212|NCT02085161|3923727|FG003|Overall Study|Adverse Event|5
2256213|NCT02085161|3923724|FG000|Overall Study|Protocol Violation|0
2256214|NCT02085161|3923725|FG001|Overall Study|Protocol Violation|1
2256215|NCT02085161|3923726|FG002|Overall Study|Protocol Violation|0
2256216|NCT02085161|3923727|FG003|Overall Study|Protocol Violation|1
2256217|NCT02085161|3923724|FG000|Overall Study|Withdrawal by Subject|2
2256218|NCT02085161|3923725|FG001|Overall Study|Withdrawal by Subject|4
2256219|NCT02085161|3923726|FG002|Overall Study|Withdrawal by Subject|0
2256220|NCT02085161|3923727|FG003|Overall Study|Withdrawal by Subject|3
2256221|NCT02085161|3923724|FG000|Overall Study|Other Reason|1
2256222|NCT02085161|3923725|FG001|Overall Study|Other Reason|0
2256223|NCT02085161|3923726|FG002|Overall Study|Other Reason|1
2256224|NCT02085161|3923727|FG003|Overall Study|Other Reason|1
2256225|NCT02085252|3923740|FG000|Overall Study|Withdrawal of Consent|1
2256226|NCT02085252|3923741|FG001|Overall Study|Withdrawal of Consent|0
2256227|NCT02085252|3923740|FG000|Overall Study|Adverse Event|0
2256228|NCT02085252|3923741|FG001|Overall Study|Adverse Event|1
2256229|NCT02085252|3923740|FG000|Overall Study|Discontinuation Due to Patient Decision|0
2256230|NCT02085252|3923741|FG001|Overall Study|Discontinuation Due to Patient Decision|1
2256231|NCT02085252|3923740|FG000|Overall Study|Reason Not Specified|0
2256232|NCT02085252|3923741|FG001|Overall Study|Reason Not Specified|1
2256233|NCT02085252|3923740|FG000|Overall Study|Reason Unknown|0
2256234|NCT02085252|3923741|FG001|Overall Study|Reason Unknown|1
2256235|NCT02085460|3923772|FG000|Overall Study|Adverse Event|2
2256236|NCT02085460|3923773|FG001|Overall Study|Adverse Event|2
2256237|NCT02085460|3923774|FG002|Overall Study|Adverse Event|1
2256238|NCT02085460|3923772|FG000|Overall Study|Physician Decision|1
2256239|NCT02085460|3923773|FG001|Overall Study|Physician Decision|1
2256240|NCT02085460|3923774|FG002|Overall Study|Physician Decision|2
2256241|NCT02085460|3923772|FG000|Overall Study|Withdrawal by Subject|11
2256242|NCT02085460|3923773|FG001|Overall Study|Withdrawal by Subject|5
2256243|NCT02085460|3923774|FG002|Overall Study|Withdrawal by Subject|7
2256244|NCT02085785|3923813|FG000|Overall Study|Withdrawal by Subject|2
2343652|NCT03529773|4078284|FG022|Overall Study|Lost to Follow-up|1
2343653|NCT03529773|4078285|FG023|Overall Study|Lost to Follow-up|4
2256245|NCT02085785|3923814|FG001|Overall Study|Withdrawal by Subject|1
2256246|NCT02085785|3923813|FG000|Overall Study|Lost to Follow-up|0
2256247|NCT02085785|3923814|FG001|Overall Study|Lost to Follow-up|1
2256248|NCT02086110|3923828|FG000|Overall Study|Withdrawal by Subject|1
2256249|NCT02086110|3923829|FG001|Overall Study|Withdrawal by Subject|1
2256250|NCT02086162|3923838|FG000|Overall Study|Withdrawal by Subject|4
2256251|NCT02086162|3923839|FG001|Overall Study|Withdrawal by Subject|4
2256252|NCT02086162|3923838|FG000|Overall Study|moved|1
2256253|NCT02086162|3923839|FG001|Overall Study|moved|1
2256254|NCT02086162|3923838|FG000|Overall Study|Lost to Follow-up|4
2256255|NCT02086162|3923839|FG001|Overall Study|Lost to Follow-up|2
2256256|NCT02086162|3923838|FG000|Overall Study|Death|1
2256257|NCT02086162|3923839|FG001|Overall Study|Death|0
2256258|NCT02086565|3923877|FG000|Overall Study|Lost to Follow-up|9
2256259|NCT02086565|3923878|FG001|Overall Study|Lost to Follow-up|7
2256260|NCT02086565|3923877|FG000|Overall Study|Withdrawal by Subject|2
2256261|NCT02086565|3923878|FG001|Overall Study|Withdrawal by Subject|1
2256262|NCT02086565|3923877|FG000|Overall Study|Death|3
2256263|NCT02086565|3923878|FG001|Overall Study|Death|2
2256264|NCT02086565|3923877|FG000|Overall Study|withdrawn by research team|2
2256265|NCT02086565|3923878|FG001|Overall Study|withdrawn by research team|2
2256266|NCT02086591|3923884|FG000|Overall Study|Adverse Event|1
2256267|NCT02086591|3923884|FG000|Overall Study|Withdrawal by Subject|1
2256268|NCT02086591|3923884|FG000|Overall Study|protocol terminated|3
2256269|NCT02086968|3923922|FG000|Overall Study|Adverse Event|1
2256270|NCT02086968|3923923|FG001|Overall Study|Adverse Event|5
2256271|NCT02086968|3923922|FG000|Overall Study|Lost to Follow-up|2
2256272|NCT02086968|3923923|FG001|Overall Study|Lost to Follow-up|3
2256273|NCT02086968|3923922|FG000|Overall Study|Study drug received outside protocol|0
2256274|NCT02086968|3923923|FG001|Overall Study|Study drug received outside protocol|1
2256275|NCT02086968|3923922|FG000|Overall Study|Physician Decision|4
2256276|NCT02086968|3923923|FG001|Overall Study|Physician Decision|0
2256277|NCT02086968|3923922|FG000|Overall Study|Withdrawal by Subject|1
2256278|NCT02086968|3923923|FG001|Overall Study|Withdrawal by Subject|4
2256279|NCT02087046|3923929|FG000|Overall Study|Adverse Event|4
2256280|NCT02087046|3923929|FG000|Overall Study|Death|1
2256281|NCT02087046|3923929|FG000|Overall Study|Lost to Follow-up|3
2256282|NCT02087046|3923929|FG000|Overall Study|Withdrawal by Subject|2
2256283|NCT02087046|3923929|FG000|Overall Study|Physician Decision|1
2256284|NCT02087059|3923934|FG000|Overall Study|Disease Progression|1
2256285|NCT02087059|3923934|FG000|Overall Study|Adverse Event|5
2256286|NCT02087059|3923934|FG000|Overall Study|Lost to Follow-up|1
2256287|NCT02087085|3923940|FG000|Overall Study|Adverse Event|10
2256288|NCT02087085|3923941|FG001|Overall Study|Adverse Event|14
2256289|NCT02087085|3923940|FG000|Overall Study|Lack of Efficacy|4
2256290|NCT02087085|3923941|FG001|Overall Study|Lack of Efficacy|3
2256291|NCT02087085|3923940|FG000|Overall Study|Lost to Follow-up|6
2256292|NCT02087085|3923941|FG001|Overall Study|Lost to Follow-up|4
2256293|NCT02087085|3923940|FG000|Overall Study|Withdrawal by Subject|9
2256294|NCT02087085|3923941|FG001|Overall Study|Withdrawal by Subject|11
2256295|NCT02087085|3923940|FG000|Overall Study|Protocol Violation|1
2256296|NCT02087085|3923941|FG001|Overall Study|Protocol Violation|0
2256297|NCT02087085|3923940|FG000|Overall Study|Study Terminated by Sponsor|87
2256298|NCT02087085|3923941|FG001|Overall Study|Study Terminated by Sponsor|80
2256299|NCT02087085|3923940|FG000|Overall Study|Other Miscellaneous Reasons|3
2256300|NCT02087085|3923941|FG001|Overall Study|Other Miscellaneous Reasons|4
2256301|NCT02087150|3923950|FG000|Overall Study|Death|0
2256302|NCT02087150|3923951|FG001|Overall Study|Death|1
2343654|NCT03529773|4078286|FG024|Overall Study|Lost to Follow-up|3
2343655|NCT03529773|4078287|FG025|Overall Study|Lost to Follow-up|4
2343656|NCT03529773|4078288|FG026|Overall Study|Lost to Follow-up|5
2343657|NCT03529773|4078289|FG027|Overall Study|Lost to Follow-up|0
2343658|NCT03529773|4078290|FG028|Overall Study|Lost to Follow-up|0
2343659|NCT03529773|4078291|FG029|Overall Study|Lost to Follow-up|0
2343660|NCT03529773|4078292|FG030|Overall Study|Lost to Follow-up|1
2343661|NCT03529773|4078293|FG031|Overall Study|Lost to Follow-up|0
2343662|NCT03529773|4078294|FG032|Overall Study|Lost to Follow-up|0
2343663|NCT03529773|4078295|FG033|Overall Study|Lost to Follow-up|1
2343664|NCT03529773|4078296|FG034|Overall Study|Lost to Follow-up|1
2343665|NCT03529773|4078297|FG035|Overall Study|Lost to Follow-up|0
2343666|NCT03529773|4078298|FG036|Overall Study|Lost to Follow-up|0
2343667|NCT03529773|4078299|FG037|Overall Study|Lost to Follow-up|0
2343668|NCT03529773|4078300|FG038|Overall Study|Lost to Follow-up|0
2343669|NCT03529773|4078301|FG039|Overall Study|Lost to Follow-up|1
2343670|NCT03529773|4078262|FG000|Overall Study|No longer meets eligibility criteria|0
2343671|NCT03529773|4078263|FG001|Overall Study|No longer meets eligibility criteria|0
2343672|NCT03529773|4078264|FG002|Overall Study|No longer meets eligibility criteria|0
2343673|NCT03529773|4078265|FG003|Overall Study|No longer meets eligibility criteria|0
2343674|NCT03529773|4078266|FG004|Overall Study|No longer meets eligibility criteria|0
2343675|NCT03529773|4078267|FG005|Overall Study|No longer meets eligibility criteria|0
2343676|NCT03529773|4078268|FG006|Overall Study|No longer meets eligibility criteria|0
2343677|NCT03529773|4078269|FG007|Overall Study|No longer meets eligibility criteria|0
2343678|NCT03529773|4078270|FG008|Overall Study|No longer meets eligibility criteria|0
2343679|NCT03529773|4078271|FG009|Overall Study|No longer meets eligibility criteria|0
2343680|NCT03529773|4078272|FG010|Overall Study|No longer meets eligibility criteria|0
2343681|NCT03529773|4078273|FG011|Overall Study|No longer meets eligibility criteria|0
2343682|NCT03529773|4078274|FG012|Overall Study|No longer meets eligibility criteria|0
2343683|NCT03529773|4078275|FG013|Overall Study|No longer meets eligibility criteria|0
2343684|NCT03529773|4078276|FG014|Overall Study|No longer meets eligibility criteria|0
2256303|NCT02087150|3923952|FG002|Overall Study|Death|0
2256304|NCT02087150|3923950|FG000|Overall Study|Lost to Follow-up|6
2256305|NCT02087150|3923951|FG001|Overall Study|Lost to Follow-up|13
2256306|NCT02087150|3923952|FG002|Overall Study|Lost to Follow-up|7
2256307|NCT02087150|3923950|FG000|Overall Study|Withdrawal by Subject|2
2256308|NCT02087150|3923951|FG001|Overall Study|Withdrawal by Subject|5
2256309|NCT02087150|3923952|FG002|Overall Study|Withdrawal by Subject|3
2256310|NCT02087150|3923950|FG000|Overall Study|Physician Decision|0
2256311|NCT02087150|3923951|FG001|Overall Study|Physician Decision|1
2256312|NCT02087150|3923952|FG002|Overall Study|Physician Decision|0
2256313|NCT02087150|3923950|FG000|Overall Study|Procedure not done|1
2256314|NCT02087150|3923951|FG001|Overall Study|Procedure not done|13
2256315|NCT02087150|3923952|FG002|Overall Study|Procedure not done|0
2256316|NCT02087150|3923950|FG000|Overall Study|F/U not completed w/in study window|0
2256317|NCT02087150|3923951|FG001|Overall Study|F/U not completed w/in study window|0
2256318|NCT02087150|3923952|FG002|Overall Study|F/U not completed w/in study window|1
2256319|NCT02087150|3923950|FG000|Overall Study|Other|1
2256320|NCT02087150|3923951|FG001|Overall Study|Other|0
2256321|NCT02087150|3923952|FG002|Overall Study|Other|0
2256322|NCT02087150|3923950|FG000|Overall Study|Pt moved out of town|0
2256323|NCT02087150|3923951|FG001|Overall Study|Pt moved out of town|1
2256324|NCT02087150|3923952|FG002|Overall Study|Pt moved out of town|0
2256325|NCT02087176|3923965|FG000|Overall Study|Withdrawal by Subject|1
2256326|NCT02087176|3923965|FG000|Overall Study|Death|10
2256327|NCT02087176|3923965|FG000|Overall Study|Censored|19
2256328|NCT02087176|3923965|FG000|Overall Study|Study Terminated by Sponsor|2
2256329|NCT02087241|3923973|FG000|Overall Study|Death|2
2256330|NCT02087241|3923974|FG001|Overall Study|Death|1
2256331|NCT02087241|3923975|FG002|Overall Study|Death|1
2256332|NCT02087241|3923976|FG003|Overall Study|Death|1
2256333|NCT02087241|3923973|FG000|Overall Study|Withdrawal by Subject|1
2256334|NCT02087241|3923974|FG001|Overall Study|Withdrawal by Subject|0
2256335|NCT02087241|3923975|FG002|Overall Study|Withdrawal by Subject|0
2256336|NCT02087241|3923976|FG003|Overall Study|Withdrawal by Subject|1
2256337|NCT02087241|3923973|FG000|Overall Study|Progressive Disease|0
2256338|NCT02087241|3923974|FG001|Overall Study|Progressive Disease|0
2256339|NCT02087241|3923975|FG002|Overall Study|Progressive Disease|0
2256340|NCT02087241|3923976|FG003|Overall Study|Progressive Disease|1
2256341|NCT02087241|3923973|FG000|Overall Study|Study Terminated by Sponsor|0
2256342|NCT02087241|3923974|FG001|Overall Study|Study Terminated by Sponsor|2
2256343|NCT02087241|3923975|FG002|Overall Study|Study Terminated by Sponsor|0
2256344|NCT02087241|3923976|FG003|Overall Study|Study Terminated by Sponsor|4
2256345|NCT02087423|3924005|FG000|Overall Study|Withdrawal by Subject|20
2256346|NCT02087423|3924006|FG001|Overall Study|Withdrawal by Subject|20
2256347|NCT02087423|3924007|FG002|Overall Study|Withdrawal by Subject|3
2256348|NCT02087423|3924005|FG000|Overall Study|Death|68
2256349|NCT02087423|3924006|FG001|Overall Study|Death|207
2256350|NCT02087423|3924007|FG002|Overall Study|Death|40
2256351|NCT02087423|3924005|FG000|Overall Study|Lost to Follow-up|0
2256352|NCT02087423|3924006|FG001|Overall Study|Lost to Follow-up|2
2256353|NCT02087423|3924007|FG002|Overall Study|Lost to Follow-up|0
2256354|NCT02087423|3924005|FG000|Overall Study|Terminated from study at final DCO|23
2256355|NCT02087423|3924006|FG001|Overall Study|Terminated from study at final DCO|36
2256356|NCT02087423|3924007|FG002|Overall Study|Terminated from study at final DCO|25
2256357|NCT02087670|3924044|FG000|Overall Study|Withdrawal by Subject|3
2256358|NCT02087670|3924045|FG001|Overall Study|Withdrawal by Subject|2
2256359|NCT02087774|3924061|FG000|Overall Study|Were absent day of data collection|8
2256360|NCT02087774|3924062|FG001|Overall Study|Were absent day of data collection|20
2256361|NCT02087904|3924072|FG000|Overall Study|Did Not Receive Study Drug|0
2256362|NCT02087904|3924073|FG001|Overall Study|Did Not Receive Study Drug|0
2256363|NCT02087904|3924074|FG002|Overall Study|Did Not Receive Study Drug|2
2256364|NCT02087904|3924075|FG003|Overall Study|Did Not Receive Study Drug|1
2256365|NCT02087904|3924072|FG000|Overall Study|Adverse Event|8
2256366|NCT02087904|3924073|FG001|Overall Study|Adverse Event|4
2256367|NCT02087904|3924074|FG002|Overall Study|Adverse Event|4
2256368|NCT02087904|3924075|FG003|Overall Study|Adverse Event|12
2256369|NCT02087904|3924072|FG000|Overall Study|Lack of Efficacy|3
2256370|NCT02087904|3924073|FG001|Overall Study|Lack of Efficacy|6
2256371|NCT02087904|3924074|FG002|Overall Study|Lack of Efficacy|3
2256372|NCT02087904|3924075|FG003|Overall Study|Lack of Efficacy|2
2256373|NCT02087904|3924072|FG000|Overall Study|Other|6
2256374|NCT02087904|3924073|FG001|Overall Study|Other|2
2256375|NCT02087904|3924074|FG002|Overall Study|Other|4
2256376|NCT02087904|3924075|FG003|Overall Study|Other|4
2256377|NCT02087904|3924072|FG000|Overall Study|Withdrawal by Subject|8
2256378|NCT02087904|3924073|FG001|Overall Study|Withdrawal by Subject|3
2256379|NCT02087904|3924074|FG002|Overall Study|Withdrawal by Subject|7
2256380|NCT02087904|3924075|FG003|Overall Study|Withdrawal by Subject|4
2256381|NCT02087904|3924072|FG000|Overall Study|Lost to Follow-up|0
2256382|NCT02087904|3924073|FG001|Overall Study|Lost to Follow-up|4
2256383|NCT02087904|3924074|FG002|Overall Study|Lost to Follow-up|2
2256384|NCT02087904|3924075|FG003|Overall Study|Lost to Follow-up|2
2256385|NCT02087943|3924088|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1
2256386|NCT02087943|3924089|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2
2256387|NCT02087943|3924090|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6
2256388|NCT02087943|3924091|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0
2256389|NCT02087943|3924092|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0
2256390|NCT02087943|3924088|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
2256391|NCT02087943|3924089|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
2256392|NCT02087943|3924090|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
2256393|NCT02087943|3924091|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
2256394|NCT02087943|3924092|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
2256395|NCT02087943|3924088|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
2256396|NCT02087943|3924089|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
2256397|NCT02087943|3924090|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
2256398|NCT02087943|3924091|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
2256399|NCT02087943|3924092|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
2256400|NCT02087943|3924088|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
2256401|NCT02087943|3924089|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
2256402|NCT02087943|3924090|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
2256403|NCT02087943|3924091|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
2256404|NCT02087943|3924092|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
2256405|NCT02087943|3924088|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2256406|NCT02087943|3924089|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
2256407|NCT02087943|3924090|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2256408|NCT02087943|3924091|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2256409|NCT02087943|3924092|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2256410|NCT02087943|3924088|FG000|Active Treatment Phase Week 12-24|Adverse Event|0
2256411|NCT02087943|3924089|FG001|Active Treatment Phase Week 12-24|Adverse Event|1
2256412|NCT02087943|3924090|FG002|Active Treatment Phase Week 12-24|Adverse Event|2
2256413|NCT02087943|3924091|FG003|Active Treatment Phase Week 12-24|Adverse Event|0
2256414|NCT02087943|3924092|FG004|Active Treatment Phase Week 12-24|Adverse Event|1
2256415|NCT02087943|3924088|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0
2256416|NCT02087943|3924089|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3
2256417|NCT02087943|3924090|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1
2256418|NCT02087943|3924091|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1
2256419|NCT02087943|3924092|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0
2256420|NCT02087943|3924088|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2256421|NCT02087943|3924089|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2256422|NCT02087943|3924090|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
2256423|NCT02087943|3924091|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2256424|NCT02087943|3924092|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2256425|NCT02087943|3924088|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2256426|NCT02087943|3924089|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2256427|NCT02087943|3924090|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2256428|NCT02087943|3924091|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2256429|NCT02087943|3924092|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1
2256430|NCT02087943|3924088|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0
2256431|NCT02087943|3924089|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0
2256432|NCT02087943|3924090|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1
2256433|NCT02087943|3924091|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1
2256434|NCT02087943|3924092|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0
2256435|NCT02088034|3924122|FG000|Overall Study|Lost to Follow-up|1
2256436|NCT02088034|3924123|FG001|Overall Study|Lost to Follow-up|1
2256437|NCT02088034|3924124|FG002|Overall Study|Lost to Follow-up|0
2256438|NCT02088034|3924122|FG000|Overall Study|Pregnancy|2
2256439|NCT02088034|3924123|FG001|Overall Study|Pregnancy|1
2256440|NCT02088034|3924124|FG002|Overall Study|Pregnancy|2
2256441|NCT02088047|3924134|FG000|Overall Study|Withdrawal by Subject|1
2256442|NCT02088047|3924135|FG001|Overall Study|Withdrawal by Subject|0
2256443|NCT02088073|3924146|FG000|Acute Phase|Withdrawal by Subject|5
2256444|NCT02088073|3924147|FG001|Acute Phase|Withdrawal by Subject|0
2256445|NCT02088073|3924148|FG002|Acute Phase|Withdrawal by Subject|0
2256446|NCT02088073|3924149|FG003|Acute Phase|Withdrawal by Subject|0
2256447|NCT02088073|3924150|FG004|Acute Phase|Withdrawal by Subject|0
2256448|NCT02088073|3924146|FG000|Acute Phase|Hyperkalemia|2
2256449|NCT02088073|3924147|FG001|Acute Phase|Hyperkalemia|0
2256450|NCT02088073|3924148|FG002|Acute Phase|Hyperkalemia|0
2256451|NCT02088073|3924149|FG003|Acute Phase|Hyperkalemia|0
2256452|NCT02088073|3924150|FG004|Acute Phase|Hyperkalemia|0
2256453|NCT02088073|3924146|FG000|Maintanance Phase|Withdrawal by Subject|0
2256454|NCT02088073|3924147|FG001|Maintanance Phase|Withdrawal by Subject|2
2256455|NCT02088073|3924148|FG002|Maintanance Phase|Withdrawal by Subject|0
2256456|NCT02088073|3924149|FG003|Maintanance Phase|Withdrawal by Subject|0
2256457|NCT02088073|3924150|FG004|Maintanance Phase|Withdrawal by Subject|0
2256458|NCT02088073|3924146|FG000|Maintanance Phase|Adverse Event|0
2256459|NCT02088073|3924147|FG001|Maintanance Phase|Adverse Event|0
2256460|NCT02088073|3924148|FG002|Maintanance Phase|Adverse Event|3
2256461|NCT02088073|3924149|FG003|Maintanance Phase|Adverse Event|0
2256462|NCT02088073|3924150|FG004|Maintanance Phase|Adverse Event|1
2256463|NCT02088073|3924146|FG000|Maintanance Phase|Physician Decision|0
2256464|NCT02088073|3924147|FG001|Maintanance Phase|Physician Decision|0
2256465|NCT02088073|3924148|FG002|Maintanance Phase|Physician Decision|0
2256466|NCT02088073|3924149|FG003|Maintanance Phase|Physician Decision|0
2256467|NCT02088073|3924150|FG004|Maintanance Phase|Physician Decision|1
2256468|NCT02088073|3924146|FG000|Maintanance Phase|Sponsor's decision|0
2256469|NCT02088073|3924147|FG001|Maintanance Phase|Sponsor's decision|2
2256470|NCT02088073|3924148|FG002|Maintanance Phase|Sponsor's decision|0
2256471|NCT02088073|3924149|FG003|Maintanance Phase|Sponsor's decision|2
2256472|NCT02088073|3924150|FG004|Maintanance Phase|Sponsor's decision|1
2256473|NCT02088073|3924146|FG000|Maintanance Phase|Hypo- or hyperkalemia|0
2256474|NCT02088073|3924147|FG001|Maintanance Phase|Hypo- or hyperkalemia|3
2256475|NCT02088073|3924148|FG002|Maintanance Phase|Hypo- or hyperkalemia|0
2256476|NCT02088073|3924149|FG003|Maintanance Phase|Hypo- or hyperkalemia|3
2256477|NCT02088073|3924150|FG004|Maintanance Phase|Hypo- or hyperkalemia|1
2256478|NCT02088073|3924146|FG000|Maintanance Phase|Miscellaneous|0
2256479|NCT02088073|3924147|FG001|Maintanance Phase|Miscellaneous|2
2256480|NCT02088073|3924148|FG002|Maintanance Phase|Miscellaneous|1
2256481|NCT02088073|3924149|FG003|Maintanance Phase|Miscellaneous|2
2256482|NCT02088073|3924150|FG004|Maintanance Phase|Miscellaneous|1
2256483|NCT02088073|3924146|FG000|Maintanance Phase|Met ECG withdrawal criteria|0
2343685|NCT03529773|4078277|FG015|Overall Study|No longer meets eligibility criteria|0
2343686|NCT03529773|4078278|FG016|Overall Study|No longer meets eligibility criteria|0
2343687|NCT03529773|4078279|FG017|Overall Study|No longer meets eligibility criteria|0
2343688|NCT03529773|4078280|FG018|Overall Study|No longer meets eligibility criteria|0
2343689|NCT03529773|4078281|FG019|Overall Study|No longer meets eligibility criteria|0
2343690|NCT03529773|4078282|FG020|Overall Study|No longer meets eligibility criteria|0
2343691|NCT03529773|4078283|FG021|Overall Study|No longer meets eligibility criteria|0
2343692|NCT03529773|4078284|FG022|Overall Study|No longer meets eligibility criteria|1
2343693|NCT03529773|4078285|FG023|Overall Study|No longer meets eligibility criteria|0
2343694|NCT03529773|4078286|FG024|Overall Study|No longer meets eligibility criteria|0
2343695|NCT03529773|4078287|FG025|Overall Study|No longer meets eligibility criteria|0
2343696|NCT03529773|4078288|FG026|Overall Study|No longer meets eligibility criteria|0
2343697|NCT03529773|4078289|FG027|Overall Study|No longer meets eligibility criteria|0
2195974|NCT01528033|3828772|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2
2195975|NCT01528033|3828773|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2
2195976|NCT01528033|3828772|FG000|Follow Up|No data available|46
2195977|NCT01528033|3828773|FG001|Follow Up|No data available|44
2195978|NCT01528072|3828779|FG000|Overall Study|Withdrawal by Subject|5
2195979|NCT01528072|3828779|FG000|Overall Study|Physician Decision|1
2195980|NCT01528072|3828779|FG000|Overall Study|Determined not eligible by AEAC|1
2195981|NCT01528072|3828779|FG000|Overall Study|Missed Visit|2
2195982|NCT01528072|3828779|FG000|Overall Study|Lost to Follow-up|5
2195983|NCT01528072|3828779|FG000|Overall Study|Explanted|2
2195984|NCT01528072|3828779|FG000|Overall Study|Site Closure|4
2195985|NCT01528072|3828779|FG000|Overall Study|Death|2
2195986|NCT01528072|3828779|FG000|Overall Study|Early Termination of Study|52
2195987|NCT01528215|3828824|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4
2195988|NCT01528215|3828825|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1
2195989|NCT01528215|3828824|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
2195990|NCT01528215|3828825|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
2195991|NCT01528215|3828824|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
2195992|NCT01528215|3828825|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
2195993|NCT01528215|3828824|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
2195994|NCT01528215|3828825|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
2195995|NCT01528254|3828842|FG000|Overall Study|Administrative problems|96
2195996|NCT01528254|3828843|FG001|Overall Study|Administrative problems|94
2195997|NCT01528254|3828842|FG000|Overall Study|Adverse Event|28
2195998|NCT01528254|3828843|FG001|Overall Study|Adverse Event|44
2195999|NCT01528254|3828842|FG000|Overall Study|Lost to Follow-up|17
2196000|NCT01528254|3828843|FG001|Overall Study|Lost to Follow-up|24
2196001|NCT01528254|3828842|FG000|Overall Study|Death|13
2196002|NCT01528254|3828843|FG001|Overall Study|Death|9
2196003|NCT01528254|3828842|FG000|Overall Study|Protocol deviation|9
2196004|NCT01528254|3828843|FG001|Overall Study|Protocol deviation|19
2196005|NCT01528254|3828842|FG000|Overall Study|New therapy for study indication|8
2196006|NCT01528254|3828843|FG001|Overall Study|New therapy for study indication|6
2196007|NCT01528254|3828842|FG000|Overall Study|Unsatisfactory therapeutic effect|6
2196008|NCT01528254|3828843|FG001|Overall Study|Unsatisfactory therapeutic effect|8
2196009|NCT01528254|3828842|FG000|Overall Study|Withdrawal by Subject|5
2196010|NCT01528254|3828843|FG001|Overall Study|Withdrawal by Subject|4
2196011|NCT01528254|3828842|FG000|Overall Study|Abnormal laboratory value(s)|3
2196012|NCT01528254|3828843|FG001|Overall Study|Abnormal laboratory value(s)|7
2196013|NCT01528254|3828842|FG000|Overall Study|Abnormal test procedure result(s)|1
2196014|NCT01528254|3828843|FG001|Overall Study|Abnormal test procedure result(s)|0
2196015|NCT01528254|3828842|FG000|Overall Study|No longer requires study drug|1
2196016|NCT01528254|3828843|FG001|Overall Study|No longer requires study drug|1
2196017|NCT01528345|3828865|FG000|Overall Study|Adverse Event|10
2196018|NCT01528345|3828866|FG001|Overall Study|Adverse Event|1
2196019|NCT01528345|3828865|FG000|Overall Study|Death|1
2196020|NCT01528345|3828866|FG001|Overall Study|Death|1
2196021|NCT01528345|3828865|FG000|Overall Study|Non-compliance with study treatment|1
2256484|NCT02088073|3924147|FG001|Maintanance Phase|Met ECG withdrawal criteria|0
2256485|NCT02088073|3924148|FG002|Maintanance Phase|Met ECG withdrawal criteria|1
2256486|NCT02088073|3924149|FG003|Maintanance Phase|Met ECG withdrawal criteria|0
2256487|NCT02088073|3924150|FG004|Maintanance Phase|Met ECG withdrawal criteria|2
2256488|NCT02088073|3924146|FG000|Maintanance Phase|Subject compliance|0
2256489|NCT02088073|3924147|FG001|Maintanance Phase|Subject compliance|1
2256490|NCT02088073|3924148|FG002|Maintanance Phase|Subject compliance|0
2256491|NCT02088073|3924149|FG003|Maintanance Phase|Subject compliance|0
2256492|NCT02088073|3924150|FG004|Maintanance Phase|Subject compliance|0
2256493|NCT02088177|3924163|FG000|Overall Study|Lost to Follow-up|3
2256494|NCT02088541|3924190|FG000|Overall Study|Adverse Event|3
2256495|NCT02088541|3924191|FG001|Overall Study|Adverse Event|0
2256496|NCT02088541|3924192|FG002|Overall Study|Adverse Event|3
2256497|NCT02088541|3924193|FG003|Overall Study|Adverse Event|3
2256498|NCT02088541|3924194|FG004|Overall Study|Adverse Event|0
2256499|NCT02088541|3924190|FG000|Overall Study|Death|51
2256500|NCT02088541|3924191|FG001|Overall Study|Death|21
2256501|NCT02088541|3924192|FG002|Overall Study|Death|85
2256502|NCT02088541|3924193|FG003|Overall Study|Death|28
2256503|NCT02088541|3924194|FG004|Overall Study|Death|38
2256504|NCT02088541|3924190|FG000|Overall Study|Lost to Follow-up|2
2256505|NCT02088541|3924191|FG001|Overall Study|Lost to Follow-up|0
2256506|NCT02088541|3924192|FG002|Overall Study|Lost to Follow-up|1
2256507|NCT02088541|3924193|FG003|Overall Study|Lost to Follow-up|0
2256508|NCT02088541|3924194|FG004|Overall Study|Lost to Follow-up|0
2256509|NCT02088541|3924190|FG000|Overall Study|Physician Decision|2
2256510|NCT02088541|3924191|FG001|Overall Study|Physician Decision|1
2256511|NCT02088541|3924192|FG002|Overall Study|Physician Decision|2
2256512|NCT02088541|3924193|FG003|Overall Study|Physician Decision|0
2256513|NCT02088541|3924194|FG004|Overall Study|Physician Decision|2
2256514|NCT02088541|3924190|FG000|Overall Study|Disease progression|7
2256515|NCT02088541|3924191|FG001|Overall Study|Disease progression|1
2256516|NCT02088541|3924192|FG002|Overall Study|Disease progression|2
2256517|NCT02088541|3924193|FG003|Overall Study|Disease progression|3
2256518|NCT02088541|3924194|FG004|Overall Study|Disease progression|1
2343698|NCT03529773|4078290|FG028|Overall Study|No longer meets eligibility criteria|0
2343699|NCT03529773|4078291|FG029|Overall Study|No longer meets eligibility criteria|0
2343700|NCT03529773|4078292|FG030|Overall Study|No longer meets eligibility criteria|0
2343701|NCT03529773|4078293|FG031|Overall Study|No longer meets eligibility criteria|0
2343702|NCT03529773|4078294|FG032|Overall Study|No longer meets eligibility criteria|0
2343703|NCT03529773|4078295|FG033|Overall Study|No longer meets eligibility criteria|0
2343704|NCT03529773|4078296|FG034|Overall Study|No longer meets eligibility criteria|0
2343705|NCT03529773|4078297|FG035|Overall Study|No longer meets eligibility criteria|0
2343706|NCT03529773|4078298|FG036|Overall Study|No longer meets eligibility criteria|0
2343707|NCT03529773|4078299|FG037|Overall Study|No longer meets eligibility criteria|0
2343708|NCT03529773|4078300|FG038|Overall Study|No longer meets eligibility criteria|0
2343709|NCT03529773|4078301|FG039|Overall Study|No longer meets eligibility criteria|0
2343710|NCT03529773|4078262|FG000|Overall Study|Other|0
2343711|NCT03529773|4078263|FG001|Overall Study|Other|0
2343712|NCT03529773|4078264|FG002|Overall Study|Other|0
2343713|NCT03529773|4078265|FG003|Overall Study|Other|0
2343714|NCT03529773|4078266|FG004|Overall Study|Other|0
2343715|NCT03529773|4078267|FG005|Overall Study|Other|0
2343716|NCT03529773|4078268|FG006|Overall Study|Other|0
2343717|NCT03529773|4078269|FG007|Overall Study|Other|0
2343718|NCT03529773|4078270|FG008|Overall Study|Other|0
2343719|NCT03529773|4078271|FG009|Overall Study|Other|0
2343720|NCT03529773|4078272|FG010|Overall Study|Other|0
2343721|NCT03529773|4078273|FG011|Overall Study|Other|0
2343722|NCT03529773|4078274|FG012|Overall Study|Other|1
2343723|NCT03529773|4078275|FG013|Overall Study|Other|0
2343724|NCT03529773|4078276|FG014|Overall Study|Other|2
2343725|NCT03529773|4078277|FG015|Overall Study|Other|0
2343726|NCT03529773|4078278|FG016|Overall Study|Other|0
2343727|NCT03529773|4078279|FG017|Overall Study|Other|2
2343728|NCT03529773|4078280|FG018|Overall Study|Other|0
2343729|NCT03529773|4078281|FG019|Overall Study|Other|0
2343730|NCT03529773|4078282|FG020|Overall Study|Other|1
2343731|NCT03529773|4078283|FG021|Overall Study|Other|0
2343732|NCT03529773|4078284|FG022|Overall Study|Other|1
2343733|NCT03529773|4078285|FG023|Overall Study|Other|0
2343734|NCT03529773|4078286|FG024|Overall Study|Other|2
2343735|NCT03529773|4078287|FG025|Overall Study|Other|2
2343736|NCT03529773|4078288|FG026|Overall Study|Other|1
2343737|NCT03529773|4078289|FG027|Overall Study|Other|0
2343738|NCT03529773|4078290|FG028|Overall Study|Other|0
2343739|NCT03529773|4078291|FG029|Overall Study|Other|0
2343740|NCT03529773|4078292|FG030|Overall Study|Other|0
2343741|NCT03529773|4078293|FG031|Overall Study|Other|0
2343742|NCT03529773|4078294|FG032|Overall Study|Other|0
2343743|NCT03529773|4078295|FG033|Overall Study|Other|0
2343744|NCT03529773|4078296|FG034|Overall Study|Other|1
2343745|NCT03529773|4078297|FG035|Overall Study|Other|1
2343746|NCT03529773|4078298|FG036|Overall Study|Other|0
2256519|NCT02088541|3924190|FG000|Overall Study|Study terminated by sponsor|1
2343747|NCT03529773|4078299|FG037|Overall Study|Other|0
2343748|NCT03529773|4078300|FG038|Overall Study|Other|0
2343749|NCT03529773|4078301|FG039|Overall Study|Other|0
2256520|NCT02088541|3924191|FG001|Overall Study|Study terminated by sponsor|1
2256521|NCT02088541|3924192|FG002|Overall Study|Study terminated by sponsor|12
2256522|NCT02088541|3924193|FG003|Overall Study|Study terminated by sponsor|2
2256523|NCT02088541|3924194|FG004|Overall Study|Study terminated by sponsor|6
2256524|NCT02088541|3924190|FG000|Overall Study|Withdrawal by Subject|3
2256525|NCT02088541|3924191|FG001|Overall Study|Withdrawal by Subject|2
2256526|NCT02088541|3924192|FG002|Overall Study|Withdrawal by Subject|9
2256527|NCT02088541|3924193|FG003|Overall Study|Withdrawal by Subject|7
2256528|NCT02088541|3924194|FG004|Overall Study|Withdrawal by Subject|10
2256529|NCT02088541|3924190|FG000|Overall Study|Other|2
2256530|NCT02088541|3924191|FG001|Overall Study|Other|1
2256531|NCT02088541|3924192|FG002|Overall Study|Other|3
2256532|NCT02088541|3924193|FG003|Overall Study|Other|1
2256533|NCT02088541|3924194|FG004|Overall Study|Other|1
2256534|NCT02088697|3924206|FG000|Period I|Physician Decision|1
2256535|NCT02088697|3924207|FG001|Period I|Physician Decision|4
2256536|NCT02088697|3924206|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1
2256537|NCT02088697|3924207|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0
2256538|NCT02088905|3924224|FG000|Overall Study|Withdrawal by Subject|5
2256539|NCT02088905|3924225|FG001|Overall Study|Withdrawal by Subject|1
2256540|NCT02089230|3924250|FG000|Overall Study|Death|0
2256541|NCT02089230|3924251|FG001|Overall Study|Death|0
2256542|NCT02089230|3924252|FG002|Overall Study|Death|2
2256543|NCT02089230|3924250|FG000|Overall Study|Seeking Alternative Therapy|0
2256544|NCT02089230|3924251|FG001|Overall Study|Seeking Alternative Therapy|0
2256545|NCT02089230|3924252|FG002|Overall Study|Seeking Alternative Therapy|4
2256546|NCT02089334|3924264|FG000|Overall Study|Withdrawal by Subject|0
2256547|NCT02089334|3924265|FG001|Overall Study|Withdrawal by Subject|0
2256548|NCT02089334|3924266|FG002|Overall Study|Withdrawal by Subject|0
2256549|NCT02089334|3924267|FG003|Overall Study|Withdrawal by Subject|2
2256550|NCT02089334|3924264|FG000|Overall Study|Adverse Event|0
2256551|NCT02089334|3924265|FG001|Overall Study|Adverse Event|0
2256552|NCT02089334|3924266|FG002|Overall Study|Adverse Event|0
2256553|NCT02089334|3924267|FG003|Overall Study|Adverse Event|2
2256554|NCT02089334|3924264|FG000|Overall Study|Progressive disease|0
2256555|NCT02089334|3924265|FG001|Overall Study|Progressive disease|0
2256556|NCT02089334|3924266|FG002|Overall Study|Progressive disease|0
2256557|NCT02089334|3924267|FG003|Overall Study|Progressive disease|2
2256558|NCT02089334|3924264|FG000|Overall Study|Physician Decision|0
2256559|NCT02089334|3924265|FG001|Overall Study|Physician Decision|0
2256560|NCT02089334|3924266|FG002|Overall Study|Physician Decision|1
2256561|NCT02089334|3924267|FG003|Overall Study|Physician Decision|1
2256562|NCT02089347|3924282|FG000|Overall Study|Protocol Violation|1
2256563|NCT02089347|3924283|FG001|Overall Study|Protocol Violation|0
2256564|NCT02089737|3924308|FG000|Overall Study|Survey form not completed|5
2256565|NCT02089737|3924308|FG000|Overall Study|Not treated|1
2256566|NCT02089997|3924313|FG000|Overall Study|Case report forms uncollected|99
2256567|NCT02089997|3924313|FG000|Overall Study|Protocol Violation|147
2256568|NCT02090283|3924334|FG000|Overall Study|Withdrawal by Subject|6
2256569|NCT02090283|3924335|FG001|Overall Study|Withdrawal by Subject|6
2256570|NCT02090283|3924336|FG002|Overall Study|Withdrawal by Subject|6
2256571|NCT02090283|3924334|FG000|Overall Study|Sponsor Terminated Study|6
2256572|NCT02090283|3924335|FG001|Overall Study|Sponsor Terminated Study|6
2343750|NCT03529773|4078262|FG000|Overall Study|Physician Decision|0
2343751|NCT03529773|4078263|FG001|Overall Study|Physician Decision|0
2343752|NCT03529773|4078264|FG002|Overall Study|Physician Decision|0
2343753|NCT03529773|4078265|FG003|Overall Study|Physician Decision|0
2343754|NCT03529773|4078266|FG004|Overall Study|Physician Decision|0
2343755|NCT03529773|4078267|FG005|Overall Study|Physician Decision|0
2343756|NCT03529773|4078268|FG006|Overall Study|Physician Decision|0
2343757|NCT03529773|4078269|FG007|Overall Study|Physician Decision|0
2343758|NCT03529773|4078270|FG008|Overall Study|Physician Decision|0
2343759|NCT03529773|4078271|FG009|Overall Study|Physician Decision|0
2343760|NCT03529773|4078272|FG010|Overall Study|Physician Decision|0
2343761|NCT03529773|4078273|FG011|Overall Study|Physician Decision|0
2343762|NCT03529773|4078274|FG012|Overall Study|Physician Decision|0
2343763|NCT03529773|4078275|FG013|Overall Study|Physician Decision|0
2343764|NCT03529773|4078276|FG014|Overall Study|Physician Decision|0
2343765|NCT03529773|4078277|FG015|Overall Study|Physician Decision|0
2343766|NCT03529773|4078278|FG016|Overall Study|Physician Decision|0
2196022|NCT01528345|3828866|FG001|Overall Study|Non-compliance with study treatment|0
2196023|NCT01528345|3828865|FG000|Overall Study|Progressive Disease|26
2196024|NCT01528345|3828866|FG001|Overall Study|Progressive Disease|40
2196025|NCT01528345|3828865|FG000|Overall Study|Study Terminated by Sponsor|4
2196026|NCT01528345|3828866|FG001|Overall Study|Study Terminated by Sponsor|8
2196027|NCT01528345|3828865|FG000|Overall Study|Subject/Guardian Decision|5
2196028|NCT01528345|3828866|FG001|Overall Study|Subject/Guardian Decision|0
2196029|NCT01528605|3828882|FG000|Overall Study|Lost to Follow-up|1
2196030|NCT01528605|3828883|FG001|Overall Study|Lost to Follow-up|0
2196031|NCT01528605|3828884|FG002|Overall Study|Lost to Follow-up|1
2196032|NCT01528605|3828885|FG003|Overall Study|Lost to Follow-up|1
2256573|NCT02090283|3924336|FG002|Overall Study|Sponsor Terminated Study|1
2256574|NCT02090283|3924334|FG000|Overall Study|Lost to Follow-up|2
2256575|NCT02090283|3924335|FG001|Overall Study|Lost to Follow-up|2
2343767|NCT03529773|4078279|FG017|Overall Study|Physician Decision|0
2343768|NCT03529773|4078280|FG018|Overall Study|Physician Decision|0
2343769|NCT03529773|4078281|FG019|Overall Study|Physician Decision|1
2343770|NCT03529773|4078282|FG020|Overall Study|Physician Decision|1
2343771|NCT03529773|4078283|FG021|Overall Study|Physician Decision|0
2343772|NCT03529773|4078284|FG022|Overall Study|Physician Decision|0
2343773|NCT03529773|4078285|FG023|Overall Study|Physician Decision|0
2343774|NCT03529773|4078286|FG024|Overall Study|Physician Decision|0
2343775|NCT03529773|4078287|FG025|Overall Study|Physician Decision|0
2343776|NCT03529773|4078288|FG026|Overall Study|Physician Decision|0
2343777|NCT03529773|4078289|FG027|Overall Study|Physician Decision|0
2343778|NCT03529773|4078290|FG028|Overall Study|Physician Decision|0
2343779|NCT03529773|4078291|FG029|Overall Study|Physician Decision|0
2343780|NCT03529773|4078292|FG030|Overall Study|Physician Decision|0
2343781|NCT03529773|4078293|FG031|Overall Study|Physician Decision|0
2343782|NCT03529773|4078294|FG032|Overall Study|Physician Decision|0
2343783|NCT03529773|4078295|FG033|Overall Study|Physician Decision|0
2343784|NCT03529773|4078296|FG034|Overall Study|Physician Decision|0
2343785|NCT03529773|4078297|FG035|Overall Study|Physician Decision|0
2343786|NCT03529773|4078298|FG036|Overall Study|Physician Decision|0
2343787|NCT03529773|4078299|FG037|Overall Study|Physician Decision|0
2343788|NCT03529773|4078300|FG038|Overall Study|Physician Decision|0
2343789|NCT03529773|4078301|FG039|Overall Study|Physician Decision|0
2343790|NCT03529773|4078262|FG000|Overall Study|Protocol Violation|0
2343791|NCT03529773|4078263|FG001|Overall Study|Protocol Violation|0
2343792|NCT03529773|4078264|FG002|Overall Study|Protocol Violation|0
2343793|NCT03529773|4078265|FG003|Overall Study|Protocol Violation|0
2343794|NCT03529773|4078266|FG004|Overall Study|Protocol Violation|0
2343795|NCT03529773|4078267|FG005|Overall Study|Protocol Violation|0
2343796|NCT03529773|4078268|FG006|Overall Study|Protocol Violation|0
2343797|NCT03529773|4078269|FG007|Overall Study|Protocol Violation|0
2343798|NCT03529773|4078270|FG008|Overall Study|Protocol Violation|0
2343799|NCT03529773|4078271|FG009|Overall Study|Protocol Violation|0
2196033|NCT01528605|3828886|FG004|Overall Study|Lost to Follow-up|0
2196034|NCT01528605|3828887|FG005|Overall Study|Lost to Follow-up|0
2196035|NCT01528605|3828882|FG000|Overall Study|Death|1
2196036|NCT01528605|3828883|FG001|Overall Study|Death|0
2196037|NCT01528605|3828884|FG002|Overall Study|Death|0
2196038|NCT01528605|3828885|FG003|Overall Study|Death|0
2196039|NCT01528605|3828886|FG004|Overall Study|Death|0
2196040|NCT01528605|3828887|FG005|Overall Study|Death|0
2196041|NCT01528709|3828903|FG000|Overall Study|Death|2
2196042|NCT01528709|3828904|FG001|Overall Study|Death|0
2196043|NCT01528709|3828903|FG000|Overall Study|Withdrawal by Subject|10
2196044|NCT01528709|3828904|FG001|Overall Study|Withdrawal by Subject|15
2196045|NCT01528709|3828903|FG000|Overall Study|allergy|1
2196046|NCT01528709|3828904|FG001|Overall Study|allergy|0
2196047|NCT01528735|3828912|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
2196048|NCT01528735|3828913|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
2196049|NCT01528735|3828912|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
2196050|NCT01528735|3828913|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
2196051|NCT01528787|3828925|FG000|Overall Study|Withdrawal by Subject|0
2196052|NCT01528787|3828926|FG001|Overall Study|Withdrawal by Subject|0
2196053|NCT01528787|3828927|FG002|Overall Study|Withdrawal by Subject|0
2196054|NCT01528787|3828928|FG003|Overall Study|Withdrawal by Subject|1
2196055|NCT01528787|3828925|FG000|Overall Study|Family Emergency|0
2196056|NCT01528787|3828926|FG001|Overall Study|Family Emergency|0
2196057|NCT01528787|3828927|FG002|Overall Study|Family Emergency|1
2196058|NCT01528787|3828928|FG003|Overall Study|Family Emergency|0
2196059|NCT01528969|3828957|FG000|Overall Study|absent from the school at baseline|2
2196060|NCT01528969|3828958|FG001|Overall Study|absent from the school at baseline|0
2196061|NCT01529034|3828964|FG000|Overall Study|Discontinued prior to study treatment|14
2196062|NCT01529034|3828964|FG000|Overall Study|Site closure|62
2196063|NCT01529034|3828964|FG000|Overall Study|Study termination|29
2196064|NCT01529034|3828964|FG000|Overall Study|Withdrawal by Subject|25
2196065|NCT01529034|3828964|FG000|Overall Study|No treated SCs within protocol window|13
2196066|NCT01529034|3828964|FG000|Overall Study|Noncompliance|8
2196067|NCT01529034|3828964|FG000|Overall Study|Caregiver no longer available|7
2196068|NCT01529034|3828964|FG000|Overall Study|Adverse Event|4
2196069|NCT01529034|3828964|FG000|Overall Study|Protocol Violation|4
2196070|NCT01529034|3828964|FG000|Overall Study|Lack of Efficacy|4
2196071|NCT01529034|3828964|FG000|Overall Study|Investigator no longer available|2
2196072|NCT01529034|3828964|FG000|Overall Study|Study drug not available|2
2196073|NCT01529112|3828981|FG000|Overall Study|Adverse Event|2
2196074|NCT01529112|3828982|FG001|Overall Study|Adverse Event|0
2196075|NCT01529112|3828981|FG000|Overall Study|Death|59
2196076|NCT01529112|3828982|FG001|Overall Study|Death|38
2196077|NCT01529112|3828981|FG000|Overall Study|Protocol Violation|1
2196078|NCT01529112|3828982|FG001|Overall Study|Protocol Violation|0
2196079|NCT01529112|3828981|FG000|Overall Study|Withdrawal by Subject|7
2196080|NCT01529112|3828982|FG001|Overall Study|Withdrawal by Subject|3
2196081|NCT01529268|3828994|FG000|Overall Study|Lost to Follow-up|9
2196082|NCT01529268|3828995|FG001|Overall Study|Lost to Follow-up|3
2196083|NCT01529268|3828994|FG000|Overall Study|Moved|3
2196084|NCT01529268|3828995|FG001|Overall Study|Moved|0
2196085|NCT01529346|3829006|FG000|Overall Study|Lost to Follow-up|2
2196086|NCT01529346|3829007|FG001|Overall Study|Lost to Follow-up|0
2343800|NCT03529773|4078272|FG010|Overall Study|Protocol Violation|0
2196087|NCT01529346|3829008|FG002|Overall Study|Lost to Follow-up|1
2196088|NCT01529346|3829009|FG003|Overall Study|Lost to Follow-up|0
2196089|NCT01529346|3829010|FG004|Overall Study|Lost to Follow-up|0
2196090|NCT01529346|3829006|FG000|Overall Study|Other|0
2196091|NCT01529346|3829007|FG001|Overall Study|Other|1
2196092|NCT01529346|3829008|FG002|Overall Study|Other|1
2196093|NCT01529346|3829009|FG003|Overall Study|Other|0
2196094|NCT01529346|3829010|FG004|Overall Study|Other|0
2196095|NCT01529385|3829025|FG000|Overall Study|Lost to Follow-up|2
2196096|NCT01529385|3829026|FG001|Overall Study|Lost to Follow-up|1
2196097|NCT01529515|3829063|FG000|TRANSITION PHASE|Adverse Event|16
2196098|NCT01529515|3829064|FG001|TRANSITION PHASE|Adverse Event|0
2196099|NCT01529515|3829065|FG002|TRANSITION PHASE|Adverse Event|0
2196100|NCT01529515|3829066|FG003|TRANSITION PHASE|Adverse Event|0
2196101|NCT01529515|3829063|FG000|TRANSITION PHASE|Death|1
2196102|NCT01529515|3829064|FG001|TRANSITION PHASE|Death|0
2196103|NCT01529515|3829065|FG002|TRANSITION PHASE|Death|0
2196104|NCT01529515|3829066|FG003|TRANSITION PHASE|Death|0
2196105|NCT01529515|3829063|FG000|TRANSITION PHASE|Lack of Efficacy|19
2196106|NCT01529515|3829064|FG001|TRANSITION PHASE|Lack of Efficacy|0
2196107|NCT01529515|3829065|FG002|TRANSITION PHASE|Lack of Efficacy|0
2196108|NCT01529515|3829066|FG003|TRANSITION PHASE|Lack of Efficacy|0
2196109|NCT01529515|3829063|FG000|TRANSITION PHASE|Lost to Follow-up|19
2196110|NCT01529515|3829064|FG001|TRANSITION PHASE|Lost to Follow-up|0
2196111|NCT01529515|3829065|FG002|TRANSITION PHASE|Lost to Follow-up|0
2196112|NCT01529515|3829066|FG003|TRANSITION PHASE|Lost to Follow-up|0
2196113|NCT01529515|3829063|FG000|TRANSITION PHASE|Protocol Violation|4
2196114|NCT01529515|3829064|FG001|TRANSITION PHASE|Protocol Violation|0
2196115|NCT01529515|3829065|FG002|TRANSITION PHASE|Protocol Violation|0
2196116|NCT01529515|3829066|FG003|TRANSITION PHASE|Protocol Violation|0
2196117|NCT01529515|3829063|FG000|TRANSITION PHASE|Withdrawal by Subject|51
2196118|NCT01529515|3829064|FG001|TRANSITION PHASE|Withdrawal by Subject|0
2196119|NCT01529515|3829065|FG002|TRANSITION PHASE|Withdrawal by Subject|0
2196120|NCT01529515|3829066|FG003|TRANSITION PHASE|Withdrawal by Subject|0
2196121|NCT01529515|3829063|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
2196122|NCT01529515|3829064|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
2196123|NCT01529515|3829065|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
2196124|NCT01529515|3829066|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
2196125|NCT01529515|3829063|FG000|TRANSITION PHASE|Other|9
2196126|NCT01529515|3829064|FG001|TRANSITION PHASE|Other|0
2196127|NCT01529515|3829065|FG002|TRANSITION PHASE|Other|0
2196128|NCT01529515|3829066|FG003|TRANSITION PHASE|Other|0
2196129|NCT01529515|3829063|FG000|MAINTENANCE PHASE|Adverse Event|0
2196130|NCT01529515|3829064|FG001|MAINTENANCE PHASE|Adverse Event|10
2196131|NCT01529515|3829065|FG002|MAINTENANCE PHASE|Adverse Event|0
2196132|NCT01529515|3829066|FG003|MAINTENANCE PHASE|Adverse Event|0
2196133|NCT01529515|3829063|FG000|MAINTENANCE PHASE|Lack of Efficacy|0
2196134|NCT01529515|3829064|FG001|MAINTENANCE PHASE|Lack of Efficacy|9
2196135|NCT01529515|3829065|FG002|MAINTENANCE PHASE|Lack of Efficacy|0
2196136|NCT01529515|3829066|FG003|MAINTENANCE PHASE|Lack of Efficacy|0
2196137|NCT01529515|3829063|FG000|MAINTENANCE PHASE|Lost to Follow-up|0
2196138|NCT01529515|3829064|FG001|MAINTENANCE PHASE|Lost to Follow-up|5
2196139|NCT01529515|3829065|FG002|MAINTENANCE PHASE|Lost to Follow-up|0
2196140|NCT01529515|3829066|FG003|MAINTENANCE PHASE|Lost to Follow-up|0
2196141|NCT01529515|3829063|FG000|MAINTENANCE PHASE|Protocol Violation|0
2196142|NCT01529515|3829064|FG001|MAINTENANCE PHASE|Protocol Violation|12
2196143|NCT01529515|3829065|FG002|MAINTENANCE PHASE|Protocol Violation|0
2196144|NCT01529515|3829066|FG003|MAINTENANCE PHASE|Protocol Violation|0
2196145|NCT01529515|3829063|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0
2196146|NCT01529515|3829064|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15
2196147|NCT01529515|3829065|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0
2196148|NCT01529515|3829066|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0
2196149|NCT01529515|3829063|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0
2196150|NCT01529515|3829064|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13
2196151|NCT01529515|3829065|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0
2196152|NCT01529515|3829066|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0
2196153|NCT01529515|3829063|FG000|MAINTENANCE PHASE|Other|0
2196154|NCT01529515|3829064|FG001|MAINTENANCE PHASE|Other|10
2196155|NCT01529515|3829065|FG002|MAINTENANCE PHASE|Other|0
2196156|NCT01529515|3829066|FG003|MAINTENANCE PHASE|Other|0
2196157|NCT01529515|3829063|FG000|DOUBLE BLIND PHASE|Adverse Event|0
2196158|NCT01529515|3829064|FG001|DOUBLE BLIND PHASE|Adverse Event|0
2196159|NCT01529515|3829065|FG002|DOUBLE BLIND PHASE|Adverse Event|1
2196160|NCT01529515|3829066|FG003|DOUBLE BLIND PHASE|Adverse Event|0
2196161|NCT01529515|3829063|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0
2196162|NCT01529515|3829064|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0
2196163|NCT01529515|3829065|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1
2196164|NCT01529515|3829066|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3
2196165|NCT01529515|3829063|FG000|DOUBLE BLIND PHASE|Pregnancy|0
2196166|NCT01529515|3829064|FG001|DOUBLE BLIND PHASE|Pregnancy|0
2196167|NCT01529515|3829065|FG002|DOUBLE BLIND PHASE|Pregnancy|1
2196168|NCT01529515|3829066|FG003|DOUBLE BLIND PHASE|Pregnancy|0
2256576|NCT02090283|3924336|FG002|Overall Study|Lost to Follow-up|3
2256577|NCT02090283|3924334|FG000|Overall Study|Adverse Event|1
2256578|NCT02090283|3924335|FG001|Overall Study|Adverse Event|1
2256579|NCT02090283|3924336|FG002|Overall Study|Adverse Event|0
2256580|NCT02090283|3924334|FG000|Overall Study|Protocol Violation|2
2256581|NCT02090283|3924335|FG001|Overall Study|Protocol Violation|0
2256582|NCT02090283|3924336|FG002|Overall Study|Protocol Violation|0
2256583|NCT02090413|3924380|FG000|Overall Study|Adverse Event|11
2256584|NCT02090413|3924381|FG001|Overall Study|Adverse Event|15
2256585|NCT02090413|3924382|FG002|Overall Study|Adverse Event|20
2256586|NCT02090413|3924380|FG000|Overall Study|Flushing event|2
2256587|NCT02090413|3924381|FG001|Overall Study|Flushing event|0
2256588|NCT02090413|3924382|FG002|Overall Study|Flushing event|1
2256589|NCT02090413|3924380|FG000|Overall Study|Withdrawal by Subject|2
2256590|NCT02090413|3924381|FG001|Overall Study|Withdrawal by Subject|2
2256591|NCT02090413|3924382|FG002|Overall Study|Withdrawal by Subject|2
2256592|NCT02090413|3924380|FG000|Overall Study|Investigator Decision|1
2256593|NCT02090413|3924381|FG001|Overall Study|Investigator Decision|1
2256594|NCT02090413|3924382|FG002|Overall Study|Investigator Decision|0
2256595|NCT02090413|3924380|FG000|Overall Study|Other|2
2256596|NCT02090413|3924381|FG001|Overall Study|Other|1
2256597|NCT02090413|3924382|FG002|Overall Study|Other|0
2256598|NCT02090413|3924380|FG000|Overall Study|Lost to Follow-up|1
2256599|NCT02090413|3924381|FG001|Overall Study|Lost to Follow-up|1
2256600|NCT02090413|3924382|FG002|Overall Study|Lost to Follow-up|0
2256601|NCT02090426|3924393|FG000|Overall Study|Lost to Follow-up|12
2256602|NCT02090426|3924394|FG001|Overall Study|Lost to Follow-up|6
2256603|NCT02090634|3924402|FG000|Overall Study|Lost to Follow-up|0
2256604|NCT02090634|3924403|FG001|Overall Study|Lost to Follow-up|1
2256605|NCT02090634|3924402|FG000|Overall Study|Death|0
2256606|NCT02090634|3924403|FG001|Overall Study|Death|1
2256607|NCT02090634|3924402|FG000|Overall Study|Protocol Violation|3
2256608|NCT02090634|3924403|FG001|Overall Study|Protocol Violation|1
2256609|NCT02090634|3924402|FG000|Overall Study|Adverse Event|2
2256610|NCT02090634|3924403|FG001|Overall Study|Adverse Event|0
2256611|NCT02090725|3924409|FG000|Overall Study|Withdrawal by Subject|1
2256612|NCT02090725|3924409|FG000|Overall Study|participants moved from area|3
2256613|NCT02090764|3924415|FG000|Overall Study|Adverse Event|1
2256614|NCT02090764|3924416|FG001|Overall Study|Adverse Event|3
2256615|NCT02090764|3924415|FG000|Overall Study|Lack of Efficacy|0
2256616|NCT02090764|3924416|FG001|Overall Study|Lack of Efficacy|13
2256617|NCT02090764|3924415|FG000|Overall Study|Withdrawal by Subject|2
2256618|NCT02090764|3924416|FG001|Overall Study|Withdrawal by Subject|1
2256619|NCT02090764|3924415|FG000|Overall Study|Intercurrent illness and other|1
2256620|NCT02090764|3924416|FG001|Overall Study|Intercurrent illness and other|1
2256621|NCT02090764|3924415|FG000|Overall Study|Lost to Follow-up|2
2256622|NCT02090764|3924416|FG001|Overall Study|Lost to Follow-up|2
2256623|NCT02090855|3924426|FG000|Overall Study|no evaluable Standard of Truth results|2
2256624|NCT02090959|3924437|FG000|Overall Study|Withdrawal by Subject|10
2256625|NCT02090959|3924437|FG000|Overall Study|Adverse Event|1
2256626|NCT02090959|3924437|FG000|Overall Study|Investigator decision|2
2256627|NCT02090959|3924437|FG000|Overall Study|Study termination|6
2256628|NCT02090959|3924437|FG000|Overall Study|Enrolled but not treated|1
2256629|NCT02090959|3924437|FG000|Overall Study|Transfer for compassionate use medicine|4
2256630|NCT02090959|3924437|FG000|Overall Study|Move to medical need program|3
2256631|NCT02090959|3924437|FG000|Overall Study|Entered in to other study|34
2256632|NCT02090959|3924437|FG000|Overall Study|Switched to commercial supply|88
2256633|NCT02090959|3924437|FG000|Overall Study|Other than specified|2
2256634|NCT02091089|3924441|FG000|Overall Study|Lost to Follow-up|2
2256635|NCT02091167|3924451|FG000|Overall Study|Lost to Follow-up|0
2256636|NCT02091167|3924452|FG001|Overall Study|Lost to Follow-up|2
2256637|NCT02091206|3924462|FG000|Treatment Period|Adverse Event|0
2256638|NCT02091206|3924463|FG001|Treatment Period|Adverse Event|1
2256639|NCT02091206|3924464|FG002|Treatment Period|Adverse Event|0
2256640|NCT02091206|3924465|FG003|Treatment Period|Adverse Event|0
2256641|NCT02091206|3924462|FG000|Treatment Period|Met withdrawal criteria|0
2256642|NCT02091206|3924463|FG001|Treatment Period|Met withdrawal criteria|0
2256643|NCT02091206|3924464|FG002|Treatment Period|Met withdrawal criteria|1
2256644|NCT02091206|3924465|FG003|Treatment Period|Met withdrawal criteria|0
2256645|NCT02091206|3924462|FG000|Taper Period|Participant refused study drug|1
2256646|NCT02091206|3924463|FG001|Taper Period|Participant refused study drug|0
2256647|NCT02091206|3924464|FG002|Taper Period|Participant refused study drug|0
2256648|NCT02091206|3924465|FG003|Taper Period|Participant refused study drug|1
2256649|NCT02091206|3924462|FG000|Taper Period|Lost to Follow-up|0
2256650|NCT02091206|3924463|FG001|Taper Period|Lost to Follow-up|0
2256651|NCT02091206|3924464|FG002|Taper Period|Lost to Follow-up|0
2256652|NCT02091206|3924465|FG003|Taper Period|Lost to Follow-up|1
2256653|NCT02091284|3924477|FG000|Overall Study|Withdrawal by Subject|2
2256654|NCT02091284|3924478|FG001|Overall Study|Withdrawal by Subject|1
2256655|NCT02091284|3924477|FG000|Overall Study|unreliable data|1
2256656|NCT02091284|3924478|FG001|Overall Study|unreliable data|0
2256657|NCT02091362|3924488|FG000|Period 1|Protocol Violation|1
2256658|NCT02091362|3924489|FG001|Period 1|Protocol Violation|0
2256659|NCT02091362|3924488|FG000|Period 1|Withdrawal by Subject|2
2256660|NCT02091362|3924489|FG001|Period 1|Withdrawal by Subject|3
2256661|NCT02091362|3924488|FG000|Period 1|Lost to Follow-up|0
2256662|NCT02091362|3924489|FG001|Period 1|Lost to Follow-up|1
2256663|NCT02091362|3924488|FG000|Period 1|Adverse Event|2
2256664|NCT02091362|3924489|FG001|Period 1|Adverse Event|0
2256665|NCT02091362|3924488|FG000|Wash-out|Lost to Follow-up|1
2256666|NCT02091362|3924489|FG001|Wash-out|Lost to Follow-up|1
2256667|NCT02091362|3924488|FG000|Wash-out|Withdrawal by Subject|0
2256668|NCT02091362|3924489|FG001|Wash-out|Withdrawal by Subject|2
2256669|NCT02091362|3924488|FG000|Period 2|Adverse Event|1
2256670|NCT02091362|3924489|FG001|Period 2|Adverse Event|0
2256671|NCT02091362|3924488|FG000|Period 2|Lost to Follow-up|0
2256672|NCT02091362|3924489|FG001|Period 2|Lost to Follow-up|1
2256673|NCT02091362|3924488|FG000|Period 2|Withdrawal by Subject|1
2256674|NCT02091362|3924489|FG001|Period 2|Withdrawal by Subject|1
2256675|NCT02091375|3924501|FG000|Overall Study|Adverse Event|8
2256676|NCT02091375|3924502|FG001|Overall Study|Adverse Event|1
2256677|NCT02091375|3924501|FG000|Overall Study|Lost to Follow-up|0
2256678|NCT02091375|3924502|FG001|Overall Study|Lost to Follow-up|1
2256679|NCT02091375|3924501|FG000|Overall Study|Withdrawal by Subject|0
2256680|NCT02091375|3924502|FG001|Overall Study|Withdrawal by Subject|1
2256681|NCT02091375|3924501|FG000|Overall Study|Withdrawn by the investigator|1
2256682|NCT02091375|3924502|FG001|Overall Study|Withdrawn by the investigator|0
2256683|NCT02091414|3924508|FG000|Overall Study|Withdrawal by Subject|2
2256684|NCT02091414|3924508|FG000|Overall Study|Death|2
2256685|NCT02091440|3924512|FG000|Overall Study|Death|2
2256686|NCT02091726|3924529|FG000|Overall Study|Lost to Follow-up|6
2343801|NCT03529773|4078273|FG011|Overall Study|Protocol Violation|0
2343802|NCT03529773|4078274|FG012|Overall Study|Protocol Violation|0
2343803|NCT03529773|4078275|FG013|Overall Study|Protocol Violation|0
2343804|NCT03529773|4078276|FG014|Overall Study|Protocol Violation|0
2343805|NCT03529773|4078277|FG015|Overall Study|Protocol Violation|0
2343806|NCT03529773|4078278|FG016|Overall Study|Protocol Violation|0
2343807|NCT03529773|4078279|FG017|Overall Study|Protocol Violation|0
2343808|NCT03529773|4078280|FG018|Overall Study|Protocol Violation|0
2343809|NCT03529773|4078281|FG019|Overall Study|Protocol Violation|0
2343810|NCT03529773|4078282|FG020|Overall Study|Protocol Violation|0
2343811|NCT03529773|4078283|FG021|Overall Study|Protocol Violation|0
2343812|NCT03529773|4078284|FG022|Overall Study|Protocol Violation|0
2343813|NCT03529773|4078285|FG023|Overall Study|Protocol Violation|0
2343814|NCT03529773|4078286|FG024|Overall Study|Protocol Violation|0
2343815|NCT03529773|4078287|FG025|Overall Study|Protocol Violation|0
2343816|NCT03529773|4078288|FG026|Overall Study|Protocol Violation|0
2343817|NCT03529773|4078289|FG027|Overall Study|Protocol Violation|0
2343818|NCT03529773|4078290|FG028|Overall Study|Protocol Violation|0
2343819|NCT03529773|4078291|FG029|Overall Study|Protocol Violation|0
2343820|NCT03529773|4078292|FG030|Overall Study|Protocol Violation|1
2343821|NCT03529773|4078293|FG031|Overall Study|Protocol Violation|0
2343822|NCT03529773|4078294|FG032|Overall Study|Protocol Violation|0
2343823|NCT03529773|4078295|FG033|Overall Study|Protocol Violation|0
2343824|NCT03529773|4078296|FG034|Overall Study|Protocol Violation|0
2343825|NCT03529773|4078297|FG035|Overall Study|Protocol Violation|0
2343826|NCT03529773|4078298|FG036|Overall Study|Protocol Violation|0
2343827|NCT03529773|4078299|FG037|Overall Study|Protocol Violation|0
2343828|NCT03529773|4078300|FG038|Overall Study|Protocol Violation|0
2343829|NCT03529773|4078301|FG039|Overall Study|Protocol Violation|0
2343830|NCT03529773|4078262|FG000|Overall Study|Withdrawal by Subject|0
2343831|NCT03529773|4078263|FG001|Overall Study|Withdrawal by Subject|0
2343832|NCT03529773|4078264|FG002|Overall Study|Withdrawal by Subject|0
2343833|NCT03529773|4078265|FG003|Overall Study|Withdrawal by Subject|0
2343834|NCT03529773|4078266|FG004|Overall Study|Withdrawal by Subject|0
2343835|NCT03529773|4078267|FG005|Overall Study|Withdrawal by Subject|0
2343836|NCT03529773|4078268|FG006|Overall Study|Withdrawal by Subject|0
2343837|NCT03529773|4078269|FG007|Overall Study|Withdrawal by Subject|1
2343838|NCT03529773|4078270|FG008|Overall Study|Withdrawal by Subject|0
2343839|NCT03529773|4078271|FG009|Overall Study|Withdrawal by Subject|1
2343840|NCT03529773|4078272|FG010|Overall Study|Withdrawal by Subject|1
2343841|NCT03529773|4078273|FG011|Overall Study|Withdrawal by Subject|0
2343842|NCT03529773|4078274|FG012|Overall Study|Withdrawal by Subject|0
2343843|NCT03529773|4078275|FG013|Overall Study|Withdrawal by Subject|0
2343844|NCT03529773|4078276|FG014|Overall Study|Withdrawal by Subject|0
2343845|NCT03529773|4078277|FG015|Overall Study|Withdrawal by Subject|3
2343846|NCT03529773|4078278|FG016|Overall Study|Withdrawal by Subject|0
2343847|NCT03529773|4078279|FG017|Overall Study|Withdrawal by Subject|3
2343848|NCT03529773|4078280|FG018|Overall Study|Withdrawal by Subject|3
2343849|NCT03529773|4078281|FG019|Overall Study|Withdrawal by Subject|1
2343850|NCT03529773|4078282|FG020|Overall Study|Withdrawal by Subject|3
2343851|NCT03529773|4078283|FG021|Overall Study|Withdrawal by Subject|1
2343852|NCT03529773|4078284|FG022|Overall Study|Withdrawal by Subject|1
2343853|NCT03529773|4078285|FG023|Overall Study|Withdrawal by Subject|1
2343854|NCT03529773|4078286|FG024|Overall Study|Withdrawal by Subject|2
2343855|NCT03529773|4078287|FG025|Overall Study|Withdrawal by Subject|4
2343856|NCT03529773|4078288|FG026|Overall Study|Withdrawal by Subject|2
2343857|NCT03529773|4078289|FG027|Overall Study|Withdrawal by Subject|1
2343858|NCT03529773|4078290|FG028|Overall Study|Withdrawal by Subject|1
2256687|NCT02091739|3924536|FG000|MP: 16 Weeks|Adverse Event|1
2256688|NCT02091739|3924537|FG001|MP: 16 Weeks|Adverse Event|1
2256689|NCT02091739|3924538|FG002|MP: 16 Weeks|Adverse Event|1
2256690|NCT02091739|3924539|FG003|MP: 16 Weeks|Adverse Event|0
2256691|NCT02091739|3924540|FG004|MP: 16 Weeks|Adverse Event|0
2256692|NCT02091739|3924536|FG000|MP: 16 Weeks|Withdrawal by Subject|3
2256693|NCT02091739|3924537|FG001|MP: 16 Weeks|Withdrawal by Subject|4
2256694|NCT02091739|3924538|FG002|MP: 16 Weeks|Withdrawal by Subject|0
2256695|NCT02091739|3924539|FG003|MP: 16 Weeks|Withdrawal by Subject|0
2256696|NCT02091739|3924540|FG004|MP: 16 Weeks|Withdrawal by Subject|0
2256697|NCT02091739|3924536|FG000|MP: 16 Weeks|Lost to Follow-up|0
2256698|NCT02091739|3924537|FG001|MP: 16 Weeks|Lost to Follow-up|0
2256699|NCT02091739|3924538|FG002|MP: 16 Weeks|Lost to Follow-up|1
2256700|NCT02091739|3924539|FG003|MP: 16 Weeks|Lost to Follow-up|0
2256701|NCT02091739|3924540|FG004|MP: 16 Weeks|Lost to Follow-up|0
2256702|NCT02091739|3924536|FG000|EP: 48 Weeks|Other|0
2256703|NCT02091739|3924537|FG001|EP: 48 Weeks|Other|0
2256704|NCT02091739|3924538|FG002|EP: 48 Weeks|Other|0
2256705|NCT02091739|3924539|FG003|EP: 48 Weeks|Other|1
2256706|NCT02091739|3924540|FG004|EP: 48 Weeks|Other|0
2256707|NCT02091739|3924536|FG000|EP: 48 Weeks|Death|0
2256708|NCT02091739|3924537|FG001|EP: 48 Weeks|Death|0
2256709|NCT02091739|3924538|FG002|EP: 48 Weeks|Death|0
2256710|NCT02091739|3924539|FG003|EP: 48 Weeks|Death|3
2256711|NCT02091739|3924540|FG004|EP: 48 Weeks|Death|2
2256712|NCT02091739|3924536|FG000|EP: 48 Weeks|Adverse Event|0
2256713|NCT02091739|3924537|FG001|EP: 48 Weeks|Adverse Event|0
2256714|NCT02091739|3924538|FG002|EP: 48 Weeks|Adverse Event|0
2256715|NCT02091739|3924539|FG003|EP: 48 Weeks|Adverse Event|2
2256716|NCT02091739|3924540|FG004|EP: 48 Weeks|Adverse Event|6
2256717|NCT02091739|3924536|FG000|EP: 48 Weeks|Withdrawal by Subject|0
2256718|NCT02091739|3924537|FG001|EP: 48 Weeks|Withdrawal by Subject|0
2256719|NCT02091739|3924538|FG002|EP: 48 Weeks|Withdrawal by Subject|0
2256720|NCT02091739|3924539|FG003|EP: 48 Weeks|Withdrawal by Subject|2
2256721|NCT02091739|3924540|FG004|EP: 48 Weeks|Withdrawal by Subject|6
2343859|NCT03529773|4078291|FG029|Overall Study|Withdrawal by Subject|0
2343860|NCT03529773|4078292|FG030|Overall Study|Withdrawal by Subject|0
2343861|NCT03529773|4078293|FG031|Overall Study|Withdrawal by Subject|0
2343862|NCT03529773|4078294|FG032|Overall Study|Withdrawal by Subject|0
2343863|NCT03529773|4078295|FG033|Overall Study|Withdrawal by Subject|0
2343864|NCT03529773|4078296|FG034|Overall Study|Withdrawal by Subject|1
2343865|NCT03529773|4078297|FG035|Overall Study|Withdrawal by Subject|1
2343866|NCT03529773|4078298|FG036|Overall Study|Withdrawal by Subject|0
2343867|NCT03529773|4078299|FG037|Overall Study|Withdrawal by Subject|1
2343868|NCT03529773|4078300|FG038|Overall Study|Withdrawal by Subject|0
2343869|NCT03529773|4078301|FG039|Overall Study|Withdrawal by Subject|0
2343870|NCT03530345|4078398|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
2343871|NCT03530345|4078399|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0
2343872|NCT03530345|4078398|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
2343873|NCT03530345|4078399|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
2343874|NCT03530345|4078398|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17
2343875|NCT03530345|4078399|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21
2343876|NCT03530345|4078398|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5
2343877|NCT03530345|4078399|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7
2343878|NCT03530995|4078462|FG000|Part 1 Period 3|Withdrawal by Subject|2
2343879|NCT03530995|4078463|FG001|Part 1 Period 3|Withdrawal by Subject|0
2343880|NCT03530995|4078462|FG000|Part 1 Period 3|Protocol Violation|1
2343881|NCT03530995|4078463|FG001|Part 1 Period 3|Protocol Violation|0
2343882|NCT03530995|4078462|FG000|Part 1 Period 4|Physician Decision|1
2343883|NCT03530995|4078463|FG001|Part 1 Period 4|Physician Decision|0
2343884|NCT03530995|4078462|FG000|Part 1 Period 4|Withdrawal by Subject|1
2343885|NCT03530995|4078463|FG001|Part 1 Period 4|Withdrawal by Subject|0
2343886|NCT03531840|4078514|FG000|Overall Study|Death on study|3
2343887|NCT03531840|4078515|FG001|Overall Study|Death on study|2
2343888|NCT03531840|4078516|FG002|Overall Study|Death on study|1
2343889|NCT03531840|4078517|FG003|Overall Study|Death on study|2
2343890|NCT03531840|4078514|FG000|Overall Study|Death during follow up|2
2343891|NCT03531840|4078515|FG001|Overall Study|Death during follow up|3
2343892|NCT03531840|4078516|FG002|Overall Study|Death during follow up|4
2343893|NCT03531840|4078517|FG003|Overall Study|Death during follow up|1
2343894|NCT03531905|4078535|FG000|Overall Study|Withdrawal by Subject|3
2343895|NCT03531905|4078536|FG001|Overall Study|Withdrawal by Subject|3
2343896|NCT03531905|4078537|FG002|Overall Study|Withdrawal by Subject|2
2343897|NCT03531905|4078535|FG000|Overall Study|Lost to Follow-up|2
2343898|NCT03531905|4078536|FG001|Overall Study|Lost to Follow-up|2
2343899|NCT03531905|4078537|FG002|Overall Study|Lost to Follow-up|1
2343900|NCT03531905|4078535|FG000|Overall Study|Participant was out of town|1
2343901|NCT03531905|4078536|FG001|Overall Study|Participant was out of town|0
2343902|NCT03531905|4078537|FG002|Overall Study|Participant was out of town|0
2343903|NCT03531905|4078535|FG000|Overall Study|Could not speak with the participant|1
2343904|NCT03531905|4078536|FG001|Overall Study|Could not speak with the participant|0
2343905|NCT03531905|4078537|FG002|Overall Study|Could not speak with the participant|0
2343906|NCT03532009|4078549|FG000|Overall Study|Other|1
2343907|NCT03532009|4078550|FG001|Overall Study|Other|1
2256722|NCT02091869|3924569|FG000|Overall Study|Withdrawal by Subject|0
2256723|NCT02091869|3924570|FG001|Overall Study|Withdrawal by Subject|3
2256724|NCT02091921|3924580|FG000|Overall Study|Adverse Event|3
2256725|NCT02091986|3924590|FG000|Overall Study|7 rand in error 1 patient decision|2
2256726|NCT02091986|3924591|FG001|Overall Study|7 rand in error 1 patient decision|3
2256727|NCT02091986|3924592|FG002|Overall Study|7 rand in error 1 patient decision|3
2256728|NCT02091986|3924590|FG000|Overall Study|Lost to Follow-up|1
2256729|NCT02091986|3924591|FG001|Overall Study|Lost to Follow-up|0
2256730|NCT02091986|3924592|FG002|Overall Study|Lost to Follow-up|0
2256731|NCT02091986|3924590|FG000|Overall Study|Withdrawal by Subject|4
2256732|NCT02091986|3924591|FG001|Overall Study|Withdrawal by Subject|8
2256733|NCT02091986|3924592|FG002|Overall Study|Withdrawal by Subject|3
2256734|NCT02091986|3924590|FG000|Overall Study|Adverse Event|0
2256735|NCT02091986|3924591|FG001|Overall Study|Adverse Event|0
2256736|NCT02091986|3924592|FG002|Overall Study|Adverse Event|2
2256737|NCT02092025|3924600|FG000|Overall Study|Case Report Forms Uncollected|44
2256738|NCT02092025|3924600|FG000|Overall Study|Protocol Deviation|24
2256739|NCT02092116|3924606|FG000|Overall Study|Withdrawal by Subject|0
2256740|NCT02092116|3924607|FG001|Overall Study|Withdrawal by Subject|3
2256741|NCT02092116|3924606|FG000|Overall Study|Adverse Event|0
2256742|NCT02092116|3924607|FG001|Overall Study|Adverse Event|1
2256743|NCT02092220|3924631|FG000|Period 1|Unrelated Illness|0
2256744|NCT02092220|3924632|FG001|Period 1|Unrelated Illness|2
2256745|NCT02092220|3924631|FG000|Period 2|Severe Hypoglycaemia|1
2256746|NCT02092220|3924632|FG001|Period 2|Severe Hypoglycaemia|0
2256747|NCT02092220|3924631|FG000|Period 2|Nausea, Anxiety, Inconvenience|0
2256748|NCT02092220|3924632|FG001|Period 2|Nausea, Anxiety, Inconvenience|1
2256749|NCT02092285|3924640|FG000|Induction Phase|Adverse Event|7
2256750|NCT02092285|3924640|FG000|Induction Phase|Physician Decision|4
2256751|NCT02092285|3924640|FG000|Induction Phase|Pregnancy|1
2256752|NCT02092285|3924640|FG000|Induction Phase|Relapse/Recurrence|7
2256753|NCT02092285|3924640|FG000|Induction Phase|Withdrawal by Subject|2
2256754|NCT02092285|3924640|FG000|Induction Phase|Lack of Efficacy|14
2256755|NCT02092285|3924640|FG000|Maintenance Phase & Follow-up|Adverse Event|22
2256756|NCT02092285|3924640|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1
2256757|NCT02092285|3924640|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2
2256758|NCT02092285|3924640|FG000|Maintenance Phase & Follow-up|Physician Decision|10
2256759|NCT02092285|3924640|FG000|Maintenance Phase & Follow-up|Pregnancy|1
2256760|NCT02092285|3924640|FG000|Maintenance Phase & Follow-up|Protocol Violation|11
2256761|NCT02092285|3924640|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29
2256762|NCT02092285|3924640|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11
2256763|NCT02092285|3924640|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23
2256764|NCT02092324|3924659|FG000|Overall Study|Adverse Event|1
2256765|NCT02092324|3924659|FG000|Overall Study|Lack of Efficacy|6
2256766|NCT02092324|3924659|FG000|Overall Study|Proceed to Transplant|3
2256767|NCT02092324|3924659|FG000|Overall Study|Physician Decision|7
2256768|NCT02092324|3924659|FG000|Overall Study|Misdiagnosis|2
2256769|NCT02092350|3924668|FG000|Overall Study|Adverse Event|0
2343908|NCT03532009|4078549|FG000|Overall Study|Death|1
2343909|NCT03532009|4078550|FG001|Overall Study|Death|1
2343910|NCT03532009|4078549|FG000|Overall Study|Withdrawal by Patient|0
2343911|NCT03532009|4078550|FG001|Overall Study|Withdrawal by Patient|2
2343912|NCT03532048|4078558|FG000|Overall Study|Lost to Follow-up|12
2343913|NCT03532048|4078559|FG001|Overall Study|Lost to Follow-up|17
2343914|NCT03532048|4078558|FG000|Overall Study|Withdrawal by Subject|7
2196169|NCT01529515|3829063|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0
2196170|NCT01529515|3829064|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0
2196171|NCT01529515|3829065|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10
2196172|NCT01529515|3829066|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7
2196173|NCT01529515|3829063|FG000|DOUBLE BLIND PHASE|Protocol Violation|0
2196174|NCT01529515|3829064|FG001|DOUBLE BLIND PHASE|Protocol Violation|0
2196175|NCT01529515|3829065|FG002|DOUBLE BLIND PHASE|Protocol Violation|1
2196176|NCT01529515|3829066|FG003|DOUBLE BLIND PHASE|Protocol Violation|0
2196177|NCT01529515|3829063|FG000|DOUBLE BLIND PHASE|Other|0
2196178|NCT01529515|3829064|FG001|DOUBLE BLIND PHASE|Other|0
2196179|NCT01529515|3829065|FG002|DOUBLE BLIND PHASE|Other|9
2196180|NCT01529515|3829066|FG003|DOUBLE BLIND PHASE|Other|2
2196181|NCT01529606|3829075|FG000|Overall Study|Lost to Follow-up|21
2196182|NCT01529606|3829076|FG001|Overall Study|Lost to Follow-up|18
2256770|NCT02092350|3924669|FG001|Overall Study|Adverse Event|3
2343915|NCT03532048|4078559|FG001|Overall Study|Withdrawal by Subject|0
2343916|NCT03533114|4078599|FG000|Overall|Adverse Event|16
2343917|NCT03533114|4078600|FG001|Overall|Adverse Event|11
2343918|NCT03533114|4078599|FG000|Overall|Consent Withdrawal by Participant|7
2343919|NCT03533114|4078600|FG001|Overall|Consent Withdrawal by Participant|6
2343920|NCT03533114|4078599|FG000|Overall|Lack of Efficacy|5
2343921|NCT03533114|4078600|FG001|Overall|Lack of Efficacy|3
2343922|NCT03533114|4078599|FG000|Overall|Lost to Follow-up|1
2343923|NCT03533114|4078600|FG001|Overall|Lost to Follow-up|1
2343924|NCT03533114|4078599|FG000|Overall|Physician Decision|0
2343925|NCT03533114|4078600|FG001|Overall|Physician Decision|2
2343926|NCT03533114|4078599|FG000|Overall|Protocol deviation|1
2343927|NCT03533114|4078600|FG001|Overall|Protocol deviation|1
2343928|NCT03533114|4078599|FG000|Overall|Failure to meet randomization criteria|1
2256771|NCT02092350|3924668|FG000|Overall Study|Death|2
2256772|NCT02092350|3924669|FG001|Overall Study|Death|5
2256773|NCT02092350|3924668|FG000|Overall Study|Lost to Follow-up|3
2256774|NCT02092350|3924669|FG001|Overall Study|Lost to Follow-up|1
2256775|NCT02092350|3924668|FG000|Overall Study|Protocol Violation|1
2256776|NCT02092350|3924669|FG001|Overall Study|Protocol Violation|0
2256777|NCT02092350|3924668|FG000|Overall Study|Physician Decision|1
2256778|NCT02092350|3924669|FG001|Overall Study|Physician Decision|1
2256779|NCT02092350|3924668|FG000|Overall Study|Screen Failure|1
2256780|NCT02092350|3924669|FG001|Overall Study|Screen Failure|0
2256781|NCT02092350|3924668|FG000|Overall Study|Withdrawal by Subject|2
2256782|NCT02092350|3924669|FG001|Overall Study|Withdrawal by Subject|2
2256783|NCT02092389|3924677|FG000|Overall Study|Adverse Event|1
2256784|NCT02092389|3924677|FG000|Overall Study|Other|5
2256785|NCT02092467|3924698|FG000|Overall Study|Death|49
2256786|NCT02092467|3924699|FG001|Overall Study|Death|66
2256787|NCT02092467|3924700|FG002|Overall Study|Death|38
2256788|NCT02092467|3924698|FG000|Overall Study|Lost to Follow-up|38
2256789|NCT02092467|3924699|FG001|Overall Study|Lost to Follow-up|35
2256790|NCT02092467|3924700|FG002|Overall Study|Lost to Follow-up|40
2256791|NCT02092467|3924698|FG000|Overall Study|Global Deterioration of Health Status|1
2256792|NCT02092467|3924699|FG001|Overall Study|Global Deterioration of Health Status|0
2256793|NCT02092467|3924700|FG002|Overall Study|Global Deterioration of Health Status|0
2256794|NCT02092467|3924698|FG000|Overall Study|Other|32
2256795|NCT02092467|3924699|FG001|Overall Study|Other|30
2256796|NCT02092467|3924700|FG002|Overall Study|Other|24
2256797|NCT02092467|3924698|FG000|Overall Study|Withdrawal by Subject|282
2256798|NCT02092467|3924699|FG001|Overall Study|Withdrawal by Subject|327
2256799|NCT02092467|3924700|FG002|Overall Study|Withdrawal by Subject|289
2256800|NCT02092467|3924698|FG000|Overall Study|Randomized but not treated|2
2256801|NCT02092467|3924699|FG001|Overall Study|Randomized but not treated|1
2256802|NCT02092467|3924700|FG002|Overall Study|Randomized but not treated|7
2256803|NCT02092662|3924730|FG000|Overall Study|Lost to Follow-up|13
2256804|NCT02092662|3924731|FG001|Overall Study|Lost to Follow-up|0
2256805|NCT02092909|3924755|FG000|Overall Study|Adverse Event|0
2256806|NCT02092909|3924756|FG001|Overall Study|Adverse Event|0
2256807|NCT02092909|3924757|FG002|Overall Study|Adverse Event|4
2256808|NCT02092909|3924758|FG003|Overall Study|Adverse Event|2
2256809|NCT02092909|3924755|FG000|Overall Study|Lack of Efficacy|0
2256810|NCT02092909|3924756|FG001|Overall Study|Lack of Efficacy|2
2256811|NCT02092909|3924757|FG002|Overall Study|Lack of Efficacy|1
2256812|NCT02092909|3924758|FG003|Overall Study|Lack of Efficacy|0
2256813|NCT02092909|3924755|FG000|Overall Study|Withdrawal by Subject|0
2256814|NCT02092909|3924756|FG001|Overall Study|Withdrawal by Subject|0
2256815|NCT02092909|3924757|FG002|Overall Study|Withdrawal by Subject|2
2256816|NCT02092909|3924758|FG003|Overall Study|Withdrawal by Subject|1
2256817|NCT02092909|3924755|FG000|Overall Study|Study terminated by Sponsor|0
2256818|NCT02092909|3924756|FG001|Overall Study|Study terminated by Sponsor|0
2256819|NCT02092909|3924757|FG002|Overall Study|Study terminated by Sponsor|0
2256820|NCT02092909|3924758|FG003|Overall Study|Study terminated by Sponsor|2
2256821|NCT02092909|3924755|FG000|Overall Study|Miscellaneous|1
2256822|NCT02092909|3924756|FG001|Overall Study|Miscellaneous|1
2256823|NCT02092909|3924757|FG002|Overall Study|Miscellaneous|2
2256824|NCT02092909|3924758|FG003|Overall Study|Miscellaneous|1
2256825|NCT02092961|3924771|FG000|Overall Study|Not reported|1
2256826|NCT02092961|3924772|FG001|Overall Study|Not reported|0
2256827|NCT02092961|3924773|FG002|Overall Study|Not reported|1
2256828|NCT02092961|3924771|FG000|Overall Study|Study stopped|13
2256829|NCT02092961|3924772|FG001|Overall Study|Study stopped|9
2256830|NCT02092961|3924773|FG002|Overall Study|Study stopped|12
2256831|NCT02092961|3924771|FG000|Overall Study|Lack of therapeutic response|2
2256832|NCT02092961|3924772|FG001|Overall Study|Lack of therapeutic response|1
2256833|NCT02092961|3924773|FG002|Overall Study|Lack of therapeutic response|3
2256834|NCT02092961|3924771|FG000|Overall Study|Dev. of study specific discont. criteria|3
2256835|NCT02092961|3924772|FG001|Overall Study|Dev. of study specific discont. criteria|0
2256836|NCT02092961|3924773|FG002|Overall Study|Dev. of study specific discont. criteria|0
2256837|NCT02092961|3924771|FG000|Overall Study|Adverse Event|2
2256838|NCT02092961|3924772|FG001|Overall Study|Adverse Event|4
2256839|NCT02092961|3924773|FG002|Overall Study|Adverse Event|0
2256840|NCT02093026|3924794|FG000|Overall Study|Adverse Event|26
2256841|NCT02093026|3924794|FG000|Overall Study|Death|10
2256842|NCT02093026|3924794|FG000|Overall Study|Other|157
2256843|NCT02093221|3924804|FG000|Overall Study|Adverse Event|1
2256844|NCT02093221|3924805|FG001|Overall Study|Adverse Event|0
2256845|NCT02093221|3924806|FG002|Overall Study|Adverse Event|0
2256846|NCT02093221|3924807|FG003|Overall Study|Adverse Event|0
2256847|NCT02093221|3924808|FG004|Overall Study|Adverse Event|0
2256848|NCT02093221|3924804|FG000|Overall Study|Withdrawal by Subject|1
2256849|NCT02093221|3924805|FG001|Overall Study|Withdrawal by Subject|1
2256850|NCT02093221|3924806|FG002|Overall Study|Withdrawal by Subject|4
2256851|NCT02093221|3924807|FG003|Overall Study|Withdrawal by Subject|1
2256852|NCT02093221|3924808|FG004|Overall Study|Withdrawal by Subject|1
2256853|NCT02093221|3924804|FG000|Overall Study|Lost to Follow-up|2
2256854|NCT02093221|3924805|FG001|Overall Study|Lost to Follow-up|0
2256855|NCT02093221|3924806|FG002|Overall Study|Lost to Follow-up|1
2256856|NCT02093221|3924807|FG003|Overall Study|Lost to Follow-up|1
2256857|NCT02093221|3924808|FG004|Overall Study|Lost to Follow-up|0
2256858|NCT02093221|3924804|FG000|Overall Study|Death|0
2256859|NCT02093221|3924805|FG001|Overall Study|Death|1
2256860|NCT02093221|3924806|FG002|Overall Study|Death|0
2256861|NCT02093221|3924807|FG003|Overall Study|Death|0
2256862|NCT02093221|3924808|FG004|Overall Study|Death|0
2256863|NCT02093221|3924804|FG000|Overall Study|Protocol Violation|0
2256864|NCT02093221|3924805|FG001|Overall Study|Protocol Violation|1
2256865|NCT02093221|3924806|FG002|Overall Study|Protocol Violation|0
2256866|NCT02093221|3924807|FG003|Overall Study|Protocol Violation|0
2256867|NCT02093221|3924808|FG004|Overall Study|Protocol Violation|0
2256868|NCT02093221|3924804|FG000|Overall Study|Study termination|6
2256869|NCT02093221|3924805|FG001|Overall Study|Study termination|5
2256870|NCT02093221|3924806|FG002|Overall Study|Study termination|4
2256871|NCT02093221|3924807|FG003|Overall Study|Study termination|6
2256872|NCT02093221|3924808|FG004|Overall Study|Study termination|7
2256873|NCT02093351|3924836|FG000|Part A|Adverse Event|0
2256874|NCT02093351|3924837|FG001|Part A|Adverse Event|1
2256875|NCT02093351|3924838|FG002|Part A|Adverse Event|1
2256876|NCT02093351|3924839|FG003|Part A|Adverse Event|0
2256877|NCT02093351|3924836|FG000|Part A|Condition under investigation worsened|2
2256878|NCT02093351|3924837|FG001|Part A|Condition under investigation worsened|0
2256879|NCT02093351|3924838|FG002|Part A|Condition under investigation worsened|2
2256880|NCT02093351|3924839|FG003|Part A|Condition under investigation worsened|0
2256881|NCT02093351|3924836|FG000|Part A|Death|0
2256882|NCT02093351|3924837|FG001|Part A|Death|1
2256883|NCT02093351|3924838|FG002|Part A|Death|0
2256884|NCT02093351|3924839|FG003|Part A|Death|0
2256885|NCT02093351|3924836|FG000|Part B|Patient decision|0
2256886|NCT02093351|3924837|FG001|Part B|Patient decision|0
2256887|NCT02093351|3924838|FG002|Part B|Patient decision|0
2256888|NCT02093351|3924839|FG003|Part B|Patient decision|3
2256889|NCT02093351|3924836|FG000|Part B|Disease progression|0
2256890|NCT02093351|3924837|FG001|Part B|Disease progression|0
2256891|NCT02093351|3924838|FG002|Part B|Disease progression|0
2256892|NCT02093351|3924839|FG003|Part B|Disease progression|4
2256893|NCT02093351|3924836|FG000|Part B|Complete response|0
2256894|NCT02093351|3924837|FG001|Part B|Complete response|0
2256895|NCT02093351|3924838|FG002|Part B|Complete response|0
2256896|NCT02093351|3924839|FG003|Part B|Complete response|1
2256897|NCT02093351|3924836|FG000|Part B|Adverse event + disease progression|0
2256898|NCT02093351|3924837|FG001|Part B|Adverse event + disease progression|0
2256899|NCT02093351|3924838|FG002|Part B|Adverse event + disease progression|0
2256900|NCT02093351|3924839|FG003|Part B|Adverse event + disease progression|1
2256901|NCT02093351|3924836|FG000|Part B|Lack of therapeutic response|0
2256902|NCT02093351|3924837|FG001|Part B|Lack of therapeutic response|0
2256903|NCT02093351|3924838|FG002|Part B|Lack of therapeutic response|0
2256904|NCT02093351|3924839|FG003|Part B|Lack of therapeutic response|12
2256905|NCT02093351|3924836|FG000|Part B|Condition under investigation worsened|0
2256906|NCT02093351|3924837|FG001|Part B|Condition under investigation worsened|0
2256907|NCT02093351|3924838|FG002|Part B|Condition under investigation worsened|0
2256908|NCT02093351|3924839|FG003|Part B|Condition under investigation worsened|39
2256909|NCT02093351|3924836|FG000|Part B|Adverse Event|0
2256910|NCT02093351|3924837|FG001|Part B|Adverse Event|0
2256911|NCT02093351|3924838|FG002|Part B|Adverse Event|0
2256912|NCT02093351|3924839|FG003|Part B|Adverse Event|2
2256913|NCT02093351|3924836|FG000|Part B|Death|0
2256914|NCT02093351|3924837|FG001|Part B|Death|0
2256915|NCT02093351|3924838|FG002|Part B|Death|0
2256916|NCT02093351|3924839|FG003|Part B|Death|1
2256917|NCT02093390|3924856|FG000|Overall Study|Withdrawal by Subject|0
2256918|NCT02093390|3924857|FG001|Overall Study|Withdrawal by Subject|1
2256919|NCT02093520|3924866|FG000|Overall Study|Not treated|6
2256920|NCT02093520|3924867|FG001|Overall Study|Not treated|22
2256921|NCT02093663|3924873|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
2256922|NCT02093663|3924874|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2256923|NCT02093663|3924875|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2256924|NCT02093663|3924876|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2256925|NCT02093663|3924877|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2256926|NCT02093663|3924873|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
2256927|NCT02093663|3924874|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2256928|NCT02093663|3924875|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2256929|NCT02093663|3924876|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2256930|NCT02093663|3924877|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2256931|NCT02093663|3924873|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
2256932|NCT02093663|3924874|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
2256933|NCT02093663|3924875|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
2256934|NCT02093663|3924876|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
2256935|NCT02093663|3924877|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
2256936|NCT02093663|3924873|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2256937|NCT02093663|3924874|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2256938|NCT02093663|3924875|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1
2256939|NCT02093663|3924876|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2256940|NCT02093663|3924877|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2256941|NCT02093663|3924873|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2256942|NCT02093663|3924874|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2256943|NCT02093663|3924875|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
2256944|NCT02093663|3924876|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2256945|NCT02093663|3924877|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2256946|NCT02093663|3924873|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
2256947|NCT02093663|3924874|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
2256948|NCT02093663|3924875|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
2256949|NCT02093663|3924876|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
2256950|NCT02093663|3924877|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
2256951|NCT02093663|3924873|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
2256952|NCT02093663|3924874|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
2256953|NCT02093663|3924875|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
2256954|NCT02093663|3924876|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
2256955|NCT02093663|3924877|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
2343929|NCT03533114|4078600|FG001|Overall|Failure to meet randomization criteria|2
2343930|NCT03533114|4078599|FG000|Overall|Non-Compliance with study drug|0
2343931|NCT03533114|4078600|FG001|Overall|Non-Compliance with study drug|1
2343932|NCT03533114|4078599|FG000|Overall|Other|0
2343933|NCT03533114|4078600|FG001|Overall|Other|1
2343934|NCT03533114|4078599|FG000|Open Label Titration and Optimization|Adverse Event|11
2343935|NCT03533114|4078600|FG001|Open Label Titration and Optimization|Adverse Event|8
2343936|NCT03533114|4078599|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2
2343937|NCT03533114|4078600|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1
2343938|NCT03533114|4078599|FG000|Open Label Titration and Optimization|Lack of Efficacy|3
2343939|NCT03533114|4078600|FG001|Open Label Titration and Optimization|Lack of Efficacy|1
2343940|NCT03533114|4078599|FG000|Open Label Titration and Optimization|Lost to Follow-up|0
2343941|NCT03533114|4078600|FG001|Open Label Titration and Optimization|Lost to Follow-up|1
2343942|NCT03533114|4078599|FG000|Open Label Titration and Optimization|Protocol Deviation|0
2343943|NCT03533114|4078600|FG001|Open Label Titration and Optimization|Protocol Deviation|1
2343944|NCT03533114|4078599|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0
2343945|NCT03533114|4078600|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1
2343946|NCT03533114|4078599|FG000|Stable Dose|Adverse Event|0
2343947|NCT03533114|4078600|FG001|Stable Dose|Adverse Event|2
2343948|NCT03533114|4078599|FG000|Stable Dose|Consent Withdrawal by Participant|1
2343949|NCT03533114|4078600|FG001|Stable Dose|Consent Withdrawal by Participant|0
2343950|NCT03533114|4078599|FG000|Stable Dose|Lack of Efficacy|1
2343951|NCT03533114|4078600|FG001|Stable Dose|Lack of Efficacy|0
2343952|NCT03533114|4078599|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1
2343953|NCT03533114|4078600|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1
2343954|NCT03533114|4078599|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1
2343955|NCT03533114|4078600|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0
2343956|NCT03533114|4078599|FG000|Open-Label Safety Extension|Adverse Event|3
2343957|NCT03533114|4078600|FG001|Open-Label Safety Extension|Adverse Event|0
2343958|NCT03533114|4078599|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2
2343959|NCT03533114|4078600|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3
2343960|NCT03533114|4078599|FG000|Open-Label Safety Extension|Lack of Efficacy|1
2343961|NCT03533114|4078600|FG001|Open-Label Safety Extension|Lack of Efficacy|0
2256956|NCT02093663|3924873|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
2256957|NCT02093663|3924874|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
2256958|NCT02093663|3924875|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
2256959|NCT02093663|3924876|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
2256960|NCT02093663|3924877|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
2256961|NCT02093663|3924873|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2256962|NCT02093663|3924874|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2256963|NCT02093663|3924875|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2256964|NCT02093663|3924876|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2256965|NCT02093663|3924877|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1
2256966|NCT02093897|3924959|FG000|Overall Study|Physician Decision|1
2256967|NCT02093897|3924959|FG000|Overall Study|Planned age group closure - no's reached|17
2256968|NCT02093897|3924959|FG000|Overall Study|Adverse event, non-fatal|1
2256969|NCT02093923|3924975|FG000|Overall Study|Lost to Follow-up|0
2256970|NCT02093923|3924976|FG001|Overall Study|Lost to Follow-up|0
2256971|NCT02093923|3924977|FG002|Overall Study|Lost to Follow-up|0
2256972|NCT02093923|3924978|FG003|Overall Study|Lost to Follow-up|1
2256973|NCT02093923|3924979|FG004|Overall Study|Lost to Follow-up|0
2256974|NCT02093923|3924975|FG000|Overall Study|Screen failure after randomization|0
2256975|NCT02093923|3924976|FG001|Overall Study|Screen failure after randomization|0
2256976|NCT02093923|3924977|FG002|Overall Study|Screen failure after randomization|0
2256977|NCT02093923|3924978|FG003|Overall Study|Screen failure after randomization|1
2256978|NCT02093923|3924979|FG004|Overall Study|Screen failure after randomization|0
2256979|NCT02094300|3925034|FG000|Overall Study|Death|7
2256980|NCT02094300|3925034|FG000|Overall Study|Lost to Follow-up|10
2256981|NCT02094300|3925034|FG000|Overall Study|Still be eligible for follow-up|3
2256982|NCT02094417|3925047|FG000|Overall Study|Adverse Event|0
2256983|NCT02094417|3925048|FG001|Overall Study|Adverse Event|0
2256984|NCT02094417|3925049|FG002|Overall Study|Adverse Event|0
2256985|NCT02094417|3925050|FG003|Overall Study|Adverse Event|1
2256986|NCT02094417|3925047|FG000|Overall Study|Eligibility criteria|0
2256987|NCT02094417|3925048|FG001|Overall Study|Eligibility criteria|1
2256988|NCT02094417|3925049|FG002|Overall Study|Eligibility criteria|0
2256989|NCT02094417|3925050|FG003|Overall Study|Eligibility criteria|0
2256990|NCT02094417|3925047|FG000|Overall Study|No responder|4
2256991|NCT02094417|3925048|FG001|Overall Study|No responder|4
2256992|NCT02094417|3925049|FG002|Overall Study|No responder|4
2256993|NCT02094417|3925050|FG003|Overall Study|No responder|3
2256994|NCT02094417|3925047|FG000|Overall Study|Unable to conduct observations or assess|0
2256995|NCT02094417|3925048|FG001|Overall Study|Unable to conduct observations or assess|1
2256996|NCT02094417|3925049|FG002|Overall Study|Unable to conduct observations or assess|0
2256997|NCT02094417|3925050|FG003|Overall Study|Unable to conduct observations or assess|0
2256998|NCT02094417|3925047|FG000|Overall Study|Withdrawal by Subject|1
2256999|NCT02094417|3925048|FG001|Overall Study|Withdrawal by Subject|2
2257000|NCT02094417|3925049|FG002|Overall Study|Withdrawal by Subject|1
2257001|NCT02094417|3925050|FG003|Overall Study|Withdrawal by Subject|3
2257002|NCT02094573|3925080|FG000|Overall Study|Adverse Event|4
2257003|NCT02094573|3925081|FG001|Overall Study|Adverse Event|14
2257004|NCT02094573|3925080|FG000|Overall Study|Clinical Progressive Disease|9
2257005|NCT02094573|3925081|FG001|Overall Study|Clinical Progressive Disease|13
2257006|NCT02094573|3925080|FG000|Overall Study|Death|11
2343962|NCT03533114|4078599|FG000|Open-Label Safety Extension|Lost to Follow-up|1
2343963|NCT03533114|4078600|FG001|Open-Label Safety Extension|Lost to Follow-up|0
2343964|NCT03533114|4078599|FG000|Open-Label Safety Extension|Protocol Deviation|1
2343965|NCT03533114|4078600|FG001|Open-Label Safety Extension|Protocol Deviation|0
2343966|NCT03533608|4078630|FG000|Overall Study|Withdrawal by Subject|3
2343967|NCT03533608|4078630|FG000|Overall Study|Physician Decision|2
2343968|NCT03535194|4078675|FG000|Induction Period|Adverse Event|2
2343969|NCT03535194|4078676|FG001|Induction Period|Adverse Event|2
2343970|NCT03535194|4078677|FG002|Induction Period|Adverse Event|1
2343971|NCT03535194|4078678|FG003|Induction Period|Adverse Event|3
2343972|NCT03535194|4078679|FG004|Induction Period|Adverse Event|0
2343973|NCT03535194|4078675|FG000|Induction Period|Death|0
2343974|NCT03535194|4078676|FG001|Induction Period|Death|1
2343975|NCT03535194|4078677|FG002|Induction Period|Death|0
2343976|NCT03535194|4078678|FG003|Induction Period|Death|0
2343977|NCT03535194|4078679|FG004|Induction Period|Death|0
2343978|NCT03535194|4078675|FG000|Induction Period|Lack of Efficacy|1
2343979|NCT03535194|4078676|FG001|Induction Period|Lack of Efficacy|3
2343980|NCT03535194|4078677|FG002|Induction Period|Lack of Efficacy|2
2343981|NCT03535194|4078678|FG003|Induction Period|Lack of Efficacy|2
2343982|NCT03535194|4078679|FG004|Induction Period|Lack of Efficacy|0
2343983|NCT03535194|4078675|FG000|Induction Period|Lost to Follow-up|3
2343984|NCT03535194|4078676|FG001|Induction Period|Lost to Follow-up|5
2343985|NCT03535194|4078677|FG002|Induction Period|Lost to Follow-up|2
2343986|NCT03535194|4078678|FG003|Induction Period|Lost to Follow-up|3
2343987|NCT03535194|4078679|FG004|Induction Period|Lost to Follow-up|0
2257007|NCT02094573|3925081|FG001|Overall Study|Death|3
2257008|NCT02094573|3925080|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63
2257009|NCT02094573|3925081|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50
2343988|NCT03535194|4078675|FG000|Induction Period|Physician Decision|1
2257010|NCT02094573|3925080|FG000|Overall Study|Non-compliance with Study Drug|1
2257011|NCT02094573|3925081|FG001|Overall Study|Non-compliance with Study Drug|1
2257012|NCT02094573|3925080|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1
2257013|NCT02094573|3925081|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0
2257014|NCT02094573|3925080|FG000|Overall Study|Physician Decision|4
2257015|NCT02094573|3925081|FG001|Overall Study|Physician Decision|4
2257016|NCT02094573|3925080|FG000|Overall Study|Site Terminated by Sponsor|10
2257017|NCT02094573|3925081|FG001|Overall Study|Site Terminated by Sponsor|17
2257018|NCT02094573|3925080|FG000|Overall Study|Withdrawal by Subject|6
2257019|NCT02094573|3925081|FG001|Overall Study|Withdrawal by Subject|8
2257020|NCT02094573|3925080|FG000|Overall Study|Randomized but not Treated|3
2257021|NCT02094573|3925081|FG001|Overall Study|Randomized but not Treated|0
2257022|NCT02094612|3925118|FG000|Overall Study|Lost to Follow-up|47
2257023|NCT02094612|3925119|FG001|Overall Study|Lost to Follow-up|47
2257024|NCT02094612|3925118|FG000|Overall Study|Never started ADHD medication|32
2257025|NCT02094612|3925119|FG001|Overall Study|Never started ADHD medication|23
2257026|NCT02094677|3925136|FG000|Overall Study|Screening|3
2257027|NCT02094677|3925137|FG001|Overall Study|Screening|1
2257028|NCT02094885|3925185|FG000|Overall Study|Death|1
2257029|NCT02094885|3925186|FG001|Overall Study|Death|5
2257030|NCT02094885|3925185|FG000|Overall Study|Withdrawn due to age|1
2257031|NCT02094885|3925186|FG001|Overall Study|Withdrawn due to age|0
2257032|NCT02094898|3925192|FG000|Overall Study|Clinical Worsening|2
2257033|NCT02094898|3925192|FG000|Overall Study|Adverse Event|2
2257034|NCT02094898|3925192|FG000|Overall Study|Lack of Efficacy|1
2257035|NCT02094937|3925198|FG000|8 Weeks in Period 1|Adverse Event|9
2257036|NCT02094937|3925199|FG001|8 Weeks in Period 1|Adverse Event|0
2257037|NCT02094937|3925200|FG002|8 Weeks in Period 1|Adverse Event|0
2257038|NCT02094937|3925201|FG003|8 Weeks in Period 1|Adverse Event|0
2257039|NCT02094937|3925198|FG000|8 Weeks in Period 1|Lack of Efficacy|3
2257040|NCT02094937|3925199|FG001|8 Weeks in Period 1|Lack of Efficacy|0
2257041|NCT02094937|3925200|FG002|8 Weeks in Period 1|Lack of Efficacy|0
2257042|NCT02094937|3925201|FG003|8 Weeks in Period 1|Lack of Efficacy|0
2257043|NCT02094937|3925198|FG000|8 Weeks in Period 1|Protocol Violation|2
2257044|NCT02094937|3925199|FG001|8 Weeks in Period 1|Protocol Violation|0
2257045|NCT02094937|3925200|FG002|8 Weeks in Period 1|Protocol Violation|0
2257046|NCT02094937|3925201|FG003|8 Weeks in Period 1|Protocol Violation|0
2257047|NCT02094937|3925198|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41
2257048|NCT02094937|3925199|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0
2257049|NCT02094937|3925200|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0
2257050|NCT02094937|3925201|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0
2257051|NCT02094937|3925198|FG000|8 Weeks in Period 1|Physician Decision|1
2257052|NCT02094937|3925199|FG001|8 Weeks in Period 1|Physician Decision|0
2257053|NCT02094937|3925200|FG002|8 Weeks in Period 1|Physician Decision|0
2257054|NCT02094937|3925201|FG003|8 Weeks in Period 1|Physician Decision|0
2257055|NCT02094937|3925198|FG000|8 Weeks in Period 1|Withdrawal by Subject|4
2257056|NCT02094937|3925199|FG001|8 Weeks in Period 1|Withdrawal by Subject|0
2257057|NCT02094937|3925200|FG002|8 Weeks in Period 1|Withdrawal by Subject|0
2257058|NCT02094937|3925201|FG003|8 Weeks in Period 1|Withdrawal by Subject|0
2257059|NCT02094937|3925198|FG000|12 Weeks in Period 2|Adverse Event|0
2257060|NCT02094937|3925199|FG001|12 Weeks in Period 2|Adverse Event|2
2257061|NCT02094937|3925200|FG002|12 Weeks in Period 2|Adverse Event|4
2257062|NCT02094937|3925201|FG003|12 Weeks in Period 2|Adverse Event|1
2257063|NCT02094937|3925198|FG000|12 Weeks in Period 2|Lack of Efficacy|0
2257064|NCT02094937|3925199|FG001|12 Weeks in Period 2|Lack of Efficacy|1
2257065|NCT02094937|3925200|FG002|12 Weeks in Period 2|Lack of Efficacy|0
2257066|NCT02094937|3925201|FG003|12 Weeks in Period 2|Lack of Efficacy|0
2257067|NCT02094937|3925198|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0
2257068|NCT02094937|3925199|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5
2257069|NCT02094937|3925200|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6
2257070|NCT02094937|3925201|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11
2257071|NCT02094937|3925198|FG000|12 Weeks in Period 2|Withdrawal by Subject|0
2257072|NCT02094937|3925199|FG001|12 Weeks in Period 2|Withdrawal by Subject|2
2257073|NCT02094937|3925200|FG002|12 Weeks in Period 2|Withdrawal by Subject|2
2257074|NCT02094937|3925201|FG003|12 Weeks in Period 2|Withdrawal by Subject|0
2257075|NCT02094937|3925198|FG000|12 Weeks in Period 2|Randomized incorrectly|0
2257076|NCT02094937|3925199|FG001|12 Weeks in Period 2|Randomized incorrectly|1
2257077|NCT02094937|3925200|FG002|12 Weeks in Period 2|Randomized incorrectly|0
2257078|NCT02094937|3925201|FG003|12 Weeks in Period 2|Randomized incorrectly|0
2257079|NCT02095106|3925212|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
2257080|NCT02095106|3925213|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
2257081|NCT02095145|3925225|FG000|Overall Study|Withdrawal by Subject|1
2257082|NCT02095145|3925226|FG001|Overall Study|Withdrawal by Subject|0
2257083|NCT02095158|3925234|FG000|Overall Study|Adverse Event|14
2257084|NCT02095158|3925234|FG000|Overall Study|Lack of Efficacy|3
2257085|NCT02095158|3925234|FG000|Overall Study|Pregnancy|1
2257086|NCT02095158|3925234|FG000|Overall Study|Lost to Follow-up|20
2257087|NCT02095158|3925234|FG000|Overall Study|Personal Reasons|35
2257088|NCT02095158|3925234|FG000|Overall Study|Protocol Violation|1
2257089|NCT02095158|3925234|FG000|Overall Study|Other Miscellaneous Reasons|1
2257090|NCT02095197|3925240|FG000|Overall Study|Lost to Follow-up|0
2257091|NCT02095197|3925241|FG001|Overall Study|Lost to Follow-up|3
2257092|NCT02095223|3925249|FG000|Overall Study|Withdrawal by Subject|1
2257093|NCT02095223|3925250|FG001|Overall Study|Withdrawal by Subject|0
2257094|NCT02095535|3925270|FG000|Recruitment|Protocol Violation|2
2257095|NCT02095678|3925285|FG000|Overall Study|Withdrawal by Subject|0
2257096|NCT02095678|3925286|FG001|Overall Study|Withdrawal by Subject|1
2257097|NCT02095678|3925285|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11
2257098|NCT02095678|3925286|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12
2257099|NCT02095678|3925285|FG000|Overall Study|lesion impacted by previous treatment|1
2257100|NCT02095678|3925286|FG001|Overall Study|lesion impacted by previous treatment|1
2257101|NCT02095678|3925285|FG000|Overall Study|No Confirmed Diagnosis|0
2257102|NCT02095678|3925286|FG001|Overall Study|No Confirmed Diagnosis|3
2257103|NCT02095678|3925285|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1
2257104|NCT02095678|3925286|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1
2257105|NCT02095678|3925285|FG000|Overall Study|No Visible Lesion or Pathological Finding|4
2257106|NCT02095678|3925286|FG001|Overall Study|No Visible Lesion or Pathological Finding|0
2257107|NCT02095691|3925295|FG000|Overall Study|Physician Decision|1
2257108|NCT02095873|3925313|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1
2257109|NCT02095873|3925314|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0
2257110|NCT02095873|3925313|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
2257111|NCT02095873|3925314|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
2257112|NCT02095873|3925313|FG000|Second Intervention (8 Weeks)|Protocol Violation|1
2257113|NCT02095873|3925314|FG001|Second Intervention (8 Weeks)|Protocol Violation|0
2257114|NCT02095951|3925324|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9
2257115|NCT02095951|3925325|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6
2257116|NCT02096003|3925337|FG000|Overall Study|Protocol Violation|0
2257117|NCT02096003|3925338|FG001|Overall Study|Protocol Violation|2
2257118|NCT02096003|3925337|FG000|Overall Study|additional surgery|2
2257119|NCT02096003|3925338|FG001|Overall Study|additional surgery|1
2257120|NCT02096263|3925374|FG000|Overall Study|Adverse Event|1
2257121|NCT02096263|3925375|FG001|Overall Study|Adverse Event|0
2257122|NCT02096263|3925376|FG002|Overall Study|Adverse Event|1
2257123|NCT02096263|3925374|FG000|Overall Study|Lost to Follow-up|14
2257124|NCT02096263|3925375|FG001|Overall Study|Lost to Follow-up|18
2257125|NCT02096263|3925376|FG002|Overall Study|Lost to Follow-up|15
2257126|NCT02096263|3925374|FG000|Overall Study|Other|7
2257127|NCT02096263|3925375|FG001|Overall Study|Other|9
2257128|NCT02096263|3925376|FG002|Overall Study|Other|6
2257129|NCT02096263|3925374|FG000|Overall Study|Sponsor study termination|0
2257130|NCT02096263|3925375|FG001|Overall Study|Sponsor study termination|0
2257131|NCT02096263|3925376|FG002|Overall Study|Sponsor study termination|1
2257132|NCT02096263|3925374|FG000|Overall Study|Protocol Violation|7
2257133|NCT02096263|3925375|FG001|Overall Study|Protocol Violation|2
2257134|NCT02096263|3925376|FG002|Overall Study|Protocol Violation|8
2257135|NCT02096263|3925374|FG000|Overall Study|Withdrawal by Subject|5
2257136|NCT02096263|3925375|FG001|Overall Study|Withdrawal by Subject|7
2257137|NCT02096263|3925376|FG002|Overall Study|Withdrawal by Subject|8
2257138|NCT02096471|3925397|FG000|Overall Study|Adverse Event|1
2257139|NCT02096471|3925397|FG000|Overall Study|Lack of Efficacy|7
2257140|NCT02096471|3925397|FG000|Overall Study|Withdrawal by Subject|3
2257141|NCT02096471|3925397|FG000|Overall Study|Non-Compliant|2
2257142|NCT02096588|3925414|FG000|Overall Study|Lack of Efficacy|2
2257143|NCT02096588|3925415|FG001|Overall Study|Lack of Efficacy|0
2257144|NCT02096588|3925414|FG000|Overall Study|Withdrawal by Subject|0
2257145|NCT02096588|3925415|FG001|Overall Study|Withdrawal by Subject|1
2257146|NCT02096705|3925431|FG000|Treatment|Adverse Event|6
2257147|NCT02096705|3925432|FG001|Treatment|Adverse Event|3
2257148|NCT02096705|3925431|FG000|Treatment|Subject request to discontinue treatment|1
2257149|NCT02096705|3925432|FG001|Treatment|Subject request to discontinue treatment|1
2257150|NCT02096705|3925431|FG000|Treatment|Withdrawal by Subject|1
2257151|NCT02096705|3925432|FG001|Treatment|Withdrawal by Subject|0
2257152|NCT02096705|3925431|FG000|Treatment|Other|1
2257153|NCT02096705|3925432|FG001|Treatment|Other|1
2257154|NCT02096705|3925431|FG000|Follow-up|Withdrawal by Subject|1
2257155|NCT02096705|3925432|FG001|Follow-up|Withdrawal by Subject|0
2257156|NCT02096705|3925431|FG000|Follow-up|Adverse Event|2
2257157|NCT02096705|3925432|FG001|Follow-up|Adverse Event|2
2257158|NCT02096705|3925431|FG000|Follow-up|Subjects not reporting status|1
2257159|NCT02096705|3925432|FG001|Follow-up|Subjects not reporting status|2
2257160|NCT02096744|3925464|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
2257161|NCT02096744|3925465|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
2257162|NCT02096744|3925464|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1
2257163|NCT02096744|3925465|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0
2257164|NCT02096744|3925464|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
2257165|NCT02096744|3925465|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
2257166|NCT02096835|3925476|FG000|Overall Study|Withdrawal by Subject|1
2257167|NCT02096835|3925477|FG001|Overall Study|Withdrawal by Subject|0
2257168|NCT02096835|3925478|FG002|Overall Study|Withdrawal by Subject|0
2257169|NCT02096835|3925476|FG000|Overall Study|converted to open procedures|1
2257170|NCT02096835|3925477|FG001|Overall Study|converted to open procedures|0
2257171|NCT02096835|3925478|FG002|Overall Study|converted to open procedures|0
2257172|NCT02096835|3925476|FG000|Overall Study|Lost to Follow-up|1
2257173|NCT02096835|3925477|FG001|Overall Study|Lost to Follow-up|0
2257174|NCT02096835|3925478|FG002|Overall Study|Lost to Follow-up|1
2257175|NCT02096900|3925507|FG000|Overall Study|Did not receive medication|3
2257176|NCT02096900|3925508|FG001|Overall Study|Did not receive medication|1
2257177|NCT02096900|3925507|FG000|Overall Study|Surgery cancelled- medication received|1
2257178|NCT02096900|3925508|FG001|Overall Study|Surgery cancelled- medication received|1
2257179|NCT02096952|3925514|FG000|Overall Study|Adverse Event|1
2257180|NCT02097030|3925520|FG000|First Intervention (3 Days)|Lost to Follow-up|1
2257181|NCT02097030|3925521|FG001|First Intervention (3 Days)|Lost to Follow-up|0
2257182|NCT02097030|3925520|FG000|First Intervention (3 Days)|Visual Acuity|0
2257183|NCT02097030|3925521|FG001|First Intervention (3 Days)|Visual Acuity|1
2257184|NCT02097056|3925531|FG000|Overall Study|Protocol Violation|2
2257185|NCT02097056|3925531|FG000|Overall Study|Withdrawal by Subject|15
2257186|NCT02097056|3925531|FG000|Overall Study|Lost to Follow-up|2
2257187|NCT02097056|3925531|FG000|Overall Study|Adverse Event|37
2257188|NCT02097056|3925531|FG000|Overall Study|Other|2
2257189|NCT02097108|3925535|FG000|Overall Study|Adverse Event|1
2257190|NCT02097108|3925535|FG000|Overall Study|patient was abroad for 6 months|1
2257191|NCT02097238|3925539|FG000|Overall Study|Death|1
2257192|NCT02097238|3925539|FG000|Overall Study|Physician Decision|1
2257193|NCT02097238|3925539|FG000|Overall Study|Progressive Disease|17
2257194|NCT02097277|3925549|FG000|Overall Study|Subject no longer meets study criteria|0
2257195|NCT02097277|3925550|FG001|Overall Study|Subject no longer meets study criteria|1
2257196|NCT02097277|3925551|FG002|Overall Study|Subject no longer meets study criteria|0
2257197|NCT02097277|3925552|FG003|Overall Study|Subject no longer meets study criteria|1
2257198|NCT02097277|3925553|FG004|Overall Study|Subject no longer meets study criteria|0
2257199|NCT02097277|3925549|FG000|Overall Study|Subject request to discontinue treatment|0
2257200|NCT02097277|3925550|FG001|Overall Study|Subject request to discontinue treatment|0
2257201|NCT02097277|3925551|FG002|Overall Study|Subject request to discontinue treatment|0
2257202|NCT02097277|3925552|FG003|Overall Study|Subject request to discontinue treatment|0
2257203|NCT02097277|3925553|FG004|Overall Study|Subject request to discontinue treatment|1
2257204|NCT02097277|3925549|FG000|Overall Study|Lost to Follow-up|0
2257205|NCT02097277|3925550|FG001|Overall Study|Lost to Follow-up|1
2257206|NCT02097277|3925551|FG002|Overall Study|Lost to Follow-up|1
2257207|NCT02097277|3925552|FG003|Overall Study|Lost to Follow-up|0
2257208|NCT02097277|3925553|FG004|Overall Study|Lost to Follow-up|0
2257209|NCT02097277|3925549|FG000|Overall Study|Withdrawal by Subject|2
2257210|NCT02097277|3925550|FG001|Overall Study|Withdrawal by Subject|1
2257211|NCT02097277|3925551|FG002|Overall Study|Withdrawal by Subject|0
2257212|NCT02097277|3925552|FG003|Overall Study|Withdrawal by Subject|1
2257213|NCT02097277|3925553|FG004|Overall Study|Withdrawal by Subject|0
2257214|NCT02097277|3925549|FG000|Overall Study|Adverse Event|0
2257215|NCT02097277|3925550|FG001|Overall Study|Adverse Event|0
2257216|NCT02097277|3925551|FG002|Overall Study|Adverse Event|1
2257217|NCT02097277|3925552|FG003|Overall Study|Adverse Event|2
2257218|NCT02097277|3925553|FG004|Overall Study|Adverse Event|0
2257219|NCT02097290|3925569|FG000|Overall Study|Death|6
2257220|NCT02097290|3925569|FG000|Overall Study|Total Withdrawals|3
2257221|NCT02097290|3925569|FG000|Overall Study|Attempt|8
2257222|NCT02097472|3925585|FG000|Received Vaccination 2|Adverse Event|0
2257223|NCT02097472|3925586|FG001|Received Vaccination 2|Adverse Event|0
2257224|NCT02097472|3925587|FG002|Received Vaccination 2|Adverse Event|0
2257225|NCT02097472|3925588|FG003|Received Vaccination 2|Adverse Event|0
2257226|NCT02097472|3925589|FG004|Received Vaccination 2|Adverse Event|0
2257227|NCT02097472|3925590|FG005|Received Vaccination 2|Adverse Event|0
2257228|NCT02097472|3925591|FG006|Received Vaccination 2|Adverse Event|1
2257229|NCT02097472|3925592|FG007|Received Vaccination 2|Adverse Event|0
2257230|NCT02097719|3925702|FG000|Overall Study|Subject Withdrew Consent|1
2257231|NCT02097719|3925703|FG001|Overall Study|Subject Withdrew Consent|0
2257232|NCT02097719|3925702|FG000|Overall Study|Lost to Follow-up|0
2257233|NCT02097719|3925703|FG001|Overall Study|Lost to Follow-up|1
2257234|NCT02097719|3925702|FG000|Overall Study|Adverse Event|2
2257235|NCT02097719|3925703|FG001|Overall Study|Adverse Event|0
2343989|NCT03535194|4078676|FG001|Induction Period|Physician Decision|1
2343990|NCT03535194|4078677|FG002|Induction Period|Physician Decision|0
2343991|NCT03535194|4078678|FG003|Induction Period|Physician Decision|0
2343992|NCT03535194|4078679|FG004|Induction Period|Physician Decision|0
2343993|NCT03535194|4078675|FG000|Induction Period|Protocol Violation|1
2343994|NCT03535194|4078676|FG001|Induction Period|Protocol Violation|0
2343995|NCT03535194|4078677|FG002|Induction Period|Protocol Violation|0
2343996|NCT03535194|4078678|FG003|Induction Period|Protocol Violation|1
2343997|NCT03535194|4078679|FG004|Induction Period|Protocol Violation|0
2343998|NCT03535194|4078675|FG000|Induction Period|Screen Failure|0
2343999|NCT03535194|4078676|FG001|Induction Period|Screen Failure|1
2344000|NCT03535194|4078677|FG002|Induction Period|Screen Failure|0
2344001|NCT03535194|4078678|FG003|Induction Period|Screen Failure|0
2344002|NCT03535194|4078679|FG004|Induction Period|Screen Failure|0
2344003|NCT03535194|4078675|FG000|Induction Period|Withdrawal by Subject|3
2344004|NCT03535194|4078676|FG001|Induction Period|Withdrawal by Subject|4
2344005|NCT03535194|4078677|FG002|Induction Period|Withdrawal by Subject|3
2196189|NCT01529645|3829101|FG000|Overall Study|Lost to Follow-up|0
2196190|NCT01529645|3829102|FG001|Overall Study|Lost to Follow-up|1
2196191|NCT01529645|3829103|FG002|Overall Study|Lost to Follow-up|1
2196192|NCT01529645|3829104|FG003|Overall Study|Lost to Follow-up|1
2196193|NCT01529645|3829105|FG004|Overall Study|Lost to Follow-up|1
2196194|NCT01529645|3829106|FG005|Overall Study|Lost to Follow-up|0
2196195|NCT01529645|3829107|FG006|Overall Study|Lost to Follow-up|2
2196196|NCT01529645|3829108|FG007|Overall Study|Lost to Follow-up|0
2196197|NCT01529645|3829109|FG008|Overall Study|Lost to Follow-up|1
2196198|NCT01529645|3829110|FG009|Overall Study|Lost to Follow-up|0
2196199|NCT01529645|3829101|FG000|Overall Study|SAE - Premature contractions|0
2196200|NCT01529645|3829102|FG001|Overall Study|SAE - Premature contractions|0
2196201|NCT01529645|3829103|FG002|Overall Study|SAE - Premature contractions|1
2196202|NCT01529645|3829104|FG003|Overall Study|SAE - Premature contractions|0
2196203|NCT01529645|3829105|FG004|Overall Study|SAE - Premature contractions|0
2196204|NCT01529645|3829106|FG005|Overall Study|SAE - Premature contractions|0
2196205|NCT01529645|3829107|FG006|Overall Study|SAE - Premature contractions|0
2196206|NCT01529645|3829108|FG007|Overall Study|SAE - Premature contractions|0
2196207|NCT01529645|3829109|FG008|Overall Study|SAE - Premature contractions|0
2196208|NCT01529645|3829110|FG009|Overall Study|SAE - Premature contractions|0
2196209|NCT01529645|3829101|FG000|Overall Study|Withdrawal by Subject|2
2196210|NCT01529645|3829102|FG001|Overall Study|Withdrawal by Subject|0
2196211|NCT01529645|3829103|FG002|Overall Study|Withdrawal by Subject|0
2196212|NCT01529645|3829104|FG003|Overall Study|Withdrawal by Subject|1
2196213|NCT01529645|3829105|FG004|Overall Study|Withdrawal by Subject|1
2196214|NCT01529645|3829106|FG005|Overall Study|Withdrawal by Subject|1
2196215|NCT01529645|3829107|FG006|Overall Study|Withdrawal by Subject|0
2196216|NCT01529645|3829108|FG007|Overall Study|Withdrawal by Subject|0
2344006|NCT03535194|4078678|FG003|Induction Period|Withdrawal by Subject|2
2344007|NCT03535194|4078679|FG004|Induction Period|Withdrawal by Subject|0
2344008|NCT03535194|4078675|FG000|Maintenance Period|Adverse Event|6
2344009|NCT03535194|4078676|FG001|Maintenance Period|Adverse Event|5
2344010|NCT03535194|4078677|FG002|Maintenance Period|Adverse Event|1
2344011|NCT03535194|4078678|FG003|Maintenance Period|Adverse Event|11
2344012|NCT03535194|4078679|FG004|Maintenance Period|Adverse Event|4
2344013|NCT03535194|4078675|FG000|Maintenance Period|Lack of Efficacy|3
2344014|NCT03535194|4078676|FG001|Maintenance Period|Lack of Efficacy|2
2344015|NCT03535194|4078677|FG002|Maintenance Period|Lack of Efficacy|5
2344016|NCT03535194|4078678|FG003|Maintenance Period|Lack of Efficacy|9
2344017|NCT03535194|4078679|FG004|Maintenance Period|Lack of Efficacy|0
2344018|NCT03535194|4078675|FG000|Maintenance Period|Lost to Follow-up|4
2196183|NCT01529632|3829084|FG000|Overall Study|Administrative problem|2
2196184|NCT01529632|3829085|FG001|Overall Study|Administrative problem|1
2196185|NCT01529632|3829084|FG000|Overall Study|Protocol Violation|0
2196186|NCT01529632|3829085|FG001|Overall Study|Protocol Violation|1
2196187|NCT01529632|3829084|FG000|Overall Study|Adverse Event|1
2196188|NCT01529632|3829085|FG001|Overall Study|Adverse Event|1
2196217|NCT01529645|3829109|FG008|Overall Study|Withdrawal by Subject|0
2196218|NCT01529645|3829110|FG009|Overall Study|Withdrawal by Subject|0
2257236|NCT02097745|3925719|FG000|Overall Study|Adverse Event|25
2257237|NCT02097745|3925719|FG000|Overall Study|Death|16
2257238|NCT02097745|3925719|FG000|Overall Study|Failure to Return|14
2257239|NCT02097745|3925719|FG000|Overall Study|Administrative/Other|27
2257240|NCT02097745|3925719|FG000|Overall Study|Reason Not Specified|96
2257241|NCT02097823|3925728|FG000|Overall Study|Withdrawal by Subject|1
2257242|NCT02097823|3925729|FG001|Overall Study|Withdrawal by Subject|1
2257243|NCT02098109|3925762|FG000|Overall Study|Protocol Violation|3
2257244|NCT02098109|3925763|FG001|Overall Study|Protocol Violation|0
2257245|NCT02098369|3925778|FG000|Overall Study|Withdrawal by Subject|1
2257246|NCT02098369|3925779|FG001|Overall Study|Withdrawal by Subject|5
2257247|NCT02098369|3925780|FG002|Overall Study|Withdrawal by Subject|0
2257248|NCT02098369|3925778|FG000|Overall Study|Lost to Follow-up|5
2257249|NCT02098369|3925779|FG001|Overall Study|Lost to Follow-up|1
2257250|NCT02098369|3925780|FG002|Overall Study|Lost to Follow-up|3
2257251|NCT02098369|3925778|FG000|Overall Study|Death|1
2257252|NCT02098369|3925779|FG001|Overall Study|Death|1
2257253|NCT02098369|3925780|FG002|Overall Study|Death|1
2257254|NCT02098369|3925778|FG000|Overall Study|Other|0
2257255|NCT02098369|3925779|FG001|Overall Study|Other|2
2257256|NCT02098369|3925780|FG002|Overall Study|Other|1
2257257|NCT02098395|3925792|FG000|Overall Study|Protocol Violation|2
2257258|NCT02098395|3925793|FG001|Overall Study|Protocol Violation|2
2257259|NCT02098395|3925794|FG002|Overall Study|Protocol Violation|0
2257260|NCT02098395|3925795|FG003|Overall Study|Protocol Violation|7
2257261|NCT02098395|3925792|FG000|Overall Study|Withdrawal by Subject|10
2257262|NCT02098395|3925793|FG001|Overall Study|Withdrawal by Subject|10
2257263|NCT02098395|3925794|FG002|Overall Study|Withdrawal by Subject|5
2257264|NCT02098395|3925795|FG003|Overall Study|Withdrawal by Subject|13
2257265|NCT02098395|3925792|FG000|Overall Study|Adverse Event|12
2257266|NCT02098395|3925793|FG001|Overall Study|Adverse Event|19
2257267|NCT02098395|3925794|FG002|Overall Study|Adverse Event|34
2257268|NCT02098395|3925795|FG003|Overall Study|Adverse Event|2
2257269|NCT02098395|3925792|FG000|Overall Study|Lost to Follow-up|2
2344019|NCT03535194|4078676|FG001|Maintenance Period|Lost to Follow-up|2
2257270|NCT02098395|3925793|FG001|Overall Study|Lost to Follow-up|1
2257271|NCT02098395|3925794|FG002|Overall Study|Lost to Follow-up|0
2257272|NCT02098395|3925795|FG003|Overall Study|Lost to Follow-up|3
2257273|NCT02098395|3925792|FG000|Overall Study|Unclassified|0
2257274|NCT02098395|3925793|FG001|Overall Study|Unclassified|0
2257275|NCT02098395|3925794|FG002|Overall Study|Unclassified|3
2257276|NCT02098395|3925795|FG003|Overall Study|Unclassified|2
2257277|NCT02098733|3925805|FG000|Overall Study|Data Not Available|5
2257278|NCT02098733|3925805|FG000|Overall Study|Lost to Follow-up|5
2257279|NCT02098746|3925809|FG000|Overall Study|Changes of Investigator|2
2257280|NCT02098746|3925809|FG000|Overall Study|Other Miscellaneous Reasons|1
2257281|NCT02098746|3925809|FG000|Overall Study|Enrolled 15 Days After the First Dose|1
2257282|NCT02098746|3925809|FG000|Overall Study|Data Not Available After Treatment|1
2257283|NCT02099110|3925840|FG000|Overall Study|Protocol Violation|2
2257284|NCT02099110|3925841|FG001|Overall Study|Protocol Violation|1
2257285|NCT02099110|3925842|FG002|Overall Study|Protocol Violation|0
2257286|NCT02099110|3925843|FG003|Overall Study|Protocol Violation|3
2257287|NCT02099110|3925844|FG004|Overall Study|Protocol Violation|1
2257288|NCT02099110|3925840|FG000|Overall Study|Participant moved|1
2257289|NCT02099110|3925841|FG001|Overall Study|Participant moved|1
2257290|NCT02099110|3925842|FG002|Overall Study|Participant moved|1
2257291|NCT02099110|3925843|FG003|Overall Study|Participant moved|0
2257292|NCT02099110|3925844|FG004|Overall Study|Participant moved|2
2257293|NCT02099110|3925840|FG000|Overall Study|Withdrawal by Subject|7
2257294|NCT02099110|3925841|FG001|Overall Study|Withdrawal by Subject|11
2257295|NCT02099110|3925842|FG002|Overall Study|Withdrawal by Subject|13
2257296|NCT02099110|3925843|FG003|Overall Study|Withdrawal by Subject|9
2257297|NCT02099110|3925844|FG004|Overall Study|Withdrawal by Subject|13
2257298|NCT02099110|3925840|FG000|Overall Study|Adverse Event|3
2257299|NCT02099110|3925841|FG001|Overall Study|Adverse Event|5
2257300|NCT02099110|3925842|FG002|Overall Study|Adverse Event|2
2257301|NCT02099110|3925843|FG003|Overall Study|Adverse Event|3
2257302|NCT02099110|3925844|FG004|Overall Study|Adverse Event|2
2257303|NCT02099110|3925840|FG000|Overall Study|Lost to Follow-up|6
2257304|NCT02099110|3925841|FG001|Overall Study|Lost to Follow-up|12
2257305|NCT02099110|3925842|FG002|Overall Study|Lost to Follow-up|11
2257306|NCT02099110|3925843|FG003|Overall Study|Lost to Follow-up|5
2257307|NCT02099110|3925844|FG004|Overall Study|Lost to Follow-up|6
2257308|NCT02099110|3925840|FG000|Overall Study|Death|0
2257309|NCT02099110|3925841|FG001|Overall Study|Death|1
2257310|NCT02099110|3925842|FG002|Overall Study|Death|0
2257311|NCT02099110|3925843|FG003|Overall Study|Death|0
2257312|NCT02099110|3925844|FG004|Overall Study|Death|0
2257313|NCT02099110|3925840|FG000|Overall Study|Screen failure|0
2257314|NCT02099110|3925841|FG001|Overall Study|Screen failure|0
2257315|NCT02099110|3925842|FG002|Overall Study|Screen failure|0
2257316|NCT02099110|3925843|FG003|Overall Study|Screen failure|0
2257317|NCT02099110|3925844|FG004|Overall Study|Screen failure|1
2257318|NCT02099110|3925840|FG000|Overall Study|Non-compliance with study drug|2
2257319|NCT02099110|3925841|FG001|Overall Study|Non-compliance with study drug|0
2257320|NCT02099110|3925842|FG002|Overall Study|Non-compliance with study drug|0
2257321|NCT02099110|3925843|FG003|Overall Study|Non-compliance with study drug|0
2257322|NCT02099110|3925844|FG004|Overall Study|Non-compliance with study drug|1
2257323|NCT02099110|3925840|FG000|Overall Study|Physician Decision|3
2257324|NCT02099110|3925841|FG001|Overall Study|Physician Decision|0
2257325|NCT02099110|3925842|FG002|Overall Study|Physician Decision|1
2257326|NCT02099110|3925843|FG003|Overall Study|Physician Decision|2
2257327|NCT02099110|3925844|FG004|Overall Study|Physician Decision|1
2257328|NCT02099682|3925876|FG000|Overall Study|Data Not Available|51
2257329|NCT02099682|3925876|FG000|Overall Study|Lost to Follow-up|31
2257330|NCT02099682|3925876|FG000|Overall Study|Other|29
2257331|NCT02099708|3925880|FG000|Overall Study|Data Not Available|30
2257332|NCT02099708|3925880|FG000|Overall Study|Lost to Follow-up|141
2257333|NCT02099708|3925880|FG000|Overall Study|Other|29
2257334|NCT02099838|3925930|FG000|Overall Study|Death|1
2257335|NCT02099838|3925931|FG001|Overall Study|Death|0
2257336|NCT02099838|3925930|FG000|Overall Study|Lost to Follow-up|3
2257337|NCT02099838|3925931|FG001|Overall Study|Lost to Follow-up|1
2257338|NCT02099838|3925930|FG000|Overall Study|Withdrawal by Subject|0
2257339|NCT02099838|3925931|FG001|Overall Study|Withdrawal by Subject|1
2257340|NCT02100124|3925957|FG000|Overall Study|Lost to Follow-up|5
2257341|NCT02100124|3925958|FG001|Overall Study|Lost to Follow-up|11
2257342|NCT02100124|3925959|FG002|Overall Study|Lost to Follow-up|3
2257343|NCT02100124|3925957|FG000|Overall Study|Withdrawal by Subject|1
2257344|NCT02100124|3925958|FG001|Overall Study|Withdrawal by Subject|0
2257345|NCT02100124|3925959|FG002|Overall Study|Withdrawal by Subject|0
2257346|NCT02100228|3925973|FG000|Overall Study|Other|19
2344020|NCT03535194|4078677|FG002|Maintenance Period|Lost to Follow-up|1
2344021|NCT03535194|4078678|FG003|Maintenance Period|Lost to Follow-up|5
2344022|NCT03535194|4078679|FG004|Maintenance Period|Lost to Follow-up|2
2344023|NCT03535194|4078675|FG000|Maintenance Period|Other|1
2344024|NCT03535194|4078676|FG001|Maintenance Period|Other|2
2257347|NCT02100228|3925974|FG001|Overall Study|Other|19
2257348|NCT02100228|3925973|FG000|Overall Study|Administrative reason|0
2257349|NCT02100228|3925974|FG001|Overall Study|Administrative reason|1
2257350|NCT02100228|3925973|FG000|Overall Study|Inclusion/Exclusion criteria not met|12
2257351|NCT02100228|3925974|FG001|Overall Study|Inclusion/Exclusion criteria not met|16
2257352|NCT02100228|3925973|FG000|Overall Study|Non-compliance|0
2344025|NCT03535194|4078677|FG002|Maintenance Period|Other|0
2344026|NCT03535194|4078678|FG003|Maintenance Period|Other|0
2344027|NCT03535194|4078679|FG004|Maintenance Period|Other|0
2344028|NCT03535194|4078675|FG000|Maintenance Period|Physician Decision|1
2344029|NCT03535194|4078676|FG001|Maintenance Period|Physician Decision|2
2344030|NCT03535194|4078677|FG002|Maintenance Period|Physician Decision|0
2344031|NCT03535194|4078678|FG003|Maintenance Period|Physician Decision|2
2344032|NCT03535194|4078679|FG004|Maintenance Period|Physician Decision|0
2344033|NCT03535194|4078675|FG000|Maintenance Period|Pregnancy|0
2344034|NCT03535194|4078676|FG001|Maintenance Period|Pregnancy|0
2344035|NCT03535194|4078677|FG002|Maintenance Period|Pregnancy|0
2344036|NCT03535194|4078678|FG003|Maintenance Period|Pregnancy|2
2344037|NCT03535194|4078679|FG004|Maintenance Period|Pregnancy|0
2344038|NCT03535194|4078675|FG000|Maintenance Period|Protocol Violation|0
2344039|NCT03535194|4078676|FG001|Maintenance Period|Protocol Violation|1
2344040|NCT03535194|4078677|FG002|Maintenance Period|Protocol Violation|0
2344041|NCT03535194|4078678|FG003|Maintenance Period|Protocol Violation|0
2344042|NCT03535194|4078679|FG004|Maintenance Period|Protocol Violation|0
2344043|NCT03535194|4078675|FG000|Maintenance Period|Withdrawal by Subject|7
2344044|NCT03535194|4078676|FG001|Maintenance Period|Withdrawal by Subject|2
2344045|NCT03535194|4078677|FG002|Maintenance Period|Withdrawal by Subject|1
2344046|NCT03535194|4078678|FG003|Maintenance Period|Withdrawal by Subject|8
2344047|NCT03535194|4078679|FG004|Maintenance Period|Withdrawal by Subject|0
2344048|NCT03535194|4078675|FG000|Post-Treatment Followup Period|Adverse Event|4
2344049|NCT03535194|4078676|FG001|Post-Treatment Followup Period|Adverse Event|5
2344050|NCT03535194|4078677|FG002|Post-Treatment Followup Period|Adverse Event|1
2344051|NCT03535194|4078678|FG003|Post-Treatment Followup Period|Adverse Event|8
2344052|NCT03535194|4078679|FG004|Post-Treatment Followup Period|Adverse Event|0
2344053|NCT03535194|4078675|FG000|Post-Treatment Followup Period|Lack of Efficacy|3
2344054|NCT03535194|4078676|FG001|Post-Treatment Followup Period|Lack of Efficacy|4
2344055|NCT03535194|4078677|FG002|Post-Treatment Followup Period|Lack of Efficacy|5
2344056|NCT03535194|4078678|FG003|Post-Treatment Followup Period|Lack of Efficacy|4
2344057|NCT03535194|4078679|FG004|Post-Treatment Followup Period|Lack of Efficacy|0
2344058|NCT03535194|4078675|FG000|Post-Treatment Followup Period|Lost to Follow-up|1
2344059|NCT03535194|4078676|FG001|Post-Treatment Followup Period|Lost to Follow-up|1
2344060|NCT03535194|4078677|FG002|Post-Treatment Followup Period|Lost to Follow-up|1
2344061|NCT03535194|4078678|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
2344062|NCT03535194|4078679|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
2344063|NCT03535194|4078675|FG000|Post-Treatment Followup Period|Other|1
2344064|NCT03535194|4078676|FG001|Post-Treatment Followup Period|Other|0
2344065|NCT03535194|4078677|FG002|Post-Treatment Followup Period|Other|0
2344066|NCT03535194|4078678|FG003|Post-Treatment Followup Period|Other|5
2344067|NCT03535194|4078679|FG004|Post-Treatment Followup Period|Other|0
2344068|NCT03535194|4078675|FG000|Post-Treatment Followup Period|Physician Decision|0
2344069|NCT03535194|4078676|FG001|Post-Treatment Followup Period|Physician Decision|2
2344070|NCT03535194|4078677|FG002|Post-Treatment Followup Period|Physician Decision|1
2344071|NCT03535194|4078678|FG003|Post-Treatment Followup Period|Physician Decision|1
2344072|NCT03535194|4078679|FG004|Post-Treatment Followup Period|Physician Decision|0
2344073|NCT03535194|4078675|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2
2344074|NCT03535194|4078676|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2
2344075|NCT03535194|4078677|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3
2344076|NCT03535194|4078678|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6
2344077|NCT03535194|4078679|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
2344078|NCT03535844|4078715|FG000|Overall Study|Withdrawal by Subject|0
2344079|NCT03535844|4078716|FG001|Overall Study|Withdrawal by Subject|1
2344080|NCT03535974|4078725|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
2344081|NCT03535974|4078726|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
2344082|NCT03535974|4078727|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
2344083|NCT03535974|4078725|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
2344084|NCT03535974|4078726|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
2344085|NCT03535974|4078727|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
2344086|NCT03536663|4078735|FG000|Endexo|Protocol Violation|1
2344087|NCT03536949|4078763|FG000|Overall Study|Adverse Event|4
2344088|NCT03536949|4078764|FG001|Overall Study|Adverse Event|0
2344089|NCT03536949|4078763|FG000|Overall Study|Lost to Follow-up|2
2344090|NCT03536949|4078764|FG001|Overall Study|Lost to Follow-up|1
2344091|NCT03536949|4078763|FG000|Overall Study|Withdrawal by Subject|6
2344092|NCT03536949|4078764|FG001|Overall Study|Withdrawal by Subject|0
2344093|NCT03536949|4078763|FG000|Overall Study|Non-compliance|2
2344094|NCT03536949|4078764|FG001|Overall Study|Non-compliance|1
2344095|NCT03537261|4078785|FG000|Overall Study|Lost to Follow-up|4
2344096|NCT03537261|4078786|FG001|Overall Study|Lost to Follow-up|5
2344097|NCT03537261|4078785|FG000|Overall Study|Withdrawal by Subject|4
2344098|NCT03537261|4078786|FG001|Overall Study|Withdrawal by Subject|6
2344099|NCT03537261|4078785|FG000|Overall Study|Did not return study questionnaires|0
2344100|NCT03537261|4078786|FG001|Overall Study|Did not return study questionnaires|1
2344101|NCT03537651|4078837|FG000|Overall Study|Adverse Event|2
2257353|NCT02100228|3925974|FG001|Overall Study|Non-compliance|3
2257354|NCT02100228|3925973|FG000|Overall Study|Lost to Follow-up|0
2257355|NCT02100228|3925974|FG001|Overall Study|Lost to Follow-up|1
2257356|NCT02100228|3925973|FG000|Overall Study|Withdrawal by Subject|27
2257357|NCT02100228|3925974|FG001|Overall Study|Withdrawal by Subject|37
2257358|NCT02100228|3925973|FG000|Overall Study|Adverse Event|16
2257359|NCT02100228|3925974|FG001|Overall Study|Adverse Event|12
2257360|NCT02100228|3925973|FG000|Overall Study|Death|1
2257361|NCT02100228|3925974|FG001|Overall Study|Death|1
2257362|NCT02100319|3925991|FG000|Overall Study|Case Report Forms Uncollected|11
2257363|NCT02100319|3925991|FG000|Overall Study|Protocol Deviation|5
2257364|NCT02100475|3926014|FG000|Overall Study|Unclassified|1
2257365|NCT02100475|3926015|FG001|Overall Study|Unclassified|2
2257366|NCT02100475|3926014|FG000|Overall Study|Withdrawal criteria|1
2257367|NCT02100475|3926015|FG001|Overall Study|Withdrawal criteria|0
2257368|NCT02100514|3926023|FG000|Treatment Period|Adverse Event|0
2257369|NCT02100514|3926024|FG001|Treatment Period|Adverse Event|5
2257370|NCT02100514|3926025|FG002|Treatment Period|Adverse Event|0
2257371|NCT02100514|3926026|FG003|Treatment Period|Adverse Event|0
2257372|NCT02100514|3926027|FG004|Treatment Period|Adverse Event|0
2257373|NCT02100514|3926023|FG000|Treatment Period|Death|2
2257374|NCT02100514|3926024|FG001|Treatment Period|Death|2
2257375|NCT02100514|3926025|FG002|Treatment Period|Death|0
2257376|NCT02100514|3926026|FG003|Treatment Period|Death|0
2257377|NCT02100514|3926027|FG004|Treatment Period|Death|0
2257378|NCT02100514|3926023|FG000|Treatment Period|Lost to Follow-up|5
2257379|NCT02100514|3926024|FG001|Treatment Period|Lost to Follow-up|17
2257380|NCT02100514|3926025|FG002|Treatment Period|Lost to Follow-up|0
2257381|NCT02100514|3926026|FG003|Treatment Period|Lost to Follow-up|0
2257382|NCT02100514|3926027|FG004|Treatment Period|Lost to Follow-up|0
2257383|NCT02100514|3926023|FG000|Treatment Period|Did Not Meet Entrance Criteria|0
2257384|NCT02100514|3926024|FG001|Treatment Period|Did Not Meet Entrance Criteria|1
2257385|NCT02100514|3926025|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
2257386|NCT02100514|3926026|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
2344102|NCT03537651|4078837|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
2344103|NCT03537651|4078837|FG000|Overall Study|Commercial Drug is Available for Participant|56
2344104|NCT03537651|4078837|FG000|Overall Study|Other|1
2344105|NCT03538431|4078856|FG000|Overall Study|Physician Decision|0
2344106|NCT03538431|4078857|FG001|Overall Study|Physician Decision|1
2344107|NCT03538431|4078856|FG000|Overall Study|Withdrawal by Subject|1
2344108|NCT03538431|4078857|FG001|Overall Study|Withdrawal by Subject|0
2344109|NCT03538743|4078883|FG000|Overall Study|Adverse Event|0
2344110|NCT03538743|4078884|FG001|Overall Study|Adverse Event|0
2344111|NCT03538743|4078885|FG002|Overall Study|Adverse Event|1
2344112|NCT03538743|4078886|FG003|Overall Study|Adverse Event|1
2344113|NCT03538743|4078887|FG004|Overall Study|Adverse Event|0
2344114|NCT03538743|4078888|FG005|Overall Study|Adverse Event|0
2344115|NCT03538743|4078889|FG006|Overall Study|Adverse Event|0
2344116|NCT03538743|4078890|FG007|Overall Study|Adverse Event|0
2344117|NCT03538743|4078891|FG008|Overall Study|Adverse Event|0
2257387|NCT02100514|3926027|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
2257388|NCT02100514|3926023|FG000|Treatment Period|Protocol Violation|1
2257389|NCT02100514|3926024|FG001|Treatment Period|Protocol Violation|1
2257390|NCT02100514|3926025|FG002|Treatment Period|Protocol Violation|0
2257391|NCT02100514|3926026|FG003|Treatment Period|Protocol Violation|0
2257392|NCT02100514|3926027|FG004|Treatment Period|Protocol Violation|0
2257393|NCT02100514|3926023|FG000|Treatment Period|Withdrawal by Subject|12
2257394|NCT02100514|3926024|FG001|Treatment Period|Withdrawal by Subject|37
2257395|NCT02100514|3926025|FG002|Treatment Period|Withdrawal by Subject|0
2257396|NCT02100514|3926026|FG003|Treatment Period|Withdrawal by Subject|0
2257397|NCT02100514|3926027|FG004|Treatment Period|Withdrawal by Subject|0
2257398|NCT02100514|3926023|FG000|Treatment Period|Other|9
2257399|NCT02100514|3926024|FG001|Treatment Period|Other|11
2257400|NCT02100514|3926025|FG002|Treatment Period|Other|0
2257401|NCT02100514|3926026|FG003|Treatment Period|Other|0
2257402|NCT02100514|3926027|FG004|Treatment Period|Other|0
2257403|NCT02100514|3926023|FG000|Extension Period|Withdrew consent|0
2257404|NCT02100514|3926024|FG001|Extension Period|Withdrew consent|0
2257405|NCT02100514|3926025|FG002|Extension Period|Withdrew consent|2
2257406|NCT02100514|3926026|FG003|Extension Period|Withdrew consent|0
2257407|NCT02100514|3926027|FG004|Extension Period|Withdrew consent|0
2257408|NCT02100631|3926053|FG000|Overall Study|Withdrawal by Subject|1
2257409|NCT02100631|3926054|FG001|Overall Study|Withdrawal by Subject|0
2257410|NCT02100631|3926055|FG002|Overall Study|Withdrawal by Subject|0
2257411|NCT02100631|3926053|FG000|Overall Study|Lost to Follow-up|3
2257412|NCT02100631|3926054|FG001|Overall Study|Lost to Follow-up|4
2257413|NCT02100631|3926055|FG002|Overall Study|Lost to Follow-up|0
2257414|NCT02100631|3926053|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3
2257415|NCT02100631|3926054|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
2257416|NCT02100631|3926055|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
2257417|NCT02100644|3926063|FG000|LTG Escalation Phase|Adverse Event|9
2257418|NCT02100644|3926064|FG001|LTG Escalation Phase|Adverse Event|0
2257419|NCT02100644|3926065|FG002|LTG Escalation Phase|Adverse Event|0
2257420|NCT02100644|3926063|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
2257421|NCT02100644|3926064|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
2257422|NCT02100644|3926065|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
2257423|NCT02100644|3926063|FG000|LTG Escalation Phase|Withdrawal by Subject|3
2257424|NCT02100644|3926064|FG001|LTG Escalation Phase|Withdrawal by Subject|0
2257425|NCT02100644|3926065|FG002|LTG Escalation Phase|Withdrawal by Subject|0
2257426|NCT02100657|3926072|FG000|Cohort 1: Dose Level 1|Progressive disease|6
2257427|NCT02100657|3926073|FG001|Cohort 1: Dose Level 1|Progressive disease|0
2257428|NCT02100657|3926074|FG002|Cohort 1: Dose Level 1|Progressive disease|0
2257429|NCT02100657|3926072|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1
2257430|NCT02100657|3926073|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0
2257431|NCT02100657|3926074|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0
2257432|NCT02100657|3926072|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1
2257433|NCT02100657|3926073|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0
2257434|NCT02100657|3926074|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0
2257435|NCT02100657|3926072|FG000|Cohort 2: Dose Level 2|Progressive disease|0
2257436|NCT02100657|3926073|FG001|Cohort 2: Dose Level 2|Progressive disease|2
2257437|NCT02100657|3926074|FG002|Cohort 2: Dose Level 2|Progressive disease|0
2257438|NCT02100657|3926072|FG000|Cohort 2: Dose Level 2|Physician Decision|0
2257439|NCT02100657|3926073|FG001|Cohort 2: Dose Level 2|Physician Decision|1
2257440|NCT02100657|3926074|FG002|Cohort 2: Dose Level 2|Physician Decision|0
2257441|NCT02100657|3926072|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0
2257442|NCT02100657|3926073|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1
2257443|NCT02100657|3926074|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0
2257444|NCT02100657|3926072|FG000|Cohort 3: Dose Level 3|Progressive disease|0
2257445|NCT02100657|3926073|FG001|Cohort 3: Dose Level 3|Progressive disease|0
2257446|NCT02100657|3926074|FG002|Cohort 3: Dose Level 3|Progressive disease|15
2257447|NCT02100657|3926072|FG000|Cohort 3: Dose Level 3|Death|0
2257448|NCT02100657|3926073|FG001|Cohort 3: Dose Level 3|Death|0
2257449|NCT02100657|3926074|FG002|Cohort 3: Dose Level 3|Death|1
2257450|NCT02100657|3926072|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
2257451|NCT02100657|3926073|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
2257452|NCT02100657|3926074|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1
2257453|NCT02100657|3926072|FG000|Cohort 3: Dose Level 3|Physician Decision|0
2257454|NCT02100657|3926073|FG001|Cohort 3: Dose Level 3|Physician Decision|0
2257455|NCT02100657|3926074|FG002|Cohort 3: Dose Level 3|Physician Decision|1
2257456|NCT02100657|3926072|FG000|Cohort 3: Dose Level 3|Never were treated|0
2257457|NCT02100657|3926073|FG001|Cohort 3: Dose Level 3|Never were treated|0
2257458|NCT02100657|3926074|FG002|Cohort 3: Dose Level 3|Never were treated|3
2257459|NCT02100657|3926072|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0
2257460|NCT02100657|3926073|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0
2257461|NCT02100657|3926074|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3
2257462|NCT02100657|3926072|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0
2257463|NCT02100657|3926073|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0
2257464|NCT02100657|3926074|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3
2257465|NCT02100670|3926087|FG000|Overall Study|Adverse Event|10
2257466|NCT02100670|3926088|FG001|Overall Study|Adverse Event|3
2257467|NCT02100670|3926089|FG002|Overall Study|Adverse Event|3
2257468|NCT02100670|3926090|FG003|Overall Study|Adverse Event|0
2257469|NCT02100670|3926087|FG000|Overall Study|Lost to Follow-up|1
2257470|NCT02100670|3926088|FG001|Overall Study|Lost to Follow-up|0
2257471|NCT02100670|3926089|FG002|Overall Study|Lost to Follow-up|0
2257472|NCT02100670|3926090|FG003|Overall Study|Lost to Follow-up|0
2257473|NCT02100670|3926087|FG000|Overall Study|Protocol Violation|0
2257474|NCT02100670|3926088|FG001|Overall Study|Protocol Violation|1
2257475|NCT02100670|3926089|FG002|Overall Study|Protocol Violation|0
2257476|NCT02100670|3926090|FG003|Overall Study|Protocol Violation|1
2344118|NCT03538743|4078883|FG000|Overall Study|Non-Treatment-Related Reasons|0
2344119|NCT03538743|4078884|FG001|Overall Study|Non-Treatment-Related Reasons|0
2344120|NCT03538743|4078885|FG002|Overall Study|Non-Treatment-Related Reasons|0
2344121|NCT03538743|4078886|FG003|Overall Study|Non-Treatment-Related Reasons|0
2344122|NCT03538743|4078887|FG004|Overall Study|Non-Treatment-Related Reasons|0
2344123|NCT03538743|4078888|FG005|Overall Study|Non-Treatment-Related Reasons|0
2344124|NCT03538743|4078889|FG006|Overall Study|Non-Treatment-Related Reasons|0
2344125|NCT03538743|4078890|FG007|Overall Study|Non-Treatment-Related Reasons|0
2344126|NCT03538743|4078891|FG008|Overall Study|Non-Treatment-Related Reasons|3
2344127|NCT03538743|4078883|FG000|Overall Study|Withdrawal by Subject|0
2344128|NCT03538743|4078884|FG001|Overall Study|Withdrawal by Subject|0
2344129|NCT03538743|4078885|FG002|Overall Study|Withdrawal by Subject|0
2344130|NCT03538743|4078886|FG003|Overall Study|Withdrawal by Subject|1
2344131|NCT03538743|4078887|FG004|Overall Study|Withdrawal by Subject|0
2344132|NCT03538743|4078888|FG005|Overall Study|Withdrawal by Subject|0
2344133|NCT03538743|4078889|FG006|Overall Study|Withdrawal by Subject|0
2344134|NCT03538743|4078890|FG007|Overall Study|Withdrawal by Subject|0
2344135|NCT03538743|4078891|FG008|Overall Study|Withdrawal by Subject|0
2257477|NCT02100670|3926087|FG000|Overall Study|Withdrawal of Consent|0
2257478|NCT02100670|3926088|FG001|Overall Study|Withdrawal of Consent|1
2257479|NCT02100670|3926089|FG002|Overall Study|Withdrawal of Consent|1
2257480|NCT02100670|3926090|FG003|Overall Study|Withdrawal of Consent|0
2257481|NCT02100670|3926087|FG000|Overall Study|No swelling no pain|1
2257482|NCT02100670|3926088|FG001|Overall Study|No swelling no pain|0
2257483|NCT02100670|3926089|FG002|Overall Study|No swelling no pain|0
2257484|NCT02100670|3926090|FG003|Overall Study|No swelling no pain|0
2257485|NCT02100670|3926087|FG000|Overall Study|Poor Efficacy|0
2257486|NCT02100670|3926088|FG001|Overall Study|Poor Efficacy|1
2257487|NCT02100670|3926089|FG002|Overall Study|Poor Efficacy|0
2257488|NCT02100670|3926090|FG003|Overall Study|Poor Efficacy|0
2257489|NCT02100670|3926087|FG000|Overall Study|Physician Decision|0
2257490|NCT02100670|3926088|FG001|Overall Study|Physician Decision|1
2257491|NCT02100670|3926089|FG002|Overall Study|Physician Decision|0
2257492|NCT02100670|3926090|FG003|Overall Study|Physician Decision|0
2257493|NCT02100670|3926087|FG000|Overall Study|Withdrawal by Subject|1
2257494|NCT02100670|3926088|FG001|Overall Study|Withdrawal by Subject|0
2257495|NCT02100670|3926089|FG002|Overall Study|Withdrawal by Subject|0
2257496|NCT02100670|3926090|FG003|Overall Study|Withdrawal by Subject|0
2257497|NCT02100696|3926113|FG000|Induction Phase|Adverse Event|0
2257498|NCT02100696|3926114|FG001|Induction Phase|Adverse Event|0
2257499|NCT02100696|3926115|FG002|Induction Phase|Adverse Event|1
2257500|NCT02100696|3926116|FG003|Induction Phase|Adverse Event|0
2257501|NCT02100696|3926117|FG004|Induction Phase|Adverse Event|0
2257502|NCT02100696|3926118|FG005|Induction Phase|Adverse Event|0
2257503|NCT02100696|3926113|FG000|Induction Phase|Lost to Follow-up|1
2257504|NCT02100696|3926114|FG001|Induction Phase|Lost to Follow-up|0
2257505|NCT02100696|3926115|FG002|Induction Phase|Lost to Follow-up|1
2257506|NCT02100696|3926116|FG003|Induction Phase|Lost to Follow-up|0
2257507|NCT02100696|3926117|FG004|Induction Phase|Lost to Follow-up|0
2257508|NCT02100696|3926118|FG005|Induction Phase|Lost to Follow-up|0
2257509|NCT02100696|3926113|FG000|Induction Phase|Protocol Violation|0
2257510|NCT02100696|3926114|FG001|Induction Phase|Protocol Violation|1
2257511|NCT02100696|3926115|FG002|Induction Phase|Protocol Violation|1
2257512|NCT02100696|3926116|FG003|Induction Phase|Protocol Violation|0
2257513|NCT02100696|3926117|FG004|Induction Phase|Protocol Violation|0
2257514|NCT02100696|3926118|FG005|Induction Phase|Protocol Violation|0
2257515|NCT02100696|3926113|FG000|Induction Phase|Withdrawal by Subject|8
2257516|NCT02100696|3926114|FG001|Induction Phase|Withdrawal by Subject|2
2257517|NCT02100696|3926115|FG002|Induction Phase|Withdrawal by Subject|13
2257518|NCT02100696|3926116|FG003|Induction Phase|Withdrawal by Subject|0
2257519|NCT02100696|3926117|FG004|Induction Phase|Withdrawal by Subject|0
2257520|NCT02100696|3926118|FG005|Induction Phase|Withdrawal by Subject|0
2257521|NCT02100696|3926113|FG000|Induction Phase|Physician Decision|1
2257522|NCT02100696|3926114|FG001|Induction Phase|Physician Decision|0
2257523|NCT02100696|3926115|FG002|Induction Phase|Physician Decision|2
2257524|NCT02100696|3926116|FG003|Induction Phase|Physician Decision|0
2257525|NCT02100696|3926117|FG004|Induction Phase|Physician Decision|0
2257526|NCT02100696|3926118|FG005|Induction Phase|Physician Decision|0
2257527|NCT02100696|3926113|FG000|Induction Phase|Multiple Reasons|5
2257528|NCT02100696|3926114|FG001|Induction Phase|Multiple Reasons|2
2257529|NCT02100696|3926115|FG002|Induction Phase|Multiple Reasons|8
2257530|NCT02100696|3926116|FG003|Induction Phase|Multiple Reasons|0
2257531|NCT02100696|3926117|FG004|Induction Phase|Multiple Reasons|0
2257532|NCT02100696|3926118|FG005|Induction Phase|Multiple Reasons|0
2257533|NCT02100696|3926113|FG000|Maintenance Phase|Adverse Event|0
2257534|NCT02100696|3926114|FG001|Maintenance Phase|Adverse Event|0
2257535|NCT02100696|3926115|FG002|Maintenance Phase|Adverse Event|0
2257536|NCT02100696|3926116|FG003|Maintenance Phase|Adverse Event|0
2257537|NCT02100696|3926117|FG004|Maintenance Phase|Adverse Event|0
2257538|NCT02100696|3926118|FG005|Maintenance Phase|Adverse Event|2
2257539|NCT02100696|3926113|FG000|Maintenance Phase|Lost to Follow-up|0
2257540|NCT02100696|3926114|FG001|Maintenance Phase|Lost to Follow-up|0
2257541|NCT02100696|3926115|FG002|Maintenance Phase|Lost to Follow-up|0
2257542|NCT02100696|3926116|FG003|Maintenance Phase|Lost to Follow-up|0
2257543|NCT02100696|3926117|FG004|Maintenance Phase|Lost to Follow-up|1
2257544|NCT02100696|3926118|FG005|Maintenance Phase|Lost to Follow-up|0
2257545|NCT02100696|3926113|FG000|Maintenance Phase|Protocol Violation|0
2257546|NCT02100696|3926114|FG001|Maintenance Phase|Protocol Violation|0
2257547|NCT02100696|3926115|FG002|Maintenance Phase|Protocol Violation|0
2257548|NCT02100696|3926116|FG003|Maintenance Phase|Protocol Violation|0
2257549|NCT02100696|3926117|FG004|Maintenance Phase|Protocol Violation|1
2257550|NCT02100696|3926118|FG005|Maintenance Phase|Protocol Violation|0
2257551|NCT02100696|3926113|FG000|Maintenance Phase|Withdrawal by Subject|0
2257552|NCT02100696|3926114|FG001|Maintenance Phase|Withdrawal by Subject|0
2257553|NCT02100696|3926115|FG002|Maintenance Phase|Withdrawal by Subject|0
2257554|NCT02100696|3926116|FG003|Maintenance Phase|Withdrawal by Subject|1
2257555|NCT02100696|3926117|FG004|Maintenance Phase|Withdrawal by Subject|4
2257556|NCT02100696|3926118|FG005|Maintenance Phase|Withdrawal by Subject|2
2257557|NCT02100696|3926113|FG000|Maintenance Phase|Physician Decision|0
2257558|NCT02100696|3926114|FG001|Maintenance Phase|Physician Decision|0
2257559|NCT02100696|3926115|FG002|Maintenance Phase|Physician Decision|0
2257560|NCT02100696|3926116|FG003|Maintenance Phase|Physician Decision|0
2257561|NCT02100696|3926117|FG004|Maintenance Phase|Physician Decision|1
2257562|NCT02100696|3926118|FG005|Maintenance Phase|Physician Decision|0
2257563|NCT02100696|3926113|FG000|Maintenance Phase|Multiple Reasons|0
2257564|NCT02100696|3926114|FG001|Maintenance Phase|Multiple Reasons|0
2257565|NCT02100696|3926115|FG002|Maintenance Phase|Multiple Reasons|0
2257566|NCT02100696|3926116|FG003|Maintenance Phase|Multiple Reasons|0
2257567|NCT02100696|3926117|FG004|Maintenance Phase|Multiple Reasons|2
2257568|NCT02100696|3926118|FG005|Maintenance Phase|Multiple Reasons|1
2257569|NCT02100813|3926196|FG000|Overall Study|Adverse Event|0
2257570|NCT02100813|3926197|FG001|Overall Study|Adverse Event|0
2257571|NCT02100813|3926198|FG002|Overall Study|Adverse Event|0
2257572|NCT02100813|3926199|FG003|Overall Study|Adverse Event|0
2257573|NCT02100813|3926200|FG004|Overall Study|Adverse Event|0
2257574|NCT02100813|3926201|FG005|Overall Study|Adverse Event|0
2257575|NCT02100813|3926202|FG006|Overall Study|Adverse Event|0
2257576|NCT02100813|3926203|FG007|Overall Study|Adverse Event|1
2257577|NCT02100839|3926230|FG000|Multiple Ascending Dose|Adverse Event|2
2257578|NCT02100839|3926231|FG001|Multiple Ascending Dose|Adverse Event|0
2257579|NCT02100839|3926230|FG000|Multiple Ascending Dose|Withdrawal by Subject|2
2257580|NCT02100839|3926231|FG001|Multiple Ascending Dose|Withdrawal by Subject|0
2257581|NCT02100969|3926241|FG000|Overall Study|Did not pass screening phase|1
2257582|NCT02101021|3926255|FG000|Overall Study|Death|4
2257583|NCT02101021|3926256|FG001|Overall Study|Death|3
2257584|NCT02101021|3926257|FG002|Overall Study|Death|6
2257585|NCT02101021|3926258|FG003|Overall Study|Death|0
2257586|NCT02101021|3926259|FG004|Overall Study|Death|3
2257587|NCT02101021|3926255|FG000|Overall Study|Withdrew Consent from study|1
2257588|NCT02101021|3926256|FG001|Overall Study|Withdrew Consent from study|1
2257589|NCT02101021|3926257|FG002|Overall Study|Withdrew Consent from study|0
2257590|NCT02101021|3926258|FG003|Overall Study|Withdrew Consent from study|2
2257591|NCT02101021|3926259|FG004|Overall Study|Withdrew Consent from study|0
2257592|NCT02101021|3926255|FG000|Overall Study|Lost to Follow-up|1
2257593|NCT02101021|3926256|FG001|Overall Study|Lost to Follow-up|0
2257594|NCT02101021|3926257|FG002|Overall Study|Lost to Follow-up|0
2257595|NCT02101021|3926258|FG003|Overall Study|Lost to Follow-up|0
2257596|NCT02101021|3926259|FG004|Overall Study|Lost to Follow-up|0
2257597|NCT02101021|3926255|FG000|Overall Study|Study Terminated by Sponsor|1
2257598|NCT02101021|3926256|FG001|Overall Study|Study Terminated by Sponsor|0
2257599|NCT02101021|3926257|FG002|Overall Study|Study Terminated by Sponsor|1
2257600|NCT02101021|3926258|FG003|Overall Study|Study Terminated by Sponsor|1
2257601|NCT02101021|3926259|FG004|Overall Study|Study Terminated by Sponsor|1
2257602|NCT02101034|3926276|FG000|Overall Study|Enrolled but did not start treatment|0
2257603|NCT02101034|3926277|FG001|Overall Study|Enrolled but did not start treatment|0
2257604|NCT02101034|3926278|FG002|Overall Study|Enrolled but did not start treatment|1
2257605|NCT02101034|3926279|FG003|Overall Study|Enrolled but did not start treatment|0
2257606|NCT02101034|3926280|FG004|Overall Study|Enrolled but did not start treatment|0
2257607|NCT02101060|3926300|FG000|Overall Study|Adverse Event|1
2257608|NCT02101060|3926301|FG001|Overall Study|Adverse Event|0
2257609|NCT02101060|3926300|FG000|Overall Study|Withdrawal by Subject|1
2257610|NCT02101060|3926301|FG001|Overall Study|Withdrawal by Subject|1
2344136|NCT03539432|4078951|FG000|Overall Study|Lost to Follow-up|0
2344137|NCT03539432|4078952|FG001|Overall Study|Lost to Follow-up|1
2353310|NCT02715765|4105031|FG000|Overall Study|Study Termination|3
2353311|NCT02715765|4105032|FG001|Overall Study|Study Termination|0
2353312|NCT02715765|4105033|FG002|Overall Study|Study Termination|0
2353313|NCT02717130|4105052|FG000|Overall Study|Withdrawal by Subject|1
2353314|NCT02717130|4105052|FG000|Overall Study|Adverse Event|1
2353315|NCT02717130|4105052|FG000|Overall Study|Physician Decision|1
2353316|NCT02717130|4105052|FG000|Overall Study|Study Closure|4
2353317|NCT02685202|4105056|FG000|Overall Study|Lost to Follow-up|9
2353318|NCT02709083|4105060|FG000|Overall Study|Original PI left institution|7
2353319|NCT02693171|4105064|FG000|Overall Study|Adverse Event|1
2353320|NCT02693171|4105064|FG000|Overall Study|Discontinuation of Study by Sponsor|8
2257611|NCT02101060|3926300|FG000|Overall Study|Lost to Follow-up|3
2257612|NCT02101060|3926301|FG001|Overall Study|Lost to Follow-up|3
2257613|NCT02101112|3926307|FG000|Overall Study|Adverse Event|0
2257614|NCT02101112|3926308|FG001|Overall Study|Adverse Event|0
2257615|NCT02101112|3926309|FG002|Overall Study|Adverse Event|1
2257616|NCT02101112|3926310|FG003|Overall Study|Adverse Event|0
2257617|NCT02101112|3926311|FG004|Overall Study|Adverse Event|0
2257618|NCT02101112|3926312|FG005|Overall Study|Adverse Event|0
2257619|NCT02101112|3926307|FG000|Overall Study|Withdrawal by Subject|0
2257620|NCT02101112|3926308|FG001|Overall Study|Withdrawal by Subject|0
2257621|NCT02101112|3926309|FG002|Overall Study|Withdrawal by Subject|0
2257622|NCT02101112|3926310|FG003|Overall Study|Withdrawal by Subject|0
2257623|NCT02101112|3926311|FG004|Overall Study|Withdrawal by Subject|1
2257624|NCT02101112|3926312|FG005|Overall Study|Withdrawal by Subject|0
2257625|NCT02101281|3926333|FG000|Overall Study|Adverse Event|0
2257626|NCT02101281|3926334|FG001|Overall Study|Adverse Event|1
2257627|NCT02101294|3926346|FG000|Overall Study|Withdrawal by Subject|5
2257628|NCT02101294|3926346|FG000|Overall Study|Lost to Follow-up|6
2257629|NCT02101359|3926355|FG000|Overall Study|Not included|23
2257630|NCT02101359|3926356|FG001|Overall Study|Not included|13
2257631|NCT02101359|3926355|FG000|Overall Study|Withdrawal by Subject|5
2257632|NCT02101359|3926356|FG001|Overall Study|Withdrawal by Subject|4
2257633|NCT02101359|3926355|FG000|Overall Study|Lost to Follow-up|1
2257634|NCT02101359|3926356|FG001|Overall Study|Lost to Follow-up|0
2257635|NCT02101359|3926355|FG000|Overall Study|Protocol Violation|0
2257636|NCT02101359|3926356|FG001|Overall Study|Protocol Violation|2
2257637|NCT02101554|3926404|FG000|Overall Study|Protocol Violation|0
2257638|NCT02101554|3926405|FG001|Overall Study|Protocol Violation|1
2257639|NCT02101554|3926406|FG002|Overall Study|Protocol Violation|0
2257640|NCT02101554|3926404|FG000|Overall Study|Insufficient Clinical Response|0
2257641|NCT02101554|3926405|FG001|Overall Study|Insufficient Clinical Response|2
2257642|NCT02101554|3926406|FG002|Overall Study|Insufficient Clinical Response|0
2257643|NCT02101554|3926404|FG000|Overall Study|Adverse Event|2
2257644|NCT02101554|3926405|FG001|Overall Study|Adverse Event|1
2257645|NCT02101554|3926406|FG002|Overall Study|Adverse Event|1
2257646|NCT02101554|3926404|FG000|Overall Study|Lost to Follow-up|0
2257647|NCT02101554|3926405|FG001|Overall Study|Lost to Follow-up|1
2257648|NCT02101554|3926406|FG002|Overall Study|Lost to Follow-up|0
2257649|NCT02101554|3926404|FG000|Overall Study|Withdrawl by Parents/Guardians|1
2257650|NCT02101554|3926405|FG001|Overall Study|Withdrawl by Parents/Guardians|0
2257651|NCT02101554|3926406|FG002|Overall Study|Withdrawl by Parents/Guardians|0
2257652|NCT02101983|3926420|FG000|Overall Study|Physician Decision|1
2257653|NCT02101983|3926421|FG001|Overall Study|Physician Decision|0
2257654|NCT02102204|3926436|FG000|Overall Study|Withdrawal by Subject|137
2257655|NCT02102204|3926436|FG000|Overall Study|Death|92
2257656|NCT02102204|3926436|FG000|Overall Study|Lost to Follow-up|65
2257657|NCT02102204|3926436|FG000|Overall Study|Sponsor Decision|5
2257658|NCT02102204|3926436|FG000|Overall Study|Ongoing|5
2257659|NCT02102399|3926456|FG000|Overall Study|Withdrawal by Subject|6
2257660|NCT02102399|3926457|FG001|Overall Study|Withdrawal by Subject|4
2257661|NCT02102464|3926470|FG000|Randomized Study|Withdrawal by Subject|0
2257662|NCT02102464|3926471|FG001|Randomized Study|Withdrawal by Subject|1
2257663|NCT02102464|3926472|FG002|Randomized Study|Withdrawal by Subject|0
2257664|NCT02102490|3926481|FG000|Overall Study|Death|6
2257665|NCT02102490|3926481|FG000|Overall Study|Lost to Follow-up|1
2257666|NCT02102724|3926487|FG000|Overall Study|Lost to Follow-up|1
2257667|NCT02102724|3926488|FG001|Overall Study|Lost to Follow-up|0
2257668|NCT02102724|3926487|FG000|Overall Study|surgery for brain aneurysm|1
2257669|NCT02102724|3926488|FG001|Overall Study|surgery for brain aneurysm|1
2257670|NCT02103062|3926529|FG000|Overall Study|Adverse Event|1
2257671|NCT02103062|3926530|FG001|Overall Study|Adverse Event|2
2257672|NCT02103062|3926529|FG000|Overall Study|Progressive Disease|17
2257673|NCT02103062|3926530|FG001|Overall Study|Progressive Disease|20
2257674|NCT02103062|3926529|FG000|Overall Study|Death|0
2257675|NCT02103062|3926530|FG001|Overall Study|Death|1
2257676|NCT02103439|3926599|FG000|Overall Study|Adverse Event|0
2257677|NCT02103439|3926600|FG001|Overall Study|Adverse Event|2
2257678|NCT02103439|3926599|FG000|Overall Study|Withdrawal by Subject|3
2257679|NCT02103439|3926600|FG001|Overall Study|Withdrawal by Subject|1
2344138|NCT03539484|4078965|FG000|Overall Study|Death|1
2344139|NCT03539484|4078966|FG001|Overall Study|Death|0
2344140|NCT03539484|4078967|FG002|Overall Study|Death|0
2344141|NCT03539484|4078968|FG003|Overall Study|Death|2
2344142|NCT03539484|4078969|FG004|Overall Study|Death|8
2344143|NCT03539484|4078970|FG005|Overall Study|Death|3
2344144|NCT03539484|4078971|FG006|Overall Study|Death|0
2344145|NCT03539484|4078965|FG000|Overall Study|Lost to Follow-up|0
2344146|NCT03539484|4078966|FG001|Overall Study|Lost to Follow-up|1
2344147|NCT03539484|4078967|FG002|Overall Study|Lost to Follow-up|0
2344148|NCT03539484|4078968|FG003|Overall Study|Lost to Follow-up|0
2344149|NCT03539484|4078969|FG004|Overall Study|Lost to Follow-up|1
2344150|NCT03539484|4078970|FG005|Overall Study|Lost to Follow-up|0
2344151|NCT03539484|4078971|FG006|Overall Study|Lost to Follow-up|0
2344152|NCT03539484|4078965|FG000|Overall Study|Withdrawal by Subject|0
2344153|NCT03539484|4078966|FG001|Overall Study|Withdrawal by Subject|0
2344154|NCT03539484|4078967|FG002|Overall Study|Withdrawal by Subject|0
2344155|NCT03539484|4078968|FG003|Overall Study|Withdrawal by Subject|0
2344156|NCT03539484|4078969|FG004|Overall Study|Withdrawal by Subject|2
2344157|NCT03539484|4078970|FG005|Overall Study|Withdrawal by Subject|0
2344158|NCT03539484|4078971|FG006|Overall Study|Withdrawal by Subject|1
2344159|NCT03539484|4078965|FG000|Overall Study|Study Terminated by Sponsor|0
2344160|NCT03539484|4078966|FG001|Overall Study|Study Terminated by Sponsor|0
2344161|NCT03539484|4078967|FG002|Overall Study|Study Terminated by Sponsor|1
2344162|NCT03539484|4078968|FG003|Overall Study|Study Terminated by Sponsor|1
2344163|NCT03539484|4078969|FG004|Overall Study|Study Terminated by Sponsor|2
2344164|NCT03539484|4078970|FG005|Overall Study|Study Terminated by Sponsor|2
2344165|NCT03539484|4078971|FG006|Overall Study|Study Terminated by Sponsor|1
2344166|NCT03539549|4078992|FG000|Overall Study|Adverse Event|12
2344167|NCT03539549|4078992|FG000|Overall Study|Lost to Follow-up|1
2344168|NCT03539549|4078992|FG000|Overall Study|Death|2
2344169|NCT03539549|4078992|FG000|Overall Study|Progressive Disease|1
2257680|NCT02103478|3926617|FG000|Overall Study|Adverse Event|0
2344170|NCT03539549|4078992|FG000|Overall Study|Reason not Specified|1
2344171|NCT03540030|4078998|FG000|Overall Study|Withdrawal by Subject|2
2257681|NCT02103478|3926618|FG001|Overall Study|Adverse Event|0
2257682|NCT02103478|3926619|FG002|Overall Study|Adverse Event|1
2257683|NCT02103478|3926620|FG003|Overall Study|Adverse Event|1
2257684|NCT02103478|3926621|FG004|Overall Study|Adverse Event|2
2257685|NCT02103478|3926622|FG005|Overall Study|Adverse Event|1
2257686|NCT02103478|3926623|FG006|Overall Study|Adverse Event|0
2257687|NCT02103478|3926624|FG007|Overall Study|Adverse Event|0
2257688|NCT02103478|3926625|FG008|Overall Study|Adverse Event|0
2257689|NCT02103478|3926617|FG000|Overall Study|Death|2
2257690|NCT02103478|3926618|FG001|Overall Study|Death|2
2257691|NCT02103478|3926619|FG002|Overall Study|Death|1
2257692|NCT02103478|3926620|FG003|Overall Study|Death|1
2257693|NCT02103478|3926621|FG004|Overall Study|Death|5
2257694|NCT02103478|3926622|FG005|Overall Study|Death|15
2257695|NCT02103478|3926623|FG006|Overall Study|Death|14
2257696|NCT02103478|3926624|FG007|Overall Study|Death|10
2257697|NCT02103478|3926625|FG008|Overall Study|Death|11
2257698|NCT02103478|3926617|FG000|Overall Study|Progressive Disease|2
2257699|NCT02103478|3926618|FG001|Overall Study|Progressive Disease|1
2257700|NCT02103478|3926619|FG002|Overall Study|Progressive Disease|2
2257701|NCT02103478|3926620|FG003|Overall Study|Progressive Disease|0
2257702|NCT02103478|3926621|FG004|Overall Study|Progressive Disease|9
2257703|NCT02103478|3926622|FG005|Overall Study|Progressive Disease|1
2257704|NCT02103478|3926623|FG006|Overall Study|Progressive Disease|2
2257705|NCT02103478|3926624|FG007|Overall Study|Progressive Disease|0
2257706|NCT02103478|3926625|FG008|Overall Study|Progressive Disease|1
2257707|NCT02103478|3926617|FG000|Overall Study|Withdrawal by Subject|2
2257708|NCT02103478|3926618|FG001|Overall Study|Withdrawal by Subject|0
2257709|NCT02103478|3926619|FG002|Overall Study|Withdrawal by Subject|0
2257710|NCT02103478|3926620|FG003|Overall Study|Withdrawal by Subject|4
2257711|NCT02103478|3926621|FG004|Overall Study|Withdrawal by Subject|0
2257712|NCT02103478|3926622|FG005|Overall Study|Withdrawal by Subject|0
2257713|NCT02103478|3926623|FG006|Overall Study|Withdrawal by Subject|1
2257714|NCT02103478|3926624|FG007|Overall Study|Withdrawal by Subject|1
2257715|NCT02103478|3926625|FG008|Overall Study|Withdrawal by Subject|0
2257716|NCT02103478|3926617|FG000|Overall Study|Lost to Follow-up|0
2257717|NCT02103478|3926618|FG001|Overall Study|Lost to Follow-up|0
2257718|NCT02103478|3926619|FG002|Overall Study|Lost to Follow-up|0
2257719|NCT02103478|3926620|FG003|Overall Study|Lost to Follow-up|0
2257720|NCT02103478|3926621|FG004|Overall Study|Lost to Follow-up|0
2257721|NCT02103478|3926622|FG005|Overall Study|Lost to Follow-up|0
2257722|NCT02103478|3926623|FG006|Overall Study|Lost to Follow-up|0
2257723|NCT02103478|3926624|FG007|Overall Study|Lost to Follow-up|1
2257724|NCT02103478|3926625|FG008|Overall Study|Lost to Follow-up|0
2257725|NCT02103478|3926617|FG000|Overall Study|Other|1
2257726|NCT02103478|3926618|FG001|Overall Study|Other|3
2257727|NCT02103478|3926619|FG002|Overall Study|Other|2
2257728|NCT02103478|3926620|FG003|Overall Study|Other|0
2257729|NCT02103478|3926621|FG004|Overall Study|Other|3
2257730|NCT02103478|3926622|FG005|Overall Study|Other|8
2257731|NCT02103478|3926623|FG006|Overall Study|Other|8
2257732|NCT02103478|3926624|FG007|Overall Study|Other|4
2257733|NCT02103478|3926625|FG008|Overall Study|Other|2
2257734|NCT02104180|3926677|FG000|Overall Study|Protocol Violation|1
2257735|NCT02104180|3926678|FG001|Overall Study|Protocol Violation|0
2257736|NCT02104505|3926725|FG000|First Intervention (14 Days)|Adverse Event|2
2257737|NCT02104505|3926726|FG001|First Intervention (14 Days)|Adverse Event|0
2257738|NCT02104505|3926725|FG000|First Intervention (14 Days)|Withdrawal by Subject|0
2257739|NCT02104505|3926726|FG001|First Intervention (14 Days)|Withdrawal by Subject|1
2257740|NCT02104505|3926725|FG000|First Intervention (14 Days)|Lost to Follow-up|0
2257741|NCT02104505|3926726|FG001|First Intervention (14 Days)|Lost to Follow-up|1
2257742|NCT02104505|3926725|FG000|First Intervention (14 Days)|exclusionary condition|0
2257743|NCT02104505|3926726|FG001|First Intervention (14 Days)|exclusionary condition|1
2257744|NCT02104505|3926725|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
2257745|NCT02104505|3926726|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
2257746|NCT02104505|3926725|FG000|Second Intervention (14 Days)|Adverse Event|2
2257747|NCT02104505|3926726|FG001|Second Intervention (14 Days)|Adverse Event|0
2257748|NCT02104557|3926733|FG000|Overall Study|Adverse Event|24
2257749|NCT02104557|3926733|FG000|Overall Study|Lost to Follow-up|34
2257750|NCT02104557|3926733|FG000|Overall Study|Violated the usage and dosage|14
2257751|NCT02104557|3926733|FG000|Overall Study|No longer met inclusion/exclusion criteria|1
2257752|NCT02104557|3926733|FG000|Overall Study|Administered Sayana prior to the contract|1
2257753|NCT02104557|3926733|FG000|Overall Study|Other|17
2257754|NCT02104557|3926733|FG000|Overall Study|Change to other contraception methods|5
2257755|NCT02104557|3926733|FG000|Overall Study|Discontinuation due to no pain|1
2257756|NCT02104557|3926733|FG000|Overall Study|Withdrawal consent|2
2257757|NCT02104557|3926733|FG000|Overall Study|Refusal of administration due to unknown reasons|69
2257758|NCT02104557|3926733|FG000|Overall Study|Discontinuation of contraception|9
2257759|NCT02104583|3926742|FG000|Overall Study|New ICD or CRT-D implanted|2
2257760|NCT02104583|3926743|FG001|Overall Study|New ICD or CRT-D implanted|0
2257761|NCT02104583|3926744|FG002|Overall Study|New ICD or CRT-D implanted|1
2257762|NCT02104583|3926745|FG003|Overall Study|New ICD or CRT-D implanted|0
2257763|NCT02104583|3926746|FG004|Overall Study|New ICD or CRT-D implanted|0
2257764|NCT02104583|3926742|FG000|Overall Study|Death|2
2257765|NCT02104583|3926743|FG001|Overall Study|Death|1
2257766|NCT02104583|3926744|FG002|Overall Study|Death|3
2257767|NCT02104583|3926745|FG003|Overall Study|Death|3
2257768|NCT02104583|3926746|FG004|Overall Study|Death|5
2257769|NCT02104583|3926742|FG000|Overall Study|Subject required cardiac ablation|6
2257770|NCT02104583|3926743|FG001|Overall Study|Subject required cardiac ablation|4
2257771|NCT02104583|3926744|FG002|Overall Study|Subject required cardiac ablation|4
2257772|NCT02104583|3926745|FG003|Overall Study|Subject required cardiac ablation|5
2257773|NCT02104583|3926746|FG004|Overall Study|Subject required cardiac ablation|4
2257774|NCT02104583|3926742|FG000|Overall Study|Subject required prohibited medication|0
2257775|NCT02104583|3926743|FG001|Overall Study|Subject required prohibited medication|1
2257776|NCT02104583|3926744|FG002|Overall Study|Subject required prohibited medication|1
2257777|NCT02104583|3926745|FG003|Overall Study|Subject required prohibited medication|0
2257778|NCT02104583|3926746|FG004|Overall Study|Subject required prohibited medication|1
2257779|NCT02104583|3926742|FG000|Overall Study|Withdrew Consent|3
2257780|NCT02104583|3926743|FG001|Overall Study|Withdrew Consent|2
2257781|NCT02104583|3926744|FG002|Overall Study|Withdrew Consent|0
2257782|NCT02104583|3926745|FG003|Overall Study|Withdrew Consent|2
2257783|NCT02104583|3926746|FG004|Overall Study|Withdrew Consent|1
2257784|NCT02104583|3926742|FG000|Overall Study|Investigator's Discretion|1
2257785|NCT02104583|3926743|FG001|Overall Study|Investigator's Discretion|0
2257786|NCT02104583|3926744|FG002|Overall Study|Investigator's Discretion|0
2257787|NCT02104583|3926745|FG003|Overall Study|Investigator's Discretion|0
2257788|NCT02104583|3926746|FG004|Overall Study|Investigator's Discretion|0
2257789|NCT02104583|3926742|FG000|Overall Study|Protocol Violation|0
2257790|NCT02104583|3926743|FG001|Overall Study|Protocol Violation|0
2257791|NCT02104583|3926744|FG002|Overall Study|Protocol Violation|1
2257792|NCT02104583|3926745|FG003|Overall Study|Protocol Violation|0
2257793|NCT02104583|3926746|FG004|Overall Study|Protocol Violation|0
2257794|NCT02104583|3926742|FG000|Overall Study|Adverse Event|3
2257795|NCT02104583|3926743|FG001|Overall Study|Adverse Event|3
2257796|NCT02104583|3926744|FG002|Overall Study|Adverse Event|6
2257797|NCT02104583|3926745|FG003|Overall Study|Adverse Event|6
2257798|NCT02104583|3926746|FG004|Overall Study|Adverse Event|1
2257799|NCT02104583|3926742|FG000|Overall Study|Lost to Follow-up|1
2257800|NCT02104583|3926743|FG001|Overall Study|Lost to Follow-up|0
2257801|NCT02104583|3926744|FG002|Overall Study|Lost to Follow-up|0
2257802|NCT02104583|3926745|FG003|Overall Study|Lost to Follow-up|0
2257803|NCT02104583|3926746|FG004|Overall Study|Lost to Follow-up|0
2257804|NCT02104583|3926742|FG000|Overall Study|Randomized but Never Treated|0
2344172|NCT03540030|4078999|FG001|Overall Study|Withdrawal by Subject|1
2344173|NCT03540030|4078998|FG000|Overall Study|screen fail|7
2344174|NCT03540030|4078999|FG001|Overall Study|screen fail|1
2344175|NCT03540030|4078998|FG000|Overall Study|never had surgery after signing consent|9
2344176|NCT03540030|4078999|FG001|Overall Study|never had surgery after signing consent|1
2344177|NCT03540160|4079021|FG000|Overall Study|Protocol Violation|1
2344178|NCT03540160|4079021|FG000|Overall Study|Physician Decision|8
2344179|NCT03540160|4079021|FG000|Overall Study|Lack of Efficacy|60
2344180|NCT03540160|4079021|FG000|Overall Study|Pregnancy|1
2344181|NCT03540160|4079021|FG000|Overall Study|Adverse Event|20
2344182|NCT03540160|4079021|FG000|Overall Study|Withdrawal by Subject|68
2344183|NCT03540160|4079021|FG000|Overall Study|COVID-19|2
2344184|NCT03540160|4079021|FG000|Overall Study|Study Closure|10
2344185|NCT03540160|4079021|FG000|Overall Study|Lost to Follow-up|18
2344186|NCT03540160|4079021|FG000|Overall Study|Sponsor decision|191
2344187|NCT03541044|4079025|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
2344188|NCT03541044|4079026|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
2344189|NCT03541044|4079025|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
2344190|NCT03541044|4079026|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
2344191|NCT03542266|4079101|FG000|Treatment Phase|Withdrawal by Subject|1
2344192|NCT03542266|4079101|FG000|Treatment Phase|Adverse Event|1
2344193|NCT03542266|4079101|FG000|Treatment Phase|PD|1
2344194|NCT03543137|4079130|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
2344195|NCT03543137|4079131|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
2344196|NCT03543137|4079130|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
2344197|NCT03543137|4079131|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
2344198|NCT03543137|4079130|FG000|Study Period 2: Up to Day 8|Adverse Event|0
2344199|NCT03543137|4079131|FG001|Study Period 2: Up to Day 8|Adverse Event|1
2344200|NCT03544333|4079179|FG000|Overall Study|Withdrawal by Subject|1
2344201|NCT03544333|4079180|FG001|Overall Study|Withdrawal by Subject|0
2344202|NCT03545503|4079207|FG000|Overall Study|Protocol Violation|14
2344203|NCT03545503|4079208|FG001|Overall Study|Protocol Violation|16
2344204|NCT03545984|4079225|FG000|Overall Study|CSF cases not present during rotation|11
2344205|NCT03545984|4079226|FG001|Overall Study|CSF cases not present during rotation|9
2344206|NCT03546621|4079264|FG000|Overall Study|Withdrawal by Subject|0
2344207|NCT03546621|4079265|FG001|Overall Study|Withdrawal by Subject|1
2344208|NCT03546621|4079266|FG002|Overall Study|Withdrawal by Subject|2
2344209|NCT03546621|4079267|FG003|Overall Study|Withdrawal by Subject|1
2344210|NCT03546621|4079264|FG000|Overall Study|Lost to Follow-up|0
2344211|NCT03546621|4079265|FG001|Overall Study|Lost to Follow-up|1
2344212|NCT03546621|4079266|FG002|Overall Study|Lost to Follow-up|0
2344213|NCT03546621|4079267|FG003|Overall Study|Lost to Follow-up|0
2344214|NCT03546621|4079264|FG000|Overall Study|Adverse Event|0
2344215|NCT03546621|4079265|FG001|Overall Study|Adverse Event|1
2257805|NCT02104583|3926743|FG001|Overall Study|Randomized but Never Treated|0
2257806|NCT02104583|3926744|FG002|Overall Study|Randomized but Never Treated|0
2257807|NCT02104583|3926745|FG003|Overall Study|Randomized but Never Treated|1
2257808|NCT02104583|3926746|FG004|Overall Study|Randomized but Never Treated|0
2257809|NCT02104752|3926785|FG000|Overall Study|Withdrawal by Subject|1
2257810|NCT02104752|3926786|FG001|Overall Study|Withdrawal by Subject|0
2257811|NCT02104752|3926785|FG000|Overall Study|Weight gain; unrelated anxiety|0
2257812|NCT02104752|3926786|FG001|Overall Study|Weight gain; unrelated anxiety|2
2257813|NCT02104765|3926799|FG000|Overall Study|Lost to Follow-up|0
2257814|NCT02104765|3926800|FG001|Overall Study|Lost to Follow-up|0
2257815|NCT02104765|3926801|FG002|Overall Study|Lost to Follow-up|1
2257816|NCT02104765|3926802|FG003|Overall Study|Lost to Follow-up|0
2257817|NCT02104765|3926803|FG004|Overall Study|Lost to Follow-up|0
2257818|NCT02104765|3926804|FG005|Overall Study|Lost to Follow-up|0
2257819|NCT02104765|3926805|FG006|Overall Study|Lost to Follow-up|0
2257820|NCT02104765|3926799|FG000|Overall Study|Withdrawal by Subject|0
2257821|NCT02104765|3926800|FG001|Overall Study|Withdrawal by Subject|0
2257822|NCT02104765|3926801|FG002|Overall Study|Withdrawal by Subject|0
2257823|NCT02104765|3926802|FG003|Overall Study|Withdrawal by Subject|1
2257824|NCT02104765|3926803|FG004|Overall Study|Withdrawal by Subject|1
2257825|NCT02104765|3926804|FG005|Overall Study|Withdrawal by Subject|0
2257826|NCT02104765|3926805|FG006|Overall Study|Withdrawal by Subject|1
2257827|NCT02104804|3926829|FG000|Overall Study|Did not take study medication|0
2257828|NCT02104804|3926830|FG001|Overall Study|Did not take study medication|1
2257829|NCT02104804|3926829|FG000|Overall Study|Study specific discontinuation criteria|6
2257830|NCT02104804|3926830|FG001|Overall Study|Study specific discontinuation criteria|1
2257831|NCT02104804|3926829|FG000|Overall Study|Other listed|2
2257832|NCT02104804|3926830|FG001|Overall Study|Other listed|1
2257833|NCT02104804|3926829|FG000|Overall Study|Protocol Violation|0
2257834|NCT02104804|3926830|FG001|Overall Study|Protocol Violation|1
2257835|NCT02104804|3926829|FG000|Overall Study|Adverse Event|4
2257836|NCT02104804|3926830|FG001|Overall Study|Adverse Event|3
2257837|NCT02104804|3926829|FG000|Overall Study|Withdrawal by Subject|4
2257838|NCT02104804|3926830|FG001|Overall Study|Withdrawal by Subject|12
2257839|NCT02104817|3926838|FG000|Overall Study|Death|363
2257840|NCT02104817|3926839|FG001|Overall Study|Death|330
2257841|NCT02104817|3926838|FG000|Overall Study|Lost to Follow-up|3
2257842|NCT02104817|3926839|FG001|Overall Study|Lost to Follow-up|2
2257843|NCT02104817|3926838|FG000|Overall Study|Protocol Violation|0
2257844|NCT02104817|3926839|FG001|Overall Study|Protocol Violation|1
2257845|NCT02104817|3926838|FG000|Overall Study|Study terminated by sponsor|5854
2257846|NCT02104817|3926839|FG001|Overall Study|Study terminated by sponsor|5901
2257847|NCT02104817|3926838|FG000|Overall Study|Withdrawal by Subject|111
2257848|NCT02104817|3926839|FG001|Overall Study|Withdrawal by Subject|78
2257849|NCT02104817|3926838|FG000|Overall Study|Other reasons|128
2257850|NCT02104817|3926839|FG001|Overall Study|Other reasons|135
2257851|NCT02104895|3926860|FG000|Overall Study|Withdrawal by Subject|0
2257852|NCT02104895|3926861|FG001|Overall Study|Withdrawal by Subject|14
2257853|NCT02104947|3926869|FG000|Overall Study|Withdrawal by Subject|10
2257854|NCT02104947|3926870|FG001|Overall Study|Withdrawal by Subject|3
2344216|NCT03546621|4079266|FG002|Overall Study|Adverse Event|0
2344217|NCT03546621|4079267|FG003|Overall Study|Adverse Event|1
2344218|NCT03546621|4079264|FG000|Overall Study|Progressive disease|0
2344219|NCT03546621|4079265|FG001|Overall Study|Progressive disease|0
2344220|NCT03546621|4079266|FG002|Overall Study|Progressive disease|0
2344221|NCT03546621|4079267|FG003|Overall Study|Progressive disease|1
2344222|NCT03546647|4079277|FG000|Overall Study|Adverse Event|1
2344223|NCT03546647|4079278|FG001|Overall Study|Adverse Event|0
2344224|NCT03546816|4079286|FG000|Overall Study|Adverse Event|5
2344225|NCT03546816|4079287|FG001|Overall Study|Adverse Event|3
2344226|NCT03546816|4079286|FG000|Overall Study|Lack of Efficacy|2
2344227|NCT03546816|4079287|FG001|Overall Study|Lack of Efficacy|4
2344228|NCT03546816|4079286|FG000|Overall Study|Pregnancy|1
2344229|NCT03546816|4079287|FG001|Overall Study|Pregnancy|0
2344230|NCT03546816|4079286|FG000|Overall Study|Physician Decision|2
2344231|NCT03546816|4079287|FG001|Overall Study|Physician Decision|0
2344232|NCT03546816|4079286|FG000|Overall Study|Withdrawal by Subject|8
2344233|NCT03546816|4079287|FG001|Overall Study|Withdrawal by Subject|10
2344234|NCT03546816|4079286|FG000|Overall Study|Lost to Follow-up|3
2344235|NCT03546816|4079287|FG001|Overall Study|Lost to Follow-up|2
2344236|NCT03546842|4079295|FG000|Overall Study|Protocol Violation|1
2344237|NCT03546842|4079295|FG000|Overall Study|Withdrawal by Subject|2
2344238|NCT03547154|4079301|FG000|Overall Study|Disease Progression/Recurrence|6
2344239|NCT03547154|4079302|FG001|Overall Study|Disease Progression/Recurrence|14
2344240|NCT03547154|4079301|FG000|Overall Study|Adverse Event|26
2344241|NCT03547154|4079302|FG001|Overall Study|Adverse Event|31
2344242|NCT03547154|4079301|FG000|Overall Study|Protocol Violation|6
2344243|NCT03547154|4079302|FG001|Overall Study|Protocol Violation|1
2344244|NCT03547154|4079301|FG000|Overall Study|Physician Decision|4
2344245|NCT03547154|4079302|FG001|Overall Study|Physician Decision|3
2344246|NCT03547154|4079301|FG000|Overall Study|Insufficient Therapeutic Response|13
2344247|NCT03547154|4079302|FG001|Overall Study|Insufficient Therapeutic Response|10
2344248|NCT03547154|4079301|FG000|Overall Study|Withdrawal by Subject|10
2344249|NCT03547154|4079302|FG001|Overall Study|Withdrawal by Subject|6
2257855|NCT02104947|3926869|FG000|Overall Study|Lost to Follow-up|4
2257856|NCT02104947|3926870|FG001|Overall Study|Lost to Follow-up|4
2257857|NCT02104947|3926869|FG000|Overall Study|Protocol Violation|6
2257858|NCT02104947|3926870|FG001|Overall Study|Protocol Violation|8
2257859|NCT02104947|3926869|FG000|Overall Study|Adverse Event|57
2257860|NCT02104947|3926870|FG001|Overall Study|Adverse Event|38
2257861|NCT02104947|3926869|FG000|Overall Study|Other than stated above|2
2257862|NCT02104947|3926870|FG001|Overall Study|Other than stated above|3
2257863|NCT02105012|3926880|FG000|Overall Study|Withdrawal by Subject|11
2257864|NCT02105012|3926880|FG000|Overall Study|Protocol Specified Criteria|9
2257865|NCT02105012|3926880|FG000|Overall Study|Lost to Follow-up|4
2257866|NCT02105012|3926880|FG000|Overall Study|Protocol Violation|4
2257867|NCT02105012|3926880|FG000|Overall Study|Physician Decision|3
2257868|NCT02105012|3926880|FG000|Overall Study|Adverse Event|1
2257869|NCT02105012|3926880|FG000|Overall Study|Lack of Efficacy|1
2344250|NCT03547154|4079301|FG000|Overall Study|Not Selected|0
2344251|NCT03547154|4079302|FG001|Overall Study|Not Selected|1
2344252|NCT03547154|4079301|FG000|Overall Study|Continued treatment beyond 12 mo.|58
2344253|NCT03547154|4079302|FG001|Overall Study|Continued treatment beyond 12 mo.|50
2344254|NCT03547167|4079310|FG000|Overall Study|Withdrawal by Subject|34
2344255|NCT03547167|4079311|FG001|Overall Study|Withdrawal by Subject|12
2344256|NCT03547167|4079310|FG000|Overall Study|Screen Failure|0
2344257|NCT03547167|4079311|FG001|Overall Study|Screen Failure|1
2344258|NCT03547167|4079310|FG000|Overall Study|Lost to Follow-up|59
2344259|NCT03547167|4079311|FG001|Overall Study|Lost to Follow-up|15
2344260|NCT03547167|4079310|FG000|Overall Study|Death|4
2344261|NCT03547167|4079311|FG001|Overall Study|Death|2
2344262|NCT03547531|4079323|FG000|Overall Study|not coming in data collection : sick|2
2344263|NCT03547531|4079324|FG001|Overall Study|not coming in data collection : sick|2
2344264|NCT03547531|4079323|FG000|Overall Study|having family occasion|0
2344265|NCT03547531|4079324|FG001|Overall Study|having family occasion|2
2344266|NCT03547583|4079333|FG000|Overall Study|Adverse Event|16
2344267|NCT03547583|4079334|FG001|Overall Study|Adverse Event|11
2344268|NCT03547583|4079335|FG002|Overall Study|Adverse Event|10
2344269|NCT03547583|4079333|FG000|Overall Study|Death|11
2344270|NCT03547583|4079334|FG001|Overall Study|Death|7
2344271|NCT03547583|4079335|FG002|Overall Study|Death|4
2344272|NCT03547583|4079333|FG000|Overall Study|Lost to Follow-up|1
2344273|NCT03547583|4079334|FG001|Overall Study|Lost to Follow-up|0
2344274|NCT03547583|4079335|FG002|Overall Study|Lost to Follow-up|0
2344275|NCT03547583|4079333|FG000|Overall Study|Non-compliance with study drug|0
2344276|NCT03547583|4079334|FG001|Overall Study|Non-compliance with study drug|0
2344277|NCT03547583|4079335|FG002|Overall Study|Non-compliance with study drug|1
2344278|NCT03547583|4079333|FG000|Overall Study|Physician Decision|1
2344279|NCT03547583|4079334|FG001|Overall Study|Physician Decision|0
2344280|NCT03547583|4079335|FG002|Overall Study|Physician Decision|3
2344281|NCT03547583|4079333|FG000|Overall Study|Protocol Violation|2
2344282|NCT03547583|4079334|FG001|Overall Study|Protocol Violation|1
2344283|NCT03547583|4079335|FG002|Overall Study|Protocol Violation|1
2344284|NCT03547583|4079333|FG000|Overall Study|Withdrawal by Subject|12
2344285|NCT03547583|4079334|FG001|Overall Study|Withdrawal by Subject|19
2344286|NCT03547583|4079335|FG002|Overall Study|Withdrawal by Subject|10
2344287|NCT03547583|4079333|FG000|Overall Study|Other|2
2344288|NCT03547583|4079334|FG001|Overall Study|Other|2
2344289|NCT03547583|4079335|FG002|Overall Study|Other|3
2344290|NCT03547635|4079349|FG000|Overall Study|Adverse Event|5
2344291|NCT03547635|4079350|FG001|Overall Study|Adverse Event|2
2344292|NCT03547635|4079351|FG002|Overall Study|Adverse Event|3
2344293|NCT03547635|4079349|FG000|Overall Study|Lost to Follow-up|1
2344294|NCT03547635|4079350|FG001|Overall Study|Lost to Follow-up|3
2344295|NCT03547635|4079351|FG002|Overall Study|Lost to Follow-up|4
2344296|NCT03547635|4079349|FG000|Overall Study|Withdrawal by Subject|1
2344297|NCT03547635|4079350|FG001|Overall Study|Withdrawal by Subject|0
2344298|NCT03547635|4079351|FG002|Overall Study|Withdrawal by Subject|0
2344299|NCT03547635|4079349|FG000|Overall Study|Withdrawal By PI|0
2344300|NCT03547635|4079350|FG001|Overall Study|Withdrawal By PI|1
2344301|NCT03547635|4079351|FG002|Overall Study|Withdrawal By PI|0
2344302|NCT03547635|4079349|FG000|Overall Study|Withdrawal by Sponsor|0
2344303|NCT03547635|4079350|FG001|Overall Study|Withdrawal by Sponsor|0
2344304|NCT03547635|4079351|FG002|Overall Study|Withdrawal by Sponsor|1
2344305|NCT03547635|4079349|FG000|Overall Study|Errant Randomization before Treatment|0
2344306|NCT03547635|4079350|FG001|Overall Study|Errant Randomization before Treatment|1
2344307|NCT03547635|4079351|FG002|Overall Study|Errant Randomization before Treatment|0
2344308|NCT03547635|4079349|FG000|Overall Study|Withdrawal by Subject|1
2344309|NCT03547635|4079350|FG001|Overall Study|Withdrawal by Subject|0
2344310|NCT03547635|4079351|FG002|Overall Study|Withdrawal by Subject|0
2344311|NCT03547687|4079359|FG000|Overall Study|Withdrawal by Subject|1
2344312|NCT03547687|4079359|FG000|Overall Study|Death|1
2344313|NCT03548337|4079365|FG000|Infant Series|Withdrawal by Parent/Guardian|8
2344314|NCT03548337|4079366|FG001|Infant Series|Withdrawal by Parent/Guardian|8
2344315|NCT03548337|4079365|FG000|Infant Series|No Longer Met Eligibility Criteria|1
2344316|NCT03548337|4079366|FG001|Infant Series|No Longer Met Eligibility Criteria|0
2344317|NCT03548337|4079365|FG000|Infant Series|Lost to Follow-up|2
2344318|NCT03548337|4079366|FG001|Infant Series|Lost to Follow-up|1
2257870|NCT02105272|3926907|FG000|Overall Study|Adverse Event|1
2257871|NCT02105272|3926908|FG001|Overall Study|Adverse Event|2
2257872|NCT02105272|3926907|FG000|Overall Study|Physician Decision|0
2257873|NCT02105272|3926908|FG001|Overall Study|Physician Decision|1
2257874|NCT02105272|3926907|FG000|Overall Study|Protocol Violation|2
2257875|NCT02105272|3926908|FG001|Overall Study|Protocol Violation|0
2257876|NCT02105272|3926907|FG000|Overall Study|Withdrawal by Subject|2
2257877|NCT02105272|3926908|FG001|Overall Study|Withdrawal by Subject|0
2257878|NCT02105285|3926917|FG000|Overall Study|Adverse Event|1
2257879|NCT02105285|3926918|FG001|Overall Study|Adverse Event|1
2257880|NCT02105285|3926919|FG002|Overall Study|Adverse Event|0
2257881|NCT02105285|3926917|FG000|Overall Study|Protocol Violation|0
2257882|NCT02105285|3926918|FG001|Overall Study|Protocol Violation|1
2257883|NCT02105285|3926919|FG002|Overall Study|Protocol Violation|0
2344319|NCT03548337|4079365|FG000|Infant Series|Adverse Event|0
2344320|NCT03548337|4079366|FG001|Infant Series|Adverse Event|2
2344321|NCT03548337|4079365|FG000|Infant Series|Randomized but Not Vaccinated|1
2344322|NCT03548337|4079366|FG001|Infant Series|Randomized but Not Vaccinated|0
2344323|NCT03548337|4079365|FG000|Toddler Dose|Withdrawal by parent/guardian|1
2344324|NCT03548337|4079366|FG001|Toddler Dose|Withdrawal by parent/guardian|1
2344325|NCT03548935|4079380|FG000|Overall Study|Withdrawal by Subject|26
2344326|NCT03548935|4079381|FG001|Overall Study|Withdrawal by Subject|17
2344327|NCT03548935|4079380|FG000|Overall Study|Lost to Follow-up|39
2344328|NCT03548935|4079381|FG001|Overall Study|Lost to Follow-up|28
2344329|NCT03548935|4079380|FG000|Overall Study|Death|1
2344330|NCT03548935|4079381|FG001|Overall Study|Death|1
2344331|NCT03549117|4079389|FG000|Overall Study|Withdrawal by Subject|1
2344332|NCT03549117|4079390|FG001|Overall Study|Withdrawal by Subject|0
2344333|NCT03549130|4079398|FG000|Overall Study|Adverse Event|0
2344334|NCT03549130|4079399|FG001|Overall Study|Adverse Event|1
2344335|NCT03549130|4079398|FG000|Overall Study|Lost to Follow-up|0
2344336|NCT03549130|4079399|FG001|Overall Study|Lost to Follow-up|1
2344337|NCT03549338|4079419|FG000|Overall Study|Progressive Disease|1
2344338|NCT03549338|4079420|FG001|Overall Study|Progressive Disease|0
2344339|NCT03549338|4079421|FG002|Overall Study|Progressive Disease|0
2344340|NCT03549338|4079419|FG000|Overall Study|Clinical Progression|0
2344341|NCT03549338|4079420|FG001|Overall Study|Clinical Progression|1
2344342|NCT03549338|4079421|FG002|Overall Study|Clinical Progression|0
2344343|NCT03549429|4079429|FG000|Overall Study|Protocol Violation|5
2344344|NCT03549429|4079430|FG001|Overall Study|Protocol Violation|3
2344345|NCT03550209|4079457|FG000|Overall Study|Lost to Follow-up|1
2344346|NCT03550209|4079458|FG001|Overall Study|Lost to Follow-up|0
2344347|NCT03550209|4079459|FG002|Overall Study|Lost to Follow-up|1
2344348|NCT03550209|4079460|FG003|Overall Study|Lost to Follow-up|0
2344349|NCT03550209|4079457|FG000|Overall Study|Withdrawal by Subject|0
2344350|NCT03550209|4079458|FG001|Overall Study|Withdrawal by Subject|3
2257884|NCT02105285|3926917|FG000|Overall Study|Withdrawal by Subject|1
2257885|NCT02105285|3926918|FG001|Overall Study|Withdrawal by Subject|0
2257886|NCT02105285|3926919|FG002|Overall Study|Withdrawal by Subject|0
2257887|NCT02105454|3926950|FG000|Overall Study|Withdrawal by Subject|1
2257888|NCT02105467|3926956|FG000|Period 1|Lost to Follow-up|1
2257889|NCT02105467|3926957|FG001|Period 1|Lost to Follow-up|0
2257890|NCT02105467|3926956|FG000|Period 1|Death|1
2257891|NCT02105467|3926957|FG001|Period 1|Death|0
2257892|NCT02105467|3926956|FG000|Period 2|Lost to Follow-up|1
2257893|NCT02105467|3926957|FG001|Period 2|Lost to Follow-up|0
2257894|NCT02105467|3926956|FG000|Period 2|Death|1
2257895|NCT02105467|3926957|FG001|Period 2|Death|0
2257896|NCT02105467|3926956|FG000|Period 2|Withdrawal by Subject|0
2257897|NCT02105467|3926957|FG001|Period 2|Withdrawal by Subject|2
2257898|NCT02105467|3926956|FG000|Period 3|Lost to Follow-up|0
2257899|NCT02105467|3926957|FG001|Period 3|Lost to Follow-up|1
2257900|NCT02105662|3926973|FG000|Overall Study|Lost to Follow-up|5
2257901|NCT02105662|3926973|FG000|Overall Study|Withdrawal by Subject|1
2257902|NCT02105688|3926979|FG000|Part A: Double-Blind|Adverse Event|1
2257903|NCT02105688|3926980|FG001|Part A: Double-Blind|Adverse Event|0
2257904|NCT02105688|3926979|FG000|Part A: Double-Blind|Death|0
2257905|NCT02105688|3926980|FG001|Part A: Double-Blind|Death|1
2257906|NCT02105688|3926979|FG000|Part A: Double-Blind|Lost to Follow-up|15
2257907|NCT02105688|3926980|FG001|Part A: Double-Blind|Lost to Follow-up|11
2257908|NCT02105688|3926979|FG000|Part A: Double-Blind|Physician Decision|0
2257909|NCT02105688|3926980|FG001|Part A: Double-Blind|Physician Decision|1
2257910|NCT02105688|3926979|FG000|Part A: Double-Blind|Status Unknown|0
2257911|NCT02105688|3926980|FG001|Part A: Double-Blind|Status Unknown|2
2257912|NCT02105688|3926979|FG000|Part A: Double-Blind|Withdrawal by Subject|4
2257913|NCT02105688|3926980|FG001|Part A: Double-Blind|Withdrawal by Subject|2
2257914|NCT02105688|3926979|FG000|Part B: Observational Follow-up|Death|2
2257915|NCT02105688|3926980|FG001|Part B: Observational Follow-up|Death|1
2257916|NCT02105688|3926979|FG000|Part B: Observational Follow-up|Lost to Follow-up|23
2257917|NCT02105688|3926980|FG001|Part B: Observational Follow-up|Lost to Follow-up|15
2257918|NCT02105688|3926979|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9
2257919|NCT02105688|3926980|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3
2257920|NCT02105688|3926979|FG000|Part B: Observational Follow-up|Physician Decision|3
2344351|NCT03550209|4079459|FG002|Overall Study|Withdrawal by Subject|1
2344352|NCT03550209|4079460|FG003|Overall Study|Withdrawal by Subject|2
2257921|NCT02105688|3926980|FG001|Part B: Observational Follow-up|Physician Decision|1
2257922|NCT02105701|3926991|FG000|Overall Study|Lost to Follow-up|1
2257923|NCT02105701|3926992|FG001|Overall Study|Lost to Follow-up|0
2257924|NCT02105701|3926993|FG002|Overall Study|Lost to Follow-up|2
2257925|NCT02105701|3926994|FG003|Overall Study|Lost to Follow-up|1
2257926|NCT02105701|3926991|FG000|Overall Study|Protocol Violation|0
2257927|NCT02105701|3926992|FG001|Overall Study|Protocol Violation|0
2257928|NCT02105701|3926993|FG002|Overall Study|Protocol Violation|1
2257929|NCT02105701|3926994|FG003|Overall Study|Protocol Violation|0
2257930|NCT02105701|3926991|FG000|Overall Study|Withdrawal by Subject|2
2257931|NCT02105701|3926992|FG001|Overall Study|Withdrawal by Subject|1
2257932|NCT02105701|3926993|FG002|Overall Study|Withdrawal by Subject|0
2257933|NCT02105701|3926994|FG003|Overall Study|Withdrawal by Subject|1
2257934|NCT02105701|3926991|FG000|Overall Study|Death|1
2257935|NCT02105701|3926992|FG001|Overall Study|Death|0
2257936|NCT02105701|3926993|FG002|Overall Study|Death|0
2257937|NCT02105701|3926994|FG003|Overall Study|Death|0
2257938|NCT02105948|3927019|FG000|Overall Study|Adverse Event|10
2257939|NCT02105948|3927020|FG001|Overall Study|Adverse Event|7
2257940|NCT02105948|3927021|FG002|Overall Study|Adverse Event|11
2257941|NCT02105948|3927022|FG003|Overall Study|Adverse Event|11
2257942|NCT02105948|3927019|FG000|Overall Study|Lack of Efficacy|0
2257943|NCT02105948|3927020|FG001|Overall Study|Lack of Efficacy|1
2257944|NCT02105948|3927021|FG002|Overall Study|Lack of Efficacy|3
2257945|NCT02105948|3927022|FG003|Overall Study|Lack of Efficacy|2
2257946|NCT02105948|3927019|FG000|Overall Study|Lost to Follow-up|0
2257947|NCT02105948|3927020|FG001|Overall Study|Lost to Follow-up|0
2257948|NCT02105948|3927021|FG002|Overall Study|Lost to Follow-up|2
2257949|NCT02105948|3927022|FG003|Overall Study|Lost to Follow-up|1
2257950|NCT02105948|3927019|FG000|Overall Study|Physician Decision|2
2257951|NCT02105948|3927020|FG001|Overall Study|Physician Decision|2
2257952|NCT02105948|3927021|FG002|Overall Study|Physician Decision|2
2257953|NCT02105948|3927022|FG003|Overall Study|Physician Decision|2
2257954|NCT02105948|3927019|FG000|Overall Study|Withdrawal by Subject|15
2257955|NCT02105948|3927020|FG001|Overall Study|Withdrawal by Subject|10
2257956|NCT02105948|3927021|FG002|Overall Study|Withdrawal by Subject|10
2257957|NCT02105948|3927022|FG003|Overall Study|Withdrawal by Subject|11
2257958|NCT02105961|3927036|FG000|Overall Study|Adverse Event|18
2257959|NCT02105961|3927037|FG001|Overall Study|Adverse Event|7
2257960|NCT02105961|3927038|FG002|Overall Study|Adverse Event|13
2257961|NCT02105961|3927036|FG000|Overall Study|Lack of Efficacy|3
2257962|NCT02105961|3927037|FG001|Overall Study|Lack of Efficacy|0
2257963|NCT02105961|3927038|FG002|Overall Study|Lack of Efficacy|3
2257964|NCT02105961|3927036|FG000|Overall Study|Lost to Follow-up|2
2257965|NCT02105961|3927037|FG001|Overall Study|Lost to Follow-up|0
2257966|NCT02105961|3927038|FG002|Overall Study|Lost to Follow-up|1
2257967|NCT02105961|3927036|FG000|Overall Study|Physician Decision|3
2257968|NCT02105961|3927037|FG001|Overall Study|Physician Decision|3
2257969|NCT02105961|3927038|FG002|Overall Study|Physician Decision|2
2257970|NCT02105961|3927036|FG000|Overall Study|Withdrawal by Subject|15
2257971|NCT02105961|3927037|FG001|Overall Study|Withdrawal by Subject|7
2257972|NCT02105961|3927038|FG002|Overall Study|Withdrawal by Subject|11
2257973|NCT02105974|3927049|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158
2257974|NCT02105974|3927050|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0
2257975|NCT02105974|3927051|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0
2257976|NCT02105974|3927049|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
2257977|NCT02105974|3927050|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
2257978|NCT02105974|3927051|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
2257979|NCT02105974|3927049|FG000|2 Week Run-in Period|Adverse Event|6
2257980|NCT02105974|3927050|FG001|2 Week Run-in Period|Adverse Event|0
2257981|NCT02105974|3927051|FG002|2 Week Run-in Period|Adverse Event|0
2257982|NCT02105974|3927049|FG000|2 Week Run-in Period|Study closed/terminated|1
2257983|NCT02105974|3927050|FG001|2 Week Run-in Period|Study closed/terminated|0
2257984|NCT02105974|3927051|FG002|2 Week Run-in Period|Study closed/terminated|0
2257985|NCT02105974|3927049|FG000|2 Week Run-in Period|Lost to Follow-up|2
2257986|NCT02105974|3927050|FG001|2 Week Run-in Period|Lost to Follow-up|0
2257987|NCT02105974|3927051|FG002|2 Week Run-in Period|Lost to Follow-up|0
2257988|NCT02105974|3927049|FG000|2 Week Run-in Period|Withdrew consent|23
2257989|NCT02105974|3927050|FG001|2 Week Run-in Period|Withdrew consent|0
2257990|NCT02105974|3927051|FG002|2 Week Run-in Period|Withdrew consent|0
2257991|NCT02105974|3927049|FG000|2 Week Run-in Period|Investigator discretion|8
2344353|NCT03550209|4079457|FG000|Overall Study|Excluded due to ineligibility after randomization|0
2344354|NCT03550209|4079458|FG001|Overall Study|Excluded due to ineligibility after randomization|0
2344355|NCT03550209|4079459|FG002|Overall Study|Excluded due to ineligibility after randomization|0
2344356|NCT03550209|4079460|FG003|Overall Study|Excluded due to ineligibility after randomization|2
2344357|NCT03550313|4079473|FG000|Overall Study|Adverse Event|0
2344358|NCT03550313|4079474|FG001|Overall Study|Adverse Event|1
2344359|NCT03550313|4079475|FG002|Overall Study|Adverse Event|0
2344360|NCT03550313|4079473|FG000|Overall Study|Lost to Follow-up|5
2344361|NCT03550313|4079474|FG001|Overall Study|Lost to Follow-up|7
2344362|NCT03550313|4079475|FG002|Overall Study|Lost to Follow-up|12
2257992|NCT02105974|3927050|FG001|2 Week Run-in Period|Investigator discretion|0
2257993|NCT02105974|3927051|FG002|2 Week Run-in Period|Investigator discretion|0
2257994|NCT02105974|3927049|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
2257995|NCT02105974|3927050|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
2257996|NCT02105974|3927051|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
2257997|NCT02105974|3927049|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
2257998|NCT02105974|3927050|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
2257999|NCT02105974|3927051|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
2258000|NCT02105974|3927049|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
2258001|NCT02105974|3927050|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
2258002|NCT02105974|3927051|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
2258003|NCT02105974|3927049|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
2258004|NCT02105974|3927050|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
2258005|NCT02105974|3927051|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
2258006|NCT02105974|3927049|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
2258007|NCT02105974|3927050|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
2258008|NCT02105974|3927051|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
2258009|NCT02105974|3927049|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
2258010|NCT02105974|3927050|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
2258011|NCT02105974|3927051|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
2258012|NCT02105974|3927049|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
2258013|NCT02105974|3927050|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
2258014|NCT02105974|3927051|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
2258015|NCT02105987|3927059|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10
2258016|NCT02105987|3927060|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0
2258017|NCT02105987|3927061|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0
2258018|NCT02105987|3927062|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0
2258019|NCT02105987|3927063|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0
2258020|NCT02105987|3927064|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0
2258021|NCT02105987|3927059|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15
2258022|NCT02105987|3927060|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17
2258023|NCT02105987|3927061|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0
2258024|NCT02105987|3927062|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0
2258025|NCT02105987|3927063|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0
2258026|NCT02105987|3927064|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0
2258027|NCT02105987|3927059|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
2258028|NCT02105987|3927060|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
2258029|NCT02105987|3927061|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2258030|NCT02105987|3927062|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2258031|NCT02105987|3927063|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2258032|NCT02105987|3927064|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2258033|NCT02105987|3927059|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
2258034|NCT02105987|3927060|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
2258035|NCT02105987|3927061|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2258036|NCT02105987|3927062|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2258037|NCT02105987|3927063|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2258038|NCT02105987|3927064|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2258039|NCT02105987|3927059|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4
2258040|NCT02105987|3927060|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3
2258041|NCT02105987|3927061|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0
2258042|NCT02105987|3927062|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0
2258043|NCT02105987|3927063|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0
2258044|NCT02105987|3927064|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0
2258045|NCT02105987|3927059|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2258046|NCT02105987|3927060|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
2258047|NCT02105987|3927061|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2258048|NCT02105987|3927062|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2258049|NCT02105987|3927063|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2258050|NCT02105987|3927064|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2258051|NCT02105987|3927059|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0
2258052|NCT02105987|3927060|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0
2258053|NCT02105987|3927061|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10
2258054|NCT02105987|3927062|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4
2258055|NCT02105987|3927063|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0
2258056|NCT02105987|3927064|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0
2258057|NCT02105987|3927059|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0
2344363|NCT03550313|4079473|FG000|Overall Study|Study terminated by sponsor|44
2344364|NCT03550313|4079474|FG001|Overall Study|Study terminated by sponsor|37
2344365|NCT03550313|4079475|FG002|Overall Study|Study terminated by sponsor|48
2344366|NCT03550313|4079473|FG000|Overall Study|No longer met eligibility criteria|3
2344367|NCT03550313|4079474|FG001|Overall Study|No longer met eligibility criteria|5
2344368|NCT03550313|4079475|FG002|Overall Study|No longer met eligibility criteria|6
2344369|NCT03550313|4079473|FG000|Overall Study|Withdrawal by parent/guardian|20
2258058|NCT02105987|3927060|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0
2258059|NCT02105987|3927061|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15
2258060|NCT02105987|3927062|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1
2258061|NCT02105987|3927063|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0
2258062|NCT02105987|3927064|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0
2258063|NCT02105987|3927059|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2258064|NCT02105987|3927060|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2258065|NCT02105987|3927061|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
2258066|NCT02105987|3927062|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
2258067|NCT02105987|3927063|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2258068|NCT02105987|3927064|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2258069|NCT02105987|3927059|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2258070|NCT02105987|3927060|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2258071|NCT02105987|3927061|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
2258072|NCT02105987|3927062|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
2258073|NCT02105987|3927063|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2258074|NCT02105987|3927064|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2258075|NCT02105987|3927059|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0
2258076|NCT02105987|3927060|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0
2258077|NCT02105987|3927061|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5
2258078|NCT02105987|3927062|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0
2258079|NCT02105987|3927063|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0
2258080|NCT02105987|3927064|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0
2258081|NCT02105987|3927059|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2258082|NCT02105987|3927060|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2258083|NCT02105987|3927061|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2258084|NCT02105987|3927062|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
2258085|NCT02105987|3927063|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2258086|NCT02105987|3927064|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2258087|NCT02105987|3927059|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0
2258088|NCT02105987|3927060|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0
2258089|NCT02105987|3927061|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1
2258090|NCT02105987|3927062|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0
2258091|NCT02105987|3927063|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0
2258092|NCT02105987|3927064|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0
2258093|NCT02105987|3927059|FG000|Continuation Phase|Protocol Violation|0
2258094|NCT02105987|3927060|FG001|Continuation Phase|Protocol Violation|0
2258095|NCT02105987|3927061|FG002|Continuation Phase|Protocol Violation|0
2258096|NCT02105987|3927062|FG003|Continuation Phase|Protocol Violation|0
2258097|NCT02105987|3927063|FG004|Continuation Phase|Protocol Violation|1
2258098|NCT02105987|3927064|FG005|Continuation Phase|Protocol Violation|0
2258099|NCT02106156|3927086|FG000|Overall Study|Patient Died|19
2258100|NCT02106156|3927087|FG001|Overall Study|Patient Died|0
2258101|NCT02106156|3927088|FG002|Overall Study|Patient Died|0
2258102|NCT02106156|3927086|FG000|Overall Study|Lack of Tolerability|305
2258103|NCT02106156|3927087|FG001|Overall Study|Lack of Tolerability|3
2258104|NCT02106156|3927088|FG002|Overall Study|Lack of Tolerability|0
2258105|NCT02106156|3927086|FG000|Overall Study|Lack of Virological Response|1044
2258106|NCT02106156|3927087|FG001|Overall Study|Lack of Virological Response|8
2258107|NCT02106156|3927088|FG002|Overall Study|Lack of Virological Response|0
2258108|NCT02106156|3927086|FG000|Overall Study|Concomitant Disease|74
2258109|NCT02106156|3927087|FG001|Overall Study|Concomitant Disease|2
2258110|NCT02106156|3927088|FG002|Overall Study|Concomitant Disease|0
2258111|NCT02106156|3927086|FG000|Overall Study|Lack of Compliance|211
2258112|NCT02106156|3927087|FG001|Overall Study|Lack of Compliance|7
2258113|NCT02106156|3927088|FG002|Overall Study|Lack of Compliance|0
2258114|NCT02106156|3927086|FG000|Overall Study|Patients Request|307
2258115|NCT02106156|3927087|FG001|Overall Study|Patients Request|9
2258116|NCT02106156|3927088|FG002|Overall Study|Patients Request|0
2258117|NCT02106156|3927086|FG000|Overall Study|Lost to Follow-up|451
2258118|NCT02106156|3927087|FG001|Overall Study|Lost to Follow-up|8
2344370|NCT03550313|4079474|FG001|Overall Study|Withdrawal by parent/guardian|18
2344371|NCT03550313|4079475|FG002|Overall Study|Withdrawal by parent/guardian|26
2344372|NCT03550313|4079473|FG000|Overall Study|Other|4
2344373|NCT03550313|4079474|FG001|Overall Study|Other|2
2344374|NCT03550313|4079475|FG002|Overall Study|Other|2
2344375|NCT03550313|4079473|FG000|Overall Study|Randomized but not vaccinated|3
2344376|NCT03550313|4079474|FG001|Overall Study|Randomized but not vaccinated|23
2344377|NCT03550313|4079475|FG002|Overall Study|Randomized but not vaccinated|2
2344378|NCT03550313|4079473|FG000|Overall Study|Sites terminated due to quality issues|18
2344379|NCT03550313|4079474|FG001|Overall Study|Sites terminated due to quality issues|17
2344380|NCT03550313|4079475|FG002|Overall Study|Sites terminated due to quality issues|18
2344381|NCT03550378|4079486|FG000|Overall Study|Death|0
2344382|NCT03550378|4079487|FG001|Overall Study|Death|1
2344383|NCT03551730|4079519|FG000|Overall Study|Adverse Event|1
2344384|NCT03551730|4079520|FG001|Overall Study|Adverse Event|0
2344385|NCT03551730|4079521|FG002|Overall Study|Adverse Event|0
2258119|NCT02106156|3927088|FG002|Overall Study|Lost to Follow-up|0
2258120|NCT02106156|3927086|FG000|Overall Study|Unplanned Event|82
2258121|NCT02106156|3927087|FG001|Overall Study|Unplanned Event|2
2258122|NCT02106156|3927088|FG002|Overall Study|Unplanned Event|0
2258123|NCT02106156|3927086|FG000|Overall Study|Change of Laboratory Parameter|10
2258124|NCT02106156|3927087|FG001|Overall Study|Change of Laboratory Parameter|0
2258125|NCT02106156|3927088|FG002|Overall Study|Change of Laboratory Parameter|0
2258126|NCT02106156|3927086|FG000|Overall Study|Hospitalization/Surgical Intervention|6
2258127|NCT02106156|3927087|FG001|Overall Study|Hospitalization/Surgical Intervention|0
2258128|NCT02106156|3927088|FG002|Overall Study|Hospitalization/Surgical Intervention|0
2258129|NCT02106156|3927086|FG000|Overall Study|Relocation/Change of Physician|40
2258130|NCT02106156|3927087|FG001|Overall Study|Relocation/Change of Physician|1
2258131|NCT02106156|3927088|FG002|Overall Study|Relocation/Change of Physician|0
2258132|NCT02106325|3927097|FG000|Phase 1|Lost to Follow-up|2
2258133|NCT02106325|3927098|FG001|Phase 1|Lost to Follow-up|2
2258134|NCT02106325|3927097|FG000|Phase 2|Lost to Follow-up|2
2258135|NCT02106325|3927098|FG001|Phase 2|Lost to Follow-up|3
2258136|NCT02106325|3927097|FG000|Phase 3|Lost to Follow-up|2
2258137|NCT02106325|3927098|FG001|Phase 3|Lost to Follow-up|1
2258138|NCT02106351|3927107|FG000|Treatment Cycle 1|Adverse Event|2
2258139|NCT02106351|3927108|FG001|Treatment Cycle 1|Adverse Event|0
2258140|NCT02106351|3927109|FG002|Treatment Cycle 1|Adverse Event|0
2258141|NCT02106351|3927107|FG000|Treatment Cycle 1|Consent withdrawn|1
2258142|NCT02106351|3927108|FG001|Treatment Cycle 1|Consent withdrawn|0
2258143|NCT02106351|3927109|FG002|Treatment Cycle 1|Consent withdrawn|2
2258144|NCT02106351|3927107|FG000|Treatment Cycle 1|Lost to Follow-up|1
2258145|NCT02106351|3927108|FG001|Treatment Cycle 1|Lost to Follow-up|0
2258146|NCT02106351|3927109|FG002|Treatment Cycle 1|Lost to Follow-up|0
2258147|NCT02106351|3927107|FG000|Treatment Cycle 1|Other|0
2258148|NCT02106351|3927108|FG001|Treatment Cycle 1|Other|3
2258149|NCT02106351|3927109|FG002|Treatment Cycle 1|Other|1
2258150|NCT02106351|3927107|FG000|Treatment Cycle 1|Randomised but not treated|1
2258151|NCT02106351|3927108|FG001|Treatment Cycle 1|Randomised but not treated|0
2258152|NCT02106351|3927109|FG002|Treatment Cycle 1|Randomised but not treated|1
2258153|NCT02106351|3927107|FG000|Treatment Cycle 2|Adverse Event|0
2258154|NCT02106351|3927108|FG001|Treatment Cycle 2|Adverse Event|2
2258155|NCT02106351|3927109|FG002|Treatment Cycle 2|Adverse Event|0
2258156|NCT02106351|3927107|FG000|Treatment Cycle 2|Consent withdrawn|0
2258157|NCT02106351|3927108|FG001|Treatment Cycle 2|Consent withdrawn|1
2258158|NCT02106351|3927109|FG002|Treatment Cycle 2|Consent withdrawn|1
2258159|NCT02106351|3927107|FG000|Treatment Cycle 2|Other|0
2258160|NCT02106351|3927108|FG001|Treatment Cycle 2|Other|2
2258161|NCT02106351|3927109|FG002|Treatment Cycle 2|Other|2
2258162|NCT02106351|3927107|FG000|Treatment Cycle 3|Adverse Event|0
2258163|NCT02106351|3927108|FG001|Treatment Cycle 3|Adverse Event|1
2258164|NCT02106351|3927109|FG002|Treatment Cycle 3|Adverse Event|0
2258165|NCT02106351|3927107|FG000|Treatment Cycle 3|Consent withdrawn|0
2258166|NCT02106351|3927108|FG001|Treatment Cycle 3|Consent withdrawn|0
2258167|NCT02106351|3927109|FG002|Treatment Cycle 3|Consent withdrawn|2
2258168|NCT02106351|3927107|FG000|Treatment Cycle 3|Lost to Follow-up|0
2258169|NCT02106351|3927108|FG001|Treatment Cycle 3|Lost to Follow-up|1
2258170|NCT02106351|3927109|FG002|Treatment Cycle 3|Lost to Follow-up|0
2258171|NCT02106351|3927107|FG000|Treatment Cycle 3|Other|0
2258172|NCT02106351|3927108|FG001|Treatment Cycle 3|Other|2
2258173|NCT02106351|3927109|FG002|Treatment Cycle 3|Other|3
2258174|NCT02106351|3927107|FG000|Treatment Cycle 4|Consent withdrawn|0
2258175|NCT02106351|3927108|FG001|Treatment Cycle 4|Consent withdrawn|0
2258176|NCT02106351|3927109|FG002|Treatment Cycle 4|Consent withdrawn|2
2258177|NCT02106351|3927107|FG000|Treatment Cycle 4|Other|0
2258178|NCT02106351|3927108|FG001|Treatment Cycle 4|Other|1
2258179|NCT02106351|3927109|FG002|Treatment Cycle 4|Other|0
2258180|NCT02106390|3927126|FG000|Overall Study|Withdrawal by Subject|15
2258181|NCT02106390|3927127|FG001|Overall Study|Withdrawal by Subject|16
2258182|NCT02106390|3927128|FG002|Overall Study|Withdrawal by Subject|15
2258183|NCT02106390|3927126|FG000|Overall Study|Lost to Follow-up|25
2258184|NCT02106390|3927127|FG001|Overall Study|Lost to Follow-up|20
2258185|NCT02106390|3927128|FG002|Overall Study|Lost to Follow-up|13
2258186|NCT02106390|3927126|FG000|Overall Study|Other: Administrative Reason|8
2258187|NCT02106390|3927127|FG001|Overall Study|Other: Administrative Reason|5
2258188|NCT02106390|3927128|FG002|Overall Study|Other: Administrative Reason|12
2258189|NCT02106390|3927126|FG000|Overall Study|Other: Unspecified|1
2258190|NCT02106390|3927127|FG001|Overall Study|Other: Unspecified|4
2258191|NCT02106390|3927128|FG002|Overall Study|Other: Unspecified|2
2258192|NCT02106390|3927126|FG000|Overall Study|Adverse Event|0
2258193|NCT02106390|3927127|FG001|Overall Study|Adverse Event|2
2258194|NCT02106390|3927128|FG002|Overall Study|Adverse Event|1
2258195|NCT02106390|3927126|FG000|Overall Study|Protocol Violation|0
2258196|NCT02106390|3927127|FG001|Overall Study|Protocol Violation|1
2258197|NCT02106390|3927128|FG002|Overall Study|Protocol Violation|0
2258198|NCT02106403|3927139|FG000|Follow-Up Visit 3|Other Reason|0
2258199|NCT02106403|3927140|FG001|Follow-Up Visit 3|Other Reason|0
2258200|NCT02106403|3927141|FG002|Follow-Up Visit 3|Other Reason|0
2258201|NCT02106403|3927142|FG003|Follow-Up Visit 3|Other Reason|0
2258202|NCT02106403|3927143|FG004|Follow-Up Visit 3|Other Reason|0
2258203|NCT02106403|3927144|FG005|Follow-Up Visit 3|Other Reason|1
2258204|NCT02106442|3927154|FG000|Overall Study|Case Report Forms Uncollected|7
2258205|NCT02106442|3927154|FG000|Overall Study|Protocol Deviation|30
2258206|NCT02106455|3927158|FG000|Overall Study|Case Report Form Uncollected|6
2258207|NCT02106455|3927158|FG000|Overall Study|Protocol Deviation|2
2258208|NCT02106832|3927192|FG000|Overall Study|Adverse Event|1
2258209|NCT02106832|3927193|FG001|Overall Study|Adverse Event|2
2258210|NCT02106832|3927194|FG002|Overall Study|Adverse Event|3
2258211|NCT02106832|3927195|FG003|Overall Study|Adverse Event|0
2344386|NCT03551730|4079522|FG003|Overall Study|Adverse Event|0
2344387|NCT03551743|4079536|FG000|Overall Study|Adverse Event|1
2344388|NCT03551743|4079537|FG001|Overall Study|Adverse Event|0
2344389|NCT03551743|4079538|FG002|Overall Study|Adverse Event|0
2344390|NCT03551743|4079539|FG003|Overall Study|Adverse Event|0
2344391|NCT03551743|4079536|FG000|Overall Study|Withdrawal by Subject|1
2344392|NCT03551743|4079537|FG001|Overall Study|Withdrawal by Subject|0
2344393|NCT03551743|4079538|FG002|Overall Study|Withdrawal by Subject|0
2344394|NCT03551743|4079539|FG003|Overall Study|Withdrawal by Subject|0
2344395|NCT03552198|4079557|FG000|Overall Study|Lost to Follow-up|42
2344396|NCT03552198|4079558|FG001|Overall Study|Lost to Follow-up|48
2344397|NCT03552198|4079559|FG002|Overall Study|Lost to Follow-up|15
2344398|NCT03552198|4079560|FG003|Overall Study|Lost to Follow-up|19
2344399|NCT03552198|4079557|FG000|Overall Study|Incomplete/unmatched questionnaire|6
2344400|NCT03552198|4079558|FG001|Overall Study|Incomplete/unmatched questionnaire|7
2344401|NCT03552198|4079559|FG002|Overall Study|Incomplete/unmatched questionnaire|2
2344402|NCT03552198|4079560|FG003|Overall Study|Incomplete/unmatched questionnaire|2
2344403|NCT03552198|4079557|FG000|Overall Study|Did not receive air alerts|1
2344404|NCT03552198|4079558|FG001|Overall Study|Did not receive air alerts|0
2344405|NCT03552198|4079559|FG002|Overall Study|Did not receive air alerts|0
2344406|NCT03552198|4079560|FG003|Overall Study|Did not receive air alerts|1
2344407|NCT03552523|4079579|FG000|Overall Study|Withdrawal by Subject|1
2344408|NCT03552523|4079580|FG001|Overall Study|Withdrawal by Subject|1
2344409|NCT03552549|4079599|FG000|Overall Study|Disease progression|25
2344410|NCT03552549|4079600|FG001|Overall Study|Disease progression|17
2344411|NCT03552549|4079599|FG000|Overall Study|Adverse event in first 12 months|12
2344412|NCT03552549|4079600|FG001|Overall Study|Adverse event in first 12 months|8
2344413|NCT03552549|4079599|FG000|Overall Study|Withdrawal by Subject|7
2344414|NCT03552549|4079600|FG001|Overall Study|Withdrawal by Subject|7
2344415|NCT03552549|4079599|FG000|Overall Study|Unknown (no reason provided)|4
2344416|NCT03552549|4079600|FG001|Overall Study|Unknown (no reason provided)|2
2344417|NCT03552549|4079599|FG000|Overall Study|Not in participant's best interest|2
2344418|NCT03552549|4079600|FG001|Overall Study|Not in participant's best interest|1
2344419|NCT03552549|4079599|FG000|Overall Study|Did not complete study treatment|2
2344420|NCT03552549|4079600|FG001|Overall Study|Did not complete study treatment|3
2344421|NCT03552549|4079599|FG000|Overall Study|Did not meet eligibility criteria|1
2344422|NCT03552549|4079600|FG001|Overall Study|Did not meet eligibility criteria|0
2344423|NCT03552549|4079599|FG000|Overall Study|Administrative|0
2344424|NCT03552549|4079600|FG001|Overall Study|Administrative|14
2258212|NCT02106832|3927192|FG000|Overall Study|Death|4
2258213|NCT02106832|3927193|FG001|Overall Study|Death|4
2258214|NCT02106832|3927194|FG002|Overall Study|Death|1
2258215|NCT02106832|3927195|FG003|Overall Study|Death|4
2258216|NCT02106832|3927192|FG000|Overall Study|Deterioration of general conditions|0
2258217|NCT02106832|3927193|FG001|Overall Study|Deterioration of general conditions|0
2258218|NCT02106832|3927194|FG002|Overall Study|Deterioration of general conditions|1
2258219|NCT02106832|3927195|FG003|Overall Study|Deterioration of general conditions|0
2258220|NCT02106832|3927192|FG000|Overall Study|Lost to Follow-up|0
2258221|NCT02106832|3927193|FG001|Overall Study|Lost to Follow-up|1
2258222|NCT02106832|3927194|FG002|Overall Study|Lost to Follow-up|1
2258223|NCT02106832|3927195|FG003|Overall Study|Lost to Follow-up|3
2258224|NCT02106832|3927192|FG000|Overall Study|Physician Decision|1
2258225|NCT02106832|3927193|FG001|Overall Study|Physician Decision|0
2258226|NCT02106832|3927194|FG002|Overall Study|Physician Decision|0
2258227|NCT02106832|3927195|FG003|Overall Study|Physician Decision|0
2258228|NCT02106832|3927192|FG000|Overall Study|Protocol Violation|0
2258229|NCT02106832|3927193|FG001|Overall Study|Protocol Violation|0
2258230|NCT02106832|3927194|FG002|Overall Study|Protocol Violation|0
2258231|NCT02106832|3927195|FG003|Overall Study|Protocol Violation|1
2258232|NCT02106832|3927192|FG000|Overall Study|Withdrawal by Subject|17
2258233|NCT02106832|3927193|FG001|Overall Study|Withdrawal by Subject|17
2258234|NCT02106832|3927194|FG002|Overall Study|Withdrawal by Subject|10
2258235|NCT02106832|3927195|FG003|Overall Study|Withdrawal by Subject|7
2258236|NCT02106832|3927192|FG000|Overall Study|Technical problems|0
2258237|NCT02106832|3927193|FG001|Overall Study|Technical problems|1
2258238|NCT02106832|3927194|FG002|Overall Study|Technical problems|0
2258239|NCT02106832|3927195|FG003|Overall Study|Technical problems|0
2258240|NCT02106884|3927209|FG000|Overall Study|Change of diagnosis/exclusion|0
2258241|NCT02106884|3927210|FG001|Overall Study|Change of diagnosis/exclusion|1
2344425|NCT03552757|4079609|FG000|Overall Study|Withdrawal by Subject|10
2344426|NCT03552757|4079610|FG001|Overall Study|Withdrawal by Subject|5
2344427|NCT03552757|4079611|FG002|Overall Study|Withdrawal by Subject|12
2344428|NCT03552757|4079609|FG000|Overall Study|Lost to Follow-up|2
2344429|NCT03552757|4079610|FG001|Overall Study|Lost to Follow-up|7
2344430|NCT03552757|4079611|FG002|Overall Study|Lost to Follow-up|7
2258242|NCT02106910|3927221|FG000|Overall Study|Lost to Follow-up|1
2258243|NCT02106910|3927222|FG001|Overall Study|Lost to Follow-up|1
2258244|NCT02106923|3927232|FG000|Overall Study|Protocol Violation|0
2258245|NCT02106923|3927233|FG001|Overall Study|Protocol Violation|0
2258246|NCT02106923|3927234|FG002|Overall Study|Protocol Violation|0
2258247|NCT02106923|3927235|FG003|Overall Study|Protocol Violation|0
2258248|NCT02106923|3927236|FG004|Overall Study|Protocol Violation|0
2258249|NCT02106923|3927237|FG005|Overall Study|Protocol Violation|1
2258250|NCT02106975|3927264|FG000|Overall Study|Death|25
2258251|NCT02106975|3927265|FG001|Overall Study|Death|39
2258252|NCT02107014|3927271|FG000|Overall Study|Withdrew before drug: moving interstate|1
2258253|NCT02107092|3927275|FG000|Overall Study|Miscellaneous|3
2258254|NCT02107092|3927275|FG000|Overall Study|Subject compliance|3
2258255|NCT02107092|3927275|FG000|Overall Study|Hypo-or hyperkalemia|2
2258256|NCT02107092|3927275|FG000|Overall Study|Met ECG withdrawal criteria|3
2258257|NCT02107092|3927275|FG000|Overall Study|Physician Decision|3
2258258|NCT02107092|3927275|FG000|Overall Study|Lost to Follow-up|2
2258259|NCT02107092|3927275|FG000|Overall Study|Withdrawal by Subject|9
2258260|NCT02107092|3927275|FG000|Overall Study|Adverse Event|7
2258261|NCT02107092|3927275|FG000|Overall Study|Expected progression of CKD|12
2258262|NCT02107131|3927281|FG000|Overall Study|Lost to Follow-up|4
2258263|NCT02107131|3927282|FG001|Overall Study|Lost to Follow-up|4
2258264|NCT02107131|3927281|FG000|Overall Study|Physician Decision|1
2258265|NCT02107131|3927282|FG001|Overall Study|Physician Decision|0
2258266|NCT02107131|3927281|FG000|Overall Study|Withdrawal by Subject|2
2258267|NCT02107131|3927282|FG001|Overall Study|Withdrawal by Subject|0
2258268|NCT02107131|3927281|FG000|Overall Study|mental instability|1
2258269|NCT02107131|3927282|FG001|Overall Study|mental instability|0
2258270|NCT02107131|3927281|FG000|Overall Study|Death|0
2258271|NCT02107131|3927282|FG001|Overall Study|Death|1
2258272|NCT02107131|3927281|FG000|Overall Study|Protocol Violation|0
2258273|NCT02107131|3927282|FG001|Overall Study|Protocol Violation|4
2258274|NCT02107196|3927305|FG000|12-week Treatment Period|Adverse Event|6
2258275|NCT02107196|3927306|FG001|12-week Treatment Period|Adverse Event|3
2258276|NCT02107196|3927305|FG000|12-week Treatment Period|Lack of Efficacy|2
2258277|NCT02107196|3927306|FG001|12-week Treatment Period|Lack of Efficacy|1
2258278|NCT02107196|3927305|FG000|12-week Treatment Period|Lost to Follow-up|3
2258279|NCT02107196|3927306|FG001|12-week Treatment Period|Lost to Follow-up|6
2258280|NCT02107196|3927305|FG000|12-week Treatment Period|Physician Decision|0
2258281|NCT02107196|3927306|FG001|12-week Treatment Period|Physician Decision|1
2258282|NCT02107196|3927305|FG000|12-week Treatment Period|Withdrawal by Subject|15
2258283|NCT02107196|3927306|FG001|12-week Treatment Period|Withdrawal by Subject|12
2258284|NCT02107196|3927305|FG000|12-week Treatment Period|Protocol Violation|7
2258285|NCT02107196|3927306|FG001|12-week Treatment Period|Protocol Violation|8
2258286|NCT02107196|3927305|FG000|12-week Treatment Period|Reason Missing|11
2258287|NCT02107196|3927306|FG001|12-week Treatment Period|Reason Missing|8
2258288|NCT02107196|3927305|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
2258289|NCT02107196|3927306|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
2258290|NCT02107196|3927305|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
2258291|NCT02107196|3927306|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
2258292|NCT02107196|3927305|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
2258293|NCT02107196|3927306|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
2258294|NCT02107196|3927305|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
2258295|NCT02107196|3927306|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
2258296|NCT02107274|3927314|FG000|Treatment vs. Placebo|Adverse Event|3
2258297|NCT02107274|3927315|FG001|Treatment vs. Placebo|Adverse Event|0
2258298|NCT02107274|3927314|FG000|Treatment vs. Placebo|Lost to Follow-up|0
2258299|NCT02107274|3927315|FG001|Treatment vs. Placebo|Lost to Follow-up|2
2258300|NCT02107274|3927314|FG000|Control Phase|Lost to Follow-up|1
2258301|NCT02107274|3927315|FG001|Control Phase|Lost to Follow-up|1
2258302|NCT02107274|3927314|FG000|Control Phase|Death|2
2258303|NCT02107274|3927315|FG001|Control Phase|Death|0
2258304|NCT02107274|3927314|FG000|Control Phase|Adverse Event|0
2258305|NCT02107274|3927315|FG001|Control Phase|Adverse Event|1
2258306|NCT02107313|3927330|FG000|Overall Study|One participant did not do the FED cohor|0
2258307|NCT02107313|3927331|FG001|Overall Study|One participant did not do the FED cohor|1
2258308|NCT02107443|3927348|FG000|Overall Study|Death|42
2258309|NCT02107443|3927349|FG001|Overall Study|Death|30
2258310|NCT02107443|3927348|FG000|Overall Study|Study Protocol Violation|3
2258311|NCT02107443|3927349|FG001|Overall Study|Study Protocol Violation|1
2258312|NCT02107443|3927348|FG000|Overall Study|Registered but Not Eligible|0
2258313|NCT02107443|3927349|FG001|Overall Study|Registered but Not Eligible|1
2258314|NCT02107443|3927348|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28
2258315|NCT02107443|3927349|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28
2258316|NCT02107443|3927348|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1
2258317|NCT02107443|3927349|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2
2258318|NCT02107443|3927348|FG000|Overall Study|Withdrawal: Changed Mind|2
2258319|NCT02107443|3927349|FG001|Overall Study|Withdrawal: Changed Mind|0
2258320|NCT02107443|3927348|FG000|Overall Study|Withdrawal: Changed MD/Facility|1
2258321|NCT02107443|3927349|FG001|Overall Study|Withdrawal: Changed MD/Facility|3
2258322|NCT02107443|3927348|FG000|Overall Study|Withdrawal: Too Many Forms|3
2258323|NCT02107443|3927349|FG001|Overall Study|Withdrawal: Too Many Forms|1
2258324|NCT02107443|3927348|FG000|Overall Study|Withdrawal: Too Time Consuming|3
2258325|NCT02107443|3927349|FG001|Overall Study|Withdrawal: Too Time Consuming|6
2258326|NCT02107443|3927348|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2
2258327|NCT02107443|3927349|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1
2258328|NCT02107443|3927348|FG000|Overall Study|Withdrawal: Other Medical|9
2258329|NCT02107443|3927349|FG001|Overall Study|Withdrawal: Other Medical|5
2258330|NCT02107443|3927348|FG000|Overall Study|Withdrawal: Disease Progression|4
2258331|NCT02107443|3927349|FG001|Overall Study|Withdrawal: Disease Progression|2
2258332|NCT02107443|3927348|FG000|Overall Study|Withdrawal: Personal Issues|0
2258333|NCT02107443|3927349|FG001|Overall Study|Withdrawal: Personal Issues|3
2258334|NCT02107482|3927356|FG000|Overall Study|inconveinence|2
2258335|NCT02107482|3927356|FG000|Overall Study|Lost to Follow-up|1
2258336|NCT02107482|3927356|FG000|Overall Study|Lack of Efficacy|1
2258337|NCT02107703|3927369|FG000|Overall Study|Withdrawal by Subject|36
2258338|NCT02107703|3927370|FG001|Overall Study|Withdrawal by Subject|19
2258339|NCT02107703|3927369|FG000|Overall Study|Lost to Follow-up|6
2258340|NCT02107703|3927370|FG001|Overall Study|Lost to Follow-up|4
2258341|NCT02107703|3927369|FG000|Overall Study|On study treatment/follow up|319
2258342|NCT02107703|3927370|FG001|Overall Study|On study treatment/follow up|152
2258343|NCT02107859|3927379|FG000|Overall Study|Withdrawal by Subject|14
2258344|NCT02107859|3927379|FG000|Overall Study|Adverse Event|3
2258345|NCT02107859|3927379|FG000|Overall Study|Study closure|41
2258346|NCT02107859|3927379|FG000|Overall Study|Other than specified|3
2258347|NCT02107898|3927385|FG000|Overall Study|Adverse Event|4
2258348|NCT02107898|3927386|FG001|Overall Study|Adverse Event|7
2258349|NCT02107898|3927385|FG000|Overall Study|Poor compliance to protocol|0
2258350|NCT02107898|3927386|FG001|Overall Study|Poor compliance to protocol|1
2258351|NCT02107898|3927385|FG000|Overall Study|Participant moved|0
2258352|NCT02107898|3927386|FG001|Overall Study|Participant moved|2
2258353|NCT02107898|3927385|FG000|Overall Study|Consent withdrawn by participant|2
2258354|NCT02107898|3927386|FG001|Overall Study|Consent withdrawn by participant|1
2258355|NCT02107898|3927385|FG000|Overall Study|Randomized but not treated|0
2258356|NCT02107898|3927386|FG001|Overall Study|Randomized but not treated|1
2258357|NCT02108262|3927422|FG000|Overall Study|Non-compliance|0
2258358|NCT02108262|3927423|FG001|Overall Study|Non-compliance|2
2258359|NCT02108262|3927424|FG002|Overall Study|Non-compliance|1
2258360|NCT02108262|3927425|FG003|Overall Study|Non-compliance|1
2258361|NCT02108262|3927422|FG000|Overall Study|Randomized by error/screen failure|0
2258362|NCT02108262|3927423|FG001|Overall Study|Randomized by error/screen failure|0
2258363|NCT02108262|3927424|FG002|Overall Study|Randomized by error/screen failure|1
2258364|NCT02108262|3927425|FG003|Overall Study|Randomized by error/screen failure|0
2258365|NCT02108262|3927422|FG000|Overall Study|Distance to center|0
2258366|NCT02108262|3927423|FG001|Overall Study|Distance to center|1
2258367|NCT02108262|3927424|FG002|Overall Study|Distance to center|1
2258368|NCT02108262|3927425|FG003|Overall Study|Distance to center|0
2258369|NCT02108262|3927422|FG000|Overall Study|Adverse Event|0
2258370|NCT02108262|3927423|FG001|Overall Study|Adverse Event|11
2258371|NCT02108262|3927424|FG002|Overall Study|Adverse Event|6
2258372|NCT02108262|3927425|FG003|Overall Study|Adverse Event|12
2258373|NCT02108262|3927422|FG000|Overall Study|Death|0
2258374|NCT02108262|3927423|FG001|Overall Study|Death|2
2258375|NCT02108262|3927424|FG002|Overall Study|Death|2
2258376|NCT02108262|3927425|FG003|Overall Study|Death|1
2258377|NCT02108262|3927422|FG000|Overall Study|Lost to Follow-up|0
2258378|NCT02108262|3927423|FG001|Overall Study|Lost to Follow-up|0
2258379|NCT02108262|3927424|FG002|Overall Study|Lost to Follow-up|1
2258380|NCT02108262|3927425|FG003|Overall Study|Lost to Follow-up|0
2258381|NCT02108262|3927422|FG000|Overall Study|Physician Decision|0
2258382|NCT02108262|3927423|FG001|Overall Study|Physician Decision|0
2258383|NCT02108262|3927424|FG002|Overall Study|Physician Decision|2
2258384|NCT02108262|3927425|FG003|Overall Study|Physician Decision|0
2258385|NCT02108262|3927422|FG000|Overall Study|Withdrawal by Subject|0
2258386|NCT02108262|3927423|FG001|Overall Study|Withdrawal by Subject|7
2258387|NCT02108262|3927424|FG002|Overall Study|Withdrawal by Subject|3
2258388|NCT02108262|3927425|FG003|Overall Study|Withdrawal by Subject|4
2258389|NCT02108262|3927422|FG000|Overall Study|Due to key hepatic values|0
2258390|NCT02108262|3927423|FG001|Overall Study|Due to key hepatic values|1
2258391|NCT02108262|3927424|FG002|Overall Study|Due to key hepatic values|0
2258392|NCT02108262|3927425|FG003|Overall Study|Due to key hepatic values|0
2258393|NCT02108262|3927422|FG000|Overall Study|Unable to contact patient|0
2258394|NCT02108262|3927423|FG001|Overall Study|Unable to contact patient|3
2258395|NCT02108262|3927424|FG002|Overall Study|Unable to contact patient|1
2258396|NCT02108262|3927425|FG003|Overall Study|Unable to contact patient|2
2258397|NCT02108262|3927422|FG000|Overall Study|Patient unable to come to site/attend visit|0
2258398|NCT02108262|3927423|FG001|Overall Study|Patient unable to come to site/attend visit|6
2258399|NCT02108262|3927424|FG002|Overall Study|Patient unable to come to site/attend visit|11
2258400|NCT02108262|3927425|FG003|Overall Study|Patient unable to come to site/attend visit|6
2258401|NCT02108262|3927422|FG000|Overall Study|Patient did not want another infusion|0
2258402|NCT02108262|3927423|FG001|Overall Study|Patient did not want another infusion|3
2258403|NCT02108262|3927424|FG002|Overall Study|Patient did not want another infusion|3
2258404|NCT02108262|3927425|FG003|Overall Study|Patient did not want another infusion|2
2258405|NCT02108262|3927422|FG000|Overall Study|Vacation|0
2258406|NCT02108262|3927423|FG001|Overall Study|Vacation|1
2258407|NCT02108262|3927424|FG002|Overall Study|Vacation|0
2258408|NCT02108262|3927425|FG003|Overall Study|Vacation|0
2258409|NCT02108262|3927422|FG000|Overall Study|Patient decision|0
2344431|NCT03552757|4079609|FG000|Overall Study|Death|1
2344432|NCT03552757|4079610|FG001|Overall Study|Death|1
2344433|NCT03552757|4079611|FG002|Overall Study|Death|1
2344434|NCT03553758|4079622|FG000|Overall Study|Lost to Follow-up|1
2344435|NCT03553823|4079630|FG000|Overall Study|Physician Decision|0
2344436|NCT03553823|4079631|FG001|Overall Study|Physician Decision|1
2344437|NCT03554005|4079652|FG000|Overall Study|Not in participant's best interest|0
2344438|NCT03554005|4079653|FG001|Overall Study|Not in participant's best interest|0
2344439|NCT03554005|4079654|FG002|Overall Study|Not in participant's best interest|0
2344440|NCT03554005|4079655|FG003|Overall Study|Not in participant's best interest|0
2344441|NCT03554005|4079656|FG004|Overall Study|Not in participant's best interest|0
2344442|NCT03554005|4079657|FG005|Overall Study|Not in participant's best interest|1
2344443|NCT03554005|4079652|FG000|Overall Study|Disease Progression|1
2344444|NCT03554005|4079653|FG001|Overall Study|Disease Progression|1
2344445|NCT03554005|4079654|FG002|Overall Study|Disease Progression|1
2344446|NCT03554005|4079655|FG003|Overall Study|Disease Progression|1
2344447|NCT03554005|4079656|FG004|Overall Study|Disease Progression|5
2344448|NCT03554005|4079657|FG005|Overall Study|Disease Progression|6
2344449|NCT03554005|4079652|FG000|Overall Study|Adverse Event|0
2344450|NCT03554005|4079653|FG001|Overall Study|Adverse Event|0
2344451|NCT03554005|4079654|FG002|Overall Study|Adverse Event|0
2344452|NCT03554005|4079655|FG003|Overall Study|Adverse Event|0
2344453|NCT03554005|4079656|FG004|Overall Study|Adverse Event|0
2344454|NCT03554005|4079657|FG005|Overall Study|Adverse Event|3
2344455|NCT03554005|4079652|FG000|Overall Study|Physician Decision|0
2344456|NCT03554005|4079653|FG001|Overall Study|Physician Decision|0
2344457|NCT03554005|4079654|FG002|Overall Study|Physician Decision|0
2344458|NCT03554005|4079655|FG003|Overall Study|Physician Decision|0
2344459|NCT03554005|4079656|FG004|Overall Study|Physician Decision|1
2344460|NCT03554005|4079657|FG005|Overall Study|Physician Decision|0
2344461|NCT03554005|4079652|FG000|Overall Study|Other|0
2344462|NCT03554005|4079653|FG001|Overall Study|Other|0
2344463|NCT03554005|4079654|FG002|Overall Study|Other|0
2344464|NCT03554005|4079655|FG003|Overall Study|Other|0
2344465|NCT03554005|4079656|FG004|Overall Study|Other|0
2344466|NCT03554005|4079657|FG005|Overall Study|Other|1
2344467|NCT03554018|4079673|FG000|Overall Study|Lost to Follow-up|3
2344468|NCT03554018|4079674|FG001|Overall Study|Lost to Follow-up|7
2344469|NCT03554486|4079682|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1
2344470|NCT03554486|4079683|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0
2344471|NCT03554486|4079684|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0
2344472|NCT03554486|4079682|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2
2344473|NCT03554486|4079683|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0
2344474|NCT03554486|4079684|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0
2344475|NCT03554486|4079682|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0
2344476|NCT03554486|4079683|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
2344477|NCT03554486|4079684|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
2344478|NCT03554629|4079691|FG000|Overall Study|Inadequate data|6
2344479|NCT03554772|4079732|FG000|Overall Study|Lost to Follow-up|0
2344480|NCT03554772|4079733|FG001|Overall Study|Lost to Follow-up|0
2344481|NCT03554772|4079734|FG002|Overall Study|Lost to Follow-up|0
2344482|NCT03554772|4079735|FG003|Overall Study|Lost to Follow-up|2
2344483|NCT03555266|4079755|FG000|Overall Study|Protocol Violation|6
2344484|NCT03555266|4079756|FG001|Overall Study|Protocol Violation|4
2344485|NCT03555305|4079762|FG000|Period 1|Physician Decision|0
2344486|NCT03555305|4079763|FG001|Period 1|Physician Decision|1
2344487|NCT03555305|4079762|FG000|Period 1|Adverse Event|0
2344488|NCT03555305|4079763|FG001|Period 1|Adverse Event|1
2344489|NCT03555435|4079772|FG000|Overall Study|Lost to Follow-up|17
2344490|NCT03555435|4079773|FG001|Overall Study|Lost to Follow-up|19
2344491|NCT03555435|4079774|FG002|Overall Study|Lost to Follow-up|8
2344492|NCT03555565|4079782|FG000|Overall Study|Case Report Forms Uncollected|2
2344493|NCT03555565|4079782|FG000|Overall Study|Protocol Deviation|13
2344494|NCT03555890|4079790|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2344495|NCT03555890|4079791|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2344496|NCT03555890|4079792|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2344497|NCT03555890|4079793|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2344498|NCT03556891|4079825|FG000|Overall Study|Adverse Event|4
2344499|NCT03556891|4079825|FG000|Overall Study|MRI Need|3
2344500|NCT03556891|4079825|FG000|Overall Study|Device Failure|1
2344501|NCT03556891|4079825|FG000|Overall Study|Death|1
2344502|NCT03556891|4079825|FG000|Overall Study|Lost to Follow-up|1
2344503|NCT03556891|4079825|FG000|Overall Study|Missing at random|1
2344504|NCT03556891|4079825|FG000|Overall Study|Missing due to COVID|1
2344505|NCT03556891|4079825|FG000|Overall Study|Protocol Violation|1
2344506|NCT03557034|4079831|FG000|Overall Study|Withdrawal by Subject|1
2344507|NCT03557034|4079832|FG001|Overall Study|Withdrawal by Subject|0
2344508|NCT03557775|4079889|FG000|Overall Study|Withdrawal by Subject|1
2344509|NCT03557775|4079890|FG001|Overall Study|Withdrawal by Subject|2
2258410|NCT02108262|3927423|FG001|Overall Study|Patient decision|7
2258411|NCT02108262|3927424|FG002|Overall Study|Patient decision|9
2258412|NCT02108262|3927425|FG003|Overall Study|Patient decision|14
2258413|NCT02108262|3927422|FG000|Overall Study|Missed IV due to pharmacy error|0
2258414|NCT02108262|3927423|FG001|Overall Study|Missed IV due to pharmacy error|0
2258415|NCT02108262|3927424|FG002|Overall Study|Missed IV due to pharmacy error|1
2258416|NCT02108262|3927425|FG003|Overall Study|Missed IV due to pharmacy error|0
2258417|NCT02108600|3927462|FG000|Overall Study|Withdrawal by Subject|2
2258418|NCT02108600|3927463|FG001|Overall Study|Withdrawal by Subject|0
2258419|NCT02108600|3927462|FG000|Overall Study|Lost to Follow-up|1
2258420|NCT02108600|3927463|FG001|Overall Study|Lost to Follow-up|1
2258421|NCT02108912|3927486|FG000|Overall Study|Lost to Follow-up|1
2258422|NCT02108912|3927487|FG001|Overall Study|Lost to Follow-up|1
2258423|NCT02108912|3927486|FG000|Overall Study|lack of transportation|1
2258424|NCT02108912|3927487|FG001|Overall Study|lack of transportation|0
2258425|NCT02108912|3927486|FG000|Overall Study|high blood pressure|1
2258426|NCT02108912|3927487|FG001|Overall Study|high blood pressure|0
2258427|NCT02108951|3927493|FG000|Overall Study|Lost to Follow-up|1
2258428|NCT02108951|3927493|FG000|Overall Study|Patient's/guardian's decision|1
2258429|NCT02108951|3927493|FG000|Overall Study|Study Terminated by Sponsor|14
2258430|NCT02109029|3927511|FG000|Part B|Adverse Event|0
2258431|NCT02109029|3927512|FG001|Part B|Adverse Event|0
2258432|NCT02109029|3927513|FG002|Part B|Adverse Event|0
2258433|NCT02109029|3927514|FG003|Part B|Adverse Event|0
2258434|NCT02109029|3927515|FG004|Part B|Adverse Event|1
2258435|NCT02109029|3927516|FG005|Part B|Adverse Event|1
2258436|NCT02109042|3927527|FG000|Overall Study|Sponsor Decision|15
2258437|NCT02109107|3927532|FG000|Overall Study|Lost to Follow-up|2
2258438|NCT02109133|3927538|FG000|Overall Study|Lost to Follow-up|1
2258439|NCT02109133|3927539|FG001|Overall Study|Lost to Follow-up|0
2258440|NCT02109432|3927562|FG000|Overall Study|Withdrawal by Subject|1
2258441|NCT02109445|3927566|FG000|Overall Study|Symptomatic deterioration|2
2258442|NCT02109445|3927566|FG000|Overall Study|Adverse Event|1
2258443|NCT02109484|3927582|FG000|Overall Study|Lost to Follow-up|0
2258444|NCT02109484|3927583|FG001|Overall Study|Lost to Follow-up|0
2258445|NCT02109484|3927584|FG002|Overall Study|Lost to Follow-up|0
2258446|NCT02109484|3927585|FG003|Overall Study|Lost to Follow-up|1
2258447|NCT02109484|3927586|FG004|Overall Study|Lost to Follow-up|1
2258448|NCT02109484|3927587|FG005|Overall Study|Lost to Follow-up|0
2258449|NCT02109484|3927588|FG006|Overall Study|Lost to Follow-up|1
2258450|NCT02109484|3927589|FG007|Overall Study|Lost to Follow-up|0
2258451|NCT02109484|3927582|FG000|Overall Study|Withdrawal by Subject|0
2258452|NCT02109484|3927583|FG001|Overall Study|Withdrawal by Subject|0
2258453|NCT02109484|3927584|FG002|Overall Study|Withdrawal by Subject|0
2258454|NCT02109484|3927585|FG003|Overall Study|Withdrawal by Subject|0
2258455|NCT02109484|3927586|FG004|Overall Study|Withdrawal by Subject|1
2258456|NCT02109484|3927587|FG005|Overall Study|Withdrawal by Subject|1
2258457|NCT02109484|3927588|FG006|Overall Study|Withdrawal by Subject|1
2258458|NCT02109484|3927589|FG007|Overall Study|Withdrawal by Subject|0
2258459|NCT02109484|3927582|FG000|Overall Study|Physician Decision|0
2258460|NCT02109484|3927583|FG001|Overall Study|Physician Decision|0
2258461|NCT02109484|3927584|FG002|Overall Study|Physician Decision|0
2258462|NCT02109484|3927585|FG003|Overall Study|Physician Decision|0
2258463|NCT02109484|3927586|FG004|Overall Study|Physician Decision|2
2258464|NCT02109484|3927587|FG005|Overall Study|Physician Decision|0
2258465|NCT02109484|3927588|FG006|Overall Study|Physician Decision|0
2258466|NCT02109484|3927589|FG007|Overall Study|Physician Decision|0
2258467|NCT02109484|3927582|FG000|Overall Study|Death|0
2258468|NCT02109484|3927583|FG001|Overall Study|Death|0
2258469|NCT02109484|3927584|FG002|Overall Study|Death|0
2258470|NCT02109484|3927585|FG003|Overall Study|Death|0
2258471|NCT02109484|3927586|FG004|Overall Study|Death|0
2258472|NCT02109484|3927587|FG005|Overall Study|Death|0
2258473|NCT02109484|3927588|FG006|Overall Study|Death|0
2258474|NCT02109484|3927589|FG007|Overall Study|Death|2
2258475|NCT02109484|3927582|FG000|Overall Study|Moved away from study area|0
2258476|NCT02109484|3927583|FG001|Overall Study|Moved away from study area|0
2258477|NCT02109484|3927584|FG002|Overall Study|Moved away from study area|0
2258478|NCT02109484|3927585|FG003|Overall Study|Moved away from study area|0
2258479|NCT02109484|3927586|FG004|Overall Study|Moved away from study area|0
2258480|NCT02109484|3927587|FG005|Overall Study|Moved away from study area|0
2258481|NCT02109484|3927588|FG006|Overall Study|Moved away from study area|1
2258482|NCT02109484|3927589|FG007|Overall Study|Moved away from study area|1
2344510|NCT03557775|4079891|FG002|Overall Study|Withdrawal by Subject|4
2344511|NCT03557775|4079889|FG000|Overall Study|Physician Decision|0
2344512|NCT03557775|4079890|FG001|Overall Study|Physician Decision|1
2344513|NCT03557775|4079891|FG002|Overall Study|Physician Decision|0
2344514|NCT03557801|4079902|FG000|Overall Study|Protocol Violation|1
2344515|NCT03557801|4079903|FG001|Overall Study|Protocol Violation|0
2344516|NCT03557801|4079904|FG002|Overall Study|Protocol Violation|0
2344517|NCT03557801|4079902|FG000|Overall Study|Withdrawal by Subject|1
2344518|NCT03557801|4079903|FG001|Overall Study|Withdrawal by Subject|0
2344519|NCT03557801|4079904|FG002|Overall Study|Withdrawal by Subject|3
2344520|NCT03557801|4079902|FG000|Overall Study|Lost to Follow-up|0
2344521|NCT03557801|4079903|FG001|Overall Study|Lost to Follow-up|1
2344522|NCT03557801|4079904|FG002|Overall Study|Lost to Follow-up|0
2344523|NCT03557931|4079915|FG000|Overall Study|Adverse Event|4
2258483|NCT02109562|3927631|FG000|Overall Study|Insufficient clinical response|2
2258484|NCT02109562|3927632|FG001|Overall Study|Insufficient clinical response|0
2258485|NCT02109562|3927633|FG002|Overall Study|Insufficient clinical response|4
2258486|NCT02109562|3927631|FG000|Overall Study|Adverse Event|0
2258487|NCT02109562|3927632|FG001|Overall Study|Adverse Event|2
2258488|NCT02109562|3927633|FG002|Overall Study|Adverse Event|3
2258489|NCT02109562|3927631|FG000|Overall Study|Lost to Follow-up|1
2258490|NCT02109562|3927632|FG001|Overall Study|Lost to Follow-up|0
2258491|NCT02109562|3927633|FG002|Overall Study|Lost to Follow-up|1
2258492|NCT02109562|3927631|FG000|Overall Study|Protocol Violation|0
2258493|NCT02109562|3927632|FG001|Overall Study|Protocol Violation|3
2258494|NCT02109562|3927633|FG002|Overall Study|Protocol Violation|1
2258495|NCT02109562|3927631|FG000|Overall Study|Withdrawal by Subject|20
2258496|NCT02109562|3927632|FG001|Overall Study|Withdrawal by Subject|25
2258497|NCT02109562|3927633|FG002|Overall Study|Withdrawal by Subject|21
2258498|NCT02109562|3927631|FG000|Overall Study|Physician Decision|3
2258499|NCT02109562|3927632|FG001|Overall Study|Physician Decision|4
2258500|NCT02109562|3927633|FG002|Overall Study|Physician Decision|5
2258501|NCT02110225|3927695|FG000|Overall Study|Lost to Follow-up|0
2258502|NCT02110225|3927696|FG001|Overall Study|Lost to Follow-up|1
2258503|NCT02110225|3927697|FG002|Overall Study|Lost to Follow-up|0
2258504|NCT02110238|3927708|FG000|12 Week Pivotal Phase|Adverse Event|3
2258505|NCT02110238|3927709|FG001|12 Week Pivotal Phase|Adverse Event|0
2344524|NCT03557931|4079916|FG001|Overall Study|Adverse Event|6
2344525|NCT03557931|4079917|FG002|Overall Study|Adverse Event|1
2344526|NCT03557931|4079915|FG000|Overall Study|Lost to Follow-up|4
2344527|NCT03557931|4079916|FG001|Overall Study|Lost to Follow-up|4
2344528|NCT03557931|4079917|FG002|Overall Study|Lost to Follow-up|1
2344529|NCT03557931|4079915|FG000|Overall Study|Protocol Violation|1
2344530|NCT03557931|4079916|FG001|Overall Study|Protocol Violation|4
2344531|NCT03557931|4079917|FG002|Overall Study|Protocol Violation|1
2344532|NCT03557931|4079915|FG000|Overall Study|Withdrawal by Subject|14
2344533|NCT03557931|4079916|FG001|Overall Study|Withdrawal by Subject|0
2344534|NCT03557931|4079917|FG002|Overall Study|Withdrawal by Subject|7
2344535|NCT03557931|4079915|FG000|Overall Study|Miscellaneous|8
2344536|NCT03557931|4079916|FG001|Overall Study|Miscellaneous|5
2344537|NCT03557931|4079917|FG002|Overall Study|Miscellaneous|3
2344538|NCT03558516|4079947|FG000|Overall Study|Protocol Violation|2
2344539|NCT03558516|4079948|FG001|Overall Study|Protocol Violation|2
2344540|NCT03558555|4079956|FG000|Overall Study|Lost to Follow-up|2
2344541|NCT03558555|4079957|FG001|Overall Study|Lost to Follow-up|1
2344542|NCT03558672|4079963|FG000|Overall Study|Study Early Termination|10
2344543|NCT03558997|4079971|FG000|Overall Study|Adverse Event|0
2344544|NCT03558997|4079972|FG001|Overall Study|Adverse Event|2
2344545|NCT03558997|4079973|FG002|Overall Study|Adverse Event|5
2344546|NCT03558997|4079974|FG003|Overall Study|Adverse Event|1
2258506|NCT02110238|3927708|FG000|12 Week Pivotal Phase|Lack of Efficacy|2
2258507|NCT02110238|3927709|FG001|12 Week Pivotal Phase|Lack of Efficacy|3
2258508|NCT02110238|3927708|FG000|12 Week Pivotal Phase|Lost to Follow-up|2
2258509|NCT02110238|3927709|FG001|12 Week Pivotal Phase|Lost to Follow-up|0
2258510|NCT02110238|3927708|FG000|12 Week Pivotal Phase|Physician Decision|0
2258511|NCT02110238|3927709|FG001|12 Week Pivotal Phase|Physician Decision|2
2258512|NCT02110238|3927708|FG000|12 Week Pivotal Phase|Protocol Violation|0
2258513|NCT02110238|3927709|FG001|12 Week Pivotal Phase|Protocol Violation|1
2258514|NCT02110238|3927708|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3
2258515|NCT02110238|3927709|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3
2258516|NCT02110238|3927708|FG000|14 Week Blinded Extension Phase|Adverse Event|1
2258517|NCT02110238|3927709|FG001|14 Week Blinded Extension Phase|Adverse Event|1
2258518|NCT02110238|3927708|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2
2258519|NCT02110238|3927709|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4
2258520|NCT02110238|3927708|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3
2258521|NCT02110238|3927709|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1
2258522|NCT02110238|3927708|FG000|14 Week Blinded Extension Phase|Protocol Violation|2
2258523|NCT02110238|3927709|FG001|14 Week Blinded Extension Phase|Protocol Violation|3
2258524|NCT02110238|3927708|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4
2258525|NCT02110238|3927709|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3
2258526|NCT02110693|3927747|FG000|Overall Study|Withdrawal by Subject|6
2258527|NCT02110693|3927748|FG001|Overall Study|Withdrawal by Subject|7
2258528|NCT02110693|3927747|FG000|Overall Study|skipped assessment|15
2258529|NCT02110693|3927748|FG001|Overall Study|skipped assessment|18
2258530|NCT02110693|3927747|FG000|Overall Study|technical difficulties|6
2258531|NCT02110693|3927748|FG001|Overall Study|technical difficulties|4
2258532|NCT02110693|3927747|FG000|Overall Study|Other|1
2258533|NCT02110693|3927748|FG001|Overall Study|Other|0
2258534|NCT02110706|3927770|FG000|Overall Study|Adverse Event|2
2258535|NCT02110706|3927771|FG001|Overall Study|Adverse Event|3
2258536|NCT02110706|3927770|FG000|Overall Study|Patients who didn't receive 2nd infusion|3
2258537|NCT02110706|3927771|FG001|Overall Study|Patients who didn't receive 2nd infusion|1
2258538|NCT02110732|3927781|FG000|Overall Study|Physician Decision|5
2258539|NCT02110732|3927782|FG001|Overall Study|Physician Decision|2
2258540|NCT02110732|3927781|FG000|Overall Study|Lost to Follow-up|1
2258541|NCT02110732|3927782|FG001|Overall Study|Lost to Follow-up|1
2344547|NCT03558997|4079971|FG000|Overall Study|Physician Decision|0
2258542|NCT02110901|3927811|FG000|Overall Study|Death|6
2258543|NCT02110901|3927812|FG001|Overall Study|Death|3
2258544|NCT02110901|3927811|FG000|Overall Study|Lost to Follow-up|12
2258545|NCT02110901|3927812|FG001|Overall Study|Lost to Follow-up|8
2258546|NCT02110901|3927811|FG000|Overall Study|Withdrawal by Subject|7
2258547|NCT02110901|3927812|FG001|Overall Study|Withdrawal by Subject|3
2258548|NCT02110901|3927811|FG000|Overall Study|received a kidney transplant|5
2258549|NCT02110901|3927812|FG001|Overall Study|received a kidney transplant|0
2258550|NCT02111083|3927821|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1
2258551|NCT02111083|3927822|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1
2258552|NCT02111096|3927831|FG000|Overall Study|Adverse Event|4
2258553|NCT02111096|3927832|FG001|Overall Study|Adverse Event|1
2258554|NCT02111096|3927833|FG002|Overall Study|Adverse Event|2
2258555|NCT02111096|3927831|FG000|Overall Study|Non-Compliance with Study Drug|1
2258556|NCT02111096|3927832|FG001|Overall Study|Non-Compliance with Study Drug|1
2258557|NCT02111096|3927833|FG002|Overall Study|Non-Compliance with Study Drug|0
2258558|NCT02111096|3927831|FG000|Overall Study|Lost to Follow Up|1
2258559|NCT02111096|3927832|FG001|Overall Study|Lost to Follow Up|1
2258560|NCT02111096|3927833|FG002|Overall Study|Lost to Follow Up|1
2258561|NCT02111096|3927831|FG000|Overall Study|Physician Decision|0
2258562|NCT02111096|3927832|FG001|Overall Study|Physician Decision|1
2258563|NCT02111096|3927833|FG002|Overall Study|Physician Decision|0
2258564|NCT02111096|3927831|FG000|Overall Study|Protocol Violation|1
2258565|NCT02111096|3927832|FG001|Overall Study|Protocol Violation|0
2258566|NCT02111096|3927833|FG002|Overall Study|Protocol Violation|1
2258567|NCT02111096|3927831|FG000|Overall Study|Terminated by Sponsor|53
2258568|NCT02111096|3927832|FG001|Overall Study|Terminated by Sponsor|35
2258569|NCT02111096|3927833|FG002|Overall Study|Terminated by Sponsor|54
2258570|NCT02111096|3927831|FG000|Overall Study|Withdrawal by Subject|4
2258571|NCT02111096|3927832|FG001|Overall Study|Withdrawal by Subject|2
2258572|NCT02111096|3927833|FG002|Overall Study|Withdrawal by Subject|8
2258573|NCT02111174|3927846|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
2258574|NCT02111174|3927847|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
2258575|NCT02111174|3927846|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2
2258576|NCT02111174|3927847|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2
2258577|NCT02111174|3927846|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
2258578|NCT02111174|3927847|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
2258579|NCT02111174|3927846|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0
2258580|NCT02111174|3927847|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1
2258581|NCT02111213|3927879|FG000|Overall Study|Withdrawal by Subject|3
2258582|NCT02111213|3927880|FG001|Overall Study|Withdrawal by Subject|2
2258583|NCT02111213|3927879|FG000|Overall Study|Lost to Follow-up|3
2258584|NCT02111213|3927880|FG001|Overall Study|Lost to Follow-up|4
2258585|NCT02111369|3927890|FG000|Overall Study|Lost to Follow-up|2
2258586|NCT02111369|3927890|FG000|Overall Study|Withdrawal by Subject|1
2258587|NCT02111564|3927913|FG000|Overall Study|Death|109
2258588|NCT02111564|3927914|FG001|Overall Study|Death|120
2258589|NCT02111564|3927913|FG000|Overall Study|Lost to Follow-up|2
2258590|NCT02111564|3927914|FG001|Overall Study|Lost to Follow-up|3
2258591|NCT02111564|3927913|FG000|Overall Study|Withdrawal by Subject|20
2258592|NCT02111564|3927914|FG001|Overall Study|Withdrawal by Subject|20
2258593|NCT02111577|3927922|FG000|Overall Study|Protocol Violation|2
2258594|NCT02111577|3927923|FG001|Overall Study|Protocol Violation|0
2258595|NCT02111577|3927922|FG000|Overall Study|Unable to tolerate leukapheresis|1
2258596|NCT02111577|3927923|FG001|Overall Study|Unable to tolerate leukapheresis|0
2258597|NCT02111577|3927922|FG000|Overall Study|Failure to produce study treatment|6
2344548|NCT03558997|4079972|FG001|Overall Study|Physician Decision|0
2344549|NCT03558997|4079973|FG002|Overall Study|Physician Decision|1
2344550|NCT03558997|4079974|FG003|Overall Study|Physician Decision|0
2344551|NCT03558997|4079971|FG000|Overall Study|Withdrawal by Subject|1
2344552|NCT03558997|4079972|FG001|Overall Study|Withdrawal by Subject|0
2344553|NCT03558997|4079973|FG002|Overall Study|Withdrawal by Subject|1
2344554|NCT03558997|4079974|FG003|Overall Study|Withdrawal by Subject|1
2344555|NCT03558997|4079971|FG000|Overall Study|Lost to Follow-up|0
2344556|NCT03558997|4079972|FG001|Overall Study|Lost to Follow-up|0
2344557|NCT03558997|4079973|FG002|Overall Study|Lost to Follow-up|1
2344558|NCT03558997|4079974|FG003|Overall Study|Lost to Follow-up|0
2344559|NCT03559062|4079990|FG000|Overall Study|Other|0
2344560|NCT03559062|4079991|FG001|Overall Study|Other|1
2344561|NCT03559062|4079992|FG002|Overall Study|Other|0
2258598|NCT02111577|3927923|FG001|Overall Study|Failure to produce study treatment|0
2258599|NCT02111577|3927922|FG000|Overall Study|Death|518
2258600|NCT02111577|3927923|FG001|Overall Study|Death|254
2258601|NCT02111577|3927922|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1
2258602|NCT02111577|3927923|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0
2258603|NCT02111577|3927922|FG000|Overall Study|Adverse Event|1
2258604|NCT02111577|3927923|FG001|Overall Study|Adverse Event|1
2258605|NCT02111577|3927922|FG000|Overall Study|Withdrawal by Subject|51
2258606|NCT02111577|3927923|FG001|Overall Study|Withdrawal by Subject|23
2258607|NCT02111577|3927922|FG000|Overall Study|Disease progression|0
2258608|NCT02111577|3927923|FG001|Overall Study|Disease progression|1
2258609|NCT02111577|3927922|FG000|Overall Study|Lost to Follow-up|19
2258610|NCT02111577|3927923|FG001|Overall Study|Lost to Follow-up|10
2258611|NCT02111603|3927931|FG000|Overall Study|Withdrawal by Subject|1
2344562|NCT03559218|4080034|FG000|Overall Study|Withdrawal by Subject|1
2344563|NCT03559218|4080035|FG001|Overall Study|Withdrawal by Subject|0
2344564|NCT03559257|4080043|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
2344565|NCT03559257|4080044|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
2344566|NCT03559257|4080043|FG000|Double Blind Treatment Period|Protocol Violation|1
2344567|NCT03559257|4080044|FG001|Double Blind Treatment Period|Protocol Violation|4
2344568|NCT03559257|4080043|FG000|Double Blind Treatment Period|Lack of Efficacy|1
2344569|NCT03559257|4080044|FG001|Double Blind Treatment Period|Lack of Efficacy|1
2344570|NCT03559257|4080043|FG000|Double Blind Treatment Period|Adverse Event|0
2344571|NCT03559257|4080044|FG001|Double Blind Treatment Period|Adverse Event|1
2344572|NCT03559257|4080043|FG000|Double Blind Treatment Period|Screen Failure|0
2344573|NCT03559257|4080044|FG001|Double Blind Treatment Period|Screen Failure|1
2344574|NCT03559257|4080043|FG000|Open-label Treatment Period|Adverse Event|1
2344575|NCT03559257|4080044|FG001|Open-label Treatment Period|Adverse Event|4
2344576|NCT03559257|4080043|FG000|Open-label Treatment Period|Lack of Efficacy|3
2344577|NCT03559257|4080044|FG001|Open-label Treatment Period|Lack of Efficacy|2
2344578|NCT03559257|4080043|FG000|Open-label Treatment Period|Withdrawal by Subject|3
2344579|NCT03559257|4080044|FG001|Open-label Treatment Period|Withdrawal by Subject|0
2344580|NCT03559257|4080043|FG000|Open-label Treatment Period|Protocol Violation|2
2344581|NCT03559257|4080044|FG001|Open-label Treatment Period|Protocol Violation|0
2344582|NCT03559257|4080043|FG000|Open-label Treatment Period|Lost to Follow-up|1
2344583|NCT03559257|4080044|FG001|Open-label Treatment Period|Lost to Follow-up|0
2344584|NCT03559257|4080043|FG000|Open-label Treatment Period|Physician Decision|0
2344585|NCT03559257|4080044|FG001|Open-label Treatment Period|Physician Decision|1
2344586|NCT03559517|4080056|FG000|Overall Study|Withdrawal by Subject|1
2344587|NCT03559517|4080057|FG001|Overall Study|Withdrawal by Subject|0
2344588|NCT03559517|4080058|FG002|Overall Study|Withdrawal by Subject|0
2344589|NCT03559530|4080066|FG000|Overall Study|non-location of medical records|44
2344590|NCT03559530|4080067|FG001|Overall Study|non-location of medical records|0
2344591|NCT03559530|4080066|FG000|Overall Study|culture results not considered for treat|29
2344592|NCT03559530|4080067|FG001|Overall Study|culture results not considered for treat|0
2344593|NCT03559530|4080066|FG000|Overall Study|duplicate cases|8
2344594|NCT03559530|4080067|FG001|Overall Study|duplicate cases|0
2344595|NCT03559530|4080066|FG000|Overall Study|other species of Acinetobacte|7
2344596|NCT03559530|4080067|FG001|Overall Study|other species of Acinetobacte|0
2344597|NCT03559530|4080066|FG000|Overall Study|contamination / colonization|3
2344598|NCT03559530|4080067|FG001|Overall Study|contamination / colonization|0
2344599|NCT03560245|4080107|FG000|Overall Study|Withdrawal by Subject|3
2344600|NCT03560245|4080108|FG001|Overall Study|Withdrawal by Subject|2
2344601|NCT03560245|4080107|FG000|Overall Study|Adverse Event|1
2344602|NCT03560245|4080108|FG001|Overall Study|Adverse Event|1
2344603|NCT03560245|4080107|FG000|Overall Study|Protocol Violation|1
2344604|NCT03560245|4080108|FG001|Overall Study|Protocol Violation|0
2344605|NCT03560245|4080107|FG000|Overall Study|Death|0
2344606|NCT03560245|4080108|FG001|Overall Study|Death|1
2344607|NCT03560245|4080107|FG000|Overall Study|Lost to Follow-up|0
2344608|NCT03560245|4080108|FG001|Overall Study|Lost to Follow-up|1
2344609|NCT03560245|4080107|FG000|Overall Study|Physician Decision|0
2344610|NCT03560245|4080108|FG001|Overall Study|Physician Decision|1
2344611|NCT03560245|4080107|FG000|Overall Study|Other|0
2344612|NCT03560245|4080108|FG001|Overall Study|Other|1
2344613|NCT03560518|4080119|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1
2344614|NCT03560518|4080120|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0
2344615|NCT03560518|4080121|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0
2344616|NCT03560518|4080119|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6
2344617|NCT03560518|4080120|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9
2344618|NCT03560518|4080121|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10
2344619|NCT03560518|4080119|FG000|Double Blind Treatment Period|Protocol Violation|1
2344620|NCT03560518|4080120|FG001|Double Blind Treatment Period|Protocol Violation|2
2344621|NCT03560518|4080121|FG002|Double Blind Treatment Period|Protocol Violation|0
2344622|NCT03560518|4080119|FG000|Double Blind Treatment Period|Pregnancy|0
2344623|NCT03560518|4080120|FG001|Double Blind Treatment Period|Pregnancy|2
2344624|NCT03560518|4080121|FG002|Double Blind Treatment Period|Pregnancy|0
2344625|NCT03560518|4080119|FG000|Double Blind Treatment Period|Lost to Follow-up|5
2258612|NCT02111785|3927957|FG000|Overall Study|Death|0
2258613|NCT02111785|3927958|FG001|Overall Study|Death|1
2258614|NCT02111785|3927959|FG002|Overall Study|Death|0
2258615|NCT02111785|3927960|FG003|Overall Study|Death|0
2258616|NCT02111811|3927994|FG000|Treatment Phase|Lost to Follow-up|22
2258617|NCT02111811|3927995|FG001|Treatment Phase|Lost to Follow-up|18
2258618|NCT02111811|3927994|FG000|Treatment Phase|Death|2
2258619|NCT02111811|3927995|FG001|Treatment Phase|Death|0
2258620|NCT02111811|3927994|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26
2258621|NCT02111811|3927995|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17
2258622|NCT02111811|3927994|FG000|Follow up Period (Aim 2)|Death|2
2258623|NCT02111811|3927995|FG001|Follow up Period (Aim 2)|Death|0
2344626|NCT03560518|4080120|FG001|Double Blind Treatment Period|Lost to Follow-up|6
2344627|NCT03560518|4080121|FG002|Double Blind Treatment Period|Lost to Follow-up|6
2344628|NCT03560518|4080119|FG000|Double Blind Treatment Period|Withdrawal by Subject|10
2344629|NCT03560518|4080120|FG001|Double Blind Treatment Period|Withdrawal by Subject|6
2344630|NCT03560518|4080121|FG002|Double Blind Treatment Period|Withdrawal by Subject|5
2344631|NCT03560518|4080119|FG000|Double Blind Treatment Period|Lack of Efficacy|2
2344632|NCT03560518|4080120|FG001|Double Blind Treatment Period|Lack of Efficacy|1
2344633|NCT03560518|4080121|FG002|Double Blind Treatment Period|Lack of Efficacy|1
2344634|NCT03560518|4080119|FG000|Double Blind Treatment Period|Adverse Event|0
2344635|NCT03560518|4080120|FG001|Double Blind Treatment Period|Adverse Event|3
2344636|NCT03560518|4080121|FG002|Double Blind Treatment Period|Adverse Event|1
2344637|NCT03560739|4080133|FG000|Overall Study|Adverse Event|0
2258624|NCT02111993|3928014|FG000|Overall Study|Physician Decision|5
2258625|NCT02111993|3928015|FG001|Overall Study|Physician Decision|4
2258626|NCT02112045|3928025|FG000|Overall Study|Withdrawal by Subject|1
2258627|NCT02112045|3928026|FG001|Overall Study|Withdrawal by Subject|0
2258628|NCT02112448|3928043|FG000|Overall Study|lab values precluding use of ketorolac|2
2258629|NCT02112448|3928044|FG001|Overall Study|lab values precluding use of ketorolac|2
2258630|NCT02112448|3928043|FG000|Overall Study|Protocol Violation|1
2258631|NCT02112448|3928044|FG001|Overall Study|Protocol Violation|2
2258632|NCT02112448|3928043|FG000|Overall Study|Physician Decision|4
2258633|NCT02112448|3928044|FG001|Overall Study|Physician Decision|6
2258634|NCT02112448|3928043|FG000|Overall Study|required heparin so could not use ketoro|1
2258635|NCT02112448|3928044|FG001|Overall Study|required heparin so could not use ketoro|0
2258636|NCT02112877|3928067|FG000|Overall Study|Withdrawal by Subject|1
2258637|NCT02112877|3928068|FG001|Overall Study|Withdrawal by Subject|7
2258638|NCT02112877|3928067|FG000|Overall Study|Visit Missed|1
2258639|NCT02112877|3928068|FG001|Overall Study|Visit Missed|6
2258640|NCT02112994|3928076|FG000|Overall Study|Progressive Disease|0
2258641|NCT02112994|3928077|FG001|Overall Study|Progressive Disease|0
2258642|NCT02112994|3928078|FG002|Overall Study|Progressive Disease|1
2258643|NCT02112994|3928076|FG000|Overall Study|Pregnancy|0
2258644|NCT02112994|3928077|FG001|Overall Study|Pregnancy|1
2258645|NCT02112994|3928078|FG002|Overall Study|Pregnancy|1
2258646|NCT02112994|3928076|FG000|Overall Study|Liver Transplant|0
2258647|NCT02112994|3928077|FG001|Overall Study|Liver Transplant|1
2258648|NCT02112994|3928078|FG002|Overall Study|Liver Transplant|0
2258649|NCT02112994|3928076|FG000|Overall Study|Withdrawal by Subject|0
2258650|NCT02112994|3928077|FG001|Overall Study|Withdrawal by Subject|0
2258651|NCT02112994|3928078|FG002|Overall Study|Withdrawal by Subject|1
2258652|NCT02113007|3928090|FG000|Overall Study|Progressive disease|2
2258653|NCT02113124|3928096|FG000|Overall Study|Unable to retrieve blood sample|1
2258654|NCT02113124|3928097|FG001|Overall Study|Unable to retrieve blood sample|1
2258655|NCT02113189|3928106|FG000|Overall Study|Lost to follow up|2
2258656|NCT02113189|3928107|FG001|Overall Study|Lost to follow up|1
2258657|NCT02113189|3928108|FG002|Overall Study|Lost to follow up|3
2258658|NCT02113436|3928141|FG000|Period 1: 8 Weeks|Adverse Event|1
2258659|NCT02113436|3928142|FG001|Period 1: 8 Weeks|Adverse Event|0
2258660|NCT02113436|3928143|FG002|Period 1: 8 Weeks|Adverse Event|0
2258661|NCT02113436|3928144|FG003|Period 1: 8 Weeks|Adverse Event|0
2258662|NCT02113436|3928141|FG000|Period 1: 8 Weeks|Protocol Violation|1
2258663|NCT02113436|3928142|FG001|Period 1: 8 Weeks|Protocol Violation|0
2258664|NCT02113436|3928143|FG002|Period 1: 8 Weeks|Protocol Violation|0
2258665|NCT02113436|3928144|FG003|Period 1: 8 Weeks|Protocol Violation|0
2258666|NCT02113436|3928141|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
2258667|NCT02113436|3928142|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
2258668|NCT02113436|3928143|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
2258669|NCT02113436|3928144|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
2258670|NCT02113436|3928141|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1
2258671|NCT02113436|3928142|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0
2258672|NCT02113436|3928143|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0
2258673|NCT02113436|3928144|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0
2258674|NCT02113436|3928141|FG000|Period 2: 16 Weeks|Adverse Event|0
2258675|NCT02113436|3928142|FG001|Period 2: 16 Weeks|Adverse Event|0
2258676|NCT02113436|3928143|FG002|Period 2: 16 Weeks|Adverse Event|4
2258677|NCT02113436|3928144|FG003|Period 2: 16 Weeks|Adverse Event|5
2258678|NCT02113436|3928141|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
2258679|NCT02113436|3928142|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
2258680|NCT02113436|3928143|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
2258681|NCT02113436|3928144|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
2258682|NCT02113436|3928141|FG000|Period 2: 16 Weeks|Physician Decision|0
2258683|NCT02113436|3928142|FG001|Period 2: 16 Weeks|Physician Decision|0
2258684|NCT02113436|3928143|FG002|Period 2: 16 Weeks|Physician Decision|2
2258685|NCT02113436|3928144|FG003|Period 2: 16 Weeks|Physician Decision|0
2258686|NCT02113436|3928141|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0
2258687|NCT02113436|3928142|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0
2258688|NCT02113436|3928143|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1
2258689|NCT02113436|3928144|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1
2258690|NCT02113449|3928153|FG000|Overall Study|Adverse Event|4
2258691|NCT02113579|3928163|FG000|Overall Study|Adverse Event|1
2344638|NCT03560739|4080134|FG001|Overall Study|Adverse Event|1
2344639|NCT03560739|4080135|FG002|Overall Study|Adverse Event|0
2344640|NCT03560739|4080136|FG003|Overall Study|Adverse Event|0
2344641|NCT03560869|4080146|FG000|Overall Study|Withdrawal by Subject|3
2344642|NCT03560869|4080147|FG001|Overall Study|Withdrawal by Subject|4
2344643|NCT03560869|4080146|FG000|Overall Study|Screening failure|4
2344644|NCT03560869|4080147|FG001|Overall Study|Screening failure|4
2344645|NCT03560869|4080146|FG000|Overall Study|Withdrawal by PI|0
2344646|NCT03560869|4080147|FG001|Overall Study|Withdrawal by PI|1
2344647|NCT03560986|4080155|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
2344648|NCT03560986|4080156|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
2344649|NCT03560986|4080155|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
2344650|NCT03560986|4080156|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
2344651|NCT03560986|4080155|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0
2344652|NCT03560986|4080156|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1
2344653|NCT03560986|4080155|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32
2344654|NCT03560986|4080156|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35
2344655|NCT03560986|4080155|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1
2344656|NCT03560986|4080156|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0
2344657|NCT03560986|4080155|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0
2344658|NCT03560986|4080156|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1
2344659|NCT03560986|4080155|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
2344660|NCT03560986|4080156|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
2344661|NCT03561090|4080170|FG000|Overall Study|Adverse Event|11
2344662|NCT03561090|4080171|FG001|Overall Study|Adverse Event|7
2344663|NCT03561090|4080170|FG000|Overall Study|Non-Compliance With Study Drug|2
2344664|NCT03561090|4080171|FG001|Overall Study|Non-Compliance With Study Drug|0
2344665|NCT03561090|4080170|FG000|Overall Study|Protocol Violation|2
2344666|NCT03561090|4080171|FG001|Overall Study|Protocol Violation|2
2344667|NCT03561090|4080170|FG000|Overall Study|Withdrawal by Subject|7
2344668|NCT03561090|4080171|FG001|Overall Study|Withdrawal by Subject|7
2344669|NCT03561090|4080170|FG000|Overall Study|Lost to Follow-up|7
2344670|NCT03561090|4080171|FG001|Overall Study|Lost to Follow-up|2
2344671|NCT03561090|4080170|FG000|Overall Study|Study Terminated by Sponsor|10
2344672|NCT03561090|4080171|FG001|Overall Study|Study Terminated by Sponsor|15
2344673|NCT03561090|4080170|FG000|Overall Study|Randomized by Mistake|1
2344674|NCT03561090|4080171|FG001|Overall Study|Randomized by Mistake|1
2344675|NCT03561090|4080170|FG000|Overall Study|Other Not Specified|0
2344676|NCT03561090|4080171|FG001|Overall Study|Other Not Specified|2
2344677|NCT03561883|4080181|FG000|Overall Study|Adverse Event|10
2344678|NCT03561883|4080182|FG001|Overall Study|Adverse Event|13
2344679|NCT03561883|4080181|FG000|Overall Study|Non-Compliance With Study Drug|1
2344680|NCT03561883|4080182|FG001|Overall Study|Non-Compliance With Study Drug|2
2344681|NCT03561883|4080181|FG000|Overall Study|Protocol Violation|2
2344682|NCT03561883|4080182|FG001|Overall Study|Protocol Violation|3
2344683|NCT03561883|4080181|FG000|Overall Study|Withdrawal by Subject|14
2344684|NCT03561883|4080182|FG001|Overall Study|Withdrawal by Subject|6
2344685|NCT03561883|4080181|FG000|Overall Study|Lost to Follow-up|2
2344686|NCT03561883|4080182|FG001|Overall Study|Lost to Follow-up|6
2344687|NCT03561883|4080181|FG000|Overall Study|Study Terminated by Sponsor|12
2344688|NCT03561883|4080182|FG001|Overall Study|Study Terminated by Sponsor|11
2344689|NCT03561883|4080181|FG000|Overall Study|Physician Decision|1
2344690|NCT03561883|4080182|FG001|Overall Study|Physician Decision|0
2344691|NCT03561883|4080181|FG000|Overall Study|Randomized by Mistake|1
2344692|NCT03561883|4080182|FG001|Overall Study|Randomized by Mistake|0
2344693|NCT03561883|4080181|FG000|Overall Study|Other, Not Specified|3
2344694|NCT03561883|4080182|FG001|Overall Study|Other, Not Specified|2
2344695|NCT03562117|4080191|FG000|Part 1, Up to 3 Days|Adverse Event|1
2344696|NCT03562117|4080192|FG001|Part 1, Up to 3 Days|Adverse Event|0
2344697|NCT03562117|4080193|FG002|Part 1, Up to 3 Days|Adverse Event|0
2344698|NCT03562481|4080212|FG000|First Intervention|Lost to Follow-up|1
2344699|NCT03562481|4080213|FG001|First Intervention|Lost to Follow-up|0
2344700|NCT03563716|4080302|FG000|Overall Study|Death|20
2344701|NCT03563716|4080303|FG001|Overall Study|Death|14
2344702|NCT03563716|4080302|FG000|Overall Study|Withdrawal by Subject|3
2344703|NCT03563716|4080303|FG001|Overall Study|Withdrawal by Subject|3
2344704|NCT03563716|4080302|FG000|Overall Study|Still on Study|45
2344705|NCT03563716|4080303|FG001|Overall Study|Still on Study|50
2344706|NCT03565068|4080336|FG000|Overall Study|Protocol Violation|0
2344707|NCT03565068|4080337|FG001|Overall Study|Protocol Violation|0
2258692|NCT02113579|3928164|FG001|Overall Study|Adverse Event|0
2258693|NCT02113579|3928163|FG000|Overall Study|Withdrawal by Subject|3
2258694|NCT02113579|3928164|FG001|Overall Study|Withdrawal by Subject|2
2258695|NCT02113579|3928163|FG000|Overall Study|Lost to Follow-up|6
2258696|NCT02113579|3928164|FG001|Overall Study|Lost to Follow-up|2
2258697|NCT02113956|3928172|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
2258698|NCT02113956|3928173|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
2258699|NCT02113956|3928172|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
2258700|NCT02113956|3928173|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
2258701|NCT02113956|3928172|FG000|3 Month Post-intervention|Lost to Follow-up|4
2258702|NCT02113956|3928173|FG001|3 Month Post-intervention|Lost to Follow-up|2
2258703|NCT02114151|3928179|FG000|Overall Study|Death|1
2258704|NCT02114151|3928179|FG000|Overall Study|Lost to Follow-up|1
2258705|NCT02114151|3928179|FG000|Overall Study|Withdrawal by Subject|5
2258706|NCT02114177|3928194|FG000|Overall Study|Lost to Follow-up|1
2258707|NCT02114177|3928195|FG001|Overall Study|Lost to Follow-up|2
2258708|NCT02114177|3928194|FG000|Overall Study|Withdrawal by Subject|6
2258709|NCT02114177|3928195|FG001|Overall Study|Withdrawal by Subject|1
2258710|NCT02114177|3928194|FG000|Overall Study|Other|2
2258711|NCT02114177|3928195|FG001|Overall Study|Other|1
2258712|NCT02114203|3928204|FG000|Overall Study|Adverse Event|0
2258713|NCT02114203|3928205|FG001|Overall Study|Adverse Event|1
2258714|NCT02114203|3928206|FG002|Overall Study|Adverse Event|0
2258715|NCT02114203|3928204|FG000|Overall Study|Withdrawal by Subject|0
2258716|NCT02114203|3928205|FG001|Overall Study|Withdrawal by Subject|1
2258717|NCT02114203|3928206|FG002|Overall Study|Withdrawal by Subject|0
2258718|NCT02114268|3928236|FG000|Overall Study|Lost to Follow-up|4
2258719|NCT02114268|3928237|FG001|Overall Study|Lost to Follow-up|1
2258720|NCT02114268|3928238|FG002|Overall Study|Lost to Follow-up|1
2258721|NCT02114268|3928239|FG003|Overall Study|Lost to Follow-up|0
2258722|NCT02114268|3928240|FG004|Overall Study|Lost to Follow-up|0
2258723|NCT02114268|3928241|FG005|Overall Study|Lost to Follow-up|2
2258724|NCT02114268|3928236|FG000|Overall Study|Withdrawal by Subject|1
2258725|NCT02114268|3928237|FG001|Overall Study|Withdrawal by Subject|0
2258726|NCT02114268|3928238|FG002|Overall Study|Withdrawal by Subject|0
2258727|NCT02114268|3928239|FG003|Overall Study|Withdrawal by Subject|0
2258728|NCT02114268|3928240|FG004|Overall Study|Withdrawal by Subject|0
2344708|NCT03565068|4080338|FG002|Overall Study|Protocol Violation|0
2344709|NCT03565068|4080339|FG003|Overall Study|Protocol Violation|0
2344710|NCT03565068|4080340|FG004|Overall Study|Protocol Violation|1
2344711|NCT03565068|4080341|FG005|Overall Study|Protocol Violation|0
2344712|NCT03565068|4080342|FG006|Overall Study|Protocol Violation|0
2344713|NCT03565068|4080343|FG007|Overall Study|Protocol Violation|1
2344714|NCT03565068|4080344|FG008|Overall Study|Protocol Violation|0
2344715|NCT03565068|4080336|FG000|Overall Study|Sponsor decision|0
2344716|NCT03565068|4080337|FG001|Overall Study|Sponsor decision|0
2344717|NCT03565068|4080338|FG002|Overall Study|Sponsor decision|0
2344718|NCT03565068|4080339|FG003|Overall Study|Sponsor decision|0
2344719|NCT03565068|4080340|FG004|Overall Study|Sponsor decision|1
2344720|NCT03565068|4080341|FG005|Overall Study|Sponsor decision|1
2344721|NCT03565068|4080342|FG006|Overall Study|Sponsor decision|0
2344722|NCT03565068|4080343|FG007|Overall Study|Sponsor decision|0
2344723|NCT03565068|4080344|FG008|Overall Study|Sponsor decision|0
2344724|NCT03565068|4080336|FG000|Overall Study|Withdrawal by Subject|0
2344725|NCT03565068|4080337|FG001|Overall Study|Withdrawal by Subject|0
2344726|NCT03565068|4080338|FG002|Overall Study|Withdrawal by Subject|1
2344727|NCT03565068|4080339|FG003|Overall Study|Withdrawal by Subject|0
2344728|NCT03565068|4080340|FG004|Overall Study|Withdrawal by Subject|2
2344729|NCT03565068|4080341|FG005|Overall Study|Withdrawal by Subject|0
2344730|NCT03565068|4080342|FG006|Overall Study|Withdrawal by Subject|1
2344731|NCT03565068|4080343|FG007|Overall Study|Withdrawal by Subject|5
2344732|NCT03565068|4080344|FG008|Overall Study|Withdrawal by Subject|1
2344733|NCT03565068|4080336|FG000|Overall Study|Physician Decision|0
2344734|NCT03565068|4080337|FG001|Overall Study|Physician Decision|0
2344735|NCT03565068|4080338|FG002|Overall Study|Physician Decision|0
2344736|NCT03565068|4080339|FG003|Overall Study|Physician Decision|0
2344737|NCT03565068|4080340|FG004|Overall Study|Physician Decision|0
2344738|NCT03565068|4080341|FG005|Overall Study|Physician Decision|0
2344739|NCT03565068|4080342|FG006|Overall Study|Physician Decision|0
2344740|NCT03565068|4080343|FG007|Overall Study|Physician Decision|1
2344741|NCT03565068|4080344|FG008|Overall Study|Physician Decision|0
2344742|NCT03565068|4080336|FG000|Overall Study|Lost to Follow-up|0
2344743|NCT03565068|4080337|FG001|Overall Study|Lost to Follow-up|0
2344744|NCT03565068|4080338|FG002|Overall Study|Lost to Follow-up|0
2344745|NCT03565068|4080339|FG003|Overall Study|Lost to Follow-up|0
2344746|NCT03565068|4080340|FG004|Overall Study|Lost to Follow-up|0
2344747|NCT03565068|4080341|FG005|Overall Study|Lost to Follow-up|0
2344748|NCT03565068|4080342|FG006|Overall Study|Lost to Follow-up|0
2344749|NCT03565068|4080343|FG007|Overall Study|Lost to Follow-up|1
2344750|NCT03565068|4080344|FG008|Overall Study|Lost to Follow-up|0
2344751|NCT03565211|4080401|FG000|Overall Study|Withdrawal by Subject|2
2344752|NCT03565211|4080401|FG000|Overall Study|Lost to Follow-up|1
2344753|NCT03565211|4080401|FG000|Overall Study|Adverse Event|44
2344754|NCT03565211|4080401|FG000|Overall Study|Personal issues|1
2258729|NCT02114268|3928241|FG005|Overall Study|Withdrawal by Subject|1
2258730|NCT02114268|3928236|FG000|Overall Study|Withdrawn by site due to noncompliance|1
2258731|NCT02114268|3928237|FG001|Overall Study|Withdrawn by site due to noncompliance|0
2258732|NCT02114268|3928238|FG002|Overall Study|Withdrawn by site due to noncompliance|0
2258733|NCT02114268|3928239|FG003|Overall Study|Withdrawn by site due to noncompliance|0
2258734|NCT02114268|3928240|FG004|Overall Study|Withdrawn by site due to noncompliance|0
2258735|NCT02114268|3928241|FG005|Overall Study|Withdrawn by site due to noncompliance|0
2258736|NCT02114385|3928273|FG000|Overall Study|Withdrawal by Subject|3
2258737|NCT02114385|3928274|FG001|Overall Study|Withdrawal by Subject|2
2258738|NCT02114385|3928273|FG000|Overall Study|Lost to Follow-up|0
2258739|NCT02114385|3928274|FG001|Overall Study|Lost to Follow-up|6
2258740|NCT02114515|3928282|FG000|Overall Study|Lost to Follow-up|52
2258741|NCT02114515|3928283|FG001|Overall Study|Lost to Follow-up|55
2258742|NCT02114515|3928282|FG000|Overall Study|Death|12
2258743|NCT02114515|3928283|FG001|Overall Study|Death|12
2258744|NCT02114515|3928282|FG000|Overall Study|Withdrawal by Subject|4
2258745|NCT02114515|3928283|FG001|Overall Study|Withdrawal by Subject|22
2258746|NCT02114515|3928282|FG000|Overall Study|Other|65
2258747|NCT02114515|3928283|FG001|Overall Study|Other|61
2258748|NCT02114606|3928289|FG000|Overall Study|Unable to swallow Cytosponge|6
2258749|NCT02114684|3928295|FG000|Overall Study|Death|6
2258750|NCT02114684|3928296|FG001|Overall Study|Death|4
2258751|NCT02114684|3928295|FG000|Overall Study|Lost to Follow-up|1
2258752|NCT02114684|3928296|FG001|Overall Study|Lost to Follow-up|2
2258753|NCT02114684|3928295|FG000|Overall Study|Withdrawal by Subject|1
2258754|NCT02114684|3928296|FG001|Overall Study|Withdrawal by Subject|2
2258755|NCT02114684|3928295|FG000|Overall Study|Relocation|3
2344755|NCT03565315|4080409|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
2344756|NCT03565315|4080410|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
2344757|NCT03565315|4080411|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
2344758|NCT03565315|4080412|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1
2344759|NCT03565887|4080461|FG000|Overall Study|Adverse Event|1
2344760|NCT03565887|4080462|FG001|Overall Study|Adverse Event|0
2344761|NCT03565887|4080461|FG000|Overall Study|Withdrawal by Subject|0
2344762|NCT03565887|4080462|FG001|Overall Study|Withdrawal by Subject|2
2344763|NCT03566238|4080471|FG000|Overall Study|Adverse Event|0
2344764|NCT03566238|4080472|FG001|Overall Study|Adverse Event|1
2344765|NCT03566238|4080473|FG002|Overall Study|Adverse Event|0
2344766|NCT03566238|4080471|FG000|Overall Study|Lack of Efficacy|4
2344767|NCT03566238|4080472|FG001|Overall Study|Lack of Efficacy|2
2258756|NCT02114684|3928296|FG001|Overall Study|Relocation|1
2258757|NCT02114684|3928295|FG000|Overall Study|Rifampicin resistant on culture|0
2258758|NCT02114684|3928296|FG001|Overall Study|Rifampicin resistant on culture|1
2258759|NCT02114684|3928295|FG000|Overall Study|Patient Incarcerated|1
2258760|NCT02114684|3928296|FG001|Overall Study|Patient Incarcerated|0
2258761|NCT02114879|3928321|FG000|Overall Study|Withdrawal by Subject|9
2258762|NCT02114879|3928322|FG001|Overall Study|Withdrawal by Subject|5
2258763|NCT02114879|3928321|FG000|Overall Study|Death|6
2258764|NCT02114879|3928322|FG001|Overall Study|Death|11
2258765|NCT02114879|3928321|FG000|Overall Study|Lost to Follow-up|4
2258766|NCT02114879|3928322|FG001|Overall Study|Lost to Follow-up|6
2258767|NCT02114879|3928321|FG000|Overall Study|Physician Decision|0
2258768|NCT02114879|3928322|FG001|Overall Study|Physician Decision|2
2258769|NCT02114892|3928330|FG000|Overall Study|Lost to Follow-up|1
2258770|NCT02114892|3928331|FG001|Overall Study|Lost to Follow-up|2
2258771|NCT02114931|3928339|FG000|Overall Study|Withdrawal by Subject|15
2258772|NCT02114931|3928340|FG001|Overall Study|Withdrawal by Subject|18
2258773|NCT02114931|3928339|FG000|Overall Study|Adverse Event|4
2258774|NCT02114931|3928340|FG001|Overall Study|Adverse Event|6
2258775|NCT02114931|3928339|FG000|Overall Study|Lost to Follow-up|3
2258776|NCT02114931|3928340|FG001|Overall Study|Lost to Follow-up|3
2258777|NCT02114931|3928339|FG000|Overall Study|Physician Decision|1
2258778|NCT02114931|3928340|FG001|Overall Study|Physician Decision|2
2258779|NCT02114931|3928339|FG000|Overall Study|Other|2
2258780|NCT02114931|3928340|FG001|Overall Study|Other|1
2258781|NCT02115113|3928355|FG000|Participants in Run-in Period|Death|0
2258782|NCT02115113|3928356|FG001|Participants in Run-in Period|Death|0
2258783|NCT02115113|3928357|FG002|Participants in Run-in Period|Death|1
2258784|NCT02115113|3928355|FG000|Participants in Run-in Period|Administrative problems|0
2258785|NCT02115113|3928356|FG001|Participants in Run-in Period|Administrative problems|0
2258786|NCT02115113|3928357|FG002|Participants in Run-in Period|Administrative problems|1
2258787|NCT02115113|3928355|FG000|Participants in Run-in Period|Lost to Follow-up|0
2258788|NCT02115113|3928356|FG001|Participants in Run-in Period|Lost to Follow-up|0
2258789|NCT02115113|3928357|FG002|Participants in Run-in Period|Lost to Follow-up|5
2258790|NCT02115113|3928355|FG000|Participants in Run-in Period|Withdrawal by Subject|0
2258791|NCT02115113|3928356|FG001|Participants in Run-in Period|Withdrawal by Subject|0
2258792|NCT02115113|3928357|FG002|Participants in Run-in Period|Withdrawal by Subject|3
2258793|NCT02115113|3928355|FG000|Participants Randomized|Lost to Follow-up|1
2258794|NCT02115113|3928356|FG001|Participants Randomized|Lost to Follow-up|0
2258795|NCT02115113|3928357|FG002|Participants Randomized|Lost to Follow-up|0
2258796|NCT02115113|3928355|FG000|Participants Randomized|Death|1
2344768|NCT03566238|4080473|FG002|Overall Study|Lack of Efficacy|5
2258797|NCT02115113|3928356|FG001|Participants Randomized|Death|0
2258798|NCT02115113|3928357|FG002|Participants Randomized|Death|0
2258799|NCT02115139|3928366|FG000|Overall Study|Protocol Violation|1
2258800|NCT02115139|3928366|FG000|Overall Study|treatment discontinuation|6
2258801|NCT02115256|3928372|FG000|Overall Study|Withdrawal by Subject|0
2258802|NCT02115256|3928373|FG001|Overall Study|Withdrawal by Subject|1
2258803|NCT02115269|3928379|FG000|Overall Study|Lost to Follow-up|43
2258804|NCT02115269|3928379|FG000|Overall Study|Did not complete patient diary|3
2258805|NCT02115269|3928379|FG000|Overall Study|Moved to another city|7
2258806|NCT02115269|3928379|FG000|Overall Study|Withdrawal by Subject|2
2258807|NCT02115269|3928379|FG000|Overall Study|Didn't take study drug|2
2258808|NCT02115282|3928396|FG000|Overall Study|Disease progression during treatment|216
2258809|NCT02115282|3928397|FG001|Overall Study|Disease progression during treatment|229
2258810|NCT02115282|3928396|FG000|Overall Study|Adverse Event|49
2258811|NCT02115282|3928397|FG001|Overall Study|Adverse Event|23
2258812|NCT02115282|3928396|FG000|Overall Study|Death|1
2258813|NCT02115282|3928397|FG001|Overall Study|Death|3
2258814|NCT02115282|3928396|FG000|Overall Study|Alternative therapy|1
2258815|NCT02115282|3928397|FG001|Overall Study|Alternative therapy|1
2258816|NCT02115282|3928396|FG000|Overall Study|Complicating disease|0
2258817|NCT02115282|3928397|FG001|Overall Study|Complicating disease|3
2258818|NCT02115282|3928396|FG000|Overall Study|Withdrawal by Subject|12
2258819|NCT02115282|3928397|FG001|Overall Study|Withdrawal by Subject|10
2258820|NCT02115282|3928396|FG000|Overall Study|Symptomatic progression/deterioration|7
2258821|NCT02115282|3928397|FG001|Overall Study|Symptomatic progression/deterioration|18
2258822|NCT02115282|3928396|FG000|Overall Study|Non-compliance|5
2258823|NCT02115282|3928397|FG001|Overall Study|Non-compliance|1
2258824|NCT02115282|3928396|FG000|Overall Study|Protocol Violation|2
2258825|NCT02115282|3928397|FG001|Overall Study|Protocol Violation|2
2258826|NCT02115282|3928396|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3
2258827|NCT02115282|3928397|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3
2258828|NCT02115282|3928396|FG000|Overall Study|Not start protocol therapy|9
2258829|NCT02115282|3928397|FG001|Overall Study|Not start protocol therapy|10
2258830|NCT02115308|3928407|FG000|Overall Study|Safety Screening|2
2258831|NCT02115308|3928408|FG001|Overall Study|Safety Screening|2
2258832|NCT02115321|3928420|FG000|Overall Study|Death|1
2258833|NCT02115321|3928421|FG001|Overall Study|Death|0
2258834|NCT02115386|3928457|FG000|Overall Study|Protocol Violation|1
2258835|NCT02115386|3928457|FG000|Overall Study|Administrative - trial was terminated|6
2258836|NCT02115607|3928474|FG000|Overall Study|Withdrawal by Subject|1
2258837|NCT02115815|3928517|FG000|Overall Study|Withdrawal by Subject|2
2258838|NCT02115815|3928518|FG001|Overall Study|Withdrawal by Subject|0
2258839|NCT02115815|3928519|FG002|Overall Study|Withdrawal by Subject|0
2258840|NCT02115815|3928520|FG003|Overall Study|Withdrawal by Subject|0
2258841|NCT02115815|3928521|FG004|Overall Study|Withdrawal by Subject|0
2258842|NCT02115815|3928522|FG005|Overall Study|Withdrawal by Subject|0
2258843|NCT02115815|3928523|FG006|Overall Study|Withdrawal by Subject|0
2258844|NCT02115815|3928517|FG000|Overall Study|Not enough drug to dose participant|0
2258845|NCT02115815|3928518|FG001|Overall Study|Not enough drug to dose participant|0
2258846|NCT02115815|3928519|FG002|Overall Study|Not enough drug to dose participant|0
2258847|NCT02115815|3928520|FG003|Overall Study|Not enough drug to dose participant|0
2258848|NCT02115815|3928521|FG004|Overall Study|Not enough drug to dose participant|0
2258849|NCT02115815|3928522|FG005|Overall Study|Not enough drug to dose participant|1
2258850|NCT02115815|3928523|FG006|Overall Study|Not enough drug to dose participant|0
2258851|NCT02115815|3928517|FG000|Overall Study|Missed appointment, randomized in error|0
2258852|NCT02115815|3928518|FG001|Overall Study|Missed appointment, randomized in error|0
2258853|NCT02115815|3928519|FG002|Overall Study|Missed appointment, randomized in error|0
2258854|NCT02115815|3928520|FG003|Overall Study|Missed appointment, randomized in error|0
2258855|NCT02115815|3928521|FG004|Overall Study|Missed appointment, randomized in error|0
2258856|NCT02115815|3928522|FG005|Overall Study|Missed appointment, randomized in error|1
2258857|NCT02115815|3928523|FG006|Overall Study|Missed appointment, randomized in error|0
2258858|NCT02116205|3928556|FG000|Overall Study|Withdrawal by Subject|2
2258859|NCT02116205|3928557|FG001|Overall Study|Withdrawal by Subject|4
2258860|NCT02116205|3928558|FG002|Overall Study|Withdrawal by Subject|1
2258861|NCT02116205|3928559|FG003|Overall Study|Withdrawal by Subject|3
2258862|NCT02116205|3928556|FG000|Overall Study|Lost to Follow-up|0
2258863|NCT02116205|3928557|FG001|Overall Study|Lost to Follow-up|2
2258864|NCT02116205|3928558|FG002|Overall Study|Lost to Follow-up|1
2258865|NCT02116205|3928559|FG003|Overall Study|Lost to Follow-up|2
2258866|NCT02116205|3928556|FG000|Overall Study|Physician Decision|0
2258867|NCT02116205|3928557|FG001|Overall Study|Physician Decision|1
2258868|NCT02116205|3928558|FG002|Overall Study|Physician Decision|1
2258869|NCT02116205|3928559|FG003|Overall Study|Physician Decision|1
2258870|NCT02116205|3928556|FG000|Overall Study|Exclusion criteria|0
2258871|NCT02116205|3928557|FG001|Overall Study|Exclusion criteria|0
2258872|NCT02116205|3928558|FG002|Overall Study|Exclusion criteria|1
2258873|NCT02116205|3928559|FG003|Overall Study|Exclusion criteria|0
2258874|NCT02116309|3928571|FG000|Overall Study|Lost to Follow-up|0
2258875|NCT02116309|3928572|FG001|Overall Study|Lost to Follow-up|1
2258876|NCT02116361|3928586|FG000|Overall Study|Pregnancy|0
2258877|NCT02116361|3928587|FG001|Overall Study|Pregnancy|0
2258878|NCT02116361|3928588|FG002|Overall Study|Pregnancy|0
2258879|NCT02116361|3928589|FG003|Overall Study|Pregnancy|1
2258880|NCT02116361|3928586|FG000|Overall Study|Protocol Violation|1
2258881|NCT02116361|3928587|FG001|Overall Study|Protocol Violation|0
2258882|NCT02116361|3928588|FG002|Overall Study|Protocol Violation|0
2258883|NCT02116361|3928589|FG003|Overall Study|Protocol Violation|2
2258884|NCT02116361|3928586|FG000|Overall Study|Physician Decision|2
2258885|NCT02116361|3928587|FG001|Overall Study|Physician Decision|3
2344769|NCT03566238|4080471|FG000|Overall Study|Other|1
2344770|NCT03566238|4080472|FG001|Overall Study|Other|0
2344771|NCT03566238|4080473|FG002|Overall Study|Other|0
2344772|NCT03566485|4080483|FG000|Overall Study|Disease progression|5
2344773|NCT03566485|4080484|FG001|Overall Study|Disease progression|4
2344774|NCT03566485|4080483|FG000|Overall Study|Clinical progression|0
2344775|NCT03566485|4080484|FG001|Overall Study|Clinical progression|1
2344776|NCT03566485|4080483|FG000|Overall Study|Toxicity|0
2344777|NCT03566485|4080484|FG001|Overall Study|Toxicity|2
2344778|NCT03566550|4080492|FG000|Overall Study|Withdrawal by Subject|0
2344779|NCT03566550|4080493|FG001|Overall Study|Withdrawal by Subject|1
2344780|NCT03566680|4080499|FG000|Overall Study|Pregnancy|1
2344781|NCT03566680|4080499|FG000|Overall Study|Lost to Follow-up|13
2344782|NCT03566680|4080499|FG000|Overall Study|Withdrawal by Subject|3
2344783|NCT03566810|4080507|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
2344784|NCT03566810|4080508|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
2344785|NCT03566810|4080509|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
2344786|NCT03566810|4080510|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
2344787|NCT03566823|4080523|FG000|Overall Study|Lack of Efficacy|0
2344788|NCT03566823|4080524|FG001|Overall Study|Lack of Efficacy|1
2344789|NCT03566823|4080525|FG002|Overall Study|Lack of Efficacy|0
2344790|NCT03566823|4080523|FG000|Overall Study|Withdrawal by Subject|1
2344791|NCT03566823|4080524|FG001|Overall Study|Withdrawal by Subject|2
2344792|NCT03566823|4080525|FG002|Overall Study|Withdrawal by Subject|0
2344793|NCT03566823|4080523|FG000|Overall Study|Adverse Event|1
2344794|NCT03566823|4080524|FG001|Overall Study|Adverse Event|0
2344795|NCT03566823|4080525|FG002|Overall Study|Adverse Event|2
2344796|NCT03566979|4080537|FG000|Overall Study|Withdrawal by Subject|2
2344797|NCT03566979|4080538|FG001|Overall Study|Withdrawal by Subject|0
2344798|NCT03566979|4080539|FG002|Overall Study|Withdrawal by Subject|1
2344799|NCT03566979|4080540|FG003|Overall Study|Withdrawal by Subject|1
2344800|NCT03566979|4080537|FG000|Overall Study|Lost to Follow-up|2
2258886|NCT02116361|3928588|FG002|Overall Study|Physician Decision|0
2258887|NCT02116361|3928589|FG003|Overall Study|Physician Decision|0
2258888|NCT02116361|3928586|FG000|Overall Study|Adverse Event|1
2258889|NCT02116361|3928587|FG001|Overall Study|Adverse Event|0
2258890|NCT02116361|3928588|FG002|Overall Study|Adverse Event|0
2258891|NCT02116361|3928589|FG003|Overall Study|Adverse Event|3
2258892|NCT02116361|3928586|FG000|Overall Study|Other Reasons|3
2258893|NCT02116361|3928587|FG001|Overall Study|Other Reasons|3
2258894|NCT02116361|3928588|FG002|Overall Study|Other Reasons|3
2258895|NCT02116361|3928589|FG003|Overall Study|Other Reasons|3
2258896|NCT02116361|3928586|FG000|Overall Study|Lack of Efficacy|5
2258897|NCT02116361|3928587|FG001|Overall Study|Lack of Efficacy|7
2258898|NCT02116361|3928588|FG002|Overall Study|Lack of Efficacy|4
2258899|NCT02116361|3928589|FG003|Overall Study|Lack of Efficacy|3
2258900|NCT02116361|3928586|FG000|Overall Study|Lost to Follow-up|4
2258901|NCT02116361|3928587|FG001|Overall Study|Lost to Follow-up|5
2258902|NCT02116361|3928588|FG002|Overall Study|Lost to Follow-up|7
2258903|NCT02116361|3928589|FG003|Overall Study|Lost to Follow-up|5
2258904|NCT02116361|3928586|FG000|Overall Study|Personal Reasons|6
2258905|NCT02116361|3928587|FG001|Overall Study|Personal Reasons|6
2258906|NCT02116361|3928588|FG002|Overall Study|Personal Reasons|4
2258907|NCT02116361|3928589|FG003|Overall Study|Personal Reasons|9
2258908|NCT02116361|3928586|FG000|Overall Study|Investigator Decision - Relapse|9
2258909|NCT02116361|3928587|FG001|Overall Study|Investigator Decision - Relapse|7
2258910|NCT02116361|3928588|FG002|Overall Study|Investigator Decision - Relapse|8
2258911|NCT02116361|3928589|FG003|Overall Study|Investigator Decision - Relapse|5
2258912|NCT02116530|3928601|FG000|Overall Study|Withdrawal by Subject|1
2258913|NCT02116530|3928602|FG001|Overall Study|Withdrawal by Subject|2
2258914|NCT02116530|3928601|FG000|Overall Study|Adverse Event|4
2258915|NCT02116530|3928602|FG001|Overall Study|Adverse Event|0
2258916|NCT02116530|3928601|FG000|Overall Study|Physician Decision|1
2258917|NCT02116530|3928602|FG001|Overall Study|Physician Decision|0
2258918|NCT02116530|3928601|FG000|Overall Study|Lost to Follow-up|1
2258919|NCT02116530|3928602|FG001|Overall Study|Lost to Follow-up|0
2258920|NCT02116530|3928601|FG000|Overall Study|Other Medical Problems|2
2258921|NCT02116530|3928602|FG001|Overall Study|Other Medical Problems|2
2258922|NCT02116582|3928608|FG000|Overall Study|Enrolled but Never Received Study Drug|1
2258923|NCT02116582|3928608|FG000|Overall Study|Adverse Event|22
2344801|NCT03566979|4080538|FG001|Overall Study|Lost to Follow-up|7
2344802|NCT03566979|4080539|FG002|Overall Study|Lost to Follow-up|9
2344803|NCT03566979|4080540|FG003|Overall Study|Lost to Follow-up|5
2344804|NCT03566979|4080537|FG000|Overall Study|Adverse Event|1
2344805|NCT03566979|4080538|FG001|Overall Study|Adverse Event|0
2344806|NCT03566979|4080539|FG002|Overall Study|Adverse Event|0
2344807|NCT03566979|4080540|FG003|Overall Study|Adverse Event|0
2258924|NCT02116582|3928608|FG000|Overall Study|Death|9
2258925|NCT02116582|3928608|FG000|Overall Study|Progressive Disease|148
2258926|NCT02116582|3928608|FG000|Overall Study|Protocol Violation|3
2258927|NCT02116582|3928608|FG000|Overall Study|Withdrawal by Subject|8
2258928|NCT02116582|3928608|FG000|Overall Study|Other: Miscellaneous|11
2258929|NCT02116582|3928608|FG000|Overall Study|Lost to Follow-up|1
2258930|NCT02116582|3928608|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12
2258931|NCT02116608|3928615|FG000|Overall Study|Lost to Follow-up|0
2258932|NCT02116608|3928616|FG001|Overall Study|Lost to Follow-up|0
2258933|NCT02116608|3928617|FG002|Overall Study|Lost to Follow-up|1
2258934|NCT02116608|3928615|FG000|Overall Study|Physician Decision|0
2258935|NCT02116608|3928616|FG001|Overall Study|Physician Decision|1
2258936|NCT02116608|3928617|FG002|Overall Study|Physician Decision|0
2258937|NCT02116608|3928615|FG000|Overall Study|Death|0
2258938|NCT02116608|3928616|FG001|Overall Study|Death|1
2258939|NCT02116608|3928617|FG002|Overall Study|Death|0
2258940|NCT02116621|3928627|FG000|Baseline|Withdrawal by Subject|0
2258941|NCT02116621|3928628|FG001|Baseline|Withdrawal by Subject|4
2258942|NCT02116621|3928627|FG000|Three Month Follow-up|Death|1
2258943|NCT02116621|3928628|FG001|Three Month Follow-up|Death|1
2258944|NCT02116621|3928627|FG000|Three Month Follow-up|Withdrawal by Subject|4
2258945|NCT02116621|3928628|FG001|Three Month Follow-up|Withdrawal by Subject|1
2258946|NCT02116621|3928627|FG000|Three Month Follow-up|Lost to Follow-up|0
2258947|NCT02116621|3928628|FG001|Three Month Follow-up|Lost to Follow-up|1
2258948|NCT02116621|3928627|FG000|Three Month Follow-up|Did not complete follow-up survey|14
2258949|NCT02116621|3928628|FG001|Three Month Follow-up|Did not complete follow-up survey|4
2258950|NCT02116621|3928627|FG000|Six Month Follow-up|Withdrawal by Subject|1
2258951|NCT02116621|3928628|FG001|Six Month Follow-up|Withdrawal by Subject|1
2258952|NCT02116621|3928627|FG000|Six Month Follow-up|Lost to Follow-up|2
2258953|NCT02116621|3928628|FG001|Six Month Follow-up|Lost to Follow-up|1
2258954|NCT02116621|3928627|FG000|Six Month Follow-up|Did not complete follow-up survey|1
2258955|NCT02116621|3928628|FG001|Six Month Follow-up|Did not complete follow-up survey|1
2258956|NCT02116621|3928627|FG000|Twelve Month Follow-up|Withdrawal by Subject|1
2258957|NCT02116621|3928628|FG001|Twelve Month Follow-up|Withdrawal by Subject|0
2258958|NCT02116621|3928627|FG000|Twelve Month Follow-up|Lost to Follow-up|0
2258959|NCT02116621|3928628|FG001|Twelve Month Follow-up|Lost to Follow-up|1
2258960|NCT02116621|3928627|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1
2258961|NCT02116621|3928628|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3
2258962|NCT02116621|3928627|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14
2258963|NCT02116621|3928628|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8
2258964|NCT02116660|3928636|FG000|Overall Study|Deteriorating renal function|0
2258965|NCT02116660|3928637|FG001|Overall Study|Deteriorating renal function|1
2258966|NCT02116660|3928636|FG000|Overall Study|Adverse Event|1
2258967|NCT02116660|3928637|FG001|Overall Study|Adverse Event|1
2258968|NCT02116660|3928636|FG000|Overall Study|Withdrawal by Subject|0
2258969|NCT02116660|3928637|FG001|Overall Study|Withdrawal by Subject|2
2258970|NCT02116660|3928636|FG000|Overall Study|Organization reason|1
2258971|NCT02116660|3928637|FG001|Overall Study|Organization reason|0
2258972|NCT02116777|3928652|FG000|Overall Study|Adverse Event|0
2258973|NCT02116777|3928653|FG001|Overall Study|Adverse Event|0
2258974|NCT02116777|3928654|FG002|Overall Study|Adverse Event|0
2258975|NCT02116777|3928655|FG003|Overall Study|Adverse Event|0
2258976|NCT02116777|3928656|FG004|Overall Study|Adverse Event|2
2258977|NCT02116777|3928657|FG005|Overall Study|Adverse Event|2
2258978|NCT02116777|3928658|FG006|Overall Study|Adverse Event|0
2344808|NCT03567291|4080566|FG000|Period I|Adverse Event|14
2344809|NCT03567291|4080567|FG001|Period I|Adverse Event|0
2344810|NCT03567291|4080568|FG002|Period I|Adverse Event|0
2344811|NCT03567291|4080569|FG003|Period I|Adverse Event|0
2344812|NCT03567291|4080566|FG000|Period I|Protocol Violation|1
2344813|NCT03567291|4080567|FG001|Period I|Protocol Violation|0
2344814|NCT03567291|4080568|FG002|Period I|Protocol Violation|0
2344815|NCT03567291|4080569|FG003|Period I|Protocol Violation|0
2344816|NCT03567291|4080566|FG000|Period I|Withdrawal by Subject|23
2344817|NCT03567291|4080567|FG001|Period I|Withdrawal by Subject|0
2344818|NCT03567291|4080568|FG002|Period I|Withdrawal by Subject|0
2344819|NCT03567291|4080569|FG003|Period I|Withdrawal by Subject|0
2344820|NCT03567291|4080566|FG000|Period I|Lost to Follow-up|2
2344821|NCT03567291|4080567|FG001|Period I|Lost to Follow-up|0
2344822|NCT03567291|4080568|FG002|Period I|Lost to Follow-up|0
2344823|NCT03567291|4080569|FG003|Period I|Lost to Follow-up|0
2344824|NCT03567291|4080566|FG000|Period I|Terminated by sponsor|44
2344825|NCT03567291|4080567|FG001|Period I|Terminated by sponsor|0
2344826|NCT03567291|4080568|FG002|Period I|Terminated by sponsor|0
2344827|NCT03567291|4080569|FG003|Period I|Terminated by sponsor|0
2344828|NCT03567291|4080566|FG000|Period I|Missing or unknown|7
2344829|NCT03567291|4080567|FG001|Period I|Missing or unknown|0
2344830|NCT03567291|4080568|FG002|Period I|Missing or unknown|0
2344831|NCT03567291|4080569|FG003|Period I|Missing or unknown|0
2344832|NCT03567291|4080566|FG000|Period II|Adverse Event|0
2344833|NCT03567291|4080567|FG001|Period II|Adverse Event|1
2344834|NCT03567291|4080568|FG002|Period II|Adverse Event|0
2344835|NCT03567291|4080569|FG003|Period II|Adverse Event|0
2344836|NCT03567291|4080566|FG000|Period II|Missing or unknown|0
2344837|NCT03567291|4080567|FG001|Period II|Missing or unknown|2
2258979|NCT02116777|3928652|FG000|Overall Study|Death|0
2258980|NCT02116777|3928653|FG001|Overall Study|Death|0
2258981|NCT02116777|3928654|FG002|Overall Study|Death|0
2258982|NCT02116777|3928655|FG003|Overall Study|Death|1
2258983|NCT02116777|3928656|FG004|Overall Study|Death|0
2258984|NCT02116777|3928657|FG005|Overall Study|Death|0
2258985|NCT02116777|3928658|FG006|Overall Study|Death|0
2258986|NCT02116777|3928652|FG000|Overall Study|Lack of Efficacy|3
2258987|NCT02116777|3928653|FG001|Overall Study|Lack of Efficacy|3
2258988|NCT02116777|3928654|FG002|Overall Study|Lack of Efficacy|3
2258989|NCT02116777|3928655|FG003|Overall Study|Lack of Efficacy|8
2258990|NCT02116777|3928656|FG004|Overall Study|Lack of Efficacy|4
2258991|NCT02116777|3928657|FG005|Overall Study|Lack of Efficacy|1
2258992|NCT02116777|3928658|FG006|Overall Study|Lack of Efficacy|9
2258993|NCT02116777|3928652|FG000|Overall Study|Physician Decision|0
2258994|NCT02116777|3928653|FG001|Overall Study|Physician Decision|0
2258995|NCT02116777|3928654|FG002|Overall Study|Physician Decision|0
2258996|NCT02116777|3928655|FG003|Overall Study|Physician Decision|2
2258997|NCT02116777|3928656|FG004|Overall Study|Physician Decision|0
2258998|NCT02116777|3928657|FG005|Overall Study|Physician Decision|0
2258999|NCT02116777|3928658|FG006|Overall Study|Physician Decision|0
2259000|NCT02116777|3928652|FG000|Overall Study|Protocol Violation|0
2259001|NCT02116777|3928653|FG001|Overall Study|Protocol Violation|0
2259002|NCT02116777|3928654|FG002|Overall Study|Protocol Violation|0
2259003|NCT02116777|3928655|FG003|Overall Study|Protocol Violation|1
2259004|NCT02116777|3928656|FG004|Overall Study|Protocol Violation|0
2259005|NCT02116777|3928657|FG005|Overall Study|Protocol Violation|0
2259006|NCT02116777|3928658|FG006|Overall Study|Protocol Violation|0
2259007|NCT02116777|3928652|FG000|Overall Study|Withdrawal by Subject|0
2259008|NCT02116777|3928653|FG001|Overall Study|Withdrawal by Subject|0
2259009|NCT02116777|3928654|FG002|Overall Study|Withdrawal by Subject|0
2259010|NCT02116777|3928655|FG003|Overall Study|Withdrawal by Subject|1
2259011|NCT02116777|3928656|FG004|Overall Study|Withdrawal by Subject|0
2259012|NCT02116777|3928657|FG005|Overall Study|Withdrawal by Subject|0
2259013|NCT02116777|3928658|FG006|Overall Study|Withdrawal by Subject|0
2259014|NCT02116803|3928679|FG000|Overall Study|Adverse Event|2
2259015|NCT02116803|3928680|FG001|Overall Study|Adverse Event|1
2259016|NCT02116803|3928679|FG000|Overall Study|Physician Decision|1
2259017|NCT02116803|3928680|FG001|Overall Study|Physician Decision|0
2259018|NCT02116803|3928679|FG000|Overall Study|Progressive disease|4
2259019|NCT02116803|3928680|FG001|Overall Study|Progressive disease|0
2259020|NCT02116803|3928679|FG000|Overall Study|Study terminated by sponsor|2
2259021|NCT02116803|3928680|FG001|Overall Study|Study terminated by sponsor|1
2259022|NCT02116803|3928679|FG000|Overall Study|Death|1
2259023|NCT02116803|3928680|FG001|Overall Study|Death|0
2259024|NCT02116972|3928689|FG000|Overall Study|Adverse Event|4
2259025|NCT02116972|3928690|FG001|Overall Study|Adverse Event|4
2259026|NCT02116972|3928691|FG002|Overall Study|Adverse Event|1
2259027|NCT02116972|3928689|FG000|Overall Study|Withdrawal by Subject|1
2259028|NCT02116972|3928690|FG001|Overall Study|Withdrawal by Subject|1
2259029|NCT02116972|3928691|FG002|Overall Study|Withdrawal by Subject|5
2259030|NCT02116972|3928689|FG000|Overall Study|Protocol Violation|1
2259031|NCT02116972|3928690|FG001|Overall Study|Protocol Violation|0
2259032|NCT02116972|3928691|FG002|Overall Study|Protocol Violation|1
2259033|NCT02116972|3928689|FG000|Overall Study|Lost to Follow-up|4
2259034|NCT02116972|3928690|FG001|Overall Study|Lost to Follow-up|3
2259035|NCT02116972|3928691|FG002|Overall Study|Lost to Follow-up|1
2259036|NCT02116972|3928689|FG000|Overall Study|Lack of Efficacy|6
2259037|NCT02116972|3928690|FG001|Overall Study|Lack of Efficacy|6
2259038|NCT02116972|3928691|FG002|Overall Study|Lack of Efficacy|5
2259039|NCT02116972|3928689|FG000|Overall Study|scheduling conflicts and relocation|3
2259040|NCT02116972|3928690|FG001|Overall Study|scheduling conflicts and relocation|3
2259041|NCT02116972|3928691|FG002|Overall Study|scheduling conflicts and relocation|6
2259042|NCT02117024|3928703|FG000|Overall Study|Progressive Disease|26
2259043|NCT02117024|3928704|FG001|Overall Study|Progressive Disease|9
2259044|NCT02117024|3928703|FG000|Overall Study|Significant Clinical Progression|7
2259045|NCT02117024|3928704|FG001|Overall Study|Significant Clinical Progression|4
2259046|NCT02117024|3928703|FG000|Overall Study|Death|5
2259047|NCT02117024|3928704|FG001|Overall Study|Death|0
2259048|NCT02117024|3928703|FG000|Overall Study|Withdrawal by Subject|3
2259049|NCT02117024|3928704|FG001|Overall Study|Withdrawal by Subject|1
2259050|NCT02117024|3928703|FG000|Overall Study|Protocol Violation|1
2259051|NCT02117024|3928704|FG001|Overall Study|Protocol Violation|0
2259052|NCT02117024|3928703|FG000|Overall Study|Adverse Event|1
2259053|NCT02117024|3928704|FG001|Overall Study|Adverse Event|2
2259054|NCT02117024|3928703|FG000|Overall Study|Randomized in Error|1
2259055|NCT02117024|3928704|FG001|Overall Study|Randomized in Error|0
2259056|NCT02117024|3928703|FG000|Overall Study|Patient returned to primary oncologist|0
2259057|NCT02117024|3928704|FG001|Overall Study|Patient returned to primary oncologist|1
2259058|NCT02117024|3928703|FG000|Overall Study|Patient took treatment break|0
2259059|NCT02117024|3928704|FG001|Overall Study|Patient took treatment break|1
2259060|NCT02117024|3928703|FG000|Overall Study|Physician Decision|0
2259061|NCT02117024|3928704|FG001|Overall Study|Physician Decision|2
2259062|NCT02117349|3928735|FG000|Overall Study|Withdrawal by Subject|1
2259063|NCT02117349|3928736|FG001|Overall Study|Withdrawal by Subject|0
2259064|NCT02117349|3928735|FG000|Overall Study|Lost to Follow-up|1
2259065|NCT02117349|3928736|FG001|Overall Study|Lost to Follow-up|1
2259066|NCT02117349|3928735|FG000|Overall Study|Death|1
2259067|NCT02117349|3928736|FG001|Overall Study|Death|0
2259068|NCT02117414|3928744|FG000|Overall Study|Death|5
2344838|NCT03567291|4080568|FG002|Period II|Missing or unknown|1
2344839|NCT03567291|4080569|FG003|Period II|Missing or unknown|0
2344840|NCT03567291|4080566|FG000|Period III|Adverse Event|0
2344841|NCT03567291|4080567|FG001|Period III|Adverse Event|0
2344842|NCT03567291|4080568|FG002|Period III|Adverse Event|0
2344843|NCT03567291|4080569|FG003|Period III|Adverse Event|4
2344844|NCT03567291|4080566|FG000|Period III|Withdrawal by Subject|0
2344845|NCT03567291|4080567|FG001|Period III|Withdrawal by Subject|0
2344846|NCT03567291|4080568|FG002|Period III|Withdrawal by Subject|0
2344847|NCT03567291|4080569|FG003|Period III|Withdrawal by Subject|4
2344848|NCT03567291|4080566|FG000|Period III|Lost to Follow-up|0
2344849|NCT03567291|4080567|FG001|Period III|Lost to Follow-up|0
2344850|NCT03567291|4080568|FG002|Period III|Lost to Follow-up|0
2344851|NCT03567291|4080569|FG003|Period III|Lost to Follow-up|1
2344852|NCT03567291|4080566|FG000|Period III|Terminated by sponsor|0
2344853|NCT03567291|4080567|FG001|Period III|Terminated by sponsor|0
2344854|NCT03567291|4080568|FG002|Period III|Terminated by sponsor|0
2344855|NCT03567291|4080569|FG003|Period III|Terminated by sponsor|68
2344856|NCT03567291|4080566|FG000|Period III|Missing or unknown|0
2344857|NCT03567291|4080567|FG001|Period III|Missing or unknown|0
2344858|NCT03567291|4080568|FG002|Period III|Missing or unknown|0
2344859|NCT03567291|4080569|FG003|Period III|Missing or unknown|8
2344860|NCT03567382|4080577|FG000|Overall Study|Lost to Follow-up|1
2344861|NCT03567382|4080578|FG001|Overall Study|Lost to Follow-up|21
2344862|NCT03567382|4080579|FG002|Overall Study|Lost to Follow-up|1
2344863|NCT03567382|4080580|FG003|Overall Study|Lost to Follow-up|21
2344864|NCT03567382|4080577|FG000|Overall Study|Withdrawal by Subject|2
2344865|NCT03567382|4080578|FG001|Overall Study|Withdrawal by Subject|14
2344866|NCT03567382|4080579|FG002|Overall Study|Withdrawal by Subject|1
2344867|NCT03567382|4080580|FG003|Overall Study|Withdrawal by Subject|12
2344868|NCT03567616|4080593|FG000|Overall Study|Disease progression|4
2344869|NCT03567616|4080593|FG000|Overall Study|Withdrawal by Subject|1
2344870|NCT03567616|4080593|FG000|Overall Study|Physician Decision|1
2344871|NCT03567616|4080593|FG000|Overall Study|Death|1
2344872|NCT03567616|4080593|FG000|Overall Study|Adverse Event|1
2344873|NCT03567980|4080600|FG000|Overall Study|Adverse Event|1
2344874|NCT03568500|4080607|FG000|Overall Study|Lost to Follow-up|1
2344875|NCT03568500|4080608|FG001|Overall Study|Lost to Follow-up|1
2344876|NCT03568500|4080609|FG002|Overall Study|Lost to Follow-up|2
2344877|NCT03568500|4080607|FG000|Overall Study|Adverse Event|1
2344878|NCT03568500|4080608|FG001|Overall Study|Adverse Event|1
2344879|NCT03568500|4080609|FG002|Overall Study|Adverse Event|2
2259069|NCT02117414|3928745|FG001|Overall Study|Death|2
2259070|NCT02117414|3928744|FG000|Overall Study|Withdrawal by Subject|10
2259071|NCT02117414|3928745|FG001|Overall Study|Withdrawal by Subject|4
2259072|NCT02117427|3928756|FG000|Overall Study|Permanent need for exogenous EPO Tx|2
2259073|NCT02117427|3928757|FG001|Overall Study|Permanent need for exogenous EPO Tx|0
2259074|NCT02117427|3928758|FG002|Overall Study|Permanent need for exogenous EPO Tx|0
2259075|NCT02117427|3928756|FG000|Overall Study|Permanent need for exogenous ESA Tx|3
2259076|NCT02117427|3928757|FG001|Overall Study|Permanent need for exogenous ESA Tx|1
2259077|NCT02117427|3928758|FG002|Overall Study|Permanent need for exogenous ESA Tx|0
2259078|NCT02117427|3928756|FG000|Overall Study|Physician Decision|0
2259079|NCT02117427|3928757|FG001|Overall Study|Physician Decision|2
2259080|NCT02117427|3928758|FG002|Overall Study|Physician Decision|0
2259081|NCT02117427|3928756|FG000|Overall Study|No longer meets inclusion criteria|0
2259082|NCT02117427|3928757|FG001|Overall Study|No longer meets inclusion criteria|1
2259083|NCT02117427|3928758|FG002|Overall Study|No longer meets inclusion criteria|0
2259084|NCT02117427|3928756|FG000|Overall Study|Death|0
2259085|NCT02117427|3928757|FG001|Overall Study|Death|1
2259086|NCT02117427|3928758|FG002|Overall Study|Death|0
2259087|NCT02117479|3928766|FG000|Overall Study|Death|13
2259088|NCT02117479|3928767|FG001|Overall Study|Death|8
2259089|NCT02117479|3928766|FG000|Overall Study|Adverse Event|8
2259090|NCT02117479|3928767|FG001|Overall Study|Adverse Event|16
2259091|NCT02117479|3928766|FG000|Overall Study|Subject decision|8
2259092|NCT02117479|3928767|FG001|Overall Study|Subject decision|9
2259093|NCT02117479|3928766|FG000|Overall Study|Disease progression|104
2259094|NCT02117479|3928767|FG001|Overall Study|Disease progression|108
2259095|NCT02117479|3928766|FG000|Overall Study|Noncompliance with study treatment|1
2259096|NCT02117479|3928767|FG001|Overall Study|Noncompliance with study treatment|0
2259097|NCT02117479|3928766|FG000|Overall Study|Study terminated by the sponsor|4
2259098|NCT02117479|3928767|FG001|Overall Study|Study terminated by the sponsor|6
2344880|NCT03568500|4080607|FG000|Overall Study|Physician Decision|1
2344881|NCT03568500|4080608|FG001|Overall Study|Physician Decision|0
2344882|NCT03568500|4080609|FG002|Overall Study|Physician Decision|0
2344883|NCT03568500|4080607|FG000|Overall Study|Withdrawal by Subject|4
2344884|NCT03568500|4080608|FG001|Overall Study|Withdrawal by Subject|2
2344885|NCT03568500|4080609|FG002|Overall Study|Withdrawal by Subject|0
2344886|NCT03568500|4080607|FG000|Overall Study|Technical Problems|2
2344887|NCT03568500|4080608|FG001|Overall Study|Technical Problems|1
2344888|NCT03568500|4080609|FG002|Overall Study|Technical Problems|0
2344889|NCT03568500|4080607|FG000|Overall Study|Participant Noncompliance|1
2259099|NCT02117479|3928766|FG000|Overall Study|Physician Decision|7
2259100|NCT02117479|3928767|FG001|Overall Study|Physician Decision|2
2259101|NCT02117479|3928766|FG000|Overall Study|Other unspecified|11
2259102|NCT02117479|3928767|FG001|Overall Study|Other unspecified|7
2259103|NCT02117544|3928773|FG000|Period 1|Lost to follow-up (prior to treatment)|2
2259104|NCT02117544|3928774|FG001|Period 1|Lost to follow-up (prior to treatment)|0
2259105|NCT02117570|3928784|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
2259106|NCT02117570|3928785|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
2259107|NCT02117570|3928786|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
2259108|NCT02117570|3928784|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
2259109|NCT02117570|3928785|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
2259110|NCT02117570|3928786|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
2259111|NCT02117570|3928784|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
2259112|NCT02117570|3928785|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
2259113|NCT02117570|3928786|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
2259114|NCT02117570|3928784|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0
2259115|NCT02117570|3928785|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0
2259116|NCT02117570|3928786|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1
2259117|NCT02117570|3928784|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
2259118|NCT02117570|3928785|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
2259119|NCT02117570|3928786|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
2259120|NCT02117570|3928784|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
2259121|NCT02117570|3928785|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
2259122|NCT02117570|3928786|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
2259123|NCT02117570|3928784|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
2259124|NCT02117570|3928785|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
2259125|NCT02117570|3928786|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
2259126|NCT02117648|3928797|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1
2259127|NCT02117648|3928797|FG000|Abemaciclib Alone Period 1|Adverse Event|1
2344890|NCT03568500|4080608|FG001|Overall Study|Participant Noncompliance|1
2344891|NCT03568500|4080609|FG002|Overall Study|Participant Noncompliance|0
2344892|NCT03568942|4080632|FG000|Overall Study|Family emergency|1
2344893|NCT03568942|4080632|FG000|Overall Study|Lost to Follow-up|1
2344894|NCT03569098|4080661|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
2344895|NCT03569098|4080662|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2
2344896|NCT03569098|4080663|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
2344897|NCT03569098|4080661|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0
2344898|NCT03569098|4080662|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6
2344899|NCT03569098|4080663|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3
2344900|NCT03569098|4080661|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
2344901|NCT03569098|4080662|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
2344902|NCT03569098|4080663|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0
2344903|NCT03569098|4080661|FG000|Double-Blind Treatment Cycle 1|Technical problems|0
2344904|NCT03569098|4080662|FG001|Double-Blind Treatment Cycle 1|Technical problems|0
2344905|NCT03569098|4080663|FG002|Double-Blind Treatment Cycle 1|Technical problems|2
2344906|NCT03569098|4080661|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1
2344907|NCT03569098|4080662|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0
2344908|NCT03569098|4080663|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0
2344909|NCT03569098|4080661|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0
2344910|NCT03569098|4080662|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1
2344911|NCT03569098|4080663|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0
2344912|NCT03569098|4080661|FG000|Double-Blind Treatment Cycle 1|Other|1
2344913|NCT03569098|4080662|FG001|Double-Blind Treatment Cycle 1|Other|0
2344914|NCT03569098|4080663|FG002|Double-Blind Treatment Cycle 1|Other|1
2344915|NCT03569098|4080661|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
2344916|NCT03569098|4080662|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21
2344917|NCT03569098|4080663|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
2344918|NCT03569098|4080661|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
2344919|NCT03569098|4080662|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11
2344920|NCT03569098|4080663|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
2344921|NCT03569098|4080661|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0
2344922|NCT03569098|4080662|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3
2344923|NCT03569098|4080663|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0
2344924|NCT03569098|4080661|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
2344925|NCT03569098|4080662|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
2344926|NCT03569098|4080663|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4
2344927|NCT03569098|4080661|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0
2344928|NCT03569098|4080662|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
2344929|NCT03569098|4080663|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
2344930|NCT03569098|4080661|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0
2344931|NCT03569098|4080662|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0
2344932|NCT03569098|4080663|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1
2259128|NCT02117648|3928797|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
2259129|NCT02117648|3928797|FG000|Abemaciclib + Clarithromycin Period 2|Death|1
2259130|NCT02117648|3928797|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
2259131|NCT02117648|3928797|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
2259132|NCT02117648|3928797|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12
2259133|NCT02117648|3928797|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1
2259134|NCT02117648|3928797|FG000|Abemaciclib Safety-Extension Phase|Death|3
2259135|NCT02117648|3928797|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
2259136|NCT02117648|3928797|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2
2259137|NCT02117687|3928807|FG000|Overall Study|Lost to Follow-up|0
2259138|NCT02117687|3928808|FG001|Overall Study|Lost to Follow-up|1
2259139|NCT02117687|3928807|FG000|Overall Study|Adverse Event|0
2259140|NCT02117687|3928808|FG001|Overall Study|Adverse Event|2
2259141|NCT02117687|3928807|FG000|Overall Study|Other Reasons|1
2259142|NCT02117687|3928808|FG001|Overall Study|Other Reasons|1
2259143|NCT02117713|3928814|FG000|Week 48|Adverse Event|4
2259144|NCT02117713|3928814|FG000|Week 48|Withdrawal by caregiver|2
2259145|NCT02117713|3928814|FG000|Week 48|Did not consent to Protocol Amendment 4|2
2259146|NCT02117713|3928814|FG000|Long Term Follow-up Treatment|Adverse Event|3
2259147|NCT02117713|3928814|FG000|Long Term Follow-up Treatment|Progressive Disease|2
2259148|NCT02117713|3928814|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1
2259149|NCT02118012|3928848|FG000|Overall Study|Adverse Event|0
2259150|NCT02118012|3928849|FG001|Overall Study|Adverse Event|1
2259151|NCT02118012|3928848|FG000|Overall Study|Physician Decision|0
2259152|NCT02118012|3928849|FG001|Overall Study|Physician Decision|1
2259153|NCT02118337|3928864|FG000|Overall Study|Other|1
2259154|NCT02118337|3928865|FG001|Overall Study|Other|0
2259155|NCT02118337|3928866|FG002|Overall Study|Other|0
2259156|NCT02118337|3928867|FG003|Overall Study|Other|0
2259157|NCT02118337|3928868|FG004|Overall Study|Other|2
2259158|NCT02118337|3928869|FG005|Overall Study|Other|3
2259159|NCT02118337|3928870|FG006|Overall Study|Other|1
2259160|NCT02118337|3928871|FG007|Overall Study|Other|28
2259161|NCT02118337|3928872|FG008|Overall Study|Other|15
2259162|NCT02118337|3928864|FG000|Overall Study|Lost to Follow-up|0
2259163|NCT02118337|3928865|FG001|Overall Study|Lost to Follow-up|0
2259164|NCT02118337|3928866|FG002|Overall Study|Lost to Follow-up|0
2259165|NCT02118337|3928867|FG003|Overall Study|Lost to Follow-up|0
2259166|NCT02118337|3928868|FG004|Overall Study|Lost to Follow-up|0
2259167|NCT02118337|3928869|FG005|Overall Study|Lost to Follow-up|0
2259168|NCT02118337|3928870|FG006|Overall Study|Lost to Follow-up|0
2259169|NCT02118337|3928871|FG007|Overall Study|Lost to Follow-up|1
2259170|NCT02118337|3928872|FG008|Overall Study|Lost to Follow-up|0
2259171|NCT02118337|3928864|FG000|Overall Study|Withdrawal by Subject|1
2259172|NCT02118337|3928865|FG001|Overall Study|Withdrawal by Subject|3
2259173|NCT02118337|3928866|FG002|Overall Study|Withdrawal by Subject|2
2259174|NCT02118337|3928867|FG003|Overall Study|Withdrawal by Subject|1
2259175|NCT02118337|3928868|FG004|Overall Study|Withdrawal by Subject|2
2259176|NCT02118337|3928869|FG005|Overall Study|Withdrawal by Subject|2
2259177|NCT02118337|3928870|FG006|Overall Study|Withdrawal by Subject|1
2259178|NCT02118337|3928871|FG007|Overall Study|Withdrawal by Subject|4
2259179|NCT02118337|3928872|FG008|Overall Study|Withdrawal by Subject|2
2259180|NCT02118337|3928864|FG000|Overall Study|Death|2
2259181|NCT02118337|3928865|FG001|Overall Study|Death|2
2259182|NCT02118337|3928866|FG002|Overall Study|Death|1
2259183|NCT02118337|3928867|FG003|Overall Study|Death|2
2259184|NCT02118337|3928868|FG004|Overall Study|Death|5
2259185|NCT02118337|3928869|FG005|Overall Study|Death|1
2259186|NCT02118337|3928870|FG006|Overall Study|Death|2
2259187|NCT02118337|3928871|FG007|Overall Study|Death|9
2259188|NCT02118337|3928872|FG008|Overall Study|Death|4
2259189|NCT02118428|3928898|FG000|Overall Study|Physician Decision|0
2259190|NCT02118428|3928899|FG001|Overall Study|Physician Decision|1
2259191|NCT02118428|3928900|FG002|Overall Study|Physician Decision|0
2259192|NCT02118428|3928898|FG000|Overall Study|Withdrawal by Subject|2
2259193|NCT02118428|3928899|FG001|Overall Study|Withdrawal by Subject|2
2344933|NCT03569202|4080676|FG000|Part 3|Physician Decision|1
2344934|NCT03569202|4080677|FG001|Part 3|Physician Decision|0
2344935|NCT03569202|4080676|FG000|Part 3|Other|1
2344936|NCT03569202|4080677|FG001|Part 3|Other|1
2344937|NCT03569371|4080683|FG000|Overall Study|Lack of Efficacy|1
2344938|NCT03569371|4080683|FG000|Overall Study|Lost to Follow-up|1
2344939|NCT03569371|4080683|FG000|Overall Study|Adverse Event|1
2344940|NCT03570554|4080754|FG000|Overall Study|Non-compliance with study drug|0
2344941|NCT03570554|4080755|FG001|Overall Study|Non-compliance with study drug|0
2344942|NCT03570554|4080756|FG002|Overall Study|Non-compliance with study drug|1
2344943|NCT03570554|4080757|FG003|Overall Study|Non-compliance with study drug|0
2344944|NCT03570554|4080754|FG000|Overall Study|Adverse Event|0
2344945|NCT03570554|4080755|FG001|Overall Study|Adverse Event|0
2259194|NCT02118428|3928900|FG002|Overall Study|Withdrawal by Subject|0
2259195|NCT02118428|3928898|FG000|Overall Study|Death|7
2259196|NCT02118428|3928899|FG001|Overall Study|Death|5
2259197|NCT02118428|3928900|FG002|Overall Study|Death|0
2259198|NCT02118428|3928898|FG000|Overall Study|Lost to Follow-up|3
2344946|NCT03570554|4080756|FG002|Overall Study|Adverse Event|0
2344947|NCT03570554|4080757|FG003|Overall Study|Adverse Event|1
2259199|NCT02118428|3928899|FG001|Overall Study|Lost to Follow-up|1
2259200|NCT02118428|3928900|FG002|Overall Study|Lost to Follow-up|0
2259201|NCT02118428|3928898|FG000|Overall Study|Screen Failure or Became Inelegible|1
2259202|NCT02118428|3928899|FG001|Overall Study|Screen Failure or Became Inelegible|0
2259203|NCT02118428|3928900|FG002|Overall Study|Screen Failure or Became Inelegible|1
2259204|NCT02118597|3928916|FG000|Overall Study|Sponsor terminated the study|14
2259205|NCT02118597|3928916|FG000|Overall Study|Serious Adverse Event|1
2259206|NCT02118597|3928916|FG000|Overall Study|Investigator's decision|1
2259207|NCT02118714|3928920|FG000|Overall Study|Lost to Follow-up|2
2259208|NCT02118714|3928920|FG000|Overall Study|Protocol Violation|1
2259209|NCT02118766|3928926|FG000|Overall Study|Adverse Event|7
2259210|NCT02118766|3928927|FG001|Overall Study|Adverse Event|2
2259211|NCT02118766|3928926|FG000|Overall Study|Withdrawal by Subject|3
2259212|NCT02118766|3928927|FG001|Overall Study|Withdrawal by Subject|6
2259213|NCT02118766|3928926|FG000|Overall Study|Lost to Follow-up|5
2259214|NCT02118766|3928927|FG001|Overall Study|Lost to Follow-up|4
2259215|NCT02118766|3928926|FG000|Overall Study|Withdrawal by parent/guardian|12
2259216|NCT02118766|3928927|FG001|Overall Study|Withdrawal by parent/guardian|18
2259217|NCT02118766|3928926|FG000|Overall Study|Other|3
2259218|NCT02118766|3928927|FG001|Overall Study|Other|1
2259219|NCT02118792|3928935|FG000|Overall Study|Withdrawal by Subject|6
2259220|NCT02118792|3928936|FG001|Overall Study|Withdrawal by Subject|3
2259221|NCT02118792|3928935|FG000|Overall Study|Lost to Follow-up|4
2259222|NCT02118792|3928936|FG001|Overall Study|Lost to Follow-up|4
2259223|NCT02118792|3928935|FG000|Overall Study|Adverse Event|5
2259224|NCT02118792|3928936|FG001|Overall Study|Adverse Event|4
2259225|NCT02118792|3928935|FG000|Overall Study|Withdrawal by parent/guardian|14
2259226|NCT02118792|3928936|FG001|Overall Study|Withdrawal by parent/guardian|20
2259227|NCT02118792|3928935|FG000|Overall Study|Other|1
2259228|NCT02118792|3928936|FG001|Overall Study|Other|6
2259229|NCT02118792|3928935|FG000|Overall Study|Randomised but not treated|1
2259230|NCT02118792|3928936|FG001|Overall Study|Randomised but not treated|0
2259231|NCT02118896|3928967|FG000|Overall Study|Death|4
2259232|NCT02118896|3928968|FG001|Overall Study|Death|0
2259233|NCT02118896|3928969|FG002|Overall Study|Death|4
2259234|NCT02118896|3928970|FG003|Overall Study|Death|6
2259235|NCT02118896|3928971|FG004|Overall Study|Death|3
2259236|NCT02118896|3928972|FG005|Overall Study|Death|1
2259237|NCT02118896|3928973|FG006|Overall Study|Death|0
2259238|NCT02118896|3928974|FG007|Overall Study|Death|0
2259239|NCT02118896|3928975|FG008|Overall Study|Death|0
2259240|NCT02118896|3928976|FG009|Overall Study|Death|0
2259241|NCT02118896|3928967|FG000|Overall Study|Adverse Event|5
2259242|NCT02118896|3928968|FG001|Overall Study|Adverse Event|4
2259243|NCT02118896|3928969|FG002|Overall Study|Adverse Event|4
2259244|NCT02118896|3928970|FG003|Overall Study|Adverse Event|5
2259245|NCT02118896|3928971|FG004|Overall Study|Adverse Event|5
2259246|NCT02118896|3928972|FG005|Overall Study|Adverse Event|9
2259247|NCT02118896|3928973|FG006|Overall Study|Adverse Event|1
2259248|NCT02118896|3928974|FG007|Overall Study|Adverse Event|1
2259249|NCT02118896|3928975|FG008|Overall Study|Adverse Event|4
2259250|NCT02118896|3928976|FG009|Overall Study|Adverse Event|0
2259251|NCT02118896|3928967|FG000|Overall Study|Consent withdrawn|2
2259252|NCT02118896|3928968|FG001|Overall Study|Consent withdrawn|0
2259253|NCT02118896|3928969|FG002|Overall Study|Consent withdrawn|3
2259254|NCT02118896|3928970|FG003|Overall Study|Consent withdrawn|4
2259255|NCT02118896|3928971|FG004|Overall Study|Consent withdrawn|1
2259256|NCT02118896|3928972|FG005|Overall Study|Consent withdrawn|4
2259257|NCT02118896|3928973|FG006|Overall Study|Consent withdrawn|0
2259258|NCT02118896|3928974|FG007|Overall Study|Consent withdrawn|0
2259259|NCT02118896|3928975|FG008|Overall Study|Consent withdrawn|0
2259260|NCT02118896|3928976|FG009|Overall Study|Consent withdrawn|0
2259261|NCT02118896|3928967|FG000|Overall Study|Non-compliance|2
2259262|NCT02118896|3928968|FG001|Overall Study|Non-compliance|1
2259263|NCT02118896|3928969|FG002|Overall Study|Non-compliance|1
2259264|NCT02118896|3928970|FG003|Overall Study|Non-compliance|5
2259265|NCT02118896|3928971|FG004|Overall Study|Non-compliance|0
2259266|NCT02118896|3928972|FG005|Overall Study|Non-compliance|1
2259267|NCT02118896|3928973|FG006|Overall Study|Non-compliance|0
2259268|NCT02118896|3928974|FG007|Overall Study|Non-compliance|1
2259269|NCT02118896|3928975|FG008|Overall Study|Non-compliance|0
2259270|NCT02118896|3928976|FG009|Overall Study|Non-compliance|0
2259271|NCT02118896|3928967|FG000|Overall Study|Pregnancy|1
2259272|NCT02118896|3928968|FG001|Overall Study|Pregnancy|1
2259273|NCT02118896|3928969|FG002|Overall Study|Pregnancy|0
2259274|NCT02118896|3928970|FG003|Overall Study|Pregnancy|0
2259275|NCT02118896|3928971|FG004|Overall Study|Pregnancy|1
2259276|NCT02118896|3928972|FG005|Overall Study|Pregnancy|3
2259277|NCT02118896|3928973|FG006|Overall Study|Pregnancy|1
2259278|NCT02118896|3928974|FG007|Overall Study|Pregnancy|0
2259279|NCT02118896|3928975|FG008|Overall Study|Pregnancy|0
2259280|NCT02118896|3928976|FG009|Overall Study|Pregnancy|0
2259281|NCT02118896|3928967|FG000|Overall Study|Lost to Follow-up|1
2259282|NCT02118896|3928968|FG001|Overall Study|Lost to Follow-up|2
2259283|NCT02118896|3928969|FG002|Overall Study|Lost to Follow-up|1
2259284|NCT02118896|3928970|FG003|Overall Study|Lost to Follow-up|0
2259285|NCT02118896|3928971|FG004|Overall Study|Lost to Follow-up|2
2259286|NCT02118896|3928972|FG005|Overall Study|Lost to Follow-up|1
2259287|NCT02118896|3928973|FG006|Overall Study|Lost to Follow-up|0
2259288|NCT02118896|3928974|FG007|Overall Study|Lost to Follow-up|0
2259289|NCT02118896|3928975|FG008|Overall Study|Lost to Follow-up|0
2259290|NCT02118896|3928976|FG009|Overall Study|Lost to Follow-up|0
2259291|NCT02118896|3928967|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1
2259292|NCT02118896|3928968|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5
2259293|NCT02118896|3928969|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1
2259294|NCT02118896|3928970|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2
2259295|NCT02118896|3928971|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4
2259296|NCT02118896|3928972|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2
2259297|NCT02118896|3928973|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0
2259298|NCT02118896|3928974|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0
2259299|NCT02118896|3928975|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0
2344948|NCT03570697|4080800|FG000|Overall Study|Lost to Follow-up|0
2344949|NCT03570697|4080801|FG001|Overall Study|Lost to Follow-up|1
2344950|NCT03570697|4080800|FG000|Overall Study|Death|2
2344951|NCT03570697|4080801|FG001|Overall Study|Death|0
2344952|NCT03570697|4080800|FG000|Overall Study|Withdrawal by Subject|4
2344953|NCT03570697|4080801|FG001|Overall Study|Withdrawal by Subject|2
2344954|NCT03571256|4080810|FG000|Overall Study|Adverse Event|3
2344955|NCT03571256|4080811|FG001|Overall Study|Adverse Event|0
2344956|NCT03571256|4080812|FG002|Overall Study|Adverse Event|1
2344957|NCT03571256|4080810|FG000|Overall Study|Withdrawal by Subject|3
2344958|NCT03571256|4080811|FG001|Overall Study|Withdrawal by Subject|1
2344959|NCT03571256|4080812|FG002|Overall Study|Withdrawal by Subject|1
2344960|NCT03571256|4080810|FG000|Overall Study|Other than specified|0
2344961|NCT03571256|4080811|FG001|Overall Study|Other than specified|1
2344962|NCT03571256|4080812|FG002|Overall Study|Other than specified|1
2344963|NCT03571256|4080810|FG000|Overall Study|Protocol Violation|0
2344964|NCT03571256|4080811|FG001|Overall Study|Protocol Violation|1
2344965|NCT03571256|4080812|FG002|Overall Study|Protocol Violation|1
2344966|NCT03571516|4080824|FG000|Overall Study|Severe diarrhea|1
2344967|NCT03571516|4080825|FG001|Overall Study|Severe diarrhea|0
2344968|NCT03571516|4080824|FG000|Overall Study|Withdrawal by Subject|0
2344969|NCT03571516|4080825|FG001|Overall Study|Withdrawal by Subject|1
2344970|NCT03572062|4080895|FG000|Overall Study|Adverse Event|0
2344971|NCT03572062|4080896|FG001|Overall Study|Adverse Event|0
2344972|NCT03572062|4080897|FG002|Overall Study|Adverse Event|0
2344973|NCT03572062|4080898|FG003|Overall Study|Adverse Event|0
2344974|NCT03572062|4080899|FG004|Overall Study|Adverse Event|0
2344975|NCT03572062|4080900|FG005|Overall Study|Adverse Event|0
2344976|NCT03572062|4080901|FG006|Overall Study|Adverse Event|0
2344977|NCT03572062|4080902|FG007|Overall Study|Adverse Event|0
2344978|NCT03572062|4080903|FG008|Overall Study|Adverse Event|1
2344979|NCT03572062|4080904|FG009|Overall Study|Adverse Event|3
2344980|NCT03572062|4080895|FG000|Overall Study|Death|0
2344981|NCT03572062|4080896|FG001|Overall Study|Death|0
2344982|NCT03572062|4080897|FG002|Overall Study|Death|0
2344983|NCT03572062|4080898|FG003|Overall Study|Death|0
2344984|NCT03572062|4080899|FG004|Overall Study|Death|0
2344985|NCT03572062|4080900|FG005|Overall Study|Death|1
2344986|NCT03572062|4080901|FG006|Overall Study|Death|0
2344987|NCT03572062|4080902|FG007|Overall Study|Death|0
2344988|NCT03572062|4080903|FG008|Overall Study|Death|0
2344989|NCT03572062|4080904|FG009|Overall Study|Death|0
2344990|NCT03572062|4080895|FG000|Overall Study|Lost to Follow-up|0
2344991|NCT03572062|4080896|FG001|Overall Study|Lost to Follow-up|0
2344992|NCT03572062|4080897|FG002|Overall Study|Lost to Follow-up|0
2344993|NCT03572062|4080898|FG003|Overall Study|Lost to Follow-up|0
2344994|NCT03572062|4080899|FG004|Overall Study|Lost to Follow-up|0
2344995|NCT03572062|4080900|FG005|Overall Study|Lost to Follow-up|1
2344996|NCT03572062|4080901|FG006|Overall Study|Lost to Follow-up|1
2344997|NCT03572062|4080902|FG007|Overall Study|Lost to Follow-up|0
2344998|NCT03572062|4080903|FG008|Overall Study|Lost to Follow-up|0
2344999|NCT03572062|4080904|FG009|Overall Study|Lost to Follow-up|0
2345000|NCT03572062|4080895|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
2345001|NCT03572062|4080896|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
2345002|NCT03572062|4080897|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
2345003|NCT03572062|4080898|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
2345004|NCT03572062|4080899|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
2345005|NCT03572062|4080900|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
2345006|NCT03572062|4080901|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
2345007|NCT03572062|4080902|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
2345008|NCT03572062|4080903|FG008|Overall Study|No Longer Meets Eligibility Criteria|1
2345009|NCT03572062|4080904|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
2345010|NCT03572062|4080895|FG000|Overall Study|Study Terminated By Sponsor|0
2345011|NCT03572062|4080896|FG001|Overall Study|Study Terminated By Sponsor|0
2345012|NCT03572062|4080897|FG002|Overall Study|Study Terminated By Sponsor|0
2345013|NCT03572062|4080898|FG003|Overall Study|Study Terminated By Sponsor|0
2345014|NCT03572062|4080899|FG004|Overall Study|Study Terminated By Sponsor|0
2345015|NCT03572062|4080900|FG005|Overall Study|Study Terminated By Sponsor|0
2345016|NCT03572062|4080901|FG006|Overall Study|Study Terminated By Sponsor|0
2345017|NCT03572062|4080902|FG007|Overall Study|Study Terminated By Sponsor|0
2345018|NCT03572062|4080903|FG008|Overall Study|Study Terminated By Sponsor|29
2259300|NCT02118896|3928976|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2
2259301|NCT02118896|3928967|FG000|Overall Study|Prohibited medication|0
2259302|NCT02118896|3928968|FG001|Overall Study|Prohibited medication|0
2259303|NCT02118896|3928969|FG002|Overall Study|Prohibited medication|0
2259304|NCT02118896|3928970|FG003|Overall Study|Prohibited medication|0
2259305|NCT02118896|3928971|FG004|Overall Study|Prohibited medication|1
2259306|NCT02118896|3928972|FG005|Overall Study|Prohibited medication|3
2259307|NCT02118896|3928973|FG006|Overall Study|Prohibited medication|0
2259308|NCT02118896|3928974|FG007|Overall Study|Prohibited medication|0
2259309|NCT02118896|3928975|FG008|Overall Study|Prohibited medication|0
2259310|NCT02118896|3928976|FG009|Overall Study|Prohibited medication|0
2259311|NCT02118896|3928967|FG000|Overall Study|Miscellaneous|1
2259312|NCT02118896|3928968|FG001|Overall Study|Miscellaneous|2
2259313|NCT02118896|3928969|FG002|Overall Study|Miscellaneous|0
2259314|NCT02118896|3928970|FG003|Overall Study|Miscellaneous|2
2259315|NCT02118896|3928971|FG004|Overall Study|Miscellaneous|0
2259316|NCT02118896|3928972|FG005|Overall Study|Miscellaneous|4
2259317|NCT02118896|3928973|FG006|Overall Study|Miscellaneous|0
2259318|NCT02118896|3928974|FG007|Overall Study|Miscellaneous|0
2259319|NCT02118896|3928975|FG008|Overall Study|Miscellaneous|0
2259320|NCT02118896|3928976|FG009|Overall Study|Miscellaneous|0
2259321|NCT02118961|3929001|FG000|Overall Study|Withdrawal by Subject|1
2259322|NCT02118961|3929002|FG001|Overall Study|Withdrawal by Subject|0
2259323|NCT02119026|3929010|FG000|1st-line Treatment|Adverse Event|9
2259324|NCT02119026|3929011|FG001|1st-line Treatment|Adverse Event|14
2259325|NCT02119026|3929010|FG000|1st-line Treatment|Physician Decision|3
2259326|NCT02119026|3929011|FG001|1st-line Treatment|Physician Decision|8
2259327|NCT02119026|3929010|FG000|1st-line Treatment|Withdrawal by Subject|4
2259328|NCT02119026|3929011|FG001|1st-line Treatment|Withdrawal by Subject|10
2259329|NCT02119026|3929010|FG000|1st-line Treatment|Patient condition or compliance|6
2259330|NCT02119026|3929011|FG001|1st-line Treatment|Patient condition or compliance|4
2259331|NCT02119026|3929010|FG000|1st-line Treatment|Surgery of metastases|2
2259332|NCT02119026|3929011|FG001|1st-line Treatment|Surgery of metastases|1
2259333|NCT02119026|3929010|FG000|1st-line Treatment|Death|2
2259334|NCT02119026|3929011|FG001|1st-line Treatment|Death|1
2259335|NCT02119026|3929010|FG000|2nd-line Treatment|Lost to Follow-up|2
2259336|NCT02119026|3929011|FG001|2nd-line Treatment|Lost to Follow-up|0
2259337|NCT02119026|3929010|FG000|2nd-line Treatment|Withdrawal by Subject|3
2259338|NCT02119026|3929011|FG001|2nd-line Treatment|Withdrawal by Subject|1
2259339|NCT02119026|3929010|FG000|2nd-line Treatment|Adverse Event|4
2259340|NCT02119026|3929011|FG001|2nd-line Treatment|Adverse Event|1
2259341|NCT02119104|3929017|FG000|Overall Study|Protocol Violation|16
2259342|NCT02119156|3929024|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
2259343|NCT02119156|3929025|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
2259344|NCT02119156|3929026|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
2259345|NCT02119156|3929024|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
2259346|NCT02119156|3929025|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
2259347|NCT02119156|3929026|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
2259348|NCT02119156|3929024|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
2259349|NCT02119156|3929025|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
2259350|NCT02119156|3929026|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
2259351|NCT02119156|3929024|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
2259352|NCT02119156|3929025|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
2259353|NCT02119156|3929026|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
2259354|NCT02119156|3929024|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
2259355|NCT02119156|3929025|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
2259356|NCT02119156|3929026|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
2259357|NCT02119260|3929048|FG000|Overall Study|Adverse Event|1
2259358|NCT02119260|3929049|FG001|Overall Study|Adverse Event|0
2259359|NCT02119260|3929050|FG002|Overall Study|Adverse Event|0
2259360|NCT02119260|3929051|FG003|Overall Study|Adverse Event|0
2259361|NCT02119260|3929052|FG004|Overall Study|Adverse Event|0
2259362|NCT02119260|3929053|FG005|Overall Study|Adverse Event|0
2259363|NCT02119260|3929054|FG006|Overall Study|Adverse Event|0
2259364|NCT02119260|3929048|FG000|Overall Study|Withdrew consent|0
2259365|NCT02119260|3929049|FG001|Overall Study|Withdrew consent|1
2259366|NCT02119260|3929050|FG002|Overall Study|Withdrew consent|1
2259367|NCT02119260|3929051|FG003|Overall Study|Withdrew consent|0
2259368|NCT02119260|3929052|FG004|Overall Study|Withdrew consent|0
2259369|NCT02119260|3929053|FG005|Overall Study|Withdrew consent|0
2259370|NCT02119260|3929054|FG006|Overall Study|Withdrew consent|0
2259371|NCT02119286|3929082|FG000|Overall Study|Adverse Event|9
2259372|NCT02119286|3929083|FG001|Overall Study|Adverse Event|7
2259373|NCT02119286|3929084|FG002|Overall Study|Adverse Event|2
2259374|NCT02119286|3929082|FG000|Overall Study|Lack of Efficacy|11
2259375|NCT02119286|3929083|FG001|Overall Study|Lack of Efficacy|3
2259376|NCT02119286|3929084|FG002|Overall Study|Lack of Efficacy|4
2259377|NCT02119286|3929082|FG000|Overall Study|Lost to Follow-up|2
2259378|NCT02119286|3929083|FG001|Overall Study|Lost to Follow-up|0
2259379|NCT02119286|3929084|FG002|Overall Study|Lost to Follow-up|1
2259380|NCT02119286|3929082|FG000|Overall Study|Withdrawal by Subject|4
2259381|NCT02119286|3929083|FG001|Overall Study|Withdrawal by Subject|1
2259382|NCT02119286|3929084|FG002|Overall Study|Withdrawal by Subject|0
2259383|NCT02119299|3929092|FG000|Overall Study|Withdrawal by Subject|7
2259384|NCT02119299|3929092|FG000|Overall Study|Lack of Efficacy|1
2345019|NCT03572062|4080904|FG009|Overall Study|Study Terminated By Sponsor|27
2345020|NCT03572062|4080895|FG000|Overall Study|Physician Decision|0
2345021|NCT03572062|4080896|FG001|Overall Study|Physician Decision|0
2345022|NCT03572062|4080897|FG002|Overall Study|Physician Decision|0
2345023|NCT03572062|4080898|FG003|Overall Study|Physician Decision|0
2345024|NCT03572062|4080899|FG004|Overall Study|Physician Decision|0
2345025|NCT03572062|4080900|FG005|Overall Study|Physician Decision|0
2345026|NCT03572062|4080901|FG006|Overall Study|Physician Decision|0
2345027|NCT03572062|4080902|FG007|Overall Study|Physician Decision|0
2345028|NCT03572062|4080903|FG008|Overall Study|Physician Decision|1
2345029|NCT03572062|4080904|FG009|Overall Study|Physician Decision|0
2345030|NCT03572062|4080895|FG000|Overall Study|Withdrawal by Subject|0
2345031|NCT03572062|4080896|FG001|Overall Study|Withdrawal by Subject|0
2345032|NCT03572062|4080897|FG002|Overall Study|Withdrawal by Subject|0
2345033|NCT03572062|4080898|FG003|Overall Study|Withdrawal by Subject|0
2345034|NCT03572062|4080899|FG004|Overall Study|Withdrawal by Subject|0
2345035|NCT03572062|4080900|FG005|Overall Study|Withdrawal by Subject|0
2345036|NCT03572062|4080901|FG006|Overall Study|Withdrawal by Subject|0
2345037|NCT03572062|4080902|FG007|Overall Study|Withdrawal by Subject|0
2345038|NCT03572062|4080903|FG008|Overall Study|Withdrawal by Subject|0
2345039|NCT03572062|4080904|FG009|Overall Study|Withdrawal by Subject|1
2345040|NCT03572062|4080895|FG000|Overall Study|Randomized But Not Treated|0
2345041|NCT03572062|4080896|FG001|Overall Study|Randomized But Not Treated|0
2345042|NCT03572062|4080897|FG002|Overall Study|Randomized But Not Treated|0
2345043|NCT03572062|4080898|FG003|Overall Study|Randomized But Not Treated|0
2345044|NCT03572062|4080899|FG004|Overall Study|Randomized But Not Treated|1
2345045|NCT03572062|4080900|FG005|Overall Study|Randomized But Not Treated|2
2345046|NCT03572062|4080901|FG006|Overall Study|Randomized But Not Treated|0
2345047|NCT03572062|4080902|FG007|Overall Study|Randomized But Not Treated|1
2345048|NCT03572062|4080903|FG008|Overall Study|Randomized But Not Treated|0
2345049|NCT03572062|4080904|FG009|Overall Study|Randomized But Not Treated|0
2345050|NCT03572218|4080926|FG000|Overall Study|Lost to Follow-up|3
2345051|NCT03572218|4080927|FG001|Overall Study|Lost to Follow-up|2
2345052|NCT03572218|4080926|FG000|Overall Study|No longer available for study visits|2
2345053|NCT03572218|4080927|FG001|Overall Study|No longer available for study visits|1
2345054|NCT03572218|4080926|FG000|Overall Study|No longer interested|1
2345055|NCT03572218|4080927|FG001|Overall Study|No longer interested|2
2345056|NCT03573323|4080972|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
2345057|NCT03573323|4080973|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
2345058|NCT03573323|4080972|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15
2345059|NCT03573323|4080973|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8
2345060|NCT03573323|4080972|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3
2345061|NCT03573323|4080973|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8
2345062|NCT03573323|4080972|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17
2345063|NCT03573323|4080973|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9
2345064|NCT03573323|4080972|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2
2345065|NCT03573323|4080973|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3
2345066|NCT03573323|4080972|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1
2345067|NCT03573323|4080973|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2
2345068|NCT03573323|4080972|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1
2345069|NCT03573323|4080973|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0
2345070|NCT03573323|4080972|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14
2345071|NCT03573323|4080973|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13
2345072|NCT03573323|4080972|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0
2345073|NCT03573323|4080973|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1
2345074|NCT03573323|4080972|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0
2345075|NCT03573323|4080973|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1
2345076|NCT03573323|4080972|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1
2345077|NCT03573323|4080973|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2
2345078|NCT03573323|4080972|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22
2259385|NCT02119299|3929092|FG000|Overall Study|Pregnancy|1
2345079|NCT03573323|4080973|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12
2345080|NCT03573323|4080972|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8
2345081|NCT03573323|4080973|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19
2345082|NCT03573323|4080972|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4
2345083|NCT03573323|4080973|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3
2345084|NCT03573323|4080972|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3
2345085|NCT03573323|4080973|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2
2345086|NCT03573323|4080972|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14
2345087|NCT03573323|4080973|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8
2259386|NCT02119325|3929096|FG000|Washout Period 1|Adverse Event|0
2259387|NCT02119325|3929097|FG001|Washout Period 1|Adverse Event|1
2259388|NCT02119650|3929130|FG000|Overall Study|Adverse Event|3
2259389|NCT02119650|3929131|FG001|Overall Study|Adverse Event|4
2259390|NCT02119650|3929130|FG000|Overall Study|Subject decision|2
2259391|NCT02119650|3929131|FG001|Overall Study|Subject decision|3
2259392|NCT02119650|3929130|FG000|Overall Study|Disease progression|11
2259393|NCT02119650|3929131|FG001|Overall Study|Disease progression|14
2259394|NCT02119650|3929130|FG000|Overall Study|Death|5
2259395|NCT02119650|3929131|FG001|Overall Study|Death|1
2259396|NCT02119650|3929130|FG000|Overall Study|Noncompliance with study treatment|1
2259397|NCT02119650|3929131|FG001|Overall Study|Noncompliance with study treatment|1
2259398|NCT02119650|3929130|FG000|Overall Study|Study terminated by the sponsor|1
2259399|NCT02119650|3929131|FG001|Overall Study|Study terminated by the sponsor|0
2259400|NCT02119650|3929130|FG000|Overall Study|Physician Decision|0
2259401|NCT02119650|3929131|FG001|Overall Study|Physician Decision|2
2259402|NCT02119650|3929130|FG000|Overall Study|Multiple reasons for termination|2
2259403|NCT02119650|3929131|FG001|Overall Study|Multiple reasons for termination|1
2259404|NCT02119663|3929139|FG000|Overall Study|Disease progression|26
2259405|NCT02119663|3929140|FG001|Overall Study|Disease progression|27
2259406|NCT02119663|3929139|FG000|Overall Study|Adverse Event|5
2259407|NCT02119663|3929140|FG001|Overall Study|Adverse Event|5
2259408|NCT02119663|3929139|FG000|Overall Study|Death|3
2259409|NCT02119663|3929140|FG001|Overall Study|Death|2
2259410|NCT02119663|3929139|FG000|Overall Study|Physician Decision|1
2259411|NCT02119663|3929140|FG001|Overall Study|Physician Decision|2
2259412|NCT02119663|3929139|FG000|Overall Study|Other unspecified|2
2259413|NCT02119663|3929140|FG001|Overall Study|Other unspecified|0
2259414|NCT02119663|3929139|FG000|Overall Study|Subject decision|0
2259415|NCT02119663|3929140|FG001|Overall Study|Subject decision|1
2259416|NCT02119663|3929139|FG000|Overall Study|Study Terminated by the Sponsor|3
2259417|NCT02119663|3929140|FG001|Overall Study|Study Terminated by the Sponsor|4
2259418|NCT02119676|3929150|FG000|Overall Study|Adverse Event|9
2259419|NCT02119676|3929151|FG001|Overall Study|Adverse Event|17
2259420|NCT02119676|3929152|FG002|Overall Study|Adverse Event|10
2259421|NCT02119676|3929153|FG003|Overall Study|Adverse Event|10
2259422|NCT02119676|3929150|FG000|Overall Study|Disease progression|53
2259423|NCT02119676|3929151|FG001|Overall Study|Disease progression|55
2259424|NCT02119676|3929152|FG002|Overall Study|Disease progression|68
2259425|NCT02119676|3929153|FG003|Overall Study|Disease progression|73
2259426|NCT02119676|3929150|FG000|Overall Study|Patient decision, inc. consent withdrawn|4
2259427|NCT02119676|3929151|FG001|Overall Study|Patient decision, inc. consent withdrawn|5
2259428|NCT02119676|3929152|FG002|Overall Study|Patient decision, inc. consent withdrawn|5
2259429|NCT02119676|3929153|FG003|Overall Study|Patient decision, inc. consent withdrawn|6
2259430|NCT02119676|3929150|FG000|Overall Study|Physician Decision|4
2259431|NCT02119676|3929151|FG001|Overall Study|Physician Decision|2
2259432|NCT02119676|3929152|FG002|Overall Study|Physician Decision|3
2259433|NCT02119676|3929153|FG003|Overall Study|Physician Decision|2
2259434|NCT02119676|3929150|FG000|Overall Study|Death|9
2259435|NCT02119676|3929151|FG001|Overall Study|Death|3
2259436|NCT02119676|3929152|FG002|Overall Study|Death|2
2259437|NCT02119676|3929153|FG003|Overall Study|Death|1
2259438|NCT02119676|3929150|FG000|Overall Study|Noncompliance|0
2259439|NCT02119676|3929151|FG001|Overall Study|Noncompliance|1
2259440|NCT02119676|3929152|FG002|Overall Study|Noncompliance|0
2259441|NCT02119676|3929153|FG003|Overall Study|Noncompliance|0
2259442|NCT02119676|3929150|FG000|Overall Study|Lost to Follow-up|0
2259443|NCT02119676|3929151|FG001|Overall Study|Lost to Follow-up|0
2259444|NCT02119676|3929152|FG002|Overall Study|Lost to Follow-up|1
2259445|NCT02119676|3929153|FG003|Overall Study|Lost to Follow-up|0
2259446|NCT02119676|3929150|FG000|Overall Study|Protocol deviation|0
2259447|NCT02119676|3929151|FG001|Overall Study|Protocol deviation|0
2259448|NCT02119676|3929152|FG002|Overall Study|Protocol deviation|1
2259449|NCT02119676|3929153|FG003|Overall Study|Protocol deviation|0
2259450|NCT02119676|3929150|FG000|Overall Study|Other, unspecified|2
2259451|NCT02119676|3929151|FG001|Overall Study|Other, unspecified|1
2259452|NCT02119676|3929152|FG002|Overall Study|Other, unspecified|3
2259453|NCT02119676|3929153|FG003|Overall Study|Other, unspecified|4
2259454|NCT02119676|3929150|FG000|Overall Study|Did not receive study med|2
2259455|NCT02119676|3929151|FG001|Overall Study|Did not receive study med|2
2259456|NCT02119676|3929152|FG002|Overall Study|Did not receive study med|4
2345088|NCT03573323|4080972|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8
2345089|NCT03573323|4080973|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11
2345090|NCT03573323|4080972|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0
2345091|NCT03573323|4080973|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1
2345092|NCT03573323|4080972|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0
2345093|NCT03573323|4080973|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1
2259457|NCT02119676|3929153|FG003|Overall Study|Did not receive study med|5
2259458|NCT02119819|3929169|FG000|Overall Study|Adverse Event|3
2259459|NCT02119819|3929170|FG001|Overall Study|Adverse Event|1
2259460|NCT02119819|3929171|FG002|Overall Study|Adverse Event|2
2259461|NCT02119819|3929172|FG003|Overall Study|Adverse Event|3
2259462|NCT02119819|3929173|FG004|Overall Study|Adverse Event|0
2259463|NCT02119819|3929174|FG005|Overall Study|Adverse Event|1
2259464|NCT02119819|3929169|FG000|Overall Study|Lack of Efficacy|0
2259465|NCT02119819|3929170|FG001|Overall Study|Lack of Efficacy|0
2259466|NCT02119819|3929171|FG002|Overall Study|Lack of Efficacy|0
2259467|NCT02119819|3929172|FG003|Overall Study|Lack of Efficacy|0
2259468|NCT02119819|3929173|FG004|Overall Study|Lack of Efficacy|0
2259469|NCT02119819|3929174|FG005|Overall Study|Lack of Efficacy|1
2259470|NCT02119819|3929169|FG000|Overall Study|Lost to Follow-up|0
2259471|NCT02119819|3929170|FG001|Overall Study|Lost to Follow-up|0
2259472|NCT02119819|3929171|FG002|Overall Study|Lost to Follow-up|1
2259473|NCT02119819|3929172|FG003|Overall Study|Lost to Follow-up|2
2259474|NCT02119819|3929173|FG004|Overall Study|Lost to Follow-up|1
2259475|NCT02119819|3929174|FG005|Overall Study|Lost to Follow-up|2
2259476|NCT02119819|3929169|FG000|Overall Study|Physician Decision|1
2259477|NCT02119819|3929170|FG001|Overall Study|Physician Decision|1
2259478|NCT02119819|3929171|FG002|Overall Study|Physician Decision|0
2259479|NCT02119819|3929172|FG003|Overall Study|Physician Decision|0
2259480|NCT02119819|3929173|FG004|Overall Study|Physician Decision|0
2259481|NCT02119819|3929174|FG005|Overall Study|Physician Decision|1
2259482|NCT02119819|3929169|FG000|Overall Study|Withdrawal by Subject|5
2259483|NCT02119819|3929170|FG001|Overall Study|Withdrawal by Subject|3
2259484|NCT02119819|3929171|FG002|Overall Study|Withdrawal by Subject|0
2259485|NCT02119819|3929172|FG003|Overall Study|Withdrawal by Subject|0
2259486|NCT02119819|3929173|FG004|Overall Study|Withdrawal by Subject|6
2259487|NCT02119819|3929174|FG005|Overall Study|Withdrawal by Subject|10
2259488|NCT02119819|3929169|FG000|Overall Study|Jury Duty|0
2259489|NCT02119819|3929170|FG001|Overall Study|Jury Duty|0
2259490|NCT02119819|3929171|FG002|Overall Study|Jury Duty|1
2259491|NCT02119819|3929172|FG003|Overall Study|Jury Duty|0
2259492|NCT02119819|3929173|FG004|Overall Study|Jury Duty|0
2259493|NCT02119819|3929174|FG005|Overall Study|Jury Duty|0
2259494|NCT02119819|3929169|FG000|Overall Study|Protocol Violation|0
2259495|NCT02119819|3929170|FG001|Overall Study|Protocol Violation|0
2259496|NCT02119819|3929171|FG002|Overall Study|Protocol Violation|0
2259497|NCT02119819|3929172|FG003|Overall Study|Protocol Violation|1
2259498|NCT02119819|3929173|FG004|Overall Study|Protocol Violation|0
2259499|NCT02119819|3929174|FG005|Overall Study|Protocol Violation|0
2259500|NCT02119819|3929169|FG000|Overall Study|Left the city to get a job|0
2259501|NCT02119819|3929170|FG001|Overall Study|Left the city to get a job|0
2259502|NCT02119819|3929171|FG002|Overall Study|Left the city to get a job|0
2259503|NCT02119819|3929172|FG003|Overall Study|Left the city to get a job|1
2259504|NCT02119819|3929173|FG004|Overall Study|Left the city to get a job|0
2259505|NCT02119819|3929174|FG005|Overall Study|Left the city to get a job|0
2259506|NCT02119936|3929197|FG000|Overall Study|Lost to Follow-up|10
2259507|NCT02120027|3929212|FG000|Overall Study|Adverse Event|4
2259508|NCT02120027|3929213|FG001|Overall Study|Adverse Event|5
2259509|NCT02120027|3929212|FG000|Overall Study|Lack of Efficacy|3
2259510|NCT02120027|3929213|FG001|Overall Study|Lack of Efficacy|5
2259511|NCT02120027|3929212|FG000|Overall Study|Lost to Follow-up|5
2259512|NCT02120027|3929213|FG001|Overall Study|Lost to Follow-up|13
2259513|NCT02120027|3929212|FG000|Overall Study|Other|4
2259514|NCT02120027|3929213|FG001|Overall Study|Other|0
2259515|NCT02120027|3929212|FG000|Overall Study|Physician Decision|4
2259516|NCT02120027|3929213|FG001|Overall Study|Physician Decision|3
2259517|NCT02120027|3929212|FG000|Overall Study|Protocol Violation|18
2259518|NCT02120027|3929213|FG001|Overall Study|Protocol Violation|21
2259519|NCT02120027|3929212|FG000|Overall Study|Study terminated by Sponsor|45
2259520|NCT02120027|3929213|FG001|Overall Study|Study terminated by Sponsor|47
2259521|NCT02120027|3929212|FG000|Overall Study|Withdrawal by Subject|33
2259522|NCT02120027|3929213|FG001|Overall Study|Withdrawal by Subject|25
2259523|NCT02120157|3929219|FG000|Overall Study|Death|8
2259524|NCT02120300|3929242|FG000|Overall Study|Enrolled but Never Treated|2
2259525|NCT02120300|3929243|FG001|Overall Study|Enrolled but Never Treated|0
2259526|NCT02120300|3929244|FG002|Overall Study|Enrolled but Never Treated|0
2259527|NCT02120300|3929245|FG003|Overall Study|Enrolled but Never Treated|0
2259528|NCT02120300|3929242|FG000|Overall Study|Lack of Efficacy|0
2259529|NCT02120300|3929243|FG001|Overall Study|Lack of Efficacy|0
2259530|NCT02120300|3929244|FG002|Overall Study|Lack of Efficacy|0
2259531|NCT02120300|3929245|FG003|Overall Study|Lack of Efficacy|1
2259532|NCT02120300|3929242|FG000|Overall Study|Lost to Follow-up|1
2259533|NCT02120300|3929243|FG001|Overall Study|Lost to Follow-up|0
2259534|NCT02120300|3929244|FG002|Overall Study|Lost to Follow-up|0
2259535|NCT02120300|3929245|FG003|Overall Study|Lost to Follow-up|0
2259536|NCT02120352|3929257|FG000|Induction Period (20 Weeks)|Adverse Event|3
2259537|NCT02120352|3929258|FG001|Induction Period (20 Weeks)|Adverse Event|0
2259538|NCT02120352|3929259|FG002|Induction Period (20 Weeks)|Adverse Event|0
2259539|NCT02120352|3929260|FG003|Induction Period (20 Weeks)|Adverse Event|0
2259540|NCT02120352|3929257|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5
2259541|NCT02120352|3929258|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0
2259542|NCT02120352|3929259|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0
2259543|NCT02120352|3929260|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0
2259544|NCT02120352|3929257|FG000|Induction Period (20 Weeks)|Protocol Violation|2
2259545|NCT02120352|3929258|FG001|Induction Period (20 Weeks)|Protocol Violation|0
2259546|NCT02120352|3929259|FG002|Induction Period (20 Weeks)|Protocol Violation|0
2259547|NCT02120352|3929260|FG003|Induction Period (20 Weeks)|Protocol Violation|0
2259548|NCT02120352|3929257|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3
2259549|NCT02120352|3929258|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
2259550|NCT02120352|3929259|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
2259551|NCT02120352|3929260|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
2259552|NCT02120352|3929257|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2
2259553|NCT02120352|3929258|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0
2259554|NCT02120352|3929259|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0
2259555|NCT02120352|3929260|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0
2259556|NCT02120352|3929257|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5
2259557|NCT02120352|3929258|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0
2259558|NCT02120352|3929259|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0
2259559|NCT02120352|3929260|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0
2259560|NCT02120352|3929257|FG000|Induction Period (20 Weeks)|Physician Decision|1
2259561|NCT02120352|3929258|FG001|Induction Period (20 Weeks)|Physician Decision|0
2259562|NCT02120352|3929259|FG002|Induction Period (20 Weeks)|Physician Decision|0
2259563|NCT02120352|3929260|FG003|Induction Period (20 Weeks)|Physician Decision|0
2259564|NCT02120352|3929257|FG000|Maintenance Period (32 Weeks)|Adverse Event|0
2259565|NCT02120352|3929258|FG001|Maintenance Period (32 Weeks)|Adverse Event|0
2259566|NCT02120352|3929259|FG002|Maintenance Period (32 Weeks)|Adverse Event|6
2259567|NCT02120352|3929260|FG003|Maintenance Period (32 Weeks)|Adverse Event|1
2259568|NCT02120352|3929257|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0
2259569|NCT02120352|3929258|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1
2259570|NCT02120352|3929259|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0
2259571|NCT02120352|3929260|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1
2259572|NCT02120352|3929257|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0
2259573|NCT02120352|3929258|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0
2259574|NCT02120352|3929259|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2
2259575|NCT02120352|3929260|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0
2259576|NCT02120352|3929257|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
2259577|NCT02120352|3929258|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
2259578|NCT02120352|3929259|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
2259579|NCT02120352|3929260|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
2259580|NCT02120352|3929257|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0
2259581|NCT02120352|3929258|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0
2259582|NCT02120352|3929259|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0
2259583|NCT02120352|3929260|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1
2259584|NCT02120352|3929257|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0
2259585|NCT02120352|3929258|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
2259586|NCT02120352|3929259|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1
2259587|NCT02120352|3929260|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
2259588|NCT02120352|3929257|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0
2259589|NCT02120352|3929258|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112
2259590|NCT02120352|3929259|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105
2259591|NCT02120352|3929260|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50
2259592|NCT02120417|3929276|FG000|Overall Study|Death|5
2259593|NCT02120417|3929277|FG001|Overall Study|Death|1
2259594|NCT02120417|3929276|FG000|Overall Study|Adverse Event|3
2259595|NCT02120417|3929277|FG001|Overall Study|Adverse Event|9
2259596|NCT02120417|3929276|FG000|Overall Study|Participant decision|4
2259597|NCT02120417|3929277|FG001|Overall Study|Participant decision|4
2259598|NCT02120417|3929276|FG000|Overall Study|Disease progression|41
2259599|NCT02120417|3929277|FG001|Overall Study|Disease progression|45
2259600|NCT02120417|3929276|FG000|Overall Study|Noncompliance with study treatment|0
2259601|NCT02120417|3929277|FG001|Overall Study|Noncompliance with study treatment|2
2259602|NCT02120417|3929276|FG000|Overall Study|Physician Decision|2
2259603|NCT02120417|3929277|FG001|Overall Study|Physician Decision|3
2345094|NCT03573505|4080985|FG000|Overall Study|Adverse Event|1
2345095|NCT03573505|4080986|FG001|Overall Study|Adverse Event|1
2345096|NCT03573505|4080985|FG000|Overall Study|Consent withdrawn|0
2345097|NCT03573505|4080986|FG001|Overall Study|Consent withdrawn|1
2345098|NCT03573505|4080985|FG000|Overall Study|Disease progression|0
2345099|NCT03573505|4080986|FG001|Overall Study|Disease progression|1
2345100|NCT03573505|4080985|FG000|Overall Study|Site Terminated by Sponsor|1
2345101|NCT03573505|4080986|FG001|Overall Study|Site Terminated by Sponsor|1
2345102|NCT03573505|4080985|FG000|Overall Study|Study terminated by sponsor|50
2345103|NCT03573505|4080986|FG001|Overall Study|Study terminated by sponsor|45
2345104|NCT03573505|4080985|FG000|Overall Study|Reason not specified|0
2345105|NCT03573505|4080986|FG001|Overall Study|Reason not specified|1
2345106|NCT03573505|4080985|FG000|Overall Study|Death|0
2345107|NCT03573505|4080986|FG001|Overall Study|Death|4
2345108|NCT03573804|4080993|FG000|Overall Study|claustrophobia or MRI table problems|10
2345109|NCT03573830|4081005|FG000|Overall Study|Dropped without completing treatment|0
2345110|NCT03573830|4081006|FG001|Overall Study|Dropped without completing treatment|7
2345111|NCT03573830|4081005|FG000|Overall Study|Lost to Follow-up|4
2345112|NCT03573830|4081006|FG001|Overall Study|Lost to Follow-up|0
2345113|NCT03573908|4081013|FG000|Treatment Period|Adverse Event|4
2345114|NCT03573908|4081014|FG001|Treatment Period|Adverse Event|9
2259604|NCT02120417|3929276|FG000|Overall Study|Other unspecified|5
2259605|NCT02120417|3929277|FG001|Overall Study|Other unspecified|4
2259606|NCT02120456|3929296|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0
2259607|NCT02120456|3929297|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0
2259608|NCT02120456|3929298|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0
2259609|NCT02120456|3929299|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0
2259610|NCT02120456|3929300|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0
2259611|NCT02120456|3929301|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0
2259612|NCT02120456|3929302|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1
2259613|NCT02120456|3929303|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0
2259614|NCT02120456|3929304|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0
2259615|NCT02120456|3929296|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0
2259616|NCT02120456|3929297|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0
2259617|NCT02120456|3929298|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0
2259618|NCT02120456|3929299|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0
2259619|NCT02120456|3929300|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0
2259620|NCT02120456|3929301|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0
2259621|NCT02120456|3929302|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1
2259622|NCT02120456|3929303|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0
2259623|NCT02120456|3929304|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0
2259624|NCT02120456|3929296|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2259625|NCT02120456|3929297|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2259626|NCT02120456|3929298|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2259627|NCT02120456|3929299|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2259628|NCT02120456|3929300|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2259629|NCT02120456|3929301|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2259630|NCT02120456|3929302|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2259631|NCT02120456|3929303|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2259632|NCT02120456|3929304|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1
2259633|NCT02120625|3929324|FG000|Overall Study|Physician Decision|2
2259634|NCT02120664|3929333|FG000|Overall Study|Withdrawal by Subject|0
2259635|NCT02120664|3929334|FG001|Overall Study|Withdrawal by Subject|0
2259636|NCT02120664|3929335|FG002|Overall Study|Withdrawal by Subject|0
2259637|NCT02120664|3929336|FG003|Overall Study|Withdrawal by Subject|1
2259638|NCT02120664|3929337|FG004|Overall Study|Withdrawal by Subject|0
2259639|NCT02120781|3929361|FG000|Overall Study|Physician Decision|2
2259640|NCT02120781|3929362|FG001|Overall Study|Physician Decision|0
2259641|NCT02120781|3929361|FG000|Overall Study|Completion not documented|2
2259642|NCT02120781|3929362|FG001|Overall Study|Completion not documented|1
2259643|NCT02120794|3929368|FG000|Overall Study|Withdrawal by Subject|43
2259644|NCT02120794|3929368|FG000|Overall Study|Adverse Event|10
2259645|NCT02120794|3929368|FG000|Overall Study|Physician Decision|4
2259646|NCT02120794|3929368|FG000|Overall Study|Due to insurance coverage|1
2259647|NCT02120833|3929374|FG000|Overall Study|Adverse Event|1
2259648|NCT02120833|3929375|FG001|Overall Study|Adverse Event|0
2259649|NCT02120833|3929374|FG000|Overall Study|Withdrawal by Subject|2
2259650|NCT02120833|3929375|FG001|Overall Study|Withdrawal by Subject|0
2259651|NCT02120833|3929374|FG000|Overall Study|Lost to Follow-up|1
2259652|NCT02120833|3929375|FG001|Overall Study|Lost to Follow-up|1
2259653|NCT02120898|3929384|FG000|Overall Study|Withdrawal by Subject|4
2259654|NCT02120898|3929385|FG001|Overall Study|Withdrawal by Subject|2
2259655|NCT02120898|3929386|FG002|Overall Study|Withdrawal by Subject|2
2259656|NCT02120898|3929384|FG000|Overall Study|Non-compliance with study drug|3
2259657|NCT02120898|3929385|FG001|Overall Study|Non-compliance with study drug|0
2259658|NCT02120898|3929386|FG002|Overall Study|Non-compliance with study drug|0
2259659|NCT02120898|3929384|FG000|Overall Study|Adverse Event|1
2259660|NCT02120898|3929385|FG001|Overall Study|Adverse Event|2
2259661|NCT02120898|3929386|FG002|Overall Study|Adverse Event|1
2259662|NCT02120898|3929384|FG000|Overall Study|Protocol Violation|1
2259663|NCT02120898|3929385|FG001|Overall Study|Protocol Violation|2
2259664|NCT02120898|3929386|FG002|Overall Study|Protocol Violation|0
2259665|NCT02120898|3929384|FG000|Overall Study|Lost to Follow-up|0
2259666|NCT02120898|3929385|FG001|Overall Study|Lost to Follow-up|0
2259667|NCT02120898|3929386|FG002|Overall Study|Lost to Follow-up|1
2259668|NCT02120924|3929397|FG000|Overall Study|Lack of Efficacy|1
2259669|NCT02120924|3929398|FG001|Overall Study|Lack of Efficacy|2
2259670|NCT02120924|3929399|FG002|Overall Study|Lack of Efficacy|3
2259671|NCT02120924|3929397|FG000|Overall Study|Adverse Event|0
2259672|NCT02120924|3929398|FG001|Overall Study|Adverse Event|1
2259673|NCT02120924|3929399|FG002|Overall Study|Adverse Event|3
2259674|NCT02120924|3929397|FG000|Overall Study|Withdrawal by Subject|16
2259675|NCT02120924|3929398|FG001|Overall Study|Withdrawal by Subject|20
2259676|NCT02120924|3929399|FG002|Overall Study|Withdrawal by Subject|8
2259677|NCT02120924|3929397|FG000|Overall Study|Lost to Follow-up|14
2259678|NCT02120924|3929398|FG001|Overall Study|Lost to Follow-up|14
2259679|NCT02120924|3929399|FG002|Overall Study|Lost to Follow-up|11
2259680|NCT02120924|3929397|FG000|Overall Study|Pregnancy|2
2259681|NCT02120924|3929398|FG001|Overall Study|Pregnancy|0
2259682|NCT02120924|3929399|FG002|Overall Study|Pregnancy|0
2259683|NCT02120924|3929397|FG000|Overall Study|Protocol Violation|3
2259684|NCT02120924|3929398|FG001|Overall Study|Protocol Violation|7
2259685|NCT02120924|3929399|FG002|Overall Study|Protocol Violation|2
2259686|NCT02120924|3929397|FG000|Overall Study|Physician Decision|0
2259687|NCT02120924|3929398|FG001|Overall Study|Physician Decision|1
2259688|NCT02120924|3929399|FG002|Overall Study|Physician Decision|1
2259689|NCT02120924|3929397|FG000|Overall Study|Death|1
2259690|NCT02120924|3929398|FG001|Overall Study|Death|0
2259691|NCT02120924|3929399|FG002|Overall Study|Death|0
2259692|NCT02120924|3929397|FG000|Overall Study|Compliance with IP|5
2259693|NCT02120924|3929398|FG001|Overall Study|Compliance with IP|1
2259694|NCT02120924|3929399|FG002|Overall Study|Compliance with IP|1
2345115|NCT03573908|4081015|FG002|Treatment Period|Adverse Event|0
2345116|NCT03573908|4081016|FG003|Treatment Period|Adverse Event|0
2345117|NCT03573908|4081017|FG004|Treatment Period|Adverse Event|0
2345118|NCT03573908|4081013|FG000|Treatment Period|Protocol Violation|1
2345119|NCT03573908|4081014|FG001|Treatment Period|Protocol Violation|0
2345120|NCT03573908|4081015|FG002|Treatment Period|Protocol Violation|0
2345121|NCT03573908|4081016|FG003|Treatment Period|Protocol Violation|0
2345122|NCT03573908|4081017|FG004|Treatment Period|Protocol Violation|0
2345123|NCT03573908|4081013|FG000|Treatment Period|Withdrawal by Subject|7
2345124|NCT03573908|4081014|FG001|Treatment Period|Withdrawal by Subject|5
2345125|NCT03573908|4081015|FG002|Treatment Period|Withdrawal by Subject|0
2345126|NCT03573908|4081016|FG003|Treatment Period|Withdrawal by Subject|0
2345127|NCT03573908|4081017|FG004|Treatment Period|Withdrawal by Subject|0
2345128|NCT03573908|4081013|FG000|Treatment Period|Lost to Follow-up|7
2345129|NCT03573908|4081014|FG001|Treatment Period|Lost to Follow-up|6
2345130|NCT03573908|4081015|FG002|Treatment Period|Lost to Follow-up|0
2345131|NCT03573908|4081016|FG003|Treatment Period|Lost to Follow-up|0
2345132|NCT03573908|4081017|FG004|Treatment Period|Lost to Follow-up|0
2345133|NCT03573908|4081013|FG000|Treatment Period|Pregnancy|1
2345134|NCT03573908|4081014|FG001|Treatment Period|Pregnancy|0
2345135|NCT03573908|4081015|FG002|Treatment Period|Pregnancy|0
2345136|NCT03573908|4081016|FG003|Treatment Period|Pregnancy|0
2345137|NCT03573908|4081017|FG004|Treatment Period|Pregnancy|0
2345138|NCT03573908|4081013|FG000|Treatment Period|Other, Not Specified|4
2345139|NCT03573908|4081014|FG001|Treatment Period|Other, Not Specified|6
2345140|NCT03573908|4081015|FG002|Treatment Period|Other, Not Specified|0
2345141|NCT03573908|4081016|FG003|Treatment Period|Other, Not Specified|0
2345142|NCT03573908|4081017|FG004|Treatment Period|Other, Not Specified|0
2345143|NCT03573908|4081013|FG000|Randomized Withdrawal Period|Adverse Event|0
2345144|NCT03573908|4081014|FG001|Randomized Withdrawal Period|Adverse Event|0
2345145|NCT03573908|4081015|FG002|Randomized Withdrawal Period|Adverse Event|3
2345146|NCT03573908|4081016|FG003|Randomized Withdrawal Period|Adverse Event|0
2345147|NCT03573908|4081017|FG004|Randomized Withdrawal Period|Adverse Event|0
2345148|NCT03573908|4081013|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
2345149|NCT03573908|4081014|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
2345150|NCT03573908|4081015|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
2345151|NCT03573908|4081016|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
2345152|NCT03573908|4081017|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2
2345153|NCT03573908|4081013|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
2345154|NCT03573908|4081014|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
2345155|NCT03573908|4081015|FG002|Randomized Withdrawal Period|Lost to Follow-up|1
2345156|NCT03573908|4081016|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
2345157|NCT03573908|4081017|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
2345158|NCT03573908|4081013|FG000|Randomized Withdrawal Period|Other, Not Specified|0
2345159|NCT03573908|4081014|FG001|Randomized Withdrawal Period|Other, Not Specified|0
2345160|NCT03573908|4081015|FG002|Randomized Withdrawal Period|Other, Not Specified|4
2345161|NCT03573908|4081016|FG003|Randomized Withdrawal Period|Other, Not Specified|2
2345162|NCT03573908|4081017|FG004|Randomized Withdrawal Period|Other, Not Specified|0
2345163|NCT03574753|4081043|FG000|Overall Study|Adverse Event|3
2345164|NCT03574753|4081043|FG000|Overall Study|Progression/relapse|19
2345165|NCT03574753|4081043|FG000|Overall Study|Death|1
2345166|NCT03575702|4081054|FG000|Overall Study|Withdrawal by Subject|1
2345167|NCT03575702|4081055|FG001|Overall Study|Withdrawal by Subject|1
2345168|NCT03575702|4081054|FG000|Overall Study|Lost to Follow-up|1
2345169|NCT03575702|4081055|FG001|Overall Study|Lost to Follow-up|2
2345170|NCT03575702|4081054|FG000|Overall Study|Protocol Violation|0
2345171|NCT03575702|4081055|FG001|Overall Study|Protocol Violation|1
2259695|NCT02120950|3929410|FG000|Overall Study|Adverse Event|5
2259696|NCT02120950|3929411|FG001|Overall Study|Adverse Event|4
2345172|NCT03575702|4081054|FG000|Overall Study|Patient non compliance|4
2345173|NCT03575702|4081055|FG001|Overall Study|Patient non compliance|0
2345174|NCT03575806|4081072|FG000|Overall Study|Withdrawal by Subject|0
2345175|NCT03575806|4081073|FG001|Overall Study|Withdrawal by Subject|2
2345176|NCT03575806|4081072|FG000|Overall Study|Protocol Violation|0
2345177|NCT03575806|4081073|FG001|Overall Study|Protocol Violation|2
2345178|NCT03575871|4081082|FG000|Overall Study|Adverse Event|5
2345179|NCT03575871|4081083|FG001|Overall Study|Adverse Event|5
2345180|NCT03575871|4081084|FG002|Overall Study|Adverse Event|8
2345181|NCT03575871|4081082|FG000|Overall Study|Death|1
2345182|NCT03575871|4081083|FG001|Overall Study|Death|0
2345183|NCT03575871|4081084|FG002|Overall Study|Death|0
2345184|NCT03575871|4081082|FG000|Overall Study|Lack of Efficacy|5
2259697|NCT02120950|3929412|FG002|Overall Study|Adverse Event|3
2259698|NCT02120950|3929410|FG000|Overall Study|Death|3
2259699|NCT02120950|3929411|FG001|Overall Study|Death|0
2259700|NCT02120950|3929412|FG002|Overall Study|Death|1
2259701|NCT02120950|3929410|FG000|Overall Study|Withdrawal by Subject|6
2259702|NCT02120950|3929411|FG001|Overall Study|Withdrawal by Subject|3
2259703|NCT02120950|3929412|FG002|Overall Study|Withdrawal by Subject|2
2259704|NCT02120950|3929410|FG000|Overall Study|Protocol Violation|1
2259705|NCT02120950|3929411|FG001|Overall Study|Protocol Violation|1
2259706|NCT02120950|3929412|FG002|Overall Study|Protocol Violation|7
2259707|NCT02120950|3929410|FG000|Overall Study|Other reasons|5
2259708|NCT02120950|3929411|FG001|Overall Study|Other reasons|4
2259709|NCT02120950|3929412|FG002|Overall Study|Other reasons|1
2259710|NCT02120950|3929410|FG000|Overall Study|Lost to Follow-up|0
2259711|NCT02120950|3929411|FG001|Overall Study|Lost to Follow-up|2
2259712|NCT02120950|3929412|FG002|Overall Study|Lost to Follow-up|1
2259713|NCT02121002|3929422|FG000|Overall Study|Physician Decision|2
2259714|NCT02121002|3929423|FG001|Overall Study|Physician Decision|0
2259715|NCT02121002|3929424|FG002|Overall Study|Physician Decision|0
2259716|NCT02121002|3929422|FG000|Overall Study|Withdrawal by Subject|3
2259717|NCT02121002|3929423|FG001|Overall Study|Withdrawal by Subject|1
2259718|NCT02121002|3929424|FG002|Overall Study|Withdrawal by Subject|4
2259719|NCT02121002|3929422|FG000|Overall Study|Protocol Violation|1
2259720|NCT02121002|3929423|FG001|Overall Study|Protocol Violation|2
2259721|NCT02121002|3929424|FG002|Overall Study|Protocol Violation|4
2259722|NCT02121002|3929422|FG000|Overall Study|Concomitant therapy|0
2259723|NCT02121002|3929423|FG001|Overall Study|Concomitant therapy|1
2259724|NCT02121002|3929424|FG002|Overall Study|Concomitant therapy|1
2259725|NCT02121002|3929422|FG000|Overall Study|Others|1
2259726|NCT02121002|3929423|FG001|Overall Study|Others|0
2259727|NCT02121002|3929424|FG002|Overall Study|Others|1
2259728|NCT02121210|3929448|FG000|Overall Study|Adverse Event|5
2259729|NCT02121210|3929449|FG001|Overall Study|Adverse Event|7
2259730|NCT02121210|3929448|FG000|Overall Study|Lack of Efficacy|2
2259731|NCT02121210|3929449|FG001|Overall Study|Lack of Efficacy|0
2259732|NCT02121210|3929448|FG000|Overall Study|Other than specified above|0
2259733|NCT02121210|3929449|FG001|Overall Study|Other than specified above|2
2259734|NCT02121262|3929457|FG000|Overall Study|Adverse Event|6
2259735|NCT02121262|3929458|FG001|Overall Study|Adverse Event|3
2259736|NCT02121262|3929457|FG000|Overall Study|Lack of Efficacy|3
2259737|NCT02121262|3929458|FG001|Overall Study|Lack of Efficacy|0
2259738|NCT02121262|3929457|FG000|Overall Study|Personal Reasons|19
2259739|NCT02121262|3929458|FG001|Overall Study|Personal Reasons|5
2259740|NCT02121262|3929457|FG000|Overall Study|Protocol Violation|1
2259741|NCT02121262|3929458|FG001|Overall Study|Protocol Violation|1
2259742|NCT02121262|3929457|FG000|Overall Study|Participant Dropped-out|0
2259743|NCT02121262|3929458|FG001|Overall Study|Participant Dropped-out|1
2259744|NCT02121262|3929457|FG000|Overall Study|Participant was Deemed Unsuitable|1
2259745|NCT02121262|3929458|FG001|Overall Study|Participant was Deemed Unsuitable|0
2259746|NCT02121262|3929457|FG000|Overall Study|Consent Withdrawn|1
2259747|NCT02121262|3929458|FG001|Overall Study|Consent Withdrawn|0
2259748|NCT02121301|3929467|FG000|Overall Study|Protocol Violation|1
2259749|NCT02121301|3929468|FG001|Overall Study|Protocol Violation|4
2259750|NCT02121301|3929469|FG002|Overall Study|Protocol Violation|1
2259751|NCT02121392|3929479|FG000|Prior to Intervention|Protocol Violation|40
2259752|NCT02121392|3929480|FG001|Prior to Intervention|Protocol Violation|35
2259753|NCT02121392|3929479|FG000|Prior to Intervention|Withdrawal by Subject|8
2259754|NCT02121392|3929480|FG001|Prior to Intervention|Withdrawal by Subject|6
2259755|NCT02121392|3929479|FG000|After Placement of AC Block vs Sham|Protocol Violation|3
2259756|NCT02121392|3929480|FG001|After Placement of AC Block vs Sham|Protocol Violation|2
2259757|NCT02121392|3929479|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0
2259758|NCT02121392|3929480|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1
2259759|NCT02121509|3929505|FG000|Washout Period (35 Days)|Adverse Event|1
2259760|NCT02121509|3929506|FG001|Washout Period (35 Days)|Adverse Event|1
2259761|NCT02121509|3929507|FG002|Washout Period (35 Days)|Adverse Event|0
2259762|NCT02121509|3929508|FG003|Washout Period (35 Days)|Adverse Event|0
2259763|NCT02121509|3929505|FG000|Washout Period (35 Days)|Withdrawal by Subject|0
2259764|NCT02121509|3929506|FG001|Washout Period (35 Days)|Withdrawal by Subject|3
2259765|NCT02121509|3929507|FG002|Washout Period (35 Days)|Withdrawal by Subject|0
2345185|NCT03575871|4081083|FG001|Overall Study|Lack of Efficacy|4
2345186|NCT03575871|4081084|FG002|Overall Study|Lack of Efficacy|7
2345187|NCT03575871|4081082|FG000|Overall Study|Lost to Follow-up|1
2345188|NCT03575871|4081083|FG001|Overall Study|Lost to Follow-up|1
2345189|NCT03575871|4081084|FG002|Overall Study|Lost to Follow-up|1
2345190|NCT03575871|4081082|FG000|Overall Study|Protocol Deviation|1
2345191|NCT03575871|4081083|FG001|Overall Study|Protocol Deviation|1
2345192|NCT03575871|4081084|FG002|Overall Study|Protocol Deviation|1
2345193|NCT03575871|4081082|FG000|Overall Study|Withdrawal by Subject|6
2345194|NCT03575871|4081083|FG001|Overall Study|Withdrawal by Subject|1
2345195|NCT03575871|4081084|FG002|Overall Study|Withdrawal by Subject|9
2259766|NCT02121509|3929508|FG003|Washout Period (35 Days)|Withdrawal by Subject|0
2259767|NCT02121509|3929505|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1
2345196|NCT03575871|4081082|FG000|Overall Study|Other than specified|2
2345197|NCT03575871|4081083|FG001|Overall Study|Other than specified|2
2259768|NCT02121509|3929506|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0
2259769|NCT02121509|3929507|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0
2259770|NCT02121509|3929508|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0
2259771|NCT02121522|3929518|FG000|Overall Study|Adverse Event|1
2259772|NCT02121535|3929524|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0
2259773|NCT02121535|3929525|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1
2259774|NCT02121535|3929524|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1
2259775|NCT02121535|3929525|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0
2259776|NCT02121756|3929534|FG000|Overall Study|Adverse Event|3
2259777|NCT02121756|3929535|FG001|Overall Study|Adverse Event|0
2259778|NCT02121756|3929534|FG000|Overall Study|Protocol Violation|1
2259779|NCT02121756|3929535|FG001|Overall Study|Protocol Violation|1
2259780|NCT02121756|3929534|FG000|Overall Study|Physician Decision|2
2259781|NCT02121756|3929535|FG001|Overall Study|Physician Decision|1
2259782|NCT02121795|3929546|FG000|Double-Blind Phase|Randomized but Never Treated|1
2259783|NCT02121795|3929547|FG001|Double-Blind Phase|Randomized but Never Treated|4
2259784|NCT02121795|3929546|FG000|Double-Blind Phase|Withdrawal by Subject|19
2259785|NCT02121795|3929547|FG001|Double-Blind Phase|Withdrawal by Subject|16
2259786|NCT02121795|3929546|FG000|Double-Blind Phase|Lost to Follow-up|7
2259787|NCT02121795|3929547|FG001|Double-Blind Phase|Lost to Follow-up|4
2259788|NCT02121795|3929546|FG000|Double-Blind Phase|Physician Decision|2
2259789|NCT02121795|3929547|FG001|Double-Blind Phase|Physician Decision|5
2259790|NCT02121795|3929546|FG000|Double-Blind Phase|Adverse Event|5
2259791|NCT02121795|3929547|FG001|Double-Blind Phase|Adverse Event|0
2259792|NCT02121795|3929546|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
2259793|NCT02121795|3929547|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
2259794|NCT02121795|3929546|FG000|Double-Blind Phase|Protocol Violation|0
2259795|NCT02121795|3929547|FG001|Double-Blind Phase|Protocol Violation|3
2259796|NCT02121795|3929546|FG000|Double-Blind Phase|Death|1
2259797|NCT02121795|3929547|FG001|Double-Blind Phase|Death|1
2259798|NCT02121795|3929546|FG000|Open-Label Phase|Physician Decision|8
2259799|NCT02121795|3929547|FG001|Open-Label Phase|Physician Decision|8
2259800|NCT02121795|3929546|FG000|Open-Label Phase|Withdrawal by Subject|3
2259801|NCT02121795|3929547|FG001|Open-Label Phase|Withdrawal by Subject|2
2259802|NCT02121795|3929546|FG000|Open-Label Phase|Lost to Follow-up|1
2259803|NCT02121795|3929547|FG001|Open-Label Phase|Lost to Follow-up|0
2259804|NCT02121808|3929555|FG000|Overall Study|Technical problem|3
2259805|NCT02121834|3929571|FG000|Overall Study|Protocol Violation|0
2259806|NCT02121834|3929572|FG001|Overall Study|Protocol Violation|1
2259807|NCT02121834|3929573|FG002|Overall Study|Protocol Violation|0
2259808|NCT02121834|3929574|FG003|Overall Study|Protocol Violation|0
2259809|NCT02121834|3929575|FG004|Overall Study|Protocol Violation|0
2259810|NCT02121834|3929576|FG005|Overall Study|Protocol Violation|0
2259811|NCT02121834|3929577|FG006|Overall Study|Protocol Violation|0
2259812|NCT02121834|3929571|FG000|Overall Study|Withdrawal by Subject|0
2259813|NCT02121834|3929572|FG001|Overall Study|Withdrawal by Subject|1
2259814|NCT02121834|3929573|FG002|Overall Study|Withdrawal by Subject|1
2259815|NCT02121834|3929574|FG003|Overall Study|Withdrawal by Subject|0
2259816|NCT02121834|3929575|FG004|Overall Study|Withdrawal by Subject|0
2259817|NCT02121834|3929576|FG005|Overall Study|Withdrawal by Subject|0
2259818|NCT02121834|3929577|FG006|Overall Study|Withdrawal by Subject|0
2259819|NCT02121834|3929571|FG000|Overall Study|Lost to Follow-up|0
2259820|NCT02121834|3929572|FG001|Overall Study|Lost to Follow-up|0
2259821|NCT02121834|3929573|FG002|Overall Study|Lost to Follow-up|1
2259822|NCT02121834|3929574|FG003|Overall Study|Lost to Follow-up|0
2259823|NCT02121834|3929575|FG004|Overall Study|Lost to Follow-up|0
2259824|NCT02121834|3929576|FG005|Overall Study|Lost to Follow-up|0
2259825|NCT02121834|3929577|FG006|Overall Study|Lost to Follow-up|0
2259826|NCT02121847|3929603|FG000|Overall Study|Administrative Reasons|1
2259827|NCT02121847|3929603|FG000|Overall Study|Adverse Event|2
2259828|NCT02122146|3929638|FG000|Part 1: Dose Escalation|Death|0
2259829|NCT02122146|3929639|FG001|Part 1: Dose Escalation|Death|1
2259830|NCT02122146|3929640|FG002|Part 1: Dose Escalation|Death|1
2259831|NCT02122146|3929641|FG003|Part 1: Dose Escalation|Death|0
2259832|NCT02122146|3929642|FG004|Part 1: Dose Escalation|Death|0
2259833|NCT02122146|3929643|FG005|Part 1: Dose Escalation|Death|0
2259834|NCT02122146|3929644|FG006|Part 1: Dose Escalation|Death|0
2345198|NCT03575871|4081084|FG002|Overall Study|Other than specified|0
2345199|NCT03575975|4081102|FG000|Overall Study|Lost to Follow-up|1
2345200|NCT03575975|4081103|FG001|Overall Study|Lost to Follow-up|0
2345201|NCT03575975|4081104|FG002|Overall Study|Lost to Follow-up|0
2345202|NCT03576066|4081112|FG000|Overall Study|Noncompliance with study drug|0
2345203|NCT03576066|4081113|FG001|Overall Study|Noncompliance with study drug|1
2345204|NCT03576716|4081143|FG000|Overall Study|Withdrawal by Subject|0
2259835|NCT02122146|3929645|FG007|Part 1: Dose Escalation|Death|0
2259836|NCT02122146|3929638|FG000|Part 1: Dose Escalation|Lost to Follow-up|0
2259837|NCT02122146|3929639|FG001|Part 1: Dose Escalation|Lost to Follow-up|0
2259838|NCT02122146|3929640|FG002|Part 1: Dose Escalation|Lost to Follow-up|1
2259839|NCT02122146|3929641|FG003|Part 1: Dose Escalation|Lost to Follow-up|0
2259840|NCT02122146|3929642|FG004|Part 1: Dose Escalation|Lost to Follow-up|1
2259841|NCT02122146|3929643|FG005|Part 1: Dose Escalation|Lost to Follow-up|0
2259842|NCT02122146|3929644|FG006|Part 1: Dose Escalation|Lost to Follow-up|0
2345205|NCT03576716|4081144|FG001|Overall Study|Withdrawal by Subject|1
2259843|NCT02122146|3929645|FG007|Part 1: Dose Escalation|Lost to Follow-up|0
2259844|NCT02122146|3929638|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
2259845|NCT02122146|3929639|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
2259846|NCT02122146|3929640|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
2259847|NCT02122146|3929641|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1
2259848|NCT02122146|3929642|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0
2259849|NCT02122146|3929643|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
2259850|NCT02122146|3929644|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
2259851|NCT02122146|3929645|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0
2259852|NCT02122146|3929638|FG000|Part 1: Dose Escalation|Other|1
2259853|NCT02122146|3929639|FG001|Part 1: Dose Escalation|Other|0
2259854|NCT02122146|3929640|FG002|Part 1: Dose Escalation|Other|0
2259855|NCT02122146|3929641|FG003|Part 1: Dose Escalation|Other|0
2259856|NCT02122146|3929642|FG004|Part 1: Dose Escalation|Other|0
2259857|NCT02122146|3929643|FG005|Part 1: Dose Escalation|Other|1
2259858|NCT02122146|3929644|FG006|Part 1: Dose Escalation|Other|1
2259859|NCT02122146|3929645|FG007|Part 1: Dose Escalation|Other|2
2259860|NCT02122380|3929675|FG000|First Intervention (30 Days)|Adverse Event|1
2259861|NCT02122380|3929676|FG001|First Intervention (30 Days)|Adverse Event|0
2259862|NCT02122380|3929675|FG000|First Intervention (30 Days)|Physician Decision|0
2259863|NCT02122380|3929676|FG001|First Intervention (30 Days)|Physician Decision|1
2259864|NCT02122380|3929675|FG000|Washout (8 Weeks)|Lost to Follow-up|1
2259865|NCT02122380|3929676|FG001|Washout (8 Weeks)|Lost to Follow-up|0
2259866|NCT02122380|3929675|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
2259867|NCT02122380|3929676|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
2259868|NCT02122380|3929675|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
2259869|NCT02122380|3929676|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
2259870|NCT02122770|3929713|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3
2259871|NCT02122770|3929714|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0
2259872|NCT02122770|3929715|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1
2259873|NCT02122770|3929716|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2
2259874|NCT02122770|3929717|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0
2259875|NCT02122770|3929718|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0
2259876|NCT02122770|3929713|FG000|Part A: Drug-drug Interaction 2|Other|0
2259877|NCT02122770|3929714|FG001|Part A: Drug-drug Interaction 2|Other|0
2259878|NCT02122770|3929715|FG002|Part A: Drug-drug Interaction 2|Other|1
2259879|NCT02122770|3929716|FG003|Part A: Drug-drug Interaction 2|Other|0
2259880|NCT02122770|3929717|FG004|Part A: Drug-drug Interaction 2|Other|0
2259881|NCT02122770|3929718|FG005|Part A: Drug-drug Interaction 2|Other|0
2259882|NCT02122770|3929713|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2259883|NCT02122770|3929714|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
2259884|NCT02122770|3929715|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2259885|NCT02122770|3929716|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2259886|NCT02122770|3929717|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2259887|NCT02122770|3929718|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2259888|NCT02122770|3929713|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
2259889|NCT02122770|3929714|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
2259890|NCT02122770|3929715|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
2259891|NCT02122770|3929716|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
2259892|NCT02122770|3929717|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
2259893|NCT02122770|3929718|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
2259894|NCT02122770|3929713|FG000|Part B: Standard of Care|Adverse Event|0
2259895|NCT02122770|3929714|FG001|Part B: Standard of Care|Adverse Event|0
2259896|NCT02122770|3929715|FG002|Part B: Standard of Care|Adverse Event|0
2259897|NCT02122770|3929716|FG003|Part B: Standard of Care|Adverse Event|0
2259898|NCT02122770|3929717|FG004|Part B: Standard of Care|Adverse Event|4
2259899|NCT02122770|3929718|FG005|Part B: Standard of Care|Adverse Event|1
2259900|NCT02122770|3929713|FG000|Part B: Standard of Care|Other|0
2259901|NCT02122770|3929714|FG001|Part B: Standard of Care|Other|0
2259902|NCT02122770|3929715|FG002|Part B: Standard of Care|Other|0
2259903|NCT02122770|3929716|FG003|Part B: Standard of Care|Other|0
2259904|NCT02122770|3929717|FG004|Part B: Standard of Care|Other|0
2259905|NCT02122770|3929718|FG005|Part B: Standard of Care|Other|2
2259906|NCT02122770|3929713|FG000|Part B: Standard of Care|Withdrawal by Subject|0
2259907|NCT02122770|3929714|FG001|Part B: Standard of Care|Withdrawal by Subject|0
2259908|NCT02122770|3929715|FG002|Part B: Standard of Care|Withdrawal by Subject|0
2259909|NCT02122770|3929716|FG003|Part B: Standard of Care|Withdrawal by Subject|0
2259910|NCT02122770|3929717|FG004|Part B: Standard of Care|Withdrawal by Subject|4
2259911|NCT02122770|3929718|FG005|Part B: Standard of Care|Withdrawal by Subject|2
2259912|NCT02122770|3929713|FG000|Part B: Standard of Care|Symptomatic Deterioration|0
2259913|NCT02122770|3929714|FG001|Part B: Standard of Care|Symptomatic Deterioration|0
2259914|NCT02122770|3929715|FG002|Part B: Standard of Care|Symptomatic Deterioration|0
2259915|NCT02122770|3929716|FG003|Part B: Standard of Care|Symptomatic Deterioration|0
2259916|NCT02122770|3929717|FG004|Part B: Standard of Care|Symptomatic Deterioration|5
2259917|NCT02122770|3929718|FG005|Part B: Standard of Care|Symptomatic Deterioration|0
2259918|NCT02122770|3929713|FG000|Part B: Standard of Care|Progressive Disease|0
2259919|NCT02122770|3929714|FG001|Part B: Standard of Care|Progressive Disease|0
2259920|NCT02122770|3929715|FG002|Part B: Standard of Care|Progressive Disease|0
2259921|NCT02122770|3929716|FG003|Part B: Standard of Care|Progressive Disease|0
2259922|NCT02122770|3929717|FG004|Part B: Standard of Care|Progressive Disease|10
2259923|NCT02122770|3929718|FG005|Part B: Standard of Care|Progressive Disease|8
2259924|NCT02122783|3929743|FG000|Overall Study|Adverse Event|0
2259925|NCT02122783|3929744|FG001|Overall Study|Adverse Event|1
2259926|NCT02122887|3929765|FG000|Overall Study|Withdrawal by Subject|20
2259927|NCT02122887|3929766|FG001|Overall Study|Withdrawal by Subject|2
2259928|NCT02123134|3929796|FG000|Overall Study|Withdrawal of consent|3
2259929|NCT02123134|3929797|FG001|Overall Study|Withdrawal of consent|2
2259930|NCT02123134|3929796|FG000|Overall Study|Administrative decision|0
2259931|NCT02123134|3929797|FG001|Overall Study|Administrative decision|1
2259932|NCT02123251|3929805|FG000|Overall Study|Death|1
2259933|NCT02123251|3929806|FG001|Overall Study|Death|1
2259934|NCT02123251|3929805|FG000|Overall Study|Withdrawal by Subject|0
2259935|NCT02123251|3929806|FG001|Overall Study|Withdrawal by Subject|3
2259936|NCT02123251|3929805|FG000|Overall Study|Lost Medicaid eligibility|29
2259937|NCT02123251|3929806|FG001|Overall Study|Lost Medicaid eligibility|22
2259938|NCT02123251|3929805|FG000|Overall Study|Switched Managed Care Organization (MCO)|4
2259939|NCT02123251|3929806|FG001|Overall Study|Switched Managed Care Organization (MCO)|4
2259940|NCT02123446|3929822|FG000|Washout Period (1 Day)|Physician Decision|1
2259941|NCT02123446|3929823|FG001|Washout Period (1 Day)|Physician Decision|0
2259942|NCT02123459|3929829|FG000|Washout Period (1 Day)|Adverse Event|1
2259943|NCT02123459|3929830|FG001|Washout Period (1 Day)|Adverse Event|0
2259944|NCT02123472|3929836|FG000|Period 2 (7 Days)|Withdrawal by Subject|0
2259945|NCT02123472|3929837|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
2259946|NCT02123511|3929854|FG000|Overall Study|Cancelled treatment|1
2259947|NCT02123511|3929855|FG001|Overall Study|Cancelled treatment|0
2259948|NCT02123511|3929854|FG000|Overall Study|Incomplete data|1
2259949|NCT02123511|3929855|FG001|Overall Study|Incomplete data|3
2259950|NCT02123511|3929854|FG000|Overall Study|Ineligible|0
2259951|NCT02123511|3929855|FG001|Overall Study|Ineligible|1
2345206|NCT03576768|4081154|FG000|Overall Study|Lost to Follow-up|3
2345207|NCT03576768|4081155|FG001|Overall Study|Lost to Follow-up|3
2345208|NCT03576768|4081156|FG002|Overall Study|Lost to Follow-up|0
2345209|NCT03576768|4081157|FG003|Overall Study|Lost to Follow-up|0
2345210|NCT03577730|4081192|FG000|Overall Study|Physician Decision|3
2345211|NCT03577730|4081193|FG001|Overall Study|Physician Decision|1
2345212|NCT03577730|4081192|FG000|Overall Study|Did not receive allocated intervention|1
2345213|NCT03577730|4081193|FG001|Overall Study|Did not receive allocated intervention|0
2259952|NCT02123576|3929863|FG000|Overall Study|Adverse Event|1
2259953|NCT02123576|3929864|FG001|Overall Study|Adverse Event|0
2259954|NCT02123797|3929876|FG000|Baseline Intervention|Death|9
2259955|NCT02123797|3929877|FG001|Baseline Intervention|Death|16
2259956|NCT02123797|3929878|FG002|Baseline Intervention|Death|0
2259957|NCT02123797|3929879|FG003|Baseline Intervention|Death|0
2259958|NCT02123797|3929880|FG004|Baseline Intervention|Death|0
2259959|NCT02123797|3929876|FG000|Baseline Intervention|Withdrawal by Subject|2
2259960|NCT02123797|3929877|FG001|Baseline Intervention|Withdrawal by Subject|8
2259961|NCT02123797|3929878|FG002|Baseline Intervention|Withdrawal by Subject|0
2259962|NCT02123797|3929879|FG003|Baseline Intervention|Withdrawal by Subject|0
2259963|NCT02123797|3929880|FG004|Baseline Intervention|Withdrawal by Subject|0
2259964|NCT02123797|3929876|FG000|Baseline Intervention|Relocation|2
2259965|NCT02123797|3929877|FG001|Baseline Intervention|Relocation|0
2259966|NCT02123797|3929878|FG002|Baseline Intervention|Relocation|0
2259967|NCT02123797|3929879|FG003|Baseline Intervention|Relocation|0
2259968|NCT02123797|3929880|FG004|Baseline Intervention|Relocation|0
2259969|NCT02123797|3929876|FG000|Baseline Intervention|Out of window for initial survey|6
2259970|NCT02123797|3929877|FG001|Baseline Intervention|Out of window for initial survey|13
2259971|NCT02123797|3929878|FG002|Baseline Intervention|Out of window for initial survey|0
2259972|NCT02123797|3929879|FG003|Baseline Intervention|Out of window for initial survey|0
2259973|NCT02123797|3929880|FG004|Baseline Intervention|Out of window for initial survey|0
2259974|NCT02123797|3929876|FG000|Baseline Intervention|Lost to Follow-up|0
2259975|NCT02123797|3929877|FG001|Baseline Intervention|Lost to Follow-up|5
2259976|NCT02123797|3929878|FG002|Baseline Intervention|Lost to Follow-up|0
2259977|NCT02123797|3929879|FG003|Baseline Intervention|Lost to Follow-up|0
2259978|NCT02123797|3929880|FG004|Baseline Intervention|Lost to Follow-up|0
2259979|NCT02123797|3929876|FG000|Baseline Intervention|Other Disease|3
2259980|NCT02123797|3929877|FG001|Baseline Intervention|Other Disease|0
2259981|NCT02123797|3929878|FG002|Baseline Intervention|Other Disease|0
2259982|NCT02123797|3929879|FG003|Baseline Intervention|Other Disease|0
2259983|NCT02123797|3929880|FG004|Baseline Intervention|Other Disease|0
2259984|NCT02123797|3929876|FG000|3-month Follow up (Cumulative Counts)|Death|33
2259985|NCT02123797|3929877|FG001|3-month Follow up (Cumulative Counts)|Death|57
2259986|NCT02123797|3929878|FG002|3-month Follow up (Cumulative Counts)|Death|0
2259987|NCT02123797|3929879|FG003|3-month Follow up (Cumulative Counts)|Death|0
2259988|NCT02123797|3929880|FG004|3-month Follow up (Cumulative Counts)|Death|0
2259989|NCT02123797|3929876|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2
2259990|NCT02123797|3929877|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7
2259991|NCT02123797|3929878|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50
2259992|NCT02123797|3929879|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82
2259993|NCT02123797|3929880|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3
2345214|NCT03578146|4081205|FG000|Overall Study|Did Not Receive Treatment|1
2345215|NCT03578146|4081206|FG001|Overall Study|Did Not Receive Treatment|0
2345216|NCT03578146|4081207|FG002|Overall Study|Did Not Receive Treatment|0
2345217|NCT03578146|4081208|FG003|Overall Study|Did Not Receive Treatment|0
2345218|NCT03578146|4081209|FG004|Overall Study|Did Not Receive Treatment|0
2345219|NCT03578146|4081210|FG005|Overall Study|Did Not Receive Treatment|2
2345220|NCT03578146|4081205|FG000|Overall Study|Lost to Follow-up|0
2345221|NCT03578146|4081206|FG001|Overall Study|Lost to Follow-up|1
2345222|NCT03578146|4081207|FG002|Overall Study|Lost to Follow-up|1
2345223|NCT03578146|4081208|FG003|Overall Study|Lost to Follow-up|0
2345224|NCT03578146|4081209|FG004|Overall Study|Lost to Follow-up|0
2345225|NCT03578146|4081210|FG005|Overall Study|Lost to Follow-up|1
2345226|NCT03579290|4081237|FG000|Overall Study|Lost to Follow-up|9
2345227|NCT03579719|4081249|FG000|Overall Study|Protocol deviation, pre-existent disease|1
2345228|NCT03579940|4081264|FG000|Period 2|Withdrawal by Subject|0
2345229|NCT03579940|4081265|FG001|Period 2|Withdrawal by Subject|0
2345230|NCT03579940|4081266|FG002|Period 2|Withdrawal by Subject|1
2345231|NCT03579940|4081267|FG003|Period 2|Withdrawal by Subject|0
2345232|NCT03579940|4081268|FG004|Period 2|Withdrawal by Subject|0
2345233|NCT03579940|4081269|FG005|Period 2|Withdrawal by Subject|0
2345234|NCT03579940|4081270|FG006|Period 2|Withdrawal by Subject|0
2345235|NCT03579940|4081271|FG007|Period 2|Withdrawal by Subject|0
2345236|NCT03579940|4081272|FG008|Period 2|Withdrawal by Subject|0
2345237|NCT03579940|4081273|FG009|Period 2|Withdrawal by Subject|0
2345238|NCT03579940|4081274|FG010|Period 2|Withdrawal by Subject|0
2345239|NCT03581825|4081329|FG000|Period 1|Lens Discomfort|1
2345240|NCT03581825|4081330|FG001|Period 1|Lens Discomfort|0
2345241|NCT03581825|4081329|FG000|Period 2|Unsatisfactory Vision to Test|0
2345242|NCT03581825|4081330|FG001|Period 2|Unsatisfactory Vision to Test|1
2345243|NCT03582215|4081344|FG000|Overall Study|Adverse Event|1
2345244|NCT03582215|4081345|FG001|Overall Study|Adverse Event|0
2345245|NCT03582215|4081346|FG002|Overall Study|Adverse Event|0
2345246|NCT03582215|4081347|FG003|Overall Study|Adverse Event|0
2345247|NCT03582215|4081348|FG004|Overall Study|Adverse Event|0
2345248|NCT03582215|4081349|FG005|Overall Study|Adverse Event|0
2345249|NCT03582215|4081350|FG006|Overall Study|Adverse Event|2
2345250|NCT03582215|4081351|FG007|Overall Study|Adverse Event|2
2345251|NCT03582813|4081411|FG000|Overall Study|Lost to Follow-up|18
2345252|NCT03582813|4081412|FG001|Overall Study|Lost to Follow-up|21
2259994|NCT02123797|3929876|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6
2259995|NCT02123797|3929877|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16
2259996|NCT02123797|3929878|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
2259997|NCT02123797|3929879|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
2259998|NCT02123797|3929880|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
2259999|NCT02123797|3929876|FG000|3-month Follow up (Cumulative Counts)|Relocation|0
2260000|NCT02123797|3929877|FG001|3-month Follow up (Cumulative Counts)|Relocation|1
2260001|NCT02123797|3929878|FG002|3-month Follow up (Cumulative Counts)|Relocation|0
2260002|NCT02123797|3929879|FG003|3-month Follow up (Cumulative Counts)|Relocation|0
2260003|NCT02123797|3929880|FG004|3-month Follow up (Cumulative Counts)|Relocation|0
2260004|NCT02123797|3929876|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16
2260005|NCT02123797|3929877|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36
2260006|NCT02123797|3929878|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
2260007|NCT02123797|3929879|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
2260008|NCT02123797|3929880|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
2260009|NCT02123797|3929876|FG000|6-month Follow up (Cumulative Counts)|Death|51
2260010|NCT02123797|3929877|FG001|6-month Follow up (Cumulative Counts)|Death|97
2260011|NCT02123797|3929878|FG002|6-month Follow up (Cumulative Counts)|Death|0
2260012|NCT02123797|3929879|FG003|6-month Follow up (Cumulative Counts)|Death|0
2260013|NCT02123797|3929880|FG004|6-month Follow up (Cumulative Counts)|Death|0
2260014|NCT02123797|3929876|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
2260015|NCT02123797|3929877|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20
2260016|NCT02123797|3929878|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66
2260017|NCT02123797|3929879|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113
2260018|NCT02123797|3929880|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
2260019|NCT02123797|3929876|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1
2260020|NCT02123797|3929877|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9
2260021|NCT02123797|3929878|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
2260022|NCT02123797|3929879|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
2260023|NCT02123797|3929880|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
2260024|NCT02123797|3929876|FG000|6-month Follow up (Cumulative Counts)|Relocation|0
2260025|NCT02123797|3929877|FG001|6-month Follow up (Cumulative Counts)|Relocation|2
2260026|NCT02123797|3929878|FG002|6-month Follow up (Cumulative Counts)|Relocation|0
2260027|NCT02123797|3929879|FG003|6-month Follow up (Cumulative Counts)|Relocation|0
2260028|NCT02123797|3929880|FG004|6-month Follow up (Cumulative Counts)|Relocation|0
2260029|NCT02123966|3929911|FG000|Overall Study|Intercurrent Illness|1
2260030|NCT02124161|3929955|FG000|Overall Study|Other unspecified|0
2260031|NCT02124161|3929956|FG001|Overall Study|Other unspecified|1
2260032|NCT02124161|3929955|FG000|Overall Study|Death|1
2260033|NCT02124161|3929956|FG001|Overall Study|Death|0
2260034|NCT02124161|3929955|FG000|Overall Study|Protocol Violation|2
2260035|NCT02124161|3929956|FG001|Overall Study|Protocol Violation|1
2260036|NCT02124161|3929955|FG000|Overall Study|Withdrawal by Subject|1
2260037|NCT02124161|3929956|FG001|Overall Study|Withdrawal by Subject|2
2260038|NCT02124161|3929955|FG000|Overall Study|Adverse Event|2
2260039|NCT02124161|3929956|FG001|Overall Study|Adverse Event|0
2260040|NCT02124161|3929955|FG000|Overall Study|Does not meet entrance criteria|2
2260041|NCT02124161|3929956|FG001|Overall Study|Does not meet entrance criteria|3
2260042|NCT02124161|3929955|FG000|Overall Study|No longer meets eligibility criteria|5
2260043|NCT02124161|3929956|FG001|Overall Study|No longer meets eligibility criteria|4
2260044|NCT02124161|3929955|FG000|Overall Study|Lost to Follow-up|3
2260045|NCT02124161|3929956|FG001|Overall Study|Lost to Follow-up|4
2260046|NCT02124265|3929969|FG000|Overall Study|Adverse Event|1
2260047|NCT02124564|3930001|FG000|Treatment Period|Adverse Event|2
2260048|NCT02124564|3930001|FG000|Treatment Period|Lack of Efficacy|3
2260049|NCT02124564|3930001|FG000|Treatment Period|Withdrawal by Subject|2
2260050|NCT02124707|3930011|FG000|Overall Study|Adverse Event|5
2260051|NCT02124707|3930011|FG000|Overall Study|Physician Decision|1
2260052|NCT02124707|3930011|FG000|Overall Study|Death|1
2260053|NCT02124746|3930019|FG000|Overall Study|Adverse Event|2
2260054|NCT02124746|3930020|FG001|Overall Study|Adverse Event|1
2260055|NCT02124746|3930021|FG002|Overall Study|Adverse Event|2
2260056|NCT02124746|3930019|FG000|Overall Study|Death|2
2260057|NCT02124746|3930020|FG001|Overall Study|Death|1
2260058|NCT02124746|3930021|FG002|Overall Study|Death|3
2260059|NCT02124746|3930019|FG000|Overall Study|Lack of Efficacy|3
2260060|NCT02124746|3930020|FG001|Overall Study|Lack of Efficacy|2
2260061|NCT02124746|3930021|FG002|Overall Study|Lack of Efficacy|2
2260062|NCT02124746|3930019|FG000|Overall Study|Physician Decision|6
2260063|NCT02124746|3930020|FG001|Overall Study|Physician Decision|4
2260064|NCT02124746|3930021|FG002|Overall Study|Physician Decision|5
2260065|NCT02124746|3930019|FG000|Overall Study|Non-Compliance with Study Drug|0
2260066|NCT02124746|3930020|FG001|Overall Study|Non-Compliance with Study Drug|1
2260067|NCT02124746|3930021|FG002|Overall Study|Non-Compliance with Study Drug|0
2260068|NCT02124746|3930019|FG000|Overall Study|Withdrawal by Subject|3
2260069|NCT02124746|3930020|FG001|Overall Study|Withdrawal by Subject|3
2260070|NCT02124746|3930021|FG002|Overall Study|Withdrawal by Subject|0
2260071|NCT02124746|3930019|FG000|Overall Study|Study Terminated by Sponsor|0
2260072|NCT02124746|3930020|FG001|Overall Study|Study Terminated by Sponsor|0
2260073|NCT02124746|3930021|FG002|Overall Study|Study Terminated by Sponsor|6
2260074|NCT02124746|3930019|FG000|Overall Study|Disease Progression|3
2260075|NCT02124746|3930020|FG001|Overall Study|Disease Progression|6
2260076|NCT02124746|3930021|FG002|Overall Study|Disease Progression|4
2260077|NCT02124759|3930032|FG000|Overall Study|Withdrawal by Subject|3
2260078|NCT02124759|3930033|FG001|Overall Study|Withdrawal by Subject|1
2260079|NCT02124759|3930034|FG002|Overall Study|Withdrawal by Subject|1
2260080|NCT02124759|3930032|FG000|Overall Study|Screen Fail|2
2260081|NCT02124759|3930033|FG001|Overall Study|Screen Fail|2
2260082|NCT02124759|3930034|FG002|Overall Study|Screen Fail|3
2260083|NCT02124772|3930060|FG000|Overall Study|Lack of Efficacy|2
2260084|NCT02124772|3930061|FG001|Overall Study|Lack of Efficacy|0
2260085|NCT02124772|3930062|FG002|Overall Study|Lack of Efficacy|0
2260086|NCT02124772|3930063|FG003|Overall Study|Lack of Efficacy|1
2260087|NCT02124772|3930064|FG004|Overall Study|Lack of Efficacy|2
2260088|NCT02124772|3930065|FG005|Overall Study|Lack of Efficacy|3
2260089|NCT02124772|3930066|FG006|Overall Study|Lack of Efficacy|0
2260090|NCT02124772|3930067|FG007|Overall Study|Lack of Efficacy|2
2260091|NCT02124772|3930068|FG008|Overall Study|Lack of Efficacy|0
2260092|NCT02124772|3930069|FG009|Overall Study|Lack of Efficacy|1
2260093|NCT02124772|3930070|FG010|Overall Study|Lack of Efficacy|0
2260094|NCT02124772|3930071|FG011|Overall Study|Lack of Efficacy|0
2260095|NCT02124772|3930072|FG012|Overall Study|Lack of Efficacy|1
2260096|NCT02124772|3930060|FG000|Overall Study|Adverse Event|1
2260097|NCT02124772|3930061|FG001|Overall Study|Adverse Event|4
2260098|NCT02124772|3930062|FG002|Overall Study|Adverse Event|1
2260099|NCT02124772|3930063|FG003|Overall Study|Adverse Event|5
2260100|NCT02124772|3930064|FG004|Overall Study|Adverse Event|2
2260101|NCT02124772|3930065|FG005|Overall Study|Adverse Event|1
2345253|NCT03582813|4081411|FG000|Overall Study|Withdrawal by Subject|1
2345254|NCT03582813|4081412|FG001|Overall Study|Withdrawal by Subject|0
2345255|NCT03582826|4081420|FG000|Overall Study|Lost to Follow-up|39
2345256|NCT03582826|4081421|FG001|Overall Study|Lost to Follow-up|0
2345257|NCT03582826|4081420|FG000|Overall Study|Withdrawal by Subject|2
2345258|NCT03582826|4081421|FG001|Overall Study|Withdrawal by Subject|0
2345259|NCT03582943|4081438|FG000|Allocated to Groups|Withdrawal by Subject|1
2345260|NCT03582943|4081439|FG001|Allocated to Groups|Withdrawal by Subject|1
2345261|NCT03582943|4081438|FG000|Intervention and Follow up|Withdrawal by Subject|4
2345262|NCT03582943|4081439|FG001|Intervention and Follow up|Withdrawal by Subject|2
2345263|NCT03582943|4081438|FG000|Analyzed|Protocol Violation|4
2345264|NCT03582943|4081439|FG001|Analyzed|Protocol Violation|1
2345265|NCT03583372|4081449|FG000|Overall Study|Withdrawal by Subject|6
2345266|NCT03583372|4081450|FG001|Overall Study|Withdrawal by Subject|11
2345267|NCT03583372|4081451|FG002|Overall Study|Withdrawal by Subject|7
2345268|NCT03583372|4081452|FG003|Overall Study|Withdrawal by Subject|8
2345269|NCT03583372|4081449|FG000|Overall Study|Lost to Follow-up|4
2345270|NCT03583372|4081450|FG001|Overall Study|Lost to Follow-up|6
2345271|NCT03583372|4081451|FG002|Overall Study|Lost to Follow-up|3
2345272|NCT03583372|4081452|FG003|Overall Study|Lost to Follow-up|2
2345273|NCT03583372|4081449|FG000|Overall Study|Adverse Event|1
2345274|NCT03583372|4081450|FG001|Overall Study|Adverse Event|3
2345275|NCT03583372|4081451|FG002|Overall Study|Adverse Event|4
2345276|NCT03583372|4081452|FG003|Overall Study|Adverse Event|4
2345277|NCT03583372|4081449|FG000|Overall Study|Physician Decision|0
2345278|NCT03583372|4081450|FG001|Overall Study|Physician Decision|1
2345279|NCT03583372|4081451|FG002|Overall Study|Physician Decision|1
2345280|NCT03583372|4081452|FG003|Overall Study|Physician Decision|1
2345281|NCT03583372|4081449|FG000|Overall Study|Lack of Efficacy|0
2345282|NCT03583372|4081450|FG001|Overall Study|Lack of Efficacy|1
2345283|NCT03583372|4081451|FG002|Overall Study|Lack of Efficacy|0
2345284|NCT03583372|4081452|FG003|Overall Study|Lack of Efficacy|1
2345285|NCT03583372|4081449|FG000|Overall Study|Death|1
2345286|NCT03583372|4081450|FG001|Overall Study|Death|0
2345287|NCT03583372|4081451|FG002|Overall Study|Death|0
2345288|NCT03583372|4081452|FG003|Overall Study|Death|0
2345289|NCT03583372|4081449|FG000|Overall Study|Protocol Violation|0
2345290|NCT03583372|4081450|FG001|Overall Study|Protocol Violation|1
2345291|NCT03583372|4081451|FG002|Overall Study|Protocol Violation|0
2345292|NCT03583372|4081452|FG003|Overall Study|Protocol Violation|0
2345293|NCT03583372|4081449|FG000|Overall Study|Subject Withdrawn due to Sponsor|0
2345294|NCT03583372|4081450|FG001|Overall Study|Subject Withdrawn due to Sponsor|0
2345295|NCT03583372|4081451|FG002|Overall Study|Subject Withdrawn due to Sponsor|0
2345296|NCT03583372|4081452|FG003|Overall Study|Subject Withdrawn due to Sponsor|1
2345297|NCT03583372|4081449|FG000|Overall Study|Did Not Receive Study Drug|0
2345298|NCT03583372|4081450|FG001|Overall Study|Did Not Receive Study Drug|1
2345299|NCT03583372|4081451|FG002|Overall Study|Did Not Receive Study Drug|0
2345300|NCT03583372|4081452|FG003|Overall Study|Did Not Receive Study Drug|0
2260102|NCT02124772|3930066|FG006|Overall Study|Adverse Event|1
2260103|NCT02124772|3930067|FG007|Overall Study|Adverse Event|5
2260104|NCT02124772|3930068|FG008|Overall Study|Adverse Event|0
2260105|NCT02124772|3930069|FG009|Overall Study|Adverse Event|3
2260106|NCT02124772|3930070|FG010|Overall Study|Adverse Event|1
2260107|NCT02124772|3930071|FG011|Overall Study|Adverse Event|3
2345301|NCT03583372|4081449|FG000|Overall Study|Captured as Other in the Database|1
2260108|NCT02124772|3930072|FG012|Overall Study|Adverse Event|1
2260109|NCT02124772|3930060|FG000|Overall Study|Withdrawal consent|0
2260110|NCT02124772|3930061|FG001|Overall Study|Withdrawal consent|1
2260111|NCT02124772|3930062|FG002|Overall Study|Withdrawal consent|1
2260112|NCT02124772|3930063|FG003|Overall Study|Withdrawal consent|1
2260113|NCT02124772|3930064|FG004|Overall Study|Withdrawal consent|0
2260114|NCT02124772|3930065|FG005|Overall Study|Withdrawal consent|1
2260115|NCT02124772|3930066|FG006|Overall Study|Withdrawal consent|1
2260116|NCT02124772|3930067|FG007|Overall Study|Withdrawal consent|0
2260117|NCT02124772|3930068|FG008|Overall Study|Withdrawal consent|0
2260118|NCT02124772|3930069|FG009|Overall Study|Withdrawal consent|1
2260119|NCT02124772|3930070|FG010|Overall Study|Withdrawal consent|0
2260120|NCT02124772|3930071|FG011|Overall Study|Withdrawal consent|1
2260121|NCT02124772|3930072|FG012|Overall Study|Withdrawal consent|0
2260122|NCT02124772|3930060|FG000|Overall Study|Investigator discretion|0
2260123|NCT02124772|3930061|FG001|Overall Study|Investigator discretion|2
2260124|NCT02124772|3930062|FG002|Overall Study|Investigator discretion|2
2260125|NCT02124772|3930063|FG003|Overall Study|Investigator discretion|1
2260126|NCT02124772|3930064|FG004|Overall Study|Investigator discretion|1
2260127|NCT02124772|3930065|FG005|Overall Study|Investigator discretion|0
2260128|NCT02124772|3930066|FG006|Overall Study|Investigator discretion|1
2260129|NCT02124772|3930067|FG007|Overall Study|Investigator discretion|0
2260130|NCT02124772|3930068|FG008|Overall Study|Investigator discretion|0
2260131|NCT02124772|3930069|FG009|Overall Study|Investigator discretion|1
2260132|NCT02124772|3930070|FG010|Overall Study|Investigator discretion|0
2260133|NCT02124772|3930071|FG011|Overall Study|Investigator discretion|1
2260134|NCT02124772|3930072|FG012|Overall Study|Investigator discretion|0
2260135|NCT02124772|3930060|FG000|Overall Study|Progressive disease|0
2260136|NCT02124772|3930061|FG001|Overall Study|Progressive disease|0
2260137|NCT02124772|3930062|FG002|Overall Study|Progressive disease|0
2260138|NCT02124772|3930063|FG003|Overall Study|Progressive disease|0
2260139|NCT02124772|3930064|FG004|Overall Study|Progressive disease|0
2260140|NCT02124772|3930065|FG005|Overall Study|Progressive disease|0
2260141|NCT02124772|3930066|FG006|Overall Study|Progressive disease|1
2260142|NCT02124772|3930067|FG007|Overall Study|Progressive disease|1
2260143|NCT02124772|3930068|FG008|Overall Study|Progressive disease|0
2260144|NCT02124772|3930069|FG009|Overall Study|Progressive disease|0
2260145|NCT02124772|3930070|FG010|Overall Study|Progressive disease|0
2260146|NCT02124772|3930071|FG011|Overall Study|Progressive disease|0
2260147|NCT02124772|3930072|FG012|Overall Study|Progressive disease|0
2260148|NCT02124772|3930060|FG000|Overall Study|Other|0
2260149|NCT02124772|3930061|FG001|Overall Study|Other|7
2260150|NCT02124772|3930062|FG002|Overall Study|Other|2
2260151|NCT02124772|3930063|FG003|Overall Study|Other|5
2260152|NCT02124772|3930064|FG004|Overall Study|Other|4
2260153|NCT02124772|3930065|FG005|Overall Study|Other|3
2260154|NCT02124772|3930066|FG006|Overall Study|Other|4
2260155|NCT02124772|3930067|FG007|Overall Study|Other|1
2260156|NCT02124772|3930068|FG008|Overall Study|Other|1
2260157|NCT02124772|3930069|FG009|Overall Study|Other|1
2260158|NCT02124772|3930070|FG010|Overall Study|Other|1
2260159|NCT02124772|3930071|FG011|Overall Study|Other|1
2260160|NCT02124772|3930072|FG012|Overall Study|Other|0
2260161|NCT02124798|3930124|FG000|Overall Study|Adverse Event|3
2260162|NCT02124798|3930124|FG000|Overall Study|Lost to Follow-up|1
2260163|NCT02124811|3930130|FG000|Overall Study|Early termination|2
2260164|NCT02124811|3930131|FG001|Overall Study|Early termination|2
2260165|NCT02124811|3930130|FG000|Overall Study|Withdrawal by Subject|1
2260166|NCT02124811|3930131|FG001|Overall Study|Withdrawal by Subject|0
2260167|NCT02125279|3930152|FG000|Overall Study|Lack of Efficacy|2
2260168|NCT02125279|3930152|FG000|Overall Study|Withdrawal by Subject|6
2260169|NCT02125279|3930152|FG000|Overall Study|Protocol Violation|1
2260170|NCT02125279|3930152|FG000|Overall Study|Lost to Follow-up|4
2260171|NCT02125331|3930174|FG000|Overall Study|Protocol Violation|1
2260172|NCT02125331|3930175|FG001|Overall Study|Protocol Violation|0
2260173|NCT02125331|3930174|FG000|Overall Study|technical problem|2
2260174|NCT02125331|3930175|FG001|Overall Study|technical problem|0
2260175|NCT02125331|3930174|FG000|Overall Study|screen failure|2
2260176|NCT02125331|3930175|FG001|Overall Study|screen failure|0
2260177|NCT02125604|3930181|FG000|Overall Study|Other|4
2260178|NCT02125604|3930181|FG000|Overall Study|Investigator Decision|1
2260179|NCT02125604|3930181|FG000|Overall Study|Lost to Follow-up|2
2260180|NCT02125604|3930181|FG000|Overall Study|Consent Withdrawn|4
2260181|NCT02125604|3930181|FG000|Overall Study|Adverse Event|20
2260182|NCT02125734|3930191|FG000|Period 2|Adverse Event|0
2260183|NCT02125734|3930192|FG001|Period 2|Adverse Event|1
2260184|NCT02125838|3930200|FG000|Overall Study|Lost to Follow-up|4
2260185|NCT02125838|3930201|FG001|Overall Study|Lost to Follow-up|4
2345302|NCT03583372|4081450|FG001|Overall Study|Captured as Other in the Database|2
2345303|NCT03583372|4081451|FG002|Overall Study|Captured as Other in the Database|4
2345304|NCT03583372|4081452|FG003|Overall Study|Captured as Other in the Database|1
2345305|NCT03583385|4081462|FG000|Treatment Period 1|Withdrawal by Subject|1
2345306|NCT03583385|4081463|FG001|Treatment Period 1|Withdrawal by Subject|1
2345307|NCT03583385|4081462|FG000|Treatment Period 2|Adverse Event|1
2345308|NCT03583385|4081463|FG001|Treatment Period 2|Adverse Event|0
2345309|NCT03583450|4081471|FG000|Overall Study|hardware malfunction (battery depletion)|1
2345310|NCT03583450|4081472|FG001|Overall Study|hardware malfunction (battery depletion)|0
2260186|NCT02125877|3930209|FG000|Overall Study|Physician Decision|1
2260187|NCT02125877|3930210|FG001|Overall Study|Physician Decision|0
2260188|NCT02125877|3930209|FG000|Overall Study|Death|0
2260189|NCT02125877|3930210|FG001|Overall Study|Death|1
2260190|NCT02125877|3930209|FG000|Overall Study|Administrative problems|0
2260191|NCT02125877|3930210|FG001|Overall Study|Administrative problems|1
2260192|NCT02125877|3930209|FG000|Overall Study|Participant/guardian decision|0
2260193|NCT02125877|3930210|FG001|Overall Study|Participant/guardian decision|2
2260194|NCT02125877|3930209|FG000|Overall Study|Withdrawal by Subject|2
2260195|NCT02125877|3930210|FG001|Overall Study|Withdrawal by Subject|1
2260196|NCT02125877|3930209|FG000|Overall Study|Protocol deviation|4
2260197|NCT02125877|3930210|FG001|Overall Study|Protocol deviation|1
2260198|NCT02125877|3930209|FG000|Overall Study|Adverse Event|6
2260199|NCT02125877|3930210|FG001|Overall Study|Adverse Event|4
2260200|NCT02126670|3930240|FG000|Overall Study|Withdrawal by Subject|1
2260201|NCT02126670|3930241|FG001|Overall Study|Withdrawal by Subject|0
2260202|NCT02126670|3930242|FG002|Overall Study|Withdrawal by Subject|0
2260203|NCT02126670|3930243|FG003|Overall Study|Withdrawal by Subject|1
2260204|NCT02126826|3930273|FG000|Overall Study|Withdrawal by Subject|0
2260205|NCT02126826|3930274|FG001|Overall Study|Withdrawal by Subject|0
2260206|NCT02126826|3930275|FG002|Overall Study|Withdrawal by Subject|0
2260207|NCT02126826|3930276|FG003|Overall Study|Withdrawal by Subject|1
2260208|NCT02126826|3930277|FG004|Overall Study|Withdrawal by Subject|0
2260209|NCT02126826|3930278|FG005|Overall Study|Withdrawal by Subject|0
2260210|NCT02126826|3930279|FG006|Overall Study|Withdrawal by Subject|0
2260211|NCT02126839|3930302|FG000|Overall Study|Adverse Event|0
2260212|NCT02126839|3930303|FG001|Overall Study|Adverse Event|1
2260213|NCT02126839|3930302|FG000|Overall Study|Withdrawal by Subject|1
2260214|NCT02126839|3930303|FG001|Overall Study|Withdrawal by Subject|0
2260215|NCT02126839|3930302|FG000|Overall Study|Withdrawal by parent/guardian|1
2260216|NCT02126839|3930303|FG001|Overall Study|Withdrawal by parent/guardian|0
2260217|NCT02126839|3930302|FG000|Overall Study|Protocol Violation|2
2260218|NCT02126839|3930303|FG001|Overall Study|Protocol Violation|3
2260219|NCT02126839|3930302|FG000|Overall Study|Sponsor request|0
2260220|NCT02126839|3930303|FG001|Overall Study|Sponsor request|1
2260221|NCT02126839|3930302|FG000|Overall Study|Lost to Follow-up|1
2260222|NCT02126839|3930303|FG001|Overall Study|Lost to Follow-up|4
2260223|NCT02126839|3930302|FG000|Overall Study|Other|5
2260224|NCT02126839|3930303|FG001|Overall Study|Other|5
2260225|NCT02126969|3930311|FG000|Overall Study|Withdrawal by Subject|1
2260226|NCT02126969|3930312|FG001|Overall Study|Withdrawal by Subject|2
2260227|NCT02127125|3930327|FG000|Overall Study|Lost to Follow-up|0
2260228|NCT02127125|3930328|FG001|Overall Study|Lost to Follow-up|0
2260229|NCT02127125|3930329|FG002|Overall Study|Lost to Follow-up|0
2260230|NCT02127125|3930330|FG003|Overall Study|Lost to Follow-up|0
2260231|NCT02127125|3930331|FG004|Overall Study|Lost to Follow-up|2
2260232|NCT02127125|3930332|FG005|Overall Study|Lost to Follow-up|1
2260233|NCT02127125|3930333|FG006|Overall Study|Lost to Follow-up|0
2260234|NCT02127125|3930334|FG007|Overall Study|Lost to Follow-up|0
2260235|NCT02127125|3930335|FG008|Overall Study|Lost to Follow-up|0
2260236|NCT02127125|3930327|FG000|Overall Study|Withdrawal by Subject|0
2260237|NCT02127125|3930328|FG001|Overall Study|Withdrawal by Subject|0
2260238|NCT02127125|3930329|FG002|Overall Study|Withdrawal by Subject|0
2260239|NCT02127125|3930330|FG003|Overall Study|Withdrawal by Subject|1
2260240|NCT02127125|3930331|FG004|Overall Study|Withdrawal by Subject|0
2260241|NCT02127125|3930332|FG005|Overall Study|Withdrawal by Subject|0
2260242|NCT02127125|3930333|FG006|Overall Study|Withdrawal by Subject|0
2260243|NCT02127125|3930334|FG007|Overall Study|Withdrawal by Subject|0
2260244|NCT02127125|3930335|FG008|Overall Study|Withdrawal by Subject|0
2260245|NCT02127125|3930327|FG000|Overall Study|Physician Decision|0
2260246|NCT02127125|3930328|FG001|Overall Study|Physician Decision|0
2260247|NCT02127125|3930329|FG002|Overall Study|Physician Decision|1
2260248|NCT02127125|3930330|FG003|Overall Study|Physician Decision|0
2260249|NCT02127125|3930331|FG004|Overall Study|Physician Decision|1
2260250|NCT02127125|3930332|FG005|Overall Study|Physician Decision|2
2260251|NCT02127125|3930333|FG006|Overall Study|Physician Decision|0
2260252|NCT02127125|3930334|FG007|Overall Study|Physician Decision|0
2260253|NCT02127125|3930335|FG008|Overall Study|Physician Decision|0
2260254|NCT02127281|3930357|FG000|Overall Study|Lost to Follow-up|1
2260255|NCT02127281|3930358|FG001|Overall Study|Lost to Follow-up|0
2260256|NCT02127307|3930364|FG000|Overall Study|Protocol Violation|36
2260257|NCT02127307|3930364|FG000|Overall Study|Lost to Follow-up|2
2260258|NCT02127307|3930364|FG000|Overall Study|Death|101
2260259|NCT02127307|3930364|FG000|Overall Study|Other than specified above|169
2260260|NCT02127372|3930370|FG000|Overall Study|Withdrawal by Subject|1
2260261|NCT02127372|3930371|FG001|Overall Study|Withdrawal by Subject|0
2260262|NCT02127931|3930432|FG000|Overall Study|Glitch in Game|1
2260263|NCT02127970|3930439|FG000|Overall Study|Adverse Event|2
2260264|NCT02127970|3930440|FG001|Overall Study|Adverse Event|1
2260265|NCT02127970|3930439|FG000|Overall Study|Death|1
2260266|NCT02127970|3930440|FG001|Overall Study|Death|1
2260267|NCT02127970|3930439|FG000|Overall Study|Lost to Follow-up|14
2260268|NCT02127970|3930440|FG001|Overall Study|Lost to Follow-up|14
2260269|NCT02127970|3930439|FG000|Overall Study|Reason not Specified|4
2260270|NCT02127970|3930440|FG001|Overall Study|Reason not Specified|7
2260271|NCT02127970|3930439|FG000|Overall Study|Pregnancy|0
2260272|NCT02127970|3930440|FG001|Overall Study|Pregnancy|1
2260273|NCT02127970|3930439|FG000|Overall Study|Subject Withdrew Consent|5
2260274|NCT02127970|3930440|FG001|Overall Study|Subject Withdrew Consent|3
2260275|NCT02128217|3930452|FG000|Overall Study|Lost to Follow-up|0
2260276|NCT02128217|3930453|FG001|Overall Study|Lost to Follow-up|1
2260277|NCT02128269|3930468|FG000|Treatment Period|Adverse Event|1
2260278|NCT02128269|3930468|FG000|Treatment Period|Physician Decision|1
2260279|NCT02128490|3930477|FG000|Overall Study|Pretreatment Event/Adverse Event|1
2260280|NCT02128490|3930478|FG001|Overall Study|Pretreatment Event/Adverse Event|0
2260281|NCT02128490|3930479|FG002|Overall Study|Pretreatment Event/Adverse Event|1
2260282|NCT02128490|3930480|FG003|Overall Study|Pretreatment Event/Adverse Event|1
2260283|NCT02128490|3930481|FG004|Overall Study|Pretreatment Event/Adverse Event|0
2260284|NCT02128490|3930477|FG000|Overall Study|Major Protocol Deviation|1
2260285|NCT02128490|3930478|FG001|Overall Study|Major Protocol Deviation|2
2260286|NCT02128490|3930479|FG002|Overall Study|Major Protocol Deviation|0
2260287|NCT02128490|3930480|FG003|Overall Study|Major Protocol Deviation|2
2260288|NCT02128490|3930481|FG004|Overall Study|Major Protocol Deviation|2
2260289|NCT02128490|3930477|FG000|Overall Study|Lost to Follow-up|0
2345311|NCT03583606|4081483|FG000|Overall Study|Lost to Follow-up|0
2345312|NCT03583606|4081484|FG001|Overall Study|Lost to Follow-up|1
2345313|NCT03583606|4081485|FG002|Overall Study|Lost to Follow-up|0
2345314|NCT03583606|4081483|FG000|Overall Study|Ineligible at baseline|1
2345315|NCT03583606|4081484|FG001|Overall Study|Ineligible at baseline|0
2345316|NCT03583606|4081485|FG002|Overall Study|Ineligible at baseline|0
2345317|NCT03584009|4081496|FG000|Overall Study|Death|18
2345318|NCT03584009|4081497|FG001|Overall Study|Death|9
2345319|NCT03584009|4081496|FG000|Overall Study|Lost to Follow-up|0
2345320|NCT03584009|4081497|FG001|Overall Study|Lost to Follow-up|1
2345321|NCT03584009|4081496|FG000|Overall Study|Physician Decision|1
2345322|NCT03584009|4081497|FG001|Overall Study|Physician Decision|1
2345323|NCT03584009|4081496|FG000|Overall Study|Withdrawal by Subject|3
2345324|NCT03584009|4081497|FG001|Overall Study|Withdrawal by Subject|1
2345325|NCT03584009|4081496|FG000|Overall Study|Ongoing in study|29
2345326|NCT03584009|4081497|FG001|Overall Study|Ongoing in study|40
2345327|NCT03585244|4081510|FG000|Overall Study|Withdrawal by Subject|15
2345328|NCT03585296|4081514|FG000|Overall Study|Adverse Event|1
2345329|NCT03585296|4081514|FG000|Overall Study|Lost to Follow-up|2
2345330|NCT03585296|4081514|FG000|Overall Study|Withdrawal by Subject|2
2345331|NCT03585504|4081520|FG000|Overall Study|Lost to Follow-up|26
2345332|NCT03585504|4081521|FG001|Overall Study|Lost to Follow-up|29
2345333|NCT03585712|4081532|FG000|Treatment Period 1|Protocol Violation|1
2345334|NCT03585712|4081533|FG001|Treatment Period 1|Protocol Violation|0
2345335|NCT03585712|4081534|FG002|Treatment Period 1|Protocol Violation|0
2345336|NCT03585712|4081532|FG000|Treatment Periods 2 and 3|Protocol Violation|0
2345337|NCT03585712|4081533|FG001|Treatment Periods 2 and 3|Protocol Violation|1
2345338|NCT03585712|4081534|FG002|Treatment Periods 2 and 3|Protocol Violation|1
2345339|NCT03585712|4081532|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0
2345340|NCT03585712|4081533|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2
2345341|NCT03585712|4081534|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0
2345342|NCT03585712|4081532|FG000|Treatment Periods 2 and 3|Physician Decision|0
2345343|NCT03585712|4081533|FG001|Treatment Periods 2 and 3|Physician Decision|0
2345344|NCT03585712|4081534|FG002|Treatment Periods 2 and 3|Physician Decision|2
2345345|NCT03585959|4081561|FG000|Overall Study|Physician Decision|1
2345346|NCT03585959|4081561|FG000|Overall Study|Unsuccessful Procedure|2
2345347|NCT03586167|4081569|FG000|Overall Study|Other|1
2345348|NCT03586167|4081570|FG001|Overall Study|Other|0
2345349|NCT03586544|4081578|FG000|First Intervention|Adverse Event|0
2345350|NCT03586544|4081579|FG001|First Intervention|Adverse Event|1
2345351|NCT03586544|4081578|FG000|Second Intervention|Withdrawal by Subject|0
2345352|NCT03586544|4081579|FG001|Second Intervention|Withdrawal by Subject|1
2345353|NCT03586648|4081590|FG000|Period 1|Withdrawal by Subject|0
2345354|NCT03586648|4081591|FG001|Period 1|Withdrawal by Subject|1
2345355|NCT03586648|4081590|FG000|Period 1|Lost to Follow-up|1
2345356|NCT03586648|4081591|FG001|Period 1|Lost to Follow-up|1
2345357|NCT03586648|4081590|FG000|Period 1|Adverse Event|1
2345358|NCT03586648|4081591|FG001|Period 1|Adverse Event|0
2345359|NCT03586648|4081590|FG000|Period 1|Study related symptoms or complaints|2
2345360|NCT03586648|4081591|FG001|Period 1|Study related symptoms or complaints|1
2345361|NCT03586648|4081590|FG000|Period 1|Physician Decision|0
2345362|NCT03586648|4081591|FG001|Period 1|Physician Decision|1
2345363|NCT03586648|4081590|FG000|Period 2|Adverse Event|1
2345364|NCT03586648|4081591|FG001|Period 2|Adverse Event|0
2345365|NCT03586726|4081597|FG000|Overall Study|Withdrawal by Subject|1
2345366|NCT03586830|4081605|FG000|Overall Study|Site terminated by Sponsor|1
2345367|NCT03586830|4081606|FG001|Overall Study|Site terminated by Sponsor|4
2345368|NCT03586830|4081607|FG002|Overall Study|Site terminated by Sponsor|3
2345369|NCT03586830|4081608|FG003|Overall Study|Site terminated by Sponsor|3
2345370|NCT03586830|4081605|FG000|Overall Study|Lost to Follow-up|0
2345371|NCT03586830|4081606|FG001|Overall Study|Lost to Follow-up|2
2260290|NCT02128490|3930478|FG001|Overall Study|Lost to Follow-up|0
2260291|NCT02128490|3930479|FG002|Overall Study|Lost to Follow-up|1
2260292|NCT02128490|3930480|FG003|Overall Study|Lost to Follow-up|1
2260293|NCT02128490|3930481|FG004|Overall Study|Lost to Follow-up|1
2260294|NCT02128490|3930477|FG000|Overall Study|Voluntary Withdrawal|3
2260295|NCT02128490|3930478|FG001|Overall Study|Voluntary Withdrawal|3
2260296|NCT02128490|3930479|FG002|Overall Study|Voluntary Withdrawal|1
2260297|NCT02128490|3930480|FG003|Overall Study|Voluntary Withdrawal|1
2260298|NCT02128490|3930481|FG004|Overall Study|Voluntary Withdrawal|2
2260299|NCT02128490|3930477|FG000|Overall Study|Lack of Efficacy|0
2260300|NCT02128490|3930478|FG001|Overall Study|Lack of Efficacy|1
2260301|NCT02128490|3930479|FG002|Overall Study|Lack of Efficacy|0
2260302|NCT02128490|3930480|FG003|Overall Study|Lack of Efficacy|0
2260303|NCT02128490|3930481|FG004|Overall Study|Lack of Efficacy|0
2260304|NCT02128490|3930477|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0
2260305|NCT02128490|3930478|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0
2260306|NCT02128490|3930479|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0
2260307|NCT02128490|3930480|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0
2260308|NCT02128490|3930481|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1
2260309|NCT02128490|3930477|FG000|Overall Study|Other Miscellaneous Reasons|0
2260310|NCT02128490|3930478|FG001|Overall Study|Other Miscellaneous Reasons|0
2260311|NCT02128490|3930479|FG002|Overall Study|Other Miscellaneous Reasons|2
2260312|NCT02128490|3930480|FG003|Overall Study|Other Miscellaneous Reasons|1
2260313|NCT02128490|3930481|FG004|Overall Study|Other Miscellaneous Reasons|1
2260314|NCT02128542|3930495|FG000|Overall Study|Lost to Follow-up|3
2260315|NCT02128542|3930496|FG001|Overall Study|Lost to Follow-up|0
2260316|NCT02128542|3930495|FG000|Overall Study|Withdrew Consent|1
2260317|NCT02128542|3930496|FG001|Overall Study|Withdrew Consent|0
2260318|NCT02128724|3930508|FG000|Overall Study|Death|1
2260319|NCT02128724|3930509|FG001|Overall Study|Death|0
2260320|NCT02128724|3930510|FG002|Overall Study|Death|0
2260321|NCT02128724|3930511|FG003|Overall Study|Death|0
2260322|NCT02128724|3930508|FG000|Overall Study|Adverse Event|0
2260323|NCT02128724|3930509|FG001|Overall Study|Adverse Event|1
2260324|NCT02128724|3930510|FG002|Overall Study|Adverse Event|0
2260325|NCT02128724|3930511|FG003|Overall Study|Adverse Event|0
2260326|NCT02128724|3930508|FG000|Overall Study|Physician Decision|0
2260327|NCT02128724|3930509|FG001|Overall Study|Physician Decision|0
2260328|NCT02128724|3930510|FG002|Overall Study|Physician Decision|0
2260329|NCT02128724|3930511|FG003|Overall Study|Physician Decision|2
2260330|NCT02128724|3930508|FG000|Overall Study|Withdrawal by Subject|0
2260331|NCT02128724|3930509|FG001|Overall Study|Withdrawal by Subject|0
2260332|NCT02128724|3930510|FG002|Overall Study|Withdrawal by Subject|0
2260333|NCT02128724|3930511|FG003|Overall Study|Withdrawal by Subject|1
2260334|NCT02128763|3930522|FG000|Overall Study|Death|1
2260335|NCT02128763|3930523|FG001|Overall Study|Death|0
2260336|NCT02128763|3930522|FG000|Overall Study|Lost to Follow-up|19
2260337|NCT02128763|3930523|FG001|Overall Study|Lost to Follow-up|16
2260338|NCT02128932|3930562|FG000|Overall Study|Withdrawal by Subject|11
2260339|NCT02128932|3930563|FG001|Overall Study|Withdrawal by Subject|7
2260340|NCT02128932|3930564|FG002|Overall Study|Withdrawal by Subject|8
2260341|NCT02128932|3930562|FG000|Overall Study|Death|2
2260342|NCT02128932|3930563|FG001|Overall Study|Death|0
2260343|NCT02128932|3930564|FG002|Overall Study|Death|2
2260344|NCT02128932|3930562|FG000|Overall Study|Lost to Follow-up|2
2260345|NCT02128932|3930563|FG001|Overall Study|Lost to Follow-up|1
2260346|NCT02128932|3930564|FG002|Overall Study|Lost to Follow-up|1
2260347|NCT02128932|3930562|FG000|Overall Study|No reason for withdrawal|12
2260348|NCT02128932|3930563|FG001|Overall Study|No reason for withdrawal|11
2260349|NCT02128932|3930564|FG002|Overall Study|No reason for withdrawal|7
2260350|NCT02128997|3930574|FG000|Overall Study|Lost to Follow-up|6
2260351|NCT02128997|3930575|FG001|Overall Study|Lost to Follow-up|11
2260352|NCT02129062|3930581|FG000|Overall Study|Death|1
2260353|NCT02129062|3930581|FG000|Overall Study|Disease Progression|2
2260354|NCT02129192|3930598|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0
2260355|NCT02129192|3930599|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1
2260356|NCT02129205|3930618|FG000|Overall Study|Withdrawal by Subject|0
2260357|NCT02129205|3930619|FG001|Overall Study|Withdrawal by Subject|0
2260358|NCT02129205|3930620|FG002|Overall Study|Withdrawal by Subject|0
2260359|NCT02129205|3930621|FG003|Overall Study|Withdrawal by Subject|0
2260360|NCT02129205|3930622|FG004|Overall Study|Withdrawal by Subject|1
2260361|NCT02129205|3930623|FG005|Overall Study|Withdrawal by Subject|1
2260362|NCT02129205|3930624|FG006|Overall Study|Withdrawal by Subject|1
2260363|NCT02129205|3930625|FG007|Overall Study|Withdrawal by Subject|0
2260364|NCT02129205|3930626|FG008|Overall Study|Withdrawal by Subject|1
2260365|NCT02129205|3930627|FG009|Overall Study|Withdrawal by Subject|0
2260366|NCT02129205|3930618|FG000|Overall Study|Other|1
2260367|NCT02129205|3930619|FG001|Overall Study|Other|0
2260368|NCT02129205|3930620|FG002|Overall Study|Other|0
2260369|NCT02129205|3930621|FG003|Overall Study|Other|0
2260370|NCT02129205|3930622|FG004|Overall Study|Other|2
2260371|NCT02129205|3930623|FG005|Overall Study|Other|3
2260372|NCT02129205|3930624|FG006|Overall Study|Other|3
2260373|NCT02129205|3930625|FG007|Overall Study|Other|2
2260374|NCT02129205|3930626|FG008|Overall Study|Other|1
2260375|NCT02129205|3930627|FG009|Overall Study|Other|0
2260376|NCT02129608|3930691|FG000|Overall Study|Lost to Follow-up|0
2260377|NCT02129608|3930692|FG001|Overall Study|Lost to Follow-up|1
2260378|NCT02129608|3930693|FG002|Overall Study|Lost to Follow-up|1
2260379|NCT02129608|3930691|FG000|Overall Study|Withdrawal by Subject|0
2260380|NCT02129608|3930692|FG001|Overall Study|Withdrawal by Subject|0
2260381|NCT02129608|3930693|FG002|Overall Study|Withdrawal by Subject|2
2260382|NCT02129777|3930737|FG000|Double-Blind Period|Adverse Event|0
2260383|NCT02129777|3930738|FG001|Double-Blind Period|Adverse Event|0
2260384|NCT02129777|3930739|FG002|Double-Blind Period|Adverse Event|0
2260385|NCT02129777|3930740|FG003|Double-Blind Period|Adverse Event|0
2260386|NCT02129777|3930741|FG004|Double-Blind Period|Adverse Event|1
2260387|NCT02129777|3930742|FG005|Double-Blind Period|Adverse Event|0
2260388|NCT02129777|3930743|FG006|Double-Blind Period|Adverse Event|0
2260389|NCT02129777|3930737|FG000|Double-Blind Period|Lost to Follow-up|1
2260390|NCT02129777|3930738|FG001|Double-Blind Period|Lost to Follow-up|1
2260391|NCT02129777|3930739|FG002|Double-Blind Period|Lost to Follow-up|1
2260392|NCT02129777|3930740|FG003|Double-Blind Period|Lost to Follow-up|2
2260393|NCT02129777|3930741|FG004|Double-Blind Period|Lost to Follow-up|0
2260394|NCT02129777|3930742|FG005|Double-Blind Period|Lost to Follow-up|0
2260395|NCT02129777|3930743|FG006|Double-Blind Period|Lost to Follow-up|0
2260396|NCT02129777|3930737|FG000|Double-Blind Period|Withdrawal by Subject|2
2260397|NCT02129777|3930738|FG001|Double-Blind Period|Withdrawal by Subject|4
2260398|NCT02129777|3930739|FG002|Double-Blind Period|Withdrawal by Subject|3
2260399|NCT02129777|3930740|FG003|Double-Blind Period|Withdrawal by Subject|2
2260400|NCT02129777|3930741|FG004|Double-Blind Period|Withdrawal by Subject|3
2260401|NCT02129777|3930742|FG005|Double-Blind Period|Withdrawal by Subject|0
2260402|NCT02129777|3930743|FG006|Double-Blind Period|Withdrawal by Subject|0
2260403|NCT02129777|3930737|FG000|Double-Blind Period|Pregnancy|0
2260404|NCT02129777|3930738|FG001|Double-Blind Period|Pregnancy|0
2260405|NCT02129777|3930739|FG002|Double-Blind Period|Pregnancy|0
2260406|NCT02129777|3930740|FG003|Double-Blind Period|Pregnancy|0
2260407|NCT02129777|3930741|FG004|Double-Blind Period|Pregnancy|1
2260408|NCT02129777|3930742|FG005|Double-Blind Period|Pregnancy|0
2260409|NCT02129777|3930743|FG006|Double-Blind Period|Pregnancy|0
2260410|NCT02129777|3930737|FG000|Double-Blind Period|Lack of Efficacy|3
2260411|NCT02129777|3930738|FG001|Double-Blind Period|Lack of Efficacy|1
2260412|NCT02129777|3930739|FG002|Double-Blind Period|Lack of Efficacy|0
2260413|NCT02129777|3930740|FG003|Double-Blind Period|Lack of Efficacy|3
2260414|NCT02129777|3930741|FG004|Double-Blind Period|Lack of Efficacy|2
2260415|NCT02129777|3930742|FG005|Double-Blind Period|Lack of Efficacy|0
2260416|NCT02129777|3930743|FG006|Double-Blind Period|Lack of Efficacy|0
2260417|NCT02129777|3930737|FG000|Double-Blind Period|Other|1
2260418|NCT02129777|3930738|FG001|Double-Blind Period|Other|2
2260419|NCT02129777|3930739|FG002|Double-Blind Period|Other|0
2260420|NCT02129777|3930740|FG003|Double-Blind Period|Other|0
2260421|NCT02129777|3930741|FG004|Double-Blind Period|Other|0
2260422|NCT02129777|3930742|FG005|Double-Blind Period|Other|0
2260423|NCT02129777|3930743|FG006|Double-Blind Period|Other|0
2260424|NCT02129777|3930737|FG000|Open-Label Period|Lack of Efficacy|0
2260425|NCT02129777|3930738|FG001|Open-Label Period|Lack of Efficacy|0
2260426|NCT02129777|3930739|FG002|Open-Label Period|Lack of Efficacy|0
2260427|NCT02129777|3930740|FG003|Open-Label Period|Lack of Efficacy|0
2260428|NCT02129777|3930741|FG004|Open-Label Period|Lack of Efficacy|0
2260429|NCT02129777|3930742|FG005|Open-Label Period|Lack of Efficacy|0
2260430|NCT02129777|3930743|FG006|Open-Label Period|Lack of Efficacy|5
2260431|NCT02129777|3930737|FG000|Open-Label Period|Lost to Follow-up|0
2260432|NCT02129777|3930738|FG001|Open-Label Period|Lost to Follow-up|0
2260433|NCT02129777|3930739|FG002|Open-Label Period|Lost to Follow-up|0
2260434|NCT02129777|3930740|FG003|Open-Label Period|Lost to Follow-up|0
2260435|NCT02129777|3930741|FG004|Open-Label Period|Lost to Follow-up|0
2260436|NCT02129777|3930742|FG005|Open-Label Period|Lost to Follow-up|1
2260437|NCT02129777|3930743|FG006|Open-Label Period|Lost to Follow-up|1
2260438|NCT02129777|3930737|FG000|Open-Label Period|Withdrawal by Subject|0
2260439|NCT02129777|3930738|FG001|Open-Label Period|Withdrawal by Subject|0
2260440|NCT02129777|3930739|FG002|Open-Label Period|Withdrawal by Subject|0
2345372|NCT03586830|4081607|FG002|Overall Study|Lost to Follow-up|2
2345373|NCT03586830|4081608|FG003|Overall Study|Lost to Follow-up|1
2345374|NCT03586830|4081605|FG000|Overall Study|Withdrawal by Subject|1
2345375|NCT03586830|4081606|FG001|Overall Study|Withdrawal by Subject|0
2345376|NCT03586830|4081607|FG002|Overall Study|Withdrawal by Subject|3
2345377|NCT03586830|4081608|FG003|Overall Study|Withdrawal by Subject|1
2345378|NCT03587974|4081654|FG000|Overall Study|caregiver demented, care recipient died|3
2345379|NCT03587974|4081655|FG001|Overall Study|caregiver demented, care recipient died|3
2345380|NCT03587974|4081654|FG000|Overall Study|Withdrawal by Subject|2
2345381|NCT03587974|4081655|FG001|Overall Study|Withdrawal by Subject|1
2345382|NCT03588572|4081663|FG000|Visitation 1|Lack of Efficacy|1
2345383|NCT03588572|4081664|FG001|Visitation 1|Lack of Efficacy|1
2345384|NCT03588572|4081663|FG000|Visitation 2|Lost to Follow-up|1
2345385|NCT03588572|4081664|FG001|Visitation 2|Lost to Follow-up|1
2345386|NCT03588572|4081663|FG000|Visitation 2|Lack of Efficacy|0
2345387|NCT03588572|4081664|FG001|Visitation 2|Lack of Efficacy|1
2345388|NCT03588572|4081663|FG000|Visitation 2|Withdrawal by Subject|1
2345389|NCT03588572|4081664|FG001|Visitation 2|Withdrawal by Subject|0
2345390|NCT03588572|4081663|FG000|Visitation 3|Lost to Follow-up|1
2260441|NCT02129777|3930740|FG003|Open-Label Period|Withdrawal by Subject|0
2260442|NCT02129777|3930741|FG004|Open-Label Period|Withdrawal by Subject|0
2260443|NCT02129777|3930742|FG005|Open-Label Period|Withdrawal by Subject|1
2260444|NCT02129777|3930743|FG006|Open-Label Period|Withdrawal by Subject|3
2260445|NCT02129777|3930737|FG000|Open-Label Period|Study Termination|0
2260446|NCT02129777|3930738|FG001|Open-Label Period|Study Termination|0
2260447|NCT02129777|3930739|FG002|Open-Label Period|Study Termination|0
2260448|NCT02129777|3930740|FG003|Open-Label Period|Study Termination|0
2260449|NCT02129777|3930741|FG004|Open-Label Period|Study Termination|0
2260450|NCT02129777|3930742|FG005|Open-Label Period|Study Termination|10
2260451|NCT02129777|3930743|FG006|Open-Label Period|Study Termination|39
2260452|NCT02129803|3930764|FG000|Overall Study|Protocol Violation|4
2260453|NCT02129803|3930765|FG001|Overall Study|Protocol Violation|0
2260454|NCT02129803|3930764|FG000|Overall Study|Physician Decision|0
2260455|NCT02129803|3930765|FG001|Overall Study|Physician Decision|1
2260456|NCT02129803|3930764|FG000|Overall Study|Difficulty sleeping|1
2260457|NCT02129803|3930765|FG001|Overall Study|Difficulty sleeping|0
2260458|NCT02129803|3930764|FG000|Overall Study|Morning headache|0
2260459|NCT02129803|3930765|FG001|Overall Study|Morning headache|1
2260460|NCT02129803|3930764|FG000|Overall Study|Withdrawal by Subject|1
2260461|NCT02129803|3930765|FG001|Overall Study|Withdrawal by Subject|1
2260462|NCT02130024|3930773|FG000|Overall Study|Adverse Event|10
2260463|NCT02130024|3930774|FG001|Overall Study|Adverse Event|11
2260464|NCT02130024|3930773|FG000|Overall Study|Death|2
2260465|NCT02130024|3930774|FG001|Overall Study|Death|2
2260466|NCT02130024|3930773|FG000|Overall Study|Lost to Follow-up|1
2260467|NCT02130024|3930774|FG001|Overall Study|Lost to Follow-up|1
2260468|NCT02130024|3930773|FG000|Overall Study|Physician Decision|1
2260469|NCT02130024|3930774|FG001|Overall Study|Physician Decision|3
2260470|NCT02130024|3930773|FG000|Overall Study|Protocol Deviation|4
2260471|NCT02130024|3930774|FG001|Overall Study|Protocol Deviation|0
2260472|NCT02130024|3930773|FG000|Overall Study|Site Administration Problems|1
2260473|NCT02130024|3930774|FG001|Overall Study|Site Administration Problems|0
2260474|NCT02130024|3930773|FG000|Overall Study|Subject Withdrew Consent|6
2260475|NCT02130024|3930774|FG001|Overall Study|Subject Withdrew Consent|14
2260476|NCT02130193|3930791|FG000|Part B: 52-week Double-blind Period|Adverse Event|0
2260477|NCT02130193|3930792|FG001|Part B: 52-week Double-blind Period|Adverse Event|5
2260478|NCT02130193|3930793|FG002|Part B: 52-week Double-blind Period|Adverse Event|3
2260479|NCT02130193|3930791|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0
2260480|NCT02130193|3930792|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2
2260481|NCT02130193|3930793|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1
2260482|NCT02130193|3930791|FG000|Part B: 52-week Double-blind Period|Physician Decision|0
2260483|NCT02130193|3930792|FG001|Part B: 52-week Double-blind Period|Physician Decision|0
2260484|NCT02130193|3930793|FG002|Part B: 52-week Double-blind Period|Physician Decision|1
2260485|NCT02130193|3930791|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
2260486|NCT02130193|3930792|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
2260487|NCT02130193|3930793|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
2345391|NCT03588572|4081664|FG001|Visitation 3|Lost to Follow-up|1
2345392|NCT03588572|4081663|FG000|Visitation 3|Physician Decision|1
2345393|NCT03588572|4081664|FG001|Visitation 3|Physician Decision|1
2345394|NCT03588572|4081663|FG000|Visitation 3|Withdrawal by Subject|1
2345395|NCT03588572|4081664|FG001|Visitation 3|Withdrawal by Subject|0
2345396|NCT03588741|4081670|FG000|Overall Study|Withdrawal by Subject|1
2345397|NCT03588910|4081680|FG000|Overall Study|Withdrawal by Subject|1
2345398|NCT03588910|4081681|FG001|Overall Study|Withdrawal by Subject|0
2345399|NCT03588910|4081680|FG000|Overall Study|Allergy|2
2345400|NCT03588910|4081681|FG001|Overall Study|Allergy|0
2345401|NCT03588910|4081680|FG000|Overall Study|Protocol Violation|0
2345402|NCT03588910|4081681|FG001|Overall Study|Protocol Violation|3
2345403|NCT03588910|4081680|FG000|Overall Study|Did not complete Day 1 Survey|5
2345404|NCT03588910|4081681|FG001|Overall Study|Did not complete Day 1 Survey|10
2345405|NCT03588910|4081680|FG000|Overall Study|Did not complete Day 7 Survey|5
2345406|NCT03588910|4081681|FG001|Overall Study|Did not complete Day 7 Survey|2
2345407|NCT03589469|4081687|FG000|Overall Study|Ongoing in study|58
2345408|NCT03589469|4081687|FG000|Overall Study|Withdrawal by Subject|6
2345409|NCT03589469|4081687|FG000|Overall Study|Physician Decision|1
2345410|NCT03589469|4081687|FG000|Overall Study|Death|77
2345411|NCT03589469|4081687|FG000|Overall Study|Lost to Follow-up|3
2345412|NCT03589807|4081697|FG000|Overall Study|Lost to Follow-up|0
2345413|NCT03589807|4081698|FG001|Overall Study|Lost to Follow-up|2
2345414|NCT03589807|4081699|FG002|Overall Study|Lost to Follow-up|2
2345415|NCT03589807|4081700|FG003|Overall Study|Lost to Follow-up|3
2345416|NCT03589807|4081701|FG004|Overall Study|Lost to Follow-up|1
2345417|NCT03589807|4081702|FG005|Overall Study|Lost to Follow-up|1
2345418|NCT03589807|4081697|FG000|Overall Study|Withdrawal by Subject|0
2345419|NCT03589807|4081698|FG001|Overall Study|Withdrawal by Subject|5
2345420|NCT03589807|4081699|FG002|Overall Study|Withdrawal by Subject|0
2345421|NCT03589807|4081700|FG003|Overall Study|Withdrawal by Subject|0
2345422|NCT03589807|4081701|FG004|Overall Study|Withdrawal by Subject|0
2345423|NCT03589807|4081702|FG005|Overall Study|Withdrawal by Subject|0
2345424|NCT03589807|4081697|FG000|Overall Study|Protocol Violation|0
2345425|NCT03589807|4081698|FG001|Overall Study|Protocol Violation|0
2345426|NCT03589807|4081699|FG002|Overall Study|Protocol Violation|0
2345427|NCT03589807|4081700|FG003|Overall Study|Protocol Violation|1
2345428|NCT03589807|4081701|FG004|Overall Study|Protocol Violation|0
2260488|NCT02130284|3930811|FG000|Overall Study|Withdrawal by Subject|3
2260489|NCT02130284|3930811|FG000|Overall Study|Subject Withdrew Consent|1
2260490|NCT02130284|3930811|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1
2260491|NCT02130284|3930811|FG000|Overall Study|Subject was screened as backup for study|3
2260492|NCT02130284|3930811|FG000|Overall Study|Screen Failure|1
2260493|NCT02130297|3930815|FG000|Overall Study|Lost to Follow-up|4
2260494|NCT02130427|3930819|FG000|Overall Study|Imaging results not interpretable|30
2260495|NCT02130557|3930825|FG000|Overall Study|Withdrawal by Subject|12
2260496|NCT02130557|3930826|FG001|Overall Study|Withdrawal by Subject|12
2260497|NCT02130557|3930825|FG000|Overall Study|Investigator Request|0
2260498|NCT02130557|3930826|FG001|Overall Study|Investigator Request|2
2260499|NCT02130557|3930825|FG000|Overall Study|Deceased|14
2260500|NCT02130557|3930826|FG001|Overall Study|Deceased|14
2260501|NCT02130557|3930825|FG000|Overall Study|Lost to Follow-up|6
2260502|NCT02130557|3930826|FG001|Overall Study|Lost to Follow-up|7
2260503|NCT02130557|3930825|FG000|Overall Study|Other|2
2260504|NCT02130557|3930826|FG001|Overall Study|Other|1
2260505|NCT02130557|3930825|FG000|Overall Study|Missing|2
2260506|NCT02130557|3930826|FG001|Overall Study|Missing|1
2260507|NCT02130570|3930834|FG000|Overall Study|Death|3
2260508|NCT02130570|3930835|FG001|Overall Study|Death|5
2260509|NCT02130570|3930834|FG000|Overall Study|Withdrawal by Subject|6
2260510|NCT02130570|3930835|FG001|Overall Study|Withdrawal by Subject|3
2260511|NCT02130570|3930834|FG000|Overall Study|Part of practice that discontinued study|0
2260512|NCT02130570|3930835|FG001|Overall Study|Part of practice that discontinued study|5
2260513|NCT02130765|3930930|FG000|Overall Study|Did not receive treatment|4
2260514|NCT02130765|3930931|FG001|Overall Study|Did not receive treatment|0
2260515|NCT02130765|3930932|FG002|Overall Study|Did not receive treatment|0
2260516|NCT02130765|3930933|FG003|Overall Study|Did not receive treatment|0
2260517|NCT02130986|3930947|FG000|Overall Study|Withdrawal by Subject|4
2260518|NCT02130986|3930948|FG001|Overall Study|Withdrawal by Subject|4
2260519|NCT02130986|3930947|FG000|Overall Study|Lost to Follow-up|151
2260520|NCT02130986|3930948|FG001|Overall Study|Lost to Follow-up|160
2260521|NCT02131064|3930970|FG000|Overall Study|Death|5
2260522|NCT02131064|3930971|FG001|Overall Study|Death|6
2260523|NCT02131064|3930970|FG000|Overall Study|Lost to Follow-up|4
2260524|NCT02131064|3930971|FG001|Overall Study|Lost to Follow-up|8
2260525|NCT02131064|3930970|FG000|Overall Study|Withdrawal by Subject|14
2260526|NCT02131064|3930971|FG001|Overall Study|Withdrawal by Subject|18
2260527|NCT02131064|3930970|FG000|Overall Study|Other|2
2260528|NCT02131064|3930971|FG001|Overall Study|Other|2
2260529|NCT02131129|3930980|FG000|Overall Study|Withdrawal by Subject|1
2260530|NCT02131129|3930981|FG001|Overall Study|Withdrawal by Subject|0
2260531|NCT02131233|3930989|FG000|Overall Study|Not Treated|2
2260532|NCT02131233|3930990|FG001|Overall Study|Not Treated|3
2260533|NCT02131233|3930989|FG000|Overall Study|Adverse Event|7
2260534|NCT02131233|3930990|FG001|Overall Study|Adverse Event|6
2260535|NCT02131233|3930989|FG000|Overall Study|Death|0
2260536|NCT02131233|3930990|FG001|Overall Study|Death|1
2260537|NCT02131233|3930989|FG000|Overall Study|Lack of Efficacy|6
2260538|NCT02131233|3930990|FG001|Overall Study|Lack of Efficacy|3
2260539|NCT02131233|3930989|FG000|Overall Study|Lost to Follow-up|14
2260540|NCT02131233|3930990|FG001|Overall Study|Lost to Follow-up|13
2260541|NCT02131233|3930989|FG000|Overall Study|Non-Compliance With Study Drug|8
2260542|NCT02131233|3930990|FG001|Overall Study|Non-Compliance With Study Drug|5
2260543|NCT02131233|3930989|FG000|Overall Study|Physician Decision|7
2260544|NCT02131233|3930990|FG001|Overall Study|Physician Decision|0
2260545|NCT02131233|3930989|FG000|Overall Study|Pregnancy|4
2345429|NCT03589807|4081702|FG005|Overall Study|Protocol Violation|0
2345430|NCT03589807|4081697|FG000|Overall Study|Enrolled but treatment not administered|0
2345431|NCT03589807|4081698|FG001|Overall Study|Enrolled but treatment not administered|0
2345432|NCT03589807|4081699|FG002|Overall Study|Enrolled but treatment not administered|0
2345433|NCT03589807|4081700|FG003|Overall Study|Enrolled but treatment not administered|0
2345434|NCT03589807|4081701|FG004|Overall Study|Enrolled but treatment not administered|1
2345435|NCT03589807|4081702|FG005|Overall Study|Enrolled but treatment not administered|0
2345436|NCT03589885|4081722|FG000|Treatment Period 1-Randomized Set|Adverse Event|0
2345437|NCT03589885|4081723|FG001|Treatment Period 1-Randomized Set|Adverse Event|1
2345438|NCT03589885|4081724|FG002|Treatment Period 1-Randomized Set|Adverse Event|0
2345439|NCT03589885|4081725|FG003|Treatment Period 1-Randomized Set|Adverse Event|0
2345440|NCT03589885|4081726|FG004|Treatment Period 1-Randomized Set|Adverse Event|0
2345441|NCT03589885|4081722|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0
2345442|NCT03589885|4081723|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0
2345443|NCT03589885|4081724|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2
2345444|NCT03589885|4081725|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0
2345445|NCT03589885|4081726|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0
2345446|NCT03589885|4081722|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0
2345447|NCT03589885|4081723|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1
2345448|NCT03589885|4081724|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0
2345449|NCT03589885|4081725|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0
2345450|NCT03589885|4081726|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0
2260546|NCT02131233|3930990|FG001|Overall Study|Pregnancy|0
2260547|NCT02131233|3930989|FG000|Overall Study|Withdrawal by Subject|18
2260548|NCT02131233|3930990|FG001|Overall Study|Withdrawal by Subject|11
2260549|NCT02131259|3930996|FG000|Overall Study|Progressive disease|751
2260550|NCT02131259|3930996|FG000|Overall Study|Adverse Event|341
2260551|NCT02131259|3930996|FG000|Overall Study|Lost to Follow-up|7
2260552|NCT02131259|3930996|FG000|Overall Study|Relocation|32
2260553|NCT02131259|3930996|FG000|Overall Study|Other|63
2260554|NCT02131259|3930996|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22
2260555|NCT02131259|3930996|FG000|Overall Study|Progressive disease/relocation|1
2260556|NCT02131259|3930996|FG000|Overall Study|Progressive disease/other|2
2260557|NCT02131259|3930996|FG000|Overall Study|AE/lost to follow-up|1
2260558|NCT02131259|3930996|FG000|Overall Study|AE/other|1
2260559|NCT02131259|3930996|FG000|Overall Study|Progressive disease/AE/other|1
2260560|NCT02131259|3930996|FG000|Overall Study|Missing|3
2260561|NCT02131272|3931002|FG000|Overall Study|Withdrawal by parent|0
2260562|NCT02131272|3931003|FG001|Overall Study|Withdrawal by parent|1
2260563|NCT02131272|3931002|FG000|Overall Study|Withdrawal by Subject|0
2260564|NCT02131272|3931003|FG001|Overall Study|Withdrawal by Subject|1
2260565|NCT02131272|3931002|FG000|Overall Study|Withdrawal Criteria|1
2260566|NCT02131272|3931003|FG001|Overall Study|Withdrawal Criteria|0
2260567|NCT02131311|3931009|FG000|Overall Study|Adverse Event|2
2260568|NCT02131311|3931009|FG000|Overall Study|Protocol Violation|1
2260569|NCT02131311|3931009|FG000|Overall Study|Lost to Follow-up|1
2260570|NCT02131324|3931016|FG000|Overall Study|Withdrawal by Subject|1
2260571|NCT02131324|3931017|FG001|Overall Study|Withdrawal by Subject|2
2260572|NCT02131324|3931016|FG000|Overall Study|Lost to Follow-up|1
2260573|NCT02131324|3931017|FG001|Overall Study|Lost to Follow-up|1
2260574|NCT02131532|3931086|FG000|Overall Study|Withdrawal by Subject|1
2260575|NCT02131532|3931086|FG000|Overall Study|Physician Decision|1
2260576|NCT02131532|3931086|FG000|Overall Study|Other health conditions|2
2260577|NCT02131636|3931093|FG000|Overall Study|Personal Reasons|4
2260578|NCT02131636|3931094|FG001|Overall Study|Personal Reasons|4
2260579|NCT02131636|3931093|FG000|Overall Study|Lost to Follow-up|4
2260580|NCT02131636|3931094|FG001|Overall Study|Lost to Follow-up|0
2260581|NCT02131636|3931093|FG000|Overall Study|Adverse Event|4
2260582|NCT02131636|3931094|FG001|Overall Study|Adverse Event|1
2260583|NCT02131662|3931105|FG000|Overall Study|Protocol Violation|1
2260584|NCT02131662|3931106|FG001|Overall Study|Protocol Violation|0
2260585|NCT02131662|3931107|FG002|Overall Study|Protocol Violation|0
2260586|NCT02131662|3931108|FG003|Overall Study|Protocol Violation|0
2260587|NCT02131662|3931109|FG004|Overall Study|Protocol Violation|0
2260588|NCT02131662|3931105|FG000|Overall Study|Other|2
2260589|NCT02131662|3931106|FG001|Overall Study|Other|4
2260590|NCT02131662|3931107|FG002|Overall Study|Other|3
2260591|NCT02131662|3931108|FG003|Overall Study|Other|3
2260592|NCT02131662|3931109|FG004|Overall Study|Other|4
2260593|NCT02131662|3931105|FG000|Overall Study|Adverse Event|0
2260594|NCT02131662|3931106|FG001|Overall Study|Adverse Event|1
2260595|NCT02131662|3931107|FG002|Overall Study|Adverse Event|1
2260596|NCT02131662|3931108|FG003|Overall Study|Adverse Event|1
2260597|NCT02131662|3931109|FG004|Overall Study|Adverse Event|3
2260598|NCT02131662|3931105|FG000|Overall Study|Pregnancy|0
2260599|NCT02131662|3931106|FG001|Overall Study|Pregnancy|1
2260600|NCT02131662|3931107|FG002|Overall Study|Pregnancy|0
2260601|NCT02131662|3931108|FG003|Overall Study|Pregnancy|1
2345451|NCT03589885|4081722|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
2345452|NCT03589885|4081723|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
2345453|NCT03589885|4081724|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1
2345454|NCT03589885|4081725|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
2345455|NCT03589885|4081726|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
2345456|NCT03589885|4081722|FG000|Treatment Period 2-Randomized Set|Adverse Event|0
2345457|NCT03589885|4081723|FG001|Treatment Period 2-Randomized Set|Adverse Event|1
2345458|NCT03589885|4081724|FG002|Treatment Period 2-Randomized Set|Adverse Event|0
2345459|NCT03589885|4081725|FG003|Treatment Period 2-Randomized Set|Adverse Event|0
2345460|NCT03589885|4081726|FG004|Treatment Period 2-Randomized Set|Adverse Event|0
2345461|NCT03589885|4081722|FG000|Treatment Period 2-Randomized Set|Pregnancy|1
2345462|NCT03589885|4081723|FG001|Treatment Period 2-Randomized Set|Pregnancy|0
2345463|NCT03589885|4081724|FG002|Treatment Period 2-Randomized Set|Pregnancy|0
2345464|NCT03589885|4081725|FG003|Treatment Period 2-Randomized Set|Pregnancy|0
2260602|NCT02131662|3931109|FG004|Overall Study|Pregnancy|0
2260603|NCT02131662|3931105|FG000|Overall Study|Wish for pregnancy|0
2260604|NCT02131662|3931106|FG001|Overall Study|Wish for pregnancy|0
2260605|NCT02131662|3931107|FG002|Overall Study|Wish for pregnancy|0
2260606|NCT02131662|3931108|FG003|Overall Study|Wish for pregnancy|0
2260607|NCT02131662|3931109|FG004|Overall Study|Wish for pregnancy|1
2260608|NCT02131662|3931105|FG000|Overall Study|Lack of Efficacy|1
2260609|NCT02131662|3931106|FG001|Overall Study|Lack of Efficacy|0
2260610|NCT02131662|3931107|FG002|Overall Study|Lack of Efficacy|0
2260611|NCT02131662|3931108|FG003|Overall Study|Lack of Efficacy|0
2260612|NCT02131662|3931109|FG004|Overall Study|Lack of Efficacy|1
2260613|NCT02131662|3931105|FG000|Overall Study|Withdrawal by Subject|1
2260614|NCT02131662|3931106|FG001|Overall Study|Withdrawal by Subject|5
2260615|NCT02131662|3931107|FG002|Overall Study|Withdrawal by Subject|1
2260616|NCT02131662|3931108|FG003|Overall Study|Withdrawal by Subject|5
2260617|NCT02131662|3931109|FG004|Overall Study|Withdrawal by Subject|6
2260618|NCT02131662|3931105|FG000|Overall Study|Lost to Follow-up|1
2260619|NCT02131662|3931106|FG001|Overall Study|Lost to Follow-up|3
2260620|NCT02131662|3931107|FG002|Overall Study|Lost to Follow-up|0
2260621|NCT02131662|3931108|FG003|Overall Study|Lost to Follow-up|9
2260622|NCT02131662|3931109|FG004|Overall Study|Lost to Follow-up|0
2260623|NCT02131662|3931105|FG000|Overall Study|Not treated|2
2260624|NCT02131662|3931106|FG001|Overall Study|Not treated|0
2260625|NCT02131662|3931107|FG002|Overall Study|Not treated|2
2260626|NCT02131662|3931108|FG003|Overall Study|Not treated|2
2260627|NCT02131662|3931109|FG004|Overall Study|Not treated|3
2260628|NCT02131766|3931125|FG000|Overall Study|Withdrawal by Subject|4
2260629|NCT02132117|3931134|FG000|Overall Study|Adverse Event|6
2260630|NCT02132117|3931135|FG001|Overall Study|Adverse Event|1
2260631|NCT02132117|3931134|FG000|Overall Study|Lost to Follow-up|2
2260632|NCT02132117|3931135|FG001|Overall Study|Lost to Follow-up|2
2260633|NCT02132117|3931134|FG000|Overall Study|Personal Reasons|1
2260634|NCT02132117|3931135|FG001|Overall Study|Personal Reasons|2
2260635|NCT02132117|3931134|FG000|Overall Study|Other Miscellaneous Reasons|2
2260636|NCT02132117|3931135|FG001|Overall Study|Other Miscellaneous Reasons|0
2260637|NCT02132130|3931145|FG000|Overall Study|Lost to Follow-up|0
2260638|NCT02132130|3931146|FG001|Overall Study|Lost to Follow-up|2
2260639|NCT02132130|3931147|FG002|Overall Study|Lost to Follow-up|0
2260640|NCT02132130|3931148|FG003|Overall Study|Lost to Follow-up|0
2260641|NCT02132130|3931145|FG000|Overall Study|Withdrawal by Subject|0
2260642|NCT02132130|3931146|FG001|Overall Study|Withdrawal by Subject|0
2260643|NCT02132130|3931147|FG002|Overall Study|Withdrawal by Subject|0
2260644|NCT02132130|3931148|FG003|Overall Study|Withdrawal by Subject|1
2260645|NCT02132195|3931174|FG000|Initial Assignment|Relapsed|14
2260646|NCT02132195|3931175|FG001|Initial Assignment|Relapsed|0
2260647|NCT02132195|3931176|FG002|Initial Assignment|Relapsed|0
2260648|NCT02132195|3931174|FG000|Rescue Therapy|Relapsed|0
2260649|NCT02132195|3931175|FG001|Rescue Therapy|Relapsed|0
2260650|NCT02132195|3931176|FG002|Rescue Therapy|Relapsed|7
2260651|NCT02132195|3931174|FG000|Rescue Therapy|Physician Decision|0
2260652|NCT02132195|3931175|FG001|Rescue Therapy|Physician Decision|0
2260653|NCT02132195|3931176|FG002|Rescue Therapy|Physician Decision|1
2260654|NCT02132195|3931174|FG000|Rescue Therapy|Withdrawal by Subject|0
2260655|NCT02132195|3931175|FG001|Rescue Therapy|Withdrawal by Subject|0
2260656|NCT02132195|3931176|FG002|Rescue Therapy|Withdrawal by Subject|1
2260657|NCT02132195|3931174|FG000|Rescue Therapy|Adverse Event|0
2260658|NCT02132195|3931175|FG001|Rescue Therapy|Adverse Event|0
2260659|NCT02132195|3931176|FG002|Rescue Therapy|Adverse Event|2
2260660|NCT02132247|3931186|FG000|Overall Study|Protocol Violation|1
2260661|NCT02132247|3931187|FG001|Overall Study|Protocol Violation|0
2260662|NCT02132312|3931195|FG000|Overall Study|Adverse Event|2
2260663|NCT02132312|3931196|FG001|Overall Study|Adverse Event|0
2260664|NCT02132312|3931195|FG000|Overall Study|Physician Decision|1
2260665|NCT02132312|3931196|FG001|Overall Study|Physician Decision|1
2260666|NCT02132312|3931195|FG000|Overall Study|Protocol Violation|0
2260667|NCT02132312|3931196|FG001|Overall Study|Protocol Violation|1
2260668|NCT02132312|3931195|FG000|Overall Study|Withdrawal by Subject|1
2260669|NCT02132312|3931196|FG001|Overall Study|Withdrawal by Subject|0
2260670|NCT02132312|3931195|FG000|Overall Study|Lost to Follow-up|2
2260671|NCT02132312|3931196|FG001|Overall Study|Lost to Follow-up|1
2260672|NCT02132637|3931237|FG000|Study Period 1|Withdrawal by Subject|0
2260673|NCT02132637|3931238|FG001|Study Period 1|Withdrawal by Subject|4
2345465|NCT03589885|4081726|FG004|Treatment Period 2-Randomized Set|Pregnancy|0
2345466|NCT03589885|4081722|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0
2345467|NCT03589885|4081723|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3
2345468|NCT03589885|4081724|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1
2345469|NCT03589885|4081725|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0
2345470|NCT03589885|4081726|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1
2345471|NCT03589885|4081722|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
2345472|NCT03589885|4081723|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1
2345473|NCT03589885|4081724|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
2345474|NCT03589885|4081725|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
2345475|NCT03589885|4081726|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
2345476|NCT03590613|4081744|FG000|Period 2, 4 Days|Physician Decision|0
2345477|NCT03590613|4081745|FG001|Period 2, 4 Days|Physician Decision|0
2345478|NCT03590613|4081746|FG002|Period 2, 4 Days|Physician Decision|0
2345479|NCT03590613|4081747|FG003|Period 2, 4 Days|Physician Decision|1
2345480|NCT03591146|4081771|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
2345481|NCT03591146|4081772|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
2345482|NCT03591146|4081773|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
2345483|NCT03591146|4081774|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
2345484|NCT03591146|4081775|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1
2260674|NCT02132637|3931237|FG000|Study Period 1|Physician Decision|1
2260675|NCT02132637|3931238|FG001|Study Period 1|Physician Decision|0
2260676|NCT02132637|3931237|FG000|Study Period 2 (Crossover)|Adverse Event|0
2260677|NCT02132637|3931238|FG001|Study Period 2 (Crossover)|Adverse Event|1
2260678|NCT02132637|3931237|FG000|Study Period 2 (Crossover)|Physician Decision|2
2260679|NCT02132637|3931238|FG001|Study Period 2 (Crossover)|Physician Decision|0
2260680|NCT02132754|3931297|FG000|Overall Study|Adverse Event|0
2260681|NCT02132754|3931298|FG001|Overall Study|Adverse Event|0
2260682|NCT02132754|3931299|FG002|Overall Study|Adverse Event|0
2260683|NCT02132754|3931300|FG003|Overall Study|Adverse Event|0
2260684|NCT02132754|3931301|FG004|Overall Study|Adverse Event|0
2260685|NCT02132754|3931302|FG005|Overall Study|Adverse Event|0
2260686|NCT02132754|3931303|FG006|Overall Study|Adverse Event|0
2260687|NCT02132754|3931304|FG007|Overall Study|Adverse Event|0
2260688|NCT02132754|3931305|FG008|Overall Study|Adverse Event|0
2260689|NCT02132754|3931306|FG009|Overall Study|Adverse Event|0
2260690|NCT02132754|3931307|FG010|Overall Study|Adverse Event|0
2260691|NCT02132754|3931308|FG011|Overall Study|Adverse Event|0
2260692|NCT02132754|3931309|FG012|Overall Study|Adverse Event|0
2260693|NCT02132754|3931310|FG013|Overall Study|Adverse Event|0
2260694|NCT02132754|3931311|FG014|Overall Study|Adverse Event|0
2260695|NCT02132754|3931312|FG015|Overall Study|Adverse Event|0
2260696|NCT02132754|3931313|FG016|Overall Study|Adverse Event|0
2260697|NCT02132754|3931314|FG017|Overall Study|Adverse Event|1
2260698|NCT02132754|3931315|FG018|Overall Study|Adverse Event|0
2260699|NCT02132754|3931316|FG019|Overall Study|Adverse Event|0
2260700|NCT02132754|3931317|FG020|Overall Study|Adverse Event|0
2260701|NCT02132754|3931318|FG021|Overall Study|Adverse Event|0
2260702|NCT02132754|3931319|FG022|Overall Study|Adverse Event|0
2260703|NCT02132754|3931320|FG023|Overall Study|Adverse Event|0
2260704|NCT02132754|3931321|FG024|Overall Study|Adverse Event|0
2260705|NCT02132754|3931322|FG025|Overall Study|Adverse Event|1
2260706|NCT02132754|3931323|FG026|Overall Study|Adverse Event|1
2260707|NCT02132754|3931324|FG027|Overall Study|Adverse Event|0
2260708|NCT02132754|3931325|FG028|Overall Study|Adverse Event|0
2260709|NCT02132754|3931326|FG029|Overall Study|Adverse Event|0
2260710|NCT02132754|3931327|FG030|Overall Study|Adverse Event|1
2260711|NCT02132754|3931328|FG031|Overall Study|Adverse Event|0
2260712|NCT02132754|3931329|FG032|Overall Study|Adverse Event|1
2260713|NCT02132754|3931330|FG033|Overall Study|Adverse Event|1
2260714|NCT02132754|3931297|FG000|Overall Study|Clinical Progression|0
2260715|NCT02132754|3931298|FG001|Overall Study|Clinical Progression|0
2260716|NCT02132754|3931299|FG002|Overall Study|Clinical Progression|0
2260717|NCT02132754|3931300|FG003|Overall Study|Clinical Progression|0
2260718|NCT02132754|3931301|FG004|Overall Study|Clinical Progression|0
2260719|NCT02132754|3931302|FG005|Overall Study|Clinical Progression|0
2260720|NCT02132754|3931303|FG006|Overall Study|Clinical Progression|0
2260721|NCT02132754|3931304|FG007|Overall Study|Clinical Progression|0
2260722|NCT02132754|3931305|FG008|Overall Study|Clinical Progression|0
2260723|NCT02132754|3931306|FG009|Overall Study|Clinical Progression|1
2260724|NCT02132754|3931307|FG010|Overall Study|Clinical Progression|0
2260725|NCT02132754|3931308|FG011|Overall Study|Clinical Progression|0
2260726|NCT02132754|3931309|FG012|Overall Study|Clinical Progression|0
2260727|NCT02132754|3931310|FG013|Overall Study|Clinical Progression|0
2260728|NCT02132754|3931311|FG014|Overall Study|Clinical Progression|0
2260729|NCT02132754|3931312|FG015|Overall Study|Clinical Progression|0
2260730|NCT02132754|3931313|FG016|Overall Study|Clinical Progression|1
2260731|NCT02132754|3931314|FG017|Overall Study|Clinical Progression|1
2260732|NCT02132754|3931315|FG018|Overall Study|Clinical Progression|0
2260733|NCT02132754|3931316|FG019|Overall Study|Clinical Progression|1
2260734|NCT02132754|3931317|FG020|Overall Study|Clinical Progression|0
2260735|NCT02132754|3931318|FG021|Overall Study|Clinical Progression|0
2260736|NCT02132754|3931319|FG022|Overall Study|Clinical Progression|1
2260737|NCT02132754|3931320|FG023|Overall Study|Clinical Progression|0
2260738|NCT02132754|3931321|FG024|Overall Study|Clinical Progression|1
2260739|NCT02132754|3931322|FG025|Overall Study|Clinical Progression|1
2260740|NCT02132754|3931323|FG026|Overall Study|Clinical Progression|0
2260741|NCT02132754|3931324|FG027|Overall Study|Clinical Progression|1
2260742|NCT02132754|3931325|FG028|Overall Study|Clinical Progression|1
2260743|NCT02132754|3931326|FG029|Overall Study|Clinical Progression|0
2260744|NCT02132754|3931327|FG030|Overall Study|Clinical Progression|1
2260745|NCT02132754|3931328|FG031|Overall Study|Clinical Progression|0
2260746|NCT02132754|3931329|FG032|Overall Study|Clinical Progression|0
2260747|NCT02132754|3931330|FG033|Overall Study|Clinical Progression|2
2260748|NCT02132754|3931297|FG000|Overall Study|Death|0
2260749|NCT02132754|3931298|FG001|Overall Study|Death|0
2260750|NCT02132754|3931299|FG002|Overall Study|Death|0
2260751|NCT02132754|3931300|FG003|Overall Study|Death|0
2260752|NCT02132754|3931301|FG004|Overall Study|Death|0
2260753|NCT02132754|3931302|FG005|Overall Study|Death|0
2260754|NCT02132754|3931303|FG006|Overall Study|Death|0
2260755|NCT02132754|3931304|FG007|Overall Study|Death|0
2260756|NCT02132754|3931305|FG008|Overall Study|Death|0
2260757|NCT02132754|3931306|FG009|Overall Study|Death|0
2260758|NCT02132754|3931307|FG010|Overall Study|Death|0
2260759|NCT02132754|3931308|FG011|Overall Study|Death|0
2260760|NCT02132754|3931309|FG012|Overall Study|Death|0
2260761|NCT02132754|3931310|FG013|Overall Study|Death|0
2260762|NCT02132754|3931311|FG014|Overall Study|Death|0
2260763|NCT02132754|3931312|FG015|Overall Study|Death|1
2260764|NCT02132754|3931313|FG016|Overall Study|Death|0
2260765|NCT02132754|3931314|FG017|Overall Study|Death|0
2260766|NCT02132754|3931315|FG018|Overall Study|Death|0
2260767|NCT02132754|3931316|FG019|Overall Study|Death|1
2260768|NCT02132754|3931317|FG020|Overall Study|Death|0
2260769|NCT02132754|3931318|FG021|Overall Study|Death|1
2260770|NCT02132754|3931319|FG022|Overall Study|Death|0
2260771|NCT02132754|3931320|FG023|Overall Study|Death|0
2260772|NCT02132754|3931321|FG024|Overall Study|Death|0
2260773|NCT02132754|3931322|FG025|Overall Study|Death|0
2260774|NCT02132754|3931323|FG026|Overall Study|Death|1
2260775|NCT02132754|3931324|FG027|Overall Study|Death|0
2260776|NCT02132754|3931325|FG028|Overall Study|Death|0
2260777|NCT02132754|3931326|FG029|Overall Study|Death|0
2260778|NCT02132754|3931327|FG030|Overall Study|Death|0
2260779|NCT02132754|3931328|FG031|Overall Study|Death|0
2260780|NCT02132754|3931329|FG032|Overall Study|Death|0
2260781|NCT02132754|3931330|FG033|Overall Study|Death|2
2260782|NCT02132754|3931297|FG000|Overall Study|Excluded Medication|0
2260783|NCT02132754|3931298|FG001|Overall Study|Excluded Medication|0
2260784|NCT02132754|3931299|FG002|Overall Study|Excluded Medication|0
2260785|NCT02132754|3931300|FG003|Overall Study|Excluded Medication|0
2260786|NCT02132754|3931301|FG004|Overall Study|Excluded Medication|0
2260787|NCT02132754|3931302|FG005|Overall Study|Excluded Medication|0
2260788|NCT02132754|3931303|FG006|Overall Study|Excluded Medication|0
2260789|NCT02132754|3931304|FG007|Overall Study|Excluded Medication|0
2260790|NCT02132754|3931305|FG008|Overall Study|Excluded Medication|0
2345485|NCT03591146|4081771|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
2345486|NCT03591146|4081772|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1
2345487|NCT03591146|4081773|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
2345488|NCT03591146|4081774|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
2345489|NCT03591146|4081775|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
2345490|NCT03591146|4081771|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
2345491|NCT03591146|4081772|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
2345492|NCT03591146|4081773|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
2345493|NCT03591146|4081774|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
2345494|NCT03591146|4081775|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1
2345495|NCT03591146|4081771|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
2345496|NCT03591146|4081772|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
2345497|NCT03591146|4081773|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
2345498|NCT03591146|4081774|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
2345499|NCT03591146|4081775|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
2345500|NCT03591406|4081789|FG000|Overall Study|Adverse Event|5
2345501|NCT03591406|4081790|FG001|Overall Study|Adverse Event|3
2345502|NCT03591406|4081789|FG000|Overall Study|Protocol Violation|2
2345503|NCT03591406|4081790|FG001|Overall Study|Protocol Violation|1
2345504|NCT03591406|4081789|FG000|Overall Study|Withdrawal by Subject|0
2345505|NCT03591406|4081790|FG001|Overall Study|Withdrawal by Subject|5
2345506|NCT03592745|4081807|FG000|Overall Study|Adverse Event|0
2345507|NCT03592745|4081808|FG001|Overall Study|Adverse Event|2
2345508|NCT03592745|4081807|FG000|Overall Study|Lost to Follow-up|2
2345509|NCT03592745|4081808|FG001|Overall Study|Lost to Follow-up|0
2345510|NCT03592745|4081807|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1
2345511|NCT03592745|4081808|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1
2345512|NCT03593681|4081831|FG000|Overall Study|Inadequate sample collected|12
2345513|NCT03593681|4081831|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11
2345514|NCT03593681|4081831|FG000|Overall Study|Protocol Violation|3
2345515|NCT03593681|4081831|FG000|Overall Study|Withdrawal by Subject|3
2345516|NCT03593681|4081831|FG000|Overall Study|Procedure not attempted|3
2345517|NCT03593681|4081831|FG000|Overall Study|Adverse Event|2
2345518|NCT03593681|4081831|FG000|Overall Study|Physician Decision|1
2345519|NCT03593876|4081852|FG000|Overall Study|Withdrawal by Subject|1
2345520|NCT03593876|4081852|FG000|Overall Study|Discharged home before intervention completion|2
2345521|NCT03594071|4081869|FG000|Overall Study|Re-operation|3
2345522|NCT03594071|4081869|FG000|Overall Study|Missed visit|2
2345523|NCT03594227|4081877|FG000|Overall Study|Adverse Event|2
2345524|NCT03594227|4081878|FG001|Overall Study|Adverse Event|1
2345525|NCT03594227|4081879|FG002|Overall Study|Adverse Event|0
2345526|NCT03594227|4081880|FG003|Overall Study|Adverse Event|2
2345527|NCT03594227|4081877|FG000|Overall Study|Lost to Follow-up|1
2345528|NCT03594227|4081878|FG001|Overall Study|Lost to Follow-up|1
2345529|NCT03594227|4081879|FG002|Overall Study|Lost to Follow-up|1
2345530|NCT03594227|4081880|FG003|Overall Study|Lost to Follow-up|0
2345531|NCT03594227|4081877|FG000|Overall Study|Withdrawal by Subject|1
2345532|NCT03594227|4081878|FG001|Overall Study|Withdrawal by Subject|1
2345533|NCT03594227|4081879|FG002|Overall Study|Withdrawal by Subject|1
2345534|NCT03594227|4081880|FG003|Overall Study|Withdrawal by Subject|1
2345535|NCT03594227|4081877|FG000|Overall Study|Pregnancy|0
2345536|NCT03594227|4081878|FG001|Overall Study|Pregnancy|1
2345537|NCT03594227|4081879|FG002|Overall Study|Pregnancy|0
2345538|NCT03594227|4081880|FG003|Overall Study|Pregnancy|0
2345539|NCT03594227|4081877|FG000|Overall Study|Sponsor Decision|0
2345540|NCT03594227|4081878|FG001|Overall Study|Sponsor Decision|0
2345541|NCT03594227|4081879|FG002|Overall Study|Sponsor Decision|0
2260791|NCT02132754|3931306|FG009|Overall Study|Excluded Medication|0
2260792|NCT02132754|3931307|FG010|Overall Study|Excluded Medication|0
2260793|NCT02132754|3931308|FG011|Overall Study|Excluded Medication|0
2260794|NCT02132754|3931309|FG012|Overall Study|Excluded Medication|0
2260795|NCT02132754|3931310|FG013|Overall Study|Excluded Medication|0
2260796|NCT02132754|3931311|FG014|Overall Study|Excluded Medication|0
2260797|NCT02132754|3931312|FG015|Overall Study|Excluded Medication|0
2260798|NCT02132754|3931313|FG016|Overall Study|Excluded Medication|0
2260799|NCT02132754|3931314|FG017|Overall Study|Excluded Medication|0
2260800|NCT02132754|3931315|FG018|Overall Study|Excluded Medication|0
2260801|NCT02132754|3931316|FG019|Overall Study|Excluded Medication|0
2260802|NCT02132754|3931317|FG020|Overall Study|Excluded Medication|1
2260803|NCT02132754|3931318|FG021|Overall Study|Excluded Medication|0
2260804|NCT02132754|3931319|FG022|Overall Study|Excluded Medication|0
2260805|NCT02132754|3931320|FG023|Overall Study|Excluded Medication|0
2260806|NCT02132754|3931321|FG024|Overall Study|Excluded Medication|0
2260807|NCT02132754|3931322|FG025|Overall Study|Excluded Medication|0
2260808|NCT02132754|3931323|FG026|Overall Study|Excluded Medication|0
2260809|NCT02132754|3931324|FG027|Overall Study|Excluded Medication|0
2260810|NCT02132754|3931325|FG028|Overall Study|Excluded Medication|0
2260811|NCT02132754|3931326|FG029|Overall Study|Excluded Medication|0
2260812|NCT02132754|3931327|FG030|Overall Study|Excluded Medication|0
2260813|NCT02132754|3931328|FG031|Overall Study|Excluded Medication|0
2260814|NCT02132754|3931329|FG032|Overall Study|Excluded Medication|0
2260815|NCT02132754|3931330|FG033|Overall Study|Excluded Medication|1
2260816|NCT02132754|3931297|FG000|Overall Study|Physician Decision|0
2260817|NCT02132754|3931298|FG001|Overall Study|Physician Decision|0
2260818|NCT02132754|3931299|FG002|Overall Study|Physician Decision|0
2260819|NCT02132754|3931300|FG003|Overall Study|Physician Decision|0
2260820|NCT02132754|3931301|FG004|Overall Study|Physician Decision|0
2260821|NCT02132754|3931302|FG005|Overall Study|Physician Decision|0
2260822|NCT02132754|3931303|FG006|Overall Study|Physician Decision|0
2260823|NCT02132754|3931304|FG007|Overall Study|Physician Decision|0
2260824|NCT02132754|3931305|FG008|Overall Study|Physician Decision|0
2260825|NCT02132754|3931306|FG009|Overall Study|Physician Decision|1
2260826|NCT02132754|3931307|FG010|Overall Study|Physician Decision|0
2260827|NCT02132754|3931308|FG011|Overall Study|Physician Decision|1
2260828|NCT02132754|3931309|FG012|Overall Study|Physician Decision|1
2260829|NCT02132754|3931310|FG013|Overall Study|Physician Decision|0
2260830|NCT02132754|3931311|FG014|Overall Study|Physician Decision|0
2260831|NCT02132754|3931312|FG015|Overall Study|Physician Decision|1
2260832|NCT02132754|3931313|FG016|Overall Study|Physician Decision|0
2260833|NCT02132754|3931314|FG017|Overall Study|Physician Decision|0
2260834|NCT02132754|3931315|FG018|Overall Study|Physician Decision|0
2260835|NCT02132754|3931316|FG019|Overall Study|Physician Decision|0
2260836|NCT02132754|3931317|FG020|Overall Study|Physician Decision|0
2260837|NCT02132754|3931318|FG021|Overall Study|Physician Decision|0
2260838|NCT02132754|3931319|FG022|Overall Study|Physician Decision|0
2260839|NCT02132754|3931320|FG023|Overall Study|Physician Decision|0
2260840|NCT02132754|3931321|FG024|Overall Study|Physician Decision|1
2260841|NCT02132754|3931322|FG025|Overall Study|Physician Decision|0
2260842|NCT02132754|3931323|FG026|Overall Study|Physician Decision|0
2260843|NCT02132754|3931324|FG027|Overall Study|Physician Decision|0
2260844|NCT02132754|3931325|FG028|Overall Study|Physician Decision|0
2260845|NCT02132754|3931326|FG029|Overall Study|Physician Decision|0
2260846|NCT02132754|3931327|FG030|Overall Study|Physician Decision|0
2260847|NCT02132754|3931328|FG031|Overall Study|Physician Decision|1
2260848|NCT02132754|3931329|FG032|Overall Study|Physician Decision|0
2260849|NCT02132754|3931330|FG033|Overall Study|Physician Decision|3
2260850|NCT02132754|3931297|FG000|Overall Study|Progressive Disease|1
2260851|NCT02132754|3931298|FG001|Overall Study|Progressive Disease|1
2260852|NCT02132754|3931299|FG002|Overall Study|Progressive Disease|1
2260853|NCT02132754|3931300|FG003|Overall Study|Progressive Disease|1
2260854|NCT02132754|3931301|FG004|Overall Study|Progressive Disease|1
2260855|NCT02132754|3931302|FG005|Overall Study|Progressive Disease|1
2260856|NCT02132754|3931303|FG006|Overall Study|Progressive Disease|1
2260857|NCT02132754|3931304|FG007|Overall Study|Progressive Disease|1
2260858|NCT02132754|3931305|FG008|Overall Study|Progressive Disease|1
2260859|NCT02132754|3931306|FG009|Overall Study|Progressive Disease|3
2260860|NCT02132754|3931307|FG010|Overall Study|Progressive Disease|3
2260861|NCT02132754|3931308|FG011|Overall Study|Progressive Disease|2
2260862|NCT02132754|3931309|FG012|Overall Study|Progressive Disease|2
2260863|NCT02132754|3931310|FG013|Overall Study|Progressive Disease|3
2260864|NCT02132754|3931311|FG014|Overall Study|Progressive Disease|2
2260865|NCT02132754|3931312|FG015|Overall Study|Progressive Disease|1
2260866|NCT02132754|3931313|FG016|Overall Study|Progressive Disease|2
2260867|NCT02132754|3931314|FG017|Overall Study|Progressive Disease|1
2260868|NCT02132754|3931315|FG018|Overall Study|Progressive Disease|3
2260869|NCT02132754|3931316|FG019|Overall Study|Progressive Disease|1
2260870|NCT02132754|3931317|FG020|Overall Study|Progressive Disease|1
2260871|NCT02132754|3931318|FG021|Overall Study|Progressive Disease|3
2260872|NCT02132754|3931319|FG022|Overall Study|Progressive Disease|2
2260873|NCT02132754|3931320|FG023|Overall Study|Progressive Disease|3
2260874|NCT02132754|3931321|FG024|Overall Study|Progressive Disease|0
2260875|NCT02132754|3931322|FG025|Overall Study|Progressive Disease|1
2260876|NCT02132754|3931323|FG026|Overall Study|Progressive Disease|2
2260877|NCT02132754|3931324|FG027|Overall Study|Progressive Disease|1
2260878|NCT02132754|3931325|FG028|Overall Study|Progressive Disease|2
2260879|NCT02132754|3931326|FG029|Overall Study|Progressive Disease|3
2260880|NCT02132754|3931327|FG030|Overall Study|Progressive Disease|1
2260881|NCT02132754|3931328|FG031|Overall Study|Progressive Disease|1
2260882|NCT02132754|3931329|FG032|Overall Study|Progressive Disease|3
2345542|NCT03594227|4081880|FG003|Overall Study|Sponsor Decision|1
2345543|NCT03594227|4081877|FG000|Overall Study|Programmatic Analysis Non-completer|1
2345544|NCT03594227|4081878|FG001|Overall Study|Programmatic Analysis Non-completer|0
2345545|NCT03594227|4081879|FG002|Overall Study|Programmatic Analysis Non-completer|1
2345546|NCT03594227|4081880|FG003|Overall Study|Programmatic Analysis Non-completer|1
2345547|NCT03595176|4081915|FG000|Overall Study|Death|0
2345548|NCT03595176|4081916|FG001|Overall Study|Death|2
2345549|NCT03595176|4081915|FG000|Overall Study|Lost to Follow-up|0
2345550|NCT03595176|4081916|FG001|Overall Study|Lost to Follow-up|1
2345551|NCT03595280|4081928|FG000|Overall Study|Lost to Follow-up|6
2345552|NCT03595280|4081929|FG001|Overall Study|Lost to Follow-up|9
2345553|NCT03595280|4081930|FG002|Overall Study|Lost to Follow-up|15
2345554|NCT03595618|4081960|FG000|Overall Study|Adverse Event|16
2345555|NCT03595618|4081961|FG001|Overall Study|Adverse Event|17
2260883|NCT02132754|3931330|FG033|Overall Study|Progressive Disease|6
2260884|NCT02132754|3931297|FG000|Overall Study|Screen Failure|0
2260885|NCT02132754|3931298|FG001|Overall Study|Screen Failure|0
2260886|NCT02132754|3931299|FG002|Overall Study|Screen Failure|0
2260887|NCT02132754|3931300|FG003|Overall Study|Screen Failure|0
2260888|NCT02132754|3931301|FG004|Overall Study|Screen Failure|0
2260889|NCT02132754|3931302|FG005|Overall Study|Screen Failure|0
2260890|NCT02132754|3931303|FG006|Overall Study|Screen Failure|0
2260891|NCT02132754|3931304|FG007|Overall Study|Screen Failure|0
2260892|NCT02132754|3931305|FG008|Overall Study|Screen Failure|0
2260893|NCT02132754|3931306|FG009|Overall Study|Screen Failure|0
2260894|NCT02132754|3931307|FG010|Overall Study|Screen Failure|0
2260895|NCT02132754|3931308|FG011|Overall Study|Screen Failure|0
2260896|NCT02132754|3931309|FG012|Overall Study|Screen Failure|0
2260897|NCT02132754|3931310|FG013|Overall Study|Screen Failure|0
2260898|NCT02132754|3931311|FG014|Overall Study|Screen Failure|0
2260899|NCT02132754|3931312|FG015|Overall Study|Screen Failure|0
2260900|NCT02132754|3931313|FG016|Overall Study|Screen Failure|0
2260901|NCT02132754|3931314|FG017|Overall Study|Screen Failure|0
2260902|NCT02132754|3931315|FG018|Overall Study|Screen Failure|0
2260903|NCT02132754|3931316|FG019|Overall Study|Screen Failure|1
2260904|NCT02132754|3931317|FG020|Overall Study|Screen Failure|0
2260905|NCT02132754|3931318|FG021|Overall Study|Screen Failure|1
2260906|NCT02132754|3931319|FG022|Overall Study|Screen Failure|0
2260907|NCT02132754|3931320|FG023|Overall Study|Screen Failure|0
2260908|NCT02132754|3931321|FG024|Overall Study|Screen Failure|0
2260909|NCT02132754|3931322|FG025|Overall Study|Screen Failure|0
2260910|NCT02132754|3931323|FG026|Overall Study|Screen Failure|0
2260911|NCT02132754|3931324|FG027|Overall Study|Screen Failure|0
2260912|NCT02132754|3931325|FG028|Overall Study|Screen Failure|0
2260913|NCT02132754|3931326|FG029|Overall Study|Screen Failure|0
2260914|NCT02132754|3931327|FG030|Overall Study|Screen Failure|0
2260915|NCT02132754|3931328|FG031|Overall Study|Screen Failure|0
2260916|NCT02132754|3931329|FG032|Overall Study|Screen Failure|0
2260917|NCT02132754|3931330|FG033|Overall Study|Screen Failure|0
2260918|NCT02132754|3931297|FG000|Overall Study|Transferred to Extension Study|0
2260919|NCT02132754|3931298|FG001|Overall Study|Transferred to Extension Study|0
2260920|NCT02132754|3931299|FG002|Overall Study|Transferred to Extension Study|0
2260921|NCT02132754|3931300|FG003|Overall Study|Transferred to Extension Study|0
2260922|NCT02132754|3931301|FG004|Overall Study|Transferred to Extension Study|0
2260923|NCT02132754|3931302|FG005|Overall Study|Transferred to Extension Study|0
2260924|NCT02132754|3931303|FG006|Overall Study|Transferred to Extension Study|0
2260925|NCT02132754|3931304|FG007|Overall Study|Transferred to Extension Study|0
2260926|NCT02132754|3931305|FG008|Overall Study|Transferred to Extension Study|0
2260927|NCT02132754|3931306|FG009|Overall Study|Transferred to Extension Study|0
2260928|NCT02132754|3931307|FG010|Overall Study|Transferred to Extension Study|0
2260929|NCT02132754|3931308|FG011|Overall Study|Transferred to Extension Study|0
2260930|NCT02132754|3931309|FG012|Overall Study|Transferred to Extension Study|0
2260931|NCT02132754|3931310|FG013|Overall Study|Transferred to Extension Study|0
2260932|NCT02132754|3931311|FG014|Overall Study|Transferred to Extension Study|0
2260933|NCT02132754|3931312|FG015|Overall Study|Transferred to Extension Study|0
2260934|NCT02132754|3931313|FG016|Overall Study|Transferred to Extension Study|0
2260935|NCT02132754|3931314|FG017|Overall Study|Transferred to Extension Study|0
2260936|NCT02132754|3931315|FG018|Overall Study|Transferred to Extension Study|0
2260937|NCT02132754|3931316|FG019|Overall Study|Transferred to Extension Study|0
2345556|NCT03595618|4081962|FG002|Overall Study|Adverse Event|20
2345557|NCT03595618|4081963|FG003|Overall Study|Adverse Event|8
2260938|NCT02132754|3931317|FG020|Overall Study|Transferred to Extension Study|0
2260939|NCT02132754|3931318|FG021|Overall Study|Transferred to Extension Study|0
2260940|NCT02132754|3931319|FG022|Overall Study|Transferred to Extension Study|0
2260941|NCT02132754|3931320|FG023|Overall Study|Transferred to Extension Study|0
2260942|NCT02132754|3931321|FG024|Overall Study|Transferred to Extension Study|0
2260943|NCT02132754|3931322|FG025|Overall Study|Transferred to Extension Study|0
2260944|NCT02132754|3931323|FG026|Overall Study|Transferred to Extension Study|0
2260945|NCT02132754|3931324|FG027|Overall Study|Transferred to Extension Study|0
2260946|NCT02132754|3931325|FG028|Overall Study|Transferred to Extension Study|0
2260947|NCT02132754|3931326|FG029|Overall Study|Transferred to Extension Study|0
2260948|NCT02132754|3931327|FG030|Overall Study|Transferred to Extension Study|0
2260949|NCT02132754|3931328|FG031|Overall Study|Transferred to Extension Study|0
2260950|NCT02132754|3931329|FG032|Overall Study|Transferred to Extension Study|0
2260951|NCT02132754|3931330|FG033|Overall Study|Transferred to Extension Study|6
2260952|NCT02132754|3931297|FG000|Overall Study|Withdrawal by Subject|0
2260953|NCT02132754|3931298|FG001|Overall Study|Withdrawal by Subject|0
2260954|NCT02132754|3931299|FG002|Overall Study|Withdrawal by Subject|0
2260955|NCT02132754|3931300|FG003|Overall Study|Withdrawal by Subject|0
2260956|NCT02132754|3931301|FG004|Overall Study|Withdrawal by Subject|0
2260957|NCT02132754|3931302|FG005|Overall Study|Withdrawal by Subject|0
2260958|NCT02132754|3931303|FG006|Overall Study|Withdrawal by Subject|0
2260959|NCT02132754|3931304|FG007|Overall Study|Withdrawal by Subject|0
2260960|NCT02132754|3931305|FG008|Overall Study|Withdrawal by Subject|0
2260961|NCT02132754|3931306|FG009|Overall Study|Withdrawal by Subject|1
2260962|NCT02132754|3931307|FG010|Overall Study|Withdrawal by Subject|0
2260963|NCT02132754|3931308|FG011|Overall Study|Withdrawal by Subject|0
2260964|NCT02132754|3931309|FG012|Overall Study|Withdrawal by Subject|1
2260965|NCT02132754|3931310|FG013|Overall Study|Withdrawal by Subject|0
2260966|NCT02132754|3931311|FG014|Overall Study|Withdrawal by Subject|1
2260967|NCT02132754|3931312|FG015|Overall Study|Withdrawal by Subject|2
2260968|NCT02132754|3931313|FG016|Overall Study|Withdrawal by Subject|1
2260969|NCT02132754|3931314|FG017|Overall Study|Withdrawal by Subject|0
2260970|NCT02132754|3931315|FG018|Overall Study|Withdrawal by Subject|0
2260971|NCT02132754|3931316|FG019|Overall Study|Withdrawal by Subject|0
2260972|NCT02132754|3931317|FG020|Overall Study|Withdrawal by Subject|1
2260973|NCT02132754|3931318|FG021|Overall Study|Withdrawal by Subject|0
2260974|NCT02132754|3931319|FG022|Overall Study|Withdrawal by Subject|0
2260975|NCT02132754|3931320|FG023|Overall Study|Withdrawal by Subject|0
2260976|NCT02132754|3931321|FG024|Overall Study|Withdrawal by Subject|1
2260977|NCT02132754|3931322|FG025|Overall Study|Withdrawal by Subject|0
2260978|NCT02132754|3931323|FG026|Overall Study|Withdrawal by Subject|0
2260979|NCT02132754|3931324|FG027|Overall Study|Withdrawal by Subject|1
2260980|NCT02132754|3931325|FG028|Overall Study|Withdrawal by Subject|0
2260981|NCT02132754|3931326|FG029|Overall Study|Withdrawal by Subject|0
2260982|NCT02132754|3931327|FG030|Overall Study|Withdrawal by Subject|0
2260983|NCT02132754|3931328|FG031|Overall Study|Withdrawal by Subject|1
2260984|NCT02132754|3931329|FG032|Overall Study|Withdrawal by Subject|0
2260985|NCT02132754|3931330|FG033|Overall Study|Withdrawal by Subject|2
2260986|NCT02132767|3931442|FG000|Overall Study|Death|3
2260987|NCT02132767|3931443|FG001|Overall Study|Death|2
2260988|NCT02132767|3931442|FG000|Overall Study|Withdrawal by Subject|10
2260989|NCT02132767|3931443|FG001|Overall Study|Withdrawal by Subject|9
2260990|NCT02132767|3931442|FG000|Overall Study|Lost to Follow-up|4
2260991|NCT02132767|3931443|FG001|Overall Study|Lost to Follow-up|4
2260992|NCT02132949|3931487|FG000|Overall Study|Death|7
2260993|NCT02132949|3931488|FG001|Overall Study|Death|13
2260994|NCT02132949|3931487|FG000|Overall Study|Lost to Follow-up|14
2260995|NCT02132949|3931488|FG001|Overall Study|Lost to Follow-up|4
2260996|NCT02132949|3931487|FG000|Overall Study|Withdrawal by Subject|6
2260997|NCT02132949|3931488|FG001|Overall Study|Withdrawal by Subject|5
2260998|NCT02132949|3931487|FG000|Overall Study|Noncompliance|5
2260999|NCT02132949|3931488|FG001|Overall Study|Noncompliance|1
2261000|NCT02132949|3931487|FG000|Overall Study|Physician Decision|3
2261001|NCT02132949|3931488|FG001|Overall Study|Physician Decision|1
2261002|NCT02132949|3931487|FG000|Overall Study|Disease Progression|3
2261003|NCT02132949|3931488|FG001|Overall Study|Disease Progression|0
2261004|NCT02132949|3931487|FG000|Overall Study|Adverse Event|2
2261005|NCT02132949|3931488|FG001|Overall Study|Adverse Event|1
2261006|NCT02132949|3931487|FG000|Overall Study|Withdrew Prior to Treatment|1
2261007|NCT02132949|3931488|FG001|Overall Study|Withdrew Prior to Treatment|2
2261008|NCT02132949|3931487|FG000|Overall Study|Reason Unspecified|0
2261009|NCT02132949|3931488|FG001|Overall Study|Reason Unspecified|1
2261010|NCT02133001|3931496|FG000|Double Blind (Day 1-25)|Adverse Event|1
2261011|NCT02133001|3931497|FG001|Double Blind (Day 1-25)|Adverse Event|5
2261012|NCT02133001|3931496|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4
2261013|NCT02133001|3931497|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1
2261014|NCT02133001|3931496|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2
2261015|NCT02133001|3931497|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0
2261016|NCT02133001|3931496|FG000|Double Blind (Day 1-25)|Other|2
2261017|NCT02133001|3931497|FG001|Double Blind (Day 1-25)|Other|2
2261018|NCT02133001|3931496|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1
2261019|NCT02133001|3931497|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1
2261020|NCT02133001|3931496|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
2261021|NCT02133001|3931497|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
2261022|NCT02133001|3931496|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
2261023|NCT02133001|3931497|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
2261024|NCT02133001|3931496|FG000|Follow-Up Phase (Day 26-81)|Other|0
2261025|NCT02133001|3931497|FG001|Follow-Up Phase (Day 26-81)|Other|1
2261026|NCT02133131|3931521|FG000|Overall Study|Adverse Event|0
2261027|NCT02133131|3931522|FG001|Overall Study|Adverse Event|0
2261028|NCT02133131|3931523|FG002|Overall Study|Adverse Event|0
2261029|NCT02133131|3931524|FG003|Overall Study|Adverse Event|1
2261030|NCT02133131|3931525|FG004|Overall Study|Adverse Event|0
2261031|NCT02133131|3931526|FG005|Overall Study|Adverse Event|0
2261032|NCT02133131|3931527|FG006|Overall Study|Adverse Event|0
2261033|NCT02133131|3931521|FG000|Overall Study|Lost to Follow-up|1
2261034|NCT02133131|3931522|FG001|Overall Study|Lost to Follow-up|0
2261035|NCT02133131|3931523|FG002|Overall Study|Lost to Follow-up|0
2261036|NCT02133131|3931524|FG003|Overall Study|Lost to Follow-up|1
2261037|NCT02133131|3931525|FG004|Overall Study|Lost to Follow-up|0
2261038|NCT02133131|3931526|FG005|Overall Study|Lost to Follow-up|0
2261039|NCT02133131|3931527|FG006|Overall Study|Lost to Follow-up|0
2261040|NCT02133131|3931521|FG000|Overall Study|Status not recorded|4
2261041|NCT02133131|3931522|FG001|Overall Study|Status not recorded|5
2261042|NCT02133131|3931523|FG002|Overall Study|Status not recorded|1
2261043|NCT02133131|3931524|FG003|Overall Study|Status not recorded|4
2261044|NCT02133131|3931525|FG004|Overall Study|Status not recorded|0
2261045|NCT02133131|3931526|FG005|Overall Study|Status not recorded|0
2261046|NCT02133131|3931527|FG006|Overall Study|Status not recorded|0
2261047|NCT02133131|3931521|FG000|Overall Study|Ongoing in study|0
2261048|NCT02133131|3931522|FG001|Overall Study|Ongoing in study|0
2261049|NCT02133131|3931523|FG002|Overall Study|Ongoing in study|0
2261050|NCT02133131|3931524|FG003|Overall Study|Ongoing in study|0
2261051|NCT02133131|3931525|FG004|Overall Study|Ongoing in study|15
2261052|NCT02133131|3931526|FG005|Overall Study|Ongoing in study|14
2261053|NCT02133131|3931527|FG006|Overall Study|Ongoing in study|11
2345558|NCT03595618|4081960|FG000|Overall Study|Withdrawal by Subject|12
2345559|NCT03595618|4081961|FG001|Overall Study|Withdrawal by Subject|14
2345560|NCT03595618|4081962|FG002|Overall Study|Withdrawal by Subject|14
2345561|NCT03595618|4081963|FG003|Overall Study|Withdrawal by Subject|10
2345562|NCT03595618|4081960|FG000|Overall Study|Lost to Follow-up|6
2345563|NCT03595618|4081961|FG001|Overall Study|Lost to Follow-up|4
2345564|NCT03595618|4081962|FG002|Overall Study|Lost to Follow-up|5
2345565|NCT03595618|4081963|FG003|Overall Study|Lost to Follow-up|6
2345566|NCT03595618|4081960|FG000|Overall Study|Protocol Violation|2
2345567|NCT03595618|4081961|FG001|Overall Study|Protocol Violation|0
2345568|NCT03595618|4081962|FG002|Overall Study|Protocol Violation|6
2345569|NCT03595618|4081963|FG003|Overall Study|Protocol Violation|2
2345570|NCT03595618|4081960|FG000|Overall Study|Physician Decision|0
2345571|NCT03595618|4081961|FG001|Overall Study|Physician Decision|0
2345572|NCT03595618|4081962|FG002|Overall Study|Physician Decision|1
2345573|NCT03595618|4081963|FG003|Overall Study|Physician Decision|2
2345574|NCT03595618|4081960|FG000|Overall Study|Miscellaneous|7
2345575|NCT03595618|4081961|FG001|Overall Study|Miscellaneous|5
2345576|NCT03595618|4081962|FG002|Overall Study|Miscellaneous|10
2345577|NCT03595618|4081963|FG003|Overall Study|Miscellaneous|6
2345578|NCT03595904|4081975|FG000|Overall Study|Protocol Violation|3
2345579|NCT03595904|4081976|FG001|Overall Study|Protocol Violation|1
2345580|NCT03595904|4081975|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4
2345581|NCT03595904|4081976|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3
2345582|NCT03595904|4081975|FG000|Overall Study|Insurance complications|1
2345583|NCT03595904|4081976|FG001|Overall Study|Insurance complications|0
2345584|NCT03595904|4081975|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2
2345585|NCT03595904|4081976|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1
2261054|NCT02133131|3931521|FG000|Overall Study|Protocol Violation|0
2261055|NCT02133131|3931522|FG001|Overall Study|Protocol Violation|0
2261056|NCT02133131|3931523|FG002|Overall Study|Protocol Violation|0
2261057|NCT02133131|3931524|FG003|Overall Study|Protocol Violation|0
2261058|NCT02133131|3931525|FG004|Overall Study|Protocol Violation|0
2261059|NCT02133131|3931526|FG005|Overall Study|Protocol Violation|0
2261060|NCT02133131|3931527|FG006|Overall Study|Protocol Violation|1
2261061|NCT02133352|3931558|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
2261062|NCT02133508|3931562|FG000|Overall Study|Decision of Investigator or Sponsor|1
2261063|NCT02133508|3931562|FG000|Overall Study|Death|12
2261064|NCT02133508|3931562|FG000|Overall Study|Lost to Follow-up|2
2261065|NCT02133664|3931568|FG000|Overall Study|Lost to Follow-up|2
2261066|NCT02133664|3931569|FG001|Overall Study|Lost to Follow-up|1
2261067|NCT02133664|3931568|FG000|Overall Study|Adverse Event|3
2261068|NCT02133664|3931569|FG001|Overall Study|Adverse Event|6
2261069|NCT02133742|3931575|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2
2261070|NCT02133742|3931575|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31
2261071|NCT02133742|3931575|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13
2261072|NCT02133742|3931575|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5
2261073|NCT02133742|3931575|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1
2345586|NCT03596151|4081982|FG000|Overall Study|Withdrawal by Subject|1
2345587|NCT03596177|4081988|FG000|Single Blind Period|Withdrawal by Subject|1
2345588|NCT03596177|4081989|FG001|Single Blind Period|Withdrawal by Subject|1
2345589|NCT03596177|4081988|FG000|Single Blind Period|Other|1
2345590|NCT03596177|4081989|FG001|Single Blind Period|Other|0
2345591|NCT03596177|4081988|FG000|Double Blind Period|Withdrawal by Subject|0
2345592|NCT03596177|4081989|FG001|Double Blind Period|Withdrawal by Subject|1
2345593|NCT03596177|4081988|FG000|Double Blind Period|Other|0
2345594|NCT03596177|4081989|FG001|Double Blind Period|Other|4
2345595|NCT03596177|4081988|FG000|Double Blind Period|Death during safety follow-up|0
2345596|NCT03596177|4081989|FG001|Double Blind Period|Death during safety follow-up|1
2345597|NCT03597022|4082011|FG000|Overall Study|Premature termination of the study|7
2261074|NCT02134015|3931596|FG000|Overall Study|Protocol Violation|0
2261075|NCT02134015|3931597|FG001|Overall Study|Protocol Violation|1
2261076|NCT02134015|3931596|FG000|Overall Study|Death|2
2261077|NCT02134015|3931597|FG001|Overall Study|Death|1
2261078|NCT02134015|3931596|FG000|Overall Study|Reason not provided|1
2261079|NCT02134015|3931597|FG001|Overall Study|Reason not provided|2
2261080|NCT02134015|3931596|FG000|Overall Study|Clinical progression|14
2261081|NCT02134015|3931597|FG001|Overall Study|Clinical progression|7
2261082|NCT02134015|3931596|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40
2261083|NCT02134015|3931597|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43
2261084|NCT02134015|3931596|FG000|Overall Study|Study terminated by sponsor|2
2261085|NCT02134015|3931597|FG001|Overall Study|Study terminated by sponsor|3
2261086|NCT02134015|3931596|FG000|Overall Study|Adverse Event|9
2261087|NCT02134015|3931597|FG001|Overall Study|Adverse Event|10
2261088|NCT02134015|3931596|FG000|Overall Study|Withdrawal by Subject|3
2261089|NCT02134015|3931597|FG001|Overall Study|Withdrawal by Subject|7
2261090|NCT02134028|3931611|FG000|Overall Study|Lack of Efficacy|1
2261091|NCT02134028|3931612|FG001|Overall Study|Lack of Efficacy|0
2261092|NCT02134028|3931613|FG002|Overall Study|Lack of Efficacy|3
2261093|NCT02134028|3931614|FG003|Overall Study|Lack of Efficacy|2
2261094|NCT02134028|3931615|FG004|Overall Study|Lack of Efficacy|1
2261095|NCT02134028|3931616|FG005|Overall Study|Lack of Efficacy|2
2261096|NCT02134028|3931617|FG006|Overall Study|Lack of Efficacy|1
2261097|NCT02134028|3931618|FG007|Overall Study|Lack of Efficacy|0
2261098|NCT02134028|3931611|FG000|Overall Study|Poor compliance to protocol|1
2261099|NCT02134028|3931612|FG001|Overall Study|Poor compliance to protocol|1
2261100|NCT02134028|3931613|FG002|Overall Study|Poor compliance to protocol|3
2261101|NCT02134028|3931614|FG003|Overall Study|Poor compliance to protocol|7
2261102|NCT02134028|3931615|FG004|Overall Study|Poor compliance to protocol|1
2261103|NCT02134028|3931616|FG005|Overall Study|Poor compliance to protocol|1
2261104|NCT02134028|3931617|FG006|Overall Study|Poor compliance to protocol|0
2261105|NCT02134028|3931618|FG007|Overall Study|Poor compliance to protocol|0
2261106|NCT02134028|3931611|FG000|Overall Study|Other unspecified|4
2261107|NCT02134028|3931612|FG001|Overall Study|Other unspecified|22
2261108|NCT02134028|3931613|FG002|Overall Study|Other unspecified|33
2261109|NCT02134028|3931614|FG003|Overall Study|Other unspecified|64
2261110|NCT02134028|3931615|FG004|Overall Study|Other unspecified|8
2261111|NCT02134028|3931616|FG005|Overall Study|Other unspecified|6
2261112|NCT02134028|3931617|FG006|Overall Study|Other unspecified|2
2261113|NCT02134028|3931618|FG007|Overall Study|Other unspecified|1
2261114|NCT02134028|3931611|FG000|Overall Study|Adverse Event|3
2261115|NCT02134028|3931612|FG001|Overall Study|Adverse Event|19
2261116|NCT02134028|3931613|FG002|Overall Study|Adverse Event|13
2261117|NCT02134028|3931614|FG003|Overall Study|Adverse Event|32
2261118|NCT02134028|3931615|FG004|Overall Study|Adverse Event|4
2261119|NCT02134028|3931616|FG005|Overall Study|Adverse Event|5
2261120|NCT02134028|3931617|FG006|Overall Study|Adverse Event|1
2261121|NCT02134028|3931618|FG007|Overall Study|Adverse Event|2
2261122|NCT02134353|3931681|FG000|Overall Study|Adverse Event|10
2261123|NCT02134353|3931682|FG001|Overall Study|Adverse Event|6
2261124|NCT02134353|3931681|FG000|Overall Study|Lost to Follow-up|1
2261125|NCT02134353|3931682|FG001|Overall Study|Lost to Follow-up|1
2261126|NCT02134353|3931681|FG000|Overall Study|Lack of Efficacy|2
2261127|NCT02134353|3931682|FG001|Overall Study|Lack of Efficacy|1
2261128|NCT02134353|3931681|FG000|Overall Study|Withdrawal by Subject|12
2261129|NCT02134353|3931682|FG001|Overall Study|Withdrawal by Subject|13
2261130|NCT02134353|3931681|FG000|Overall Study|Death|0
2261131|NCT02134353|3931682|FG001|Overall Study|Death|1
2261132|NCT02134353|3931681|FG000|Overall Study|Pregnancy|0
2261133|NCT02134353|3931682|FG001|Overall Study|Pregnancy|1
2261134|NCT02134353|3931681|FG000|Overall Study|Relocation|1
2261135|NCT02134353|3931682|FG001|Overall Study|Relocation|0
2261136|NCT02134353|3931681|FG000|Overall Study|Other - Patient's Choice|0
2261137|NCT02134353|3931682|FG001|Overall Study|Other - Patient's Choice|1
2261138|NCT02134587|3931692|FG000|Overall Study|Did not completed all meetings|30
2261139|NCT02134977|3931719|FG000|Overall Study|Protocol Deviation|102
2261140|NCT02135107|3931747|FG000|Treatment Period|Withdrawal by Subject|11
2261141|NCT02135107|3931748|FG001|Treatment Period|Withdrawal by Subject|0
2261142|NCT02135107|3931749|FG002|Treatment Period|Withdrawal by Subject|0
2261143|NCT02135107|3931750|FG003|Treatment Period|Withdrawal by Subject|0
2261144|NCT02135107|3931747|FG000|Treatment Period|Adverse Event|5
2261145|NCT02135107|3931748|FG001|Treatment Period|Adverse Event|2
2261146|NCT02135107|3931749|FG002|Treatment Period|Adverse Event|0
2261147|NCT02135107|3931750|FG003|Treatment Period|Adverse Event|0
2261148|NCT02135107|3931747|FG000|Treatment Period|Pregnancy|1
2261149|NCT02135107|3931748|FG001|Treatment Period|Pregnancy|0
2261150|NCT02135107|3931749|FG002|Treatment Period|Pregnancy|0
2261151|NCT02135107|3931750|FG003|Treatment Period|Pregnancy|0
2345598|NCT03597022|4082012|FG001|Overall Study|Premature termination of the study|7
2261152|NCT02135107|3931747|FG000|Treatment Period|Other|115
2261153|NCT02135107|3931748|FG001|Treatment Period|Other|24
2261154|NCT02135107|3931749|FG002|Treatment Period|Other|0
2261155|NCT02135107|3931750|FG003|Treatment Period|Other|0
2261156|NCT02135107|3931747|FG000|Maintenance Therapy Period|Adverse Event|0
2261157|NCT02135107|3931748|FG001|Maintenance Therapy Period|Adverse Event|0
2261158|NCT02135107|3931749|FG002|Maintenance Therapy Period|Adverse Event|3
2261159|NCT02135107|3931750|FG003|Maintenance Therapy Period|Adverse Event|7
2261160|NCT02135107|3931747|FG000|Maintenance Therapy Period|Withdrawal by Subject|0
2261161|NCT02135107|3931748|FG001|Maintenance Therapy Period|Withdrawal by Subject|0
2261162|NCT02135107|3931749|FG002|Maintenance Therapy Period|Withdrawal by Subject|5
2261163|NCT02135107|3931750|FG003|Maintenance Therapy Period|Withdrawal by Subject|4
2261164|NCT02135107|3931747|FG000|Maintenance Therapy Period|Pregnancy|0
2261165|NCT02135107|3931748|FG001|Maintenance Therapy Period|Pregnancy|0
2261166|NCT02135107|3931749|FG002|Maintenance Therapy Period|Pregnancy|0
2261167|NCT02135107|3931750|FG003|Maintenance Therapy Period|Pregnancy|1
2261168|NCT02135107|3931747|FG000|Maintenance Therapy Period|Other|0
2261169|NCT02135107|3931748|FG001|Maintenance Therapy Period|Other|0
2261170|NCT02135107|3931749|FG002|Maintenance Therapy Period|Other|7
2261171|NCT02135107|3931750|FG003|Maintenance Therapy Period|Other|8
2261172|NCT02135445|3931783|FG000|Overall Study|Lost to Follow-up|1
2261173|NCT02135445|3931784|FG001|Overall Study|Lost to Follow-up|0
2261174|NCT02135445|3931783|FG000|Overall Study|Withdrawal by Subject|1
2261175|NCT02135445|3931784|FG001|Overall Study|Withdrawal by Subject|0
2261176|NCT02135614|3931792|FG000|Overall Study|Randomized but Not Treated|2
2261177|NCT02135614|3931793|FG001|Overall Study|Randomized but Not Treated|1
2261178|NCT02135614|3931792|FG000|Overall Study|Adverse Event|0
2261179|NCT02135614|3931793|FG001|Overall Study|Adverse Event|1
2261180|NCT02135614|3931792|FG000|Overall Study|Death|1
2261181|NCT02135614|3931793|FG001|Overall Study|Death|0
2261182|NCT02135614|3931792|FG000|Overall Study|Investigator's Discretion|0
2261183|NCT02135614|3931793|FG001|Overall Study|Investigator's Discretion|1
2261184|NCT02135614|3931792|FG000|Overall Study|Withdrew Consent|2
2261185|NCT02135614|3931793|FG001|Overall Study|Withdrew Consent|2
2261186|NCT02135614|3931792|FG000|Overall Study|Lost to Follow-up|3
2261187|NCT02135614|3931793|FG001|Overall Study|Lost to Follow-up|0
2261188|NCT02135692|3931810|FG000|Overall Study|Adverse Event|3
2261189|NCT02135692|3931810|FG000|Overall Study|Lack of Efficacy|2
2261190|NCT02135692|3931810|FG000|Overall Study|Protocol Violation|2
2261191|NCT02135692|3931810|FG000|Overall Study|Subject met Liver Stopping Criteria|1
2261192|NCT02135692|3931810|FG000|Overall Study|Product commercially available|159
2261193|NCT02135692|3931810|FG000|Overall Study|Study closed/terminated|153
2261194|NCT02135692|3931810|FG000|Overall Study|Lost to Follow-up|4
2261195|NCT02135692|3931810|FG000|Overall Study|Withdrawal by Subject|15
2261196|NCT02135848|3931816|FG000|Overall Study|Adverse Event|2
2261197|NCT02135848|3931817|FG001|Overall Study|Adverse Event|0
2261198|NCT02135848|3931816|FG000|Overall Study|Withdrawal by Subject|1
2261199|NCT02135848|3931817|FG001|Overall Study|Withdrawal by Subject|1
2261200|NCT02136576|3931910|FG000|Overall Study|Lost to Follow-up|2
2261201|NCT02136576|3931911|FG001|Overall Study|Lost to Follow-up|0
2261202|NCT02136576|3931912|FG002|Overall Study|Lost to Follow-up|0
2261203|NCT02136680|3931922|FG000|Overall Study|No Longer Interested|1
2261204|NCT02136680|3931923|FG001|Overall Study|No Longer Interested|1
2261205|NCT02136680|3931922|FG000|Overall Study|No longer receiving care at clinic|3
2261206|NCT02136680|3931923|FG001|Overall Study|No longer receiving care at clinic|5
2261207|NCT02136680|3931922|FG000|Overall Study|Moved away|5
2261208|NCT02136680|3931923|FG001|Overall Study|Moved away|4
2261209|NCT02136680|3931922|FG000|Overall Study|Unable to schedule|17
2261210|NCT02136680|3931923|FG001|Overall Study|Unable to schedule|16
2261211|NCT02136680|3931922|FG000|Overall Study|Study ended before interview due|6
2261212|NCT02136680|3931923|FG001|Overall Study|Study ended before interview due|3
2261213|NCT02136914|3931935|FG000|Overall Study|Sponsor's Decision to Stop the Study|7
2261214|NCT02136914|3931936|FG001|Overall Study|Sponsor's Decision to Stop the Study|7
2261215|NCT02136914|3931935|FG000|Overall Study|Withdrawal by Subject|3
2261216|NCT02136914|3931936|FG001|Overall Study|Withdrawal by Subject|10
2261217|NCT02136914|3931935|FG000|Overall Study|Subject Unwilling to Proceed|7
2261218|NCT02136914|3931936|FG001|Overall Study|Subject Unwilling to Proceed|2
2261219|NCT02136914|3931935|FG000|Overall Study|Lost to Follow-up|1
2261220|NCT02136914|3931936|FG001|Overall Study|Lost to Follow-up|1
2261221|NCT02136914|3931935|FG000|Overall Study|Did Not Receive Study Drug|2
2261222|NCT02136914|3931936|FG001|Overall Study|Did Not Receive Study Drug|0
2261223|NCT02136914|3931935|FG000|Overall Study|Lack of Efficacy|1
2261224|NCT02136914|3931936|FG001|Overall Study|Lack of Efficacy|0
2261225|NCT02136914|3931935|FG000|Overall Study|Death|0
2261226|NCT02136914|3931936|FG001|Overall Study|Death|1
2261227|NCT02137226|3931944|FG000|Period 1 (Initial Randomization)|Adverse Event|3
2261228|NCT02137226|3931945|FG001|Period 1 (Initial Randomization)|Adverse Event|3
2261229|NCT02137226|3931946|FG002|Period 1 (Initial Randomization)|Adverse Event|0
2261230|NCT02137226|3931947|FG003|Period 1 (Initial Randomization)|Adverse Event|0
2261231|NCT02137226|3931948|FG004|Period 1 (Initial Randomization)|Adverse Event|0
2261232|NCT02137226|3931944|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11
2261233|NCT02137226|3931945|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5
2261234|NCT02137226|3931946|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0
2261235|NCT02137226|3931947|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0
2261236|NCT02137226|3931948|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0
2261237|NCT02137226|3931944|FG000|Period 1 (Initial Randomization)|Physician Decision|1
2261238|NCT02137226|3931945|FG001|Period 1 (Initial Randomization)|Physician Decision|3
2261239|NCT02137226|3931946|FG002|Period 1 (Initial Randomization)|Physician Decision|0
2261240|NCT02137226|3931947|FG003|Period 1 (Initial Randomization)|Physician Decision|0
2261241|NCT02137226|3931948|FG004|Period 1 (Initial Randomization)|Physician Decision|0
2261242|NCT02137226|3931944|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3
2261243|NCT02137226|3931945|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2
2261244|NCT02137226|3931946|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0
2261245|NCT02137226|3931947|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0
2261246|NCT02137226|3931948|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0
2261247|NCT02137226|3931944|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1
2261248|NCT02137226|3931945|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0
2261249|NCT02137226|3931946|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0
2261250|NCT02137226|3931947|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0
2261251|NCT02137226|3931948|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0
2261252|NCT02137226|3931944|FG000|Period 1 (Initial Randomization)|Other Reason|1
2261253|NCT02137226|3931945|FG001|Period 1 (Initial Randomization)|Other Reason|3
2261254|NCT02137226|3931946|FG002|Period 1 (Initial Randomization)|Other Reason|0
2261255|NCT02137226|3931947|FG003|Period 1 (Initial Randomization)|Other Reason|0
2261256|NCT02137226|3931948|FG004|Period 1 (Initial Randomization)|Other Reason|0
2345599|NCT03597022|4082013|FG002|Overall Study|Premature termination of the study|8
2345600|NCT03597022|4082011|FG000|Overall Study|Serious adverse event|1
2345601|NCT03597022|4082012|FG001|Overall Study|Serious adverse event|1
2345602|NCT03597022|4082013|FG002|Overall Study|Serious adverse event|0
2345603|NCT03597061|4082023|FG000|Overall Study|Lost to Follow-up|1
2345604|NCT03597061|4082024|FG001|Overall Study|Lost to Follow-up|0
2345605|NCT03597061|4082023|FG000|Overall Study|Protocol Violation|0
2345606|NCT03597061|4082024|FG001|Overall Study|Protocol Violation|1
2345607|NCT03597139|4082032|FG000|Overall Study|Adverse Event|3
2345608|NCT03597139|4082033|FG001|Overall Study|Adverse Event|0
2345609|NCT03597139|4082032|FG000|Overall Study|Protocol Non-compliance|1
2345610|NCT03597139|4082033|FG001|Overall Study|Protocol Non-compliance|0
2345611|NCT03597347|4082046|FG000|Overall Study|Withdrawal by Subject|1
2345612|NCT03597347|4082047|FG001|Overall Study|Withdrawal by Subject|1
2345613|NCT03597347|4082048|FG002|Overall Study|Withdrawal by Subject|0
2345614|NCT03597347|4082046|FG000|Overall Study|Withdrawal due to Covid-19|3
2345615|NCT03597347|4082047|FG001|Overall Study|Withdrawal due to Covid-19|0
2345616|NCT03597347|4082048|FG002|Overall Study|Withdrawal due to Covid-19|0
2345617|NCT03597347|4082046|FG000|Overall Study|Sponsor decision to terminate study|3
2345618|NCT03597347|4082047|FG001|Overall Study|Sponsor decision to terminate study|2
2345619|NCT03597347|4082048|FG002|Overall Study|Sponsor decision to terminate study|4
2345620|NCT03597529|4082058|FG000|Overall Study|Lost to Follow-up|10
2345621|NCT03597529|4082059|FG001|Overall Study|Lost to Follow-up|12
2345622|NCT03597529|4082058|FG000|Overall Study|Physician Decision|3
2345623|NCT03597529|4082059|FG001|Overall Study|Physician Decision|1
2345624|NCT03597529|4082058|FG000|Overall Study|Withdrawal by Subject|6
2345625|NCT03597529|4082059|FG001|Overall Study|Withdrawal by Subject|3
2345626|NCT03597529|4082058|FG000|Overall Study|Non-compliant with study activities|1
2345627|NCT03597529|4082059|FG001|Overall Study|Non-compliant with study activities|2
2345628|NCT03599089|4082088|FG000|Overall Study|Lost to Follow-up|1
2345629|NCT03599089|4082089|FG001|Overall Study|Lost to Follow-up|0
2345630|NCT03599089|4082090|FG002|Overall Study|Lost to Follow-up|0
2345631|NCT03599089|4082091|FG003|Overall Study|Lost to Follow-up|0
2345632|NCT03599089|4082088|FG000|Overall Study|Withdrawal by Subject|2
2345633|NCT03599089|4082089|FG001|Overall Study|Withdrawal by Subject|1
2345634|NCT03599089|4082090|FG002|Overall Study|Withdrawal by Subject|0
2345635|NCT03599089|4082091|FG003|Overall Study|Withdrawal by Subject|0
2345636|NCT03599089|4082088|FG000|Overall Study|Lack of Efficacy|0
2345637|NCT03599089|4082089|FG001|Overall Study|Lack of Efficacy|0
2345638|NCT03599089|4082090|FG002|Overall Study|Lack of Efficacy|1
2345639|NCT03599089|4082091|FG003|Overall Study|Lack of Efficacy|2
2345640|NCT03599193|4082103|FG000|Overall Study|Adverse Event|0
2345641|NCT03599193|4082104|FG001|Overall Study|Adverse Event|2
2345642|NCT03599193|4082103|FG000|Overall Study|Withdrawal by Subject|1
2345643|NCT03599193|4082104|FG001|Overall Study|Withdrawal by Subject|0
2345644|NCT03599193|4082103|FG000|Overall Study|Protocol Violation|1
2345645|NCT03599193|4082104|FG001|Overall Study|Protocol Violation|0
2345646|NCT03599193|4082103|FG000|Overall Study|Lost to Follow-up|0
2345647|NCT03599193|4082104|FG001|Overall Study|Lost to Follow-up|1
2345648|NCT03599349|4082122|FG000|Overall Study|Lost to Follow-up|1
2345649|NCT03599362|4082126|FG000|Overall Study|Screen Failure|3
2345650|NCT03600376|4082170|FG000|Overall Study|Adverse Event|1
2345651|NCT03600376|4082171|FG001|Overall Study|Adverse Event|1
2345652|NCT03600376|4082170|FG000|Overall Study|Transferred to other facility|1
2345653|NCT03600376|4082171|FG001|Overall Study|Transferred to other facility|0
2345654|NCT03600376|4082170|FG000|Overall Study|Investigator Decision|0
2345655|NCT03600376|4082171|FG001|Overall Study|Investigator Decision|4
2345656|NCT03600376|4082170|FG000|Overall Study|Determined to be ineligible for study|0
2345657|NCT03600376|4082171|FG001|Overall Study|Determined to be ineligible for study|1
2345658|NCT03600428|4082179|FG000|Overall Study|Not eligible|0
2345659|NCT03600428|4082180|FG001|Overall Study|Not eligible|1
2345660|NCT03600428|4082179|FG000|Overall Study|Lost to Follow-up|5
2345661|NCT03600428|4082180|FG001|Overall Study|Lost to Follow-up|4
2345662|NCT03601052|4082186|FG000|Overall Study|Lost to Follow-up|2
2261257|NCT02137226|3931944|FG000|Period 2 (Re - Randomization)|Adverse Event|0
2261258|NCT02137226|3931945|FG001|Period 2 (Re - Randomization)|Adverse Event|0
2261259|NCT02137226|3931946|FG002|Period 2 (Re - Randomization)|Adverse Event|3
2261260|NCT02137226|3931947|FG003|Period 2 (Re - Randomization)|Adverse Event|1
2261261|NCT02137226|3931948|FG004|Period 2 (Re - Randomization)|Adverse Event|4
2261262|NCT02137226|3931944|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0
2261263|NCT02137226|3931945|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0
2261264|NCT02137226|3931946|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8
2261265|NCT02137226|3931947|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5
2261266|NCT02137226|3931948|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4
2261267|NCT02137226|3931944|FG000|Period 2 (Re - Randomization)|Physician Decision|0
2261268|NCT02137226|3931945|FG001|Period 2 (Re - Randomization)|Physician Decision|0
2261269|NCT02137226|3931946|FG002|Period 2 (Re - Randomization)|Physician Decision|0
2261270|NCT02137226|3931947|FG003|Period 2 (Re - Randomization)|Physician Decision|1
2261271|NCT02137226|3931948|FG004|Period 2 (Re - Randomization)|Physician Decision|0
2261272|NCT02137226|3931944|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0
2261273|NCT02137226|3931945|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0
2261274|NCT02137226|3931946|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3
2261275|NCT02137226|3931947|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0
2261276|NCT02137226|3931948|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0
2261277|NCT02137226|3931944|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0
2261278|NCT02137226|3931945|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0
2261279|NCT02137226|3931946|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2
2261280|NCT02137226|3931947|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0
2261281|NCT02137226|3931948|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0
2261282|NCT02137226|3931944|FG000|Period 2 (Re - Randomization)|Other Reason|0
2261283|NCT02137226|3931945|FG001|Period 2 (Re - Randomization)|Other Reason|0
2345663|NCT03601715|4082209|FG000|Second Intervention|Lost to Follow-up|1
2345664|NCT03601715|4082210|FG001|Second Intervention|Lost to Follow-up|1
2345665|NCT03601715|4082211|FG002|Second Intervention|Lost to Follow-up|0
2345666|NCT03602053|4082222|FG000|Overall Study|Withdrawal by Subject|7
2345667|NCT03602053|4082223|FG001|Overall Study|Withdrawal by Subject|9
2345668|NCT03602053|4082224|FG002|Overall Study|Withdrawal by Subject|7
2345669|NCT03602053|4082222|FG000|Overall Study|Lost to Follow-up|5
2345670|NCT03602053|4082223|FG001|Overall Study|Lost to Follow-up|6
2345671|NCT03602053|4082224|FG002|Overall Study|Lost to Follow-up|0
2345672|NCT03602053|4082222|FG000|Overall Study|Protocol Violation|3
2345673|NCT03602053|4082223|FG001|Overall Study|Protocol Violation|0
2345674|NCT03602053|4082224|FG002|Overall Study|Protocol Violation|4
2345675|NCT03602053|4082222|FG000|Overall Study|Physician Decision|1
2345676|NCT03602053|4082223|FG001|Overall Study|Physician Decision|0
2345677|NCT03602053|4082224|FG002|Overall Study|Physician Decision|0
2345678|NCT03602053|4082222|FG000|Overall Study|migration|2
2345679|NCT03602053|4082223|FG001|Overall Study|migration|3
2345680|NCT03602053|4082224|FG002|Overall Study|migration|0
2345681|NCT03602053|4082222|FG000|Overall Study|Other|1
2345682|NCT03602053|4082223|FG001|Overall Study|Other|0
2345683|NCT03602053|4082224|FG002|Overall Study|Other|0
2345684|NCT03602339|4082236|FG000|Overall Study|Withdrawal by Subject|9
2345685|NCT03602339|4082236|FG000|Overall Study|Physician Decision|2
2345686|NCT03602339|4082236|FG000|Overall Study|Other reason|4
2345687|NCT03602482|4082245|FG000|Overall Study|Withdrawal by Subject|6
2345688|NCT03602482|4082246|FG001|Overall Study|Withdrawal by Subject|7
2345689|NCT03602482|4082247|FG002|Overall Study|Withdrawal by Subject|0
2345690|NCT03602482|4082248|FG003|Overall Study|Withdrawal by Subject|0
2345691|NCT03603028|4082261|FG000|Overall Study|Withdrawal by Subject|1
2345692|NCT03603652|4082319|FG000|Overall Study|Death|2
2261284|NCT02137226|3931946|FG002|Period 2 (Re - Randomization)|Other Reason|1
2261285|NCT02137226|3931947|FG003|Period 2 (Re - Randomization)|Other Reason|1
2261286|NCT02137226|3931948|FG004|Period 2 (Re - Randomization)|Other Reason|1
2261287|NCT02137369|3931958|FG000|Overall Study|Withdrawal by Subject|3
2261288|NCT02137369|3931959|FG001|Overall Study|Withdrawal by Subject|2
2261289|NCT02137369|3931958|FG000|Overall Study|Adverse Event|2
2261290|NCT02137369|3931959|FG001|Overall Study|Adverse Event|0
2261291|NCT02137369|3931958|FG000|Overall Study|Lost to Follow-up|1
2261292|NCT02137369|3931959|FG001|Overall Study|Lost to Follow-up|0
2261293|NCT02137369|3931958|FG000|Overall Study|Moved away|2
2261294|NCT02137369|3931959|FG001|Overall Study|Moved away|0
2261295|NCT02137772|3932036|FG000|Overall Study|Adverse Event|6
2261296|NCT02137772|3932037|FG001|Overall Study|Adverse Event|3
2261297|NCT02137772|3932036|FG000|Overall Study|Death|71
2261298|NCT02137772|3932037|FG001|Overall Study|Death|44
2261299|NCT02137772|3932036|FG000|Overall Study|Lost to Follow-up|8
2261300|NCT02137772|3932037|FG001|Overall Study|Lost to Follow-up|4
2261301|NCT02137772|3932036|FG000|Overall Study|Physician Decision|15
2261302|NCT02137772|3932037|FG001|Overall Study|Physician Decision|5
2261303|NCT02137772|3932036|FG000|Overall Study|Withdrawal by Subject|28
2261304|NCT02137772|3932037|FG001|Overall Study|Withdrawal by Subject|17
2261305|NCT02137772|3932036|FG000|Overall Study|Non-compliance with study drug|1
2261306|NCT02137772|3932037|FG001|Overall Study|Non-compliance with study drug|0
2261307|NCT02137772|3932036|FG000|Overall Study|Not treated|3
2261308|NCT02137772|3932037|FG001|Overall Study|Not treated|2
2261309|NCT02137785|3932045|FG000|Overall Study|Lost to Follow-up|1
2261310|NCT02137785|3932046|FG001|Overall Study|Lost to Follow-up|0
2261311|NCT02137785|3932045|FG000|Overall Study|Withdrawal by Subject|1
2261312|NCT02137785|3932046|FG001|Overall Study|Withdrawal by Subject|4
2261313|NCT02137785|3932045|FG000|Overall Study|subject moved out of state|1
2261314|NCT02137785|3932046|FG001|Overall Study|subject moved out of state|0
2261315|NCT02137837|3932055|FG000|Overall Study|Adverse Event|0
2261316|NCT02137837|3932056|FG001|Overall Study|Adverse Event|2
2261317|NCT02137837|3932057|FG002|Overall Study|Adverse Event|1
2261318|NCT02137837|3932055|FG000|Overall Study|Refusal unrelated to adverse event|2
2261319|NCT02137837|3932056|FG001|Overall Study|Refusal unrelated to adverse event|2
2261320|NCT02137837|3932057|FG002|Overall Study|Refusal unrelated to adverse event|1
2261321|NCT02137837|3932055|FG000|Overall Study|Progression/relapse|9
2261322|NCT02137837|3932056|FG001|Overall Study|Progression/relapse|7
2261323|NCT02137837|3932057|FG002|Overall Study|Progression/relapse|7
2261324|NCT02137837|3932055|FG000|Overall Study|Not protocol specified|2
2261325|NCT02137837|3932056|FG001|Overall Study|Not protocol specified|1
2261326|NCT02137837|3932057|FG002|Overall Study|Not protocol specified|3
2261327|NCT02138110|3932122|FG000|Enrolled for Scaffold Implantation|Physician Decision|1
2261328|NCT02138110|3932122|FG000|Overall Scaffold Implantation|Death|3
2261329|NCT02138136|3932126|FG000|Overall Study|Protocol Violation|4
2261330|NCT02138136|3932126|FG000|Overall Study|Physician Decision|7
2261331|NCT02138136|3932126|FG000|Overall Study|Lack of Efficacy|35
2261332|NCT02138136|3932126|FG000|Overall Study|Pregnancy|2
2261333|NCT02138136|3932126|FG000|Overall Study|Adverse Event|18
2261334|NCT02138136|3932126|FG000|Overall Study|Withdrawal by Subject|36
2261335|NCT02138136|3932126|FG000|Overall Study|Lost to Follow-up|32
2261336|NCT02138136|3932126|FG000|Overall Study|Withdrawn by Sponsor|5
2261337|NCT02138214|3932134|FG000|Overall Study|Withdrawal by Subject|0
2261338|NCT02138214|3932135|FG001|Overall Study|Withdrawal by Subject|1
2261339|NCT02138214|3932136|FG002|Overall Study|Withdrawal by Subject|0
2261340|NCT02138214|3932134|FG000|Overall Study|Lost to Follow-up|0
2261341|NCT02138214|3932135|FG001|Overall Study|Lost to Follow-up|2
2261342|NCT02138214|3932136|FG002|Overall Study|Lost to Follow-up|4
2261343|NCT02138214|3932134|FG000|Overall Study|Screen Failure|0
2261344|NCT02138214|3932135|FG001|Overall Study|Screen Failure|1
2261345|NCT02138214|3932136|FG002|Overall Study|Screen Failure|0
2261346|NCT02138253|3932183|FG000|Overall Study|Adverse Event|3
2261347|NCT02138253|3932184|FG001|Overall Study|Adverse Event|3
2261348|NCT02138253|3932183|FG000|Overall Study|Lost to Follow-up|2
2261349|NCT02138253|3932184|FG001|Overall Study|Lost to Follow-up|1
2261350|NCT02138253|3932183|FG000|Overall Study|Physician Decision|2
2261351|NCT02138253|3932184|FG001|Overall Study|Physician Decision|0
2261352|NCT02138253|3932183|FG000|Overall Study|Non compliance|1
2261353|NCT02138253|3932184|FG001|Overall Study|Non compliance|0
2261354|NCT02138253|3932183|FG000|Overall Study|Withdrawal by Subject|1
2261355|NCT02138253|3932184|FG001|Overall Study|Withdrawal by Subject|0
2261356|NCT02138747|3932216|FG000|Treatment Period 1|Adverse Event|10
2261357|NCT02138747|3932217|FG001|Treatment Period 1|Adverse Event|14
2261358|NCT02138747|3932218|FG002|Treatment Period 1|Adverse Event|2
2261359|NCT02138747|3932219|FG003|Treatment Period 1|Adverse Event|1
2261360|NCT02138747|3932216|FG000|Treatment Period 1|Lost to Follow-up|0
2261361|NCT02138747|3932217|FG001|Treatment Period 1|Lost to Follow-up|1
2261362|NCT02138747|3932218|FG002|Treatment Period 1|Lost to Follow-up|1
2261363|NCT02138747|3932219|FG003|Treatment Period 1|Lost to Follow-up|0
2261364|NCT02138747|3932216|FG000|Treatment Period 1|Protocol Violation|0
2261365|NCT02138747|3932217|FG001|Treatment Period 1|Protocol Violation|2
2261366|NCT02138747|3932218|FG002|Treatment Period 1|Protocol Violation|0
2261367|NCT02138747|3932219|FG003|Treatment Period 1|Protocol Violation|0
2261368|NCT02138747|3932216|FG000|Treatment Period 1|Withdrawal by Subject|8
2261369|NCT02138747|3932217|FG001|Treatment Period 1|Withdrawal by Subject|4
2261370|NCT02138747|3932218|FG002|Treatment Period 1|Withdrawal by Subject|1
2261371|NCT02138747|3932219|FG003|Treatment Period 1|Withdrawal by Subject|3
2261372|NCT02138747|3932216|FG000|Treatment Period 1|Other - Miscellaneous|2
2261373|NCT02138747|3932217|FG001|Treatment Period 1|Other - Miscellaneous|4
2261374|NCT02138747|3932218|FG002|Treatment Period 1|Other - Miscellaneous|0
2345693|NCT03604341|4082329|FG000|Overall Study|Withdrawal by Subject|1
2345694|NCT03604341|4082330|FG001|Overall Study|Withdrawal by Subject|1
2345695|NCT03604341|4082329|FG000|Overall Study|Adverse Event|1
2345696|NCT03604341|4082330|FG001|Overall Study|Adverse Event|0
2345697|NCT03604341|4082329|FG000|Overall Study|Protocol Violation|0
2345698|NCT03604341|4082330|FG001|Overall Study|Protocol Violation|1
2345699|NCT03604497|4082336|FG000|Overall Study|Protocol Violation|52
2345700|NCT03604523|4082346|FG000|Overall Study|Physician Decision|1
2345701|NCT03604523|4082347|FG001|Overall Study|Physician Decision|0
2345702|NCT03605212|4082370|FG000|Treatment Period|Adverse Event|1
2345703|NCT03605212|4082371|FG001|Treatment Period|Adverse Event|0
2345704|NCT03605212|4082372|FG002|Treatment Period|Adverse Event|0
2345705|NCT03605212|4082373|FG003|Treatment Period|Adverse Event|0
2345706|NCT03605212|4082374|FG004|Treatment Period|Adverse Event|0
2261375|NCT02138747|3932219|FG003|Treatment Period 1|Other - Miscellaneous|0
2261376|NCT02138747|3932216|FG000|Treatment Period 2|Adverse Event|6
2261377|NCT02138747|3932217|FG001|Treatment Period 2|Adverse Event|3
2261378|NCT02138747|3932218|FG002|Treatment Period 2|Adverse Event|1
2261379|NCT02138747|3932219|FG003|Treatment Period 2|Adverse Event|1
2261380|NCT02138747|3932216|FG000|Treatment Period 2|Lost to Follow-up|2
2261381|NCT02138747|3932217|FG001|Treatment Period 2|Lost to Follow-up|0
2261382|NCT02138747|3932218|FG002|Treatment Period 2|Lost to Follow-up|0
2261383|NCT02138747|3932219|FG003|Treatment Period 2|Lost to Follow-up|0
2261384|NCT02138747|3932216|FG000|Treatment Period 2|Protocol Violation|1
2261385|NCT02138747|3932217|FG001|Treatment Period 2|Protocol Violation|0
2261386|NCT02138747|3932218|FG002|Treatment Period 2|Protocol Violation|0
2261387|NCT02138747|3932219|FG003|Treatment Period 2|Protocol Violation|0
2261388|NCT02138747|3932216|FG000|Treatment Period 2|Withdrawal by Subject|5
2261389|NCT02138747|3932217|FG001|Treatment Period 2|Withdrawal by Subject|4
2261390|NCT02138747|3932218|FG002|Treatment Period 2|Withdrawal by Subject|1
2261391|NCT02138747|3932219|FG003|Treatment Period 2|Withdrawal by Subject|2
2261392|NCT02138747|3932216|FG000|Treatment Period 2|Other - Miscellaneous|3
2261393|NCT02138747|3932217|FG001|Treatment Period 2|Other - Miscellaneous|0
2261394|NCT02138747|3932218|FG002|Treatment Period 2|Other - Miscellaneous|0
2261395|NCT02138747|3932219|FG003|Treatment Period 2|Other - Miscellaneous|0
2261396|NCT02138786|3932232|FG000|Overall Study|Adverse Event|0
2261397|NCT02138786|3932233|FG001|Overall Study|Adverse Event|2
2261398|NCT02138786|3932234|FG002|Overall Study|Adverse Event|1
2261399|NCT02138786|3932232|FG000|Overall Study|Death|1
2261400|NCT02138786|3932233|FG001|Overall Study|Death|7
2261401|NCT02138786|3932234|FG002|Overall Study|Death|2
2261402|NCT02138786|3932232|FG000|Overall Study|Disease Progression|1
2261403|NCT02138786|3932233|FG001|Overall Study|Disease Progression|1
2261404|NCT02138786|3932234|FG002|Overall Study|Disease Progression|3
2261405|NCT02138786|3932232|FG000|Overall Study|Withdrawal by Subject|1
2261406|NCT02138786|3932233|FG001|Overall Study|Withdrawal by Subject|2
2261407|NCT02138786|3932234|FG002|Overall Study|Withdrawal by Subject|0
2261408|NCT02138786|3932232|FG000|Overall Study|Patient's Wish|0
2261409|NCT02138786|3932233|FG001|Overall Study|Patient's Wish|2
2261410|NCT02138786|3932234|FG002|Overall Study|Patient's Wish|0
2261411|NCT02138786|3932232|FG000|Overall Study|Sponsor Terminated Study|0
2261412|NCT02138786|3932233|FG001|Overall Study|Sponsor Terminated Study|1
2261413|NCT02138786|3932234|FG002|Overall Study|Sponsor Terminated Study|1
2261414|NCT02138786|3932232|FG000|Overall Study|Non-Compliance|0
2261415|NCT02138786|3932233|FG001|Overall Study|Non-Compliance|0
2261416|NCT02138786|3932234|FG002|Overall Study|Non-Compliance|1
2261417|NCT02138825|3932242|FG000|Main Study Treatment|Adverse Event|11
2261418|NCT02138825|3932243|FG001|Main Study Treatment|Adverse Event|3
2261419|NCT02138825|3932242|FG000|Main Study Treatment|Death|1
2261420|NCT02138825|3932243|FG001|Main Study Treatment|Death|2
2261421|NCT02138825|3932242|FG000|Main Study Treatment|Protocol Violation|2
2261422|NCT02138825|3932243|FG001|Main Study Treatment|Protocol Violation|2
2261423|NCT02138825|3932242|FG000|Main Study Treatment|Sponsor decision|12
2261424|NCT02138825|3932243|FG001|Main Study Treatment|Sponsor decision|18
2261425|NCT02138825|3932242|FG000|Main Study Treatment|Study terminated by sponsor|10
2261426|NCT02138825|3932243|FG001|Main Study Treatment|Study terminated by sponsor|9
2261427|NCT02138825|3932242|FG000|Main Study Treatment|Withdrawal by Subject|3
2261428|NCT02138825|3932243|FG001|Main Study Treatment|Withdrawal by Subject|1
2261429|NCT02138825|3932242|FG000|Main Study Treatment|Medical decision|1
2261430|NCT02138825|3932243|FG001|Main Study Treatment|Medical decision|0
2261431|NCT02138825|3932242|FG000|Long-term Extension|Study termination by sponsor|32
2261432|NCT02138825|3932243|FG001|Long-term Extension|Study termination by sponsor|38
2345707|NCT03605212|4082370|FG000|Treatment Period|Physician Decision|0
2345708|NCT03605212|4082371|FG001|Treatment Period|Physician Decision|0
2261433|NCT02138825|3932242|FG000|Safety Follow-up|Adverse Event|4
2261434|NCT02138825|3932243|FG001|Safety Follow-up|Adverse Event|3
2261435|NCT02138825|3932242|FG000|Safety Follow-up|Death|11
2345709|NCT03605212|4082372|FG002|Treatment Period|Physician Decision|0
2261436|NCT02138825|3932243|FG001|Safety Follow-up|Death|5
2261437|NCT02138825|3932242|FG000|Safety Follow-up|Withdrawal by Subject|5
2261438|NCT02138825|3932243|FG001|Safety Follow-up|Withdrawal by Subject|3
2261439|NCT02138825|3932242|FG000|Safety Follow-up|clinic worsening|1
2261440|NCT02138825|3932243|FG001|Safety Follow-up|clinic worsening|0
2261441|NCT02138825|3932242|FG000|Safety Follow-up|withdrawal by PI|1
2261442|NCT02138825|3932243|FG001|Safety Follow-up|withdrawal by PI|0
2261443|NCT02138825|3932242|FG000|Safety Follow-up|logistical difficulties|0
2261444|NCT02138825|3932243|FG001|Safety Follow-up|logistical difficulties|1
2261445|NCT02138825|3932242|FG000|Safety Follow-up|progressive disease|0
2261446|NCT02138825|3932243|FG001|Safety Follow-up|progressive disease|2
2261447|NCT02138825|3932242|FG000|Safety Follow-up|too unwell to attend the visit|0
2261448|NCT02138825|3932243|FG001|Safety Follow-up|too unwell to attend the visit|1
2261449|NCT02138825|3932242|FG000|Safety Follow-up|treatment unblinded|0
2261450|NCT02138825|3932243|FG001|Safety Follow-up|treatment unblinded|1
2261451|NCT02138825|3932242|FG000|Safety Follow-up|withdrawn due to lung transplant|0
2261452|NCT02138825|3932243|FG001|Safety Follow-up|withdrawn due to lung transplant|1
2261453|NCT02138838|3932256|FG000|Overall Study|Study Closure|7
2261454|NCT02138838|3932257|FG001|Overall Study|Study Closure|6
2261455|NCT02138838|3932256|FG000|Overall Study|Withdrawal by Subject|1
2261456|NCT02138838|3932257|FG001|Overall Study|Withdrawal by Subject|5
2261457|NCT02138890|3932265|FG000|Overall Study|Adverse Event|1
2261458|NCT02138890|3932266|FG001|Overall Study|Adverse Event|0
2261459|NCT02138916|3932276|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6
2261460|NCT02138916|3932277|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9
2261461|NCT02138916|3932278|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7
2261462|NCT02138916|3932276|FG000|Overall Study|Death|14
2261463|NCT02138916|3932277|FG001|Overall Study|Death|11
2261464|NCT02138916|3932278|FG002|Overall Study|Death|12
2261465|NCT02138916|3932276|FG000|Overall Study|Withdrawal by Subject|27
2261466|NCT02138916|3932277|FG001|Overall Study|Withdrawal by Subject|31
2261467|NCT02138916|3932278|FG002|Overall Study|Withdrawal by Subject|32
2261468|NCT02138916|3932276|FG000|Overall Study|Study specific withdrawal criteria|0
2345710|NCT03605212|4082373|FG003|Treatment Period|Physician Decision|0
2345711|NCT03605212|4082374|FG004|Treatment Period|Physician Decision|1
2345712|NCT03605680|4082391|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6
2345713|NCT03605680|4082392|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0
2345714|NCT03605680|4082393|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0
2345715|NCT03605680|4082394|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0
2345716|NCT03605680|4082391|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1
2345717|NCT03605680|4082392|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
2345718|NCT03605680|4082393|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
2345719|NCT03605680|4082394|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
2345720|NCT03605680|4082391|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9
2345721|NCT03605680|4082392|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
2345722|NCT03605680|4082393|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
2345723|NCT03605680|4082394|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
2345724|NCT03605680|4082391|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3
2345725|NCT03605680|4082392|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
2345726|NCT03605680|4082393|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
2345727|NCT03605680|4082394|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
2345728|NCT03605680|4082391|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13
2345729|NCT03605680|4082392|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
2345730|NCT03605680|4082393|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
2345731|NCT03605680|4082394|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
2345732|NCT03605680|4082391|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12
2345733|NCT03605680|4082392|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
2345734|NCT03605680|4082393|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
2345735|NCT03605680|4082394|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
2345736|NCT03605680|4082391|FG000|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|1
2345737|NCT03605680|4082392|FG001|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|0
2345738|NCT03605680|4082393|FG002|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|0
2345739|NCT03605680|4082394|FG003|SB Placebo Run-in Period (1 Week)|Study Terminated by Sponsor|0
2345740|NCT03605680|4082391|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6
2345741|NCT03605680|4082392|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0
2345742|NCT03605680|4082393|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0
2345743|NCT03605680|4082394|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0
2345744|NCT03605680|4082391|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87
2345745|NCT03605680|4082392|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
2345746|NCT03605680|4082393|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
2345747|NCT03605680|4082394|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
2345748|NCT03605680|4082391|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0
2345749|NCT03605680|4082392|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5
2261469|NCT02138916|3932277|FG001|Overall Study|Study specific withdrawal criteria|0
2261470|NCT02138916|3932278|FG002|Overall Study|Study specific withdrawal criteria|1
2261471|NCT02138916|3932276|FG000|Overall Study|incorrect enrolment|1
2261472|NCT02138916|3932277|FG001|Overall Study|incorrect enrolment|1
2261473|NCT02138916|3932278|FG002|Overall Study|incorrect enrolment|0
2261474|NCT02138916|3932276|FG000|Overall Study|Severe non-compliance|1
2261475|NCT02138916|3932277|FG001|Overall Study|Severe non-compliance|2
2261476|NCT02138916|3932278|FG002|Overall Study|Severe non-compliance|1
2261477|NCT02138916|3932276|FG000|Overall Study|Lost to Follow-up|4
2261478|NCT02138916|3932277|FG001|Overall Study|Lost to Follow-up|2
2261479|NCT02138916|3932278|FG002|Overall Study|Lost to Follow-up|3
2261480|NCT02138916|3932276|FG000|Overall Study|Adverse Event|4
2261481|NCT02138916|3932277|FG001|Overall Study|Adverse Event|4
2261482|NCT02138916|3932278|FG002|Overall Study|Adverse Event|3
2345750|NCT03605680|4082393|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7
2345751|NCT03605680|4082394|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8
2345752|NCT03605680|4082391|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0
2345753|NCT03605680|4082392|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
2345754|NCT03605680|4082393|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
2345755|NCT03605680|4082394|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3
2345756|NCT03605680|4082391|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
2345757|NCT03605680|4082392|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
2345758|NCT03605680|4082393|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
2345759|NCT03605680|4082394|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
2261483|NCT02139046|3932303|FG000|Overall Study|Pretreatment Event/Adverse Event|9
2261484|NCT02139046|3932304|FG001|Overall Study|Pretreatment Event/Adverse Event|9
2261485|NCT02139046|3932305|FG002|Overall Study|Pretreatment Event/Adverse Event|10
2261486|NCT02139046|3932306|FG003|Overall Study|Pretreatment Event/Adverse Event|13
2261487|NCT02139046|3932307|FG004|Overall Study|Pretreatment Event/Adverse Event|7
2261488|NCT02139046|3932303|FG000|Overall Study|Major Protocol Deviation|9
2261489|NCT02139046|3932304|FG001|Overall Study|Major Protocol Deviation|10
2261490|NCT02139046|3932305|FG002|Overall Study|Major Protocol Deviation|16
2261491|NCT02139046|3932306|FG003|Overall Study|Major Protocol Deviation|12
2261492|NCT02139046|3932307|FG004|Overall Study|Major Protocol Deviation|6
2261493|NCT02139046|3932303|FG000|Overall Study|Lost to Follow-up|13
2261494|NCT02139046|3932304|FG001|Overall Study|Lost to Follow-up|16
2261495|NCT02139046|3932305|FG002|Overall Study|Lost to Follow-up|16
2261496|NCT02139046|3932306|FG003|Overall Study|Lost to Follow-up|18
2261497|NCT02139046|3932307|FG004|Overall Study|Lost to Follow-up|13
2261498|NCT02139046|3932303|FG000|Overall Study|Voluntary Withdrawal|20
2261499|NCT02139046|3932304|FG001|Overall Study|Voluntary Withdrawal|8
2261500|NCT02139046|3932305|FG002|Overall Study|Voluntary Withdrawal|10
2261501|NCT02139046|3932306|FG003|Overall Study|Voluntary Withdrawal|15
2261502|NCT02139046|3932307|FG004|Overall Study|Voluntary Withdrawal|16
2261503|NCT02139046|3932303|FG000|Overall Study|Lack of Efficacy|0
2261504|NCT02139046|3932304|FG001|Overall Study|Lack of Efficacy|1
2261505|NCT02139046|3932305|FG002|Overall Study|Lack of Efficacy|2
2261506|NCT02139046|3932306|FG003|Overall Study|Lack of Efficacy|1
2261507|NCT02139046|3932307|FG004|Overall Study|Lack of Efficacy|2
2261508|NCT02139046|3932303|FG000|Overall Study|Withdrawal due to a Gout Flare|1
2261509|NCT02139046|3932304|FG001|Overall Study|Withdrawal due to a Gout Flare|1
2261510|NCT02139046|3932305|FG002|Overall Study|Withdrawal due to a Gout Flare|1
2261511|NCT02139046|3932306|FG003|Overall Study|Withdrawal due to a Gout Flare|0
2261512|NCT02139046|3932307|FG004|Overall Study|Withdrawal due to a Gout Flare|1
2261513|NCT02139046|3932303|FG000|Overall Study|Other Miscellaneous Reasons|10
2261514|NCT02139046|3932304|FG001|Overall Study|Other Miscellaneous Reasons|9
2261515|NCT02139046|3932305|FG002|Overall Study|Other Miscellaneous Reasons|4
2261516|NCT02139046|3932306|FG003|Overall Study|Other Miscellaneous Reasons|9
2261517|NCT02139046|3932307|FG004|Overall Study|Other Miscellaneous Reasons|12
2261518|NCT02139124|3932324|FG000|Overall Study|Adverse Event|2
2261519|NCT02139124|3932325|FG001|Overall Study|Adverse Event|0
2261520|NCT02139124|3932326|FG002|Overall Study|Adverse Event|1
2261521|NCT02139124|3932327|FG003|Overall Study|Adverse Event|2
2261522|NCT02139124|3932328|FG004|Overall Study|Adverse Event|5
2261523|NCT02139124|3932324|FG000|Overall Study|Withdrawal by Subject|2
2261524|NCT02139124|3932325|FG001|Overall Study|Withdrawal by Subject|2
2261525|NCT02139124|3932326|FG002|Overall Study|Withdrawal by Subject|2
2261526|NCT02139124|3932327|FG003|Overall Study|Withdrawal by Subject|2
2261527|NCT02139124|3932328|FG004|Overall Study|Withdrawal by Subject|3
2261528|NCT02139124|3932324|FG000|Overall Study|Protocol Violation|0
2261529|NCT02139124|3932325|FG001|Overall Study|Protocol Violation|0
2261530|NCT02139124|3932326|FG002|Overall Study|Protocol Violation|0
2261531|NCT02139124|3932327|FG003|Overall Study|Protocol Violation|1
2261532|NCT02139124|3932328|FG004|Overall Study|Protocol Violation|1
2261533|NCT02139124|3932324|FG000|Overall Study|non-compliant|1
2261534|NCT02139124|3932325|FG001|Overall Study|non-compliant|0
2261535|NCT02139124|3932326|FG002|Overall Study|non-compliant|0
2261536|NCT02139124|3932327|FG003|Overall Study|non-compliant|2
2261537|NCT02139124|3932328|FG004|Overall Study|non-compliant|0
2261538|NCT02139124|3932324|FG000|Overall Study|incarceration|0
2261539|NCT02139124|3932325|FG001|Overall Study|incarceration|0
2261540|NCT02139124|3932326|FG002|Overall Study|incarceration|1
2261541|NCT02139124|3932327|FG003|Overall Study|incarceration|0
2261542|NCT02139124|3932328|FG004|Overall Study|incarceration|0
2261543|NCT02139124|3932324|FG000|Overall Study|subject moved|1
2261544|NCT02139124|3932325|FG001|Overall Study|subject moved|0
2261545|NCT02139124|3932326|FG002|Overall Study|subject moved|0
2261546|NCT02139124|3932327|FG003|Overall Study|subject moved|0
2261547|NCT02139124|3932328|FG004|Overall Study|subject moved|0
2261548|NCT02139124|3932324|FG000|Overall Study|Lost to Follow-up|3
2261549|NCT02139124|3932325|FG001|Overall Study|Lost to Follow-up|2
2261550|NCT02139124|3932326|FG002|Overall Study|Lost to Follow-up|0
2261551|NCT02139124|3932327|FG003|Overall Study|Lost to Follow-up|5
2261552|NCT02139124|3932328|FG004|Overall Study|Lost to Follow-up|4
2261553|NCT02139280|3932370|FG000|Overall Study|No longer eligible|2
2261554|NCT02139280|3932371|FG001|Overall Study|No longer eligible|0
2261555|NCT02139306|3932379|FG000|Overall Study|Withdrawal by Subject|4
2261556|NCT02139306|3932380|FG001|Overall Study|Withdrawal by Subject|6
2261557|NCT02139306|3932379|FG000|Overall Study|Adverse Event|3
2261558|NCT02139306|3932380|FG001|Overall Study|Adverse Event|4
2261559|NCT02139306|3932379|FG000|Overall Study|Physician Decision|0
2261560|NCT02139306|3932380|FG001|Overall Study|Physician Decision|1
2261561|NCT02139306|3932379|FG000|Overall Study|Other Unspecified|2
2261562|NCT02139306|3932380|FG001|Overall Study|Other Unspecified|3
2261563|NCT02139306|3932379|FG000|Overall Study|Protocol Violation|4
2261564|NCT02139306|3932380|FG001|Overall Study|Protocol Violation|0
2261565|NCT02139592|3932400|FG000|Overall Study|Case Report Forms Uncollected|8
2261566|NCT02139644|3932409|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70
2261567|NCT02139644|3932410|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2261568|NCT02139644|3932411|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2261569|NCT02139644|3932412|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2261570|NCT02139644|3932413|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2261571|NCT02139644|3932414|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2261572|NCT02139644|3932409|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
2261573|NCT02139644|3932410|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2261574|NCT02139644|3932411|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2261575|NCT02139644|3932412|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2261576|NCT02139644|3932413|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2261577|NCT02139644|3932414|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2261578|NCT02139644|3932409|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
2345760|NCT03605680|4082391|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
2345761|NCT03605680|4082392|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
2345762|NCT03605680|4082393|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4
2345763|NCT03605680|4082394|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
2345764|NCT03605680|4082391|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0
2345765|NCT03605680|4082392|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3
2261579|NCT02139644|3932410|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2261580|NCT02139644|3932411|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2261581|NCT02139644|3932412|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2261582|NCT02139644|3932413|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2261583|NCT02139644|3932414|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2261584|NCT02139644|3932409|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11
2261585|NCT02139644|3932410|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2261586|NCT02139644|3932411|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2261587|NCT02139644|3932412|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2261588|NCT02139644|3932413|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2261589|NCT02139644|3932414|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2261590|NCT02139644|3932409|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8
2261591|NCT02139644|3932410|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2345766|NCT03605680|4082393|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1
2345767|NCT03605680|4082394|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2
2345768|NCT03605680|4082391|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0
2345769|NCT03605680|4082392|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14
2345770|NCT03605680|4082393|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7
2345771|NCT03605680|4082394|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5
2345772|NCT03605680|4082391|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0
2345773|NCT03605680|4082392|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
2345774|NCT03605680|4082393|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
2345775|NCT03605680|4082394|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7
2345776|NCT03605680|4082391|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
2345777|NCT03605680|4082392|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1
2345778|NCT03605680|4082393|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2
2345779|NCT03605680|4082394|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
2345780|NCT03605680|4082391|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0
2345781|NCT03605680|4082392|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5
2345782|NCT03605680|4082393|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4
2345783|NCT03605680|4082394|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3
2345784|NCT03605680|4082391|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0
2345785|NCT03605680|4082392|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1
2345786|NCT03605680|4082393|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2
2345787|NCT03605680|4082394|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3
2345788|NCT03605693|4082405|FG000|Overall Study|Lost to Follow-up|4
2345789|NCT03605693|4082406|FG001|Overall Study|Lost to Follow-up|0
2345790|NCT03605693|4082405|FG000|Overall Study|Physician Decision|1
2345791|NCT03605693|4082406|FG001|Overall Study|Physician Decision|0
2345792|NCT03605745|4082412|FG000|Overall Study|Study was terminated for business reasons|47
2345793|NCT03605836|4082420|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2
2345794|NCT03605836|4082421|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0
2345795|NCT03605836|4082422|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0
2345796|NCT03605836|4082423|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0
2345797|NCT03605836|4082420|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2
2345798|NCT03605836|4082421|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
2345799|NCT03605836|4082422|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
2345800|NCT03605836|4082423|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
2345801|NCT03605836|4082420|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8
2345802|NCT03605836|4082421|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
2345803|NCT03605836|4082422|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
2345804|NCT03605836|4082423|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
2345805|NCT03605836|4082420|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4
2345806|NCT03605836|4082421|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
2345807|NCT03605836|4082422|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
2345808|NCT03605836|4082423|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
2345809|NCT03605836|4082420|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4
2345810|NCT03605836|4082421|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
2345811|NCT03605836|4082422|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
2345812|NCT03605836|4082423|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
2345813|NCT03605836|4082420|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17
2345814|NCT03605836|4082421|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
2345815|NCT03605836|4082422|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
2345816|NCT03605836|4082423|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
2345817|NCT03605836|4082420|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5
2345818|NCT03605836|4082421|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
2345819|NCT03605836|4082422|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
2345820|NCT03605836|4082423|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
2261592|NCT02139644|3932411|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2261593|NCT02139644|3932412|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2261594|NCT02139644|3932413|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2261595|NCT02139644|3932414|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2261596|NCT02139644|3932409|FG000|Run-In Period (Pre-assignment)|Adverse Event|3
2261597|NCT02139644|3932410|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
2261598|NCT02139644|3932411|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
2261599|NCT02139644|3932412|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
2261600|NCT02139644|3932413|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
2261601|NCT02139644|3932414|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
2261602|NCT02139644|3932409|FG000|Run-In Period (Pre-assignment)|Other|6
2261603|NCT02139644|3932410|FG001|Run-In Period (Pre-assignment)|Other|0
2261604|NCT02139644|3932411|FG002|Run-In Period (Pre-assignment)|Other|0
2261605|NCT02139644|3932412|FG003|Run-In Period (Pre-assignment)|Other|0
2261606|NCT02139644|3932413|FG004|Run-In Period (Pre-assignment)|Other|0
2261607|NCT02139644|3932414|FG005|Run-In Period (Pre-assignment)|Other|0
2261608|NCT02139644|3932409|FG000|Treatment Period|Adverse Event|0
2261609|NCT02139644|3932410|FG001|Treatment Period|Adverse Event|0
2261610|NCT02139644|3932411|FG002|Treatment Period|Adverse Event|3
2261611|NCT02139644|3932412|FG003|Treatment Period|Adverse Event|2
2261612|NCT02139644|3932413|FG004|Treatment Period|Adverse Event|1
2261613|NCT02139644|3932414|FG005|Treatment Period|Adverse Event|6
2261614|NCT02139644|3932409|FG000|Treatment Period|Withdrawal by Subject|0
2261615|NCT02139644|3932410|FG001|Treatment Period|Withdrawal by Subject|0
2261616|NCT02139644|3932411|FG002|Treatment Period|Withdrawal by Subject|2
2261617|NCT02139644|3932412|FG003|Treatment Period|Withdrawal by Subject|2
2261618|NCT02139644|3932413|FG004|Treatment Period|Withdrawal by Subject|3
2261619|NCT02139644|3932414|FG005|Treatment Period|Withdrawal by Subject|2
2261620|NCT02139644|3932409|FG000|Treatment Period|Non-compliance|0
2261621|NCT02139644|3932410|FG001|Treatment Period|Non-compliance|0
2261622|NCT02139644|3932411|FG002|Treatment Period|Non-compliance|0
2261623|NCT02139644|3932412|FG003|Treatment Period|Non-compliance|1
2261624|NCT02139644|3932413|FG004|Treatment Period|Non-compliance|0
2261625|NCT02139644|3932414|FG005|Treatment Period|Non-compliance|0
2261626|NCT02139644|3932409|FG000|Treatment Period|Protocol Violation|0
2261627|NCT02139644|3932410|FG001|Treatment Period|Protocol Violation|0
2261628|NCT02139644|3932411|FG002|Treatment Period|Protocol Violation|0
2261629|NCT02139644|3932412|FG003|Treatment Period|Protocol Violation|1
2261630|NCT02139644|3932413|FG004|Treatment Period|Protocol Violation|1
2261631|NCT02139644|3932414|FG005|Treatment Period|Protocol Violation|1
2261632|NCT02139644|3932409|FG000|Treatment Period|Disease progression|0
2261633|NCT02139644|3932410|FG001|Treatment Period|Disease progression|0
2261634|NCT02139644|3932411|FG002|Treatment Period|Disease progression|0
2261635|NCT02139644|3932412|FG003|Treatment Period|Disease progression|1
2261636|NCT02139644|3932413|FG004|Treatment Period|Disease progression|1
2261637|NCT02139644|3932414|FG005|Treatment Period|Disease progression|2
2261638|NCT02139644|3932409|FG000|Treatment Period|Lost to Follow-up|0
2261639|NCT02139644|3932410|FG001|Treatment Period|Lost to Follow-up|0
2261640|NCT02139644|3932411|FG002|Treatment Period|Lost to Follow-up|1
2261641|NCT02139644|3932412|FG003|Treatment Period|Lost to Follow-up|1
2261642|NCT02139644|3932413|FG004|Treatment Period|Lost to Follow-up|1
2261643|NCT02139644|3932414|FG005|Treatment Period|Lost to Follow-up|1
2261644|NCT02139644|3932409|FG000|Treatment Period|Lack of Efficacy|0
2261645|NCT02139644|3932410|FG001|Treatment Period|Lack of Efficacy|0
2261646|NCT02139644|3932411|FG002|Treatment Period|Lack of Efficacy|1
2261647|NCT02139644|3932412|FG003|Treatment Period|Lack of Efficacy|0
2261648|NCT02139644|3932413|FG004|Treatment Period|Lack of Efficacy|1
2261649|NCT02139644|3932414|FG005|Treatment Period|Lack of Efficacy|4
2261650|NCT02139644|3932409|FG000|Treatment Period|Other|0
2261651|NCT02139644|3932410|FG001|Treatment Period|Other|3
2261652|NCT02139644|3932411|FG002|Treatment Period|Other|1
2261653|NCT02139644|3932412|FG003|Treatment Period|Other|1
2261654|NCT02139644|3932413|FG004|Treatment Period|Other|0
2261655|NCT02139644|3932414|FG005|Treatment Period|Other|1
2261656|NCT02139826|3932435|FG000|Overall Study|Adverse Event|1
2261657|NCT02139943|3932455|FG000|Overall Study|Adverse Event|0
2261658|NCT02139943|3932456|FG001|Overall Study|Adverse Event|1
2261659|NCT02139943|3932457|FG002|Overall Study|Adverse Event|2
2261660|NCT02139943|3932455|FG000|Overall Study|Lost to Follow-up|3
2261661|NCT02139943|3932456|FG001|Overall Study|Lost to Follow-up|2
2261662|NCT02139943|3932457|FG002|Overall Study|Lost to Follow-up|2
2261663|NCT02139943|3932455|FG000|Overall Study|Withdrawal by Subject|4
2261664|NCT02139943|3932456|FG001|Overall Study|Withdrawal by Subject|3
2261665|NCT02139943|3932457|FG002|Overall Study|Withdrawal by Subject|0
2345821|NCT03605836|4082420|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7
2345822|NCT03605836|4082421|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0
2345823|NCT03605836|4082422|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0
2345824|NCT03605836|4082423|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0
2345825|NCT03605836|4082420|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85
2345826|NCT03605836|4082421|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
2261666|NCT02139943|3932455|FG000|Overall Study|Other|0
2261667|NCT02139943|3932456|FG001|Overall Study|Other|0
2261668|NCT02139943|3932457|FG002|Overall Study|Other|1
2261669|NCT02139943|3932455|FG000|Overall Study|Participant wishes to discontinue|2
2261670|NCT02139943|3932456|FG001|Overall Study|Participant wishes to discontinue|0
2261671|NCT02139943|3932457|FG002|Overall Study|Participant wishes to discontinue|0
2261672|NCT02139943|3932455|FG000|Overall Study|Participant in Poor Compliance|1
2261673|NCT02139943|3932456|FG001|Overall Study|Participant in Poor Compliance|0
2261674|NCT02139943|3932457|FG002|Overall Study|Participant in Poor Compliance|1
2261675|NCT02139943|3932455|FG000|Overall Study|eGFR Withdrawal Criteria|0
2261676|NCT02139943|3932456|FG001|Overall Study|eGFR Withdrawal Criteria|0
2261677|NCT02139943|3932457|FG002|Overall Study|eGFR Withdrawal Criteria|1
2261678|NCT02139982|3932479|FG000|Overall Study|Lack of Efficacy|0
2261679|NCT02139982|3932480|FG001|Overall Study|Lack of Efficacy|1
2261680|NCT02139982|3932481|FG002|Overall Study|Lack of Efficacy|0
2261681|NCT02139982|3932482|FG003|Overall Study|Lack of Efficacy|1
2261682|NCT02139982|3932483|FG004|Overall Study|Lack of Efficacy|0
2261683|NCT02139982|3932484|FG005|Overall Study|Lack of Efficacy|0
2261684|NCT02139982|3932485|FG006|Overall Study|Lack of Efficacy|0
2261685|NCT02139982|3932486|FG007|Overall Study|Lack of Efficacy|0
2261686|NCT02139982|3932487|FG008|Overall Study|Lack of Efficacy|0
2261687|NCT02139982|3932488|FG009|Overall Study|Lack of Efficacy|0
2261688|NCT02140060|3932516|FG000|Overall Study|Adverse Event|0
2261689|NCT02140060|3932517|FG001|Overall Study|Adverse Event|0
2261690|NCT02140060|3932518|FG002|Overall Study|Adverse Event|0
2261691|NCT02140060|3932519|FG003|Overall Study|Adverse Event|1
2261692|NCT02140060|3932520|FG004|Overall Study|Adverse Event|1
2261693|NCT02140060|3932521|FG005|Overall Study|Adverse Event|1
2261694|NCT02140060|3932516|FG000|Overall Study|Lack of Efficacy|0
2261695|NCT02140060|3932517|FG001|Overall Study|Lack of Efficacy|0
2261696|NCT02140060|3932518|FG002|Overall Study|Lack of Efficacy|0
2261697|NCT02140060|3932519|FG003|Overall Study|Lack of Efficacy|1
2261698|NCT02140060|3932520|FG004|Overall Study|Lack of Efficacy|0
2261699|NCT02140060|3932521|FG005|Overall Study|Lack of Efficacy|0
2261700|NCT02140164|3932536|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2
2261701|NCT02140411|3932544|FG000|Overall Study|Adverse Event|1
2261702|NCT02140567|3932548|FG000|Overall Study|Problems with recording equipment|6
2261703|NCT02140645|3932568|FG000|Overall Study|Not linked|5489
2261704|NCT02140645|3932569|FG001|Overall Study|Not linked|61654
2261705|NCT02140645|3932570|FG002|Overall Study|Not linked|4236
2261706|NCT02140645|3932571|FG003|Overall Study|Not linked|13833
2261707|NCT02140645|3932572|FG004|Overall Study|Not linked|3286
2261708|NCT02140645|3932573|FG005|Overall Study|Not linked|70896
2261709|NCT02140762|3932584|FG000|Overall Study|Adverse Event|1
2261710|NCT02140762|3932585|FG001|Overall Study|Adverse Event|1
2261711|NCT02140762|3932584|FG000|Overall Study|Lost to Follow-up|9
2261712|NCT02140762|3932585|FG001|Overall Study|Lost to Follow-up|5
2261713|NCT02140762|3932584|FG000|Overall Study|Protocol Violation|1
2261714|NCT02140762|3932585|FG001|Overall Study|Protocol Violation|1
2261715|NCT02140762|3932584|FG000|Overall Study|Withdrawal by Subject|6
2261716|NCT02140762|3932585|FG001|Overall Study|Withdrawal by Subject|4
2261717|NCT02140762|3932584|FG000|Overall Study|Other|0
2261718|NCT02140762|3932585|FG001|Overall Study|Other|1
2261719|NCT02140775|3932598|FG000|Overall Study|Withdrawal by Subject|30
2261720|NCT02140775|3932599|FG001|Overall Study|Withdrawal by Subject|7
2261721|NCT02140970|3932618|FG000|Overall Study|Lost to Follow-up|1
2261722|NCT02140970|3932619|FG001|Overall Study|Lost to Follow-up|2
2261723|NCT02140970|3932618|FG000|Overall Study|Misplaced consent, subject withdrawn|1
2261724|NCT02140970|3932619|FG001|Overall Study|Misplaced consent, subject withdrawn|0
2261725|NCT02140970|3932618|FG000|Overall Study|Did not meet inclusion criteria|0
2261726|NCT02140970|3932619|FG001|Overall Study|Did not meet inclusion criteria|1
2261727|NCT02141204|3932627|FG000|Overall Study|Lost to Follow-up|2
2261728|NCT02141204|3932628|FG001|Overall Study|Lost to Follow-up|1
2261729|NCT02141204|3932627|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1
2261730|NCT02141204|3932628|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2
2261731|NCT02141204|3932627|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
2261732|NCT02141204|3932628|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5
2261733|NCT02141204|3932627|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9
2261734|NCT02141204|3932628|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7
2261735|NCT02141217|3932636|FG000|Overall Study|Adverse Event|1
2261736|NCT02141217|3932637|FG001|Overall Study|Adverse Event|2
2261737|NCT02141217|3932636|FG000|Overall Study|Protocol Violation|1
2261738|NCT02141217|3932637|FG001|Overall Study|Protocol Violation|4
2261739|NCT02141217|3932636|FG000|Overall Study|Withdrawal by Subject|6
2261740|NCT02141217|3932637|FG001|Overall Study|Withdrawal by Subject|0
2261741|NCT02141217|3932636|FG000|Overall Study|Lost to Follow-up|1
2261742|NCT02141217|3932637|FG001|Overall Study|Lost to Follow-up|1
2261743|NCT02141217|3932636|FG000|Overall Study|Physician Decision|1
2261744|NCT02141217|3932637|FG001|Overall Study|Physician Decision|0
2261745|NCT02141217|3932636|FG000|Overall Study|Surgical Intervention|1
2261746|NCT02141217|3932637|FG001|Overall Study|Surgical Intervention|1
2261747|NCT02141295|3932649|FG000|Overall Study|Adverse Event|1
2261748|NCT02141295|3932650|FG001|Overall Study|Adverse Event|18
2261749|NCT02141295|3932651|FG002|Overall Study|Adverse Event|11
2261750|NCT02141295|3932649|FG000|Overall Study|Physician Decision|2
2261751|NCT02141295|3932650|FG001|Overall Study|Physician Decision|19
2261752|NCT02141295|3932651|FG002|Overall Study|Physician Decision|14
2261753|NCT02141295|3932649|FG000|Overall Study|Study terminated by sponsor|0
2261754|NCT02141295|3932650|FG001|Overall Study|Study terminated by sponsor|6
2345827|NCT03605836|4082422|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
2345828|NCT03605836|4082423|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
2345829|NCT03605836|4082420|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15
2345830|NCT03605836|4082421|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
2261755|NCT02141295|3932651|FG002|Overall Study|Study terminated by sponsor|6
2261756|NCT02141295|3932649|FG000|Overall Study|Non-compliance|0
2261757|NCT02141295|3932650|FG001|Overall Study|Non-compliance|1
2261758|NCT02141295|3932651|FG002|Overall Study|Non-compliance|0
2261759|NCT02141295|3932649|FG000|Overall Study|Progressive disease|3
2261760|NCT02141295|3932650|FG001|Overall Study|Progressive disease|32
2261761|NCT02141295|3932651|FG002|Overall Study|Progressive disease|50
2261762|NCT02141295|3932649|FG000|Overall Study|Reason not specified|0
2261763|NCT02141295|3932650|FG001|Overall Study|Reason not specified|9
2261764|NCT02141295|3932651|FG002|Overall Study|Reason not specified|10
2261765|NCT02141295|3932649|FG000|Overall Study|Withdrawal by Subject|0
2261766|NCT02141295|3932650|FG001|Overall Study|Withdrawal by Subject|9
2261767|NCT02141295|3932651|FG002|Overall Study|Withdrawal by Subject|4
2261768|NCT02141360|3932663|FG000|Overall Study|Withdrawal by Subject|6
2261769|NCT02141360|3932664|FG001|Overall Study|Withdrawal by Subject|0
2261770|NCT02141360|3932665|FG002|Overall Study|Withdrawal by Subject|0
2261771|NCT02141360|3932663|FG000|Overall Study|Study Terminated before Visit|1
2261772|NCT02141360|3932664|FG001|Overall Study|Study Terminated before Visit|0
2261773|NCT02141360|3932665|FG002|Overall Study|Study Terminated before Visit|0
2261774|NCT02141399|3932673|FG000|Overall Study|Adverse Event|158
2261775|NCT02141399|3932673|FG000|Overall Study|Lack of Efficacy|62
2261776|NCT02141399|3932673|FG000|Overall Study|Lost to Follow-up|151
2261777|NCT02141399|3932673|FG000|Overall Study|Non-compliance with study drug|18
2261778|NCT02141399|3932673|FG000|Overall Study|Other|45
2261779|NCT02141399|3932673|FG000|Overall Study|Physician Decision|17
2261780|NCT02141399|3932673|FG000|Overall Study|Pregnancy|3
2261781|NCT02141399|3932673|FG000|Overall Study|Protocol Violation|38
2261782|NCT02141399|3932673|FG000|Overall Study|Withdrawal by Subject|238
2261783|NCT02141399|3932673|FG000|Overall Study|Failure to meet eligibility criteria|14
2261784|NCT02141490|3932700|FG000|Overall Study|Screening failures|4
2261785|NCT02141490|3932701|FG001|Overall Study|Screening failures|0
2261786|NCT02141490|3932702|FG002|Overall Study|Screening failures|0
2261787|NCT02141516|3932715|FG000|Overall Study|Adverse Event|0
2261788|NCT02141516|3932716|FG001|Overall Study|Adverse Event|1
2261789|NCT02141516|3932717|FG002|Overall Study|Adverse Event|0
2261790|NCT02141516|3932715|FG000|Overall Study|Lost to Follow-up|0
2261791|NCT02141516|3932716|FG001|Overall Study|Lost to Follow-up|1
2261792|NCT02141516|3932717|FG002|Overall Study|Lost to Follow-up|0
2261793|NCT02141516|3932715|FG000|Overall Study|Other|0
2261794|NCT02141516|3932716|FG001|Overall Study|Other|3
2261795|NCT02141516|3932717|FG002|Overall Study|Other|0
2345831|NCT03605836|4082422|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
2345832|NCT03605836|4082423|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
2345833|NCT03605836|4082420|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1
2345834|NCT03605836|4082421|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
2345835|NCT03605836|4082422|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
2345836|NCT03605836|4082423|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
2345837|NCT03605836|4082420|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0
2345838|NCT03605836|4082421|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2
2345839|NCT03605836|4082422|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
2345840|NCT03605836|4082423|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
2345841|NCT03605836|4082420|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
2345842|NCT03605836|4082421|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5
2345843|NCT03605836|4082422|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8
2345844|NCT03605836|4082423|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
2345845|NCT03605836|4082420|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
2345846|NCT03605836|4082421|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
2345847|NCT03605836|4082422|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2
2345848|NCT03605836|4082423|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1
2345849|NCT03605836|4082420|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0
2345850|NCT03605836|4082421|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3
2345851|NCT03605836|4082422|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5
2345852|NCT03605836|4082423|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1
2345853|NCT03605836|4082420|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
2345854|NCT03605836|4082421|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1
2345855|NCT03605836|4082422|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
2345856|NCT03605836|4082423|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4
2345857|NCT03605836|4082420|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
2345858|NCT03605836|4082421|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1
2261796|NCT02141620|3932751|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1
2261797|NCT02141620|3932752|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0
2261798|NCT02141633|3932760|FG000|Overall Study|Physician Decision|1
2261799|NCT02141633|3932761|FG001|Overall Study|Physician Decision|0
2261800|NCT02141659|3932773|FG000|Overall Study|Major Protocol Deviation|0
2261801|NCT02141659|3932774|FG001|Overall Study|Major Protocol Deviation|1
2261802|NCT02141659|3932775|FG002|Overall Study|Major Protocol Deviation|0
2261803|NCT02141659|3932776|FG003|Overall Study|Major Protocol Deviation|0
2261804|NCT02141659|3932777|FG004|Overall Study|Major Protocol Deviation|0
2261805|NCT02141659|3932778|FG005|Overall Study|Major Protocol Deviation|0
2261806|NCT02141659|3932773|FG000|Overall Study|Lack of Efficacy|0
2261807|NCT02141659|3932774|FG001|Overall Study|Lack of Efficacy|0
2261808|NCT02141659|3932775|FG002|Overall Study|Lack of Efficacy|0
2261809|NCT02141659|3932776|FG003|Overall Study|Lack of Efficacy|0
2261810|NCT02141659|3932777|FG004|Overall Study|Lack of Efficacy|0
2261811|NCT02141659|3932778|FG005|Overall Study|Lack of Efficacy|1
2261812|NCT02141659|3932773|FG000|Overall Study|Pretreatment Event/ Adverse Event|0
2261813|NCT02141659|3932774|FG001|Overall Study|Pretreatment Event/ Adverse Event|0
2261814|NCT02141659|3932775|FG002|Overall Study|Pretreatment Event/ Adverse Event|0
2261815|NCT02141659|3932776|FG003|Overall Study|Pretreatment Event/ Adverse Event|0
2261816|NCT02141659|3932777|FG004|Overall Study|Pretreatment Event/ Adverse Event|2
2261817|NCT02141659|3932778|FG005|Overall Study|Pretreatment Event/ Adverse Event|1
2261818|NCT02141672|3932795|FG000|Overall Study|Adverse Event|0
2261819|NCT02141672|3932796|FG001|Overall Study|Adverse Event|1
2261820|NCT02141672|3932797|FG002|Overall Study|Adverse Event|0
2261821|NCT02141672|3932795|FG000|Overall Study|Death|10
2261822|NCT02141672|3932796|FG001|Overall Study|Death|2
2261823|NCT02141672|3932797|FG002|Overall Study|Death|1
2261824|NCT02141672|3932795|FG000|Overall Study|Lack of Efficacy|0
2261825|NCT02141672|3932796|FG001|Overall Study|Lack of Efficacy|0
2261826|NCT02141672|3932797|FG002|Overall Study|Lack of Efficacy|2
2261827|NCT02141672|3932795|FG000|Overall Study|Lost to Follow-up|1
2261828|NCT02141672|3932796|FG001|Overall Study|Lost to Follow-up|1
2261829|NCT02141672|3932797|FG002|Overall Study|Lost to Follow-up|3
2261830|NCT02141672|3932795|FG000|Overall Study|Physician Decision|1
2261831|NCT02141672|3932796|FG001|Overall Study|Physician Decision|2
2261832|NCT02141672|3932797|FG002|Overall Study|Physician Decision|5
2261833|NCT02141672|3932795|FG000|Overall Study|Protocol Violation|0
2261834|NCT02141672|3932796|FG001|Overall Study|Protocol Violation|0
2261835|NCT02141672|3932797|FG002|Overall Study|Protocol Violation|1
2261836|NCT02141672|3932795|FG000|Overall Study|Withdrawal by Subject|3
2261837|NCT02141672|3932796|FG001|Overall Study|Withdrawal by Subject|2
2261838|NCT02141672|3932797|FG002|Overall Study|Withdrawal by Subject|5
2261839|NCT02141672|3932795|FG000|Overall Study|refused to follow-up|1
2261840|NCT02141672|3932796|FG001|Overall Study|refused to follow-up|0
2261841|NCT02141672|3932797|FG002|Overall Study|refused to follow-up|1
2261842|NCT02141854|3932810|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
2261843|NCT02141854|3932811|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2261844|NCT02141854|3932812|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2261845|NCT02141854|3932813|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2261846|NCT02141854|3932814|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2261847|NCT02141854|3932815|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2261848|NCT02141854|3932810|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76
2261849|NCT02141854|3932811|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2261850|NCT02141854|3932812|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2261851|NCT02141854|3932813|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2261852|NCT02141854|3932814|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2261853|NCT02141854|3932815|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2261854|NCT02141854|3932810|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14
2261855|NCT02141854|3932811|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2261856|NCT02141854|3932812|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2261857|NCT02141854|3932813|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2261858|NCT02141854|3932814|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2261859|NCT02141854|3932815|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2261860|NCT02141854|3932810|FG000|Run-In Period (Pre-assignment)|Other|14
2261861|NCT02141854|3932811|FG001|Run-In Period (Pre-assignment)|Other|0
2261862|NCT02141854|3932812|FG002|Run-In Period (Pre-assignment)|Other|0
2261863|NCT02141854|3932813|FG003|Run-In Period (Pre-assignment)|Other|0
2261864|NCT02141854|3932814|FG004|Run-In Period (Pre-assignment)|Other|0
2261865|NCT02141854|3932815|FG005|Run-In Period (Pre-assignment)|Other|0
2261866|NCT02141854|3932810|FG000|Run-In Period (Pre-assignment)|Adverse Event|10
2261867|NCT02141854|3932811|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
2261868|NCT02141854|3932812|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
2261869|NCT02141854|3932813|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
2261870|NCT02141854|3932814|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
2261871|NCT02141854|3932815|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
2261872|NCT02141854|3932810|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
2261873|NCT02141854|3932811|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2261874|NCT02141854|3932812|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2261875|NCT02141854|3932813|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2261876|NCT02141854|3932814|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2261877|NCT02141854|3932815|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2261878|NCT02141854|3932810|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
2261879|NCT02141854|3932811|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2261880|NCT02141854|3932812|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2261881|NCT02141854|3932813|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2261882|NCT02141854|3932814|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2261883|NCT02141854|3932815|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2261884|NCT02141854|3932810|FG000|Treatment Period|Protocol Violation|0
2261885|NCT02141854|3932811|FG001|Treatment Period|Protocol Violation|1
2261886|NCT02141854|3932812|FG002|Treatment Period|Protocol Violation|0
2261887|NCT02141854|3932813|FG003|Treatment Period|Protocol Violation|2
2261888|NCT02141854|3932814|FG004|Treatment Period|Protocol Violation|2
2261889|NCT02141854|3932815|FG005|Treatment Period|Protocol Violation|1
2261890|NCT02141854|3932810|FG000|Treatment Period|Noncompliance|0
2261891|NCT02141854|3932811|FG001|Treatment Period|Noncompliance|0
2261892|NCT02141854|3932812|FG002|Treatment Period|Noncompliance|0
2261893|NCT02141854|3932813|FG003|Treatment Period|Noncompliance|1
2261894|NCT02141854|3932814|FG004|Treatment Period|Noncompliance|0
2261895|NCT02141854|3932815|FG005|Treatment Period|Noncompliance|0
2261896|NCT02141854|3932810|FG000|Treatment Period|Lack of Efficacy|0
2261897|NCT02141854|3932811|FG001|Treatment Period|Lack of Efficacy|0
2261898|NCT02141854|3932812|FG002|Treatment Period|Lack of Efficacy|0
2261899|NCT02141854|3932813|FG003|Treatment Period|Lack of Efficacy|1
2261900|NCT02141854|3932814|FG004|Treatment Period|Lack of Efficacy|1
2261901|NCT02141854|3932815|FG005|Treatment Period|Lack of Efficacy|7
2261902|NCT02141854|3932810|FG000|Treatment Period|Pregnancy|0
2261903|NCT02141854|3932811|FG001|Treatment Period|Pregnancy|1
2261904|NCT02141854|3932812|FG002|Treatment Period|Pregnancy|0
2261905|NCT02141854|3932813|FG003|Treatment Period|Pregnancy|0
2261906|NCT02141854|3932814|FG004|Treatment Period|Pregnancy|0
2261907|NCT02141854|3932815|FG005|Treatment Period|Pregnancy|0
2261908|NCT02141854|3932810|FG000|Treatment Period|Other|0
2261909|NCT02141854|3932811|FG001|Treatment Period|Other|1
2261910|NCT02141854|3932812|FG002|Treatment Period|Other|2
2261911|NCT02141854|3932813|FG003|Treatment Period|Other|0
2261912|NCT02141854|3932814|FG004|Treatment Period|Other|1
2261913|NCT02141854|3932815|FG005|Treatment Period|Other|2
2261914|NCT02141854|3932810|FG000|Treatment Period|Adverse Event|0
2261915|NCT02141854|3932811|FG001|Treatment Period|Adverse Event|2
2261916|NCT02141854|3932812|FG002|Treatment Period|Adverse Event|2
2261917|NCT02141854|3932813|FG003|Treatment Period|Adverse Event|0
2261918|NCT02141854|3932814|FG004|Treatment Period|Adverse Event|2
2261919|NCT02141854|3932815|FG005|Treatment Period|Adverse Event|2
2261920|NCT02141854|3932810|FG000|Treatment Period|Withdrawal by Subject|0
2261921|NCT02141854|3932811|FG001|Treatment Period|Withdrawal by Subject|2
2261922|NCT02141854|3932812|FG002|Treatment Period|Withdrawal by Subject|3
2261923|NCT02141854|3932813|FG003|Treatment Period|Withdrawal by Subject|3
2261924|NCT02141854|3932814|FG004|Treatment Period|Withdrawal by Subject|4
2261925|NCT02141854|3932815|FG005|Treatment Period|Withdrawal by Subject|7
2261926|NCT02141854|3932810|FG000|Treatment Period|Disease progression|0
2261927|NCT02141854|3932811|FG001|Treatment Period|Disease progression|2
2261928|NCT02141854|3932812|FG002|Treatment Period|Disease progression|1
2261929|NCT02141854|3932813|FG003|Treatment Period|Disease progression|3
2261930|NCT02141854|3932814|FG004|Treatment Period|Disease progression|0
2261931|NCT02141854|3932815|FG005|Treatment Period|Disease progression|18
2261932|NCT02141854|3932810|FG000|Treatment Period|Lost to Follow-up|0
2261933|NCT02141854|3932811|FG001|Treatment Period|Lost to Follow-up|1
2261934|NCT02141854|3932812|FG002|Treatment Period|Lost to Follow-up|1
2261935|NCT02141854|3932813|FG003|Treatment Period|Lost to Follow-up|1
2261936|NCT02141854|3932814|FG004|Treatment Period|Lost to Follow-up|0
2261937|NCT02141854|3932815|FG005|Treatment Period|Lost to Follow-up|1
2261938|NCT02141984|3932831|FG000|Overall Study|Lack of Efficacy|2
2261939|NCT02141997|3932839|FG000|Overall Study|Adverse Event|0
2261940|NCT02141997|3932840|FG001|Overall Study|Adverse Event|2
2261941|NCT02141997|3932841|FG002|Overall Study|Adverse Event|0
2261942|NCT02141997|3932842|FG003|Overall Study|Adverse Event|1
2261943|NCT02141997|3932839|FG000|Overall Study|Participant noncompliance|1
2261944|NCT02141997|3932840|FG001|Overall Study|Participant noncompliance|0
2261945|NCT02141997|3932841|FG002|Overall Study|Participant noncompliance|0
2261946|NCT02141997|3932842|FG003|Overall Study|Participant noncompliance|0
2261947|NCT02141997|3932839|FG000|Overall Study|Withdrew consent|1
2261948|NCT02141997|3932840|FG001|Overall Study|Withdrew consent|0
2261949|NCT02141997|3932841|FG002|Overall Study|Withdrew consent|3
2261950|NCT02141997|3932842|FG003|Overall Study|Withdrew consent|0
2261951|NCT02141997|3932839|FG000|Overall Study|Other|1
2261952|NCT02141997|3932840|FG001|Overall Study|Other|4
2261953|NCT02141997|3932841|FG002|Overall Study|Other|0
2261954|NCT02141997|3932842|FG003|Overall Study|Other|0
2261955|NCT02142283|3932931|FG000|Overall Study|Death|20
2261956|NCT02142283|3932932|FG001|Overall Study|Death|18
2261957|NCT02142283|3932931|FG000|Overall Study|Withdrawal by Subject|1
2261958|NCT02142283|3932932|FG001|Overall Study|Withdrawal by Subject|3
2261959|NCT02142387|3932953|FG000|Overall Study|<19 years old|49
2261960|NCT02142387|3932954|FG001|Overall Study|<19 years old|326
2261961|NCT02142387|3932953|FG000|Overall Study|non-cardiac etiology|504
2261962|NCT02142387|3932954|FG001|Overall Study|non-cardiac etiology|3431
2261963|NCT02142387|3932953|FG000|Overall Study|CPR not performed|74
2261964|NCT02142387|3932954|FG001|Overall Study|CPR not performed|473
2261965|NCT02142387|3932953|FG000|Overall Study|witnessed by paramedic|139
2261966|NCT02142387|3932954|FG001|Overall Study|witnessed by paramedic|917
2261967|NCT02142387|3932953|FG000|Overall Study|incomplete data|1
2261968|NCT02142387|3932954|FG001|Overall Study|incomplete data|9
2261969|NCT02142387|3932953|FG000|Overall Study|occurred not at home|298
2261970|NCT02142387|3932954|FG001|Overall Study|occurred not at home|2474
2261971|NCT02142504|3932963|FG000|Overall Study|Protocol Violation|2
2261972|NCT02142504|3932964|FG001|Overall Study|Protocol Violation|1
2261973|NCT02142504|3932965|FG002|Overall Study|Protocol Violation|2
2261974|NCT02142504|3932963|FG000|Overall Study|Adverse Event|2
2261975|NCT02142504|3932964|FG001|Overall Study|Adverse Event|3
2261976|NCT02142504|3932965|FG002|Overall Study|Adverse Event|4
2261977|NCT02142504|3932963|FG000|Overall Study|Lost to Follow-up|12
2261978|NCT02142504|3932964|FG001|Overall Study|Lost to Follow-up|19
2261979|NCT02142504|3932965|FG002|Overall Study|Lost to Follow-up|17
2261980|NCT02142504|3932963|FG000|Overall Study|Withdrawal by Subject|7
2261981|NCT02142504|3932964|FG001|Overall Study|Withdrawal by Subject|9
2261982|NCT02142504|3932965|FG002|Overall Study|Withdrawal by Subject|11
2261983|NCT02142504|3932963|FG000|Overall Study|Pregnancy|4
2261984|NCT02142504|3932964|FG001|Overall Study|Pregnancy|4
2261985|NCT02142504|3932965|FG002|Overall Study|Pregnancy|2
2261986|NCT02142504|3932963|FG000|Overall Study|Physician Decision|0
2261987|NCT02142504|3932964|FG001|Overall Study|Physician Decision|1
2261988|NCT02142504|3932965|FG002|Overall Study|Physician Decision|3
2261989|NCT02142504|3932963|FG000|Overall Study|Reason Not Specified|4
2261990|NCT02142504|3932964|FG001|Overall Study|Reason Not Specified|5
2345859|NCT03605836|4082422|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
2345860|NCT03605836|4082423|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
2345861|NCT03605836|4082420|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0
2345862|NCT03605836|4082421|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5
2345863|NCT03605836|4082422|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
2345864|NCT03605836|4082423|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
2345865|NCT03605836|4082420|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0
2345866|NCT03605836|4082421|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10
2345867|NCT03605836|4082422|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6
2345868|NCT03605836|4082423|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4
2345869|NCT03605836|4082420|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
2345870|NCT03605836|4082421|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3
2345871|NCT03605836|4082422|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1
2345872|NCT03605836|4082423|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
2345873|NCT03605836|4082420|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0
2345874|NCT03605836|4082421|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6
2345875|NCT03605836|4082422|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16
2345876|NCT03605836|4082423|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7
2345877|NCT03605836|4082420|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
2345878|NCT03605836|4082421|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
2345879|NCT03605836|4082422|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2
2345880|NCT03605836|4082423|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1
2345881|NCT03606460|4082456|FG000|Overall Study|Lost to Follow-up|1
2345882|NCT03606460|4082457|FG001|Overall Study|Lost to Follow-up|8
2345883|NCT03607487|4082468|FG000|Overall Study|Withdrawal by Subject|2
2345884|NCT03607487|4082469|FG001|Overall Study|Withdrawal by Subject|0
2345885|NCT03607487|4082470|FG002|Overall Study|Withdrawal by Subject|0
2345886|NCT03607487|4082471|FG003|Overall Study|Withdrawal by Subject|1
2345887|NCT03607682|4082492|FG000|Overall Study|Withdrawal by Subject|1
2345888|NCT03607682|4082492|FG000|Overall Study|Disease progression|1
2345889|NCT03607695|4082496|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1
2345890|NCT03607695|4082496|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2
2345891|NCT03607994|4082502|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
2345892|NCT03607994|4082503|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
2345893|NCT03608774|4082528|FG000|Overall Study|Lost to Follow-up|5
2345894|NCT03608774|4082529|FG001|Overall Study|Lost to Follow-up|5
2345895|NCT03608774|4082528|FG000|Overall Study|Withdrawal by Subject|1
2345896|NCT03608774|4082529|FG001|Overall Study|Withdrawal by Subject|0
2345897|NCT03608774|4082528|FG000|Overall Study|Protocol Violation|1
2345898|NCT03608774|4082529|FG001|Overall Study|Protocol Violation|0
2261991|NCT02142504|3932965|FG002|Overall Study|Reason Not Specified|4
2261992|NCT02142712|3932981|FG000|Overall Study|Lost to Follow-up|1
2261993|NCT02142712|3932982|FG001|Overall Study|Lost to Follow-up|1
2261994|NCT02142712|3932983|FG002|Overall Study|Lost to Follow-up|1
2261995|NCT02142712|3932984|FG003|Overall Study|Lost to Follow-up|0
2261996|NCT02142738|3932995|FG000|Overall Study|Adverse Event|9
2261997|NCT02142738|3932996|FG001|Overall Study|Adverse Event|8
2261998|NCT02142738|3932995|FG000|Overall Study|Death|33
2261999|NCT02142738|3932996|FG001|Overall Study|Death|55
2262000|NCT02142738|3932995|FG000|Overall Study|Progressive Disease|0
2262001|NCT02142738|3932996|FG001|Overall Study|Progressive Disease|1
2262002|NCT02142738|3932995|FG000|Overall Study|Withdrawal by Subject|5
2262003|NCT02142738|3932996|FG001|Overall Study|Withdrawal by Subject|5
2262004|NCT02142738|3932995|FG000|Overall Study|Ongoing in Study|107
2262005|NCT02142738|3932996|FG001|Overall Study|Ongoing in Study|82
2262006|NCT02142894|3933002|FG000|Overall Study|Protocol Violation|8
2262007|NCT02143024|3933008|FG000|Overall Study|Lost to Follow-up|1
2262008|NCT02143024|3933009|FG001|Overall Study|Lost to Follow-up|1
2262009|NCT02143024|3933008|FG000|Overall Study|Withdrawal by Subject|1
2262010|NCT02143024|3933009|FG001|Overall Study|Withdrawal by Subject|0
2262011|NCT02143102|3933017|FG000|Overall Study|Lost to Follow-up|11
2262012|NCT02143102|3933018|FG001|Overall Study|Lost to Follow-up|0
2262013|NCT02143141|3933026|FG000|Overall Study|pain scores at 24 hours not collected|1
2262014|NCT02143141|3933027|FG001|Overall Study|pain scores at 24 hours not collected|0
2262015|NCT02143583|3933040|FG000|Overall Study|Withdrawal by Subject|1
2262016|NCT02143583|3933041|FG001|Overall Study|Withdrawal by Subject|0
2262017|NCT02143583|3933042|FG002|Overall Study|Withdrawal by Subject|1
2262018|NCT02143583|3933040|FG000|Overall Study|husband illness|0
2262019|NCT02143583|3933041|FG001|Overall Study|husband illness|0
2262020|NCT02143583|3933042|FG002|Overall Study|husband illness|1
2262021|NCT02143713|3933067|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1
2262022|NCT02143713|3933068|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2
2262023|NCT02143713|3933069|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5
2262024|NCT02143713|3933070|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4
2262025|NCT02143713|3933067|FG000|Treatment Period (6 Months)|Adverse Event|7
2262026|NCT02143713|3933068|FG001|Treatment Period (6 Months)|Adverse Event|8
2262027|NCT02143713|3933069|FG002|Treatment Period (6 Months)|Adverse Event|8
2262028|NCT02143713|3933070|FG003|Treatment Period (6 Months)|Adverse Event|9
2262029|NCT02143713|3933067|FG000|Treatment Period (6 Months)|Lost to Follow-up|3
2262030|NCT02143713|3933068|FG001|Treatment Period (6 Months)|Lost to Follow-up|0
2262031|NCT02143713|3933069|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
2262032|NCT02143713|3933070|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
2262033|NCT02143713|3933067|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
2262034|NCT02143713|3933068|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
2262035|NCT02143713|3933069|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
2262036|NCT02143713|3933070|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
2262037|NCT02143713|3933067|FG000|Treatment Period (6 Months)|Pregnancy|0
2262038|NCT02143713|3933068|FG001|Treatment Period (6 Months)|Pregnancy|2
2262039|NCT02143713|3933069|FG002|Treatment Period (6 Months)|Pregnancy|2
2262040|NCT02143713|3933070|FG003|Treatment Period (6 Months)|Pregnancy|0
2262041|NCT02143713|3933067|FG000|Treatment Period (6 Months)|Non-compliance|1
2262042|NCT02143713|3933068|FG001|Treatment Period (6 Months)|Non-compliance|0
2262043|NCT02143713|3933069|FG002|Treatment Period (6 Months)|Non-compliance|0
2262044|NCT02143713|3933070|FG003|Treatment Period (6 Months)|Non-compliance|3
2262045|NCT02143713|3933067|FG000|Treatment Period (6 Months)|Other|3
2262046|NCT02143713|3933068|FG001|Treatment Period (6 Months)|Other|0
2262047|NCT02143713|3933069|FG002|Treatment Period (6 Months)|Other|3
2262048|NCT02143713|3933070|FG003|Treatment Period (6 Months)|Other|2
2262049|NCT02143713|3933067|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
2262050|NCT02143713|3933068|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
2262051|NCT02143713|3933069|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
2262052|NCT02143713|3933070|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
2262053|NCT02143713|3933067|FG000|Treatment Period (6 Months)|Exclusionary Medication|2
2262054|NCT02143713|3933068|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
2262055|NCT02143713|3933069|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
2262056|NCT02143713|3933070|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
2262057|NCT02143713|3933067|FG000|Treatment Period (6 Months)|Lack of Efficacy|1
2262058|NCT02143713|3933068|FG001|Treatment Period (6 Months)|Lack of Efficacy|0
2262059|NCT02143713|3933069|FG002|Treatment Period (6 Months)|Lack of Efficacy|0
2262060|NCT02143713|3933070|FG003|Treatment Period (6 Months)|Lack of Efficacy|1
2262061|NCT02143713|3933067|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
2262062|NCT02143713|3933068|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
2262063|NCT02143713|3933069|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
2262064|NCT02143713|3933070|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
2262065|NCT02143713|3933067|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0
2262066|NCT02143713|3933068|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0
2262067|NCT02143713|3933069|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1
2262068|NCT02143713|3933070|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0
2262069|NCT02143713|3933067|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
2262070|NCT02143713|3933068|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
2345899|NCT03608774|4082528|FG000|Overall Study|Not eligible at enrollment|0
2345900|NCT03608774|4082529|FG001|Overall Study|Not eligible at enrollment|1
2262071|NCT02143713|3933069|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
2262072|NCT02143713|3933070|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
2262073|NCT02143713|3933067|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
2262074|NCT02143713|3933068|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
2262075|NCT02143713|3933069|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
2262076|NCT02143713|3933070|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
2262077|NCT02143713|3933067|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
2262078|NCT02143713|3933068|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
2262079|NCT02143713|3933069|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
2262080|NCT02143713|3933070|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
2262081|NCT02143713|3933067|FG000|Post-treatment Follow-up (12 Months)|Other|3
2262082|NCT02143713|3933068|FG001|Post-treatment Follow-up (12 Months)|Other|4
2262083|NCT02143713|3933069|FG002|Post-treatment Follow-up (12 Months)|Other|7
2262084|NCT02143713|3933070|FG003|Post-treatment Follow-up (12 Months)|Other|7
2262085|NCT02143778|3933081|FG000|Overall Study|Withdrawal by Subject|2
2262086|NCT02143778|3933081|FG000|Overall Study|Device malfunction|1
2262087|NCT02143843|3933086|FG000|Overall Study|Adverse Event|8
2262088|NCT02143843|3933086|FG000|Overall Study|Lack of Efficacy|2
2262089|NCT02143843|3933086|FG000|Overall Study|Withdrawal by Subject|2
2262090|NCT02143947|3933092|FG000|Overall Study|Lost to Follow-up|4
2262091|NCT02143947|3933093|FG001|Overall Study|Lost to Follow-up|2
2262092|NCT02144012|3933107|FG000|Overall Study|Adverse Event|1
2262093|NCT02144012|3933108|FG001|Overall Study|Adverse Event|0
2262094|NCT02144012|3933107|FG000|Overall Study|Death|1
2262095|NCT02144012|3933108|FG001|Overall Study|Death|0
2262096|NCT02144012|3933107|FG000|Overall Study|Withdrawal by Subject|11
2262097|NCT02144012|3933108|FG001|Overall Study|Withdrawal by Subject|3
2262098|NCT02144012|3933107|FG000|Overall Study|Study Terminated by Sponsor|18
2262099|NCT02144012|3933108|FG001|Overall Study|Study Terminated by Sponsor|12
2262100|NCT02144012|3933107|FG000|Overall Study|Other|3
2262101|NCT02144012|3933108|FG001|Overall Study|Other|0
2262102|NCT02144077|3933116|FG000|Overall Study|Withdrawal by Subject|3
2262103|NCT02144077|3933117|FG001|Overall Study|Withdrawal by Subject|3
2262104|NCT02144077|3933116|FG000|Overall Study|Adverse Event|2
2262105|NCT02144077|3933117|FG001|Overall Study|Adverse Event|3
2262106|NCT02144077|3933116|FG000|Overall Study|Lost to Follow-up|2
2262107|NCT02144077|3933117|FG001|Overall Study|Lost to Follow-up|2
2262108|NCT02144077|3933116|FG000|Overall Study|Protocol Violation|1
2262109|NCT02144077|3933117|FG001|Overall Study|Protocol Violation|2
2262110|NCT02144077|3933116|FG000|Overall Study|Death|0
2262111|NCT02144077|3933117|FG001|Overall Study|Death|1
2262112|NCT02144077|3933116|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2
2262113|NCT02144077|3933117|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0
2262114|NCT02144220|3933123|FG000|Overall Study|technology incompatibility|9
2262115|NCT02144220|3933123|FG000|Overall Study|Lack of Efficacy|4
2262116|NCT02144220|3933123|FG000|Overall Study|Physician Decision|3
2262117|NCT02144220|3933123|FG000|Overall Study|Withdrawal by Subject|2
2262118|NCT02144220|3933123|FG000|Overall Study|Protocol Violation|1
2262119|NCT02144285|3933159|FG000|Overall Study|Withdrawal by Subject|0
2262120|NCT02144285|3933160|FG001|Overall Study|Withdrawal by Subject|0
2262121|NCT02144285|3933161|FG002|Overall Study|Withdrawal by Subject|0
2262122|NCT02144285|3933162|FG003|Overall Study|Withdrawal by Subject|0
2262123|NCT02144285|3933163|FG004|Overall Study|Withdrawal by Subject|1
2262124|NCT02144285|3933164|FG005|Overall Study|Withdrawal by Subject|0
2262125|NCT02144285|3933165|FG006|Overall Study|Withdrawal by Subject|0
2262126|NCT02144285|3933166|FG007|Overall Study|Withdrawal by Subject|0
2262127|NCT02144285|3933167|FG008|Overall Study|Withdrawal by Subject|0
2262128|NCT02144285|3933168|FG009|Overall Study|Withdrawal by Subject|0
2262129|NCT02144337|3933206|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
2262130|NCT02144337|3933207|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
2262131|NCT02144337|3933206|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
2262132|NCT02144337|3933207|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
2262133|NCT02144337|3933206|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
2262134|NCT02144337|3933207|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
2262135|NCT02144337|3933206|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
2262136|NCT02144337|3933207|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
2262137|NCT02144337|3933206|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
2262138|NCT02144337|3933207|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
2262139|NCT02144610|3933238|FG000|Overall Study|Physician Decision|1
2262140|NCT02144610|3933239|FG001|Overall Study|Physician Decision|0
2262141|NCT02144610|3933238|FG000|Overall Study|Withdrawal by Subject|1
2262142|NCT02144610|3933239|FG001|Overall Study|Withdrawal by Subject|5
2262143|NCT02144610|3933238|FG000|Overall Study|Death|2
2262144|NCT02144610|3933239|FG001|Overall Study|Death|2
2345901|NCT03608774|4082528|FG000|Overall Study|Health related event|0
2345902|NCT03608774|4082529|FG001|Overall Study|Health related event|1
2345903|NCT03609619|4082550|FG000|Overall Study|Adverse Event|1
2345904|NCT03609619|4082551|FG001|Overall Study|Adverse Event|0
2345905|NCT03609619|4082550|FG000|Overall Study|Lack of Efficacy|1
2262145|NCT02144610|3933238|FG000|Overall Study|Study Discontinuation by Sponsor|19
2262146|NCT02144610|3933239|FG001|Overall Study|Study Discontinuation by Sponsor|14
2262147|NCT02144610|3933238|FG000|Overall Study|Other|0
2262148|NCT02144610|3933239|FG001|Overall Study|Other|1
2262149|NCT02144701|3933256|FG000|Overall Study|development of relapse, GVHD or death|9
2262150|NCT02144701|3933257|FG001|Overall Study|development of relapse, GVHD or death|3
2262151|NCT02145026|3933276|FG000|Overall Study|Adverse Event|2
2262152|NCT02145026|3933276|FG000|Overall Study|Death|4
2262153|NCT02145026|3933276|FG000|Overall Study|Withdrawal by Subject|2
2262154|NCT02145026|3933276|FG000|Overall Study|Physician Decision|4
2262155|NCT02145078|3933284|FG000|Overall Study|Death|1
2262156|NCT02145078|3933284|FG000|Overall Study|Reason not given|3
2262157|NCT02145156|3933291|FG000|Overall Study|No match to vaccination records|60
2262158|NCT02145156|3933292|FG001|Overall Study|No match to vaccination records|52
2262159|NCT02145156|3933293|FG002|Overall Study|No match to vaccination records|41
2262160|NCT02145182|3933303|FG000|Overall Study|Adverse Event|4
2262161|NCT02145182|3933304|FG001|Overall Study|Adverse Event|1
2262162|NCT02145182|3933303|FG000|Overall Study|Death|7
2262163|NCT02145182|3933304|FG001|Overall Study|Death|7
2262164|NCT02145182|3933303|FG000|Overall Study|Lost to Follow-up|2
2262165|NCT02145182|3933304|FG001|Overall Study|Lost to Follow-up|2
2262166|NCT02145182|3933303|FG000|Overall Study|Pre-transplant Withdrawal|0
2262167|NCT02145182|3933304|FG001|Overall Study|Pre-transplant Withdrawal|2
2262168|NCT02145182|3933303|FG000|Overall Study|Withdrawal by Subject|5
2262169|NCT02145182|3933304|FG001|Overall Study|Withdrawal by Subject|4
2262170|NCT02145429|3933330|FG000|Overall Study|Death|4
2262171|NCT02145429|3933331|FG001|Overall Study|Death|5
2262172|NCT02145429|3933330|FG000|Overall Study|Lost to Follow-up|4
2262173|NCT02145429|3933331|FG001|Overall Study|Lost to Follow-up|3
2262174|NCT02145429|3933330|FG000|Overall Study|Withdrawal by Subject|8
2262175|NCT02145429|3933331|FG001|Overall Study|Withdrawal by Subject|3
2262176|NCT02145468|3933339|FG000|Overall Study|Withdrawal by Subject|5
2262177|NCT02145468|3933340|FG001|Overall Study|Withdrawal by Subject|8
2262178|NCT02146105|3933372|FG000|Overall Study|Adverse Event|1
2262179|NCT02146105|3933372|FG000|Overall Study|Withdrawal by Subject|5
2262180|NCT02146131|3933378|FG000|Overall Study|Physician Decision|61
2262181|NCT02146131|3933379|FG001|Overall Study|Physician Decision|56
2262182|NCT02146248|3933385|FG000|Overall Study|Withdrawal by Subject|2
2262183|NCT02146274|3933393|FG000|Overall Study|Protocol Violation|73
2262184|NCT02146326|3933404|FG000|Overall Study|Lost to Follow-up|3
2262185|NCT02146326|3933405|FG001|Overall Study|Lost to Follow-up|3
2262186|NCT02146326|3933406|FG002|Overall Study|Lost to Follow-up|11
2262187|NCT02146326|3933407|FG003|Overall Study|Lost to Follow-up|19
2262188|NCT02146326|3933404|FG000|Overall Study|Withdrawal by Subject|2
2262189|NCT02146326|3933405|FG001|Overall Study|Withdrawal by Subject|1
2262190|NCT02146326|3933406|FG002|Overall Study|Withdrawal by Subject|15
2262191|NCT02146326|3933407|FG003|Overall Study|Withdrawal by Subject|11
2262192|NCT02146326|3933404|FG000|Overall Study|Separated from mental health center|23
2262193|NCT02146326|3933405|FG001|Overall Study|Separated from mental health center|33
2262194|NCT02146326|3933406|FG002|Overall Study|Separated from mental health center|0
2262195|NCT02146326|3933407|FG003|Overall Study|Separated from mental health center|0
2262196|NCT02146326|3933404|FG000|Overall Study|Incarcerated|0
2262197|NCT02146326|3933405|FG001|Overall Study|Incarcerated|0
2262198|NCT02146326|3933406|FG002|Overall Study|Incarcerated|3
2262199|NCT02146326|3933407|FG003|Overall Study|Incarcerated|8
2262200|NCT02146326|3933404|FG000|Overall Study|Death|0
2262201|NCT02146326|3933405|FG001|Overall Study|Death|0
2262202|NCT02146326|3933406|FG002|Overall Study|Death|4
2262203|NCT02146326|3933407|FG003|Overall Study|Death|4
2262204|NCT02146326|3933404|FG000|Overall Study|Unable to complete interview|0
2262205|NCT02146326|3933405|FG001|Overall Study|Unable to complete interview|0
2262206|NCT02146326|3933406|FG002|Overall Study|Unable to complete interview|10
2262207|NCT02146326|3933407|FG003|Overall Study|Unable to complete interview|6
2262208|NCT02146352|3933423|FG000|Overall Study|Death|1
2262209|NCT02146352|3933423|FG000|Overall Study|Patient entered hospice care|1
2262210|NCT02146365|3933433|FG000|Overall Study|Lost to Follow-up|2
2262211|NCT02146365|3933434|FG001|Overall Study|Lost to Follow-up|1
2262212|NCT02146365|3933435|FG002|Overall Study|Lost to Follow-up|3
2262213|NCT02146365|3933436|FG003|Overall Study|Lost to Follow-up|3
2262214|NCT02146365|3933437|FG004|Overall Study|Lost to Follow-up|1
2262215|NCT02146365|3933438|FG005|Overall Study|Lost to Follow-up|1
2262216|NCT02146365|3933439|FG006|Overall Study|Lost to Follow-up|0
2262217|NCT02146365|3933440|FG007|Overall Study|Lost to Follow-up|1
2262218|NCT02146365|3933433|FG000|Overall Study|Withdrawal by Subject|1
2262219|NCT02146365|3933434|FG001|Overall Study|Withdrawal by Subject|2
2262220|NCT02146365|3933435|FG002|Overall Study|Withdrawal by Subject|1
2262221|NCT02146365|3933436|FG003|Overall Study|Withdrawal by Subject|5
2345906|NCT03609619|4082551|FG001|Overall Study|Lack of Efficacy|2
2262222|NCT02146365|3933437|FG004|Overall Study|Withdrawal by Subject|1
2262223|NCT02146365|3933438|FG005|Overall Study|Withdrawal by Subject|0
2262224|NCT02146365|3933439|FG006|Overall Study|Withdrawal by Subject|0
2262225|NCT02146365|3933440|FG007|Overall Study|Withdrawal by Subject|0
2262226|NCT02146365|3933433|FG000|Overall Study|Unable to Comply with Protocol|0
2262227|NCT02146365|3933434|FG001|Overall Study|Unable to Comply with Protocol|1
2262228|NCT02146365|3933435|FG002|Overall Study|Unable to Comply with Protocol|1
2262229|NCT02146365|3933436|FG003|Overall Study|Unable to Comply with Protocol|0
2262230|NCT02146365|3933437|FG004|Overall Study|Unable to Comply with Protocol|0
2262231|NCT02146365|3933438|FG005|Overall Study|Unable to Comply with Protocol|0
2262232|NCT02146365|3933439|FG006|Overall Study|Unable to Comply with Protocol|0
2262233|NCT02146365|3933440|FG007|Overall Study|Unable to Comply with Protocol|0
2262234|NCT02146365|3933433|FG000|Overall Study|Other|1
2262235|NCT02146365|3933434|FG001|Overall Study|Other|0
2262236|NCT02146365|3933435|FG002|Overall Study|Other|2
2262237|NCT02146365|3933436|FG003|Overall Study|Other|1
2262238|NCT02146365|3933437|FG004|Overall Study|Other|0
2262239|NCT02146365|3933438|FG005|Overall Study|Other|0
2262240|NCT02146365|3933439|FG006|Overall Study|Other|0
2262241|NCT02146365|3933440|FG007|Overall Study|Other|0
2262242|NCT02146430|3933462|FG000|Overall Study|Protocol Violation|5
2262243|NCT02146430|3933463|FG001|Overall Study|Protocol Violation|4
2262244|NCT02146430|3933464|FG002|Overall Study|Protocol Violation|8
2262245|NCT02146430|3933465|FG003|Overall Study|Protocol Violation|6
2262246|NCT02146430|3933462|FG000|Overall Study|Lack of Efficacy|13
2262247|NCT02146430|3933463|FG001|Overall Study|Lack of Efficacy|11
2262248|NCT02146430|3933464|FG002|Overall Study|Lack of Efficacy|8
2262249|NCT02146430|3933465|FG003|Overall Study|Lack of Efficacy|5
2262250|NCT02146430|3933462|FG000|Overall Study|Adverse Event|20
2262251|NCT02146430|3933463|FG001|Overall Study|Adverse Event|40
2262252|NCT02146430|3933464|FG002|Overall Study|Adverse Event|32
2262253|NCT02146430|3933465|FG003|Overall Study|Adverse Event|49
2262254|NCT02146430|3933462|FG000|Overall Study|Reason missing or not reported|2
2262255|NCT02146430|3933463|FG001|Overall Study|Reason missing or not reported|3
2345907|NCT03609619|4082550|FG000|Overall Study|Protocol Violation|5
2345908|NCT03609619|4082551|FG001|Overall Study|Protocol Violation|0
2345909|NCT03609619|4082550|FG000|Overall Study|Withdrawal by Subject|2
2345910|NCT03609619|4082551|FG001|Overall Study|Withdrawal by Subject|3
2345911|NCT03609619|4082550|FG000|Overall Study|Lost to Follow-up|1
2345912|NCT03609619|4082551|FG001|Overall Study|Lost to Follow-up|1
2345913|NCT03610048|4082566|FG000|Overall Study|Study terminated by sponsor|84
2345914|NCT03610048|4082566|FG000|Overall Study|Adverse Event|32
2345915|NCT03610048|4082566|FG000|Overall Study|Withdrawal by Subject|31
2345916|NCT03610048|4082566|FG000|Overall Study|Lost to Follow-up|8
2345917|NCT03610048|4082566|FG000|Overall Study|Other|4
2345918|NCT03610048|4082566|FG000|Overall Study|Physician Decision|1
2345919|NCT03610048|4082566|FG000|Overall Study|Pregnancy|1
2345920|NCT03610165|4082572|FG000|Overall Study|Device didn't work|0
2345921|NCT03610165|4082573|FG001|Overall Study|Device didn't work|1
2345922|NCT03610269|4082579|FG000|Overall Study|Physician Decision|10
2345923|NCT03610269|4082579|FG000|Overall Study|Protocol Violation|1
2345924|NCT03610269|4082579|FG000|Overall Study|Unable to draw blood|1
2345925|NCT03610269|4082579|FG000|Overall Study|Screen fail|4
2345926|NCT03610581|4082603|FG000|Overall Study|Study terminated by sponsor|2
2345927|NCT03610581|4082604|FG001|Overall Study|Study terminated by sponsor|0
2345928|NCT03610581|4082603|FG000|Overall Study|Other|0
2345929|NCT03610581|4082604|FG001|Overall Study|Other|1
2345930|NCT03610581|4082603|FG000|Overall Study|Withdrawal by Subject|1
2345931|NCT03610581|4082604|FG001|Overall Study|Withdrawal by Subject|0
2345932|NCT03611075|4082637|FG000|Overall Study|Physician Decision|0
2345933|NCT03611075|4082638|FG001|Overall Study|Physician Decision|1
2345934|NCT03611075|4082639|FG002|Overall Study|Physician Decision|1
2345935|NCT03611075|4082640|FG003|Overall Study|Physician Decision|0
2345936|NCT03611075|4082641|FG004|Overall Study|Physician Decision|0
2345937|NCT03611075|4082642|FG005|Overall Study|Physician Decision|0
2345938|NCT03611075|4082643|FG006|Overall Study|Physician Decision|0
2345939|NCT03611075|4082644|FG007|Overall Study|Physician Decision|0
2345940|NCT03611075|4082645|FG008|Overall Study|Physician Decision|0
2345941|NCT03611075|4082637|FG000|Overall Study|Lost to Follow-up|1
2345942|NCT03611075|4082638|FG001|Overall Study|Lost to Follow-up|0
2345943|NCT03611075|4082639|FG002|Overall Study|Lost to Follow-up|0
2345944|NCT03611075|4082640|FG003|Overall Study|Lost to Follow-up|2
2345945|NCT03611075|4082641|FG004|Overall Study|Lost to Follow-up|0
2345946|NCT03611075|4082642|FG005|Overall Study|Lost to Follow-up|0
2345947|NCT03611075|4082643|FG006|Overall Study|Lost to Follow-up|0
2345948|NCT03611075|4082644|FG007|Overall Study|Lost to Follow-up|0
2345949|NCT03611075|4082645|FG008|Overall Study|Lost to Follow-up|0
2345950|NCT03611075|4082637|FG000|Overall Study|Withdrawal by Subject|0
2345951|NCT03611075|4082638|FG001|Overall Study|Withdrawal by Subject|1
2345952|NCT03611075|4082639|FG002|Overall Study|Withdrawal by Subject|1
2345953|NCT03611075|4082640|FG003|Overall Study|Withdrawal by Subject|1
2345954|NCT03611075|4082641|FG004|Overall Study|Withdrawal by Subject|0
2345955|NCT03611075|4082642|FG005|Overall Study|Withdrawal by Subject|0
2345956|NCT03611075|4082643|FG006|Overall Study|Withdrawal by Subject|1
2345957|NCT03611075|4082644|FG007|Overall Study|Withdrawal by Subject|0
2262256|NCT02146430|3933464|FG002|Overall Study|Reason missing or not reported|4
2262257|NCT02146430|3933465|FG003|Overall Study|Reason missing or not reported|5
2262258|NCT02146430|3933462|FG000|Overall Study|Withdrawal by Subject|27
2262259|NCT02146430|3933463|FG001|Overall Study|Withdrawal by Subject|29
2262260|NCT02146430|3933464|FG002|Overall Study|Withdrawal by Subject|30
2345958|NCT03611075|4082645|FG008|Overall Study|Withdrawal by Subject|0
2345959|NCT03611075|4082637|FG000|Overall Study|Reason unknown|0
2262261|NCT02146430|3933465|FG003|Overall Study|Withdrawal by Subject|34
2262262|NCT02146599|3933488|FG000|Overall Study|Failed to meet inclusion criteria|5
2262263|NCT02146833|3933492|FG000|Overall Study|Death|10
2262264|NCT02146833|3933492|FG000|Overall Study|No longer consented to study treatment|1
2262265|NCT02147067|3933498|FG000|Overall Study|Withdrawal by Subject|2
2345960|NCT03611075|4082638|FG001|Overall Study|Reason unknown|0
2345961|NCT03611075|4082639|FG002|Overall Study|Reason unknown|0
2345962|NCT03611075|4082640|FG003|Overall Study|Reason unknown|1
2345963|NCT03611075|4082641|FG004|Overall Study|Reason unknown|0
2345964|NCT03611075|4082642|FG005|Overall Study|Reason unknown|0
2345965|NCT03611075|4082643|FG006|Overall Study|Reason unknown|1
2345966|NCT03611075|4082644|FG007|Overall Study|Reason unknown|0
2345967|NCT03611075|4082645|FG008|Overall Study|Reason unknown|0
2345968|NCT03611582|4082690|FG000|Overall Study|Adverse Event|26
2345969|NCT03611582|4082691|FG001|Overall Study|Adverse Event|6
2345970|NCT03611582|4082690|FG000|Overall Study|Protocol Violation|0
2345971|NCT03611582|4082691|FG001|Overall Study|Protocol Violation|1
2345972|NCT03611582|4082690|FG000|Overall Study|Pregnancy|1
2345973|NCT03611582|4082691|FG001|Overall Study|Pregnancy|2
2345974|NCT03611582|4082690|FG000|Overall Study|Lack of Efficacy|0
2345975|NCT03611582|4082691|FG001|Overall Study|Lack of Efficacy|1
2345976|NCT03611582|4082690|FG000|Overall Study|At the discretion of the investigator|1
2345977|NCT03611582|4082691|FG001|Overall Study|At the discretion of the investigator|0
2345978|NCT03611582|4082690|FG000|Overall Study|Safety concern as judged by the investigator|1
2345979|NCT03611582|4082691|FG001|Overall Study|Safety concern as judged by the investigator|2
2345980|NCT03611582|4082690|FG000|Overall Study|Withdrawal by Subject|4
2345981|NCT03611582|4082691|FG001|Overall Study|Withdrawal by Subject|3
2345982|NCT03611582|4082690|FG000|Overall Study|Lost to Follow-up|18
2345983|NCT03611582|4082691|FG001|Overall Study|Lost to Follow-up|7
2345984|NCT03611582|4082690|FG000|Overall Study|other|17
2345985|NCT03611582|4082691|FG001|Overall Study|other|16
2345986|NCT03612856|4082722|FG000|Pre-dose Period|Physician Decision|0
2345987|NCT03612856|4082723|FG001|Pre-dose Period|Physician Decision|1
2345988|NCT03612856|4082724|FG002|Pre-dose Period|Physician Decision|1
2345989|NCT03612856|4082722|FG000|Pre-dose Period|Withdrawal by Subject|0
2345990|NCT03612856|4082723|FG001|Pre-dose Period|Withdrawal by Subject|1
2345991|NCT03612856|4082724|FG002|Pre-dose Period|Withdrawal by Subject|0
2345992|NCT03613129|4082736|FG000|Pre-treatment Assessment|Protocol Violation|2
2345993|NCT03613129|4082737|FG001|Pre-treatment Assessment|Protocol Violation|0
2345994|NCT03613129|4082738|FG002|Pre-treatment Assessment|Protocol Violation|0
2345995|NCT03613129|4082739|FG003|Pre-treatment Assessment|Protocol Violation|0
2345996|NCT03613129|4082740|FG004|Pre-treatment Assessment|Protocol Violation|0
2345997|NCT03613129|4082736|FG000|Pre-treatment Assessment|Withdrawal by Subject|1
2345998|NCT03613129|4082737|FG001|Pre-treatment Assessment|Withdrawal by Subject|0
2345999|NCT03613129|4082738|FG002|Pre-treatment Assessment|Withdrawal by Subject|0
2346000|NCT03613129|4082739|FG003|Pre-treatment Assessment|Withdrawal by Subject|0
2346001|NCT03613129|4082740|FG004|Pre-treatment Assessment|Withdrawal by Subject|0
2346002|NCT03613454|4082754|FG000|Overall Study|Protocol Violation|1
2346003|NCT03613454|4082755|FG001|Overall Study|Protocol Violation|0
2346004|NCT03613454|4082754|FG000|Overall Study|Protocol Violation|0
2346005|NCT03613454|4082755|FG001|Overall Study|Protocol Violation|1
2346006|NCT03613649|4082789|FG000|Second Treatment|Lost to Follow-up|0
2346007|NCT03613649|4082790|FG001|Second Treatment|Lost to Follow-up|0
2262266|NCT02147067|3933499|FG001|Overall Study|Withdrawal by Subject|2
2262267|NCT02147093|3933507|FG000|Period 1|Lost to Follow-up|0
2262268|NCT02147093|3933508|FG001|Period 1|Lost to Follow-up|1
2262269|NCT02147093|3933507|FG000|Period 2|Protocol Violation|2
2262270|NCT02147093|3933508|FG001|Period 2|Protocol Violation|0
2262271|NCT02147132|3933514|FG000|Overall Study|Lost to Follow-up|1
2262272|NCT02147132|3933515|FG001|Overall Study|Lost to Follow-up|0
2262273|NCT02147132|3933516|FG002|Overall Study|Lost to Follow-up|0
2262274|NCT02147132|3933517|FG003|Overall Study|Lost to Follow-up|0
2262275|NCT02147158|3933533|FG000|Treatment Course 1|Adverse Event|1
2262276|NCT02147158|3933534|FG001|Treatment Course 1|Adverse Event|4
2262277|NCT02147158|3933535|FG002|Treatment Course 1|Adverse Event|3
2262278|NCT02147158|3933536|FG003|Treatment Course 1|Adverse Event|4
2262279|NCT02147158|3933537|FG004|Treatment Course 1|Adverse Event|1
2262280|NCT02147158|3933538|FG005|Treatment Course 1|Adverse Event|2
2262281|NCT02147158|3933533|FG000|Treatment Course 1|Lost to Follow-up|2
2262282|NCT02147158|3933534|FG001|Treatment Course 1|Lost to Follow-up|4
2262283|NCT02147158|3933535|FG002|Treatment Course 1|Lost to Follow-up|3
2262284|NCT02147158|3933536|FG003|Treatment Course 1|Lost to Follow-up|3
2262285|NCT02147158|3933537|FG004|Treatment Course 1|Lost to Follow-up|2
2262286|NCT02147158|3933538|FG005|Treatment Course 1|Lost to Follow-up|4
2262287|NCT02147158|3933533|FG000|Treatment Course 1|Protocol Violation|0
2262288|NCT02147158|3933534|FG001|Treatment Course 1|Protocol Violation|0
2262289|NCT02147158|3933535|FG002|Treatment Course 1|Protocol Violation|1
2262290|NCT02147158|3933536|FG003|Treatment Course 1|Protocol Violation|1
2262291|NCT02147158|3933537|FG004|Treatment Course 1|Protocol Violation|0
2262292|NCT02147158|3933538|FG005|Treatment Course 1|Protocol Violation|0
2346008|NCT03613649|4082791|FG002|Second Treatment|Lost to Follow-up|1
2346009|NCT03613649|4082792|FG003|Second Treatment|Lost to Follow-up|0
2346010|NCT03613649|4082793|FG004|Second Treatment|Lost to Follow-up|0
2262293|NCT02147158|3933533|FG000|Treatment Course 1|Withdrawal of Consent|1
2262294|NCT02147158|3933534|FG001|Treatment Course 1|Withdrawal of Consent|1
2262295|NCT02147158|3933535|FG002|Treatment Course 1|Withdrawal of Consent|1
2262296|NCT02147158|3933536|FG003|Treatment Course 1|Withdrawal of Consent|5
2262297|NCT02147158|3933537|FG004|Treatment Course 1|Withdrawal of Consent|3
2262298|NCT02147158|3933538|FG005|Treatment Course 1|Withdrawal of Consent|2
2262299|NCT02147158|3933533|FG000|Off-Treatment Interval 1|Adverse Event|1
2262300|NCT02147158|3933534|FG001|Off-Treatment Interval 1|Adverse Event|0
2262301|NCT02147158|3933535|FG002|Off-Treatment Interval 1|Adverse Event|0
2262302|NCT02147158|3933536|FG003|Off-Treatment Interval 1|Adverse Event|1
2262303|NCT02147158|3933537|FG004|Off-Treatment Interval 1|Adverse Event|0
2262304|NCT02147158|3933538|FG005|Off-Treatment Interval 1|Adverse Event|0
2262305|NCT02147158|3933533|FG000|Off-Treatment Interval 1|Lost to Follow-up|2
2262306|NCT02147158|3933534|FG001|Off-Treatment Interval 1|Lost to Follow-up|1
2262307|NCT02147158|3933535|FG002|Off-Treatment Interval 1|Lost to Follow-up|3
2262308|NCT02147158|3933536|FG003|Off-Treatment Interval 1|Lost to Follow-up|2
2262309|NCT02147158|3933537|FG004|Off-Treatment Interval 1|Lost to Follow-up|4
2262310|NCT02147158|3933538|FG005|Off-Treatment Interval 1|Lost to Follow-up|2
2262311|NCT02147158|3933533|FG000|Off-Treatment Interval 1|Protocol Violation|1
2262312|NCT02147158|3933534|FG001|Off-Treatment Interval 1|Protocol Violation|0
2262313|NCT02147158|3933535|FG002|Off-Treatment Interval 1|Protocol Violation|2
2262314|NCT02147158|3933536|FG003|Off-Treatment Interval 1|Protocol Violation|0
2262315|NCT02147158|3933537|FG004|Off-Treatment Interval 1|Protocol Violation|1
2262316|NCT02147158|3933538|FG005|Off-Treatment Interval 1|Protocol Violation|0
2262317|NCT02147158|3933533|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4
2262318|NCT02147158|3933534|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3
2262319|NCT02147158|3933535|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5
2262320|NCT02147158|3933536|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10
2262321|NCT02147158|3933537|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2
2262322|NCT02147158|3933538|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3
2262323|NCT02147158|3933533|FG000|Off-Treatment Interval 1|Lack of Efficacy|0
2262324|NCT02147158|3933534|FG001|Off-Treatment Interval 1|Lack of Efficacy|0
2262325|NCT02147158|3933535|FG002|Off-Treatment Interval 1|Lack of Efficacy|2
2262326|NCT02147158|3933536|FG003|Off-Treatment Interval 1|Lack of Efficacy|0
2346011|NCT03613649|4082794|FG005|Second Treatment|Lost to Follow-up|0
2346012|NCT03613649|4082795|FG006|Second Treatment|Lost to Follow-up|0
2346013|NCT03613649|4082796|FG007|Second Treatment|Lost to Follow-up|0
2346014|NCT03613649|4082797|FG008|Second Treatment|Lost to Follow-up|0
2346015|NCT03613649|4082798|FG009|Second Treatment|Lost to Follow-up|0
2346016|NCT03613649|4082799|FG010|Second Treatment|Lost to Follow-up|0
2346017|NCT03613649|4082800|FG011|Second Treatment|Lost to Follow-up|0
2346018|NCT03613649|4082789|FG000|Second Treatment|Withdrawal by Subject|0
2346019|NCT03613649|4082790|FG001|Second Treatment|Withdrawal by Subject|0
2346020|NCT03613649|4082791|FG002|Second Treatment|Withdrawal by Subject|0
2346021|NCT03613649|4082792|FG003|Second Treatment|Withdrawal by Subject|0
2346022|NCT03613649|4082793|FG004|Second Treatment|Withdrawal by Subject|1
2346023|NCT03613649|4082794|FG005|Second Treatment|Withdrawal by Subject|0
2346024|NCT03613649|4082795|FG006|Second Treatment|Withdrawal by Subject|0
2346025|NCT03613649|4082796|FG007|Second Treatment|Withdrawal by Subject|0
2346026|NCT03613649|4082797|FG008|Second Treatment|Withdrawal by Subject|0
2346027|NCT03613649|4082798|FG009|Second Treatment|Withdrawal by Subject|0
2346028|NCT03613649|4082799|FG010|Second Treatment|Withdrawal by Subject|0
2346029|NCT03613649|4082800|FG011|Second Treatment|Withdrawal by Subject|0
2346030|NCT03613649|4082789|FG000|Third Treatment|Lost to Follow-up|0
2346031|NCT03613649|4082790|FG001|Third Treatment|Lost to Follow-up|0
2346032|NCT03613649|4082791|FG002|Third Treatment|Lost to Follow-up|0
2346033|NCT03613649|4082792|FG003|Third Treatment|Lost to Follow-up|0
2346034|NCT03613649|4082793|FG004|Third Treatment|Lost to Follow-up|1
2346035|NCT03613649|4082794|FG005|Third Treatment|Lost to Follow-up|0
2346036|NCT03613649|4082795|FG006|Third Treatment|Lost to Follow-up|0
2346037|NCT03613649|4082796|FG007|Third Treatment|Lost to Follow-up|0
2346038|NCT03613649|4082797|FG008|Third Treatment|Lost to Follow-up|0
2346039|NCT03613649|4082798|FG009|Third Treatment|Lost to Follow-up|0
2346040|NCT03613649|4082799|FG010|Third Treatment|Lost to Follow-up|0
2346041|NCT03613649|4082800|FG011|Third Treatment|Lost to Follow-up|1
2346042|NCT03613649|4082789|FG000|Third Treatment|Protocol Violation|0
2346043|NCT03613649|4082790|FG001|Third Treatment|Protocol Violation|0
2346044|NCT03613649|4082791|FG002|Third Treatment|Protocol Violation|0
2346045|NCT03613649|4082792|FG003|Third Treatment|Protocol Violation|0
2346046|NCT03613649|4082793|FG004|Third Treatment|Protocol Violation|0
2346047|NCT03613649|4082794|FG005|Third Treatment|Protocol Violation|0
2346048|NCT03613649|4082795|FG006|Third Treatment|Protocol Violation|1
2346049|NCT03613649|4082796|FG007|Third Treatment|Protocol Violation|0
2346050|NCT03613649|4082797|FG008|Third Treatment|Protocol Violation|0
2346051|NCT03613649|4082798|FG009|Third Treatment|Protocol Violation|0
2346052|NCT03613649|4082799|FG010|Third Treatment|Protocol Violation|0
2346053|NCT03613649|4082800|FG011|Third Treatment|Protocol Violation|1
2346054|NCT03613649|4082789|FG000|Fourth Treatment|Protocol Violation|1
2346055|NCT03613649|4082790|FG001|Fourth Treatment|Protocol Violation|0
2346056|NCT03613649|4082791|FG002|Fourth Treatment|Protocol Violation|0
2262327|NCT02147158|3933537|FG004|Off-Treatment Interval 1|Lack of Efficacy|1
2262328|NCT02147158|3933538|FG005|Off-Treatment Interval 1|Lack of Efficacy|0
2262329|NCT02147158|3933533|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
2262330|NCT02147158|3933534|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
2262331|NCT02147158|3933535|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
2262332|NCT02147158|3933536|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
2262333|NCT02147158|3933537|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
2262334|NCT02147158|3933538|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
2262335|NCT02147158|3933533|FG000|Treatment Course 2|Adverse Event|0
2262336|NCT02147158|3933534|FG001|Treatment Course 2|Adverse Event|4
2262337|NCT02147158|3933535|FG002|Treatment Course 2|Adverse Event|2
2262338|NCT02147158|3933536|FG003|Treatment Course 2|Adverse Event|1
2262339|NCT02147158|3933537|FG004|Treatment Course 2|Adverse Event|0
2262340|NCT02147158|3933538|FG005|Treatment Course 2|Adverse Event|1
2262341|NCT02147158|3933533|FG000|Treatment Course 2|Withdrawal of Consent|0
2262342|NCT02147158|3933534|FG001|Treatment Course 2|Withdrawal of Consent|1
2262343|NCT02147158|3933535|FG002|Treatment Course 2|Withdrawal of Consent|2
2262344|NCT02147158|3933536|FG003|Treatment Course 2|Withdrawal of Consent|3
2262345|NCT02147158|3933537|FG004|Treatment Course 2|Withdrawal of Consent|0
2262346|NCT02147158|3933538|FG005|Treatment Course 2|Withdrawal of Consent|0
2262347|NCT02147158|3933533|FG000|Treatment Course 2|Lost to Follow-up|1
2262348|NCT02147158|3933534|FG001|Treatment Course 2|Lost to Follow-up|0
2262349|NCT02147158|3933535|FG002|Treatment Course 2|Lost to Follow-up|1
2262350|NCT02147158|3933536|FG003|Treatment Course 2|Lost to Follow-up|1
2262351|NCT02147158|3933537|FG004|Treatment Course 2|Lost to Follow-up|0
2262352|NCT02147158|3933538|FG005|Treatment Course 2|Lost to Follow-up|1
2262353|NCT02147158|3933533|FG000|Off-Treatment Interval 2|Lack of Efficacy|0
2262354|NCT02147158|3933534|FG001|Off-Treatment Interval 2|Lack of Efficacy|1
2262355|NCT02147158|3933535|FG002|Off-Treatment Interval 2|Lack of Efficacy|1
2262356|NCT02147158|3933536|FG003|Off-Treatment Interval 2|Lack of Efficacy|0
2262357|NCT02147158|3933537|FG004|Off-Treatment Interval 2|Lack of Efficacy|0
2262358|NCT02147158|3933538|FG005|Off-Treatment Interval 2|Lack of Efficacy|0
2262359|NCT02147158|3933533|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4
2262360|NCT02147158|3933534|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0
2262361|NCT02147158|3933535|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5
2262362|NCT02147158|3933536|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4
2262363|NCT02147158|3933537|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0
2262364|NCT02147158|3933538|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1
2262365|NCT02147158|3933533|FG000|Off-Treatment Interval 2|Lost to Follow-up|0
2262366|NCT02147158|3933534|FG001|Off-Treatment Interval 2|Lost to Follow-up|0
2262367|NCT02147158|3933535|FG002|Off-Treatment Interval 2|Lost to Follow-up|3
2262368|NCT02147158|3933536|FG003|Off-Treatment Interval 2|Lost to Follow-up|2
2262369|NCT02147158|3933537|FG004|Off-Treatment Interval 2|Lost to Follow-up|2
2262370|NCT02147158|3933538|FG005|Off-Treatment Interval 2|Lost to Follow-up|2
2262371|NCT02147158|3933533|FG000|Off-Treatment Interval 2|Protocol Violation|0
2262372|NCT02147158|3933534|FG001|Off-Treatment Interval 2|Protocol Violation|0
2262373|NCT02147158|3933535|FG002|Off-Treatment Interval 2|Protocol Violation|0
2262374|NCT02147158|3933536|FG003|Off-Treatment Interval 2|Protocol Violation|1
2262375|NCT02147158|3933537|FG004|Off-Treatment Interval 2|Protocol Violation|0
2262376|NCT02147158|3933538|FG005|Off-Treatment Interval 2|Protocol Violation|0
2262377|NCT02147158|3933533|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
2262378|NCT02147158|3933534|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
2262379|NCT02147158|3933535|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
2262380|NCT02147158|3933536|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
2262381|NCT02147158|3933537|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
2262382|NCT02147158|3933538|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
2262383|NCT02147197|3933558|FG000|Overall Study|Adverse Event|1
2262384|NCT02147197|3933559|FG001|Overall Study|Adverse Event|0
2262385|NCT02147197|3933560|FG002|Overall Study|Adverse Event|0
2262386|NCT02147197|3933558|FG000|Overall Study|Withdrawal of Consent|4
2262387|NCT02147197|3933559|FG001|Overall Study|Withdrawal of Consent|3
2262388|NCT02147197|3933560|FG002|Overall Study|Withdrawal of Consent|2
2262389|NCT02147197|3933558|FG000|Overall Study|Lost to Follow-up|2
2262390|NCT02147197|3933559|FG001|Overall Study|Lost to Follow-up|3
2262391|NCT02147197|3933560|FG002|Overall Study|Lost to Follow-up|1
2262392|NCT02147197|3933558|FG000|Overall Study|Protocol Violation|1
2262393|NCT02147197|3933559|FG001|Overall Study|Protocol Violation|0
2262394|NCT02147197|3933560|FG002|Overall Study|Protocol Violation|3
2262395|NCT02147197|3933558|FG000|Overall Study|Other Miscellaneous Reasons|1
2262396|NCT02147197|3933559|FG001|Overall Study|Other Miscellaneous Reasons|0
2262397|NCT02147197|3933560|FG002|Overall Study|Other Miscellaneous Reasons|3
2262398|NCT02147288|3933570|FG000|Overall Study|post-operative hematoma|1
2262399|NCT02147288|3933571|FG001|Overall Study|post-operative hematoma|1
2262400|NCT02147288|3933572|FG002|Overall Study|post-operative hematoma|0
2262401|NCT02147288|3933573|FG003|Overall Study|post-operative hematoma|0
2262402|NCT02147288|3933574|FG004|Overall Study|post-operative hematoma|0
2262403|NCT02147288|3933575|FG005|Overall Study|post-operative hematoma|0
2262404|NCT02147288|3933576|FG006|Overall Study|post-operative hematoma|0
2262405|NCT02147288|3933577|FG007|Overall Study|post-operative hematoma|0
2262406|NCT02147288|3933578|FG008|Overall Study|post-operative hematoma|0
2262407|NCT02147288|3933579|FG009|Overall Study|post-operative hematoma|0
2262408|NCT02147288|3933570|FG000|Overall Study|complications from concurrent hernia rep|0
2262409|NCT02147288|3933571|FG001|Overall Study|complications from concurrent hernia rep|1
2262410|NCT02147288|3933572|FG002|Overall Study|complications from concurrent hernia rep|0
2262411|NCT02147288|3933573|FG003|Overall Study|complications from concurrent hernia rep|0
2262412|NCT02147288|3933574|FG004|Overall Study|complications from concurrent hernia rep|0
2262413|NCT02147288|3933575|FG005|Overall Study|complications from concurrent hernia rep|0
2262414|NCT02147288|3933576|FG006|Overall Study|complications from concurrent hernia rep|0
2262415|NCT02147288|3933577|FG007|Overall Study|complications from concurrent hernia rep|0
2262416|NCT02147288|3933578|FG008|Overall Study|complications from concurrent hernia rep|0
2262417|NCT02147288|3933579|FG009|Overall Study|complications from concurrent hernia rep|0
2262418|NCT02147353|3933591|FG000|Overall Study|Lost to Follow-up|2
2262419|NCT02147353|3933592|FG001|Overall Study|Lost to Follow-up|0
2262420|NCT02147353|3933591|FG000|Overall Study|unable to make visits|4
2262421|NCT02147353|3933592|FG001|Overall Study|unable to make visits|0
2262422|NCT02147353|3933591|FG000|Overall Study|medication noncompliance|3
2262423|NCT02147353|3933592|FG001|Overall Study|medication noncompliance|0
2262424|NCT02147561|3933607|FG000|Overall Study|Lost to Follow-up|3
2262425|NCT02147561|3933607|FG000|Overall Study|Subjects who didn't receive BOTOX|1
2262426|NCT02147587|3933613|FG000|Overall Study|Adverse Event|9
2262427|NCT02147587|3933614|FG001|Overall Study|Adverse Event|4
2262428|NCT02147587|3933613|FG000|Overall Study|Lack of Efficacy|2
2262429|NCT02147587|3933614|FG001|Overall Study|Lack of Efficacy|1
2262430|NCT02147626|3933631|FG000|Overall Study|Lost to Follow-up|4
2262431|NCT02147626|3933632|FG001|Overall Study|Lost to Follow-up|4
2262432|NCT02147626|3933631|FG000|Overall Study|Pregnancy|1
2262433|NCT02147626|3933632|FG001|Overall Study|Pregnancy|2
2262434|NCT02147626|3933631|FG000|Overall Study|Withdrawal by Subject|0
2262435|NCT02147626|3933632|FG001|Overall Study|Withdrawal by Subject|1
2262436|NCT02147691|3933640|FG000|Overall Study|Withdrawal by Subject|2
2262437|NCT02147691|3933641|FG001|Overall Study|Withdrawal by Subject|0
2262438|NCT02147691|3933640|FG000|Overall Study|Adverse Event|2
2262439|NCT02147691|3933641|FG001|Overall Study|Adverse Event|0
2262440|NCT02147691|3933640|FG000|Overall Study|Lost to Follow-up|0
2262441|NCT02147691|3933641|FG001|Overall Study|Lost to Follow-up|1
2262442|NCT02148211|3933691|FG000|Overall Study|Lost to Follow-up|352
2262443|NCT02148250|3933695|FG000|Screening|Withdrawal by Subject|5
2262444|NCT02148250|3933696|FG001|Screening|Withdrawal by Subject|0
2262445|NCT02148445|3933714|FG000|Overall Study|Death|1
2262446|NCT02148445|3933715|FG001|Overall Study|Death|3
2262447|NCT02148718|3933740|FG000|Overall Study|Protocol Violation|26
2262448|NCT02148718|3933740|FG000|Overall Study|Discontinued Study Prematurely|5
2262449|NCT02148952|3933769|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
2262450|NCT02148952|3933770|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
2262451|NCT02148952|3933769|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
2262452|NCT02148952|3933770|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
2262453|NCT02148952|3933769|FG000|Follow-Up|Lost to Follow-up|219
2262454|NCT02148952|3933770|FG001|Follow-Up|Lost to Follow-up|231
2262455|NCT02148952|3933769|FG000|Follow-Up|Withdrawal by Subject|46
2262456|NCT02148952|3933770|FG001|Follow-Up|Withdrawal by Subject|48
2262457|NCT02149108|3933786|FG000|Overall Study|Not treated|1
2262458|NCT02149108|3933787|FG001|Overall Study|Not treated|2
2262459|NCT02149108|3933786|FG000|Overall Study|Progressive Disease (PD)|324
2262460|NCT02149108|3933787|FG001|Overall Study|Progressive Disease (PD)|318
2262461|NCT02149108|3933786|FG000|Overall Study|Worsening/adverse event cancer disease|31
2262462|NCT02149108|3933787|FG001|Overall Study|Worsening/adverse event cancer disease|32
2262463|NCT02149108|3933786|FG000|Overall Study|Other Adverse Event (AE)|8
2262464|NCT02149108|3933787|FG001|Overall Study|Other Adverse Event (AE)|18
2262465|NCT02149108|3933786|FG000|Overall Study|Other not defined above|0
2262466|NCT02149108|3933787|FG001|Overall Study|Other not defined above|2
2262467|NCT02149108|3933786|FG000|Overall Study|Refusal to continue trial medication|15
2262468|NCT02149108|3933787|FG001|Overall Study|Refusal to continue trial medication|11
2262469|NCT02149108|3933786|FG000|Overall Study|Lost to Follow-up|1
2262470|NCT02149108|3933787|FG001|Overall Study|Lost to Follow-up|0
2262471|NCT02149199|3933806|FG000|Overall Study|Study specific withdrawal criteria|4
2262472|NCT02149199|3933807|FG001|Overall Study|Study specific withdrawal criteria|21
2262473|NCT02149199|3933808|FG002|Overall Study|Study specific withdrawal criteria|6
2262474|NCT02149199|3933806|FG000|Overall Study|Other|20
2262475|NCT02149199|3933807|FG001|Overall Study|Other|25
2262476|NCT02149199|3933808|FG002|Overall Study|Other|20
2262477|NCT02149199|3933806|FG000|Overall Study|Eligibility criteria not fulfilled|9
2262478|NCT02149199|3933807|FG001|Overall Study|Eligibility criteria not fulfilled|14
2262479|NCT02149199|3933808|FG002|Overall Study|Eligibility criteria not fulfilled|8
2262480|NCT02149199|3933806|FG000|Overall Study|Withdrawal by Subject|75
2262481|NCT02149199|3933807|FG001|Overall Study|Withdrawal by Subject|93
2262482|NCT02149199|3933808|FG002|Overall Study|Withdrawal by Subject|77
2262483|NCT02149199|3933806|FG000|Overall Study|Protocol Violation|16
2262484|NCT02149199|3933807|FG001|Overall Study|Protocol Violation|13
2262485|NCT02149199|3933808|FG002|Overall Study|Protocol Violation|15
2262486|NCT02149199|3933806|FG000|Overall Study|Lost to Follow-up|3
2262487|NCT02149199|3933807|FG001|Overall Study|Lost to Follow-up|12
2262488|NCT02149199|3933808|FG002|Overall Study|Lost to Follow-up|11
2262489|NCT02149199|3933806|FG000|Overall Study|Death|0
2262490|NCT02149199|3933807|FG001|Overall Study|Death|0
2262491|NCT02149199|3933808|FG002|Overall Study|Death|1
2262492|NCT02149199|3933806|FG000|Overall Study|Adverse Event|6
2262493|NCT02149199|3933807|FG001|Overall Study|Adverse Event|15
2262494|NCT02149199|3933808|FG002|Overall Study|Adverse Event|9
2262495|NCT02149264|3933816|FG000|Overall Study|Withdrawal by Subject|9
2262496|NCT02149264|3933816|FG000|Overall Study|Adverse Event|7
2262497|NCT02149264|3933816|FG000|Overall Study|Physician Decision|3
2262498|NCT02149264|3933816|FG000|Overall Study|Protocol Violation|1
2346057|NCT03613649|4082792|FG003|Fourth Treatment|Protocol Violation|0
2346058|NCT03613649|4082793|FG004|Fourth Treatment|Protocol Violation|1
2346059|NCT03613649|4082794|FG005|Fourth Treatment|Protocol Violation|0
2346060|NCT03613649|4082795|FG006|Fourth Treatment|Protocol Violation|0
2346061|NCT03613649|4082796|FG007|Fourth Treatment|Protocol Violation|0
2346062|NCT03613649|4082797|FG008|Fourth Treatment|Protocol Violation|0
2346063|NCT03613649|4082798|FG009|Fourth Treatment|Protocol Violation|0
2346064|NCT03613649|4082799|FG010|Fourth Treatment|Protocol Violation|0
2346065|NCT03613649|4082800|FG011|Fourth Treatment|Protocol Violation|0
2346066|NCT03613649|4082789|FG000|Fourth Treatment|Physician Decision|0
2346067|NCT03613649|4082790|FG001|Fourth Treatment|Physician Decision|0
2346068|NCT03613649|4082791|FG002|Fourth Treatment|Physician Decision|0
2346069|NCT03613649|4082792|FG003|Fourth Treatment|Physician Decision|0
2346070|NCT03613649|4082793|FG004|Fourth Treatment|Physician Decision|0
2346071|NCT03613649|4082794|FG005|Fourth Treatment|Physician Decision|0
2346072|NCT03613649|4082795|FG006|Fourth Treatment|Physician Decision|1
2346073|NCT03613649|4082796|FG007|Fourth Treatment|Physician Decision|0
2346074|NCT03613649|4082797|FG008|Fourth Treatment|Physician Decision|0
2346075|NCT03613649|4082798|FG009|Fourth Treatment|Physician Decision|0
2346076|NCT03613649|4082799|FG010|Fourth Treatment|Physician Decision|0
2346077|NCT03613649|4082800|FG011|Fourth Treatment|Physician Decision|0
2346078|NCT03614078|4082830|FG000|Overall Study|Withdrawal by Subject|2
2346079|NCT03614078|4082831|FG001|Overall Study|Withdrawal by Subject|2
2346080|NCT03614078|4082832|FG002|Overall Study|Withdrawal by Subject|3
2346081|NCT03614078|4082830|FG000|Overall Study|Participant Did Not Return for Visit|0
2346082|NCT03614078|4082831|FG001|Overall Study|Participant Did Not Return for Visit|1
2346083|NCT03614078|4082832|FG002|Overall Study|Participant Did Not Return for Visit|0
2346084|NCT03614078|4082830|FG000|Overall Study|High Neutrophils|0
2346085|NCT03614078|4082831|FG001|Overall Study|High Neutrophils|0
2346086|NCT03614078|4082832|FG002|Overall Study|High Neutrophils|2
2346087|NCT03614078|4082830|FG000|Overall Study|Patient Did Not Meet Eligibility|1
2346088|NCT03614078|4082831|FG001|Overall Study|Patient Did Not Meet Eligibility|0
2346089|NCT03614078|4082832|FG002|Overall Study|Patient Did Not Meet Eligibility|0
2346090|NCT03614078|4082830|FG000|Overall Study|Exacerbation of Psoriasis|0
2346091|NCT03614078|4082831|FG001|Overall Study|Exacerbation of Psoriasis|1
2346092|NCT03614078|4082832|FG002|Overall Study|Exacerbation of Psoriasis|0
2346093|NCT03614078|4082830|FG000|Overall Study|Adverse Event|0
2346094|NCT03614078|4082831|FG001|Overall Study|Adverse Event|2
2346095|NCT03614078|4082832|FG002|Overall Study|Adverse Event|0
2346096|NCT03614078|4082830|FG000|Overall Study|Dizziness and Rash|0
2346097|NCT03614078|4082831|FG001|Overall Study|Dizziness and Rash|1
2346098|NCT03614078|4082832|FG002|Overall Study|Dizziness and Rash|0
2346099|NCT03614156|4082854|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6
2346100|NCT03614156|4082855|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0
2346101|NCT03614156|4082856|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0
2346102|NCT03614156|4082857|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0
2346103|NCT03614156|4082854|FG000|Open-Label Treatment Period|Adverse Event|7
2346104|NCT03614156|4082855|FG001|Open-Label Treatment Period|Adverse Event|0
2346105|NCT03614156|4082856|FG002|Open-Label Treatment Period|Adverse Event|0
2346106|NCT03614156|4082857|FG003|Open-Label Treatment Period|Adverse Event|0
2346107|NCT03614156|4082854|FG000|Open-Label Treatment Period|Lack of Efficacy|18
2346108|NCT03614156|4082855|FG001|Open-Label Treatment Period|Lack of Efficacy|0
2346109|NCT03614156|4082856|FG002|Open-Label Treatment Period|Lack of Efficacy|0
2346110|NCT03614156|4082857|FG003|Open-Label Treatment Period|Lack of Efficacy|0
2346111|NCT03614156|4082854|FG000|Open-Label Treatment Period|Withdrawal by Subject|36
2346112|NCT03614156|4082855|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
2346113|NCT03614156|4082856|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
2346114|NCT03614156|4082857|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
2346115|NCT03614156|4082854|FG000|Open-Label Treatment Period|Lost to Follow-up|10
2346116|NCT03614156|4082855|FG001|Open-Label Treatment Period|Lost to Follow-up|0
2346117|NCT03614156|4082856|FG002|Open-Label Treatment Period|Lost to Follow-up|0
2346118|NCT03614156|4082857|FG003|Open-Label Treatment Period|Lost to Follow-up|0
2346119|NCT03614156|4082854|FG000|Open-Label Treatment Period|Protocol Violation|2
2346120|NCT03614156|4082855|FG001|Open-Label Treatment Period|Protocol Violation|0
2346121|NCT03614156|4082856|FG002|Open-Label Treatment Period|Protocol Violation|0
2346122|NCT03614156|4082857|FG003|Open-Label Treatment Period|Protocol Violation|0
2346123|NCT03614156|4082854|FG000|Open-Label Treatment Period|Non-compliance with study drug|1
2262499|NCT02149420|3933840|FG000|Core Study|Administrative problems|0
2262500|NCT02149420|3933841|FG001|Core Study|Administrative problems|1
2262501|NCT02149420|3933842|FG002|Core Study|Administrative problems|2
2262502|NCT02149420|3933840|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
2262503|NCT02149420|3933841|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
2262504|NCT02149420|3933842|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
2262505|NCT02149810|3933866|FG000|Overall Study|Physician Decision|1
2262506|NCT02149810|3933867|FG001|Overall Study|Physician Decision|2
2262507|NCT02149810|3933866|FG000|Overall Study|Lost to Follow-up|2
2262508|NCT02149810|3933867|FG001|Overall Study|Lost to Follow-up|1
2262509|NCT02149810|3933866|FG000|Overall Study|Withdrawal by Subject|5
2262510|NCT02149810|3933867|FG001|Overall Study|Withdrawal by Subject|1
2262511|NCT02149836|3933873|FG000|Overall Study|Withdrawal by Subject|1
2262512|NCT02149875|3933880|FG000|Overall Study|Lost to Follow-up|3
2262513|NCT02149875|3933881|FG001|Overall Study|Lost to Follow-up|4
2262514|NCT02149875|3933882|FG002|Overall Study|Lost to Follow-up|5
2262515|NCT02149875|3933880|FG000|Overall Study|Withdrawal by Subject|3
2262516|NCT02149875|3933881|FG001|Overall Study|Withdrawal by Subject|2
2262517|NCT02149875|3933882|FG002|Overall Study|Withdrawal by Subject|2
2262518|NCT02149875|3933880|FG000|Overall Study|Physician Decision|1
2262519|NCT02149875|3933881|FG001|Overall Study|Physician Decision|2
2262520|NCT02149875|3933882|FG002|Overall Study|Physician Decision|2
2262521|NCT02150057|3933896|FG000|Overall Study|Lost to Follow-up|6
2262522|NCT02150057|3933897|FG001|Overall Study|Lost to Follow-up|4
2262523|NCT02150213|3933913|FG000|Overall Study|Lost to Follow-up|1
2262524|NCT02150213|3933913|FG000|Overall Study|Withdrawal by Subject|1
2262525|NCT02150343|3933921|FG000|Overall Study|Adverse Event|2
2262526|NCT02150343|3933922|FG001|Overall Study|Adverse Event|0
2262527|NCT02150343|3933923|FG002|Overall Study|Adverse Event|1
2346124|NCT03614156|4082855|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
2346125|NCT03614156|4082856|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
2346126|NCT03614156|4082857|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
2346127|NCT03614156|4082854|FG000|Open-Label Treatment Period|Study terminated by sponsor|74
2346128|NCT03614156|4082855|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
2346129|NCT03614156|4082856|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
2346130|NCT03614156|4082857|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
2346131|NCT03614156|4082854|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0
2346132|NCT03614156|4082855|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2
2346133|NCT03614156|4082856|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0
2346134|NCT03614156|4082857|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1
2346135|NCT03614156|4082854|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0
2262528|NCT02150343|3933924|FG003|Overall Study|Adverse Event|1
2262529|NCT02150343|3933921|FG000|Overall Study|Withdrawal by Subject|13
2262530|NCT02150343|3933922|FG001|Overall Study|Withdrawal by Subject|10
2262531|NCT02150343|3933923|FG002|Overall Study|Withdrawal by Subject|9
2262532|NCT02150343|3933924|FG003|Overall Study|Withdrawal by Subject|4
2262533|NCT02150343|3933921|FG000|Overall Study|Lost to Follow-up|4
2262534|NCT02150343|3933922|FG001|Overall Study|Lost to Follow-up|4
2262535|NCT02150343|3933923|FG002|Overall Study|Lost to Follow-up|2
2262536|NCT02150343|3933924|FG003|Overall Study|Lost to Follow-up|3
2262537|NCT02150343|3933921|FG000|Overall Study|Other|2
2262538|NCT02150343|3933922|FG001|Overall Study|Other|6
2262539|NCT02150343|3933923|FG002|Overall Study|Other|0
2262540|NCT02150343|3933924|FG003|Overall Study|Other|2
2262541|NCT02150954|3933972|FG000|Overall Study|Protocol Violation|1
2262542|NCT02150954|3933973|FG001|Overall Study|Protocol Violation|0
2262543|NCT02151058|3933982|FG000|Overall Study|Withdrawal by Subject|1
2262544|NCT02151058|3933983|FG001|Overall Study|Withdrawal by Subject|1
2262545|NCT02151058|3933984|FG002|Overall Study|Withdrawal by Subject|3
2262546|NCT02151058|3933982|FG000|Overall Study|Lost to Follow-up|1
2262547|NCT02151058|3933983|FG001|Overall Study|Lost to Follow-up|0
2262548|NCT02151058|3933984|FG002|Overall Study|Lost to Follow-up|2
2262549|NCT02151110|3934000|FG000|Overall Study|Withdrawal by Subject|0
2262550|NCT02151110|3934001|FG001|Overall Study|Withdrawal by Subject|0
2262551|NCT02151110|3934002|FG002|Overall Study|Withdrawal by Subject|0
2262552|NCT02151110|3934003|FG003|Overall Study|Withdrawal by Subject|0
2262553|NCT02151110|3934004|FG004|Overall Study|Withdrawal by Subject|0
2262554|NCT02151110|3934005|FG005|Overall Study|Withdrawal by Subject|0
2262555|NCT02151110|3934006|FG006|Overall Study|Withdrawal by Subject|0
2262556|NCT02151110|3934007|FG007|Overall Study|Withdrawal by Subject|1
2262557|NCT02151110|3934000|FG000|Overall Study|Lost to Follow-up|0
2262558|NCT02151110|3934001|FG001|Overall Study|Lost to Follow-up|0
2262559|NCT02151110|3934002|FG002|Overall Study|Lost to Follow-up|0
2262560|NCT02151110|3934003|FG003|Overall Study|Lost to Follow-up|0
2262561|NCT02151110|3934004|FG004|Overall Study|Lost to Follow-up|0
2262562|NCT02151110|3934005|FG005|Overall Study|Lost to Follow-up|0
2262563|NCT02151110|3934006|FG006|Overall Study|Lost to Follow-up|0
2262564|NCT02151110|3934007|FG007|Overall Study|Lost to Follow-up|2
2262565|NCT02151149|3934034|FG000|Treatment Period|Death|2
2262566|NCT02151149|3934035|FG001|Treatment Period|Death|3
2262567|NCT02151149|3934034|FG000|Treatment Period|Adverse Event|17
2262568|NCT02151149|3934035|FG001|Treatment Period|Adverse Event|14
2262569|NCT02151149|3934034|FG000|Treatment Period|Progressive Disease|25
2262570|NCT02151149|3934035|FG001|Treatment Period|Progressive Disease|24
2262571|NCT02151149|3934034|FG000|Treatment Period|Symptomatic Deterioration|2
2262572|NCT02151149|3934035|FG001|Treatment Period|Symptomatic Deterioration|10
2262573|NCT02151149|3934034|FG000|Treatment Period|Withdrawal by Subject|13
2262574|NCT02151149|3934035|FG001|Treatment Period|Withdrawal by Subject|11
2262575|NCT02151149|3934034|FG000|Treatment Period|Miscellaneous|8
2262576|NCT02151149|3934035|FG001|Treatment Period|Miscellaneous|7
2262577|NCT02151149|3934034|FG000|Treatment Period|Participants randomized but not treated|3
2262578|NCT02151149|3934035|FG001|Treatment Period|Participants randomized but not treated|2
2262579|NCT02151149|3934034|FG000|Follow-Up Period|Lost to Follow-up|2
2262580|NCT02151149|3934035|FG001|Follow-Up Period|Lost to Follow-up|3
2262581|NCT02151149|3934034|FG000|Follow-Up Period|Death|37
2262582|NCT02151149|3934035|FG001|Follow-Up Period|Death|34
2262583|NCT02151266|3934051|FG000|Overall Study|Lost to Follow-up|1
2262584|NCT02151266|3934052|FG001|Overall Study|Lost to Follow-up|4
2262585|NCT02151266|3934053|FG002|Overall Study|Lost to Follow-up|1
2262586|NCT02151266|3934051|FG000|Overall Study|Did NOT receive intervention|3
2262587|NCT02151266|3934052|FG001|Overall Study|Did NOT receive intervention|6
2262588|NCT02151266|3934053|FG002|Overall Study|Did NOT receive intervention|2
2262589|NCT02151266|3934051|FG000|Overall Study|Not able to exercise|4
2262590|NCT02151266|3934052|FG001|Overall Study|Not able to exercise|5
2346136|NCT03614156|4082855|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4
2346137|NCT03614156|4082856|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
2346138|NCT03614156|4082857|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
2346139|NCT03614156|4082854|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
2346140|NCT03614156|4082855|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
2346141|NCT03614156|4082856|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3
2346142|NCT03614156|4082857|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4
2346143|NCT03614156|4082854|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0
2346144|NCT03614156|4082855|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
2346145|NCT03614156|4082856|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
2346146|NCT03614156|4082857|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
2346147|NCT03614156|4082854|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0
2346148|NCT03614156|4082855|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22
2346149|NCT03614156|4082856|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26
2346150|NCT03614156|4082857|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38
2346151|NCT03614156|4082854|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
2346152|NCT03614156|4082855|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1
2346153|NCT03614156|4082856|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
2346154|NCT03614156|4082857|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
2346155|NCT03614156|4082854|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2
2346156|NCT03614156|4082855|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0
2346157|NCT03614156|4082856|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0
2346158|NCT03614156|4082857|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0
2346159|NCT03614156|4082854|FG000|Safety Follow-Up Period|Withdrawal by Subject|0
2346160|NCT03614156|4082855|FG001|Safety Follow-Up Period|Withdrawal by Subject|0
2346161|NCT03614156|4082856|FG002|Safety Follow-Up Period|Withdrawal by Subject|1
2346162|NCT03614156|4082857|FG003|Safety Follow-Up Period|Withdrawal by Subject|0
2346163|NCT03614156|4082854|FG000|Safety Follow-Up Period|Lost to Follow-up|1
2346164|NCT03614156|4082855|FG001|Safety Follow-Up Period|Lost to Follow-up|0
2346165|NCT03614156|4082856|FG002|Safety Follow-Up Period|Lost to Follow-up|0
2346166|NCT03614156|4082857|FG003|Safety Follow-Up Period|Lost to Follow-up|1
2346167|NCT03614975|4082874|FG000|Overall Study|Physician Decision|7
2346168|NCT03614975|4082875|FG001|Overall Study|Physician Decision|5
2346169|NCT03614975|4082874|FG000|Overall Study|Withdrawal by Subject|2
2346170|NCT03614975|4082875|FG001|Overall Study|Withdrawal by Subject|2
2346171|NCT03614975|4082874|FG000|Overall Study|Specimens not in lab batch shipment|1
2346172|NCT03614975|4082875|FG001|Overall Study|Specimens not in lab batch shipment|1
2346173|NCT03615066|4082888|FG000|Overall Study|Protocol Violation|1
2346174|NCT03615066|4082889|FG001|Overall Study|Protocol Violation|0
2346175|NCT03615066|4082890|FG002|Overall Study|Protocol Violation|0
2346176|NCT03615066|4082888|FG000|Overall Study|Withdrew Consent|0
2346177|NCT03615066|4082889|FG001|Overall Study|Withdrew Consent|2
2346178|NCT03615066|4082890|FG002|Overall Study|Withdrew Consent|1
2346179|NCT03615066|4082888|FG000|Overall Study|Lost to Follow-up|0
2346180|NCT03615066|4082889|FG001|Overall Study|Lost to Follow-up|0
2346181|NCT03615066|4082890|FG002|Overall Study|Lost to Follow-up|1
2262591|NCT02151266|3934053|FG002|Overall Study|Not able to exercise|4
2262592|NCT02151461|3934082|FG000|Overall Study|Adverse Event|5
2262593|NCT02151461|3934083|FG001|Overall Study|Adverse Event|1
2262594|NCT02151461|3934084|FG002|Overall Study|Adverse Event|0
2262595|NCT02151461|3934085|FG003|Overall Study|Adverse Event|2
2262596|NCT02151461|3934082|FG000|Overall Study|Lost to Follow-up|0
2262597|NCT02151461|3934083|FG001|Overall Study|Lost to Follow-up|0
2262598|NCT02151461|3934084|FG002|Overall Study|Lost to Follow-up|1
2262599|NCT02151461|3934085|FG003|Overall Study|Lost to Follow-up|1
2262600|NCT02151461|3934082|FG000|Overall Study|Withdrawal by Subject|1
2262601|NCT02151461|3934083|FG001|Overall Study|Withdrawal by Subject|0
2262602|NCT02151461|3934084|FG002|Overall Study|Withdrawal by Subject|1
2262603|NCT02151461|3934085|FG003|Overall Study|Withdrawal by Subject|1
2262604|NCT02151461|3934082|FG000|Overall Study|Treatment discontinuation|0
2262605|NCT02151461|3934083|FG001|Overall Study|Treatment discontinuation|0
2262606|NCT02151461|3934084|FG002|Overall Study|Treatment discontinuation|1
2262607|NCT02151461|3934085|FG003|Overall Study|Treatment discontinuation|0
2262608|NCT02151591|3934125|FG000|Overall Study|Lost to Follow-up|6
2262609|NCT02151591|3934126|FG001|Overall Study|Lost to Follow-up|3
2262610|NCT02151643|3934137|FG000|Overall Study|Adverse Event|2
2262611|NCT02151643|3934138|FG001|Overall Study|Adverse Event|0
2262612|NCT02151643|3934139|FG002|Overall Study|Adverse Event|1
2262613|NCT02151643|3934140|FG003|Overall Study|Adverse Event|4
2262614|NCT02151643|3934141|FG004|Overall Study|Adverse Event|0
2262615|NCT02151643|3934137|FG000|Overall Study|Withdrawal by Subject|0
2262616|NCT02151643|3934138|FG001|Overall Study|Withdrawal by Subject|1
2262617|NCT02151643|3934139|FG002|Overall Study|Withdrawal by Subject|1
2262618|NCT02151643|3934140|FG003|Overall Study|Withdrawal by Subject|1
2262619|NCT02151643|3934141|FG004|Overall Study|Withdrawal by Subject|1
2262620|NCT02151643|3934137|FG000|Overall Study|Hyperphosphataemia|1
2346182|NCT03615066|4082888|FG000|Overall Study|Still on Study|8
2346183|NCT03615066|4082889|FG001|Overall Study|Still on Study|6
2346184|NCT03615066|4082890|FG002|Overall Study|Still on Study|2
2346185|NCT03615404|4082923|FG000|Overall Study|Death|1
2346186|NCT03615404|4082923|FG000|Overall Study|vaccine did not pass quality assurance|1
2346187|NCT03615482|4082929|FG000|Overall Study|Death|1
2346188|NCT03615482|4082930|FG001|Overall Study|Death|0
2346189|NCT03615482|4082929|FG000|Overall Study|Lost to Follow-up|7
2346190|NCT03615482|4082930|FG001|Overall Study|Lost to Follow-up|7
2346191|NCT03615482|4082929|FG000|Overall Study|Physician Decision|2
2346192|NCT03615482|4082930|FG001|Overall Study|Physician Decision|3
2346193|NCT03615482|4082929|FG000|Overall Study|Withdrawal by Subject|7
2346194|NCT03615482|4082930|FG001|Overall Study|Withdrawal by Subject|7
2346195|NCT03615924|4082975|FG000|Overall Study|Withdrawal by Subject|2
2346196|NCT03615924|4082976|FG001|Overall Study|Withdrawal by Subject|5
2346197|NCT03615924|4082975|FG000|Overall Study|Death|3
2346198|NCT03615924|4082976|FG001|Overall Study|Death|1
2346199|NCT03615924|4082975|FG000|Overall Study|Lost to Follow-up|1
2346200|NCT03615924|4082976|FG001|Overall Study|Lost to Follow-up|0
2346201|NCT03615924|4082975|FG000|Overall Study|Randomized in error|1
2346202|NCT03615924|4082976|FG001|Overall Study|Randomized in error|0
2346203|NCT03615924|4082975|FG000|Overall Study|Study termination by Sponsor|94
2346204|NCT03615924|4082976|FG001|Overall Study|Study termination by Sponsor|86
2346205|NCT03616106|4082984|FG000|Overall Study|Removed by PI|6
2346206|NCT03616106|4082985|FG001|Overall Study|Removed by PI|0
2346207|NCT03616106|4082984|FG000|Overall Study|Withdrawal by Subject|1
2346208|NCT03616106|4082985|FG001|Overall Study|Withdrawal by Subject|1
2346209|NCT03616106|4082984|FG000|Overall Study|Lost to Follow-up|7
2346210|NCT03616106|4082985|FG001|Overall Study|Lost to Follow-up|0
2346211|NCT03616600|4083002|FG000|Overall Study|Withdrawal by Subject|1
2346212|NCT03616600|4083003|FG001|Overall Study|Withdrawal by Subject|0
2346213|NCT03616977|4083019|FG000|Period 1|Physician Decision|0
2346214|NCT03616977|4083020|FG001|Period 1|Physician Decision|1
2346215|NCT03616977|4083019|FG000|Period 3|Adverse Event|1
2346216|NCT03616977|4083020|FG001|Period 3|Adverse Event|1
2346217|NCT03617588|4083059|FG000|Overall Study|Withdrawal by Subject|1
2346218|NCT03617588|4083060|FG001|Overall Study|Withdrawal by Subject|0
2346219|NCT03617770|4083072|FG000|Overall Study|Lost to Follow-up|1
2346220|NCT03617770|4083073|FG001|Overall Study|Lost to Follow-up|0
2346221|NCT03617861|4083081|FG000|Second Intervention (1 Day)|Adverse Event|0
2346222|NCT03617861|4083082|FG001|Second Intervention (1 Day)|Adverse Event|0
2346223|NCT03617861|4083083|FG002|Second Intervention (1 Day)|Adverse Event|1
2346224|NCT03617861|4083084|FG003|Second Intervention (1 Day)|Adverse Event|0
2346225|NCT03618628|4083140|FG000|Overall Study|Death|1
2346226|NCT03618628|4083140|FG000|Overall Study|Lost to Follow-up|1
2346227|NCT03618823|4083150|FG000|Overall Study|Lost to Follow-up|63
2346228|NCT03618823|4083151|FG001|Overall Study|Lost to Follow-up|61
2346229|NCT03619837|4083177|FG000|Screening|received organs from HCV-negative donors|47
2262621|NCT02151643|3934138|FG001|Overall Study|Hyperphosphataemia|0
2262622|NCT02151643|3934139|FG002|Overall Study|Hyperphosphataemia|0
2262623|NCT02151643|3934140|FG003|Overall Study|Hyperphosphataemia|0
2262624|NCT02151643|3934141|FG004|Overall Study|Hyperphosphataemia|1
2262625|NCT02151643|3934137|FG000|Overall Study|High Ferritin levels|3
2262626|NCT02151643|3934138|FG001|Overall Study|High Ferritin levels|3
2346230|NCT03619837|4083177|FG000|Screening|died on the wait-list|2
2346231|NCT03619837|4083177|FG000|Screening|remained on the wait list|40
2346232|NCT03619837|4083177|FG000|Screening|didn't meet eligibility criteria|3
2346233|NCT03619837|4083177|FG000|Screening|withdrew consent|2
2346234|NCT03619837|4083177|FG000|Screening|never listed for HCV-viremic donor|1
2346235|NCT03619837|4083177|FG000|Screening|developed exclusion criteria|2
2346236|NCT03619837|4083177|FG000|Screening|excluded by the investigator due to non-compliance|1
2346237|NCT03620162|4083195|FG000|Overall Study|Physician Decision|4
2346238|NCT03620162|4083196|FG001|Overall Study|Physician Decision|0
2346239|NCT03620162|4083197|FG002|Overall Study|Physician Decision|1
2346240|NCT03620162|4083198|FG003|Overall Study|Physician Decision|0
2262627|NCT02151643|3934139|FG002|Overall Study|High Ferritin levels|2
2262628|NCT02151643|3934140|FG003|Overall Study|High Ferritin levels|2
2262629|NCT02151643|3934141|FG004|Overall Study|High Ferritin levels|1
2262630|NCT02151682|3934155|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2262631|NCT02151682|3934156|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
2262632|NCT02151682|3934157|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2262633|NCT02151682|3934158|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2262634|NCT02151682|3934159|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2262635|NCT02151682|3934160|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2262636|NCT02151682|3934155|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2262637|NCT02151682|3934156|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
2262638|NCT02151682|3934157|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2262639|NCT02151682|3934158|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2262640|NCT02151682|3934159|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2262641|NCT02151682|3934160|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2262642|NCT02151682|3934155|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2262643|NCT02151682|3934156|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
2262644|NCT02151682|3934157|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2346241|NCT03620162|4083199|FG004|Overall Study|Physician Decision|2
2346242|NCT03620162|4083195|FG000|Overall Study|Lost to Follow-up|2
2346243|NCT03620162|4083196|FG001|Overall Study|Lost to Follow-up|6
2346244|NCT03620162|4083197|FG002|Overall Study|Lost to Follow-up|7
2346245|NCT03620162|4083198|FG003|Overall Study|Lost to Follow-up|3
2346246|NCT03620162|4083199|FG004|Overall Study|Lost to Follow-up|2
2346247|NCT03620162|4083195|FG000|Overall Study|Consent withdrawn by parent/guardian|9
2346248|NCT03620162|4083196|FG001|Overall Study|Consent withdrawn by parent/guardian|8
2346249|NCT03620162|4083197|FG002|Overall Study|Consent withdrawn by parent/guardian|25
2346250|NCT03620162|4083198|FG003|Overall Study|Consent withdrawn by parent/guardian|17
2346251|NCT03620162|4083199|FG004|Overall Study|Consent withdrawn by parent/guardian|9
2346252|NCT03620708|4083225|FG000|Overall Study|Lost to Follow-up|1
2346253|NCT03620708|4083226|FG001|Overall Study|Lost to Follow-up|1
2346254|NCT03620708|4083227|FG002|Overall Study|Lost to Follow-up|2
2346255|NCT03620708|4083225|FG000|Overall Study|Withdrawal by Subject|0
2346256|NCT03620708|4083226|FG001|Overall Study|Withdrawal by Subject|0
2346257|NCT03620708|4083227|FG002|Overall Study|Withdrawal by Subject|1
2346258|NCT03621189|4083253|FG000|Overall Study|Withdrawal by Subject|0
2346259|NCT03621189|4083254|FG001|Overall Study|Withdrawal by Subject|3
2346260|NCT03621189|4083253|FG000|Overall Study|Physician Decision|0
2346261|NCT03621189|4083254|FG001|Overall Study|Physician Decision|2
2346262|NCT03622112|4083289|FG000|Overall Study|Withdrawal by Subject|6
2346263|NCT03622112|4083290|FG001|Overall Study|Withdrawal by Subject|2
2346264|NCT03622112|4083291|FG002|Overall Study|Withdrawal by Subject|4
2346265|NCT03622112|4083292|FG003|Overall Study|Withdrawal by Subject|2
2346266|NCT03622112|4083293|FG004|Overall Study|Withdrawal by Subject|1
2346267|NCT03622112|4083294|FG005|Overall Study|Withdrawal by Subject|2
2346268|NCT03622112|4083295|FG006|Overall Study|Withdrawal by Subject|2
2346269|NCT03622112|4083289|FG000|Overall Study|Death|0
2346270|NCT03622112|4083290|FG001|Overall Study|Death|0
2346271|NCT03622112|4083291|FG002|Overall Study|Death|0
2346272|NCT03622112|4083292|FG003|Overall Study|Death|1
2346273|NCT03622112|4083293|FG004|Overall Study|Death|0
2346274|NCT03622112|4083294|FG005|Overall Study|Death|0
2346275|NCT03622112|4083295|FG006|Overall Study|Death|0
2346276|NCT03622112|4083289|FG000|Overall Study|Lost to Follow-up|1
2346277|NCT03622112|4083290|FG001|Overall Study|Lost to Follow-up|1
2346278|NCT03622112|4083291|FG002|Overall Study|Lost to Follow-up|0
2346279|NCT03622112|4083292|FG003|Overall Study|Lost to Follow-up|0
2346280|NCT03622112|4083293|FG004|Overall Study|Lost to Follow-up|0
2346281|NCT03622112|4083294|FG005|Overall Study|Lost to Follow-up|0
2346282|NCT03622112|4083295|FG006|Overall Study|Lost to Follow-up|0
2346283|NCT03622112|4083289|FG000|Overall Study|Study-specific withdrawal criteria|10
2346284|NCT03622112|4083290|FG001|Overall Study|Study-specific withdrawal criteria|8
2346285|NCT03622112|4083291|FG002|Overall Study|Study-specific withdrawal criteria|7
2346286|NCT03622112|4083292|FG003|Overall Study|Study-specific withdrawal criteria|6
2346287|NCT03622112|4083293|FG004|Overall Study|Study-specific withdrawal criteria|4
2346288|NCT03622112|4083294|FG005|Overall Study|Study-specific withdrawal criteria|18
2346289|NCT03622112|4083295|FG006|Overall Study|Study-specific withdrawal criteria|4
2346290|NCT03622112|4083289|FG000|Overall Study|Protocol Violation|2
2346291|NCT03622112|4083290|FG001|Overall Study|Protocol Violation|0
2346292|NCT03622112|4083291|FG002|Overall Study|Protocol Violation|1
2346293|NCT03622112|4083292|FG003|Overall Study|Protocol Violation|1
2346294|NCT03622112|4083293|FG004|Overall Study|Protocol Violation|0
2346295|NCT03622112|4083294|FG005|Overall Study|Protocol Violation|0
2346296|NCT03622112|4083295|FG006|Overall Study|Protocol Violation|0
2346297|NCT03622112|4083289|FG000|Overall Study|Adverse Event|6
2346298|NCT03622112|4083290|FG001|Overall Study|Adverse Event|8
2346299|NCT03622112|4083291|FG002|Overall Study|Adverse Event|4
2346300|NCT03622112|4083292|FG003|Overall Study|Adverse Event|11
2346301|NCT03622112|4083293|FG004|Overall Study|Adverse Event|4
2346302|NCT03622112|4083294|FG005|Overall Study|Adverse Event|20
2262645|NCT02151682|3934158|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2262646|NCT02151682|3934159|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2262647|NCT02151682|3934160|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2262648|NCT02151682|3934155|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
2262649|NCT02151682|3934156|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
2262650|NCT02151682|3934157|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2262651|NCT02151682|3934158|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2262652|NCT02151682|3934159|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2262653|NCT02151682|3934160|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2262654|NCT02151682|3934155|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1
2262655|NCT02151682|3934156|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2262656|NCT02151682|3934157|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2262657|NCT02151682|3934158|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2262658|NCT02151682|3934159|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2262659|NCT02151682|3934160|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2262660|NCT02151682|3934155|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0
2262661|NCT02151682|3934156|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0
2262662|NCT02151682|3934157|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3
2262663|NCT02151682|3934158|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0
2262664|NCT02151682|3934159|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0
2262665|NCT02151682|3934160|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0
2262666|NCT02151682|3934155|FG000|Part 2: Tapent. Extension or Observation|Death|0
2346303|NCT03622112|4083295|FG006|Overall Study|Adverse Event|2
2346304|NCT03622112|4083289|FG000|Overall Study|Reason not specified|0
2346305|NCT03622112|4083290|FG001|Overall Study|Reason not specified|1
2346306|NCT03622112|4083291|FG002|Overall Study|Reason not specified|0
2346307|NCT03622112|4083292|FG003|Overall Study|Reason not specified|1
2346308|NCT03622112|4083293|FG004|Overall Study|Reason not specified|1
2346309|NCT03622112|4083294|FG005|Overall Study|Reason not specified|2
2346310|NCT03622112|4083295|FG006|Overall Study|Reason not specified|1
2346311|NCT03624192|4083348|FG000|Overall Study|Lost to Follow-up|1
2346312|NCT03624192|4083349|FG001|Overall Study|Lost to Follow-up|1
2346313|NCT03624504|4083357|FG000|Overall Study|Unsuccessful Implant|1
2346314|NCT03624946|4083382|FG000|Overall Study|Lost to Follow-up|0
2346315|NCT03624946|4083383|FG001|Overall Study|Lost to Follow-up|1
2346316|NCT03624972|4083396|FG000|Overall Study|Lost to Follow-up|2
2346317|NCT03624972|4083397|FG001|Overall Study|Lost to Follow-up|0
2346318|NCT03624972|4083398|FG002|Overall Study|Lost to Follow-up|0
2346319|NCT03624972|4083396|FG000|Overall Study|Withdrawal by Subject|0
2346320|NCT03624972|4083397|FG001|Overall Study|Withdrawal by Subject|2
2346321|NCT03624972|4083398|FG002|Overall Study|Withdrawal by Subject|0
2262667|NCT02151682|3934156|FG001|Part 2: Tapent. Extension or Observation|Death|0
2262668|NCT02151682|3934157|FG002|Part 2: Tapent. Extension or Observation|Death|0
2262669|NCT02151682|3934158|FG003|Part 2: Tapent. Extension or Observation|Death|2
2262670|NCT02151682|3934159|FG004|Part 2: Tapent. Extension or Observation|Death|0
2262671|NCT02151682|3934160|FG005|Part 2: Tapent. Extension or Observation|Death|0
2262672|NCT02151682|3934155|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2262673|NCT02151682|3934156|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2262674|NCT02151682|3934157|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
2262675|NCT02151682|3934158|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
2262676|NCT02151682|3934159|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2262677|NCT02151682|3934160|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2262678|NCT02151682|3934155|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2262679|NCT02151682|3934156|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2262680|NCT02151682|3934157|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
2262681|NCT02151682|3934158|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2262682|NCT02151682|3934159|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2262683|NCT02151682|3934160|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2262684|NCT02151682|3934155|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2262685|NCT02151682|3934156|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2262686|NCT02151682|3934157|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1
2262687|NCT02151682|3934158|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2262688|NCT02151682|3934159|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2262689|NCT02151682|3934160|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2262690|NCT02151682|3934155|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0
2262691|NCT02151682|3934156|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0
2262692|NCT02151682|3934157|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13
2262693|NCT02151682|3934158|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0
2262694|NCT02151682|3934159|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0
2262695|NCT02151682|3934160|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0
2262696|NCT02151682|3934155|FG000|Part 2: Tapent. Extension or Observation|Missing|0
2262697|NCT02151682|3934156|FG001|Part 2: Tapent. Extension or Observation|Missing|0
2262698|NCT02151682|3934157|FG002|Part 2: Tapent. Extension or Observation|Missing|0
2262699|NCT02151682|3934158|FG003|Part 2: Tapent. Extension or Observation|Missing|1
2262700|NCT02151682|3934159|FG004|Part 2: Tapent. Extension or Observation|Missing|0
2262701|NCT02151682|3934160|FG005|Part 2: Tapent. Extension or Observation|Missing|0
2262702|NCT02151682|3934155|FG000|Part 2: Tapent. Extension or Observation|Various other|0
2262703|NCT02151682|3934156|FG001|Part 2: Tapent. Extension or Observation|Various other|0
2262704|NCT02151682|3934157|FG002|Part 2: Tapent. Extension or Observation|Various other|6
2262705|NCT02151682|3934158|FG003|Part 2: Tapent. Extension or Observation|Various other|0
2262706|NCT02151682|3934159|FG004|Part 2: Tapent. Extension or Observation|Various other|0
2262707|NCT02151682|3934160|FG005|Part 2: Tapent. Extension or Observation|Various other|0
2262708|NCT02151682|3934155|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2262709|NCT02151682|3934156|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2262710|NCT02151682|3934157|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
2262711|NCT02151682|3934158|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2262712|NCT02151682|3934159|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2262713|NCT02151682|3934160|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2262714|NCT02151682|3934155|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2262715|NCT02151682|3934156|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2262716|NCT02151682|3934157|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2262717|NCT02151682|3934158|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2262718|NCT02151682|3934159|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2262719|NCT02151682|3934160|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
2262720|NCT02151682|3934155|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0
2262721|NCT02151682|3934156|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0
2262722|NCT02151682|3934157|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0
2262723|NCT02151682|3934158|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0
2346322|NCT03627065|4083433|FG000|Overall Study|Study Terminated by sponsor|1
2346323|NCT03627065|4083433|FG000|Overall Study|Withdrawal by Subject|2
2346324|NCT03627195|4083443|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1
2346325|NCT03627195|4083444|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0
2346326|NCT03627195|4083445|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0
2346327|NCT03627195|4083446|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0
2346328|NCT03627195|4083447|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0
2346329|NCT03627195|4083448|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0
2346330|NCT03627416|4083468|FG000|Overall Study|Adverse Event|0
2346331|NCT03627416|4083469|FG001|Overall Study|Adverse Event|1
2346332|NCT03627494|4083487|FG000|Part A Washout 2 (7 Days)|Adverse Event|1
2346333|NCT03627494|4083488|FG001|Part A Washout 2 (7 Days)|Adverse Event|0
2262724|NCT02151682|3934159|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0
2262725|NCT02151682|3934160|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1
2262726|NCT02151682|3934155|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2262727|NCT02151682|3934156|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2262728|NCT02151682|3934157|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2262729|NCT02151682|3934158|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2262730|NCT02151682|3934159|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2262731|NCT02151682|3934160|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3
2262732|NCT02151682|3934155|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2262733|NCT02151682|3934156|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2262734|NCT02151682|3934157|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2262735|NCT02151682|3934158|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2262736|NCT02151682|3934159|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2262737|NCT02151682|3934160|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2
2262738|NCT02151773|3934178|FG000|Overall Study|Protocol Deviation|64
2262739|NCT02151786|3934182|FG000|Overall Study|Unavailability of Case Report Form|26
2262740|NCT02151786|3934182|FG000|Overall Study|Outside the Contract Period|1
2262741|NCT02151786|3934182|FG000|Overall Study|Randomized, not Treated|1
2262742|NCT02151786|3934182|FG000|Overall Study|Unavailability of Information|8
2262743|NCT02151851|3934188|FG000|Overall Study|Lack of Efficacy|67
2262744|NCT02151851|3934189|FG001|Overall Study|Lack of Efficacy|94
2262745|NCT02151851|3934188|FG000|Overall Study|Protocol Violation|0
2262746|NCT02151851|3934189|FG001|Overall Study|Protocol Violation|1
2262747|NCT02151851|3934188|FG000|Overall Study|Withdrawal by Subject|2
2262748|NCT02151851|3934189|FG001|Overall Study|Withdrawal by Subject|5
2262749|NCT02151851|3934188|FG000|Overall Study|Medical impairment|1
2262750|NCT02151851|3934189|FG001|Overall Study|Medical impairment|0
2262751|NCT02151851|3934188|FG000|Overall Study|Low compliance to study visits|0
2262752|NCT02151851|3934189|FG001|Overall Study|Low compliance to study visits|1
2262753|NCT02151851|3934188|FG000|Overall Study|Subject entered into study in error|0
2262754|NCT02151851|3934189|FG001|Overall Study|Subject entered into study in error|1
2262755|NCT02151851|3934188|FG000|Overall Study|Adverse Event|6
2262756|NCT02151851|3934189|FG001|Overall Study|Adverse Event|28
2262757|NCT02151903|3934208|FG000|Overall Study|Withdrawal by Subject|1
2262758|NCT02151903|3934209|FG001|Overall Study|Withdrawal by Subject|0
2262759|NCT02151903|3934208|FG000|Overall Study|Progressive disease|2
2262760|NCT02151903|3934209|FG001|Overall Study|Progressive disease|1
2262761|NCT02151981|3934217|FG000|Overall Study|Death|184
2262762|NCT02151981|3934218|FG001|Overall Study|Death|88
2262763|NCT02151981|3934217|FG000|Overall Study|Lost to Follow-up|7
2262764|NCT02151981|3934218|FG001|Overall Study|Lost to Follow-up|1
2262765|NCT02151981|3934217|FG000|Overall Study|Withdrawal by Subject|27
2262766|NCT02151981|3934218|FG001|Overall Study|Withdrawal by Subject|21
2262767|NCT02151981|3934217|FG000|Overall Study|Ongoing Study at Data Cut-off|60
2262768|NCT02151981|3934218|FG001|Overall Study|Ongoing Study at Data Cut-off|27
2262769|NCT02151981|3934217|FG000|Overall Study|Eligibility criteria not fulfilled|0
2262770|NCT02151981|3934218|FG001|Overall Study|Eligibility criteria not fulfilled|1
2262771|NCT02151981|3934217|FG000|Overall Study|Patient had no clinical benefit|1
2262772|NCT02151981|3934218|FG001|Overall Study|Patient had no clinical benefit|0
2262773|NCT02151981|3934217|FG000|Overall Study|Unwilling to continue to follow up visit|0
2262774|NCT02151981|3934218|FG001|Overall Study|Unwilling to continue to follow up visit|1
2262775|NCT02151981|3934217|FG000|Overall Study|Study terminated|0
2262776|NCT02151981|3934218|FG001|Overall Study|Study terminated|1
2262777|NCT02152007|3934276|FG000|Overall Study|Withdrawal by Subject|1
2262778|NCT02152137|3934290|FG000|Overall Study|Withdrawal by Subject|1
2262779|NCT02152137|3934290|FG000|Overall Study|Originally assigned to Arm B|3
2262780|NCT02152163|3934296|FG000|Overall Study|Physician Decision|12
2262781|NCT02152163|3934297|FG001|Overall Study|Physician Decision|13
2262782|NCT02152345|3934305|FG000|Overall Study|Case Cancellations|2
2262783|NCT02152345|3934306|FG001|Overall Study|Case Cancellations|4
2262784|NCT02152345|3934305|FG000|Overall Study|Withdrawal by Subject|2
2262785|NCT02152345|3934306|FG001|Overall Study|Withdrawal by Subject|1
2262786|NCT02152371|3934314|FG000|Overall Study|Adverse Event|6
2262787|NCT02152371|3934315|FG001|Overall Study|Adverse Event|2
2262788|NCT02152371|3934314|FG000|Overall Study|Withdrawal by Subject|3
2262789|NCT02152371|3934315|FG001|Overall Study|Withdrawal by Subject|7
2262790|NCT02152371|3934314|FG000|Overall Study|Protocol Violation|2
2262791|NCT02152371|3934315|FG001|Overall Study|Protocol Violation|3
2262792|NCT02152371|3934314|FG000|Overall Study|Lost to Follow-up|1
2262793|NCT02152371|3934315|FG001|Overall Study|Lost to Follow-up|0
2262794|NCT02152371|3934314|FG000|Overall Study|Lack of Efficacy|0
2262795|NCT02152371|3934315|FG001|Overall Study|Lack of Efficacy|1
2262796|NCT02152371|3934314|FG000|Overall Study|Physician Decision|0
2262797|NCT02152371|3934315|FG001|Overall Study|Physician Decision|2
2262798|NCT02152371|3934314|FG000|Overall Study|Reason Not Given|0
2262799|NCT02152371|3934315|FG001|Overall Study|Reason Not Given|1
2262800|NCT02152384|3934321|FG000|Period 1|Withdrawal by Subject|0
2262801|NCT02152384|3934322|FG001|Period 1|Withdrawal by Subject|1
2262802|NCT02152384|3934321|FG000|Period 1|Adverse Event|1
2262803|NCT02152384|3934322|FG001|Period 1|Adverse Event|1
2262804|NCT02152605|3934350|FG000|Overall Study|Adverse Event|6
2262805|NCT02152605|3934351|FG001|Overall Study|Adverse Event|8
2262806|NCT02152605|3934350|FG000|Overall Study|Lack of Efficacy|7
2262807|NCT02152605|3934351|FG001|Overall Study|Lack of Efficacy|4
2262808|NCT02152605|3934350|FG000|Overall Study|Protocol deviation|1
2262809|NCT02152605|3934351|FG001|Overall Study|Protocol deviation|4
2262810|NCT02152605|3934350|FG000|Overall Study|Lost to Follow-up|1
2262811|NCT02152605|3934351|FG001|Overall Study|Lost to Follow-up|0
2262812|NCT02152605|3934350|FG000|Overall Study|Withdrew consent|4
2262813|NCT02152605|3934351|FG001|Overall Study|Withdrew consent|2
2262814|NCT02152631|3934360|FG000|Overall Study|Adverse Event|32
2262815|NCT02152631|3934361|FG001|Overall Study|Adverse Event|4
2262816|NCT02152631|3934360|FG000|Overall Study|Withdrawal by Subject|13
2262817|NCT02152631|3934361|FG001|Overall Study|Withdrawal by Subject|16
2262818|NCT02152631|3934360|FG000|Overall Study|Noncompliance with study drug|1
2262819|NCT02152631|3934361|FG001|Overall Study|Noncompliance with study drug|0
2262820|NCT02152631|3934360|FG000|Overall Study|Physician Decision|1
2262821|NCT02152631|3934361|FG001|Overall Study|Physician Decision|2
2262822|NCT02152631|3934360|FG000|Overall Study|Lost to Follow-up|0
2262823|NCT02152631|3934361|FG001|Overall Study|Lost to Follow-up|1
2262824|NCT02152631|3934360|FG000|Overall Study|On Treatment|19
2262825|NCT02152631|3934361|FG001|Overall Study|On Treatment|3
2262826|NCT02152761|3934384|FG000|Epoch: Treatment Epoch|Technical problems|0
2262827|NCT02152761|3934385|FG001|Epoch: Treatment Epoch|Technical problems|0
2262828|NCT02152761|3934386|FG002|Epoch: Treatment Epoch|Technical problems|0
2262829|NCT02152761|3934387|FG003|Epoch: Treatment Epoch|Technical problems|1
2262830|NCT02152761|3934384|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0
2262831|NCT02152761|3934385|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2
2262832|NCT02152761|3934386|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0
2262833|NCT02152761|3934387|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0
2262834|NCT02152761|3934384|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7
2262835|NCT02152761|3934385|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8
2262836|NCT02152761|3934386|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3
2262837|NCT02152761|3934387|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5
2262838|NCT02152761|3934384|FG000|Epoch: Treatment Epoch|Adverse Event|3
2262839|NCT02152761|3934385|FG001|Epoch: Treatment Epoch|Adverse Event|6
2262840|NCT02152761|3934386|FG002|Epoch: Treatment Epoch|Adverse Event|1
2262841|NCT02152761|3934387|FG003|Epoch: Treatment Epoch|Adverse Event|2
2346334|NCT03627494|4083489|FG002|Part A Washout 2 (7 Days)|Adverse Event|1
2346335|NCT03627494|4083490|FG003|Part A Washout 2 (7 Days)|Adverse Event|0
2346336|NCT03627494|4083491|FG004|Part A Washout 2 (7 Days)|Adverse Event|0
2346337|NCT03627494|4083492|FG005|Part A Washout 2 (7 Days)|Adverse Event|0
2346338|NCT03627494|4083493|FG006|Part A Washout 2 (7 Days)|Adverse Event|0
2346339|NCT03627494|4083494|FG007|Part A Washout 2 (7 Days)|Adverse Event|0
2346340|NCT03627494|4083495|FG008|Part A Washout 2 (7 Days)|Adverse Event|0
2346341|NCT03627494|4083496|FG009|Part A Washout 2 (7 Days)|Adverse Event|0
2346342|NCT03627494|4083497|FG010|Part A Washout 2 (7 Days)|Adverse Event|0
2346343|NCT03627494|4083498|FG011|Part A Washout 2 (7 Days)|Adverse Event|0
2346344|NCT03627494|4083487|FG000|Part B (Maximum of 34 Days)|Adverse Event|0
2346345|NCT03627494|4083488|FG001|Part B (Maximum of 34 Days)|Adverse Event|0
2346346|NCT03627494|4083489|FG002|Part B (Maximum of 34 Days)|Adverse Event|0
2346347|NCT03627494|4083490|FG003|Part B (Maximum of 34 Days)|Adverse Event|0
2346348|NCT03627494|4083491|FG004|Part B (Maximum of 34 Days)|Adverse Event|0
2346349|NCT03627494|4083492|FG005|Part B (Maximum of 34 Days)|Adverse Event|0
2346350|NCT03627494|4083493|FG006|Part B (Maximum of 34 Days)|Adverse Event|0
2346351|NCT03627494|4083494|FG007|Part B (Maximum of 34 Days)|Adverse Event|0
2346352|NCT03627494|4083495|FG008|Part B (Maximum of 34 Days)|Adverse Event|2
2346353|NCT03627494|4083496|FG009|Part B (Maximum of 34 Days)|Adverse Event|0
2346354|NCT03627494|4083497|FG010|Part B (Maximum of 34 Days)|Adverse Event|0
2346355|NCT03627494|4083498|FG011|Part B (Maximum of 34 Days)|Adverse Event|0
2346356|NCT03627494|4083487|FG000|Part C Washout 1 (7 Days)|Adverse Event|0
2346357|NCT03627494|4083488|FG001|Part C Washout 1 (7 Days)|Adverse Event|0
2346358|NCT03627494|4083489|FG002|Part C Washout 1 (7 Days)|Adverse Event|0
2346359|NCT03627494|4083490|FG003|Part C Washout 1 (7 Days)|Adverse Event|0
2346360|NCT03627494|4083491|FG004|Part C Washout 1 (7 Days)|Adverse Event|0
2346361|NCT03627494|4083492|FG005|Part C Washout 1 (7 Days)|Adverse Event|0
2346362|NCT03627494|4083493|FG006|Part C Washout 1 (7 Days)|Adverse Event|0
2346363|NCT03627494|4083494|FG007|Part C Washout 1 (7 Days)|Adverse Event|0
2346364|NCT03627494|4083495|FG008|Part C Washout 1 (7 Days)|Adverse Event|0
2346365|NCT03627494|4083496|FG009|Part C Washout 1 (7 Days)|Adverse Event|0
2346366|NCT03627494|4083497|FG010|Part C Washout 1 (7 Days)|Adverse Event|1
2346367|NCT03627494|4083498|FG011|Part C Washout 1 (7 Days)|Adverse Event|1
2346368|NCT03627767|4083540|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48
2262842|NCT02152761|3934384|FG000|Epoch: Treatment Epoch|Death|0
2262843|NCT02152761|3934385|FG001|Epoch: Treatment Epoch|Death|3
2262844|NCT02152761|3934386|FG002|Epoch: Treatment Epoch|Death|1
2262845|NCT02152761|3934387|FG003|Epoch: Treatment Epoch|Death|0
2262846|NCT02152761|3934384|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1
2262847|NCT02152761|3934385|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1
2262848|NCT02152761|3934386|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0
2262849|NCT02152761|3934387|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0
2262850|NCT02152761|3934384|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
2262851|NCT02152761|3934385|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3
2262852|NCT02152761|3934386|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0
2262853|NCT02152761|3934387|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
2262854|NCT02152761|3934384|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1
2262855|NCT02152761|3934385|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4
2262856|NCT02152761|3934386|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
2262857|NCT02152761|3934387|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
2262858|NCT02152761|3934384|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1
2262859|NCT02152761|3934385|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
2262860|NCT02152761|3934386|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
2262861|NCT02152761|3934387|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
2262862|NCT02152761|3934384|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1
2262863|NCT02152761|3934385|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0
2262864|NCT02152761|3934386|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0
2262865|NCT02152761|3934387|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1
2262866|NCT02153073|3934412|FG000|Overall Study|Case Report Forms Uncollected|230
2262867|NCT02153073|3934412|FG000|Overall Study|Protocol Deviation|68
2262868|NCT02153086|3934416|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2
2262869|NCT02153086|3934416|FG000|Overall Study|Other|2
2262870|NCT02153112|3934459|FG000|Overall Study|Adverse Event|0
2262871|NCT02153112|3934460|FG001|Overall Study|Adverse Event|0
2262872|NCT02153112|3934461|FG002|Overall Study|Adverse Event|1
2262873|NCT02153112|3934462|FG003|Overall Study|Adverse Event|0
2262874|NCT02153112|3934463|FG004|Overall Study|Adverse Event|0
2262875|NCT02153112|3934464|FG005|Overall Study|Adverse Event|0
2262876|NCT02153112|3934465|FG006|Overall Study|Adverse Event|0
2262877|NCT02153112|3934466|FG007|Overall Study|Adverse Event|0
2262878|NCT02153112|3934467|FG008|Overall Study|Adverse Event|0
2262879|NCT02153112|3934468|FG009|Overall Study|Adverse Event|0
2262880|NCT02153112|3934459|FG000|Overall Study|Lost to Follow-up|1
2262881|NCT02153112|3934460|FG001|Overall Study|Lost to Follow-up|1
2262882|NCT02153112|3934461|FG002|Overall Study|Lost to Follow-up|0
2262883|NCT02153112|3934462|FG003|Overall Study|Lost to Follow-up|0
2262884|NCT02153112|3934463|FG004|Overall Study|Lost to Follow-up|2
2262885|NCT02153112|3934464|FG005|Overall Study|Lost to Follow-up|1
2262886|NCT02153112|3934465|FG006|Overall Study|Lost to Follow-up|1
2262887|NCT02153112|3934466|FG007|Overall Study|Lost to Follow-up|0
2262888|NCT02153112|3934467|FG008|Overall Study|Lost to Follow-up|1
2262889|NCT02153112|3934468|FG009|Overall Study|Lost to Follow-up|1
2262890|NCT02153112|3934459|FG000|Overall Study|Withdrawal by Subject|3
2262891|NCT02153112|3934460|FG001|Overall Study|Withdrawal by Subject|1
2262892|NCT02153112|3934461|FG002|Overall Study|Withdrawal by Subject|2
2262893|NCT02153112|3934462|FG003|Overall Study|Withdrawal by Subject|2
2346369|NCT03627767|4083541|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
2346370|NCT03627767|4083542|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
2346371|NCT03627767|4083543|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
2346372|NCT03627767|4083544|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
2346373|NCT03627767|4083540|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1
2346374|NCT03627767|4083541|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0
2346375|NCT03627767|4083542|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0
2346376|NCT03627767|4083543|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0
2346377|NCT03627767|4083544|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0
2346378|NCT03627767|4083540|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315
2346379|NCT03627767|4083541|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
2346380|NCT03627767|4083542|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
2346381|NCT03627767|4083543|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
2346382|NCT03627767|4083544|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
2346383|NCT03627767|4083540|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13
2346384|NCT03627767|4083541|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
2346385|NCT03627767|4083542|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
2346386|NCT03627767|4083543|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
2346387|NCT03627767|4083544|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
2346388|NCT03627767|4083540|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11
2346389|NCT03627767|4083541|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
2346390|NCT03627767|4083542|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
2346391|NCT03627767|4083543|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
2346392|NCT03627767|4083544|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
2346393|NCT03627767|4083540|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40
2346394|NCT03627767|4083541|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
2346395|NCT03627767|4083542|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
2346396|NCT03627767|4083543|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
2346397|NCT03627767|4083544|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
2346398|NCT03627767|4083540|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1
2346399|NCT03627767|4083541|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
2262894|NCT02153112|3934463|FG004|Overall Study|Withdrawal by Subject|1
2262895|NCT02153112|3934464|FG005|Overall Study|Withdrawal by Subject|1
2262896|NCT02153112|3934465|FG006|Overall Study|Withdrawal by Subject|7
2262897|NCT02153112|3934466|FG007|Overall Study|Withdrawal by Subject|2
2262898|NCT02153112|3934467|FG008|Overall Study|Withdrawal by Subject|13
2262899|NCT02153112|3934468|FG009|Overall Study|Withdrawal by Subject|12
2262900|NCT02153112|3934459|FG000|Overall Study|Reason not Specified|0
2262901|NCT02153112|3934460|FG001|Overall Study|Reason not Specified|0
2262902|NCT02153112|3934461|FG002|Overall Study|Reason not Specified|0
2262903|NCT02153112|3934462|FG003|Overall Study|Reason not Specified|0
2262904|NCT02153112|3934463|FG004|Overall Study|Reason not Specified|0
2262905|NCT02153112|3934464|FG005|Overall Study|Reason not Specified|0
2262906|NCT02153112|3934465|FG006|Overall Study|Reason not Specified|0
2262907|NCT02153112|3934466|FG007|Overall Study|Reason not Specified|0
2262908|NCT02153112|3934467|FG008|Overall Study|Reason not Specified|1
2262909|NCT02153112|3934468|FG009|Overall Study|Reason not Specified|1
2262910|NCT02153346|3934492|FG000|Overall Study|Lost to Follow-up|11
2262911|NCT02153359|3934497|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0
2262912|NCT02153359|3934498|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2
2262913|NCT02153398|3934512|FG000|Overall Study|Withdrawal by Subject|1
2262914|NCT02153398|3934513|FG001|Overall Study|Withdrawal by Subject|0
2262915|NCT02153398|3934514|FG002|Overall Study|Withdrawal by Subject|0
2262916|NCT02153398|3934515|FG003|Overall Study|Withdrawal by Subject|0
2262917|NCT02153398|3934516|FG004|Overall Study|Withdrawal by Subject|0
2262918|NCT02153398|3934512|FG000|Overall Study|Adverse Event|0
2262919|NCT02153398|3934513|FG001|Overall Study|Adverse Event|0
2262920|NCT02153398|3934514|FG002|Overall Study|Adverse Event|1
2262921|NCT02153398|3934515|FG003|Overall Study|Adverse Event|1
2346400|NCT03627767|4083542|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
2346401|NCT03627767|4083543|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
2346402|NCT03627767|4083544|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
2346403|NCT03627767|4083540|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2
2346404|NCT03627767|4083541|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
2346405|NCT03627767|4083542|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
2346406|NCT03627767|4083543|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
2346407|NCT03627767|4083544|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
2346408|NCT03627767|4083540|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4
2346409|NCT03627767|4083541|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0
2346410|NCT03627767|4083542|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0
2346411|NCT03627767|4083543|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0
2346412|NCT03627767|4083544|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0
2346413|NCT03627767|4083540|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2
2346414|NCT03627767|4083541|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
2346415|NCT03627767|4083542|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
2346416|NCT03627767|4083543|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
2346417|NCT03627767|4083544|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
2346418|NCT03627767|4083540|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
2346419|NCT03627767|4083541|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6
2346420|NCT03627767|4083542|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7
2346421|NCT03627767|4083543|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19
2346422|NCT03627767|4083544|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
2346423|NCT03627767|4083540|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
2346424|NCT03627767|4083541|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
2346425|NCT03627767|4083542|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2
2346426|NCT03627767|4083543|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3
2346427|NCT03627767|4083544|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
2346428|NCT03627767|4083540|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
2346429|NCT03627767|4083541|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1
2346430|NCT03627767|4083542|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5
2346431|NCT03627767|4083543|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2
2346432|NCT03627767|4083544|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
2346433|NCT03627767|4083540|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
2346434|NCT03627767|4083541|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9
2346435|NCT03627767|4083542|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6
2346436|NCT03627767|4083543|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10
2262922|NCT02153398|3934516|FG004|Overall Study|Adverse Event|0
2262923|NCT02153736|3934579|FG000|Overall Study|Lost to Follow-up|1
2262924|NCT02153736|3934580|FG001|Overall Study|Lost to Follow-up|0
2262925|NCT02153736|3934579|FG000|Overall Study|Medical status change made ineligible|1
2262926|NCT02153736|3934580|FG001|Overall Study|Medical status change made ineligible|0
2262927|NCT02153736|3934579|FG000|Overall Study|Death|0
2262928|NCT02153736|3934580|FG001|Overall Study|Death|1
2262929|NCT02153736|3934579|FG000|Overall Study|Withdrawal by Subject|0
2262930|NCT02153736|3934580|FG001|Overall Study|Withdrawal by Subject|1
2262931|NCT02153788|3934588|FG000|Overall Study|Physician Decision|2
2262932|NCT02153788|3934589|FG001|Overall Study|Physician Decision|1
2262933|NCT02153827|3934597|FG000|Overall Study|Lost to Follow-up|3
2262934|NCT02153827|3934598|FG001|Overall Study|Lost to Follow-up|9
2262935|NCT02153905|3934606|FG000|Overall Study|Death|1
2262936|NCT02153905|3934607|FG001|Overall Study|Death|0
2262937|NCT02153918|3934613|FG000|Overall Study|Refused further treatment|1
2262938|NCT02154061|3934657|FG000|Overall Study|Pregnancy|1
2262939|NCT02154061|3934658|FG001|Overall Study|Pregnancy|0
2262940|NCT02154061|3934657|FG000|Overall Study|enrolled but not vaccinated|1
2262941|NCT02154061|3934658|FG001|Overall Study|enrolled but not vaccinated|0
2262942|NCT02154139|3934664|FG000|Overall Study|Injection not administered|2
2262943|NCT02154139|3934664|FG000|Overall Study|Other|2
2262944|NCT02154139|3934664|FG000|Overall Study|Investigator transferred|3
2262945|NCT02154347|3934683|FG000|Double-blind Period|Adverse Event|1
2262946|NCT02154347|3934684|FG001|Double-blind Period|Adverse Event|2
2262947|NCT02154347|3934683|FG000|Double-blind Period|Lack of Efficacy|1
2262948|NCT02154347|3934684|FG001|Double-blind Period|Lack of Efficacy|0
2262949|NCT02154347|3934683|FG000|Double-blind Period|Physician Decision|0
2262950|NCT02154347|3934684|FG001|Double-blind Period|Physician Decision|1
2262951|NCT02154347|3934683|FG000|Double-blind Period|Withdrawal by Subject|1
2262952|NCT02154347|3934684|FG001|Double-blind Period|Withdrawal by Subject|1
2262953|NCT02154347|3934683|FG000|Open-label Period|Adverse Event|3
2262954|NCT02154347|3934684|FG001|Open-label Period|Adverse Event|4
2262955|NCT02154347|3934683|FG000|Open-label Period|Lack of Efficacy|4
2262956|NCT02154347|3934684|FG001|Open-label Period|Lack of Efficacy|19
2262957|NCT02154347|3934683|FG000|Open-label Period|Protocol Violation|0
2262958|NCT02154347|3934684|FG001|Open-label Period|Protocol Violation|1
2262959|NCT02154347|3934683|FG000|Open-label Period|Withdrawal by Subject|0
2262960|NCT02154347|3934684|FG001|Open-label Period|Withdrawal by Subject|1
2262961|NCT02154425|3934700|FG000|Screening Period|Adverse Event|1
2262962|NCT02154581|3934719|FG000|Overall Study|Lost to Follow-up|7
2262963|NCT02154581|3934720|FG001|Overall Study|Lost to Follow-up|8
2262964|NCT02155283|3934783|FG000|Overall Study|Lost to Follow-up|3
2262965|NCT02155283|3934783|FG000|Overall Study|Withdrawal by Subject|1
2262966|NCT02155283|3934783|FG000|Overall Study|Protocol Violation|3
2262967|NCT02155309|3934789|FG000|Overall Study|Protocol Violation|0
2262968|NCT02155309|3934790|FG001|Overall Study|Protocol Violation|0
2262969|NCT02155309|3934791|FG002|Overall Study|Protocol Violation|1
2262970|NCT02155322|3934798|FG000|Overall Study|Adverse Event|1
2262971|NCT02155322|3934798|FG000|Overall Study|Physician Decision|1
2262972|NCT02155322|3934798|FG000|Overall Study|Relapse/Recurrence|8
2262973|NCT02155322|3934798|FG000|Overall Study|Withdrawal by Subject|4
2262974|NCT02155608|3934867|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
2262975|NCT02155608|3934868|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
2262976|NCT02155608|3934867|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
2262977|NCT02155608|3934868|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
2262978|NCT02155647|3934882|FG000|Overall Study|Still on Treatment|26
2262979|NCT02155647|3934883|FG001|Overall Study|Still on Treatment|26
2262980|NCT02155647|3934882|FG000|Overall Study|Off-Treatment, but follow up ongoing|15
2262981|NCT02155647|3934883|FG001|Overall Study|Off-Treatment, but follow up ongoing|26
2346437|NCT03627767|4083544|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
2346438|NCT03627767|4083540|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
2346439|NCT03627767|4083541|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
2346440|NCT03627767|4083542|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1
2346441|NCT03627767|4083543|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
2346442|NCT03627767|4083544|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
2346443|NCT03627767|4083540|FG000|Double-blind Treatment Period (40 Weeks)|Other|0
2346444|NCT03627767|4083541|FG001|Double-blind Treatment Period (40 Weeks)|Other|0
2346445|NCT03627767|4083542|FG002|Double-blind Treatment Period (40 Weeks)|Other|1
2346446|NCT03627767|4083543|FG003|Double-blind Treatment Period (40 Weeks)|Other|1
2346447|NCT03627767|4083544|FG004|Double-blind Treatment Period (40 Weeks)|Other|0
2346448|NCT03627767|4083540|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0
2346449|NCT03627767|4083541|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0
2346450|NCT03627767|4083542|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0
2346451|NCT03627767|4083543|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0
2346452|NCT03627767|4083544|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9
2346453|NCT03627767|4083540|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
2346454|NCT03627767|4083541|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
2346455|NCT03627767|4083542|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
2346456|NCT03627767|4083543|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
2346457|NCT03627767|4083544|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1
2346458|NCT03627767|4083540|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
2346459|NCT03627767|4083541|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
2346460|NCT03627767|4083542|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
2346461|NCT03627767|4083543|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
2262982|NCT02155660|3934893|FG000|Overall Study|Other Reason|8
2262983|NCT02155660|3934894|FG001|Overall Study|Other Reason|6
2262984|NCT02155660|3934895|FG002|Overall Study|Other Reason|10
2262985|NCT02155660|3934896|FG003|Overall Study|Other Reason|10
2346462|NCT03627767|4083544|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9
2346463|NCT03627767|4083540|FG000|Open-label Rescue Period (12 Weeks)|Other|0
2346464|NCT03627767|4083541|FG001|Open-label Rescue Period (12 Weeks)|Other|0
2346465|NCT03627767|4083542|FG002|Open-label Rescue Period (12 Weeks)|Other|0
2346466|NCT03627767|4083543|FG003|Open-label Rescue Period (12 Weeks)|Other|0
2346467|NCT03627767|4083544|FG004|Open-label Rescue Period (12 Weeks)|Other|1
2346468|NCT03627832|4083557|FG000|Overall Study|Withdrawal by Subject|10
2346469|NCT03627832|4083558|FG001|Overall Study|Withdrawal by Subject|1
2346470|NCT03628417|4083564|FG000|Overall Study|Death|1
2346471|NCT03628417|4083565|FG001|Overall Study|Death|1
2346472|NCT03628508|4083583|FG000|Overall Study|Lost to Follow-up|1
2346473|NCT03628599|4083589|FG000|Overall Study|Adverse Event|0
2346474|NCT03628599|4083590|FG001|Overall Study|Adverse Event|1
2346475|NCT03628898|4083613|FG000|Overall Study|Device deficiency|1
2346476|NCT03628924|4083620|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2
2346477|NCT03628924|4083621|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
2346478|NCT03628924|4083622|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
2346479|NCT03628924|4083623|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
2346480|NCT03628924|4083624|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
2346481|NCT03628924|4083625|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
2346482|NCT03628924|4083626|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
2346483|NCT03628924|4083620|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2346484|NCT03628924|4083621|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2346485|NCT03628924|4083622|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
2346486|NCT03628924|4083623|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2346487|NCT03628924|4083624|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2346488|NCT03628924|4083625|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2346489|NCT03628924|4083626|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2346490|NCT03628924|4083620|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
2346491|NCT03628924|4083621|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2
2346492|NCT03628924|4083622|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
2346493|NCT03628924|4083623|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
2346494|NCT03628924|4083624|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
2346495|NCT03628924|4083625|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
2346496|NCT03628924|4083626|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
2346497|NCT03628924|4083620|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2346498|NCT03628924|4083621|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
2346499|NCT03628924|4083622|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2346500|NCT03628924|4083623|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2346501|NCT03628924|4083624|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2346502|NCT03628924|4083625|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2346503|NCT03628924|4083626|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2346504|NCT03628924|4083620|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3
2346505|NCT03628924|4083621|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
2346506|NCT03628924|4083622|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1
2346507|NCT03628924|4083623|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
2346508|NCT03628924|4083624|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
2346509|NCT03628924|4083625|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
2346510|NCT03628924|4083626|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
2346511|NCT03628924|4083620|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
2346512|NCT03628924|4083621|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
2346513|NCT03628924|4083622|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
2346514|NCT03628924|4083623|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
2346515|NCT03628924|4083624|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
2346516|NCT03628924|4083625|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2
2346517|NCT03628924|4083626|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
2346518|NCT03628924|4083620|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0
2346519|NCT03628924|4083621|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0
2346520|NCT03628924|4083622|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0
2346521|NCT03628924|4083623|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1
2346522|NCT03628924|4083624|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0
2346523|NCT03628924|4083625|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2
2346524|NCT03628924|4083626|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4
2346525|NCT03628924|4083620|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0
2346526|NCT03628924|4083621|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0
2346527|NCT03628924|4083622|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0
2346528|NCT03628924|4083623|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1
2346529|NCT03628924|4083624|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1
2346530|NCT03628924|4083625|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0
2262986|NCT02155660|3934893|FG000|Overall Study|Study-specific withdrawal criteria|0
2262987|NCT02155660|3934894|FG001|Overall Study|Study-specific withdrawal criteria|1
2262988|NCT02155660|3934895|FG002|Overall Study|Study-specific withdrawal criteria|1
2262989|NCT02155660|3934896|FG003|Overall Study|Study-specific withdrawal criteria|1
2262990|NCT02155660|3934893|FG000|Overall Study|Severe non-compliance|0
2262991|NCT02155660|3934894|FG001|Overall Study|Severe non-compliance|4
2262992|NCT02155660|3934895|FG002|Overall Study|Severe non-compliance|0
2262993|NCT02155660|3934896|FG003|Overall Study|Severe non-compliance|1
2262994|NCT02155660|3934893|FG000|Overall Study|Adverse Event|2
2262995|NCT02155660|3934894|FG001|Overall Study|Adverse Event|6
2262996|NCT02155660|3934895|FG002|Overall Study|Adverse Event|3
2262997|NCT02155660|3934896|FG003|Overall Study|Adverse Event|1
2262998|NCT02155660|3934893|FG000|Overall Study|Lost to Follow-up|3
2262999|NCT02155660|3934894|FG001|Overall Study|Lost to Follow-up|6
2263000|NCT02155660|3934895|FG002|Overall Study|Lost to Follow-up|5
2263001|NCT02155660|3934896|FG003|Overall Study|Lost to Follow-up|8
2263002|NCT02155660|3934893|FG000|Overall Study|Death|17
2263003|NCT02155660|3934894|FG001|Overall Study|Death|19
2263004|NCT02155660|3934895|FG002|Overall Study|Death|17
2263005|NCT02155660|3934896|FG003|Overall Study|Death|19
2263006|NCT02155660|3934893|FG000|Overall Study|Withdrawal by Subject|28
2263007|NCT02155660|3934894|FG001|Overall Study|Withdrawal by Subject|31
2263008|NCT02155660|3934895|FG002|Overall Study|Withdrawal by Subject|24
2263009|NCT02155660|3934896|FG003|Overall Study|Withdrawal by Subject|21
2263010|NCT02155712|3934908|FG000|Primary Objective|Death|3
2263011|NCT02155712|3934909|FG001|Primary Objective|Death|0
2263012|NCT02155712|3934908|FG000|Primary Objective|Lost to Follow-up|22
2263013|NCT02155712|3934909|FG001|Primary Objective|Lost to Follow-up|0
2263014|NCT02155712|3934908|FG000|Primary Objective|No 2-Year Forms but not Terminated|13
2263015|NCT02155712|3934909|FG001|Primary Objective|No 2-Year Forms but not Terminated|0
2263016|NCT02155712|3934908|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1
2263017|NCT02155712|3934909|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0
2263018|NCT02155712|3934908|FG000|Primary Objective|Withdrawal by Subject|21
2263019|NCT02155712|3934909|FG001|Primary Objective|Withdrawal by Subject|0
2263020|NCT02155738|3934934|FG000|Overall Study|Missing critical information|1
2263021|NCT02155738|3934935|FG001|Overall Study|Missing critical information|0
2263022|NCT02155738|3934936|FG002|Overall Study|Missing critical information|0
2263023|NCT02155738|3934937|FG003|Overall Study|Missing critical information|1
2263024|NCT02155829|3934949|FG000|Overall Study|Adverse Event|1
2263025|NCT02155829|3934950|FG001|Overall Study|Adverse Event|0
2263026|NCT02155829|3934949|FG000|Overall Study|Withdrawal by Subject|3
2263027|NCT02155829|3934950|FG001|Overall Study|Withdrawal by Subject|3
2263028|NCT02155829|3934949|FG000|Overall Study|Protocol Violation|2
2263029|NCT02155829|3934950|FG001|Overall Study|Protocol Violation|0
2263030|NCT02155881|3934959|FG000|Overall Study|Withdrawal by Subject|0
2263031|NCT02155881|3934960|FG001|Overall Study|Withdrawal by Subject|2
2263032|NCT02155881|3934959|FG000|Overall Study|Inappropriately randomized|2
2263033|NCT02155881|3934960|FG001|Overall Study|Inappropriately randomized|2
2263034|NCT02155985|3934969|FG000|Overall Study|Withdrawal by Subject|0
2263035|NCT02155985|3934970|FG001|Overall Study|Withdrawal by Subject|0
2263036|NCT02155985|3934971|FG002|Overall Study|Withdrawal by Subject|1
2263037|NCT02155985|3934969|FG000|Overall Study|Lost to Follow-up|1
2263038|NCT02155985|3934970|FG001|Overall Study|Lost to Follow-up|0
2263039|NCT02155985|3934971|FG002|Overall Study|Lost to Follow-up|0
2263040|NCT02156076|3934983|FG000|Treatment Period|no longer meets study criteria|0
2263041|NCT02156076|3934984|FG001|Treatment Period|no longer meets study criteria|0
2346531|NCT03628924|4083626|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1
2346532|NCT03628924|4083620|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
2346533|NCT03628924|4083621|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
2346534|NCT03628924|4083622|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
2346535|NCT03628924|4083623|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5
2346536|NCT03628924|4083624|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1
2346537|NCT03628924|4083625|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4
2346538|NCT03628924|4083626|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2
2346539|NCT03628924|4083620|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
2346540|NCT03628924|4083621|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
2346541|NCT03628924|4083622|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
2346542|NCT03628924|4083623|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
2346543|NCT03628924|4083624|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1
2346544|NCT03628924|4083625|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5
2346545|NCT03628924|4083626|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3
2346546|NCT03629028|4083640|FG000|Overall Study|Lost to Follow-up|26
2346547|NCT03629028|4083641|FG001|Overall Study|Lost to Follow-up|23
2346548|NCT03629028|4083640|FG000|Overall Study|Pregnancy|4
2346549|NCT03629028|4083641|FG001|Overall Study|Pregnancy|2
2346550|NCT03629028|4083640|FG000|Overall Study|intolerance to examination|2
2346551|NCT03629028|4083641|FG001|Overall Study|intolerance to examination|0
2346552|NCT03629041|4083657|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
2263042|NCT02156076|3934985|FG002|Treatment Period|no longer meets study criteria|1
2263043|NCT02156076|3934986|FG003|Treatment Period|no longer meets study criteria|0
2263044|NCT02156076|3934983|FG000|Treatment Period|Poor/non-compliance|0
2263045|NCT02156076|3934984|FG001|Treatment Period|Poor/non-compliance|1
2263046|NCT02156076|3934985|FG002|Treatment Period|Poor/non-compliance|0
2263047|NCT02156076|3934986|FG003|Treatment Period|Poor/non-compliance|0
2263048|NCT02156076|3934983|FG000|Treatment Period|Lost to Follow-up|0
2263049|NCT02156076|3934984|FG001|Treatment Period|Lost to Follow-up|0
2263050|NCT02156076|3934985|FG002|Treatment Period|Lost to Follow-up|0
2263051|NCT02156076|3934986|FG003|Treatment Period|Lost to Follow-up|1
2263052|NCT02156076|3934983|FG000|Treatment Period|Withdrawal by Subject|0
2263053|NCT02156076|3934984|FG001|Treatment Period|Withdrawal by Subject|0
2263054|NCT02156076|3934985|FG002|Treatment Period|Withdrawal by Subject|1
2263055|NCT02156076|3934986|FG003|Treatment Period|Withdrawal by Subject|0
2263056|NCT02156076|3934983|FG000|Treatment Period|Subject request to discontinue treatment|0
2263057|NCT02156076|3934984|FG001|Treatment Period|Subject request to discontinue treatment|1
2263058|NCT02156076|3934985|FG002|Treatment Period|Subject request to discontinue treatment|0
2263059|NCT02156076|3934986|FG003|Treatment Period|Subject request to discontinue treatment|0
2263060|NCT02156076|3934983|FG000|Treatment Period|Adverse Event|0
2263061|NCT02156076|3934984|FG001|Treatment Period|Adverse Event|0
2263062|NCT02156076|3934985|FG002|Treatment Period|Adverse Event|0
2263063|NCT02156076|3934986|FG003|Treatment Period|Adverse Event|1
2263064|NCT02156076|3934983|FG000|Follow-up Period|Withdrawal by Subject|1
2263065|NCT02156076|3934984|FG001|Follow-up Period|Withdrawal by Subject|0
2263066|NCT02156076|3934985|FG002|Follow-up Period|Withdrawal by Subject|0
2263067|NCT02156076|3934986|FG003|Follow-up Period|Withdrawal by Subject|0
2346553|NCT03629041|4083658|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
2346554|NCT03629041|4083659|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
2346555|NCT03629041|4083660|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
2346556|NCT03629054|4083680|FG000|Period 2 (4 Days)|Not treated|0
2346557|NCT03629054|4083681|FG001|Period 2 (4 Days)|Not treated|1
2346558|NCT03629184|4083689|FG000|Overall Study|Withdrawal by Subject|2
2346559|NCT03629184|4083690|FG001|Overall Study|Withdrawal by Subject|1
2346560|NCT03629184|4083689|FG000|Overall Study|Physician Decision|1
2346561|NCT03629184|4083690|FG001|Overall Study|Physician Decision|0
2346562|NCT03629249|4083699|FG000|Overall Study|Study terminated by sponsor|197
2346563|NCT03629249|4083700|FG001|Overall Study|Study terminated by sponsor|197
2346564|NCT03629249|4083701|FG002|Overall Study|Study terminated by sponsor|194
2346565|NCT03629249|4083699|FG000|Overall Study|Protocol deviation|0
2346566|NCT03629249|4083700|FG001|Overall Study|Protocol deviation|2
2346567|NCT03629249|4083701|FG002|Overall Study|Protocol deviation|5
2346568|NCT03629249|4083699|FG000|Overall Study|Subject decision|1
2346569|NCT03629249|4083700|FG001|Overall Study|Subject decision|1
2346570|NCT03629249|4083701|FG002|Overall Study|Subject decision|3
2346571|NCT03629249|4083699|FG000|Overall Study|Adverse Event|1
2346572|NCT03629249|4083700|FG001|Overall Study|Adverse Event|1
2346573|NCT03629249|4083701|FG002|Overall Study|Adverse Event|0
2346574|NCT03629249|4083699|FG000|Overall Study|Death|1
2346575|NCT03629249|4083700|FG001|Overall Study|Death|0
2346576|NCT03629249|4083701|FG002|Overall Study|Death|0
2346577|NCT03629249|4083699|FG000|Overall Study|Physician Decision|1
2346578|NCT03629249|4083700|FG001|Overall Study|Physician Decision|0
2346579|NCT03629249|4083701|FG002|Overall Study|Physician Decision|0
2346580|NCT03629886|4083715|FG000|Overall Study|Migrated / moved from the study area|0
2346581|NCT03629886|4083716|FG001|Overall Study|Migrated / moved from the study area|55
2346582|NCT03629886|4083715|FG000|Overall Study|Consent withdrawal, not due to an AE|0
2346583|NCT03629886|4083716|FG001|Overall Study|Consent withdrawal, not due to an AE|50
2346584|NCT03629886|4083715|FG000|Overall Study|Study vaccine not administrated|0
2346585|NCT03629886|4083716|FG001|Overall Study|Study vaccine not administrated|3
2346586|NCT03629886|4083715|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0
2346587|NCT03629886|4083716|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28
2346588|NCT03629886|4083715|FG000|Overall Study|Refused vaccination step of the study|0
2346589|NCT03629886|4083716|FG001|Overall Study|Refused vaccination step of the study|44
2346590|NCT03630016|4083732|FG000|Overall Study|Poor Sensor Placement|1
2346591|NCT03630302|4083754|FG000|Surgery|hardware issue prevented LFP recordings|1
2346592|NCT03630302|4083754|FG000|3 Month Visit|Adverse Event|2
2346593|NCT03630302|4083754|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2
2346594|NCT03631355|4083769|FG000|Overall Study|Lost to Follow-up|1
2346595|NCT03631355|4083770|FG001|Overall Study|Lost to Follow-up|2
2346596|NCT03631732|4083787|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3
2346597|NCT03631732|4083788|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0
2346598|NCT03631732|4083787|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1
2346599|NCT03631732|4083788|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2
2346600|NCT03631732|4083787|FG000|Randomized Phase Up to Week 24|Adverse Event|2
2346601|NCT03631732|4083788|FG001|Randomized Phase Up to Week 24|Adverse Event|0
2346602|NCT03631732|4083787|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1
2346603|NCT03631732|4083788|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0
2346604|NCT03631732|4083787|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6
2346605|NCT03631732|4083788|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1
2346606|NCT03631732|4083787|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
2263068|NCT02156271|3935024|FG000|Overall Study|Physician Decision|4
2263069|NCT02156271|3935025|FG001|Overall Study|Physician Decision|3
2263070|NCT02156466|3935036|FG000|Overall Study|Adverse Event|0
2263071|NCT02156466|3935037|FG001|Overall Study|Adverse Event|0
2263072|NCT02156466|3935038|FG002|Overall Study|Adverse Event|1
2263073|NCT02156466|3935039|FG003|Overall Study|Adverse Event|1
2263074|NCT02156466|3935040|FG004|Overall Study|Adverse Event|0
2263075|NCT02156466|3935036|FG000|Overall Study|Quantiferon Positivity|0
2263076|NCT02156466|3935037|FG001|Overall Study|Quantiferon Positivity|0
2263077|NCT02156466|3935038|FG002|Overall Study|Quantiferon Positivity|0
2263078|NCT02156466|3935039|FG003|Overall Study|Quantiferon Positivity|1
2263079|NCT02156466|3935040|FG004|Overall Study|Quantiferon Positivity|0
2263080|NCT02156492|3935064|FG000|Period 1|No Reason Given|0
2263081|NCT02156492|3935065|FG001|Period 1|No Reason Given|1
2263082|NCT02156492|3935066|FG002|Period 1|No Reason Given|0
2263083|NCT02156492|3935064|FG000|Period 3|Adverse Event|0
2263084|NCT02156492|3935065|FG001|Period 3|Adverse Event|1
2263085|NCT02156492|3935066|FG002|Period 3|Adverse Event|0
2263086|NCT02156804|3935097|FG000|Overall Study|Withdrawal by Subject|1
2263087|NCT02157298|3935133|FG000|Overall Study|Adverse Event|1
2263088|NCT02157298|3935134|FG001|Overall Study|Adverse Event|0
2263089|NCT02157298|3935133|FG000|Overall Study|Subject no longer meets study criteria|1
2263090|NCT02157298|3935134|FG001|Overall Study|Subject no longer meets study criteria|2
2263091|NCT02157298|3935133|FG000|Overall Study|Poor/Non-compliance|1
2263092|NCT02157298|3935134|FG001|Overall Study|Poor/Non-compliance|0
2263093|NCT02157298|3935133|FG000|Overall Study|Withdrawal by Subject|1
2263094|NCT02157298|3935134|FG001|Overall Study|Withdrawal by Subject|0
2263095|NCT02157376|3935142|FG000|Overall Study|Death|10
2263096|NCT02157376|3935143|FG001|Overall Study|Death|4
2263097|NCT02157376|3935142|FG000|Overall Study|Eligibility criteria not fulfilled|0
2263098|NCT02157376|3935143|FG001|Overall Study|Eligibility criteria not fulfilled|1
2263099|NCT02157376|3935142|FG000|Overall Study|Withdrawal by Subject|3
2263100|NCT02157376|3935143|FG001|Overall Study|Withdrawal by Subject|8
2263101|NCT02157376|3935142|FG000|Overall Study|Not treated|8
2263102|NCT02157376|3935143|FG001|Overall Study|Not treated|3
2263103|NCT02157376|3935142|FG000|Overall Study|Investigator's misjudgement|1
2263104|NCT02157376|3935143|FG001|Overall Study|Investigator's misjudgement|2
2263105|NCT02157506|3935154|FG000|Overall Study|Adverse Event|0
2263106|NCT02157506|3935155|FG001|Overall Study|Adverse Event|1
2263107|NCT02157506|3935156|FG002|Overall Study|Adverse Event|0
2263108|NCT02157506|3935157|FG003|Overall Study|Adverse Event|0
2263109|NCT02157506|3935158|FG004|Overall Study|Adverse Event|0
2263110|NCT02157506|3935154|FG000|Overall Study|Lost to Follow-up|0
2263111|NCT02157506|3935155|FG001|Overall Study|Lost to Follow-up|0
2263112|NCT02157506|3935156|FG002|Overall Study|Lost to Follow-up|1
2263113|NCT02157506|3935157|FG003|Overall Study|Lost to Follow-up|0
2263114|NCT02157506|3935158|FG004|Overall Study|Lost to Follow-up|0
2263115|NCT02157519|3935172|FG000|Overall Study|Death|3
2263116|NCT02157519|3935173|FG001|Overall Study|Death|1
2263117|NCT02157519|3935172|FG000|Overall Study|Withdrawal by Subject|7
2263118|NCT02157519|3935173|FG001|Overall Study|Withdrawal by Subject|0
2263119|NCT02157519|3935172|FG000|Overall Study|Lost to Follow-up|1
2263120|NCT02157519|3935173|FG001|Overall Study|Lost to Follow-up|0
2263121|NCT02157779|3935191|FG000|Overall Study|Logistical|9
2263122|NCT02157779|3935192|FG001|Overall Study|Logistical|3
2263123|NCT02157779|3935191|FG000|Overall Study|Stopped attending, reason unknown|11
2263124|NCT02157779|3935192|FG001|Overall Study|Stopped attending, reason unknown|7
2263125|NCT02157779|3935191|FG000|Overall Study|No response to outreach after Baseline|1
2263126|NCT02157779|3935192|FG001|Overall Study|No response to outreach after Baseline|1
2263127|NCT02157779|3935191|FG000|Overall Study|Moved|1
2263128|NCT02157779|3935192|FG001|Overall Study|Moved|0
2263129|NCT02157779|3935191|FG000|Overall Study|Medical|1
2263130|NCT02157779|3935192|FG001|Overall Study|Medical|0
2263131|NCT02157779|3935191|FG000|Overall Study|Legal issue|1
2263132|NCT02157779|3935192|FG001|Overall Study|Legal issue|0
2263133|NCT02157935|3935213|FG000|Overall Study|Withdrawal by Subject|25
2263134|NCT02157935|3935214|FG001|Overall Study|Withdrawal by Subject|39
2263135|NCT02157935|3935213|FG000|Overall Study|Screen failure|1
2263136|NCT02157935|3935214|FG001|Overall Study|Screen failure|2
2263137|NCT02157935|3935213|FG000|Overall Study|Protocol Violation|1
2263138|NCT02157935|3935214|FG001|Overall Study|Protocol Violation|0
2263139|NCT02157935|3935213|FG000|Overall Study|Progressive disease|0
2263140|NCT02157935|3935214|FG001|Overall Study|Progressive disease|2
2263141|NCT02157935|3935213|FG000|Overall Study|Other|5
2346607|NCT03631732|4083788|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
2346608|NCT03631732|4083787|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4
2346609|NCT03631732|4083788|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1
2346610|NCT03631732|4083787|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1
2346611|NCT03631732|4083788|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0
2346612|NCT03631732|4083787|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1
2346613|NCT03631732|4083788|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0
2346614|NCT03631732|4083787|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1
2263142|NCT02157935|3935214|FG001|Overall Study|Other|12
2263143|NCT02157935|3935213|FG000|Overall Study|Lack of Efficacy|0
2263144|NCT02157935|3935214|FG001|Overall Study|Lack of Efficacy|1
2263145|NCT02157935|3935213|FG000|Overall Study|Death|4
2263146|NCT02157935|3935214|FG001|Overall Study|Death|4
2263147|NCT02157935|3935213|FG000|Overall Study|Adverse Event|3
2263148|NCT02157935|3935214|FG001|Overall Study|Adverse Event|5
2263149|NCT02157948|3935222|FG000|Overall Study|Withdrawal by Subject|4
2263150|NCT02157948|3935223|FG001|Overall Study|Withdrawal by Subject|5
2263151|NCT02157948|3935222|FG000|Overall Study|Lost to Follow-up|3
2263152|NCT02157948|3935223|FG001|Overall Study|Lost to Follow-up|2
2263153|NCT02157948|3935222|FG000|Overall Study|Protocol Specified Criteria|2
2263154|NCT02157948|3935223|FG001|Overall Study|Protocol Specified Criteria|1
2263155|NCT02157948|3935222|FG000|Overall Study|Decision by Sponsor|0
2263156|NCT02157948|3935223|FG001|Overall Study|Decision by Sponsor|1
2263157|NCT02158039|3935229|FG000|Overall Study|Withdrawal by Subject|1
2263158|NCT02158039|3935229|FG000|Overall Study|Screen Failure|9
2263159|NCT02158091|3935236|FG000|Overall Study|DLT|2
2263160|NCT02158091|3935237|FG001|Overall Study|DLT|1
2263161|NCT02158091|3935238|FG002|Overall Study|DLT|0
2263162|NCT02158247|3935248|FG000|Overall Study|Invisible vocal cords|5
2263163|NCT02158364|3935273|FG000|Overall Study|Case report forms uncollected|10
2263164|NCT02158364|3935273|FG000|Overall Study|Protocol Deviation|50
2263165|NCT02158442|3935279|FG000|Overall Study|Withdrawal by Subject|1
2263166|NCT02158442|3935280|FG001|Overall Study|Withdrawal by Subject|0
2263167|NCT02158442|3935279|FG000|Overall Study|Perfusion staff not available|1
2263168|NCT02158442|3935280|FG001|Overall Study|Perfusion staff not available|0
2263169|NCT02158533|3935314|FG000|Stage 1|Adverse Event|6
2263170|NCT02158533|3935315|FG001|Stage 1|Adverse Event|4
2263171|NCT02158533|3935316|FG002|Stage 1|Adverse Event|7
2263172|NCT02158533|3935317|FG003|Stage 1|Adverse Event|0
2263173|NCT02158533|3935318|FG004|Stage 1|Adverse Event|0
2263174|NCT02158533|3935319|FG005|Stage 1|Adverse Event|0
2263175|NCT02158533|3935314|FG000|Stage 1|Withdrawal by Subject|3
2263176|NCT02158533|3935315|FG001|Stage 1|Withdrawal by Subject|2
2263177|NCT02158533|3935316|FG002|Stage 1|Withdrawal by Subject|1
2263178|NCT02158533|3935317|FG003|Stage 1|Withdrawal by Subject|0
2263179|NCT02158533|3935318|FG004|Stage 1|Withdrawal by Subject|0
2263180|NCT02158533|3935319|FG005|Stage 1|Withdrawal by Subject|0
2263181|NCT02158533|3935314|FG000|Stage 1|Lack of Efficacy|1
2263182|NCT02158533|3935315|FG001|Stage 1|Lack of Efficacy|0
2263183|NCT02158533|3935316|FG002|Stage 1|Lack of Efficacy|0
2263184|NCT02158533|3935317|FG003|Stage 1|Lack of Efficacy|0
2263185|NCT02158533|3935318|FG004|Stage 1|Lack of Efficacy|0
2263186|NCT02158533|3935319|FG005|Stage 1|Lack of Efficacy|0
2263187|NCT02158533|3935314|FG000|Stage 1|Lost to Follow-up|3
2263188|NCT02158533|3935315|FG001|Stage 1|Lost to Follow-up|1
2263189|NCT02158533|3935316|FG002|Stage 1|Lost to Follow-up|0
2263190|NCT02158533|3935317|FG003|Stage 1|Lost to Follow-up|0
2263191|NCT02158533|3935318|FG004|Stage 1|Lost to Follow-up|0
2263192|NCT02158533|3935319|FG005|Stage 1|Lost to Follow-up|0
2263193|NCT02158533|3935314|FG000|Stage 1|Failure to Meet Eligibility Criteria|0
2263194|NCT02158533|3935315|FG001|Stage 1|Failure to Meet Eligibility Criteria|1
2263195|NCT02158533|3935316|FG002|Stage 1|Failure to Meet Eligibility Criteria|0
2346615|NCT03631732|4083788|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0
2346616|NCT03633331|4083845|FG000|Overall Study|Withdrawal by Subject|1
2346617|NCT03633825|4083883|FG000|Enrollment|Did not post on network|5066
2346618|NCT03633825|4083884|FG001|Enrollment|Did not post on network|5080
2346619|NCT03633825|4083883|FG000|Enrollment|Post not classified as crisis|13967
2263196|NCT02158533|3935317|FG003|Stage 1|Failure to Meet Eligibility Criteria|0
2263197|NCT02158533|3935318|FG004|Stage 1|Failure to Meet Eligibility Criteria|0
2263198|NCT02158533|3935319|FG005|Stage 1|Failure to Meet Eligibility Criteria|0
2263199|NCT02158533|3935314|FG000|Stage 1|Non-compliance with study visits|1
2263200|NCT02158533|3935315|FG001|Stage 1|Non-compliance with study visits|0
2263201|NCT02158533|3935316|FG002|Stage 1|Non-compliance with study visits|0
2263202|NCT02158533|3935317|FG003|Stage 1|Non-compliance with study visits|0
2263203|NCT02158533|3935318|FG004|Stage 1|Non-compliance with study visits|0
2263204|NCT02158533|3935319|FG005|Stage 1|Non-compliance with study visits|0
2263205|NCT02158533|3935314|FG000|Stage 2|Adverse Event|0
2263206|NCT02158533|3935315|FG001|Stage 2|Adverse Event|0
2263207|NCT02158533|3935316|FG002|Stage 2|Adverse Event|0
2263208|NCT02158533|3935317|FG003|Stage 2|Adverse Event|0
2263209|NCT02158533|3935318|FG004|Stage 2|Adverse Event|0
2263210|NCT02158533|3935319|FG005|Stage 2|Adverse Event|1
2263211|NCT02158533|3935314|FG000|Stage 2|Lack of Efficacy|0
2263212|NCT02158533|3935315|FG001|Stage 2|Lack of Efficacy|0
2263213|NCT02158533|3935316|FG002|Stage 2|Lack of Efficacy|0
2263214|NCT02158533|3935317|FG003|Stage 2|Lack of Efficacy|0
2263215|NCT02158533|3935318|FG004|Stage 2|Lack of Efficacy|1
2263216|NCT02158533|3935319|FG005|Stage 2|Lack of Efficacy|0
2263217|NCT02158533|3935314|FG000|Stage 2|Lost to Follow-up|0
2263218|NCT02158533|3935315|FG001|Stage 2|Lost to Follow-up|0
2263219|NCT02158533|3935316|FG002|Stage 2|Lost to Follow-up|0
2263220|NCT02158533|3935317|FG003|Stage 2|Lost to Follow-up|1
2263221|NCT02158533|3935318|FG004|Stage 2|Lost to Follow-up|1
2263222|NCT02158533|3935319|FG005|Stage 2|Lost to Follow-up|2
2263223|NCT02158533|3935314|FG000|Stage 2|Withdrawal by Subject|0
2263224|NCT02158533|3935315|FG001|Stage 2|Withdrawal by Subject|0
2263225|NCT02158533|3935316|FG002|Stage 2|Withdrawal by Subject|0
2263226|NCT02158533|3935317|FG003|Stage 2|Withdrawal by Subject|0
2263227|NCT02158533|3935318|FG004|Stage 2|Withdrawal by Subject|1
2263228|NCT02158533|3935319|FG005|Stage 2|Withdrawal by Subject|2
2263229|NCT02158533|3935314|FG000|Stage 2|Physician Decision|0
2263230|NCT02158533|3935315|FG001|Stage 2|Physician Decision|0
2263231|NCT02158533|3935316|FG002|Stage 2|Physician Decision|0
2263232|NCT02158533|3935317|FG003|Stage 2|Physician Decision|0
2263233|NCT02158533|3935318|FG004|Stage 2|Physician Decision|1
2263234|NCT02158533|3935319|FG005|Stage 2|Physician Decision|0
2263235|NCT02158533|3935314|FG000|Stage 2|Pregnancy|0
2263236|NCT02158533|3935315|FG001|Stage 2|Pregnancy|0
2263237|NCT02158533|3935316|FG002|Stage 2|Pregnancy|0
2263238|NCT02158533|3935317|FG003|Stage 2|Pregnancy|1
2263239|NCT02158533|3935318|FG004|Stage 2|Pregnancy|0
2263240|NCT02158533|3935319|FG005|Stage 2|Pregnancy|0
2263241|NCT02158533|3935314|FG000|Stage 2|Psychiatrist decision to try new tx|0
2263242|NCT02158533|3935315|FG001|Stage 2|Psychiatrist decision to try new tx|0
2263243|NCT02158533|3935316|FG002|Stage 2|Psychiatrist decision to try new tx|0
2263244|NCT02158533|3935317|FG003|Stage 2|Psychiatrist decision to try new tx|1
2263245|NCT02158533|3935318|FG004|Stage 2|Psychiatrist decision to try new tx|0
2263246|NCT02158533|3935319|FG005|Stage 2|Psychiatrist decision to try new tx|0
2263247|NCT02158533|3935314|FG000|Stage 2|Non-adherence with study visits|0
2263248|NCT02158533|3935315|FG001|Stage 2|Non-adherence with study visits|0
2263249|NCT02158533|3935316|FG002|Stage 2|Non-adherence with study visits|0
2263250|NCT02158533|3935317|FG003|Stage 2|Non-adherence with study visits|0
2263251|NCT02158533|3935318|FG004|Stage 2|Non-adherence with study visits|0
2263252|NCT02158533|3935319|FG005|Stage 2|Non-adherence with study visits|1
2263253|NCT02158546|3935337|FG000|Overall Study|Physician Decision|0
2263254|NCT02158546|3935338|FG001|Overall Study|Physician Decision|1
2263255|NCT02158546|3935339|FG002|Overall Study|Physician Decision|0
2263256|NCT02158546|3935340|FG003|Overall Study|Physician Decision|0
2263257|NCT02158546|3935337|FG000|Overall Study|Non-compliance|0
2263258|NCT02158546|3935338|FG001|Overall Study|Non-compliance|1
2263259|NCT02158546|3935339|FG002|Overall Study|Non-compliance|0
2263260|NCT02158546|3935340|FG003|Overall Study|Non-compliance|1
2263261|NCT02158546|3935337|FG000|Overall Study|Failure to meet eligibility criteria|0
2346620|NCT03633825|4083884|FG001|Enrollment|Post not classified as crisis|13757
2346621|NCT03633825|4083883|FG000|Follow up|Lost to Follow-up|478
2346622|NCT03633825|4083884|FG001|Follow up|Lost to Follow-up|450
2346623|NCT03633903|4083892|FG000|Overall Study|Withdrawal by Subject|1
2346624|NCT03633903|4083893|FG001|Overall Study|Withdrawal by Subject|2
2346625|NCT03633903|4083892|FG000|Overall Study|Lost to Follow-up|5
2346626|NCT03633903|4083893|FG001|Overall Study|Lost to Follow-up|5
2346627|NCT03633929|4083899|FG000|Overall Study|Lost to Follow-up|1
2346628|NCT03633929|4083899|FG000|Overall Study|Did not login to software. Did not participate|3
2346629|NCT03634085|4083905|FG000|Overall Study|Adverse Event|1
2346630|NCT03634085|4083906|FG001|Overall Study|Adverse Event|0
2346631|NCT03634085|4083905|FG000|Overall Study|Withdrawal by Subject|0
2346632|NCT03634085|4083906|FG001|Overall Study|Withdrawal by Subject|2
2346633|NCT03634579|4083932|FG000|Overall Study|study termination|9
2346634|NCT03634800|4083936|FG000|Overall Study|Adverse Event|1
2346635|NCT03634800|4083936|FG000|Overall Study|Disease Progression|4
2346636|NCT03634800|4083936|FG000|Overall Study|Withdrawal by Subject|1
2346637|NCT03635086|4083955|FG000|Overall Study|Withdrawal of consent|0
2346638|NCT03635086|4083956|FG001|Overall Study|Withdrawal of consent|0
2346639|NCT03635086|4083957|FG002|Overall Study|Withdrawal of consent|1
2346640|NCT03635086|4083958|FG003|Overall Study|Withdrawal of consent|0
2346641|NCT03635086|4083959|FG004|Overall Study|Withdrawal of consent|0
2346642|NCT03635086|4083955|FG000|Overall Study|Adverse Event|0
2346643|NCT03635086|4083956|FG001|Overall Study|Adverse Event|1
2346644|NCT03635086|4083957|FG002|Overall Study|Adverse Event|0
2346645|NCT03635086|4083958|FG003|Overall Study|Adverse Event|0
2346646|NCT03635086|4083959|FG004|Overall Study|Adverse Event|0
2346647|NCT03635086|4083955|FG000|Overall Study|Lost to Follow-up|1
2346648|NCT03635086|4083956|FG001|Overall Study|Lost to Follow-up|0
2346649|NCT03635086|4083957|FG002|Overall Study|Lost to Follow-up|0
2346650|NCT03635086|4083958|FG003|Overall Study|Lost to Follow-up|0
2346651|NCT03635086|4083959|FG004|Overall Study|Lost to Follow-up|0
2346652|NCT03635320|4083974|FG000|Overall Study|not implanted the device|1
2346653|NCT03635320|4083975|FG001|Overall Study|not implanted the device|2
2346654|NCT03635320|4083974|FG000|Overall Study|Withdrawal by Subject|11
2346655|NCT03635320|4083975|FG001|Overall Study|Withdrawal by Subject|6
2346656|NCT03635424|4083981|FG000|Overall Study|Adverse Event|1
2346657|NCT03635424|4083981|FG000|Overall Study|Death|1
2346658|NCT03635424|4083981|FG000|Overall Study|Device not implanted|1
2346659|NCT03635775|4083989|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
2346660|NCT03635775|4083990|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
2346661|NCT03635775|4083991|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
2346662|NCT03635775|4083992|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1
2263262|NCT02158546|3935338|FG001|Overall Study|Failure to meet eligibility criteria|1
2263263|NCT02158546|3935339|FG002|Overall Study|Failure to meet eligibility criteria|0
2263264|NCT02158546|3935340|FG003|Overall Study|Failure to meet eligibility criteria|0
2263265|NCT02158546|3935337|FG000|Overall Study|Lack of Efficacy|1
2346663|NCT03635957|4084002|FG000|Run-In Period|Lost to Follow-up|1
2346664|NCT03635957|4084002|FG000|Pegloticase + IMM Period|Lack of Efficacy|3
2346665|NCT03636893|4084038|FG000|Overall Study|Death|0
2263266|NCT02158546|3935338|FG001|Overall Study|Lack of Efficacy|1
2263267|NCT02158546|3935339|FG002|Overall Study|Lack of Efficacy|0
2263268|NCT02158546|3935340|FG003|Overall Study|Lack of Efficacy|0
2263269|NCT02158546|3935337|FG000|Overall Study|Adverse Event|2
2263270|NCT02158546|3935338|FG001|Overall Study|Adverse Event|2
2263271|NCT02158546|3935339|FG002|Overall Study|Adverse Event|0
2263272|NCT02158546|3935340|FG003|Overall Study|Adverse Event|0
2263273|NCT02158546|3935337|FG000|Overall Study|Withdrawal by Subject|6
2263274|NCT02158546|3935338|FG001|Overall Study|Withdrawal by Subject|2
2263275|NCT02158546|3935339|FG002|Overall Study|Withdrawal by Subject|1
2263276|NCT02158546|3935340|FG003|Overall Study|Withdrawal by Subject|0
2263277|NCT02158546|3935337|FG000|Overall Study|Lost to Follow-up|5
2263278|NCT02158546|3935338|FG001|Overall Study|Lost to Follow-up|4
2263279|NCT02158546|3935339|FG002|Overall Study|Lost to Follow-up|0
2263280|NCT02158546|3935340|FG003|Overall Study|Lost to Follow-up|1
2263281|NCT02158546|3935337|FG000|Overall Study|Site Excluded|5
2263282|NCT02158546|3935338|FG001|Overall Study|Site Excluded|5
2263283|NCT02158546|3935339|FG002|Overall Study|Site Excluded|3
2263284|NCT02158546|3935340|FG003|Overall Study|Site Excluded|4
2263285|NCT02158663|3935356|FG000|Overall Study|Withdrawal by Subject|5
2263286|NCT02158663|3935357|FG001|Overall Study|Withdrawal by Subject|4
2263287|NCT02158728|3935365|FG000|Overall Study|no procedure according to CIP done|3
2263288|NCT02158728|3935365|FG000|Overall Study|no qualified dataset|24
2263289|NCT02158806|3935371|FG000|Overall Study|Death|2
2263290|NCT02158806|3935372|FG001|Overall Study|Death|0
2263291|NCT02158806|3935371|FG000|Overall Study|Withdrawal by Subject|2
2263292|NCT02158806|3935372|FG001|Overall Study|Withdrawal by Subject|0
2263293|NCT02158806|3935371|FG000|Overall Study|Lost to Follow-up|0
2263294|NCT02158806|3935372|FG001|Overall Study|Lost to Follow-up|3
2263295|NCT02158806|3935371|FG000|Overall Study|Moved out of area|0
2263296|NCT02158806|3935372|FG001|Overall Study|Moved out of area|1
2263297|NCT02158806|3935371|FG000|Overall Study|Transferred to palliative care|0
2263298|NCT02158806|3935372|FG001|Overall Study|Transferred to palliative care|1
2263299|NCT02158884|3935378|FG000|Baseline Assessment|Missed performance assessment|3
2263300|NCT02158884|3935378|FG000|Baseline Assessment|Missed SMFA|1
2263301|NCT02158884|3935378|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6
2263302|NCT02158884|3935378|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
2263303|NCT02158884|3935378|FG000|6 Month Assessment|Missed SMFA|20
2263304|NCT02158884|3935378|FG000|12 Month Assessment|Missed SMFA|17
2263305|NCT02158936|3935385|FG000|Overall Study|Study closed/ terminated|57
2263306|NCT02158936|3935386|FG001|Overall Study|Study closed/ terminated|77
2263307|NCT02158936|3935385|FG000|Overall Study|Azacitidine tx discontinued|53
2263308|NCT02158936|3935386|FG001|Overall Study|Azacitidine tx discontinued|46
2263309|NCT02158936|3935385|FG000|Overall Study|Adverse Event|39
2263310|NCT02158936|3935386|FG001|Overall Study|Adverse Event|24
2263311|NCT02158936|3935385|FG000|Overall Study|Withdrawal by Subject|15
2263312|NCT02158936|3935386|FG001|Overall Study|Withdrawal by Subject|16
2263313|NCT02158936|3935385|FG000|Overall Study|Physician Decision|15
2263314|NCT02158936|3935386|FG001|Overall Study|Physician Decision|13
2263315|NCT02158936|3935385|FG000|Overall Study|Lost to Follow-up|0
2263316|NCT02158936|3935386|FG001|Overall Study|Lost to Follow-up|1
2263317|NCT02158949|3935394|FG000|Overall Study|Withdrawal by Subject|1
2263318|NCT02158949|3935395|FG001|Overall Study|Withdrawal by Subject|0
2263319|NCT02158949|3935394|FG000|Overall Study|Lost to Follow-up|5
2263320|NCT02158949|3935395|FG001|Overall Study|Lost to Follow-up|11
2263321|NCT02158975|3935401|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1
2263322|NCT02159053|3935409|FG000|Overall Study|Death|2
2263323|NCT02159053|3935410|FG001|Overall Study|Death|0
2263324|NCT02159053|3935411|FG002|Overall Study|Death|1
2263325|NCT02159053|3935409|FG000|Overall Study|Physician Decision|0
2263326|NCT02159053|3935410|FG001|Overall Study|Physician Decision|1
2263327|NCT02159053|3935411|FG002|Overall Study|Physician Decision|1
2263328|NCT02159053|3935409|FG000|Overall Study|Lack of Efficacy|3
2263329|NCT02159053|3935410|FG001|Overall Study|Lack of Efficacy|4
2346666|NCT03636893|4084039|FG001|Overall Study|Death|1
2346667|NCT03636893|4084038|FG000|Overall Study|Protocol Violation|0
2346668|NCT03636893|4084039|FG001|Overall Study|Protocol Violation|3
2346669|NCT03636893|4084038|FG000|Overall Study|Withdrawal by Subject|1
2346670|NCT03636893|4084039|FG001|Overall Study|Withdrawal by Subject|2
2346671|NCT03636893|4084038|FG000|Overall Study|Refusal to surgery|4
2346672|NCT03636893|4084039|FG001|Overall Study|Refusal to surgery|3
2346673|NCT03636893|4084038|FG000|Overall Study|Early surgery (for acute bleeding)|3
2346674|NCT03636893|4084039|FG001|Overall Study|Early surgery (for acute bleeding)|0
2346675|NCT03636893|4084038|FG000|Overall Study|Adverse Event|1
2346676|NCT03636893|4084039|FG001|Overall Study|Adverse Event|1
2346677|NCT03638635|4084115|FG000|Initial Hospitalization|Study terminated prematurely|0
2346678|NCT03638635|4084116|FG001|Initial Hospitalization|Study terminated prematurely|1
2346679|NCT03638635|4084115|FG000|Initial Hospitalization|Withdrawal by study personnel|0
2346680|NCT03638635|4084116|FG001|Initial Hospitalization|Withdrawal by study personnel|1
2346681|NCT03638635|4084115|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
2346682|NCT03638635|4084116|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
2346683|NCT03639311|4084132|FG000|Overall Study|Ongoing at the time of analysis|88
2263330|NCT02159053|3935411|FG002|Overall Study|Lack of Efficacy|7
2263331|NCT02159053|3935409|FG000|Overall Study|Adverse Event|7
2263332|NCT02159053|3935410|FG001|Overall Study|Adverse Event|6
2263333|NCT02159053|3935411|FG002|Overall Study|Adverse Event|5
2263334|NCT02159053|3935409|FG000|Overall Study|Participants/guardian decision|8
2263335|NCT02159053|3935410|FG001|Overall Study|Participants/guardian decision|10
2263336|NCT02159053|3935411|FG002|Overall Study|Participants/guardian decision|6
2263337|NCT02159183|3935441|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2
2263338|NCT02159183|3935442|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1
2263339|NCT02159183|3935441|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1
2263340|NCT02159183|3935442|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0
2263341|NCT02159183|3935441|FG000|Analysis After the 36 Months Follow-up|Death|0
2263342|NCT02159183|3935442|FG001|Analysis After the 36 Months Follow-up|Death|1
2263343|NCT02159183|3935441|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
2263344|NCT02159183|3935442|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
2263345|NCT02159183|3935441|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
2263346|NCT02159183|3935442|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
2263347|NCT02159352|3935450|FG000|Overall Study|Adverse Event|3
2263348|NCT02159352|3935451|FG001|Overall Study|Adverse Event|1
2263349|NCT02159352|3935450|FG000|Overall Study|Withdrawal by Subject|0
2263350|NCT02159352|3935451|FG001|Overall Study|Withdrawal by Subject|1
2263351|NCT02159365|3935476|FG000|Overall Study|Disease Progression|23
2263352|NCT02159365|3935476|FG000|Overall Study|Other reasons|11
2263353|NCT02159365|3935476|FG000|Overall Study|Administrative reason by Sponsor|9
2263354|NCT02159365|3935476|FG000|Overall Study|Adverse Event unrelated to study drug|9
2263355|NCT02159365|3935476|FG000|Overall Study|Study drug toxicity|7
2263356|NCT02159365|3935476|FG000|Overall Study|Maximum clinical benefit|3
2263357|NCT02159365|3935476|FG000|Overall Study|Subject request to discontinue treatment|3
2263358|NCT02159365|3935476|FG000|Overall Study|Subject withdrew consent|3
2263359|NCT02159365|3935476|FG000|Overall Study|Death|1
2263360|NCT02159365|3935476|FG000|Overall Study|Lost to Follow-up|1
2263361|NCT02159469|3935480|FG000|Overall Study|Missing Completion status|1
2263362|NCT02159469|3935480|FG000|Overall Study|Adverse Event|5
2263363|NCT02159469|3935480|FG000|Overall Study|Non-compliance|2
2263364|NCT02159469|3935480|FG000|Overall Study|Withdrawal by Subject|9
2263365|NCT02159469|3935480|FG000|Overall Study|Lost to Follow-up|1
2263366|NCT02159469|3935480|FG000|Overall Study|Sponsor's request|2
2263367|NCT02159469|3935480|FG000|Overall Study|Met Stopping Criteria|3
2263368|NCT02159469|3935480|FG000|Overall Study|Other|1
2263369|NCT02159469|3935480|FG000|Overall Study|Multiple|29
2263370|NCT02159482|3935485|FG000|Overall Study|Withdrawal by Subject|2
2263371|NCT02159482|3935485|FG000|Overall Study|Physician Decision|3
2263372|NCT02159521|3935489|FG000|Overall Study|Enrolled but not treated|3
2263373|NCT02159521|3935489|FG000|Overall Study|Withdrawal by Subject|7
2263374|NCT02159521|3935489|FG000|Overall Study|Lost to Follow-up|6
2263375|NCT02159521|3935489|FG000|Overall Study|Death|1
2263376|NCT02159521|3935489|FG000|Overall Study|Other than specified|1
2263377|NCT02159729|3935509|FG000|Overall Study|Adverse Event|0
2346684|NCT03639311|4084133|FG001|Overall Study|Ongoing at the time of analysis|0
2346685|NCT03639311|4084132|FG000|Overall Study|Lost to Follow-up|1
2346686|NCT03639311|4084133|FG001|Overall Study|Lost to Follow-up|0
2346687|NCT03639311|4084132|FG000|Overall Study|Adverse Event|1
2346688|NCT03639311|4084133|FG001|Overall Study|Adverse Event|0
2346689|NCT03639675|4084142|FG000|Overall Study|Withdrawal by Subject|1
2346690|NCT03639779|4084152|FG000|Overall Study|Lost to Follow-up|1
2346691|NCT03639987|4084170|FG000|Overall Study|Study terminated by sponsor|26
2346692|NCT03639987|4084171|FG001|Overall Study|Study terminated by sponsor|25
2346693|NCT03639987|4084170|FG000|Overall Study|Lost to Follow-up|0
2346694|NCT03639987|4084171|FG001|Overall Study|Lost to Follow-up|1
2346695|NCT03640052|4084177|FG000|Overall Study|Lost to Follow-up|0
2346696|NCT03640052|4084178|FG001|Overall Study|Lost to Follow-up|1
2346697|NCT03640052|4084179|FG002|Overall Study|Lost to Follow-up|0
2346698|NCT03640052|4084180|FG003|Overall Study|Lost to Follow-up|0
2346699|NCT03640052|4084181|FG004|Overall Study|Lost to Follow-up|0
2346700|NCT03640507|4084196|FG000|Overall Study|Withdrawal by Subject|0
2346701|NCT03640507|4084197|FG001|Overall Study|Withdrawal by Subject|0
2346702|NCT03640507|4084198|FG002|Overall Study|Withdrawal by Subject|1
2346703|NCT03640559|4084208|FG000|Overall Study|Physician Decision|1
2346704|NCT03640559|4084209|FG001|Overall Study|Physician Decision|1
2346705|NCT03640559|4084208|FG000|Overall Study|Withdrawal by Subject|1
2346706|NCT03640559|4084209|FG001|Overall Study|Withdrawal by Subject|0
2346707|NCT03641508|4084226|FG000|First Injection|Lost to Follow-up|2
2346708|NCT03641508|4084227|FG001|First Injection|Lost to Follow-up|0
2346709|NCT03642262|4084237|FG000|Period 1|Withdrawal by Subject|1
2346710|NCT03642262|4084238|FG001|Period 1|Withdrawal by Subject|1
2346711|NCT03642262|4084237|FG000|Period 1|Adverse Event|0
2346712|NCT03642262|4084238|FG001|Period 1|Adverse Event|1
2346713|NCT03642717|4084254|FG000|Overall Study|Lost to Follow-up|2
2346714|NCT03642717|4084254|FG000|Overall Study|Inclusion/exclusion criteria violation|33
2346715|NCT03642717|4084254|FG000|Overall Study|Taken study drug prior to contract date|3
2346716|NCT03642873|4084259|FG000|Third Intervention (1 Day)|Screen failure|0
2346717|NCT03642873|4084260|FG001|Third Intervention (1 Day)|Screen failure|0
2346718|NCT03642873|4084261|FG002|Third Intervention (1 Day)|Screen failure|0
2263378|NCT02159729|3935510|FG001|Overall Study|Adverse Event|1
2263379|NCT02159729|3935509|FG000|Overall Study|Subject's Request|13
2263380|NCT02159729|3935510|FG001|Overall Study|Subject's Request|10
2263381|NCT02159729|3935509|FG000|Overall Study|Lost to Follow-up|24
2263382|NCT02159729|3935510|FG001|Overall Study|Lost to Follow-up|9
2263383|NCT02159729|3935509|FG000|Overall Study|Non compliance|2
2263384|NCT02159729|3935510|FG001|Overall Study|Non compliance|0
2263385|NCT02159729|3935509|FG000|Overall Study|Other Unspecified|3
2263386|NCT02159729|3935510|FG001|Overall Study|Other Unspecified|1
2263387|NCT02159807|3935523|FG000|Overall Study|Adverse Event|0
2263388|NCT02159807|3935524|FG001|Overall Study|Adverse Event|0
2263389|NCT02159807|3935525|FG002|Overall Study|Adverse Event|1
2263390|NCT02159807|3935523|FG000|Overall Study|No CSF|1
2263391|NCT02159807|3935524|FG001|Overall Study|No CSF|1
2263392|NCT02159807|3935525|FG002|Overall Study|No CSF|1
2263393|NCT02159807|3935523|FG000|Overall Study|elevated blood pressure|0
2263394|NCT02159807|3935524|FG001|Overall Study|elevated blood pressure|0
2263395|NCT02159807|3935525|FG002|Overall Study|elevated blood pressure|1
2263396|NCT02159950|3935554|FG000|Overall Study|Adverse Event|0
2263397|NCT02159950|3935555|FG001|Overall Study|Adverse Event|1
2263398|NCT02159950|3935554|FG000|Overall Study|Progression|0
2263399|NCT02159950|3935555|FG001|Overall Study|Progression|1
2263400|NCT02160002|3935574|FG000|Overall Study|Withdrawal by Subject|2
2263401|NCT02160002|3935575|FG001|Overall Study|Withdrawal by Subject|1
2263402|NCT02160041|3935581|FG000|Overall Study|Adverse Event|11
2263403|NCT02160041|3935581|FG000|Overall Study|Death|2
2263404|NCT02160041|3935581|FG000|Overall Study|disease progression|57
2263405|NCT02160041|3935581|FG000|Overall Study|Protocol Violation|1
2263406|NCT02160041|3935581|FG000|Overall Study|non-compliance with study|1
2263407|NCT02160041|3935581|FG000|Overall Study|Physician Decision|3
2263408|NCT02160041|3935581|FG000|Overall Study|Withdrawal by Subject|8
2263409|NCT02160041|3935581|FG000|Overall Study|study terminated by by sponsor|1
2263410|NCT02160145|3935587|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23
2263411|NCT02160145|3935588|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0
2263412|NCT02160145|3935589|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0
2263413|NCT02160145|3935587|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
2263414|NCT02160145|3935588|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
2263415|NCT02160145|3935589|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
2263416|NCT02160145|3935587|FG000|Randomized Double-blind Period|Subject decision|0
2263417|NCT02160145|3935588|FG001|Randomized Double-blind Period|Subject decision|21
2346719|NCT03642873|4084262|FG003|Third Intervention (1 Day)|Screen failure|0
2346720|NCT03642873|4084263|FG004|Third Intervention (1 Day)|Screen failure|1
2346721|NCT03642873|4084264|FG005|Third Intervention (1 Day)|Screen failure|0
2346722|NCT03643432|4084278|FG000|Overall Study|Lost to Follow-up|1
2346723|NCT03643432|4084279|FG001|Overall Study|Lost to Follow-up|0
2346724|NCT03643575|4084285|FG000|Washout: 7 Days|Withdrew consent due to illness|0
2346725|NCT03643575|4084286|FG001|Washout: 7 Days|Withdrew consent due to illness|0
2346726|NCT03643575|4084287|FG002|Washout: 7 Days|Withdrew consent due to illness|0
2346727|NCT03643575|4084288|FG003|Washout: 7 Days|Withdrew consent due to illness|1
2346728|NCT03643575|4084289|FG004|Washout: 7 Days|Withdrew consent due to illness|0
2346729|NCT03643575|4084290|FG005|Washout: 7 Days|Withdrew consent due to illness|0
2346730|NCT03643575|4084285|FG000|Washout: 7 Days|Adverse Event|1
2346731|NCT03643575|4084286|FG001|Washout: 7 Days|Adverse Event|0
2346732|NCT03643575|4084287|FG002|Washout: 7 Days|Adverse Event|0
2346733|NCT03643575|4084288|FG003|Washout: 7 Days|Adverse Event|0
2346734|NCT03643575|4084289|FG004|Washout: 7 Days|Adverse Event|0
2346735|NCT03643575|4084290|FG005|Washout: 7 Days|Adverse Event|0
2346736|NCT03643575|4084285|FG000|Washout: 7 Days|Non compliance check in|0
2346737|NCT03643575|4084286|FG001|Washout: 7 Days|Non compliance check in|1
2346738|NCT03643575|4084287|FG002|Washout: 7 Days|Non compliance check in|0
2346739|NCT03643575|4084288|FG003|Washout: 7 Days|Non compliance check in|0
2346740|NCT03643575|4084289|FG004|Washout: 7 Days|Non compliance check in|0
2346741|NCT03643575|4084290|FG005|Washout: 7 Days|Non compliance check in|0
2346742|NCT03643952|4084302|FG000|Overall Study|Lack of Efficacy|1
2263418|NCT02160145|3935589|FG002|Randomized Double-blind Period|Subject decision|20
2263419|NCT02160145|3935587|FG000|Randomized Double-blind Period|Lost to Follow-up|0
2263420|NCT02160145|3935588|FG001|Randomized Double-blind Period|Lost to Follow-up|1
2263421|NCT02160145|3935589|FG002|Randomized Double-blind Period|Lost to Follow-up|3
2263422|NCT02160145|3935587|FG000|Randomized Double-blind Period|Physician Decision|0
2263423|NCT02160145|3935588|FG001|Randomized Double-blind Period|Physician Decision|7
2263424|NCT02160145|3935589|FG002|Randomized Double-blind Period|Physician Decision|5
2263425|NCT02160314|3935607|FG000|Overall Study|Adverse Event|0
2263426|NCT02160314|3935608|FG001|Overall Study|Adverse Event|6
2263427|NCT02160314|3935607|FG000|Overall Study|Protocol Violation|0
2263428|NCT02160314|3935608|FG001|Overall Study|Protocol Violation|4
2263429|NCT02160314|3935607|FG000|Overall Study|Withdrawal by Subject|1
2263430|NCT02160314|3935608|FG001|Overall Study|Withdrawal by Subject|2
2263431|NCT02160314|3935607|FG000|Overall Study|Lost to Follow-up|0
2263432|NCT02160314|3935608|FG001|Overall Study|Lost to Follow-up|1
2263433|NCT02160626|3935621|FG000|Overall Study|Adverse Event|1
2346743|NCT03644173|4084325|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21
2263434|NCT02160626|3935622|FG001|Overall Study|Adverse Event|0
2263435|NCT02160626|3935623|FG002|Overall Study|Adverse Event|0
2263436|NCT02160626|3935621|FG000|Overall Study|Schedule not conducive to study visits|0
2263437|NCT02160626|3935622|FG001|Overall Study|Schedule not conducive to study visits|0
2263438|NCT02160626|3935623|FG002|Overall Study|Schedule not conducive to study visits|1
2263439|NCT02160626|3935621|FG000|Overall Study|Withdrawal by Subject|0
2263440|NCT02160626|3935622|FG001|Overall Study|Withdrawal by Subject|1
2263441|NCT02160626|3935623|FG002|Overall Study|Withdrawal by Subject|0
2263442|NCT02160782|3935638|FG000|Open-label Period: Maralixibat|Adverse Event|2
2263443|NCT02160782|3935639|FG001|Open-label Period: Maralixibat|Adverse Event|0
2263444|NCT02160782|3935640|FG002|Open-label Period: Maralixibat|Adverse Event|0
2263445|NCT02160782|3935641|FG003|Open-label Period: Maralixibat|Adverse Event|0
2263446|NCT02160782|3935642|FG004|Open-label Period: Maralixibat|Adverse Event|0
2263447|NCT02160782|3935638|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0
2263448|NCT02160782|3935639|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0
2263449|NCT02160782|3935640|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0
2263450|NCT02160782|3935641|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1
2263451|NCT02160782|3935642|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0
2263452|NCT02160782|3935638|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
2263453|NCT02160782|3935639|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
2263454|NCT02160782|3935640|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
2263455|NCT02160782|3935641|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5
2263456|NCT02160782|3935642|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
2263457|NCT02160782|3935638|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
2263458|NCT02160782|3935639|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
2263459|NCT02160782|3935640|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
2263460|NCT02160782|3935641|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
2263461|NCT02160782|3935642|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4
2263462|NCT02160782|3935638|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0
2263463|NCT02160782|3935639|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0
2263464|NCT02160782|3935640|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0
2263465|NCT02160782|3935641|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0
2263466|NCT02160782|3935642|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1
2263467|NCT02160782|3935638|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0
2263468|NCT02160782|3935639|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0
2263469|NCT02160782|3935640|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0
2263470|NCT02160782|3935641|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0
2263471|NCT02160782|3935642|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3
2263472|NCT02160782|3935638|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
2263473|NCT02160782|3935639|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
2263474|NCT02160782|3935640|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
2263475|NCT02160782|3935641|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
2263476|NCT02160782|3935642|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1
2263477|NCT02160899|3935705|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
2263478|NCT02160899|3935706|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
2263479|NCT02160899|3935707|FG002|Overall Study|Adverse Event or Serious Adverse Event|0
2263480|NCT02160899|3935708|FG003|Overall Study|Adverse Event or Serious Adverse Event|1
2263481|NCT02160899|3935709|FG004|Overall Study|Adverse Event or Serious Adverse Event|2
2263482|NCT02160899|3935710|FG005|Overall Study|Adverse Event or Serious Adverse Event|0
2263483|NCT02160977|3935726|FG000|Six Weeks After Surgery|Lost to Follow-up|1
2263484|NCT02160977|3935727|FG001|Six Weeks After Surgery|Lost to Follow-up|0
2263485|NCT02160977|3935726|FG000|Three Months After Surgery|Lost to Follow-up|0
2263486|NCT02160977|3935727|FG001|Three Months After Surgery|Lost to Follow-up|2
2263487|NCT02160977|3935726|FG000|Six Months After Surgery|Lost to Follow-up|2
2263488|NCT02160977|3935727|FG001|Six Months After Surgery|Lost to Follow-up|1
2263489|NCT02161146|3935756|FG000|Overall Study|Adverse Event|1
2263490|NCT02161146|3935757|FG001|Overall Study|Adverse Event|1
2263491|NCT02161146|3935758|FG002|Overall Study|Adverse Event|0
2263492|NCT02161146|3935759|FG003|Overall Study|Adverse Event|1
2263493|NCT02161146|3935760|FG004|Overall Study|Adverse Event|0
2263494|NCT02161146|3935756|FG000|Overall Study|Lost to Follow-up|0
2263495|NCT02161146|3935757|FG001|Overall Study|Lost to Follow-up|1
2263496|NCT02161146|3935758|FG002|Overall Study|Lost to Follow-up|0
2263497|NCT02161146|3935759|FG003|Overall Study|Lost to Follow-up|0
2263498|NCT02161146|3935760|FG004|Overall Study|Lost to Follow-up|0
2263499|NCT02161146|3935756|FG000|Overall Study|Personal Reasons|0
2263500|NCT02161146|3935757|FG001|Overall Study|Personal Reasons|1
2263501|NCT02161146|3935758|FG002|Overall Study|Personal Reasons|0
2263502|NCT02161146|3935759|FG003|Overall Study|Personal Reasons|2
2263503|NCT02161146|3935760|FG004|Overall Study|Personal Reasons|1
2263504|NCT02161146|3935756|FG000|Overall Study|Other Miscellaneous Reasons|0
2263505|NCT02161146|3935757|FG001|Overall Study|Other Miscellaneous Reasons|1
2263506|NCT02161146|3935758|FG002|Overall Study|Other Miscellaneous Reasons|0
2263507|NCT02161146|3935759|FG003|Overall Study|Other Miscellaneous Reasons|0
2263508|NCT02161146|3935760|FG004|Overall Study|Other Miscellaneous Reasons|0
2263509|NCT02161185|3935770|FG000|Treatment Phase|Administrative/Other|7
2263510|NCT02161406|3935776|FG000|Overall Study|Death|2
2263511|NCT02161406|3935777|FG001|Overall Study|Death|1
2263512|NCT02161406|3935776|FG000|Overall Study|Lost to Follow-up|2
2263513|NCT02161406|3935777|FG001|Overall Study|Lost to Follow-up|1
2263514|NCT02161406|3935776|FG000|Overall Study|Withdrawal by Subject|2
2263515|NCT02161406|3935777|FG001|Overall Study|Withdrawal by Subject|4
2346744|NCT03644173|4084325|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2
2346745|NCT03644173|4084325|FG000|Participants at the 1-month Follow up|Death|2
2346746|NCT03644173|4084325|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2
2346747|NCT03645421|4084343|FG000|Overall Study|Adverse Event|0
2346748|NCT03645421|4084344|FG001|Overall Study|Adverse Event|0
2346749|NCT03645421|4084345|FG002|Overall Study|Adverse Event|4
2346750|NCT03645421|4084346|FG003|Overall Study|Adverse Event|1
2346751|NCT03645421|4084343|FG000|Overall Study|Withdrawal by patient|0
2346752|NCT03645421|4084344|FG001|Overall Study|Withdrawal by patient|0
2346753|NCT03645421|4084345|FG002|Overall Study|Withdrawal by patient|0
2346754|NCT03645421|4084346|FG003|Overall Study|Withdrawal by patient|3
2346755|NCT03645421|4084343|FG000|Overall Study|Study specific withdrawal criteria|0
2346756|NCT03645421|4084344|FG001|Overall Study|Study specific withdrawal criteria|0
2346757|NCT03645421|4084345|FG002|Overall Study|Study specific withdrawal criteria|1
2346758|NCT03645421|4084346|FG003|Overall Study|Study specific withdrawal criteria|0
2346759|NCT03645434|4084359|FG000|Period 1|Adverse Event|0
2346760|NCT03645434|4084360|FG001|Period 1|Adverse Event|0
2346761|NCT03645434|4084361|FG002|Period 1|Adverse Event|0
2346762|NCT03645434|4084362|FG003|Period 1|Adverse Event|1
2346763|NCT03645434|4084363|FG004|Period 1|Adverse Event|0
2346764|NCT03645434|4084364|FG005|Period 1|Adverse Event|0
2346765|NCT03645434|4084359|FG000|Period 1|COPD exacerbation|0
2346766|NCT03645434|4084360|FG001|Period 1|COPD exacerbation|0
2346767|NCT03645434|4084361|FG002|Period 1|COPD exacerbation|0
2346768|NCT03645434|4084362|FG003|Period 1|COPD exacerbation|0
2346769|NCT03645434|4084363|FG004|Period 1|COPD exacerbation|1
2346770|NCT03645434|4084364|FG005|Period 1|COPD exacerbation|0
2346771|NCT03646305|4084414|FG000|Overall Study|Lost to Follow-up|4
2346772|NCT03646305|4084415|FG001|Overall Study|Lost to Follow-up|2
2346773|NCT03646305|4084416|FG002|Overall Study|Lost to Follow-up|2
2346774|NCT03646305|4084417|FG003|Overall Study|Lost to Follow-up|1
2346775|NCT03646305|4084414|FG000|Overall Study|Withdrawal by Subject|1
2346776|NCT03646305|4084415|FG001|Overall Study|Withdrawal by Subject|0
2346777|NCT03646305|4084416|FG002|Overall Study|Withdrawal by Subject|0
2346778|NCT03646305|4084417|FG003|Overall Study|Withdrawal by Subject|1
2346779|NCT03646656|4084433|FG000|Overall Study|Lost to Follow-up|1
2346780|NCT03646656|4084434|FG001|Overall Study|Lost to Follow-up|0
2263516|NCT02161406|3935776|FG000|Overall Study|investigator withdrew subject|3
2263517|NCT02161406|3935777|FG001|Overall Study|investigator withdrew subject|1
2263518|NCT02161406|3935776|FG000|Overall Study|Lack of Efficacy|1
2263519|NCT02161406|3935777|FG001|Overall Study|Lack of Efficacy|1
2263520|NCT02161406|3935776|FG000|Overall Study|relocation|0
2263521|NCT02161406|3935777|FG001|Overall Study|relocation|1
2263522|NCT02161458|3935787|FG000|Overall Study|Withdrawal by Subject|0
2263523|NCT02161458|3935788|FG001|Overall Study|Withdrawal by Subject|4
2263524|NCT02161458|3935789|FG002|Overall Study|Withdrawal by Subject|4
2263525|NCT02161458|3935790|FG003|Overall Study|Withdrawal by Subject|0
2263526|NCT02161458|3935787|FG000|Overall Study|Lost to Follow-up|0
2263527|NCT02161458|3935788|FG001|Overall Study|Lost to Follow-up|2
2263528|NCT02161458|3935789|FG002|Overall Study|Lost to Follow-up|1
2263529|NCT02161458|3935790|FG003|Overall Study|Lost to Follow-up|0
2263530|NCT02161549|3935824|FG000|Overall Study|Physician Decision|6
2263531|NCT02161549|3935825|FG001|Overall Study|Physician Decision|2
2263532|NCT02161562|3935833|FG000|Overall Study|Withdrawal by Subject|5
2263533|NCT02161562|3935834|FG001|Overall Study|Withdrawal by Subject|8
2263534|NCT02161562|3935833|FG000|Overall Study|Protocol Violation|9
2263535|NCT02161562|3935834|FG001|Overall Study|Protocol Violation|4
2263536|NCT02161562|3935833|FG000|Overall Study|Pregnancy|1
2263537|NCT02161562|3935834|FG001|Overall Study|Pregnancy|2
2263538|NCT02161562|3935833|FG000|Overall Study|Lost to Follow-up|3
2263539|NCT02161562|3935834|FG001|Overall Study|Lost to Follow-up|1
2263540|NCT02161562|3935833|FG000|Overall Study|Lack of Efficacy|4
2263541|NCT02161562|3935834|FG001|Overall Study|Lack of Efficacy|1
2263542|NCT02161562|3935833|FG000|Overall Study|Adverse Event|1
2263543|NCT02161562|3935834|FG001|Overall Study|Adverse Event|1
2263544|NCT02161562|3935833|FG000|Overall Study|Participant moved back to home country|1
2346781|NCT03646656|4084433|FG000|Overall Study|Withdrawal by Subject|2
2346782|NCT03646656|4084434|FG001|Overall Study|Withdrawal by Subject|0
2263545|NCT02161562|3935834|FG001|Overall Study|Participant moved back to home country|0
2263546|NCT02161562|3935833|FG000|Overall Study|Withdrew due to being out of the country|1
2263547|NCT02161562|3935834|FG001|Overall Study|Withdrew due to being out of the country|0
2263548|NCT02161562|3935833|FG000|Overall Study|Participant moved out of province|1
2263549|NCT02161562|3935834|FG001|Overall Study|Participant moved out of province|0
2263550|NCT02161575|3935853|FG000|Overall Study|Protocol Violation|8
2263551|NCT02161575|3935853|FG000|Overall Study|Lack of Efficacy|1
2263552|NCT02161575|3935853|FG000|Overall Study|Adverse Event|2
2263553|NCT02161718|3935868|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2
2263554|NCT02161718|3935869|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0
2263555|NCT02161718|3935870|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0
2263556|NCT02161718|3935868|FG000|Open-Label ALKS 3831 Period|Physician Decision|1
2263557|NCT02161718|3935869|FG001|Open-Label ALKS 3831 Period|Physician Decision|0
2263558|NCT02161718|3935870|FG002|Open-Label ALKS 3831 Period|Physician Decision|0
2263559|NCT02161718|3935868|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1
2346783|NCT03647267|4084459|FG000|Overall Study|Lost to Follow-up|1
2346784|NCT03647267|4084460|FG001|Overall Study|Lost to Follow-up|0
2346785|NCT03647709|4084472|FG000|Overall Study|Lost to Follow-up|5
2346786|NCT03647709|4084472|FG000|Overall Study|Physician Decision|6
2346787|NCT03647709|4084472|FG000|Overall Study|Withdrawal by Subject|3
2346788|NCT03648879|4084482|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1
2346789|NCT03649412|4084488|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1
2346790|NCT03649412|4084489|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0
2346791|NCT03649412|4084488|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1
2346792|NCT03649412|4084489|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0
2346793|NCT03649412|4084488|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
2346794|NCT03649412|4084489|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
2346795|NCT03649412|4084488|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1
2346796|NCT03649412|4084489|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0
2346797|NCT03649412|4084488|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0
2346798|NCT03649412|4084489|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1
2346799|NCT03649412|4084488|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0
2346800|NCT03649412|4084489|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1
2346801|NCT03649477|4084535|FG000|Overall Study|Adverse Event|2
2346802|NCT03649477|4084536|FG001|Overall Study|Adverse Event|0
2346803|NCT03649477|4084537|FG002|Overall Study|Adverse Event|0
2346804|NCT03650387|4084582|FG000|Overall Study|Withdrawal by Subject|13
2346805|NCT03650387|4084582|FG000|Overall Study|Lost to Follow-up|12
2346806|NCT03650387|4084582|FG000|Overall Study|Adverse Event (Not related)|1
2346807|NCT03650387|4084582|FG000|Overall Study|Due to COVID-19 Pandemic|8
2346808|NCT03650400|4084597|FG000|Overall Study|Study terminated by sponsor|0
2346809|NCT03650400|4084598|FG001|Overall Study|Study terminated by sponsor|5
2346810|NCT03650452|4084606|FG000|Overall Study|Physician Decision|1
2346811|NCT03650452|4084607|FG001|Overall Study|Physician Decision|0
2346812|NCT03650452|4084606|FG000|Overall Study|Withdrawal by Parent/Guardian|3
2346813|NCT03650452|4084607|FG001|Overall Study|Withdrawal by Parent/Guardian|1
2346814|NCT03650452|4084606|FG000|Overall Study|Adverse Event|3
2346815|NCT03650452|4084607|FG001|Overall Study|Adverse Event|4
2346816|NCT03650452|4084606|FG000|Overall Study|Early Withdrawal from Study Treatment|3
2346817|NCT03650452|4084607|FG001|Overall Study|Early Withdrawal from Study Treatment|0
2346818|NCT03652610|4084632|FG000|Overall Study|Lost to Follow-up|1
2346819|NCT03652610|4084633|FG001|Overall Study|Lost to Follow-up|0
2346820|NCT03652610|4084632|FG000|Overall Study|Withdrawal by Subject|3
2346821|NCT03652610|4084633|FG001|Overall Study|Withdrawal by Subject|5
2346822|NCT03652662|4084641|FG000|Overall Study|Withdrawal by Subject|2
2346823|NCT03652662|4084642|FG001|Overall Study|Withdrawal by Subject|1
2346824|NCT03652662|4084641|FG000|Overall Study|Lost to Follow-up|1
2346825|NCT03652662|4084642|FG001|Overall Study|Lost to Follow-up|0
2346826|NCT03652675|4084650|FG000|Overall Study|Lost to Follow-up|4
2346827|NCT03652675|4084651|FG001|Overall Study|Lost to Follow-up|4
2346828|NCT03652818|4084662|FG000|Overall Study|Adverse Event|1
2346829|NCT03652818|4084663|FG001|Overall Study|Adverse Event|0
2346830|NCT03652818|4084664|FG002|Overall Study|Adverse Event|0
2346831|NCT03652818|4084665|FG003|Overall Study|Adverse Event|0
2346832|NCT03652818|4084666|FG004|Overall Study|Adverse Event|0
2346833|NCT03652818|4084662|FG000|Overall Study|Physician Decision|1
2346834|NCT03652818|4084663|FG001|Overall Study|Physician Decision|0
2346835|NCT03652818|4084664|FG002|Overall Study|Physician Decision|0
2346836|NCT03652818|4084665|FG003|Overall Study|Physician Decision|0
2346837|NCT03652818|4084666|FG004|Overall Study|Physician Decision|0
2346838|NCT03652818|4084662|FG000|Overall Study|Lost to Follow-up|0
2346839|NCT03652818|4084663|FG001|Overall Study|Lost to Follow-up|1
2346840|NCT03652818|4084664|FG002|Overall Study|Lost to Follow-up|2
2346841|NCT03652818|4084665|FG003|Overall Study|Lost to Follow-up|1
2346842|NCT03652818|4084666|FG004|Overall Study|Lost to Follow-up|1
2346843|NCT03653026|4084680|FG000|Part 1: Placebo-controlled Period|Adverse Event|5
2346844|NCT03653026|4084681|FG001|Part 1: Placebo-controlled Period|Adverse Event|6
2346845|NCT03653026|4084682|FG002|Part 1: Placebo-controlled Period|Adverse Event|0
2346846|NCT03653026|4084683|FG003|Part 1: Placebo-controlled Period|Adverse Event|0
2346847|NCT03653026|4084680|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6
2263560|NCT02161718|3935869|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
2263561|NCT02161718|3935870|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
2263562|NCT02161718|3935868|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1
2263563|NCT02161718|3935869|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0
2263564|NCT02161718|3935870|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0
2263565|NCT02161718|3935868|FG000|Open-Label ALKS 3831 Period|Adverse Event|3
2263566|NCT02161718|3935869|FG001|Open-Label ALKS 3831 Period|Adverse Event|0
2263567|NCT02161718|3935870|FG002|Open-Label ALKS 3831 Period|Adverse Event|0
2263568|NCT02161718|3935868|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4
2263569|NCT02161718|3935869|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
2263570|NCT02161718|3935870|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
2263571|NCT02161718|3935868|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3
2263572|NCT02161718|3935869|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0
2263573|NCT02161718|3935870|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0
2263574|NCT02161718|3935868|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6
2263575|NCT02161718|3935869|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
2263576|NCT02161718|3935870|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
2263577|NCT02161718|3935868|FG000|Post- Randomization Period|Withdrawal by Subject|0
2263578|NCT02161718|3935869|FG001|Post- Randomization Period|Withdrawal by Subject|23
2263579|NCT02161718|3935870|FG002|Post- Randomization Period|Withdrawal by Subject|18
2263580|NCT02161718|3935868|FG000|Post- Randomization Period|Lost to Follow-up|0
2263581|NCT02161718|3935869|FG001|Post- Randomization Period|Lost to Follow-up|9
2263582|NCT02161718|3935870|FG002|Post- Randomization Period|Lost to Follow-up|15
2263583|NCT02161718|3935868|FG000|Post- Randomization Period|Adverse Event|0
2263584|NCT02161718|3935869|FG001|Post- Randomization Period|Adverse Event|9
2263585|NCT02161718|3935870|FG002|Post- Randomization Period|Adverse Event|10
2263586|NCT02161718|3935868|FG000|Post- Randomization Period|Non- compliance with study drug|0
2263587|NCT02161718|3935869|FG001|Post- Randomization Period|Non- compliance with study drug|8
2263588|NCT02161718|3935870|FG002|Post- Randomization Period|Non- compliance with study drug|2
2263589|NCT02161718|3935868|FG000|Post- Randomization Period|Physician Decision|0
2263590|NCT02161718|3935869|FG001|Post- Randomization Period|Physician Decision|2
2263591|NCT02161718|3935870|FG002|Post- Randomization Period|Physician Decision|4
2263592|NCT02161718|3935868|FG000|Post- Randomization Period|Protocol Violation|0
2263593|NCT02161718|3935869|FG001|Post- Randomization Period|Protocol Violation|2
2263594|NCT02161718|3935870|FG002|Post- Randomization Period|Protocol Violation|3
2263595|NCT02161718|3935868|FG000|Post- Randomization Period|Lack of Efficacy|0
2263596|NCT02161718|3935869|FG001|Post- Randomization Period|Lack of Efficacy|0
2263597|NCT02161718|3935870|FG002|Post- Randomization Period|Lack of Efficacy|1
2263598|NCT02161718|3935868|FG000|Post- Randomization Period|Non-compliance with study procedures|0
2263599|NCT02161718|3935869|FG001|Post- Randomization Period|Non-compliance with study procedures|2
2263600|NCT02161718|3935870|FG002|Post- Randomization Period|Non-compliance with study procedures|4
2263601|NCT02161718|3935868|FG000|Post- Randomization Period|Received prohibitive treatment|0
2263602|NCT02161718|3935869|FG001|Post- Randomization Period|Received prohibitive treatment|1
2263603|NCT02161718|3935870|FG002|Post- Randomization Period|Received prohibitive treatment|2
2263604|NCT02161718|3935868|FG000|Post- Randomization Period|Relocation|0
2263605|NCT02161718|3935869|FG001|Post- Randomization Period|Relocation|3
2263606|NCT02161718|3935870|FG002|Post- Randomization Period|Relocation|0
2263607|NCT02161731|3935877|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
2263608|NCT02161731|3935878|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
2263609|NCT02161731|3935877|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
2263610|NCT02161731|3935878|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
2263611|NCT02161757|3935888|FG000|Randomised Through Start Treatment|Did not receive treatment|3
2263612|NCT02161757|3935889|FG001|Randomised Through Start Treatment|Did not receive treatment|2
2263613|NCT02161757|3935890|FG002|Randomised Through Start Treatment|Did not receive treatment|0
2263614|NCT02161757|3935888|FG000|Treatment Through Study Completion|Adverse Event|1
2263615|NCT02161757|3935889|FG001|Treatment Through Study Completion|Adverse Event|1
2263616|NCT02161757|3935890|FG002|Treatment Through Study Completion|Adverse Event|0
2263617|NCT02161757|3935888|FG000|Treatment Through Study Completion|Protocol Violation|0
2263618|NCT02161757|3935889|FG001|Treatment Through Study Completion|Protocol Violation|1
2263619|NCT02161757|3935890|FG002|Treatment Through Study Completion|Protocol Violation|2
2263620|NCT02161757|3935888|FG000|Treatment Through Study Completion|Withdrawal by Subject|27
2263621|NCT02161757|3935889|FG001|Treatment Through Study Completion|Withdrawal by Subject|19
2263622|NCT02161757|3935890|FG002|Treatment Through Study Completion|Withdrawal by Subject|20
2263623|NCT02161757|3935888|FG000|Treatment Through Study Completion|Lost to Follow-up|7
2263624|NCT02161757|3935889|FG001|Treatment Through Study Completion|Lost to Follow-up|2
2263625|NCT02161757|3935890|FG002|Treatment Through Study Completion|Lost to Follow-up|4
2263626|NCT02161757|3935888|FG000|Treatment Through Study Completion|Other|20
2263627|NCT02161757|3935889|FG001|Treatment Through Study Completion|Other|19
2263628|NCT02161757|3935890|FG002|Treatment Through Study Completion|Other|12
2263629|NCT02161757|3935888|FG000|Treatment Through Study Completion|Death|2
2263630|NCT02161757|3935889|FG001|Treatment Through Study Completion|Death|1
2263631|NCT02161757|3935890|FG002|Treatment Through Study Completion|Death|1
2263632|NCT02162719|3935957|FG000|Overall Study|Death|41
2263633|NCT02162719|3935958|FG001|Overall Study|Death|46
2263634|NCT02162719|3935957|FG000|Overall Study|Lost to Follow-up|1
2263635|NCT02162719|3935958|FG001|Overall Study|Lost to Follow-up|3
2263636|NCT02162719|3935957|FG000|Overall Study|Disease Progression|2
2263637|NCT02162719|3935958|FG001|Overall Study|Disease Progression|1
2263638|NCT02162719|3935957|FG000|Overall Study|Withdrawal by Subject|8
2263639|NCT02162719|3935958|FG001|Overall Study|Withdrawal by Subject|2
2263640|NCT02162719|3935957|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10
2263641|NCT02162719|3935958|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10
2263642|NCT02162758|3935966|FG000|Overall Study|Study termination|0
2263643|NCT02162758|3935967|FG001|Overall Study|Study termination|1
2263644|NCT02162771|3935975|FG000|Core Study Period (Part 2)|Progressive Disease|2
2263645|NCT02162771|3935976|FG001|Core Study Period (Part 2)|Progressive Disease|3
2263646|NCT02162771|3935975|FG000|Core Study Period (Part 2)|Adverse Event|4
2263647|NCT02162771|3935976|FG001|Core Study Period (Part 2)|Adverse Event|1
2263648|NCT02162771|3935975|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1
2263649|NCT02162771|3935976|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2
2263650|NCT02162771|3935975|FG000|Core Study Period (Part 2)|Physician Decision|0
2263651|NCT02162771|3935976|FG001|Core Study Period (Part 2)|Physician Decision|2
2263652|NCT02162771|3935975|FG000|Core Study Period (Part 2)|Death|1
2263653|NCT02162771|3935976|FG001|Core Study Period (Part 2)|Death|0
2263654|NCT02162771|3935975|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11
2263655|NCT02162771|3935976|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13
2263656|NCT02162771|3935975|FG000|Maintenance Study Period (Part 2)|Adverse Event|3
2263657|NCT02162771|3935976|FG001|Maintenance Study Period (Part 2)|Adverse Event|3
2263658|NCT02162771|3935975|FG000|Maintenance Study Period (Part 2)|Death|2
2263659|NCT02162771|3935976|FG001|Maintenance Study Period (Part 2)|Death|1
2263660|NCT02162771|3935975|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
2263661|NCT02162771|3935976|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
2263662|NCT02162771|3935975|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0
2263663|NCT02162771|3935976|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1
2263664|NCT02162771|3935975|FG000|Maintenance Study Period (Part 2)|Stable Disease|0
2263665|NCT02162771|3935976|FG001|Maintenance Study Period (Part 2)|Stable Disease|1
2263666|NCT02162862|3935985|FG000|Overall Study|Lost to Follow-up|0
2263667|NCT02162862|3935986|FG001|Overall Study|Lost to Follow-up|11
2263668|NCT02162862|3935987|FG002|Overall Study|Lost to Follow-up|0
2263669|NCT02162862|3935985|FG000|Overall Study|Subject did not feel the med was needed|0
2263670|NCT02162862|3935986|FG001|Overall Study|Subject did not feel the med was needed|0
2263671|NCT02162862|3935987|FG002|Overall Study|Subject did not feel the med was needed|4
2263672|NCT02163057|3936008|FG000|Overall Study|Participant Refusal to Continue|2
2263673|NCT02163057|3936009|FG001|Overall Study|Participant Refusal to Continue|2
2263674|NCT02163057|3936008|FG000|Overall Study|Participant Significant Noncompliance|0
2263675|NCT02163057|3936009|FG001|Overall Study|Participant Significant Noncompliance|1
2263676|NCT02163057|3936008|FG000|Overall Study|Progression of Disease|1
2263677|NCT02163057|3936009|FG001|Overall Study|Progression of Disease|2
2263678|NCT02163226|3936019|FG000|Overall Study|Death|2
2263679|NCT02163226|3936020|FG001|Overall Study|Death|1
2263680|NCT02163226|3936019|FG000|Overall Study|Withdrawal by Subject|5
2263681|NCT02163226|3936020|FG001|Overall Study|Withdrawal by Subject|2
2263682|NCT02163226|3936019|FG000|Overall Study|Returned home, local radiotherapy|3
2263683|NCT02163226|3936020|FG001|Overall Study|Returned home, local radiotherapy|0
2263684|NCT02163226|3936019|FG000|Overall Study|Repeat imaging showed no disease|2
2263685|NCT02163226|3936020|FG001|Overall Study|Repeat imaging showed no disease|0
2263686|NCT02163226|3936019|FG000|Overall Study|Incomplete radiotherapy|3
2263687|NCT02163226|3936020|FG001|Overall Study|Incomplete radiotherapy|0
2263688|NCT02163226|3936019|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1
2263689|NCT02163226|3936020|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0
2263690|NCT02163226|3936019|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0
2263691|NCT02163226|3936020|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5
2263692|NCT02163226|3936019|FG000|Overall Study|ineligible|0
2263693|NCT02163226|3936020|FG001|Overall Study|ineligible|3
2263694|NCT02163395|3936026|FG000|Overall Study|Withdrawal by Subject|1
2263695|NCT02163395|3936026|FG000|Overall Study|Lost to Follow-up|3
2263696|NCT02163395|3936026|FG000|Overall Study|Adverse Event|1
2346848|NCT03653026|4084681|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4
2346849|NCT03653026|4084682|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
2346850|NCT03653026|4084683|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
2346851|NCT03653026|4084680|FG000|Part 1: Placebo-controlled Period|Other|0
2346852|NCT03653026|4084681|FG001|Part 1: Placebo-controlled Period|Other|3
2346853|NCT03653026|4084682|FG002|Part 1: Placebo-controlled Period|Other|0
2346854|NCT03653026|4084683|FG003|Part 1: Placebo-controlled Period|Other|0
2346855|NCT03653026|4084680|FG000|Part 2: Open-label Extension|Adverse Event|0
2346856|NCT03653026|4084681|FG001|Part 2: Open-label Extension|Adverse Event|0
2346857|NCT03653026|4084682|FG002|Part 2: Open-label Extension|Adverse Event|1
2346858|NCT03653026|4084683|FG003|Part 2: Open-label Extension|Adverse Event|1
2346859|NCT03653026|4084680|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0
2346860|NCT03653026|4084681|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0
2263697|NCT02163447|3936056|FG000|Overall Study|Withdrawal by Subject|2
2263698|NCT02163447|3936057|FG001|Overall Study|Withdrawal by Subject|0
2263699|NCT02163447|3936058|FG002|Overall Study|Withdrawal by Subject|1
2263700|NCT02163447|3936056|FG000|Overall Study|Lost to Follow-up|1
2263701|NCT02163447|3936057|FG001|Overall Study|Lost to Follow-up|3
2263702|NCT02163447|3936058|FG002|Overall Study|Lost to Follow-up|0
2263703|NCT02163447|3936056|FG000|Overall Study|Moved out of study area|2
2263704|NCT02163447|3936057|FG001|Overall Study|Moved out of study area|3
2263705|NCT02163447|3936058|FG002|Overall Study|Moved out of study area|2
2263706|NCT02163447|3936056|FG000|Overall Study|Became HIV infected at time of delivery|1
2346861|NCT03653026|4084682|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1
2346862|NCT03653026|4084683|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2
2346863|NCT03653026|4084680|FG000|Part 2: Open-label Extension|Other|0
2346864|NCT03653026|4084681|FG001|Part 2: Open-label Extension|Other|0
2346865|NCT03653026|4084682|FG002|Part 2: Open-label Extension|Other|1
2346866|NCT03653026|4084683|FG003|Part 2: Open-label Extension|Other|2
2346867|NCT03653208|4084700|FG000|Overall Study|Withdrawal by Subject|0
2346868|NCT03653208|4084701|FG001|Overall Study|Withdrawal by Subject|0
2346869|NCT03653208|4084702|FG002|Overall Study|Withdrawal by Subject|0
2346870|NCT03653208|4084703|FG003|Overall Study|Withdrawal by Subject|0
2263707|NCT02163447|3936057|FG001|Overall Study|Became HIV infected at time of delivery|0
2263708|NCT02163447|3936058|FG002|Overall Study|Became HIV infected at time of delivery|0
2263709|NCT02163499|3936085|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1
2263710|NCT02163499|3936085|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
2263711|NCT02163499|3936085|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1
2263712|NCT02163499|3936085|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1
2263713|NCT02163499|3936085|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
2263714|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Adverse Event|51
2263715|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40
2263716|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Hypokalemia|9
2263717|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5
2263718|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
2263719|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81
2263720|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Physician Decision|8
2263721|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31
2263722|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Protocol Violation|2
2263723|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Death|8
2263724|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Subject Compliance|17
2263725|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5
2263726|NCT02163499|3936085|FG000|Extended Dosing Phase: ZS|Various reasons|16
2346871|NCT03653208|4084704|FG004|Overall Study|Withdrawal by Subject|1
2346872|NCT03653208|4084705|FG005|Overall Study|Withdrawal by Subject|0
2346873|NCT03653208|4084706|FG006|Overall Study|Withdrawal by Subject|0
2346874|NCT03653208|4084707|FG007|Overall Study|Withdrawal by Subject|1
2346875|NCT03653208|4084708|FG008|Overall Study|Withdrawal by Subject|1
2346876|NCT03653416|4084739|FG000|Overall Study|Protocol Violation|6
2346877|NCT03653416|4084740|FG001|Overall Study|Protocol Violation|1
2346878|NCT03653429|4084748|FG000|Overall Study|Physician Decision|4
2346879|NCT03653429|4084749|FG001|Overall Study|Physician Decision|10
2346880|NCT03654326|4084757|FG000|Overall Study|Withdrawal by Subject|5
2263727|NCT02163538|3936095|FG000|Overall Study|Protocol Violation|1
2263728|NCT02163538|3936096|FG001|Overall Study|Protocol Violation|0
2263729|NCT02163538|3936095|FG000|Overall Study|Physician Decision|0
2263730|NCT02163538|3936096|FG001|Overall Study|Physician Decision|1
2263731|NCT02163759|3936114|FG000|Overall Study|Withdrawal by Subject|1
2263732|NCT02163759|3936115|FG001|Overall Study|Withdrawal by Subject|5
2263733|NCT02163759|3936116|FG002|Overall Study|Withdrawal by Subject|1
2263734|NCT02163759|3936114|FG000|Overall Study|Adverse Event|0
2263735|NCT02163759|3936115|FG001|Overall Study|Adverse Event|0
2263736|NCT02163759|3936116|FG002|Overall Study|Adverse Event|1
2263737|NCT02163759|3936114|FG000|Overall Study|Death|0
2263738|NCT02163759|3936115|FG001|Overall Study|Death|0
2263739|NCT02163759|3936116|FG002|Overall Study|Death|1
2263740|NCT02163902|3936155|FG000|Overall Study|Subject's Request|3
2263741|NCT02163902|3936156|FG001|Overall Study|Subject's Request|4
2263742|NCT02163902|3936155|FG000|Overall Study|Lost to Follow-up|6
2263743|NCT02163902|3936156|FG001|Overall Study|Lost to Follow-up|7
2263744|NCT02163902|3936155|FG000|Overall Study|Administrative Decision|2
2263745|NCT02163902|3936156|FG001|Overall Study|Administrative Decision|2
2263746|NCT02163915|3936167|FG000|Overall Study|Withdrawal by Subject|2
2263747|NCT02163915|3936168|FG001|Overall Study|Withdrawal by Subject|0
2263748|NCT02163915|3936169|FG002|Overall Study|Withdrawal by Subject|2
2263749|NCT02163915|3936170|FG003|Overall Study|Withdrawal by Subject|2
2263750|NCT02163915|3936171|FG004|Overall Study|Withdrawal by Subject|2
2263751|NCT02163915|3936167|FG000|Overall Study|Study termination|1
2263752|NCT02163915|3936168|FG001|Overall Study|Study termination|0
2263753|NCT02163915|3936169|FG002|Overall Study|Study termination|0
2263754|NCT02163915|3936170|FG003|Overall Study|Study termination|0
2263755|NCT02163915|3936171|FG004|Overall Study|Study termination|2
2263756|NCT02163915|3936167|FG000|Overall Study|Physician Decision|0
2263757|NCT02163915|3936168|FG001|Overall Study|Physician Decision|0
2263758|NCT02163915|3936169|FG002|Overall Study|Physician Decision|0
2263759|NCT02163915|3936170|FG003|Overall Study|Physician Decision|1
2263760|NCT02163915|3936171|FG004|Overall Study|Physician Decision|0
2263761|NCT02163993|3936208|FG000|Treatment Period|Adverse Event|0
2263762|NCT02163993|3936209|FG001|Treatment Period|Adverse Event|1
2263763|NCT02163993|3936210|FG002|Treatment Period|Adverse Event|0
2263764|NCT02163993|3936211|FG003|Treatment Period|Adverse Event|0
2263765|NCT02163993|3936212|FG004|Treatment Period|Adverse Event|1
2263766|NCT02163993|3936208|FG000|Treatment Period|Lost to Follow-up|2
2263767|NCT02163993|3936209|FG001|Treatment Period|Lost to Follow-up|3
2263768|NCT02163993|3936210|FG002|Treatment Period|Lost to Follow-up|1
2263769|NCT02163993|3936211|FG003|Treatment Period|Lost to Follow-up|3
2263770|NCT02163993|3936212|FG004|Treatment Period|Lost to Follow-up|1
2263771|NCT02163993|3936208|FG000|Treatment Period|Physician Decision|1
2263772|NCT02163993|3936209|FG001|Treatment Period|Physician Decision|0
2263773|NCT02163993|3936210|FG002|Treatment Period|Physician Decision|0
2263774|NCT02163993|3936211|FG003|Treatment Period|Physician Decision|0
2263775|NCT02163993|3936212|FG004|Treatment Period|Physician Decision|0
2346881|NCT03654326|4084758|FG001|Overall Study|Withdrawal by Subject|3
2346882|NCT03654326|4084757|FG000|Overall Study|Physician Decision|0
2346883|NCT03654326|4084758|FG001|Overall Study|Physician Decision|1
2346884|NCT03654326|4084757|FG000|Overall Study|Unable to adhere to study schedule|0
2346885|NCT03654326|4084758|FG001|Overall Study|Unable to adhere to study schedule|1
2346886|NCT03654326|4084757|FG000|Overall Study|Lost to Follow-up|1
2346887|NCT03654326|4084758|FG001|Overall Study|Lost to Follow-up|1
2346888|NCT03654560|4084775|FG000|Overall Study|Death|3
2346889|NCT03654560|4084776|FG001|Overall Study|Death|1
2346890|NCT03654560|4084775|FG000|Overall Study|Lost to Follow-up|1
2346891|NCT03654560|4084776|FG001|Overall Study|Lost to Follow-up|0
2346892|NCT03655054|4084782|FG000|Overall Study|Lost to Follow-up|1
2346893|NCT03655106|4084792|FG000|Overall Study|Withdrawal by Subject|3
2346894|NCT03655106|4084793|FG001|Overall Study|Withdrawal by Subject|2
2346895|NCT03655106|4084792|FG000|Overall Study|Lost to Follow-up|2
2346896|NCT03655106|4084793|FG001|Overall Study|Lost to Follow-up|1
2346897|NCT03655106|4084792|FG000|Overall Study|Duplicate Enrollment|1
2346898|NCT03655106|4084793|FG001|Overall Study|Duplicate Enrollment|1
2346899|NCT03655106|4084792|FG000|Overall Study|Protocol Violation|3
2346900|NCT03655106|4084793|FG001|Overall Study|Protocol Violation|0
2346901|NCT03655405|4084805|FG000|Overall Study|Death after initial data collection|4
2346902|NCT03655405|4084806|FG001|Overall Study|Death after initial data collection|2
2346903|NCT03655405|4084805|FG000|Overall Study|Died before initial data collection|1
2346904|NCT03655405|4084806|FG001|Overall Study|Died before initial data collection|2
2346905|NCT03655405|4084805|FG000|Overall Study|Protocol Violation|0
2346906|NCT03655405|4084806|FG001|Overall Study|Protocol Violation|1
2263776|NCT02163993|3936208|FG000|Treatment Period|Protocol Violation|2
2263777|NCT02163993|3936209|FG001|Treatment Period|Protocol Violation|1
2263778|NCT02163993|3936210|FG002|Treatment Period|Protocol Violation|0
2263779|NCT02163993|3936211|FG003|Treatment Period|Protocol Violation|1
2263780|NCT02163993|3936212|FG004|Treatment Period|Protocol Violation|2
2263781|NCT02163993|3936208|FG000|Treatment Period|Withdrawal by Subject|6
2263782|NCT02163993|3936209|FG001|Treatment Period|Withdrawal by Subject|4
2263783|NCT02163993|3936210|FG002|Treatment Period|Withdrawal by Subject|1
2263784|NCT02163993|3936211|FG003|Treatment Period|Withdrawal by Subject|4
2263785|NCT02163993|3936212|FG004|Treatment Period|Withdrawal by Subject|1
2263786|NCT02163993|3936208|FG000|Treatment Period|Not treated|1
2263787|NCT02163993|3936209|FG001|Treatment Period|Not treated|0
2263788|NCT02163993|3936210|FG002|Treatment Period|Not treated|0
2263789|NCT02163993|3936211|FG003|Treatment Period|Not treated|1
2263790|NCT02163993|3936212|FG004|Treatment Period|Not treated|2
2263791|NCT02163993|3936208|FG000|Post-treatment Period|Adverse Event|0
2263792|NCT02163993|3936209|FG001|Post-treatment Period|Adverse Event|0
2263793|NCT02163993|3936210|FG002|Post-treatment Period|Adverse Event|1
2263794|NCT02163993|3936211|FG003|Post-treatment Period|Adverse Event|0
2263795|NCT02163993|3936212|FG004|Post-treatment Period|Adverse Event|0
2263796|NCT02163993|3936208|FG000|Post-treatment Period|Lost to Follow-up|2
2263797|NCT02163993|3936209|FG001|Post-treatment Period|Lost to Follow-up|2
2263798|NCT02163993|3936210|FG002|Post-treatment Period|Lost to Follow-up|3
2263799|NCT02163993|3936211|FG003|Post-treatment Period|Lost to Follow-up|1
2263800|NCT02163993|3936212|FG004|Post-treatment Period|Lost to Follow-up|0
2263801|NCT02163993|3936208|FG000|Post-treatment Period|Protocol Violation|0
2263802|NCT02163993|3936209|FG001|Post-treatment Period|Protocol Violation|0
2263803|NCT02163993|3936210|FG002|Post-treatment Period|Protocol Violation|0
2263804|NCT02163993|3936211|FG003|Post-treatment Period|Protocol Violation|0
2263805|NCT02163993|3936212|FG004|Post-treatment Period|Protocol Violation|1
2263806|NCT02163993|3936208|FG000|Post-treatment Period|Withdrawal by Subject|2
2263807|NCT02163993|3936209|FG001|Post-treatment Period|Withdrawal by Subject|4
2263808|NCT02163993|3936210|FG002|Post-treatment Period|Withdrawal by Subject|0
2263809|NCT02163993|3936211|FG003|Post-treatment Period|Withdrawal by Subject|1
2263810|NCT02163993|3936212|FG004|Post-treatment Period|Withdrawal by Subject|2
2263811|NCT02164318|3936248|FG000|Overall Study|Withdrawal by Subject|0
2263812|NCT02164318|3936249|FG001|Overall Study|Withdrawal by Subject|1
2263813|NCT02164318|3936250|FG002|Overall Study|Withdrawal by Subject|0
2263814|NCT02164318|3936251|FG003|Overall Study|Withdrawal by Subject|1
2263815|NCT02164383|3936263|FG000|Overall Study|Lost to Follow-up|1
2263816|NCT02164383|3936264|FG001|Overall Study|Lost to Follow-up|0
2263817|NCT02164513|3936299|FG000|Overall Study|Adverse Event|162
2263818|NCT02164513|3936300|FG001|Overall Study|Adverse Event|180
2263819|NCT02164513|3936301|FG002|Overall Study|Adverse Event|111
2263820|NCT02164513|3936299|FG000|Overall Study|Other: Study Closed or terminated|5
2263821|NCT02164513|3936300|FG001|Overall Study|Other: Study Closed or terminated|2
2263822|NCT02164513|3936301|FG002|Overall Study|Other: Study Closed or terminated|4
2263823|NCT02164513|3936299|FG000|Overall Study|Lost to Follow-up|30
2263824|NCT02164513|3936300|FG001|Overall Study|Lost to Follow-up|36
2263825|NCT02164513|3936301|FG002|Overall Study|Lost to Follow-up|22
2263826|NCT02164513|3936299|FG000|Overall Study|Physician Decision|47
2263827|NCT02164513|3936300|FG001|Overall Study|Physician Decision|57
2263828|NCT02164513|3936301|FG002|Overall Study|Physician Decision|28
2263829|NCT02164513|3936299|FG000|Overall Study|Withdrawal by Subject|192
2263830|NCT02164513|3936300|FG001|Overall Study|Withdrawal by Subject|261
2263831|NCT02164513|3936301|FG002|Overall Study|Withdrawal by Subject|130
2263832|NCT02164513|3936299|FG000|Overall Study|Other: Reason not provided by site|1
2263833|NCT02164513|3936300|FG001|Overall Study|Other: Reason not provided by site|0
2263834|NCT02164513|3936301|FG002|Overall Study|Other: Reason not provided by site|0
2263835|NCT02164539|3936316|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
2263836|NCT02164539|3936317|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
2263837|NCT02164539|3936318|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
2263838|NCT02164539|3936319|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
2263839|NCT02164539|3936320|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
2263840|NCT02164539|3936321|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
2263841|NCT02164539|3936322|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
2263842|NCT02164539|3936316|FG000|Treatment Phase B (1 Week)|Adverse Event|0
2263843|NCT02164539|3936317|FG001|Treatment Phase B (1 Week)|Adverse Event|0
2263844|NCT02164539|3936318|FG002|Treatment Phase B (1 Week)|Adverse Event|0
2263845|NCT02164539|3936319|FG003|Treatment Phase B (1 Week)|Adverse Event|0
2263846|NCT02164539|3936320|FG004|Treatment Phase B (1 Week)|Adverse Event|2
2263847|NCT02164539|3936321|FG005|Treatment Phase B (1 Week)|Adverse Event|0
2263848|NCT02164539|3936322|FG006|Treatment Phase B (1 Week)|Adverse Event|0
2263849|NCT02164539|3936316|FG000|Treatment Phase B (1 Week)|Physician Decision|0
2263850|NCT02164539|3936317|FG001|Treatment Phase B (1 Week)|Physician Decision|0
2263851|NCT02164539|3936318|FG002|Treatment Phase B (1 Week)|Physician Decision|0
2263852|NCT02164539|3936319|FG003|Treatment Phase B (1 Week)|Physician Decision|0
2263853|NCT02164539|3936320|FG004|Treatment Phase B (1 Week)|Physician Decision|1
2263854|NCT02164539|3936321|FG005|Treatment Phase B (1 Week)|Physician Decision|0
2263855|NCT02164539|3936322|FG006|Treatment Phase B (1 Week)|Physician Decision|1
2263856|NCT02164539|3936316|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1
2263857|NCT02164539|3936317|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2263858|NCT02164539|3936318|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2346907|NCT03655951|4084823|FG000|Overall Study|Lost to Follow-up|39
2346908|NCT03655951|4084824|FG001|Overall Study|Lost to Follow-up|20
2346909|NCT03655951|4084823|FG000|Overall Study|Withdrawal by Subject|0
2346910|NCT03655951|4084824|FG001|Overall Study|Withdrawal by Subject|1
2263859|NCT02164539|3936319|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2263860|NCT02164539|3936320|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2263861|NCT02164539|3936321|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2263862|NCT02164539|3936322|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2263863|NCT02164539|3936316|FG000|Treatment Phase C (1 Week)|Adverse Event|0
2263864|NCT02164539|3936317|FG001|Treatment Phase C (1 Week)|Adverse Event|0
2263865|NCT02164539|3936318|FG002|Treatment Phase C (1 Week)|Adverse Event|0
2263866|NCT02164539|3936319|FG003|Treatment Phase C (1 Week)|Adverse Event|0
2263867|NCT02164539|3936320|FG004|Treatment Phase C (1 Week)|Adverse Event|0
2263868|NCT02164539|3936321|FG005|Treatment Phase C (1 Week)|Adverse Event|0
2263869|NCT02164539|3936322|FG006|Treatment Phase C (1 Week)|Adverse Event|1
2263870|NCT02164539|3936316|FG000|Treatment Phase C (1 Week)|Physician Decision|0
2263871|NCT02164539|3936317|FG001|Treatment Phase C (1 Week)|Physician Decision|0
2263872|NCT02164539|3936318|FG002|Treatment Phase C (1 Week)|Physician Decision|0
2263873|NCT02164539|3936319|FG003|Treatment Phase C (1 Week)|Physician Decision|0
2263874|NCT02164539|3936320|FG004|Treatment Phase C (1 Week)|Physician Decision|0
2263875|NCT02164539|3936321|FG005|Treatment Phase C (1 Week)|Physician Decision|0
2263876|NCT02164539|3936322|FG006|Treatment Phase C (1 Week)|Physician Decision|1
2263877|NCT02164864|3936345|FG000|Overall Study|Trial disease worsening|7
2263878|NCT02164864|3936346|FG001|Overall Study|Trial disease worsening|5
2263879|NCT02164864|3936347|FG002|Overall Study|Trial disease worsening|1
2263880|NCT02164864|3936345|FG000|Overall Study|Other pre-existing disease worsening|6
2263881|NCT02164864|3936346|FG001|Overall Study|Other pre-existing disease worsening|4
2263882|NCT02164864|3936347|FG002|Overall Study|Other pre-existing disease worsening|9
2263883|NCT02164864|3936345|FG000|Overall Study|Other Adverse Event (AE)|52
2263884|NCT02164864|3936346|FG001|Overall Study|Other Adverse Event (AE)|32
2263885|NCT02164864|3936347|FG002|Overall Study|Other Adverse Event (AE)|49
2263886|NCT02164864|3936345|FG000|Overall Study|Protocol Violation|2
2263887|NCT02164864|3936346|FG001|Overall Study|Protocol Violation|4
2263888|NCT02164864|3936347|FG002|Overall Study|Protocol Violation|1
2263889|NCT02164864|3936345|FG000|Overall Study|Lost to Follow-up|4
2263890|NCT02164864|3936346|FG001|Overall Study|Lost to Follow-up|3
2263891|NCT02164864|3936347|FG002|Overall Study|Lost to Follow-up|2
2263892|NCT02164864|3936345|FG000|Overall Study|Consent withdrawn, not due to AE|21
2263893|NCT02164864|3936346|FG001|Overall Study|Consent withdrawn, not due to AE|8
2263894|NCT02164864|3936347|FG002|Overall Study|Consent withdrawn, not due to AE|56
2263895|NCT02164864|3936345|FG000|Overall Study|Other than stated|3
2263896|NCT02164864|3936346|FG001|Overall Study|Other than stated|4
2263897|NCT02164864|3936347|FG002|Overall Study|Other than stated|14
2263898|NCT02164916|3936360|FG000|Overall Study|Adverse Event|3
2263899|NCT02164916|3936361|FG001|Overall Study|Adverse Event|8
2263900|NCT02164916|3936360|FG000|Overall Study|Death|1
2263901|NCT02164916|3936361|FG001|Overall Study|Death|1
2263902|NCT02164916|3936360|FG000|Overall Study|Refusal unrelated to adverse event|3
2263903|NCT02164916|3936361|FG001|Overall Study|Refusal unrelated to adverse event|7
2263904|NCT02164916|3936360|FG000|Overall Study|Progression|37
2263905|NCT02164916|3936361|FG001|Overall Study|Progression|26
2263906|NCT02164916|3936360|FG000|Overall Study|Not protocol specified|5
2346911|NCT03657095|4084838|FG000|Overall Study|Withdrawal by Subject|1
2346912|NCT03657095|4084839|FG001|Overall Study|Withdrawal by Subject|1
2346913|NCT03657095|4084838|FG000|Overall Study|Adverse Event|0
2346914|NCT03657095|4084839|FG001|Overall Study|Adverse Event|3
2346915|NCT03657095|4084838|FG000|Overall Study|Study Terminated by Sponsor|58
2346916|NCT03657095|4084839|FG001|Overall Study|Study Terminated by Sponsor|49
2346917|NCT03657277|4084868|FG000|Overall Study|Physician Decision|2
2346918|NCT03657277|4084868|FG000|Overall Study|Lost to Follow-up|1
2346919|NCT03657277|4084868|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8
2346920|NCT03658811|4084881|FG000|Overall Study|Lost to Follow-up|3
2346921|NCT03658876|4084887|FG000|Overall Study|Protocol Violation|3
2346922|NCT03658876|4084888|FG001|Overall Study|Protocol Violation|2
2346923|NCT03658876|4084887|FG000|Overall Study|Withdrawal by Subject|2
2346924|NCT03658876|4084888|FG001|Overall Study|Withdrawal by Subject|0
2346925|NCT03658876|4084887|FG000|Overall Study|Death|0
2346926|NCT03658876|4084888|FG001|Overall Study|Death|1
2346927|NCT03658876|4084887|FG000|Overall Study|Intercurrent illness|6
2346928|NCT03658876|4084888|FG001|Overall Study|Intercurrent illness|4
2346929|NCT03658876|4084887|FG000|Overall Study|Transplantation/other operation|1
2346930|NCT03658876|4084888|FG001|Overall Study|Transplantation/other operation|5
2346931|NCT03658889|4084896|FG000|Overall Study|Protocol Violation|2
2346932|NCT03658889|4084897|FG001|Overall Study|Protocol Violation|0
2346933|NCT03661983|4085001|FG000|Open Label Stabilization Phase|Adverse Event|5
2346934|NCT03661983|4085002|FG001|Open Label Stabilization Phase|Adverse Event|0
2346935|NCT03661983|4085003|FG002|Open Label Stabilization Phase|Adverse Event|0
2346936|NCT03661983|4085004|FG003|Open Label Stabilization Phase|Adverse Event|0
2346937|NCT03661983|4085001|FG000|Open Label Stabilization Phase|Lack of Efficacy|1
2346938|NCT03661983|4085002|FG001|Open Label Stabilization Phase|Lack of Efficacy|0
2346939|NCT03661983|4085003|FG002|Open Label Stabilization Phase|Lack of Efficacy|0
2346940|NCT03661983|4085004|FG003|Open Label Stabilization Phase|Lack of Efficacy|0
2346941|NCT03661983|4085001|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2
2346942|NCT03661983|4085002|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
2346943|NCT03661983|4085003|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
2346944|NCT03661983|4085004|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
2346945|NCT03661983|4085001|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3
2263907|NCT02164916|3936361|FG001|Overall Study|Not protocol specified|1
2263908|NCT02164916|3936360|FG000|Overall Study|Reason under review|1
2263909|NCT02164916|3936361|FG001|Overall Study|Reason under review|6
2263910|NCT02164916|3936360|FG000|Overall Study|Not eligible|2
2263911|NCT02164916|3936361|FG001|Overall Study|Not eligible|5
2263912|NCT02164929|3936376|FG000|Overall Study|Converted to open procedure|1
2263913|NCT02164929|3936377|FG001|Overall Study|Converted to open procedure|0
2263914|NCT02164929|3936378|FG002|Overall Study|Converted to open procedure|0
2263915|NCT02164929|3936379|FG003|Overall Study|Converted to open procedure|2
2263916|NCT02164929|3936376|FG000|Overall Study|Failed regional block|0
2263917|NCT02164929|3936377|FG001|Overall Study|Failed regional block|0
2263918|NCT02164929|3936378|FG002|Overall Study|Failed regional block|1
2263919|NCT02164929|3936379|FG003|Overall Study|Failed regional block|0
2263920|NCT02164981|3936392|FG000|Started|Withdrawal by Subject|2
2263921|NCT02164981|3936393|FG001|Started|Withdrawal by Subject|1
2263922|NCT02164981|3936394|FG002|Started|Withdrawal by Subject|0
2263923|NCT02164981|3936392|FG000|Started|Protocol Violation|2
2263924|NCT02164981|3936393|FG001|Started|Protocol Violation|0
2263925|NCT02164981|3936394|FG002|Started|Protocol Violation|0
2263926|NCT02164981|3936392|FG000|Started|Adverse Event|1
2263927|NCT02164981|3936393|FG001|Started|Adverse Event|2
2263928|NCT02164981|3936394|FG002|Started|Adverse Event|0
2263929|NCT02164981|3936392|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0
2263930|NCT02164981|3936393|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2
2263931|NCT02164981|3936394|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0
2263932|NCT02164981|3936392|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2
2263933|NCT02164981|3936393|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1
2263934|NCT02164981|3936394|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0
2263935|NCT02164981|3936392|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
2263936|NCT02164981|3936393|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
2263937|NCT02164981|3936394|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
2263938|NCT02165202|3936436|FG000|Oral Phase|Refused further participation|5
2263939|NCT02165202|3936437|FG001|Oral Phase|Refused further participation|1
2263940|NCT02165202|3936436|FG000|Oral Phase|Study product Related Toxicity|1
2263941|NCT02165202|3936437|FG001|Oral Phase|Study product Related Toxicity|0
2346946|NCT03661983|4085002|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0
2346947|NCT03661983|4085003|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0
2263942|NCT02165202|3936436|FG000|Oral Phase|Unable to contact Participant|1
2263943|NCT02165202|3936437|FG001|Oral Phase|Unable to contact Participant|1
2263944|NCT02165202|3936436|FG000|Oral Phase|Clinical reasons|1
2263945|NCT02165202|3936437|FG001|Oral Phase|Clinical reasons|0
2263946|NCT02165202|3936436|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1
2263947|NCT02165202|3936437|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0
2263948|NCT02165202|3936436|FG000|Oral Phase|CMC advised termination|1
2263949|NCT02165202|3936437|FG001|Oral Phase|CMC advised termination|0
2263950|NCT02165202|3936436|FG000|Oral Phase|Relocated, no follow-up planned|1
2263951|NCT02165202|3936437|FG001|Oral Phase|Relocated, no follow-up planned|0
2263952|NCT02165202|3936436|FG000|Oral Phase|Abnormal EKG|0
2263953|NCT02165202|3936437|FG001|Oral Phase|Abnormal EKG|1
2263954|NCT02165202|3936436|FG000|Injection Phase|Abnormal Lab Value|5
2263955|NCT02165202|3936437|FG001|Injection Phase|Abnormal Lab Value|1
2263956|NCT02165202|3936436|FG000|Injection Phase|Reactive HIV or HIV Suspected|0
2263957|NCT02165202|3936437|FG001|Injection Phase|Reactive HIV or HIV Suspected|2
2263958|NCT02165202|3936436|FG000|Injection Phase|Unable to attend within Visit Window|1
2263959|NCT02165202|3936437|FG001|Injection Phase|Unable to attend within Visit Window|0
2263960|NCT02165202|3936436|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0
2263961|NCT02165202|3936437|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1
2263962|NCT02165202|3936436|FG000|Injection Phase|End of Study|2
2263963|NCT02165202|3936437|FG001|Injection Phase|End of Study|1
2263964|NCT02165202|3936436|FG000|Injection Phase|Study Product related Toxicity|1
2263965|NCT02165202|3936437|FG001|Injection Phase|Study Product related Toxicity|0
2263966|NCT02165202|3936436|FG000|Injection Phase|No longer interested|0
2263967|NCT02165202|3936437|FG001|Injection Phase|No longer interested|1
2263968|NCT02165202|3936436|FG000|Injection Phase|Participant unwilling to comply|1
2263969|NCT02165202|3936437|FG001|Injection Phase|Participant unwilling to comply|0
2263970|NCT02165397|3936450|FG000|Overall Study|Death|7
2263971|NCT02165397|3936451|FG001|Overall Study|Death|10
2263972|NCT02165397|3936452|FG002|Overall Study|Death|8
2263973|NCT02165397|3936450|FG000|Overall Study|Lost to Follow-up|1
2263974|NCT02165397|3936451|FG001|Overall Study|Lost to Follow-up|3
2263975|NCT02165397|3936452|FG002|Overall Study|Lost to Follow-up|0
2263976|NCT02165397|3936450|FG000|Overall Study|Withdrawal by Subject|6
2263977|NCT02165397|3936451|FG001|Overall Study|Withdrawal by Subject|6
2263978|NCT02165397|3936452|FG002|Overall Study|Withdrawal by Subject|1
2263979|NCT02165397|3936450|FG000|Overall Study|Other, Not Specified|0
2263980|NCT02165397|3936451|FG001|Overall Study|Other, Not Specified|0
2263981|NCT02165397|3936452|FG002|Overall Study|Other, Not Specified|1
2263982|NCT02165735|3936490|FG000|Overall Study|Lost to Follow-up|12
2263983|NCT02165735|3936491|FG001|Overall Study|Lost to Follow-up|10
2263984|NCT02165735|3936490|FG000|Overall Study|Withdrawal by Subject|3
2263985|NCT02165735|3936491|FG001|Overall Study|Withdrawal by Subject|0
2263986|NCT02165735|3936490|FG000|Overall Study|Participant indicated lack of time|1
2263987|NCT02165735|3936491|FG001|Overall Study|Participant indicated lack of time|3
2263988|NCT02165735|3936490|FG000|Overall Study|Protocol Violation|0
2263989|NCT02165735|3936491|FG001|Overall Study|Protocol Violation|1
2263990|NCT02165826|3936509|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44
2263991|NCT02165826|3936510|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57
2263992|NCT02165826|3936511|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68
2263993|NCT02165826|3936509|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0
2263994|NCT02165826|3936510|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1
2263995|NCT02165826|3936511|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3
2263996|NCT02165826|3936509|FG000|Main Treatment Period|Lost to Follow-up|4
2263997|NCT02165826|3936510|FG001|Main Treatment Period|Lost to Follow-up|2
2263998|NCT02165826|3936511|FG002|Main Treatment Period|Lost to Follow-up|1
2263999|NCT02165826|3936509|FG000|Main Treatment Period|Voluntary Withdrawal|23
2264000|NCT02165826|3936510|FG001|Main Treatment Period|Voluntary Withdrawal|23
2264001|NCT02165826|3936511|FG002|Main Treatment Period|Voluntary Withdrawal|21
2264002|NCT02165826|3936509|FG000|Main Treatment Period|Lack of Efficacy|2
2264003|NCT02165826|3936510|FG001|Main Treatment Period|Lack of Efficacy|0
2264004|NCT02165826|3936511|FG002|Main Treatment Period|Lack of Efficacy|0
2264005|NCT02165826|3936509|FG000|Main Treatment Period|Reason Not Specified|8
2264006|NCT02165826|3936510|FG001|Main Treatment Period|Reason Not Specified|5
2264007|NCT02165826|3936511|FG002|Main Treatment Period|Reason Not Specified|16
2264008|NCT02165826|3936509|FG000|Main Treatment Period|Did Not Receive Study Drug|0
2264009|NCT02165826|3936510|FG001|Main Treatment Period|Did Not Receive Study Drug|2
2264010|NCT02165826|3936511|FG002|Main Treatment Period|Did Not Receive Study Drug|0
2264011|NCT02165826|3936509|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4
2264012|NCT02165826|3936510|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10
2264013|NCT02165826|3936511|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3
2264014|NCT02165826|3936509|FG000|Down-Titration Period|Voluntary Withdrawal|2
2264015|NCT02165826|3936510|FG001|Down-Titration Period|Voluntary Withdrawal|1
2264016|NCT02165826|3936511|FG002|Down-Titration Period|Voluntary Withdrawal|2
2264017|NCT02165826|3936509|FG000|Down-Titration Period|Reason Not Specified|1
2264018|NCT02165826|3936510|FG001|Down-Titration Period|Reason Not Specified|0
2264019|NCT02165826|3936511|FG002|Down-Titration Period|Reason Not Specified|2
2264020|NCT02166047|3936562|FG000|Overall Study|Withdrawal by Participant|0
2264021|NCT02166047|3936563|FG001|Overall Study|Withdrawal by Participant|1
2264022|NCT02166047|3936564|FG002|Overall Study|Withdrawal by Participant|2
2264023|NCT02166047|3936565|FG003|Overall Study|Withdrawal by Participant|0
2264024|NCT02166047|3936566|FG004|Overall Study|Withdrawal by Participant|0
2264025|NCT02166047|3936567|FG005|Overall Study|Withdrawal by Participant|0
2264026|NCT02166047|3936568|FG006|Overall Study|Withdrawal by Participant|1
2264027|NCT02166047|3936569|FG007|Overall Study|Withdrawal by Participant|0
2264028|NCT02166047|3936570|FG008|Overall Study|Withdrawal by Participant|0
2264029|NCT02166047|3936571|FG009|Overall Study|Withdrawal by Participant|0
2264030|NCT02166047|3936572|FG010|Overall Study|Withdrawal by Participant|0
2264031|NCT02166047|3936573|FG011|Overall Study|Withdrawal by Participant|0
2264032|NCT02166047|3936562|FG000|Overall Study|Adverse Event|0
2264033|NCT02166047|3936563|FG001|Overall Study|Adverse Event|0
2264034|NCT02166047|3936564|FG002|Overall Study|Adverse Event|0
2264035|NCT02166047|3936565|FG003|Overall Study|Adverse Event|0
2264036|NCT02166047|3936566|FG004|Overall Study|Adverse Event|1
2264037|NCT02166047|3936567|FG005|Overall Study|Adverse Event|0
2264038|NCT02166047|3936568|FG006|Overall Study|Adverse Event|1
2264039|NCT02166047|3936569|FG007|Overall Study|Adverse Event|0
2264040|NCT02166047|3936570|FG008|Overall Study|Adverse Event|0
2264041|NCT02166047|3936571|FG009|Overall Study|Adverse Event|0
2264042|NCT02166047|3936572|FG010|Overall Study|Adverse Event|2
2264043|NCT02166047|3936573|FG011|Overall Study|Adverse Event|0
2264044|NCT02166333|3936603|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4
2346948|NCT03661983|4085004|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0
2346949|NCT03661983|4085001|FG000|Double-blind Randomized Phase|Adverse Event|0
2346950|NCT03661983|4085002|FG001|Double-blind Randomized Phase|Adverse Event|1
2346951|NCT03661983|4085003|FG002|Double-blind Randomized Phase|Adverse Event|0
2346952|NCT03661983|4085004|FG003|Double-blind Randomized Phase|Adverse Event|0
2346953|NCT03661983|4085001|FG000|Double-blind Randomized Phase|Disease Relapse|0
2346954|NCT03661983|4085002|FG001|Double-blind Randomized Phase|Disease Relapse|0
2346955|NCT03661983|4085003|FG002|Double-blind Randomized Phase|Disease Relapse|0
2346956|NCT03661983|4085004|FG003|Double-blind Randomized Phase|Disease Relapse|6
2346957|NCT03661983|4085001|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
2346958|NCT03661983|4085002|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
2346959|NCT03661983|4085003|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
2346960|NCT03661983|4085004|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1
2346961|NCT03661983|4085001|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0
2346962|NCT03661983|4085002|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1
2346963|NCT03661983|4085003|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1
2346964|NCT03661983|4085004|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1
2264045|NCT02166333|3936604|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
2264046|NCT02166333|3936605|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
2264047|NCT02166333|3936606|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
2264048|NCT02166333|3936607|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3
2264049|NCT02166333|3936608|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1
2264050|NCT02166333|3936603|FG000|Stage 1|Death|4
2264051|NCT02166333|3936604|FG001|Stage 1|Death|0
2264052|NCT02166333|3936605|FG002|Stage 1|Death|2
2264053|NCT02166333|3936606|FG003|Stage 1|Death|0
2264054|NCT02166333|3936607|FG004|Stage 1|Death|3
2264055|NCT02166333|3936608|FG005|Stage 1|Death|2
2264056|NCT02166333|3936603|FG000|Stage 1|Lost to Follow-up|12
2264057|NCT02166333|3936604|FG001|Stage 1|Lost to Follow-up|0
2264058|NCT02166333|3936605|FG002|Stage 1|Lost to Follow-up|6
2264059|NCT02166333|3936606|FG003|Stage 1|Lost to Follow-up|0
2264060|NCT02166333|3936607|FG004|Stage 1|Lost to Follow-up|3
2264061|NCT02166333|3936608|FG005|Stage 1|Lost to Follow-up|3
2264062|NCT02166333|3936603|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180
2264063|NCT02166333|3936604|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
2264064|NCT02166333|3936605|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63
2264065|NCT02166333|3936606|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
2264066|NCT02166333|3936607|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54
2264067|NCT02166333|3936608|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52
2264068|NCT02166333|3936603|FG000|Stage 2|Death|4
2264069|NCT02166333|3936604|FG001|Stage 2|Death|2
2264070|NCT02166333|3936605|FG002|Stage 2|Death|1
2264071|NCT02166333|3936606|FG003|Stage 2|Death|0
2264072|NCT02166333|3936607|FG004|Stage 2|Death|0
2264073|NCT02166333|3936608|FG005|Stage 2|Death|1
2264074|NCT02166333|3936603|FG000|Stage 2|Lost to Follow-up|23
2264075|NCT02166333|3936604|FG001|Stage 2|Lost to Follow-up|4
2264076|NCT02166333|3936605|FG002|Stage 2|Lost to Follow-up|11
2264077|NCT02166333|3936606|FG003|Stage 2|Lost to Follow-up|9
2264078|NCT02166333|3936607|FG004|Stage 2|Lost to Follow-up|3
2264079|NCT02166333|3936608|FG005|Stage 2|Lost to Follow-up|6
2264080|NCT02166476|3936629|FG000|Overall Study|Withdrawal by Subject|5
2264081|NCT02166476|3936630|FG001|Overall Study|Withdrawal by Subject|7
2264082|NCT02166476|3936629|FG000|Overall Study|Adverse Event|3
2264083|NCT02166476|3936630|FG001|Overall Study|Adverse Event|3
2264084|NCT02166476|3936629|FG000|Overall Study|Lost to Follow-up|5
2264085|NCT02166476|3936630|FG001|Overall Study|Lost to Follow-up|10
2264086|NCT02166476|3936629|FG000|Overall Study|Physician Decision|1
2264087|NCT02166476|3936630|FG001|Overall Study|Physician Decision|0
2264088|NCT02166476|3936629|FG000|Overall Study|Unable to Come for Visit|0
2264089|NCT02166476|3936630|FG001|Overall Study|Unable to Come for Visit|3
2264090|NCT02166606|3936639|FG000|Overall Study|Adverse Event|3
2264091|NCT02166606|3936639|FG000|Overall Study|Death|31
2264092|NCT02166606|3936639|FG000|Overall Study|Protocol Violation|7
2264093|NCT02166606|3936639|FG000|Overall Study|Lost to Follow-up|30
2264094|NCT02166606|3936639|FG000|Overall Study|Withdrawal by Subject|1
2264095|NCT02166606|3936639|FG000|Overall Study|Physician Decision|1
2264096|NCT02166606|3936639|FG000|Overall Study|Device upgrade|1
2346965|NCT03662334|4085034|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
2346966|NCT03662334|4085035|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
2346967|NCT03662750|4085051|FG000|Overall Study|Withdrawal by Subject|1
2346968|NCT03662789|4085057|FG000|Overall Study|Lost to Follow-up|1
2346969|NCT03662789|4085058|FG001|Overall Study|Lost to Follow-up|2
2346970|NCT03662789|4085057|FG000|Overall Study|Could not perform treadmill test|4
2346971|NCT03662789|4085058|FG001|Overall Study|Could not perform treadmill test|4
2346972|NCT03662789|4085057|FG000|Overall Study|Death|0
2346973|NCT03662789|4085058|FG001|Overall Study|Death|1
2346974|NCT03662997|4085068|FG000|Overall Study|Adverse Event|0
2346975|NCT03662997|4085069|FG001|Overall Study|Adverse Event|2
2346976|NCT03662997|4085070|FG002|Overall Study|Adverse Event|0
2346977|NCT03662997|4085071|FG003|Overall Study|Adverse Event|0
2346978|NCT03663179|4085102|FG000|Overall Study|Withdrawal by Subject|2
2346979|NCT03663179|4085103|FG001|Overall Study|Withdrawal by Subject|0
2346980|NCT03663179|4085102|FG000|Overall Study|Lost to Follow-up|1
2346981|NCT03663179|4085103|FG001|Overall Study|Lost to Follow-up|1
2346982|NCT03663179|4085102|FG000|Overall Study|Revealed exclusionary condition|1
2346983|NCT03663179|4085103|FG001|Overall Study|Revealed exclusionary condition|0
2346984|NCT03663569|4085127|FG000|Overall Study|Discontinuation of study|11
2346985|NCT03663569|4085127|FG000|Overall Study|Never taken Spiolto® Respimat®|1
2264097|NCT02166606|3936639|FG000|Overall Study|Enrolled after End of Enrollment|4
2264098|NCT02166697|3936643|FG000|Overall Study|Protocol Violation|347
2264099|NCT02167035|3936649|FG000|Overall Study|Adverse Event|2
2264100|NCT02167035|3936650|FG001|Overall Study|Adverse Event|2
2346986|NCT03663569|4085127|FG000|Overall Study|Deceased patient|6
2346987|NCT03663569|4085127|FG000|Overall Study|Lost to Follow-up|18
2346988|NCT03663569|4085127|FG000|Overall Study|Withdrawal of consent|5
2346989|NCT03663569|4085127|FG000|Overall Study|Patient's request|11
2346990|NCT03663569|4085127|FG000|Overall Study|Adverse Event|4
2264101|NCT02167035|3936649|FG000|Overall Study|Lost to Follow-up|3
2264102|NCT02167035|3936650|FG001|Overall Study|Lost to Follow-up|3
2264103|NCT02167035|3936649|FG000|Overall Study|Randomized to incorrect Study Medication|0
2264104|NCT02167035|3936650|FG001|Overall Study|Randomized to incorrect Study Medication|1
2264105|NCT02167139|3936669|FG000|Randomised, Double-blind|Withdrawal by Subject|11
2264106|NCT02167139|3936670|FG001|Randomised, Double-blind|Withdrawal by Subject|8
2264107|NCT02167139|3936671|FG002|Randomised, Double-blind|Withdrawal by Subject|0
2264108|NCT02167139|3936672|FG003|Randomised, Double-blind|Withdrawal by Subject|0
2264109|NCT02167139|3936669|FG000|Randomised, Double-blind|Adverse Event|2
2264110|NCT02167139|3936670|FG001|Randomised, Double-blind|Adverse Event|9
2264111|NCT02167139|3936671|FG002|Randomised, Double-blind|Adverse Event|0
2264112|NCT02167139|3936672|FG003|Randomised, Double-blind|Adverse Event|0
2264113|NCT02167139|3936669|FG000|Randomised, Double-blind|Lack of Efficacy|1
2264114|NCT02167139|3936670|FG001|Randomised, Double-blind|Lack of Efficacy|2
2264115|NCT02167139|3936671|FG002|Randomised, Double-blind|Lack of Efficacy|0
2264116|NCT02167139|3936672|FG003|Randomised, Double-blind|Lack of Efficacy|0
2264117|NCT02167139|3936669|FG000|Randomised, Double-blind|Other|3
2264118|NCT02167139|3936670|FG001|Randomised, Double-blind|Other|0
2264119|NCT02167139|3936671|FG002|Randomised, Double-blind|Other|0
2264120|NCT02167139|3936672|FG003|Randomised, Double-blind|Other|0
2264121|NCT02167139|3936669|FG000|Transition-extension|Adverse Event|2
2264122|NCT02167139|3936670|FG001|Transition-extension|Adverse Event|0
2264123|NCT02167139|3936671|FG002|Transition-extension|Adverse Event|2
2264124|NCT02167139|3936672|FG003|Transition-extension|Adverse Event|3
2264125|NCT02167139|3936669|FG000|Transition-extension|Withdrawal by Subject|2
2264126|NCT02167139|3936670|FG001|Transition-extension|Withdrawal by Subject|0
2264127|NCT02167139|3936671|FG002|Transition-extension|Withdrawal by Subject|4
2264128|NCT02167139|3936672|FG003|Transition-extension|Withdrawal by Subject|1
2264129|NCT02167139|3936669|FG000|Transition-extension|Lack of Efficacy|0
2264130|NCT02167139|3936670|FG001|Transition-extension|Lack of Efficacy|0
2264131|NCT02167139|3936671|FG002|Transition-extension|Lack of Efficacy|1
2264132|NCT02167139|3936672|FG003|Transition-extension|Lack of Efficacy|1
2264133|NCT02167139|3936669|FG000|Transition-extension|Other|1
2264134|NCT02167139|3936670|FG001|Transition-extension|Other|0
2264135|NCT02167139|3936671|FG002|Transition-extension|Other|1
2264136|NCT02167139|3936672|FG003|Transition-extension|Other|0
2264137|NCT02167139|3936669|FG000|Transition-extension|Lost to Follow-up|1
2264138|NCT02167139|3936670|FG001|Transition-extension|Lost to Follow-up|0
2264139|NCT02167139|3936671|FG002|Transition-extension|Lost to Follow-up|0
2264140|NCT02167139|3936672|FG003|Transition-extension|Lost to Follow-up|0
2264141|NCT02167256|3936702|FG000|Overall Study|Adverse Event|13
2264142|NCT02167256|3936703|FG001|Overall Study|Adverse Event|6
2264143|NCT02167256|3936702|FG000|Overall Study|Withdrawal by Subject|4
2264144|NCT02167256|3936703|FG001|Overall Study|Withdrawal by Subject|4
2264145|NCT02167256|3936702|FG000|Overall Study|non-compliance|3
2264146|NCT02167256|3936703|FG001|Overall Study|non-compliance|0
2264147|NCT02167256|3936702|FG000|Overall Study|Study partner unable to participate|1
2264148|NCT02167256|3936703|FG001|Overall Study|Study partner unable to participate|0
2264149|NCT02167451|3936709|FG000|Overall Study|Withdrawal by Subject|1
2264150|NCT02167594|3936716|FG000|Overall Study|Withdrawal by Subject|2
2264151|NCT02167594|3936717|FG001|Overall Study|Withdrawal by Subject|0
2264152|NCT02167594|3936718|FG002|Overall Study|Withdrawal by Subject|0
2264153|NCT02167594|3936716|FG000|Overall Study|Death|0
2264154|NCT02167594|3936717|FG001|Overall Study|Death|1
2264155|NCT02167594|3936718|FG002|Overall Study|Death|0
2264156|NCT02167893|3936746|FG000|Overall Study|Investigator transferred|85
2264157|NCT02167893|3936746|FG000|Overall Study|Investigator health reasons|10
2264158|NCT02167893|3936746|FG000|Overall Study|Case report forms not collected|68
2264159|NCT02168101|3936768|FG000|Overall Study|Death|2
2264160|NCT02168101|3936769|FG001|Overall Study|Death|2
2264161|NCT02168101|3936770|FG002|Overall Study|Death|1
2264162|NCT02168387|3936808|FG000|Overall Study|Planned exubation|6
2264163|NCT02168387|3936809|FG001|Overall Study|Planned exubation|3
2264164|NCT02168387|3936808|FG000|Overall Study|Death|1
2264165|NCT02168387|3936809|FG001|Overall Study|Death|0
2264166|NCT02168439|3936817|FG000|Overall Study|Protocol Violation|0
2264167|NCT02168439|3936818|FG001|Overall Study|Protocol Violation|2
2264168|NCT02168478|3936824|FG000|Overall Study|Withdrawal by Subject|1
2264169|NCT02168478|3936824|FG000|Overall Study|Did Not Consent to Participation|2
2264170|NCT02168478|3936824|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1
2264171|NCT02168491|3936828|FG000|Overall Study|Withdrawal by Subject|1
2264172|NCT02168777|3936851|FG000|Overall Study|Withdrawal by Subject|1
2264173|NCT02168777|3936852|FG001|Overall Study|Withdrawal by Subject|0
2264174|NCT02168777|3936853|FG002|Overall Study|Withdrawal by Subject|2
2264175|NCT02168777|3936851|FG000|Overall Study|Adverse Event|1
2264176|NCT02168777|3936852|FG001|Overall Study|Adverse Event|0
2264177|NCT02168777|3936853|FG002|Overall Study|Adverse Event|1
2264178|NCT02168777|3936851|FG000|Overall Study|Disease recurrence|0
2264179|NCT02168777|3936852|FG001|Overall Study|Disease recurrence|0
2264180|NCT02168777|3936853|FG002|Overall Study|Disease recurrence|1
2264181|NCT02168777|3936851|FG000|Overall Study|Radiological disease progression|0
2264182|NCT02168777|3936852|FG001|Overall Study|Radiological disease progression|5
2264183|NCT02168777|3936853|FG002|Overall Study|Radiological disease progression|5
2264184|NCT02168777|3936851|FG000|Overall Study|Clinical disease progression|0
2264185|NCT02168777|3936852|FG001|Overall Study|Clinical disease progression|1
2264186|NCT02168777|3936853|FG002|Overall Study|Clinical disease progression|2
2264187|NCT02168777|3936851|FG000|Overall Study|Other reason|0
2264188|NCT02168777|3936852|FG001|Overall Study|Other reason|1
2264189|NCT02168777|3936853|FG002|Overall Study|Other reason|0
2264190|NCT02168803|3936867|FG000|Overall Study|Lost to Follow-up|1
2264191|NCT02168803|3936868|FG001|Overall Study|Lost to Follow-up|0
2264192|NCT02168803|3936869|FG002|Overall Study|Lost to Follow-up|1
2264193|NCT02168803|3936867|FG000|Overall Study|Withdrawal by Subject|1
2264194|NCT02168803|3936868|FG001|Overall Study|Withdrawal by Subject|1
2264195|NCT02168803|3936869|FG002|Overall Study|Withdrawal by Subject|2
2264196|NCT02168803|3936867|FG000|Overall Study|Physician Decision|0
2264197|NCT02168803|3936868|FG001|Overall Study|Physician Decision|1
2264198|NCT02168803|3936869|FG002|Overall Study|Physician Decision|0
2264199|NCT02168803|3936867|FG000|Overall Study|Adverse Event|0
2264200|NCT02168803|3936868|FG001|Overall Study|Adverse Event|1
2264201|NCT02168803|3936869|FG002|Overall Study|Adverse Event|1
2264202|NCT02168803|3936867|FG000|Overall Study|Death|0
2264203|NCT02168803|3936868|FG001|Overall Study|Death|0
2264204|NCT02168803|3936869|FG002|Overall Study|Death|1
2264205|NCT02168803|3936867|FG000|Overall Study|Sponsor Decision|0
2264206|NCT02168803|3936868|FG001|Overall Study|Sponsor Decision|0
2264207|NCT02168803|3936869|FG002|Overall Study|Sponsor Decision|1
2264208|NCT02168816|3936886|FG000|Overall Study|Lost to Follow-up|2
2264209|NCT02168816|3936887|FG001|Overall Study|Lost to Follow-up|2
2264210|NCT02168842|3936895|FG000|Overall Study|Withdrawal by Subject|5
2264211|NCT02168842|3936896|FG001|Overall Study|Withdrawal by Subject|3
2264212|NCT02168842|3936895|FG000|Overall Study|Lost to Follow-up|0
2264213|NCT02168842|3936896|FG001|Overall Study|Lost to Follow-up|2
2264214|NCT02168842|3936895|FG000|Overall Study|Death|2
2264215|NCT02168842|3936896|FG001|Overall Study|Death|1
2264216|NCT02168842|3936895|FG000|Overall Study|Physician Decision|1
2264217|NCT02168842|3936896|FG001|Overall Study|Physician Decision|2
2264218|NCT02168946|3936925|FG000|Overall Study|Adverse Event|8
2264219|NCT02168946|3936926|FG001|Overall Study|Adverse Event|5
2264220|NCT02168946|3936925|FG000|Overall Study|Lost to Follow-up|3
2264221|NCT02168946|3936926|FG001|Overall Study|Lost to Follow-up|0
2264222|NCT02168946|3936925|FG000|Overall Study|Subject unable to come back for visits|1
2264223|NCT02168946|3936926|FG001|Overall Study|Subject unable to come back for visits|0
2264224|NCT02169219|3936946|FG000|Overall Study|Lack of Efficacy|6
2264225|NCT02169271|3936957|FG000|Overall Study|Protocol Violation|1
2264226|NCT02169271|3936958|FG001|Overall Study|Protocol Violation|2
2264227|NCT02169284|3936966|FG000|Overall Study|Physician Decision|0
2264228|NCT02169284|3936967|FG001|Overall Study|Physician Decision|1
2264229|NCT02169336|3936978|FG000|Overall Study|Lack of Efficacy|1
2264230|NCT02169336|3936979|FG001|Overall Study|Lack of Efficacy|1
2264231|NCT02169336|3936980|FG002|Overall Study|Lack of Efficacy|0
2264232|NCT02169336|3936978|FG000|Overall Study|Adverse Event|2
2264233|NCT02169336|3936979|FG001|Overall Study|Adverse Event|3
2264234|NCT02169336|3936980|FG002|Overall Study|Adverse Event|1
2264235|NCT02169336|3936978|FG000|Overall Study|Withdrawal by Subject|1
2264236|NCT02169336|3936979|FG001|Overall Study|Withdrawal by Subject|0
2264237|NCT02169336|3936980|FG002|Overall Study|Withdrawal by Subject|0
2264238|NCT02169336|3936978|FG000|Overall Study|Physician Decision|0
2264239|NCT02169336|3936979|FG001|Overall Study|Physician Decision|0
2264240|NCT02169336|3936980|FG002|Overall Study|Physician Decision|1
2264241|NCT02169336|3936978|FG000|Overall Study|Subject declined to continue dosing|0
2264242|NCT02169336|3936979|FG001|Overall Study|Subject declined to continue dosing|0
2264243|NCT02169336|3936980|FG002|Overall Study|Subject declined to continue dosing|1
2264244|NCT02169414|3936992|FG000|Overall Study|Withdrawal by Subject|1
2264245|NCT02169414|3936993|FG001|Overall Study|Withdrawal by Subject|0
2264246|NCT02169414|3936994|FG002|Overall Study|Withdrawal by Subject|0
2264247|NCT02169414|3936995|FG003|Overall Study|Withdrawal by Subject|0
2264248|NCT02169414|3936992|FG000|Overall Study|Adverse Event|0
2264249|NCT02169414|3936993|FG001|Overall Study|Adverse Event|1
2264250|NCT02169414|3936994|FG002|Overall Study|Adverse Event|0
2264251|NCT02169414|3936995|FG003|Overall Study|Adverse Event|0
2264252|NCT02169505|3937078|FG000|Overall Study|Withdrawal by Subject|1
2346991|NCT03663569|4085127|FG000|Overall Study|Not come to second visit|3
2346992|NCT03663569|4085127|FG000|Overall Study|Not meet inclusion / exclusion criterion|3
2346993|NCT03663569|4085127|FG000|Overall Study|Serious adverse event|1
2346994|NCT03663582|4085131|FG000|Overall Study|Physician Decision|1
2346995|NCT03666858|4085197|FG000|Cohort 1|Adverse Event|1
2346996|NCT03666858|4085198|FG001|Cohort 1|Adverse Event|0
2346997|NCT03666858|4085197|FG000|Cohort 2|Adverse Event|0
2346998|NCT03666858|4085198|FG001|Cohort 2|Adverse Event|1
2346999|NCT03667053|4085207|FG000|Overall Study|Withdrawal by Subject|1
2264253|NCT02169674|3937084|FG000|Overall Study|Withdrawal by Subject|2
2264254|NCT02169674|3937085|FG001|Overall Study|Withdrawal by Subject|1
2347000|NCT03667053|4085208|FG001|Overall Study|Withdrawal by Subject|0
2347001|NCT03667053|4085209|FG002|Overall Study|Withdrawal by Subject|0
2264255|NCT02169674|3937084|FG000|Overall Study|Seroprotected|30
2264256|NCT02169674|3937085|FG001|Overall Study|Seroprotected|76
2264257|NCT02169674|3937084|FG000|Overall Study|Lost to Follow-up|0
2264258|NCT02169674|3937085|FG001|Overall Study|Lost to Follow-up|1
2264259|NCT02169739|3937093|FG000|Overall Study|Lost to Follow-up|0
2264260|NCT02169739|3937094|FG001|Overall Study|Lost to Follow-up|4
2264261|NCT02169791|3937101|FG000|Overall Study|Death|6
2264262|NCT02169791|3937101|FG000|Overall Study|patient withdrew consent|1
2264263|NCT02170025|3937133|FG000|Overall Study|Adverse Event|2
2264264|NCT02170025|3937134|FG001|Overall Study|Adverse Event|0
2264265|NCT02170051|3937142|FG000|Overall Study|Withdrawal by Subject|10
2264266|NCT02170051|3937143|FG001|Overall Study|Withdrawal by Subject|10
2264267|NCT02170051|3937142|FG000|Overall Study|Lost to Follow-up|1
2264268|NCT02170051|3937143|FG001|Overall Study|Lost to Follow-up|3
2347002|NCT03668600|4085228|FG000|Overall Study|Study Terminated by the Sponsor|157
2347003|NCT03668600|4085228|FG000|Overall Study|Protocol Violation|1
2347004|NCT03668600|4085228|FG000|Overall Study|Pregnancy|1
2347005|NCT03668600|4085228|FG000|Overall Study|Lost to Follow-up|7
2347006|NCT03668600|4085228|FG000|Overall Study|Withdrawal by Subject|56
2347007|NCT03668600|4085228|FG000|Overall Study|Lack of Efficacy|7
2347008|NCT03668600|4085228|FG000|Overall Study|Adverse Event|1
2347009|NCT03668613|4085234|FG000|Overall Study|Adverse Event|0
2347010|NCT03668613|4085235|FG001|Overall Study|Adverse Event|2
2347011|NCT03668613|4085234|FG000|Overall Study|Lack of Efficacy|0
2347012|NCT03668613|4085235|FG001|Overall Study|Lack of Efficacy|1
2347013|NCT03669081|4085244|FG000|Overall Study|Data could not be validated|1
2347014|NCT03669081|4085245|FG001|Overall Study|Data could not be validated|1
2347015|NCT03669549|4085269|FG000|Overall Study|Adverse Event|4
2347016|NCT03669549|4085269|FG000|Overall Study|Withdrawal by Subject|1
2347017|NCT03669549|4085269|FG000|Overall Study|Study terminated by the Sponsor|1
2347018|NCT03669861|4085277|FG000|Overall Study|Disease Flare|5
2347019|NCT03669861|4085277|FG000|Overall Study|Lack of Efficacy|2
2264269|NCT02170064|3937152|FG000|Overall Study|Withdrawal by Subject|5
2264270|NCT02170064|3937153|FG001|Overall Study|Withdrawal by Subject|1
2264271|NCT02170064|3937154|FG002|Overall Study|Withdrawal by Subject|1
2264272|NCT02170064|3937152|FG000|Overall Study|Physician Decision|1
2264273|NCT02170064|3937153|FG001|Overall Study|Physician Decision|1
2264274|NCT02170064|3937154|FG002|Overall Study|Physician Decision|0
2264275|NCT02170077|3937165|FG000|Overall Study|Withdrawal by Subject|3
2264276|NCT02170077|3937166|FG001|Overall Study|Withdrawal by Subject|4
2264277|NCT02170077|3937167|FG002|Overall Study|Withdrawal by Subject|2
2264278|NCT02170077|3937165|FG000|Overall Study|Adverse Event|4
2264279|NCT02170077|3937166|FG001|Overall Study|Adverse Event|4
2264280|NCT02170077|3937167|FG002|Overall Study|Adverse Event|4
2264281|NCT02170077|3937165|FG000|Overall Study|Lost to Follow-up|0
2264282|NCT02170077|3937166|FG001|Overall Study|Lost to Follow-up|1
2264283|NCT02170077|3937167|FG002|Overall Study|Lost to Follow-up|0
2264284|NCT02170077|3937165|FG000|Overall Study|Exclusion criteria|2
2264285|NCT02170077|3937166|FG001|Overall Study|Exclusion criteria|2
2264286|NCT02170077|3937167|FG002|Overall Study|Exclusion criteria|5
2264287|NCT02170077|3937165|FG000|Overall Study|Exacerbation of seizures|0
2264288|NCT02170077|3937166|FG001|Overall Study|Exacerbation of seizures|2
2264289|NCT02170077|3937167|FG002|Overall Study|Exacerbation of seizures|1
2264290|NCT02170207|3937175|FG000|Overall Study|Case report forms unavailable|5
2264291|NCT02170389|3937215|FG000|Overall Study|Study terminated prior to start of treat|1
2347020|NCT03670537|4085311|FG000|Overall Study|Protocol Violation|1
2347021|NCT03670641|4085315|FG000|Overall Study|Lost to Follow-up|3
2347022|NCT03670810|4085325|FG000|Overall Study|Adverse Event|36
2347023|NCT03670810|4085326|FG001|Overall Study|Adverse Event|38
2347024|NCT03670810|4085327|FG002|Overall Study|Adverse Event|2
2347025|NCT03670810|4085328|FG003|Overall Study|Adverse Event|4
2347026|NCT03670810|4085325|FG000|Overall Study|Lack of Efficacy|8
2347027|NCT03670810|4085326|FG001|Overall Study|Lack of Efficacy|8
2347028|NCT03670810|4085327|FG002|Overall Study|Lack of Efficacy|3
2347029|NCT03670810|4085328|FG003|Overall Study|Lack of Efficacy|4
2347030|NCT03670810|4085325|FG000|Overall Study|Lost to Follow-up|6
2347031|NCT03670810|4085326|FG001|Overall Study|Lost to Follow-up|6
2347032|NCT03670810|4085327|FG002|Overall Study|Lost to Follow-up|4
2347033|NCT03670810|4085328|FG003|Overall Study|Lost to Follow-up|6
2347034|NCT03670810|4085325|FG000|Overall Study|Non-compliance with Study Drug|0
2347035|NCT03670810|4085326|FG001|Overall Study|Non-compliance with Study Drug|2
2347036|NCT03670810|4085327|FG002|Overall Study|Non-compliance with Study Drug|3
2347037|NCT03670810|4085328|FG003|Overall Study|Non-compliance with Study Drug|0
2347038|NCT03670810|4085325|FG000|Overall Study|Missing|1
2347039|NCT03670810|4085326|FG001|Overall Study|Missing|1
2347040|NCT03670810|4085327|FG002|Overall Study|Missing|0
2347041|NCT03670810|4085328|FG003|Overall Study|Missing|1
2347042|NCT03670810|4085325|FG000|Overall Study|Physician Decision|3
2347043|NCT03670810|4085326|FG001|Overall Study|Physician Decision|0
2347044|NCT03670810|4085327|FG002|Overall Study|Physician Decision|1
2347045|NCT03670810|4085328|FG003|Overall Study|Physician Decision|0
2347046|NCT03670810|4085325|FG000|Overall Study|Pregnancy|1
2347047|NCT03670810|4085326|FG001|Overall Study|Pregnancy|1
2347048|NCT03670810|4085327|FG002|Overall Study|Pregnancy|0
2347049|NCT03670810|4085328|FG003|Overall Study|Pregnancy|0
2347050|NCT03670810|4085325|FG000|Overall Study|Protocol Violation|2
2347051|NCT03670810|4085326|FG001|Overall Study|Protocol Violation|12
2347052|NCT03670810|4085327|FG002|Overall Study|Protocol Violation|8
2347053|NCT03670810|4085328|FG003|Overall Study|Protocol Violation|4
2264292|NCT02170688|3937258|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4
2264293|NCT02170688|3937259|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2
2264294|NCT02170688|3937260|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3
2264295|NCT02170688|3937261|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2
2264296|NCT02170688|3937262|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0
2264297|NCT02170688|3937258|FG000|Overall Study|Full dose not received|0
2264298|NCT02170688|3937259|FG001|Overall Study|Full dose not received|1
2264299|NCT02170688|3937260|FG002|Overall Study|Full dose not received|0
2264300|NCT02170688|3937261|FG003|Overall Study|Full dose not received|0
2264301|NCT02170688|3937262|FG004|Overall Study|Full dose not received|0
2264302|NCT02170688|3937258|FG000|Overall Study|Physician Decision|0
2264303|NCT02170688|3937259|FG001|Overall Study|Physician Decision|0
2264304|NCT02170688|3937260|FG002|Overall Study|Physician Decision|1
2264305|NCT02170688|3937261|FG003|Overall Study|Physician Decision|0
2264306|NCT02170688|3937262|FG004|Overall Study|Physician Decision|0
2264307|NCT02170727|3937276|FG000|Overall Study|Lost to Follow-up|1
2264308|NCT02170727|3937277|FG001|Overall Study|Lost to Follow-up|0
2264309|NCT02170727|3937276|FG000|Overall Study|Withdrawal by Subject|2
2264310|NCT02170727|3937277|FG001|Overall Study|Withdrawal by Subject|0
2264311|NCT02170779|3937288|FG000|Overall Study|Withdrawal by Subject|1
2264312|NCT02170779|3937289|FG001|Overall Study|Withdrawal by Subject|0
2264313|NCT02170779|3937288|FG000|Overall Study|Lost to Follow-up|0
2264314|NCT02170779|3937289|FG001|Overall Study|Lost to Follow-up|1
2264315|NCT02171065|3937326|FG000|Overall Study|Withdrawal by Subject|1
2347054|NCT03670810|4085325|FG000|Overall Study|Withdrawal by Subject|20
2347055|NCT03670810|4085326|FG001|Overall Study|Withdrawal by Subject|20
2347056|NCT03670810|4085327|FG002|Overall Study|Withdrawal by Subject|8
2347057|NCT03670810|4085328|FG003|Overall Study|Withdrawal by Subject|9
2347058|NCT03670810|4085325|FG000|Overall Study|Continuing Study|27
2347059|NCT03670810|4085326|FG001|Overall Study|Continuing Study|29
2347060|NCT03670810|4085327|FG002|Overall Study|Continuing Study|12
2347061|NCT03670810|4085328|FG003|Overall Study|Continuing Study|10
2347062|NCT03672006|4085340|FG000|Overall Study|exclusion criteria met|0
2347063|NCT03672006|4085341|FG001|Overall Study|exclusion criteria met|1
2347064|NCT03672097|4085358|FG000|Period 1|Withdrawal by Subject|2
2347065|NCT03672097|4085358|FG000|Period 1|Adverse Event|1
2347066|NCT03672097|4085358|FG000|Period 1|Did not receive treatment|1
2347067|NCT03672097|4085358|FG000|Period 2|Withdrawal by Subject|3
2347068|NCT03672097|4085358|FG000|Period 2|Other|1
2347069|NCT03672396|4085366|FG000|Overall Study|Withdrawal by Subject|4
2347070|NCT03672396|4085366|FG000|Overall Study|Physician Decision|1
2347071|NCT03672396|4085366|FG000|Overall Study|Adverse Event|1
2347072|NCT03673670|4085376|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
2347073|NCT03673670|4085377|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2347074|NCT03673670|4085378|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2347075|NCT03673670|4085379|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2347076|NCT03673670|4085380|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2347077|NCT03673670|4085381|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2347078|NCT03673670|4085376|FG000|Treatment Period 1 (3 Days)|Physician Decision|0
2347079|NCT03673670|4085377|FG001|Treatment Period 1 (3 Days)|Physician Decision|0
2347080|NCT03673670|4085378|FG002|Treatment Period 1 (3 Days)|Physician Decision|1
2347081|NCT03673670|4085379|FG003|Treatment Period 1 (3 Days)|Physician Decision|0
2347082|NCT03673670|4085380|FG004|Treatment Period 1 (3 Days)|Physician Decision|0
2347083|NCT03673670|4085381|FG005|Treatment Period 1 (3 Days)|Physician Decision|0
2347084|NCT03673670|4085376|FG000|Treatment Period 1 (3 Days)|Adverse Event|0
2347085|NCT03673670|4085377|FG001|Treatment Period 1 (3 Days)|Adverse Event|0
2347086|NCT03673670|4085378|FG002|Treatment Period 1 (3 Days)|Adverse Event|0
2347087|NCT03673670|4085379|FG003|Treatment Period 1 (3 Days)|Adverse Event|0
2347088|NCT03673670|4085380|FG004|Treatment Period 1 (3 Days)|Adverse Event|0
2347089|NCT03673670|4085381|FG005|Treatment Period 1 (3 Days)|Adverse Event|1
2347090|NCT03673670|4085376|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2347091|NCT03673670|4085377|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2347092|NCT03673670|4085378|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2347093|NCT03673670|4085379|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2347094|NCT03673670|4085380|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2347095|NCT03673670|4085381|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
2347096|NCT03673670|4085376|FG000|Treatment Period 2 (3 Days)|Adverse Event|0
2264316|NCT02171065|3937327|FG001|Overall Study|Withdrawal by Subject|0
2264317|NCT02171065|3937328|FG002|Overall Study|Withdrawal by Subject|0
2264318|NCT02171065|3937326|FG000|Overall Study|Lost to Follow-up|0
2264319|NCT02171065|3937327|FG001|Overall Study|Lost to Follow-up|0
2264320|NCT02171065|3937328|FG002|Overall Study|Lost to Follow-up|1
2264321|NCT02171130|3937338|FG000|Overall Study|Death|1
2264322|NCT02171130|3937338|FG000|Overall Study|Discontinued; Clinical Material Issue|16
2264323|NCT02171130|3937338|FG000|Overall Study|Discontinued; Site Termination|5
2264324|NCT02171130|3937338|FG000|Overall Study|Withdrawal by Subject|3
2264325|NCT02171130|3937338|FG000|Overall Study|Physician Decision|1
2264326|NCT02171130|3937338|FG000|Overall Study|Lost to Follow-up|1
2264327|NCT02171130|3937338|FG000|Overall Study|Met Exclusion Criteria|1
2264328|NCT02171260|3937413|FG000|Overall Study|Death|0
2264329|NCT02171260|3937414|FG001|Overall Study|Death|0
2264330|NCT02171260|3937415|FG002|Overall Study|Death|0
2264331|NCT02171260|3937416|FG003|Overall Study|Death|1
2264332|NCT02171260|3937413|FG000|Overall Study|Physician Decision|1
2264333|NCT02171260|3937414|FG001|Overall Study|Physician Decision|0
2264334|NCT02171260|3937415|FG002|Overall Study|Physician Decision|1
2264335|NCT02171260|3937416|FG003|Overall Study|Physician Decision|0
2264336|NCT02171260|3937413|FG000|Overall Study|Withdrawal by Subject|1
2264337|NCT02171260|3937414|FG001|Overall Study|Withdrawal by Subject|0
2264338|NCT02171260|3937415|FG002|Overall Study|Withdrawal by Subject|0
2264339|NCT02171260|3937416|FG003|Overall Study|Withdrawal by Subject|0
2264340|NCT02171260|3937413|FG000|Overall Study|Evidence of progressive disease|4
2264341|NCT02171260|3937414|FG001|Overall Study|Evidence of progressive disease|6
2264342|NCT02171260|3937415|FG002|Overall Study|Evidence of progressive disease|4
2264343|NCT02171260|3937416|FG003|Overall Study|Evidence of progressive disease|4
2264344|NCT02171429|3937435|FG000|Overall Study|Other|0
2347097|NCT03673670|4085377|FG001|Treatment Period 2 (3 Days)|Adverse Event|0
2347098|NCT03673670|4085378|FG002|Treatment Period 2 (3 Days)|Adverse Event|1
2347099|NCT03673670|4085379|FG003|Treatment Period 2 (3 Days)|Adverse Event|0
2347100|NCT03673670|4085380|FG004|Treatment Period 2 (3 Days)|Adverse Event|1
2347101|NCT03673670|4085381|FG005|Treatment Period 2 (3 Days)|Adverse Event|0
2347102|NCT03673670|4085376|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2347103|NCT03673670|4085377|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2347104|NCT03673670|4085378|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2347105|NCT03673670|4085379|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2347106|NCT03673670|4085380|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
2347107|NCT03673670|4085381|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2347108|NCT03673670|4085376|FG000|Treatment Period 3 (3 Days)|Adverse Event|0
2347109|NCT03673670|4085377|FG001|Treatment Period 3 (3 Days)|Adverse Event|0
2347110|NCT03673670|4085378|FG002|Treatment Period 3 (3 Days)|Adverse Event|0
2347111|NCT03673670|4085379|FG003|Treatment Period 3 (3 Days)|Adverse Event|0
2347112|NCT03673670|4085380|FG004|Treatment Period 3 (3 Days)|Adverse Event|1
2347113|NCT03673670|4085381|FG005|Treatment Period 3 (3 Days)|Adverse Event|0
2347114|NCT03674177|4085402|FG000|Overall Study|Lost to Follow-up|2
2347115|NCT03674177|4085403|FG001|Overall Study|Lost to Follow-up|1
2347116|NCT03674177|4085404|FG002|Overall Study|Lost to Follow-up|0
2347117|NCT03674177|4085405|FG003|Overall Study|Lost to Follow-up|2
2264345|NCT02171429|3937436|FG001|Overall Study|Other|1
2264346|NCT02171429|3937437|FG002|Overall Study|Other|1
2264347|NCT02171429|3937435|FG000|Overall Study|Non-Compliance|0
2264348|NCT02171429|3937436|FG001|Overall Study|Non-Compliance|0
2264349|NCT02171429|3937437|FG002|Overall Study|Non-Compliance|1
2264350|NCT02171429|3937435|FG000|Overall Study|Physician Decision|0
2264351|NCT02171429|3937436|FG001|Overall Study|Physician Decision|0
2264352|NCT02171429|3937437|FG002|Overall Study|Physician Decision|1
2264353|NCT02171429|3937435|FG000|Overall Study|Withdrawal by Subject|1
2264354|NCT02171429|3937436|FG001|Overall Study|Withdrawal by Subject|1
2264355|NCT02171429|3937437|FG002|Overall Study|Withdrawal by Subject|1
2264356|NCT02171429|3937435|FG000|Overall Study|Lost to Follow-up|0
2264357|NCT02171429|3937436|FG001|Overall Study|Lost to Follow-up|1
2264358|NCT02171429|3937437|FG002|Overall Study|Lost to Follow-up|0
2264359|NCT02171429|3937435|FG000|Overall Study|Death|0
2264360|NCT02171429|3937436|FG001|Overall Study|Death|0
2264361|NCT02171429|3937437|FG002|Overall Study|Death|1
2264362|NCT02172040|3937482|FG000|Overall Study|Adverse Event|0
2264363|NCT02172040|3937483|FG001|Overall Study|Adverse Event|2
2264364|NCT02172040|3937484|FG002|Overall Study|Adverse Event|0
2264365|NCT02172040|3937485|FG003|Overall Study|Adverse Event|0
2264366|NCT02172040|3937482|FG000|Overall Study|Protocol Violation|0
2347118|NCT03674281|4085418|FG000|Overall Study|screen failure|2
2347119|NCT03674281|4085419|FG001|Overall Study|screen failure|0
2347120|NCT03674281|4085420|FG002|Overall Study|screen failure|0
2347121|NCT03674281|4085418|FG000|Overall Study|Withdrawal by Subject|1
2347122|NCT03674281|4085419|FG001|Overall Study|Withdrawal by Subject|3
2347123|NCT03674281|4085420|FG002|Overall Study|Withdrawal by Subject|3
2347124|NCT03675776|4085479|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5
2347125|NCT03675776|4085480|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6
2347126|NCT03675776|4085481|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8
2347127|NCT03675776|4085479|FG000|Double Blind Treatment Period|Lack of Efficacy|1
2347128|NCT03675776|4085480|FG001|Double Blind Treatment Period|Lack of Efficacy|0
2347129|NCT03675776|4085481|FG002|Double Blind Treatment Period|Lack of Efficacy|0
2347130|NCT03676634|4085493|FG000|Overall Study|Red blood cell loss|1
2347131|NCT03676634|4085493|FG000|Overall Study|Out-of-limit pulse|2
2347132|NCT03677375|4085545|FG000|Overall Study|Incomplete procedure|8
2347133|NCT03677375|4085545|FG000|Overall Study|Adverse Event|3
2347134|NCT03677375|4085545|FG000|Overall Study|Physician Decision|1
2347135|NCT03677401|4085551|FG000|Overall Study|Adverse Event|4
2347136|NCT03677401|4085552|FG001|Overall Study|Adverse Event|14
2347137|NCT03677401|4085551|FG000|Overall Study|Lack of Efficacy|3
2347138|NCT03677401|4085552|FG001|Overall Study|Lack of Efficacy|1
2347139|NCT03677401|4085551|FG000|Overall Study|Withdrawal by Subject|2
2347140|NCT03677401|4085552|FG001|Overall Study|Withdrawal by Subject|2
2347141|NCT03677401|4085551|FG000|Overall Study|Sponsor decision|0
2347142|NCT03677401|4085552|FG001|Overall Study|Sponsor decision|1
2347143|NCT03677401|4085551|FG000|Overall Study|Reason Unspecified|1
2347144|NCT03677401|4085552|FG001|Overall Study|Reason Unspecified|0
2347145|NCT03677869|4085558|FG000|Overall Study|Withdrawal by Subject|1
2347146|NCT03678103|4085562|FG000|Overall Study|Withdrawn prior to completion|4
2347147|NCT03678285|4085566|FG000|Overall Study|Adverse Event|2
2347148|NCT03678285|4085566|FG000|Overall Study|Withdrawal by subject prior to start of workout|1
2347149|NCT03678285|4085566|FG000|Overall Study|Dehydrated prior to start of workout|1
2347150|NCT03678870|4085576|FG000|Overall Study|prescribed non- protocol medications|10
2347151|NCT03678870|4085577|FG001|Overall Study|prescribed non- protocol medications|6
2347152|NCT03678870|4085576|FG000|Overall Study|Lost to Follow-up|3
2347153|NCT03678870|4085577|FG001|Overall Study|Lost to Follow-up|2
2347154|NCT03679741|4085592|FG000|Period 1|No longer meet eligibility criteria|1
2347155|NCT03679741|4085593|FG001|Period 1|No longer meet eligibility criteria|0
2347156|NCT03679741|4085592|FG000|Period 1|Lost to Follow-up|0
2347157|NCT03679741|4085593|FG001|Period 1|Lost to Follow-up|1
2347158|NCT03679741|4085592|FG000|Period 1|Adverse Event|1
2347159|NCT03679741|4085593|FG001|Period 1|Adverse Event|1
2347160|NCT03679741|4085592|FG000|Period 1|Withdrawal by Subject|0
2347161|NCT03679741|4085593|FG001|Period 1|Withdrawal by Subject|1
2347162|NCT03679741|4085592|FG000|Period 2|Adverse Event|2
2347163|NCT03679741|4085593|FG001|Period 2|Adverse Event|1
2347164|NCT03679741|4085592|FG000|Period 2|Withdrawal by Subject|1
2347165|NCT03679741|4085593|FG001|Period 2|Withdrawal by Subject|1
2347166|NCT03680521|4085646|FG000|Overall Study|Ongoing in long-term follow up|7
2347167|NCT03680521|4085647|FG001|Overall Study|Ongoing in long-term follow up|11
2347168|NCT03680742|4085656|FG000|Overall Study|Unsuccessful Implant Attempt|2
2347169|NCT03681093|4085663|FG000|Overall Study|Subject decision|0
2347170|NCT03681093|4085664|FG001|Overall Study|Subject decision|2
2347171|NCT03681093|4085665|FG002|Overall Study|Subject decision|1
2264367|NCT02172040|3937483|FG001|Overall Study|Protocol Violation|1
2347172|NCT03681119|4085675|FG000|Overall Study|No specific reason|4
2347173|NCT03681119|4085676|FG001|Overall Study|No specific reason|0
2347174|NCT03681119|4085675|FG000|Overall Study|Sickness|2
2347175|NCT03681119|4085676|FG001|Overall Study|Sickness|0
2347176|NCT03681353|4085680|FG000|Overall Study|Lost to Follow-up|2
2347177|NCT03681353|4085680|FG000|Overall Study|Withdrawal by Subject|3
2264368|NCT02172040|3937484|FG002|Overall Study|Protocol Violation|0
2347178|NCT03681353|4085680|FG000|Overall Study|withdrawn by PI|2
2264369|NCT02172040|3937485|FG003|Overall Study|Protocol Violation|0
2264370|NCT02172040|3937482|FG000|Overall Study|Withdrawal by Subject|0
2264371|NCT02172040|3937483|FG001|Overall Study|Withdrawal by Subject|0
2264372|NCT02172040|3937484|FG002|Overall Study|Withdrawal by Subject|1
2264373|NCT02172040|3937485|FG003|Overall Study|Withdrawal by Subject|0
2264374|NCT02172040|3937482|FG000|Overall Study|Not available for Day 13 & 14 visits|0
2264375|NCT02172040|3937483|FG001|Overall Study|Not available for Day 13 & 14 visits|0
2264376|NCT02172040|3937484|FG002|Overall Study|Not available for Day 13 & 14 visits|1
2264377|NCT02172040|3937485|FG003|Overall Study|Not available for Day 13 & 14 visits|0
2264378|NCT02172040|3937482|FG000|Overall Study|Family emergency abroad|0
2264379|NCT02172040|3937483|FG001|Overall Study|Family emergency abroad|0
2264380|NCT02172040|3937484|FG002|Overall Study|Family emergency abroad|0
2264381|NCT02172040|3937485|FG003|Overall Study|Family emergency abroad|1
2264382|NCT02172625|3937498|FG000|Overall Study|Adverse Event|0
2264383|NCT02172625|3937499|FG001|Overall Study|Adverse Event|1
2264384|NCT02172625|3937498|FG000|Overall Study|Pregnancy|0
2264385|NCT02172625|3937499|FG001|Overall Study|Pregnancy|1
2264386|NCT02172625|3937498|FG000|Overall Study|car accident|0
2264387|NCT02172625|3937499|FG001|Overall Study|car accident|1
2264388|NCT02172664|3937509|FG000|Overall Study|Lost to Follow-up|4
2264389|NCT02172664|3937510|FG001|Overall Study|Lost to Follow-up|4
2264390|NCT02172664|3937509|FG000|Overall Study|Death|1
2347179|NCT03681405|4085686|FG000|Overall Study|Found to be ineligible after randomized|1
2347180|NCT03681405|4085687|FG001|Overall Study|Found to be ineligible after randomized|0
2347181|NCT03681951|4085733|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1
2347182|NCT03681951|4085734|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
2347183|NCT03681951|4085735|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
2347184|NCT03681951|4085736|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
2347185|NCT03681951|4085737|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
2347186|NCT03681951|4085738|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
2347187|NCT03681951|4085739|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
2347188|NCT03681951|4085740|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
2347189|NCT03681951|4085733|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4
2347190|NCT03681951|4085734|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
2347191|NCT03681951|4085735|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
2347192|NCT03681951|4085736|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
2347193|NCT03681951|4085737|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
2347194|NCT03681951|4085738|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
2347195|NCT03681951|4085739|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
2347196|NCT03681951|4085740|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
2347197|NCT03681951|4085733|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3
2347198|NCT03681951|4085734|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
2347199|NCT03681951|4085735|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
2347200|NCT03681951|4085736|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
2347201|NCT03681951|4085737|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
2347202|NCT03681951|4085738|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
2264391|NCT02172664|3937510|FG001|Overall Study|Death|1
2264392|NCT02172664|3937509|FG000|Overall Study|Moved out of area|1
2264393|NCT02172664|3937510|FG001|Overall Study|Moved out of area|1
2264394|NCT02172911|3937543|FG000|Overall Study|Serious Adverse Event|0
2264395|NCT02172911|3937544|FG001|Overall Study|Serious Adverse Event|1
2264396|NCT02172911|3937543|FG000|Overall Study|Progression of Disease|0
2264397|NCT02172911|3937544|FG001|Overall Study|Progression of Disease|1
2264398|NCT02172911|3937543|FG000|Overall Study|Loss of insurance coverage|1
2264399|NCT02172911|3937544|FG001|Overall Study|Loss of insurance coverage|0
2264400|NCT02172950|3937552|FG000|Overall Study|Physician Decision|3
2264401|NCT02172950|3937553|FG001|Overall Study|Physician Decision|3
2264402|NCT02172950|3937552|FG000|Overall Study|Lack of Efficacy|1
2264403|NCT02172950|3937553|FG001|Overall Study|Lack of Efficacy|0
2264404|NCT02172950|3937552|FG000|Overall Study|Adverse Event|4
2264405|NCT02172950|3937553|FG001|Overall Study|Adverse Event|1
2264406|NCT02172950|3937552|FG000|Overall Study|Withdrawal by Subject|10
2264407|NCT02172950|3937553|FG001|Overall Study|Withdrawal by Subject|0
2264408|NCT02172950|3937552|FG000|Overall Study|Protocol Violation|1
2264409|NCT02172950|3937553|FG001|Overall Study|Protocol Violation|0
2264410|NCT02172950|3937552|FG000|Overall Study|Lost to Follow-up|1
2264411|NCT02172950|3937553|FG001|Overall Study|Lost to Follow-up|0
2264412|NCT02172950|3937552|FG000|Overall Study|Death|1
2264413|NCT02172950|3937553|FG001|Overall Study|Death|0
2264414|NCT02172950|3937552|FG000|Overall Study|Patient traveling|1
2264415|NCT02172950|3937553|FG001|Overall Study|Patient traveling|0
2264416|NCT02172950|3937552|FG000|Overall Study|Patient went to other country|1
2264417|NCT02172950|3937553|FG001|Overall Study|Patient went to other country|0
2264418|NCT02172950|3937552|FG000|Overall Study|Patient relocated overseas|1
2264419|NCT02172950|3937553|FG001|Overall Study|Patient relocated overseas|1
2264420|NCT02172950|3937552|FG000|Overall Study|Patient moving|1
2264421|NCT02172950|3937553|FG001|Overall Study|Patient moving|0
2264422|NCT02173054|3937563|FG000|Overall Study|lack of compliance|1
2264423|NCT02173054|3937564|FG001|Overall Study|lack of compliance|0
2264424|NCT02173054|3937565|FG002|Overall Study|lack of compliance|0
2264425|NCT02173054|3937563|FG000|Overall Study|Withdrawal by Subject|0
2264426|NCT02173054|3937564|FG001|Overall Study|Withdrawal by Subject|0
2264427|NCT02173054|3937565|FG002|Overall Study|Withdrawal by Subject|1
2264428|NCT02173158|3937573|FG000|Efficacy Phase|Adverse Event|1
2264429|NCT02173379|3937580|FG000|Overall Study|Lost to Follow-up|48
2264430|NCT02173379|3937581|FG001|Overall Study|Lost to Follow-up|34
2264431|NCT02173379|3937580|FG000|Overall Study|Withdrawal by Subject|14
2264432|NCT02173379|3937581|FG001|Overall Study|Withdrawal by Subject|17
2264433|NCT02173379|3937580|FG000|Overall Study|Physician Decision|7
2264434|NCT02173379|3937581|FG001|Overall Study|Physician Decision|4
2264435|NCT02173379|3937580|FG000|Overall Study|Death|22
2264436|NCT02173379|3937581|FG001|Overall Study|Death|22
2264437|NCT02173548|3937674|FG000|Overall Study|Lost to Follow-up|0
2264438|NCT02173548|3937675|FG001|Overall Study|Lost to Follow-up|2
2264439|NCT02173548|3937674|FG000|Overall Study|Withdrawal by Subject|1
2264440|NCT02173548|3937675|FG001|Overall Study|Withdrawal by Subject|0
2264441|NCT02173704|3937683|FG000|Overall Study|Adverse Event|1
2264442|NCT02173704|3937684|FG001|Overall Study|Adverse Event|0
2264443|NCT02173704|3937683|FG000|Overall Study|Lost to Follow-up|1
2264444|NCT02173704|3937684|FG001|Overall Study|Lost to Follow-up|0
2264445|NCT02173704|3937683|FG000|Overall Study|Other|1
2264446|NCT02173704|3937684|FG001|Overall Study|Other|0
2264447|NCT02173704|3937683|FG000|Overall Study|Protocol Violation|1
2264448|NCT02173704|3937684|FG001|Overall Study|Protocol Violation|0
2264449|NCT02173704|3937683|FG000|Overall Study|Withdrawal by Subject|9
2264450|NCT02173704|3937684|FG001|Overall Study|Withdrawal by Subject|4
2264451|NCT02173769|3937690|FG000|Overall Study|Protocol Violation|4
2347203|NCT03681951|4085739|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
2347204|NCT03681951|4085740|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
2347205|NCT03682107|4085768|FG000|Overall Study|Withdrawal by Subject|0
2347206|NCT03682107|4085769|FG001|Overall Study|Withdrawal by Subject|1
2347207|NCT03682107|4085770|FG002|Overall Study|Withdrawal by Subject|0
2347208|NCT03682107|4085771|FG003|Overall Study|Withdrawal by Subject|0
2347209|NCT03682107|4085772|FG004|Overall Study|Withdrawal by Subject|0
2347210|NCT03682120|4085788|FG000|Overall Study|Lost to Follow-up|11
2347211|NCT03682120|4085789|FG001|Overall Study|Lost to Follow-up|4
2347212|NCT03682120|4085790|FG002|Overall Study|Lost to Follow-up|5
2347213|NCT03682120|4085791|FG003|Overall Study|Lost to Follow-up|2
2347214|NCT03682120|4085788|FG000|Overall Study|Physician Decision|1
2347215|NCT03682120|4085789|FG001|Overall Study|Physician Decision|0
2347216|NCT03682120|4085790|FG002|Overall Study|Physician Decision|0
2347217|NCT03682120|4085791|FG003|Overall Study|Physician Decision|0
2347218|NCT03682120|4085788|FG000|Overall Study|Withdrawal by Subject|1
2347219|NCT03682120|4085789|FG001|Overall Study|Withdrawal by Subject|2
2347220|NCT03682120|4085790|FG002|Overall Study|Withdrawal by Subject|3
2347221|NCT03682120|4085791|FG003|Overall Study|Withdrawal by Subject|0
2347222|NCT03682120|4085788|FG000|Overall Study|Death|0
2347223|NCT03682120|4085789|FG001|Overall Study|Death|1
2347224|NCT03682120|4085790|FG002|Overall Study|Death|0
2347225|NCT03682120|4085791|FG003|Overall Study|Death|0
2347226|NCT03682120|4085788|FG000|Overall Study|Enrolled but Treatment Not Administered|0
2347227|NCT03682120|4085789|FG001|Overall Study|Enrolled but Treatment Not Administered|1
2347228|NCT03682120|4085790|FG002|Overall Study|Enrolled but Treatment Not Administered|0
2347229|NCT03682120|4085791|FG003|Overall Study|Enrolled but Treatment Not Administered|0
2347230|NCT03682302|4085807|FG000|Overall Study|Lost to Follow-up|1
2347231|NCT03682302|4085808|FG001|Overall Study|Lost to Follow-up|2
2347232|NCT03682302|4085809|FG002|Overall Study|Lost to Follow-up|0
2347233|NCT03682302|4085810|FG003|Overall Study|Lost to Follow-up|1
2347234|NCT03682302|4085807|FG000|Overall Study|Study drug was not administered|0
2347235|NCT03682302|4085808|FG001|Overall Study|Study drug was not administered|0
2347236|NCT03682302|4085809|FG002|Overall Study|Study drug was not administered|1
2347237|NCT03682302|4085810|FG003|Overall Study|Study drug was not administered|1
2347238|NCT03682705|4085826|FG000|Overall Study|Adverse Event|1
2347239|NCT03682705|4085827|FG001|Overall Study|Adverse Event|1
2347240|NCT03682705|4085828|FG002|Overall Study|Adverse Event|1
2347241|NCT03682705|4085829|FG003|Overall Study|Adverse Event|0
2347242|NCT03682705|4085830|FG004|Overall Study|Adverse Event|1
2347243|NCT03682705|4085831|FG005|Overall Study|Adverse Event|1
2347244|NCT03682705|4085826|FG000|Overall Study|Withdrawal by Subject|1
2347245|NCT03682705|4085827|FG001|Overall Study|Withdrawal by Subject|3
2347246|NCT03682705|4085828|FG002|Overall Study|Withdrawal by Subject|2
2347247|NCT03682705|4085829|FG003|Overall Study|Withdrawal by Subject|4
2347248|NCT03682705|4085830|FG004|Overall Study|Withdrawal by Subject|0
2347249|NCT03682705|4085831|FG005|Overall Study|Withdrawal by Subject|1
2347250|NCT03682705|4085826|FG000|Overall Study|Other, not specified|0
2347251|NCT03682705|4085827|FG001|Overall Study|Other, not specified|0
2347252|NCT03682705|4085828|FG002|Overall Study|Other, not specified|0
2347253|NCT03682705|4085829|FG003|Overall Study|Other, not specified|1
2347254|NCT03682705|4085830|FG004|Overall Study|Other, not specified|2
2347255|NCT03682705|4085831|FG005|Overall Study|Other, not specified|0
2264452|NCT02174276|3937708|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
2347256|NCT03682705|4085826|FG000|Overall Study|Lost to Follow-up|0
2264453|NCT02174276|3937709|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
2264454|NCT02174276|3937710|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
2264455|NCT02174276|3937711|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
2264456|NCT02174276|3937708|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
2264457|NCT02174276|3937709|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
2264458|NCT02174276|3937710|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
2264459|NCT02174276|3937711|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
2264460|NCT02174276|3937708|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
2264461|NCT02174276|3937709|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
2264462|NCT02174276|3937710|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
2264463|NCT02174276|3937711|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
2264464|NCT02174276|3937708|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
2347257|NCT03682705|4085827|FG001|Overall Study|Lost to Follow-up|0
2347258|NCT03682705|4085828|FG002|Overall Study|Lost to Follow-up|0
2347259|NCT03682705|4085829|FG003|Overall Study|Lost to Follow-up|0
2347260|NCT03682705|4085830|FG004|Overall Study|Lost to Follow-up|3
2347261|NCT03682705|4085831|FG005|Overall Study|Lost to Follow-up|0
2347262|NCT03683576|4085867|FG000|Overall Study|Withdrawal by Subject|2
2347263|NCT03683576|4085868|FG001|Overall Study|Withdrawal by Subject|0
2347264|NCT03683576|4085869|FG002|Overall Study|Withdrawal by Subject|8
2347265|NCT03683576|4085870|FG003|Overall Study|Withdrawal by Subject|3
2347266|NCT03683576|4085867|FG000|Overall Study|Adverse Event|3
2347267|NCT03683576|4085868|FG001|Overall Study|Adverse Event|0
2347268|NCT03683576|4085869|FG002|Overall Study|Adverse Event|0
2347269|NCT03683576|4085870|FG003|Overall Study|Adverse Event|4
2347270|NCT03683576|4085867|FG000|Overall Study|Lack of Efficacy|1
2347271|NCT03683576|4085868|FG001|Overall Study|Lack of Efficacy|0
2347272|NCT03683576|4085869|FG002|Overall Study|Lack of Efficacy|1
2347273|NCT03683576|4085870|FG003|Overall Study|Lack of Efficacy|1
2347274|NCT03683576|4085867|FG000|Overall Study|Lost to Follow-up|0
2347275|NCT03683576|4085868|FG001|Overall Study|Lost to Follow-up|1
2347276|NCT03683576|4085869|FG002|Overall Study|Lost to Follow-up|2
2347277|NCT03683576|4085870|FG003|Overall Study|Lost to Follow-up|0
2347278|NCT03683576|4085867|FG000|Overall Study|Other, Not Specified|0
2347279|NCT03683576|4085868|FG001|Overall Study|Other, Not Specified|2
2347280|NCT03683576|4085869|FG002|Overall Study|Other, Not Specified|0
2347281|NCT03683576|4085870|FG003|Overall Study|Other, Not Specified|0
2347282|NCT03683576|4085867|FG000|Overall Study|Protocol Violation|0
2347283|NCT03683576|4085868|FG001|Overall Study|Protocol Violation|1
2347284|NCT03683576|4085869|FG002|Overall Study|Protocol Violation|1
2347285|NCT03683576|4085870|FG003|Overall Study|Protocol Violation|0
2347286|NCT03683719|4085885|FG000|Overall Study|Lack of Efficacy|1
2347287|NCT03683719|4085886|FG001|Overall Study|Lack of Efficacy|3
2264465|NCT02174276|3937709|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
2264466|NCT02174276|3937710|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
2264467|NCT02174276|3937711|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
2264468|NCT02174276|3937708|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0
2264469|NCT02174276|3937709|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0
2264470|NCT02174276|3937710|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1
2264471|NCT02174276|3937711|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0
2264472|NCT02174276|3937708|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1
2264473|NCT02174276|3937709|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0
2264474|NCT02174276|3937710|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1
2264475|NCT02174276|3937711|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2
2264476|NCT02174523|3937756|FG000|Overall Study|Withdrawal by Subject|1
2264477|NCT02174523|3937757|FG001|Overall Study|Withdrawal by Subject|0
2264478|NCT02174562|3937764|FG000|Overall Study|Withdrawal by Subject|7
2264479|NCT02174562|3937765|FG001|Overall Study|Withdrawal by Subject|2
2264480|NCT02174562|3937764|FG000|Overall Study|Death|2
2264481|NCT02174562|3937765|FG001|Overall Study|Death|0
2264482|NCT02174562|3937764|FG000|Overall Study|Lost to Follow-up|0
2264483|NCT02174562|3937765|FG001|Overall Study|Lost to Follow-up|3
2264484|NCT02174627|3937773|FG000|Overall Study|Missing|0
2264485|NCT02174627|3937774|FG001|Overall Study|Missing|1
2264486|NCT02174627|3937773|FG000|Overall Study|Incorrect enrolment before randomization|0
2264487|NCT02174627|3937774|FG001|Overall Study|Incorrect enrolment before randomization|1
2264488|NCT02174627|3937773|FG000|Overall Study|Participant decision|84
2264489|NCT02174627|3937774|FG001|Overall Study|Participant decision|128
2264490|NCT02174731|3937782|FG000|Overall Study|Participant decision|67
2264491|NCT02174731|3937783|FG001|Overall Study|Participant decision|64
2264492|NCT02174731|3937782|FG000|Overall Study|Incorrect enrolment before randomization|0
2264493|NCT02174731|3937783|FG001|Overall Study|Incorrect enrolment before randomization|1
2264494|NCT02174731|3937782|FG000|Overall Study|Missing|2
2264495|NCT02174731|3937783|FG001|Overall Study|Missing|0
2264496|NCT02174848|3937791|FG000|Overall Study|Adverse Event|2
2264497|NCT02174848|3937792|FG001|Overall Study|Adverse Event|1
2264498|NCT02174848|3937791|FG000|Overall Study|Withdrawal by Subject|3
2264499|NCT02174848|3937792|FG001|Overall Study|Withdrawal by Subject|3
2264500|NCT02174848|3937791|FG000|Overall Study|Lost to Follow-up|0
2264501|NCT02174848|3937792|FG001|Overall Study|Lost to Follow-up|1
2264502|NCT02174848|3937791|FG000|Overall Study|Worsening of disease|1
2347288|NCT03683719|4085887|FG002|Overall Study|Lack of Efficacy|4
2264503|NCT02174848|3937792|FG001|Overall Study|Worsening of disease|1
2264504|NCT02174848|3937791|FG000|Overall Study|Unable to comply with study requirements|1
2264505|NCT02174848|3937792|FG001|Overall Study|Unable to comply with study requirements|0
2264506|NCT02174861|3937803|FG000|Overall Study|Decision by sponsor|8
2264507|NCT02174861|3937803|FG000|Overall Study|Withdrawal by Subject|124
2264508|NCT02174861|3937803|FG000|Overall Study|Lost to Follow-up|26
2264509|NCT02175121|3937823|FG000|Overall Study|Lack of Efficacy|1
2264510|NCT02175121|3937824|FG001|Overall Study|Lack of Efficacy|0
2264511|NCT02175121|3937825|FG002|Overall Study|Lack of Efficacy|0
2264512|NCT02175121|3937826|FG003|Overall Study|Lack of Efficacy|0
2264513|NCT02175121|3937827|FG004|Overall Study|Lack of Efficacy|0
2264514|NCT02175121|3937823|FG000|Overall Study|Lost to Follow-up|0
2264515|NCT02175121|3937824|FG001|Overall Study|Lost to Follow-up|1
2264516|NCT02175121|3937825|FG002|Overall Study|Lost to Follow-up|0
2264517|NCT02175121|3937826|FG003|Overall Study|Lost to Follow-up|1
2264518|NCT02175121|3937827|FG004|Overall Study|Lost to Follow-up|0
2264519|NCT02175121|3937823|FG000|Overall Study|Personal emergency|0
2264520|NCT02175121|3937824|FG001|Overall Study|Personal emergency|0
2264521|NCT02175121|3937825|FG002|Overall Study|Personal emergency|0
2264522|NCT02175121|3937826|FG003|Overall Study|Personal emergency|0
2264523|NCT02175121|3937827|FG004|Overall Study|Personal emergency|1
2264524|NCT02175121|3937823|FG000|Overall Study|Schedule conflict|0
2264525|NCT02175121|3937824|FG001|Overall Study|Schedule conflict|0
2264526|NCT02175121|3937825|FG002|Overall Study|Schedule conflict|1
2264527|NCT02175121|3937826|FG003|Overall Study|Schedule conflict|0
2264528|NCT02175121|3937827|FG004|Overall Study|Schedule conflict|0
2264529|NCT02175121|3937823|FG000|Overall Study|Time issues|0
2264530|NCT02175121|3937824|FG001|Overall Study|Time issues|0
2264531|NCT02175121|3937825|FG002|Overall Study|Time issues|1
2264532|NCT02175121|3937826|FG003|Overall Study|Time issues|0
2264533|NCT02175121|3937827|FG004|Overall Study|Time issues|0
2264534|NCT02175199|3937845|FG000|Overall Study|Withdrawal by Subject|1
2264535|NCT02175199|3937846|FG001|Overall Study|Withdrawal by Subject|5
2264536|NCT02175199|3937845|FG000|Overall Study|Randomized in Error|1
2264537|NCT02175199|3937846|FG001|Overall Study|Randomized in Error|0
2264538|NCT02175199|3937845|FG000|Overall Study|Sponsor Decision|1
2264539|NCT02175199|3937846|FG001|Overall Study|Sponsor Decision|0
2264540|NCT02175225|3937864|FG000|Overall Study|Withdrawal by Subject|1
2264541|NCT02175225|3937865|FG001|Overall Study|Withdrawal by Subject|2
2264542|NCT02175225|3937864|FG000|Overall Study|Lost to Follow-up|6
2264543|NCT02175225|3937865|FG001|Overall Study|Lost to Follow-up|7
2264544|NCT02175225|3937864|FG000|Overall Study|Study drug not administered|1
2264545|NCT02175225|3937865|FG001|Overall Study|Study drug not administered|2
2264546|NCT02175277|3937871|FG000|Overall Study|Protocol-specified Criteria|1
2264547|NCT02175368|3937875|FG000|Overall Study|Lost to Follow-up|1
2264548|NCT02175641|3937890|FG000|Overall Study|Death|3
2264549|NCT02175641|3937891|FG001|Overall Study|Death|4
2264550|NCT02175641|3937890|FG000|Overall Study|Lost to Follow-up|4
2264551|NCT02175641|3937891|FG001|Overall Study|Lost to Follow-up|4
2264552|NCT02175641|3937890|FG000|Overall Study|Withdrawal by Subject|7
2264553|NCT02175641|3937891|FG001|Overall Study|Withdrawal by Subject|4
2264554|NCT02175641|3937890|FG000|Overall Study|Discharged from Supportive Housing Agenc|13
2264555|NCT02175641|3937891|FG001|Overall Study|Discharged from Supportive Housing Agenc|15
2264556|NCT02175641|3937890|FG000|Overall Study|Developed Contraindicated Condition|8
2264557|NCT02175641|3937891|FG001|Overall Study|Developed Contraindicated Condition|0
2264558|NCT02175745|3937897|FG000|Overall Study|Not Eligible|1
2264559|NCT02175758|3937907|FG000|Treatment Phase|Lost to Follow-up|0
2264560|NCT02175758|3937908|FG001|Treatment Phase|Lost to Follow-up|1
2264561|NCT02175758|3937909|FG002|Treatment Phase|Lost to Follow-up|0
2347289|NCT03683719|4085888|FG003|Overall Study|Lack of Efficacy|0
2347290|NCT03683719|4085889|FG004|Overall Study|Lack of Efficacy|4
2347291|NCT03683719|4085885|FG000|Overall Study|Adverse Event|6
2347292|NCT03683719|4085886|FG001|Overall Study|Adverse Event|6
2347293|NCT03683719|4085887|FG002|Overall Study|Adverse Event|0
2347294|NCT03683719|4085888|FG003|Overall Study|Adverse Event|1
2347295|NCT03683719|4085889|FG004|Overall Study|Adverse Event|3
2347296|NCT03683719|4085885|FG000|Overall Study|Withdrawal by Subject|4
2347297|NCT03683719|4085886|FG001|Overall Study|Withdrawal by Subject|4
2347298|NCT03683719|4085887|FG002|Overall Study|Withdrawal by Subject|3
2347299|NCT03683719|4085888|FG003|Overall Study|Withdrawal by Subject|5
2347300|NCT03683719|4085889|FG004|Overall Study|Withdrawal by Subject|5
2347301|NCT03683719|4085885|FG000|Overall Study|Lost to Follow-up|1
2347302|NCT03683719|4085886|FG001|Overall Study|Lost to Follow-up|0
2347303|NCT03683719|4085887|FG002|Overall Study|Lost to Follow-up|0
2347304|NCT03683719|4085888|FG003|Overall Study|Lost to Follow-up|1
2347305|NCT03683719|4085889|FG004|Overall Study|Lost to Follow-up|1
2347306|NCT03683719|4085885|FG000|Overall Study|Other personal reasons|0
2347307|NCT03683719|4085886|FG001|Overall Study|Other personal reasons|0
2347308|NCT03683719|4085887|FG002|Overall Study|Other personal reasons|1
2264562|NCT02175758|3937910|FG003|Treatment Phase|Lost to Follow-up|0
2264563|NCT02175758|3937911|FG004|Treatment Phase|Lost to Follow-up|0
2264564|NCT02175758|3937912|FG005|Treatment Phase|Lost to Follow-up|0
2264565|NCT02175758|3937907|FG000|Treatment Phase|Adverse Event|0
2264566|NCT02175758|3937908|FG001|Treatment Phase|Adverse Event|0
2264567|NCT02175758|3937909|FG002|Treatment Phase|Adverse Event|0
2264568|NCT02175758|3937910|FG003|Treatment Phase|Adverse Event|0
2264569|NCT02175758|3937911|FG004|Treatment Phase|Adverse Event|1
2264570|NCT02175758|3937912|FG005|Treatment Phase|Adverse Event|0
2264571|NCT02175771|3937960|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23
2264572|NCT02175771|3937961|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2264573|NCT02175771|3937962|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2264574|NCT02175771|3937963|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2264575|NCT02175771|3937964|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2264576|NCT02175771|3937965|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2264577|NCT02175771|3937966|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2264578|NCT02175771|3937967|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2347309|NCT03683719|4085888|FG003|Overall Study|Other personal reasons|0
2347310|NCT03683719|4085889|FG004|Overall Study|Other personal reasons|1
2347311|NCT03683758|4085903|FG000|Overall Study|Non-study commitment conflict|1
2347312|NCT03683758|4085904|FG001|Overall Study|Non-study commitment conflict|3
2347313|NCT03683758|4085903|FG000|Overall Study|Illness preventing participation|1
2347314|NCT03683758|4085904|FG001|Overall Study|Illness preventing participation|0
2347315|NCT03683758|4085903|FG000|Overall Study|Adverse Event|1
2347316|NCT03683758|4085904|FG001|Overall Study|Adverse Event|0
2347317|NCT03684044|4085918|FG000|Overall Study|Adverse Event|3
2347318|NCT03684044|4085919|FG001|Overall Study|Adverse Event|0
2347319|NCT03684044|4085918|FG000|Overall Study|Death|4
2347320|NCT03684044|4085919|FG001|Overall Study|Death|7
2347321|NCT03684044|4085918|FG000|Overall Study|Lost to Follow-up|3
2347322|NCT03684044|4085919|FG001|Overall Study|Lost to Follow-up|2
2347323|NCT03684044|4085918|FG000|Overall Study|Patient Not Available|0
2347324|NCT03684044|4085919|FG001|Overall Study|Patient Not Available|2
2347325|NCT03684044|4085918|FG000|Overall Study|Physician Decision|1
2347326|NCT03684044|4085919|FG001|Overall Study|Physician Decision|0
2347327|NCT03684044|4085918|FG000|Overall Study|Withdrawal by Subject|11
2347328|NCT03684044|4085919|FG001|Overall Study|Withdrawal by Subject|9
2347329|NCT03684642|4085937|FG000|Overall Study|Adverse Event|6
2347330|NCT03684642|4085938|FG001|Overall Study|Adverse Event|15
2264579|NCT02175771|3937968|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2264580|NCT02175771|3937960|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20
2264581|NCT02175771|3937961|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2264582|NCT02175771|3937962|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2264583|NCT02175771|3937963|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2264584|NCT02175771|3937964|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2264585|NCT02175771|3937965|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2264586|NCT02175771|3937966|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2264587|NCT02175771|3937967|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2264588|NCT02175771|3937968|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2264589|NCT02175771|3937960|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
2264590|NCT02175771|3937961|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2264591|NCT02175771|3937962|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2264592|NCT02175771|3937963|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2264593|NCT02175771|3937964|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2264594|NCT02175771|3937965|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2264595|NCT02175771|3937966|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2264596|NCT02175771|3937967|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2264597|NCT02175771|3937968|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2264598|NCT02175771|3937960|FG000|Run-In Period (Pre-assignment)|Adverse Event|9
2264599|NCT02175771|3937961|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
2264600|NCT02175771|3937962|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
2264601|NCT02175771|3937963|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
2264602|NCT02175771|3937964|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
2264603|NCT02175771|3937965|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
2264604|NCT02175771|3937966|FG006|Run-In Period (Pre-assignment)|Adverse Event|0
2264605|NCT02175771|3937967|FG007|Run-In Period (Pre-assignment)|Adverse Event|0
2264606|NCT02175771|3937968|FG008|Run-In Period (Pre-assignment)|Adverse Event|0
2264607|NCT02175771|3937960|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
2264608|NCT02175771|3937961|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2264609|NCT02175771|3937962|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2264610|NCT02175771|3937963|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2264611|NCT02175771|3937964|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2264612|NCT02175771|3937965|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2264613|NCT02175771|3937966|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2264614|NCT02175771|3937967|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2264615|NCT02175771|3937968|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2264616|NCT02175771|3937960|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
2264617|NCT02175771|3937961|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2347331|NCT03684642|4085939|FG002|Overall Study|Adverse Event|11
2347332|NCT03684642|4085937|FG000|Overall Study|Withdrawal by Subject|35
2347333|NCT03684642|4085938|FG001|Overall Study|Withdrawal by Subject|53
2347334|NCT03684642|4085939|FG002|Overall Study|Withdrawal by Subject|23
2347335|NCT03684642|4085937|FG000|Overall Study|Lack of Efficacy|0
2347336|NCT03684642|4085938|FG001|Overall Study|Lack of Efficacy|0
2347337|NCT03684642|4085939|FG002|Overall Study|Lack of Efficacy|1
2347338|NCT03684642|4085937|FG000|Overall Study|Poor compliance to protocol|0
2347339|NCT03684642|4085938|FG001|Overall Study|Poor compliance to protocol|4
2347340|NCT03684642|4085939|FG002|Overall Study|Poor compliance to protocol|1
2347341|NCT03684642|4085937|FG000|Overall Study|Other than specified|62
2347342|NCT03684642|4085938|FG001|Overall Study|Other than specified|60
2347343|NCT03684642|4085939|FG002|Overall Study|Other than specified|67
2347344|NCT03684642|4085937|FG000|Overall Study|Randomized and not treated|0
2347345|NCT03684642|4085938|FG001|Overall Study|Randomized and not treated|0
2347346|NCT03684642|4085939|FG002|Overall Study|Randomized and not treated|1
2347347|NCT03684642|4085937|FG000|Overall Study|Missing completion status but alive at last contact|0
2347348|NCT03684642|4085938|FG001|Overall Study|Missing completion status but alive at last contact|1
2347349|NCT03684642|4085939|FG002|Overall Study|Missing completion status but alive at last contact|2
2347350|NCT03684928|4085947|FG000|First Intervention|Lost to Follow-up|0
2347351|NCT03684928|4085948|FG001|First Intervention|Lost to Follow-up|1
2347352|NCT03684928|4085947|FG000|First Intervention|Withdrawal by Subject|0
2347353|NCT03684928|4085948|FG001|First Intervention|Withdrawal by Subject|2
2347354|NCT03684928|4085947|FG000|Second Intervention|Soft Tissue Injury|1
2347355|NCT03684928|4085948|FG001|Second Intervention|Soft Tissue Injury|0
2347356|NCT03685344|4085958|FG000|Overall Study|Withdrawal by Subject|1
2347357|NCT03685344|4085959|FG001|Overall Study|Withdrawal by Subject|1
2347358|NCT03685344|4085960|FG002|Overall Study|Withdrawal by Subject|2
2347359|NCT03685344|4085961|FG003|Overall Study|Withdrawal by Subject|0
2347360|NCT03685344|4085958|FG000|Overall Study|Physician Decision|1
2347361|NCT03685344|4085959|FG001|Overall Study|Physician Decision|1
2347362|NCT03685344|4085960|FG002|Overall Study|Physician Decision|5
2347363|NCT03685344|4085961|FG003|Overall Study|Physician Decision|0
2347364|NCT03685344|4085958|FG000|Overall Study|Death|1
2347365|NCT03685344|4085959|FG001|Overall Study|Death|1
2347366|NCT03685344|4085960|FG002|Overall Study|Death|0
2347367|NCT03685344|4085961|FG003|Overall Study|Death|0
2347368|NCT03685643|4085982|FG000|Overall Study|Lost to Follow-up|14
2347369|NCT03685643|4085983|FG001|Overall Study|Lost to Follow-up|22
2347370|NCT03686033|4086002|FG000|Treatment Period 2 (1 Day)|Adverse Event|0
2347371|NCT03686033|4086003|FG001|Treatment Period 2 (1 Day)|Adverse Event|0
2347372|NCT03686033|4086004|FG002|Treatment Period 2 (1 Day)|Adverse Event|0
2347373|NCT03686033|4086005|FG003|Treatment Period 2 (1 Day)|Adverse Event|0
2347374|NCT03686033|4086006|FG004|Treatment Period 2 (1 Day)|Adverse Event|1
2347375|NCT03686033|4086007|FG005|Treatment Period 2 (1 Day)|Adverse Event|0
2347376|NCT03686176|4086024|FG000|Overall Study|Procedure cancelled|1
2347377|NCT03686176|4086025|FG001|Overall Study|Procedure cancelled|0
2347378|NCT03686176|4086026|FG002|Overall Study|Procedure cancelled|0
2347379|NCT03686176|4086024|FG000|Overall Study|VR Malfunction|1
2347380|NCT03686176|4086025|FG001|Overall Study|VR Malfunction|0
2347381|NCT03686176|4086026|FG002|Overall Study|VR Malfunction|0
2347382|NCT03687125|4086036|FG000|Overall Study|Progressive Disease|2
2264618|NCT02175771|3937962|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2264619|NCT02175771|3937963|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2264620|NCT02175771|3937964|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2264621|NCT02175771|3937965|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2264622|NCT02175771|3937966|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2264623|NCT02175771|3937967|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2264624|NCT02175771|3937968|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2264625|NCT02175771|3937960|FG000|Run-In Period (Pre-assignment)|Other|8
2264626|NCT02175771|3937961|FG001|Run-In Period (Pre-assignment)|Other|0
2264627|NCT02175771|3937962|FG002|Run-In Period (Pre-assignment)|Other|0
2264628|NCT02175771|3937963|FG003|Run-In Period (Pre-assignment)|Other|0
2264629|NCT02175771|3937964|FG004|Run-In Period (Pre-assignment)|Other|0
2264630|NCT02175771|3937965|FG005|Run-In Period (Pre-assignment)|Other|0
2264631|NCT02175771|3937966|FG006|Run-In Period (Pre-assignment)|Other|0
2264632|NCT02175771|3937967|FG007|Run-In Period (Pre-assignment)|Other|0
2264633|NCT02175771|3937968|FG008|Run-In Period (Pre-assignment)|Other|0
2264634|NCT02175771|3937960|FG000|Treatment Period|Adverse Event|0
2264635|NCT02175771|3937961|FG001|Treatment Period|Adverse Event|2
2264636|NCT02175771|3937962|FG002|Treatment Period|Adverse Event|1
2264637|NCT02175771|3937963|FG003|Treatment Period|Adverse Event|1
2264638|NCT02175771|3937964|FG004|Treatment Period|Adverse Event|1
2264639|NCT02175771|3937965|FG005|Treatment Period|Adverse Event|3
2264640|NCT02175771|3937966|FG006|Treatment Period|Adverse Event|2
2264641|NCT02175771|3937967|FG007|Treatment Period|Adverse Event|0
2264642|NCT02175771|3937968|FG008|Treatment Period|Adverse Event|1
2347383|NCT03687125|4086037|FG001|Overall Study|Progressive Disease|1
2347384|NCT03687125|4086036|FG000|Overall Study|Protocol Violation|1
2347385|NCT03687125|4086037|FG001|Overall Study|Protocol Violation|0
2347386|NCT03687372|4086047|FG000|Overall Study|Lost to Follow-up|12
2347387|NCT03687372|4086048|FG001|Overall Study|Lost to Follow-up|21
2347388|NCT03687372|4086047|FG000|Overall Study|Withdrawal by Subject|4
2347389|NCT03687372|4086048|FG001|Overall Study|Withdrawal by Subject|17
2347390|NCT03687372|4086047|FG000|Overall Study|Investigator Decision|1
2347391|NCT03687372|4086048|FG001|Overall Study|Investigator Decision|1
2347392|NCT03687736|4086112|FG000|Overall Study|Lost to Follow-up|7
2347393|NCT03687736|4086112|FG000|Overall Study|Withdrawal by Subject|3
2347394|NCT03687827|4086118|FG000|Treatment Period 1|Death|0
2347395|NCT03687827|4086119|FG001|Treatment Period 1|Death|1
2347396|NCT03687827|4086118|FG000|Treatment Period 1|Lost to Follow-up|2
2347397|NCT03687827|4086119|FG001|Treatment Period 1|Lost to Follow-up|2
2347398|NCT03687827|4086118|FG000|Treatment Period 1|Physician Decision|5
2347399|NCT03687827|4086119|FG001|Treatment Period 1|Physician Decision|2
2347400|NCT03687827|4086118|FG000|Treatment Period 1|Withdrawal by Subject|7
2347401|NCT03687827|4086119|FG001|Treatment Period 1|Withdrawal by Subject|3
2347402|NCT03687827|4086118|FG000|Treatment Period 2|Physician Decision|4
2347403|NCT03687827|4086119|FG001|Treatment Period 2|Physician Decision|1
2347404|NCT03687827|4086118|FG000|Treatment Period 2|Withdrawal by Subject|1
2347405|NCT03687827|4086119|FG001|Treatment Period 2|Withdrawal by Subject|2
2347406|NCT03687970|4086127|FG000|Overall Study|visit scheduling conflicts|2
2347407|NCT03687970|4086128|FG001|Overall Study|visit scheduling conflicts|0
2347408|NCT03688620|4086154|FG000|Overall Study|Other|0
2347409|NCT03688620|4086155|FG001|Overall Study|Other|0
2347410|NCT03688620|4086156|FG002|Overall Study|Other|1
2347411|NCT03688620|4086154|FG000|Overall Study|Unwilling to attend the scheduled visit|0
2347412|NCT03688620|4086155|FG001|Overall Study|Unwilling to attend the scheduled visit|1
2347413|NCT03688620|4086156|FG002|Overall Study|Unwilling to attend the scheduled visit|0
2347414|NCT03688620|4086154|FG000|Overall Study|Lost to Follow-up|16
2347415|NCT03688620|4086155|FG001|Overall Study|Lost to Follow-up|0
2347416|NCT03688620|4086156|FG002|Overall Study|Lost to Follow-up|1
2347417|NCT03688620|4086154|FG000|Overall Study|Withdrawal by Subject|0
2347418|NCT03688620|4086155|FG001|Overall Study|Withdrawal by Subject|0
2347419|NCT03688620|4086156|FG002|Overall Study|Withdrawal by Subject|6
2347420|NCT03688711|4086172|FG000|Overall Study|Withdrawal by Subject|0
2347421|NCT03688711|4086173|FG001|Overall Study|Withdrawal by Subject|1
2347422|NCT03688880|4086181|FG000|Overall Study|Withdrawal by Subject|0
2347423|NCT03688880|4086182|FG001|Overall Study|Withdrawal by Subject|2
2347424|NCT03688880|4086181|FG000|Overall Study|Use of non-permitted concurrent therapy|0
2347425|NCT03688880|4086182|FG001|Overall Study|Use of non-permitted concurrent therapy|2
2347426|NCT03688880|4086181|FG000|Overall Study|Lost to Follow-up|4
2347427|NCT03688880|4086182|FG001|Overall Study|Lost to Follow-up|7
2347428|NCT03688880|4086181|FG000|Overall Study|Adverse Event|0
2347429|NCT03688880|4086182|FG001|Overall Study|Adverse Event|2
2347430|NCT03688880|4086181|FG000|Overall Study|Device deficiencies|0
2347431|NCT03688880|4086182|FG001|Overall Study|Device deficiencies|2
2347432|NCT03688880|4086181|FG000|Overall Study|Other|10
2347433|NCT03688880|4086182|FG001|Overall Study|Other|16
2347434|NCT03689452|4086190|FG000|Overall Study|Lost to Follow-up|1
2347435|NCT03689452|4086191|FG001|Overall Study|Lost to Follow-up|1
2347436|NCT03691779|4086218|FG000|Part B (24 Weeks)|Adverse Event|0
2347437|NCT03691779|4086219|FG001|Part B (24 Weeks)|Adverse Event|1
2347438|NCT03691779|4086218|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0
2347439|NCT03691779|4086219|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1
2347440|NCT03691831|4086228|FG000|Overall Study|Lost to Follow-up|16
2264643|NCT02175771|3937960|FG000|Treatment Period|Withdrawal by Subject|0
2264644|NCT02175771|3937961|FG001|Treatment Period|Withdrawal by Subject|9
2264645|NCT02175771|3937962|FG002|Treatment Period|Withdrawal by Subject|3
2264646|NCT02175771|3937963|FG003|Treatment Period|Withdrawal by Subject|6
2264647|NCT02175771|3937964|FG004|Treatment Period|Withdrawal by Subject|2
2264648|NCT02175771|3937965|FG005|Treatment Period|Withdrawal by Subject|4
2264649|NCT02175771|3937966|FG006|Treatment Period|Withdrawal by Subject|2
2264650|NCT02175771|3937967|FG007|Treatment Period|Withdrawal by Subject|9
2264651|NCT02175771|3937968|FG008|Treatment Period|Withdrawal by Subject|2
2264652|NCT02175771|3937960|FG000|Treatment Period|Noncompliance|0
2264653|NCT02175771|3937961|FG001|Treatment Period|Noncompliance|1
2264654|NCT02175771|3937962|FG002|Treatment Period|Noncompliance|2
2264655|NCT02175771|3937963|FG003|Treatment Period|Noncompliance|0
2264656|NCT02175771|3937964|FG004|Treatment Period|Noncompliance|0
2264657|NCT02175771|3937965|FG005|Treatment Period|Noncompliance|0
2264658|NCT02175771|3937966|FG006|Treatment Period|Noncompliance|0
2264659|NCT02175771|3937967|FG007|Treatment Period|Noncompliance|0
2264660|NCT02175771|3937968|FG008|Treatment Period|Noncompliance|1
2264661|NCT02175771|3937960|FG000|Treatment Period|Protocol Violation|0
2264662|NCT02175771|3937961|FG001|Treatment Period|Protocol Violation|0
2264663|NCT02175771|3937962|FG002|Treatment Period|Protocol Violation|0
2264664|NCT02175771|3937963|FG003|Treatment Period|Protocol Violation|0
2264665|NCT02175771|3937964|FG004|Treatment Period|Protocol Violation|0
2264666|NCT02175771|3937965|FG005|Treatment Period|Protocol Violation|0
2264667|NCT02175771|3937966|FG006|Treatment Period|Protocol Violation|0
2264668|NCT02175771|3937967|FG007|Treatment Period|Protocol Violation|1
2264669|NCT02175771|3937968|FG008|Treatment Period|Protocol Violation|0
2264670|NCT02175771|3937960|FG000|Treatment Period|Disease progression|0
2264671|NCT02175771|3937961|FG001|Treatment Period|Disease progression|0
2264672|NCT02175771|3937962|FG002|Treatment Period|Disease progression|0
2264673|NCT02175771|3937963|FG003|Treatment Period|Disease progression|0
2264674|NCT02175771|3937964|FG004|Treatment Period|Disease progression|0
2264675|NCT02175771|3937965|FG005|Treatment Period|Disease progression|0
2264676|NCT02175771|3937966|FG006|Treatment Period|Disease progression|0
2264677|NCT02175771|3937967|FG007|Treatment Period|Disease progression|2
2264678|NCT02175771|3937968|FG008|Treatment Period|Disease progression|0
2264679|NCT02175771|3937960|FG000|Treatment Period|Lost to Follow-up|0
2264680|NCT02175771|3937961|FG001|Treatment Period|Lost to Follow-up|3
2264681|NCT02175771|3937962|FG002|Treatment Period|Lost to Follow-up|1
2264682|NCT02175771|3937963|FG003|Treatment Period|Lost to Follow-up|3
2347441|NCT03691831|4086229|FG001|Overall Study|Lost to Follow-up|12
2347442|NCT03691831|4086228|FG000|Overall Study|Withdrawal by Subject|9
2347443|NCT03691831|4086229|FG001|Overall Study|Withdrawal by Subject|17
2264683|NCT02175771|3937964|FG004|Treatment Period|Lost to Follow-up|1
2264684|NCT02175771|3937965|FG005|Treatment Period|Lost to Follow-up|2
2264685|NCT02175771|3937966|FG006|Treatment Period|Lost to Follow-up|1
2264686|NCT02175771|3937967|FG007|Treatment Period|Lost to Follow-up|2
2264687|NCT02175771|3937968|FG008|Treatment Period|Lost to Follow-up|2
2264688|NCT02175771|3937960|FG000|Treatment Period|Lack of Efficacy|0
2264689|NCT02175771|3937961|FG001|Treatment Period|Lack of Efficacy|0
2264690|NCT02175771|3937962|FG002|Treatment Period|Lack of Efficacy|0
2264691|NCT02175771|3937963|FG003|Treatment Period|Lack of Efficacy|0
2264692|NCT02175771|3937964|FG004|Treatment Period|Lack of Efficacy|0
2264693|NCT02175771|3937965|FG005|Treatment Period|Lack of Efficacy|1
2264694|NCT02175771|3937966|FG006|Treatment Period|Lack of Efficacy|0
2264695|NCT02175771|3937967|FG007|Treatment Period|Lack of Efficacy|1
2264696|NCT02175771|3937968|FG008|Treatment Period|Lack of Efficacy|0
2264697|NCT02175771|3937960|FG000|Treatment Period|Other|0
2264698|NCT02175771|3937961|FG001|Treatment Period|Other|1
2264699|NCT02175771|3937962|FG002|Treatment Period|Other|0
2264700|NCT02175771|3937963|FG003|Treatment Period|Other|3
2264701|NCT02175771|3937964|FG004|Treatment Period|Other|1
2264702|NCT02175771|3937965|FG005|Treatment Period|Other|0
2264703|NCT02175771|3937966|FG006|Treatment Period|Other|0
2264704|NCT02175771|3937967|FG007|Treatment Period|Other|2
2264705|NCT02175771|3937968|FG008|Treatment Period|Other|0
2264706|NCT02175966|3937988|FG000|Follow-up Period|Lack of Efficacy|10
2264707|NCT02175966|3937989|FG001|Follow-up Period|Lack of Efficacy|6
2264708|NCT02176018|3938023|FG000|Overall Study|Adverse Event|0
2264709|NCT02176018|3938024|FG001|Overall Study|Adverse Event|2
2264710|NCT02176018|3938023|FG000|Overall Study|Lost to Follow-up|3
2264711|NCT02176018|3938024|FG001|Overall Study|Lost to Follow-up|1
2264712|NCT02176018|3938023|FG000|Overall Study|Protocol Violation|1
2264713|NCT02176018|3938024|FG001|Overall Study|Protocol Violation|1
2264714|NCT02176018|3938023|FG000|Overall Study|Withdrawal by Subject|1
2264715|NCT02176018|3938024|FG001|Overall Study|Withdrawal by Subject|2
2264716|NCT02176226|3938044|FG000|Overall Study|Lost to Follow-up|3
2264717|NCT02176226|3938044|FG000|Overall Study|Withdrew prior to treatment|6
2264718|NCT02176291|3938050|FG000|Overall Study|Death|1
2264719|NCT02176291|3938051|FG001|Overall Study|Death|0
2264720|NCT02176291|3938050|FG000|Overall Study|non compliance with protocol|2
2264721|NCT02176291|3938051|FG001|Overall Study|non compliance with protocol|0
2264722|NCT02176291|3938050|FG000|Overall Study|Withdrawal by Subject|2
2264723|NCT02176291|3938051|FG001|Overall Study|Withdrawal by Subject|0
2264724|NCT02176356|3938061|FG000|Overall Study|Screen Failure|14
2264725|NCT02176356|3938061|FG000|Overall Study|Lost to Follow-up|4
2264726|NCT02176356|3938061|FG000|Overall Study|Personal Reasons|3
2264727|NCT02176356|3938061|FG000|Overall Study|Other Miscellaneous Reasons|2
2264728|NCT02176421|3938083|FG000|Overall Study|Lost to Follow-up|4
2264729|NCT02176421|3938083|FG000|Overall Study|Adverse Event|1
2264730|NCT02176525|3938110|FG000|Overall Study|Adverse Event|0
2264731|NCT02176525|3938111|FG001|Overall Study|Adverse Event|0
2264732|NCT02176525|3938112|FG002|Overall Study|Adverse Event|0
2264733|NCT02176525|3938113|FG003|Overall Study|Adverse Event|1
2264734|NCT02176525|3938114|FG004|Overall Study|Adverse Event|1
2264735|NCT02176525|3938115|FG005|Overall Study|Adverse Event|0
2264736|NCT02176525|3938116|FG006|Overall Study|Adverse Event|1
2264737|NCT02176525|3938117|FG007|Overall Study|Adverse Event|0
2264738|NCT02176525|3938110|FG000|Overall Study|not treated|1
2264739|NCT02176525|3938111|FG001|Overall Study|not treated|0
2264740|NCT02176525|3938112|FG002|Overall Study|not treated|0
2264741|NCT02176525|3938113|FG003|Overall Study|not treated|0
2264742|NCT02176525|3938114|FG004|Overall Study|not treated|0
2264743|NCT02176525|3938115|FG005|Overall Study|not treated|1
2264744|NCT02176525|3938116|FG006|Overall Study|not treated|0
2264745|NCT02176525|3938117|FG007|Overall Study|not treated|0
2264746|NCT02176642|3938145|FG000|Overall Study|Withdrawal by Subject|0
2264747|NCT02176642|3938146|FG001|Overall Study|Withdrawal by Subject|1
2264748|NCT02176655|3938152|FG000|Overall Study|Subjects did not treat|6
2264749|NCT02176928|3938163|FG000|Overall Study|Lost to Follow-up|2
2264750|NCT02176928|3938164|FG001|Overall Study|Lost to Follow-up|4
2264751|NCT02177032|3938174|FG000|Overall Study|ADMINISTRATIVE REASON|2
2264752|NCT02177032|3938175|FG001|Overall Study|ADMINISTRATIVE REASON|0
2264753|NCT02177032|3938176|FG002|Overall Study|ADMINISTRATIVE REASON|1
2264754|NCT02177032|3938177|FG003|Overall Study|ADMINISTRATIVE REASON|0
2264755|NCT02177032|3938174|FG000|Overall Study|Lost to Follow-up|0
2264756|NCT02177032|3938175|FG001|Overall Study|Lost to Follow-up|2
2264757|NCT02177032|3938176|FG002|Overall Study|Lost to Follow-up|0
2264758|NCT02177032|3938177|FG003|Overall Study|Lost to Follow-up|0
2264759|NCT02177032|3938174|FG000|Overall Study|OTHER|2
2264760|NCT02177032|3938175|FG001|Overall Study|OTHER|0
2264761|NCT02177032|3938176|FG002|Overall Study|OTHER|1
2264762|NCT02177032|3938177|FG003|Overall Study|OTHER|0
2264763|NCT02177032|3938174|FG000|Overall Study|Withdrawal by Subject|1
2264764|NCT02177032|3938175|FG001|Overall Study|Withdrawal by Subject|0
2264765|NCT02177032|3938176|FG002|Overall Study|Withdrawal by Subject|1
2264766|NCT02177032|3938177|FG003|Overall Study|Withdrawal by Subject|0
2264767|NCT02177123|3938198|FG000|Overall Study|Lost to Follow-up|6
2264768|NCT02177123|3938198|FG000|Overall Study|Withdrawal by Subject|4
2264769|NCT02177123|3938198|FG000|Overall Study|Adverse Event|4
2264770|NCT02177123|3938198|FG000|Overall Study|Physician Decision|3
2264771|NCT02177123|3938198|FG000|Overall Study|Excluded by Sponsor - other reason|2
2264772|NCT02177123|3938198|FG000|Overall Study|Excluded for medical reasons|2
2264773|NCT02177123|3938198|FG000|Overall Study|Death|1
2264774|NCT02177123|3938198|FG000|Overall Study|Other|1
2264775|NCT02177123|3938198|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1
2264776|NCT02177136|3938208|FG000|DB Phase|Withdrawal by Subject|2
2264777|NCT02177136|3938209|FG001|DB Phase|Withdrawal by Subject|0
2264778|NCT02177136|3938210|FG002|DB Phase|Withdrawal by Subject|0
2264779|NCT02177136|3938211|FG003|DB Phase|Withdrawal by Subject|0
2264780|NCT02177136|3938208|FG000|DB Phase|Discontinued Due to Pruritus|1
2264781|NCT02177136|3938209|FG001|DB Phase|Discontinued Due to Pruritus|3
2264782|NCT02177136|3938210|FG002|DB Phase|Discontinued Due to Pruritus|0
2264783|NCT02177136|3938211|FG003|DB Phase|Discontinued Due to Pruritus|0
2264784|NCT02177136|3938208|FG000|DB Phase|Adverse Event|3
2264785|NCT02177136|3938209|FG001|DB Phase|Adverse Event|2
2264786|NCT02177136|3938210|FG002|DB Phase|Adverse Event|3
2264787|NCT02177136|3938211|FG003|DB Phase|Adverse Event|0
2264788|NCT02177136|3938208|FG000|DB Phase|Protocol Violation|0
2264789|NCT02177136|3938209|FG001|DB Phase|Protocol Violation|0
2264790|NCT02177136|3938210|FG002|DB Phase|Protocol Violation|1
2264791|NCT02177136|3938211|FG003|DB Phase|Protocol Violation|0
2264792|NCT02177136|3938208|FG000|DB Phase|Withdrew Consent Prior to Dosing|1
2264793|NCT02177136|3938209|FG001|DB Phase|Withdrew Consent Prior to Dosing|0
2264794|NCT02177136|3938210|FG002|DB Phase|Withdrew Consent Prior to Dosing|0
2264795|NCT02177136|3938211|FG003|DB Phase|Withdrew Consent Prior to Dosing|0
2264796|NCT02177136|3938208|FG000|LTSE Phase|Withdrawal by Subject|0
2264797|NCT02177136|3938209|FG001|LTSE Phase|Withdrawal by Subject|0
2264798|NCT02177136|3938210|FG002|LTSE Phase|Withdrawal by Subject|0
2264799|NCT02177136|3938211|FG003|LTSE Phase|Withdrawal by Subject|6
2347444|NCT03691831|4086228|FG000|Overall Study|Investigator Decision|2
2347445|NCT03691831|4086229|FG001|Overall Study|Investigator Decision|2
2347446|NCT03691948|4086256|FG000|Overall Study|Lost to Follow-up|1
2347447|NCT03691948|4086257|FG001|Overall Study|Lost to Follow-up|3
2347448|NCT03692676|4086268|FG000|Overall Study|exclude patients with prior use|4424
2347449|NCT03692676|4086269|FG001|Overall Study|exclude patients with prior use|24726
2347450|NCT03692676|4086270|FG002|Overall Study|exclude patients with prior use|0
2347451|NCT03692676|4086271|FG003|Overall Study|exclude patients with prior use|0
2347452|NCT03692676|4086268|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480
2347453|NCT03692676|4086269|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037
2264800|NCT02177136|3938208|FG000|LTSE Phase|Adverse Event|0
2264801|NCT02177136|3938209|FG001|LTSE Phase|Adverse Event|0
2264802|NCT02177136|3938210|FG002|LTSE Phase|Adverse Event|0
2264803|NCT02177136|3938211|FG003|LTSE Phase|Adverse Event|10
2264804|NCT02177136|3938208|FG000|LTSE Phase|Discontinued Due to Pruritus|0
2264805|NCT02177136|3938209|FG001|LTSE Phase|Discontinued Due to Pruritus|0
2264806|NCT02177136|3938210|FG002|LTSE Phase|Discontinued Due to Pruritus|0
2264807|NCT02177136|3938211|FG003|LTSE Phase|Discontinued Due to Pruritus|4
2264808|NCT02177136|3938208|FG000|LTSE Phase|Physician Decision|0
2264809|NCT02177136|3938209|FG001|LTSE Phase|Physician Decision|0
2264810|NCT02177136|3938210|FG002|LTSE Phase|Physician Decision|0
2264811|NCT02177136|3938211|FG003|LTSE Phase|Physician Decision|2
2264812|NCT02177136|3938208|FG000|LTSE Phase|Lost to Follow-up|0
2264813|NCT02177136|3938209|FG001|LTSE Phase|Lost to Follow-up|0
2264814|NCT02177136|3938210|FG002|LTSE Phase|Lost to Follow-up|0
2264815|NCT02177136|3938211|FG003|LTSE Phase|Lost to Follow-up|1
2264816|NCT02177136|3938208|FG000|LTSE Phase|Participant Moved|0
2264817|NCT02177136|3938209|FG001|LTSE Phase|Participant Moved|0
2264818|NCT02177136|3938210|FG002|LTSE Phase|Participant Moved|0
2264819|NCT02177136|3938211|FG003|LTSE Phase|Participant Moved|1
2264820|NCT02177786|3938235|FG000|Overall Study|Withdrew Consent|2
2264821|NCT02177786|3938236|FG001|Overall Study|Withdrew Consent|6
2264822|NCT02177786|3938237|FG002|Overall Study|Withdrew Consent|9
2264823|NCT02177786|3938238|FG003|Overall Study|Withdrew Consent|5
2264824|NCT02177786|3938235|FG000|Overall Study|Progression to End Stage Renal Disease|2
2264825|NCT02177786|3938236|FG001|Overall Study|Progression to End Stage Renal Disease|3
2264826|NCT02177786|3938237|FG002|Overall Study|Progression to End Stage Renal Disease|2
2264827|NCT02177786|3938238|FG003|Overall Study|Progression to End Stage Renal Disease|1
2264828|NCT02177786|3938235|FG000|Overall Study|Adverse Event|1
2264829|NCT02177786|3938236|FG001|Overall Study|Adverse Event|1
2264830|NCT02177786|3938237|FG002|Overall Study|Adverse Event|2
2264831|NCT02177786|3938238|FG003|Overall Study|Adverse Event|3
2264832|NCT02177786|3938235|FG000|Overall Study|Death|1
2264833|NCT02177786|3938236|FG001|Overall Study|Death|1
2264834|NCT02177786|3938237|FG002|Overall Study|Death|1
2264835|NCT02177786|3938238|FG003|Overall Study|Death|1
2264836|NCT02177786|3938235|FG000|Overall Study|Lost to Follow-up|0
2264837|NCT02177786|3938236|FG001|Overall Study|Lost to Follow-up|0
2264838|NCT02177786|3938237|FG002|Overall Study|Lost to Follow-up|2
2264839|NCT02177786|3938238|FG003|Overall Study|Lost to Follow-up|2
2264840|NCT02177786|3938235|FG000|Overall Study|Non-Compliance with Study Drug|0
2264841|NCT02177786|3938236|FG001|Overall Study|Non-Compliance with Study Drug|1
2264842|NCT02177786|3938237|FG002|Overall Study|Non-Compliance with Study Drug|0
2264843|NCT02177786|3938238|FG003|Overall Study|Non-Compliance with Study Drug|1
2264844|NCT02177786|3938235|FG000|Overall Study|Protocol Violation|0
2264845|NCT02177786|3938236|FG001|Overall Study|Protocol Violation|0
2264846|NCT02177786|3938237|FG002|Overall Study|Protocol Violation|2
2264847|NCT02177786|3938238|FG003|Overall Study|Protocol Violation|0
2264848|NCT02177786|3938235|FG000|Overall Study|Progressive Disease|0
2264849|NCT02177786|3938236|FG001|Overall Study|Progressive Disease|1
2264850|NCT02177786|3938237|FG002|Overall Study|Progressive Disease|0
2264851|NCT02177786|3938238|FG003|Overall Study|Progressive Disease|0
2264852|NCT02177786|3938235|FG000|Overall Study|Missing study completion status|0
2264853|NCT02177786|3938236|FG001|Overall Study|Missing study completion status|1
2264854|NCT02177786|3938237|FG002|Overall Study|Missing study completion status|0
2264855|NCT02177786|3938238|FG003|Overall Study|Missing study completion status|0
2264856|NCT02177812|3938257|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2264857|NCT02177812|3938258|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2264858|NCT02177812|3938259|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2264859|NCT02177812|3938260|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2264860|NCT02177812|3938261|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2264861|NCT02177812|3938262|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
2264862|NCT02177812|3938263|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
2264863|NCT02177812|3938264|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
2264864|NCT02177812|3938265|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2264865|NCT02177812|3938257|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0
2264866|NCT02177812|3938258|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0
2264867|NCT02177812|3938259|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0
2264868|NCT02177812|3938260|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0
2264869|NCT02177812|3938261|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0
2264870|NCT02177812|3938262|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1
2264871|NCT02177812|3938263|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1
2264872|NCT02177812|3938264|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0
2264873|NCT02177812|3938265|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0
2264874|NCT02177812|3938257|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0
2264875|NCT02177812|3938258|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0
2264876|NCT02177812|3938259|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0
2264877|NCT02177812|3938260|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1
2264878|NCT02177812|3938261|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1
2264879|NCT02177812|3938262|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1
2264880|NCT02177812|3938263|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6
2264881|NCT02177812|3938264|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1
2264882|NCT02177812|3938265|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0
2264883|NCT02177838|3938294|FG000|Overall Study|Withdrawal by Subject|1
2264884|NCT02177838|3938294|FG000|Overall Study|Physician Decision|1
2264885|NCT02177838|3938294|FG000|Overall Study|Death|1
2264886|NCT02177942|3938300|FG000|Overall Study|Adverse Event|1
2264887|NCT02177942|3938301|FG001|Overall Study|Adverse Event|0
2264888|NCT02177942|3938300|FG000|Overall Study|Lost to Follow-up|1
2264889|NCT02177942|3938301|FG001|Overall Study|Lost to Follow-up|1
2264890|NCT02177942|3938300|FG000|Overall Study|Protocol Violation|4
2264891|NCT02177942|3938301|FG001|Overall Study|Protocol Violation|6
2264892|NCT02177942|3938300|FG000|Overall Study|Withdrawal by Subject|71
2264893|NCT02177942|3938301|FG001|Overall Study|Withdrawal by Subject|81
2264894|NCT02178059|3938311|FG000|Washout|Physician Decision|1
2264895|NCT02178059|3938312|FG001|Washout|Physician Decision|0
2264896|NCT02178475|3938322|FG000|Overall Study|Withdrawal by Subject|7
2264897|NCT02178475|3938322|FG000|Overall Study|Lost to Follow-up|10
2264898|NCT02178475|3938322|FG000|Overall Study|Death|13
2264899|NCT02178475|3938322|FG000|Overall Study|Protocol-specified Criteria|99
2264900|NCT02178553|3938335|FG000|Overall Study|Did not proceed to open thoracotomy|7
2264901|NCT02178553|3938336|FG001|Overall Study|Did not proceed to open thoracotomy|3
2264902|NCT02178553|3938335|FG000|Overall Study|Physician Decision|0
2264903|NCT02178553|3938336|FG001|Overall Study|Physician Decision|4
2264904|NCT02178553|3938335|FG000|Overall Study|Technical problem with injection|1
2264905|NCT02178553|3938336|FG001|Overall Study|Technical problem with injection|3
2264906|NCT02178592|3938344|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0
2264907|NCT02178592|3938345|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2
2264908|NCT02178592|3938344|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
2264909|NCT02178592|3938345|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
2264910|NCT02178592|3938344|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3
2264911|NCT02178592|3938345|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2
2264912|NCT02178592|3938344|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3
2264913|NCT02178592|3938345|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1
2264914|NCT02178592|3938344|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11
2264915|NCT02178592|3938345|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3
2264916|NCT02178592|3938344|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1
2264917|NCT02178592|3938345|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0
2264918|NCT02178592|3938344|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1
2264919|NCT02178592|3938345|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0
2264920|NCT02178592|3938344|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0
2264921|NCT02178592|3938345|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1
2264922|NCT02178592|3938344|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2
2264923|NCT02178592|3938345|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0
2264924|NCT02178592|3938344|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4
2264925|NCT02178592|3938345|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1
2264926|NCT02178592|3938344|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2
2264927|NCT02178592|3938345|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0
2264928|NCT02178592|3938344|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3
2264929|NCT02178592|3938345|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1
2264930|NCT02178787|3938368|FG000|Overall Study|Lost to Follow-up|1
2264931|NCT02178787|3938369|FG001|Overall Study|Lost to Follow-up|0
2264932|NCT02178787|3938368|FG000|Overall Study|Withdrawal by Subject|0
2264933|NCT02178787|3938369|FG001|Overall Study|Withdrawal by Subject|2
2347454|NCT03692676|4086270|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
2347455|NCT03692676|4086271|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
2347456|NCT03692676|4086268|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881
2347457|NCT03692676|4086269|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563
2347458|NCT03692676|4086270|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281
2347459|NCT03692676|4086271|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558
2347460|NCT03692676|4086268|FG000|Overall Study|exclude patients less than 18 years of age on index date|8
2347461|NCT03692676|4086269|FG001|Overall Study|exclude patients less than 18 years of age on index date|613
2347462|NCT03692676|4086270|FG002|Overall Study|exclude patients less than 18 years of age on index date|836
2347463|NCT03692676|4086271|FG003|Overall Study|exclude patients less than 18 years of age on index date|193
2347464|NCT03692676|4086268|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149
2347465|NCT03692676|4086269|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717
2347466|NCT03692676|4086270|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723
2347467|NCT03692676|4086271|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273
2347468|NCT03692676|4086268|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208
2347469|NCT03692676|4086269|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759
2347470|NCT03692676|4086270|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419
2347471|NCT03692676|4086271|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684
2347472|NCT03692676|4086268|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275
2264934|NCT02178787|3938368|FG000|Overall Study|No TCD window|3
2264935|NCT02178787|3938369|FG001|Overall Study|No TCD window|7
2264936|NCT02178787|3938368|FG000|Overall Study|Physician Decision|1
2264937|NCT02178787|3938369|FG001|Overall Study|Physician Decision|0
2264938|NCT02178956|3938396|FG000|Overall Study|Lost to Follow-up|4
2264939|NCT02178956|3938397|FG001|Overall Study|Lost to Follow-up|4
2264940|NCT02178956|3938396|FG000|Overall Study|Sponsor terminated study|49
2264941|NCT02178956|3938397|FG001|Overall Study|Sponsor terminated study|58
2264942|NCT02178956|3938396|FG000|Overall Study|Withdrawal by Subject|15
2264943|NCT02178956|3938397|FG001|Overall Study|Withdrawal by Subject|11
2264944|NCT02178956|3938396|FG000|Overall Study|Various Reasons|3
2264945|NCT02178956|3938397|FG001|Overall Study|Various Reasons|5
2264946|NCT02178995|3938409|FG000|Double Blind|Adverse Event|0
2264947|NCT02178995|3938410|FG001|Double Blind|Adverse Event|0
2264948|NCT02178995|3938411|FG002|Double Blind|Adverse Event|0
2264949|NCT02178995|3938412|FG003|Double Blind|Adverse Event|0
2264950|NCT02178995|3938413|FG004|Double Blind|Adverse Event|0
2264951|NCT02178995|3938414|FG005|Double Blind|Adverse Event|1
2264952|NCT02178995|3938415|FG006|Double Blind|Adverse Event|0
2264953|NCT02178995|3938416|FG007|Double Blind|Adverse Event|1
2264954|NCT02178995|3938417|FG008|Double Blind|Adverse Event|1
2264955|NCT02178995|3938409|FG000|Double Blind|Lost to Follow-up|0
2264956|NCT02178995|3938410|FG001|Double Blind|Lost to Follow-up|1
2264957|NCT02178995|3938411|FG002|Double Blind|Lost to Follow-up|0
2264958|NCT02178995|3938412|FG003|Double Blind|Lost to Follow-up|0
2264959|NCT02178995|3938413|FG004|Double Blind|Lost to Follow-up|0
2264960|NCT02178995|3938414|FG005|Double Blind|Lost to Follow-up|0
2264961|NCT02178995|3938415|FG006|Double Blind|Lost to Follow-up|0
2264962|NCT02178995|3938416|FG007|Double Blind|Lost to Follow-up|1
2264963|NCT02178995|3938417|FG008|Double Blind|Lost to Follow-up|0
2264964|NCT02178995|3938409|FG000|Open Label|Adverse Event|2
2264965|NCT02178995|3938410|FG001|Open Label|Adverse Event|0
2264966|NCT02178995|3938411|FG002|Open Label|Adverse Event|0
2264967|NCT02178995|3938412|FG003|Open Label|Adverse Event|0
2264968|NCT02178995|3938413|FG004|Open Label|Adverse Event|0
2264969|NCT02178995|3938414|FG005|Open Label|Adverse Event|0
2264970|NCT02178995|3938415|FG006|Open Label|Adverse Event|0
2264971|NCT02178995|3938416|FG007|Open Label|Adverse Event|0
2264972|NCT02178995|3938417|FG008|Open Label|Adverse Event|0
2264973|NCT02179177|3938463|FG000|Overall Study|Lost to Follow-up|1
2264974|NCT02179177|3938464|FG001|Overall Study|Lost to Follow-up|1
2264975|NCT02179177|3938463|FG000|Overall Study|Withdrawal by Subject|1
2264976|NCT02179177|3938464|FG001|Overall Study|Withdrawal by Subject|1
2264977|NCT02179190|3938470|FG000|Enrollment|Exit Prior to Device Attempt|11
2264978|NCT02179190|3938470|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
2264979|NCT02179190|3938470|FG000|Follow-Up Post Barrel VRD Implanted|Death|3
2264980|NCT02179190|3938470|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
2264981|NCT02179190|3938470|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
2264982|NCT02179190|3938470|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
2264983|NCT02179398|3938476|FG000|Overall Study|Lack of obligatory data|3
2264984|NCT02179398|3938477|FG001|Overall Study|Lack of obligatory data|3
2264985|NCT02179398|3938476|FG000|Overall Study|Lost to Follow-up|0
2264986|NCT02179398|3938477|FG001|Overall Study|Lost to Follow-up|1
2347473|NCT03692676|4086269|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218
2347474|NCT03692676|4086270|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515
2347475|NCT03692676|4086271|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173
2347476|NCT03692676|4086268|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
2347477|NCT03692676|4086269|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
2347478|NCT03692676|4086270|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147
2347479|NCT03692676|4086271|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4
2347480|NCT03692676|4086268|FG000|Overall Study|exclude patients with prior use of same substances and device|0
2347481|NCT03692676|4086269|FG001|Overall Study|exclude patients with prior use of same substances and device|0
2347482|NCT03692676|4086270|FG002|Overall Study|exclude patients with prior use of same substances and device|3700
2347483|NCT03692676|4086271|FG003|Overall Study|exclude patients with prior use of same substances and device|0
2347484|NCT03692676|4086268|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
2347485|NCT03692676|4086269|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
2347486|NCT03692676|4086270|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965
2347487|NCT03692676|4086271|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198
2347488|NCT03692676|4086268|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
2347489|NCT03692676|4086269|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
2347490|NCT03692676|4086270|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
2347491|NCT03692676|4086271|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223
2347492|NCT03692676|4086268|FG000|Overall Study|Other|0
2347493|NCT03692676|4086269|FG001|Overall Study|Other|805
2347494|NCT03692676|4086270|FG002|Overall Study|Other|758
2347495|NCT03692676|4086271|FG003|Overall Study|Other|277
2264987|NCT02179515|3938508|FG000|Overall Study|switched to alternative treatment|0
2264988|NCT02179515|3938509|FG001|Overall Study|switched to alternative treatment|1
2264989|NCT02179515|3938510|FG002|Overall Study|switched to alternative treatment|1
2264990|NCT02179515|3938508|FG000|Overall Study|Death|0
2264991|NCT02179515|3938509|FG001|Overall Study|Death|1
2264992|NCT02179515|3938510|FG002|Overall Study|Death|1
2264993|NCT02179515|3938508|FG000|Overall Study|refused further treatment|0
2264994|NCT02179515|3938509|FG001|Overall Study|refused further treatment|3
2264995|NCT02179515|3938510|FG002|Overall Study|refused further treatment|4
2264996|NCT02179515|3938508|FG000|Overall Study|Disease progression on study|2
2264997|NCT02179515|3938509|FG001|Overall Study|Disease progression on study|11
2264998|NCT02179515|3938510|FG002|Overall Study|Disease progression on study|8
2264999|NCT02179918|3938566|FG000|Overall Study|Death|0
2265000|NCT02179918|3938567|FG001|Overall Study|Death|0
2265001|NCT02179918|3938568|FG002|Overall Study|Death|0
2265002|NCT02179918|3938569|FG003|Overall Study|Death|1
2265003|NCT02179918|3938570|FG004|Overall Study|Death|0
2265004|NCT02179918|3938566|FG000|Overall Study|Lost to Follow-up|0
2265005|NCT02179918|3938567|FG001|Overall Study|Lost to Follow-up|0
2265006|NCT02179918|3938568|FG002|Overall Study|Lost to Follow-up|1
2265007|NCT02179918|3938569|FG003|Overall Study|Lost to Follow-up|0
2265008|NCT02179918|3938570|FG004|Overall Study|Lost to Follow-up|0
2265009|NCT02179918|3938566|FG000|Overall Study|Progressive Disease|4
2265010|NCT02179918|3938567|FG001|Overall Study|Progressive Disease|1
2265011|NCT02179918|3938568|FG002|Overall Study|Progressive Disease|1
2265012|NCT02179918|3938569|FG003|Overall Study|Progressive Disease|2
2265013|NCT02179918|3938570|FG004|Overall Study|Progressive Disease|6
2265014|NCT02179918|3938566|FG000|Overall Study|Other|0
2265015|NCT02179918|3938567|FG001|Overall Study|Other|1
2265016|NCT02179918|3938568|FG002|Overall Study|Other|0
2265017|NCT02179918|3938569|FG003|Overall Study|Other|0
2265018|NCT02179918|3938570|FG004|Overall Study|Other|1
2265019|NCT02179918|3938566|FG000|Overall Study|Subject refused further follow-up|0
2265020|NCT02179918|3938567|FG001|Overall Study|Subject refused further follow-up|1
2265021|NCT02179918|3938568|FG002|Overall Study|Subject refused further follow-up|0
2265022|NCT02179918|3938569|FG003|Overall Study|Subject refused further follow-up|0
2265023|NCT02179918|3938570|FG004|Overall Study|Subject refused further follow-up|1
2265024|NCT02180061|3938585|FG000|Overall Study|Adverse Event|4
2265025|NCT02180061|3938586|FG001|Overall Study|Adverse Event|2
2265026|NCT02180061|3938585|FG000|Overall Study|Clinical Progression|5
2265027|NCT02180061|3938586|FG001|Overall Study|Clinical Progression|1
2265028|NCT02180061|3938585|FG000|Overall Study|Progressive Disease|15
2265029|NCT02180061|3938586|FG001|Overall Study|Progressive Disease|5
2265030|NCT02180061|3938585|FG000|Overall Study|Physician Decision|1
2265031|NCT02180061|3938586|FG001|Overall Study|Physician Decision|0
2265032|NCT02180165|3938605|FG000|Overall Study|Not Treated|0
2265033|NCT02180165|3938606|FG001|Overall Study|Not Treated|0
2265034|NCT02180165|3938607|FG002|Overall Study|Not Treated|1
2265035|NCT02180165|3938608|FG003|Overall Study|Not Treated|0
2265036|NCT02180165|3938605|FG000|Overall Study|Adverse Event|7
2265037|NCT02180165|3938606|FG001|Overall Study|Adverse Event|0
2265038|NCT02180165|3938607|FG002|Overall Study|Adverse Event|18
2265039|NCT02180165|3938608|FG003|Overall Study|Adverse Event|3
2265040|NCT02180165|3938605|FG000|Overall Study|Lack of Efficacy|0
2265041|NCT02180165|3938606|FG001|Overall Study|Lack of Efficacy|1
2265042|NCT02180165|3938607|FG002|Overall Study|Lack of Efficacy|3
2265043|NCT02180165|3938608|FG003|Overall Study|Lack of Efficacy|2
2265044|NCT02180165|3938605|FG000|Overall Study|Physician Decision|1
2265045|NCT02180165|3938606|FG001|Overall Study|Physician Decision|0
2265046|NCT02180165|3938607|FG002|Overall Study|Physician Decision|5
2265047|NCT02180165|3938608|FG003|Overall Study|Physician Decision|0
2265048|NCT02180165|3938605|FG000|Overall Study|Withdrawal by Subject|3
2265049|NCT02180165|3938606|FG001|Overall Study|Withdrawal by Subject|0
2265050|NCT02180165|3938607|FG002|Overall Study|Withdrawal by Subject|2
2265051|NCT02180165|3938608|FG003|Overall Study|Withdrawal by Subject|1
2265052|NCT02180438|3938624|FG000|Overall Study|Lost to Follow-up|1
2265053|NCT02180659|3938641|FG000|Overall Study|Adverse Event|1
2265054|NCT02180659|3938642|FG001|Overall Study|Adverse Event|0
2265055|NCT02180659|3938641|FG000|Overall Study|Lost to Follow-up|4
2265056|NCT02180659|3938642|FG001|Overall Study|Lost to Follow-up|2
2265057|NCT02180659|3938641|FG000|Overall Study|Subject incarcerated during conduct|1
2265058|NCT02180659|3938642|FG001|Overall Study|Subject incarcerated during conduct|0
2265059|NCT02180659|3938641|FG000|Overall Study|Withdrawal by Subject|0
2265060|NCT02180659|3938642|FG001|Overall Study|Withdrawal by Subject|2
2265061|NCT02180659|3938641|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0
2265062|NCT02180659|3938642|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1
2265063|NCT02180672|3938650|FG000|Overall Study|Lost to Follow-up|5
2265064|NCT02180672|3938651|FG001|Overall Study|Lost to Follow-up|7
2265065|NCT02180867|3938673|FG000|Overall Study|Adverse Event|3
2265066|NCT02180867|3938674|FG001|Overall Study|Adverse Event|4
2265067|NCT02180867|3938675|FG002|Overall Study|Adverse Event|1
2265068|NCT02180867|3938676|FG003|Overall Study|Adverse Event|5
2265069|NCT02180867|3938677|FG004|Overall Study|Adverse Event|0
2265070|NCT02180867|3938678|FG005|Overall Study|Adverse Event|0
2265071|NCT02180867|3938679|FG006|Overall Study|Adverse Event|0
2265072|NCT02180867|3938673|FG000|Overall Study|Death|0
2265073|NCT02180867|3938674|FG001|Overall Study|Death|0
2265074|NCT02180867|3938675|FG002|Overall Study|Death|0
2265075|NCT02180867|3938676|FG003|Overall Study|Death|0
2265076|NCT02180867|3938677|FG004|Overall Study|Death|1
2265077|NCT02180867|3938678|FG005|Overall Study|Death|0
2265078|NCT02180867|3938679|FG006|Overall Study|Death|0
2265079|NCT02180867|3938673|FG000|Overall Study|Lack of Efficacy|0
2265080|NCT02180867|3938674|FG001|Overall Study|Lack of Efficacy|2
2265081|NCT02180867|3938675|FG002|Overall Study|Lack of Efficacy|0
2265082|NCT02180867|3938676|FG003|Overall Study|Lack of Efficacy|1
2265083|NCT02180867|3938677|FG004|Overall Study|Lack of Efficacy|6
2265084|NCT02180867|3938678|FG005|Overall Study|Lack of Efficacy|0
2265085|NCT02180867|3938679|FG006|Overall Study|Lack of Efficacy|1
2265086|NCT02180867|3938673|FG000|Overall Study|Physician Decision|1
2265087|NCT02180867|3938674|FG001|Overall Study|Physician Decision|3
2265088|NCT02180867|3938675|FG002|Overall Study|Physician Decision|1
2265089|NCT02180867|3938676|FG003|Overall Study|Physician Decision|10
2265090|NCT02180867|3938677|FG004|Overall Study|Physician Decision|9
2265091|NCT02180867|3938678|FG005|Overall Study|Physician Decision|3
2265092|NCT02180867|3938679|FG006|Overall Study|Physician Decision|4
2265093|NCT02180867|3938673|FG000|Overall Study|Withdrawal by Subject|0
2265094|NCT02180867|3938674|FG001|Overall Study|Withdrawal by Subject|0
2265095|NCT02180867|3938675|FG002|Overall Study|Withdrawal by Subject|0
2265096|NCT02180867|3938676|FG003|Overall Study|Withdrawal by Subject|1
2265097|NCT02180867|3938677|FG004|Overall Study|Withdrawal by Subject|1
2265098|NCT02180867|3938678|FG005|Overall Study|Withdrawal by Subject|0
2265099|NCT02180867|3938679|FG006|Overall Study|Withdrawal by Subject|0
2265100|NCT02180867|3938673|FG000|Overall Study|Ineligible|1
2265101|NCT02180867|3938674|FG001|Overall Study|Ineligible|2
2265102|NCT02180867|3938675|FG002|Overall Study|Ineligible|0
2265103|NCT02180867|3938676|FG003|Overall Study|Ineligible|3
2265104|NCT02180867|3938677|FG004|Overall Study|Ineligible|5
2265105|NCT02180867|3938678|FG005|Overall Study|Ineligible|0
2265106|NCT02180867|3938679|FG006|Overall Study|Ineligible|0
2265107|NCT02180867|3938673|FG000|Overall Study|Repeat Eligibility Studies|0
2347496|NCT03692676|4086268|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
2347497|NCT03692676|4086269|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
2347498|NCT03692676|4086270|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
2347499|NCT03692676|4086271|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3
2347500|NCT03693625|4086283|FG000|Overall Study|Adverse Event|2
2347501|NCT03693625|4086284|FG001|Overall Study|Adverse Event|0
2347502|NCT03693625|4086283|FG000|Overall Study|Study Terminated By Sponsor|20
2347503|NCT03693625|4086284|FG001|Overall Study|Study Terminated By Sponsor|7
2347504|NCT03693625|4086283|FG000|Overall Study|Withdrawal by Subject|1
2347505|NCT03693625|4086284|FG001|Overall Study|Withdrawal by Subject|1
2347506|NCT03693950|4086307|FG000|Overall Study|Withdrawal by Subject|1
2347507|NCT03693950|4086308|FG001|Overall Study|Withdrawal by Subject|0
2347508|NCT03693989|4086316|FG000|Overall Study|Protocol Violation|3
2347509|NCT03693989|4086317|FG001|Overall Study|Protocol Violation|4
2347510|NCT03694197|4086323|FG000|Overall Study|Adverse Event|9
2347511|NCT03694197|4086323|FG000|Overall Study|Protocol became inconvenient to participate|1
2347512|NCT03694197|4086323|FG000|Overall Study|Physician Decision|4
2347513|NCT03694197|4086323|FG000|Overall Study|Study terminated by sponsor|1350
2347514|NCT03694197|4086323|FG000|Overall Study|Participant moved|5
2347515|NCT03694197|4086323|FG000|Overall Study|Participant withdrew consent|10
2347516|NCT03694197|4086323|FG000|Overall Study|Related to IMP administration|1
2347517|NCT03694197|4086323|FG000|Overall Study|Not disclosed|5
2347518|NCT03694210|4086327|FG000|Overall Study|Death|1
2347519|NCT03694210|4086327|FG000|Overall Study|Screen Failure|7
2347520|NCT03694275|4086335|FG000|Overall Study|Adverse Event|0
2347521|NCT03694275|4086336|FG001|Overall Study|Adverse Event|1
2347522|NCT03694275|4086335|FG000|Overall Study|Reason not Specified|0
2347523|NCT03694275|4086336|FG001|Overall Study|Reason not Specified|1
2347524|NCT03694548|4086345|FG000|Part A Survey|Protocol Violation|3
2347525|NCT03694548|4086346|FG001|Part A Survey|Protocol Violation|3
2347526|NCT03694548|4086347|FG002|Part A Survey|Protocol Violation|0
2347527|NCT03694548|4086345|FG000|Part B Yoga Program|Protocol Violation|0
2347528|NCT03694548|4086346|FG001|Part B Yoga Program|Protocol Violation|0
2347529|NCT03694548|4086347|FG002|Part B Yoga Program|Protocol Violation|3
2347530|NCT03694548|4086345|FG000|Part B Yoga Program|Did not attend intervention|0
2347531|NCT03694548|4086346|FG001|Part B Yoga Program|Did not attend intervention|0
2347532|NCT03694548|4086347|FG002|Part B Yoga Program|Did not attend intervention|8
2347533|NCT03694925|4086373|FG000|Overall Study|Inadequate laboratory testing|0
2347534|NCT03694925|4086374|FG001|Overall Study|Inadequate laboratory testing|3
2347535|NCT03694925|4086375|FG002|Overall Study|Inadequate laboratory testing|0
2347536|NCT03695094|4086387|FG000|Overall Study|Adverse Event|1
2265108|NCT02180867|3938674|FG001|Overall Study|Repeat Eligibility Studies|0
2265109|NCT02180867|3938675|FG002|Overall Study|Repeat Eligibility Studies|0
2265110|NCT02180867|3938676|FG003|Overall Study|Repeat Eligibility Studies|0
2265111|NCT02180867|3938677|FG004|Overall Study|Repeat Eligibility Studies|1
2265112|NCT02180867|3938678|FG005|Overall Study|Repeat Eligibility Studies|0
2265113|NCT02180867|3938679|FG006|Overall Study|Repeat Eligibility Studies|0
2265114|NCT02180867|3938673|FG000|Overall Study|Refusal of further protocol therapy|1
2265115|NCT02180867|3938674|FG001|Overall Study|Refusal of further protocol therapy|0
2265116|NCT02180867|3938675|FG002|Overall Study|Refusal of further protocol therapy|2
2265117|NCT02180867|3938676|FG003|Overall Study|Refusal of further protocol therapy|6
2265118|NCT02180867|3938677|FG004|Overall Study|Refusal of further protocol therapy|4
2265119|NCT02180867|3938678|FG005|Overall Study|Refusal of further protocol therapy|0
2265120|NCT02180867|3938679|FG006|Overall Study|Refusal of further protocol therapy|0
2265121|NCT02181296|3938753|FG000|Overall Study|Lost to Follow-up|7
2265122|NCT02181296|3938754|FG001|Overall Study|Lost to Follow-up|6
2265123|NCT02181413|3938784|FG000|Overall Study|Adverse Event|7
2265124|NCT02181413|3938785|FG001|Overall Study|Adverse Event|24
2265125|NCT02181413|3938784|FG000|Overall Study|Progressive Disease|121
2265126|NCT02181413|3938785|FG001|Overall Study|Progressive Disease|143
2265127|NCT02181413|3938784|FG000|Overall Study|Withdrawal by Subject|5
2265128|NCT02181413|3938785|FG001|Overall Study|Withdrawal by Subject|8
2265129|NCT02181413|3938784|FG000|Overall Study|Reason Not Specified|19
2265130|NCT02181413|3938785|FG001|Overall Study|Reason Not Specified|20
2265131|NCT02181413|3938784|FG000|Overall Study|Ongoing Study Treatment|0
2265132|NCT02181413|3938785|FG001|Overall Study|Ongoing Study Treatment|1
2265133|NCT02181413|3938784|FG000|Overall Study|Lost to Follow-up|0
2265134|NCT02181413|3938785|FG001|Overall Study|Lost to Follow-up|1
2265135|NCT02181504|3938811|FG000|Overall Study|Adverse Event|1
2265136|NCT02181504|3938812|FG001|Overall Study|Adverse Event|1
2265137|NCT02181504|3938813|FG002|Overall Study|Adverse Event|1
2265138|NCT02181556|3938839|FG000|Overall Study|Withdrawal by Subject|1
2265139|NCT02181634|3938843|FG000|Overall Study|Lack of Efficacy|33
2265140|NCT02181634|3938843|FG000|Overall Study|Adverse Event|17
2265141|NCT02181634|3938843|FG000|Overall Study|Physician Decision|8
2265142|NCT02181634|3938843|FG000|Overall Study|Withdrawal by Subject|5
2265143|NCT02181634|3938843|FG000|Overall Study|Death|2
2265144|NCT02181634|3938843|FG000|Overall Study|Treatment delayed greater than 4 weeks|3
2265145|NCT02181634|3938843|FG000|Overall Study|Ineligible|1
2265146|NCT02181634|3938843|FG000|Overall Study|Max number of dose reduction|1
2265147|NCT02181634|3938843|FG000|Overall Study|Symptomatic progression|1
2265148|NCT02181634|3938843|FG000|Overall Study|Patient opted to proceed to surgery|1
2265149|NCT02181673|3938849|FG000|Up to Week 24|Adverse Event|2
2265150|NCT02181673|3938850|FG001|Up to Week 24|Adverse Event|0
2265151|NCT02181673|3938851|FG002|Up to Week 24|Adverse Event|3
2265152|NCT02181673|3938849|FG000|Up to Week 24|Death|1
2265153|NCT02181673|3938850|FG001|Up to Week 24|Death|0
2265154|NCT02181673|3938851|FG002|Up to Week 24|Death|0
2265155|NCT02181673|3938849|FG000|Up to Week 24|Lack of Efficacy|1
2265156|NCT02181673|3938850|FG001|Up to Week 24|Lack of Efficacy|0
2265157|NCT02181673|3938851|FG002|Up to Week 24|Lack of Efficacy|0
2265158|NCT02181673|3938849|FG000|Up to Week 24|Lost to Follow-up|1
2265159|NCT02181673|3938850|FG001|Up to Week 24|Lost to Follow-up|0
2265160|NCT02181673|3938851|FG002|Up to Week 24|Lost to Follow-up|0
2265161|NCT02181673|3938849|FG000|Up to Week 24|Physician Decision|0
2265162|NCT02181673|3938850|FG001|Up to Week 24|Physician Decision|0
2265163|NCT02181673|3938851|FG002|Up to Week 24|Physician Decision|3
2265164|NCT02181673|3938849|FG000|Up to Week 24|Withdrawal by Subject|10
2265165|NCT02181673|3938850|FG001|Up to Week 24|Withdrawal by Subject|0
2265166|NCT02181673|3938851|FG002|Up to Week 24|Withdrawal by Subject|1
2265167|NCT02181673|3938849|FG000|Up to Week 24|Other|2
2265168|NCT02181673|3938850|FG001|Up to Week 24|Other|0
2265169|NCT02181673|3938851|FG002|Up to Week 24|Other|3
2265170|NCT02181673|3938849|FG000|Up to Week 24|Randomized not Treated|0
2265171|NCT02181673|3938850|FG001|Up to Week 24|Randomized not Treated|0
2265172|NCT02181673|3938851|FG002|Up to Week 24|Randomized not Treated|1
2265173|NCT02181673|3938849|FG000|Week 24-Week 60|Adverse Event|0
2265174|NCT02181673|3938850|FG001|Week 24-Week 60|Adverse Event|4
2265175|NCT02181673|3938851|FG002|Week 24-Week 60|Adverse Event|10
2265176|NCT02181673|3938849|FG000|Week 24-Week 60|Other|0
2265177|NCT02181673|3938850|FG001|Week 24-Week 60|Other|2
2265178|NCT02181673|3938851|FG002|Week 24-Week 60|Other|1
2265179|NCT02181673|3938849|FG000|Week 24-Week 60|Withdrawal by Subject|0
2265180|NCT02181673|3938850|FG001|Week 24-Week 60|Withdrawal by Subject|2
2265181|NCT02181673|3938851|FG002|Week 24-Week 60|Withdrawal by Subject|2
2265182|NCT02181673|3938849|FG000|Week 24-Week 60|Pregnancy|0
2265183|NCT02181673|3938850|FG001|Week 24-Week 60|Pregnancy|0
2265184|NCT02181673|3938851|FG002|Week 24-Week 60|Pregnancy|1
2265185|NCT02181673|3938849|FG000|Week 24-Week 60|Lack of Efficacy|0
2265186|NCT02181673|3938850|FG001|Week 24-Week 60|Lack of Efficacy|0
2265187|NCT02181673|3938851|FG002|Week 24-Week 60|Lack of Efficacy|1
2265188|NCT02181673|3938849|FG000|Week 24-Week 60|Lost to Follow-up|0
2265189|NCT02181673|3938850|FG001|Week 24-Week 60|Lost to Follow-up|0
2347537|NCT03695094|4086388|FG001|Overall Study|Adverse Event|1
2265190|NCT02181673|3938851|FG002|Week 24-Week 60|Lost to Follow-up|1
2265191|NCT02181673|3938849|FG000|Week 24-Week 60|Physician Decision|0
2265192|NCT02181673|3938850|FG001|Week 24-Week 60|Physician Decision|0
2265193|NCT02181673|3938851|FG002|Week 24-Week 60|Physician Decision|1
2265194|NCT02181738|3938862|FG000|Overall Study|Death|1
2265195|NCT02181738|3938863|FG001|Overall Study|Death|1
2265196|NCT02181738|3938864|FG002|Overall Study|Death|6
2265197|NCT02181738|3938865|FG003|Overall Study|Death|1
2265198|NCT02181738|3938862|FG000|Overall Study|Subject Withdrew Consent|1
2265199|NCT02181738|3938863|FG001|Overall Study|Subject Withdrew Consent|3
2265200|NCT02181738|3938864|FG002|Overall Study|Subject Withdrew Consent|2
2265201|NCT02181738|3938865|FG003|Overall Study|Subject Withdrew Consent|1
2265202|NCT02181738|3938862|FG000|Overall Study|Lost to Follow-up|0
2265203|NCT02181738|3938863|FG001|Overall Study|Lost to Follow-up|4
2265204|NCT02181738|3938864|FG002|Overall Study|Lost to Follow-up|2
2265205|NCT02181738|3938865|FG003|Overall Study|Lost to Follow-up|0
2265206|NCT02181738|3938862|FG000|Overall Study|Patient Return to Home Country|0
2265207|NCT02181738|3938863|FG001|Overall Study|Patient Return to Home Country|1
2265208|NCT02181738|3938864|FG002|Overall Study|Patient Return to Home Country|0
2265209|NCT02181738|3938865|FG003|Overall Study|Patient Return to Home Country|0
2265210|NCT02181803|3938884|FG000|Overall Study|Withdrawal by Subject|0
2265211|NCT02181803|3938885|FG001|Overall Study|Withdrawal by Subject|2
2265212|NCT02181803|3938886|FG002|Overall Study|Withdrawal by Subject|0
2265213|NCT02181803|3938887|FG003|Overall Study|Withdrawal by Subject|0
2265214|NCT02181803|3938888|FG004|Overall Study|Withdrawal by Subject|0
2265215|NCT02181803|3938889|FG005|Overall Study|Withdrawal by Subject|0
2265216|NCT02181803|3938890|FG006|Overall Study|Withdrawal by Subject|0
2265217|NCT02181803|3938891|FG007|Overall Study|Withdrawal by Subject|0
2265218|NCT02181803|3938892|FG008|Overall Study|Withdrawal by Subject|0
2265219|NCT02181803|3938884|FG000|Overall Study|Physician Decision|0
2265220|NCT02181803|3938885|FG001|Overall Study|Physician Decision|0
2265221|NCT02181803|3938886|FG002|Overall Study|Physician Decision|0
2265222|NCT02181803|3938887|FG003|Overall Study|Physician Decision|1
2265223|NCT02181803|3938888|FG004|Overall Study|Physician Decision|0
2265224|NCT02181803|3938889|FG005|Overall Study|Physician Decision|0
2265225|NCT02181803|3938890|FG006|Overall Study|Physician Decision|0
2265226|NCT02181803|3938891|FG007|Overall Study|Physician Decision|1
2265227|NCT02181803|3938892|FG008|Overall Study|Physician Decision|0
2265228|NCT02181803|3938884|FG000|Overall Study|Adverse Event|0
2265229|NCT02181803|3938885|FG001|Overall Study|Adverse Event|2
2265230|NCT02181803|3938886|FG002|Overall Study|Adverse Event|0
2265231|NCT02181803|3938887|FG003|Overall Study|Adverse Event|1
2265232|NCT02181803|3938888|FG004|Overall Study|Adverse Event|0
2265233|NCT02181803|3938889|FG005|Overall Study|Adverse Event|0
2265234|NCT02181803|3938890|FG006|Overall Study|Adverse Event|1
2265235|NCT02181803|3938891|FG007|Overall Study|Adverse Event|0
2265236|NCT02181803|3938892|FG008|Overall Study|Adverse Event|0
2265237|NCT02181816|3938937|FG000|Overall Study|Case Report Forms Uncollected|38
2265238|NCT02181816|3938937|FG000|Overall Study|Protocol Deviation|21
2265239|NCT02181842|3938945|FG000|Overall Study|Case Report Forms Uncollected|2
2265240|NCT02182440|3938962|FG000|Overall Study|Adverse Event|0
2265241|NCT02182440|3938963|FG001|Overall Study|Adverse Event|1
2265242|NCT02182440|3938964|FG002|Overall Study|Adverse Event|0
2265243|NCT02182440|3938965|FG003|Overall Study|Adverse Event|0
2265244|NCT02182440|3938962|FG000|Overall Study|Death|31
2265245|NCT02182440|3938963|FG001|Overall Study|Death|8
2265246|NCT02182440|3938964|FG002|Overall Study|Death|5
2265247|NCT02182440|3938965|FG003|Overall Study|Death|16
2265248|NCT02182440|3938962|FG000|Overall Study|Protocol Violation|0
2265249|NCT02182440|3938963|FG001|Overall Study|Protocol Violation|1
2265250|NCT02182440|3938964|FG002|Overall Study|Protocol Violation|0
2265251|NCT02182440|3938965|FG003|Overall Study|Protocol Violation|0
2265252|NCT02182440|3938962|FG000|Overall Study|Physician Decision|1
2265253|NCT02182440|3938963|FG001|Overall Study|Physician Decision|0
2265254|NCT02182440|3938964|FG002|Overall Study|Physician Decision|0
2265255|NCT02182440|3938965|FG003|Overall Study|Physician Decision|0
2265256|NCT02182440|3938962|FG000|Overall Study|Withdrawal by Subject|1
2265257|NCT02182440|3938963|FG001|Overall Study|Withdrawal by Subject|1
2265258|NCT02182440|3938964|FG002|Overall Study|Withdrawal by Subject|3
2265259|NCT02182440|3938965|FG003|Overall Study|Withdrawal by Subject|4
2265260|NCT02182440|3938962|FG000|Overall Study|different, e.g adm other hospital|12
2265261|NCT02182440|3938963|FG001|Overall Study|different, e.g adm other hospital|3
2265262|NCT02182440|3938964|FG002|Overall Study|different, e.g adm other hospital|3
2265263|NCT02182440|3938965|FG003|Overall Study|different, e.g adm other hospital|10
2265264|NCT02182830|3938992|FG000|Overall Study|Not Treated|1
2265265|NCT02182830|3938993|FG001|Overall Study|Not Treated|1
2265266|NCT02182830|3938992|FG000|Overall Study|Trial stopped, reason missing|3
2265267|NCT02182830|3938993|FG001|Overall Study|Trial stopped, reason missing|3
2265268|NCT02182830|3938992|FG000|Overall Study|Consent withdrawn|8
2265269|NCT02182830|3938993|FG001|Overall Study|Consent withdrawn|8
2265270|NCT02182830|3938992|FG000|Overall Study|Lost to Follow-up|3
2265271|NCT02182830|3938993|FG001|Overall Study|Lost to Follow-up|3
2265272|NCT02182843|3938999|FG000|Overall Study|Withdrawal by Subject|7
2265273|NCT02182843|3938999|FG000|Overall Study|Lost to Follow-up|2
2265274|NCT02182843|3938999|FG000|Overall Study|Adverse Event|1
2265275|NCT02182895|3939005|FG000|Overall Study|Discharged from hospital within 24 hours|2
2265276|NCT02182895|3939006|FG001|Overall Study|Discharged from hospital within 24 hours|4
2265277|NCT02182947|3939012|FG000|Overall Study|Withdrawal by Subject|7
2265278|NCT02182947|3939012|FG000|Overall Study|Lost to Follow-up|3
2265279|NCT02182947|3939012|FG000|Overall Study|Failed screening activities|8
2265280|NCT02182973|3939018|FG000|Overall Study|Withdrawal by Subject|3
2265281|NCT02182973|3939019|FG001|Overall Study|Withdrawal by Subject|0
2265282|NCT02182999|3939028|FG000|Overall Study|Adverse Event|4
2265283|NCT02182999|3939029|FG001|Overall Study|Adverse Event|3
2265284|NCT02182999|3939028|FG000|Overall Study|Physician Decision|1
2265285|NCT02182999|3939029|FG001|Overall Study|Physician Decision|0
2265286|NCT02183519|3939037|FG000|Overall Study|computer error|3
2265287|NCT02183519|3939038|FG001|Overall Study|computer error|0
2265288|NCT02183519|3939037|FG000|Overall Study|Did not respond to cough inducter|0
2265289|NCT02183519|3939038|FG001|Overall Study|Did not respond to cough inducter|3
2265290|NCT02183675|3939050|FG000|Treatment Period 2 (10 Days)|Adverse Event|0
2265291|NCT02183675|3939051|FG001|Treatment Period 2 (10 Days)|Adverse Event|0
2265292|NCT02183675|3939052|FG002|Treatment Period 2 (10 Days)|Adverse Event|0
2265293|NCT02183675|3939053|FG003|Treatment Period 2 (10 Days)|Adverse Event|0
2265294|NCT02183675|3939054|FG004|Treatment Period 2 (10 Days)|Adverse Event|0
2265295|NCT02183675|3939055|FG005|Treatment Period 2 (10 Days)|Adverse Event|2
2265296|NCT02184143|3939076|FG000|Overall Study|Withdrawal by Subject|4
2265297|NCT02184143|3939077|FG001|Overall Study|Withdrawal by Subject|4
2265298|NCT02184143|3939076|FG000|Overall Study|Lost to Follow-up|5
2265299|NCT02184143|3939077|FG001|Overall Study|Lost to Follow-up|3
2265300|NCT02184143|3939076|FG000|Overall Study|Death|1
2265301|NCT02184143|3939077|FG001|Overall Study|Death|0
2265302|NCT02184195|3939098|FG000|Overall Study|Patient decision|3
2265303|NCT02184195|3939099|FG001|Overall Study|Patient decision|1
2265304|NCT02184195|3939098|FG000|Overall Study|Eligibility criteria not fulfilled|0
2265305|NCT02184195|3939099|FG001|Overall Study|Eligibility criteria not fulfilled|1
2265306|NCT02184195|3939098|FG000|Overall Study|Death|40
2265307|NCT02184195|3939099|FG001|Overall Study|Death|29
2265308|NCT02184195|3939098|FG000|Overall Study|Lost to Follow-up|0
2265309|NCT02184195|3939099|FG001|Overall Study|Lost to Follow-up|2
2265310|NCT02184195|3939098|FG000|Overall Study|Other|0
2265311|NCT02184195|3939099|FG001|Overall Study|Other|2
2265312|NCT02184442|3939113|FG000|Overall Study|Death|61
2265313|NCT02184442|3939114|FG001|Overall Study|Death|65
2265314|NCT02184442|3939113|FG000|Overall Study|Withdrawal by Subject|3
2265315|NCT02184442|3939114|FG001|Overall Study|Withdrawal by Subject|11
2265316|NCT02184455|3939120|FG000|Overall Study|Lost to Follow-up|1
2265317|NCT02184572|3939139|FG000|Overall Study|Lost to Follow-up|29
2265318|NCT02184572|3939140|FG001|Overall Study|Lost to Follow-up|21
2265319|NCT02184572|3939139|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1
2265320|NCT02184572|3939140|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0
2265321|NCT02184572|3939139|FG000|Overall Study|Loss Of Kaiser Insurance|1
2265322|NCT02184572|3939140|FG001|Overall Study|Loss Of Kaiser Insurance|0
2265323|NCT02184572|3939139|FG000|Overall Study|2nd blooddraw & diary card incomplete|1
2265324|NCT02184572|3939140|FG001|Overall Study|2nd blooddraw & diary card incomplete|0
2265325|NCT02184572|3939139|FG000|Overall Study|Traveling Outside The Country|1
2265326|NCT02184572|3939140|FG001|Overall Study|Traveling Outside The Country|0
2265327|NCT02184572|3939139|FG000|Overall Study|Withdrawal by Subject|14
2265328|NCT02184572|3939140|FG001|Overall Study|Withdrawal by Subject|9
2265329|NCT02184611|3939150|FG000|Overall Study|Lack of Efficacy|11
2265330|NCT02184611|3939151|FG001|Overall Study|Lack of Efficacy|15
2265331|NCT02184611|3939150|FG000|Overall Study|Withdrawal by Subject|5
2265332|NCT02184611|3939151|FG001|Overall Study|Withdrawal by Subject|6
2265333|NCT02184611|3939150|FG000|Overall Study|Adverse Event|4
2265334|NCT02184611|3939151|FG001|Overall Study|Adverse Event|5
2265335|NCT02184611|3939150|FG000|Overall Study|Protocol Violation|1
2265336|NCT02184611|3939151|FG001|Overall Study|Protocol Violation|1
2265337|NCT02184611|3939150|FG000|Overall Study|Protocol defined stopping criteria|0
2265338|NCT02184611|3939151|FG001|Overall Study|Protocol defined stopping criteria|1
2265339|NCT02184988|3939178|FG000|Overall Study|Pregnancy|2
2265340|NCT02184988|3939178|FG000|Overall Study|Adverse Event|2
2265341|NCT02184988|3939178|FG000|Overall Study|moving away/travelling/unable to complet|6
2265342|NCT02184988|3939178|FG000|Overall Study|work scheduling issues|4
2265343|NCT02184988|3939178|FG000|Overall Study|various other reasons|9
2265344|NCT02184988|3939178|FG000|Overall Study|Lost to Follow-up|32
2265345|NCT02185014|3939182|FG000|Overall Study|Adverse Event|18
2265346|NCT02185014|3939182|FG000|Overall Study|Withdrew Consent|8
2265347|NCT02185014|3939182|FG000|Overall Study|Lost to Follow-up|4
2265348|NCT02185014|3939182|FG000|Overall Study|Lack of Efficacy|14
2265349|NCT02185014|3939182|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5
2265350|NCT02185014|3939182|FG000|Overall Study|Subject Noncompliance|1
2265351|NCT02185014|3939182|FG000|Overall Study|Other|4
2265352|NCT02185040|3939191|FG000|Part 1 Treatment Phase|Miscellaneous|0
2265353|NCT02185040|3939192|FG001|Part 1 Treatment Phase|Miscellaneous|0
2265354|NCT02185040|3939193|FG002|Part 1 Treatment Phase|Miscellaneous|1
2265355|NCT02185040|3939194|FG003|Part 1 Treatment Phase|Miscellaneous|0
2265356|NCT02185040|3939195|FG004|Part 1 Treatment Phase|Miscellaneous|0
2265357|NCT02185040|3939196|FG005|Part 1 Treatment Phase|Miscellaneous|0
2265358|NCT02185040|3939197|FG006|Part 1 Treatment Phase|Miscellaneous|0
2265359|NCT02185040|3939191|FG000|Part 1 Treatment Phase|Adverse Event|1
2265360|NCT02185040|3939192|FG001|Part 1 Treatment Phase|Adverse Event|0
2265361|NCT02185040|3939193|FG002|Part 1 Treatment Phase|Adverse Event|0
2265362|NCT02185040|3939194|FG003|Part 1 Treatment Phase|Adverse Event|2
2265363|NCT02185040|3939195|FG004|Part 1 Treatment Phase|Adverse Event|3
2265364|NCT02185040|3939196|FG005|Part 1 Treatment Phase|Adverse Event|0
2265365|NCT02185040|3939197|FG006|Part 1 Treatment Phase|Adverse Event|0
2347538|NCT03695094|4086387|FG000|Overall Study|Withdrawal by Subject|1
2265366|NCT02185040|3939191|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0
2265367|NCT02185040|3939192|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1
2265368|NCT02185040|3939193|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0
2265369|NCT02185040|3939194|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0
2265370|NCT02185040|3939195|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0
2265371|NCT02185040|3939196|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0
2265372|NCT02185040|3939197|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0
2265373|NCT02185040|3939191|FG000|Part 1 Treatment Phase|Lost to Follow-up|0
2265374|NCT02185040|3939192|FG001|Part 1 Treatment Phase|Lost to Follow-up|1
2347539|NCT03695094|4086388|FG001|Overall Study|Withdrawal by Subject|0
2347540|NCT03695367|4086398|FG000|Overall Study|Missed the Day 28 visit.|1
2347541|NCT03695367|4086399|FG001|Overall Study|Missed the Day 28 visit.|0
2347542|NCT03695367|4086398|FG000|Overall Study|Lost to Follow-up|0
2347543|NCT03695367|4086399|FG001|Overall Study|Lost to Follow-up|1
2347544|NCT03695367|4086398|FG000|Overall Study|Withdrawal by Subject|0
2347545|NCT03695367|4086399|FG001|Overall Study|Withdrawal by Subject|1
2347546|NCT03695367|4086398|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0
2347547|NCT03695367|4086399|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2
2347548|NCT03695393|4086407|FG000|Overall Study|Death|3
2347549|NCT03695393|4086408|FG001|Overall Study|Death|1
2347550|NCT03695393|4086407|FG000|Overall Study|Lost to Follow-up|0
2347551|NCT03695393|4086408|FG001|Overall Study|Lost to Follow-up|1
2347552|NCT03696108|4086420|FG000|Overall Study|Physician Decision|1
2347553|NCT03696108|4086421|FG001|Overall Study|Physician Decision|0
2347554|NCT03696108|4086420|FG000|Overall Study|Withdrawal by Subject|3
2347555|NCT03696108|4086421|FG001|Overall Study|Withdrawal by Subject|6
2347556|NCT03696342|4086429|FG000|Overall Study|Lost to Follow-up|1
2347557|NCT03696342|4086430|FG001|Overall Study|Lost to Follow-up|0
2347558|NCT03696576|4086438|FG000|Overall Study|Soreness of throat after therapy|1
2347559|NCT03696576|4086439|FG001|Overall Study|Soreness of throat after therapy|1
2347560|NCT03696576|4086438|FG000|Overall Study|Lost to Follow-up|2
2347561|NCT03696576|4086439|FG001|Overall Study|Lost to Follow-up|4
2347562|NCT03697252|4086484|FG000|Overall Study|Adverse Event|3
2347563|NCT03697252|4086485|FG001|Overall Study|Adverse Event|2
2347564|NCT03697252|4086484|FG000|Overall Study|Withdrawal by Subject|14
2347565|NCT03697252|4086485|FG001|Overall Study|Withdrawal by Subject|14
2347566|NCT03697252|4086484|FG000|Overall Study|Lost to Follow-up|0
2347567|NCT03697252|4086485|FG001|Overall Study|Lost to Follow-up|1
2347568|NCT03697252|4086484|FG000|Overall Study|Physician Decision|1
2347569|NCT03697252|4086485|FG001|Overall Study|Physician Decision|1
2347570|NCT03697252|4086484|FG000|Overall Study|Other|0
2347571|NCT03697252|4086485|FG001|Overall Study|Other|1
2347572|NCT03697460|4086491|FG000|Overall Study|Withdrawal by Subject|3
2347573|NCT03697993|4086497|FG000|Overall Study|Became Ineligible after Enrollment|1
2347574|NCT03697993|4086498|FG001|Overall Study|Became Ineligible after Enrollment|3
2265375|NCT02185040|3939193|FG002|Part 1 Treatment Phase|Lost to Follow-up|0
2265376|NCT02185040|3939194|FG003|Part 1 Treatment Phase|Lost to Follow-up|0
2265377|NCT02185040|3939195|FG004|Part 1 Treatment Phase|Lost to Follow-up|0
2265378|NCT02185040|3939196|FG005|Part 1 Treatment Phase|Lost to Follow-up|0
2265379|NCT02185040|3939197|FG006|Part 1 Treatment Phase|Lost to Follow-up|0
2265380|NCT02185040|3939191|FG000|Active Treatment Extension Phase|Miscellaneous|0
2265381|NCT02185040|3939192|FG001|Active Treatment Extension Phase|Miscellaneous|0
2265382|NCT02185040|3939193|FG002|Active Treatment Extension Phase|Miscellaneous|0
2265383|NCT02185040|3939194|FG003|Active Treatment Extension Phase|Miscellaneous|0
2265384|NCT02185040|3939195|FG004|Active Treatment Extension Phase|Miscellaneous|0
2265385|NCT02185040|3939196|FG005|Active Treatment Extension Phase|Miscellaneous|1
2265386|NCT02185040|3939197|FG006|Active Treatment Extension Phase|Miscellaneous|0
2265387|NCT02185040|3939191|FG000|Active Treatment Extension Phase|Adverse Event|0
2265388|NCT02185040|3939192|FG001|Active Treatment Extension Phase|Adverse Event|0
2265389|NCT02185040|3939193|FG002|Active Treatment Extension Phase|Adverse Event|0
2265390|NCT02185040|3939194|FG003|Active Treatment Extension Phase|Adverse Event|0
2265391|NCT02185040|3939195|FG004|Active Treatment Extension Phase|Adverse Event|0
2265392|NCT02185040|3939196|FG005|Active Treatment Extension Phase|Adverse Event|1
2265393|NCT02185040|3939197|FG006|Active Treatment Extension Phase|Adverse Event|4
2265394|NCT02185040|3939191|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0
2265395|NCT02185040|3939192|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0
2265396|NCT02185040|3939193|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0
2265397|NCT02185040|3939194|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0
2265398|NCT02185040|3939195|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0
2265399|NCT02185040|3939196|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1
2265400|NCT02185040|3939197|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1
2265401|NCT02185040|3939191|FG000|Active Treatment Extension Phase|Lost to Follow-up|0
2265402|NCT02185040|3939192|FG001|Active Treatment Extension Phase|Lost to Follow-up|0
2265403|NCT02185040|3939193|FG002|Active Treatment Extension Phase|Lost to Follow-up|0
2265404|NCT02185040|3939194|FG003|Active Treatment Extension Phase|Lost to Follow-up|0
2265405|NCT02185040|3939195|FG004|Active Treatment Extension Phase|Lost to Follow-up|0
2347575|NCT03697993|4086497|FG000|Overall Study|Enrolled but Treatment not Administered|2
2265406|NCT02185040|3939196|FG005|Active Treatment Extension Phase|Lost to Follow-up|0
2265407|NCT02185040|3939197|FG006|Active Treatment Extension Phase|Lost to Follow-up|2
2265408|NCT02185053|3939217|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1
2265409|NCT02185053|3939218|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
2265410|NCT02185053|3939219|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
2265411|NCT02185053|3939217|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2
2265412|NCT02185053|3939218|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
2265413|NCT02185053|3939219|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
2265414|NCT02185053|3939217|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0
2265415|NCT02185053|3939218|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1
2265416|NCT02185053|3939219|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0
2265417|NCT02185053|3939217|FG000|Donepezil Dose Escalation Phase|Adverse Event|0
2265418|NCT02185053|3939218|FG001|Donepezil Dose Escalation Phase|Adverse Event|1
2265419|NCT02185053|3939219|FG002|Donepezil Dose Escalation Phase|Adverse Event|0
2265420|NCT02185053|3939217|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
2265421|NCT02185053|3939218|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2
2265422|NCT02185053|3939219|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
2265423|NCT02185053|3939217|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
2265424|NCT02185053|3939218|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1
2265425|NCT02185053|3939219|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
2265426|NCT02185053|3939217|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
2265427|NCT02185053|3939218|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
2265428|NCT02185053|3939219|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1
2265429|NCT02185053|3939217|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
2265430|NCT02185053|3939218|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
2265431|NCT02185053|3939219|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2
2265432|NCT02185521|3939265|FG000|Overall Study|Withdrawal by Subject|1
2265433|NCT02185521|3939265|FG000|Overall Study|Protocol Violation|1
2265434|NCT02185534|3939276|FG000|First Period|Withdrawal by Subject|0
2265435|NCT02185534|3939277|FG001|First Period|Withdrawal by Subject|0
2265436|NCT02185534|3939278|FG002|First Period|Withdrawal by Subject|0
2265437|NCT02185534|3939279|FG003|First Period|Withdrawal by Subject|1
2265438|NCT02185534|3939280|FG004|First Period|Withdrawal by Subject|0
2347576|NCT03697993|4086498|FG001|Overall Study|Enrolled but Treatment not Administered|1
2347577|NCT03697993|4086497|FG000|Overall Study|Lost to Follow-up|3
2347578|NCT03697993|4086498|FG001|Overall Study|Lost to Follow-up|0
2347579|NCT03697993|4086497|FG000|Overall Study|Physician Decision|4
2347580|NCT03697993|4086498|FG001|Overall Study|Physician Decision|0
2347581|NCT03697993|4086497|FG000|Overall Study|Initial Urine Culture Negative|0
2347582|NCT03697993|4086498|FG001|Overall Study|Initial Urine Culture Negative|1
2347583|NCT03698279|4086511|FG000|Overall Study|Withdrawal by parent/guardian|1
2347584|NCT03698279|4086512|FG001|Overall Study|Withdrawal by parent/guardian|1
2347585|NCT03698279|4086513|FG002|Overall Study|Withdrawal by parent/guardian|1
2347586|NCT03698279|4086514|FG003|Overall Study|Withdrawal by parent/guardian|1
2347587|NCT03698279|4086515|FG004|Overall Study|Withdrawal by parent/guardian|0
2347588|NCT03698279|4086516|FG005|Overall Study|Withdrawal by parent/guardian|0
2347589|NCT03698279|4086511|FG000|Overall Study|Protocol deviation|1
2347590|NCT03698279|4086512|FG001|Overall Study|Protocol deviation|0
2347591|NCT03698279|4086513|FG002|Overall Study|Protocol deviation|1
2347592|NCT03698279|4086514|FG003|Overall Study|Protocol deviation|0
2347593|NCT03698279|4086515|FG004|Overall Study|Protocol deviation|0
2347594|NCT03698279|4086516|FG005|Overall Study|Protocol deviation|0
2347595|NCT03698279|4086511|FG000|Overall Study|Withdrawal by Subject|0
2347596|NCT03698279|4086512|FG001|Overall Study|Withdrawal by Subject|0
2347597|NCT03698279|4086513|FG002|Overall Study|Withdrawal by Subject|1
2347598|NCT03698279|4086514|FG003|Overall Study|Withdrawal by Subject|0
2347599|NCT03698279|4086515|FG004|Overall Study|Withdrawal by Subject|0
2347600|NCT03698279|4086516|FG005|Overall Study|Withdrawal by Subject|0
2347601|NCT03698279|4086511|FG000|Overall Study|Lost to Follow-up|3
2347602|NCT03698279|4086512|FG001|Overall Study|Lost to Follow-up|1
2347603|NCT03698279|4086513|FG002|Overall Study|Lost to Follow-up|4
2347604|NCT03698279|4086514|FG003|Overall Study|Lost to Follow-up|5
2347605|NCT03698279|4086515|FG004|Overall Study|Lost to Follow-up|0
2347606|NCT03698279|4086516|FG005|Overall Study|Lost to Follow-up|0
2265439|NCT02185534|3939281|FG005|First Period|Withdrawal by Subject|0
2265440|NCT02185534|3939276|FG000|First Washout Period|Withdrawal by Subject|1
2265441|NCT02185534|3939277|FG001|First Washout Period|Withdrawal by Subject|0
2265442|NCT02185534|3939278|FG002|First Washout Period|Withdrawal by Subject|0
2265443|NCT02185534|3939279|FG003|First Washout Period|Withdrawal by Subject|0
2265444|NCT02185534|3939280|FG004|First Washout Period|Withdrawal by Subject|1
2265445|NCT02185534|3939281|FG005|First Washout Period|Withdrawal by Subject|0
2265446|NCT02185534|3939276|FG000|First Washout Period|Protocol Violation|0
2265447|NCT02185534|3939277|FG001|First Washout Period|Protocol Violation|0
2265448|NCT02185534|3939278|FG002|First Washout Period|Protocol Violation|0
2265449|NCT02185534|3939279|FG003|First Washout Period|Protocol Violation|0
2265450|NCT02185534|3939280|FG004|First Washout Period|Protocol Violation|0
2265451|NCT02185534|3939281|FG005|First Washout Period|Protocol Violation|1
2265452|NCT02185794|3939303|FG000|Overall Study|Enrolled but Never Dosed|1
2265453|NCT02185794|3939304|FG001|Overall Study|Enrolled but Never Dosed|6
2265454|NCT02185794|3939305|FG002|Overall Study|Enrolled but Never Dosed|3
2265455|NCT02185794|3939306|FG003|Overall Study|Enrolled but Never Dosed|1
2265456|NCT02185794|3939307|FG004|Overall Study|Enrolled but Never Dosed|1
2265457|NCT02185794|3939308|FG005|Overall Study|Enrolled but Never Dosed|0
2265458|NCT02185794|3939303|FG000|Overall Study|Investigator's Discretion|1
2265459|NCT02185794|3939304|FG001|Overall Study|Investigator's Discretion|0
2265460|NCT02185794|3939305|FG002|Overall Study|Investigator's Discretion|1
2265461|NCT02185794|3939306|FG003|Overall Study|Investigator's Discretion|2
2265462|NCT02185794|3939307|FG004|Overall Study|Investigator's Discretion|2
2265463|NCT02185794|3939308|FG005|Overall Study|Investigator's Discretion|15
2265464|NCT02185794|3939303|FG000|Overall Study|Withdrew Consent|2
2265465|NCT02185794|3939304|FG001|Overall Study|Withdrew Consent|5
2265466|NCT02185794|3939305|FG002|Overall Study|Withdrew Consent|10
2347607|NCT03698331|4086537|FG000|Overall Study|Adverse Event|2
2347608|NCT03698331|4086538|FG001|Overall Study|Adverse Event|3
2347609|NCT03698331|4086537|FG000|Overall Study|Withdrawal by Subject|1
2347610|NCT03698331|4086538|FG001|Overall Study|Withdrawal by Subject|1
2347611|NCT03698331|4086537|FG000|Overall Study|Lost to Follow-up|0
2347612|NCT03698331|4086538|FG001|Overall Study|Lost to Follow-up|2
2347613|NCT03698331|4086537|FG000|Overall Study|Non-compliance with study drug|1
2347614|NCT03698331|4086538|FG001|Overall Study|Non-compliance with study drug|0
2347615|NCT03698591|4086546|FG000|Overall Study|Withdrawal by Subject|2
2347616|NCT03698591|4086547|FG001|Overall Study|Withdrawal by Subject|2
2347617|NCT03698591|4086546|FG000|Overall Study|Failed drug screen|1
2347618|NCT03698591|4086547|FG001|Overall Study|Failed drug screen|1
2347619|NCT03698591|4086546|FG000|Overall Study|Failed health screen|0
2347620|NCT03698591|4086547|FG001|Overall Study|Failed health screen|1
2347621|NCT03698591|4086546|FG000|Overall Study|Ineligible for financial compensation|1
2347622|NCT03698591|4086547|FG001|Overall Study|Ineligible for financial compensation|0
2347623|NCT03698591|4086546|FG000|Overall Study|Equipment Error|1
2347624|NCT03698591|4086547|FG001|Overall Study|Equipment Error|0
2347625|NCT03698591|4086546|FG000|Overall Study|Could not establish TMS dosage|0
2347626|NCT03698591|4086547|FG001|Overall Study|Could not establish TMS dosage|1
2347627|NCT03699124|4086556|FG000|Overall Study|Adverse Event|6
2347628|NCT03699124|4086557|FG001|Overall Study|Adverse Event|5
2347629|NCT03699124|4086558|FG002|Overall Study|Adverse Event|2
2347630|NCT03699124|4086556|FG000|Overall Study|Death|0
2347631|NCT03699124|4086557|FG001|Overall Study|Death|2
2347632|NCT03699124|4086558|FG002|Overall Study|Death|0
2347633|NCT03699124|4086556|FG000|Overall Study|Lost to Follow-up|20
2347634|NCT03699124|4086557|FG001|Overall Study|Lost to Follow-up|16
2347635|NCT03699124|4086558|FG002|Overall Study|Lost to Follow-up|15
2347636|NCT03699124|4086556|FG000|Overall Study|Protocol Violation|1
2347637|NCT03699124|4086557|FG001|Overall Study|Protocol Violation|0
2347638|NCT03699124|4086558|FG002|Overall Study|Protocol Violation|0
2347639|NCT03699124|4086556|FG000|Overall Study|Withdrawal by Subject|13
2347640|NCT03699124|4086557|FG001|Overall Study|Withdrawal by Subject|14
2347641|NCT03699124|4086558|FG002|Overall Study|Withdrawal by Subject|13
2347642|NCT03699124|4086556|FG000|Overall Study|Other reasons|5
2347643|NCT03699124|4086557|FG001|Overall Study|Other reasons|3
2347644|NCT03699124|4086558|FG002|Overall Study|Other reasons|10
2347645|NCT03700320|4086568|FG000|Overall Study|Adverse Event|5
2347646|NCT03700320|4086569|FG001|Overall Study|Adverse Event|31
2347647|NCT03700320|4086568|FG000|Overall Study|Lack of Efficacy|2
2347648|NCT03700320|4086569|FG001|Overall Study|Lack of Efficacy|5
2347649|NCT03700320|4086568|FG000|Overall Study|Withdrawal by Subject|29
2347650|NCT03700320|4086569|FG001|Overall Study|Withdrawal by Subject|75
2347651|NCT03700320|4086568|FG000|Overall Study|Lost to Follow-up|16
2347652|NCT03700320|4086569|FG001|Overall Study|Lost to Follow-up|23
2347653|NCT03700320|4086568|FG000|Overall Study|Pregnancy|2
2347654|NCT03700320|4086569|FG001|Overall Study|Pregnancy|4
2347655|NCT03700320|4086568|FG000|Overall Study|Protocol Deviation|7
2265467|NCT02185794|3939306|FG003|Overall Study|Withdrew Consent|2
2265468|NCT02185794|3939307|FG004|Overall Study|Withdrew Consent|0
2265469|NCT02185794|3939308|FG005|Overall Study|Withdrew Consent|0
2265470|NCT02185794|3939303|FG000|Overall Study|Lost to Follow-up|1
2265471|NCT02185794|3939304|FG001|Overall Study|Lost to Follow-up|2
2265472|NCT02185794|3939305|FG002|Overall Study|Lost to Follow-up|2
2265473|NCT02185794|3939306|FG003|Overall Study|Lost to Follow-up|3
2265474|NCT02185794|3939307|FG004|Overall Study|Lost to Follow-up|0
2265475|NCT02185794|3939308|FG005|Overall Study|Lost to Follow-up|1
2265476|NCT02186015|3939338|FG000|Overall Study|Physician Decision|1
2265477|NCT02186015|3939339|FG001|Overall Study|Physician Decision|0
2265478|NCT02186171|3939348|FG000|Overall Study|Withdrawal by Subject|1
2265479|NCT02186171|3939349|FG001|Overall Study|Withdrawal by Subject|9
2265480|NCT02186171|3939348|FG000|Overall Study|Lost to Follow-up|2
2265481|NCT02186171|3939349|FG001|Overall Study|Lost to Follow-up|2
2265482|NCT02186171|3939348|FG000|Overall Study|Death|1
2265483|NCT02186171|3939349|FG001|Overall Study|Death|2
2265484|NCT02186171|3939348|FG000|Overall Study|Protocol-specified Criteria|0
2265485|NCT02186171|3939349|FG001|Overall Study|Protocol-specified Criteria|2
2265486|NCT02186223|3939366|FG000|Overall Study|Not eligible for device placement|6
2265487|NCT02186223|3939366|FG000|Overall Study|Unable to obtain femoral access|3
2347656|NCT03700320|4086569|FG001|Overall Study|Protocol Deviation|31
2347657|NCT03700320|4086568|FG000|Overall Study|Non-compliance with Study Drug|1
2347658|NCT03700320|4086569|FG001|Overall Study|Non-compliance with Study Drug|3
2347659|NCT03700320|4086568|FG000|Overall Study|Reason not Specified|0
2347660|NCT03700320|4086569|FG001|Overall Study|Reason not Specified|1
2347661|NCT03700385|4086579|FG000|Overall Study|Lost to Follow-up|1
2347662|NCT03700671|4086585|FG000|Overall Study|Lack of Efficacy|1
2347663|NCT03700671|4086586|FG001|Overall Study|Lack of Efficacy|2
2347664|NCT03700736|4086596|FG000|Overall Study|Pregnancy|1
2347665|NCT03700736|4086597|FG001|Overall Study|Pregnancy|1
2347666|NCT03700736|4086596|FG000|Overall Study|Withdrawal by Subject|2
2347667|NCT03700736|4086597|FG001|Overall Study|Withdrawal by Subject|6
2347668|NCT03700892|4086608|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
2347669|NCT03700892|4086609|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1
2347670|NCT03700892|4086610|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
2347671|NCT03701074|4086630|FG000|Overall Study|Physician Decision|1
2347672|NCT03701074|4086631|FG001|Overall Study|Physician Decision|0
2347673|NCT03702010|4086639|FG000|Follow-up (30days)|Lack of Efficacy|2
2347674|NCT03702010|4086640|FG001|Follow-up (30days)|Lack of Efficacy|2
2347675|NCT03702166|4086652|FG000|Overall Study|Lost to Follow-up|1
2347676|NCT03702166|4086652|FG000|Overall Study|Withdrawal by Subject|1
2347677|NCT03703336|4086663|FG000|Overall Study|Parent withdrew consent|29
2347678|NCT03703336|4086664|FG001|Overall Study|Parent withdrew consent|8
2347679|NCT03703336|4086663|FG000|Overall Study|Migration|3
2347680|NCT03703336|4086664|FG001|Overall Study|Migration|3
2347681|NCT03703336|4086663|FG000|Overall Study|Protocol Violation|3
2347682|NCT03703336|4086664|FG001|Overall Study|Protocol Violation|1
2347683|NCT03703336|4086663|FG000|Overall Study|Physician Decision|2
2347684|NCT03703336|4086664|FG001|Overall Study|Physician Decision|0
2347685|NCT03703336|4086663|FG000|Overall Study|Adverse Event|0
2347686|NCT03703336|4086664|FG001|Overall Study|Adverse Event|2
2347687|NCT03703336|4086663|FG000|Overall Study|Lost to Follow-up|1
2347688|NCT03703336|4086664|FG001|Overall Study|Lost to Follow-up|0
2347689|NCT03703466|4086673|FG000|Overall Study|Death|2
2347690|NCT03703466|4086674|FG001|Overall Study|Death|1
2347691|NCT03703466|4086675|FG002|Overall Study|Death|0
2347692|NCT03703466|4086673|FG000|Overall Study|Protocol Violation|1
2347693|NCT03703466|4086674|FG001|Overall Study|Protocol Violation|0
2347694|NCT03703466|4086675|FG002|Overall Study|Protocol Violation|0
2347695|NCT03703466|4086673|FG000|Overall Study|Withdrawal by Subject|0
2347696|NCT03703466|4086674|FG001|Overall Study|Withdrawal by Subject|3
2347697|NCT03703466|4086675|FG002|Overall Study|Withdrawal by Subject|0
2347698|NCT03703466|4086673|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1
2347699|NCT03703466|4086674|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
2347700|NCT03703466|4086675|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
2347701|NCT03703817|4086686|FG000|Overall Study|Not meeting eligibility criteria|7
2347702|NCT03703817|4086687|FG001|Overall Study|Not meeting eligibility criteria|4
2347703|NCT03704194|4086695|FG000|Overall Study|Withdrawal by Subject|0
2347704|NCT03704194|4086696|FG001|Overall Study|Withdrawal by Subject|1
2347705|NCT03705494|4086735|FG000|Overall Study|Lost to Follow-up|2
2347706|NCT03705494|4086736|FG001|Overall Study|Lost to Follow-up|1
2347707|NCT03705494|4086735|FG000|Overall Study|Withdrawal by Subject|5
2347708|NCT03705494|4086736|FG001|Overall Study|Withdrawal by Subject|2
2347709|NCT03705793|4086744|FG000|Overall Study|Lost to Follow-up|3
2347710|NCT03705793|4086745|FG001|Overall Study|Lost to Follow-up|4
2347711|NCT03705793|4086744|FG000|Overall Study|Withdrawal by Subject|2
2347712|NCT03705793|4086745|FG001|Overall Study|Withdrawal by Subject|1
2347713|NCT03706040|4086754|FG000|Period A (Week 0 to Week 16)|Adverse Event|3
2347714|NCT03706040|4086755|FG001|Period A (Week 0 to Week 16)|Adverse Event|2
2347715|NCT03706040|4086756|FG002|Period A (Week 0 to Week 16)|Adverse Event|1
2347716|NCT03706040|4086757|FG003|Period A (Week 0 to Week 16)|Adverse Event|0
2347717|NCT03706040|4086758|FG004|Period A (Week 0 to Week 16)|Adverse Event|0
2347718|NCT03706040|4086759|FG005|Period A (Week 0 to Week 16)|Adverse Event|0
2347719|NCT03706040|4086760|FG006|Period A (Week 0 to Week 16)|Adverse Event|0
2347720|NCT03706040|4086754|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3
2347721|NCT03706040|4086755|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5
2347722|NCT03706040|4086756|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4
2265488|NCT02186223|3939366|FG000|Overall Study|Death|3
2265489|NCT02186223|3939366|FG000|Overall Study|Device in place less than 48 hours|9
2265490|NCT02186301|3939374|FG000|Overall Study|Progressive Disease|7
2265491|NCT02186301|3939375|FG001|Overall Study|Progressive Disease|22
2265492|NCT02186301|3939376|FG002|Overall Study|Progressive Disease|27
2265493|NCT02186301|3939374|FG000|Overall Study|Adverse Event|5
2265494|NCT02186301|3939375|FG001|Overall Study|Adverse Event|5
2265495|NCT02186301|3939376|FG002|Overall Study|Adverse Event|5
2265496|NCT02186301|3939374|FG000|Overall Study|Death|1
2265497|NCT02186301|3939375|FG001|Overall Study|Death|0
2265498|NCT02186301|3939376|FG002|Overall Study|Death|0
2265499|NCT02186301|3939374|FG000|Overall Study|Withdrawal by Subject|5
2265500|NCT02186301|3939375|FG001|Overall Study|Withdrawal by Subject|1
2265501|NCT02186301|3939376|FG002|Overall Study|Withdrawal by Subject|3
2265502|NCT02186301|3939374|FG000|Overall Study|Physician Decision|1
2265503|NCT02186301|3939375|FG001|Overall Study|Physician Decision|0
2265504|NCT02186301|3939376|FG002|Overall Study|Physician Decision|1
2265505|NCT02186301|3939374|FG000|Overall Study|Study Terminated by Sponsor|1
2265506|NCT02186301|3939375|FG001|Overall Study|Study Terminated by Sponsor|0
2265507|NCT02186301|3939376|FG002|Overall Study|Study Terminated by Sponsor|11
2265508|NCT02186301|3939374|FG000|Overall Study|Protocol Deviation|0
2265509|NCT02186301|3939375|FG001|Overall Study|Protocol Deviation|2
2265510|NCT02186301|3939376|FG002|Overall Study|Protocol Deviation|0
2265511|NCT02186301|3939374|FG000|Overall Study|Missing|0
2265512|NCT02186301|3939375|FG001|Overall Study|Missing|0
2265513|NCT02186301|3939376|FG002|Overall Study|Missing|2
2265514|NCT02186301|3939374|FG000|Overall Study|Other|0
2347723|NCT03706040|4086757|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0
2347724|NCT03706040|4086758|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0
2347725|NCT03706040|4086759|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0
2347726|NCT03706040|4086760|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0
2347727|NCT03706040|4086754|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1
2347728|NCT03706040|4086755|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1
2347729|NCT03706040|4086756|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4
2347730|NCT03706040|4086757|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0
2347731|NCT03706040|4086758|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0
2347732|NCT03706040|4086759|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0
2347733|NCT03706040|4086760|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0
2347734|NCT03706040|4086754|FG000|Period A (Week 0 to Week 16)|Other|2
2347735|NCT03706040|4086755|FG001|Period A (Week 0 to Week 16)|Other|0
2347736|NCT03706040|4086756|FG002|Period A (Week 0 to Week 16)|Other|2
2347737|NCT03706040|4086757|FG003|Period A (Week 0 to Week 16)|Other|0
2347738|NCT03706040|4086758|FG004|Period A (Week 0 to Week 16)|Other|0
2347739|NCT03706040|4086759|FG005|Period A (Week 0 to Week 16)|Other|0
2347740|NCT03706040|4086760|FG006|Period A (Week 0 to Week 16)|Other|0
2347741|NCT03706040|4086754|FG000|Period B (Week 16 to Week 52)|Adverse Event|0
2347742|NCT03706040|4086755|FG001|Period B (Week 16 to Week 52)|Adverse Event|0
2347743|NCT03706040|4086756|FG002|Period B (Week 16 to Week 52)|Adverse Event|0
2347744|NCT03706040|4086757|FG003|Period B (Week 16 to Week 52)|Adverse Event|1
2347745|NCT03706040|4086758|FG004|Period B (Week 16 to Week 52)|Adverse Event|2
2347746|NCT03706040|4086759|FG005|Period B (Week 16 to Week 52)|Adverse Event|3
2347747|NCT03706040|4086760|FG006|Period B (Week 16 to Week 52)|Adverse Event|0
2347748|NCT03706040|4086754|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0
2347749|NCT03706040|4086755|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0
2347750|NCT03706040|4086756|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0
2347751|NCT03706040|4086757|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3
2347752|NCT03706040|4086758|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2
2347753|NCT03706040|4086759|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1
2347754|NCT03706040|4086760|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10
2347755|NCT03706040|4086754|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0
2347756|NCT03706040|4086755|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0
2347757|NCT03706040|4086756|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0
2347758|NCT03706040|4086757|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0
2347759|NCT03706040|4086758|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0
2347760|NCT03706040|4086759|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1
2347761|NCT03706040|4086760|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1
2347762|NCT03706040|4086754|FG000|Period B (Week 16 to Week 52)|Other|0
2347763|NCT03706040|4086755|FG001|Period B (Week 16 to Week 52)|Other|0
2347764|NCT03706040|4086756|FG002|Period B (Week 16 to Week 52)|Other|0
2347765|NCT03706040|4086757|FG003|Period B (Week 16 to Week 52)|Other|4
2347766|NCT03706040|4086758|FG004|Period B (Week 16 to Week 52)|Other|5
2347767|NCT03706040|4086759|FG005|Period B (Week 16 to Week 52)|Other|23
2347768|NCT03706040|4086760|FG006|Period B (Week 16 to Week 52)|Other|17
2347769|NCT03706456|4086785|FG000|Overall Study|Lack of Efficacy|1
2347770|NCT03706456|4086785|FG000|Overall Study|Ongoing|21
2347771|NCT03707522|4086837|FG000|Overall Study|Lost to Follow-up|24
2347772|NCT03707522|4086838|FG001|Overall Study|Lost to Follow-up|27
2347773|NCT03707522|4086839|FG002|Overall Study|Lost to Follow-up|41
2265515|NCT02186301|3939375|FG001|Overall Study|Other|0
2347774|NCT03707522|4086840|FG003|Overall Study|Lost to Follow-up|36
2347775|NCT03707587|4086852|FG000|Overall Study|Death|0
2347776|NCT03707587|4086853|FG001|Overall Study|Death|1
2265516|NCT02186301|3939376|FG002|Overall Study|Other|1
2265517|NCT02186561|3939390|FG000|Enrollment|Did Not Meet Inclusion Criteria|46
2265518|NCT02186561|3939390|FG000|Enrollment|Enrollment Cap Reached|5
2265519|NCT02186561|3939390|FG000|Enrollment|Insurance Denial|2
2265520|NCT02186561|3939390|FG000|Enrollment|Withdrawal by Subject|2
2265521|NCT02186561|3939390|FG000|Enrollment|Investigator Withdrew Consent|1
2265522|NCT02186561|3939390|FG000|30-Day Post Index Procedure Visit|Death|1
2265523|NCT02186561|3939390|FG000|1- Year Post Index Procedure Visit|Death|1
2265524|NCT02186561|3939390|FG000|1- Year Post Index Procedure Visit|Missed|1
2265525|NCT02186652|3939406|FG000|Overall Study|Lost to Follow-up|2
2265526|NCT02186652|3939407|FG001|Overall Study|Lost to Follow-up|0
2265527|NCT02186821|3939442|FG000|Overall Study|Adverse Event|9
2347777|NCT03707821|4086861|FG000|Overall Study|Protocol Violation|0
2347778|NCT03707821|4086862|FG001|Overall Study|Protocol Violation|1
2265528|NCT02186821|3939442|FG000|Overall Study|Death|2
2265529|NCT02186821|3939442|FG000|Overall Study|Disease progression|32
2265530|NCT02186821|3939442|FG000|Overall Study|Protocol Violation|1
2265531|NCT02186821|3939442|FG000|Overall Study|Physician Decision|1
2265532|NCT02186821|3939442|FG000|Overall Study|Study terminated by sponsor|2
2265533|NCT02186847|3939448|FG000|Overall Study|Protocol Violation|3
2265534|NCT02186847|3939449|FG001|Overall Study|Protocol Violation|0
2265535|NCT02186873|3939457|FG000|Overall Study|Adverse Event|1
2265536|NCT02186873|3939458|FG001|Overall Study|Adverse Event|3
2265537|NCT02186873|3939457|FG000|Overall Study|Lack of Efficacy|0
2265538|NCT02186873|3939458|FG001|Overall Study|Lack of Efficacy|1
2265539|NCT02186873|3939457|FG000|Overall Study|Lost to Follow-up|1
2265540|NCT02186873|3939458|FG001|Overall Study|Lost to Follow-up|2
2265541|NCT02186873|3939457|FG000|Overall Study|Withdrawal by Subject|7
2265542|NCT02186873|3939458|FG001|Overall Study|Withdrawal by Subject|2
2265543|NCT02187029|3939495|FG000|Overall Study|Adverse Event|0
2265544|NCT02187029|3939496|FG001|Overall Study|Adverse Event|1
2265545|NCT02187029|3939497|FG002|Overall Study|Adverse Event|1
2265546|NCT02187029|3939498|FG003|Overall Study|Adverse Event|0
2265547|NCT02187029|3939495|FG000|Overall Study|Study Terminated by Sponsor|0
2265548|NCT02187029|3939496|FG001|Overall Study|Study Terminated by Sponsor|0
2265549|NCT02187029|3939497|FG002|Overall Study|Study Terminated by Sponsor|10
2265550|NCT02187029|3939498|FG003|Overall Study|Study Terminated by Sponsor|3
2265551|NCT02187029|3939495|FG000|Overall Study|Withdrawal by Subject|1
2265552|NCT02187029|3939496|FG001|Overall Study|Withdrawal by Subject|0
2265553|NCT02187029|3939497|FG002|Overall Study|Withdrawal by Subject|0
2265554|NCT02187029|3939498|FG003|Overall Study|Withdrawal by Subject|0
2265555|NCT02187042|3939510|FG000|Overall Study|Death|1
2265556|NCT02187042|3939511|FG001|Overall Study|Death|1
2265557|NCT02187042|3939510|FG000|Overall Study|Toxicity|6
2265558|NCT02187042|3939511|FG001|Overall Study|Toxicity|5
2265559|NCT02187042|3939510|FG000|Overall Study|Participant choice|1
2265560|NCT02187042|3939511|FG001|Overall Study|Participant choice|0
2265561|NCT02187042|3939510|FG000|Overall Study|Doctor choice|1
2265562|NCT02187042|3939511|FG001|Overall Study|Doctor choice|0
2265563|NCT02187042|3939510|FG000|Overall Study|Progressive disease|4
2265564|NCT02187042|3939511|FG001|Overall Study|Progressive disease|8
2265565|NCT02187055|3939521|FG000|Overall Study|Lack of Efficacy|10
2265566|NCT02187055|3939522|FG001|Overall Study|Lack of Efficacy|3
2265567|NCT02187055|3939523|FG002|Overall Study|Lack of Efficacy|7
2265568|NCT02187055|3939521|FG000|Overall Study|Lost to Follow-up|2
2265569|NCT02187055|3939522|FG001|Overall Study|Lost to Follow-up|7
2265570|NCT02187055|3939523|FG002|Overall Study|Lost to Follow-up|3
2265571|NCT02187055|3939521|FG000|Overall Study|No longer meets eligibility criteria|0
2265572|NCT02187055|3939522|FG001|Overall Study|No longer meets eligibility criteria|2
2265573|NCT02187055|3939523|FG002|Overall Study|No longer meets eligibility criteria|0
2265574|NCT02187055|3939521|FG000|Overall Study|No longer willing to participate|6
2265575|NCT02187055|3939522|FG001|Overall Study|No longer willing to participate|8
2265576|NCT02187055|3939523|FG002|Overall Study|No longer willing to participate|10
2265577|NCT02187055|3939521|FG000|Overall Study|Other|5
2265578|NCT02187055|3939522|FG001|Overall Study|Other|6
2265579|NCT02187055|3939523|FG002|Overall Study|Other|3
2265580|NCT02187055|3939521|FG000|Overall Study|Protocol Violation|9
2265581|NCT02187055|3939522|FG001|Overall Study|Protocol Violation|9
2265582|NCT02187055|3939523|FG002|Overall Study|Protocol Violation|4
2265583|NCT02187055|3939521|FG000|Overall Study|Pregnancy|3
2265584|NCT02187055|3939522|FG001|Overall Study|Pregnancy|1
2265585|NCT02187055|3939523|FG002|Overall Study|Pregnancy|0
2265586|NCT02187055|3939521|FG000|Overall Study|Withdrawal by Subject|11
2265587|NCT02187055|3939522|FG001|Overall Study|Withdrawal by Subject|11
2265588|NCT02187055|3939523|FG002|Overall Study|Withdrawal by Subject|11
2265589|NCT02187055|3939521|FG000|Overall Study|Adverse Event|21
2265590|NCT02187055|3939522|FG001|Overall Study|Adverse Event|26
2265591|NCT02187055|3939523|FG002|Overall Study|Adverse Event|36
2265592|NCT02187055|3939521|FG000|Overall Study|Death|2
2265593|NCT02187055|3939522|FG001|Overall Study|Death|0
2265594|NCT02187055|3939523|FG002|Overall Study|Death|0
2265595|NCT02187159|3939535|FG000|Overall Study|Protocol Violation|4
2265596|NCT02187159|3939536|FG001|Overall Study|Protocol Violation|6
2265597|NCT02187159|3939537|FG002|Overall Study|Protocol Violation|3
2265598|NCT02187159|3939538|FG003|Overall Study|Protocol Violation|4
2265599|NCT02187159|3939535|FG000|Overall Study|Lack of Efficacy|10
2265600|NCT02187159|3939536|FG001|Overall Study|Lack of Efficacy|5
2265601|NCT02187159|3939537|FG002|Overall Study|Lack of Efficacy|4
2265602|NCT02187159|3939538|FG003|Overall Study|Lack of Efficacy|7
2265603|NCT02187159|3939535|FG000|Overall Study|Adverse Event|28
2265604|NCT02187159|3939536|FG001|Overall Study|Adverse Event|33
2265605|NCT02187159|3939537|FG002|Overall Study|Adverse Event|42
2265606|NCT02187159|3939538|FG003|Overall Study|Adverse Event|50
2265607|NCT02187159|3939535|FG000|Overall Study|Withdrawal by Subject|24
2265608|NCT02187159|3939536|FG001|Overall Study|Withdrawal by Subject|28
2265609|NCT02187159|3939537|FG002|Overall Study|Withdrawal by Subject|25
2265610|NCT02187159|3939538|FG003|Overall Study|Withdrawal by Subject|26
2265611|NCT02187159|3939535|FG000|Overall Study|Other|3
2265612|NCT02187159|3939536|FG001|Overall Study|Other|7
2265613|NCT02187159|3939537|FG002|Overall Study|Other|3
2265614|NCT02187159|3939538|FG003|Overall Study|Other|9
2265615|NCT02187172|3939550|FG000|Overall Study|Lost to Follow-up|1
2265616|NCT02187172|3939551|FG001|Overall Study|Lost to Follow-up|2
2265617|NCT02187172|3939550|FG000|Overall Study|Lack of Efficacy|1
2265618|NCT02187172|3939551|FG001|Overall Study|Lack of Efficacy|2
2265619|NCT02187172|3939550|FG000|Overall Study|Adverse Event|0
2265620|NCT02187172|3939551|FG001|Overall Study|Adverse Event|1
2265621|NCT02187172|3939550|FG000|Overall Study|Physician Decision|1
2265622|NCT02187172|3939551|FG001|Overall Study|Physician Decision|1
2265623|NCT02187471|3939563|FG000|Overall Study|Protocol Violation|4
2265624|NCT02187471|3939564|FG001|Overall Study|Protocol Violation|5
2265625|NCT02187471|3939565|FG002|Overall Study|Protocol Violation|4
2265626|NCT02187471|3939566|FG003|Overall Study|Protocol Violation|4
2265627|NCT02187471|3939563|FG000|Overall Study|Missing|0
2265628|NCT02187471|3939564|FG001|Overall Study|Missing|0
2265629|NCT02187471|3939565|FG002|Overall Study|Missing|0
2265630|NCT02187471|3939566|FG003|Overall Study|Missing|1
2265631|NCT02187471|3939563|FG000|Overall Study|Lack of Efficacy|18
2265632|NCT02187471|3939564|FG001|Overall Study|Lack of Efficacy|9
2265633|NCT02187471|3939565|FG002|Overall Study|Lack of Efficacy|13
2265634|NCT02187471|3939566|FG003|Overall Study|Lack of Efficacy|11
2265635|NCT02187471|3939563|FG000|Overall Study|Adverse Event|24
2265636|NCT02187471|3939564|FG001|Overall Study|Adverse Event|34
2265637|NCT02187471|3939565|FG002|Overall Study|Adverse Event|44
2265638|NCT02187471|3939566|FG003|Overall Study|Adverse Event|36
2265639|NCT02187471|3939563|FG000|Overall Study|Withdrawal by Subject|23
2265640|NCT02187471|3939564|FG001|Overall Study|Withdrawal by Subject|29
2265641|NCT02187471|3939565|FG002|Overall Study|Withdrawal by Subject|22
2265642|NCT02187471|3939566|FG003|Overall Study|Withdrawal by Subject|24
2265643|NCT02187471|3939563|FG000|Overall Study|Other|7
2265644|NCT02187471|3939564|FG001|Overall Study|Other|5
2265645|NCT02187471|3939565|FG002|Overall Study|Other|3
2265646|NCT02187471|3939566|FG003|Overall Study|Other|4
2265647|NCT02187744|3939579|FG000|Study|Participant refused further follow-up|1
2265648|NCT02187744|3939580|FG001|Study|Participant refused further follow-up|0
2265649|NCT02187744|3939579|FG000|Study|Other|2
2265650|NCT02187744|3939580|FG001|Study|Other|1
2265651|NCT02187744|3939579|FG000|Study|Lost to Follow-up|0
2265652|NCT02187744|3939580|FG001|Study|Lost to Follow-up|2
2265653|NCT02187744|3939579|FG000|Study|Related adverse event, not serious|0
2265654|NCT02187744|3939580|FG001|Study|Related adverse event, not serious|2
2265655|NCT02187744|3939579|FG000|Study|Death|1
2347779|NCT03707821|4086861|FG000|Overall Study|Unsatisfactory Visual Response|1
2347780|NCT03707821|4086862|FG001|Overall Study|Unsatisfactory Visual Response|0
2347781|NCT03707821|4086861|FG000|Overall Study|Unsatisfactory Lens Fitting|1
2347782|NCT03707821|4086862|FG001|Overall Study|Unsatisfactory Lens Fitting|0
2347783|NCT03707912|4086870|FG000|Overall Study|Violation of inclusion criteria|1
2347784|NCT03707912|4086871|FG001|Overall Study|Violation of inclusion criteria|0
2347785|NCT03708211|4086879|FG000|Overall Study|Progressive Disease|10
2347786|NCT03708211|4086880|FG001|Overall Study|Progressive Disease|7
2347787|NCT03708211|4086879|FG000|Overall Study|Withdrawal by Subject|0
2347788|NCT03708211|4086880|FG001|Overall Study|Withdrawal by Subject|1
2347789|NCT03708211|4086879|FG000|Overall Study|Other|2
2347790|NCT03708211|4086880|FG001|Overall Study|Other|0
2347791|NCT03708744|4086911|FG000|Overall Study|Withdrawal by Subject|0
2347792|NCT03708744|4086912|FG001|Overall Study|Withdrawal by Subject|0
2347793|NCT03708744|4086913|FG002|Overall Study|Withdrawal by Subject|1
2347794|NCT03708744|4086914|FG003|Overall Study|Withdrawal by Subject|0
2265656|NCT02187744|3939580|FG001|Study|Death|0
2265657|NCT02187744|3939579|FG000|Study|Related adverse event, serious non-fatal|0
2265658|NCT02187744|3939580|FG001|Study|Related adverse event, serious non-fatal|1
2265659|NCT02187744|3939579|FG000|Treatment|Death|1
2265660|NCT02187744|3939580|FG001|Treatment|Death|0
2265661|NCT02187744|3939579|FG000|Treatment|Related adverse event, serious non-fatal|0
2265662|NCT02187744|3939580|FG001|Treatment|Related adverse event, serious non-fatal|1
2265663|NCT02187744|3939579|FG000|Treatment|Related adverse event, not serious|0
2265664|NCT02187744|3939580|FG001|Treatment|Related adverse event, not serious|2
2265665|NCT02187744|3939579|FG000|Treatment|Lost to Follow-up|0
2265666|NCT02187744|3939580|FG001|Treatment|Lost to Follow-up|1
2265667|NCT02187744|3939579|FG000|Treatment|Other|2
2265668|NCT02187744|3939580|FG001|Treatment|Other|0
2265669|NCT02187744|3939579|FG000|Treatment|Participant refused continued treatment|1
2347795|NCT03709654|4086941|FG000|Overall Study|Lost to Follow-up|1
2265670|NCT02187744|3939580|FG001|Treatment|Participant refused continued treatment|1
2265671|NCT02187783|3939586|FG000|Overall Study|Adverse Event|8
2265672|NCT02187783|3939586|FG000|Overall Study|Death|3
2265673|NCT02187783|3939586|FG000|Overall Study|Progressive disease|80
2265674|NCT02187783|3939586|FG000|Overall Study|Protocol Violation|3
2265675|NCT02187783|3939586|FG000|Overall Study|Physician Decision|2
2265676|NCT02187783|3939586|FG000|Overall Study|Withdrawal by Subject|9
2265677|NCT02187783|3939586|FG000|Overall Study|Study terminated by sponsor|1
2265678|NCT02187809|3939590|FG000|Overall Study|The study was terminated|3
2265679|NCT02187861|3939598|FG000|Overall Study|Adverse Event|2
2265680|NCT02187861|3939599|FG001|Overall Study|Adverse Event|1
2265681|NCT02187861|3939600|FG002|Overall Study|Adverse Event|2
2265682|NCT02187861|3939601|FG003|Overall Study|Adverse Event|1
2265683|NCT02187861|3939598|FG000|Overall Study|Death|0
2265684|NCT02187861|3939599|FG001|Overall Study|Death|3
2265685|NCT02187861|3939600|FG002|Overall Study|Death|1
2265686|NCT02187861|3939601|FG003|Overall Study|Death|2
2265687|NCT02187861|3939598|FG000|Overall Study|Physician Decision|0
2265688|NCT02187861|3939599|FG001|Overall Study|Physician Decision|1
2265689|NCT02187861|3939600|FG002|Overall Study|Physician Decision|0
2265690|NCT02187861|3939601|FG003|Overall Study|Physician Decision|3
2265691|NCT02187861|3939598|FG000|Overall Study|Progressive Disease|4
2265692|NCT02187861|3939599|FG001|Overall Study|Progressive Disease|42
2265693|NCT02187861|3939600|FG002|Overall Study|Progressive Disease|19
2265694|NCT02187861|3939601|FG003|Overall Study|Progressive Disease|22
2265695|NCT02187861|3939598|FG000|Overall Study|Withdrawal by Subject|0
2265696|NCT02187861|3939599|FG001|Overall Study|Withdrawal by Subject|0
2265697|NCT02187861|3939600|FG002|Overall Study|Withdrawal by Subject|3
2265698|NCT02187861|3939601|FG003|Overall Study|Withdrawal by Subject|3
2265699|NCT02187861|3939598|FG000|Overall Study|Other|0
2265700|NCT02187861|3939599|FG001|Overall Study|Other|1
2265701|NCT02187861|3939600|FG002|Overall Study|Other|7
2265702|NCT02187861|3939601|FG003|Overall Study|Other|1
2347796|NCT03709654|4086942|FG001|Overall Study|Lost to Follow-up|1
2347797|NCT03709654|4086941|FG000|Overall Study|Withdrawal by Subject|1
2347798|NCT03709654|4086942|FG001|Overall Study|Withdrawal by Subject|1
2347799|NCT03709654|4086941|FG000|Overall Study|Adverse Event|1
2347800|NCT03709654|4086942|FG001|Overall Study|Adverse Event|0
2347801|NCT03709823|4086961|FG000|Overall Study|Adverse Event|0
2347802|NCT03709823|4086962|FG001|Overall Study|Adverse Event|0
2347803|NCT03709823|4086963|FG002|Overall Study|Adverse Event|1
2347804|NCT03709823|4086964|FG003|Overall Study|Adverse Event|0
2347805|NCT03709823|4086965|FG004|Overall Study|Adverse Event|0
2347806|NCT03709823|4086966|FG005|Overall Study|Adverse Event|0
2347807|NCT03709823|4086961|FG000|Overall Study|Lost to Follow-up|2
2347808|NCT03709823|4086962|FG001|Overall Study|Lost to Follow-up|2
2347809|NCT03709823|4086963|FG002|Overall Study|Lost to Follow-up|2
2347810|NCT03709823|4086964|FG003|Overall Study|Lost to Follow-up|1
2347811|NCT03709823|4086965|FG004|Overall Study|Lost to Follow-up|1
2347812|NCT03709823|4086966|FG005|Overall Study|Lost to Follow-up|0
2347813|NCT03709823|4086961|FG000|Overall Study|Withdrawal by Subject|1
2347814|NCT03709823|4086962|FG001|Overall Study|Withdrawal by Subject|3
2347815|NCT03709823|4086963|FG002|Overall Study|Withdrawal by Subject|0
2347816|NCT03709823|4086964|FG003|Overall Study|Withdrawal by Subject|0
2347817|NCT03709823|4086965|FG004|Overall Study|Withdrawal by Subject|0
2347818|NCT03709823|4086966|FG005|Overall Study|Withdrawal by Subject|0
2347819|NCT03709823|4086961|FG000|Overall Study|Other, Not Specified|0
2347820|NCT03709823|4086962|FG001|Overall Study|Other, Not Specified|0
2347821|NCT03709823|4086963|FG002|Overall Study|Other, Not Specified|0
2347822|NCT03709823|4086964|FG003|Overall Study|Other, Not Specified|1
2347823|NCT03709823|4086965|FG004|Overall Study|Other, Not Specified|0
2347824|NCT03709823|4086966|FG005|Overall Study|Other, Not Specified|0
2347825|NCT03710083|4086983|FG000|Overall Study|Withdrawal by Subject|2
2347826|NCT03710083|4086983|FG000|Overall Study|Unsuccessful Procedure|1
2347827|NCT03710161|4086989|FG000|Overall Study|Study halted due to COVID pandemic|3
2347828|NCT03710161|4086990|FG001|Overall Study|Study halted due to COVID pandemic|2
2347829|NCT03710590|4087016|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10
2347830|NCT03710590|4087017|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8
2347831|NCT03710889|4087023|FG000|Overall Study|Adverse Event|2
2347832|NCT03710889|4087023|FG000|Overall Study|Protocol Deviation|1
2347833|NCT03712280|4087052|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0
2347834|NCT03712280|4087053|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1
2347835|NCT03712280|4087054|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0
2347836|NCT03712280|4087055|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1
2347837|NCT03712280|4087052|FG000|Overall Study|Withdrawal by Participant or Caregiver|1
2347838|NCT03712280|4087053|FG001|Overall Study|Withdrawal by Participant or Caregiver|0
2347839|NCT03712280|4087054|FG002|Overall Study|Withdrawal by Participant or Caregiver|0
2347840|NCT03712280|4087055|FG003|Overall Study|Withdrawal by Participant or Caregiver|0
2347841|NCT03712280|4087052|FG000|Overall Study|Adverse Event|0
2347842|NCT03712280|4087053|FG001|Overall Study|Adverse Event|0
2347843|NCT03712280|4087054|FG002|Overall Study|Adverse Event|1
2347844|NCT03712280|4087055|FG003|Overall Study|Adverse Event|0
2347845|NCT03712449|4087067|FG000|Overall Study|Withdraw Consent|0
2265703|NCT02188160|3939622|FG000|Overall Study|Adverse Event|1
2265704|NCT02188160|3939623|FG001|Overall Study|Adverse Event|0
2265705|NCT02188160|3939622|FG000|Overall Study|Use of an excluded medication|0
2265706|NCT02188160|3939623|FG001|Overall Study|Use of an excluded medication|1
2265707|NCT02188303|3939637|FG000|Overall Study|Adverse Event|0
2265708|NCT02188303|3939638|FG001|Overall Study|Adverse Event|0
2265709|NCT02188303|3939639|FG002|Overall Study|Adverse Event|0
2265710|NCT02188303|3939640|FG003|Overall Study|Adverse Event|0
2265711|NCT02188303|3939641|FG004|Overall Study|Adverse Event|0
2265712|NCT02188303|3939642|FG005|Overall Study|Adverse Event|2
2265713|NCT02188303|3939643|FG006|Overall Study|Adverse Event|0
2265714|NCT02188303|3939644|FG007|Overall Study|Adverse Event|2
2265715|NCT02188303|3939637|FG000|Overall Study|Dose Termination Criteria Met|0
2265716|NCT02188303|3939638|FG001|Overall Study|Dose Termination Criteria Met|0
2265717|NCT02188303|3939639|FG002|Overall Study|Dose Termination Criteria Met|0
2265718|NCT02188303|3939640|FG003|Overall Study|Dose Termination Criteria Met|0
2265719|NCT02188303|3939641|FG004|Overall Study|Dose Termination Criteria Met|0
2265720|NCT02188303|3939642|FG005|Overall Study|Dose Termination Criteria Met|0
2265721|NCT02188303|3939643|FG006|Overall Study|Dose Termination Criteria Met|2
2265722|NCT02188303|3939644|FG007|Overall Study|Dose Termination Criteria Met|4
2265723|NCT02188459|3939670|FG000|Overall Study|Lost to Follow-up|3
2265724|NCT02188459|3939671|FG001|Overall Study|Lost to Follow-up|4
2265725|NCT02188459|3939670|FG000|Overall Study|Early Termination|0
2265726|NCT02188459|3939671|FG001|Overall Study|Early Termination|3
2265727|NCT02188485|3939683|FG000|Overall Study|Withdrawal by Subject|2
2265728|NCT02188485|3939684|FG001|Overall Study|Withdrawal by Subject|1
2265729|NCT02188485|3939683|FG000|Overall Study|PI withdrew, lack of capacity|0
2265730|NCT02188485|3939684|FG001|Overall Study|PI withdrew, lack of capacity|2
2265731|NCT02188589|3939699|FG000|Overall Study|Withdrawal by Subject|5
2265732|NCT02188719|3939708|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
2265733|NCT02188719|3939709|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1
2265734|NCT02188719|3939710|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
2265735|NCT02188719|3939711|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
2265736|NCT02188784|3939721|FG000|Overall Study|Death|3
2265737|NCT02188784|3939722|FG001|Overall Study|Death|1
2265738|NCT02188784|3939721|FG000|Overall Study|Lost to Follow-up|1
2265739|NCT02188784|3939722|FG001|Overall Study|Lost to Follow-up|0
2265740|NCT02188784|3939721|FG000|Overall Study|Withdrawal by Subject|3
2265741|NCT02188784|3939722|FG001|Overall Study|Withdrawal by Subject|9
2265742|NCT02188784|3939721|FG000|Overall Study|Physician Decision|2
2265743|NCT02188784|3939722|FG001|Overall Study|Physician Decision|3
2265744|NCT02188849|3939730|FG000|Overall Study|Lost to Follow-up|3
2265745|NCT02188849|3939731|FG001|Overall Study|Lost to Follow-up|8
2265746|NCT02189252|3939765|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
2265747|NCT02189252|3939766|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
2265748|NCT02189252|3939767|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
2265749|NCT02189252|3939768|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
2265750|NCT02189252|3939765|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0
2265751|NCT02189252|3939766|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1
2265752|NCT02189252|3939767|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0
2265753|NCT02189252|3939768|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0
2265754|NCT02189473|3939799|FG000|Overall Study|Death|22
2265755|NCT02189473|3939800|FG001|Overall Study|Death|23
2265756|NCT02189473|3939799|FG000|Overall Study|Lost to Follow-up|1
2265757|NCT02189473|3939800|FG001|Overall Study|Lost to Follow-up|2
2265758|NCT02189759|3939823|FG000|Overall Study|Lost to Follow-up|0
2265759|NCT02189759|3939824|FG001|Overall Study|Lost to Follow-up|0
2265760|NCT02189759|3939825|FG002|Overall Study|Lost to Follow-up|2
2265761|NCT02189759|3939826|FG003|Overall Study|Lost to Follow-up|5
2265762|NCT02189837|3939842|FG000|Overall Study|Withdrawal by Subject|2
2265763|NCT02189837|3939843|FG001|Overall Study|Withdrawal by Subject|1
2265764|NCT02189837|3939844|FG002|Overall Study|Withdrawal by Subject|3
2265765|NCT02189837|3939845|FG003|Overall Study|Withdrawal by Subject|1
2265766|NCT02189837|3939842|FG000|Overall Study|Sponsor Decision|0
2265767|NCT02189837|3939843|FG001|Overall Study|Sponsor Decision|0
2265768|NCT02189837|3939844|FG002|Overall Study|Sponsor Decision|0
2265769|NCT02189837|3939845|FG003|Overall Study|Sponsor Decision|1
2265770|NCT02189863|3939864|FG000|First 2 Weeks|Motion Sickness|4
2265771|NCT02189863|3939865|FG001|First 2 Weeks|Motion Sickness|2
2265772|NCT02189941|3939887|FG000|Overall Study|Non-compliance|0
2265773|NCT02189941|3939888|FG001|Overall Study|Non-compliance|0
2265774|NCT02189941|3939889|FG002|Overall Study|Non-compliance|1
2265775|NCT02190279|3939918|FG000|Overall Study|Withdrawal consent|1
2265776|NCT02190279|3939919|FG001|Overall Study|Withdrawal consent|0
2265777|NCT02190279|3939920|FG002|Overall Study|Withdrawal consent|1
2265778|NCT02190279|3939918|FG000|Overall Study|Lost to Follow-up|2
2265779|NCT02190279|3939919|FG001|Overall Study|Lost to Follow-up|0
2265780|NCT02190279|3939920|FG002|Overall Study|Lost to Follow-up|0
2265781|NCT02190279|3939918|FG000|Overall Study|Refused further treatment|0
2265782|NCT02190279|3939919|FG001|Overall Study|Refused further treatment|0
2265783|NCT02190279|3939920|FG002|Overall Study|Refused further treatment|1
2265784|NCT02190279|3939918|FG000|Overall Study|Screening failure|0
2265785|NCT02190279|3939919|FG001|Overall Study|Screening failure|0
2265786|NCT02190279|3939920|FG002|Overall Study|Screening failure|1
2265787|NCT02190435|3939932|FG000|Overall Study|First 12 patients were lead-ins|12
2265788|NCT02190435|3939933|FG001|Overall Study|First 12 patients were lead-ins|0
2265789|NCT02190435|3939932|FG000|Overall Study|3 consented screen fails|3
2265790|NCT02190435|3939933|FG001|Overall Study|3 consented screen fails|0
2265791|NCT02190591|3939946|FG000|Overall Study|Withdrawal by Subject|1
2265792|NCT02190591|3939947|FG001|Overall Study|Withdrawal by Subject|8
2265793|NCT02190591|3939946|FG000|Overall Study|Protocol Violation|1
2265794|NCT02190591|3939947|FG001|Overall Study|Protocol Violation|0
2265795|NCT02190591|3939946|FG000|Overall Study|did not use peanut ball as instructed|0
2265796|NCT02190591|3939947|FG001|Overall Study|did not use peanut ball as instructed|2
2265797|NCT02190591|3939946|FG000|Overall Study|face presentation so she was ineligible|0
2265798|NCT02190591|3939947|FG001|Overall Study|face presentation so she was ineligible|1
2265799|NCT02190604|3939972|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265800|NCT02190604|3939973|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265801|NCT02190604|3939974|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265802|NCT02190604|3939975|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265803|NCT02190604|3939976|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265804|NCT02190604|3939977|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265805|NCT02190604|3939978|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265806|NCT02190604|3939979|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265807|NCT02190604|3939980|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265808|NCT02190604|3939981|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265809|NCT02190604|3939982|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265810|NCT02190604|3939983|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265811|NCT02190604|3939984|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265812|NCT02190604|3939985|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265813|NCT02190604|3939986|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
2265814|NCT02190604|3939987|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265815|NCT02190604|3939988|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265816|NCT02190604|3939989|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265817|NCT02190604|3939990|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2265818|NCT02190604|3939972|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265819|NCT02190604|3939973|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265820|NCT02190604|3939974|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265821|NCT02190604|3939975|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265822|NCT02190604|3939976|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265823|NCT02190604|3939977|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265824|NCT02190604|3939978|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265825|NCT02190604|3939979|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265826|NCT02190604|3939980|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265827|NCT02190604|3939981|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2347846|NCT03712449|4087068|FG001|Overall Study|Withdraw Consent|1
2347847|NCT03712917|4087090|FG000|Overall Study|Pregnancy|0
2347848|NCT03712917|4087091|FG001|Overall Study|Pregnancy|0
2347849|NCT03712917|4087092|FG002|Overall Study|Pregnancy|1
2347850|NCT03712917|4087090|FG000|Overall Study|Adverse Event|0
2347851|NCT03712917|4087091|FG001|Overall Study|Adverse Event|4
2347852|NCT03712917|4087092|FG002|Overall Study|Adverse Event|3
2347853|NCT03712917|4087090|FG000|Overall Study|Lost to Follow-up|9
2347854|NCT03712917|4087091|FG001|Overall Study|Lost to Follow-up|4
2347855|NCT03712917|4087092|FG002|Overall Study|Lost to Follow-up|5
2347856|NCT03712930|4087100|FG000|Overall Study|Death|7
2347857|NCT03712930|4087100|FG000|Overall Study|Physician Decision|1
2347858|NCT03712930|4087100|FG000|Overall Study|Study Terminated by Sponsor|3
2347859|NCT03712930|4087100|FG000|Overall Study|Progressive Disease|2
2347860|NCT03714022|4087115|FG000|Overall Study|Adverse Event|1
2347861|NCT03714022|4087116|FG001|Overall Study|Adverse Event|0
2347862|NCT03714022|4087115|FG000|Overall Study|Consent withdrawal|0
2347863|NCT03714022|4087116|FG001|Overall Study|Consent withdrawal|1
2347864|NCT03714022|4087115|FG000|Overall Study|Lost to Follow-up|3
2347865|NCT03714022|4087116|FG001|Overall Study|Lost to Follow-up|2
2347866|NCT03714672|4087139|FG000|Overall Study|Adverse Event|0
2347867|NCT03714672|4087140|FG001|Overall Study|Adverse Event|0
2347868|NCT03714672|4087141|FG002|Overall Study|Adverse Event|3
2347869|NCT03714672|4087142|FG003|Overall Study|Adverse Event|0
2347870|NCT03714672|4087139|FG000|Overall Study|Physician Decision|0
2347871|NCT03714672|4087140|FG001|Overall Study|Physician Decision|1
2347872|NCT03714672|4087141|FG002|Overall Study|Physician Decision|0
2347873|NCT03714672|4087142|FG003|Overall Study|Physician Decision|0
2347874|NCT03714672|4087139|FG000|Overall Study|Other Reason|1
2347875|NCT03714672|4087140|FG001|Overall Study|Other Reason|2
2347876|NCT03714672|4087141|FG002|Overall Study|Other Reason|1
2347877|NCT03714672|4087142|FG003|Overall Study|Other Reason|1
2347878|NCT03714672|4087139|FG000|Overall Study|Lost to Follow-up|1
2347879|NCT03714672|4087140|FG001|Overall Study|Lost to Follow-up|1
2347880|NCT03714672|4087141|FG002|Overall Study|Lost to Follow-up|0
2347881|NCT03714672|4087142|FG003|Overall Study|Lost to Follow-up|0
2347882|NCT03715530|4087173|FG000|Overall Study|Lost to Follow-up|3
2347883|NCT03715530|4087174|FG001|Overall Study|Lost to Follow-up|1
2347884|NCT03715530|4087175|FG002|Overall Study|Lost to Follow-up|2
2265828|NCT02190604|3939982|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265829|NCT02190604|3939983|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265830|NCT02190604|3939984|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265831|NCT02190604|3939985|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
2265832|NCT02190604|3939986|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265833|NCT02190604|3939987|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265834|NCT02190604|3939988|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265835|NCT02190604|3939989|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265836|NCT02190604|3939990|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2265837|NCT02191046|3940080|FG000|Overall Study|low compliance|5
2265838|NCT02191046|3940081|FG001|Overall Study|low compliance|1
2265839|NCT02191137|3940087|FG000|Treatment|Death|4
2265840|NCT02191137|3940087|FG000|Treatment|Withdrawal by Subject|3
2265841|NCT02191137|3940087|FG000|Treatment|Adverse Event|2
2265842|NCT02191137|3940087|FG000|Treatment|Other|1
2265843|NCT02191137|3940087|FG000|Follow-up|Lost to Follow-up|2
2265844|NCT02191137|3940087|FG000|Follow-up|Ongoing/unknown|2
2265845|NCT02191137|3940087|FG000|Follow-up|Adverse Event|1
2265846|NCT02191267|3940094|FG000|Overall Study|Withdrawal by Subject|1
2265847|NCT02191267|3940095|FG001|Overall Study|Withdrawal by Subject|0
2265848|NCT02191267|3940096|FG002|Overall Study|Withdrawal by Subject|0
2265849|NCT02191397|3940106|FG000|Overall Study|Adverse Event|28
2265850|NCT02191397|3940107|FG001|Overall Study|Adverse Event|17
2265851|NCT02191397|3940106|FG000|Overall Study|Lack of Efficacy|10
2265852|NCT02191397|3940107|FG001|Overall Study|Lack of Efficacy|5
2265853|NCT02191397|3940106|FG000|Overall Study|Protocol Violation|0
2265854|NCT02191397|3940107|FG001|Overall Study|Protocol Violation|3
2265855|NCT02191397|3940106|FG000|Overall Study|Met protocol-defined stopping criteria|5
2265856|NCT02191397|3940107|FG001|Overall Study|Met protocol-defined stopping criteria|4
2265857|NCT02191397|3940106|FG000|Overall Study|Lost to Follow-up|10
2265858|NCT02191397|3940107|FG001|Overall Study|Lost to Follow-up|11
2265859|NCT02191397|3940106|FG000|Overall Study|Physician Decision|8
2265860|NCT02191397|3940107|FG001|Overall Study|Physician Decision|3
2265861|NCT02191397|3940106|FG000|Overall Study|Withdrawal by Subject|22
2265862|NCT02191397|3940107|FG001|Overall Study|Withdrawal by Subject|27
2265863|NCT02191579|3940115|FG000|Treatment 1|Multiple Reasons Specified|27
2265864|NCT02191579|3940116|FG001|Treatment 1|Multiple Reasons Specified|58
2347885|NCT03716024|4087194|FG000|Overall Study|Randomized, not Treated|7
2347886|NCT03716024|4087195|FG001|Overall Study|Randomized, not Treated|8
2347887|NCT03716024|4087194|FG000|Overall Study|Adverse Event|1
2347888|NCT03716024|4087195|FG001|Overall Study|Adverse Event|2
2347889|NCT03716024|4087194|FG000|Overall Study|Treatment Failure|1
2347890|NCT03716024|4087195|FG001|Overall Study|Treatment Failure|0
2347891|NCT03716024|4087194|FG000|Overall Study|Lost to Follow-up|2
2347892|NCT03716024|4087195|FG001|Overall Study|Lost to Follow-up|6
2347893|NCT03716024|4087194|FG000|Overall Study|Withdrawal by Subject|0
2347894|NCT03716024|4087195|FG001|Overall Study|Withdrawal by Subject|1
2347895|NCT03716024|4087194|FG000|Overall Study|Missing Reason|0
2347896|NCT03716024|4087195|FG001|Overall Study|Missing Reason|1
2347897|NCT03716050|4087209|FG000|Overall Study|Lost to Follow-up|0
2347898|NCT03716050|4087210|FG001|Overall Study|Lost to Follow-up|0
2347899|NCT03716050|4087211|FG002|Overall Study|Lost to Follow-up|1
2347900|NCT03716050|4087212|FG003|Overall Study|Lost to Follow-up|0
2347901|NCT03716050|4087213|FG004|Overall Study|Lost to Follow-up|0
2347902|NCT03716050|4087214|FG005|Overall Study|Lost to Follow-up|0
2347903|NCT03716050|4087215|FG006|Overall Study|Lost to Follow-up|0
2347904|NCT03716050|4087216|FG007|Overall Study|Lost to Follow-up|0
2347905|NCT03716050|4087209|FG000|Overall Study|Physician Decision|0
2347906|NCT03716050|4087210|FG001|Overall Study|Physician Decision|0
2265865|NCT02191579|3940115|FG000|Treatment 2|Multiple Reasons Specified|0
2265866|NCT02191579|3940116|FG001|Treatment 2|Multiple Reasons Specified|25
2265867|NCT02191605|3940127|FG000|Overall Study|Lost to Follow-up|9
2265868|NCT02191605|3940128|FG001|Overall Study|Lost to Follow-up|4
2265869|NCT02191605|3940129|FG002|Overall Study|Lost to Follow-up|7
2265870|NCT02191605|3940130|FG003|Overall Study|Lost to Follow-up|3
2265871|NCT02191605|3940131|FG004|Overall Study|Lost to Follow-up|4
2265872|NCT02191618|3940143|FG000|Overall Study|Withdrawal by Subject|3
2265873|NCT02191618|3940143|FG000|Overall Study|Missed Visit|4
2265874|NCT02192099|3940163|FG000|Overall Study|Adverse Event|1
2265875|NCT02192099|3940163|FG000|Overall Study|Lost to Follow-up|2
2265876|NCT02192099|3940163|FG000|Overall Study|Physician Decision|1
2265877|NCT02192099|3940163|FG000|Overall Study|Pregnancy|1
2265878|NCT02192099|3940163|FG000|Overall Study|Protocol Violation|8
2265879|NCT02192099|3940163|FG000|Overall Study|Study Terminated by Sponsor|32
2265880|NCT02192099|3940163|FG000|Overall Study|Withdrawal by Subject|11
2265881|NCT02192099|3940163|FG000|Overall Study|Miscellaneous Reasons|5
2265882|NCT02192164|3940167|FG000|Overall Study|Other|8
2265883|NCT02192164|3940167|FG000|Overall Study|Withdrawal by Subject|1
2265884|NCT02192164|3940167|FG000|Overall Study|Physician Decision|4
2265885|NCT02192164|3940167|FG000|Overall Study|Did not meet the exclusion criteria|1
2265886|NCT02192190|3940180|FG000|Overall Study|Adverse Event|1
2265887|NCT02192190|3940181|FG001|Overall Study|Adverse Event|1
2265888|NCT02192190|3940182|FG002|Overall Study|Adverse Event|0
2347907|NCT03716050|4087211|FG002|Overall Study|Physician Decision|0
2265889|NCT02192190|3940183|FG003|Overall Study|Adverse Event|0
2265890|NCT02192190|3940184|FG004|Overall Study|Adverse Event|0
2265891|NCT02192190|3940185|FG005|Overall Study|Adverse Event|0
2265892|NCT02192190|3940180|FG000|Overall Study|Lost to Follow-up|3
2265893|NCT02192190|3940181|FG001|Overall Study|Lost to Follow-up|3
2265894|NCT02192190|3940182|FG002|Overall Study|Lost to Follow-up|2
2265895|NCT02192190|3940183|FG003|Overall Study|Lost to Follow-up|1
2265896|NCT02192190|3940184|FG004|Overall Study|Lost to Follow-up|4
2265897|NCT02192190|3940185|FG005|Overall Study|Lost to Follow-up|3
2265898|NCT02192190|3940180|FG000|Overall Study|Physician Decision|2
2265899|NCT02192190|3940181|FG001|Overall Study|Physician Decision|0
2265900|NCT02192190|3940182|FG002|Overall Study|Physician Decision|0
2265901|NCT02192190|3940183|FG003|Overall Study|Physician Decision|0
2265902|NCT02192190|3940184|FG004|Overall Study|Physician Decision|0
2265903|NCT02192190|3940185|FG005|Overall Study|Physician Decision|0
2265904|NCT02192190|3940180|FG000|Overall Study|Terminated by Sponsor|43
2265905|NCT02192190|3940181|FG001|Overall Study|Terminated by Sponsor|23
2265906|NCT02192190|3940182|FG002|Overall Study|Terminated by Sponsor|20
2265907|NCT02192190|3940183|FG003|Overall Study|Terminated by Sponsor|23
2265908|NCT02192190|3940184|FG004|Overall Study|Terminated by Sponsor|21
2265909|NCT02192190|3940185|FG005|Overall Study|Terminated by Sponsor|23
2265910|NCT02192190|3940180|FG000|Overall Study|Withdrawal by Subject|4
2265911|NCT02192190|3940181|FG001|Overall Study|Withdrawal by Subject|1
2265912|NCT02192190|3940182|FG002|Overall Study|Withdrawal by Subject|2
2265913|NCT02192190|3940183|FG003|Overall Study|Withdrawal by Subject|1
2265914|NCT02192190|3940184|FG004|Overall Study|Withdrawal by Subject|5
2265915|NCT02192190|3940185|FG005|Overall Study|Withdrawal by Subject|3
2265916|NCT02192190|3940180|FG000|Overall Study|Could not Keep Visit Schedule|1
2265917|NCT02192190|3940181|FG001|Overall Study|Could not Keep Visit Schedule|0
2265918|NCT02192190|3940182|FG002|Overall Study|Could not Keep Visit Schedule|0
2265919|NCT02192190|3940183|FG003|Overall Study|Could not Keep Visit Schedule|0
2265920|NCT02192190|3940184|FG004|Overall Study|Could not Keep Visit Schedule|0
2265921|NCT02192190|3940185|FG005|Overall Study|Could not Keep Visit Schedule|0
2265922|NCT02192190|3940180|FG000|Overall Study|Positive Drug Screen|0
2265923|NCT02192190|3940181|FG001|Overall Study|Positive Drug Screen|0
2265924|NCT02192190|3940182|FG002|Overall Study|Positive Drug Screen|0
2347908|NCT03716050|4087212|FG003|Overall Study|Physician Decision|1
2347909|NCT03716050|4087213|FG004|Overall Study|Physician Decision|0
2347910|NCT03716050|4087214|FG005|Overall Study|Physician Decision|0
2347911|NCT03716050|4087215|FG006|Overall Study|Physician Decision|0
2347912|NCT03716050|4087216|FG007|Overall Study|Physician Decision|0
2347913|NCT03716050|4087209|FG000|Overall Study|Protocol Violation|0
2347914|NCT03716050|4087210|FG001|Overall Study|Protocol Violation|0
2347915|NCT03716050|4087211|FG002|Overall Study|Protocol Violation|0
2347916|NCT03716050|4087212|FG003|Overall Study|Protocol Violation|1
2347917|NCT03716050|4087213|FG004|Overall Study|Protocol Violation|0
2347918|NCT03716050|4087214|FG005|Overall Study|Protocol Violation|0
2347919|NCT03716050|4087215|FG006|Overall Study|Protocol Violation|0
2347920|NCT03716050|4087216|FG007|Overall Study|Protocol Violation|2
2347921|NCT03717012|4087244|FG000|Overall Study|Due to trial termination|1
2347922|NCT03717012|4087245|FG001|Overall Study|Due to trial termination|2
2347923|NCT03717012|4087244|FG000|Overall Study|Protocol Violation|0
2347924|NCT03717012|4087245|FG001|Overall Study|Protocol Violation|2
2347925|NCT03717012|4087244|FG000|Overall Study|Adverse Event|0
2347926|NCT03717012|4087245|FG001|Overall Study|Adverse Event|1
2347927|NCT03717012|4087244|FG000|Overall Study|Lung transplant|0
2347928|NCT03717012|4087245|FG001|Overall Study|Lung transplant|1
2347929|NCT03717064|4087260|FG000|Period 2|Adverse Event|1
2347930|NCT03718000|4087283|FG000|Overall Study|Relocation|2
2347931|NCT03718000|4087284|FG001|Overall Study|Relocation|4
2347932|NCT03718000|4087283|FG000|Overall Study|Pregnancy|0
2347933|NCT03718000|4087284|FG001|Overall Study|Pregnancy|1
2347934|NCT03719586|4087318|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8
2347935|NCT03719586|4087319|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7
2347936|NCT03719586|4087320|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4
2347937|NCT03719586|4087321|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0
2347938|NCT03720470|4087355|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5
2347939|NCT03720470|4087356|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0
2347940|NCT03720470|4087357|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0
2347941|NCT03720470|4087358|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5
2347942|NCT03720470|4087359|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8
2347943|NCT03720470|4087360|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6
2347944|NCT03720470|4087355|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
2347945|NCT03720470|4087356|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
2347946|NCT03720470|4087357|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
2347947|NCT03720470|4087358|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
2347948|NCT03720470|4087359|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
2347949|NCT03720470|4087360|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
2347950|NCT03720470|4087355|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
2265925|NCT02192190|3940183|FG003|Overall Study|Positive Drug Screen|1
2265926|NCT02192190|3940184|FG004|Overall Study|Positive Drug Screen|0
2265927|NCT02192190|3940185|FG005|Overall Study|Positive Drug Screen|0
2265928|NCT02192190|3940180|FG000|Overall Study|Inadequate Pain Relief|0
2265929|NCT02192190|3940181|FG001|Overall Study|Inadequate Pain Relief|1
2265930|NCT02192190|3940182|FG002|Overall Study|Inadequate Pain Relief|1
2265931|NCT02192190|3940183|FG003|Overall Study|Inadequate Pain Relief|0
2265932|NCT02192190|3940184|FG004|Overall Study|Inadequate Pain Relief|0
2265933|NCT02192190|3940185|FG005|Overall Study|Inadequate Pain Relief|0
2265934|NCT02192606|3940221|FG000|Overall Study|surgery type was changed|1
2265935|NCT02192606|3940222|FG001|Overall Study|surgery type was changed|1
2265936|NCT02192606|3940221|FG000|Overall Study|Physician Decision|1
2265937|NCT02192606|3940222|FG001|Overall Study|Physician Decision|2
2265938|NCT02192606|3940221|FG000|Overall Study|3D equipment rep unable to join|0
2265939|NCT02192606|3940222|FG001|Overall Study|3D equipment rep unable to join|1
2265940|NCT02192905|3940254|FG000|Overall Study|Lost to Follow-up|1
2265941|NCT02192970|3940261|FG000|Overall Study|Lost to Follow-up|6
2265942|NCT02192970|3940262|FG001|Overall Study|Lost to Follow-up|0
2265943|NCT02193074|3940270|FG000|Overall Study|Withdrawal by Subject|1
2265944|NCT02193074|3940271|FG001|Overall Study|Withdrawal by Subject|2
2265945|NCT02193074|3940270|FG000|Overall Study|Adverse Event|16
2265946|NCT02193074|3940271|FG001|Overall Study|Adverse Event|13
2265947|NCT02193087|3940281|FG000|Overall Study|Adverse Event|2
2265948|NCT02193087|3940282|FG001|Overall Study|Adverse Event|0
2265949|NCT02193087|3940283|FG002|Overall Study|Adverse Event|0
2265950|NCT02193087|3940284|FG003|Overall Study|Adverse Event|11
2265951|NCT02193087|3940281|FG000|Overall Study|Lost to Follow-up|14
2265952|NCT02193087|3940282|FG001|Overall Study|Lost to Follow-up|6
2265953|NCT02193087|3940283|FG002|Overall Study|Lost to Follow-up|4
2265954|NCT02193087|3940284|FG003|Overall Study|Lost to Follow-up|37
2265955|NCT02193087|3940281|FG000|Overall Study|Protocol Violation|2
2265956|NCT02193087|3940282|FG001|Overall Study|Protocol Violation|0
2265957|NCT02193087|3940283|FG002|Overall Study|Protocol Violation|1
2265958|NCT02193087|3940284|FG003|Overall Study|Protocol Violation|2
2265959|NCT02193087|3940281|FG000|Overall Study|Withdrawal by Subject|10
2265960|NCT02193087|3940282|FG001|Overall Study|Withdrawal by Subject|3
2265961|NCT02193087|3940283|FG002|Overall Study|Withdrawal by Subject|1
2265962|NCT02193087|3940284|FG003|Overall Study|Withdrawal by Subject|19
2265963|NCT02193087|3940281|FG000|Overall Study|Other Reason Not Specified|7
2265964|NCT02193087|3940282|FG001|Overall Study|Other Reason Not Specified|2
2265965|NCT02193087|3940283|FG002|Overall Study|Other Reason Not Specified|1
2265966|NCT02193087|3940284|FG003|Overall Study|Other Reason Not Specified|9
2265967|NCT02193087|3940281|FG000|Overall Study|Did Not Receive Any Vaccination|2
2265968|NCT02193087|3940282|FG001|Overall Study|Did Not Receive Any Vaccination|3
2265969|NCT02193087|3940283|FG002|Overall Study|Did Not Receive Any Vaccination|0
2265970|NCT02193087|3940284|FG003|Overall Study|Did Not Receive Any Vaccination|1
2265971|NCT02193165|3940308|FG000|4 Week Product Use|Lost to Follow-up|1
2265972|NCT02193165|3940309|FG001|4 Week Product Use|Lost to Follow-up|1
2265973|NCT02193165|3940310|FG002|4 Week Product Use|Lost to Follow-up|1
2265974|NCT02193165|3940308|FG000|6 Week Product Use|Lost to Follow-up|0
2265975|NCT02193165|3940309|FG001|6 Week Product Use|Lost to Follow-up|1
2265976|NCT02193165|3940310|FG002|6 Week Product Use|Lost to Follow-up|0
2265977|NCT02193178|3940318|FG000|Overall Study|Lost to Follow-up|1
2265978|NCT02193178|3940318|FG000|Overall Study|Dry eyes|1
2265979|NCT02193776|3940353|FG000|Overall Study|Consent withdrawn|1
2265980|NCT02193776|3940354|FG001|Overall Study|Consent withdrawn|0
2265981|NCT02193776|3940355|FG002|Overall Study|Consent withdrawn|0
2265982|NCT02193776|3940356|FG003|Overall Study|Consent withdrawn|0
2265983|NCT02193776|3940353|FG000|Overall Study|Failure to comply with protocol|0
2265984|NCT02193776|3940354|FG001|Overall Study|Failure to comply with protocol|1
2265985|NCT02193776|3940355|FG002|Overall Study|Failure to comply with protocol|0
2265986|NCT02193776|3940356|FG003|Overall Study|Failure to comply with protocol|0
2265987|NCT02193776|3940353|FG000|Overall Study|Investigator/Sponsor decision|1
2265988|NCT02193776|3940354|FG001|Overall Study|Investigator/Sponsor decision|1
2265989|NCT02193776|3940355|FG002|Overall Study|Investigator/Sponsor decision|0
2265990|NCT02193776|3940356|FG003|Overall Study|Investigator/Sponsor decision|0
2265991|NCT02193776|3940353|FG000|Overall Study|Death|1
2265992|NCT02193776|3940354|FG001|Overall Study|Death|0
2265993|NCT02193776|3940355|FG002|Overall Study|Death|0
2265994|NCT02193776|3940356|FG003|Overall Study|Death|0
2265995|NCT02193776|3940353|FG000|Overall Study|Adverse event/Specific toxicity|5
2265996|NCT02193776|3940354|FG001|Overall Study|Adverse event/Specific toxicity|5
2265997|NCT02193776|3940355|FG002|Overall Study|Adverse event/Specific toxicity|2
2265998|NCT02193776|3940356|FG003|Overall Study|Adverse event/Specific toxicity|2
2265999|NCT02193828|3940384|FG000|Overall Study|Withdrawal by Subject|0
2266000|NCT02193828|3940385|FG001|Overall Study|Withdrawal by Subject|0
2266001|NCT02193828|3940386|FG002|Overall Study|Withdrawal by Subject|1
2266002|NCT02193828|3940387|FG003|Overall Study|Withdrawal by Subject|1
2266003|NCT02193880|3940397|FG000|Overall Study|patients did not collect enough HPC|3
2266004|NCT02194062|3940404|FG000|Overall Study|Lost to Follow-up|2
2266005|NCT02194062|3940405|FG001|Overall Study|Lost to Follow-up|2
2266006|NCT02194062|3940406|FG002|Overall Study|Lost to Follow-up|5
2266007|NCT02194465|3940436|FG000|Overall Study|Adverse Event|6
2266008|NCT02194465|3940437|FG001|Overall Study|Adverse Event|1
2266009|NCT02194465|3940438|FG002|Overall Study|Adverse Event|4
2266010|NCT02194465|3940439|FG003|Overall Study|Adverse Event|4
2266011|NCT02194465|3940440|FG004|Overall Study|Adverse Event|4
2266012|NCT02194465|3940441|FG005|Overall Study|Adverse Event|2
2266013|NCT02194465|3940442|FG006|Overall Study|Adverse Event|0
2266014|NCT02194465|3940436|FG000|Overall Study|Lost to Follow-up|0
2266015|NCT02194465|3940437|FG001|Overall Study|Lost to Follow-up|0
2266016|NCT02194465|3940438|FG002|Overall Study|Lost to Follow-up|0
2266017|NCT02194465|3940439|FG003|Overall Study|Lost to Follow-up|1
2266018|NCT02194465|3940440|FG004|Overall Study|Lost to Follow-up|0
2266019|NCT02194465|3940441|FG005|Overall Study|Lost to Follow-up|1
2266020|NCT02194465|3940442|FG006|Overall Study|Lost to Follow-up|0
2266021|NCT02194465|3940436|FG000|Overall Study|Physician Decision|1
2266022|NCT02194465|3940437|FG001|Overall Study|Physician Decision|0
2347951|NCT03720470|4087356|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
2347952|NCT03720470|4087357|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
2347953|NCT03720470|4087358|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
2347954|NCT03720470|4087359|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
2347955|NCT03720470|4087360|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
2347956|NCT03720470|4087355|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0
2347957|NCT03720470|4087356|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0
2347958|NCT03720470|4087357|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0
2347959|NCT03720470|4087358|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0
2347960|NCT03720470|4087359|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1
2347961|NCT03720470|4087360|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1
2347962|NCT03720470|4087355|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2
2347963|NCT03720470|4087356|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0
2347964|NCT03720470|4087357|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0
2347965|NCT03720470|4087358|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2
2266023|NCT02194465|3940438|FG002|Overall Study|Physician Decision|0
2266024|NCT02194465|3940439|FG003|Overall Study|Physician Decision|0
2266025|NCT02194465|3940440|FG004|Overall Study|Physician Decision|0
2266026|NCT02194465|3940441|FG005|Overall Study|Physician Decision|0
2266027|NCT02194465|3940442|FG006|Overall Study|Physician Decision|0
2266028|NCT02194465|3940436|FG000|Overall Study|Protocol Violation|1
2266029|NCT02194465|3940437|FG001|Overall Study|Protocol Violation|1
2266030|NCT02194465|3940438|FG002|Overall Study|Protocol Violation|2
2266031|NCT02194465|3940439|FG003|Overall Study|Protocol Violation|1
2266032|NCT02194465|3940440|FG004|Overall Study|Protocol Violation|1
2266033|NCT02194465|3940441|FG005|Overall Study|Protocol Violation|0
2266034|NCT02194465|3940442|FG006|Overall Study|Protocol Violation|0
2266035|NCT02194465|3940436|FG000|Overall Study|Withdrawal by Subject|1
2266036|NCT02194465|3940437|FG001|Overall Study|Withdrawal by Subject|3
2266037|NCT02194465|3940438|FG002|Overall Study|Withdrawal by Subject|1
2266038|NCT02194465|3940439|FG003|Overall Study|Withdrawal by Subject|2
2266039|NCT02194465|3940440|FG004|Overall Study|Withdrawal by Subject|2
2266040|NCT02194465|3940441|FG005|Overall Study|Withdrawal by Subject|1
2266041|NCT02194465|3940442|FG006|Overall Study|Withdrawal by Subject|2
2266042|NCT02194465|3940436|FG000|Overall Study|Discontinued follow-up period|0
2266043|NCT02194465|3940437|FG001|Overall Study|Discontinued follow-up period|2
2266044|NCT02194465|3940438|FG002|Overall Study|Discontinued follow-up period|1
2266045|NCT02194465|3940439|FG003|Overall Study|Discontinued follow-up period|0
2266046|NCT02194465|3940440|FG004|Overall Study|Discontinued follow-up period|2
2266047|NCT02194465|3940441|FG005|Overall Study|Discontinued follow-up period|0
2266048|NCT02194465|3940442|FG006|Overall Study|Discontinued follow-up period|0
2266049|NCT02194621|3940465|FG000|Overall Study|6 withdrew prior to randomization|2
2266050|NCT02194621|3940466|FG001|Overall Study|6 withdrew prior to randomization|2
2266051|NCT02194621|3940467|FG002|Overall Study|6 withdrew prior to randomization|2
2266052|NCT02194621|3940465|FG000|Overall Study|Withdrawal by Subject|4
2266053|NCT02194621|3940466|FG001|Overall Study|Withdrawal by Subject|4
2266054|NCT02194621|3940467|FG002|Overall Study|Withdrawal by Subject|7
2266055|NCT02194699|3940477|FG000|Randomised|Did not receive treatment|1
2266056|NCT02194699|3940478|FG001|Randomised|Did not receive treatment|5
2266057|NCT02194699|3940477|FG000|Randomised|Without potential for 52 weeks of IP|5
2266058|NCT02194699|3940478|FG001|Randomised|Without potential for 52 weeks of IP|5
2266059|NCT02194699|3940477|FG000|Randomised|Duplicate patient|2
2266060|NCT02194699|3940478|FG001|Randomised|Duplicate patient|1
2266061|NCT02194699|3940477|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4
2266062|NCT02194699|3940478|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3
2266063|NCT02194699|3940477|FG000|With Potential to Receive 52 Weeks of IP|Death|1
2266064|NCT02194699|3940478|FG001|With Potential to Receive 52 Weeks of IP|Death|3
2266065|NCT02194699|3940477|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
2266066|NCT02194699|3940478|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
2266067|NCT02194699|3940477|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
2266068|NCT02194699|3940478|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
2266069|NCT02194699|3940477|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
2266070|NCT02194699|3940478|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
2266071|NCT02194699|3940477|FG000|With Potential to Receive 52 Weeks of IP|Other|24
2266072|NCT02194699|3940478|FG001|With Potential to Receive 52 Weeks of IP|Other|16
2266073|NCT02194933|3940494|FG000|Overall Study|Lost to Follow-up|1
2266074|NCT02194933|3940495|FG001|Overall Study|Lost to Follow-up|2
2266075|NCT02194933|3940494|FG000|Overall Study|Participant met withdrawal criteria|1
2266076|NCT02194933|3940495|FG001|Overall Study|Participant met withdrawal criteria|3
2266077|NCT02194933|3940494|FG000|Overall Study|Withdrawal by Subject|0
2266078|NCT02194933|3940495|FG001|Overall Study|Withdrawal by Subject|2
2266079|NCT02194933|3940494|FG000|Overall Study|Lack of Efficacy|1
2266080|NCT02194933|3940495|FG001|Overall Study|Lack of Efficacy|2
2266081|NCT02194985|3940503|FG000|Overall Study|Adverse Event|1
2266082|NCT02194985|3940503|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3
2266083|NCT02194985|3940503|FG000|Overall Study|Physician Decision|4
2266084|NCT02194985|3940503|FG000|Overall Study|Lost to Follow-up|1
2266085|NCT02194985|3940503|FG000|Overall Study|Withdrawal by Subject|2
2266086|NCT02194998|3940511|FG000|On-HCV Treatment|Did not pick up study medication|0
2266087|NCT02194998|3940512|FG001|On-HCV Treatment|Did not pick up study medication|1
2266088|NCT02194998|3940513|FG002|On-HCV Treatment|Did not pick up study medication|0
2266089|NCT02194998|3940514|FG003|On-HCV Treatment|Did not pick up study medication|0
2266090|NCT02194998|3940511|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
2266091|NCT02194998|3940512|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
2266092|NCT02194998|3940513|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
2266093|NCT02194998|3940514|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
2266094|NCT02195011|3940526|FG000|Overall Study|Adverse Event|4
2266095|NCT02195011|3940527|FG001|Overall Study|Adverse Event|0
2266096|NCT02195011|3940526|FG000|Overall Study|Progressive Disease|18
2266097|NCT02195011|3940527|FG001|Overall Study|Progressive Disease|1
2266098|NCT02195011|3940526|FG000|Overall Study|Withdrawal by Subject|3
2266099|NCT02195011|3940527|FG001|Overall Study|Withdrawal by Subject|0
2266100|NCT02195427|3940622|FG000|Overall Study|Did not consent to study extension|13
2266101|NCT02195427|3940623|FG001|Overall Study|Did not consent to study extension|9
2266102|NCT02195427|3940622|FG000|Overall Study|Withdrawal by Subject|4
2266103|NCT02195427|3940623|FG001|Overall Study|Withdrawal by Subject|2
2266104|NCT02195427|3940622|FG000|Overall Study|Lost to Follow-up|0
2266105|NCT02195427|3940623|FG001|Overall Study|Lost to Follow-up|1
2266106|NCT02195427|3940622|FG000|Overall Study|Protocol Violation|7
2266107|NCT02195427|3940623|FG001|Overall Study|Protocol Violation|14
2266108|NCT02195427|3940622|FG000|Overall Study|Conditional re-treatment at W52|2
2266109|NCT02195427|3940623|FG001|Overall Study|Conditional re-treatment at W52|1
2266110|NCT02195518|3940633|FG000|Overall Study|Adverse Event|1
2266111|NCT02195518|3940633|FG000|Overall Study|Protocol Violation|4
2266112|NCT02195518|3940633|FG000|Overall Study|Pregnancy|2
2266113|NCT02195518|3940633|FG000|Overall Study|Withdrawal by Subject|1
2266114|NCT02195518|3940633|FG000|Overall Study|Lost to Follow-up|1
2266115|NCT02195531|3940640|FG000|Overall Study|Withdrawal by Subject|1
2266116|NCT02195531|3940641|FG001|Overall Study|Withdrawal by Subject|1
2266117|NCT02195531|3940642|FG002|Overall Study|Withdrawal by Subject|1
2347966|NCT03720470|4087359|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2
2347967|NCT03720470|4087360|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1
2347968|NCT03720470|4087355|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5
2347969|NCT03720470|4087356|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
2347970|NCT03720470|4087357|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
2347971|NCT03720470|4087358|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9
2347972|NCT03720470|4087359|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3
2347973|NCT03720470|4087360|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6
2347974|NCT03720470|4087355|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
2347975|NCT03720470|4087356|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
2347976|NCT03720470|4087357|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
2347977|NCT03720470|4087358|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
2347978|NCT03720470|4087359|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
2347979|NCT03720470|4087360|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
2347980|NCT03720470|4087355|FG000|Treatment Period: First Part 16 Weeks|Other|1
2347981|NCT03720470|4087356|FG001|Treatment Period: First Part 16 Weeks|Other|0
2347982|NCT03720470|4087357|FG002|Treatment Period: First Part 16 Weeks|Other|0
2347983|NCT03720470|4087358|FG003|Treatment Period: First Part 16 Weeks|Other|1
2347984|NCT03720470|4087359|FG004|Treatment Period: First Part 16 Weeks|Other|2
2347985|NCT03720470|4087360|FG005|Treatment Period: First Part 16 Weeks|Other|2
2347986|NCT03720470|4087355|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
2347987|NCT03720470|4087356|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
2347988|NCT03720470|4087357|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
2347989|NCT03720470|4087358|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
2347990|NCT03720470|4087359|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
2347991|NCT03720470|4087360|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1
2347992|NCT03720470|4087355|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0
2266118|NCT02195583|3940650|FG000|Overall Study|Lost to Follow-up|1
2266119|NCT02195583|3940650|FG000|Overall Study|Withdrawal by Subject|4
2266120|NCT02195583|3940650|FG000|Overall Study|Adverse Event|2
2266121|NCT02195583|3940650|FG000|Overall Study|Other Reason|2
2266122|NCT02195687|3940676|FG000|Overall Study|Personal Reasons|1
2266123|NCT02195687|3940677|FG001|Overall Study|Personal Reasons|1
2266124|NCT02195687|3940676|FG000|Overall Study|Lost to Follow-up|4
2266125|NCT02195687|3940677|FG001|Overall Study|Lost to Follow-up|1
2266126|NCT02195700|3940685|FG000|Overall Study|Protocol Violation|0
2266127|NCT02195700|3940686|FG001|Overall Study|Protocol Violation|2
2266128|NCT02195700|3940685|FG000|Overall Study|Noncompliance|1
2266129|NCT02195700|3940686|FG001|Overall Study|Noncompliance|0
2266130|NCT02195700|3940685|FG000|Overall Study|Adverse Event|1
2266131|NCT02195700|3940686|FG001|Overall Study|Adverse Event|2
2266132|NCT02195700|3940685|FG000|Overall Study|Withdrawal by Subject|3
2266133|NCT02195700|3940686|FG001|Overall Study|Withdrawal by Subject|2
2266134|NCT02195700|3940685|FG000|Overall Study|Lost to Follow-up|1
2266135|NCT02195700|3940686|FG001|Overall Study|Lost to Follow-up|1
2266136|NCT02195869|3940701|FG000|Overall Study|cGVHD Progression|5
2266137|NCT02195869|3940701|FG000|Overall Study|Malignancy Progression/relapse|2
2266138|NCT02195869|3940701|FG000|Overall Study|Adverse Event|15
2266139|NCT02195869|3940701|FG000|Overall Study|Withdrawal by Subject|7
2266140|NCT02195869|3940701|FG000|Overall Study|Physician Decision|4
2266141|NCT02195869|3940701|FG000|Overall Study|Study Terminated by Sponsor|7
2266142|NCT02195869|3940701|FG000|Overall Study|Noncompliance with study drug|2
2266143|NCT02195986|3940737|FG000|Overall Study|Adverse Event|3
2266144|NCT02195986|3940738|FG001|Overall Study|Adverse Event|0
2266145|NCT02195986|3940739|FG002|Overall Study|Adverse Event|0
2266146|NCT02195986|3940737|FG000|Overall Study|Withdrawal by Subject|0
2266147|NCT02195986|3940738|FG001|Overall Study|Withdrawal by Subject|3
2266148|NCT02195986|3940739|FG002|Overall Study|Withdrawal by Subject|0
2266149|NCT02195986|3940737|FG000|Overall Study|Family Emergency|0
2266150|NCT02195986|3940738|FG001|Overall Study|Family Emergency|0
2266151|NCT02195986|3940739|FG002|Overall Study|Family Emergency|1
2266152|NCT02195986|3940737|FG000|Overall Study|Protocol Violation|0
2266153|NCT02195986|3940738|FG001|Overall Study|Protocol Violation|1
2266154|NCT02195986|3940739|FG002|Overall Study|Protocol Violation|1
2266155|NCT02195986|3940737|FG000|Overall Study|Non-compliance|0
2266156|NCT02195986|3940738|FG001|Overall Study|Non-compliance|1
2266157|NCT02195986|3940739|FG002|Overall Study|Non-compliance|0
2266158|NCT02196038|3940749|FG000|Overall Study|Death|16
2266159|NCT02196038|3940750|FG001|Overall Study|Death|21
2266160|NCT02196038|3940749|FG000|Overall Study|Withdrawal by Subject|0
2266161|NCT02196038|3940750|FG001|Overall Study|Withdrawal by Subject|1
2266162|NCT02196038|3940749|FG000|Overall Study|Lost to Follow-up|1
2266163|NCT02196038|3940750|FG001|Overall Study|Lost to Follow-up|0
2266164|NCT02196077|3940756|FG000|Overall Study|Adverse Event|4
2266165|NCT02196077|3940756|FG000|Overall Study|Lack of Efficacy|1
2266166|NCT02196077|3940756|FG000|Overall Study|Withdrawal by Subject|14
2266167|NCT02196077|3940756|FG000|Overall Study|Physician Decision|1
2266168|NCT02196077|3940756|FG000|Overall Study|Lost to Follow-up|3
2266169|NCT02196077|3940756|FG000|Overall Study|Protocol Violation|24
2266170|NCT02196259|3940780|FG000|Overall Study|Researcher choice|0
2266171|NCT02196259|3940781|FG001|Overall Study|Researcher choice|0
2266172|NCT02196259|3940782|FG002|Overall Study|Researcher choice|1
2266173|NCT02196259|3940780|FG000|Overall Study|Partial data analysis|0
2266174|NCT02196259|3940781|FG001|Overall Study|Partial data analysis|3
2266175|NCT02196259|3940782|FG002|Overall Study|Partial data analysis|0
2266176|NCT02196324|3940791|FG000|Overall Study|Withdrawal by Subject|8
2266177|NCT02196324|3940792|FG001|Overall Study|Withdrawal by Subject|4
2266178|NCT02196324|3940791|FG000|Overall Study|Adverse Event or Serious Adverse Event|6
2266179|NCT02196324|3940792|FG001|Overall Study|Adverse Event or Serious Adverse Event|3
2266180|NCT02196324|3940791|FG000|Overall Study|Occurrence of an Exclusion Criterion|0
2266181|NCT02196324|3940792|FG001|Overall Study|Occurrence of an Exclusion Criterion|1
2266182|NCT02196324|3940791|FG000|Overall Study|Other|1
2266183|NCT02196324|3940792|FG001|Overall Study|Other|0
2266184|NCT02196506|3940800|FG000|Phase A|Participant Met Withdrawal Criteria|34
2266185|NCT02196506|3940801|FG001|Phase A|Participant Met Withdrawal Criteria|0
2266186|NCT02196506|3940802|FG002|Phase A|Participant Met Withdrawal Criteria|0
2266187|NCT02196506|3940803|FG003|Phase A|Participant Met Withdrawal Criteria|0
2266188|NCT02196506|3940800|FG000|Phase A|Withdrawal by Subject|34
2266189|NCT02196506|3940801|FG001|Phase A|Withdrawal by Subject|0
2266190|NCT02196506|3940802|FG002|Phase A|Withdrawal by Subject|0
2266191|NCT02196506|3940803|FG003|Phase A|Withdrawal by Subject|0
2266192|NCT02196506|3940800|FG000|Phase A|Adverse Event|22
2266193|NCT02196506|3940801|FG001|Phase A|Adverse Event|0
2266194|NCT02196506|3940802|FG002|Phase A|Adverse Event|0
2266195|NCT02196506|3940803|FG003|Phase A|Adverse Event|0
2266196|NCT02196506|3940800|FG000|Phase A|Lost to Follow-up|9
2266197|NCT02196506|3940801|FG001|Phase A|Lost to Follow-up|0
2266198|NCT02196506|3940802|FG002|Phase A|Lost to Follow-up|0
2266199|NCT02196506|3940803|FG003|Phase A|Lost to Follow-up|0
2266200|NCT02196506|3940800|FG000|Phase A|Protocol deviation|12
2266201|NCT02196506|3940801|FG001|Phase A|Protocol deviation|0
2266202|NCT02196506|3940802|FG002|Phase A|Protocol deviation|0
2266203|NCT02196506|3940803|FG003|Phase A|Protocol deviation|0
2266204|NCT02196506|3940800|FG000|Phase A|Participant withdrawn by investigator|10
2266205|NCT02196506|3940801|FG001|Phase A|Participant withdrawn by investigator|0
2266206|NCT02196506|3940802|FG002|Phase A|Participant withdrawn by investigator|0
2266207|NCT02196506|3940803|FG003|Phase A|Participant withdrawn by investigator|0
2266208|NCT02196506|3940800|FG000|Phase B|Participant Met Withdrawal Criteria|0
2266209|NCT02196506|3940801|FG001|Phase B|Participant Met Withdrawal Criteria|0
2266210|NCT02196506|3940802|FG002|Phase B|Participant Met Withdrawal Criteria|1
2266211|NCT02196506|3940803|FG003|Phase B|Participant Met Withdrawal Criteria|0
2347993|NCT03720470|4087356|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0
2347994|NCT03720470|4087357|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0
2347995|NCT03720470|4087358|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2
2347996|NCT03720470|4087359|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1
2347997|NCT03720470|4087360|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1
2347998|NCT03720470|4087355|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
2347999|NCT03720470|4087356|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
2348000|NCT03720470|4087357|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1
2348001|NCT03720470|4087358|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
2348002|NCT03720470|4087359|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
2348003|NCT03720470|4087360|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
2348004|NCT03720470|4087355|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
2348005|NCT03720470|4087356|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
2348006|NCT03720470|4087357|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
2348007|NCT03720470|4087358|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
2348008|NCT03720470|4087359|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
2348009|NCT03720470|4087360|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
2348010|NCT03720470|4087355|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0
2348011|NCT03720470|4087356|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0
2348012|NCT03720470|4087357|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0
2348013|NCT03720470|4087358|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0
2348014|NCT03720470|4087359|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0
2348015|NCT03720470|4087360|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1
2348016|NCT03720470|4087355|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0
2266212|NCT02196506|3940800|FG000|Phase B|Lack of Efficacy|0
2266213|NCT02196506|3940801|FG001|Phase B|Lack of Efficacy|1
2266214|NCT02196506|3940802|FG002|Phase B|Lack of Efficacy|2
2266215|NCT02196506|3940803|FG003|Phase B|Lack of Efficacy|0
2266216|NCT02196506|3940800|FG000|Phase B|Withdrawal by Participant|0
2266217|NCT02196506|3940801|FG001|Phase B|Withdrawal by Participant|8
2266218|NCT02196506|3940802|FG002|Phase B|Withdrawal by Participant|1
2266219|NCT02196506|3940803|FG003|Phase B|Withdrawal by Participant|0
2266220|NCT02196506|3940800|FG000|Phase B|Adverse Event|0
2266221|NCT02196506|3940801|FG001|Phase B|Adverse Event|4
2266222|NCT02196506|3940802|FG002|Phase B|Adverse Event|1
2266223|NCT02196506|3940803|FG003|Phase B|Adverse Event|0
2266224|NCT02196506|3940800|FG000|Phase B|Lost to Follow-up|0
2266225|NCT02196506|3940801|FG001|Phase B|Lost to Follow-up|2
2266226|NCT02196506|3940802|FG002|Phase B|Lost to Follow-up|1
2266227|NCT02196506|3940803|FG003|Phase B|Lost to Follow-up|0
2266228|NCT02196506|3940800|FG000|Phase A+|Participant Met Withdrawal Criteria|0
2266229|NCT02196506|3940801|FG001|Phase A+|Participant Met Withdrawal Criteria|0
2266230|NCT02196506|3940802|FG002|Phase A+|Participant Met Withdrawal Criteria|0
2266231|NCT02196506|3940803|FG003|Phase A+|Participant Met Withdrawal Criteria|1
2266232|NCT02196506|3940800|FG000|Phase A+|Withdrawal by Participant|0
2266233|NCT02196506|3940801|FG001|Phase A+|Withdrawal by Participant|0
2266234|NCT02196506|3940802|FG002|Phase A+|Withdrawal by Participant|0
2266235|NCT02196506|3940803|FG003|Phase A+|Withdrawal by Participant|5
2266236|NCT02196506|3940800|FG000|Phase A+|Adverse Event|0
2266237|NCT02196506|3940801|FG001|Phase A+|Adverse Event|0
2266238|NCT02196506|3940802|FG002|Phase A+|Adverse Event|0
2266239|NCT02196506|3940803|FG003|Phase A+|Adverse Event|1
2266240|NCT02196506|3940800|FG000|Phase A+|Lost to Follow-up|0
2266241|NCT02196506|3940801|FG001|Phase A+|Lost to Follow-up|0
2266242|NCT02196506|3940802|FG002|Phase A+|Lost to Follow-up|0
2266243|NCT02196506|3940803|FG003|Phase A+|Lost to Follow-up|6
2266244|NCT02196506|3940800|FG000|Phase A+|Participant withdrawn by investigator|0
2266245|NCT02196506|3940801|FG001|Phase A+|Participant withdrawn by investigator|0
2266246|NCT02196506|3940802|FG002|Phase A+|Participant withdrawn by investigator|0
2266247|NCT02196506|3940803|FG003|Phase A+|Participant withdrawn by investigator|1
2266248|NCT02196558|3940812|FG000|Treatment Phase (12 Weeks)|Adverse Event|0
2266249|NCT02196558|3940813|FG001|Treatment Phase (12 Weeks)|Adverse Event|2
2266250|NCT02196558|3940814|FG002|Treatment Phase (12 Weeks)|Adverse Event|0
2266251|NCT02196558|3940812|FG000|Treatment Phase (12 Weeks)|Participant Choice|0
2266252|NCT02196558|3940813|FG001|Treatment Phase (12 Weeks)|Participant Choice|1
2266253|NCT02196558|3940814|FG002|Treatment Phase (12 Weeks)|Participant Choice|1
2266254|NCT02196558|3940812|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0
2266255|NCT02196558|3940813|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0
2266256|NCT02196558|3940814|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1
2266257|NCT02196558|3940812|FG000|Extension Phase (40 Weeks)|Adverse Event|1
2266258|NCT02196558|3940813|FG001|Extension Phase (40 Weeks)|Adverse Event|2
2266259|NCT02196558|3940814|FG002|Extension Phase (40 Weeks)|Adverse Event|0
2266260|NCT02196558|3940812|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
2266261|NCT02196558|3940813|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
2266262|NCT02196558|3940814|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
2266263|NCT02196675|3940825|FG000|Overall Study|Withdrawal by Subject|1
2266264|NCT02196675|3940826|FG001|Overall Study|Withdrawal by Subject|0
2266265|NCT02196675|3940827|FG002|Overall Study|Withdrawal by Subject|0
2266266|NCT02196675|3940825|FG000|Overall Study|Intra-operative surgical exclusion|1
2266267|NCT02196675|3940826|FG001|Overall Study|Intra-operative surgical exclusion|1
2266268|NCT02196675|3940827|FG002|Overall Study|Intra-operative surgical exclusion|0
2266269|NCT02196675|3940825|FG000|Overall Study|Protocol Violation|0
2266270|NCT02196675|3940826|FG001|Overall Study|Protocol Violation|1
2266271|NCT02196675|3940827|FG002|Overall Study|Protocol Violation|0
2266272|NCT02196675|3940825|FG000|Overall Study|Death|0
2266273|NCT02196675|3940826|FG001|Overall Study|Death|0
2266274|NCT02196675|3940827|FG002|Overall Study|Death|1
2348017|NCT03720470|4087356|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0
2348018|NCT03720470|4087357|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1
2348019|NCT03720470|4087358|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0
2348020|NCT03720470|4087359|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0
2348021|NCT03720470|4087360|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0
2348022|NCT03720470|4087355|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
2348023|NCT03720470|4087356|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1
2348024|NCT03720470|4087357|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
2348025|NCT03720470|4087358|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
2348026|NCT03720470|4087359|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
2348027|NCT03720470|4087360|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
2348028|NCT03720470|4087355|FG000|Treatment Period: Final 4 Weeks|Other|0
2348029|NCT03720470|4087356|FG001|Treatment Period: Final 4 Weeks|Other|1
2348030|NCT03720470|4087357|FG002|Treatment Period: Final 4 Weeks|Other|0
2348031|NCT03720470|4087358|FG003|Treatment Period: Final 4 Weeks|Other|2
2348032|NCT03720470|4087359|FG004|Treatment Period: Final 4 Weeks|Other|1
2348033|NCT03720470|4087360|FG005|Treatment Period: Final 4 Weeks|Other|0
2348034|NCT03720652|4087382|FG000|Overall Study|Withdrawal by Subject|2
2348035|NCT03720652|4087383|FG001|Overall Study|Withdrawal by Subject|7
2348036|NCT03720652|4087382|FG000|Overall Study|Lost to Follow-up|0
2348037|NCT03720652|4087383|FG001|Overall Study|Lost to Follow-up|4
2348038|NCT03720847|4087391|FG000|Washout|Physician Decision|1
2348039|NCT03720847|4087392|FG001|Washout|Physician Decision|2
2348040|NCT03721172|4087421|FG000|Placebo-controlled Phase|Adverse Event|7
2348041|NCT03721172|4087422|FG001|Placebo-controlled Phase|Adverse Event|7
2348042|NCT03721172|4087423|FG002|Placebo-controlled Phase|Adverse Event|0
2348043|NCT03721172|4087421|FG000|Placebo-controlled Phase|Lack of Efficacy|4
2348044|NCT03721172|4087422|FG001|Placebo-controlled Phase|Lack of Efficacy|0
2348045|NCT03721172|4087423|FG002|Placebo-controlled Phase|Lack of Efficacy|0
2348046|NCT03721172|4087421|FG000|Placebo-controlled Phase|Non-compliance with study drug|0
2348047|NCT03721172|4087422|FG001|Placebo-controlled Phase|Non-compliance with study drug|1
2348048|NCT03721172|4087423|FG002|Placebo-controlled Phase|Non-compliance with study drug|0
2348049|NCT03721172|4087421|FG000|Placebo-controlled Phase|Lost to Follow-up|15
2348050|NCT03721172|4087422|FG001|Placebo-controlled Phase|Lost to Follow-up|13
2348051|NCT03721172|4087423|FG002|Placebo-controlled Phase|Lost to Follow-up|0
2348052|NCT03721172|4087421|FG000|Placebo-controlled Phase|Withdrawal by Subject|23
2348053|NCT03721172|4087422|FG001|Placebo-controlled Phase|Withdrawal by Subject|18
2348054|NCT03721172|4087423|FG002|Placebo-controlled Phase|Withdrawal by Subject|0
2348055|NCT03721172|4087421|FG000|Placebo-controlled Phase|Other|3
2348056|NCT03721172|4087422|FG001|Placebo-controlled Phase|Other|0
2348057|NCT03721172|4087423|FG002|Placebo-controlled Phase|Other|0
2348058|NCT03721172|4087421|FG000|Apremilast Extension Phase|Adverse Event|0
2348059|NCT03721172|4087422|FG001|Apremilast Extension Phase|Adverse Event|0
2348060|NCT03721172|4087423|FG002|Apremilast Extension Phase|Adverse Event|10
2348061|NCT03721172|4087421|FG000|Apremilast Extension Phase|Lack of Efficacy|0
2348062|NCT03721172|4087422|FG001|Apremilast Extension Phase|Lack of Efficacy|0
2348063|NCT03721172|4087423|FG002|Apremilast Extension Phase|Lack of Efficacy|2
2266275|NCT02196701|3940846|FG000|Overall Study|Adverse Event|1
2266276|NCT02196701|3940846|FG000|Overall Study|Lost to Follow-up|1
2266277|NCT02196701|3940846|FG000|Overall Study|Non-adherence to Protocol|1
2266278|NCT02196714|3940853|FG000|Overall Study|Protocol Violation|0
2266279|NCT02196714|3940854|FG001|Overall Study|Protocol Violation|0
2266280|NCT02196714|3940855|FG002|Overall Study|Protocol Violation|1
2266281|NCT02196714|3940856|FG003|Overall Study|Protocol Violation|0
2266282|NCT02197130|3940964|FG000|Overall Study|Adverse Event|13
2266283|NCT02197130|3940965|FG001|Overall Study|Adverse Event|4
2266284|NCT02197130|3940966|FG002|Overall Study|Adverse Event|23
2266285|NCT02197130|3940964|FG000|Overall Study|Death|0
2266286|NCT02197130|3940965|FG001|Overall Study|Death|1
2266287|NCT02197130|3940966|FG002|Overall Study|Death|0
2266288|NCT02197130|3940964|FG000|Overall Study|Lost to Follow-up|2
2266289|NCT02197130|3940965|FG001|Overall Study|Lost to Follow-up|0
2266290|NCT02197130|3940966|FG002|Overall Study|Lost to Follow-up|1
2266291|NCT02197130|3940964|FG000|Overall Study|Does not meet entrance criteria|0
2266292|NCT02197130|3940965|FG001|Overall Study|Does not meet entrance criteria|0
2266293|NCT02197130|3940966|FG002|Overall Study|Does not meet entrance criteria|1
2266294|NCT02197130|3940964|FG000|Overall Study|Withdrawal by Subject|0
2266295|NCT02197130|3940965|FG001|Overall Study|Withdrawal by Subject|3
2266296|NCT02197130|3940966|FG002|Overall Study|Withdrawal by Subject|4
2266297|NCT02197130|3940964|FG000|Overall Study|Other|1
2266298|NCT02197130|3940965|FG001|Overall Study|Other|0
2266299|NCT02197130|3940966|FG002|Overall Study|Other|3
2266300|NCT02197247|3940974|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
2266301|NCT02197247|3940974|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
2266302|NCT02197247|3940974|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
2266303|NCT02197247|3940974|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
2266304|NCT02197247|3940974|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
2266305|NCT02197247|3940974|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
2266306|NCT02197247|3940974|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1
2266307|NCT02197247|3940974|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
2266308|NCT02197377|3940995|FG000|Overall Study|Insertion Failure|0
2266309|NCT02197377|3940996|FG001|Overall Study|Insertion Failure|3
2266310|NCT02197416|3941005|FG000|Overall Study|Other reasons|0
2266311|NCT02197416|3941006|FG001|Overall Study|Other reasons|2
2348064|NCT03721172|4087421|FG000|Apremilast Extension Phase|Non-compliance with study drug|0
2348065|NCT03721172|4087422|FG001|Apremilast Extension Phase|Non-compliance with study drug|0
2348066|NCT03721172|4087423|FG002|Apremilast Extension Phase|Non-compliance with study drug|1
2348067|NCT03721172|4087421|FG000|Apremilast Extension Phase|Lost to Follow-up|0
2348068|NCT03721172|4087422|FG001|Apremilast Extension Phase|Lost to Follow-up|0
2348069|NCT03721172|4087423|FG002|Apremilast Extension Phase|Lost to Follow-up|20
2348070|NCT03721172|4087421|FG000|Apremilast Extension Phase|Protocol Violation|0
2348071|NCT03721172|4087422|FG001|Apremilast Extension Phase|Protocol Violation|0
2348072|NCT03721172|4087423|FG002|Apremilast Extension Phase|Protocol Violation|1
2348073|NCT03721172|4087421|FG000|Apremilast Extension Phase|Physician Decision|0
2348074|NCT03721172|4087422|FG001|Apremilast Extension Phase|Physician Decision|0
2348075|NCT03721172|4087423|FG002|Apremilast Extension Phase|Physician Decision|1
2348076|NCT03721172|4087421|FG000|Apremilast Extension Phase|Withdrawal by Subject|0
2348077|NCT03721172|4087422|FG001|Apremilast Extension Phase|Withdrawal by Subject|0
2348078|NCT03721172|4087423|FG002|Apremilast Extension Phase|Withdrawal by Subject|21
2348079|NCT03721172|4087421|FG000|Apremilast Extension Phase|Other|0
2348080|NCT03721172|4087422|FG001|Apremilast Extension Phase|Other|0
2348081|NCT03721172|4087423|FG002|Apremilast Extension Phase|Other|3
2348082|NCT03721172|4087421|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0
2348083|NCT03721172|4087422|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0
2348084|NCT03721172|4087423|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7
2348085|NCT03722030|4087442|FG000|Overall Study|Withdrawal by Subject|1
2348086|NCT03722030|4087443|FG001|Overall Study|Withdrawal by Subject|0
2348087|NCT03722238|4087452|FG000|Overall Study|Protocol Violation|1
2348088|NCT03722238|4087453|FG001|Overall Study|Protocol Violation|0
2348089|NCT03722238|4087452|FG000|Overall Study|Physician Decision|1
2348090|NCT03722238|4087453|FG001|Overall Study|Physician Decision|0
2348091|NCT03722238|4087452|FG000|Overall Study|Death|1
2348092|NCT03722238|4087453|FG001|Overall Study|Death|0
2348093|NCT03722238|4087452|FG000|Overall Study|Lost to Follow-up|6
2348094|NCT03722238|4087453|FG001|Overall Study|Lost to Follow-up|0
2348095|NCT03722238|4087452|FG000|Overall Study|Partial missing data|44
2348096|NCT03722238|4087453|FG001|Overall Study|Partial missing data|1
2348097|NCT03722238|4087452|FG000|Overall Study|Withdrawal by Subject|2
2348098|NCT03722238|4087453|FG001|Overall Study|Withdrawal by Subject|0
2348099|NCT03722238|4087452|FG000|Overall Study|Other|4
2348100|NCT03722238|4087453|FG001|Overall Study|Other|0
2348101|NCT03722238|4087452|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2
2348102|NCT03722238|4087453|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0
2348103|NCT03722238|4087452|FG000|Overall Study|Did not meet risk classification group criteria|90
2348104|NCT03722238|4087453|FG001|Overall Study|Did not meet risk classification group criteria|0
2266312|NCT02197416|3941007|FG002|Overall Study|Other reasons|5
2266313|NCT02197416|3941005|FG000|Overall Study|Withdrawal by Subject|0
2266314|NCT02197416|3941006|FG001|Overall Study|Withdrawal by Subject|2
2266315|NCT02197416|3941007|FG002|Overall Study|Withdrawal by Subject|1
2266316|NCT02197416|3941005|FG000|Overall Study|Protocol Violation|1
2266317|NCT02197416|3941006|FG001|Overall Study|Protocol Violation|0
2266318|NCT02197416|3941007|FG002|Overall Study|Protocol Violation|1
2266319|NCT02197416|3941005|FG000|Overall Study|Adverse Event|0
2266320|NCT02197416|3941006|FG001|Overall Study|Adverse Event|0
2266321|NCT02197416|3941007|FG002|Overall Study|Adverse Event|1
2266322|NCT02197520|3941026|FG000|Period 1|Withdrawal by Subject|1
2266323|NCT02197520|3941027|FG001|Period 1|Withdrawal by Subject|0
2266324|NCT02197520|3941026|FG000|Period 2|Adverse Event|0
2266325|NCT02197520|3941027|FG001|Period 2|Adverse Event|2
2266326|NCT02197520|3941026|FG000|Period 2|Withdrawal by Subject|1
2348105|NCT03722238|4087452|FG000|Overall Study|Did not sign consent|17
2348106|NCT03722238|4087453|FG001|Overall Study|Did not sign consent|0
2348107|NCT03722238|4087452|FG000|Overall Study|Other eligibility criteria not met pre-consent|22
2348108|NCT03722238|4087453|FG001|Overall Study|Other eligibility criteria not met pre-consent|0
2348109|NCT03722238|4087452|FG000|Overall Study|Not willing to purchase study medication|142
2348110|NCT03722238|4087453|FG001|Overall Study|Not willing to purchase study medication|0
2348111|NCT03722238|4087452|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133
2348112|NCT03722238|4087453|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0
2348113|NCT03722264|4087459|FG000|Overall Study|Physician Decision|3
2348114|NCT03722446|4087467|FG000|Overall Study|Protocol Violation|15
2348115|NCT03722446|4087468|FG001|Overall Study|Protocol Violation|2
2348116|NCT03722524|4087474|FG000|Overall Study|Protocol Violation|86
2348117|NCT03722524|4087474|FG000|Overall Study|Adverse Event|7
2348118|NCT03722524|4087474|FG000|Overall Study|Lost to Follow-up|1
2348119|NCT03722524|4087474|FG000|Overall Study|Reason is not stated|1
2348120|NCT03722524|4087474|FG000|Overall Study|Physician Decision|1
2348121|NCT03722524|4087474|FG000|Overall Study|Patient's decision (refusal to continue participation)|3
2348122|NCT03722576|4087478|FG000|Overall Study|Withdrawal by Subject|3
2348123|NCT03722576|4087478|FG000|Overall Study|Adverse Event|2
2348124|NCT03722576|4087478|FG000|Overall Study|Physician Decision|1
2348125|NCT03722576|4087478|FG000|Overall Study|Lost to Follow-up|1
2348126|NCT03722784|4087484|FG000|Overall Study|Withdrawal by Subject|1
2348127|NCT03722784|4087485|FG001|Overall Study|Withdrawal by Subject|0
2348128|NCT03722784|4087484|FG000|Overall Study|Physician Decision|1
2348129|NCT03722784|4087485|FG001|Overall Study|Physician Decision|1
2348130|NCT03722784|4087484|FG000|Overall Study|Protocol Violation|0
2348131|NCT03722784|4087485|FG001|Overall Study|Protocol Violation|1
2348132|NCT03723915|4087492|FG000|Screening|Failed to meet screening requirements.|2
2348133|NCT03723915|4087492|FG000|On Treatment|Failed to meet treatment requirements|2
2348134|NCT03724812|4087496|FG000|Overall Study|Missed Visit|1
2348135|NCT03724812|4087496|FG000|Overall Study|Death|2
2348136|NCT03724812|4087496|FG000|Overall Study|Withdrawal by Subject|1
2348137|NCT03725982|4087503|FG000|First Intervention|Withdrawal by Subject|0
2348138|NCT03725982|4087504|FG001|First Intervention|Withdrawal by Subject|1
2348139|NCT03725982|4087503|FG000|First Intervention|Physician Decision|1
2348140|NCT03725982|4087504|FG001|First Intervention|Physician Decision|1
2266327|NCT02197520|3941027|FG001|Period 2|Withdrawal by Subject|0
2266328|NCT02197572|3941035|FG000|Overall Study|Progressive Disease|28
2266329|NCT02197572|3941035|FG000|Overall Study|Withdrawal by Subject|9
2266330|NCT02197572|3941035|FG000|Overall Study|Adverse Event|3
2266331|NCT02197572|3941035|FG000|Overall Study|Reason Not Specified|4
2266332|NCT02197806|3941047|FG000|Overall Study|Adverse Event|0
2266333|NCT02197806|3941048|FG001|Overall Study|Adverse Event|1
2266334|NCT02197806|3941049|FG002|Overall Study|Adverse Event|0
2266335|NCT02197806|3941050|FG003|Overall Study|Adverse Event|1
2266336|NCT02197897|3941060|FG000|Overall Study|not eligible|1
2266337|NCT02198040|3941067|FG000|Overall Study|Work reasons|0
2266338|NCT02198040|3941068|FG001|Overall Study|Work reasons|1
2266339|NCT02198040|3941069|FG002|Overall Study|Work reasons|0
2266340|NCT02198040|3941067|FG000|Overall Study|Withdrawal by Subject|0
2266341|NCT02198040|3941068|FG001|Overall Study|Withdrawal by Subject|0
2266342|NCT02198040|3941069|FG002|Overall Study|Withdrawal by Subject|1
2266343|NCT02198235|3941082|FG000|Overall Study|Lost to Follow-up|3
2266344|NCT02198235|3941083|FG001|Overall Study|Lost to Follow-up|2
2266345|NCT02198235|3941084|FG002|Overall Study|Lost to Follow-up|2
2266346|NCT02198651|3941101|FG000|Lead-in Period|Withdrew consent|13
2266347|NCT02198651|3941102|FG001|Lead-in Period|Withdrew consent|0
2266348|NCT02198651|3941103|FG002|Lead-in Period|Withdrew consent|0
2266349|NCT02198651|3941104|FG003|Lead-in Period|Withdrew consent|0
2266350|NCT02198651|3941105|FG004|Lead-in Period|Withdrew consent|0
2266351|NCT02198651|3941101|FG000|Lead-in Period|Adverse Event|2
2266352|NCT02198651|3941102|FG001|Lead-in Period|Adverse Event|0
2266353|NCT02198651|3941103|FG002|Lead-in Period|Adverse Event|0
2266354|NCT02198651|3941104|FG003|Lead-in Period|Adverse Event|0
2266355|NCT02198651|3941105|FG004|Lead-in Period|Adverse Event|0
2266356|NCT02198651|3941101|FG000|Lead-in Period|Other, not specified|22
2266357|NCT02198651|3941102|FG001|Lead-in Period|Other, not specified|0
2266358|NCT02198651|3941103|FG002|Lead-in Period|Other, not specified|0
2266359|NCT02198651|3941104|FG003|Lead-in Period|Other, not specified|0
2266360|NCT02198651|3941105|FG004|Lead-in Period|Other, not specified|0
2266361|NCT02198651|3941101|FG000|Double-blind Period|Withdrew consent|0
2266362|NCT02198651|3941102|FG001|Double-blind Period|Withdrew consent|4
2266363|NCT02198651|3941103|FG002|Double-blind Period|Withdrew consent|0
2266364|NCT02198651|3941104|FG003|Double-blind Period|Withdrew consent|0
2266365|NCT02198651|3941105|FG004|Double-blind Period|Withdrew consent|0
2266366|NCT02198651|3941101|FG000|Double-blind Period|Adverse Event|0
2266367|NCT02198651|3941102|FG001|Double-blind Period|Adverse Event|1
2266368|NCT02198651|3941103|FG002|Double-blind Period|Adverse Event|0
2266369|NCT02198651|3941104|FG003|Double-blind Period|Adverse Event|0
2266370|NCT02198651|3941105|FG004|Double-blind Period|Adverse Event|0
2266371|NCT02198651|3941101|FG000|Double-blind Period|Other, not specified|0
2266372|NCT02198651|3941102|FG001|Double-blind Period|Other, not specified|4
2266373|NCT02198651|3941103|FG002|Double-blind Period|Other, not specified|1
2266374|NCT02198651|3941104|FG003|Double-blind Period|Other, not specified|0
2266375|NCT02198651|3941105|FG004|Double-blind Period|Other, not specified|0
2266376|NCT02198651|3941101|FG000|Open-label Rescue Period|Withdrew consent|0
2266377|NCT02198651|3941102|FG001|Open-label Rescue Period|Withdrew consent|0
2266378|NCT02198651|3941103|FG002|Open-label Rescue Period|Withdrew consent|0
2266379|NCT02198651|3941104|FG003|Open-label Rescue Period|Withdrew consent|2
2266380|NCT02198651|3941105|FG004|Open-label Rescue Period|Withdrew consent|0
2266381|NCT02198651|3941101|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2266382|NCT02198651|3941102|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2266383|NCT02198651|3941103|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2266384|NCT02198651|3941104|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
2266385|NCT02198651|3941105|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2266386|NCT02198664|3941120|FG000|Overall Study|Adverse Event|2
2266387|NCT02198664|3941121|FG001|Overall Study|Adverse Event|0
2266388|NCT02198664|3941120|FG000|Overall Study|Withdrawal by Subject|11
2266389|NCT02198664|3941121|FG001|Overall Study|Withdrawal by Subject|8
2266390|NCT02198664|3941120|FG000|Overall Study|Failure to tolerate|2
2266391|NCT02198664|3941121|FG001|Overall Study|Failure to tolerate|0
2266392|NCT02198664|3941120|FG000|Overall Study|Not stated|1
2266393|NCT02198664|3941121|FG001|Overall Study|Not stated|0
2266394|NCT02198963|3941129|FG000|Overall Study|Adverse Event|1
2266395|NCT02198963|3941129|FG000|Overall Study|Withdrawal by Subject|6
2266396|NCT02199028|3941140|FG000|Week 1|Adverse Event|1
2266397|NCT02199028|3941141|FG001|Week 1|Adverse Event|0
2266398|NCT02199028|3941140|FG000|Week 3|Adverse Event|1
2266399|NCT02199028|3941141|FG001|Week 3|Adverse Event|0
2266400|NCT02199080|3941153|FG000|Overall Study|Protocol Violation|12
2266401|NCT02199314|3941169|FG000|Overall Study|Withdrawal by Subject|6
2266402|NCT02199314|3941169|FG000|Overall Study|Physician Decision|10
2266403|NCT02199509|3941184|FG000|Overall Study|Suicidal Ideation|0
2266404|NCT02199509|3941185|FG001|Overall Study|Suicidal Ideation|1
2266405|NCT02199509|3941184|FG000|Overall Study|Misunderstood titration schedule|1
2266406|NCT02199509|3941185|FG001|Overall Study|Misunderstood titration schedule|0
2266407|NCT02199691|3941214|FG000|Overall Study|Protocol Violation|3
2266408|NCT02199691|3941215|FG001|Overall Study|Protocol Violation|3
2266409|NCT02199691|3941216|FG002|Overall Study|Protocol Violation|6
2266410|NCT02199691|3941217|FG003|Overall Study|Protocol Violation|7
2266411|NCT02199691|3941214|FG000|Overall Study|Withdrawal by Subject|5
2266412|NCT02199691|3941215|FG001|Overall Study|Withdrawal by Subject|3
2266413|NCT02199691|3941216|FG002|Overall Study|Withdrawal by Subject|12
2266414|NCT02199691|3941217|FG003|Overall Study|Withdrawal by Subject|13
2266415|NCT02199691|3941214|FG000|Overall Study|Lost to Follow-up|2
2266416|NCT02199691|3941215|FG001|Overall Study|Lost to Follow-up|1
2266417|NCT02199691|3941216|FG002|Overall Study|Lost to Follow-up|9
2266418|NCT02199691|3941217|FG003|Overall Study|Lost to Follow-up|10
2266419|NCT02199795|3941247|FG000|Overall Study|no longer met inclusion criteria|1
2266420|NCT02199795|3941248|FG001|Overall Study|no longer met inclusion criteria|0
2266421|NCT02199795|3941247|FG000|Overall Study|withdrew due to shoulder pain|1
2266422|NCT02199795|3941248|FG001|Overall Study|withdrew due to shoulder pain|0
2266423|NCT02200211|3941273|FG000|Overall Study|Lost to Follow-up|7
2266424|NCT02200211|3941274|FG001|Overall Study|Lost to Follow-up|7
2266425|NCT02200211|3941275|FG002|Overall Study|Lost to Follow-up|1
2266426|NCT02200211|3941276|FG003|Overall Study|Lost to Follow-up|2
2266427|NCT02200211|3941273|FG000|Overall Study|Withdrawal by Subject|1
2266428|NCT02200211|3941274|FG001|Overall Study|Withdrawal by Subject|0
2266429|NCT02200211|3941275|FG002|Overall Study|Withdrawal by Subject|0
2266430|NCT02200211|3941276|FG003|Overall Study|Withdrawal by Subject|0
2266431|NCT02200445|3941297|FG000|Overall Study|Lack of Efficacy|1
2266432|NCT02200445|3941298|FG001|Overall Study|Lack of Efficacy|2
2266433|NCT02200445|3941299|FG002|Overall Study|Lack of Efficacy|2
2266434|NCT02200445|3941297|FG000|Overall Study|Adverse Event|0
2266435|NCT02200445|3941298|FG001|Overall Study|Adverse Event|2
2266436|NCT02200445|3941299|FG002|Overall Study|Adverse Event|0
2266437|NCT02200510|3941313|FG000|Overall Study|Death|1
2266438|NCT02200510|3941314|FG001|Overall Study|Death|1
2266439|NCT02200510|3941313|FG000|Overall Study|Protocol Violation|0
2266440|NCT02200510|3941314|FG001|Overall Study|Protocol Violation|1
2266441|NCT02200510|3941313|FG000|Overall Study|Lost to Follow-up|7
2266442|NCT02200510|3941314|FG001|Overall Study|Lost to Follow-up|1
2266443|NCT02200510|3941313|FG000|Overall Study|potential COI - joined study team|1
2266444|NCT02200510|3941314|FG001|Overall Study|potential COI - joined study team|0
2266445|NCT02200614|3941344|FG000|Double Blind Treatment|Adverse Event|86
2266446|NCT02200614|3941345|FG001|Double Blind Treatment|Adverse Event|48
2266447|NCT02200614|3941344|FG000|Double Blind Treatment|Confirmed metastasis|119
2266448|NCT02200614|3941345|FG001|Double Blind Treatment|Confirmed metastasis|140
2266449|NCT02200614|3941344|FG000|Double Blind Treatment|Judgment of the investigator|60
2266450|NCT02200614|3941345|FG001|Double Blind Treatment|Judgment of the investigator|99
2266451|NCT02200614|3941344|FG000|Double Blind Treatment|Metastasis by local reading|1
2266452|NCT02200614|3941345|FG001|Double Blind Treatment|Metastasis by local reading|3
2266453|NCT02200614|3941344|FG000|Double Blind Treatment|Other reason|6
2266454|NCT02200614|3941345|FG001|Double Blind Treatment|Other reason|2
2266455|NCT02200614|3941344|FG000|Double Blind Treatment|Personal reason|77
2266456|NCT02200614|3941345|FG001|Double Blind Treatment|Personal reason|85
2266457|NCT02200614|3941344|FG000|Double Blind Treatment|Protocol deviation|14
2266458|NCT02200614|3941345|FG001|Double Blind Treatment|Protocol deviation|7
2266459|NCT02200614|3941344|FG000|Double Blind Treatment|Not treated|1
2266460|NCT02200614|3941345|FG001|Double Blind Treatment|Not treated|0
2266461|NCT02200614|3941344|FG000|Open Label|Adverse Event|15
2266462|NCT02200614|3941345|FG001|Open Label|Adverse Event|8
2266463|NCT02200614|3941344|FG000|Open Label|Confirmed metastasis|1
2266464|NCT02200614|3941345|FG001|Open Label|Confirmed metastasis|0
2348141|NCT03727841|4087518|FG000|Overall Study|Physician Decision|2
2348142|NCT03727841|4087519|FG001|Overall Study|Physician Decision|1
2348143|NCT03736967|4087529|FG000|Overall Study|Withdrawal by Subject|26
2348144|NCT03736967|4087530|FG001|Overall Study|Withdrawal by Subject|25
2348145|NCT03736967|4087531|FG002|Overall Study|Withdrawal by Subject|23
2348146|NCT03736967|4087532|FG003|Overall Study|Withdrawal by Subject|26
2348147|NCT03736967|4087529|FG000|Overall Study|Lost to Follow-up|3
2348148|NCT03736967|4087530|FG001|Overall Study|Lost to Follow-up|2
2348149|NCT03736967|4087531|FG002|Overall Study|Lost to Follow-up|1
2348150|NCT03736967|4087532|FG003|Overall Study|Lost to Follow-up|1
2348151|NCT03736967|4087529|FG000|Overall Study|Physician Decision|1
2348152|NCT03736967|4087530|FG001|Overall Study|Physician Decision|0
2348153|NCT03736967|4087531|FG002|Overall Study|Physician Decision|0
2348154|NCT03736967|4087532|FG003|Overall Study|Physician Decision|1
2348155|NCT03736967|4087529|FG000|Overall Study|Adverse Event|0
2348156|NCT03736967|4087530|FG001|Overall Study|Adverse Event|1
2348157|NCT03736967|4087531|FG002|Overall Study|Adverse Event|0
2348158|NCT03736967|4087532|FG003|Overall Study|Adverse Event|1
2348159|NCT03736967|4087529|FG000|Overall Study|Death|0
2348160|NCT03736967|4087530|FG001|Overall Study|Death|0
2348161|NCT03736967|4087531|FG002|Overall Study|Death|0
2348162|NCT03736967|4087532|FG003|Overall Study|Death|1
2348163|NCT03736967|4087529|FG000|Overall Study|Randomized but never treated|1
2348164|NCT03736967|4087530|FG001|Overall Study|Randomized but never treated|0
2348165|NCT03736967|4087531|FG002|Overall Study|Randomized but never treated|0
2348166|NCT03736967|4087532|FG003|Overall Study|Randomized but never treated|0
2348167|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Adverse Event|2
2348168|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Adverse Event|6
2348169|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Adverse Event|6
2348170|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Adverse Event|12
2348171|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0
2266465|NCT02200614|3941344|FG000|Open Label|Judgment of the investigator|15
2266466|NCT02200614|3941345|FG001|Open Label|Judgment of the investigator|0
2266467|NCT02200614|3941344|FG000|Open Label|Metastasis by local reading|58
2266468|NCT02200614|3941345|FG001|Open Label|Metastasis by local reading|10
2266469|NCT02200614|3941344|FG000|Open Label|Other reason|6
2266470|NCT02200614|3941345|FG001|Open Label|Other reason|1
2266471|NCT02200614|3941344|FG000|Open Label|Personal reason|29
2266472|NCT02200614|3941345|FG001|Open Label|Personal reason|3
2266473|NCT02200614|3941344|FG000|Open Label|Protocol deviation|1
2266474|NCT02200614|3941345|FG001|Open Label|Protocol deviation|1
2266475|NCT02201108|3941390|FG000|Overall Study|Adverse Event|0
2266476|NCT02201108|3941391|FG001|Overall Study|Adverse Event|6
2266477|NCT02201108|3941390|FG000|Overall Study|Lack of Efficacy|2
2266478|NCT02201108|3941391|FG001|Overall Study|Lack of Efficacy|1
2266479|NCT02201108|3941390|FG000|Overall Study|Withdrawal by Subject|2
2266480|NCT02201108|3941391|FG001|Overall Study|Withdrawal by Subject|0
2266481|NCT02201251|3941406|FG000|Overall Study|Adverse Event|1
2266482|NCT02201251|3941407|FG001|Overall Study|Adverse Event|1
2266483|NCT02201251|3941406|FG000|Overall Study|Protocol Violation|1
2266484|NCT02201251|3941407|FG001|Overall Study|Protocol Violation|0
2266485|NCT02201251|3941406|FG000|Overall Study|Noncompliance with Study Drug|0
2266486|NCT02201251|3941407|FG001|Overall Study|Noncompliance with Study Drug|1
2266487|NCT02201251|3941406|FG000|Overall Study|Withdrawal by Subject|2
2266488|NCT02201251|3941407|FG001|Overall Study|Withdrawal by Subject|1
2266489|NCT02201277|3941415|FG000|Overall Study|Death|3
2266490|NCT02201277|3941416|FG001|Overall Study|Death|4
2266491|NCT02201277|3941415|FG000|Overall Study|Lost to Follow-up|2
2266492|NCT02201277|3941416|FG001|Overall Study|Lost to Follow-up|1
2266493|NCT02201277|3941415|FG000|Overall Study|Failed retrieval|1
2266494|NCT02201277|3941416|FG001|Overall Study|Failed retrieval|0
2266495|NCT02201277|3941415|FG000|Overall Study|Physician Decision|1
2266496|NCT02201277|3941416|FG001|Overall Study|Physician Decision|0
2266497|NCT02201290|3941426|FG000|Overall Study|Withdrawal by Subject|2
2266498|NCT02201290|3941426|FG000|Overall Study|Lack of Efficacy|2
2266499|NCT02201290|3941426|FG000|Overall Study|Adverse Event|1
2348172|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
2348173|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
2348174|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3
2348175|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Protocol Violation|0
2348176|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Protocol Violation|0
2348177|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Protocol Violation|1
2348178|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Protocol Violation|0
2348179|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1
2348180|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3
2348181|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1
2348182|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1
2348183|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Program Termination|3
2348184|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Program Termination|0
2348185|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Program Termination|1
2348186|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Program Termination|1
2348187|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1
2348188|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
2348189|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
2348190|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
2348191|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Sponsors Decision|3
2348192|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Sponsors Decision|2
2348193|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Sponsors Decision|1
2348194|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Sponsors Decision|3
2348195|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Promotor Decision|0
2348196|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Promotor Decision|1
2348197|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Promotor Decision|0
2348198|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Promotor Decision|0
2348199|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
2348200|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1
2348201|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
2348202|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
2348203|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Premature Program Termination|0
2348204|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Premature Program Termination|1
2348205|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Premature Program Termination|0
2348206|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Premature Program Termination|0
2348207|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
2348208|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1
2348209|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
2348210|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
2348211|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Study Early Closure|0
2348212|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Study Early Closure|0
2348213|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Study Early Closure|1
2348214|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Study Early Closure|0
2266500|NCT02201329|3941430|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
2266501|NCT02201329|3941430|FG000|Overall Study|Withdrawal by Subject|2
2266502|NCT02201524|3941456|FG000|Overall Study|Adverse Event|0
2266503|NCT02201524|3941457|FG001|Overall Study|Adverse Event|2
2266504|NCT02201524|3941458|FG002|Overall Study|Adverse Event|1
2266505|NCT02201524|3941459|FG003|Overall Study|Adverse Event|0
2266506|NCT02201524|3941456|FG000|Overall Study|Insufficient clinical response|1
2266507|NCT02201524|3941457|FG001|Overall Study|Insufficient clinical response|0
2266508|NCT02201524|3941458|FG002|Overall Study|Insufficient clinical response|0
2266509|NCT02201524|3941459|FG003|Overall Study|Insufficient clinical response|0
2266510|NCT02201524|3941456|FG000|Overall Study|Lost to Follow-up|0
2266511|NCT02201524|3941457|FG001|Overall Study|Lost to Follow-up|0
2266512|NCT02201524|3941458|FG002|Overall Study|Lost to Follow-up|2
2266513|NCT02201524|3941459|FG003|Overall Study|Lost to Follow-up|0
2266514|NCT02201524|3941456|FG000|Overall Study|No longer meets eligibility criteria|0
2266515|NCT02201524|3941457|FG001|Overall Study|No longer meets eligibility criteria|0
2266516|NCT02201524|3941458|FG002|Overall Study|No longer meets eligibility criteria|0
2266517|NCT02201524|3941459|FG003|Overall Study|No longer meets eligibility criteria|2
2266518|NCT02201524|3941456|FG000|Overall Study|Protocol Violation|0
2266519|NCT02201524|3941457|FG001|Overall Study|Protocol Violation|0
2266520|NCT02201524|3941458|FG002|Overall Study|Protocol Violation|0
2266521|NCT02201524|3941459|FG003|Overall Study|Protocol Violation|1
2266522|NCT02201524|3941456|FG000|Overall Study|Withdrawal by Subject|0
2266523|NCT02201524|3941457|FG001|Overall Study|Withdrawal by Subject|0
2266524|NCT02201524|3941458|FG002|Overall Study|Withdrawal by Subject|1
2266525|NCT02201524|3941459|FG003|Overall Study|Withdrawal by Subject|1
2266526|NCT02201524|3941456|FG000|Overall Study|Other|1
2266527|NCT02201524|3941457|FG001|Overall Study|Other|1
2266528|NCT02201524|3941458|FG002|Overall Study|Other|0
2266529|NCT02201524|3941459|FG003|Overall Study|Other|0
2266530|NCT02201771|3941472|FG000|Overall Study|Death|3
2266531|NCT02201771|3941473|FG001|Overall Study|Death|2
2266532|NCT02201771|3941474|FG002|Overall Study|Death|0
2266533|NCT02201771|3941472|FG000|Overall Study|Protocol Violation|10
2266534|NCT02201771|3941473|FG001|Overall Study|Protocol Violation|8
2266535|NCT02201771|3941474|FG002|Overall Study|Protocol Violation|10
2266536|NCT02201784|3941484|FG000|Overall Study|Failure to achieve adequate block|2
2266537|NCT02201784|3941485|FG001|Overall Study|Failure to achieve adequate block|0
2266538|NCT02201901|3941494|FG000|Overall Study|Randomized but never treated|0
2266539|NCT02201901|3941495|FG001|Overall Study|Randomized but never treated|1
2266540|NCT02201901|3941496|FG002|Overall Study|Randomized but never treated|0
2266541|NCT02201901|3941494|FG000|Overall Study|Lack of Efficacy|7
2266542|NCT02201901|3941495|FG001|Overall Study|Lack of Efficacy|1
2266543|NCT02201901|3941496|FG002|Overall Study|Lack of Efficacy|6
2266544|NCT02201901|3941494|FG000|Overall Study|Death|3
2266545|NCT02201901|3941495|FG001|Overall Study|Death|3
2266546|NCT02201901|3941496|FG002|Overall Study|Death|3
2266547|NCT02201901|3941494|FG000|Overall Study|Lost to Follow-up|2
2266548|NCT02201901|3941495|FG001|Overall Study|Lost to Follow-up|3
2266549|NCT02201901|3941496|FG002|Overall Study|Lost to Follow-up|2
2266550|NCT02201901|3941494|FG000|Overall Study|Withdrew Consent|2
2266551|NCT02201901|3941495|FG001|Overall Study|Withdrew Consent|0
2266552|NCT02201901|3941496|FG002|Overall Study|Withdrew Consent|2
2266553|NCT02201901|3941494|FG000|Overall Study|Adverse Event|1
2266554|NCT02201901|3941495|FG001|Overall Study|Adverse Event|1
2266555|NCT02201901|3941496|FG002|Overall Study|Adverse Event|0
2266556|NCT02201940|3941507|FG000|Overall Study|Randomized/Enrolled but Never Treated|1
2266557|NCT02201940|3941508|FG001|Overall Study|Randomized/Enrolled but Never Treated|0
2266558|NCT02201940|3941507|FG000|Overall Study|Lack of Efficacy|2
2266559|NCT02201940|3941508|FG001|Overall Study|Lack of Efficacy|113
2266560|NCT02201940|3941507|FG000|Overall Study|Lost to Follow-up|5
2266561|NCT02201940|3941508|FG001|Overall Study|Lost to Follow-up|0
2266562|NCT02201940|3941507|FG000|Overall Study|Withdrew Consent|2
2266563|NCT02201940|3941508|FG001|Overall Study|Withdrew Consent|1
2266564|NCT02201940|3941507|FG000|Overall Study|Investigator's Discretion|1
2266565|NCT02201940|3941508|FG001|Overall Study|Investigator's Discretion|1
2266566|NCT02201940|3941507|FG000|Overall Study|Death|1
2266567|NCT02201940|3941508|FG001|Overall Study|Death|0
2266568|NCT02201940|3941507|FG000|Overall Study|Adverse Event|0
2266569|NCT02201940|3941508|FG001|Overall Study|Adverse Event|1
2266570|NCT02201953|3941516|FG000|Overall Study|Randomized but Never Treated|1
2266571|NCT02201953|3941517|FG001|Overall Study|Randomized but Never Treated|5
2266572|NCT02201953|3941516|FG000|Overall Study|Lack of Efficacy|9
2348215|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
2348216|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
2348217|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1
2348218|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
2348219|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0
2348220|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0
2348221|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1
2348222|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0
2266573|NCT02201953|3941517|FG001|Overall Study|Lack of Efficacy|30
2266574|NCT02201953|3941516|FG000|Overall Study|Lost to Follow-up|8
2266575|NCT02201953|3941517|FG001|Overall Study|Lost to Follow-up|8
2266576|NCT02201953|3941516|FG000|Overall Study|Withdrew Consent|2
2266577|NCT02201953|3941517|FG001|Overall Study|Withdrew Consent|5
2266578|NCT02201953|3941516|FG000|Overall Study|Adverse Event|0
2266579|NCT02201953|3941517|FG001|Overall Study|Adverse Event|5
2266580|NCT02201953|3941516|FG000|Overall Study|Death|0
2266581|NCT02201953|3941517|FG001|Overall Study|Death|3
2266582|NCT02202031|3941525|FG000|Overall Study|Lost to Follow-up|1
2266583|NCT02202031|3941526|FG001|Overall Study|Lost to Follow-up|0
2266584|NCT02202031|3941525|FG000|Overall Study|Too Busy|1
2266585|NCT02202031|3941526|FG001|Overall Study|Too Busy|3
2266586|NCT02202031|3941525|FG000|Overall Study|Illness/Medical Reason|0
2266587|NCT02202031|3941526|FG001|Overall Study|Illness/Medical Reason|2
2266588|NCT02202031|3941525|FG000|Overall Study|Intolerance/Lack of Improvement|3
2266589|NCT02202031|3941526|FG001|Overall Study|Intolerance/Lack of Improvement|0
2266590|NCT02202109|3941534|FG000|Overall Study|Lost to Follow-up|88
2266591|NCT02202109|3941535|FG001|Overall Study|Lost to Follow-up|87
2266592|NCT02202109|3941534|FG000|Overall Study|Withdrawal by Subject|2
2266593|NCT02202109|3941535|FG001|Overall Study|Withdrawal by Subject|0
2266594|NCT02202161|3941553|FG000|Overall Study|Adverse Event|1
2266595|NCT02202161|3941554|FG001|Overall Study|Adverse Event|1
2266596|NCT02202161|3941555|FG002|Overall Study|Adverse Event|0
2266597|NCT02202161|3941556|FG003|Overall Study|Adverse Event|0
2266598|NCT02202161|3941557|FG004|Overall Study|Adverse Event|0
2266599|NCT02202161|3941558|FG005|Overall Study|Adverse Event|1
2266600|NCT02202161|3941559|FG006|Overall Study|Adverse Event|0
2266601|NCT02202161|3941560|FG007|Overall Study|Adverse Event|0
2266602|NCT02202161|3941553|FG000|Overall Study|Did not meet continuation criteria|0
2266603|NCT02202161|3941554|FG001|Overall Study|Did not meet continuation criteria|0
2266604|NCT02202161|3941555|FG002|Overall Study|Did not meet continuation criteria|0
2266605|NCT02202161|3941556|FG003|Overall Study|Did not meet continuation criteria|0
2266606|NCT02202161|3941557|FG004|Overall Study|Did not meet continuation criteria|0
2266607|NCT02202161|3941558|FG005|Overall Study|Did not meet continuation criteria|0
2266608|NCT02202161|3941559|FG006|Overall Study|Did not meet continuation criteria|0
2266609|NCT02202161|3941560|FG007|Overall Study|Did not meet continuation criteria|3
2266610|NCT02202161|3941553|FG000|Overall Study|Physician Decision|0
2266611|NCT02202161|3941554|FG001|Overall Study|Physician Decision|0
2266612|NCT02202161|3941555|FG002|Overall Study|Physician Decision|0
2266613|NCT02202161|3941556|FG003|Overall Study|Physician Decision|0
2266614|NCT02202161|3941557|FG004|Overall Study|Physician Decision|0
2266615|NCT02202161|3941558|FG005|Overall Study|Physician Decision|0
2266616|NCT02202161|3941559|FG006|Overall Study|Physician Decision|0
2266617|NCT02202161|3941560|FG007|Overall Study|Physician Decision|3
2266618|NCT02202161|3941553|FG000|Overall Study|Withdrawal by Subject|0
2266619|NCT02202161|3941554|FG001|Overall Study|Withdrawal by Subject|0
2266620|NCT02202161|3941555|FG002|Overall Study|Withdrawal by Subject|0
2266621|NCT02202161|3941556|FG003|Overall Study|Withdrawal by Subject|0
2266622|NCT02202161|3941557|FG004|Overall Study|Withdrawal by Subject|1
2266623|NCT02202161|3941558|FG005|Overall Study|Withdrawal by Subject|0
2266624|NCT02202161|3941559|FG006|Overall Study|Withdrawal by Subject|0
2266625|NCT02202161|3941560|FG007|Overall Study|Withdrawal by Subject|0
2266626|NCT02202317|3941588|FG000|Overall Study|Lost to Follow-up|1
2266627|NCT02202499|3941595|FG000|Overall Study|Cancer diagnosis|0
2266628|NCT02202499|3941596|FG001|Overall Study|Cancer diagnosis|0
2266629|NCT02202499|3941597|FG002|Overall Study|Cancer diagnosis|1
2266630|NCT02202499|3941595|FG000|Overall Study|Moved from area|0
2266631|NCT02202499|3941596|FG001|Overall Study|Moved from area|0
2266632|NCT02202499|3941597|FG002|Overall Study|Moved from area|1
2266633|NCT02202499|3941595|FG000|Overall Study|Declined before randomization|1
2266634|NCT02202499|3941596|FG001|Overall Study|Declined before randomization|0
2266635|NCT02202499|3941597|FG002|Overall Study|Declined before randomization|0
2266636|NCT02202499|3941595|FG000|Overall Study|Auto accident|1
2266637|NCT02202499|3941596|FG001|Overall Study|Auto accident|0
2266638|NCT02202499|3941597|FG002|Overall Study|Auto accident|0
2266639|NCT02202538|3941610|FG000|Overall Study|Withdrawal by Subject|5
2266640|NCT02202538|3941610|FG000|Overall Study|Did not meet all inclusion criteria|2
2266641|NCT02202538|3941610|FG000|Overall Study|Investigator Decision|1
2266642|NCT02202551|3941618|FG000|Overall Study|Adverse Event|8
2266643|NCT02202551|3941619|FG001|Overall Study|Adverse Event|19
2266644|NCT02202551|3941620|FG002|Overall Study|Adverse Event|5
2266645|NCT02202551|3941621|FG003|Overall Study|Adverse Event|9
2266646|NCT02202551|3941618|FG000|Overall Study|Death|3
2266647|NCT02202551|3941619|FG001|Overall Study|Death|2
2266648|NCT02202551|3941620|FG002|Overall Study|Death|1
2266649|NCT02202551|3941621|FG003|Overall Study|Death|1
2266650|NCT02202551|3941618|FG000|Overall Study|Lost to Follow-up|0
2266651|NCT02202551|3941619|FG001|Overall Study|Lost to Follow-up|1
2266652|NCT02202551|3941620|FG002|Overall Study|Lost to Follow-up|0
2266653|NCT02202551|3941621|FG003|Overall Study|Lost to Follow-up|1
2266654|NCT02202551|3941618|FG000|Overall Study|Needed to take excluded medication|0
2266655|NCT02202551|3941619|FG001|Overall Study|Needed to take excluded medication|2
2266656|NCT02202551|3941620|FG002|Overall Study|Needed to take excluded medication|0
2266657|NCT02202551|3941621|FG003|Overall Study|Needed to take excluded medication|1
2266658|NCT02202551|3941618|FG000|Overall Study|Subject moved away|0
2266659|NCT02202551|3941619|FG001|Overall Study|Subject moved away|1
2266660|NCT02202551|3941620|FG002|Overall Study|Subject moved away|0
2266661|NCT02202551|3941621|FG003|Overall Study|Subject moved away|0
2266662|NCT02202551|3941618|FG000|Overall Study|DBS surgery|3
2266663|NCT02202551|3941619|FG001|Overall Study|DBS surgery|0
2266664|NCT02202551|3941620|FG002|Overall Study|DBS surgery|0
2266665|NCT02202551|3941621|FG003|Overall Study|DBS surgery|0
2266666|NCT02202551|3941618|FG000|Overall Study|Dyskinesia upon taper|1
2266667|NCT02202551|3941619|FG001|Overall Study|Dyskinesia upon taper|0
2266668|NCT02202551|3941620|FG002|Overall Study|Dyskinesia upon taper|0
2266669|NCT02202551|3941621|FG003|Overall Study|Dyskinesia upon taper|0
2266670|NCT02202551|3941618|FG000|Overall Study|Lack of Efficacy|0
2266671|NCT02202551|3941619|FG001|Overall Study|Lack of Efficacy|1
2266672|NCT02202551|3941620|FG002|Overall Study|Lack of Efficacy|0
2266673|NCT02202551|3941621|FG003|Overall Study|Lack of Efficacy|0
2266674|NCT02202551|3941618|FG000|Overall Study|Physician Decision|1
2266675|NCT02202551|3941619|FG001|Overall Study|Physician Decision|0
2266676|NCT02202551|3941620|FG002|Overall Study|Physician Decision|0
2266677|NCT02202551|3941621|FG003|Overall Study|Physician Decision|0
2266678|NCT02202551|3941618|FG000|Overall Study|Site closure|3
2266679|NCT02202551|3941619|FG001|Overall Study|Site closure|0
2266680|NCT02202551|3941620|FG002|Overall Study|Site closure|0
2266681|NCT02202551|3941621|FG003|Overall Study|Site closure|1
2266682|NCT02202551|3941618|FG000|Overall Study|Unable to complete visits per protocol|1
2266683|NCT02202551|3941619|FG001|Overall Study|Unable to complete visits per protocol|0
2266684|NCT02202551|3941620|FG002|Overall Study|Unable to complete visits per protocol|0
2266685|NCT02202551|3941621|FG003|Overall Study|Unable to complete visits per protocol|0
2266686|NCT02202551|3941618|FG000|Overall Study|Worsening Dyskinesia|0
2266687|NCT02202551|3941619|FG001|Overall Study|Worsening Dyskinesia|0
2266688|NCT02202551|3941620|FG002|Overall Study|Worsening Dyskinesia|0
2266689|NCT02202551|3941621|FG003|Overall Study|Worsening Dyskinesia|1
2266690|NCT02202551|3941618|FG000|Overall Study|Protocol Violation|0
2266691|NCT02202551|3941619|FG001|Overall Study|Protocol Violation|1
2266692|NCT02202551|3941620|FG002|Overall Study|Protocol Violation|0
2266693|NCT02202551|3941621|FG003|Overall Study|Protocol Violation|0
2266694|NCT02202551|3941618|FG000|Overall Study|Sponsor's decision|2
2266695|NCT02202551|3941619|FG001|Overall Study|Sponsor's decision|0
2266696|NCT02202551|3941620|FG002|Overall Study|Sponsor's decision|0
2266697|NCT02202551|3941621|FG003|Overall Study|Sponsor's decision|0
2266698|NCT02202551|3941618|FG000|Overall Study|Subject unwilling to proceed|1
2266699|NCT02202551|3941619|FG001|Overall Study|Subject unwilling to proceed|5
2266700|NCT02202551|3941620|FG002|Overall Study|Subject unwilling to proceed|3
2266701|NCT02202551|3941621|FG003|Overall Study|Subject unwilling to proceed|5
2266702|NCT02202551|3941618|FG000|Overall Study|Subject consent withdrawn|0
2266703|NCT02202551|3941619|FG001|Overall Study|Subject consent withdrawn|3
2266704|NCT02202551|3941620|FG002|Overall Study|Subject consent withdrawn|1
2266705|NCT02202551|3941621|FG003|Overall Study|Subject consent withdrawn|2
2266706|NCT02202551|3941618|FG000|Overall Study|eGFR<50mL/min/m2|2
2266707|NCT02202551|3941619|FG001|Overall Study|eGFR<50mL/min/m2|2
2266708|NCT02202551|3941620|FG002|Overall Study|eGFR<50mL/min/m2|0
2266709|NCT02202551|3941621|FG003|Overall Study|eGFR<50mL/min/m2|1
2266710|NCT02202616|3941635|FG000|Overall Study|Screen failed|24
2266711|NCT02202616|3941635|FG000|Overall Study|Adverse Event|32
2266712|NCT02202616|3941635|FG000|Overall Study|Protocol deviation|18
2266713|NCT02202616|3941635|FG000|Overall Study|Patient withdrew consent|12
2266714|NCT02202616|3941635|FG000|Overall Study|Lost to Follow-up|6
2266715|NCT02202616|3941635|FG000|Overall Study|Administrative problems|6
2266716|NCT02202616|3941635|FG000|Overall Study|Abnormal test procedure result|1
2266717|NCT02202616|3941635|FG000|Overall Study|Unsatisfactory therapeutic effect|1
2266718|NCT02202759|3941655|FG000|Overall Study|Study Terminated by Sponsor|3
2266719|NCT02202759|3941656|FG001|Overall Study|Study Terminated by Sponsor|3
2266720|NCT02202759|3941657|FG002|Overall Study|Study Terminated by Sponsor|3
2266721|NCT02202759|3941655|FG000|Overall Study|Withdrawal by Subject|2
2266722|NCT02202759|3941656|FG001|Overall Study|Withdrawal by Subject|1
2266723|NCT02202759|3941657|FG002|Overall Study|Withdrawal by Subject|1
2266724|NCT02202759|3941655|FG000|Overall Study|Reason not Specified|4
2266725|NCT02202759|3941656|FG001|Overall Study|Reason not Specified|11
2266726|NCT02202759|3941657|FG002|Overall Study|Reason not Specified|10
2266727|NCT02202785|3941667|FG000|Overall Study|Study Terminated by Sponsor|1
2266728|NCT02202785|3941668|FG001|Overall Study|Study Terminated by Sponsor|6
2266729|NCT02202785|3941669|FG002|Overall Study|Study Terminated by Sponsor|4
2266730|NCT02202785|3941667|FG000|Overall Study|Withdrawal by Subject|0
2266731|NCT02202785|3941668|FG001|Overall Study|Withdrawal by Subject|1
2266732|NCT02202785|3941669|FG002|Overall Study|Withdrawal by Subject|0
2266733|NCT02202785|3941667|FG000|Overall Study|Lost to Follow-up|0
2266734|NCT02202785|3941668|FG001|Overall Study|Lost to Follow-up|1
2266735|NCT02202785|3941669|FG002|Overall Study|Lost to Follow-up|0
2266736|NCT02202785|3941667|FG000|Overall Study|Reason not Specified|10
2266737|NCT02202785|3941668|FG001|Overall Study|Reason not Specified|7
2266738|NCT02202785|3941669|FG002|Overall Study|Reason not Specified|13
2266739|NCT02202837|3941679|FG000|Overall Study|Enbrel treatment discontinued|36
2266740|NCT02202837|3941680|FG001|Overall Study|Enbrel treatment discontinued|4
2266741|NCT02202837|3941679|FG000|Overall Study|Other|10
2266742|NCT02202837|3941680|FG001|Overall Study|Other|0
2266743|NCT02202837|3941679|FG000|Overall Study|Lost to Follow-up|7
2266744|NCT02202837|3941680|FG001|Overall Study|Lost to Follow-up|1
2266745|NCT02202850|3941688|FG000|Overall Study|Other|2
2266746|NCT02202850|3941689|FG001|Overall Study|Other|2
2266747|NCT02202850|3941688|FG000|Overall Study|Enbrel treatment discontinued|15
2266748|NCT02202850|3941689|FG001|Overall Study|Enbrel treatment discontinued|3
2266749|NCT02202850|3941688|FG000|Overall Study|Lost to Follow-up|7
2266750|NCT02202850|3941689|FG001|Overall Study|Lost to Follow-up|1
2266751|NCT02202980|3941709|FG000|Overall Study|Lack of Efficacy|1
2266752|NCT02202980|3941710|FG001|Overall Study|Lack of Efficacy|0
2266753|NCT02202980|3941711|FG002|Overall Study|Lack of Efficacy|7
2266754|NCT02202980|3941712|FG003|Overall Study|Lack of Efficacy|0
2266755|NCT02202980|3941713|FG004|Overall Study|Lack of Efficacy|3
2266756|NCT02202980|3941714|FG005|Overall Study|Lack of Efficacy|1
2266757|NCT02202980|3941715|FG006|Overall Study|Lack of Efficacy|11
2266758|NCT02202980|3941716|FG007|Overall Study|Lack of Efficacy|2
2266759|NCT02202980|3941717|FG008|Overall Study|Lack of Efficacy|2
2266760|NCT02202980|3941718|FG009|Overall Study|Lack of Efficacy|0
2266761|NCT02202980|3941719|FG010|Overall Study|Lack of Efficacy|0
2266762|NCT02202980|3941720|FG011|Overall Study|Lack of Efficacy|3
2266763|NCT02202980|3941721|FG012|Overall Study|Lack of Efficacy|10
2266764|NCT02202980|3941722|FG013|Overall Study|Lack of Efficacy|0
2266765|NCT02202980|3941709|FG000|Overall Study|Protocol Violation|0
2266766|NCT02202980|3941710|FG001|Overall Study|Protocol Violation|0
2266767|NCT02202980|3941711|FG002|Overall Study|Protocol Violation|0
2266768|NCT02202980|3941712|FG003|Overall Study|Protocol Violation|3
2266769|NCT02202980|3941713|FG004|Overall Study|Protocol Violation|3
2266770|NCT02202980|3941714|FG005|Overall Study|Protocol Violation|0
2266771|NCT02202980|3941715|FG006|Overall Study|Protocol Violation|0
2266772|NCT02202980|3941716|FG007|Overall Study|Protocol Violation|0
2266773|NCT02202980|3941717|FG008|Overall Study|Protocol Violation|0
2266774|NCT02202980|3941718|FG009|Overall Study|Protocol Violation|0
2266775|NCT02202980|3941719|FG010|Overall Study|Protocol Violation|0
2266776|NCT02202980|3941720|FG011|Overall Study|Protocol Violation|0
2266777|NCT02202980|3941721|FG012|Overall Study|Protocol Violation|0
2266778|NCT02202980|3941722|FG013|Overall Study|Protocol Violation|0
2266779|NCT02202980|3941709|FG000|Overall Study|Lost to Follow-up|0
2266780|NCT02202980|3941710|FG001|Overall Study|Lost to Follow-up|1
2266781|NCT02202980|3941711|FG002|Overall Study|Lost to Follow-up|1
2266782|NCT02202980|3941712|FG003|Overall Study|Lost to Follow-up|1
2266783|NCT02202980|3941713|FG004|Overall Study|Lost to Follow-up|0
2266784|NCT02202980|3941714|FG005|Overall Study|Lost to Follow-up|0
2266785|NCT02202980|3941715|FG006|Overall Study|Lost to Follow-up|0
2266786|NCT02202980|3941716|FG007|Overall Study|Lost to Follow-up|1
2348223|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
2348224|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
2348225|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
2348226|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1
2348227|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
2348228|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
2348229|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
2348230|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1
2348231|NCT03739840|4087549|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
2348232|NCT03739840|4087550|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
2348233|NCT03739840|4087551|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
2348234|NCT03739840|4087552|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1
2348235|NCT03739840|4087549|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3
2348236|NCT03739840|4087550|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0
2348237|NCT03739840|4087551|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0
2348238|NCT03739840|4087552|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0
2348239|NCT03739840|4087549|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
2348240|NCT03739840|4087550|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
2348241|NCT03739840|4087551|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
2348242|NCT03739840|4087552|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1
2348243|NCT03739840|4087549|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1
2348244|NCT03739840|4087550|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
2348245|NCT03739840|4087551|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
2348246|NCT03739840|4087552|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
2348247|NCT03739840|4087549|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
2348248|NCT03739840|4087550|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1
2348249|NCT03739840|4087551|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
2266787|NCT02202980|3941717|FG008|Overall Study|Lost to Follow-up|1
2266788|NCT02202980|3941718|FG009|Overall Study|Lost to Follow-up|0
2266789|NCT02202980|3941719|FG010|Overall Study|Lost to Follow-up|0
2266790|NCT02202980|3941720|FG011|Overall Study|Lost to Follow-up|0
2266791|NCT02202980|3941721|FG012|Overall Study|Lost to Follow-up|1
2266792|NCT02202980|3941722|FG013|Overall Study|Lost to Follow-up|0
2266793|NCT02202980|3941709|FG000|Overall Study|Withdrew Consent|0
2266794|NCT02202980|3941710|FG001|Overall Study|Withdrew Consent|1
2266795|NCT02202980|3941711|FG002|Overall Study|Withdrew Consent|2
2266796|NCT02202980|3941712|FG003|Overall Study|Withdrew Consent|0
2266797|NCT02202980|3941713|FG004|Overall Study|Withdrew Consent|0
2266798|NCT02202980|3941714|FG005|Overall Study|Withdrew Consent|0
2266799|NCT02202980|3941715|FG006|Overall Study|Withdrew Consent|0
2266800|NCT02202980|3941716|FG007|Overall Study|Withdrew Consent|0
2266801|NCT02202980|3941717|FG008|Overall Study|Withdrew Consent|1
2266802|NCT02202980|3941718|FG009|Overall Study|Withdrew Consent|0
2266803|NCT02202980|3941719|FG010|Overall Study|Withdrew Consent|0
2266804|NCT02202980|3941720|FG011|Overall Study|Withdrew Consent|0
2266805|NCT02202980|3941721|FG012|Overall Study|Withdrew Consent|0
2266806|NCT02202980|3941722|FG013|Overall Study|Withdrew Consent|0
2266807|NCT02203032|3941761|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
2266808|NCT02203032|3941762|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
2266809|NCT02203032|3941763|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
2266810|NCT02203032|3941764|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
2266811|NCT02203032|3941761|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
2266812|NCT02203032|3941762|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
2266813|NCT02203032|3941763|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
2266814|NCT02203032|3941764|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
2266815|NCT02203032|3941761|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
2266816|NCT02203032|3941762|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
2266817|NCT02203032|3941763|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
2266818|NCT02203032|3941764|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
2266819|NCT02203032|3941761|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
2266820|NCT02203032|3941762|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
2266821|NCT02203032|3941763|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
2266822|NCT02203032|3941764|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
2266823|NCT02203032|3941761|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
2266824|NCT02203032|3941762|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
2266825|NCT02203032|3941763|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
2266826|NCT02203032|3941764|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
2266827|NCT02203032|3941761|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2
2266828|NCT02203032|3941762|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0
2266829|NCT02203032|3941763|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0
2266830|NCT02203032|3941764|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0
2266831|NCT02203032|3941761|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
2266832|NCT02203032|3941762|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
2266833|NCT02203032|3941763|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
2266834|NCT02203032|3941764|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
2266835|NCT02203032|3941761|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
2266836|NCT02203032|3941762|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
2266837|NCT02203032|3941763|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
2266838|NCT02203032|3941764|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
2266839|NCT02203032|3941761|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
2266840|NCT02203032|3941762|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
2266841|NCT02203032|3941763|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
2266842|NCT02203032|3941764|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
2266843|NCT02203032|3941761|FG000|Blinded Phase (Week 16 to Week 44)|Other|0
2266844|NCT02203032|3941762|FG001|Blinded Phase (Week 16 to Week 44)|Other|4
2266845|NCT02203032|3941763|FG002|Blinded Phase (Week 16 to Week 44)|Other|1
2266846|NCT02203032|3941764|FG003|Blinded Phase (Week 16 to Week 44)|Other|15
2266847|NCT02203032|3941761|FG000|Blinded Phase (Week 16 to Week 44)|Death|0
2266848|NCT02203032|3941762|FG001|Blinded Phase (Week 16 to Week 44)|Death|0
2266849|NCT02203032|3941763|FG002|Blinded Phase (Week 16 to Week 44)|Death|0
2266850|NCT02203032|3941764|FG003|Blinded Phase (Week 16 to Week 44)|Death|1
2266851|NCT02203032|3941761|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
2266852|NCT02203032|3941762|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
2266853|NCT02203032|3941763|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
2266854|NCT02203032|3941764|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
2266855|NCT02203071|3941774|FG000|Overall Study|Lost to Follow-up|3
2266856|NCT02203071|3941775|FG001|Overall Study|Lost to Follow-up|1
2266857|NCT02203149|3941786|FG000|Part 1|Adverse Event|0
2266858|NCT02203149|3941787|FG001|Part 1|Adverse Event|1
2266859|NCT02203149|3941788|FG002|Part 1|Adverse Event|0
2266860|NCT02203149|3941789|FG003|Part 1|Adverse Event|0
2266861|NCT02203149|3941790|FG004|Part 1|Adverse Event|0
2266862|NCT02203149|3941786|FG000|Part 2|Death|0
2266863|NCT02203149|3941787|FG001|Part 2|Death|0
2266864|NCT02203149|3941788|FG002|Part 2|Death|1
2266865|NCT02203149|3941789|FG003|Part 2|Death|1
2266866|NCT02203149|3941790|FG004|Part 2|Death|0
2266867|NCT02203149|3941786|FG000|Part 2|Withdrawal by Subject|0
2266868|NCT02203149|3941787|FG001|Part 2|Withdrawal by Subject|0
2266869|NCT02203149|3941788|FG002|Part 2|Withdrawal by Subject|0
2266870|NCT02203149|3941789|FG003|Part 2|Withdrawal by Subject|1
2266871|NCT02203149|3941790|FG004|Part 2|Withdrawal by Subject|0
2266872|NCT02203149|3941786|FG000|Part 2|Adverse Event|0
2266873|NCT02203149|3941787|FG001|Part 2|Adverse Event|0
2266874|NCT02203149|3941788|FG002|Part 2|Adverse Event|0
2266875|NCT02203149|3941789|FG003|Part 2|Adverse Event|1
2348250|NCT03739840|4087552|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
2348251|NCT03739840|4087549|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
2348252|NCT03739840|4087550|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1
2348253|NCT03739840|4087551|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
2348254|NCT03739840|4087552|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
2348255|NCT03739840|4087549|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
2348256|NCT03739840|4087550|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
2348257|NCT03739840|4087551|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1
2348258|NCT03739840|4087552|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
2348259|NCT03739840|4087549|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0
2348260|NCT03739840|4087550|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0
2348261|NCT03739840|4087551|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1
2348262|NCT03739840|4087552|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0
2348263|NCT03739840|4087549|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
2348264|NCT03739840|4087550|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
2348265|NCT03739840|4087551|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1
2348266|NCT03739840|4087552|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
2348267|NCT03753763|4087611|FG000|Overall Study|Adverse Event|2
2348268|NCT03753763|4087612|FG001|Overall Study|Adverse Event|0
2348269|NCT03753763|4087611|FG000|Overall Study|Withdrawal by Subject|3
2348270|NCT03753763|4087612|FG001|Overall Study|Withdrawal by Subject|1
2348271|NCT03753763|4087611|FG000|Overall Study|clinical deterioration|1
2348272|NCT03753763|4087612|FG001|Overall Study|clinical deterioration|0
2348273|NCT03756571|4087620|FG000|Overall Study|Lost to Follow-up|1
2348274|NCT03756571|4087621|FG001|Overall Study|Lost to Follow-up|1
2348275|NCT03763877|4087648|FG000|Overall Study|Withdrawal by Subject|3
2348276|NCT03763877|4087649|FG001|Overall Study|Withdrawal by Subject|1
2348277|NCT03763877|4087650|FG002|Overall Study|Withdrawal by Subject|3
2348278|NCT03763877|4087651|FG003|Overall Study|Withdrawal by Subject|4
2348279|NCT03763877|4087648|FG000|Overall Study|Adverse Event|1
2348280|NCT03763877|4087649|FG001|Overall Study|Adverse Event|1
2348281|NCT03763877|4087650|FG002|Overall Study|Adverse Event|3
2348282|NCT03763877|4087651|FG003|Overall Study|Adverse Event|1
2348283|NCT03763877|4087648|FG000|Overall Study|Protocol Violation|1
2348284|NCT03763877|4087649|FG001|Overall Study|Protocol Violation|1
2348285|NCT03763877|4087650|FG002|Overall Study|Protocol Violation|0
2348286|NCT03763877|4087651|FG003|Overall Study|Protocol Violation|0
2348287|NCT03763877|4087648|FG000|Overall Study|Lost to Follow-up|0
2348288|NCT03763877|4087649|FG001|Overall Study|Lost to Follow-up|1
2348289|NCT03763877|4087650|FG002|Overall Study|Lost to Follow-up|1
2266876|NCT02203149|3941790|FG004|Part 2|Adverse Event|1
2266877|NCT02203331|3941822|FG000|Overall Study|Pregnancy|1
2266878|NCT02203331|3941823|FG001|Overall Study|Pregnancy|0
2266879|NCT02203331|3941824|FG002|Overall Study|Pregnancy|0
2266880|NCT02203331|3941825|FG003|Overall Study|Pregnancy|0
2266881|NCT02203331|3941826|FG004|Overall Study|Pregnancy|2
2266882|NCT02203331|3941827|FG005|Overall Study|Pregnancy|0
2266883|NCT02203331|3941822|FG000|Overall Study|Withdrawal by Subject|1
2266884|NCT02203331|3941823|FG001|Overall Study|Withdrawal by Subject|0
2266885|NCT02203331|3941824|FG002|Overall Study|Withdrawal by Subject|1
2266886|NCT02203331|3941825|FG003|Overall Study|Withdrawal by Subject|0
2266887|NCT02203331|3941826|FG004|Overall Study|Withdrawal by Subject|0
2266888|NCT02203331|3941827|FG005|Overall Study|Withdrawal by Subject|3
2266889|NCT02203331|3941822|FG000|Overall Study|Adverse Event|4
2266890|NCT02203331|3941823|FG001|Overall Study|Adverse Event|8
2266891|NCT02203331|3941824|FG002|Overall Study|Adverse Event|3
2266892|NCT02203331|3941825|FG003|Overall Study|Adverse Event|4
2266893|NCT02203331|3941826|FG004|Overall Study|Adverse Event|3
2266894|NCT02203331|3941827|FG005|Overall Study|Adverse Event|3
2266895|NCT02203331|3941822|FG000|Overall Study|Other Reasons|1
2266896|NCT02203331|3941823|FG001|Overall Study|Other Reasons|2
2266897|NCT02203331|3941824|FG002|Overall Study|Other Reasons|0
2266898|NCT02203331|3941825|FG003|Overall Study|Other Reasons|2
2266899|NCT02203331|3941826|FG004|Overall Study|Other Reasons|0
2266900|NCT02203331|3941827|FG005|Overall Study|Other Reasons|0
2266901|NCT02203331|3941822|FG000|Overall Study|Lack of Efficacy|0
2266902|NCT02203331|3941823|FG001|Overall Study|Lack of Efficacy|2
2266903|NCT02203331|3941824|FG002|Overall Study|Lack of Efficacy|1
2266904|NCT02203331|3941825|FG003|Overall Study|Lack of Efficacy|0
2266905|NCT02203331|3941826|FG004|Overall Study|Lack of Efficacy|0
2266906|NCT02203331|3941827|FG005|Overall Study|Lack of Efficacy|1
2266907|NCT02203331|3941822|FG000|Overall Study|Protocol Violation|0
2266908|NCT02203331|3941823|FG001|Overall Study|Protocol Violation|2
2266909|NCT02203331|3941824|FG002|Overall Study|Protocol Violation|0
2266910|NCT02203331|3941825|FG003|Overall Study|Protocol Violation|1
2266911|NCT02203331|3941826|FG004|Overall Study|Protocol Violation|1
2266912|NCT02203331|3941827|FG005|Overall Study|Protocol Violation|0
2266913|NCT02203331|3941822|FG000|Overall Study|Lost to Follow-up|0
2266914|NCT02203331|3941823|FG001|Overall Study|Lost to Follow-up|0
2266915|NCT02203331|3941824|FG002|Overall Study|Lost to Follow-up|0
2266916|NCT02203331|3941825|FG003|Overall Study|Lost to Follow-up|0
2266917|NCT02203331|3941826|FG004|Overall Study|Lost to Follow-up|1
2266918|NCT02203331|3941827|FG005|Overall Study|Lost to Follow-up|0
2266919|NCT02203357|3941844|FG000|Overall Study|Lost to Follow-up|58
2266920|NCT02203357|3941845|FG001|Overall Study|Lost to Follow-up|66
2266921|NCT02203357|3941846|FG002|Overall Study|Lost to Follow-up|70
2266922|NCT02203591|3941873|FG000|Overall Study|Did not meet treatment day baseline|147
2266923|NCT02203591|3941874|FG001|Overall Study|Did not meet treatment day baseline|141
2266924|NCT02203591|3941875|FG002|Overall Study|Did not meet treatment day baseline|150
2266925|NCT02203591|3941876|FG003|Overall Study|Did not meet treatment day baseline|45
2266926|NCT02203591|3941877|FG004|Overall Study|Did not meet treatment day baseline|33
2266927|NCT02203591|3941878|FG005|Overall Study|Did not meet treatment day baseline|35
2266928|NCT02203591|3941879|FG006|Overall Study|Did not meet treatment day baseline|29
2266929|NCT02203591|3941880|FG007|Overall Study|Did not meet treatment day baseline|12
2266930|NCT02203591|3941873|FG000|Overall Study|Discontinued early due to compromised test sites|0
2266931|NCT02203591|3941874|FG001|Overall Study|Discontinued early due to compromised test sites|1
2266932|NCT02203591|3941875|FG002|Overall Study|Discontinued early due to compromised test sites|1
2266933|NCT02203591|3941876|FG003|Overall Study|Discontinued early due to compromised test sites|0
2266934|NCT02203591|3941877|FG004|Overall Study|Discontinued early due to compromised test sites|1
2266935|NCT02203591|3941878|FG005|Overall Study|Discontinued early due to compromised test sites|0
2266936|NCT02203591|3941879|FG006|Overall Study|Discontinued early due to compromised test sites|0
2266937|NCT02203591|3941880|FG007|Overall Study|Discontinued early due to compromised test sites|1
2266938|NCT02203721|3941913|FG000|Overall Study|Lost to Follow-up|1
2266939|NCT02203721|3941914|FG001|Overall Study|Lost to Follow-up|0
2266940|NCT02203721|3941913|FG000|Overall Study|Death|0
2266941|NCT02203721|3941914|FG001|Overall Study|Death|2
2266942|NCT02203721|3941913|FG000|Overall Study|Illness|0
2266943|NCT02203721|3941914|FG001|Overall Study|Illness|1
2266944|NCT02203838|3941952|FG000|Overall Study|Lack of Efficacy|7
2266945|NCT02203838|3941953|FG001|Overall Study|Lack of Efficacy|0
2266946|NCT02203838|3941954|FG002|Overall Study|Lack of Efficacy|1
2266947|NCT02203838|3941955|FG003|Overall Study|Lack of Efficacy|1
2266948|NCT02203838|3941952|FG000|Overall Study|Adverse Event|46
2266949|NCT02203838|3941953|FG001|Overall Study|Adverse Event|6
2266950|NCT02203838|3941954|FG002|Overall Study|Adverse Event|3
2266951|NCT02203838|3941955|FG003|Overall Study|Adverse Event|2
2266952|NCT02203838|3941952|FG000|Overall Study|Lost to Follow-up|39
2266953|NCT02203838|3941953|FG001|Overall Study|Lost to Follow-up|3
2266954|NCT02203838|3941954|FG002|Overall Study|Lost to Follow-up|2
2266955|NCT02203838|3941955|FG003|Overall Study|Lost to Follow-up|1
2266956|NCT02203838|3941952|FG000|Overall Study|Protocol Violation|7
2266957|NCT02203838|3941953|FG001|Overall Study|Protocol Violation|3
2266958|NCT02203838|3941954|FG002|Overall Study|Protocol Violation|0
2266959|NCT02203838|3941955|FG003|Overall Study|Protocol Violation|0
2266960|NCT02203838|3941952|FG000|Overall Study|Withdrawal by Subject|83
2266961|NCT02203838|3941953|FG001|Overall Study|Withdrawal by Subject|10
2266962|NCT02203838|3941954|FG002|Overall Study|Withdrawal by Subject|8
2266963|NCT02203838|3941955|FG003|Overall Study|Withdrawal by Subject|11
2266964|NCT02203838|3941952|FG000|Overall Study|Physician Decision|27
2266965|NCT02203838|3941953|FG001|Overall Study|Physician Decision|0
2266966|NCT02203838|3941954|FG002|Overall Study|Physician Decision|2
2266967|NCT02203838|3941955|FG003|Overall Study|Physician Decision|3
2266968|NCT02203838|3941952|FG000|Overall Study|Other|1
2266969|NCT02203838|3941953|FG001|Overall Study|Other|0
2266970|NCT02203838|3941954|FG002|Overall Study|Other|0
2266971|NCT02203838|3941955|FG003|Overall Study|Other|0
2266972|NCT02203851|3941965|FG000|Overall Study|Lost to Follow-up|4
2266973|NCT02203851|3941965|FG000|Overall Study|Withdrawal by Subject|6
2266974|NCT02203851|3941965|FG000|Overall Study|Other|1
2266975|NCT02203916|3941979|FG000|Overall Study|Pretreatment Event/Adverse Event|1
2266976|NCT02203916|3941980|FG001|Overall Study|Pretreatment Event/Adverse Event|3
2266977|NCT02203916|3941981|FG002|Overall Study|Pretreatment Event/Adverse Event|2
2266978|NCT02203916|3941979|FG000|Overall Study|Major Protocol Deviation|1
2266979|NCT02203916|3941980|FG001|Overall Study|Major Protocol Deviation|1
2266980|NCT02203916|3941981|FG002|Overall Study|Major Protocol Deviation|0
2266981|NCT02203916|3941979|FG000|Overall Study|Lost to Follow-up|0
2266982|NCT02203916|3941980|FG001|Overall Study|Lost to Follow-up|1
2266983|NCT02203916|3941981|FG002|Overall Study|Lost to Follow-up|0
2266984|NCT02203916|3941979|FG000|Overall Study|Voluntary Withdrawal|3
2266985|NCT02203916|3941980|FG001|Overall Study|Voluntary Withdrawal|3
2266986|NCT02203916|3941981|FG002|Overall Study|Voluntary Withdrawal|8
2266987|NCT02203916|3941979|FG000|Overall Study|Lack of Efficacy|3
2266988|NCT02203916|3941980|FG001|Overall Study|Lack of Efficacy|0
2266989|NCT02203916|3941981|FG002|Overall Study|Lack of Efficacy|0
2266990|NCT02203916|3941979|FG000|Overall Study|Reason Not Specified|0
2266991|NCT02203916|3941980|FG001|Overall Study|Reason Not Specified|2
2266992|NCT02203916|3941981|FG002|Overall Study|Reason Not Specified|1
2266993|NCT02204007|3941991|FG000|Overall Study|Surgery Canceled|1
2266994|NCT02204007|3941992|FG001|Overall Study|Surgery Canceled|1
2348290|NCT03763877|4087651|FG003|Overall Study|Lost to Follow-up|0
2348291|NCT03772587|4087674|FG000|Overall Study|COVID-19|0
2348292|NCT03772587|4087675|FG001|Overall Study|COVID-19|0
2348293|NCT03772587|4087676|FG002|Overall Study|COVID-19|1
2348294|NCT03772587|4087677|FG003|Overall Study|COVID-19|1
2348295|NCT03772587|4087678|FG004|Overall Study|COVID-19|0
2266995|NCT02204293|3942026|FG000|Core Study Part I|Met one or more exclusion criteria|1
2266996|NCT02204293|3942027|FG001|Core Study Part I|Met one or more exclusion criteria|0
2266997|NCT02204293|3942028|FG002|Core Study Part I|Met one or more exclusion criteria|0
2266998|NCT02204293|3942029|FG003|Core Study Part I|Met one or more exclusion criteria|0
2266999|NCT02204293|3942030|FG004|Core Study Part I|Met one or more exclusion criteria|0
2267000|NCT02204293|3942031|FG005|Core Study Part I|Met one or more exclusion criteria|0
2267001|NCT02204293|3942026|FG000|Core Study Part I|Adverse Event|1
2267002|NCT02204293|3942027|FG001|Core Study Part I|Adverse Event|0
2267003|NCT02204293|3942028|FG002|Core Study Part I|Adverse Event|0
2267004|NCT02204293|3942029|FG003|Core Study Part I|Adverse Event|0
2267005|NCT02204293|3942030|FG004|Core Study Part I|Adverse Event|0
2267006|NCT02204293|3942031|FG005|Core Study Part I|Adverse Event|0
2267007|NCT02204293|3942026|FG000|Core Study Part I|Physician Decision|0
2267008|NCT02204293|3942027|FG001|Core Study Part I|Physician Decision|3
2267009|NCT02204293|3942028|FG002|Core Study Part I|Physician Decision|0
2267010|NCT02204293|3942029|FG003|Core Study Part I|Physician Decision|0
2267011|NCT02204293|3942030|FG004|Core Study Part I|Physician Decision|0
2267012|NCT02204293|3942031|FG005|Core Study Part I|Physician Decision|0
2267013|NCT02204293|3942026|FG000|LTE Phase|Study Suspended|0
2267014|NCT02204293|3942027|FG001|LTE Phase|Study Suspended|0
2267015|NCT02204293|3942028|FG002|LTE Phase|Study Suspended|0
2267016|NCT02204293|3942029|FG003|LTE Phase|Study Suspended|0
2267017|NCT02204293|3942030|FG004|LTE Phase|Study Suspended|0
2267018|NCT02204293|3942031|FG005|LTE Phase|Study Suspended|7
2267019|NCT02204319|3942045|FG000|Overall Study|Pregnancy|1
2267020|NCT02204319|3942045|FG000|Overall Study|Withdrawal by Subject|2
2267021|NCT02204371|3942050|FG000|Overall Study|Adverse Event|1
2267022|NCT02204410|3942054|FG000|Overall Study|Lost to Follow-up|5
2267023|NCT02204410|3942054|FG000|Overall Study|Physician Decision|2
2267024|NCT02204410|3942054|FG000|Overall Study|Protocol Violation|1
2267025|NCT02204410|3942054|FG000|Overall Study|Withdrawal by Subject|3
2267026|NCT02204449|3942060|FG000|Overall Study|Lost to Follow-up|7
2267027|NCT02204449|3942061|FG001|Overall Study|Lost to Follow-up|9
2267028|NCT02204449|3942060|FG000|Overall Study|Death|0
2267029|NCT02204449|3942061|FG001|Overall Study|Death|1
2267030|NCT02204449|3942060|FG000|Overall Study|Withdrawal by Subject|0
2267031|NCT02204449|3942061|FG001|Overall Study|Withdrawal by Subject|1
2267032|NCT02204579|3942071|FG000|Overall Study|Screen failures|2
2267033|NCT02204917|3942097|FG000|Overall Study|Protocol Violation|1
2267034|NCT02204982|3942106|FG000|Overall Study|Patient ineligible-medical monitor|1
2267035|NCT02204982|3942107|FG001|Overall Study|Patient ineligible-medical monitor|0
2267036|NCT02204982|3942106|FG000|Overall Study|Withdrawal by Subject|1
2267037|NCT02204982|3942107|FG001|Overall Study|Withdrawal by Subject|0
2267038|NCT02204982|3942106|FG000|Overall Study|Adverse Event|1
2267039|NCT02204982|3942107|FG001|Overall Study|Adverse Event|0
2267040|NCT02204982|3942106|FG000|Overall Study|Adverse Event and Investigator decision|1
2267041|NCT02204982|3942107|FG001|Overall Study|Adverse Event and Investigator decision|0
2267042|NCT02204982|3942106|FG000|Overall Study|Physician Decision|0
2267043|NCT02204982|3942107|FG001|Overall Study|Physician Decision|2
2267044|NCT02204982|3942106|FG000|Overall Study|Protocol-Specified Disease Progression|0
2267045|NCT02204982|3942107|FG001|Overall Study|Protocol-Specified Disease Progression|4
2267046|NCT02204982|3942106|FG000|Overall Study|Termination of Study bySponsor|0
2267047|NCT02204982|3942107|FG001|Overall Study|Termination of Study bySponsor|1
2267048|NCT02205333|3942141|FG000|Overall Study|Death|5
2267049|NCT02205333|3942142|FG001|Overall Study|Death|6
2267050|NCT02205333|3942143|FG002|Overall Study|Death|2
2267051|NCT02205333|3942144|FG003|Overall Study|Death|6
2267052|NCT02205333|3942145|FG004|Overall Study|Death|5
2267053|NCT02205333|3942146|FG005|Overall Study|Death|3
2267054|NCT02205333|3942147|FG006|Overall Study|Death|3
2267055|NCT02205333|3942148|FG007|Overall Study|Death|2
2267056|NCT02205333|3942149|FG008|Overall Study|Death|0
2267057|NCT02205333|3942141|FG000|Overall Study|Withdrawal by Subject|1
2267058|NCT02205333|3942142|FG001|Overall Study|Withdrawal by Subject|0
2267059|NCT02205333|3942143|FG002|Overall Study|Withdrawal by Subject|0
2267060|NCT02205333|3942144|FG003|Overall Study|Withdrawal by Subject|1
2267061|NCT02205333|3942145|FG004|Overall Study|Withdrawal by Subject|0
2267062|NCT02205333|3942146|FG005|Overall Study|Withdrawal by Subject|0
2267063|NCT02205333|3942147|FG006|Overall Study|Withdrawal by Subject|2
2267064|NCT02205333|3942148|FG007|Overall Study|Withdrawal by Subject|0
2267065|NCT02205333|3942149|FG008|Overall Study|Withdrawal by Subject|0
2267066|NCT02205476|3942171|FG000|Overall Study|Study termination by Sponsor|7
2267067|NCT02205476|3942172|FG001|Overall Study|Study termination by Sponsor|3
2267068|NCT02205814|3942205|FG000|Overall Study|Lost to Follow-up|0
2267069|NCT02205814|3942206|FG001|Overall Study|Lost to Follow-up|0
2267070|NCT02205814|3942207|FG002|Overall Study|Lost to Follow-up|0
2267071|NCT02205814|3942208|FG003|Overall Study|Lost to Follow-up|1
2267072|NCT02205814|3942205|FG000|Overall Study|Lack of Efficacy|1
2348296|NCT03772587|4087674|FG000|Overall Study|Withdrawal by Subject|1
2348297|NCT03772587|4087675|FG001|Overall Study|Withdrawal by Subject|0
2348298|NCT03772587|4087676|FG002|Overall Study|Withdrawal by Subject|0
2267073|NCT02205814|3942206|FG001|Overall Study|Lack of Efficacy|0
2267074|NCT02205814|3942207|FG002|Overall Study|Lack of Efficacy|1
2348299|NCT03772587|4087677|FG003|Overall Study|Withdrawal by Subject|0
2267075|NCT02205814|3942208|FG003|Overall Study|Lack of Efficacy|1
2267076|NCT02205814|3942205|FG000|Overall Study|Physician Decision|0
2267077|NCT02205814|3942206|FG001|Overall Study|Physician Decision|0
2267078|NCT02205814|3942207|FG002|Overall Study|Physician Decision|1
2267079|NCT02205814|3942208|FG003|Overall Study|Physician Decision|0
2267080|NCT02205814|3942205|FG000|Overall Study|Protocol Violation|1
2267081|NCT02205814|3942206|FG001|Overall Study|Protocol Violation|0
2267082|NCT02205814|3942207|FG002|Overall Study|Protocol Violation|0
2267083|NCT02205814|3942208|FG003|Overall Study|Protocol Violation|1
2267084|NCT02205814|3942205|FG000|Overall Study|Withdrawal by Subject|0
2267085|NCT02205814|3942206|FG001|Overall Study|Withdrawal by Subject|1
2267086|NCT02205814|3942207|FG002|Overall Study|Withdrawal by Subject|2
2267087|NCT02205814|3942208|FG003|Overall Study|Withdrawal by Subject|1
2267088|NCT02205814|3942205|FG000|Overall Study|not compliant with study procedures|0
2267089|NCT02205814|3942206|FG001|Overall Study|not compliant with study procedures|0
2267090|NCT02205814|3942207|FG002|Overall Study|not compliant with study procedures|1
2267091|NCT02205814|3942208|FG003|Overall Study|not compliant with study procedures|0
2267092|NCT02206061|3942238|FG000|Overall Study|Withdrawal by Subject|4
2267093|NCT02206061|3942239|FG001|Overall Study|Withdrawal by Subject|7
2267094|NCT02206061|3942240|FG002|Overall Study|Withdrawal by Subject|1
2267095|NCT02206061|3942238|FG000|Overall Study|Lost to Follow-up|14
2267096|NCT02206061|3942239|FG001|Overall Study|Lost to Follow-up|7
2267097|NCT02206061|3942240|FG002|Overall Study|Lost to Follow-up|20
2267098|NCT02206152|3942248|FG000|Pre-Randomization|Withdrawal by Subject|2
2267099|NCT02206607|3942263|FG000|Open-Label Run-In|Withdrawal by Subject|3
2267100|NCT02206607|3942264|FG001|Open-Label Run-In|Withdrawal by Subject|0
2267101|NCT02206607|3942265|FG002|Open-Label Run-In|Withdrawal by Subject|0
2267102|NCT02206607|3942266|FG003|Open-Label Run-In|Withdrawal by Subject|0
2267103|NCT02206607|3942267|FG004|Open-Label Run-In|Withdrawal by Subject|0
2267104|NCT02206607|3942263|FG000|Second Intervention Period|Insufficient Clinical Response|0
2267105|NCT02206607|3942264|FG001|Second Intervention Period|Insufficient Clinical Response|0
2267106|NCT02206607|3942265|FG002|Second Intervention Period|Insufficient Clinical Response|0
2267107|NCT02206607|3942266|FG003|Second Intervention Period|Insufficient Clinical Response|1
2267108|NCT02206607|3942267|FG004|Second Intervention Period|Insufficient Clinical Response|0
2267109|NCT02206620|3942283|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
2267110|NCT02206620|3942284|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
2267111|NCT02206620|3942283|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
2267112|NCT02206620|3942284|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
2267113|NCT02206685|3942298|FG000|Overall Study|Surgery cancelled/changed|2
2267114|NCT02206685|3942299|FG001|Overall Study|Surgery cancelled/changed|3
2267115|NCT02206685|3942298|FG000|Overall Study|Withdrawal by Subject|1
2267116|NCT02206685|3942299|FG001|Overall Study|Withdrawal by Subject|2
2348300|NCT03772587|4087678|FG004|Overall Study|Withdrawal by Subject|0
2348301|NCT03789292|4087702|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7
2348302|NCT03789292|4087703|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8
2348303|NCT03789292|4087704|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0
2348304|NCT03789292|4087702|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2
2348305|NCT03789292|4087703|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
2348306|NCT03789292|4087704|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
2348307|NCT03789292|4087702|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1
2348308|NCT03789292|4087703|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
2348309|NCT03789292|4087704|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
2348310|NCT03789292|4087702|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
2348311|NCT03789292|4087703|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
2348312|NCT03789292|4087704|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0
2348313|NCT03789292|4087702|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9
2348314|NCT03789292|4087703|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8
2348315|NCT03789292|4087704|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0
2348316|NCT03789292|4087702|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1
2348317|NCT03789292|4087703|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
2348318|NCT03789292|4087704|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
2348319|NCT03789292|4087702|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0
2348320|NCT03789292|4087703|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2
2348321|NCT03789292|4087704|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0
2348322|NCT03789292|4087702|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
2348323|NCT03789292|4087703|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
2348324|NCT03789292|4087704|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6
2348325|NCT03789292|4087702|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
2348326|NCT03789292|4087703|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
2348327|NCT03789292|4087704|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1
2348328|NCT03789292|4087702|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1
2348329|NCT03789292|4087703|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
2348330|NCT03789292|4087704|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
2348331|NCT03789292|4087702|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9
2267117|NCT02206685|3942298|FG000|Overall Study|Protocol Violation|2
2267118|NCT02206685|3942299|FG001|Overall Study|Protocol Violation|2
2267119|NCT02206828|3942314|FG000|Overall Study|Lost to Follow-up|7
2267120|NCT02207088|3942341|FG000|Overall Study|Adverse Event|2
2267121|NCT02207231|3942348|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
2267122|NCT02207231|3942349|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
2267123|NCT02207231|3942350|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
2267124|NCT02207231|3942351|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2267125|NCT02207231|3942348|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
2267126|NCT02207231|3942349|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2267127|NCT02207231|3942350|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
2267128|NCT02207231|3942351|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2267129|NCT02207231|3942348|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
2267130|NCT02207231|3942349|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
2267131|NCT02207231|3942350|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
2267132|NCT02207231|3942351|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2267133|NCT02207231|3942348|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
2267134|NCT02207231|3942349|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2267135|NCT02207231|3942350|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
2267136|NCT02207231|3942351|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2267137|NCT02207231|3942348|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2267138|NCT02207231|3942349|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2267139|NCT02207231|3942350|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
2267140|NCT02207231|3942351|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2267141|NCT02207231|3942348|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
2267142|NCT02207231|3942349|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
2267143|NCT02207231|3942350|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
2267144|NCT02207231|3942351|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
2267145|NCT02207231|3942348|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1
2267146|NCT02207231|3942349|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6
2348332|NCT03789292|4087703|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
2348333|NCT03789292|4087704|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
2348334|NCT03789292|4087702|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1
2348335|NCT03789292|4087703|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
2348336|NCT03789292|4087704|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
2348337|NCT03789292|4087702|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2
2348338|NCT03789292|4087703|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1
2348339|NCT03789292|4087704|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0
2348340|NCT03805438|4087731|FG000|Overall Study|Lack of Efficacy|1
2348341|NCT03805438|4087731|FG000|Overall Study|Protocol Violation|1
2348342|NCT03812224|4087745|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
2348343|NCT03812224|4087746|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
2348344|NCT03812224|4087745|FG000|Double-blind Treatment Period|Decision by Sponsor|0
2348345|NCT03812224|4087746|FG001|Double-blind Treatment Period|Decision by Sponsor|1
2348346|NCT03812224|4087745|FG000|Open-label Treatment Period|Withdrawal by Subject|2
2348347|NCT03812224|4087746|FG001|Open-label Treatment Period|Withdrawal by Subject|2
2348348|NCT03812224|4087745|FG000|Open-label Treatment Period|Decision by Sponsor|0
2348349|NCT03812224|4087746|FG001|Open-label Treatment Period|Decision by Sponsor|1
2348350|NCT03817528|4087753|FG000|Overall Study|Withdrawal by Subject|1
2348351|NCT03817528|4087753|FG000|Overall Study|Adverse Event|2
2348352|NCT03829228|4087780|FG000|Overall Study|Protocol Violation|1
2348353|NCT03830333|4087799|FG000|Overall Study|Death|0
2348354|NCT03830333|4087800|FG001|Overall Study|Death|1
2348355|NCT03830333|4087799|FG000|Overall Study|Withdrawal by Subject|5
2348356|NCT03830333|4087800|FG001|Overall Study|Withdrawal by Subject|1
2348357|NCT03830333|4087799|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3
2348358|NCT03830333|4087800|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2
2348359|NCT03831880|4087808|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0
2348360|NCT03831880|4087809|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1
2348361|NCT03831880|4087808|FG000|Period 2 (12 Weeks)|Protocol Deviation|0
2348362|NCT03831880|4087809|FG001|Period 2 (12 Weeks)|Protocol Deviation|1
2348363|NCT03831945|4087819|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
2348364|NCT03831945|4087820|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
2348365|NCT03831945|4087819|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
2348366|NCT03831945|4087820|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
2348367|NCT03831945|4087819|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2
2348368|NCT03831945|4087820|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1
2267147|NCT02207231|3942350|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10
2267148|NCT02207231|3942351|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0
2267149|NCT02207231|3942348|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0
2267150|NCT02207231|3942349|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0
2267151|NCT02207231|3942350|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1
2267152|NCT02207231|3942351|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0
2267153|NCT02207231|3942348|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
2267154|NCT02207231|3942349|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
2267155|NCT02207231|3942350|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
2267156|NCT02207231|3942351|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
2267157|NCT02207231|3942348|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
2267158|NCT02207231|3942349|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
2267159|NCT02207231|3942350|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
2267160|NCT02207231|3942351|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0
2267161|NCT02207231|3942348|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
2267162|NCT02207231|3942349|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
2267163|NCT02207231|3942350|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
2267164|NCT02207231|3942351|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0
2267165|NCT02207231|3942348|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0
2267166|NCT02207231|3942349|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1
2267167|NCT02207231|3942350|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0
2267168|NCT02207231|3942351|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0
2267169|NCT02207231|3942348|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0
2267170|NCT02207231|3942349|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3
2348369|NCT03840174|4087839|FG000|Overall Study|Withdrawal by Subject|1
2348370|NCT03840174|4087840|FG001|Overall Study|Withdrawal by Subject|0
2348371|NCT03840174|4087841|FG002|Overall Study|Withdrawal by Subject|0
2348372|NCT03840174|4087842|FG003|Overall Study|Withdrawal by Subject|0
2348373|NCT03857841|4087871|FG000|Overall Study|Death|1
2348374|NCT03857841|4087872|FG001|Overall Study|Death|0
2348375|NCT03857841|4087873|FG002|Overall Study|Death|0
2348376|NCT03857841|4087874|FG003|Overall Study|Death|0
2348377|NCT03857841|4087871|FG000|Overall Study|Study Terminated by Sponsor|1
2348378|NCT03857841|4087872|FG001|Overall Study|Study Terminated by Sponsor|0
2348379|NCT03857841|4087873|FG002|Overall Study|Study Terminated by Sponsor|0
2348380|NCT03857841|4087874|FG003|Overall Study|Study Terminated by Sponsor|0
2348381|NCT03862625|4087899|FG000|Overall Study|Lost to Follow-up|0
2348382|NCT03862625|4087900|FG001|Overall Study|Lost to Follow-up|1
2348383|NCT03877224|4087928|FG000|Overall Study|Death|3
2348384|NCT03877224|4087929|FG001|Overall Study|Death|2
2348385|NCT03877224|4087928|FG000|Overall Study|Withdrawal by Subject|1
2348386|NCT03877224|4087929|FG001|Overall Study|Withdrawal by Subject|6
2348387|NCT03877224|4087928|FG000|Overall Study|Participant is alive, just unable to come for visits|1
2348388|NCT03877224|4087929|FG001|Overall Study|Participant is alive, just unable to come for visits|0
2348389|NCT03880565|4087937|FG000|Overall Study|Withdrawal by Subject|1
2348390|NCT03880565|4087938|FG001|Overall Study|Withdrawal by Subject|0
2348391|NCT03885596|4087957|FG000|Overall Study|Withdrawal by Subject|2
2348392|NCT03885596|4087958|FG001|Overall Study|Withdrawal by Subject|1
2348393|NCT03885596|4087959|FG002|Overall Study|Withdrawal by Subject|0
2348394|NCT03885596|4087960|FG003|Overall Study|Withdrawal by Subject|0
2348395|NCT03885661|4087975|FG000|Overall Study|Withdrawal by Subject|0
2348396|NCT03885661|4087976|FG001|Overall Study|Withdrawal by Subject|1
2348397|NCT03885661|4087975|FG000|Overall Study|Unwilling to undergo required study procedure|1
2348398|NCT03885661|4087976|FG001|Overall Study|Unwilling to undergo required study procedure|0
2348399|NCT03886493|4087982|FG000|Overall Study|Adverse Event|1
2348400|NCT03888235|4087989|FG000|Overall Study|Lost to Follow-up|1
2348401|NCT03888235|4087990|FG001|Overall Study|Lost to Follow-up|1
2348402|NCT03888235|4087991|FG002|Overall Study|Lost to Follow-up|0
2348403|NCT03900416|4088063|FG000|Six Week Follow-up|Lost to Follow-up|1
2348404|NCT03900416|4088064|FG001|Six Week Follow-up|Lost to Follow-up|0
2348405|NCT03900416|4088063|FG000|Six Week Follow-up|Withdrawal by Subject|1
2348406|NCT03900416|4088064|FG001|Six Week Follow-up|Withdrawal by Subject|0
2348407|NCT03900416|4088063|FG000|Twelve Week Follow-up|Lost to Follow-up|0
2348408|NCT03900416|4088064|FG001|Twelve Week Follow-up|Lost to Follow-up|2
2348409|NCT03900416|4088063|FG000|Twelve Week Follow-up|Withdrawal by Subject|0
2348410|NCT03900416|4088064|FG001|Twelve Week Follow-up|Withdrawal by Subject|1
2348411|NCT03900416|4088063|FG000|Twelve Week Follow-up|Adverse Event|1
2348412|NCT03900416|4088064|FG001|Twelve Week Follow-up|Adverse Event|1
2348413|NCT03900416|4088063|FG000|Six Month Follow-up|Lost to Follow-up|4
2348414|NCT03900416|4088064|FG001|Six Month Follow-up|Lost to Follow-up|3
2348415|NCT03900416|4088063|FG000|Six Month Follow-up|Withdrawal by Subject|1
2348416|NCT03900416|4088064|FG001|Six Month Follow-up|Withdrawal by Subject|1
2348417|NCT03905863|4088072|FG000|Overall Study|Adverse Event|2
2348418|NCT03905863|4088073|FG001|Overall Study|Adverse Event|4
2348419|NCT03905863|4088072|FG000|Overall Study|Withdrawal by Subject|2
2348420|NCT03905863|4088073|FG001|Overall Study|Withdrawal by Subject|2
2348421|NCT03905863|4088072|FG000|Overall Study|Physician Decision|0
2348422|NCT03905863|4088073|FG001|Overall Study|Physician Decision|3
2267171|NCT02207231|3942350|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3
2267172|NCT02207231|3942351|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0
2267173|NCT02207231|3942348|FG000|Active Controlled Period: Week 16 - 48|Other|0
2267174|NCT02207231|3942349|FG001|Active Controlled Period: Week 16 - 48|Other|2
2267175|NCT02207231|3942350|FG002|Active Controlled Period: Week 16 - 48|Other|3
2267176|NCT02207231|3942351|FG003|Active Controlled Period: Week 16 - 48|Other|0
2267177|NCT02207231|3942348|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
2267178|NCT02207231|3942349|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
2267179|NCT02207231|3942350|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12
2267180|NCT02207231|3942351|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19
2267181|NCT02207231|3942348|FG000|Open-label Guselkumab: Week 48 - 264|Death|0
2267182|NCT02207231|3942349|FG001|Open-label Guselkumab: Week 48 - 264|Death|0
2267183|NCT02207231|3942350|FG002|Open-label Guselkumab: Week 48 - 264|Death|1
2267184|NCT02207231|3942351|FG003|Open-label Guselkumab: Week 48 - 264|Death|3
2267185|NCT02207231|3942348|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
2348423|NCT03905863|4088072|FG000|Overall Study|Lost to Follow-up|1
2348424|NCT03905863|4088073|FG001|Overall Study|Lost to Follow-up|0
2348425|NCT03905863|4088072|FG000|Overall Study|Protocol Violation|0
2348426|NCT03905863|4088073|FG001|Overall Study|Protocol Violation|2
2348427|NCT03905863|4088072|FG000|Overall Study|Death|0
2348428|NCT03905863|4088073|FG001|Overall Study|Death|1
2348429|NCT03909971|4088101|FG000|Overall Study|Other Reasons Not Specified|0
2348430|NCT03909971|4088102|FG001|Overall Study|Other Reasons Not Specified|1
2348431|NCT03909971|4088101|FG000|Overall Study|Global Deterioration of Health Status|2
2348432|NCT03909971|4088102|FG001|Overall Study|Global Deterioration of Health Status|1
2348433|NCT03909971|4088101|FG000|Overall Study|Progressive Disease|6
2348434|NCT03909971|4088102|FG001|Overall Study|Progressive Disease|14
2348435|NCT03909971|4088101|FG000|Overall Study|Death|2
2348436|NCT03909971|4088102|FG001|Overall Study|Death|6
2348437|NCT03920215|4088113|FG000|Overall Study|Lost to Follow-up|1
2348438|NCT03920215|4088114|FG001|Overall Study|Lost to Follow-up|2
2348439|NCT03920215|4088115|FG002|Overall Study|Lost to Follow-up|0
2348440|NCT03920215|4088116|FG003|Overall Study|Lost to Follow-up|0
2348441|NCT03920215|4088113|FG000|Overall Study|Death|0
2348442|NCT03920215|4088114|FG001|Overall Study|Death|0
2348443|NCT03920215|4088115|FG002|Overall Study|Death|0
2348444|NCT03920215|4088116|FG003|Overall Study|Death|1
2267186|NCT02207231|3942349|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
2267187|NCT02207231|3942350|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3
2267188|NCT02207231|3942351|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7
2267189|NCT02207231|3942348|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
2267190|NCT02207231|3942349|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
2267191|NCT02207231|3942350|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2
2267192|NCT02207231|3942351|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4
2267193|NCT02207231|3942348|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
2267194|NCT02207231|3942349|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
2267195|NCT02207231|3942350|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6
2267196|NCT02207231|3942351|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11
2267197|NCT02207231|3942348|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
2267198|NCT02207231|3942349|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
2267199|NCT02207231|3942350|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10
2267200|NCT02207231|3942351|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28
2267201|NCT02207231|3942348|FG000|Open-label Guselkumab: Week 48 - 264|Other|0
2267202|NCT02207231|3942349|FG001|Open-label Guselkumab: Week 48 - 264|Other|0
2267203|NCT02207231|3942350|FG002|Open-label Guselkumab: Week 48 - 264|Other|4
2267204|NCT02207231|3942351|FG003|Open-label Guselkumab: Week 48 - 264|Other|11
2267205|NCT02207244|3942372|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2
2267206|NCT02207244|3942373|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9
2267207|NCT02207244|3942374|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4
2267208|NCT02207244|3942375|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0
2267209|NCT02207244|3942376|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0
2267210|NCT02207244|3942377|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0
2267211|NCT02207244|3942378|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0
2267212|NCT02207244|3942379|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0
2267213|NCT02207244|3942380|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0
2267214|NCT02207244|3942381|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0
2267215|NCT02207244|3942382|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0
2267216|NCT02207244|3942372|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4
2267217|NCT02207244|3942373|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
2267218|NCT02207244|3942374|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2
2267219|NCT02207244|3942375|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
2267220|NCT02207244|3942376|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
2267221|NCT02207244|3942377|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
2267222|NCT02207244|3942378|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
2348445|NCT03921151|4088128|FG000|Overall Study|Withdrawal by Subject|11
2267223|NCT02207244|3942379|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
2267224|NCT02207244|3942380|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
2267225|NCT02207244|3942381|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
2267226|NCT02207244|3942382|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
2267227|NCT02207244|3942372|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1
2267228|NCT02207244|3942373|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3
2267229|NCT02207244|3942374|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2
2267230|NCT02207244|3942375|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
2267231|NCT02207244|3942376|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
2267232|NCT02207244|3942377|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
2267233|NCT02207244|3942378|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
2267234|NCT02207244|3942379|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
2267235|NCT02207244|3942380|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
2267236|NCT02207244|3942381|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
2267237|NCT02207244|3942382|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
2267238|NCT02207244|3942372|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7
2267239|NCT02207244|3942373|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1
2267240|NCT02207244|3942374|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
2267241|NCT02207244|3942375|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
2267242|NCT02207244|3942376|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
2267243|NCT02207244|3942377|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
2267244|NCT02207244|3942378|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
2267245|NCT02207244|3942379|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
2267246|NCT02207244|3942380|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
2267247|NCT02207244|3942381|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
2267248|NCT02207244|3942382|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
2267249|NCT02207244|3942372|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1
2267250|NCT02207244|3942373|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3
2267251|NCT02207244|3942374|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1
2267252|NCT02207244|3942375|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0
2267253|NCT02207244|3942376|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0
2267254|NCT02207244|3942377|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0
2267255|NCT02207244|3942378|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0
2267256|NCT02207244|3942379|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0
2267257|NCT02207244|3942380|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0
2267258|NCT02207244|3942381|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0
2267259|NCT02207244|3942382|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0
2267260|NCT02207244|3942372|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0
2267261|NCT02207244|3942373|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1
2267262|NCT02207244|3942374|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2
2267263|NCT02207244|3942375|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0
2267264|NCT02207244|3942376|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0
2267265|NCT02207244|3942377|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0
2267266|NCT02207244|3942378|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0
2267267|NCT02207244|3942379|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0
2267268|NCT02207244|3942380|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0
2348446|NCT03921151|4088129|FG001|Overall Study|Withdrawal by Subject|16
2348447|NCT03927911|4088150|FG000|Overall Study|problems with eDiary|0
2348448|NCT03927911|4088151|FG001|Overall Study|problems with eDiary|1
2348449|NCT03927911|4088152|FG002|Overall Study|problems with eDiary|0
2348450|NCT03927911|4088153|FG003|Overall Study|problems with eDiary|1
2348451|NCT03927911|4088154|FG004|Overall Study|problems with eDiary|0
2348452|NCT03927911|4088155|FG005|Overall Study|problems with eDiary|4
2348453|NCT03927911|4088150|FG000|Overall Study|Adverse Event|0
2348454|NCT03927911|4088151|FG001|Overall Study|Adverse Event|0
2348455|NCT03927911|4088152|FG002|Overall Study|Adverse Event|0
2348456|NCT03927911|4088153|FG003|Overall Study|Adverse Event|0
2348457|NCT03927911|4088154|FG004|Overall Study|Adverse Event|0
2348458|NCT03927911|4088155|FG005|Overall Study|Adverse Event|1
2348459|NCT03927911|4088150|FG000|Overall Study|not treated -study terminated by sponsor|0
2348460|NCT03927911|4088151|FG001|Overall Study|not treated -study terminated by sponsor|1
2348461|NCT03927911|4088152|FG002|Overall Study|not treated -study terminated by sponsor|0
2348462|NCT03927911|4088153|FG003|Overall Study|not treated -study terminated by sponsor|0
2348463|NCT03927911|4088154|FG004|Overall Study|not treated -study terminated by sponsor|0
2348464|NCT03927911|4088155|FG005|Overall Study|not treated -study terminated by sponsor|0
2348465|NCT03927911|4088150|FG000|Overall Study|Surgery cancelled|0
2348466|NCT03927911|4088151|FG001|Overall Study|Surgery cancelled|0
2348467|NCT03927911|4088152|FG002|Overall Study|Surgery cancelled|0
2348468|NCT03927911|4088153|FG003|Overall Study|Surgery cancelled|1
2348469|NCT03927911|4088154|FG004|Overall Study|Surgery cancelled|0
2348470|NCT03927911|4088155|FG005|Overall Study|Surgery cancelled|1
2348471|NCT03927911|4088150|FG000|Overall Study|Protocol Violation|0
2348472|NCT03927911|4088151|FG001|Overall Study|Protocol Violation|0
2267269|NCT02207244|3942381|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0
2267270|NCT02207244|3942382|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0
2267271|NCT02207244|3942372|FG000|Placebo Controlled Period: Week 0-16|OTHER|0
2267272|NCT02207244|3942373|FG001|Placebo Controlled Period: Week 0-16|OTHER|1
2267273|NCT02207244|3942374|FG002|Placebo Controlled Period: Week 0-16|OTHER|0
2267274|NCT02207244|3942375|FG003|Placebo Controlled Period: Week 0-16|OTHER|0
2267275|NCT02207244|3942376|FG004|Placebo Controlled Period: Week 0-16|OTHER|0
2267276|NCT02207244|3942377|FG005|Placebo Controlled Period: Week 0-16|OTHER|0
2267277|NCT02207244|3942378|FG006|Placebo Controlled Period: Week 0-16|OTHER|0
2267278|NCT02207244|3942379|FG007|Placebo Controlled Period: Week 0-16|OTHER|0
2267279|NCT02207244|3942380|FG008|Placebo Controlled Period: Week 0-16|OTHER|0
2267280|NCT02207244|3942381|FG009|Placebo Controlled Period: Week 0-16|OTHER|0
2267281|NCT02207244|3942382|FG010|Placebo Controlled Period: Week 0-16|OTHER|0
2267282|NCT02207244|3942372|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
2267283|NCT02207244|3942373|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
2267284|NCT02207244|3942374|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
2267285|NCT02207244|3942375|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
2267286|NCT02207244|3942376|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3
2267287|NCT02207244|3942377|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2
2267288|NCT02207244|3942378|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
2267289|NCT02207244|3942379|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
2267290|NCT02207244|3942380|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
2267291|NCT02207244|3942381|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
2267292|NCT02207244|3942382|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
2267293|NCT02207244|3942372|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
2267294|NCT02207244|3942373|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
2267295|NCT02207244|3942374|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
2267296|NCT02207244|3942375|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
2267297|NCT02207244|3942376|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
2267298|NCT02207244|3942377|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2
2267299|NCT02207244|3942378|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
2267300|NCT02207244|3942379|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
2267301|NCT02207244|3942380|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
2267302|NCT02207244|3942381|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
2267303|NCT02207244|3942382|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
2267304|NCT02207244|3942372|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
2267305|NCT02207244|3942373|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
2267306|NCT02207244|3942374|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
2267307|NCT02207244|3942375|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1
2267308|NCT02207244|3942376|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
2267309|NCT02207244|3942377|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
2267310|NCT02207244|3942378|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
2267311|NCT02207244|3942379|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
2267312|NCT02207244|3942380|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
2267313|NCT02207244|3942381|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
2267314|NCT02207244|3942382|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
2267315|NCT02207244|3942372|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
2267316|NCT02207244|3942373|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
2267317|NCT02207244|3942374|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
2267318|NCT02207244|3942375|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
2267319|NCT02207244|3942376|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
2267320|NCT02207244|3942377|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2
2267321|NCT02207244|3942378|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
2267322|NCT02207244|3942379|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
2267323|NCT02207244|3942380|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
2267324|NCT02207244|3942381|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
2267325|NCT02207244|3942382|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
2267326|NCT02207244|3942372|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
2267327|NCT02207244|3942373|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
2267328|NCT02207244|3942374|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
2267329|NCT02207244|3942375|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
2267330|NCT02207244|3942376|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
2267331|NCT02207244|3942377|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
2267332|NCT02207244|3942378|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
2267333|NCT02207244|3942379|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
2267334|NCT02207244|3942380|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
2267335|NCT02207244|3942381|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
2267336|NCT02207244|3942382|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
2267337|NCT02207244|3942372|FG000|Placebo Crossover and ACP: Week 16-28|Other|0
2348473|NCT03927911|4088152|FG002|Overall Study|Protocol Violation|0
2267338|NCT02207244|3942373|FG001|Placebo Crossover and ACP: Week 16-28|Other|0
2267339|NCT02207244|3942374|FG002|Placebo Crossover and ACP: Week 16-28|Other|0
2267340|NCT02207244|3942375|FG003|Placebo Crossover and ACP: Week 16-28|Other|1
2267341|NCT02207244|3942376|FG004|Placebo Crossover and ACP: Week 16-28|Other|0
2267342|NCT02207244|3942377|FG005|Placebo Crossover and ACP: Week 16-28|Other|0
2267343|NCT02207244|3942378|FG006|Placebo Crossover and ACP: Week 16-28|Other|0
2267344|NCT02207244|3942379|FG007|Placebo Crossover and ACP: Week 16-28|Other|0
2267345|NCT02207244|3942380|FG008|Placebo Crossover and ACP: Week 16-28|Other|0
2267346|NCT02207244|3942381|FG009|Placebo Crossover and ACP: Week 16-28|Other|0
2267347|NCT02207244|3942382|FG010|Placebo Crossover and ACP: Week 16-28|Other|0
2267348|NCT02207244|3942372|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
2267349|NCT02207244|3942373|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
2267350|NCT02207244|3942374|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
2267351|NCT02207244|3942375|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
2267352|NCT02207244|3942376|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
2267353|NCT02207244|3942377|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
2267354|NCT02207244|3942378|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1
2267355|NCT02207244|3942379|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5
2267356|NCT02207244|3942380|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3
2267357|NCT02207244|3942381|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2
2267358|NCT02207244|3942382|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
2267359|NCT02207244|3942372|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
2267360|NCT02207244|3942373|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
2267361|NCT02207244|3942374|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
2267362|NCT02207244|3942375|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
2267363|NCT02207244|3942376|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
2267364|NCT02207244|3942377|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
2267365|NCT02207244|3942378|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
2267366|NCT02207244|3942379|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2
2267367|NCT02207244|3942380|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
2267368|NCT02207244|3942381|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
2267369|NCT02207244|3942382|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
2267370|NCT02207244|3942372|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
2267371|NCT02207244|3942373|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
2267372|NCT02207244|3942374|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
2267373|NCT02207244|3942375|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
2267374|NCT02207244|3942376|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
2267375|NCT02207244|3942377|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
2267376|NCT02207244|3942378|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1
2267377|NCT02207244|3942379|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3
2267378|NCT02207244|3942380|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
2267379|NCT02207244|3942381|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
2267380|NCT02207244|3942382|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
2267381|NCT02207244|3942372|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
2267382|NCT02207244|3942373|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
2267383|NCT02207244|3942374|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
2267384|NCT02207244|3942375|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
2267385|NCT02207244|3942376|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
2267386|NCT02207244|3942377|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
2267387|NCT02207244|3942378|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
2267388|NCT02207244|3942379|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7
2267389|NCT02207244|3942380|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
2267390|NCT02207244|3942381|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
2267391|NCT02207244|3942382|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
2267392|NCT02207244|3942372|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
2267393|NCT02207244|3942373|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
2348474|NCT03927911|4088153|FG003|Overall Study|Protocol Violation|0
2348475|NCT03927911|4088154|FG004|Overall Study|Protocol Violation|0
2348476|NCT03927911|4088155|FG005|Overall Study|Protocol Violation|1
2348477|NCT03938857|4088182|FG000|Overall Study|Physician Decision|1
2348478|NCT03938857|4088183|FG001|Overall Study|Physician Decision|0
2348479|NCT03938857|4088184|FG002|Overall Study|Physician Decision|0
2348480|NCT03938857|4088185|FG003|Overall Study|Physician Decision|0
2348481|NCT03945981|4088199|FG000|Overall Study|Lost to Follow-up|12
2348482|NCT03945981|4088199|FG000|Overall Study|Physician Decision|4
2348483|NCT03945981|4088199|FG000|Overall Study|Withdrawal by Subject|6
2348484|NCT03945981|4088199|FG000|Overall Study|Protocol Violation|1
2348485|NCT03950674|4088214|FG000|Overall Study|Death|3
2348486|NCT03950674|4088215|FG001|Overall Study|Death|7
2348487|NCT03950674|4088214|FG000|Overall Study|Ongoing in Study|22
2348488|NCT03950674|4088215|FG001|Overall Study|Ongoing in Study|8
2348489|NCT03954834|4088226|FG000|Overall Study|Adverse Event|1
2348490|NCT03954834|4088227|FG001|Overall Study|Adverse Event|3
2348491|NCT03954834|4088228|FG002|Overall Study|Adverse Event|1
2348492|NCT03954834|4088229|FG003|Overall Study|Adverse Event|1
2267394|NCT02207244|3942374|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
2267395|NCT02207244|3942375|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
2267396|NCT02207244|3942376|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
2267397|NCT02207244|3942377|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
2267398|NCT02207244|3942378|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
2267399|NCT02207244|3942379|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7
2267400|NCT02207244|3942380|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
2267401|NCT02207244|3942381|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
2267402|NCT02207244|3942382|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
2267403|NCT02207244|3942372|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
2267404|NCT02207244|3942373|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
2267405|NCT02207244|3942374|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
2267406|NCT02207244|3942375|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
2267407|NCT02207244|3942376|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
2267408|NCT02207244|3942377|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
2267409|NCT02207244|3942378|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
2267410|NCT02207244|3942379|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
2267411|NCT02207244|3942380|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
2267412|NCT02207244|3942381|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
2267413|NCT02207244|3942382|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
2267414|NCT02207244|3942372|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
2267415|NCT02207244|3942373|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
2267416|NCT02207244|3942374|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
2267417|NCT02207244|3942375|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
2267418|NCT02207244|3942376|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
2267419|NCT02207244|3942377|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
2267420|NCT02207244|3942378|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
2267421|NCT02207244|3942379|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
2267422|NCT02207244|3942380|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1
2267423|NCT02207244|3942381|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
2267424|NCT02207244|3942382|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
2267425|NCT02207244|3942372|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0
2267426|NCT02207244|3942373|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0
2267427|NCT02207244|3942374|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0
2267428|NCT02207244|3942375|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0
2267429|NCT02207244|3942376|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0
2267430|NCT02207244|3942377|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0
2267431|NCT02207244|3942378|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0
2267432|NCT02207244|3942379|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2
2267433|NCT02207244|3942380|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0
2267434|NCT02207244|3942381|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0
2267435|NCT02207244|3942382|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0
2267436|NCT02207244|3942372|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
2267437|NCT02207244|3942373|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
2267438|NCT02207244|3942374|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
2267439|NCT02207244|3942375|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
2267440|NCT02207244|3942376|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
2267441|NCT02207244|3942377|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
2267442|NCT02207244|3942378|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8
2267443|NCT02207244|3942379|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
2267444|NCT02207244|3942380|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
2267445|NCT02207244|3942381|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
2267446|NCT02207244|3942382|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
2267447|NCT02207244|3942372|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
2267448|NCT02207244|3942373|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
2267449|NCT02207244|3942374|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
2267450|NCT02207244|3942375|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
2267451|NCT02207244|3942376|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
2267452|NCT02207244|3942377|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
2267453|NCT02207244|3942378|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
2267454|NCT02207244|3942379|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
2267455|NCT02207244|3942380|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10
2267456|NCT02207244|3942381|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
2267457|NCT02207244|3942382|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30
2267458|NCT02207244|3942372|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
2267459|NCT02207244|3942373|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
2267460|NCT02207244|3942374|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
2267461|NCT02207244|3942375|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
2267462|NCT02207244|3942376|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
2267463|NCT02207244|3942377|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
2267464|NCT02207244|3942378|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
2267465|NCT02207244|3942379|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
2267466|NCT02207244|3942380|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2
2267467|NCT02207244|3942381|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
2267468|NCT02207244|3942382|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3
2267469|NCT02207244|3942372|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
2267470|NCT02207244|3942373|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
2267471|NCT02207244|3942374|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
2267472|NCT02207244|3942375|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
2267473|NCT02207244|3942376|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
2267474|NCT02207244|3942377|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
2267475|NCT02207244|3942378|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
2267476|NCT02207244|3942379|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
2267477|NCT02207244|3942380|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5
2267478|NCT02207244|3942381|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
2267479|NCT02207244|3942382|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26
2267480|NCT02207244|3942372|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0
2267481|NCT02207244|3942373|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0
2267482|NCT02207244|3942374|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0
2267483|NCT02207244|3942375|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0
2267484|NCT02207244|3942376|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0
2267485|NCT02207244|3942377|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0
2348493|NCT03954834|4088226|FG000|Overall Study|Death|0
2348494|NCT03954834|4088227|FG001|Overall Study|Death|0
2348495|NCT03954834|4088228|FG002|Overall Study|Death|0
2348496|NCT03954834|4088229|FG003|Overall Study|Death|1
2348497|NCT03954834|4088226|FG000|Overall Study|Physician Decision|0
2348498|NCT03954834|4088227|FG001|Overall Study|Physician Decision|1
2348499|NCT03954834|4088228|FG002|Overall Study|Physician Decision|0
2348500|NCT03954834|4088229|FG003|Overall Study|Physician Decision|2
2348501|NCT03954834|4088226|FG000|Overall Study|Protocol Violation|1
2348502|NCT03954834|4088227|FG001|Overall Study|Protocol Violation|0
2348503|NCT03954834|4088228|FG002|Overall Study|Protocol Violation|0
2348504|NCT03954834|4088229|FG003|Overall Study|Protocol Violation|1
2348505|NCT03954834|4088226|FG000|Overall Study|Withdrawal by Subject|2
2348506|NCT03954834|4088227|FG001|Overall Study|Withdrawal by Subject|3
2348507|NCT03954834|4088228|FG002|Overall Study|Withdrawal by Subject|13
2348508|NCT03954834|4088229|FG003|Overall Study|Withdrawal by Subject|6
2348509|NCT03954834|4088226|FG000|Overall Study|Participant left the country|0
2348510|NCT03954834|4088227|FG001|Overall Study|Participant left the country|0
2348511|NCT03954834|4088228|FG002|Overall Study|Participant left the country|1
2348512|NCT03954834|4088229|FG003|Overall Study|Participant left the country|0
2348513|NCT03954834|4088226|FG000|Overall Study|Lost to Follow-up|3
2348514|NCT03954834|4088227|FG001|Overall Study|Lost to Follow-up|2
2348515|NCT03954834|4088228|FG002|Overall Study|Lost to Follow-up|3
2348516|NCT03954834|4088229|FG003|Overall Study|Lost to Follow-up|5
2348517|NCT03961529|4088256|FG000|Overall Study|Adverse Event|13
2348518|NCT03961529|4088257|FG001|Overall Study|Adverse Event|5
2348519|NCT03961529|4088258|FG002|Overall Study|Adverse Event|2
2348520|NCT03961529|4088256|FG000|Overall Study|Withdrawal by Subject|17
2348521|NCT03961529|4088257|FG001|Overall Study|Withdrawal by Subject|2
2348522|NCT03961529|4088258|FG002|Overall Study|Withdrawal by Subject|1
2348523|NCT03961529|4088256|FG000|Overall Study|Withdrawal by parent/guardian|0
2348524|NCT03961529|4088257|FG001|Overall Study|Withdrawal by parent/guardian|7
2348525|NCT03961529|4088258|FG002|Overall Study|Withdrawal by parent/guardian|0
2348526|NCT03961529|4088256|FG000|Overall Study|Physician Decision|2
2348527|NCT03961529|4088257|FG001|Overall Study|Physician Decision|1
2348528|NCT03961529|4088258|FG002|Overall Study|Physician Decision|1
2348529|NCT03961529|4088256|FG000|Overall Study|Lost to Follow-up|2
2348530|NCT03961529|4088257|FG001|Overall Study|Lost to Follow-up|1
2348531|NCT03961529|4088258|FG002|Overall Study|Lost to Follow-up|0
2348532|NCT03961529|4088256|FG000|Overall Study|Lack of Efficacy|2
2348533|NCT03961529|4088257|FG001|Overall Study|Lack of Efficacy|0
2348534|NCT03961529|4088258|FG002|Overall Study|Lack of Efficacy|1
2348535|NCT03961529|4088256|FG000|Overall Study|Other|6
2348536|NCT03961529|4088257|FG001|Overall Study|Other|1
2348537|NCT03961529|4088258|FG002|Overall Study|Other|0
2348538|NCT03968159|4088268|FG000|Overall Study|Adverse Event|4
2348539|NCT03968159|4088269|FG001|Overall Study|Adverse Event|4
2348540|NCT03968159|4088268|FG000|Overall Study|Lost to Follow-up|1
2348541|NCT03968159|4088269|FG001|Overall Study|Lost to Follow-up|1
2348542|NCT03968159|4088268|FG000|Overall Study|Use of prohibited medication|0
2348543|NCT03968159|4088269|FG001|Overall Study|Use of prohibited medication|1
2348544|NCT03968159|4088268|FG000|Overall Study|Protocol Violation|2
2348545|NCT03968159|4088269|FG001|Overall Study|Protocol Violation|2
2348546|NCT03968159|4088268|FG000|Overall Study|Withdrawal by Subject|4
2267486|NCT02207244|3942378|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0
2267487|NCT02207244|3942379|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0
2267488|NCT02207244|3942380|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12
2267489|NCT02207244|3942381|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0
2267490|NCT02207244|3942382|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21
2267491|NCT02207244|3942372|FG000|Open-label Guselkumab: Week 72-264|Death|0
2267492|NCT02207244|3942373|FG001|Open-label Guselkumab: Week 72-264|Death|0
2267493|NCT02207244|3942374|FG002|Open-label Guselkumab: Week 72-264|Death|0
2267494|NCT02207244|3942375|FG003|Open-label Guselkumab: Week 72-264|Death|0
2267495|NCT02207244|3942376|FG004|Open-label Guselkumab: Week 72-264|Death|0
2267496|NCT02207244|3942377|FG005|Open-label Guselkumab: Week 72-264|Death|0
2267497|NCT02207244|3942378|FG006|Open-label Guselkumab: Week 72-264|Death|0
2267498|NCT02207244|3942379|FG007|Open-label Guselkumab: Week 72-264|Death|0
2267499|NCT02207244|3942380|FG008|Open-label Guselkumab: Week 72-264|Death|1
2267500|NCT02207244|3942381|FG009|Open-label Guselkumab: Week 72-264|Death|0
2267501|NCT02207244|3942382|FG010|Open-label Guselkumab: Week 72-264|Death|1
2267502|NCT02207244|3942372|FG000|Open-label Guselkumab: Week 72-264|Other|0
2267503|NCT02207244|3942373|FG001|Open-label Guselkumab: Week 72-264|Other|0
2267504|NCT02207244|3942374|FG002|Open-label Guselkumab: Week 72-264|Other|0
2267505|NCT02207244|3942375|FG003|Open-label Guselkumab: Week 72-264|Other|0
2267506|NCT02207244|3942376|FG004|Open-label Guselkumab: Week 72-264|Other|0
2267507|NCT02207244|3942377|FG005|Open-label Guselkumab: Week 72-264|Other|0
2267508|NCT02207244|3942378|FG006|Open-label Guselkumab: Week 72-264|Other|0
2267509|NCT02207244|3942379|FG007|Open-label Guselkumab: Week 72-264|Other|0
2267510|NCT02207244|3942380|FG008|Open-label Guselkumab: Week 72-264|Other|8
2267511|NCT02207244|3942381|FG009|Open-label Guselkumab: Week 72-264|Other|0
2267512|NCT02207244|3942382|FG010|Open-label Guselkumab: Week 72-264|Other|19
2267513|NCT02207244|3942372|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0
2267514|NCT02207244|3942373|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0
2267515|NCT02207244|3942374|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0
2267516|NCT02207244|3942375|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0
2267517|NCT02207244|3942376|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0
2267518|NCT02207244|3942377|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0
2267519|NCT02207244|3942378|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0
2267520|NCT02207244|3942379|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0
2267521|NCT02207244|3942380|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0
2267522|NCT02207244|3942381|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0
2267523|NCT02207244|3942382|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2
2267524|NCT02207374|3942423|FG000|Overall Study|Withdrawal by Subject|5
2267525|NCT02207374|3942424|FG001|Overall Study|Withdrawal by Subject|9
2267526|NCT02207374|3942425|FG002|Overall Study|Withdrawal by Subject|4
2267527|NCT02207374|3942423|FG000|Overall Study|Death|1
2267528|NCT02207374|3942424|FG001|Overall Study|Death|0
2267529|NCT02207374|3942425|FG002|Overall Study|Death|1
2267530|NCT02207374|3942423|FG000|Overall Study|Missing follow-up information|0
2267531|NCT02207374|3942424|FG001|Overall Study|Missing follow-up information|1
2267532|NCT02207374|3942425|FG002|Overall Study|Missing follow-up information|1
2267533|NCT02207400|3942435|FG000|Overall Study|Adverse Event|1
2267534|NCT02207400|3942436|FG001|Overall Study|Adverse Event|1
2267535|NCT02207400|3942435|FG000|Overall Study|Lost to Follow-up|6
2267536|NCT02207400|3942436|FG001|Overall Study|Lost to Follow-up|7
2267537|NCT02207400|3942435|FG000|Overall Study|Protocol Violation|1
2267538|NCT02207400|3942436|FG001|Overall Study|Protocol Violation|1
2267539|NCT02207400|3942435|FG000|Overall Study|Withdrawal by Subject|8
2267540|NCT02207400|3942436|FG001|Overall Study|Withdrawal by Subject|4
2267541|NCT02207400|3942435|FG000|Overall Study|Positive Urine Pregnancy Test|0
2267542|NCT02207400|3942436|FG001|Overall Study|Positive Urine Pregnancy Test|1
2267543|NCT02207413|3942451|FG000|Overall Study|Withdrawal by Subject|1
2267544|NCT02207413|3942452|FG001|Overall Study|Withdrawal by Subject|0
2267545|NCT02207413|3942453|FG002|Overall Study|Withdrawal by Subject|0
2267546|NCT02207413|3942454|FG003|Overall Study|Withdrawal by Subject|0
2267547|NCT02207413|3942455|FG004|Overall Study|Withdrawal by Subject|3
2267548|NCT02207413|3942456|FG005|Overall Study|Withdrawal by Subject|7
2267549|NCT02207413|3942451|FG000|Overall Study|Lost to Follow-up|0
2267550|NCT02207413|3942452|FG001|Overall Study|Lost to Follow-up|0
2267551|NCT02207413|3942453|FG002|Overall Study|Lost to Follow-up|0
2267552|NCT02207413|3942454|FG003|Overall Study|Lost to Follow-up|1
2267553|NCT02207413|3942455|FG004|Overall Study|Lost to Follow-up|1
2267554|NCT02207413|3942456|FG005|Overall Study|Lost to Follow-up|5
2267555|NCT02207413|3942451|FG000|Overall Study|Adverse Event|0
2267556|NCT02207413|3942452|FG001|Overall Study|Adverse Event|0
2267557|NCT02207413|3942453|FG002|Overall Study|Adverse Event|0
2267558|NCT02207413|3942454|FG003|Overall Study|Adverse Event|0
2267559|NCT02207413|3942455|FG004|Overall Study|Adverse Event|2
2267560|NCT02207413|3942456|FG005|Overall Study|Adverse Event|1
2267561|NCT02207413|3942451|FG000|Overall Study|Migrated/moved from study area|0
2267562|NCT02207413|3942452|FG001|Overall Study|Migrated/moved from study area|0
2267563|NCT02207413|3942453|FG002|Overall Study|Migrated/moved from study area|0
2267564|NCT02207413|3942454|FG003|Overall Study|Migrated/moved from study area|0
2267565|NCT02207413|3942455|FG004|Overall Study|Migrated/moved from study area|1
2267566|NCT02207413|3942456|FG005|Overall Study|Migrated/moved from study area|0
2267567|NCT02207491|3942487|FG000|Overall Study|Adverse Event|20
2267568|NCT02207491|3942488|FG001|Overall Study|Adverse Event|4
2267569|NCT02207491|3942487|FG000|Overall Study|Withdrawal by Subject|3
2267570|NCT02207491|3942488|FG001|Overall Study|Withdrawal by Subject|2
2267571|NCT02207491|3942487|FG000|Overall Study|Non-compliant|0
2267572|NCT02207491|3942488|FG001|Overall Study|Non-compliant|1
2267573|NCT02207491|3942487|FG000|Overall Study|Lost to Follow-up|0
2267574|NCT02207491|3942488|FG001|Overall Study|Lost to Follow-up|1
2267575|NCT02207491|3942487|FG000|Overall Study|Lack of Efficacy|3
2267576|NCT02207491|3942488|FG001|Overall Study|Lack of Efficacy|0
2267577|NCT02207491|3942487|FG000|Overall Study|Physician Decision|2
2267578|NCT02207491|3942488|FG001|Overall Study|Physician Decision|0
2267579|NCT02207491|3942487|FG000|Overall Study|Protocol Violation|3
2348547|NCT03968159|4088269|FG001|Overall Study|Withdrawal by Subject|6
2348548|NCT03968159|4088268|FG000|Overall Study|Lack of Efficacy|0
2348549|NCT03968159|4088269|FG001|Overall Study|Lack of Efficacy|1
2348550|NCT03968159|4088268|FG000|Overall Study|Not further specified|2
2348551|NCT03968159|4088269|FG001|Overall Study|Not further specified|0
2348552|NCT03970824|4088287|FG000|Overall Study|Withdrawal by Subject|1
2348553|NCT03970824|4088288|FG001|Overall Study|Withdrawal by Subject|1
2348554|NCT03970824|4088289|FG002|Overall Study|Withdrawal by Subject|3
2348555|NCT03970824|4088287|FG000|Overall Study|Lost to Follow-up|0
2348556|NCT03970824|4088288|FG001|Overall Study|Lost to Follow-up|2
2348557|NCT03970824|4088289|FG002|Overall Study|Lost to Follow-up|1
2267580|NCT02207491|3942488|FG001|Overall Study|Protocol Violation|5
2267581|NCT02207530|3942494|FG000|Overall Study|Worsening condition under investigation|78
2267582|NCT02207530|3942494|FG000|Overall Study|Patient decision to stop study treatment|5
2267583|NCT02207530|3942494|FG000|Overall Study|Adverse Event|8
2267584|NCT02207556|3942500|FG000|Overall Study|Physician Decision|1
2267585|NCT02207556|3942501|FG001|Overall Study|Physician Decision|0
2267586|NCT02207556|3942500|FG000|Overall Study|Withdrawal by Subject|1
2267587|NCT02207556|3942501|FG001|Overall Study|Withdrawal by Subject|0
2267588|NCT02207556|3942500|FG000|Overall Study|Death|0
2267589|NCT02207556|3942501|FG001|Overall Study|Death|5
2267590|NCT02207569|3942510|FG000|Implant to 1-Month|Death|6
2267591|NCT02207569|3942510|FG000|Implant to 1-Month|Withdrawal by Subject|2
2267592|NCT02207569|3942510|FG000|Implant to 1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1
2267593|NCT02207569|3942510|FG000|1-Month to 6-Month|Death|8
2267594|NCT02207569|3942510|FG000|1-Month to 6-Month|Withdrawal by Subject|2
2267595|NCT02207569|3942510|FG000|12-Month|Death|8
2267596|NCT02207569|3942510|FG000|12-Month|Withdrawal by Subject|1
2267597|NCT02207569|3942510|FG000|6-Month to 12-Month|Death|14
2267598|NCT02207569|3942510|FG000|6-Month to 12-Month|Withdrawal by Subject|2
2267599|NCT02207569|3942510|FG000|12-Month to 24 Month|Death|23
2267600|NCT02207569|3942510|FG000|12-Month to 24 Month|Withdrawal by Subject|3
2267601|NCT02207569|3942510|FG000|24-Month to 36-Month|Death|23
2267602|NCT02207569|3942510|FG000|24-Month to 36-Month|Withdrawal by Subject|4
2267603|NCT02207569|3942510|FG000|36-Month to 48-Month|Death|25
2267604|NCT02207569|3942510|FG000|36-Month to 48-Month|Withdrawal by Subject|2
2267605|NCT02207569|3942510|FG000|36-Month to 48-Month|Lost to Follow-up|4
2267606|NCT02207569|3942510|FG000|48-Month to 60-Month|Death|1
2267607|NCT02207569|3942510|FG000|48-Month to 60-Month|Lost to Follow-up|1
2267608|NCT02207569|3942510|FG000|48-Month to 60-Month|pt 103 years old no longer traveling for MD visits|1
2267609|NCT02207569|3942510|FG000|48-Month to 60-Month|Covid-19 pt not willing to be seen|1
2267610|NCT02207608|3942516|FG000|Overall Study|Adverse Event|1
2267611|NCT02207608|3942517|FG001|Overall Study|Adverse Event|0
2267612|NCT02207621|3942526|FG000|Overall Study|Adverse Event|71
2267613|NCT02207621|3942527|FG001|Overall Study|Adverse Event|15
2267614|NCT02207621|3942528|FG002|Overall Study|Adverse Event|132
2267615|NCT02207621|3942526|FG000|Overall Study|Withdrawal by Subject|9
2267616|NCT02207621|3942527|FG001|Overall Study|Withdrawal by Subject|9
2267617|NCT02207621|3942528|FG002|Overall Study|Withdrawal by Subject|13
2267618|NCT02207621|3942526|FG000|Overall Study|Non-Compliant|3
2267619|NCT02207621|3942527|FG001|Overall Study|Non-Compliant|3
2267620|NCT02207621|3942528|FG002|Overall Study|Non-Compliant|1
2267621|NCT02207621|3942526|FG000|Overall Study|Lost to Follow-up|1
2267622|NCT02207621|3942527|FG001|Overall Study|Lost to Follow-up|0
2267623|NCT02207621|3942528|FG002|Overall Study|Lost to Follow-up|3
2267624|NCT02207621|3942526|FG000|Overall Study|Lack of Efficacy|10
2267625|NCT02207621|3942527|FG001|Overall Study|Lack of Efficacy|2
2267626|NCT02207621|3942528|FG002|Overall Study|Lack of Efficacy|4
2267627|NCT02207621|3942526|FG000|Overall Study|Disallowed Concurrent Medication|2
2267628|NCT02207621|3942527|FG001|Overall Study|Disallowed Concurrent Medication|5
2267629|NCT02207621|3942528|FG002|Overall Study|Disallowed Concurrent Medication|2
2267630|NCT02207621|3942526|FG000|Overall Study|Physician Decision|1
2267631|NCT02207621|3942527|FG001|Overall Study|Physician Decision|2
2267632|NCT02207621|3942528|FG002|Overall Study|Physician Decision|2
2267633|NCT02207621|3942526|FG000|Overall Study|Protocol Violation|4
2267634|NCT02207621|3942527|FG001|Overall Study|Protocol Violation|10
2267635|NCT02207621|3942528|FG002|Overall Study|Protocol Violation|6
2267636|NCT02207621|3942526|FG000|Overall Study|Death|2
2267637|NCT02207621|3942527|FG001|Overall Study|Death|0
2267638|NCT02207621|3942528|FG002|Overall Study|Death|0
2267639|NCT02207621|3942526|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2
2267640|NCT02207621|3942527|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1
2267641|NCT02207621|3942528|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5
2267642|NCT02207634|3942539|FG000|Overall Study|Withdrawal by Subject|21
2267643|NCT02207634|3942540|FG001|Overall Study|Withdrawal by Subject|31
2267644|NCT02207634|3942539|FG000|Overall Study|Lost to Follow-up|1
2267645|NCT02207634|3942540|FG001|Overall Study|Lost to Follow-up|0
2267646|NCT02207725|3942550|FG000|Overall Study|Did Not Receive Treatment|0
2267647|NCT02207725|3942551|FG001|Overall Study|Did Not Receive Treatment|1
2267648|NCT02207725|3942552|FG002|Overall Study|Did Not Receive Treatment|1
2267649|NCT02207725|3942553|FG003|Overall Study|Did Not Receive Treatment|1
2267650|NCT02207816|3942577|FG000|Overall Study|Serious Adverse Event|0
2267651|NCT02207816|3942578|FG001|Overall Study|Serious Adverse Event|5
2267652|NCT02207816|3942579|FG002|Overall Study|Serious Adverse Event|2
2267653|NCT02207816|3942577|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
2267654|NCT02207816|3942578|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1
2267655|NCT02207816|3942579|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2
2267656|NCT02207816|3942577|FG000|Overall Study|Withdrawal by Subject|4
2267657|NCT02207816|3942578|FG001|Overall Study|Withdrawal by Subject|9
2267658|NCT02207816|3942579|FG002|Overall Study|Withdrawal by Subject|7
2267659|NCT02207816|3942577|FG000|Overall Study|Migrated/Moved From Study Area|41
2267660|NCT02207816|3942578|FG001|Overall Study|Migrated/Moved From Study Area|60
2267661|NCT02207816|3942579|FG002|Overall Study|Migrated/Moved From Study Area|51
2267662|NCT02207816|3942577|FG000|Overall Study|Lost to Follow-up|3
2267663|NCT02207816|3942578|FG001|Overall Study|Lost to Follow-up|9
2267664|NCT02207816|3942579|FG002|Overall Study|Lost to Follow-up|1
2267665|NCT02207816|3942577|FG000|Overall Study|Other|1
2267666|NCT02207816|3942578|FG001|Overall Study|Other|2
2267667|NCT02207816|3942579|FG002|Overall Study|Other|4
2267668|NCT02207829|3942592|FG000|Overall Study|Adverse Event|10
2267669|NCT02207829|3942593|FG001|Overall Study|Adverse Event|9
2267670|NCT02207829|3942592|FG000|Overall Study|Lack of Efficacy|7
2267671|NCT02207829|3942593|FG001|Overall Study|Lack of Efficacy|5
2267672|NCT02207829|3942592|FG000|Overall Study|Lost to Follow-up|2
2267673|NCT02207829|3942593|FG001|Overall Study|Lost to Follow-up|2
2267674|NCT02207829|3942592|FG000|Overall Study|Protocol deviation|5
2267675|NCT02207829|3942593|FG001|Overall Study|Protocol deviation|4
2267676|NCT02207829|3942592|FG000|Overall Study|Withdrew consent|18
2267677|NCT02207829|3942593|FG001|Overall Study|Withdrew consent|14
2267678|NCT02207907|3942601|FG000|Overall Study|Lost to Follow-up|3
2267679|NCT02207907|3942602|FG001|Overall Study|Lost to Follow-up|1
2267680|NCT02207907|3942601|FG000|Overall Study|Withdrawal by Subject|5
2267681|NCT02207907|3942602|FG001|Overall Study|Withdrawal by Subject|6
2267682|NCT02207907|3942601|FG000|Overall Study|Did not meet study criteria|3
2267683|NCT02207907|3942602|FG001|Overall Study|Did not meet study criteria|0
2267684|NCT02207907|3942601|FG000|Overall Study|Pregnancy|0
2267685|NCT02207907|3942602|FG001|Overall Study|Pregnancy|1
2267686|NCT02207946|3942611|FG000|Overall Study|Lost to Follow-up|1
2267687|NCT02207946|3942612|FG001|Overall Study|Lost to Follow-up|0
2267688|NCT02207946|3942611|FG000|Overall Study|Adverse Event|0
2267689|NCT02207946|3942612|FG001|Overall Study|Adverse Event|1
2267690|NCT02208050|3942644|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1
2267691|NCT02208050|3942645|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0
2267692|NCT02208063|3942667|FG000|Overall Study|Death|3
2267693|NCT02208063|3942668|FG001|Overall Study|Death|5
2267694|NCT02208063|3942667|FG000|Overall Study|Not Specified in report|3
2267695|NCT02208063|3942668|FG001|Overall Study|Not Specified in report|4
2267696|NCT02208063|3942667|FG000|Overall Study|Withdrawal by Subject|5
2267697|NCT02208063|3942668|FG001|Overall Study|Withdrawal by Subject|2
2267698|NCT02208063|3942667|FG000|Overall Study|Lost to Follow-up|1
2267699|NCT02208063|3942668|FG001|Overall Study|Lost to Follow-up|0
2267700|NCT02208089|3942676|FG000|Overall Study|Withdrawal by Subject|1
2267701|NCT02208089|3942677|FG001|Overall Study|Withdrawal by Subject|0
2267702|NCT02208089|3942676|FG000|Overall Study|Lost to Follow-up|6
2348558|NCT03970824|4088287|FG000|Overall Study|Adverse Event|1
2348559|NCT03970824|4088288|FG001|Overall Study|Adverse Event|0
2348560|NCT03970824|4088289|FG002|Overall Study|Adverse Event|0
2348561|NCT03982069|4088335|FG000|Overall Study|Lost to Follow-up|5
2348562|NCT03982069|4088336|FG001|Overall Study|Lost to Follow-up|5
2348563|NCT03982069|4088337|FG002|Overall Study|Lost to Follow-up|3
2348564|NCT03982069|4088338|FG003|Overall Study|Lost to Follow-up|5
2348565|NCT03982069|4088335|FG000|Overall Study|Physician Decision|0
2348566|NCT03982069|4088336|FG001|Overall Study|Physician Decision|1
2348567|NCT03982069|4088337|FG002|Overall Study|Physician Decision|0
2348568|NCT03982069|4088338|FG003|Overall Study|Physician Decision|0
2348569|NCT03982069|4088335|FG000|Overall Study|Withdrawal by Subject|2
2348570|NCT03982069|4088336|FG001|Overall Study|Withdrawal by Subject|1
2348571|NCT03982069|4088337|FG002|Overall Study|Withdrawal by Subject|5
2348572|NCT03982069|4088338|FG003|Overall Study|Withdrawal by Subject|2
2348573|NCT03982069|4088335|FG000|Overall Study|Specimen loss|3
2348574|NCT03982069|4088336|FG001|Overall Study|Specimen loss|3
2348575|NCT03982069|4088337|FG002|Overall Study|Specimen loss|1
2348576|NCT03982069|4088338|FG003|Overall Study|Specimen loss|1
2348577|NCT03984812|4088357|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0
2348578|NCT03984812|4088358|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0
2348579|NCT03984812|4088359|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1
2348580|NCT03984812|4088360|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0
2348581|NCT03984812|4088361|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0
2348582|NCT03984812|4088362|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0
2348583|NCT03984812|4088363|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0
2348584|NCT03984812|4088364|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0
2348585|NCT03984812|4088365|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0
2348586|NCT03984812|4088366|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0
2348587|NCT03984812|4088367|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0
2348588|NCT04006171|4088439|FG000|Overall Study|Withdrawal by Subject|8
2348589|NCT04006171|4088440|FG001|Overall Study|Withdrawal by Subject|7
2348590|NCT04006171|4088439|FG000|Overall Study|missing serum samples|2
2348591|NCT04006171|4088440|FG001|Overall Study|missing serum samples|2
2348592|NCT04006171|4088439|FG000|Overall Study|insufficient sample volume|2
2348593|NCT04006171|4088440|FG001|Overall Study|insufficient sample volume|3
2348594|NCT04013529|4088467|FG000|Overall Study|Withdrawal by Subject|1
2267703|NCT02208089|3942677|FG001|Overall Study|Lost to Follow-up|0
2267704|NCT02208843|3942726|FG000|Overall Study|Clinical symptoms of progression|2
2267705|NCT02208843|3942726|FG000|Overall Study|Progression disease according to RECIST|24
2267706|NCT02208843|3942726|FG000|Overall Study|Adverse Event|12
2267707|NCT02208843|3942726|FG000|Overall Study|Protocol Violation|1
2267708|NCT02208843|3942726|FG000|Overall Study|Withdrawal by Subject|1
2267709|NCT02208843|3942726|FG000|Overall Study|Switched to commercial afatinib|20
2267710|NCT02208999|3942732|FG000|Overall Study|Lost to Follow-up|1
2267711|NCT02209181|3942760|FG000|Overall Study|Adverse Event|1
2267712|NCT02209181|3942761|FG001|Overall Study|Adverse Event|0
2267713|NCT02209181|3942762|FG002|Overall Study|Adverse Event|1
2267714|NCT02209181|3942763|FG003|Overall Study|Adverse Event|0
2267715|NCT02209181|3942760|FG000|Overall Study|Withdrawal by Subject|0
2267716|NCT02209181|3942761|FG001|Overall Study|Withdrawal by Subject|1
2267717|NCT02209181|3942762|FG002|Overall Study|Withdrawal by Subject|0
2267718|NCT02209181|3942763|FG003|Overall Study|Withdrawal by Subject|0
2267719|NCT02209454|3942795|FG000|Second Period|Adverse Event|1
2267720|NCT02209454|3942796|FG001|Second Period|Adverse Event|0
2267721|NCT02209506|3942807|FG000|Overall Study|Withdrawal by Subject|0
2267722|NCT02209506|3942808|FG001|Overall Study|Withdrawal by Subject|0
2267723|NCT02209506|3942809|FG002|Overall Study|Withdrawal by Subject|0
2267724|NCT02209506|3942810|FG003|Overall Study|Withdrawal by Subject|0
2267725|NCT02209506|3942811|FG004|Overall Study|Withdrawal by Subject|1
2267726|NCT02209597|3942846|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
2267727|NCT02209597|3942846|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
2267728|NCT02209597|3942846|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
2267729|NCT02209597|3942846|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
2267730|NCT02209766|3942870|FG000|Overall Study|Withdrawal by Subject|0
2267731|NCT02209766|3942871|FG001|Overall Study|Withdrawal by Subject|0
2267732|NCT02209766|3942872|FG002|Overall Study|Withdrawal by Subject|0
2267733|NCT02209766|3942873|FG003|Overall Study|Withdrawal by Subject|1
2267734|NCT02209766|3942874|FG004|Overall Study|Withdrawal by Subject|0
2267735|NCT02210000|3942895|FG000|Overall Study|Study Terminated|11
2267736|NCT02210000|3942896|FG001|Overall Study|Study Terminated|12
2267737|NCT02210000|3942895|FG000|Overall Study|Withdrawal by Subject|7
2267738|NCT02210000|3942896|FG001|Overall Study|Withdrawal by Subject|1
2267739|NCT02210000|3942895|FG000|Overall Study|Adverse Event|1
2267740|NCT02210000|3942896|FG001|Overall Study|Adverse Event|5
2267741|NCT02210000|3942895|FG000|Overall Study|Lost to Follow-up|0
2267742|NCT02210000|3942896|FG001|Overall Study|Lost to Follow-up|2
2267743|NCT02210000|3942895|FG000|Overall Study|Physician Decision|0
2267744|NCT02210000|3942896|FG001|Overall Study|Physician Decision|1
2267745|NCT02210091|3942916|FG000|Overall Study|Physician Decision|0
2267746|NCT02210091|3942917|FG001|Overall Study|Physician Decision|1
2267747|NCT02210091|3942916|FG000|Overall Study|Withdrawal by Sponsor|0
2267748|NCT02210091|3942917|FG001|Overall Study|Withdrawal by Sponsor|1
2267749|NCT02210208|3942948|FG000|Period A (Graft Site)|Withdrawal by Subject|1
2267750|NCT02210208|3942948|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1
2267751|NCT02210208|3942948|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7
2267752|NCT02210221|3942954|FG000|Overall Study|Lack of Efficacy|7
2267753|NCT02210221|3942954|FG000|Overall Study|Withdrawal by Subject|43
2267754|NCT02210689|3943000|FG000|Overall Study|Withdrawal by Subject|7
2267755|NCT02210689|3943001|FG001|Overall Study|Withdrawal by Subject|4
2267756|NCT02210689|3943002|FG002|Overall Study|Withdrawal by Subject|2
2267757|NCT02210689|3943000|FG000|Overall Study|Adverse Event|0
2267758|NCT02210689|3943001|FG001|Overall Study|Adverse Event|1
2267759|NCT02210689|3943002|FG002|Overall Study|Adverse Event|0
2267760|NCT02210689|3943000|FG000|Overall Study|Protocol Violation|1
2267761|NCT02210689|3943001|FG001|Overall Study|Protocol Violation|0
2267762|NCT02210689|3943002|FG002|Overall Study|Protocol Violation|0
2267763|NCT02210689|3943000|FG000|Overall Study|Lost to Follow-up|11
2267764|NCT02210689|3943001|FG001|Overall Study|Lost to Follow-up|9
2267765|NCT02210689|3943002|FG002|Overall Study|Lost to Follow-up|5
2267766|NCT02210689|3943000|FG000|Overall Study|Pregnancy|0
2267767|NCT02210689|3943001|FG001|Overall Study|Pregnancy|1
2267768|NCT02210689|3943002|FG002|Overall Study|Pregnancy|0
2267769|NCT02210689|3943000|FG000|Overall Study|Lack of Efficacy|0
2267770|NCT02210689|3943001|FG001|Overall Study|Lack of Efficacy|1
2267771|NCT02210689|3943002|FG002|Overall Study|Lack of Efficacy|5
2267772|NCT02210689|3943000|FG000|Overall Study|Prohibited medication|2
2267773|NCT02210689|3943001|FG001|Overall Study|Prohibited medication|8
2267774|NCT02210689|3943002|FG002|Overall Study|Prohibited medication|1
2267775|NCT02210689|3943000|FG000|Overall Study|Negative Nugent score at baseline|6
2267776|NCT02210689|3943001|FG001|Overall Study|Negative Nugent score at baseline|2
2267777|NCT02210689|3943002|FG002|Overall Study|Negative Nugent score at baseline|2
2267778|NCT02210689|3943000|FG000|Overall Study|Other|25
2267779|NCT02210689|3943001|FG001|Overall Study|Other|21
2267780|NCT02210689|3943002|FG002|Overall Study|Other|8
2267781|NCT02210780|3943012|FG000|Overall Study|Adverse Event|0
2267782|NCT02210780|3943013|FG001|Overall Study|Adverse Event|5
2267783|NCT02210780|3943012|FG000|Overall Study|Lost to Follow-up|2
2267784|NCT02210780|3943013|FG001|Overall Study|Lost to Follow-up|1
2267785|NCT02210780|3943012|FG000|Overall Study|Withdrawal by Subject|1
2267786|NCT02210780|3943013|FG001|Overall Study|Withdrawal by Subject|1
2348595|NCT04013529|4088468|FG001|Overall Study|Withdrawal by Subject|1
2348596|NCT04018066|4088483|FG000|Overall Study|participants started taking medications during the study period|3
2348597|NCT04018066|4088483|FG000|Overall Study|participant dropped out due to schedule conflicts.|1
2348598|NCT04041440|4088528|FG000|Overall Study|Withdrawal by Subject|0
2348599|NCT04041440|4088529|FG001|Overall Study|Withdrawal by Subject|1
2348600|NCT04041440|4088528|FG000|Overall Study|Lost to Follow-up|0
2348601|NCT04041440|4088529|FG001|Overall Study|Lost to Follow-up|1
2348602|NCT04041570|4088538|FG000|Overall Study|Moved from Area|0
2348603|NCT04041570|4088539|FG001|Overall Study|Moved from Area|2
2348604|NCT04043143|4088548|FG000|Overall Study|Lost to Follow-up|5
2348605|NCT04043143|4088549|FG001|Overall Study|Lost to Follow-up|5
2348606|NCT04043143|4088548|FG000|Overall Study|screen failure|1
2348607|NCT04043143|4088549|FG001|Overall Study|screen failure|0
2348608|NCT04052204|4088574|FG000|Overall Study|Death|1
2348609|NCT04052204|4088575|FG001|Overall Study|Death|0
2348610|NCT04052204|4088576|FG002|Overall Study|Death|0
2348611|NCT04052204|4088574|FG000|Overall Study|Progressive disease|1
2348612|NCT04052204|4088575|FG001|Overall Study|Progressive disease|0
2348613|NCT04052204|4088576|FG002|Overall Study|Progressive disease|0
2348614|NCT04052204|4088574|FG000|Overall Study|Other|1
2348615|NCT04052204|4088575|FG001|Overall Study|Other|0
2348616|NCT04052204|4088576|FG002|Overall Study|Other|0
2348617|NCT04067011|4088596|FG000|Overall Study|Not Treated|8
2348618|NCT04067011|4088597|FG001|Overall Study|Not Treated|7
2348619|NCT04067011|4088598|FG002|Overall Study|Not Treated|5
2348620|NCT04067011|4088596|FG000|Overall Study|Adverse Event|2
2348621|NCT04067011|4088597|FG001|Overall Study|Adverse Event|1
2348622|NCT04067011|4088598|FG002|Overall Study|Adverse Event|0
2348623|NCT04067011|4088596|FG000|Overall Study|Withdrawal by Subject|6
2348624|NCT04067011|4088597|FG001|Overall Study|Withdrawal by Subject|2
2348625|NCT04067011|4088598|FG002|Overall Study|Withdrawal by Subject|1
2348626|NCT04067011|4088596|FG000|Overall Study|Lost to Follow-up|0
2348627|NCT04067011|4088597|FG001|Overall Study|Lost to Follow-up|0
2348628|NCT04067011|4088598|FG002|Overall Study|Lost to Follow-up|1
2348629|NCT04067011|4088596|FG000|Overall Study|Physician Decision|1
2267787|NCT02210780|3943012|FG000|Overall Study|Physician Decision|1
2267788|NCT02210780|3943013|FG001|Overall Study|Physician Decision|0
2267789|NCT02210780|3943012|FG000|Overall Study|Protocol Violation|1
2267790|NCT02210780|3943013|FG001|Overall Study|Protocol Violation|0
2267791|NCT02210780|3943012|FG000|Overall Study|Other than specified above|0
2267792|NCT02210780|3943013|FG001|Overall Study|Other than specified above|1
2348630|NCT04067011|4088597|FG001|Overall Study|Physician Decision|1
2348631|NCT04067011|4088598|FG002|Overall Study|Physician Decision|0
2267793|NCT02211014|3943021|FG000|Overall Study|Adverse Event|0
2267794|NCT02211014|3943022|FG001|Overall Study|Adverse Event|2
2267795|NCT02211014|3943021|FG000|Overall Study|Physician Decision|1
2267796|NCT02211014|3943022|FG001|Overall Study|Physician Decision|2
2267797|NCT02211014|3943021|FG000|Overall Study|Started another cancer therapy|1
2267798|NCT02211014|3943022|FG001|Overall Study|Started another cancer therapy|0
2267799|NCT02211014|3943021|FG000|Overall Study|Withdrawal by Subject|0
2267800|NCT02211014|3943022|FG001|Overall Study|Withdrawal by Subject|1
2267801|NCT02211014|3943021|FG000|Overall Study|In agreement with patient, no benefit|0
2267802|NCT02211014|3943022|FG001|Overall Study|In agreement with patient, no benefit|1
2267803|NCT02211261|3943055|FG000|Overall Study|Withdrawal by Subject|0
2267804|NCT02211261|3943056|FG001|Overall Study|Withdrawal by Subject|0
2267805|NCT02211261|3943057|FG002|Overall Study|Withdrawal by Subject|1
2267806|NCT02211261|3943058|FG003|Overall Study|Withdrawal by Subject|0
2267807|NCT02211261|3943059|FG004|Overall Study|Withdrawal by Subject|2
2267808|NCT02211261|3943060|FG005|Overall Study|Withdrawal by Subject|0
2267809|NCT02211261|3943061|FG006|Overall Study|Withdrawal by Subject|0
2267810|NCT02211261|3943062|FG007|Overall Study|Withdrawal by Subject|0
2267811|NCT02211261|3943063|FG008|Overall Study|Withdrawal by Subject|0
2267812|NCT02211261|3943064|FG009|Overall Study|Withdrawal by Subject|0
2267813|NCT02211261|3943065|FG010|Overall Study|Withdrawal by Subject|0
2267814|NCT02211261|3943055|FG000|Overall Study|Other|0
2267815|NCT02211261|3943056|FG001|Overall Study|Other|0
2267816|NCT02211261|3943057|FG002|Overall Study|Other|0
2267817|NCT02211261|3943058|FG003|Overall Study|Other|0
2267818|NCT02211261|3943059|FG004|Overall Study|Other|0
2267819|NCT02211261|3943060|FG005|Overall Study|Other|1
2267820|NCT02211261|3943061|FG006|Overall Study|Other|0
2267821|NCT02211261|3943062|FG007|Overall Study|Other|0
2267822|NCT02211261|3943063|FG008|Overall Study|Other|0
2267823|NCT02211261|3943064|FG009|Overall Study|Other|2
2267824|NCT02211261|3943065|FG010|Overall Study|Other|0
2267825|NCT02211261|3943055|FG000|Overall Study|Lost to Follow-up|0
2267826|NCT02211261|3943056|FG001|Overall Study|Lost to Follow-up|0
2267827|NCT02211261|3943057|FG002|Overall Study|Lost to Follow-up|0
2267828|NCT02211261|3943058|FG003|Overall Study|Lost to Follow-up|0
2267829|NCT02211261|3943059|FG004|Overall Study|Lost to Follow-up|0
2267830|NCT02211261|3943060|FG005|Overall Study|Lost to Follow-up|0
2267831|NCT02211261|3943061|FG006|Overall Study|Lost to Follow-up|0
2267832|NCT02211261|3943062|FG007|Overall Study|Lost to Follow-up|1
2267833|NCT02211261|3943063|FG008|Overall Study|Lost to Follow-up|0
2267834|NCT02211261|3943064|FG009|Overall Study|Lost to Follow-up|0
2267835|NCT02211261|3943065|FG010|Overall Study|Lost to Follow-up|0
2267836|NCT02211313|3943100|FG000|Overall Study|Treatment Failure|5
2267837|NCT02211313|3943101|FG001|Overall Study|Treatment Failure|2
2267838|NCT02211313|3943100|FG000|Overall Study|No Follow up Questionnaires|1
2267839|NCT02211313|3943101|FG001|Overall Study|No Follow up Questionnaires|1
2267840|NCT02211638|3943133|FG000|Overall Study|Case Report Forms Uncollected|291
2267841|NCT02211638|3943133|FG000|Overall Study|Protocol Violation|692
2267842|NCT02212197|3943159|FG000|Overall Study|Need for radiotherapy|1
2267843|NCT02212197|3943160|FG001|Overall Study|Need for radiotherapy|0
2267844|NCT02212197|3943161|FG002|Overall Study|Need for radiotherapy|0
2267845|NCT02212301|3943169|FG000|Period 1|Lost to Follow-up|0
2267846|NCT02212301|3943170|FG001|Period 1|Lost to Follow-up|1
2267847|NCT02212379|3943177|FG000|From Baseline to Week 48|Lack of Efficacy|1
2267848|NCT02212379|3943177|FG000|From Baseline to Week 48|Adverse Event|7
2267849|NCT02212379|3943177|FG000|From Baseline to Week 48|Withdrawal by Subject|1
2267850|NCT02212379|3943177|FG000|From Week 48 to Week 96|Lack of Efficacy|1
2267851|NCT02212379|3943177|FG000|From Week 48 to Week 96|Adverse Event|1
2267852|NCT02212379|3943177|FG000|From Week 48 to Week 96|Withdrawal by Subject|2
2267853|NCT02212457|3943190|FG000|Overall Study|Adverse Event|1
2267854|NCT02212457|3943191|FG001|Overall Study|Adverse Event|2
2267855|NCT02212457|3943192|FG002|Overall Study|Adverse Event|2
2267856|NCT02212457|3943193|FG003|Overall Study|Adverse Event|2
2267857|NCT02212457|3943194|FG004|Overall Study|Adverse Event|0
2267858|NCT02212457|3943195|FG005|Overall Study|Adverse Event|1
2267859|NCT02212457|3943190|FG000|Overall Study|Withdrawal by Subject|8
2267860|NCT02212457|3943191|FG001|Overall Study|Withdrawal by Subject|10
2267861|NCT02212457|3943192|FG002|Overall Study|Withdrawal by Subject|8
2267862|NCT02212457|3943193|FG003|Overall Study|Withdrawal by Subject|6
2267863|NCT02212457|3943194|FG004|Overall Study|Withdrawal by Subject|5
2267864|NCT02212457|3943195|FG005|Overall Study|Withdrawal by Subject|4
2267865|NCT02212457|3943190|FG000|Overall Study|Lost to Follow-up|6
2267866|NCT02212457|3943191|FG001|Overall Study|Lost to Follow-up|7
2267867|NCT02212457|3943192|FG002|Overall Study|Lost to Follow-up|4
2267868|NCT02212457|3943193|FG003|Overall Study|Lost to Follow-up|1
2267869|NCT02212457|3943194|FG004|Overall Study|Lost to Follow-up|8
2267870|NCT02212457|3943195|FG005|Overall Study|Lost to Follow-up|4
2267871|NCT02212457|3943190|FG000|Overall Study|Protocol Violation|2
2267872|NCT02212457|3943191|FG001|Overall Study|Protocol Violation|1
2267873|NCT02212457|3943192|FG002|Overall Study|Protocol Violation|0
2267874|NCT02212457|3943193|FG003|Overall Study|Protocol Violation|1
2267875|NCT02212457|3943194|FG004|Overall Study|Protocol Violation|2
2267876|NCT02212457|3943195|FG005|Overall Study|Protocol Violation|3
2267877|NCT02212457|3943190|FG000|Overall Study|Other|2
2267878|NCT02212457|3943191|FG001|Overall Study|Other|1
2267879|NCT02212457|3943192|FG002|Overall Study|Other|2
2267880|NCT02212457|3943193|FG003|Overall Study|Other|1
2267881|NCT02212457|3943194|FG004|Overall Study|Other|0
2267882|NCT02212457|3943195|FG005|Overall Study|Other|1
2267883|NCT02212678|3943220|FG000|Overall Study|Adverse Event|1
2267884|NCT02212730|3943226|FG000|Overall Study|Tumor not of the required cell histology|1
2267885|NCT02212730|3943227|FG001|Overall Study|Tumor not of the required cell histology|0
2267886|NCT02212730|3943226|FG000|Overall Study|Withdrawal by Subject|1
2267887|NCT02212730|3943227|FG001|Overall Study|Withdrawal by Subject|0
2267888|NCT02212730|3943226|FG000|Overall Study|Disease progression prior to RCC surgery|0
2267889|NCT02212730|3943227|FG001|Overall Study|Disease progression prior to RCC surgery|1
2348632|NCT04067011|4088596|FG000|Overall Study|Other Reasons|2
2348633|NCT04067011|4088597|FG001|Overall Study|Other Reasons|0
2348634|NCT04067011|4088598|FG002|Overall Study|Other Reasons|1
2348635|NCT04067011|4088596|FG000|Overall Study|Missing|0
2348636|NCT04067011|4088597|FG001|Overall Study|Missing|2
2348637|NCT04067011|4088598|FG002|Overall Study|Missing|0
2348638|NCT04072159|4088610|FG000|Overall Study|Lost to Follow-up|6
2348639|NCT04072159|4088611|FG001|Overall Study|Lost to Follow-up|6
2348640|NCT04072159|4088610|FG000|Overall Study|Withdrawal by Subject|2
2348641|NCT04072159|4088611|FG001|Overall Study|Withdrawal by Subject|0
2348642|NCT04094870|4088630|FG000|Overall Study|Lost to Follow-up|1
2348643|NCT04094870|4088631|FG001|Overall Study|Lost to Follow-up|1
2267890|NCT02213042|3943256|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14
2267891|NCT02213042|3943257|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13
2267892|NCT02213042|3943258|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8
2267893|NCT02213042|3943256|FG000|Overall Study|Adverse Event|2
2267894|NCT02213042|3943257|FG001|Overall Study|Adverse Event|1
2267895|NCT02213042|3943258|FG002|Overall Study|Adverse Event|0
2267896|NCT02213042|3943256|FG000|Overall Study|Withdrawal by Subject|0
2267897|NCT02213042|3943257|FG001|Overall Study|Withdrawal by Subject|1
2267898|NCT02213042|3943258|FG002|Overall Study|Withdrawal by Subject|1
2267899|NCT02213042|3943256|FG000|Overall Study|Protocol Violation|1
2267900|NCT02213042|3943257|FG001|Overall Study|Protocol Violation|0
2267901|NCT02213042|3943258|FG002|Overall Study|Protocol Violation|0
2267902|NCT02213042|3943256|FG000|Overall Study|Investigator discretion|0
2267903|NCT02213042|3943257|FG001|Overall Study|Investigator discretion|0
2267904|NCT02213042|3943258|FG002|Overall Study|Investigator discretion|1
2267905|NCT02213055|3943270|FG000|Overall Study|Protocol was not Followed at Enrollment|5
2267906|NCT02213055|3943271|FG001|Overall Study|Protocol was not Followed at Enrollment|0
2267907|NCT02213055|3943270|FG000|Overall Study|Protocol was not Followed during Study|1
2267908|NCT02213055|3943271|FG001|Overall Study|Protocol was not Followed during Study|0
2267909|NCT02213055|3943270|FG000|Overall Study|Documentation Issue at Enrollment|1
2267910|NCT02213055|3943271|FG001|Overall Study|Documentation Issue at Enrollment|0
2267911|NCT02213055|3943270|FG000|Overall Study|Documentation Issue during Study|10
2267912|NCT02213055|3943271|FG001|Overall Study|Documentation Issue during Study|0
2267913|NCT02213055|3943270|FG000|Overall Study|Did not have Live Lice|8
2267914|NCT02213055|3943271|FG001|Overall Study|Did not have Live Lice|0
2267915|NCT02213055|3943270|FG000|Overall Study|Had another Treatment during the Study|3
2267916|NCT02213055|3943271|FG001|Overall Study|Had another Treatment during the Study|0
2267917|NCT02213055|3943270|FG000|Overall Study|Did not meet Inclusion Criteria|6
2267918|NCT02213055|3943271|FG001|Overall Study|Did not meet Inclusion Criteria|0
2267919|NCT02213055|3943270|FG000|Overall Study|Did not Return to School|5
2267920|NCT02213055|3943271|FG001|Overall Study|Did not Return to School|0
2267921|NCT02213094|3943292|FG000|Overall Study|Adverse Event|1
2267922|NCT02213094|3943293|FG001|Overall Study|Adverse Event|0
2267923|NCT02213133|3943302|FG000|Overall Study|Participant discontinued study therapy|2
2267924|NCT02213133|3943303|FG001|Overall Study|Participant discontinued study therapy|0
2267925|NCT02213133|3943304|FG002|Overall Study|Participant discontinued study therapy|0
2267926|NCT02213133|3943302|FG000|Overall Study|Participant withdrew informed consent|2
2267927|NCT02213133|3943303|FG001|Overall Study|Participant withdrew informed consent|1
2348644|NCT04123405|4088672|FG000|Overall Study|Adverse Event|1
2348645|NCT04123405|4088673|FG001|Overall Study|Adverse Event|2
2348646|NCT04123405|4088674|FG002|Overall Study|Adverse Event|3
2348647|NCT04123405|4088675|FG003|Overall Study|Adverse Event|3
2348648|NCT04123405|4088672|FG000|Overall Study|Exclusion criteria met|1
2348649|NCT04123405|4088673|FG001|Overall Study|Exclusion criteria met|2
2348650|NCT04123405|4088674|FG002|Overall Study|Exclusion criteria met|0
2348651|NCT04123405|4088675|FG003|Overall Study|Exclusion criteria met|2
2348652|NCT04123405|4088672|FG000|Overall Study|Withdrawal by Subject|1
2348653|NCT04123405|4088673|FG001|Overall Study|Withdrawal by Subject|3
2348654|NCT04123405|4088674|FG002|Overall Study|Withdrawal by Subject|0
2348655|NCT04123405|4088675|FG003|Overall Study|Withdrawal by Subject|2
2348656|NCT04123405|4088672|FG000|Overall Study|Contact to subject lost|0
2348657|NCT04123405|4088673|FG001|Overall Study|Contact to subject lost|0
2348658|NCT04123405|4088674|FG002|Overall Study|Contact to subject lost|0
2348659|NCT04123405|4088675|FG003|Overall Study|Contact to subject lost|1
2348660|NCT04123405|4088672|FG000|Overall Study|screening failure|1
2348661|NCT04123405|4088673|FG001|Overall Study|screening failure|0
2348662|NCT04123405|4088674|FG002|Overall Study|screening failure|0
2348663|NCT04123405|4088675|FG003|Overall Study|screening failure|0
2348664|NCT04147715|4088718|FG000|Overall Study|Adverse Event|0
2348665|NCT04147715|4088719|FG001|Overall Study|Adverse Event|0
2348666|NCT04147715|4088720|FG002|Overall Study|Adverse Event|0
2348667|NCT04147715|4088721|FG003|Overall Study|Adverse Event|0
2348668|NCT04147715|4088722|FG004|Overall Study|Adverse Event|0
2348669|NCT04147715|4088723|FG005|Overall Study|Adverse Event|0
2348670|NCT04147715|4088724|FG006|Overall Study|Adverse Event|0
2348671|NCT04147715|4088725|FG007|Overall Study|Adverse Event|2
2348672|NCT04147715|4088726|FG008|Overall Study|Adverse Event|1
2348673|NCT04147715|4088727|FG009|Overall Study|Adverse Event|0
2348674|NCT04147715|4088728|FG010|Overall Study|Adverse Event|0
2348675|NCT04147715|4088729|FG011|Overall Study|Adverse Event|0
2348676|NCT04150068|4088804|FG000|Overall Study|Still on study|24
2348677|NCT04150068|4088805|FG001|Overall Study|Still on study|12
2348678|NCT04150068|4088806|FG002|Overall Study|Still on study|16
2348679|NCT04154605|4088815|FG000|Overall Study|Procedure Canceled|1
2348680|NCT04154605|4088816|FG001|Overall Study|Procedure Canceled|1
2348681|NCT04154605|4088815|FG000|Overall Study|Missed follow up|1
2348682|NCT04154605|4088816|FG001|Overall Study|Missed follow up|1
2348683|NCT04154605|4088815|FG000|Overall Study|Withdrawal by Subject|1
2348684|NCT04154605|4088816|FG001|Overall Study|Withdrawal by Subject|0
2348685|NCT04160091|4088826|FG000|Overall Study|Terminated by Sponsor|7
2267928|NCT02213133|3943304|FG002|Overall Study|Participant withdrew informed consent|2
2267929|NCT02213133|3943302|FG000|Overall Study|Disease progression|11
2267930|NCT02213133|3943303|FG001|Overall Study|Disease progression|2
2267931|NCT02213133|3943304|FG002|Overall Study|Disease progression|0
2267932|NCT02213133|3943302|FG000|Overall Study|Adverse Event (AE)|1
2267933|NCT02213133|3943303|FG001|Overall Study|Adverse Event (AE)|0
2267934|NCT02213133|3943304|FG002|Overall Study|Adverse Event (AE)|0
2267935|NCT02213133|3943302|FG000|Overall Study|Death|16
2267936|NCT02213133|3943303|FG001|Overall Study|Death|2
2267937|NCT02213133|3943304|FG002|Overall Study|Death|1
2267938|NCT02213133|3943302|FG000|Overall Study|Other|5
2267939|NCT02213133|3943303|FG001|Overall Study|Other|0
2267940|NCT02213133|3943304|FG002|Overall Study|Other|0
2267941|NCT02213198|3943315|FG000|Baseline|No show for intake|7
2267942|NCT02213198|3943316|FG001|Baseline|No show for intake|9
2267943|NCT02213198|3943315|FG000|Baseline|Withdrawal by Subject|34
2267944|NCT02213198|3943316|FG001|Baseline|Withdrawal by Subject|11
2267945|NCT02213198|3943315|FG000|Baseline|transferred out of clinic|7
2267946|NCT02213198|3943316|FG001|Baseline|transferred out of clinic|9
2267947|NCT02213198|3943315|FG000|Baseline|Lost to Follow-up|40
2267948|NCT02213198|3943316|FG001|Baseline|Lost to Follow-up|21
2267949|NCT02213198|3943315|FG000|Baseline|incarcerated,violent|0
2267950|NCT02213198|3943316|FG001|Baseline|incarcerated,violent|1
2267951|NCT02213198|3943315|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
2267952|NCT02213198|3943316|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
2267953|NCT02213198|3943315|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
2267954|NCT02213198|3943316|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
2267955|NCT02213198|3943315|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
2267956|NCT02213198|3943316|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
2267957|NCT02213198|3943315|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
2267958|NCT02213198|3943316|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
2267959|NCT02213198|3943315|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
2267960|NCT02213198|3943316|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
2267961|NCT02213198|3943315|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
2267962|NCT02213198|3943316|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
2267963|NCT02213263|3943332|FG000|Overall Study|Insufficient clinical response|4
2267964|NCT02213263|3943333|FG001|Overall Study|Insufficient clinical response|3
2267965|NCT02213263|3943332|FG000|Overall Study|Lost to Follow-up|0
2267966|NCT02213263|3943333|FG001|Overall Study|Lost to Follow-up|1
2267967|NCT02213263|3943332|FG000|Overall Study|No longer willing to participate|3
2267968|NCT02213263|3943333|FG001|Overall Study|No longer willing to participate|4
2267969|NCT02213263|3943332|FG000|Overall Study|Progressive disease|20
2267970|NCT02213263|3943333|FG001|Overall Study|Progressive disease|14
2267971|NCT02213263|3943332|FG000|Overall Study|Protocol Violation|0
2267972|NCT02213263|3943333|FG001|Overall Study|Protocol Violation|1
2267973|NCT02213263|3943332|FG000|Overall Study|Adverse Event|1
2267974|NCT02213263|3943333|FG001|Overall Study|Adverse Event|3
2267975|NCT02213380|3943354|FG000|Underwent Randomization|Withdrawal by Subject|2
2267976|NCT02213380|3943355|FG001|Underwent Randomization|Withdrawal by Subject|0
2267977|NCT02213380|3943354|FG000|Underwent Randomization|Not treated|3
2267978|NCT02213380|3943355|FG001|Underwent Randomization|Not treated|3
2267979|NCT02213380|3943354|FG000|Per-protocol Analysis|Protocol Violation|32
2267980|NCT02213380|3943355|FG001|Per-protocol Analysis|Protocol Violation|36
2267981|NCT02213458|3943363|FG000|Overall Study|No longer meets criteria: caregiver deceased|4
2267982|NCT02213458|3943364|FG001|Overall Study|No longer meets criteria: caregiver deceased|0
2267983|NCT02213458|3943363|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4
2267984|NCT02213458|3943364|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0
2267985|NCT02213458|3943363|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2
2267986|NCT02213458|3943364|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0
2267987|NCT02213458|3943363|FG000|Overall Study|No longer meets criteria: patient moved out of state|10
2267988|NCT02213458|3943364|FG001|Overall Study|No longer meets criteria: patient moved out of state|0
2267989|NCT02213458|3943363|FG000|Overall Study|Refused re-consent|6
2267990|NCT02213458|3943364|FG001|Overall Study|Refused re-consent|0
2267991|NCT02213458|3943363|FG000|Overall Study|Lost to Follow-up|2
2267992|NCT02213458|3943364|FG001|Overall Study|Lost to Follow-up|2
2348686|NCT04160091|4088827|FG001|Overall Study|Terminated by Sponsor|3
2348687|NCT04160091|4088828|FG002|Overall Study|Terminated by Sponsor|5
2348688|NCT04160091|4088829|FG003|Overall Study|Terminated by Sponsor|2
2348689|NCT04160091|4088826|FG000|Overall Study|Noncompliance|0
2348690|NCT04160091|4088827|FG001|Overall Study|Noncompliance|0
2348691|NCT04160091|4088828|FG002|Overall Study|Noncompliance|0
2348692|NCT04160091|4088829|FG003|Overall Study|Noncompliance|1
2348693|NCT04160091|4088826|FG000|Overall Study|Withdrawal by Subject|0
2348694|NCT04160091|4088827|FG001|Overall Study|Withdrawal by Subject|0
2348695|NCT04160091|4088828|FG002|Overall Study|Withdrawal by Subject|0
2348696|NCT04160091|4088829|FG003|Overall Study|Withdrawal by Subject|1
2348697|NCT04164758|4088846|FG000|Overall Study|COVID-19 withdrawal of consent|1
2267993|NCT02213458|3943363|FG000|Overall Study|Withdrawal by Subject|26
2267994|NCT02213458|3943364|FG001|Overall Study|Withdrawal by Subject|8
2267995|NCT02213510|3943372|FG000|Overall Study|Death|0
2267996|NCT02213510|3943373|FG001|Overall Study|Death|1
2267997|NCT02213510|3943372|FG000|Overall Study|Lost to Follow-up|1
2267998|NCT02213510|3943373|FG001|Overall Study|Lost to Follow-up|0
2267999|NCT02213666|3943379|FG000|Overall Study|Withdrawal by Subject|1
2268000|NCT02214121|3943404|FG000|Part A|Patient decision|2
2268001|NCT02214121|3943405|FG001|Part A|Patient decision|0
2268002|NCT02214121|3943406|FG002|Part A|Patient decision|0
2268003|NCT02214121|3943404|FG000|Part A|Dev. of study-specific withdrawal crit.|4
2268004|NCT02214121|3943405|FG001|Part A|Dev. of study-specific withdrawal crit.|0
2268005|NCT02214121|3943406|FG002|Part A|Dev. of study-specific withdrawal crit.|0
2268006|NCT02214121|3943404|FG000|Part A|Other|1
2268007|NCT02214121|3943405|FG001|Part A|Other|0
2268008|NCT02214121|3943406|FG002|Part A|Other|0
2268009|NCT02214121|3943404|FG000|Part B|Patient decision|0
2268010|NCT02214121|3943405|FG001|Part B|Patient decision|1
2268011|NCT02214121|3943406|FG002|Part B|Patient decision|0
2268012|NCT02214121|3943404|FG000|Part B|Dev. of study-specific withdrawal crit.|0
2268013|NCT02214121|3943405|FG001|Part B|Dev. of study-specific withdrawal crit.|2
2268014|NCT02214121|3943406|FG002|Part B|Dev. of study-specific withdrawal crit.|0
2268015|NCT02214121|3943404|FG000|Part B|Lost to Follow-up|0
2268016|NCT02214121|3943405|FG001|Part B|Lost to Follow-up|0
2268017|NCT02214121|3943406|FG002|Part B|Lost to Follow-up|1
2268018|NCT02214186|3943441|FG000|Overall Study|Lost to Follow-up|1
2268019|NCT02214186|3943442|FG001|Overall Study|Lost to Follow-up|1
2268020|NCT02214186|3943441|FG000|Overall Study|Protocol Violation|1
2268021|NCT02214186|3943442|FG001|Overall Study|Protocol Violation|1
2268022|NCT02214225|3943465|FG000|Overall Study|Lost to Follow-up|46
2268023|NCT02214225|3943466|FG001|Overall Study|Lost to Follow-up|18
2268024|NCT02214225|3943467|FG002|Overall Study|Lost to Follow-up|18
2268025|NCT02214225|3943465|FG000|Overall Study|Withdrawal by Subject|2
2268026|NCT02214225|3943466|FG001|Overall Study|Withdrawal by Subject|0
2268027|NCT02214225|3943467|FG002|Overall Study|Withdrawal by Subject|2
2268028|NCT02214225|3943465|FG000|Overall Study|Death|5
2268029|NCT02214225|3943466|FG001|Overall Study|Death|0
2268030|NCT02214225|3943467|FG002|Overall Study|Death|1
2268031|NCT02214225|3943465|FG000|Overall Study|randomized in error, not vaccinated|2
2268032|NCT02214225|3943466|FG001|Overall Study|randomized in error, not vaccinated|1
2268033|NCT02214225|3943467|FG002|Overall Study|randomized in error, not vaccinated|1
2268034|NCT02215252|3943595|FG000|Overall Study|Adverse Event|1
2268035|NCT02215252|3943596|FG001|Overall Study|Adverse Event|5
2268036|NCT02215252|3943597|FG002|Overall Study|Adverse Event|2
2268037|NCT02215252|3943595|FG000|Overall Study|Lost to Follow-up|0
2268038|NCT02215252|3943596|FG001|Overall Study|Lost to Follow-up|0
2268039|NCT02215252|3943597|FG002|Overall Study|Lost to Follow-up|1
2268040|NCT02215252|3943595|FG000|Overall Study|Does not Meet Entrance Criteria|0
2268041|NCT02215252|3943596|FG001|Overall Study|Does not Meet Entrance Criteria|1
2268042|NCT02215252|3943597|FG002|Overall Study|Does not Meet Entrance Criteria|0
2268043|NCT02215252|3943595|FG000|Overall Study|Protocol Violation|0
2268044|NCT02215252|3943596|FG001|Overall Study|Protocol Violation|1
2268045|NCT02215252|3943597|FG002|Overall Study|Protocol Violation|0
2268046|NCT02215252|3943595|FG000|Overall Study|Withdrawal by Subject|1
2268047|NCT02215252|3943596|FG001|Overall Study|Withdrawal by Subject|0
2268048|NCT02215252|3943597|FG002|Overall Study|Withdrawal by Subject|0
2268049|NCT02215252|3943595|FG000|Overall Study|Other|0
2268050|NCT02215252|3943596|FG001|Overall Study|Other|1
2268051|NCT02215252|3943597|FG002|Overall Study|Other|1
2268052|NCT02215616|3943613|FG000|Overall Study|Sponsor requested to stop study drug|0
2268053|NCT02215616|3943614|FG001|Overall Study|Sponsor requested to stop study drug|0
2268054|NCT02215616|3943615|FG002|Overall Study|Sponsor requested to stop study drug|1
2268055|NCT02215616|3943616|FG003|Overall Study|Sponsor requested to stop study drug|4
2268056|NCT02215616|3943613|FG000|Overall Study|Death|1
2268057|NCT02215616|3943614|FG001|Overall Study|Death|0
2268058|NCT02215616|3943615|FG002|Overall Study|Death|0
2268059|NCT02215616|3943616|FG003|Overall Study|Death|0
2268060|NCT02215616|3943613|FG000|Overall Study|Adverse Event|7
2268061|NCT02215616|3943614|FG001|Overall Study|Adverse Event|4
2268062|NCT02215616|3943615|FG002|Overall Study|Adverse Event|9
2268063|NCT02215616|3943616|FG003|Overall Study|Adverse Event|2
2268064|NCT02215616|3943613|FG000|Overall Study|Withdrawal by Subject|1
2348698|NCT04164758|4088847|FG001|Overall Study|COVID-19 withdrawal of consent|0
2348699|NCT04164758|4088848|FG002|Overall Study|COVID-19 withdrawal of consent|0
2348700|NCT04164758|4088846|FG000|Overall Study|Adverse Event|0
2348701|NCT04164758|4088847|FG001|Overall Study|Adverse Event|1
2348702|NCT04164758|4088848|FG002|Overall Study|Adverse Event|0
2348703|NCT04165031|4088862|FG000|Overall Study|Adverse Event|1
2348704|NCT04165031|4088863|FG001|Overall Study|Adverse Event|1
2348705|NCT04165031|4088864|FG002|Overall Study|Adverse Event|0
2348706|NCT04165031|4088865|FG003|Overall Study|Adverse Event|0
2268065|NCT02215616|3943614|FG001|Overall Study|Withdrawal by Subject|8
2268066|NCT02215616|3943615|FG002|Overall Study|Withdrawal by Subject|2
2268067|NCT02215616|3943616|FG003|Overall Study|Withdrawal by Subject|5
2268068|NCT02215616|3943613|FG000|Overall Study|Non-compliance|0
2268069|NCT02215616|3943614|FG001|Overall Study|Non-compliance|2
2268070|NCT02215616|3943615|FG002|Overall Study|Non-compliance|1
2268071|NCT02215616|3943616|FG003|Overall Study|Non-compliance|0
2268072|NCT02215616|3943613|FG000|Overall Study|Protocol Violation|0
2268073|NCT02215616|3943614|FG001|Overall Study|Protocol Violation|2
2268074|NCT02215616|3943615|FG002|Overall Study|Protocol Violation|0
2268075|NCT02215616|3943616|FG003|Overall Study|Protocol Violation|0
2268076|NCT02215616|3943613|FG000|Overall Study|Lost to Follow-up|1
2268077|NCT02215616|3943614|FG001|Overall Study|Lost to Follow-up|1
2268078|NCT02215616|3943615|FG002|Overall Study|Lost to Follow-up|0
2268079|NCT02215616|3943616|FG003|Overall Study|Lost to Follow-up|1
2268080|NCT02215616|3943613|FG000|Overall Study|Other than specified|1
2268081|NCT02215616|3943614|FG001|Overall Study|Other than specified|0
2268082|NCT02215616|3943615|FG002|Overall Study|Other than specified|1
2268083|NCT02215616|3943616|FG003|Overall Study|Other than specified|1
2268084|NCT02215954|3943629|FG000|Overall Study|Adverse Event|0
2268085|NCT02215954|3943630|FG001|Overall Study|Adverse Event|0
2268086|NCT02215954|3943631|FG002|Overall Study|Adverse Event|1
2268087|NCT02215954|3943629|FG000|Overall Study|Withdrawal by Subject|0
2268088|NCT02215954|3943630|FG001|Overall Study|Withdrawal by Subject|0
2268089|NCT02215954|3943631|FG002|Overall Study|Withdrawal by Subject|2
2268090|NCT02215954|3943629|FG000|Overall Study|Not exposed|1
2268091|NCT02215954|3943630|FG001|Overall Study|Not exposed|1
2268092|NCT02215954|3943631|FG002|Overall Study|Not exposed|3
2268093|NCT02215967|3943644|FG000|Overall Study|Patient became ineligible for treatment|0
2268094|NCT02215967|3943645|FG001|Overall Study|Patient became ineligible for treatment|0
2268095|NCT02215967|3943646|FG002|Overall Study|Patient became ineligible for treatment|0
2268096|NCT02215967|3943647|FG003|Overall Study|Patient became ineligible for treatment|3
2268097|NCT02215967|3943644|FG000|Overall Study|Patient did not get CAR T-Cells|0
2268098|NCT02215967|3943645|FG001|Overall Study|Patient did not get CAR T-Cells|0
2268099|NCT02215967|3943646|FG002|Overall Study|Patient did not get CAR T-Cells|1
2268100|NCT02215967|3943647|FG003|Overall Study|Patient did not get CAR T-Cells|0
2268101|NCT02216071|3943659|FG000|Overall Study|Withdrawal by Subject|7
2268102|NCT02216071|3943660|FG001|Overall Study|Withdrawal by Subject|2
2268103|NCT02216071|3943659|FG000|Overall Study|Lost to Follow-up|3
2268104|NCT02216071|3943660|FG001|Overall Study|Lost to Follow-up|3
2268105|NCT02216071|3943659|FG000|Overall Study|Protocol Violation|3
2268106|NCT02216071|3943660|FG001|Overall Study|Protocol Violation|5
2268107|NCT02216071|3943659|FG000|Overall Study|Other|2
2268108|NCT02216071|3943660|FG001|Overall Study|Other|2
2268109|NCT02216123|3943677|FG000|Overall Study|Lost to Follow-up|4
2268110|NCT02216123|3943678|FG001|Overall Study|Lost to Follow-up|2
2268111|NCT02216123|3943677|FG000|Overall Study|Withdrawal by Subject|2
2268112|NCT02216123|3943678|FG001|Overall Study|Withdrawal by Subject|0
2268113|NCT02216214|3943703|FG000|Overall Study|Randomized Never Received Study Drug|1
2268114|NCT02216214|3943704|FG001|Overall Study|Randomized Never Received Study Drug|0
2268115|NCT02216214|3943703|FG000|Overall Study|Adverse Event|10
2268116|NCT02216214|3943704|FG001|Overall Study|Adverse Event|8
2268117|NCT02216214|3943703|FG000|Overall Study|Lack of Efficacy|2
2268118|NCT02216214|3943704|FG001|Overall Study|Lack of Efficacy|2
2268119|NCT02216214|3943703|FG000|Overall Study|Lost to Follow-up|3
2268120|NCT02216214|3943704|FG001|Overall Study|Lost to Follow-up|2
2268121|NCT02216214|3943703|FG000|Overall Study|Protocol Violation|4
2268122|NCT02216214|3943704|FG001|Overall Study|Protocol Violation|2
2268123|NCT02216214|3943703|FG000|Overall Study|Withdrawal by Subject|22
2268124|NCT02216214|3943704|FG001|Overall Study|Withdrawal by Subject|20
2268125|NCT02216214|3943703|FG000|Overall Study|Study Terminated By Sponsor|0
2268126|NCT02216214|3943704|FG001|Overall Study|Study Terminated By Sponsor|1
2268127|NCT02216214|3943703|FG000|Overall Study|Miscellaneous|1
2268128|NCT02216214|3943704|FG001|Overall Study|Miscellaneous|1
2268129|NCT02216357|3943712|FG000|Overall Study|Inclusion or exclusion criteria not met|2
2268130|NCT02216357|3943713|FG001|Overall Study|Inclusion or exclusion criteria not met|1
2268131|NCT02216526|3943726|FG000|Overall Study|Adverse Event|1
2268132|NCT02216526|3943727|FG001|Overall Study|Adverse Event|1
2268133|NCT02216526|3943728|FG002|Overall Study|Adverse Event|0
2268134|NCT02216526|3943726|FG000|Overall Study|Death|0
2268135|NCT02216526|3943727|FG001|Overall Study|Death|1
2268136|NCT02216526|3943728|FG002|Overall Study|Death|3
2268137|NCT02216526|3943726|FG000|Overall Study|Protocol Violation|2
2268138|NCT02216526|3943727|FG001|Overall Study|Protocol Violation|0
2268139|NCT02216526|3943728|FG002|Overall Study|Protocol Violation|2
2268140|NCT02216526|3943726|FG000|Overall Study|Hospitalization|2
2268141|NCT02216526|3943727|FG001|Overall Study|Hospitalization|1
2268142|NCT02216526|3943728|FG002|Overall Study|Hospitalization|3
2268143|NCT02216591|3943738|FG000|Overall Study|Lost to Follow-up|0
2268144|NCT02216591|3943739|FG001|Overall Study|Lost to Follow-up|1
2268145|NCT02216773|3943756|FG000|Overall Study|Disease progression|4
2268146|NCT02216773|3943757|FG001|Overall Study|Disease progression|2
2268147|NCT02216773|3943756|FG000|Overall Study|Insufficient FLRV|4
2268148|NCT02216773|3943757|FG001|Overall Study|Insufficient FLRV|0
2268149|NCT02216773|3943756|FG000|Overall Study|Abandoned|4
2268150|NCT02216773|3943757|FG001|Overall Study|Abandoned|3
2268151|NCT02216812|3943765|FG000|Overall Study|Lost to Follow-up|10
2268152|NCT02216812|3943766|FG001|Overall Study|Lost to Follow-up|5
2268153|NCT02217280|3943781|FG000|Overall Study|Withdrawal by Subject|2
2268154|NCT02217280|3943781|FG000|Overall Study|Post-consent sceen fail|2
2268155|NCT02217332|3943786|FG000|Overall Study|Adverse Event|3
2268156|NCT02217332|3943786|FG000|Overall Study|Dose interruption >1 month|1
2268157|NCT02217332|3943786|FG000|Overall Study|Protocol Violation (eligibility)|1
2268158|NCT02217332|3943786|FG000|Overall Study|Withdrawal by Subject|1
2268159|NCT02217332|3943786|FG000|Overall Study|Lost to Follow-up|1
2268160|NCT02217410|3943793|FG000|Overall Study|Graft Loss|0
2268161|NCT02217410|3943794|FG001|Overall Study|Graft Loss|0
2268162|NCT02217410|3943795|FG002|Overall Study|Graft Loss|2
2268163|NCT02217410|3943793|FG000|Overall Study|Withdrawal by Subject|0
2268164|NCT02217410|3943794|FG001|Overall Study|Withdrawal by Subject|0
2268165|NCT02217410|3943795|FG002|Overall Study|Withdrawal by Subject|2
2268166|NCT02217410|3943793|FG000|Overall Study|Lost to Follow-up|0
2268167|NCT02217410|3943794|FG001|Overall Study|Lost to Follow-up|0
2268168|NCT02217410|3943795|FG002|Overall Study|Lost to Follow-up|1
2268169|NCT02217410|3943793|FG000|Overall Study|Lack of Efficacy|0
2268170|NCT02217410|3943794|FG001|Overall Study|Lack of Efficacy|1
2268171|NCT02217410|3943795|FG002|Overall Study|Lack of Efficacy|0
2268172|NCT02217410|3943793|FG000|Overall Study|Physician Decision|1
2268173|NCT02217410|3943794|FG001|Overall Study|Physician Decision|3
2268174|NCT02217410|3943795|FG002|Overall Study|Physician Decision|0
2268175|NCT02217436|3943810|FG000|Overall Study|Protocol Violation|1
2268176|NCT02217436|3943811|FG001|Overall Study|Protocol Violation|1
2268177|NCT02217436|3943810|FG000|Overall Study|Incomplete data|0
2268178|NCT02217436|3943811|FG001|Overall Study|Incomplete data|1
2268179|NCT02217475|3943820|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
2268180|NCT02217475|3943821|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
2268181|NCT02217475|3943822|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
2268182|NCT02217475|3943820|FG000|Treatment Period 1 (Year 1)|Adverse Event|4
2268183|NCT02217475|3943821|FG001|Treatment Period 1 (Year 1)|Adverse Event|5
2268184|NCT02217475|3943822|FG002|Treatment Period 1 (Year 1)|Adverse Event|9
2268185|NCT02217475|3943820|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1
2268186|NCT02217475|3943821|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0
2268187|NCT02217475|3943822|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0
2268188|NCT02217475|3943820|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
2268189|NCT02217475|3943821|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
2268190|NCT02217475|3943822|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
2268191|NCT02217475|3943820|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
2268192|NCT02217475|3943821|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
2268193|NCT02217475|3943822|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
2268194|NCT02217475|3943820|FG000|Discontinued After Period 1|Adverse Event|1
2268195|NCT02217475|3943821|FG001|Discontinued After Period 1|Adverse Event|2
2268196|NCT02217475|3943822|FG002|Discontinued After Period 1|Adverse Event|0
2268197|NCT02217475|3943820|FG000|Discontinued After Period 1|Participant Withdrew Consent|1
2268198|NCT02217475|3943821|FG001|Discontinued After Period 1|Participant Withdrew Consent|1
2268199|NCT02217475|3943822|FG002|Discontinued After Period 1|Participant Withdrew Consent|2
2268200|NCT02217475|3943820|FG000|Discontinued After Period 1|Physician Decision|0
2268201|NCT02217475|3943821|FG001|Discontinued After Period 1|Physician Decision|0
2268202|NCT02217475|3943822|FG002|Discontinued After Period 1|Physician Decision|1
2348707|NCT04165031|4088866|FG004|Overall Study|Adverse Event|0
2348708|NCT04165031|4088867|FG005|Overall Study|Adverse Event|0
2348709|NCT04165031|4088862|FG000|Overall Study|Withdrawal by Subject|0
2348710|NCT04165031|4088863|FG001|Overall Study|Withdrawal by Subject|0
2348711|NCT04165031|4088864|FG002|Overall Study|Withdrawal by Subject|1
2348712|NCT04165031|4088865|FG003|Overall Study|Withdrawal by Subject|0
2348713|NCT04165031|4088866|FG004|Overall Study|Withdrawal by Subject|0
2348714|NCT04165031|4088867|FG005|Overall Study|Withdrawal by Subject|0
2348715|NCT04171414|4088886|FG000|Overall Study|Death|1
2348716|NCT04171414|4088886|FG000|Overall Study|Withdrawal by Subject|1
2348717|NCT04175808|4088890|FG000|Part A|Miscellaneous|2
2348718|NCT04175808|4088891|FG001|Part A|Miscellaneous|0
2348719|NCT04175808|4088892|FG002|Part A|Miscellaneous|0
2348720|NCT04175808|4088893|FG003|Part A|Miscellaneous|0
2348721|NCT04175808|4088894|FG004|Part A|Miscellaneous|0
2348722|NCT04175808|4088895|FG005|Part A|Miscellaneous|0
2348723|NCT04175808|4088896|FG006|Part A|Miscellaneous|0
2348724|NCT04178720|4088914|FG000|Overall Study|Withdrawal by Subject|2
2348725|NCT04178720|4088915|FG001|Overall Study|Withdrawal by Subject|0
2348726|NCT04178720|4088914|FG000|Overall Study|Relocation|0
2348727|NCT04178720|4088915|FG001|Overall Study|Relocation|1
2348728|NCT04218110|4088958|FG000|Overall Study|Withdrawal by Subject|0
2348729|NCT04218110|4088959|FG001|Overall Study|Withdrawal by Subject|0
2348730|NCT04218110|4088960|FG002|Overall Study|Withdrawal by Subject|0
2348731|NCT04218110|4088961|FG003|Overall Study|Withdrawal by Subject|1
2348732|NCT04222725|4088975|FG000|Overall Study|Adverse Event|0
2348733|NCT04222725|4088976|FG001|Overall Study|Adverse Event|1
2348734|NCT04222725|4088977|FG002|Overall Study|Adverse Event|0
2348735|NCT04222725|4088978|FG003|Overall Study|Adverse Event|0
2348736|NCT04231825|4089050|FG000|Overall Study|Protocol Violation|3
2348737|NCT04231825|4089051|FG001|Overall Study|Protocol Violation|3
2268203|NCT02217475|3943820|FG000|Treatment Period 2 (Year 2)|Adverse Event|0
2348738|NCT04231825|4089050|FG000|Overall Study|Lost to Follow-up|0
2348739|NCT04231825|4089051|FG001|Overall Study|Lost to Follow-up|1
2348740|NCT04258995|4089082|FG000|Overall Study|Lost to Follow-up|1
2268204|NCT02217475|3943821|FG001|Treatment Period 2 (Year 2)|Adverse Event|1
2268205|NCT02217475|3943822|FG002|Treatment Period 2 (Year 2)|Adverse Event|5
2268206|NCT02217475|3943820|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0
2268207|NCT02217475|3943821|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1
2268208|NCT02217475|3943822|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2
2268209|NCT02217475|3943820|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
2268210|NCT02217475|3943821|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
2268211|NCT02217475|3943822|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
2268212|NCT02217475|3943820|FG000|Treatment Period 2 (Year 2)|Physician Decision|0
2268213|NCT02217475|3943821|FG001|Treatment Period 2 (Year 2)|Physician Decision|0
2268214|NCT02217475|3943822|FG002|Treatment Period 2 (Year 2)|Physician Decision|2
2268215|NCT02217475|3943820|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
2268216|NCT02217475|3943821|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
2268217|NCT02217475|3943822|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
2268218|NCT02217501|3943841|FG000|Overall Study|Death|3
2268219|NCT02217501|3943842|FG001|Overall Study|Death|4
2268220|NCT02217527|3943850|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
2268221|NCT02217527|3943851|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
2268222|NCT02217527|3943850|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
2268223|NCT02217527|3943851|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
2268224|NCT02217566|3943857|FG000|Overall Study|Lost to Follow-up|2
2268225|NCT02217566|3943857|FG000|Overall Study|Death|3
2268226|NCT02217566|3943857|FG000|Overall Study|Early study termination|6
2268227|NCT02217878|3943879|FG000|Overall Study|required morphine due to chest pain|1
2268228|NCT02217878|3943880|FG001|Overall Study|required morphine due to chest pain|2
2268229|NCT02217878|3943879|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1
2268230|NCT02217878|3943880|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0
2268231|NCT02217982|3943911|FG000|Overall Study|Trial discontinued|1
2268232|NCT02217982|3943912|FG001|Overall Study|Trial discontinued|0
2268233|NCT02217982|3943911|FG000|Overall Study|Adverse Event|0
2268234|NCT02217982|3943912|FG001|Overall Study|Adverse Event|1
2268235|NCT02218008|3943921|FG000|Stage 1 (S1)|Adverse Event|6
2268236|NCT02218008|3943922|FG001|Stage 1 (S1)|Adverse Event|5
2268237|NCT02218008|3943923|FG002|Stage 1 (S1)|Adverse Event|11
2268238|NCT02218008|3943924|FG003|Stage 1 (S1)|Adverse Event|0
2268239|NCT02218008|3943925|FG004|Stage 1 (S1)|Adverse Event|0
2268240|NCT02218008|3943926|FG005|Stage 1 (S1)|Adverse Event|0
2268241|NCT02218008|3943921|FG000|Stage 1 (S1)|Withdrawal by Subject|6
2268242|NCT02218008|3943922|FG001|Stage 1 (S1)|Withdrawal by Subject|1
2268243|NCT02218008|3943923|FG002|Stage 1 (S1)|Withdrawal by Subject|1
2268244|NCT02218008|3943924|FG003|Stage 1 (S1)|Withdrawal by Subject|0
2268245|NCT02218008|3943925|FG004|Stage 1 (S1)|Withdrawal by Subject|0
2268246|NCT02218008|3943926|FG005|Stage 1 (S1)|Withdrawal by Subject|0
2268247|NCT02218008|3943921|FG000|Stage 1 (S1)|Lack of Efficacy|3
2268248|NCT02218008|3943922|FG001|Stage 1 (S1)|Lack of Efficacy|0
2268249|NCT02218008|3943923|FG002|Stage 1 (S1)|Lack of Efficacy|0
2268250|NCT02218008|3943924|FG003|Stage 1 (S1)|Lack of Efficacy|0
2348741|NCT04258995|4089083|FG001|Overall Study|Lost to Follow-up|1
2348742|NCT04317040|4089122|FG000|Overall Study|Lost to Follow-up|2
2348743|NCT04317040|4089123|FG001|Overall Study|Lost to Follow-up|0
2348744|NCT04317040|4089122|FG000|Overall Study|Death|16
2348745|NCT04317040|4089123|FG001|Overall Study|Death|18
2348746|NCT04317040|4089122|FG000|Overall Study|Withdrawal by Subject|0
2348747|NCT04317040|4089123|FG001|Overall Study|Withdrawal by Subject|1
2348748|NCT04317040|4089122|FG000|Overall Study|Incomplete assessments|0
2348749|NCT04317040|4089123|FG001|Overall Study|Incomplete assessments|1
2348750|NCT04319159|4089140|FG000|Overall Study|Screening failure|13
2348751|NCT04319159|4089140|FG000|Overall Study|Re-screening due to COVID-19 implications|2
2348752|NCT04319159|4089140|FG000|Overall Study|Withdrawal by Subject|1
2348753|NCT04331899|4089170|FG000|Trial Period (28 Days)|Withdrawal by Subject|2
2348754|NCT04331899|4089171|FG001|Trial Period (28 Days)|Withdrawal by Subject|2
2348755|NCT04334148|4089179|FG000|Overall Study|positive nasal swab at baseline|0
2348756|NCT04334148|4089180|FG001|Overall Study|positive nasal swab at baseline|1
2348757|NCT04347954|4089200|FG000|Overall Study|Did not present to study site for allocated intervention|3
2348758|NCT04347954|4089201|FG001|Overall Study|Did not present to study site for allocated intervention|0
2348759|NCT04347954|4089202|FG002|Overall Study|Did not present to study site for allocated intervention|3
2348760|NCT04347954|4089200|FG000|Overall Study|Lost to Follow-up|0
2348761|NCT04347954|4089201|FG001|Overall Study|Lost to Follow-up|1
2348762|NCT04347954|4089202|FG002|Overall Study|Lost to Follow-up|0
2348763|NCT04349098|4089212|FG000|Overall Study|Death|16
2348764|NCT04349098|4089213|FG001|Overall Study|Death|8
2348765|NCT04349098|4089212|FG000|Overall Study|Lost to Follow-up|11
2348766|NCT04349098|4089213|FG001|Overall Study|Lost to Follow-up|8
2348767|NCT04349098|4089212|FG000|Overall Study|Withdrawal by Subject|8
2348768|NCT04349098|4089213|FG001|Overall Study|Withdrawal by Subject|5
2348769|NCT04349098|4089212|FG000|Overall Study|Other|3
2348770|NCT04349098|4089213|FG001|Overall Study|Other|5
2348771|NCT04353037|4089223|FG000|Overall Study|Lost to Follow-up|0
2348772|NCT04353037|4089224|FG001|Overall Study|Lost to Follow-up|1
2348773|NCT04353037|4089225|FG002|Overall Study|Lost to Follow-up|2
2268251|NCT02218008|3943925|FG004|Stage 1 (S1)|Lack of Efficacy|0
2268252|NCT02218008|3943926|FG005|Stage 1 (S1)|Lack of Efficacy|0
2268253|NCT02218008|3943921|FG000|Stage 1 (S1)|Lost to Follow-up|3
2268254|NCT02218008|3943922|FG001|Stage 1 (S1)|Lost to Follow-up|0
2268255|NCT02218008|3943923|FG002|Stage 1 (S1)|Lost to Follow-up|1
2268256|NCT02218008|3943924|FG003|Stage 1 (S1)|Lost to Follow-up|0
2268257|NCT02218008|3943925|FG004|Stage 1 (S1)|Lost to Follow-up|0
2268258|NCT02218008|3943926|FG005|Stage 1 (S1)|Lost to Follow-up|0
2268259|NCT02218008|3943921|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2
2268260|NCT02218008|3943922|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1
2268261|NCT02218008|3943923|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0
2268262|NCT02218008|3943924|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0
2268263|NCT02218008|3943925|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0
2268264|NCT02218008|3943926|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0
2268265|NCT02218008|3943921|FG000|Stage 1 (S1)|Non-compliance; drug use|1
2268266|NCT02218008|3943922|FG001|Stage 1 (S1)|Non-compliance; drug use|0
2268267|NCT02218008|3943923|FG002|Stage 1 (S1)|Non-compliance; drug use|0
2268268|NCT02218008|3943924|FG003|Stage 1 (S1)|Non-compliance; drug use|0
2268269|NCT02218008|3943925|FG004|Stage 1 (S1)|Non-compliance; drug use|0
2268270|NCT02218008|3943926|FG005|Stage 1 (S1)|Non-compliance; drug use|0
2268271|NCT02218008|3943921|FG000|Stage 1 (S1)|Pregnancy|0
2268272|NCT02218008|3943922|FG001|Stage 1 (S1)|Pregnancy|0
2268273|NCT02218008|3943923|FG002|Stage 1 (S1)|Pregnancy|1
2268274|NCT02218008|3943924|FG003|Stage 1 (S1)|Pregnancy|0
2268275|NCT02218008|3943925|FG004|Stage 1 (S1)|Pregnancy|0
2268276|NCT02218008|3943926|FG005|Stage 1 (S1)|Pregnancy|0
2268277|NCT02218008|3943921|FG000|Stage 1 (S1)|Protocol Violation|0
2268278|NCT02218008|3943922|FG001|Stage 1 (S1)|Protocol Violation|0
2268279|NCT02218008|3943923|FG002|Stage 1 (S1)|Protocol Violation|1
2268280|NCT02218008|3943924|FG003|Stage 1 (S1)|Protocol Violation|0
2268281|NCT02218008|3943925|FG004|Stage 1 (S1)|Protocol Violation|0
2268282|NCT02218008|3943926|FG005|Stage 1 (S1)|Protocol Violation|0
2268283|NCT02218008|3943921|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
2268284|NCT02218008|3943922|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2268285|NCT02218008|3943923|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2268286|NCT02218008|3943924|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2268287|NCT02218008|3943925|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2268288|NCT02218008|3943926|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2268289|NCT02218008|3943921|FG000|Stage 2 (S2)|Adverse Event|0
2268290|NCT02218008|3943922|FG001|Stage 2 (S2)|Adverse Event|0
2268291|NCT02218008|3943923|FG002|Stage 2 (S2)|Adverse Event|0
2268292|NCT02218008|3943924|FG003|Stage 2 (S2)|Adverse Event|2
2268293|NCT02218008|3943925|FG004|Stage 2 (S2)|Adverse Event|3
2268294|NCT02218008|3943926|FG005|Stage 2 (S2)|Adverse Event|3
2268295|NCT02218008|3943921|FG000|Stage 2 (S2)|Withdrawal by Subject|0
2268296|NCT02218008|3943922|FG001|Stage 2 (S2)|Withdrawal by Subject|0
2348774|NCT04353037|4089226|FG003|Overall Study|Lost to Follow-up|3
2348775|NCT04353037|4089223|FG000|Overall Study|Withdrawal by Subject|0
2348776|NCT04353037|4089224|FG001|Overall Study|Withdrawal by Subject|2
2348777|NCT04353037|4089225|FG002|Overall Study|Withdrawal by Subject|3
2348778|NCT04353037|4089226|FG003|Overall Study|Withdrawal by Subject|5
2348779|NCT04353037|4089223|FG000|Overall Study|Adverse Event|0
2348780|NCT04353037|4089224|FG001|Overall Study|Adverse Event|0
2348781|NCT04353037|4089225|FG002|Overall Study|Adverse Event|2
2348782|NCT04353037|4089226|FG003|Overall Study|Adverse Event|0
2348783|NCT04353037|4089223|FG000|Overall Study|Exposure Change|0
2348784|NCT04353037|4089224|FG001|Overall Study|Exposure Change|0
2348785|NCT04353037|4089225|FG002|Overall Study|Exposure Change|0
2348786|NCT04353037|4089226|FG003|Overall Study|Exposure Change|2
2348787|NCT04355767|4089246|FG000|Overall Study|Withdrawal by Subject|2
2348788|NCT04355767|4089247|FG001|Overall Study|Withdrawal by Subject|2
2348789|NCT04355767|4089246|FG000|Overall Study|Death|5
2348790|NCT04355767|4089247|FG001|Overall Study|Death|1
2348791|NCT04356573|4089255|FG000|Overall Study|Didn't Qualify|1
2348792|NCT04356573|4089256|FG001|Overall Study|Didn't Qualify|0
2348793|NCT04358068|4089268|FG000|Overall Study|Did not initiate study treatment|2
2348794|NCT04358068|4089269|FG001|Overall Study|Did not initiate study treatment|2
2348795|NCT04366349|4089281|FG000|Overall Study|Withdrawal by Subject|1
2348796|NCT04366349|4089282|FG001|Overall Study|Withdrawal by Subject|0
2348797|NCT04366349|4089283|FG002|Overall Study|Withdrawal by Subject|0
2348798|NCT04366349|4089284|FG003|Overall Study|Withdrawal by Subject|0
2348799|NCT04366349|4089285|FG004|Overall Study|Withdrawal by Subject|0
2348800|NCT04366349|4089286|FG005|Overall Study|Withdrawal by Subject|0
2348801|NCT04382053|4089330|FG000|Overall Study|Death|6
2348802|NCT04382053|4089331|FG001|Overall Study|Death|8
2268297|NCT02218008|3943923|FG002|Stage 2 (S2)|Withdrawal by Subject|0
2268298|NCT02218008|3943924|FG003|Stage 2 (S2)|Withdrawal by Subject|1
2268299|NCT02218008|3943925|FG004|Stage 2 (S2)|Withdrawal by Subject|1
2268300|NCT02218008|3943926|FG005|Stage 2 (S2)|Withdrawal by Subject|0
2268301|NCT02218008|3943921|FG000|Stage 2 (S2)|Lack of Efficacy|0
2268302|NCT02218008|3943922|FG001|Stage 2 (S2)|Lack of Efficacy|0
2268303|NCT02218008|3943923|FG002|Stage 2 (S2)|Lack of Efficacy|0
2268304|NCT02218008|3943924|FG003|Stage 2 (S2)|Lack of Efficacy|0
2268305|NCT02218008|3943925|FG004|Stage 2 (S2)|Lack of Efficacy|0
2268306|NCT02218008|3943926|FG005|Stage 2 (S2)|Lack of Efficacy|2
2268307|NCT02218008|3943921|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2268308|NCT02218008|3943922|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2268309|NCT02218008|3943923|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2268310|NCT02218008|3943924|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
2268311|NCT02218008|3943925|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2268312|NCT02218008|3943926|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2268313|NCT02218008|3943921|FG000|Stage 2 (S2)|Lost to Follow-up|0
2268314|NCT02218008|3943922|FG001|Stage 2 (S2)|Lost to Follow-up|0
2268315|NCT02218008|3943923|FG002|Stage 2 (S2)|Lost to Follow-up|0
2268316|NCT02218008|3943924|FG003|Stage 2 (S2)|Lost to Follow-up|0
2268317|NCT02218008|3943925|FG004|Stage 2 (S2)|Lost to Follow-up|0
2268318|NCT02218008|3943926|FG005|Stage 2 (S2)|Lost to Follow-up|1
2268319|NCT02218216|3943977|FG000|Overall Study|Study terminated before completed|6
2268320|NCT02218216|3943978|FG001|Overall Study|Study terminated before completed|0
2268321|NCT02218216|3943979|FG002|Overall Study|Study terminated before completed|0
2268322|NCT02218268|3943991|FG000|24 Hour Washout|Physician Decision|11
2268323|NCT02218268|3943992|FG001|24 Hour Washout|Physician Decision|9
2268324|NCT02218372|3944018|FG000|Overall Study|Adverse Event|1
2268325|NCT02218372|3944019|FG001|Overall Study|Adverse Event|1
2268326|NCT02218372|3944018|FG000|Overall Study|Miscellaneous|2
2268327|NCT02218372|3944019|FG001|Overall Study|Miscellaneous|1
2268328|NCT02218372|3944018|FG000|Overall Study|Randomized but did not receive treatment|2
2268329|NCT02218372|3944019|FG001|Overall Study|Randomized but did not receive treatment|3
2268330|NCT02218372|3944018|FG000|Overall Study|Withdrawal by Parent/Guardian|0
2268331|NCT02218372|3944019|FG001|Overall Study|Withdrawal by Parent/Guardian|1
2268332|NCT02218489|3944050|FG000|Overall Study|Withdrawal by Subject|4
2268333|NCT02218489|3944051|FG001|Overall Study|Withdrawal by Subject|3
2268334|NCT02218489|3944050|FG000|Overall Study|Lost to Follow-up|1
2268335|NCT02218489|3944051|FG001|Overall Study|Lost to Follow-up|0
2268336|NCT02218541|3944060|FG000|Overall Study|Lost to Follow-up|2
2268337|NCT02218541|3944061|FG001|Overall Study|Lost to Follow-up|1
2268338|NCT02218541|3944060|FG000|Overall Study|Implant Failure|4
2268339|NCT02218541|3944061|FG001|Overall Study|Implant Failure|1
2348803|NCT04382053|4089330|FG000|Overall Study|Lost to Follow-up|0
2348804|NCT04382053|4089331|FG001|Overall Study|Lost to Follow-up|2
2348805|NCT04382053|4089330|FG000|Overall Study|Protocol Deviation|1
2348806|NCT04382053|4089331|FG001|Overall Study|Protocol Deviation|2
2348807|NCT04382053|4089330|FG000|Overall Study|Withdrawal by Subject|2
2348808|NCT04382053|4089331|FG001|Overall Study|Withdrawal by Subject|1
2348809|NCT04388826|4089340|FG000|Overall Study|Lost to Follow-up|3
2348810|NCT04388826|4089341|FG001|Overall Study|Lost to Follow-up|2
2348811|NCT04388826|4089340|FG000|Overall Study|Adverse Event|1
2348812|NCT04388826|4089341|FG001|Overall Study|Adverse Event|0
2348813|NCT04398732|4089353|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50
2348814|NCT04401293|4089361|FG000|Overall Study|Withdrawal by Subject|1
2348815|NCT04401293|4089362|FG001|Overall Study|Withdrawal by Subject|3
2348816|NCT04411628|4089372|FG000|Overall Study|Withdrawal by Subject|1
2348817|NCT04411628|4089373|FG001|Overall Study|Withdrawal by Subject|1
2348818|NCT04411628|4089374|FG002|Overall Study|Withdrawal by Subject|2
2348819|NCT04411628|4089375|FG003|Overall Study|Withdrawal by Subject|0
2348820|NCT04411628|4089372|FG000|Overall Study|Lost to Follow-up|0
2348821|NCT04411628|4089373|FG001|Overall Study|Lost to Follow-up|1
2348822|NCT04411628|4089374|FG002|Overall Study|Lost to Follow-up|0
2348823|NCT04411628|4089375|FG003|Overall Study|Lost to Follow-up|0
2348824|NCT04428411|4089427|FG000|Overall Study|Lost to Follow-up|114
2348825|NCT04435184|4089436|FG000|Overall Study|follow-up blood draws missing|3
2348826|NCT04435184|4089437|FG001|Overall Study|follow-up blood draws missing|5
2348827|NCT04476784|4089445|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1
2348828|NCT04476784|4089446|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0
2348829|NCT04492475|4089477|FG000|Overall Study|Enrolled but not treated|8
2348830|NCT04492475|4089478|FG001|Overall Study|Enrolled but not treated|8
2348831|NCT04492475|4089477|FG000|Overall Study|Withdrawal by Subject|4
2348832|NCT04492475|4089478|FG001|Overall Study|Withdrawal by Subject|0
2348833|NCT04492475|4089477|FG000|Overall Study|Became ineligible after enrollment|2
2348834|NCT04492475|4089478|FG001|Overall Study|Became ineligible after enrollment|0
2348835|NCT04495283|4089494|FG000|Overall Study|Physician Decision|0
2348836|NCT04495283|4089495|FG001|Overall Study|Physician Decision|0
2348837|NCT04495283|4089496|FG002|Overall Study|Physician Decision|1
2348838|NCT04495283|4089494|FG000|Overall Study|Withdrawal by Subject|0
2348839|NCT04495283|4089495|FG001|Overall Study|Withdrawal by Subject|1
2348840|NCT04495283|4089496|FG002|Overall Study|Withdrawal by Subject|1
2348841|NCT04495283|4089494|FG000|Overall Study|Other|1
2348842|NCT04495283|4089495|FG001|Overall Study|Other|0
2348843|NCT04495283|4089496|FG002|Overall Study|Other|1
2348844|NCT04497948|4089507|FG000|Overall Study|Death|2
2348845|NCT04501952|4089534|FG000|Overall Study|Adverse Event|0
2348846|NCT04501952|4089535|FG001|Overall Study|Adverse Event|3
2348847|NCT04501952|4089534|FG000|Overall Study|Investigator's Discretion|0
2268340|NCT02218736|3944070|FG000|Overall Study|Withdrawal by Subject|10
2268341|NCT02218736|3944071|FG001|Overall Study|Withdrawal by Subject|9
2268342|NCT02218736|3944070|FG000|Overall Study|Protocol Violation|2
2268343|NCT02218736|3944071|FG001|Overall Study|Protocol Violation|0
2268344|NCT02219009|3944079|FG000|Overall Study|Withdrawal by Subject|5
2268345|NCT02219009|3944080|FG001|Overall Study|Withdrawal by Subject|1
2268346|NCT02219009|3944079|FG000|Overall Study|Adverse Event|2
2268347|NCT02219009|3944080|FG001|Overall Study|Adverse Event|4
2268348|NCT02219009|3944079|FG000|Overall Study|Lost to Follow-up|2
2268349|NCT02219009|3944080|FG001|Overall Study|Lost to Follow-up|2
2268350|NCT02219009|3944079|FG000|Overall Study|Protocol deviation|1
2268351|NCT02219009|3944080|FG001|Overall Study|Protocol deviation|0
2268352|NCT02219009|3944079|FG000|Overall Study|Physician Decision|0
2268353|NCT02219009|3944080|FG001|Overall Study|Physician Decision|1
2268354|NCT02219048|3944088|FG000|Overall Study|Adverse Event|2
2268355|NCT02219048|3944089|FG001|Overall Study|Adverse Event|5
2268356|NCT02219048|3944088|FG000|Overall Study|No longer meets eligibility criteria|1
2268357|NCT02219048|3944089|FG001|Overall Study|No longer meets eligibility criteria|0
2268358|NCT02219048|3944088|FG000|Overall Study|Study terminated by sponsor|16
2268359|NCT02219048|3944089|FG001|Overall Study|Study terminated by sponsor|15
2268360|NCT02219048|3944088|FG000|Overall Study|Withdrawal by Subject|2
2268361|NCT02219048|3944089|FG001|Overall Study|Withdrawal by Subject|0
2268362|NCT02219048|3944088|FG000|Overall Study|Other|0
2268363|NCT02219048|3944089|FG001|Overall Study|Other|1
2268364|NCT02219087|3944097|FG000|Overall Study|Randomization envelope pulled out of seq|0
2268365|NCT02219087|3944098|FG001|Overall Study|Randomization envelope pulled out of seq|1
2268366|NCT02219308|3944168|FG000|Overall Study|Withdrawal by Subject|1
2268367|NCT02219308|3944169|FG001|Overall Study|Withdrawal by Subject|2
2268368|NCT02219334|3944186|FG000|Overall Study|Withdrawal by Subject|1
2268369|NCT02219334|3944187|FG001|Overall Study|Withdrawal by Subject|0
2268370|NCT02219334|3944186|FG000|Overall Study|Protocol Violation|7
2268371|NCT02219334|3944187|FG001|Overall Study|Protocol Violation|3
2268372|NCT02219464|3944206|FG000|Overall Study|Withdrawal by Subject|1
2268373|NCT02219464|3944207|FG001|Overall Study|Withdrawal by Subject|0
2268374|NCT02219464|3944206|FG000|Overall Study|case cancelled|1
2268375|NCT02219464|3944207|FG001|Overall Study|case cancelled|0
2268376|NCT02219464|3944206|FG000|Overall Study|catheter malfunction|1
2268377|NCT02219464|3944207|FG001|Overall Study|catheter malfunction|0
2268378|NCT02219477|3944216|FG000|Overall Study|Adverse Event|0
2268379|NCT02219477|3944217|FG001|Overall Study|Adverse Event|1
2268380|NCT02219477|3944218|FG002|Overall Study|Adverse Event|1
2268381|NCT02219477|3944216|FG000|Overall Study|Withdrawal by Subject|0
2268382|NCT02219477|3944217|FG001|Overall Study|Withdrawal by Subject|1
2268383|NCT02219477|3944218|FG002|Overall Study|Withdrawal by Subject|0
2268384|NCT02219685|3944250|FG000|Blinded Treatment Phase|Lost to Follow-up|1
2268385|NCT02219685|3944251|FG001|Blinded Treatment Phase|Lost to Follow-up|0
2348848|NCT04501952|4089535|FG001|Overall Study|Investigator's Discretion|1
2348849|NCT04501952|4089534|FG000|Overall Study|Protocol Violation|1
2348850|NCT04501952|4089535|FG001|Overall Study|Protocol Violation|1
2348851|NCT04501952|4089534|FG000|Overall Study|Withdrew Consent|5
2348852|NCT04501952|4089535|FG001|Overall Study|Withdrew Consent|4
2348853|NCT04501952|4089534|FG000|Overall Study|Lost to Follow-up|7
2348854|NCT04501952|4089535|FG001|Overall Study|Lost to Follow-up|2
2348855|NCT04501952|4089534|FG000|Overall Study|Randomized and Never Treated|13
2348856|NCT04501952|4089535|FG001|Overall Study|Randomized and Never Treated|9
2348857|NCT04504032|4089544|FG000|Overall Study|Adverse Event|1
2348858|NCT04504032|4089545|FG001|Overall Study|Adverse Event|2
2348859|NCT04504032|4089544|FG000|Overall Study|Lost to Follow-up|6
2348860|NCT04504032|4089545|FG001|Overall Study|Lost to Follow-up|9
2348861|NCT04504032|4089544|FG000|Overall Study|Protocol Violation|2
2348862|NCT04504032|4089545|FG001|Overall Study|Protocol Violation|0
2348863|NCT04504032|4089544|FG000|Overall Study|Study terminated by sponsor|1
2348864|NCT04504032|4089545|FG001|Overall Study|Study terminated by sponsor|2
2348865|NCT04504032|4089544|FG000|Overall Study|Withdrawal by Subject|9
2348866|NCT04504032|4089545|FG001|Overall Study|Withdrawal by Subject|11
2348867|NCT04504032|4089544|FG000|Overall Study|Disease progression prior to dosing|15
2348868|NCT04504032|4089545|FG001|Overall Study|Disease progression prior to dosing|3
2348869|NCT04504032|4089544|FG000|Overall Study|Drug supply issues|1
2348870|NCT04504032|4089545|FG001|Overall Study|Drug supply issues|1
2348871|NCT04504032|4089544|FG000|Overall Study|Progressed to moderate/severe COVID-19|1
2348872|NCT04504032|4089545|FG001|Overall Study|Progressed to moderate/severe COVID-19|0
2348873|NCT04507763|4089551|FG000|Overall Study|Participants did not meet entrance criteria|201
2348874|NCT04507867|4089560|FG000|Overall Study|Death|7
2348875|NCT04507867|4089561|FG001|Overall Study|Death|1
2348876|NCT04527978|4089606|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1
2348877|NCT04527978|4089607|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0
2348878|NCT04529109|4089628|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0
2348879|NCT04529109|4089629|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1
2348880|NCT04537234|4089648|FG000|Overall Study|Withdrawal by Subject|2
2348881|NCT04537234|4089649|FG001|Overall Study|Withdrawal by Subject|0
2348882|NCT04573972|4089726|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32
2348883|NCT04573972|4089727|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14
2348884|NCT04601103|4089762|FG000|Overall Study|Needed crown & cleaning|0
2348885|NCT04601103|4089763|FG001|Overall Study|Needed crown & cleaning|0
2348886|NCT04601103|4089764|FG002|Overall Study|Needed crown & cleaning|1
2348887|NCT04601103|4089762|FG000|Overall Study|study was terminated|18
2268386|NCT02219685|3944250|FG000|Blinded Treatment Phase|Withdrew Consent|1
2268387|NCT02219685|3944251|FG001|Blinded Treatment Phase|Withdrew Consent|0
2268388|NCT02219932|3944270|FG000|Overall Study|Other|5
2268389|NCT02219932|3944271|FG001|Overall Study|Other|11
2268390|NCT02219932|3944270|FG000|Overall Study|Death|1
2268391|NCT02219932|3944271|FG001|Overall Study|Death|1
2268392|NCT02219932|3944270|FG000|Overall Study|Investigator Decision|0
2268393|NCT02219932|3944271|FG001|Overall Study|Investigator Decision|1
2268394|NCT02219932|3944270|FG000|Overall Study|Consent Withdrawn|11
2268395|NCT02219932|3944271|FG001|Overall Study|Consent Withdrawn|7
2268396|NCT02219932|3944270|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10
2268397|NCT02219932|3944271|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2
2268398|NCT02219932|3944270|FG000|Overall Study|Protocol Violation|10
2268399|NCT02219932|3944271|FG001|Overall Study|Protocol Violation|6
2268400|NCT02219932|3944270|FG000|Overall Study|Pregnancy|1
2268401|NCT02219932|3944271|FG001|Overall Study|Pregnancy|0
2268402|NCT02219932|3944270|FG000|Overall Study|Lost to Follow-up|4
2268403|NCT02219932|3944271|FG001|Overall Study|Lost to Follow-up|2
2268404|NCT02219932|3944270|FG000|Overall Study|Adverse Event|23
2268405|NCT02219932|3944271|FG001|Overall Study|Adverse Event|21
2268406|NCT02220205|3944294|FG000|Overall Study|Withdrawal by Subject|1
2268407|NCT02220205|3944295|FG001|Overall Study|Withdrawal by Subject|0
2268408|NCT02220712|3944301|FG000|Overall Study|Adverse Event|1
2268409|NCT02220712|3944301|FG000|Overall Study|Withdrawal by Subject|2
2268410|NCT02220712|3944301|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1
2268411|NCT02220725|3944313|FG000|Overall Study|Lost to Follow-up|0
2268412|NCT02220725|3944314|FG001|Overall Study|Lost to Follow-up|0
2268413|NCT02220725|3944315|FG002|Overall Study|Lost to Follow-up|0
2268414|NCT02220725|3944316|FG003|Overall Study|Lost to Follow-up|1
2268415|NCT02220725|3944313|FG000|Overall Study|Withdrawal by Subject|0
2268416|NCT02220725|3944314|FG001|Overall Study|Withdrawal by Subject|0
2268417|NCT02220725|3944315|FG002|Overall Study|Withdrawal by Subject|0
2268418|NCT02220725|3944316|FG003|Overall Study|Withdrawal by Subject|1
2268419|NCT02220764|3944331|FG000|Overall Study|Lost to Follow-up|3
2268420|NCT02220764|3944332|FG001|Overall Study|Lost to Follow-up|1
2268421|NCT02220764|3944331|FG000|Overall Study|Death|1
2268422|NCT02220764|3944332|FG001|Overall Study|Death|0
2268423|NCT02220855|3944338|FG000|Overall Study|Adverse Event|8
2268424|NCT02220855|3944338|FG000|Overall Study|Disease Progression|5
2268425|NCT02220855|3944338|FG000|Overall Study|Withdrawal by Subject|1
2268426|NCT02220907|3944342|FG000|Overall Study|Adverse Event|7
2268427|NCT02220907|3944342|FG000|Overall Study|Physician Decision|1
2268428|NCT02220907|3944342|FG000|Overall Study|Withdrawal by Subject|2
2268429|NCT02220907|3944342|FG000|Overall Study|Conflict with the stopping criteria|1
2348888|NCT04601103|4089763|FG001|Overall Study|study was terminated|18
2348889|NCT04601103|4089764|FG002|Overall Study|study was terminated|16
2348890|NCT04664855|4089792|FG000|Overall Study|Withdrawal by Subject|0
2348891|NCT04664855|4089793|FG001|Overall Study|Withdrawal by Subject|2
2348892|NCT04701658|4089799|FG000|Overall Study|Lost to Follow-up|6
2348893|NCT04706416|4089805|FG000|Overall Study|Lost to Follow-up|2
2348894|NCT04706416|4089806|FG001|Overall Study|Lost to Follow-up|0
2268430|NCT02220920|3944348|FG000|Overall Study|Adverse Event|1
2268431|NCT02220920|3944349|FG001|Overall Study|Adverse Event|0
2268432|NCT02220920|3944348|FG000|Overall Study|Lack of Efficacy|0
2268433|NCT02220920|3944349|FG001|Overall Study|Lack of Efficacy|1
2268434|NCT02220920|3944348|FG000|Overall Study|Withdrawal by Subject|1
2268435|NCT02220920|3944349|FG001|Overall Study|Withdrawal by Subject|0
2268436|NCT02220920|3944348|FG000|Overall Study|Conflict with the stopping criteria|1
2268437|NCT02220920|3944349|FG001|Overall Study|Conflict with the stopping criteria|2
2268438|NCT02220998|3944357|FG000|Overall Study|Randomized but Never Treated|1
2268439|NCT02220998|3944358|FG001|Overall Study|Randomized but Never Treated|2
2268440|NCT02220998|3944357|FG000|Overall Study|Death|2
2348895|NCT04727749|4089835|FG000|Overall Study|Lost to Follow-up|10
2348896|NCT04727749|4089836|FG001|Overall Study|Lost to Follow-up|3
2348897|NCT04854707|4089858|FG000|Overall Study|Lack of Efficacy|78
2348898|NCT04854707|4089859|FG001|Overall Study|Lack of Efficacy|59
2348899|NCT04854707|4089860|FG002|Overall Study|Lack of Efficacy|30
2348900|NCT04947436|4089955|FG000|Overall Study|Lost to Follow-up|3
2348901|NCT04947436|4089956|FG001|Overall Study|Lost to Follow-up|7
2348902|NCT04947436|4089957|FG002|Overall Study|Lost to Follow-up|5
2348903|NCT04947436|4089955|FG000|Overall Study|Death|1
2348904|NCT04947436|4089956|FG001|Overall Study|Death|1
2348905|NCT04947436|4089957|FG002|Overall Study|Death|1
2348906|NCT05002972|4089965|FG000|Overall Study|Withdrawal by Subject|2
2348907|NCT05002985|4089969|FG000|Overall Study|Withdrawal by Subject|1
2348908|NCT04512482|4089975|FG000|Second Intervention (1 Day)|Protocol Violation|2
2348909|NCT04512482|4089976|FG001|Second Intervention (1 Day)|Protocol Violation|1
2348910|NCT04523831|4090001|FG000|Overall Study|Lost to Follow-up|15
2348911|NCT04523831|4090002|FG001|Overall Study|Lost to Follow-up|17
2348912|NCT04523831|4090001|FG000|Overall Study|Death|0
2348913|NCT04523831|4090002|FG001|Overall Study|Death|3
2348914|NCT04523831|4090001|FG000|Overall Study|Adverse Event|2
2348915|NCT04523831|4090002|FG001|Overall Study|Adverse Event|0
2348916|NCT04521777|4090011|FG000|Overall Study|Death|2
2348917|NCT04521777|4090011|FG000|Overall Study|Withdrawal by Subject|2
2348918|NCT04507776|4090041|FG000|Overall Study|Participants did not meet the entrance criteria|201
2348919|NCT04502979|4090052|FG000|Overall Study|Lost to Follow-up|1
2348920|NCT04502979|4090053|FG001|Overall Study|Lost to Follow-up|3
2348921|NCT04502979|4090052|FG000|Overall Study|Withdrawal by Subject|2
2268441|NCT02220998|3944358|FG001|Overall Study|Death|0
2268442|NCT02220998|3944357|FG000|Overall Study|Lack of Efficacy|0
2268443|NCT02220998|3944358|FG001|Overall Study|Lack of Efficacy|5
2268444|NCT02220998|3944357|FG000|Overall Study|Lost to Follow-up|4
2268445|NCT02220998|3944358|FG001|Overall Study|Lost to Follow-up|4
2268446|NCT02221284|3944385|FG000|Overall Study|Case Report Forms Uncollected|56
2268447|NCT02221284|3944385|FG000|Overall Study|Protocol Deviation|5
2268448|NCT02221648|3944410|FG000|Overall Study|Withdrawal by Subject|3
2268449|NCT02221648|3944411|FG001|Overall Study|Withdrawal by Subject|3
2268450|NCT02221674|3944424|FG000|Overall Study|Lost to Follow-up|1
2268451|NCT02221674|3944425|FG001|Overall Study|Lost to Follow-up|0
2268452|NCT02221674|3944426|FG002|Overall Study|Lost to Follow-up|0
2268453|NCT02221882|3944458|FG000|Overall Study|Withdrawal by Subject|0
2268454|NCT02221882|3944459|FG001|Overall Study|Withdrawal by Subject|0
2268455|NCT02221882|3944460|FG002|Overall Study|Withdrawal by Subject|4
2268456|NCT02221882|3944461|FG003|Overall Study|Withdrawal by Subject|2
2268457|NCT02221882|3944462|FG004|Overall Study|Withdrawal by Subject|2
2268458|NCT02221882|3944463|FG005|Overall Study|Withdrawal by Subject|2
2268459|NCT02221882|3944458|FG000|Overall Study|Death|0
2268460|NCT02221882|3944459|FG001|Overall Study|Death|1
2268461|NCT02221882|3944460|FG002|Overall Study|Death|0
2268462|NCT02221882|3944461|FG003|Overall Study|Death|0
2268463|NCT02221882|3944462|FG004|Overall Study|Death|0
2268464|NCT02221882|3944463|FG005|Overall Study|Death|0
2268465|NCT02222207|3944507|FG000|Overall Study|Death|1
2268466|NCT02222207|3944507|FG000|Overall Study|Other reasons|2
2268467|NCT02222207|3944507|FG000|Overall Study|Adverse Event|1
2268468|NCT02222246|3944513|FG000|Overall Study|No Emergency Department Visits|27
2268469|NCT02222246|3944514|FG001|Overall Study|No Emergency Department Visits|26
2268470|NCT02222246|3944513|FG000|Overall Study|Physician Decision|0
2268471|NCT02222246|3944514|FG001|Overall Study|Physician Decision|1
2268472|NCT02222493|3944537|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
2268473|NCT02222493|3944538|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
2268474|NCT02222493|3944537|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
2268475|NCT02222493|3944538|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
2268476|NCT02222493|3944537|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
2268477|NCT02222493|3944538|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
2268478|NCT02222493|3944537|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
2268479|NCT02222493|3944538|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
2268480|NCT02222493|3944537|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
2348922|NCT04502979|4090053|FG001|Overall Study|Withdrawal by Subject|1
2348923|NCT04498403|4090096|FG000|Overall Study|Adverse Event|1
2348924|NCT04498403|4090097|FG001|Overall Study|Adverse Event|0
2348925|NCT04498403|4090096|FG000|Overall Study|Study Terminated By Sponsor|29
2348926|NCT04498403|4090097|FG001|Overall Study|Study Terminated By Sponsor|10
2268481|NCT02222493|3944538|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
2268482|NCT02222493|3944537|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
2268483|NCT02222493|3944538|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
2268484|NCT02222493|3944537|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
2268485|NCT02222493|3944538|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
2268486|NCT02222493|3944537|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
2268487|NCT02222493|3944538|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
2268488|NCT02222493|3944537|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
2268489|NCT02222493|3944538|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
2268490|NCT02222493|3944537|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
2268491|NCT02222493|3944538|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
2268492|NCT02222493|3944537|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
2268493|NCT02222493|3944538|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
2268494|NCT02222493|3944537|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
2348927|NCT04495374|4090105|FG000|Overall Study|Protocol Violation|2
2348928|NCT04495374|4090106|FG001|Overall Study|Protocol Violation|1
2348929|NCT04491994|4090130|FG000|Overall Study|Withdrawal by Subject|10
2348930|NCT04491994|4090131|FG001|Overall Study|Withdrawal by Subject|5
2348931|NCT04491994|4090130|FG000|Overall Study|developed fever > 3 days|4
2348932|NCT04491994|4090131|FG001|Overall Study|developed fever > 3 days|1
2348933|NCT04491994|4090130|FG000|Overall Study|Protocol Violation|11
2348934|NCT04491994|4090131|FG001|Overall Study|Protocol Violation|2
2348935|NCT04491994|4090130|FG000|Overall Study|Lost to Follow-up|4
2348936|NCT04491994|4090131|FG001|Overall Study|Lost to Follow-up|3
2348937|NCT04490499|4090154|FG000|Overall Study|Withdrawal by Subject|2
2348938|NCT04486235|4090164|FG000|Overall Study|Pregnancy|1
2348939|NCT04486235|4090165|FG001|Overall Study|Pregnancy|0
2348940|NCT04486235|4090164|FG000|Overall Study|Lost to Follow-up|1
2348941|NCT04486235|4090165|FG001|Overall Study|Lost to Follow-up|0
2348942|NCT04483011|4090174|FG000|Washout (7 Days)|Withdrawal by Subject|0
2348943|NCT04483011|4090175|FG001|Washout (7 Days)|Withdrawal by Subject|1
2348944|NCT04475588|4090185|FG000|Overall Study|Adverse Event|2
2348945|NCT04475588|4090186|FG001|Overall Study|Adverse Event|0
2348946|NCT04474405|4090212|FG000|Overall Study|Withdrawal by Subject|0
2348947|NCT04474405|4090213|FG001|Overall Study|Withdrawal by Subject|0
2348948|NCT04474405|4090214|FG002|Overall Study|Withdrawal by Subject|1
2348949|NCT04474405|4090215|FG003|Overall Study|Withdrawal by Subject|0
2348950|NCT04474405|4090216|FG004|Overall Study|Withdrawal by Subject|1
2348951|NCT04474405|4090217|FG005|Overall Study|Withdrawal by Subject|0
2348952|NCT04474405|4090212|FG000|Overall Study|Other|0
2348953|NCT04474405|4090213|FG001|Overall Study|Other|0
2348954|NCT04474405|4090214|FG002|Overall Study|Other|0
2348955|NCT04474405|4090215|FG003|Overall Study|Other|0
2348956|NCT04474405|4090216|FG004|Overall Study|Other|3
2348957|NCT04474405|4090217|FG005|Overall Study|Other|0
2348958|NCT04468347|4090239|FG000|Overall Study|Withdrawal by Subject|0
2348959|NCT04468347|4090240|FG001|Overall Study|Withdrawal by Subject|1
2348960|NCT04468347|4090241|FG002|Overall Study|Withdrawal by Subject|3
2348961|NCT04468347|4090242|FG003|Overall Study|Withdrawal by Subject|3
2348962|NCT04468347|4090239|FG000|Overall Study|Lost to Follow-up|0
2348963|NCT04468347|4090240|FG001|Overall Study|Lost to Follow-up|0
2348964|NCT04468347|4090241|FG002|Overall Study|Lost to Follow-up|1
2348965|NCT04468347|4090242|FG003|Overall Study|Lost to Follow-up|1
2348966|NCT04468347|4090239|FG000|Overall Study|Physician Decision|1
2348967|NCT04468347|4090240|FG001|Overall Study|Physician Decision|0
2348968|NCT04468347|4090241|FG002|Overall Study|Physician Decision|2
2348969|NCT04468347|4090242|FG003|Overall Study|Physician Decision|0
2348970|NCT04468347|4090239|FG000|Overall Study|Protocol Violation|1
2348971|NCT04468347|4090240|FG001|Overall Study|Protocol Violation|0
2348972|NCT04468347|4090241|FG002|Overall Study|Protocol Violation|0
2348973|NCT04468347|4090242|FG003|Overall Study|Protocol Violation|0
2348974|NCT04465422|4090267|FG000|Overall Study|Lost to Follow-up|0
2348975|NCT04465422|4090268|FG001|Overall Study|Lost to Follow-up|2
2348976|NCT04463069|4090287|FG000|Overall Study|Withdrawal by Subject|2
2348977|NCT04463069|4090288|FG001|Overall Study|Withdrawal by Subject|10
2348978|NCT04463069|4090287|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0
2348979|NCT04463069|4090288|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13
2348980|NCT04448561|4090296|FG000|Overall Study|Noncompliance|1
2348981|NCT04448561|4090297|FG001|Overall Study|Noncompliance|0
2348982|NCT04450381|4090372|FG000|Overall Study|Protocol Violation|4
2348983|NCT04450381|4090372|FG000|Overall Study|Wrong device setting|2
2348984|NCT04449341|4090378|FG000|Overall Study|Protocol Violation|1
2348985|NCT04449341|4090379|FG001|Overall Study|Protocol Violation|0
2348986|NCT04440449|4090396|FG000|Overall Study|Lost to Follow-up|2
2348987|NCT04440449|4090397|FG001|Overall Study|Lost to Follow-up|0
2348988|NCT04439214|4090404|FG000|Overall Study|Adverse Event|13
2348989|NCT04439214|4090404|FG000|Overall Study|Disease progression|16
2348990|NCT04439214|4090404|FG000|Overall Study|Death|1
2348991|NCT04439214|4090404|FG000|Overall Study|Withdrawal by Subject|2
2348992|NCT04439214|4090404|FG000|Overall Study|Declining health|1
2348993|NCT04439214|4090404|FG000|Overall Study|Still receiving treatment at the time of the analysis|9
2268495|NCT02222493|3944538|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
2268496|NCT02222493|3944537|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
2268497|NCT02222493|3944538|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
2268498|NCT02222493|3944537|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
2268499|NCT02222493|3944538|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
2268500|NCT02222493|3944537|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
2268501|NCT02222493|3944538|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
2268502|NCT02222493|3944537|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
2268503|NCT02222493|3944538|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
2268504|NCT02222493|3944537|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
2268505|NCT02222493|3944538|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
2268506|NCT02222493|3944537|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
2268507|NCT02222493|3944538|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
2268508|NCT02222493|3944537|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
2268509|NCT02222493|3944538|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
2268510|NCT02222493|3944537|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
2348994|NCT04439214|4090404|FG000|Overall Study|Ineligible|5
2348995|NCT04439240|4090408|FG000|Overall Study|Ineligible|2
2348996|NCT04439240|4090408|FG000|Overall Study|Never started treatment|2
2348997|NCT04439240|4090408|FG000|Overall Study|Adverse Event|12
2348998|NCT04439240|4090408|FG000|Overall Study|Death|2
2348999|NCT04439240|4090408|FG000|Overall Study|Disease progression|25
2349000|NCT04439240|4090408|FG000|Overall Study|Other diseases|2
2349001|NCT04439240|4090408|FG000|Overall Study|Withdrawal by Subject|3
2349002|NCT04439240|4090408|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1
2349003|NCT04439240|4090408|FG000|Overall Study|Symptomatic decline|1
2349004|NCT04439240|4090408|FG000|Overall Study|Pogression of the lymphadenopathy|1
2349005|NCT04439240|4090408|FG000|Overall Study|Clinical progression|1
2349006|NCT04438785|4090414|FG000|Overall Study|change of weight, give up intervention|2
2349007|NCT04438785|4090415|FG001|Overall Study|change of weight, give up intervention|10
2349008|NCT04428502|4090504|FG000|Overall Study|Did not meet entrance criteria|14
2349009|NCT04428424|4090509|FG000|Overall Study|Does not meet entrance criteria|132
2349010|NCT04428424|4090509|FG000|Overall Study|Lost to Follow-up|115
2349011|NCT04425863|4090553|FG000|Overall Study|Death|0
2349012|NCT04425863|4090554|FG001|Overall Study|Death|0
2349013|NCT04425863|4090555|FG002|Overall Study|Death|1
2349014|NCT04422561|4090588|FG000|Overall Study|Lost to Follow-up|25
2349015|NCT04422561|4090589|FG001|Overall Study|Lost to Follow-up|11
2349016|NCT04419311|4090606|FG000|Overall Study|Lost to Follow-up|1
2349017|NCT04419311|4090607|FG001|Overall Study|Lost to Follow-up|0
2349018|NCT04411667|4090627|FG000|Overall Study|Physician Decision|1
2349019|NCT04411667|4090628|FG001|Overall Study|Physician Decision|0
2349020|NCT04407507|4090640|FG000|Overall Study|Withdrawal by Subject|0
2349021|NCT04407507|4090641|FG001|Overall Study|Withdrawal by Subject|1
2349022|NCT04406194|4090649|FG000|Period 1|Withdrawal by Subject|0
2349023|NCT04406194|4090650|FG001|Period 1|Withdrawal by Subject|1
2349024|NCT04404010|4090670|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1
2349025|NCT04404010|4090671|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0
2349026|NCT04403399|4090681|FG000|Period 2|Physician Decision|0
2349027|NCT04403399|4090682|FG001|Period 2|Physician Decision|1
2349028|NCT04401202|4090712|FG000|Overall Study|Lost to Follow-up|2
2349029|NCT04401202|4090713|FG001|Overall Study|Lost to Follow-up|2
2349030|NCT04401202|4090712|FG000|Overall Study|Adverse Event|0
2349031|NCT04401202|4090713|FG001|Overall Study|Adverse Event|1
2349032|NCT04401202|4090712|FG000|Overall Study|Hospitalized|4
2349033|NCT04401202|4090713|FG001|Overall Study|Hospitalized|1
2349034|NCT04401579|4090722|FG000|Overall Study|Death|23
2349035|NCT04401579|4090723|FG001|Overall Study|Death|36
2349036|NCT04401579|4090722|FG000|Overall Study|Lost to Follow-up|40
2349037|NCT04401579|4090723|FG001|Overall Study|Lost to Follow-up|41
2349038|NCT04401579|4090722|FG000|Overall Study|Withdrawal by Subject|8
2268511|NCT02222493|3944538|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
2268512|NCT02222493|3944537|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
2268513|NCT02222493|3944538|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
2268514|NCT02222493|3944537|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
2268515|NCT02222493|3944538|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
2268516|NCT02222558|3944557|FG000|Period 1: Single Dose|Withdrawal by Subject|4
2268517|NCT02222558|3944558|FG001|Period 1: Single Dose|Withdrawal by Subject|0
2268518|NCT02222558|3944559|FG002|Period 1: Single Dose|Withdrawal by Subject|0
2268519|NCT02222558|3944560|FG003|Period 1: Single Dose|Withdrawal by Subject|0
2268520|NCT02222558|3944561|FG004|Period 1: Single Dose|Withdrawal by Subject|0
2268521|NCT02222558|3944562|FG005|Period 1: Single Dose|Withdrawal by Subject|0
2268522|NCT02222558|3944557|FG000|Period 3|Withdrawal by Subject|0
2268523|NCT02222558|3944558|FG001|Period 3|Withdrawal by Subject|0
2268524|NCT02222558|3944559|FG002|Period 3|Withdrawal by Subject|0
2268525|NCT02222558|3944560|FG003|Period 3|Withdrawal by Subject|0
2268526|NCT02222558|3944561|FG004|Period 3|Withdrawal by Subject|0
2268527|NCT02222558|3944562|FG005|Period 3|Withdrawal by Subject|1
2268528|NCT02222688|3944596|FG000|Overall Study|Withdrawal by Subject|0
2268529|NCT02222688|3944597|FG001|Overall Study|Withdrawal by Subject|0
2268530|NCT02222688|3944598|FG002|Overall Study|Withdrawal by Subject|0
2268531|NCT02222688|3944599|FG003|Overall Study|Withdrawal by Subject|2
2268532|NCT02222688|3944600|FG004|Overall Study|Withdrawal by Subject|1
2268533|NCT02222688|3944601|FG005|Overall Study|Withdrawal by Subject|0
2268534|NCT02222688|3944602|FG006|Overall Study|Withdrawal by Subject|1
2268535|NCT02222688|3944596|FG000|Overall Study|Disease progression|1
2268536|NCT02222688|3944597|FG001|Overall Study|Disease progression|0
2268537|NCT02222688|3944598|FG002|Overall Study|Disease progression|0
2268538|NCT02222688|3944599|FG003|Overall Study|Disease progression|0
2268539|NCT02222688|3944600|FG004|Overall Study|Disease progression|0
2268540|NCT02222688|3944601|FG005|Overall Study|Disease progression|0
2268541|NCT02222688|3944602|FG006|Overall Study|Disease progression|0
2268542|NCT02222714|3944625|FG000|Overall Study|Death|0
2268543|NCT02222714|3944626|FG001|Overall Study|Death|2
2268544|NCT02222714|3944627|FG002|Overall Study|Death|3
2268545|NCT02222714|3944628|FG003|Overall Study|Death|4
2268546|NCT02222714|3944629|FG004|Overall Study|Death|6
2268547|NCT02222714|3944625|FG000|Overall Study|Withdrawal by Subject|0
2268548|NCT02222714|3944626|FG001|Overall Study|Withdrawal by Subject|0
2268549|NCT02222714|3944627|FG002|Overall Study|Withdrawal by Subject|1
2268550|NCT02222714|3944628|FG003|Overall Study|Withdrawal by Subject|0
2268551|NCT02222714|3944629|FG004|Overall Study|Withdrawal by Subject|1
2268552|NCT02222818|3944646|FG000|Period 1|Eligibility criteria not met|0
2268553|NCT02222818|3944647|FG001|Period 1|Eligibility criteria not met|3
2268554|NCT02222896|3944661|FG000|Abdomen|Did not qualify|34
2349039|NCT04401579|4090723|FG001|Overall Study|Withdrawal by Subject|16
2349040|NCT04401579|4090722|FG000|Overall Study|Physician Decision|1
2349041|NCT04401579|4090723|FG001|Overall Study|Physician Decision|2
2349042|NCT04401579|4090722|FG000|Overall Study|Became ineligible after enrollment|1
2349043|NCT04401579|4090723|FG001|Overall Study|Became ineligible after enrollment|1
2349044|NCT04401579|4090722|FG000|Overall Study|Enrolled but treatment not administered|7
2349045|NCT04401579|4090723|FG001|Overall Study|Enrolled but treatment not administered|9
2349046|NCT04401579|4090722|FG000|Overall Study|Adverse Event|2
2349047|NCT04401579|4090723|FG001|Overall Study|Adverse Event|1
2349048|NCT04401579|4090722|FG000|Overall Study|Scheduling error|1
2349049|NCT04401579|4090723|FG001|Overall Study|Scheduling error|2
2349050|NCT04401579|4090722|FG000|Overall Study|Transferred to another hospital|1
2349051|NCT04401579|4090723|FG001|Overall Study|Transferred to another hospital|2
2349052|NCT04400682|4090731|FG000|Period 1|Withdrawal by Subject|1
2349053|NCT04400682|4090732|FG001|Period 1|Withdrawal by Subject|4
2349054|NCT04399161|4090741|FG000|Overall Study|Withdrawal by Subject|1
2349055|NCT04399161|4090742|FG001|Overall Study|Withdrawal by Subject|0
2349056|NCT04399161|4090743|FG002|Overall Study|Withdrawal by Subject|2
2349057|NCT04399161|4090741|FG000|Overall Study|Protocol Violation|1
2349058|NCT04399161|4090742|FG001|Overall Study|Protocol Violation|2
2349059|NCT04399161|4090743|FG002|Overall Study|Protocol Violation|0
2349060|NCT04399122|4090762|FG000|Overall Study|Lost to Follow-up|2
2349061|NCT04399122|4090763|FG001|Overall Study|Lost to Follow-up|0
2349062|NCT04399122|4090762|FG000|Overall Study|Withdrawal by Subject|1
2349063|NCT04399122|4090763|FG001|Overall Study|Withdrawal by Subject|0
2349064|NCT04397445|4090769|FG000|Overall Study|Withdrawal by Subject|1
2349065|NCT04397445|4090770|FG001|Overall Study|Withdrawal by Subject|0
2349066|NCT04397445|4090771|FG002|Overall Study|Withdrawal by Subject|0
2349067|NCT04397445|4090772|FG003|Overall Study|Withdrawal by Subject|0
2349068|NCT04396639|4090798|FG000|Overall Study|Withdrawal by Subject|1
2268555|NCT02222896|3944662|FG001|Abdomen|Did not qualify|10
2268556|NCT02222896|3944663|FG002|Abdomen|Did not qualify|32
2268557|NCT02222896|3944661|FG000|Groin|Did not qualify|43
2268558|NCT02222896|3944662|FG001|Groin|Did not qualify|9
2268559|NCT02222896|3944663|FG002|Groin|Did not qualify|40
2268560|NCT02222922|3944683|FG000|Overall Study|Death|0
2268561|NCT02222922|3944684|FG001|Overall Study|Death|0
2268562|NCT02222922|3944685|FG002|Overall Study|Death|0
2268563|NCT02222922|3944686|FG003|Overall Study|Death|0
2268564|NCT02222922|3944687|FG004|Overall Study|Death|13
2268565|NCT02222922|3944688|FG005|Overall Study|Death|0
2268566|NCT02222922|3944689|FG006|Overall Study|Death|0
2268567|NCT02222922|3944690|FG007|Overall Study|Death|0
2268568|NCT02222922|3944691|FG008|Overall Study|Death|2
2268569|NCT02222922|3944683|FG000|Overall Study|Lost to Follow-up|0
2268570|NCT02222922|3944684|FG001|Overall Study|Lost to Follow-up|0
2268571|NCT02222922|3944685|FG002|Overall Study|Lost to Follow-up|1
2268572|NCT02222922|3944686|FG003|Overall Study|Lost to Follow-up|0
2268573|NCT02222922|3944687|FG004|Overall Study|Lost to Follow-up|9
2268574|NCT02222922|3944688|FG005|Overall Study|Lost to Follow-up|1
2268575|NCT02222922|3944689|FG006|Overall Study|Lost to Follow-up|0
2349069|NCT04396639|4090798|FG000|Overall Study|Other|1
2349070|NCT04393493|4090817|FG000|First 4 Days of Intervention|Early improvement|5
2349071|NCT04393493|4090818|FG001|First 4 Days of Intervention|Early improvement|7
2349072|NCT04391842|4090917|FG000|Overall Study|Withdrawal by Subject|2
2349073|NCT04386902|4090930|FG000|Overall Study|Withdrawal by Subject|5
2349074|NCT04386902|4090930|FG000|Overall Study|Technical problems in the recording|5
2349075|NCT04384523|4090949|FG000|Overall Study|Lost to Follow-up|0
2349076|NCT04384523|4090950|FG001|Overall Study|Lost to Follow-up|0
2349077|NCT04384523|4090951|FG002|Overall Study|Lost to Follow-up|0
2349078|NCT04384523|4090952|FG003|Overall Study|Lost to Follow-up|0
2349079|NCT04384523|4090953|FG004|Overall Study|Lost to Follow-up|0
2349080|NCT04384523|4090954|FG005|Overall Study|Lost to Follow-up|1
2349081|NCT04384523|4090949|FG000|Overall Study|Protocol Violation|0
2349082|NCT04384523|4090950|FG001|Overall Study|Protocol Violation|1
2268576|NCT02222922|3944690|FG007|Overall Study|Lost to Follow-up|0
2268577|NCT02222922|3944691|FG008|Overall Study|Lost to Follow-up|0
2268578|NCT02222922|3944683|FG000|Overall Study|Other|0
2268579|NCT02222922|3944684|FG001|Overall Study|Other|0
2268580|NCT02222922|3944685|FG002|Overall Study|Other|0
2268581|NCT02222922|3944686|FG003|Overall Study|Other|2
2268582|NCT02222922|3944687|FG004|Overall Study|Other|10
2268583|NCT02222922|3944688|FG005|Overall Study|Other|2
2268584|NCT02222922|3944689|FG006|Overall Study|Other|2
2268585|NCT02222922|3944690|FG007|Overall Study|Other|4
2268586|NCT02222922|3944691|FG008|Overall Study|Other|1
2268587|NCT02222922|3944683|FG000|Overall Study|Participant refused further follow-up|1
2268588|NCT02222922|3944684|FG001|Overall Study|Participant refused further follow-up|0
2268589|NCT02222922|3944685|FG002|Overall Study|Participant refused further follow-up|0
2268590|NCT02222922|3944686|FG003|Overall Study|Participant refused further follow-up|1
2268591|NCT02222922|3944687|FG004|Overall Study|Participant refused further follow-up|6
2268592|NCT02222922|3944688|FG005|Overall Study|Participant refused further follow-up|0
2268593|NCT02222922|3944689|FG006|Overall Study|Participant refused further follow-up|0
2268594|NCT02222922|3944690|FG007|Overall Study|Participant refused further follow-up|0
2268595|NCT02222922|3944691|FG008|Overall Study|Participant refused further follow-up|3
2268596|NCT02223364|3944767|FG000|Overall Study|Protocol Violation|3
2268597|NCT02223364|3944768|FG001|Overall Study|Protocol Violation|0
2268598|NCT02223364|3944769|FG002|Overall Study|Protocol Violation|3
2268599|NCT02223364|3944767|FG000|Overall Study|subject expired before surgery|1
2268600|NCT02223364|3944768|FG001|Overall Study|subject expired before surgery|0
2268601|NCT02223364|3944769|FG002|Overall Study|subject expired before surgery|0
2268602|NCT02223364|3944767|FG000|Overall Study|Physician Decision|1
2268603|NCT02223364|3944768|FG001|Overall Study|Physician Decision|0
2268604|NCT02223364|3944769|FG002|Overall Study|Physician Decision|0
2268605|NCT02223390|3944779|FG000|Overall Study|Lost to Follow-up|9
2268606|NCT02223390|3944780|FG001|Overall Study|Lost to Follow-up|4
2268607|NCT02223715|3944855|FG000|Overall Study|Death|31
2268608|NCT02223715|3944855|FG000|Overall Study|Lost to Follow-up|73
2268609|NCT02223754|3944864|FG000|Period 1|Adverse Event|1
2268610|NCT02223754|3944865|FG001|Period 1|Adverse Event|0
2268611|NCT02223754|3944864|FG000|Period 1|Lost to Follow-up|0
2268612|NCT02223754|3944865|FG001|Period 1|Lost to Follow-up|1
2268613|NCT02223754|3944864|FG000|Period 1|Protocol Violation|2
2268614|NCT02223754|3944865|FG001|Period 1|Protocol Violation|4
2268615|NCT02223754|3944864|FG000|Period 1|Withdrawal by Subject|0
2268616|NCT02223754|3944865|FG001|Period 1|Withdrawal by Subject|4
2268617|NCT02223754|3944864|FG000|Period 1|Test Article No Longer Available|1
2268618|NCT02223754|3944865|FG001|Period 1|Test Article No Longer Available|5
2268619|NCT02223754|3944864|FG000|Period 1|Unsatisfactory Visual Response|0
2268620|NCT02223754|3944865|FG001|Period 1|Unsatisfactory Visual Response|1
2268621|NCT02223754|3944864|FG000|Period 2|Adverse Event|0
2268622|NCT02223754|3944865|FG001|Period 2|Adverse Event|1
2268623|NCT02223754|3944864|FG000|Period 2|Protocol Violation|1
2268624|NCT02223754|3944865|FG001|Period 2|Protocol Violation|0
2268625|NCT02223754|3944864|FG000|Period 2|Lens Discomfort|1
2268626|NCT02223754|3944865|FG001|Period 2|Lens Discomfort|1
2268627|NCT02223754|3944864|FG000|Period 2|Lost to Follow-up|1
2268628|NCT02223754|3944865|FG001|Period 2|Lost to Follow-up|0
2268629|NCT02223754|3944864|FG000|Period 2|Test Article No Longer Available|0
2268630|NCT02223754|3944865|FG001|Period 2|Test Article No Longer Available|1
2268631|NCT02223793|3944875|FG000|Overall Study|Lost to Follow-up|10
2268632|NCT02223793|3944876|FG001|Overall Study|Lost to Follow-up|1
2268633|NCT02223793|3944877|FG002|Overall Study|Lost to Follow-up|2
2268634|NCT02223793|3944875|FG000|Overall Study|Withdrawal by Subject|3
2349083|NCT04384523|4090951|FG002|Overall Study|Protocol Violation|0
2268635|NCT02223793|3944876|FG001|Overall Study|Withdrawal by Subject|2
2268636|NCT02223793|3944877|FG002|Overall Study|Withdrawal by Subject|3
2268637|NCT02223793|3944875|FG000|Overall Study|Moved/studycenter unable to participate|4
2268638|NCT02223793|3944876|FG001|Overall Study|Moved/studycenter unable to participate|6
2268639|NCT02223793|3944877|FG002|Overall Study|Moved/studycenter unable to participate|8
2268640|NCT02223858|3944887|FG000|Overall Study|Death|1
2268641|NCT02223858|3944888|FG001|Overall Study|Death|1
2268642|NCT02223858|3944887|FG000|Overall Study|Lost to Follow-up|6
2268643|NCT02223858|3944888|FG001|Overall Study|Lost to Follow-up|11
2268644|NCT02223858|3944887|FG000|Overall Study|Withdrawal by Subject|8
2268645|NCT02223858|3944888|FG001|Overall Study|Withdrawal by Subject|5
2268646|NCT02223858|3944887|FG000|Overall Study|Refused|9
2268647|NCT02223858|3944888|FG001|Overall Study|Refused|9
2268648|NCT02224053|3944898|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
2268649|NCT02224053|3944898|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
2268650|NCT02224053|3944898|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3
2268651|NCT02224053|3944898|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
2268652|NCT02224053|3944898|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
2268653|NCT02224157|3944906|FG000|Overall Study|Severe non-compliance to protocol|2
2268654|NCT02224157|3944907|FG001|Overall Study|Severe non-compliance to protocol|2
2268655|NCT02224157|3944906|FG000|Overall Study|Other|13
2268656|NCT02224157|3944907|FG001|Overall Study|Other|10
2268657|NCT02224157|3944906|FG000|Overall Study|Subject decision|58
2268658|NCT02224157|3944907|FG001|Overall Study|Subject decision|50
2268659|NCT02224157|3944906|FG000|Overall Study|Prematurely closed site|4
2268660|NCT02224157|3944907|FG001|Overall Study|Prematurely closed site|2
2268661|NCT02224157|3944906|FG000|Overall Study|Eligibility criteria not fulfilled|4
2268662|NCT02224157|3944907|FG001|Overall Study|Eligibility criteria not fulfilled|8
2349084|NCT04384523|4090952|FG003|Overall Study|Protocol Violation|0
2349085|NCT04384523|4090953|FG004|Overall Study|Protocol Violation|0
2349086|NCT04384523|4090954|FG005|Overall Study|Protocol Violation|0
2349087|NCT04384523|4090949|FG000|Overall Study|Withdrawal by Subject|1
2349088|NCT04384523|4090950|FG001|Overall Study|Withdrawal by Subject|0
2349089|NCT04384523|4090951|FG002|Overall Study|Withdrawal by Subject|0
2349090|NCT04384523|4090952|FG003|Overall Study|Withdrawal by Subject|0
2349091|NCT04384523|4090953|FG004|Overall Study|Withdrawal by Subject|0
2349092|NCT04384523|4090954|FG005|Overall Study|Withdrawal by Subject|0
2268663|NCT02224157|3944906|FG000|Overall Study|Lost to Follow-up|27
2268664|NCT02224157|3944907|FG001|Overall Study|Lost to Follow-up|35
2268665|NCT02224157|3944906|FG000|Overall Study|Death|1
2268666|NCT02224157|3944907|FG001|Overall Study|Death|1
2268667|NCT02224157|3944906|FG000|Overall Study|Adverse Event|1
2268668|NCT02224157|3944907|FG001|Overall Study|Adverse Event|3
2268669|NCT02224274|3944915|FG000|Overall Study|Death|1
2268670|NCT02224274|3944916|FG001|Overall Study|Death|0
2268671|NCT02224560|3944957|FG000|Overall Study|Protocol Deviation|1
2268672|NCT02224560|3944958|FG001|Overall Study|Protocol Deviation|0
2268673|NCT02224560|3944959|FG002|Overall Study|Protocol Deviation|0
2268674|NCT02224560|3944957|FG000|Overall Study|Withdrawal by Subject|2
2268675|NCT02224560|3944958|FG001|Overall Study|Withdrawal by Subject|0
2268676|NCT02224560|3944959|FG002|Overall Study|Withdrawal by Subject|1
2268677|NCT02224560|3944957|FG000|Overall Study|Met Withdrawal Criteria|1
2268678|NCT02224560|3944958|FG001|Overall Study|Met Withdrawal Criteria|0
2268679|NCT02224560|3944959|FG002|Overall Study|Met Withdrawal Criteria|0
2268680|NCT02224560|3944957|FG000|Overall Study|Adverse Event|4
2268681|NCT02224560|3944958|FG001|Overall Study|Adverse Event|1
2268682|NCT02224560|3944959|FG002|Overall Study|Adverse Event|1
2268683|NCT02224560|3944957|FG000|Overall Study|Withdrawn by Investigator|1
2268684|NCT02224560|3944958|FG001|Overall Study|Withdrawn by Investigator|1
2268685|NCT02224560|3944959|FG002|Overall Study|Withdrawn by Investigator|0
2268686|NCT02224625|3944976|FG000|Irritation|Adverse Event|6
2268687|NCT02224625|3944976|FG000|Sensitization|Adverse Event|55
2268688|NCT02224638|3944990|FG000|Overall Study|Adverse Event|1
2268689|NCT02224638|3944991|FG001|Overall Study|Adverse Event|1
2268690|NCT02224664|3944999|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5
2268691|NCT02224664|3945000|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2268692|NCT02224664|3945001|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2268693|NCT02224664|3945002|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2268694|NCT02224664|3945003|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2268695|NCT02224664|3944999|FG000|Dose Escalation Period (21 Days)|Adverse Event|0
2268696|NCT02224664|3945000|FG001|Dose Escalation Period (21 Days)|Adverse Event|0
2268697|NCT02224664|3945001|FG002|Dose Escalation Period (21 Days)|Adverse Event|2
2268698|NCT02224664|3945002|FG003|Dose Escalation Period (21 Days)|Adverse Event|2
2268699|NCT02224664|3945003|FG004|Dose Escalation Period (21 Days)|Adverse Event|7
2268700|NCT02224664|3944999|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
2268701|NCT02224664|3945000|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
2268702|NCT02224664|3945001|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
2268703|NCT02224664|3945002|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
2268704|NCT02224664|3945003|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
2268705|NCT02224690|3945021|FG000|Overall Study|Adverse Event|8
2268706|NCT02224690|3945022|FG001|Overall Study|Adverse Event|1
2268707|NCT02224690|3945021|FG000|Overall Study|Met Withdrawal Criteria|4
2268708|NCT02224690|3945022|FG001|Overall Study|Met Withdrawal Criteria|0
2268709|NCT02224690|3945021|FG000|Overall Study|Use of G-tube|1
2268710|NCT02224690|3945022|FG001|Overall Study|Use of G-tube|0
2268711|NCT02224690|3945021|FG000|Overall Study|Did not meet eligibility criteria|1
2268712|NCT02224690|3945022|FG001|Overall Study|Did not meet eligibility criteria|0
2268713|NCT02224703|3945031|FG000|Overall Study|Adverse Event|0
2268714|NCT02224703|3945032|FG001|Overall Study|Adverse Event|5
2268715|NCT02224703|3945033|FG002|Overall Study|Adverse Event|0
2268716|NCT02224703|3945031|FG000|Overall Study|Withdrawn by investigator|1
2268717|NCT02224703|3945032|FG001|Overall Study|Withdrawn by investigator|0
2268718|NCT02224703|3945033|FG002|Overall Study|Withdrawn by investigator|0
2268719|NCT02224703|3945031|FG000|Overall Study|Advised by medical monitor|1
2268720|NCT02224703|3945032|FG001|Overall Study|Advised by medical monitor|0
2268721|NCT02224703|3945033|FG002|Overall Study|Advised by medical monitor|0
2268722|NCT02224703|3945031|FG000|Overall Study|Withdrawn by parent/guardian|0
2268723|NCT02224703|3945032|FG001|Overall Study|Withdrawn by parent/guardian|1
2268724|NCT02224703|3945033|FG002|Overall Study|Withdrawn by parent/guardian|0
2268725|NCT02224703|3945031|FG000|Overall Study|Lack of Efficacy|1
2268726|NCT02224703|3945032|FG001|Overall Study|Lack of Efficacy|0
2268727|NCT02224703|3945033|FG002|Overall Study|Lack of Efficacy|0
2268728|NCT02224755|3945048|FG000|Randomization to Device Implant|Withdrawn prior to implant|7
2268729|NCT02224755|3945049|FG001|Randomization to Device Implant|Withdrawn prior to implant|1
2268730|NCT02224755|3945048|FG000|Two Year Follow up Post-implant|Death|103
2268731|NCT02224755|3945049|FG001|Two Year Follow up Post-implant|Death|98
2268732|NCT02224755|3945048|FG000|Two Year Follow up Post-implant|Heart transplant|137
2268733|NCT02224755|3945049|FG001|Two Year Follow up Post-implant|Heart transplant|119
2268734|NCT02224755|3945048|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
2268735|NCT02224755|3945049|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
2268736|NCT02224755|3945048|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15
2268737|NCT02224755|3945049|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6
2268738|NCT02224846|3945065|FG000|Period 1 (Month 3)|Adverse Event|2
2268739|NCT02224846|3945066|FG001|Period 1 (Month 3)|Adverse Event|1
2268740|NCT02224846|3945065|FG000|Period 1 (Month 3)|Lost to Follow-up|3
2268741|NCT02224846|3945066|FG001|Period 1 (Month 3)|Lost to Follow-up|8
2268742|NCT02224846|3945065|FG000|Period 1 (Month 3)|Protocol Violation|4
2268743|NCT02224846|3945066|FG001|Period 1 (Month 3)|Protocol Violation|8
2268744|NCT02224846|3945065|FG000|Period 1 (Month 3)|Withdrawal by Subject|8
2268745|NCT02224846|3945066|FG001|Period 1 (Month 3)|Withdrawal by Subject|18
2268746|NCT02224846|3945065|FG000|Period 1 (Month 3)|Sponsor Decision|2
2268747|NCT02224846|3945066|FG001|Period 1 (Month 3)|Sponsor Decision|1
2268748|NCT02224846|3945065|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1
2268749|NCT02224846|3945066|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2
2268750|NCT02224846|3945065|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
2268751|NCT02224846|3945066|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
2268752|NCT02224846|3945065|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0
2268753|NCT02224846|3945066|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3
2268754|NCT02224846|3945065|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
2268755|NCT02224846|3945066|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
2268756|NCT02224846|3945065|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0
2268757|NCT02224846|3945066|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2
2268758|NCT02224846|3945065|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3
2268759|NCT02224846|3945066|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4
2268760|NCT02224846|3945065|FG000|Period 2 (Month 12 to Month 24)|Death|1
2268761|NCT02224846|3945066|FG001|Period 2 (Month 12 to Month 24)|Death|0
2268762|NCT02224846|3945065|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
2268763|NCT02224846|3945066|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
2349093|NCT04382066|4090999|FG000|Overall Study|Adverse Event|1
2268764|NCT02224846|3945065|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4
2268765|NCT02224846|3945066|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11
2268766|NCT02224846|3945065|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
2268767|NCT02224846|3945066|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
2268768|NCT02224846|3945065|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0
2268769|NCT02224846|3945066|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2
2268770|NCT02224846|3945065|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
2268771|NCT02224846|3945066|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
2349094|NCT04382066|4091000|FG001|Overall Study|Adverse Event|0
2349095|NCT04382066|4091001|FG002|Overall Study|Adverse Event|0
2349096|NCT04382066|4090999|FG000|Overall Study|Death|1
2349097|NCT04382066|4091000|FG001|Overall Study|Death|0
2349098|NCT04382066|4091001|FG002|Overall Study|Death|1
2349099|NCT04380688|4091062|FG000|Overall Study|Death|2
2349100|NCT04380688|4091063|FG001|Overall Study|Death|2
2349101|NCT04380688|4091062|FG000|Overall Study|Lost to Follow-up|2
2349102|NCT04380688|4091063|FG001|Overall Study|Lost to Follow-up|4
2349103|NCT04380688|4091062|FG000|Overall Study|Withdrawal by Subject|3
2349104|NCT04380688|4091063|FG001|Overall Study|Withdrawal by Subject|3
2349105|NCT04376060|4091069|FG000|Overall Study|Physician Decision|1
2349106|NCT04372186|4091088|FG000|Overall Study|Death|24
2349107|NCT04372186|4091089|FG001|Overall Study|Death|11
2349108|NCT04372186|4091088|FG000|Overall Study|Transferred to a different facility for care|0
2349109|NCT04372186|4091089|FG001|Overall Study|Transferred to a different facility for care|2
2349110|NCT04370028|4091163|FG000|Overall Study|Withdrawal by Subject|695
2349111|NCT04370028|4091163|FG000|Overall Study|Protocol Violation|9
2349112|NCT04370028|4091163|FG000|Overall Study|Adverse Event|3
2349113|NCT04368429|4091176|FG000|Overall Study|Adverse Event|1
2349114|NCT04368429|4091177|FG001|Overall Study|Adverse Event|0
2349115|NCT04363736|4091185|FG000|Overall Study|Withdrawal by Subject|1
2349116|NCT04363736|4091186|FG001|Overall Study|Withdrawal by Subject|0
2349117|NCT04363736|4091185|FG000|Overall Study|Lost to Follow-up|10
2349118|NCT04363736|4091186|FG001|Overall Study|Lost to Follow-up|7
2349119|NCT04363736|4091185|FG000|Overall Study|Death|8
2349120|NCT04363736|4091186|FG001|Overall Study|Death|6
2349121|NCT04365699|4091204|FG000|Overall Study|Death|2
2349122|NCT04365699|4091205|FG001|Overall Study|Death|5
2349123|NCT04365699|4091206|FG002|Overall Study|Death|15
2349124|NCT04362137|4091239|FG000|Overall Study|Death|9
2349125|NCT04362137|4091240|FG001|Overall Study|Death|3
2349126|NCT04362137|4091239|FG000|Overall Study|Patient decision|6
2349127|NCT04362137|4091240|FG001|Overall Study|Patient decision|3
2349128|NCT04362137|4091239|FG000|Overall Study|Adverse Event|1
2349129|NCT04362137|4091240|FG001|Overall Study|Adverse Event|0
2349130|NCT04362137|4091239|FG000|Overall Study|Lost to Follow-up|1
2349131|NCT04362137|4091240|FG001|Overall Study|Lost to Follow-up|0
2349132|NCT04362137|4091239|FG000|Overall Study|Protocol deviation|1
2349133|NCT04362137|4091240|FG001|Overall Study|Protocol deviation|0
2349134|NCT04359771|4091248|FG000|Overall Study|Lack of Efficacy|2
2349135|NCT04359771|4091249|FG001|Overall Study|Lack of Efficacy|2
2349136|NCT04358081|4091262|FG000|Treatment Phase of Study|Withdrawal by Subject|0
2349137|NCT04358081|4091263|FG001|Treatment Phase of Study|Withdrawal by Subject|1
2349138|NCT04358081|4091264|FG002|Treatment Phase of Study|Withdrawal by Subject|1
2349139|NCT04358081|4091262|FG000|Treatment Phase of Study|Adverse Event|1
2349140|NCT04358081|4091263|FG001|Treatment Phase of Study|Adverse Event|0
2349141|NCT04358081|4091264|FG002|Treatment Phase of Study|Adverse Event|1
2349142|NCT04358081|4091262|FG000|Treatment Phase of Study|Physician Decision|2
2349143|NCT04358081|4091263|FG001|Treatment Phase of Study|Physician Decision|0
2349144|NCT04358081|4091264|FG002|Treatment Phase of Study|Physician Decision|1
2349145|NCT04358081|4091262|FG000|Treatment Phase of Study|Protocol Violation|1
2349146|NCT04358081|4091263|FG001|Treatment Phase of Study|Protocol Violation|0
2349147|NCT04358081|4091264|FG002|Treatment Phase of Study|Protocol Violation|0
2349148|NCT04358081|4091262|FG000|Study Completion Phase|Death|0
2349149|NCT04358081|4091263|FG001|Study Completion Phase|Death|0
2349150|NCT04358081|4091264|FG002|Study Completion Phase|Death|1
2349151|NCT04358081|4091262|FG000|Study Completion Phase|Lost to Follow-up|1
2349152|NCT04358081|4091263|FG001|Study Completion Phase|Lost to Follow-up|0
2349153|NCT04358081|4091264|FG002|Study Completion Phase|Lost to Follow-up|1
2349154|NCT04356937|4091276|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0
2268772|NCT02225223|3945086|FG000|Overall Study|Death|10
2268773|NCT02225223|3945087|FG001|Overall Study|Death|1
2268774|NCT02225223|3945086|FG000|Overall Study|Lost to Follow-up|5
2268775|NCT02225223|3945087|FG001|Overall Study|Lost to Follow-up|0
2268776|NCT02225223|3945086|FG000|Overall Study|Other|1
2268777|NCT02225223|3945087|FG001|Overall Study|Other|2
2268778|NCT02225223|3945086|FG000|Overall Study|Physician Decision|1
2268779|NCT02225223|3945087|FG001|Overall Study|Physician Decision|0
2268780|NCT02225223|3945086|FG000|Overall Study|Withdrawal by Subject|2
2268781|NCT02225223|3945087|FG001|Overall Study|Withdrawal by Subject|2
2268782|NCT02225353|3945096|FG000|Overall Study|Lost to Follow-up|0
2268783|NCT02225353|3945097|FG001|Overall Study|Lost to Follow-up|1
2268784|NCT02225353|3945098|FG002|Overall Study|Lost to Follow-up|3
2268785|NCT02225353|3945096|FG000|Overall Study|Protocol Violation|4
2268786|NCT02225353|3945097|FG001|Overall Study|Protocol Violation|5
2268787|NCT02225353|3945098|FG002|Overall Study|Protocol Violation|12
2268788|NCT02225587|3945111|FG000|Overall Study|Adverse Event|5
2268789|NCT02225587|3945112|FG001|Overall Study|Adverse Event|5
2268790|NCT02225587|3945111|FG000|Overall Study|Lost to Follow-up|5
2268791|NCT02225587|3945112|FG001|Overall Study|Lost to Follow-up|5
2268792|NCT02225587|3945111|FG000|Overall Study|Non-Compliance With Study Drug|1
2268793|NCT02225587|3945112|FG001|Overall Study|Non-Compliance With Study Drug|0
2268794|NCT02225587|3945111|FG000|Overall Study|Physician Decision|2
2268795|NCT02225587|3945112|FG001|Overall Study|Physician Decision|0
2268796|NCT02225587|3945111|FG000|Overall Study|Protocol Violation|1
2268797|NCT02225587|3945112|FG001|Overall Study|Protocol Violation|0
2268798|NCT02225587|3945111|FG000|Overall Study|Participant Moved|1
2268799|NCT02225587|3945112|FG001|Overall Study|Participant Moved|0
2268800|NCT02225587|3945111|FG000|Overall Study|Withdrawal by Subject|13
2268801|NCT02225587|3945112|FG001|Overall Study|Withdrawal by Subject|28
2268802|NCT02225665|3945120|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1
2268803|NCT02225665|3945121|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0
2268804|NCT02225665|3945120|FG000|Overall Study|Subject restarted HAART prior to month 18.|0
2268805|NCT02225665|3945121|FG001|Overall Study|Subject restarted HAART prior to month 18.|1
2268806|NCT02225743|3945127|FG000|Overall Study|Withdrawal by Subject|18
2268807|NCT02226003|3945148|FG000|Overall Study|Lost to Follow-up|2
2268808|NCT02226003|3945149|FG001|Overall Study|Lost to Follow-up|1
2268809|NCT02226003|3945150|FG002|Overall Study|Lost to Follow-up|3
2268810|NCT02226003|3945148|FG000|Overall Study|Withdrawal by Subject|0
2268811|NCT02226003|3945149|FG001|Overall Study|Withdrawal by Subject|0
2268812|NCT02226003|3945150|FG002|Overall Study|Withdrawal by Subject|3
2268813|NCT02226120|3945158|FG000|Overall Study|Adverse Event|60
2268814|NCT02226120|3945158|FG000|Overall Study|Death|172
2268815|NCT02226120|3945158|FG000|Overall Study|Study terminated by sponsor|1
2268816|NCT02226120|3945158|FG000|Overall Study|Technical problems|4
2268817|NCT02226120|3945158|FG000|Overall Study|Lost to Follow-up|13
2268818|NCT02226120|3945158|FG000|Overall Study|Physician Decision|21
2268819|NCT02226120|3945158|FG000|Overall Study|Withdrawal by parent/guardian|36
2268820|NCT02226120|3945158|FG000|Overall Study|Non-compliance with study drug|10
2268821|NCT02226120|3945158|FG000|Overall Study|Protocol deviation|1
2268822|NCT02226120|3945158|FG000|Overall Study|missing treatment disposition pages|2
2268823|NCT02226172|3945171|FG000|Overall Study|Participant refused further follow-up|4
2268824|NCT02226172|3945171|FG000|Overall Study|Other|5
2268825|NCT02226172|3945171|FG000|Overall Study|Death|1
2268826|NCT02226172|3945171|FG000|Overall Study|Study terminated by sponsor|1
2268827|NCT02226172|3945171|FG000|Overall Study|Adverse Event|6
2268828|NCT02226198|3945175|FG000|Lead-in Phase|Protocol Violation|1
2268829|NCT02226198|3945176|FG001|Lead-in Phase|Protocol Violation|0
2268830|NCT02226198|3945177|FG002|Lead-in Phase|Protocol Violation|0
2268831|NCT02226198|3945175|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
2268832|NCT02226198|3945176|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
2268833|NCT02226198|3945177|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
2268834|NCT02226549|3945205|FG000|Overall Study|Randomized but Never Treated|1
2268835|NCT02226549|3945206|FG001|Overall Study|Randomized but Never Treated|0
2268836|NCT02226549|3945205|FG000|Overall Study|Lost to Follow-up|0
2268837|NCT02226549|3945206|FG001|Overall Study|Lost to Follow-up|1
2268838|NCT02226562|3945214|FG000|Overall Study|Lost to Follow-up|0
2268839|NCT02226562|3945215|FG001|Overall Study|Lost to Follow-up|1
2268840|NCT02226653|3945223|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1
2268841|NCT02226653|3945224|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0
2268842|NCT02226653|3945223|FG000|Treatment Period 5 Fed State|Adverse Event|0
2268843|NCT02226653|3945224|FG001|Treatment Period 5 Fed State|Adverse Event|1
2268844|NCT02227108|3945248|FG000|Overall Study|Did not receive treatment|2
2268845|NCT02227108|3945248|FG000|Overall Study|Other|3
2268846|NCT02227108|3945248|FG000|Overall Study|Progressive disease|17
2268847|NCT02227108|3945248|FG000|Overall Study|Initiation of alternative therapy|2
2268848|NCT02227108|3945248|FG000|Overall Study|Investigator discretion|1
2268849|NCT02227108|3945248|FG000|Overall Study|Adverse Event|6
2268850|NCT02227147|3945258|FG000|Controlled Treatment Period|Adverse Event|4
2268851|NCT02227147|3945259|FG001|Controlled Treatment Period|Adverse Event|3
2268852|NCT02227147|3945258|FG000|Controlled Treatment Period|Other|2
2268853|NCT02227147|3945259|FG001|Controlled Treatment Period|Other|0
2268854|NCT02227147|3945258|FG000|Follow-up Period|Other|3
2268855|NCT02227147|3945259|FG001|Follow-up Period|Other|5
2268856|NCT02227368|3945297|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
2268857|NCT02227368|3945298|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
2268858|NCT02227368|3945297|FG000|Overall Study|Lost to Follow-up|1
2268859|NCT02227368|3945298|FG001|Overall Study|Lost to Follow-up|0
2268860|NCT02227368|3945297|FG000|Overall Study|Adverse Event|1
2268861|NCT02227368|3945298|FG001|Overall Study|Adverse Event|0
2268862|NCT02227446|3945306|FG000|Overall Study|not eligible post randomization|18
2268863|NCT02227446|3945307|FG001|Overall Study|not eligible post randomization|29
2268864|NCT02227446|3945306|FG000|Overall Study|Withdrawal by Subject|4
2268865|NCT02227446|3945307|FG001|Overall Study|Withdrawal by Subject|5
2268866|NCT02227784|3945367|FG000|Double-Blind Phase|Adverse Event|3
2268867|NCT02227784|3945368|FG001|Double-Blind Phase|Adverse Event|2
2349155|NCT04356937|4091277|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1
2349156|NCT04355663|4091286|FG000|Overall Study|Physician Decision|2
2349157|NCT04355663|4091287|FG001|Overall Study|Physician Decision|7
2349158|NCT04355663|4091288|FG002|Overall Study|Physician Decision|0
2349159|NCT04355663|4091286|FG000|Overall Study|Adverse Event|0
2349160|NCT04355663|4091287|FG001|Overall Study|Adverse Event|0
2349161|NCT04355663|4091288|FG002|Overall Study|Adverse Event|1
2349162|NCT04355663|4091286|FG000|Overall Study|Withdrawal by Subject|0
2349163|NCT04355663|4091287|FG001|Overall Study|Withdrawal by Subject|8
2349164|NCT04355663|4091288|FG002|Overall Study|Withdrawal by Subject|3
2349165|NCT04354870|4091298|FG000|Overall Study|Lost to Follow-up|32
2349166|NCT04354870|4091299|FG001|Overall Study|Lost to Follow-up|12
2349167|NCT04354870|4091298|FG000|Overall Study|Withdrawal by Subject|10
2349168|NCT04354870|4091299|FG001|Overall Study|Withdrawal by Subject|16
2349169|NCT04354870|4091298|FG000|Overall Study|Did not complete all study visits|6
2349170|NCT04354870|4091299|FG001|Overall Study|Did not complete all study visits|5
2349171|NCT04350788|4091325|FG000|Overall Study|Lost to Follow-up|6
2349172|NCT04350788|4091326|FG001|Overall Study|Lost to Follow-up|2
2349173|NCT04350788|4091325|FG000|Overall Study|Withdrawal by Subject|2
2349174|NCT04350788|4091326|FG001|Overall Study|Withdrawal by Subject|4
2349175|NCT04350788|4091325|FG000|Overall Study|Protocol Violation|4
2349176|NCT04350788|4091326|FG001|Overall Study|Protocol Violation|0
2349177|NCT04349917|4091339|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0
2349178|NCT04349917|4091340|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1
2349179|NCT04349917|4091339|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0
2349180|NCT04349917|4091340|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1
2349181|NCT04348851|4091351|FG000|Post-Test 1|Withdrawal by Subject|0
2349182|NCT04348851|4091352|FG001|Post-Test 1|Withdrawal by Subject|1
2349183|NCT04348851|4091353|FG002|Post-Test 1|Withdrawal by Subject|0
2349184|NCT04348851|4091354|FG003|Post-Test 1|Withdrawal by Subject|0
2349185|NCT04348851|4091351|FG000|Post-Test 1|Lost to Follow-up|0
2349186|NCT04348851|4091352|FG001|Post-Test 1|Lost to Follow-up|1
2349187|NCT04348851|4091353|FG002|Post-Test 1|Lost to Follow-up|0
2349188|NCT04348851|4091354|FG003|Post-Test 1|Lost to Follow-up|0
2349189|NCT04348851|4091351|FG000|Post-Test 2|Stroke survivor death|0
2349190|NCT04348851|4091352|FG001|Post-Test 2|Stroke survivor death|1
2349191|NCT04348851|4091353|FG002|Post-Test 2|Stroke survivor death|0
2349192|NCT04348851|4091354|FG003|Post-Test 2|Stroke survivor death|1
2349193|NCT04346199|4091375|FG000|Overall Study|Death|8
2349194|NCT04346199|4091376|FG001|Overall Study|Death|9
2349195|NCT04346199|4091375|FG000|Overall Study|Lost to Follow-up|0
2349196|NCT04346199|4091376|FG001|Overall Study|Lost to Follow-up|1
2349197|NCT04346199|4091375|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2
2349198|NCT04346199|4091376|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0
2349199|NCT04346199|4091375|FG000|Overall Study|Withdrawal by Subject|5
2349200|NCT04346199|4091376|FG001|Overall Study|Withdrawal by Subject|1
2349201|NCT04345653|4091382|FG000|Overall Study|Withdrawal by Subject|2
2349202|NCT04343261|4091387|FG000|Overall Study|Adverse Event|1
2349203|NCT04343261|4091387|FG000|Overall Study|received inadequate amount of antibodies|7
2349204|NCT04342897|4091419|FG000|Overall Study|Death|7
2349205|NCT04342897|4091420|FG001|Overall Study|Death|4
2349206|NCT04342897|4091419|FG000|Overall Study|Lost to Follow-up|6
2349207|NCT04342897|4091420|FG001|Overall Study|Lost to Follow-up|6
2349208|NCT04342897|4091419|FG000|Overall Study|Withdrawal by Subject|1
2349209|NCT04342897|4091420|FG001|Overall Study|Withdrawal by Subject|2
2349210|NCT04340557|4091432|FG000|Overall Study|Transferred to ICU and/or death|1
2349211|NCT04340557|4091433|FG001|Overall Study|Transferred to ICU and/or death|2
2349212|NCT04339972|4091441|FG000|Overall Study|Scheduling Issues|3
2349213|NCT04339972|4091442|FG001|Overall Study|Scheduling Issues|3
2349214|NCT04339972|4091441|FG000|Overall Study|dropout|1
2349215|NCT04339972|4091442|FG001|Overall Study|dropout|1
2349216|NCT04339972|4091441|FG000|Overall Study|Technical issues|1
2349217|NCT04339972|4091442|FG001|Overall Study|Technical issues|0
2349218|NCT04339972|4091441|FG000|Overall Study|Claustraphobia|0
2349219|NCT04339972|4091442|FG001|Overall Study|Claustraphobia|1
2349220|NCT04339296|4091450|FG000|Overall Study|Refuse to participate after allocation|1
2349221|NCT04339296|4091451|FG001|Overall Study|Refuse to participate after allocation|1
2349222|NCT04339296|4091450|FG000|Overall Study|Withdrew after completion of baseline|2
2349223|NCT04339296|4091451|FG001|Overall Study|Withdrew after completion of baseline|1
2349224|NCT04339296|4091450|FG000|Overall Study|Lost to Follow-up|0
2349225|NCT04339296|4091451|FG001|Overall Study|Lost to Follow-up|4
2349226|NCT04339296|4091450|FG000|Overall Study|Discontinued intervention|5
2349227|NCT04339296|4091451|FG001|Overall Study|Discontinued intervention|3
2349228|NCT04336475|4091481|FG000|Overall Study|pain|1
2349229|NCT04336475|4091482|FG001|Overall Study|pain|0
2349230|NCT04336475|4091481|FG000|Overall Study|upper respiratory infection|1
2349231|NCT04336475|4091482|FG001|Overall Study|upper respiratory infection|0
2349232|NCT04336475|4091481|FG000|Overall Study|Lost to Follow-up|0
2349233|NCT04336475|4091482|FG001|Overall Study|Lost to Follow-up|2
2349234|NCT04335929|4091488|FG000|Overall Study|Lost to Follow-up|10
2349235|NCT04335812|4091494|FG000|Overall Study|Withdrawal by Subject|1
2268868|NCT02227784|3945369|FG002|Double-Blind Phase|Adverse Event|1
2268869|NCT02227784|3945370|FG003|Double-Blind Phase|Adverse Event|3
2268870|NCT02227784|3945371|FG004|Double-Blind Phase|Adverse Event|0
2268871|NCT02227784|3945367|FG000|Double-Blind Phase|Physician Decision|1
2268872|NCT02227784|3945368|FG001|Double-Blind Phase|Physician Decision|0
2268873|NCT02227784|3945369|FG002|Double-Blind Phase|Physician Decision|0
2268874|NCT02227784|3945370|FG003|Double-Blind Phase|Physician Decision|1
2268875|NCT02227784|3945371|FG004|Double-Blind Phase|Physician Decision|0
2268876|NCT02227784|3945367|FG000|Double-Blind Phase|Protocol Violation|0
2268877|NCT02227784|3945368|FG001|Double-Blind Phase|Protocol Violation|0
2268878|NCT02227784|3945369|FG002|Double-Blind Phase|Protocol Violation|1
2268879|NCT02227784|3945370|FG003|Double-Blind Phase|Protocol Violation|1
2268880|NCT02227784|3945371|FG004|Double-Blind Phase|Protocol Violation|0
2268881|NCT02227784|3945367|FG000|Double-Blind Phase|Sponsor Decision|34
2268882|NCT02227784|3945368|FG001|Double-Blind Phase|Sponsor Decision|15
2268883|NCT02227784|3945369|FG002|Double-Blind Phase|Sponsor Decision|14
2268884|NCT02227784|3945370|FG003|Double-Blind Phase|Sponsor Decision|32
2268885|NCT02227784|3945371|FG004|Double-Blind Phase|Sponsor Decision|0
2268886|NCT02227784|3945367|FG000|Double-Blind Phase|Withdrawal by Subject|2
2268887|NCT02227784|3945368|FG001|Double-Blind Phase|Withdrawal by Subject|1
2268888|NCT02227784|3945369|FG002|Double-Blind Phase|Withdrawal by Subject|5
2268889|NCT02227784|3945370|FG003|Double-Blind Phase|Withdrawal by Subject|2
2268890|NCT02227784|3945371|FG004|Double-Blind Phase|Withdrawal by Subject|0
2268891|NCT02227784|3945367|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0
2268892|NCT02227784|3945368|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0
2268893|NCT02227784|3945369|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0
2268894|NCT02227784|3945370|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0
2268895|NCT02227784|3945371|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1
2268896|NCT02227784|3945367|FG000|Open-Label Extension Phase (OLE)|Death|0
2268897|NCT02227784|3945368|FG001|Open-Label Extension Phase (OLE)|Death|0
2268898|NCT02227784|3945369|FG002|Open-Label Extension Phase (OLE)|Death|0
2268899|NCT02227784|3945370|FG003|Open-Label Extension Phase (OLE)|Death|0
2268900|NCT02227784|3945371|FG004|Open-Label Extension Phase (OLE)|Death|1
2268901|NCT02227784|3945367|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2268902|NCT02227784|3945368|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2268903|NCT02227784|3945369|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2268904|NCT02227784|3945370|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2268905|NCT02227784|3945371|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243
2268906|NCT02227784|3945367|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2268907|NCT02227784|3945368|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2268908|NCT02227784|3945369|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2268909|NCT02227784|3945370|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2268910|NCT02227784|3945371|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
2268911|NCT02227849|3945399|FG000|Overall Study|Adverse Event|4
2268912|NCT02227849|3945399|FG000|Overall Study|Physician Decision|1
2268913|NCT02227849|3945399|FG000|Overall Study|Withdrawal by Subject|3
2268914|NCT02227862|3945405|FG000|Overall Study|Protocol Violation|7
2268915|NCT02227862|3945406|FG001|Overall Study|Protocol Violation|9
2268916|NCT02227862|3945405|FG000|Overall Study|Other|0
2268917|NCT02227862|3945406|FG001|Overall Study|Other|2
2268918|NCT02227862|3945405|FG000|Overall Study|Adverse Event|4
2268919|NCT02227862|3945406|FG001|Overall Study|Adverse Event|3
2268920|NCT02227862|3945405|FG000|Overall Study|Withdrawal by Subject|7
2268921|NCT02227862|3945406|FG001|Overall Study|Withdrawal by Subject|6
2268922|NCT02227862|3945405|FG000|Overall Study|Lost to Follow-up|1
2268923|NCT02227862|3945406|FG001|Overall Study|Lost to Follow-up|2
2268924|NCT02227875|3945414|FG000|Overall Study|Protocol Violation|10
2349236|NCT04335812|4091495|FG001|Overall Study|Withdrawal by Subject|3
2349237|NCT04335812|4091494|FG000|Overall Study|Lost to Follow-up|12
2349238|NCT04335812|4091495|FG001|Overall Study|Lost to Follow-up|12
2349239|NCT04335812|4091494|FG000|Overall Study|Did not engage in the intervention|22
2349240|NCT04335812|4091495|FG001|Overall Study|Did not engage in the intervention|18
2349241|NCT04335136|4091503|FG000|Overall Study|Death|8
2349242|NCT04335136|4091504|FG001|Overall Study|Death|4
2349243|NCT04335136|4091503|FG000|Overall Study|Lost to Follow-up|2
2349244|NCT04335136|4091504|FG001|Overall Study|Lost to Follow-up|0
2349245|NCT04335136|4091503|FG000|Overall Study|Protocol Violation|1
2349246|NCT04335136|4091504|FG001|Overall Study|Protocol Violation|0
2349247|NCT04335136|4091503|FG000|Overall Study|Withdrawal by Subject|1
2349248|NCT04335136|4091504|FG001|Overall Study|Withdrawal by Subject|1
2349249|NCT04335136|4091503|FG000|Overall Study|Health-threatening condition|0
2349250|NCT04335136|4091504|FG001|Overall Study|Health-threatening condition|1
2349251|NCT04335136|4091503|FG000|Overall Study|Adverse Event|0
2349252|NCT04335136|4091504|FG001|Overall Study|Adverse Event|1
2268925|NCT02227875|3945415|FG001|Overall Study|Protocol Violation|7
2268926|NCT02227875|3945414|FG000|Overall Study|Other|1
2268927|NCT02227875|3945415|FG001|Overall Study|Other|3
2268928|NCT02227875|3945414|FG000|Overall Study|Physician Decision|1
2268929|NCT02227875|3945415|FG001|Overall Study|Physician Decision|0
2268930|NCT02227875|3945414|FG000|Overall Study|Adverse Event|3
2268931|NCT02227875|3945415|FG001|Overall Study|Adverse Event|0
2268932|NCT02227875|3945414|FG000|Overall Study|Withdrawal by Subject|12
2268933|NCT02227875|3945415|FG001|Overall Study|Withdrawal by Subject|13
2268934|NCT02227875|3945414|FG000|Overall Study|Lost to Follow-up|10
2268935|NCT02227875|3945415|FG001|Overall Study|Lost to Follow-up|10
2349253|NCT04335136|4091503|FG000|Overall Study|Erroneously randomized|2
2349254|NCT04335136|4091504|FG001|Overall Study|Erroneously randomized|0
2349255|NCT04333199|4091554|FG000|Evaluated Patients|Lost to Follow-up|0
2349256|NCT04333199|4091555|FG001|Evaluated Patients|Lost to Follow-up|1
2349257|NCT04333199|4091556|FG002|Evaluated Patients|Lost to Follow-up|2
2349258|NCT04332419|4091617|FG000|Overall Study|Withdrawal by Subject|1
2349259|NCT04332107|4091632|FG000|Day 3|Lost to Follow-up|23
2349260|NCT04332107|4091633|FG001|Day 3|Lost to Follow-up|14
2349261|NCT04332107|4091632|FG000|Day 3|Missing outcome data|3
2349262|NCT04332107|4091633|FG001|Day 3|Missing outcome data|6
2349263|NCT04332107|4091632|FG000|Day 14|Lost to Follow-up|13
2349264|NCT04332107|4091633|FG001|Day 14|Lost to Follow-up|4
2349265|NCT04332107|4091632|FG000|Day 14|Missing outcome data|4
2349266|NCT04332107|4091633|FG001|Day 14|Missing outcome data|4
2349267|NCT04332107|4091632|FG000|Day 21|Lost to Follow-up|10
2349268|NCT04332107|4091633|FG001|Day 21|Lost to Follow-up|2
2349269|NCT04329923|4091667|FG000|Overall Study|Withdrawal by Subject|1
2349270|NCT04329923|4091668|FG001|Overall Study|Withdrawal by Subject|4
2349271|NCT04329923|4091669|FG002|Overall Study|Withdrawal by Subject|1
2349272|NCT04329923|4091670|FG003|Overall Study|Withdrawal by Subject|1
2349273|NCT04329923|4091671|FG004|Overall Study|Withdrawal by Subject|1
2349274|NCT04329923|4091672|FG005|Overall Study|Withdrawal by Subject|1
2349275|NCT04329923|4091667|FG000|Overall Study|early termination of study|0
2349276|NCT04329923|4091668|FG001|Overall Study|early termination of study|0
2349277|NCT04329923|4091669|FG002|Overall Study|early termination of study|0
2349278|NCT04329923|4091670|FG003|Overall Study|early termination of study|0
2349279|NCT04329923|4091671|FG004|Overall Study|early termination of study|1
2349280|NCT04329923|4091672|FG005|Overall Study|early termination of study|2
2349281|NCT04329923|4091667|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0
2349282|NCT04329923|4091668|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0
2349283|NCT04329923|4091669|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0
2349284|NCT04329923|4091670|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0
2349285|NCT04329923|4091671|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0
2349286|NCT04329923|4091672|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2
2349287|NCT04328467|4091689|FG000|Overall Study|Did not meet inclusion criteria after randomization|4
2349288|NCT04328467|4091690|FG001|Overall Study|Did not meet inclusion criteria after randomization|2
2349289|NCT04328467|4091691|FG002|Overall Study|Did not meet inclusion criteria after randomization|1
2349290|NCT04327388|4091702|FG000|Overall Study|Adverse Event|17
2349291|NCT04327388|4091703|FG001|Overall Study|Adverse Event|18
2349292|NCT04327388|4091704|FG002|Overall Study|Adverse Event|9
2349293|NCT04327388|4091702|FG000|Overall Study|Other|1
2349294|NCT04327388|4091703|FG001|Overall Study|Other|2
2349295|NCT04327388|4091704|FG002|Overall Study|Other|0
2349296|NCT04327388|4091702|FG000|Overall Study|Randomized and not treated|2
2349297|NCT04327388|4091703|FG001|Overall Study|Randomized and not treated|0
2349298|NCT04327388|4091704|FG002|Overall Study|Randomized and not treated|2
2349299|NCT04322526|4091714|FG000|First Intervention (1 Day)|Withdrawal by Subject|1
2349300|NCT04322526|4091715|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
2349301|NCT04322526|4091714|FG000|Washout (1 Week)|Lost to Follow-up|1
2349302|NCT04322526|4091715|FG001|Washout (1 Week)|Lost to Follow-up|2
2349303|NCT04322682|4091732|FG000|Overall Study|Withdrawal by Subject|33
2349304|NCT04322682|4091733|FG001|Overall Study|Withdrawal by Subject|47
2349305|NCT04322682|4091732|FG000|Overall Study|Death|5
2349306|NCT04322682|4091733|FG001|Overall Study|Death|9
2349307|NCT04322682|4091732|FG000|Overall Study|Lost to Follow-up|4
2349308|NCT04322682|4091733|FG001|Overall Study|Lost to Follow-up|8
2349309|NCT04322682|4091732|FG000|Overall Study|Admitted to Hospital and Intubated|1
2349310|NCT04322682|4091733|FG001|Overall Study|Admitted to Hospital and Intubated|0
2349311|NCT04320615|4091784|FG000|Overall Study|Withdrawal by Subject|4
2349312|NCT04320615|4091785|FG001|Overall Study|Withdrawal by Subject|10
2349313|NCT04320615|4091784|FG000|Overall Study|Physician Decision|2
2349314|NCT04320615|4091785|FG001|Overall Study|Physician Decision|0
2349315|NCT04320615|4091784|FG000|Overall Study|Other|2
2349316|NCT04320615|4091785|FG001|Overall Study|Other|0
2349317|NCT04320615|4091784|FG000|Overall Study|Lost to Follow-up|5
2349318|NCT04320615|4091785|FG001|Overall Study|Lost to Follow-up|23
2349319|NCT04320615|4091784|FG000|Overall Study|Death|35
2349320|NCT04320615|4091785|FG001|Overall Study|Death|71
2349321|NCT04318535|4091795|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
2349322|NCT04318535|4091796|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1
2349323|NCT04318535|4091797|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
2349324|NCT04314037|4091818|FG000|Treatment Period 2|Adverse Event|1
2349325|NCT04314037|4091819|FG001|Treatment Period 2|Adverse Event|0
2349326|NCT04314037|4091818|FG000|Treatment Period 3|Protocol Violation|1
2349327|NCT04314037|4091819|FG001|Treatment Period 3|Protocol Violation|0
2349328|NCT04314037|4091818|FG000|Treatment Period 3|Adverse Event|0
2349329|NCT04314037|4091819|FG001|Treatment Period 3|Adverse Event|1
2349330|NCT04315298|4091850|FG000|Overall Study|Withdrawal by Subject|0
2349331|NCT04315298|4091851|FG001|Overall Study|Withdrawal by Subject|0
2349332|NCT04315298|4091852|FG002|Overall Study|Withdrawal by Subject|0
2268936|NCT02228096|3945423|FG000|Overall Study|Study terminated by Sponsor|24
2268937|NCT02228096|3945423|FG000|Overall Study|Lack of Efficacy|18
2268938|NCT02228096|3945423|FG000|Overall Study|Death|12
2268939|NCT02228096|3945423|FG000|Overall Study|Physician Decision|3
2268940|NCT02228096|3945423|FG000|Overall Study|Subject/guardian decision|2
2268941|NCT02228096|3945423|FG000|Overall Study|New therapy for study indication|1
2268942|NCT02228096|3945423|FG000|Overall Study|Enrolled, not infused|11
2268943|NCT02228395|3945445|FG000|First Intervention Period|No longer willing to participate|1
2268944|NCT02228395|3945446|FG001|First Intervention Period|No longer willing to participate|0
2268945|NCT02228395|3945447|FG002|First Intervention Period|No longer willing to participate|0
2349333|NCT04315298|4091853|FG003|Overall Study|Withdrawal by Subject|2
2349334|NCT04315298|4091854|FG004|Overall Study|Withdrawal by Subject|2
2349335|NCT04315298|4091855|FG005|Overall Study|Withdrawal by Subject|2
2349336|NCT04315298|4091856|FG006|Overall Study|Withdrawal by Subject|0
2349337|NCT04315298|4091857|FG007|Overall Study|Withdrawal by Subject|1
2349338|NCT04315298|4091858|FG008|Overall Study|Withdrawal by Subject|1
2349339|NCT04315298|4091859|FG009|Overall Study|Withdrawal by Subject|1
2349340|NCT04315298|4091860|FG010|Overall Study|Withdrawal by Subject|0
2349341|NCT04315298|4091861|FG011|Overall Study|Withdrawal by Subject|0
2349342|NCT04315298|4091862|FG012|Overall Study|Withdrawal by Subject|0
2349343|NCT04315298|4091863|FG013|Overall Study|Withdrawal by Subject|0
2349344|NCT04315298|4091864|FG014|Overall Study|Withdrawal by Subject|0
2349345|NCT04315298|4091865|FG015|Overall Study|Withdrawal by Subject|0
2349346|NCT04315298|4091866|FG016|Overall Study|Withdrawal by Subject|0
2349347|NCT04315298|4091867|FG017|Overall Study|Withdrawal by Subject|0
2349348|NCT04315298|4091868|FG018|Overall Study|Withdrawal by Subject|0
2349349|NCT04315298|4091850|FG000|Overall Study|Physician Decision|0
2349350|NCT04315298|4091851|FG001|Overall Study|Physician Decision|0
2349351|NCT04315298|4091852|FG002|Overall Study|Physician Decision|0
2349352|NCT04315298|4091853|FG003|Overall Study|Physician Decision|0
2349353|NCT04315298|4091854|FG004|Overall Study|Physician Decision|1
2349354|NCT04315298|4091855|FG005|Overall Study|Physician Decision|0
2349355|NCT04315298|4091856|FG006|Overall Study|Physician Decision|0
2349356|NCT04315298|4091857|FG007|Overall Study|Physician Decision|0
2349357|NCT04315298|4091858|FG008|Overall Study|Physician Decision|0
2349358|NCT04315298|4091859|FG009|Overall Study|Physician Decision|0
2349359|NCT04315298|4091860|FG010|Overall Study|Physician Decision|0
2349360|NCT04315298|4091861|FG011|Overall Study|Physician Decision|0
2349361|NCT04315298|4091862|FG012|Overall Study|Physician Decision|0
2349362|NCT04315298|4091863|FG013|Overall Study|Physician Decision|0
2349363|NCT04315298|4091864|FG014|Overall Study|Physician Decision|0
2349364|NCT04315298|4091865|FG015|Overall Study|Physician Decision|0
2349365|NCT04315298|4091866|FG016|Overall Study|Physician Decision|0
2349366|NCT04315298|4091867|FG017|Overall Study|Physician Decision|0
2349367|NCT04315298|4091868|FG018|Overall Study|Physician Decision|0
2349368|NCT04315298|4091850|FG000|Overall Study|Lost to Follow-up|5
2349369|NCT04315298|4091851|FG001|Overall Study|Lost to Follow-up|10
2349370|NCT04315298|4091852|FG002|Overall Study|Lost to Follow-up|6
2349371|NCT04315298|4091853|FG003|Overall Study|Lost to Follow-up|8
2349372|NCT04315298|4091854|FG004|Overall Study|Lost to Follow-up|12
2349373|NCT04315298|4091855|FG005|Overall Study|Lost to Follow-up|13
2349374|NCT04315298|4091856|FG006|Overall Study|Lost to Follow-up|9
2349375|NCT04315298|4091857|FG007|Overall Study|Lost to Follow-up|16
2349376|NCT04315298|4091858|FG008|Overall Study|Lost to Follow-up|14
2349377|NCT04315298|4091859|FG009|Overall Study|Lost to Follow-up|0
2349378|NCT04315298|4091860|FG010|Overall Study|Lost to Follow-up|2
2349379|NCT04315298|4091861|FG011|Overall Study|Lost to Follow-up|1
2349380|NCT04315298|4091862|FG012|Overall Study|Lost to Follow-up|0
2349381|NCT04315298|4091863|FG013|Overall Study|Lost to Follow-up|0
2349382|NCT04315298|4091864|FG014|Overall Study|Lost to Follow-up|0
2349383|NCT04315298|4091865|FG015|Overall Study|Lost to Follow-up|2
2349384|NCT04315298|4091866|FG016|Overall Study|Lost to Follow-up|0
2349385|NCT04315298|4091867|FG017|Overall Study|Lost to Follow-up|0
2349386|NCT04315298|4091868|FG018|Overall Study|Lost to Follow-up|0
2349387|NCT04315298|4091850|FG000|Overall Study|Death|24
2349388|NCT04315298|4091851|FG001|Overall Study|Death|60
2349389|NCT04315298|4091852|FG002|Overall Study|Death|49
2349390|NCT04315298|4091853|FG003|Overall Study|Death|59
2349391|NCT04315298|4091854|FG004|Overall Study|Death|70
2349392|NCT04315298|4091855|FG005|Overall Study|Death|114
2349393|NCT04315298|4091856|FG006|Overall Study|Death|9
2349394|NCT04315298|4091857|FG007|Overall Study|Death|12
2349395|NCT04315298|4091858|FG008|Overall Study|Death|21
2349396|NCT04315298|4091859|FG009|Overall Study|Death|16
2349397|NCT04315298|4091860|FG010|Overall Study|Death|40
2349398|NCT04315298|4091861|FG011|Overall Study|Death|40
2349399|NCT04315298|4091862|FG012|Overall Study|Death|3
2349400|NCT04315298|4091863|FG013|Overall Study|Death|4
2349401|NCT04315298|4091864|FG014|Overall Study|Death|6
2349402|NCT04315298|4091865|FG015|Overall Study|Death|4
2349403|NCT04315298|4091866|FG016|Overall Study|Death|3
2349404|NCT04315298|4091867|FG017|Overall Study|Death|1
2349405|NCT04315298|4091868|FG018|Overall Study|Death|0
2349406|NCT04308239|4091978|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
2349407|NCT04308239|4091979|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
2349408|NCT04308239|4091978|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
2268946|NCT02228395|3945445|FG000|First Intervention Period|Unable to comply with study dates|0
2268947|NCT02228395|3945446|FG001|First Intervention Period|Unable to comply with study dates|1
2268948|NCT02228395|3945447|FG002|First Intervention Period|Unable to comply with study dates|1
2268949|NCT02228460|3945466|FG000|Overall Study|Adverse Event|1
2268950|NCT02228460|3945466|FG000|Overall Study|Lost to Follow-up|1
2268951|NCT02228564|3945480|FG000|Overall Study|Withdrawal by Subject|10
2268952|NCT02228564|3945480|FG000|Overall Study|Death|11
2268953|NCT02228564|3945480|FG000|Overall Study|Physician Decision|5
2268954|NCT02228564|3945480|FG000|Overall Study|Lost to Follow-up|17
2268955|NCT02228564|3945480|FG000|Overall Study|Other|6
2268956|NCT02228590|3945484|FG000|Overall Study|Withdrawal by Subject|1
2268957|NCT02228720|3945498|FG000|Open Label - Day 30|Lost to Follow-up|1
2268958|NCT02228967|3945513|FG000|Overall Study|Lost to Follow-up|146
2268959|NCT02228967|3945514|FG001|Overall Study|Lost to Follow-up|142
2268960|NCT02228967|3945513|FG000|Overall Study|Withdrawal by Subject|13
2268961|NCT02228967|3945514|FG001|Overall Study|Withdrawal by Subject|18
2268962|NCT02228980|3945524|FG000|Overall Study|Adverse Event|14
2268963|NCT02228980|3945525|FG001|Overall Study|Adverse Event|0
2268964|NCT02228980|3945526|FG002|Overall Study|Adverse Event|0
2268965|NCT02228980|3945527|FG003|Overall Study|Adverse Event|0
2268966|NCT02228980|3945524|FG000|Overall Study|Protocol Violation|7
2268967|NCT02228980|3945525|FG001|Overall Study|Protocol Violation|0
2268968|NCT02228980|3945526|FG002|Overall Study|Protocol Violation|0
2268969|NCT02228980|3945527|FG003|Overall Study|Protocol Violation|0
2268970|NCT02228980|3945524|FG000|Overall Study|Withdrawal by Subject|3
2268971|NCT02228980|3945525|FG001|Overall Study|Withdrawal by Subject|3
2268972|NCT02228980|3945526|FG002|Overall Study|Withdrawal by Subject|2
2268973|NCT02228980|3945527|FG003|Overall Study|Withdrawal by Subject|3
2268974|NCT02229214|3945543|FG000|Overall Study|Adverse Event|2
2268975|NCT02229214|3945544|FG001|Overall Study|Adverse Event|0
2268976|NCT02229214|3945543|FG000|Overall Study|Withdrawal by Subject|4
2268977|NCT02229214|3945544|FG001|Overall Study|Withdrawal by Subject|0
2268978|NCT02229227|3945554|FG000|Overall Study|Adverse Event|14
2268979|NCT02229227|3945555|FG001|Overall Study|Adverse Event|9
2268980|NCT02229227|3945554|FG000|Overall Study|Lack of Efficacy|3
2268981|NCT02229227|3945555|FG001|Overall Study|Lack of Efficacy|3
2268982|NCT02229227|3945554|FG000|Overall Study|Protocol Violation|6
2268983|NCT02229227|3945555|FG001|Overall Study|Protocol Violation|8
2268984|NCT02229227|3945554|FG000|Overall Study|Protocol defined stopping criteria|1
2268985|NCT02229227|3945555|FG001|Overall Study|Protocol defined stopping criteria|3
2268986|NCT02229227|3945554|FG000|Overall Study|Lost to Follow-up|3
2268987|NCT02229227|3945555|FG001|Overall Study|Lost to Follow-up|3
2268988|NCT02229227|3945554|FG000|Overall Study|Study terminated by sponsor|11
2268989|NCT02229227|3945555|FG001|Overall Study|Study terminated by sponsor|11
2268990|NCT02229227|3945554|FG000|Overall Study|Withdrawal by Subject|8
2268991|NCT02229227|3945555|FG001|Overall Study|Withdrawal by Subject|12
2268992|NCT02229227|3945554|FG000|Overall Study|Other|0
2268993|NCT02229227|3945555|FG001|Overall Study|Other|1
2268994|NCT02229227|3945554|FG000|Overall Study|Physician Decision|5
2268995|NCT02229227|3945555|FG001|Overall Study|Physician Decision|12
2268996|NCT02229383|3945568|FG000|Overall Study|Adverse Event|7
2268997|NCT02229383|3945569|FG001|Overall Study|Adverse Event|4
2268998|NCT02229383|3945568|FG000|Overall Study|Death|0
2268999|NCT02229383|3945569|FG001|Overall Study|Death|1
2269000|NCT02229383|3945568|FG000|Overall Study|Lost to Follow-up|5
2269001|NCT02229383|3945569|FG001|Overall Study|Lost to Follow-up|3
2269002|NCT02229383|3945568|FG000|Overall Study|Withdrawal by Subject|4
2269003|NCT02229383|3945569|FG001|Overall Study|Withdrawal by Subject|6
2269004|NCT02229383|3945568|FG000|Overall Study|Did not receive treatment|1
2269005|NCT02229383|3945569|FG001|Overall Study|Did not receive treatment|0
2269006|NCT02229383|3945568|FG000|Overall Study|Other|3
2269007|NCT02229383|3945569|FG001|Overall Study|Other|8
2269008|NCT02229396|3945578|FG000|Overall Study|Adverse Event|6
2269009|NCT02229396|3945579|FG001|Overall Study|Adverse Event|12
2269010|NCT02229396|3945580|FG002|Overall Study|Adverse Event|12
2269011|NCT02229396|3945578|FG000|Overall Study|Death|2
2269012|NCT02229396|3945579|FG001|Overall Study|Death|3
2269013|NCT02229396|3945580|FG002|Overall Study|Death|1
2269014|NCT02229396|3945578|FG000|Overall Study|Lost to Follow-up|14
2269015|NCT02229396|3945579|FG001|Overall Study|Lost to Follow-up|14
2269016|NCT02229396|3945580|FG002|Overall Study|Lost to Follow-up|21
2269017|NCT02229396|3945578|FG000|Overall Study|Protocol Violation|2
2269018|NCT02229396|3945579|FG001|Overall Study|Protocol Violation|1
2269019|NCT02229396|3945580|FG002|Overall Study|Protocol Violation|0
2269020|NCT02229396|3945578|FG000|Overall Study|Patient Incorrectly Randomized|0
2269021|NCT02229396|3945579|FG001|Overall Study|Patient Incorrectly Randomized|0
2269022|NCT02229396|3945580|FG002|Overall Study|Patient Incorrectly Randomized|1
2269023|NCT02229396|3945578|FG000|Overall Study|Other|10
2269024|NCT02229396|3945579|FG001|Overall Study|Other|18
2269025|NCT02229396|3945580|FG002|Overall Study|Other|15
2269026|NCT02229396|3945578|FG000|Overall Study|Withdrawal by Subject|42
2269027|NCT02229396|3945579|FG001|Overall Study|Withdrawal by Subject|28
2269028|NCT02229396|3945580|FG002|Overall Study|Withdrawal by Subject|41
2269029|NCT02229396|3945578|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
2269030|NCT02229396|3945579|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
2269031|NCT02229396|3945580|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
2269032|NCT02229396|3945578|FG000|Overall Study|Withdrew; No Record on Termination Page|2
2269033|NCT02229396|3945579|FG001|Overall Study|Withdrew; No Record on Termination Page|0
2269034|NCT02229396|3945580|FG002|Overall Study|Withdrew; No Record on Termination Page|1
2269035|NCT02229539|3945646|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
2269036|NCT02229539|3945647|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
2269037|NCT02229539|3945648|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
2269038|NCT02229539|3945646|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
2269039|NCT02229539|3945647|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
2269040|NCT02229539|3945648|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
2269041|NCT02229539|3945646|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
2269042|NCT02229539|3945647|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
2269043|NCT02229539|3945648|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
2269044|NCT02229539|3945646|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
2269045|NCT02229539|3945647|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
2269046|NCT02229539|3945648|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
2269047|NCT02229539|3945646|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
2269048|NCT02229539|3945647|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
2269049|NCT02229539|3945648|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
2269050|NCT02229539|3945646|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
2269051|NCT02229539|3945647|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
2269052|NCT02229539|3945648|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
2269053|NCT02229539|3945646|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
2269054|NCT02229539|3945647|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
2269055|NCT02229539|3945648|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
2349409|NCT04308239|4091979|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
2349410|NCT04308239|4091978|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
2349411|NCT04308239|4091979|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
2349412|NCT04308239|4091978|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
2349413|NCT04308239|4091979|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
2349414|NCT04308668|4091991|FG000|Overall Study|Lost to Follow-up|32
2349415|NCT04308668|4091992|FG001|Overall Study|Lost to Follow-up|38
2349416|NCT04308668|4091991|FG000|Overall Study|Withdrawal by Subject|4
2349417|NCT04308668|4091992|FG001|Overall Study|Withdrawal by Subject|4
2349418|NCT04307940|4092001|FG000|Overall Study|Adverse Event|1
2349419|NCT04307940|4092002|FG001|Overall Study|Adverse Event|0
2349420|NCT04307940|4092003|FG002|Overall Study|Adverse Event|0
2349421|NCT04307940|4092001|FG000|Overall Study|Withdrawal by Subject|2
2349422|NCT04307940|4092002|FG001|Overall Study|Withdrawal by Subject|3
2349423|NCT04307940|4092003|FG002|Overall Study|Withdrawal by Subject|1
2349424|NCT04307940|4092001|FG000|Overall Study|Lost to Follow-up|2
2349425|NCT04307940|4092002|FG001|Overall Study|Lost to Follow-up|0
2349426|NCT04307940|4092003|FG002|Overall Study|Lost to Follow-up|1
2349427|NCT04302545|4092013|FG000|Overall Study|Lost to Follow-up|3
2349428|NCT04302545|4092014|FG001|Overall Study|Lost to Follow-up|4
2349429|NCT04297241|4092036|FG000|Overall Study|Withdrawal by Subject|1
2349430|NCT04297241|4092036|FG000|Overall Study|Adverse Event|1
2349431|NCT04297241|4092036|FG000|Overall Study|Physician Decision|3
2349432|NCT04295356|4092065|FG000|Overall Study|Physician Decision|1
2349433|NCT04295356|4092066|FG001|Overall Study|Physician Decision|0
2349434|NCT04295356|4092065|FG000|Overall Study|Lost to Follow-up|0
2349435|NCT04295356|4092066|FG001|Overall Study|Lost to Follow-up|3
2349436|NCT04295356|4092065|FG000|Overall Study|Protocol Violation|0
2349437|NCT04295356|4092066|FG001|Overall Study|Protocol Violation|1
2349438|NCT04292535|4092090|FG000|Overall Study|Withdrawal by Subject|0
2349439|NCT04292535|4092091|FG001|Overall Study|Withdrawal by Subject|0
2349440|NCT04292535|4092092|FG002|Overall Study|Withdrawal by Subject|0
2349441|NCT04292535|4092093|FG003|Overall Study|Withdrawal by Subject|0
2349442|NCT04292535|4092094|FG004|Overall Study|Withdrawal by Subject|0
2349443|NCT04292535|4092095|FG005|Overall Study|Withdrawal by Subject|0
2349444|NCT04292535|4092096|FG006|Overall Study|Withdrawal by Subject|0
2349445|NCT04292535|4092097|FG007|Overall Study|Withdrawal by Subject|1
2349446|NCT04292535|4092098|FG008|Overall Study|Withdrawal by Subject|0
2349447|NCT04292535|4092099|FG009|Overall Study|Withdrawal by Subject|0
2349448|NCT04292535|4092100|FG010|Overall Study|Withdrawal by Subject|0
2349449|NCT04292535|4092101|FG011|Overall Study|Withdrawal by Subject|0
2349450|NCT04292535|4092102|FG012|Overall Study|Withdrawal by Subject|0
2349451|NCT04292535|4092103|FG013|Overall Study|Withdrawal by Subject|0
2349452|NCT04292535|4092090|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
2349453|NCT04292535|4092091|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
2349454|NCT04292535|4092092|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
2349455|NCT04292535|4092093|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
2349456|NCT04292535|4092094|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
2349457|NCT04292535|4092095|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
2349458|NCT04292535|4092096|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
2269056|NCT02229539|3945646|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
2269057|NCT02229539|3945647|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
2269058|NCT02229539|3945648|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
2269059|NCT02229539|3945646|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
2269060|NCT02229539|3945647|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
2269061|NCT02229539|3945648|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
2269062|NCT02229552|3945656|FG000|Baseline|Withdrawal by Subject|6
2269063|NCT02229552|3945656|FG000|1-year Follow up|Withdrawal by Subject|7
2269064|NCT02229552|3945656|FG000|1-year Follow up|Lost to Follow-up|18
2269065|NCT02229552|3945656|FG000|2-Year Follow up|Withdrawal by Subject|9
2269066|NCT02229552|3945656|FG000|2-Year Follow up|Lost to Follow-up|17
2269067|NCT02229851|3945663|FG000|Main Phase (Double-blind Phase)|Unclassified|1
2269068|NCT02229851|3945664|FG001|Main Phase (Double-blind Phase)|Unclassified|2
2269069|NCT02229851|3945665|FG002|Main Phase (Double-blind Phase)|Unclassified|0
2269070|NCT02229851|3945666|FG003|Main Phase (Double-blind Phase)|Unclassified|0
2269071|NCT02229851|3945667|FG004|Main Phase (Double-blind Phase)|Unclassified|0
2269072|NCT02229851|3945668|FG005|Main Phase (Double-blind Phase)|Unclassified|0
2269073|NCT02229851|3945669|FG006|Main Phase (Double-blind Phase)|Unclassified|0
2269074|NCT02229851|3945663|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0
2269075|NCT02229851|3945664|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1
2269076|NCT02229851|3945665|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0
2269077|NCT02229851|3945666|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0
2269078|NCT02229851|3945667|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0
2269079|NCT02229851|3945668|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0
2269080|NCT02229851|3945669|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0
2269081|NCT02229851|3945663|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
2269082|NCT02229851|3945664|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12
2269083|NCT02229851|3945665|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
2269084|NCT02229851|3945666|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
2269085|NCT02229851|3945667|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
2269086|NCT02229851|3945668|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
2269087|NCT02229851|3945669|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
2269088|NCT02229851|3945663|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0
2269089|NCT02229851|3945664|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0
2269090|NCT02229851|3945665|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2
2269091|NCT02229851|3945666|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0
2269092|NCT02229851|3945667|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0
2269093|NCT02229851|3945668|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0
2269094|NCT02229851|3945669|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0
2269095|NCT02229851|3945663|FG000|Main Phase (Double-blind Phase)|Death|1
2269096|NCT02229851|3945664|FG001|Main Phase (Double-blind Phase)|Death|1
2269097|NCT02229851|3945665|FG002|Main Phase (Double-blind Phase)|Death|0
2269098|NCT02229851|3945666|FG003|Main Phase (Double-blind Phase)|Death|0
2269099|NCT02229851|3945667|FG004|Main Phase (Double-blind Phase)|Death|0
2269100|NCT02229851|3945668|FG005|Main Phase (Double-blind Phase)|Death|0
2269101|NCT02229851|3945669|FG006|Main Phase (Double-blind Phase)|Death|0
2269102|NCT02229851|3945663|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0
2269103|NCT02229851|3945664|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0
2269104|NCT02229851|3945665|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0
2349459|NCT04292535|4092097|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
2349460|NCT04292535|4092098|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
2349461|NCT04292535|4092099|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
2349462|NCT04292535|4092100|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
2349463|NCT04292535|4092101|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
2349464|NCT04292535|4092102|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
2349465|NCT04292535|4092103|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
2349466|NCT04292535|4092090|FG000|Overall Study|Report of Dizziness|0
2349467|NCT04292535|4092091|FG001|Overall Study|Report of Dizziness|0
2349468|NCT04292535|4092092|FG002|Overall Study|Report of Dizziness|0
2349469|NCT04292535|4092093|FG003|Overall Study|Report of Dizziness|0
2349470|NCT04292535|4092094|FG004|Overall Study|Report of Dizziness|0
2349471|NCT04292535|4092095|FG005|Overall Study|Report of Dizziness|0
2349472|NCT04292535|4092096|FG006|Overall Study|Report of Dizziness|0
2349473|NCT04292535|4092097|FG007|Overall Study|Report of Dizziness|0
2349474|NCT04292535|4092098|FG008|Overall Study|Report of Dizziness|0
2349475|NCT04292535|4092099|FG009|Overall Study|Report of Dizziness|0
2349476|NCT04292535|4092100|FG010|Overall Study|Report of Dizziness|0
2349477|NCT04292535|4092101|FG011|Overall Study|Report of Dizziness|0
2349478|NCT04292535|4092102|FG012|Overall Study|Report of Dizziness|0
2349479|NCT04292535|4092103|FG013|Overall Study|Report of Dizziness|1
2349480|NCT04292535|4092090|FG000|Overall Study|Equipment Failure|0
2349481|NCT04292535|4092091|FG001|Overall Study|Equipment Failure|0
2349482|NCT04292535|4092092|FG002|Overall Study|Equipment Failure|0
2349483|NCT04292535|4092093|FG003|Overall Study|Equipment Failure|0
2349484|NCT04292535|4092094|FG004|Overall Study|Equipment Failure|0
2269105|NCT02229851|3945666|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0
2269106|NCT02229851|3945667|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1
2269107|NCT02229851|3945668|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1
2269108|NCT02229851|3945669|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1
2269109|NCT02229851|3945663|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
2269110|NCT02229851|3945664|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
2269111|NCT02229851|3945665|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
2269112|NCT02229851|3945666|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
2269113|NCT02229851|3945667|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4
2269114|NCT02229851|3945668|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3
2269115|NCT02229851|3945669|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
2269116|NCT02229851|3945663|FG000|Extension Phase (Open-label Phase)|Death|0
2269117|NCT02229851|3945664|FG001|Extension Phase (Open-label Phase)|Death|0
2269118|NCT02229851|3945665|FG002|Extension Phase (Open-label Phase)|Death|0
2269119|NCT02229851|3945666|FG003|Extension Phase (Open-label Phase)|Death|1
2269120|NCT02229851|3945667|FG004|Extension Phase (Open-label Phase)|Death|0
2269121|NCT02229851|3945668|FG005|Extension Phase (Open-label Phase)|Death|1
2269122|NCT02229851|3945669|FG006|Extension Phase (Open-label Phase)|Death|1
2269123|NCT02229864|3945684|FG000|Overall Study|Death|2
2269124|NCT02229864|3945684|FG000|Overall Study|Lost to Follow-up|1
2269125|NCT02230085|3945688|FG000|Overall Study|Physician Decision|1
2269126|NCT02230085|3945688|FG000|Overall Study|Withdrawal by Subject|3
2269127|NCT02230306|3945692|FG000|Overall Study|Did not receive study treatment|1
2269128|NCT02230332|3945698|FG000|Overall Study|Adverse Event|2
2269129|NCT02230332|3945699|FG001|Overall Study|Adverse Event|1
2269130|NCT02230332|3945698|FG000|Overall Study|Lost to Follow-up|1
2269131|NCT02230332|3945699|FG001|Overall Study|Lost to Follow-up|0
2269132|NCT02230332|3945698|FG000|Overall Study|Protocol Violation|1
2269133|NCT02230332|3945699|FG001|Overall Study|Protocol Violation|0
2269134|NCT02230384|3945707|FG000|Phase 1|Lost to Follow-up|1
2269135|NCT02230384|3945708|FG001|Phase 1|Lost to Follow-up|0
2269136|NCT02230384|3945707|FG000|Phase 1|Physician Decision|0
2269137|NCT02230384|3945708|FG001|Phase 1|Physician Decision|1
2269138|NCT02230384|3945707|FG000|Phase 2 - Switch|Withdrawal by Subject|0
2269139|NCT02230384|3945708|FG001|Phase 2 - Switch|Withdrawal by Subject|1
2269140|NCT02230384|3945707|FG000|Phase 2 - Switch|Lost to Follow-up|1
2269141|NCT02230384|3945708|FG001|Phase 2 - Switch|Lost to Follow-up|0
2269142|NCT02230384|3945707|FG000|Phase 2 - Switch|Adverse Event|2
2269143|NCT02230384|3945708|FG001|Phase 2 - Switch|Adverse Event|0
2269144|NCT02230527|3945724|FG000|Overall Study|Withdrawal by Subject|1
2269145|NCT02230527|3945725|FG001|Overall Study|Withdrawal by Subject|1
2269146|NCT02230527|3945724|FG000|Overall Study|Death|1
2269147|NCT02230527|3945725|FG001|Overall Study|Death|0
2269148|NCT02230527|3945724|FG000|Overall Study|Lost to Follow-up|2
2269149|NCT02230527|3945725|FG001|Overall Study|Lost to Follow-up|1
2269150|NCT02230527|3945724|FG000|Overall Study|Other|1
2269151|NCT02230527|3945725|FG001|Overall Study|Other|0
2269152|NCT02230670|3945779|FG000|Overall Study|Adverse Event|1
2269153|NCT02230670|3945780|FG001|Overall Study|Adverse Event|2
2269154|NCT02230670|3945779|FG000|Overall Study|Withdrawal by Subject|2
2269155|NCT02230670|3945780|FG001|Overall Study|Withdrawal by Subject|2
2269156|NCT02230670|3945779|FG000|Overall Study|Physician Decision|0
2269157|NCT02230670|3945780|FG001|Overall Study|Physician Decision|1
2269158|NCT02230670|3945779|FG000|Overall Study|Protocol Violation|0
2269159|NCT02230670|3945780|FG001|Overall Study|Protocol Violation|1
2269160|NCT02230670|3945779|FG000|Overall Study|Progression to Child-Pugh C|1
2269161|NCT02230670|3945780|FG001|Overall Study|Progression to Child-Pugh C|2
2269162|NCT02230683|3945786|FG000|Overall Study|Adverse Event|1
2349485|NCT04292535|4092095|FG005|Overall Study|Equipment Failure|0
2349486|NCT04292535|4092096|FG006|Overall Study|Equipment Failure|0
2349487|NCT04292535|4092097|FG007|Overall Study|Equipment Failure|0
2349488|NCT04292535|4092098|FG008|Overall Study|Equipment Failure|0
2349489|NCT04292535|4092099|FG009|Overall Study|Equipment Failure|0
2349490|NCT04292535|4092100|FG010|Overall Study|Equipment Failure|0
2349491|NCT04292535|4092101|FG011|Overall Study|Equipment Failure|1
2349492|NCT04292535|4092102|FG012|Overall Study|Equipment Failure|0
2349493|NCT04292535|4092103|FG013|Overall Study|Equipment Failure|0
2349494|NCT04292171|4092135|FG000|Overall Study|Pharmacy error|2
2349495|NCT04292171|4092136|FG001|Overall Study|Pharmacy error|0
2349496|NCT04292171|4092135|FG000|Overall Study|Delivered prior to procedure|0
2349497|NCT04292171|4092136|FG001|Overall Study|Delivered prior to procedure|1
2349498|NCT04292899|4092146|FG000|Overall Study|Death|21
2349499|NCT04292899|4092147|FG001|Overall Study|Death|28
2349500|NCT04292899|4092148|FG002|Overall Study|Death|188
2349501|NCT04292899|4092149|FG003|Overall Study|Death|371
2349502|NCT04292899|4092146|FG000|Overall Study|Lost to Follow-up|8
2349503|NCT04292899|4092147|FG001|Overall Study|Lost to Follow-up|4
2349504|NCT04292899|4092148|FG002|Overall Study|Lost to Follow-up|22
2349505|NCT04292899|4092149|FG003|Overall Study|Lost to Follow-up|235
2349506|NCT04292899|4092146|FG000|Overall Study|Withdrew consent|1
2349507|NCT04292899|4092147|FG001|Overall Study|Withdrew consent|0
2349508|NCT04292899|4092148|FG002|Overall Study|Withdrew consent|11
2349509|NCT04292899|4092149|FG003|Overall Study|Withdrew consent|32
2349510|NCT04292899|4092146|FG000|Overall Study|Adverse Event|2
2269163|NCT02230904|3945820|FG000|Overall Study|Safety follow up could not take place|0
2269164|NCT02230904|3945821|FG001|Overall Study|Safety follow up could not take place|1
2269165|NCT02230956|3945832|FG000|Overall Study|Adverse Event|1
2269166|NCT02230956|3945833|FG001|Overall Study|Adverse Event|1
2269167|NCT02230956|3945834|FG002|Overall Study|Adverse Event|0
2269168|NCT02230956|3945832|FG000|Overall Study|Lack of Efficacy|1
2269169|NCT02230956|3945833|FG001|Overall Study|Lack of Efficacy|1
2269170|NCT02230956|3945834|FG002|Overall Study|Lack of Efficacy|1
2269171|NCT02230956|3945832|FG000|Overall Study|Lost to Follow-up|1
2269172|NCT02230956|3945833|FG001|Overall Study|Lost to Follow-up|1
2269173|NCT02230956|3945834|FG002|Overall Study|Lost to Follow-up|2
2269174|NCT02230956|3945832|FG000|Overall Study|Personal Reasons|2
2269175|NCT02230956|3945833|FG001|Overall Study|Personal Reasons|1
2269176|NCT02230956|3945834|FG002|Overall Study|Personal Reasons|1
2269177|NCT02230956|3945832|FG000|Overall Study|Protocol Violation|0
2269178|NCT02230956|3945833|FG001|Overall Study|Protocol Violation|1
2269179|NCT02230956|3945834|FG002|Overall Study|Protocol Violation|1
2269180|NCT02230956|3945832|FG000|Overall Study|Other Miscellaneous Reason|0
2269181|NCT02230956|3945833|FG001|Overall Study|Other Miscellaneous Reason|1
2269182|NCT02230956|3945834|FG002|Overall Study|Other Miscellaneous Reason|2
2269183|NCT02231164|3945862|FG000|Overall Study|Adverse Event|1
2269184|NCT02231164|3945863|FG001|Overall Study|Adverse Event|1
2269185|NCT02231164|3945862|FG000|Overall Study|Lack of Efficacy|4
2269186|NCT02231164|3945863|FG001|Overall Study|Lack of Efficacy|3
2269187|NCT02231164|3945862|FG000|Overall Study|Withdrawal by Subject|1
2269188|NCT02231164|3945863|FG001|Overall Study|Withdrawal by Subject|2
2269189|NCT02231580|3945885|FG000|Overall Study|Adverse Event|5
2269190|NCT02231580|3945886|FG001|Overall Study|Adverse Event|0
2269191|NCT02231749|3945896|FG000|Overall Study|Disease progression|229
2269192|NCT02231749|3945897|FG001|Overall Study|Disease progression|297
2269193|NCT02231749|3945896|FG000|Overall Study|Study Drug Toxicity|134
2269194|NCT02231749|3945897|FG001|Overall Study|Study Drug Toxicity|63
2269195|NCT02231749|3945896|FG000|Overall Study|Death|1
2269196|NCT02231749|3945897|FG001|Overall Study|Death|1
2269197|NCT02231749|3945896|FG000|Overall Study|AE unrelated to Study drug|32
2269198|NCT02231749|3945897|FG001|Overall Study|AE unrelated to Study drug|31
2269199|NCT02231749|3945896|FG000|Overall Study|Participant's request to discontinue|10
2269200|NCT02231749|3945897|FG001|Overall Study|Participant's request to discontinue|21
2269201|NCT02231749|3945896|FG000|Overall Study|Participant withdrew Consent|8
2269202|NCT02231749|3945897|FG001|Overall Study|Participant withdrew Consent|15
2269203|NCT02231749|3945896|FG000|Overall Study|Lost to Follow-up|1
2269204|NCT02231749|3945897|FG001|Overall Study|Lost to Follow-up|2
2269205|NCT02231749|3945896|FG000|Overall Study|Maximum Clinical Benefit|5
2269206|NCT02231749|3945897|FG001|Overall Study|Maximum Clinical Benefit|8
2269207|NCT02231749|3945896|FG000|Overall Study|Poor/Non-Compliance|0
2269208|NCT02231749|3945897|FG001|Overall Study|Poor/Non-Compliance|3
2269209|NCT02231749|3945896|FG000|Overall Study|Pregnancy|1
2269210|NCT02231749|3945897|FG001|Overall Study|Pregnancy|0
2269211|NCT02231749|3945896|FG000|Overall Study|other|0
2269212|NCT02231749|3945897|FG001|Overall Study|other|8
2269213|NCT02231749|3945896|FG000|Overall Study|No longer meets Study Criteria|1
2269214|NCT02231749|3945897|FG001|Overall Study|No longer meets Study Criteria|0
2269215|NCT02231918|3945906|FG000|Overall Study|Withdrawal by Subject|0
2269216|NCT02231918|3945907|FG001|Overall Study|Withdrawal by Subject|1
2269217|NCT02231918|3945908|FG002|Overall Study|Withdrawal by Subject|0
2269218|NCT02231918|3945906|FG000|Overall Study|Adverse Event|0
2269219|NCT02231918|3945907|FG001|Overall Study|Adverse Event|0
2269220|NCT02231918|3945908|FG002|Overall Study|Adverse Event|1
2269221|NCT02232061|3945926|FG000|Overall Study|Administrative problems|1
2269222|NCT02232061|3945926|FG000|Overall Study|Withdrawal by Subject|1
2269223|NCT02232074|3945932|FG000|Overall Study|Withdrawal by Subject|5
2269224|NCT02232074|3945933|FG001|Overall Study|Withdrawal by Subject|3
2269225|NCT02232074|3945932|FG000|Overall Study|No legal concerns at baseline|36
2269226|NCT02232074|3945933|FG001|Overall Study|No legal concerns at baseline|41
2349511|NCT04292899|4092147|FG001|Overall Study|Adverse Event|1
2349512|NCT04292899|4092148|FG002|Overall Study|Adverse Event|2
2349513|NCT04292899|4092149|FG003|Overall Study|Adverse Event|2
2349514|NCT04292899|4092146|FG000|Overall Study|Investigator's Discretion|0
2349515|NCT04292899|4092147|FG001|Overall Study|Investigator's Discretion|0
2349516|NCT04292899|4092148|FG002|Overall Study|Investigator's Discretion|0
2349517|NCT04292899|4092149|FG003|Overall Study|Investigator's Discretion|3
2349518|NCT04292899|4092146|FG000|Overall Study|Non-compliance With Study Drug|0
2349519|NCT04292899|4092147|FG001|Overall Study|Non-compliance With Study Drug|0
2349520|NCT04292899|4092148|FG002|Overall Study|Non-compliance With Study Drug|0
2349521|NCT04292899|4092149|FG003|Overall Study|Non-compliance With Study Drug|1
2349522|NCT04292899|4092146|FG000|Overall Study|Protocol Violation|0
2349523|NCT04292899|4092147|FG001|Overall Study|Protocol Violation|0
2349524|NCT04292899|4092148|FG002|Overall Study|Protocol Violation|0
2349525|NCT04292899|4092149|FG003|Overall Study|Protocol Violation|1
2349526|NCT04292730|4092161|FG000|Overall Study|Lost to Follow-up|8
2349527|NCT04292730|4092162|FG001|Overall Study|Lost to Follow-up|12
2349528|NCT04292730|4092163|FG002|Overall Study|Lost to Follow-up|12
2349529|NCT04292730|4092164|FG003|Overall Study|Lost to Follow-up|48
2349530|NCT04292730|4092161|FG000|Overall Study|Death|2
2269227|NCT02232074|3945932|FG000|Overall Study|deemed ineligible|0
2269228|NCT02232074|3945933|FG001|Overall Study|deemed ineligible|1
2269229|NCT02232087|3945945|FG000|Overall Study|Withdrawal by Subject|2
2269230|NCT02232087|3945946|FG001|Overall Study|Withdrawal by Subject|0
2269231|NCT02232087|3945947|FG002|Overall Study|Withdrawal by Subject|0
2269232|NCT02232087|3945948|FG003|Overall Study|Withdrawal by Subject|0
2269233|NCT02232087|3945949|FG004|Overall Study|Withdrawal by Subject|0
2269234|NCT02232087|3945950|FG005|Overall Study|Withdrawal by Subject|1
2269235|NCT02232087|3945945|FG000|Overall Study|poor inhalation technique|0
2269236|NCT02232087|3945946|FG001|Overall Study|poor inhalation technique|1
2269237|NCT02232087|3945947|FG002|Overall Study|poor inhalation technique|0
2269238|NCT02232087|3945948|FG003|Overall Study|poor inhalation technique|0
2269239|NCT02232087|3945949|FG004|Overall Study|poor inhalation technique|0
2269240|NCT02232087|3945950|FG005|Overall Study|poor inhalation technique|2
2269241|NCT02232087|3945945|FG000|Overall Study|protocol stop criteria|0
2269242|NCT02232087|3945946|FG001|Overall Study|protocol stop criteria|1
2269243|NCT02232087|3945947|FG002|Overall Study|protocol stop criteria|0
2269244|NCT02232087|3945948|FG003|Overall Study|protocol stop criteria|1
2269245|NCT02232087|3945949|FG004|Overall Study|protocol stop criteria|0
2269246|NCT02232087|3945950|FG005|Overall Study|protocol stop criteria|0
2269247|NCT02232087|3945945|FG000|Overall Study|Adverse Event|0
2269248|NCT02232087|3945946|FG001|Overall Study|Adverse Event|0
2269249|NCT02232087|3945947|FG002|Overall Study|Adverse Event|0
2269250|NCT02232087|3945948|FG003|Overall Study|Adverse Event|0
2269251|NCT02232087|3945949|FG004|Overall Study|Adverse Event|1
2269252|NCT02232087|3945950|FG005|Overall Study|Adverse Event|0
2269253|NCT02232178|3945983|FG000|Overall Study|Lost to Follow-up|0
2269254|NCT02232178|3945984|FG001|Overall Study|Lost to Follow-up|1
2269255|NCT02232178|3945985|FG002|Overall Study|Lost to Follow-up|0
2269256|NCT02232178|3945983|FG000|Overall Study|ineligibility|0
2269257|NCT02232178|3945984|FG001|Overall Study|ineligibility|0
2269258|NCT02232178|3945985|FG002|Overall Study|ineligibility|1
2269259|NCT02232178|3945983|FG000|Overall Study|surgical complication|1
2269260|NCT02232178|3945984|FG001|Overall Study|surgical complication|0
2269261|NCT02232178|3945985|FG002|Overall Study|surgical complication|0
2269262|NCT02232243|3945996|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
2269263|NCT02232243|3945997|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
2269264|NCT02232243|3945998|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
2269265|NCT02232425|3946022|FG000|Overall Study|Lost to Follow-up|6
2269266|NCT02232425|3946023|FG001|Overall Study|Lost to Follow-up|2
2269267|NCT02232425|3946022|FG000|Overall Study|Adverse Event|2
2269268|NCT02232425|3946023|FG001|Overall Study|Adverse Event|0
2269269|NCT02232425|3946022|FG000|Overall Study|Withdrawal by Subject|5
2269270|NCT02232425|3946023|FG001|Overall Study|Withdrawal by Subject|6
2269271|NCT02232425|3946022|FG000|Overall Study|Lack of Efficacy|1
2269272|NCT02232425|3946023|FG001|Overall Study|Lack of Efficacy|0
2269273|NCT02232698|3946031|FG000|Overall Study|Pregnancy|1
2269274|NCT02232698|3946032|FG001|Overall Study|Pregnancy|1
2269275|NCT02232698|3946031|FG000|Overall Study|Met exclusion criteria|1
2269276|NCT02232698|3946032|FG001|Overall Study|Met exclusion criteria|1
2269277|NCT02232698|3946031|FG000|Overall Study|Had device-associated symptoms|7
2269278|NCT02232698|3946032|FG001|Overall Study|Had device-associated symptoms|0
2269279|NCT02232698|3946031|FG000|Overall Study|Non-compliance with study device|1
2269280|NCT02232698|3946032|FG001|Overall Study|Non-compliance with study device|4
2269281|NCT02232698|3946031|FG000|Overall Study|Allocated to control group|0
2349531|NCT04292730|4092162|FG001|Overall Study|Death|2
2349532|NCT04292730|4092163|FG002|Overall Study|Death|4
2349533|NCT04292730|4092164|FG003|Overall Study|Death|12
2349534|NCT04292730|4092161|FG000|Overall Study|Withdrew Consent|2
2349535|NCT04292730|4092162|FG001|Overall Study|Withdrew Consent|2
2349536|NCT04292730|4092163|FG002|Overall Study|Withdrew Consent|5
2349537|NCT04292730|4092164|FG003|Overall Study|Withdrew Consent|6
2349538|NCT04292730|4092161|FG000|Overall Study|Non-Compliance with Study Drug|0
2349539|NCT04292730|4092162|FG001|Overall Study|Non-Compliance with Study Drug|1
2349540|NCT04292730|4092163|FG002|Overall Study|Non-Compliance with Study Drug|0
2349541|NCT04292730|4092164|FG003|Overall Study|Non-Compliance with Study Drug|0
2349542|NCT04292730|4092161|FG000|Overall Study|Protocol Violation|0
2349543|NCT04292730|4092162|FG001|Overall Study|Protocol Violation|0
2349544|NCT04292730|4092163|FG002|Overall Study|Protocol Violation|1
2349545|NCT04292730|4092164|FG003|Overall Study|Protocol Violation|0
2349546|NCT04292730|4092161|FG000|Overall Study|Randomized but not Treated|8
2349547|NCT04292730|4092162|FG001|Overall Study|Randomized but not Treated|4
2349548|NCT04292730|4092163|FG002|Overall Study|Randomized but not Treated|0
2349549|NCT04292730|4092164|FG003|Overall Study|Randomized but not Treated|14
2349550|NCT04289623|4092197|FG000|Wave 1 Emails|Email was not delivered|268
2349551|NCT04289623|4092198|FG001|Wave 1 Emails|Email was not delivered|257
2349552|NCT04289623|4092199|FG002|Wave 1 Emails|Email was not delivered|0
2349553|NCT04289623|4092200|FG003|Wave 1 Emails|Email was not delivered|0
2269282|NCT02232698|3946032|FG001|Overall Study|Allocated to control group|3
2269283|NCT02232698|3946031|FG000|Overall Study|Withdrawal by Subject|0
2349554|NCT04289623|4092201|FG004|Wave 1 Emails|Email was not delivered|0
2349555|NCT04289623|4092202|FG005|Wave 1 Emails|Email was not delivered|0
2349556|NCT04276207|4092216|FG000|Period 1|Withdrawal by Subject|0
2269284|NCT02232698|3946032|FG001|Overall Study|Withdrawal by Subject|11
2269285|NCT02232802|3946040|FG000|Period 1|Sponsor request|1
2269286|NCT02232802|3946041|FG001|Period 1|Sponsor request|0
2269287|NCT02232802|3946040|FG000|Period 1|Adverse Event|1
2269288|NCT02232802|3946041|FG001|Period 1|Adverse Event|1
2269289|NCT02232893|3946049|FG000|Overall Study|Withdrawal by Subject|4
2269290|NCT02232893|3946050|FG001|Overall Study|Withdrawal by Subject|1
2269291|NCT02232893|3946049|FG000|Overall Study|Adverse Event|0
2269292|NCT02232893|3946050|FG001|Overall Study|Adverse Event|1
2269293|NCT02232893|3946049|FG000|Overall Study|Sponsor request early termination|0
2269294|NCT02232893|3946050|FG001|Overall Study|Sponsor request early termination|1
2269295|NCT02232893|3946049|FG000|Overall Study|Developed exclusion criteria|0
2269296|NCT02232893|3946050|FG001|Overall Study|Developed exclusion criteria|1
2269297|NCT02232893|3946049|FG000|Overall Study|Other|0
2269298|NCT02232893|3946050|FG001|Overall Study|Other|3
2269299|NCT02232984|3946056|FG000|Overall Study|Withdrawal by Subject|5
2269300|NCT02232984|3946056|FG000|Overall Study|Death|1
2269301|NCT02232984|3946056|FG000|Overall Study|Investigator withdrawal|10
2269302|NCT02232984|3946056|FG000|Overall Study|Device implant unsuccessful|53
2269303|NCT02232984|3946056|FG000|Overall Study|not disclosed by site|7
2269304|NCT02232984|3946056|FG000|Overall Study|Protocol Violation|1
2269305|NCT02233309|3946085|FG000|Overall Study|Physician Decision|5
2269306|NCT02233413|3946091|FG000|Overall Study|Lost to Follow-up|7
2269307|NCT02233413|3946092|FG001|Overall Study|Lost to Follow-up|9
2269308|NCT02233413|3946091|FG000|Overall Study|Withdrawal by Subject|4
2269309|NCT02233413|3946092|FG001|Overall Study|Withdrawal by Subject|5
2269310|NCT02233543|3946124|FG000|Period 1|Withdrawal by Subject|1
2269311|NCT02233543|3946125|FG001|Period 1|Withdrawal by Subject|0
2269312|NCT02233543|3946124|FG000|Period 1|Participants required other treatment.|2
2269313|NCT02233543|3946125|FG001|Period 1|Participants required other treatment.|3
2269314|NCT02233543|3946124|FG000|Period 2|Adverse Event|1
2269315|NCT02233543|3946125|FG001|Period 2|Adverse Event|0
2269316|NCT02233543|3946124|FG000|Period 2|Participant required other treatment.|0
2269317|NCT02233543|3946125|FG001|Period 2|Participant required other treatment.|1
2269318|NCT02233543|3946124|FG000|Period 2|COPD exacerbation|1
2269319|NCT02233543|3946125|FG001|Period 2|COPD exacerbation|0
2269320|NCT02233647|3946131|FG000|Overall Study|Adverse Event|1
2269321|NCT02233738|3946137|FG000|Overall Study|Lost to Follow-up|5
2269322|NCT02233738|3946138|FG001|Overall Study|Lost to Follow-up|12
2269323|NCT02233738|3946137|FG000|Overall Study|Death|0
2269324|NCT02233738|3946138|FG001|Overall Study|Death|1
2269325|NCT02233738|3946137|FG000|Overall Study|Withdrawal by Subject|0
2269326|NCT02233738|3946138|FG001|Overall Study|Withdrawal by Subject|1
2269327|NCT02233738|3946137|FG000|Overall Study|Did not return after Baseline|3
2269328|NCT02233738|3946138|FG001|Overall Study|Did not return after Baseline|2
2269329|NCT02233803|3946315|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
2269330|NCT02233803|3946316|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
2269331|NCT02233803|3946315|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0
2269332|NCT02233803|3946316|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1
2269333|NCT02233803|3946315|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2
2269334|NCT02233803|3946316|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2
2269335|NCT02233803|3946315|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
2269336|NCT02233803|3946316|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
2269337|NCT02233803|3946315|FG000|Washout Period (4-Wks)|Lost to Follow-up|0
2269338|NCT02233803|3946316|FG001|Washout Period (4-Wks)|Lost to Follow-up|1
2269339|NCT02233803|3946315|FG000|Washout Period (4-Wks)|Physician Decision|1
2269340|NCT02233803|3946316|FG001|Washout Period (4-Wks)|Physician Decision|0
2269341|NCT02233803|3946315|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1
2269342|NCT02233803|3946316|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1
2269343|NCT02233803|3946315|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
2269344|NCT02233803|3946316|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
2269345|NCT02233803|3946315|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
2269346|NCT02233803|3946316|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
2269347|NCT02233946|3946331|FG000|Baseline|Withdrawal by Subject|2
2269348|NCT02233946|3946332|FG001|Baseline|Withdrawal by Subject|0
2269349|NCT02233946|3946331|FG000|3-months Follow-up|Lost to Follow-up|53
2269350|NCT02233946|3946332|FG001|3-months Follow-up|Lost to Follow-up|29
2269351|NCT02233946|3946331|FG000|6-months Follow-up|Lost to Follow-up|21
2269352|NCT02233946|3946332|FG001|6-months Follow-up|Lost to Follow-up|2
2269353|NCT02233946|3946331|FG000|9-month Follow-up|Lost to Follow-up|20
2269354|NCT02233946|3946332|FG001|9-month Follow-up|Lost to Follow-up|11
2269355|NCT02233946|3946331|FG000|12-month Follow-up|Lost to Follow-up|28
2269356|NCT02233946|3946332|FG001|12-month Follow-up|Lost to Follow-up|11
2269357|NCT02234063|3946364|FG000|Overall Study|Lost to Follow-up|235
2269358|NCT02234063|3946365|FG001|Overall Study|Lost to Follow-up|42
2349557|NCT04276207|4092217|FG001|Period 1|Withdrawal by Subject|1
2349558|NCT04280705|4092247|FG000|Overall Study|Enrolled but not treated|4
2349559|NCT04280705|4092248|FG001|Overall Study|Enrolled but not treated|10
2349560|NCT04280705|4092247|FG000|Overall Study|Physician Decision|1
2349561|NCT04280705|4092248|FG001|Overall Study|Physician Decision|0
2349562|NCT04280705|4092247|FG000|Overall Study|Withdrawal by Subject|7
2269359|NCT02234063|3946364|FG000|Overall Study|Withdrawal by Subject|20
2269360|NCT02234063|3946365|FG001|Overall Study|Withdrawal by Subject|1
2269361|NCT02234141|3946397|FG000|Treatment Period (24 Weeks)|Protocol Violation|0
2269362|NCT02234141|3946398|FG001|Treatment Period (24 Weeks)|Protocol Violation|0
2269363|NCT02234141|3946399|FG002|Treatment Period (24 Weeks)|Protocol Violation|0
2269364|NCT02234141|3946400|FG003|Treatment Period (24 Weeks)|Protocol Violation|1
2269365|NCT02234141|3946401|FG004|Treatment Period (24 Weeks)|Protocol Violation|0
2269366|NCT02234141|3946402|FG005|Treatment Period (24 Weeks)|Protocol Violation|0
2269367|NCT02234141|3946403|FG006|Treatment Period (24 Weeks)|Protocol Violation|0
2269368|NCT02234141|3946397|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0
2269369|NCT02234141|3946398|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2
2269370|NCT02234141|3946399|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0
2269371|NCT02234141|3946400|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0
2269372|NCT02234141|3946401|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0
2269373|NCT02234141|3946402|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0
2269374|NCT02234141|3946403|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0
2269375|NCT02234141|3946397|FG000|Treatment Period (24 Weeks)|Death|1
2269376|NCT02234141|3946398|FG001|Treatment Period (24 Weeks)|Death|2
2269377|NCT02234141|3946399|FG002|Treatment Period (24 Weeks)|Death|0
2269378|NCT02234141|3946400|FG003|Treatment Period (24 Weeks)|Death|1
2269379|NCT02234141|3946401|FG004|Treatment Period (24 Weeks)|Death|0
2269380|NCT02234141|3946402|FG005|Treatment Period (24 Weeks)|Death|0
2269381|NCT02234141|3946403|FG006|Treatment Period (24 Weeks)|Death|0
2269382|NCT02234141|3946397|FG000|Treatment Period (24 Weeks)|Adverse Event|3
2269383|NCT02234141|3946398|FG001|Treatment Period (24 Weeks)|Adverse Event|1
2269384|NCT02234141|3946399|FG002|Treatment Period (24 Weeks)|Adverse Event|2
2269385|NCT02234141|3946400|FG003|Treatment Period (24 Weeks)|Adverse Event|3
2269386|NCT02234141|3946401|FG004|Treatment Period (24 Weeks)|Adverse Event|0
2269387|NCT02234141|3946402|FG005|Treatment Period (24 Weeks)|Adverse Event|0
2269388|NCT02234141|3946403|FG006|Treatment Period (24 Weeks)|Adverse Event|0
2269389|NCT02234141|3946397|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0
2269390|NCT02234141|3946398|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1
2269391|NCT02234141|3946399|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0
2269392|NCT02234141|3946400|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0
2269393|NCT02234141|3946401|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0
2269394|NCT02234141|3946402|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0
2269395|NCT02234141|3946403|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0
2349563|NCT04280705|4092248|FG001|Overall Study|Withdrawal by Subject|9
2349564|NCT04280705|4092247|FG000|Overall Study|Adverse Event|0
2349565|NCT04280705|4092248|FG001|Overall Study|Adverse Event|4
2349566|NCT04280705|4092247|FG000|Overall Study|Transferred to another hospital|1
2349567|NCT04280705|4092248|FG001|Overall Study|Transferred to another hospital|1
2269396|NCT02234141|3946397|FG000|Long-Term Treatment Period|Death|0
2269397|NCT02234141|3946398|FG001|Long-Term Treatment Period|Death|0
2269398|NCT02234141|3946399|FG002|Long-Term Treatment Period|Death|0
2269399|NCT02234141|3946400|FG003|Long-Term Treatment Period|Death|0
2269400|NCT02234141|3946401|FG004|Long-Term Treatment Period|Death|0
2269401|NCT02234141|3946402|FG005|Long-Term Treatment Period|Death|1
2269402|NCT02234141|3946403|FG006|Long-Term Treatment Period|Death|0
2269403|NCT02234141|3946397|FG000|Long-Term Treatment Period|Investigator's discretion|1
2269404|NCT02234141|3946398|FG001|Long-Term Treatment Period|Investigator's discretion|3
2269405|NCT02234141|3946399|FG002|Long-Term Treatment Period|Investigator's discretion|2
2269406|NCT02234141|3946400|FG003|Long-Term Treatment Period|Investigator's discretion|0
2269407|NCT02234141|3946401|FG004|Long-Term Treatment Period|Investigator's discretion|0
2269408|NCT02234141|3946402|FG005|Long-Term Treatment Period|Investigator's discretion|0
2269409|NCT02234141|3946403|FG006|Long-Term Treatment Period|Investigator's discretion|1
2269410|NCT02234141|3946397|FG000|Long-Term Treatment Period|Adverse Event|4
2269411|NCT02234141|3946398|FG001|Long-Term Treatment Period|Adverse Event|0
2269412|NCT02234141|3946399|FG002|Long-Term Treatment Period|Adverse Event|5
2269413|NCT02234141|3946400|FG003|Long-Term Treatment Period|Adverse Event|0
2269414|NCT02234141|3946401|FG004|Long-Term Treatment Period|Adverse Event|1
2349568|NCT04287517|4092256|FG000|Overall Study|Withdrawal by Subject|1
2349569|NCT04287517|4092257|FG001|Overall Study|Withdrawal by Subject|1
2349570|NCT04275336|4092327|FG000|Overall Study|First venipuncture failed|4
2349571|NCT04275336|4092328|FG001|Overall Study|First venipuncture failed|6
2349572|NCT04275336|4092329|FG002|Overall Study|First venipuncture failed|5
2349573|NCT04275336|4092327|FG000|Overall Study|Unscheduled venipuncture|9
2349574|NCT04275336|4092328|FG001|Overall Study|Unscheduled venipuncture|13
2349575|NCT04275336|4092329|FG002|Overall Study|Unscheduled venipuncture|7
2349576|NCT04275336|4092327|FG000|Overall Study|Failed specimen of saliva|4
2349577|NCT04275336|4092328|FG001|Overall Study|Failed specimen of saliva|3
2349578|NCT04275336|4092329|FG002|Overall Study|Failed specimen of saliva|4
2349579|NCT04272775|4092342|FG000|Overall Study|Study Terminated by Sponsor|1
2349580|NCT04272775|4092343|FG001|Overall Study|Study Terminated by Sponsor|0
2349581|NCT04272775|4092342|FG000|Overall Study|Protocol Violation|0
2349582|NCT04272775|4092343|FG001|Overall Study|Protocol Violation|1
2349583|NCT04272775|4092342|FG000|Overall Study|Symptomatic Deterioration|1
2349584|NCT04272775|4092343|FG001|Overall Study|Symptomatic Deterioration|1
2349585|NCT04272775|4092342|FG000|Overall Study|Withdrawal by Subject|1
2349586|NCT04272775|4092343|FG001|Overall Study|Withdrawal by Subject|2
2349587|NCT04272775|4092342|FG000|Overall Study|Adverse Event|1
2349588|NCT04272775|4092343|FG001|Overall Study|Adverse Event|2
2349589|NCT04272775|4092342|FG000|Overall Study|Progressive Disease|3
2349590|NCT04272775|4092343|FG001|Overall Study|Progressive Disease|1
2349591|NCT04271605|4092375|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5
2349592|NCT04268316|4092386|FG000|Overall Study|Withdrawal by Subject|2
2349593|NCT04268316|4092387|FG001|Overall Study|Withdrawal by Subject|1
2349594|NCT04268316|4092388|FG002|Overall Study|Withdrawal by Subject|0
2349595|NCT04263142|4092431|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0
2349596|NCT04263142|4092432|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0
2349597|NCT04263142|4092433|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0
2349598|NCT04263142|4092434|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0
2349599|NCT04263142|4092435|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1
2349600|NCT04263142|4092431|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0
2349601|NCT04263142|4092432|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0
2349602|NCT04263142|4092433|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0
2349603|NCT04263142|4092434|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0
2349604|NCT04263142|4092435|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1
2349605|NCT04256785|4092450|FG000|Overall Study|Adverse Event|8
2349606|NCT04256785|4092451|FG001|Overall Study|Adverse Event|6
2349607|NCT04256785|4092450|FG000|Overall Study|Lack of Efficacy|3
2349608|NCT04256785|4092451|FG001|Overall Study|Lack of Efficacy|4
2349609|NCT04256785|4092450|FG000|Overall Study|Lost to Follow-up|7
2349610|NCT04256785|4092451|FG001|Overall Study|Lost to Follow-up|7
2349611|NCT04256785|4092450|FG000|Overall Study|Protocol Violation|1
2349612|NCT04256785|4092451|FG001|Overall Study|Protocol Violation|0
2349613|NCT04256785|4092450|FG000|Overall Study|Withdrawal by Subject|4
2349614|NCT04256785|4092451|FG001|Overall Study|Withdrawal by Subject|1
2349615|NCT04256785|4092450|FG000|Overall Study|Surgery or quarantined due to Covid-19|5
2349616|NCT04256785|4092451|FG001|Overall Study|Surgery or quarantined due to Covid-19|7
2349617|NCT04249336|4092486|FG000|Overall Study|Lost to Follow-up|3
2349618|NCT04249336|4092487|FG001|Overall Study|Lost to Follow-up|3
2349619|NCT04249336|4092488|FG002|Overall Study|Lost to Follow-up|3
2349620|NCT04249336|4092489|FG003|Overall Study|Lost to Follow-up|3
2349621|NCT04247061|4092517|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6
2349622|NCT04247061|4092517|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2
2349623|NCT04247061|4092517|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1
2349624|NCT04245202|4092523|FG000|Overall Study|Lack of Efficacy|10
2349625|NCT04245202|4092524|FG001|Overall Study|Lack of Efficacy|1
2349626|NCT04238650|4092555|FG000|Overall Study|Withdrawal by Subject|0
2349627|NCT04238650|4092556|FG001|Overall Study|Withdrawal by Subject|1
2269415|NCT02234141|3946402|FG005|Long-Term Treatment Period|Adverse Event|1
2269416|NCT02234141|3946403|FG006|Long-Term Treatment Period|Adverse Event|1
2269417|NCT02234141|3946397|FG000|Long-Term Treatment Period|Withdrew Consent|0
2269418|NCT02234141|3946398|FG001|Long-Term Treatment Period|Withdrew Consent|1
2269419|NCT02234141|3946399|FG002|Long-Term Treatment Period|Withdrew Consent|1
2269420|NCT02234141|3946400|FG003|Long-Term Treatment Period|Withdrew Consent|0
2269421|NCT02234141|3946401|FG004|Long-Term Treatment Period|Withdrew Consent|0
2269422|NCT02234141|3946402|FG005|Long-Term Treatment Period|Withdrew Consent|0
2269423|NCT02234141|3946403|FG006|Long-Term Treatment Period|Withdrew Consent|0
2269424|NCT02234141|3946397|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28
2269425|NCT02234141|3946398|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27
2269426|NCT02234141|3946399|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25
2269427|NCT02234141|3946400|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0
2269428|NCT02234141|3946401|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9
2269429|NCT02234141|3946402|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10
2269430|NCT02234141|3946403|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8
2269431|NCT02234284|3946421|FG000|Overall Study|Death|4
2269432|NCT02234284|3946422|FG001|Overall Study|Death|2
2269433|NCT02234284|3946421|FG000|Overall Study|Withdrawal by Subject|1
2269434|NCT02234284|3946422|FG001|Overall Study|Withdrawal by Subject|0
2269435|NCT02234284|3946421|FG000|Overall Study|Lost to Follow-up|20
2269436|NCT02234284|3946422|FG001|Overall Study|Lost to Follow-up|7
2269437|NCT02234310|3946432|FG000|Overall Study|Physician Decision|1
2269438|NCT02234310|3946432|FG000|Overall Study|Adverse Event|1
2269439|NCT02234310|3946432|FG000|Overall Study|Eligibility Criteria not fulfilled|2
2269440|NCT02234310|3946432|FG000|Overall Study|Withdrawal by Subject|2
2269441|NCT02234323|3946436|FG000|All Enrolled|Not Treated: Completed study in database|2
2269442|NCT02234323|3946436|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2
2269443|NCT02234323|3946436|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1
2269444|NCT02234323|3946436|FG000|All Treated|Death|1
2269445|NCT02234323|3946436|FG000|All Treated|Physician Decision|5
2269446|NCT02234323|3946436|FG000|All Treated|Lack of Efficacy|3
2269447|NCT02234323|3946436|FG000|All Treated|Exceeded lab value limit|2
2349628|NCT04238663|4092565|FG000|Overall Study|Lost to Follow-up|0
2349629|NCT04238663|4092566|FG001|Overall Study|Lost to Follow-up|1
2349630|NCT04238663|4092567|FG002|Overall Study|Lost to Follow-up|0
2349631|NCT04222699|4092641|FG000|Overall Study|Lost to Follow-up|2
2349632|NCT04206293|4092664|FG000|Overall Study|Consent withdrawal|1
2349633|NCT04228302|4092675|FG000|Overall Study|Adverse Event|0
2349634|NCT04228302|4092676|FG001|Overall Study|Adverse Event|0
2349635|NCT04228302|4092677|FG002|Overall Study|Adverse Event|0
2349636|NCT04228302|4092678|FG003|Overall Study|Adverse Event|0
2349637|NCT04228302|4092679|FG004|Overall Study|Adverse Event|1
2349638|NCT04228302|4092680|FG005|Overall Study|Adverse Event|0
2349639|NCT04223687|4092718|FG000|Overall Study|Missing primary outcome|1
2349640|NCT04223687|4092719|FG001|Overall Study|Missing primary outcome|0
2349641|NCT04223232|4092725|FG000|Overall Study|Withdrawal by Subject|1
2349642|NCT04189224|4092729|FG000|Period 2|Adverse Event|0
2349643|NCT04189224|4092730|FG001|Period 2|Adverse Event|1
2349644|NCT04214600|4092738|FG000|Overall Study|Lost to Follow-up|9
2349645|NCT04214600|4092739|FG001|Overall Study|Lost to Follow-up|14
2349646|NCT04202497|4092746|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1
2349647|NCT04202497|4092747|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
2349648|NCT04202497|4092748|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
2349649|NCT04202497|4092749|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
2349650|NCT04209530|4092776|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4
2349651|NCT04209530|4092777|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2
2349652|NCT04209530|4092776|FG000|Overall Study|Withdrawal by Subject|0
2349653|NCT04209530|4092777|FG001|Overall Study|Withdrawal by Subject|1
2349654|NCT04207840|4092797|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
2349655|NCT04207840|4092798|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
2349656|NCT04207840|4092799|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1
2349657|NCT04207840|4092797|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
2349658|NCT04207840|4092798|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
2349659|NCT04207840|4092799|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1
2349660|NCT04206384|4092834|FG000|Overall Study|Withdrawal by Subject|8
2349661|NCT04206384|4092834|FG000|Overall Study|Adverse Event|2
2349662|NCT04195893|4092855|FG000|Second Intervention|Withdrawal by Subject|1
2349663|NCT04195893|4092856|FG001|Second Intervention|Withdrawal by Subject|0
2349664|NCT04195581|4092871|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4
2349665|NCT04195581|4092871|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5
2349666|NCT04195581|4092871|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1
2349667|NCT04195581|4092871|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1
2349668|NCT04195581|4092871|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3
2349669|NCT04195581|4092871|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2
2349670|NCT04194151|4092895|FG000|Overall Study|Physician Decision|1
2349671|NCT04194151|4092896|FG001|Overall Study|Physician Decision|1
2269448|NCT02234323|3946436|FG000|All Treated|Other|7
2269449|NCT02234362|3946442|FG000|Overall Study|Not eligible after first screening visit|17
2269450|NCT02234362|3946442|FG000|Overall Study|Lost to Follow-up|6
2269451|NCT02234362|3946442|FG000|Overall Study|Withdrawal by Subject|3
2269452|NCT02234479|3946452|FG000|Overall Study|Withdrawal by Subject|1
2269453|NCT02234479|3946453|FG001|Overall Study|Withdrawal by Subject|3
2269454|NCT02234583|3946494|FG000|Overall Study|Adverse Event|172
2269455|NCT02234583|3946495|FG001|Overall Study|Adverse Event|156
2269456|NCT02234583|3946494|FG000|Overall Study|Withdrawal by Subject|109
2269457|NCT02234583|3946495|FG001|Overall Study|Withdrawal by Subject|157
2269458|NCT02234583|3946494|FG000|Overall Study|Lost to Follow-up|0
2269459|NCT02234583|3946495|FG001|Overall Study|Lost to Follow-up|1
2269460|NCT02234583|3946494|FG000|Overall Study|Lack of Efficacy|58
2269461|NCT02234583|3946495|FG001|Overall Study|Lack of Efficacy|103
2269462|NCT02234583|3946494|FG000|Overall Study|Protocol Violation|35
2269463|NCT02234583|3946495|FG001|Overall Study|Protocol Violation|42
2269464|NCT02234583|3946494|FG000|Overall Study|Other|39
2269465|NCT02234583|3946495|FG001|Overall Study|Other|97
2269466|NCT02234596|3946507|FG000|Overall Study|Participant not treated|2
2269467|NCT02234622|3946513|FG000|Overall Study|Withdrawal by Subject|16
2269468|NCT02234622|3946514|FG001|Overall Study|Withdrawal by Subject|22
2269469|NCT02234622|3946513|FG000|Overall Study|Lost to Follow-up|27
2269470|NCT02234622|3946514|FG001|Overall Study|Lost to Follow-up|14
2269471|NCT02235077|3946550|FG000|Overall Study|Death|5
2269472|NCT02235077|3946551|FG001|Overall Study|Death|7
2269473|NCT02235077|3946550|FG000|Overall Study|Lost to Follow-up|5
2269474|NCT02235077|3946551|FG001|Overall Study|Lost to Follow-up|6
2269475|NCT02235077|3946550|FG000|Overall Study|Withdrawal by Subject|8
2269476|NCT02235077|3946551|FG001|Overall Study|Withdrawal by Subject|5
2269477|NCT02235077|3946550|FG000|Overall Study|Physician Decision|0
2269478|NCT02235077|3946551|FG001|Overall Study|Physician Decision|1
2269479|NCT02235298|3946563|FG000|Overall Study|Lost to Follow-up|6
2269480|NCT02235298|3946564|FG001|Overall Study|Lost to Follow-up|5
2269481|NCT02235298|3946563|FG000|Overall Study|Adverse Event|2
2269482|NCT02235298|3946564|FG001|Overall Study|Adverse Event|2
2269483|NCT02235298|3946563|FG000|Overall Study|Withdrawal by Subject|0
2269484|NCT02235298|3946564|FG001|Overall Study|Withdrawal by Subject|1
2269485|NCT02235311|3946572|FG000|Overall Study|Lost to Follow-up|0
2269486|NCT02235311|3946573|FG001|Overall Study|Lost to Follow-up|1
2269487|NCT02235311|3946572|FG000|Overall Study|Protocol Violation|0
2269488|NCT02235311|3946573|FG001|Overall Study|Protocol Violation|1
2269489|NCT02235454|3946579|FG000|Overall Study|Withdrawal by Subject|2
2349672|NCT04194151|4092897|FG002|Overall Study|Physician Decision|1
2349673|NCT04194151|4092898|FG003|Overall Study|Physician Decision|1
2349674|NCT04194151|4092899|FG004|Overall Study|Physician Decision|0
2349675|NCT04194151|4092900|FG005|Overall Study|Physician Decision|1
2349676|NCT04194151|4092895|FG000|Overall Study|Monitorization problem|0
2349677|NCT04194151|4092896|FG001|Overall Study|Monitorization problem|1
2349678|NCT04194151|4092897|FG002|Overall Study|Monitorization problem|0
2349679|NCT04194151|4092898|FG003|Overall Study|Monitorization problem|0
2349680|NCT04194151|4092899|FG004|Overall Study|Monitorization problem|0
2349681|NCT04194151|4092900|FG005|Overall Study|Monitorization problem|0
2349682|NCT04194008|4092914|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19
2349683|NCT04194008|4092914|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6
2349684|NCT04194008|4092914|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2
2349685|NCT04194008|4092914|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3
2349686|NCT04194008|4092914|FG000|Treatment Phase With Nerivio|Missing data|4
2349687|NCT04194008|4092914|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1
2349688|NCT04189081|4092925|FG000|Overall Study|Lost to Follow-up|1
2349689|NCT04189081|4092926|FG001|Overall Study|Lost to Follow-up|0
2349690|NCT04189081|4092927|FG002|Overall Study|Lost to Follow-up|0
2349691|NCT04189081|4092925|FG000|Overall Study|Withdrawal by Subject|0
2349692|NCT04189081|4092926|FG001|Overall Study|Withdrawal by Subject|0
2349693|NCT04189081|4092927|FG002|Overall Study|Withdrawal by Subject|1
2349694|NCT04186806|4092948|FG000|Period 1: 7 Days|Adverse Event|1
2349695|NCT04186806|4092949|FG001|Period 1: 7 Days|Adverse Event|0
2349696|NCT04179838|4092983|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
2349697|NCT04179838|4092984|FG001|First Intervention (1 Day)|Withdrawal by Subject|3
2349698|NCT04179838|4092983|FG000|Second Intervention (1 Day)|Protocol Violation|0
2349699|NCT04179838|4092984|FG001|Second Intervention (1 Day)|Protocol Violation|1
2349700|NCT04179461|4092990|FG000|Overall Study|Lost to Follow-up|4
2349701|NCT04178590|4093018|FG000|Overall Study|Pregnancy|1
2349702|NCT04178590|4093018|FG000|Overall Study|Lost to Follow-up|1
2349703|NCT04177862|4093046|FG000|Overall Study|Protocol Violation|2
2349704|NCT04177862|4093047|FG001|Overall Study|Protocol Violation|7
2349705|NCT04173741|4093122|FG000|Overall Study|IVC measurement cannot be done|1
2349706|NCT04173741|4093123|FG001|Overall Study|IVC measurement cannot be done|1
2349707|NCT04169061|4093129|FG000|Overall Study|Adverse Event|2
2349708|NCT04169061|4093129|FG000|Overall Study|Death|1
2349709|NCT04169061|4093129|FG000|Overall Study|Withdrawal by Subject|1
2349710|NCT04169061|4093129|FG000|Overall Study|Protocol Violation|1
2349711|NCT04157738|4093135|FG000|Overall Study|Moved out of state|0
2349712|NCT04157738|4093136|FG001|Overall Study|Moved out of state|2
2349713|NCT04157738|4093135|FG000|Overall Study|Did not show up to the Follow-up appointment|1
2269490|NCT02236130|3946624|FG000|Overall Study|Lost to Follow-up|7
2269491|NCT02236130|3946625|FG001|Overall Study|Lost to Follow-up|12
2269492|NCT02236520|3946644|FG000|Overall Study|Physician Decision|0
2269493|NCT02236520|3946645|FG001|Overall Study|Physician Decision|5
2269494|NCT02236520|3946646|FG002|Overall Study|Physician Decision|0
2269495|NCT02236520|3946647|FG003|Overall Study|Physician Decision|0
2269496|NCT02236520|3946644|FG000|Overall Study|Withdrawal by Subject|1
2269497|NCT02236520|3946645|FG001|Overall Study|Withdrawal by Subject|0
2269498|NCT02236520|3946646|FG002|Overall Study|Withdrawal by Subject|0
2269499|NCT02236520|3946647|FG003|Overall Study|Withdrawal by Subject|1
2269500|NCT02236520|3946644|FG000|Overall Study|Pregnancy|1
2269501|NCT02236520|3946645|FG001|Overall Study|Pregnancy|0
2269502|NCT02236520|3946646|FG002|Overall Study|Pregnancy|0
2269503|NCT02236520|3946647|FG003|Overall Study|Pregnancy|0
2269504|NCT02236559|3946659|FG000|Overall Study|Met Exclusion|3
2269505|NCT02236559|3946660|FG001|Overall Study|Met Exclusion|6
2269506|NCT02236559|3946659|FG000|Overall Study|Did not Meet Inclusion|3
2269507|NCT02236559|3946660|FG001|Overall Study|Did not Meet Inclusion|3
2269508|NCT02236559|3946659|FG000|Overall Study|Subject Did Not Consent|4
2269509|NCT02236559|3946660|FG001|Overall Study|Subject Did Not Consent|2
2269510|NCT02236559|3946659|FG000|Overall Study|Physician Decision|1
2269511|NCT02236559|3946660|FG001|Overall Study|Physician Decision|1
2269512|NCT02236559|3946659|FG000|Overall Study|Withdrawal by Subject|1
2269513|NCT02236559|3946660|FG001|Overall Study|Withdrawal by Subject|0
2269514|NCT02236598|3946668|FG000|Overall Study|Adverse Event|0
2269515|NCT02236598|3946669|FG001|Overall Study|Adverse Event|1
2269516|NCT02236598|3946668|FG000|Overall Study|Withdrawal by Subject|0
2269517|NCT02236598|3946669|FG001|Overall Study|Withdrawal by Subject|1
2269518|NCT02236611|3946677|FG000|Overall Study|Adverse Event|10
2269519|NCT02236611|3946678|FG001|Overall Study|Adverse Event|16
2269520|NCT02236611|3946677|FG000|Overall Study|Lack of Efficacy|4
2269521|NCT02236611|3946678|FG001|Overall Study|Lack of Efficacy|7
2269522|NCT02236611|3946677|FG000|Overall Study|Lost to Follow-up|0
2269523|NCT02236611|3946678|FG001|Overall Study|Lost to Follow-up|2
2269524|NCT02236611|3946677|FG000|Overall Study|Protocol deviation|3
2269525|NCT02236611|3946678|FG001|Overall Study|Protocol deviation|5
2269526|NCT02236611|3946677|FG000|Overall Study|Withdrew consent|9
2269527|NCT02236611|3946678|FG001|Overall Study|Withdrew consent|4
2269528|NCT02236988|3946692|FG000|Overall Study|Lost to Follow-up|0
2269529|NCT02236988|3946693|FG001|Overall Study|Lost to Follow-up|0
2269530|NCT02236988|3946694|FG002|Overall Study|Lost to Follow-up|0
2269531|NCT02236988|3946695|FG003|Overall Study|Lost to Follow-up|1
2269532|NCT02236988|3946692|FG000|Overall Study|Unable to Comply with Study Visits|0
2269533|NCT02236988|3946693|FG001|Overall Study|Unable to Comply with Study Visits|0
2269534|NCT02236988|3946694|FG002|Overall Study|Unable to Comply with Study Visits|0
2269535|NCT02236988|3946695|FG003|Overall Study|Unable to Comply with Study Visits|2
2269536|NCT02237001|3946746|FG000|Overall Study|Lost to Follow-up|2
2269537|NCT02237001|3946746|FG000|Overall Study|Withdrawal by Subject|1
2269538|NCT02237001|3946746|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3
2269539|NCT02237001|3946746|FG000|Overall Study|Re-operation|4
2269540|NCT02237001|3946746|FG000|Overall Study|Incarceration|1
2269541|NCT02237118|3946767|FG000|Overall Study|Protocol Violation|0
2269542|NCT02237118|3946768|FG001|Overall Study|Protocol Violation|1
2269543|NCT02237118|3946767|FG000|Overall Study|consent withdrawn|1
2269544|NCT02237118|3946768|FG001|Overall Study|consent withdrawn|0
2269545|NCT02237157|3946782|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3
2269546|NCT02237157|3946783|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
2269547|NCT02237157|3946784|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
2269548|NCT02237157|3946785|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
2269549|NCT02237157|3946782|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1
2269550|NCT02237157|3946783|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
2269551|NCT02237157|3946784|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
2269552|NCT02237157|3946785|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
2269553|NCT02237196|3946796|FG000|Overall Study|Adverse Event|0
2269554|NCT02237196|3946797|FG001|Overall Study|Adverse Event|1
2269555|NCT02237196|3946798|FG002|Overall Study|Adverse Event|1
2269556|NCT02237196|3946799|FG003|Overall Study|Adverse Event|0
2269557|NCT02237196|3946796|FG000|Overall Study|Lost to Follow-up|4
2269558|NCT02237196|3946797|FG001|Overall Study|Lost to Follow-up|2
2269559|NCT02237196|3946798|FG002|Overall Study|Lost to Follow-up|4
2269560|NCT02237196|3946799|FG003|Overall Study|Lost to Follow-up|6
2269561|NCT02237196|3946796|FG000|Overall Study|Physician Decision|2
2269562|NCT02237196|3946797|FG001|Overall Study|Physician Decision|0
2269563|NCT02237196|3946798|FG002|Overall Study|Physician Decision|0
2269564|NCT02237196|3946799|FG003|Overall Study|Physician Decision|1
2269565|NCT02237196|3946796|FG000|Overall Study|Pregnancy|0
2269566|NCT02237196|3946797|FG001|Overall Study|Pregnancy|0
2269567|NCT02237196|3946798|FG002|Overall Study|Pregnancy|1
2269568|NCT02237196|3946799|FG003|Overall Study|Pregnancy|1
2269569|NCT02237196|3946796|FG000|Overall Study|Withdrawal by Subject|1
2269570|NCT02237196|3946797|FG001|Overall Study|Withdrawal by Subject|1
2269571|NCT02237196|3946798|FG002|Overall Study|Withdrawal by Subject|4
2269572|NCT02237196|3946799|FG003|Overall Study|Withdrawal by Subject|1
2269573|NCT02237196|3946796|FG000|Overall Study|Site Error|1
2269574|NCT02237196|3946797|FG001|Overall Study|Site Error|2
2269575|NCT02237196|3946798|FG002|Overall Study|Site Error|0
2269576|NCT02237196|3946799|FG003|Overall Study|Site Error|2
2269577|NCT02237911|3946836|FG000|Overall Study|Withdrawal by Subject|4
2269578|NCT02237911|3946837|FG001|Overall Study|Withdrawal by Subject|7
2269579|NCT02237911|3946838|FG002|Overall Study|Withdrawal by Subject|2
2269580|NCT02237911|3946836|FG000|Overall Study|Lost to Follow-up|3
2269581|NCT02237911|3946837|FG001|Overall Study|Lost to Follow-up|1
2269582|NCT02237911|3946838|FG002|Overall Study|Lost to Follow-up|1
2269583|NCT02238067|3946876|FG000|Overall Study|Not completed survey at Month 6|45
2269584|NCT02238080|3946880|FG000|Overall Study|Death|13
2269585|NCT02238080|3946880|FG000|Overall Study|Treatment interrupted|6
2269586|NCT02238080|3946880|FG000|Overall Study|Withdrawal by Subject|2
2269587|NCT02238080|3946880|FG000|Overall Study|Other|4
2269588|NCT02238379|3946886|FG000|Overall Study|Lost to Follow-up|1
2269589|NCT02238379|3946887|FG001|Overall Study|Lost to Follow-up|0
2269590|NCT02238483|3946895|FG000|Overall Study|Withdrawal by Subject|2
2269591|NCT02238483|3946896|FG001|Overall Study|Withdrawal by Subject|7
2269592|NCT02238483|3946895|FG000|Overall Study|Lost to Follow-up|1
2269593|NCT02238483|3946896|FG001|Overall Study|Lost to Follow-up|1
2269594|NCT02238483|3946895|FG000|Overall Study|Protocol Violation|1
2269595|NCT02238483|3946896|FG001|Overall Study|Protocol Violation|2
2269596|NCT02238483|3946895|FG000|Overall Study|Death|1
2269597|NCT02238483|3946896|FG001|Overall Study|Death|0
2269598|NCT02238483|3946895|FG000|Overall Study|Adverse Event|7
2269599|NCT02238483|3946896|FG001|Overall Study|Adverse Event|3
2269600|NCT02238483|3946895|FG000|Overall Study|Withdrawn due to physician decision|1
2269601|NCT02238483|3946896|FG001|Overall Study|Withdrawn due to physician decision|0
2269602|NCT02238483|3946895|FG000|Overall Study|Completion status not recorded|1
2269603|NCT02238483|3946896|FG001|Overall Study|Completion status not recorded|1
2269604|NCT02238483|3946895|FG000|Overall Study|Illness in family member|1
2269605|NCT02238483|3946896|FG001|Overall Study|Illness in family member|0
2269606|NCT02238626|3946906|FG000|Overall Study|Adverse Event|3
2269607|NCT02238626|3946907|FG001|Overall Study|Adverse Event|5
2269608|NCT02238626|3946908|FG002|Overall Study|Adverse Event|0
2269609|NCT02238626|3946909|FG003|Overall Study|Adverse Event|3
2269610|NCT02238626|3946906|FG000|Overall Study|Lost to Follow-up|2
2269611|NCT02238626|3946907|FG001|Overall Study|Lost to Follow-up|4
2269612|NCT02238626|3946908|FG002|Overall Study|Lost to Follow-up|2
2269613|NCT02238626|3946909|FG003|Overall Study|Lost to Follow-up|2
2269614|NCT02238626|3946906|FG000|Overall Study|Withdrawal by Subject|0
2269615|NCT02238626|3946907|FG001|Overall Study|Withdrawal by Subject|3
2269616|NCT02238626|3946908|FG002|Overall Study|Withdrawal by Subject|0
2269617|NCT02238626|3946909|FG003|Overall Study|Withdrawal by Subject|1
2269618|NCT02238626|3946906|FG000|Overall Study|Death|0
2269619|NCT02238626|3946907|FG001|Overall Study|Death|0
2269620|NCT02238626|3946908|FG002|Overall Study|Death|1
2269621|NCT02238626|3946909|FG003|Overall Study|Death|1
2269622|NCT02238626|3946906|FG000|Overall Study|Other|0
2269623|NCT02238626|3946907|FG001|Overall Study|Other|2
2269624|NCT02238626|3946908|FG002|Overall Study|Other|0
2269625|NCT02238626|3946909|FG003|Overall Study|Other|0
2269626|NCT02239094|3946956|FG000|Overall Study|Withdrawal by Subject|1
2269627|NCT02239094|3946956|FG000|Overall Study|Remitted before started|1
2269628|NCT02239120|3946962|FG000|Overall Study|Death|56
2269629|NCT02239120|3946963|FG001|Overall Study|Death|58
2269630|NCT02239120|3946962|FG000|Overall Study|Lost to Follow-up|19
2269631|NCT02239120|3946963|FG001|Overall Study|Lost to Follow-up|14
2269632|NCT02239224|3946973|FG000|Overall Study|Administrative|0
2269633|NCT02239224|3946974|FG001|Overall Study|Administrative|0
2269634|NCT02239224|3946975|FG002|Overall Study|Administrative|3
2269635|NCT02239224|3946976|FG003|Overall Study|Administrative|1
2269636|NCT02239263|3946986|FG000|Overall Study|Protocol Violation|6
2269637|NCT02239328|3946996|FG000|Overall Study|Benign disease noted at time of surgery|6
2269638|NCT02239328|3946996|FG000|Overall Study|Equipment or website malfunction|2
2269639|NCT02239510|3947006|FG000|Overall Study|Lost to Follow-up|2
2269640|NCT02239510|3947007|FG001|Overall Study|Lost to Follow-up|1
2269641|NCT02239536|3947015|FG000|Overall Study|Non-neoplastic polyp|23
2269642|NCT02239536|3947016|FG001|Overall Study|Non-neoplastic polyp|17
2269643|NCT02239601|3947051|FG000|Overall Study|Withdrawal by Subject|3
2269644|NCT02239601|3947052|FG001|Overall Study|Withdrawal by Subject|4
2269645|NCT02239601|3947051|FG000|Overall Study|Protocol Violation|4
2269646|NCT02239601|3947052|FG001|Overall Study|Protocol Violation|2
2269647|NCT02239640|3947063|FG000|Overall Study|Withdrawal by Subject|3
2269648|NCT02239640|3947063|FG000|Overall Study|Lost to Follow-up|72
2269649|NCT02239640|3947063|FG000|Overall Study|Death|142
2269650|NCT02239679|3947076|FG000|Overall Study|Lost to Follow-up|1
2269651|NCT02239679|3947077|FG001|Overall Study|Lost to Follow-up|0
2269652|NCT02239679|3947078|FG002|Overall Study|Lost to Follow-up|0
2269653|NCT02239679|3947076|FG000|Overall Study|Withdrawal by Subject|2
2269654|NCT02239679|3947077|FG001|Overall Study|Withdrawal by Subject|3
2269655|NCT02239679|3947078|FG002|Overall Study|Withdrawal by Subject|1
2269656|NCT02239692|3947088|FG000|Overall Study|Incomplete colonoscopy|1
2269657|NCT02239692|3947089|FG001|Overall Study|Incomplete colonoscopy|2
2269658|NCT02239692|3947088|FG000|Overall Study|Adverse Event|0
2269659|NCT02239692|3947089|FG001|Overall Study|Adverse Event|1
2269660|NCT02239692|3947088|FG000|Overall Study|Physician Decision|0
2269661|NCT02239692|3947089|FG001|Overall Study|Physician Decision|1
2349714|NCT04157738|4093136|FG001|Overall Study|Did not show up to the Follow-up appointment|0
2349715|NCT04156646|4093144|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0
2349716|NCT04156646|4093145|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1
2349717|NCT04170686|4093156|FG000|Screening|Physician Decision|12
2349718|NCT04170686|4093157|FG001|Screening|Physician Decision|13
2349719|NCT04170686|4093156|FG000|Randomization and Treatment|Lost to Follow-up|26
2349720|NCT04170686|4093157|FG001|Randomization and Treatment|Lost to Follow-up|15
2269662|NCT02239692|3947088|FG000|Overall Study|Lost to Follow-up|1
2269663|NCT02239692|3947089|FG001|Overall Study|Lost to Follow-up|4
2269664|NCT02239692|3947088|FG000|Overall Study|Withdrawal by Subject|3
2269665|NCT02239692|3947089|FG001|Overall Study|Withdrawal by Subject|5
2269666|NCT02239692|3947088|FG000|Overall Study|Other reason|1
2269667|NCT02239692|3947089|FG001|Overall Study|Other reason|0
2269668|NCT02239939|3947140|FG000|Overall Study|Adverse Event|1
2269669|NCT02239939|3947141|FG001|Overall Study|Adverse Event|0
2269670|NCT02239939|3947140|FG000|Overall Study|Withdrawal by Subject|1
2269671|NCT02239939|3947141|FG001|Overall Study|Withdrawal by Subject|1
2269672|NCT02239939|3947140|FG000|Overall Study|Lost to Follow-up|0
2349721|NCT04162795|4093217|FG000|Overall Study|Other|16
2349722|NCT04162795|4093217|FG000|Overall Study|Screen failures|10
2349723|NCT04161807|4093221|FG000|Overall Study|Withdrawal by Subject|2
2349724|NCT04161807|4093221|FG000|Overall Study|Performed only 1 treatment|2
2349725|NCT04161144|4093227|FG000|Overall Study|Withdrawal by Subject|0
2349726|NCT04161144|4093228|FG001|Overall Study|Withdrawal by Subject|1
2349727|NCT04161144|4093227|FG000|Overall Study|Protocol Violation|1
2349728|NCT04161144|4093228|FG001|Overall Study|Protocol Violation|0
2349729|NCT04161131|4093234|FG000|Overall Study|Ineligible|2
2349730|NCT04161131|4093234|FG000|Overall Study|Lost to Follow-up|4
2349731|NCT04161079|4093238|FG000|Clinical Investigation 2010-040|Adverse Event|1
2349732|NCT04152083|4093257|FG000|Overall Study|Lost to Follow-up|2
2349733|NCT04152083|4093258|FG001|Overall Study|Lost to Follow-up|1
2349734|NCT04152083|4093257|FG000|Overall Study|Adverse Event|1
2349735|NCT04152083|4093258|FG001|Overall Study|Adverse Event|0
2349736|NCT04152083|4093257|FG000|Overall Study|Randomized but not treated|3
2349737|NCT04152083|4093258|FG001|Overall Study|Randomized but not treated|2
2349738|NCT04155047|4093270|FG000|Overall Study|Adverse Event|1
2349739|NCT04155047|4093271|FG001|Overall Study|Adverse Event|0
2349740|NCT04155047|4093270|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1
2349741|NCT04155047|4093271|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0
2349742|NCT04150250|4093300|FG000|Overall Study|Lost to Follow-up|0
2349743|NCT04150250|4093301|FG001|Overall Study|Lost to Follow-up|2
2349744|NCT04149353|4093386|FG000|Overall Study|Study terminated|1
2349745|NCT04148651|4093391|FG000|Overall Study|Lost to Follow-up|2
2349746|NCT04136444|4093411|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0
2349747|NCT04136444|4093412|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1
2349748|NCT04147611|4093446|FG000|Overall Study|Physician Decision|0
2349749|NCT04147611|4093447|FG001|Overall Study|Physician Decision|1
2349750|NCT04142216|4093516|FG000|Overall Study|Hospitalization|0
2349751|NCT04142216|4093517|FG001|Overall Study|Hospitalization|2
2349752|NCT04142216|4093516|FG000|Overall Study|Death|3
2349753|NCT04142216|4093517|FG001|Overall Study|Death|1
2349754|NCT04142216|4093516|FG000|Overall Study|Referral to another hemodialysis unit|3
2349755|NCT04142216|4093517|FG001|Overall Study|Referral to another hemodialysis unit|2
2349756|NCT04142216|4093516|FG000|Overall Study|Use of clove|0
2349757|NCT04142216|4093517|FG001|Overall Study|Use of clove|1
2349758|NCT04142450|4093528|FG000|Overall Study|Screen Failure|1
2349759|NCT04142450|4093528|FG000|Overall Study|Lost to Follow-up|1
2349760|NCT04142242|4093538|FG000|Overall Study|Non-compliance with the protocol|1
2349761|NCT04142242|4093539|FG001|Overall Study|Non-compliance with the protocol|0
2349762|NCT04142242|4093540|FG002|Overall Study|Non-compliance with the protocol|0
2349763|NCT04142242|4093541|FG003|Overall Study|Non-compliance with the protocol|0
2349764|NCT04142242|4093542|FG004|Overall Study|Non-compliance with the protocol|0
2349765|NCT04142242|4093543|FG005|Overall Study|Non-compliance with the protocol|1
2349766|NCT04142242|4093538|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
2349767|NCT04142242|4093539|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1
2349768|NCT04142242|4093540|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
2349769|NCT04142242|4093541|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
2349770|NCT04142242|4093542|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
2349771|NCT04142242|4093543|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
2349772|NCT04142242|4093538|FG000|Overall Study|Ongoing|0
2349773|NCT04142242|4093539|FG001|Overall Study|Ongoing|0
2349774|NCT04142242|4093540|FG002|Overall Study|Ongoing|31
2349775|NCT04142242|4093541|FG003|Overall Study|Ongoing|39
2349776|NCT04142242|4093542|FG004|Overall Study|Ongoing|0
2349777|NCT04142242|4093543|FG005|Overall Study|Ongoing|0
2349778|NCT04140890|4093558|FG000|Overall Study|Withdrawal by Subject|0
2349779|NCT04140890|4093559|FG001|Overall Study|Withdrawal by Subject|1
2349780|NCT04139018|4093570|FG000|Overall Study|Screen fail|1
2349781|NCT04139018|4093571|FG001|Overall Study|Screen fail|0
2349782|NCT04139018|4093570|FG000|Overall Study|Withdrawal by Subject|2
2349783|NCT04139018|4093571|FG001|Overall Study|Withdrawal by Subject|0
2269673|NCT02239939|3947141|FG001|Overall Study|Lost to Follow-up|1
2269674|NCT02239978|3947151|FG000|Overall Study|Withdrawal by Subject|2
2269675|NCT02239978|3947152|FG001|Overall Study|Withdrawal by Subject|0
2349784|NCT04139018|4093570|FG000|Overall Study|Lost to Follow-up|0
2349785|NCT04139018|4093571|FG001|Overall Study|Lost to Follow-up|1
2349786|NCT04138810|4093579|FG000|Overall Study|Withdrawal by Subject|0
2349787|NCT04138810|4093580|FG001|Overall Study|Withdrawal by Subject|1
2349788|NCT04138810|4093579|FG000|Overall Study|Subject cancelled surgery|1
2269676|NCT02240108|3947177|FG000|Overall Study|Other than specified|8
2269677|NCT02240108|3947178|FG001|Overall Study|Other than specified|6
2269678|NCT02240108|3947177|FG000|Overall Study|Adverse Event|1
2269679|NCT02240108|3947178|FG001|Overall Study|Adverse Event|9
2269680|NCT02240108|3947177|FG000|Overall Study|Pregnancy|1
2269681|NCT02240108|3947178|FG001|Overall Study|Pregnancy|0
2269682|NCT02240108|3947177|FG000|Overall Study|Withdrawal by Subject|4
2269683|NCT02240108|3947178|FG001|Overall Study|Withdrawal by Subject|9
2269684|NCT02240108|3947177|FG000|Overall Study|StudyTerminated by Sponsor|0
2269685|NCT02240108|3947178|FG001|Overall Study|StudyTerminated by Sponsor|1
2269686|NCT02240121|3947186|FG000|Overall Study|Protocol Violation|1
2269687|NCT02240121|3947187|FG001|Overall Study|Protocol Violation|2
2269688|NCT02240121|3947186|FG000|Overall Study|Physician Decision|0
2269689|NCT02240121|3947187|FG001|Overall Study|Physician Decision|1
2269690|NCT02240121|3947186|FG000|Overall Study|Change in protocol interpretation|1
2269691|NCT02240121|3947187|FG001|Overall Study|Change in protocol interpretation|0
2269692|NCT02240121|3947186|FG000|Overall Study|Lack of Efficacy|2
2269693|NCT02240121|3947187|FG001|Overall Study|Lack of Efficacy|3
2269694|NCT02240121|3947186|FG000|Overall Study|Site closed|1
2269695|NCT02240121|3947187|FG001|Overall Study|Site closed|1
2269696|NCT02240121|3947186|FG000|Overall Study|Pregnancy|1
2269697|NCT02240121|3947187|FG001|Overall Study|Pregnancy|0
2269698|NCT02240121|3947186|FG000|Overall Study|Adverse Event|2
2269699|NCT02240121|3947187|FG001|Overall Study|Adverse Event|4
2269700|NCT02240121|3947186|FG000|Overall Study|Withdrawal by Subject|6
2269701|NCT02240121|3947187|FG001|Overall Study|Withdrawal by Subject|2
2269702|NCT02240121|3947186|FG000|Overall Study|Lost to Follow-up|3
2269703|NCT02240121|3947187|FG001|Overall Study|Lost to Follow-up|4
2269704|NCT02240121|3947186|FG000|Overall Study|Other than specified|1
2269705|NCT02240121|3947187|FG001|Overall Study|Other than specified|3
2269706|NCT02240368|3947207|FG000|Overall Study|Surgery lasted less then 20 minutes|1
2269707|NCT02240368|3947208|FG001|Overall Study|Surgery lasted less then 20 minutes|0
2269708|NCT02240368|3947209|FG002|Overall Study|Surgery lasted less then 20 minutes|0
2269709|NCT02240368|3947207|FG000|Overall Study|Entropy failed to detect more than 50%|0
2269710|NCT02240368|3947208|FG001|Overall Study|Entropy failed to detect more than 50%|0
2269711|NCT02240368|3947209|FG002|Overall Study|Entropy failed to detect more than 50%|1
2269712|NCT02240628|3947228|FG000|Overall Study|Physician Decision|6
2269713|NCT02240628|3947229|FG001|Overall Study|Physician Decision|5
2269714|NCT02240680|3947267|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6
2269715|NCT02240680|3947268|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6
2269716|NCT02240680|3947269|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0
2269717|NCT02240680|3947270|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0
2349789|NCT04138810|4093580|FG001|Overall Study|Subject cancelled surgery|0
2349790|NCT04131556|4093586|FG000|Overall Study|Adverse Event|1
2349791|NCT04131556|4093586|FG000|Overall Study|Withdrawal by Subject|1
2349792|NCT04126174|4093593|FG000|Overall Study|Lost to Follow-up|3
2349793|NCT04126174|4093594|FG001|Overall Study|Lost to Follow-up|3
2349794|NCT04138043|4093638|FG000|Overall Study|Withdrawal by Subject|0
2349795|NCT04138043|4093639|FG001|Overall Study|Withdrawal by Subject|1
2349796|NCT04132336|4093672|FG000|Overall Study|Investigator Decision|0
2349797|NCT04132336|4093673|FG001|Overall Study|Investigator Decision|1
2349798|NCT04132336|4093674|FG002|Overall Study|Investigator Decision|0
2349799|NCT04132336|4093675|FG003|Overall Study|Investigator Decision|0
2349800|NCT04132336|4093676|FG004|Overall Study|Investigator Decision|0
2349801|NCT04132336|4093677|FG005|Overall Study|Investigator Decision|0
2349802|NCT04132336|4093678|FG006|Overall Study|Investigator Decision|0
2349803|NCT04128293|4093718|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
2349804|NCT04128293|4093719|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
2349805|NCT04128293|4093720|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
2349806|NCT04128293|4093721|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
2349807|NCT04126343|4093742|FG000|Overall Study|Adverse Event|0
2349808|NCT04126343|4093743|FG001|Overall Study|Adverse Event|0
2349809|NCT04126343|4093744|FG002|Overall Study|Adverse Event|0
2349810|NCT04126343|4093745|FG003|Overall Study|Adverse Event|0
2349811|NCT04126343|4093746|FG004|Overall Study|Adverse Event|0
2349812|NCT04126343|4093747|FG005|Overall Study|Adverse Event|1
2349813|NCT04126343|4093742|FG000|Overall Study|Withdrawal by Subject|0
2349814|NCT04126343|4093743|FG001|Overall Study|Withdrawal by Subject|0
2349815|NCT04126343|4093744|FG002|Overall Study|Withdrawal by Subject|0
2349816|NCT04126343|4093745|FG003|Overall Study|Withdrawal by Subject|1
2349817|NCT04126343|4093746|FG004|Overall Study|Withdrawal by Subject|0
2349818|NCT04126343|4093747|FG005|Overall Study|Withdrawal by Subject|0
2349819|NCT04126343|4093742|FG000|Overall Study|Related to COVID-19 pandemic|3
2349820|NCT04126343|4093743|FG001|Overall Study|Related to COVID-19 pandemic|4
2349821|NCT04126343|4093744|FG002|Overall Study|Related to COVID-19 pandemic|3
2349822|NCT04126343|4093745|FG003|Overall Study|Related to COVID-19 pandemic|3
2269718|NCT02240680|3947267|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4
2269719|NCT02240680|3947268|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1
2269720|NCT02240680|3947269|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0
2269721|NCT02240680|3947270|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0
2269722|NCT02240680|3947267|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
2269723|NCT02240680|3947268|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
2269724|NCT02240680|3947269|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
2269725|NCT02240680|3947270|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
2269726|NCT02240680|3947267|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
2269727|NCT02240680|3947268|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
2269728|NCT02240680|3947269|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
2269729|NCT02240680|3947270|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
2269730|NCT02240680|3947267|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1
2269731|NCT02240680|3947268|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0
2269732|NCT02240680|3947269|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0
2269733|NCT02240680|3947270|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0
2269734|NCT02240680|3947267|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
2269735|NCT02240680|3947268|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
2269736|NCT02240680|3947269|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
2269737|NCT02240680|3947270|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
2269738|NCT02240680|3947267|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
2269739|NCT02240680|3947268|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
2269740|NCT02240680|3947269|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
2269741|NCT02240680|3947270|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
2269742|NCT02240680|3947267|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
2269743|NCT02240680|3947268|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
2269744|NCT02240680|3947269|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
2269745|NCT02240680|3947270|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
2269746|NCT02240693|3947283|FG000|Overall Study|Adverse Event|0
2349823|NCT04126343|4093746|FG004|Overall Study|Related to COVID-19 pandemic|3
2349824|NCT04126343|4093747|FG005|Overall Study|Related to COVID-19 pandemic|3
2349825|NCT04124952|4093766|FG000|Overall Study|Lost to Follow-up|1
2349826|NCT04123665|4093772|FG000|Overall Study|Withdrawal by Subject|7
2349827|NCT04123665|4093773|FG001|Overall Study|Withdrawal by Subject|0
2269747|NCT02240693|3947284|FG001|Overall Study|Adverse Event|0
2269748|NCT02240693|3947285|FG002|Overall Study|Adverse Event|0
2269749|NCT02240693|3947286|FG003|Overall Study|Adverse Event|0
2269750|NCT02240693|3947287|FG004|Overall Study|Adverse Event|1
2269751|NCT02240693|3947283|FG000|Overall Study|Withdrawal by Subject|0
2269752|NCT02240693|3947284|FG001|Overall Study|Withdrawal by Subject|0
2269753|NCT02240693|3947285|FG002|Overall Study|Withdrawal by Subject|2
2269754|NCT02240693|3947286|FG003|Overall Study|Withdrawal by Subject|1
2269755|NCT02240693|3947287|FG004|Overall Study|Withdrawal by Subject|0
2269756|NCT02240693|3947283|FG000|Overall Study|Other than specified|0
2269757|NCT02240693|3947284|FG001|Overall Study|Other than specified|0
2269758|NCT02240693|3947285|FG002|Overall Study|Other than specified|2
2269759|NCT02240693|3947286|FG003|Overall Study|Other than specified|0
2269760|NCT02240693|3947287|FG004|Overall Study|Other than specified|0
2269761|NCT02240706|3947306|FG000|Overall Study|Lack of Efficacy|2
2269762|NCT02240706|3947307|FG001|Overall Study|Lack of Efficacy|2
2269763|NCT02240706|3947308|FG002|Overall Study|Lack of Efficacy|2
2269764|NCT02240706|3947309|FG003|Overall Study|Lack of Efficacy|2
2269765|NCT02240706|3947310|FG004|Overall Study|Lack of Efficacy|5
2269766|NCT02240706|3947311|FG005|Overall Study|Lack of Efficacy|0
2269767|NCT02240706|3947312|FG006|Overall Study|Lack of Efficacy|0
2269768|NCT02240706|3947306|FG000|Overall Study|Adverse Event|1
2269769|NCT02240706|3947307|FG001|Overall Study|Adverse Event|0
2269770|NCT02240706|3947308|FG002|Overall Study|Adverse Event|1
2269771|NCT02240706|3947309|FG003|Overall Study|Adverse Event|0
2269772|NCT02240706|3947310|FG004|Overall Study|Adverse Event|2
2269773|NCT02240706|3947311|FG005|Overall Study|Adverse Event|0
2269774|NCT02240706|3947312|FG006|Overall Study|Adverse Event|0
2269775|NCT02240706|3947306|FG000|Overall Study|Progressive disease|0
2269776|NCT02240706|3947307|FG001|Overall Study|Progressive disease|0
2269777|NCT02240706|3947308|FG002|Overall Study|Progressive disease|0
2269778|NCT02240706|3947309|FG003|Overall Study|Progressive disease|0
2269779|NCT02240706|3947310|FG004|Overall Study|Progressive disease|1
2269780|NCT02240706|3947311|FG005|Overall Study|Progressive disease|0
2269781|NCT02240706|3947312|FG006|Overall Study|Progressive disease|0
2269782|NCT02240706|3947306|FG000|Overall Study|Dose limiting toxicity|0
2269783|NCT02240706|3947307|FG001|Overall Study|Dose limiting toxicity|0
2269784|NCT02240706|3947308|FG002|Overall Study|Dose limiting toxicity|0
2269785|NCT02240706|3947309|FG003|Overall Study|Dose limiting toxicity|0
2269786|NCT02240706|3947310|FG004|Overall Study|Dose limiting toxicity|1
2269787|NCT02240706|3947311|FG005|Overall Study|Dose limiting toxicity|0
2269788|NCT02240706|3947312|FG006|Overall Study|Dose limiting toxicity|0
2269789|NCT02240706|3947306|FG000|Overall Study|Refused to continue taking medication|0
2269790|NCT02240706|3947307|FG001|Overall Study|Refused to continue taking medication|1
2269791|NCT02240706|3947308|FG002|Overall Study|Refused to continue taking medication|3
2269792|NCT02240706|3947309|FG003|Overall Study|Refused to continue taking medication|1
2269793|NCT02240706|3947310|FG004|Overall Study|Refused to continue taking medication|2
2269794|NCT02240706|3947311|FG005|Overall Study|Refused to continue taking medication|0
2269795|NCT02240706|3947312|FG006|Overall Study|Refused to continue taking medication|0
2269796|NCT02240706|3947306|FG000|Overall Study|Insurance billing concerns|0
2269797|NCT02240706|3947307|FG001|Overall Study|Insurance billing concerns|0
2269798|NCT02240706|3947308|FG002|Overall Study|Insurance billing concerns|0
2269799|NCT02240706|3947309|FG003|Overall Study|Insurance billing concerns|1
2269800|NCT02240706|3947310|FG004|Overall Study|Insurance billing concerns|0
2269801|NCT02240706|3947311|FG005|Overall Study|Insurance billing concerns|0
2269802|NCT02240706|3947312|FG006|Overall Study|Insurance billing concerns|0
2269803|NCT02241512|3947343|FG000|Overall Study|Pump malfunction, drug not delivered|1
2269804|NCT02241512|3947344|FG001|Overall Study|Pump malfunction, drug not delivered|0
2269805|NCT02241733|3947370|FG000|Overall Study|Lost to Follow-up|9
2269806|NCT02241733|3947371|FG001|Overall Study|Lost to Follow-up|4
2269807|NCT02241733|3947370|FG000|Overall Study|Physician Decision|6
2269808|NCT02241733|3947371|FG001|Overall Study|Physician Decision|2
2269809|NCT02241733|3947370|FG000|Overall Study|Withdrawal by Subject|0
2269810|NCT02241733|3947371|FG001|Overall Study|Withdrawal by Subject|2
2269811|NCT02241733|3947370|FG000|Overall Study|Death|0
2349828|NCT04123665|4093772|FG000|Overall Study|Lost to Follow-up|1
2349829|NCT04123665|4093773|FG001|Overall Study|Lost to Follow-up|0
2269812|NCT02241733|3947371|FG001|Overall Study|Death|2
2269813|NCT02241785|3947377|FG000|Overall Study|Sponsor Termination|43
2269814|NCT02241785|3947377|FG000|Overall Study|Withdrawal by Subject|1
2269815|NCT02241785|3947377|FG000|Overall Study|Lost to Follow-up|2
2269816|NCT02241785|3947377|FG000|Overall Study|Adverse Event|1
2269817|NCT02241889|3947381|FG000|Overall Study|device issues|0
2269818|NCT02241889|3947382|FG001|Overall Study|device issues|0
2269819|NCT02241889|3947383|FG002|Overall Study|device issues|1
2269820|NCT02241889|3947384|FG003|Overall Study|device issues|0
2269821|NCT02241889|3947385|FG004|Overall Study|device issues|0
2269822|NCT02241889|3947386|FG005|Overall Study|device issues|0
2269823|NCT02241889|3947381|FG000|Overall Study|Withdrawal by Subject|0
2269824|NCT02241889|3947382|FG001|Overall Study|Withdrawal by Subject|0
2269825|NCT02241889|3947383|FG002|Overall Study|Withdrawal by Subject|0
2269826|NCT02241889|3947384|FG003|Overall Study|Withdrawal by Subject|0
2269827|NCT02241889|3947385|FG004|Overall Study|Withdrawal by Subject|0
2269828|NCT02241889|3947386|FG005|Overall Study|Withdrawal by Subject|1
2269829|NCT02242045|3947415|FG000|Overall Study|Investigator's Discretion|1
2269830|NCT02242045|3947415|FG000|Overall Study|Progressive Disease|2
2269831|NCT02242045|3947415|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1
2269832|NCT02242045|3947415|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2
2269833|NCT02242201|3947422|FG000|Overall Study|preoperative identified neuropathy|2
2269834|NCT02242201|3947423|FG001|Overall Study|preoperative identified neuropathy|0
2269835|NCT02242201|3947424|FG002|Overall Study|preoperative identified neuropathy|0
2269836|NCT02242201|3947422|FG000|Overall Study|planned post-op anticoagulation|1
2269837|NCT02242201|3947423|FG001|Overall Study|planned post-op anticoagulation|0
2269838|NCT02242201|3947424|FG002|Overall Study|planned post-op anticoagulation|0
2269839|NCT02242201|3947422|FG000|Overall Study|changed surgical procedure|1
2269840|NCT02242201|3947423|FG001|Overall Study|changed surgical procedure|0
2269841|NCT02242201|3947424|FG002|Overall Study|changed surgical procedure|0
2269842|NCT02242201|3947422|FG000|Overall Study|postponed surgery|0
2269843|NCT02242201|3947423|FG001|Overall Study|postponed surgery|0
2269844|NCT02242201|3947424|FG002|Overall Study|postponed surgery|1
2269845|NCT02242201|3947422|FG000|Overall Study|preoperative opioid consumption|0
2269846|NCT02242201|3947423|FG001|Overall Study|preoperative opioid consumption|1
2269847|NCT02242201|3947424|FG002|Overall Study|preoperative opioid consumption|0
2269848|NCT02242305|3947434|FG000|Overall Study|Without spasm-like pain during 3 weeks|1
2269849|NCT02242305|3947435|FG001|Overall Study|Without spasm-like pain during 3 weeks|4
2269850|NCT02242305|3947434|FG000|Overall Study|Adverse Event|1
2269851|NCT02242305|3947435|FG001|Overall Study|Adverse Event|0
2269852|NCT02242305|3947434|FG000|Overall Study|Non-compliance dosing regimen or visit|2
2269853|NCT02242305|3947435|FG001|Overall Study|Non-compliance dosing regimen or visit|2
2269854|NCT02242305|3947434|FG000|Overall Study|Subject withdraws inform consent|0
2269855|NCT02242305|3947435|FG001|Overall Study|Subject withdraws inform consent|4
2269856|NCT02242305|3947434|FG000|Overall Study|Lost to Follow-up|2
2269857|NCT02242305|3947435|FG001|Overall Study|Lost to Follow-up|0
2269858|NCT02242487|3947443|FG000|Overall Study|Adverse Event|13
2269859|NCT02242487|3947444|FG001|Overall Study|Adverse Event|15
2269860|NCT02242487|3947443|FG000|Overall Study|Lack of Efficacy|4
2269861|NCT02242487|3947444|FG001|Overall Study|Lack of Efficacy|6
2269862|NCT02242487|3947443|FG000|Overall Study|Protocol Violation|2
2269863|NCT02242487|3947444|FG001|Overall Study|Protocol Violation|0
2269864|NCT02242487|3947443|FG000|Overall Study|Lost to Follow-up|2
2269865|NCT02242487|3947444|FG001|Overall Study|Lost to Follow-up|1
2269866|NCT02242487|3947443|FG000|Overall Study|Other - Miscellaneous|4
2269867|NCT02242487|3947444|FG001|Overall Study|Other - Miscellaneous|6
2269868|NCT02242487|3947443|FG000|Overall Study|Withdrawal by Subject|37
2269869|NCT02242487|3947444|FG001|Overall Study|Withdrawal by Subject|19
2269870|NCT02242643|3947471|FG000|Overall Study|Protocol Violation|1
2269871|NCT02242643|3947472|FG001|Overall Study|Protocol Violation|2
2269872|NCT02242643|3947471|FG000|Overall Study|Withdrawal by Subject|15
2269873|NCT02242643|3947472|FG001|Overall Study|Withdrawal by Subject|10
2269874|NCT02242643|3947471|FG000|Overall Study|Migrated/moved from study area|1
2269875|NCT02242643|3947472|FG001|Overall Study|Migrated/moved from study area|3
2269876|NCT02242643|3947471|FG000|Overall Study|Lost to Follow-up|54
2269877|NCT02242643|3947472|FG001|Overall Study|Lost to Follow-up|61
2269878|NCT02242643|3947471|FG000|Overall Study|Child placed in foster care by family|0
2269879|NCT02242643|3947472|FG001|Overall Study|Child placed in foster care by family|1
2269880|NCT02242643|3947471|FG000|Overall Study|Non-compliance|1
2269881|NCT02242643|3947472|FG001|Overall Study|Non-compliance|0
2269882|NCT02242643|3947471|FG000|Overall Study|Consent withdrawal by parent|1
2269883|NCT02242643|3947472|FG001|Overall Study|Consent withdrawal by parent|0
2269884|NCT02242643|3947471|FG000|Overall Study|Protocol requirements not followed|1
2269885|NCT02242643|3947472|FG001|Overall Study|Protocol requirements not followed|0
2269886|NCT02242643|3947471|FG000|Overall Study|Language barrier|1
2269887|NCT02242643|3947472|FG001|Overall Study|Language barrier|0
2269888|NCT02242643|3947471|FG000|Overall Study|Withdrawal by subject at Visit 2|0
2269889|NCT02242643|3947472|FG001|Overall Study|Withdrawal by subject at Visit 2|1
2269890|NCT02242903|3947487|FG000|Overall Study|Withdrawal by Subject|1
2269891|NCT02242903|3947488|FG001|Overall Study|Withdrawal by Subject|0
2269892|NCT02242903|3947489|FG002|Overall Study|Withdrawal by Subject|0
2269893|NCT02242903|3947490|FG003|Overall Study|Withdrawal by Subject|0
2269894|NCT02242903|3947491|FG004|Overall Study|Withdrawal by Subject|0
2269895|NCT02242903|3947492|FG005|Overall Study|Withdrawal by Subject|0
2269896|NCT02242903|3947493|FG006|Overall Study|Withdrawal by Subject|0
2269897|NCT02242942|3947518|FG000|Overall Study|Death|17
2269898|NCT02242942|3947519|FG001|Overall Study|Death|20
2269899|NCT02242942|3947520|FG002|Overall Study|Death|2
2269900|NCT02242942|3947518|FG000|Overall Study|Physician Decision|1
2269901|NCT02242942|3947519|FG001|Overall Study|Physician Decision|0
2269902|NCT02242942|3947520|FG002|Overall Study|Physician Decision|0
2269903|NCT02242942|3947518|FG000|Overall Study|Withdrawal by Subject|8
2269904|NCT02242942|3947519|FG001|Overall Study|Withdrawal by Subject|10
2269905|NCT02242942|3947520|FG002|Overall Study|Withdrawal by Subject|0
2269906|NCT02242942|3947518|FG000|Overall Study|On-going in Study|190
2269907|NCT02242942|3947519|FG001|Overall Study|On-going in Study|186
2269908|NCT02242942|3947520|FG002|Overall Study|On-going in Study|11
2269909|NCT02242981|3947530|FG000|Overall Study|Withdrawal by Subject|1
2269910|NCT02243046|3947559|FG000|Overall Study|Lost to Follow-up|1
2269911|NCT02243046|3947560|FG001|Overall Study|Lost to Follow-up|1
2269912|NCT02243046|3947561|FG002|Overall Study|Lost to Follow-up|4
2269913|NCT02243176|3947571|FG000|Overall Study|Other reason|1
2269914|NCT02243176|3947572|FG001|Overall Study|Other reason|2
2269915|NCT02243176|3947571|FG000|Overall Study|protocol specified withdrawal critera|1
2269916|NCT02243176|3947572|FG001|Overall Study|protocol specified withdrawal critera|3
2269917|NCT02243176|3947571|FG000|Overall Study|Protocol Violation|2
2269918|NCT02243176|3947572|FG001|Overall Study|Protocol Violation|1
2269919|NCT02243176|3947571|FG000|Overall Study|Withdrawal by Subject|8
2269920|NCT02243176|3947572|FG001|Overall Study|Withdrawal by Subject|7
2269921|NCT02243176|3947571|FG000|Overall Study|Adverse Event|2
2349830|NCT04122534|4093779|FG000|Overall Study|Lost to Follow-up|4
2349831|NCT04117607|4093795|FG000|Overall Study|Early Termination|0
2349832|NCT04117607|4093796|FG001|Overall Study|Early Termination|1
2349833|NCT04117607|4093797|FG002|Overall Study|Early Termination|0
2349834|NCT04117607|4093798|FG003|Overall Study|Early Termination|0
2349835|NCT04117607|4093799|FG004|Overall Study|Early Termination|0
2349836|NCT04117607|4093800|FG005|Overall Study|Early Termination|0
2349837|NCT04117607|4093801|FG006|Overall Study|Early Termination|1
2349838|NCT04117607|4093802|FG007|Overall Study|Early Termination|0
2349839|NCT04117607|4093803|FG008|Overall Study|Early Termination|0
2349840|NCT04117607|4093804|FG009|Overall Study|Early Termination|0
2349841|NCT04117607|4093805|FG010|Overall Study|Early Termination|0
2349842|NCT04117607|4093806|FG011|Overall Study|Early Termination|0
2349843|NCT04117607|4093807|FG012|Overall Study|Early Termination|0
2349844|NCT04117607|4093808|FG013|Overall Study|Early Termination|0
2349845|NCT04096365|4093833|FG000|Overall Study|Adverse Event|1
2349846|NCT04080297|4093839|FG000|Overall Study|Adverse Event|1
2349847|NCT04080297|4093840|FG001|Overall Study|Adverse Event|3
2349848|NCT04080297|4093839|FG000|Overall Study|concurrent illness|1
2349849|NCT04080297|4093840|FG001|Overall Study|concurrent illness|0
2349850|NCT04115358|4093849|FG000|Overall Study|exfoliation|0
2349851|NCT04115358|4093850|FG001|Overall Study|exfoliation|0
2349852|NCT04115358|4093851|FG002|Overall Study|exfoliation|1
2349853|NCT04113694|4093875|FG000|Overall Study|Adverse Event|2
2349854|NCT04113694|4093875|FG000|Overall Study|Lost to Follow-up|2
2349855|NCT04113694|4093875|FG000|Overall Study|Withdrawal by Subject|6
2349856|NCT04113694|4093875|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1
2349857|NCT04109222|4093924|FG000|Overall Study|Adverse Event|1
2349858|NCT04109222|4093925|FG001|Overall Study|Adverse Event|0
2349859|NCT04109222|4093926|FG002|Overall Study|Adverse Event|0
2349860|NCT04106817|4093944|FG000|Overall Study|Lost to Follow-up|1
2349861|NCT04106817|4093945|FG001|Overall Study|Lost to Follow-up|0
2349862|NCT04106817|4093946|FG002|Overall Study|Lost to Follow-up|0
2349863|NCT04105972|4093956|FG000|Overall Study|Adverse Event|2
2349864|NCT04105972|4093957|FG001|Overall Study|Adverse Event|1
2349865|NCT04105218|4093965|FG000|Overall Study|Withdrawal by Subject|3
2349866|NCT04105218|4093966|FG001|Overall Study|Withdrawal by Subject|2
2349867|NCT04105218|4093965|FG000|Overall Study|Study was terminated; unable to complete study visits|1
2349868|NCT04105218|4093966|FG001|Overall Study|Study was terminated; unable to complete study visits|3
2349869|NCT04105218|4093965|FG000|Overall Study|Failed screening tests|2
2349870|NCT04105218|4093966|FG001|Overall Study|Failed screening tests|1
2349871|NCT04102540|4093981|FG000|Overall Study|Withdrawn by PI|2
2349872|NCT04102540|4093981|FG000|Overall Study|Lost to Follow-up|6
2349873|NCT04102345|4093987|FG000|Overall Study|Withdrawal by Subject|1
2349874|NCT04102345|4093988|FG001|Overall Study|Withdrawal by Subject|0
2349875|NCT04099277|4094028|FG000|Overall Study|Physician Decision|1
2349876|NCT04099277|4094028|FG000|Overall Study|Withdrawal by Subject|1
2349877|NCT04098809|4094034|FG000|Overall Study|Withdrawal by Subject|1
2349878|NCT04098809|4094035|FG001|Overall Study|Withdrawal by Subject|3
2349879|NCT04098809|4094034|FG000|Overall Study|Physician Decision|2
2349880|NCT04098809|4094035|FG001|Overall Study|Physician Decision|1
2349881|NCT04098458|4094054|FG000|Overall Study|Death|1
2349882|NCT04098458|4094054|FG000|Overall Study|did not meet study inclusion criteria|3
2349883|NCT04095286|4094059|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
2349884|NCT04095286|4094060|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1
2349885|NCT04095286|4094061|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
2349886|NCT04095286|4094062|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
2349887|NCT04095286|4094063|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
2349888|NCT04095286|4094064|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
2349889|NCT04095286|4094059|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1
2349890|NCT04095286|4094060|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
2349891|NCT04095286|4094061|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
2349892|NCT04095286|4094062|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
2349893|NCT04095286|4094063|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
2349894|NCT04095286|4094064|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
2269922|NCT02243176|3947572|FG001|Overall Study|Adverse Event|2
2269923|NCT02243202|3947582|FG000|Overall Study|Adverse Event|5
2269924|NCT02243202|3947583|FG001|Overall Study|Adverse Event|6
2269925|NCT02243202|3947584|FG002|Overall Study|Adverse Event|10
2269926|NCT02243202|3947585|FG003|Overall Study|Adverse Event|4
2269927|NCT02243202|3947582|FG000|Overall Study|Lost to Follow-up|9
2269928|NCT02243202|3947583|FG001|Overall Study|Lost to Follow-up|9
2269929|NCT02243202|3947584|FG002|Overall Study|Lost to Follow-up|14
2269930|NCT02243202|3947585|FG003|Overall Study|Lost to Follow-up|11
2269931|NCT02243202|3947582|FG000|Overall Study|Protocol Violation|3
2269932|NCT02243202|3947583|FG001|Overall Study|Protocol Violation|1
2269933|NCT02243202|3947584|FG002|Overall Study|Protocol Violation|2
2269934|NCT02243202|3947585|FG003|Overall Study|Protocol Violation|1
2269935|NCT02243202|3947582|FG000|Overall Study|Withdrawal by Subject|7
2269936|NCT02243202|3947583|FG001|Overall Study|Withdrawal by Subject|6
2269937|NCT02243202|3947584|FG002|Overall Study|Withdrawal by Subject|4
2269938|NCT02243202|3947585|FG003|Overall Study|Withdrawal by Subject|4
2269939|NCT02243202|3947582|FG000|Overall Study|Other|1
2269940|NCT02243202|3947583|FG001|Overall Study|Other|3
2269941|NCT02243202|3947584|FG002|Overall Study|Other|1
2269942|NCT02243202|3947585|FG003|Overall Study|Other|2
2269943|NCT02243202|3947582|FG000|Overall Study|Randomized but not received treatment|0
2269944|NCT02243202|3947583|FG001|Overall Study|Randomized but not received treatment|0
2269945|NCT02243202|3947584|FG002|Overall Study|Randomized but not received treatment|0
2269946|NCT02243202|3947585|FG003|Overall Study|Randomized but not received treatment|1
2269947|NCT02243280|3947606|FG000|Treated|Adverse Event|1
2269948|NCT02243280|3947607|FG001|Treated|Adverse Event|0
2269949|NCT02243280|3947608|FG002|Treated|Adverse Event|0
2269950|NCT02243280|3947609|FG003|Treated|Adverse Event|0
2269951|NCT02243280|3947610|FG004|Treated|Adverse Event|0
2269952|NCT02243280|3947611|FG005|Treated|Adverse Event|0
2269953|NCT02243280|3947612|FG006|Treated|Adverse Event|0
2269954|NCT02243280|3947613|FG007|Treated|Adverse Event|0
2269955|NCT02243280|3947614|FG008|Treated|Adverse Event|0
2269956|NCT02243280|3947615|FG009|Treated|Adverse Event|0
2269957|NCT02243280|3947616|FG010|Treated|Adverse Event|1
2269958|NCT02243280|3947606|FG000|Treated|Lost to Follow-up|0
2269959|NCT02243280|3947607|FG001|Treated|Lost to Follow-up|0
2269960|NCT02243280|3947608|FG002|Treated|Lost to Follow-up|0
2269961|NCT02243280|3947609|FG003|Treated|Lost to Follow-up|0
2269962|NCT02243280|3947610|FG004|Treated|Lost to Follow-up|0
2269963|NCT02243280|3947611|FG005|Treated|Lost to Follow-up|0
2269964|NCT02243280|3947612|FG006|Treated|Lost to Follow-up|0
2269965|NCT02243280|3947613|FG007|Treated|Lost to Follow-up|0
2269966|NCT02243280|3947614|FG008|Treated|Lost to Follow-up|1
2269967|NCT02243280|3947615|FG009|Treated|Lost to Follow-up|0
2269968|NCT02243280|3947616|FG010|Treated|Lost to Follow-up|2
2269969|NCT02243293|3947651|FG000|Overall Study|Adverse Event|1
2269970|NCT02243293|3947652|FG001|Overall Study|Adverse Event|0
2269971|NCT02243293|3947653|FG002|Overall Study|Adverse Event|0
2269972|NCT02243293|3947654|FG003|Overall Study|Adverse Event|0
2269973|NCT02243293|3947655|FG004|Overall Study|Adverse Event|0
2349895|NCT04095286|4094059|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
2349896|NCT04095286|4094060|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
2349897|NCT04095286|4094061|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1
2349898|NCT04095286|4094062|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
2349899|NCT04095286|4094063|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
2349900|NCT04095286|4094064|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
2349901|NCT04095286|4094059|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
2349902|NCT04095286|4094060|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
2349903|NCT04095286|4094061|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2
2349904|NCT04095286|4094062|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
2349905|NCT04095286|4094063|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
2349906|NCT04095286|4094064|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
2349907|NCT04095286|4094059|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
2349908|NCT04095286|4094060|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
2349909|NCT04095286|4094061|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
2349910|NCT04095286|4094062|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
2349911|NCT04095286|4094063|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1
2349912|NCT04095286|4094064|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
2349913|NCT04094883|4094072|FG000|Overall Study|Withdrawal by Subject|1
2349914|NCT04091659|4094078|FG000|Overall Study|Protocol Violation|3
2349915|NCT04091659|4094079|FG001|Overall Study|Protocol Violation|0
2349916|NCT04091659|4094078|FG000|Overall Study|Lost to Follow-up|0
2349917|NCT04091659|4094079|FG001|Overall Study|Lost to Follow-up|1
2269974|NCT02243293|3947656|FG005|Overall Study|Adverse Event|0
2269975|NCT02243293|3947657|FG006|Overall Study|Adverse Event|0
2269976|NCT02243293|3947658|FG007|Overall Study|Adverse Event|0
2269977|NCT02243293|3947659|FG008|Overall Study|Adverse Event|0
2269978|NCT02243293|3947660|FG009|Overall Study|Adverse Event|0
2269979|NCT02243293|3947661|FG010|Overall Study|Adverse Event|0
2269980|NCT02243293|3947662|FG011|Overall Study|Adverse Event|0
2269981|NCT02243293|3947663|FG012|Overall Study|Adverse Event|0
2269982|NCT02243293|3947664|FG013|Overall Study|Adverse Event|0
2269983|NCT02243293|3947665|FG014|Overall Study|Adverse Event|0
2269984|NCT02243293|3947666|FG015|Overall Study|Adverse Event|1
2269985|NCT02243293|3947667|FG016|Overall Study|Adverse Event|0
2269986|NCT02243293|3947668|FG017|Overall Study|Adverse Event|0
2269987|NCT02243293|3947669|FG018|Overall Study|Adverse Event|0
2269988|NCT02243293|3947670|FG019|Overall Study|Adverse Event|0
2269989|NCT02243293|3947671|FG020|Overall Study|Adverse Event|1
2269990|NCT02243293|3947672|FG021|Overall Study|Adverse Event|0
2269991|NCT02243293|3947651|FG000|Overall Study|Withdrawal by Subject|1
2269992|NCT02243293|3947652|FG001|Overall Study|Withdrawal by Subject|0
2269993|NCT02243293|3947653|FG002|Overall Study|Withdrawal by Subject|0
2269994|NCT02243293|3947654|FG003|Overall Study|Withdrawal by Subject|0
2269995|NCT02243293|3947655|FG004|Overall Study|Withdrawal by Subject|0
2269996|NCT02243293|3947656|FG005|Overall Study|Withdrawal by Subject|0
2269997|NCT02243293|3947657|FG006|Overall Study|Withdrawal by Subject|0
2269998|NCT02243293|3947658|FG007|Overall Study|Withdrawal by Subject|0
2269999|NCT02243293|3947659|FG008|Overall Study|Withdrawal by Subject|0
2270000|NCT02243293|3947660|FG009|Overall Study|Withdrawal by Subject|1
2270001|NCT02243293|3947661|FG010|Overall Study|Withdrawal by Subject|0
2270002|NCT02243293|3947662|FG011|Overall Study|Withdrawal by Subject|1
2270003|NCT02243293|3947663|FG012|Overall Study|Withdrawal by Subject|0
2270004|NCT02243293|3947664|FG013|Overall Study|Withdrawal by Subject|0
2270005|NCT02243293|3947665|FG014|Overall Study|Withdrawal by Subject|0
2270006|NCT02243293|3947666|FG015|Overall Study|Withdrawal by Subject|0
2270007|NCT02243293|3947667|FG016|Overall Study|Withdrawal by Subject|0
2270008|NCT02243293|3947668|FG017|Overall Study|Withdrawal by Subject|0
2270009|NCT02243293|3947669|FG018|Overall Study|Withdrawal by Subject|0
2270010|NCT02243293|3947670|FG019|Overall Study|Withdrawal by Subject|0
2270011|NCT02243293|3947671|FG020|Overall Study|Withdrawal by Subject|0
2270012|NCT02243293|3947672|FG021|Overall Study|Withdrawal by Subject|1
2270013|NCT02243293|3947651|FG000|Overall Study|Lost to Follow-up|0
2270014|NCT02243293|3947652|FG001|Overall Study|Lost to Follow-up|1
2270015|NCT02243293|3947653|FG002|Overall Study|Lost to Follow-up|1
2270016|NCT02243293|3947654|FG003|Overall Study|Lost to Follow-up|1
2270017|NCT02243293|3947655|FG004|Overall Study|Lost to Follow-up|0
2270018|NCT02243293|3947656|FG005|Overall Study|Lost to Follow-up|0
2270019|NCT02243293|3947657|FG006|Overall Study|Lost to Follow-up|3
2270020|NCT02243293|3947658|FG007|Overall Study|Lost to Follow-up|0
2270021|NCT02243293|3947659|FG008|Overall Study|Lost to Follow-up|0
2270022|NCT02243293|3947660|FG009|Overall Study|Lost to Follow-up|0
2270023|NCT02243293|3947661|FG010|Overall Study|Lost to Follow-up|0
2270024|NCT02243293|3947662|FG011|Overall Study|Lost to Follow-up|2
2270025|NCT02243293|3947663|FG012|Overall Study|Lost to Follow-up|0
2270026|NCT02243293|3947664|FG013|Overall Study|Lost to Follow-up|0
2270027|NCT02243293|3947665|FG014|Overall Study|Lost to Follow-up|0
2270028|NCT02243293|3947666|FG015|Overall Study|Lost to Follow-up|0
2270029|NCT02243293|3947667|FG016|Overall Study|Lost to Follow-up|3
2270030|NCT02243293|3947668|FG017|Overall Study|Lost to Follow-up|1
2270031|NCT02243293|3947669|FG018|Overall Study|Lost to Follow-up|0
2270032|NCT02243293|3947670|FG019|Overall Study|Lost to Follow-up|0
2349918|NCT04090242|4094104|FG000|Overall Study|Withdrawal by Subject|1
2349919|NCT04090242|4094105|FG001|Overall Study|Withdrawal by Subject|0
2349920|NCT04089761|4094112|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14
2349921|NCT04089761|4094112|FG000|"Run In Phase"|Lost to Follow-up|1
2349922|NCT04089761|4094112|FG000|"Treatment Phase"|No evaluable data|5
2349923|NCT04089761|4094112|FG000|"Treatment Phase"|Lost to Follow-up|1
2349924|NCT04079803|4094119|FG000|Overall Study|Withdrawal by Subject|0
2349925|NCT04079803|4094120|FG001|Overall Study|Withdrawal by Subject|0
2349926|NCT04079803|4094121|FG002|Overall Study|Withdrawal by Subject|1
2349927|NCT04084769|4094160|FG000|Overall Study|Protocol Violation|1
2349928|NCT04084769|4094161|FG001|Overall Study|Protocol Violation|3
2349929|NCT04084769|4094162|FG002|Overall Study|Protocol Violation|0
2349930|NCT04084769|4094163|FG003|Overall Study|Protocol Violation|1
2349931|NCT04084769|4094160|FG000|Overall Study|Withdrawal by Subject|0
2349932|NCT04084769|4094161|FG001|Overall Study|Withdrawal by Subject|1
2349933|NCT04084769|4094162|FG002|Overall Study|Withdrawal by Subject|0
2349934|NCT04084769|4094163|FG003|Overall Study|Withdrawal by Subject|0
2349935|NCT04084769|4094160|FG000|Overall Study|Withdrawal by parent/guardian|1
2349936|NCT04084769|4094161|FG001|Overall Study|Withdrawal by parent/guardian|0
2349937|NCT04084769|4094162|FG002|Overall Study|Withdrawal by parent/guardian|0
2349938|NCT04084769|4094163|FG003|Overall Study|Withdrawal by parent/guardian|1
2349939|NCT04084769|4094160|FG000|Overall Study|Lost to Follow-up|2
2349940|NCT04084769|4094161|FG001|Overall Study|Lost to Follow-up|0
2349941|NCT04084769|4094162|FG002|Overall Study|Lost to Follow-up|0
2270033|NCT02243293|3947671|FG020|Overall Study|Lost to Follow-up|1
2270034|NCT02243293|3947672|FG021|Overall Study|Lost to Follow-up|2
2270035|NCT02243293|3947651|FG000|Overall Study|Enrolled into a Re-treatment Study|0
2270036|NCT02243293|3947652|FG001|Overall Study|Enrolled into a Re-treatment Study|0
2270037|NCT02243293|3947653|FG002|Overall Study|Enrolled into a Re-treatment Study|0
2270038|NCT02243293|3947654|FG003|Overall Study|Enrolled into a Re-treatment Study|0
2270039|NCT02243293|3947655|FG004|Overall Study|Enrolled into a Re-treatment Study|0
2270040|NCT02243293|3947656|FG005|Overall Study|Enrolled into a Re-treatment Study|0
2270041|NCT02243293|3947657|FG006|Overall Study|Enrolled into a Re-treatment Study|0
2270042|NCT02243293|3947658|FG007|Overall Study|Enrolled into a Re-treatment Study|0
2270043|NCT02243293|3947659|FG008|Overall Study|Enrolled into a Re-treatment Study|0
2270044|NCT02243293|3947660|FG009|Overall Study|Enrolled into a Re-treatment Study|0
2270045|NCT02243293|3947661|FG010|Overall Study|Enrolled into a Re-treatment Study|0
2270046|NCT02243293|3947662|FG011|Overall Study|Enrolled into a Re-treatment Study|0
2270047|NCT02243293|3947663|FG012|Overall Study|Enrolled into a Re-treatment Study|0
2270048|NCT02243293|3947664|FG013|Overall Study|Enrolled into a Re-treatment Study|0
2270049|NCT02243293|3947665|FG014|Overall Study|Enrolled into a Re-treatment Study|1
2270050|NCT02243293|3947666|FG015|Overall Study|Enrolled into a Re-treatment Study|0
2270051|NCT02243293|3947667|FG016|Overall Study|Enrolled into a Re-treatment Study|0
2270052|NCT02243293|3947668|FG017|Overall Study|Enrolled into a Re-treatment Study|0
2270053|NCT02243293|3947669|FG018|Overall Study|Enrolled into a Re-treatment Study|0
2270054|NCT02243293|3947670|FG019|Overall Study|Enrolled into a Re-treatment Study|0
2270055|NCT02243293|3947671|FG020|Overall Study|Enrolled into a Re-treatment Study|0
2270056|NCT02243293|3947672|FG021|Overall Study|Enrolled into a Re-treatment Study|0
2270057|NCT02243293|3947651|FG000|Overall Study|Randomized but did'nt receive study drug|0
2270058|NCT02243293|3947652|FG001|Overall Study|Randomized but did'nt receive study drug|0
2270059|NCT02243293|3947653|FG002|Overall Study|Randomized but did'nt receive study drug|0
2270060|NCT02243293|3947654|FG003|Overall Study|Randomized but did'nt receive study drug|0
2270061|NCT02243293|3947655|FG004|Overall Study|Randomized but did'nt receive study drug|1
2270062|NCT02243293|3947656|FG005|Overall Study|Randomized but did'nt receive study drug|0
2270063|NCT02243293|3947657|FG006|Overall Study|Randomized but did'nt receive study drug|0
2270064|NCT02243293|3947658|FG007|Overall Study|Randomized but did'nt receive study drug|0
2270065|NCT02243293|3947659|FG008|Overall Study|Randomized but did'nt receive study drug|0
2270066|NCT02243293|3947660|FG009|Overall Study|Randomized but did'nt receive study drug|1
2270067|NCT02243293|3947661|FG010|Overall Study|Randomized but did'nt receive study drug|0
2270068|NCT02243293|3947662|FG011|Overall Study|Randomized but did'nt receive study drug|0
2270069|NCT02243293|3947663|FG012|Overall Study|Randomized but did'nt receive study drug|0
2270070|NCT02243293|3947664|FG013|Overall Study|Randomized but did'nt receive study drug|0
2270071|NCT02243293|3947665|FG014|Overall Study|Randomized but did'nt receive study drug|0
2270072|NCT02243293|3947666|FG015|Overall Study|Randomized but did'nt receive study drug|0
2270073|NCT02243293|3947667|FG016|Overall Study|Randomized but did'nt receive study drug|0
2270074|NCT02243293|3947668|FG017|Overall Study|Randomized but did'nt receive study drug|0
2270075|NCT02243293|3947669|FG018|Overall Study|Randomized but did'nt receive study drug|0
2270076|NCT02243293|3947670|FG019|Overall Study|Randomized but did'nt receive study drug|1
2270077|NCT02243293|3947671|FG020|Overall Study|Randomized but did'nt receive study drug|0
2270078|NCT02243293|3947672|FG021|Overall Study|Randomized but did'nt receive study drug|0
2270079|NCT02243371|3947711|FG000|Overall Study|Progressive Disease (clinic & radio)|35
2270080|NCT02243371|3947712|FG001|Overall Study|Progressive Disease (clinic & radio)|24
2270081|NCT02243371|3947711|FG000|Overall Study|Death (unrelated)|2
2270082|NCT02243371|3947712|FG001|Overall Study|Death (unrelated)|4
2270083|NCT02243371|3947711|FG000|Overall Study|Adverse Event (unrelated)|0
2270084|NCT02243371|3947712|FG001|Overall Study|Adverse Event (unrelated)|1
2270085|NCT02243371|3947711|FG000|Overall Study|Lack of Clinical Benefit|0
2270086|NCT02243371|3947712|FG001|Overall Study|Lack of Clinical Benefit|1
2270087|NCT02243371|3947711|FG000|Overall Study|Withdrawal by Subject|0
2270088|NCT02243371|3947712|FG001|Overall Study|Withdrawal by Subject|2
2270089|NCT02243605|3947733|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1
2270090|NCT02243605|3947734|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1
2270091|NCT02243605|3947733|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1
2270092|NCT02243605|3947734|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0
2270093|NCT02243605|3947733|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5
2270094|NCT02243605|3947734|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1
2270095|NCT02243605|3947733|FG000|Stage 2 - Final Analysis Population|Adverse Event|1
2270096|NCT02243605|3947734|FG001|Stage 2 - Final Analysis Population|Adverse Event|1
2270097|NCT02243605|3947733|FG000|Stage 2 - Final Analysis Population|Progression|0
2270098|NCT02243605|3947734|FG001|Stage 2 - Final Analysis Population|Progression|1
2270099|NCT02243696|3947740|FG000|Overall Study|Death|282
2270100|NCT02243696|3947740|FG000|Overall Study|Withdrawal by Subject|79
2270101|NCT02243696|3947740|FG000|Overall Study|Lost to Follow-up|57
2270102|NCT02243696|3947740|FG000|Overall Study|Subject No Longer has Study System|42
2270103|NCT02243696|3947740|FG000|Overall Study|Subject Withdrawn by Investigator|273
2270104|NCT02243696|3947740|FG000|Overall Study|Study Terminated for EP PASSION|961
2270105|NCT02243865|3947746|FG000|Overall Study|Protocol Violation|1
2270106|NCT02243865|3947747|FG001|Overall Study|Protocol Violation|3
2270107|NCT02243865|3947746|FG000|Overall Study|Lost to Follow-up|1
2270108|NCT02243865|3947747|FG001|Overall Study|Lost to Follow-up|1
2270109|NCT02243865|3947746|FG000|Overall Study|Withdrawal by Subject|1
2270110|NCT02243865|3947747|FG001|Overall Study|Withdrawal by Subject|0
2270111|NCT02243865|3947746|FG000|Overall Study|Adverse Event|1
2270112|NCT02243865|3947747|FG001|Overall Study|Adverse Event|1
2270113|NCT02244424|3947766|FG000|Overall Study|Lost to Follow-up|20
2270114|NCT02244424|3947767|FG001|Overall Study|Lost to Follow-up|10
2270115|NCT02244580|3947773|FG000|Overall Study|No cancer tissues available|241
2270116|NCT02244619|3947783|FG000|Overall Study|Did not receive study intervention|8
2349942|NCT04084769|4094163|FG003|Overall Study|Lost to Follow-up|0
2349943|NCT04086641|4094199|FG000|Foot 1 (Two Week Utilization)|COVID-19|1
2349944|NCT04086641|4094200|FG001|Foot 1 (Two Week Utilization)|COVID-19|2
2349945|NCT04086472|4094220|FG000|Overall Study|Lost to Follow-up|1
2349946|NCT04086472|4094221|FG001|Overall Study|Lost to Follow-up|0
2270117|NCT02244619|3947784|FG001|Overall Study|Did not receive study intervention|21
2349947|NCT04086472|4094222|FG002|Overall Study|Lost to Follow-up|0
2349948|NCT04086472|4094223|FG003|Overall Study|Lost to Follow-up|0
2349949|NCT04086472|4094224|FG004|Overall Study|Lost to Follow-up|1
2349950|NCT04086472|4094220|FG000|Overall Study|Physician Decision|0
2349951|NCT04086472|4094221|FG001|Overall Study|Physician Decision|1
2349952|NCT04086472|4094222|FG002|Overall Study|Physician Decision|1
2349953|NCT04086472|4094223|FG003|Overall Study|Physician Decision|0
2349954|NCT04086472|4094224|FG004|Overall Study|Physician Decision|0
2349955|NCT04086472|4094220|FG000|Overall Study|Withdrawal by Subject|1
2349956|NCT04086472|4094221|FG001|Overall Study|Withdrawal by Subject|1
2349957|NCT04086472|4094222|FG002|Overall Study|Withdrawal by Subject|1
2349958|NCT04086472|4094223|FG003|Overall Study|Withdrawal by Subject|0
2349959|NCT04086472|4094224|FG004|Overall Study|Withdrawal by Subject|0
2349960|NCT04086472|4094220|FG000|Overall Study|Various reasons|2
2349961|NCT04086472|4094221|FG001|Overall Study|Various reasons|0
2349962|NCT04086472|4094222|FG002|Overall Study|Various reasons|0
2349963|NCT04086472|4094223|FG003|Overall Study|Various reasons|3
2349964|NCT04086472|4094224|FG004|Overall Study|Various reasons|1
2349965|NCT04085289|4094239|FG000|Overall Study|Withdrawal by Subject|0
2349966|NCT04085289|4094240|FG001|Overall Study|Withdrawal by Subject|0
2349967|NCT04085289|4094241|FG002|Overall Study|Withdrawal by Subject|1
2349968|NCT04082663|4094252|FG000|Overall Study|Adverse Event|6
2349969|NCT04082663|4094252|FG000|Overall Study|Lost to Follow-up|1
2270118|NCT02244957|3947806|FG000|Overall Study|Lack of Efficacy|1
2270119|NCT02244957|3947807|FG001|Overall Study|Lack of Efficacy|0
2270120|NCT02244996|3947817|FG000|Overall Study|Lack of Efficacy|2
2270121|NCT02244996|3947818|FG001|Overall Study|Lack of Efficacy|6
2270122|NCT02245412|3947840|FG000|Treatment Period|Death|1
2270123|NCT02245412|3947841|FG001|Treatment Period|Death|1
2270124|NCT02245412|3947842|FG002|Treatment Period|Death|0
2270125|NCT02245412|3947840|FG000|Treatment Period|Physician Decision|1
2270126|NCT02245412|3947841|FG001|Treatment Period|Physician Decision|1
2270127|NCT02245412|3947842|FG002|Treatment Period|Physician Decision|0
2270128|NCT02245412|3947840|FG000|Treatment Period|Withdrawal by Subject|2
2270129|NCT02245412|3947841|FG001|Treatment Period|Withdrawal by Subject|1
2270130|NCT02245412|3947842|FG002|Treatment Period|Withdrawal by Subject|0
2270131|NCT02245412|3947840|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1
2270132|NCT02245412|3947841|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0
2270133|NCT02245412|3947842|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0
2270134|NCT02245412|3947840|FG000|Follow-Up Period|Death|4
2270135|NCT02245412|3947841|FG001|Follow-Up Period|Death|2
2270136|NCT02245412|3947842|FG002|Follow-Up Period|Death|1
2270137|NCT02245412|3947840|FG000|Follow-Up Period|Physician Decision|1
2270138|NCT02245412|3947841|FG001|Follow-Up Period|Physician Decision|0
2270139|NCT02245412|3947842|FG002|Follow-Up Period|Physician Decision|0
2270140|NCT02245412|3947840|FG000|Follow-Up Period|Other - Terminated by Sponsor|0
2270141|NCT02245412|3947841|FG001|Follow-Up Period|Other - Terminated by Sponsor|0
2270142|NCT02245412|3947842|FG002|Follow-Up Period|Other - Terminated by Sponsor|1
2270143|NCT02245568|3947859|FG000|Overall Study|Study terminated by Sponsor|346
2270144|NCT02245568|3947859|FG000|Overall Study|Adverse Event|144
2270145|NCT02245568|3947859|FG000|Overall Study|Lack of Efficacy|98
2270146|NCT02245568|3947859|FG000|Overall Study|Withdrawal by Caregiver|85
2270147|NCT02245568|3947859|FG000|Overall Study|Withdrawal by Subject|77
2270148|NCT02245568|3947859|FG000|Overall Study|Withdrawal by Legal Representative|31
2270149|NCT02245568|3947859|FG000|Overall Study|Missing (Site closure)|16
2270150|NCT02245568|3947859|FG000|Overall Study|Physician Decision|14
2270151|NCT02245568|3947859|FG000|Overall Study|Non-compliance with study drug|11
2270152|NCT02245568|3947859|FG000|Overall Study|Death|9
2270153|NCT02245568|3947859|FG000|Overall Study|Blue staining|6
2270154|NCT02245568|3947859|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6
2270155|NCT02245568|3947859|FG000|Overall Study|Intolerance/dosing issues/interruption|5
2270156|NCT02245568|3947859|FG000|Overall Study|Lost to Follow-up|5
2270157|NCT02245620|3947865|FG000|Overall Study|Physician Decision|1
2270158|NCT02245620|3947866|FG001|Overall Study|Physician Decision|1
2270159|NCT02245737|3947875|FG000|Overall Study|Adverse Event|23
2270160|NCT02245737|3947876|FG001|Overall Study|Adverse Event|26
2270161|NCT02245737|3947877|FG002|Overall Study|Adverse Event|33
2270162|NCT02245737|3947875|FG000|Overall Study|Condition Worsened|9
2270163|NCT02245737|3947876|FG001|Overall Study|Condition Worsened|10
2270164|NCT02245737|3947877|FG002|Overall Study|Condition Worsened|9
2270165|NCT02245737|3947875|FG000|Overall Study|Death|2
2270166|NCT02245737|3947876|FG001|Overall Study|Death|4
2270167|NCT02245737|3947877|FG002|Overall Study|Death|4
2270168|NCT02245737|3947875|FG000|Overall Study|Eligibility Criteria No Longer Met|2
2270169|NCT02245737|3947876|FG001|Overall Study|Eligibility Criteria No Longer Met|4
2270170|NCT02245737|3947877|FG002|Overall Study|Eligibility Criteria No Longer Met|4
2270171|NCT02245737|3947875|FG000|Overall Study|Initiation of Symptomatic AD medication|2
2270172|NCT02245737|3947876|FG001|Overall Study|Initiation of Symptomatic AD medication|0
2270173|NCT02245737|3947877|FG002|Overall Study|Initiation of Symptomatic AD medication|0
2270174|NCT02245737|3947875|FG000|Overall Study|Lost to Follow-up|2
2270175|NCT02245737|3947876|FG001|Overall Study|Lost to Follow-up|5
2270176|NCT02245737|3947877|FG002|Overall Study|Lost to Follow-up|4
2270177|NCT02245737|3947875|FG000|Overall Study|Other-determined by Investigator|9
2270178|NCT02245737|3947876|FG001|Overall Study|Other-determined by Investigator|10
2270179|NCT02245737|3947877|FG002|Overall Study|Other-determined by Investigator|10
2270180|NCT02245737|3947875|FG000|Overall Study|Physician Decision|6
2270181|NCT02245737|3947876|FG001|Overall Study|Physician Decision|3
2270182|NCT02245737|3947877|FG002|Overall Study|Physician Decision|6
2270183|NCT02245737|3947875|FG000|Overall Study|Protocol Violation|3
2270184|NCT02245737|3947876|FG001|Overall Study|Protocol Violation|2
2349970|NCT04079790|4094333|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1
2349971|NCT04079790|4094334|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
2349972|NCT04079790|4094335|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
2349973|NCT04079790|4094336|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
2349974|NCT04079790|4094333|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
2349975|NCT04079790|4094334|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
2349976|NCT04079790|4094335|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1
2349977|NCT04079790|4094336|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
2349978|NCT04079790|4094333|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
2349979|NCT04079790|4094334|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
2349980|NCT04079790|4094335|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2
2349981|NCT04079790|4094336|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
2349982|NCT04073407|4094427|FG000|Part 1|Withdrawal by Subject|1
2270185|NCT02245737|3947877|FG002|Overall Study|Protocol Violation|3
2270186|NCT02245737|3947875|FG000|Overall Study|Withdrawal by Subject|40
2270187|NCT02245737|3947876|FG001|Overall Study|Withdrawal by Subject|41
2270188|NCT02245737|3947877|FG002|Overall Study|Withdrawal by Subject|44
2270189|NCT02245737|3947875|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10
2270190|NCT02245737|3947876|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20
2270191|NCT02245737|3947877|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22
2270192|NCT02245737|3947875|FG000|Overall Study|Sponsor Decision|445
2270193|NCT02245737|3947876|FG001|Overall Study|Sponsor Decision|430
2270194|NCT02245737|3947877|FG002|Overall Study|Sponsor Decision|432
2270195|NCT02246166|3947926|FG000|Overall Study|Protocol Violation|1
2270196|NCT02246166|3947927|FG001|Overall Study|Protocol Violation|0
2270197|NCT02246218|3947935|FG000|Overall Study|Withdrawal by Parent/Guardian|0
2270198|NCT02246218|3947936|FG001|Overall Study|Withdrawal by Parent/Guardian|1
2270199|NCT02246218|3947935|FG000|Overall Study|Stopping Rule: Liver Transplant|2
2270200|NCT02246218|3947936|FG001|Overall Study|Stopping Rule: Liver Transplant|4
2270201|NCT02246218|3947935|FG000|Overall Study|Adverse Event|1
2270202|NCT02246218|3947936|FG001|Overall Study|Adverse Event|1
2270203|NCT02246218|3947935|FG000|Overall Study|Lost to Follow-up|1
2270204|NCT02246218|3947936|FG001|Overall Study|Lost to Follow-up|0
2270205|NCT02246439|3947962|FG000|Overall Study|Adverse Event|3
2270206|NCT02246439|3947963|FG001|Overall Study|Adverse Event|0
2270207|NCT02246439|3947962|FG000|Overall Study|Lost to Follow-up|7
2270208|NCT02246439|3947963|FG001|Overall Study|Lost to Follow-up|5
2270209|NCT02246439|3947962|FG000|Overall Study|Protocol Violation|0
2270210|NCT02246439|3947963|FG001|Overall Study|Protocol Violation|2
2270211|NCT02246439|3947962|FG000|Overall Study|Physician Decision|0
2270212|NCT02246439|3947963|FG001|Overall Study|Physician Decision|1
2270213|NCT02246439|3947962|FG000|Overall Study|Unkonwn|1
2270214|NCT02246439|3947963|FG001|Overall Study|Unkonwn|3
2270215|NCT02246439|3947962|FG000|Overall Study|Withdrawal by Subject|1
2270216|NCT02246439|3947963|FG001|Overall Study|Withdrawal by Subject|0
2270217|NCT02246478|3947973|FG000|Multiple-dose Phase|Protocol Violation|1
2270218|NCT02246478|3947974|FG001|Multiple-dose Phase|Protocol Violation|0
2270219|NCT02246478|3947975|FG002|Multiple-dose Phase|Protocol Violation|0
2270220|NCT02246478|3947976|FG003|Multiple-dose Phase|Protocol Violation|1
2270221|NCT02246582|3947993|FG000|Overall Study|Withdrawal by Subject|3
2270222|NCT02246582|3947994|FG001|Overall Study|Withdrawal by Subject|4
2270223|NCT02246647|3948009|FG000|Overall Study|Withdrawal by Subject|1
2270224|NCT02246647|3948010|FG001|Overall Study|Withdrawal by Subject|1
2270225|NCT02246660|3948033|FG000|Overall Study|Withdrawal by Subject|0
2270226|NCT02246660|3948034|FG001|Overall Study|Withdrawal by Subject|1
2270227|NCT02246660|3948035|FG002|Overall Study|Withdrawal by Subject|0
2270228|NCT02246660|3948033|FG000|Overall Study|Death|0
2270229|NCT02246660|3948034|FG001|Overall Study|Death|0
2270230|NCT02246660|3948035|FG002|Overall Study|Death|1
2270231|NCT02246673|3948048|FG000|Overall Study|Sponsor Decision|1
2270232|NCT02246673|3948049|FG001|Overall Study|Sponsor Decision|0
2270233|NCT02246673|3948050|FG002|Overall Study|Sponsor Decision|0
2270234|NCT02246673|3948051|FG003|Overall Study|Sponsor Decision|0
2270235|NCT02246673|3948052|FG004|Overall Study|Sponsor Decision|0
2270236|NCT02246673|3948048|FG000|Overall Study|Withdrawal by Subject|0
2270237|NCT02246673|3948049|FG001|Overall Study|Withdrawal by Subject|0
2270238|NCT02246673|3948050|FG002|Overall Study|Withdrawal by Subject|0
2270239|NCT02246673|3948051|FG003|Overall Study|Withdrawal by Subject|0
2270240|NCT02246673|3948052|FG004|Overall Study|Withdrawal by Subject|1
2270241|NCT02246673|3948048|FG000|Overall Study|Lost to Follow-up|0
2270242|NCT02246673|3948049|FG001|Overall Study|Lost to Follow-up|0
2270243|NCT02246673|3948050|FG002|Overall Study|Lost to Follow-up|0
2270244|NCT02246673|3948051|FG003|Overall Study|Lost to Follow-up|1
2270245|NCT02246673|3948052|FG004|Overall Study|Lost to Follow-up|0
2270246|NCT02246673|3948048|FG000|Overall Study|Protocol Violation|0
2270247|NCT02246673|3948049|FG001|Overall Study|Protocol Violation|0
2270248|NCT02246673|3948050|FG002|Overall Study|Protocol Violation|0
2270249|NCT02246673|3948051|FG003|Overall Study|Protocol Violation|1
2270250|NCT02246673|3948052|FG004|Overall Study|Protocol Violation|0
2270251|NCT02246764|3948097|FG000|Overall Study|Adverse Event|15
2270252|NCT02246764|3948098|FG001|Overall Study|Adverse Event|29
2270253|NCT02246764|3948099|FG002|Overall Study|Adverse Event|1
2270254|NCT02246764|3948097|FG000|Overall Study|Withdrawal by Subject|0
2270255|NCT02246764|3948098|FG001|Overall Study|Withdrawal by Subject|0
2270256|NCT02246764|3948099|FG002|Overall Study|Withdrawal by Subject|1
2270257|NCT02246764|3948097|FG000|Overall Study|Disallowed Concomitant Medication|1
2270258|NCT02246764|3948098|FG001|Overall Study|Disallowed Concomitant Medication|0
2270259|NCT02246764|3948099|FG002|Overall Study|Disallowed Concomitant Medication|0
2270260|NCT02246764|3948097|FG000|Overall Study|Physician Decision|0
2270261|NCT02246764|3948098|FG001|Overall Study|Physician Decision|2
2270262|NCT02246764|3948099|FG002|Overall Study|Physician Decision|1
2270263|NCT02246764|3948097|FG000|Overall Study|Protocol Violation|2
2270264|NCT02246764|3948098|FG001|Overall Study|Protocol Violation|1
2270265|NCT02246764|3948099|FG002|Overall Study|Protocol Violation|1
2270266|NCT02246777|3948107|FG000|Overall Study|Adverse Event|2
2270267|NCT02246777|3948107|FG000|Overall Study|Change of residence|1
2270268|NCT02246998|3948120|FG000|Overall Study|Adverse Event|0
2270269|NCT02246998|3948121|FG001|Overall Study|Adverse Event|1
2270270|NCT02246998|3948122|FG002|Overall Study|Adverse Event|1
2270271|NCT02246998|3948123|FG003|Overall Study|Adverse Event|0
2270272|NCT02246998|3948120|FG000|Overall Study|Lost to Follow-up|1
2270273|NCT02246998|3948121|FG001|Overall Study|Lost to Follow-up|0
2270274|NCT02246998|3948122|FG002|Overall Study|Lost to Follow-up|0
2270275|NCT02246998|3948123|FG003|Overall Study|Lost to Follow-up|1
2270276|NCT02246998|3948120|FG000|Overall Study|Randomized but Never Dosed|1
2270277|NCT02246998|3948121|FG001|Overall Study|Randomized but Never Dosed|2
2270278|NCT02246998|3948122|FG002|Overall Study|Randomized but Never Dosed|2
2270279|NCT02246998|3948123|FG003|Overall Study|Randomized but Never Dosed|1
2270280|NCT02247011|3948138|FG000|Overall Study|Poor quality of radiological results|125
2270281|NCT02247401|3948192|FG000|Overall Study|Adverse Event|1
2270282|NCT02247401|3948193|FG001|Overall Study|Adverse Event|0
2270283|NCT02247401|3948194|FG002|Overall Study|Adverse Event|0
2270284|NCT02247401|3948192|FG000|Overall Study|Withdrawal by Subject|4
2270285|NCT02247401|3948193|FG001|Overall Study|Withdrawal by Subject|1
2270286|NCT02247401|3948194|FG002|Overall Study|Withdrawal by Subject|1
2270287|NCT02247401|3948192|FG000|Overall Study|Lost to Follow-up|1
2270288|NCT02247401|3948193|FG001|Overall Study|Lost to Follow-up|1
2270289|NCT02247401|3948194|FG002|Overall Study|Lost to Follow-up|1
2270290|NCT02247440|3948203|FG000|Overall Study|Withdrawal by Subject|1
2270291|NCT02247440|3948203|FG000|Overall Study|Lack of Efficacy|3
2270292|NCT02247466|3948209|FG000|Overall Study|Procedure changed to open surgery|0
2270293|NCT02247466|3948210|FG001|Overall Study|Procedure changed to open surgery|3
2270294|NCT02247479|3948219|FG000|Overall Study|Adverse Event|8
2270295|NCT02247479|3948220|FG001|Overall Study|Adverse Event|9
2270296|NCT02247479|3948221|FG002|Overall Study|Adverse Event|8
2270297|NCT02247479|3948219|FG000|Overall Study|Death|5
2270298|NCT02247479|3948220|FG001|Overall Study|Death|4
2270299|NCT02247479|3948221|FG002|Overall Study|Death|6
2270300|NCT02247479|3948219|FG000|Overall Study|Lost to Follow-up|3
2270301|NCT02247479|3948220|FG001|Overall Study|Lost to Follow-up|3
2270302|NCT02247479|3948221|FG002|Overall Study|Lost to Follow-up|1
2270303|NCT02247479|3948219|FG000|Overall Study|Non-compliance|0
2270304|NCT02247479|3948220|FG001|Overall Study|Non-compliance|0
2270305|NCT02247479|3948221|FG002|Overall Study|Non-compliance|1
2270306|NCT02247479|3948219|FG000|Overall Study|Withdrawal by Subject|25
2270307|NCT02247479|3948220|FG001|Overall Study|Withdrawal by Subject|29
2270308|NCT02247479|3948221|FG002|Overall Study|Withdrawal by Subject|24
2270309|NCT02247479|3948219|FG000|Overall Study|Study Terminated by Sponsor|98
2270310|NCT02247479|3948220|FG001|Overall Study|Study Terminated by Sponsor|88
2349983|NCT04073407|4094428|FG001|Part 1|Withdrawal by Subject|0
2349984|NCT04073407|4094427|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4
2349985|NCT04073407|4094428|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1
2349986|NCT04073407|4094427|FG000|Part 2|Withdrawal by Subject|0
2349987|NCT04073407|4094428|FG001|Part 2|Withdrawal by Subject|1
2349988|NCT04073368|4094438|FG000|Overall Study|Adverse Event|2
2349989|NCT04073368|4094439|FG001|Overall Study|Adverse Event|0
2349990|NCT04073368|4094440|FG002|Overall Study|Adverse Event|1
2349991|NCT04073368|4094441|FG003|Overall Study|Adverse Event|1
2349992|NCT04073368|4094438|FG000|Overall Study|Withdrawal by Subject|2
2349993|NCT04073368|4094439|FG001|Overall Study|Withdrawal by Subject|2
2349994|NCT04073368|4094440|FG002|Overall Study|Withdrawal by Subject|1
2349995|NCT04073368|4094441|FG003|Overall Study|Withdrawal by Subject|1
2349996|NCT04073368|4094438|FG000|Overall Study|Lost to Follow-up|1
2349997|NCT04073368|4094439|FG001|Overall Study|Lost to Follow-up|1
2349998|NCT04073368|4094440|FG002|Overall Study|Lost to Follow-up|1
2349999|NCT04073368|4094441|FG003|Overall Study|Lost to Follow-up|0
2350000|NCT04073368|4094438|FG000|Overall Study|Protocol Violation|0
2350001|NCT04073368|4094439|FG001|Overall Study|Protocol Violation|1
2350002|NCT04073368|4094440|FG002|Overall Study|Protocol Violation|0
2350003|NCT04073368|4094441|FG003|Overall Study|Protocol Violation|0
2350004|NCT04073368|4094438|FG000|Overall Study|Subject noncompliance|7
2350005|NCT04073368|4094439|FG001|Overall Study|Subject noncompliance|4
2350006|NCT04073368|4094440|FG002|Overall Study|Subject noncompliance|0
2350007|NCT04073368|4094441|FG003|Overall Study|Subject noncompliance|0
2270311|NCT02247479|3948221|FG002|Overall Study|Study Terminated by Sponsor|94
2270312|NCT02247479|3948219|FG000|Overall Study|Physician Decision|1
2270313|NCT02247479|3948220|FG001|Overall Study|Physician Decision|0
2270314|NCT02247479|3948221|FG002|Overall Study|Physician Decision|2
2270315|NCT02247479|3948219|FG000|Overall Study|Unspecified Reason|2
2270316|NCT02247479|3948220|FG001|Overall Study|Unspecified Reason|5
2270317|NCT02247479|3948221|FG002|Overall Study|Unspecified Reason|2
2270318|NCT02247531|3948232|FG000|Overall Study|Adverse Event|3
2270319|NCT02247531|3948233|FG001|Overall Study|Adverse Event|4
2270320|NCT02247531|3948234|FG002|Overall Study|Adverse Event|9
2270321|NCT02247531|3948232|FG000|Overall Study|Death|8
2270322|NCT02247531|3948233|FG001|Overall Study|Death|9
2270323|NCT02247531|3948234|FG002|Overall Study|Death|5
2270324|NCT02247531|3948232|FG000|Overall Study|Lost to Follow-up|1
2270325|NCT02247531|3948233|FG001|Overall Study|Lost to Follow-up|8
2270326|NCT02247531|3948234|FG002|Overall Study|Lost to Follow-up|3
2270327|NCT02247531|3948232|FG000|Overall Study|Non-compliance|2
2270328|NCT02247531|3948233|FG001|Overall Study|Non-compliance|2
2270329|NCT02247531|3948234|FG002|Overall Study|Non-compliance|0
2270330|NCT02247531|3948232|FG000|Overall Study|Withdrawal by Subject|26
2270331|NCT02247531|3948233|FG001|Overall Study|Withdrawal by Subject|31
2270332|NCT02247531|3948234|FG002|Overall Study|Withdrawal by Subject|25
2270333|NCT02247531|3948232|FG000|Overall Study|Study Terminated by Sponsor|64
2270334|NCT02247531|3948233|FG001|Overall Study|Study Terminated by Sponsor|66
2270335|NCT02247531|3948234|FG002|Overall Study|Study Terminated by Sponsor|62
2270336|NCT02247531|3948232|FG000|Overall Study|Physician Decision|0
2270337|NCT02247531|3948233|FG001|Overall Study|Physician Decision|2
2270338|NCT02247531|3948234|FG002|Overall Study|Physician Decision|2
2270339|NCT02247531|3948232|FG000|Overall Study|Unspecified Reason|2
2270340|NCT02247531|3948233|FG001|Overall Study|Unspecified Reason|3
2270341|NCT02247531|3948234|FG002|Overall Study|Unspecified Reason|4
2270342|NCT02247804|3948264|FG000|Treatment Period 1|Adverse Event|9
2270343|NCT02247804|3948265|FG001|Treatment Period 1|Adverse Event|2
2270344|NCT02247804|3948266|FG002|Treatment Period 1|Adverse Event|0
2270345|NCT02247804|3948264|FG000|Treatment Period 1|Lack of Efficacy|0
2270346|NCT02247804|3948265|FG001|Treatment Period 1|Lack of Efficacy|0
2270347|NCT02247804|3948266|FG002|Treatment Period 1|Lack of Efficacy|2
2270348|NCT02247804|3948264|FG000|Treatment Period 1|Lost to Follow-up|1
2270349|NCT02247804|3948265|FG001|Treatment Period 1|Lost to Follow-up|0
2270350|NCT02247804|3948266|FG002|Treatment Period 1|Lost to Follow-up|2
2270351|NCT02247804|3948264|FG000|Treatment Period 1|Personal Reasons|7
2270352|NCT02247804|3948265|FG001|Treatment Period 1|Personal Reasons|1
2270353|NCT02247804|3948266|FG002|Treatment Period 1|Personal Reasons|2
2270354|NCT02247804|3948264|FG000|Treatment Period 1|Protocol Deviation|0
2270355|NCT02247804|3948265|FG001|Treatment Period 1|Protocol Deviation|0
2270356|NCT02247804|3948266|FG002|Treatment Period 1|Protocol Deviation|1
2270357|NCT02247804|3948264|FG000|Treatment Period 1|Randomized but not Treated|5
2270358|NCT02247804|3948265|FG001|Treatment Period 1|Randomized but not Treated|1
2270359|NCT02247804|3948266|FG002|Treatment Period 1|Randomized but not Treated|1
2270360|NCT02247804|3948264|FG000|Treatment Period 2|Adverse Event|6
2270361|NCT02247804|3948265|FG001|Treatment Period 2|Adverse Event|3
2270362|NCT02247804|3948266|FG002|Treatment Period 2|Adverse Event|3
2350008|NCT04073186|4094451|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1
2350009|NCT04073186|4094451|FG000|First Wearing Cycle|Withdrawal by Subject|1
2350010|NCT04073186|4094451|FG000|First Wearing Cycle|Protocol Violation|1
2350011|NCT04073186|4094451|FG000|First Wearing Cycle|Lens Discomfort|2
2350012|NCT04073186|4094451|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1
2350013|NCT04073186|4094451|FG000|Second Wearing Cycle|Adverse Event|1
2350014|NCT04071301|4094519|FG000|Overall Study|Withdrawal by Subject|6
2350015|NCT04071301|4094519|FG000|Overall Study|Death|1
2350016|NCT04071158|4094528|FG000|Overall Study|Lost to Follow-up|1
2350017|NCT04071158|4094529|FG001|Overall Study|Lost to Follow-up|2
2350018|NCT04071158|4094530|FG002|Overall Study|Lost to Follow-up|3
2350019|NCT04071158|4094531|FG003|Overall Study|Lost to Follow-up|3
2350020|NCT04071158|4094532|FG004|Overall Study|Lost to Follow-up|5
2350021|NCT04071158|4094528|FG000|Overall Study|Randomized but not treated|2
2350022|NCT04071158|4094529|FG001|Overall Study|Randomized but not treated|2
2350023|NCT04071158|4094530|FG002|Overall Study|Randomized but not treated|0
2350024|NCT04071158|4094531|FG003|Overall Study|Randomized but not treated|0
2350025|NCT04071158|4094532|FG004|Overall Study|Randomized but not treated|0
2350026|NCT04069715|4094573|FG000|Overall Study|Lost to Follow-up|1
2350027|NCT04069715|4094574|FG001|Overall Study|Lost to Follow-up|1
2350028|NCT04069715|4094573|FG000|Overall Study|Physician Decision|1
2350029|NCT04069715|4094574|FG001|Overall Study|Physician Decision|1
2350030|NCT04069715|4094573|FG000|Overall Study|Withdrawal by Subject|3
2350031|NCT04069715|4094574|FG001|Overall Study|Withdrawal by Subject|3
2350032|NCT04050722|4094582|FG000|Overall Study|Withdrawal by Subject|1
2350033|NCT04050722|4094583|FG001|Overall Study|Withdrawal by Subject|0
2350034|NCT04067141|4094604|FG000|First Intervention|Withdrawal by Subject|0
2350035|NCT04067141|4094605|FG001|First Intervention|Withdrawal by Subject|1
2350036|NCT04067141|4094604|FG000|Second Intervention|Adverse Event|0
2350037|NCT04067141|4094605|FG001|Second Intervention|Adverse Event|2
2350038|NCT04049578|4094611|FG000|Overall Study|Physician Decision|1
2350039|NCT04067401|4094617|FG000|Overall Study|Withdrawal by Subject|7
2350040|NCT04067401|4094618|FG001|Overall Study|Withdrawal by Subject|0
2350041|NCT04067401|4094617|FG000|Overall Study|no data provided|1
2350042|NCT04067401|4094618|FG001|Overall Study|no data provided|0
2350043|NCT04067050|4094626|FG000|One Month|Lost to Follow-up|4
2350044|NCT04067050|4094627|FG001|One Month|Lost to Follow-up|0
2350045|NCT04067050|4094626|FG000|Two Month|Lost to Follow-up|1
2350046|NCT04067050|4094627|FG001|Two Month|Lost to Follow-up|0
2350047|NCT04067050|4094626|FG000|Two Month|Adverse Event|1
2350048|NCT04067050|4094627|FG001|Two Month|Adverse Event|0
2350049|NCT04060654|4094663|FG000|Overall Study|Withdrawal by Subject|1
2350050|NCT04060654|4094663|FG000|Overall Study|Lost to Follow-up|5
2350051|NCT04058353|4094676|FG000|Overall Study|Adverse Event|2
2350052|NCT04058353|4094677|FG001|Overall Study|Adverse Event|1
2350053|NCT04058353|4094676|FG000|Overall Study|Physician Decision|1
2350054|NCT04058353|4094677|FG001|Overall Study|Physician Decision|0
2350055|NCT04058353|4094676|FG000|Overall Study|Other|1
2350056|NCT04058353|4094677|FG001|Overall Study|Other|0
2350057|NCT04054765|4094709|FG000|Baseline|Withdrawal by Subject|5
2350058|NCT04054765|4094710|FG001|Baseline|Withdrawal by Subject|3
2270363|NCT02247804|3948264|FG000|Treatment Period 2|Lack of Efficacy|0
2270364|NCT02247804|3948265|FG001|Treatment Period 2|Lack of Efficacy|0
2270365|NCT02247804|3948266|FG002|Treatment Period 2|Lack of Efficacy|1
2270366|NCT02247804|3948264|FG000|Treatment Period 2|Lost to Follow-up|0
2270367|NCT02247804|3948265|FG001|Treatment Period 2|Lost to Follow-up|1
2270368|NCT02247804|3948266|FG002|Treatment Period 2|Lost to Follow-up|1
2270369|NCT02247804|3948264|FG000|Treatment Period 2|Personal Reasons|2
2270370|NCT02247804|3948265|FG001|Treatment Period 2|Personal Reasons|1
2270371|NCT02247804|3948266|FG002|Treatment Period 2|Personal Reasons|1
2270372|NCT02247804|3948264|FG000|Treatment Period 2|Reason not Specified|0
2270373|NCT02247804|3948265|FG001|Treatment Period 2|Reason not Specified|0
2270374|NCT02247804|3948266|FG002|Treatment Period 2|Reason not Specified|2
2270375|NCT02247804|3948264|FG000|Treatment Period 3|Adverse Event|4
2270376|NCT02247804|3948265|FG001|Treatment Period 3|Adverse Event|3
2270377|NCT02247804|3948266|FG002|Treatment Period 3|Adverse Event|3
2270378|NCT02247804|3948264|FG000|Treatment Period 3|Lack of Efficacy|0
2270379|NCT02247804|3948265|FG001|Treatment Period 3|Lack of Efficacy|1
2270380|NCT02247804|3948266|FG002|Treatment Period 3|Lack of Efficacy|0
2270381|NCT02247804|3948264|FG000|Treatment Period 3|Lost to Follow-up|1
2270382|NCT02247804|3948265|FG001|Treatment Period 3|Lost to Follow-up|2
2270383|NCT02247804|3948266|FG002|Treatment Period 3|Lost to Follow-up|2
2270384|NCT02247804|3948264|FG000|Treatment Period 3|Personal Reasons|4
2270385|NCT02247804|3948265|FG001|Treatment Period 3|Personal Reasons|3
2270386|NCT02247804|3948266|FG002|Treatment Period 3|Personal Reasons|2
2270387|NCT02247804|3948264|FG000|Treatment Period 3|Reason not Specified|2
2270388|NCT02247804|3948265|FG001|Treatment Period 3|Reason not Specified|1
2270389|NCT02247804|3948266|FG002|Treatment Period 3|Reason not Specified|3
2270390|NCT02247960|3948276|FG000|Patient Consent and Randomization|Physician Decision|2
2270391|NCT02247960|3948277|FG001|Patient Consent and Randomization|Physician Decision|2
2270392|NCT02247960|3948276|FG000|Patient Consent and Randomization|Withdrawal by Subject|0
2270393|NCT02247960|3948277|FG001|Patient Consent and Randomization|Withdrawal by Subject|4
2270394|NCT02247960|3948276|FG000|Catheter Removed|Lost to Follow-up|7
2270395|NCT02247960|3948277|FG001|Catheter Removed|Lost to Follow-up|10
2270396|NCT02248480|3948307|FG000|Overall Study|Lack of Efficacy|4
2270397|NCT02248480|3948308|FG001|Overall Study|Lack of Efficacy|6
2270398|NCT02248480|3948307|FG000|Overall Study|Adverse Event|11
2270399|NCT02248480|3948308|FG001|Overall Study|Adverse Event|2
2270400|NCT02248480|3948307|FG000|Overall Study|Withdrawal by Subject|2
2270401|NCT02248480|3948308|FG001|Overall Study|Withdrawal by Subject|4
2270402|NCT02248480|3948307|FG000|Overall Study|Entry Criteria Not Met|0
2270403|NCT02248480|3948308|FG001|Overall Study|Entry Criteria Not Met|1
2270404|NCT02248480|3948307|FG000|Overall Study|Other:Physician Decision|0
2270405|NCT02248480|3948308|FG001|Overall Study|Other:Physician Decision|1
2270406|NCT02248649|3948337|FG000|Overall Study|Death|7
2270407|NCT02248649|3948338|FG001|Overall Study|Death|11
2270408|NCT02248649|3948337|FG000|Overall Study|Lost to Follow-up|14
2270409|NCT02248649|3948338|FG001|Overall Study|Lost to Follow-up|10
2270410|NCT02248675|3948359|FG000|Overall Study|Lost to Follow-up|3
2270411|NCT02248675|3948360|FG001|Overall Study|Lost to Follow-up|1
2270412|NCT02248818|3948398|FG000|Screening|Protocol Violation|0
2270413|NCT02248818|3948399|FG001|Screening|Protocol Violation|0
2270414|NCT02248818|3948400|FG002|Screening|Protocol Violation|0
2270415|NCT02248818|3948401|FG003|Screening|Protocol Violation|0
2270416|NCT02248818|3948402|FG004|Screening|Protocol Violation|0
2270417|NCT02248818|3948403|FG005|Screening|Protocol Violation|0
2270418|NCT02248818|3948404|FG006|Screening|Protocol Violation|0
2270419|NCT02248818|3948405|FG007|Screening|Protocol Violation|0
2270420|NCT02248818|3948406|FG008|Screening|Protocol Violation|7
2270421|NCT02248818|3948398|FG000|Screening|Study fully enrolled|0
2270422|NCT02248818|3948399|FG001|Screening|Study fully enrolled|0
2270423|NCT02248818|3948400|FG002|Screening|Study fully enrolled|0
2270424|NCT02248818|3948401|FG003|Screening|Study fully enrolled|0
2270425|NCT02248818|3948402|FG004|Screening|Study fully enrolled|0
2270426|NCT02248818|3948403|FG005|Screening|Study fully enrolled|0
2270427|NCT02248818|3948404|FG006|Screening|Study fully enrolled|0
2270428|NCT02248818|3948405|FG007|Screening|Study fully enrolled|0
2270429|NCT02248818|3948406|FG008|Screening|Study fully enrolled|14
2270430|NCT02248818|3948398|FG000|Screening|Physician Decision|0
2270431|NCT02248818|3948399|FG001|Screening|Physician Decision|0
2270432|NCT02248818|3948400|FG002|Screening|Physician Decision|0
2270433|NCT02248818|3948401|FG003|Screening|Physician Decision|0
2270434|NCT02248818|3948402|FG004|Screening|Physician Decision|0
2270435|NCT02248818|3948403|FG005|Screening|Physician Decision|0
2270436|NCT02248818|3948404|FG006|Screening|Physician Decision|0
2270437|NCT02248818|3948405|FG007|Screening|Physician Decision|0
2270438|NCT02248818|3948406|FG008|Screening|Physician Decision|73
2270439|NCT02248818|3948398|FG000|Screening|Withdrawal by Subject|0
2270440|NCT02248818|3948399|FG001|Screening|Withdrawal by Subject|0
2270441|NCT02248818|3948400|FG002|Screening|Withdrawal by Subject|0
2270442|NCT02248818|3948401|FG003|Screening|Withdrawal by Subject|0
2270443|NCT02248818|3948402|FG004|Screening|Withdrawal by Subject|0
2270444|NCT02248818|3948403|FG005|Screening|Withdrawal by Subject|0
2270445|NCT02248818|3948404|FG006|Screening|Withdrawal by Subject|0
2270446|NCT02248818|3948405|FG007|Screening|Withdrawal by Subject|0
2270447|NCT02248818|3948406|FG008|Screening|Withdrawal by Subject|6
2270448|NCT02248818|3948398|FG000|Screening|Lost to Follow-up|0
2270449|NCT02248818|3948399|FG001|Screening|Lost to Follow-up|0
2270450|NCT02248818|3948400|FG002|Screening|Lost to Follow-up|0
2270451|NCT02248818|3948401|FG003|Screening|Lost to Follow-up|0
2270452|NCT02248818|3948402|FG004|Screening|Lost to Follow-up|0
2270453|NCT02248818|3948403|FG005|Screening|Lost to Follow-up|0
2270454|NCT02248818|3948404|FG006|Screening|Lost to Follow-up|0
2270455|NCT02248818|3948405|FG007|Screening|Lost to Follow-up|0
2270456|NCT02248818|3948406|FG008|Screening|Lost to Follow-up|7
2270457|NCT02248818|3948398|FG000|Randomised Study|Administrative - randomization error|0
2270458|NCT02248818|3948399|FG001|Randomised Study|Administrative - randomization error|0
2270459|NCT02248818|3948400|FG002|Randomised Study|Administrative - randomization error|0
2270460|NCT02248818|3948401|FG003|Randomised Study|Administrative - randomization error|0
2270461|NCT02248818|3948402|FG004|Randomised Study|Administrative - randomization error|0
2270462|NCT02248818|3948403|FG005|Randomised Study|Administrative - randomization error|8
2270463|NCT02248818|3948404|FG006|Randomised Study|Administrative - randomization error|0
2270464|NCT02248818|3948405|FG007|Randomised Study|Administrative - randomization error|0
2270465|NCT02248818|3948406|FG008|Randomised Study|Administrative - randomization error|0
2270466|NCT02248857|3948427|FG000|3 Month|Withdrawal by Subject|9
2270467|NCT02248857|3948428|FG001|3 Month|Withdrawal by Subject|3
2270468|NCT02248857|3948429|FG002|3 Month|Withdrawal by Subject|4
2270469|NCT02248857|3948427|FG000|3 Month|Unable to reach for 3 month|35
2270470|NCT02248857|3948428|FG001|3 Month|Unable to reach for 3 month|29
2270471|NCT02248857|3948429|FG002|3 Month|Unable to reach for 3 month|26
2270472|NCT02248857|3948427|FG000|3 Month|Partially completed, unable to finish|2
2270473|NCT02248857|3948428|FG001|3 Month|Partially completed, unable to finish|2
2270474|NCT02248857|3948429|FG002|3 Month|Partially completed, unable to finish|1
2270475|NCT02248857|3948427|FG000|6 Month|Lost to Follow-up|27
2270476|NCT02248857|3948428|FG001|6 Month|Lost to Follow-up|26
2270477|NCT02248857|3948429|FG002|6 Month|Lost to Follow-up|15
2270478|NCT02248857|3948427|FG000|6 Month|Partially completed, unable to finish|0
2270479|NCT02248857|3948428|FG001|6 Month|Partially completed, unable to finish|1
2270480|NCT02248857|3948429|FG002|6 Month|Partially completed, unable to finish|0
2270481|NCT02248857|3948427|FG000|6 Month|Withdrawal by Subject|0
2270482|NCT02248857|3948428|FG001|6 Month|Withdrawal by Subject|2
2270483|NCT02248857|3948429|FG002|6 Month|Withdrawal by Subject|2
2270484|NCT02248857|3948427|FG000|6 Month|Death|1
2270485|NCT02248857|3948428|FG001|6 Month|Death|0
2270486|NCT02248857|3948429|FG002|6 Month|Death|0
2270487|NCT02248961|3948447|FG000|Overall Study|Adverse Event|1
2270488|NCT02248961|3948448|FG001|Overall Study|Adverse Event|0
2270489|NCT02248961|3948447|FG000|Overall Study|Withdrawal by Subject|1
2270490|NCT02248961|3948448|FG001|Overall Study|Withdrawal by Subject|2
2270491|NCT02248961|3948447|FG000|Overall Study|Unmet inclusion/exclusion criteria|1
2270492|NCT02248961|3948448|FG001|Overall Study|Unmet inclusion/exclusion criteria|0
2270493|NCT02248974|3948456|FG000|1-Day Follow-Up|Lost to Follow-up|4
2270494|NCT02248974|3948457|FG001|1-Day Follow-Up|Lost to Follow-up|0
2270495|NCT02248974|3948456|FG000|1-Day Follow-Up|Withdrawal by Subject|5
2270496|NCT02248974|3948457|FG001|1-Day Follow-Up|Withdrawal by Subject|0
2350059|NCT04054765|4094709|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8
2350060|NCT04054765|4094710|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3
2350061|NCT04054765|4094709|FG000|3-month Follow up|Withdrawal by Subject|0
2350062|NCT04054765|4094710|FG001|3-month Follow up|Withdrawal by Subject|3
2350063|NCT04054765|4094709|FG000|6-month Follow up|Lost to Follow-up|32
2350064|NCT04054765|4094710|FG001|6-month Follow up|Lost to Follow-up|32
2350065|NCT04054011|4094716|FG000|Overall Study|COVID|3
2350066|NCT04059094|4094727|FG000|Overall Study|Adverse Event|0
2350067|NCT04059094|4094728|FG001|Overall Study|Adverse Event|0
2350068|NCT04059094|4094729|FG002|Overall Study|Adverse Event|0
2350069|NCT04059094|4094730|FG003|Overall Study|Adverse Event|0
2350070|NCT04059094|4094731|FG004|Overall Study|Adverse Event|1
2350071|NCT04059094|4094727|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0
2350072|NCT04059094|4094728|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2
2350073|NCT04059094|4094729|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0
2350074|NCT04059094|4094730|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0
2350075|NCT04059094|4094731|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0
2270497|NCT02248974|3948456|FG000|1-Day Follow-Up|Enrolled in another study|1
2270498|NCT02248974|3948457|FG001|1-Day Follow-Up|Enrolled in another study|0
2270499|NCT02248974|3948456|FG000|1-Week Follow-Up|Became ineligible for LVAD|4
2270500|NCT02248974|3948457|FG001|1-Week Follow-Up|Became ineligible for LVAD|1
2270501|NCT02248974|3948456|FG000|1-Week Follow-Up|Enrolled in another study|1
2270502|NCT02248974|3948457|FG001|1-Week Follow-Up|Enrolled in another study|1
2270503|NCT02248974|3948456|FG000|1-Week Follow-Up|Transferred to another facility|1
2270504|NCT02248974|3948457|FG001|1-Week Follow-Up|Transferred to another facility|0
2270505|NCT02248974|3948456|FG000|1-Week Follow-Up|Cognitive Difficulty|1
2270506|NCT02248974|3948457|FG001|1-Week Follow-Up|Cognitive Difficulty|0
2270507|NCT02248974|3948456|FG000|1-Week Follow-Up|Death|1
2270508|NCT02248974|3948457|FG001|1-Week Follow-Up|Death|1
2270509|NCT02248974|3948456|FG000|1-Week Follow-Up|Excluded because of age|0
2270510|NCT02248974|3948457|FG001|1-Week Follow-Up|Excluded because of age|1
2270511|NCT02248974|3948456|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0
2270512|NCT02248974|3948457|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1
2270513|NCT02248974|3948456|FG000|1-Week Follow-Up|Timing: implanted before survey|0
2270514|NCT02248974|3948457|FG001|1-Week Follow-Up|Timing: implanted before survey|2
2270515|NCT02248974|3948456|FG000|1-Week Follow-Up|Withdrawal by Subject|0
2270516|NCT02248974|3948457|FG001|1-Week Follow-Up|Withdrawal by Subject|2
2270517|NCT02248974|3948456|FG000|1-Week Follow-Up|Lost to Follow-up|0
2270518|NCT02248974|3948457|FG001|1-Week Follow-Up|Lost to Follow-up|8
2270519|NCT02248974|3948456|FG000|1-Month Follow-Up|Lost to Follow-up|2
2270520|NCT02248974|3948457|FG001|1-Month Follow-Up|Lost to Follow-up|3
2270521|NCT02249091|3948477|FG000|Overall Study|Lack of Efficacy|8
2270522|NCT02249091|3948478|FG001|Overall Study|Lack of Efficacy|3
2270523|NCT02249091|3948477|FG000|Overall Study|Physician Decision|4
2270524|NCT02249091|3948478|FG001|Overall Study|Physician Decision|1
2270525|NCT02249091|3948477|FG000|Overall Study|Withdrawal by Subject|2
2270526|NCT02249091|3948478|FG001|Overall Study|Withdrawal by Subject|2
2270527|NCT02249091|3948477|FG000|Overall Study|Death|3
2270528|NCT02249091|3948478|FG001|Overall Study|Death|4
2270529|NCT02249091|3948477|FG000|Overall Study|Adverse Event|1
2270530|NCT02249091|3948478|FG001|Overall Study|Adverse Event|0
2270531|NCT02249091|3948477|FG000|Overall Study|Stable disease with following SCT|0
2270532|NCT02249091|3948478|FG001|Overall Study|Stable disease with following SCT|1
2270533|NCT02249091|3948477|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0
2270534|NCT02249091|3948478|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1
2270535|NCT02249091|3948477|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1
2270536|NCT02249091|3948478|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0
2270537|NCT02249091|3948477|FG000|Overall Study|Refractory AML|1
2270538|NCT02249091|3948478|FG001|Overall Study|Refractory AML|1
2270539|NCT02249182|3948502|FG000|Treatment Phase|Lost to Follow-up|4
2270540|NCT02249182|3948503|FG001|Treatment Phase|Lost to Follow-up|0
2270541|NCT02249182|3948504|FG002|Treatment Phase|Lost to Follow-up|0
2270542|NCT02249182|3948505|FG003|Treatment Phase|Lost to Follow-up|0
2270543|NCT02249182|3948506|FG004|Treatment Phase|Lost to Follow-up|0
2270544|NCT02249767|3948554|FG000|Overall Study|Did not use medication|8
2270545|NCT02249767|3948555|FG001|Overall Study|Did not use medication|9
2270546|NCT02249767|3948556|FG002|Overall Study|Did not use medication|8
2270547|NCT02249832|3948576|FG000|Overall Study|Withdrawal by Subject|3
2270548|NCT02249832|3948576|FG000|Overall Study|Lost to Follow-up|10
2270549|NCT02249949|3948585|FG000|Overall Study|Cancelled prior to treatment|2
2270550|NCT02250183|3948598|FG000|Overall Study|Withdrawal by Subject|2
2270551|NCT02250183|3948598|FG000|Overall Study|Adverse Event|5
2270552|NCT02250183|3948598|FG000|Overall Study|Lost to Follow-up|1
2270553|NCT02250274|3948607|FG000|Overall Study|Insufficient blood draw amount|7
2270554|NCT02250274|3948608|FG001|Overall Study|Insufficient blood draw amount|6
2270555|NCT02250443|3948630|FG000|Overall Study|Administrative problems|7
2270556|NCT02250443|3948630|FG000|Overall Study|Adverse Event|3
2270557|NCT02250651|3948669|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0
2270558|NCT02250651|3948670|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
2270559|NCT02250651|3948671|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
2270560|NCT02250651|3948669|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1
2270561|NCT02250651|3948670|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
2270562|NCT02250651|3948671|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
2270563|NCT02250651|3948669|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2
2270564|NCT02250651|3948670|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3
2270565|NCT02250651|3948671|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5
2270566|NCT02250651|3948669|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1
2270567|NCT02250651|3948670|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
2270568|NCT02250651|3948671|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
2270569|NCT02250651|3948669|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
2270570|NCT02250651|3948670|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
2270571|NCT02250651|3948671|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1
2270572|NCT02250651|3948669|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0
2270573|NCT02250651|3948670|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1
2270574|NCT02250651|3948671|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3
2270575|NCT02250651|3948669|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4
2270576|NCT02250651|3948670|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1
2270577|NCT02250651|3948671|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0
2270578|NCT02250651|3948669|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
2270579|NCT02250651|3948670|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
2270580|NCT02250651|3948671|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3
2270581|NCT02250651|3948669|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
2270582|NCT02250651|3948670|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3
2270583|NCT02250651|3948671|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
2270584|NCT02250651|3948669|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
2270585|NCT02250651|3948670|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1
2270586|NCT02250651|3948671|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
2270587|NCT02250651|3948669|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
2270588|NCT02250651|3948670|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1
2270589|NCT02250651|3948671|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
2270590|NCT02250651|3948669|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4
2270591|NCT02250651|3948670|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
2270592|NCT02250651|3948671|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
2270593|NCT02250651|3948669|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
2270594|NCT02250651|3948670|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2
2270595|NCT02250651|3948671|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
2270596|NCT02250651|3948669|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
2270597|NCT02250651|3948670|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0
2270598|NCT02250651|3948671|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
2270599|NCT02250651|3948669|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2
2270600|NCT02250651|3948670|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
2270601|NCT02250651|3948671|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
2270602|NCT02251275|3948710|FG000|Overall Study|Adverse Event|23
2270603|NCT02251275|3948711|FG001|Overall Study|Adverse Event|60
2270604|NCT02251275|3948712|FG002|Overall Study|Adverse Event|28
2270605|NCT02251275|3948713|FG003|Overall Study|Adverse Event|0
2270606|NCT02251275|3948714|FG004|Overall Study|Adverse Event|0
2270607|NCT02251275|3948710|FG000|Overall Study|Lost to Follow-up|5
2270608|NCT02251275|3948711|FG001|Overall Study|Lost to Follow-up|6
2270609|NCT02251275|3948712|FG002|Overall Study|Lost to Follow-up|4
2270610|NCT02251275|3948713|FG003|Overall Study|Lost to Follow-up|0
2270611|NCT02251275|3948714|FG004|Overall Study|Lost to Follow-up|0
2270612|NCT02251275|3948710|FG000|Overall Study|Physician Decision|19
2270613|NCT02251275|3948711|FG001|Overall Study|Physician Decision|30
2270614|NCT02251275|3948712|FG002|Overall Study|Physician Decision|26
2270615|NCT02251275|3948713|FG003|Overall Study|Physician Decision|0
2270616|NCT02251275|3948714|FG004|Overall Study|Physician Decision|1
2270617|NCT02251275|3948710|FG000|Overall Study|Protocol Deviation|0
2270618|NCT02251275|3948711|FG001|Overall Study|Protocol Deviation|0
2270619|NCT02251275|3948712|FG002|Overall Study|Protocol Deviation|1
2270620|NCT02251275|3948713|FG003|Overall Study|Protocol Deviation|0
2270621|NCT02251275|3948714|FG004|Overall Study|Protocol Deviation|0
2270622|NCT02251275|3948710|FG000|Overall Study|Withdrawal by Subject|25
2270623|NCT02251275|3948711|FG001|Overall Study|Withdrawal by Subject|51
2270624|NCT02251275|3948712|FG002|Overall Study|Withdrawal by Subject|35
2270625|NCT02251275|3948713|FG003|Overall Study|Withdrawal by Subject|1
2270626|NCT02251275|3948714|FG004|Overall Study|Withdrawal by Subject|0
2270627|NCT02251652|3948761|FG000|Overall Study|Withdrawal by Subject|1
2270628|NCT02251717|3948769|FG000|Overall Study|Adverse Event|0
2270629|NCT02251717|3948770|FG001|Overall Study|Adverse Event|1
2270630|NCT02251717|3948769|FG000|Overall Study|Withdrew Consent|1
2270631|NCT02251717|3948770|FG001|Overall Study|Withdrew Consent|0
2270632|NCT02251743|3948778|FG000|Overall Study|Withdrawal by Subject|1
2270633|NCT02251743|3948779|FG001|Overall Study|Withdrawal by Subject|1
2270634|NCT02251912|3948804|FG000|Overall Study|Withdrawal by Subject|2
2270635|NCT02251912|3948805|FG001|Overall Study|Withdrawal by Subject|3
2270636|NCT02251912|3948804|FG000|Overall Study|Adverse Event|0
2270637|NCT02251912|3948805|FG001|Overall Study|Adverse Event|2
2270638|NCT02251990|3948817|FG000|Period 1 (Double-blind [DB])|Adverse Event|1
2270639|NCT02251990|3948818|FG001|Period 1 (Double-blind [DB])|Adverse Event|1
2270640|NCT02251990|3948817|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5
2270641|NCT02251990|3948818|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0
2270642|NCT02251990|3948817|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
2270643|NCT02251990|3948818|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
2270644|NCT02251990|3948817|FG000|Period 1 (Double-blind [DB])|Not Treated|1
2350076|NCT04046341|4094756|FG000|Overall Study|Lost to Follow-up|2
2350077|NCT04046341|4094756|FG000|Overall Study|Withdrawal by Subject|1
2350078|NCT04043416|4094771|FG000|Washout|Change in health condition|0
2350079|NCT04043416|4094772|FG001|Washout|Change in health condition|1
2350080|NCT04054193|4094834|FG000|Cycle 1|Physician Decision|1
2350081|NCT04054193|4094834|FG000|Cycle 1|Consent withdrawn by parent/guardian|1
2350082|NCT04054193|4094834|FG000|Cycle 1|Allocated but not treated|3
2350083|NCT04054193|4094834|FG000|Cycles 2-3|Physician Decision|2
2350084|NCT04054193|4094834|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2
2350085|NCT04054193|4094834|FG000|Cycles 2-3|Various reasons|17
2350086|NCT04050618|4094841|FG000|First Intervention|Withdrawal by Subject|2
2270645|NCT02251990|3948818|FG001|Period 1 (Double-blind [DB])|Not Treated|0
2270646|NCT02251990|3948817|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
2270647|NCT02251990|3948818|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
2270648|NCT02251990|3948817|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
2270649|NCT02251990|3948818|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
2270650|NCT02252016|3948827|FG000|Overall Study|Lost to Follow-up|2
2270651|NCT02252016|3948828|FG001|Overall Study|Lost to Follow-up|1
2270652|NCT02252016|3948827|FG000|Overall Study|Physician Decision|1
2270653|NCT02252016|3948828|FG001|Overall Study|Physician Decision|0
2270654|NCT02252016|3948827|FG000|Overall Study|Withdrawal by Subject|0
2270655|NCT02252016|3948828|FG001|Overall Study|Withdrawal by Subject|2
2270656|NCT02252042|3948836|FG000|Overall Study|Death|170
2270657|NCT02252042|3948837|FG001|Overall Study|Death|192
2270658|NCT02252042|3948836|FG000|Overall Study|Physician Decision|0
2270659|NCT02252042|3948837|FG001|Overall Study|Physician Decision|1
2270660|NCT02252042|3948836|FG000|Overall Study|Withdrawal by Subject|13
2270661|NCT02252042|3948837|FG001|Overall Study|Withdrawal by Subject|20
2270662|NCT02252042|3948836|FG000|Overall Study|Ongoing in study|64
2270663|NCT02252042|3948837|FG001|Overall Study|Ongoing in study|35
2270664|NCT02252081|3948858|FG000|Overall Study|Withdrawal by Subject|2
2270665|NCT02252081|3948859|FG001|Overall Study|Withdrawal by Subject|1
2270666|NCT02252081|3948858|FG000|Overall Study|Adverse Event|4
2270667|NCT02252081|3948859|FG001|Overall Study|Adverse Event|1
2270668|NCT02252081|3948858|FG000|Overall Study|non compliance & others|0
2270669|NCT02252081|3948859|FG001|Overall Study|non compliance & others|2
2350087|NCT04050618|4094842|FG001|First Intervention|Withdrawal by Subject|0
2350088|NCT04050618|4094841|FG000|Second Intervention|Withdrawal by Subject|1
2350089|NCT04050618|4094842|FG001|Second Intervention|Withdrawal by Subject|0
2350090|NCT04053465|4094855|FG000|Overall Study|Withdrawal by Subject|4
2350091|NCT04053465|4094856|FG001|Overall Study|Withdrawal by Subject|4
2350092|NCT04049552|4094875|FG000|Overall Study|Lost to Follow-up|1
2350093|NCT04053023|4094883|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1
2350094|NCT04053023|4094884|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0
2350095|NCT04050865|4094909|FG000|Overall Study|Adverse Event|1
2350096|NCT04050865|4094910|FG001|Overall Study|Adverse Event|0
2350097|NCT04050865|4094909|FG000|Overall Study|no insert|1
2350098|NCT04050865|4094910|FG001|Overall Study|no insert|0
2350099|NCT04050865|4094909|FG000|Overall Study|Only 1 insert|2
2350100|NCT04050865|4094910|FG001|Overall Study|Only 1 insert|3
2350101|NCT04050865|4094909|FG000|Overall Study|Physician Decision|0
2350102|NCT04050865|4094910|FG001|Overall Study|Physician Decision|1
2350103|NCT04050865|4094909|FG000|Overall Study|Withdrawal by Subject|0
2350104|NCT04050865|4094910|FG001|Overall Study|Withdrawal by Subject|1
2350105|NCT04050371|4094928|FG000|Overall Study|Withdrawal by Subject|1
2350106|NCT04050371|4094929|FG001|Overall Study|Withdrawal by Subject|0
2350107|NCT04048681|4094939|FG000|Overall Study|family emergency|0
2350108|NCT04048681|4094940|FG001|Overall Study|family emergency|0
2350109|NCT04048681|4094941|FG002|Overall Study|family emergency|0
2350110|NCT04048681|4094942|FG003|Overall Study|family emergency|1
2350111|NCT04048681|4094943|FG004|Overall Study|family emergency|0
2350112|NCT04046250|4094953|FG000|Overall Study|Death|0
2350113|NCT04046250|4094954|FG001|Overall Study|Death|1
2350114|NCT04046250|4094953|FG000|Overall Study|Withdrawal by Subject|3
2350115|NCT04046250|4094954|FG001|Overall Study|Withdrawal by Subject|3
2350116|NCT04044352|4094969|FG000|Overall Study|Lost to Follow-up|9
2350117|NCT04044352|4094969|FG000|Overall Study|Withdrawal by Subject|2
2350118|NCT04043728|4094977|FG000|Overall Study|Lost to Follow-up|1
2350119|NCT04043728|4094978|FG001|Overall Study|Lost to Follow-up|2
2350120|NCT04043728|4094979|FG002|Overall Study|Lost to Follow-up|0
2350121|NCT04041414|4095008|FG000|Overall Study|Lost to Follow-up|1
2350122|NCT04041414|4095009|FG001|Overall Study|Lost to Follow-up|2
2350123|NCT04041700|4095022|FG000|Overall Study|Pregnancy|1
2350124|NCT04041700|4095022|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1
2350125|NCT04040933|4095026|FG000|Overall Study|Protocol Violation|1
2350126|NCT04040933|4095026|FG000|Overall Study|Withdrawal by Subject|2
2350127|NCT04029519|4095067|FG000|Overall Study|Protocol Violation|1
2350128|NCT04029519|4095067|FG000|Overall Study|Withdrawal by Subject|3
2350129|NCT04029519|4095067|FG000|Overall Study|Lost to Follow-up|1
2350130|NCT04024228|4095073|FG000|Overall Study|Adverse Event|1
2350131|NCT04024228|4095074|FG001|Overall Study|Adverse Event|0
2350132|NCT04024228|4095073|FG000|Overall Study|Protocol Deviation|0
2350133|NCT04024228|4095074|FG001|Overall Study|Protocol Deviation|2
2350134|NCT04024228|4095073|FG000|Overall Study|Withdrawal by Subject|3
2350135|NCT04024228|4095074|FG001|Overall Study|Withdrawal by Subject|4
2350136|NCT04039919|4095087|FG000|Treatment Period 1|Withdrawal by Subject|1
2350137|NCT04039919|4095088|FG001|Treatment Period 1|Withdrawal by Subject|0
2350138|NCT04039919|4095089|FG002|Treatment Period 1|Withdrawal by Subject|0
2350139|NCT04039919|4095090|FG003|Treatment Period 1|Withdrawal by Subject|0
2350140|NCT04039919|4095091|FG004|Treatment Period 1|Withdrawal by Subject|0
2350141|NCT04039919|4095087|FG000|Treatment Period 1|Sponsor's decision|0
2350142|NCT04039919|4095088|FG001|Treatment Period 1|Sponsor's decision|0
2350143|NCT04039919|4095089|FG002|Treatment Period 1|Sponsor's decision|0
2350144|NCT04039919|4095090|FG003|Treatment Period 1|Sponsor's decision|0
2350145|NCT04039919|4095091|FG004|Treatment Period 1|Sponsor's decision|16
2350146|NCT04039919|4095087|FG000|Treatment Period 5|Withdrawal by Subject|1
2350147|NCT04039919|4095088|FG001|Treatment Period 5|Withdrawal by Subject|0
2350148|NCT04039919|4095089|FG002|Treatment Period 5|Withdrawal by Subject|0
2350149|NCT04039919|4095090|FG003|Treatment Period 5|Withdrawal by Subject|0
2350150|NCT04039919|4095091|FG004|Treatment Period 5|Withdrawal by Subject|0
2350151|NCT04037748|4095140|FG000|Treatment Period 1|Withdrawal by Subject|3
2350152|NCT04037748|4095141|FG001|Treatment Period 1|Withdrawal by Subject|0
2350153|NCT04037748|4095140|FG000|Treatment Period 1|Adverse Event|1
2350154|NCT04037748|4095141|FG001|Treatment Period 1|Adverse Event|1
2350155|NCT04037748|4095140|FG000|Treatment Period 1|Protocol Violation|4
2270670|NCT02252146|3948877|FG000|Overall Study|Lack of Efficacy|4
2270671|NCT02252146|3948877|FG000|Overall Study|Entered hospice care|1
2270672|NCT02252146|3948877|FG000|Overall Study|Inability to travel to study site|1
2270673|NCT02252211|3948883|FG000|Overall Study|Adverse Event|0
2270674|NCT02252211|3948884|FG001|Overall Study|Adverse Event|1
2270675|NCT02252211|3948885|FG002|Overall Study|Adverse Event|0
2270676|NCT02252211|3948883|FG000|Overall Study|Progressive disease|3
2270677|NCT02252211|3948884|FG001|Overall Study|Progressive disease|2
2270678|NCT02252211|3948885|FG002|Overall Study|Progressive disease|0
2270679|NCT02252211|3948883|FG000|Overall Study|Withdrawal by Subject|1
2350156|NCT04037748|4095141|FG001|Treatment Period 1|Protocol Violation|5
2350157|NCT04037748|4095140|FG000|Treatment Period 2|Adverse Event|0
2350158|NCT04037748|4095141|FG001|Treatment Period 2|Adverse Event|1
2350159|NCT04037748|4095140|FG000|Treatment Period 2|Protocol Violation|2
2350160|NCT04037748|4095141|FG001|Treatment Period 2|Protocol Violation|0
2350161|NCT04027686|4095158|FG000|Overall Study|Lost to Follow-up|2
2350162|NCT04027686|4095159|FG001|Overall Study|Lost to Follow-up|0
2350163|NCT04027686|4095158|FG000|Overall Study|Withdrawal by Subject|0
2350164|NCT04027686|4095159|FG001|Overall Study|Withdrawal by Subject|1
2350165|NCT04036110|4095189|FG000|Overall Study|Lost to Follow-up|3
2350166|NCT04036110|4095190|FG001|Overall Study|Lost to Follow-up|2
2350167|NCT04036110|4095191|FG002|Overall Study|Lost to Follow-up|1
2350168|NCT04036110|4095189|FG000|Overall Study|Study Suspended|4
2350169|NCT04036110|4095190|FG001|Overall Study|Study Suspended|5
2350170|NCT04036110|4095191|FG002|Overall Study|Study Suspended|1
2350171|NCT04035577|4095208|FG000|Overall Study|Lost to Follow-up|1
2350172|NCT04035577|4095208|FG000|Overall Study|Withdrawal by Subject|1
2350173|NCT04035564|4095216|FG000|Overall Study|Protocol Violation|1
2350174|NCT04035564|4095217|FG001|Overall Study|Protocol Violation|2
2350175|NCT04035564|4095216|FG000|Overall Study|No laboratory available|2
2350176|NCT04035564|4095217|FG001|Overall Study|No laboratory available|2
2350177|NCT04035564|4095216|FG000|Overall Study|Guardian declined consent|1
2350178|NCT04035564|4095217|FG001|Overall Study|Guardian declined consent|2
2350179|NCT04032977|4095225|FG000|Overall Study|Withdrawal by Subject|6
2350180|NCT04032977|4095226|FG001|Overall Study|Withdrawal by Subject|1
2350181|NCT04032977|4095225|FG000|Overall Study|Lost to Follow-up|2
2350182|NCT04032977|4095226|FG001|Overall Study|Lost to Follow-up|7
2350183|NCT04032977|4095225|FG000|Overall Study|Pregnancy|1
2350184|NCT04032977|4095226|FG001|Overall Study|Pregnancy|0
2350185|NCT04032652|4095234|FG000|Overall Study|The study was terminated and the PI has|1
2350186|NCT04032652|4095235|FG001|Overall Study|The study was terminated and the PI has|1
2350187|NCT04032613|4095255|FG000|Overall Study|Did not complete post-program assessment|5
2350188|NCT04032613|4095256|FG001|Overall Study|Did not complete post-program assessment|2
2350189|NCT04032171|4095264|FG000|Overall Study|Study Termination|1
2350190|NCT04032171|4095265|FG001|Overall Study|Study Termination|0
2350191|NCT04032158|4095273|FG000|Overall Study|Study Termination|2
2350192|NCT04032158|4095274|FG001|Overall Study|Study Termination|1
2350193|NCT04031404|4095280|FG000|Baseline|Lost to Follow-up|0
2350194|NCT04031404|4095281|FG001|Baseline|Lost to Follow-up|1
2350195|NCT04031404|4095280|FG000|Baseline|Did not meet full inclusion/exclusion.|2
2350196|NCT04031404|4095281|FG001|Baseline|Did not meet full inclusion/exclusion.|4
2350197|NCT04031404|4095280|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1
2350198|NCT04031404|4095281|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3
2350199|NCT04031404|4095280|FG000|Pre-randomization|Disqualified by TMS safety screening|1
2350200|NCT04031404|4095281|FG001|Pre-randomization|Disqualified by TMS safety screening|0
2350201|NCT04031404|4095280|FG000|Washout (5 Day Min)|Lost to Follow-up|1
2350202|NCT04031404|4095281|FG001|Washout (5 Day Min)|Lost to Follow-up|0
2350203|NCT04029961|4095326|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1
2350204|NCT04029961|4095327|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0
2270680|NCT02252211|3948884|FG001|Overall Study|Withdrawal by Subject|0
2270681|NCT02252211|3948885|FG002|Overall Study|Withdrawal by Subject|0
2270682|NCT02252211|3948883|FG000|Overall Study|Serious Adverse Event During Screening|1
2270683|NCT02252211|3948884|FG001|Overall Study|Serious Adverse Event During Screening|0
2270684|NCT02252211|3948885|FG002|Overall Study|Serious Adverse Event During Screening|1
2270685|NCT02252406|3948903|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
2270686|NCT02252406|3948904|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
2270687|NCT02252406|3948903|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
2270688|NCT02252406|3948904|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
2270689|NCT02252406|3948903|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
2270690|NCT02252406|3948904|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
2270691|NCT02252406|3948903|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
2270692|NCT02252406|3948904|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
2270693|NCT02252406|3948903|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2
2270694|NCT02252406|3948904|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0
2270695|NCT02252536|3948921|FG000|Overall Study|Lost to Follow-up|5
2270696|NCT02252536|3948922|FG001|Overall Study|Lost to Follow-up|3
2350205|NCT04029961|4095326|FG000|Overall Study|Change in Treatment Course|0
2350206|NCT04029961|4095327|FG001|Overall Study|Change in Treatment Course|1
2350207|NCT04025684|4095337|FG000|Overall Study|Withdrawal by Subject|1
2270697|NCT02252588|3948940|FG000|Overall Study|Withdrawal by Subject|4
2270698|NCT02252588|3948941|FG001|Overall Study|Withdrawal by Subject|0
2270699|NCT02252939|3948959|FG000|Overall Study|Lost to Follow-up|3
2270700|NCT02252965|3948970|FG000|Overall Study|Adverse Event|9
2270701|NCT02252965|3948971|FG001|Overall Study|Adverse Event|14
2270702|NCT02252965|3948970|FG000|Overall Study|Lost to Follow-up|16
2270703|NCT02252965|3948971|FG001|Overall Study|Lost to Follow-up|8
2270704|NCT02252965|3948970|FG000|Overall Study|Protocol Violation|4
2270705|NCT02252965|3948971|FG001|Overall Study|Protocol Violation|5
2270706|NCT02252965|3948970|FG000|Overall Study|Lack of Efficacy|0
2270707|NCT02252965|3948971|FG001|Overall Study|Lack of Efficacy|2
2270708|NCT02252965|3948970|FG000|Overall Study|Withdrawal by Subject|7
2270709|NCT02252965|3948971|FG001|Overall Study|Withdrawal by Subject|9
2270710|NCT02252965|3948970|FG000|Overall Study|Other|4
2270711|NCT02252965|3948971|FG001|Overall Study|Other|5
2270712|NCT02253147|3948979|FG000|Overall Study|Protocol Violation|30
2270713|NCT02253147|3948979|FG000|Overall Study|Did not consent to study extension|9
2270714|NCT02253147|3948979|FG000|Overall Study|Conditional re-treatment at W52|5
2270715|NCT02253147|3948979|FG000|Overall Study|Lost to Follow-up|2
2270716|NCT02253147|3948979|FG000|Overall Study|Withdrawal by Subject|1
2270717|NCT02253433|3949023|FG000|Overall Study|Unable to Contact|9
2270718|NCT02253433|3949024|FG001|Overall Study|Unable to Contact|16
2270719|NCT02253433|3949023|FG000|Overall Study|Death|1
2270720|NCT02253433|3949024|FG001|Overall Study|Death|1
2270721|NCT02253433|3949023|FG000|Overall Study|No Longer Interested|3
2270722|NCT02253433|3949024|FG001|Overall Study|No Longer Interested|15
2270723|NCT02253433|3949023|FG000|Overall Study|Out of Study Area|2
2270724|NCT02253433|3949024|FG001|Overall Study|Out of Study Area|7
2270725|NCT02253433|3949023|FG000|Overall Study|Uncomfortable with home visitors|0
2270726|NCT02253433|3949024|FG001|Overall Study|Uncomfortable with home visitors|3
2270727|NCT02253433|3949023|FG000|Overall Study|Unstable Housing/Homeless|0
2270728|NCT02253433|3949024|FG001|Overall Study|Unstable Housing/Homeless|7
2270729|NCT02253433|3949023|FG000|Overall Study|Too Busy|0
2270730|NCT02253433|3949024|FG001|Overall Study|Too Busy|4
2270731|NCT02253433|3949023|FG000|Overall Study|Medical or Other Concerns|1
2270732|NCT02253433|3949024|FG001|Overall Study|Medical or Other Concerns|2
2270733|NCT02253654|3949037|FG000|Overall Study|Withdrawal by Subject|12
2270734|NCT02253654|3949038|FG001|Overall Study|Withdrawal by Subject|4
2270735|NCT02253654|3949037|FG000|Overall Study|Decision by Sponsor|1
2270736|NCT02253654|3949038|FG001|Overall Study|Decision by Sponsor|1
2270737|NCT02253654|3949037|FG000|Overall Study|Lost to Follow-up|2
2270738|NCT02253654|3949038|FG001|Overall Study|Lost to Follow-up|5
2270739|NCT02253654|3949037|FG000|Overall Study|Death|4
2270740|NCT02253654|3949038|FG001|Overall Study|Death|7
2270741|NCT02253654|3949037|FG000|Overall Study|Did Not Receive Study Treatment|4
2270742|NCT02253654|3949038|FG001|Overall Study|Did Not Receive Study Treatment|1
2270743|NCT02253992|3949047|FG000|Overall Study|Study drug toxicity|1
2270744|NCT02253992|3949048|FG001|Overall Study|Study drug toxicity|0
2270745|NCT02253992|3949049|FG002|Overall Study|Study drug toxicity|10
2270746|NCT02253992|3949047|FG000|Overall Study|Disease progression|4
2270747|NCT02253992|3949048|FG001|Overall Study|Disease progression|3
2270748|NCT02253992|3949049|FG002|Overall Study|Disease progression|98
2270749|NCT02253992|3949047|FG000|Overall Study|Withdrawal by Subject|0
2270750|NCT02253992|3949048|FG001|Overall Study|Withdrawal by Subject|0
2270751|NCT02253992|3949049|FG002|Overall Study|Withdrawal by Subject|3
2270752|NCT02253992|3949047|FG000|Overall Study|Adverse Event|0
2270753|NCT02253992|3949048|FG001|Overall Study|Adverse Event|0
2270754|NCT02253992|3949049|FG002|Overall Study|Adverse Event|8
2270755|NCT02253992|3949047|FG000|Overall Study|Death|0
2270756|NCT02253992|3949048|FG001|Overall Study|Death|0
2270757|NCT02253992|3949049|FG002|Overall Study|Death|1
2270758|NCT02253992|3949047|FG000|Overall Study|Subject discontinued study drug|1
2270759|NCT02253992|3949048|FG001|Overall Study|Subject discontinued study drug|0
2270760|NCT02253992|3949049|FG002|Overall Study|Subject discontinued study drug|1
2270761|NCT02253992|3949047|FG000|Overall Study|Completed treatment as per protocol|0
2270762|NCT02253992|3949048|FG001|Overall Study|Completed treatment as per protocol|1
2270763|NCT02253992|3949049|FG002|Overall Study|Completed treatment as per protocol|22
2270764|NCT02253992|3949047|FG000|Overall Study|Other|0
2270765|NCT02253992|3949048|FG001|Overall Study|Other|0
2270766|NCT02253992|3949049|FG002|Overall Study|Other|1
2270767|NCT02254278|3949095|FG000|Overall Study|Protocol Violation|1
2270768|NCT02254278|3949096|FG001|Overall Study|Protocol Violation|1
2270769|NCT02254291|3949108|FG000|Overall Study|Withdrawal by Subject|0
2270770|NCT02254291|3949109|FG001|Overall Study|Withdrawal by Subject|3
2270771|NCT02254291|3949110|FG002|Overall Study|Withdrawal by Subject|1
2270772|NCT02254291|3949108|FG000|Overall Study|Missing follow-up information|0
2270773|NCT02254291|3949109|FG001|Overall Study|Missing follow-up information|0
2270774|NCT02254291|3949110|FG002|Overall Study|Missing follow-up information|1
2270775|NCT02254304|3949120|FG000|Overall Study|Adverse Event|2
2270776|NCT02254304|3949121|FG001|Overall Study|Adverse Event|1
2270777|NCT02254304|3949120|FG000|Overall Study|Lost to Follow-up|2
2270778|NCT02254304|3949121|FG001|Overall Study|Lost to Follow-up|2
2270779|NCT02254304|3949120|FG000|Overall Study|Protocol Violation|1
2270780|NCT02254304|3949121|FG001|Overall Study|Protocol Violation|0
2270781|NCT02254304|3949120|FG000|Overall Study|Withdrawal by Subject|3
2270782|NCT02254304|3949121|FG001|Overall Study|Withdrawal by Subject|0
2270783|NCT02254304|3949120|FG000|Overall Study|Injection site pain and Injection fear|1
2270784|NCT02254304|3949121|FG001|Overall Study|Injection site pain and Injection fear|0
2270785|NCT02254304|3949120|FG000|Overall Study|Personal causes|4
2270786|NCT02254304|3949121|FG001|Overall Study|Personal causes|1
2270787|NCT02254304|3949120|FG000|Overall Study|Personal decision|1
2270788|NCT02254304|3949121|FG001|Overall Study|Personal decision|0
2270789|NCT02254408|3949131|FG000|Overall Study|Randomized But Not Treated|1
2270790|NCT02254408|3949132|FG001|Overall Study|Randomized But Not Treated|3
2270791|NCT02254408|3949131|FG000|Overall Study|Adverse Event|1
2270792|NCT02254408|3949132|FG001|Overall Study|Adverse Event|0
2270793|NCT02254408|3949131|FG000|Overall Study|Death|2
2270794|NCT02254408|3949132|FG001|Overall Study|Death|3
2270795|NCT02254408|3949131|FG000|Overall Study|Investigator's Discretion|0
2270796|NCT02254408|3949132|FG001|Overall Study|Investigator's Discretion|1
2270797|NCT02254408|3949131|FG000|Overall Study|Withdrawal by Subject|3
2270798|NCT02254408|3949132|FG001|Overall Study|Withdrawal by Subject|3
2270799|NCT02254408|3949131|FG000|Overall Study|Lost to Follow-up|1
2270800|NCT02254408|3949132|FG001|Overall Study|Lost to Follow-up|0
2270801|NCT02254421|3949140|FG000|Overall Study|Randomized but Not Treated|1
2270802|NCT02254421|3949141|FG001|Overall Study|Randomized but Not Treated|0
2270803|NCT02254421|3949140|FG000|Overall Study|Death|0
2270804|NCT02254421|3949141|FG001|Overall Study|Death|2
2270805|NCT02254421|3949140|FG000|Overall Study|Withdrew Consent|1
2270806|NCT02254421|3949141|FG001|Overall Study|Withdrew Consent|1
2270807|NCT02254460|3949147|FG000|Overall Study|Adverse Event|1
2270808|NCT02254460|3949148|FG001|Overall Study|Adverse Event|0
2270809|NCT02254486|3949165|FG000|Overall Study|Adverse Event|1
2270810|NCT02254486|3949166|FG001|Overall Study|Adverse Event|1
2270811|NCT02254486|3949165|FG000|Overall Study|Lack of Efficacy|1
2270812|NCT02254486|3949166|FG001|Overall Study|Lack of Efficacy|0
2270813|NCT02254486|3949165|FG000|Overall Study|Lost to Follow-up|2
2270814|NCT02254486|3949166|FG001|Overall Study|Lost to Follow-up|4
2270815|NCT02254486|3949165|FG000|Overall Study|Protocol Violation|1
2270816|NCT02254486|3949166|FG001|Overall Study|Protocol Violation|2
2270817|NCT02254486|3949165|FG000|Overall Study|Withdrawal by Subject|17
2270818|NCT02254486|3949166|FG001|Overall Study|Withdrawal by Subject|15
2270819|NCT02254486|3949165|FG000|Overall Study|GFR<60mL/min|16
2270820|NCT02254486|3949166|FG001|Overall Study|GFR<60mL/min|21
2270821|NCT02254486|3949165|FG000|Overall Study|Various|12
2270822|NCT02254486|3949166|FG001|Overall Study|Various|12
2270823|NCT02254551|3949172|FG000|Dose Escalation|Physician Decision|1
2270824|NCT02254551|3949172|FG000|Dose Escalation|Dose-limiting toxicity|2
2270825|NCT02254681|3949179|FG000|Overall Study|Lack of Efficacy|6
2270826|NCT02254772|3949184|FG000|Overall Study|Ineligible|1
2270827|NCT02254772|3949184|FG000|Overall Study|Withdrawal by Subject|1
2270828|NCT02255097|3949197|FG000|Overall Study|Adverse Event|24
2270829|NCT02255097|3949197|FG000|Overall Study|Clinical Progression|23
2270830|NCT02255097|3949197|FG000|Overall Study|Complete Response|1
2270831|NCT02255097|3949197|FG000|Overall Study|Excluded Medication|1
2270832|NCT02255097|3949197|FG000|Overall Study|Death|2
2270833|NCT02255097|3949197|FG000|Overall Study|Lost to Follow-up|1
2270834|NCT02255097|3949197|FG000|Overall Study|Physician Decision|1
2270835|NCT02255097|3949197|FG000|Overall Study|Progressive Disease|80
2270836|NCT02255097|3949197|FG000|Overall Study|Withdrawal by Subject|2
2270837|NCT02255097|3949197|FG000|Overall Study|Allocated but not treated|1
2270838|NCT02255097|3949197|FG000|Overall Study|Treatment Ongoing|36
2270839|NCT02255149|3949205|FG000|Overall Study|Lost to Follow-up|2
2270840|NCT02255149|3949205|FG000|Overall Study|Withdrawal by Subject|1
2270841|NCT02255149|3949205|FG000|Overall Study|Withdrawal by PI|1
2270842|NCT02255149|3949205|FG000|Overall Study|Implant Failure|1
2270843|NCT02255279|3949224|FG000|Overall Study|Lost to Follow-up|2
2270844|NCT02255279|3949225|FG001|Overall Study|Lost to Follow-up|2
2270845|NCT02255279|3949224|FG000|Overall Study|Protocol Violation|0
2270846|NCT02255279|3949225|FG001|Overall Study|Protocol Violation|1
2270847|NCT02255279|3949224|FG000|Overall Study|Withdrawal by Subject|3
2270848|NCT02255279|3949225|FG001|Overall Study|Withdrawal by Subject|6
2270849|NCT02255422|3949261|FG000|Overall Study|Withdrawal by Subject|0
2270850|NCT02255422|3949262|FG001|Overall Study|Withdrawal by Subject|0
2270851|NCT02255422|3949263|FG002|Overall Study|Withdrawal by Subject|0
2270852|NCT02255422|3949264|FG003|Overall Study|Withdrawal by Subject|0
2270853|NCT02255422|3949265|FG004|Overall Study|Withdrawal by Subject|0
2270854|NCT02255422|3949266|FG005|Overall Study|Withdrawal by Subject|0
2270855|NCT02255422|3949267|FG006|Overall Study|Withdrawal by Subject|2
2270856|NCT02255422|3949261|FG000|Overall Study|Lost to Follow-up|0
2270857|NCT02255422|3949262|FG001|Overall Study|Lost to Follow-up|0
2270858|NCT02255422|3949263|FG002|Overall Study|Lost to Follow-up|1
2270859|NCT02255422|3949264|FG003|Overall Study|Lost to Follow-up|0
2270860|NCT02255422|3949265|FG004|Overall Study|Lost to Follow-up|0
2270861|NCT02255422|3949266|FG005|Overall Study|Lost to Follow-up|0
2350208|NCT04025684|4095338|FG001|Overall Study|Withdrawal by Subject|1
2350209|NCT04025684|4095339|FG002|Overall Study|Withdrawal by Subject|0
2350210|NCT04025684|4095340|FG003|Overall Study|Withdrawal by Subject|0
2350211|NCT04025684|4095337|FG000|Overall Study|Multiple reasons|1
2270862|NCT02255422|3949267|FG006|Overall Study|Lost to Follow-up|0
2350212|NCT04025684|4095338|FG001|Overall Study|Multiple reasons|3
2270863|NCT02255461|3949288|FG000|Overall Study|Adverse Event|0
2270864|NCT02255461|3949289|FG001|Overall Study|Adverse Event|1
2270865|NCT02255461|3949290|FG002|Overall Study|Adverse Event|0
2270866|NCT02255461|3949291|FG003|Overall Study|Adverse Event|0
2270867|NCT02255461|3949292|FG004|Overall Study|Adverse Event|1
2270868|NCT02255461|3949288|FG000|Overall Study|Withdrawal by Subject|0
2270869|NCT02255461|3949289|FG001|Overall Study|Withdrawal by Subject|0
2270870|NCT02255461|3949290|FG002|Overall Study|Withdrawal by Subject|1
2270871|NCT02255461|3949291|FG003|Overall Study|Withdrawal by Subject|0
2270872|NCT02255461|3949292|FG004|Overall Study|Withdrawal by Subject|1
2270873|NCT02255461|3949288|FG000|Overall Study|Not meet dose reduction BSA requirement|0
2270874|NCT02255461|3949289|FG001|Overall Study|Not meet dose reduction BSA requirement|1
2270875|NCT02255461|3949290|FG002|Overall Study|Not meet dose reduction BSA requirement|0
2270876|NCT02255461|3949291|FG003|Overall Study|Not meet dose reduction BSA requirement|0
2270877|NCT02255461|3949292|FG004|Overall Study|Not meet dose reduction BSA requirement|0
2270878|NCT02255474|3949312|FG000|Overall Study|Lost to Follow-up|1
2270879|NCT02255474|3949313|FG001|Overall Study|Lost to Follow-up|1
2270880|NCT02255474|3949314|FG002|Overall Study|Lost to Follow-up|3
2270881|NCT02255474|3949312|FG000|Overall Study|Withdrawal by Subject|1
2270882|NCT02255474|3949313|FG001|Overall Study|Withdrawal by Subject|1
2270883|NCT02255474|3949314|FG002|Overall Study|Withdrawal by Subject|0
2270884|NCT02255500|3949325|FG000|Overall Study|Withdrawal by Subject|1
2270885|NCT02255500|3949326|FG001|Overall Study|Withdrawal by Subject|0
2270886|NCT02255552|3949343|FG000|Overall Study|Participants enrolled into another study|0
2270887|NCT02255552|3949344|FG001|Overall Study|Participants enrolled into another study|11
2270888|NCT02255552|3949343|FG000|Overall Study|Withdrawal by Subject|1
2270889|NCT02255552|3949344|FG001|Overall Study|Withdrawal by Subject|4
2270890|NCT02255565|3949353|FG000|Overall Study|Withdrawal by Subject|0
2270891|NCT02255565|3949354|FG001|Overall Study|Withdrawal by Subject|1
2270892|NCT02255565|3949355|FG002|Overall Study|Withdrawal by Subject|0
2350213|NCT04025684|4095339|FG002|Overall Study|Multiple reasons|0
2350214|NCT04025684|4095340|FG003|Overall Study|Multiple reasons|1
2350215|NCT04019054|4095352|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0
2350216|NCT04019054|4095353|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1
2350217|NCT04019054|4095352|FG000|Overall Study|Withdrawal by Subject|3
2350218|NCT04019054|4095353|FG001|Overall Study|Withdrawal by Subject|1
2270893|NCT02255656|3949409|FG000|Overall Study|Adverse Event|11
2270894|NCT02255656|3949409|FG000|Overall Study|Poor compliance to protocol|3
2270895|NCT02255656|3949409|FG000|Overall Study|Lost to Follow-up|30
2270896|NCT02255656|3949409|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300
2270897|NCT02255656|3949409|FG000|Overall Study|Other|126
2270898|NCT02255760|3949425|FG000|Overall Study|Lost to Follow-up|0
2270899|NCT02255760|3949426|FG001|Overall Study|Lost to Follow-up|1
2270900|NCT02255760|3949427|FG002|Overall Study|Lost to Follow-up|0
2270901|NCT02255760|3949428|FG003|Overall Study|Lost to Follow-up|0
2270902|NCT02255760|3949429|FG004|Overall Study|Lost to Follow-up|0
2270903|NCT02255981|3949445|FG000|Overall Study|Lost to Follow-up|3
2270904|NCT02255981|3949445|FG000|Overall Study|Withdrawal by Subject|1
2270905|NCT02256267|3949486|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
2270906|NCT02256267|3949486|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1
2270907|NCT02256384|3949511|FG000|Overall Study|Withdrawal by Subject|12
2270908|NCT02256384|3949511|FG000|Overall Study|Equipment not capturing data|2
2270909|NCT02256436|3949521|FG000|Overall Study|Adverse Event|9
2270910|NCT02256436|3949522|FG001|Overall Study|Adverse Event|14
2270911|NCT02256436|3949521|FG000|Overall Study|Death|216
2270912|NCT02256436|3949522|FG001|Overall Study|Death|208
2270913|NCT02256436|3949521|FG000|Overall Study|Lost to Follow-up|1
2270914|NCT02256436|3949522|FG001|Overall Study|Lost to Follow-up|2
2270915|NCT02256436|3949521|FG000|Overall Study|Physician Decision|1
2270916|NCT02256436|3949522|FG001|Overall Study|Physician Decision|0
2270917|NCT02256436|3949521|FG000|Overall Study|Protocol Violation|0
2270918|NCT02256436|3949522|FG001|Overall Study|Protocol Violation|1
2270919|NCT02256436|3949521|FG000|Overall Study|Withdrawal by Subject|26
2270920|NCT02256436|3949522|FG001|Overall Study|Withdrawal by Subject|10
2270921|NCT02256436|3949521|FG000|Overall Study|Transferred to Extension Study|11
2270922|NCT02256436|3949522|FG001|Overall Study|Transferred to Extension Study|23
2270923|NCT02256436|3949521|FG000|Overall Study|Did Not Continue on Extension Study|8
2270924|NCT02256436|3949522|FG001|Overall Study|Did Not Continue on Extension Study|12
2270925|NCT02256488|3949533|FG000|Overall Study|Lost to Follow-up|6
2270926|NCT02256488|3949534|FG001|Overall Study|Lost to Follow-up|6
2270927|NCT02256488|3949535|FG002|Overall Study|Lost to Follow-up|9
2270928|NCT02256488|3949536|FG003|Overall Study|Lost to Follow-up|3
2270929|NCT02256488|3949533|FG000|Overall Study|OTHER|1
2270930|NCT02256488|3949534|FG001|Overall Study|OTHER|0
2270931|NCT02256488|3949535|FG002|Overall Study|OTHER|1
2270932|NCT02256488|3949536|FG003|Overall Study|OTHER|1
2270933|NCT02256488|3949533|FG000|Overall Study|Withdrawal by Subject|1
2270934|NCT02256488|3949534|FG001|Overall Study|Withdrawal by Subject|0
2270935|NCT02256488|3949535|FG002|Overall Study|Withdrawal by Subject|0
2270936|NCT02256488|3949536|FG003|Overall Study|Withdrawal by Subject|2
2270937|NCT02256540|3949547|FG000|Overall Study|Withdrawal by Subject|0
2270938|NCT02256540|3949548|FG001|Overall Study|Withdrawal by Subject|1
2270939|NCT02256540|3949549|FG002|Overall Study|Withdrawal by Subject|1
2270940|NCT02256540|3949547|FG000|Overall Study|Back pain preventing exercise|0
2270941|NCT02256540|3949548|FG001|Overall Study|Back pain preventing exercise|0
2270942|NCT02256540|3949549|FG002|Overall Study|Back pain preventing exercise|1
2270943|NCT02256553|3949557|FG000|Period I|Adverse Event|5
2270944|NCT02256553|3949557|FG000|Period I|Protocol Violation|1
2270945|NCT02256553|3949557|FG000|Period II|Adverse Event|1
2270946|NCT02256553|3949557|FG000|Period II|Subject Moved|1
2270947|NCT02256553|3949557|FG000|Period III|Adverse Event|3
2270948|NCT02256839|3949565|FG000|Overall Study|Did not meet Eligibility Criteria|2
2270949|NCT02256839|3949566|FG001|Overall Study|Did not meet Eligibility Criteria|3
2270950|NCT02256891|3949574|FG000|Overall Study|Death|0
2270951|NCT02256891|3949575|FG001|Overall Study|Death|2
2270952|NCT02256891|3949574|FG000|Overall Study|Lost to Follow-up|0
2270953|NCT02256891|3949575|FG001|Overall Study|Lost to Follow-up|3
2270954|NCT02256891|3949574|FG000|Overall Study|Physician Decision|7
2270955|NCT02256891|3949575|FG001|Overall Study|Physician Decision|3
2270956|NCT02256891|3949574|FG000|Overall Study|Screen Fail|5
2270957|NCT02256891|3949575|FG001|Overall Study|Screen Fail|4
2270958|NCT02256891|3949574|FG000|Overall Study|Equipment Malfunction|0
2270959|NCT02256891|3949575|FG001|Overall Study|Equipment Malfunction|1
2270960|NCT02256917|3949583|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1
2270961|NCT02256917|3949583|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1
2270962|NCT02256917|3949583|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1
2270963|NCT02256917|3949583|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1
2270964|NCT02256917|3949583|FG000|Prophylactic Treatment Phase II|Discontinued medication|1
2270965|NCT02256969|3949597|FG000|Overall Study|Screenfailed or withdrew|2
2270966|NCT02256969|3949598|FG001|Overall Study|Screenfailed or withdrew|1
2270967|NCT02256969|3949599|FG002|Overall Study|Screenfailed or withdrew|1
2270968|NCT02256982|3949609|FG000|Overall Study|Disease Progression|0
2270969|NCT02256982|3949610|FG001|Overall Study|Disease Progression|1
2270970|NCT02257372|3949669|FG000|Overall Study|Adverse Event|3
2270971|NCT02257372|3949670|FG001|Overall Study|Adverse Event|7
2270972|NCT02257372|3949669|FG000|Overall Study|Lack of Efficacy|2
2270973|NCT02257372|3949670|FG001|Overall Study|Lack of Efficacy|1
2270974|NCT02257372|3949669|FG000|Overall Study|Protocol Violation|1
2270975|NCT02257372|3949670|FG001|Overall Study|Protocol Violation|1
2270976|NCT02257372|3949669|FG000|Overall Study|Lost to Follow-up|0
2270977|NCT02257372|3949670|FG001|Overall Study|Lost to Follow-up|1
2270978|NCT02257372|3949669|FG000|Overall Study|Withdrew consent|1
2270979|NCT02257372|3949670|FG001|Overall Study|Withdrew consent|0
2270980|NCT02257385|3949678|FG000|Overall Study|Adverse Event|12
2270981|NCT02257385|3949679|FG001|Overall Study|Adverse Event|8
2270982|NCT02257385|3949678|FG000|Overall Study|Lack of Efficacy|1
2270983|NCT02257385|3949679|FG001|Overall Study|Lack of Efficacy|2
2270984|NCT02257385|3949678|FG000|Overall Study|Protocol Violation|5
2270985|NCT02257385|3949679|FG001|Overall Study|Protocol Violation|7
2270986|NCT02257385|3949678|FG000|Overall Study|Lost to Follow-up|0
2270987|NCT02257385|3949679|FG001|Overall Study|Lost to Follow-up|1
2270988|NCT02257385|3949678|FG000|Overall Study|Withdrawal by Subject|4
2270989|NCT02257385|3949679|FG001|Overall Study|Withdrawal by Subject|4
2270990|NCT02257489|3949694|FG000|Overall Study|Withdrawal by Subject|0
2350219|NCT04016311|4095486|FG000|Overall Study|Withdrawal by Subject|1
2270991|NCT02257489|3949695|FG001|Overall Study|Withdrawal by Subject|0
2270992|NCT02257489|3949696|FG002|Overall Study|Withdrawal by Subject|0
2270993|NCT02257489|3949697|FG003|Overall Study|Withdrawal by Subject|1
2270994|NCT02257489|3949698|FG004|Overall Study|Withdrawal by Subject|0
2270995|NCT02257489|3949699|FG005|Overall Study|Withdrawal by Subject|0
2270996|NCT02257489|3949700|FG006|Overall Study|Withdrawal by Subject|0
2270997|NCT02257489|3949701|FG007|Overall Study|Withdrawal by Subject|0
2270998|NCT02257489|3949702|FG008|Overall Study|Withdrawal by Subject|0
2270999|NCT02257632|3949744|FG000|Overall Study|Withdrawal by Subject|0
2271000|NCT02257632|3949745|FG001|Overall Study|Withdrawal by Subject|1
2271001|NCT02257632|3949744|FG000|Overall Study|Adverse Event|1
2271002|NCT02257632|3949745|FG001|Overall Study|Adverse Event|2
2271003|NCT02257684|3949753|FG000|Overall Study|Adverse Event|2
2271004|NCT02257684|3949753|FG000|Overall Study|Lack of Efficacy|1
2271005|NCT02257684|3949753|FG000|Overall Study|Sponsor's Decision|1
2271006|NCT02258074|3949796|FG000|Overall Study|Withdrawal by Subject|1
2271007|NCT02258074|3949797|FG001|Overall Study|Withdrawal by Subject|0
2271008|NCT02258074|3949798|FG002|Overall Study|Withdrawal by Subject|0
2271009|NCT02258074|3949799|FG003|Overall Study|Withdrawal by Subject|0
2271010|NCT02258334|3949836|FG000|Overall Study|Adverse Event|1
2271011|NCT02258334|3949837|FG001|Overall Study|Adverse Event|0
2271012|NCT02258334|3949838|FG002|Overall Study|Adverse Event|0
2271013|NCT02258334|3949839|FG003|Overall Study|Adverse Event|0
2271014|NCT02258464|3949874|FG000|Overall Study|Progressive disease (PD)|9
2271015|NCT02258464|3949875|FG001|Overall Study|Progressive disease (PD)|17
2271016|NCT02258464|3949874|FG000|Overall Study|Study drug never administered|1
2271017|NCT02258464|3949875|FG001|Overall Study|Study drug never administered|1
2271018|NCT02258464|3949874|FG000|Overall Study|AE not related to clinical PD|1
2271019|NCT02258464|3949875|FG001|Overall Study|AE not related to clinical PD|3
2271020|NCT02258464|3949874|FG000|Overall Study|Withdrawal by Subject|5
2271021|NCT02258464|3949875|FG001|Overall Study|Withdrawal by Subject|4
2271022|NCT02258464|3949874|FG000|Overall Study|AE related to clinical PD|1
2271023|NCT02258464|3949875|FG001|Overall Study|AE related to clinical PD|0
2271024|NCT02258529|3949893|FG000|Overall Study|Study Terminated by Sponsor|9
2271025|NCT02258529|3949893|FG000|Overall Study|Adverse Event|1
2271026|NCT02259010|3949897|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5
2271027|NCT02259088|3949905|FG000|Overall Study|Adverse Event|6
2271028|NCT02259088|3949906|FG001|Overall Study|Adverse Event|4
2271029|NCT02259088|3949905|FG000|Overall Study|Lost to Follow-up|2
2271030|NCT02259088|3949906|FG001|Overall Study|Lost to Follow-up|0
2271031|NCT02259088|3949905|FG000|Overall Study|Death|2
2271032|NCT02259088|3949906|FG001|Overall Study|Death|0
2271033|NCT02259088|3949905|FG000|Overall Study|Physician Decision|5
2271034|NCT02259088|3949906|FG001|Overall Study|Physician Decision|2
2271035|NCT02259088|3949905|FG000|Overall Study|Protocol deviation|5
2271036|NCT02259088|3949906|FG001|Overall Study|Protocol deviation|0
2271037|NCT02259088|3949905|FG000|Overall Study|Subject/guardian decision|8
2350220|NCT04016311|4095487|FG001|Overall Study|Withdrawal by Subject|0
2350221|NCT04023682|4095580|FG000|Overall Study|Clinical schedules did not allow continued participation|6
2350222|NCT04023994|4095627|FG000|Overall Study|Lost to Follow-up|0
2350223|NCT04023994|4095628|FG001|Overall Study|Lost to Follow-up|1
2350224|NCT04023994|4095629|FG002|Overall Study|Lost to Follow-up|2
2350225|NCT04023994|4095630|FG003|Overall Study|Lost to Follow-up|0
2350226|NCT04023994|4095631|FG004|Overall Study|Lost to Follow-up|0
2350227|NCT04023994|4095632|FG005|Overall Study|Lost to Follow-up|0
2350228|NCT04023994|4095627|FG000|Overall Study|Withdrawal by Subject|0
2350229|NCT04023994|4095628|FG001|Overall Study|Withdrawal by Subject|0
2350230|NCT04023994|4095629|FG002|Overall Study|Withdrawal by Subject|0
2350231|NCT04023994|4095630|FG003|Overall Study|Withdrawal by Subject|1
2350232|NCT04023994|4095631|FG004|Overall Study|Withdrawal by Subject|0
2350233|NCT04023994|4095632|FG005|Overall Study|Withdrawal by Subject|0
2350234|NCT04017611|4095675|FG000|Overall Study|Withdrawn prior to completion|1
2350235|NCT04015232|4095681|FG000|Overall Study|Withdrawal by Subject|7
2350236|NCT04015232|4095682|FG001|Overall Study|Withdrawal by Subject|4
2350237|NCT04015232|4095681|FG000|Overall Study|Protocol Violation|1
2350238|NCT04015232|4095682|FG001|Overall Study|Protocol Violation|0
2350239|NCT04015232|4095681|FG000|Overall Study|Medical Grounds|3
2350240|NCT04015232|4095682|FG001|Overall Study|Medical Grounds|3
2350241|NCT04014062|4095722|FG000|Period I: Dosing|Medical Grounds|4
2350242|NCT04014062|4095723|FG001|Period I: Dosing|Medical Grounds|5
2350243|NCT04014062|4095722|FG000|Period I: Dosing|Withdrawal by Subject|3
2350244|NCT04014062|4095723|FG001|Period I: Dosing|Withdrawal by Subject|1
2350245|NCT04013191|4095760|FG000|Overall Study|Adverse Event|1
2350246|NCT04013191|4095761|FG001|Overall Study|Adverse Event|0
2350247|NCT04011735|4095778|FG000|Overall Study|Withdrawal by Subject|1
2350248|NCT04011735|4095779|FG001|Overall Study|Withdrawal by Subject|0
2350249|NCT04011735|4095780|FG002|Overall Study|Withdrawal by Subject|1
2350250|NCT04011735|4095778|FG000|Overall Study|Met exclusion criteria after study entry|0
2350251|NCT04011735|4095779|FG001|Overall Study|Met exclusion criteria after study entry|1
2350252|NCT04011735|4095780|FG002|Overall Study|Met exclusion criteria after study entry|0
2350253|NCT04009577|4095799|FG000|Core Study|Adverse Event|1
2350254|NCT04009577|4095800|FG001|Core Study|Adverse Event|0
2350255|NCT04009577|4095801|FG002|Core Study|Adverse Event|2
2350256|NCT04009577|4095802|FG003|Core Study|Adverse Event|4
2350257|NCT04009577|4095799|FG000|Core Study|Withdrawal by Subject|0
2350258|NCT04009577|4095800|FG001|Core Study|Withdrawal by Subject|0
2350259|NCT04009577|4095801|FG002|Core Study|Withdrawal by Subject|2
2350260|NCT04009577|4095802|FG003|Core Study|Withdrawal by Subject|0
2271038|NCT02259088|3949906|FG001|Overall Study|Subject/guardian decision|8
2271039|NCT02259114|3949917|FG000|Overall Study|Progressive Disease|14
2271040|NCT02259114|3949918|FG001|Overall Study|Progressive Disease|2
2271041|NCT02259114|3949919|FG002|Overall Study|Progressive Disease|10
2271042|NCT02259114|3949920|FG003|Overall Study|Progressive Disease|2
2271043|NCT02259114|3949921|FG004|Overall Study|Progressive Disease|5
2271044|NCT02259114|3949917|FG000|Overall Study|Adverse Event|2
2271045|NCT02259114|3949918|FG001|Overall Study|Adverse Event|1
2271046|NCT02259114|3949919|FG002|Overall Study|Adverse Event|0
2271047|NCT02259114|3949920|FG003|Overall Study|Adverse Event|0
2271048|NCT02259114|3949921|FG004|Overall Study|Adverse Event|1
2271049|NCT02259114|3949917|FG000|Overall Study|Death|3
2271050|NCT02259114|3949918|FG001|Overall Study|Death|0
2271051|NCT02259114|3949919|FG002|Overall Study|Death|1
2271052|NCT02259114|3949920|FG003|Overall Study|Death|0
2271053|NCT02259114|3949921|FG004|Overall Study|Death|0
2271054|NCT02259114|3949917|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2271055|NCT02259114|3949918|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2271056|NCT02259114|3949919|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1
2271057|NCT02259114|3949920|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2271058|NCT02259114|3949921|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2271059|NCT02259114|3949917|FG000|Overall Study|Withdrawal by Subject|0
2271060|NCT02259114|3949918|FG001|Overall Study|Withdrawal by Subject|0
2271061|NCT02259114|3949919|FG002|Overall Study|Withdrawal by Subject|1
2271062|NCT02259114|3949920|FG003|Overall Study|Withdrawal by Subject|1
2271063|NCT02259114|3949921|FG004|Overall Study|Withdrawal by Subject|0
2271064|NCT02259114|3949917|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1
2271065|NCT02259114|3949918|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1
2271066|NCT02259114|3949919|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0
2271067|NCT02259114|3949920|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0
2271068|NCT02259114|3949921|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0
2271069|NCT02259114|3949917|FG000|Overall Study|Not Treated|1
2271070|NCT02259114|3949918|FG001|Overall Study|Not Treated|0
2271071|NCT02259114|3949919|FG002|Overall Study|Not Treated|0
2271072|NCT02259114|3949920|FG003|Overall Study|Not Treated|0
2271073|NCT02259114|3949921|FG004|Overall Study|Not Treated|0
2271074|NCT02259231|3949940|FG000|Overall Study|Adverse Event|1
2271075|NCT02259231|3949941|FG001|Overall Study|Adverse Event|1
2271076|NCT02259231|3949942|FG002|Overall Study|Adverse Event|2
2271077|NCT02259231|3949943|FG003|Overall Study|Adverse Event|0
2271078|NCT02259231|3949944|FG004|Overall Study|Adverse Event|0
2271079|NCT02259231|3949945|FG005|Overall Study|Adverse Event|0
2271080|NCT02259231|3949946|FG006|Overall Study|Adverse Event|0
2271081|NCT02259231|3949940|FG000|Overall Study|Progressive Disease|4
2271082|NCT02259231|3949941|FG001|Overall Study|Progressive Disease|5
2271083|NCT02259231|3949942|FG002|Overall Study|Progressive Disease|4
2271084|NCT02259231|3949943|FG003|Overall Study|Progressive Disease|5
2271085|NCT02259231|3949944|FG004|Overall Study|Progressive Disease|4
2271086|NCT02259231|3949945|FG005|Overall Study|Progressive Disease|5
2271087|NCT02259231|3949946|FG006|Overall Study|Progressive Disease|4
2271088|NCT02259231|3949940|FG000|Overall Study|Sponsor termination of study|1
2271089|NCT02259231|3949941|FG001|Overall Study|Sponsor termination of study|0
2271090|NCT02259231|3949942|FG002|Overall Study|Sponsor termination of study|0
2271091|NCT02259231|3949943|FG003|Overall Study|Sponsor termination of study|1
2271092|NCT02259231|3949944|FG004|Overall Study|Sponsor termination of study|2
2271093|NCT02259231|3949945|FG005|Overall Study|Sponsor termination of study|1
2271094|NCT02259231|3949946|FG006|Overall Study|Sponsor termination of study|1
2271095|NCT02259348|3949962|FG000|Overall Study|Donors|6
2271096|NCT02259348|3949962|FG000|Overall Study|Death|4
2271097|NCT02259400|3949968|FG000|Overall Study|Death|0
2271098|NCT02259400|3949969|FG001|Overall Study|Death|2
2271099|NCT02259582|3949978|FG000|Overall Study|Physician Decision|0
2271100|NCT02259582|3949979|FG001|Overall Study|Physician Decision|1
2271101|NCT02259582|3949980|FG002|Overall Study|Physician Decision|0
2271102|NCT02259582|3949978|FG000|Overall Study|Death|0
2271103|NCT02259582|3949979|FG001|Overall Study|Death|0
2271104|NCT02259582|3949980|FG002|Overall Study|Death|1
2271105|NCT02259582|3949978|FG000|Overall Study|Adverse Event|1
2271106|NCT02259582|3949979|FG001|Overall Study|Adverse Event|0
2271107|NCT02259582|3949980|FG002|Overall Study|Adverse Event|1
2271108|NCT02259582|3949978|FG000|Overall Study|Withdrawal by Subject|0
2271109|NCT02259582|3949979|FG001|Overall Study|Withdrawal by Subject|0
2271110|NCT02259582|3949980|FG002|Overall Study|Withdrawal by Subject|1
2271111|NCT02259582|3949978|FG000|Overall Study|Disease progression|14
2271112|NCT02259582|3949979|FG001|Overall Study|Disease progression|15
2271113|NCT02259582|3949980|FG002|Overall Study|Disease progression|17
2271114|NCT02259582|3949978|FG000|Overall Study|Lack of Subject Adherence to Protocol|1
2271115|NCT02259582|3949979|FG001|Overall Study|Lack of Subject Adherence to Protocol|1
2271116|NCT02259582|3949980|FG002|Overall Study|Lack of Subject Adherence to Protocol|1
2271117|NCT02260154|3950001|FG000|Overall Study|Screening failure|2
2271118|NCT02260180|3950009|FG000|Overall Study|Adverse Event|2
2271119|NCT02260180|3950010|FG001|Overall Study|Adverse Event|0
2271120|NCT02260180|3950011|FG002|Overall Study|Adverse Event|1
2350261|NCT04009577|4095799|FG000|Core Study|Other|0
2350262|NCT04009577|4095800|FG001|Core Study|Other|0
2271121|NCT02260258|3950021|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2
2271122|NCT02260258|3950022|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1
2271123|NCT02260388|3950033|FG000|Overall Study|Lost to Follow-up|2
2271124|NCT02260388|3950034|FG001|Overall Study|Lost to Follow-up|8
2271125|NCT02260388|3950035|FG002|Overall Study|Lost to Follow-up|3
2271126|NCT02260388|3950036|FG003|Overall Study|Lost to Follow-up|4
2271127|NCT02260492|3950062|FG000|Overall Study|Adverse Event|6
2271128|NCT02260492|3950063|FG001|Overall Study|Adverse Event|1
2271129|NCT02260492|3950064|FG002|Overall Study|Adverse Event|2
2271130|NCT02260492|3950062|FG000|Overall Study|Death|0
2271131|NCT02260492|3950063|FG001|Overall Study|Death|1
2271132|NCT02260492|3950064|FG002|Overall Study|Death|0
2350263|NCT04009577|4095801|FG002|Core Study|Other|0
2350264|NCT04009577|4095802|FG003|Core Study|Other|1
2350265|NCT04009577|4095799|FG000|Extension Phase|Adverse Event|0
2350266|NCT04009577|4095800|FG001|Extension Phase|Adverse Event|0
2350267|NCT04009577|4095801|FG002|Extension Phase|Adverse Event|0
2350268|NCT04009577|4095802|FG003|Extension Phase|Adverse Event|1
2350269|NCT04009577|4095799|FG000|Extension Phase|Inadequate therapeutic effect|0
2350270|NCT04009577|4095800|FG001|Extension Phase|Inadequate therapeutic effect|0
2350271|NCT04009577|4095801|FG002|Extension Phase|Inadequate therapeutic effect|1
2350272|NCT04009577|4095802|FG003|Extension Phase|Inadequate therapeutic effect|0
2350273|NCT04009577|4095799|FG000|Extension Phase|Withdrawal by Subject|0
2350274|NCT04009577|4095800|FG001|Extension Phase|Withdrawal by Subject|0
2350275|NCT04009577|4095801|FG002|Extension Phase|Withdrawal by Subject|1
2350276|NCT04009577|4095802|FG003|Extension Phase|Withdrawal by Subject|0
2350277|NCT04009577|4095799|FG000|Extension Phase|Not Treated|0
2350278|NCT04009577|4095800|FG001|Extension Phase|Not Treated|0
2350279|NCT04009577|4095801|FG002|Extension Phase|Not Treated|2
2350280|NCT04009577|4095802|FG003|Extension Phase|Not Treated|0
2350281|NCT04007159|4095828|FG000|Induction Phase|(missed study visits)|16
2350282|NCT04007159|4095828|FG000|Induction Phase|Withdrawal by Subject|4
2350283|NCT04007159|4095828|FG000|Induction Phase|Adverse Event|2
2350284|NCT04007159|4095828|FG000|Challenge Phase|missed study visits|3
2350285|NCT04007107|4095839|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
2350286|NCT04007107|4095840|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1
2350287|NCT04007107|4095841|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
2350288|NCT04007107|4095842|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
2350289|NCT04005885|4095858|FG000|First Intervention|Withdrawal by Subject|1
2350290|NCT04005885|4095859|FG001|First Intervention|Withdrawal by Subject|1
2350291|NCT04005885|4095858|FG000|Second Intervention|Withdrawal by Subject|0
2350292|NCT04005885|4095859|FG001|Second Intervention|Withdrawal by Subject|2
2350293|NCT04000815|4095873|FG000|Overall Study|Lost to Follow-up|9
2350294|NCT04000815|4095874|FG001|Overall Study|Lost to Follow-up|2
2350295|NCT04000815|4095875|FG002|Overall Study|Lost to Follow-up|3
2350296|NCT04000815|4095873|FG000|Overall Study|Withdrawal by Subject|4
2350297|NCT04000815|4095874|FG001|Overall Study|Withdrawal by Subject|3
2350298|NCT04000815|4095875|FG002|Overall Study|Withdrawal by Subject|2
2350299|NCT04000815|4095873|FG000|Overall Study|Right ovarian cyst occured|1
2350300|NCT04000815|4095874|FG001|Overall Study|Right ovarian cyst occured|0
2350301|NCT04000815|4095875|FG002|Overall Study|Right ovarian cyst occured|0
2350302|NCT04000815|4095873|FG000|Overall Study|Hypertension occured on follow up|0
2350303|NCT04000815|4095874|FG001|Overall Study|Hypertension occured on follow up|0
2350304|NCT04000815|4095875|FG002|Overall Study|Hypertension occured on follow up|2
2350305|NCT04006366|4095900|FG000|Overall Study|Withdrawal by Subject|1
2350306|NCT04006145|4095906|FG000|Overall Study|Lost to Follow-up|0
2350307|NCT04006145|4095907|FG001|Overall Study|Lost to Follow-up|1
2350308|NCT04006145|4095906|FG000|Overall Study|Other|1
2350309|NCT04006145|4095907|FG001|Overall Study|Other|2
2350310|NCT04005755|4095913|FG000|Overall Study|Adverse Event|6
2350311|NCT04005755|4095913|FG000|Overall Study|Physician Decision|3
2350312|NCT04005755|4095913|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4
2350313|NCT04005755|4095913|FG000|Overall Study|Withdrawal by Subject|3
2271133|NCT02260492|3950062|FG000|Overall Study|Lost to Follow-up|12
2271134|NCT02260492|3950063|FG001|Overall Study|Lost to Follow-up|9
2271135|NCT02260492|3950064|FG002|Overall Study|Lost to Follow-up|0
2271136|NCT02260492|3950062|FG000|Overall Study|Physician Decision|2
2271137|NCT02260492|3950063|FG001|Overall Study|Physician Decision|0
2271138|NCT02260492|3950064|FG002|Overall Study|Physician Decision|1
2271139|NCT02260492|3950062|FG000|Overall Study|Withdrawal by Subject|3
2271140|NCT02260492|3950063|FG001|Overall Study|Withdrawal by Subject|2
2271141|NCT02260492|3950064|FG002|Overall Study|Withdrawal by Subject|2
2271142|NCT02260635|3950103|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
2271143|NCT02260635|3950104|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
2271144|NCT02260635|3950103|FG000|Open-Label Extension|Study Termination|25
2271145|NCT02260635|3950104|FG001|Open-Label Extension|Study Termination|25
2271146|NCT02260635|3950103|FG000|Open-Label Extension|Withdrawal by Subject|1
2271147|NCT02260635|3950104|FG001|Open-Label Extension|Withdrawal by Subject|0
2271148|NCT02260648|3950115|FG000|Overall Study|Adverse Event|3
2271149|NCT02260648|3950116|FG001|Overall Study|Adverse Event|0
2271150|NCT02260648|3950117|FG002|Overall Study|Adverse Event|1
2271151|NCT02260648|3950115|FG000|Overall Study|Withdrawal by Subject|1
2271152|NCT02260648|3950116|FG001|Overall Study|Withdrawal by Subject|1
2271153|NCT02260648|3950117|FG002|Overall Study|Withdrawal by Subject|0
2271154|NCT02260648|3950115|FG000|Overall Study|Protocol Violation|1
2271155|NCT02260648|3950116|FG001|Overall Study|Protocol Violation|0
2271156|NCT02260648|3950117|FG002|Overall Study|Protocol Violation|0
2271157|NCT02260648|3950115|FG000|Overall Study|Discontinue Due to Study Termination|13
2271158|NCT02260648|3950116|FG001|Overall Study|Discontinue Due to Study Termination|12
2271159|NCT02260648|3950117|FG002|Overall Study|Discontinue Due to Study Termination|7
2271160|NCT02260791|3950127|FG000|Overall Study|Lost to Follow-up|4
2271161|NCT02260791|3950128|FG001|Overall Study|Lost to Follow-up|4
2271162|NCT02260791|3950127|FG000|Overall Study|Lack of Efficacy|2
2271163|NCT02260791|3950128|FG001|Overall Study|Lack of Efficacy|1
2271164|NCT02260791|3950127|FG000|Overall Study|Adverse Event|13
2271165|NCT02260791|3950128|FG001|Overall Study|Adverse Event|9
2271166|NCT02260791|3950127|FG000|Overall Study|Death|1
2271167|NCT02260791|3950128|FG001|Overall Study|Death|0
2271168|NCT02260791|3950127|FG000|Overall Study|Withdrawal by Subject|11
2271169|NCT02260791|3950128|FG001|Overall Study|Withdrawal by Subject|16
2271170|NCT02260791|3950127|FG000|Overall Study|Screen failure|0
2271171|NCT02260791|3950128|FG001|Overall Study|Screen failure|1
2271172|NCT02260791|3950127|FG000|Overall Study|Protocol deviation|2
2271173|NCT02260791|3950128|FG001|Overall Study|Protocol deviation|3
2271174|NCT02260804|3950136|FG000|Induction Study Period|Protocol Violation|2
2271175|NCT02260804|3950137|FG001|Induction Study Period|Protocol Violation|0
2271176|NCT02260804|3950136|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6
2271177|NCT02260804|3950137|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9
2271178|NCT02260804|3950136|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3
2271179|NCT02260804|3950137|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1
2271180|NCT02260804|3950136|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1
2271181|NCT02260804|3950137|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3
2271182|NCT02260804|3950136|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1
2271183|NCT02260804|3950137|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0
2271184|NCT02260804|3950136|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1
2271185|NCT02260804|3950137|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0
2271186|NCT02260804|3950136|FG000|1st Year of the Maintenance Period (MP1)|Death|0
2271187|NCT02260804|3950137|FG001|1st Year of the Maintenance Period (MP1)|Death|1
2271188|NCT02260804|3950136|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0
2271189|NCT02260804|3950137|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1
2271190|NCT02260804|3950136|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6
2271191|NCT02260804|3950137|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5
2271192|NCT02260804|3950136|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3
2271193|NCT02260804|3950137|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0
2271194|NCT02260804|3950136|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0
2271195|NCT02260804|3950137|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1
2271196|NCT02260817|3950145|FG000|Overall Study|Lost to Follow-up|0
2271197|NCT02260817|3950146|FG001|Overall Study|Lost to Follow-up|14
2271198|NCT02260817|3950145|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0
2271199|NCT02260817|3950146|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7
2271200|NCT02260817|3950145|FG000|Overall Study|Observation, no biopsy|0
2271201|NCT02260817|3950146|FG001|Overall Study|Observation, no biopsy|1
2271202|NCT02260817|3950145|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
2271203|NCT02260817|3950146|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
2271204|NCT02260817|3950145|FG000|Overall Study|Protocol Violation|0
2271205|NCT02260817|3950146|FG001|Overall Study|Protocol Violation|14
2271206|NCT02260882|3950154|FG000|Overall Study|Protocol Violation|0
2271207|NCT02260882|3950155|FG001|Overall Study|Protocol Violation|1
2271208|NCT02260921|3950164|FG000|Overall Study|Adverse Event|1
2271209|NCT02260921|3950165|FG001|Overall Study|Adverse Event|0
2271210|NCT02260921|3950164|FG000|Overall Study|Lost to Follow-up|4
2271211|NCT02260921|3950165|FG001|Overall Study|Lost to Follow-up|3
2271212|NCT02260921|3950164|FG000|Overall Study|Withdraw Consent|4
2271213|NCT02260921|3950165|FG001|Overall Study|Withdraw Consent|1
2271214|NCT02260921|3950164|FG000|Overall Study|Death|1
2271215|NCT02260921|3950165|FG001|Overall Study|Death|0
2271216|NCT02260921|3950164|FG000|Overall Study|Prohibited Treatment for Knee Pain|4
2271217|NCT02260921|3950165|FG001|Overall Study|Prohibited Treatment for Knee Pain|0
2271218|NCT02260934|3950173|FG000|Overall Study|Lost to Follow-up|2
2271219|NCT02260934|3950174|FG001|Overall Study|Lost to Follow-up|1
2271220|NCT02260934|3950173|FG000|Overall Study|Withdrawal by Subject|0
2271221|NCT02260934|3950174|FG001|Overall Study|Withdrawal by Subject|2
2271222|NCT02260934|3950173|FG000|Overall Study|Participant Relocated|1
2271223|NCT02260934|3950174|FG001|Overall Study|Participant Relocated|0
2271224|NCT02260934|3950173|FG000|Overall Study|Site error|0
2271225|NCT02260934|3950174|FG001|Overall Study|Site error|1
2271226|NCT02260986|3950190|FG000|Overall Study|Adverse Event|24
2271227|NCT02260986|3950191|FG001|Overall Study|Adverse Event|0
2271228|NCT02260986|3950192|FG002|Overall Study|Adverse Event|11
2271229|NCT02260986|3950190|FG000|Overall Study|Lack of Efficacy|27
2271230|NCT02260986|3950191|FG001|Overall Study|Lack of Efficacy|3
2271231|NCT02260986|3950192|FG002|Overall Study|Lack of Efficacy|0
2271232|NCT02260986|3950190|FG000|Overall Study|Protocol Violation|14
2271233|NCT02260986|3950191|FG001|Overall Study|Protocol Violation|5
2271234|NCT02260986|3950192|FG002|Overall Study|Protocol Violation|16
2271235|NCT02260986|3950190|FG000|Overall Study|Car accident|0
2271236|NCT02260986|3950191|FG001|Overall Study|Car accident|0
2271237|NCT02260986|3950192|FG002|Overall Study|Car accident|1
2271238|NCT02260986|3950190|FG000|Overall Study|Withdrawal by Subject|17
2271239|NCT02260986|3950191|FG001|Overall Study|Withdrawal by Subject|4
2271240|NCT02260986|3950192|FG002|Overall Study|Withdrawal by Subject|9
2271241|NCT02260986|3950190|FG000|Overall Study|Incorrect randomization|0
2271242|NCT02260986|3950191|FG001|Overall Study|Incorrect randomization|1
2271243|NCT02260986|3950192|FG002|Overall Study|Incorrect randomization|0
2271244|NCT02260986|3950190|FG000|Overall Study|Lack of investigation product supply|2
2350314|NCT04005755|4095913|FG000|Overall Study|Lost to Follow-up|1
2350315|NCT03993288|4095936|FG000|Overall Study|Lost to Follow-up|2
2350316|NCT03993288|4095937|FG001|Overall Study|Lost to Follow-up|1
2350317|NCT03993288|4095936|FG000|Overall Study|non-compliance to the inclusion criteria|0
2350318|NCT03993288|4095937|FG001|Overall Study|non-compliance to the inclusion criteria|1
2350319|NCT03993288|4095936|FG000|Overall Study|wrong randomization|0
2350320|NCT03993288|4095937|FG001|Overall Study|wrong randomization|1
2350321|NCT03993288|4095936|FG000|Overall Study|improper enrollment|0
2350322|NCT03993288|4095937|FG001|Overall Study|improper enrollment|1
2350323|NCT03993288|4095936|FG000|Overall Study|prescribed with prohibited concomitant therapy|1
2350324|NCT03993288|4095937|FG001|Overall Study|prescribed with prohibited concomitant therapy|0
2350325|NCT03993288|4095936|FG000|Overall Study|developed SAE|2
2350326|NCT03993288|4095937|FG001|Overall Study|developed SAE|0
2350327|NCT03993288|4095936|FG000|Overall Study|consent withdrawal|1
2350328|NCT03993288|4095937|FG001|Overall Study|consent withdrawal|0
2350329|NCT03993288|4095936|FG000|Overall Study|did not follow the treatment schedule|1
2350330|NCT03993288|4095937|FG001|Overall Study|did not follow the treatment schedule|0
2350331|NCT03993288|4095936|FG000|Overall Study|did not follow the treatment regimen|1
2350332|NCT03993288|4095937|FG001|Overall Study|did not follow the treatment regimen|0
2350333|NCT03993288|4095936|FG000|Overall Study|Adverse Event|1
2350334|NCT03993288|4095937|FG001|Overall Study|Adverse Event|0
2350335|NCT03993288|4095936|FG000|Overall Study|Withdrawal by Subject|1
2350336|NCT03993288|4095937|FG001|Overall Study|Withdrawal by Subject|1
2350337|NCT03978832|4095968|FG000|Overall Study|Adverse Event|1
2350338|NCT03978832|4095968|FG000|Overall Study|Lost to Follow-up|1
2350339|NCT03978832|4095968|FG000|Overall Study|Withdrawal by Subject|6
2350340|NCT03978832|4095968|FG000|Overall Study|Physician Decision|2
2350341|NCT03978832|4095968|FG000|Overall Study|did not pass screening criteria|44
2350342|NCT04004260|4096009|FG000|Overall Study|Withdrawal by Subject|7
2350343|NCT04004260|4096010|FG001|Overall Study|Withdrawal by Subject|3
2350344|NCT04004260|4096009|FG000|Overall Study|Lost to Follow-up|22
2350345|NCT04004260|4096010|FG001|Overall Study|Lost to Follow-up|12
2350346|NCT04004260|4096009|FG000|Overall Study|Did not engage in intervention|13
2350347|NCT04004260|4096010|FG001|Overall Study|Did not engage in intervention|17
2350348|NCT04002960|4096043|FG000|Overall Study|Withdrawn prior to Completion|2
2350349|NCT04002648|4096053|FG000|Overall Study|Lost to Follow-up|2
2350350|NCT04002648|4096054|FG001|Overall Study|Lost to Follow-up|0
2350351|NCT03990649|4096083|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
2350352|NCT03990649|4096084|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1
2350353|NCT03990649|4096085|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
2350354|NCT03990649|4096083|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
2350355|NCT03990649|4096084|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1
2350356|NCT03990649|4096085|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
2350357|NCT03990649|4096083|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2
2350358|NCT03990649|4096084|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
2350359|NCT03990649|4096085|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
2350360|NCT03990649|4096083|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
2350361|NCT03990649|4096084|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
2350362|NCT03990649|4096085|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0
2350363|NCT03990649|4096083|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
2350364|NCT03990649|4096084|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
2350365|NCT03990649|4096085|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1
2350366|NCT03990649|4096083|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
2350367|NCT03990649|4096084|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
2350368|NCT03990649|4096085|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2
2350369|NCT03990649|4096083|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
2350370|NCT03990649|4096084|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
2350371|NCT03990649|4096085|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1
2350372|NCT04000581|4096103|FG000|Overall Study|Withdrawal by Subject|0
2350373|NCT04000581|4096104|FG001|Overall Study|Withdrawal by Subject|1
2350374|NCT03996694|4096110|FG000|First Washout (7 Days)|positive urine drug screen|0
2271245|NCT02260986|3950191|FG001|Overall Study|Lack of investigation product supply|0
2271246|NCT02260986|3950192|FG002|Overall Study|Lack of investigation product supply|1
2271247|NCT02260986|3950190|FG000|Overall Study|Lost to Follow-up|4
2271248|NCT02260986|3950191|FG001|Overall Study|Lost to Follow-up|0
2271249|NCT02260986|3950192|FG002|Overall Study|Lost to Follow-up|3
2271250|NCT02260986|3950190|FG000|Overall Study|Pregnancy|2
2271251|NCT02260986|3950191|FG001|Overall Study|Pregnancy|0
2271252|NCT02260986|3950192|FG002|Overall Study|Pregnancy|0
2271253|NCT02261467|3950228|FG000|Overall Study|Enrolled in Error|1
2271254|NCT02261467|3950229|FG001|Overall Study|Enrolled in Error|0
2271255|NCT02261467|3950228|FG000|Overall Study|Protocol Violation|0
2271256|NCT02261467|3950229|FG001|Overall Study|Protocol Violation|1
2271257|NCT02261467|3950228|FG000|Overall Study|Personal Reasons|17
2271258|NCT02261467|3950229|FG001|Overall Study|Personal Reasons|22
2271259|NCT02261467|3950228|FG000|Overall Study|Lost to Follow-up|2
2271260|NCT02261467|3950229|FG001|Overall Study|Lost to Follow-up|13
2271261|NCT02261467|3950228|FG000|Overall Study|Adverse Event|1
2271262|NCT02261467|3950229|FG001|Overall Study|Adverse Event|1
2271263|NCT02261493|3950238|FG000|Overall Study|Noncompliance|0
2271264|NCT02261493|3950239|FG001|Overall Study|Noncompliance|0
2271265|NCT02261493|3950240|FG002|Overall Study|Noncompliance|2
2271266|NCT02261493|3950238|FG000|Overall Study|Physician Decision|0
2271267|NCT02261493|3950239|FG001|Overall Study|Physician Decision|1
2271268|NCT02261493|3950240|FG002|Overall Study|Physician Decision|0
2271269|NCT02261493|3950238|FG000|Overall Study|Undisclosed alcohol abuse|0
2271270|NCT02261493|3950239|FG001|Overall Study|Undisclosed alcohol abuse|1
2271271|NCT02261493|3950240|FG002|Overall Study|Undisclosed alcohol abuse|0
2271272|NCT02261493|3950238|FG000|Overall Study|Protocol Violation|1
2271273|NCT02261493|3950239|FG001|Overall Study|Protocol Violation|0
2271274|NCT02261493|3950240|FG002|Overall Study|Protocol Violation|0
2271275|NCT02261493|3950238|FG000|Overall Study|Personal Reasons|14
2271276|NCT02261493|3950239|FG001|Overall Study|Personal Reasons|14
2271277|NCT02261493|3950240|FG002|Overall Study|Personal Reasons|16
2271278|NCT02261493|3950238|FG000|Overall Study|Lost to Follow-up|14
2271279|NCT02261493|3950239|FG001|Overall Study|Lost to Follow-up|27
2271280|NCT02261493|3950240|FG002|Overall Study|Lost to Follow-up|8
2271281|NCT02261493|3950238|FG000|Overall Study|Pregnancy|1
2271282|NCT02261493|3950239|FG001|Overall Study|Pregnancy|2
2271283|NCT02261493|3950240|FG002|Overall Study|Pregnancy|0
2271284|NCT02261493|3950238|FG000|Overall Study|Lack of Efficacy|0
2271285|NCT02261493|3950239|FG001|Overall Study|Lack of Efficacy|1
2271286|NCT02261493|3950240|FG002|Overall Study|Lack of Efficacy|0
2271287|NCT02261493|3950238|FG000|Overall Study|Adverse Event|0
2271288|NCT02261493|3950239|FG001|Overall Study|Adverse Event|1
2271289|NCT02261493|3950240|FG002|Overall Study|Adverse Event|0
2271290|NCT02261974|3950318|FG000|Overall Study|Withdrawal by Subject|3
2271291|NCT02261974|3950319|FG001|Overall Study|Withdrawal by Subject|2
2271292|NCT02261974|3950318|FG000|Overall Study|Pregnancy|0
2271293|NCT02261974|3950319|FG001|Overall Study|Pregnancy|1
2271294|NCT02261974|3950318|FG000|Overall Study|Missed treatment cut-off date|6
2271295|NCT02261974|3950319|FG001|Overall Study|Missed treatment cut-off date|3
2271296|NCT02261974|3950318|FG000|Overall Study|Received partial treatment; FU to 1 mo|3
2271297|NCT02261974|3950319|FG001|Overall Study|Received partial treatment; FU to 1 mo|1
2271298|NCT02261974|3950318|FG000|Overall Study|Lost to Follow-up|2
2271299|NCT02261974|3950319|FG001|Overall Study|Lost to Follow-up|0
2271300|NCT02261974|3950318|FG000|Overall Study|Adverse Event|1
2271301|NCT02261974|3950319|FG001|Overall Study|Adverse Event|0
2271302|NCT02262260|3950349|FG000|Overall Study|Adverse Event|4
2271303|NCT02262260|3950350|FG001|Overall Study|Adverse Event|1
2271304|NCT02262260|3950349|FG000|Overall Study|Withdrawal of consent|4
2271305|NCT02262260|3950350|FG001|Overall Study|Withdrawal of consent|2
2271306|NCT02262260|3950349|FG000|Overall Study|Lost to Follow-up|1
2271307|NCT02262260|3950350|FG001|Overall Study|Lost to Follow-up|2
2271308|NCT02262260|3950349|FG000|Overall Study|Protocol deviation|2
2271309|NCT02262260|3950350|FG001|Overall Study|Protocol deviation|5
2271310|NCT02262364|3950356|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1
2271311|NCT02262377|3950362|FG000|Overall Study|Lost to Follow-up|5
2271312|NCT02262377|3950363|FG001|Overall Study|Lost to Follow-up|6
2271313|NCT02262377|3950362|FG000|Overall Study|Found ineligible after enrollment|3
2271314|NCT02262377|3950363|FG001|Overall Study|Found ineligible after enrollment|0
2271315|NCT02262377|3950362|FG000|Overall Study|Withdrawal by Subject|4
2271316|NCT02262377|3950363|FG001|Overall Study|Withdrawal by Subject|0
2271317|NCT02262728|3950377|FG000|Follow-up Phase (3 Years)|Death|0
2271318|NCT02262728|3950378|FG001|Follow-up Phase (3 Years)|Death|1
2271319|NCT02262728|3950377|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4
2271320|NCT02262728|3950378|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1
2271321|NCT02262728|3950377|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0
2271322|NCT02262728|3950378|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1
2271323|NCT02262754|3950387|FG000|Overall Study|Adverse Event|3
2271324|NCT02262754|3950388|FG001|Overall Study|Adverse Event|4
2271325|NCT02262754|3950389|FG002|Overall Study|Adverse Event|0
2271326|NCT02262754|3950387|FG000|Overall Study|Lack of Efficacy|2
2271327|NCT02262754|3950388|FG001|Overall Study|Lack of Efficacy|0
2271328|NCT02262754|3950389|FG002|Overall Study|Lack of Efficacy|1
2271329|NCT02262754|3950387|FG000|Overall Study|Lost to Follow-up|0
2271330|NCT02262754|3950388|FG001|Overall Study|Lost to Follow-up|0
2271331|NCT02262754|3950389|FG002|Overall Study|Lost to Follow-up|1
2271332|NCT02262754|3950387|FG000|Overall Study|No longer meets eligibility criteria|0
2271333|NCT02262754|3950388|FG001|Overall Study|No longer meets eligibility criteria|1
2271334|NCT02262754|3950389|FG002|Overall Study|No longer meets eligibility criteria|0
2271335|NCT02262754|3950387|FG000|Overall Study|Study terminated by sponsor|5
2271336|NCT02262754|3950388|FG001|Overall Study|Study terminated by sponsor|4
2271337|NCT02262754|3950389|FG002|Overall Study|Study terminated by sponsor|4
2271338|NCT02262754|3950387|FG000|Overall Study|Protocol Violation|1
2271339|NCT02262754|3950388|FG001|Overall Study|Protocol Violation|0
2350375|NCT03996694|4096111|FG001|First Washout (7 Days)|positive urine drug screen|0
2350376|NCT03996694|4096112|FG002|First Washout (7 Days)|positive urine drug screen|1
2350377|NCT03996694|4096113|FG003|First Washout (7 Days)|positive urine drug screen|0
2350378|NCT03996694|4096114|FG004|First Washout (7 Days)|positive urine drug screen|0
2350379|NCT03996694|4096115|FG005|First Washout (7 Days)|positive urine drug screen|0
2350380|NCT03996694|4096110|FG000|First Washout (7 Days)|Adverse Event|0
2350381|NCT03996694|4096111|FG001|First Washout (7 Days)|Adverse Event|1
2350382|NCT03996694|4096112|FG002|First Washout (7 Days)|Adverse Event|0
2350383|NCT03996694|4096113|FG003|First Washout (7 Days)|Adverse Event|0
2350384|NCT03996694|4096114|FG004|First Washout (7 Days)|Adverse Event|0
2350385|NCT03996694|4096115|FG005|First Washout (7 Days)|Adverse Event|0
2350386|NCT03996694|4096110|FG000|First Washout (7 Days)|Lost to Follow-up|0
2350387|NCT03996694|4096111|FG001|First Washout (7 Days)|Lost to Follow-up|0
2350388|NCT03996694|4096112|FG002|First Washout (7 Days)|Lost to Follow-up|1
2350389|NCT03996694|4096113|FG003|First Washout (7 Days)|Lost to Follow-up|0
2350390|NCT03996694|4096114|FG004|First Washout (7 Days)|Lost to Follow-up|0
2350391|NCT03996694|4096115|FG005|First Washout (7 Days)|Lost to Follow-up|0
2350392|NCT03996694|4096110|FG000|Third Washout (7 Days)|Withdrawal by Subject|0
2350393|NCT03996694|4096111|FG001|Third Washout (7 Days)|Withdrawal by Subject|0
2350394|NCT03996694|4096112|FG002|Third Washout (7 Days)|Withdrawal by Subject|0
2350395|NCT03996694|4096113|FG003|Third Washout (7 Days)|Withdrawal by Subject|0
2350396|NCT03996694|4096114|FG004|Third Washout (7 Days)|Withdrawal by Subject|1
2350397|NCT03996694|4096115|FG005|Third Washout (7 Days)|Withdrawal by Subject|0
2350398|NCT03988907|4096131|FG000|Overall Study|Unable to complete visit|0
2350399|NCT03988907|4096132|FG001|Overall Study|Unable to complete visit|1
2350400|NCT03988088|4096146|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0
2350401|NCT03988088|4096147|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1
2350402|NCT03988088|4096148|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0
2350403|NCT03988088|4096149|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0
2350404|NCT03988088|4096146|FG000|Open-Label Addendum|Lost to Follow-up|0
2350405|NCT03988088|4096147|FG001|Open-Label Addendum|Lost to Follow-up|0
2350406|NCT03988088|4096148|FG002|Open-Label Addendum|Lost to Follow-up|1
2350407|NCT03988088|4096149|FG003|Open-Label Addendum|Lost to Follow-up|0
2350408|NCT03980522|4096162|FG000|Treatment Period|Adverse Event|1
2350409|NCT03980522|4096163|FG001|Treatment Period|Adverse Event|0
2350410|NCT03980522|4096164|FG002|Treatment Period|Adverse Event|0
2350411|NCT03980522|4096165|FG003|Treatment Period|Adverse Event|0
2350412|NCT03980522|4096166|FG004|Treatment Period|Adverse Event|0
2350413|NCT03995784|4096182|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1
2350414|NCT03993392|4096193|FG000|Overall Study|Withdrawal by Subject|3
2350415|NCT03993392|4096193|FG000|Overall Study|Lost to Follow-up|2
2350416|NCT03993392|4096193|FG000|Overall Study|Did not meet Day 1 check-in criteria|1
2350417|NCT03981822|4096216|FG000|Overall Study|Lost to Follow-up|0
2350418|NCT03981822|4096217|FG001|Overall Study|Lost to Follow-up|1
2350419|NCT03981822|4096218|FG002|Overall Study|Lost to Follow-up|1
2350420|NCT03981822|4096219|FG003|Overall Study|Lost to Follow-up|0
2350421|NCT03981822|4096220|FG004|Overall Study|Lost to Follow-up|6
2350422|NCT03981822|4096221|FG005|Overall Study|Lost to Follow-up|4
2350423|NCT03981822|4096222|FG006|Overall Study|Lost to Follow-up|4
2350424|NCT03981822|4096223|FG007|Overall Study|Lost to Follow-up|2
2350425|NCT03981822|4096216|FG000|Overall Study|Withdrawal by Subject|0
2350426|NCT03981822|4096217|FG001|Overall Study|Withdrawal by Subject|1
2350427|NCT03981822|4096218|FG002|Overall Study|Withdrawal by Subject|0
2350428|NCT03981822|4096219|FG003|Overall Study|Withdrawal by Subject|0
2350429|NCT03981822|4096220|FG004|Overall Study|Withdrawal by Subject|0
2350430|NCT03981822|4096221|FG005|Overall Study|Withdrawal by Subject|1
2350431|NCT03981822|4096222|FG006|Overall Study|Withdrawal by Subject|0
2350432|NCT03981822|4096223|FG007|Overall Study|Withdrawal by Subject|2
2350433|NCT03981822|4096216|FG000|Overall Study|COVID-19 Related|0
2350434|NCT03981822|4096217|FG001|Overall Study|COVID-19 Related|0
2350435|NCT03981822|4096218|FG002|Overall Study|COVID-19 Related|0
2350436|NCT03981822|4096219|FG003|Overall Study|COVID-19 Related|0
2350437|NCT03981822|4096220|FG004|Overall Study|COVID-19 Related|2
2350438|NCT03981822|4096221|FG005|Overall Study|COVID-19 Related|1
2350439|NCT03981822|4096222|FG006|Overall Study|COVID-19 Related|2
2350440|NCT03981822|4096223|FG007|Overall Study|COVID-19 Related|1
2350441|NCT03991494|4096276|FG000|Overall Study|Progressive Disease|4
2350442|NCT03988803|4096295|FG000|Period 2|Prematurely discontinued from medication|2
2271340|NCT02262754|3950389|FG002|Overall Study|Protocol Violation|0
2271341|NCT02262754|3950387|FG000|Overall Study|Withdrawal by Subject|1
2271342|NCT02262754|3950388|FG001|Overall Study|Withdrawal by Subject|0
2271343|NCT02262754|3950389|FG002|Overall Study|Withdrawal by Subject|1
2271344|NCT02262754|3950387|FG000|Overall Study|Other|4
2271345|NCT02262754|3950388|FG001|Overall Study|Other|0
2271346|NCT02262754|3950389|FG002|Overall Study|Other|2
2271347|NCT02263079|3950426|FG000|Overall Study|Physician Decision|1
2271348|NCT02263079|3950427|FG001|Overall Study|Physician Decision|0
2271349|NCT02263079|3950428|FG002|Overall Study|Physician Decision|0
2271350|NCT02263079|3950426|FG000|Overall Study|Withdrawal by Subject|2
2271351|NCT02263079|3950427|FG001|Overall Study|Withdrawal by Subject|8
2271352|NCT02263079|3950428|FG002|Overall Study|Withdrawal by Subject|0
2271353|NCT02263326|3950466|FG000|Overall Study|Lost to Follow-up|1
2271354|NCT02263326|3950467|FG001|Overall Study|Lost to Follow-up|1
2271355|NCT02263547|3950473|FG000|Overall Study|Adverse Event|1
2271356|NCT02263547|3950473|FG000|Overall Study|Lost to Follow-up|2
2271357|NCT02264574|3950520|FG000|Overall Study|Death|21
2271358|NCT02264574|3950521|FG001|Overall Study|Death|21
2271359|NCT02264574|3950520|FG000|Overall Study|Withdrawal by Subject|8
2271360|NCT02264574|3950521|FG001|Overall Study|Withdrawal by Subject|6
2271361|NCT02264574|3950520|FG000|Overall Study|Other, Not Specified|0
2271362|NCT02264574|3950521|FG001|Overall Study|Other, Not Specified|3
2271363|NCT02264639|3950532|FG000|Overall Study|Death (after completing single-dose phase)|1
2271364|NCT02264639|3950533|FG001|Overall Study|Death (after completing single-dose phase)|0
2271365|NCT02264639|3950534|FG002|Overall Study|Death (after completing single-dose phase)|0
2271366|NCT02264639|3950535|FG003|Overall Study|Death (after completing single-dose phase)|0
2271367|NCT02264639|3950536|FG004|Overall Study|Death (after completing single-dose phase)|0
2271368|NCT02264639|3950532|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1
2271369|NCT02264639|3950533|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
2271370|NCT02264639|3950534|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
2271371|NCT02264639|3950535|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
2271372|NCT02264639|3950536|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
2271373|NCT02264639|3950532|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0
2271374|NCT02264639|3950533|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0
2271375|NCT02264639|3950534|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1
2271376|NCT02264639|3950535|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0
2271377|NCT02264639|3950536|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0
2271378|NCT02264639|3950532|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
2271379|NCT02264639|3950533|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
2271380|NCT02264639|3950534|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
2271381|NCT02264639|3950535|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
2271382|NCT02264639|3950536|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1
2271383|NCT02264821|3950554|FG000|Overall Study|Protocol Violation|1
2271384|NCT02264821|3950555|FG001|Overall Study|Protocol Violation|3
2271385|NCT02264821|3950556|FG002|Overall Study|Protocol Violation|6
2271386|NCT02264990|3950566|FG000|Overall Study|Death|255
2271387|NCT02264990|3950567|FG001|Overall Study|Death|250
2271388|NCT02264990|3950566|FG000|Overall Study|Withdrawal by Subject|4
2271389|NCT02264990|3950567|FG001|Overall Study|Withdrawal by Subject|5
2271390|NCT02264990|3950566|FG000|Overall Study|Lost to Follow-up|1
2271391|NCT02264990|3950567|FG001|Overall Study|Lost to Follow-up|3
2271392|NCT02264990|3950566|FG000|Overall Study|Other|0
2271393|NCT02264990|3950567|FG001|Overall Study|Other|1
2271394|NCT02265237|3950585|FG000|As Treated (Overall Study)|Adverse Event|1
2350443|NCT03988803|4096295|FG000|Period 2|Adverse Event|1
2350444|NCT03987932|4096306|FG000|Overall Study|Lost to Follow-up|2
2350445|NCT03987932|4096307|FG001|Overall Study|Lost to Follow-up|1
2350446|NCT03987932|4096308|FG002|Overall Study|Lost to Follow-up|1
2350447|NCT03987932|4096306|FG000|Overall Study|Non-study related elective surgery|0
2350448|NCT03987932|4096307|FG001|Overall Study|Non-study related elective surgery|0
2350449|NCT03987932|4096308|FG002|Overall Study|Non-study related elective surgery|1
2350450|NCT03987191|4096318|FG000|Overall Study|COVID-19 related research disruption|0
2350451|NCT03987191|4096319|FG001|Overall Study|COVID-19 related research disruption|2
2350452|NCT03988842|4096325|FG000|Overall Study|Death|1
2350453|NCT03981861|4096330|FG000|Overall Study|Withdrawal by Subject|3
2350454|NCT03974334|4096334|FG000|Overall Study|Lost to Follow-up|1
2350455|NCT03987074|4096362|FG000|Overall Study|Withdrew Consent|1
2350456|NCT03987074|4096363|FG001|Overall Study|Withdrew Consent|1
2350457|NCT03987074|4096364|FG002|Overall Study|Withdrew Consent|0
2350458|NCT03987074|4096365|FG003|Overall Study|Withdrew Consent|2
2350459|NCT03987074|4096366|FG004|Overall Study|Withdrew Consent|1
2350460|NCT03987074|4096362|FG000|Overall Study|Adverse Event|2
2350461|NCT03987074|4096363|FG001|Overall Study|Adverse Event|1
2350462|NCT03987074|4096364|FG002|Overall Study|Adverse Event|0
2350463|NCT03987074|4096365|FG003|Overall Study|Adverse Event|0
2350464|NCT03987074|4096366|FG004|Overall Study|Adverse Event|1
2350465|NCT03987074|4096362|FG000|Overall Study|Lost to Follow-up|0
2350466|NCT03987074|4096363|FG001|Overall Study|Lost to Follow-up|0
2271395|NCT02265237|3950586|FG001|As Treated (Overall Study)|Adverse Event|1
2271396|NCT02265237|3950587|FG002|As Treated (Overall Study)|Adverse Event|0
2271397|NCT02265237|3950588|FG003|As Treated (Overall Study)|Adverse Event|0
2271398|NCT02265237|3950585|FG000|As Treated (Overall Study)|Withdrawal by Subject|1
2271399|NCT02265237|3950586|FG001|As Treated (Overall Study)|Withdrawal by Subject|0
2271400|NCT02265237|3950587|FG002|As Treated (Overall Study)|Withdrawal by Subject|1
2271401|NCT02265237|3950588|FG003|As Treated (Overall Study)|Withdrawal by Subject|0
2271402|NCT02265237|3950585|FG000|As Treated (Overall Study)|Lost to Follow-up|1
2271403|NCT02265237|3950586|FG001|As Treated (Overall Study)|Lost to Follow-up|2
2271404|NCT02265237|3950587|FG002|As Treated (Overall Study)|Lost to Follow-up|6
2271405|NCT02265237|3950588|FG003|As Treated (Overall Study)|Lost to Follow-up|0
2271406|NCT02265237|3950585|FG000|As Treated (Overall Study)|Other|2
2271407|NCT02265237|3950586|FG001|As Treated (Overall Study)|Other|0
2271408|NCT02265237|3950587|FG002|As Treated (Overall Study)|Other|3
2271409|NCT02265237|3950588|FG003|As Treated (Overall Study)|Other|1
2271410|NCT02265510|3950617|FG000|Overall Study|Withdrawal by Subject|1
2271411|NCT02265510|3950618|FG001|Overall Study|Withdrawal by Subject|1
2271412|NCT02265510|3950619|FG002|Overall Study|Withdrawal by Subject|2
2271413|NCT02265510|3950620|FG003|Overall Study|Withdrawal by Subject|1
2271414|NCT02265510|3950621|FG004|Overall Study|Withdrawal by Subject|0
2271415|NCT02265510|3950622|FG005|Overall Study|Withdrawal by Subject|2
2271416|NCT02265510|3950623|FG006|Overall Study|Withdrawal by Subject|0
2271417|NCT02265510|3950624|FG007|Overall Study|Withdrawal by Subject|2
2271418|NCT02265510|3950625|FG008|Overall Study|Withdrawal by Subject|0
2271419|NCT02265510|3950626|FG009|Overall Study|Withdrawal by Subject|0
2271420|NCT02265510|3950627|FG010|Overall Study|Withdrawal by Subject|0
2271421|NCT02265510|3950628|FG011|Overall Study|Withdrawal by Subject|0
2271422|NCT02265510|3950629|FG012|Overall Study|Withdrawal by Subject|1
2271423|NCT02265510|3950630|FG013|Overall Study|Withdrawal by Subject|0
2271424|NCT02265510|3950617|FG000|Overall Study|Disease Progression|0
2271425|NCT02265510|3950618|FG001|Overall Study|Disease Progression|1
2271426|NCT02265510|3950619|FG002|Overall Study|Disease Progression|2
2271427|NCT02265510|3950620|FG003|Overall Study|Disease Progression|1
2271428|NCT02265510|3950621|FG004|Overall Study|Disease Progression|1
2271429|NCT02265510|3950622|FG005|Overall Study|Disease Progression|0
2271430|NCT02265510|3950623|FG006|Overall Study|Disease Progression|0
2271431|NCT02265510|3950624|FG007|Overall Study|Disease Progression|0
2271432|NCT02265510|3950625|FG008|Overall Study|Disease Progression|0
2271433|NCT02265510|3950626|FG009|Overall Study|Disease Progression|0
2271434|NCT02265510|3950627|FG010|Overall Study|Disease Progression|0
2271435|NCT02265510|3950628|FG011|Overall Study|Disease Progression|0
2271436|NCT02265510|3950629|FG012|Overall Study|Disease Progression|0
2271437|NCT02265510|3950630|FG013|Overall Study|Disease Progression|0
2271438|NCT02265510|3950617|FG000|Overall Study|Death|2
2271439|NCT02265510|3950618|FG001|Overall Study|Death|0
2271440|NCT02265510|3950619|FG002|Overall Study|Death|2
2271441|NCT02265510|3950620|FG003|Overall Study|Death|2
2271442|NCT02265510|3950621|FG004|Overall Study|Death|1
2271443|NCT02265510|3950622|FG005|Overall Study|Death|3
2271444|NCT02265510|3950623|FG006|Overall Study|Death|2
2271445|NCT02265510|3950624|FG007|Overall Study|Death|1
2271446|NCT02265510|3950625|FG008|Overall Study|Death|3
2271447|NCT02265510|3950626|FG009|Overall Study|Death|3
2271448|NCT02265510|3950627|FG010|Overall Study|Death|4
2271449|NCT02265510|3950628|FG011|Overall Study|Death|12
2271450|NCT02265510|3950629|FG012|Overall Study|Death|7
2271451|NCT02265510|3950630|FG013|Overall Study|Death|6
2271452|NCT02265510|3950617|FG000|Overall Study|Lost to Follow-up|0
2271453|NCT02265510|3950618|FG001|Overall Study|Lost to Follow-up|0
2271454|NCT02265510|3950619|FG002|Overall Study|Lost to Follow-up|0
2271455|NCT02265510|3950620|FG003|Overall Study|Lost to Follow-up|0
2271456|NCT02265510|3950621|FG004|Overall Study|Lost to Follow-up|1
2271457|NCT02265510|3950622|FG005|Overall Study|Lost to Follow-up|0
2271458|NCT02265510|3950623|FG006|Overall Study|Lost to Follow-up|0
2271459|NCT02265510|3950624|FG007|Overall Study|Lost to Follow-up|0
2271460|NCT02265510|3950625|FG008|Overall Study|Lost to Follow-up|0
2271461|NCT02265510|3950626|FG009|Overall Study|Lost to Follow-up|2
2271462|NCT02265510|3950627|FG010|Overall Study|Lost to Follow-up|0
2271463|NCT02265510|3950628|FG011|Overall Study|Lost to Follow-up|0
2271464|NCT02265510|3950629|FG012|Overall Study|Lost to Follow-up|0
2271465|NCT02265510|3950630|FG013|Overall Study|Lost to Follow-up|2
2271466|NCT02265510|3950617|FG000|Overall Study|Other|0
2271467|NCT02265510|3950618|FG001|Overall Study|Other|1
2271468|NCT02265510|3950619|FG002|Overall Study|Other|0
2271469|NCT02265510|3950620|FG003|Overall Study|Other|0
2271470|NCT02265510|3950621|FG004|Overall Study|Other|0
2271471|NCT02265510|3950622|FG005|Overall Study|Other|0
2271472|NCT02265510|3950623|FG006|Overall Study|Other|0
2271473|NCT02265510|3950624|FG007|Overall Study|Other|0
2271474|NCT02265510|3950625|FG008|Overall Study|Other|0
2271475|NCT02265510|3950626|FG009|Overall Study|Other|0
2271476|NCT02265510|3950627|FG010|Overall Study|Other|0
2271477|NCT02265510|3950628|FG011|Overall Study|Other|0
2271478|NCT02265510|3950629|FG012|Overall Study|Other|0
2271479|NCT02265510|3950630|FG013|Overall Study|Other|0
2271480|NCT02265510|3950617|FG000|Overall Study|Study Terminated by Sponsor|0
2271481|NCT02265510|3950618|FG001|Overall Study|Study Terminated by Sponsor|0
2271482|NCT02265510|3950619|FG002|Overall Study|Study Terminated by Sponsor|0
2271483|NCT02265510|3950620|FG003|Overall Study|Study Terminated by Sponsor|0
2271484|NCT02265510|3950621|FG004|Overall Study|Study Terminated by Sponsor|0
2271485|NCT02265510|3950622|FG005|Overall Study|Study Terminated by Sponsor|1
2271486|NCT02265510|3950623|FG006|Overall Study|Study Terminated by Sponsor|1
2271487|NCT02265510|3950624|FG007|Overall Study|Study Terminated by Sponsor|1
2271488|NCT02265510|3950625|FG008|Overall Study|Study Terminated by Sponsor|1
2271489|NCT02265510|3950626|FG009|Overall Study|Study Terminated by Sponsor|2
2271490|NCT02265510|3950627|FG010|Overall Study|Study Terminated by Sponsor|1
2271491|NCT02265510|3950628|FG011|Overall Study|Study Terminated by Sponsor|4
2271492|NCT02265510|3950629|FG012|Overall Study|Study Terminated by Sponsor|1
2350467|NCT03987074|4096364|FG002|Overall Study|Lost to Follow-up|1
2350468|NCT03987074|4096365|FG003|Overall Study|Lost to Follow-up|1
2350469|NCT03987074|4096366|FG004|Overall Study|Lost to Follow-up|0
2350470|NCT03987074|4096362|FG000|Overall Study|Investigator's Discretion|0
2350471|NCT03987074|4096363|FG001|Overall Study|Investigator's Discretion|0
2350472|NCT03987074|4096364|FG002|Overall Study|Investigator's Discretion|0
2350473|NCT03987074|4096365|FG003|Overall Study|Investigator's Discretion|1
2350474|NCT03987074|4096366|FG004|Overall Study|Investigator's Discretion|0
2350475|NCT03979820|4096400|FG000|Overall Study|Protocol Violation|1
2350476|NCT03979820|4096401|FG001|Overall Study|Protocol Violation|0
2350477|NCT03979820|4096402|FG002|Overall Study|Protocol Violation|0
2350478|NCT03979820|4096403|FG003|Overall Study|Protocol Violation|0
2350479|NCT03979820|4096400|FG000|Overall Study|Withdrawal by Subject|0
2350480|NCT03979820|4096401|FG001|Overall Study|Withdrawal by Subject|0
2350481|NCT03979820|4096402|FG002|Overall Study|Withdrawal by Subject|1
2350482|NCT03979820|4096403|FG003|Overall Study|Withdrawal by Subject|0
2350483|NCT03979820|4096400|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5
2350484|NCT03979820|4096401|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
2350485|NCT03979820|4096402|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
2350486|NCT03979820|4096403|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10
2350487|NCT03972137|4096417|FG000|Overall Study|Lost to Follow-up|2
2350488|NCT03972137|4096417|FG000|Overall Study|Withdrawal by Subject|4
2350489|NCT03970395|4096435|FG000|Overall Study|Withdrawal by Subject|3
2350490|NCT03970395|4096436|FG001|Overall Study|Withdrawal by Subject|4
2350491|NCT03970395|4096435|FG000|Overall Study|Lost to Follow-up|4
2350492|NCT03970395|4096436|FG001|Overall Study|Lost to Follow-up|8
2350493|NCT03987620|4096448|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43
2350494|NCT03987620|4096449|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41
2350495|NCT03987620|4096448|FG000|Overall Study|Adverse Event|3
2350496|NCT03987620|4096449|FG001|Overall Study|Adverse Event|0
2350497|NCT03987620|4096448|FG000|Overall Study|Lost to Follow-up|1
2350498|NCT03987620|4096449|FG001|Overall Study|Lost to Follow-up|2
2350499|NCT03987620|4096448|FG000|Overall Study|Physician Decision|0
2350500|NCT03987620|4096449|FG001|Overall Study|Physician Decision|1
2350501|NCT03987620|4096448|FG000|Overall Study|Pregnancy|1
2350502|NCT03987620|4096449|FG001|Overall Study|Pregnancy|0
2350503|NCT03987620|4096448|FG000|Overall Study|Withdrawal by Subject|7
2350504|NCT03987620|4096449|FG001|Overall Study|Withdrawal by Subject|1
2350505|NCT03987620|4096448|FG000|Overall Study|Other|2
2350506|NCT03987620|4096449|FG001|Overall Study|Other|5
2350507|NCT03983317|4096455|FG000|Overall Study|Physician Decision|5
2350508|NCT03984825|4096518|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2
2350509|NCT03984825|4096518|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1
2350510|NCT03984825|4096518|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3
2271493|NCT02265510|3950630|FG013|Overall Study|Study Terminated by Sponsor|2
2271494|NCT02265705|3950688|FG000|Treatment Period Week 0-24|Adverse Event|3
2271495|NCT02265705|3950689|FG001|Treatment Period Week 0-24|Adverse Event|2
2271496|NCT02265705|3950690|FG002|Treatment Period Week 0-24|Adverse Event|0
2271497|NCT02265705|3950691|FG003|Treatment Period Week 0-24|Adverse Event|0
2271498|NCT02265705|3950692|FG004|Treatment Period Week 0-24|Adverse Event|0
2271499|NCT02265705|3950693|FG005|Treatment Period Week 0-24|Adverse Event|0
2271500|NCT02265705|3950694|FG006|Treatment Period Week 0-24|Adverse Event|0
2271501|NCT02265705|3950688|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1
2271502|NCT02265705|3950689|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1
2271503|NCT02265705|3950690|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0
2271504|NCT02265705|3950691|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0
2271505|NCT02265705|3950692|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0
2271506|NCT02265705|3950693|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0
2271507|NCT02265705|3950694|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0
2271508|NCT02265705|3950688|FG000|Treatment Period Week 0-24|Physician Decision|1
2271509|NCT02265705|3950689|FG001|Treatment Period Week 0-24|Physician Decision|0
2271510|NCT02265705|3950690|FG002|Treatment Period Week 0-24|Physician Decision|0
2271511|NCT02265705|3950691|FG003|Treatment Period Week 0-24|Physician Decision|0
2271512|NCT02265705|3950692|FG004|Treatment Period Week 0-24|Physician Decision|0
2271513|NCT02265705|3950693|FG005|Treatment Period Week 0-24|Physician Decision|0
2271514|NCT02265705|3950694|FG006|Treatment Period Week 0-24|Physician Decision|0
2271515|NCT02265705|3950688|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7
2271516|NCT02265705|3950689|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5
2271517|NCT02265705|3950690|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0
2271518|NCT02265705|3950691|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0
2271519|NCT02265705|3950692|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0
2271520|NCT02265705|3950693|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0
2271521|NCT02265705|3950694|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0
2271522|NCT02265705|3950688|FG000|Treatment Period Week 0-24|Lack of Efficacy|0
2271523|NCT02265705|3950689|FG001|Treatment Period Week 0-24|Lack of Efficacy|1
2271524|NCT02265705|3950690|FG002|Treatment Period Week 0-24|Lack of Efficacy|0
2271525|NCT02265705|3950691|FG003|Treatment Period Week 0-24|Lack of Efficacy|0
2271526|NCT02265705|3950692|FG004|Treatment Period Week 0-24|Lack of Efficacy|0
2271527|NCT02265705|3950693|FG005|Treatment Period Week 0-24|Lack of Efficacy|0
2271528|NCT02265705|3950694|FG006|Treatment Period Week 0-24|Lack of Efficacy|0
2271529|NCT02265705|3950688|FG000|Rescue Period|Withdrawal by Subject|0
2271530|NCT02265705|3950689|FG001|Rescue Period|Withdrawal by Subject|0
2271531|NCT02265705|3950690|FG002|Rescue Period|Withdrawal by Subject|1
2271532|NCT02265705|3950691|FG003|Rescue Period|Withdrawal by Subject|0
2271533|NCT02265705|3950692|FG004|Rescue Period|Withdrawal by Subject|0
2271534|NCT02265705|3950693|FG005|Rescue Period|Withdrawal by Subject|0
2271535|NCT02265705|3950694|FG006|Rescue Period|Withdrawal by Subject|0
2271536|NCT02265705|3950688|FG000|Rescue Period|Death|0
2271537|NCT02265705|3950689|FG001|Rescue Period|Death|0
2271538|NCT02265705|3950690|FG002|Rescue Period|Death|1
2271539|NCT02265705|3950691|FG003|Rescue Period|Death|0
2271540|NCT02265705|3950692|FG004|Rescue Period|Death|0
2271541|NCT02265705|3950693|FG005|Rescue Period|Death|0
2271542|NCT02265705|3950694|FG006|Rescue Period|Death|0
2271543|NCT02265705|3950688|FG000|Rescue Period|Lack of Efficacy|0
2271544|NCT02265705|3950689|FG001|Rescue Period|Lack of Efficacy|0
2271545|NCT02265705|3950690|FG002|Rescue Period|Lack of Efficacy|1
2271546|NCT02265705|3950691|FG003|Rescue Period|Lack of Efficacy|0
2271547|NCT02265705|3950692|FG004|Rescue Period|Lack of Efficacy|0
2271548|NCT02265705|3950693|FG005|Rescue Period|Lack of Efficacy|0
2271549|NCT02265705|3950694|FG006|Rescue Period|Lack of Efficacy|0
2271550|NCT02265705|3950688|FG000|Open Label Period|Adverse Event|0
2271551|NCT02265705|3950689|FG001|Open Label Period|Adverse Event|0
2271552|NCT02265705|3950690|FG002|Open Label Period|Adverse Event|0
2271553|NCT02265705|3950691|FG003|Open Label Period|Adverse Event|2
2271554|NCT02265705|3950692|FG004|Open Label Period|Adverse Event|2
2271555|NCT02265705|3950693|FG005|Open Label Period|Adverse Event|0
2271556|NCT02265705|3950694|FG006|Open Label Period|Adverse Event|0
2271557|NCT02265705|3950688|FG000|Open Label Period|Physician Decision|0
2271558|NCT02265705|3950689|FG001|Open Label Period|Physician Decision|0
2271559|NCT02265705|3950690|FG002|Open Label Period|Physician Decision|0
2271560|NCT02265705|3950691|FG003|Open Label Period|Physician Decision|0
2271561|NCT02265705|3950692|FG004|Open Label Period|Physician Decision|1
2271562|NCT02265705|3950693|FG005|Open Label Period|Physician Decision|0
2271563|NCT02265705|3950694|FG006|Open Label Period|Physician Decision|0
2271564|NCT02265705|3950688|FG000|Open Label Period|Withdrawal by Subject|0
2271565|NCT02265705|3950689|FG001|Open Label Period|Withdrawal by Subject|0
2271566|NCT02265705|3950690|FG002|Open Label Period|Withdrawal by Subject|0
2271567|NCT02265705|3950691|FG003|Open Label Period|Withdrawal by Subject|0
2271568|NCT02265705|3950692|FG004|Open Label Period|Withdrawal by Subject|2
2271569|NCT02265705|3950693|FG005|Open Label Period|Withdrawal by Subject|0
2271570|NCT02265705|3950694|FG006|Open Label Period|Withdrawal by Subject|0
2271571|NCT02265705|3950688|FG000|Follow-up Period|Sponsor Decision|0
2271572|NCT02265705|3950689|FG001|Follow-up Period|Sponsor Decision|0
2271573|NCT02265705|3950690|FG002|Follow-up Period|Sponsor Decision|0
2271574|NCT02265705|3950691|FG003|Follow-up Period|Sponsor Decision|0
2271575|NCT02265705|3950692|FG004|Follow-up Period|Sponsor Decision|0
2271576|NCT02265705|3950693|FG005|Follow-up Period|Sponsor Decision|1
2271577|NCT02265705|3950694|FG006|Follow-up Period|Sponsor Decision|6
2271578|NCT02265705|3950688|FG000|Follow-up Period|Adverse Event|0
2271579|NCT02265705|3950689|FG001|Follow-up Period|Adverse Event|0
2271580|NCT02265705|3950690|FG002|Follow-up Period|Adverse Event|0
2271581|NCT02265705|3950691|FG003|Follow-up Period|Adverse Event|0
2271582|NCT02265705|3950692|FG004|Follow-up Period|Adverse Event|0
2271583|NCT02265705|3950693|FG005|Follow-up Period|Adverse Event|0
2271584|NCT02265705|3950694|FG006|Follow-up Period|Adverse Event|3
2271585|NCT02265705|3950688|FG000|Follow-up Period|Physician Decision|0
2271586|NCT02265705|3950689|FG001|Follow-up Period|Physician Decision|0
2350511|NCT03982433|4096531|FG000|Overall Study|Lost to Follow-up|1
2271587|NCT02265705|3950690|FG002|Follow-up Period|Physician Decision|0
2271588|NCT02265705|3950691|FG003|Follow-up Period|Physician Decision|0
2271589|NCT02265705|3950692|FG004|Follow-up Period|Physician Decision|0
2271590|NCT02265705|3950693|FG005|Follow-up Period|Physician Decision|0
2271591|NCT02265705|3950694|FG006|Follow-up Period|Physician Decision|1
2271592|NCT02265705|3950688|FG000|Follow-up Period|Withdrawal by Subject|0
2271593|NCT02265705|3950689|FG001|Follow-up Period|Withdrawal by Subject|0
2271594|NCT02265705|3950690|FG002|Follow-up Period|Withdrawal by Subject|0
2271595|NCT02265705|3950691|FG003|Follow-up Period|Withdrawal by Subject|0
2271596|NCT02265705|3950692|FG004|Follow-up Period|Withdrawal by Subject|0
2271597|NCT02265705|3950693|FG005|Follow-up Period|Withdrawal by Subject|0
2271598|NCT02265705|3950694|FG006|Follow-up Period|Withdrawal by Subject|1
2271599|NCT02265744|3950710|FG000|Overall Study|Poor/Non-compliance|1
2350512|NCT03976466|4096541|FG000|Overall Study|Lost to Follow-up|1
2350513|NCT03976466|4096542|FG001|Overall Study|Lost to Follow-up|3
2350514|NCT03979638|4096552|FG000|Period 1|Physician Decision|1
2350515|NCT03979638|4096553|FG001|Period 1|Physician Decision|1
2350516|NCT03979638|4096552|FG000|Period 1|Withdrawal by Subject|4
2350517|NCT03979638|4096553|FG001|Period 1|Withdrawal by Subject|3
2350518|NCT03979638|4096552|FG000|Period 1|Study terminated by Sponsor|1
2350519|NCT03979638|4096553|FG001|Period 1|Study terminated by Sponsor|3
2350520|NCT03979638|4096552|FG000|Period 1|Protocol Violation|1
2350521|NCT03979638|4096553|FG001|Period 1|Protocol Violation|0
2350522|NCT03979638|4096552|FG000|Period 2|Study terminated by Sponsor|1
2350523|NCT03979638|4096553|FG001|Period 2|Study terminated by Sponsor|1
2350524|NCT03979274|4096568|FG000|Treatment Period 2|Withdrawal by Subject|0
2350525|NCT03979274|4096569|FG001|Treatment Period 2|Withdrawal by Subject|1
2350526|NCT03977727|4096586|FG000|Second Treatment|Lost to Follow-up|0
2350527|NCT03977727|4096587|FG001|Second Treatment|Lost to Follow-up|3
2350528|NCT03977155|4096596|FG000|Overall Study|Adverse Event|3
2350529|NCT03977155|4096597|FG001|Overall Study|Adverse Event|0
2350530|NCT03977155|4096598|FG002|Overall Study|Adverse Event|0
2350531|NCT03977155|4096596|FG000|Overall Study|Lost to Follow-up|0
2350532|NCT03977155|4096597|FG001|Overall Study|Lost to Follow-up|1
2350533|NCT03977155|4096598|FG002|Overall Study|Lost to Follow-up|0
2350534|NCT03977155|4096596|FG000|Overall Study|Withdrawal by Subject|1
2350535|NCT03977155|4096597|FG001|Overall Study|Withdrawal by Subject|1
2350536|NCT03977155|4096598|FG002|Overall Study|Withdrawal by Subject|2
2350537|NCT03977155|4096596|FG000|Overall Study|Participant was unable to come in for the Visit|1
2350538|NCT03977155|4096597|FG001|Overall Study|Participant was unable to come in for the Visit|0
2350539|NCT03977155|4096598|FG002|Overall Study|Participant was unable to come in for the Visit|0
2350540|NCT03970733|4096620|FG000|Overall Study|Withdrawal by Subject|0
2350541|NCT03970733|4096621|FG001|Overall Study|Withdrawal by Subject|5
2350542|NCT03970733|4096622|FG002|Overall Study|Withdrawal by Subject|1
2350543|NCT03970733|4096620|FG000|Overall Study|e.g.: moved from study area|1
2350544|NCT03970733|4096621|FG001|Overall Study|e.g.: moved from study area|0
2350545|NCT03970733|4096622|FG002|Overall Study|e.g.: moved from study area|0
2350546|NCT03970733|4096620|FG000|Overall Study|Lost to Follow-up|2
2350547|NCT03970733|4096621|FG001|Overall Study|Lost to Follow-up|1
2350548|NCT03970733|4096622|FG002|Overall Study|Lost to Follow-up|1
2350549|NCT03970733|4096620|FG000|Overall Study|Other|1
2350550|NCT03970733|4096621|FG001|Overall Study|Other|0
2350551|NCT03970733|4096622|FG002|Overall Study|Other|0
2350552|NCT03968978|4096632|FG000|Overall Study|Adverse Event|1
2350553|NCT03968978|4096633|FG001|Overall Study|Adverse Event|0
2350554|NCT03967444|4096650|FG000|Overall Study|Lost to Follow-up|1
2271600|NCT02265744|3950711|FG001|Overall Study|Poor/Non-compliance|1
2271601|NCT02265744|3950712|FG002|Overall Study|Poor/Non-compliance|0
2271602|NCT02265744|3950713|FG003|Overall Study|Poor/Non-compliance|0
2271603|NCT02265744|3950714|FG004|Overall Study|Poor/Non-compliance|2
2271604|NCT02265744|3950710|FG000|Overall Study|Lost to Follow-up|0
2271605|NCT02265744|3950711|FG001|Overall Study|Lost to Follow-up|0
2271606|NCT02265744|3950712|FG002|Overall Study|Lost to Follow-up|0
2271607|NCT02265744|3950713|FG003|Overall Study|Lost to Follow-up|1
2271608|NCT02265744|3950714|FG004|Overall Study|Lost to Follow-up|0
2271609|NCT02265744|3950710|FG000|Overall Study|Death|0
2271610|NCT02265744|3950711|FG001|Overall Study|Death|0
2271611|NCT02265744|3950712|FG002|Overall Study|Death|0
2271612|NCT02265744|3950713|FG003|Overall Study|Death|2
2271613|NCT02265744|3950714|FG004|Overall Study|Death|0
2271614|NCT02265744|3950710|FG000|Overall Study|Withdrawal by Subject|2
2271615|NCT02265744|3950711|FG001|Overall Study|Withdrawal by Subject|0
2271616|NCT02265744|3950712|FG002|Overall Study|Withdrawal by Subject|0
2271617|NCT02265744|3950713|FG003|Overall Study|Withdrawal by Subject|2
2271618|NCT02265744|3950714|FG004|Overall Study|Withdrawal by Subject|0
2271619|NCT02265744|3950710|FG000|Overall Study|Participant request to discontinue|2
2271620|NCT02265744|3950711|FG001|Overall Study|Participant request to discontinue|2
2271621|NCT02265744|3950712|FG002|Overall Study|Participant request to discontinue|2
2271622|NCT02265744|3950713|FG003|Overall Study|Participant request to discontinue|0
2271623|NCT02265744|3950714|FG004|Overall Study|Participant request to discontinue|0
2271624|NCT02265744|3950710|FG000|Overall Study|Adverse Event|8
2271625|NCT02265744|3950711|FG001|Overall Study|Adverse Event|4
2350555|NCT03967444|4096651|FG001|Overall Study|Lost to Follow-up|2
2271626|NCT02265744|3950712|FG002|Overall Study|Adverse Event|9
2271627|NCT02265744|3950713|FG003|Overall Study|Adverse Event|8
2271628|NCT02265744|3950714|FG004|Overall Study|Adverse Event|2
2271629|NCT02265744|3950710|FG000|Overall Study|Lack of Efficacy|2
2271630|NCT02265744|3950711|FG001|Overall Study|Lack of Efficacy|4
2271631|NCT02265744|3950712|FG002|Overall Study|Lack of Efficacy|3
2271632|NCT02265744|3950713|FG003|Overall Study|Lack of Efficacy|4
2271633|NCT02265744|3950714|FG004|Overall Study|Lack of Efficacy|5
2271634|NCT02265744|3950710|FG000|Overall Study|Reason not provided by Investigator|1
2271635|NCT02265744|3950711|FG001|Overall Study|Reason not provided by Investigator|0
2271636|NCT02265744|3950712|FG002|Overall Study|Reason not provided by Investigator|0
2271637|NCT02265744|3950713|FG003|Overall Study|Reason not provided by Investigator|2
2271638|NCT02265744|3950714|FG004|Overall Study|Reason not provided by Investigator|0
2271639|NCT02265744|3950710|FG000|Overall Study|Administrative reason by sponsor|3
2271640|NCT02265744|3950711|FG001|Overall Study|Administrative reason by sponsor|2
2271641|NCT02265744|3950712|FG002|Overall Study|Administrative reason by sponsor|2
2271642|NCT02265744|3950713|FG003|Overall Study|Administrative reason by sponsor|3
2271643|NCT02265744|3950714|FG004|Overall Study|Administrative reason by sponsor|3
2271644|NCT02265744|3950710|FG000|Overall Study|Subject no longer meets study criteria|0
2271645|NCT02265744|3950711|FG001|Overall Study|Subject no longer meets study criteria|0
2271646|NCT02265744|3950712|FG002|Overall Study|Subject no longer meets study criteria|0
2271647|NCT02265744|3950713|FG003|Overall Study|Subject no longer meets study criteria|0
2271648|NCT02265744|3950714|FG004|Overall Study|Subject no longer meets study criteria|1
2271649|NCT02265744|3950710|FG000|Overall Study|Pregnancy|1
2271650|NCT02265744|3950711|FG001|Overall Study|Pregnancy|2
2271651|NCT02265744|3950712|FG002|Overall Study|Pregnancy|1
2271652|NCT02265744|3950713|FG003|Overall Study|Pregnancy|1
2271653|NCT02265744|3950714|FG004|Overall Study|Pregnancy|0
2271654|NCT02265796|3950732|FG000|Overall Study|Death|1
2271655|NCT02265796|3950733|FG001|Overall Study|Death|0
2271656|NCT02265796|3950732|FG000|Overall Study|started on excluded medication|1
2271657|NCT02265796|3950733|FG001|Overall Study|started on excluded medication|0
2271658|NCT02265796|3950732|FG000|Overall Study|Withdrawal by Subject|1
2271659|NCT02265796|3950733|FG001|Overall Study|Withdrawal by Subject|1
2271660|NCT02265952|3950761|FG000|Open Label Extension (OLE) Period|Physician Decision|0
2271661|NCT02265952|3950762|FG001|Open Label Extension (OLE) Period|Physician Decision|7
2271662|NCT02265952|3950761|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
2271663|NCT02265952|3950762|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1
2271664|NCT02266004|3950777|FG000|Overall Study|unrelated adverse event|1
2271665|NCT02266004|3950777|FG000|Overall Study|Physician Decision|1
2271666|NCT02266147|3950794|FG000|PART 1: Dose Escalation|Physician Decision|0
2271667|NCT02266147|3950795|FG001|PART 1: Dose Escalation|Physician Decision|0
2271668|NCT02266147|3950796|FG002|PART 1: Dose Escalation|Physician Decision|1
2271669|NCT02266147|3950797|FG003|PART 1: Dose Escalation|Physician Decision|0
2271670|NCT02266147|3950794|FG000|PART 1: Dose Escalation|Lack of Efficacy|0
2271671|NCT02266147|3950795|FG001|PART 1: Dose Escalation|Lack of Efficacy|2
2271672|NCT02266147|3950796|FG002|PART 1: Dose Escalation|Lack of Efficacy|1
2271673|NCT02266147|3950797|FG003|PART 1: Dose Escalation|Lack of Efficacy|1
2271674|NCT02266147|3950794|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0
2271675|NCT02266147|3950795|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0
2271676|NCT02266147|3950796|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1
2271677|NCT02266147|3950797|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3
2271678|NCT02266147|3950794|FG000|PART 1: Dose Escalation|Other|1
2271679|NCT02266147|3950795|FG001|PART 1: Dose Escalation|Other|1
2271680|NCT02266147|3950796|FG002|PART 1: Dose Escalation|Other|0
2271681|NCT02266147|3950797|FG003|PART 1: Dose Escalation|Other|0
2271682|NCT02266147|3950794|FG000|PART 2: Dose Expansion|Lack of Efficacy|1
2271683|NCT02266147|3950795|FG001|PART 2: Dose Expansion|Lack of Efficacy|0
2271684|NCT02266147|3950796|FG002|PART 2: Dose Expansion|Lack of Efficacy|0
2271685|NCT02266147|3950797|FG003|PART 2: Dose Expansion|Lack of Efficacy|1
2271686|NCT02266147|3950794|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6
2271687|NCT02266147|3950795|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0
2271688|NCT02266147|3950796|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0
2271689|NCT02266147|3950797|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8
2271690|NCT02266225|3950809|FG000|Overall Study|Lost to Follow-up|2
2271691|NCT02266225|3950809|FG000|Overall Study|Death|1
2271692|NCT02266225|3950809|FG000|Overall Study|Withdrawal by Subject|13
2271693|NCT02266381|3950844|FG000|Overall Study|Physician Decision|3
2271694|NCT02266381|3950845|FG001|Overall Study|Physician Decision|5
2271695|NCT02266381|3950846|FG002|Overall Study|Physician Decision|4
2271696|NCT02266433|3950858|FG000|Overall Study|Lost to Follow-up|54
2271697|NCT02266433|3950859|FG001|Overall Study|Lost to Follow-up|46
2271698|NCT02266433|3950858|FG000|Overall Study|Withdrawal by Subject|5
2271699|NCT02266433|3950859|FG001|Overall Study|Withdrawal by Subject|7
2271700|NCT02266706|3950893|FG000|Overall Study|Withdrawal by Subject|0
2271701|NCT02266706|3950894|FG001|Overall Study|Withdrawal by Subject|1
2350556|NCT03966911|4096663|FG000|Overall Study|Adverse Event|1
2350557|NCT03966911|4096664|FG001|Overall Study|Adverse Event|1
2350558|NCT03966911|4096663|FG000|Overall Study|Withdrawal by Subject|8
2350559|NCT03966911|4096664|FG001|Overall Study|Withdrawal by Subject|2
2350560|NCT03966911|4096663|FG000|Overall Study|Unable to complete study visits due to COVID-19|0
2271702|NCT02266706|3950895|FG002|Overall Study|Withdrawal by Subject|1
2271703|NCT02266706|3950896|FG003|Overall Study|Withdrawal by Subject|0
2271704|NCT02266706|3950897|FG004|Overall Study|Withdrawal by Subject|0
2271705|NCT02266706|3950898|FG005|Overall Study|Withdrawal by Subject|1
2271706|NCT02266706|3950899|FG006|Overall Study|Withdrawal by Subject|0
2271707|NCT02266706|3950900|FG007|Overall Study|Withdrawal by Subject|0
2350561|NCT03966911|4096664|FG001|Overall Study|Unable to complete study visits due to COVID-19|13
2350562|NCT03966365|4096674|FG000|Overall Study|Protocol Violation|1
2350563|NCT03966365|4096675|FG001|Overall Study|Protocol Violation|0
2350564|NCT03965403|4096681|FG000|Overall Study|Subject not meeting eligibility criteria|1
2350565|NCT03965351|4096738|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
2350566|NCT03965351|4096739|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
2350567|NCT03965351|4096738|FG000|Second Intervention (4 Weeks)|Adverse Event|0
2350568|NCT03965351|4096739|FG001|Second Intervention (4 Weeks)|Adverse Event|1
2350569|NCT03958955|4096754|FG000|Overall Study|Adverse Event|1
2350570|NCT03965052|4096762|FG000|Overall Study|Protocol Violation|1
2350571|NCT03965052|4096763|FG001|Overall Study|Protocol Violation|0
2350572|NCT03963401|4096792|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1
2350573|NCT03963401|4096793|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2
2350574|NCT03963401|4096794|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0
2350575|NCT03963401|4096795|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0
2350576|NCT03963401|4096796|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1
2350577|NCT03963401|4096797|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2
2350578|NCT03963401|4096792|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
2350579|NCT03963401|4096793|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
2350580|NCT03963401|4096794|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
2350581|NCT03963401|4096795|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
2350582|NCT03963401|4096796|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
2350583|NCT03963401|4096797|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
2350584|NCT03963401|4096792|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
2350585|NCT03963401|4096793|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
2350586|NCT03963401|4096794|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
2350587|NCT03963401|4096795|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
2350588|NCT03963401|4096796|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
2350589|NCT03963401|4096797|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0
2350590|NCT03963401|4096792|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
2350591|NCT03963401|4096793|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1
2350592|NCT03963401|4096794|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
2350593|NCT03963401|4096795|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
2350594|NCT03963401|4096796|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
2350595|NCT03963401|4096797|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
2350596|NCT03963401|4096792|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6
2350597|NCT03963401|4096793|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3
2350598|NCT03963401|4096794|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2
2350599|NCT03963401|4096795|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0
2350600|NCT03963401|4096796|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4
2350601|NCT03963401|4096797|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3
2350602|NCT03963401|4096792|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
2350603|NCT03963401|4096793|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
2350604|NCT03963401|4096794|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
2350605|NCT03963401|4096795|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
2350606|NCT03963401|4096796|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
2350607|NCT03963401|4096797|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
2350608|NCT03963401|4096792|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
2350609|NCT03963401|4096793|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
2350610|NCT03963401|4096794|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1
2350611|NCT03963401|4096795|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
2350612|NCT03963401|4096796|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
2350613|NCT03963401|4096797|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
2350614|NCT03963401|4096792|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1
2350615|NCT03963401|4096793|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
2350616|NCT03963401|4096794|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
2350617|NCT03963401|4096795|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
2350618|NCT03963401|4096796|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
2350619|NCT03963401|4096797|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
2350620|NCT03963401|4096792|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4
2350621|NCT03963401|4096793|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
2350622|NCT03963401|4096794|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
2350623|NCT03963401|4096795|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
2350624|NCT03963401|4096796|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
2350625|NCT03963401|4096797|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
2271708|NCT02266706|3950901|FG008|Overall Study|Withdrawal by Subject|0
2271709|NCT02266706|3950893|FG000|Overall Study|Screen failure|0
2271710|NCT02266706|3950894|FG001|Overall Study|Screen failure|0
2271711|NCT02266706|3950895|FG002|Overall Study|Screen failure|0
2271712|NCT02266706|3950896|FG003|Overall Study|Screen failure|0
2271713|NCT02266706|3950897|FG004|Overall Study|Screen failure|0
2271714|NCT02266706|3950898|FG005|Overall Study|Screen failure|1
2271715|NCT02266706|3950899|FG006|Overall Study|Screen failure|1
2271716|NCT02266706|3950900|FG007|Overall Study|Screen failure|0
2271717|NCT02266706|3950901|FG008|Overall Study|Screen failure|0
2271718|NCT02266706|3950893|FG000|Overall Study|Enrollment in another study|0
2271719|NCT02266706|3950894|FG001|Overall Study|Enrollment in another study|0
2271720|NCT02266706|3950895|FG002|Overall Study|Enrollment in another study|0
2350626|NCT03963401|4096792|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1
2350627|NCT03963401|4096793|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
2350628|NCT03963401|4096794|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
2350629|NCT03963401|4096795|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
2350630|NCT03963401|4096796|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
2350631|NCT03963401|4096797|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
2350632|NCT03963401|4096792|FG000|Extension Period (Week 17 - Week 52)|Other|1
2350633|NCT03963401|4096793|FG001|Extension Period (Week 17 - Week 52)|Other|1
2350634|NCT03963401|4096794|FG002|Extension Period (Week 17 - Week 52)|Other|0
2350635|NCT03963401|4096795|FG003|Extension Period (Week 17 - Week 52)|Other|1
2350636|NCT03963401|4096796|FG004|Extension Period (Week 17 - Week 52)|Other|1
2350637|NCT03963401|4096797|FG005|Extension Period (Week 17 - Week 52)|Other|1
2350638|NCT03962790|4096824|FG000|Period 1|Adverse Event|0
2350639|NCT03962790|4096825|FG001|Period 1|Adverse Event|1
2350640|NCT03962790|4096824|FG000|Period 1|Failed to meet all eligibility criteria|1
2350641|NCT03962790|4096825|FG001|Period 1|Failed to meet all eligibility criteria|1
2350642|NCT03962790|4096824|FG000|Period 1|No Longer Meets Eligibility Criteria|1
2350643|NCT03962790|4096825|FG001|Period 1|No Longer Meets Eligibility Criteria|0
2350644|NCT03962790|4096824|FG000|Period 1|Withdrawal by Subject|1
2350645|NCT03962790|4096825|FG001|Period 1|Withdrawal by Subject|0
2350646|NCT03956225|4096833|FG000|Overall Study|Lack of Efficacy|1
2350647|NCT03956225|4096834|FG001|Overall Study|Lack of Efficacy|1
2350648|NCT03956225|4096833|FG000|Overall Study|Lost to Follow-up|0
2350649|NCT03956225|4096834|FG001|Overall Study|Lost to Follow-up|1
2350650|NCT03956225|4096833|FG000|Overall Study|Withdrawal by Subject|2
2350651|NCT03956225|4096834|FG001|Overall Study|Withdrawal by Subject|1
2350652|NCT03956225|4096833|FG000|Overall Study|Other Reasons|2
2350653|NCT03956225|4096834|FG001|Overall Study|Other Reasons|1
2350654|NCT03958149|4096852|FG000|Overall Study|Withdrawal by Subject|0
2350655|NCT03958149|4096853|FG001|Overall Study|Withdrawal by Subject|1
2350656|NCT03953183|4096865|FG000|Overall Study|Physician Decision|0
2350657|NCT03953183|4096866|FG001|Overall Study|Physician Decision|1
2350658|NCT03953183|4096865|FG000|Overall Study|Withdrawal by Subject|0
2350659|NCT03953183|4096866|FG001|Overall Study|Withdrawal by Subject|1
2350660|NCT03962738|4096887|FG000|Overall Study|Protocol Deviation|3
2350661|NCT03962738|4096888|FG001|Overall Study|Protocol Deviation|0
2350662|NCT03962738|4096889|FG002|Overall Study|Protocol Deviation|1
2350663|NCT03962738|4096890|FG003|Overall Study|Protocol Deviation|1
2350664|NCT03962738|4096887|FG000|Overall Study|Withdrawal by Subject|4
2350665|NCT03962738|4096888|FG001|Overall Study|Withdrawal by Subject|0
2350666|NCT03962738|4096889|FG002|Overall Study|Withdrawal by Subject|0
2350667|NCT03962738|4096890|FG003|Overall Study|Withdrawal by Subject|0
2350668|NCT03962738|4096887|FG000|Overall Study|Lost to Follow-up|0
2350669|NCT03962738|4096888|FG001|Overall Study|Lost to Follow-up|0
2350670|NCT03962738|4096889|FG002|Overall Study|Lost to Follow-up|1
2350671|NCT03962738|4096890|FG003|Overall Study|Lost to Follow-up|0
2350672|NCT03962101|4096908|FG000|Overall Study|Adverse Event|1
2350673|NCT03962101|4096908|FG000|Overall Study|Physician Decision|2
2350674|NCT03962101|4096908|FG000|Overall Study|Not related to medical events|1
2350675|NCT03959137|4096913|FG000|Overall Study|Protocol Violation|6
2350676|NCT03946124|4096917|FG000|Overall Study|Withdrawal by Subject|19
2350677|NCT03961308|4096923|FG000|Overall Study|Withdrawal by Subject|1
2350678|NCT03961308|4096924|FG001|Overall Study|Withdrawal by Subject|0
2350679|NCT03961308|4096923|FG000|Overall Study|Other|1
2350680|NCT03961308|4096924|FG001|Overall Study|Other|0
2350681|NCT03961308|4096923|FG000|Overall Study|Lost to Follow-up|0
2350682|NCT03961308|4096924|FG001|Overall Study|Lost to Follow-up|1
2350683|NCT03961308|4096923|FG000|Overall Study|Adverse Event|0
2350684|NCT03961308|4096924|FG001|Overall Study|Adverse Event|1
2350685|NCT03956862|4096950|FG000|Overall Study|Lost to Follow-up|1
2350686|NCT03956862|4096951|FG001|Overall Study|Lost to Follow-up|1
2350687|NCT03956862|4096950|FG000|Overall Study|Withdrawal by Subject|1
2350688|NCT03956862|4096951|FG001|Overall Study|Withdrawal by Subject|1
2271721|NCT02266706|3950896|FG003|Overall Study|Enrollment in another study|1
2271722|NCT02266706|3950897|FG004|Overall Study|Enrollment in another study|0
2271723|NCT02266706|3950898|FG005|Overall Study|Enrollment in another study|0
2271724|NCT02266706|3950899|FG006|Overall Study|Enrollment in another study|0
2271725|NCT02266706|3950900|FG007|Overall Study|Enrollment in another study|0
2271726|NCT02266706|3950901|FG008|Overall Study|Enrollment in another study|0
2271727|NCT02266875|3950941|FG000|Overall Study|Withdrawal by Subject|9
2271728|NCT02266875|3950942|FG001|Overall Study|Withdrawal by Subject|0
2271729|NCT02266875|3950941|FG000|Overall Study|Lost to Follow-up|2
2271730|NCT02266875|3950942|FG001|Overall Study|Lost to Follow-up|0
2271731|NCT02266888|3950950|FG000|Overall Study|Death|2
2271732|NCT02266888|3950951|FG001|Overall Study|Death|2
2271733|NCT02266888|3950952|FG002|Overall Study|Death|4
2271734|NCT02266888|3950953|FG003|Overall Study|Death|2
2271735|NCT02266888|3950950|FG000|Overall Study|Physician Decision|0
2271736|NCT02266888|3950951|FG001|Overall Study|Physician Decision|1
2271737|NCT02266888|3950952|FG002|Overall Study|Physician Decision|2
2271738|NCT02266888|3950953|FG003|Overall Study|Physician Decision|2
2271739|NCT02266888|3950950|FG000|Overall Study|Study Terminated|5
2271740|NCT02266888|3950951|FG001|Overall Study|Study Terminated|1
2271741|NCT02266888|3950952|FG002|Overall Study|Study Terminated|0
2271742|NCT02266888|3950953|FG003|Overall Study|Study Terminated|0
2271743|NCT02266888|3950950|FG000|Overall Study|No Longer Eligible|0
2271744|NCT02266888|3950951|FG001|Overall Study|No Longer Eligible|0
2271745|NCT02266888|3950952|FG002|Overall Study|No Longer Eligible|0
2271746|NCT02266888|3950953|FG003|Overall Study|No Longer Eligible|2
2271747|NCT02266888|3950950|FG000|Overall Study|Randomization Closed|0
2271748|NCT02266888|3950951|FG001|Overall Study|Randomization Closed|0
2271749|NCT02266888|3950952|FG002|Overall Study|Randomization Closed|4
2271750|NCT02266888|3950953|FG003|Overall Study|Randomization Closed|0
2271751|NCT02266888|3950950|FG000|Overall Study|Personnel unavailable at transplant|0
2271752|NCT02266888|3950951|FG001|Overall Study|Personnel unavailable at transplant|0
2271753|NCT02266888|3950952|FG002|Overall Study|Personnel unavailable at transplant|0
2271754|NCT02266888|3950953|FG003|Overall Study|Personnel unavailable at transplant|1
2271755|NCT02266888|3950950|FG000|Overall Study|Transfer of care|0
2271756|NCT02266888|3950951|FG001|Overall Study|Transfer of care|0
2271757|NCT02266888|3950952|FG002|Overall Study|Transfer of care|1
2271758|NCT02266888|3950953|FG003|Overall Study|Transfer of care|0
2271759|NCT02267135|3950967|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1
2271760|NCT02267135|3950968|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3
2271761|NCT02267135|3950967|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0
2271762|NCT02267135|3950968|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1
2271763|NCT02267135|3950967|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1
2271764|NCT02267135|3950968|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1
2271765|NCT02267135|3950967|FG000|Period 2 (Randomized Set)|Adverse Event|2
2271766|NCT02267135|3950968|FG001|Period 2 (Randomized Set)|Adverse Event|0
2271767|NCT02267135|3950967|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1
2271768|NCT02267135|3950968|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0
2271769|NCT02267187|3950977|FG000|Overall Study|Physician Decision|2
2271770|NCT02267187|3950977|FG000|Overall Study|Screen fail|3
2271771|NCT02267278|3951000|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1
2271772|NCT02267278|3951000|FG000|Overall Study|transformation to acute leukemia (AML)|1
2271773|NCT02267278|3951000|FG000|Overall Study|Developed new cancer diagnoses|2
2271774|NCT02267278|3951000|FG000|Overall Study|prescribed prohibited medication|1
2271775|NCT02267317|3951007|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
2271776|NCT02267317|3951008|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2271777|NCT02267317|3951009|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2271778|NCT02267317|3951010|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2271779|NCT02267317|3951011|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2271780|NCT02267317|3951012|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2271781|NCT02267317|3951007|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
2271782|NCT02267317|3951008|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2271783|NCT02267317|3951009|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2271784|NCT02267317|3951010|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2271785|NCT02267317|3951011|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2271786|NCT02267317|3951012|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2271787|NCT02267746|3951103|FG000|Overall Study|Adverse Event|0
2271788|NCT02267746|3951104|FG001|Overall Study|Adverse Event|2
2271789|NCT02267746|3951105|FG002|Overall Study|Adverse Event|1
2271790|NCT02267746|3951103|FG000|Overall Study|Protocol Violation|8
2271791|NCT02267746|3951104|FG001|Overall Study|Protocol Violation|7
2271792|NCT02267746|3951105|FG002|Overall Study|Protocol Violation|3
2271793|NCT02267746|3951103|FG000|Overall Study|Lack of Efficacy|11
2271794|NCT02267746|3951104|FG001|Overall Study|Lack of Efficacy|11
2271795|NCT02267746|3951105|FG002|Overall Study|Lack of Efficacy|15
2271796|NCT02267746|3951103|FG000|Overall Study|Protocol Violation|1
2271797|NCT02267746|3951104|FG001|Overall Study|Protocol Violation|2
2271798|NCT02267746|3951105|FG002|Overall Study|Protocol Violation|1
2271799|NCT02267746|3951103|FG000|Overall Study|Miscellaneous|1
2350689|NCT03954444|4096960|FG000|Overall Study|Withdrawal by Subject|5
2350690|NCT03954444|4096961|FG001|Overall Study|Withdrawal by Subject|5
2350691|NCT03954444|4096962|FG002|Overall Study|Withdrawal by Subject|5
2350692|NCT03954444|4096960|FG000|Overall Study|Adverse Event|1
2350693|NCT03954444|4096961|FG001|Overall Study|Adverse Event|3
2350694|NCT03954444|4096962|FG002|Overall Study|Adverse Event|2
2350695|NCT03954444|4096960|FG000|Overall Study|Protocol Violation|0
2271800|NCT02267746|3951104|FG001|Overall Study|Miscellaneous|0
2271801|NCT02267746|3951105|FG002|Overall Study|Miscellaneous|1
2271802|NCT02267824|3951137|FG000|Overall Study|Pregnancy|1
2271803|NCT02267824|3951138|FG001|Overall Study|Pregnancy|1
2271804|NCT02267824|3951137|FG000|Overall Study|Lost to Follow-up|4
2271805|NCT02267824|3951138|FG001|Overall Study|Lost to Follow-up|0
2271806|NCT02267824|3951137|FG000|Overall Study|Protocol Violation|3
2271807|NCT02267824|3951138|FG001|Overall Study|Protocol Violation|0
2271808|NCT02267824|3951137|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2
2271809|NCT02267824|3951138|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0
2271810|NCT02268045|3951164|FG000|Overall Study|Death|4
2271811|NCT02268045|3951165|FG001|Overall Study|Death|4
2271812|NCT02268045|3951164|FG000|Overall Study|Disease Progression|2
2271813|NCT02268045|3951165|FG001|Overall Study|Disease Progression|1
2271814|NCT02268045|3951164|FG000|Overall Study|Adverse Event|7
2271815|NCT02268045|3951165|FG001|Overall Study|Adverse Event|7
2271816|NCT02268045|3951164|FG000|Overall Study|Withdrawal by Subject|2
2271817|NCT02268045|3951165|FG001|Overall Study|Withdrawal by Subject|6
2271818|NCT02268045|3951164|FG000|Overall Study|Physician Decision|0
2271819|NCT02268045|3951165|FG001|Overall Study|Physician Decision|1
2271820|NCT02268045|3951164|FG000|Overall Study|Protocol Violation|1
2271821|NCT02268045|3951165|FG001|Overall Study|Protocol Violation|1
2271822|NCT02268058|3951177|FG000|Overall Study|Protocol Violation|1
2271823|NCT02268058|3951178|FG001|Overall Study|Protocol Violation|0
2271824|NCT02268058|3951179|FG002|Overall Study|Protocol Violation|0
2271825|NCT02268058|3951180|FG003|Overall Study|Protocol Violation|0
2271826|NCT02268084|3951192|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0
2271827|NCT02268084|3951193|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3
2271828|NCT02268084|3951192|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9
2271829|NCT02268084|3951193|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4
2271830|NCT02268214|3951217|FG000|Overall Study|Subject no longer meets study criteria|0
2271831|NCT02268214|3951218|FG001|Overall Study|Subject no longer meets study criteria|2
2271832|NCT02268214|3951219|FG002|Overall Study|Subject no longer meets study criteria|0
2271833|NCT02268214|3951217|FG000|Overall Study|Pregnancy|2
2271834|NCT02268214|3951218|FG001|Overall Study|Pregnancy|2
2271835|NCT02268214|3951219|FG002|Overall Study|Pregnancy|1
2271836|NCT02268214|3951217|FG000|Overall Study|Lost to Follow-up|3
2271837|NCT02268214|3951218|FG001|Overall Study|Lost to Follow-up|3
2271838|NCT02268214|3951219|FG002|Overall Study|Lost to Follow-up|4
2271839|NCT02268214|3951217|FG000|Overall Study|Lack of Efficacy|1
2271840|NCT02268214|3951218|FG001|Overall Study|Lack of Efficacy|0
2271841|NCT02268214|3951219|FG002|Overall Study|Lack of Efficacy|2
2271842|NCT02268214|3951217|FG000|Overall Study|Adverse Event|11
2271843|NCT02268214|3951218|FG001|Overall Study|Adverse Event|14
2271844|NCT02268214|3951219|FG002|Overall Study|Adverse Event|9
2271845|NCT02268214|3951217|FG000|Overall Study|Withdrawal by Subject|4
2271846|NCT02268214|3951218|FG001|Overall Study|Withdrawal by Subject|5
2271847|NCT02268214|3951219|FG002|Overall Study|Withdrawal by Subject|10
2271848|NCT02268214|3951217|FG000|Overall Study|Subject request to discontinue treatment|10
2271849|NCT02268214|3951218|FG001|Overall Study|Subject request to discontinue treatment|8
2271850|NCT02268214|3951219|FG002|Overall Study|Subject request to discontinue treatment|6
2271851|NCT02268214|3951217|FG000|Overall Study|Poor/non-compliance|2
2271852|NCT02268214|3951218|FG001|Overall Study|Poor/non-compliance|1
2271853|NCT02268214|3951219|FG002|Overall Study|Poor/non-compliance|2
2271854|NCT02268214|3951217|FG000|Overall Study|Other reasons|7
2271855|NCT02268214|3951218|FG001|Overall Study|Other reasons|3
2271856|NCT02268214|3951219|FG002|Overall Study|Other reasons|3
2271857|NCT02268214|3951217|FG000|Overall Study|Not entering long-term period|2
2271858|NCT02268214|3951218|FG001|Overall Study|Not entering long-term period|3
2271859|NCT02268214|3951219|FG002|Overall Study|Not entering long-term period|5
2350696|NCT03954444|4096961|FG001|Overall Study|Protocol Violation|3
2350697|NCT03954444|4096962|FG002|Overall Study|Protocol Violation|5
2350698|NCT03954444|4096960|FG000|Overall Study|Use of prohibited therapy|1
2350699|NCT03954444|4096961|FG001|Overall Study|Use of prohibited therapy|1
2350700|NCT03954444|4096962|FG002|Overall Study|Use of prohibited therapy|2
2350701|NCT03954444|4096960|FG000|Overall Study|Lost to Follow-up|1
2350702|NCT03954444|4096961|FG001|Overall Study|Lost to Follow-up|0
2350703|NCT03954444|4096962|FG002|Overall Study|Lost to Follow-up|1
2350704|NCT03954444|4096960|FG000|Overall Study|Non-compliant with study drug application|2
2350705|NCT03954444|4096961|FG001|Overall Study|Non-compliant with study drug application|2
2350706|NCT03954444|4096962|FG002|Overall Study|Non-compliant with study drug application|0
2350707|NCT03954444|4096960|FG000|Overall Study|Administrative reasons|0
2350708|NCT03954444|4096961|FG001|Overall Study|Administrative reasons|0
2350709|NCT03954444|4096962|FG002|Overall Study|Administrative reasons|1
2350710|NCT03954444|4096960|FG000|Overall Study|Miscellaneous|3
2350711|NCT03954444|4096961|FG001|Overall Study|Miscellaneous|2
2350712|NCT03954444|4096962|FG002|Overall Study|Miscellaneous|1
2350713|NCT03953820|4096970|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1
2350714|NCT03953820|4096971|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0
2350715|NCT03953820|4096972|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0
2271860|NCT02268396|3951227|FG000|Overall Study|Adverse Event|3
2271861|NCT02268396|3951227|FG000|Overall Study|Administrative|2
2271862|NCT02268396|3951227|FG000|Overall Study|Withdrawal by Subject|1
2271863|NCT02268396|3951227|FG000|Overall Study|Lost to Follow-up|2
2271864|NCT02268396|3951227|FG000|Overall Study|Protocol-Specified Criteria|2
2271865|NCT02268396|3951227|FG000|Overall Study|2 Subjects no Day 29 Assessment|2
2271866|NCT02268526|3951243|FG000|Overall Study|Adverse Event|0
2271867|NCT02268526|3951244|FG001|Overall Study|Adverse Event|2
2271868|NCT02268526|3951245|FG002|Overall Study|Adverse Event|1
2271869|NCT02268526|3951243|FG000|Overall Study|Death|1
2271870|NCT02268526|3951244|FG001|Overall Study|Death|11
2271871|NCT02268526|3951245|FG002|Overall Study|Death|0
2271872|NCT02268526|3951243|FG000|Overall Study|protocol deviation|0
2271873|NCT02268526|3951244|FG001|Overall Study|protocol deviation|1
2271874|NCT02268526|3951245|FG002|Overall Study|protocol deviation|0
2271875|NCT02268526|3951243|FG000|Overall Study|Physician Decision|0
2271876|NCT02268526|3951244|FG001|Overall Study|Physician Decision|0
2271877|NCT02268526|3951245|FG002|Overall Study|Physician Decision|1
2271878|NCT02268526|3951243|FG000|Overall Study|Subject/guardian decision|0
2271879|NCT02268526|3951244|FG001|Overall Study|Subject/guardian decision|7
2271880|NCT02268526|3951245|FG002|Overall Study|Subject/guardian decision|3
2271881|NCT02268786|3951257|FG000|Overall Study|No Euploid Embryos available|42
2271882|NCT02268786|3951258|FG001|Overall Study|No Euploid Embryos available|0
2271883|NCT02268786|3951257|FG000|Overall Study|Withdrawal by Subject|7
2271884|NCT02268786|3951258|FG001|Overall Study|Withdrawal by Subject|14
2271885|NCT02268786|3951257|FG000|Overall Study|Thaw Failure|6
2271886|NCT02268786|3951258|FG001|Overall Study|Thaw Failure|4
2271887|NCT02268786|3951257|FG000|Overall Study|Protocol Violation|1
2271888|NCT02268786|3951258|FG001|Overall Study|Protocol Violation|0
2271889|NCT02268812|3951268|FG000|Overall Study|Adverse Event|8
2271890|NCT02268812|3951269|FG001|Overall Study|Adverse Event|26
2271891|NCT02268812|3951270|FG002|Overall Study|Adverse Event|7
2271892|NCT02268812|3951271|FG003|Overall Study|Adverse Event|10
2271893|NCT02268812|3951268|FG000|Overall Study|Protocol deviation|0
2271894|NCT02268812|3951269|FG001|Overall Study|Protocol deviation|0
2271895|NCT02268812|3951270|FG002|Overall Study|Protocol deviation|1
2271896|NCT02268812|3951271|FG003|Overall Study|Protocol deviation|0
2271897|NCT02268812|3951268|FG000|Overall Study|Withdrawal by Subject|0
2271898|NCT02268812|3951269|FG001|Overall Study|Withdrawal by Subject|1
2271899|NCT02268812|3951270|FG002|Overall Study|Withdrawal by Subject|0
2271900|NCT02268812|3951271|FG003|Overall Study|Withdrawal by Subject|0
2271901|NCT02268812|3951268|FG000|Overall Study|Physician Decision|3
2271902|NCT02268812|3951269|FG001|Overall Study|Physician Decision|1
2271903|NCT02268812|3951270|FG002|Overall Study|Physician Decision|0
2271904|NCT02268812|3951271|FG003|Overall Study|Physician Decision|1
2271905|NCT02268812|3951268|FG000|Overall Study|Other|5
2271906|NCT02268812|3951269|FG001|Overall Study|Other|4
2271907|NCT02268812|3951270|FG002|Overall Study|Other|1
2271908|NCT02268812|3951271|FG003|Overall Study|Other|3
2271909|NCT02268851|3951287|FG000|Overall Study|Death|0
2271910|NCT02268851|3951288|FG001|Overall Study|Death|0
2271911|NCT02268851|3951289|FG002|Overall Study|Death|0
2271912|NCT02268851|3951290|FG003|Overall Study|Death|1
2271913|NCT02268851|3951291|FG004|Overall Study|Death|2
2271914|NCT02268851|3951292|FG005|Overall Study|Death|1
2271915|NCT02268851|3951287|FG000|Overall Study|Adverse Event|0
2271916|NCT02268851|3951288|FG001|Overall Study|Adverse Event|0
2271917|NCT02268851|3951289|FG002|Overall Study|Adverse Event|0
2271918|NCT02268851|3951290|FG003|Overall Study|Adverse Event|0
2271919|NCT02268851|3951291|FG004|Overall Study|Adverse Event|2
2271920|NCT02268851|3951292|FG005|Overall Study|Adverse Event|2
2271921|NCT02268851|3951287|FG000|Overall Study|Withdrawal by Subject|0
2271922|NCT02268851|3951288|FG001|Overall Study|Withdrawal by Subject|0
2271923|NCT02268851|3951289|FG002|Overall Study|Withdrawal by Subject|0
2271924|NCT02268851|3951290|FG003|Overall Study|Withdrawal by Subject|2
2271925|NCT02268851|3951291|FG004|Overall Study|Withdrawal by Subject|0
2271926|NCT02268851|3951292|FG005|Overall Study|Withdrawal by Subject|1
2271927|NCT02268851|3951287|FG000|Overall Study|Progressive Disease|1
2271928|NCT02268851|3951288|FG001|Overall Study|Progressive Disease|3
2271929|NCT02268851|3951289|FG002|Overall Study|Progressive Disease|0
2350716|NCT03953820|4096970|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1
2350717|NCT03953820|4096971|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0
2350718|NCT03953820|4096972|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0
2350719|NCT03951766|4096985|FG000|Treatment Phase|Lost to Follow-up|1
2350720|NCT03951766|4096985|FG000|Follow-up Phase|Lost to Follow-up|10
2350721|NCT03950856|4097015|FG000|Overall Study|Death|1
2350722|NCT03950856|4097016|FG001|Overall Study|Death|2
2350723|NCT03950856|4097017|FG002|Overall Study|Death|0
2350724|NCT03950856|4097018|FG003|Overall Study|Death|0
2350725|NCT03950856|4097015|FG000|Overall Study|Lost to Follow-up|5
2350726|NCT03950856|4097016|FG001|Overall Study|Lost to Follow-up|6
2350727|NCT03950856|4097017|FG002|Overall Study|Lost to Follow-up|8
2350728|NCT03950856|4097018|FG003|Overall Study|Lost to Follow-up|2
2350729|NCT03950856|4097015|FG000|Overall Study|Protocol Violation|2
2271930|NCT02268851|3951290|FG003|Overall Study|Progressive Disease|0
2271931|NCT02268851|3951291|FG004|Overall Study|Progressive Disease|1
2350730|NCT03950856|4097016|FG001|Overall Study|Protocol Violation|0
2271932|NCT02268851|3951292|FG005|Overall Study|Progressive Disease|4
2271933|NCT02268851|3951287|FG000|Overall Study|Physician Decision|0
2271934|NCT02268851|3951288|FG001|Overall Study|Physician Decision|0
2271935|NCT02268851|3951289|FG002|Overall Study|Physician Decision|1
2271936|NCT02268851|3951290|FG003|Overall Study|Physician Decision|0
2271937|NCT02268851|3951291|FG004|Overall Study|Physician Decision|0
2271938|NCT02268851|3951292|FG005|Overall Study|Physician Decision|1
2271939|NCT02268851|3951287|FG000|Overall Study|Patient Compliance|0
2271940|NCT02268851|3951288|FG001|Overall Study|Patient Compliance|0
2271941|NCT02268851|3951289|FG002|Overall Study|Patient Compliance|0
2271942|NCT02268851|3951290|FG003|Overall Study|Patient Compliance|0
2271943|NCT02268851|3951291|FG004|Overall Study|Patient Compliance|1
2271944|NCT02268851|3951292|FG005|Overall Study|Patient Compliance|1
2271945|NCT02268851|3951287|FG000|Overall Study|Co-Morbid Condition|0
2271946|NCT02268851|3951288|FG001|Overall Study|Co-Morbid Condition|0
2271947|NCT02268851|3951289|FG002|Overall Study|Co-Morbid Condition|0
2271948|NCT02268851|3951290|FG003|Overall Study|Co-Morbid Condition|0
2271949|NCT02268851|3951291|FG004|Overall Study|Co-Morbid Condition|1
2271950|NCT02268851|3951292|FG005|Overall Study|Co-Morbid Condition|1
2271951|NCT02268864|3951309|FG000|Overall Study|Withdrawal by Subject|2
2271952|NCT02268864|3951310|FG001|Overall Study|Withdrawal by Subject|0
2271953|NCT02268864|3951311|FG002|Overall Study|Withdrawal by Subject|0
2271954|NCT02268864|3951309|FG000|Overall Study|Death|0
2271955|NCT02268864|3951310|FG001|Overall Study|Death|1
2271956|NCT02268864|3951311|FG002|Overall Study|Death|0
2271957|NCT02269098|3951357|FG000|Overall Study|Lost to Follow-up|14
2271958|NCT02269098|3951358|FG001|Overall Study|Lost to Follow-up|9
2271959|NCT02269124|3951367|FG000|Overall Study|Lost to Follow-up|1
2271960|NCT02269124|3951368|FG001|Overall Study|Lost to Follow-up|0
2271961|NCT02269124|3951367|FG000|Overall Study|Withdrawal by Subject|0
2271962|NCT02269124|3951368|FG001|Overall Study|Withdrawal by Subject|2
2271963|NCT02269163|3951377|FG000|Overall Study|Lost to Follow-up|1
2271964|NCT02269163|3951378|FG001|Overall Study|Lost to Follow-up|0
2271965|NCT02269163|3951377|FG000|Overall Study|Major protocol violation|0
2271966|NCT02269163|3951378|FG001|Overall Study|Major protocol violation|1
2271967|NCT02269163|3951377|FG000|Overall Study|Other|2
2271968|NCT02269163|3951378|FG001|Overall Study|Other|2
2271969|NCT02269163|3951377|FG000|Overall Study|Withdrawal by Subject|0
2271970|NCT02269163|3951378|FG001|Overall Study|Withdrawal by Subject|3
2271971|NCT02269163|3951377|FG000|Overall Study|Physician Decision|0
2271972|NCT02269163|3951378|FG001|Overall Study|Physician Decision|1
2271973|NCT02269241|3951386|FG000|Overall Study|Lost to Follow-up|269
2271974|NCT02269241|3951386|FG000|Overall Study|Withdrawal by Subject|155
2271975|NCT02269241|3951386|FG000|Overall Study|Protocol Violation|1
2271976|NCT02269241|3951386|FG000|Overall Study|Physician Decision|7
2271977|NCT02269241|3951386|FG000|Overall Study|Pregnancy|15
2271978|NCT02269241|3951386|FG000|Overall Study|Wish for pregnancy|5
2271979|NCT02269241|3951386|FG000|Overall Study|Development of an exclusion criteria|16
2271980|NCT02269241|3951386|FG000|Overall Study|Adverse Event|113
2271981|NCT02269241|3951386|FG000|Overall Study|At the specific request of the sponsor|20
2271982|NCT02269241|3951386|FG000|Overall Study|Several reasons not classified|53
2271983|NCT02269241|3951386|FG000|Overall Study|Screening failures|546
2271984|NCT02269423|3951395|FG000|Overall Study|Discontinued due to change in residence|0
2271985|NCT02269423|3951396|FG001|Overall Study|Discontinued due to change in residence|1
2271986|NCT02269423|3951397|FG002|Overall Study|Discontinued due to change in residence|0
2271987|NCT02269423|3951398|FG003|Overall Study|Discontinued due to change in residence|1
2271988|NCT02269475|3951410|FG000|Overall Study|Meet Exclusion Criteria No. 17|3
2271989|NCT02269475|3951411|FG001|Overall Study|Meet Exclusion Criteria No. 17|0
2271990|NCT02269475|3951410|FG000|Overall Study|Withdrawal by Subject|0
2271991|NCT02269475|3951411|FG001|Overall Study|Withdrawal by Subject|1
2271992|NCT02269657|3951431|FG000|Overall Study|Protocol Violation|3
2271993|NCT02269709|3951437|FG000|Time of Enrollment|Withdrawal by Subject|3
2271994|NCT02269709|3951437|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
2271995|NCT02269709|3951437|FG000|Six Month Follow-up|Lost to Follow-up|12
2350731|NCT03950856|4097017|FG002|Overall Study|Protocol Violation|0
2350732|NCT03950856|4097018|FG003|Overall Study|Protocol Violation|1
2350733|NCT03950856|4097015|FG000|Overall Study|Withdrawal by Subject|4
2350734|NCT03950856|4097016|FG001|Overall Study|Withdrawal by Subject|1
2350735|NCT03950856|4097017|FG002|Overall Study|Withdrawal by Subject|3
2350736|NCT03950856|4097018|FG003|Overall Study|Withdrawal by Subject|1
2350737|NCT03950856|4097015|FG000|Overall Study|Unable to phone|7
2350738|NCT03950856|4097016|FG001|Overall Study|Unable to phone|6
2350739|NCT03950856|4097017|FG002|Overall Study|Unable to phone|7
2350740|NCT03950856|4097018|FG003|Overall Study|Unable to phone|2
2350741|NCT03956550|4097071|FG000|Overall Study|Sponsor decision|65
2350742|NCT03956550|4097072|FG001|Overall Study|Sponsor decision|66
2350743|NCT03956550|4097073|FG002|Overall Study|Sponsor decision|64
2350744|NCT03956550|4097071|FG000|Overall Study|Adverse Event|0
2350745|NCT03956550|4097072|FG001|Overall Study|Adverse Event|1
2350746|NCT03956550|4097073|FG002|Overall Study|Adverse Event|0
2350747|NCT03956550|4097071|FG000|Overall Study|Withdrawal by Subject|5
2350748|NCT03956550|4097072|FG001|Overall Study|Withdrawal by Subject|5
2350749|NCT03956550|4097073|FG002|Overall Study|Withdrawal by Subject|6
2350750|NCT03958656|4097125|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0
2271996|NCT02269787|3951444|FG000|Overall Study|Lost to Follow-up|20
2271997|NCT02269787|3951445|FG001|Overall Study|Lost to Follow-up|6
2271998|NCT02269787|3951444|FG000|Overall Study|Death|2
2271999|NCT02269787|3951445|FG001|Overall Study|Death|3
2272000|NCT02269787|3951444|FG000|Overall Study|Incapacitated|0
2272001|NCT02269787|3951445|FG001|Overall Study|Incapacitated|1
2272002|NCT02269943|3951453|FG000|Treatment Period|Death|0
2272003|NCT02269943|3951454|FG001|Treatment Period|Death|1
2272004|NCT02269943|3951453|FG000|Treatment Period|Adverse Event|1
2272005|NCT02269943|3951454|FG001|Treatment Period|Adverse Event|10
2272006|NCT02269943|3951453|FG000|Treatment Period|Progressive Disease|5
2272007|NCT02269943|3951454|FG001|Treatment Period|Progressive Disease|17
2272008|NCT02269943|3951453|FG000|Treatment Period|Symptomatic Deterioration|0
2272009|NCT02269943|3951454|FG001|Treatment Period|Symptomatic Deterioration|2
2272010|NCT02269943|3951453|FG000|Follow-Up Survival Period|Death|3
2272011|NCT02269943|3951454|FG001|Follow-Up Survival Period|Death|16
2272012|NCT02269943|3951453|FG000|Follow-Up Survival Period|Lost to Follow-up|0
2272013|NCT02269943|3951454|FG001|Follow-Up Survival Period|Lost to Follow-up|2
2272014|NCT02269943|3951453|FG000|Follow-Up Survival Period|Alive|2
2272015|NCT02269943|3951454|FG001|Follow-Up Survival Period|Alive|8
2272016|NCT02270242|3951475|FG000|Overall Study|Withdrawal by Subject|18
2272017|NCT02270242|3951476|FG001|Overall Study|Withdrawal by Subject|25
2272018|NCT02270242|3951475|FG000|Overall Study|Lost to Follow-up|41
2272019|NCT02270242|3951476|FG001|Overall Study|Lost to Follow-up|27
2272020|NCT02270242|3951475|FG000|Overall Study|Physician Decision|0
2272021|NCT02270242|3951476|FG001|Overall Study|Physician Decision|1
2272022|NCT02270515|3951491|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
2272023|NCT02270515|3951491|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5
2272024|NCT02270515|3951491|FG000|Intervention Period 1: 0-6 Months|Received transplant|3
2272025|NCT02270515|3951491|FG000|Intervention Period 1: 0-6 Months|Death|7
2272026|NCT02270515|3951491|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
2272027|NCT02270515|3951491|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7
2272028|NCT02270515|3951491|FG000|Intervention Period 2: 6-12 Months|Received transplant|1
2272029|NCT02270515|3951491|FG000|Intervention Period 2: 6-12 Months|Death|5
2272030|NCT02270515|3951491|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
2272031|NCT02270515|3951491|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
2272032|NCT02270515|3951491|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2
2272033|NCT02270515|3951491|FG000|Intervention Period 3: 12-18 Months|Received transplant|2
2272034|NCT02270515|3951491|FG000|Intervention Period 3: 12-18 Months|Death|3
2272035|NCT02270515|3951491|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
2272036|NCT02270671|3951513|FG000|Overall Study|Withdrawal by Subject|1
2272037|NCT02270671|3951514|FG001|Overall Study|Withdrawal by Subject|1
2272038|NCT02270671|3951513|FG000|Overall Study|Protocol Violation|0
2272039|NCT02270671|3951514|FG001|Overall Study|Protocol Violation|1
2272040|NCT02270671|3951513|FG000|Overall Study|Missed Post-intervention Data Collection|2
2272041|NCT02270671|3951514|FG001|Overall Study|Missed Post-intervention Data Collection|2
2272042|NCT02270671|3951513|FG000|Overall Study|Lost to Follow-up|2
2272043|NCT02270671|3951514|FG001|Overall Study|Lost to Follow-up|1
2272044|NCT02270736|3951523|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
2272045|NCT02270736|3951524|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1
2272046|NCT02270736|3951525|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
2272047|NCT02270736|3951526|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
2272048|NCT02270736|3951527|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
2272049|NCT02270736|3951523|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2
2272050|NCT02270736|3951524|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
2350751|NCT03958656|4097126|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1
2350752|NCT03958656|4097127|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0
2350753|NCT03958656|4097128|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0
2350754|NCT03958656|4097125|FG000|Overall Study|No longer meets eligibility criteria|0
2350755|NCT03958656|4097126|FG001|Overall Study|No longer meets eligibility criteria|0
2350756|NCT03958656|4097127|FG002|Overall Study|No longer meets eligibility criteria|1
2350757|NCT03958656|4097128|FG003|Overall Study|No longer meets eligibility criteria|0
2350758|NCT03958656|4097125|FG000|Overall Study|Started anti-cancer treatment|0
2350759|NCT03958656|4097126|FG001|Overall Study|Started anti-cancer treatment|0
2350760|NCT03958656|4097127|FG002|Overall Study|Started anti-cancer treatment|1
2350761|NCT03958656|4097128|FG003|Overall Study|Started anti-cancer treatment|0
2350762|NCT03954743|4097149|FG000|Overall Study|Adverse Event|1
2350763|NCT03954743|4097150|FG001|Overall Study|Adverse Event|0
2350764|NCT03954743|4097149|FG000|Overall Study|Lost to Follow-up|6
2350765|NCT03954743|4097150|FG001|Overall Study|Lost to Follow-up|4
2350766|NCT03954743|4097149|FG000|Overall Study|Protocol Violation|1
2350767|NCT03954743|4097150|FG001|Overall Study|Protocol Violation|0
2350768|NCT03954743|4097149|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13
2350769|NCT03954743|4097150|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12
2350770|NCT03954743|4097149|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
2350771|NCT03954743|4097150|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
2350772|NCT03951805|4097160|FG000|Overall Study|Adverse Event|1
2350773|NCT03951805|4097161|FG001|Overall Study|Adverse Event|0
2272051|NCT02270736|3951525|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1
2272052|NCT02270736|3951526|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
2272053|NCT02270736|3951527|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
2272054|NCT02270736|3951523|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
2272055|NCT02270736|3951524|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1
2272056|NCT02270736|3951525|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
2272057|NCT02270736|3951526|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
2272058|NCT02270736|3951527|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
2272059|NCT02270736|3951523|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
2272060|NCT02270736|3951524|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
2272061|NCT02270736|3951525|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1
2272062|NCT02270736|3951526|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
2272063|NCT02270736|3951527|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
2272064|NCT02270736|3951523|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0
2272065|NCT02270736|3951524|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0
2272066|NCT02270736|3951525|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0
2272067|NCT02270736|3951526|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1
2272068|NCT02270736|3951527|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0
2272069|NCT02270736|3951523|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
2272070|NCT02270736|3951524|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
2272071|NCT02270736|3951525|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
2272072|NCT02270736|3951526|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2
2272073|NCT02270736|3951527|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
2272074|NCT02270736|3951523|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0
2272075|NCT02270736|3951524|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0
2272076|NCT02270736|3951525|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0
2272077|NCT02270736|3951526|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4
2272078|NCT02270736|3951527|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0
2272079|NCT02270736|3951523|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
2272080|NCT02270736|3951524|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
2272081|NCT02270736|3951525|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
2272082|NCT02270736|3951526|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16
2272083|NCT02270736|3951527|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
2272084|NCT02270736|3951523|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
2350774|NCT03951805|4097162|FG002|Overall Study|Adverse Event|0
2350775|NCT03951805|4097163|FG003|Overall Study|Adverse Event|0
2350776|NCT03950622|4097188|FG000|Overall Study|Withdrawal by Subject|1
2350777|NCT03950622|4097189|FG001|Overall Study|Withdrawal by Subject|0
2350778|NCT03950622|4097188|FG000|Overall Study|Protocol Deviation|0
2350779|NCT03950622|4097189|FG001|Overall Study|Protocol Deviation|1
2350780|NCT03950622|4097188|FG000|Overall Study|Physician Decision|1
2350781|NCT03950622|4097189|FG001|Overall Study|Physician Decision|0
2350782|NCT03950622|4097188|FG000|Overall Study|Lost to Follow-up|5
2350783|NCT03950622|4097189|FG001|Overall Study|Lost to Follow-up|5
2350784|NCT03950622|4097188|FG000|Overall Study|Death|1
2350785|NCT03950622|4097189|FG001|Overall Study|Death|1
2350786|NCT03948581|4097219|FG000|Overall Study|Lost to Follow-up|0
2350787|NCT03948581|4097220|FG001|Overall Study|Lost to Follow-up|1
2350788|NCT03948334|4097241|FG000|Overall Study|Adverse Event|1
2350789|NCT03948334|4097242|FG001|Overall Study|Adverse Event|4
2350790|NCT03948334|4097241|FG000|Overall Study|Lack of Efficacy|2
2350791|NCT03948334|4097242|FG001|Overall Study|Lack of Efficacy|0
2350792|NCT03948334|4097241|FG000|Overall Study|Lost to Follow-up|1
2350793|NCT03948334|4097242|FG001|Overall Study|Lost to Follow-up|0
2350794|NCT03948334|4097241|FG000|Overall Study|Physician Decision|1
2350795|NCT03948334|4097242|FG001|Overall Study|Physician Decision|0
2350796|NCT03948334|4097241|FG000|Overall Study|Pregnancy|0
2350797|NCT03948334|4097242|FG001|Overall Study|Pregnancy|1
2350798|NCT03948334|4097241|FG000|Overall Study|Protocol Deviation|1
2350799|NCT03948334|4097242|FG001|Overall Study|Protocol Deviation|0
2350800|NCT03948334|4097241|FG000|Overall Study|Study terminated by Sponsor|50
2350801|NCT03948334|4097242|FG001|Overall Study|Study terminated by Sponsor|51
2350802|NCT03948334|4097241|FG000|Overall Study|Subject Decision /Guardian Decision|4
2350803|NCT03948334|4097242|FG001|Overall Study|Subject Decision /Guardian Decision|7
2350804|NCT03944707|4097269|FG000|Overall Study|Adverse Event|0
2350805|NCT03944707|4097270|FG001|Overall Study|Adverse Event|2
2350806|NCT03944707|4097269|FG000|Overall Study|Study terminated by sponsor|12
2350807|NCT03944707|4097270|FG001|Overall Study|Study terminated by sponsor|7
2350808|NCT03944707|4097269|FG000|Overall Study|Subject decision|0
2350809|NCT03944707|4097270|FG001|Overall Study|Subject decision|1
2350810|NCT03943095|4097287|FG000|Overall Study|Incorrectly dispensed wrong box kit|0
2350811|NCT03943095|4097288|FG001|Overall Study|Incorrectly dispensed wrong box kit|1
2350812|NCT03943095|4097287|FG000|Overall Study|Withdrawal by Subject|1
2350813|NCT03943095|4097288|FG001|Overall Study|Withdrawal by Subject|0
2350814|NCT03943290|4097304|FG000|Overall Study|Sponsor Terminated Study|6
2350815|NCT03943290|4097305|FG001|Overall Study|Sponsor Terminated Study|1
2350816|NCT03943290|4097306|FG002|Overall Study|Sponsor Terminated Study|11
2350817|NCT03943290|4097307|FG003|Overall Study|Sponsor Terminated Study|6
2350818|NCT03943290|4097308|FG004|Overall Study|Sponsor Terminated Study|7
2272085|NCT02270736|3951524|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
2272086|NCT02270736|3951525|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
2272087|NCT02270736|3951526|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2
2272088|NCT02270736|3951527|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
2272089|NCT02270944|3951542|FG000|Overall Study|Lost to Follow-up|9
2272090|NCT02270944|3951543|FG001|Overall Study|Lost to Follow-up|4
2272091|NCT02270944|3951542|FG000|Overall Study|Withdrawal by Subject|2
2272092|NCT02270944|3951543|FG001|Overall Study|Withdrawal by Subject|1
2272093|NCT02270983|3951553|FG000|Overall Study|Adverse Event|3
2272094|NCT02270983|3951554|FG001|Overall Study|Adverse Event|2
2272095|NCT02270983|3951555|FG002|Overall Study|Adverse Event|6
2272096|NCT02270983|3951553|FG000|Overall Study|Lack of Efficacy|2
2272097|NCT02270983|3951554|FG001|Overall Study|Lack of Efficacy|1
2272098|NCT02270983|3951555|FG002|Overall Study|Lack of Efficacy|1
2272099|NCT02270983|3951553|FG000|Overall Study|Withdrawal by Subject|1
2272100|NCT02270983|3951554|FG001|Overall Study|Withdrawal by Subject|0
2272101|NCT02270983|3951555|FG002|Overall Study|Withdrawal by Subject|2
2272102|NCT02270983|3951553|FG000|Overall Study|Lost to Follow-up|1
2272103|NCT02270983|3951554|FG001|Overall Study|Lost to Follow-up|1
2272104|NCT02270983|3951555|FG002|Overall Study|Lost to Follow-up|2
2272105|NCT02270983|3951553|FG000|Overall Study|Protocol Violation|1
2272106|NCT02270983|3951554|FG001|Overall Study|Protocol Violation|1
2272107|NCT02270983|3951555|FG002|Overall Study|Protocol Violation|1
2272108|NCT02270983|3951553|FG000|Overall Study|family emergency|0
2272109|NCT02270983|3951554|FG001|Overall Study|family emergency|1
2272110|NCT02270983|3951555|FG002|Overall Study|family emergency|0
2272111|NCT02270983|3951553|FG000|Overall Study|study procedure non-compliance|1
2272112|NCT02270983|3951554|FG001|Overall Study|study procedure non-compliance|0
2272113|NCT02270983|3951555|FG002|Overall Study|study procedure non-compliance|0
2272114|NCT02270983|3951553|FG000|Overall Study|moved away from study site|0
2272115|NCT02270983|3951554|FG001|Overall Study|moved away from study site|1
2272116|NCT02270983|3951555|FG002|Overall Study|moved away from study site|0
2272117|NCT02271529|3951621|FG000|Overall Study|Withdrawal by Subject|1
2272118|NCT02271854|3951642|FG000|Overall Study|Withdrawal by Subject|2
2272119|NCT02271854|3951642|FG000|Overall Study|Unable or unwilling to cooperate with st|1
2272120|NCT02271854|3951642|FG000|Overall Study|Lost to Follow-up|1
2272121|NCT02271880|3951649|FG000|Overall Study|Premature discontinuation of study|3
2272122|NCT02271880|3951650|FG001|Overall Study|Premature discontinuation of study|4
2272123|NCT02271945|3951664|FG000|Overall Study|Death|3
2272124|NCT02271945|3951665|FG001|Overall Study|Death|3
2272125|NCT02271945|3951664|FG000|Overall Study|Withdrawal by Subject|1
2272126|NCT02271945|3951665|FG001|Overall Study|Withdrawal by Subject|1
2272127|NCT02271945|3951664|FG000|Overall Study|Other|1
2272128|NCT02271945|3951665|FG001|Overall Study|Other|1
2272129|NCT02271984|3951671|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2272130|NCT02271984|3951672|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2272131|NCT02271984|3951673|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2272132|NCT02271984|3951674|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2272133|NCT02271984|3951675|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2272134|NCT02271984|3951676|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1
2272135|NCT02271984|3951677|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2272136|NCT02271984|3951678|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1
2272137|NCT02271984|3951679|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2272138|NCT02271984|3951680|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2272139|NCT02271984|3951681|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2272140|NCT02271984|3951682|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2272141|NCT02272413|3951708|FG000|Randomized Through Treatment Start|Not treated|3
2272142|NCT02272413|3951709|FG001|Randomized Through Treatment Start|Not treated|5
2272143|NCT02272413|3951708|FG000|Pre-switch Period|Adverse Event|38
2272144|NCT02272413|3951709|FG001|Pre-switch Period|Adverse Event|37
2272145|NCT02272413|3951708|FG000|Pre-switch Period|Death|26
2272146|NCT02272413|3951709|FG001|Pre-switch Period|Death|26
2272147|NCT02272413|3951708|FG000|Pre-switch Period|Withdrawal by Subject|27
2272148|NCT02272413|3951709|FG001|Pre-switch Period|Withdrawal by Subject|15
2272149|NCT02272413|3951708|FG000|Pre-switch Period|Physician Decision|6
2272150|NCT02272413|3951709|FG001|Pre-switch Period|Physician Decision|18
2272151|NCT02272413|3951708|FG000|Pre-switch Period|Progressive disease|185
2272152|NCT02272413|3951709|FG001|Pre-switch Period|Progressive disease|173
2272153|NCT02272413|3951708|FG000|Pre-switch Period|Lost to Follow-up|0
2272154|NCT02272413|3951709|FG001|Pre-switch Period|Lost to Follow-up|2
2272155|NCT02272413|3951708|FG000|Pre-switch Period|Protocol Violation|1
2272156|NCT02272413|3951709|FG001|Pre-switch Period|Protocol Violation|0
2272157|NCT02272413|3951708|FG000|Pre-switch Period|Other than listed|10
2272158|NCT02272413|3951709|FG001|Pre-switch Period|Other than listed|11
2272159|NCT02272413|3951708|FG000|Post-switch Period|Adverse Event|4
2272160|NCT02272413|3951709|FG001|Post-switch Period|Adverse Event|4
2272161|NCT02272413|3951708|FG000|Post-switch Period|Death|3
2272162|NCT02272413|3951709|FG001|Post-switch Period|Death|2
2272163|NCT02272413|3951708|FG000|Post-switch Period|Withdrawal by Subject|1
2272164|NCT02272413|3951709|FG001|Post-switch Period|Withdrawal by Subject|2
2272165|NCT02272413|3951708|FG000|Post-switch Period|Physician Decision|1
2272166|NCT02272413|3951709|FG001|Post-switch Period|Physician Decision|1
2272167|NCT02272413|3951708|FG000|Post-switch Period|Progressive disease|21
2272168|NCT02272413|3951709|FG001|Post-switch Period|Progressive disease|21
2272169|NCT02272413|3951708|FG000|Post-switch Period|Study terminated by sponsor|8
2272170|NCT02272413|3951709|FG001|Post-switch Period|Study terminated by sponsor|11
2272171|NCT02272413|3951708|FG000|Post-switch Period|Other than listed|4
2272172|NCT02272413|3951709|FG001|Post-switch Period|Other than listed|5
2272173|NCT02272634|3951720|FG000|Overall Study|Adverse Event|1
2272174|NCT02272634|3951721|FG001|Overall Study|Adverse Event|0
2272175|NCT02272634|3951722|FG002|Overall Study|Adverse Event|0
2272176|NCT02272634|3951720|FG000|Overall Study|Protocol Violation|0
2272177|NCT02272634|3951721|FG001|Overall Study|Protocol Violation|0
2272178|NCT02272634|3951722|FG002|Overall Study|Protocol Violation|1
2272179|NCT02272634|3951720|FG000|Overall Study|Withdrawal by Subject|0
2272180|NCT02272634|3951721|FG001|Overall Study|Withdrawal by Subject|1
2272181|NCT02272634|3951722|FG002|Overall Study|Withdrawal by Subject|0
2272182|NCT02272725|3951739|FG000|Overall Study|equipment malfunction|2
2272183|NCT02272725|3951740|FG001|Overall Study|equipment malfunction|0
2272184|NCT02272777|3951748|FG000|Overall Study|Adverse Event|0
2272185|NCT02272777|3951749|FG001|Overall Study|Adverse Event|1
2272186|NCT02272777|3951748|FG000|Overall Study|Withdrawal by Subject|0
2272187|NCT02272777|3951749|FG001|Overall Study|Withdrawal by Subject|3
2272188|NCT02272777|3951748|FG000|Overall Study|Lost to Follow-up|2
2272189|NCT02272777|3951749|FG001|Overall Study|Lost to Follow-up|0
2272190|NCT02272777|3951748|FG000|Overall Study|Other|2
2272191|NCT02272777|3951749|FG001|Overall Study|Other|0
2272192|NCT02272790|3951761|FG000|Overall Study|Physician Decision|0
2272193|NCT02272790|3951762|FG001|Overall Study|Physician Decision|1
2272194|NCT02272790|3951763|FG002|Overall Study|Physician Decision|0
2272195|NCT02272790|3951764|FG003|Overall Study|Physician Decision|0
2272196|NCT02272790|3951765|FG004|Overall Study|Physician Decision|0
2272197|NCT02272790|3951766|FG005|Overall Study|Physician Decision|0
2272198|NCT02272816|3951786|FG000|Overall Study|Adverse Event|1
2272199|NCT02272842|3951792|FG000|Overall Study|Lost to Follow-up|8
2272200|NCT02272842|3951793|FG001|Overall Study|Lost to Follow-up|8
2272201|NCT02272842|3951792|FG000|Overall Study|Withdrawal by Subject|8
2272202|NCT02272842|3951793|FG001|Overall Study|Withdrawal by Subject|2
2272203|NCT02272985|3951800|FG000|Overall Study|Withdrawal by Subject|1
2272204|NCT02272985|3951800|FG000|Overall Study|hip fracture|1
2272205|NCT02272985|3951800|FG000|Overall Study|kidney transplantation|1
2272206|NCT02273037|3951807|FG000|Overall Study|Lost to Follow-up|1
2272207|NCT02273037|3951808|FG001|Overall Study|Lost to Follow-up|0
2272208|NCT02273037|3951807|FG000|Overall Study|Delivered before monitoring initiated|1
2272209|NCT02273037|3951808|FG001|Overall Study|Delivered before monitoring initiated|3
2272210|NCT02273037|3951807|FG000|Overall Study|Breech delivery|2
2272211|NCT02273037|3951808|FG001|Overall Study|Breech delivery|3
2272212|NCT02273037|3951807|FG000|Overall Study|Multiple delivery|2
2272213|NCT02273037|3951808|FG001|Overall Study|Multiple delivery|2
2272214|NCT02273037|3951807|FG000|Overall Study|Other complication|2
2272215|NCT02273037|3951808|FG001|Overall Study|Other complication|0
2272216|NCT02273050|3951819|FG000|Overall Study|Adverse Event|4
2272217|NCT02273050|3951820|FG001|Overall Study|Adverse Event|3
2272218|NCT02273050|3951821|FG002|Overall Study|Adverse Event|3
2272219|NCT02273050|3951819|FG000|Overall Study|Death|0
2272220|NCT02273050|3951820|FG001|Overall Study|Death|0
2272221|NCT02273050|3951821|FG002|Overall Study|Death|1
2272222|NCT02273050|3951819|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0
2272223|NCT02273050|3951820|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1
2272224|NCT02273050|3951821|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1
2272225|NCT02273050|3951819|FG000|Overall Study|Lack of Efficacy|0
2272226|NCT02273050|3951820|FG001|Overall Study|Lack of Efficacy|1
2272227|NCT02273050|3951821|FG002|Overall Study|Lack of Efficacy|1
2272228|NCT02273050|3951819|FG000|Overall Study|Withdrawal by Subject|17
2272229|NCT02273050|3951820|FG001|Overall Study|Withdrawal by Subject|14
2272230|NCT02273050|3951821|FG002|Overall Study|Withdrawal by Subject|16
2272231|NCT02273050|3951819|FG000|Overall Study|Lost to Follow-up|0
2272232|NCT02273050|3951820|FG001|Overall Study|Lost to Follow-up|2
2272233|NCT02273050|3951821|FG002|Overall Study|Lost to Follow-up|3
2272234|NCT02273050|3951819|FG000|Overall Study|Protocol Violation|3
2272235|NCT02273050|3951820|FG001|Overall Study|Protocol Violation|1
2272236|NCT02273050|3951821|FG002|Overall Study|Protocol Violation|4
2272237|NCT02273141|3951853|FG000|Overall Study|Adverse Event|0
2272238|NCT02273141|3951854|FG001|Overall Study|Adverse Event|1
2272239|NCT02273141|3951853|FG000|Overall Study|Lost to Follow-up|1
2272240|NCT02273141|3951854|FG001|Overall Study|Lost to Follow-up|3
2272241|NCT02273141|3951853|FG000|Overall Study|Withdrawal by Subject|10
2272242|NCT02273141|3951854|FG001|Overall Study|Withdrawal by Subject|15
2272243|NCT02273141|3951853|FG000|Overall Study|Various|6
2272244|NCT02273141|3951854|FG001|Overall Study|Various|6
2272245|NCT02273167|3951863|FG000|Overall Study|Adverse Event|1
2272246|NCT02273167|3951864|FG001|Overall Study|Adverse Event|0
2272247|NCT02273167|3951865|FG002|Overall Study|Adverse Event|0
2272248|NCT02273167|3951863|FG000|Overall Study|Protocol Violation|3
2272249|NCT02273167|3951864|FG001|Overall Study|Protocol Violation|1
2272250|NCT02273167|3951865|FG002|Overall Study|Protocol Violation|1
2272251|NCT02273167|3951863|FG000|Overall Study|Lost to Follow-up|0
2272252|NCT02273167|3951864|FG001|Overall Study|Lost to Follow-up|1
2272253|NCT02273167|3951865|FG002|Overall Study|Lost to Follow-up|1
2272254|NCT02273167|3951863|FG000|Overall Study|Withdrawal by Subject|10
2272255|NCT02273167|3951864|FG001|Overall Study|Withdrawal by Subject|12
2272256|NCT02273167|3951865|FG002|Overall Study|Withdrawal by Subject|11
2272257|NCT02273167|3951863|FG000|Overall Study|Various|10
2272258|NCT02273167|3951864|FG001|Overall Study|Various|9
2272259|NCT02273167|3951865|FG002|Overall Study|Various|8
2272260|NCT02273180|3951876|FG000|Overall Study|Adverse Event|2
2272261|NCT02273180|3951877|FG001|Overall Study|Adverse Event|2
2272262|NCT02273180|3951876|FG000|Overall Study|Lack of Efficacy|1
2272263|NCT02273180|3951877|FG001|Overall Study|Lack of Efficacy|0
2272264|NCT02273180|3951876|FG000|Overall Study|Protocol Violation|1
2272265|NCT02273180|3951877|FG001|Overall Study|Protocol Violation|7
2272266|NCT02273180|3951876|FG000|Overall Study|Randomized but not treated|1
2272267|NCT02273180|3951877|FG001|Overall Study|Randomized but not treated|0
2272268|NCT02273180|3951876|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1
2272269|NCT02273180|3951877|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0
2272270|NCT02273180|3951876|FG000|Overall Study|Other than specified above|21
2272271|NCT02273180|3951877|FG001|Overall Study|Other than specified above|10
2272272|NCT02273596|3951909|FG000|24-Week Treatment Period|Adverse Event|3
2272273|NCT02273596|3951909|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1
2272274|NCT02273596|3951909|FG000|24-Week Treatment Period|Participant was unable to Come|1
2272275|NCT02273596|3951909|FG000|24-Week Treatment Period|Physician Decision|1
2272276|NCT02273596|3951909|FG000|24-Week Treatment Period|Protocol Deviation|1
2272277|NCT02273596|3951909|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19
2272278|NCT02273596|3951909|FG000|Extension Period|Participant Withdrew for Personal Reasons|1
2272279|NCT02273596|3951909|FG000|Extension Period|Lost to Follow-up|1
2272280|NCT02273596|3951909|FG000|Extension Period|Protocol Deviation|1
2272281|NCT02273726|3951921|FG000|Overall Study|Death|70
2272282|NCT02273726|3951922|FG001|Overall Study|Death|62
2272283|NCT02273726|3951921|FG000|Overall Study|Withdrawal by Subject|41
2272284|NCT02273726|3951922|FG001|Overall Study|Withdrawal by Subject|29
2272285|NCT02273726|3951921|FG000|Overall Study|Kidney transplant|31
2272286|NCT02273726|3951922|FG001|Overall Study|Kidney transplant|39
2272287|NCT02273726|3951921|FG000|Overall Study|Physician Decision|30
2272288|NCT02273726|3951922|FG001|Overall Study|Physician Decision|15
2272289|NCT02273726|3951921|FG000|Overall Study|Adverse Event|27
2272290|NCT02273726|3951922|FG001|Overall Study|Adverse Event|9
2272291|NCT02273726|3951921|FG000|Overall Study|Lost to Follow-up|6
2272292|NCT02273726|3951922|FG001|Overall Study|Lost to Follow-up|3
2272293|NCT02273726|3951921|FG000|Overall Study|Lack of Efficacy|6
2272294|NCT02273726|3951922|FG001|Overall Study|Lack of Efficacy|1
2272295|NCT02273726|3951921|FG000|Overall Study|Protocol Violation|4
2272296|NCT02273726|3951922|FG001|Overall Study|Protocol Violation|0
2272297|NCT02273726|3951921|FG000|Overall Study|Other than specified|28
2272298|NCT02273726|3951922|FG001|Overall Study|Other than specified|30
2272299|NCT02273739|3951932|FG000|Overall Study|Progression of Disease|3
2272300|NCT02273739|3951933|FG001|Overall Study|Progression of Disease|4
2272301|NCT02273739|3951934|FG002|Overall Study|Progression of Disease|5
2272302|NCT02273739|3951935|FG003|Overall Study|Progression of Disease|2
2272303|NCT02273739|3951932|FG000|Overall Study|Death|0
2272304|NCT02273739|3951933|FG001|Overall Study|Death|0
2272305|NCT02273739|3951934|FG002|Overall Study|Death|0
2272306|NCT02273739|3951935|FG003|Overall Study|Death|2
2272307|NCT02273739|3951932|FG000|Overall Study|Adverse Event|0
2272308|NCT02273739|3951933|FG001|Overall Study|Adverse Event|0
2272309|NCT02273739|3951934|FG002|Overall Study|Adverse Event|0
2272310|NCT02273739|3951935|FG003|Overall Study|Adverse Event|1
2272311|NCT02273739|3951932|FG000|Overall Study|Withdrawal by Subject|0
2272312|NCT02273739|3951933|FG001|Overall Study|Withdrawal by Subject|0
2272313|NCT02273739|3951934|FG002|Overall Study|Withdrawal by Subject|2
2272314|NCT02273739|3951935|FG003|Overall Study|Withdrawal by Subject|1
2272315|NCT02273739|3951932|FG000|Overall Study|Physician Decision|0
2272316|NCT02273739|3951933|FG001|Overall Study|Physician Decision|0
2272317|NCT02273739|3951934|FG002|Overall Study|Physician Decision|0
2272318|NCT02273739|3951935|FG003|Overall Study|Physician Decision|1
2272319|NCT02273908|3951952|FG000|Overall Study|Adverse Event|16
2272320|NCT02273908|3951953|FG001|Overall Study|Adverse Event|0
2272321|NCT02273908|3951952|FG000|Overall Study|Lost to Follow-up|10
2272322|NCT02273908|3951953|FG001|Overall Study|Lost to Follow-up|1
2272323|NCT02273908|3951952|FG000|Overall Study|Did not meet entrance criteria|3
2272324|NCT02273908|3951953|FG001|Overall Study|Did not meet entrance criteria|2
2272325|NCT02273908|3951952|FG000|Overall Study|Withdrawal by Subject|4
2272326|NCT02273908|3951953|FG001|Overall Study|Withdrawal by Subject|2
2272327|NCT02273960|3951967|FG000|Short Term Period|Lost to Follow-up|1
2272328|NCT02273960|3951968|FG001|Short Term Period|Lost to Follow-up|0
2272329|NCT02273960|3951969|FG002|Short Term Period|Lost to Follow-up|0
2272330|NCT02273960|3951970|FG003|Short Term Period|Lost to Follow-up|0
2272331|NCT02273960|3951967|FG000|Short Term Period|Lack of Efficacy|0
2272332|NCT02273960|3951968|FG001|Short Term Period|Lack of Efficacy|0
2272333|NCT02273960|3951969|FG002|Short Term Period|Lack of Efficacy|0
2272334|NCT02273960|3951970|FG003|Short Term Period|Lack of Efficacy|1
2272335|NCT02273960|3951967|FG000|Short Term Period|ST complete, not entering LTE|4
2272336|NCT02273960|3951968|FG001|Short Term Period|ST complete, not entering LTE|6
2272337|NCT02273960|3951969|FG002|Short Term Period|ST complete, not entering LTE|4
2272338|NCT02273960|3951970|FG003|Short Term Period|ST complete, not entering LTE|5
2272339|NCT02273960|3951967|FG000|Long Term Extension|Death|0
2272340|NCT02273960|3951968|FG001|Long Term Extension|Death|0
2272341|NCT02273960|3951969|FG002|Long Term Extension|Death|0
2272342|NCT02273960|3951970|FG003|Long Term Extension|Death|1
2272343|NCT02273973|3951982|FG000|Overall Study|Adverse Event|4
2272344|NCT02273973|3951983|FG001|Overall Study|Adverse Event|0
2272345|NCT02273973|3951982|FG000|Overall Study|Withdrawal by Subject|2
2272346|NCT02273973|3951983|FG001|Overall Study|Withdrawal by Subject|3
2272347|NCT02273973|3951982|FG000|Overall Study|Death|1
2272348|NCT02273973|3951983|FG001|Overall Study|Death|0
2272349|NCT02273973|3951982|FG000|Overall Study|Non-compliance|1
2272350|NCT02273973|3951983|FG001|Overall Study|Non-compliance|0
2272351|NCT02273973|3951982|FG000|Overall Study|Protocol Violation|1
2272352|NCT02273973|3951983|FG001|Overall Study|Protocol Violation|0
2272353|NCT02273973|3951982|FG000|Overall Study|Progression of disease|0
2272354|NCT02273973|3951983|FG001|Overall Study|Progression of disease|2
2272355|NCT02273973|3951982|FG000|Overall Study|Lost to Follow-up|0
2350819|NCT03943290|4097309|FG005|Overall Study|Sponsor Terminated Study|6
2350820|NCT03943290|4097310|FG006|Overall Study|Sponsor Terminated Study|6
2350821|NCT03943290|4097311|FG007|Overall Study|Sponsor Terminated Study|7
2350822|NCT03943290|4097312|FG008|Overall Study|Sponsor Terminated Study|8
2350823|NCT03943290|4097304|FG000|Overall Study|Lost to Follow-up|1
2350824|NCT03943290|4097305|FG001|Overall Study|Lost to Follow-up|0
2350825|NCT03943290|4097306|FG002|Overall Study|Lost to Follow-up|1
2350826|NCT03943290|4097307|FG003|Overall Study|Lost to Follow-up|0
2350827|NCT03943290|4097308|FG004|Overall Study|Lost to Follow-up|0
2350828|NCT03943290|4097309|FG005|Overall Study|Lost to Follow-up|0
2350829|NCT03943290|4097310|FG006|Overall Study|Lost to Follow-up|0
2350830|NCT03943290|4097311|FG007|Overall Study|Lost to Follow-up|1
2350831|NCT03943290|4097312|FG008|Overall Study|Lost to Follow-up|0
2350832|NCT03943290|4097304|FG000|Overall Study|Withdrawal by Subject|0
2350833|NCT03943290|4097305|FG001|Overall Study|Withdrawal by Subject|0
2350834|NCT03943290|4097306|FG002|Overall Study|Withdrawal by Subject|1
2350835|NCT03943290|4097307|FG003|Overall Study|Withdrawal by Subject|0
2350836|NCT03943290|4097308|FG004|Overall Study|Withdrawal by Subject|0
2350837|NCT03943290|4097309|FG005|Overall Study|Withdrawal by Subject|0
2350838|NCT03943290|4097310|FG006|Overall Study|Withdrawal by Subject|0
2350839|NCT03943290|4097311|FG007|Overall Study|Withdrawal by Subject|0
2350840|NCT03943290|4097312|FG008|Overall Study|Withdrawal by Subject|0
2350841|NCT03942042|4097347|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0
2350842|NCT03942042|4097348|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1
2350843|NCT03942042|4097347|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1
2350844|NCT03942042|4097348|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0
2350845|NCT03923530|4097367|FG000|Overall Study|Withdrawal by Subject|1
2350846|NCT03923530|4097367|FG000|Overall Study|screen failure|3
2350847|NCT03914417|4097371|FG000|Overall Study|Withdrawal by Subject|2
2350848|NCT03913377|4097377|FG000|Period 1|Test Article no longer available|0
2350849|NCT03913377|4097378|FG001|Period 1|Test Article no longer available|1
2350850|NCT03913377|4097379|FG002|Period 1|Test Article no longer available|0
2350851|NCT03913377|4097377|FG000|Period 1|No Longer Meets Eligibility Criteria|0
2350852|NCT03913377|4097378|FG001|Period 1|No Longer Meets Eligibility Criteria|0
2272356|NCT02273973|3951983|FG001|Overall Study|Lost to Follow-up|1
2272357|NCT02273973|3951982|FG000|Overall Study|Physician Decision|0
2272358|NCT02273973|3951983|FG001|Overall Study|Physician Decision|1
2272359|NCT02273973|3951982|FG000|Overall Study|Reason not specified|0
2272360|NCT02273973|3951983|FG001|Overall Study|Reason not specified|1
2272361|NCT02274038|3951989|FG000|Overall Study|Death|1
2272362|NCT02274311|3951995|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
2272363|NCT02274493|3952001|FG000|Overall Study|Withdrawal by Subject|1
2272364|NCT02274558|3952008|FG000|Overall Study|Adverse Event|2
2272365|NCT02274558|3952009|FG001|Overall Study|Adverse Event|4
2272366|NCT02274558|3952010|FG002|Overall Study|Adverse Event|2
2272367|NCT02274558|3952008|FG000|Overall Study|Non-compliance|2
2272368|NCT02274558|3952009|FG001|Overall Study|Non-compliance|1
2272369|NCT02274558|3952010|FG002|Overall Study|Non-compliance|0
2272370|NCT02274558|3952008|FG000|Overall Study|Withdrawal by Subject|1
2272371|NCT02274558|3952009|FG001|Overall Study|Withdrawal by Subject|5
2272372|NCT02274558|3952010|FG002|Overall Study|Withdrawal by Subject|4
2272373|NCT02274558|3952008|FG000|Overall Study|Death|0
2272374|NCT02274558|3952009|FG001|Overall Study|Death|0
2272375|NCT02274558|3952010|FG002|Overall Study|Death|1
2272376|NCT02274558|3952008|FG000|Overall Study|Lost to Follow-up|2
2272377|NCT02274558|3952009|FG001|Overall Study|Lost to Follow-up|1
2272378|NCT02274558|3952010|FG002|Overall Study|Lost to Follow-up|1
2272379|NCT02274558|3952008|FG000|Overall Study|Physician Decision|0
2272380|NCT02274558|3952009|FG001|Overall Study|Physician Decision|2
2272381|NCT02274558|3952010|FG002|Overall Study|Physician Decision|1
2272382|NCT02274766|3952045|FG000|Overall Study|Withdrawal by Subject|3
2272383|NCT02274766|3952046|FG001|Overall Study|Withdrawal by Subject|6
2272384|NCT02274766|3952045|FG000|Overall Study|Did Not Receive Study Drug|1
2272385|NCT02274766|3952046|FG001|Overall Study|Did Not Receive Study Drug|1
2272386|NCT02274766|3952045|FG000|Overall Study|Subject Unwilling to Proceed|0
2272387|NCT02274766|3952046|FG001|Overall Study|Subject Unwilling to Proceed|1
2272388|NCT02274766|3952045|FG000|Overall Study|Adverse Event|0
2272389|NCT02274766|3952046|FG001|Overall Study|Adverse Event|1
2272390|NCT02274792|3952052|FG000|Overall Study|Withdrawal by Subject|13
2272391|NCT02274792|3952052|FG000|Overall Study|Lost to Follow-up|8
2272392|NCT02274792|3952052|FG000|Overall Study|Protocol Specified Criteria|2
2272393|NCT02274792|3952052|FG000|Overall Study|Sponsor Decision|2
2272394|NCT02274857|3952067|FG000|Overall Study|Adverse Event|1
2272395|NCT02274857|3952068|FG001|Overall Study|Adverse Event|0
2350853|NCT03913377|4097379|FG002|Period 1|No Longer Meets Eligibility Criteria|1
2350854|NCT03937778|4097390|FG000|Overall Study|Withdrawal by Subject|1
2350855|NCT03937778|4097390|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1
2350856|NCT03937479|4097399|FG000|Overall Study|Adverse Event|2
2350857|NCT03937479|4097400|FG001|Overall Study|Adverse Event|3
2350858|NCT03937479|4097401|FG002|Overall Study|Adverse Event|0
2350859|NCT03937479|4097402|FG003|Overall Study|Adverse Event|0
2350860|NCT03937479|4097403|FG004|Overall Study|Adverse Event|1
2350861|NCT03937479|4097399|FG000|Overall Study|Withdrawal by Subject|3
2350862|NCT03937479|4097400|FG001|Overall Study|Withdrawal by Subject|5
2350863|NCT03937479|4097401|FG002|Overall Study|Withdrawal by Subject|2
2350864|NCT03937479|4097402|FG003|Overall Study|Withdrawal by Subject|2
2350865|NCT03937479|4097403|FG004|Overall Study|Withdrawal by Subject|1
2350866|NCT03937479|4097399|FG000|Overall Study|Protocol Violation|5
2350867|NCT03937479|4097400|FG001|Overall Study|Protocol Violation|6
2350868|NCT03937479|4097401|FG002|Overall Study|Protocol Violation|4
2350869|NCT03937479|4097402|FG003|Overall Study|Protocol Violation|3
2350870|NCT03937479|4097403|FG004|Overall Study|Protocol Violation|2
2350871|NCT03937479|4097399|FG000|Overall Study|Lost to Follow-up|0
2350872|NCT03937479|4097400|FG001|Overall Study|Lost to Follow-up|1
2350873|NCT03937479|4097401|FG002|Overall Study|Lost to Follow-up|0
2350874|NCT03937479|4097402|FG003|Overall Study|Lost to Follow-up|1
2350875|NCT03937479|4097403|FG004|Overall Study|Lost to Follow-up|0
2350876|NCT03937479|4097399|FG000|Overall Study|Physician Decision|0
2350877|NCT03937479|4097400|FG001|Overall Study|Physician Decision|0
2350878|NCT03937479|4097401|FG002|Overall Study|Physician Decision|1
2350879|NCT03937479|4097402|FG003|Overall Study|Physician Decision|0
2350880|NCT03937479|4097403|FG004|Overall Study|Physician Decision|1
2350881|NCT03936244|4097439|FG000|Overall Study|Lost to Follow-up|5
2350882|NCT03936244|4097440|FG001|Overall Study|Lost to Follow-up|1
2350883|NCT03936244|4097439|FG000|Overall Study|Physician Decision|7
2350884|NCT03936244|4097440|FG001|Overall Study|Physician Decision|3
2350885|NCT03935126|4097447|FG000|Overall Study|Study termination by sponsor|3
2350886|NCT03933462|4097466|FG000|Overall Study|Adverse Event|2
2350887|NCT03933462|4097467|FG001|Overall Study|Adverse Event|0
2350888|NCT03931330|4097482|FG000|Overall Study|Physician Decision|1
2272396|NCT02274857|3952067|FG000|Overall Study|Death|1
2272397|NCT02274857|3952068|FG001|Overall Study|Death|2
2350889|NCT03912259|4097498|FG000|Overall Study|Adverse Event (AE)|2
2350890|NCT03912259|4097499|FG001|Overall Study|Adverse Event (AE)|4
2272398|NCT02274857|3952067|FG000|Overall Study|Lost to Follow-up|3
2272399|NCT02274857|3952068|FG001|Overall Study|Lost to Follow-up|0
2272400|NCT02274857|3952067|FG000|Overall Study|Physician Decision|2
2272401|NCT02274857|3952068|FG001|Overall Study|Physician Decision|0
2272402|NCT02274857|3952067|FG000|Overall Study|Trial screen failure|0
2272403|NCT02274857|3952068|FG001|Overall Study|Trial screen failure|2
2272404|NCT02274857|3952067|FG000|Overall Study|Withdrawal by Subject|11
2350891|NCT03912259|4097498|FG000|Overall Study|Lack of Efficacy|4
2350892|NCT03912259|4097499|FG001|Overall Study|Lack of Efficacy|1
2272405|NCT02274857|3952068|FG001|Overall Study|Withdrawal by Subject|2
2272406|NCT02274857|3952067|FG000|Overall Study|Other|2
2272407|NCT02274857|3952068|FG001|Overall Study|Other|0
2272408|NCT02274948|3952089|FG000|Overall Study|Lost to Follow-up|28
2272409|NCT02274948|3952090|FG001|Overall Study|Lost to Follow-up|25
2272410|NCT02274948|3952089|FG000|Overall Study|Withdrawal by Subject|64
2272411|NCT02274948|3952090|FG001|Overall Study|Withdrawal by Subject|58
2272412|NCT02274948|3952089|FG000|Overall Study|Stopped on family Practitioner advice|2
2272413|NCT02274948|3952090|FG001|Overall Study|Stopped on family Practitioner advice|5
2272414|NCT02274948|3952089|FG000|Overall Study|Left the area|4
2272415|NCT02274948|3952090|FG001|Overall Study|Left the area|3
2272416|NCT02275026|3952097|FG000|Overall Study|Ineligible after cognitive baseline testing|11
2272417|NCT02275026|3952097|FG000|Overall Study|Withdrawal by Subject|4
2272418|NCT02275026|3952097|FG000|Overall Study|Ineligible due to medical history|13
2272419|NCT02275026|3952097|FG000|Overall Study|MRI malfunction precluded testing|1
2272420|NCT02275026|3952097|FG000|Overall Study|Ineligible after MRI findings|1
2272421|NCT02275026|3952097|FG000|Overall Study|Lost to Follow-up|2
2272422|NCT02275026|3952097|FG000|Overall Study|Scanner failure|1
2272423|NCT02275052|3952104|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2272424|NCT02275052|3952105|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2272425|NCT02275052|3952106|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2272426|NCT02275052|3952107|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2272427|NCT02275052|3952104|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
2272428|NCT02275052|3952105|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
2272429|NCT02275052|3952106|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
2272430|NCT02275052|3952107|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
2272431|NCT02275052|3952104|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
2272432|NCT02275052|3952105|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
2272433|NCT02275052|3952106|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2272434|NCT02275052|3952107|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2272435|NCT02275052|3952104|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
2272436|NCT02275052|3952105|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
2272437|NCT02275052|3952106|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
2272438|NCT02275052|3952107|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
2272439|NCT02275052|3952104|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
2272440|NCT02275052|3952105|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
2272441|NCT02275052|3952106|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
2350893|NCT03912259|4097498|FG000|Overall Study|Withdrawal by Subject|11
2350894|NCT03912259|4097499|FG001|Overall Study|Withdrawal by Subject|1
2350895|NCT03931785|4097535|FG000|Overall Study|Lost to Follow-up|4
2350896|NCT03931785|4097536|FG001|Overall Study|Lost to Follow-up|1
2350897|NCT03931785|4097537|FG002|Overall Study|Lost to Follow-up|4
2350898|NCT03931785|4097538|FG003|Overall Study|Lost to Follow-up|3
2350899|NCT03931785|4097535|FG000|Overall Study|Adverse Event|1
2350900|NCT03931785|4097536|FG001|Overall Study|Adverse Event|0
2350901|NCT03931785|4097537|FG002|Overall Study|Adverse Event|3
2350902|NCT03931785|4097538|FG003|Overall Study|Adverse Event|4
2350903|NCT03931785|4097535|FG000|Overall Study|Protocol Violation|0
2350904|NCT03931785|4097536|FG001|Overall Study|Protocol Violation|1
2350905|NCT03931785|4097537|FG002|Overall Study|Protocol Violation|0
2350906|NCT03931785|4097538|FG003|Overall Study|Protocol Violation|0
2350907|NCT03931785|4097535|FG000|Overall Study|Noncompliance With Study drug|0
2350908|NCT03931785|4097536|FG001|Overall Study|Noncompliance With Study drug|1
2350909|NCT03931785|4097537|FG002|Overall Study|Noncompliance With Study drug|0
2350910|NCT03931785|4097538|FG003|Overall Study|Noncompliance With Study drug|0
2350911|NCT03931785|4097535|FG000|Overall Study|Other Not specified|0
2350912|NCT03931785|4097536|FG001|Overall Study|Other Not specified|2
2350913|NCT03931785|4097537|FG002|Overall Study|Other Not specified|2
2350914|NCT03931785|4097538|FG003|Overall Study|Other Not specified|2
2350915|NCT03931785|4097535|FG000|Overall Study|Withdrawal by Subject|0
2350916|NCT03931785|4097536|FG001|Overall Study|Withdrawal by Subject|2
2350917|NCT03931785|4097537|FG002|Overall Study|Withdrawal by Subject|4
2350918|NCT03931785|4097538|FG003|Overall Study|Withdrawal by Subject|1
2350919|NCT03931785|4097535|FG000|Overall Study|Pregnancy|0
2350920|NCT03931785|4097536|FG001|Overall Study|Pregnancy|0
2350921|NCT03931785|4097537|FG002|Overall Study|Pregnancy|0
2350922|NCT03931785|4097538|FG003|Overall Study|Pregnancy|1
2350923|NCT03927846|4097554|FG000|Overall Study|Lost to Follow-up|10
2350924|NCT03927846|4097555|FG001|Overall Study|Lost to Follow-up|11
2350925|NCT03927105|4097561|FG000|Overall Study|Death|1
2350926|NCT03927105|4097561|FG000|Overall Study|In observation for potential re-treatment|2
2350927|NCT03927105|4097561|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1
2350928|NCT03923933|4097567|FG000|Overall Study|Lost to Follow-up|1
2350929|NCT03923933|4097568|FG001|Overall Study|Lost to Follow-up|0
2350930|NCT03923933|4097567|FG000|Overall Study|Withdrawal by Subject|0
2350931|NCT03923933|4097568|FG001|Overall Study|Withdrawal by Subject|1
2350932|NCT03909295|4097574|FG000|Overall Study|Adverse Event|2
2350933|NCT03909295|4097574|FG000|Overall Study|Study terminated by sponsor|50
2272442|NCT02275052|3952107|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
2272443|NCT02275052|3952104|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3
2272444|NCT02275052|3952105|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0
2272445|NCT02275052|3952106|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0
2272446|NCT02275052|3952107|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0
2272447|NCT02275052|3952104|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1
2272448|NCT02275052|3952105|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0
2272449|NCT02275052|3952106|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0
2272450|NCT02275052|3952107|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0
2272451|NCT02275052|3952104|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
2272452|NCT02275052|3952105|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
2272453|NCT02275052|3952106|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
2272454|NCT02275052|3952107|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
2272455|NCT02275052|3952104|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2272456|NCT02275052|3952105|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2272457|NCT02275052|3952106|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2272458|NCT02275052|3952107|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
2272459|NCT02275052|3952104|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
2272460|NCT02275052|3952105|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
2272461|NCT02275052|3952106|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2272462|NCT02275052|3952107|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
2272463|NCT02275052|3952104|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2272464|NCT02275052|3952105|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2272465|NCT02275052|3952106|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2272466|NCT02275052|3952107|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
2272467|NCT02275065|3952118|FG000|Overall Study|Randomized but not treated|1
2272468|NCT02275065|3952119|FG001|Overall Study|Randomized but not treated|0
2272469|NCT02275065|3952120|FG002|Overall Study|Randomized but not treated|1
2272470|NCT02275065|3952121|FG003|Overall Study|Randomized but not treated|1
2272471|NCT02275065|3952122|FG004|Overall Study|Randomized but not treated|0
2272472|NCT02275117|3952139|FG000|Overall Study|Adverse Event|0
2272473|NCT02275117|3952140|FG001|Overall Study|Adverse Event|0
2272474|NCT02275117|3952141|FG002|Overall Study|Adverse Event|0
2272475|NCT02275117|3952142|FG003|Overall Study|Adverse Event|0
2272476|NCT02275117|3952143|FG004|Overall Study|Adverse Event|1
2272477|NCT02275117|3952139|FG000|Overall Study|Lack of Efficacy|6
2272478|NCT02275117|3952140|FG001|Overall Study|Lack of Efficacy|7
2272479|NCT02275117|3952141|FG002|Overall Study|Lack of Efficacy|5
2272480|NCT02275117|3952142|FG003|Overall Study|Lack of Efficacy|2
2272481|NCT02275117|3952143|FG004|Overall Study|Lack of Efficacy|10
2350934|NCT03908970|4097580|FG000|Overall Study|Adverse Event|7
2350935|NCT03908970|4097581|FG001|Overall Study|Adverse Event|21
2350936|NCT03908970|4097580|FG000|Overall Study|Physician Decision|1
2350937|NCT03908970|4097581|FG001|Overall Study|Physician Decision|4
2350938|NCT03908970|4097580|FG000|Overall Study|Withdrawal by Subject|9
2350939|NCT03908970|4097581|FG001|Overall Study|Withdrawal by Subject|22
2350940|NCT03897179|4097587|FG000|Overall Study|Withdrawal by Subject|1
2272482|NCT02275117|3952139|FG000|Overall Study|Lost to Follow-up|11
2272483|NCT02275117|3952140|FG001|Overall Study|Lost to Follow-up|16
2272484|NCT02275117|3952141|FG002|Overall Study|Lost to Follow-up|15
2272485|NCT02275117|3952142|FG003|Overall Study|Lost to Follow-up|16
2272486|NCT02275117|3952143|FG004|Overall Study|Lost to Follow-up|8
2272487|NCT02275117|3952139|FG000|Overall Study|Physician Decision|0
2272488|NCT02275117|3952140|FG001|Overall Study|Physician Decision|1
2272489|NCT02275117|3952141|FG002|Overall Study|Physician Decision|1
2272490|NCT02275117|3952142|FG003|Overall Study|Physician Decision|0
2272491|NCT02275117|3952143|FG004|Overall Study|Physician Decision|1
2272492|NCT02275117|3952139|FG000|Overall Study|Protocol Violation|1
2272493|NCT02275117|3952140|FG001|Overall Study|Protocol Violation|0
2272494|NCT02275117|3952141|FG002|Overall Study|Protocol Violation|1
2272495|NCT02275117|3952142|FG003|Overall Study|Protocol Violation|1
2272496|NCT02275117|3952143|FG004|Overall Study|Protocol Violation|0
2272497|NCT02275117|3952139|FG000|Overall Study|Withdrawal by Subject|6
2272498|NCT02275117|3952140|FG001|Overall Study|Withdrawal by Subject|4
2272499|NCT02275117|3952141|FG002|Overall Study|Withdrawal by Subject|7
2272500|NCT02275117|3952142|FG003|Overall Study|Withdrawal by Subject|3
2272501|NCT02275117|3952143|FG004|Overall Study|Withdrawal by Subject|3
2272502|NCT02275117|3952139|FG000|Overall Study|Terminated by Sponsor|4
2272503|NCT02275117|3952140|FG001|Overall Study|Terminated by Sponsor|4
2272504|NCT02275117|3952141|FG002|Overall Study|Terminated by Sponsor|4
2272505|NCT02275117|3952142|FG003|Overall Study|Terminated by Sponsor|6
2272506|NCT02275117|3952143|FG004|Overall Study|Terminated by Sponsor|4
2272507|NCT02275117|3952139|FG000|Overall Study|Worsening of Study Indication|0
2272508|NCT02275117|3952140|FG001|Overall Study|Worsening of Study Indication|1
2272509|NCT02275117|3952141|FG002|Overall Study|Worsening of Study Indication|2
2272510|NCT02275117|3952142|FG003|Overall Study|Worsening of Study Indication|0
2272511|NCT02275117|3952143|FG004|Overall Study|Worsening of Study Indication|0
2272512|NCT02275117|3952139|FG000|Overall Study|Study Burden|5
2272513|NCT02275117|3952140|FG001|Overall Study|Study Burden|4
2272514|NCT02275117|3952141|FG002|Overall Study|Study Burden|7
2272515|NCT02275117|3952142|FG003|Overall Study|Study Burden|5
2272516|NCT02275117|3952143|FG004|Overall Study|Study Burden|7
2272517|NCT02275117|3952139|FG000|Overall Study|Other|1
2272518|NCT02275117|3952140|FG001|Overall Study|Other|0
2272519|NCT02275117|3952141|FG002|Overall Study|Other|0
2272520|NCT02275117|3952142|FG003|Overall Study|Other|0
2272521|NCT02275117|3952143|FG004|Overall Study|Other|2
2272522|NCT02275338|3952169|FG000|Overall Study|Adverse Event|15
2272523|NCT02275338|3952169|FG000|Overall Study|Lack of Efficacy|3
2272524|NCT02275338|3952169|FG000|Overall Study|Withdrawal by Subject|4
2272525|NCT02275338|3952169|FG000|Overall Study|Disease progression (death)|1
2272526|NCT02275338|3952169|FG000|Overall Study|Ineligible to start Phase 2|4
2350941|NCT03927950|4097651|FG000|Overall Study|Adverse Event|9
2350942|NCT03920670|4097673|FG000|Overall Study|Protocol Violation|2
2350943|NCT03920670|4097674|FG001|Overall Study|Protocol Violation|2
2350944|NCT03920670|4097673|FG000|Overall Study|Adverse Event|1
2350945|NCT03920670|4097674|FG001|Overall Study|Adverse Event|0
2350946|NCT03898063|4097704|FG000|Overall Study|Withdrawal by Subject|10
2350947|NCT03898063|4097705|FG001|Overall Study|Withdrawal by Subject|8
2350948|NCT03909100|4097751|FG000|Overall Study|Protocol Deviation|2
2350949|NCT03909100|4097751|FG000|Overall Study|Technical Problems|4
2350950|NCT03909100|4097751|FG000|Overall Study|Withdrawal by Subject|4
2350951|NCT03909100|4097751|FG000|Overall Study|Lost to Follow-up|1
2350952|NCT03909100|4097751|FG000|Overall Study|Reason not Specified|4
2350953|NCT03905642|4097758|FG000|Overall Study|Withdrawal by Subject|3
2350954|NCT03905642|4097758|FG000|Overall Study|Pregnancy|1
2350955|NCT03905642|4097758|FG000|Overall Study|Adverse Event|1
2350956|NCT03905642|4097758|FG000|Overall Study|Lack of Efficacy|1
2350957|NCT03905642|4097758|FG000|Overall Study|Completed study but not 24 of 28 days|2
2350958|NCT03892889|4097762|FG000|Overall Study|Adverse Event|17
2350959|NCT03892889|4097762|FG000|Overall Study|Lack of Efficacy|1
2350960|NCT03892889|4097762|FG000|Overall Study|Lost to Follow-up|46
2350961|NCT03892889|4097762|FG000|Overall Study|Non-compliance with study drug|22
2350962|NCT03892889|4097762|FG000|Overall Study|Pregnancy|1
2350963|NCT03892889|4097762|FG000|Overall Study|Protocol Deviation|3
2350964|NCT03892889|4097762|FG000|Overall Study|Withdrawal by Subject|50
2350965|NCT03892889|4097762|FG000|Overall Study|Withdrawal by Caregiver|1
2350966|NCT03892889|4097762|FG000|Overall Study|Study Terminated by Sponsor|50
2350967|NCT03892889|4097762|FG000|Overall Study|Physician Decision|8
2350968|NCT03892889|4097762|FG000|Overall Study|Reason not Specified|5
2350969|NCT03921723|4097766|FG000|Period 2 (4 Days)|Withdrawal by Subject|3
2350970|NCT03921723|4097766|FG000|Period 3 (4 Days)|Withdrawal by Subject|1
2350971|NCT03918239|4097810|FG000|Overall Study|Lost to Follow-up|3
2350972|NCT03918239|4097811|FG001|Overall Study|Lost to Follow-up|1
2350973|NCT03918239|4097810|FG000|Overall Study|Pregnancy|0
2350974|NCT03918239|4097811|FG001|Overall Study|Pregnancy|2
2350975|NCT03918239|4097810|FG000|Overall Study|Withdrawal by Subject|3
2350976|NCT03918239|4097811|FG001|Overall Study|Withdrawal by Subject|3
2350977|NCT03918239|4097810|FG000|Overall Study|positive urine drug screening results|4
2350978|NCT03918239|4097811|FG001|Overall Study|positive urine drug screening results|1
2350979|NCT03917823|4097819|FG000|Overall Study|Lost to Follow-up|1
2350980|NCT03917823|4097820|FG001|Overall Study|Lost to Follow-up|1
2350981|NCT03917823|4097819|FG000|Overall Study|Withdrawal by Subject|0
2350982|NCT03917823|4097820|FG001|Overall Study|Withdrawal by Subject|1
2350983|NCT03902613|4097841|FG000|Overall Study|Physician Decision|1
2350984|NCT03902574|4097848|FG000|Overall Study|Urinary drug test was positive on Day 20|0
2350985|NCT03902574|4097849|FG001|Overall Study|Urinary drug test was positive on Day 20|0
2350986|NCT03902574|4097850|FG002|Overall Study|Urinary drug test was positive on Day 20|1
2350987|NCT03914950|4097858|FG000|Overall Study|Physician Decision|54
2350988|NCT03911843|4097870|FG000|Overall Study|Adverse Event|2
2350989|NCT03911843|4097871|FG001|Overall Study|Adverse Event|0
2350990|NCT03911843|4097870|FG000|Overall Study|Protocol Violation|2
2350991|NCT03911843|4097871|FG001|Overall Study|Protocol Violation|0
2350992|NCT03911843|4097870|FG000|Overall Study|Lost to Follow-up|0
2350993|NCT03911843|4097871|FG001|Overall Study|Lost to Follow-up|1
2350994|NCT03894813|4097888|FG000|Overall Study|Adverse Event|1
2350995|NCT03894813|4097889|FG001|Overall Study|Adverse Event|1
2350996|NCT03894813|4097888|FG000|Overall Study|Lack of Efficacy|3
2350997|NCT03894813|4097889|FG001|Overall Study|Lack of Efficacy|3
2272527|NCT02275338|3952169|FG000|Overall Study|Reason not specified|5
2272528|NCT02275338|3952169|FG000|Overall Study|Does not meet entry criteria|1
2272529|NCT02275364|3952174|FG000|Period 1|Withdrawal by Subject|1
2272530|NCT02275364|3952175|FG001|Period 1|Withdrawal by Subject|0
2272531|NCT02275364|3952174|FG000|Period 1|Other reason|1
2272532|NCT02275364|3952175|FG001|Period 1|Other reason|0
2272533|NCT02275611|3952196|FG000|Inpatient Withdrawal|Withdrawal by Subject|1
2272534|NCT02275611|3952197|FG001|Inpatient Withdrawal|Withdrawal by Subject|0
2272535|NCT02275611|3952198|FG002|Inpatient Withdrawal|Withdrawal by Subject|0
2272536|NCT02275611|3952199|FG003|Inpatient Withdrawal|Withdrawal by Subject|0
2272537|NCT02275780|3952226|FG000|Base Study: 96 Weeks|Adverse Event|6
2272538|NCT02275780|3952227|FG001|Base Study: 96 Weeks|Adverse Event|14
2272539|NCT02275780|3952226|FG000|Base Study: 96 Weeks|Death|3
2272540|NCT02275780|3952227|FG001|Base Study: 96 Weeks|Death|1
2272541|NCT02275780|3952226|FG000|Base Study: 96 Weeks|Lack of Efficacy|21
2272542|NCT02275780|3952227|FG001|Base Study: 96 Weeks|Lack of Efficacy|32
2272543|NCT02275780|3952226|FG000|Base Study: 96 Weeks|Lost to Follow-up|28
2272544|NCT02275780|3952227|FG001|Base Study: 96 Weeks|Lost to Follow-up|24
2272545|NCT02275780|3952226|FG000|Base Study: 96 Weeks|Protocol Violation|1
2272546|NCT02275780|3952227|FG001|Base Study: 96 Weeks|Protocol Violation|6
2272547|NCT02275780|3952226|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19
2272548|NCT02275780|3952227|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22
2272549|NCT02275780|3952226|FG000|Base Study: 96 Weeks|Noncompliance with drug|9
2272550|NCT02275780|3952227|FG001|Base Study: 96 Weeks|Noncompliance with drug|6
2272551|NCT02275780|3952226|FG000|Base Study: 96 Weeks|Physician Decision|2
2272552|NCT02275780|3952227|FG001|Base Study: 96 Weeks|Physician Decision|4
2272553|NCT02275780|3952226|FG000|Base Study: 96 Weeks|Pregnancy|2
2272554|NCT02275780|3952227|FG001|Base Study: 96 Weeks|Pregnancy|1
2272555|NCT02275780|3952226|FG000|Base Study: 96 Weeks|Randomized not treated|2
2272556|NCT02275780|3952227|FG001|Base Study: 96 Weeks|Randomized not treated|1
2272557|NCT02275780|3952226|FG000|Extension Study: up to 192 Weeks|Ongoing|260
2272558|NCT02275780|3952227|FG001|Extension Study: up to 192 Weeks|Ongoing|233
2272559|NCT02275819|3952235|FG000|Overall Study|Adverse Event|0
2272560|NCT02275819|3952236|FG001|Overall Study|Adverse Event|1
2272561|NCT02276027|3952250|FG000|Overall Study|Death|1
2272562|NCT02276027|3952251|FG001|Overall Study|Death|0
2272563|NCT02276027|3952252|FG002|Overall Study|Death|0
2350998|NCT03894813|4097888|FG000|Overall Study|Lost to Follow-up|1
2350999|NCT03894813|4097889|FG001|Overall Study|Lost to Follow-up|0
2351000|NCT03894813|4097888|FG000|Overall Study|Pregnancy|2
2351001|NCT03894813|4097889|FG001|Overall Study|Pregnancy|1
2351002|NCT03894813|4097888|FG000|Overall Study|Protocol Violation|3
2351003|NCT03894813|4097889|FG001|Overall Study|Protocol Violation|7
2351004|NCT03894813|4097888|FG000|Overall Study|Withdrawal by Subject|1
2351005|NCT03894813|4097889|FG001|Overall Study|Withdrawal by Subject|3
2351006|NCT03894813|4097888|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0
2351007|NCT03894813|4097889|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1
2351008|NCT03911960|4097897|FG000|Overall Study|Lost to Follow-up|5
2351009|NCT03911960|4097898|FG001|Overall Study|Lost to Follow-up|3
2351010|NCT03907072|4097908|FG000|Overall Study|Study Terminated by Sponsor|2
2351011|NCT03907072|4097909|FG001|Overall Study|Study Terminated by Sponsor|2
2351012|NCT03907072|4097910|FG002|Overall Study|Study Terminated by Sponsor|2
2351013|NCT03911401|4097930|FG000|Overall Study|Adverse Event|1
2351014|NCT03911401|4097931|FG001|Overall Study|Adverse Event|2
2351015|NCT03911401|4097932|FG002|Overall Study|Adverse Event|5
2351016|NCT03911401|4097930|FG000|Overall Study|Lack of Efficacy|1
2272564|NCT02276027|3952253|FG003|Overall Study|Death|2
2272565|NCT02276027|3952250|FG000|Overall Study|Physician Decision|0
2272566|NCT02276027|3952251|FG001|Overall Study|Physician Decision|0
2272567|NCT02276027|3952252|FG002|Overall Study|Physician Decision|0
2272568|NCT02276027|3952253|FG003|Overall Study|Physician Decision|1
2272569|NCT02276027|3952250|FG000|Overall Study|Progressive disease|1
2272570|NCT02276027|3952251|FG001|Overall Study|Progressive disease|13
2272571|NCT02276027|3952252|FG002|Overall Study|Progressive disease|12
2272572|NCT02276027|3952253|FG003|Overall Study|Progressive disease|14
2272573|NCT02276027|3952250|FG000|Overall Study|Subject/guardian decision|0
2272574|NCT02276027|3952251|FG001|Overall Study|Subject/guardian decision|1
2272575|NCT02276027|3952252|FG002|Overall Study|Subject/guardian decision|0
2272576|NCT02276027|3952253|FG003|Overall Study|Subject/guardian decision|3
2272577|NCT02276027|3952250|FG000|Overall Study|Adverse Event|0
2272578|NCT02276027|3952251|FG001|Overall Study|Adverse Event|2
2272579|NCT02276027|3952252|FG002|Overall Study|Adverse Event|8
2272580|NCT02276027|3952253|FG003|Overall Study|Adverse Event|2
2272581|NCT02276040|3952263|FG000|Overall Study|Physician Decision|15
2272582|NCT02276053|3952267|FG000|Overall Study|Death|2
2272583|NCT02276053|3952267|FG000|Overall Study|Adverse Event|5
2272584|NCT02276053|3952267|FG000|Overall Study|Lack of Efficacy|2
2272585|NCT02276053|3952267|FG000|Overall Study|Withdrawal by Subject|1
2272586|NCT02276053|3952267|FG000|Overall Study|Patient does not meet selection criteria|3
2272587|NCT02276053|3952267|FG000|Overall Study|Patient needs to increase baseline AED|1
2272588|NCT02276222|3952274|FG000|Overall Study|Adverse Event|62
2272589|NCT02276222|3952275|FG001|Overall Study|Adverse Event|11
2272590|NCT02276222|3952274|FG000|Overall Study|Death|3
2272591|NCT02276222|3952275|FG001|Overall Study|Death|4
2272592|NCT02276222|3952274|FG000|Overall Study|Lack of Efficacy|13
2272593|NCT02276222|3952275|FG001|Overall Study|Lack of Efficacy|3
2272594|NCT02276222|3952274|FG000|Overall Study|Protocol Violation|3
2272595|NCT02276222|3952275|FG001|Overall Study|Protocol Violation|2
2272596|NCT02276222|3952274|FG000|Overall Study|Withdrawal by Subject|79
2272597|NCT02276222|3952275|FG001|Overall Study|Withdrawal by Subject|33
2272598|NCT02276222|3952274|FG000|Overall Study|non compliance with study medication|6
2272599|NCT02276222|3952275|FG001|Overall Study|non compliance with study medication|2
2272600|NCT02276222|3952274|FG000|Overall Study|sponsor decision|0
2272601|NCT02276222|3952275|FG001|Overall Study|sponsor decision|3
2272602|NCT02276222|3952274|FG000|Overall Study|Lost to Follow-up|15
2272603|NCT02276222|3952275|FG001|Overall Study|Lost to Follow-up|5
2272604|NCT02276222|3952274|FG000|Overall Study|Physician Decision|2
2272605|NCT02276222|3952275|FG001|Overall Study|Physician Decision|1
2272606|NCT02276222|3952274|FG000|Overall Study|sheduling conflict|1
2272607|NCT02276222|3952275|FG001|Overall Study|sheduling conflict|0
2272608|NCT02276222|3952274|FG000|Overall Study|subject withdrew after randomization|1
2272609|NCT02276222|3952275|FG001|Overall Study|subject withdrew after randomization|0
2351017|NCT03911401|4097931|FG001|Overall Study|Lack of Efficacy|1
2351018|NCT03911401|4097932|FG002|Overall Study|Lack of Efficacy|8
2351019|NCT03911401|4097930|FG000|Overall Study|Physician Decision|0
2351020|NCT03911401|4097931|FG001|Overall Study|Physician Decision|0
2351021|NCT03911401|4097932|FG002|Overall Study|Physician Decision|1
2351022|NCT03911401|4097930|FG000|Overall Study|Withdrawal by Subject|1
2351023|NCT03911401|4097931|FG001|Overall Study|Withdrawal by Subject|2
2351024|NCT03911401|4097932|FG002|Overall Study|Withdrawal by Subject|0
2351025|NCT03911401|4097930|FG000|Overall Study|Withdrawal by parent/guardian|4
2351026|NCT03911401|4097931|FG001|Overall Study|Withdrawal by parent/guardian|4
2351027|NCT03911401|4097932|FG002|Overall Study|Withdrawal by parent/guardian|11
2351028|NCT03904420|4097959|FG000|Overall Study|Study terminated|2
2351029|NCT03904420|4097960|FG001|Overall Study|Study terminated|2
2351030|NCT03903822|4097974|FG000|Treatment Phase (6 Weeks)|Adverse Event|3
2351031|NCT03903822|4097975|FG001|Treatment Phase (6 Weeks)|Adverse Event|3
2351032|NCT03903822|4097976|FG002|Treatment Phase (6 Weeks)|Adverse Event|1
2351033|NCT03903822|4097977|FG003|Treatment Phase (6 Weeks)|Adverse Event|1
2351034|NCT03903822|4097978|FG004|Treatment Phase (6 Weeks)|Adverse Event|1
2351035|NCT03903822|4097979|FG005|Treatment Phase (6 Weeks)|Adverse Event|6
2351036|NCT03903822|4097980|FG006|Treatment Phase (6 Weeks)|Adverse Event|1
2351037|NCT03903822|4097981|FG007|Treatment Phase (6 Weeks)|Adverse Event|0
2351038|NCT03903822|4097974|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0
2351039|NCT03903822|4097975|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0
2351040|NCT03903822|4097976|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0
2351041|NCT03903822|4097977|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0
2351042|NCT03903822|4097978|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1
2351043|NCT03903822|4097979|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1
2351044|NCT03903822|4097980|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0
2351045|NCT03903822|4097981|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0
2351046|NCT03903822|4097974|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0
2351047|NCT03903822|4097975|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0
2351048|NCT03903822|4097976|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0
2351049|NCT03903822|4097977|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0
2351050|NCT03903822|4097978|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0
2351051|NCT03903822|4097979|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0
2351052|NCT03903822|4097980|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1
2351053|NCT03903822|4097981|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1
2351054|NCT03903822|4097974|FG000|Treatment Phase (6 Weeks)|Physician Decision|0
2351055|NCT03903822|4097975|FG001|Treatment Phase (6 Weeks)|Physician Decision|2
2351056|NCT03903822|4097976|FG002|Treatment Phase (6 Weeks)|Physician Decision|0
2351057|NCT03903822|4097977|FG003|Treatment Phase (6 Weeks)|Physician Decision|0
2351058|NCT03903822|4097978|FG004|Treatment Phase (6 Weeks)|Physician Decision|0
2351059|NCT03903822|4097979|FG005|Treatment Phase (6 Weeks)|Physician Decision|0
2351060|NCT03903822|4097980|FG006|Treatment Phase (6 Weeks)|Physician Decision|0
2351061|NCT03903822|4097981|FG007|Treatment Phase (6 Weeks)|Physician Decision|0
2351062|NCT03903822|4097974|FG000|Treatment Phase (6 Weeks)|Pregnancy|0
2351063|NCT03903822|4097975|FG001|Treatment Phase (6 Weeks)|Pregnancy|0
2351064|NCT03903822|4097976|FG002|Treatment Phase (6 Weeks)|Pregnancy|0
2351065|NCT03903822|4097977|FG003|Treatment Phase (6 Weeks)|Pregnancy|1
2351066|NCT03903822|4097978|FG004|Treatment Phase (6 Weeks)|Pregnancy|1
2351067|NCT03903822|4097979|FG005|Treatment Phase (6 Weeks)|Pregnancy|0
2351068|NCT03903822|4097980|FG006|Treatment Phase (6 Weeks)|Pregnancy|0
2351069|NCT03903822|4097981|FG007|Treatment Phase (6 Weeks)|Pregnancy|0
2351070|NCT03903822|4097974|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0
2351071|NCT03903822|4097975|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0
2351072|NCT03903822|4097976|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0
2351073|NCT03903822|4097977|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1
2351074|NCT03903822|4097978|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0
2351075|NCT03903822|4097979|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0
2351076|NCT03903822|4097980|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0
2272610|NCT02276482|3952292|FG000|Overall Study|Adverse Event|1
2272611|NCT02276482|3952293|FG001|Overall Study|Adverse Event|0
2272612|NCT02276482|3952292|FG000|Overall Study|Withdrawal by Subject|1
2272613|NCT02276482|3952293|FG001|Overall Study|Withdrawal by Subject|0
2272614|NCT02276482|3952292|FG000|Overall Study|Gram-negative infection|1
2272615|NCT02276482|3952293|FG001|Overall Study|Gram-negative infection|0
2272616|NCT02276482|3952292|FG000|Overall Study|Reason not specified|0
2272617|NCT02276482|3952293|FG001|Overall Study|Reason not specified|1
2272618|NCT02276612|3952301|FG000|Overall Study|Death|1
2272619|NCT02276612|3952302|FG001|Overall Study|Death|0
2272620|NCT02276612|3952301|FG000|Overall Study|Pregnancy|1
2272621|NCT02276612|3952302|FG001|Overall Study|Pregnancy|0
2272622|NCT02276612|3952301|FG000|Overall Study|Withdrew Consent|1
2272623|NCT02276612|3952302|FG001|Overall Study|Withdrew Consent|0
2272624|NCT02276612|3952301|FG000|Overall Study|Lost to Follow-up|1
2272625|NCT02276612|3952302|FG001|Overall Study|Lost to Follow-up|0
2272626|NCT02276807|3952323|FG000|Overall Study|Withdrawal by Subject|8
2272627|NCT02276807|3952324|FG001|Overall Study|Withdrawal by Subject|7
2272628|NCT02276807|3952323|FG000|Overall Study|Lost to Follow-up|10
2272629|NCT02276807|3952324|FG001|Overall Study|Lost to Follow-up|10
2272630|NCT02276872|3952333|FG000|Overall Study|Adverse Event|1
2272631|NCT02276872|3952334|FG001|Overall Study|Adverse Event|0
2272632|NCT02276872|3952335|FG002|Overall Study|Adverse Event|0
2272633|NCT02277691|3952411|FG000|Overall Study|Pretreatment Event/Adverse Event|33
2272634|NCT02277691|3952411|FG000|Overall Study|Voluntary Withdrawal|7
2272635|NCT02277691|3952411|FG000|Overall Study|Lack of Efficacy|5
2272636|NCT02277691|3952411|FG000|Overall Study|Used Other Antihypertensive Drug|1
2272637|NCT02277743|3952418|FG000|Overall Study|Protocol Violation|1
2272638|NCT02277743|3952419|FG001|Overall Study|Protocol Violation|1
2272639|NCT02277743|3952420|FG002|Overall Study|Protocol Violation|1
2272640|NCT02277743|3952418|FG000|Overall Study|Adverse Event|10
2272641|NCT02277743|3952419|FG001|Overall Study|Adverse Event|6
2272642|NCT02277743|3952420|FG002|Overall Study|Adverse Event|6
2272643|NCT02277743|3952418|FG000|Overall Study|Lack of Efficacy|11
2272644|NCT02277743|3952419|FG001|Overall Study|Lack of Efficacy|4
2272645|NCT02277743|3952420|FG002|Overall Study|Lack of Efficacy|3
2272646|NCT02277743|3952418|FG000|Overall Study|Other than specified above|18
2272647|NCT02277743|3952419|FG001|Overall Study|Other than specified above|5
2272648|NCT02277743|3952420|FG002|Overall Study|Other than specified above|16
2272649|NCT02277769|3952431|FG000|Overall Study|Protocol Violation|3
2272650|NCT02277769|3952432|FG001|Overall Study|Protocol Violation|3
2272651|NCT02277769|3952433|FG002|Overall Study|Protocol Violation|5
2272652|NCT02277769|3952431|FG000|Overall Study|Lack of Efficacy|17
2272653|NCT02277769|3952432|FG001|Overall Study|Lack of Efficacy|0
2272654|NCT02277769|3952433|FG002|Overall Study|Lack of Efficacy|4
2272655|NCT02277769|3952431|FG000|Overall Study|Adverse Event|14
2272656|NCT02277769|3952432|FG001|Overall Study|Adverse Event|2
2272657|NCT02277769|3952433|FG002|Overall Study|Adverse Event|4
2272658|NCT02277769|3952431|FG000|Overall Study|Other than specified above|12
2272659|NCT02277769|3952432|FG001|Overall Study|Other than specified above|8
2272660|NCT02277769|3952433|FG002|Overall Study|Other than specified above|5
2272661|NCT02277990|3952454|FG000|Overall Study|Death|170
2272662|NCT02277990|3952455|FG001|Overall Study|Death|188
2272663|NCT02277990|3952454|FG000|Overall Study|Withdrawal by Subject|64
2272664|NCT02277990|3952455|FG001|Overall Study|Withdrawal by Subject|53
2272665|NCT02277990|3952454|FG000|Overall Study|Physician Decision|40
2272666|NCT02277990|3952455|FG001|Overall Study|Physician Decision|34
2272667|NCT02277990|3952454|FG000|Overall Study|Lost to Follow-up|66
2272668|NCT02277990|3952455|FG001|Overall Study|Lost to Follow-up|69
2272669|NCT02277990|3952454|FG000|Overall Study|Had other reason|26
2272670|NCT02277990|3952455|FG001|Overall Study|Had other reason|32
2272671|NCT02278003|3952463|FG000|Overall Study|Withdrawal by Subject|11
2272672|NCT02278003|3952464|FG001|Overall Study|Withdrawal by Subject|0
2272673|NCT02278003|3952463|FG000|Overall Study|Not Treated|1
2272674|NCT02278003|3952464|FG001|Overall Study|Not Treated|0
2272675|NCT02278003|3952463|FG000|Overall Study|Recognition task improperly completed|7
2272676|NCT02278003|3952464|FG001|Overall Study|Recognition task improperly completed|0
2272677|NCT02278263|3952486|FG000|Overall Study|Protocol Violation|7
2272678|NCT02278263|3952487|FG001|Overall Study|Protocol Violation|0
2272679|NCT02278263|3952488|FG002|Overall Study|Protocol Violation|9
2272680|NCT02278328|3952508|FG000|Neuropsych Screening|found ineligible on neuropsych|1
2272681|NCT02278328|3952509|FG001|Neuropsych Screening|found ineligible on neuropsych|0
2272682|NCT02278328|3952510|FG002|Neuropsych Screening|found ineligible on neuropsych|0
2272683|NCT02278328|3952508|FG000|Neuropsych Screening|Withdrawal by Subject|0
2272684|NCT02278328|3952509|FG001|Neuropsych Screening|Withdrawal by Subject|1
2272685|NCT02278328|3952510|FG002|Neuropsych Screening|Withdrawal by Subject|0
2272686|NCT02278328|3952508|FG000|Neuropsych Screening|incomplete consent|0
2272687|NCT02278328|3952509|FG001|Neuropsych Screening|incomplete consent|0
2272688|NCT02278328|3952510|FG002|Neuropsych Screening|incomplete consent|2
2272689|NCT02278341|3952518|FG000|Overall Study|Randomized but never received study drug|1
2272690|NCT02278341|3952519|FG001|Overall Study|Randomized but never received study drug|1
2272691|NCT02278341|3952518|FG000|Overall Study|Adverse Event|3
2272692|NCT02278341|3952519|FG001|Overall Study|Adverse Event|0
2272693|NCT02278341|3952518|FG000|Overall Study|Death|68
2272694|NCT02278341|3952519|FG001|Overall Study|Death|56
2272695|NCT02278341|3952518|FG000|Overall Study|Withdrawal by Subject|30
2272696|NCT02278341|3952519|FG001|Overall Study|Withdrawal by Subject|19
2272697|NCT02278341|3952518|FG000|Overall Study|Lost to Follow-up|0
2272698|NCT02278341|3952519|FG001|Overall Study|Lost to Follow-up|1
2272699|NCT02278341|3952518|FG000|Overall Study|Physician Decision|1
2272700|NCT02278341|3952519|FG001|Overall Study|Physician Decision|1
2272701|NCT02278341|3952518|FG000|Overall Study|Miscellaneous|15
2272702|NCT02278341|3952519|FG001|Overall Study|Miscellaneous|14
2272703|NCT02278354|3952528|FG000|Overall Study|Lost to Follow-up|2
2272704|NCT02278354|3952529|FG001|Overall Study|Lost to Follow-up|2
2272705|NCT02278354|3952528|FG000|Overall Study|Withdrawal by Subject|0
2272706|NCT02278354|3952529|FG001|Overall Study|Withdrawal by Subject|1
2272707|NCT02278354|3952528|FG000|Overall Study|<10 professional fights|2
2272708|NCT02278354|3952529|FG001|Overall Study|<10 professional fights|0
2272709|NCT02278367|3952539|FG000|Overall Study|Physician Decision|5
2272710|NCT02278367|3952540|FG001|Overall Study|Physician Decision|0
2351077|NCT03903822|4097981|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0
2351078|NCT03903822|4097974|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
2351079|NCT03903822|4097975|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4
2351080|NCT03903822|4097976|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
2351081|NCT03903822|4097977|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
2351082|NCT03903822|4097978|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1
2351083|NCT03903822|4097979|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
2351084|NCT03903822|4097980|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
2351085|NCT03903822|4097981|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
2351086|NCT03903822|4097974|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2
2351087|NCT03903822|4097975|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0
2351088|NCT03903822|4097976|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0
2351089|NCT03903822|4097977|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0
2351090|NCT03903822|4097978|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0
2351091|NCT03903822|4097979|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1
2351092|NCT03903822|4097980|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0
2351093|NCT03903822|4097981|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0
2351094|NCT03903822|4097974|FG000|Treatment Phase (6 Weeks)|Other|2
2351095|NCT03903822|4097975|FG001|Treatment Phase (6 Weeks)|Other|1
2351096|NCT03903822|4097976|FG002|Treatment Phase (6 Weeks)|Other|0
2351097|NCT03903822|4097977|FG003|Treatment Phase (6 Weeks)|Other|0
2351098|NCT03903822|4097978|FG004|Treatment Phase (6 Weeks)|Other|1
2351099|NCT03903822|4097979|FG005|Treatment Phase (6 Weeks)|Other|1
2351100|NCT03903822|4097980|FG006|Treatment Phase (6 Weeks)|Other|0
2351101|NCT03903822|4097981|FG007|Treatment Phase (6 Weeks)|Other|0
2351102|NCT03903822|4097974|FG000|Follow up Phase (4 Weeks)|Adverse Event|3
2351103|NCT03903822|4097975|FG001|Follow up Phase (4 Weeks)|Adverse Event|2
2272711|NCT02278367|3952539|FG000|Overall Study|Withdrawal by Subject|5
2272712|NCT02278367|3952540|FG001|Overall Study|Withdrawal by Subject|0
2272713|NCT02278471|3952548|FG000|Overall Study|Lost to Follow-up|6
2272714|NCT02278471|3952549|FG001|Overall Study|Lost to Follow-up|15
2272715|NCT02278471|3952548|FG000|Overall Study|Death|2
2272716|NCT02278471|3952549|FG001|Overall Study|Death|2
2272717|NCT02278471|3952548|FG000|Overall Study|Withdrawal by Subject|0
2272718|NCT02278471|3952549|FG001|Overall Study|Withdrawal by Subject|3
2272719|NCT02278614|3952576|FG000|Overall Study|Withdrawal by Subject|3
2272720|NCT02278614|3952577|FG001|Overall Study|Withdrawal by Subject|5
2272721|NCT02278614|3952576|FG000|Overall Study|Adverse Event|1
2272722|NCT02278614|3952577|FG001|Overall Study|Adverse Event|0
2272723|NCT02278614|3952576|FG000|Overall Study|left eye was not eligible|1
2272724|NCT02278614|3952577|FG001|Overall Study|left eye was not eligible|0
2272725|NCT02278939|3952593|FG000|Overall Study|lack of time|1
2272726|NCT02278939|3952594|FG001|Overall Study|lack of time|0
2272727|NCT02278939|3952593|FG000|Overall Study|Lost to Follow-up|1
2272728|NCT02278939|3952594|FG001|Overall Study|Lost to Follow-up|1
2272729|NCT02278939|3952593|FG000|Overall Study|death in family|1
2272730|NCT02278939|3952594|FG001|Overall Study|death in family|0
2272731|NCT02278939|3952593|FG000|Overall Study|family emergency unable to commit|2
2272732|NCT02278939|3952594|FG001|Overall Study|family emergency unable to commit|0
2272733|NCT02278952|3952600|FG000|Overall Study|Insufficient Sample|6
2272734|NCT02279043|3952613|FG000|Overall Study|Post-rand. exclusion - not eligible|1
2272735|NCT02279043|3952614|FG001|Overall Study|Post-rand. exclusion - not eligible|1
2272736|NCT02279043|3952615|FG002|Overall Study|Post-rand. exclusion - not eligible|0
2272737|NCT02279043|3952613|FG000|Overall Study|Lost to Follow-up|46
2272738|NCT02279043|3952614|FG001|Overall Study|Lost to Follow-up|88
2272739|NCT02279043|3952615|FG002|Overall Study|Lost to Follow-up|0
2272740|NCT02279173|3952643|FG000|Overall Study|Protocol-specified Criteria|67
2272741|NCT02279173|3952643|FG000|Overall Study|Withdrawal by Subject|20
2272742|NCT02279173|3952643|FG000|Overall Study|Decision by Sponsor|4
2272743|NCT02279173|3952643|FG000|Overall Study|Lost to Follow-up|3
2272744|NCT02279407|3952653|FG000|Overall Study|Couldn't swallow IP; noncompliance|0
2272745|NCT02279407|3952654|FG001|Overall Study|Couldn't swallow IP; noncompliance|0
2272746|NCT02279407|3952655|FG002|Overall Study|Couldn't swallow IP; noncompliance|2
2272747|NCT02279407|3952656|FG003|Overall Study|Couldn't swallow IP; noncompliance|0
2272748|NCT02279407|3952653|FG000|Overall Study|Withdrawal by Subject|1
2272749|NCT02279407|3952654|FG001|Overall Study|Withdrawal by Subject|0
2272750|NCT02279407|3952655|FG002|Overall Study|Withdrawal by Subject|1
2272751|NCT02279407|3952656|FG003|Overall Study|Withdrawal by Subject|1
2272752|NCT02279407|3952653|FG000|Overall Study|Adverse Event|1
2272753|NCT02279407|3952654|FG001|Overall Study|Adverse Event|1
2272754|NCT02279407|3952655|FG002|Overall Study|Adverse Event|2
2272755|NCT02279407|3952656|FG003|Overall Study|Adverse Event|0
2272756|NCT02279420|3952666|FG000|Overall Study|Lost to Follow-up|23
2272757|NCT02279498|3952672|FG000|Overall Study|Adverse Event|3
2272758|NCT02279498|3952673|FG001|Overall Study|Adverse Event|0
2272759|NCT02279498|3952672|FG000|Overall Study|Lack of Efficacy|4
2272760|NCT02279498|3952673|FG001|Overall Study|Lack of Efficacy|0
2272761|NCT02279498|3952672|FG000|Overall Study|Lost to Follow-up|0
2272762|NCT02279498|3952673|FG001|Overall Study|Lost to Follow-up|1
2272763|NCT02279498|3952672|FG000|Overall Study|Withdrawal by Subject|9
2272764|NCT02279498|3952673|FG001|Overall Study|Withdrawal by Subject|2
2272765|NCT02279498|3952672|FG000|Overall Study|Undefined|2
2272766|NCT02279498|3952673|FG001|Overall Study|Undefined|1
2272767|NCT02279524|3952683|FG000|Overall Study|Withdrawal by Subject|3
2272768|NCT02279524|3952684|FG001|Overall Study|Withdrawal by Subject|6
2272769|NCT02279524|3952685|FG002|Overall Study|Withdrawal by Subject|3
2272770|NCT02279524|3952683|FG000|Overall Study|Adverse Event|4
2272771|NCT02279524|3952684|FG001|Overall Study|Adverse Event|3
2272772|NCT02279524|3952685|FG002|Overall Study|Adverse Event|2
2272773|NCT02279524|3952683|FG000|Overall Study|Lost to Follow-up|1
2272774|NCT02279524|3952684|FG001|Overall Study|Lost to Follow-up|1
2272775|NCT02279524|3952685|FG002|Overall Study|Lost to Follow-up|0
2272776|NCT02279524|3952683|FG000|Overall Study|Disallowed medication|1
2272777|NCT02279524|3952684|FG001|Overall Study|Disallowed medication|1
2272778|NCT02279524|3952685|FG002|Overall Study|Disallowed medication|2
2272779|NCT02279524|3952683|FG000|Overall Study|Bariatric surgery|1
2272780|NCT02279524|3952684|FG001|Overall Study|Bariatric surgery|0
2272781|NCT02279524|3952685|FG002|Overall Study|Bariatric surgery|0
2272782|NCT02279719|3952733|FG000|Overall Study|Patients randomized but never treated|0
2272783|NCT02279719|3952734|FG001|Overall Study|Patients randomized but never treated|0
2272784|NCT02279719|3952735|FG002|Overall Study|Patients randomized but never treated|0
2272785|NCT02279719|3952736|FG003|Overall Study|Patients randomized but never treated|0
2272786|NCT02279719|3952737|FG004|Overall Study|Patients randomized but never treated|3
2272787|NCT02279719|3952738|FG005|Overall Study|Patients randomized but never treated|0
2272788|NCT02279719|3952739|FG006|Overall Study|Patients randomized but never treated|3
2272789|NCT02279732|3952774|FG000|Overall Study|Death|23
2272790|NCT02279732|3952775|FG001|Overall Study|Death|20
2272791|NCT02279732|3952774|FG000|Overall Study|Disease Progression|13
2272792|NCT02279732|3952775|FG001|Overall Study|Disease Progression|3
2272793|NCT02279732|3952774|FG000|Overall Study|Withdrawal by Subject|2
2272794|NCT02279732|3952775|FG001|Overall Study|Withdrawal by Subject|7
2272795|NCT02279732|3952774|FG000|Overall Study|Adverse Event|1
2272796|NCT02279732|3952775|FG001|Overall Study|Adverse Event|2
2272797|NCT02279732|3952774|FG000|Overall Study|Administrative Reason By Sponsor|0
2272798|NCT02279732|3952775|FG001|Overall Study|Administrative Reason By Sponsor|2
2272799|NCT02279732|3952774|FG000|Overall Study|Study Drug Toxicity|2
2272800|NCT02279732|3952775|FG001|Overall Study|Study Drug Toxicity|0
2272801|NCT02279732|3952774|FG000|Overall Study|Lost to Follow-up|0
2272802|NCT02279732|3952775|FG001|Overall Study|Lost to Follow-up|1
2272803|NCT02279732|3952774|FG000|Overall Study|Maximum Clinical Benefit|1
2272804|NCT02279732|3952775|FG001|Overall Study|Maximum Clinical Benefit|0
2272805|NCT02279732|3952774|FG000|Overall Study|Subject Requested to Discontinue|0
2272806|NCT02279732|3952775|FG001|Overall Study|Subject Requested to Discontinue|1
2272807|NCT02279732|3952774|FG000|Overall Study|Other|53
2272808|NCT02279732|3952775|FG001|Overall Study|Other|67
2272809|NCT02279732|3952774|FG000|Overall Study|Other|3
2272810|NCT02279732|3952775|FG001|Overall Study|Other|3
2272811|NCT02279862|3952783|FG000|Overall Study|Study drug toxicity|3
2272812|NCT02279862|3952784|FG001|Overall Study|Study drug toxicity|6
2272813|NCT02279862|3952783|FG000|Overall Study|No longer meets criteria|0
2272814|NCT02279862|3952784|FG001|Overall Study|No longer meets criteria|1
2272815|NCT02279862|3952783|FG000|Overall Study|Administrative reason by sponsor|0
2272816|NCT02279862|3952784|FG001|Overall Study|Administrative reason by sponsor|1
2272817|NCT02279862|3952783|FG000|Overall Study|Disease progression|5
2272818|NCT02279862|3952784|FG001|Overall Study|Disease progression|2
2272819|NCT02279862|3952783|FG000|Overall Study|Study closed by sponsor|16
2272820|NCT02279862|3952784|FG001|Overall Study|Study closed by sponsor|13
2272821|NCT02279862|3952783|FG000|Overall Study|Other|1
2272822|NCT02279862|3952784|FG001|Overall Study|Other|2
2351104|NCT03903822|4097976|FG002|Follow up Phase (4 Weeks)|Adverse Event|1
2351105|NCT03903822|4097977|FG003|Follow up Phase (4 Weeks)|Adverse Event|1
2351106|NCT03903822|4097978|FG004|Follow up Phase (4 Weeks)|Adverse Event|0
2351107|NCT03903822|4097979|FG005|Follow up Phase (4 Weeks)|Adverse Event|5
2351108|NCT03903822|4097980|FG006|Follow up Phase (4 Weeks)|Adverse Event|1
2351109|NCT03903822|4097981|FG007|Follow up Phase (4 Weeks)|Adverse Event|0
2351110|NCT03903822|4097974|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0
2351111|NCT03903822|4097975|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0
2272823|NCT02279862|3952783|FG000|Overall Study|Withdrawal by Subject|1
2272824|NCT02279862|3952784|FG001|Overall Study|Withdrawal by Subject|0
2272825|NCT02280044|3952792|FG000|Overall Study|Planned alternate|0
2272826|NCT02280044|3952793|FG001|Overall Study|Planned alternate|2
2272827|NCT02280096|3952801|FG000|Overall Study|Pregnancy|1
2272828|NCT02280096|3952802|FG001|Overall Study|Pregnancy|0
2272829|NCT02280096|3952801|FG000|Overall Study|Functional neurological disorder|1
2272830|NCT02280096|3952802|FG001|Overall Study|Functional neurological disorder|0
2272831|NCT02280096|3952801|FG000|Overall Study|Lack of attachment|0
2272832|NCT02280096|3952802|FG001|Overall Study|Lack of attachment|1
2272833|NCT02280187|3952827|FG000|Overall Study|Lost to Follow-up|218
2272834|NCT02280291|3952848|FG000|Overall Study|Lost to Follow-up|2
2272835|NCT02280291|3952849|FG001|Overall Study|Lost to Follow-up|1
2272836|NCT02280291|3952850|FG002|Overall Study|Lost to Follow-up|3
2272837|NCT02280291|3952851|FG003|Overall Study|Lost to Follow-up|8
2272838|NCT02280291|3952848|FG000|Overall Study|Protocol Violation|1
2272839|NCT02280291|3952849|FG001|Overall Study|Protocol Violation|0
2272840|NCT02280291|3952850|FG002|Overall Study|Protocol Violation|0
2272841|NCT02280291|3952851|FG003|Overall Study|Protocol Violation|0
2272842|NCT02280291|3952848|FG000|Overall Study|Other|1
2272843|NCT02280291|3952849|FG001|Overall Study|Other|1
2272844|NCT02280291|3952850|FG002|Overall Study|Other|0
2272845|NCT02280291|3952851|FG003|Overall Study|Other|0
2272846|NCT02280304|3952865|FG000|Overall Study|Lost to Follow-up|7
2272847|NCT02280304|3952866|FG001|Overall Study|Lost to Follow-up|8
2272848|NCT02280408|3952915|FG000|Overall Study|Lost to Follow-up|0
2272849|NCT02280408|3952916|FG001|Overall Study|Lost to Follow-up|2
2272850|NCT02280408|3952917|FG002|Overall Study|Lost to Follow-up|0
2272851|NCT02280408|3952918|FG003|Overall Study|Lost to Follow-up|0
2272852|NCT02280421|3952930|FG000|Washout (2 Weeks)|Adverse Event|0
2272853|NCT02280421|3952931|FG001|Washout (2 Weeks)|Adverse Event|1
2272854|NCT02280421|3952930|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
2272855|NCT02280421|3952931|FG001|Washout (2 Weeks)|Withdrawal by Subject|0
2272856|NCT02280473|3952951|FG000|Overall Study|Adverse Event|1
2272857|NCT02280473|3952952|FG001|Overall Study|Adverse Event|1
2272858|NCT02280473|3952951|FG000|Overall Study|Lack of Efficacy|0
2272859|NCT02280473|3952952|FG001|Overall Study|Lack of Efficacy|1
2272860|NCT02280473|3952951|FG000|Overall Study|Lost to Follow-up|0
2272861|NCT02280473|3952952|FG001|Overall Study|Lost to Follow-up|1
2272862|NCT02280499|3952958|FG000|Overall Study|Death|14
2272863|NCT02280499|3952958|FG000|Overall Study|Lost to Follow-up|42
2272864|NCT02280499|3952958|FG000|Overall Study|Adverse Event|5
2272865|NCT02280863|3952996|FG000|Integrated Platform|Met stopping criteria|0
2272866|NCT02280863|3952997|FG001|Integrated Platform|Met stopping criteria|1
2272867|NCT02281318|3953013|FG000|Overall Study|Adverse Event|2
2272868|NCT02281318|3953014|FG001|Overall Study|Adverse Event|2
2272869|NCT02281318|3953013|FG000|Overall Study|Lack of Efficacy|2
2272870|NCT02281318|3953014|FG001|Overall Study|Lack of Efficacy|0
2351112|NCT03903822|4097976|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0
2351113|NCT03903822|4097977|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0
2351114|NCT03903822|4097978|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1
2351115|NCT03903822|4097979|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0
2351116|NCT03903822|4097980|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0
2351117|NCT03903822|4097981|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0
2351118|NCT03903822|4097974|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2
2351119|NCT03903822|4097975|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0
2351120|NCT03903822|4097976|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0
2351121|NCT03903822|4097977|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0
2351122|NCT03903822|4097978|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0
2351123|NCT03903822|4097979|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0
2351124|NCT03903822|4097980|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1
2351125|NCT03903822|4097981|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3
2351126|NCT03903822|4097974|FG000|Follow up Phase (4 Weeks)|Pregnancy|0
2351127|NCT03903822|4097975|FG001|Follow up Phase (4 Weeks)|Pregnancy|0
2351128|NCT03903822|4097976|FG002|Follow up Phase (4 Weeks)|Pregnancy|0
2351129|NCT03903822|4097977|FG003|Follow up Phase (4 Weeks)|Pregnancy|1
2351130|NCT03903822|4097978|FG004|Follow up Phase (4 Weeks)|Pregnancy|1
2351131|NCT03903822|4097979|FG005|Follow up Phase (4 Weeks)|Pregnancy|0
2351132|NCT03903822|4097980|FG006|Follow up Phase (4 Weeks)|Pregnancy|0
2351133|NCT03903822|4097981|FG007|Follow up Phase (4 Weeks)|Pregnancy|0
2351134|NCT03903822|4097974|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
2351135|NCT03903822|4097975|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5
2351136|NCT03903822|4097976|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
2351137|NCT03903822|4097977|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
2351138|NCT03903822|4097978|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
2351139|NCT03903822|4097979|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
2351140|NCT03903822|4097980|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
2351141|NCT03903822|4097981|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
2351142|NCT03903822|4097974|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
2351143|NCT03903822|4097975|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
2272871|NCT02281318|3953013|FG000|Overall Study|Lost to Follow-up|2
2272872|NCT02281318|3953014|FG001|Overall Study|Lost to Follow-up|1
2272873|NCT02281318|3953013|FG000|Overall Study|Physician Decision|2
2272874|NCT02281318|3953014|FG001|Overall Study|Physician Decision|0
2272875|NCT02281318|3953013|FG000|Overall Study|Withdrawal by Subject|6
2272876|NCT02281318|3953014|FG001|Overall Study|Withdrawal by Subject|2
2272877|NCT02281357|3953026|FG000|Overall Study|Adverse Event|2
2272878|NCT02281357|3953027|FG001|Overall Study|Adverse Event|1
2272879|NCT02281357|3953026|FG000|Overall Study|Lost to Follow-up|1
2272880|NCT02281357|3953027|FG001|Overall Study|Lost to Follow-up|0
2272881|NCT02281357|3953026|FG000|Overall Study|Withdrawal by Subject|4
2272882|NCT02281357|3953027|FG001|Overall Study|Withdrawal by Subject|3
2272883|NCT02281552|3953096|FG000|Overall Study|Medication error|1
2272884|NCT02281552|3953097|FG001|Overall Study|Medication error|0
2272885|NCT02281552|3953096|FG000|Overall Study|Insufficient clinical response|0
2272886|NCT02281552|3953097|FG001|Overall Study|Insufficient clinical response|1
2272887|NCT02281552|3953096|FG000|Overall Study|Adverse Event|3
2272888|NCT02281552|3953097|FG001|Overall Study|Adverse Event|9
2272889|NCT02281760|3953120|FG000|Overall Study|Withdrawal by Subject|1
2272890|NCT02281773|3953129|FG000|Overall Study|Adverse Event|6
2272891|NCT02281773|3953130|FG001|Overall Study|Adverse Event|1
2272892|NCT02281773|3953131|FG002|Overall Study|Adverse Event|4
2272893|NCT02281773|3953132|FG003|Overall Study|Adverse Event|8
2272894|NCT02281773|3953133|FG004|Overall Study|Adverse Event|9
2272895|NCT02281773|3953129|FG000|Overall Study|Protocol Violation|1
2272896|NCT02281773|3953130|FG001|Overall Study|Protocol Violation|0
2272897|NCT02281773|3953131|FG002|Overall Study|Protocol Violation|0
2272898|NCT02281773|3953132|FG003|Overall Study|Protocol Violation|2
2272899|NCT02281773|3953133|FG004|Overall Study|Protocol Violation|2
2272900|NCT02281773|3953129|FG000|Overall Study|Lost to Follow-up|2
2272901|NCT02281773|3953130|FG001|Overall Study|Lost to Follow-up|2
2272902|NCT02281773|3953131|FG002|Overall Study|Lost to Follow-up|6
2272903|NCT02281773|3953132|FG003|Overall Study|Lost to Follow-up|2
2272904|NCT02281773|3953133|FG004|Overall Study|Lost to Follow-up|10
2272905|NCT02281773|3953129|FG000|Overall Study|Withdrawal by Subject|2
2272906|NCT02281773|3953130|FG001|Overall Study|Withdrawal by Subject|8
2272907|NCT02281773|3953131|FG002|Overall Study|Withdrawal by Subject|6
2272908|NCT02281773|3953132|FG003|Overall Study|Withdrawal by Subject|6
2272909|NCT02281773|3953133|FG004|Overall Study|Withdrawal by Subject|8
2272910|NCT02281773|3953129|FG000|Overall Study|Other Reason|0
2272911|NCT02281773|3953130|FG001|Overall Study|Other Reason|4
2272912|NCT02281773|3953131|FG002|Overall Study|Other Reason|2
2272913|NCT02281773|3953132|FG003|Overall Study|Other Reason|3
2272914|NCT02281773|3953133|FG004|Overall Study|Other Reason|1
2272915|NCT02282163|3953163|FG000|Overall Study|Protocol Violation|1
2272916|NCT02282293|3953178|FG000|Overall Study|Lost to Follow-up|2
2272917|NCT02282293|3953179|FG001|Overall Study|Lost to Follow-up|2
2272918|NCT02282293|3953178|FG000|Overall Study|Unable to comply with study procedures|1
2272919|NCT02282293|3953179|FG001|Overall Study|Unable to comply with study procedures|0
2272920|NCT02282293|3953178|FG000|Overall Study|Moved out of study area|0
2272921|NCT02282293|3953179|FG001|Overall Study|Moved out of study area|1
2272922|NCT02282527|3953191|FG000|Overall Study|Lost to Follow-up|0
2272923|NCT02282527|3953192|FG001|Overall Study|Lost to Follow-up|1
2272924|NCT02282527|3953191|FG000|Overall Study|Lack of home health aid|1
2272925|NCT02282527|3953192|FG001|Overall Study|Lack of home health aid|0
2272926|NCT02282605|3953204|FG000|Overall Study|negative SA result on Day -1|3
2272927|NCT02282605|3953205|FG001|Overall Study|negative SA result on Day -1|0
2272928|NCT02282605|3953206|FG002|Overall Study|negative SA result on Day -1|0
2272929|NCT02282631|3953216|FG000|Overall Study|Lost to Follow-up|2
2272930|NCT02282631|3953217|FG001|Overall Study|Lost to Follow-up|0
2272931|NCT02282813|3953241|FG000|Overall Study|Withdrawal by Subject|4
2272932|NCT02282813|3953242|FG001|Overall Study|Withdrawal by Subject|5
2272933|NCT02282813|3953243|FG002|Overall Study|Withdrawal by Subject|0
2272934|NCT02282813|3953241|FG000|Overall Study|Adverse Event|3
2272935|NCT02282813|3953242|FG001|Overall Study|Adverse Event|10
2272936|NCT02282813|3953243|FG002|Overall Study|Adverse Event|1
2272937|NCT02282813|3953241|FG000|Overall Study|Subject non-compliance|1
2272938|NCT02282813|3953242|FG001|Overall Study|Subject non-compliance|4
2272939|NCT02282813|3953243|FG002|Overall Study|Subject non-compliance|0
2272940|NCT02282813|3953241|FG000|Overall Study|Physician Decision|0
2272941|NCT02282813|3953242|FG001|Overall Study|Physician Decision|3
2272942|NCT02282813|3953243|FG002|Overall Study|Physician Decision|1
2272943|NCT02282813|3953241|FG000|Overall Study|Lost to Follow-up|2
2272944|NCT02282813|3953242|FG001|Overall Study|Lost to Follow-up|0
2272945|NCT02282813|3953243|FG002|Overall Study|Lost to Follow-up|1
2272946|NCT02282813|3953241|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1
2272947|NCT02282813|3953242|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0
2272948|NCT02282813|3953243|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0
2272949|NCT02282813|3953241|FG000|Overall Study|Lack of Efficacy|1
2272950|NCT02282813|3953242|FG001|Overall Study|Lack of Efficacy|0
2272951|NCT02282813|3953243|FG002|Overall Study|Lack of Efficacy|0
2272952|NCT02282813|3953241|FG000|Overall Study|Administrative reasons|0
2272953|NCT02282813|3953242|FG001|Overall Study|Administrative reasons|1
2272954|NCT02282813|3953243|FG002|Overall Study|Administrative reasons|0
2272955|NCT02282982|3953261|FG000|Overall Study|Lost to Follow-up|15
2272956|NCT02282982|3953261|FG000|Overall Study|Withdrew consent|2
2272957|NCT02282982|3953261|FG000|Overall Study|Death|4
2272958|NCT02282982|3953261|FG000|Overall Study|Lack of product|156
2272959|NCT02282982|3953261|FG000|Overall Study|Palivizumab is ended|11
2272960|NCT02282982|3953261|FG000|Overall Study|Other, not specified|18
2272961|NCT02283268|3953265|FG000|Overall Study|Withdrawal by Subject|1
2351144|NCT03903822|4097976|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
2351145|NCT03903822|4097977|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
2351146|NCT03903822|4097978|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
2351147|NCT03903822|4097979|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1
2351148|NCT03903822|4097980|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
2351149|NCT03903822|4097981|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
2351150|NCT03903822|4097974|FG000|Follow up Phase (4 Weeks)|Other|1
2351151|NCT03903822|4097975|FG001|Follow up Phase (4 Weeks)|Other|1
2351152|NCT03903822|4097976|FG002|Follow up Phase (4 Weeks)|Other|0
2351153|NCT03903822|4097977|FG003|Follow up Phase (4 Weeks)|Other|0
2351154|NCT03903822|4097978|FG004|Follow up Phase (4 Weeks)|Other|0
2351155|NCT03903822|4097979|FG005|Follow up Phase (4 Weeks)|Other|0
2351156|NCT03903822|4097980|FG006|Follow up Phase (4 Weeks)|Other|0
2351157|NCT03903822|4097981|FG007|Follow up Phase (4 Weeks)|Other|0
2351158|NCT03905096|4098001|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1
2351159|NCT03905096|4098002|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0
2351160|NCT03899064|4098015|FG000|Overall Study|Lost to Follow-up|1
2351161|NCT03899064|4098015|FG000|Overall Study|Protocol Violation|2
2351162|NCT03899064|4098015|FG000|Overall Study|Withdrawal by Subject|2
2351163|NCT03899064|4098015|FG000|Overall Study|Other|2
2351164|NCT03894969|4098024|FG000|Overall Study|Adverse Event|0
2351165|NCT03894969|4098025|FG001|Overall Study|Adverse Event|2
2351166|NCT03894969|4098026|FG002|Overall Study|Adverse Event|0
2351167|NCT03894969|4098027|FG003|Overall Study|Adverse Event|3
2351168|NCT03894969|4098028|FG004|Overall Study|Adverse Event|3
2351169|NCT03894969|4098024|FG000|Overall Study|Lost to Follow-up|1
2351170|NCT03894969|4098025|FG001|Overall Study|Lost to Follow-up|0
2351171|NCT03894969|4098026|FG002|Overall Study|Lost to Follow-up|1
2351172|NCT03894969|4098027|FG003|Overall Study|Lost to Follow-up|0
2351173|NCT03894969|4098028|FG004|Overall Study|Lost to Follow-up|0
2351174|NCT03894969|4098024|FG000|Overall Study|Withdrawal by Subject|1
2351175|NCT03894969|4098025|FG001|Overall Study|Withdrawal by Subject|1
2351176|NCT03894969|4098026|FG002|Overall Study|Withdrawal by Subject|1
2351177|NCT03894969|4098027|FG003|Overall Study|Withdrawal by Subject|3
2351178|NCT03894969|4098028|FG004|Overall Study|Withdrawal by Subject|8
2351179|NCT03894969|4098024|FG000|Overall Study|Other|0
2351180|NCT03894969|4098025|FG001|Overall Study|Other|0
2351181|NCT03894969|4098026|FG002|Overall Study|Other|0
2351182|NCT03894969|4098027|FG003|Overall Study|Other|0
2351183|NCT03894969|4098028|FG004|Overall Study|Other|3
2351184|NCT03903159|4098041|FG000|Overall Study|Discharged with Staff Approval|2
2351185|NCT03903159|4098041|FG000|Overall Study|Discharged at Staff Request|2
2351186|NCT03903159|4098041|FG000|Overall Study|Discharged Against Staff Advice|1
2351187|NCT03902392|4098047|FG000|Overall Study|Lost to Follow-up|7
2351188|NCT03902392|4098048|FG001|Overall Study|Lost to Follow-up|7
2351189|NCT03895034|4098101|FG000|Overall Study|Lost to Follow-up|2
2351190|NCT03900728|4098108|FG000|Overall Study|No text responses|0
2351191|NCT03900728|4098109|FG001|Overall Study|No text responses|0
2351192|NCT03900728|4098110|FG002|Overall Study|No text responses|4
2351193|NCT03895372|4098149|FG000|Investigational Treatment Period|Adverse Event|1
2351194|NCT03895372|4098150|FG001|Investigational Treatment Period|Adverse Event|0
2351195|NCT03895372|4098151|FG002|Investigational Treatment Period|Adverse Event|0
2351196|NCT03895372|4098152|FG003|Investigational Treatment Period|Adverse Event|0
2351197|NCT03895372|4098153|FG004|Investigational Treatment Period|Adverse Event|0
2351198|NCT03895372|4098154|FG005|Investigational Treatment Period|Adverse Event|0
2351199|NCT03895372|4098155|FG006|Investigational Treatment Period|Adverse Event|4
2351200|NCT03895372|4098156|FG007|Investigational Treatment Period|Adverse Event|3
2351201|NCT03895372|4098149|FG000|Investigational Treatment Period|Lack of Efficacy|1
2351202|NCT03895372|4098150|FG001|Investigational Treatment Period|Lack of Efficacy|0
2351203|NCT03895372|4098151|FG002|Investigational Treatment Period|Lack of Efficacy|0
2351204|NCT03895372|4098152|FG003|Investigational Treatment Period|Lack of Efficacy|0
2351205|NCT03895372|4098153|FG004|Investigational Treatment Period|Lack of Efficacy|0
2351206|NCT03895372|4098154|FG005|Investigational Treatment Period|Lack of Efficacy|0
2351207|NCT03895372|4098155|FG006|Investigational Treatment Period|Lack of Efficacy|0
2351208|NCT03895372|4098156|FG007|Investigational Treatment Period|Lack of Efficacy|0
2351209|NCT03895372|4098149|FG000|Investigational Treatment Period|Lost to Follow-up|0
2351210|NCT03895372|4098150|FG001|Investigational Treatment Period|Lost to Follow-up|0
2351211|NCT03895372|4098151|FG002|Investigational Treatment Period|Lost to Follow-up|0
2351212|NCT03895372|4098152|FG003|Investigational Treatment Period|Lost to Follow-up|0
2351213|NCT03895372|4098153|FG004|Investigational Treatment Period|Lost to Follow-up|0
2351214|NCT03895372|4098154|FG005|Investigational Treatment Period|Lost to Follow-up|0
2351215|NCT03895372|4098155|FG006|Investigational Treatment Period|Lost to Follow-up|1
2351216|NCT03895372|4098156|FG007|Investigational Treatment Period|Lost to Follow-up|0
2351217|NCT03895372|4098149|FG000|Investigational Treatment Period|Other|0
2351218|NCT03895372|4098150|FG001|Investigational Treatment Period|Other|0
2351219|NCT03895372|4098151|FG002|Investigational Treatment Period|Other|0
2351220|NCT03895372|4098152|FG003|Investigational Treatment Period|Other|0
2272962|NCT02283294|3953279|FG000|Overall Study|Lost to Follow-up|1
2272963|NCT02283294|3953280|FG001|Overall Study|Lost to Follow-up|1
2272964|NCT02283294|3953279|FG000|Overall Study|Withdrawal by Subject|1
2272965|NCT02283294|3953280|FG001|Overall Study|Withdrawal by Subject|6
2272966|NCT02283294|3953279|FG000|Overall Study|Protocol Violation|1
2272967|NCT02283294|3953280|FG001|Overall Study|Protocol Violation|0
2272968|NCT02283294|3953279|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0
2272969|NCT02283294|3953280|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1
2272970|NCT02283411|3953296|FG000|Overall Study|Withdrawal by Subject|3
2272971|NCT02283411|3953296|FG000|Overall Study|Screen Failed|28
2272972|NCT02283658|3953309|FG000|Overall Study|Withdrawal by Subject|1
2272973|NCT02283762|3953319|FG000|Main Treatment Phase (MT)|Adverse Event|9
2272974|NCT02283762|3953320|FG001|Main Treatment Phase (MT)|Adverse Event|9
2272975|NCT02283762|3953319|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1
2272976|NCT02283762|3953320|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0
2272977|NCT02283762|3953319|FG000|Main Treatment Phase (MT)|Physician Decision|1
2272978|NCT02283762|3953320|FG001|Main Treatment Phase (MT)|Physician Decision|1
2272979|NCT02283762|3953319|FG000|Main Treatment Phase (MT)|Pregnancy|0
2272980|NCT02283762|3953320|FG001|Main Treatment Phase (MT)|Pregnancy|1
2272981|NCT02283762|3953319|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7
2272982|NCT02283762|3953320|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4
2272983|NCT02283762|3953319|FG000|Long-term Extension Phase (LTE)|Adverse Event|2
2272984|NCT02283762|3953320|FG001|Long-term Extension Phase (LTE)|Adverse Event|6
2272985|NCT02283762|3953319|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1
2351221|NCT03895372|4098153|FG004|Investigational Treatment Period|Other|0
2272986|NCT02283762|3953320|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1
2272987|NCT02283762|3953319|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1
2272988|NCT02283762|3953320|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0
2272989|NCT02283762|3953319|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
2272990|NCT02283762|3953320|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
2272991|NCT02283762|3953319|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1
2272992|NCT02283762|3953320|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1
2272993|NCT02283762|3953319|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0
2272994|NCT02283762|3953320|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1
2272995|NCT02283762|3953319|FG000|Long-term Extension Phase (LTE)|Physician Decision|1
2272996|NCT02283762|3953320|FG001|Long-term Extension Phase (LTE)|Physician Decision|2
2272997|NCT02283788|3953332|FG000|Overall Study|Adverse Event|1
2272998|NCT02283788|3953333|FG001|Overall Study|Adverse Event|3
2272999|NCT02283788|3953334|FG002|Overall Study|Adverse Event|5
2273000|NCT02283788|3953335|FG003|Overall Study|Adverse Event|1
2273001|NCT02283788|3953332|FG000|Overall Study|Withdrawal by Subject|0
2273002|NCT02283788|3953333|FG001|Overall Study|Withdrawal by Subject|1
2273003|NCT02283788|3953334|FG002|Overall Study|Withdrawal by Subject|0
2273004|NCT02283788|3953335|FG003|Overall Study|Withdrawal by Subject|1
2351222|NCT03895372|4098154|FG005|Investigational Treatment Period|Other|1
2351223|NCT03895372|4098155|FG006|Investigational Treatment Period|Other|0
2351224|NCT03895372|4098156|FG007|Investigational Treatment Period|Other|2
2351225|NCT03895372|4098149|FG000|Investigational Treatment Period|Protocol Violation|0
2351226|NCT03895372|4098150|FG001|Investigational Treatment Period|Protocol Violation|0
2351227|NCT03895372|4098151|FG002|Investigational Treatment Period|Protocol Violation|0
2351228|NCT03895372|4098152|FG003|Investigational Treatment Period|Protocol Violation|1
2351229|NCT03895372|4098153|FG004|Investigational Treatment Period|Protocol Violation|0
2351230|NCT03895372|4098154|FG005|Investigational Treatment Period|Protocol Violation|0
2351231|NCT03895372|4098155|FG006|Investigational Treatment Period|Protocol Violation|0
2351232|NCT03895372|4098156|FG007|Investigational Treatment Period|Protocol Violation|0
2351233|NCT03895372|4098149|FG000|Investigational Treatment Period|Withdrawal by Subject|2
2351234|NCT03895372|4098150|FG001|Investigational Treatment Period|Withdrawal by Subject|3
2351235|NCT03895372|4098151|FG002|Investigational Treatment Period|Withdrawal by Subject|1
2351236|NCT03895372|4098152|FG003|Investigational Treatment Period|Withdrawal by Subject|1
2351237|NCT03895372|4098153|FG004|Investigational Treatment Period|Withdrawal by Subject|0
2351238|NCT03895372|4098154|FG005|Investigational Treatment Period|Withdrawal by Subject|1
2351239|NCT03895372|4098155|FG006|Investigational Treatment Period|Withdrawal by Subject|3
2351240|NCT03895372|4098156|FG007|Investigational Treatment Period|Withdrawal by Subject|0
2351241|NCT03895372|4098149|FG000|Extension Treatment Period|Adverse Event|0
2351242|NCT03895372|4098150|FG001|Extension Treatment Period|Adverse Event|1
2351243|NCT03895372|4098151|FG002|Extension Treatment Period|Adverse Event|0
2351244|NCT03895372|4098152|FG003|Extension Treatment Period|Adverse Event|1
2351245|NCT03895372|4098153|FG004|Extension Treatment Period|Adverse Event|0
2351246|NCT03895372|4098154|FG005|Extension Treatment Period|Adverse Event|0
2351247|NCT03895372|4098155|FG006|Extension Treatment Period|Adverse Event|3
2351248|NCT03895372|4098156|FG007|Extension Treatment Period|Adverse Event|3
2351249|NCT03895372|4098149|FG000|Extension Treatment Period|Other|1
2351250|NCT03895372|4098150|FG001|Extension Treatment Period|Other|3
2351251|NCT03895372|4098151|FG002|Extension Treatment Period|Other|0
2351252|NCT03895372|4098152|FG003|Extension Treatment Period|Other|0
2351253|NCT03895372|4098153|FG004|Extension Treatment Period|Other|1
2273005|NCT02284009|3953387|FG000|Overall Study|Adverse Event|3
2273006|NCT02284009|3953388|FG001|Overall Study|Adverse Event|0
2273007|NCT02284009|3953387|FG000|Overall Study|Lost to Follow-up|1
2273008|NCT02284009|3953388|FG001|Overall Study|Lost to Follow-up|3
2273009|NCT02284009|3953387|FG000|Overall Study|Physician Decision|0
2273010|NCT02284009|3953388|FG001|Overall Study|Physician Decision|2
2273011|NCT02284009|3953387|FG000|Overall Study|Withdrawal by Subject|2
2273012|NCT02284009|3953388|FG001|Overall Study|Withdrawal by Subject|5
2273013|NCT02284178|3953418|FG000|Overall Study|Met exclusion criteria|49
2273014|NCT02284178|3953419|FG001|Overall Study|Met exclusion criteria|54
2273015|NCT02284243|3953427|FG000|Overall Study|Lack of Efficacy|3
2273016|NCT02284243|3953428|FG001|Overall Study|Lack of Efficacy|3
2273017|NCT02284243|3953427|FG000|Overall Study|Adverse Event|1
2273018|NCT02284243|3953428|FG001|Overall Study|Adverse Event|0
2273019|NCT02284347|3953434|FG000|Overall Study|Lost to Follow-up|2
2273020|NCT02284347|3953434|FG000|Overall Study|Withdrawn prior to treatment|1
2273021|NCT02284568|3953478|FG000|Overall Study|Adverse Event|2
2273022|NCT02284568|3953479|FG001|Overall Study|Adverse Event|9
2273023|NCT02284568|3953480|FG002|Overall Study|Adverse Event|4
2273024|NCT02284568|3953478|FG000|Overall Study|Withdrawal by Subject|22
2273025|NCT02284568|3953479|FG001|Overall Study|Withdrawal by Subject|21
2273026|NCT02284568|3953480|FG002|Overall Study|Withdrawal by Subject|1
2273027|NCT02284568|3953478|FG000|Overall Study|Noncompliance with study drug admin|1
2273028|NCT02284568|3953479|FG001|Overall Study|Noncompliance with study drug admin|2
2273029|NCT02284568|3953480|FG002|Overall Study|Noncompliance with study drug admin|0
2273030|NCT02284568|3953478|FG000|Overall Study|Noncompliance|1
2273031|NCT02284568|3953479|FG001|Overall Study|Noncompliance|0
2273032|NCT02284568|3953480|FG002|Overall Study|Noncompliance|0
2273033|NCT02284568|3953478|FG000|Overall Study|Protocol Violation|0
2273034|NCT02284568|3953479|FG001|Overall Study|Protocol Violation|1
2273035|NCT02284568|3953480|FG002|Overall Study|Protocol Violation|0
2273036|NCT02284568|3953478|FG000|Overall Study|Sponsor requested patient stop treatment|0
2273037|NCT02284568|3953479|FG001|Overall Study|Sponsor requested patient stop treatment|0
2273038|NCT02284568|3953480|FG002|Overall Study|Sponsor requested patient stop treatment|90
2273039|NCT02284568|3953478|FG000|Overall Study|Lost to Follow-up|0
2273040|NCT02284568|3953479|FG001|Overall Study|Lost to Follow-up|3
2273041|NCT02284568|3953480|FG002|Overall Study|Lost to Follow-up|0
2273042|NCT02284568|3953478|FG000|Overall Study|Lack of Efficacy|4
2273043|NCT02284568|3953479|FG001|Overall Study|Lack of Efficacy|7
2273044|NCT02284568|3953480|FG002|Overall Study|Lack of Efficacy|0
2273045|NCT02284568|3953478|FG000|Overall Study|Other|1
2273046|NCT02284568|3953479|FG001|Overall Study|Other|2
2273047|NCT02284568|3953480|FG002|Overall Study|Other|0
2273048|NCT02284568|3953478|FG000|Overall Study|Withdrew before taking study drug|0
2273049|NCT02284568|3953479|FG001|Overall Study|Withdrew before taking study drug|1
2273050|NCT02284568|3953480|FG002|Overall Study|Withdrew before taking study drug|0
2273051|NCT02284893|3953537|FG000|26 Week (Short Term)|Adverse Event|1
2273052|NCT02284893|3953538|FG001|26 Week (Short Term)|Adverse Event|9
2273053|NCT02284893|3953537|FG000|26 Week (Short Term)|Discontinuation by the subject|2
2273054|NCT02284893|3953538|FG001|26 Week (Short Term)|Discontinuation by the subject|2
2273055|NCT02284893|3953537|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7
2273056|NCT02284893|3953538|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10
2351254|NCT03895372|4098154|FG005|Extension Treatment Period|Other|0
2351255|NCT03895372|4098155|FG006|Extension Treatment Period|Other|0
2351256|NCT03895372|4098156|FG007|Extension Treatment Period|Other|2
2351257|NCT03895372|4098149|FG000|Extension Treatment Period|Pregnancy|0
2351258|NCT03895372|4098150|FG001|Extension Treatment Period|Pregnancy|0
2351259|NCT03895372|4098151|FG002|Extension Treatment Period|Pregnancy|0
2351260|NCT03895372|4098152|FG003|Extension Treatment Period|Pregnancy|0
2351261|NCT03895372|4098153|FG004|Extension Treatment Period|Pregnancy|1
2351262|NCT03895372|4098154|FG005|Extension Treatment Period|Pregnancy|0
2351263|NCT03895372|4098155|FG006|Extension Treatment Period|Pregnancy|0
2351264|NCT03895372|4098156|FG007|Extension Treatment Period|Pregnancy|0
2351265|NCT03895372|4098149|FG000|Extension Treatment Period|Withdrawal by Subject|2
2351266|NCT03895372|4098150|FG001|Extension Treatment Period|Withdrawal by Subject|1
2351267|NCT03895372|4098151|FG002|Extension Treatment Period|Withdrawal by Subject|0
2351268|NCT03895372|4098152|FG003|Extension Treatment Period|Withdrawal by Subject|0
2351269|NCT03895372|4098153|FG004|Extension Treatment Period|Withdrawal by Subject|1
2351270|NCT03895372|4098154|FG005|Extension Treatment Period|Withdrawal by Subject|1
2351271|NCT03895372|4098155|FG006|Extension Treatment Period|Withdrawal by Subject|1
2351272|NCT03895372|4098156|FG007|Extension Treatment Period|Withdrawal by Subject|1
2351273|NCT03896022|4098182|FG000|Overall Study|Withdrawal by Subject|1
2351274|NCT03896022|4098183|FG001|Overall Study|Withdrawal by Subject|0
2351275|NCT03896022|4098184|FG002|Overall Study|Withdrawal by Subject|0
2351276|NCT03896022|4098182|FG000|Overall Study|Did not have procedure|3
2351277|NCT03896022|4098183|FG001|Overall Study|Did not have procedure|0
2351278|NCT03896022|4098184|FG002|Overall Study|Did not have procedure|0
2351279|NCT03891862|4098196|FG000|Open-label Period|Adverse Event|2
2351280|NCT03891862|4098197|FG001|Open-label Period|Adverse Event|0
2351281|NCT03891862|4098198|FG002|Open-label Period|Adverse Event|0
2351282|NCT03891862|4098196|FG000|Open-label Period|Protocol Violation|5
2351283|NCT03891862|4098197|FG001|Open-label Period|Protocol Violation|0
2273057|NCT02284893|3953537|FG000|26 Week (Short Term)|Lost to Follow-up|3
2273058|NCT02284893|3953538|FG001|26 Week (Short Term)|Lost to Follow-up|1
2273059|NCT02284893|3953537|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5
2273060|NCT02284893|3953538|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8
2273061|NCT02284893|3953537|FG000|26 Week (Short Term)|Other|1
2273062|NCT02284893|3953538|FG001|26 Week (Short Term)|Other|1
2273063|NCT02284893|3953537|FG000|52 Week (Long Term)|Adverse Event|3
2273064|NCT02284893|3953538|FG001|52 Week (Long Term)|Adverse Event|1
2273065|NCT02284893|3953537|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0
2273066|NCT02284893|3953538|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1
2273067|NCT02284893|3953537|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4
2273068|NCT02284893|3953538|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6
2273069|NCT02284893|3953537|FG000|52 Week (Long Term)|Lost to Follow-up|2
2273070|NCT02284893|3953538|FG001|52 Week (Long Term)|Lost to Follow-up|2
2273071|NCT02284893|3953537|FG000|52 Week (Long Term)|Non-Compliance|2
2273072|NCT02284893|3953538|FG001|52 Week (Long Term)|Non-Compliance|3
2273073|NCT02285010|3953546|FG000|Overall Study|not abdominal hysterectomy|2
2273074|NCT02285010|3953547|FG001|Overall Study|not abdominal hysterectomy|0
2273075|NCT02285010|3953546|FG000|Overall Study|Not spinal anesthesia|3
2273076|NCT02285010|3953547|FG001|Overall Study|Not spinal anesthesia|1
2273077|NCT02285114|3953566|FG000|Overall Study|Investigator's Discretion|0
2273078|NCT02285114|3953567|FG001|Overall Study|Investigator's Discretion|2
2273079|NCT02285114|3953568|FG002|Overall Study|Investigator's Discretion|0
2273080|NCT02285114|3953566|FG000|Overall Study|Withdrew Consent|0
2273081|NCT02285114|3953567|FG001|Overall Study|Withdrew Consent|0
2273082|NCT02285114|3953568|FG002|Overall Study|Withdrew Consent|1
2273083|NCT02285114|3953566|FG000|Overall Study|Enrolled but not treated|1
2273084|NCT02285114|3953567|FG001|Overall Study|Enrolled but not treated|0
2273085|NCT02285114|3953568|FG002|Overall Study|Enrolled but not treated|0
2273086|NCT02285114|3953566|FG000|Overall Study|Still on study|21
2273087|NCT02285114|3953567|FG001|Overall Study|Still on study|5
2273088|NCT02285114|3953568|FG002|Overall Study|Still on study|2
2273089|NCT02285153|3953584|FG000|Overall Study|Adverse Event|1
2273090|NCT02285153|3953585|FG001|Overall Study|Adverse Event|0
2273091|NCT02285361|3953600|FG000|Overall Study|Protocol Violation|43
2273092|NCT02285361|3953600|FG000|Overall Study|Lost to Follow-up|5
2273093|NCT02285361|3953600|FG000|Overall Study|Not taken GIOTRIF|2
2273094|NCT02285361|3953600|FG000|Overall Study|Consented prior to the contract date|1
2273095|NCT02285777|3953624|FG000|Overall Study|Withdrawal by Subject|1
2273096|NCT02285777|3953625|FG001|Overall Study|Withdrawal by Subject|1
2351284|NCT03891862|4098198|FG002|Open-label Period|Protocol Violation|0
2351285|NCT03891862|4098196|FG000|Open-label Period|Withdrawal by Subject|6
2351286|NCT03891862|4098197|FG001|Open-label Period|Withdrawal by Subject|0
2351287|NCT03891862|4098198|FG002|Open-label Period|Withdrawal by Subject|0
2351288|NCT03891862|4098196|FG000|Open-label Period|Death|1
2351289|NCT03891862|4098197|FG001|Open-label Period|Death|0
2351290|NCT03891862|4098198|FG002|Open-label Period|Death|0
2351291|NCT03891862|4098196|FG000|Open-label Period|Lost to Follow-up|2
2351292|NCT03891862|4098197|FG001|Open-label Period|Lost to Follow-up|0
2351293|NCT03891862|4098198|FG002|Open-label Period|Lost to Follow-up|0
2351294|NCT03891862|4098196|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0
2351295|NCT03891862|4098197|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1
2351296|NCT03891862|4098198|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1
2351297|NCT03891862|4098196|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0
2351298|NCT03891862|4098197|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2
2351299|NCT03891862|4098198|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1
2351300|NCT03891862|4098196|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0
2351301|NCT03891862|4098197|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1
2351302|NCT03891862|4098198|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2
2351303|NCT03891862|4098196|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
2351304|NCT03891862|4098197|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2
2351305|NCT03891862|4098198|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
2351306|NCT03892564|4098226|FG000|Overall Study|Withdrawal by Subject|2
2351307|NCT03892707|4098233|FG000|Overall Study|Screen failure|6
2351308|NCT03892707|4098234|FG001|Overall Study|Screen failure|0
2351309|NCT03892707|4098233|FG000|Overall Study|Pain resolution|0
2351310|NCT03892707|4098234|FG001|Overall Study|Pain resolution|4
2351311|NCT03892707|4098233|FG000|Overall Study|Withdrawal by Subject|0
2351312|NCT03892707|4098234|FG001|Overall Study|Withdrawal by Subject|1
2351313|NCT03892707|4098233|FG000|Overall Study|Other (long business trip)|0
2351314|NCT03892707|4098234|FG001|Overall Study|Other (long business trip)|1
2351315|NCT03891641|4098253|FG000|Overall Study|Study Stoppage Due to COVID-19|2
2351316|NCT03891641|4098254|FG001|Overall Study|Study Stoppage Due to COVID-19|2
2351317|NCT03890367|4098263|FG000|Overall Study|Withdrawal by parent/guardian|1
2351318|NCT03890367|4098264|FG001|Overall Study|Withdrawal by parent/guardian|3
2351319|NCT03890367|4098265|FG002|Overall Study|Withdrawal by parent/guardian|0
2351320|NCT03890367|4098263|FG000|Overall Study|Protocol deviation|2
2351321|NCT03890367|4098264|FG001|Overall Study|Protocol deviation|2
2351322|NCT03890367|4098265|FG002|Overall Study|Protocol deviation|1
2273097|NCT02285777|3953624|FG000|Overall Study|Lost to Follow-up|4
2273098|NCT02285777|3953625|FG001|Overall Study|Lost to Follow-up|2
2273099|NCT02285855|3953633|FG000|Overall Study|Withdrawal by Subject|2
2273100|NCT02285855|3953634|FG001|Overall Study|Withdrawal by Subject|1
2273101|NCT02285920|3953657|FG000|Overall Study|Kidney transplantation|2
2273102|NCT02285920|3953658|FG001|Overall Study|Kidney transplantation|2
2273103|NCT02285920|3953659|FG002|Overall Study|Kidney transplantation|2
2273104|NCT02285920|3953660|FG003|Overall Study|Kidney transplantation|0
2273105|NCT02285920|3953657|FG000|Overall Study|Change to peritoneal dialysis|0
2273106|NCT02285920|3953658|FG001|Overall Study|Change to peritoneal dialysis|0
2273107|NCT02285920|3953659|FG002|Overall Study|Change to peritoneal dialysis|1
2273108|NCT02285920|3953660|FG003|Overall Study|Change to peritoneal dialysis|0
2273109|NCT02285920|3953657|FG000|Overall Study|Transfer to non-participating unit|0
2273110|NCT02285920|3953658|FG001|Overall Study|Transfer to non-participating unit|1
2273111|NCT02285920|3953659|FG002|Overall Study|Transfer to non-participating unit|0
2273112|NCT02285920|3953660|FG003|Overall Study|Transfer to non-participating unit|0
2273113|NCT02285920|3953657|FG000|Overall Study|Dialysis discontinuation|0
2273114|NCT02285920|3953658|FG001|Overall Study|Dialysis discontinuation|1
2273115|NCT02285920|3953659|FG002|Overall Study|Dialysis discontinuation|0
2273116|NCT02285920|3953660|FG003|Overall Study|Dialysis discontinuation|0
2273117|NCT02285920|3953657|FG000|Overall Study|Death|2
2273118|NCT02285920|3953658|FG001|Overall Study|Death|0
2273119|NCT02285920|3953659|FG002|Overall Study|Death|2
2273120|NCT02285920|3953660|FG003|Overall Study|Death|1
2273121|NCT02285998|3953672|FG000|Overall Study|Adverse Event|9
2273122|NCT02285998|3953673|FG001|Overall Study|Adverse Event|8
2273123|NCT02285998|3953672|FG000|Overall Study|Physician Decision|1
2273124|NCT02285998|3953673|FG001|Overall Study|Physician Decision|2
2273125|NCT02285998|3953672|FG000|Overall Study|Lost to Follow-up|176
2273126|NCT02285998|3953673|FG001|Overall Study|Lost to Follow-up|172
2351323|NCT03890367|4098263|FG000|Overall Study|Lost to Follow-up|1
2351324|NCT03890367|4098264|FG001|Overall Study|Lost to Follow-up|1
2351325|NCT03890367|4098265|FG002|Overall Study|Lost to Follow-up|0
2351326|NCT03889704|4098273|FG000|Overall Study|Study terminated due to pandemic|1
2351327|NCT03888391|4098287|FG000|Overall Study|Lost to Follow-up|15
2351328|NCT03888482|4098293|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0
2351329|NCT03888482|4098294|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1
2351330|NCT03888482|4098293|FG000|Second Wear (8 -1/+2 Days)|Other|1
2351331|NCT03888482|4098294|FG001|Second Wear (8 -1/+2 Days)|Other|0
2351332|NCT03887442|4098329|FG000|Overall Study|Adverse Event|1
2351333|NCT03887442|4098330|FG001|Overall Study|Adverse Event|0
2351334|NCT03878602|4098354|FG000|Overall Study|cord blood donation|7
2351335|NCT03878602|4098355|FG001|Overall Study|cord blood donation|1
2351336|NCT03878602|4098354|FG000|Overall Study|incomplete data collection|2
2351337|NCT03878602|4098355|FG001|Overall Study|incomplete data collection|0
2351338|NCT03875118|4098365|FG000|Overall Study|Withdrawal by Subject|4
2351339|NCT03875118|4098366|FG001|Overall Study|Withdrawal by Subject|4
2351340|NCT03873987|4098374|FG000|Overall Study|Adverse Event|1
2351341|NCT03873987|4098375|FG001|Overall Study|Adverse Event|0
2351342|NCT03873987|4098374|FG000|Overall Study|staff was unable to start a new IV line|1
2351343|NCT03873987|4098375|FG001|Overall Study|staff was unable to start a new IV line|0
2351344|NCT03873987|4098374|FG000|Overall Study|Lost to Follow-up|0
2351345|NCT03873987|4098375|FG001|Overall Study|Lost to Follow-up|1
2351346|NCT03878758|4098401|FG000|Overall Study|Withdrawal by Subject|1
2351347|NCT03878758|4098401|FG000|Overall Study|Protocol defined|2
2351348|NCT03878758|4098401|FG000|Overall Study|Improper consent documentation|1
2351349|NCT03849300|4098418|FG000|Overall Study|move out to different area|1
2351350|NCT03849300|4098419|FG001|Overall Study|move out to different area|3
2351351|NCT03849300|4098420|FG002|Overall Study|move out to different area|1
2273127|NCT02285998|3953672|FG000|Overall Study|Withdrawal by Subject|53
2273128|NCT02285998|3953673|FG001|Overall Study|Withdrawal by Subject|61
2273129|NCT02285998|3953672|FG000|Overall Study|Other Reasons|7
2273130|NCT02285998|3953673|FG001|Overall Study|Other Reasons|10
2273131|NCT02286102|3953681|FG000|Overall Study|Screen Failure|1
2273132|NCT02286102|3953682|FG001|Overall Study|Screen Failure|1
2273133|NCT02286193|3953688|FG000|Overall Study|Referred: CRS unable to make contact|62
2273134|NCT02286193|3953688|FG000|Overall Study|Referred: unable to reach/resource sent|104
2273135|NCT02286193|3953688|FG000|Overall Study|Referred: Declined service|38
2273136|NCT02286466|3953695|FG000|Overall Study|Death|1
2273137|NCT02286466|3953696|FG001|Overall Study|Death|3
2273138|NCT02286466|3953695|FG000|Overall Study|Withdrawal by Subject|5
2273139|NCT02286466|3953696|FG001|Overall Study|Withdrawal by Subject|2
2273140|NCT02286466|3953695|FG000|Overall Study|Lost to Follow-up|1
2273141|NCT02286466|3953696|FG001|Overall Study|Lost to Follow-up|4
2273142|NCT02286466|3953695|FG000|Overall Study|Declined Clinician Assessment|0
2273143|NCT02286466|3953696|FG001|Overall Study|Declined Clinician Assessment|1
2273144|NCT02286713|3953777|FG000|One Week Follow-Up|Death|1
2273145|NCT02286713|3953778|FG001|One Week Follow-Up|Death|0
2273146|NCT02286713|3953777|FG000|One Week Follow-Up|Lost to Follow-up|17
2273147|NCT02286713|3953778|FG001|One Week Follow-Up|Lost to Follow-up|21
2273148|NCT02286713|3953777|FG000|One Week Follow-Up|Withdrawal by Subject|6
2273149|NCT02286713|3953778|FG001|One Week Follow-Up|Withdrawal by Subject|3
2273150|NCT02286713|3953777|FG000|Three Month Follow-Up|Death|1
2273151|NCT02286713|3953778|FG001|Three Month Follow-Up|Death|1
2273152|NCT02286713|3953777|FG000|Three Month Follow-Up|Lost to Follow-up|26
2273153|NCT02286713|3953778|FG001|Three Month Follow-Up|Lost to Follow-up|24
2273154|NCT02286713|3953777|FG000|Three Month Follow-Up|Withdrawal by Subject|1
2273155|NCT02286713|3953778|FG001|Three Month Follow-Up|Withdrawal by Subject|1
2273156|NCT02286713|3953777|FG000|Six Month Follow-Up|Death|2
2273157|NCT02286713|3953778|FG001|Six Month Follow-Up|Death|0
2273158|NCT02286713|3953777|FG000|Six Month Follow-Up|Lost to Follow-up|30
2273159|NCT02286713|3953778|FG001|Six Month Follow-Up|Lost to Follow-up|27
2273160|NCT02286843|3953797|FG000|Overall Study|Not Treated|4
2273161|NCT02286843|3953797|FG000|Overall Study|Protocol Violation|1
2273162|NCT02286843|3953797|FG000|Overall Study|Withdrawal by Subject|1
2273163|NCT02286895|3953803|FG000|Assessed for Measles Seroconversion|Protocol Violation|1
2273164|NCT02286895|3953804|FG001|Assessed for Measles Seroconversion|Protocol Violation|4
2273165|NCT02286895|3953803|FG000|Assessed for Measles Seroconversion|Missing measurement|6
2273166|NCT02286895|3953804|FG001|Assessed for Measles Seroconversion|Missing measurement|3
2273167|NCT02286895|3953803|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41
2273168|NCT02286895|3953804|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32
2273169|NCT02286947|3953819|FG000|Overall Study|Withdrawal by Subject|2
2273170|NCT02286960|3953827|FG000|Overall Study|Lost to Follow-up|3
2273171|NCT02286960|3953828|FG001|Overall Study|Lost to Follow-up|3
2273172|NCT02287038|3953836|FG000|Overall Study|Stopped attending appointments|3
2273173|NCT02287038|3953837|FG001|Overall Study|Stopped attending appointments|2
2273174|NCT02287038|3953836|FG000|Overall Study|Anxiety after starting medication|0
2273175|NCT02287038|3953837|FG001|Overall Study|Anxiety after starting medication|1
2273176|NCT02287038|3953836|FG000|Overall Study|Nausea after starting medication|1
2273177|NCT02287038|3953837|FG001|Overall Study|Nausea after starting medication|0
2273178|NCT02287038|3953836|FG000|Overall Study|Abnormal ECG after starting medication|1
2273179|NCT02287038|3953837|FG001|Overall Study|Abnormal ECG after starting medication|0
2273180|NCT02287402|3953853|FG000|Treatment Period|Adverse Event|17
2273181|NCT02287402|3953853|FG000|Treatment Period|Voluntary Withdrawal|10
2273182|NCT02287402|3953853|FG000|Follow-up|Lost to Follow-up|1
2273183|NCT02287402|3953853|FG000|Follow-up|Voluntary Withdrawal|2
2273184|NCT02287467|3953863|FG000|Overall Study|Protocol Violation|12
2273185|NCT02287467|3953864|FG001|Overall Study|Protocol Violation|9
2273186|NCT02287584|3953876|FG000|the Double-blind Phase|Adverse Event|17
2273187|NCT02287584|3953877|FG001|the Double-blind Phase|Adverse Event|17
2273188|NCT02287584|3953878|FG002|the Double-blind Phase|Adverse Event|12
2273189|NCT02287584|3953879|FG003|the Double-blind Phase|Adverse Event|0
2273190|NCT02287584|3953880|FG004|the Double-blind Phase|Adverse Event|0
2273191|NCT02287584|3953881|FG005|the Double-blind Phase|Adverse Event|0
2273192|NCT02287584|3953876|FG000|the Double-blind Phase|Lack of Efficacy|18
2273193|NCT02287584|3953877|FG001|the Double-blind Phase|Lack of Efficacy|8
2273194|NCT02287584|3953878|FG002|the Double-blind Phase|Lack of Efficacy|8
2273195|NCT02287584|3953879|FG003|the Double-blind Phase|Lack of Efficacy|0
2273196|NCT02287584|3953880|FG004|the Double-blind Phase|Lack of Efficacy|0
2273197|NCT02287584|3953881|FG005|the Double-blind Phase|Lack of Efficacy|0
2273198|NCT02287584|3953876|FG000|the Double-blind Phase|Lost to Follow-up|0
2273199|NCT02287584|3953877|FG001|the Double-blind Phase|Lost to Follow-up|1
2273200|NCT02287584|3953878|FG002|the Double-blind Phase|Lost to Follow-up|1
2273201|NCT02287584|3953879|FG003|the Double-blind Phase|Lost to Follow-up|0
2273202|NCT02287584|3953880|FG004|the Double-blind Phase|Lost to Follow-up|0
2273203|NCT02287584|3953881|FG005|the Double-blind Phase|Lost to Follow-up|0
2273204|NCT02287584|3953876|FG000|the Double-blind Phase|Withdrawal by Subject|17
2273205|NCT02287584|3953877|FG001|the Double-blind Phase|Withdrawal by Subject|17
2273206|NCT02287584|3953878|FG002|the Double-blind Phase|Withdrawal by Subject|11
2273207|NCT02287584|3953879|FG003|the Double-blind Phase|Withdrawal by Subject|0
2273208|NCT02287584|3953880|FG004|the Double-blind Phase|Withdrawal by Subject|0
2273209|NCT02287584|3953881|FG005|the Double-blind Phase|Withdrawal by Subject|0
2273210|NCT02287584|3953876|FG000|the Double-blind Phase|Pregnancy|0
2273211|NCT02287584|3953877|FG001|the Double-blind Phase|Pregnancy|1
2273212|NCT02287584|3953878|FG002|the Double-blind Phase|Pregnancy|0
2273213|NCT02287584|3953879|FG003|the Double-blind Phase|Pregnancy|0
2273214|NCT02287584|3953880|FG004|the Double-blind Phase|Pregnancy|0
2273215|NCT02287584|3953881|FG005|the Double-blind Phase|Pregnancy|0
2273216|NCT02287584|3953876|FG000|the Double-blind Phase|Protocol Violation|0
2273217|NCT02287584|3953877|FG001|the Double-blind Phase|Protocol Violation|3
2273218|NCT02287584|3953878|FG002|the Double-blind Phase|Protocol Violation|0
2273219|NCT02287584|3953879|FG003|the Double-blind Phase|Protocol Violation|0
2273220|NCT02287584|3953880|FG004|the Double-blind Phase|Protocol Violation|0
2273221|NCT02287584|3953881|FG005|the Double-blind Phase|Protocol Violation|0
2273222|NCT02287584|3953876|FG000|the Double-blind Phase|other reasons|0
2273223|NCT02287584|3953877|FG001|the Double-blind Phase|other reasons|0
2273224|NCT02287584|3953878|FG002|the Double-blind Phase|other reasons|1
2273225|NCT02287584|3953879|FG003|the Double-blind Phase|other reasons|0
2273226|NCT02287584|3953880|FG004|the Double-blind Phase|other reasons|0
2273227|NCT02287584|3953881|FG005|the Double-blind Phase|other reasons|0
2273228|NCT02287584|3953876|FG000|the Open-label Phase|Did not receive drug|0
2273229|NCT02287584|3953877|FG001|the Open-label Phase|Did not receive drug|0
2273230|NCT02287584|3953878|FG002|the Open-label Phase|Did not receive drug|0
2273231|NCT02287584|3953879|FG003|the Open-label Phase|Did not receive drug|7
2273232|NCT02287584|3953880|FG004|the Open-label Phase|Did not receive drug|6
2273233|NCT02287584|3953881|FG005|the Open-label Phase|Did not receive drug|4
2273234|NCT02287584|3953876|FG000|the Open-label Phase|Adverse Event|0
2273235|NCT02287584|3953877|FG001|the Open-label Phase|Adverse Event|0
2273236|NCT02287584|3953878|FG002|the Open-label Phase|Adverse Event|0
2273237|NCT02287584|3953879|FG003|the Open-label Phase|Adverse Event|15
2273238|NCT02287584|3953880|FG004|the Open-label Phase|Adverse Event|12
2273239|NCT02287584|3953881|FG005|the Open-label Phase|Adverse Event|16
2273240|NCT02287584|3953876|FG000|the Open-label Phase|Lack of Efficacy|0
2273241|NCT02287584|3953877|FG001|the Open-label Phase|Lack of Efficacy|0
2273242|NCT02287584|3953878|FG002|the Open-label Phase|Lack of Efficacy|0
2273243|NCT02287584|3953879|FG003|the Open-label Phase|Lack of Efficacy|8
2273244|NCT02287584|3953880|FG004|the Open-label Phase|Lack of Efficacy|3
2273245|NCT02287584|3953881|FG005|the Open-label Phase|Lack of Efficacy|7
2273246|NCT02287584|3953876|FG000|the Open-label Phase|Lost to Follow-up|0
2273247|NCT02287584|3953877|FG001|the Open-label Phase|Lost to Follow-up|0
2273248|NCT02287584|3953878|FG002|the Open-label Phase|Lost to Follow-up|0
2273249|NCT02287584|3953879|FG003|the Open-label Phase|Lost to Follow-up|4
2273250|NCT02287584|3953880|FG004|the Open-label Phase|Lost to Follow-up|1
2273251|NCT02287584|3953881|FG005|the Open-label Phase|Lost to Follow-up|2
2273252|NCT02287584|3953876|FG000|the Open-label Phase|Withdrawal by Subject|0
2273253|NCT02287584|3953877|FG001|the Open-label Phase|Withdrawal by Subject|0
2273254|NCT02287584|3953878|FG002|the Open-label Phase|Withdrawal by Subject|0
2273255|NCT02287584|3953879|FG003|the Open-label Phase|Withdrawal by Subject|18
2273256|NCT02287584|3953880|FG004|the Open-label Phase|Withdrawal by Subject|29
2273257|NCT02287584|3953881|FG005|the Open-label Phase|Withdrawal by Subject|21
2273258|NCT02287584|3953876|FG000|the Open-label Phase|non-compliance|0
2273259|NCT02287584|3953877|FG001|the Open-label Phase|non-compliance|0
2273260|NCT02287584|3953878|FG002|the Open-label Phase|non-compliance|0
2273261|NCT02287584|3953879|FG003|the Open-label Phase|non-compliance|2
2273262|NCT02287584|3953880|FG004|the Open-label Phase|non-compliance|5
2273263|NCT02287584|3953881|FG005|the Open-label Phase|non-compliance|1
2273264|NCT02287584|3953876|FG000|the Open-label Phase|other reasons|0
2273265|NCT02287584|3953877|FG001|the Open-label Phase|other reasons|0
2273266|NCT02287584|3953878|FG002|the Open-label Phase|other reasons|0
2273267|NCT02287584|3953879|FG003|the Open-label Phase|other reasons|3
2273268|NCT02287584|3953880|FG004|the Open-label Phase|other reasons|6
2273269|NCT02287584|3953881|FG005|the Open-label Phase|other reasons|6
2273270|NCT02287610|3953895|FG000|Overall Study|Lost to Follow-up|3
2273271|NCT02287610|3953895|FG000|Overall Study|Withdrawal by Subject|8
2273272|NCT02287610|3953895|FG000|Overall Study|Excluded-investigator non-responsiveness|5
2273273|NCT02287623|3953901|FG000|Overall Study|Protocol Violation|0
2273274|NCT02287623|3953902|FG001|Overall Study|Protocol Violation|1
2273275|NCT02287883|3953969|FG000|Overall Study|Death|8
2273276|NCT02287883|3953970|FG001|Overall Study|Death|7
2273277|NCT02287883|3953969|FG000|Overall Study|No longer eligible|222
2273278|NCT02287883|3953970|FG001|Overall Study|No longer eligible|182
2351352|NCT03849300|4098421|FG003|Overall Study|move out to different area|4
2351353|NCT03849300|4098418|FG000|Overall Study|scheduling/transportation conflict|4
2351354|NCT03849300|4098419|FG001|Overall Study|scheduling/transportation conflict|4
2351355|NCT03849300|4098420|FG002|Overall Study|scheduling/transportation conflict|3
2351356|NCT03849300|4098421|FG003|Overall Study|scheduling/transportation conflict|2
2351357|NCT03883113|4098463|FG000|Overall Study|Physician Decision|4
2351358|NCT03883113|4098464|FG001|Overall Study|Physician Decision|2
2351359|NCT03883113|4098463|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9
2351360|NCT03883113|4098464|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7
2351361|NCT03883113|4098463|FG000|Overall Study|Pregnancy|1
2351362|NCT03883113|4098464|FG001|Overall Study|Pregnancy|0
2351363|NCT03883113|4098463|FG000|Overall Study|Adverse Event|0
2351364|NCT03883113|4098464|FG001|Overall Study|Adverse Event|1
2351365|NCT03883113|4098463|FG000|Overall Study|Withdrawal by Subject|1
2351366|NCT03883113|4098464|FG001|Overall Study|Withdrawal by Subject|2
2351367|NCT03883113|4098463|FG000|Overall Study|Lost to Follow-up|1
2351368|NCT03883113|4098464|FG001|Overall Study|Lost to Follow-up|0
2351369|NCT03880227|4098486|FG000|First Visit|Withdrawal by Subject|1
2351370|NCT03880227|4098487|FG001|First Visit|Withdrawal by Subject|0
2351371|NCT03880227|4098488|FG002|First Visit|Withdrawal by Subject|0
2351372|NCT03880227|4098489|FG003|First Visit|Withdrawal by Subject|0
2351373|NCT03880227|4098486|FG000|1 Week Washout/ Delay|Lost to Follow-up|0
2351374|NCT03880227|4098487|FG001|1 Week Washout/ Delay|Lost to Follow-up|1
2351375|NCT03880227|4098488|FG002|1 Week Washout/ Delay|Lost to Follow-up|0
2351376|NCT03880227|4098489|FG003|1 Week Washout/ Delay|Lost to Follow-up|0
2351377|NCT03880227|4098486|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0
2351378|NCT03880227|4098487|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0
2351379|NCT03880227|4098488|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2
2351380|NCT03880227|4098489|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0
2273279|NCT02287883|3953969|FG000|Overall Study|Non-response to survey|229
2273280|NCT02287883|3953970|FG001|Overall Study|Non-response to survey|237
2273281|NCT02287896|3953978|FG000|Second Injection Visit|Withdrawal by Subject|0
2273282|NCT02287896|3953979|FG001|Second Injection Visit|Withdrawal by Subject|1
2273283|NCT02287922|3954012|FG000|Overall Study|Adverse Event|1
2273284|NCT02287922|3954013|FG001|Overall Study|Adverse Event|1
2273285|NCT02287922|3954014|FG002|Overall Study|Adverse Event|3
2273286|NCT02287922|3954015|FG003|Overall Study|Adverse Event|4
2273287|NCT02287922|3954012|FG000|Overall Study|Withdrawal by Subject|1
2273288|NCT02287922|3954013|FG001|Overall Study|Withdrawal by Subject|1
2273289|NCT02287922|3954014|FG002|Overall Study|Withdrawal by Subject|1
2273290|NCT02287922|3954015|FG003|Overall Study|Withdrawal by Subject|2
2273291|NCT02287922|3954012|FG000|Overall Study|Lost to Follow-up|0
2273292|NCT02287922|3954013|FG001|Overall Study|Lost to Follow-up|0
2273293|NCT02287922|3954014|FG002|Overall Study|Lost to Follow-up|1
2273294|NCT02287922|3954015|FG003|Overall Study|Lost to Follow-up|0
2273295|NCT02287922|3954012|FG000|Overall Study|Sponsor's decision|0
2273296|NCT02287922|3954013|FG001|Overall Study|Sponsor's decision|0
2273297|NCT02287922|3954014|FG002|Overall Study|Sponsor's decision|0
2273298|NCT02287922|3954015|FG003|Overall Study|Sponsor's decision|1
2273299|NCT02287922|3954012|FG000|Overall Study|Other|1
2273300|NCT02287922|3954013|FG001|Overall Study|Other|0
2273301|NCT02287922|3954014|FG002|Overall Study|Other|2
2273302|NCT02287922|3954015|FG003|Overall Study|Other|0
2273303|NCT02288091|3954026|FG000|Overall Study|Lost to Follow-up|1
2273304|NCT02288091|3954026|FG000|Overall Study|Screen fail|7
2273305|NCT02288182|3954051|FG000|Overall Study|Adverse Event|0
2273306|NCT02288182|3954052|FG001|Overall Study|Adverse Event|1
2273307|NCT02288182|3954051|FG000|Overall Study|Lost to Follow-up|0
2273308|NCT02288182|3954052|FG001|Overall Study|Lost to Follow-up|1
2273309|NCT02288312|3954072|FG000|Overall Study|Pregnancy|1
2273310|NCT02288312|3954073|FG001|Overall Study|Pregnancy|0
2273311|NCT02288312|3954074|FG002|Overall Study|Pregnancy|0
2273312|NCT02288325|3954082|FG000|Run-in Period|Adverse Event|48
2351381|NCT03880227|4098486|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
2351382|NCT03880227|4098487|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
2351383|NCT03880227|4098488|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1
2351384|NCT03880227|4098489|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
2351385|NCT03876743|4098503|FG000|Overall Study|Lost to Follow-up|6
2351386|NCT03876743|4098504|FG001|Overall Study|Lost to Follow-up|4
2351387|NCT03876743|4098505|FG002|Overall Study|Lost to Follow-up|4
2351388|NCT03876743|4098506|FG003|Overall Study|Lost to Follow-up|7
2351389|NCT03885934|4098526|FG000|Overall Study|Withdrawn by Parent/Guardian|1
2351390|NCT03885934|4098527|FG001|Overall Study|Withdrawn by Parent/Guardian|0
2351391|NCT03885934|4098528|FG002|Overall Study|Withdrawn by Parent/Guardian|0
2351392|NCT03885934|4098529|FG003|Overall Study|Withdrawn by Parent/Guardian|0
2351393|NCT03885934|4098530|FG004|Overall Study|Withdrawn by Parent/Guardian|0
2351394|NCT03885934|4098531|FG005|Overall Study|Withdrawn by Parent/Guardian|0
2351395|NCT03885726|4098545|FG000|Overall Study|Staffing issues/lost interest|1
2351396|NCT03885726|4098545|FG000|Overall Study|Early discharge from hospital|3
2351397|NCT03883386|4098570|FG000|First Assignment|Lost to Follow-up|1
2351398|NCT03883386|4098571|FG001|First Assignment|Lost to Follow-up|0
2351399|NCT03883386|4098570|FG000|First Assignment|Withdrawal by Subject|1
2351400|NCT03883386|4098571|FG001|First Assignment|Withdrawal by Subject|1
2351401|NCT03882801|4098583|FG000|Period 1|Adverse Event|0
2351402|NCT03882801|4098584|FG001|Period 1|Adverse Event|1
2351403|NCT03882801|4098583|FG000|Period 1|Non-compliance with study drug|1
2351404|NCT03882801|4098584|FG001|Period 1|Non-compliance with study drug|1
2351405|NCT03882801|4098583|FG000|Period 1|Never treated with study drug|1
2351406|NCT03882801|4098584|FG001|Period 1|Never treated with study drug|0
2351407|NCT03882801|4098583|FG000|Washout Period|Physician Decision|0
2351408|NCT03882801|4098584|FG001|Washout Period|Physician Decision|1
2351409|NCT03882801|4098583|FG000|Period 2|Non-compliance with study drug|0
2351410|NCT03882801|4098584|FG001|Period 2|Non-compliance with study drug|1
2351411|NCT03882424|4098595|FG000|Overall Study|Lost to Follow-up|3
2351412|NCT03882424|4098596|FG001|Overall Study|Lost to Follow-up|0
2351413|NCT03882424|4098597|FG002|Overall Study|Lost to Follow-up|0
2351414|NCT03882424|4098595|FG000|Overall Study|schedule conflict|1
2351415|NCT03882424|4098596|FG001|Overall Study|schedule conflict|0
2351416|NCT03882424|4098597|FG002|Overall Study|schedule conflict|0
2351417|NCT03880266|4098630|FG000|Overall Study|Withdrawal by Subject|0
2351418|NCT03880266|4098631|FG001|Overall Study|Withdrawal by Subject|1
2351419|NCT03880266|4098632|FG002|Overall Study|Withdrawal by Subject|1
2351420|NCT03880266|4098633|FG003|Overall Study|Withdrawal by Subject|0
2351421|NCT03880266|4098634|FG004|Overall Study|Withdrawal by Subject|0
2351422|NCT03880266|4098635|FG005|Overall Study|Withdrawal by Subject|0
2351423|NCT03880266|4098636|FG006|Overall Study|Withdrawal by Subject|0
2351424|NCT03880266|4098637|FG007|Overall Study|Withdrawal by Subject|0
2351425|NCT03878160|4098689|FG000|Overall Study|Lost to Follow-up|1
2351426|NCT03878160|4098690|FG001|Overall Study|Lost to Follow-up|1
2351427|NCT03878160|4098691|FG002|Overall Study|Lost to Follow-up|1
2351428|NCT03878160|4098689|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1
2351429|NCT03878160|4098690|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
2351430|NCT03878160|4098691|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
2351431|NCT03864627|4098701|FG000|Overall Study|Adverse Event|0
2351432|NCT03864627|4098702|FG001|Overall Study|Adverse Event|1
2273313|NCT02288325|3954083|FG001|Run-in Period|Adverse Event|0
2273314|NCT02288325|3954084|FG002|Run-in Period|Adverse Event|0
2273315|NCT02288325|3954082|FG000|Run-in Period|Lack of Efficacy|16
2273316|NCT02288325|3954083|FG001|Run-in Period|Lack of Efficacy|0
2273317|NCT02288325|3954084|FG002|Run-in Period|Lack of Efficacy|0
2273318|NCT02288325|3954082|FG000|Run-in Period|Withdrawal of Consent|28
2273319|NCT02288325|3954083|FG001|Run-in Period|Withdrawal of Consent|0
2273320|NCT02288325|3954084|FG002|Run-in Period|Withdrawal of Consent|0
2273321|NCT02288325|3954082|FG000|Run-in Period|Lost to Follow-up|25
2273322|NCT02288325|3954083|FG001|Run-in Period|Lost to Follow-up|0
2273323|NCT02288325|3954084|FG002|Run-in Period|Lost to Follow-up|0
2273324|NCT02288325|3954082|FG000|Run-in Period|Protocol Violation|17
2273325|NCT02288325|3954083|FG001|Run-in Period|Protocol Violation|0
2273326|NCT02288325|3954084|FG002|Run-in Period|Protocol Violation|0
2273327|NCT02288325|3954082|FG000|Run-in Period|Non-Compliance With Study Drug|3
2273328|NCT02288325|3954083|FG001|Run-in Period|Non-Compliance With Study Drug|0
2273329|NCT02288325|3954084|FG002|Run-in Period|Non-Compliance With Study Drug|0
2273330|NCT02288325|3954082|FG000|Run-in Period|Reason not Specified|8
2273331|NCT02288325|3954083|FG001|Run-in Period|Reason not Specified|0
2273332|NCT02288325|3954084|FG002|Run-in Period|Reason not Specified|0
2273333|NCT02288325|3954082|FG000|Stabilization Period|Adverse Event|13
2273334|NCT02288325|3954083|FG001|Stabilization Period|Adverse Event|0
2273335|NCT02288325|3954084|FG002|Stabilization Period|Adverse Event|0
2273336|NCT02288325|3954082|FG000|Stabilization Period|Lack of Efficacy|22
2273337|NCT02288325|3954083|FG001|Stabilization Period|Lack of Efficacy|0
2273338|NCT02288325|3954084|FG002|Stabilization Period|Lack of Efficacy|0
2273339|NCT02288325|3954082|FG000|Stabilization Period|Withdrawal of Consent|23
2273340|NCT02288325|3954083|FG001|Stabilization Period|Withdrawal of Consent|0
2273341|NCT02288325|3954084|FG002|Stabilization Period|Withdrawal of Consent|0
2273342|NCT02288325|3954082|FG000|Stabilization Period|Lost to Follow-up|12
2273343|NCT02288325|3954083|FG001|Stabilization Period|Lost to Follow-up|0
2273344|NCT02288325|3954084|FG002|Stabilization Period|Lost to Follow-up|0
2273345|NCT02288325|3954082|FG000|Stabilization Period|Protocol Violation|8
2273346|NCT02288325|3954083|FG001|Stabilization Period|Protocol Violation|0
2273347|NCT02288325|3954084|FG002|Stabilization Period|Protocol Violation|0
2273348|NCT02288325|3954082|FG000|Stabilization Period|Non-Compliance With Study Drug|5
2273349|NCT02288325|3954083|FG001|Stabilization Period|Non-Compliance With Study Drug|0
2273350|NCT02288325|3954084|FG002|Stabilization Period|Non-Compliance With Study Drug|0
2273351|NCT02288325|3954082|FG000|Stabilization Period|Reason not Specified|15
2273352|NCT02288325|3954083|FG001|Stabilization Period|Reason not Specified|0
2273353|NCT02288325|3954084|FG002|Stabilization Period|Reason not Specified|0
2273354|NCT02288325|3954082|FG000|Double-blind Treatment Period|Adverse Event|0
2273355|NCT02288325|3954083|FG001|Double-blind Treatment Period|Adverse Event|2
2273356|NCT02288325|3954084|FG002|Double-blind Treatment Period|Adverse Event|5
2273357|NCT02288325|3954082|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
2273358|NCT02288325|3954083|FG001|Double-blind Treatment Period|Withdrawal of Consent|8
2273359|NCT02288325|3954084|FG002|Double-blind Treatment Period|Withdrawal of Consent|8
2273360|NCT02288325|3954082|FG000|Double-blind Treatment Period|Lost to Follow-up|0
2273361|NCT02288325|3954083|FG001|Double-blind Treatment Period|Lost to Follow-up|4
2273362|NCT02288325|3954084|FG002|Double-blind Treatment Period|Lost to Follow-up|5
2273363|NCT02288325|3954082|FG000|Double-blind Treatment Period|Protocol Violation|0
2273364|NCT02288325|3954083|FG001|Double-blind Treatment Period|Protocol Violation|1
2273365|NCT02288325|3954084|FG002|Double-blind Treatment Period|Protocol Violation|2
2273366|NCT02288325|3954082|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0
2273367|NCT02288325|3954083|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1
2273368|NCT02288325|3954084|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4
2273369|NCT02288325|3954082|FG000|Double-blind Treatment Period|Multiple Reasons|0
2273370|NCT02288325|3954083|FG001|Double-blind Treatment Period|Multiple Reasons|8
2273371|NCT02288325|3954084|FG002|Double-blind Treatment Period|Multiple Reasons|2
2273372|NCT02288559|3954113|FG000|Overall Study|Adverse Event|1
2273373|NCT02288559|3954114|FG001|Overall Study|Adverse Event|1
2273374|NCT02288559|3954115|FG002|Overall Study|Adverse Event|5
2273375|NCT02288559|3954116|FG003|Overall Study|Adverse Event|0
2273376|NCT02288559|3954113|FG000|Overall Study|Death|0
2273377|NCT02288559|3954114|FG001|Overall Study|Death|0
2273378|NCT02288559|3954115|FG002|Overall Study|Death|1
2273379|NCT02288559|3954116|FG003|Overall Study|Death|0
2273380|NCT02288559|3954113|FG000|Overall Study|Lost to Follow-up|0
2273381|NCT02288559|3954114|FG001|Overall Study|Lost to Follow-up|0
2351433|NCT03864627|4098701|FG000|Overall Study|Lack of Efficacy|0
2273382|NCT02288559|3954115|FG002|Overall Study|Lost to Follow-up|0
2273383|NCT02288559|3954116|FG003|Overall Study|Lost to Follow-up|1
2273384|NCT02288559|3954113|FG000|Overall Study|Withdrawal by Subject|0
2273385|NCT02288559|3954114|FG001|Overall Study|Withdrawal by Subject|0
2273386|NCT02288559|3954115|FG002|Overall Study|Withdrawal by Subject|2
2273387|NCT02288559|3954116|FG003|Overall Study|Withdrawal by Subject|1
2273388|NCT02288559|3954113|FG000|Overall Study|Reason Not Specified|0
2273389|NCT02288559|3954114|FG001|Overall Study|Reason Not Specified|0
2273390|NCT02288559|3954115|FG002|Overall Study|Reason Not Specified|3
2273391|NCT02288559|3954116|FG003|Overall Study|Reason Not Specified|0
2273392|NCT02289079|3954134|FG000|Overall Study|Physician Decision|2
2273393|NCT02289079|3954135|FG001|Overall Study|Physician Decision|0
2273394|NCT02289079|3954134|FG000|Overall Study|Lost to Follow-up|0
2273395|NCT02289079|3954135|FG001|Overall Study|Lost to Follow-up|1
2273396|NCT02289352|3954166|FG000|Overall Study|Withdrawal by Subject|1
2273397|NCT02289352|3954167|FG001|Overall Study|Withdrawal by Subject|1
2273398|NCT02289352|3954168|FG002|Overall Study|Withdrawal by Subject|0
2273399|NCT02289417|3954180|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
2273400|NCT02289417|3954181|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2273401|NCT02289417|3954182|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
2273402|NCT02289417|3954183|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2273403|NCT02289417|3954184|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2273404|NCT02289417|3954185|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2273405|NCT02289417|3954186|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2273406|NCT02289417|3954187|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2273407|NCT02289417|3954188|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2273408|NCT02289417|3954180|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
2273409|NCT02289417|3954181|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
2273410|NCT02289417|3954182|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
2273411|NCT02289417|3954183|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2273412|NCT02289417|3954184|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2273413|NCT02289417|3954185|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2273414|NCT02289417|3954186|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2273415|NCT02289417|3954187|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2273416|NCT02289417|3954188|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2273417|NCT02289417|3954180|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2273418|NCT02289417|3954181|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
2273419|NCT02289417|3954182|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2273420|NCT02289417|3954183|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2273421|NCT02289417|3954184|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2273422|NCT02289417|3954185|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2273423|NCT02289417|3954186|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2273424|NCT02289417|3954187|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2273425|NCT02289417|3954188|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2273426|NCT02289417|3954180|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
2273427|NCT02289417|3954181|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2273428|NCT02289417|3954182|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2273429|NCT02289417|3954183|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2273430|NCT02289417|3954184|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2273431|NCT02289417|3954185|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2273432|NCT02289417|3954186|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2273433|NCT02289417|3954187|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2273434|NCT02289417|3954188|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2273435|NCT02289417|3954180|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0
2273436|NCT02289417|3954181|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1
2273437|NCT02289417|3954182|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4
2273438|NCT02289417|3954183|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2
2273439|NCT02289417|3954184|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2
2273440|NCT02289417|3954185|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1
2273441|NCT02289417|3954186|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0
2273442|NCT02289417|3954187|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0
2273443|NCT02289417|3954188|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0
2273444|NCT02289417|3954180|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0
2273445|NCT02289417|3954181|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0
2273446|NCT02289417|3954182|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1
2273447|NCT02289417|3954183|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0
2273448|NCT02289417|3954184|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0
2273449|NCT02289417|3954185|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0
2273450|NCT02289417|3954186|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0
2273451|NCT02289417|3954187|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0
2273452|NCT02289417|3954188|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0
2273453|NCT02289417|3954180|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2273454|NCT02289417|3954181|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
2273455|NCT02289417|3954182|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
2273456|NCT02289417|3954183|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
2273457|NCT02289417|3954184|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
2273458|NCT02289417|3954185|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
2273459|NCT02289417|3954186|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2273460|NCT02289417|3954187|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2273461|NCT02289417|3954188|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2273462|NCT02289417|3954180|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2273463|NCT02289417|3954181|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2273464|NCT02289417|3954182|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
2273465|NCT02289417|3954183|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2273466|NCT02289417|3954184|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
2273467|NCT02289417|3954185|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
2273468|NCT02289417|3954186|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2273469|NCT02289417|3954187|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2273470|NCT02289417|3954188|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2273471|NCT02289417|3954180|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2273472|NCT02289417|3954181|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2273473|NCT02289417|3954182|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2273474|NCT02289417|3954183|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2273475|NCT02289417|3954184|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2273476|NCT02289417|3954185|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2273477|NCT02289417|3954186|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
2273478|NCT02289417|3954187|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2273479|NCT02289417|3954188|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2273480|NCT02289417|3954180|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2273481|NCT02289417|3954181|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2273482|NCT02289417|3954182|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2273483|NCT02289417|3954183|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1
2273484|NCT02289417|3954184|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2273485|NCT02289417|3954185|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2273486|NCT02289417|3954186|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1
2273487|NCT02289417|3954187|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2273488|NCT02289417|3954188|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2273489|NCT02289417|3954180|FG000|Extension Phase Weeks 52-104|Adverse Event|0
2273490|NCT02289417|3954181|FG001|Extension Phase Weeks 52-104|Adverse Event|0
2273491|NCT02289417|3954182|FG002|Extension Phase Weeks 52-104|Adverse Event|0
2273492|NCT02289417|3954183|FG003|Extension Phase Weeks 52-104|Adverse Event|0
2273493|NCT02289417|3954184|FG004|Extension Phase Weeks 52-104|Adverse Event|0
2273494|NCT02289417|3954185|FG005|Extension Phase Weeks 52-104|Adverse Event|0
2273495|NCT02289417|3954186|FG006|Extension Phase Weeks 52-104|Adverse Event|0
2273496|NCT02289417|3954187|FG007|Extension Phase Weeks 52-104|Adverse Event|2
2273497|NCT02289417|3954188|FG008|Extension Phase Weeks 52-104|Adverse Event|3
2273498|NCT02289417|3954180|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0
2273499|NCT02289417|3954181|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0
2273500|NCT02289417|3954182|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0
2273501|NCT02289417|3954183|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0
2273502|NCT02289417|3954184|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0
2273503|NCT02289417|3954185|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0
2273504|NCT02289417|3954186|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0
2273505|NCT02289417|3954187|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2
2273506|NCT02289417|3954188|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2
2273507|NCT02289417|3954180|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2273508|NCT02289417|3954181|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2273509|NCT02289417|3954182|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2273510|NCT02289417|3954183|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2273511|NCT02289417|3954184|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2273512|NCT02289417|3954185|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2273513|NCT02289417|3954186|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2273514|NCT02289417|3954187|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2
2273515|NCT02289417|3954188|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1
2273516|NCT02289417|3954180|FG000|Extension Phase Weeks 52-104|Miscellaneous|0
2273517|NCT02289417|3954181|FG001|Extension Phase Weeks 52-104|Miscellaneous|0
2273518|NCT02289417|3954182|FG002|Extension Phase Weeks 52-104|Miscellaneous|0
2273519|NCT02289417|3954183|FG003|Extension Phase Weeks 52-104|Miscellaneous|0
2273520|NCT02289417|3954184|FG004|Extension Phase Weeks 52-104|Miscellaneous|0
2273521|NCT02289417|3954185|FG005|Extension Phase Weeks 52-104|Miscellaneous|0
2273522|NCT02289417|3954186|FG006|Extension Phase Weeks 52-104|Miscellaneous|0
2273523|NCT02289417|3954187|FG007|Extension Phase Weeks 52-104|Miscellaneous|1
2273524|NCT02289417|3954188|FG008|Extension Phase Weeks 52-104|Miscellaneous|0
2273525|NCT02289456|3954204|FG000|Induction Period|Death|2
2273526|NCT02289456|3954204|FG000|Induction Period|Adverse Event|11
2273527|NCT02289456|3954204|FG000|Induction Period|Progressive Disease (PD)|4
2273528|NCT02289456|3954204|FG000|Induction Period|Symptomatic Deterioration|4
2273529|NCT02289456|3954204|FG000|Induction Period|Withdrawal by Subject|2
2273530|NCT02289456|3954204|FG000|Induction Period|Miscellaneous|1
2273531|NCT02289456|3954204|FG000|Monotherapy Period|Death|1
2273532|NCT02289456|3954204|FG000|Monotherapy Period|Adverse Event|1
2273533|NCT02289456|3954204|FG000|Monotherapy Period|Progressive Disease (PD)|8
2273534|NCT02289456|3954204|FG000|Monotherapy Period|Symptomatic Deterioration|1
2273535|NCT02289456|3954204|FG000|Monotherapy Period|Withdrawal by Subject|2
2273536|NCT02289456|3954204|FG000|Monotherapy Period|Study Terminated by Sponsor|2
2273537|NCT02289456|3954204|FG000|Monotherapy Period|Miscellaneous|1
2273538|NCT02289469|3954215|FG000|Overall Study|Unable to match a control|6
2273539|NCT02289469|3954216|FG001|Overall Study|Unable to match a control|0
2273540|NCT02289690|3954232|FG000|Overall Study|Adverse Event Related to Progression|0
2273541|NCT02289690|3954233|FG001|Overall Study|Adverse Event Related to Progression|1
2273542|NCT02289690|3954234|FG002|Overall Study|Adverse Event Related to Progression|1
2273543|NCT02289690|3954235|FG003|Overall Study|Adverse Event Related to Progression|0
2273544|NCT02289690|3954236|FG004|Overall Study|Adverse Event Related to Progression|1
2273545|NCT02289690|3954237|FG005|Overall Study|Adverse Event Related to Progression|0
2273546|NCT02289690|3954238|FG006|Overall Study|Adverse Event Related to Progression|1
2273547|NCT02289690|3954239|FG007|Overall Study|Adverse Event Related to Progression|0
2273548|NCT02289690|3954240|FG008|Overall Study|Adverse Event Related to Progression|0
2273549|NCT02289690|3954241|FG009|Overall Study|Adverse Event Related to Progression|0
2273550|NCT02289690|3954232|FG000|Overall Study|Withdrawal by Subject|1
2273551|NCT02289690|3954233|FG001|Overall Study|Withdrawal by Subject|0
2273552|NCT02289690|3954234|FG002|Overall Study|Withdrawal by Subject|0
2273553|NCT02289690|3954235|FG003|Overall Study|Withdrawal by Subject|0
2273554|NCT02289690|3954236|FG004|Overall Study|Withdrawal by Subject|1
2273555|NCT02289690|3954237|FG005|Overall Study|Withdrawal by Subject|1
2273556|NCT02289690|3954238|FG006|Overall Study|Withdrawal by Subject|0
2273557|NCT02289690|3954239|FG007|Overall Study|Withdrawal by Subject|0
2273558|NCT02289690|3954240|FG008|Overall Study|Withdrawal by Subject|4
2273559|NCT02289690|3954241|FG009|Overall Study|Withdrawal by Subject|2
2273560|NCT02289690|3954232|FG000|Overall Study|Progressive Disease, Per Protocol|3
2273561|NCT02289690|3954233|FG001|Overall Study|Progressive Disease, Per Protocol|2
2273562|NCT02289690|3954234|FG002|Overall Study|Progressive Disease, Per Protocol|3
2273563|NCT02289690|3954235|FG003|Overall Study|Progressive Disease, Per Protocol|2
2273564|NCT02289690|3954236|FG004|Overall Study|Progressive Disease, Per Protocol|5
2273565|NCT02289690|3954237|FG005|Overall Study|Progressive Disease, Per Protocol|13
2273566|NCT02289690|3954238|FG006|Overall Study|Progressive Disease, Per Protocol|2
2273567|NCT02289690|3954239|FG007|Overall Study|Progressive Disease, Per Protocol|0
2273568|NCT02289690|3954240|FG008|Overall Study|Progressive Disease, Per Protocol|0
2273569|NCT02289690|3954241|FG009|Overall Study|Progressive Disease, Per Protocol|0
2273570|NCT02289690|3954232|FG000|Overall Study|Lost to Follow-up|0
2273571|NCT02289690|3954233|FG001|Overall Study|Lost to Follow-up|0
2273572|NCT02289690|3954234|FG002|Overall Study|Lost to Follow-up|0
2273573|NCT02289690|3954235|FG003|Overall Study|Lost to Follow-up|0
2273574|NCT02289690|3954236|FG004|Overall Study|Lost to Follow-up|0
2273575|NCT02289690|3954237|FG005|Overall Study|Lost to Follow-up|0
2273576|NCT02289690|3954238|FG006|Overall Study|Lost to Follow-up|0
2273577|NCT02289690|3954239|FG007|Overall Study|Lost to Follow-up|1
2273578|NCT02289690|3954240|FG008|Overall Study|Lost to Follow-up|0
2273579|NCT02289690|3954241|FG009|Overall Study|Lost to Follow-up|2
2273580|NCT02289690|3954232|FG000|Overall Study|Death|0
2273581|NCT02289690|3954233|FG001|Overall Study|Death|0
2273582|NCT02289690|3954234|FG002|Overall Study|Death|0
2273583|NCT02289690|3954235|FG003|Overall Study|Death|0
2273584|NCT02289690|3954236|FG004|Overall Study|Death|0
2273585|NCT02289690|3954237|FG005|Overall Study|Death|0
2273586|NCT02289690|3954238|FG006|Overall Study|Death|0
2273587|NCT02289690|3954239|FG007|Overall Study|Death|49
2273588|NCT02289690|3954240|FG008|Overall Study|Death|45
2273589|NCT02289690|3954241|FG009|Overall Study|Death|41
2273590|NCT02289690|3954232|FG000|Overall Study|Sponsor Discontinued Study|0
2273591|NCT02289690|3954233|FG001|Overall Study|Sponsor Discontinued Study|0
2273592|NCT02289690|3954234|FG002|Overall Study|Sponsor Discontinued Study|0
2273593|NCT02289690|3954235|FG003|Overall Study|Sponsor Discontinued Study|0
2273594|NCT02289690|3954236|FG004|Overall Study|Sponsor Discontinued Study|0
2273595|NCT02289690|3954237|FG005|Overall Study|Sponsor Discontinued Study|0
2273596|NCT02289690|3954238|FG006|Overall Study|Sponsor Discontinued Study|0
2273597|NCT02289690|3954239|FG007|Overall Study|Sponsor Discontinued Study|9
2273598|NCT02289690|3954240|FG008|Overall Study|Sponsor Discontinued Study|7
2273599|NCT02289690|3954241|FG009|Overall Study|Sponsor Discontinued Study|15
2273600|NCT02289690|3954232|FG000|Overall Study|Other|0
2273601|NCT02289690|3954233|FG001|Overall Study|Other|0
2273602|NCT02289690|3954234|FG002|Overall Study|Other|0
2273603|NCT02289690|3954235|FG003|Overall Study|Other|1
2273604|NCT02289690|3954236|FG004|Overall Study|Other|1
2273605|NCT02289690|3954237|FG005|Overall Study|Other|0
2273606|NCT02289690|3954238|FG006|Overall Study|Other|1
2273607|NCT02289690|3954239|FG007|Overall Study|Other|2
2351434|NCT03864627|4098702|FG001|Overall Study|Lack of Efficacy|1
2351435|NCT03864627|4098701|FG000|Overall Study|Lost to Follow-up|0
2351436|NCT03864627|4098702|FG001|Overall Study|Lost to Follow-up|1
2351437|NCT03864627|4098701|FG000|Overall Study|Withdrawal by Subject|4
2351438|NCT03864627|4098702|FG001|Overall Study|Withdrawal by Subject|8
2351439|NCT03864627|4098701|FG000|Overall Study|Study terminated by sponsor|0
2351440|NCT03864627|4098702|FG001|Overall Study|Study terminated by sponsor|1
2273608|NCT02289690|3954240|FG008|Overall Study|Other|3
2273609|NCT02289690|3954241|FG009|Overall Study|Other|1
2273610|NCT02289729|3954277|FG000|Overall Study|Lack of Efficacy|3
2273611|NCT02289729|3954277|FG000|Overall Study|Very Narrow Therapeutic Margin|1
2273612|NCT02289729|3954277|FG000|Overall Study|Withdrawal by Subject|1
2273613|NCT02289729|3954277|FG000|Overall Study|Death|1
2273614|NCT02289742|3954283|FG000|First Wear Period|Adverse event prior to treatment|0
2273615|NCT02289742|3954284|FG001|First Wear Period|Adverse event prior to treatment|1
2273616|NCT02289742|3954285|FG002|First Wear Period|Adverse event prior to treatment|0
2273617|NCT02289742|3954286|FG003|First Wear Period|Adverse event prior to treatment|0
2273618|NCT02289742|3954283|FG000|First Wear Period|Adverse Event|0
2273619|NCT02289742|3954284|FG001|First Wear Period|Adverse Event|0
2273620|NCT02289742|3954285|FG002|First Wear Period|Adverse Event|1
2273621|NCT02289742|3954286|FG003|First Wear Period|Adverse Event|0
2273622|NCT02289742|3954283|FG000|First Wear Period|Other prior to treatment|0
2273623|NCT02289742|3954284|FG001|First Wear Period|Other prior to treatment|0
2273624|NCT02289742|3954285|FG002|First Wear Period|Other prior to treatment|0
2273625|NCT02289742|3954286|FG003|First Wear Period|Other prior to treatment|1
2273626|NCT02289742|3954283|FG000|Third Wear Period|Adverse Event|0
2273627|NCT02289742|3954284|FG001|Third Wear Period|Adverse Event|1
2273628|NCT02289742|3954285|FG002|Third Wear Period|Adverse Event|0
2273629|NCT02289742|3954286|FG003|Third Wear Period|Adverse Event|0
2273630|NCT02289742|3954283|FG000|Third Wear Period|Reason not given|0
2273631|NCT02289742|3954284|FG001|Third Wear Period|Reason not given|0
2273632|NCT02289742|3954285|FG002|Third Wear Period|Reason not given|0
2273633|NCT02289742|3954286|FG003|Third Wear Period|Reason not given|1
2273634|NCT02289820|3954311|FG000|Overall Study|Withdrawal by Subject|2
2273635|NCT02289820|3954312|FG001|Overall Study|Withdrawal by Subject|1
2273636|NCT02289820|3954313|FG002|Overall Study|Withdrawal by Subject|2
2273637|NCT02289820|3954314|FG003|Overall Study|Withdrawal by Subject|1
2273638|NCT02289820|3954315|FG004|Overall Study|Withdrawal by Subject|0
2273639|NCT02289820|3954316|FG005|Overall Study|Withdrawal by Subject|0
2273640|NCT02289820|3954317|FG006|Overall Study|Withdrawal by Subject|1
2273641|NCT02289820|3954311|FG000|Overall Study|Death|0
2273642|NCT02289820|3954312|FG001|Overall Study|Death|0
2273643|NCT02289820|3954313|FG002|Overall Study|Death|1
2273644|NCT02289820|3954314|FG003|Overall Study|Death|0
2273645|NCT02289820|3954315|FG004|Overall Study|Death|0
2273646|NCT02289820|3954316|FG005|Overall Study|Death|0
2273647|NCT02289820|3954317|FG006|Overall Study|Death|0
2273648|NCT02289820|3954311|FG000|Overall Study|Lost to Follow-up|0
2273649|NCT02289820|3954312|FG001|Overall Study|Lost to Follow-up|0
2273650|NCT02289820|3954313|FG002|Overall Study|Lost to Follow-up|3
2273651|NCT02289820|3954314|FG003|Overall Study|Lost to Follow-up|1
2273652|NCT02289820|3954315|FG004|Overall Study|Lost to Follow-up|0
2273653|NCT02289820|3954316|FG005|Overall Study|Lost to Follow-up|1
2273654|NCT02289820|3954317|FG006|Overall Study|Lost to Follow-up|1
2273655|NCT02289820|3954311|FG000|Overall Study|withdrawal of consent|0
2273656|NCT02289820|3954312|FG001|Overall Study|withdrawal of consent|1
2273657|NCT02289820|3954313|FG002|Overall Study|withdrawal of consent|0
2273658|NCT02289820|3954314|FG003|Overall Study|withdrawal of consent|0
2273659|NCT02289820|3954315|FG004|Overall Study|withdrawal of consent|0
2273660|NCT02289820|3954316|FG005|Overall Study|withdrawal of consent|0
2273661|NCT02289820|3954317|FG006|Overall Study|withdrawal of consent|0
2273662|NCT02289833|3954339|FG000|Overall Study|Study discontinuation|0
2273663|NCT02289833|3954340|FG001|Overall Study|Study discontinuation|1
2273664|NCT02289833|3954339|FG000|Overall Study|Lost to Follow-up|4
2273665|NCT02289833|3954340|FG001|Overall Study|Lost to Follow-up|0
2273666|NCT02289833|3954339|FG000|Overall Study|Death|23
2273667|NCT02289833|3954340|FG001|Overall Study|Death|16
2273668|NCT02289898|3954351|FG000|Overall Study|Death|5
2273669|NCT02289898|3954352|FG001|Overall Study|Death|4
2273670|NCT02289898|3954353|FG002|Overall Study|Death|3
2273671|NCT02289898|3954351|FG000|Overall Study|Physician Decision|2
2273672|NCT02289898|3954352|FG001|Overall Study|Physician Decision|5
2273673|NCT02289898|3954353|FG002|Overall Study|Physician Decision|2
2273674|NCT02289898|3954351|FG000|Overall Study|Withdrawal by Subject|0
2273675|NCT02289898|3954352|FG001|Overall Study|Withdrawal by Subject|4
2273676|NCT02289898|3954353|FG002|Overall Study|Withdrawal by Subject|1
2273677|NCT02289898|3954351|FG000|Overall Study|Adverse Event|3
2273678|NCT02289898|3954352|FG001|Overall Study|Adverse Event|5
2273679|NCT02289898|3954353|FG002|Overall Study|Adverse Event|5
2273680|NCT02289898|3954351|FG000|Overall Study|Disease progression|34
2273681|NCT02289898|3954352|FG001|Overall Study|Disease progression|28
2273682|NCT02289898|3954353|FG002|Overall Study|Disease progression|34
2273683|NCT02289898|3954351|FG000|Overall Study|Use of another anticancer therapy|0
2273684|NCT02289898|3954352|FG001|Overall Study|Use of another anticancer therapy|0
2273685|NCT02289898|3954353|FG002|Overall Study|Use of another anticancer therapy|1
2273686|NCT02289898|3954351|FG000|Overall Study|Other|8
2273687|NCT02289898|3954352|FG001|Overall Study|Other|7
2273688|NCT02289898|3954353|FG002|Overall Study|Other|10
2273689|NCT02289950|3954362|FG000|Overall Study|Progressive disease by RECIST 1.1|99
2273690|NCT02289950|3954363|FG001|Overall Study|Progressive disease by RECIST 1.1|52
2273691|NCT02289950|3954362|FG000|Overall Study|Progressive disease by Clinical Assessment|4
2351441|NCT03848403|4098717|FG000|Period 2 (Day 8)|Adverse Event|1
2273692|NCT02289950|3954363|FG001|Overall Study|Progressive disease by Clinical Assessment|4
2273693|NCT02289950|3954362|FG000|Overall Study|Lost to Follow-up|1
2273694|NCT02289950|3954363|FG001|Overall Study|Lost to Follow-up|0
2273695|NCT02289950|3954362|FG000|Overall Study|Physician Decision|9
2273696|NCT02289950|3954363|FG001|Overall Study|Physician Decision|3
2273697|NCT02289950|3954362|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9
2273698|NCT02289950|3954363|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2
2273699|NCT02289950|3954362|FG000|Overall Study|Withdrawal by Subject|1
2273700|NCT02289950|3954363|FG001|Overall Study|Withdrawal by Subject|3
2273701|NCT02289950|3954362|FG000|Overall Study|Test article held for greater than 28 days|0
2273702|NCT02289950|3954363|FG001|Overall Study|Test article held for greater than 28 days|1
2273703|NCT02289950|3954362|FG000|Overall Study|Adverse Event|11
2273704|NCT02289950|3954363|FG001|Overall Study|Adverse Event|3
2273705|NCT02289950|3954362|FG000|Overall Study|Death|1
2273706|NCT02289950|3954363|FG001|Overall Study|Death|1
2273707|NCT02289950|3954362|FG000|Overall Study|Other|5
2273708|NCT02289950|3954363|FG001|Overall Study|Other|2
2273709|NCT02289950|3954362|FG000|Overall Study|Not Treated|2
2273710|NCT02289950|3954363|FG001|Overall Study|Not Treated|1
2273711|NCT02289963|3954371|FG000|Overall Study|Adverse Event|1
2273712|NCT02289963|3954372|FG001|Overall Study|Adverse Event|2
2273713|NCT02289963|3954371|FG000|Overall Study|Poor compliance to protocol|1
2273714|NCT02289963|3954372|FG001|Overall Study|Poor compliance to protocol|0
2273715|NCT02289963|3954371|FG000|Overall Study|Withdrawal by Subject|1
2273716|NCT02289963|3954372|FG001|Overall Study|Withdrawal by Subject|0
2273717|NCT02289963|3954371|FG000|Overall Study|Last injection missed|2
2273718|NCT02289963|3954372|FG001|Overall Study|Last injection missed|2
2273719|NCT02289963|3954371|FG000|Overall Study|End treatment visit outside visit window|0
2273720|NCT02289963|3954372|FG001|Overall Study|End treatment visit outside visit window|4
2273721|NCT02289963|3954371|FG000|Overall Study|Other than specified above|0
2273722|NCT02289963|3954372|FG001|Overall Study|Other than specified above|2
2273723|NCT02290028|3954387|FG000|Overall Study|Death|217
2273724|NCT02290028|3954387|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186
2273725|NCT02290028|3954387|FG000|Overall Study|No longer under care of study physician|76
2273726|NCT02290028|3954387|FG000|Overall Study|Sentus lead or required CRT-D explanted|55
2273727|NCT02290028|3954387|FG000|Overall Study|Withdrawal by Subject|52
2273728|NCT02290028|3954387|FG000|Overall Study|Study site closure|44
2273729|NCT02290028|3954387|FG000|Overall Study|Lost to Follow-up|34
2273730|NCT02290028|3954387|FG000|Overall Study|Miscellaneous|10
2273731|NCT02290028|3954387|FG000|Overall Study|Transition to EP PASSION|1295
2273732|NCT02290028|3954387|FG000|Overall Study|Planned study completion at 12 months|257
2273733|NCT02290223|3954420|FG000|6 Months|Lost to Follow-up|9
2273734|NCT02290223|3954421|FG001|6 Months|Lost to Follow-up|6
2273735|NCT02290223|3954420|FG000|6 Months|Withdrawal by Subject|5
2273736|NCT02290223|3954421|FG001|6 Months|Withdrawal by Subject|0
2273737|NCT02290223|3954420|FG000|6 Months|deceased (not related to study)|2
2273738|NCT02290223|3954421|FG001|6 Months|deceased (not related to study)|0
2273739|NCT02290223|3954420|FG000|12 Months|Lost to Follow-up|16
2273740|NCT02290223|3954421|FG001|12 Months|Lost to Follow-up|10
2273741|NCT02290223|3954420|FG000|12 Months|Refusal|0
2273742|NCT02290223|3954421|FG001|12 Months|Refusal|1
2273743|NCT02290340|3954431|FG000|Overall Study|Lost to Follow-up|0
2273744|NCT02290340|3954432|FG001|Overall Study|Lost to Follow-up|0
2273745|NCT02290340|3954433|FG002|Overall Study|Lost to Follow-up|0
2273746|NCT02290340|3954434|FG003|Overall Study|Lost to Follow-up|1
2273747|NCT02290340|3954431|FG000|Overall Study|Withdrawal by Subject|1
2273748|NCT02290340|3954432|FG001|Overall Study|Withdrawal by Subject|0
2273749|NCT02290340|3954433|FG002|Overall Study|Withdrawal by Subject|0
2273750|NCT02290340|3954434|FG003|Overall Study|Withdrawal by Subject|0
2273751|NCT02290340|3954431|FG000|Overall Study|Other|1
2273752|NCT02290340|3954432|FG001|Overall Study|Other|0
2273753|NCT02290340|3954433|FG002|Overall Study|Other|0
2273754|NCT02290340|3954434|FG003|Overall Study|Other|1
2273755|NCT02290405|3954449|FG000|Overall Study|Withdrawal by Subject|1
2273756|NCT02290405|3954450|FG001|Overall Study|Withdrawal by Subject|0
2273757|NCT02290691|3954490|FG000|Overall Study|Noncompliance|0
2273758|NCT02290691|3954491|FG001|Overall Study|Noncompliance|1
2273759|NCT02290691|3954490|FG000|Overall Study|Withdrawal by Subject|1
2273760|NCT02290691|3954491|FG001|Overall Study|Withdrawal by Subject|1
2273761|NCT02290691|3954490|FG000|Overall Study|Lost to Follow-up|7
2273762|NCT02290691|3954491|FG001|Overall Study|Lost to Follow-up|7
2273763|NCT02290821|3954499|FG000|Overall Study|Withdrawal by Subject|1
2273764|NCT02290821|3954500|FG001|Overall Study|Withdrawal by Subject|1
2273765|NCT02290821|3954499|FG000|Overall Study|Unable or unwilling to cooperate with|2
2273766|NCT02290821|3954500|FG001|Overall Study|Unable or unwilling to cooperate with|0
2273767|NCT02290821|3954499|FG000|Overall Study|Lost to Follow-up|3
2273768|NCT02290821|3954500|FG001|Overall Study|Lost to Follow-up|2
2351442|NCT03848403|4098718|FG001|Period 2 (Day 8)|Adverse Event|2
2351443|NCT03848403|4098719|FG002|Period 2 (Day 8)|Adverse Event|2
2351444|NCT03848403|4098717|FG000|Period 2 (Day 8)|Physician Decision|0
2351445|NCT03848403|4098718|FG001|Period 2 (Day 8)|Physician Decision|1
2351446|NCT03848403|4098719|FG002|Period 2 (Day 8)|Physician Decision|0
2351447|NCT03848403|4098717|FG000|Period 2 (Day 8)|Sponsor Decision|8
2273769|NCT02290873|3954509|FG000|Overall Study|Withdrawal by Subject|0
2273770|NCT02290873|3954510|FG001|Overall Study|Withdrawal by Subject|1
2273771|NCT02290873|3954511|FG002|Overall Study|Withdrawal by Subject|1
2273772|NCT02290873|3954509|FG000|Overall Study|Nellcor device error|1
2273773|NCT02290873|3954510|FG001|Overall Study|Nellcor device error|0
2273774|NCT02290873|3954511|FG002|Overall Study|Nellcor device error|0
2351448|NCT03848403|4098718|FG001|Period 2 (Day 8)|Sponsor Decision|6
2351449|NCT03848403|4098719|FG002|Period 2 (Day 8)|Sponsor Decision|5
2351450|NCT03878108|4098786|FG000|Overall Study|Adverse Event|1
2351451|NCT03878108|4098787|FG001|Overall Study|Adverse Event|0
2351452|NCT03877237|4098803|FG000|Overall Study|Adverse Event|1
2351453|NCT03877237|4098804|FG001|Overall Study|Adverse Event|2
2351454|NCT03877237|4098803|FG000|Overall Study|Death|3
2351455|NCT03877237|4098804|FG001|Overall Study|Death|2
2351456|NCT03877237|4098803|FG000|Overall Study|Physician Decision|1
2351457|NCT03877237|4098804|FG001|Overall Study|Physician Decision|0
2351458|NCT03877237|4098803|FG000|Overall Study|Withdrawal by Subject|0
2351459|NCT03877237|4098804|FG001|Overall Study|Withdrawal by Subject|2
2351460|NCT03859323|4098833|FG000|Overall Study|Lost to Follow-up|0
2351461|NCT03859323|4098834|FG001|Overall Study|Lost to Follow-up|0
2351462|NCT03859323|4098835|FG002|Overall Study|Lost to Follow-up|0
2351463|NCT03859323|4098836|FG003|Overall Study|Lost to Follow-up|0
2351464|NCT03859323|4098837|FG004|Overall Study|Lost to Follow-up|0
2351465|NCT03859323|4098838|FG005|Overall Study|Lost to Follow-up|0
2351466|NCT03859323|4098839|FG006|Overall Study|Lost to Follow-up|1
2351467|NCT03859323|4098840|FG007|Overall Study|Lost to Follow-up|0
2351468|NCT03859323|4098841|FG008|Overall Study|Lost to Follow-up|0
2351469|NCT03859323|4098842|FG009|Overall Study|Lost to Follow-up|0
2351470|NCT03859323|4098843|FG010|Overall Study|Lost to Follow-up|0
2351471|NCT03859323|4098844|FG011|Overall Study|Lost to Follow-up|0
2351472|NCT03859323|4098845|FG012|Overall Study|Lost to Follow-up|0
2351473|NCT03859323|4098833|FG000|Overall Study|Withdrawal by Subject|0
2351474|NCT03859323|4098834|FG001|Overall Study|Withdrawal by Subject|0
2351475|NCT03859323|4098835|FG002|Overall Study|Withdrawal by Subject|1
2351476|NCT03859323|4098836|FG003|Overall Study|Withdrawal by Subject|0
2351477|NCT03859323|4098837|FG004|Overall Study|Withdrawal by Subject|0
2351478|NCT03859323|4098838|FG005|Overall Study|Withdrawal by Subject|1
2351479|NCT03859323|4098839|FG006|Overall Study|Withdrawal by Subject|0
2351480|NCT03859323|4098840|FG007|Overall Study|Withdrawal by Subject|0
2351481|NCT03859323|4098841|FG008|Overall Study|Withdrawal by Subject|0
2351482|NCT03859323|4098842|FG009|Overall Study|Withdrawal by Subject|1
2351483|NCT03859323|4098843|FG010|Overall Study|Withdrawal by Subject|1
2351484|NCT03859323|4098844|FG011|Overall Study|Withdrawal by Subject|2
2351485|NCT03859323|4098845|FG012|Overall Study|Withdrawal by Subject|1
2351486|NCT03859323|4098833|FG000|Overall Study|Pregnancy|0
2351487|NCT03859323|4098834|FG001|Overall Study|Pregnancy|0
2351488|NCT03859323|4098835|FG002|Overall Study|Pregnancy|0
2351489|NCT03859323|4098836|FG003|Overall Study|Pregnancy|0
2351490|NCT03859323|4098837|FG004|Overall Study|Pregnancy|0
2351491|NCT03859323|4098838|FG005|Overall Study|Pregnancy|0
2351492|NCT03859323|4098839|FG006|Overall Study|Pregnancy|0
2351493|NCT03859323|4098840|FG007|Overall Study|Pregnancy|0
2351494|NCT03859323|4098841|FG008|Overall Study|Pregnancy|0
2351495|NCT03859323|4098842|FG009|Overall Study|Pregnancy|1
2351496|NCT03859323|4098843|FG010|Overall Study|Pregnancy|0
2351497|NCT03859323|4098844|FG011|Overall Study|Pregnancy|0
2351498|NCT03859323|4098845|FG012|Overall Study|Pregnancy|0
2351499|NCT03875508|4098910|FG000|Overall Study|Adverse Event|1
2351500|NCT03875508|4098910|FG000|Overall Study|Lost to Follow-up|8
2351501|NCT03875508|4098910|FG000|Overall Study|Lack of Efficacy|1
2351502|NCT03875508|4098910|FG000|Overall Study|Other, not specified|2
2351503|NCT03869333|4098918|FG000|Overall Study|Lost to Follow-up|1
2351504|NCT03869333|4098919|FG001|Overall Study|Lost to Follow-up|0
2351505|NCT03869333|4098920|FG002|Overall Study|Lost to Follow-up|0
2351506|NCT03869333|4098921|FG003|Overall Study|Lost to Follow-up|0
2351507|NCT03869333|4098918|FG000|Overall Study|Pregnancy|1
2351508|NCT03869333|4098919|FG001|Overall Study|Pregnancy|0
2351509|NCT03869333|4098920|FG002|Overall Study|Pregnancy|0
2351510|NCT03869333|4098921|FG003|Overall Study|Pregnancy|0
2351511|NCT03869333|4098918|FG000|Overall Study|Physician Decision|0
2351512|NCT03869333|4098919|FG001|Overall Study|Physician Decision|1
2351513|NCT03869333|4098920|FG002|Overall Study|Physician Decision|0
2351514|NCT03869333|4098921|FG003|Overall Study|Physician Decision|0
2351515|NCT03864900|4098933|FG000|Overall Study|Withdrawal by Subject|1
2351516|NCT03864900|4098934|FG001|Overall Study|Withdrawal by Subject|1
2351517|NCT03864900|4098933|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2
2273775|NCT02290873|3954509|FG000|Overall Study|Esophagogastroduodenoscopy was added|1
2273776|NCT02290873|3954510|FG001|Overall Study|Esophagogastroduodenoscopy was added|0
2273777|NCT02290873|3954511|FG002|Overall Study|Esophagogastroduodenoscopy was added|0
2273778|NCT02290873|3954509|FG000|Overall Study|Protocol Violation|0
2273779|NCT02290873|3954510|FG001|Overall Study|Protocol Violation|0
2273780|NCT02290873|3954511|FG002|Overall Study|Protocol Violation|1
2273781|NCT02290925|3954522|FG000|First Period of Three Months|Lost to Follow-up|2
2273782|NCT02290925|3954523|FG001|First Period of Three Months|Lost to Follow-up|1
2273783|NCT02290925|3954522|FG000|First Period of Three Months|Death|1
2351518|NCT03864900|4098934|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5
2351519|NCT03875482|4098959|FG000|Overall Study|Adverse Event|0
2351520|NCT03875482|4098960|FG001|Overall Study|Adverse Event|1
2351521|NCT03875482|4098959|FG000|Overall Study|Withdrew consent|5
2351522|NCT03875482|4098960|FG001|Overall Study|Withdrew consent|6
2351523|NCT03875482|4098959|FG000|Overall Study|Lost to Follow-up|8
2351524|NCT03875482|4098960|FG001|Overall Study|Lost to Follow-up|2
2351525|NCT03875482|4098959|FG000|Overall Study|Lack of Efficacy|0
2351526|NCT03875482|4098960|FG001|Overall Study|Lack of Efficacy|11
2351527|NCT03874013|4098978|FG000|Overall Study|Adverse Event|0
2351528|NCT03874013|4098979|FG001|Overall Study|Adverse Event|1
2351529|NCT03873116|4098988|FG000|Overall Study|Study drug discontinuation due to rash|0
2351530|NCT03873116|4098989|FG001|Overall Study|Study drug discontinuation due to rash|0
2351531|NCT03873116|4098990|FG002|Overall Study|Study drug discontinuation due to rash|1
2351532|NCT03872843|4099000|FG000|Overall Study|Lost to Follow-up|5
2351533|NCT03872843|4099001|FG001|Overall Study|Lost to Follow-up|7
2351534|NCT03870997|4099013|FG000|Overall Study|Did not complete mid-study/final survey|10544
2351535|NCT03870997|4099014|FG001|Overall Study|Did not complete mid-study/final survey|10431
2351536|NCT03870997|4099015|FG002|Overall Study|Did not complete mid-study/final survey|10978
2351537|NCT03870997|4099016|FG003|Overall Study|Did not complete mid-study/final survey|10947
2351538|NCT03870997|4099017|FG004|Overall Study|Did not complete mid-study/final survey|10588
2351539|NCT03870997|4099018|FG005|Overall Study|Did not complete mid-study/final survey|10531
2351540|NCT03869684|4099030|FG000|Overall Study|Adverse Event|0
2351541|NCT03869684|4099031|FG001|Overall Study|Adverse Event|3
2351542|NCT03869684|4099032|FG002|Overall Study|Adverse Event|1
2351543|NCT03869684|4099030|FG000|Overall Study|Withdrawal by Subject|1
2351544|NCT03869684|4099031|FG001|Overall Study|Withdrawal by Subject|0
2351545|NCT03869684|4099032|FG002|Overall Study|Withdrawal by Subject|0
2351546|NCT03869684|4099030|FG000|Overall Study|Lost to Follow-up|1
2351547|NCT03869684|4099031|FG001|Overall Study|Lost to Follow-up|0
2351548|NCT03869684|4099032|FG002|Overall Study|Lost to Follow-up|0
2351549|NCT03869684|4099030|FG000|Overall Study|Study prematurely terminated by sponsor|0
2351550|NCT03869684|4099031|FG001|Overall Study|Study prematurely terminated by sponsor|0
2351551|NCT03869684|4099032|FG002|Overall Study|Study prematurely terminated by sponsor|2
2351552|NCT03848416|4099086|FG000|Overall Study|Withdrawal by Subject|1
2351553|NCT03848416|4099087|FG001|Overall Study|Withdrawal by Subject|0
2351554|NCT03848416|4099088|FG002|Overall Study|Withdrawal by Subject|0
2351555|NCT03848416|4099086|FG000|Overall Study|Death|0
2351556|NCT03848416|4099087|FG001|Overall Study|Death|0
2351557|NCT03848416|4099088|FG002|Overall Study|Death|1
2351558|NCT03847987|4099098|FG000|Overall Study|Lost to Follow-up|1
2351559|NCT03847987|4099099|FG001|Overall Study|Lost to Follow-up|0
2351560|NCT03847987|4099098|FG000|Overall Study|Adverse Event|2
2351561|NCT03847987|4099099|FG001|Overall Study|Adverse Event|0
2351562|NCT03853551|4099161|FG000|Overall Study|Death|2
2351563|NCT03853551|4099161|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7
2351564|NCT03870555|4099168|FG000|Period 3 (2 Days)|Adverse Event|1
2351565|NCT03870555|4099169|FG001|Period 3 (2 Days)|Adverse Event|0
2351566|NCT03870555|4099170|FG002|Period 3 (2 Days)|Adverse Event|0
2351567|NCT03851094|4099196|FG000|Overall Study|Withdrawal by Subject|0
2351568|NCT03851094|4099197|FG001|Overall Study|Withdrawal by Subject|1
2351569|NCT03851094|4099196|FG000|Overall Study|Participant lost device|0
2351570|NCT03851094|4099197|FG001|Overall Study|Participant lost device|1
2351571|NCT03851094|4099196|FG000|Overall Study|Participant returned device|0
2351572|NCT03851094|4099197|FG001|Overall Study|Participant returned device|2
2351573|NCT03868631|4099220|FG000|Baseline to Week 6|Adverse Event|0
2351574|NCT03868631|4099221|FG001|Baseline to Week 6|Adverse Event|3
2351575|NCT03868631|4099220|FG000|Baseline to Week 6|Protocol Violation|1
2351576|NCT03868631|4099221|FG001|Baseline to Week 6|Protocol Violation|1
2351577|NCT03868631|4099220|FG000|Baseline to Week 6|Withdrawal by Subject|3
2351578|NCT03868631|4099221|FG001|Baseline to Week 6|Withdrawal by Subject|0
2351579|NCT03868631|4099220|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2
2351580|NCT03868631|4099221|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0
2351581|NCT03868631|4099220|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
2351582|NCT03868631|4099221|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
2351583|NCT03868631|4099220|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
2351584|NCT03868631|4099221|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
2351585|NCT03865953|4099229|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2
2351586|NCT03865953|4099230|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
2351587|NCT03865953|4099229|FG000|First Intervention (4 Weeks)|Protocol Violation|0
2351588|NCT03865953|4099230|FG001|First Intervention (4 Weeks)|Protocol Violation|1
2351589|NCT03865953|4099229|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0
2351590|NCT03865953|4099230|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2
2351591|NCT03865381|4099236|FG000|Overall Study|Protocol Violation/Non-Compliance|3
2351592|NCT03865381|4099236|FG000|Overall Study|Withdrawal by Subject|2
2351593|NCT03868059|4099264|FG000|Overall Study|Adverse Event|3
2351594|NCT03868059|4099264|FG000|Overall Study|Lost to Follow-up|3
2351595|NCT03868059|4099264|FG000|Overall Study|Withdrawal by Subject|6
2351596|NCT03850444|4099270|FG000|Overall Study|Adverse Event|12
2351597|NCT03850444|4099271|FG001|Overall Study|Adverse Event|9
2351598|NCT03850444|4099270|FG000|Overall Study|Death|38
2351599|NCT03850444|4099271|FG001|Overall Study|Death|64
2351600|NCT03850444|4099270|FG000|Overall Study|Lost to Follow-up|0
2351601|NCT03850444|4099271|FG001|Overall Study|Lost to Follow-up|1
2351602|NCT03850444|4099270|FG000|Overall Study|Withdrawal by Subject|0
2351603|NCT03850444|4099271|FG001|Overall Study|Withdrawal by Subject|1
2351604|NCT03850444|4099270|FG000|Overall Study|Ongoing in Study|78
2351605|NCT03850444|4099271|FG001|Overall Study|Ongoing in Study|59
2351606|NCT03865407|4099288|FG000|Overall Study|Adverse Event|1
2351607|NCT03865407|4099289|FG001|Overall Study|Adverse Event|0
2351608|NCT03865407|4099288|FG000|Overall Study|Withdrawal by Subject|1
2351609|NCT03865407|4099289|FG001|Overall Study|Withdrawal by Subject|0
2351610|NCT03865407|4099288|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1
2351611|NCT03865407|4099289|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0
2351612|NCT03864653|4099308|FG000|Overall Study|Withdrawal by Subject|1
2351613|NCT03853213|4099325|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1
2351614|NCT03853213|4099326|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0
2351615|NCT03853213|4099325|FG000|Overall Study|Other (e.g., too busy)|0
2351616|NCT03853213|4099326|FG001|Overall Study|Other (e.g., too busy)|2
2351617|NCT03847610|4099332|FG000|Overall Study|Withdrawal by Subject|1
2351618|NCT03850093|4099339|FG000|Overall Study|Withdrawal by Subject|1
2351619|NCT03850093|4099340|FG001|Overall Study|Withdrawal by Subject|0
2351620|NCT03850093|4099341|FG002|Overall Study|Withdrawal by Subject|2
2351621|NCT03861936|4099422|FG000|Overall Study|Withdrawal by Subject|4
2351622|NCT03861936|4099423|FG001|Overall Study|Withdrawal by Subject|1
2351623|NCT03861936|4099424|FG002|Overall Study|Withdrawal by Subject|3
2351624|NCT03861936|4099422|FG000|Overall Study|Lost to Follow-up|5
2351625|NCT03861936|4099423|FG001|Overall Study|Lost to Follow-up|3
2351626|NCT03861936|4099424|FG002|Overall Study|Lost to Follow-up|3
2351627|NCT03861936|4099422|FG000|Overall Study|Physician Decision|0
2351628|NCT03861936|4099423|FG001|Overall Study|Physician Decision|1
2351629|NCT03861936|4099424|FG002|Overall Study|Physician Decision|0
2351630|NCT03861936|4099422|FG000|Overall Study|Protocol Deviation|0
2351631|NCT03861936|4099423|FG001|Overall Study|Protocol Deviation|0
2351632|NCT03861936|4099424|FG002|Overall Study|Protocol Deviation|1
2351633|NCT03861936|4099422|FG000|Overall Study|Reason not Specified|5
2351634|NCT03861936|4099423|FG001|Overall Study|Reason not Specified|5
2351635|NCT03861936|4099424|FG002|Overall Study|Reason not Specified|3
2351636|NCT03850509|4099464|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2
2351637|NCT03850509|4099465|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1
2351638|NCT03851016|4099550|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
2351639|NCT03851016|4099551|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2
2351640|NCT03850496|4099560|FG000|Overall Study|Withdrawal by Subject|1
2351641|NCT03850496|4099561|FG001|Overall Study|Withdrawal by Subject|0
2351642|NCT03850496|4099562|FG002|Overall Study|Withdrawal by Subject|0
2351643|NCT03850496|4099560|FG000|Overall Study|Lost to Follow-up|0
2351644|NCT03850496|4099561|FG001|Overall Study|Lost to Follow-up|1
2351645|NCT03850496|4099562|FG002|Overall Study|Lost to Follow-up|4
2351646|NCT03848949|4099572|FG000|Overall Study|Lost to Follow-up|5
2351647|NCT03848949|4099573|FG001|Overall Study|Lost to Follow-up|7
2351648|NCT03844945|4099601|FG000|Overall Study|Adverse Event|1
2351649|NCT03844945|4099602|FG001|Overall Study|Adverse Event|1
2351650|NCT03844945|4099603|FG002|Overall Study|Adverse Event|4
2351651|NCT03844945|4099604|FG003|Overall Study|Adverse Event|0
2351652|NCT03844945|4099601|FG000|Overall Study|Withdrawal by Subject|0
2351653|NCT03844945|4099602|FG001|Overall Study|Withdrawal by Subject|0
2351654|NCT03844945|4099603|FG002|Overall Study|Withdrawal by Subject|1
2351655|NCT03844945|4099604|FG003|Overall Study|Withdrawal by Subject|0
2351656|NCT03844945|4099601|FG000|Overall Study|Lack of Efficacy|0
2351657|NCT03844945|4099602|FG001|Overall Study|Lack of Efficacy|0
2351658|NCT03844945|4099603|FG002|Overall Study|Lack of Efficacy|0
2351659|NCT03844945|4099604|FG003|Overall Study|Lack of Efficacy|1
2351660|NCT03843632|4099627|FG000|Overall Study|Withdrawal by Subject|1
2351661|NCT03843632|4099628|FG001|Overall Study|Withdrawal by Subject|0
2351662|NCT03843632|4099629|FG002|Overall Study|Withdrawal by Subject|0
2351663|NCT03843632|4099630|FG003|Overall Study|Withdrawal by Subject|0
2351664|NCT03840811|4099643|FG000|Overall Study|Lost to Follow-up|0
2351665|NCT03840811|4099644|FG001|Overall Study|Lost to Follow-up|0
2351666|NCT03840811|4099645|FG002|Overall Study|Lost to Follow-up|1
2351667|NCT03837028|4099657|FG000|Overall Study|Lost to Follow-up|4
2351668|NCT03837028|4099658|FG001|Overall Study|Lost to Follow-up|0
2351669|NCT03837028|4099659|FG002|Overall Study|Lost to Follow-up|2
2351670|NCT03837028|4099660|FG003|Overall Study|Lost to Follow-up|0
2351671|NCT03837028|4099657|FG000|Overall Study|Withdrawal by Subject|12
2351672|NCT03837028|4099658|FG001|Overall Study|Withdrawal by Subject|11
2351673|NCT03837028|4099659|FG002|Overall Study|Withdrawal by Subject|11
2351674|NCT03837028|4099660|FG003|Overall Study|Withdrawal by Subject|7
2351675|NCT03841331|4099703|FG000|Overall Study|Withdrawal by Subject|4
2351676|NCT03841331|4099704|FG001|Overall Study|Withdrawal by Subject|9
2351677|NCT03841331|4099703|FG000|Overall Study|Lost to Follow-up|5
2351678|NCT03841331|4099704|FG001|Overall Study|Lost to Follow-up|1
2351679|NCT03840135|4099719|FG000|Overall Study|Protocol Violation|6
2351680|NCT03840135|4099720|FG001|Overall Study|Protocol Violation|1
2351681|NCT03840135|4099719|FG000|Overall Study|Withdrawal by Subject|1
2351682|NCT03840135|4099720|FG001|Overall Study|Withdrawal by Subject|0
2351683|NCT03839641|4099732|FG000|Overall Study|Withdrawal by Subject|1
2351684|NCT03839641|4099733|FG001|Overall Study|Withdrawal by Subject|1
2351685|NCT03839212|4099741|FG000|Overall Study|COVID-19 related suspension of research activities.|4
2351686|NCT03839355|4099747|FG000|Overall Study|Withdrawal by Subject|1
2351687|NCT03839355|4099748|FG001|Overall Study|Withdrawal by Subject|0
2351688|NCT03838731|4099765|FG000|Overall Study|Pregnancy|0
2351689|NCT03838731|4099766|FG001|Overall Study|Pregnancy|1
2351690|NCT03838731|4099765|FG000|Overall Study|Withdrawal of consent|1
2351691|NCT03838731|4099766|FG001|Overall Study|Withdrawal of consent|0
2351692|NCT03838198|4099774|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
2351693|NCT03838198|4099775|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
2351694|NCT03838198|4099776|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1
2351695|NCT03838198|4099777|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
2351696|NCT03838198|4099774|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
2351697|NCT03838198|4099775|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
2351698|NCT03838198|4099776|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
2351699|NCT03838198|4099777|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
2351700|NCT03836677|4099896|FG000|Period 1|Adverse Event|0
2351701|NCT03836677|4099897|FG001|Period 1|Adverse Event|1
2351702|NCT03836677|4099896|FG000|Period 2|Severe non-compliance to protocol|1
2351703|NCT03836677|4099897|FG001|Period 2|Severe non-compliance to protocol|0
2351704|NCT03827564|4099917|FG000|Overall Study|Discontinued due to Study Termination|1
2351705|NCT03827564|4099918|FG001|Overall Study|Discontinued due to Study Termination|0
2351706|NCT03824236|4099927|FG000|Overall Study|Lost to Follow-up|0
2351707|NCT03824236|4099928|FG001|Overall Study|Lost to Follow-up|0
2351708|NCT03824236|4099929|FG002|Overall Study|Lost to Follow-up|1
2351709|NCT03810235|4099950|FG000|Overall Study|Withdrawal by Subject|2
2351710|NCT03810235|4099951|FG001|Overall Study|Withdrawal by Subject|0
2351711|NCT03836664|4099970|FG000|Overall Study|Didn't complete forms and lost drug|3
2351712|NCT03836664|4099971|FG001|Overall Study|Didn't complete forms and lost drug|3
2351713|NCT03832738|4099984|FG000|Overall Study|Withdrawal by Subject|6
2351714|NCT03832738|4099985|FG001|Overall Study|Withdrawal by Subject|7
2351715|NCT03832738|4099986|FG002|Overall Study|Withdrawal by Subject|16
2351716|NCT03832738|4099984|FG000|Overall Study|Physician Decision|0
2351717|NCT03832738|4099985|FG001|Overall Study|Physician Decision|1
2351718|NCT03832738|4099986|FG002|Overall Study|Physician Decision|2
2351719|NCT03832738|4099984|FG000|Overall Study|Adverse Event|2
2351720|NCT03832738|4099985|FG001|Overall Study|Adverse Event|3
2351721|NCT03832738|4099986|FG002|Overall Study|Adverse Event|1
2351722|NCT03832738|4099984|FG000|Overall Study|Pregnancy|0
2351723|NCT03832738|4099985|FG001|Overall Study|Pregnancy|1
2351724|NCT03832738|4099986|FG002|Overall Study|Pregnancy|0
2351725|NCT03823391|4099996|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1
2351726|NCT03823391|4099997|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1
2351727|NCT03823391|4099996|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1
2351728|NCT03823391|4099997|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0
2351729|NCT03808298|4100019|FG000|Overall Study|Adverse Event|3
2351730|NCT03808298|4100019|FG000|Overall Study|Physician Decision|1
2351731|NCT03808298|4100019|FG000|Overall Study|Withdrawal by Subject|1
2351732|NCT03808298|4100019|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3
2351733|NCT03836729|4100048|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1
2351734|NCT03835975|4100061|FG000|Overall Study|Lost to Follow-up|1
2351735|NCT03835975|4100062|FG001|Overall Study|Lost to Follow-up|1
2351736|NCT03835975|4100063|FG002|Overall Study|Lost to Follow-up|0
2351737|NCT03835975|4100064|FG003|Overall Study|Lost to Follow-up|0
2351738|NCT03835975|4100065|FG004|Overall Study|Lost to Follow-up|0
2351739|NCT03835975|4100061|FG000|Overall Study|No longer met eligibility criteria|0
2351740|NCT03835975|4100062|FG001|Overall Study|No longer met eligibility criteria|1
2351741|NCT03835975|4100063|FG002|Overall Study|No longer met eligibility criteria|0
2351742|NCT03835975|4100064|FG003|Overall Study|No longer met eligibility criteria|0
2351743|NCT03835975|4100065|FG004|Overall Study|No longer met eligibility criteria|0
2351744|NCT03835975|4100061|FG000|Overall Study|Protocol Violation|1
2351745|NCT03835975|4100062|FG001|Overall Study|Protocol Violation|1
2351746|NCT03835975|4100063|FG002|Overall Study|Protocol Violation|2
2351747|NCT03835975|4100064|FG003|Overall Study|Protocol Violation|0
2351748|NCT03835975|4100065|FG004|Overall Study|Protocol Violation|0
2351749|NCT03835975|4100061|FG000|Overall Study|Withdrawal by Subject|1
2351750|NCT03835975|4100062|FG001|Overall Study|Withdrawal by Subject|0
2351751|NCT03835975|4100063|FG002|Overall Study|Withdrawal by Subject|1
2351752|NCT03835975|4100064|FG003|Overall Study|Withdrawal by Subject|1
2351753|NCT03835975|4100065|FG004|Overall Study|Withdrawal by Subject|0
2351754|NCT03835221|4100120|FG000|Methafilcon A|Withdrawal by Subject|1
2351755|NCT03819634|4100126|FG000|Overall Study|Physician Decision|2
2351756|NCT03812679|4100130|FG000|Overall Study|Adverse Event|2
2351757|NCT03812679|4100130|FG000|Overall Study|Missed >4 consecutive therapy days|1
2351758|NCT03812679|4100130|FG000|Overall Study|Renal transplant|1
2351759|NCT03812679|4100130|FG000|Overall Study|Withdrawal by Subject|1
2351760|NCT03812679|4100130|FG000|Overall Study|Termination of study|2
2351761|NCT03812679|4100130|FG000|Overall Study|Water device replacement|1
2351762|NCT03801148|4100185|FG000|Period 1 (2 Days)|Adverse Event|1
2351763|NCT03801148|4100186|FG001|Period 1 (2 Days)|Adverse Event|1
2351764|NCT03801148|4100187|FG002|Period 1 (2 Days)|Adverse Event|0
2351765|NCT03801148|4100188|FG003|Period 1 (2 Days)|Adverse Event|0
2351766|NCT03801148|4100185|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2351767|NCT03801148|4100186|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2351768|NCT03801148|4100187|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2351769|NCT03801148|4100188|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1
2351770|NCT03801148|4100185|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2351771|NCT03801148|4100186|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2351772|NCT03801148|4100187|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2351773|NCT03801148|4100188|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2351774|NCT03801148|4100185|FG000|Follow-Up (12 Days)|Lost to Follow-up|0
2351775|NCT03801148|4100186|FG001|Follow-Up (12 Days)|Lost to Follow-up|1
2351776|NCT03801148|4100187|FG002|Follow-Up (12 Days)|Lost to Follow-up|1
2351777|NCT03801148|4100188|FG003|Follow-Up (12 Days)|Lost to Follow-up|0
2351778|NCT03832322|4100204|FG000|Overall Study|Failed cecal intubation in 2nd exam|3
2351779|NCT03832322|4100205|FG001|Overall Study|Failed cecal intubation in 2nd exam|1
2351780|NCT03832387|4100215|FG000|Overall Study|Protocol Violation|2
2351781|NCT03832387|4100216|FG001|Overall Study|Protocol Violation|6
2351782|NCT03832387|4100215|FG000|Overall Study|EXCLUSION CRITERIA|3
2351783|NCT03832387|4100216|FG001|Overall Study|EXCLUSION CRITERIA|1
2351784|NCT03807739|4100239|FG000|Overall Study|Adverse Event|1
2351785|NCT03807739|4100240|FG001|Overall Study|Adverse Event|0
2273784|NCT02290925|3954523|FG001|First Period of Three Months|Death|0
2273785|NCT02290925|3954522|FG000|First Period of Three Months|Insulin Started|1
2273786|NCT02290925|3954523|FG001|First Period of Three Months|Insulin Started|1
2273787|NCT02290925|3954522|FG000|Second Period of 3 Months|Lost to Follow-up|1
2273788|NCT02290925|3954523|FG001|Second Period of 3 Months|Lost to Follow-up|3
2273789|NCT02290925|3954522|FG000|Second Period of 3 Months|insulin started|0
2273790|NCT02290925|3954523|FG001|Second Period of 3 Months|insulin started|1
2273791|NCT02291029|3954547|FG000|Overall Study|Withdrawal by Subject|0
2273792|NCT02291029|3954548|FG001|Overall Study|Withdrawal by Subject|0
2273793|NCT02291029|3954549|FG002|Overall Study|Withdrawal by Subject|1
2273794|NCT02291029|3954550|FG003|Overall Study|Withdrawal by Subject|0
2273795|NCT02291029|3954551|FG004|Overall Study|Withdrawal by Subject|0
2273796|NCT02291029|3954552|FG005|Overall Study|Withdrawal by Subject|0
2273797|NCT02291029|3954547|FG000|Overall Study|Adverse Event|0
2273798|NCT02291029|3954548|FG001|Overall Study|Adverse Event|1
2273799|NCT02291029|3954549|FG002|Overall Study|Adverse Event|0
2273800|NCT02291029|3954550|FG003|Overall Study|Adverse Event|0
2273801|NCT02291029|3954551|FG004|Overall Study|Adverse Event|0
2273802|NCT02291029|3954552|FG005|Overall Study|Adverse Event|0
2273803|NCT02291237|3954572|FG000|Overall Study|Study Terminated by Sponsor|72
2273804|NCT02291237|3954573|FG001|Overall Study|Study Terminated by Sponsor|67
2273805|NCT02291237|3954572|FG000|Overall Study|Adverse Event|1
2273806|NCT02291237|3954573|FG001|Overall Study|Adverse Event|3
2273807|NCT02291237|3954572|FG000|Overall Study|Investigator's Discretion|0
2273808|NCT02291237|3954573|FG001|Overall Study|Investigator's Discretion|3
2273809|NCT02291237|3954572|FG000|Overall Study|Withdrew Consent|11
2273810|NCT02291237|3954573|FG001|Overall Study|Withdrew Consent|11
2273811|NCT02291237|3954572|FG000|Overall Study|Lost to Follow-up|0
2273812|NCT02291237|3954573|FG001|Overall Study|Lost to Follow-up|2
2273813|NCT02291237|3954572|FG000|Overall Study|Subject Required Prohibited Medication|2
2273814|NCT02291237|3954573|FG001|Overall Study|Subject Required Prohibited Medication|0
2273815|NCT02291289|3954583|FG000|Induction Treatment|Not Dosed|2
2273816|NCT02291289|3954584|FG001|Induction Treatment|Not Dosed|0
2273817|NCT02291289|3954585|FG002|Induction Treatment|Not Dosed|0
2273818|NCT02291289|3954586|FG003|Induction Treatment|Not Dosed|9
2273819|NCT02291289|3954587|FG004|Induction Treatment|Not Dosed|0
2351786|NCT03807739|4100241|FG002|Overall Study|Adverse Event|0
2351787|NCT03807739|4100242|FG003|Overall Study|Adverse Event|0
2351788|NCT03807739|4100239|FG000|Overall Study|Withdrawal by Subject|1
2351789|NCT03807739|4100240|FG001|Overall Study|Withdrawal by Subject|0
2351790|NCT03807739|4100241|FG002|Overall Study|Withdrawal by Subject|0
2351791|NCT03807739|4100242|FG003|Overall Study|Withdrawal by Subject|0
2351792|NCT03831282|4100252|FG000|Overall Study|Could not place sensor|1
2351793|NCT03824912|4100259|FG000|Overall Study|Lost to Follow-up|18
2351794|NCT03824912|4100260|FG001|Overall Study|Lost to Follow-up|15
2351795|NCT03824912|4100261|FG002|Overall Study|Lost to Follow-up|8
2351796|NCT03824912|4100259|FG000|Overall Study|Negative Baseline Culture Result|118
2351797|NCT03824912|4100260|FG001|Overall Study|Negative Baseline Culture Result|112
2351798|NCT03824912|4100261|FG002|Overall Study|Negative Baseline Culture Result|57
2351799|NCT03824912|4100259|FG000|Overall Study|Non-Compliance with Study Drug|0
2351800|NCT03824912|4100260|FG001|Overall Study|Non-Compliance with Study Drug|0
2351801|NCT03824912|4100261|FG002|Overall Study|Non-Compliance with Study Drug|1
2351802|NCT03824912|4100259|FG000|Overall Study|Protocol Violation|1
2351803|NCT03824912|4100260|FG001|Overall Study|Protocol Violation|4
2351804|NCT03824912|4100261|FG002|Overall Study|Protocol Violation|1
2351805|NCT03824912|4100259|FG000|Overall Study|Withdrawal by Subject|3
2351806|NCT03824912|4100260|FG001|Overall Study|Withdrawal by Subject|2
2351807|NCT03824912|4100261|FG002|Overall Study|Withdrawal by Subject|1
2351808|NCT03824912|4100259|FG000|Overall Study|Participation in another study|0
2351809|NCT03824912|4100260|FG001|Overall Study|Participation in another study|1
2351810|NCT03824912|4100261|FG002|Overall Study|Participation in another study|0
2351811|NCT03822884|4100275|FG000|Overall Study|Withdrawal by Subject|0
2351812|NCT03822884|4100276|FG001|Overall Study|Withdrawal by Subject|0
2351813|NCT03822884|4100277|FG002|Overall Study|Withdrawal by Subject|0
2351814|NCT03822884|4100278|FG003|Overall Study|Withdrawal by Subject|0
2351815|NCT03822884|4100279|FG004|Overall Study|Withdrawal by Subject|1
2351816|NCT03822884|4100280|FG005|Overall Study|Withdrawal by Subject|0
2351817|NCT03810014|4100296|FG000|Overall Study|Pregnancy|2
2351818|NCT03810014|4100297|FG001|Overall Study|Pregnancy|2
2351819|NCT03810014|4100298|FG002|Overall Study|Pregnancy|0
2351820|NCT03810014|4100299|FG003|Overall Study|Pregnancy|2
2351821|NCT03830892|4100324|FG000|Overall Study|Physician Decision|2
2351822|NCT03830892|4100325|FG001|Overall Study|Physician Decision|3
2351823|NCT03830892|4100324|FG000|Overall Study|Study terminated due to COVID|4
2351824|NCT03830892|4100325|FG001|Overall Study|Study terminated due to COVID|0
2351825|NCT03830892|4100324|FG000|Overall Study|Protocol Violation|0
2351826|NCT03830892|4100325|FG001|Overall Study|Protocol Violation|1
2351827|NCT03830892|4100324|FG000|Overall Study|Withdrawal by Subject|0
2351828|NCT03830892|4100325|FG001|Overall Study|Withdrawal by Subject|2
2351829|NCT03825042|4100337|FG000|Overall Study|Adverse Event|1
2351830|NCT03825042|4100338|FG001|Overall Study|Adverse Event|0
2351831|NCT03825042|4100337|FG000|Overall Study|Withdrawal by Subject|1
2351832|NCT03825042|4100338|FG001|Overall Study|Withdrawal by Subject|0
2351833|NCT03823378|4100350|FG000|Overall Study|Adverse Event|2
2351834|NCT03823378|4100351|FG001|Overall Study|Adverse Event|2
2351835|NCT03823378|4100352|FG002|Overall Study|Adverse Event|0
2351836|NCT03823378|4100353|FG003|Overall Study|Adverse Event|0
2351837|NCT03823378|4100354|FG004|Overall Study|Adverse Event|0
2351838|NCT03823378|4100355|FG005|Overall Study|Adverse Event|0
2351839|NCT03823378|4100350|FG000|Overall Study|Lost to Follow-up|0
2351840|NCT03823378|4100351|FG001|Overall Study|Lost to Follow-up|1
2351841|NCT03823378|4100352|FG002|Overall Study|Lost to Follow-up|0
2351842|NCT03823378|4100353|FG003|Overall Study|Lost to Follow-up|0
2351843|NCT03823378|4100354|FG004|Overall Study|Lost to Follow-up|1
2351844|NCT03823378|4100355|FG005|Overall Study|Lost to Follow-up|0
2351845|NCT03823378|4100350|FG000|Overall Study|Withdrawal by Subject|0
2351846|NCT03823378|4100351|FG001|Overall Study|Withdrawal by Subject|1
2351847|NCT03823378|4100352|FG002|Overall Study|Withdrawal by Subject|4
2351848|NCT03823378|4100353|FG003|Overall Study|Withdrawal by Subject|2
2351849|NCT03823378|4100354|FG004|Overall Study|Withdrawal by Subject|0
2351850|NCT03823378|4100355|FG005|Overall Study|Withdrawal by Subject|1
2351851|NCT03823378|4100350|FG000|Overall Study|Other, not specified|19
2351852|NCT03823378|4100351|FG001|Overall Study|Other, not specified|12
2351853|NCT03823378|4100352|FG002|Overall Study|Other, not specified|6
2351854|NCT03823378|4100353|FG003|Overall Study|Other, not specified|8
2351855|NCT03823378|4100354|FG004|Overall Study|Other, not specified|17
2351856|NCT03823378|4100355|FG005|Overall Study|Other, not specified|7
2351857|NCT03831191|4100373|FG000|Induction Period (16 Weeks)|Adverse Event|2
2351858|NCT03831191|4100374|FG001|Induction Period (16 Weeks)|Adverse Event|1
2351859|NCT03831191|4100375|FG002|Induction Period (16 Weeks)|Adverse Event|3
2351860|NCT03831191|4100376|FG003|Induction Period (16 Weeks)|Adverse Event|4
2351861|NCT03831191|4100377|FG004|Induction Period (16 Weeks)|Adverse Event|0
2351862|NCT03831191|4100378|FG005|Induction Period (16 Weeks)|Adverse Event|0
2351863|NCT03831191|4100379|FG006|Induction Period (16 Weeks)|Adverse Event|0
2351864|NCT03831191|4100380|FG007|Induction Period (16 Weeks)|Adverse Event|0
2351865|NCT03831191|4100381|FG008|Induction Period (16 Weeks)|Adverse Event|0
2351866|NCT03831191|4100382|FG009|Induction Period (16 Weeks)|Adverse Event|0
2351867|NCT03831191|4100383|FG010|Induction Period (16 Weeks)|Adverse Event|0
2351868|NCT03831191|4100384|FG011|Induction Period (16 Weeks)|Adverse Event|0
2351869|NCT03831191|4100385|FG012|Induction Period (16 Weeks)|Adverse Event|0
2351870|NCT03831191|4100386|FG013|Induction Period (16 Weeks)|Adverse Event|0
2351871|NCT03831191|4100387|FG014|Induction Period (16 Weeks)|Adverse Event|0
2351872|NCT03831191|4100373|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2
2351873|NCT03831191|4100374|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3
2351874|NCT03831191|4100375|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
2351875|NCT03831191|4100376|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
2351876|NCT03831191|4100377|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
2351877|NCT03831191|4100378|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
2351878|NCT03831191|4100379|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
2351879|NCT03831191|4100380|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
2351880|NCT03831191|4100381|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0
2351881|NCT03831191|4100382|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0
2351882|NCT03831191|4100383|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0
2351883|NCT03831191|4100384|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0
2351884|NCT03831191|4100385|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0
2351885|NCT03831191|4100386|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0
2351886|NCT03831191|4100387|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0
2351887|NCT03831191|4100373|FG000|Induction Period (16 Weeks)|Pregnancy|0
2351888|NCT03831191|4100374|FG001|Induction Period (16 Weeks)|Pregnancy|0
2351889|NCT03831191|4100375|FG002|Induction Period (16 Weeks)|Pregnancy|1
2351890|NCT03831191|4100376|FG003|Induction Period (16 Weeks)|Pregnancy|0
2351891|NCT03831191|4100377|FG004|Induction Period (16 Weeks)|Pregnancy|0
2351892|NCT03831191|4100378|FG005|Induction Period (16 Weeks)|Pregnancy|0
2351893|NCT03831191|4100379|FG006|Induction Period (16 Weeks)|Pregnancy|0
2351894|NCT03831191|4100380|FG007|Induction Period (16 Weeks)|Pregnancy|0
2351895|NCT03831191|4100381|FG008|Induction Period (16 Weeks)|Pregnancy|0
2351896|NCT03831191|4100382|FG009|Induction Period (16 Weeks)|Pregnancy|0
2351897|NCT03831191|4100383|FG010|Induction Period (16 Weeks)|Pregnancy|0
2351898|NCT03831191|4100384|FG011|Induction Period (16 Weeks)|Pregnancy|0
2351899|NCT03831191|4100385|FG012|Induction Period (16 Weeks)|Pregnancy|0
2351900|NCT03831191|4100386|FG013|Induction Period (16 Weeks)|Pregnancy|0
2351901|NCT03831191|4100387|FG014|Induction Period (16 Weeks)|Pregnancy|0
2351902|NCT03831191|4100373|FG000|Induction Period (16 Weeks)|Protocol Violation|0
2351903|NCT03831191|4100374|FG001|Induction Period (16 Weeks)|Protocol Violation|0
2351904|NCT03831191|4100375|FG002|Induction Period (16 Weeks)|Protocol Violation|0
2351905|NCT03831191|4100376|FG003|Induction Period (16 Weeks)|Protocol Violation|2
2351906|NCT03831191|4100377|FG004|Induction Period (16 Weeks)|Protocol Violation|0
2351907|NCT03831191|4100378|FG005|Induction Period (16 Weeks)|Protocol Violation|0
2351908|NCT03831191|4100379|FG006|Induction Period (16 Weeks)|Protocol Violation|0
2351909|NCT03831191|4100380|FG007|Induction Period (16 Weeks)|Protocol Violation|0
2351910|NCT03831191|4100381|FG008|Induction Period (16 Weeks)|Protocol Violation|0
2351911|NCT03831191|4100382|FG009|Induction Period (16 Weeks)|Protocol Violation|0
2351912|NCT03831191|4100383|FG010|Induction Period (16 Weeks)|Protocol Violation|0
2351913|NCT03831191|4100384|FG011|Induction Period (16 Weeks)|Protocol Violation|0
2351914|NCT03831191|4100385|FG012|Induction Period (16 Weeks)|Protocol Violation|0
2351915|NCT03831191|4100386|FG013|Induction Period (16 Weeks)|Protocol Violation|0
2351916|NCT03831191|4100387|FG014|Induction Period (16 Weeks)|Protocol Violation|0
2351917|NCT03831191|4100373|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7
2351918|NCT03831191|4100374|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2
2351919|NCT03831191|4100375|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1
2351920|NCT03831191|4100376|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3
2351921|NCT03831191|4100377|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
2351922|NCT03831191|4100378|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
2351923|NCT03831191|4100379|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
2351924|NCT03831191|4100380|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
2351925|NCT03831191|4100381|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
2351926|NCT03831191|4100382|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
2351927|NCT03831191|4100383|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
2351928|NCT03831191|4100384|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0
2351929|NCT03831191|4100385|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0
2351930|NCT03831191|4100386|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0
2351931|NCT03831191|4100387|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0
2351932|NCT03831191|4100373|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12
2351933|NCT03831191|4100374|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15
2351934|NCT03831191|4100375|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16
2351935|NCT03831191|4100376|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13
2351936|NCT03831191|4100377|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
2351937|NCT03831191|4100378|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
2351938|NCT03831191|4100379|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
2351939|NCT03831191|4100380|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
2351940|NCT03831191|4100381|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
2351941|NCT03831191|4100382|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
2351942|NCT03831191|4100383|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
2351943|NCT03831191|4100384|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
2351944|NCT03831191|4100385|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
2351945|NCT03831191|4100386|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
2351946|NCT03831191|4100387|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
2351947|NCT03831191|4100373|FG000|Induction Period (16 Weeks)|Sponsor Decision|0
2351948|NCT03831191|4100374|FG001|Induction Period (16 Weeks)|Sponsor Decision|0
2351949|NCT03831191|4100375|FG002|Induction Period (16 Weeks)|Sponsor Decision|0
2351950|NCT03831191|4100376|FG003|Induction Period (16 Weeks)|Sponsor Decision|1
2351951|NCT03831191|4100377|FG004|Induction Period (16 Weeks)|Sponsor Decision|0
2351952|NCT03831191|4100378|FG005|Induction Period (16 Weeks)|Sponsor Decision|0
2351953|NCT03831191|4100379|FG006|Induction Period (16 Weeks)|Sponsor Decision|0
2351954|NCT03831191|4100380|FG007|Induction Period (16 Weeks)|Sponsor Decision|0
2351955|NCT03831191|4100381|FG008|Induction Period (16 Weeks)|Sponsor Decision|0
2351956|NCT03831191|4100382|FG009|Induction Period (16 Weeks)|Sponsor Decision|0
2351957|NCT03831191|4100383|FG010|Induction Period (16 Weeks)|Sponsor Decision|0
2351958|NCT03831191|4100384|FG011|Induction Period (16 Weeks)|Sponsor Decision|0
2351959|NCT03831191|4100385|FG012|Induction Period (16 Weeks)|Sponsor Decision|0
2351960|NCT03831191|4100386|FG013|Induction Period (16 Weeks)|Sponsor Decision|0
2351961|NCT03831191|4100387|FG014|Induction Period (16 Weeks)|Sponsor Decision|0
2351962|NCT03831191|4100373|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
2351963|NCT03831191|4100374|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
2351964|NCT03831191|4100375|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
2351965|NCT03831191|4100376|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
2351966|NCT03831191|4100377|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
2351967|NCT03831191|4100378|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5
2351968|NCT03831191|4100379|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2
2351969|NCT03831191|4100380|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
2351970|NCT03831191|4100381|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8
2351971|NCT03831191|4100382|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
2351972|NCT03831191|4100383|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
2351973|NCT03831191|4100384|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7
2351974|NCT03831191|4100385|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
2351975|NCT03831191|4100386|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
2351976|NCT03831191|4100387|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6
2351977|NCT03831191|4100373|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351978|NCT03831191|4100374|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351979|NCT03831191|4100375|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351980|NCT03831191|4100376|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351981|NCT03831191|4100377|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351982|NCT03831191|4100378|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351983|NCT03831191|4100379|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351984|NCT03831191|4100380|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351985|NCT03831191|4100381|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351986|NCT03831191|4100382|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351987|NCT03831191|4100383|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351988|NCT03831191|4100384|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351989|NCT03831191|4100385|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2351990|NCT03831191|4100386|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
2273820|NCT02291289|3954588|FG005|Induction Treatment|Not Dosed|0
2273821|NCT02291289|3954589|FG006|Induction Treatment|Not Dosed|0
2273822|NCT02291289|3954590|FG007|Induction Treatment|Not Dosed|0
2273823|NCT02291289|3954591|FG008|Induction Treatment|Not Dosed|0
2273824|NCT02291289|3954592|FG009|Induction Treatment|Not Dosed|1
2273825|NCT02291289|3954593|FG010|Induction Treatment|Not Dosed|0
2273826|NCT02291289|3954594|FG011|Induction Treatment|Not Dosed|0
2273827|NCT02291289|3954583|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
2273828|NCT02291289|3954584|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0
2273829|NCT02291289|3954585|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0
2273830|NCT02291289|3954586|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0
2351991|NCT03831191|4100387|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
2351992|NCT03831191|4100373|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2351993|NCT03831191|4100374|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2351994|NCT03831191|4100375|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2351995|NCT03831191|4100376|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2351996|NCT03831191|4100377|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2351997|NCT03831191|4100378|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2351998|NCT03831191|4100379|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2351999|NCT03831191|4100380|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2352000|NCT03831191|4100381|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2352001|NCT03831191|4100382|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2352002|NCT03831191|4100383|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2352003|NCT03831191|4100384|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2352004|NCT03831191|4100385|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2352005|NCT03831191|4100386|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0
2352006|NCT03831191|4100387|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1
2352007|NCT03830281|4100422|FG000|Lead-in Period (2 Weeks)|Adverse Event|2
2352008|NCT03830281|4100423|FG001|Lead-in Period (2 Weeks)|Adverse Event|0
2352009|NCT03830281|4100422|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6
2352010|NCT03830281|4100423|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0
2352011|NCT03830281|4100422|FG000|Lead-in Period (2 Weeks)|Physician Decision|2
2352012|NCT03830281|4100423|FG001|Lead-in Period (2 Weeks)|Physician Decision|0
2352013|NCT03830281|4100422|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29
2352014|NCT03830281|4100423|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0
2352015|NCT03830281|4100422|FG000|Treatment Period (16 Weeks)|Adverse Event|1
2352016|NCT03830281|4100423|FG001|Treatment Period (16 Weeks)|Adverse Event|7
2352017|NCT03830281|4100422|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4
2352018|NCT03830281|4100423|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3
2352019|NCT03830281|4100422|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1
2352020|NCT03830281|4100423|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1
2352021|NCT03830281|4100422|FG000|Treatment Period (16 Weeks)|Physician Decision|1
2352022|NCT03830281|4100423|FG001|Treatment Period (16 Weeks)|Physician Decision|0
2352023|NCT03830281|4100422|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5
2352024|NCT03830281|4100423|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6
2352025|NCT03827395|4100439|FG000|Overall Study|Lost to Follow-up|1
2352026|NCT03827395|4100440|FG001|Overall Study|Lost to Follow-up|0
2352027|NCT03827395|4100439|FG000|Overall Study|Protocol Violation|1
2352028|NCT03827395|4100440|FG001|Overall Study|Protocol Violation|0
2352029|NCT03827395|4100439|FG000|Overall Study|Became ineligible after enrollment|1
2352030|NCT03827395|4100440|FG001|Overall Study|Became ineligible after enrollment|2
2352031|NCT03819218|4100446|FG000|Overall Study|Protocol Violation|1
2352032|NCT03828487|4100459|FG000|Overall Study|Physician Decision|1
2352033|NCT03828617|4100467|FG000|Overall Study|Lost to Follow-up|22
2352034|NCT03828617|4100468|FG001|Overall Study|Lost to Follow-up|12
2352035|NCT03828617|4100469|FG002|Overall Study|Lost to Follow-up|23
2352036|NCT03828617|4100470|FG003|Overall Study|Lost to Follow-up|7
2352037|NCT03828617|4100467|FG000|Overall Study|No longer met eligibility criteria|0
2352038|NCT03828617|4100468|FG001|Overall Study|No longer met eligibility criteria|1
2352039|NCT03828617|4100469|FG002|Overall Study|No longer met eligibility criteria|1
2352040|NCT03828617|4100470|FG003|Overall Study|No longer met eligibility criteria|3
2352041|NCT03828617|4100467|FG000|Overall Study|Protocol Violation|0
2352042|NCT03828617|4100468|FG001|Overall Study|Protocol Violation|2
2352043|NCT03828617|4100469|FG002|Overall Study|Protocol Violation|0
2352044|NCT03828617|4100470|FG003|Overall Study|Protocol Violation|0
2352045|NCT03828617|4100467|FG000|Overall Study|Withdrawal by Subject|2
2352046|NCT03828617|4100468|FG001|Overall Study|Withdrawal by Subject|0
2352047|NCT03828617|4100469|FG002|Overall Study|Withdrawal by Subject|2
2352048|NCT03828617|4100470|FG003|Overall Study|Withdrawal by Subject|0
2352049|NCT03828539|4100481|FG000|Overall Study|Adverse Event|3
2352050|NCT03828539|4100482|FG001|Overall Study|Adverse Event|12
2352051|NCT03828539|4100481|FG000|Overall Study|Patient's/guardian's decision|3
2352052|NCT03828539|4100482|FG001|Overall Study|Patient's/guardian's decision|5
2352053|NCT03828539|4100481|FG000|Overall Study|Lost to Follow-up|4
2352054|NCT03828539|4100482|FG001|Overall Study|Lost to Follow-up|2
2352055|NCT03828539|4100481|FG000|Overall Study|Protocol Violation|3
2352056|NCT03828539|4100482|FG001|Overall Study|Protocol Violation|2
2352057|NCT03828539|4100481|FG000|Overall Study|Withdrawal of informed consent|2
2352058|NCT03828539|4100482|FG001|Overall Study|Withdrawal of informed consent|1
2352059|NCT03828539|4100481|FG000|Overall Study|New therapy for study indication|1
2352060|NCT03828539|4100482|FG001|Overall Study|New therapy for study indication|0
2352061|NCT03824704|4100488|FG000|Overall Study|Study Terminated by Sponsor|1
2352062|NCT03817879|4100503|FG000|Overall Study|Drop out|5
2352063|NCT03817879|4100504|FG001|Overall Study|Drop out|12
2352064|NCT03817879|4100503|FG000|Overall Study|Withdrawal by Subject|0
2352065|NCT03817879|4100504|FG001|Overall Study|Withdrawal by Subject|1
2352066|NCT03811834|4100510|FG000|Period 1 ( 7 Days)|Adverse Event|1
2352067|NCT03806127|4100525|FG000|Overall Study|Withdrawal by Subject|4
2352068|NCT03806127|4100526|FG001|Overall Study|Withdrawal by Subject|5
2352069|NCT03806127|4100525|FG000|Overall Study|Protocol Violation|3
2352070|NCT03806127|4100526|FG001|Overall Study|Protocol Violation|1
2352071|NCT03806127|4100525|FG000|Overall Study|Adverse Event|3
2352072|NCT03806127|4100526|FG001|Overall Study|Adverse Event|0
2352073|NCT03806127|4100525|FG000|Overall Study|Unable to Complete Procedures|0
2352074|NCT03806127|4100526|FG001|Overall Study|Unable to Complete Procedures|1
2352075|NCT03806127|4100525|FG000|Overall Study|Pregnancy|0
2352076|NCT03806127|4100526|FG001|Overall Study|Pregnancy|1
2352077|NCT03806127|4100525|FG000|Overall Study|Lost to Follow-up|5
2352078|NCT03806127|4100526|FG001|Overall Study|Lost to Follow-up|1
2352079|NCT03806127|4100525|FG000|Overall Study|Physician Decision|1
2352080|NCT03806127|4100526|FG001|Overall Study|Physician Decision|1
2352081|NCT03806127|4100525|FG000|Overall Study|Could Not Come Due to Covid|1
2352082|NCT03806127|4100526|FG001|Overall Study|Could Not Come Due to Covid|0
2352083|NCT03806127|4100525|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1
2352084|NCT03806127|4100526|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0
2352085|NCT03806127|4100525|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1
2352086|NCT03806127|4100526|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0
2352087|NCT03806127|4100525|FG000|Overall Study|Covid 19 Restrictions|2
2352088|NCT03806127|4100526|FG001|Overall Study|Covid 19 Restrictions|0
2352089|NCT03806127|4100525|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0
2352090|NCT03806127|4100526|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1
2352091|NCT03806127|4100525|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0
2352092|NCT03806127|4100526|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1
2352093|NCT03827473|4100534|FG000|Overall Study|Withdrawal by Subject|1
2352094|NCT03827473|4100535|FG001|Overall Study|Withdrawal by Subject|0
2352095|NCT03826914|4100543|FG000|Overall Study|Withdrawal by Subject|1
2352096|NCT03826914|4100544|FG001|Overall Study|Withdrawal by Subject|1
2352097|NCT03808688|4100567|FG000|Overall Study|Adverse Event|13
2352098|NCT03808688|4100568|FG001|Overall Study|Adverse Event|17
2352099|NCT03808688|4100567|FG000|Overall Study|Lack of Efficacy|2
2352100|NCT03808688|4100568|FG001|Overall Study|Lack of Efficacy|0
2352101|NCT03808688|4100567|FG000|Overall Study|Lost to Follow-up|0
2352102|NCT03808688|4100568|FG001|Overall Study|Lost to Follow-up|2
2352103|NCT03808688|4100567|FG000|Overall Study|Withdrawal by Subject|1
2352104|NCT03808688|4100568|FG001|Overall Study|Withdrawal by Subject|0
2352105|NCT03808688|4100567|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1
2352106|NCT03808688|4100568|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0
2352107|NCT03808688|4100567|FG000|Overall Study|IOP Too High|1
2352108|NCT03808688|4100568|FG001|Overall Study|IOP Too High|1
2352109|NCT03808688|4100567|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0
2352110|NCT03808688|4100568|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1
2352111|NCT03808688|4100567|FG000|Overall Study|Visit Out of Window|0
2352112|NCT03808688|4100568|FG001|Overall Study|Visit Out of Window|1
2352113|NCT03808688|4100567|FG000|Overall Study|Medication Non-Compliance|0
2352114|NCT03808688|4100568|FG001|Overall Study|Medication Non-Compliance|1
2352115|NCT03811093|4100578|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
2352116|NCT03811093|4100579|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
2352117|NCT03811093|4100578|FG000|Overall Study|Unable to measure body fat percentage|2
2352118|NCT03811093|4100579|FG001|Overall Study|Unable to measure body fat percentage|0
2352119|NCT03822182|4100591|FG000|Overall Study|Protocol Violation|0
2352120|NCT03822182|4100592|FG001|Overall Study|Protocol Violation|1
2352121|NCT03822182|4100593|FG002|Overall Study|Protocol Violation|1
2352122|NCT03822416|4100604|FG000|Overall Study|Lost to Follow-up|1
2352123|NCT03822416|4100605|FG001|Overall Study|Lost to Follow-up|0
2352124|NCT03822416|4100604|FG000|Overall Study|Withdrawal by Subject|0
2352125|NCT03822416|4100605|FG001|Overall Study|Withdrawal by Subject|1
2352126|NCT03809104|4100611|FG000|Overall Study|Withdrawal by Subject|3
2352127|NCT03806231|4100626|FG000|Overall Study|Physician Decision|1
2352128|NCT03806231|4100627|FG001|Overall Study|Physician Decision|0
2352129|NCT03806231|4100626|FG000|Overall Study|Withdrawal by Subject|1
2352130|NCT03806231|4100627|FG001|Overall Study|Withdrawal by Subject|0
2352131|NCT03804710|4100635|FG000|Overall Study|Adverse Event|0
2352132|NCT03804710|4100636|FG001|Overall Study|Adverse Event|3
2352133|NCT03804710|4100635|FG000|Overall Study|Withdrawal by Subject|2
2352134|NCT03804710|4100636|FG001|Overall Study|Withdrawal by Subject|1
2352135|NCT03804710|4100635|FG000|Overall Study|Other|0
2352136|NCT03804710|4100636|FG001|Overall Study|Other|1
2352137|NCT03821064|4100680|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1
2352138|NCT03820024|4100695|FG000|Overall Study|Physician Decision|1
2352139|NCT03820024|4100696|FG001|Overall Study|Physician Decision|2
2352140|NCT03816761|4100721|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0
2352141|NCT03816761|4100722|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0
2352142|NCT03816761|4100723|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0
2352143|NCT03816761|4100724|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0
2352144|NCT03816761|4100725|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0
2352145|NCT03816761|4100726|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1
2352146|NCT03816761|4100721|FG000|Second Treatment Period (7 Days)|Unclassified|0
2352147|NCT03816761|4100722|FG001|Second Treatment Period (7 Days)|Unclassified|0
2352148|NCT03816761|4100723|FG002|Second Treatment Period (7 Days)|Unclassified|0
2352149|NCT03816761|4100724|FG003|Second Treatment Period (7 Days)|Unclassified|1
2352150|NCT03816761|4100725|FG004|Second Treatment Period (7 Days)|Unclassified|0
2352151|NCT03816761|4100726|FG005|Second Treatment Period (7 Days)|Unclassified|0
2352152|NCT03812510|4100791|FG000|Overall Study|Lost to Follow-up|39
2352153|NCT03812510|4100791|FG000|Overall Study|Withdrawal by Subject|42
2352154|NCT03812510|4100791|FG000|Overall Study|Physician Decision|2
2352155|NCT03812510|4100791|FG000|Overall Study|Study Terminated by Sponsor|9
2352156|NCT03812510|4100791|FG000|Overall Study|Did Not Start Study Medication|55
2352157|NCT03812510|4100791|FG000|Overall Study|Adverse Event|5
2352158|NCT03802994|4100801|FG000|Overall Study|Lost to Follow-up|0
2352159|NCT03802994|4100802|FG001|Overall Study|Lost to Follow-up|2
2352160|NCT03802994|4100803|FG002|Overall Study|Lost to Follow-up|3
2352161|NCT03802994|4100804|FG003|Overall Study|Lost to Follow-up|2
2352162|NCT03802994|4100805|FG004|Overall Study|Lost to Follow-up|2
2352163|NCT03810183|4100830|FG000|Overall Study|Study terminated by Sponsor|2
2352164|NCT03810183|4100831|FG001|Overall Study|Study terminated by Sponsor|1
2352165|NCT03809611|4100860|FG000|Overall Study|Withdrawal by Subject|1
2352166|NCT03809611|4100861|FG001|Overall Study|Withdrawal by Subject|1
2352167|NCT03805971|4100881|FG000|Overall Study|Withdrawal by Subject|1
2352168|NCT03805971|4100881|FG000|Overall Study|Protocol Violation|2
2352169|NCT03802916|4100888|FG000|Overall Study|Adverse Event|0
2352170|NCT03802916|4100889|FG001|Overall Study|Adverse Event|1
2352171|NCT03802916|4100888|FG000|Overall Study|Withdrawal by Subject|0
2352172|NCT03802916|4100889|FG001|Overall Study|Withdrawal by Subject|1
2352173|NCT03809039|4100906|FG000|Part 1|Withdrawal by Subject|1
2352174|NCT03809039|4100907|FG001|Part 1|Withdrawal by Subject|0
2352175|NCT03809039|4100908|FG002|Part 1|Withdrawal by Subject|0
2352176|NCT03809039|4100909|FG003|Part 1|Withdrawal by Subject|1
2352177|NCT03809039|4100910|FG004|Part 1|Withdrawal by Subject|0
2352178|NCT03809039|4100911|FG005|Part 1|Withdrawal by Subject|0
2352179|NCT03809039|4100912|FG006|Part 1|Withdrawal by Subject|0
2352180|NCT03809039|4100913|FG007|Part 1|Withdrawal by Subject|0
2352181|NCT03809039|4100914|FG008|Part 1|Withdrawal by Subject|0
2352182|NCT03809039|4100906|FG000|Part 3|Withdrawn by study termination|0
2352183|NCT03809039|4100907|FG001|Part 3|Withdrawn by study termination|0
2352184|NCT03809039|4100908|FG002|Part 3|Withdrawn by study termination|0
2352185|NCT03809039|4100909|FG003|Part 3|Withdrawn by study termination|0
2352186|NCT03809039|4100910|FG004|Part 3|Withdrawn by study termination|0
2352187|NCT03809039|4100911|FG005|Part 3|Withdrawn by study termination|0
2352188|NCT03809039|4100912|FG006|Part 3|Withdrawn by study termination|0
2352189|NCT03809039|4100913|FG007|Part 3|Withdrawn by study termination|2
2352190|NCT03809039|4100914|FG008|Part 3|Withdrawn by study termination|6
2352191|NCT03807700|4100949|FG000|Overall Study|Withdrawal by Subject|2
2352192|NCT03807700|4100950|FG001|Overall Study|Withdrawal by Subject|1
2352193|NCT03804918|4100957|FG000|Overall Study|Participant did not use the app|1
2352194|NCT03803475|4100973|FG000|Overall Study|Physician Decision|1
2352195|NCT03801928|4101026|FG000|Overall Study|Adverse Event|1
2352196|NCT03801928|4101027|FG001|Overall Study|Adverse Event|0
2352197|NCT03801928|4101028|FG002|Overall Study|Adverse Event|1
2352198|NCT03801928|4101029|FG003|Overall Study|Adverse Event|2
2352199|NCT03801928|4101030|FG004|Overall Study|Adverse Event|0
2352200|NCT03801928|4101031|FG005|Overall Study|Adverse Event|2
2352201|NCT03801928|4101026|FG000|Overall Study|Lack of Efficacy|0
2352202|NCT03801928|4101027|FG001|Overall Study|Lack of Efficacy|0
2352203|NCT03801928|4101028|FG002|Overall Study|Lack of Efficacy|1
2352204|NCT03801928|4101029|FG003|Overall Study|Lack of Efficacy|0
2352205|NCT03801928|4101030|FG004|Overall Study|Lack of Efficacy|0
2352206|NCT03801928|4101031|FG005|Overall Study|Lack of Efficacy|0
2352207|NCT03801928|4101026|FG000|Overall Study|Lost to Follow-up|5
2352208|NCT03801928|4101027|FG001|Overall Study|Lost to Follow-up|1
2352209|NCT03801928|4101028|FG002|Overall Study|Lost to Follow-up|1
2352210|NCT03801928|4101029|FG003|Overall Study|Lost to Follow-up|4
2352211|NCT03801928|4101030|FG004|Overall Study|Lost to Follow-up|4
2352212|NCT03801928|4101031|FG005|Overall Study|Lost to Follow-up|2
2352213|NCT03801928|4101026|FG000|Overall Study|Withdrawal by Subject|0
2352214|NCT03801928|4101027|FG001|Overall Study|Withdrawal by Subject|0
2352215|NCT03801928|4101028|FG002|Overall Study|Withdrawal by Subject|2
2352216|NCT03801928|4101029|FG003|Overall Study|Withdrawal by Subject|1
2352217|NCT03801928|4101030|FG004|Overall Study|Withdrawal by Subject|0
2352218|NCT03801928|4101031|FG005|Overall Study|Withdrawal by Subject|0
2352219|NCT03801928|4101026|FG000|Overall Study|Other|0
2352220|NCT03801928|4101027|FG001|Overall Study|Other|2
2352221|NCT03801928|4101028|FG002|Overall Study|Other|0
2352222|NCT03801928|4101029|FG003|Overall Study|Other|1
2352223|NCT03801928|4101030|FG004|Overall Study|Other|0
2352224|NCT03801928|4101031|FG005|Overall Study|Other|1
2352225|NCT03800173|4101053|FG000|Overall Study|Lost to Follow-up|0
2352226|NCT03800173|4101054|FG001|Overall Study|Lost to Follow-up|0
2352227|NCT03800173|4101055|FG002|Overall Study|Lost to Follow-up|0
2352228|NCT03800173|4101056|FG003|Overall Study|Lost to Follow-up|0
2352229|NCT03800173|4101057|FG004|Overall Study|Lost to Follow-up|1
2352230|NCT03799211|4101092|FG000|Overall Study|Lost to Follow-up|2
2352231|NCT03799211|4101093|FG001|Overall Study|Lost to Follow-up|13
2352232|NCT03799211|4101092|FG000|Overall Study|Withdrawal by Subject|2
2352233|NCT03799211|4101093|FG001|Overall Study|Withdrawal by Subject|0
2352234|NCT03798717|4101107|FG000|Overall Study|Failed Screening|0
2352235|NCT03798717|4101108|FG001|Overall Study|Failed Screening|0
2352236|NCT03798717|4101109|FG002|Overall Study|Failed Screening|0
2352237|NCT03798717|4101110|FG003|Overall Study|Failed Screening|0
2352238|NCT03798717|4101111|FG004|Overall Study|Failed Screening|0
2352239|NCT03798717|4101112|FG005|Overall Study|Failed Screening|1
2352240|NCT03798717|4101107|FG000|Overall Study|Physician Decision|1
2352241|NCT03798717|4101108|FG001|Overall Study|Physician Decision|0
2352242|NCT03798717|4101109|FG002|Overall Study|Physician Decision|1
2352243|NCT03798717|4101110|FG003|Overall Study|Physician Decision|0
2352244|NCT03798717|4101111|FG004|Overall Study|Physician Decision|0
2352245|NCT03798717|4101112|FG005|Overall Study|Physician Decision|0
2352246|NCT03798717|4101107|FG000|Overall Study|Withdrawal by Subject|0
2352247|NCT03798717|4101108|FG001|Overall Study|Withdrawal by Subject|0
2352248|NCT03798717|4101109|FG002|Overall Study|Withdrawal by Subject|0
2352249|NCT03798717|4101110|FG003|Overall Study|Withdrawal by Subject|1
2352250|NCT03798717|4101111|FG004|Overall Study|Withdrawal by Subject|0
2352251|NCT03798717|4101112|FG005|Overall Study|Withdrawal by Subject|0
2352252|NCT03798717|4101107|FG000|Overall Study|Lost to Follow-up|1
2352253|NCT03798717|4101108|FG001|Overall Study|Lost to Follow-up|0
2352254|NCT03798717|4101109|FG002|Overall Study|Lost to Follow-up|0
2352255|NCT03798717|4101110|FG003|Overall Study|Lost to Follow-up|1
2352256|NCT03798717|4101111|FG004|Overall Study|Lost to Follow-up|0
2352257|NCT03798717|4101112|FG005|Overall Study|Lost to Follow-up|0
2352258|NCT03798717|4101107|FG000|Overall Study|Adverse Event|0
2352259|NCT03798717|4101108|FG001|Overall Study|Adverse Event|1
2352260|NCT03798717|4101109|FG002|Overall Study|Adverse Event|0
2352261|NCT03798717|4101110|FG003|Overall Study|Adverse Event|0
2352262|NCT03798717|4101111|FG004|Overall Study|Adverse Event|0
2352263|NCT03798717|4101112|FG005|Overall Study|Adverse Event|0
2352264|NCT03798717|4101107|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
2352265|NCT03798717|4101108|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
2352266|NCT03798717|4101109|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
2352267|NCT03798717|4101110|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
2352268|NCT03798717|4101111|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1
2352269|NCT03798717|4101112|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
2352270|NCT03798483|4101121|FG000|Overall Study|Lost to Follow-up|2
2352271|NCT03798366|4101131|FG000|Overall Study|Lost to Follow-up|0
2352272|NCT03798366|4101132|FG001|Overall Study|Lost to Follow-up|1
2352273|NCT03799952|4101140|FG000|Overall Study|Program was too easy, discontinued|1
2352274|NCT03799952|4101141|FG001|Overall Study|Program was too easy, discontinued|0
2352275|NCT03799952|4101140|FG000|Overall Study|Lost to Follow-up|0
2352276|NCT03799952|4101141|FG001|Overall Study|Lost to Follow-up|2
2352277|NCT03796728|4101175|FG000|Overall Study|Lost to Follow-up|8
2352278|NCT03796728|4101175|FG000|Overall Study|Reason not Specified|16
2352279|NCT03797144|4101181|FG000|Enrollment|Protocol Violation|4
2352280|NCT03797144|4101182|FG001|Enrollment|Protocol Violation|1
2352281|NCT03797144|4101181|FG000|Surgery|Protocol Violation|1
2352282|NCT03797144|4101182|FG001|Surgery|Protocol Violation|0
2352283|NCT03797144|4101181|FG000|3 Month|Early termination cut-off date|2
2352284|NCT03797144|4101182|FG001|3 Month|Early termination cut-off date|0
2352285|NCT03797144|4101181|FG000|12 Month|Early termination cut-off date|8
2352286|NCT03797144|4101182|FG001|12 Month|Early termination cut-off date|9
2352287|NCT03797144|4101181|FG000|24 Month|Early termination cut-off date|1
2352288|NCT03797144|4101182|FG001|24 Month|Early termination cut-off date|1
2352289|NCT03782571|4101189|FG000|Period 1|Withdrawal by Subject|1
2352290|NCT03782571|4101190|FG001|Period 1|Withdrawal by Subject|0
2352291|NCT03782571|4101191|FG002|Period 1|Withdrawal by Subject|0
2352292|NCT03782571|4101192|FG003|Period 1|Withdrawal by Subject|0
2352293|NCT03782571|4101189|FG000|Period 3|Subject Unable to Attend V5|1
2352294|NCT03782571|4101190|FG001|Period 3|Subject Unable to Attend V5|0
2352295|NCT03782571|4101191|FG002|Period 3|Subject Unable to Attend V5|0
2352296|NCT03782571|4101192|FG003|Period 3|Subject Unable to Attend V5|0
2352297|NCT03782571|4101189|FG000|Period 3|Adverse Event|1
2352298|NCT03782571|4101190|FG001|Period 3|Adverse Event|0
2352299|NCT03782571|4101191|FG002|Period 3|Adverse Event|0
2352300|NCT03782571|4101192|FG003|Period 3|Adverse Event|0
2352301|NCT03796039|4101215|FG000|Overall Study|Death|2
2352302|NCT03796039|4101216|FG001|Overall Study|Death|1
2352303|NCT03796039|4101215|FG000|Overall Study|Withdrawal by Subject|7
2352304|NCT03796039|4101216|FG001|Overall Study|Withdrawal by Subject|4
2352305|NCT03783780|4101222|FG000|Overall Study|Withdrawn prior to completion|1
2352306|NCT03780959|4101230|FG000|Part 1|Adverse Event|1
2352307|NCT03780959|4101231|FG001|Part 1|Adverse Event|0
2273831|NCT02291289|3954587|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13
2273832|NCT02291289|3954588|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11
2273833|NCT02291289|3954589|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0
2273834|NCT02291289|3954590|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0
2273835|NCT02291289|3954591|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0
2273836|NCT02291289|3954592|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0
2273837|NCT02291289|3954593|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2
2273838|NCT02291289|3954594|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3
2273839|NCT02291289|3954583|FG000|Maintenance Treatment Phase|Protocol Violation|0
2273840|NCT02291289|3954584|FG001|Maintenance Treatment Phase|Protocol Violation|1
2273841|NCT02291289|3954585|FG002|Maintenance Treatment Phase|Protocol Violation|0
2273842|NCT02291289|3954586|FG003|Maintenance Treatment Phase|Protocol Violation|0
2273843|NCT02291289|3954587|FG004|Maintenance Treatment Phase|Protocol Violation|2
2273844|NCT02291289|3954588|FG005|Maintenance Treatment Phase|Protocol Violation|1
2273845|NCT02291289|3954589|FG006|Maintenance Treatment Phase|Protocol Violation|0
2273846|NCT02291289|3954590|FG007|Maintenance Treatment Phase|Protocol Violation|0
2273847|NCT02291289|3954591|FG008|Maintenance Treatment Phase|Protocol Violation|0
2273848|NCT02291289|3954592|FG009|Maintenance Treatment Phase|Protocol Violation|0
2273849|NCT02291289|3954593|FG010|Maintenance Treatment Phase|Protocol Violation|0
2273850|NCT02291289|3954594|FG011|Maintenance Treatment Phase|Protocol Violation|0
2273851|NCT02291289|3954583|FG000|Maintenance Treatment Phase|Death|0
2273852|NCT02291289|3954584|FG001|Maintenance Treatment Phase|Death|23
2273853|NCT02291289|3954585|FG002|Maintenance Treatment Phase|Death|13
2273854|NCT02291289|3954586|FG003|Maintenance Treatment Phase|Death|0
2273855|NCT02291289|3954587|FG004|Maintenance Treatment Phase|Death|185
2273856|NCT02291289|3954588|FG005|Maintenance Treatment Phase|Death|100
2273857|NCT02291289|3954589|FG006|Maintenance Treatment Phase|Death|0
2273858|NCT02291289|3954590|FG007|Maintenance Treatment Phase|Death|1
2273859|NCT02291289|3954591|FG008|Maintenance Treatment Phase|Death|1
2273860|NCT02291289|3954592|FG009|Maintenance Treatment Phase|Death|0
2273861|NCT02291289|3954593|FG010|Maintenance Treatment Phase|Death|26
2273862|NCT02291289|3954594|FG011|Maintenance Treatment Phase|Death|11
2273863|NCT02291289|3954583|FG000|Maintenance Treatment Phase|Adverse Event|0
2273864|NCT02291289|3954584|FG001|Maintenance Treatment Phase|Adverse Event|0
2273865|NCT02291289|3954585|FG002|Maintenance Treatment Phase|Adverse Event|0
2273866|NCT02291289|3954586|FG003|Maintenance Treatment Phase|Adverse Event|0
2273867|NCT02291289|3954587|FG004|Maintenance Treatment Phase|Adverse Event|1
2273868|NCT02291289|3954588|FG005|Maintenance Treatment Phase|Adverse Event|0
2273869|NCT02291289|3954589|FG006|Maintenance Treatment Phase|Adverse Event|0
2273870|NCT02291289|3954590|FG007|Maintenance Treatment Phase|Adverse Event|0
2273871|NCT02291289|3954591|FG008|Maintenance Treatment Phase|Adverse Event|0
2273872|NCT02291289|3954592|FG009|Maintenance Treatment Phase|Adverse Event|0
2273873|NCT02291289|3954593|FG010|Maintenance Treatment Phase|Adverse Event|0
2273874|NCT02291289|3954594|FG011|Maintenance Treatment Phase|Adverse Event|0
2273875|NCT02291289|3954583|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
2273876|NCT02291289|3954584|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
2273877|NCT02291289|3954585|FG002|Maintenance Treatment Phase|Lost to Follow-up|0
2273878|NCT02291289|3954586|FG003|Maintenance Treatment Phase|Lost to Follow-up|0
2273879|NCT02291289|3954587|FG004|Maintenance Treatment Phase|Lost to Follow-up|12
2273880|NCT02291289|3954588|FG005|Maintenance Treatment Phase|Lost to Follow-up|3
